PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Xiong, XH; Rao, G; Roy, RV; Zhang, YS; Means, N; Dey, A; Tsaliki, M; Saha, S; Bhattacharyya, S; Dwivedi, SKD; Rao, CV; McCormick, DJ; Dhanasekaran, D; Ding, K; Gillies, E; Zhang, M; Yang, D; Bhattacharya, R; Mukherjee, P				Xiong, Xunhao; Rao, Geeta; Roy, Ram Vinod; Zhang, Yushan; Means, Nicolas; Dey, Anindya; Tsaliki, Martha; Saha, Sounik; Bhattacharyya, Sanjib; Dwivedi, Shailendra Kumar Dhar; Rao, Chinthalapally, V; McCormick, Daniel J.; Dhanasekaran, Danny; Ding, Kai; Gillies, Elizabeth; Zhang, Min; Yang, Da; Bhattacharya, Resham; Mukherjee, Priyabrata			Ubiquitin-binding associated protein 2 regulates KRAS activation and macropinocytosis in pancreatic cancer	FASEB JOURNAL			English	Article						KRAS; macropinocytosis; pancreatic cancer; small GTPases; therapeutic target; UBAP2	RAS; GLUTAMINE; ANTIBODY; BIOLOGY; GROWTH	Macropinocytosis supports the metabolic requirement of RAS-transformed pancreatic ductal adenocarcinoma cells (PDACs). However, regulators of RAS-transformation (activation) that lead to macropinocytosis have not been identified. Herein, we report that UBAP2 (ubiquitin-binding associated protein 2), regulates the activation of KRAS and macropinocytosis in pancreatic cancer. We demonstrate that UBAP2 is highly expressed in both pancreatic cancer cell lines and tumor tissues of PDAC patients. The expression of UBAP2 is associated with poor overall survival in several cancers, including PDAC. Silencing UBAP2 decreases the levels of activated KRAS, and inhibits macropinocytosis, and tumor growth in vivo. Using a UBAP2-deletion construct, we demonstrate that the UBA-domain of UBAP2 is critical for the regulation of macropinocytosis and maintaining the levels of activated KRAS. In addition, UBAP2 regulates RAS downstream signaling and helps maintain RAS in the GTP-bound form. However, the exact mechanism by which UBAP2 regulates KRAS activation is unknown and needs further investigation. Thus, UBAP2 may be exploited as a potential therapeutic target to inhibit macropinocytosis and tumor growth in activated KRAS-driven cancers.	[Xiong, Xunhao; Rao, Geeta; Roy, Ram Vinod; Zhang, Yushan; Means, Nicolas; Dey, Anindya; Tsaliki, Martha; Saha, Sounik; Dwivedi, Shailendra Kumar Dhar; Dhanasekaran, Danny; Bhattacharya, Resham; Mukherjee, Priyabrata] Univ Oklahoma, Hlth Sci Ctr, Peggy & Charles Stephenson Canc Ctr, 975 NE 10th St, Oklahoma City, OK 73104 USA; [Xiong, Xunhao; Rao, Geeta; Roy, Ram Vinod; Zhang, Yushan; Means, Nicolas; Dey, Anindya; Tsaliki, Martha; Saha, Sounik; Dwivedi, Shailendra Kumar Dhar; Gillies, Elizabeth; Mukherjee, Priyabrata] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK 73104 USA; [Bhattacharyya, Sanjib; McCormick, Daniel J.] Mayo Clin, Dept Biochem & Mol Biol, Coll Med, Rochester, MN USA; [Rao, Chinthalapally, V] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Stephenson Canc Ctr,Ctr Canc Prevent & Drug Dev, Oklahoma City, OK 73104 USA; [Dhanasekaran, Danny] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA; [Ding, Kai] Univ Oklahoma, Hlth Sci Ctr, Dept Biostat & Epidemiol, Oklahoma City, OK 73104 USA; [Zhang, Min; Yang, Da] Univ Pittsburgh, Dept Pharmaceut Sci, Pittsburgh, PA USA; [Bhattacharya, Resham] Univ Oklahoma, Dept Obstet & Gynecol, Hlth Sci Ctr, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Mayo Clinic; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Oklahoma System; University of Oklahoma Health Sciences Center	Mukherjee, P (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Peggy & Charles Stephenson Canc Ctr, 975 NE 10th St, Oklahoma City, OK 73104 USA.	Priyabrata-Mukherjee@ouhsc.edu	Chinthalapally, Rao V/B-3633-2010	Chinthalapally, Rao V/0000-0002-5715-7979; Bhattacharyya, Sanjib/0000-0001-8738-7188	National Institutes of Health (NIH) [2CA136494, CA213278, CA220237]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	National Institutes of Health (NIH), Grant/Award Number: 2CA136494, CA213278 and CA220237	ALMOGUERA C, 1988, CELL, V53, P549, DOI 10.1016/0092-8674(88)90571-5; Arvizo RR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033650; Bai DS, 2016, ONCOTARGET, V7, P32946, DOI 10.18632/oncotarget.8783; Bhattacharyya S, 2012, ANGEW CHEM INT EDIT, V51, P1563, DOI 10.1002/anie.201105432; Bhattacharyya S, 2010, P NATL ACAD SCI USA, V107, P14541, DOI 10.1073/pnas.1006507107; Chi XJ, 2013, INT J MOL SCI, V14, P7089, DOI 10.3390/ijms14047089; Commisso C, 2014, NAT PROTOC, V9, P182, DOI 10.1038/nprot.2014.004; Commisso C, 2013, NATURE, V497, P633, DOI 10.1038/nature12138; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Finicle BT, 2018, NAT REV CANCER, V18, P619, DOI 10.1038/s41568-018-0048-x; Giri K, 2014, BIOCONJUGATE CHEM, V25, P1078, DOI 10.1021/bc500084f; Gwinn DM, 2018, CANCER CELL, V33, P91, DOI 10.1016/j.ccell.2017.12.003; Hensley CT, 2013, J CLIN INVEST, V123, P3678, DOI 10.1172/JCI69600; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Husnjak K, 2012, ANNU REV BIOCHEM, V81, P291, DOI 10.1146/annurev-biochem-051810-094654; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Kim S, 2006, FASEB J, V20, P2399, DOI 10.1096/fj.05-4621fje; Kopp JL, 2012, CANCER CELL, V22, P737, DOI 10.1016/j.ccr.2012.10.025; Latonen L, 2016, GENE CHROMOSOME CANC, V55, P617, DOI 10.1002/gcc.22364; Logsdon CD, 2016, INT J BIOL SCI, V12, P338, DOI 10.7150/ijbs.15020; Malik R, 2019, MATRIX BIOL, V81, P50, DOI 10.1016/j.matbio.2018.11.001; Popovic D, 2014, NAT MED, V20, P1242, DOI 10.1038/nm.3739; Sasaki AT, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001518; Son J, 2013, NATURE, V496, P101, DOI 10.1038/nature12040; Sousa CM, 2014, CARCINOGENESIS, V35, P1441, DOI 10.1093/carcin/bgu097; SWANSON JA, 1995, TRENDS CELL BIOL, V5, P424, DOI 10.1016/S0962-8924(00)89101-1; Thompson H, 2013, NAT MED, V19, P949, DOI 10.1038/nm0813-949; Torrence ME, 2018, ANNU REV CANC BIOL, V2, P251, DOI 10.1146/annurev-cancerbio-030617-050329; Wolfgang CL, 2013, CA-CANCER J CLIN, V63, P318, DOI 10.3322/caac.21190; Zhou BY, 2016, SEMIN CELL DEV BIOL, V58, P60, DOI 10.1016/j.semcdb.2016.07.012	31	5	5	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12024	12039		10.1096/fj.201902826RR	http://dx.doi.org/10.1096/fj.201902826RR		JUL 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32692445	Green Accepted			2022-12-28	WOS:000554624400001
J	Yang, Y; Li, MX; Zou, X; Chen, CY; Zheng, S; Fu, CJ; Chen, K; Jose, PA; Lan, C; Liu, YK				Yang, Yang; Li, Meixiang; Zou, Xue; Chen, Caiyu; Zheng, Shuo; Fu, Chunjiang; Chen, Ken; Jose, Pedro A.; Lan, Cong; Liu, Yukai			Role of GRK4 in the regulation of the renal ETB receptor in hypertension	FASEB JOURNAL			English	Article						endothelin type B receptor; G protein-coupled receptor kinase 4; hypertension; natriuresis	PROTEIN-COUPLED RECEPTOR; SALT-SENSITIVE HYPERTENSION; PROXIMAL TUBULE CELLS; KINASE 4; AT(1) RECEPTOR; BLOOD-PRESSURE; ENDOTHELIN; DOPAMINE; KIDNEY; PHOSPHORYLATION	The endothelin receptor type B (ETBR) regulates water and electrolyte balance and blood pressure, in part, by inhibiting renal sodium transport. Our preliminary study found that the ETBR-mediated diuresis and natriuresis are impaired in hypertension with unknown mechanism. Persistently increased activity of G protein-coupled receptor kinase 4 (GRK4), caused by increased expression or genetic variants (eg, GRK gamma 142V), impairs the ability of the kidney to excrete a sodium load, in part, by impairing renal dopamine D(1)receptor function through persistent phosphorylation. Our present study found that although renal ETBR expression was not different between Wistar-Kyoto (WKY) and spontaneously hypertensive rats (SHRs), renal ETBR phosphorylation was higher in SHRs. The role of hyper-phosphorylation in impaired ETBR-function was supported by results in human (h) GRK4 gamma transgenic mice. Stimulation of ETBR by BQ3020-induced natriuresis in human (h) GRK4 gamma wild-type (WT) mice. However, in hGRK4 gamma 142V transgenic mice, the renal ETBR was hyperphosphorylated and ETBR-mediated natriuresis and diuresis were not evident. There were co-localization and co-immunoprecipitation of ETBR and GRK4 in renal proximal tubule (RPT) cells from both WKY and SHRs but was greater in the latter than the former group. SiRNA-mediated downregulation of GRK4 expression, recovered the impaired inhibitory effect of ETBR on Na+-K+-ATPase activity in RPT cells from SHR. In vivo downregulation of renal GRK4 expression, via ultrasound-targeted microbubble destruction, decreased ETBR phosphorylation and restored ETBR-mediated natriuresis and diuresis in SHRs. This study provides a mechanism by which GRK4, via regulation of renal ETBR function, participates in the pathogenesis of hypertension.	[Yang, Yang; Li, Meixiang; Zou, Xue; Chen, Caiyu; Zheng, Shuo; Fu, Chunjiang; Chen, Ken; Lan, Cong; Liu, Yukai] Third Mil Med Univ, Daping Hosp, Dept Cardiol, Chongqing, Peoples R China; [Yang, Yang; Li, Meixiang; Zou, Xue; Chen, Caiyu; Zheng, Shuo; Fu, Chunjiang; Chen, Ken; Lan, Cong; Liu, Yukai] Chongqing Inst Cardiol, Chongqing, Peoples R China; [Yang, Yang; Li, Meixiang; Zou, Xue; Chen, Caiyu; Zheng, Shuo; Fu, Chunjiang; Chen, Ken; Lan, Cong; Liu, Yukai] Chongqing Cardiovasc Clin Res Ctr, Chongqing, Peoples R China; [Li, Meixiang; Liu, Yukai] First Peoples Hosp Liangjiang New Dist, Chongqing, Peoples R China; [Jose, Pedro A.] George Washington Univ, Sch Med & Hlth Sci, Dept Med & Pharmacol Physiol, Div Renal Dis & Hypertens, Washington, DC 20052 USA	Army Medical University; Chinese Academy of Sciences; George Washington University	Lan, C; Liu, YK (corresponding author), Third Mil Med Univ, Daping Hosp, Dept Cardiol, Chongqing, Peoples R China.	conglan100@yeah.net; liuyukai12345678@163.com		Chen, Ken/0000-0002-8958-1088	National Natural Science Foundation of China [81700371, 31771281]; National Key R&D Program of China [2018YFC1312700]; Program of Innovative Research Team by National Natural Science Foundation [81721001]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1216]; National Institutes of Health (USA) [R01DK039308, R01HL092196, P01HL74940]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; Program of Innovative Research Team by National Natural Science Foundation; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National Institutes of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	These studies were supported in part by grants from the National Natural Science Foundation of China (81700371, 31771281), National Key R&D Program of China (2018YFC1312700), Program of Innovative Research Team by National Natural Science Foundation (81721001), Program for Changjiang Scholars and Innovative Research Team in University; IRT1216), and National Institutes of Health (USA), R01DK039308, R01HL092196, and P01HL74940	Assal AA, 1997, BRAIN RES PROTOC, V1, P23, DOI 10.1016/S1385-299X(96)00004-9; Chen K, 2014, HYPERTENSION, V63, P289, DOI 10.1161/HYPERTENSIONAHA.113.01766; Cramer H, 1998, J CARDIOVASC PHARM, V31, pS203, DOI 10.1097/00005344-199800001-00057; Dhaun N, 2008, HYPERTENSION, V52, P452, DOI 10.1161/HYPERTENSIONAHA.108.117366; Felder RA, 2002, P NATL ACAD SCI USA, V99, P3872, DOI 10.1073/pnas.062694599; Freedman NJ, 1997, J BIOL CHEM, V272, P17734, DOI 10.1074/jbc.272.28.17734; Gariepy CE, 2000, J CLIN INVEST, V105, P925, DOI 10.1172/JCI8609; Ge YQ, 2006, AM J PHYSIOL-RENAL, V291, pF1274, DOI 10.1152/ajprenal.00190.2006; Harris RC, 2012, CURR HYPERTENS REP, V14, P138, DOI 10.1007/s11906-012-0253-z; Harris RC, 2012, CURR OPIN NEPHROL HY, V21, P61, DOI 10.1097/MNH.0b013e32834de2cb; Herrera M, 2012, CURR OPIN NEPHROL HY, V21, P171, DOI 10.1097/MNH.0b013e3283503068; Hoffman A, 2000, HYPERTENSION, V35, P732, DOI 10.1161/01.HYP.35.3.732; Huang HF, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.004028; HUGHES AK, 1992, HYPERTENSION, V20, P666, DOI 10.1161/01.HYP.20.5.666; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Jose PA, 2010, BBA-MOL BASIS DIS, V1802, P1259, DOI 10.1016/j.bbadis.2010.02.004; Kohan DE, 2011, PHYSIOL REV, V91, P1, DOI 10.1152/physrev.00060.2009; Liu Y, 2009, HYPERTENS RES, V32, P846, DOI 10.1038/hr.2009.112; Lohmueller KE, 2006, ANN HUM GENET, V70, P27, DOI 10.1111/j.1529-8817.2005.00197.x; Mills KT, 2016, CIRCULATION, V134, P441, DOI 10.1161/CIRCULATIONAHA.115.018912; Ohuchi T, 2000, CURR OPIN NEPHROL HY, V9, P435, DOI 10.1097/00041552-200007000-00016; Sanada H, 2016, PHARMACOGENOMICS J, V16, P3, DOI 10.1038/tpj.2015.6; Sanada H, 2006, HYPERTENSION, V47, P1131, DOI 10.1161/01.HYP.0000222004.74872.17; Speed JS, 2015, SEMIN NEPHROL, V35, P137, DOI 10.1016/j.semnephrol.2015.02.003; Speed JS, 2013, HYPERTENSION, V61, P1142, DOI 10.1161/HYPERTENSIONAHA.113.00595; Vassileva I, 2003, HYPERTENSION, V41, P1359, DOI 10.1161/01.HYP.0000070958.39174.7E; Villar VM, 2009, J BIOL CHEM, V284, P21425, DOI 10.1074/jbc.M109.003665; Wang LF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096586; Wang W, 2012, KIDNEY INT, V82, P26, DOI 10.1038/ki.2012.41; Xu J, 2000, HYPERTENSION, V36, P395, DOI 10.1161/01.HYP.36.3.395; Yang J, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003519; Yang J, 2015, HYPERTENSION, V65, P1148, DOI 10.1161/HYPERTENSIONAHA.115.05189; Yatabe J, 2008, HYPERTENS RES, V31, P1455, DOI 10.1291/hypres.31.1455; Yu CQ, 2009, AM J HYPERTENS, V22, P877, DOI 10.1038/ajh.2009.80; Zeng CY, 2005, HYPERTENSION, V46, P926, DOI 10.1161/01.HYP.0000174595.41637.13; Zhang H, 2016, CLIN INTERV AGING, V11, P17, DOI 10.2147/CIA.S94510; Zhang Y, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0149-2; Zhang Y, 2011, CONTRIB NEPHROL, V172, P63, DOI 10.1159/000328684	38	2	2	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					11594	11604		10.1096/fj.201902552R	http://dx.doi.org/10.1096/fj.201902552R		JUL 2020	11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32687659	Green Accepted			2022-12-28	WOS:000553642600001
J	Yu, XQ; Zeng, Y; Bao, MY; Wen, JR; Zhu, GG; Cao, CJ; He, XL; Li, L				Yu, Xiaoqin; Zeng, Ye; Bao, Mingyue; Wen, Jirui; Zhu, Guangguang; Cao, Chengjian; He, Xueling; Li, Liang			Low-magnitude vibration induces osteogenic differentiation of bone marrow mesenchymal stem cells via miR-378a-3p/Grb2 pathway to promote bone formation in a rat model of age-related bone loss	FASEB JOURNAL			English	Article						age-related bone loss; bone marrow mesenchymal stem cells; growth factor receptor-bound protein 2; low-magnitude vibration; miR-378a-3p; osteogenic differentiation	WHOLE-BODY VIBRATION; MINERAL DENSITY; FRACTURE RISK; OSTEOPOROSIS; OSTEOBLAST; MICRORNA; THERAPY; MORPHOLOGY	The dysfunction of bone marrow mesenchymal stem cells (BMSCs) in osteogenic differentiation is one of the main causes of age-related bone loss. Our previous studies have shown that low-magnitude vibration (LMV) induces the osteogenic differentiation of BMSCs derived from ovariectomized osteoporotic rats. To investigate whether LMV promotes osteogenic differentiation of BMSCs and its underlying mechanisms in aged rats, 20-month-old female Sprague-Dawley rats (n = 20) were randomly divided into LMV group (rats were vibrated at 0.3 g and 90 Hz for 30 minutes, once daily, 5 days a week until 12 weeks for subsequent analysis, n = 10), static group (rats were placed in the box on the vibration platform without vibration, n = 10); 6-month-old female Sprague-Dawley rats were used as control (young group, n = 10). The bone mineral density and bone strength of aged rats were significantly decreased compared with the young rats. Furthermore, the primary BMSCs isolated and cultured from the aged rats with the whole-bone marrow differential pasting method showed a decreased ability in osteogenic differentiation compared with that from the young rats. Then the differentially expressed miRNAs between the aged and young rat-derived BMSCs were screened by high-throughput sequencing and verified by qRT-PCR, and we found that miR-378a-3p was significantly downregulated in the aged rat-derived BMSCs compared with the young rat-derived BMSCs. By transfecting miRNA mimics and inhibitors, miR-378a-3p was confirmed to promote the expression levels of osteogenic genes (Runx2, ALP, Col I, and OCN) and ALP activity of the aged rat-derived BMSCs. Meanwhile, the expression levels of osteogenic genes and miR-378a-3p of aged rat-derived BMSCs were significantly upregulated by LMV (cells were vibrated at 0.3 g and 90 Hz for 30 minutes a day, until 5 days for subsequent analysis), while the LMV-induced osteogenic gene expression levels of aged rat-derived BMSCs were suppressed by miR-378a-3p inhibitors. Furthermore, the inhibition of growth factor receptor-bound protein 2 (Grb2) by miR-378a-3p and Grb2-siRNA promoted the LMV-induced osteogenic differentiation of aged rat-derived BMSCs. Additionally, LMV was found to promote bone mineral density and bone strength of aged rats in vivo, as well as upregulating the expression level of miR-378a-3p and downregulating the expression level of Grb2 of BMSCs from aged rats. These results suggest that LMV induces osteogenic differentiation of BMSCs through miR-378a-3p/Grb2 pathway to improve bone mineral density and mechanical properties in a rat model of age-related bone loss.	[Yu, Xiaoqin; Zeng, Ye; Bao, Mingyue; Wen, Jirui; Zhu, Guangguang; Cao, Chengjian; He, Xueling; Li, Liang] Sichuan Univ, Inst Biomed Engn, West China Sch Basic Med Sci & Forens Med, Chengdu 610041, Peoples R China; [He, Xueling] Sichuan Univ, Lab Anim Ctr, Chengdu, Peoples R China	Sichuan University; Sichuan University	Li, L (corresponding author), Sichuan Univ, Inst Biomed Engn, West China Sch Basic Med Sci & Forens Med, Chengdu 610041, Peoples R China.	lilianghx@163.com	Zeng, Ye/E-3010-2010; Wen, Jirui/GRX-8236-2022	Zeng, Ye/0000-0001-5440-6194; 	National Natural Science Foundation of China (NSFC) [11572209, 11872260, 11272225]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 11572209, 11872260 and 11272225	Arfat Y, 2018, MOL THER-NUCL ACIDS, V11, P323, DOI 10.1016/j.omtn.2017.11.009; BALDWIN AL, 1984, J HISTOCHEM CYTOCHEM, V32, P259, DOI 10.1177/32.3.6198357; Bartel DP, 2018, CELL, V173, P20, DOI 10.1016/j.cell.2018.03.006; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Canalis E, 2007, NEW ENGL J MED, V357, P905, DOI 10.1056/NEJMra067395; Compston JE, 2019, LANCET, V393, P364, DOI 10.1016/S0140-6736(18)32112-3; Coughlan T, 2014, CLIN MED, V14, P187, DOI 10.7861/clinmedicine.14-2-187; Eskildsen T, 2011, P NATL ACAD SCI USA, V108, P6139, DOI 10.1073/pnas.1016758108; Guo Q, 2016, BONE RES, V4, DOI 10.1038/boneres.2016.22; He XL, 2019, PROG BIOPHYS MOL BIO, V148, P47, DOI 10.1016/j.pbiomolbio.2017.09.023; Issler O, 2015, NAT REV NEUROSCI, V16, P201, DOI 10.1038/nrn3879; Karinkanta S, 2010, NAT REV ENDOCRINOL, V6, P396, DOI 10.1038/nrendo.2010.70; Kusuyama J, 2018, J CELL PHYSIOL, V233, P2549, DOI 10.1002/jcp.26130; Lau E, 2011, J ORTHOP RES, V29, P1075, DOI 10.1002/jor.21334; Lau E, 2010, BONE, V46, P1508, DOI 10.1016/j.bone.2010.02.031; Lee So Min, 2017, J Phys Ther Sci, V29, P1125, DOI 10.1589/jpts.29.1125; Leslie William D, 2011, Curr Osteoporos Rep, V9, P129, DOI 10.1007/s11914-011-0060-5; Li CJ, 2015, J CLIN INVEST, V125, P1509, DOI 10.1172/JCI77716; Li HM, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20191011; Ma RS, 2012, HIP INT, V22, P218, DOI 10.5301/HIP.2012.9033; Marx Robert E, 2014, Int J Oral Maxillofac Implants, V29, pe247, DOI 10.11607/jomi.te61; Muir J, 2013, J SCI MED SPORT, V16, P526, DOI 10.1016/j.jsams.2013.01.004; Nagalingam RS, 2013, J BIOL CHEM, V288, P11216, DOI 10.1074/jbc.M112.442384; Okubo R, 2017, OSTEOPOROSIS INT, V28, P1461, DOI 10.1007/s00198-017-3905-7; Pagnotti GM, 2019, NAT REV ENDOCRINOL, V15, P339, DOI 10.1038/s41574-019-0170-1; Paspaliaris V, 2019, STEM CELLS INT, V2019, DOI 10.1155/2019/1730978; Pre D, 2013, BONE MARROW RES, DOI 10.1155/2013/803450; Rachner TD, 2011, LANCET, V377, P1276, DOI 10.1016/S0140-6736(10)62349-5; Ramanadham S, 2008, AM J PATHOL, V172, P868, DOI 10.2353/ajpath.2008.070756; Rosen CJ, 2016, NEW ENGL J MED, V375, P1583, DOI 10.1056/NEJMe1611863; Rupaimoole R, 2017, NAT REV DRUG DISCOV, V16, P203, DOI 10.1038/nrd.2016.246; Shanb AA, 2017, J BACK MUSCULOSKELET, V30, P903, DOI 10.3233/BMR-160607; Sun F, 2019, J MOL CELL CARDIOL, V133, P188, DOI 10.1016/j.yjmcc.2019.06.011; Suttamanatwong S, 2017, CONNECT TISSUE RES, V58, P90, DOI 10.3109/03008207.2016.1139580; Wang X, 2013, MATER RES LETT, V1, P19, DOI 10.1080/21663831.2012.686586; Wysocki A, 2011, ANN INTERN MED, V155, P680, DOI 10.7326/0003-4819-155-10-201111150-00006; Yuan Y, 2017, J CELL PHYSIOL, V232, P1239, DOI 10.1002/jcp.25688; Zeng YE, 2017, PROG BIOPHYS MOL BIO, V148, P54; Zhao XY, 2020, J MOL CELL BIOL, V12, P55, DOI 10.1093/jmcb/mjz028; Zuo B, 2015, J BONE MINER RES, V30, P330, DOI 10.1002/jbmr.2352	40	7	8	2	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					11754	11771		10.1096/fj.201902830RRR	http://dx.doi.org/10.1096/fj.201902830RRR		JUL 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32652777	Bronze			2022-12-28	WOS:000548007900001
J	Liu, Y; Jin, X; Hong, HG; Xiang, LY; Jiang, QY; Ma, YC; Chen, ZD; Cheng, L; Jian, ZY; Wei, ZT; Ai, JZ; Qi, SQ; Sun, Q; Li, H; Li, Y; Wang, KJ				Liu, Yu; Jin, Xi; Hong, Hyokyoung G.; Xiang, Liyuan; Jiang, Qingyao; Ma, Yucheng; Chen, Zude; Cheng, Liang; Jian, Zhongyu; Wei, Zhitao; Ai, Jianzhong; Qi, Shiqian; Sun, Qun; Li, Hong; Li, Yi; Wang, Kunjie			The relationship between gut microbiota and short chain fatty acids in the renal calcium oxalate stones disease	FASEB JOURNAL			English	Article						16s Rrna; renal calcium oxalate stones; sgut microbiota; short chain fatty acids; shotgun metagenomics	OXALOBACTER-FORMIGENES; KIDNEY; UROLITHIASIS; EPIDEMIOLOGY; BUTYRATE	The relationship of gut microbiota and calcium oxalate stone has been limited investigated, especially with no study of gut microbiota and short chain fatty acids (SCFAs) in nephrolithiasis. We provided Sprague Dawley rats of renal calcium oxalate stones with antibiotics and examined the renal crystals deposition. We also performed a case-control study by analyzing 16S rRNA microbial profiling, shotgun metagenomics and SCFAs in 153 fecal samples from non-kidney stone (NS) controls, patients with occasional renal calcium oxalate stones (OS) and patients with recurrent stones (RS). Antibiotics reduced bacterial load in feces and could promote the formation of renal calcium crystals in model rats. In addition, both OS and RS patients exhibited higher fecal microbial diversity than NS controls. Several SCFAs-producing gut bacteria, as well as metabolic pathways associated with SCFAs production, were considerably lower in the gut microbiota among the kidney stone patients compared with the NS controls. Representation of genes involved in oxalate degradation showed no significance difference among groups. However, fecal acetic acid concentration was the highest in RS patients with high level of urinary oxalate, which was positively correlated with genes involvement in oxalate synthesis. Administration of SCFAs reduced renal crystals. These results shed new light on bacteria and SCFAs, which may promote the development of treatment strategy in nephrolithiasis.	[Liu, Yu; Jin, Xi; Xiang, Liyuan; Jiang, Qingyao; Ma, Yucheng; Chen, Zude; Cheng, Liang; Jian, Zhongyu; Wei, Zhitao; Ai, Jianzhong; Li, Hong; Wang, Kunjie] Sichuan Univ, West China Hosp, Inst Urol, Dept Urol,Lab Reconstruct Urol, 37 Guoxue Alley, Chengdu, Peoples R China; [Hong, Hyokyoung G.] Michigan State Univ, Dept Stat & Probabil, E Lansing, MI 48824 USA; [Qi, Shiqian] Sichuan Univ, West China Hosp, State Key Lab Biotherapy & Canc Ctr, Chengdu, Peoples R China; [Sun, Qun] Sichuan Univ, Minist Educ, Coll Life Sci, Key Lab Bioresources & Ecoenvironm, Chengdu, Peoples R China; [Li, Yi] Univ Michigan, Dept Biostat, 1415 Washington Hts, Ann Arbor, MI 48109 USA	Sichuan University; Michigan State University; Sichuan University; Sichuan University; University of Michigan System; University of Michigan	Wang, KJ (corresponding author), Sichuan Univ, West China Hosp, Inst Urol, Dept Urol,Lab Reconstruct Urol, 37 Guoxue Alley, Chengdu, Peoples R China.; Li, Y (corresponding author), Univ Michigan, Dept Biostat, 1415 Washington Hts, Ann Arbor, MI 48109 USA.	yili@umich.edu; wangkj@scu.edu.cn	Hong, Hyokyoung Grace/ABG-6009-2020	Hong, Hyokyoung Grace/0000-0002-4280-6243	National Natural Science Foundation of China [81770703, 81970602]; Foundation of Science & Technology Department of Sichuan Province [2018SZ0118]; Sichuan University [ZYGD18011, ZYJC18015, Y2016104]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Science & Technology Department of Sichuan Province; Sichuan University(Sichuan University)	National Natural Science Foundation of China, Grant/Award Number: 81770703 and 81970602; Foundation of Science & Technology Department of Sichuan Province, Grant/Award Number: 2018SZ0118; Sichuan University, Grant/Award Number: ZYGD18011, ZYJC18015, Z and Y2016104	Acharya A, 2017, ORAL DIS, V23, P926, DOI 10.1111/odi.12676; ALLISON MJ, 1985, ARCH MICROBIOL, V141, P1, DOI 10.1007/BF00446731; Amato M, 2004, UROL INT, V72, P1, DOI 10.1159/000076582; Bultman SJ, 2018, NAT MICROBIOL, V3, P1332, DOI 10.1038/s41564-018-0299-z; Canfora EE, 2019, NAT REV ENDOCRINOL, V15, P261, DOI 10.1038/s41574-019-0156-z; Franco-de-Moraes AC, 2017, DIABETOL METAB SYNDR, V9, DOI 10.1186/s13098-017-0261-x; Heaney LM, 2019, FUTUR SCI OA, V5, DOI 10.4155/fsoa-2019-0013; Juanola O, 2019, FASEB J, V33, P11595, DOI 10.1096/fj.201901327R; Kaufman DW, 2008, J AM SOC NEPHROL, V19, P1197, DOI 10.1681/ASN.2007101058; Khan S, 2014, FOOD CHEM TOXICOL, V73, P127, DOI 10.1016/j.fct.2014.08.010; Koh A, 2016, CELL, V165, P1332, DOI 10.1016/j.cell.2016.05.041; Lee PC, 2008, J MICROBIOL BIOTECHN, V18, P1792, DOI 10.4014/jmb.0800.129; Li LZ, 2017, DRUG DES DEV THER, V11, P3531, DOI 10.2147/DDDT.S150825; Liu Y, 2018, ASIAN J UROL, V5, P205, DOI 10.1016/j.ajur.2018.08.007; Louis P, 2014, NAT REV MICROBIOL, V12, P661, DOI 10.1038/nrmicro3344; Miller AW, 2019, KIDNEY INT, V96, P180, DOI 10.1016/j.kint.2019.02.012; Milliner D, 2018, UROLITHIASIS, V46, P313, DOI 10.1007/s00240-017-0998-6; Moludi J, 2018, J CARDIOVASC THORAC, V10, P129, DOI 10.15171/jcvtr.2018.21; Nishino K, 2018, J GASTROENTEROL, V53, P95, DOI 10.1007/s00535-017-1384-4; Oliphant K, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0704-8; Pukall R, 2010, STAND GENOMIC SCI, V2, P212, DOI 10.4056/sigs.751339; Sadaf H, 2017, MICROB PATHOGENESIS, V109, P287, DOI 10.1016/j.micpath.2017.06.009; Scheiman J, 2019, NAT MED, V25, P1104, DOI 10.1038/s41591-019-0485-4; Spiljar M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01353; Suryavanshi MV, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33773-5; Suryavanshi MV, 2016, SCI REP-UK, V6, DOI 10.1038/srep34712; Tang RQ, 2018, UROLITHIASIS, V46, P503, DOI 10.1007/s00240-018-1037-y; Tasian GE, 2018, J AM SOC NEPHROL, V29, P1731, DOI 10.1681/ASN.2017111213; Tavasoli S, 2020, BJU INT, V125, P133, DOI 10.1111/bju.14840; Ticinesi A, 2018, GUT, V67, P2097, DOI 10.1136/gutjnl-2017-315734; Vaziri ND, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114881; Xiang ST, 2015, UROLITHIASIS, V43, P433, DOI 10.1007/s00240-015-0795-z; Yamamoto K, 2019, HEPATOL INT, V13, P234, DOI 10.1007/s12072-019-09932-9	33	24	25	6	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					11200	11214		10.1096/fj.202000786R	http://dx.doi.org/10.1096/fj.202000786R		JUL 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32645241	Green Published, hybrid			2022-12-28	WOS:000548042000001
J	Du, Y; Yang, YT; Tang, G; Jia, JS; Zhu, N; Yuan, WJ				Du, Yi; Yang, Yi-Tong; Tang, Gang; Jia, Jie-Shuang; Zhu, Nan; Yuan, Wei-Jie			Butyrate alleviates diabetic kidney disease by mediating the miR-7a-5p/P311/TGF-beta 1 pathway	FASEB JOURNAL			English	Article						butyrate; db; db mice; diabetic kidney disease; fibrosis; SV40-MES-13 cells	TISSUE GROWTH-FACTOR; SODIUM-BUTYRATE; DB/DB MICE; SIGNALING PATHWAY; RENAL FIBROSIS; COLON-CANCER; TGF-BETA; EXPRESSION; APOPTOSIS; INFLAMMATION	It has been reported that butyrate played an protect role in diabetic kidney disease (DKD) while the mechanism was still not clear. Transforming growth factor-beta 1 (TGF-beta 1) is the initial factor which triggers the profibrotic signaling cascades. P311 is an RNA-binding protein, which could stimulate TGF-beta 1 translation in several cell types. In our study, we found that supplementary of butyrate alleviated fibrosis and suppressed the expression of TGF-beta 1 and P311 in the kidney of db/db mice as well as high glucose (HG)-induced SV40-MES-13 cells. Overexpression of P311 offset the inhibition of butyrate on TGF-beta 1 in SV40-MES-13 cells. To make clear the mechanism of butyrate in regulating P311, microRNAs (miRNAs) of the SV40-MES-13 cells were sequenced. We found that miR-7a-5p was significantly decreased in the HG-induced SV40-MES-13 cells and the kidney of db/db mice, while giving butyrate reversed this change. Besides, miR-7a-5p could specifically target the 3' UTR of P311's mRNA and suppressed the expression of P311 in the SV40-MES-13 cells. Giving miR-7a-5p inhibitor blocked the inhibition of butyrate on P311 and TGF-beta 1. Introducing the miR-7a-5p agomir into db/db mice alleviated renal fibrosis and inhibit the expression of P311 and TGF-beta 1. In conclusion, butyrate alleviated DKD by mediating the miR-7a-5p/P311/TGF-beta 1 pathway.	[Du, Yi; Tang, Gang; Jia, Jie-Shuang; Zhu, Nan; Yuan, Wei-Jie] Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Dept Nephrol, Sch Med, 100 HaiNing Rd, Shanghai 200080, Peoples R China; [Yang, Yi-Tong] Qingdao Municipal Hosp, Dept Nephrol, Qingdao, Peoples R China	Shanghai Jiao Tong University; Qingdao Municipal Hospital	Yuan, WJ (corresponding author), Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Dept Nephrol, Sch Med, 100 HaiNing Rd, Shanghai 200080, Peoples R China.	ywj4168@163.com		Yuan, Weijie/0000-0001-5008-4255	National Natural Science Foundation of China (NSFC) [81700621]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81700621	Alicic RZ, 2017, CLIN J AM SOC NEPHRO, V12, P2032, DOI 10.2215/CJN.11491116; Alpers CE, 2011, CURR OPIN NEPHROL HY, V20, P278, DOI 10.1097/MNH.0b013e3283451901; Andrade-Oliveira V, 2015, J AM SOC NEPHROL, V26, P1877, DOI 10.1681/ASN.2014030288; Bu HQ, 2019, ONCOTARGETS THER, V12, P7467, DOI 10.2147/OTT.S220401; Chen L, 2018, BIOMED PHARMACOTHER, V101, P670, DOI 10.1016/j.biopha.2018.02.090; Cheng T, 2017, AM J PATHOL, V187, P292, DOI 10.1016/j.ajpath.2016.10.004; COUSER WG, 1994, AM J KIDNEY DIS, V23, P193, DOI 10.1016/S0272-6386(12)80971-1; CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221; Dong WP, 2017, J ENDOCRINOL, V232, P71, DOI 10.1530/JOE-16-0322; Dronavalli S, 2008, NAT CLIN PRACT ENDOC, V4, P444, DOI 10.1038/ncpendmet0894; Duan FF, 2019, AM J RESP CELL MOL, V60, P221, DOI 10.1165/rcmb.2018-0028OC; Geiss LS, 2014, JAMA-J AM MED ASSOC, V312, P1218, DOI 10.1001/jama.2014.11494; Guo Y, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00630; Hu SE, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0450-x; Huang Y, 2008, J AM SOC NEPHROL, V19, P329, DOI 10.1681/ASN.2007040510; IGARASHI A, 1993, MOL BIOL CELL, V4, P637, DOI 10.1091/mbc.4.6.637; Kato M, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003389; Khan S, 2014, FOOD CHEM TOXICOL, V73, P127, DOI 10.1016/j.fct.2014.08.010; Kim T, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aat4285; Kolling M, 2017, MOL THER, V25, P165, DOI 10.1016/j.ymthe.2016.08.001; Loeffler I, 2018, CELL TISSUE RES, V372, P115, DOI 10.1007/s00441-017-2754-1; Machado RA, 2012, NEPHROL DIAL TRANSPL, V27, P3136, DOI 10.1093/ndt/gfr807; Meng XM, 2016, NAT REV NEPHROL, V12, P325, DOI 10.1038/nrneph.2016.48; Miller CG, 2014, MOL BIOL CELL, V25, P2342, DOI 10.1091/mbc.E14-03-0800; Pant K, 2017, REDOX BIOL, V12, P340, DOI 10.1016/j.redox.2017.03.006; Riser BL, 2000, J AM SOC NEPHROL, V11, P25, DOI 10.1681/ASN.V11125; Sabatino A, 2017, CURR DIABETES REP, V17, DOI 10.1007/s11892-017-0841-z; Sharma K, 2003, AM J PHYSIOL-RENAL, V284, pF1138, DOI 10.1152/ajprenal.00315.2002; Sonnylal S, 2010, ARTHRITIS RHEUM-US, V62, P1523, DOI 10.1002/art.27382; Sun SF, 2018, DIABETES, V67, P731, DOI 10.2337/db17-0816; Sureshbabu A, 2016, AM J PHYSIOL-RENAL, V310, pF596, DOI 10.1152/ajprenal.00365.2015; Tang FJ, 2017, DRUG DES DEV THER, V11, P2813, DOI 10.2147/DDDT.S143805; Toda N, 2018, INFLAMM REGEN, V38, DOI 10.1186/s41232-018-0070-0; Xiao XQ, 2018, J CELL BIOCHEM, V119, P3563, DOI 10.1002/jcb.26547; Xu BH, 2020, METABOLISM, V103, DOI 10.1016/j.metabol.2019.154013; Xu YH, 2018, J ENDOCRINOL, V238, P231, DOI 10.1530/JOE-18-0137; Yao WX, 2018, TOXICOL SCI, V166, P465, DOI 10.1093/toxsci/kfy221; Yao ZH, 2015, SCI REP-UK, V5, DOI 10.1038/srep17032; Yiu WH, 2016, KIDNEY INT, V89, P386, DOI 10.1038/ki.2015.331; Zanchi C, 2017, DIABETOLOGIA, V60, P1114, DOI 10.1007/s00125-017-4248-9; Zhang ZB, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00016; Zhao JJ, 2015, CANCER CELL INT, V15, DOI 10.1186/s12935-015-0259-0	42	11	11	4	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10462	10475		10.1096/fj.202000431R	http://dx.doi.org/10.1096/fj.202000431R		JUN 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32539181	hybrid			2022-12-28	WOS:000541801700001
J	Minguez, MG; Wolters-Eisfeld, G; Lutz, D; Buck, F; Schachner, ML; Kleene, R				Girbes Minguez, Maria; Wolters-Eisfeld, Gerrit; Lutz, David; Buck, Friedrich; Schachner, Melitta; Kleene, Ralf			The cell adhesion molecule L1 interacts with nuclear proteins via its intracellular domain	FASEB JOURNAL			English	Article						cell adhesion molecule L1; DNA; RNA-binding proteins; Drosophilabehavior; human splicing (DBHS) proteins; nuclear import; proteolytic processing	X-CHROMOSOME INACTIVATION; STRAND BREAK REPAIR; HISTONE H1; BINDING-PROTEIN; PORE COMPLEX; DNA-BINDING; PRESENILIN/GAMMA-SECRETASE; IMMUNOGLOBULIN SUPERFAMILY; RECOGNITION MOLECULES; CLINICAL SPECTRUM	Proteolytic cleavage of the cell adhesion molecule L1 (L1) in brain tissue and in cultured cerebellar neurons results in the generation and nuclear import of a 30 kDa fragment comprising most of L1's C-terminal, intracellular domain. In search of molecules that interact with this domain, we performed affinity chromatography with the recombinant intracellular L1 domain and a nuclear extract from mouse brains, and identified potential nuclear L1 binding partners involved in transcriptional regulation, RNA processing and transport, DNA repair, chromatin remodeling, and nucleocytoplasmic transport. By co-immunoprecipitation and enzyme-linked immunosorbent assay using recombinant proteins, we verified the direct interaction between L1 and the nuclear binding partners non-POU domain containing octamer-binding protein and splicing factor proline/glutamine-rich. The proximity ligation assay confirmed this close interaction in cultures of cerebellar granule cells. Our findings suggest that L1 fragments regulate multiple nuclear functions in the nervous system. We discuss possible physiological and pathological roles of these interactions in regulation of chromatin structure, gene expression, RNA processing, and DNA repair.	[Girbes Minguez, Maria; Wolters-Eisfeld, Gerrit; Lutz, David; Kleene, Ralf] Univ Klinikum Hamburg Eppendorf, Zentrum Mol Neurobiol, Hamburg, Germany; [Buck, Friedrich] Univ Klinikum Hamburg Eppendorf, Inst Klin Chem, Zentrum Diagnost, Hamburg, Germany; [Schachner, Melitta] Shantou Univ, Coll Med, Ctr Neurosci, 22 Xin Ling Rd, Shantou 515041, Guangdong, Peoples R China; [Schachner, Melitta] Rutgers State Univ, Keck Ctr Collaborat Neurosci, Piscataway, NJ USA; [Schachner, Melitta] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ USA	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Shantou University; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Schachner, ML (corresponding author), Shantou Univ, Coll Med, Ctr Neurosci, 22 Xin Ling Rd, Shantou 515041, Guangdong, Peoples R China.	schachner@stu.edu.cn	Lutz, David/AAX-1607-2021; Girbes Minguez, Maria/AAV-4278-2020; Wolters-Eisfeld, Gerrit/H-8333-2019	Wolters-Eisfeld, Gerrit/0000-0002-2984-6515; Lutz, David/0000-0001-9171-4081; Girbes Minguez, Maria/0000-0002-9619-1299	Li Kashing Foundation	Li Kashing Foundation	We are grateful to Ute Bork for excellent technical assistance. M. Schachner is grateful to the Li Kashing Foundation for support.	Alfano L, 2016, ONCOGENE, V35, P567, DOI 10.1038/onc.2015.107; Andreyeva A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012018; APPEL F, 1995, J NEUROBIOL, V28, P297, DOI 10.1002/neu.480280304; Ausio J, 2018, EPIGENOMICS-UK, V10, P5, DOI 10.2217/epi-2017-0128; Ausio J, 2014, TRENDS MOL MED, V20, P487, DOI 10.1016/j.molmed.2014.03.004; Benegiamo G, 2018, CELL METAB, V27, P404, DOI 10.1016/j.cmet.2017.12.010; Bond CS, 2009, J CELL BIOL, V186, P637, DOI 10.1083/jcb.200906113; Bowen NJ, 2004, CELL MOL LIFE SCI, V61, P2163, DOI 10.1007/s00018-004-4177-x; Breuer M, 2015, GENE DEV, V29, P1789, DOI 10.1101/gad.264341.115; Bustin M, 2005, MOL CELL, V17, P617, DOI 10.1016/j.molcel.2005.02.019; Carlston CM, 2019, AM J MED GENET A, V179, P792, DOI 10.1002/ajmg.a.61091; Cheng L, 2011, EMBO J, V30, P800, DOI 10.1038/emboj.2011.10; Cheng TL, 2014, NEUROSCI BULL, V30, P601, DOI 10.1007/s12264-014-1452-6; CIAVARRA RP, 1994, P NATL ACAD SCI USA, V91, P1751, DOI 10.1073/pnas.91.5.1751; de Paz AM, 2017, ADV EXP MED BIOL, V978, P3, DOI 10.1007/978-3-319-53889-1_1; Della Ragione F, 2016, BRIEF FUNCT GENOMICS, V15, P420, DOI 10.1093/bfgp/elw023; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Emili A, 2002, RNA, V8, P1102, DOI 10.1017/S1355838202025037; Fasolino M, 2017, GENES-BASEL, V8, DOI 10.3390/genes8050141; Fox AH, 2005, MOL BIOL CELL, V16, P5304, DOI 10.1091/mbc.e05-06-0587; Fox AH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000687; FRANSEN E, 1995, EUR J HUM GENET, V3, P273; Fransen E, 1996, AM J MED GENET, V64, P73, DOI 10.1002/(SICI)1096-8628(19960712)64:1<73::AID-AJMG11>3.0.CO;2-P; Galy V, 2003, MOL BIOL CELL, V14, P5104, DOI 10.1091/mbc.E03-04-0237; Gao XJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097174; Ghosh RP, 2010, MOL CELL BIOL, V30, P4656, DOI 10.1128/MCB.00379-10; Grandi P, 1997, MOL BIOL CELL, V8, P2017, DOI 10.1091/mbc.8.10.2017; Guillaumond F, 2011, FASEB J, V25, P2740, DOI 10.1096/fj.10-178616; Guseva D, 2011, EXP NEUROL, V229, P339, DOI 10.1016/j.expneurol.2011.02.018; Guseva D, 2009, BRAIN, V132, P2180, DOI 10.1093/brain/awp160; Gutwein P, 2005, CLIN CANCER RES, V11, P2492, DOI 10.1158/1078-0432.CCR-04-1688; Gutwein P, 2000, J BIOL CHEM, V275, P15490, DOI 10.1074/jbc.275.20.15490; Gutwein P, 2002, FASEB J, V16, P292, DOI 10.1096/fj.02-0430fje; Ha K, 2011, DNA REPAIR, V10, P252, DOI 10.1016/j.dnarep.2010.11.009; Hansen JC, 2011, J BIOL CHEM, V286, P18938, DOI 10.1074/jbc.M111.234609; Hansen JC, 2010, IUBMB LIFE, V62, P732, DOI 10.1002/iub.386; Happel N, 2009, GENE, V431, P1, DOI 10.1016/j.gene.2008.11.003; He YW, 2009, CELL MOL LIFE SCI, V66, P1239, DOI 10.1007/s00018-008-8532-1; Hill DA, 2001, BIOCHEM CELL BIOL, V79, P317, DOI 10.1139/bcb-79-3-317; Hoffbuhr KC, 2002, MENT RETARD DEV D R, V8, P99, DOI 10.1002/mrdd.10026; Horvath PM, 2018, TRENDS NEUROSCI, V41, P72, DOI 10.1016/j.tins.2017.11.005; Huang CJ, 2016, AGING-US, V8, P3356, DOI 10.18632/aging.101125; Huang J, 2018, J BIOL CHEM, V293, P6593, DOI 10.1074/jbc.RA117.001451; Huang PR, 2008, BBA-MOL CELL RES, V1783, P193, DOI 10.1016/j.bbamcr.2007.08.006; Huang PR, 2010, BBA-MOL CELL RES, V1803, P1164, DOI 10.1016/j.bbamcr.2010.06.003; Jaafar L, 2017, NUCLEIC ACIDS RES, V45, P1848, DOI 10.1093/nar/gkw1209; Kalus I, 2003, J BIOL CHEM, V278, P10381, DOI 10.1074/jbc.M208351200; Kleene R, 2010, J BIOL CHEM, V285, P28968, DOI 10.1074/jbc.M110.114876; Knott GJ, 2016, NUCLEIC ACIDS RES, V44, P3989, DOI 10.1093/nar/gkw271; Kurumaji A, 2001, AM J MED GENET, V105, P99; Kuwahara S, 2006, BIOL REPROD, V75, P352, DOI 10.1095/biolreprod.106.051136; Labade AS, 2016, EPIGENET CHROMATIN, V9, DOI 10.1186/s13072-016-0106-0; LaSalle JM, 2009, EPIGENOMICS-UK, V1, P119, DOI [10.2217/epi.09.13, 10.2217/EPI.09.13]; Lee MW, 2015, NUCLEIC ACIDS RES, V43, P3826, DOI 10.1093/nar/gkv156; Li SY, 2014, NUCLEIC ACIDS RES, V42, P9771, DOI 10.1093/nar/gku650; Lutz D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15311-x; Lutz D, 2016, MOL NEUROBIOL, V53, P3360, DOI 10.1007/s12035-015-9277-0; Lutz D, 2014, J BIOL CHEM, V289, P13503, DOI 10.1074/jbc.M113.530238; Lutz D, 2014, J NEUROCHEM, V128, P713, DOI 10.1111/jnc.12473; Lutz D, 2012, J BIOL CHEM, V287, P17161, DOI 10.1074/jbc.M112.346759; Makhina T, 2009, MOL CELL NEUROSCI, V41, P206, DOI 10.1016/j.mcn.2009.02.010; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; Maretzky T, 2005, MOL CELL BIOL, V25, P9040, DOI 10.1128/MCB.25.20.9040-9053.2005; Matsumoto-Miyai K, 2003, J NEUROSCI, V23, P7727; Mechtersheimer S, 2001, J CELL BIOL, V155, P661, DOI 10.1083/jcb.200101099; Moran-Jones K, 2009, CANCER RES, V69, P9219, DOI 10.1158/0008-5472.CAN-09-1852; Nagarajan RP, 2008, AUTISM RES, V1, P169, DOI 10.1002/aur.24; Nakagawa T, 2011, MOL CELL, V43, P381, DOI 10.1016/j.molcel.2011.05.033; Nayeem N, 1999, J CELL SCI, V112, P4739; Neul Jeffrey Lorenz, 2012, Dialogues Clin Neurosci, V14, P253; Passon DM, 2012, P NATL ACAD SCI USA, V109, P4846, DOI 10.1073/pnas.1120792109; Passon DM, 2011, ACTA CRYSTALLOGR F, V67, P1231, DOI [10.1107/S1744309111026212, 10.1107/S17443091110262121231]; Petti E, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08863-1; POLTORAK M, 1995, EXP NEUROL, V131, P266, DOI 10.1016/0014-4886(95)90048-9; Reinstein E, 2016, EUR J HUM GENET, V24, P1635, DOI 10.1038/ejhg.2016.72; Riedle S, 2009, BIOCHEM J, V420, P391, DOI 10.1042/BJ20081625; Rupp RAW, 2005, CELL, V123, P1178, DOI 10.1016/j.cell.2005.12.004; SADOUL K, 1988, J NEUROCHEM, V50, P510, DOI 10.1111/j.1471-4159.1988.tb02941.x; Salton M, 2010, CELL CYCLE, V9, P1568, DOI 10.4161/cc.9.8.11298; Schafer MKE, 2010, CELL MOL LIFE SCI, V67, P2425, DOI 10.1007/s00018-010-0339-1; Shav-Tal Y, 2002, FEBS LETT, V531, P109, DOI 10.1016/S0014-5793(02)03447-6; Silletti S, 2000, J CELL BIOL, V149, P1485, DOI 10.1083/jcb.149.7.1485; Strekalova H, 2006, NEUROBIOL AGING, V27, P1, DOI 10.1016/j.neurobiolaging.2004.11.013; Sytnyk V, 2017, TRENDS NEUROSCI, V40, P295, DOI 10.1016/j.tins.2017.03.003; Thomas-Jinu S, 2017, NEURON, V94, P322, DOI 10.1016/j.neuron.2017.03.026; Trievel RC, 2009, NAT STRUCT MOL BIOL, V16, P678, DOI 10.1038/nsmb0709-678; Udayakumar D, 2015, BIOCHEM BIOPH RES CO, V463, P473, DOI 10.1016/j.bbrc.2015.05.024; Vollmer B, 2014, BIOL CHEM, V395, P515, DOI 10.1515/hsz-2013-0285; Wakabayashi Y, 2008, PROG NEURO-PSYCHOPH, V32, P1199, DOI 10.1016/j.pnpbp.2008.03.005; Wang SW, 2011, J NEUROSCI, V31, P7275, DOI 10.1523/JNEUROSCI.6476-10.2011; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Xiao BT, 2012, MOL BIOL CELL, V23, P4864, DOI 10.1091/mbc.E12-07-0518; Xiao MF, 2009, J NEUROSCI, V29, P14752, DOI 10.1523/JNEUROSCI.4860-09.2009; Yang YS, 1997, NUCLEIC ACIDS RES, V25, P2284, DOI 10.1093/nar/25.12.2284; YANG YS, 1993, MOL CELL BIOL, V13, P5593, DOI 10.1128/MCB.13.9.5593; Zhang QS, 2006, RNA, V12, P1116, DOI 10.1261/rna.58806; Zhou LJ, 2012, J BIOL CHEM, V287, P25927, DOI 10.1074/jbc.M112.377465	97	2	2	2	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					9869	9883		10.1096/fj.201902242R	http://dx.doi.org/10.1096/fj.201902242R		JUN 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32533745	hybrid			2022-12-28	WOS:000541526900001
J	Wu, QY; Xia, YT; Dai, K; Bai, PZ; Kwan, KKL; Guo, MSS; Dong, TTX; Tsim, KWK				Wu, Qiyun; Xia, Yiteng; Dai, Kun; Bai, Panzhu; Kwan, Kenneth K. L.; Guo, Maggie S. S.; Dong, Tina T. X.; Tsim, Karl W. K.			Solar light induces the release of acetylcholine from skin keratinocytes affecting melanogenesis	FASEB JOURNAL			English	Article						acetylcholine; cholinergic; keratinocyte; opsin; skin	CELL-ADHESION; NEURITE GROWTH; RECEPTOR; PHOTORECEPTOR; MECHANISM; PROTEIN; TRANSCRIPTION; EXPRESSION; GENES; CHOLINESTERASE	Cholinergic system conducts signal transmission in brain and muscle. Besides nervous system, the nonneuronal functions of cholinergic system have been proposed in various tissues. The expression of cholinergic proteins and release of acetylcholine in human skin have been reported, but its mechanism and influence on dermatological functions is not elucidated. Here, the expression profile of cholinergic markers was further investigated in skin and keratinocyte. The expression levels of choline acetyltransferase (ChAT), acetylcholinesterase (AChE), vesicular acetylcholine transporter (VAChT), and synaptophysin, were upregulated during differentiation of keratinocytes. In cultured keratinocytes, a transient exposure of solar light induced the release of acetylcholine, which was mediated by intracellular Ca2+ mobilization. The light-induced acetylcholine release was mediated by the present of opsin. The light-induced melanogenesis was inhibited by acetylcholine or AChE inhibitor in melanocyte in vitro and mouse skin ex vivo. These results indicated that the potential role of cholinergic system could be a negative regulator in skin pigmentation.	[Wu, Qiyun; Dai, Kun; Bai, Panzhu; Guo, Maggie S. S.; Dong, Tina T. X.; Tsim, Karl W. K.] Shenzhen Res Inst, Shenzhen Key Lab Edible & Med Bioresources, Shenzhen 518000, Peoples R China; [Wu, Qiyun; Xia, Yiteng; Dai, Kun; Bai, Panzhu; Kwan, Kenneth K. L.; Dong, Tina T. X.; Tsim, Karl W. K.] Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Peoples R China; [Wu, Qiyun; Xia, Yiteng; Dai, Kun; Bai, Panzhu; Kwan, Kenneth K. L.; Dong, Tina T. X.; Tsim, Karl W. K.] Hong Kong Univ Sci & Technol, Ctr Chinese Med, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology	Tsim, KWK (corresponding author), Shenzhen Res Inst, Shenzhen Key Lab Edible & Med Bioresources, Shenzhen 518000, Peoples R China.	botsim@ust.hk			Shenzhen Science and Technology Innovation Commission [JCYJ20170413173747440, ZDSYS201707281432317, JCYJ20180306174903174]; China Postdoctoral Science Foundation [2019M653087]; Guangzhou Science and Technology Committee Research Grant [GZSTI16SC02, GZSTI17SC02]; Hong Kong RGC Theme-based Research Scheme [T13-607/12R]; Hong Kong Innovation Technology Fund [UIM/340, UIM/385, ITS/500/18FP, TCPD/17-9, HMRF18SC06, PD18SC01]; Zhongshan Municipal Bureau of Science and Technology [ZSST20SC03]	Shenzhen Science and Technology Innovation Commission; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Guangzhou Science and Technology Committee Research Grant; Hong Kong RGC Theme-based Research Scheme; Hong Kong Innovation Technology Fund; Zhongshan Municipal Bureau of Science and Technology	Shenzhen Science and Technology Innovation Commission, Grant/Award Number: JCYJ20170413173747440, ZDSYS201707281432317 and JCYJ20180306174903174; China Postdoctoral Science Foundation, Grant/Award Number: 2019M653087; Guangzhou Science and Technology Committee Research Grant, Grant/Award Number: GZSTI16SC02 and GZSTI17SC02; Hong Kong RGC Theme-based Research Scheme, Grant/Award Number: T13-607/12R; Hong Kong Innovation Technology Fund, Grant/Award Number: UIM/340, UIM/385, ITS/500/18FP, TCPD/17-9, HMRF18SC06 and PD18SC01; Zhongshan Municipal Bureau of Science and Technology, Grant/Award Number: ZSST20SC03	Arredondo J, 2003, LAB INVEST, V83, P207, DOI 10.1097/01.LAB.0000053917.46614.12; Bellono NW, 2014, J GEN PHYSIOL, V143, P203, DOI 10.1085/jgp.201311094; Bellono NW, 2013, P NATL ACAD SCI USA, V110, P2383, DOI 10.1073/pnas.1215555110; Borovansky J, 2011, MELANINS AND MELANOSOMES: BIOSYNTHESIS, BIOGENESIS, PHYSIOLOGICAL, AND PATHOLOGICAL FUNCTIONS, P1, DOI 10.1002/9783527636150; Botti SA, 1998, PROTEIN ENG, V11, P415, DOI 10.1093/protein/11.6.415; Brenner M, 2008, PHOTOCHEM PHOTOBIOL, V84, P539, DOI 10.1111/j.1751-1097.2007.00226.x; Chen SM, 1997, NEURON, V19, P1017, DOI 10.1016/S0896-6273(00)80394-3; Dedkova E N, 2000, Membr Cell Biol, V13, P357; EDELMAN GM, 1983, SCIENCE, V219, P450, DOI 10.1126/science.6823544; Eimar H, 2013, J MUSCULOSKEL NEURON, V13, P124; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Fujieda H, 2009, J NEUROCHEM, V108, P91, DOI 10.1111/j.1471-4159.2008.05739.x; Genever PG, 1999, BONE, V24, P297, DOI 10.1016/S8756-3282(98)00187-2; GORDON PR, 1988, J NUTR, V118, P1487, DOI 10.1093/jn/118.12.2187; GRANDO SA, 1995, J INVEST DERMATOL, V105, P774, DOI 10.1111/1523-1747.ep12325606; GRANDO SA, 1993, J INVEST DERMATOL, V101, P32, DOI 10.1111/1523-1747.ep12358588; Grando SA, 1997, JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS, VOL 2, NO 1, AUGUST 1997, P41, DOI 10.1038/jidsymp.1997.10; Haltaufderhyde K, 2015, PHOTOCHEM PHOTOBIOL, V91, P117, DOI 10.1111/php.12354; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hisatomi O, 2002, COMP BIOCHEM PHYS B, V133, P509, DOI 10.1016/S1096-4959(02)00127-6; Imai H, 1997, P NATL ACAD SCI USA, V94, P2322, DOI 10.1073/pnas.94.6.2322; Inkson CA, 2004, BONE, V35, P819, DOI 10.1016/j.bone.2004.05.026; Johnson G, 2003, NEUROSCI LETT, V337, P37, DOI 10.1016/S0304-3940(02)01298-3; KATZ B, 1965, PROC R SOC SER B-BIO, V161, P496, DOI 10.1098/rspb.1965.0017; Kehat R, 2004, INVEST OPHTH VIS SCI, V45, pU518; Kim MH, 2008, APOPTOSIS, V13, P295, DOI 10.1007/s10495-007-0160-y; Kishibe M, 2015, INT IMMUNOPHARMACOL, V29, P63, DOI 10.1016/j.intimp.2015.05.047; Klapproth H, 1997, N-S ARCH PHARMACOL, V355, P515, DOI 10.1007/PL00004977; LAYER PG, 1993, CELL TISSUE RES, V273, P219, DOI 10.1007/BF00312823; Lerner LE, 2005, J BIOL CHEM, V280, P20642, DOI 10.1074/jbc.M500957200; MASSOULIE J, 1982, ANNU REV NEUROSCI, V5, P57, DOI 10.1146/annurev.ne.05.030182.000421; MASSOULIE J, 1993, PROG NEUROBIOL, V41, P31, DOI 10.1016/0301-0082(93)90040-Y; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Nachmansohn D, 1943, J NEUROPHYSIOL, V6, P397, DOI 10.1152/jn.1943.6.5.397; Ndoye A, 1998, J INVEST DERMATOL, V111, P410, DOI 10.1046/j.1523-1747.1998.00299.x; Paraoanu LE, 2008, FEBS J, V275, P618, DOI 10.1111/j.1742-4658.2007.06237.x; Parsons SM, 2000, FASEB J, V14, P2423, DOI 10.1096/fj.00-0203rev; PATON WDM, 1971, J PHYSIOL-LONDON, V215, P819, DOI 10.1113/jphysiol.1971.sp009500; Peng GH, 2007, HUM MOL GENET, V16, P2433, DOI 10.1093/hmg/ddm200; Picciotto MR, 2012, NEURON, V76, P116, DOI 10.1016/j.neuron.2012.08.036; Qu L, 2009, J COMP NEUROL, V514, P343, DOI 10.1002/cne.22007; Regazzetti C, 2018, J INVEST DERMATOL, V138, P171, DOI 10.1016/j.jid.2017.07.833; Reinheimer T, 1996, AM J PHYSIOL-LUNG C, V270, pL722, DOI 10.1152/ajplung.1996.270.5.L722; Rosas-Ballina M, 2009, J INTERN MED, V265, P663, DOI 10.1111/j.1365-2796.2009.02098.x; ROSENBERRY TL, 1975, ADV ENZYMOL RAMB, V43, P103; Schlereth T, 2006, BRIT J PHARMACOL, V147, P183, DOI 10.1038/sj.bjp.0706451; Scholl FG, 2003, TRENDS NEUROSCI, V26, P618, DOI 10.1016/j.tins.2003.09.004; SCHUBERT D, 1977, P NATL ACAD SCI USA, V74, P5184, DOI 10.1073/pnas.74.11.5184; SCOTT A, 1962, BRIT J DERMATOL, V74, P317, DOI 10.1111/j.1365-2133.1962.tb13518.x; Sharma KV, 1998, J NEUROSCI RES, V53, P454, DOI 10.1002/(SICI)1097-4547(19980815)53:4<454::AID-JNR7>3.3.CO;2-E; Shi G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013216; Shichida Y, 1998, CELL MOL LIFE SCI, V54, P1299, DOI 10.1007/s000180050256; Shichida Y, 2009, PHILOS T R SOC B, V364, P2881, DOI 10.1098/rstb.2009.0051; Spieker J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170252; Spieker J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161675; Stavenga DG, 2008, PLOS BIOL, V6, P675, DOI 10.1371/journal.pbio.0060115; STEVEN DM, 1963, BIOL REV, V38, P204, DOI 10.1111/j.1469-185X.1963.tb00783.x; SUDHOF TC, 1987, SCIENCE, V238, P1142, DOI 10.1126/science.3120313; TANG A, 1994, J CELL SCI, V107, P983; Terakita A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-213; TERAKITA A, 1993, FEBS LETT, V330, P197, DOI 10.1016/0014-5793(93)80272-V; Thangaraj G, 2016, CHEM-BIOL INTERACT, V259, P313, DOI 10.1016/j.cbi.2016.03.027; Thangaraj G, 2012, J COMP NEUROL, V520, P3181, DOI 10.1002/cne.23083; TIWARI P, 2013, ASIAN PAC J TROP DIS, V3, P413, DOI DOI 10.1016/S2222-1808(13)60094-8; TSIM KWK, 1988, P NATL ACAD SCI USA, V85, P1262, DOI 10.1073/pnas.85.4.1262; Van den Bossche K, 2006, TRAFFIC, V7, P769, DOI 10.1111/j.1600-0854.2006.00425.x; Weyand CM, 2000, ARTHRITIS RES, V2, P457, DOI 10.1186/ar128; Wu QY, 2018, J BIOL CHEM, V293, P14417, DOI 10.1074/jbc.RA118.003729; Xu ML, 2019, CHEM-BIOL INTERACT, V308, P317, DOI 10.1016/j.cbi.2019.06.006; Xu ML, 2018, J NEUROCHEM, V146, P390, DOI 10.1111/jnc.14448; Xu ML, 2017, J BIOL CHEM, V292, P12667, DOI 10.1074/jbc.M117.777581; Yau KW, 2009, CELL, V139, P246, DOI 10.1016/j.cell.2009.09.029	72	9	9	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					8941	8958		10.1096/fj.202000708R	http://dx.doi.org/10.1096/fj.202000708R		JUN 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32519787				2022-12-28	WOS:000539525600001
J	Wang, YP; Nakajima, T; Diao, P; Yamada, Y; Nakamura, K; Nakayama, J; Tanaka, N; Aoyama, T; Kamijo, Y				Wang, Yaping; Nakajima, Takero; Diao, Pan; Yamada, Yosuke; Nakamura, Kozo; Nakayama, Jun; Tanaka, Naoki; Aoyama, Toshifumi; Kamijo, Yuji			Polyunsaturated fatty acid deficiency affects sulfatides and other sulfated glycans in lysosomes through autophagy-mediated degradation	FASEB JOURNAL			English	Article						amyloid precursor protein; Erk1; 2; glycosaminoglycans; lysosome enzyme; mTOR; nutritional deprivation	ACTIVATED RECEPTOR-ALPHA; EARLY ALZHEIMERS-DISEASE; CHONDROITIN SULFATE; BETA-GLUCURONIDASE; HEPARAN-SULFATE; KIDNEY; BRAIN; MTOR; CELLS; GLYCOSAMINOGLYCANS	Metabolic changes in sulfatides and other sulfated glycans have been related to various diseases, including Alzheimer's disease (AD). However, the importance of polyunsaturated fatty acids (PUFA) in sulfated lysosomal substrate metabolism and its related disorders is currently unknown. We investigated the effects of deficiency or supplementation of PUFA on the metabolism of sulfatides and sulfated glycosaminoglycans (sGAGs) in sulfatide-rich organs (brain and kidney) of mice. A PUFA-deficient diet for over 5 weeks significantly reduced the sulfatide expression by increasing the sulfatide degradative enzymes arylsulfatase A and galactosylceramidase in brain and kidney. This sulfatide degradation was clearly associated with the activation of autophagy and lysosomal hyperfunction, the former of which was induced by suppression of the Erk/mTOR pathway. A PUFA-deficient diet also activated the degradation of sGAGs in the brain and kidney and that of amyloid precursor proteins in the brain, indicating an involvement in general lysosomal function and the early developmental process of AD. PUFA supplementation prevented all of the above abnormalities. Taken together, a PUFA deficiency might lead to sulfatide and sGAG degradation associated with autophagy activation and general lysosomal hyperfunction and play a role in many types of disease development, suggesting a possible benefit of prophylactic PUFA supplementation.	[Wang, Yaping; Nakajima, Takero; Diao, Pan; Yamada, Yosuke; Tanaka, Naoki; Aoyama, Toshifumi; Kamijo, Yuji] Shinshu Univ, Dept Metab Regulat, Sch Med, Matsumoto, Nagano, Japan; [Yamada, Yosuke; Kamijo, Yuji] Shinshu Univ, Dept Nephrol, Sch Med, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan; [Nakamura, Kozo] Shinshu Univ, Dept Biosci & Biotechnol, Fac Agr, Minamiminowa, Japan; [Nakayama, Jun] Shinshu Univ, Dept Mol Pathol, Sch Med, Matsumoto, Nagano, Japan	Shinshu University; Shinshu University; Shinshu University; Shinshu University	Kamijo, Y (corresponding author), Shinshu Univ, Dept Nephrol, Sch Med, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	yujibeat@shinshu-u.ac.jp		Tanaka, Naoki/0000-0002-3212-3836	 [18K08204]		Grant-in-Aid for Scientific Research (Kakenhi) in Japan, Grant/Award Number: 18K08204	Aggleton JP, 2016, BRAIN, V139, P1877, DOI 10.1093/brain/aww083; Aoyama T, 1998, J BIOL CHEM, V273, P5678, DOI 10.1074/jbc.273.10.5678; Ashabi G, 2013, TOXICOL IN VITRO, V27, P1780, DOI 10.1016/j.tiv.2013.05.005; Bankaitis VA, 2015, EMBO J, V34, P978, DOI 10.15252/embj.201591392; Bazinet RP, 2014, NAT REV NEUROSCI, V15, P771, DOI 10.1038/nrn3820; Belibi F, 2011, AM J PHYSIOL-RENAL, V300, pF1235, DOI 10.1152/ajprenal.00348.2010; Cheng BJ, 2018, FOOD CHEM TOXICOL, V122, P143, DOI 10.1016/j.fct.2018.10.030; Cheng H, 2013, J NEUROCHEM, V127, P733, DOI 10.1111/jnc.12368; Cheng H, 2010, J LIPID RES, V51, P1599, DOI 10.1194/jlr.D004077; DECATERINA R, 1994, AM J KIDNEY DIS, V24, P397, DOI 10.1016/S0272-6386(12)80896-1; Dehay B, 2010, J NEUROSCI, V30, P12535, DOI 10.1523/JNEUROSCI.1920-10.2010; DESHMUKH GD, 1994, J LIPID RES, V35, P1611; DONADIO JV, 1991, MAYO CLIN PROC, V66, P1018, DOI 10.1016/S0025-6196(12)61725-X; Dunlop EA, 2014, SEMIN CELL DEV BIOL, V36, P121, DOI 10.1016/j.semcdb.2014.08.006; Egan DF, 2011, AUTOPHAGY, V7, P645, DOI 10.4161/auto.7.6.15123; Fabelo N, 2011, MOL MED, V17, P1107, DOI 10.2119/molmed.2011.00119; Han XL, 2010, MOL NEUROBIOL, V41, P97, DOI 10.1007/s12035-009-8092-x; Han XL, 2002, J NEUROCHEM, V82, P809, DOI 10.1046/j.1471-4159.2002.00997.x; HARA A, 1978, ANAL BIOCHEM, V90, P420, DOI 10.1016/0003-2697(78)90046-5; Harvey SJ, 2012, METHODS MOL BIOL, V836, P259, DOI 10.1007/978-1-61779-498-8_17; He LY, 2014, NEPHRON CLIN PRACT, V127, P56, DOI 10.1159/000363677; Honke K, 2002, P NATL ACAD SCI USA, V99, P4227, DOI 10.1073/pnas.032068299; Hosono T, 2015, BRAIN RES, V1613, P92, DOI 10.1016/j.brainres.2015.04.005; Hu BL, 2015, AUTOPHAGY, V11, P503, DOI 10.1080/15548627.2015.1017184; Huang XY, 2013, J NEPHROL, V26, P960, DOI 10.5301/jn.5000284; INNIS SM, 1991, PROG LIPID RES, V30, P39, DOI 10.1016/0163-7827(91)90006-Q; Ishibashi T, 2002, J NEUROSCI, V22, P6507; Ishii M, 2015, CELL METAB, V22, P761, DOI 10.1016/j.cmet.2015.08.016; Ishizuka I, 1997, PROG LIPID RES, V36, P245, DOI 10.1016/S0163-7827(97)00011-8; Jeon SB, 2008, J IMMUNOL, V181, P8077, DOI 10.4049/jimmunol.181.11.8077; Jonsson M, 2012, DEMENT GERIATR COGN, V34, P61, DOI 10.1159/000341576; Kadomatsu K, 2014, ARCH BIOCHEM BIOPHYS, V558, P36, DOI 10.1016/j.abb.2014.06.009; Kamijo Y, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000018403.61042.56; Kamijo Y, 2007, J AM SOC NEPHROL, V18, P3089, DOI 10.1681/ASN.2007020238; Kelsey KM, 2020, CELL TISSUE RES, V379, P561, DOI 10.1007/s00441-019-03144-1; Kim IC, 2016, J MASS SPECTROM, V51, P182, DOI 10.1002/jms.3736; Kim SG, 2013, MOL CELLS, V35, P463, DOI 10.1007/s10059-013-0138-2; Kocaturk NM, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00128; Lafourcade M, 2011, NAT NEUROSCI, V14, P345, DOI 10.1038/nn.2736; Lemos CCS, 2013, BRAZ J MED BIOL RES, V46, P567, DOI 10.1590/1414-431X20132339; Lensen JFM, 2005, J AM SOC NEPHROL, V16, P1279, DOI 10.1681/ASN.2004050413; Li G, 2007, ANAL BIOCHEM, V362, P1, DOI 10.1016/j.ab.2006.12.024; Li HY, 2016, AUTOPHAGY, V12, P1472, DOI 10.1080/15548627.2016.1190071; Li XJ, 2017, ACTA HISTOCHEM, V119, P439, DOI 10.1016/j.acthis.2017.04.001; Li YL, 2015, NEUROSCI LETT, V600, P206, DOI 10.1016/j.neulet.2015.06.024; Lindahl B, 1996, J BIOL CHEM, V271, P16991, DOI 10.1074/jbc.271.29.16991; Lu J, 2003, J NUTR, V133, P180, DOI 10.1093/jn/133.1.180; Ludewig S, 2017, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00161; Maeda N, 2011, NEUROCHEM RES, V36, P1228, DOI 10.1007/s11064-010-0324-y; Marcus J, 2006, GLIA, V53, P372, DOI 10.1002/glia.20292; Marsching C, 2011, ANAL BIOANAL CHEM, V401, P53, DOI 10.1007/s00216-011-4802-0; Masola V, 2014, NEPHROL DIAL TRANSPL, V29, pI74, DOI 10.1093/ndt/gft389; McLaughlin RW, 2006, PROTEIN SCI, V15, P1710, DOI 10.1110/ps.051997606; Mehra S, 2018, J BIOL CHEM, V293, P12975, DOI 10.1074/jbc.RA118.004267; Melk A, 2016, AUTOPHAGY, V12, P596, DOI 10.1080/15548627.2015.1135284; Huynh MB, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0209573; Miyata S, 2016, FRONT BIOSCI-LANDMRK, V21, P1330, DOI 10.2741/4460; Moriyama T, 2018, INTERNAL MED, V57, P173, DOI 10.2169/internalmedicine.9155-17; Nakajima T, 2017, TOHOKU J EXP MED, V242, P229, DOI 10.1620/tjem.242.229; Niso-Santano M, 2015, AUTOPHAGY, V11, P575, DOI 10.1080/15548627.2015.1017222; Niso-Santano M, 2015, EMBO J, V34, P1025, DOI 10.15252/embj.201489363; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Palmieri M, 2011, HUM MOL GENET, V20, P3852, DOI 10.1093/hmg/ddr306; POLLACK SJ, 1995, NEUROSCI LETT, V197, P211, DOI 10.1016/0304-3940(95)11939-T; Puglielli L, 2003, J BIOL CHEM, V278, P19777, DOI 10.1074/jbc.M300466200; Reine TM, 2013, J HISTOCHEM CYTOCHEM, V61, P606, DOI 10.1369/0022155413494392; Ren HX, 2017, FASEB J, V31, P282, DOI 10.1096/fj.201600896; Rice HC, 2019, SCIENCE, V363, P143, DOI 10.1126/science.aao4827; Schreiber A, 2014, BBA-MOL CELL RES, V1843, P163, DOI 10.1016/j.bbamcr.2013.03.019; Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Sharma A, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050751; SNOW AD, 1990, AM J PATHOL, V137, P1253; Spector AA, 2015, J LIPID RES, V56, P11, DOI 10.1194/jlr.R055095; Spence Justin, 2017, Consult Pharm, V32, P412, DOI 10.4140/TCP.n.2017.412; Stettner P, 2013, P NATL ACAD SCI USA, V110, P9998, DOI 10.1073/pnas.1217775110; Su HM, 2010, J NUTR BIOCHEM, V21, P364, DOI 10.1016/j.jnutbio.2009.11.003; Su LY, 2015, AUTOPHAGY, V11, P1745, DOI 10.1080/15548627.2015.1082020; SUKEGAWA K, 1985, J INHERIT METAB DIS, V8, P145, DOI 10.1007/BF01819300; Sun YJ, 2013, FOOD CHEM TOXICOL, V51, P53, DOI 10.1016/j.fct.2012.09.012; Sun Y, 2013, AUTOPHAGY, V9, P1115, DOI 10.4161/auto.24919; Suttkus A, 2016, MOL NEUROBIOL, V53, P73, DOI 10.1007/s12035-014-8990-4; Takahashi T, 2012, J LIPID RES, V53, P1437, DOI 10.1194/jlr.R026682; Thomas J, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/172801; Vogler C, 2003, P NATL ACAD SCI USA, V100, P2669, DOI 10.1073/pnas.0437941100; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xiao SY, 2013, ADV EXP MED BIOL, V991, P27, DOI 10.1007/978-94-007-6331-9_3; Xing SH, 2012, AUTOPHAGY, V8, P63, DOI 10.4161/auto.8.1.18217; Yamada Y, 2019, GLYCOCONJUGATE J, V36, P1, DOI 10.1007/s10719-018-9850-7; Yu WH, 2004, INT J BIOCHEM CELL B, V36, P2531, DOI 10.1016/j.biocel.2004.05.010; ZALC B, 1978, FEBS LETT, V92, P92, DOI 10.1016/0014-5793(78)80729-7; Zeng YC, 2008, J NEUROCHEM, V106, P1275, DOI 10.1111/j.1471-4159.2008.05481.x; Zhang BY, 2019, J VIROL, V93, DOI 10.1128/JVI.00172-19; Zhang J, 2012, J NEUROCHEM, V120, P564, DOI 10.1111/j.1471-4159.2011.07496.x; Zhang Z, 2016, NAGOYA J MED SCI, V78, P293; Zheng H, 2018, BBA-MOL BASIS DIS, V1864, P263, DOI 10.1016/j.bbadis.2017.10.028	96	2	2	2	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9594	9614		10.1096/fj.202000030RR	http://dx.doi.org/10.1096/fj.202000030RR		JUN 2020	21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32501606	Green Submitted, Green Published			2022-12-28	WOS:000539539500001
J	Schnoder, ML; Gasparoni, G; Nordstrom, K; Schottek, A; Tomic, I; Christmann, A; Schofer, KH; Menger, MD; Walter, J; Fassbender, K; Liu, Y				Schnoeder, Models Laura; Gasparoni, Gilles; Nordstroem, Karl; Schottek, Andrea; Tomic, Inge; Christmann, Anne; Schoefer, Karl H.; Menger, Michael D.; Walter, Joern; Fassbender, Klaus; Liu, Yang			Neuronal deficiency of p38 alpha-MAPK ameliorates symptoms and pathology of APP or Tau-transgenic Alzheimer's mouse models	FASEB JOURNAL			English	Article						Alzheimer's disease; calcium homeostasis; Mapk14; neurodegeneration; transcriptome analysis	DISEASE-RELATED SYMPTOMS; A-BETA; P38 KINASE; PHOSPHORYLATION; ACTIVATION; MICROGLIA; CALCIUM; OVEREXPRESSION; DEGRADATION; DYSFUNCTION	Alzheimer's disease (AD) is the leading cause of dementia with very limited therapeutic options. Amyloid beta (A beta) and phosphorylated Tau (p-Tau) are key pathogenic molecules in AD. P38 alpha-MAPK is specifically activated in AD lesion sites. However, its effects on AD pathogenesis, especially on p-Tau-associated brain pathology, and the underlying molecular mechanisms remain unclear. We mated human APP-transgenic mice and human P301S Tau-transgenic mice with mapk14-floxed and neuron-specific Cre-knock-in mice. We observed that deletion of p38 alpha-MAPK specifically in neurons improves the cognitive function of both 9-month-old APP and Tau-transgenic AD mice, which is associated with decreased A beta and p-Tau load in the brain. We further used next-generation sequencing to analyze the gene transcription in brains of p38 alpha-MAPK deficient and wild-type APP-transgenic mice, which indicated that deletion of p38 alpha-MAPK regulates the transcription of calcium homeostasis-related genes, especially downregulates the expression of grin2a, a gene encoding NMDAR subunit NR2A. Cell culture experiments further verified that deletion of p38 alpha-MAPK inhibits NMDA-triggered calcium influx and neuronal apoptosis. Our systemic studies of AD pathogenic mechanisms using both APP- and Tau-transgenic mice suggested that deletion of neuronal p38 alpha-MAPK attenuates AD-associated brain pathology and protects neurons in AD pathogenesis. This study supports p38 alpha-MAPK as a novel target for AD therapy.	[Schnoeder, Models Laura; Schottek, Andrea; Tomic, Inge; Fassbender, Klaus; Liu, Yang] Saarland Univ, Dept Neurol, Kirrberger Str, D-66421 Homburg, Germany; [Schnoeder, Models Laura; Schottek, Andrea; Tomic, Inge; Fassbender, Klaus; Liu, Yang] Saarland Univ, German Inst Dementia Prevent DIDP, Homburg, Germany; [Gasparoni, Gilles; Nordstroem, Karl; Walter, Joern] Saarland Univ, Dept Genet, Saarbrucken, Germany; [Christmann, Anne; Schoefer, Karl H.] Univ Appl Sci, Working Grp Enter Nervous Syst, Zweibrucken, Germany; [Menger, Michael D.] Saarland Univ, Dept Expt Surg, Homburg, Germany	Universitatsklinikum des Saarlandes; Universitatsklinikum des Saarlandes; Saarland University; Universitatsklinikum des Saarlandes	Liu, Y (corresponding author), Saarland Univ, Dept Neurol, Kirrberger Str, D-66421 Homburg, Germany.; Liu, Y (corresponding author), Saarland Univ, German Inst Dementia Prevent DIDP, Homburg, Germany.	a.liu@mx.uni-saarland.de	Walter, Jörn/AFN-6428-2022; Liu, Yang/GSD-5476-2022	Walter, Jörn/0000-0003-0563-7417; Liu, Yang/0000-0002-7614-4233; Fassbender, Klaus/0000-0003-3596-868X	Deutsche Forschungsgemeinschaft (DFG) [LI1725/2-1]; German federal ministry of research and education [031L0101D]; HOMFORexcell program	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); German federal ministry of research and education; HOMFORexcell program	Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: LI1725/2-1; German federal ministry of research and education, Grant/Award Number: 031L0101D; HOMFORexcell program	Arbel-Ornath M, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0169-9; Bachstetter AD, 2012, J NEUROSCI, V32, P10201, DOI 10.1523/JNEUROSCI.1496-12.2012; Bachstetter AD, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-79; Berry KP, 2017, NEURON, V96, P43, DOI 10.1016/j.neuron.2017.08.008; Cho MH, 2014, AUTOPHAGY, V10, P1761, DOI 10.4161/auto.29647; Colie S, 2017, SCI REP-UK, V7, DOI 10.1038/srep45306; COTMAN CW, 1988, ANNU REV NEUROSCI, V11, P61, DOI 10.1146/annurev.neuro.11.1.61; DeVos SL, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag0481; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Doody RS, 2014, NEW ENGL J MED, V370, P311, DOI 10.1056/NEJMoa1312889; Eales KL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5701; Egan MF, 2018, NEW ENGL J MED, V378, P1691, DOI 10.1056/NEJMoa1706441; Franzen O, 2019, DATABASE-OXFORD, DOI 10.1093/database/baz046; Ghosh S, 2013, J NEUROSCI, V33, P5053, DOI 10.1523/JNEUROSCI.4361-12.2013; Goebbels S, 2006, GENESIS, V44, P611, DOI 10.1002/dvg.20256; Green KN, 2008, NEURON, V59, P190, DOI 10.1016/j.neuron.2008.07.013; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; Hensley K, 1999, J NEUROCHEM, V72, P2053, DOI 10.1046/j.1471-4159.1999.0722053.x; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Inoue K, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-48; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Keil E, 2013, CELL DEATH DIFFER, V20, P321, DOI 10.1038/cdd.2012.129; Khananshvili D, 2013, MOL ASPECTS MED, V34, P220, DOI 10.1016/j.mam.2012.07.003; Kuchibhotla KV, 2008, NEURON, V59, P214, DOI 10.1016/j.neuron.2008.06.008; Lahiri DK, 2014, ALZHEIMERS DEMENT, V10, pS411, DOI 10.1016/j.jalz.2013.11.004; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li SM, 2011, J NEUROSCI, V31, P6627, DOI 10.1523/JNEUROSCI.0203-11.2011; Li YK, 2003, J NEUROSCI, V23, P1605; Liu Y, 2014, J NEUROSCI, V34, P12982, DOI 10.1523/JNEUROSCI.1348-14.2014; Lucin KM, 2013, NEURON, V79, P873, DOI 10.1016/j.neuron.2013.06.046; Luo WJ, 2017, NUCLEIC ACIDS RES, V45, pW501, DOI 10.1093/nar/gkx372; Luo WJ, 2013, BIOINFORMATICS, V29, P1830, DOI 10.1093/bioinformatics/btt285; Luo WJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-161; Maphis N, 2016, ALZHEIMERS RES THER, V8, DOI 10.1186/s13195-016-0221-y; Maphis N, 2015, BRAIN, V138, P1738, DOI 10.1093/brain/awv081; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Mucke L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006338; Munoz L, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-21; Nishida K, 2004, MOL CELL BIOL, V24, P10611, DOI 10.1128/MCB.24.24.10611-10620.2004; Nuzzo D, 2017, J PROTEOME RES, V16, P1526, DOI 10.1021/acs.jproteome.6b00925; Parr C, 2012, MOL CELL BIOL, V32, P4410, DOI 10.1128/MCB.00930-12; Qin YR, 2016, J IMMUNOL, V197, P3281, DOI 10.4049/jimmunol.1600873; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Reisberg B, 2003, NEW ENGL J MED, V348, P1333, DOI 10.1056/NEJMoa013128; Reynolds CH, 1997, J NEUROCHEM, V69, P191; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ryan SD, 2009, P NATL ACAD SCI USA, V106, P20936, DOI 10.1073/pnas.0905654106; Scheltens P, 2018, ANN CLIN TRANSL NEUR, V5, P464, DOI 10.1002/acn3.549; Schnoder L, 2016, J BIOL CHEM, V291, P2067, DOI 10.1074/jbc.M115.695916; Sheng JG, 2001, NEUROCHEM INT, V39, P341, DOI 10.1016/S0197-0186(01)00041-9; Shi YG, 2017, NAT REV MOL CELL BIO, V18, P655, DOI 10.1038/nrm.2017.86; Shimada Hitoshi, 2017, Alzheimers Dement (Amst), V6, P11, DOI 10.1016/j.dadm.2016.12.009; Soneson C., 2016, F1000RES, V4, DOI [10.12688/F1000RESEARCH.7563.2. F1000Research, DOI 10.12688/F1000RESEARCH.7563.2]; Srivats S, 2016, J CELL BIOL, V213, P65, DOI 10.1083/jcb.201506022; Sun AY, 2003, EXP NEUROL, V183, P394, DOI 10.1016/S0014-4886(03)00180-8; Tamura K, 2000, CELL, V102, P221, DOI 10.1016/S0092-8674(00)00027-1; Texido L, 2011, CELL CALCIUM, V49, P184, DOI 10.1016/j.ceca.2011.02.001; Vossel KA, 2010, SCIENCE, V330, P198, DOI 10.1126/science.1194653; Whitehead G, 2017, NEUROPHARMACOLOGY, V112, P221, DOI 10.1016/j.neuropharm.2016.08.022; Wyss-Coray T, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006346; Yin J, 2015, NEUROPHARMACOLOGY, V89, P215, DOI 10.1016/j.neuropharm.2014.09.027; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Zhu XW, 2000, J NEUROPATH EXP NEUR, V59, P880, DOI 10.1093/jnen/59.10.880	65	11	11	4	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9628	9649		10.1096/fj.201902731RR	http://dx.doi.org/10.1096/fj.201902731RR		MAY 2020	22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32475008	Green Published			2022-12-28	WOS:000538127100001
J	Ghazi, S; Bourgeois, S; Gomariz, A; Bugarski, M; Haenni, D; Martins, JR; Nombela-Arrieta, C; Unwin, RJ; Wagner, CA; Hall, AM; Craigie, E				Ghazi, Susan; Bourgeois, Soline; Gomariz, Alvaro; Bugarski, Milica; Haenni, Dominik; Martins, Joana R.; Nombela-Arrieta, Cesar; Unwin, Robert J.; Wagner, Carsten A.; Hall, Andrew M.; Craigie, Eilidh			Multiparametric imaging reveals that mitochondria-rich intercalated cells in the kidney collecting duct have a very high glycolytic capacity	FASEB JOURNAL			English	Article						calcium; epididymis; mitochondria; multiphoton microscopy	RENAL TUBULAR-ACIDOSIS; VACUOLAR H+-ATPASE; V-ATPASE; MOUSE; PROTON; PH; LOCALIZATION; METABOLISM; MICE; IDENTIFICATION	Alpha intercalated cells (alpha ICs) in the kidney collecting duct (CD) belong to a family of mitochondria rich cells (MRCs) and have a crucial role in acidifying the urine via apical V-ATPase pumps. The nature of metabolism in alpha ICs and its relationship to transport was not well-understood. Here, using multiphoton live cell imaging in mouse kidney tissue, FIB-SEM, and other complementary techniques, we provide new insights into mitochondrial structure and function in alpha ICs. We show that alpha IC mitochondria have a rounded structure and are not located in close proximity to V-ATPase containing vesicles. They display a bright NAD(P)H fluorescence signal and low uptake of voltage-dependent dyes, but are energized by a pH gradient. However, expression of complex V (ATP synthase) is relatively low in alpha ICs, even when stimulated by metabolic acidosis. In contrast, anaerobic glycolytic capacity is surprisingly high, and sufficient to maintain intracellular calcium homeostasis in the presence of complete aerobic inhibition. Moreover, glycolysis is essential for V-ATPase-mediated proton pumping. Key findings were replicated in narrow/clear cells in the epididymis, also part of the MRC family. In summary, using a range of cutting-edge techniques to investigate alpha IC metabolism in situ, we have discovered that these mitochondria dense cells have a high glycolytic capacity.	[Ghazi, Susan; Bugarski, Milica; Haenni, Dominik; Hall, Andrew M.; Craigie, Eilidh] Univ Zurich, Inst Anat, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Bourgeois, Soline; Wagner, Carsten A.] Univ Zurich, Inst Physiol, Zurich, Switzerland; [Gomariz, Alvaro; Nombela-Arrieta, Cesar] Univ Zurich, Dept Med Oncol & Hematol, Zurich, Switzerland; [Gomariz, Alvaro] Swiss Fed Inst Technol, Comp Vis Lab, Zurich, Switzerland; [Haenni, Dominik; Martins, Joana R.] Univ Zurich, Ctr Microscopy & Image Anal, Zurich, Switzerland; [Unwin, Robert J.] UCL, Dept Renal Med, London, England; [Unwin, Robert J.] AstraZeneca Biopharmaceut R&D, Gothenburg, Sweden; [Hall, Andrew M.] Univ Hosp Zurich, Dept Nephrol, Zurich, Switzerland	University of Zurich; University of Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University of London; University College London; University of Zurich; University Zurich Hospital	Hall, AM (corresponding author), Univ Zurich, Inst Anat, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	andrew.hall@uzh.ch	Hall, Andrew/GWV-2838-2022; Gomariz, Alvaro/AAY-7529-2020	Gomariz, Alvaro/0000-0002-6172-5190; Hall, Andrew/0000-0002-6328-7892; Bugarski, Milica/0000-0001-9845-1368; Haenni, Dominik/0000-0002-2166-7109	Swiss National Science Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Swiss National Science Foundation	BAGNASCO S, 1985, AM J PHYSIOL, V248, pF522, DOI 10.1152/ajprenal.1985.248.4.F522; Bagnis C, 2001, AM J PHYSIOL-RENAL, V280, pF437, DOI 10.1152/ajprenal.2001.280.3.F437; BASSNETT S, 1990, AM J PHYSIOL, V258, pC171, DOI 10.1152/ajpcell.1990.258.1.C171; Battistone MA, 2018, J AM SOC NEPHROL, V29, P545, DOI 10.1681/ASN.2017060643; Becker HM, 2010, AM J PHYSIOL-RENAL, V299, pF141, DOI 10.1152/ajprenal.00488.2009; BERGERON M, 1980, KIDNEY INT, V17, P175, DOI 10.1038/ki.1980.21; Beyenbach KW, 2006, J EXP BIOL, V209, P577, DOI 10.1242/jeb.02014; Bhargava P, 2017, NAT REV NEPHROL, V13, P629, DOI 10.1038/nrneph.2017.107; Biver S, 2008, NATURE, V456, P339, DOI 10.1038/nature07518; Bourgeois S, 2018, KIDNEY INT, V93, P390, DOI 10.1016/j.kint.2017.07.027; Brown D, 1996, J EXP BIOL, V199, P2345; Brown D, 2009, J EXP BIOL, V212, P1762, DOI 10.1242/jeb.028803; Cardona A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038011; Chambrey R, 2005, AM J PHYSIOL-RENAL, V289, pF1281, DOI 10.1152/ajprenal.00172.2005; Chambrey R, 2013, P NATL ACAD SCI USA, V110, P7928, DOI 10.1073/pnas.1221496110; Chen LH, 2017, P NATL ACAD SCI USA, V114, pE9989, DOI 10.1073/pnas.1710964114; Chiaravalli M, 2016, J AM SOC NEPHROL, V27, P1958, DOI 10.1681/ASN.2015030231; Christensen EI, 2012, COMPR PHYSIOL, V2, P805, DOI 10.1002/cphy.c100073; Da Silva N, 2010, AM J PHYSIOL-CELL PH, V298, pC1326, DOI 10.1152/ajpcell.00552.2009; Duchen MR, 2003, METHOD ENZYMOL, V361, P353; Dunn Kenneth W, 2018, Curr Protoc Cytom, V83, DOI 10.1002/cpcy.32; ERECINSKA M, 1995, J NEUROCHEM, V65, P2765; Fry AC, 2007, PHYSIOLOGY, V22, P202, DOI 10.1152/physiol.00044.2006; Ghesquiere B, 2014, NATURE, V511, P167, DOI 10.1038/nature13312; Gomariz A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04770-z; Hall AM, 2013, KIDNEY INT, V83, P72, DOI 10.1038/ki.2012.328; Hall AM, 2009, J AM SOC NEPHROL, V20, P1293, DOI 10.1681/ASN.2008070759; Helmuth JA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-372; Hering-Smith KS, 1998, KIDNEY INT, V53, P408, DOI 10.1046/j.1523-1755.1998.00754.x; Kreshuk A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024899; Lu M, 2001, J BIOL CHEM, V276, P30407, DOI 10.1074/jbc.M008768200; Luisier F, 2010, SIGNAL PROCESS, V90, P415, DOI 10.1016/j.sigpro.2009.07.009; Madisen L, 2015, NEURON, V85, P942, DOI 10.1016/j.neuron.2015.02.022; McKenzie M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154371; Miller RL, 2005, AM J PHYSIOL-CELL PH, V288, pC1134, DOI 10.1152/ajpcell.00084.2004; MUTO S, 1990, J CLIN INVEST, V86, P1829, DOI 10.1172/JCI114913; Nakamura S, 2004, AM J PHYSIOL-CELL PH, V287, pC97, DOI 10.1152/ajpcell.00469.2003; Nicholls DG, 2004, AGING CELL, V3, P35, DOI 10.1111/j.1474-9728.2003.00079.x; Nowik M, 2010, CELL PHYSIOL BIOCHEM, V26, P1059, DOI 10.1159/000323984; OWEN CS, 1992, ANAL BIOCHEM, V204, P65, DOI 10.1016/0003-2697(92)90140-3; Park J, 2018, SCIENCE, V360, P758, DOI 10.1126/science.aar2131; Parra KJ, 1998, MOL CELL BIOL, V18, P7064, DOI 10.1128/MCB.18.12.7064; Pelicano H, 2006, J CELL BIOL, V175, P913, DOI 10.1083/jcb.200512100; Peppiatt-Wildman CM, 2012, NEPHRON EXP NEPHROL, V121, pE49, DOI 10.1159/000342812; Petersen OH, 2005, CELL CALCIUM, V38, P161, DOI 10.1016/j.ceca.2005.06.023; Peti-Peterdi J, 2012, AM J PHYSIOL-RENAL, V302, pF227, DOI 10.1152/ajprenal.00561.2011; Ramshesh VK, 2018, METHODS MOL BIOL, V1782, P351, DOI 10.1007/978-1-4939-7831-1_21; Ransick A, 2019, DEV CELL, V51, P399, DOI 10.1016/j.devcel.2019.10.005; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; Roy A, 2015, CLIN J AM SOC NEPHRO, V10, P305, DOI 10.2215/CJN.08880914; Santo-Domingo J, 2012, J GEN PHYSIOL, V139, P415, DOI 10.1085/jgp.201110767; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Sieber MH, 2016, CELL, V164, P420, DOI 10.1016/j.cell.2015.12.020; Smolkova Katarina, 2012, Int J Cell Biol, V2012, P273947, DOI 10.1155/2012/273947; SOLTOFF SP, 1986, ANNU REV PHYSIOL, V48, P9; SPICER SS, 1958, J HISTOCHEM CYTOCHEM, V6, P52, DOI 10.1177/6.1.52; Stehberger PA, 2007, J AM SOC NEPHROL, V18, P1408, DOI 10.1681/ASN.2006101072; STEINMETZ PR, 1981, J MEMBRANE BIOL, V59, P27, DOI 10.1007/BF01870818; Su Y, 2008, AM J PHYSIOL-RENAL, V295, pF950, DOI 10.1152/ajprenal.90258.2008; TengUmnuay P, 1996, J AM SOC NEPHROL, V7, P260; THORENS B, 1990, AM J PHYSIOL, V259, pC286; UCHIDA S, 1988, AM J PHYSIOL, V255, pF977, DOI 10.1152/ajprenal.1988.255.5.F977; Wagner CA, 2004, PHYSIOL REV, V84, P1263, DOI 10.1152/physrev.00045.2003; WATTS BA, 1994, J BIOL CHEM, V269, P20250; Weiner ID, 2016, CURR OPIN NEPHROL HY, V25, P436, DOI 10.1097/MNH.0000000000000255; Winter C, 2011, AM J PHYSIOL-CELL PH, V301, pC1251, DOI 10.1152/ajpcell.00076.2011; WIRTHENSOHN G, 1986, PHYSIOL REV, V66, P469, DOI 10.1152/physrev.1986.66.2.469; Wu J, 2016, CELL, V166, P1371, DOI 10.1016/j.cell.2016.08.008; YAMADA E, 1995, J ELECTRON MICROSC, V44, P148	70	5	5	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8510	8525		10.1096/fj.202000273R	http://dx.doi.org/10.1096/fj.202000273R		MAY 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32367531				2022-12-28	WOS:000530925000001
J	Gupta, B; Liu, YH; Chopyk, DM; Rai, RP; Desai, C; Kumar, P; Farris, AB; Nusrat, A; Parkos, CA; Anania, FA; Raeman, R				Gupta, Biki; Liu, Yunshan; Chopyk, Daniel M.; Rai, Ravi P.; Desai, Chirayu; Kumar, Pradeep; Farris, Alton B.; Nusrat, Asma; Parkos, Charles A.; Anania, Frank A.; Raeman, Reben			Western diet-induced increase in colonic bile acids compromises epithelial barrier in nonalcoholic steatohepatitis	FASEB JOURNAL			English	Article						bile acids; intestinal permeability; microbiome; NAFLD; NASH; tight junction	INTESTINAL PERMEABILITY; BACTERIAL UPTAKE; GUT MICROBIOTA; LIVER; FAT; PATHOGENESIS; METABOLISM; DISEASE; CACO-2; MICE	There is compelling evidence implicating intestinal permeability in the pathogenesis of nonalcoholic steatohepatitis (NASH), but the underlying mechanisms remain poorly understood. Here we examined the role of bile acids (BA) in western diet (WD)-induced loss of colonic epithelial barrier (CEB) function in mice with a genetic impairment in intestinal epithelial barrier function, junctional adhesion molecule A knockout mice, F11r(-/-). WD-fed knockout mice developed severe NASH, which was associated with increased BA concentration in the cecum and loss of CEB function. Analysis of cecal BA composition revealed selective increases in primary unconjugated BAs in the WD-fed mice, which correlated with increased abundance of microbial taxa linked to BA metabolism. In vitro permeability assays revealed that chenodeoxycholic acid (CDCA), which was elevated in the cecum of WD-fed mice, increased paracellular permeability, while the BA-binding resin sevelamer hydrochloride protected against CDCA-induced loss of barrier function. Sequestration of intestinal BAs by in vivo delivery of sevelamer to WD-fed knockout mice attenuated colonic mucosal inflammation and improved CEB. Sevelamer also reduced hepatic inflammation and fibrosis, and improved metabolic derangements associated with NASH. Collectively, these findings highlight a hitherto unappreciated role for BAs in WD-induced impairment of the intestinal epithelial barrier in NASH.	[Gupta, Biki; Rai, Ravi P.; Raeman, Reben] Univ Pittsburgh, Dept Pathol, Div Expt Pathol, 200 Lothrop St,S408 S-BST, Pittsburgh, PA 15261 USA; [Liu, Yunshan; Chopyk, Daniel M.; Kumar, Pradeep] Emory Univ, Dept Med, Div Digest Dis, Atlanta, GA 30322 USA; [Desai, Chirayu] Charotar Univ Sci & Technol, Dept Microbiol & Immunol, PD Patel Inst Appl Sci, Anand, Gujarat, India; [Farris, Alton B.] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Nusrat, Asma; Parkos, Charles A.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Anania, Frank A.] US FDA, Div Gastroenterol & Inborn Error Prod, Silver Spring, MD USA; [Raeman, Reben] Univ Pittsburgh, Med Ctr, Sch Med, Pittsburgh Liver Res Ctr, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Emory University; Charotar University of Science & Technology - Charusat; Emory University; University of Michigan System; University of Michigan; US Food & Drug Administration (FDA); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Raeman, R (corresponding author), Univ Pittsburgh, Dept Pathol, Div Expt Pathol, 200 Lothrop St,S408 S-BST, Pittsburgh, PA 15261 USA.	reben.raeman@pitt.edu	Desai, Chirayu/V-8573-2019; Chopyk, Daniel/ABD-3591-2020; Gupta, Biki/AAF-6859-2020; Rai, Ravi Prakash/AGS-7101-2022; Raeman, Reben/AAF-7282-2021	Desai, Chirayu/0000-0001-8211-3575; Chopyk, Daniel/0000-0003-4207-1360; Raeman, Reben/0000-0002-3914-1797; Gupta, Biki/0000-0002-2315-1026; Gupta, Biki/0000-0001-8158-6813	National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health [DK061379, DK072564] Funding Source: Medline; NIAAA NIH HHS [F31 AA024960, F31AA024960] Funding Source: Medline; NIDDK NIH HHS [P30 DK120531, P30 DK034933, K01 DK110264, R01 DK072564, R01 DK061379] Funding Source: Medline	National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Araki Y, 2005, FREE RADICAL BIO MED, V39, P769, DOI 10.1016/j.freeradbiomed.2005.04.026; Barrasa JI, 2013, TOXICOL IN VITRO, V27, P964, DOI 10.1016/j.tiv.2012.12.020; Bernstein C, 2011, ARCH TOXICOL, V85, P863, DOI 10.1007/s00204-011-0648-7; Braunlin W, 2002, KIDNEY INT, V62, P611, DOI 10.1046/j.1523-1755.2002.00459.x; Camilleri M, 2015, GUT LIVER, V9, P332, DOI 10.5009/gnl14397; Chiang JYL, 2009, J LIPID RES, V50, P1955, DOI 10.1194/jlr.R900010-JLR200; Chiang John Yl, 2017, F1000Res, V6, P2029, DOI 10.12688/f1000research.12449.1; Chopyk DM, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13541; Dawson PA, 2015, J LIPID RES, V56, P1085, DOI 10.1194/jlr.R054114; Debruyne PR, 2001, MUTAT RES-FUND MOL M, V480, P359, DOI 10.1016/S0027-5107(01)00195-6; Devkota S, 2012, NATURE, V487, P104, DOI 10.1038/nature11225; Drucker DJ, 2001, ENDOCRINOLOGY, V142, P521, DOI 10.1210/en.142.2.521; Estes C, 2018, HEPATOLOGY, V67, P123, DOI 10.1002/hep.29466; Fang S, 2015, NAT MED, V21, P159, DOI 10.1038/nm.3760; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Hegyi P, 2018, PHYSIOL REV, V98, P1983, DOI 10.1152/physrev.00054.2017; HIDALGO IJ, 1989, GASTROENTEROLOGY, V96, P736; Barrasa JI, 2011, APOPTOSIS, V16, P1054, DOI 10.1007/s10495-011-0633-x; Jones BV, 2008, P NATL ACAD SCI USA, V105, P13580, DOI 10.1073/pnas.0804437105; Kanwal F, 2018, GASTROENTEROLOGY, V155, P1828, DOI 10.1053/j.gastro.2018.08.024; Kitahara M, 2000, INT J SYST EVOL MICR, V50, P971, DOI 10.1099/00207713-50-3-971; Lemoinne S, 2019, CURR OPIN PHARMACOL, V49, P60, DOI 10.1016/j.coph.2019.09.006; Li F, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3384; Li TG, 2013, HEPATOLOGY, V58, P1111, DOI 10.1002/hep.26427; Li TG, 2010, HEPATOLOGY, V52, P678, DOI 10.1002/hep.23721; Luther J, 2015, CELL MOL GASTROENTER, V1, P222, DOI 10.1016/j.jcmgh.2015.01.001; McGettigan BM, 2016, J BIOL CHEM, V291, P23058, DOI 10.1074/jbc.M116.731042; Miele L, 2009, HEPATOLOGY, V49, P1877, DOI 10.1002/hep.22848; Mouzaki M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151829; Munch A, 2007, SCAND J GASTROENTERO, V42, P1167, DOI 10.1080/00365520701320463; Munch A, 2011, ALIMENT PHARM THER, V33, P954, DOI 10.1111/j.1365-2036.2011.04611.x; Narushima S, 2000, LIPIDS, V35, P639, DOI 10.1007/s11745-000-0568-0; Narushima S, 2006, LIPIDS, V41, P835, DOI 10.1007/s11745-006-5038-1; O'Grady MJ, ASSESSING EC OB OB I, P1; Oduyebo I, 2017, CURR OPIN GASTROEN, V33, P189, DOI 10.1097/MOG.0000000000000344; Rahman K, 2016, GASTROENTEROLOGY, V151, P733, DOI 10.1053/j.gastro.2016.06.022; Raimondi F, 2008, AM J PHYSIOL-GASTR L, V294, pG906, DOI 10.1152/ajpgi.00043.2007; Ramirez-Perez O, 2017, ANN HEPATOL, V16, pS21, DOI 10.5604/01.3001.0010.5672; Rao A, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf4823; Ridlon JM, 2014, CURR OPIN GASTROEN, V30, P332, DOI 10.1097/MOG.0000000000000057; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; Sarathy J, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13294; Sayin SI, 2013, CELL METAB, V17, P225, DOI 10.1016/j.cmet.2013.01.003; Schuppan D, 2013, J GASTROEN HEPATOL, V28, P68, DOI 10.1111/jgh.12212; Staley C, 2017, APPL MICROBIOL BIOT, V101, P47, DOI 10.1007/s00253-016-8006-6; Stenman LK, 2013, AM J PHYSIOL-GASTR L, V304, pG227, DOI 10.1152/ajpgi.00267.2012; Thomas C, 2008, NAT REV DRUG DISCOV, V7, P678, DOI 10.1038/nrd2619; Wahlstrom A, 2016, CELL METAB, V24, P41, DOI 10.1016/j.cmet.2016.05.005; Wigg AJ, 2001, GUT, V48, P206, DOI 10.1136/gut.48.2.206	51	20	20	1	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					7089	7102		10.1096/fj.201902687R	http://dx.doi.org/10.1096/fj.201902687R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32275114	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000531325500073
J	Yang, SC; Wang, YH; Tsai, YF; Chang, YW; Wu, TS; Ho, CM; Hwang, TL				Yang, Shun-Chin; Wang, Yi-Hsuan; Tsai, Yung-Fong; Chang, Ya-Wen; Wu, Tian-Shung; Ho, Chiu-Ming; Hwang, Tsong-Long			A synthesized heterocyclic chalcone inhibits neutrophilic inflammation through K+-dependent pH regulation	FASEB JOURNAL			English	Article						alkalization; degranulation; Mannich bases of heterocyclic chalcone; neutrophil; respiratory burst	SUPEROXIDE-PRODUCTION; EXTRACELLULAR TRAPS; ELASTASE RELEASE; MANNICH-BASES; LUNG INJURY; CALCIUM; ACTIVATION; EXCHANGE; CHANNEL; ANALOGS	Human neutrophils have a vital role in host defense and inflammatory responses in innate immune systems. Growing evidence shows that the overproduction of reactive oxygen species and granular proteolytic enzymes from activated neutrophils is linked to the pathogenesis of acute inflammatory diseases. However, adequate therapeutic targets are still lacking to regulate neutrophil functions. Herein, we report that MVBR-28, synthesized from the Mannich bases of heterocyclic chalcone, has anti-neutrophilic inflammatory effects through regulation of intracellular pH. MVBR-28 modulates neutrophil functions by attenuating respiratory burst, degranulation, and migration. Conversely, MVBR-28 has no antioxidant effects and fails to alter elastase activity in cell-free systems. The anti-inflammatory effects of MVBR-28 are not seen through cAMP pathways. Significantly, MVBR-28 potently inhibits extracellular Ca2+ influx in N-formyl-methionyl-leucyl-phenylalanine (fMLF)- and thapsigargin-activated human neutrophils. Notably, MVBR-28 attenuates fMLF-induced intracellular alkalization in a K+-dependent manner, which is upstream of Ca2+ pathways. Collectively, these findings provide new insight into Mannich bases of heterocyclic chalcone regarding the regulation of neutrophil functions and the potential for the development of MVBR-28 as a lead compound for treating neutrophilic inflammatory diseases.	[Yang, Shun-Chin; Ho, Chiu-Ming] Taipei Vet Gen Hosp, Dept Anesthesiol, Taipei, Taiwan; [Yang, Shun-Chin; Ho, Chiu-Ming] Natl Yang Ming Univ, Taipei, Taiwan; [Yang, Shun-Chin; Wang, Yi-Hsuan; Chang, Ya-Wen; Hwang, Tsong-Long] Chang Gung Univ, Coll Med, Grad Inst Nat Prod, 259 Wen Hwa 1st Rd, Taoyuan 333, Taiwan; [Wang, Yi-Hsuan; Hwang, Tsong-Long] Coll Med Chang Gung Univ, Grad Inst Biomed Sci, Div Nat Prod, Taoyuan, Taiwan; [Tsai, Yung-Fong; Hwang, Tsong-Long] Chang Gung Mem Hosp, Dept Anesthesiol, Taoyuan, Taiwan; [Tsai, Yung-Fong] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Taoyuan, Taiwan; [Wu, Tian-Shung] Tajen Univ, Coll Pharm & Hlth Care, Dept Pharm, Pingtung, Taiwan; [Wu, Tian-Shung] Natl Cheng Kung Univ, Coll Med, Sch Pharm, Tainan, Taiwan; [Hwang, Tsong-Long] Chang Gung Univ Sci & Technol, Res Ctr Chinese Herbal Med, Res Ctr Food & Cosmet Safety, Taoyuan, Taiwan; [Hwang, Tsong-Long] Chang Gung Univ Sci & Technol, Grad Inst Hlth Ind Technol, Coll Human Ecol, Taoyuan, Taiwan; [Hwang, Tsong-Long] Chang Gung Univ, Hlth Aging Res Ctr, Chinese Herbal Med Res Team, Taoyuan, Taiwan; [Hwang, Tsong-Long] Ming Chi Univ Technol, Dept Chem Engn, New Taipei, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; National Cheng Kung University; Chang Gung University of Science & Technology; Chang Gung University of Science & Technology; Chang Gung University; Ming Chi University of Technology	Hwang, TL (corresponding author), Chang Gung Univ, Coll Med, Grad Inst Nat Prod, 259 Wen Hwa 1st Rd, Taoyuan 333, Taiwan.	htl@mail.cgu.edu.tw	Ho, Chiu-Ming/D-5102-2018; Hwang, Tsong-Long/AAE-6944-2020	Ho, Chiu-Ming/0000-0002-1277-2855; Hwang, Tsong-Long/0000-0002-5780-3977				Ackland GL, 2019, BRIT J ANAESTH, V122, P180, DOI 10.1016/j.bja.2018.09.002; Ahluwalia J, 2004, NATURE, V427, P853, DOI 10.1038/nature02356; Bedi P, 2018, AM J RESP CRIT CARE, V198, P880, DOI 10.1164/rccm.201712-2423OC; Brazil JC, 2016, AM J PATHOL, V186, P297, DOI 10.1016/j.ajpath.2015.10.015; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; Chen CY, 2018, FREE RADICAL BIO MED, V129, P372, DOI 10.1016/j.freeradbiomed.2018.09.048; Chiaradia LD, 2008, BIOORGAN MED CHEM, V16, P658, DOI 10.1016/j.bmc.2007.10.039; Clemens RA, 2015, J LEUKOCYTE BIOL, V98, P497, DOI 10.1189/jlb.2MR1114-573R; Coakley RJ, 2002, J LEUKOCYTE BIOL, V71, P603; De Vito P, 2006, CELL IMMUNOL, V240, P69, DOI 10.1016/j.cellimm.2006.07.001; DeCoursey Thomas E, 2004, Sci STKE, V2004, ppe21, DOI 10.1126/stke.2332004pe21; Denk S, 2017, J IMMUNOL, V198, P4846, DOI 10.4049/jimmunol.1700393; Dicker AJ, 2018, J ALLERGY CLIN IMMUN, V141, P117, DOI 10.1016/j.jaci.2017.04.022; Essin K, 2007, AM J PHYSIOL-CELL PH, V293, pC45, DOI 10.1152/ajpcell.00450.2006; FAILLI P, 1993, BRIT J PHARMACOL, V110, P213, DOI 10.1111/j.1476-5381.1993.tb13794.x; Giambelluca MS, 2014, CELL PHYSIOL BIOCHEM, V33, P982, DOI 10.1159/000358669; Go ML, 2005, CURR MED CHEM, V12, P483, DOI 10.2174/0929867053363153; Grommes J, 2011, MOL MED, V17, P293, DOI 10.2119/molmed.2010.00138; Hayashi H, 2008, AM J PHYSIOL-CELL PH, V294, pC526, DOI 10.1152/ajpcell.00219.2007; Hellebrekers P, 2018, EUR J CLIN INVEST, V48, DOI 10.1111/eci.12943; Herencia F, 1998, BIOORG MED CHEM LETT, V8, P1169, DOI 10.1016/S0960-894X(98)00179-6; Hidalgo MA, 2004, BRIT J PHARMACOL, V141, P311, DOI 10.1038/sj.bjp.0705590; Hsieh HK, 2000, J PHARM PHARMACOL, V52, P163, DOI 10.1211/0022357001773814; Hwang TL, 2006, BRIT J PHARMACOL, V148, P78, DOI 10.1038/sj.bjp.0706712; Immler R, 2018, EUR J CLIN INVEST, V48, DOI 10.1111/eci.12964; Ivanova Y, 2007, EUR J MED CHEM, V42, P1382, DOI 10.1016/j.ejmech.2007.02.019; Jorch SK, 2017, NAT MED, V23, P279, DOI 10.1038/nm.4294; Kappala SS, 2014, MOL CELL BIOCHEM, V387, P251, DOI 10.1007/s11010-013-1890-5; Kruger P, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004651; Lacy Paige, 2006, Allergy Asthma Clin Immunol, V2, P98, DOI 10.1186/1710-1492-2-3-98; Mahapatra DK, 2017, CURR TOP MED CHEM, V17, P3146, DOI 10.2174/1568026617666170914160446; Minders C, 2015, BIOORG MED CHEM LETT, V25, P5270, DOI 10.1016/j.bmcl.2015.09.049; Nowakowska Z, 2007, EUR J MED CHEM, V42, P125, DOI 10.1016/j.ejmech.2006.09.019; Ortiz-Acevedo A, 2008, AM J PHYSIOL-CELL PH, V295, pC1316, DOI 10.1152/ajpcell.00160.2008; POZZAN T, 1983, SCIENCE, V221, P1413, DOI 10.1126/science.6310757; Reddy MVB, 2008, BIOORGAN MED CHEM, V16, P7358, DOI 10.1016/j.bmc.2008.06.018; Reddy MVB, 2011, BIOORGAN MED CHEM, V19, P2751, DOI 10.1016/j.bmc.2011.02.038; Reeves EP, 2002, NATURE, V416, P291, DOI 10.1038/416291a; ROTSTEIN OD, 1987, INFECT IMMUN, V55, P864, DOI 10.1128/IAI.55.4.864-870.1987; Sahu NK, 2012, CURR MED CHEM, V19, P209; Schaff UY, 2010, BLOOD, V115, P657, DOI 10.1182/blood-2009-05-224659; Sharma V, 2013, ANTI-CANCER AGENT ME, V13, P422; Tsai Yung-Fong, 2018, Cell Physiol Biochem, V51, P2776, DOI 10.1159/000495970; Tsai YF, 2015, FREE RADICAL BIO MED, V89, P387, DOI 10.1016/j.freeradbiomed.2015.08.008; WU ML, 1994, CIRC RES, V75, P123, DOI 10.1161/01.RES.75.1.123; Yang SC, 2018, BIOCHEM PHARMACOL, V154, P384, DOI 10.1016/j.bcp.2018.06.003; Yang SC, 2017, FREE RADICAL BIO MED, V106, P254, DOI 10.1016/j.freeradbiomed.2017.02.038; Yang Shun-Chin, 2016, Front Biosci (Elite Ed), V8, P436; Yang SC, 2013, J IMMUNOL, V190, P6511, DOI 10.4049/jimmunol.1202215; Yu HP, 2011, FREE RADICAL BIO MED, V50, P1737, DOI 10.1016/j.freeradbiomed.2011.03.026	50	1	1	2	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					7127	7143		10.1096/fj.201903123R	http://dx.doi.org/10.1096/fj.201903123R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32275103	Bronze			2022-12-28	WOS:000531325500076
J	Zhang, YH; Zou, JN; Tolbert, E; Zhao, TC; Bayliss, G; Zhuang, SG				Zhang, Yunhe; Zou, Jianan; Tolbert, Evelyn; Zhao, Ting C.; Bayliss, George; Zhuang, Shougang			Identification of histone deacetylase 8 as a novel therapeutic target for renal fibrosis	FASEB JOURNAL			English	Article						epithelial-mesenchymal transition; histone deacetylase 8; renal fibrosis; transforming growth factor beta 1; unilateral ureteral obstruction; beta-catenin	INTERSTITIAL FIBROBLAST ACTIVATION; TO-MESENCHYMAL TRANSITION; KIDNEY; INHIBITION; STAT3; BETA; MECHANISMS; REGULATOR; CANCER; HDAC8	Histone deacetylases (HDACs) have been shown to alleviate renal fibrosis, however, the role of individual HDAC isoforms in this process is poorly understood. In this study, we examined the role of HDAC8 in the development of renal fibrosis and partial epithelial-mesenchymal transitions (EMT). In a murine model of renal fibrosis induced by unilateral ureteral obstruction (UUO), HDAC8 was primarily expressed in renal tubular epithelial cells and time-dependently upregulated. This occurred in parallel with the deacetylation of cortactin, a nonhistone substrate of HDAC8, and increased expression of three fibrotic markers: alpha-smooth muscle actin, collagen 1, and fibronectin. Administration of PCI34051, a highly selective inhibitor of HDAC8, restored acetylation of contactin and reduced expression of those proteins. PCI34051 treatment also reduced the number of renal tubular epithelial cells arrested at the G2/M phase of the cell cycle and suppressed phosphorylation of Smad3, STAT3, beta-catenin, and expression of Snail after ureteral obstruction. In contrast, HDAC8 inhibition reversed UUO-induced downregulation of BMP7 and Klotho, two renoprotective proteins. In cultured murine proximal tubular cells, treatment with PCI34051 or specific HDAC8 siRNA was also effective in inhibiting transforming growth factor beta 1 (TGF beta 1)-induced deacetylation of contactin, EMT, phosphorylation of Smad3, STAT3, and beta-catenin, upregulation of Snail, and downregulation of BMP7 and Klotho. Collectively, these results suggest that HDAC8 activation is required for the EMT and renal fibrogenesis by activation of multiple profibrotic signaling and transcription factors, and suppression of antifibrotic proteins. Therefore, targeting HDAC8 may be novel therapeutic approach for treatment of renal fibrosis.	[Zhang, Yunhe; Zou, Jianan; Tolbert, Evelyn; Bayliss, George; Zhuang, Shougang] Brown Univ, Rhode Isl Hosp, Alpert Med Sch, Dept Med, Providence, RI 02903 USA; [Zhang, Yunhe] Tongji Univ, Shanghai East Hosp, Dept Emergency Care, Sch Med, Shanghai, Peoples R China; [Zhao, Ting C.] Boston Univ, Dept Surg, Roger Williams Med Ctr, Med Sch, Providence, RI USA; [Zhuang, Shougang] Tongji Univ, Shanghai East Hosp, Dept Nephrol, Sch Med, Shanghai 200120, Peoples R China	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Tongji University; Boston University; Roger Williams Medical Center; Tongji University	Zhuang, SG (corresponding author), Tongji Univ, Shanghai East Hosp, Dept Nephrol, Sch Med, Shanghai 200120, Peoples R China.	szhuang@lifespan.org		Zhang, Yunhe/0000-0003-3684-7580	National Nature Science Foundation of China [81830021, 81670623]; Branch Grant of National Key Grants of the Ministry of Science and Technology [2018YFA0108802]; US National Institutes of Health [1R01DK113256-01A1]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Branch Grant of National Key Grants of the Ministry of Science and Technology; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	National Nature Science Foundation of China, Grant/Award Number: 81830021 and 81670623; Branch Grant of National Key Grants of the Ministry of Science and Technology, Grant/Award Number: 2018YFA0108802; US National Institutes of Health, Grant/Award Number: 1R01DK113256-01A1	Bajpai R, 2010, NATURE, V463, P958, DOI 10.1038/nature08733; Balasubramanian S, 2008, LEUKEMIA, V22, P1026, DOI 10.1038/leu.2008.9; Basile C, 2008, J NEPHROL, V21, P657; Bienaime F, 2016, J AM SOC NEPHROL, V27, P3690, DOI 10.1681/ASN.2015091014; Canaud G, 2015, NEPHROL DIAL TRANSPL, V30, P575, DOI 10.1093/ndt/gfu230; Chakrabarti A, 2015, TRENDS PHARMACOL SCI, V36, P481, DOI 10.1016/j.tips.2015.04.013; Chen W, 2017, NAT REV NEPHROL, V13, P601, DOI 10.1038/nrneph.2017.118; Choi SY, 2016, J CELL MOL MED, V20, P2289, DOI 10.1111/jcmm.12919; Das L, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.26; Docherty MH, 2019, J AM SOC NEPHROL, V30, P726, DOI 10.1681/ASN.2018121251; Duffield JS, 2016, J AM SOC NEPHROL, V27, P3502, DOI 10.1681/ASN.2016060603; Hao S, 2011, J AM SOC NEPHROL, V22, P1642, DOI 10.1681/ASN.2010101079; Higgins DF, 2017, BBA-MOL BASIS DIS, V1863, P3095, DOI 10.1016/j.bbadis.2017.09.011; Iaconelli J, 2015, ACS CHEM BIOL, V10, P883, DOI 10.1021/cb500838r; Imai N, 2007, STEM CELLS, V25, P2469, DOI 10.1634/stemcells.2007-0049; Ji FH, 2019, J CELL BIOCHEM, V120, P4573, DOI 10.1002/jcb.27746; Kaiser FJ, 2014, HUM MOL GENET, V23, P2888, DOI 10.1093/hmg/ddu002; Kuro-o M, 2019, NAT REV NEPHROL, V15, P27, DOI 10.1038/s41581-018-0078-3; Li RX, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00114; Lin WJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep46195; Liu AH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056536, 10.1371/journal.pone.0057359, 10.1371/journal.pone.0056570, 10.1371/journal.pone.0054001]; Liu YH, 2010, J AM SOC NEPHROL, V21, P212, DOI 10.1681/ASN.2008121226; Loboda A, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/8319283; Lovisa S, 2016, TRENDS ENDOCRIN MET, V27, P681, DOI 10.1016/j.tem.2016.06.004; Lovisa S, 2015, NAT MED, V21, P998, DOI 10.1038/nm.3902; Lu X, 2017, KIDNEY DIS-BASEL, V3, P15, DOI 10.1159/000452880; Marumo T, 2008, J AM SOC NEPHROL, V19, P1311, DOI 10.1681/ASN.2007091040; Matsui F, 2012, J SURG RES, V178, P339, DOI 10.1016/j.jss.2012.06.050; Mencke R, 2017, ADV DRUG DELIVER REV, V121, P85, DOI 10.1016/j.addr.2017.07.009; Meng XM, 2016, NAT REV NEPHROL, V12, P325, DOI 10.1038/nrneph.2016.48; Ng JK, NEPHROLOGY CARLTO S4, V23, P116; Ning XX, 2018, J CELL MOL MED, V22, P1383, DOI 10.1111/jcmm.13465; Pan J, 2019, BIOMED PHARMACOTHER, V109, P1802, DOI 10.1016/j.biopha.2018.11.022; Pang MY, 2010, KIDNEY INT, V78, P257, DOI 10.1038/ki.2010.154; Pang MY, 2009, AM J PHYSIOL-RENAL, V297, pF996, DOI 10.1152/ajprenal.00282.2009; Saito S, 2019, AM J PHYSIOL-LUNG C, V316, pL175, DOI 10.1152/ajplung.00551.2017; Simon-Tillaux N, 2017, NEPHROL DIAL TRANSPL, V32, P224, DOI 10.1093/ndt/gfw333; Stone RC, 2016, CELL TISSUE RES, V365, P495, DOI 10.1007/s00441-016-2464-0; Tang JH, 2015, CURR OPIN NEPHROL HY, V24, P351, DOI 10.1097/MNH.0000000000000140; Xiong CX, 2019, FASEB J, V33, P8249, DOI 10.1096/fj.201801067RR; Yamauchi Y, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002316; Yan YL, 2016, KIDNEY INT, V89, P68, DOI 10.1038/ki.2015.293; Yang M, 2019, PHARMACOL RES, V142, P192, DOI 10.1016/j.phrs.2019.02.011; Zhuang SG, 2018, NEPHROLOGY, V23, P21, DOI 10.1111/nep.13466; Zuo YY, 2018, NEPHROLOGY, V23, P38, DOI 10.1111/nep.13472	45	17	17	3	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					7295	7310		10.1096/fj.201903254R	http://dx.doi.org/10.1096/fj.201903254R		APR 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32281211	Green Accepted			2022-12-28	WOS:000526117500001
J	Kim, NR; Jardi, F; Khalil, R; Antonio, L; Schollaert, D; Deboel, L; van Lenthe, GH; Decallonne, B; Carmeliet, G; Gustafsson, JA; Claessens, F; Ohlsson, C; Lagerquist, MK; Dubois, V; Vanderschueren, D				Kim, Na Ri; Jardi, Ferran; Khalil, Rougin; Antonio, Leen; Schollaert, Dieter; Deboel, Ludo; van Lenthe, G. Harry; Decallonne, Brigitte; Carmeliet, Geert; Gustafsson, Jan-Ake; Claessens, Frank; Ohlsson, Claes; Lagerquist, Marie K.; Dubois, Vanessa; Vanderschueren, Dirk			Estrogen receptor alpha signaling in extrahypothalamic neurons during late puberty decreases bone size and strength in female but not in male mice	FASEB JOURNAL			English	Article						GH; IGF-1; neuroendocrine bone axis; puberty; sex steroids; skeletal sexual dimorphism	GROWTH-HORMONE-SECRETION; SEXUAL-DIMORPHISM; ER-ALPHA; ANDROGENS; GENE; BETA; HYPOTHALAMUS; INACTIVATION; INNERVATION; DEFICIENCY	Sexually dimorphic bone structure emerges largely during puberty. Sex steroids are critical for peak bone mass acquisition in both genders. In particular, the biphasic effects of estrogens mediate the skeletal sexual dimorphism. However, so far the stimulatory vs inhibitory actions of estrogens on bone mass are not fully explained by direct effects on bone cells. Recently, it has become evident that there is possible neuroendocrine action of estrogen receptor alpha (ER alpha) on the skeleton. Based on these considerations, we hypothesized that neuronal ER alpha-signaling may contribute to the skeletal growth during puberty. Here, we generated mice with tamoxifen-inducible Thy1-Cre mediated ER alpha inactivation during late puberty specifically in extrahypothalamic neurons (N-ER alpha KO). Inactivation of neuronal ER alpha did not alter the body weight in males, whereas N-ER alpha KO females exhibited a higher body weight and increased body and bone length compared to their control littermates at 16 weeks of age. Ex vivo microCT analysis showed increased radial bone expansion of the midshaft femur in female N-ER alpha KO along with higher serum levels of insulin-like growth factor (IGF)-1 as well as IGF-binding protein (IGFBP)-3. Furthermore, the 3-point bending test revealed increased bone strength in female N-ER alpha KO. In contrast, inactivation of neuronal ER alpha had no major effect on bone growth in males. In conclusion, we demonstrate that central ER alpha-signaling limits longitudinal bone growth and radial bone expansion specifically in females potentially by interacting with the GH/IGF-1 axis.	[Kim, Na Ri; Jardi, Ferran; Khalil, Rougin; Antonio, Leen; Schollaert, Dieter; Deboel, Ludo; Decallonne, Brigitte; Carmeliet, Geert; Dubois, Vanessa; Vanderschueren, Dirk] Katholieke Univ Leuven, Dept Chron Dis Metab & Ageing CHROMETA, Clin & Expt Endocrinol, Herestr 49 Box 902, B-3000 Leuven, Belgium; [van Lenthe, G. Harry] Katholieke Univ Leuven, Biomech Sect, Dept Mech Engn, Leuven, Belgium; [Gustafsson, Jan-Ake] Univ Houston, Ctr Nucl Receptors & Cell Signaling, Dept Biol & Biochem, Houston, TX USA; [Claessens, Frank] Katholieke Univ Leuven, Mol Endocrinol Lab, Dept Cellular & Mol Med, Leuven, Belgium; [Ohlsson, Claes; Lagerquist, Marie K.] Univ Gothenburg, Sahlgrenska Acad, Ctr Bone & Arthrit Res, Inst Med, Gothenburg, Sweden	KU Leuven; KU Leuven; University of Houston System; University of Houston; KU Leuven; University of Gothenburg	Vanderschueren, D (corresponding author), Katholieke Univ Leuven, Dept Chron Dis Metab & Ageing CHROMETA, Clin & Expt Endocrinol, Herestr 49 Box 902, B-3000 Leuven, Belgium.	dirk.vanderschueren@uzleuven.be	Ohlsson, Claes/HIR-6959-2022; van Lenthe, Harry (GH)/C-1030-2008; Antonio, Leen/T-1206-2018; Lagerquist, Marie/A-9531-2010; Ohlsson, Claes/AGP-3544-2022; Dubois, Vanessa/ABF-9551-2021; Claessens, Frank/M-8565-2016	Ohlsson, Claes/0000-0002-9633-2805; van Lenthe, Harry (GH)/0000-0001-8303-4959; Antonio, Leen/0000-0002-1079-2860; Lagerquist, Marie/0000-0002-9089-8605; Ohlsson, Claes/0000-0002-9633-2805; Dubois, Vanessa/0000-0001-8894-2980; vanderschueren, dirk/0000-0003-1395-0104; DEBOEL, LUDO/0000-0002-2303-513X; Claessens, Frank/0000-0002-8676-7709; Jardi, Ferran/0000-0003-4468-6123	Flemish Fund for Scientific Research (FWO) [P192/2016]; Eunice Kennedy Shriver NICHD/NIH (NCTRI) [P50-HD28934]	Flemish Fund for Scientific Research (FWO)(FWO); Eunice Kennedy Shriver NICHD/NIH (NCTRI)	This work was funded by a research grant from the Flemish Fund for Scientific Research (FWO; P192/2016). The authors thank Erik Van Herck for his excellent technical assistance and prof. Julie Bakker and prof. Charlotte Cornil (Research Group in Behavioral Neuroendocrinology, University of Liege) for helpful discussions. The University of Virginia Center for Research in Reproduction Ligand Assay and Analysis Core (Charlottesville, VA, USA) is supported by the Eunice Kennedy Shriver NICHD/NIH (NCTRI) Grant P50-HD28934.	Addison ML, 2012, ENDOCRINOLOGY, V153, P1898, DOI 10.1210/en.2011-1982; Ahlborg HG, 2003, NEW ENGL J MED, V349, P327, DOI 10.1056/NEJMoa022464; Akingbemi BT, 2003, ENDOCRINOLOGY, V144, P84, DOI 10.1210/en.2002-220292; Almeida M, 2017, PHYSIOL REV, V97, P135, DOI 10.1152/physrev.00033.2015; Almeida M, 2013, J CLIN INVEST, V123, P394, DOI 10.1172/JCI65910; Antonson P, 2012, BIOCHEM BIOPH RES CO, V424, P710, DOI 10.1016/j.bbrc.2012.07.016; Borjesson AE, 2010, J BONE MINER RES, V25, P2414, DOI 10.1002/jbmr.156; Burghardt AJ, 2010, J BONE MINER RES, V25, P983, DOI 10.1359/jbmr.091104; Callewaert F, 2010, J BONE MINER RES, V25, P617, DOI 10.1359/jbmr.090828; Callewaert F, 2009, FASEB J, V23, P232, DOI 10.1096/fj.08-113456; Chagin AS, 2004, J BONE MINER RES, V19, P72, DOI 10.1359/JBMR.0301203; Farman HH, 2016, ENDOCRINOLOGY, V157, P3242, DOI 10.1210/en.2016-1181; Herber CB, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08046-4; JANSSON JO, 1985, ENDOCR REV, V6, P128, DOI 10.1210/edrv-6-2-128; Jardi F, 2017, MOL CELL ENDOCRINOL, V452, P57, DOI 10.1016/j.mce.2017.05.012; Juul A, 2001, HUM REPROD UPDATE, V7, P303, DOI 10.1093/humupd/7.3.303; KERRIGAN JR, 1992, ENDOCR REV, V13, P281, DOI 10.1210/er.13.2.281; Kondoh S, 2014, BONE, V60, P68, DOI 10.1016/j.bone.2013.12.005; Laperre K, 2011, BONE, V49, P613, DOI 10.1016/j.bone.2011.06.031; Laurent M, 2014, ASIAN J ANDROL, V16, P213, DOI 10.4103/1008-682X.122356; Lindberg MK, 2003, MOL ENDOCRINOL, V17, P203, DOI 10.1210/me.2002-0206; Lindberg MK, 2001, J ENDOCRINOL, V171, P229, DOI 10.1677/joe.0.1710229; Maatta JA, 2013, FASEB J, V27, P478, DOI 10.1096/fj.12-213587; Mach DB, 2002, NEUROSCIENCE, V113, P155, DOI 10.1016/S0306-4522(02)00165-3; Melville KM, 2014, J BONE MINER RES, V29, P370, DOI 10.1002/jbmr.2082; Mitra SW, 2003, ENDOCRINOLOGY, V144, P2055, DOI 10.1210/en.2002-221069; Nicks KM, 2012, J BONE MINER RES, V27, P637, DOI 10.1002/jbmr.1468; Nilsson ME, 2015, ENDOCRINOLOGY, V156, P2492, DOI 10.1210/en.2014-1890; Ohlsson C, 2012, P NATL ACAD SCI USA, V109, P983, DOI 10.1073/pnas.1111436109; Riggs BL, 2002, ENDOCR REV, V23, P279, DOI 10.1210/er.23.3.279; Seeman E, 2002, LANCET, V359, P1841, DOI 10.1016/S0140-6736(02)08706-8; Serre CM, 1999, BONE, V25, P623, DOI 10.1016/S8756-3282(99)00215-X; Sims NA, 2006, AM J PHYSIOL-ENDOC M, V290, pE456, DOI 10.1152/ajpendo.00311.2005; SMITH EP, 1994, NEW ENGL J MED, V331, P1056, DOI 10.1056/NEJM199410203311604; Steyn FJ, 2013, ENDOCRINOLOGY, V154, P4939, DOI 10.1210/en.2013-1502; Sundh D, 2015, J BONE MINER RES, V30, P1692, DOI 10.1002/jbmr.2509; TURNER RT, 1990, J ORTHOPAED RES, V8, P612, DOI 10.1002/jor.1100080418; Vanderschueren D, 2000, J CLIN ENDOCR METAB, V85, P3024, DOI 10.1210/jc.85.9.3024; Vanderschueren D, 2014, ENDOCR REV, V35, P906, DOI 10.1210/er.2014-1024; Veldhuis JD, 2000, J CLIN ENDOCR METAB, V85, P2385, DOI 10.1210/jc.85.7.2385; VERHAEGHE J, 1990, DIABETES, V39, P477, DOI 10.2337/diabetes.39.4.477; Vidal O, 1999, BIOCHEM BIOPH RES CO, V265, P569, DOI 10.1006/bbrc.1999.1711; Windahl SH, 2013, P NATL ACAD SCI USA, V110, P2294, DOI 10.1073/pnas.1220811110; Windahl SH, 1999, J CLIN INVEST, V104, P895, DOI 10.1172/JCI6730; Young P, 2008, NAT NEUROSCI, V11, P721, DOI 10.1038/nn.2118	45	3	3	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					7118	7126		10.1096/fj.202000272R	http://dx.doi.org/10.1096/fj.202000272R		APR 2020	9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32239553	Green Published, hybrid			2022-12-28	WOS:000523590400001
J	Chen, NN; Zhou, PX; Liu, XZ; Li, JC; Wan, Y; Liu, SY; Wei, FX				Chen, Ningning; Zhou, Pengxiang; Liu, Xizhe; Li, Jiachun; Wan, Yong; Liu, Shaoyu; Wei, Fuxin			Overexpression of Rictor in the injured spinal cord promotes functional recovery in a rat model of spinal cord injury	FASEB JOURNAL			English	Article						functional recovery; neurogenesis; Rictor; spinal cord injury	NEURAL STEM-CELLS; INFLAMMATORY RESPONSE; REGENERATION; PHENOTYPE; AUTOPHAGY; RAPAMYCIN; PROLIFERATION; POLARIZATION; MACROPHAGES; HYPOTHERMIA	Rictor is an essential component that directly activates the mammalian target of rapamycin (mTOR) activity, which contributes to the intrinsic axon growth capacity of adult sensory neurons after injury. However, whether its action also applies to regeneration after spinal cord injury (SCI) remains unknown. In this study, rats were given spinal cord contusion at the T9-10 level to establish the SCI model and were subsequently treated with intraspinal cord injection of a Rictor overexpression lentiviral vector to locally upregulate the Rictor expression in the injured spinal cord. Thereafter, we investigated the therapeutic effects of Rictor overexpression in the injured spinal cords of SCI rats. Rictor overexpression not only significantly attenuated the acute inflammatory response and cell death after SCI but also markedly increased the shift in macrophages around the lesion from the M1 to M2 phenotype compared to those of the control lentiviral vector injection-treated group. Furthermore, Rictor overexpression dramatically increased neurogenesis in the lesion epicenter, subsequently promoting the tissue repair and functional recovery in SCI rats. Interestingly, the mechanism underlying the beneficial effects of Rictor overexpression on SCI may be associated with the Rictor overexpression playing a role in the anti-inflammatory response and driving macrophage polarization toward the M2 phenotype, which benefits resident neuronal and oligodendrocyte survival. Our findings demonstrate that Rictor is an effective target that affects the generation of molecules that inhibit spinal cord regeneration. In conclusion, localized Rictor overexpression represents a promising potential strategy for the repair of SCI.	[Chen, Ningning; Li, Jiachun; Liu, Shaoyu; Wei, Fuxin] Sun Yat Sen Univ, Affiliated Hosp 7, Dept Orthoped, 628 Zhenyuan Rd, Shenzhen 518107, Peoples R China; [Zhou, Pengxiang] Daqing Longnan Hosp, Dept Phys Diagnost, Daqing, Peoples R China; [Liu, Xizhe; Wan, Yong] Sun Yat Sen Univ, Dept Spine Surg, Affiliated Hosp 1, Guangzhou, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Liu, SY; Wei, FX (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 7, Dept Orthoped, 628 Zhenyuan Rd, Shenzhen 518107, Peoples R China.; Wan, Y (corresponding author), Sun Yat Sen Univ, Dept Spine Surg, Affiliated Hosp 1, Guangzhou, Peoples R China.	yongwanphd@163.com; gzshaoyuliu@163.com; fuxinweiphd@163.com			National Natural Science Foundation of China Youth Found [81801907]; Shenzhen Committee of Science and Technology, China [JCYJ20180307 145215811]; Sun Yat-sen University Youth Teacher Training Project Foundation, China [19ykpy11]; Sanming Project of Medicine in Shenzhen [SZSM201911002]	National Natural Science Foundation of China Youth Found; Shenzhen Committee of Science and Technology, China; Sun Yat-sen University Youth Teacher Training Project Foundation, China; Sanming Project of Medicine in Shenzhen	This work was supported by grant funds from the National Natural Science Foundation of China Youth Found (No. 81801907), Shenzhen Committee of Science and Technology, China (No. JCYJ20180307 145215811), Sun Yat-sen University Youth Teacher Training Project Foundation, China (No. 19ykpy11), and the Sanming Project of Medicine in Shenzhen (No. SZSM201911002)	Alkabie S, 2016, WORLD NEUROSURG, V86, P432, DOI 10.1016/j.wneu.2015.09.079; Tran AP, 2018, PHYSIOL REV, V98, P881, DOI 10.1152/physrev.00017.2017; Benavides-Serrato A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176599; Bhattacharya I, 2013, ARTERIOSCL THROM VAS, V33, P2105, DOI 10.1161/ATVBAHA.112.301001; Byles V, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3834; Chen HC, 2013, J SURG RES, V179, pE203, DOI 10.1016/j.jss.2012.02.023; Chen NN, 2016, CRIT CARE MED, V44, pE146, DOI 10.1097/CCM.0000000000001351; Chen WT, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0358-16.2016; Clarke AJ, 2019, NAT REV IMMUNOL, V19, P170, DOI 10.1038/s41577-018-0095-2; Esposito E, 2011, TRENDS PHARMACOL SCI, V32, P107, DOI 10.1016/j.tips.2010.11.009; Gaudet AD, 2016, J NEUROSCI, V36, P8516, DOI 10.1523/JNEUROSCI.0735-16.2016; Gensel JC, 2017, SCI REP-UK, V7, DOI 10.1038/srep40144; Goldshmit Y, 2015, MOL CELL NEUROSCI, V68, P82, DOI 10.1016/j.mcn.2015.04.006; Haan N, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0327-3; Hallowell RW, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14208; Hesp ZC, 2015, J NEUROSCI, V35, P1274, DOI 10.1523/JNEUROSCI.2568-14.2015; Ji XC, 2015, CELL MOL NEUROBIOL, V35, P881, DOI 10.1007/s10571-015-0182-x; Ji YF, 2013, GLIA, V61, P1959, DOI 10.1002/glia.22566; Kim JH, 2017, EXP NEUROBIOL, V26, P278, DOI 10.5607/en.2017.26.5.278; Kobashi S, 2019, MOL THER; Liu GY, 2020, NAT REV MOL CELL BIO, V21, P183, DOI 10.1038/s41580-019-0199-y; Liu S, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.527; Ma SF, 2015, BRAIN BEHAV IMMUN, V45, P157, DOI 10.1016/j.bbi.2014.11.007; Maybhate A, 2012, CRIT CARE MED, V40, P573, DOI 10.1097/CCM.0b013e318232d97e; Menezes K, 2010, FASEB J, V24, P4513, DOI 10.1096/fj.10-157628; Nesic O, 2001, J NEUROTRAUM, V18, P947, DOI 10.1089/089771501750451857; New PW, 2019, SPINAL CORD, V57, P183, DOI 10.1038/s41393-018-0209-5; Ni SF, 2019, MOL THER, V27, P2134, DOI 10.1016/j.ymthe.2019.08.009; Oh MH, 2017, CELL REP, V20, P2439, DOI 10.1016/j.celrep.2017.08.046; Ohri SS, 2018, J NEUROSCI, V38, P5900, DOI 10.1523/JNEUROSCI.0679-17.2018; Park J, 2018, MOL THER, V26, P1756, DOI 10.1016/j.ymthe.2018.04.022; Pineau I, 2007, J COMP NEUROL, V500, P267, DOI 10.1002/cne.21149; Ren JF, 2017, J PATHOL, V242, P488, DOI 10.1002/path.4921; Sekiguchi A, 2012, J NEUROTRAUM, V29, P946, DOI 10.1089/neu.2011.1919; Shibutani ST, 2015, NAT IMMUNOL, V16, P1014, DOI 10.1038/ni.3273; Shrivastava R, 2019, CYTOKINE, V118, P130, DOI 10.1016/j.cyto.2018.03.032; Silva NA, 2014, PROG NEUROBIOL, V114, P25, DOI 10.1016/j.pneurobio.2013.11.002; Stenudd M, 2015, JAMA NEUROL, V72, P235, DOI 10.1001/jamaneurol.2014.2927; Thomanetz V, 2013, J CELL BIOL, V201, P293, DOI 10.1083/jcb.201205030; Wang C, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1630-1; Wu HF, 2013, BIOMATERIALS, V34, P1686, DOI 10.1016/j.biomaterials.2012.11.013; Yao AH, 2014, NEUROTHERAPEUTICS, V11, P636, DOI 10.1007/s13311-013-0254-x; Zhou T, 2019, NAT NEUROSCI, V22, P421, DOI 10.1038/s41593-018-0324-9	43	8	8	5	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6984	6998		10.1096/fj.201903171R	http://dx.doi.org/10.1096/fj.201903171R		MAR 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32232913	hybrid			2022-12-28	WOS:000522882500001
J	Wang, Y; Bai, YY; Liu, YX; Noel, SW; Yan, QS; Thi, HP; Sun, XG; Wei, W; Ma, J; Zheng, F				Wang, Yang; Bai, Yingyu; Liu, Yixin; Noel, Sam Wilfried; Yan, Qiushuang; Huyen Pham Thi; Sun, Xuguo; Wei, Wei; Ma, Jun; Zheng, Fang			Plasma exosomal miRNAs involved in endothelial injury in microscopic polyangiitis patients	FASEB JOURNAL			English	Article						high-throughput sequencing; microRNA profile; plasma exosomes	ANCA-ASSOCIATED VASCULITIS; CELLS; EXPRESSION	Microscopic polyangiitis (MPA) is a systemic autoimmune disease that primarily affects the small and medium blood vessels. Endothelial injury is one of the pathological hallmarks of MPA. However, the pathogenesis for this has not yet been fully elucidated. Exosomal microRNAs (miRNAs) have recently emerged as a new molecular pattern involved in the endothelial injury in other diseases. Hence, we speculated that MPA plasma-derived exosomes (MPA-exo) could induce the endothelial injury, which was likely to be aroused by the dysregulated exosomal miRNAs in MPA. In the present study, plasma-derived exosomes were isolated and identified. MPA-exo could be internalized by human renal glomerular endothelial cells (HRGECs) in vitro and induced HRGECs injury. Subsequently, a series of differentially expressed miRNAs in MPA-exo were identified by high-throughput sequencing analysis. Further bioinformatics analysis for the target genes of these differentially expressed miRNAs showed a potential mechanism for their possible role in MPA endothelial injury. Notably, we revealed a considerable correlation between miR-185-3p, miR-125a-3p, and clinical parameters. In conclusion, the current study revealed that differentially expressed miRNAs in MPA-exo are associated with the endothelial injury. Our results suggested that these miRNAs and their target genes might be involved in the inflammation process of MPA.	[Wang, Yang; Bai, Yingyu; Noel, Sam Wilfried; Yan, Qiushuang; Huyen Pham Thi; Sun, Xuguo; Zheng, Fang] Tianjin Med Univ, Sch Med Lab, Dept Clin Immunol, Tianjin 300203, Peoples R China; [Liu, Yixin] Fudan Univ, Donghua Hosp, Dept Clin Lab, Shanghai, Peoples R China; [Wei, Wei] Tianjin Med Univ, Gen Hosp, Dept Rheumatol, Tianjin 300052, Peoples R China; [Ma, Jun] Tianjin Med Univ, Coll Publ Hlth, Dept Hlth Stat, Tianjin 300070, Peoples R China	Tianjin Medical University; Fudan University; Tianjin Medical University; Tianjin Medical University	Zheng, F (corresponding author), Tianjin Med Univ, Sch Med Lab, Dept Clin Immunol, Tianjin 300203, Peoples R China.; Wei, W (corresponding author), Tianjin Med Univ, Gen Hosp, Dept Rheumatol, Tianjin 300052, Peoples R China.; Ma, J (corresponding author), Tianjin Med Univ, Coll Publ Hlth, Dept Hlth Stat, Tianjin 300070, Peoples R China.	tjweiwei2003@163.com; majun@tmu.edu.cn; fangzheng@tmu.edu.cn			Tianjin Medical University (TMU) [2017XK030605]; Natural Science Foundation of Tianjin City (Tianjin Natural Science Foundation) [19JCTPJC 57200]	Tianjin Medical University (TMU); Natural Science Foundation of Tianjin City (Tianjin Natural Science Foundation)	Tianjin Medical University (TMU), Grant/Award Number: 2017XK030605; Natural Science Foundation of Tianjin City (Tianjin Natural Science Foundation), Grant/Award Number: 19JCTPJC 57200	Bertram A, 2015, J AM SOC NEPHROL, V26, P2860, DOI 10.1681/ASN.2014050477; Braudeau C, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00102; Chang DY, 2019, SEMIN ARTHRITIS RHEU, V48, P701, DOI 10.1016/j.semarthrit.2018.05.003; Csernok E, 2018, BEST PRACT RES CL RH, V32, P52, DOI 10.1016/j.berh.2018.07.005; Hou ZX, 2019, CIRC RES, V124, P1386, DOI 10.1161/CIRCRESAHA.118.314635; Jarrot PA, 2016, AUTOIMMUN REV, V15, P704, DOI 10.1016/j.autrev.2016.03.007; Jennette JC, 2013, ARTHRITIS RHEUM-US, V65, P1, DOI 10.1002/art.37715; Kettritz R, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000019411.36000.06; Krebs CF, 2013, J AM SOC NEPHROL, V24, P1955, DOI 10.1681/ASN.2013020130; Kuschnerus K, 2019, DIABETES, V68, P349, DOI 10.2337/db18-0084; Li XZ, 2019, FASEB J, V33, P12704, DOI 10.1096/fj.201901548R; Ma D, 2019, INFLAMM BOWEL DIS, V25, P862, DOI 10.1093/ibd/izy381; Mavropoulos A, 2013, AUTOIMMUN REV, V12, P580, DOI 10.1016/j.autrev.2012.10.019; Melo SA, 2015, NATURE, V523, P177, DOI 10.1038/nature14581; Merkel PA, 2011, J RHEUMATOL, V38, P1480, DOI 10.3899/jrheum.110276; Miao D, 2019, RHEUMATOLOGY OXFORD; Morris RK, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4342; Mun D, 2019, FASEB J, V33, P5979, DOI 10.1096/fj.201801758R; Nagao T, 2011, NEPHROL DIAL TRANSPL, V26, P2752, DOI 10.1093/ndt/gfr032; Nolan SL, 2008, J AM SOC NEPHROL, V19, P973, DOI 10.1681/ASN.2007111166; Page AV, 2013, VIRULENCE, V4, P507, DOI 10.4161/viru.24530; Raimondi L, 2019, CARCINOGENESIS; Rees MD, 2012, FREE RADICAL BIO MED, V53, P2344, DOI 10.1016/j.freeradbiomed.2012.10.002; Shah D, 2019, AM J RESP CELL MOL, V60, P465, DOI 10.1165/rcmb.2018-0194OC; Sinico RA, 2013, AUTOIMMUN REV, V12, P477, DOI 10.1016/j.autrev.2012.08.006; Sun XJ, 2018, J CELL MOL MED, V22, P4550, DOI 10.1111/jcmm.13736; Tadema H, 2011, RHEUMATOLOGY, V50, P689, DOI 10.1093/rheumatology/keq375; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Treiber T, 2019, NAT REV MOL CELL BIO, V20, P5, DOI 10.1038/s41580-018-0059-1; Wang LY, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-019-1949-5; Westerterp M, 2016, ARTERIOSCL THROM VAS, V36, P1328, DOI 10.1161/ATVBAHA.115.306670; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Xiao H, 2005, AM J PATHOL, V167, P39, DOI 10.1016/S0002-9440(10)62951-3; Zhang W, 2019, ARTIF CELL NANOMED B, V47, P2791, DOI 10.1080/21691401.2019.1636806; Zheng B, 2017, MOL THER, V25, P1279, DOI 10.1016/j.ymthe.2017.03.031	36	6	6	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6215	6228		10.1096/fj.201902964R	http://dx.doi.org/10.1096/fj.201902964R		MAR 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32232900	Bronze			2022-12-28	WOS:000522546800001
J	Ji, XR; Cheng, KC; Chen, YR; Lin, TY; Cheung, CHA; Wu, CL; Chiang, HC				Ji, Xuan-Ru; Cheng, Kuan-Chung; Chen, Yu-Ru; Lin, Tzu-Yu; Cheung, Chun Hei Antonio; Wu, Chia-Lin; Chiang, Hsueh-Cheng			Dysfunction of different cellular degradation pathways contributes to specific beta-amyloid42-induced pathologies (vol 32, pg 1375, 2018)	FASEB JOURNAL			English	Correction									[Ji, Xuan-Ru; Cheng, Kuan-Chung; Chen, Yu-Ru; Lin, Tzu-Yu; Cheung, Chun Hei Antonio; Chiang, Hsueh-Cheng] Natl Cheng Kung Univ, Coll Med, Dept Pharmacol, Tainan, Taiwan; [Cheng, Kuan-Chung; Cheung, Chun Hei Antonio; Chiang, Hsueh-Cheng] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan, Taiwan; [Wu, Chia-Lin] Chang Gung Univ, Coll Med, Dept Biochem, Taoyuan, Taiwan; [Wu, Chia-Lin] Chang Gung Univ, Coll Med, Grad Inst Biomed Sci, Taoyuan, Taiwan; [Wu, Chia-Lin] Chang Gung Mem Hosp, Dept Neurol, Linkou, Taiwan	National Cheng Kung University; National Cheng Kung University; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital	Chiang, HC (corresponding author), Natl Cheng Kung Univ, 1 Univ Rd, Nainan City 701, Taiwan.	chianghc@mail.ncku.edu.tw						Ji XR, 2018, FASEB J, V32, P1375, DOI 10.1096/fj.201700199RR	1	2	2	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2018	32	11					6354	6354		10.1096/fj.201700199RRERR	http://dx.doi.org/10.1096/fj.201700199RRERR			1	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GW7TC	32092798	Bronze			2022-12-28	WOS:000447172000049
J	van der Hoek, MD; Nieuwenhuizen, AG; Kuda, O; Bos, P; Paluchova, V; Verschuren, L; van den Hoek, AM; Kleemann, R; Veeger, NJGM; van der Leij, FR; Keijer, J				van der Hoek, Marjanne D.; Nieuwenhuizen, Arie G.; Kuda, Ondrej; Bos, Paul; Paluchova, Veronika; Verschuren, Lars; van den Hoek, Anita M.; Kleemann, Robert; Veeger, Nic J. G. M.; van der Leij, Feike R.; Keijer, Jaap			Intramuscular short-chain acylcarnitines in elderly people are decreased in (pre-)frail females, but not in males	FASEB JOURNAL			English	Article						acetylcarnitine; carnitine; frailty; physical function; mitochondrial dysfunction; mitochondrial energy production	LOWER-EXTREMITY FUNCTION; SKELETAL-MUSCLE; CARNITINE METABOLISM; SEX-DIFFERENCES; FRAILTY; AGE; ASSOCIATION; TRANSPORTER; DEFICIENCY; DISABILITY	This study tested the hypothesis that in human aging, a decreased intramuscular acylcarnitine status is associated with (pre-)frailty, reduced physical performance, and altered mitochondrial function. We used a cross-sectional study design with well-matched fit and (pre-)frail old males and females, using young males and females as healthy controls. Frailty was assessed according to the Fried criteria and physical performance was determined by 400 m walk test, short physical performance battery and handgrip strength. Muscle and plasma acylcarnitine status, and muscle mitochondrial gene expression was analyzed. Results showed that intramuscular total carnitine levels and short-chain acylcarnitine levels were lower in (pre-)frail old females compared to fit old females and young females, whereas no differences were observed in males. The low intramuscular short-chain acylcarnitine levels in females correlated with low physical performance, even after correction for muscle mass (%), and were accompanied with lowered expression of genes involved in mitochondrial energy production and functionality. It is, therefore, concluded that in (pre-)frail old females, intramuscular total carnitine levels and short-chain acylcarnitine levels are decreased, and this decrease is associated with reduced physical performance and low expression of a wide range of genes critical for mitochondrial function. The results stress the importance of taking sex differences into account in aging research.	[van der Hoek, Marjanne D.; Nieuwenhuizen, Arie G.; Keijer, Jaap] Wageningen Univ, Human & Anim Physiol, POB 338, NL-6700 AH Wageningen, Netherlands; [van der Hoek, Marjanne D.; van der Leij, Feike R.] Van Hall Larenstein Univ Appl Sci, Appl Res Ctr Food & Dairy, Leeuwarden, Netherlands; [van der Hoek, Marjanne D.; Bos, Paul; Veeger, Nic J. G. M.] MCL Acad, Med Ctr Leeuwarden, Leeuwarden, Netherlands; [Kuda, Ondrej; Paluchova, Veronika] Czech Acad Sci, Inst Physiol, Prague, Czech Republic; [Verschuren, Lars; van den Hoek, Anita M.; Kleemann, Robert] Netherlands Org Appl Sci Res TNO, TNO Metab Hlth Res, Dept Metab Hlth Res, Leiden, Netherlands; [van der Leij, Feike R.] RIC AFL Inholland Univ Appl Sci, Delft, Netherlands; [van der Leij, Feike R.] RIC AFL Inholland Univ Appl Sci, Amsterdam, Netherlands	Wageningen University & Research; Medical Center Leeuwarden; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Netherlands Organization Applied Science Research	Keijer, J (corresponding author), Wageningen Univ, Human & Anim Physiol, POB 338, NL-6700 AH Wageningen, Netherlands.	jaap.keijer@wur.nl	Kuda, Ondrej/B-7990-2012; Paluchova, Veronika/AAP-6970-2020	Kuda, Ondrej/0000-0001-7034-4536; Paluchova, Veronika/0000-0002-1016-7854; Veeger, Nic/0000-0002-1492-7937; van der Leij, Feike/0000-0001-6702-403X; Nieuwenhuizen, Arie/0000-0003-0999-5422	Province of Friesland; Sigma Tau B.V. [UCF 13-032]	Province of Friesland; Sigma Tau B.V.	Province of Friesland and Sigma Tau B.V., Grant/Award Number: UCF 13-032	Akki A, 2014, AGE, V36, P21, DOI 10.1007/s11357-013-9540-0; Amara CE, 2007, P NATL ACAD SCI USA, V104, P1057, DOI 10.1073/pnas.0610131104; Andreux PA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26944-x; BERGSTROM J, 1975, SCAND J CLIN LAB INV, V35, P606, DOI 10.3109/00365517509095787; Bupp MRG, 2015, CELL IMMUNOL, V294, P102, DOI 10.1016/j.cellimm.2015.02.002; Calvo SE, 2016, NUCLEIC ACIDS RES, V44, pD1251, DOI 10.1093/nar/gkv1003; Chung S, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13588; Clegg A, 2013, LANCET, V381, P752, DOI 10.1016/S0140-6736(12)62167-9; COSTELL M, 1989, BIOCHEM BIOPH RES CO, V161, P1135, DOI 10.1016/0006-291X(89)91360-0; Crentsil V, 2010, AGEING RES REV, V9, P265, DOI 10.1016/j.arr.2010.02.005; Demarquoy J, 2004, FOOD CHEM, V86, P137, DOI 10.1016/j.foodchem.2003.09.023; Doherty TJ, 2001, CURR OPIN CLIN NUTR, V4, P503, DOI 10.1097/00075197-200111000-00007; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Gonzalez-Crespo MR, 1999, J RHEUMATOL, V26, P2229; Gordon EH, 2017, EXP GERONTOL, V89, P30, DOI 10.1016/j.exger.2016.12.021; Guralnik JM, 2000, J GERONTOL A-BIOL, V55, pM221, DOI 10.1093/gerona/55.4.M221; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; He X, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000011152; Hennessey JV, 1997, J APPL PHYSIOL, V82, P1739, DOI 10.1152/jappl.1997.82.6.1739; Hobbelen PHF, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0099366, 10.1371/journal.pone.0087348, 10.1371/journal.pone.0096514, 10.1371/journal.pone.0113637, 10.1371/journal.pone.0103267, 10.1371/journal.pone.0091910, 10.1371/journal.pone.0093049, 10.1371/journal.pone.0110033, 10.1371/journal.pone.0103480, 10.1371/journal.pone.0107196, 10.1371/journal.pone.0087588, 10.1371/journal.pone.0095422, 10.1371/journal.pone.0103535, 10.1371/journal.pone.0105072, 10.1371/journal.pone.0095536]; Kojima G, 2016, J EPIDEMIOL COMMUN H, V70, P716, DOI 10.1136/jech-2015-206717; Lagerwaard B, 2020, GEROSCIENCE, V42, P299, DOI 10.1007/s11357-019-00145-4; Lamhonwah AM, 2006, BIOCHEM BIOPH RES CO, V345, P1315, DOI 10.1016/j.bbrc.2006.05.026; Li W, 2017, J FRALITY AGING, V6, P129, DOI 10.14283/jfa.2017.15; Liu DM, 2013, J GERONTOL A-BIOL, V68, P1035, DOI 10.1093/gerona/glt015; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Miotto PM, 2018, AM J PHYSIOL-REG I, V314, pR909, DOI 10.1152/ajpregu.00025.2018; MITCHELL ME, 1978, AM J CLIN NUTR, V31, P293, DOI 10.1093/ajcn/31.2.293; Morley JE, 2013, J AM MED DIR ASSOC, V14, P392, DOI 10.1016/j.jamda.2013.03.022; Oksuzyan A, 2008, AGING CLIN EXP RES, V20, P91; Opalka JR, 2001, CLIN CHEM, V47, P2150; Pomar CA, 2018, FASEB J, V33, P1; Ramsay RR, 2001, BBA-PROTEIN STRUCT M, V1546, P21, DOI 10.1016/S0167-4838(01)00147-9; REBOUCHE CJ, 1984, J CLIN INVEST, V73, P857, DOI 10.1172/JCI111281; REBOUCHE CJ, 1986, ANNU REV NUTR, V6, P41, DOI 10.1146/annurev.nu.06.070186.000353; RIVM, 2016, BILTH; Rodriguez-Manas L, 2013, J GERONTOL A-BIOL, V68, P62, DOI 10.1093/gerona/gls119; Rolland YM, 2004, J AM GERIATR SOC, V52, P972, DOI 10.1111/j.1532-5415.2004.52267.x; Samson MM, 2000, AGE AGEING, V29, P235, DOI 10.1093/ageing/29.3.235; Santanasto AJ, 2015, J GERONTOL A-BIOL, V70, P1379, DOI 10.1093/gerona/glu134; Schooneman MG, 2015, AM J PHYSIOL-ENDOC M, V309, pE256, DOI 10.1152/ajpendo.00503.2014; Schooneman MG, 2014, BBA-MOL CELL BIOL L, V1841, P987, DOI 10.1016/j.bbalip.2014.04.001; Seline KG, 2007, FOOD CHEM, V105, P793, DOI 10.1016/j.foodchem.2007.01.058; Shin Hyehyung, 2011, J Aging Res, V2011, P191896, DOI 10.4061/2011/191896; Sonjak V, 2019, J GERONTOL A-BIOL, V74, P1887, DOI 10.1093/gerona/glz066; STARLING RD, 1995, EUR J APPL PHYSIOL O, V71, P143, DOI 10.1007/BF00854971; Stephens FB, 2007, J PHYSIOL-LONDON, V581, P431, DOI 10.1113/jphysiol.2006.125799; Tein I, 1996, ARCH BIOCHEM BIOPHYS, V329, P145, DOI 10.1006/abbi.1996.0203; van der Leij FR, 2000, MOL GENET METAB, V71, P139, DOI 10.1006/mgme.2000.3055; Woollard DC, 1999, FOOD CHEM, V66, P121, DOI 10.1016/S0308-8146(99)00042-4	50	4	4	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					11658	11671		10.1096/fj.202000493R	http://dx.doi.org/10.1096/fj.202000493R		JUL 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32672378	Green Published, hybrid			2022-12-28	WOS:000552096600001
J	Shukla, PK; Meena, AS; Gangwar, R; Szabo, E; Balogh, A; Lee, SC; Vandewalle, A; Tigyi, G; Rao, R				Shukla, Pradeep K.; Meena, Avtar S.; Gangwar, Ruchika; Szabo, Erzsebet; Balogh, Andrea; Chin Lee, Sue; Vandewalle, Alain; Tigyi, Gabor; Rao, RadhaKrishna			LPAR2 receptor activation attenuates radiation-induced disruption of apical junctional complexes and mucosal barrier dysfunction in mouse colon	FASEB JOURNAL			English	Article						endotoxemia; intestine; irradiation; lysophosphatidic acid; tight junction	INTESTINAL EPITHELIAL-CELLS; TIGHT JUNCTIONS; GASTROINTESTINAL SYNDROME; COFILIN PHOSPHORYLATION; STIMULATION; MITIGATION; APOPTOSIS; OCCLUDIN; LIM-KINASE-2; PERMEABILITY	The tight junction (TJ) and barrier function of colonic epithelium is highly sensitive to ionizing radiation. We evaluated the effect of lysophosphatidic acid (LPA) and its analog, Radioprotein-1, on gamma-radiation-induced colonic epithelial barrier dysfunction using Caco-2 and m-IC(C12)cell monolayers in vitro and mice in vivo. Mice were subjected to either total body irradiation (TBI) or partial body irradiation (PBI-BM5). Intestinal barrier function was assessed by analyzing immunofluorescence localization of TJ proteins, mucosal inulin permeability, and plasma lipopolysaccharide (LPS) levels. Oxidative stress was analyzed by measuring protein thiol oxidation and antioxidant mRNA. In Caco-2 and m-IC(C12)cell monolayers, LPA attenuated radiation-induced redistribution of TJ proteins, which was blocked by a Rho-kinase inhibitor. In mice, TBI and PBI-BM5 disrupted colonic epithelial tight junction and adherens junction, increased mucosal permeability, and elevated plasma LPS; TJ disruption by TBI was more severe inLpar2(-/-)mice compared to wild-type mice. RP1, administered before or after irradiation, alleviated TBI and PBI-BM5-induced TJ disruption, barrier dysfunction, and endotoxemia accompanied by protein thiol oxidation and downregulation of antioxidant gene expression, cofilin activation, and remodeling of the actin cytoskeleton. These data demonstrate that LPAR2 receptor activation prevents and mitigates gamma-irradiation-induced colonic mucosal barrier dysfunction and endotoxemia.	[Shukla, Pradeep K.; Meena, Avtar S.; Gangwar, Ruchika; Szabo, Erzsebet; Balogh, Andrea; Chin Lee, Sue; Tigyi, Gabor; Rao, RadhaKrishna] Univ Tennessee, Hlth Sci Ctr, Coll Med, Dept Physiol, 3 North Dunlap,Suite S303, Memphis, TN 38103 USA; [Vandewalle, Alain] Ctr Rech Biomed, INSERM U773, CRB3, UFR Med, Paris 18, France	University of Tennessee System; University of Tennessee Health Science Center; Institut National de la Sante et de la Recherche Medicale (Inserm)	Rao, R (corresponding author), Univ Tennessee, Hlth Sci Ctr, Coll Med, Dept Physiol, 3 North Dunlap,Suite S303, Memphis, TN 38103 USA.	rrao2@uthsc.edu	Meena, Avtar S/AAZ-8213-2020; Meena, Avtar Singh/AAG-4419-2021		HHS \ NIH \ National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [DK55532]; HHS \ NIH \ National Institute on Alcohol Abuse and Alcoholism (NIAAA) [AA12307]; HHS \ NIH \ National Cancer Institute (NCI) [CA013621]; HHS \ NIH \ National Institute of Allergy and Infectious Diseases (NIAID) [1UO-1AI107331]	HHS \ NIH \ National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); HHS \ NIH \ National Institute on Alcohol Abuse and Alcoholism (NIAAA); HHS \ NIH \ National Cancer Institute (NCI); HHS \ NIH \ National Institute of Allergy and Infectious Diseases (NIAID)	HHS vertical bar NIH vertical bar National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Grant/Award Number: DK55532; HHS vertical bar NIH vertical bar National Institute on Alcohol Abuse and Alcoholism (NIAAA), Grant/Award Number: AA12307; HHS vertical bar NIH vertical bar National Cancer Institute (NCI), Grant/Award Number: CA013621; HHS vertical bar NIH vertical bar National Institute of Allergy and Infectious Diseases (NIAID), Grant/Award Number: 1UO-1AI107331	Anderson JM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002584; Basuroy S, 2006, BIOCHEM J, V393, P69, DOI 10.1042/BJ20050959; Basuroy S, 2003, J BIOL CHEM, V278, P11916, DOI 10.1074/jbc.M211710200; Bens M, 1996, AM J PHYSIOL-CELL PH, V270, pC1666, DOI 10.1152/ajpcell.1996.270.6.C1666; Booth C, 2012, HEALTH PHYS, V103, P400, DOI 10.1097/HP.0b013e31826530e2; Booth C, 2012, HEALTH PHYS, V103, P383, DOI 10.1097/HP.0b013e318266ee13; Cameron BD, 2018, RADIAT RES, V190, P99, DOI 10.1667/RR15059.1; CERDA H, 1979, INT J RADIAT BIOL, V36, P65, DOI 10.1080/09553007914550821; Chen XY, 2006, J CELL BIOL, V172, P671, DOI 10.1083/jcb.200510061; Datta K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042224; Deng W, 2007, GASTROENTEROLOGY, V132, P1834, DOI 10.1053/j.gastro.2007.03.038; Deng WL, 2015, RADIAT RES, V183, P465, DOI 10.1667/RR13830.1; Deng WL, 2003, AM J PHYSIOL-GASTR L, V284, pG821, DOI 10.1152/ajpgi.00406.2002; Deng WL, 2002, GASTROENTEROLOGY, V123, P206, DOI 10.1053/gast.2002.34209; Elias BC, 2009, J BIOL CHEM, V284, P1559, DOI 10.1074/jbc.M804783200; HENDRY JH, 1982, INT J RADIAT BIOL, V42, P611, DOI 10.1080/09553008214551591; Jaiswal AK, 2004, FREE RADICAL BIO MED, V36, P1199, DOI 10.1016/j.freeradbiomed.2004.02.074; Khurana S, 2008, EXP CELL RES, V314, P530, DOI 10.1016/j.yexcr.2007.10.028; Kiss GN, 2013, BBA-MOL CELL BIOL L, V1831, P117, DOI 10.1016/j.bbalip.2012.08.020; Konno T, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215255; Kuo B, 2018, CELL SIGNAL, V51, P23, DOI 10.1016/j.cellsig.2018.07.007; Li CY, 2005, J EXP MED, V202, P975, DOI 10.1084/jem.20050421; Lin FT, 2007, J BIOL CHEM, V282, P37759, DOI 10.1074/jbc.M705025200; Lin SB, 2010, GASTROENTEROLOGY, V138, P649, DOI 10.1053/j.gastro.2009.09.055; MADARA JL, 1988, AM J PHYSIOL, V254, pG416, DOI 10.1152/ajpgi.1988.254.3.G416; MADARA JL, 1987, AM J PHYSIOL, V253, pC854, DOI 10.1152/ajpcell.1987.253.6.C854; Marchiando AM, 2011, GASTROENTEROLOGY, V140, P1208, DOI 10.1053/j.gastro.2011.01.004; Moding EJ, 2013, NAT REV DRUG DISCOV, V12, P526, DOI 10.1038/nrd4003; Pandey D, 2007, BLOOD CELL MOL DIS, V38, P269, DOI 10.1016/j.bcmd.2007.01.002; Patil R, 2015, CHEM BIOL, V22, P206, DOI 10.1016/j.chembiol.2014.12.009; Patil R, 2014, J MED CHEM, V57, P7136, DOI 10.1021/jm5007116; POTTEN CS, 1990, INT J RADIAT BIOL, V58, P925, DOI 10.1080/09553009014552281; POTTEN CS, 1977, NATURE, V269, P518, DOI 10.1038/269518a0; POTTEN CS, 1994, INT J RADIAT BIOL, V65, P71, DOI 10.1080/09553009414550101; Rao R, 2008, FRONT BIOSCI-LANDMRK, V13, P7210, DOI 10.2741/3223; Rao RK, 2004, AM J PHYSIOL-GASTR L, V286, pG881, DOI 10.1152/ajpgi.00006.2004; Rao RK, 2002, BIOCHEM J, V368, P471, DOI 10.1042/BJ20011804; Seth A, 2007, J BIOL CHEM, V282, P11487, DOI 10.1074/jbc.M610597200; Sheth P, 2007, BIOCHEM J, V402, P291, DOI 10.1042/BJ20060665; Sheth P, 2009, BIOCHEM J, V421, P59, DOI 10.1042/BJ20081951; Shukla PK, FASEB J, V2018; Shukla PK, 2016, AM J PHYSIOL-GASTR L, V310, pG705, DOI 10.1152/ajpgi.00314.2015; Singla A, 2010, AM J PHYSIOL-GASTR L, V298, pG182, DOI 10.1152/ajpgi.00345.2009; Thompson KE, 2018, EXP BIOL MED, V243, P1056, DOI 10.1177/1535370218803349; Tigyi GJ, 2019, J LIPID RES, V60, P464, DOI 10.1194/jlr.S091744; Van Itallie CM, 2006, ANNU REV PHYSIOL, V68, P403, DOI 10.1146/annurev.physiol.68.040104.131404; Vardouli L, 2005, J BIOL CHEM, V280, P11448, DOI 10.1074/jbc.M402651200; Wang WW, 2019, INVEST OPHTH VIS SCI, V60, P2274, DOI 10.1167/iovs.18-26077; Yoshida M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154527; Yun CC, 2015, EXP CELL RES, V333, P201, DOI 10.1016/j.yexcr.2014.11.013	50	6	6	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					11641	11657		10.1096/fj.202000544R	http://dx.doi.org/10.1096/fj.202000544R		JUL 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32654268	Bronze, Green Accepted			2022-12-28	WOS:000549273800001
J	Song, E; Wang, RS; Leopold, JA; Loscalzo, J				Song, Euijun; Wang, Rui-Sheng; Leopold, Jane A.; Loscalzo, Joseph			Network determinants of cardiovascular calcification and repositioned drug treatments	FASEB JOURNAL			English	Article						blood vessel; calcification; protein interaction; smooth muscle cell; therapeutics	CORONARY-ARTERY CALCIFICATION; SMOOTH-MUSCLE-CELLS; INTIMA-MEDIA THICKNESS; PROTEOME-SCALE MAP; VASCULAR CALCIFICATION; HUMAN INTERACTOME; SIGNALING PATHWAY; MAMMALIAN TARGET; DISEASE; INFLAMMATION	Ectopic cardiovascular calcification is a highly prevalent pathology for which there are no effective novel or repurposed pharmacotherapeutics to prevent disease progression. We created a human calcification endophenotype module (ie, the "calcificasome") by mapping vascular calcification genes (proteins) to the human vascular smooth muscle-specific protein-protein interactome (218 nodes and 632 edges,P < 10(-5)). Network proximity analysis was used to demonstrate that the calcificasome overlapped significantly with endophenotype modules governing inflammation, thrombosis, and fibrosis in the human interactome (P < 0.001). A network-based drug repurposing analysis further revealed that everolimus, temsirolimus, and pomalidomide are predicted to target the calcificasome. The efficacy of these agents in limiting calcification was confirmed experimentally by treating human coronary artery smooth muscle cells in an in vitro calcification assay. Each of the drugs affected expression or activity of their predicted target in the network, and decreased calcification significantly (P < 0.009). An integrated network analytical approach identified novel mediators of ectopic cardiovascular calcification and biologically plausible candidate drugs that could be repurposed to target calcification. This methodological framework for drug repurposing has broad applicability to other diseases.	[Song, Euijun; Wang, Rui-Sheng; Loscalzo, Joseph] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Leopold, Jane A.] Harvard Med Sch, Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Loscalzo, J (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.	jloscalzo@rics.bwh.harvard.edu	Loscalzo, Joseph/ABD-8980-2021	Song, Jun-Seop/0000-0002-5886-4210; Wang, Ruisheng/0000-0003-4920-4357	National Heart, Lung, and Blood Institute (NHLBI) [HG007690, HL108630, HL119145, HL125215]; American Heart Association (AHA) [D700382, 19AIML34980000]	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association (AHA)(American Heart Association)	National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: HG007690, HL108630, HL119145 and HL125215; American Heart Association (AHA), Grant/Award Number: D700382 and 19AIML34980000	Alyesh DM, 2019, CIRC-ARRHYTHMIA ELEC, V12, DOI 10.1161/CIRCEP.118.007023; Balcells M, 2010, CIRCULATION, V121, P2192, DOI 10.1161/CIRCULATIONAHA.109.877282; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Budoff MJ, 2010, JACC-CARDIOVASC IMAG, V3, P1229, DOI 10.1016/j.jcmg.2010.08.018; Budoff MJ, 2009, AM HEART J, V158, P554, DOI 10.1016/j.ahj.2009.08.007; Cai ZJ, 2016, CIRC RES, V119, P422, DOI 10.1161/CIRCRESAHA.116.308301; Calderon-Margalit R, 2014, ARTERIOSCL THROM VAS, V34, P2688, DOI 10.1161/ATVBAHA.114.304136; Chen FL, 2020, NAT PROD RES, V34, P2816, DOI 10.1080/14786419.2019.1596092; Cheng FX, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05116-5; Demer LL, 2008, CIRCULATION, V117, P2938, DOI 10.1161/CIRCULATIONAHA.107.743161; Doherty TM, 2003, P NATL ACAD SCI USA, V100, P11201, DOI 10.1073/pnas.1932554100; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Folsom AR, 2008, ARCH INTERN MED, V168, P1333, DOI 10.1001/archinte.168.12.1333; Fox EA, 2005, THROMB HAEMOSTASIS, V94, P362, DOI 10.1160/TH05-04-0266; Frauscher B, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01866; Ganesan AN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110662; Garcia-Gras E, 2006, J CLIN INVEST, V116, P2012, DOI 10.1172/JCI27751; Ghiassian SD, 2016, SCI REP-UK, V6, DOI 10.1038/srep27414; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Guney E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10331; Gysi DM, 2020, ARXIV200407229; Havugimana PC, 2012, CELL, V150, P1068, DOI 10.1016/j.cell.2012.08.011; Hein MY, 2015, CELL, V163, P712, DOI 10.1016/j.cell.2015.09.053; Henaut L, 2016, EXPERT OPIN THER TAR, V20, P89, DOI 10.1517/14728222.2015.1081685; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Huttlin EL, 2017, NATURE, V545, P505, DOI 10.1038/nature22366; Huttlin EL, 2015, CELL, V162, P425, DOI 10.1016/j.cell.2015.06.043; Jayalath RW, 2005, EUR J VASC ENDOVASC, V30, P476, DOI 10.1016/j.ejvs.2005.04.030; Johnson RC, 2006, CIRC RES, V99, P1044, DOI 10.1161/01.RES.0000249379.55535.21; Koschutzki D, 2008, GENE REGUL SYST BIO, V2, P193, DOI 10.4137/GRSB.S702; Kristensen AR, 2012, NAT METHODS, V9, P907, DOI 10.1038/nmeth.2131; Krusche CA, 2011, BASIC RES CARDIOL, V106, P617, DOI 10.1007/s00395-011-0175-y; Lebwohl D, 2013, ANN NY ACAD SCI, V1291, P14, DOI 10.1111/nyas.12122; Lee KM, 2011, BBA-MOL CELL RES, V1813, P448, DOI 10.1016/j.bbamcr.2011.01.005; Li JF, 2011, MOL CELL BIOL, V31, P1134, DOI 10.1128/MCB.01025-10; Liabeuf S, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-85; Libby P, 2001, CIRCULATION, V103, P1718, DOI 10.1161/01.CIR.103.13.1718; Liu YB, 2015, FASEB J, V29, P4829, DOI 10.1096/fj.15-274050; Lopez-Girona A, 2012, LEUKEMIA, V26, P2326, DOI 10.1038/leu.2012.119; Loscalzo J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100163; Meigs JB, 2002, DIABETES CARE, V25, P1313, DOI 10.2337/diacare.25.8.1313; Menche J, 2015, SCIENCE, V347, DOI 10.1126/science.1257601; Newman RH, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.12; Pilichou K, 2009, J EXP MED, V206, P1787, DOI 10.1084/jem.20090641; Rajamannan NM, 2011, CIRCULATION, V124, P1783, DOI 10.1161/CIRCULATIONAHA.110.006767; Rogers MA, 2019, NAT REV CARDIOL, V16, P261, DOI 10.1038/s41569-018-0123-8; Rolland T, 2014, CELL, V159, P1212, DOI 10.1016/j.cell.2014.10.050; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Schlotter F, 2018, CIRCULATION, V138, P377, DOI 10.1161/CIRCULATIONAHA.117.032291; Sim HJ, 2016, MOL CELL BIOCHEM, V419, P157, DOI 10.1007/s11010-016-2760-8; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Talbott EO, 2004, J CLIN ENDOCR METAB, V89, P5454, DOI 10.1210/jc.2003-032237; Turei D, 2016, NAT METHODS, V13, P965, DOI 10.1038/nmeth.4077; Venkatesan K, 2009, NAT METHODS, V6, P83, DOI 10.1038/NMETH.1280; Vinayagam A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001699; Wan CH, 2015, NATURE, V525, P339, DOI 10.1038/nature14877; Wang RS, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/10/105014; Wei R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46824-2; Xu JZ, 2006, BIOINFORMATICS, V22, P2800, DOI 10.1093/bioinformatics/btl467; Yachie N, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20156660; Yang XP, 2016, CELL, V164, P805, DOI 10.1016/j.cell.2016.01.029; Yang Z, 2006, CIRC RES, V99, P646, DOI 10.1161/01.RES.0000241482.19382.c6; Yao L, 2017, J CELL BIOCHEM, V118, P4708, DOI 10.1002/jcb.26137; Yu HY, 2011, NAT METHODS, V8, P478, DOI [10.1038/NMETH.1597, 10.1038/nmeth.1597]; Zeng ZH, 2007, BLOOD, V109, P3509, DOI 10.1182/blood-2006-06-030833; Zhan JK, 2014, CAN J CARDIOL, V30, P568, DOI 10.1016/j.cjca.2013.11.005; Zhao Y, 2015, KIDNEY INT, V88, P711, DOI 10.1038/ki.2015.160; Zhou XZ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5212; Zhou YD, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-0153-3; Zickler D, 2018, NEPHROL DIAL TRANSPL, V33, P574, DOI 10.1093/ndt/gfx316	70	11	11	2	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					11087	11100		10.1096/fj.202001062R	http://dx.doi.org/10.1096/fj.202001062R		JUL 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32638415	Green Published, hybrid			2022-12-28	WOS:000547534000001
J	Tinning, H; Taylor, A; Wang, DP; Constantinides, B; Sutton, R; Oikonomou, G; Velazquez, MA; Thompson, P; Treumann, A; O'Connell, MJ; Forde, N				Tinning, Haidee; Taylor, Alysha; Wang, Dapeng; Constantinides, Bede; Sutton, Ruth; Oikonomou, Georgios; Velazquez, Miguel A.; Thompson, Paul; Treumann, Achim; O'Connell, Mary J.; Forde, Niamh			The role of CAPG in molecular communication between the embryo and the uterine endometrium: Is its function conserved in species with different implantation strategies?	FASEB JOURNAL			English	Article							BOVINE ESTROUS-CYCLE; GENE-EXPRESSION; SEQUENCE ALIGNMENT; PREGNANCY; GELSOLIN; PROGESTERONE; ATTACHMENT; RECEPTORS; PROTEIN; FAMILY	During the preimplantation period of pregnancy in eutherian mammals, transcriptional and proteomic changes in the uterine endometrium are required to facilitate receptivity to an implanting blastocyst. These changes are mediated, in part, by proteins produced by the developing conceptus (inner cell mass and extraembryonic membranes). We hypothesized that this common process in early pregnancy in eutheria may be facilitated by highly conserved conceptus-derived proteins such as macrophage capping protein (CAPG). We propose that CAPG may share functionality in modifying the transcriptome of the endometrial epithelial cells to facilitate receptivity to implantation in species with different implantation strategies. A recombinant bovine form of CAPG (91% sequence identity between bovine and human) was produced and bovine endometrial epithelial (bEECs) and stromal (bESCs) and human endometrial epithelial cells (hEECs) were cultured for 24 hours with and without recombinant bovine CAPG (rbCAPG). RNA sequencing and quantitative real-time PCR analysis were used to assess the transcriptional response to rbCAPG (Control, vehicle, CAPG 10, 100, 1000 ng/mL: n = 3 biological replicates per treatment per species). Treatment of bEECs with CAPG resulted in alterations in the abundance of 1052 transcripts (629 increased and 423 decreased) compared to vehicle controls. Treatment of hEECs with bovine CAPG increased expression of transcripts previously known to interact with CAPG in different systems (CAPZB, CAPZA2, ADD1,andADK) compared with vehicle controls (P < .05). In conclusion, we have demonstrated that CAPG, a highly conserved protein in eutherian mammals, elicits a transcriptional response in the endometrial epithelium in species with different implantation strategies that may contribute to pregnancy success.	[Tinning, Haidee; Taylor, Alysha; Sutton, Ruth; Forde, Niamh] Univ Leeds, Leeds Inst Cardiovasc & Metab Med, Fac Med & Hlth, Discovery & Translat Sci Dept, Leeds LS2 9JT, W Yorkshire, England; [Taylor, Alysha; Constantinides, Bede; O'Connell, Mary J.] Univ Leeds, Sch Biol, Fac Biol Sci, Leeds, W Yorkshire, England; [Wang, Dapeng] Univ Leeds, LeedsOm, Leeds, W Yorkshire, England; [Oikonomou, Georgios] Univ Liverpool, Inst Vet Sci, Dept Livestock Hlth & Welf, Liverpool, Merseyside, England; [Velazquez, Miguel A.] Newcastle Univ, Sch Nat & Environm Sci, Newcastle Upon Tyne, Tyne & Wear, England; [Thompson, Paul; Treumann, Achim] Newcastle Univ, Prot & Proteome Anal NUPPA, Newcastle Upon Tyne, Tyne & Wear, England; [O'Connell, Mary J.] Univ Nottingham, Sch Sch Life Sci, Fac Med & Hlth Sci, Nottingham, England; [Constantinides, Bede] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Modernising Med Microbiol Consortium, Oxford, England	University of Leeds; University of Leeds; University of Leeds; University of Liverpool; Newcastle University - UK; Newcastle University - UK; University of Nottingham; University of Oxford	Forde, N (corresponding author), Univ Leeds, Leeds Inst Cardiovasc & Metab Med, Fac Med & Hlth, Discovery & Translat Sci Dept, Leeds LS2 9JT, W Yorkshire, England.	n.forde@leeds.ac.uk	Wang, Dapeng/AAK-5651-2020; Wang, Dapeng/HGD-4818-2022	Wang, Dapeng/0000-0002-9925-4574; Forde, Niamh/0000-0002-3539-9643; O'Connell, Mary/0000-0002-1877-1001; Constantinides, Bede/0000-0002-3480-3819; Treumann, Achim/0000-0002-9417-3505	RCUK \ Biotechnology and Biological Sciences Research Council (BBSRC) [BB/R017522/1]; N8 AgriFood Pump Priming; QR GCRF; BBSRC [BB/R017522/1] Funding Source: UKRI	RCUK \ Biotechnology and Biological Sciences Research Council (BBSRC); N8 AgriFood Pump Priming; QR GCRF; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	RCUK vertical bar Biotechnology and Biological Sciences Research Council (BBSRC), Grant/Award Number: BB/R017522/1; N8 AgriFood Pump Priming; QR GCRF	[Anonymous], 2015, BIOL REPROD; Archer SK, 2004, BIOCHEM SOC T, V32, P940, DOI 10.1042/BST0320940; Bauersachs S, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.094771; Bazer FW, 2008, REPROD BIOL, V8, P179, DOI 10.1016/S1642-431X(12)60012-6; Burton GJ, 2002, J CLIN ENDOCR METAB, V87, P2954, DOI 10.1210/jc.87.6.2954; Campbell HD, 2002, MOL CELL BIOL, V22, P3518, DOI 10.1128/MCB.22.10.3518-3526.2002; Carter AM, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0070; Cronin JG, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.092718; Cunningham F, 2019, NUCLEIC ACIDS RES, V47, pD745, DOI 10.1093/nar/gky1113; DABIRI GA, 1992, J BIOL CHEM, V267, P16545; Fernandez MH, 2005, BIOL REV, V80, P269, DOI 10.1017/S1464793104006670; Forde N, 2011, BIOL REPROD, V85, P144, DOI 10.1095/biolreprod.110.090019; Forde N, 2011, BIOL REPROD, V84, P266, DOI 10.1095/biolreprod.110.085910; Forde N, 2009, BIOL REPROD, V81, P784, DOI 10.1095/biolreprod.108.074336; Forde N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100010; Frankish A, 2019, NUCLEIC ACIDS RES, V47, pD766, DOI 10.1093/nar/gky955; Glaser J, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/379847; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; GUILLOMOT M, 1981, PLACENTA, V2, P169, DOI 10.1016/S0143-4004(81)80021-5; IRELAND JJ, 1980, J DAIRY SCI, V63, P155, DOI 10.3168/jds.S0022-0302(80)82901-8; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kimmins S, 2001, PLACENTA, V22, P742, DOI 10.1053/plac.2001.0708; Kwiatkowski DJ, 1999, CURR OPIN CELL BIOL, V11, P103, DOI 10.1016/S0955-0674(99)80012-X; Liao Y, 2019, NUCLEIC ACIDS RES, V47, DOI 10.1093/nar/gkz114; Liao YX, 2019, NUCLEIC ACIDS RES, V47, pW199, DOI 10.1093/nar/gkz401; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lonergan P, 2014, ANIMAL, V8, P64, DOI 10.1017/S1751731114000470; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Macklon Nick S, 2014, Biol Reprod, V91, P98, DOI 10.1095/biolreprod.114.122846; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Martinez-Garcia E, 2017, CLIN CANCER RES, V23, P6458, DOI 10.1158/1078-0432.CCR-17-0474; MASTERS RA, 1982, J REPROD FERTIL, V66, P571, DOI 10.1530/jrf.0.0660571; Mathew DJ, 2019, BIOL REPROD, V100, P365, DOI 10.1093/biolre/ioy199; Mullen MP, 2012, J PROTEOME RES, V11, P3004, DOI 10.1021/pr300144q; Nakamura K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158278; Okumu LA, 2010, REPRODUCTION, V140, P143, DOI 10.1530/REP-10-0113; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Spencer TE, 2013, REPRODUCTION, V146, P377, DOI 10.1530/REP-13-0165; Stirparo GG, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.158501; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Tarver JE, 2016, GENOME BIOL EVOL, V8, P330, DOI 10.1093/gbe/evv261; Whitworth KM, 2011, CELL REPROGRAM, V13, P191, DOI 10.1089/cell.2010.0087; Witke W, 2001, J CELL BIOL, V154, P775, DOI 10.1083/jcb.200101113; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157	44	5	5	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					11015	11029		10.1096/fj.202000882RR	http://dx.doi.org/10.1096/fj.202000882RR		JUL 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32619075	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000547517200001
J	Zhang, CH; He, XY; Sheng, Y; Yang, C; Xu, J; Zheng, SJ; Liu, JY; Xu, WT; Luo, YB; Huang, K				Zhang, Chuanhai; He, Xiaoyun; Sheng, Yao; Yang, Cui; Xu, Jia; Zheng, Shujuan; Liu, Junyu; Xu, Wentao; Luo, Yunbo; Huang, Kunlun			Allicin-induced host-gut microbe interactions improves energy homeostasis	FASEB JOURNAL			English	Article						allicin; brown adipose tissue; energy homeostasis; host-gut microbe interactions; obesity	ADIPOSE-TISSUE; FAT; BROWN; BIFIDOBACTERIUM; OBESITY; LACTOBACILLUS; TRANSPLANTATION; ADIPOCYTES; PHYSIOLOGY; CHILDHOOD	Allicin (diallylthiosulfinate) is a natural food compound with multiple biological and pharmacological functions. However, the mechanism of beneficial role of Allicin on energy homeostasis is not well studied. Gut microbiota (GM) profoundly affects host metabolism via microbiota-host interactions and coevolution. Here, we investigated the interventions of beneficial microbiome induced by Allicin on energy homeostasis, particularly obesity, and related complications. Interestingly, Allicin treatment significantly improved GM composition and induced the most significant alteration enrichment of Bifidobacterium and Lactobacillus. Importantly, transplantation of the Allicin-induced GM to HFD mice (AGMT) played a remarkable role in decreasing adiposity, maintaining glucose homeostasis, and ameliorating hepatic steatosis. Furthermore, AGMT was effective in modulating lipid metabolism, activated brown adipose tissues (BATs), induced browning in sWAT, reduced inflammation, and inhibited the degradation of intestinal villi. Mechanically, AGMT significantly increasedBlautia[short-chain fatty acids (SCFAs)-producing microbiota] andBifidobacteriumin HFD mice, also increased the SCFAs in the cecum, which has been proved many beneficial effects on energy homeostasis. Our study highlights that Allicin-induced host-gut microbe interactions plays an important role in regulating energy homeostasis, which provides a promising potential therapy for obesity and metabolic disorders based on host-microbe interactions.	[Zhang, Chuanhai; He, Xiaoyun; Sheng, Yao; Yang, Cui; Xu, Jia; Zheng, Shujuan; Liu, Junyu; Xu, Wentao; Luo, Yunbo; Huang, Kunlun] China Agr Univ, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Coll Food Sci & Nutr Engn, Beijing, Peoples R China; [Zhang, Chuanhai; He, Xiaoyun; Sheng, Yao; Yang, Cui; Xu, Jia; Zheng, Shujuan; Liu, Junyu; Xu, Wentao; Luo, Yunbo; Huang, Kunlun] Minist Agr, Key Lab Safety Assessment Genetically Modified Or, Beijing, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs	Luo, YB; Huang, K (corresponding author), China Agr Univ, Coll Food Sci & Nutr Engn, 17 Tsinghua East Rd, Beijing 100083, Peoples R China.	lyb@cau.edu.cn; foodsafety66@cau.edu.cn	Zhang, Chuanhai/O-3137-2018	Zhang, Chuanhai/0000-0001-7644-2436; Kunlun, Huang/0000-0002-2350-5859; Shujuan, Zheng/0000-0001-6545-0748	Genetically Modified Organisms Breeding Major Projects of PR China [2018ZX0801102B]; National Natural Science Foundation of China [81700684]	Genetically Modified Organisms Breeding Major Projects of PR China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The current research was supported by the Genetically Modified Organisms Breeding Major Projects of PR China (2018ZX0801102B) and National Natural Science Foundation of China (81700684).	Aizawa E, 2016, J AFFECT DISORDERS, V202, P254, DOI 10.1016/j.jad.2016.05.038; Allegretti JR, 2019, LANCET, V394, P420, DOI 10.1016/S0140-6736(19)31266-8; Bai J, 2016, J ETHNOPHARMACOL, V194, P717, DOI 10.1016/j.jep.2016.10.043; Bernini LJ, 2018, BRIT J NUTR, V120, P645, DOI 10.1017/S0007114518001861; Blaut M, 2015, P NUTR SOC, V74, P227, DOI 10.1017/S0029665114001700; Blaut M, 2013, CURR TOP MICROBIOL, V358, P247, DOI 10.1007/82_2011_192; Borody Thomas J, 2013, Curr Gastroenterol Rep, V15, P337, DOI 10.1007/s11894-013-0337-1; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Cerdo T, 2019, NUTRIENTS, V11, DOI 10.3390/nu11030635; Chagwedera DN, 2019, CELL METAB, V30, P364, DOI 10.1016/j.cmet.2019.05.002; Chan JYY, 2013, PHYTOTHER RES, V27, P637, DOI 10.1002/ptr.4796; Chevalier C, 2015, CELL, V163, P1360, DOI 10.1016/j.cell.2015.11.004; Chi QS, 2011, J COMP PHYSIOL B, V181, P91, DOI 10.1007/s00360-010-0506-6; Ding GL, 2016, EXP THER MED, V11, P2553, DOI 10.3892/etm.2016.3179; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; El-Sheakh AR, 2016, CAN J PHYSIOL PHARM, V94, P216, DOI 10.1139/cjpp-2015-0267; Farooqi IS, 2005, ANNU REV MED, V56, P443, DOI 10.1146/annurev.med.56.062904.144924; Gerard P, 2016, CELL MOL LIFE SCI, V73, P147, DOI 10.1007/s00018-015-2061-5; Geserick M, 2018, NEW ENGL J MED, V379, P1303, DOI 10.1056/NEJMoa1803527; Geurts L, 2014, BENEF MICROBES, V5, P3, DOI 10.3920/BM2012.0065; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Hernandez JB, 2015, NAT COMMUN, V6, DOI [10.1038/ncomms8216, 10.1038/ncomms8489]; Hong YL, 2019, LIFE SCI, V231, DOI 10.1016/j.lfs.2019.116550; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Kajimura S, 2015, CELL METAB, V22, P546, DOI 10.1016/j.cmet.2015.09.007; Kassaian N, 2017, TRIALS, V18, DOI 10.1186/s13063-017-1885-8; Kassam Z, 2013, AM J GASTROENTEROL, V108, P500, DOI 10.1038/ajg.2013.59; Kim HI, 2019, NUTR RES, V67, P78, DOI 10.1016/j.nutres.2019.03.008; Koh A, 2016, CELL, V165, P1332, DOI 10.1016/j.cell.2016.05.041; Le Barz M, 2019, FASEB J, V33, P4921, DOI 10.1096/fj.201801672R; Lee CG, 2019, J NUTR BIOCHEM, V64, P13, DOI 10.1016/j.jnutbio.2018.09.014; Leshem A, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01341; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Li BG, 2019, CELL REP, V26, P2720, DOI 10.1016/j.celrep.2019.02.015; Li XP, 2017, J AGR FOOD CHEM, V65, P3801, DOI 10.1021/acs.jafc.7b00233; Ling X, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161635; Liu SJ, 2018, J SCI FOOD AGR, V98, P5816, DOI 10.1002/jsfa.9131; Matsushita M, 2014, INT J OBESITY, V38, P812, DOI 10.1038/ijo.2013.206; Mazidi M, 2016, DIABETES METAB SYND, V10, pS150, DOI 10.1016/j.dsx.2016.01.024; McRae MP, 2005, J CHIROPR MED, V4, P182, DOI 10.1016/S0899-3467(07)60149-9; Merrick D, 2019, SCIENCE, V364, P353, DOI 10.1126/science.aav2501; Minami J, 2018, BIOSCI MICROB FOOD H, V37, P67, DOI 10.12938/bmfh.18-001; Murphy KG, 2006, NATURE, V444, P854, DOI 10.1038/nature05484; Nishtar S, 2016, LANCET, V387, P825, DOI 10.1016/S0140-6736(16)00140-9; Papizadeh M, 2017, MICROB PATHOGENESIS, V111, P118, DOI 10.1016/j.micpath.2017.08.021; Park SK, 2013, INT J SYST EVOL MICR, V63, P599, DOI 10.1099/ijs.0.036541-0; Petersen C, 2019, SCIENCE, V365, P340, DOI 10.1126/science.aat9351; Quan LH, 2020, GUT, V69, P1239, DOI 10.1136/gutjnl-2019-319114; Rezazadeh A, 2018, INT IMMUNOPHARMACOL, V59, P168, DOI 10.1016/j.intimp.2018.04.007; Sanchis-Chorda J, 2019, EUR J NUTR, V58, P2789, DOI 10.1007/s00394-018-1828-5; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Sood A, 2020, J GASTROEN HEPATOL, V35, P418, DOI 10.1111/jgh.14829; Tanida M, 2008, OBES RES CLIN PRACT, V2, P159, DOI 10.1016/j.orcp.2008.04.003; Thyagarajan B, 2017, HORM MOL BIOL CLIN I, V31, DOI 10.1515/hmbci-2017-0016; Tong XL, 2018, MBIO, V9, DOI 10.1128/mBio.02392-17; Torres-Fuentes C, 2017, LANCET GASTROENTEROL, V2, P747, DOI 10.1016/S2468-1253(17)30147-4; Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031; Wang P, 2020, INT J OBESITY, V44, P213, DOI 10.1038/s41366-019-0332-1; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wilkins T, 2017, AM FAM PHYSICIAN, V96, P170; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Yin N, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20071622; Yuan XX, 2017, FASEB J, V31, P333, DOI [10.1096/fj.201600459RR, 10.1096/fj.201600459rr]; Zhang CH, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101113; Zhang CH, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20205150; Zhang H, 2019, BIOMED PHARMACOTHER, V114, DOI 10.1016/j.biopha.2019.108781; Zhang M, 2017, CELL PHYSIOL BIOCHEM, V41, P2255, DOI 10.1159/000475640; Zhang Y, 2017, SURGERY, V161, P546, DOI 10.1016/j.surg.2016.08.029; Zhou J, 2018, BIOCHEM BIOPH RES CO, V504, P470, DOI 10.1016/j.bbrc.2018.08.106	69	15	15	8	24	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10682	10698		10.1096/fj.202001007R	http://dx.doi.org/10.1096/fj.202001007R		JUL 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32619085	hybrid			2022-12-28	WOS:000547516600001
J	Bortolazzo, FO; Lucke, LD; Fujii, LD; Marqueti, RD; Ramos, GV; Theodoro, V; Bombeiro, AL; Felonato, M; Dalia, RA; Carneiro, GD; Vicente, CP; Esquisatto, MAM; Mendonca, FAS; dos Santos, GMT; Pimentel, ER; de Aro, AA				Bortolazzo, Fernanda O.; Lucke, Leticia D.; Fujii, Lucas de Oliveira; Marqueti, Rita de Cassia; Ramos, Gracielle Vicira; Theodoro, Viviane; Bombeiro, Andre L.; Felonato, Maira; Dalia, Rodrigo A.; Carneiro, Giane D.; Vicente, Cristina Pontes; Esquisatto, Marcelo A. M.; Mendonca, Fernanda A. S.; dos Santos, Glaucia Maria T.; Pimentel, Edson R.; de Aro, Andrea A.			Microcurrent and adipose-derived stem cells modulate genes expression involved in the structural recovery of transected tendon of rats	FASEB JOURNAL			English	Article						cell therapy; collagen; CTGF; electrical stimulation; tendon repair	ELECTRICAL-STIMULATION; EPITHELIAL-CELLS; FLEXOR TENDON; THERAPY; WOUNDS; REPAIR; INTERLEUKIN-10; TENDINITIS; CARTILAGE; TENASCIN	Tendon injuries are common and have a high incidence of re-rupture that can cause loss of functionality. Therapies with adipose-derived stem cells (ASC) and the microcurrent (low-intensity electrical stimulation) application present promising effects on the tissue repair. We analyzed the expression of genes and the participation of some molecules potentially involved in the structural recovery of the Achilles tendon of rats, in response to the application of both therapies, isolated and combined. The tendons were distributed in five groups: normal (N), transected (T), transected and ASC (C) or microcurrent (M) or with ASC, and microcurrent (MC). Microcurrent therapy was beneficial for tendon repair, as it was observed a statistically significant increase in the organization of the collagen fibers, with involvement of theTNC, CTGF, FN, FMDO,andCOL3A1genes as well as PCNA, IL-10, and TNF-alpha. ASC therapy significantly increased theTNCandFMDOgenes expression with no changes in the molecular organization of collagen. With the association of therapies, a significant greater collagen fibers organization was observed with involvement of theFMODgene. The therapies did not affect the expression ofCOL1A1, SMAD2,SMAD3,MKX,andEGR1genes, nor did they influence the amount of collagen I and III, caspase-3, tenomodulin (Tnmd), and hydroxyproline. In conclusion, the application of the microcurrent isolated or associated with ASC increased the organization of the collagen fibers, which can result in a greater biomechanical resistance in relation to the tendons treated only with ASC. Future studies will be needed to demonstrate the biological effects of these therapies on the functional recovery of injured tendons.	[Bortolazzo, Fernanda O.; Lucke, Leticia D.; Bombeiro, Andre L.; Carneiro, Giane D.; Vicente, Cristina Pontes; Pimentel, Edson R.; de Aro, Andrea A.] Univ Estadual Campinas, UNICAMP, Inst Biol, Dept Struct & Funct Biol, Sao Paulo, Brazil; [Marqueti, Rita de Cassia] Univ Brasilia UnB, Grad Program Rehabil Sci, Brasilia, DF, Brazil; [Marqueti, Rita de Cassia] Univ Brasilia UnB, Grad Program Sci & Technol Hlth & Rehabil Sci, Brasilia, DF, Brazil; [Ramos, Gracielle Vicira] Paulista Univ UNIP, ICESP Ctr Univ, Brasilia, DF, Brazil; [Fujii, Lucas de Oliveira; Theodoro, Viviane; Felonato, Maira; Dalia, Rodrigo A.; Esquisatto, Marcelo A. M.; Mendonca, Fernanda A. S.; dos Santos, Glaucia Maria T.; de Aro, Andrea A.] Univ Ctr Herminio Ometto Fdn FHO, Biomed Sci Grad Program, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Brasilia; Universidade de Brasilia; Universidade Paulista	de Aro, AA (corresponding author), Univ Ctr Herminio Ometto Fdn FHO, Biomed Sci Grad Program, Av Dr Maximilian Baritto,500 Jd Univ, Araras, SP, Brazil.	andreaaro80@gmail.com	Marqueti, Rita de Cassia/D-1622-2012; de Aro, Andrea Aparecida/E-3753-2012; Ramos, Gracielle/D-8926-2017	Marqueti, Rita de Cassia/0000-0001-9126-3882; de Aro, Andrea Aparecida/0000-0003-2895-0000; Ramos, Gracielle/0000-0003-4746-0357; Fujii, Lucas de Oliveira/0000-0002-5962-6804; Bombeiro, Andre Luis/0000-0003-2303-8127	Capes (Coordination for the Improvement of Higher Education Personnel); Herminio Ometto Foundation/FHO	Capes (Coordination for the Improvement of Higher Education Personnel)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Herminio Ometto Foundation/FHO	Capes (Coordination for the Improvement of Higher Education Personnel); Herminio Ometto Foundation/FHO	Ahmed AF, 2012, J ADV RES, V3, P109, DOI 10.1016/j.jare.2011.05.004; ALVAREZ OM, 1983, J INVEST DERMATOL, V81, P144, DOI 10.1111/1523-1747.ep12543498; Aro AA, 2013, INJURY, V44, P884, DOI 10.1016/j.injury.2012.08.055; Aro AA, 2012, LIFE SCI, V91, P885, DOI 10.1016/j.lfs.2012.09.002; Backer Henrik C, 2019, Foot Ankle Spec, V12, P471, DOI 10.1177/1938640018819779; Behrendt P, 2018, OSTEOARTHR CARTILAGE, V26, P264, DOI 10.1016/j.joca.2017.11.007; Bertolini F, 2012, BBA-REV CANCER, V1826, P209, DOI 10.1016/j.bbcan.2012.04.004; Biancalana A, 2010, CONNECT TISSUE RES, V51, P171, DOI 10.3109/03008200903191312; Brighton CT, 2001, J BONE JOINT SURG AM, V83A, P1514, DOI 10.2106/00004623-200110000-00009; Broughton G, 2006, PLAST RECONSTR SURG, V117, p6S, DOI 10.1097/01.prs.0000225429.76355.dd; Caetano GF, 2015, PROCEDIA ENGINEER, V110, P59, DOI 10.1016/j.proeng.2015.07.010; Callegari I, 2019, J NEUROL, V266, P2629, DOI 10.1007/s00415-019-09453-3; Carvalho AD, 2011, J EQUINE VET SCI, V31, P26, DOI 10.1016/j.jevs.2010.11.014; Castro FCB, 2012, HOMEOPATHY, V101, P147, DOI 10.1016/j.homp.2012.05.006; Chan HKF, 2007, J ORTHOP SPORT PHYS, V37, P399, DOI 10.2519/jospt.2007.2412; CHENG N, 1982, CLIN ORTHOP RELAT R, P264; Chiquet M, 2009, BBA-MOL CELL RES, V1793, P911, DOI 10.1016/j.bbamcr.2009.01.012; Chithra P, 1998, J ETHNOPHARMACOL, V59, P195, DOI 10.1016/S0378-8741(97)00124-4; Cho KS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165661; Ciccone CD, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-17; de Aro AA, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7090127; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Fonseca JH, 2019, J BIOMED MATER RES B, V107, P924, DOI 10.1002/jbm.b.34187; Frauz K, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8010056; Hsiao STF, 2012, STEM CELLS DEV, V21, P2189, DOI 10.1089/scd.2011.0674; Janes KA, 2006, CELL, V124, P1225, DOI 10.1016/j.cell.2006.01.041; Jorge MP, 2008, J ETHNOPHARMACOL, V118, P361, DOI 10.1016/j.jep.2008.04.024; Ju YJ, 2008, CELL TISSUE RES, V332, P469, DOI 10.1007/s00441-008-0610-z; Juhasz A, 2000, LARYNGOSCOPE, V110, P84, DOI 10.1097/00005537-200001000-00016; Kalamajski S, 2010, MATRIX BIOL, V29, P248, DOI 10.1016/j.matbio.2010.01.001; Kleiner DM, J ATHL TRAIN, V331998, P185; Kloth Luther C, 2005, Int J Low Extrem Wounds, V4, P23; Kreja L, 2012, J MATER SCI-MATER M, V23, P2575, DOI 10.1007/s10856-012-4710-7; Lacitignola L, 2008, VET RES COMMUN, V32, pS33, DOI 10.1007/s11259-008-9085-3; Learn GD, 2019, J BIOMED MATER RES B, V107, P1864, DOI 10.1002/jbm.b.34279; Lin YL, 2006, AM J VET RES, V67, P845, DOI 10.2460/ajvr.67.5.845; Lipson KE, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S24; Liu T, 2016, MOL MED REP, V13, P2053, DOI 10.3892/mmr.2016.4768; Lucke LD, 2019, CELL PROLIFERAT, V52, DOI 10.1111/cpr.12580; Marqueti RC, 2018, FASEB J, V32, P353, DOI 10.1096/fj.201700543R; Midwood KS, 2004, MOL BIOL CELL, V15, P5670, DOI 10.1091/mbc.E04-08-0759; Murthi AM, 2019, ORTHOP CLIN N AM, V50, P103, DOI 10.1016/j.ocl.2018.08.005; Nakagaki WR, 2013, ANAT REC, V296, P1546, DOI 10.1002/ar.22759; Nixon AJ, 2008, AM J VET RES, V69, P928, DOI 10.2460/ajvr.69.7.928; Omar A, 2017, EGYPT J HISTOL, V40, P12, DOI [10.21608/ejh.2017.3693, DOI 10.21608/EJH.2017.3693]; Oshiro W, 2003, J HAND SURG-AM, V28A, P814, DOI 10.1016/S0363-5023(03)00366-6; Pajala A, 2002, J BONE JOINT SURG AM, V84A, P2016, DOI 10.2106/00004623-200211000-00017; Pankevich EV, 2017, BIOCHEMISTRY-MOSCOW+, V82, P1276, DOI 10.1134/S0006297917110050; Passarini JR, 2012, ACTA CIR BRAS, V27, P441, DOI 10.1590/S0102-86502012000700002; Raja, 2007, Front Biosci, V12, P2849; Ricchetti ET, 2008, J HAND SURG-AM, V33A, P1843, DOI 10.1016/j.jhsa.2008.07.020; Rivera-Izquierdo M, 2019, EXPERT OPIN BIOL TH, V19, P233, DOI 10.1080/14712598.2019.1563069; Rothrauff BB, 2019, J SHOULDER ELB SURG, V28, P654, DOI 10.1016/j.jse.2018.08.044; Saini NS, 2002, J VET MED A, V49, P321, DOI 10.1046/j.1439-0442.2002.00441.x; Sakr HI, 2021, ARCH PHYSIOL BIOCHEM, V127, P136, DOI 10.1080/13813455.2019.1623263; Sensini A, 2018, MATERIALS, V11, DOI 10.3390/ma11101963; Spadari GS, 2017, CLIN ORAL INVEST, V21, P111, DOI 10.1007/s00784-016-1759-6; STEGEMAN.H, 1967, CLIN CHIM ACTA, V18, P267, DOI 10.1016/0009-8981(67)90167-2; Strem Brian M., 2005, Keio Journal of Medicine, V54, P132, DOI 10.2302/kjm.54.132; Tai GP, 2018, BURNS TRAUMA, V6, DOI 10.1186/s41038-018-0123-2; Tang M, 2020, J CELL BIOCHEM, V121, P3720, DOI 10.1002/jcb.29529; Tangerino EP, 2016, TISSUE CELL, V48, P224, DOI 10.1016/j.tice.2016.03.004; Taye N, 2020, J ORTHOP RES, V38, P23, DOI 10.1002/jor.24440; Tofino-Vian M, 2018, CELL PHYSIOL BIOCHEM, V47, P11, DOI 10.1159/000489739; Tomiosso TC, 2009, CELL TISSUE RES, V337, P235, DOI 10.1007/s00441-009-0819-5; Ulloa L, 2005, TRENDS MOL MED, V11, P56, DOI 10.1016/j.molmed.2004.12.007; Uysal CA, 2012, J PLAST RECONSTR AES, V65, P1712, DOI 10.1016/j.bjps.2012.06.011; Veronesi F, 2014, J BIOMED MATER RES A, V102, P2448, DOI 10.1002/jbm.a.34896; VIDAL BD, 1980, CELL MOL BIOL, V26, P415; Vidal BD, 2011, MICRON, V42, P283, DOI 10.1016/j.micron.2010.09.010; Vidal BD, 2010, ACTA HISTOCHEM, V112, P53, DOI 10.1016/j.acthis.2008.07.005; Vila M, 2013, J BIOMED MATER RES A, V101, P213, DOI 10.1002/jbm.a.34325; Wang JHC, 2012, J HAND THER, V25, P133, DOI 10.1016/j.jht.2011.07.004; Witko-Sarsat V, 2010, J EXP MED, V207, P2631, DOI 10.1084/jem.20092241; Yang XF, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-59; Yu C, 2019, MILITARY MED RES, V6, DOI 10.1186/s40779-019-0213-x; Yu C, 2014, MILITARY MED RES, V1, DOI 10.1186/2054-9369-1-24; Zaniboni E, 2019, CLIN ORAL INVEST, V23, P4083, DOI 10.1007/s00784-019-02845-9; Zhao M, 2002, FASEB J, V16, P857, DOI 10.1096/fj.01-0811fje; Zheng Y, 2017, EUR REV MED PHARMACO, V21, P5160, DOI 10.26355/eurrev_201711_13833; Zuzzi DC, 2013, TISSUE CELL, V45, P275, DOI 10.1016/j.tice.2013.02.003	81	3	3	1	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10011	10026		10.1096/fj.201902942RR	http://dx.doi.org/10.1096/fj.201902942RR		JUN 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32558993				2022-12-28	WOS:000541806600001
J	Drumm, BT; Rembetski, BE; Huynh, K; Nizar, A; Baker, SA; Sanders, KM				Drumm, Bernard T.; Rembetski, Benjamin E.; Huynh, Kaitlin; Nizar, Aqeel; Baker, Salah A.; Sanders, Kenton M.			Excitatory cholinergic responses in mouse colon intramuscular interstitial cells of Cajal are due to enhanced Ca(2+)release via M(3)receptor activation	FASEB JOURNAL			English	Article						Ca(2+)imaging; Ca(2+)stores; cholinergic; c-Kit; gastrointestinal motility; optogenetics; SIP syncytium	DEEP MUSCULAR PLEXUS; NITRERGIC NEUROMUSCULAR-TRANSMISSION; ENTERIC MOTOR NEUROTRANSMISSION; SLOW-WAVE CURRENTS; SMOOTH-MUSCLE; INHIBITORY NEUROTRANSMISSION; MUSCARINIC RECEPTORS; LOWER ESOPHAGEAL; CA2+ TRANSIENTS; SMALL-INTESTINE	Colonic intramuscular interstitial cells of Cajal (ICC-IM) are associated with cholinergic varicosities, suggesting a role in mediating excitatory neurotransmission. Ca(2+)release in ICC-IM activates Ano1, a Ca2+-activated Cl(-)conductance, causing tissue depolarization and increased smooth muscle excitability. We employed Ca(2+)imaging of colonic ICC-IM in situ, using mice expressing GCaMP6f in ICC to evaluate ICC-IM responses to excitatory neurotransmission. Expression of muscarinic type 2, 3 (M-2, M-3), and NK(1)receptors were enriched in ICC-IM. NK(1)receptor agonists had minimal effects on ICC-IM, whereas neostigmine and carbachol increased Ca(2+)transients. These effects were reversed by DAU 5884 (M(3)receptor antagonist) but not AF-DX 116 (M(2)receptor antagonist). Electrical field stimulation (EFS) in the presence of L-NNA and MRS 2500 enhanced ICC-IM Ca(2+)transients. Responses were blocked by atropine or DAU 5884, but not AF-DX 116. ICC-IM responses to EFS were ablated by inhibiting Ca(2+)stores with cyclopiazonic acid and reduced by inhibiting Ca(2+)influx via Orai channels. Contractions induced by EFS were reduced by an Ano1 channel antagonist, abolished by DAU 5884, and unaffected by AF-DX 116. Colonic ICC-IM receive excitatory inputs from cholinergic neurons via M(3)receptor activation. Enhancing ICC-IM Ca(2+)release and Ano1 activation contributes to excitatory responses of colonic muscles.	[Drumm, Bernard T.; Rembetski, Benjamin E.; Huynh, Kaitlin; Nizar, Aqeel; Baker, Salah A.; Sanders, Kenton M.] Univ Nevada, Reno Sch Med, Dept Physiol & Cell Biol, MS 352, Reno, NV 89557 USA; [Drumm, Bernard T.] Dundalk Inst Technol, Dept Life & Hlth Sci, Dundalk, Ireland	Nevada System of Higher Education (NSHE); University of Nevada Reno; Dundalk Institute of Technology	Sanders, KM (corresponding author), Univ Nevada, Reno Sch Med, Dept Physiol & Cell Biol, MS 352, Reno, NV 89557 USA.	ksanders@med.unr.edu		BAKER, SAL/0000-0002-1514-6876; Drumm, Bernard/0000-0002-4762-844X	NIDDK [R01 DK-120759]	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This project was supported by R01 DK-120759 from the NIDDK.	Aranishi H, 2009, CELL TISSUE RES, V335, P323, DOI 10.1007/s00441-008-0730-5; Baker S. A., 2018, FRONT PHYSIOL, V9, P1; Baker SA, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0080-18.2018; Baker SA, 2016, J PHYSIOL-LONDON, V594, P3317, DOI 10.1113/JP271699; Bayguinov PO, 2010, J PHYSIOL-LONDON, V588, P4453, DOI 10.1113/jphysiol.2010.196824; Beckett EAH, 2005, J COMP NEUROL, V493, P193, DOI 10.1002/cne.20746; Beckett EAH, 2004, J PHYSIOL-LONDON, V559, P259, DOI 10.1113/jphysiol.2004.063016; Beckett EAH, 2002, J PHYSIOL-LONDON, V543, P871, DOI 10.1113/jphysiol.2002.021915; Beckett EAH, 2017, SCI REP-UK, V7, DOI 10.1038/srep44759; Berridge M, 1999, CURR BIOL, V9, pR157, DOI 10.1016/S0960-9822(99)80101-8; Berridge MJ, 2009, BBA-MOL CELL RES, V1793, P933, DOI 10.1016/j.bbamcr.2008.10.005; Bhetwal BP, 2013, J PHYSIOL-LONDON, V591, P2971, DOI 10.1113/jphysiol.2013.255745; Blair PJ, 2012, NEUROGASTROENT MOTIL, V24, pe437, DOI 10.1111/j.1365-2982.2012.01975.x; Blair PJ, 2012, CELL TISSUE RES, V350, P199, DOI 10.1007/s00441-012-1468-7; Burns AJ, 1996, P NATL ACAD SCI USA, V93, P12008, DOI 10.1073/pnas.93.21.12008; Cobine CA, 2014, AM J PHYSIOL-GASTR L, V307, pG1057, DOI 10.1152/ajpgi.00331.2014; Cobine CA, 2011, CELL TISSUE RES, V344, P17, DOI 10.1007/s00441-011-1138-1; DANIEL EE, 1984, AM J PHYSIOL, V246, pG305, DOI 10.1152/ajpgi.1984.246.3.G305; Drumm B. T., 2019, J VIS EXP, V2019, P1; Drumm BT, 2020, J PHYSIOL-LONDON, V598, P651, DOI 10.1113/JP279102; Drumm BT, 2019, J PHYSIOL-LONDON, V597, P3587, DOI 10.1113/JP278036; Drumm BT, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39729-7; Drumm BT, 2018, CELL CALCIUM, V72, P1, DOI 10.1016/j.ceca.2018.01.003; Drumm BT, 2017, J GEN PHYSIOL, V149, P703, DOI [10.1085/jgp.20171177106142017c, 10.1085/jgp.201711771]; Duffy AM, 2012, NEUROGASTROENT MOTIL, V24, pE41, DOI 10.1111/j.1365-2982.2011.01806.x; Durnin L, 2017, AM J PHYSIOL-GASTR L, V313, pG419, DOI 10.1152/ajpgi.00045.2017; Eglen RM, 1996, PHARMACOL REV, V48, P531; Eglen RM, 2001, LIFE SCI, V68, P2573, DOI 10.1016/S0024-3205(01)01054-2; Ehlert FJ, 1997, LIFE SCI, V61, P1729, DOI 10.1016/S0024-3205(97)00433-5; Forrest AS, 2006, AM J PHYSIOL-GASTR L, V290, pG486, DOI 10.1152/ajpgi.00349.2005; Fryer AD, 1998, AM J RESP CRIT CARE, V158, pS154, DOI 10.1164/ajrccm.158.supplement_2.13tac120; Furness JB, 2012, NAT REV GASTRO HEPAT, V9, P286, DOI 10.1038/nrgastro.2012.32; Gao N, 2016, J PHYSIOL-LONDON, V594, P3209, DOI 10.1113/JP271703; Gomez-Pinilla PJ, 2009, AM J PHYSIOL-GASTR L, V296, pG1370, DOI 10.1152/ajpgi.00074.2009; Groneberg D, 2015, J PHYSIOL-LONDON, V593, P403, DOI 10.1113/jphysiol.2014.273540; Groneberg D, 2013, GASTROENTEROLOGY, V145, P188, DOI 10.1053/j.gastro.2013.03.042; He CL, 2000, GASTROENTEROLOGY, V118, P14, DOI 10.1016/S0016-5085(00)70409-4; Hwang SJ, 2009, J PHYSIOL-LONDON, V587, P4887, DOI 10.1113/jphysiol.2009.176198; Iino S, 2006, NEUROSCIENCE, V138, P549, DOI 10.1016/j.neuroscience.2005.11.021; Iino S, 2004, J PHYSIOL-LONDON, V556, P521, DOI 10.1113/jphysiol.2003.058792; Ishikawa K, 1996, ANAT EMBRYOL, V194, P49; Kashyap P, 2011, NEUROGASTROENT MOTIL, V23, P760, DOI 10.1111/j.1365-2982.2011.01729.x; Komuro T, 1999, MICROSC RES TECHNIQ, V47, P267, DOI 10.1002/(SICI)1097-0029(19991115)47:4<267::AID-JEMT5>3.0.CO;2-O; Komuro T, 2006, J PHYSIOL-LONDON, V576, P653, DOI 10.1113/jphysiol.2006.116624; Kunze WAA, 1999, ANNU REV PHYSIOL, V61, P117, DOI 10.1146/annurev.physiol.61.1.117; Lavin ST, 1998, HISTOCHEM CELL BIOL, V110, P263, DOI 10.1007/s004180050288; Lee HT, 2009, GASTROENTEROLOGY, V136, P2226, DOI 10.1053/j.gastro.2009.02.060; Lies B, 2015, J PHYSIOL-LONDON, V593, P4589, DOI 10.1113/JP270511; Lies B, 2014, AM J PHYSIOL-GASTR L, V307, pG98, DOI 10.1152/ajpgi.00082.2014; Lyford GL, 2002, GUT, V51, P496, DOI 10.1136/gut.51.4.496; Ro S, 2010, GASTROENTEROLOGY, V138, P1068, DOI 10.1053/j.gastro.2009.11.007; RUMESSEN JJ, 1992, GASTROENTEROLOGY, V102, P56, DOI 10.1016/0016-5085(92)91784-2; Rumessen JJ, 2013, CELLS TISSUES ORGANS, V197, P322, DOI 10.1159/000346314; Sanders KM, 2014, PHYSIOL REV, V94, P859, DOI 10.1152/physrev.00037.2013; Sanders KM, 2012, NAT REV GASTRO HEPAT, V9, P633, DOI 10.1038/nrgastro.2012.168; Sanders KM, 2010, J PHYSIOL-LONDON, V588, P4621, DOI 10.1113/jphysiol.2010.196030; Sanders KM, 1996, GASTROENTEROLOGY, V111, P492, DOI 10.1053/gast.1996.v111.pm8690216; Sawyer GW, 1998, J PHARMACOL EXP THER, V284, P269; Seo Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155771; SMITH TK, 1987, AM J PHYSIOL, V252, pC290, DOI 10.1152/ajpcell.1987.252.3.C290; SMITH TK, 1987, AM J PHYSIOL, V252, pC215, DOI 10.1152/ajpcell.1987.252.2.C215; Southwell BR, 2001, GASTROENTEROLOGY, V120, P1140, DOI 10.1053/gast.2001.23251; Spencer NJ, 2020, NAT REV GASTRO HEPAT, V17, P338, DOI 10.1038/s41575-020-0271-2; Spencer NJ, 2020, AM J PHYSIOL-GASTR L, V318, pG244, DOI 10.1152/ajpgi.00317.2019; Spencer NJ, 2018, J NEUROSCI, V38, P5507, DOI 10.1523/JNEUROSCI.3489-17.2018; Sung TS, 2018, J PHYSIOL-LONDON, V596, P1549, DOI 10.1113/JP275478; Vanderwinden JM, 1996, GASTROENTEROLOGY, V111, P901, DOI 10.1016/S0016-5085(96)70057-4; Vanderwinden JM, 2000, CELL TISSUE RES, V302, P155, DOI 10.1007/s004419900170; Wang XY, 2000, CELL TISSUE RES, V302, P331, DOI 10.1007/s004410000272; Wang XY, 1999, CELL TISSUE RES, V295, P247, DOI 10.1007/s004410051231; Ward SM, 2006, J PHYSIOL-LONDON, V576, P675, DOI 10.1113/jphysiol.2006.117390; Ward SM, 2006, J PHYSIOL-LONDON, V573, P147, DOI 10.1113/jphysiol.2006.105189; Ward SM, 2000, J NEUROSCI, V20, P1393; Ward SM, 1998, GASTROENTEROLOGY, V115, P314, DOI 10.1016/S0016-5085(98)70198-2; Wedel T, 2002, GASTROENTEROLOGY, V123, P1459, DOI 10.1053/gast.2002.36600; Worth AA, 2015, J NEUROGASTROENTEROL, V21, P200, DOI 10.5056/jnm14120; YAMAMOTO M, 1977, ARCH HISTOL JAPON, V40, P171, DOI 10.1679/aohc1950.40.171; Youm JB, 2019, BIOPHYS J, V117, P767, DOI 10.1016/j.bpj.2019.07.020; ZHANG LB, 1991, MOL PHARMACOL, V40, P943; Zheng HF, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00230; Zheng HF, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aaq0918; Zhu MH, 2015, AM J PHYSIOL-CELL PH, V308, pC608, DOI 10.1152/ajpcell.00360.2014; Zhu MH, 2011, J PHYSIOL-LONDON, V589, P4565, DOI 10.1113/jphysiol.2011.211094; Zhu MH, 2009, J PHYSIOL-LONDON, V587, P4905, DOI 10.1113/jphysiol.2009.176206	84	6	6	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10073	10095		10.1096/fj.202000672R	http://dx.doi.org/10.1096/fj.202000672R		JUN 2020	23	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32539213	Green Accepted, Bronze			2022-12-28	WOS:000541637800001
J	Shi, Y; Huang, CL; Yi, H; Cao, QH; Zhao, YL; Chen, JS; Chen, XM; Pollock, C				Shi, Ying; Huang, Chunling; Yi, Hao; Cao, Qinghua; Zhao, Yongli; Chen, Jason; Chen, Xinming; Pollock, Carol			RIPK3 blockade attenuates kidney fibrosis in a folic acid model of renal injury	FASEB JOURNAL			English	Article						chronic kidney disease; dabrafenib; NLRP3; renal fibrosis; RIPK3	NLRP3 INFLAMMASOME; OVERCOMING RESISTANCE; BRAF INHIBITOR; NECROPTOSIS; DABRAFENIB; CELL; DISEASE; ACTIVATION; NECROSIS; PHARMACOKINETICS	Renal fibrosis is common to all forms of progressive kidney disease. However, current therapies to limit renal fibrosis are largely ineffective. Phosphorylation of receptor-interacting serine/threonine-protein kinase (RIPK) 3 has been recently suggested to be a key regulator of the pyrin domain containing 3 (NLRP3) inflammasome, which provides new insights into mechanisms of chronic kidney disease (CKD). However, the specific effect of RIPK3 on renal cortical fibrosis has not been fully understood. To study the function of RIPK3, both genetic ablation and pharmacological inhibition of RIPK3 (dabrafenib) were used in the study. Our studies identify that RIPK3 promotes renal fibrosis via the activation of the NLRP3 inflammasome in a mouse model of folic acid-induced nephropathy. Both interventional strategies decreased the renal fibrotic response, and beneficial effects converged on the NLRP3 inflammasome. This study demonstrates a role for RIPK3 as the mediator of renal fibrosis via the upregulation of inflammasome activation. Dabrafenib, as an inhibitor of RIPK3, may be an effective treatment to limit the progression of the tubulointerstitial fibrosis.	[Shi, Ying; Huang, Chunling; Yi, Hao; Cao, Qinghua; Chen, Xinming; Pollock, Carol] Univ Sydney, Kolling Inst Med Res, Sydney Med Sch, Sydney, NSW 2065, Australia; [Zhao, Yongli] Dalian Med Univ, Dept Pediat, Affiliated Hosp 2, Dalian, Peoples R China; [Chen, Jason] Royal North Shore Hosp, Dept Anat Pathol, St Leonards, NSW, Australia	University of Sydney; Kolling Institute of Medical Research; Dalian Medical University; Royal North Shore Hospital	Pollock, C (corresponding author), Univ Sydney, Kolling Inst Med Res, Sydney Med Sch, Sydney, NSW 2065, Australia.	carol.pollock@sydney.edu.au			Australian National Health and Medical Research Council (NSLHD) [RESP/15/206]	Australian National Health and Medical Research Council (NSLHD)	This work was supported by an Australian National Health and Medical Research Council project grant (NSLHD reference RESP/15/206)	Anders HJ, 2018, KIDNEY INT, V93, P656, DOI 10.1016/j.kint.2017.09.022; Awad AS, 2015, KIDNEY INT, V88, P722, DOI 10.1038/ki.2015.162; Buchholz B, 2011, NEPHROL DIAL TRANSPL, V26, P3458, DOI 10.1093/ndt/gfr432; Carew RM, 2012, CELL TISSUE RES, V347, P103, DOI 10.1007/s00441-011-1227-1; Coca SG, 2017, J AM SOC NEPHROL, V28, P2786, DOI 10.1681/ASN.2016101101; Conos SA, 2017, P NATL ACAD SCI USA, V114, pE961, DOI 10.1073/pnas.1613305114; Cruz SA, 2018, NEURAL REGEN RES, V13, P252, DOI 10.4103/1673-5374.226394; Denton CL, 2013, J CLIN PHARMACOL, V53, P955, DOI 10.1002/jcph.127; Duffield JS, 2010, SEMIN NEPHROL, V30, P234, DOI 10.1016/j.semnephrol.2010.03.003; Fan JM, 2001, AM J KIDNEY DIS, V37, P820, DOI 10.1016/S0272-6386(01)80132-3; Farris AB, 2011, J AM SOC NEPHROL, V22, P176, DOI 10.1681/ASN.2009091005; FINK M, 1987, PATHOLOGY, V19, P143, DOI 10.3109/00313028709077125; Foresto-Neto O, 2018, LAB INVEST, V98, P773, DOI 10.1038/s41374-018-0029-4; Francois H., 2017, MATRIX BIOL, DOI [10.10161j.matbio.2017.12.013, DOI 10.10161J.MATBIO.2017.12.013]; Gerarduzzi C, 2017, J CELL PHYSIOL, V232, P202, DOI 10.1002/jcp.25412; Ghasemi H, 2019, IRAN J BASIC MED SCI, V22, P376, DOI 10.22038/ijbms.2019.31922.7674; Guo HL, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/8316560; Huang GR, 2018, TOXICOLOGY, V406, P33, DOI 10.1016/j.tox.2018.05.015; Imamura M, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.94979; Kaiser WJ, 2013, J BIOL CHEM, V288, P31268, DOI 10.1074/jbc.M113.462341; Kang TB, 2013, IMMUNITY, V38, P27, DOI 10.1016/j.immuni.2012.09.015; Kelley N, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20133328; Lau A, 2013, AM J TRANSPLANT, V13, P2805, DOI 10.1111/ajt.12447; Lawlor KE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7282; Lee SB, 2010, KIDNEY INT, V78, pS22, DOI 10.1038/ki.2010.418; Li JX, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.241; Li S, 2019, EXP CELL RES, V383, DOI 10.1016/j.yexcr.2019.07.001; Lorenz G, 2014, NEPHROL DIAL TRANSPL, V29, P41, DOI 10.1093/ndt/gft332; Martin-Sanchez D, 2017, J AM SOC NEPHROL, V28, P218, DOI 10.1681/ASN.2015121376; Meran S, 2011, INT J EXP PATHOL, V92, P158, DOI 10.1111/j.1365-2613.2011.00764.x; Miao NJ, 2019, ACTA PHARMACOL SIN, V40, P790, DOI 10.1038/s41401-018-0177-5; Mittapalli RK, 2013, J PHARMACOL EXP THER, V344, P655, DOI 10.1124/jpet.112.201475; Newton K, 2004, MOL CELL BIOL, V24, P1464, DOI 10.1128/MCB.24.4.1464-1469.2004; Odogwu L, 2018, ONCOLOGIST, V23, P740, DOI 10.1634/theoncologist.2017-0642; Ouellet D, 2014, J CLIN PHARMACOL, V54, P696, DOI 10.1002/jcph.263; Perkovic V, 2019, NEW ENGL J MED, V380, P2295, DOI 10.1056/NEJMoa1811744; Pulskens WP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085775; Rao C, 2012, EUR J PUBLIC HEALTH, V22, P280, DOI 10.1093/eurpub/ckq205; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shlomovitz I, 2017, IMMUNOL CELL BIOL, V95, P166, DOI 10.1038/icb.2016.124; Silke J, 2015, NAT IMMUNOL, V16, P689, DOI [10.1038/ni.3206, 10.1038/ni0815-889b]; Spagnolo F, 2014, ONCOTARGET, V5, P10206, DOI 10.18632/oncotarget.2602; Stallons LJ, 2014, TOXICOL LETT, V224, P326, DOI 10.1016/j.toxlet.2013.11.014; Swenson-Fields KI, 2013, KIDNEY INT, V83, P855, DOI 10.1038/ki.2012.446; Vaidhyanathan S, 2016, J PHARMACOL EXP THER, V356, P251, DOI 10.1124/jpet.115.229393; Vince JE, 2016, CELL MOL LIFE SCI, V73, P2349, DOI 10.1007/s00018-016-2205-2; Wang Shengliu, 2017, Biophys Rep, V3, P8, DOI 10.1007/s41048-017-0035-x; Wang W, 2013, J IMMUNOL, V190, P1239, DOI 10.4049/jimmunol.1201959; Wang XQ, 2014, NAT IMMUNOL, V15, P1126, DOI 10.1038/ni.3015; Wang XL, 2014, EUR J ENTOMOL, V111, P1, DOI 10.14411/eje.2014.001; Wasung ME, 2015, CLIN CHIM ACTA, V438, P350, DOI 10.1016/j.cca.2014.08.039; Xiao X, 2017, AM J NEPHROL, V46, P131, DOI 10.1159/000478746; Yang Hai-Chun, 2010, Drug Discov Today Dis Models, V7, P13, DOI 10.1016/j.ddmod.2010.08.002; Zheng LF, 2018, NEPHROLOGY, V23, P573, DOI 10.1111/nep.13062; Zhu YJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156729	55	14	14	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10286	10298		10.1096/fj.201902544RR	http://dx.doi.org/10.1096/fj.201902544RR		JUN 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32542792	Bronze			2022-12-28	WOS:000541637500001
J	Liu, DD; Ndongwe, TP; Puray-Chavez, M; Casey, MC; Izumi, T; Pathak, VK; Tedbury, PR; Sarafianos, SG				Liu, Dandan; Ndongwe, Tanyaradzwa P.; Puray-Chavez, Maritza; Casey, Mary C.; Izumi, Taisuke; Pathak, Vinay K.; Tedbury, Philip R.; Sarafianos, Stefan G.			Effect of P-body component Mov10 on HCV virus production and infectivity	FASEB JOURNAL			English	Article						HCV; infectivity; lipid droplets; Mov10; P-body; RNA replication	HEPATITIS-C VIRUS; INTERFERON-STIMULATED GENES; CORE PROTEIN; PEGINTERFERON ALPHA-2B; LIVER-TRANSPLANTATION; PROCESSING BODIES; PLUS RIBAVIRIN; B-VIRUS; REPLICATION; RNA	Mov10 is a processing body (P-body) protein and an interferon-stimulated gene that can affect replication of retroviruses, hepatitis B virus, and hepatitis C virus (HCV). The mechanism of HCV inhibition by Mov10 is unknown. Here, we investigate the effect of Mov10 on HCV infection and determine the virus life cycle steps affected by changes in Mov10 overexpression. Mov10 overexpression suppresses HCV RNA in both infectious virus and subgenomic replicon systems. Additionally, Mov10 overexpression decreases the infectivity of released virus, unlike control P-body protein DCP1a that has no effect on HCV RNA production or infectivity of progeny virus. Confocal imaging of uninfected cells shows endogenous Mov10 localized at P-bodies. However, in HCV-infected cells, Mov10 localizes in circular structures surrounding cytoplasmic lipid droplets with NS5A and core protein. Mutagenesis experiments show that the RNA binding activity of Mov10 is required for HCV inhibition, while its P-body localization, helicase, and ATP-binding functions are not required. Unexpectedly, endogenous Mov10 promotes HCV replication, as CRISPR-Cas9-based Mov10 depletion decreases HCV replication and infection levels. Our data reveal an important and complex role for Mov10 in HCV replication, which can be perturbed by excess or insufficient Mov10.	[Liu, Dandan; Ndongwe, Tanyaradzwa P.; Puray-Chavez, Maritza; Casey, Mary C.] Univ Missouri, Christopher Bond Life Sci Ctr, Dept Mol Microbiol & Immunol, Columbia, MO USA; [Izumi, Taisuke; Pathak, Vinay K.] Natl Canc Inst Frederick, Viral Mutat Sect, HIV Dynam & Replicat Program, Frederick, MD USA; [Tedbury, Philip R.; Sarafianos, Stefan G.] Emory Univ, Sch Med, Dept Pediat, Lab Biochem Pharmacol, Atlanta, GA 30322 USA	University of Missouri System; University of Missouri Columbia; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Emory University	Sarafianos, SG (corresponding author), Emory Univ, Sch Med, Dept Pediat, Lab Biochem Pharmacol, Atlanta, GA 30322 USA.	ssarafi@emory.edu	Tedbury, Philip/H-3945-2019; Izumi, Taisuke/GNP-1175-2022	Tedbury, Philip/0000-0001-8151-4967; Izumi, Taisuke/0000-0001-8193-0813; Pathak, Vinay/0000-0003-2441-8412	NIH [R01 AI099284 R01 AI121315]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	NIH, Grant/Award Number: R01 AI099284 R01 AI121315	Abudu A, 2012, J BIOL CHEM, V287, P1220, DOI 10.1074/jbc.M111.309831; Adam P, 2003, LIVER TRANSPLANT, V9, P1231, DOI 10.1016/j.lts.2003.09.018; Adedeji AO, 2012, ANTIMICROB AGENTS CH, V56, P4718, DOI 10.1128/AAC.00957-12; Ariumi Y, 2011, J VIROL, V85, P6882, DOI 10.1128/JVI.02418-10; Barba G, 1997, P NATL ACAD SCI USA, V94, P1200, DOI 10.1073/pnas.94.4.1200; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Boulant S, 2005, J VIROL, V79, P11353, DOI 10.1128/JVI.79.17.11353-11365.2005; Burdick R, 2010, J VIROL, V84, P10241, DOI 10.1128/JVI.00585-10; Cao XZ, 2015, J HEPATOL, V62, P771, DOI 10.1016/j.jhep.2014.11.007; Chendrimada TP, 2007, NATURE, V447, P823, DOI 10.1038/nature05841; Conrad KD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056272; Dreux M, 2012, CELL HOST MICROBE, V12, P558, DOI 10.1016/j.chom.2012.08.010; Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Furtak V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009081; Gallois-Montbrun S, 2007, J VIROL, V81, P2165, DOI 10.1128/JVI.02287-06; Goodier JL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002941; Gregersen LH, 2014, MOL CELL, V54, P573, DOI 10.1016/j.molcel.2014.03.017; Grunvogel O, 2015, J VIROL, V89, P10548, DOI 10.1128/JVI.01297-15; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Horner SM, 2014, J MOL BIOL, V426, P1198, DOI 10.1016/j.jmb.2013.10.032; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Huys A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067437; Israelow B, 2014, HEPATOLOGY, V60, P1170, DOI 10.1002/hep.27227; Itsui Y, 2006, J VIRAL HEPATITIS, V13, P690, DOI 10.1111/j.1365-2893.2006.00732.x; Izumi T, 2013, J VIROL, V87, P11047, DOI 10.1128/JVI.02070-13; Jangra RK, 2010, J VIROL, V84, P6810, DOI 10.1128/JVI.00397-10; Jiang D, 2008, J VIROL, V82, P1665, DOI 10.1128/JVI.02113-07; Kenny PJ, 2014, CELL REP, V9, P1729, DOI 10.1016/j.celrep.2014.10.054; Kim CW, 2013, CLIN MOL HEPATOL, V19, P17, DOI 10.3350/cmh.2013.19.1.17; Kirby KA, 2012, ANTIMICROB AGENTS CH, V56, P2048, DOI 10.1128/AAC.06000-11; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Liu C, 2012, J BIOL CHEM, V287, P29373, DOI 10.1074/jbc.M112.354001; Liu DD, 2015, ANTIMICROB AGENTS CH, V59, P3482, DOI 10.1128/AAC.00223-15; Liu TT, 2019, J BIOL CHEM, V294, P19804, DOI 10.1074/jbc.RA119.009435; Lu CY, 2012, J VIROL, V86, P10517, DOI 10.1128/JVI.00868-12; Ma YX, 2015, VIRUS RES, V197, P85, DOI 10.1016/j.virusres.2014.12.011; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Marukian S, 2008, HEPATOLOGY, V48, P1843, DOI 10.1002/hep.22550; Masaki T, 2008, J VIROL, V82, P7964, DOI 10.1128/JVI.00826-08; McGivern DR, 2014, GASTROENTEROLOGY, V147, P453, DOI 10.1053/j.gastro.2014.04.021; McHutchison JG, 2009, NEW ENGL J MED, V361, P580, DOI 10.1056/NEJMoa0808010; Meister G, 2005, CURR BIOL, V15, P2149, DOI 10.1016/j.cub.2005.10.048; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Moriishi K, 2007, REV MED VIROL, V17, P343, DOI 10.1002/rmv.542; Niu JW, 2014, MOL BIOTECHNOL, V56, P681, DOI 10.1007/s12033-014-9771-z; Pager CT, 2013, VIROLOGY, V435, P472, DOI 10.1016/j.virol.2012.10.027; Pawlotsky JM, 2013, CURR TOP MICROBIOL, V369, P321, DOI 10.1007/978-3-642-27340-7_13; Perez-Vilaro G, 2012, J VIROL, V86, P8740, DOI 10.1128/JVI.07167-11; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Poenisch M, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004573; Puray-Chavez MN, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11070651; Ramakrishnaiah V, 2013, P NATL ACAD SCI USA, V110, P13109, DOI 10.1073/pnas.1221899110; REED L. J., 1938, AMER JOUR HYG, V27, P493; Roberts APE, 2014, NUCLEIC ACIDS RES, V42, P1257, DOI 10.1093/nar/gkt941; Scheller N, 2009, P NATL ACAD SCI USA, V106, P13517, DOI 10.1073/pnas.0906413106; Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Shimakami T, 2012, P NATL ACAD SCI USA, V109, P941, DOI 10.1073/pnas.1112263109; Sugawara Yasuhiko, 2005, Clin Gastroenterol Hepatol, V3, pS122, DOI 10.1016/S1542-3565(05)00708-1; Targett-Adams P, 2011, J VIROL, V85, P6353, DOI 10.1128/JVI.00215-11; Upadhyay A, 2013, MOL CELL PROTEOMICS, V12, P1539, DOI 10.1074/mcp.M112.017020; Wang XJ, 2010, J BIOL CHEM, V285, P14346, DOI 10.1074/jbc.M110.109314; Wiesner RH, 2003, LIVER TRANSPLANT, V9, pS1, DOI 10.1053/jlts.2003.50268; Wilson JA, 2011, J VIROL, V85, P2342, DOI 10.1128/JVI.02046-10; Wulczyn FG, 2007, FASEB J, V21, P415, DOI 10.1096/fj.06-6130com; Yang DL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024788; Zeuzem S, 2008, NAT CLIN PRACT GASTR, V5, P610, DOI 10.1038/ncpgasthep1274; Zhou YX, 2014, NATURE, V509, P487, DOI 10.1038/nature13166	69	8	8	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9433	9449		10.1096/fj.201800641R	http://dx.doi.org/10.1096/fj.201800641R		JUN 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32496609	Green Accepted			2022-12-28	WOS:000538309200001
J	Chen, DQ; Li, L; Wang, Y; Xu, RT; Peng, SL; Zhou, L; Deng, Z				Chen, Danqi; Li, Ling; Wang, Ying; Xu, Ruoting; Peng, Shunli; Zhou, Liang; Deng, Zhen			Ischemia-reperfusion injury of brain induces endothelial-mesenchymal transition and vascular fibrosis via activating let-7i/TGF-beta R1 double-negative feedback loop	FASEB JOURNAL			English	Article						endothelial-mesenchymal transition (endMT); ischemic stroke; let-7; transforming growth factor-beta receptor type 1 (TGF-beta R1); vascular fibrosis	GROWTH-FACTOR-BETA; EXTRACELLULAR-MATRIX; COGNITIVE IMPAIRMENT; SUBCORTICAL INFARCTS; TRANSGENIC MICE; LET-7 FAMILY; DISEASE; ARTERIOPATHY; MECHANISMS; PATHOLOGY	Let-7i modulates the physical function and inflammation in endothelial cells (ECs). However, whether the let-7i of ECs involves in brain vasculature and ischemic stroke is unknown. Using inducible Cadherin5-Cre lineage-tracking mice, a loxp-RNA-sponge conditional knockdown of let-7 in ECs- induced increase of transforming growth factor-beta receptor type 1 (TGF-beta R1), endothelial-mesenchymal transition (endMT), vascular fibrosis, and opening of the brain-blood barrier (BBB). By this lineage-tracking mice, we found that ECs underwent endMT after transient middle cerebral artery occlusion (MCAO). Through specifically overexpressed let-7i in ECs, we found that it reduced TGF-beta R1, endMT, and vascular fibrosis. Furthermore, this overexpression reduced the infarct volume and leakage of the BBB, and improved the neurological function. Further, the expression of let-7i decreased after MCAO, but was reversed by antagonist of TGF-beta R1 or inhibition of Mek phosphorylation. And the inhibition of Mek attenuated the vascular fibrosis after MCAO. In summary, we concluded that ischemic stroke activates a let-7i/TGF-beta R1 double-negative feedback loop, thereby inducing endMT and vascular fibrosis. These results suggest that endMT is a potential target for the treatment of cerebral vascular fibrosis.	[Chen, Danqi; Li, Ling; Xu, Ruoting; Zhou, Liang; Deng, Zhen] Southern Med Univ, Dept Neurol, Nanfang Hosp, Guangzhou, Peoples R China; [Wang, Ying] Southern Med Univ, Clin Coll 1, Guangzhou, Peoples R China; [Peng, Shunli] Southern Med Univ, Dept Radiat Oncol, Nanfang Hosp, Guangzhou, Peoples R China	Southern Medical University - China; Southern Medical University - China; Southern Medical University - China	Zhou, L; Deng, Z (corresponding author), Southern Med Univ, Dept Neurol, Nanfang Hosp, Guangzhou, Peoples R China.	zhouliang_1963@126.com; dengzhencn83@smu.edu.cn	Deng, Zhen/AAV-3031-2020; deng, zhen/G-5518-2010	deng, zhen/0000-0001-8337-1920				Adams KL, 2018, NAT NEUROSCI, V21, P9, DOI 10.1038/s41593-017-0033-9; Arvanitakis Z, 2016, LANCET NEUROL, V15, P934, DOI 10.1016/S1474-4422(16)30029-1; Bai Y, 2018, J NEUROSCI, V38, P32, DOI 10.1523/JNEUROSCI.1348-17.2017; Barta T, 2016, SCI REP-UK, V6, DOI 10.1038/srep36625; Bischoff J, 2019, CIRC RES, V124, P1163, DOI 10.1161/CIRCRESAHA.119.314813; Buisson A, 2003, CELL MOL NEUROBIOL, V23, P539, DOI 10.1023/A:1025072013107; Chen PY, 2012, CELL REP, V2, P1684, DOI 10.1016/j.celrep.2012.10.021; Fernandez-Klett F, 2013, J CEREBR BLOOD F MET, V33, P428, DOI 10.1038/jcbfm.2012.187; Gong Z, 2016, J NEUROL SCI, V361, P150, DOI 10.1016/j.jns.2015.12.047; Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165; Grinberg LT, 2010, ACTA NEUROPATHOL, V119, P277, DOI 10.1007/s00401-010-0652-7; Gui YX, 2019, TRANSL STROKE RES, V10, P352, DOI 10.1007/s12975-018-0659-2; Hong L, 2018, EUR J CELL BIOL, V97, P493, DOI 10.1016/j.ejcb.2018.07.005; Howe MD, 2019, GEROSCIENCE, V41, P543, DOI 10.1007/s11357-019-00118-7; Huang SL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163951; Kovacic JC, 2019, J AM COLL CARDIOL, V73, P190, DOI 10.1016/j.jacc.2018.09.089; Lehmann SM, 2012, NAT NEUROSCI, V15, P827, DOI 10.1038/nn.3113; Ley K, 2008, NAT MED, V14, P20, DOI 10.1038/nm0108-20; Li SH, 2019, ACTA NEUROBIOL EXP, V79, P205, DOI 10.21307/ane-2019-018; Li Y, 2018, NAT REV CARDIOL, V15, P445, DOI 10.1038/s41569-018-0023-y; Liao YC, 2014, J AM COLL CARDIOL, V63, P1685, DOI 10.1016/j.jacc.2013.09.069; Liu JL, 2014, PROG NEUROBIOL, V115, P138, DOI 10.1016/j.pneurobio.2013.11.004; Long GW, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-178; Makihara N, 2015, EXP NEUROL, V264, P127, DOI 10.1016/j.expneurol.2014.12.007; McCall MN, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-78; Miao Q, 2004, BRAIN PATHOL, V14, P358; Moonen JRAJ, 2015, CARDIOVASC RES, V108, P377, DOI 10.1093/cvr/cvv175; Mueller M, 2014, P NATL ACAD SCI USA, V111, P13882, DOI 10.1073/pnas.1411674111; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; O'Brien JT, 2015, LANCET, V386, P1698, DOI 10.1016/S0140-6736(15)00463-8; Oide T, 2008, NEUROPATHOLOGY, V28, P132, DOI 10.1111/j.1440-1789.2007.00864.x; Paroo Z, 2009, CELL, V139, P112, DOI 10.1016/j.cell.2009.06.044; Pendlebury Sarah T, 2009, Cerebrovasc Dis, V27 Suppl 3, P1, DOI 10.1159/000209260; Pendlebury ST, 2009, LANCET NEUROL, V8, P1006, DOI 10.1016/S1474-4422(09)70236-4; Peng GP, 2015, TRANSL STROKE RES, V6, P437, DOI 10.1007/s12975-015-0422-x; Piera-Velazquez S, 2019, PHYSIOL REV, V99, P1281, DOI 10.1152/physrev.00021.2018; Rom S, 2015, J CEREBR BLOOD F MET, V35, P1957, DOI 10.1038/jcbfm.2015.154; Rosenberg GA, 2017, CLIN SCI, V131, P425, DOI 10.1042/CS20160604; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Snyder HM, 2015, ALZHEIMERS DEMENT, V11, P710, DOI 10.1016/j.jalz.2014.10.008; Sun J, 2016, J MOL NEUROSCI, V59, P90, DOI 10.1007/s12031-016-0717-8; Tanoi Y, 2000, ACTA NEUROPATHOL, V100, P347, DOI 10.1007/s004010000203; ter Telgte A, 2019, ANN NEUROL, V86, P582, DOI 10.1002/ana.25556; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; Wegiel J, 2002, ACTA NEUROPATHOL, V103, P333, DOI 10.1007/s00401-001-0471-y; Wiesmann M, 2013, J CEREBR BLOOD F MET, V33, P1696, DOI 10.1038/jcbfm.2013.159; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Wyss-Coray T, 2000, AM J PATHOL, V156, P139, DOI 10.1016/S0002-9440(10)64713-X; WyssCoray T, 1997, NATURE, V389, P603, DOI 10.1038/39321; WYSSCORAY T, 1995, AM J PATHOL, V147, P53; Xiang W, 2017, BIOCHEM BIOPH RES CO, V493, P788, DOI 10.1016/j.bbrc.2017.08.093; Xiang W, 2017, THROMB RES, V158, P121, DOI 10.1016/j.thromres.2017.09.004; Yin KJ, 2010, J NEUROSCI, V30, P6398, DOI 10.1523/JNEUROSCI.0780-10.2010; Yin KJ, 2010, NEUROBIOL DIS, V38, P17, DOI 10.1016/j.nbd.2009.12.021	54	18	19	1	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					7178	7191		10.1096/fj.202000201R	http://dx.doi.org/10.1096/fj.202000201R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32274860	Bronze			2022-12-28	WOS:000531325500079
J	Tiu, AC; Yang, J; Asico, LD; Konkalmatt, P; Zheng, XX; Cuevas, S; Wang, XY; Lee, H; Mazhar, M; Felder, RA; Jose, PA; Villar, VM				Tiu, Andrew C.; Yang, Jian; Asico, Laureano D.; Konkalmatt, Prasad; Zheng, Xiaoxu; Cuevas, Santiago; Wang, Xiaoyan; Lee, Hewang; Mazhar, Momina; Felder, Robin A.; Jose, Pedro A.; Villar, Van Anthony M.			Lipid rafts are required for effective renal D-1 dopamine receptor function	FASEB JOURNAL			English	Article						blood pressure; CRAC motif; dopamine receptors; gene rescue; lipid raft; palmitoylation; sorting nexin 19 (SNX19)	OXIDATIVE STRESS; BLOOD-PRESSURE; VASCULAR RELAXATION; CYSTEINE RESIDUES; NADPH OXIDASE; IN-VIVO; PALMITOYLATION; HYPERTENSION; CAVEOLIN-1; MICE	Effective receptor signaling is anchored on the preferential localization of the receptor in lipid rafts, which are plasma membrane platforms replete with cholesterol and sphingolipids. We hypothesized that the dopamine D-1 receptor (D1R) contains structural features that allow it to reside in lipid rafts for its activity. Mutation of C347 palmitoylation site and Y218 of a newly identified Cholesterol Recognition Amino Acid Consensus motif resulted in the exclusion of D1R from lipid rafts, blunted cAMP response, impaired sodium transport, and increased oxidative stress in renal proximal tubule cells (RPTCs). Kidney-restricted silencing of Drd1 in C57BL/6J mice increased blood pressure (BP) that was normalized by renal tubule-restricted rescue with D1R-wild-type but not the mutant D1R 347A that lacks a palmitoylation site. Kidney-restricted disruption of lipid rafts by beta-MCD jettisoned the D1R from the brush border, decreased sodium excretion, and increased oxidative stress and BP in C57BL/6J mice. Deletion of the PX domain of the novel D1R-binding partner sorting nexin 19 (SNX19) resulted in D1R partitioning solely to non-raft domains, while silencing of SNX19 impaired D1R function in RPTCs. Kidney-restricted silencing of Snx19 resulted in hypertension in C57BL/6J mice. Our results highlight the essential role of lipid rafts for effective D1R signaling.	[Tiu, Andrew C.; Asico, Laureano D.; Konkalmatt, Prasad; Zheng, Xiaoxu; Cuevas, Santiago; Wang, Xiaoyan; Mazhar, Momina; Jose, Pedro A.; Villar, Van Anthony M.] George Washington Univ, Sch Med & Hlth Sci, Div Renal Dis & Hypertens, Dept Med, Washington, DC 20052 USA; [Tiu, Andrew C.] Einstein Med Ctr, Dept Med, 5501 Old York Rd, Philadelphia, PA 19141 USA; [Yang, Jian] Chongqing Med Univ, Dept Clin Nutr, Affiliated Hosp 3, Chongqing 410020, Peoples R China; [Lee, Hewang] NIDDK, Kidney Dis Branch, Bethesda, MD 20892 USA; [Felder, Robin A.] Univ Virginia, Sch Med, Dept Pathol, Charlottesville, VA 22908 USA; [Jose, Pedro A.] George Washington Univ, Sch Med & Hlth Sci, Dept Pharmacol Physiol, Washington, DC 20052 USA	George Washington University; Chongqing Medical University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Virginia; George Washington University	Tiu, AC (corresponding author), Einstein Med Ctr, Dept Med, 5501 Old York Rd, Philadelphia, PA 19141 USA.; Yang, J (corresponding author), Chongqing Med Univ, Dept Clin Nutr, Affiliated Hosp 3, Chongqing 410020, Peoples R China.	andrewchuatiu@yahoo.com.ph; jianyang@hospital.cqmu.edu.cn	Wang, Xiaoyan/GOK-1663-2022; Cuevas, Santiago/AAG-4985-2021	Wang, Xiaoyan/0000-0001-7406-5008; Cuevas, Santiago/0000-0002-0832-5446; Lee, Hewang/0000-0003-1338-2573	NHLBI NIH HHS [R01 HL092196, P01 HL074940, R37 HL023081] Funding Source: Medline; NIDDK NIH HHS [R01 DK039308, R56 DK116828, R01 DK090918, R01 DK119652] Funding Source: Medline; NIH HHS [KY19024] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Albrecht FE, 1996, J CLIN INVEST, V97, P2283, DOI 10.1172/JCI118670; Aliche-Djoudi F, 2013, FOOD CHEM TOXICOL, V60, P286, DOI 10.1016/j.fct.2013.07.061; Anderson RGW, 2002, SCIENCE, V296, P1821, DOI 10.1126/science.1068886; Armando I, 2011, COMPR PHYSIOL, V1, P1075, DOI 10.1002/cphy.c100032; Asico LD, 2018, BIOCHEM BIOPH RES CO, V497, P19, DOI 10.1016/j.bbrc.2018.01.169; Banday AA, 2007, J AM SOC NEPHROL, V18, P1446, DOI 10.1681/ASN.2006121373; Boini KM, 2010, BBA-MOL CELL BIOL L, V1801, P1294, DOI 10.1016/j.bbalip.2010.09.001; Butz GM, 2001, PHYSIOL GENOMICS, V5, P89, DOI 10.1152/physiolgenomics.2001.5.2.89; Cuevas S, 2015, HYPERTENSION, V65, P1251, DOI 10.1161/HYPERTENSIONAHA.114.04525; DeLalio LJ, 2018, ARTERIOSCL THROM VAS, V38, P2065, DOI 10.1161/ATVBAHA.118.311290; Deng GM, 2008, J IMMUNOL, V181, P4019, DOI 10.4049/jimmunol.181.6.4019; Desjardins F, 2008, CARDIOVASC RES, V79, P527, DOI 10.1093/cvr/cvn080; Diaz-Rohrer BB, 2014, P NATL ACAD SCI USA, V111, P8500, DOI 10.1073/pnas.1404582111; DIETZEN DJ, 1995, J BIOL CHEM, V270, P6838, DOI 10.1074/jbc.270.12.6838; Ebersole B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140661; Fang C, 2006, J NEUROSCI, V26, P12758, DOI 10.1523/JNEUROSCI.4214-06.2006; Felder RA, 2002, P NATL ACAD SCI USA, V99, P3872, DOI 10.1073/pnas.062694599; Fridolfsson HN, 2013, J GERIATR CARDIOL, V10, P66, DOI [10.3969/j.issn.1671-5411.2013.01.011, 10.3724/SP.J.1263.2012.08071]; GILDEA JJ, 2014, HYPERTENSION S1, V64, pA532; Gildea JJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0189464; Gildea JJ, 2014, KIDNEY INT, V86, P118, DOI 10.1038/ki.2014.5; Gildea JJ, 2011, AM J PHYSIOL-RENAL, V300, pF914, DOI 10.1152/ajprenal.00380.2010; Gildea JJ, 2009, HYPERTENSION, V54, P1070, DOI 10.1161/HYPERTENSIONAHA.109.134338; Guo Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029204; Gurevich EV, 2016, PHARMACOL RES, V111, P1, DOI 10.1016/j.phrs.2016.05.010; Han WX, 2008, HYPERTENSION, V51, P481, DOI 10.1161/HYPERTENSIONAHA.107.103275; Harris RC, 2012, CURR OPIN NEPHROL HY, V21, P61, DOI 10.1097/MNH.0b013e32834de2cb; Huang YS, 2012, MOL CELL BIOL, V32, P1408, DOI 10.1128/MCB.06557-11; Jamin N, 2005, MOL ENDOCRINOL, V19, P588, DOI 10.1210/me.2004-0308; JENSEN AA, 1995, J NEUROCHEM, V65, P1325, DOI 10.1046/j.1471-4159.1995.65031325.x; Jin H, 1999, EUR J PHARMACOL, V386, P305, DOI 10.1016/S0014-2999(99)00727-X; Jin H, 1997, EUR J PHARMACOL, V324, P109, DOI 10.1016/S0014-2999(97)00059-9; Kim YH, 2014, BIOCHEM BIOPH RES CO, V450, P824, DOI 10.1016/j.bbrc.2014.06.069; Kong MMC, 2007, MOL PHARMACOL, V72, P1157, DOI 10.1124/mol.107.034769; Kong MMC, 2011, BIOCHEM BIOPH RES CO, V405, P445, DOI 10.1016/j.bbrc.2011.01.050; Konkalmatt PR, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.85888; Lai JB, 2013, J BIOL CHEM, V288, P22862, DOI 10.1074/jbc.M113.458794; Levental I, 2010, P NATL ACAD SCI USA, V107, P22050, DOI 10.1073/pnas.1016184107; Li HW, 2009, HYPERTENSION, V53, P1054, DOI 10.1161/HYPERTENSIONAHA.108.120642; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Lorent JH, 2015, CHEM PHYS LIPIDS, V192, P23, DOI 10.1016/j.chemphyslip.2015.07.022; Mas C, 2014, J BIOL CHEM, V289, P28554, DOI 10.1074/jbc.M114.595959; Milne GL, 2005, BIOMARKERS, V10, pS10, DOI 10.1080/13547500500216546; Murata T, 2007, J EXP MED, V204, P2373, DOI 10.1084/jem.20062340; Ostrom RS, 2004, BRIT J PHARMACOL, V143, P235, DOI 10.1038/sj.bjp.0705930; Palmer CP, 2007, CANCER RES, V67, P11166, DOI 10.1158/0008-5472.CAN-07-1771; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Pinto V, 2013, FASEB J, V27, P2927, DOI 10.1096/fj.12-224998; Pojoga LH, 2008, AM J PHYSIOL-HEART C, V294, pH1258, DOI 10.1152/ajpheart.01014.2007; Pojoga LH, 2010, AM J PHYSIOL-HEART C, V298, pH1776, DOI 10.1152/ajpheart.00661.2009; Premont RT, 1996, J BIOL CHEM, V271, P6403, DOI 10.1074/jbc.271.11.6403; Riquier ADM, 2009, AM J PHYSIOL-CELL PH, V296, pC900, DOI 10.1152/ajpcell.00526.2008; Schwarzer R, 2014, CELL MICROBIOL, V16, P1565, DOI 10.1111/cmi.12314; Sensoy O, 2015, BBA-BIOMEMBRANES, V1848, P976, DOI 10.1016/j.bbamem.2014.12.002; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Valles PG, 2007, PEDIATR NEPHROL, V22, P237, DOI 10.1007/s00467-006-0290-4; Villar VM, 2016, METHOD CELL BIOL, V132, P3, DOI 10.1016/bs.mcb.2015.11.008; Villar VAM, 2013, FASEB J, V27, P1808, DOI 10.1096/fj.12-208439; Villar VM, 2013, J BIOL CHEM, V288, P152, DOI 10.1074/jbc.M112.428458; Wang Q, 2001, J BIOL CHEM, V276, P39386, DOI 10.1074/jbc.M104981200; Welker P, 2007, AM J PHYSIOL-REG I, V292, pR1328, DOI 10.1152/ajpregu.00166.2006; Wunderlich C, 2008, J MOL CELL CARDIOL, V44, P938, DOI 10.1016/j.yjmcc.2008.02.275; Yang S, 2015, FREE RADICAL RES, V49, P397, DOI 10.3109/10715762.2015.1006215; Yoon MS, 2015, J VASC RES, V52, P321, DOI 10.1159/000443888; Yu PY, 2014, CELL SIGNAL, V26, P2521, DOI 10.1016/j.cellsig.2014.07.003; Yu Peiying, 2013, Methods Mol Biol, V964, P15, DOI 10.1007/978-1-62703-251-3_2; Yu PY, 2011, FREE RADICAL BIO MED, V50, P832, DOI 10.1016/j.freeradbiomed.2010.12.027; Yu PY, 2004, KIDNEY INT, V66, P2167, DOI 10.1111/j.1523-1755.2004.66007.x; Zhang C, 2010, BBA-MOL CELL RES, V1803, P482, DOI 10.1016/j.bbamcr.2009.12.006; Zhang Y, 2016, J BIOCHEM MOL TOXIC, V30, P71, DOI 10.1002/jbt.21738; Zheng BH, 2015, ACS CHEM BIOL, V10, P115, DOI 10.1021/cb500758s	71	6	6	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6999	7017		10.1096/fj.201902710RR	http://dx.doi.org/10.1096/fj.201902710RR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32259353	Bronze, Green Accepted			2022-12-28	WOS:000531325500068
J	Kriaa, A; Jablaoui, A; Mkaouar, H; Akermi, N; Maguin, E; Rhimi, M				Kriaa, Aicha; Jablaoui, Amin; Mkaouar, Hela; Akermi, Nizar; Maguin, Emmanuelle; Rhimi, Moez			Serine proteases at the cutting edge of IBD: Focus on gastrointestinal inflammation	FASEB JOURNAL			English	Article						digestive inflammation; gut microbiota; holobiont; microbiome; protease activity profiling; serine proteases	MAST-CELL TRYPTASE; PROTEINASE-ACTIVATED RECEPTOR-2; EPITHELIAL-BARRIER; BOWEL-DISEASE; NEUTROPHIL ELASTASE; ESCHERICHIA-COLI; INTESTINAL PERMEABILITY; CROHNS-DISEASE; ANTIINFLAMMATORY SIGNAL; SUBSTRATE-SPECIFICITY	Serine proteases have been long recognized to coordinate many physiological processes and play key roles in regulating the inflammatory response. Accordingly, their dysregulation has been regularly associated with several inflammatory disorders and suggested as a central mechanism in the pathophysiology of digestive inflammation. So far, studies addressing the proteolytic homeostasis in the gut have mainly focused on host serine proteases as candidates of interest, while largely ignoring the potential contribution of their bacterial counterparts. The human gut microbiota comprises a complex ecosystem that contributes to host health and disease. Yet, our understanding of microbially produced serine proteases and investigation of whether they are causally linked to IBD is still in its infancy. In this review, we highlight recent advances in the emerging roles of host and bacterial serine proteases in digestive inflammation. We also discuss the application of available tools in the gut to monitor disease-related serine proteases. An exhaustive representation and understanding of such functional potential would help in closing existing gaps in mechanistic knowledge.	[Kriaa, Aicha; Jablaoui, Amin; Mkaouar, Hela; Akermi, Nizar; Maguin, Emmanuelle; Rhimi, Moez] Univ Paris Saclay, Micalis Inst, INRAE, Microbiota Interact Human & Anim Team MIHA,AgroPa, F-78350 Jouy En Josas, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Rhimi, M (corresponding author), Univ Paris Saclay, Micalis Inst, INRAE, Microbiota Interact Human & Anim Team MIHA,AgroPa, F-78350 Jouy En Josas, France.	moez.rhimi@inrae.fr		RHIMI, Moez/0000-0001-8067-6526	CMCU-PHC Utique [19G0819]; Campus France (Agence Francaise pour la Promotion de l'Enseignement Superieur, l'Accueil et la Mobilite Internationale) [41786NC]; SerpinGuTarget [ANR-14-CE16-0018]; Titan [ANR-18-CE18-0019-03]	CMCU-PHC Utique; Campus France (Agence Francaise pour la Promotion de l'Enseignement Superieur, l'Accueil et la Mobilite Internationale); SerpinGuTarget; Titan	CMCU-PHC Utique, Grant/Award Number: 19G0819; Campus France (Agence Francaise pour la Promotion de l'Enseignement Superieur, l'Accueil et la Mobilite Internationale), Grant/Award Number: 41786NC; SerpinGuTarget, Grant/Award Number: ANR-14-CE16-0018; Titan, Grant/Award Number: ANR-18-CE18-0019-03	Abfalter CM, 2016, CELL COMMUN SIGNAL, V14, DOI 10.1186/s12964-016-0153-y; Albert-Bayo M, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8020135; Ando K, 2019, DIGESTION, V100, P229, DOI 10.1159/000495289; AZGHANI AO, 1993, INFECT IMMUN, V61, P2681, DOI 10.1128/IAI.61.6.2681-2686.1993; Backert S, 2018, CELL MICROBIOL, V20, DOI 10.1111/cmi.12845; Barry M, 2002, NAT REV IMMUNOL, V2, P401, DOI 10.1038/nri819; Barry R, 2019, MUCOSAL IMMUNOL, V2019, P1; Belaaouaj A, 2002, MICROBES INFECT, V4, P1259, DOI 10.1016/S1286-4579(02)01654-4; BENNO P, 1993, SCAND J GASTROENTERO, V28, P839, DOI 10.3109/00365529309104019; Biancheri P, 2013, CELL TISSUE RES, V351, P269, DOI 10.1007/s00441-012-1390-z; BLACK R, 1991, AGENT ACTION SUPPL, V35, P85; Boehm M, 2018, EUR J MICROBIOL IMMU, V8, P70, DOI 10.1556/1886.2018.00011; Boisen N, 2009, AM J TROP MED HYG, V80, P294, DOI 10.4269/ajtmh.2009.80.294; Buhner S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193943; Buzza MS, 2013, J BIOL CHEM, V288, P10328, DOI 10.1074/jbc.M112.443432; Buzza MS, 2010, P NATL ACAD SCI USA, V107, P4200, DOI 10.1073/pnas.0903923107; Caminero A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09037-9; Carroll IM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078017; Castanheira FVS, 2019, BLOOD, V133, P2178, DOI 10.1182/blood-2018-11-844530; Cenac N, 2005, INFLAMM BOWEL DIS, V11, P792, DOI 10.1097/01.mib.0000177506.71784.bd; Cenac N, 2002, AM J PATHOL, V161, P1903, DOI 10.1016/S0002-9440(10)64466-5; Cenac N, 2013, CURR NEUROPHARMACOL, V11, P598, DOI 10.2174/1570159X113119990039; Chen D, 2009, J THROMB HAEMOST, V7, P122, DOI 10.1111/j.1538-7836.2009.03413.x; Chen LP, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000051; Chudy-Onwugaje KO, 2019, INFLAMM BOWEL DIS, V25, P820, DOI 10.1093/ibd/izy327; Clausen T, 2002, MOL CELL, V10, P443, DOI 10.1016/S1097-2765(02)00658-5; Clayburgh DR, 2004, LAB INVEST, V84, P282, DOI 10.1038/labinvest.3700050; Cornick S, 2015, TISSUE BARRIERS, V3, DOI 10.4161/21688370.2014.982426; Cottrell GS, 2007, GASTROENTEROLOGY, V132, P2422, DOI 10.1053/j.gastro.2007.03.101; da Silva MN, 2015, REV AMBIENT CONTAB, V7, P1; Dabek M, 2009, AM J PATHOL, V175, P207, DOI 10.2353/ajpath.2009.080986; Danese S, 2007, AM J GASTROENTEROL, V102, P174, DOI 10.1111/j.1572-0241.2006.00943.x; Darfeuille-Michaud A, 2004, GASTROENTEROLOGY, V127, P412, DOI 10.1053/j.gastro.2004.04.061; De Candia E, 2012, THROMB RES, V129, P250, DOI 10.1016/j.thromres.2011.11.001; De la Fuente M, 2014, INT J MED MICROBIOL, V304, P384, DOI 10.1016/j.ijmm.2014.01.002; Denadai-Souza A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26282-y; Di Cera E, 2009, IUBMB LIFE, V61, P510, DOI 10.1002/iub.186; Dickson Iain, 2017, Nat Rev Gastroenterol Hepatol, V14, P195, DOI 10.1038/nrgastro.2017.25; Dorfel MJ, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/807356; Drag M, 2010, NAT REV DRUG DISCOV, V9, P690, DOI 10.1038/nrd3053; Dulon S, 2005, AM J RESP CELL MOL, V32, P411, DOI 10.1165/rcmb.2004-0274OC; Dutta PR, 2002, INFECT IMMUN, V70, P7105, DOI 10.1128/IAI.70.12.7105-7113.2002; Edgington-Mitchell LE, 2016, AM J PHYSIOL-GASTR L, V310, pG234, DOI 10.1152/ajpgi.00393.2015; Edogawa S, 2020, GUT, V69, P62, DOI 10.1136/gutjnl-2018-317416; Ehrhardt K, 2019, INFLAMM BOWEL DIS, V25, P1629, DOI 10.1093/ibd/izz070; Elmi A, 2016, CELL MICROBIOL, V18, P561, DOI 10.1111/cmi.12534; Fava F, 2011, WORLD J GASTROENTERO, V17, P557, DOI 10.3748/wjg.v17.i5.557; Fiorucci S, 2001, P NATL ACAD SCI USA, V98, P13936, DOI 10.1073/pnas.241377298; Forster SC, 2019, NAT BIOTECHNOL, V37, P186, DOI 10.1038/s41587-018-0009-7; Gecse K, 2008, GUT, V57, P591, DOI 10.1136/gut.2007.140210; Geraghty P, 2007, J IMMUNOL, V178, P5871, DOI 10.4049/jimmunol.178.9.5871; Giannotta M, 2015, THROMB J, V13, DOI 10.1186/s12959-015-0044-2; Ginzberg HH, 2001, AM J PHYSIOL-GASTR L, V281, pG705, DOI 10.1152/ajpgi.2001.281.3.G705; Glasser AL, 2001, INFECT IMMUN, V69, P5529, DOI 10.1128/IAI.69.9.5529-5537.2001; Gordon MH, 2019, CELL MOL GASTROENTER, V7, P43, DOI 10.1016/j.jcmgh.2018.10.012; Graziani C, 2019, EUR REV MED PHARMACO, V23, P795, DOI 10.26355/eurrev_201901_16894; Grzywa R, 2019, BIOCHIMIE, V166, P142, DOI 10.1016/j.biochi.2019.03.005; Guarino C, 2018, J MED CHEM, V61, P1858, DOI 10.1021/acs.jmedchem.7b01416; Guignot J, 2007, CELL MICROBIOL, V9, P204, DOI 10.1111/j.1462-5822.2006.00782.x; Gurumallesh P, 2019, INT J BIOL MACROMOL, V128, P254, DOI 10.1016/j.ijbiomac.2019.01.081; Harrer A, 2017, GUT PATHOG, V9, DOI 10.1186/s13099-017-0189-6; Harrington SM, 2009, INFECT IMMUN, V77, P2465, DOI 10.1128/IAI.01494-08; He WQ, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21030993; Henderson IR, 1999, INFECT IMMUN, V67, P5587, DOI 10.1128/IAI.67.11.5587-5596.1999; Heuberger DM, 2019, THROMB J, V17, DOI 10.1186/s12959-019-0194-8; Holzhausen M, 2006, AM J PATHOL, V168, P1189, DOI 10.2353/ajpath.2006.050658; Irving JA, 2002, MOL BIOL EVOL, V19, P1881, DOI 10.1093/oxfordjournals.molbev.a004012; Isozaki Y, 2006, SCAND J GASTROENTERO, V41, P944, DOI 10.1080/00365520500529470; Jablaoui A, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.00021; Jacob C, 2005, J BIOL CHEM, V280, P31936, DOI 10.1074/jbc.M506338200; Kajikawa H, 2007, DIGESTION, V76, P248, DOI 10.1159/000113041; Kaplan GG, 2015, NAT REV GASTRO HEPAT, V12, P720, DOI 10.1038/nrgastro.2015.150; Kasperkiewicz P, 2014, P NATL ACAD SCI USA, V111, P2518, DOI 10.1073/pnas.1318548111; Kawabata A, 2008, BRIT J PHARMACOL, V153, pS230, DOI 10.1038/sj.bjp.0707491; KILIAN M, 1988, MICROBIOL REV, V52, P296, DOI 10.1128/MMBR.52.2.296-303.1988; Kodani M, 2018, MOL MED REP, V17, P8167, DOI 10.3892/mmr.2018.8926; Koshikawa N, 1997, FEBS LETT, V409, P442, DOI 10.1016/S0014-5793(97)00565-6; Kotlowski R, 2007, GUT, V56, P669, DOI 10.1136/gut.2006.099796; Lahey KA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180259; LANTZ MS, 1991, J BACTERIOL, V173, P495, DOI 10.1128/jb.173.2.495-504.1991; Lantz MS, 1997, J PERIODONTAL RES, V32, P126, DOI 10.1111/j.1600-0765.1997.tb01393.x; Laskowski M, 2000, BBA-PROTEIN STRUCT M, V1477, P324, DOI 10.1016/S0167-4838(99)00284-8; Lefrancais E, 2012, P NATL ACAD SCI USA, V109, P1673, DOI 10.1073/pnas.1115884109; Lieu T, 2016, BRIT J PHARMACOL, V173, P2752, DOI 10.1111/bph.13554; List K, 2009, AM J PATHOL, V175, P1453, DOI 10.2353/ajpath.2009.090240; Lopez-Otin C, 2008, J BIOL CHEM, V283, P30433, DOI 10.1074/jbc.R800035200; MACFARLANE GT, 1986, J GEN MICROBIOL, V132, P1647; MACFARLANE GT, 1988, J APPL BACTERIOL, V64, P37, DOI 10.1111/j.1365-2672.1988.tb02427.x; MADARA JL, 1987, AM J PHYSIOL, V253, pC171, DOI 10.1152/ajpcell.1987.253.1.C171; Maharshak N, 2015, INFECT IMMUN, V83, P2762, DOI 10.1128/IAI.00425-15; Mao JW, 2012, MOL MED REP, V6, P996, DOI 10.3892/mmr.2012.1021; Marchbank T, 1996, AM J PATHOL, V148, P715; Matowicka-Karna Joanna, 2016, Postepy Hig Med Dosw (Online), V70, P305; Maukonen J, 2015, J CROHNS COLITIS, V9, P1088, DOI 10.1093/ecco-jcc/jjv147; Mayers MD, 2017, J PROTEOME RES, V16, P1014, DOI 10.1021/acs.jproteome.6b00938; MAZZUCCHELLI L, 1994, AM J PATHOL, V144, P997; Michielan A, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/628157; Midtvedt T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066074; Mkaouar H, 2019, PEERJ, V7, DOI 10.7717/peerj.7224; Mkaouar H, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0596-2; Monttinen HAM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216659; Mortaz E, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02171; Motta JP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11140-w; Motta JP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004212; Motta JP, 2011, GASTROENTEROLOGY, V140, P1272, DOI 10.1053/j.gastro.2010.12.050; Moustafa A, 2018, CLIN TRANSL GASTROEN, V9, DOI 10.1038/ctg.2017.58; Mrozkova P, 2016, PHYSIOL RES, V65, P357, DOI 10.33549/physiolres.933269; Nayfach S, 2019, NATURE, V568, P505, DOI 10.1038/s41586-019-1058-x; Netzel-Arnett S, 2012, INFLAMM BOWEL DIS, V18, P1303, DOI 10.1002/ibd.21930; NEURATH H, 1976, P NATL ACAD SCI USA, V73, P3825, DOI 10.1073/pnas.73.11.3825; Neurath MF, 2019, NAT IMMUNOL, V20, P970, DOI 10.1038/s41590-019-0415-0; Ng SC, 2017, LANCET, V390, P2769, DOI 10.1016/S0140-6736(17)32448-0; Odenwald MA, 2017, NAT REV GASTRO HEPAT, V14, P9, DOI 10.1038/nrgastro.2016.169; OSTRESH JM, 1994, BIOPOLYMERS, V34, P1681, DOI 10.1002/bip.360341212; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Pan ZY, 2006, BIOORG MED CHEM LETT, V16, P2882, DOI 10.1016/j.bmcl.2006.03.012; Perna A, 2020, J CELL PHYSL, V2020, P1; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Pontarollo G, 2019, FEBS J, V2019, P1; Pontarollo G, 2017, J BIOL CHEM, V292, P15161, DOI 10.1074/jbc.M117.795245; Popow-Stellmaszyk J, 2013, ANAL BIOCHEM, V442, P75, DOI 10.1016/j.ab.2013.07.028; Poreba M, 2010, CURR MED CHEM, V17, P3968, DOI 10.2174/092986710793205381; Poulsen NA, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-76; Prosberg M, 2016, SCAND J GASTROENTERO, P1; Puente XS, 2005, BIOCHEM SOC T, V33, P331, DOI 10.1042/BST0330331; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Qin XF, 2007, WORLD J GASTROENTERO, V13, P2390, DOI 10.3748/wjg.v13.i16.2390; Qin XF, 2012, WORLD J GASTROENTERO, V18, P1708, DOI 10.3748/wjg.v18.i15.1708; Raithel H, 2001, SCAND J GASTROENTERO, V36, P174, DOI 10.1080/003655201750065933; Rajakovich LJ, 2019, NAT PROD REP, V36, P593, DOI 10.1039/c8np00074c; Ramachandran R, 2008, BRIT J PHARMACOL, V153, pS263, DOI 10.1038/sj.bjp.0707507; Ramare F, 1996, APPL ENVIRON MICROB, V62, P1434, DOI 10.1128/AEM.62.4.1434-1436.1996; Rawlings ND, 2018, NUCLEIC ACIDS RES, V46, pD624, DOI 10.1093/nar/gkx1134; Reed DE, 2003, J PHYSIOL-LONDON, V547, P531, DOI 10.1113/jphysiol.2002.032011; Rolland-Fourcade C, 2017, GUT, V66, P1767, DOI 10.1136/gutjnl-2016-312094; Ronaghan NJ, 2016, AM J PHYSIOL-GASTR L, V311, pG466, DOI 10.1152/ajpgi.00441.2015; Ruiz-Perez F, 2014, CELL MOL LIFE SCI, V71, P745, DOI 10.1007/s00018-013-1355-8; Rut W, 2015, BIOL CHEM, V396, P329, DOI 10.1515/hsz-2014-0315; Sebert M, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00717; Seksik P, 2003, GUT, V52, P237, DOI 10.1136/gut.52.2.237; Sepehri S, 2011, INFLAMM BOWEL DIS, V17, P1451, DOI 10.1002/ibd.21509; Shawki A, 2017, CELL MOL GASTROENTER, V3, P41, DOI 10.1016/j.jcmgh.2016.10.004; Shen L, 2012, ANN NY ACAD SCI, V1258, P9, DOI 10.1111/j.1749-6632.2012.06613.x; Siegel RM, 2006, NAT REV IMMUNOL, V6, P308, DOI 10.1038/nri1809; Smith SA, 2015, CRIT REV BIOCHEM MOL, V50, P326, DOI 10.3109/10409238.2015.1050550; Starr AE, 2017, GUT, V66, P1573, DOI 10.1136/gutjnl-2015-310705; STEAD RH, 1987, P NATL ACAD SCI USA, V84, P2975, DOI 10.1073/pnas.84.9.2975; Steinhoff M, 2000, NAT MED, V6, P151, DOI 10.1038/72247; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; Swystun VA, 2009, AM J PHYSIOL-GASTR L, V297, pG60, DOI 10.1152/ajpgi.00096.2009; Tremaine WJ, 2002, ALIMENT PHARM THERAP, V16, P407, DOI 10.1046/j.1365-2036.2002.01194.x; Tripathi LP, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-549; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; Uchiyama K, 2012, AM J PHYSIOL-GASTR L, V302, pG1163, DOI 10.1152/ajpgi.00292.2011; Van Spaendonk H, 2017, WORLD J GASTROENTERO, V23, P2106, DOI 10.3748/wjg.v23.i12.2106; VANDEMERWE JP, 1982, DIGESTION, V24, P1, DOI 10.1159/000198767; Verdoes M, 2016, BBA-PROTEINS PROTEOM, V1864, P130, DOI 10.1016/j.bbapap.2015.04.029; Vergnolle N, 2005, GUT, V54, P867, DOI 10.1136/gut.2004.048876; Vergnolle N, 2016, GUT, V65, P1215, DOI 10.1136/gutjnl-2015-309147; Wahl, 2020, CLIN GASTROENTEROL H, V20, P1; Wershil BK, 1996, GASTROENTEROLOGY, V110, P1482, DOI 10.1053/gast.1996.v110.pm8613053; Wysocka M, 2008, ANAL BIOCHEM, V378, P208, DOI 10.1016/j.ab.2008.04.003; Xiong YJ, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00292; Xu WF, 1998, P NATL ACAD SCI USA, V95, P6642, DOI 10.1073/pnas.95.12.6642; Yoon H, 2018, CELL MOL GASTROENTER, V6, P370, DOI 10.1016/j.jcmgh.2018.05.008; Zarzecka U, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00961; Zhang M, 2017, FRONT IMMUNOL, V8, P1, DOI 10.3389/fimmu.2017.00942; Zhou YL, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005019; Zou YQ, 2019, NAT BIOTECHNOL, V37, P179, DOI 10.1038/s41587-018-0008-8	169	15	15	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					7270	7282		10.1096/fj.202000031RR	http://dx.doi.org/10.1096/fj.202000031RR		APR 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32307770	Bronze			2022-12-28	WOS:000528389500001
J	Tan, L; Harper, L; McNulty, MA; Carlson, CS; Yammani, RR				Tan, Li; Harper, Lindsey; McNulty, Margaret A.; Carlson, Cathy S.; Yammani, Raghunatha R.			High-fat diet induces endoplasmic reticulum stress to promote chondrocyte apoptosis in mouse knee joints	FASEB JOURNAL			English	Article						apoptosis; endoplasmic reticulum stress; obesity; osteoarthritis; PBA	UNFOLDED PROTEIN RESPONSE; SUBCHONDRAL BONE; ER STRESS; OSTEOARTHRITIS; PATHWAY; INSULIN; OBESITY; TRB3; INFLAMMATION; PREVALENCE	Mice fed a high-fat diet (HFD) become obese and develop osteoarthritis (OA)-like lesions, including chondrocyte apoptosis, in the knee joints. However, the mechanism by which HFD/obesity induces chondrocyte apoptosis is not clearly understood. In the present study, male mice were fed a low-fat diet (LFD, 10% kcal), HFD (45% kcal), or a HFD administered with 0.5 g/kg bodyweight of 4-phenyl butyric acid (PBA, a small chaperone known to ease endoplasmic reticulum [ER] stress), via the drinking water. At the end of the 18-week study, stifle (knee) joints from all animals were collected, fixed, paraffin embedded, and sectioned. Immunostaining of joints from the HFD group showed increased expression of ER stress and apoptotic markers and increased expression of nuclear protein 1 and tribbles related protein-3 compared to the LFD group. Mice on HFD also showed higher percentage of chondrocyte death, lower chondrocyte numbers per cartilage area, and thickening of subchondral bone. Administration of PBA alleviated all of the HFD-induced symptoms. Our study demonstrated that HFD induces ER stress to promote chondrocyte death and subchondral bone thickening, which could be relieved by alleviating ER stress via PBA administration, suggesting that ER stress could play an important role in obesity-linked OA and could be targeted for OA therapeutics.	[Tan, Li; Yammani, Raghunatha R.] Wake Forest Sch Med, Dept Internal Med, Sect Mol Med, Winston Salem, NC 27157 USA; [Harper, Lindsey; Carlson, Cathy S.] Univ Minnesota, Coll Vet Med, Dept Vet Clin Sci, St Paul, MN 55108 USA; [McNulty, Margaret A.] Indiana Univ Sch Med, Dept Anat Cell Biol & Physiol, Indianapolis, IN 46202 USA	Wake Forest University; University of Minnesota System; University of Minnesota Twin Cities; Indiana University System; Indiana University Bloomington	Yammani, RR (corresponding author), Wake Forest Sch Med, Dept Internal Med, Sect Mol Med, Winston Salem, NC 27157 USA.	ryammani@wakehealth.edu		McNulty, Margaret/0000-0001-6638-253X	HHS \ NIH \ National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [AR066105]	HHS \ NIH \ National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)	HHS vertical bar NIH vertical bar National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Grant/Award Number: AR066105	Asou Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162794; Basseri S, 2009, J LIPID RES, V50, P2486, DOI 10.1194/jlr.M900216-JLR200; Berenbaum F, 2013, CURR OPIN RHEUMATOL, V25, P114, DOI 10.1097/BOR.0b013e32835a9414; Blanco FJ, 1998, ARTHRITIS RHEUM, V41, P284, DOI 10.1002/1529-0131(199802)41:2<284::AID-ART12>3.0.CO;2-T; Boden G, 2008, ENDOCRIN METAB CLIN, V37, P635, DOI 10.1016/j.ecl.2008.06.007; Cano CE, 2011, J CELL PHYSIOL, V226, P1439, DOI 10.1002/jcp.22324; Carracedo A, 2006, CANCER CELL, V9, P301, DOI 10.1016/j.ccr.2006.03.005; Castaneda S, 2012, BIOCHEM PHARMACOL, V83, P315, DOI 10.1016/j.bcp.2011.09.018; Choi JY, 2016, INT J OBESITY, V40, P1452, DOI 10.1038/ijo.2016.70; Cravero JD, 2009, ARTHRITIS RHEUM-US, V60, P492, DOI 10.1002/art.24225; Darzynkiewicz Z, 2008, METHODS, V44, P250, DOI 10.1016/j.ymeth.2007.11.008; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Felson DT, 2000, ANN INTERN MED, V133, P635, DOI 10.7326/0003-4819-133-8-200010170-00016; Goldring SR, 2016, NAT REV RHEUMATOL, V12, P632, DOI 10.1038/nrrheum.2016.148; Goruppi S, 2010, J BIOL CHEM, V285, P1577, DOI 10.1074/jbc.R109.080887; Griffin TM, 2012, ARTHRITIS RHEUM-US, V64, P443, DOI 10.1002/art.33332; Griffin TM, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3068; Griffin TM, 2005, EXERC SPORT SCI REV, V33, P195, DOI 10.1097/00003677-200510000-00008; Haywood J, 2016, OSTEOARTHR CARTILAGE, V24, P942, DOI 10.1016/j.joca.2015.11.020; Hootman JM, 2006, ARTHRITIS RHEUM-US, V54, P226, DOI 10.1002/art.21562; Husa M, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4415; Kawasaki N, 2012, SCI REP-UK, V2, DOI 10.1038/srep00799; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Li GY, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4405; Loeser RF, 2012, ARTHRITIS RHEUM-US, V64, P1697, DOI 10.1002/art.34453; McNulty MA, 2011, CARTILAGE, V2, P354, DOI 10.1177/1947603511402665; Mistry D, 2004, OSTEOARTHR CARTILAGE, V12, P131, DOI 10.1016/j.joca.2003.10.006; Nazli SA, 2017, OSTEOARTHR CARTILAGE, V25, P1516, DOI 10.1016/j.joca.2017.05.011; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Oliveria SA, 1999, EPIDEMIOLOGY, V10, P161, DOI 10.1097/00001648-199903000-00013; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Presle N, 2006, OSTEOARTHR CARTILAGE, V14, P690, DOI 10.1016/j.joca.2006.01.009; Qian B, 2008, J ENDOCRINOL, V199, P407, DOI 10.1677/JOE-08-0331; Schonthal AH, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/857516; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Takada K, 2011, INT J EXP PATHOL, V92, P232, DOI 10.1111/j.1365-2613.2010.00758.x; Tan L, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20181473; Todd DJ, 2008, NAT REV IMMUNOL, V8, P663, DOI 10.1038/nri2359; Uehara Y, 2014, OSTEOARTHR CARTILAGE, V22, P1007, DOI 10.1016/j.joca.2014.04.025; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang XZ, 1998, EMBO J, V17, P3619, DOI 10.1093/emboj/17.13.3619; Wang YY, 2010, RHEUMATOLOGY, V49, P997, DOI 10.1093/rheumatology/keq034; Xu X, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00203; Yammani RR, 2014, ARTHRITIS RHEUMATOL, V66, P1266, DOI 10.1002/art.38391; Yammani RR, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3705	47	11	11	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5818	5826		10.1096/fj.201902746R	http://dx.doi.org/10.1096/fj.201902746R		MAR 2020	9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32124494	Bronze			2022-12-28	WOS:000517934700001
J	Nie, JX; Wei, XY; Xu, X; Li, NQ; Li, YH; Zhao, YH; Guan, Y; Ge, FF; Guan, XW				Nie, Jiaxun; Wei, Xiaoyan; Xu, Xing; Li, Nanqin; Li, Yuehan; Zhao, Yonghua; Guan, Yun; Ge, Feifei; Guan, Xiaowei			Electro-acupuncture alleviates adolescent cocaine exposure-enhanced anxiety-like behaviors in adult mice by attenuating the activities of PV interneurons in PrL	FASEB JOURNAL			English	Article						adolescent cocaine exposure; adult PrL; electro-acupuncture; PV GABA interneuron	PREFRONTAL CORTEX; ALZHEIMERS-DISEASE; ACUPUNCTURE; PARVALBUMIN; NEUROTRANSMISSION; SCHIZOPHRENIA; EXPRESSION; NEURONS; SYSTEM; PERIOD	We recently found that adolescent cocaine exposure (ACE) resulted in an enhancement of the gamma-aminobutyric acid (GABA) neurotransmitter system in the prelimbic cortex (PrL) of adult mice. Here, we aim to further investigate the role of GABAergic transmission, especially parvalbumin (PV) interneurons within PrL in the development of ACE-induced anxiety-like behavior, and to assess whether and how electro-acupuncture (EA) therapeutically manage the ACE-induced abnormal behaviors in adulthood. ACE mice exhibited the enhanced anxiety-like behaviors in their adulthood, accompanied by increased GABAergic transmission and PV interneurons in PrL. Chemogenetic blocking PV interneurons in PrL alleviated ACE-enhanced anxiety-like behaviors in mice. Importantly, 37-day EA treatments (mixture of 2 Hz/100 Hz, 1 mA, 30 minutes once a day) at the acupoints of Yintang (GV29) and Baihui (GV20) also alleviated ACE-induced anxiety-like behaviors, and rescued ACE-impaired GABAergic neurotransmitter system and PV interneurons in PrL. In parallel, EA treatments further suppressed the activities of pyramidal neurons in PrL, suggesting that EA treatments seem to perform it beneficial effects on the ACE-induced abnormal emotional behaviors by "calming down" the whole PrL. Collectively, these findings revealed that hyper-function of GABAergic transmission, especially mediating by PV interneurons in PrL may be key etiology underlying ACE-induced anxiety-like behaviors. At least by normalizing the function of GABAergic and PV interneurons, EA may represent a promising therapeutic strategy for managing adolescent substance use-related emotional disorders.	[Nie, Jiaxun; Wei, Xiaoyan; Xu, Xing; Li, Nanqin; Li, Yuehan; Ge, Feifei; Guan, Xiaowei] Nanjing Univ Chinese Med, Dept Human Anat & Histoembryol, 138 Xianlin Ave, Nanjing 210023, Peoples R China; [Zhao, Yonghua] Univ Macau, Inst Chinese Med Sci, Macau, Peoples R China; [Guan, Yun] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA	Nanjing University of Chinese Medicine; University of Macau; Johns Hopkins University	Ge, FF; Guan, XW (corresponding author), Nanjing Univ Chinese Med, Dept Human Anat & Histoembryol, 138 Xianlin Ave, Nanjing 210023, Peoples R China.	ffge@njucm.edu.cn; guanxw918@njucm.edu.cn	Zhao, Yonghua/AAC-4728-2019	Zhao, Yonghua/0000-0001-8714-0476; Ge, Feifei/0000-0003-1336-8587	National Natural Science Foundation of China [81571303, 81901353]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China, Grant/Award Number: 81571303 and 81901353; Priority Academic Program Development of Jiangsu Higher Education Institutions	Abbas AI, 2018, NEURON, V100, P926, DOI 10.1016/j.neuron.2018.09.029; Baho E, 2019, J NEUROSCI, V39, P4489, DOI 10.1523/JNEUROSCI.2881-18.2019; Belleau EL, 2019, BIOL PSYCHIAT, V85, P443, DOI 10.1016/j.biopsych.2018.09.031; Butt SJB, 2017, CURR OPIN NEUROBIOL, V43, P149, DOI 10.1016/j.conb.2017.03.011; Caffino L, 2017, PSYCHOPHARMACOLOGY, V234, P1217, DOI 10.1007/s00213-017-4559-z; Chambers RA, 2003, AM J PSYCHIAT, V160, P1041, DOI 10.1176/appi.ajp.160.6.1041; Chang BH, 2014, AM J ADDICTION, V23, P129, DOI 10.1111/j.1521-0391.2013.12079.x; Chang S, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax1342; Chung DW, 2016, AM J PSYCHIAT, V173, P1131, DOI 10.1176/appi.ajp.2016.16010025; Chung DW, 2016, AM J PSYCHIAT, V173, P60, DOI 10.1176/appi.ajp.2015.15020150; Conrod PJ, 2016, J CHILD PSYCHOL PSYC, V57, P371, DOI 10.1111/jcpp.12516; Duan GX, 2020, BRAIN IMAGING BEHAV, V14, P2269, DOI 10.1007/s11682-019-00178-5; Ferguson BR, 2018, FRONT NEURAL CIRCUIT, V12, DOI 10.3389/fncir.2018.00037; Fuhrmann D, 2015, TRENDS COGN SCI, V19, P558, DOI 10.1016/j.tics.2015.07.008; Garcia-Cabrerizo R, 2019, J PSYCHOPHARMACOL, V33, P154, DOI 10.1177/0269881118812353; Giannotti G, 2015, PSYCHOPHARMACOLOGY, V232, P713, DOI 10.1007/s00213-014-3708-x; Hou Wei-Qing, 2018, Shengli Xuebao, V70, P463, DOI 10.13294/j.aps.2018.0066; Jia YJ, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-2064-x; Jin W, 2018, ADDICT BIOL, V23, P165, DOI 10.1111/adb.12499; Kim DH, 2018, NEUROSCI LETT, V664, P38, DOI 10.1016/j.neulet.2017.11.008; Kim H, 2016, CELL, V164, P208, DOI 10.1016/j.cell.2015.11.038; Larson TA, 2018, J PSYCHOPHARMACOL; Leng L, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000011905; Lim L, 2018, NEURON, V100, P294, DOI 10.1016/j.neuron.2018.10.009; Lin LX, 2019, FRONT BEHAV NEUROSCI, V13, DOI 10.3389/fnbeh.2019.00239; Liu WL, 2017, FREE RADICAL BIO MED, V112, P174, DOI 10.1016/j.freeradbiomed.2017.07.024; Luo ZY, 2020, BIOL PSYCHIAT, V87, P926, DOI 10.1016/j.biopsych.2019.10.021; Miyamae T, 2017, J NEUROSCI, V37, P4883, DOI 10.1523/JNEUROSCI.3325-16.2017; Nolan A, 2018, J NEUROTRAUM, V35, P2425, DOI 10.1089/neu.2018.5731; Page CE, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-56424-9; Page CE, 2019, NEUROSCI BIOBEHAV R, V105, P39, DOI 10.1016/j.neubiorev.2019.07.024; Park J, 2017, NEUROSCIENCE, V345, P193, DOI 10.1016/j.neuroscience.2016.06.013; Pilkington K, 2013, INT REV NEUROBIOL, V111, P197, DOI 10.1016/B978-0-12-411545-3.00010-9; Pozzi L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091486; Reichelt AC, 2019, FOOD FUNCT, V10, P1985, DOI [10.1039/c8fo02118j, 10.1039/C8FO02118J]; Rice J, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0829-9; Saitoh A, 2018, BEHAV BRAIN RES, V336, P77, DOI 10.1016/j.bbr.2017.08.041; Salmanzadeh H, 2020, BRAIN RES BULL, V156, P105, DOI 10.1016/j.brainresbull.2020.01.007; Scheggia D, 2020, NAT NEUROSCI, V23, P47, DOI 10.1038/s41593-019-0551-8; Shi PB, 2019, FASEB J, V33, P8614, DOI 10.1096/fj.201802192RR; Trantham-Davidson H, 2017, NEUROPSYCHOPHARMACOL, V42, P1024, DOI 10.1038/npp.2016.190; Tu CH, 2019, FRONT PSYCHIATRY, V10, DOI 10.3389/fpsyt.2019.00014; Volk DW, 2016, SCHIZOPHR RES, V177, P3, DOI 10.1016/j.schres.2016.03.001; Wang HY, 2018, AM J CHINESE MED, V46, P1387, DOI 10.1142/S0192415X18500738; Yan W, 2020, MOL PSYCHIATR, V25, P3113, DOI 10.1038/s41380-019-0391-7; Yan W, 2018, MOL PSYCHIATR, V23, DOI 10.1038/mp.2017.219; Yu J., 2016, EVID-BASED COMPL ALT, V2016; Yue N, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00149; Zhang Y, 2019, BRAIN BEHAV IMMUN, V79, P256, DOI 10.1016/j.bbi.2019.02.010; Zhao ZL, 2015, NEUROSCI LETT, V597, P143, DOI 10.1016/j.neulet.2015.04.045	50	6	6	2	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					11913	11924		10.1096/fj.202000346RR	http://dx.doi.org/10.1096/fj.202000346RR		JUL 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32683743				2022-12-28	WOS:000553200500001
J	Crescente, M; Armstrong, PC; Kirkby, NS; Edin, ML; Chan, MV; Lih, FB; Jiao, J; Maffucci, T; Allan, HE; Mein, CA; Gaston-Massuet, C; Cottrell, GS; Mitchell, JA; Zeldin, DC; Herschman, HR; Warner, TD				Crescente, Marilena; Armstrong, Paul C.; Kirkby, Nicholas S.; Edin, Matthew L.; Chan, Melissa, V; Lih, Fred B.; Jiao, Jing; Maffucci, Tania; Allan, Harriet E.; Mein, Charles A.; Gaston-Massuet, Carles; Cottrell, Graeme S.; Mitchell, Jillian A.; Zeldin, Darryl C.; Herschman, Harvey R.; Warner, Timothy D.			Profiling the eicosanoid networks that underlie the anti- and pro-thrombotic effects of aspirin	FASEB JOURNAL			English	Article						antithrombotic therapy; aspirin; endothelium; eicosanoid profiling; platelets	LOW-DOSE ASPIRIN; PLATELET-AGGREGATION; SECONDARY PREVENTION; ARTERIAL THROMBOSIS; CORONARY-ARTERY; IN-VIVO; INHIBITION; ACID; MICE; CYCLOOXYGENASE-2	Aspirin prevents thrombosis by inhibiting platelet cyclooxygenase (COX)-1 activity and the production of thromboxane (Tx)A(2), a pro-thrombotic eicosanoid. However, the non-platelet actions of aspirin limit its antithrombotic effects. Here, we used platelet-COX-1-ko mice to define the platelet and non-platelet eicosanoids affected by aspirin. Mass-spectrometry analysis demonstrated blood from platelet-COX-1-ko and global-COX-1-ko mice produced similar eicosanoid profiles in vitro: for example, formation of TxA(2), prostaglandin (PG) F-2 alpha, 11-hydroxyeicosatraenoic acid (HETE), and 15-HETE was absent in both platelet- and global-COX-1-ko mice. Conversely, in vivo,platelet-COX-1-ko mice had a distinctly different profile from global-COX-1-ko or aspirin-treated control mice, notably significantly higher levels of PGI(2)metabolite. Ingenuity Pathway Analysis (IPA) predicted that platelet-COX-1-ko mice would be protected from thrombosis, forming less pro-thrombotic TxA(2)and PGE(2). Conversely, aspirin or lack of systemic COX-1 activity decreased the synthesis of anti-aggregatory PGI(2)and PGD(2)at non-platelet sites leading to predicted thrombosis increase. In vitro and in vivo thrombosis studies proved these predictions. Overall, we have established the eicosanoid profiles linked to inhibition of COX-1 in platelets and in the remainder of the cardiovascular system and linked them to anti- and pro-thrombotic effects of aspirin. These results explain why increasing aspirin dosage or aspirin addition to other drugs may lessen antithrombotic protection.	[Crescente, Marilena; Armstrong, Paul C.; Chan, Melissa, V; Allan, Harriet E.; Mein, Charles A.; Warner, Timothy D.] Queen Mary Univ London, Ctr Immunobiol, Barts & London Sch Med & Dent, Blizard Inst, London, England; [Kirkby, Nicholas S.; Mitchell, Jillian A.] Imperial Coll London, Natl Heart & Lung Inst, London, England; [Edin, Matthew L.; Lih, Fred B.; Zeldin, Darryl C.] NIEHS, Div Intramural Res, POB 12233, Res Triangle Pk, NC 27709 USA; [Jiao, Jing; Herschman, Harvey R.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med & Mol Pharmacol, Los Angeles, CA 90095 USA; [Maffucci, Tania] Queen Mary Univ London, Ctr Cell Biol & Cutaneous Res, Barts & London Sch Med & Dent, Blizard Inst, London, England; [Gaston-Massuet, Carles] Queen Mary Univ London, Ctr Endocrinol, Barts & London Sch Med & Dent, William Harvey Res Inst, London, England; [Cottrell, Graeme S.] Univ Reading, Reading Sch Pharm, Reading, Berks, England; [Cottrell, Graeme S.] Univ Reading, ICMR, Reading, Berks, England	University of London; Queen Mary University London; Imperial College London; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of London; Queen Mary University London; University of London; Queen Mary University London; University of Reading; University of Reading	Crescente, M; Warner, TD (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, Ctr Imrnunobiol, 4 Newark St, London E1 2AT, England.	m.crescente@qmul.ac.uk; t.d.warner@qmul.ac.uk	Allan, Harriet/AAG-8484-2021; Armstrong, Paul/Z-1408-2019	Crescente, Marilena/0000-0003-3164-512X; Allan, Harriet/0000-0002-2104-4972; Cottrell, Graeme/0000-0001-9098-7627; Edin, Matthew/0000-0002-7042-500X	British Heart Foundation [PG/15/79/31777, FS/16/1/31699, PG/17/40/33028]; Action Medical Research [GN2272]; National Institute of Environmental Health Sciences [ES025034]; Phelps Family Foundation; Crump Family Foundation	British Heart Foundation(British Heart Foundation); Action Medical Research; National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Phelps Family Foundation; Crump Family Foundation	British Heart Foundation, Grant/Award Number: PG/15/79/31777, FS/16/1/31699 and PG/17/40/33028; Action Medical Research, Grant/Award Number: GN2272; National Institute of Environmental Health Sciences, Grant/Award Number: ES025034; Phelps Family Foundation and the Crump Family Foundation	Ahmetaj-Shala B, 2015, CIRCULATION, V131, P633, DOI 10.1161/CIRCULATIONAHA.114.011591; Armstrong PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020062; Armstrong PCJ, 2015, BLOOD, V126, pE11, DOI 10.1182/blood-2015-01-621656; Baber U, 2016, AM HEART J, V182, P125, DOI 10.1016/j.ahj.2016.09.006; Berg K, 2005, FREE RADICAL RES, V39, P629, DOI 10.1080/10715760400028027; Berry JD, 2007, AM HEART J, V154, P80, DOI 10.1016/j.ahj.2007.03.042; BRAUN M, 1992, CIRC RES, V71, P1305, DOI 10.1161/01.RES.71.6.1305; CERLETTI C, 1982, BIOCHIM BIOPHYS ACTA, V714, P122, DOI 10.1016/0304-4165(82)90133-7; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Crescente M, 2019, BRIT J PHARMACOL, V176, P988, DOI 10.1111/bph.14196; CROSET M, 1988, BIOCHEM PHARMACOL, V37, P1275, DOI 10.1016/0006-2952(88)90782-4; DIMINNO G, 1983, J PHARMACOL EXP THER, V225, P57; Edin ML, 2018, J BIOL CHEM, V293, P3281, DOI 10.1074/jbc.RA117.000298; FITZGERALD GA, 1983, J CLIN INVEST, V71, P676, DOI 10.1172/JCI110814; Gargiulo G, 2016, CIRCULATION, V134, P1881, DOI 10.1161/CIRCULATIONAHA.116.023952; Glenn JR, 2012, PLATELETS, V23, P344, DOI 10.3109/09537104.2011.625575; GRIFFETT EM, 1981, BRIT J PHARMACOL, V72, P697, DOI 10.1111/j.1476-5381.1981.tb09151.x; Gross S, 2007, J EXP MED, V204, P311, DOI 10.1084/jem.20061617; Jackson SP, 2011, NAT MED, V17, P1423, DOI 10.1038/nm.2515; James SL, 2018, LANCET, V392, P1789, DOI 10.1016/s0140-6736(18)32279-7; Johnson EN, 1998, P NATL ACAD SCI USA, V95, P3100, DOI 10.1073/pnas.95.6.3100; Johnston A, 2016, CURR CARDIOL REP, V18, DOI 10.1007/s11886-016-0749-2; Kahr WHA, 2013, BLOOD, V122, P3349, DOI 10.1182/blood-2013-04-499491; Kashiwagi H, 2019, THROMB HAEMOSTASIS, V119, P1311, DOI 10.1055/s-0039-1688906; Kirkby NS, 2020, CARDIOVASC RES, V116, P1972, DOI 10.1093/cvr/cvz290; Kirkby NS, 2015, FASEB J, V29, P4568, DOI 10.1096/fj.15-275065; Kirkby NS, 2013, FASEB J, V27, P3938, DOI 10.1096/fj.12-215533; Kirkby NS, 2012, P NATL ACAD SCI USA, V109, P17597, DOI 10.1073/pnas.1209192109; LANGENBACH R, 1995, CELL, V83, P483, DOI 10.1016/0092-8674(95)90126-4; Leadbeater PDM, 2011, J THROMB HAEMOST, V9, P2050, DOI 10.1111/j.1538-7836.2011.04450.x; Mahaffey KW, 2011, CIRCULATION, V124, P544, DOI 10.1161/CIRCULATIONAHA.111.047498; Maskrey BH, 2014, J INFLAMM-LOND, V11, DOI 10.1186/s12950-014-0033-4; MAYER B, 1986, BIOCHIM BIOPHYS ACTA, V875, P641, DOI 10.1016/0005-2760(86)90088-3; MCAULIFFE SJG, 1993, BRIT J PHARMACOL, V108, P901, DOI 10.1111/j.1476-5381.1993.tb13484.x; McFadyen JD, 2018, BLOOD, V132, P465, DOI 10.1182/blood-2018-06-854950; Mehran R, 2019, NEW ENGL J MED, V381, P2032, DOI 10.1056/NEJMoa1908419; Mitchell JA, 2019, CIRC RES, V125, P847, DOI 10.1161/CIRCRESAHA.119.314927; Newman JW, 2002, J LIPID RES, V43, P1563, DOI 10.1194/jlr.D200018-JLR200; O'Brien JJ, 2007, PROSTAG OTH LIPID M, V82, P68, DOI 10.1016/j.prostaglandins.2006.05.018; PATRIGNANI P, 1982, J CLIN INVEST, V69, P1366, DOI 10.1172/JCI110576; Patrono C, 2005, NEW ENGL J MED, V353, P2373, DOI 10.1056/NEJMra052717; Peng B, 2018, BLOOD, V132, pE1, DOI 10.1182/blood-2017-12-822890; Petrucci G, 2011, J PHARMACOL EXP THER, V336, P391, DOI 10.1124/jpet.110.174821; Porro B, 2014, J CHROMATOGR B, V964, P26, DOI 10.1016/j.jchromb.2014.03.015; Puddu P, 2009, ACTA CARDIOL, V64, P157, DOI 10.2143/AC.64.2.2035338; Rauzi F, 2016, FASEB J, V30, P4256, DOI 10.1096/fj.201600530R; REILLY M, 1993, EUR HEART J, V14, P88; Ruggeri ZM, 2002, NAT MED, V8, P1227, DOI 10.1038/nm1102-1227; Sacco A, 2019, J PHARMACOL EXP THER, V370, P416, DOI 10.1124/jpet.119.259382; SETTY BNY, 1992, BLOOD, V80, P2765; SETTY BNY, 1986, J CLIN INVEST, V77, P202, DOI 10.1172/JCI112277; Shen ZQ, 1998, J PHARM PHARMACOL, V50, P1275, DOI 10.1111/j.2042-7158.1998.tb03345.x; Song WL, 2012, J CLIN INVEST, V122, P1459, DOI 10.1172/JCI59262; Tomaniak M, 2019, JAMA CARDIOL, V4, P1092, DOI 10.1001/jamacardio.2019.3355; UOTILA P, 1984, PROSTA LEUKOTR MED, V14, P41, DOI 10.1016/0262-1746(84)90022-2; VANE JR, 1971, NATURE-NEW BIOL, V231, P232, DOI 10.1038/newbio231232a0; Vranckx P, 2016, EUROINTERVENTION, V12, P1239, DOI 10.4244/EIJY15M11_07; Warner TD, 2010, HEART, V96, P1693, DOI 10.1136/hrt.2010.205724; Welsh RC, 2016, AM HEART J, V181, P92, DOI 10.1016/j.ahj.2016.08.008; Zhang J, 2010, FRONT PHARMACOL, V1, DOI 10.3389/fphar.2010.00116	60	6	6	3	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10027	10040		10.1096/fj.202000312R	http://dx.doi.org/10.1096/fj.202000312R		JUN 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32592197	Green Accepted, hybrid, Green Submitted			2022-12-28	WOS:000544401100001
J	Guo, D; Zhang, D; Ren, MD; Lu, GF; Zhang, X; He, SX; Li, YR				Guo, Dan; Zhang, Dan; Ren, Mudan; Lu, Guifang; Zhang, Xu; He, Shuixiang; Li, Yarui			THBS4 promotes HCC progression by regulating ITGB1 via FAK/PI3K/AKT pathway	FASEB JOURNAL			English	Article						epithelial-mesenchymal transition; FAK; PI3K; AKT pathway; hepatocellular carcinoma development; integrin beta 1; thrombospondin 4	HUMAN HEPATOCELLULAR-CARCINOMA; EXPRESSION; CANCER; METASTASIS	Our research aims to identify the role of thrombospondin 4 (THBS4) in hepatocellular carcinoma (HCC). First, bioinformatic analysis was applied for detection the expression of THBS4 in HCC samples, and qRT-PCR and western blot were performed to explore the expression of THBS4 in HCC tissues and adjacent samples. Next, colony formation assay and cell viability assay were used to assess the function of THBS4 on HCC cells growth while transwell assay and scratch test were for metastasis. Meanwhile Xenograft tumor models were further conducted to verify the function of THBS4 in HCC. As for mechanism in deep, we investigated the influence of THBS4 on epithelial-mesenchymal transition (EMT) development and the interaction between THBS4 and integrin (ITG) family using multiple experiments, including western blot, immunofluorescence and immunoprecipitation (IP). As a result, our research discovered that the overexpression of THBS4 in both HCC patients' tissues and cell lines mediates HCC cells proliferation and metastasis in vitro and in vivo. In-depth, THBS4 regulated EMT progression and interacted with ITG family to modulate FAK/PI3K/AKT pathway. In conclusion, THBS4 as an oncogene interacts with integrin beta 1 (ITGB1) to regulate HCC development via FAK/PI3K/AKT pathway.	[Guo, Dan; Zhang, Dan; Ren, Mudan; Lu, Guifang; Zhang, Xu; He, Shuixiang; Li, Yarui] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Gastroenterol, 277 Yanta West Rd, Xian 710061, Shaanxi, Peoples R China	Xi'an Jiaotong University	He, SX; Li, YR (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Gastroenterol, 277 Yanta West Rd, Xian 710061, Shaanxi, Peoples R China.	hesx321@sina.com; liyarui0529@163.com			National Science Foundation of China [81602611]; Social Development, Scientific and Technological Research Project of Shannxi Province	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Social Development, Scientific and Technological Research Project of Shannxi Province	National Science Foundation of China, Grant/Award Number: 81602611; the Social Development, Scientific and Technological Research Project of Shannxi Province	Cannito S, 2010, ANTIOXID REDOX SIGN, V12, P1383, DOI 10.1089/ars.2009.2737; Chen CD, 2014, J PROTEOME RES, V13, P2818, DOI 10.1021/pr4012377; Chen XB, 2019, J PHYSIOL BIOCHEM, V75, P117, DOI 10.1007/s13105-019-00665-9; Forster S, 2011, MODERN PATHOL, V24, P1390, DOI 10.1038/modpathol.2011.99; Greco SA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-494; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lee YH, 2011, ONCOGENE, V30, P4175, DOI 10.1038/onc.2011.126; Li CB, 2019, CELL MOL LIFE SCI, V76, P4203, DOI 10.1007/s00018-019-03215-0; Li JH, 2014, NUCLEIC ACIDS RES, V42, pD92, DOI 10.1093/nar/gkt1248; Li YR, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0882-5; Lim LJ, 2019, CANCER RES, V79, P5131, DOI 10.1158/0008-5472.CAN-19-0255; Lin XD, 2016, CANCER GENET-NY, V209, P215, DOI 10.1016/j.cancergen.2016.04.003; Liu JL, 2016, MOL MED REP, V14, P1451, DOI 10.3892/mmr.2016.5443; Liu SQ, 2019, INT J ONCOL, V54, P41, DOI 10.3892/ijo.2018.4607; NAITO S, 1986, CANCER RES, V46, P4109; Niu JJ, 2016, ONCOTARGET, V7, P76169, DOI 10.18632/oncotarget.12732; Qiu LP, 2019, LIFE SCI, V231, DOI 10.1016/j.lfs.2019.116660; Reed AEM, 2013, VIRCHOWS ARCH, V463, P535, DOI 10.1007/s00428-013-1468-3; Reghupaty SC, 2019, CANCERS, V11, DOI 10.3390/cancers11091265; Rorive S, 2006, J NEUROPATH EXP NEUR, V65, P794, DOI 10.1097/01.jnen.0000228203.12292.a1; Su F, 2017, ONCOTARGET, V8, P23277, DOI 10.18632/oncotarget.15054; Suh D, 2019, J CHEM THEORY COMPUT, V15, P5829, DOI 10.1021/acs.jctc.9b00499; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Tang ZF, 2017, NUCLEIC ACIDS RES, V45, pW98, DOI 10.1093/nar/gkx247; Wong CH, 2020, CANCER RES, V80, P2138, DOI 10.1158/0008-5472.CAN-19-3268; Wu HF, 2019, GENE, V696, P219, DOI 10.1016/j.gene.2019.02.049; Xu ZX, 2017, ONCOL REP, V37, P259, DOI 10.3892/or.2016.5215; Yang JH, 2011, NUCLEIC ACIDS RES, V39, pD202, DOI 10.1093/nar/gkq1056; Yang JD, 2019, NAT REV GASTRO HEPAT, V16, P589, DOI 10.1038/s41575-019-0186-y; Zha RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087665; Zhang YY, 2018, CANCER LETT, V429, P29, DOI 10.1016/j.canlet.2018.05.004	31	26	27	2	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10668	10681		10.1096/fj.202000043R	http://dx.doi.org/10.1096/fj.202000043R		JUN 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32567740	hybrid			2022-12-28	WOS:000543545000001
J	Alam, C; Hoque, MT; Sangha, V; Bendayan, R				Alam, Camille; Hoque, Md. Tozammel; Sangha, Vishal; Bendayan, Reina			Nuclear respiratory factor 1 (NRF-1) upregulates the expression and function of reduced folate carrier (RFC) at the blood-brain barrier	FASEB JOURNAL			English	Article						brain folate transport; folate deficiency; reduced folate carrier; transcription factor	KEARNS-SAYRE-SYNDROME; VITAMIN-D-RECEPTOR; MITOCHONDRIAL BIOGENESIS; DOWN-SYNDROME; TRANSPORTER; DEFICIENCY; AUTOANTIBODIES; DYSFUNCTION; DISEASES; SLC46A1	Folates are important for neurodevelopment and cognitive function. Folate transport across biological membranes is mediated by three major pathways: folate receptor alpha (FR alpha), proton-coupled folate transporter (PCFT), and reduced folate carrier (RFC). Brain folate transport primarily occurs at the choroid plexus through FR alpha and PCFT; inactivation of these transport systems results in suboptimal folate levels in the cerebrospinal fluid (CSF) causing childhood neurological disorders. Our group has reported that upregulation of RFC at the blood-brain barrier (BBB) through interactions with specific transcription factors, that is, vitamin D receptor (VDR) could increase brain folate delivery. This study investigates the role of nuclear respiratory factor 1 (NRF-1) in the regulation of RFC at the BBB. Activation of NRF-1/PGC-1 alpha signaling through treatment with its specific ligand, pyrroloquinoline quinone (PQQ), significantly induced RFC expression and transport activity in hCMEC/D3 cells. In contrast, transfection with NRF-1 or PGC-1 alpha targeting siRNA downregulated RFC functional expression in the same cell system. Applying chromatin immunoprecipitation (ChIP) assay, we further demonstrated that PQQ treatment increased NRF-1 binding to putative NRF-1 binding sites within theSLC19A1promoter, which encodes for RFC. Additionally, in vivo treatment of wild type mice with PQQ-induced RFC expression in isolated mouse brain capillaries. Together, these findings demonstrate that NRF-1/PGC-1 alpha activation by PQQ upregulates RFC functional expression at the BBB and could potentially enhance brain folate uptake.	[Alam, Camille; Hoque, Md. Tozammel; Sangha, Vishal; Bendayan, Reina] Univ Toronto, Leslie Dan Fac Pharm, Dept Pharmaceut Sci, 144 Coll St,Room 1001, Toronto, ON M5S 3M2, Canada	University of Toronto	Bendayan, R (corresponding author), Univ Toronto, Leslie Dan Fac Pharm, Dept Pharmaceut Sci, 144 Coll St,Room 1001, Toronto, ON M5S 3M2, Canada.	r.bendayan@utoronto.ca			Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (NSERC) [498383]	Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (NSERC)	Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (NSERC), Grant/Award Number: 498383	Alam C, 2020, TRENDS PHARMACOL SCI, V41, P349, DOI 10.1016/j.tips.2020.02.004; Alam C, 2019, P NATL ACAD SCI USA, V116, P17531, DOI 10.1073/pnas.1907077116; Alam C, 2017, MOL PHARMACEUT, V14, P3848, DOI 10.1021/acs.molpharmaceut.7b00572; Araujo JR, 2010, BIOFACTORS, V36, P201, DOI 10.1002/biof.82; Assaraf YG, 2006, DRUG RESIST UPDATE, V9, P227, DOI 10.1016/j.drup.2006.09.001; Busciglio J, 2002, NEURON, V33, P677, DOI 10.1016/S0896-6273(02)00604-9; Chan Gary N Y, 2017, Curr Protoc Pharmacol, V76, DOI 10.1002/cpph.21; Chow ECY, 2013, AM J PHYSIOL-ENDOC M, V304, pE977, DOI 10.1152/ajpendo.00489.2012; Chowanadisai W, 2010, J BIOL CHEM, V285, P142, DOI 10.1074/jbc.M109.030130; Conti A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-268; Elnakat H, 2004, ADV DRUG DELIVER REV, V56, P1067, DOI 10.1016/j.addr.2004.01.001; Fornes O, 2020, NUCLEIC ACIDS RES, V48, pD87, DOI 10.1093/nar/gkz1001; Frye RE, 2011, PEDIATR RES, V69, p41R, DOI 10.1203/PDR.0b013e318212f16b; Garcia-Cazorla A, 2008, NEUROLOGY, V70, P1360, DOI 10.1212/01.wnl.0000309223.98616.e4; Gibson JH, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-53; Gonen N, 2010, J BIOL CHEM, V285, P33602, DOI 10.1074/jbc.M110.135640; Grapp M, 2012, BRAIN, V135, P2022, DOI 10.1093/brain/aws122; Halwachs S, 2010, TOXICOL APPL PHARM, V246, P100, DOI 10.1016/j.taap.2010.04.020; Kamen BA, 2004, ADV DRUG DELIVER REV, V56, P1085, DOI 10.1016/j.addr.2004.01.002; Lambert SA, 2018, CELL, V172, P650, DOI 10.1016/j.cell.2018.01.029; Piccoli C, 2013, HUM MOL GENET, V22, P1218, DOI 10.1093/hmg/dds529; Qiu AD, 2006, CELL, V127, P917, DOI 10.1016/j.cell.2006.09.041; Ramaekers VT, 2007, NEUROPEDIATRICS, V38, P276, DOI 10.1055/s-2008-1065354; Ramaekers VT, 2013, MOL PSYCHIATR, V18, P270, DOI 10.1038/mp.2012.22; Ramaekers VT, 2005, NEW ENGL J MED, V352, P1985, DOI 10.1056/NEJMoa043160; Rucker R, 2009, ALTERN MED REV, V14, P268; Saihara K, 2017, BIOCHEMISTRY-US, V56, P6615, DOI 10.1021/acs.biochem.7b01185; Salbaum JM, 2009, BIRTH DEFECTS RES A, V85, P303, DOI 10.1002/bdra.20537; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Serrano M, 2010, MITOCHONDRION, V10, P429, DOI 10.1016/j.mito.2010.04.001; Shemesh A, 2022, STATPEARLS INTERNET; Spector Reynold, 2010, Cerebrospinal Fluid Res, V7, P14, DOI 10.1186/1743-8454-7-14; Steinfeld R, 2009, AM J HUM GENET, V85, P354, DOI 10.1016/j.ajhg.2009.08.005; Tanji K, 2000, J NEUROL SCI, V178, P29, DOI 10.1016/S0022-510X(00)00354-3; Tibbetts AS, 2010, ANNU REV NUTR, V30, P57, DOI 10.1146/annurev.nutr.012809.104810; Torres A, 2015, JIMD REP, V24, P91, DOI 10.1007/8904_2015_445; Tran T, 2005, CANCER RES, V65, P4431, DOI 10.1158/0008-5472.CAN-04-2890; Valenti D, 2014, NEUROSCI BIOBEHAV R, V46, P202, DOI 10.1016/j.neubiorev.2014.01.012; Visentin M, 2014, ANNU REV PHYSIOL, V76, P251, DOI 10.1146/annurev-physiol-020911-153251; Weissman JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003815; Wu DF, 1999, PHARMACEUT RES, V16, P415, DOI 10.1023/A:1018829920158; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yang CF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109502; Zhao RB, 2017, MOL ASPECTS MED, V53, P57, DOI 10.1016/j.mam.2016.09.002; Zhao RB, 2013, MOL ASPECTS MED, V34, P373, DOI 10.1016/j.mam.2012.07.006	45	7	8	3	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10516	10530		10.1096/fj.202000239RR	http://dx.doi.org/10.1096/fj.202000239RR		JUN 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32543769	Bronze			2022-12-28	WOS:000541638400001
J	Ogura, S; Baldeosingh, R; Bhutto, IA; Kambhampati, SP; McLeod, DS; Edwards, MM; Rais, R; Schubert, W; Lutty, GA				Ogura, Shuntaro; Baldeosingh, Rajkumar; Bhutto, Imran A.; Kambhampati, Siva P.; Scott McLeod, Donald; Edwards, Malia M.; Rais, Rana; Schubert, William; Lutty, Gerard A.			A role for mast cells in geographic atrophy	FASEB JOURNAL			English	Article						48/80; age-related macular degeneration; choroid; degranulation; ketotifen fumarate; retinal pigment epithelium; tryptase	HUMAN EYES; TRYPTASE; KETOTIFEN; DEGENERATION; RPE; CHORIOCAPILLARIS; INFLAMMATION; HISTAMINE; DRUSEN; ASTHMA	Mast cells (MCs) are the initial responders of innate immunity and their degranulation contribute to various etiologies. While the abundance of MCs in the choroid implies their fundamental importance in the eye, little is known about the significance of MCs and their degranulation in choroid. The cause of geographic atrophy (GA), a progressive dry form of age-related macular degeneration is elusive and there is currently no therapy for this blinding disorder. Here we demonstrate in both human GA and a rat model for GA, that MC degranulation and MC-derived tryptase are central to disease progression. Retinal pigment epithelium degeneration followed by retinal and choroidal thinning, characteristic phenotypes of GA, were driven by continuous choroidal MC stimulation and activation in a slow release fashion in the rat. Genetic manipulation of MCs, pharmacological intervention targeting MC degranulation with ketotifen fumarate or inhibition of MC-derived tryptase with APC 366 prevented all of GA-like phenotypes following MC degranulation in the rat model. Our results demonstrate the fundamental role of choroidal MC involvement in GA disease etiology, and will provide new opportunities for understanding GA pathology and identifying novel therapies targeting MCs.	[Ogura, Shuntaro; Baldeosingh, Rajkumar; Bhutto, Imran A.; Kambhampati, Siva P.; Scott McLeod, Donald; Edwards, Malia M.; Lutty, Gerard A.] Johns Hopkins Univ Hosp, Wilmer Ophthalmol Inst, M041 Smith Bldg,400 North Broadway, Baltimore, MD 21287 USA; [Rais, Rana] Johns Hopkins Univ, Sch Med, Johns Hopkins Drug Discovery, Baltimore, MD USA; [Rais, Rana] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Schubert, William] Bayer AG Pharmaceut, Wuppertal, Germany	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University	Lutty, GA (corresponding author), Johns Hopkins Univ Hosp, Wilmer Ophthalmol Inst, M041 Smith Bldg,400 North Broadway, Baltimore, MD 21287 USA.	glutty@jhmi.edu	Kambhampati, Siva Pramodh/AAK-6269-2020	Ogura, Shuntaro/0000-0002-5191-8933	HHS \ NIH \ National Eye Institute (NEI) [EY016151, EY01765]; Bayer; Arnold and Mabel Beckman Foundation; Research to Prevent Blindness (RPB)	HHS \ NIH \ National Eye Institute (NEI); Bayer(Bayer AG); Arnold and Mabel Beckman Foundation; Research to Prevent Blindness (RPB)(Research to Prevent Blindness (RPB))	HHS vertical bar NIH vertical bar National Eye Institute (NEI), Grant/Award Number: EY016151 and EY01765; Bayer; Arnold and Mabel Beckman Foundation; Research to Prevent Blindness (RPB)	Bhutto IA, 2018, INVEST OPHTH VIS SCI, V59, P143, DOI DOI 10.1167/I0VS.18-24245; Bhutto IA, 2016, BRIT J OPHTHALMOL, V100, P720, DOI 10.1136/bjophthalmol-2015-308290; Bhutto IA, 2011, BRIT J OPHTHALMOL, V95, P1323, DOI 10.1136/bjo.2010.199216; Bousquet E, 2015, AM J PATHOL, V185, P2083, DOI 10.1016/j.ajpath.2015.04.002; Bradding P, 2006, J ALLERGY CLIN IMMUN, V117, P1277, DOI 10.1016/j.jaci.2006.02.039; Cairns JA, 1996, J IMMUNOL, V156, P275; CRAPS LP, 1984, RESPIRATION, V45, P411, DOI 10.1159/000194648; Datta S, 2017, PROG RETIN EYE RES, V60, P201, DOI 10.1016/j.preteyeres.2017.03.002; Delori FC, 2000, INVEST OPHTH VIS SCI, V41, P496; Godfrey W A, 1987, Trans Am Ophthalmol Soc, V85, P557; GRANT SM, 1990, DRUGS, V40, P412, DOI 10.2165/00003495-199040030-00006; Guillonneau X, 2017, PROG RETIN EYE RES, V61, P98, DOI 10.1016/j.preteyeres.2017.06.002; Hartmann K, 1997, BLOOD, V89, P2863, DOI 10.1182/blood.V89.8.2863; Hayashi A, 1999, GRAEF ARCH CLIN EXP, V237, P668, DOI 10.1007/s004170050295; Holz FG, 2014, OPHTHALMOLOGY, V121, P1079, DOI 10.1016/j.ophtha.2013.11.023; Iddamalgoda A, 2008, ARCH DERMATOL RES, V300, pS69, DOI 10.1007/s00403-007-0806-1; Kabra SK, 2000, ANN ALLERG ASTHMA IM, V85, P46, DOI 10.1016/S1081-1206(10)62433-7; Kauppinen A, 2016, CELL MOL LIFE SCI, V73, P1765, DOI 10.1007/s00018-016-2147-8; Kidd M, 2003, BRIT J OPHTHALMOL, V87, P1206, DOI 10.1136/bjo.87.10.1206; Kinoshita M, 2005, ARTERIOSCL THROM VAS, V25, P1858, DOI 10.1161/01.ATV.0000174797.71708.97; Krishna MT, 2001, J ALLERGY CLIN IMMUN, V107, P1039, DOI 10.1067/mai.2001.115631; Krystel-Whittemore M, 2016, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00620; Lu J, 2014, INT IMMUNOPHARMACOL, V20, P352, DOI 10.1016/j.intimp.2014.04.001; Marone G, 2001, LEUKEMIA RES, V25, P583, DOI 10.1016/S0145-2126(01)00039-X; McLeod DS, 2017, INVEST OPHTH VIS SCI, V58, P5879, DOI 10.1167/iovs.17-22989; McLeod DS, 2016, INVEST OPHTH VIS SCI, V57, P5843, DOI 10.1167/iovs.16-20049; McLeod DS, 2009, INVEST OPHTH VIS SCI, V50, P4982, DOI 10.1167/iovs.09-3639; McMenamin PG, 1997, EYE, V11, P183, DOI 10.1038/eye.1997.49; NIWA Y, 1991, BLOOD, V78, P1936; Nozaki M, 2006, P NATL ACAD SCI USA, V103, P2328, DOI 10.1073/pnas.0408835103; Omri S, 2011, AM J PATHOL, V179, P942, DOI 10.1016/j.ajpath.2011.04.018; Pardue MT, 2014, DOC OPHTHALMOL, V128, P77, DOI 10.1007/s10633-013-9424-8; Passante E, 2009, INFLAMM RES, V58, P737, DOI 10.1007/s00011-009-0074-y; Payne V, 2004, ANAESTHESIA, V59, P695, DOI 10.1111/j.1365-2044.2004.03757.x; Pennesi ME, 2012, MOL ASPECTS MED, V33, P487, DOI 10.1016/j.mam.2012.06.003; Ponomaryov T, 2017, CIRC RES, V121, P941, DOI 10.1161/CIRCRESAHA.117.311185; SCHWARTZ LB, 1987, ANN ALLERGY, V58, P226; SCHWARTZ LB, 1987, J IMMUNOL, V138, P2611; Soiberman U, 2017, BIOMATERIALS, V125, P38, DOI 10.1016/j.biomaterials.2017.02.016; Sun J, 2007, J CLIN INVEST, V117, P3359, DOI 10.1172/JCI31311; Theoharides TC, 2012, BBA-MOL BASIS DIS, V1822, P21, DOI 10.1016/j.bbadis.2010.12.014; Unno K, 2012, EUR J PHARMACOL, V683, P179, DOI 10.1016/j.ejphar.2012.03.017; Valent P, 2004, J ALLERGY CLIN IMMUN, V114, P3, DOI 10.1016/j.jaci.2004.02.045; Walter P, 1999, GRAEF ARCH CLIN EXP, V237, P962, DOI 10.1007/s004170050331; Wang Q, 2019, ELIFE, V8, DOI 10.7554/eLife.39905; Weatherly LM, 2013, JOVE-J VIS EXP, DOI 10.3791/50671; Wernersson S, 2014, NAT REV IMMUNOL, V14, P478, DOI 10.1038/nri3690; Wong WL, 2014, LANCET GLOB HEALTH, V2, pE106, DOI 10.1016/S2214-109X(13)70145-1; Yamada Y, 2006, EXP EYE RES, V82, P840, DOI 10.1016/j.exer.2005.10.005; Yamagishi S, 1998, DIABETOLOGIA, V41, P1435, DOI 10.1007/s001250051089	50	10	10	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10117	10131		10.1096/fj.202000807R	http://dx.doi.org/10.1096/fj.202000807R		JUN 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32525594	Green Accepted			2022-12-28	WOS:000539639000001
J	Murao, A; Arif, A; Brenner, M; Denning, NL; Jin, H; Takizawa, S; Nicastro, B; Wang, P; Aziz, M				Murao, Atsushi; Arif, Adnan; Brenner, Max; Denning, Naomi-Liza; Jin, Hui; Takizawa, Satoshi; Nicastro, Benjamin; Wang, Ping; Aziz, Monowar			Extracellular CIRP and TREM-1 axis promotes ICAM-1-Rho-mediated NETosis in sepsis	FASEB JOURNAL			English	Article						eCIRP; ICAM-1; NETs; sepsis; TREM-1	INFLAMMATORY RESPONSES; SIGNALING PATHWAYS; CUTTING EDGE; RECEPTOR; NEUTROPHILS; ICAM-1; TRAPS; ACTIVATION; ADHESION; IDENTIFICATION	Extracellular cold-inducible RNA-binding protein (eCIRP) is a damage-associated molecular pattern (DAMP). Intercellular adhesion molecule-1 (ICAM-1) expressing neutrophils produce excessive amounts of neutrophil extracellular traps (NETs). We reveal that eCIRP generates ICAM-1(+) neutrophils through triggering receptor expressed on myeloid cells-1 (TREM-1) and the ICAM-1(+) neutrophils involve Rho GTPase to promote NETosis. Treatment of BMDN with rmCIRP increased the frequency of ICAM-1(+) BMDN, while rmCIRP-treated TREM-1(-/-) BMDN or pretreatment of BMDN with TREM-1 inhibitor LP17 significantly decreased the frequency of ICAM-1(+) neutrophils. The frequencies of ICAM-1(+) neutrophils in blood and lungs were markedly decreased in rmCIRP-injected mice or septic mice treated with LP17. Coculture of ICAM-1(-/-) neutrophils or wild-type (WT) neutrophils with WT macrophages in the presence of a peptidylarginine deiminase 4 (PAD4) inhibitor reduced TNF-alpha and IL-6 compared to WT neutrophils treated with rmCIRP. Treatment of ICAM-1(-/-) neutrophils with rmCIRP resulted in reduced quantities of NETs compared to WT rmCIRP-treated neutrophils. Treatment of BMDN with rmCIRP-induced Rho activation, while blockade of ICAM-1 significantly decreased Rho activation. Inhibition of Rho significantly decreased rmCIRP-induced NET formation in BMDN. TREM-1 plays a critical role in the eCIRP-mediated increase of ICAM-1 expression in neutrophils, leading to the increased NET formation via Rho activation to exaggerate inflammation.	[Murao, Atsushi; Arif, Adnan; Brenner, Max; Denning, Naomi-Liza; Jin, Hui; Takizawa, Satoshi; Nicastro, Benjamin; Wang, Ping; Aziz, Monowar] Feinstein Inst Med Res, Ctr Immunol & Inflammat, 350 Community Dr, Manhasset, NY 11030 USA; [Brenner, Max; Wang, Ping] Hofstra Northwell, Zucker Sch Med, Dept Mol Med, Manhasset, NY USA; [Denning, Naomi-Liza; Wang, Ping; Aziz, Monowar] Elmezzi Grad Sch Mol Med, Manhasset, NY USA; [Denning, Naomi-Liza; Wang, Ping] Hofstra Northwell, Zucker Sch Med, Dept Surg, Manhasset, NY USA	Northwell Health; Northwell Health; Northwell Health; Northwell Health	Wang, P; Aziz, M (corresponding author), Feinstein Inst Med Res, Ctr Immunol & Inflammat, 350 Community Dr, Manhasset, NY 11030 USA.	pwang@northwell.edu; Maziz1@northwell.edu		Brenner, Max/0000-0002-8010-148X; Wang, Ping/0000-0002-1557-0394; Aziz, Monowar/0000-0002-8195-4505	National Institutes of Health (NIH) [R35GM118337, R01GM129633]; Shock Society's Faculty Research	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shock Society's Faculty Research	National Institutes of Health (NIH), Grant/Award Number: R35GM118337 and R01GM129633; Shock Society's Faculty Research	Adamson P, 1999, J IMMUNOL, V162, P2964; Allingham MJ, 2007, J IMMUNOL, V179, P4053, DOI 10.4049/jimmunol.179.6.4053; Amulic B, 2012, ANNU REV IMMUNOL, V30, P459, DOI 10.1146/annurev-immunol-020711-074942; Arts RJW, 2013, J LEUKOCYTE BIOL, V93, P209, DOI 10.1189/jlb.0312145; Arts RJW, 2011, EUR CYTOKINE NETW, V22, P11, DOI 10.1684/ecn.2011.0274; Aziz M, 2019, J LEUKOCYTE BIOL, V106, P133, DOI 10.1002/JLB.3MIR1118-443R; Aziz M, 2017, J IMMUNOL, V199, P750, DOI 10.4049/jimmunol.1602056; BERENDT AR, 1989, NATURE, V341, P57, DOI 10.1038/341057a0; Biron BM, 2017, J INNATE IMMUN, V9, P22, DOI 10.1159/000448808; Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; Bouchon A, 2001, NATURE, V410, P1103, DOI 10.1038/35074114; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Cen C, 2017, SURGERY, V162, P915, DOI 10.1016/j.surg.2017.06.004; Claushuis TAM, 2018, J IMMUNOL, V201, P1241, DOI 10.4049/jimmunol.1800314; Colon DF, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2407-8; Denning NL, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.134172; Denning NL, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02536; Dower K, 2008, J IMMUNOL, V180, P3520, DOI 10.4049/jimmunol.180.5.3520; Dragoni S, 2017, J IMMUNOL, V198, P4074, DOI 10.4049/jimmunol.1600823; Ericsson AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116704; Etienne S, 1998, J IMMUNOL, V161, P5755; Etienne-Manneville S, 2000, J IMMUNOL, V165, P3375, DOI 10.4049/jimmunol.165.6.3375; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fu L, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00917; Gavillet M, 2015, AM J HEMATOL, V90, P1155, DOI 10.1002/ajh.24185; Gibot S, 2004, J EXP MED, V200, P1419, DOI 10.1084/jem.20040708; Gurien SD, 2020, EMBO REP, V21, DOI 10.15252/embr.201948075; Kaplan MJ, 2012, J IMMUNOL, V189, P2689, DOI 10.4049/jimmunol.1201719; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Ng LG, 2019, NAT REV IMMUNOL, V19, P255, DOI 10.1038/s41577-019-0141-8; Luo Y, 2006, BIOCHEMISTRY-US, V45, P11727, DOI 10.1021/bi061180d; Nauseef WM, 2014, NAT IMMUNOL, V15, P602, DOI 10.1038/ni.2921; Neubert E, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06263-5; Ode Y, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42762-1; Ode Y, 2018, J LEUKOCYTE BIOL, V103, P693, DOI 10.1002/JLB.3A0817-327RR; Phillipson M, 2006, J EXP MED, V203, P2569, DOI 10.1084/jem.20060925; Qiang XL, 2013, NAT MED, V19, P1489, DOI 10.1038/nm.3368; Rasmussen TS, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11050435; Read CB, 2015, J IMMUNOL, V194, P1417, DOI 10.4049/jimmunol.1402303; Silvestre-Roig C, 2016, BLOOD, V127, P2173, DOI 10.1182/blood-2016-01-688887; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Wang YM, 2009, J CELL BIOL, V184, P205, DOI 10.1083/jcb.200806072; Warnatsch A, 2017, IMMUNITY, V46, P421, DOI 10.1016/j.immuni.2017.02.013; Wong SL, 2018, FASEB J, V32, P6358, DOI 10.1096/fj.201800691R; Woodfin A, 2016, BLOOD, V127, P898, DOI 10.1182/blood-2015-08-664995; Wu J, 2012, CANCER RES, V72, P3977, DOI 10.1158/0008-5472.CAN-12-0938; Yang H, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00302; Yang L, 2005, BLOOD, V106, P584, DOI 10.1182/blood-2004-12-4942; Zhou YS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116095	50	21	22	3	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9771	9786		10.1096/fj.202000482R	http://dx.doi.org/10.1096/fj.202000482R		JUN 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32506691	Bronze, Green Accepted			2022-12-28	WOS:000539606200001
J	Awaji, M; Saxena, S; Wu, LY; Prajapati, DR; Purohit, A; Varney, ML; Kumar, S; Rachagani, S; Ly, QP; Jain, M; Batra, SK; Singh, RK				Awaji, Mohammad; Saxena, Sugandha; Wu, Lingyun; Prajapati, Dipakkumar R.; Purohit, Abhilasha; Varney, Michelle L.; Kumar, Sushil; Rachagani, Satyanarayana; Ly, Quan P.; Jain, Maneesh; Batra, Surinder K.; Singh, Rakesh K.			CXCR2 signaling promotes secretory cancer-associated fibroblasts in pancreatic ductal adenocarcinoma	FASEB JOURNAL			English	Article						CAFs; chemokines; desmoplasia; inflammation; oncogenic Kras	NF-KAPPA-B; STELLATE CELLS; MOUSE MODEL; INFLAMMATION; INHIBITION; SURVIVAL; GROWTH; TRANSFORMATION; TRANSCRIPTION; RECEPTORS	Pancreatic ductal adenocarcinoma (PDAC) remains one of the most challenging malignancies. Desmoplasia and tumor-supporting inflammation are hallmarks of PDAC. The tumor microenvironment contributes significantly to tumor progression and spread. Cancer-associated fibroblasts (CAFs) facilitate therapy resistance and metastasis. Recent reports emphasized the concurrence of multiple subtypes of CAFs with diverse roles, fibrogenic, and secretory. C-X-C motif chemokine receptor 2 (CXCR2) is a chemokine receptor known for its role during inflammation and its adverse role in PDAC. Oncogenic Kras upregulates CXCR2 and its ligands and, thus, contribute to tumor proliferation and immunosuppression. CXCR2 deletion in a PDAC syngeneic mouse model produced increased fibrosis revealing a potential undescribed role of CXCR2 in CAFs. In this study, we demonstrate that the oncogenic Kras-CXCR2 axis regulates the CAFs function in PDAC and contributes to CAFs heterogeneity. We observed that oncogenic Kras and CXCR2 signaling alter CAFs, producing a secretory CAF phenotype with low fibrogenic features; and increased secretion of pro-tumor cytokines and CXCR2 ligands, utilizing the NF-kappa B activity. Finally, using syngeneic mouse models, we demonstrate that oncogenic Kras is associated with secretory CAFs and that CXCR2 inhibition promotes activation of fibrotic cells (myofibroblasts) and impact tumors in a mutation-dependent manner.	[Awaji, Mohammad; Saxena, Sugandha; Wu, Lingyun; Prajapati, Dipakkumar R.; Purohit, Abhilasha; Varney, Michelle L.; Singh, Rakesh K.] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, 985900 Nebraska Med Ctr, Omaha, NE 68198 USA; [Awaji, Mohammad] King Fahad Specialist Hosp, Dept Pathol & Lab Med, Dammam, Saudi Arabia; [Kumar, Sushil; Rachagani, Satyanarayana; Jain, Maneesh; Batra, Surinder K.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Ly, Quan P.] Univ Nebraska Med Ctr, Dept Surg Oncol, Omaha, NE 68198 USA; [Varney, Michelle L.] Univ Nebraska Med Ctr, Dept Internal Med, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Singh, RK (corresponding author), Univ Nebraska Med Ctr, Dept Pathol & Microbiol, 985900 Nebraska Med Ctr, Omaha, NE 68198 USA.	rsingh@unmc.edu	Saxena, Sugandha/AAX-6646-2020; Prajapati, Dipakkumar R/AAH-7578-2021; Purohit, Abhilasha/AAM-3881-2021; Wu, Ling/GZN-2235-2022	Prajapati, Dipakkumar R/0000-0001-8954-890X; Purohit, Abhilasha/0000-0002-0792-6610; Saxena, Sugandha/0000-0003-4226-9318; Varney, Michelle/0000-0001-5339-2077	HHS | National Institutes of Health (NIH) [CA228525]	HHS | National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	HHS | National Institutes of Health (NIH), Grant/Award Number: CA228525	Apte MV, 2013, GASTROENTEROLOGY, V144, P1210, DOI 10.1053/j.gastro.2012.11.037; Baumgart S, 2014, CANCER DISCOV, V4, P688, DOI 10.1158/2159-8290.CD-13-0593; Bizzarri C, 2006, PHARMACOL THERAPEUT, V112, P139, DOI 10.1016/j.pharmthera.2006.04.002; Campbell PM, 2007, CANCER RES, V67, P2098, DOI 10.1158/0008-5472.CAN-06-3752; Chan TS, 2016, J EXP MED, V213, P2967, DOI 10.1084/jem.20151665; Chu GC, 2007, J CELL BIOCHEM, V101, P887, DOI 10.1002/jcb.21209; DiDonato JA, 2012, IMMUNOL REV, V246, P379, DOI 10.1111/j.1600-065X.2012.01099.x; Fesinmeyer MD, 2005, CANCER EPIDEM BIOMAR, V14, P1766, DOI 10.1158/1055-9965.EPI-05-0120; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hamada S, 2014, J GASTROENTEROL, V49, P605, DOI 10.1007/s00535-013-0915-x; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Highfill SL, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007974; Hruban RH, 2007, GASTROENTEROL CLIN N, V36, P831, DOI 10.1016/j.gtc.2007.08.012; Hruban RH, 2007, MODERN PATHOL, V20, pS61, DOI 10.1038/modpathol.3800685; Ijichi H, 2011, J CLIN INVEST, V121, P4106, DOI 10.1172/JCI42754; Ikenaga N, 2010, GASTROENTEROLOGY, V139, P1041, DOI 10.1053/j.gastro.2010.05.084; Kleeff J, 2007, INT J CANCER, V121, P699, DOI 10.1002/ijc.22871; Kumar V, 2017, CANCER CELL, V32, P654, DOI 10.1016/j.ccell.2017.10.005; Lawrenson K, 2010, NEOPLASIA, V12, P317, DOI 10.1593/neo.91948; Lesina M, 2016, J CLIN INVEST, V126, P2919, DOI 10.1172/JCI86477; Li AH, 2002, MICROVASC RES, V64, P476, DOI 10.1006/mvre.2002.2442; Ling JH, 2012, CANCER CELL, V21, P105, DOI 10.1016/j.ccr.2011.12.006; Maguer-Satta V, 2011, STEM CELLS, V29, P389, DOI 10.1002/stem.592; Mathison A, 2010, PANCREATOLOGY, V10, P505, DOI [10.1016/S1424-3903(10)80035-3, 10.1159/000320540]; Matsuo Y, 2012, CURR PHARM DESIGN, V18, P2416, DOI 10.2174/13816128112092416; McCarthy JB, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00048; Moir JAG, 2015, SURG ONCOL, V24, P232, DOI 10.1016/j.suronc.2015.05.002; Nagtegaal ID, 2020, HISTOPATHOLOGY, V76, P182, DOI 10.1111/his.13975; Ohlund D, 2014, J EXP MED, V211, P1503, DOI 10.1084/jem.20140692; Ozdemir BC, 2014, CANCER CELL, V25, P719, DOI 10.1016/j.ccr.2014.04.005; Ohlund D, 2017, J EXP MED, V214, P579, DOI 10.1084/jem.20162024; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Omary MB, 2007, J CLIN INVEST, V117, P50, DOI 10.1172/JCI30082; Parrinello S, 2005, J CELL SCI, V118, P485, DOI 10.1242/jcs.01635; Purohit A., 2015, THESIS; Purohit A, 2016, ONCOTARGET, V7, P7280, DOI 10.18632/oncotarget.6906; Rachagani S, 2011, BRIT J CANCER, V104, P1038, DOI 10.1038/bjc.2011.31; Rhim AD, 2014, CANCER CELL, V25, P735, DOI 10.1016/j.ccr.2014.04.021; Richmond A, 2002, NAT REV IMMUNOL, V2, P664, DOI 10.1038/nri887; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Singh S, 2009, CANCER RES, V69, P411, DOI 10.1158/0008-5472.CAN-08-3378; Steele CW, 2016, CANCER CELL, V29, P832, DOI 10.1016/j.ccell.2016.04.014; Strieter RM, 2006, EUR J CANCER, V42, P768, DOI 10.1016/j.ejca.2006.01.006; Su SC, 2018, CELL, V172, P841, DOI 10.1016/j.cell.2018.01.009; Suzuki A, 2015, CYTOKINE, V75, P79, DOI 10.1016/j.cyto.2015.05.026; Torres MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080580; Walana W, 2018, HUM IMMUNOL, V79, P809, DOI 10.1016/j.humimm.2018.08.007; Wang T, 2017, MOL CANCER RES, V15, P3, DOI 10.1158/1541-7786.MCR-16-0192; Wang Y, 2012, CURR MOL MED, V12, P331, DOI 10.2174/156652412799218868; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Wente MN, 2006, CANCER LETT, V241, P221, DOI 10.1016/j.canlet.2005.10.041	51	29	30	4	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9405	9418		10.1096/fj.201902990R	http://dx.doi.org/10.1096/fj.201902990R		MAY 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32453916	Green Accepted			2022-12-28	WOS:000535511500001
J	Bianchetto-Aguilera, F; Tamassia, N; Gasperini, S; Calzetti, F; Finotti, G; Gardiman, E; Montioli, R; Bresciani, D; Vermi, W; Cassatella, MA				Bianchetto-Aguilera, Francisco; Tamassia, Nicola; Gasperini, Sara; Calzetti, Federica; Finotti, Giulia; Gardiman, Elisa; Montioli, Riccardo; Bresciani, Debora; Vermi, William; Cassatella, Marco Antonio			Deciphering the fate of slan(+)-monocytes in human tonsils by gene expression profiling	FASEB JOURNAL			English	Article						blood; CD1c(+)DC; cDC2; classical; non-classical monocytes; gene expression; slan(+)-monocytes; tonsil	HUMAN DENDRITIC CELLS; 6-SULFO LACNAC; MONOCYTES REVEALS; HUMAN MACROPHAGES; APOPTOTIC CELLS; TRANSCRIPTION; CLEARANCE; RECEPTORS; SUBSET	Monocytic cells perform crucial homeostatic and defensive functions. However, their fate and characterization at the transcriptomic level in human tissues are partially understood, often as a consequence of the lack of specific markers allowing their unequivocal identification. The 6-sulfo LacNAc (slan) antigen identifies a subset of non-classical (NC) monocytes in the bloodstream, namely the slan(+)-monocytes. In recent studies, we and other groups have reported that, in tonsils, slan marks dendritic cell (DC)-like cells, as defined by morphological, phenotypical, and functional criteria. However, subsequent investigations in lymphomas have uncovered a significant heterogeneity of tumor-infiltrating slan(+)-cells, including a macrophage-like state. Based on their emerging role in tissue inflammation and cancer, herein we investigated slan(+)-cell fate in tonsils by using a molecular-based approach. Hence, RNA from tonsil slan(+)-cells, conventional CD1c(+)DCs (cDC2) and CD11b(+)CD14(+)-macrophages was subjected to gene expression analysis. For comparison, transcriptomes were also obtained from blood cDC2, classical (CL), intermediate (INT), NC, and slan(+)-monocytes. Data demonstrate that the main trajectory of human slan(+)-monocytes infiltrating the tonsil tissue is toward a macrophage-like population, displaying molecular features distinct from those of tonsil CD11b(+)CD14(+)-macrophages and cDC2. These findings provide a novel view on the terminal differentiation path of slan(+)-monocytes, which is relevant for inflammatory diseases and lymphomas.	[Bianchetto-Aguilera, Francisco; Tamassia, Nicola; Gasperini, Sara; Calzetti, Federica; Finotti, Giulia; Gardiman, Elisa; Cassatella, Marco Antonio] Univ Verona, Dept Med, Sect Gen Pathol, Str Le Grazie 8, Verona, Italy; [Montioli, Riccardo] Univ Verona, Dept Neurosci Biomed & Movement Sci, Verona, Italy; [Bresciani, Debora; Vermi, William] Univ Brescia, Dept Mol & Translat Med, Sect Pathol, Brescia, Italy; [Vermi, William] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA	University of Verona; University of Verona; University of Brescia; Washington University (WUSTL)	Tamassia, N; Cassatella, MA (corresponding author), Univ Verona, Dept Med, Sect Gen Pathol, Str Le Grazie 8, Verona, Italy.	nicola.tamassia@univr.it; marco.cassatella@univr.it	Cassatella, M A/B-8037-2013; Bianchetto Aguilera, Francisco Miguel Angel/GNW-3583-2022; Tamassia, Nicola/J-8621-2016; Gardiman, Elisa/ABD-6131-2021	Cassatella, M A/0000-0001-7824-1806; Bianchetto Aguilera, Francisco Miguel Angel/0000-0003-3910-4715; Tamassia, Nicola/0000-0003-2990-3003; Gardiman, Elisa/0000-0002-5431-9610	Associazione Italiana per la Ricerca sul Cancro [IG-20339]; Ministero dell'Istruzione, dell'Universita e della Ricerca [2015YYKPNN_002, 20177J4E75_004]; University of Verona	Associazione Italiana per la Ricerca sul Cancro; Ministero dell'Istruzione, dell'Universita e della Ricerca; University of Verona	Associazione Italiana per la Ricerca sul Cancro, Grant/Award Number: IG-20339; Ministero dell'Istruzione, dell'Universita e della Ricerca, Grant/Award Number: 2015YYKPNN_002 and 20177J4E75_004;University of Verona, Grant/Award Number: Ricerca di Base 2015	A-Gonzalez N, 2011, BBA-MOL BASIS DIS, V1812, P982, DOI 10.1016/j.bbadis.2010.12.015; Ahmad F, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00948; Ancuta P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-403; Aziz A, 2009, SCIENCE, V326, P867, DOI 10.1126/science.1176056; Brocheriou I, 2011, ATHEROSCLEROSIS, V214, P316, DOI 10.1016/j.atherosclerosis.2010.11.023; Calzetti F, 2018, J ALLERGY CLIN IMMUN, V141, P2276, DOI 10.1016/j.jaci.2017.12.988; CONSTANTIN G, 1994, FEBS LETT, V350, P66, DOI 10.1016/0014-5793(94)00735-7; Costantini C, 2011, BLOOD, V117, P1677, DOI 10.1182/blood-2010-06-287243; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; de Baey A, 2003, J IMMUNOL, V170, P5089, DOI 10.4049/jimmunol.170.10.5089; de Baey A, 2001, EUR J IMMUNOL, V31, P1646, DOI 10.1002/1521-4141(200106)31:6<1646::AID-IMMU1646>3.0.CO;2-X; Duque GA, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00491; Endreffy I, 2017, IMMUNOL RES, V65, P1025, DOI 10.1007/s12026-017-8943-x; Frankenberger M, 2012, EUR J IMMUNOL, V42, P957, DOI 10.1002/eji.201141907; Freese NH, 2016, BIOINFORMATICS, V32, P2089, DOI 10.1093/bioinformatics/btw069; Goudot C, 2017, IMMUNITY, V47, P582, DOI 10.1016/j.immuni.2017.08.016; Gren ST, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144351; Hansel A, 2013, J AUTOIMMUN, V40, P1, DOI 10.1016/j.jaut.2012.07.005; Hansel A, 2011, J ALLERGY CLIN IMMUN, V127, P787, DOI 10.1016/j.jaci.2010.12.009; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Hamers AAJ, 2019, ARTERIOSCL THROM VAS, V39, P25, DOI 10.1161/ATVBAHA.118.311022; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hofer TP, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02052; Hofer TP, 2015, BLOOD, V126, P2601, DOI 10.1182/blood-2015-06-651331; HOLNESS CL, 1993, BLOOD, V81, P1607; Ingersoll MA, 2010, BLOOD, V115, pE10, DOI 10.1182/blood-2009-07-235028; Italiani P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087680; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Tran MTN, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01711-0; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Micheletti A, 2016, ONCOTARGET, V7, P161, DOI 10.18632/oncotarget.6660; Mildner A, 2017, IMMUNITY, V46, P849, DOI 10.1016/j.immuni.2017.04.018; Murray PJ, 2017, ANNU REV PHYSIOL, V79, P541, DOI 10.1146/annurev-physiol-022516-034339; Olingy CE, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00477-1; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; PrabhuDas MR, 2017, J IMMUNOL, V198, P3775, DOI 10.4049/jimmunol.1700373; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Roszer T, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/816460; Schakel K, 2002, IMMUNITY, V17, P289, DOI 10.1016/S1074-7613(02)00393-X; Schmidl C, 2014, BLOOD, V123, pE90, DOI 10.1182/blood-2013-02-484188; Schnoor M, 2008, J IMMUNOL, V180, P5707, DOI 10.4049/jimmunol.180.8.5707; Segura E, 2013, IMMUNITY, V38, P336, DOI 10.1016/j.immuni.2012.10.018; Taylor PR, 2000, J EXP MED, V192, P359, DOI 10.1084/jem.192.3.359; Thielens NM, 2017, MOL IMMUNOL, V89, P73, DOI 10.1016/j.molimm.2017.05.025; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; van Leeuwen-Kerkhoff N, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01619; van Leeuwen-Kerkhoff N, 2017, J LEUKOCYTE BIOL, V102, P1055, DOI 10.1189/jlb.3MA0117-037R; Vandooren J, 2013, CRIT REV BIOCHEM MOL, V48, P222, DOI 10.3109/10409238.2013.770819; Vermi W, 2018, CANCER RES, V78, P3544, DOI 10.1158/0008-5472.CAN-17-2344; Vermi W, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4029; Villani AC, 2017, SCIENCE, V356, DOI 10.1126/science.aah4573; Wong KL, 2011, BLOOD, V118, pE15, DOI 10.1182/blood-2010-12-326355; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558; Zilionis R, 2019, IMMUNITY, V50, P1317, DOI 10.1016/j.immuni.2019.03.009; Zizzo G, 2012, J IMMUNOL, V189, P3508, DOI 10.4049/jimmunol.1200662	58	2	2	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9269	9284		10.1096/fj.202000181R	http://dx.doi.org/10.1096/fj.202000181R		MAY 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32413173				2022-12-28	WOS:000533182000001
J	Nadanaka, S; Hashiguchi, T; Kitagawa, H				Nadanaka, Satomi; Hashiguchi, Taishi; Kitagawa, Hiroshi			Aberrant glycosaminoglycan biosynthesis by tumor suppressor EXTL2 deficiency promotes liver inflammation and tumorigenesis through Toll-like 4 receptor signaling	FASEB JOURNAL			English	Article						glycosaminoglycan; inflammation; liver cancer; NF-kappaB (NF-kappa B); proteoglycans (PG)	HEPARAN-SULFATE BIOSYNTHESIS; GENE; EXPRESSION; BIGLYCAN; MEMBER; PROTEOGLYCANS; FAMILY; IDENTIFICATION; OBESITY; ROLES	Certain proteoglycans, consisting of a core protein and glycosaminoglycan (GAG) chains, are among the many types of biomolecules that can function as damage-associated molecular pattern molecules (DAMPs). We, therefore, hypothesized that the expression level and structural alteration of GAGs affect inflammation. We have previously reported that the effects on GAG biosynthesis caused by loss of the tumor suppressor gene exostosin-like 2 (Extl2) influence liver injury and regeneration processes. To examine how altered GAG biosynthesis may underscore the relationship between inflammation and tumorigenesis, we assessed its role in non-alcoholic steatohepatitis and hepatocarcinoma (HCC) induced by dietary obesity and insulin-resistance. We demonstrated that GAGs produced in the absence of EXTL2 act as DAMPs and directly input signals into cells via the Toll-like 4 receptor. In addition, the subsequent transcriptional activation of inflammatory and tumor-promoting cytokines by NF-kappa B contributes to injury- and inflammation-driven tumor promotion. Thus, dysregulated biosynthesis of GAGs is considered to increase the risk of HCC in a background of obesity and diabetes.	[Nadanaka, Satomi; Kitagawa, Hiroshi] Kobe Pharmaceut Univ, Lab Biochem, Kobe, Hyogo, Japan; [Hashiguchi, Taishi] SMC Labs Inc, Tokyo, Japan	Kobe Pharmaceutical University	Kitagawa, H (corresponding author), Kobe Pharmaceut Univ, Biochem Lab, Higashinada Ku, 4-19-1 Motoyamakita Machi, Kobe, Hyogo 6588558, Japan.	kitagawa@kobepharma-u.ac.jp	Kitagawa, Hiroshi/AAJ-1344-2020	Kitagawa, Hiroshi/0000-0002-9307-7079	Ministry of Education, Culture, Sports, Science, and Technology, Japan;  [JP23110003];  [JP16H05088];  [JP20H03386];  [JP25460080]	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; ; ; 	This work was supported in part by Grants-in-Aid for Scientific Research on Innovative Areas JP23110003 (to H. K.) and for Scientific Research (B) JP16H05088 and JP20H03386 (to H. K.) and (C) JP25460080 (to S. N.) and the Supported Program for the Strategic Research Foundation at Private Universities, 2012-2016 (to H. K.) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Afratis N, 2012, FEBS J, V279, P1177, DOI 10.1111/j.1742-4658.2012.08529.x; Babelova A, 2009, J BIOL CHEM, V284, P24035, DOI 10.1074/jbc.M109.014266; Dapito DH, 2012, CANCER CELL, V21, P504, DOI 10.1016/j.ccr.2012.02.007; Erridge C, 2010, J LEUKOCYTE BIOL, V87, P989, DOI 10.1189/jlb.1209775; Fujii M, 2013, MED MOL MORPHOL, V46, P141, DOI 10.1007/s00795-013-0016-1; Gordts PLSM, 2015, CYTOKINE, V72, P118, DOI 10.1016/j.cyto.2014.12.013; Gordts PLSM, 2014, CELL METAB, V20, P813, DOI 10.1016/j.cmet.2014.09.016; He MZ, 2018, MOL MED, V24, DOI 10.1186/s10020-018-0030-9; HEINEGAR.D, 1972, BIOCHIM BIOPHYS ACTA, V285, P193, DOI 10.1016/0005-2795(72)90191-2; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Jiang DH, 2006, CELL RES, V16, P693, DOI 10.1038/sj.cr.7310085; Kali A, 2014, INDIAN J PHARMACOL, V46, P579, DOI 10.4103/0253-7613.144891; Kazankov K, 2018, J PEDIATR GASTR NUTR, V67, P635, DOI 10.1097/MPG.0000000000002111; Kitagawa H, 1999, J BIOL CHEM, V274, P13933, DOI 10.1074/jbc.274.20.13933; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Lin X, 2000, DEV BIOL, V224, P299, DOI 10.1006/dbio.2000.9798; Mardinoglu A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4083; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Mikami T, 2013, BBA-GEN SUBJECTS, V1830, P4719, DOI 10.1016/j.bbagen.2013.06.006; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Nadanaka S, 1998, J BIOL CHEM, V273, P33728, DOI 10.1074/jbc.273.50.33728; Nadanaka S, 2008, J BIOCHEM, V144, P7, DOI 10.1093/jb/mvn040; Nadanaka S, 2008, J BIOL CHEM, V283, P27333, DOI 10.1074/jbc.M802997200; Nadanaka S, 2018, J BIOL CHEM, V293, P444, DOI 10.1074/jbc.M117.814509; Nadanaka S, 2013, BIOCHEM J, V454, P133, DOI 10.1042/BJ20130323; Nadanaka S, 2013, J BIOL CHEM, V288, P9321, DOI 10.1074/jbc.M112.416909; Nadanaka S, 2011, J BIOL CHEM, V286, P4199, DOI 10.1074/jbc.M110.155093; Nastase MV, 2012, J HISTOCHEM CYTOCHEM, V60, P963, DOI 10.1369/0022155412456380; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Purnomo E, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000405; Saito T, 1998, BIOCHEM BIOPH RES CO, V243, P61, DOI 10.1006/bbrc.1997.8062; Schaefer L, 2005, J CLIN INVEST, V115, P2223, DOI 10.1172/JCI23755; Schaefer L, 2001, FASEB J, V15, P559; Stickens D, 2005, DEVELOPMENT, V132, P5055, DOI 10.1242/dev.02088; Sugahara K, 2000, CURR OPIN STRUC BIOL, V10, P518, DOI 10.1016/S0959-440X(00)00125-1; Takahashi I, 2009, BIOCHEM BIOPH RES CO, V383, P113, DOI 10.1016/j.bbrc.2009.03.140; Thelin MA, 2012, CANCER RES, V72, P1943, DOI 10.1158/0008-5472.CAN-11-1351; Troegeler A, 2014, IMMUNOL CELL BIOL, V92, P699, DOI 10.1038/icb.2014.39; Wise CA, 1997, GENOME RES, V7, P10, DOI 10.1101/gr.7.1.10; Wuyts W, 1997, EUR J HUM GENET, V5, P382, DOI 10.1159/000484796	40	10	10	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8385	8401		10.1096/fj.201902076R	http://dx.doi.org/10.1096/fj.201902076R		APR 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32347583	Bronze			2022-12-28	WOS:000529982000001
J	Wang, D; Zeng, ZY; Zhang, SS; Xiong, F; He, BY; Wu, YF; Li, WM; Tang, L; Wei, F; Xiang, B; Li, Z; Zhou, YH; Zhou, M; Li, XL; Li, Y; Li, GY; Xiong, W; Guo, C				Wang, Dan; Zeng, Zhaoyang; Zhang, Shanshan; Xiong, Fang; He, Baoyu; Wu, Yingfen; Li, Weimin; Tang, Le; Wei, Fang; Xiang, Bo; Li, Zheng; Zhou, Yanhong; Zhou, Ming; Li, Xiaoling; Li, Yong; Li, Guiyuan; Xiong, Wei; Guo, Can			Epstein-Barr virus-encoded miR-BART6-3p inhibits cancer cell proliferation through the LOC553103-STMN1 axis	FASEB JOURNAL			English	Article						BART6-3p; Epstein-Barr virus; gastric cancer; nasopharyngeal carcinoma; Stathmin 1; tumor suppressor	NASOPHARYNGEAL CARCINOMA; EXPRESSION PROFILES; MICRORNA TARGETS; EMERGING ROLE; PROMOTES; STATHMIN; ROLES; METASTASIS; APOPTOSIS; RNA	Epstein-Barr virus (EBV) is a tumorigenic virus that can cause various human malignancies such as nasopharyngeal carcinoma (NPC) and gastric cancer (GC). EBV encodes 44 mature micro (mi)RNAs, mostly exhibiting oncogenic properties and promoting cancer progression. However, we have previously found that one EBV-encoded miRNA, namely EBV-miR-BART6-3p, acts as a tumor suppressor by inhibiting metastasis and invasion. Here, we report that EBV-miR-BART6-3p inhibits the proliferation of EBV-associated cancers, NPC, and GC, by targeting and downregulating a long non-coding RNA (lncRNA), LOC553103. Through proteomics analysis, we determined that stathmin (STMN1) is affected by EBV-miR-BART6-3p and LOC553103. Further, via RNA immunoprecipitation and luciferase reporter assay, we confirmed that LOC553103 directly binds and stabilizes the 3 ' UTR region of STMN1 mRNA. These results indicate that the EBV-miR-BART6-3p/LOC553103/STMN1 axis regulates the expression of cell cycle-associated proteins, which then inhibit EBV-associated tumor cell proliferation. These findings provide potential targets or strategies for novel EBV-related cancer treatments, as well as contributes new insights into the understanding of EBV infection-related carcinogenesis.	[Wang, Dan; Zeng, Zhaoyang; Xiong, Wei; Guo, Can] Cent South Univ, Xiangya Sch Med, Hunan Canc Hosp, NHC Key Lab Carcinogenesis, Changsha, Hunan, Peoples R China; [Wang, Dan; Zeng, Zhaoyang; Xiong, Wei; Guo, Can] Cent South Univ, Xiangya Sch Med, Affiliated Canc Hosp, NHC Key Lab Carcinogenesis, Changsha, Hunan, Peoples R China; [Wang, Dan; Zeng, Zhaoyang; He, Baoyu; Wu, Yingfen; Li, Weimin; Tang, Le; Wei, Fang; Xiang, Bo; Li, Zheng; Zhou, Yanhong; Zhou, Ming; Li, Xiaoling; Li, Guiyuan; Xiong, Wei; Guo, Can] Cent South Univ, Canc Res Inst, Chinese Minist Educ, Key Lab Carcinogenesis & Canc Invas, Changsha, Peoples R China; [Wang, Dan; Zeng, Zhaoyang; He, Baoyu; Wu, Yingfen; Li, Weimin; Tang, Le; Wei, Fang; Xiang, Bo; Li, Zheng; Zhou, Yanhong; Zhou, Ming; Li, Xiaoling; Li, Guiyuan; Xiong, Wei; Guo, Can] Cent South Univ, Sch Basic Med Sci, Changsha, Peoples R China; [Zhang, Shanshan; Xiong, Fang] Cent South Univ, Xiangya Hosp, Dept Stomatol, Changsha, Peoples R China; [Xiang, Bo; Li, Zheng; Zhou, Yanhong; Xiong, Wei] Cent South Univ, Xiangya Hosp 3, Dis Genome Res Ctr, Hunan Key Lab Nonresolving Inflammat & Canc, Changsha, Peoples R China; [Li, Yong] Baylor Coll Med, Dept Med, Dan L Duncan Comprehens Canc Ctr, Houston, TX 77030 USA	Central South University; Central South University; Central South University; Central South University; Central South University; Central South University; Baylor College of Medicine	Guo, C (corresponding author), Cent South Univ, Xiangya Sch Med, Hunan Canc Hosp, NHC Key Lab Carcinogenesis, Changsha, Hunan, Peoples R China.; Guo, C (corresponding author), Cent South Univ, Xiangya Sch Med, Affiliated Canc Hosp, NHC Key Lab Carcinogenesis, Changsha, Hunan, Peoples R China.	guocde@csu.edu.cn	li, xiao/GSN-6181-2022; li, xiaofeng/GXF-9442-2022	Li, Yong/0000-0001-8838-1714	National Natural Science Foundation of China [81972776, 81803025, 81903138, 81772928, 81872278, 81672993, 81702907, 81672683]; Overseas Expertise Introduction Project for Discipline Innovation [111-2-12]; Natural Science Foundation of Hunan Province [2017SK2105, 2018JJ3704, 2018JJ3815, 2018SK21210, 2018SK21211, 2019JJ50778]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Overseas Expertise Introduction Project for Discipline Innovation; Natural Science Foundation of Hunan Province(Natural Science Foundation of Hunan Province)	the National Natural Science Foundation of China, Grant/Award Number: 81972776, 81803025, 81903138, 81772928, 81872278, 81672993, 81803025, 81702907 and 81672683; the Overseas Expertise Introduction Project for Discipline Innovation, Grant/Award Number: 111 Project,No. 111-2-12; the Natural Science Foundation of Hunan Province, Grant/Award Number: 2017SK2105, 2018JJ3704, 2018JJ3815, 2018SK21210, 2018SK21211 and 2019JJ50778	Barth S, 2008, NUCLEIC ACIDS RES, V36, P666, DOI 10.1093/nar/gkm1080; Bellot G, 2007, CELL DEATH DIFFER, V14, P785, DOI 10.1038/sj.cdd.4402055; Bo H, 2018, J CANCER, V9, P4677, DOI 10.7150/jca.26461; Cai LM, 2015, ONCOGENE, V34, P2156, DOI 10.1038/onc.2014.341; Choi H, 2013, J VIROL, V87, P8135, DOI 10.1128/JVI.03159-12; Choy EYW, 2008, J EXP MED, V205, P2551, DOI 10.1084/jem.20072581; Coqueret O, 2003, TRENDS CELL BIOL, V13, P65, DOI 10.1016/S0962-8924(02)00043-0; Dolken L, 2010, CELL HOST MICROBE, V7, P324, DOI 10.1016/j.chom.2010.03.008; Duan SX, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-0956-8; Fan CM, 2019, J CANCER, V10, P3926, DOI 10.7150/jca.31345; Fan CM, 2019, CARCINOGENESIS, V40, P380, DOI 10.1093/carcin/bgy143; Fan CM, 2018, J CANCER, V9, P2852, DOI 10.7150/jca.25460; Ge JS, 2020, J CANCER, V11, P932, DOI 10.7150/jca.33105; Guo QW, 2010, MOL IMMUNOL, V47, P1783, DOI 10.1016/j.molimm.2010.02.017; He BY, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.253; He RF, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0614-1; He Y, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0265-y; Hsu CY, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003974; Jeon TY, 2010, BRIT J CANCER, V102, P710, DOI 10.1038/sj.bjc.6605537; Jiang XJ, 2019, MOL CANCER, V18, DOI 10.1186/s12943-018-0928-4; Jin K, 2019, CELL MOL LIFE SCI, V76, P4275, DOI 10.1007/s00018-019-03222-1; Johnston CM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040009; Kang D, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004979; Kim H, 2016, J VIROL, V90, P1359, DOI 10.1128/JVI.02794-15; Lian Y, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0918-9; Lu YJ, 2017, J INNATE IMMUN, V9, P574, DOI 10.1159/000479749; Lung RWM, 2013, INT J MOL SCI, V14, P17378, DOI 10.3390/ijms140917378; Maes E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061933; Mistry SJ, 2002, MT SINAI J MED, V69, P299; Mo YZ, 2019, J CANCER, V10, P3789, DOI 10.7150/jca.31166; Mo YZ, 2019, J CANCER, V10, P2342, DOI 10.7150/jca.30454; Ott M, 2009, CELL DEATH DIFFER, V16, P1075, DOI 10.1038/cdd.2009.61; Pandya D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136058; Peng M, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1055-6; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Ren DX, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-1144-6; Rodriguez A, 2001, J VIROL, V75, P4482, DOI 10.1128/JVI.75.10.4482-4489.2001; Rubin CI, 2004, J CELL BIOCHEM, V93, P242, DOI 10.1002/jcb.20187; Seto E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001063; Shinozaki-Ushiku A, 2015, J VIROL, V89, P5581, DOI 10.1128/JVI.03639-14; Song YL, 2016, ONCOTARGET, V7, P36783, DOI 10.18632/oncotarget.9170; Su D, 2009, CANCER-AM CANCER SOC, V115, P2453, DOI 10.1002/cncr.24282; Tu CF, 2018, CARCINOGENESIS, V39, P1517, DOI 10.1093/carcin/bgy108; Tu CF, 2017, J VIROL, V91, DOI 10.1128/JVI.00301-17; Vereide DT, 2014, ONCOGENE, V33, P1258, DOI 10.1038/onc.2013.71; Vetter NS, 2017, MOL CANCER RES, V15, P953, DOI 10.1158/1541-7786.MCR-16-0372; Wan XX, 2015, ONCOL REP, V34, P2585, DOI 10.3892/or.2015.4237; Wang D, 2020, CELL MOL LIFE SCI, V77, P2949, DOI 10.1007/s00018-020-03469-z; Wang FW, 2019, J CLIN INVEST, V129, P727, DOI 10.1172/JCI122478; Wang J, 2019, J BIOL CHEM, V294, P4854, DOI 10.1074/jbc.RA118.006853; Wang WX, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00609; Wang YA, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0913-y; Wei F, 2019, J CANCER, V10, P1145, DOI 10.7150/jca.29049; Wei F, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0409-0; Wu P, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-1147-3; Wu YF, 2019, J CANCER, V10, P2185, DOI 10.7150/jca.30222; Wu Y, 2014, CELL ONCOL, V37, P53, DOI 10.1007/s13402-013-0163-3; Xiao K, 2016, J CANCER, V7, P214, DOI 10.7150/jca.13150; Xiao L, 2019, CARCINOGENESIS, V40, P819, DOI 10.1093/carcin/bgz095; Xiong F, 2019, CHINESE MED J-PEKING, V132, P749, DOI 10.1097/CM9.0000000000000132; Yan QJ, 2015, ONCOTARGET, V6, P41766, DOI 10.18632/oncotarget.6155; Yang J, 2014, J PROTEOMICS, V109, P162, DOI 10.1016/j.jprot.2014.06.025; Zeng Z, 2016, CLIN TRANSL ONCOL, V18, P206, DOI 10.1007/s12094-015-1354-3; Zeng ZY, 2007, J CANCER RES CLIN, V133, P71, DOI 10.1007/s00432-006-0136-2; Zeng ZY, 2014, SCI CHINA LIFE SCI, V57, P315, DOI 10.1007/s11427-013-4577-y; Zhang YZ, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0796-y; Zhao J, 2020, CANCER LETT, V477, P131, DOI 10.1016/j.canlet.2020.02.010; Zheng X, 2018, J VIROL, V92, DOI 10.1128/JVI.01022-18; Zhong YX, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0827-8; Zhou BL, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00575	70	31	34	0	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8012	8027		10.1096/fj.202000039RR	http://dx.doi.org/10.1096/fj.202000039RR		APR 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32306460	Bronze			2022-12-28	WOS:000526960200001
J	Abou Daher, A; Francis, M; Azzam, P; Ahmad, A; Eid, AA; Fornoni, A; Marples, B; Zeidan, YH				Abou Daher, Alaa; Francis, Marina; Azzam, Patrick; Ahmad, Anis; Eid, Assaad A.; Fornoni, Alessia; Marples, Brian; Zeidan, Youssef H.			Modulation of radiation-induced damage of human glomerular endothelial cells by SMPDL3B	FASEB JOURNAL			English	Article						cancer; ceramide; glomerular endothelial cells; nephropathy; radioprotection; reactive oxygen species; SMPDL3b; sphingolipids	NADPH OXIDASE; OXIDATIVE STRESS; TRANSLATIONAL ASPECTS; PODOCYTE INJURY; ACTIVATION; APOPTOSIS; SURVIVAL; CERAMIDE-1-PHOSPHATE; PROLIFERATION; IRRADIATION	The intracellular molecular pathways involved in radiation-induced nephropathy are still poorly understood. Glomerular endothelial cells are key components of the structure and function of the glomerular filtration barrier but little is known about the mechanisms implicated in their injury and repair. The current study establishes the response of immortalized human glomerular endothelial cells (GEnC) to ionizing radiation (IR). We investigated the role of sphingolipids and the lipid-modifying enzyme sphingomyelin phosphodiesterase acid-like 3b (SMPDL3b) in radiation-induced GEnC damage. After delivering a single dose of radiation, long and very-long-chain ceramide species, and the expression levels of SMPDL3b were elevated. In contrast, levels of ceramide-1-phosphate (C1P) dropped in a time-dependent manner although mRNA and protein levels of ceramide kinase (CERK) remained stable. Treatment with C1P or knocking down SMPDL3b partially restored cell survival and conferred radioprotection. We also report a novel role for the NADPH oxidase enzymes (NOXs), namely NOX1, and NOX-derived reactive oxygen species (ROS) in radiation-induced GEnC damage. Subjecting cultured endothelial cells to radiation was associated with increased NOX activity and superoxide anion generation. Silencing NOX1 using NOX1-specific siRNA mitigated radiation-induced oxidative stress and cellular injury. In addition, we report a novel connection between NOX and SMPDL3b. Treatment with the NOX inhibitor, GKT, decreased radiation-induced cellular injury and restored SMPDL3b basal levels of expression. Our findings indicate the importance of SMPDL3b as a potential therapeutic target in radiation-induced kidney damage.	[Abou Daher, Alaa; Francis, Marina; Azzam, Patrick; Eid, Assaad A.] Amer Univ Beirut, Fac Med, Beirut, Lebanon; [Ahmad, Anis; Marples, Brian; Zeidan, Youssef H.] Univ Miami, Miller Sch Med, Sylvester Canc Ctr, Dept Radiat Oncol, Miami, FL 33136 USA; [Fornoni, Alessia] Univ Miami, Dept Med, Dept Med Peggy Harold Katz Family Div Nephrol & H, Div Nephrol, Miami, FL USA; [Zeidan, Youssef H.] Amer Univ Beirut, Dept Radiat Oncol, Beirut, Lebanon	American University of Beirut; University of Miami; University of Miami; American University of Beirut	Zeidan, YH (corresponding author), Amer Univ Beirut, Med Ctr, Dept Radiat Oncol, POB 11-0236, Beirut 11072020, Lebanon.	yz09@aub.edu.lb		fornoni, Alessia/0000-0002-1313-7773; Francis, Marina/0000-0001-7264-8111; Abou Daher, Alaa/0000-0002-1682-5707; Azzam, Patrick/0000-0002-1336-065X	National Institutes of Health (NIH) [1R01CA227493-01]; AUB MPP Award [320166]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AUB MPP Award	National Institutes of Health (NIH), Grant/Award Number: 1R01CA227493-01; AUB MPP Award, Grant/Award Number: 320166	Abou Daher A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122528; Ago T, 2005, STROKE, V36, P1040, DOI 10.1161/01.STR.0000163111.05825.0b; Ahmad A, 2017, FASEB J, V31, P771, DOI 10.1096/fj.201600618R; Azzam EI, 2002, CANCER RES, V62, P5436; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; CASSADY JR, 1995, INT J RADIAT ONCOL, V31, P1249, DOI 10.1016/0360-3016(94)00428-N; Coates PJ, 2005, J PATHOL, V205, P221, DOI 10.1002/path.1701; Cohen EP, 2003, SEMIN NEPHROL, V23, P486, DOI 10.1016/S0270-9295(03)00093-7; Collins-Underwood JR, 2008, FREE RADICAL BIO MED, V45, P929, DOI 10.1016/j.freeradbiomed.2008.06.024; Dawson LA, 2010, INT J RADIAT ONCOL, V76, pS108, DOI 10.1016/j.ijrobp.2009.02.089; Eid AA, 2010, J BIOL CHEM, V285, P37503, DOI 10.1074/jbc.M110.136796; Eid AA, 2009, DIABETES, V58, P1201, DOI 10.2337/db08-1536; Eid S, 2016, ANTIOXID REDOX SIGN, V25, P703, DOI 10.1089/ars.2015.6562; Fornoni A, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002231; Gangoiti P, 2008, CELL SIGNAL, V20, P726, DOI 10.1016/j.cellsig.2007.12.008; Gangoiti P, 2012, BIOCHIMIE, V94, P597, DOI 10.1016/j.biochi.2011.09.009; Gangoiti P, 2011, CELL SIGNAL, V23, P27, DOI 10.1016/j.cellsig.2010.08.001; Gomez-Munoz A, 2006, BBA-BIOMEMBRANES, V1758, P2049, DOI 10.1016/j.bbamem.2006.05.011; Gomez-Munoz A, 2010, ADV EXP MED BIOL, V688, P118; Hu TS, 2005, AM J PHYSIOL-RENAL, V289, pF816, DOI 10.1152/ajprenal.00024.2005; Kim JH, 2014, RADIAT ONCOL J, V32, P103, DOI 10.3857/roj.2014.32.3.103; Kobayashi S, 2004, EXP CELL RES, V300, P455, DOI 10.1016/j.yexcr.2004.07.023; LUXTON RW, 1961, LANCET, V2, P1221; Mallela SK, 2019, BBA-MOL CELL BIOL L, V1864, DOI 10.1016/j.bbalip.2019.158517; Merscher S, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00127; Miranda GE, 2011, INVEST OPHTH VIS SCI, V52, P6580, DOI 10.1167/iovs.10-7065; Mitra P, 2007, FEBS LETT, V581, P735, DOI 10.1016/j.febslet.2007.01.041; Mitrofanova A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10584-4; Mitrofanova A, 2019, AM J PHYSIOL-RENAL, V317, pF1241, DOI 10.1152/ajprenal.00379.2019; Presa N, 2020, BBA-MOL CELL BIOL L, V1865, DOI 10.1016/j.bbalip.2020.158630; Pullen N, 2016, KIDNEY INT, V89, P1211, DOI 10.1016/j.kint.2015.12.058; RILEY PA, 1994, INT J RADIAT BIOL, V65, P27, DOI 10.1080/09553009414550041; Robbins MEC, 2004, INT J RADIAT BIOL, V80, P251, DOI 10.1080/09553000410001692726; Satchell SC, 2006, KIDNEY INT, V69, P1633, DOI 10.1038/sj.ki.5000277; Sha H, 2016, ONCOTARGET, V7, P18825, DOI 10.18632/oncotarget.7939; Shin HK, 2004, CIRCULATION, V109, P1022, DOI 10.1161/01.CIR.0000117403.64398.53; STEWART FA, 1995, RADIAT RES, V143, P235, DOI 10.2307/3579208; Tateishi Y, 2008, BIOCHEM BIOPH RES CO, V366, P301, DOI 10.1016/j.bbrc.2007.11.039; Valencia A, 2008, J INVEST DERMATOL, V128, P214, DOI 10.1038/sj.jid.5700960; Van Laethem A, 2006, FREE RADICAL BIO MED, V41, P1361, DOI 10.1016/j.freeradbiomed.2006.07.007; Wahl P, 2016, AM J PHYSIOL-RENAL, V310, pF433, DOI 10.1152/ajprenal.00375.2015; Wang HJ, 2005, FREE RADICAL BIO MED, V38, P890, DOI 10.1016/j.freeradbiomed.2004.12.005; Yang GY, 2010, INT J RADIAT ONCOL, V78, P539, DOI 10.1016/j.ijrobp.2009.07.1744; Yang J, 2003, CARCINOGENESIS, V24, P1571, DOI 10.1093/carcin/bgg137; Yoo TH, 2015, J AM SOC NEPHROL, V26, P133, DOI 10.1681/ASN.2013111213; Zeidan YH, 2008, J CELL BIOL, V181, P335, DOI 10.1083/jcb.200705060; Zeidan YH, 2007, TRENDS MOL MED, V13, P327, DOI 10.1016/j.molmed.2007.06.002	48	8	8	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					7915	7926		10.1096/fj.201902179R	http://dx.doi.org/10.1096/fj.201902179R		APR 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32293077				2022-12-28	WOS:000526104200001
J	Ahn, J; Ha, TY; Ahn, J; Jung, CH; Seo, HD; Kim, MJ; Kim, YS; Jang, YJ				Ahn, Jisong; Ha, Tae Youl; Ahn, Jiyun; Jung, Chang Hwa; Seo, Hyo Deok; Kim, Min Jung; Kim, Young-Soo; Jang, Young Jin			Undaria pinnatifida extract feeding increases exercise endurance and skeletal muscle mass by promoting oxidative muscle remodeling in mice	FASEB JOURNAL			English	Article						fucoxanthin; mitochondria biogenesis; oxidative muscle remodeling; running endurance; Undaria pinnatifida	FIBER-TYPE; TRANSCRIPTIONAL COACTIVATOR; MITOCHONDRIAL BIOGENESIS; RECEPTOR-GAMMA; NUTRITIONAL-VALUE; MESSENGER-RNA; ERR-ALPHA; PGC-1-ALPHA; ANGIOGENESIS; FUCOXANTHIN	Dietary habits can alter the skeletal muscle performance and mass, and Undaria pinnatifida extracts are considered a potent candidate for improving the muscle mass and function. Therefore, in this study, we aimed to assess the effect of U pinnatifida extracts on exercise endurance and skeletal muscle mass. C57BL/6 mice were fed a 0.25% U pinnatifida extract-containing diet for 8 weeks. U pinnatifida extract-fed mice showed increased running distance, total running time, and extensor digitorum longus and gastrocnemius muscle weights. U pinnatifida extract supplementation upregulated the expression of myocyte enhancer factor 2C, oxidative muscle fiber markers such as myosin heavy chain 1 (MHC1), and oxidative biomarkers in the gastrocnemius muscles. Compared to the controls, U pinnatifida extract-fed mice showed larger mitochondria and increased gene and protein expression of molecules involved in mitochondrial biogenesis and oxidative phosphorylation, including nuclear respiratory factor 2 and mitochondrial transcription factor A. U pinnatifida extract supplementation also increased the mRNA expression of angiogenesis markers, including VEGFa, VEGFb, FGF1, angiopoietin 1, and angiopoietin 2, in the gastrocnemius muscles. Importantly, U pinnatifida extracts upregulated the estrogen-related receptor gamma and peroxisome proliferator-activated receptor gamma co-activator 1-alpha (PGC-1 alpha)/AMP-activated protein kinase (AMPK)/sirtuin 1 (SIRT1) networks, which are partially increased by fucoxanthin, hesperetin, and caffeic acid treatments. Collectively, U pinnatifida extracts enhance mitochondrial biogenesis, increase oxidative muscle fiber, and promote angiogenesis in skeletal muscles, resulting in improved exercise capacity and skeletal muscle mass. These effects are attributable to fucoxanthin, hesperetin, and caffeic acid, bioactive components of U pinnatifida extracts.	[Ahn, Jisong; Ha, Tae Youl; Ahn, Jiyun; Jung, Chang Hwa; Seo, Hyo Deok; Jang, Young Jin] Korea Food Res Inst, Nat Mat & Metab Res Grp, Wanju Gun 55365, South Korea; [Ahn, Jisong; Kim, Young-Soo] Chonbuk Natl Univ, Dept Food Sci & Technol, Jeonju Si, South Korea; [Ha, Tae Youl; Ahn, Jiyun; Jung, Chang Hwa] Univ Sci & Technol, Div Food Biotechnol, Daejeon, South Korea; [Kim, Min Jung] Korea Food Res Inst, Healthcare Res Grp, Wanju Gun, South Korea	Korea Food Research Institute (KFRI); Jeonbuk National University; University of Science & Technology (UST); Korea Food Research Institute (KFRI)	Jang, YJ (corresponding author), Korea Food Res Inst, Nat Mat & Metab Res Grp, Wanju Gun 55365, South Korea.	jyj616@kfri.re.kr	Jang, Young Jin/GLU-3087-2022; Jang, Young Jin/AAT-1192-2020		ISTK \ Korea Food Research Institute (KFRI)	ISTK \ Korea Food Research Institute (KFRI)	ISTK vertical bar Korea Food Research Institute (KFRI)	Amat R, 2009, J BIOL CHEM, V284, P21872, DOI 10.1074/jbc.M109.022749; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Bezaire V, 2005, FASEB J, V19, P977, DOI 10.1096/fj.04-2765fje; Biesemann N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27614-8; Bocanegra A, 2009, J MED FOOD, V12, P236, DOI 10.1089/jmf.2008.0151; Bogdanis GC, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00142; Brown EM, 2014, NUTR REV, V72, P205, DOI 10.1111/nure.12091; Canto C, 2010, CELL METAB, V11, P213, DOI 10.1016/j.cmet.2010.02.006; Chang YH, 2018, BIOCHEM BIOPH RES CO, V495, P197, DOI 10.1016/j.bbrc.2017.11.022; Chen YM, 2015, NUTRIENTS, V7, P239, DOI 10.3390/nu7010239; Chinsomboon J, 2009, P NATL ACAD SCI USA, V106, P21401, DOI 10.1073/pnas.0909131106; Cohen S, 2015, NAT REV DRUG DISCOV, V14, P58, DOI 10.1038/nrd4467; Craig DM, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00296; DeLisser HM, 1997, AM J PATHOL, V151, P671; Dufour CR, 2007, CELL METAB, V5, P345, DOI 10.1016/j.cmet.2007.03.007; Fan WW, 2018, CELL REP, V22, P2521, DOI 10.1016/j.celrep.2018.02.047; Fung A, 2013, FOOD CHEM, V136, P1055, DOI 10.1016/j.foodchem.2012.09.024; Granic A, 2019, NUTRIENTS, V11, DOI 10.3390/nu11040745; Grasa-Lopez A, 2016, MAR DRUGS, V14, DOI 10.3390/md14080148; Gray SR, 2018, CURR OPIN CLIN NUTR, V21, P104, DOI 10.1097/MCO.0000000000000441; Guridi M, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab3715; Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hashemi R, 2015, NUTRITION, V31, P97, DOI 10.1016/j.nut.2014.05.003; Horowitz JF, 2000, AM J CLIN NUTR, V72, p558S, DOI 10.1093/ajcn/72.2.558S; HOWALD H, 1985, PFLUG ARCH EUR J PHY, V403, P369, DOI 10.1007/BF00589248; Huss JM, 2002, J BIOL CHEM, V277, P40265, DOI 10.1074/jbc.M206324200; Jang YJ, 2019, MOL NUTR FOOD RES, V63, DOI 10.1002/mnfr.201801149; Jang YJ, 2018, FOOD FUNCT, V9, P1102, DOI [10.1039/c7fo01683b, 10.1039/C7FO01683B]; Jeon SM, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.81; Jiang QY, 2019, FOOD FUNCT, V10, P3334, DOI [10.1039/c8fo02518e, 10.1039/C8FO02518E]; Jones TE, 2003, AM J PHYSIOL-ENDOC M, V284, pE96, DOI 10.1152/ajpendo.00316.2002; Jornayvaz FR, 2010, ESSAYS BIOCHEM, V47, P69, DOI [10.1042/BSE0470069, 10.1042/bse0470069]; Kadar L, 2000, ANN NY ACAD SCI, V904, P584; Khan MNA, 2008, J ENVIRON BIOL, V29, P465; Kissane RWP, 2019, CURR OPIN PHYSIOL, V10, P193, DOI 10.1016/j.cophys.2019.06.005; Lan F, 2008, J BIOL CHEM, V283, P27628, DOI 10.1074/jbc.M805711200; Lange K. W., 2015, Food Science and Human Wellness, V4, P87, DOI 10.1016/j.fshw.2015.08.001; Lee MK, 2018, MAR DRUGS, V16, DOI 10.3390/md16090328; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Liu J, 2015, SCI CHINA LIFE SCI, V58, P321, DOI 10.1007/s11427-015-4833-4; MacArtain P, 2007, NUTR REV, V65, P535, DOI 10.1111/j.1753-4887.2007.tb00278.x; McGee SL, 2009, J PHYSIOL-LONDON, V587, P5951, DOI 10.1113/jphysiol.2009.181065; Medeiros DM, 2002, J BIOENERG BIOMEMBR, V34, P389, DOI 10.1023/A:1021206220851; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Narkar VA, 2011, CELL METAB, V13, P283, DOI 10.1016/j.cmet.2011.01.019; Park HJ, 2011, FOOD CHEM TOXICOL, V49, P727, DOI 10.1016/j.fct.2010.11.032; Pette D, 2000, MICROSC RES TECHNIQ, V50, P500, DOI 10.1002/1097-0029(20000915)50:6<500::AID-JEMT7>3.0.CO;2-7; Potthoff MJ, 2007, J CLIN INVEST, V117, P2459, DOI 10.1172/JCI31960; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Rangwala SM, 2010, J BIOL CHEM, V285, P22619, DOI 10.1074/jbc.M110.125401; REN JM, 1994, J BIOL CHEM, V269, P14396; ROMANUL FCA, 1965, ARCH NEUROL-CHICAGO, V12, P497, DOI 10.1001/archneur.1965.00460290053007; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101; Suetsuna K, 2004, J NUTR BIOCHEM, V15, P267, DOI 10.1016/j.jnutbio.2003.11.004; Taboada C, 2013, J SCI FOOD AGR, V93, P1863, DOI 10.1002/jsfa.5981; Thompson KD, 2004, PHYTOTHER RES, V18, P551, DOI 10.1002/ptr.1487; Tong T, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201800173; Trovato FM, 2018, NUTRIENTS, V10, DOI 10.3390/nu10020231; Tsuboyama-Kasaoka N, 1999, BIOCHEM BIOPH RES CO, V258, P187, DOI 10.1006/bbrc.1999.0617; Wang SK, 2014, J FUNCT BIOMATER, V5, P29, DOI 10.3390/jfb5020029; Wilson JM, 2012, J STRENGTH COND RES, V26, P1724, DOI 10.1519/JSC.0b013e318234eb6f; Wolfe RR, 2006, AM J CLIN NUTR, V84, P475, DOI 10.1093/ajcn/84.3.475; Wu H, 2000, EMBO J, V19, P1963, DOI 10.1093/emboj/19.9.1963; Wu MT, 2014, MAR DRUGS, V12, P964, DOI 10.3390/md12020964; Xu SY, 2017, MAR DRUGS, V15, DOI 10.3390/md15120388; Yan Z, 2011, J APPL PHYSIOL, V110, P264, DOI 10.1152/japplphysiol.00993.2010; Zhao Y, 2018, MAR DRUGS, V16, DOI 10.3390/md16090321; Zierath JR, 2004, PLOS BIOL, V2, P1523, DOI 10.1371/journal.pbio.0020348	71	8	8	2	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8068	8081		10.1096/fj.201902399RR	http://dx.doi.org/10.1096/fj.201902399RR		APR 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32293073				2022-12-28	WOS:000526104500001
J	Guzman-Ruiz, R; Tercero-Alcazar, C; Rabanal-Ruiz, Y; Diaz-Ruiz, A; El Bekay, R; Rangel-Zuniga, OA; Navarro-Ruiz, MC; Molero, L; Membrives, A; Ruiz-Rabelo, JF; Pandit, A; Lopez-Miranda, J; Tinahones, FJ; Malagon, MM				Guzman-Ruiz, Rocio; Tercero-Alcazar, Carmen; Rabanal-Ruiz, Yoana; Diaz-Ruiz, Alberto; El Bekay, Rajaa; Rangel-Zuniga, Oriol A.; Carmen Navarro-Ruiz, M.; Molero, Laura; Membrives, Antonio; Ruiz-Rabelo, Juan F.; Pandit, Abhay; Lopez-Miranda, Jose; Tinahones, Francisco J.; Malagon, Maria M.			Adipose tissue depot-specific intracellular and extracellular cues contributing to insulin resistance in obese individuals	FASEB JOURNAL			English	Article						3D culture; adipocytes; extracellular matrix; lipid droplets	FIBROSIS; ADIPOCYTE; LUMICAN; MATRIX; INFLAMMATION; METABOLISM; PROTEINS	Adipose tissue dysregulation in obesity strongly influences systemic metabolic homeostasis and is often linked to insulin resistance (IR). However, the molecular mechanisms underlying adipose tissue dysfunction in obesity are not fully understood. Herein, a proteomic analysis of subcutaneous (SC) and omental (OM) fat from lean subjects and obese individuals with different degrees of insulin sensitivity was performed to identify adipose tissue biomarkers related to obesity-associated metabolic disease. Our results suggest that dysregulation of both adipose tissue extracellular matrix (ECM) organization and intracellular trafficking processes may be associated with IR in obesity. Thus, abnormal accumulation of the small leucine-rich proteoglycan, lumican, as observed in SC fat of IR obese individuals, modifies collagen I organization, impairs adipogenesis and activates stress processes [endoplasmic reticulum and oxidative stress] in adipocytes. In OM fat, IR is associated with increased levels of the negative regulator of the Rab family of small GTPases, GDI2, which alters lipid storage in adipocytes by inhibiting insulin-stimulated binding of the Rab protein, Rab18, to lipid droplets. Together, these results indicate that lumican and GDI2 might play depot-dependent, pathogenic roles in obesity-associated IR. Our findings provide novel insights into the differential maladaptive responses of SC and OM adipose tissue linking obesity to IR.	[Guzman-Ruiz, Rocio; Tercero-Alcazar, Carmen; Rabanal-Ruiz, Yoana; Diaz-Ruiz, Alberto; Carmen Navarro-Ruiz, M.; Molero, Laura; Malagon, Maria M.] Univ Cordoba, Reina Sofia Univ Hosp, Inst Maimonides Invest Biomed Cordoba IMIBIC, Dept Cell Biol Physiol & Immunol, Cordoba, Spain; [Guzman-Ruiz, Rocio; Tercero-Alcazar, Carmen; Rabanal-Ruiz, Yoana; Diaz-Ruiz, Alberto; El Bekay, Rajaa; Rangel-Zuniga, Oriol A.; Carmen Navarro-Ruiz, M.; Molero, Laura; Lopez-Miranda, Jose; Tinahones, Francisco J.; Malagon, Maria M.] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CIBERobn, Madrid, Spain; [El Bekay, Rajaa] Univ Malaga, Hosp Reg Univ, Inst Invest Biomed Malaga IBIMA, Unidad Gest Clin Endocrinol & Nutr, Malaga, Spain; [Rangel-Zuniga, Oriol A.; Lopez-Miranda, Jose] Univ Cordoba, Reina Sofia Univ Hosp, Lipids & Atherosclerosis Unit, IMIBIC, Cordoba, Spain; [Membrives, Antonio; Ruiz-Rabelo, Juan F.] Reina Sofia Univ Hosp, IMIBIC, Secc Obesidad, Unidad Gest Clin Cirugia Gen & Digest, Cordoba, Spain; [Pandit, Abhay] Natl Univ Ireland, Ctr Res Med Devices CURAM, Galway, Ireland; [Tinahones, Francisco J.] Univ Malaga, Virgen de la Victoria Hosp IBIMA, Dept Endocrinol & Nutr, Malaga, Spain	Universidad de Cordoba; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Universidad de Malaga; Universidad de Cordoba; Ollscoil na Gaillimhe-University of Galway; Universidad de Malaga	Guzman-Ruiz, R; Malagon, MM (corresponding author), Univ Cordoba, Reina Sofia Univ Hosp, Dept Cell Biol Physiol & Immunol, IMIBIC, Cordoba 14004, Spain.	bc2gurur@uco.es; bc1mapom@uco.es	El Bekay, RAJAA/AGN-6069-2022; Pandit, Abhay/B-6187-2008; Malagon, Maria M/L-5386-2014; Rabanal, Yoana/R-9471-2019; Bekay, Rajaa El/AAZ-3959-2020	El Bekay, RAJAA/0000-0003-3332-3431; Pandit, Abhay/0000-0002-6292-4933; Malagon, Maria M/0000-0002-2419-2727; Rabanal, Yoana/0000-0003-1904-8218; Rangel-Zuniga, Oriol Alberto/0000-0003-3495-5705; Tinahones, Francisco J/0000-0001-6871-4403; Diaz-Ruiz, Alberto/0000-0002-0488-4216	Ministerio de Ciencia, Innovacion y Universidades/FEDER [BFU2013-44229-R, BFU201676711-R, BFU2017-90578]; Consejeria de Salud y Bienestar Social [PI-0200/2013, PI-0159-2016]; Instituto de Salud Carlos III [PIE14/00005]; Science Foundation Ireland [13/RC/2073]	Ministerio de Ciencia, Innovacion y Universidades/FEDER; Consejeria de Salud y Bienestar Social; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	Funding information Ministerio de Ciencia, Innovacion y Universidades/FEDER, Grant/Award Number: BFU2013-44229-R, BFU201676711-R and BFU2017-90578; Consejeria de Salud y Bienestar Social, Grant/Award Number: PI-0200/2013 and PI-0159-2016; Instituto de Salud Carlos III, Grant/Award Number: PIE14/00005; Science Foundation Ireland, Grant/Award Number: 13/RC/2073	Asterholm IW, 2016, OBESITY, V24, P552, DOI 10.1002/oby.21430; Brezillon S, 2013, FEBS J, V280, P2369, DOI 10.1111/febs.12210; Carobbio S, 2017, ADV EXP MED BIOL, V960, P161, DOI 10.1007/978-3-319-48382-5_7; Cefalu WT, 2019, DIABETES CARE, V42, pS13, DOI 10.2337/dc19-S002; Chouchani ET, 2019, NAT METAB, V1, P189, DOI 10.1038/s42255-018-0021-8; Christensen G, 2019, MATRIX BIOL, V75-76, P286, DOI 10.1016/j.matbio.2018.01.001; Crewe C, 2017, J CLIN INVEST, V127, P74, DOI 10.1172/JCI88883; Dankel SN, 2014, OBESITY, V22, P1807, DOI 10.1002/oby.20758; Datta R, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.122289; Decaris ML, 2017, HEPATOLOGY, V65, P78, DOI 10.1002/hep.28860; Diaz-Ruiz A, 2015, ANTIOXID REDOX SIGN, V23, P597, DOI 10.1089/ars.2014.5939; Divoux A, 2010, DIABETES, V59, P2817, DOI 10.2337/db10-0585; Faerch K, 2008, DIABETOLOGIA, V51, P853, DOI 10.1007/s00125-008-0951-x; Friesen M, 2019, TRENDS ENDOCRIN MET, V30, P396, DOI 10.1016/j.tem.2019.03.002; Gavriljuk K, 2013, P NATL ACAD SCI USA, V110, P13380, DOI 10.1073/pnas.1307655110; Gray JL, 2020, ANGEW CHEM INT EDIT, V59, P6342, DOI 10.1002/anie.201900585; Guglielmi V, 2015, NUTR DIABETES, V5, DOI 10.1038/nutd.2015.22; Guzman-Ruiz R, 2014, INT J OBESITY, V38, P1545, DOI 10.1038/ijo.2014.36; Heindryckx F, 2018, MATRIX BIOL, V68-69, P589, DOI 10.1016/j.matbio.2018.01.015; Henegar C, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r14; Hultgardh-Nilsson A, 2015, J INTERN MED, V278, P447, DOI 10.1111/joim.12400; Jose Tinahones Francisco, 2012, BMC Physiology, V12, P4, DOI 10.1186/1472-6793-12-4; Khan T, 2009, MOL CELL BIOL, V29, P1575, DOI 10.1128/MCB.01300-08; Konige M, 2014, BBA-MOL BASIS DIS, V1842, P393, DOI 10.1016/j.bbadis.2013.05.007; Krishnan A, 2012, LAB INVEST, V92, P1712, DOI 10.1038/labinvest.2012.121; Lackey DE, 2014, AM J PHYSIOL-ENDOC M, V306, pE233, DOI 10.1152/ajpendo.00476.2013; Lakra R, 2015, BIOMED MATER, V10, DOI 10.1088/1748-6041/10/6/065015; Lamber EP, 2019, CURR OPIN CELL BIOL, V59, P34, DOI 10.1016/j.ceb.2019.03.004; Moreno-Castellanos N, 2017, DIABETOLOGIA, V60, P324, DOI 10.1007/s00125-016-4155-5; Moreno-Castellanos N, 2016, OBES SURG, V26, P1757, DOI 10.1007/s11695-015-1995-x; Muir LA, 2016, OBESITY, V24, P597, DOI 10.1002/oby.21377; Muller Matthias P, 2018, Small GTPases, V9, P5, DOI 10.1080/21541248.2016.1276999; Pasarica M, 2009, J CLIN ENDOCR METAB, V94, P5155, DOI 10.1210/jc.2009-0947; Pulido MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022931; Rodriguez A, 2012, DIABETOLOGIA, V55, P3038, DOI 10.1007/s00125-012-2671-5; Rodriguez A, 2015, AM J PHYSIOL-ENDOC M, V309, pE691, DOI 10.1152/ajpendo.00297.2015; Sugiura A, 2014, EMBO J, V33, P2142, DOI 10.15252/embj.201488104; Sun K, 2013, CELL METAB, V18, P470, DOI 10.1016/j.cmet.2013.06.016; Theocharis AD, 2019, FEBS J, V286, P2830, DOI 10.1111/febs.14818; Theocharis AD, 2019, MATRIX BIOL, V75-76, P220, DOI 10.1016/j.matbio.2017.10.008; Vakaloglou KM, 2016, CELL REP, V14, P2668, DOI 10.1016/j.celrep.2016.02.052; Vila IK, 2014, CELL REP, V7, P1116, DOI 10.1016/j.celrep.2014.03.062; Williams AS, 2015, TRENDS ENDOCRIN MET, V26, P357, DOI 10.1016/j.tem.2015.05.006; Wolff G, 2019, MOL METAB, V19, P97, DOI 10.1016/j.molmet.2018.10.007; Xu SM, 2018, BBA-MOL BASIS DIS, V1864, P1968, DOI 10.1016/j.bbadis.2017.07.019; Yamamoto T, 2012, CANCER LETT, V320, P31, DOI 10.1016/j.canlet.2012.01.023; Yamashita Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25635-x; Zeltz C, 2016, J CELL SCI, V129, P653, DOI 10.1242/jcs.180992; Zhen Y, 2015, J CELL SCI, V128, P3171, DOI 10.1242/jcs.166074; Zong HH, 2009, J BIOL CHEM, V284, P4679, DOI 10.1074/jbc.M807408200	51	17	17	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					7520	7539		10.1096/fj.201902703R	http://dx.doi.org/10.1096/fj.201902703R		APR 2020	20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32293066	Green Published, hybrid			2022-12-28	WOS:000526102600001
J	Pan, XM; Jiang, B; Wu, X; Xu, HD; Cao, SR; Bai, N; Li, XM; Yi, F; Guo, QQ; Guo, WD; Song, XY; Meng, F; Li, XN; Liu, Y; Cao, L				Pan, Xumeng; Jiang, Bo; Wu, Xuan; Xu, Hongde; Cao, Sunrun; Bai, Ning; Li, Xiaoman; Yi, Fei; Guo, Qiqiang; Guo, Wendong; Song, Xiaoyu; Meng, Fang; Li, Xining; Liu, Yi; Cao, Liu			Accumulation of prelamin A induces premature aging through mTOR overactivation	FASEB JOURNAL			English	Article						HGPS; prelamin A; premature aging; progerin; Zmpste24	LIFE-SPAN; MOUSE MODEL; FARNESYLTRANSFERASE INHIBITOR; AMELIORATES DISEASE; PROGERIA; LAMIN; AUTOPHAGY; TOR; RAPAMYCIN; DEFICIENT	Hutchinson-Gilford progeria syndrome (HGPS) arises when a truncated form of farnesylated prelamin A accumulates at the nuclear envelope, leading to misshapen nuclei. Previous studies of adult Zmpste24-deficient mice, a mouse model of progeria, have reported a metabolic response involving inhibition of the mTOR (mammalian target of rapamycin) kinase and activation of autophagy. However, exactly how mTOR or autophagy is involved in progeria remains unclear. Here, we investigate this question by crossing Zmpste24(+/-) mice with mice hypomorphic in mTOR (mTOR(o/+)), or mice heterozygous in autophagy-related gene 7 (Atg7(+/-)). We find that accumulation of prelamin A induces premature aging through mTOR overactivation and impaired autophagy in newborn Zmpste24(-/-) mice. Zmpste24(-/-) mice with genetically reduced mTOR activity, but not heterozygosity in Atg7, show extended lifespan. Moreover, mTOR inhibition partially restores autophagy and S6K1 activity. We also show that progerin interacts with the Akt phosphatase to promote full activation of the Akt/mTOR signaling pathway. Finally, although we find that genetic reduction of mTOR postpones premature aging in Zmpste24 KO mice, frequent embryonic lethality occurs. Together, our findings show that over-activated mTOR contributes to premature aging in Zmpste24(-/-) mice, and suggest a potential strategy in treating HGPS patients with mTOR inhibitors.	[Pan, Xumeng; Liu, Yi] China Med Univ, Sch Stomatol, Shenyang, Peoples R China; [Jiang, Bo; Wu, Xuan; Xu, Hongde; Cao, Sunrun; Bai, Ning; Li, Xiaoman; Yi, Fei; Guo, Qiqiang; Guo, Wendong; Song, Xiaoyu; Meng, Fang; Cao, Liu] China Med Univ, Inst Translat Med, Key Lab Cell Biol, Minist Publ Hlth, 77 Puhe Rd, Shenyang 110122, Liaoning, Peoples R China; [Jiang, Bo; Wu, Xuan; Xu, Hongde; Cao, Sunrun; Bai, Ning; Li, Xiaoman; Yi, Fei; Guo, Qiqiang; Guo, Wendong; Song, Xiaoyu; Meng, Fang; Cao, Liu] China Med Univ, Key Lab Med Cell Biol, Minist Educ, Liaoning Prov Collaborat Innovat Ctr Aging Relate, 77 Puhe Rd, Shenyang 110122, Liaoning, Peoples R China; [Li, Xining] Huzhou Univ, Dept Pathol, Huzhou, Peoples R China	China Medical University; China Medical University; China Medical University; Huzhou University	Liu, Y (corresponding author), China Med Univ, Sch Stomatol, Shenyang, Peoples R China.; Jiang, B; Cao, L (corresponding author), China Med Univ, Inst Translat Med, Key Lab Cell Biol, Minist Publ Hlth, 77 Puhe Rd, Shenyang 110122, Liaoning, Peoples R China.; Jiang, B; Cao, L (corresponding author), China Med Univ, Key Lab Med Cell Biol, Minist Educ, Liaoning Prov Collaborat Innovat Ctr Aging Relate, 77 Puhe Rd, Shenyang 110122, Liaoning, Peoples R China.	bjiang@cmu.edu.cn; liuyi@cmu.edu.cn; lcao@cmu.edu.cn			National Key Ramp;amp;D Program of China [2016YFC1302400]; Ministry of Education Innovation Team Development Plan [IRT13101/17R107]; China Postdoctoral Science Foundation [2019M651167]; Natural Science Foundation of Liaoning Province [201601126]	National Key Ramp;amp;D Program of China; Ministry of Education Innovation Team Development Plan; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Natural Science Foundation of Liaoning Province(Natural Science Foundation of Liaoning Province)	National Key R & D Program of China, Grant/Award Number: 2016YFC1302400; Ministry of Education Innovation Team Development Plan, Grant/Award Number: IRT13101/17R107; China Postdoctoral Science Foundation, Grant/Award Number: 2019M651167; Natural Science Foundation of Liaoning Province, Grant/Award Number: 20180550809; Natural Science Foundation of Liaoning Province, Grant/Award Number: 201601126	Abraham RT, 2002, CELL, V111, P9, DOI 10.1016/S0092-8674(02)01009-7; Bergo MO, 2002, P NATL ACAD SCI USA, V99, P13049, DOI 10.1073/pnas.192460799; Bjedov I, 2010, CELL METAB, V11, P35, DOI 10.1016/j.cmet.2009.11.010; Cao K, 2007, P NATL ACAD SCI USA, V104, P4949, DOI 10.1073/pnas.0611640104; Cao K, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002346; Cenni V, 2008, J PROTEOME RES, V7, P4727, DOI 10.1021/pr800262g; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; Dechat T, 2007, P NATL ACAD SCI USA, V104, P4955, DOI 10.1073/pnas.0700854104; DuBose AJ, 2018, P NATL ACAD SCI USA, V115, P4206, DOI 10.1073/pnas.1802811115; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Fernandez AF, 2018, NATURE, V558, P136, DOI 10.1038/s41586-018-0162-7; Fong LG, 2006, SCIENCE, V311, P1621, DOI 10.1126/science.1124875; Gangloff YG, 2004, MOL CELL BIOL, V24, P9508, DOI 10.1128/MCB.24.21.9508-9516.2004; Goldman RD, 2004, P NATL ACAD SCI USA, V101, P8963, DOI 10.1073/pnas.0402943101; Gordon LB, 2014, CELL, V156, P400, DOI 10.1016/j.cell.2013.12.028; Gordon LB, 2012, P NATL ACAD SCI USA, V109, P16666, DOI 10.1073/pnas.1202529109; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Ibrahim MX, 2013, SCIENCE, V340, P1330, DOI 10.1126/science.1238880; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Liu BH, 2005, NAT MED, V11, P780, DOI 10.1038/nm1266; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Marino G, 2008, HUM MOL GENET, V17, P2196, DOI 10.1093/hmg/ddn120; Merideth MA, 2008, NEW ENGL J MED, V358, P592, DOI 10.1056/NEJMoa0706898; Meta M, 2006, TRENDS MOL MED, V12, P480, DOI 10.1016/j.molmed.2006.08.006; Oldham S, 2003, TRENDS CELL BIOL, V13, P79, DOI 10.1016/S0962-8924(02)00042-9; Osorio FG, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002847; Pendas AM, 2002, NAT GENET, V31, P94, DOI 10.1038/ng871; Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168; Scaffidi P, 2005, NAT MED, V11, P440, DOI 10.1038/nm1204; Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221; Toth JI, 2005, P NATL ACAD SCI USA, V102, P12873, DOI 10.1073/pnas.0505767102; Varela I, 2005, NATURE, V437, P564, DOI 10.1038/nature04019; Varela I, 2008, NAT MED, V14, P767, DOI 10.1038/nm1786; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; Wu JJ, 2013, CELL REP, V4, P913, DOI 10.1016/j.celrep.2013.07.030; Xiao FH, 2018, GENOME RES, V28, P1601, DOI 10.1101/gr.220780.117; Zhang SL, 2011, BLOOD, V117, P1228, DOI 10.1182/blood-2010-05-287821	43	7	7	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					7905	7914		10.1096/fj.201903048RR	http://dx.doi.org/10.1096/fj.201903048RR		APR 2020	10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32282093				2022-12-28	WOS:000526116200001
J	Su, YC; Huang, YF; Wu, YW; Chen, HF; Wu, YH; Hsu, CC; Hsu, YC; Lee, JC				Su, Yu-Chieh; Huang, Yi-Fang; Wu, Yu-Wen; Chen, Hui-Feng; Wu, Yu-Hsuan; Hsu, Chia-Chun; Hsu, Yao-Chin; Lee, Jin-Ching			MicroRNA-155 inhibits dengue virus replication by inducing heme oxygenase-1-mediated antiviral interferon responses	FASEB JOURNAL			English	Article						dengue virus; heme oxygenase-1; interferon; microRNA; protease	OXIDATIVE STRESS; INNATE IMMUNITY; OXYGENASE 1; INFLAMMATION; ACTIVATION; GENE; NRF2; MODULATION; BACH1	MicroRNAs (miRNAs) have been reported to directly alter the virus life cycle and virus-host interactions, and so are considered promising molecules for controlling virus infection. In the present study, we observed that miR-155 time-dependently downregulated upon dengue virus (DENV) infection. In contrast, exogenous overexpression of miR-155 appeared to limit viral replication in vitro, suggesting that the low levels of miR-155 would be beneficial for DENV replication. In vivo, overexpression of miR-155 protected ICR suckling mice from the life-threatening effects of DENV infection and reduced virus propagation. Further investigation revealed that the anti-DENV activity of miR-155 was due to target Bach1, resulting in the induction of the heme oxygenase-1 (HO-1)-mediated inhibition of DENV NS2B/NS3 protease activity, ultimately leading to induction of antiviral interferon responses, including interferon-induced protein kinase R (PKR), 2 '-5 '-oligoadenylate synthetase 1 (OAS1), OAS2, and OAS3 expression, against DENV replication. Collectively, our results provide a promising new strategy to manage DENV infection by modulation of miR-155 expression.	[Su, Yu-Chieh] E Da Hosp, Dept Internal Med, Div Hematol Oncol, Kaohsiung, Taiwan; [Su, Yu-Chieh] I Shou Univ, Sch Med, Kaohsiung, Taiwan; [Huang, Yi-Fang; Wu, Yu-Wen; Chen, Hui-Feng; Wu, Yu-Hsuan; Hsu, Chia-Chun; Lee, Jin-Ching] Kaohsiung Med Univ, Coll Life Sci, Dept Biotechnol, 100,Shih Chuan 1st Rd, Kaohsiung 807, Taiwan; [Hsu, Yao-Chin] Chi Mei Med Ctr, Dept Chinese Med, Tainan, Taiwan; [Lee, Jin-Ching] Kaohsiung Med Univ, Drug Dev & Value Creat Res Ctr, Kaohsiung, Taiwan; [Lee, Jin-Ching] Kaohsiung Med Univ, Coll Pharm, Coll Med, Grad Inst Med, Kaohsiung, Taiwan; [Lee, Jin-Ching] Kaohsiung Med Univ, Coll Pharm, Grad Inst Nat Prod, Kaohsiung, Taiwan; [Lee, Jin-Ching] Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung, Taiwan; [Lee, Jin-Ching] Natl Sun Yat Sen Univ, Dept Marine Biotechnol & Resources, Kaohsiung, Taiwan	E-Da Hospital; I Shou University; Kaohsiung Medical University; Chi Mei Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; National Sun Yat Sen University	Hsu, YC; Lee, JC (corresponding author), Kaohsiung Med Univ, Coll Life Sci, Dept Biotechnol, 100,Shih Chuan 1st Rd, Kaohsiung 807, Taiwan.	cmh7100@mail.chimei.org.tw; jclee@kmu.edu.tw		Lee, Jin-Ching/0000-0003-0729-9589	Ministry of Sciences and Technology of Taiwan [MOST107-2311-B-037-005-MY3]; Chi-Mei Medical Center [107CM-KMU-03, 108CM-KMU-13]; Kaohsiung Medical University Research Foundation [107CM-KMU-03, 108CM-KMU-13]	Ministry of Sciences and Technology of Taiwan; Chi-Mei Medical Center; Kaohsiung Medical University Research Foundation	Ministry of Sciences and Technology of Taiwan, Grant/Award Number: MOST107-2311-B-037-005-MY3; Chi-Mei Medical Center and Kaohsiung Medical University Research Foundation, Grant/Award Number: 107CM-KMU-03 and 108CM-KMU-13	Abed DA, 2015, ACTA PHARM SIN B, V5, P285, DOI 10.1016/j.apsb.2015.05.008; Bao LP, 2018, INT IMMUNOPHARMACOL, V54, P245, DOI 10.1016/j.intimp.2017.11.021; Chahal J, 2019, NUCLEIC ACIDS RES, V47, P5307, DOI 10.1093/nar/gkz194; Chen WC, 2019, J VIRAL HEPATITIS, V26, P655, DOI 10.1111/jvh.13072; Chen YN, 2011, FASEB J, V25, P4511, DOI 10.1096/fj.11-187781; Deramaudt TB, 2013, MED MALADIES INFECT, V43, P100, DOI 10.1016/j.medmal.2013.02.004; Dundar HZ, 2019, TRANSPL P, V51, P1157, DOI 10.1016/j.transproceed.2019.01.089; Ekiz HA, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.126543; Escalera-Cueto M, 2015, VIRUS RES, V196, P105, DOI 10.1016/j.virusres.2014.11.010; Espinoza JA, 2017, AM J PATHOL, V187, P487, DOI 10.1016/j.ajpath.2016.11.011; Green AM, 2014, J MOL BIOL, V426, P1148, DOI 10.1016/j.jmb.2013.11.023; Guo YW, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00125; Guzman MG, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.55; Halsey ES, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001638; Hill-Kapturczak N, 2003, AM J PHYSIOL-RENAL, V285, pF515, DOI 10.1152/ajprenal.00137.2003; Hsin JP, 2018, NAT IMMUNOL, V19, P1137, DOI 10.1038/s41590-018-0208-x; Huang J, 2014, VIROLOGY, V456, P319, DOI 10.1016/j.virol.2014.03.032; Koliaraki V, 2011, ADV EXP MED BIOL, V780, P101, DOI 10.1007/978-1-4419-5632-3_9; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; Kupczyk Maciej, 2014, Pneumonol Alergol Pol, V82, P183, DOI 10.5603/PiAP.2014.0024; Lee JW, 2014, MOL CELL BIOCHEM, V390, P143, DOI 10.1007/s11010-014-1965-y; Lee JC, 2015, ANTIVIR RES, V116, P1, DOI 10.1016/j.antiviral.2015.01.002; Lee JC, 2014, BRIT J PHARMACOL, V171, P237, DOI 10.1111/bph.12440; Lehmann E, 2010, HEPATOLOGY, V51, P398, DOI 10.1002/hep.23339; Ma ZQ, 2017, J GEN VIROL, V98, P2982, DOI 10.1099/jgv.0.000955; Maarouf M, 2019, CELL MICROBIOL, V21, DOI 10.1111/cmi.13036; Monroy-Arreola A, 2018, CHEM RES TOXICOL, V31, P454, DOI 10.1021/acs.chemrestox.7b00330; Morris G, 2016, MOL NEUROBIOL, V53, P1195, DOI 10.1007/s12035-015-9090-9; Navarro E, 2017, ANTIOXID REDOX SIGN, V27, P93, DOI 10.1089/ars.2016.6698; Ng JKW, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004031; Paine A, 2010, BIOCHEM PHARMACOL, V80, P1895, DOI 10.1016/j.bcp.2010.07.014; Pareek S, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-97; Pereira MLM, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00161; Pulkkinen KH, 2011, FREE RADICAL BIO MED, V51, P2124, DOI 10.1016/j.freeradbiomed.2011.09.014; Saiki H, 2017, AM J PHYSIOL-HEART C, V313, pH392, DOI 10.1152/ajpheart.00124.2017; Seet RCS, 2009, FREE RADICAL BIO MED, V47, P375, DOI 10.1016/j.freeradbiomed.2009.04.035; Shan Y, 2006, FASEB J, V20, P2651, DOI 10.1096/fj.06-6346fje; Swaminathan G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002937; Origassa CST, 2013, WORLD J HEPATOL, V5, P541, DOI 10.4254/wjh.v5.i10.541; Trobaugh DW, 2017, TRENDS MOL MED, V23, P80, DOI 10.1016/j.molmed.2016.11.003; Tseng CH, 2016, SCI REP-UK, V6, DOI 10.1038/srep20701; Wang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055407; Wang ZQ, 2019, EPIGENETICS-US, V14, P494, DOI 10.1080/15592294.2019.1600388; Wu N, 2014, MICROBES INFECT, V16, P911, DOI 10.1016/j.micinf.2014.08.011; Wu YX, 2018, J IMMUNOL RES, V2018, DOI 10.1155/2018/6249085; Xia GT, 2018, CAN J PHYSIOL PHARM, V96, P1293, DOI 10.1139/cjpp-2018-0467; Xiao SQ, 2015, J VIROL, V89, P4494, DOI 10.1128/JVI.02810-14; Xie C, 2018, Zhonghua Gan Zang Bing Za Zhi, V26, P489, DOI 10.3760/cma.j.issn.1007-3418.2018.07.002; Yu CY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002780; Zhai AX, 2013, ANTIVIR RES, V98, P66, DOI 10.1016/j.antiviral.2013.02.009; Zhu X, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003088; Zhu ZW, 2008, HEPATOLOGY, V48, P1430, DOI 10.1002/hep.22491	52	19	20	2	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					7283	7294		10.1096/fj.201902878R	http://dx.doi.org/10.1096/fj.201902878R		APR 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32277848	Bronze			2022-12-28	WOS:000525003000001
J	Koike, Y; Li, B; Lee, CR; Alganabi, M; Zhu, HT; Chusilp, S; Lee, DR; Cheng, SG; Li, Q; Pierro, A				Koike, Yuhki; Li, Bo; Lee, Carol; Alganabi, Mashriq; Zhu, Haitao; Chusilp, Sinobol; Lee, Dorothy; Cheng, Shigang; Li, Qi; Pierro, Agostino			The intestinal injury caused by ischemia-reperfusion is attenuated by amniotic fluid stem cells via the release of tumor necrosis factor-stimulated gene 6 protein	FASEB JOURNAL			English	Article						amniotic fluid stem cell (AFSC); intestinal injury; ischemia; reperfusion (I; R); tumor necrosis factor-stimulated gene 6 protein (TSG-6)	MODERATE HYPOTHERMIA; TSG-6; METABOLISM; RECOVERY; EFFICACY; THERAPY; HEART; MODEL; MICE; LUNG	Ischemia/reperfusion (I/R) is implicated in the pathogenesis of various acute intestinal injuries. Amniotic fluid stem cells (AFSC) are beneficial in experimental intestinal diseases. Tumor necrosis factor-induced protein 6 (TSG-6) has been shown to exert anti-inflammatory effects. We aimed to investigate if AFSC secreted TSG-6 reduces inflammation and rescues intestinal I/R injury. The superior mesenteric artery of 3-week-old rats was occluded for 90 minutes and green fluorescent protein-labeled AFSC or recombinant TSG-6 was injected intravenously upon reperfusion. AFSC distribution was evaluated at 24, 48, and 72 hours after I/R. AFSC and TSG-6 effects on the intestine were assessed 48 hours postsurgery. Intestinal organoids were used to study the effects of TSG-6 after hypoxia-induced epithelial damage. After I/R-induced intestinal injury, AFSC migrated preferentially to the ileum, the primary site of injury, through blood circulation. Engrafted AFSC reduced ileum injury, inflammation, and oxidative stress. These AFSC-mediated beneficial effects were dependent on secretion of TSG-6. Administration of TSG-6 protected against hypoxia-induced epithelial damage in intestinal organoids. Finally, TSG-6 attenuated intestinal damage during I/R by suppressing genes involved in wound and injury pathways. This study indicates that AFSC or TSG-6 have the potential of rescuing the intestine from the damage caused by I/R.	[Koike, Yuhki; Li, Bo; Lee, Carol; Alganabi, Mashriq; Zhu, Haitao; Chusilp, Sinobol; Lee, Dorothy; Cheng, Shigang; Li, Qi; Pierro, Agostino] Hosp Sick Children, Div Gen & Thorac Surg, Translat Med, Toronto, ON, Canada; [Koike, Yuhki] Mie Univ, Grad Sch Med, Dept Gastrointestinal & Paediat Surg, Tsu, Mie, Japan	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Mie University	Pierro, A (corresponding author), Univ Toronto, Hosp Sick Children, Div Gen & Thorac Surg, Translat Med, 1526-555 Univ Ave, Toronto, ON M5G 1X8, Canada.	agostino.pierro@sickkids.ca	zhu, HAITAO/GVL-0589-2022; Li, Bo/AAP-6556-2020; Alganabi, Mashriq/AAR-3656-2020	Li, Bo/0000-0002-8298-8344; Alganabi, Mashriq/0000-0001-9835-9609; Chusilp, Sinobol/0000-0001-6473-0385	Canadian Institutes of Health Research (CIHR) [353857]; Restracomp Fellowship, The Hospital for Sick Children	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Restracomp Fellowship, The Hospital for Sick Children	AP is supported by a Canadian Institutes of Health Research (CIHR) Foundation Grant 353857 and is the Robert M. Filler Chair of Surgery for The Hospital for Sick Children. BL is the recipient of Restracomp Fellowship, The Hospital for Sick Children. The funders were not involved in the study design, the collection, analysis, interpretation of data, writing of the report or the decision to submit the paper for publication	Angelini A, 2011, J HEART LUNG TRANSPL, V30, P1281, DOI 10.1016/j.healun.2011.07.017; Ben Shahar Y, 2016, EUR J PEDIATR SURG, V26, P47, DOI 10.1055/s-0035-1559886; Bryan C, 2019, PEDIATR RES, V85, P390, DOI 10.1038/s41390-018-0250-2; Caracuel L, 2012, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00118; Carden DL, 2000, J PATHOL, V190, P255, DOI 10.1002/(SICI)1096-9896(200002)190:3<255::AID-PATH526>3.0.CO;2-6; da Cunha MGMCM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136145; Choi H, 2011, BLOOD, V118, P330, DOI 10.1182/blood-2010-12-327353; Crosignani V, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.11.116023; Da Sacco S, 2011, CURR OPIN ORGAN TRAN, V16, P101, DOI 10.1097/MOT.0b013e3283424f6e; Danchuk S, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt68; De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274; Hu Y, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/7239181; Idrovo JP, 2014, MOL MED, V20, P676, DOI 10.2119/molmed.2014.00134; Kalogeris T, 2012, INT REV CEL MOL BIO, V298, P229, DOI 10.1016/B978-0-12-394309-5.00006-7; Lee C, 2018, PEDIATR SURG INT, V34, P155, DOI 10.1007/s00383-017-4183-3; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; LEE TH, 1992, J CELL BIOL, V116, P545, DOI 10.1083/jcb.116.2.545; Lesage F, 2017, HERNIA, V21, P973, DOI 10.1007/s10029-017-1635-6; Li B, 2019, PEDIATR SURG INT, V35, P3, DOI 10.1007/s00383-018-4369-3; Li B, 2017, SCI REP-UK, V7, DOI 10.1038/srep46616; Li B, 2016, J PEDIATR SURG, V51, P775, DOI 10.1016/j.jpedsurg.2016.02.019; Martin J, 2016, J BIOL CHEM, V291, P13789, DOI 10.1074/jbc.M115.670521; Martinez-Revelles S, 2012, BRIT J PHARMACOL, V165, P937, DOI 10.1111/j.1476-5381.2011.01617.x; McCulloh CJ, 2017, J SURG RES, V214, P278, DOI 10.1016/j.jss.2017.03.026; Milner CM, 2006, BIOCHEM SOC T, V34, P446, DOI 10.1042/BST0340446; Milner CM, 2003, J CELL SCI, V116, P1863, DOI 10.1242/jcs.00407; Mindrescu C, 2005, BIOCHEM BIOPH RES CO, V330, P737, DOI 10.1016/j.bbrc.2005.03.040; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Piccoli M, 2012, STEM CELLS, V30, P1675, DOI 10.1002/stem.1134; Qi Y, 2014, J INVEST DERMATOL, V134, P526, DOI 10.1038/jid.2013.328; Rehni AK, 2007, BEHAV BRAIN RES, V183, P95, DOI 10.1016/j.bbr.2007.05.028; Sala E, 2015, GASTROENTEROLOGY, V149, P163, DOI 10.1053/j.gastro.2015.03.013; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; SCHOENBERG MH, 1993, CRIT CARE MED, V21, P1376, DOI 10.1097/00003246-199309000-00023; SONG WJ, 2018, STEM CELL RES THER, V9; Song WJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04766-7; Stefanutti G, 2008, CRIT CARE MED, V36, P1564, DOI 10.1097/CCM.0b013e3181709e9f; Stefanutti G, 2007, PEDIATR RES, V62, P43, DOI 10.1203/PDR.0b013e31806790c0; Sukhotnik I, 2007, DIGEST DIS SCI, V52, P1497, DOI 10.1007/s10620-006-9629-8; Sukhotnik I, 2019, EUR J PEDIATR SURG, V29, P188, DOI 10.1055/s-0037-1618593; Sukhotnik I, 2011, J PEDIATR SURG, V46, P1353, DOI 10.1016/j.jpedsurg.2010.09.051; Toiyama Y, 2010, J GASTROENTEROL, V45, P544, DOI 10.1007/s00535-009-0187-7; Vejchapipat P, 2002, J PEDIATR SURG, V37, P786, DOI 10.1053/jpsu.2002.32288; Vejchapipat P, 2000, J PEDIATR SURG, V35, P759, DOI 10.1053/jpsu.2000.6062; Wang Y, 2016, MOL MED REP, V14, P234, DOI 10.3892/mmr.2016.5212; Watkins DJ, 2013, J PEDIATR SURG, V48, P1323, DOI 10.1016/j.jpedsurg.2013.03.032; Zani A, 2014, GUT, V63, P300, DOI 10.1136/gutjnl-2012-303735; Zhang SQ, 2018, J CELL BIOCHEM, V119, P1627, DOI 10.1002/jcb.26322	49	9	10	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6824	6836		10.1096/fj.201902892RR	http://dx.doi.org/10.1096/fj.201902892RR		MAR 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32223023	Bronze			2022-12-28	WOS:000522486500001
J	Datta, A; Yang, CR; Limbutara, K; Chou, CL; Rinschen, MM; Raghuram, V; Knepper, MA				Datta, Arnab; Yang, Chin-Rang; Limbutara, Kavee; Chou, Chung-Lin; Rinschen, Markus M.; Raghuram, Viswanathan; Knepper, Mark A.			PKA-independent vasopressin signaling in renal collecting duct	FASEB JOURNAL			English	Article						AMPK; AQP2; cAMP; mpkCCD; phosphoproteomics; PRM-MS	ACTIVATED PROTEIN-KINASE; SYSTEMS-LEVEL ANALYSIS; AQP2 GENE-EXPRESSION; LUMEN POLARITY; NITRIC-OXIDE; PHOSPHORYLATION SITES; AQUAPORIN 2; KIDNEY; CELLS; RECEPTOR	Vasopressin regulates renal water excretion by binding to a G(alpha)s-coupled receptor (V2R) in collecting duct cells, resulting in increased water permeability through regulation of the aquaporin-2 (AQP2) water channel. This action is widely accepted to be associated with cAMP-mediated activation of protein kinase A (PKA). Here, we use phosphoproteomics in collecting duct cells in which PKA has been deleted (CRISPR-Cas9) to identify PKA-independent responses to vasopressin. The results show that V2R-mediated vasopressin signaling is predominantly, but not entirely, PKA-dependent. Upregulated sites in PKA-null cells include Ser256 of AQP2, which is critical to regulation of AQP2 trafficking. In addition, phosphorylation changes in the protein kinases Stk39 (SPAK) and Prkci (an atypical PKC) are consistent with PKA-independent regulation of these protein kinases. Target motif analysis of the phosphopeptides increased in PKA-null cells indicates that vasopressin activates one or more members of the AMPK/SNF1-subfamily of basophilic protein kinases. In vitro phosphorylation assays using recombinant, purified SNF1-subfamily kinases confirmed postulated target specificities. Of interest, measured IBMX-dependent cAMP levels were an order of magnitude higher in PKA-null than in PKA-intact cells, indicative of a PKA-dependent feedback mechanism. Overall, the findings support the conclusion that V2-receptor mediated signaling in collecting duct cells is in part PKA-independent.	[Datta, Arnab; Yang, Chin-Rang; Limbutara, Kavee; Chou, Chung-Lin; Raghuram, Viswanathan; Knepper, Mark A.] NHLBI, Epithelial Syst Biol Lab, Syst Biol Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA; [Datta, Arnab] Yenepoya Deemed Be Univ, Yenepoya Res Ctr, Mangalore, India; [Rinschen, Markus M.] Scripps Res Inst, Dept Chem, Ctr Metabol & Mass Spectrometry, La Jolla, CA 92037 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Yenepoya (Deemed to be University); Scripps Research Institute	Knepper, MA (corresponding author), NHLBI, Epithelial Syst Biol Lab, Syst Biol Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA.	knep@helix.nih.gov	Datta, Arnab/H-2755-2013	Datta, Arnab/0000-0002-9220-7812; Limbutara, Kavee/0000-0003-0889-5833	HHS \ NIH \ National Heart, Lung, and Blood Institute (NHLBI) [ZIA-HL-006129, ZIA-HL-001285]	HHS \ NIH \ National Heart, Lung, and Blood Institute (NHLBI)	HHS vertical bar NIH vertical bar National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: ZIA-HL-001285; HHS vertical bar NIH vertical bar National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: ZIA-HL-006129	Al-bataineh MM, 2016, AM J PHYSIOL-RENAL, V311, pF890, DOI 10.1152/ajprenal.00308.2016; Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; Bouley R, 2000, J CLIN INVEST, V106, P1115, DOI 10.1172/JCI9594; Bradford D, 2014, AM J PHYSIOL-CELL PH, V307, pC123, DOI 10.1152/ajpcell.00377.2012; Brown D, 2003, AM J PHYSIOL-RENAL, V284, pF893, DOI 10.1152/ajprenal.00387.2002; CHAMPIGNEULLE A, 1993, AM J PHYSIOL, V265, pF35, DOI 10.1152/ajprenal.1993.265.1.F35; Chen LH, 2017, P NATL ACAD SCI USA, V114, pE9989, DOI 10.1073/pnas.1710964114; Chou CL, 2000, J BIOL CHEM, V275, P36839, DOI 10.1074/jbc.M005552200; Cohen D, 2004, J CELL BIOL, V164, P717, DOI 10.1083/jcb.200308104; Cohen D, 2003, METHODS, V30, P269, DOI 10.1016/S1046-2023(03)00033-1; Cohen D, 2007, MOL BIOL CELL, V18, P2203, DOI 10.1091/mbc.E07-02-0095; Dephoure N, 2013, MOL BIOL CELL, V24, P535, DOI 10.1091/mbc.E12-09-0677; Deshmukh AS, 2010, DIABETOLOGIA, V53, P1142, DOI 10.1007/s00125-010-1716-x; Donsmark M, 2004, BIOCHEM BIOPH RES CO, V316, P867, DOI 10.1016/j.bbrc.2004.02.140; Douglass J, 2012, AM J PHYSIOL-CELL PH, V303, pC715, DOI 10.1152/ajpcell.00166.2012; Ducharme NA, 2006, MOL BIOL CELL, V17, P3625, DOI 10.1091/mbc.E05-08-0736; Elbert M, 2006, MOL BIOL CELL, V17, P3345, DOI 10.1091/mbc.E06-03-0193; Fu D, 2011, P NATL ACAD SCI USA, V108, P1403, DOI 10.1073/pnas.1018376108; Gagnon KB, 2010, AM J PHYSIOL-CELL PH, V299, pC614, DOI 10.1152/ajpcell.00074.2010; Hardie DG, 2016, TRENDS CELL BIOL, V26, P190, DOI 10.1016/j.tcb.2015.10.013; Hasler U, 2009, AM J PHYSIOL-RENAL, V297, pF10, DOI 10.1152/ajprenal.00053.2009; Isobe K, 2017, P NATL ACAD SCI USA, V114, pE8875, DOI 10.1073/pnas.1709123114; Katsura T, 1997, AM J PHYSIOL-RENAL, V272, pF816; Kim JH, 2011, PLOS ONE, V6; Klein JD, 2016, AM J PHYSIOL-RENAL, V310, pF1008, DOI 10.1152/ajprenal.00102.2016; Knepper MA, 2015, NEW ENGL J MED, V372, P1349, DOI 10.1056/NEJMra1404726; Kortenoeven MLA, 2012, AM J PHYSIOL-RENAL, V302, pF1395, DOI 10.1152/ajprenal.00376.2011; Lapierre LA, 2017, MOL BIOL CELL, V28, P1088, DOI 10.1091/mbc.E16-04-0214; Lapierre LA, 2012, MOL BIOL CELL, V23, P2302, DOI 10.1091/mbc.E11-08-0681; Lazaro-Dieguez F, 2013, J CELL BIOL, V203, P251, DOI 10.1083/jcb.201303013; Liwang JK, 2019, AM J PHYSIOL-RENAL, V316, pF253, DOI 10.1152/ajprenal.00491.2017; Loo CS, 2013, P NATL ACAD SCI USA, V110, P17119, DOI 10.1073/pnas.1309219110; Lorenz R, 2017, HANDB EXP PHARMACOL, V238, P105, DOI 10.1007/164_2015_36; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Matsumura Y, 1997, J AM SOC NEPHROL, V8, P861; Mohammadi A, 2001, J LIPID RES, V42, P1062; Murphy BA, 2009, AM J PHYSIOL-CELL PH, V297, pC750, DOI 10.1152/ajpcell.00127.2009; Naruse M, 1992, Nihon Jinzo Gakkai Shi, V34, P337; Nickols HH, 2004, J BIOL CHEM, V279, P46969, DOI 10.1074/jbc.M407351200; Nielsen S, 2002, PHYSIOL REV, V82, P205, DOI 10.1152/physrev.00024.2001; NIELSEN S, 1995, P NATL ACAD SCI USA, V92, P1013, DOI 10.1073/pnas.92.4.1013; Nishimoto G, 1999, AM J PHYSIOL-RENAL, V276, pF254, DOI 10.1152/ajprenal.1999.276.2.F254; Ohno S, 2001, CURR OPIN CELL BIOL, V13, P641, DOI 10.1016/S0955-0674(00)00264-7; Olesen ETB, 2016, AM J PHYSIOL-RENAL, V311, pF935, DOI 10.1152/ajprenal.00559.2015; Pedersen NB, 2010, KIDNEY INT, V78, P160, DOI 10.1038/ki.2010.130; Prats C, 2009, J BIOL CHEM, V284, P15692, DOI 10.1074/jbc.M900845200; Procino G, 2003, FASEB J, V17, P1886, DOI 10.1096/fj.02-0870fje; Richardson C, 2008, J CELL SCI, V121, P3293, DOI 10.1242/jcs.029223; Saethang T, 2019, BIOINFORMATICS, V35, P5313, DOI 10.1093/bioinformatics/btz568; Sandi MJ, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aan3286; Sandoval PC, 2016, SCI REP-UK, V6, DOI 10.1038/srep34863; Saritas T, 2013, J AM SOC NEPHROL, V24, P407, DOI 10.1681/ASN.2012040404; Schenk LK, 2012, J AM SOC NEPHROL, V23, P1008, DOI 10.1681/ASN.2011070738; STAR RA, 1988, J CLIN INVEST, V81, P1879, DOI 10.1172/JCI113534; Suzuki A, 2004, CURR BIOL, V14, P1425, DOI 10.1016/j.cub.2004.08.021; UCHIDA S, 1994, J BIOL CHEM, V269, P23451; Walls PLL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14531-5; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Yip KP, 2006, AM J PHYSIOL-RENAL, V291, pF882, DOI 10.1152/ajprenal.00411.2005; Yu MJ, 2009, P NATL ACAD SCI USA, V106, P2441, DOI 10.1073/pnas.0813002106; Zeaiter Z, 2008, CELL MICROBIOL, V10, P781, DOI 10.1111/j.1462-5822.2007.01084.x; Zwartkruis FJT, 1999, EXP CELL RES, V253, P157, DOI 10.1006/excr.1999.4695	62	18	18	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6129	6146		10.1096/fj.201902982R	http://dx.doi.org/10.1096/fj.201902982R		MAR 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32219907	Bronze, Green Accepted			2022-12-28	WOS:000522483000001
J	Takasumi, M; Omori, T; Machida, T; Ishida, Y; Hayashi, M; Suzuki, T; Homma, Y; Endo, Y; Takahashi, M; Ohira, H; Fujita, T; Sekine, H				Takasumi, Mika; Omori, Tomoko; Machida, Takeshi; Ishida, Yumi; Hayashi, Manabu; Suzuki, Toshiyuki; Homma, Yoshimi; Endo, Yuichi; Takahashi, Minoru; Ohira, Hiromasa; Fujita, Teizo; Sekine, Hideharu			A novel complement inhibitor sMAP-FH targeting both the lectin and alternative complement pathways	FASEB JOURNAL			English	Article						alternative complement pathway; factor H; lectin complement pathway; MAp44; small mannose-binding lectin-associated protein	MANNOSE-BINDING LECTIN; PATTERN-RECOGNITION MOLECULES; SERINE-PROTEASE (MASP)-1; FACTOR-H; REPERFUSION INJURY; ACTIVATION; SYSTEM; IMMUNOLOGY; DOMAINS; FUSION	Inhibition of the complement activation has emerged as an option for treatment of a range of diseases. Activation of the lectin and alternative pathways (LP and AP, respectively) contribute to the deterioration of conditions in certain diseases such as ischemia-reperfusion injuries and age-related macular degeneration (AMD). In the current study, we generated dual complement inhibitors of the pathways MAp44-FH and sMAP-FH by fusing full-length MAp44 or small mannose-binding lectin-associated protein (sMAP), LP regulators, with the N-terminal five short consensus repeat (SCR) domains of complement factor H (SCR1/5-FH), an AP regulator. The murine forms of both fusion proteins formed a complex with endogenous mannose-binding lectin (MBL) or ficolin A in the circulation when administered in mice intraperitoneally. Multiple complement activation assays revealed that sMAP-FH had significantly higher inhibitory effects on activation of the LP and AP in vivo as well as in vitro compared to MAp44-FH. Human form of sMAP-FH also showed dual inhibitory effects on LP and AP activation in human sera. Our results indicate that the novel fusion protein sMAP-FH inhibits both the LP and AP activation in mice and in human sera, and could be an effective therapeutic agent for diseases in which both the LP and AP activation are significantly involved.	[Takasumi, Mika; Omori, Tomoko; Machida, Takeshi; Ishida, Yumi; Hayashi, Manabu; Endo, Yuichi; Takahashi, Minoru; Sekine, Hideharu] Fukushima Med Univ, Dept Immunol, Sch Med, Fukushima, Japan; [Takasumi, Mika; Hayashi, Manabu; Ohira, Hiromasa] Fukushima Med Univ, Dept Gastroenterol, Sch Med, Fukushima, Japan; [Suzuki, Toshiyuki; Homma, Yoshimi] Fukushima Med Univ, Dept Biomol Sci, Sch Med, Fukushima, Japan; [Fujita, Teizo] Fukushima Prefectural Gen Hyg Inst, Fukushima, Japan	Fukushima Medical University; Fukushima Medical University; Fukushima Medical University	Machida, T (corresponding author), Fukushima Med Univ, Dept Immunol, 1 Hikarigaoka, Fukushima, Fukushima 9601295, Japan.	be204093@fmu.ac.jp			Japan Agency for Medical Research and Development (AMED) [JP17lm0203002]; MEXT | Japan Society for the Promotion of Science (JSPS) [26670478, 19K17440]	Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); MEXT | Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Curadim Pharma Co., Ltd.; Japan Agency for Medical Research and Development (AMED), Grant/Award Number: JP17lm0203002; MEXT | Japan Society for the Promotion of Science (JSPS), Grant/Award Number: 26670478 and 19K17440	Chan RK, 2006, J IMMUNOL, V177, P8080, DOI 10.4049/jimmunol.177.11.8080; Cicardi M, 2005, SPRINGER SEMIN IMMUN, V27, P286, DOI 10.1007/s00281-005-0001-4; Daha MR, 2016, J NEPHROL, V29, P1, DOI 10.1007/s40620-015-0245-6; Degn SE, 2014, P NATL ACAD SCI USA, V111, P13445, DOI 10.1073/pnas.1406849111; Degn SE, 2013, J IMMUNOL, V191, P1334, DOI 10.4049/jimmunol.1300780; Degn SE, 2009, J IMMUNOL, V183, P7371, DOI 10.4049/jimmunol.0902388; Fridkis-Hareli M, 2011, BLOOD, V118, P4705, DOI 10.1182/blood-2011-06-359646; Fujita T, 2002, NAT REV IMMUNOL, V2, P346, DOI 10.1038/nri800; FUJITA T, 1983, J EXP MED, V157, P1239, DOI 10.1084/jem.157.4.1239; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Hart ML, 2005, J IMMUNOL, V174, P6373, DOI 10.4049/jimmunol.174.10.6373; Hayashi M, 2019, J IMMUNOL, V203, P1411, DOI 10.4049/jimmunol.1900605; Holers VM, 2016, SEMIN IMMUNOL, V28, P260, DOI 10.1016/j.smim.2016.05.007; Huang YX, 2008, J IMMUNOL, V181, P8068, DOI 10.4049/jimmunol.181.11.8068; Iwaki D, 2005, J ENDOTOXIN RES, V11, P47, DOI 10.1179/096805105225006704; Jokiranta TS, 2000, J BIOL CHEM, V275, P27657; Jordan JE, 2001, CIRCULATION, V104, P1413, DOI 10.1161/hc3601.095578; Joseph K, 2013, J BIOL CHEM, V288, P12753, DOI 10.1074/jbc.M112.421891; KAWASAKI T, 1978, BIOCHEM BIOPH RES CO, V81, P1018, DOI 10.1016/0006-291X(78)91452-3; Kuraya M, 2003, INT IMMUNOL, V15, P109, DOI 10.1093/intimm/dxg008; Merinero HM, 2018, KIDNEY INT, V93, P470, DOI 10.1016/j.kint.2017.07.015; Matsushita M, 1996, J BIOL CHEM, V271, P2448, DOI 10.1074/jbc.271.5.2448; Matsushita M, 2000, J IMMUNOL, V165, P2637, DOI 10.4049/jimmunol.165.5.2637; MATSUSHITA M, 1992, J EXP MED, V176, P1497, DOI 10.1084/jem.176.6.1497; Morgan HP, 2011, NAT STRUCT MOL BIOL, V18, P463, DOI 10.1038/nsmb.2018; Morrison H, 2011, CURR NEUROVASC RES, V8, P52, DOI 10.2174/156720211794520260; Nordmaj MA, 2015, FASEB J, V29, P4945, DOI 10.1096/fj.15-277103; Orsini F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0684-6; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Risitano AM, 2012, BLOOD, V119, P6307, DOI 10.1182/blood-2011-12-398792; Rohrer B, 2012, J OCUL PHARMACOL TH, V28, P402, DOI 10.1089/jop.2011.0212; Rohrer Barbel, 2011, Mol Immunol, V48, pe1, DOI 10.1016/j.molimm.2010.12.016; Schmidt CQ, 2008, CLIN EXP IMMUNOL, V151, P14, DOI 10.1111/j.1365-2249.2007.03553.x; Seelen MA, 2005, J IMMUNOL METHODS, V296, P187, DOI 10.1016/j.jim.2004.11.016; Sekine H, 2011, ARTHRITIS RHEUM-US, V63, P1076, DOI 10.1002/art.30222; Takahashi M, 2008, J IMMUNOL, V180, P6132, DOI 10.4049/jimmunol.180.9.6132; Takahashi M, 2010, J EXP MED, V207, P29, DOI 10.1084/jem.20090633; Thielens NM, 2001, J IMMUNOL, V166, P5068, DOI 10.4049/jimmunol.166.8.5068; Troldborg A, 2017, CLIN EXP IMMUNOL, V188, P138, DOI 10.1111/cei.12909; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506	41	2	2	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6598	6612		10.1096/fj.201902475R	http://dx.doi.org/10.1096/fj.201902475R		MAR 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32219899	Bronze, Green Published			2022-12-28	WOS:000522483300001
J	Ke, XR; Qiu, JD; Wang, XJ; Yang, XY; Shen, JH; Ye, S; Yang, GJ; Xu, SZ; Bi, Q; Gou, ZR; Jia, XF; Zhang, L				Ke, Xiurong; Qiu, Jiandi; Wang, Xijuan; Yang, Xianyan; Shen, Jianhua; Ye, Shuo; Yang, Guojing; Xu, Sanzhong; Bi, Qing; Gou, Zhongru; Jia, Xiaofeng; Zhang, Lei			Modification of pore-wall in direct ink writing wollastonite scaffolds favorable for tuning biodegradation and mechanical stability and enhancing osteogenic capability	FASEB JOURNAL			English	Article						additive manufacture; bioceramic scaffold; electrostatic interaction; foreign-ion doping; pore-wall modification	BONE REGENERATION CAPACITY; BIOCERAMIC SCAFFOLDS; CERAMIC SCAFFOLDS; MAGNESIUM; PHOSPHATE; IMPLANTS; STRENGTH; SUBSTITUTES; FABRICATION; FRACTURES	Surface chemistry and mechanical stability determine the osteogenic capability of bone implants. The development of high-strength bioactive scaffolds for in-situ repair of large bone defects is challenging because of the lack of satisfying biomaterials. In this study, highly bioactive Ca-silicate (CSi) bioceramic scaffolds were fabricated by additive manufacturing and then modified for pore-wall reinforcement. Pure CSi scaffolds were fabricated using a direct ink writing technique, and the pore-wall was modified with 0%, 6%, or 10% Mg-doped CSi slurry (CSi, CSi-Mg6, or CSi-Mg10) through electrostatic interaction. Modified CSi@CSi-Mg6 and CSi@CSi-Mg10 scaffolds with over 60% porosity demonstrated an appreciable compressive strength beyond 20 MPa, which was 2-fold higher than that of pure CSi scaffolds. CSi-Mg6 and CSi-Mg10 coating layers were specifically favorable for retarding bio-dissolution and mechanical decay of scaffolds in vitro. In-vivo investigation of critical-size femoral bone defects repair revealed that CSi@CSi-Mg6 and CSi@CSi-Mg10 scaffolds displayed limited biodegradation, accelerated new bone ingrowth (4-12 weeks), and elicited a suitable mechanical response. In contrast, CSi scaffolds exhibited fast biodegradation and retarded new bone regeneration after 8 weeks. Thus, tailoring of the chemical composition of pore-wall struts of CSi scaffolds is beneficial for enhancing the biomechanical properties and bone repair efficacy.	[Ke, Xiurong; Qiu, Jiandi; Ye, Shuo; Yang, Guojing; Zhang, Lei] Wenzhou Med Univ, Hosp Affiliated 3, Dept Orthopaed Surg, Ruian, Peoples R China; [Wang, Xijuan] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Key Lab Mol Biol Med Sci, Hangzhou, Peoples R China; [Yang, Xianyan; Shen, Jianhua; Gou, Zhongru] Zhejiang Univ, Zhejiang California Int Nanosyst Inst, Bionanomat & Regenerat Med Res Div, Yuhangtang Rd 866, Hangzhou 310058, Peoples R China; [Xu, Sanzhong] Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Orthopaed Surg, Hangzhou, Peoples R China; [Bi, Qing] Zhejiang Prov Peoples Hosp, Hangzhou Med Coll, Peoples Hosp, Dept Orthoped Surg, Hangzhou, Peoples R China; [Jia, Xiaofeng] Univ Maryland, Sch Med, Dept Neurosurg, 10 South Pine St,MSTF Bldg 823, Baltimore, MD 21201 USA; [Jia, Xiaofeng] Univ Maryland, Sch Med, Dept Orthoped, Baltimore, MD 21201 USA; [Jia, Xiaofeng] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [Jia, Xiaofeng] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Jia, Xiaofeng] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA	Wenzhou Medical University; Zhejiang University; Zhejiang University; Zhejiang University; Hangzhou Medical College; Zhejiang Provincial People's Hospital; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Johns Hopkins University; Johns Hopkins University	Gou, ZR (corresponding author), Zhejiang Univ, Zhejiang California Int Nanosyst Inst, Bionanomat & Regenerat Med Res Div, Yuhangtang Rd 866, Hangzhou 310058, Peoples R China.; Jia, XF (corresponding author), Univ Maryland, Sch Med, Dept Neurosurg, 10 South Pine St,MSTF Bldg 823, Baltimore, MD 21201 USA.; Zhang, L (corresponding author), Wenzhou Med Univ, Affiliated Hosp 3, Dept Orthoped, Wansong Rd 108, Ruian 325200, Peoples R China.	zhrgou@zju.edu.cn; xjia@som.umaryland.edu; zhanglei@wmu.edu.cn	Yang, Xian/GVU-9087-2022; Jia, Xiaofeng/B-2145-2008	Jia, Xiaofeng/0000-0003-1445-8525; Zhang, Lei/0000-0001-6302-8383; Xu, Sanzhong/0000-0002-1881-2723	National Key Research and Development Program of China [2017YFE0117700]; National Natural Science Foundation of China [81601881, 81871775, 81772311]; Basic Public Welfare Research Project of Zhejiang Province [LGF19H180007]; Medical and Health Research Project of Zhejiang Province [2018KY768]; Zhejiang Province Bureau of Health [WKJ-ZJ-1711]; Basic Medical Technology Project of Wenzhou [2018Y1347]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Basic Public Welfare Research Project of Zhejiang Province; Medical and Health Research Project of Zhejiang Province; Zhejiang Province Bureau of Health; Basic Medical Technology Project of Wenzhou	The National Key Research and Development Program of China, Grant/Award Number: 2017YFE0117700; the National Natural Science Foundation of China, Grant/Award Number: 81601881, 81871775 and 81772311; The Basic Public Welfare Research Project of Zhejiang Province, Grant/Award Number: LGF19H180007; The Medical and Health Research Project of Zhejiang Province, Grant/Award Number: 2018KY768; The Zhejiang Province Bureau of Health, Grant/Award Number: WKJ-ZJ-1711; The Basic Medical Technology Project of Wenzhou, Grant/Award Number: 2018Y1347	Barinov S. M., 2015, Inorganic Materials: Applied Research, V6, P316, DOI 10.1134/S207511331504005X; Bhandari Mohit, 2012, J Bone Joint Surg Am, V94, pe1091, DOI 10.2106/JBJS.K.01344; BONFIELD W, 1981, BIOMATERIALS, V2, P185, DOI 10.1016/0142-9612(81)90050-8; Braem A, 2012, MAT SCI ENG C-MATER, V32, P2267, DOI 10.1016/j.msec.2012.06.013; Campana V, 2014, J MATER SCI-MATER M, V25, P2445, DOI 10.1007/s10856-014-5240-2; Chen IW, 2000, NATURE, V404, P168, DOI 10.1038/35004548; Chia HN, 2015, J BIOL ENG, V9, DOI 10.1186/s13036-015-0001-4; Dadhich P, 2016, ACS APPL MATER INTER, V8, P11910, DOI 10.1021/acsami.5b11981; Daskalova A, 2018, APPL PHYS A-MATER, V124, DOI 10.1007/s00339-018-1831-y; Descamps M, 2008, J EUR CERAM SOC, V28, P149, DOI 10.1016/j.jeurceramsoc.2007.05.025; Diba M, 2014, CURR OPIN SOLID ST M, V18, P147, DOI 10.1016/j.cossms.2014.02.004; Du J, 2018, BIOMATERIALS, V181, P347, DOI 10.1016/j.biomaterials.2018.07.015; Flierl MA, 2013, J ORTHOP SURG RES, V8, DOI 10.1186/1749-799X-8-33; Ginebra MP, 2018, EFORT OPEN REV, V3, P173, DOI 10.1302/2058-5241.3.170056; Gou ZR, 2006, J CONTROL RELEASE, V116, P360, DOI 10.1016/j.jconrel.2006.09.003; He DS, 2016, ACS BIOMATER SCI ENG, V2, P1519, DOI 10.1021/acsbiomaterials.6b00282; Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404; HENCH LL, 1973, J BIOMED MATER RES, V7, P25, DOI 10.1002/jbm.820070304; Jell G, 2006, J MATER SCI-MATER M, V17, P997, DOI 10.1007/s10856-006-0435-9; Jones AC, 2009, BIOMATERIALS, V30, P1440, DOI 10.1016/j.biomaterials.2008.10.056; Jones N, 2012, NATURE, V487, P22, DOI 10.1038/487022a; Keating JF, 2005, J BONE JOINT SURG BR, V87B, P142, DOI 10.1302/0301-620X.87B2.15874; Kim HD, 2017, ADV HEALTHC MATER, V6, DOI 10.1002/adhm.201700612; Lee WH, 2013, RSC ADV, V3, P4040, DOI 10.1039/c3ra22966a; LeGeros RZ, 2008, CHEM REV, V108, P4742, DOI 10.1021/cr800427g; Li R, 2018, BIOMATERIALS, V168, P24, DOI 10.1016/j.biomaterials.2018.03.044; Lin KL, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-015-5523-2; Liu A, 2016, J MATER CHEM B, V4, P3945, DOI 10.1039/c6tb00449k; Liu A, 2016, SCI REP-UK, V6, DOI 10.1038/srep21704; Liu S, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/1038476; Luo YX, 2015, ACS APPL MATER INTER, V7, P24377, DOI 10.1021/acsami.5b08911; Marcacci M, 2007, TISSUE ENG, V13, P947, DOI 10.1089/ten.2006.0271; Meininger S, 2016, ACTA BIOMATER, V31, P401, DOI 10.1016/j.actbio.2015.11.050; Mroz W, 2015, J BIOMED MATER RES B, V103, P151, DOI 10.1002/jbm.b.33170; Neufurth M, 2017, ACTA BIOMATER, V64, P377, DOI 10.1016/j.actbio.2017.09.031; Ni S, 2010, J BIOMED MATER RES A, V76, P196; Otsuki B, 2006, BIOMATERIALS, V27, P5892, DOI 10.1016/j.biomaterials.2006.08.013; Penney DP, 2002, BIOTECH HISTOCHEM, V77, P237, DOI 10.1080/714028210; Reffitt DM, 2003, BONE, V32, P127, DOI 10.1016/S8756-3282(02)00950-X; Shao HF, 2017, J MATER CHEM B, V5, P2941, DOI 10.1039/c7tb00217c; Shao HF, 2017, BIOFABRICATION, V9, DOI 10.1088/1758-5090/aa663c; Shao HF, 2016, J EUR CERAM SOC, V36, P1495, DOI 10.1016/j.jeurceramsoc.2016.01.010; Shao HF, 2015, BIOFABRICATION, V7, DOI 10.1088/1758-5090/7/3/035010; Tarafder S, 2014, ACS APPL MATER INTER, V6, P9955, DOI 10.1021/am501048n; Travitzky N, 2014, ADV ENG MATER, V16, P729, DOI 10.1002/adem.201400097; Turner BN, 2014, RAPID PROTOTYPING J, V20, P192, DOI 10.1108/RPJ-01-2013-0012; van der Stok J., 2015, NED TIJDSCHR TRAUMAC, V23, P84, DOI DOI 10.1007/S12506-015-0024-Y; Van Lieshout EMM, 2016, INJURY, V47, pS43, DOI 10.1016/S0020-1383(16)30011-0; Wang C, 2012, ACTA BIOMATER, V8, P350, DOI 10.1016/j.actbio.2011.08.019; Wu CT, 2012, J MATER CHEM, V22, P12288, DOI 10.1039/c2jm30566f; Xie JJ, 2015, MRS COMMUN, V5, P631, DOI 10.1557/mrc.2015.74; Xie JJ, 2016, J MECH BEHAV BIOMED, V54, P60, DOI 10.1016/j.jmbbm.2015.09.012; Xu S, 2008, BIOMATERIALS, V29, P2588, DOI 10.1016/j.biomaterials.2008.03.013; Yi DL, 2014, J BIOMATER APPL, V28, P1343, DOI 10.1177/0885328213508165; You F, 2015, ACS BIOMATER SCI ENG, V1, P825, DOI 10.1021/acsbiomaterials.5b00199; Yu W, 2017, BIOMATER SCI-UK, V5, P1690, DOI 10.1039/c7bm00315c; Zhang L, 2019, ACTA BIOMATER, V84, P16, DOI 10.1016/j.actbio.2018.11.039; Zhang YL, 2015, NANOSCALE, V7, P19207, DOI 10.1039/c5nr05421d; Zhu HY, 2016, J MATER CHEM B, V4, P6200, DOI 10.1039/c6tb01692h	60	4	4	5	32	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5673	5687		10.1096/fj.201903044R	http://dx.doi.org/10.1096/fj.201903044R		MAR 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32115776				2022-12-28	WOS:000517977500001
J	Nakamoto, S; Ito, Y; Nishizawa, N; Goto, T; Kojo, K; Kumamoto, Y; Watanabe, M; Narumiya, S; Majima, M				Nakamoto, Shuji; Ito, Yoshiya; Nishizawa, Nobuyuki; Goto, Takuya; Kojo, Ken; Kumamoto, Yusuke; Watanabe, Masahiko; Narumiya, Shuh; Majima, Masataka			EP3 signaling in dendritic cells promotes liver repair by inducing IL-13-mediated macrophage differentiation in mice	FASEB JOURNAL			English	Article						crosstalk; immune cells; ischemia; prostaglandin; reperfusion	E RECEPTOR SUBTYPE; ISCHEMIA/REPERFUSION INJURY; MONOCYTES; INFLAMMATION; HOMEOSTASIS; INDUCTION; SITE	Macrophage plasticity is essential for liver wound healing; however, the mechanisms underlying macrophage phenotype switching are largely unknown. Dendritic cells (DCs) are critical initiators of innate immune responses; as such, they orchestrate inflammation following hepatic injury. Here, we subjected EP3-deficient (Ptger3(-/-)) and wild-type (WT) mice to hepatic ischemia-reperfusion (I/R) and demonstrate that signaling via the prostaglandin E (PGE) receptor EP3 in DCs regulates macrophage plasticity during liver repair. Compared with WT mice, Ptger3(-/-) mice showed delayed liver repair accompanied by reduced expression of hepatic growth factors and accumulation of Ly6C(low) reparative macrophages and monocyte-derived DCs (moDCs). MoDCs were recruited to the boundary between damaged and undamaged liver tissue in an EP3-dependent manner. Adoptive transfer of moDCs from Ptger3(-/-) mice resulted in impaired repair, along with increased numbers of Ly6C(high) inflammatory macrophages. Bone marrow macrophages (BMMs) up-regulated expression of genes related to a reparative macrophage phenotype when co-cultured with moDCs; this phenomenon was dependent on EP3 signaling. In the presence of an EP3 agonist, interleukin (IL)-13 derived from moDCs drove BMMs to increase expression of genes characteristic of a reparative macrophage phenotype. The results suggest that EP3 signaling in moDCs facilitates liver repair by inducing IL-13-mediated switching of macrophage phenotype from pro-inflammatory to pro-reparative.	[Nakamoto, Shuji; Ito, Yoshiya; Goto, Takuya; Majima, Masataka] Kitasato Univ, Grad Sch Med Sci, Dept Mol Pharmacol, Sagamihara, Kanagawa, Japan; [Nakamoto, Shuji; Ito, Yoshiya; Nishizawa, Nobuyuki; Goto, Takuya; Majima, Masataka] Kitasato Univ, Dept Pharmacol, Sch Med, Sagamihara, Kanagawa, Japan; [Nakamoto, Shuji; Nishizawa, Nobuyuki; Goto, Takuya; Kojo, Ken; Kumamoto, Yusuke; Watanabe, Masahiko] Kitasato Univ, Dept Surg, Sch Med, Sagamihara, Kanagawa, Japan; [Narumiya, Shuh] Kyoto Univ, Grad Sch Med, Ctr Innovat Immunoregulat Technol & Therapeut, Kyoto, Japan	Kitasato University; Kitasato University; Kitasato University; Kyoto University	Majima, M (corresponding author), Kitasato Univ, Sch Med, Dept Pharmacol, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan.	mmajima@med.kitasato-u.ac.jp	Majima, Masataka/ABH-3063-2021	Nakamoto, Shuji/0000-0002-6225-9355	Ministry of Education, Culture, Sports, Science and Technology (MEXT) [16K10581, 18K16373, 18H02605]; Takeda Foundation; Kitasato University Research Grant for Young Researchers	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Foundation(Takeda Science Foundation (TSF)); Kitasato University Research Grant for Young Researchers	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Grant/Award Number: 16K10581, 18K16373 and 18H02605; Takeda Foundation; Kitasato University Research Grant for Young Researchers	Anzai A, 2012, CIRCULATION, V125, P1234, DOI 10.1161/CIRCULATIONAHA.111.052126; Bamboat ZM, 2010, J CLIN INVEST, V120, P559, DOI 10.1172/JCI40008; Bonnardel J, 2019, IMMUNITY, V51, P638, DOI 10.1016/j.immuni.2019.08.017; Brempelis KJ, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.62; Castellaneta A, 2014, HEPATOLOGY, V60, P267, DOI 10.1002/hep.27037; Choo EH, 2017, CIRCULATION, V135, P1444, DOI 10.1161/CIRCULATIONAHA.116.023106; Clavien P, 2007, NEW ENGL J MED, V356, P1545, DOI 10.1056/NEJMra065156; Connolly MK, 2009, J CLIN INVEST, V119, P3213, DOI 10.1172/JCI37581; Dal-Secco D, 2015, J EXP MED, V212, P447, DOI 10.1084/jem.20141539; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Heier EC, 2017, J HEPATOL, V66, P1241, DOI 10.1016/j.jhep.2017.01.008; Heymann F, 2016, NAT REV GASTRO HEPAT, V13, P88, DOI 10.1038/nrgastro.2015.200; Hosono K, 2011, ARTERIOSCL THROM VAS, V31, P1049, DOI 10.1161/ATVBAHA.110.222356; Jenne CN, 2013, NAT IMMUNOL, V14, P996, DOI 10.1038/ni.2691; Jiao JJ, 2012, HEPATOLOGY, V55, P243, DOI 10.1002/hep.24621; Kamoshita E, 2006, AM J PATHOL, V169, P1458, DOI 10.2353/ajpath.2006.051358; Kato A, 2003, HEPATOLOGY, V37, P304, DOI 10.1053/jhep.2003.50075; Kawai S, 2011, EXP ANIM TOKYO, V60, P481, DOI 10.1538/expanim.60.481; Kojo K, 2016, SCI REP-UK, V6, DOI 10.1038/srep29650; Krenkel O, 2017, NAT REV IMMUNOL, V17, P306, DOI 10.1038/nri.2017.11; Kubes P, 2012, GASTROENTEROLOGY, V143, P1158, DOI 10.1053/j.gastro.2012.09.008; Kuzumoto Y, 2005, HEPATOLOGY, V42, P608, DOI 10.1002/hep.20827; Lentsch AB, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/513192; Leon B, 2007, IMMUNITY, V26, P519, DOI 10.1016/j.immuni.2007.01.017; Liew PX, 2017, IMMUNITY, V47, P752, DOI 10.1016/j.immuni.2017.09.016; Mildner A, 2013, ADV IMMUNOL, V120, P69, DOI 10.1016/B978-0-12-417028-5.00003-X; Motino O, 2019, HEPATOLOGY, V70, P650, DOI 10.1002/hep.30241; Nakao T, 2019, HEPATOLOGY, V70, P696, DOI 10.1002/hep.30334; Nishizawa N, 2018, J HEPATOL, V69, P110, DOI 10.1016/j.jhep.2018.02.009; Noll J, 2016, J HEPATOL, V64, P1147, DOI 10.1016/j.jhep.2016.01.013; Ogawa F, 2014, J CLIN INVEST, V124, P4882, DOI 10.1172/JCI73530; Ohkubo H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105533; Proto JD, 2018, IMMUNITY, V49, P666, DOI 10.1016/j.immuni.2018.07.015; Scandella E, 2002, BLOOD, V100, P1354, DOI 10.1182/blood-2001-11-0017; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; Tang JA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13724; Ushikubi F, 1998, NATURE, V395, P281, DOI 10.1038/26233; Zhang M, 2013, HEPATOLOGY, V57, P1585, DOI 10.1002/hep.26129	38	8	8	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5610	5627		10.1096/fj.201901955R	http://dx.doi.org/10.1096/fj.201901955R		FEB 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32112485	Bronze			2022-12-28	WOS:000517912100001
J	Han, XY; Xiao, H; Chen, J; Xu, WQ; Dou, DQ				Han, Xueying; Xiao, Hang; Chen, Jing; Xu, Weiqun; Dou, Deqiang			The substance basis of Poria ameliorates hypothyroidism other than hyperthyroidism based on proteomics and metabolomics	FASEB JOURNAL			English	Article						energy metabolism; drug efficacy; drug nature; substance metabolism; traditional Chinese medicine	ENERGY-METABOLISM; THYROID-HORMONES; CHINESE MEDICINE; TCA CYCLE; EVOLUTION	Integrated metabolomics and proteomics analysis was carried out to study the effects ofPoriaand its split components (volatile oil, triterpenoid, oligosaccharide, amino acid, and crude polysaccharide) on rats of normal physiological model, hyperthyroidism model, and hypothyroidism model to explore the substance basis ofPoriafor hypothyroidism from the perspective of a holistic view in substance and energy metalism. The key pathways regulating substance and energy metabolism were screened, encompassing tricarboxylic acid cycle pathway, glycolysis/ gluconeogenesis pathways, biosynthesis of amino acid pathway, fatty acid biosynthesis pathway, pentose phosphate pathway, peroxisome proliferator-activated receptors pathway, etcPoriaand its split components showed promoting effects on substance and energy metabolism in normal model, while showed amelioration effects on hypothyroidism model at different degrees, and had no significant improvement effects on hyperthyroidism in rats. Volatile oil, triterpenoid, and crude polysaccharide fromPoriawere regarded as substance basis ofPoriaameliorating hypothyroidism other than hyperthyroidism. This work also revealed the feasibility of metabolomics and proteomics analysis to elucidate the effective substance basis of traditional Chinese medicine from a new viewpoint based on its effects on substance and energy metabolism.	[Han, Xueying; Xiao, Hang; Chen, Jing; Xu, Weiqun; Dou, Deqiang] Liaoning Univ Tradit Chinese Med, Coll Pharm, 77 Life One Rd, Dalian 116600, Peoples R China	Liaoning University of Traditional Chinese Medicine	Xu, WQ; Dou, DQ (corresponding author), Liaoning Univ Tradit Chinese Med, Coll Pharm, 77 Life One Rd, Dalian 116600, Peoples R China.	864866743@qq.com; deqiangdou@126.com	Dou, Deqiang/GLR-4592-2022		National Natural Science Foundation of China (NSFC) [81773858]; National Basic Research Program of China [2013CB531803]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81773858; National Basic Research Program of China, Grant/Award Number: 2013CB531803	Anderson NM, 2018, PROTEIN CELL, V9, P216, DOI 10.1007/s13238-017-0451-1; Bryant SK, 2013, ANAL BIOCHEM, V437, P32, DOI 10.1016/j.ab.2013.02.005; Chinese Pharmacopoeia Commission (Ed.), 2015, PHARMACOPOEIA PEOPLE, VI, P240; Choi J, 2018, DIS MARKERS, V2018, DOI 10.1155/2018/9369358; Choksi NY, 2003, BIRTH DEFECTS RES B, V68, P479, DOI 10.1002/bdrb.10045; Cui GZ, 2013, WORLD SCI TECHNOL MO, V6, P1314; Cavalcanti JHF, 2014, GENOME BIOL EVOL, V6, P2830, DOI 10.1093/gbe/evu221; Gao J, 2014, J LIAONING U TCM, V14, P111; Gao XM, 2007, CHINESE MAT MED, P1; GOWARD CR, 1994, PROTEIN SCI, V3, P1883, DOI 10.1002/pro.5560031027; Han XY, 2018, CHIN J NAT MEDICINES, V16, P936, DOI 10.1016/S1875-5364(18)30135-3; Han XY, 2019, J ETHNOPHARMACOL, V239, DOI 10.1016/j.jep.2019.111942; Han XY, J LIAONING U T UNPUB; Hou YY, 2016, ACTA PHARM SIN B, V6, P212, DOI 10.1016/j.apsb.2016.03.002; Janssen HJ, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-7; Kim JW, 2005, TRENDS BIOCHEM SCI, V30, P142, DOI 10.1016/j.tibs.2005.01.005; Kong LF, 2015, J REPROD DEVELOP, V61, P219, DOI 10.1262/jrd.2014-129; Kuang H, 2009, WORLD SCI TECHNOL MO, V11, P768; Lee WS, 2015, PPAR RES, V2015, DOI 10.1155/2015/271983; Li B, 2015, INT J PHARMACOL, V11, P130, DOI 10.3923/ijp.2015.130.136; Li Y, 2016, PHARM CLIN CHIN MAT, V7, P51; Lin Zhe, 2013, Zhongguo Zhong Yao Za Zhi, V38, P4340; Mandard S, 2013, PPAR RES, V2013, DOI 10.1155/2013/613864; Metz LD, 1996, J MOL CELL CARDIOL, V28, P1033, DOI 10.1006/jmcc.1996.0096; Peters JM, 2012, NAT REV CANCER, V12, P181, DOI 10.1038/nrc3214; Shu Kunhui, 2019, Asian Journal of Ecotoxicology, V14, P242, DOI 10.7524/AJE.1673-5897.20180412002; Shurubor YI, 2017, MOLECULES, V22, DOI 10.3390/molecules22091388; Springsteen G, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02591-0; Stincone A, 2015, BIOL REV, V90, P927, DOI 10.1111/brv.12140; Sui Feng, 2010, Zhongguo Zhong Yao Za Zhi, V35, P1594; Sun H, 2012, PHYTOTHER RES, V26, P1466, DOI 10.1002/ptr.4613; Suryawan A, 2011, FRONT BIOSCI-LANDMRK, V16, P1445, DOI 10.2741/3798; Tao L, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006949; Visalli V, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-106; Vlasova II, 2018, MOLECULES, V23, DOI 10.3390/molecules23102561; Wan WT, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00333; Wang DN, 2019, WORLD LATEST MED INF, V19, P127; Wang Q, 2012, WORLD J INTEGR TRADI, V7, P1005; Wang Q. H., 2015, WORLD CHINESE MED, V10, P1824; Wang W, 2011, NW PHARM J, V26, P303; Wang XF, 2014, MODERN CHIN MED, V16, P901; Wang XJ, 2011, J PHARMACEUT BIOMED, V55, P859, DOI 10.1016/j.jpba.2011.01.042; Xiao H, 2017, J GINSENG RES, V41, P556, DOI 10.1016/j.jgr.2016.11.005; Zhang AH, 2013, ANALYST, V138, P353, DOI 10.1039/c2an36382h; Zhang AH, 2010, PLANTA MED, V76, P2026, DOI 10.1055/s-0030-1250542; Zhang ZH, 2016, SCI REP-UK, V6, DOI 10.1038/srep22151; Zhang ZH, 2015, SCI REP-UK, V5, DOI 10.1038/srep14472; Zong M, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0619-0	48	6	6	5	20	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					11970	11982		10.1096/fj.202000984R	http://dx.doi.org/10.1096/fj.202000984R		JUL 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32667083	Bronze			2022-12-28	WOS:000553017700001
J	Zhu, JJ; Liu, X; Cai, XL; Ouyang, G; Zha, HY; Zhou, ZW; Liao, Q; Wang, J; Xiao, WH				Zhu, Junji; Liu, Xing; Cai, Xiaolian; Ouyang, Gang; Zha, Huangyuan; Zhou, Ziwen; Liao, Qian; Wang, Jing; Xiao, Wuhan			Zebrafish prmt3 negatively regulates antiviral responses	FASEB JOURNAL			English	Article						GCRV; innate immunity; prmt3; SVCV; zebrafish	ARGININE N-METHYLTRANSFERASE; INDUCIBLE GENE-I; RIG-I; SUBSTRATE-SPECIFICITY; SPRING VIREMIA; RECOGNITION; METHYLATION; RNA; OLIGOMERIZATION; EXPRESSION	Arginine methylation catalyzed by protein arginine methyltransferases (PRMT) is a common post-translational modification in histone and nonhistone proteins, which regulates many cellular functions. Protein arginine methyltransferase 3 (prmt3), a type I arginine methyltransferase, has been shown to carry out the formation of stable monomethylarginine as an intermediate before the establishment of asymmetric dimethylarginine. To date, however, the role of PRMT3 in antiviral innate immunity has not been elucidated. This study showed that zebrafishprmt3was upregulated by virus infection and that the overexpression ofprmt3suppressed cellular antiviral response. The PRMT3 inhibitor, SGC707, enhanced antiviral capability. Consistently,prmt3-null zebrafish were more resistant to Spring Viremia of Carp Virus (SVCV) and Grass Carp Reovirus (GCRV) infection. Further assays showed that the overexpression ofprmt3diminished the phosphorylation of irf3 and prmt3 interacted with rig-i. In addition, both zinc-finger domain and catalytic domain of prmt3 were required for the suppressive function ofprmt3on IFN activation. Our findings suggested that zebrafishprmt3negatively regulated the antiviral responses, implicating the vital role ofprmt3-or even arginine methylation-in antiviral innate immunity.	[Zhu, Junji; Liu, Xing; Cai, Xiaolian; Ouyang, Gang; Zha, Huangyuan; Zhou, Ziwen; Liao, Qian; Wang, Jing; Xiao, Wuhan] Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan, Peoples R China; [Zhu, Junji; Cai, Xiaolian; Zhou, Ziwen; Liao, Qian; Xiao, Wuhan] Univ Chinese Acad Sci, Beijing, Peoples R China; [Liu, Xing; Ouyang, Gang; Wang, Jing; Xiao, Wuhan] Minist Agr, Key Lab Aquaculture Dis Control, Wuhan, Peoples R China; [Liu, Xing; Ouyang, Gang; Wang, Jing; Xiao, Wuhan] Chinese Acad Sci, Innovat Seed Design, Wuhan, Peoples R China; [Zha, Huangyuan] Dalian Ocean Univ, Dalian, Peoples R China; [Xiao, Wuhan] Chinese Acad Sci, Inst Hydrobiol, Key Aquat Biodivers & Conservat, Wuhan, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Sciences; Dalian Ocean University; Chinese Academy of Sciences; Institute of Hydrobiology, CAS	Xiao, WH (corresponding author), Chinese Acad Sci, Inst Hydrobiol, Wuhan 430072, Peoples R China.	w-xiao@ihb.ac.cn	Zhu, Junji/AGG-9650-2022; Xiao, Wuhan/GLU-7352-2022; Zhu, Junji/GPF-8726-2022	Zhu, Junji/0000-0003-2968-180X	Strategic Priority Research Program of the Chinese Academy of Sciences [XDA 24010308]; National Natural Science Foundation of China [31721005, 31830101, 31671315]; National Key RAMP;D Program of China [2018YFD0900602]	Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key RAMP;D Program of China	The Strategic Priority Research Program of the Chinese Academy of Sciences, Grant/Award Number: XDA 24010308; The National Natural Science Foundation of China, Grant/Award Number: 31721005, 31830101 and 31671315; National Key R&D Program of China, Grant/Award Number: 2018YFD0900602	Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Ahne W, 2002, DIS AQUAT ORGAN, V52, P261, DOI 10.3354/dao052261; Bachand F, 2004, EMBO J, V23, P2641, DOI 10.1038/sj.emboj.7600265; Blanc RS, 2017, MOL CELL, V65, P8, DOI 10.1016/j.molcel.2016.11.003; Cai XL, 2018, J BIOL CHEM, V293, P15370, DOI 10.1074/jbc.RA118.003004; Cai X, 2014, MOL CELL, V54, P289, DOI 10.1016/j.molcel.2014.03.040; Cao XT, 2016, NAT REV IMMUNOL, V16, P35, DOI 10.1038/nri.2015.8; Choi S, 2008, BBA-GEN SUBJECTS, V1780, P1062, DOI 10.1016/j.bbagen.2008.05.010; Dionne KL, 2019, J BIOL CHEM, V294, P1944, DOI 10.1074/jbc.RA118.004928; Dong CW, 2007, FISH SHELLFISH IMMUN, V22, P380, DOI 10.1016/j.fsi.2006.06.010; Feng Y, 2013, J BIOL CHEM, V288, P37010, DOI 10.1074/jbc.M113.525345; Frankel A, 2000, J BIOL CHEM, V275, P32974, DOI 10.1074/jbc.M006445200; Galindo-Villegas J, 2012, P NATL ACAD SCI USA, V109, pE2605, DOI 10.1073/pnas.1209920109; Gomez-Casado E, 2011, VACCINE, V29, P2657, DOI 10.1016/j.vaccine.2011.01.097; Goubau D, 2014, NATURE, V514, P372, DOI 10.1038/nature13590; Goubau D, 2013, IMMUNITY, V38, P855, DOI 10.1016/j.immuni.2013.05.007; Greenblatt SM, 2016, EXP HEMATOL, V44, P435, DOI 10.1016/j.exphem.2016.03.009; Infantino S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01009-1; Ji JF, 2018, J IMMUNOL, V200, P573, DOI 10.4049/jimmunol.1701149; Jiang XM, 2012, IMMUNITY, V36, P959, DOI 10.1016/j.immuni.2012.03.022; Kaniskan HU, 2015, ANGEW CHEM INT EDIT, V54, P5166, DOI 10.1002/anie.201412154; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kim J, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/6058147; Liu F, 2015, J CLIN INVEST, V125, P3532, DOI 10.1172/JCI81749; Liu J, 2016, IMMUNITY, V45, P15, DOI 10.1016/j.immuni.2016.06.020; Liu X, 2016, J IMMUNOL, V197, P4736, DOI 10.4049/jimmunol.1601187; Liu X, 2015, J BIOL CHEM, V290, P25933, DOI 10.1074/jbc.M115.663542; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Miyata S, 2010, BRAIN RES, V1352, P11, DOI 10.1016/j.brainres.2010.07.033; Paludan SR, 2013, IMMUNITY, V38, P870, DOI 10.1016/j.immuni.2013.05.004; Peng C, 2017, EXPERT REV PROTEOMIC, V14, P157, DOI 10.1080/14789450.2017.1275573; Rao YL, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/670437; Raposo AE, 2018, CELL DIV, V13, DOI 10.1186/s13008-018-0036-2; ROY P, 1978, J VIROL, V25, P912, DOI 10.1128/JVI.25.3.912-916.1978; Swiercz R, 2005, BIOCHEM J, V386, P85, DOI 10.1042/BJ20041466; Swiercz R, 2007, J BIOL CHEM, V282, P16917, DOI 10.1074/jbc.M609778200; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tan XJ, 2018, ANNU REV MICROBIOL, V72, P447, DOI 10.1146/annurev-micro-102215-095605; Tang J, 1998, J BIOL CHEM, V273, P16935, DOI 10.1074/jbc.273.27.16935; Tikhanovich I, 2017, J BIOL CHEM, V292, P6882, DOI 10.1074/jbc.M117.778761; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Webb LM, 2017, J IMMUNOL, V198, P1439, DOI 10.4049/jimmunol.1601702; Wesche J, 2017, CELL MOL LIFE SCI, V74, P3305, DOI 10.1007/s00018-017-2515-z; Xu J, 2017, P NATL ACAD SCI USA, V114, P8620, DOI 10.1073/pnas.1700917114; Yang YZ, 2013, NAT REV CANCER, V13, P37, DOI 10.1038/nrc3409; Ying ZZ, 2015, J IMMUNOL, V195, P1538, DOI 10.4049/jimmunol.1500224; Zhang H., 2018, INT J CONTROL AUTOM INT J CONTROL AUTOM, V16, P1; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091; Zhu JJ, 2020, FASEB J, V34, P988, DOI 10.1096/fj.201902219R	49	16	16	4	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10212	10227		10.1096/fj.201902569R	http://dx.doi.org/10.1096/fj.201902569R		JUL 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32643209	Bronze			2022-12-28	WOS:000547819100001
J	Tay, HM; Yeap, WH; Dalan, R; Wong, SC; Hou, HW				Tay, Hui Min; Yeap, Wei Hseun; Dalan, Rinkoo; Wong, Siew Cheng; Hou, Han Wei			Increased monocyte-platelet aggregates and monocyte-endothelial adhesion in healthy individuals with vitamin D deficiency	FASEB JOURNAL			English	Article						atherosclerosis; microfluidics; monocytes; vitamin D	CARDIOVASCULAR-DISEASES; GENE-EXPRESSION; EARLY MARKER; ACTIVATION; BINDING; ATHEROSCLEROSIS; SUPPRESSION; MECHANISMS; MIGRATION; SELECTIN	Vitamin D deficiency is a major public health problem worldwide, linked to several chronic diseases including cardiovascular diseases. While immunomodulatory effects of vitamin D on monocytes have been reported in cardiovascular and metabolic diseases, there is limited understanding on monocyte phenotype in healthy individuals with suboptimal vitamin D levels and without any clinical diseases. In this work, we performed label-free, microfluidic isolation of monocytes, and characterized their functional phenotype using flow cytometry and in vitro vascular models in healthy subjects with (n = 7) and without vitamin D deficiency (n = 16). Vitamin D deficient (VitD-Def) subjects (25(OH)D(3)level < 26 ng/mL) expressed significant downregulation of vitamin D receptor (VDR) on monocytes as compared to controls (P < .0001), and VDR expression was well-associated with serum 25(OH)D(3)levels. Increased monocyte-platelet aggregates (MPA), a marker for platelet activation, were also observed in VitD-Def subjects (P < .05) which suggests a pro-inflammatory monocyte phenotype. Monocyte adhesion to endothelial cells, an early-stage atherosclerosis event, was also higher in VitD-Def individuals, and inversely correlated to serum 25(OH)D(3)level (P < .05). Taken together, these results indicate the pro-inflammatory state and atherogenic potential of monocytes in VitD-Def healthy subjects, and propound the use of vitamin D supplementation as a prospective immunomodulatory and anti-inflammatory therapy in atherosclerosis.	[Tay, Hui Min; Hou, Han Wei] Nanyang Technol Univ, Sch Mech & Aerosp Engn, 50 Nanyang Ave,Blk N3,Level 2c,Room 86, Singapore 639798, Singapore; [Yeap, Wei Hseun; Wong, Siew Cheng] ASTAR, Singapore Immunol Network SIgN, 8A Biomed Grove,04-06 Immunos, Singapore 138648, Singapore; [Dalan, Rinkoo] Tan Tock Seng Hosp, Endocrine & Diabet, Singapore, Singapore; [Dalan, Rinkoo; Hou, Han Wei] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore; [Wong, Siew Cheng] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Tan Tock Seng Hospital; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Hou, HW (corresponding author), Nanyang Technol Univ, Sch Mech & Aerosp Engn, 50 Nanyang Ave,Blk N3,Level 2c,Room 86, Singapore 639798, Singapore.; Wong, SC (corresponding author), ASTAR, Singapore Immunol Network SIgN, 8A Biomed Grove,04-06 Immunos, Singapore 138648, Singapore.	Wong_Siew_Cheng@immunol.a-star.edu.sg; hwhou@ntu.edu.sg	Dalan, Rinkoo/C-1099-2019	Dalan, Rinkoo/0000-0001-9769-2696; Hou, Han Wei/0000-0001-6631-6321	National Research Foundation Singapore [NMRC/BNIG/2038/2015]; Singapore Ministry of Health's; National Medical Research Council; Biomedical Research Council (BMRC); ASTAR; Singapore Ministry of Education (MOE) [RG53/18]	National Research Foundation Singapore(National Research Foundation, Singapore); Singapore Ministry of Health's; National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biomedical Research Council (BMRC)(Agency for Science Technology & Research (A*STAR)); ASTAR(Agency for Science Technology & Research (A*STAR)); Singapore Ministry of Education (MOE)(Ministry of Education, Singapore)	National Research Foundation Singapore, Grant/Award Number: NMRC/BNIG/2038/2015; Singapore Ministry of Health's; National Medical Research Council; Biomedical Research Council (BMRC); ASTAR; Singapore Ministry of Education (MOE), Grant/Award Number: RG53/18	Bradfield PF, 2007, BLOOD, V110, P2545, DOI 10.1182/blood-2007-03-078733; Carlberg C, 2018, J STEROID BIOCHEM, V175, P12, DOI 10.1016/j.jsbmb.2016.12.011; Carlberg C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071042; Chen SC, 2010, J STEROID BIOCHEM, V118, P135, DOI 10.1016/j.jsbmb.2009.11.002; Chen Y, 2017, AUDITING-J PRACT TH, V36, P63, DOI 10.2308/ajpt-51574; Dalan R, 2014, IJC METAB ENDOCR, V4, P4, DOI 10.1016/j.ijcme.2014.06.003; Equils O, 2006, CLIN EXP IMMUNOL, V143, P58, DOI 10.1111/j.1365-2249.2005.02961.x; Feldman D, 2014, NAT REV CANCER, V14, P342, DOI 10.1038/nrc3691; Furman MI, 2001, J AM COLL CARDIOL, V38, P1002, DOI 10.1016/S0735-1097(01)01485-1; Gautier EL, 2009, ARTERIOSCL THROM VAS, V29, P1412, DOI 10.1161/ATVBAHA.108.180505; Giulietti A, 2007, DIABETES RES CLIN PR, V77, P47, DOI 10.1016/j.diabres.2006.10.007; Gudbrandsdottir S, 2013, J IMMUNOL, V191, P4059, DOI 10.4049/jimmunol.1201103; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Heikkinen S, 2011, NUCLEIC ACIDS RES, V39, P9181, DOI 10.1093/nar/gkr654; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hossein-nezhad A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058725; Kassi E, 2013, CIRCULATION, V128, P2517, DOI 10.1161/CIRCULATIONAHA.113.002654; Kim DH, 2008, AM J CARDIOL, V102, P1540, DOI 10.1016/j.amjcard.2008.06.067; Kim S, 2005, J BONE MINER RES, V20, P305, DOI 10.1359/JBMR.041112; Lee JH, 2008, J AM COLL CARDIOL, V52, P1949, DOI 10.1016/j.jacc.2008.08.050; Lee YT, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-016-0402-5; Liaskou E, 2013, HEPATOLOGY, V57, P385, DOI 10.1002/hep.26016; Linden MD, 2010, INT J BIOCHEM CELL B, V42, P1762, DOI 10.1016/j.biocel.2010.07.012; Luu NT, 2007, ATHEROSCLEROSIS, V193, P259, DOI 10.1016/j.atherosclerosis.2006.08.050; Michelson AD, 2001, CIRCULATION, V104, P1533, DOI 10.1161/hc3801.095588; Muscogiuri G, 2012, NUTR METAB CARDIOVAS, V22, P81, DOI 10.1016/j.numecd.2011.11.001; Noble KE, 1996, EUR J IMMUNOL, V26, P2944, DOI 10.1002/eji.1830261221; Oh JS, 2015, CELL REP, V10, P1872, DOI 10.1016/j.celrep.2015.02.043; Oh J, 2009, CIRCULATION, V120, P687, DOI 10.1161/CIRCULATIONAHA.109.856070; Olsen KS, 2013, EUR J CLIN NUTR, V67, P773, DOI 10.1038/ejcn.2013.53; Passacquale G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025595; Patko Z, 2012, INTERV MED APPL SCI, V4, P181, DOI 10.1556/IMAS.4.2012.4.2; Petchakup C, 2018, BIOSENS BIOELECTRON, V118, P195, DOI 10.1016/j.bios.2018.07.052; Pike JW, 2017, ENDOCRIN METAB CLIN, V46, P815, DOI 10.1016/j.ecl.2017.07.001; Ramagopalan SV, 2010, GENOME RES, V20, P1352, DOI 10.1101/gr.107920.110; Riek AE, 2012, J BIOL CHEM, V287, P38482, DOI 10.1074/jbc.M112.386912; Rollo E, 2017, BIOSENS BIOELECTRON, V94, P193, DOI 10.1016/j.bios.2017.02.047; Roth DE, 2018, ANN NY ACAD SCI, V1430, P44, DOI 10.1111/nyas.13968; Sadeghi K, 2006, EUR J IMMUNOL, V36, P361, DOI 10.1002/eji.200425995; Seuter S, 2017, J STEROID BIOCHEM, V174, P314, DOI 10.1016/j.jsbmb.2016.06.003; Shoji T, 2005, J ATHEROSCLER THROMB, V12, P344, DOI 10.5551/jat.12.344; Tay HM, 2018, ANAL CHEM, V90, P14535, DOI 10.1021/acs.analchem.8b04415; TERAMOTO T, 1995, BIOCHEM BIOPH RES CO, V215, P199, DOI 10.1006/bbrc.1995.2453; von Essen MR, 2010, NAT IMMUNOL, V11, P344, DOI 10.1038/ni.1851; Vukic M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124339; Weng S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054625; Zhang Y, 2012, J IMMUNOL, V188, P2127, DOI 10.4049/jimmunol.1102412	47	7	8	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					11133	11142		10.1096/fj.202000822R	http://dx.doi.org/10.1096/fj.202000822R		JUL 2020	10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32627899				2022-12-28	WOS:000547607500001
J	Hsueh, AJW; Feng, Y				Hsueh, Aaron J. W.; Feng, Yi			Discovery of polypeptide ligand-receptor pairs based on their co-evolution	FASEB JOURNAL			English	Review						co-evolution; evolutionary genomics; ligand; receptor; reproduction	LUTEINIZING-HORMONE RECEPTOR; GONADOTROPIN BETA-SUBUNIT; WNT/BETA-CATENIN; THYROTROPIN RECEPTORS; INSULIN-RESISTANCE; ORPHAN RECEPTORS; PROTEIN; LGR4; GENES; STIMULATION	Sequencing diverse genomes allowed the tracing of orthologous and paralogous genes to understand the co-evolution of polypeptide ligands and receptors. This review documents the discovery of several polypeptide ligands and their cognate receptors mainly expressed in the reproductive tissue using evolutionary genomics. We discussed the sub-functionization of paralogs and co-evolution of ligand-receptor families. Based on the conserved signaling among paralogous receptors and common knock-out phenotypes of ligand-receptor pairs, relationships between relaxin family peptides and leucine-rich repeat-containing, G protein-coupled receptors (LGR) were revealed. We also described the identification of a novel paralogous glycoprotein hormone thyrostimulin and design of a long-acting FSH. Human stresscopin and stresscopin-related peptide, paralogous to CRH, were also identified based on the conserved signaling pathways. Recently, a novel ligand placensin expressed in human placenta was found based on the paralogous relationship with a metabolic hormone asprosin. Placensin likely contributes to stage-dependent increases in insulin resistance during human pregnancy and its elevated secretion was associated with gestational diabetes mellitus. Although many ligands were predicted based on sequence signatures, ligands of shorter sequences have not been identified, together with many "orphan" receptors without known ligands. Future development of tools for predicting ligands and high throughput assays to identify ligand-receptor pairs based on ligand binding and/or signal transduction could advance hormone-based physiology and pathophysiology.	[Hsueh, Aaron J. W.; Feng, Yi] Stanford Univ, Div Reprod & Stem Cell Biol, Dept Obstet, Sch Med, Stanford, CA 94305 USA; [Hsueh, Aaron J. W.; Feng, Yi] Stanford Univ, Div Reprod & Stem Cell Biol, Dept Gynecol, Sch Med, Stanford, CA 94305 USA; [Feng, Yi] Fudan Univ, State Key Lab Med Neurobiol, Dept Integrat Med & Neurobiol,Inst Brain Sci, Sch Basic Med Sci,Inst Integrat Med, Shanghai, Peoples R China	Stanford University; Stanford University; Fudan University	Hsueh, AJW (corresponding author), Stanford Univ, Div Reprod & Stem Cell Biol, Dept Obstet, Sch Med, Stanford, CA 94305 USA.; Hsueh, AJW (corresponding author), Stanford Univ, Div Reprod & Stem Cell Biol, Dept Gynecol, Sch Med, Stanford, CA 94305 USA.	aaron.hsueh@stanford.edu			National Natural Science Foundation of China [81673766, 81973945]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China, Grant/Award Number: 81673766 and 81973945	Bale TL, 2004, ANNU REV PHARMACOL, V44, P525, DOI 10.1146/annurev.pharmtox.44.101802.121410; Bassett JHD, 2015, ENDOCRINOLOGY, V156, P3098, DOI 10.1210/en.2014-1943; Beckers NGM, 2003, FERTIL STERIL, V79, P621, DOI 10.1016/S0015-0282(02)04804-5; BO M, 1992, J BIOL CHEM, V267, P3179; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; CATALANO PM, 1991, AM J OBSTET GYNECOL, V165, P1667, DOI 10.1016/0002-9378(91)90012-G; Chen J, 2020, SCIENCE, V367, P1140, DOI 10.1126/science.aay0262; Cheng CK, 2005, ENDOCR REV, V26, P283, DOI 10.1210/er.2003-0039; Cheng Y, 2013, FASEB J, V27, P2175, DOI 10.1096/fj.12-223412; Davis ME, 2007, EUR HEART J, V28, P2589, DOI 10.1093/eurheartj/ehm340; Deng C, 2013, J CELL SCI, V126, P2060, DOI 10.1242/jcs.123471; Devroey P, 2009, HUM REPROD, V24, P3063, DOI 10.1093/humrep/dep291; Dinopoulou V, 2013, ENDOCRINOLOGY, V154, P222, DOI 10.1210/en.2012-1838; Edson MA, 2010, ENDOCRINOLOGY, V151, P358, DOI 10.1210/en.2009-0760; FARES FA, 1992, P NATL ACAD SCI USA, V89, P4304, DOI 10.1073/pnas.89.10.4304; Faurholm B, 2001, GENOMICS, V78, P15, DOI 10.1006/geno.2001.6650; Gallardo TD, 2007, GENETICS, V177, P179, DOI 10.1534/genetics.107.074823; Glinka A, 2011, EMBO REP, V12, P1055, DOI 10.1038/embor.2011.175; Haegebarth A, 2009, AM J PATHOL, V174, P715, DOI 10.2353/ajpath.2009.080758; Hsu SY, 1998, MOL ENDOCRINOL, V12, P1830, DOI 10.1210/me.12.12.1830; Hsu SY, 2002, SCIENCE, V295, P671, DOI 10.1126/science.1065654; Hsu SY, 2000, MOL ENDOCRINOL, V14, P1257, DOI 10.1210/me.14.8.1257; Hsu SY, 2001, NAT MED, V7, P605, DOI 10.1038/87936; Hsueh AJ, 2018, BIOL REPROD, V99, P3, DOI 10.1093/biolre/ioy012; Hsueh AJW, 2005, J ENDOCRINOL, V187, P333, DOI 10.1677/joe.1.06372; Karponis Dimitrios, 2017, Endocr Regul, V51, P117, DOI 10.1515/enr-2017-0012; Kishimoto T, 2000, NAT GENET, V24, P415, DOI 10.1038/74271; Kudo M, 1996, J BIOL CHEM, V271, P22470, DOI 10.1074/jbc.271.37.22470; Kumagai J, 2002, J BIOL CHEM, V277, P31283, DOI 10.1074/jbc.C200398200; LAPOLT PS, 1992, ENDOCRINOLOGY, V131, P2514, DOI 10.1210/en.131.6.2514; LAUE L, 1995, P NATL ACAD SCI USA, V92, P1906, DOI 10.1073/pnas.92.6.1906; Li C, 2007, P NATL ACAD SCI USA, V104, P4206, DOI 10.1073/pnas.0611641104; Luhmann UFO, 2005, GENESIS, V42, P253, DOI 10.1002/gene.20141; Luo CW, 2005, P NATL ACAD SCI USA, V102, P2820, DOI 10.1073/pnas.0409916102; Ma XT, 2016, ENDOCRINOLOGY, V157, P1248, DOI 10.1210/en.2015-1750; MATZUK MM, 1990, ENDOCRINOLOGY, V126, P376, DOI 10.1210/endo-126-1-376; Mazerbourg S, 2004, MOL ENDOCRINOL, V18, P2241, DOI 10.1210/me.2004-0133; Mendive F, 2006, DEV BIOL, V290, P421, DOI 10.1016/j.ydbio.2005.11.043; Muramatsu Y, 2001, J CLIN ENDOCR METAB, V86, P1362, DOI 10.1210/jc.86.3.1362; Nagirnaja L, 2010, MOL CELL ENDOCRINOL, V329, P4, DOI 10.1016/j.mce.2010.04.024; Nakabayashi K, 2002, J CLIN INVEST, V109, P1445, DOI 10.1172/JCI200214340; Nef S, 1999, NAT GENET, V22, P295, DOI 10.1038/10364; Overbeek PA, 2001, GENESIS, V30, P26, DOI 10.1002/gene.1029; Pan HJ, 2014, ENDOCRINOLOGY, V155, P3624, DOI 10.1210/en.2013-2183; Piontkivska H, 2002, MOL BIOL EVOL, V19, P689, DOI 10.1093/oxfordjournals.molbev.a004127; Qian Y, 2013, DEVELOPMENT, V140, P1751, DOI 10.1242/dev.093641; Romere C, 2016, CELL, V165, P566, DOI 10.1016/j.cell.2016.02.063; Ruan XH, 2019, MOL THER-ONCOLYTICS, V14, P94, DOI 10.1016/j.omto.2019.04.002; Schuh-Huerta SM, 2012, HUM GENET, V131, P1709, DOI 10.1007/s00439-012-1184-0; Smith GW, 1998, NEURON, V20, P1093, DOI 10.1016/S0896-6273(00)80491-2; Sone M, 2013, FASEB J, V27, P4917, DOI 10.1096/fj.13-232215; Sudo S, 2005, ENDOCRINOLOGY, V146, P3596, DOI 10.1210/en.2005-0317; Sudo S, 2003, J BIOL CHEM, V278, P7855, DOI 10.1074/jbc.M212457200; Sun SC, 2010, J BIOL CHEM, V285, P3758, DOI 10.1074/jbc.M109.066266; Sun XF, 2014, FASEB J, V28, P2380, DOI 10.1096/fj.13-248344; Temur M, 2017, GYNECOL ENDOCRINOL, V33, P124, DOI 10.1080/09513590.2016.1240772; Temur M, 2016, GYNECOL ENDOCRINOL, V32, P218, DOI 10.3109/09513590.2015.1110135; Vallejo DM, 2015, SCIENCE, V350, DOI 10.1126/science.aac6767; Xing G, 2012, PLOS ONE, V7; Yu YP, 2020, EMBO REP, V21, DOI 10.15252/embr.201949530; Zimmermann S, 1999, MOL ENDOCRINOL, V13, P681, DOI 10.1210/me.13.5.681	61	1	1	2	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					8824	8832		10.1096/fj.202000779R	http://dx.doi.org/10.1096/fj.202000779R		JUN 2020	9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32501617				2022-12-28	WOS:000539538700001
J	Ke, LY; Chan, HC; Chen, CC; Chang, CF; Lu, PL; Chu, CS; Lai, WT; Shin, SJ; Liu, FT; Chen, CH				Ke, Liang-Yin; Chan, Hua-Chen; Chen, Chih-Chieh; Chang, Chuan-Fa; Lu, Po-Liang; Chu, Chih-Sheng; Lai, Wen-Ter; Shin, Shyi-Jang; Liu, Fu-Tong; Chen, Chu-Huang			Increased APOE glycosylation plays a key role in the atherogenicity of L5 low-density lipoprotein	FASEB JOURNAL			English	Article						APOE; atherosclerosis; electronegative low-density lipoproteins; glycosylation; L5 LDL	APOLIPOPROTEIN-E; ELECTRONEGATIVE LDL; MYOCARDIAL-INFARCTION; BINDING DOMAIN; NO EVIDENCE; CHOLESTEROL; DISEASE; PROTEIN; DESIALYLATION; SUBFRACTIONS	Low-density lipoprotein (LDL) is heterogeneous, composed of particles with variable atherogenicity. Electronegative L5 LDL exhibits atherogenic properties in vitro and in vivo, and its levels are elevated in patients with increased cardiovascular risk. Apolipoprotein E (APOE) content is increased in L5, but what role APOE plays in L5 function remains unclear. Here, we characterized the contributions of APOE posttranslational modification to L5's atherogenicity. Using two-dimensional electrophoresis and liquid chromatography-mass spectrometry, we studied APOE's posttranslational modification in L5 from human plasma. APOE structures with various glycan residues were predicted. Molecular docking and molecular dynamics simulation were performed to examine the functional changes of APOE resulting from glycosylation. We also examined the effects of L5 deglycosylation on endothelial cell apoptosis. The glycan sequence N-acetylgalactosamine, galactose, and sialic acid was consistently expressed on serine 94, threonine 194, and threonine 289 of APOE in L5 and was predicted to contribute to L5's negative surface charge and hydrophilicity. The electrostatic force between the negatively charged sialic acid-containing glycan residue of APOE and positively charged amino acids at the receptor-binding area suggested that glycosylation interferes with APOE's attraction to receptors, lipid-binding ability, and lipid transportation and metabolism functions. Importantly, L5 containing glycosylated APOE induced apoptosis in cultured endothelial cells through lectin-like oxidized LDL receptor-1 (LOX-1) signaling, and glycosylation removal from L5 attenuated L5-induced apoptosis. APOE glycosylation may contribute to the atherogenicity of L5 and be a useful biomarker for rapidly quantifying L5.	[Ke, Liang-Yin; Chan, Hua-Chen; Chen, Chu-Huang] Texas Heart Inst, Vasc & Med Res, 6770 Bertner Ave, Houston, TX 77030 USA; [Ke, Liang-Yin; Chan, Hua-Chen; Lu, Po-Liang; Chu, Chih-Sheng] Kaohsiung Med Univ, Lipid Sci & Aging Res Ctr, Kaohsiung Med Univ Hosp, Ctr Lipid Biosci, Kaohsiung, Taiwan; [Ke, Liang-Yin; Chang, Chuan-Fa] Kaohsiung Med Univ, Coll Hlth Sci, Dept Med Lab Sci & Biotechnol, Kaohsiung, Taiwan; [Ke, Liang-Yin; Lai, Wen-Ter; Shin, Shyi-Jang] Kaohsiung Med Univ, Drug Dev & Value Creat Res Ctr, Coll Med, Grad Inst Med, Kaohsiung, Taiwan; [Chen, Chih-Chieh] Natl Sun Yat Sen Univ, Inst Med Sci & Technol, Kaohsiung, Taiwan; [Chang, Chuan-Fa] Natl Cheng Kung Univ, Coll Med, Dept Med Lab Sci & Biotechnol, Tainan, Taiwan; [Chu, Chih-Sheng; Lai, Wen-Ter; Shin, Shyi-Jang] Kaohsiung Med Univ Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Liu, Fu-Tong] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Liu, Fu-Tong] Univ Calif Davis, Sch Med, Dept Dermatol, Sacramento, CA 95817 USA; [Chen, Chu-Huang] New York Heart Res Fdn, New York, NY USA	Texas Heart Institute; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; National Sun Yat Sen University; National Cheng Kung University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Academia Sinica - Taiwan; University of California System; University of California Davis	Chen, CH (corresponding author), Texas Heart Inst, Vasc & Med Res, 6770 Bertner Ave, Houston, TX 77030 USA.; Ke, LY (corresponding author), Kaohsiung Med Univ, Med Lab Sci & Biotechnol, 100 Tzyou Rd,Int Res Bldg 11F Ctr Lipid Biosci, Kaohsiung 807, Taiwan.	kly@gap.kmu.edu.tw; cchen@texasheart.org	Chang, Chuan-Fa/F-8660-2011; Liu, FU-TONG/A-5749-2019; Ke, Liang-Yin/A-2778-2009	Chang, Chuan-Fa/0000-0003-2404-1248; Liu, FU-TONG/0000-0002-3354-1001; Ke, Liang-Yin/0000-0002-2547-0987	Vascular and Medicinal Research Fund, Texas Heart Institute [765-64050]; KMU [KMU-TP105D14, KMU-DK107012, KMU-TC108A03-0]; Taiwan Ministry of Science and Technology [105-2320-B-037-004-MY3, 106-2314-B-037-069-]	Vascular and Medicinal Research Fund, Texas Heart Institute; KMU; Taiwan Ministry of Science and Technology	This work was supported in part by grants from the Vascular and Medicinal Research Fund, Texas Heart Institute (#765-64050) to C-HC; KMU (KMU-TP105D14, KMU-DK107012, KMU-TC108A03-0) to L-YK; and Taiwan Ministry of Science and Technology (105-2320-B-037-004-MY3 and 106-2314-B-037-069-) to L-YK and C-HC	Akyol S, 2017, TRENDS CARDIOVAS MED, V27, P239, DOI 10.1016/j.tcm.2016.11.002; AVIRAM M, 1983, BIOCHEM MED METAB B, V30, P111, DOI 10.1016/0006-2944(83)90013-3; AVOGARO P, 1988, ARTERIOSCLEROSIS, V8, P79, DOI 10.1161/01.ATV.8.1.79; Bancells C, 2010, J LIPID RES, V51, P3508, DOI 10.1194/jlr.M009258; Chan HC, 2013, BLOOD, V122, P3632, DOI 10.1182/blood-2013-05-504639; Chappey B, 1995, BBA-LIPID LIPID MET, V1259, P261, DOI 10.1016/0005-2760(95)00172-7; Chappey B, 1998, ARTERIOSCL THROM VAS, V18, P876, DOI 10.1161/01.ATV.18.6.876; Chen CH, 2003, CIRCULATION, V107, P2102, DOI 10.1161/01.CIR.0000065220.70220.F7; Chen CH, 2012, DIABETES CARE, V35, P648, DOI 10.2337/dc11-1623; Chen HH, 2007, J LIPID RES, V48, P177, DOI 10.1194/jlr.M500481-JLR200; Chen JL, 2011, P NATL ACAD SCI USA, V108, P14813, DOI 10.1073/pnas.1106420108; Chu CS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30243-w; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; De Castellarnau C, 2000, ARTERIOSCL THROM VAS, V20, P2281; Demuth K, 1996, ARTERIOSCL THROM VAS, V16, P773, DOI 10.1161/01.ATV.16.6.773; Fernandes CL, 2010, CARBOHYD RES, V345, P663, DOI 10.1016/j.carres.2009.12.018; Ferretti G, 2018, J CELL PHYSIOL, V233, P2966, DOI 10.1002/jcp.26050; Flowers SA, 2020, NEUROBIOL DIS, V136, DOI 10.1016/j.nbd.2019.104724; Flowers SA, 2020, GLYCOBIOLOGY, V30, P74, DOI 10.1093/glycob/cwz084; Gerber PA, 2017, CURR OPIN CARDIOL, V32, P454, DOI 10.1097/HCO.0000000000000410; Geromanos SJ, 2009, PROTEOMICS, V9, P1683, DOI 10.1002/pmic.200800562; Grundy SM, 2019, J AM COLL CARDIOL, V73, pE285, DOI 10.1016/j.jacc.2018.11.003; Hsu KC, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S33; Huang TT, 2015, NUCLEIC ACIDS RES, V43, pW338, DOI 10.1093/nar/gkv454; INNERARITY TL, 1983, J BIOL CHEM, V258, P2341; Ivanova EA, 2015, VASC HEALTH RISK MAN, V11, P525, DOI 10.2147/VHRM.S74697; Kandt C, 2007, METHODS, V41, P475, DOI 10.1016/j.ymeth.2006.08.006; Ke LY, 2017, J CLIN ENDOCR METAB, V102, P4615, DOI 10.1210/jc.2017-01657; Ke LY, 2016, J MED CHEM, V59, P1032, DOI 10.1021/acs.jmedchem.5b01534; Ke LY, 2014, CURR ATHEROSCLER REP, V16, DOI 10.1007/s11883-014-0428-y; Ke LY, 2011, PURE APPL CHEM, V83, P1731, DOI 10.1351/PAC-CON-10-12-07; Krahenbuhl S, 2016, DRUGS, V76, P1175, DOI 10.1007/s40265-016-0613-0; Lemkul JA, 2010, J CHEM INF MODEL, V50, P2221, DOI 10.1021/ci100335w; Libby P, 2018, J AM COLL CARDIOL, V72, P2071, DOI 10.1016/j.jacc.2018.08.1043; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; LOHSE P, 1991, J BIOL CHEM, V266, P10479; Lu J, 2008, DIABETES, V57, P158, DOI 10.2337/db07-1287; Lu J, 2009, CIRC RES, V104, P619, DOI 10.1161/CIRCRESAHA.108.190116; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Mbeunkui F, 2011, PROTEOMICS, V11, P898, DOI 10.1002/pmic.200900698; OREKHOV AN, 1989, BIOCHEM BIOPH RES CO, V162, P206, DOI 10.1016/0006-291X(89)91982-7; Pendse AA, 2009, J LIPID RES, V50, pS178, DOI 10.1194/jlr.R800070-JLR200; Rivas-Urbina A, 2019, CURR MED CHEM, V26, P1665, DOI 10.2174/0929867325666180330093953; Savinova OV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104833; Shen MY, 2016, BLOOD, V127, P1336, DOI 10.1182/blood-2015-05-646117; Sobenin IA, 1998, J LIPID RES, V39, P2293; Solanki A, 2018, PHARMACOL THERAPEUT, V187, P1, DOI 10.1016/j.pharmthera.2018.02.002; Swarnakar S, 1998, J BIOL CHEM, V273, P12140, DOI 10.1074/jbc.273.20.12140; Tang D, 2008, J LIPID RES, V49, P33, DOI 10.1194/jlr.M700305-JLR200; Varki A., 2017, ESSENTIALS GLYCOBIOL; Vedhachalam C, 2007, BIOCHEMISTRY-US, V46, P2583, DOI 10.1021/bi602407r; Wadhera RK, 2016, J CLIN LIPIDOL, V10, P472, DOI 10.1016/j.jacl.2015.11.010; Wilson Nicole, 2009, V534, P205, DOI 10.1007/978-1-59745-022-5_15; Winklhofer-Roob BM, 2017, FREE RADICAL BIO MED, V111, P38, DOI 10.1016/j.freeradbiomed.2017.04.345; Yang CY, 2003, ARTERIOSCL THROM VAS, V23, P1083, DOI 10.1161/01.ATV.0000071350.78872.C4; Zhu CH, 2019, J PROTEOME RES, V18, P3977, DOI 10.1021/acs.jproteome.9b00450	57	12	12	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9802	9813		10.1096/fj.202000659R	http://dx.doi.org/10.1096/fj.202000659R		JUN 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32501643				2022-12-28	WOS:000539538400001
J	Zhu, H; Peng, B; Klausen, C; Yi, YY; Li, Y; Xiong, SY; von Dadelszen, P; Leung, PCK				Zhu, Hua; Peng, Bo; Klausen, Christian; Yi, Yuyin; Li, Yan; Xiong, Siyuan; von Dadelszen, Peter; Leung, Peter C. K.			NPFF increases fusogenic proteins syncytin 1 and syncytin 2 via GCM1 in first trimester primary human cytotrophoblast cells	FASEB JOURNAL			English	Article						hCG; Neuropeptide FF; NPFFR2; placenta; trophoblast	W ENV GLYCOPROTEIN; NEUROPEPTIDE-FF; HERV-W; SPINAL-CORD; FUNCTIONAL-CHARACTERIZATION; NERVOUS-SYSTEM; HUMAN PLACENTA; EXPRESSION; RECEPTOR; TROPHOBLAST	Neuropeptide FF (NPFF) is well-known for its roles in the central nervous system. Despite studies demonstrating that NPFF receptor 2 (NPFFR2) mRNA is highest in placenta, nothing is known about NPFF-NPFFR2 functions in placental development. Here, we investigated the effects of NPFF-NPFFR2 on expression of syncytial [human chorionic gonadotropin (hCG) beta] and fusogenic [syncytin 1, syncytin 2, and glial cells missing 1 (GCM1)] genes in first trimester primary human cytotrophoblast cells. By analyzing two publicly available microarray data sets, we found that NPFF is consistently expressed throughout gestation whereas NPFFR2 increases in first trimester and is elevated in placenta samples from women with preeclampsia. Immunohistochemistry showed that NPFFR2, syncytin 1/2, and GCM1 each displayed unique patterns of expression among different trophoblast populations in first trimester placenta. Treatment of primary human cytotrophoblast cells with NPFF increased the mRNA and protein levels of hCG beta, syncytin 1, syncytin 2, and GCM1; and knockdown of NPFFR2 abolished these effects. Interestingly, GCM1 mediated NPFF-induced upregulation of syncytin 1 and syncytin 2, but not hCG beta, in primary human cytotrophoblasts. Our results demonstrate that NPFF acts via NPFFR2 to enhance production of hCG beta and promote GCM1-dependent expression of syncytin 1 and 2 in human cytotrophoblasts.	[Zhu, Hua; Peng, Bo; Klausen, Christian; Yi, Yuyin; Li, Yan; Xiong, Siyuan; Leung, Peter C. K.] Univ British Columbia, BC Childrens Hosp Res Inst, Dept Obstet & Gynaecol, Room 317,950 West 28th Ave, Vancouver, BC V5Z 4H4, Canada; [von Dadelszen, Peter] Kings Coll London, Global Womens Hlth, London, England	University of British Columbia; University of London; King's College London	Leung, PCK (corresponding author), Univ British Columbia, BC Childrens Hosp Res Inst, Dept Obstet & Gynaecol, Room 317,950 West 28th Ave, Vancouver, BC V5Z 4H4, Canada.	peter.leung@ubc.ca	von Dadelszen, Peter/AAP-7480-2021	von Dadelszen, Peter/0000-0003-4136-3070; Leung, Peter/0000-0003-3152-3800; Peng, Bo/0000-0002-3142-547X; Li, Yan/0000-0003-1813-8115	Canadian Institute of Health Research Foundation [143317]	Canadian Institute of Health Research Foundation(Canadian Institutes of Health Research (CIHR))	Canadian Institute of Health Research Foundation, Grant/Award Number: 143317	Akiyama Y, 1996, P NATL ACAD SCI USA, V93, P14912, DOI 10.1073/pnas.93.25.14912; ALLARD M, 1991, NEUROSCIENCE, V40, P81, DOI 10.1016/0306-4522(91)90176-O; Anko ML, 2006, J NEUROCHEM, V96, P573, DOI 10.1111/j.1471-4159.2005.03581.x; Bjerregaard B, 2006, CELL MOL LIFE SCI, V63, P1906, DOI 10.1007/s00018-006-6201-9; Bjerregaard B, 2014, J ASSIST REPROD GEN, V31, P533, DOI 10.1007/s10815-014-0224-1; Blond JL, 2000, J VIROL, V74, P3321, DOI 10.1128/JVI.74.7.3321-3329.2000; Blond JL, 1999, J VIROL, V73, P1175, DOI 10.1128/JVI.73.2.1175-1185.1999; Bonini JA, 2000, J BIOL CHEM, V275, P39324, DOI 10.1074/jbc.M004385200; Chen CP, 2008, BIOL REPROD, V79, P815, DOI 10.1095/biolreprod.108.069765; Cheng YH, 2005, BIOL REPROD, V73, P500, DOI 10.1095/biolreprod.105.039941; Cheong ML, 2016, MOL CELL BIOL, V36, P197, DOI 10.1128/MCB.00655-15; Cole LA, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-8; DAMSKY CH, 1992, J CLIN INVEST, V89, P210, DOI 10.1172/JCI115565; Elshourbagy NA, 2000, J BIOL CHEM, V275, P25965, DOI 10.1074/jbc.M004515200; Frendo JL, 2003, MOL CELL BIOL, V23, P3566, DOI 10.1128/MCB.23.10.3566-3574.2003; Gherardi N, 1997, PEPTIDES, V18, P577, DOI 10.1016/S0196-9781(97)00071-5; Gimenez J, 2009, DNA RES, V16, P195, DOI 10.1093/dnares/dsp011; Gouarderes C, 2007, NEUROPHARMACOLOGY, V52, P376, DOI 10.1016/j.neuropharm.2006.07.034; GOUARDERES C, 1993, EUR J PHARMACOL, V237, P73, DOI 10.1016/0014-2999(93)90095-Y; Grandi N, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00462; Huang Q, 2013, CELL SIGNAL, V25, P1027, DOI 10.1016/j.cellsig.2013.01.008; Kim JS, 1998, P NATL ACAD SCI USA, V95, P12364, DOI 10.1073/pnas.95.21.12364; KIVIPELTO L, 1989, J COMP NEUROL, V286, P269, DOI 10.1002/cne.902860211; Knerr I, 2005, FEBS LETT, V579, P3991, DOI 10.1016/j.febslet.2005.06.029; Knerr I, 2007, APOPTOSIS, V12, P37, DOI 10.1007/s10495-006-0329-9; Kotani M, 2001, BRIT J PHARMACOL, V133, P138, DOI 10.1038/sj.bjp.0704038; Leavey K, 2016, HYPERTENSION, V68, P137, DOI 10.1161/HYPERTENSIONAHA.116.07293; LEE CH, 1993, EUR J NEUROSCI, V5, P1339, DOI 10.1111/j.1460-9568.1993.tb00920.x; Liang CY, 2010, BIOL REPROD, V83, P387, DOI 10.1095/biolreprod.110.083915; Lu XY, 2017, CELL REP, V21, P1150, DOI 10.1016/j.celrep.2017.10.019; MAJANE EA, 1993, ENDOCRINOLOGY, V133, P1578, DOI 10.1210/en.133.4.1578; MAJANE EA, 1989, BRAIN RES, V494, P1, DOI 10.1016/0006-8993(89)90137-6; MAJANE EA, 1990, PEPTIDES, V11, P345, DOI 10.1016/0196-9781(90)90091-I; Malassine A, 2007, PLACENTA, V28, P185, DOI 10.1016/j.placenta.2006.03.001; Malassine A, 2005, PLACENTA, V26, P556, DOI 10.1016/j.placenta.2004.09.002; MALIN DH, 1990, PEPTIDES, V11, P277, DOI 10.1016/0196-9781(90)90082-G; Mangeney M, 2007, P NATL ACAD SCI USA, V104, P20534, DOI 10.1073/pnas.0707873105; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; Panula P, 1996, PROG NEUROBIOL, V48, P461, DOI 10.1016/0301-0082(96)00001-9; Perry SJ, 1997, FEBS LETT, V409, P426, DOI 10.1016/S0014-5793(97)00557-7; PRICE DA, 1977, SCIENCE, V197, P670, DOI 10.1126/science.877582; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Schreiber J, 1997, P NATL ACAD SCI USA, V94, P4739, DOI 10.1073/pnas.94.9.4739; Smallwood A, 2003, BIOL REPROD, V69, P286, DOI 10.1095/biolreprod.102.013078; Soe K, 2011, BONE, V48, P837, DOI 10.1016/j.bone.2010.11.011; Soncin F, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.156273; Stenqvist AC, 2008, AM J REPROD IMMUNOL, V60, P33, DOI 10.1111/j.1600-0897.2008.00588.x; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; TANG J, 1984, P NATL ACAD SCI-BIOL, V81, P5002, DOI 10.1073/pnas.81.15.5002; Toufaily C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121468; Turco MY, 2018, NATURE, V564, P263, DOI 10.1038/s41586-018-0753-3; Vargas A, 2009, J MOL BIOL, V392, P301, DOI 10.1016/j.jmb.2009.07.025; Vilim FS, 1999, MOL PHARMACOL, V55, P804; YANG HYT, 1985, P NATL ACAD SCI USA, V82, P7757, DOI 10.1073/pnas.82.22.7757; Yu CC, 2002, J BIOL CHEM, V277, P50062, DOI 10.1074/jbc.M209316200	55	7	7	3	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9419	9432		10.1096/fj.201902978R	http://dx.doi.org/10.1096/fj.201902978R		JUN 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32501590	Bronze			2022-12-28	WOS:000539537700001
J	Mukherjeel, M; Ratnayake, I; Janga, M; Fogarty, E; Scheidt, S; Grassmeyer, J; DeRiso, J; Chandrasekar, I; Ahrenkiel, SP; Kopan, R; Surendran, K				Mukherjeel, Malini; Ratnayake, Ishara; Janga, Madhusudhana; Fogarty, Eric; Scheidt, Shania; Grassmeyer, Justin; DeRiso, Jennifer; Chandrasekar, Indra; Ahrenkiel, S. Phil; Kopan, Raphael; Surendran, Kameswaran			Notch signaling regulates Akap12 expression and primary cilia length during renal tubule morphogenesis	FASEB JOURNAL			English	Article						Akap12; Alagille; cilia; Notch; tubule morphogenesis	MITOTIC SPINDLE ORIENTATION; POLYCYSTIC KIDNEY-DISEASE; PLANAR CELL POLARITY; BRANCHING MORPHOGENESIS; NEPHRON SEGMENTATION; ALAGILLE-SYNDROME; GENE HES1; AURORA; FATE; RELEASE	Alagille syndrome patients present with loss of function mutations in either JAG1 or NOTCH2. About 40%-50% of patients have kidney abnormalities, and frequently display multicystic, dysplastic kidneys. Additionally, gain-of-function mutations in NOTCH2 are associated with cystic kidneys in Hajdu-Cheney syndrome patients. How perturbations in Notch signaling cause renal tubular cysts remains unclear. Here, we have determined that reduced Notch signaling mediated transcription by ectopic expression of dominant-negative mastermind-like (dnMaml) peptide in the nephrogenic epithelia from after the s-shaped body formation and in the developing collecting ducts results in proximal tubular and collecting duct cysts, respectively. An acute inhibition of Notch signaling for two days during kidney development is sufficient to disrupt tubule formation, and significantly increases Akap12 expression. Ectopic expression of Akap12 in renal epithelia results in abnormally long primary cilia similar to that observed in Notch-signaling-deficient epithelia. Both loss of Notch signaling and elevated Akap12 expression disrupt the ability of renal epithelial cells to form spherical structures with a single lumen when grown embedded in matrix. Interestingly, Akap12 can inhibit Notch signaling mediated transcription, which likely explains how both loss of Notch signaling and ectopic expression of Akap12 result in similar renal epithelial abnormalities. We conclude that Notch signaling regulates Akap12 expression while also ensuring normal primary cilia length and renal epithelial morphogenesis, and suggest that one aspect of diseases associated with defective Notch signaling, such as Alagille syndrome, maybe mechanistically related to ciliopathies.	[Mukherjeel, Malini; Janga, Madhusudhana; Scheidt, Shania; DeRiso, Jennifer; Chandrasekar, Indra; Surendran, Kameswaran] Sanford Res, Pediat & Rare Dis Grp, 2301 East 60th St North, Sioux Falls, SD 57104 USA; [Ratnayake, Ishara; Ahrenkiel, S. Phil] South Dakota Sch Mines & Technol, Dept Nanosci & Nanoengn, Rapid City, SD USA; [Fogarty, Eric] Univ South Dakota, Div Basic Biomed Sci, Sanford Sch Med, Vermillion, SD USA; [Grassmeyer, Justin] Univ Nebraska Med Ctr, Omaha, NE USA; [Chandrasekar, Indra] Sanford Res, Enabling Technol Grp, Sioux Falls, SD USA; [Kopan, Raphael] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA; [Surendran, Kameswaran] Univ South Dakota, Sanford Sch Med, Dept Pediat, Sioux Falls, SD USA	Sanford Health; South Dakota School Mines & Technology; University of South Dakota; University of Nebraska System; University of Nebraska Medical Center; Sanford Health; Cincinnati Children's Hospital Medical Center; University of South Dakota	Surendran, K (corresponding author), Sanford Res, Pediat & Rare Dis Grp, 2301 East 60th St North, Sioux Falls, SD 57104 USA.	kameswaran.surendran@sanfordhealth.org	Kopan, Raphael/AFG-3275-2022; Kopan, Raphael/AAF-1357-2022; Mukherjee, Malini/ABG-1341-2020	Surendran, Kameswaran/0000-0001-5693-4409; Grassmeyer, Justin/0000-0001-9624-9027	NIH [R01DK106135, P20GM10358, P20GM121341, P20GM103620]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	NIH, Grant/Award Number: R01DK106135, P20GM10358, P20GM121341 and P20GM103620	Arnett KL, 2010, NAT STRUCT MOL BIOL, V17, P1312, DOI 10.1038/nsmb.1938; Bateman NW, 2015, J PROTEOME RES, V14, P1900, DOI 10.1021/pr5012894; Bell GP, 2015, CURR BIOL, V25, P61, DOI 10.1016/j.cub.2014.10.052; Berbari NF, 2008, MOL BIOL CELL, V19, P1540, DOI 10.1091/mbc.E07-09-0942; Bettencourt-Dias M, 2011, TRENDS GENET, V27, P307, DOI 10.1016/j.tig.2011.05.004; Bonegio RGB, 2011, KIDNEY INT, V79, P1099, DOI 10.1038/ki.2010.553; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Carroll TJ, 2005, DEV CELL, V9, P283, DOI 10.1016/j.devcel.2005.05.016; Carvalho CA, 2015, CURR BIOL, V25, P53, DOI 10.1016/j.cub.2014.10.053; Cebrian C, 2004, DEV DYNAM, V231, P601, DOI 10.1002/dvdy.20143; Chen LH, 2017, P NATL ACAD SCI USA, V114, pE9989, DOI 10.1073/pnas.1710964114; Cheng HT, 2007, DEVELOPMENT, V134, P801, DOI 10.1242/dev.02773; Chung E, 2017, DEVELOPMENT, V144, P4530, DOI 10.1242/dev.156661; Chung E, 2016, DEVELOPMENT, V143, P3907, DOI 10.1242/dev.143503; Costantini F, 2010, DEV CELL, V18, P698, DOI 10.1016/j.devcel.2010.04.008; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Ezratty EJ, 2011, CELL, V145, P1129, DOI 10.1016/j.cell.2011.05.030; Fischer E, 2006, NAT GENET, V38, P21, DOI 10.1038/ng1701; Gelman IH, 2002, FRONT BIOSCI-LANDMRK, V7, pD1782, DOI 10.2741/gelman; Gelman Irwin H, 2010, Genes Cancer, V1, P1147, DOI 10.1177/1947601910392984; Grisanti L, 2016, DEVELOPMENT, V143, P2160, DOI 10.1242/dev.132704; Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313; Gunay-Aygun M, 2009, AM J MED GENET C, V151C, P296, DOI 10.1002/ajmg.c.30225; Habbig Sandra, 2015, Mol Cell Pediatr, V2, P8, DOI 10.1186/s40348-015-0019-1; Han B, 2015, PFLUG ARCH EUR J PHY, V467, P2401, DOI 10.1007/s00424-015-1718-0; Hartman HA, 2007, DEV BIOL, V310, P379, DOI 10.1016/j.ydbio.2007.08.021; Hartman TR, 2009, HUM MOL GENET, V18, P151, DOI 10.1093/hmg/ddn325; Hehnly H, 2015, ELIFE, V4, DOI 10.7554/eLife.09384; Hildebrandt F, 2007, J AM SOC NEPHROL, V18, P1855, DOI 10.1681/ASN.2006121344; Hopp K, 2012, J CLIN INVEST, V122, P4257, DOI 10.1172/JCI64313; Ilagan MXG, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001656; Ishikawa T, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a028076; Jaffe AB, 2008, J CELL BIOL, V183, P625, DOI 10.1083/jcb.200807121; Jouve C, 2000, DEVELOPMENT, V127, P1421; Kamath BM, 2013, NAT REV NEPHROL, V9, P409, DOI 10.1038/nrneph.2013.102; Kamath BM, 2012, AM J MED GENET A, V158A, P85, DOI 10.1002/ajmg.a.34369; Kobayashi A, 2008, CELL STEM CELL, V3, P169, DOI 10.1016/j.stem.2008.05.020; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Lienkamp SS, 2012, NAT GENET, V44, P1382, DOI 10.1038/ng.2452; Lin FM, 2003, P NATL ACAD SCI USA, V100, P5286, DOI 10.1073/pnas.0836980100; Little MH, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008300; Liu Y, 2007, DEVELOPMENT, V134, P1111, DOI 10.1242/dev.02806; Liu ZY, 2013, DEV CELL, V25, P585, DOI 10.1016/j.devcel.2013.05.022; Maillard I, 2004, BLOOD, V104, P1696, DOI 10.1182/blood-2004-02-0514; Martin SR, 1996, ARCH DIS CHILD, V74, P232, DOI 10.1136/adc.74.3.232; McDaniell R, 2006, AM J HUM GENET, V79, P169, DOI 10.1086/505332; Menezes LF, 2009, METHOD CELL BIOL, V94, P273, DOI 10.1016/S0091-679X(08)94014-0; Morimoto M, 2010, J CELL SCI, V123, P213, DOI 10.1242/jcs.058669; Nakajima Y, 2015, CURR BIOL, V25, pR43, DOI 10.1016/j.cub.2014.11.052; Nam Y, 2006, CELL, V124, P973, DOI 10.1016/j.cell.2005.12.037; Nishimura M, 1998, GENOMICS, V49, P69, DOI 10.1006/geno.1998.5213; Pan JM, 2013, CELL MOL LIFE SCI, V70, P1849, DOI 10.1007/s00018-012-1052-z; Park J, 2018, SCIENCE, V360, P758, DOI 10.1126/science.aar2131; Pazour GJ, 2004, J AM SOC NEPHROL, V15, P2528, DOI 10.1097/01.ASN.0000141055.57643.E0; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rajagopalan R, 2016, AM J MED GENET A, V170, P750, DOI 10.1002/ajmg.a.37512; Regan JL, 2013, CELL REP, V4, P110, DOI 10.1016/j.celrep.2013.05.044; Reiter JF, 2017, NAT REV MOL CELL BIO, V18, P533, DOI 10.1038/nrm.2017.60; Rodriguez-Fraticelli AE, 2010, J CELL BIOL, V189, P725, DOI 10.1083/jcb.201002047; Satir P, 2008, HISTOCHEM CELL BIOL, V129, P687, DOI 10.1007/s00418-008-0416-9; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Self M, 2006, EMBO J, V25, P5214, DOI 10.1038/sj.emboj.7601381; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; SOROKIN S, 1962, J CELL BIOL, V15, P363, DOI 10.1083/jcb.15.2.363; Stratman JL, 2003, TRANSGENIC RES, V12, P521, DOI 10.1023/A:1024225408961; Stubbs JL, 2012, NAT CELL BIOL, V14, P140, DOI 10.1038/ncb2406; Surendran K, 2010, J AM SOC NEPHROL, V21, P819, DOI 10.1681/ASN.2009090925; Surendran K, 2010, DEV BIOL, V337, P386, DOI 10.1016/j.ydbio.2009.11.017; Thoma CR, 2007, NAT CELL BIOL, V9, P588, DOI 10.1038/ncb1579; Tomita K, 1999, GENE DEV, V13, P1203, DOI 10.1101/gad.13.9.1203; Traykova-Brauch M, 2008, NAT MED, V14, P979, DOI 10.1038/nm.1865; Watanabe T, 2004, DEV BIOL, V271, P98, DOI 10.1016/j.ydbio.2004.03.025; Xia W, 2001, CANCER RES, V61, P5644; Yoder BK, 2007, J AM SOC NEPHROL, V18, P1381, DOI 10.1681/ASN.2006111215; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118	75	9	9	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9512	9530		10.1096/fj.201902358RR	http://dx.doi.org/10.1096/fj.201902358RR		MAY 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32474964	Green Submitted, Green Accepted			2022-12-28	WOS:000538128000001
J	Tarnopolsky, MA; Kerkhof, J; Stuart, A; Bujak, A; Nilsson, ML; Hettinga, B; May, L; Rupar, CA; Sadikovic, B				Tarnopolsky, Mark A.; Kerkhof, Jennifer; Stuart, Alan; Bujak, Adam; Nilsson, Mats L.; Hettinga, Bart; May, Linda; Rupar, C. Anthony; Sadikovic, Bekim			Bone marrow-derived mitochondrial DNA has limited capacity for inter-tissue transfer in vivo	FASEB JOURNAL			English	Article						exosomes; extracellular vesicles; microvesicles; mitochondrial transplant; mitochondrial disease	SKELETAL-MUSCLE; TRANSPLANTATION; CELLS; PROTECTS; RESCUE; MTDNA; MELAS; ASTROCYTES; VESICLES; EXERCISE	Studies have shown that mitochondrial DNA (mtDNA) can be exchanged between tissues; however, the mechanism(s) behind this phenomenon remain unclear. Exosomes and other extracellular vesicles (EVs) including microvesicles (MV) have been shown to contain mtDNA. EVs can be derived from a number of tissues; however, the source and relative proportion of EVs containing mtDNA remains unknown. We sampled whole blood and the EV fractions (exosome-enriched, MV-enriched, and apoptotic body-enriched) as well as several tissues (epithelial-cheek and urine sediment), connective (fibroblasts), and skeletal muscle in two subjects who received allogenic bone marrow transplants. Next generation sequencing of the mtDNA confirmed that all EV fractions contained mtDNA and most was derived from the donor, confirming that most of the EV fractions in the serum are bone marrow/blood cell-derived. Even after exposure to the donor mtDNA in EV fractions (and potentially free in the plasma) for years, there was little to no transfer of the donor mtDNA to the host mtDNA fraction in epithelial, connective, or skeletal muscle tissues. These data call into question the potential therapeutic use of bone marrow transplant or EV-based delivery systems for mtDNA-based disorders and establish bone marrow as the primary source of most of the mtDNA enriched EVs in serum.	[Tarnopolsky, Mark A.; Nilsson, Mats L.; May, Linda] McMaster Univ, Dept Pediat, Hamilton, ON L8N 3Z5, Canada; [Kerkhof, Jennifer; Stuart, Alan; Sadikovic, Bekim] London Hlth Sci Ctr, Childrens Hlth Res Inst, Mol Diagnost Div, Mol Genet Lab, London, ON, Canada; [Bujak, Adam; Hettinga, Bart] McMaster Univ, Exerkine Corp, Hamilton, ON, Canada; [Rupar, C. Anthony] Western Univ, Dept Pathol & Lab Med, London, ON, Canada; [Rupar, C. Anthony] Western Univ, Dept Pediat, London, ON, Canada; [Rupar, C. Anthony] Western Univ, Dept Biochem, London, ON, Canada; [Rupar, C. Anthony] Western Univ, Childrens Hlth Res Inst, London, ON, Canada	McMaster University; London Health Sciences Centre; McMaster University; Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Tarnopolsky, MA (corresponding author), McMaster Univ, Dept Pediat, Hamilton, ON L8N 3Z5, Canada.; Sadikovic, B (corresponding author), London Hlth Sci Ctr, Childrens Hlth Res Inst, Mol Genet Lab, London, ON, Canada.	tarnopol@mcmaster.ca; Bekim.Sadikovic@lhsc.on.ca	Nilsson, Mats/AAG-2068-2021	Nilsson, Mats/0000-0001-5656-5578; Stuart, Alan/0000-0001-6370-8581	Canadian Institute of Health Research [143325]; Health Research [143325]; Giant; McMaster University	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Health Research; Giant; McMaster University	Canadian Institute of Health Research, Grant/Award Number: 143325; Health Research, Grant/Award Number: 143325; Giant; McMaster University	Ahmad T, 2014, EMBO J, V33, P994, DOI 10.1002/embj.201386030; Alvarez-Garcia V, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22473-9; Bai YL, 2018, BRIT J HAEMATOL, V181, P11, DOI 10.1111/bjh.15075; Baker JM, 2017, J APPL PHYSIOL, V122, P182, DOI 10.1152/japplphysiol.00696.2016; Berridge MV, 2016, CELL METAB, V24, P376, DOI 10.1016/j.cmet.2016.08.023; Brahmer A, 2019, J EXTRACELL VESICLES, V8, DOI 10.1080/20013078.2019.1615820; Cartoni R, 2005, J PHYSIOL-LONDON, V567, P349, DOI 10.1113/jphysiol.2005.092031; Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Crane JD, 2015, AGING CELL, V14, P625, DOI 10.1111/acel.12341; Devries MC, 2013, J CLIN ENDOCR METAB, V98, P4852, DOI 10.1210/jc.2013-2044; Dreyfus PA, 2004, AM J PATHOL, V164, P773, DOI 10.1016/S0002-9440(10)63165-3; Emani SM, 2018, TRANSL PEDIATR, V7, P169, DOI 10.21037/tp.2018.02.02; Geng X, 2019, DIABETIC MED, V36, P776, DOI 10.1111/dme.13874; Grady JP, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708262; Guescini M, 2010, EXP CELL RES, V316, P1977, DOI 10.1016/j.yexcr.2010.04.006; Guescini M, 2010, J NEURAL TRANSM, V117, P1, DOI 10.1007/s00702-009-0288-8; Haimovich G, 2017, P NATL ACAD SCI USA, V114, pE9873, DOI 10.1073/pnas.1706365114; Halter JP, 2015, BRAIN, V138, P2847, DOI 10.1093/brain/awv226; Hayakawa K, 2016, NATURE, V535, P551, DOI 10.1038/nature18928; Helwa I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170628; Iqbal S, 2013, MUSCLE NERVE, V48, P963, DOI 10.1002/mus.23838; Islam MN, 2012, NAT MED, V18, P759, DOI 10.1038/nm.2736; Itoh K, 2018, J BIOL CHEM, V293, P11809, DOI 10.1074/jbc.RA117.001253; Joanisse S, 2015, AM J PHYSIOL-REG I, V309, pR1101, DOI 10.1152/ajpregu.00249.2015; Kaza AK, 2017, J THORAC CARDIOV SUR, V153, P934, DOI 10.1016/j.jtcvs.2016.10.077; Kelland E, 2016, MOL GENET METAB REP, V6, P64, DOI 10.1016/j.ymgmr.2016.02.003; Kerkhof J, 2017, J MOL DIAGN, V19, P905, DOI 10.1016/j.jmoldx.2017.07.004; KING MP, 1988, CELL, V52, P811, DOI 10.1016/0092-8674(88)90423-0; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Livshts MA, 2015, SCI REP-UK, V5, DOI 10.1038/srep17319; Lotvall J, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.26913; Marcus ME, 2013, PHARMACEUTICALS-BASE, V6, P659, DOI 10.3390/ph6050659; Martijn J, 2018, NATURE, V557, P101, DOI 10.1038/s41586-018-0059-5; Masuzawa A, 2013, AM J PHYSIOL-HEART C, V304, pH966, DOI 10.1152/ajpheart.00883.2012; McCully JD, 2017, MITOCHONDRION, V34, P127, DOI 10.1016/j.mito.2017.03.004; Menck K, 2017, JOVE-J VIS EXP, DOI 10.3791/55057; Murray LMA, 2019, STEM CELLS, V37, P14, DOI 10.1002/stem.2922; Prasad M, 2014, CAN J NEUROL SCI, V41, P210, DOI 10.1017/S0317167100016607; Ribeiro-Rodrigues TM, 2017, J CELL SCI, V130, P3619, DOI 10.1242/jcs.200667; Rikkert LG, 2019, J EXTRACELL VESICLES, V8, DOI 10.1080/20013078.2018.1555419; Schenkel LC, 2016, J MOL DIAGN, V18, P657, DOI 10.1016/j.jmoldx.2016.04.002; Shin B, 2017, ADV EXP MED BIOL, V982, P595, DOI 10.1007/978-3-319-55330-6_31; Spees JL, 2006, P NATL ACAD SCI USA, V103, P1283, DOI 10.1073/pnas.0510511103; Stupka N, 2000, J APPL PHYSIOL, V89, P2325, DOI 10.1152/jappl.2000.89.6.2325; Takamatsu H, 2017, J CLIN MED, V6, DOI 10.3390/jcm6100091; Tarnopolsky MA, 1998, MUSCLE NERVE, V21, P25, DOI 10.1002/(SICI)1097-4598(199801)21:1<25::AID-MUS4>3.3.CO;2-R; Tarnopolsky MA, 2011, MUSCLE NERVE, V43, P717, DOI 10.1002/mus.21945; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; Zaremba-Niedzwiedzka K, 2017, NATURE, V541, P353, DOI 10.1038/nature21031; Zhang BD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049767	51	2	2	0	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9297	9306		10.1096/fj.202000463R	http://dx.doi.org/10.1096/fj.202000463R		MAY 2020	10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32441840				2022-12-28	WOS:000535411400001
J	Kang, N; Matsui, TS; Liu, SY; Fujiwara, S; Deguchi, S				Kang, Na; Matsui, Tsubasa S.; Liu, Shiyou; Fujiwara, Sachiko; Deguchi, Shinji			Comprehensive analysis on the whole Rho-GAP family reveals that ARHGAP4 suppresses EMT in epithelial cells under negative regulation by Septin9	FASEB JOURNAL			English	Article						ARHGAP4; epithelial-mesenchymal transition; FAK; Src pathway; Rho-GAP; Septin9	PROTEINS; MECHANISMS; MIGRATION; NETWORKS; DYNAMICS; GTPASES	Epithelial to mesenchymal transition (EMT) is a fundamental biological process that occurs during development and tumorigenesis. The Rho family of GTPases (Rho-family) is a well-characterized regulator of actin cytoskeleton that gives rise to EMT-associated cell activities. Meanwhile, there are in total at least 66 different Rho-GTPase-activating proteins (Rho-GAPs), which, as an upstream regulator, inactivate specific members of the Rho-family in a cell context-dependent manner. However, molecular roles of individual Rho-GAPs are poorly understood, particularly regarding their involvements in EMT. Here, based on comprehensive screening on the whole Rho-GAP family, we identified specific Rho-GAPs that are responsible for the maintenance of epithelial cell phenotypes, suppressing EMT in human mammary epithelial cells. Specifically, we revealed that at least two Rho-GAPs, that is, ARHGAP4 and SH3BP1, critically regulate the cell morphology. Among them, we focused on ARHGAP4 and demonstrated with multidisciplinary approaches that this specific Rho-GAP regulates epithelial/mesenchymal-selective marker expression, cell proliferation, migration, 3D morphogenesis, and focal adhesion/stress fiber-driven physical force generation in a manner reminiscent of the EMT process. Furthermore, we identified Septin9 with proteomic analyses as a negative regulator of ARHGAP4, which promotes the occurrence of EMT by activation of the FAK/Src signaling pathway. These findings shed light on the novel Rho-GAP-associated pathway in the EMT process under development and tumorigenesis.	[Kang, Na; Matsui, Tsubasa S.; Liu, Shiyou; Fujiwara, Sachiko; Deguchi, Shinji] Osaka Univ, Grad Sch Engn Sci, Div Bioengn, 1-3 Machikaneyama, Toyonaka, Osaka 5608531, Japan; [Fujiwara, Sachiko] Univ Leipzig, Inst Biol, Leipzig, Germany	Osaka University; Leipzig University	Deguchi, S (corresponding author), Osaka Univ, Grad Sch Engn Sci, Div Bioengn, 1-3 Machikaneyama, Toyonaka, Osaka 5608531, Japan.	deguchi@me.es.osaka-u.ac.jp		Fujiwara, Sachiko/0000-0002-5620-637X; Deguchi, Shinji/0000-0002-0556-4599	Chinese Scholarship Council; JSPS [15H03004, 18H03518]	Chinese Scholarship Council(China Scholarship Council); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Chinese Scholarship Council; JSPS, Grant/Award Number: 15H03004 and 18H03518	Amin E, 2016, J BIOL CHEM, V291, P20353, DOI 10.1074/jbc.M116.736967; Bahler M, 2011, BIOCHEM SOC T, V39, P1166, DOI 10.1042/BST0391166; Bai X, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3910; Barrett T, 1997, NATURE, V385, P458, DOI 10.1038/385458a0; Basu Sayon, 2018, F1000Res, V7, DOI 10.12688/f1000research.15782.1; Berndt S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215140; Blangy A, 2017, BIOL CELL, V109, P115, DOI 10.1111/boc.201600053; Braun AC, 2015, J CELL SCI, V128, P1386, DOI 10.1242/jcs.163857; Chan KT, 2009, J CELL BIOL, V185, P357, DOI 10.1083/jcb.200809110; CICCHETTI P, 1995, EMBO J, V14, P3127, DOI 10.1002/j.1460-2075.1995.tb07315.x; Elbediwy A, 2012, J CELL BIOL, V198, P677, DOI 10.1083/jcb.201202094; Fuchtbauer A, 2011, BIOL CHEM, V392, P769, DOI 10.1515/BC.2011.088; Fujiwara S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195124; Guo SS, 2010, J BIOL CHEM, V285, P35133, DOI 10.1074/jbc.M110.153429; Han Y, 2019, AM J CANCER RES, V9, P800; Hanley PJ, 2010, P NATL ACAD SCI USA, V107, P12145, DOI 10.1073/pnas.0911986107; Harding MA, 2010, EUR J CANCER, V46, P1252, DOI 10.1016/j.ejca.2010.02.025; Hatzoglou A, 2007, MOL BIOL CELL, V18, P1242, DOI 10.1091/mbc.E06-06-0510; Huang GH, 2017, MOL CELL NEUROSCI, V80, P18, DOI 10.1016/j.mcn.2017.01.007; Hunter GL, 2019, BMC BIOL, V17, DOI 10.1186/s12915-019-0625-9; Ichikawa T, 2017, J CELL SCI, V130, P3517, DOI 10.1242/jcs.200691; Insinna C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08192-9; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lazarini M, 2013, BBA-MOL BASIS DIS, V1832, P365, DOI 10.1016/j.bbadis.2012.11.010; Leggett SE, 2016, INTEGR BIOL-UK, V8, P1133, DOI 10.1039/c6ib00139d; Lim J, 2012, DEVELOPMENT, V139, P3471, DOI 10.1242/dev.071209; Matte BF, 2019, J CELL SCI, V132, DOI 10.1242/jcs.224360; Mead TJ, 2018, CELL REP, V23, P485, DOI 10.1016/j.celrep.2018.03.034; Nasrollahi S, 2016, SCI REP-UK, V6, DOI 10.1038/srep18831; Regev M, 2017, CELL ADHES MIGR, V11, P367, DOI 10.1080/19336918.2016.1227910; Ridley AJ, 2015, CURR OPIN CELL BIOL, V36, P103, DOI 10.1016/j.ceb.2015.08.005; Rosa LRO, 2018, J CELL PHYSIOL, V233, P8477, DOI 10.1002/jcp.26829; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Saenz-Narciso B, 2016, BIOESSAYS, V38, P1246, DOI 10.1002/bies.201600165; Shen L, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2013.48; Tajadura-Ortega V, 2018, BMC BIOL, V16, DOI 10.1186/s12915-018-0489-4; Tang JY, 2019, EXP CELL RES, V374, P46, DOI 10.1016/j.yexcr.2018.11.007; Tojkander S, 2012, J CELL SCI, V125, P1855, DOI 10.1242/jcs.098087; Ungefroren H, 2018, DEV DYNAM, V247, P11; Wang J, 2017, BMC BIOL, V15, DOI 10.1186/s12915-016-0335-5; Wang Z.B., 2011, INT J VIDEO IMAGE PR, V11, P13; Wheelock MJ, 2008, J CELL SCI, V121, P727, DOI 10.1242/jcs.000455; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007; Xu DC, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0547-4; Xu Y, 2014, J IMMUNOL, V192, P3559, DOI 10.4049/jimmunol.1300695; Zhang Y, 2019, FASEB J, V33, P7822, DOI 10.1096/fj.201801936RRR; Zhao GX, 2019, ONCOGENE, V38, P4574, DOI 10.1038/s41388-019-0740-7	47	13	13	2	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8326	8340		10.1096/fj.201902750RR	http://dx.doi.org/10.1096/fj.201902750RR		MAY 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32378260	Bronze			2022-12-28	WOS:000530924700001
J	Borrachero-Conejo, AI; Adams, WR; Saracino, E; Mola, MG; Wang, MQ; Posati, T; Formaggio, F; De Bellis, M; Frigeri, A; Caprini, M; Hutchinson, MR; Muccini, M; Zamboni, R; Nicchia, GP; Mahadevan-Jansen, A; Benfenati, V				Borrachero-Conejo, Ana, I; Adams, Wilson R.; Saracino, Emanuela; Mola, Maria Grazia; Wang, Manqing; Posati, Tamara; Formaggio, Francesco; De Bellis, Manuela; Frigeri, Antonio; Caprini, Marco; Hutchinson, Mark R.; Muccini, Michele; Zamboni, Roberto; Nicchia, Grazia Paola; Mahadevan-Jansen, Anita; Benfenati, Valentina			Stimulation of water and calcium dynamics in astrocytes with pulsed infrared light	FASEB JOURNAL			English	Article						AQP4; astrocytes; infrared stimulation; TRPV4; water dynamics	SENSITIZES TRPV4 CHANNEL; CELL-VOLUME; OPTICAL STIMULATION; CA2+; AQUAPORIN-4; AQP4; PHOTOSTIMULATION; CONDUCTANCE; ACTIVATION; EXPRESSION	Astrocytes are non-neuronal cells that govern the homeostatic regulation of the brain through ions and water transport, and Ca2+-mediated signaling. As they are tightly integrated into neural networks, label-free tools that can modulate cell function are needed to evaluate the role of astrocytes in brain physiology and dysfunction. Using live-cell fluorescence imaging, pharmacology, electrophysiology, and genetic manipulation, we show that pulsed infrared light can modulate astrocyte function through changes in intracellular Ca2+ and water dynamics, providing unique mechanistic insight into the effect of pulsed infrared laser light on astroglial cells. Water transport is activated and, IP3R, TRPA1, TRPV4, and Aquaporin-4 are all involved in shaping the dynamics of infrared pulse-evoked intracellular calcium signal. These results demonstrate that astrocyte function can be modulated with infrared light. We expect that targeted control over calcium dynamics and water transport will help to study the crucial role of astrocytes in edema, ischemia, glioma progression, stroke, and epilepsy.	[Borrachero-Conejo, Ana, I; Caprini, Marco; Muccini, Michele] CNR, Ist Studio Mat Nanostrutturati, Bologna, Italy; [Adams, Wilson R.; Mahadevan-Jansen, Anita] Vanderbilt Univ, Dept Biomed Engn, 5824 Stevenson Ctr, Nashville, TN 37235 USA; [Adams, Wilson R.; Wang, Manqing; Mahadevan-Jansen, Anita] Vanderbilt Univ, Vanderbilt Biophoton Ctr, Nashville, TN 37232 USA; [Saracino, Emanuela; Posati, Tamara; Zamboni, Roberto; Nicchia, Grazia Paola; Benfenati, Valentina] CNR, Ist Sintesi Organ & Fotoreatt, Via Gobetti 101, I-40129 Bologna, Italy; [Mola, Maria Grazia; De Bellis, Manuela; Nicchia, Grazia Paola] Univ Bari Aldo Moro, Dept Biosci Biotechnol & Biopharmaceut & Ctr Exce, Bari, Italy; [Wang, Manqing] Chongqing Univ, Bioengn Coll, Chongqing, Peoples R China; [Formaggio, Francesco; Caprini, Marco] Univ Bologna, Dipartimento Farm & Biotecnol, Bologna, Italy; [Frigeri, Antonio] Univ Bari Aldo Moro, Sch Med, Dept Basic Med Sci Neurosci & Sense Organs, Bari, Italy; [Frigeri, Antonio; Nicchia, Grazia Paola] Yeshiva Univ, Albert Einstein Coll Med, Dept Neurosci, New York, NY 10033 USA; [Hutchinson, Mark R.] Univ Adelaide, Australian Res Council Ctr Excellence Nanoscale B, Adelaide Med Sch, Adelaide, SA, Australia; [Mahadevan-Jansen, Anita] Vanderbilt Univ, Med Ctr, Dept Neurol Surg, Nashville, TN 37232 USA	Consiglio Nazionale delle Ricerche (CNR); Istituto per lo Studio dei Materiali Nanostrutturati (ISMN-CNR); Vanderbilt University; Vanderbilt University; Consiglio Nazionale delle Ricerche (CNR); Istituto per la Sintesi Organica e la Fotoreattivita (ISOF-CNR); Universita degli Studi di Bari Aldo Moro; Chongqing University; University of Bologna; Universita degli Studi di Bari Aldo Moro; Yeshiva University; University of Adelaide; Vanderbilt University	Mahadevan-Jansen, A (corresponding author), Vanderbilt Univ, Dept Biomed Engn, 5824 Stevenson Ctr, Nashville, TN 37235 USA.; Benfenati, V (corresponding author), CNR, Ist Sintesi Organ & Fotoreatt, Via Gobetti 101, I-40129 Bologna, Italy.	anita.mahadevan-jansen@vanderbilt.edu; valentina.benfenati@isof.cnr.it	frigeri, Antonio/AAC-6336-2022; Borrachero-Conejo, Ana I./AAA-6590-2021; Hutchinson, Mark/N-1815-2019; Saracino, Emanuela/Q-4385-2018; Benfenati, Valentina/D-4579-2016	Borrachero-Conejo, Ana I./0000-0002-0479-5598; Hutchinson, Mark/0000-0003-2154-5950; Benfenati, Valentina/0000-0002-2858-8497; Formaggio, Francesco/0000-0002-7504-6607	NIDDK NIH HHS [U24 DK059637] Funding Source: Medline; NIH HHS [DK20593, CA68485, DK58404, EY08126] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Barrett JN, 2018, J NEUROPHYSIOL, V120, P509, DOI 10.1152/jn.00740.2017; Benfenati V, 2007, NEUROSCIENCE, V148, P876, DOI 10.1016/j.neuroscience.2007.06.039; Benfenati V, 2010, NEUROSCIENCE, V168, P926, DOI 10.1016/j.neuroscience.2009.12.017; Benfenati V, 2014, ADV HEALTHC MATER, V3, P392, DOI 10.1002/adhm.201300179; Benfenati V, 2013, NAT MATER, V12, P672, DOI [10.1038/NMAT3630, 10.1038/nmat3630]; Benfenati V, 2011, P NATL ACAD SCI USA, V108, P2563, DOI 10.1073/pnas.1012867108; Benfenati V, 2009, CHANNELS, V3, P323, DOI 10.4161/chan.3.5.9568; Bindocci E, 2017, SCIENCE, V356, DOI 10.1126/science.aai8185; Borrachero-Conejo AI, 2019, ADV HEALTHC MATER, V8, DOI 10.1002/adhm.201801139; Butenko O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039959; Cayce JM, 2015, NEUROPHOTONICS, V2, DOI 10.1117/1.NPh.2.1.015007; Cayce JM, 2010, IEEE J SEL TOP QUANT, V16, P565, DOI 10.1109/JSTQE.2009.2032424; Cayce JM, 2014, CELL CALCIUM, V55, P183, DOI 10.1016/j.ceca.2014.01.004; Cho WH, 2016, EXP NEUROBIOL, V25, P197, DOI 10.5607/en.2016.25.5.197; Choi M, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3600774; Dunn KM, 2013, P NATL ACAD SCI USA, V110, P6157, DOI 10.1073/pnas.1216514110; Ebtehaj Z, 2018, J PHYS CHEM B, V122, P7319, DOI 10.1021/acs.jpcb.8b02616; Eom K, 2017, J BIOPHOTONICS, V10, P486, DOI 10.1002/jbio.201600280; Ermakova YG, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15362; Fernandes J, 2008, J CELL BIOL, V181, P143, DOI 10.1083/jcb.200712058; Formaggio F, 2019, FASEB J, V33, P101, DOI 10.1096/fj.201701397RR; Fujita F, 2018, J PHYSIOL SCI, V68, P431, DOI 10.1007/s12576-017-0545-9; Garcia-Elias A, 2008, J BIOL CHEM, V283, P31284, DOI 10.1074/jbc.C800184200; Garcia-Elias A, 2013, P NATL ACAD SCI USA, V110, P9553, DOI 10.1073/pnas.1220231110; Hofer AM, 1998, J CELL BIOL, V140, P325, DOI 10.1083/jcb.140.2.325; Jo AO, 2015, J NEUROSCI, V35, P13525, DOI 10.1523/JNEUROSCI.1987-15.2015; Lumbreras V, 2014, J NEUROPHYSIOL, V112, P1246, DOI 10.1152/jn.00253.2014; Maya-Vetencourt JF, 2017, NAT MATER, V16, P681, DOI [10.1038/nmat4874, 10.1038/NMAT4874]; Mederos S, 2019, GLIA, V67, P915, DOI 10.1002/glia.23580; Mola MG, 2016, GLIA, V64, P139, DOI 10.1002/glia.22921; Moreau D, 2018, J BIOPHOTONICS, V11, DOI 10.1002/jbio.201700020; Nicchia GP, 2004, NEUROSCIENCE, V129, P935, DOI 10.1016/j.neuroscience.2004.07.055; Nicchia GP, 2000, GLIA, V31, P29, DOI 10.1002/(SICI)1098-1136(200007)31:1<29::AID-GLIA30>3.0.CO;2-3; Nicchia GP, 2016, EXP EYE RES, V146, P259, DOI 10.1016/j.exer.2016.03.019; Nilius B, 2004, AM J PHYSIOL-CELL PH, V286, pC195, DOI 10.1152/ajpcell.00365.2003; Noell S, 2012, CELL TISSUE RES, V347, P429, DOI 10.1007/s00441-011-1321-4; Owen SF, 2019, NAT NEUROSCI, V22, P1061, DOI 10.1038/s41593-019-0422-3; Paris L, 2017, BIOMED OPT EXPRESS, V8, P4568, DOI 10.1364/BOE.8.004568; Plaksin M, 2018, PHYS REV X, V8, DOI 10.1103/PhysRevX.8.011043; Posati T, 2016, SCI REP-UK, V6, DOI 10.1038/srep31226; Santello M, 2019, NAT NEUROSCI, V22, P154, DOI 10.1038/s41593-018-0325-8; Scemes E, 2000, MOL NEUROBIOL, V22, P167, DOI 10.1385/MN:22:1-3:167; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shapiro MG, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1742; Sherwood MW, 2017, GLIA, V65, P502, DOI 10.1002/glia.23107; Shigetomi E, 2013, J NEUROSCI, V33, P10143, DOI 10.1523/JNEUROSCI.5779-12.2013; Solenov E, 2004, AM J PHYSIOL-CELL PH, V286, pC426, DOI 10.1152/ajpcell.00298.2003; Startek JB, 2019, ELIFE, V8, DOI 10.7554/eLife.46084; Startek JB, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20020371; Thompson Alexander C, 2014, Curr Mol Imaging, V3, P162; Thrane AS, 2011, P NATL ACAD SCI USA, V108, P846, DOI 10.1073/pnas.1015217108; Tolstykh GP, 2017, NEUROPHOTONICS, V4, DOI 10.1117/1.NPh.4.2.025001; Verkhratsky A, 2018, PHYSIOL REV, V98, P239, DOI 10.1152/physrev.00042.2016; Vincent F, 2009, BIOCHEM BIOPH RES CO, V389, P490, DOI 10.1016/j.bbrc.2009.09.007; Walsh AJ, 2017, SPIE BIOS SAN FRANC; Wells J, 2005, OPT LETT, V30, P504, DOI 10.1364/OL.30.000504; Wells J, 2007, BIOPHYS J, V93, P2567, DOI 10.1529/biophysj.107.104786; Yool AJ, 2010, CLIN EXP PHARMACOL P, V37, P403, DOI 10.1111/j.1440-1681.2009.05244.x; Zhao Y, 2009, OPT EXPRESS, V17, P1291, DOI 10.1364/OE.17.001291	59	11	11	6	29	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6539	6553		10.1096/fj.201903049R	http://dx.doi.org/10.1096/fj.201903049R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32202681	Bronze			2022-12-28	WOS:000531325500038
J	Gu, J; Zhang, T; Guo, JR; Chen, K; Wang, GB; Li, HL; Wang, JL				Gu Jian; Zhang Tao; Guo Jianrong; Chen Ke; Wang Guobin; Li Huili; Wang Jiliang			Ursodeoxycholyl lysophosphatidylethanolamide protects against hepatic ischemia/reperfusion injury via phospholipid metabolism-mediated mitochondrial quality control	FASEB JOURNAL			English	Article						cPLA(2); defect mitochondria; mitochondrial membrane; oxidative stress; phospholipid metabolism disorders; reperfusion injury	REPERFUSION INJURY; MYOCARDIAL-ISCHEMIA; DYSFUNCTION; ACID; TRANSLOCATION; BIOSYNTHESIS; DEFICIENCY; APOPTOSIS; DISEASE; CANCER	Mitochondrial dysfunction is the leading cause of reactive oxygen species (ROS) burst and apoptosis in hepatic ischemia/reperfusion (I/R) injury. Ursodeoxycholyl lysophosphatidylethanolamide (UDCA-LPE) is a hepatotargeted agent that exerts hepatoprotective roles by regulating lipid metabolism. Our previous studies have shown that UDCA-LPE improves hepatic I/R injury by inhibiting apoptosis and inflammation. However, the role of UDCA-LPE in lipid metabolism and mitochondrial function in hepatic I/R remains unknown. In the present study, we investigated the role of UDCA-LPE in hepatic I/R by focusing on the interface of phospholipid metabolism and mitochondrial homeostasis. Livers from 28-week-old mice, primary hepatocytes and HepG2 cells were subjected to in vivo and in vitro I/R, respectively. Analyses of oxidative stress, imaging, ATP generation, genetics, and lipidomics showed that I/R was associated with mitochondrial dysfunction and a reduction in phospholipids. UDCA-LPE alleviated mitochondria-dependent oxidative stress and apoptosis and prevented the decrease of phospholipid levels. Our study found that cytosolic phospholipase A(2) (cPLA(2)), a phospholipase that is activated during I/R, hydrolyzed mitochondrial membrane phospholipids and led to mitochondria-mediated oxidative stress and apoptosis. UDCA-LPE inhibited the interaction between cPLA(2) and mitochondria and reduced phospholipid hydrolysis-mediated injury. UDCA-LPE might regulate the crosstalk between the phospholipid metabolism and the mitochondria, restore mitochondrial function and ameliorate I/R injury.	[Gu Jian; Zhang Tao; Guo Jianrong; Chen Ke; Wang Guobin; Li Huili; Wang Jiliang] Huazhong Univ Sci & Technol, Dept Gastrointestinal Surg, Union Hosp, Tongji Med Coll, Wuhan 430022, Peoples R China	Huazhong University of Science & Technology	Li, HL; Wang, JL (corresponding author), Huazhong Univ Sci & Technol, Dept Gastrointestinal Surg, Union Hosp, Tongji Med Coll, Wuhan 430022, Peoples R China.	huili_li@hust.edu.cn; jiliang_wang@hust.edu.cn		Wang, Jiliang/0000-0001-6169-637X				Adachi Y, 2016, MOL CELL, V63, P1034, DOI 10.1016/j.molcel.2016.08.013; Ademowo OS, 2017, BIOGERONTOLOGY, V18, P859, DOI 10.1007/s10522-017-9710-z; Adler DH, 2008, J CLIN INVEST, V118, P2121, DOI 10.1172/JCI30473; Chamulitrat W, 2009, HEPATOLOGY, V50, P143, DOI 10.1002/hep.22955; CLARK JD, 1991, CELL, V65, P1043, DOI 10.1016/0092-8674(91)90556-E; Dessen A, 1999, CELL, V97, P349, DOI 10.1016/S0092-8674(00)80744-8; Downey JM, 2009, CIRC J, V73, P1171, DOI 10.1253/circj.CJ-09-0338; Ford DA, 2002, PROG LIPID RES, V41, P6, DOI 10.1016/S0163-7827(01)00014-5; Granger DN, 2015, REDOX BIOL, V6, P524, DOI 10.1016/j.redox.2015.08.020; Gu XM, 2012, NEUROSCI BULL, V28, P631, DOI 10.1007/s12264-012-1270-2; GULDUTUNA S, 1993, GASTROENTEROLOGY, V104, P1736; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heusch G, 2017, EUR HEART J, V38, P774, DOI 10.1093/eurheartj/ehw224; Horvath SE, 2013, PROG LIPID RES, V52, P590, DOI 10.1016/j.plipres.2013.07.002; Jaeschke H, 2003, GASTROENTEROLOGY, V125, P1246, DOI 10.1016/S0016-5085(03)01209-5; Kim HE, 2016, CELL, V166, P1539, DOI 10.1016/j.cell.2016.08.027; Koopman WJH, 2008, METHODS, V46, P304, DOI 10.1016/j.ymeth.2008.09.018; KRAMER RM, 1991, J BIOL CHEM, V266, P5268; Lejay A, 2016, J MOL CELL CARDIOL, V91, P11, DOI 10.1016/j.yjmcc.2015.12.020; Leslie CC, 2015, J LIPID RES, V56, P1386, DOI 10.1194/jlr.R057588; Lesnefsky EJ, 2017, ANNU REV PHARMACOL, V57, P535, DOI 10.1146/annurev-pharmtox-010715-103335; Lin SZ, 2018, AGEING RES REV, V44, P22, DOI 10.1016/j.arr.2018.03.006; Lin YB, 2017, BIOCHEM BIOPH RES CO, V483, P885, DOI 10.1016/j.bbrc.2017.01.028; Liu R, 2017, NAT CELL BIOL, V19, P760, DOI 10.1038/ncb3565; Marquez-Jurado S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02787-4; Metlagel Z, 2014, AUTOPHAGY, V10, P522, DOI 10.4161/auto.27594; Ong SB, 2010, CIRCULATION, V121, P2012, DOI 10.1161/CIRCULATIONAHA.109.906610; Onyango IG, 2016, AGING DIS, V7, P201, DOI 10.14336/AD.2015.1007; Osman C, 2011, J CELL BIOL, V192, P7, DOI 10.1083/jcb.201006159; Pathil A, 2014, BRIT J PHARMACOL, V171, P5113, DOI 10.1111/bph.12837; Pathil A, 2012, HEPATOLOGY, V55, P1369, DOI 10.1002/hep.25531; Peralta C, 2013, J HEPATOL, V59, P1094, DOI 10.1016/j.jhep.2013.06.017; Qu BX, 2013, BRAIN RES, V1497, P101, DOI 10.1016/j.brainres.2012.12.018; Quesnelle KM, 2015, ARCH TOXICOL, V89, P651, DOI 10.1007/s00204-014-1437-x; Ren MD, 2014, PROG LIPID RES, V55, P1, DOI 10.1016/j.plipres.2014.04.001; Rigobello MP, 2005, FREE RADICAL RES, V39, P687, DOI 10.1080/10715760500135391; Rodrigues CMP, 1998, J CLIN INVEST, V101, P2790, DOI 10.1172/JCI1325; Selzner N, 2003, GASTROENTEROLOGY, V125, P917, DOI 10.1016/S0016-5085(03)01048-5; Smith RAJ, 2012, TRENDS PHARMACOL SCI, V33, P341, DOI 10.1016/j.tips.2012.03.010; Stanley BA, 2011, J BIOL CHEM, V286, P33669, DOI 10.1074/jbc.M111.284612; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vasquez Alexis M., 2018, Advances in Biological Regulation, V67, P212, DOI 10.1016/j.jbior.2017.10.009; Wang JL, 2015, SHOCK, V43, P379, DOI 10.1097/SHK.0000000000000312; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; Zhang C, 2017, HEPATOLOGY, V66, P1989, DOI 10.1002/hep.29326; Zhou H, 2018, CELL DEATH DIFFER, V25, P1080, DOI 10.1038/s41418-018-0086-7; Zhou ZJ, 2016, CHEM SOC REV, V45, P6597, DOI 10.1039/c6cs00271d; Zorov DB, 2014, PHYSIOL REV, V94, P909, DOI 10.1152/physrev.00026.2013	51	4	5	4	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6198	6214		10.1096/fj.201902013RRR	http://dx.doi.org/10.1096/fj.201902013RRR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32162746	hybrid			2022-12-28	WOS:000531325500016
J	Yang, YH; He, XM; Cheng, R; Chen, Q; Shan, CY; Chen, LM; Ma, JX				Yang Yanhui; He Xuemin; Cheng Rui; Chen Qian; Shan Chunyan; Chen Liming; Ma Jian-xing			Diabetes-induced upregulation of kallistatin levels exacerbates diabetic nephropathy via RAS activation	FASEB JOURNAL			English	Article						diabetic nephropathy; fibrosis; hypoxia; kallikrein; kallistatin; kidney; RAS	KALLIKREIN-KININ SYSTEM; EPITHELIUM-DERIVED FACTOR; RENIN-ANGIOTENSIN SYSTEM; TISSUE KALLIKREIN; MICROVASCULAR COMPLICATIONS; RENAL-DISEASES; WNT PATHWAY; PPAR-ALPHA; INHIBITION; INFLAMMATION	Kallistatin is an inhibitor of tissue kallikrein and also inhibits the Wnt pathway. Its role in diabetic nephropathy (DN) is uncertain. Here we reported that serum kallistatin levels were significantly increased in diabetic patients with DN compared to those in diabetic patients without DN and healthy controls, and positively correlated with urinary albumin excretion. In addition, renal kallistatin levels were significantly upregulated in mouse models of type 1 (Akita, OVE26) and type 2 diabetes (db/db). To unveil the effects of kallistatin on DN and its underlying mechanism, we crossed transgenic mice overexpressing kallistatin with OVE26 mice (KS-tg/OVE). Kallistatin overexpression exacerbated albuminuria, renal fibrosis, inflammation, and oxidative stress in diabetes. Kallikrein activity was inhibited while the renin-angiotensin system (RAS) upregulated in the kidney of KS-tg/OVE mice compared to WT/OVE mice, suggesting a disturbed balance between the RAS and kallikrein-kinin systems. As shown by immunostaining of endothelial makers, renal vascular densities were decreased accompanied by increased HIF-1 alpha and erythropoietin levels in the kidneys of KS-tg/OVE mice. Taken together, high levels of kallistatin exacerbate DN at least partly by inducing RAS overactivation and hypoxia. The present study demonstrated a positive correlation between kallistatin levels and DN, suggesting a potential biomarker for prognosis of DN.	[Yang Yanhui; Shan Chunyan; Chen Liming] Tianjin Med Univ, Chu Hsien I Mem Hosp, NHC Key Lab Hormones & Dev, Tianjin Key Lab Metab Dis, Tianjin, Peoples R China; [Yang Yanhui; Shan Chunyan; Chen Liming] Tianjin Inst Endocrinol, Tianjin, Peoples R China; [Yang Yanhui; He Xuemin; Cheng Rui; Chen Qian; Ma Jian-xing] Univ Oklahoma, Hlth Sci Ctr, Dept Physiol, BSEB 328B,941 Stanton L Young Blvd, Oklahoma City, OK 73104 USA; [He Xuemin] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Endocrinol & Metab Dis, Guangzhou, Peoples R China	Tianjin Medical University; University of Oklahoma System; University of Oklahoma Health Sciences Center; Sun Yat Sen University	Ma, JX (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Physiol, BSEB 328B,941 Stanton L Young Blvd, Oklahoma City, OK 73104 USA.; Chen, LM (corresponding author), Tianjin Med Univ, Chu Hsien I Mem Hosp, Tianjin 300134, Peoples R China.	xfx22081@vip.163.com; jian-xing-ma@ouhsc.edu	He, Xuemin/HGA-1805-2022	He, Xuemin/0000-0001-9231-4426	NIH [EY012231, EY018659, EY019309, EY028949, GM122744]; JDRF [SRA2019-711-S-B]; OCAST grant [HR16041]; National Nature Science Foundation of China [81700631]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JDRF(Juvenile Diabetes Research Foundation); OCAST grant; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by NIH grants EY012231, EY018659, EY019309, EY028949, GM122744, JDRF grant SRA2019-711-S-B (JXM), OCAST grant HR16041, National Nature Science Foundation of China 81700631.	Amundsen E, 1979, Adv Exp Med Biol, V120A, P83; Bledsoe G, 2006, NEPHROL DIAL TRANSPL, V21, P624, DOI 10.1093/ndt/gfi225; Bodin S, 2009, KIDNEY INT, V76, P395, DOI 10.1038/ki.2009.208; Brosius FC, 2009, J AM SOC NEPHROL, V20, P2503, DOI 10.1681/ASN.2009070721; CHAO J, 1990, J BIOL CHEM, V265, P16394; Chao J, 2001, BIOL CHEM, V382, P15, DOI 10.1515/BC.2001.003; Chao J, 1998, HUM GENE THER, V9, P21, DOI 10.1089/hum.1998.9.1-21; Chao JL, 1996, J LAB CLIN MED, V127, P612, DOI 10.1016/S0022-2143(96)90152-3; Chao J, 2006, BIOL CHEM, V387, P665, DOI 10.1515/BC.2006.085; Chen Y, 2013, DIABETES, V62, P261, DOI 10.2337/db11-0413; Cheng R, 2016, DIABETES, V65, P3730, DOI 10.2337/db16-0426; Colafella KMM, 2017, HYPERTENSION, V69, P994, DOI 10.1161/HYPERTENSIONAHA.117.08931; Diao Y, 2007, WORLD J GASTROENTERO, V13, P4615, DOI 10.3748/wjg.v13.i34.4615; El Din UAAS, 2017, J ADV RES, V8, P363, DOI 10.1016/j.jare.2017.04.004; El-Asrar MA, 2015, VASC MED, V20, P509, DOI 10.1177/1358863X15591089; Elmarakby AA, 2012, CARDIOVASC THER, V30, P49, DOI 10.1111/j.1755-5922.2010.00218.x; Fine LG, 2000, KIDNEY INT, V57, pS22, DOI 10.1046/j.1523-1755.2000.07512.x; Franzen S, 2016, AM J PHYSIOL-RENAL, V310, pF807, DOI 10.1152/ajprenal.00049.2016; Gross JL, 2005, DIABETES CARE, V28, P164, DOI 10.2337/diacare.28.1.164; He XM, 2017, KIDNEY INT, V91, P642, DOI 10.1016/j.kint.2016.09.036; Jenkins Alicia J, 2010, J Angiogenes Res, V2, P19, DOI 10.1186/2040-2384-2-19; Kamiyama M, 2013, INT J MOL SCI, V14, P23045, DOI 10.3390/ijms141123045; Kim S, 2000, PHARMACOL REV, V52, P11; Kobori H, 2013, PFLUG ARCH EUR J PHY, V465, P3, DOI 10.1007/s00424-012-1143-6; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; Liu WJ, 2017, CURR OPIN NEPHROL HY, V26, P351, DOI 10.1097/MNH.0000000000000344; Liu XC, 2013, DIABETES, V62, P4228, DOI 10.2337/db12-1710; Ma JX, 1996, CURR EYE RES, V15, P1117, DOI 10.3109/02713689608995143; McBride JD, 2014, J INVEST DERMATOL, V134, P1725, DOI 10.1038/jid.2014.40; Mezzano S, 2003, KIDNEY INT, V64, pS64, DOI 10.1046/j.1523-1755.64.s86.12.x; Miao RQ, 2002, BLOOD, V100, P3245, DOI 10.1182/blood-2002-01-0185; Mima A, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/248563; Naicker S, 1999, IMMUNOPHARMACOLOGY, V44, P183, DOI 10.1016/S0162-3109(99)00089-2; Nangaku M, 2006, J AM SOC NEPHROL, V17, P17, DOI 10.1681/ASN.2005070757; Persson P, 2017, CURR OPIN NEPHROL HY, V26, P345, DOI 10.1097/MNH.0000000000000341; Riad A, 2007, CURR OPIN NEPHROL HY, V16, P22, DOI 10.1097/MNH.0b013e328011a20c; Rocco MV, 2012, AM J KIDNEY DIS, V60, P857, DOI 10.1053/j.ajkd.2012.07.005; Rodriguez-Iturbe B, 2001, KIDNEY INT, V59, P2222, DOI 10.1046/j.1523-1755.2001.00737.x; Roksnoer LCW, 2016, HYPERTENSION, V67, P927, DOI 10.1161/HYPERTENSIONAHA.115.07012; Rosatelli TB, 2005, BRIT J DERMATOL, V152, P650, DOI 10.1111/j.1365-2133.2005.06427.x; Shen B, 2008, HYPERTENSION, V51, P1358, DOI 10.1161/HYPERTENSIONAHA.107.108514; Shen B, 2010, AM J PHYSIOL-HEART C, V299, pH1419, DOI 10.1152/ajpheart.00591.2010; Tomita H, 2012, KIDNEY INT, V81, P733, DOI 10.1038/ki.2011.499; VENIANT M, 1994, KIDNEY INT, V46, P421, DOI 10.1038/ki.1994.290; Wang CR, 2005, ARTHRITIS RHEUM-US, V52, P1319, DOI 10.1002/art.20991; Wang JJ, 2006, DIABETES, V55, P1678, DOI 10.2337/db05-1448; Xing Q, 2017, OPHTHALMIC RES, V57, P141, DOI 10.1159/000447776; Yin H, 2010, HYPERTENSION, V56, P260, DOI 10.1161/HYPERTENSIONAHA.110.152330; Yiu WH, 2016, KIDNEY INT, V89, P386, DOI 10.1038/ki.2015.331; Yoo TH, 2007, KIDNEY INT, V71, P1019, DOI 10.1038/sj.ki.5002195; Yuan HT, 2003, AM J PATHOL, V163, P2289, DOI 10.1016/S0002-9440(10)63586-9; Zhang B, 2010, DIABETES, V59, P1809, DOI 10.2337/db09-1056; Zhang B, 2010, P NATL ACAD SCI USA, V107, P6900, DOI 10.1073/pnas.0906764107; Zheng SR, 2004, DIABETES, V53, P3248, DOI 10.2337/diabetes.53.12.3248; ZHOU GX, 1992, J BIOL CHEM, V267, P25873; Zhou T, 2012, DIABETOLOGIA, V55, P255, DOI 10.1007/s00125-011-2314-2; Zou X, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/310645	57	5	6	2	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8428	8441		10.1096/fj.201903149R	http://dx.doi.org/10.1096/fj.201903149R		APR 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32352602	Green Published			2022-12-28	WOS:000530007600001
J	Davidov, T; Efraim, Y; Dahan, N; Baruch, L; Machluf, M				Davidov, Tzila; Efraim, Yael; Dahan, Nitsan; Baruch, Limor; Machluf, Marcelle			Porcine arterial ECM hydrogel: Designing an in vitro angiogenesis model for long-term high-throughput research	FASEB JOURNAL			English	Article						angiogenesis; arterial ECM; ECM hydrogel; in vitro model	EXTRACELLULAR-MATRIX; GROWTH-FACTOR; SUNITINIB; VIVO; DECELLULARIZATION; ENCAPSULATION; CULTURE; ASSAYS	The field of angiogenesis research provides deep understanding regarding this important process, which plays fundamental roles in tissue development and different abnormalities. In vitro models offer the advantages of low-cost high-throughput research of angiogenesis while sparing animal lives, and enabling the use of human cells. Nevertheless, prevailing in vitro models lack stability and are limited to a few days' assays. This study, therefore, examines the hypothesis that closely mimicking the vascular microenvironment can more reliably support longer angiogenesis processes in vitro. To this end, porcine arterial extracellular matrix (paECM)- a key component of blood vessels-was isolated and processed into a thermally induced hydrogel and characterized in terms of composition, structure, and mechanical properties, thus confirming the preservation of important characteristics of arterial extracellular matrix. This unique hydrogel was further tailored into a three-dimensional model of angiogenesis using endothelial cells and supporting cells, in a configuration that allows high-throughput quantitative analysis of cell viability and proliferation, cell migration, and apoptosis, thus revealing the advantages of paECM over frequently used biomaterials. Markedly, when applied with well-known effectors of angiogenesis, the model measures reflected the expected response, hence validating its efficacy and establishing its potential as a promising tool for the research of angiogenesis.	[Davidov, Tzila; Efraim, Yael; Baruch, Limor; Machluf, Marcelle] Technion Israel Inst Technol, Fac Biotechnol & Food Engn, Haifa, Israel; [Dahan, Nitsan] Technion Israel Inst Technol, Life Sci & Engn Ctr, Infrastruct Unit, Haifa, Israel	Technion Israel Institute of Technology; Technion Israel Institute of Technology	Machluf, M (corresponding author), Technion Israel Inst Technol, Life Sci & Engn Ctr, Haifa, Israel.	machlufm@bfe.technion.ac.il	Baruch, Limor/AAC-7019-2022		Technion-Israel Institute of Technology (Technion)	Technion-Israel Institute of Technology (Technion)	Technion-Israel Institute of Technology (Technion)	Abdel-Aziz AK, 2016, EXP NEUROL, V283, P129, DOI 10.1016/j.expneurol.2016.06.004; Aguirre A, 2010, BIOCHEM BIOPH RES CO, V400, P284, DOI 10.1016/j.bbrc.2010.08.073; Arnaoutova I, 2010, NAT PROTOC, V5, P628, DOI 10.1038/nprot.2010.6; Auerbach R, 2003, CLIN CHEM, V49, P32, DOI 10.1373/49.1.32; Cebe-Suarez S, 2006, CELL MOL LIFE SCI, V63, P601, DOI 10.1007/s00018-005-5426-3; Chaimov D, 2017, J CONTROL RELEASE, V257, P91, DOI 10.1016/j.jconrel.2016.07.045; Chwalek K, 2014, SCI REP-UK, V4, DOI 10.1038/srep04414; Clause KC, 2013, CURR OPIN BIOTECH, V24, P830, DOI 10.1016/j.copbio.2013.04.011; Coronado RE, 2017, CELL TRANSPLANT, V26, P1840, DOI 10.1177/0963689717742157; Dahan N, 2017, TISSUE ENG PT A, V23, P69, DOI [10.1089/ten.tea.2016.0126, 10.1089/ten.TEA.2016.0126]; Dahan N, 2012, TISSUE ENG PT A, V18, P411, DOI [10.1089/ten.tea.2011.0173, 10.1089/ten.TEA.2011.0173]; de Bouard S, 2007, NEURO-ONCOLOGY, V9, P412, DOI 10.1215/15228517-2007-024; Deng L, 2003, J INVEST DERMATOL, V121, P1060, DOI 10.1046/j.1523-1747.2003.12565.x; DeQuach JA, 2011, TISSUE ENG PT A, V17, P2583, DOI [10.1089/ten.tea.2010.0724, 10.1089/ten.TEA.2010.0724]; Efraim Y, 2017, ACTA BIOMATER, V50, P220, DOI 10.1016/j.actbio.2016.12.015; Eitan Y, 2010, TISSUE ENG PART C-ME, V16, P671, DOI [10.1089/ten.tec.2009.0111, 10.1089/ten.TEC.2009.0111]; Faibish M, 2011, JOVE-J VIS EXP, V55, P2; Feng XL, 2013, J ANAL METHODS CHEM, V2013, DOI 10.1155/2013/246986; Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014; Grant CA, 2011, J MECH BEHAV BIOMED, V4, P535, DOI 10.1016/j.jmbbm.2010.12.011; Hao ZL, 2016, ONCOTARGETS THER, V9, P5495, DOI 10.2147/OTT.S112242; Heiss M, 2015, FASEB J, V29, P3076, DOI 10.1096/fj.14-267633; Hinderer S, 2016, ADV DRUG DELIVER REV, V97, P260, DOI 10.1016/j.addr.2015.11.019; Hoeben A, 2004, PHARMACOL REV, V56, P549, DOI 10.1124/pr.56.4.3; Karamanos NK, 2019, MATRIX BIOL, V75-76, P1, DOI 10.1016/j.matbio.2018.08.007; Kenyon BM, 1996, INVEST OPHTH VIS SCI, V37, P1625; Keshaw H, 2005, BIOMATERIALS, V26, P4171, DOI 10.1016/j.biomaterials.2004.10.021; Khoo CP, 2011, TISSUE ENG PART C-ME, V17, P895, DOI [10.1089/ten.tec.2011.0150, 10.1089/ten.TEC.2011.0150]; Kim SH, 2011, J ENDOCRINOL, V209, P139, DOI 10.1530/JOE-10-0377; Maj E, 2016, INT J ONCOL, V49, P1773, DOI 10.3892/ijo.2016.3709; Martin S., 2009, ANGIOGENESIS PROTOCO; Massensini AR, 2015, ACTA BIOMATER, V27, P116, DOI 10.1016/j.actbio.2015.08.040; Moon JJ, 2010, BIOMATERIALS, V31, P3840, DOI 10.1016/j.biomaterials.2010.01.104; Morin KT, 2013, EXP CELL RES, V319, P2409, DOI 10.1016/j.yexcr.2013.06.006; Nakatsu Martin N, 2007, J Vis Exp, P186, DOI 10.3791/186; Nemati S, 2017, BIOTECHNOL BIOENG, V114, P2920, DOI 10.1002/bit.26395; Rosalina I, 2002, CARBOHYD POLYM, V48, P191, DOI 10.1016/S0144-8617(01)00235-1; Sarig U, 2016, ACTA BIOMATER, V44, P209, DOI 10.1016/j.actbio.2016.08.031; Sarig U, 2015, TISSUE ENG PT A, V21, P1507, DOI [10.1089/ten.tea.2014.0477, 10.1089/ten.TEA.2014.0477]; Sarkanen JR, 2011, FRONT PHARMACOL, V1, DOI 10.3389/fphar.2010.00147; Schor AM, 2001, METH MOLEC MED, V46, P145, DOI 10.1385/1-59259-143-4:145; Taylor DA, 2018, ACTA BIOMATER, V74, P74, DOI 10.1016/j.actbio.2018.04.044; Ucuzian AA, 2014, MICROVASC RES, V14, P220; Ucuzian AA, 2007, WORLD J SURG, V31, P654, DOI 10.1007/s00268-006-0763-4; West DC, 2001, METH MOLEC MED, V46, P107, DOI 10.1385/1-59259-143-4:107; Wolf MT, 2012, BIOMATERIALS, V33, P7028, DOI 10.1016/j.biomaterials.2012.06.051; Wood DJ, 2014, J R SOC INTERFACE, V12, P20141079	47	4	5	3	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					7745	7758		10.1096/fj.202000264	http://dx.doi.org/10.1096/fj.202000264		APR 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32337805	Bronze			2022-12-28	WOS:000529407300001
J	Xie, RN; Jiang, P; Lin, L; Yu, B; Wang, CM; Pan, YY; Rao, JJ; Wei, W; Qiao, Y				Xie, Ruining; Jiang, Pei; Lin, Li; Yu, Bin; Wang, Chunmei; Pan, Yanyou; Rao, Jingjing; Wei, Wei; Qiao, Yi			Association of lymphoid tissue-resident commensal bacteria in mice with depressive-like behaviors induced by chronic social defeat stress	FASEB JOURNAL			English	Article						chronic social defeat stress; depressive-like behaviors; lymphoid-tissue-resident commensal bacteria; Peyer's patches; Treg cells	SEGMENTED FILAMENTOUS BACTERIA; GUT MICROBIOTA; T-CELLS; IMMUNE; INFLAMMATION; MATURATION; INDUCTION; CYTOKINES; MOUSE	Emerging evidence suggests that the microbiota-gut-brain axis affects a variety of complex behaviors, including social, emotional, and depressive-like behaviors. Peyer's patches (PPs), a well-characterized gut-associated lymphoid tissue, are the entry site for luminal antigens and the initiation site for antigen-specific immune responses. However, few studies have explored the composition of lymphoid tissue-resident commensal bacteria (LRCs) in stress-associated disorders. Male C57BL/6 mice exposed to chronic social stress were analyzed for microbiome on the interior of PPs and changes in inflammation. Susceptible mice (SUS) exhibited a composition of bacteria inside PPs that was distinct from that of control (CON) and resilient (RES) mice, including an increase in Candidatus Arthromitus (SFB) and a decrease in Lactobacillus. The CD4(+)CD25(+)Foxp3(+) T cells were significantly reduced in SUS mice. Relative mRNA levels of IL-2 were significantly reduced in SUS mice, and the mRNA levels of Bcl-6, IFN-gamma, IL-6, and the IgA protein levels in the ileum were significantly increased. Moreover, in the prefrontal cortex of SUS mice, IL-6 and TNF-alpha were increased, whereas IL-10 was decreased. The correlational analyses revealed that social interaction ratio was negatively correlated with SFB and positively associated with Lactobacillus and four other candidate protective organisms. These results pointed the possibility that the changes in the LRCs induced by chronic social defeat stress were ultimately associated with the inflammation of the brain and exacerbation of depressive-like behaviors.	[Xie, Ruining; Lin, Li; Wei, Wei; Qiao, Yi] Jining Med Univ, Dept Publ Hlth, Jining, Peoples R China; [Jiang, Pei] Jining First Peoples Hosp, Inst Clin Pharm & Pharmacol, Jining, Peoples R China; [Yu, Bin] Jining Med Univ, Coll Integrated Chinese & Western Med, Jining, Peoples R China; [Wang, Chunmei; Pan, Yanyou; Rao, Jingjing] Jining Med Univ, Inst Neurobiol, Jining, Peoples R China	Jining Medical University; Jining Medical University; Jining Medical University	Qiao, Y (corresponding author), Jining Med Univ, Dept Publ Hlth, Jining, Peoples R China.	qiaoyi2018@mail.jnmc.edu.cn			Teachersapos; research of Jining Medical University [JY2017KJ005]; National Natural Science Foundation of China (NSFC) [31600947, 81603509, 81602846]	Teachersapos; research of Jining Medical University; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	Teachers & apos; research of Jining Medical University, Grant/Award Number: JY2017KJ005; National Natural Science Foundation of China (NSFC), Grant/Award Number: 31600947, 81603509 and 81602846	Al-Nedawi K, 2015, FASEB J, V29, P684, DOI 10.1096/fj.14-259721; Atarashi K, 2015, CELL, V163, P367, DOI 10.1016/j.cell.2015.08.058; Bharwani A, 2016, PSYCHONEUROENDOCRINO, V63, P217, DOI 10.1016/j.psyneuen.2015.10.001; Brambilla P, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.46; Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108; Chaouloff F, 2013, CELL TISSUE RES, V354, P179, DOI 10.1007/s00441-013-1606-x; Chassaing B, 2011, J CLIN INVEST, V121, P966, DOI 10.1172/JCI44632; Chung HC, 2012, CELL, V149, P1578, DOI 10.1016/j.cell.2012.04.037; Cox LM, 2014, CELL, V158, P705, DOI 10.1016/j.cell.2014.05.052; De Palma G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8735; De-Paula VDR, 2018, PHARMACOL RES, V136, P29, DOI 10.1016/j.phrs.2018.07.007; Emge JR, 2016, AM J PHYSIOL-GASTR L, V310, pG989, DOI 10.1152/ajpgi.00086.2016; Ezenwa VO, 2012, SCIENCE, V338, P198, DOI 10.1126/science.1227412; Fagarasan S, 2010, ANNU REV IMMUNOL, V28, P243, DOI 10.1146/annurev-immunol-030409-101314; Fung TC, 2017, NAT NEUROSCI, V20, P145, DOI 10.1038/nn.4476; Galley JD, 2014, GUT MICROBES, V5, P748, DOI 10.4161/19490976.2014.972241; Gimeno D, 2009, PSYCHOL MED, V39, P413, DOI 10.1017/S0033291708003723; Gur TL, 2017, BRAIN BEHAV IMMUN, V64, P50, DOI 10.1016/j.bbi.2016.12.021; Hooper SJ, 2006, J CLIN MICROBIOL, V44, P1719, DOI 10.1128/JCM.44.5.1719-1725.2006; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kawamoto S, 2014, IMMUNITY, V41, P152, DOI 10.1016/j.immuni.2014.05.016; Kim SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042054; Kiyone H., 2008, FUNDAMENTAL IMMUNOLO, P983; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Lee YK, 2011, P NATL ACAD SCI USA, V108, P4615, DOI 10.1073/pnas.1000082107; Li Y, 2010, J AFFECT DISORDERS, V124, P68, DOI 10.1016/j.jad.2009.10.018; Liu MY, 2018, NAT PROTOC, V13, P1686, DOI 10.1038/s41596-018-0011-z; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Martin V, 2017, SCI REP-UK, V7, DOI 10.1038/srep45907; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Miller AH, 2016, NAT REV IMMUNOL, V16, P22, DOI 10.1038/nri.2015.5; Miller AH, 2009, BIOL PSYCHIAT, V65, P732, DOI 10.1016/j.biopsych.2008.11.029; Nagai S, 2007, P NATL ACAD SCI USA, V104, P8971, DOI 10.1073/pnas.0609014104; Obata T, 2010, P NATL ACAD SCI USA, V107, P7419, DOI 10.1073/pnas.1001061107; Palm NW, 2014, CELL, V158, P1000, DOI 10.1016/j.cell.2014.08.006; Qian YW, 2018, BRAIN BEHAV IMMUN, V70, P194, DOI 10.1016/j.bbi.2018.02.016; Qiao Y, 2015, J FUNCT FOODS, V14, P424, DOI 10.1016/j.jff.2015.02.013; Rios D, 2016, MUCOSAL IMMUNOL, V9, P907, DOI 10.1038/mi.2015.121; Rudzki L, 2019, PSYCHONEUROENDOCRINO, V100, P213, DOI 10.1016/j.psyneuen.2018.10.010; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Schnupf P, 2015, NATURE, V520, P99, DOI 10.1038/nature14027; Schnupf P, 2013, SEMIN IMMUNOL, V25, P342, DOI 10.1016/j.smim.2013.09.001; SCOTT KA, 2016, FASEB J S1, V30, P749; Szyszkowicz JK, 2017, BRAIN BEHAV IMMUN, V66, P45, DOI 10.1016/j.bbi.2017.06.009; Talham GL, 1999, INFECT IMMUN, V67, P1992; Teng F, 2016, IMMUNITY, V44, P875, DOI 10.1016/j.immuni.2016.03.013; VICENTINI FA, 2018, FASEB J S, V32, P921; Wong ML, 2016, MOL PSYCHIATR, V21, P797, DOI 10.1038/mp.2016.46; Wood AM, 2012, J AFFECT DISORDERS, V136, P882, DOI 10.1016/j.jad.2011.09.014; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yu M, 2017, J PHARMACEUT BIOMED, V138, P231, DOI 10.1016/j.jpba.2017.02.008; Zhang T, 2014, ANAESTH INTENS CARE, V42, P220, DOI 10.1177/0310057X1404200209; Zheng P, 2016, MOL PSYCHIATR, V21, P786, DOI 10.1038/mp.2016.44	54	3	3	0	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8310	8325		10.1096/fj.201902680RR	http://dx.doi.org/10.1096/fj.201902680RR		APR 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32333445				2022-12-28	WOS:000529447700001
J	Laschinger, M; Wang, Y; Holzmann, G; Wang, BC; Stoss, C; Lu, M; Brugger, M; Schneider, A; Knolle, P; Wohlleber, D; Schulze, S; Steiger, K; Tsujikawa, K; Altmayr, F; Friess, H; Hartmann, D; Huser, N; Holzmann, B				Laschinger, Melanie; Wang, Yang; Holzmann, Gabriela; Wang, Baocai; Stoess, Christian; Lu, Miao; Brugger, Marcus; Schneider, Annika; Knolle, Percy; Wohlleber, Dirk; Schulze, Sarah; Steiger, Katja; Tsujikawa, Kazutake; Altmayr, Felicitas; Friess, Helmut; Hartmann, Daniel; Hueser, Norbert; Holzmann, Bernhard			The CGRP receptor component RAMP1 links sensory innervation with YAP activity in the regenerating liver	FASEB JOURNAL			English	Article						CGRP; liver regeneration; RAMP1; sensory innervation; YAP; TAZ	GENE-RELATED PEPTIDE; HIPPO PATHWAY; HEPATOCYTE PROLIFERATION; IMMUNE-RESPONSES; PHOSPHORYLATION; ADRENOMEDULLIN; SURGERY; SIZE; TAZ	The effectiveness of liver regeneration limits surgical therapies of hepatic disorders and determines patient outcome. Here, we investigated the role of the neuropeptide calcitonin gene-related peptide (CGRP) for liver regeneration after acute or chronic injury. Mice deficient for the CGRP receptor component receptor activity-modifying protein 1 (RAMP1) were subjected to a 70% partial hepatectomy or repeated intraperitoneal injections of carbon tetrachloride. RAMP1 deficiency severely impaired recovery of organ mass and hepatocyte proliferation after both acute and chronic liver injury. Mechanistically, protein expression of the transcriptional coactivators Yes-associated protein (YAP) and transcriptional coactivator with PDZ-binding motif (TAZ) was decreased in regenerating livers of RAMP1-deficient mice. Lack of RAMP1 was associated with hyperphosphorylation of YAP on Ser127 and Ser397, which regulates YAP functional activity and protein levels. Consequently, expression of various YAP-controlled cell cycle regulators and hepatocyte proliferation were severely reduced in the absence of RAMP1. In vitro, CGRP treatment caused increased YAP protein expression and a concomitant decline of YAP phosphorylation in liver tissue slice cultures of mouse and human origin and in primary human hepatocytes. Thus, our results indicate that sensory nerves represent a crucial control element of liver regeneration after acute and chronic injury acting through the CGRP-RAMP1 pathway, which stimulates YAP/TAZ expression and activity.	[Laschinger, Melanie; Wang, Yang; Holzmann, Gabriela; Wang, Baocai; Stoess, Christian; Lu, Miao; Schulze, Sarah; Altmayr, Felicitas; Friess, Helmut; Hartmann, Daniel; Hueser, Norbert; Holzmann, Bernhard] Tech Univ Munich, Sch Med, Dept Surg, Ismaninger Str 22, D-81675 Munich, Germany; [Brugger, Marcus; Schneider, Annika; Knolle, Percy; Wohlleber, Dirk] Tech Univ Munich, Sch Med, Inst Mol Immunol & Expt Oncol, Munich, Germany; [Steiger, Katja] Tech Univ Munich, Sch Med, Inst Pathol, Munich, Germany; [Tsujikawa, Kazutake] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Mol & Cellular Physiol, Osaka, Japan	Technical University of Munich; Technical University of Munich; Technical University of Munich; Osaka University	Holzmann, B (corresponding author), Tech Univ Munich, Sch Med, Dept Surg, Ismaninger Str 22, D-81675 Munich, Germany.	bernhard.holzmann@tum.de	Wohlleber, Dirk/J-2549-2017	Wohlleber, Dirk/0000-0003-3861-5150; Stoess, Christian/0000-0002-0682-8808	China Scholarship Council; PhD program "Translational Medicine" of the School of Medicine, Technical University of Munich	China Scholarship Council(China Scholarship Council); PhD program "Translational Medicine" of the School of Medicine, Technical University of Munich	The authors would like to thank Silke Hegenbarth (Technical University of Munich, School of Medicine, Institute of Molecular Immunology & Experimental Oncology) for excellent technical support during the isolation of primary human hepatocytes. Y. W., BW, and ML were supported by the China Scholarship Council. This work was supported in part by a grant from the PhD program "Translational Medicine" of the School of Medicine, Technical University of Munich, to CS	Alison MR, 2016, J PATHOL, V238, P371, DOI 10.1002/path.4667; Apte U, 2009, HEPATOLOGY, V50, P844, DOI 10.1002/hep.23059; Berthoud HR, 2004, ANAT REC PART A, V280A, P827, DOI 10.1002/ar.a.20088; Booe JM, 2015, MOL CELL, V58, P1040, DOI 10.1016/j.molcel.2015.04.018; BRACQ S, 1994, FEBS LETT, V351, P63, DOI 10.1016/0014-5793(94)00823-X; Clavien P, 2007, NEW ENGL J MED, V356, P1545, DOI 10.1056/NEJMra065156; Clavien PA, 2010, HEPATOLOGY, V52, P715, DOI 10.1002/hep.23713; de Graaf IAM, 2010, NAT PROTOC, V5, P1540, DOI 10.1038/nprot.2010.111; Di Agostino S, 2016, EMBO REP, V17, P188, DOI 10.15252/embr.201540488; Ehmer U, 2014, CELL REP, V8, P370, DOI 10.1016/j.celrep.2014.06.025; Evans BN, 2000, J BIOL CHEM, V275, P31438, DOI 10.1074/jbc.M005604200; Fausto N, 2012, J HEPATOL, V57, P692, DOI 10.1016/j.jhep.2012.04.016; Gingell JJ, 2019, TRENDS PHARMACOL SCI, V40, P71, DOI 10.1016/j.tips.2018.11.005; Glaser SS, 2007, LAB INVEST, V87, P914, DOI 10.1038/labinvest.3700602; Hansen CG, 2015, TRENDS CELL BIOL, V25, P499, DOI 10.1016/j.tcb.2015.05.002; Holzmann B, 2013, CURR PROTEIN PEPT SC, V14, P268, DOI 10.2174/13892037113149990046; Holzmann B, 2013, AMINO ACIDS, V45, P1, DOI 10.1007/s00726-011-1161-2; Hwang ISS, 2006, REGUL PEPTIDES, V135, P69, DOI 10.1016/j.regpep.2006.04.006; Kawanami Y, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-8; Kim AR, 2019, FASEB J, V33, P5914, DOI 10.1096/fj.201801256RR; Klein EA, 2008, J CELL SCI, V121, P3853, DOI 10.1242/jcs.039131; Li JW, 2011, J GENET, V90, P435; Liu B, 2010, HEPATOLOGY, V52, P1060, DOI 10.1002/hep.23794; Loforese G, 2017, EMBO MOL MED, V9, P46, DOI 10.15252/emmm.201506089; Lu L, 2018, EXP MOL MED, V50, DOI 10.1038/emm.2017.205; Miller E, 2012, CHEM BIOL, V19, P955, DOI 10.1016/j.chembiol.2012.07.005; Mitchell C, 2008, NAT PROTOC, V3, P1167, DOI 10.1038/nprot.2008.80; Mizutani T, 2013, J SURG RES, V183, P138, DOI 10.1016/j.jss.2012.11.028; Ouwens DM, 2002, EMBO J, V21, P3782, DOI 10.1093/emboj/cdf361; Patel SH, 2017, GASTROENTEROLOGY, V152, P533, DOI 10.1053/j.gastro.2016.10.047; Piccolo S, 2014, PHYSIOL REV, V94, P1287, DOI 10.1152/physrev.00005.2014; Riehle KJ, 2008, J EXP MED, V205, P91, DOI 10.1084/jem.20070820; Rozengurt E, 2007, J CELL PHYSIOL, V213, P589, DOI 10.1002/jcp.21246; Russell FA, 2014, PHYSIOL REV, V94, P1099, DOI 10.1152/physrev.00034.2013; Scholten D, 2015, LAB ANIM-UK, V49, P4, DOI 10.1177/0023677215571192; Swiderska-Syn M, 2016, HEPATOLOGY, V64, P232, DOI 10.1002/hep.28542; Tsujikawa K, 2007, P NATL ACAD SCI USA, V104, P16702, DOI 10.1073/pnas.0705974104; Walker CS, 2010, TRENDS PHARMACOL SCI, V31, P476, DOI 10.1016/j.tips.2010.06.006; Wan Y, 2019, LAB INVEST, V99, P764, DOI 10.1038/s41374-018-0178-5; Yu FX, 2013, GENE DEV, V27, P1223, DOI 10.1101/gad.219402.113; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Zanconato F, 2015, NAT CELL BIOL, V17, P1218, DOI 10.1038/ncb3216; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810	45	5	5	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8125	8138		10.1096/fj.201903200R	http://dx.doi.org/10.1096/fj.201903200R		APR 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32329113	hybrid, Green Published			2022-12-28	WOS:000529446600001
J	Canals, D; Salamone, S; Santacreu, BJ; Nemeth, E; Aguilar, D; Hernandez-Corbacho, MJ; Adada, M; Staquicini, DI; Arap, W; Pasqualini, R; Haley, J; Obeid, LM; Hannun, YA				Canals, Daniel; Salamone, Silvia; Santacreu, Bruno Jaime; Nemeth, Erika; Aguilar, Daniel; Hernandez-Corbacho, Maria Jose; Adada, Mohamad; Staquicini, Daniela I.; Arap, Wadih; Pasqualini, Renata; Haley, John; Obeid, Lina M.; Hannun, Yusuf A.			Ceramide launches an acute anti-adhesion pro-migration cell signaling program in response to chemotherapy	FASEB JOURNAL			English	Article						doxorubicin; plasma membrane; sphingolipids; sphingomyelinase; vorinostat	NEUTRAL SPHINGOMYELINASE-2; PROTEIN PHOSPHATASE; INDUCED ACTIVATION; DEATH; PATHWAY; KINASE; DEPHOSPHORYLATION; OVEREXPRESSION; SPHINGOLIPIDS; PURIFICATION	Chemotherapy has been reported to upregulate sphingomylinases and increase cellular ceramide, often linked to the induction to cell death. In this work, we show that sublethal doses of doxorubicin and vorinostat still increased cellular ceramide, which was located predominantly at the plasma membrane. To interrogate possible functions of this specific pool of ceramide, we used recombinant enzymes to mimic physiological levels of ceramide at the plasma membrane upon chemotherapy treatment. Using mass spectrometry and network analysis, followed by experimental confirmation, the results revealed that this pool of ceramide acutely regulates cell adhesion and cell migration pathways with weak connections to commonly established ceramide functions (eg, cell death). Neutral sphingomyelinase 2 (nSMase2) was identified as responsible for the generation of plasma membrane ceramide upon chemotherapy treatment, and both ceramide at the plasma membrane and nSMase2 were necessary and sufficient to mediate these "side" effects of chemotherapy on cell adhesion and migration. This is the first time a specific pool of ceramide is interrogated for acute signaling functions, and the results define plasma membrane ceramide as an acute signaling effector necessary and sufficient for regulation of cell adhesion and cell migration under chemotherapeutical stress.	[Canals, Daniel; Salamone, Silvia; Santacreu, Bruno Jaime; Nemeth, Erika; Hernandez-Corbacho, Maria Jose; Adada, Mohamad; Haley, John; Obeid, Lina M.; Hannun, Yusuf A.] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA; [Santacreu, Bruno Jaime] Fac Farm & Bioquim, Catedra Biol Celular & Mol, Buenos Aires, DF, Argentina; [Aguilar, Daniel] Biomed Res Networking Ctr Hepat & Digest Dis CIBE, Barcelona, Spain; [Adada, Mohamad] Mayo Clin, Dept Internal Med, Rochester, MN USA; [Staquicini, Daniela I.; Arap, Wadih; Pasqualini, Renata] Rutgers Canc Inst New Jersey, Newark, NJ USA; [Staquicini, Daniela I.; Pasqualini, Renata] Rutgers New Jersey Med Sch, Div Canc Biol, Dept Radiat Oncol, Newark, NJ USA; [Arap, Wadih] Rutgers New Jersey Med Sch, Div Hematol Oncol, Dept Med, Newark, NJ USA; [Haley, John] SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11794 USA; [Obeid, Lina M.] Northport VA Hosp, Northport, NY USA; [Obeid, Lina M.; Hannun, Yusuf A.] Stony Brook Canc Ctr, Stony Brook, NY USA; [Hannun, Yusuf A.] SUNY Stony Brook, Dept Biochem, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Buenos Aires; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Mayo Clinic; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Hannun, YA (corresponding author), SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA.	yusuf.hannun@stonybrookmedicine.edu	Canals, Daniel/AAJ-8176-2021; Canals, Daniel/AAW-1998-2021	Canals, Daniel/0000-0002-9293-5123; Santacreu, Bruno/0000-0003-2506-5006	National Cancer Institute (NCI) [CA218678]	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	National Cancer Institute (NCI), Grant/Award Number: CA218678	Airola Michael V, 2013, Handb Exp Pharmacol, P57, DOI 10.1007/978-3-7091-1368-4_3; Andrieu-Abadie N, 2002, BBA-MOL CELL BIOL L, V1585, P126, DOI 10.1016/S1388-1981(02)00332-3; Bateman A, 2019, NUCLEIC ACIDS RES, V47, pD506, DOI 10.1093/nar/gky1049; Bennett WFD, 2012, J LIPID RES, V53, P421, DOI 10.1194/jlr.M022491; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Birbes H, 2001, FASEB J, V15, P2669, DOI 10.1096/fj.01-0539com; Bockelmann S, 2018, J LIPID RES, V59, P515, DOI 10.1194/jlr.M082354; Breuer K, 2013, NUCLEIC ACIDS RES, V41, pD1228, DOI 10.1093/nar/gks1147; Canals D, 2018, CHEM PHYS LIPIDS, V216, P142, DOI 10.1016/j.chemphyslip.2018.09.013; Canals Daniel, 2013, Handb Exp Pharmacol, P211, DOI 10.1007/978-3-7091-1368-4_12; Canals D, 2012, J BIOL CHEM, V287, P10145, DOI 10.1074/jbc.M111.306456; Canals D, 2011, BRIT J PHARMACOL, V163, P694, DOI 10.1111/j.1476-5381.2011.01279.x; Canals D, 2010, J BIOL CHEM, V285, P32476, DOI 10.1074/jbc.M110.141028; CHEN CS, 1995, J BIOL CHEM, V270, P13291, DOI 10.1074/jbc.270.22.13291; Cheng Z, 2014, J MOL CELL CARDIOL, V67, P1, DOI 10.1016/j.yjmcc.2013.12.002; Chudakova DA, 2008, J BIOL CHEM, V283, P28806, DOI 10.1074/jbc.M803301200; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Colombini M, 2010, BBA-BIOENERGETICS, V1797, P1239, DOI 10.1016/j.bbabio.2010.01.021; Dadsena S, 2019, CELL STRESS, V3, P280, DOI 10.15698/cst2019.08.196; Dadsena S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09654-4; Davis AP, 2017, NUCLEIC ACIDS RES, V45, pD972, DOI 10.1093/nar/gkw838; Diaz Osterman CJ, 2019, ELIFE, V8, DOI 10.7554/eLife.47327; DOBROWSKY RT, 1993, ADV LIPID RES, V25, P91; DOBROWSKY RT, 1992, J BIOL CHEM, V267, P5048; Dong XL, 2010, J PROTEOME RES, V9, P5943, DOI 10.1021/pr1007043; Dumitru CA, 2007, APOPTOSIS, V12, P1533, DOI 10.1007/s10495-007-0081-9; Elliott A, 2018, BIOINFORMATICS, V34, P64, DOI 10.1093/bioinformatics/btx419; Fabregat A, 2018, NUCLEIC ACIDS RES, V46, pD649, DOI [10.1093/nar/gkz1031, 10.1093/nar/gkx1132]; Grada A, 2017, J INVEST DERMATOL, V137, pE11, DOI 10.1016/j.jid.2016.11.020; Grammatikos G, 2007, ANTIOXID REDOX SIGN, V9, P1449, DOI 10.1089/ars.2007.1673; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hannun YA, 2018, NAT REV MOL CELL BIO, V19, P175, DOI 10.1038/nrm.2017.107; Hannun YA, 2011, J BIOL CHEM, V286, P27855, DOI 10.1074/jbc.R111.254359; Izquierdo E, 2018, CHEM PHYS LIPIDS, V215, P71, DOI 10.1016/j.chemphyslip.2018.07.004; Jaramillo-Gomez J, 2015, NEUROSCI LETT, V603, P71, DOI 10.1016/j.neulet.2015.07.032; Jenkins RW, 2011, J BIOL CHEM, V286, P13292, DOI 10.1074/jbc.M110.163378; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; KARAGIANNIS GS, 2017, SCI TRANSL MED, V9, P1; Key M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S16-S10; Kitatani K, 2006, J BIOL CHEM, V281, P36793, DOI 10.1074/jbc.M608137200; Kobayashi T, 2006, BIOL PHARM BULL, V29, P1526, DOI 10.1248/bpb.29.1526; Kota V, 2012, PROTEOMICS, V12, P2179, DOI 10.1002/pmic.201100527; Krishnamurthy K, 2007, J LIPID RES, V48, P968, DOI 10.1194/jlr.D600043-JLR200; Li Y, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2252-y; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liu CL, 2019, J BREAST CANCER, V22, P185, DOI 10.4048/jbc.2019.22.e22; Liu YY, 2008, FASEB J, V22, P2541, DOI 10.1096/fj.07-092981; Marchesini N, 2004, J BIOL CHEM, V279, P25101, DOI 10.1074/jbc.M313662200; MATHIAS S, 1991, P NATL ACAD SCI USA, V88, P10009, DOI 10.1073/pnas.88.22.10009; Milhas D, 2010, BBA-MOL CELL BIOL L, V1801, P1361, DOI 10.1016/j.bbalip.2010.08.001; Mistry D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187091; Mustafa Ebtihal H, 2015, Asian Pac J Cancer Prev, V16, P3213; Newcomb B, 2018, J LIPID RES, V59, P1219, DOI 10.1194/jlr.M084202; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; Oh HL, 2006, NEUROTOXICOLOGY, V27, P31, DOI 10.1016/j.neuro.2005.05.008; Park MA, 2010, CANCER RES, V70, P6313, DOI 10.1158/0008-5472.CAN-10-0999; Piccolo SR, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20156506; Pinheiro MAL, 2016, J IMMUNOL, V196, P72, DOI 10.4049/jimmunol.1500702; R Core Team, 2018, R LANG ENV STAT COMP; Rebillard A, 2010, EUR J CANCER, V46, P1445, DOI 10.1016/j.ejca.2010.01.034; Roodhart JML, 2013, BLOOD, V122, P143, DOI 10.1182/blood-2012-11-459347; Rotolo J, 2012, J CLIN INVEST, V122, P1786, DOI 10.1172/JCI59920; Sales G, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-20; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schulte-Zweckel J, 2018, CHEM COMMUN, V54, P13742, DOI 10.1039/c8cc05691a; Seitz AP, 2015, BIOL CHEM, V396, P611, DOI 10.1515/hsz-2014-0285; Shamseddine Achraf A, 2015, Adv Biol Regul, V57, P24, DOI 10.1016/j.jbior.2014.10.002; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Snider JM, 2019, J LIPID RES, V60, P819, DOI 10.1194/jlr.M089714; Sun Y, 2012, NAT MED, V18, P1359, DOI 10.1038/nm.2890; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Tani M, 2007, FEBS LETT, V581, P1323, DOI 10.1016/j.febslet.2007.02.046; Tani M, 2007, J BIOL CHEM, V282, P10047, DOI 10.1074/jbc.M611249200; Tellier E, 2007, MOL CELL BIOL, V27, P2997, DOI 10.1128/MCB.01485-06; van der Walt S, 2011, COMPUT SCI ENG, V13, P22, DOI 10.1109/MCSE.2011.37; Walev I, 1996, INFECT IMMUN, V64, P2974, DOI 10.1128/IAI.64.8.2974-2979.1996; Wang G, 2008, J NEUROCHEM, V106, P718, DOI 10.1111/j.1471-4159.2008.05451.x; Wu BX, 2007, J LIPID RES, V48, P600, DOI 10.1194/jlr.M600423-JLR200; Yang DI, 2004, NEUROBIOL DIS, V17, P99, DOI 10.1016/j.nbd.2004.06.001; Zeidan YH, 2008, J CELL BIOL, V181, P335, DOI 10.1083/jcb.200705060; Zhang SY, 2018, INT CONF BIG DATA, P1, DOI 10.1109/BigComp.2018.00010; Zwick M, 2019, DATA BRIEF, V25, DOI 10.1016/j.dib.2019.104284	82	14	14	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					7610	7630		10.1096/fj.202000205R	http://dx.doi.org/10.1096/fj.202000205R		APR 2020	21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32307766	Green Accepted, Bronze			2022-12-28	WOS:000527568500001
J	McDonald, TS; McCombe, PA; Woodruff, TM; Lee, JD				McDonald, Tanya S.; McCombe, Pamela A.; Woodruff, Trent M.; Lee, John D.			The potential interplay between energy metabolism and innate complement activation in amyotrophic lateral sclerosis	FASEB JOURNAL			English	Review						glucose metabolism; neurodegeneration; neuroinflammation; TCA cycle	BODY-MASS INDEX; TRANSGENIC MOUSE MODEL; INSULIN-RESISTANCE; CARBOHYDRATE-METABOLISM; GLUCOSE TRANSPORTERS; SKELETAL-MUSCLE; FDG-PET; RECEPTOR; ALS; ANAPHYLATOXIN	Amyotrophic lateral sclerosis (ALS) is a fatal and rapidly progressing motor neuron disease without effective treatment. Although the precise mechanisms leading to ALS are yet to be determined, there is now increasing evidence implicating the defective energy metabolism and components of the innate immune complement system in the onset and progression of its motor phenotypes. This review will survey the mechanisms by which the energy metabolism and the complement system are altered during the disease progression of ALS and how it can contribute to disease. Furthermore, it will also examine how complement activation can modify the energy metabolism in metabolic disorders, in order to highlight how the complement system and energy metabolism may be linked in ALS.	[McDonald, Tanya S.; Woodruff, Trent M.; Lee, John D.] Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia; [McCombe, Pamela A.; Lee, John D.] Univ Queensland, Ctr Clin Res, Herston, Qld, Australia; [McCombe, Pamela A.] Royal Brisbane & Womens Hosp, Dept Neurol, Herston, Qld, Australia	University of Queensland; University of Queensland; Royal Brisbane & Women's Hospital	Lee, JD (corresponding author), Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia.	j.lee9@uq.edu.au	Woodruff, Trent/AAS-4629-2020; McCombe, Pamela/C-9692-2010; Woodruff, Trent M/B-4861-2009; Lee, John/Y-2066-2018	Woodruff, Trent/0000-0003-1382-911X; McCombe, Pamela/0000-0003-2704-8517; Woodruff, Trent M/0000-0003-1382-911X; McDonald, Tanya/0000-0003-4325-3537; Lee, John/0000-0002-9976-7396	Motor Neurone Disease Research Institute of Australia (MNDRIA) [GIA1830, PDF1604]; Department of Health \ National Health and Medical Research Council (NHMRC) [1105420, 1082271]	Motor Neurone Disease Research Institute of Australia (MNDRIA); Department of Health \ National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	Motor Neurone Disease Research Institute of Australia (MNDRIA), Grant/Award Number: GIA1830 and PDF1604; Department of Health vertical bar National Health and Medical Research Council (NHMRC), Grant/Award Number: 1105420 and 1082271	Ahmed RM, 2014, J NEUROL, V261, P1774, DOI 10.1007/s00415-014-7416-6; Apelt J, 1999, J NEUROSCI RES, V57, P693, DOI 10.1002/(SICI)1097-4547(19990901)57:5<693::AID-JNR11>3.0.CO;2-X; Bahia El Idrissi N., 2016, ANN NEURODEGENER DIS, V1, P1015; Boucher J, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a009191; Bouteloup C, 2009, J NEUROL, V256, P1236, DOI 10.1007/s00415-009-5100-z; BRANT AM, 1993, BIOCHEM BIOPH RES CO, V192, P1297, DOI 10.1006/bbrc.1993.1557; Brennan FH, 2016, SEMIN IMMUNOL, V28, P292, DOI 10.1016/j.smim.2016.03.015; Brown RH, 2017, NEW ENGL J MED, V377, P1602, DOI [10.1056/NEJMra1603471, 10.1038/nrdp.2017.71, 10.1016/S0140-6736(10)61156-7, 10.1056/NEJMc1710379, 10.1038/nrdp.2017.85, 10.1016/S0140-6736(17)31287-4]; Browne SE, 2006, NEUROBIOL DIS, V22, P599, DOI 10.1016/j.nbd.2006.01.001; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; Carri MT, 2011, J BIOENERG BIOMEMBR, V43, P593, DOI 10.1007/s10863-011-9394-z; Cistaro A, 2012, EUR J NUCL MED MOL I, V39, P251, DOI 10.1007/s00259-011-1979-6; Desseille C, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00332; Dupuis L, 2004, P NATL ACAD SCI USA, V101, P11159, DOI 10.1073/pnas.0402026101; El Messari S, 1998, J COMP NEUROL, V399, P492, DOI 10.1002/(SICI)1096-9861(19981005)399:4<492::AID-CNE4>3.0.CO;2-X; Fergani A, 2007, J LIPID RES, V48, P1571, DOI 10.1194/jlr.M700017-JLR200; Funalot B, 2009, AMYOTROPH LATERAL SC, V10, P113, DOI 10.1080/17482960802295192; Genton L, 2011, CLIN NUTR, V30, P553, DOI 10.1016/j.clnu.2011.06.004; Gitcho MA, 2008, ANN NEUROL, V63, P535, DOI 10.1002/ana.21344; Habegger KM, 2010, NAT REV ENDOCRINOL, V6, P689, DOI 10.1038/nrendo.2010.187; Hamadeh MJ, 2005, MUSCLE NERVE, V31, P214, DOI 10.1002/mus.20255; HENRIKSEN EJ, 1991, J APPL PHYSIOL, V70, P2322, DOI 10.1152/jappl.1991.70.5.2322; Heurich B, 2011, J NEUROIMMUNOL, V235, P104, DOI 10.1016/j.jneuroim.2011.03.011; Humayun S, 2009, J NEUROIMMUNOL, V210, P52, DOI 10.1016/j.jneuroim.2009.01.028; IONASESCU V, 1964, ACTA NEUROL SCAND, V40, P47, DOI 10.1111/j.1600-0404.1964.tb04265.x; Johswich K, 2007, ADV EXP MED BIOL, V598, P159; Johswich K, 2006, J BIOL CHEM, V281, P39088, DOI 10.1074/jbc.M609734200; Kaneb HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024189; Kasarskis EJ, 1996, AM J CLIN NUTR, V63, P130, DOI 10.1093/ajcn/63.1.130; Kiaei M, 2005, EXP NEUROL, V191, P331, DOI 10.1016/j.expneurol.2004.10.007; Kioumourtzoglou MA, 2015, JAMA NEUROL, V72, P905, DOI 10.1001/jamaneurol.2015.0910; Lee JD, 2017, BRIT J PHARMACOL, V174, P689, DOI 10.1111/bph.13730; Lee JD, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-119; Li R, 2013, FASEB J, V27, P855, DOI 10.1096/fj.12-220509; Lindauer E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067783; Llanos P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129238; Lou JS, 2008, PHYS MED REH CLIN N, V19, P533, DOI 10.1016/j.pmr.2008.02.001; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Mamane Y, 2009, DIABETES, V58, P2006, DOI 10.2337/db09-0323; Manthey HD, 2009, INT J BIOCHEM CELL B, V41, P2114, DOI 10.1016/j.biocel.2009.04.005; Mariosa D, 2015, EUR J NEUROL, V22, P1436, DOI 10.1111/ene.12632; Mattson MP, 2007, NEUROMOL MED, V9, P17, DOI 10.1385/NMM:9:1:17; McElhiney MC, 2009, J NEUROL NEUROSUR PS, V80, P1146, DOI 10.1136/jnnp.2008.163246; MUELLER PS, 1970, J LAB CLIN MED, V76, P190; Pagani M, 2014, NEUROLOGY, V83, P1067, DOI 10.1212/WNL.0000000000000792; Paganoni S, 2011, MUSCLE NERVE, V44, P20, DOI 10.1002/mus.22114; Paglialunga S, 2007, J ENDOCRINOL, V194, P293, DOI 10.1677/JOE-07-0205; Palamiuc L, 2015, EMBO MOL MED, V7, P526, DOI 10.15252/emmm.201404433; Parker SE, 2019, NEUROBIOL DIS, V127, P223, DOI 10.1016/j.nbd.2019.03.003; Patel BP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009386; Phieler J, 2013, J IMMUNOL, V191, P4367, DOI 10.4049/jimmunol.1300038; Quesada I, 2008, J ENDOCRINOL, V199, P5, DOI 10.1677/JOE-08-0290; REYES ET, 1984, J NEUROL SCI, V63, P317, DOI 10.1016/0022-510X(84)90154-0; Rosler KM, 2000, CLIN NEUROPHYSIOL, V111, P2208, DOI 10.1016/S1388-2457(00)00481-8; Roy C, 2008, AM J PHYSIOL-ENDOC M, V294, pE1051, DOI 10.1152/ajpendo.00689.2007; Roy C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062531; Roy C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057494; SAFFER D, 1977, J NEUROL NEUROSUR PS, V40, P533, DOI 10.1136/jnnp.40.6.533; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Sarma JV, 2011, CELL TISSUE RES, V343, P227, DOI 10.1007/s00441-010-1034-0; Schutz B, 2005, J NEUROSCI, V25, P7805, DOI 10.1523/JNEUROSCI.2038-05.2005; Shimizu T, 2012, AMYOTROPH LATERAL SC, V13, P363, DOI 10.3109/17482968.2012.678366; SINACORE DR, 1993, PHYS THER, V73, P878, DOI 10.1093/ptj/73.12.878; Sleigh A, 2011, J CLIN INVEST, V121, P2457, DOI 10.1172/JCI46405; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Staels B, 2006, CURR MED RES OPIN, V22, pS27, DOI 10.1185/030079906X112732; Stallings NR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071793; Steyn FJ, 2018, J NEUROL NEUROSUR PS, V89, P1016, DOI 10.1136/jnnp-2017-317887; Sun Y, 2014, J EPIDEMIOLOGY JAPAN, V25, P445; Szelechowski M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22318-5; UNGER JW, 1991, PROG NEUROBIOL, V36, P343, DOI 10.1016/0301-0082(91)90015-S; Van Laere K, 2014, JAMA NEUROL, V71, P553, DOI 10.1001/jamaneurol.2014.62; Vandoorne T, 2018, ACTA NEUROPATHOL, V135, P489, DOI 10.1007/s00401-018-1835-x; Vannucci SJ, 1998, BRAIN RES, V797, P1, DOI 10.1016/S0006-8993(98)00103-6; Wang HTA, 2017, SKELET MUSCLE, V7, DOI 10.1186/s13395-017-0128-8; West EE, 2018, ANNU REV IMMUNOL, V36, P309, DOI 10.1146/annurev-immunol-042617-053245; Wilcox Gisela, 2005, Clin Biochem Rev, V26, P19; Woodruff TM, 2014, P NATL ACAD SCI USA, V111, pE3, DOI 10.1073/pnas.1321248111; Woodruff TM, 2008, J IMMUNOL, V181, P8727, DOI 10.4049/jimmunol.181.12.8727; Xia ZN, 2004, J BIOL CHEM, V279, P4051, DOI 10.1074/jbc.M311319200; Zhang JJ, 2014, IUBMB LIFE, V66, P485, DOI 10.1002/iub.1293; Zhao XL, 2014, J PROTEOME RES, V13, P2359, DOI 10.1021/pr401163t	82	5	5	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					7225	7233		10.1096/fj.201901781	http://dx.doi.org/10.1096/fj.201901781		APR 2020	9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32307753	Bronze			2022-12-28	WOS:000527382900001
J	Cui, D; Drake, JC; Wilson, RJ; Shute, RJ; Lewellen, B; Zhang, M; Zhao, HN; Sabik, OL; Onengut, S; Berr, SS; Rich, SS; Farber, CR; Yan, Z				Cui, Di; Drake, Joshua C.; Wilson, Rebecca J.; Shute, Robert J.; Lewellen, Bevan; Zhang, Mei; Zhao, Henan; Sabik, Olivia L.; Onengut, Suna; Berr, Stuart S.; Rich, Stephen S.; Farber, Charles R.; Yan, Zhen			A novel voluntary weightlifting model in mice promotes muscle adaptation and insulin sensitivity with simultaneous enhancement of autophagy and mTOR pathway	FASEB JOURNAL			English	Article						contractile adaptation; hypertrophy; metabolic adaptation; muscle power; resistance exercise	MOUSE SKELETAL-MUSCLE; RESISTANCE EXERCISE; PROTEIN BREAKDOWN; EXPRESSION; HYPERTROPHY; ENDURANCE; STRENGTH; GLUCOSE; PHOSPHORYLATION; TRANSPORT	Our understanding of the molecular mechanisms underlying adaptations to resistance exercise remains elusive despite the significant biological and clinical relevance. We developed a novel voluntary mouse weightlifting model, which elicits squat-like activities against adjustable load during feeding, to investigate the resistance exercise-induced contractile and metabolic adaptations. RNAseq analysis revealed that a single bout of weightlifting induced significant transcriptome responses of genes that function in posttranslational modification, metabolism, and muscle differentiation in recruited skeletal muscles, which were confirmed by increased expression of fibroblast growth factor-inducible 14 (Fn14), Down syndrome critical region 1 (Dscr1) and Nuclear receptor subfamily 4, group A, member 3 (Nr4a3) genes. Long-term (8 weeks) voluntary weightlifting training resulted in significantly increases of muscle mass, protein synthesis (puromycin incorporation in SUnSET assay) and mTOR pathway protein expression (raptor, 4e-bp-1, and p70S6K proteins) along with enhanced muscle power (specific torque and contraction speed), but not endurance capacity, mitochondrial biogenesis, and fiber type transformation. Importantly, weightlifting training profound improved whole-body glucose clearance and skeletal muscle insulin sensitivity along with enhanced autophagy (increased LC3 and LC3-II/I ratio, and decreased p62/Sqstm1). These data suggest that resistance training in mice promotes muscle adaptation and insulin sensitivity with simultaneous enhancement of autophagy and mTOR pathway.	[Cui, Di; Drake, Joshua C.; Wilson, Rebecca J.; Shute, Robert J.; Lewellen, Bevan; Zhang, Mei; Zhao, Henan; Yan, Zhen] Univ Virginia, Sch Med, Robert M Berne Cardiovasc Res Ctr, Ctr Skeletal Muscle Res, 409 Lane Rd,MR4-6031A, Charlottesville, VA 22908 USA; [Cui, Di] East China Normal Univ, Minist Educ, Key Lab Adolescent & Exercise Intervent, Shanghai, Peoples R China; [Wilson, Rebecca J.; Sabik, Olivia L.; Farber, Charles R.] Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; [Zhang, Mei; Yan, Zhen] Univ Virginia, Sch Med, Dept Med, Charlottesville, VA 22908 USA; [Sabik, Olivia L.; Onengut, Suna; Rich, Stephen S.; Farber, Charles R.] Univ Virginia, Sch Med, Ctr Publ Hlth Genom, Charlottesville, VA USA; [Berr, Stuart S.] Univ Virginia, Sch Med, Dept Radiol & Med Imaging, Charlottesville, VA 22908 USA; [Farber, Charles R.] Univ Virginia, Sch Med, Dept Publ Hlth Sci, Charlottesville, VA 22908 USA; [Yan, Zhen] Univ Virginia, Sch Med, Dept Pharmacol, Charlottesville, VA 22908 USA; [Yan, Zhen] Univ Virginia, Sch Med, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA	University of Virginia; East China Normal University; University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia	Yan, Z (corresponding author), Univ Virginia, Sch Med, Robert M Berne Cardiovasc Res Ctr, Ctr Skeletal Muscle Res, 409 Lane Rd,MR4-6031A, Charlottesville, VA 22908 USA.	zhen.yan@virginia.edu	Cui, Di/AHB-4211-2022	Rich, Stephen/0000-0003-3872-7793; Cui, Di/0000-0002-7356-9877; Yan, Zhen/0000-0002-4826-9813; Wilson, Rebecca/0000-0001-5884-0705	National Institutes of Health [R01AR050429]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	National Institutes of Health, Grant/Award Number: R01AR050429	Andersen LL, 2005, J APPL PHYSIOL, V99, P87, DOI 10.1152/japplphysiol.00091.2005; ARMSTRONG RB, 1979, J APPL PHYSIOL, V46, P835, DOI 10.1152/jappl.1979.46.4.835; Barash IA, 2007, AM J PHYSIOL-CELL PH, V293, pC218, DOI 10.1152/ajpcell.00055.2007; Blazevich AJ, 2007, J APPL PHYSIOL, V103, P1565, DOI 10.1152/japplphysiol.00578.2007; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Call JA, 2015, CIRC-HEART FAIL, V8, P188, DOI 10.1161/CIRCHEARTFAILURE.114.001540; Choi S, 2005, J APPL PHYSIOL, V99, P2406, DOI 10.1152/japplphysiol.00545.2005; Cholewa J, 2014, J CELL PHYSIOL, V229, P1148, DOI 10.1002/jcp.24542; DALLE PP, 2016, NAT COMMUN, V7, DOI [10.1038/ncomms13254, DOI 10.1038/NC0MMS13254]; Davidson LE, 2009, ARCH INTERN MED, V169, P122, DOI 10.1001/archinternmed.2008.558; Fernandez-Verdejo R, 2017, BIOCHEM BIOPH RES CO, V492, P249, DOI 10.1016/j.bbrc.2017.08.059; Fernandez-Verdejo R, 2017, FASEB J, V31, P840, DOI 10.1096/fj.201600987R; FIATARONE MA, 1990, JAMA-J AM MED ASSOC, V263, P3029, DOI 10.1001/jama.263.22.3029; Fry CS, 2013, J GERONTOL A-BIOL, V68, P599, DOI 10.1093/gerona/gls209; Galluzzi L, 2017, EMBO J, V36, P1811, DOI 10.15252/embj.201796697; Ganta VC, 2019, CIRCULATION, V139, P226, DOI 10.1161/CIRCULATIONAHA.118.034165; Glynn EL, 2010, AM J PHYSIOL-REG I, V299, pR533, DOI 10.1152/ajpregu.00077.2010; Goodman CA, 2013, EXERC SPORT SCI REV, V41, P107, DOI 10.1097/JES.0b013e3182798a95; Goodman CA, 2011, J PHYSIOL-LONDON, V589, P5485, DOI 10.1113/jphysiol.2011.218255; Goodman CA, 2011, FASEB J, V25, P1028, DOI 10.1096/fj.10-168799; Guridi M, 2016, SKELET MUSCLE, V6, DOI 10.1186/s13395-016-0084-8; Hawley JA, 2014, CELL, V159, P738, DOI 10.1016/j.cell.2014.10.029; He CC, 2012, AUTOPHAGY, V8, P1548, DOI 10.4161/auto.21327; Hentila J, 2018, ACTA PHYSIOL, V224, DOI 10.1111/apha.13069; Hitomi Y, 2003, IUBMB LIFE, V55, P409, DOI 10.1080/15216540310001592825; Jia LG, 2005, AM J PHYSIOL-HEART C, V288, pH1982, DOI 10.1152/ajpheart.00142.2004; Kanehisa H, 1997, INT J SPORTS MED, V18, P106, DOI 10.1055/s-2007-972604; Kido K, 2017, AM J PHYSIOL-REG I, V313, pR110, DOI 10.1152/ajpregu.00063.2017; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; KLITGAARD H, 1988, J APPL PHYSIOL, V64, P1740, DOI 10.1152/jappl.1988.64.4.1740; Koskinen SOA, 2017, HISTOCHEM CELL BIOL, V148, P545, DOI 10.1007/s00418-017-1595-z; Kwon I, 2018, J PHYSIOL SCI, V68, P269, DOI 10.1007/s12576-017-0531-2; Laker RC, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00520-9; Lee S, 2004, J APPL PHYSIOL, V96, P1097, DOI 10.1152/japplphysiol.00479.2003; Lee S, 2012, DIABETES, V61, P2787, DOI 10.2337/db12-0214; Lira VA, 2013, FASEB J, V27, P4184, DOI 10.1096/fj.13-228486; Luo L, 2013, EXP GERONTOL, V48, P427, DOI 10.1016/j.exger.2013.02.009; Mahoney DJ, 2005, FASEB J, V19, P1498, DOI 10.1096/fj.04-3149fje; Marzetti E, 2017, AGING CLIN EXP RES, V29, P35, DOI 10.1007/s40520-016-0705-4; McCarthy JJ, 2011, DEVELOPMENT, V138, P3657, DOI 10.1242/dev.068858; Ogasawara R, 2017, J APPL PHYSIOL, V123, P710, DOI 10.1152/japplphysiol.01009.2016; Ogasawara R, 2016, SCI REP-UK, V6, DOI 10.1038/srep31142; Ohanna M, 2005, NAT CELL BIOL, V7, P286, DOI 10.1038/ncb1231; Pearen MA, 2012, MOL ENDOCRINOL, V26, P372, DOI 10.1210/me.2011-1274; Philippe AG, 2019, EXP PHYSIOL, V104, P1274, DOI 10.1113/EP087071; Pollock ML, 2000, CIRCULATION, V101, P828, DOI 10.1161/01.CIR.101.7.828; Raue U, 2015, J APPL PHYSIOL, V118, P569, DOI 10.1152/japplphysiol.00759.2014; Russell RD, 2014, J STRENGTH COND RES, V28, P2760, DOI 10.1519/JSC.0000000000000624; Safdar A, 2016, NAT REV ENDOCRINOL, V12, P504, DOI 10.1038/nrendo.2016.76; Sandri M, 2013, J CELL SCI, V126, P5325, DOI 10.1242/jcs.114041; Sandri M, 2013, INT J BIOCHEM CELL B, V45, P2121, DOI 10.1016/j.biocel.2013.04.023; Sandri M, 2010, AM J PHYSIOL-CELL PH, V298, pC1291, DOI 10.1152/ajpcell.00531.2009; Schoenfeld BJ, 2010, J STRENGTH COND RES, V24, P3497, DOI 10.1519/JSC.0b013e3181bac2d7; SONG Z, 2017, SCI REP UK, V7; Spence AL, 2011, J PHYSIOL-LONDON, V589, P5443, DOI 10.1113/jphysiol.2011.217125; Stylianou AP, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4023982; Sylow L, 2015, J PHYSIOL-LONDON, V593, P645, DOI 10.1113/jphysiol.2014.284281; Widrick JJ, 2002, AM J PHYSIOL-REG I, V283, pR408, DOI 10.1152/ajpregu.00120.2002; Wilson RJ, 2019, J APPL PHYSIOL, V126, P193, DOI 10.1152/japplphysiol.00358.2018; WONG TS, 1990, J APPL PHYSIOL, V69, P1718, DOI 10.1152/jappl.1990.69.5.1718; Yan L, 2017, APPL PHYSIOL NUTR ME, V42, P1179, DOI 10.1139/apnm-2017-0285; Yaspelkis BB, 2002, ACTA PHYSIOL SCAND, V175, P315, DOI 10.1046/j.1365-201X.2002.00998.x	62	20	20	4	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					7330	7344		10.1096/fj.201903055R	http://dx.doi.org/10.1096/fj.201903055R		APR 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32304342	Green Accepted, Bronze			2022-12-28	WOS:000526959900001
J	Li, JW; Wang, YS; Wang, Y; Yan, YQ; Tong, HL; Li, SF				Li Jiwei; Wang Yanshuang; Wang Yan; Yan Yunqin; Tong Huili; Li Shufeng			Fibronectin type III domain containing four promotes differentiation of C2C12 through the Wnt/beta-catenin signaling pathway	FASEB JOURNAL			English	Article						Dickkopf-related protein 1; low-density lipoprotein receptor-related protein 6; myogenin	DORSAL NEURAL-TUBE; PARAXIAL MESODERM; STEM-CELLS; MUSCLE; RECEPTOR; MYOGENESIS; PROTEINS; DISTINCT; FAMILY; VASCULARIZATION	Fibronectin type III domain containing 4 (FNDC4) belongs to the fibronectin type III domain containing protein family. FNDC5, which is highly homologous to FNDC4, can promote the differentiation of cardiac cells. We aimed to investigate the role of FNDC4 in the differentiation of C2C12 mouse skeletal muscle cells. Western blotting and immunofluorescence analysis showed that FNDC4 gradually increased with the differentiation of C2C12. Muscle injury repair experiments indicated that FNDC4 may promote the repair of injured muscles. When FNDC4 was either overexpressed or knocked down, the expression of desmin and myogenin myogenic marker molecules followed that of FNDC4, suggesting that FNDC4 can influence the differentiation of C2C12. In addition, immunoprecipitation results showed that FNDC4 can interact with the Wnt/beta-catenin signaling pathway receptor low-density lipoprotein receptor-related protein 6 (LRP6), and that beta-catenin levels in the nucleus decreased after knocking down FNDC4. Exogenous addition of FNDC4 protein could not restore the blocking of differentiation due to inhibition of both Wnt/beta-catenin signal transduction and LRP6 activity via the beta-catenin inhibitor XAV-939. Overall, our findings indicate that FDNC4 can influence the differentiation of C2C12 by activating Wnt/beta-catenin signal transduction.	[Li Jiwei; Wang Yanshuang; Wang Yan; Yan Yunqin; Tong Huili; Li Shufeng] Northeast Agr Univ, Lab Cell & Dev Biol, Changjiang Rd 600, Harbin 150030, Heilongjiang, Peoples R China	Northeast Agricultural University - China	Li, SF (corresponding author), Northeast Agr Univ, Lab Cell & Dev Biol, Changjiang Rd 600, Harbin 150030, Heilongjiang, Peoples R China.	lishufeng11@sina.com		jiwei, li/0000-0002-1353-4445	Heilongjiang Natural Science Foundation [C2016029]	Heilongjiang Natural Science Foundation(Natural Science Foundation of Heilongjiang Province)	Heilongjiang Natural Science Foundation, Grant/Award Number: C2016029	Agley CC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10731-1; Alexander MS, 2013, CELL DEATH DIFFER, V20, P1194, DOI 10.1038/cdd.2013.62; Anakwe K, 2003, DEVELOPMENT, V130, P3503, DOI 10.1242/dev.00538; Asfour HA, 2018, EXP BIOL MED, V243, P118, DOI 10.1177/1535370217749494; Bassel-Duby R, 2006, ANNU REV BIOCHEM, V75, P19, DOI 10.1146/annurev.biochem.75.103004.142622; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Church VL, 2002, INT J DEV BIOL, V46, P927; Colaianni G, 2017, ANN NY ACAD SCI, V1402, P5, DOI 10.1111/nyas.13345; Cui YF, 2018, EXP CELL RES, V366, P199, DOI 10.1016/j.yexcr.2018.03.027; Daley WP, 2008, J CELL SCI, V121, P255, DOI 10.1242/jcs.006064; Dellett M, 2012, DEV GROWTH DIFFER, V54, P327, DOI 10.1111/j.1440-169X.2012.01339.x; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Herz J, 2002, ANNU REV BIOCHEM, V71, P405, DOI 10.1146/annurev.biochem.71.110601.135342; Hey PJ, 1998, GENE, V216, P103, DOI 10.1016/S0378-1119(98)00311-4; Ikeya M, 1998, DEVELOPMENT, V125, P4969; Jones AE, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0038-6; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kim JH, 2018, CELL DEATH DIFFER, V25, P1921, DOI 10.1038/s41418-018-0165-9; Kuang S, 2006, J CELL BIOL, V172, P103, DOI 10.1083/jcb.200508001; Lee W, 2018, BIOCHEM BIOPH RES CO, V502, P129, DOI 10.1016/j.bbrc.2018.05.133; Liu D, 2019, J CELL PHYSIOL, V234, P11130, DOI 10.1002/jcp.27763; Lv ZT, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/3936257; MAIN AL, 1992, CELL, V71, P671, DOI 10.1016/0092-8674(92)90600-H; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Meadows E, 2008, DEV BIOL, V322, P406, DOI 10.1016/j.ydbio.2008.07.024; Nam JS, 2006, J BIOL CHEM, V281, P13247, DOI 10.1074/jbc.M508324200; Nazem S, 2018, J CELL BIOCHEM, V119, P4528, DOI 10.1002/jcb.26590; Nemeth MJ, 2007, P NATL ACAD SCI USA, V104, P15436, DOI 10.1073/pnas.0704747104; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Park JS, 2007, DEVELOPMENT, V134, P2533, DOI 10.1242/dev.006155; Paulin D, 2004, EXP CELL RES, V301, P1, DOI 10.1016/j.yexcr.2004.08.004; Perry RA, 2016, MECH AGEING DEV, V157, P7, DOI 10.1016/j.mad.2016.05.007; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Relaix F, 2006, J CELL BIOL, V172, P91, DOI 10.1083/jcb.200508044; Rochat A, 2004, MOL BIOL CELL, V15, P4544, DOI 10.1091/mbc.E03-11-0816; ROSKELLEY CD, 1995, CURR OPIN CELL BIOL, V7, P736, DOI 10.1016/0955-0674(95)80117-0; RUOSLAHTI E, 1988, ANNU REV BIOCHEM, V57, P375, DOI 10.1146/annurev.bi.57.070188.002111; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; STERN HM, 1995, DEVELOPMENT, V121, P3675; Strutt D, 2003, DEVELOPMENT, V130, P4501, DOI 10.1242/dev.00695; Tajbakhsh S, 1998, DEVELOPMENT, V125, P4155; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; Teufel A, 2002, GENE, V297, P79, DOI 10.1016/S0378-1119(02)00828-4; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Wrann CD, 2013, CELL METAB, V18, P649, DOI 10.1016/j.cmet.2013.09.008; Zhang H, 2018, MOL BIOTECHNOL, V60, P396, DOI 10.1007/s12033-018-0079-2; Zhang WW, 2018, J CELL PHYSIOL, V233, P350, DOI 10.1002/jcp.25883	54	7	7	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					7759	7772		10.1096/fj.201902860RRR	http://dx.doi.org/10.1096/fj.201902860RRR		APR 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32298013				2022-12-28	WOS:000526946200001
J	Saraswati, S; Lietman, CD; Li, B; Mathew, S; Zent, R; Young, PP				Saraswati, Sarika; Lietman, Caressa D.; Li, Bin; Mathew, Sijo; Zent, Roy; Young, Pampee P.			Small proline-rich repeat 3 is a novel coordinator of PDGFR beta and integrin beta 1 crosstalk to augment proliferation and matrix synthesis by cardiac fibroblasts	FASEB JOURNAL			English	Article						collagen; fibrosis; heart failure; pressure overload; transverse aortic constriction	FOCAL ADHESION KINASE; SMOOTH-MUSCLE-CELLS; GROWTH-FACTOR; SIGNALING PATHWAYS; GENE-EXPRESSION; MOLECULAR CHARACTERIZATION; MYOCARDIAL FIBROSIS; COLLAGEN GENE; UP-REGULATION; EGF RECEPTOR	Nearly 6 million Americans suffer from heart failure. Increased fibrosis contributes to functional decline of the heart that leads to heart failure. Previously, we identified a mechanosensitive protein, small proline-rich repeat 3 (SPRR3), in vascular smooth muscle cells of atheromas. In this study, we demonstrate SPRR3 expression in cardiac fibroblasts which is induced in activated fibroblasts following pressure-induced heart failure. Sprr3 deletion in mice showed preserved cardiac function and reduced interstitial fibrosis in vivo and reduced fibroblast proliferation and collagen expression in vitro. SPRR3 loss resulted in reduced activation of Akt, FAK, ERK, and p38 signaling pathways, which are coordinately regulated by integrins and growth factors. SPRR3 deletion did not impede integrin-associated functions including cell adhesion, migration, or contraction. SPRR3 loss resulted in reduced activation of PDGFR beta in fibroblasts. This was not due to the reduced PDGFR beta expression levels or decreased binding of the PDGF ligand to PDGFR beta. SPRR3 facilitated the association of integrin beta 1 with PDGFR beta and subsequently fibroblast proliferation, suggesting a role in PDGFR beta-Integrin synergy. We postulate that SPRR3 may function as a conduit for the coordinated activation of PDGFR beta by integrin beta 1, leading to augmentation of fibroblast proliferation and matrix synthesis downstream of biomechanical and growth factor signals.	[Saraswati, Sarika; Lietman, Caressa D.; Li, Bin; Young, Pampee P.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, 1161 21st Ave South,MCN C2217, Nashville, TN 37232 USA; [Mathew, Sijo] North Dakota State Univ, Sch Pharm, Dept Pharmaceut Sci, Fargo, ND USA; [Zent, Roy] Vanderbilt Univ, Med Ctr, Dept Med, Div Nephrol & Hypertens, Nashville, TN USA; [Young, Pampee P.] Amer Red Cross, Div Biomed, Washington, DC USA	Vanderbilt University; North Dakota State University Fargo; Vanderbilt University; American Red Cross	Saraswati, S; Young, PP (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, 1161 21st Ave South,MCN C2217, Nashville, TN 37232 USA.	sarika.saraswati@vanderbilt.edu; pampee.young@redcross.org		Saraswati, Sarika/0000-0002-5674-8371	VA merit award [1BX002337A]; National Institute of General Medical Sciences of the National Institutes of Health (NIH) [R01GM118300]; National Institute of Biomedical Imaging and Bioengineering of the NIH [R21EB019509]; National Blood Foundation; American Heart Association Postdoctoral Fellowship Award [17POST33670744]; American Heart Association [17SDG33630187]	VA merit award(US Department of Veterans Affairs); National Institute of General Medical Sciences of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Biomedical Imaging and Bioengineering of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Blood Foundation; American Heart Association Postdoctoral Fellowship Award(American Heart Association); American Heart Association(American Heart Association)	Research reported in this publication was supported by VA merit award 1BX002337A (PPY), the National Institute of General Medical Sciences of the National Institutes of Health (NIH) Award R01GM118300 (SS), National Institute of Biomedical Imaging and Bioengineering of the NIH Award R21EB019509 (PPY), National Blood Foundation Grant (SS), American Heart Association Postdoctoral Fellowship Award 17POST33670744 (CL) and Scientist Development Grant from the American Heart Association Award 17SDG33630187 (SS).The authors want to thank Dr Jeffrey M. Davidson for careful reading of the manuscript and his critical feedback. The authors are very thankful to Dr Hind Lal and his laboratory from the University of Alabama at Birmingham for providing cardiomyocytes RNA following TAC surgery. The authors are thankful to Youli Yao and Sarah Lechner for their help in migration and cell adhesion experiments.	Abeyrathna P, 2015, VASC PHARMACOL, V74, P38, DOI 10.1016/j.vph.2015.05.008; Aplin AE, 2001, J CELL BIOL, V153, P273, DOI 10.1083/jcb.153.2.273; Babbitt CJ, 2002, HISTOCHEM CELL BIOL, V118, P431, DOI 10.1007/s00418-002-0476-1; BACKENDORF C, 1992, NAT GENET, V2, P91, DOI 10.1038/ng1092-91; Banerjee I, 2006, ANN NY ACAD SCI, V1080, P76, DOI 10.1196/annals.1380.007; Baudino TA, 2006, AM J PHYSIOL-HEART C, V291, pH1015, DOI 10.1152/ajpheart.00023.2006; Bellucci A, 2014, METHODS MOL BIOL, V1174, P397, DOI 10.1007/978-1-4939-0944-5_27; Berk BC, 2007, J CLIN INVEST, V117, P568, DOI 10.1172/JCI31044; BITTERMAN P, 1983, CHEST, V83, pS96; Borkham-Kamphorst E, 2016, CYTOKINE GROWTH F R, V28, P53, DOI 10.1016/j.cytogfr.2015.10.002; BORNFELDT KE, 1994, J CLIN INVEST, V93, P1266, DOI 10.1172/JCI117081; Cabodi S, 2004, BIOCHEM SOC T, V32, P438, DOI 10.1042/BST0320438; Camelliti P, 2005, CARDIOVASC RES, V65, P40, DOI 10.1016/j.cardiores.2004.08.020; Carregaro F, 2013, ARCH DERMATOL RES, V305, P857, DOI 10.1007/s00403-013-1415-9; CHAPMAN D, 1990, CIRC RES, V67, P787, DOI 10.1161/01.RES.67.4.787; Chen C, 2016, J MOL CELL CARDIOL, V93, P162, DOI 10.1016/j.yjmcc.2015.11.010; Cho DH, 2010, MOL MED, V16, P271, DOI 10.2119/molmed.2009.00187; CLAESSONWELSH L, 1994, J BIOL CHEM, V269, P32023; Clemente CFMZ, 2007, CIRC RES, V101, P1339, DOI 10.1161/CIRCRESAHA.107.160978; Dalla Costa AP, 2010, CARDIOVASC RES, V86, P421, DOI 10.1093/cvr/cvp416; Fan B, 2014, INT J CLIN EXP PATHO, V7, P16; Fan H, 2014, AM J TRANSL RES, V6, P714; Fischer DF, 2007, ADV BIOCHEM ENG BIOT, V104, P37, DOI 10.1007/10_027; Fischer DF, 1999, GENOMICS, V55, P88, DOI 10.1006/geno.1998.5622; Fischer DF, 1996, MOL CELL BIOL, V16, P5365, DOI 10.1128/mcb.16.10.5365; Frangogiannis NG, 2012, PHYSIOL REV, V92, P635, DOI 10.1152/physrev.00008.2011; Gallini R, 2016, EXP CELL RES, V349, P282, DOI 10.1016/j.yexcr.2016.10.022; Giancotti FG, 2003, ANNU REV CELL DEV BI, V19, P173, DOI 10.1146/annurev.cellbio.19.031103.133334; GIBBS S, 1993, GENOMICS, V16, P630, DOI 10.1006/geno.1993.1240; Gulati A, 2013, JAMA-J AM MED ASSOC, V309, P896, DOI 10.1001/jama.2013.1363; Hayashida T, 1999, KIDNEY INT, V56, P1710, DOI 10.1046/j.1523-1755.1999.00733.x; HOHL D, 1995, J INVEST DERMATOL, V104, P902, DOI 10.1111/1523-1747.ep12606176; Holmes JW, 2005, ANNU REV BIOMED ENG, V7, P223, DOI 10.1146/annurev.bioeng.7.060804.100453; Ivaska J, 2011, ANNU REV CELL DEV BI, V27, P291, DOI 10.1146/annurev-cellbio-092910-154017; Kim JC, 2012, BREAST CANCER RES TR, V133, P909, DOI 10.1007/s10549-011-1868-5; Koizumi H, 1996, BRIT J DERMATOL, V134, P686, DOI 10.1111/j.1365-2133.1996.tb06971.x; Kong P, 2013, AM J PHYSIOL-HEART C, V305, pH1363, DOI 10.1152/ajpheart.00395.2013; Lietman CD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184620; Manso AM, 2009, AM J PHYSIOL-HEART C, V296, pH627, DOI 10.1152/ajpheart.00444.2008; Marenholz I, 2001, GENOME RES, V11, P341, DOI 10.1101/gr.114801; Moreno-Layseca P, 2014, MATRIX BIOL, V34, P144, DOI 10.1016/j.matbio.2013.10.011; Moro L, 1998, EMBO J, V17, P6622, DOI 10.1093/emboj/17.22.6622; Oka T, 2014, CIRC RES, V114, P565, DOI 10.1161/CIRCRESAHA.114.300507; Palcy S, 1999, BIOCHEM J, V343, P21, DOI 10.1042/0264-6021:3430021; Pyle AL, 2008, AM J PATHOL, V173, P1577, DOI 10.2353/ajpath.2008.080042; Rajshankar D, 2017, FASEB J, V31, P937, DOI 10.1096/fj.201600645R; Runyan CE, 2004, J BIOL CHEM, V279, P2632, DOI 10.1074/jbc.M310412200; SADOSHIMA J, 1992, J BIOL CHEM, V267, P10551; Schluter KD, 2004, CARDIOVASC RES, V63, P367, DOI 10.1016/j.cardiores.2004.06.012; Schwartz MA, 2002, NAT CELL BIOL, V4, pE65, DOI 10.1038/ncb0402-e65; Segedy AK, 2014, ARTERIOSCL THROM VAS, V34, P2527, DOI 10.1161/ATVBAHA.114.303644; Snider P, 2009, CIRC RES, V105, P934, DOI 10.1161/CIRCRESAHA.109.201400; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; Souders CA, 2012, AM J PATHOL, V181, P1226, DOI 10.1016/j.ajpath.2012.06.015; Souders CA, 2009, CIRC RES, V105, P1164, DOI 10.1161/CIRCRESAHA.109.209809; Stewart JA, 2010, CELL TISSUE RES, V340, P117, DOI 10.1007/s00441-010-0943-2; STRUTZ F, 1995, J CELL BIOL, V130, P393, DOI 10.1083/jcb.130.2.393; Sundberg C, 1996, J CELL BIOL, V132, P741, DOI 10.1083/jcb.132.4.741; Svegliati-Baroni G, 2001, HEPATOLOGY, V33, P1130, DOI 10.1053/jhep.2001.23788; Takada Y, 2017, CYTOKINE GROWTH F R, V34, P67, DOI 10.1016/j.cytogfr.2017.01.003; TERRACIO L, 1991, CIRC RES, V68, P734, DOI 10.1161/01.RES.68.3.734; Travers JG, 2016, CIRC RES, V118, P1021, DOI 10.1161/CIRCRESAHA.115.306565; Valiente-Alandi I, 2018, CIRCULATION, V138, P1236, DOI 10.1161/CIRCULATIONAHA.118.034609; Veevers-Lowe J, 2011, J CELL SCI, V124, P1288, DOI 10.1242/jcs.076935; Wang L, 2016, J PHYSIOL BIOCHEM, V72, P213, DOI 10.1007/s13105-016-0471-y; WILLIAMS LT, 1989, SCIENCE, V243, P1564, DOI 10.1126/science.2538922; YAAR M, 1995, EXP CELL RES, V217, P217, DOI 10.1006/excr.1995.1081; Yokoyama K, 2012, GRAEF ARCH CLIN EXP, V250, P15, DOI 10.1007/s00417-011-1766-x; Young PP, 2005, CIRCULATION, V111, P2382, DOI 10.1161/01.CIR.0000164235.26339.78; Zemskov EA, 2009, J BIOL CHEM, V284, P16693, DOI 10.1074/jbc.M109.010769	70	10	10	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					7885	7904		10.1096/fj.201902815R	http://dx.doi.org/10.1096/fj.201902815R		APR 2020	20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32297675	Green Published, hybrid			2022-12-28	WOS:000526945700001
J	Li, X; Yang, L; Mao, ZM; Pan, XY; Zhao, YS; Gu, X; Eckel-Mahan, K; Zuo, ZY; Tong, Q; Hartig, SM; Cheng, XD; Du, GW; Moore, DD; Bellen, HJ; Sesaki, H; Sun, K				Li, Xin; Yang, Li; Mao, Zhengmei; Pan, Xueyang; Zhao, Yueshui; Gu, Xue; Eckel-Mahan, Kristin; Zuo, Zhongyuan; Tong, Qiang; Hartig, Sean M.; Cheng, Xiaodong; Du, Guangwei; Moore, David D.; Bellen, Hugo J.; Sesaki, Hiromi; Sun, Kai			Novel role of dynamin-related-protein 1 in dynamics of ER-lipid droplets in adipose tissue	FASEB JOURNAL			English	Article						energy expenditure; ER retention; LD budding; LD morphology; lipolysis	ENDOPLASMIC-RETICULUM STRESS; MITOCHONDRIAL FISSION; AUTOPHAGY; MEMBRANE; OBESITY; TUBULES; GROWTH; S3-12; FAT	Dynamin-Related-Protein 1 (DRP1) critically regulates mitochondrial and peroxisomal fission in multicellular organisms. However, the impact of DRP1 on other organelles, especially its direct influence on ER functions remains largely unclear. Here, we report that DRP1 translocates to endoplasmic reticulum (ER) in response to beta-adrenergic stimulation. To further investigate the function of DRP1 on ER-lipid droplet (LD) dynamics and the metabolic subsequences, we generated an adipose tissue-specific DRP1 knockout model (Adipo-Drp1(flx/flx)). We found that the LDs in adipose tissues of Adipo-Drp1(flx/flx) mice exhibited more unilocular morphology with larger sizes, and formed less multilocular structures upon cold exposure. Mechanistically, we discovered that abnormal LD morphology occurs because newly generated micro-LDs fail to dissociate from the ER due to DRP1 ablation. Conversely, the ER retention of LDs can be rescued by the overexpressed DRP1 in the adipocytes. The alteration of LD dynamics, combined with abnormal mitochondrial and autophagy functions in adipose tissue, ultimately lead to abnormalities in lipid metabolism in Adipo-Drp1(flx/flx) mice.	[Li, Xin; Yang, Li; Zhao, Yueshui; Gu, Xue; Eckel-Mahan, Kristin; Sun, Kai] Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med Prevent Human Dis, Ctr Metab & Degenerat Dis, 1825 Pressler ST, Houston, TX 77030 USA; [Mao, Zhengmei] Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med Prevent Human Dis, Microscopy Core, Houston, TX 77030 USA; [Pan, Xueyang] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN USA; [Eckel-Mahan, Kristin; Cheng, Xiaodong; Du, Guangwei; Sun, Kai] Univ Texas Hlth Sci Ctr Houston, Grad Sch Biomed Sci, Dept Integrat Biol & Pharmacol, Grad Program Cell & Regulatory Biol, Houston, TX 77030 USA; [Zuo, Zhongyuan; Bellen, Hugo J.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Zuo, Zhongyuan; Bellen, Hugo J.] Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA; [Zuo, Zhongyuan; Bellen, Hugo J.] Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; [Zuo, Zhongyuan; Bellen, Hugo J.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Zuo, Zhongyuan; Bellen, Hugo J.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Tong, Qiang] Baylor Coll Med, Childrens Nutr Res Ctr, Houston, TX 77030 USA; [Hartig, Sean M.; Moore, David D.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Cheng, Xiaodong] Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med Prevent Human Dis, Texas Therapeut Inst, Houston, TX 77030 USA; [Sesaki, Hiromi] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Minnesota System; University of Minnesota Twin Cities; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; Johns Hopkins University	Sun, K (corresponding author), Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med Prevent Human Dis, Ctr Metab & Degenerat Dis, 1825 Pressler ST, Houston, TX 77030 USA.	kai.sun@uth.tmc.edu	Pan, Xueyang/Y-1641-2019	Pan, Xueyang/0000-0003-4453-4971; Sun, Kai/0000-0002-4778-4549; /0000-0002-6232-791X; Du, Guangwei/0000-0003-4193-6975	NIH [R01DK109001, GM123266, R01DK114356, AR075830, R01DK114037]; NIGMS [R35GM122536]; USDA [CRIS 3092-5001-059]; AHA [18TPA34170539, 19TPA34910051]; American Diabetes Association [1-18-IBS-105]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); USDA(United States Department of Agriculture (USDA)); AHA(American Heart Association); American Diabetes Association(American Diabetes Association)	NIH, Grant/Award Number: R01DK109001, GM123266, R01DK114356, AR075830 and R01DK114037; NIGMS, Grant/Award Number: R35GM122536; USDA, Grant/Award Number: CRIS 3092-5001-059; AHA, Grant/Award Number: 18TPA34170539 and 19TPA34910051; American Diabetes Association, Grant/Award Number: #1-18-IBS-105	Adler J, 2010, CYTOM PART A, V77A, P733, DOI 10.1002/cyto.a.20896; Bhattacharya A, 2018, EMBO J, V37, DOI 10.15252/embj.201899277; Cermelli S, 2006, CURR BIOL, V16, P1783, DOI 10.1016/j.cub.2006.07.062; Chung J, 2019, DEV CELL, V51, P551, DOI 10.1016/j.devcel.2019.10.006; Datta S, 2019, J CELL BIOL, V218, P1335, DOI 10.1083/jcb.201808133; Fei WH, 2008, J CELL BIOL, V180, P473, DOI 10.1083/jcb.200711136; Fei WH, 2009, BIOCHEM J, V424, P61, DOI 10.1042/BJ20090785; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385; Frohlich C, 2013, EMBO J, V32, P1280, DOI 10.1038/emboj.2013.74; Gao G, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000355; Gao MM, 2019, PROG LIPID RES, V75, DOI 10.1016/j.plipres.2019.100989; Gao MM, 2018, J CELL BIOL, V217, P3322, DOI 10.1083/jcb.201808151; Green DR, 2011, SCIENCE, V333, P1109, DOI 10.1126/science.1201940; Guo Y, 2009, J CELL SCI, V122, P749, DOI 10.1242/jcs.037630; Hapala I, 2011, BIOL CELL, V103, P271, DOI 10.1042/BC20100144; Hariri H, 2019, J CELL BIOL, V218, P1319, DOI 10.1083/jcb.201808119; Hashemi HF, 2015, CURR OPIN CELL BIOL, V33, P119, DOI 10.1016/j.ceb.2015.02.002; Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907; Jaishy B, 2016, J LIPID RES, V57, P1619, DOI 10.1194/jlr.R067520; Ji WK, 2017, J CELL BIOL, V216, P4123, DOI 10.1083/jcb.201610057; Kamerkar SC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07543-w; Koch A, 2003, J BIOL CHEM, V278, P8597, DOI 10.1074/jbc.M211761200; Kolahi K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153522; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Krahmer N, 2013, EMBO MOL MED, V5, P973, DOI 10.1002/emmm.201100671; Labrousse AM, 1999, MOL CELL, V4, P815, DOI 10.1016/S1097-2765(00)80391-3; Li X, 2020, MOL CELL BIOL, V40, DOI 10.1128/MCB.00564-19; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Martinez-Lopez N, 2016, CELL METAB, V23, P113, DOI 10.1016/j.cmet.2015.10.008; Nguyen TB, 2019, J CELL BIOL, V218, P1089, DOI 10.1083/jcb.201902160; Ohsaki Y, 2008, J CELL SCI, V121, P2415, DOI 10.1242/jcs.025452; Ohsaki Y, 2017, ADV EXP MED BIOL, V997, P111, DOI 10.1007/978-981-10-4567-7_8; Olzmann JA, 2019, NAT REV MOL CELL BIO, V20, P137, DOI 10.1038/s41580-018-0085-z; Oyadomari S, 2008, CELL METAB, V7, P520, DOI 10.1016/j.cmet.2008.04.011; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Pidoux G, 2011, EMBO J, V30, P4371, DOI 10.1038/emboj.2011.365; Pitts KR, 1999, MOL BIOL CELL, V10, P4403, DOI 10.1091/mbc.10.12.4403; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Rutkowski DT, 2008, DEV CELL, V15, P829, DOI 10.1016/j.devcel.2008.10.015; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sathyanarayan A, 2017, CELL REP, V19, P1, DOI 10.1016/j.celrep.2017.03.026; Schulze RJ, 2013, J CELL BIOL, V203, P315, DOI 10.1083/jcb.201306140; Smirnova E, 1998, J CELL BIOL, V143, P351, DOI 10.1083/jcb.143.2.351; Steffen J, 2018, J CELL BIOL, V217, P15, DOI 10.1083/jcb.201711075; Tamura Y, 2011, CELL, V145, DOI 10.1016/j.cell.2011.06.018; Thiam AR, 2016, BBA-MOL CELL BIOL L, V1861, P715, DOI 10.1016/j.bbalip.2016.04.018; Wakabayashi J, 2009, J CELL BIOL, V186, P805, DOI 10.1083/jcb.200903065; Walther TC, 2012, ANNU REV BIOCHEM, V81, P687, DOI 10.1146/annurev-biochem-061009-102430; Wang LX, 2015, DIABETOLOGIA, V58, P2371, DOI 10.1007/s00125-015-3704-7; Wikstrom JD, 2014, EMBO J, V33, P418, DOI 10.1002/embj.201385014; Wolins NE, 2005, J BIOL CHEM, V280, P19146, DOI 10.1074/jbc.M500978200; Wolins NE, 2003, J BIOL CHEM, V278, P37713, DOI 10.1074/jbc.M304025200; Xu DJ, 2018, J CELL BIOL, V217, P975, DOI 10.1083/jcb.201704184; Xu SM, 2018, BBA-MOL BASIS DIS, V1864, P1968, DOI 10.1016/j.bbadis.2017.07.019; Yan RH, 2018, DEV CELL, V47, P248, DOI 10.1016/j.devcel.2018.09.010; Yang L, 2019, DIABETES, V68, P1178, DOI 10.2337/db18-1210; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Zhao YS, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00242-18; Zhao YS, 2016, AM J PHYSIOL-ENDOC M, V311, pE952, DOI 10.1152/ajpendo.00314.2016; Zhou ZS, 2020, SCIENCE, V368, P54, DOI 10.1126/science.aay2494	61	6	6	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8265	8282		10.1096/fj.201903100RR	http://dx.doi.org/10.1096/fj.201903100RR		APR 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32294302	Bronze, Green Accepted			2022-12-28	WOS:000526104400001
J	Zhang, QZ; He, L; Dong, Y; Fei, Y; Wen, JJ; Li, XM; Guan, J; Liu, F; Zhou, T; Li, Z; Fan, Y; Wang, NS				Zhang, Qunzi; He, Li; Dong, Yang; Fei, Yang; Wen, Jiejun; Li, Xiaomei; Guan, Jian; Liu, Feng; Zhou, Ting; Li, Ze; Fan, Ying; Wang, Niansong			Sitagliptin ameliorates renal tubular injury in diabetic kidney disease via STAT3-dependent mitochondrial homeostasis through SDF-1 alpha/CXCR4 pathway	FASEB JOURNAL			English	Article						CXCR4; diabetic kidney disease; mitochondria; SDF-1 alpha; sitagliptin; STAT3	DIPEPTIDYL PEPTIDASE-4; FACTOR-I; ACTIVATION; INHIBITORS; FISSION; STAT3; NATRIURESIS; DYSFUNCTION; PROGRESSION; MECHANISMS	Mitochondrial abnormalities play critical roles in diabetic tubular injury progression. Dipeptidyl peptidase-4 (DPP4) inhibitors are widely used antihyperglycemic agents that exert renal protective and positive effects against mitochondrial dysfunction in diabetic kidney disease (DKD). However, their underlying mechanism remains unclear. In this study, DPP4 upregulation, mitochondrial fragmentation, and altered mitochondrial dynamics-associated protein expression were observed in the tubules of DBA2/J (D2) diabetic mice with unilateral nephrectomy and in albumin-stimulated tubular cells. The inhibition of DPP4 by sitagliptin (Sita) ameliorated these mitochondrial perturbations both in vivo and in vitro, whereas DPP4 overexpression aggravated mitochondrial fusion-fission disorder and tubular cell injury in albumin-treated HK-2 cells. Downstream of DPP4, the SDF-1 alpha/CXCR4 pathway was significantly suppressed in diabetic tubules. After Sita treatment, this signaling pathway was restored, and the mitochondrial dynamics was improved. Furthermore, a direct interaction between STAT3 and OPA1 was found in the mitochondria of tubular cells, and this effect was weakened by overloading albumin and by CXCR4 siRNA treatment, suggesting a possible link between DPP4-mediated SDF-1 alpha/CXCR4/STAT3 signaling and mitochondrial dysfunction in diabetic tubular cells. The results suggest that a novel mechanism links the DPP4 enzyme to impaired mitochondrial dynamics homeostasis during tubular injury in DKD and highlight that the SDF-1 alpha/CXCR4/STAT3 signaling pathway could become a potential target for managing DKD.	[Zhang, Qunzi; He, Li; Dong, Yang; Fei, Yang; Wen, Jiejun; Li, Xiaomei; Zhou, Ting; Li, Ze; Fan, Ying; Wang, Niansong] Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6, Dept Nephrol, 600 Yishan Rd, Shanghai 200233, Peoples R China; [Guan, Jian; Liu, Feng] Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6, Therapy Ctr Obstruct Sleep Apnea, Dept Otolaryngol, Shanghai, Peoples R China; [Guan, Jian; Liu, Feng] Shanghai Jiao Tong Univ, Otolaryngol Inst, Shanghai, Peoples R China; [Guan, Jian; Liu, Feng] Shanghai Key Lab Sleep Disordered Breathing, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Fei, Y (corresponding author), Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6, Dept Nephrol, 600 Yishan Rd, Shanghai 200233, Peoples R China.	fanyingsh@126.com; wangniansong2012@163.com	Liu, Feng/AAA-9645-2022	Liu, Feng/0000-0002-4442-7028; Wang, Niansong/0000-0002-5265-5792	National Natural Science Foundation of China [81670657, 81870504, 81870468, 81400735]; National "Twelfth Five-Year" Plan for Science & Technology Support [2013BAI02B01-01]; Shanghai Jiao Tong University [YG2017MS10]; Shanghai Municipal Commission of Science and Technology [18DZ2260200]; Open Project of Shanghai Key Laboratory of Sleep Disordered Breathing [SHKSDB-KF-19-04]; Science and Technology Commission of Shanghai Municipality [14DZ2260200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National "Twelfth Five-Year" Plan for Science & Technology Support; Shanghai Jiao Tong University; Shanghai Municipal Commission of Science and Technology; Open Project of Shanghai Key Laboratory of Sleep Disordered Breathing; Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	National Natural Science Foundation of China, Grant/Award Number: 81670657, 81870504, 81870468 and 81400735; National "Twelfth Five-Year" Plan for Science & Technology Support, Grant/Award Number: 2013BAI02B01-01; Shanghai Jiao Tong University, Grant/Award Number: YG2017MS10; Shanghai Municipal Commission of Science and Technology, Grant/Award Number: 18DZ2260200; Open Project of Shanghai Key Laboratory of Sleep Disordered Breathing, Grant/Award Number: SHKSDB-KF-19-04; Science and Technology Commission of Shanghai Municipality, Grant/Award Number: 14DZ2260200	Arcanjo NMO, 2018, BBA-GEN SUBJECTS, V1862, P1938, DOI 10.1016/j.bbagen.2018.06.007; Bhargava P, 2017, NAT REV NEPHROL, V13, P629, DOI 10.1038/nrneph.2017.107; Bonventre JV, 2012, SEMIN NEPHROL, V32, P452, DOI 10.1016/j.semnephrol.2012.07.008; Chang CR, 2010, ANN NY ACAD SCI, V1201, P34, DOI 10.1111/j.1749-6632.2010.05629.x; Chang YP, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00780; Che RC, 2014, AM J PHYSIOL-RENAL, V306, pF367, DOI 10.1152/ajprenal.00571.2013; Chen JC, 2013, J AM SOC NEPHROL, V24, P2023, DOI 10.1681/ASN.2013010076; Chen LH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092227; Cipolat S, 2006, CELL, V126, P163, DOI 10.1016/j.cell.2006.06.021; Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032; Dong Y, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00153; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Fan Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8841; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Ge GQ, 2017, SHOCK, V47, P251, DOI 10.1097/SHK.0000000000000694; Gough DJ, 2009, SCIENCE, V324, P1713, DOI 10.1126/science.1171721; Guo HM, 2016, DIABETES RES CLIN PR, V121, P184, DOI 10.1016/j.diabres.2016.08.022; Gupta S, 2019, PHARMACOL RES, V147, DOI 10.1016/j.phrs.2019.104391; Hartner A, 2010, AM J PHYSIOL-RENAL, V299, pF1151, DOI 10.1152/ajprenal.00058.2010; Hasan AA, 2019, KIDNEY INT, V95, P1373, DOI 10.1016/j.kint.2019.01.010; Hasan AA, 2017, J MOL ENDOCRINOL, V59, pR1, DOI 10.1530/JME-17-0005; Henke J, 2014, KIDNEY INT, V86, P780, DOI 10.1038/ki.2014.109; Hsiao CC, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/8259645; Ingelfinger JR, 2019, NEW ENGL J MED, V380, P2371, DOI 10.1056/NEJMe1904740; Jackson EK, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.007253; Kanwar YS, 2011, ANNU REV PATHOL-MECH, V6, P395, DOI 10.1146/annurev.pathol.4.110807.092150; Lindenmeyer MT, 2008, J AM SOC NEPHROL, V19, P2225, DOI 10.1681/ASN.2007121313; Liu RJ, 2014, DIABETES, V63, P2440, DOI 10.2337/db13-1810; Long M, 2018, DIABETES, V67, P518, DOI 10.2337/db17-0934; Lovshin JA, 2017, DIABETES CARE, V40, P1073, DOI 10.2337/dc17-0061; Lovshin JA, 2015, DIABETES CARE, V38, P132, DOI 10.2337/dc14-1958; Ma ZW, 2018, AM J PHYSIOL-RENAL, V315, pF1822, DOI 10.1152/ajprenal.00402.2018; Marques C, 2019, LIFE SCI, V234, DOI 10.1016/j.lfs.2019.116738; Nistala R, 2014, OBESITY, V22, P2172, DOI 10.1002/oby.20833; Osellame LD, 2016, J CELL SCI, V129, P2170, DOI 10.1242/jcs.185165; Qi HY, 2017, DIABETES, V66, P763, DOI 10.2337/db16-0695; Qi W, 2017, NAT MED, V23, P753, DOI 10.1038/nm.4328; Qin X, 2019, THERANOSTICS, V9, P1698, DOI 10.7150/thno.30640; Rosenstock J, 2019, JAMA-J AM MED ASSOC, V321, P69, DOI 10.1001/jama.2018.18269; Sala D, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09746-1; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Sung PH, 2019, BIOMED PHARMACOTHER, V111, P1088, DOI 10.1016/j.biopha.2019.01.025; Takashima S, 2016, KIDNEY INT, V90, P783, DOI 10.1016/j.kint.2016.06.012; Tang H, 2019, MOL MED REP, V19, P3696, DOI 10.3892/mmr.2019.10045; Tsuprykov O, 2016, KIDNEY INT, V89, P1049, DOI 10.1016/j.kint.2016.01.016; Uil M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23839-9; Wang H, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad6095; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; Xiao L, 2017, REDOX BIOL, V11, P297, DOI 10.1016/j.redox.2016.12.022; Xiao L, 2014, DIABETES, V63, P1366, DOI 10.2337/db13-1412; Yano T, 2007, DIABETES, V56, P2946, DOI 10.2337/db07-0291; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Yu BB, 2019, EBIOMEDICINE, V42, P64, DOI 10.1016/j.ebiom.2019.03.031; Zhan M, 2015, J AM SOC NEPHROL, V26, P1304, DOI 10.1681/ASN.2014050457; Zhan M, 2013, KIDNEY INT, V83, P568, DOI 10.1038/ki.2012.441; Zhang HY, 2017, KIDNEY INT, V92, P909, DOI 10.1016/j.kint.2017.03.027; Zhang XW, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.005945	58	11	13	5	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					7500	7519		10.1096/fj.201903038R	http://dx.doi.org/10.1096/fj.201903038R		APR 2020	20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32281218	Bronze			2022-12-28	WOS:000526117400001
J	Ge, YJ; Zhang, S; Wang, JL; Xia, FB; Wan, JB; Lu, JJ; Ye, RD				Ge, Yunjun; Zhang, Shuo; Wang, Junlin; Xia, Fangbo; Wan, Jian-Bo; Lu, Jinjian; Ye, Richard D.			Dual modulation of formyl peptide receptor 2 by aspirin-triggered lipoxin contributes to its anti-inflammatory activity	FASEB JOURNAL			English	Article						biased signaling; G protein-coupled receptor; inflammation; inverse agonism	PROTEIN-COUPLED RECEPTOR; BETA-ARRESTIN; ACTIVATES NEUTROPHILS; ALLOSTERIC MODULATION; A(4) RECEPTORS; STABLE ANALOGS; LIGAND; 7-TRANSMEMBRANE; FPR2/ALX; AGONIST	The eicosanoid lipoxin A(4) and aspirin-triggered 15-epi-lipoxin A(4) (ATL) are potent anti-inflammatory agents. How their anti-inflammatory effects are mediated by receptors such as the formyl peptide receptor 2 (FPR2/ALX) remains incompletely understood. In the present study, fluorescent biosensors of FPR2/ALX were prepared and ATL-induced conformational changes were recorded. A biphasic dose curve consisting of a descending phase and an ascending phase was observed, with the descending phase corresponding to diminished FPR2 response such as Ca2+ mobilization induced by the potent synthetic agonist WKYMVm. Preincubation of FPR2-expressing cells with 100 pM of ATL also lowered the threshold for WKYMVm to induce beta-arrestin-2 membrane translocation, and inhibited WKYMVm-induced interleukin 8 secretion, suggesting signaling bias favoring anti-inflammatory activities. At 100 pM and above, ATL-induced receptor conformational changes resembling that of the WKYMVm along with a weak but measurable inhibition of forskolin-induced cAMP accumulation. However, no Ca2+ mobilization was induced by ATL until its concentration reached 1 mu M. Taken together, these results suggest a dual regulatory mechanism by which ATL exerts anti-inflammatory effects through FPR2/ALX.	[Ge, Yunjun; Wang, Junlin; Xia, Fangbo; Wan, Jian-Bo; Lu, Jinjian; Ye, Richard D.] Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Zhuhai, Macau Special A, Peoples R China; [Zhang, Shuo] Shanghai Jiao Tong Univ, Sch Pharm, Shanghai, Peoples R China; [Ye, Richard D.] Chinese Univ Hong Kong, Sch Life & Hlth Sci, Kobilka Inst Innovat Drug Discovery, Shenzhen, Peoples R China	University of Macau; Shanghai Jiao Tong University; Chinese University of Hong Kong, Shenzhen	Ye, RD (corresponding author), Chinese Univ Hong Kong, Sch Life & Hlth Sci, Kobilka Inst Innovat Drug Discovery, Shenzhen, Peoples R China.	richardye@cuhk.edu.cn	Lu, Jinjian/X-2083-2019; Ye, Richard/ABF-2413-2020; Wan, Jian-Bo/D-8368-2014	Lu, Jinjian/0000-0001-6703-3120; Ye, Richard/0000-0002-2164-5620; Wan, Jian-Bo/0000-0002-6750-2617	University of Macau [MYRG2016-00152-ICMS-QRCM, MYRG2016-00246-ICMS-QRCM]	University of Macau	University of Macau, Grant/Award Number: MYRG2016-00152-ICMS-QRCM and MYRG2016-00246-ICMS-QRCM	Bae YS, 2003, MOL PHARMACOL, V64, P721, DOI 10.1124/mol.64.3.721; Cattaneo F, 2013, INT J MOL SCI, V14, P7193, DOI 10.3390/ijms14047193; Chen T, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15009-1; Chiang N, 2000, J EXP MED, V191, P1197, DOI 10.1084/jem.191.7.1197; Chiang N, 2006, PHARMACOL REV, V58, P463, DOI 10.1124/pr.58.3.4; Christophe T, 2001, J BIOL CHEM, V276, P21585, DOI 10.1074/jbc.M007769200; Christophe T, 2002, SCAND J IMMUNOL, V56, P470, DOI 10.1046/j.1365-3083.2002.01149.x; Civciristov S, 2019, BRIT J PHARMACOL, V176, P2382, DOI 10.1111/bph.14636; CLARIA J, 1995, P NATL ACAD SCI USA, V92, P9475, DOI 10.1073/pnas.92.21.9475; Clish CB, 1999, P NATL ACAD SCI USA, V96, P8247, DOI 10.1073/pnas.96.14.8247; Cooray SN, 2013, P NATL ACAD SCI USA, V110, P18232, DOI 10.1073/pnas.1308253110; Covic L, 2002, P NATL ACAD SCI USA, V99, P643, DOI 10.1073/pnas.022460899; Dahlgren C, 2000, BLOOD, V95, P1810, DOI 10.1182/blood.V95.5.1810.005k06_1810_1818; Dahlgren C, 2016, BIOCHEM PHARMACOL, V114, P22, DOI 10.1016/j.bcp.2016.04.014; Dogan B, 2015, MED SCI MONITOR, V21, P2485, DOI 10.12659/MSM.895115; Dorward DA, 2015, AM J PATHOL, V185, P1172, DOI 10.1016/j.ajpath.2015.01.020; Du Y, 2019, CELL, V177, P1232, DOI 10.1016/j.cell.2019.04.022; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; FIORE S, 1994, J EXP MED, V180, P253, DOI 10.1084/jem.180.1.253; Fiorucci S, 2003, BRIT J PHARMACOL, V139, P1351, DOI 10.1038/sj.bjp.0705356; Forsman H, 2011, SCAND J IMMUNOL, V74, P227, DOI 10.1111/j.1365-3083.2011.02570.x; Forsman H, 2009, SCAND J IMMUNOL, V70, P396, DOI 10.1111/j.1365-3083.2009.02311.x; Gabl M, 2017, BIOCHEM PHARMACOL, V145, P114, DOI 10.1016/j.bcp.2017.08.018; Gewirtz AT, 1998, J CLIN INVEST, V101, P1860, DOI 10.1172/JCI1339; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Gregory KJ, 2018, ACS PHARMACOL TRANSL, V1, P96, DOI 10.1021/acsptsci.8b00021; Guo ZD, 2016, STROKE, V47, P490, DOI 10.1161/STROKEAHA.115.011223; Hanson J, 2013, BIOCHEM PHARMACOL, V85, P1795, DOI 10.1016/j.bcp.2013.04.019; He HQ, 2017, MOLECULES, V22, DOI 10.3390/molecules22030455; He HQ, 2014, J BIOL CHEM, V289, P2295, DOI 10.1074/jbc.M113.509216; He R, 2003, BLOOD, V101, P1572, DOI 10.1182/blood-2002-05-1431; Hodges RR, 2017, MUCOSAL IMMUNOL, V10, P46, DOI 10.1038/mi.2016.33; Hoffmann C, 2005, NAT METHODS, V2, P171, DOI 10.1038/NMETH742; Hoffmann C, 2010, NAT PROTOC, V5, P1666, DOI 10.1038/nprot.2010.129; Holdfeldt A, 2019, ACS OMEGA, V4, P5968, DOI 10.1021/acsomega.9b00098; Huet E, 2007, CELL SIGNAL, V19, P1939, DOI 10.1016/j.cellsig.2007.05.006; Koehl A, 2018, NATURE, V558, P547, DOI 10.1038/s41586-018-0219-7; Le YY, 1999, J IMMUNOL, V163, P6777; Le YY, 2002, INT IMMUNOPHARMACOL, V2, P1, DOI 10.1016/S1567-5769(01)00150-3; Li LZ, 2016, J LEUKOCYTE BIOL, V99, P425, DOI 10.1189/jlb.2RI0815-354RR; Lohse MJ, 2012, PHARMACOL REV, V64, P299, DOI 10.1124/pr.110.004309; Machado FS, 2006, NAT MED, V12, P330, DOI 10.1038/nm1355; Maddox JF, 1997, J BIOL CHEM, V272, P6972, DOI 10.1074/jbc.272.11.6972; Maderna P, 2010, FASEB J, V24, P4240, DOI 10.1096/fj.10-159913; Maderna P, 2009, BRIT J PHARMACOL, V158, P947, DOI 10.1111/j.1476-5381.2009.00386.x; May LT, 2007, ANNU REV PHARMACOL, V47, P1, DOI 10.1146/annurev.pharmtox.47.120505.105159; Migeotte I, 2006, CYTOKINE GROWTH F R, V17, P501, DOI 10.1016/j.cytogfr.2006.09.009; Nanamori M, 2004, MOL PHARMACOL, V66, P1213, DOI 10.1124/mol.104.004309; Paul-Clark MJ, 2004, J EXP MED, V200, P69, DOI 10.1084/jem.20040566; Perretti M, 2009, BRIT J PHARMACOL, V158, P936, DOI 10.1111/j.1476-5381.2009.00483.x; Price MR, 2005, MOL PHARMACOL, V68, P1484, DOI 10.1124/mol.105.016162; Qin CX, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14232; Ranjan R, 2017, TRENDS CELL BIOL, V27, P861, DOI 10.1016/j.tcb.2017.05.008; Reiter E, 2012, ANNU REV PHARMACOL, V52, P179, DOI 10.1146/annurev.pharmtox.010909.105800; Shimizu S, 2013, ANN OTO RHINOL LARYN, V122, P683, DOI 10.1177/000348941312201104; Smith JS, 2016, J BIOL CHEM, V291, P8969, DOI 10.1074/jbc.R115.713313; Su SB, 1999, J EXP MED, V189, P395, DOI 10.1084/jem.189.2.395; Takano T, 1997, J EXP MED, V185, P1693, DOI 10.1084/jem.185.9.1693; Thompson D, 2014, J BIOL CHEM, V289, P36166, DOI 10.1074/jbc.M114.612630; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578; Yu D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142848; Zhuang YW, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14728-9	62	28	28	2	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6920	6933		10.1096/fj.201903206R	http://dx.doi.org/10.1096/fj.201903206R		APR 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32239559				2022-12-28	WOS:000522968700001
J	Cao, MQ; You, AB; Cui, W; Zhang, S; Guo, ZG; Chen, L; Zhu, XD; Zhang, W; Zhu, XL; Guo, H; Deng, DJ; Sun, HC; Zhang, T				Cao, Man-Qing; You, A-Bin; Cui, Wei; Zhang, Su; Guo, Zhi-Gui; Chen, Lu; Zhu, Xiao-Dong; Zhang, Wei; Zhu, Xiao-Lin; Guo, Hua; Deng, Da-Jun; Sun, Hui-Chuan; Zhang, Ti			Cross talk between oxidative stress and hypoxia via thioredoxin and HIF-2 alpha drives metastasis of hepatocellular carcinoma	FASEB JOURNAL			English	Article						hepatocellular carcinoma; HIF-2 alpha; metastasis; thioredoxin	RENAL-CELL CARCINOMA; BREAST-TUMOR CELLS; HIF2A GAIN; CANCER; EXPRESSION; OVEREXPRESSION; TRANSLOCATION; ESTABLISHMENT; PROGRESSION; RECURRENCE	Oxidative stress and hypoxia are two opposite microenvironments involved in HCC metastasis. Thioredoxin (TXN) and hypoxia-inducible factor 2 alpha (HIF-2 alpha) are typical proteins involved in these two different microenvironments, respectively. How these two factors interact to influence the fate on tumor cells remains unknown. Hypoxia facilitated HCC cells withstood oxidative stress and eventually promoted HCC cells metastasis, in which TXN and HIF-2 alpha were mostly involved. Upregulation of TXN/HIF-2 alpha correlated with poor HCC prognosis and promoted HCC metastasis both in vitro and in vivo. Epithelial-mesenchymal transition (EMT) process was involved in TXN/HIF-2 alpha -enhanced invasiveness of HCC cells. Additionally, the stability and activity of HIF-2 alpha were precisely regulated by TXN via SUMOylation and acetylation, which contributed to HCC metastasis. Our data revealed that the redox protein TXN and HIF-2 alpha are both associated with HCC metastasis, and the fine regulation of TXN on HIF-2 alpha contributes essentially during the process of metastasis. Our study provides new insight into the interaction mechanism between hypoxia and oxidative stress and implies potential therapeutic benefits by targeting both TXN and HIF-2 alpha in the treatment of HCC metastasis.	[Cao, Man-Qing; Zhang, Su; Guo, Zhi-Gui; Chen, Lu; Zhang, Wei; Zhu, Xiao-Lin; Guo, Hua; Zhang, Ti] Tianjin Med Univ Canc Inst & Hosp, Dept Breast Surg, Natl Clin Res Ctr Canc, Tianjins Clin Res Ctr Canc,Key Lab Canc Prevent &, Tianjin, Peoples R China; [Cao, Man-Qing; Zhu, Xiao-Dong; Sun, Hui-Chuan] Fudan Univ, Liver Canc Inst, Dept Hepatobiliary Surg, 180 Fenglin Rd, Shanghai 200032, Peoples R China; [Cao, Man-Qing; Zhu, Xiao-Dong; Sun, Hui-Chuan] Fudan Univ, Zhongshan Hosp, 180 Fenglin Rd, Shanghai 200032, Peoples R China; [You, A-Bin; Deng, Da-Jun] Peking Univ Canc Hosp & Inst, Div Etiol, Minist Educ Beijing, Key Lab Carcinogenesis & Translat Res, 52 Fu Cheng Rd, Beijing 100142, Peoples R China; [Cui, Wei] Tianjin Third Cent Hosp, Inst Hepatobiliary Dis, Key Lab Artificial Cell, Tianjin, Peoples R China	Tianjin Medical University; Fudan University; Fudan University	Sun, HC (corresponding author), Fudan Univ, Liver Canc Inst, Dept Hepatobiliary Surg, 180 Fenglin Rd, Shanghai 200032, Peoples R China.; Sun, HC (corresponding author), Fudan Univ, Zhongshan Hosp, 180 Fenglin Rd, Shanghai 200032, Peoples R China.; Deng, DJ (corresponding author), Peking Univ Canc Hosp & Inst, Div Etiol, Minist Educ Beijing, Key Lab Carcinogenesis & Translat Res, 52 Fu Cheng Rd, Beijing 100142, Peoples R China.; Zhang, T (corresponding author), Tianjin Med Univ Canc Inst & Hosp, Dept Hepatobiliary Surg, 24 Bin Shui Rd, Tianjin 300060, Peoples R China.	dengdajun@bjmu.edu.cn; sun.huichuan@zs-hospital.sh.cn; zhangti@tjmuch.com		Sun, Hui-Chuan/0000-0003-3761-7058				Cao MQ, 2016, TUMOR BIOL, V37, P1651, DOI 10.1007/s13277-015-3527-7; Chen R, 2012, J BIOL CHEM, V287, P30800, DOI 10.1074/jbc.M111.244780; Chen WF, 2016, NATURE, V539, P112, DOI 10.1038/nature19796; Cheng J, 2007, CELL, V131, P584, DOI 10.1016/j.cell.2007.08.045; Cho H, 2016, NATURE, V539, P107, DOI 10.1038/nature19795; Cox TR, 2015, NATURE, V522, P106, DOI 10.1038/nature14492; Dioum EM, 2009, SCIENCE, V324, P1289, DOI 10.1126/science.1169956; Graeber TG, 1996, NATURE, V379, P88, DOI 10.1038/379088a0; Gunaratnam L, 2003, J BIOL CHEM, V278, P44966, DOI 10.1074/jbc.M305502200; Harris IS, 2015, CANCER CELL, V27, P211, DOI 10.1016/j.ccell.2014.11.019; Helczynska K, 2008, CANCER RES, V68, P9212, DOI 10.1158/0008-5472.CAN-08-1135; Holmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026; Jones DT, 2006, CLIN CANCER RES, V12, P5384, DOI 10.1158/1078-0432.CCR-05-2380; Kamal AM, 2016, HEMATOLOGY, V21, P567, DOI 10.1080/10245332.2016.1173341; Li X, 2008, CELL DEATH DIFFER, V15, P739, DOI 10.1038/sj.cdd.4402303; Li Y, 2003, J CANCER RES CLIN, V129, P43, DOI 10.1007/s00432-002-0396-4; Li Y, 2001, WORLD J GASTROENTERO, V7, P630; Lim JH, 2010, MOL CELL, V38, P864, DOI 10.1016/j.molcel.2010.05.023; Lo PK, 2017, J BIOL CHEM, V292, P11466, DOI 10.1074/jbc.M117.775080; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; NAKAMURA H, 1994, IMMUNOL LETT, V42, P75, DOI 10.1016/0165-2478(94)90038-8; Pietras A, 2010, CURR TOP MICROBIOL, V345, P1, DOI 10.1007/82_2010_72; Piskounova E, 2015, NATURE, V527, P186, DOI 10.1038/nature15726; Ralph SJ, 2010, MOL ASPECTS MED, V31, P145, DOI 10.1016/j.mam.2010.02.008; Ramanathan RK, 2011, CANCER CHEMOTH PHARM, V67, P503, DOI 10.1007/s00280-010-1343-8; Semenza GL, 2009, PHYSIOLOGY, V24, P97, DOI 10.1152/physiol.00045.2008; Siegel RL, 2021, CA-CANCER J CLIN, V71, P7, DOI 10.3322/caac.21654; Stott SL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000403; Taieb D, 2016, J NEURO-ONCOL, V126, P473, DOI 10.1007/s11060-015-1983-y; Tan QL, 2013, J BIOL CHEM, V288, P17134, DOI 10.1074/jbc.M112.444059; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; van Hagen M, 2010, NUCLEIC ACIDS RES, V38, P1922, DOI 10.1093/nar/gkp1157; Vanharanta S, 2013, CANCER CELL, V24, P410, DOI 10.1016/j.ccr.2013.09.007; Welsh SJ, 2002, CANCER RES, V62, P5089; Xia GB, 2001, CANCER-AM CANCER SOC, V91, P1429, DOI 10.1002/1097-0142(20010415)91:8<1429::AID-CNCR1149>3.0.CO;2-V; Xu M, 2014, NAT MED, V20, P1018, DOI 10.1038/nm.3587; Yang YH, 2007, NAT CELL BIOL, V9, P1253, DOI 10.1038/ncb1645; You A, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0253-6; Yu M, 2014, SCIENCE, V345, P216, DOI 10.1126/science.1253533; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522; Zeng HM, 2015, INT J CANCER, V136, P1921, DOI 10.1002/ijc.29227; Zhao L, 2015, FREE RADICAL BIO MED, V82, P29, DOI 10.1016/j.freeradbiomed.2015.01.014; Zhuang ZP, 2012, NEW ENGL J MED, V367, P922, DOI 10.1056/NEJMoa1205119	43	12	12	2	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5892	5905		10.1096/fj.202000082R	http://dx.doi.org/10.1096/fj.202000082R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32157720	Bronze			2022-12-28	WOS:000530242100072
J	Fischer, S; Uckert, AK; Landenberger, M; Papatheodorou, P; Hoffmann-Richter, C; Mittler, AK; Ziener, U; Hagele, M; Schwan, C; Muller, M; Kleger, A; Benz, R; Popoff, MR; Aktories, K; Barth, H				Fischer, Stephan; Ueckert, Anna-Katharina; Landenberger, Marc; Papatheodorou, Panagiotis; Hoffmann-Richter, Carola; Mittler, Ann-Katrin; Ziener, Ulrich; Haegele, Marlen; Schwan, Carsten; Mueller, Martin; Kleger, Alexander; Benz, Roland; Popoff, Michel R.; Aktories, Klaus; Barth, Holger			Human peptide alpha-defensin-1 interferes with Clostridioides difficile toxins TcdA, TcdB, and CDT	FASEB JOURNAL			English	Article						bacterial AB-type toxins; CDAD; clostridial actin ADP-ribosylating toxin; clostridial Rho-glucosylating toxin; defensins; toxin inhibitor	BOTULINUM C2 TOXIN; LIPID BILAYER-MEMBRANES; CHANNEL FUNCTION; ADP-RIBOSYLTRANSFERASE; BACTERIAL TOXINS; BINDING-KINETICS; LETHAL TOXIN; RHO-GTPASES; IN-VITRO; INHIBITION	The human pathogenic bacterium Clostridioides difficile produces two exotoxins TcdA and TcdB, which inactivate Rho GTPases thereby causing C. difficile-associated diseases (CDAD) including life-threatening pseudomembranous colitis. Hypervirulent strains produce additionally the binary actin ADP-ribosylating toxin CDT. These strains are hallmarked by more severe forms of CDAD and increased frequency and severity. Once in the cytosol, the toxins act as enzymes resulting in the typical clinical symptoms. Therefore, targeting and inactivation of the released toxins are of peculiar interest. Prompted by earlier findings that human alpha-defensin-1 neutralizes TcdB, we investigated the effects of the defensin on all three C. difficile toxins. Inhibition of TcdA, TcdB, and CDT was demonstrated by analyzing toxin-induced changes in cell morphology, substrate modification, and decrease in transepithelial electrical resistance. Application of alpha-defensin-1 protected cells and human intestinal organoids from the cytotoxic effects of TcdA, TcdB, CDT, and their combination which is attributed to a direct interaction between the toxins and alpha-defensin-1. In mice, the application of alpha-defensin-1 reduced the TcdA-induced damage of intestinal loops in vivo. In conclusion, human alpha-defensin-1 is a specific and potent inhibitor of the C. difficile toxins and a promising agent to develop novel therapeutic options against C. difficile infections.	[Fischer, Stephan; Ueckert, Anna-Katharina; Landenberger, Marc; Papatheodorou, Panagiotis; Mittler, Ann-Katrin; Barth, Holger] Univ Ulm, Med Ctr, Inst Pharmacol & Toxicol, Albert Einstein Allee 11, D-89081 Ulm, Germany; [Hoffmann-Richter, Carola; Ziener, Ulrich] Ulm Univ, Inst Organ Chem 3, Ulm, Germany; [Haegele, Marlen; Mueller, Martin; Kleger, Alexander] Univ Ulm, Med Ctr, Dept Internal Med 1, Ulm, Germany; [Schwan, Carsten; Aktories, Klaus] Univ Freiburg, Inst Expt & Clin Pharmacol & Toxicol, Freiburg, Germany; [Benz, Roland] Jacobs Univ Bremen, Dept Life Sci & Chem, Bremen, Germany; [Popoff, Michel R.] Pasteur Inst, Dept Anaerob Bacteria, Paris, France	Ulm University; Ulm University; Ulm University; University of Freiburg; Jacobs University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Barth, H (corresponding author), Univ Ulm, Med Ctr, Inst Pharmacol & Toxicol, Albert Einstein Allee 11, D-89081 Ulm, Germany.	holger.barth@uni-ulm.de	Aktories, Klaus/CAJ-5682-2022	Aktories, Klaus/0000-0002-5397-0436; Kleger, Alexander/0000-0003-0592-5232; Fischer, Stephan/0000-0001-6862-2971; Papatheodorou, Panagiotis/0000-0003-3571-695X	Deutsche Forschungsgemeinschaft (DFG) [316249678, CRC1279]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: 316249678 (CRC1279)	AKTORIES K, 1995, TRENDS CELL BIOL, V5, P441, DOI 10.1016/S0962-8924(00)89107-2; Aktories K, 1997, J CLIN INVEST, V99, P827, DOI 10.1172/JCI119245; Bachmeyer C, 2003, J MOL BIOL, V333, P527, DOI 10.1016/j.jmb.2003.08.044; Bachmeyer C, 2001, FASEB J, V15, P1658, DOI 10.1096/fj.00-0671fje; Barth H, 2004, MICROBIOL MOL BIOL R, V68, P373, DOI 10.1128/MMBR.68.3.373-402.2004; Beitzinger C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066099; BENZ R, 1978, BIOCHIM BIOPHYS ACTA, V511, P305, DOI 10.1016/0005-2736(78)90269-9; Benz R, 2017, CURR TOP MICROBIOL, V406, P229, DOI 10.1007/82_2017_17; BLAUSTEIN RO, 1990, J GEN PHYSIOL, V96, P921, DOI 10.1085/jgp.96.5.921; Britton RA, 2014, GASTROENTEROLOGY, V146, P1547, DOI 10.1053/j.gastro.2014.01.059; Bronnhuber A, 2014, TOXICOLOGY, V316, P25, DOI 10.1016/j.tox.2013.12.006; Carter GP, 2015, MBIO, V6, DOI 10.1128/mBio.00551-15; Carter GP, 2012, TRENDS MICROBIOL, V20, P21, DOI 10.1016/j.tim.2011.11.003; Castagliuolo I, 1998, J CLIN INVEST, V101, P1547, DOI 10.1172/JCI2039; Connan C, 2016, CELL MICROBIOL, V18, P282, DOI 10.1111/cmi.12502; Davies NL, 2013, CLIN VACCINE IMMUNOL, V20, P377, DOI 10.1128/CVI.00625-12; di Masi A, 2018, J INFECT DIS, V218, P1424, DOI 10.1093/infdis/jiy338; Egerer M, 2007, J BIOL CHEM, V282, P25314, DOI 10.1074/jbc.M703062200; Ernst K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02882-y; Fischer S, 2018, PATHOG DIS, V76, DOI 10.1093/femspd/fty022; Genth H, 2006, FEBS LETT, V580, P3565, DOI 10.1016/j.febslet.2006.04.100; Gerding DN, 2014, GUT MICROBES, V5, P15, DOI 10.4161/gmic.26854; Giesemann T, 2008, J MED MICROBIOL, V57, P690, DOI 10.1099/jmm.0.47742-0; Giesemann T, 2008, GASTROENTEROLOGY, V134, P2049, DOI 10.1053/j.gastro.2008.03.008; Gulke I, 2001, INFECT IMMUN, V69, P6004, DOI 10.1128/IAI.69.10.6004-6011.2001; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hohwieler M, 2016, Z GASTROENTEROL, V54, P748, DOI 10.1055/s-0042-105520; Ishida Y, 2004, J IMMUNOL, V172, P3018, DOI 10.4049/jimmunol.172.5.3018; JUST I, 1995, J CLIN INVEST, V95, P1026, DOI 10.1172/JCI117747; Kelly Ciaran P, 2008, N Engl J Med, V359, P1932, DOI 10.1056/NEJMra0707500; Kim C, 2005, P NATL ACAD SCI USA, V102, P4830, DOI 10.1073/pnas.0500508102; Kim C, 2006, TRENDS MICROBIOL, V14, P428, DOI 10.1016/j.tim.2006.08.001; Kim C, 2006, BIOCHEM J, V399, P225, DOI 10.1042/BJ20060425; Kreidler AM, 2017, ARCH TOXICOL, V91, P1431, DOI 10.1007/s00204-016-1716-9; Kronhardt A, 2017, BAOJ CHEM, V3; Kronhardt A, 2016, TOXINS, V8, DOI 10.3390/toxins8080237; Kudryashova E, 2015, ONCOTARGET, V6, P28533, DOI 10.18632/oncotarget.5109; Kuehne SA, 2014, J INFECT DIS, V209, P83, DOI 10.1093/infdis/jit426; Kuehne SA, 2010, NATURE, V467, P711, DOI 10.1038/nature09397; Kuijper EJ, 2006, CLIN MICROBIOL INFEC, V12, P2, DOI 10.1111/j.1469-0691.2006.01580.x; Leffler DA, 2015, NEW ENGL J MED, V372, P1539, DOI 10.1056/NEJMra1403772; LEHRER RI, 1993, ANNU REV IMMUNOL, V11, P105, DOI 10.1146/annurev.iy.11.040193.000541; Leslie JL, 2015, INFECT IMMUN, V83, P138, DOI 10.1128/IAI.02561-14; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; Menendez A, 2007, CURR OPIN IMMUNOL, V19, P385, DOI 10.1016/j.coi.2007.06.008; Nagahama M, 2011, INFECT IMMUN, V79, P4353, DOI 10.1128/IAI.05677-11; Nestorovich EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023927; Neumeyer T, 2008, J BIOL CHEM, V283, P3904, DOI 10.1074/jbc.M709807200; Nishimura M, 2004, J DERMATOL SCI, V36, P87, DOI 10.1016/j.jdermsci.2004.07.001; Orlik F, 2005, BIOPHYS J, V88, P1715, DOI 10.1529/biophysj.104.050336; Papatheodorou P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010673; Perelle S, 1997, INFECT IMMUN, V65, P1402, DOI 10.1128/IAI.65.4.1402-1407.1997; POPOFF MR, 1987, INFECT IMMUN, V55, P35, DOI 10.1128/IAI.55.1.35-43.1987; Rao K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092578; SCHMID A, 1994, J BIOL CHEM, V269, P16706; Schwan C, 2011, J BIOL CHEM, V286, P29356, DOI 10.1074/jbc.M111.261925; Schwan C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000626; Shen A, 2012, J INNATE IMMUN, V4, P149, DOI 10.1159/000332946; Steele J, 2013, J INFECT DIS, V207, P323, DOI 10.1093/infdis/jis669; VONEICHELSTREIBER C, 1987, MICROB PATHOGENESIS, V2, P307, DOI 10.1016/0882-4010(87)90073-8; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhao CQ, 1996, FEBS LETT, V396, P319, DOI 10.1016/0014-5793(96)01123-4	62	14	14	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6244	6261		10.1096/fj.201902816R	http://dx.doi.org/10.1096/fj.201902816R		MAR 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32190927	hybrid			2022-12-28	WOS:000521549700001
J	Yang, P; Zeng, H; Tan, W; Luo, XQ; Zheng, EZ; Zhao, L; Wei, L; Ruan, XZ; Chen, Y; Chen, YX				Yang, Ping; Zeng, Han; Tan, Wei; Luo, Xiaoqing; Zheng, Enze; Zhao, Lei; Wei, Li; Ruan, Xiong Z.; Chen, Yao; Chen, Yaxi			Loss of CD36 impairs hepatic insulin signaling by enhancing the interaction of PTP1B with IR	FASEB JOURNAL			English	Article						CD36; ER stress; insulin sensitivity; IR; PTP1B	ENDOPLASMIC-RETICULUM STRESS; TYROSINE-PHOSPHATASE 1B; FATTY-ACID TRANSPORT; RECEPTOR CD36; SOLUBLE CD36; RESISTANCE; INFLAMMATION; MUSCLE; LIVER; ATHEROSCLEROSIS	A contradictory role of CD36 in insulin resistance was found to be related to the nutrient state. Here, we examined that the physiological functions of CD36 in insulin signal transduction in mice fed a low-fat diet. CD36 deficiency led to hepatic insulin resistance and decreased insulin-stimulated tyrosine phosphorylation of insulin receptor beta (IR beta) in mice fed a low-fat diet. The ability of insulin to bind with IR did not differ between WT and CD36-deficient hepatocytes. CD36 formed a complex with IR beta and dissociation of CD36/Fyn complex or inhibition of Fyn only partially reversed the effects of CD36 on hepatic insulin signaling. Furthermore, we found that CD36 deficiency led to abnormally increased hepatic protein-tyrosine phosphatase 1B (PTP1B) expression and enhanced PTP1B and IR interactions, which contributed to the decreased insulin signaling and disordered glucose metabolism. In addition, increased endoplasmic reticulum (ER) stress was found in the livers of the CD36-deficient mice, while inhibited ER stress normalized the PTP1B expression and restored insulin signaling in the CD36-deficient mice. Our findings suggest that the loss of CD36 impairs hepatic insulin signaling by enhancing the PTP1B/IR interaction that is induced by ER stress, indicating a possible critical step in the progression of hepatic insulin resistance.	[Yang, Ping; Zeng, Han; Tan, Wei; Luo, Xiaoqing; Zheng, Enze; Zhao, Lei; Wei, Li; Ruan, Xiong Z.; Chen, Yaxi] Chongqing Med Univ, Key Lab Mol Biol Infect Dis, Affiliated Hosp 2,Inst Viral Hepatitis, Minist Educ,Dept Infect Dis,Ctr Lipid Res, Chongqing, Peoples R China; [Ruan, Xiong Z.] Fudan Univ, Huashan Hosp, Natl Clin Res Ctr Aging & Med, Shanghai, Peoples R China; [Ruan, Xiong Z.] UCL, Sch Med, Ctr Nephrol, John Moorhead Res Lab, Royal Free Campus, London, England; [Chen, Yao] Chongqing Med Univ, Affiliated Hosp 2, Med Examinat Ctr, Chongqing, Peoples R China	Chongqing Medical University; Fudan University; University of London; University College London; UCL Medical School; Chongqing Medical University	Ruan, XZ; Chen, YX (corresponding author), Chongqing Med Univ, Key Lab Mol Biol Infect Dis, Affiliated Hosp 2,Inst Viral Hepatitis, Minist Educ,Dept Infect Dis,Ctr Lipid Res, Chongqing, Peoples R China.; Chen, Y (corresponding author), Chongqing Med Univ, Affiliated Hosp 2, Med Examinat Ctr, Chongqing, Peoples R China.	x.ruan@ucl.ac.uk; chenyao@cqmu.edu.cn; chenyaxi@cqmu.edu.cn	Ruan, Xiong Zhong/GZA-5963-2022	Ruan, Xiong Zhong/0000-0001-5199-4971	National Natural Science Foundation of China [81873569, 31571210, 81400786]; National Key R&D Program of China [2018YFC1312700]; Science and Technology Research Program of Chongqing Municipal Education Commission [KJZD-K201800401]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; Science and Technology Research Program of Chongqing Municipal Education Commission	This research was supported by the National Natural Science Foundation of China (81873569, 31571210, 81400786), National Key R&D Program of China (2018YFC1312700), and the Science and Technology Research Program of Chongqing Municipal Education Commission (Grant No. KJZD-K201800401).	Aouadi M, 2014, AM J PHYSIOL-ENDOC M, V307, pE374, DOI 10.1152/ajpendo.00187.2014; Bakke J, 2015, SEMIN CELL DEV BIOL, V37, P58, DOI 10.1016/j.semcdb.2014.09.020; BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506; Bonen A, 2015, DIABETOLOGIA, V58, P2381, DOI 10.1007/s00125-015-3691-8; Cai L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036785; Coburn CT, 2000, J BIOL CHEM, V275, P32523, DOI 10.1074/jbc.M003826200; Ekici M, 2018, BRIT J NUTR, V119, P153, DOI [10.1017/S0007114517003269, 10.1017/s0007114517003269]; Miquilena-Colina ME, 2011, GUT, V60, P1394, DOI 10.1136/gut.2010.222844; Febbraio M, 1999, J BIOL CHEM, V274, P19055, DOI 10.1074/jbc.274.27.19055; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Flamment M, 2012, TRENDS ENDOCRIN MET, V23, P381, DOI 10.1016/j.tem.2012.06.003; Garbacz WG, 2016, MOL CELL BIOL, V36, P2715, DOI 10.1128/MCB.00138-16; Goudriaan JR, 2003, J LIPID RES, V44, P2270, DOI 10.1194/jlr.M300143-JLR200; Hajri T, 2002, J CLIN INVEST, V109, P1381, DOI [10.1172/JCI200214596, 10.1172/JCI0214596]; Hajri T, 2007, DIABETES, V56, P1872, DOI 10.2337/db06-1699; Heron-Milhavet L, 2004, ENDOCRINOLOGY, V145, P4667, DOI 10.1210/en.2003-1543; Hetz C, 2011, PHYSIOL REV, V91, P1219, DOI 10.1152/physrev.00001.2011; Hirano K, 2003, TRENDS CARDIOVAS MED, V13, P136, DOI 10.1016/S1050-1738(03)00026-4; Iizuka Y, 2001, LANCET, V358, P243, DOI 10.1016/S0140-6736(01)05429-0; Kennedy DJ, 2011, METAB SYNDR RELAT D, V9, P239, DOI 10.1089/met.2011.0003; Kennedy DJ, 2011, CARDIOVASC RES, V89, P604, DOI 10.1093/cvr/cvq360; Klingmuller U, 2006, IEE P SYST BIOL, V153, P433, DOI 10.1049/ip-syb:20050067; Koonen Debby P. Y., 2011, Archives of Physiology and Biochemistry, V117, P57, DOI 10.3109/13813455.2010.543136; Kulkarni NB, 2018, INDIAN J MED RES, V147, P169, DOI 10.4103/ijmr.IJMR_852_16; Kuwasako T, 2003, DIABETES CARE, V26, P1647, DOI 10.2337/diacare.26.5.1647-a; Love-Gregory L, 2011, CURR OPIN CLIN NUTR, V14, P527, DOI 10.1097/MCO.0b013e32834bbac9; Nassir F, 2013, J LIPID RES, V54, P2988, DOI 10.1194/jlr.M037812; Panzhinskiy E, 2013, DIABETOLOGIA, V56, P598, DOI 10.1007/s00125-012-2782-z; Panzhinskiy E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077228; Park YM, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2014.38; Popov D, 2012, BIOCHEM BIOPH RES CO, V422, P535, DOI 10.1016/j.bbrc.2012.05.048; Samovski D, 2018, DIABETES, V67, P1272, DOI 10.2337/db17-1226; Shiju TM, 2015, J DIABETES COMPLICAT, V29, P400, DOI 10.1016/j.jdiacomp.2014.12.012; Silverstein RL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.272re3; Sun SS, 2018, J BIOL CHEM, V293, P2383, DOI 10.1074/jbc.M117.811471; Wang N, 2009, MOL CELL ENDOCRINOL, V307, P89, DOI 10.1016/j.mce.2009.03.001; Yamashita S, 2007, MOL CELL BIOCHEM, V299, P19, DOI 10.1007/s11010-005-9031-4; Yang P, 2017, J LIPID RES, V58, P1417, DOI 10.1194/jlr.M076216; Zhong S, 2017, ANTIOXID REDOX SIGN, V27, P201, DOI 10.1089/ars.2016.6808	39	8	11	3	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5658	5672		10.1096/fj.201902777RR	http://dx.doi.org/10.1096/fj.201902777RR		FEB 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32100381	Green Submitted, Bronze			2022-12-28	WOS:000518581700001
J	Man, XF; Hu, N; Tan, SW; Tang, HN; Guo, Y; Tang, CY; Liu, YQ; Tang, J; Zhou, CL; Wang, F; Zhou, HD				Man, Xiao-Fei; Hu, Nan; Tan, Shu-Wen; Tang, Hao-Neng; Guo, Yue; Tang, Chen-Yi; Liu, Ya-Qing; Tang, Jun; Zhou, Ci-La; Wang, Fang; Zhou, Hou-De			Insulin receptor substrate-1 inhibits high-fat diet-induced obesity by browning of white adipose tissue through miR-503	FASEB JOURNAL			English	Article						BMPR1a; brown adipogenesis; IRS-1; miR-503; PI3K; Akt pathway	BONE MORPHOGENETIC PROTEIN; THERAPEUTIC-EFFICACY; DIFFERENTIAL ROLES; ADIPOGENESIS; MELANOMA; PREADIPOCYTE; DACARBAZINE; EXPRESSION; OSTEOBLAST	Genetic variation of insulin receptor substrate 1 (IRS-1) was found to modulate the insulin resistance of adipose tissues, but the underlying mechanism was not clear. To investigate how the IRS-1 was involved in the browning of white adipose tissue through miRNA, we identified a mutatedIrs-1(Irs-1(-/-)) mice model and found that this mice had a reduced subcutaneous WAT (sWAT) and increased brown adipose tissue (BAT) in the interscapular region. So we isolated the bone marrow stromal cells and analyzed differentially expressed miRNAs and adipogenesis-related genes with miRNA arrays and PCR arrays.Irs-1(-/-)mice showed decreased miR-503 expression, but increased expression of its target, bone morphogenetic protein receptor type 1a (BMPR1a). Overexpression of miR-503 in preadipocytes downregulated BMPR1a and impaired adipogenic activity through the phosphotidylinositol 3-kinase (PI3K/Akt) pathway, while the inhibitor had the opposite effect. In bothIrs-1(-/-)and cold-induced models, sWAT exhibited BAT features, and showed tissue-specific increased BMPR1a expression, PI3K expression, and Akt phosphorylation. Thus, our results showed that IRS-1 regulated brown preadipocyte differentiation and induced browning in sWAT through the miR-503-BMPR1a pathway, which played important roles in high-fat diet-induced obesity.	[Man, Xiao-Fei; Hu, Nan; Tan, Shu-Wen; Tang, Hao-Neng; Guo, Yue; Tang, Chen-Yi; Liu, Ya-Qing; Tang, Jun; Zhou, Ci-La; Wang, Fang; Zhou, Hou-De] Cent South Univ, Xiangya Hosp 2, Natl Clin Res Ctr Metab Dis, Hunan Prov Key Lab Metab Bone Dis,Dept Endocrinol, Changsha, Hunan, Peoples R China; [Man, Xiao-Fei] Qingdao Univ, Dept Nephrol, Affiliated Hosp, Qingdao, Peoples R China	Central South University; Qingdao University	Zhou, HD (corresponding author), Cent South Univ, Xiangya Hosp 2, Natl Clin Res Ctr Metab Dis, Hunan Prov Key Lab Metab Bone Dis,Dept Endocrinol, Changsha, Hunan, Peoples R China.	houdezhou@csu.edu.cn	Tang, Jun/GRX-1749-2022	Zhou, Hou-De/0000-0001-9131-4141; Tang, Jun/0000-0002-6908-1027	NSFC; National Natural Science Foundation of China [81770880, 81800788, 81970762]; Science and Technology Department of Hunan Province [2015JC3012, 2018SK52511]	NSFC(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Department of Hunan Province	NSFC vertical bar National Natural Science Foundation of China, Grant/Award Number: 81770880, 81800788 and 81970762; Science and Technology Department of Hunan Province, Grant/Award Number: 2015JC3012 and 2018SK52511	Accili D, 1996, NAT GENET, V12, P106, DOI 10.1038/ng0196-106; Achari AE, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061321; Castorena CM, 2014, DIABETES, V63, P2297, DOI 10.2337/db13-1686; Cervantes-Camacho C, 2015, ADIPOCYTE, V4, P248, DOI 10.1080/21623945.2015.1007823; Chen D, 1998, J CELL BIOL, V142, P295, DOI 10.1083/jcb.142.1.295; Chen LA, 2010, J BONE MINER RES, V25, P2447, DOI 10.1002/jbmr.133; Chen ZF, 2020, CIRC RES, V126, P330, DOI 10.1161/CIRCRESAHA.119.315246; de Sa PM, 2017, COMPR PHYSIOL, V7, P635, DOI 10.1002/cphy.c160022; Fasshauer M, 2001, MOL CELL BIOL, V21, P319, DOI 10.1128/MCB.21.1.319-329.2001; Fischer C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02158-z; Gasparetti AL, 2003, J PHYSIOL-LONDON, V552, P149, DOI 10.1113/jphysiol.2003.050369; Ghaben AL, 2019, NAT REV MOL CELL BIO, V20, P242, DOI 10.1038/s41580-018-0093-z; Guerra C, 2001, J CLIN INVEST, V108, P1205, DOI 10.1172/JCI200113103; Guo Y, 2016, FASEB J, V30, P4214, DOI 10.1096/fj.201600445RR; Hammarstedt A, 2018, PHYSIOL REV, V98, P1911, DOI 10.1152/physrev.00034.2017; Jeong MY, 2017, METABOLISM, V73, P85, DOI 10.1016/j.metabol.2017.05.009; Kubota T, 2017, CELL METAB, V25, P797, DOI 10.1016/j.cmet.2017.03.004; Kuri-Harcuch W, 2019, J CELL PHYSIOL, V234, P1111, DOI 10.1002/jcp.27060; Kwon DN, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/236385; Lavin DP, 2016, DIABETOLOGIA, V59, P2280, DOI 10.1007/s00125-016-4072-7; Liu ZH, 2019, STEM CELLS INT, V2019, DOI 10.1155/2019/4143167; Malvi P, 2018, CANCER METAB, V6, DOI 10.1186/s40170-018-0176-5; Malvi P, 2016, CANCER METAB, V4, DOI 10.1186/s40170-016-0162-8; Malvi P, 2015, MOL ONCOL, V9, P689, DOI 10.1016/j.molonc.2014.11.006; Man XF, 2016, AM J TRANSL RES, V8, P2727; Montgomery MK, 2019, FASEB J, V33, P13267, DOI 10.1096/fj.201900909RR; Morley TS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8906; Ortega FB, 2016, CIRC RES, V118, P1752, DOI 10.1161/CIRCRESAHA.115.306883; Park Anna, 2014, World J Stem Cells, V6, P33, DOI 10.4252/wjsc.v6.i1.33; Poher AL, 2015, DIABETES, V64, P3700, DOI 10.2337/db15-0210; Sarantopoulos CN, 2018, STEM CELL REV REP, V14, P27, DOI 10.1007/s12015-017-9774-9; Schulz TJ, 2013, NATURE, V495, P379, DOI 10.1038/nature11943; Skillington J, 2002, J CELL BIOL, V159, P135, DOI 10.1083/jcb.200204060; Sun L, 2011, NAT CELL BIOL, V13, P958, DOI 10.1038/ncb2286; TAMEMOTO H, 1994, NATURE, V372, P182, DOI 10.1038/372182a0; Tang CY, 2017, MOL CELLS, V40, P123, DOI 10.14348/molcells.2017.2228; Than A, 2015, J BIOL CHEM, V290, P14679, DOI 10.1074/jbc.M115.643817; Tseng YH, 2005, NAT CELL BIOL, V7, P601, DOI 10.1038/ncb1259; Tseng YH, 2004, MOL CELL BIOL, V24, P1918, DOI 10.1128/MCB.24.5.1918-1929.2004; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; Westrick RJ, 2010, P NATL ACAD SCI USA, V107, P16904, DOI 10.1073/pnas.1012050107; Xu JF, 2004, J BIOL CHEM, V279, P35914, DOI 10.1074/jbc.M402297200	42	4	4	0	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12308	12323		10.1096/fj.201903283RR	http://dx.doi.org/10.1096/fj.201903283RR		JUL 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32721050				2022-12-28	WOS:000556062700001
J	Soundharrajan, I; Kuppusamy, P; Srisesharam, S; Lee, JC; Sivanesan, R; Kim, D; Choi, KC				Soundharrajan, Ilavenil; Kuppusamy, Palaniselvam; Srisesharam, Srigopalram; Lee, Jeong Chae; Sivanesan, Ravikumar; Kim, Dahye; Choi, Ki Choon			Positive metabolic effects of selected probiotic bacteria on diet-induced obesity in mice are associated with improvement of dysbiotic gut microbiota	FASEB JOURNAL			English	Article						anti-obesity; metabolic disorders; microbiota; Lactobacillus plantarum; probiotics	HIGH-FAT DIET; CHOLESTEROL-LOWERING PROPERTIES; LACTOBACILLUS-PLANTARUM; ADIPOCYTE SIZE; INSULIN-RESISTANCE; LIPID-METABOLISM; ADIPOSE-TISSUE; WEIGHT-GAIN; INHIBITION; ADIPOGENESIS	Given the rising evidence that gut malfunction including changes in the gut microbiota composition, plays a major role in the development of obesity and associated metabolic diseases, the exploring of novel probiotic bacteria with potential health benefits has attracted great attention. RecentlyLactobacillusspp., exert potent anti-obesity effects by regulating key transcriptional and translational factors in adipose tissues. However, the molecular mechanism behind the anti-obesity effect of probiotics is not yet fully understood. Therefore, we investigated the effect ofLactobacillus plantarumA29 on the expression of adipogenic and lipogenic genes in 3T3-L1 adipocytes and high-fat diet (HFD)-fed mice. We observed that the treatment of 3T3-L1 adipocytes with the cell-free metabolites ofL plantaruminhibited their differentiation and fat depositions via downregulating the key adipogenic transcriptional factors (PPAR-gamma, C/EBP-alpha, and C/EBP-beta) and their downstream targets (FAS, aP2, ACC, and SREBP-1). Interestingly, supplementation withL plantarumreduced the fat mass and serum lipid profile concurrently with downregulation of lipogenic gene expression in the adipocytes, resulting in reductions in the bodyweight of HFD-fed obese mice.L plantarumtreatment attenuated the development of obesity in HFD-fed mice via the activation of p38MAPK, p44/42, and AMPK-alpha by increasing their phosphorylation. Further analysis revealed that A29 modulated gut-associated microbiota composition. Thus, A 29 potential probiotic strain may alleviate the obesity development and its associated metabolic disorders via inhibiting PPAR gamma through activating the p38MAPK and p44/42 signaling pathways.	[Soundharrajan, Ilavenil; Kuppusamy, Palaniselvam; Srisesharam, Srigopalram; Choi, Ki Choon] Rural Dev Adm, Natl Inst Anim Sci, Grassland & Forage Div, Cheonan 31000, South Korea; [Lee, Jeong Chae] Chonbuk Natl Univ, Res Ctr Bioact Mat, Inst Mol Biol & Genet, Jeonju, South Korea; [Sivanesan, Ravikumar] Rajah Serfoji Govt Arts Coll, Dept Zool, Thanjavur, Tamil Nadu, India; [Kim, Dahye] Jeju Natl Univ, Coll Appl Life Sci, Fac Biotechnol, Jeju, South Korea	National Institute of Animal Science, Republic of Korea; Rural Development Administration (RDA), Republic of Korea; Jeonbuk National University; Jeju National University	Choi, KC (corresponding author), Rural Dev Adm, Natl Inst Anim Sci, Grassland & Forage Div, Cheonan 31000, South Korea.; Kim, D (corresponding author), Univ Kentucky, Coll Med, Ctr Res Environm Dis, 1095 VA Dr, Lexington, KY 40536 USA.	pioioiq@nate.com; choiwh@korea.kr		Soundharrajan, Ilavenil/0000-0002-7854-5954	Cooperative Research Program for Agriculture Science and Technology Development [PJ01358902]	Cooperative Research Program for Agriculture Science and Technology Development(Rural Development Administration (RDA), Republic of Korea)	Cooperative Research Program for Agriculture Science and Technology Development, Grant/Award Number: PJ01358902	Achari A, 2017, INT J MOL SCI, V18, P1; Alard J, 2016, ENVIRON MICROBIOL, V18, P1484, DOI 10.1111/1462-2920.13181; Albano C, 2018, J DAIRY SCI, V101, P10807, DOI 10.3168/jds.2018-15096; Angin Y, 2016, EXPERIENTIA SUPPL, V107, P23, DOI 10.1007/978-3-319-43589-3_2; Aouadi M, 2006, DIABETES, V55, P281, DOI 10.2337/diabetes.55.02.06.db05-0963; Armougom F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007125; Aronsson L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013087; Bermudez-Brito M, 2012, ANN NUTR METAB, V61, P160, DOI 10.1159/000342079; Bluher M, 2019, NAT REV ENDOCRINOL, V15, P288, DOI 10.1038/s41574-019-0176-8; Borgeraas H, 2018, OBES REV, V19, P219, DOI 10.1111/obr.12626; Moreira APB, 2012, BRIT J NUTR, V108, P801, DOI 10.1017/S0007114512001213; Brestoff JR, 2013, NAT IMMUNOL, V14, P676, DOI 10.1038/ni.2640; Bubnov RV, 2017, EPMA J, V8, P357, DOI 10.1007/s13167-017-0117-3; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Casarotti SN, 2015, INT DAIRY J, V41, P1, DOI 10.1016/j.idairyj.2014.08.021; Chiu CC, 2017, NUTRIENTS, V9, DOI 10.3390/nu9111220; Choi WJ, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-57615-5; Choi WJ, 2019, J MED FOOD, V22, P560, DOI 10.1089/jmf.2018.4329; Cotillard A, 2013, NATURE, V500, P585, DOI 10.1038/nature12480; Cui HX, 2017, NAT REV ENDOCRINOL, V13, P338, DOI 10.1038/nrendo.2016.222; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Del Re B, 2000, LETT APPL MICROBIOL, V31, P438, DOI 10.1046/j.1365-2672.2000.00845.x; Delzenne NM, 2011, NAT REV ENDOCRINOL, V7, P639, DOI 10.1038/nrendo.2011.126; den Besten G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136364; den Besten G, 2015, DIABETES, V64, P2398, DOI 10.2337/db14-1213; Derrien M, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00166; Duncan SH, 2008, INT J OBESITY, V32, P1720, DOI 10.1038/ijo.2008.155; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Endo H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063388; Fajas L, 1998, CURR OPIN CELL BIOL, V10, P165, DOI 10.1016/S0955-0674(98)80138-5; FAO/WHO, 2002, GUID EV PROB FOODS; Fijan S, 2014, INT J ENV RES PUB HE, V11, P4745, DOI 10.3390/ijerph110504745; Forssten SD, 2013, APPETITE, V71, P16, DOI 10.1016/j.appet.2013.06.093; Fullerton MD, 2013, NAT MED, V19, P1649, DOI 10.1038/nm.3372; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Hamad EM, 2009, BRIT J NUTR, V101, P716, DOI 10.1017/S0007114508043808; Heo J, 2016, SCI REP-UK, V6, DOI 10.1038/srep33566; Hildebrandt M, 2009, GASTROENTEROLOGY, V136; Huang WC, 2019, NUTRIENTS, V11, DOI 10.3390/nu11020353; Huang Y, 2014, APPL ENVIRON MICROB, V80, P7496, DOI 10.1128/AEM.02926-14; Hunter PM, 2017, NAT REV ENDOCRINOL, V13, P278, DOI 10.1038/nrendo.2016.210; Ilavenil S, 2016, J SCI FOOD AGR, V96, P593, DOI 10.1002/jsfa.7128; Iranmanesh M, 2014, LWT-FOOD SCI TECHNOL, V58, P355, DOI 10.1016/j.lwt.2013.10.005; Ivanovic B, 2015, AM J CARDIOVASC DRUG, V15, P403, DOI 10.1007/s40256-015-0128-1; Ji Y, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43092-y; JOLLOW DJ, 1974, PHARMACOLOGY, V11, P151, DOI 10.1159/000136485; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Khan RA, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-181; Kim KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047713; Kim S-J, 2016, MOL CELL BIOL, V36; Kim SW, 2001, J BIOL CHEM, V276, P10199, DOI 10.1074/jbc.M010640200; Kloeting N, 2007, CELL METAB, V6, P79, DOI 10.1016/j.cmet.2007.06.002; Kumar CSVS, 2015, INT IMMUNOPHARMACOL, V25, P504, DOI 10.1016/j.intimp.2015.02.026; Kumar M, 2012, EXP DIABETES RES, DOI 10.1155/2012/902917; Le Barz M, 2019, FASEB J, V33, P4921, DOI 10.1096/fj.201801672R; Lee CY, 2009, KAOHSIUNG J MED SCI, V25, P116, DOI 10.1016/S1607-551X(09)70050-6; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li HZ, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00512; Lin HV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035240; Liu YW, 2018, J MICROBIOL, V56, P601, DOI 10.1007/s12275-018-8079-2; Loffreda S, 1998, FASEB J, V12, P57, DOI 10.1096/fasebj.12.1.57; Makki Kassem, 2013, ISRN Inflamm, V2013, P139239, DOI 10.1155/2013/139239; Makowski L, 2005, CURR OPIN LIPIDOL, V16, P543, DOI 10.1097/01.mol.0000180166.08196.07; Mercenier A., 2008, B INT DAIRY FED, V429, P2; Million M, 2012, MICROB PATHOGENESIS, V53, P100, DOI 10.1016/j.micpath.2012.05.007; MISRA HP, 1972, J BIOL CHEM, V247, P3170; Miyoshi M, 2014, EUR J NUTR, V53, P599, DOI 10.1007/s00394-013-0568-9; Moseti D, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010124; Murphy EF, 2010, GUT, V59, P1635, DOI 10.1136/gut.2010.215665; Muthusamy K, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10010417; Nakamura Futoshi, 2016, Microbial Ecology in Health and Disease, V27, P30312, DOI 10.3402/mehd.v27.30312; Nakamura F, 2016, J AGR FOOD CHEM, V64, P2549, DOI 10.1021/acs.jafc.5b05827; Neish AS, 2009, GASTROENTEROLOGY, V136, P65, DOI 10.1053/j.gastro.2008.10.080; NIEHAUS WG, 1968, EUR J BIOCHEM, V6, P126, DOI 10.1111/j.1432-1033.1968.tb00428.x; Ogawa A, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-36; Onishi JC, 2017, MICROBIOL-SGM, V163, P1189, DOI 10.1099/mic.0.000496; Park JE, 2014, J APPL MICROBIOL, V116, P145, DOI 10.1111/jam.12354; Park SY, 2018, KOREAN J FOOD SCI AN, V38, P99, DOI 10.5851/kosfa.2018.38.1.99; Park SY, 2015, KOREAN J FOOD SCI AN, V35, P171, DOI 10.5851/kosfa.2015.35.2.171; Park UH, 2012, J AGR FOOD CHEM, V60, P3853, DOI 10.1021/jf204514a; Pettinelli P, 2011, J CLIN ENDOCR METAB, V96, P1424, DOI 10.1210/jc.2010-2129; Prasanna PHP, 2017, YOGURT IN HEALTH AND DISEASE PREVENTION, P171, DOI 10.1016/B978-0-12-805134-4.00009-2; Raoult D, 2009, NAT REV MICROBIOL, V7, P616, DOI 10.1038/nrmicro2209; REID G, 1988, CAN J MICROBIOL, V34, P344, DOI 10.1139/m88-063; Rinninella E, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7010014; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Salguero MV, 2019, EXP THER MED, V18, P3461, DOI 10.3892/etm.2019.7943; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Serban DE, 2014, CANCER LETT, V345, P258, DOI 10.1016/j.canlet.2013.08.013; Soundharrajan I, 2018, EVID-BASED COMPL ALT, V2018, P1; Soundharrajan I, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7090318; Soundharrajan I, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45793-w; Takemura N, 2010, EXP BIOL MED, V235, P849, DOI 10.1258/ebm.2010.009377; Tang QQ, 2012, ANNU REV BIOCHEM, V81, P715, DOI 10.1146/annurev-biochem-052110-115718; Teng Y, 2020, J FUNCT FOODS, V64, DOI 10.1016/j.jff.2019.103665; Tsai YT, 2014, APPL MICROBIOL BIOT, V98, P1, DOI 10.1007/s00253-013-5346-3; Tulumoglu S, 2013, ANAEROBE, V24, P36, DOI 10.1016/j.anaerobe.2013.09.006; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Wang BH, 2017, ENGINEERING, V3, P71, DOI 10.1016/J.ENG.2017.01.008; Wang J, 2012, J DAIRY SCI, V95, P1645, DOI 10.3168/jds.2011-4768; Wang JJ, 2015, ISME J, V9, P1, DOI 10.1038/ismej.2014.99; Wang YH, 2018, MICROMACHINES-BASEL, V9, DOI 10.3390/mi9010019; World Health Organization, 2016, ANTIMICROBIAL RESIST; Xie N, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-53; Yu A-Q, 2016, NUTR CANC, V68, P1; Zago M, 2011, FOOD MICROBIOL, V28, P1033, DOI 10.1016/j.fm.2011.02.009; Zhang H, 2018, SYN SYST BIOTECHNO, V3, P113, DOI 10.1016/j.synbio.2018.03.001	109	14	14	4	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12289	12307		10.1096/fj.202000971R	http://dx.doi.org/10.1096/fj.202000971R		JUL 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32701200				2022-12-28	WOS:000555047900001
J	Zhao, H; Ding, F; Zheng, GH				Zhao, Hui; Ding, Feng; Zheng, Guanghong			LncRNA TMPO-AS1 promotes LCN2 transcriptional activity and exerts oncogenic functions in ovarian cancer	FASEB JOURNAL			English	Article						LCN2; LncRNA TMPO-AS1; ovarian cancer; transcription factor	LONG NONCODING RNAS; LIPOCALIN 2; SURVIVAL	Ovarian cancer remains the sixth most frequently occurring cancer in women worldwide. Long noncoding RNAs (lncRNAs) are capable of regulating gene expression, and thus, participating in a wide range of biological functions and disease processes including cancer development. Our work suggests that lncRNA TMPO antisense RNA 1 (TMPO-AS1) represents an oncogenic lncRNA in ovarian cancer and presents a novel mechanism involving transcription factor E2F transcription factor 6 (E2F6) and lipocalin-2 (LCN2). We identified upregulated lncRNA TMPO-AS1 in ovarian cancer tissues and cells. siRNA-mediated silencing of lncRNA TMPO-AS1 restrained the aggressiveness of ovarian cancer cells and their pro-angiogenic ability, and reduced the expression of LCN2. LncRNA TMPO-AS1 was found to interact with E2F6, a transcriptional repressor that could bind to the promoter region of LCN2 gene. In addition, silencing of E2F6 or overexpression of LCN2 restored the aggressiveness of ovarian cancer cells and their pro-angiogenic ability following siRNA-mediated silencing of lncRNA TMPO-AS1. Taken together, we demonstrated lncRNA TMPO-AS1 could potentially promote LCN2 transcriptional activity by binding to transcription factor E2F6, and thus, stimulated the progression of ovarian cancer. These findings underscore a possible alternative therapeutic strategy for ovarian cancer treatment.	[Zhao, Hui; Zheng, Guanghong] Linyi Peoples Hosp, Dept Gynecol & Obstet, 27 Eastern Jiefang Rd, Linyi 276003, Shandong, Peoples R China; [Ding, Feng] Linyi Peoples Hosp, Dept Educ & Teaching, Linyi, Shandong, Peoples R China		Zheng, GH (corresponding author), Linyi Peoples Hosp, Dept Gynecol & Obstet, 27 Eastern Jiefang Rd, Linyi 276003, Shandong, Peoples R China.	drGuanghong@163.com						Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Chang TH, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S2-S4; Chay D, 2010, INT J ONCOL, V37, P399, DOI 10.3892/ijo_00000688; Cheng FHC, 2019, CANCER SCI, V110, P1085, DOI 10.1111/cas.13920; Cho H, 2009, J HISTOCHEM CYTOCHEM, V57, P513, DOI 10.1369/jhc.2009.953257; Gertz J, 2013, MOL CELL, V52, P25, DOI 10.1016/j.molcel.2013.08.037; Guo QY, 2019, J CELL MOL MED, V23, P1840, DOI 10.1111/jcmm.14084; Gupta S, 2010, CANCER RES, V70, P6735, DOI 10.1158/0008-5472.CAN-10-0244; Hu XX, 2012, ARCH GYNECOL OBSTET, V286, P1537, DOI 10.1007/s00404-012-2456-6; Huang WH, 2018, PROSTATE, V78, P1248, DOI 10.1002/pros.23700; Johnson N, 2017, INT J GYNECOL CANCER, V27, pS14, DOI 10.1097/IGC.0000000000001115; Li YF, 2019, NETPL'19: PROCEEDINGS OF THE 2019 ACM SIGCOMM WORKSHOP ON NETWORKING AND PROGRAMMING LANGUAGES, P2, DOI 10.1145/3341561.3349591; Liu Z, 2018, DATA BRIEF, V19, P1902, DOI 10.1016/j.dib.2018.06.048; Liu Z, 2018, BBA-MOL BASIS DIS, V1864, P2785, DOI 10.1016/j.bbadis.2018.05.006; Matulonis UA, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.61; Nikpayam Elahe, 2017, Iranian Biomedical Journal, V21, P3, DOI 10.6091/.21.1.3; Ning L, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000011481; Peng FD, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0666-z; Qin ZM, 2019, BIOCHEM BIOPH RES CO, V516, P486, DOI 10.1016/j.bbrc.2019.06.088; Ren CC, 2015, INT J GYNECOL CANCER, V25, P566, DOI 10.1097/IGC.0000000000000413; Renganathan A, 2017, ADV EXP MED BIOL, V1008, P199, DOI 10.1007/978-981-10-5203-3_7; Rodvold JJ, 2012, CANCER LETT, V316, P132, DOI 10.1016/j.canlet.2011.11.002; Rojo AI, 2012, FREE RADICAL BIO MED, V52, P473, DOI 10.1016/j.freeradbiomed.2011.11.003; Sharma D, 2009, GEN COMP ENDOCR, V162, P319, DOI 10.1016/j.ygcen.2009.04.009; Shi XF, 2013, CANCER LETT, V339, P159, DOI 10.1016/j.canlet.2013.06.013; Sirotkin AV, 2010, J CELL PHYSIOL, V225, P20, DOI 10.1002/jcp.22248; Sundar S, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4443; Tripathi MK, 2018, DRUG DISCOV TODAY, V23, P1635, DOI 10.1016/j.drudis.2018.04.010; Yamada Y, 2016, FREE RADICAL RES, V50, P414, DOI 10.3109/10715762.2015.1134795; Yang J, 2019, J GENE MED, V21, DOI 10.1002/jgm.3125; Yang J, 2013, FASEB J, V27, P45, DOI 10.1096/fj.12-211730; Yevshin I, 2017, NUCLEIC ACIDS RES, V45, pD61, DOI 10.1093/nar/gkw951; Yu J, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317709129; Zhan L, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0793-4	34	11	12	4	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					11382	11394		10.1096/fj.201902683R	http://dx.doi.org/10.1096/fj.201902683R		JUL 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32692467				2022-12-28	WOS:000554624800001
J	Yousuf, MS; Samtleben, S; Lamothe, SM; Friedman, TN; Catuneanu, A; Thorburn, K; Desai, M; Tenorio, G; Schenk, GJ; Ballanyi, K; Kurata, HT; Simmen, T; Kerr, BJ				Yousuf, Muhammad Saad; Samtleben, Samira; Lamothe, Shawn M.; Friedman, Timothy N.; Catuneanu, Ana; Thorburn, Kevin; Desai, Mansi; Tenorio, Gustavo; Schenk, Geert J.; Ballanyi, Klaus; Kurata, Harley T.; Simmen, Thomas; Kerr, Bradley J.			Endoplasmic reticulum stress in the dorsal root ganglia regulates large-conductance potassium channels and contributes to pain in a model of multiple sclerosis	FASEB JOURNAL			English	Article						BK channel; DRG; EAE; ER stress; MS; pain	BK CHANNELS; 4-PHENYLBUTYRIC ACID; RYANODINE RECEPTORS; INFLAMMATORY PAIN; ENCEPHALOMYELITIS; HYPERSENSITIVITY; OLIGODENDROCYTES; MICE; INACTIVATION; CELLS	Neuropathic pain is a common symptom of multiple sclerosis (MS) and current treatment options are ineffective. In this study, we investigated whether endoplasmic reticulum (ER) stress in dorsal root ganglia (DRG) contributes to pain hypersensitivity in the experimental autoimmune encephalomyelitis (EAE) mouse model of MS. Inflammatory cells and increased levels of ER stress markers are evident in post-mortem DRGs from MS patients. Similarly, we observed ER stress in the DRG of mice with EAE and relieving ER stress with a chemical chaperone, 4-phenylbutyric acid (4-PBA), reduced pain hypersensitivity. In vitro, 4-PBA and the selective PERK inhibitor, AMG44, normalize cytosolic Ca(2+)transients in putative DRG nociceptors. We went on to assess disease-mediated changes in the functional properties of Ca2+-sensitive BK-type K(+)channels in DRG neurons. We found that the conductance-voltage (GV) relationship of BK channels was shifted to a more positive voltage, together with a more depolarized resting membrane potential in EAE cells. Our results suggest that ER stress in sensory neurons of MS patients and mice with EAE is a source of pain and that ER stress modulators can effectively counteract this phenotype.	[Yousuf, Muhammad Saad; Friedman, Timothy N.; Desai, Mansi; Kurata, Harley T.; Kerr, Bradley J.] Univ Alberta, Neurosci & Mental Hlth Inst, Edmonton, AB, Canada; [Samtleben, Samira; Simmen, Thomas] Univ Alberta, Dept Cell Biol, Edmonton, AB, Canada; [Lamothe, Shawn M.; Catuneanu, Ana; Thorburn, Kevin; Kurata, Harley T.; Kerr, Bradley J.] Univ Alberta, Dept Pharmacol, Edmonton, AB, Canada; [Tenorio, Gustavo; Kerr, Bradley J.] Univ Alberta, Dept Anesthesiol & Pain Med, Clin Sci Bldg 2-150, Edmonton, AB T6G 2G3, Canada; [Schenk, Geert J.] Vrije Univ Amsterdam Med Ctr, VUmc MS Ctr Amsterdam, Dept Anat & Neurosci, Amsterdam UMC,Neurosci Amsterdam, Amsterdam, Netherlands; [Ballanyi, Klaus] Univ Alberta, Dept Physiol, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta; University of Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Alberta	Kerr, BJ (corresponding author), Univ Alberta, Dept Anesthesiol & Pain Med, Clin Sci Bldg 2-150, Edmonton, AB T6G 2G3, Canada.	bradley.kerr@ualberta.ca	Yousuf, Muhammad Saad/AAW-1533-2020	Lamothe, Shawn/0000-0001-8722-2631	CIHR; University of Alberta Hospital Foundation; MS Society of Canada (MSSC); NSERC; Canada Foundation for Innovation (CFI); Alberta Advanced Technology and Education; Campus Alberta Neuroscience postdoctoral fellowship; Alexander Graham Bell Canada Graduate Scholarship from NSERC	CIHR(Canadian Institutes of Health Research (CIHR)); University of Alberta Hospital Foundation(University of Alberta); MS Society of Canada (MSSC); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Alberta Advanced Technology and Education; Campus Alberta Neuroscience postdoctoral fellowship; Alexander Graham Bell Canada Graduate Scholarship from NSERC	We would like to thank Drs. Simonetta Sipione, Christine Webber, and Jason Plemel (University of Alberta) for graciously sharing select equipment and software. Funding for this project was provided by operating grants from CIHR, the University of Alberta Hospital Foundation, the MS Society of Canada (MSSC), NSERC, Canada Foundation for Innovation (CFI), and Alberta Advanced Technology and Education. MSY was supported by the Alexander Graham Bell Canada Graduate Scholarship from NSERC. SS was supported by a Campus Alberta Neuroscience postdoctoral fellowship. The authors would like to thank the donors, their families, and the Netherlands brain bank.	Andhavarapu S, 2019, EXP MOL PATHOL, V108, P183, DOI 10.1016/j.yexmp.2019.04.016; Ayala P, 2012, EXP MOL PATHOL, V92, P97, DOI 10.1016/j.yexmp.2011.10.012; Barragan-Iglesias P, 2019, PAIN, V160, P160, DOI 10.1097/j.pain.0000000000001387; Behrens R, 2000, FEBS LETT, V474, P99, DOI 10.1016/S0014-5793(00)01584-2; Benson Curtis, 2014, Curr Top Behav Neurosci, V20, P201, DOI 10.1007/7854_2014_309; Berta T, 2014, J CLIN INVEST, V124, P1173, DOI 10.1172/JCI72230; Bourinet E, 2014, PHYSIOL REV, V94, P81, DOI 10.1152/physrev.00023.2013; Cao XH, 2012, J NEUROCHEM, V121, P944, DOI 10.1111/j.1471-4159.2012.07736.x; Chen CH, 2019, INFLAMMOPHARMACOLOGY, V27, P713, DOI 10.1007/s10787-019-00604-6; Chen SR, 2009, J NEUROCHEM, V110, P352, DOI 10.1111/j.1471-4159.2009.06138.x; Chen YA, 2019, BRAIN, V142, P344, DOI 10.1093/brain/awy322; Chopra S, 2019, SCIENCE, V365, P248, DOI 10.1126/science.aau6499; Chung Jin Mo, 2002, Pain Pract, V2, P87, DOI 10.1046/j.1533-2500.2002.02011.x; Contet C, 2016, INT REV NEUROBIOL, V128, P281, DOI 10.1016/bs.irn.2016.04.001; Dasgupta S, 2003, J IMMUNOL, V170, P3874, DOI 10.4049/jimmunol.170.7.3874; Drulovic J, 2015, PAIN MED, V16, P1597, DOI 10.1111/pme.12731; Duffy SS, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00369; Frezel N, 2016, EXP NEUROL, V283, P224, DOI 10.1016/j.expneurol.2016.06.019; Gavini CK, 2018, CELL REP, V25, P271, DOI 10.1016/j.celrep.2018.09.046; Griguoli M, 2016, J PHYSIOL-LONDON, V594, P3489, DOI 10.1113/JP271841; Hadjimichael O, 2007, PAIN, V127, P35, DOI 10.1016/j.pain.2006.07.015; Hagenston A, 2014, CELL TISSUE RES, V357, P407, DOI 10.1007/s00441-014-1942-5; Hetz C, 2019, NAT CHEM BIOL, V15, P764, DOI 10.1038/s41589-019-0326-2; Hetz C, 2014, NAT REV NEUROSCI, V15, P233, DOI 10.1038/nrn3689; Hussien Y, 2014, GLIA, V62, P680, DOI 10.1002/glia.22634; Inceoglu B, 2015, P NATL ACAD SCI USA, V112, P9082, DOI 10.1073/pnas.1510137112; Irie T, 2017, NEURON, V96, P856, DOI 10.1016/j.neuron.2017.10.014; Kaur B, 2018, MOL OMICS, V14, P53, DOI 10.1039/c7mo00114b; Khan N, 2014, INFLAMMOPHARMACOLOGY, V22, P1, DOI 10.1007/s10787-013-0195-3; Khoutorsky A, 2018, TRENDS NEUROSCI, V41, P100, DOI 10.1016/j.tins.2017.11.006; Khoutorsky A, 2016, P NATL ACAD SCI USA, V113, P11949, DOI 10.1073/pnas.1614047113; Kolb PS, 2015, INT J BIOCHEM CELL B, V61, P45, DOI 10.1016/j.biocel.2015.01.015; Kong D, 2019, EXP CLIN ENDOCRINOL, V128, P59; Kshatri AS, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00258; Latremoliere A, 2009, J PAIN, V10, P895, DOI 10.1016/j.jpain.2009.06.012; Lin WS, 2007, J CLIN INVEST, V117, P448, DOI 10.1172/JCI29571; Lin WS, 2013, J NEUROSCI, V33, P5980, DOI 10.1523/JNEUROSCI.1636-12.2013; Lu JN, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-233; Lu RR, 2014, PAIN, V155, P556, DOI 10.1016/j.pain.2013.12.005; Mifflin KA, 2019, PAIN, V160, P870, DOI 10.1097/j.pain.0000000000001465; Olechowski CJ, 2013, EXP NEUROL, V241, P113, DOI 10.1016/j.expneurol.2012.12.012; Olechowski CJ, 2010, PAIN, V149, P565, DOI 10.1016/j.pain.2010.03.037; Pakos-Zebrucka K, 2016, EMBO REP, V17, P1374, DOI 10.15252/embr.201642195; Pan PT, 2019, CLIN EXP PHARMACOL P, V46, P770, DOI 10.1111/1440-1681.13105; Sano R, 2013, BBA-MOL CELL RES, V1833, P3460, DOI 10.1016/j.bbamcr.2013.06.028; Schenk GJ, 2013, GLIA, V61, P1890, DOI 10.1002/glia.22565; Smith AL, 2015, J MED CHEM, V58, P1426, DOI 10.1021/jm5017494; Solaro C, 2018, J NEUROL, V265, P828, DOI 10.1007/s00415-018-8758-2; Stone S, 2018, GLIA, V66, P1331, DOI 10.1002/glia.23307; Stone S, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00264; Sun XP, 2017, J PHYSIOL-LONDON, V595, P4449, DOI 10.1113/JP274132; Thorburn KC, 2016, PAIN, V157, P627, DOI 10.1097/j.pain.0000000000000409; Urits I, 2019, CURR PAIN HEADACHE R, V23, DOI 10.1007/s11916-019-0800-2; Usoskin D, 2015, NAT NEUROSCI, V18, P145, DOI 10.1038/nn.3881; Verkhratsky A, 2005, PHYSIOL REV, V85, P201, DOI 10.1152/physrev.00004.2004; Vidal RL, 2013, CELL RES, V23, P463, DOI 10.1038/cr.2013.9; Wang B, 2016, J NEUROPHYSIOL, V116, P456, DOI 10.1152/jn.00857.2015; Waxman SG, 2014, NAT NEUROSCI, V17, P153, DOI 10.1038/nn.3602; Way SW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7532; Whitmire LE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188064; Yamaguchi Y, 2018, NEUROSCIENCE, V394, P288, DOI 10.1016/j.neuroscience.2018.08.005; Yang Eun Sun, 2014, Exp Neurobiol, V23, P372, DOI 10.5607/en.2014.23.4.372; Yousuf MS, 2019, ENEURO, V6, DOI 10.1523/ENEURO.0024-19.2019; Yousuf MS, 2017, NEUROSCIENCE, V344, P178, DOI 10.1016/j.neuroscience.2016.12.046; Yue Y, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1415-6; Zhang EJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep11555; Zhang XL, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-37; Zhang XL, 2010, EUR J NEUROSCI, V31, P450, DOI 10.1111/j.1460-9568.2009.07060.x	68	9	9	3	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12577	12598		10.1096/fj.202001163R	http://dx.doi.org/10.1096/fj.202001163R		JUL 2020	22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32677089	hybrid			2022-12-28	WOS:000552110400001
J	Susjan, P; Lainscek, D; Strmsek, Z; Hodnik, V; Anderluh, G; Hafner-Bratkovic, I				Susjan, Petra; Lainscek, Dusko; Strmsek, Ziga; Hodnik, Vesna; Anderluh, Gregor; Hafner-Bratkovic, Iva			Selective inhibition of NLRP3 inflammasome by designed peptide originating from ASC	FASEB JOURNAL			English	Article						blood-brain barrier; inflammation; IL-1 beta; peptide inhibitors	PYRIN DOMAIN; NALP3 INFLAMMASOME; ATP-BINDING; GASDERMIN D; ACTIVATION; IDENTIFICATION; INTERLEUKIN-1; RECRUITMENT; REVEALS; TOXINS	NACHT, LRR, and PYD domains-containing protein 3 (NLRP3) inflammasome is a multiprotein complex which forms within cells in response to various microbial and self-derived triggers. Mutations in the gene encoding NLRP3 cause rare cryopyrin-associated periodic syndromes (CAPS) and growing evidence links NLRP3 inflammasome to common diseases such as Alzheimer ' s disease. In order to modulate different stages of NLRP3 inflammasome assembly nine peptides whose sequences correspond to segments of inflammasome components NLRP3 and apoptosis-associated speck-like protein containing a CARD (ASC) were selected. Five peptides inhibited IL-1 beta release, caspase-1 activation and ASC oligomerization in response to soluble and particulate NLRP3 triggers. Modulatory peptides also attenuated IL-1 beta maturation induced by constitutive CAPS-associated NLRP3 mutants. Peptide corresponding to H2-H3 segment of ASC pyrin domain selectively inhibited NLRP3 inflammasome by binding to NLRP3 pyrin domain in the micromolar range. The peptide had no effect on AIM2 and NLRC4 inflammasomes as well as NF-kappa B pathway. The peptide effectively dampened neutrophil infiltration in the silica-induced peritonitis and when equipped with Antennapedia or Angiopep-2 motifs crossed the blood-brain barrier in a mouse model. Our study demonstrates that peptides represent an important tool for targeting multiprotein inflammatory complexes and can serve as the basis for the development of novel anti-inflammatory strategies for neurodegeneration.	[Susjan, Petra; Lainscek, Dusko; Strmsek, Ziga; Hafner-Bratkovic, Iva] Natl Inst Chem, Dept Synthet Biol & Immunol, Hajdrihova 19, Ljubljana 1000, Slovenia; [Susjan, Petra; Strmsek, Ziga] Univ Ljubljana, Grad Sch Biomed, Ljubljana, Slovenia; [Hodnik, Vesna; Anderluh, Gregor] Natl Inst Chem, Dept Mol Biol & Nanobiotechnol, Ljubljana, Slovenia; [Hodnik, Vesna] Univ Ljubljana, Biotech Fac, Dept Biol, Ljubljana, Slovenia; [Hafner-Bratkovic, Iva] EN FIST Ctr Excellence, Ljubljana, Slovenia	National Institute of Chemistry - Slovenia; University of Ljubljana; National Institute of Chemistry - Slovenia; University of Ljubljana	Hafner-Bratkovic, I (corresponding author), Natl Inst Chem, Dept Synthet Biol & Immunol, Hajdrihova 19, Ljubljana 1000, Slovenia.	iva.hafner@ki.si		Susjan, Petra/0000-0002-0133-9896; Hafner Bratkovic, Iva/0000-0001-5635-931X	International Centre for Genetic Engineering and Biotechnology (ICGEB) [CRP-SVN18-01]; Slovenian Research Agency [J3-5503, J3-6791, J3-1746, Z3-9276];  [P4-176]	International Centre for Genetic Engineering and Biotechnology (ICGEB); Slovenian Research Agency(Slovenian Research Agency - Slovenia); 	International Centre for Genetic Engineering and Biotechnology (ICGEB), Grant/Award Number: ICGEB grant CRP-SVN18-01; Slovenian Research Agency, Grant/Award Number: J3-5503, J3-6791, J3-1746 and Z3-9276; Core funding, Grant/Award Number: P4-176	Ahn H, 2014, IMMUNOBIOLOGY, V219, P315, DOI 10.1016/j.imbio.2013.11.003; Atianand MK, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-56; Avbelj M, 2011, J IMMUNOL, V187, P2394, DOI 10.4049/jimmunol.1100515; Bae JY, 2011, J BIOL CHEM, V286, P39528, DOI 10.1074/jbc.M111.278812; Baroja-Mazo A, 2014, NAT IMMUNOL, V15, P738, DOI 10.1038/ni.2919; Bedoya F, 2007, J IMMUNOL, V178, P3837, DOI 10.4049/jimmunol.178.6.3837; Cai X, 2014, CELL, V156, P1207, DOI 10.1016/j.cell.2014.01.063; Chang YP, 2015, J CELL PHYSIOL, V230, P1567, DOI 10.1002/jcp.24903; Chu LH, 2015, APOPTOSIS, V20, P157, DOI 10.1007/s10495-014-1065-1; Cocco M, 2017, J MED CHEM, V60, P3656, DOI 10.1021/acs.jmedchem.6b01624; Coll RC, 2019, NAT CHEM BIOL, V15, P556, DOI 10.1038/s41589-019-0277-7; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; de Alba E, 2019, ARCH BIOCHEM BIOPHYS, V670, P15, DOI 10.1016/j.abb.2019.05.023; de Alba E, 2009, J BIOL CHEM, V284, P32932, DOI 10.1074/jbc.M109.024273; de Almeida L, 2015, IMMUNITY, V43, P264, DOI 10.1016/j.immuni.2015.07.018; De Nardo D, 2014, NAT IMMUNOL, V15, P152, DOI 10.1038/ni.2784; Demeule M, 2008, J PHARMACOL EXP THER, V324, P1064, DOI 10.1124/jpet.107.131318; Dick MS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11929; Dinarello CA, 2013, SEMIN IMMUNOL, V25, P469, DOI 10.1016/j.smim.2013.10.008; Doig AJ, 2015, CURR OPIN STRUC BIOL, V30, P50, DOI 10.1016/j.sbi.2014.12.004; Dostert C., 2008, SCIENCE, V674, P674; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Duncan JA, 2007, P NATL ACAD SCI USA, V104, P8041, DOI 10.1073/pnas.0611496104; Evavold CL, 2019, IMMUNITY, V51, P609, DOI 10.1016/j.immuni.2019.08.005; Evavold CL, 2018, IMMUNITY, V48, P35, DOI 10.1016/j.immuni.2017.11.013; Forstneric V, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006574; Fox E, 2010, J NEUROIMMUNOL, V223, P138, DOI 10.1016/j.jneuroim.2010.03.022; Gambin Y, 2018, J MOL BIOL, V430, P491, DOI 10.1016/j.jmb.2017.12.013; Hafner-Bratkovic I, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07573-4; Hafner-Bratkovic I, 2018, CURR OPIN IMMUNOL, V52, P8, DOI 10.1016/j.coi.2018.03.010; Hafner-Bratkovic I, 2017, SWISS MED WKLY, V147, DOI 10.4414/smw.2017.14424; Hafner-Bratkovic I, 2012, CELL MOL LIFE SCI, V69, P4215, DOI 10.1007/s00018-012-1140-0; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; He HB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04947-6; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hu ZH, 2015, SCIENCE, V350, P399, DOI 10.1126/science.aac5489; Huang Y, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708689; Jerala R, 2004, CURR TOP MED CHEM, V4, P1173, DOI 10.2174/1568026043388079; Jiang H, 2017, J EXP MED, V214, P3219, DOI 10.1084/jem.20171419; Juliana C, 2010, J BIOL CHEM, V285, P9792, DOI 10.1074/jbc.M109.082305; Kagan JC, 2014, NAT REV IMMUNOL, V14, P821, DOI 10.1038/nri3757; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Khare S, 2014, NAT IMMUNOL, V15, P343, DOI 10.1038/ni.2829; Kudelova J, 2015, J PHYSIOL PHARMACOL, V66, P473; Lee HM, 2013, DIABETES, V62, P194, DOI 10.2337/db12-0420; Li Y, 2018, P NATL ACAD SCI USA, V115, P10845, DOI 10.1073/pnas.1810524115; Lu A, 2016, NAT STRUCT MOL BIOL, V23, P416, DOI 10.1038/nsmb.3199; Lu A, 2014, CELL, V156, P1193, DOI 10.1016/j.cell.2014.02.008; Lysakova-Devine T, 2010, J IMMUNOL, V185, P4261, DOI 10.4049/jimmunol.1002013; MacDonald JA, 2013, IUBMB LIFE, V65, P851, DOI 10.1002/iub.1210; Man SM, 2014, P NATL ACAD SCI USA, V111, P7403, DOI 10.1073/pnas.1402911111; Mangan MSJ, 2018, NAT REV DRUG DISCOV, V17, P588, DOI [10.1038/nrd.2018.149, 10.1038/nrd.2018.97]; Marchetti C, 2018, P NATL ACAD SCI USA, V115, pE1530, DOI 10.1073/pnas.1716095115; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Nelson AR, 2007, BIOCHEMISTRY-US, V46, P14771, DOI 10.1021/bi701295k; Oroz J, 2016, J BIOL CHEM, V291, P19487, DOI 10.1074/jbc.M116.741082; Pal A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41211-3; Pardridge William M, 2005, NeuroRx, V2, P3; Periasamy S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15564; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Proell M, 2013, BIOCHEM J, V449, P613, DOI 10.1042/BJ20121198; Qu Y, 2016, J EXP MED, V213, P877, DOI 10.1084/jem.20132234; Ratsimandresy RA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15556; Sborgi L, 2015, P NATL ACAD SCI USA, V112, P13237, DOI 10.1073/pnas.1507579112; Schmidt FI, 2016, J EXP MED, V213, P771, DOI 10.1084/jem.20151790; Sharif H, 2019, NATURE, V570, P338, DOI 10.1038/s41586-019-1295-z; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Srimathi T, 2008, J BIOL CHEM, V283, P15390, DOI 10.1074/jbc.M801589200; Susjan P, 2017, BIOCHEM BIOPH RES CO, V483, P823, DOI 10.1016/j.bbrc.2017.01.008; Swanson KV, 2019, NAT REV IMMUNOL, V19, P477, DOI 10.1038/s41577-019-0165-0; Tan YH, 2019, CELL, V177, P384, DOI 10.1016/j.cell.2019.01.039; Tapia-Abelian A, 2019, NAT CHEM BIOL, V15, P560, DOI 10.1038/s41589-019-0278-6; Touitou I, 2004, HUM MUTAT, V24, P194, DOI 10.1002/humu.20080; Van Gijn ME, 2018, J MED GENET, V55, P530, DOI 10.1136/jmedgenet-2017-105216; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Vande Walle L, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000354; Venegas C, 2019, FASEB J; Venegas C, 2017, NATURE, V552, P355, DOI 10.1038/nature25158; Voet S, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201810248; Walensky LD, 2014, J MED CHEM, V57, P6275, DOI 10.1021/jm4011675; Youm YH, 2013, CELL METAB, V18, P519, DOI 10.1016/j.cmet.2013.09.010; Zhang LM, 2015, SCIENCE, V350, P404, DOI 10.1126/science.aac5789; Zorman J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159826	85	5	5	5	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					11068	11086		10.1096/fj.201902938RR	http://dx.doi.org/10.1096/fj.201902938RR		JUL 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32648626	Green Published, Bronze			2022-12-28	WOS:000547914500001
J	Jin, ZL; Yao, XR; Wen, L; Hao, G; Kwon, JW; Hao, J; Kim, NH				Jin, Zhe-Long; Yao, Xue-Rui; Wen, Liu; Hao, Guo; Kwon, Jeong-Woo; Hao, Jiang; Kim, Nam-Hyung			AIP1 and Cofilin control the actin dynamics to modulate the asymmetric division and cytokinesis in mouse oocytes	FASEB JOURNAL			English	Article						actin; ADF; Cofilin; AIP1; oocyte	LIM-KINASE 1; INTERACTING PROTEIN-1; DEPOLYMERIZING FACTOR/COFILIN; F-ACTIN; FILAMENT DYNAMICS; BINDING PROTEINS; PHOSPHORYLATION; ROLES; FAMILY; FRAGMENTATION	Actin-interacting protein 1 (AIP1), also known as WD repeat-containing protein 1 (WDR1), is ubiquitous in eukaryotic organisms, and it plays critical roles in the dynamic reorganization of the actin cytoskeleton. However, the biological function and mechanism of AIP1 in mammalian oocyte maturation is still largely unclear. In this study, we demonstrated that AIP1 boosts ADF/Cofilin activity in mouse oocytes. AIP1 is primarily distributed around the spindle region during oocyte maturation, and its depletion impairs meiotic spindle migration and asymmetric division. The knockdown of AIP1 resulted in the gathering of a large number of actin-positive patches around the spindle region. This effect was reduced by human AIP1 (hAIP1) or Cofilin (S3A) expression. AIP1 knockdown also reduced the phosphorylation of Cofilin near the spindle, indicating that AIP1 interacts with ADF/Cofilin-decorated actin filaments and enhances filament disassembly. Moreover, the deletion of AIP1 disrupts Cofilin localization in metaphase I (MI) and induces cytokinesis defects in metaphase II (MII). Taken together, our results provide evidence that AIP1 promotes actin dynamics and cytokinesis via Cofilin in the gametes of female mice.	[Jin, Zhe-Long; Yao, Xue-Rui; Wen, Liu; Hao, Guo; Kwon, Jeong-Woo; Kim, Nam-Hyung] Wuyi Univ, Sch Biotechnol & Healthcare, Jiangmen, Peoples R China; [Jin, Zhe-Long; Yao, Xue-Rui; Hao, Guo; Kim, Nam-Hyung] Chungbuk Natl Univ, Dept Anim Sci, Cheongju, South Korea; [Hao, Jiang] Jilin Univ, Dept Lab Anim, Coll Anim Sci, Changchun, Peoples R China	Wuyi University; Chungbuk National University; Jilin University	Kim, NH (corresponding author), Chungbuk Natl Univ, Dept Anim Sci, Cheongju 362763, Chungcheongbuk, South Korea.	nhkim@chungbuk.ac.kr		JIN, Zhe-Long/0000-0002-3408-0649	Bio Green 21 Program [PJ01322101]; Rural Development Administration of South Korea; National Research Foundation of Korea (NRF) - Korean government (MSIT) [2018RIA2B2005880]	Bio Green 21 Program(Rural Development Administration (RDA), Republic of Korea); Rural Development Administration of South Korea; National Research Foundation of Korea (NRF) - Korean government (MSIT)(National Research Foundation of Korea)	This work was carried out with the support of the Bio Green 21 Program (Project PJ01322101), Rural Development Administration of South Korea, and a National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT) (No. 2018RIA2B2005880)	Aggeli D, 2014, CYTOSKELETON, V71, P361, DOI 10.1002/cm.21178; Almonacid M, 2014, J CELL SCI, V127, P477, DOI 10.1242/jcs.142711; AMBERG DC, 1995, NAT STRUCT BIOL, V2, P28, DOI 10.1038/nsb0195-28; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Azoury J, 2008, CURR BIOL, V18, P1514, DOI 10.1016/j.cub.2008.08.044; Azoury J, 2011, DEVELOPMENT, V138, P2903, DOI 10.1242/dev.060269; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Chen H, 2000, TRENDS BIOCHEM SCI, V25, P19, DOI 10.1016/S0968-0004(99)01511-X; Chen Q, 2015, J BIOL CHEM, V290, P2289, DOI 10.1074/jbc.M114.612978; Elam WA, 2013, BIOCHEM BIOPH RES CO, V438, P728, DOI 10.1016/j.bbrc.2013.07.109; Fujibuchi T, 2005, BIOCHEM BIOPH RES CO, V327, P268, DOI 10.1016/j.bbrc.2004.11.156; Hari SB, 2014, CHEM BIOL, V21, P628, DOI 10.1016/j.chembiol.2014.02.016; Iida K, 1999, GENES CELLS, V4, P21, DOI 10.1046/j.1365-2443.1999.00235.x; Ikawa K, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05605-7; Jang WI, 2014, CELL CYCLE, V13, P2359, DOI 10.4161/cc.29333; Jansen S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8202; Jin ZL, 2018, J CELL SCI, V131, DOI 10.1242/jcs.222356; Jo YJ, 2019, FASEB J, V33, P4432, DOI 10.1096/fj.201801905R; Jo YJ, 2015, J CELL SCI, V128, P160, DOI 10.1242/jcs.163576; Kaji N, 2008, J BIOL CHEM, V283, P4983, DOI 10.1074/jbc.M708644200; Kato A, 2008, BIOCHEM J, V414, P261, DOI 10.1042/BJ20071655; Ketelaar T, 2004, CURR BIOL, V14, P145, DOI 10.1016/j.cub.2004.01.004; Kile BT, 2007, BLOOD, V110, P2371, DOI 10.1182/blood-2006-10-055087; Kueh HY, 2008, J CELL BIOL, V182, P341, DOI 10.1083/jcb.200801027; Kuhns DB, 2016, BLOOD, V128, P2135, DOI 10.1182/blood-2016-03-706028; Li JY, 2007, NAT CELL BIOL, V9, P276, DOI 10.1038/ncb1541; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Mizuno K, 2013, CELL SIGNAL, V25, P457, DOI 10.1016/j.cellsig.2012.11.001; Mogessie B, 2017, SCIENCE, V357, DOI 10.1126/science.aal1647; Mohri K, 2006, MOL BIOL CELL, V17, P2190, DOI 10.1091/mbc.E05-11-1016; Mohri K, 2004, J BIOL CHEM, V279, P31697, DOI 10.1074/jbc.M403351200; Moriyama K, 1996, GENES CELLS, V1, P73, DOI 10.1046/j.1365-2443.1996.05005.x; Nadkarni AV, 2014, CURR BIOL, V24, P2749, DOI 10.1016/j.cub.2014.09.048; Namgoong S, 2016, CELL CYCLE, V15, P1830, DOI 10.1080/15384101.2016.1181239; NISHIDA E, 1984, BIOCHEMISTRY-US, V23, P5307, DOI 10.1021/bi00317a032; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Ohashi K, 2000, J BIOL CHEM, V275, P3577, DOI 10.1074/jbc.275.5.3577; Okada K, 1999, J CELL SCI, V112, P1553; Okada K, 2002, J BIOL CHEM, V277, P43011, DOI 10.1074/jbc.M203111200; Okada K, 2006, MOL BIOL CELL, V17, P2855, DOI 10.1091/mbc.e06-02-0135; Ono S, 2003, BIOCHEMISTRY-US, V42, P13363, DOI 10.1021/bi034600x; Ono S, 2001, J BIOL CHEM, V276, P5952, DOI 10.1074/jbc.M007563200; Ono S, 2007, INT REV CYTOL, V258, P1, DOI 10.1016/S0074-7696(07)58001-0; Ono S, 2018, BIOCHEM BIOPH RES CO, V506, P315, DOI 10.1016/j.bbrc.2017.10.096; Ono S, 2011, MOL BIOL CELL, V22, P2258, DOI 10.1091/mbc.E10-12-0934; Pavlov D, 2007, J MOL BIOL, V365, P1350, DOI 10.1016/j.jmb.2006.10.102; Pope BJ, 2000, J MOL BIOL, V298, P649, DOI 10.1006/jmbi.2000.3688; Ren N, 2007, GENETICS, V176, P2223, DOI 10.1534/genetics.107.072959; Rodal AA, 1999, J CELL BIOL, V145, P1251, DOI 10.1083/jcb.145.6.1251; Roeles J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12674-9; Shoji K, 2012, BIOCHEM BIOPH RES CO, V424, P52, DOI 10.1016/j.bbrc.2012.06.063; Standing ASI, 2017, J EXP MED, V214, P59, DOI 10.1084/jem.20161228; Suarez C, 2011, CURR BIOL, V21, P862, DOI 10.1016/j.cub.2011.03.064; Sun QY, 2006, REPRODUCTION, V131, P193, DOI 10.1530/rep.1.00847; Van Troys M, 2008, EUR J CELL BIOL, V87, P649, DOI 10.1016/j.ejcb.2008.04.001; Voegtli WC, 2003, J BIOL CHEM, V278, P34373, DOI 10.1074/jbc.M302773200; Xiao Y, 2017, J BIOL CHEM, V292, P1438, DOI 10.1074/jbc.M116.759886; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; YONEZAWA N, 1990, J BIOL CHEM, V265, P8382	59	3	3	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					11292	11306		10.1096/fj.202000093R	http://dx.doi.org/10.1096/fj.202000093R		JUN 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32602619				2022-12-28	WOS:000546041500001
J	Liu, HC; Su, DQ; Liu, L; Chen, L; Zhao, Y; Chan, SO; Zhang, WG; Wang, Y; Wang, J				Liu, Huaicun; Su, Dongqiang; Liu, Lei; Chen, Ling; Zhao, Yan; Chan, Sun-On; Zhang, Weiguang; Wang, Yun; Wang, Jun			Identification of a new functional domain of Nogo-A that promotes inflammatory pain and inhibits neurite growth through binding to NgR1	FASEB JOURNAL			English	Article						axon growth; inflammatory pain; NgR1; Nogo-A	MYELIN-ASSOCIATED INHIBITORS; MHC CLASS-I; OUTGROWTH INHIBITOR; AXON REGENERATION; ADULT-RAT; RECEPTOR; SCLEROSIS; PROTEIN; CIS	Nogo-A is a key inhibitory molecule to axon regeneration, and plays diverse roles in other pathological conditions, such as stroke, schizophrenia, and neurodegenerative diseases. Nogo-66 and Nogo-Delta 20 fragments are two known functional domains of Nogo-A, which act through the Nogo-66 receptor (NgR1) and sphingosine-1-phosphate receptor 2 (S1PR2), respectively. Here, we reported a new functional domain of Nogo-A, Nogo-A aa 846-861, was identified in the Nogo-A-specific segment that promotes complete Freund's adjuvant (CFA)-induced inflammatory pain. Intrathecal injection of its antagonist peptide 846-861PE or the specific antibody attenuated the CFA-induced inflammatory heat hyperalgesia. The 846-861 PE reduced the content of transient receptor potential vanilloid subfamily member 1 (TRPV1) in dorsal root ganglia (DRG) and decreased the response of DRG neurons to capsaicin. These effects were accompanied by a reduction in LIMK/cofilin phosphorylation and actin polymerization. GST pull-down and fluorescence resonance energy transfer (FRET) assays both showed that Nogo-A aa 846-861 bound to NgR1. Moreover, we demonstrated that Nogo-A aa 846-861 inhibited neurite outgrowth from cortical neurons and DRG explants. We concluded that Nogo-A aa 846-861 is a novel ligand of NgR1, which activates the downstream signaling pathways that inhibit axon growth and promote inflammatory pain.	[Liu, Huaicun; Su, Dongqiang; Chen, Ling; Zhao, Yan; Zhang, Weiguang; Wang, Jun] Peking Univ, Sch Basic Med Sci, Dept Human Anat Histol & Embryol, Beijing, Peoples R China; [Liu, Lei; Wang, Yun] Peking Univ, Sch Basic Med Sci, Dept Neurobiol, Beijing, Peoples R China; [Liu, Lei; Wang, Yun] Peking Univ, Minist Educ China, Neurosci Res Inst, Key Lab Neurosci, Beijing, Peoples R China; [Liu, Lei; Wang, Yun] Peking Univ, Natl Hlth Commiss, Beijing, Peoples R China; [Liu, Lei; Wang, Yun] Peking Univ, State Key Lab Nat & Biomimet Drugs, Beijing, Peoples R China; [Liu, Lei; Wang, Yun] Peking Univ, PKU IDG McGovern Inst Brain Res, Beijing, Peoples R China; [Chan, Sun-On] Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Hong Kong, Peoples R China	Peking University; Peking University; Ministry of Education, China; Peking University; Peking University; Peking University; Peking University; Chinese University of Hong Kong	Zhang, WG; Wang, J (corresponding author), Peking Univ, Sch Basic Med Sci, Dept Human Anat & Histol & Embryol, Beijing 100191, Peoples R China.; Wang, Y (corresponding author), Peking Univ, Sch Basic Med Sci, Dept Neurobiol, Neurosci Res Inst, Beijing 100191, Peoples R China.	zhangwg@bjmu.edu.cn; wangy66@bjmu.edu.cn; wangjun74008@bjmu.edu.cn			Natural Science Foundation of Beijing Municipality (Beijing Natural Science Foundation) [7192089]; National Natural Science Foundation of China [81971053, 31530028, 31720103908, 81821092]; Ministry of Science and Technology of China [2017YFA0701300]; Hong Kong Research Grant Council [CUHK14113815]	Natural Science Foundation of Beijing Municipality (Beijing Natural Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Hong Kong Research Grant Council(Hong Kong Research Grants Council)	Natural Science Foundation of Beijing Municipality (Beijing Natural Science Foundation), Grant/Award Number: 7192089; National Natural Science Foundation of China, Grant/Award Number: 81971053, 31530028, 31720103908 and 81821092; The Ministry of Science and Technology of China, Grant/Award Number: 2017YFA0701300; Hong Kong Research Grant Council, Grant/Award Number: CUHK14113815	Mdzomba JB, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2302-x; Bessoles S, 2013, J IMMUNOL, V191, P5044, DOI 10.4049/jimmunol.1301971; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Dodd DA, 2005, J BIOL CHEM, V280, P12494, DOI 10.1074/jbc.M411827200; Filbin MT, 2003, NAT REV NEUROSCI, V4, P703, DOI 10.1038/nrn1195; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Geoffroy CG, 2014, CURR OPIN NEUROBIOL, V27, P31, DOI 10.1016/j.conb.2014.02.012; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; GrandPre T, 2002, NATURE, V417, P547, DOI 10.1038/417547a; Hu F, 2019, FASEB J, V33, P668, DOI 10.1096/fj.201800382RR; Hu FH, 2005, J NEUROSCI, V25, P5298, DOI 10.1523/JNEUROSCI.5235-04.2005; Huber AB, 2002, J NEUROSCI, V22, P3553; Huebner EA, 2011, J BIOL CHEM, V286, P18026, DOI 10.1074/jbc.M110.208108; Ineichen B, 2017, CNS DRUGS, V31, P187, DOI 10.1007/s40263-017-0407-2; Jokic N, 2006, EMBO REP, V7, P1162, DOI 10.1038/sj.embor.7400826; Joset A, 2010, J CELL BIOL, V188, P271, DOI 10.1083/jcb.200906089; Kempf A, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001763; Kim JE, 2004, NEURON, V44, P439, DOI 10.1016/j.neuron.2004.10.015; Lauren J, 2007, J BIOL CHEM, V282, P5715, DOI 10.1074/jbc.M609797200; Lee JY, 2013, NEUROSCIENTIST, V19, P394, DOI 10.1177/1073858413477207; Li MF, 2007, PROTEINS, V68, P100, DOI 10.1002/prot.21385; Li Y, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005353; Lindau NT, 2014, BRAIN, V137, P739, DOI 10.1093/brain/awt336; Masuda A, 2007, J EXP MED, V204, P907, DOI 10.1084/jem.20060631; Montani L, 2009, J BIOL CHEM, V284, P10793, DOI 10.1074/jbc.M808297200; Nash M, 2009, MOL NEUROBIOL, V40, P224, DOI 10.1007/s12035-009-8083-y; Niederost B, 2002, J NEUROSCI, V22, P10368; Oertle T, 2003, J NEUROSCI, V23, P5393; Oertle T, 2003, J MOL BIOL, V325, P299, DOI 10.1016/S0022-2836(02)01179-8; Pabbidi Mallikarjuna R, 2017, J Diabetes Treat, V2017; Pernet V, 2017, BBA-MOL BASIS DIS, V1863, P1300, DOI 10.1016/j.bbadis.2017.04.008; Prinjha R, 2000, NATURE, V403, P383, DOI 10.1038/35000287; Rust R, 2019, P NATL ACAD SCI USA, V116, P14270, DOI 10.1073/pnas.1905309116; Schwab ME, 2010, NAT REV NEUROSCI, V11, P799, DOI 10.1038/nrn2936; Sekine Y, 2020, J BIOL CHEM, V295, P2175, DOI 10.1074/jbc.RA119.009896; Storkson RV, 1996, J NEUROSCI METH, V65, P167, DOI 10.1016/0165-0270(95)00164-6; Willi R, 2013, NEUROBIOL DIS, V54, P150, DOI 10.1016/j.nbd.2013.01.011; Willi R, 2010, J NEUROSCI, V30, P556, DOI 10.1523/JNEUROSCI.4393-09.2010; Wills AM, 2017, LANCET NEUROL, V16, P175, DOI 10.1016/S1474-4422(17)30009-1; Xing BM, 2012, J NEUROSCI, V32, P14709, DOI 10.1523/JNEUROSCI.1634-12.2012; Xu YQ, 2015, CNS NEUROSCI THER, V21, P479, DOI 10.1111/cns.12387; Yang YR, 2007, PAIN, V127, P109, DOI 10.1016/j.pain.2006.08.008; Yoon G, 2018, MOL NEUROBIOL, V55, P6673, DOI 10.1007/s12035-017-0847-1; Zagrebelsky M, 2014, NEUROSCIENCE, V283, P17, DOI 10.1016/j.neuroscience.2014.08.030	46	3	3	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10948	10965		10.1096/fj.202000377R	http://dx.doi.org/10.1096/fj.202000377R		JUN 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32598099				2022-12-28	WOS:000543868600001
J	Wang, JJ; Sun, J; Hu, J; Wang, CM; Prinz, RA; Peng, DX; Liu, XF; Xu, XL				Wang, Jiongjiong; Sun, Jing; Hu, Jiao; Wang, Chengming; Prinz, Richard A.; Peng, Daxin; Liu, Xiufan; Xu, Xiulong			A77 1726, the active metabolite of the anti-rheumatoid arthritis drug leflunomide, inhibits influenza A virus replication in vitro and in vivo by inhibiting the activity of Janus kinases	FASEB JOURNAL			English	Article						A77 1726; dihydroorotate dehydrogenase; influenza A virus; leflunomide; p70 S6 kinase; protein tyrosine kinases	IMMUNOSUPPRESSIVE AGENT; DENGUE VIRUS; TYROSINE PHOSPHORYLATION; NUCLEOTIDE SYNTHESIS; AUTOIMMUNE-DISEASE; T-CELLS; OSELTAMIVIR; CYTOMEGALOVIRUS; MECHANISMS; PROTEIN	The newly reassorted IAV subtypes from zoonotic reservoirs respond poorly to current vaccines and antiviral therapy. There is an unmet need in developing novel antiviral drugs for better control of IAV infection. The cellular factors that are crucial for virus replication have been sought as novel molecular targets for antiviral therapy. Recent studies have shown that Janus kinases (JAK), JAK1, and JAK2, play an important role in IAV replication. Leflunomide is an anti-inflammatory drug primarily used for treating rheumatoid arthritis (RA). Prior studies suggest that A77 1726, the active metabolite of leflunomide, inhibits the activity of JAK1 and JAK3. Our current study aims to determine if A77 1726 can function as a JAK inhibitor to control IAV infection. Here, we report that A77 1726 inhibited the replication of three IAV subtypes(H5N1, H1N1, H9N2?in three cell types (chicken embryonic fibroblasts, A549, and MDCK). A77 1726 inhibited JAK1, JAK2, and STAT3 tyrosine phosphorylation. Similar observations were made with Ruxolitinib (Rux), a JAK-specific inhibitor. JAK2 overexpression enhanced H5N1 virus replication and compromised the antiviral activity of A77 1726. Leflunomide inhibited virus replication in the lungs of IAV-infected mice, alleviated their body weight loss, and prolonged their survival. Our study demonstrates for the first time the ability of A77 1726 to inhibit JAK2 activity and suggests that inhibition of JAK activity contributes to its antiviral activity.	[Wang, Jiongjiong; Sun, Jing; Xu, Xiulong] Yangzhou Univ, Coll Vet Med, Yangzhou 225009, Jiangsu, Peoples R China; [Sun, Jing; Peng, Daxin; Xu, Xiulong] Yangzhou Univ, Inst Agr Sci & Technol Dev, Yangzhou, Jiangsu, Peoples R China; [Sun, Jing; Peng, Daxin; Liu, Xiufan; Xu, Xiulong] Yangzhou Univ, Joint Int Res Lab Agr & Agri Prod Safety, Minist Educ China, Yangzhou, Jiangsu, Peoples R China; [Sun, Jing; Peng, Daxin; Liu, Xiufan; Xu, Xiulong] Yangzhou Univ, Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Jiangsu, Peoples R China; [Hu, Jiao; Peng, Daxin; Liu, Xiufan] Yangzhou Univ, Coll Vet Med, Anim Infect Dis Lab, Yangzhou, Jiangsu, Peoples R China; [Wang, Chengming] Auburn Univ, Coll Vet Med, Dept Pathobiol, Auburn, AL 36849 USA; [Prinz, Richard A.] NorthShore Univ Hlth Syst, Dept Surg, Evanston, IL USA	Yangzhou University; Yangzhou University; Ministry of Education, China; Yangzhou University; Yangzhou University; Yangzhou University; Auburn University System; Auburn University; NorthShore University Health System	Xu, XL (corresponding author), Yangzhou Univ, Coll Vet Med, Yangzhou 225009, Jiangsu, Peoples R China.	xxl@yzu.edu.cn	Peng, Daxin/AAJ-3476-2021		Priority Academic Program Development of Jiangsu Higher Education Institutions	Priority Academic Program Development of Jiangsu Higher Education Institutions	The Priority Academic Program Development of Jiangsu Higher Education Institutions	Aeffner F, 2012, AM J RESP CELL MOL, V47, P543, DOI 10.1165/rcmb.2012-0112OC; Bantia S, 2001, ANTIMICROB AGENTS CH, V45, P1162, DOI 10.1128/AAC.45.4.1162-1167.2001; Baranovich T, 2014, J INFECT DIS, V209, P1343, DOI 10.1093/infdis/jit554; Bernhoff E, 2010, J VIROL, V84, P2150, DOI 10.1128/JVI.01737-09; Bilger A, 2017, ONCOTARGET, V8, P44266, DOI 10.18632/oncotarget.17863; Bonavia A, 2011, P NATL ACAD SCI USA, V108, P6739, DOI 10.1073/pnas.1017142108; Carubbi F, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000016399; Chacko B, 2012, TRANSPL INFECT DIS, V14, P111, DOI 10.1111/j.1399-3062.2011.00682.x; Chen SR, 2019, ANTIVIR RES, V167, P35, DOI 10.1016/j.antiviral.2019.04.005; Denisova OV, 2014, ANTIMICROB AGENTS CH, V58, P3689, DOI 10.1128/AAC.02798-13; Dirven L, 2012, SCAND J RHEUMATOL, V41, P359, DOI 10.3109/03009742.2012.670729; Doscas ME, 2014, NEOPLASIA, V16, P824, DOI 10.1016/j.neo.2014.08.006; Dunn MCC, 2011, ANTIVIR THER, V16, P309, DOI 10.3851/IMP1763; Eierhoff T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001099; Elder RT, 1997, J IMMUNOL, V159, P22; Govorkova EA, 2009, ANTIMICROB AGENTS CH, V53, P3088, DOI 10.1128/AAC.01667-08; Han J, 2018, CELL REP, V23, P596, DOI 10.1016/j.celrep.2018.03.045; He L, 2013, ARCH VIROL, V158, P2531, DOI 10.1007/s00705-013-1771-y; Hoffmann HH, 2011, P NATL ACAD SCI USA, V108, P5777, DOI 10.1073/pnas.1101143108; Horman WSJ, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2018.01812; Ison MG, 2006, J INFECT DIS, V193, P765, DOI 10.1086/500464; Keller N, 2019, TRANSPL INFECT DIS, V21, DOI 10.1111/tid.13058; Knight DA, 2001, TRANSPLANTATION, V71, P170, DOI 10.1097/00007890-200101150-00031; Konig R, 2010, NATURE, V463, P813, DOI 10.1038/nature08699; Liacini A, 2010, TRANSPLANTATION, V90, P1450, DOI 10.1097/TP.0b013e3182007be2; Long JS, 2019, NAT REV MICROBIOL, V17, P67, DOI 10.1038/s41579-018-0115-z; Loregian A, 2014, CELL MOL LIFE SCI, V71, P3659, DOI 10.1007/s00018-014-1615-2; Luan L, 2016, SCI REP-UK, V6, DOI 10.1038/srep30015; Lucas-Hourani M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003678; Mostafa A, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10090497; Murray James L., 2012, Antiviral Chemistry & Chemotherapy, V22, P205, DOI 10.3851/IMP2080; Ortiz-Riano E, 2014, J VIROL, V88, P878, DOI 10.1128/JVI.02275-13; Paules C, 2017, LANCET, V390, P697, DOI 10.1016/S0140-6736(17)30129-0; Qing M, 2010, ANTIMICROB AGENTS CH, V54, P3686, DOI 10.1128/AAC.00561-10; Ruckemann K, 1998, J BIOL CHEM, V273, P21682, DOI 10.1074/jbc.273.34.21682; Sheng TY, 2019, VIROLOGY, V537, P263, DOI 10.1016/j.virol.2019.09.004; Siemasko K, 1998, J IMMUNOL, V160, P1581; Siemasko KF, 1996, TRANSPLANTATION, V61, P635, DOI 10.1097/00007890-199602270-00020; Sutton TC, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10090461; Silva JT, 2018, CLIN TRANSPLANT, V32, DOI 10.1111/ctr.13176; Waldman WJ, 1999, TRANSPLANTATION, V68, P814, DOI 10.1097/00007890-199909270-00014; Waldman WJ, 1999, INTERVIROLOGY, V42, P412, DOI 10.1159/000053979; Wang QY, 2011, J VIROL, V85, P6548, DOI 10.1128/JVI.02510-10; Wang SS, 2013, J VIROL, V87, P6182, DOI 10.1128/JVI.03024-12; Wang YJ, 2016, ANTIMICROB AGENTS CH, V60, P2834, DOI 10.1128/AAC.02700-15; Watanabe T, 2014, CELL HOST MICROBE, V16, P795, DOI 10.1016/j.chom.2014.11.002; Xu XL, 1999, BIOCHEM PHARMACOL, V58, P1405, DOI 10.1016/S0006-2952(99)00228-2; Xu XL, 1997, J IMMUNOL, V159, P167; Xu XL, 1997, J PHARMACOL EXP THER, V283, P869; XU XL, 1995, J BIOL CHEM, V270, P12398, DOI 10.1074/jbc.270.21.12398; Xu XL, 1996, BIOCHEM PHARMACOL, V52, P527, DOI 10.1016/0006-2952(96)00303-6; Yeo KL, 2015, ANTIMICROB AGENTS CH, V59, P2086, DOI 10.1128/AAC.04779-14; Zhang JT, 2019, VIROLOGY, V526, P1, DOI 10.1016/j.virol.2018.09.020; Zhang PH, 2008, J GEN VIROL, V89, P3102, DOI 10.1099/vir.0.2008/005652-0; Zheng ZY, 2015, CELL REP, V12, P511, DOI 10.1016/j.celrep.2015.06.044	55	9	9	2	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10132	10145		10.1096/fj.201902793RR	http://dx.doi.org/10.1096/fj.201902793RR		JUN 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32598086				2022-12-28	WOS:000546063700001
J	Ruiz, CF; Montal, ED; Haley, JA; Bott, AJ; Haley, JD				Ruiz, Christian F.; Montal, Emily D.; Haley, John A.; Bott, Alex J.; Haley, John D.			SREBP1 regulates mitochondrial metabolism in oncogenic KRAS expressing NSCLC	FASEB JOURNAL			English	Article						cancer metabolism; de novo lipogenesis; electron transport chain; oxidative phosphorylation	CELL LUNG-CANCER; LIPID-METABOLISM; PANCREATIC-CANCER; TUMOR-GROWTH; COPY NUMBER; RAS-ERK; STEROL; MUTANT; CHOLESTEROL; CONTRIBUTES	Cancer cells require extensive metabolic reprograming in order to provide the bioenergetics and macromolecular precursors needed to sustain a malignant phenotype. MutantKRASis a driver oncogene that is well-known for its ability to regulate the ERK and PI3K signaling pathways. However, it is now appreciated that KRAS can promote the tumor growth via upregulation of anabolic metabolism. We recently reported that oncogenic KRAS promotes a gene expression program of de novolipogenesisin non-small cell lung cancer (NSCLC). To define the mechanism(s) responsible, we focused on the lipogenic transcription factor SREBP1. We observed that KRAS increases SREBP1 expression and genetic knockdown of SREBP1 significantly inhibited the cell proliferation of mutantKRAS-expressing cells. Unexpectedly, lipogenesis was not significantly altered in cells subject to SREBP1 knockdown. Carbon tracing metabolic studies showed a significant decrease in oxidative phosphorylation and RNA-seq data revealed a significant decrease in mitochondrial encoded subunits of the electron transport chain (ETC). Taken together, these data support a novel role, distinct from lipogenesis, of SREBP1 on mitochondrial function in mutantKRASNSCLC.	[Ruiz, Christian F.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Montal, Emily D.] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA; [Haley, John A.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA USA; [Bott, Alex J.] Univ Utah, Dept Biochem, Salt Lake City, UT USA; [Haley, John D.] SUNY Stony Brook, Sch Med, Dept Pathol, Stony Brook, NY 11794 USA	Yale University; Memorial Sloan Kettering Cancer Center; University of Massachusetts System; University of Massachusetts Worcester; Utah System of Higher Education; University of Utah; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Ruiz, CF (corresponding author), Yale Univ, Sch Med, Yale Canc Biol Inst, Dept Genet, West Campus Adv Biosci Ctr 840 West Campus Dr, West Haven, CT 06516 USA.	Christian.f.ruiz@yale.edu	Bott, Alex/AAM-5538-2021	Bott, Alex/0000-0003-2273-8922	HHS \ NIH \ National Cancer Institute (NCI) [1F31CA210626-01, K00CA212445]	HHS \ NIH \ National Cancer Institute (NCI)	HHS vertical bar NIH vertical bar National Cancer Institute (NCI), Grant/Award Number: F31 Grant 1F31CA210626-01 and K00CA212445	Afgan E, 2018, NUCLEIC ACIDS RES, V46, pW537, DOI 10.1093/nar/gky379; Assmann N, 2017, NAT IMMUNOL, V18, P1197, DOI 10.1038/ni.3838; Bao JS, 2016, ONCOL LETT, V12, P2409, DOI 10.3892/ol.2016.4988; Barshad G, 2018, TRENDS GENET, V34, P682, DOI 10.1016/j.tig.2018.05.009; Bridges JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091376; BRUNET A, 1994, ONCOGENE, V9, P3379; Bryant KL, 2014, TRENDS BIOCHEM SCI, V39, P91, DOI 10.1016/j.tibs.2013.12.004; Canon J, 2019, NATURE, V575, P217, DOI 10.1038/s41586-019-1694-1; Carter CA, 2016, ANN ONCOL, V27, P693, DOI 10.1093/annonc/mdw008; Daemen S, 2013, GENES NUTR, V8, P289, DOI 10.1007/s12263-013-0342-x; DeBerardinis RJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600200; Deng Y, 2015, MOL CELL ONCOL, V2, DOI 10.4161/23723556.2014.974465; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Gouw AM, 2017, P NATL ACAD SCI USA, V114, P4300, DOI 10.1073/pnas.1617709114; Griffiths B, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-3; Guo DL, 2014, CURR PHARM DESIGN, V20, P2619, DOI 10.2174/13816128113199990486; Guo DL, 2011, CANCER DISCOV, V1, P442, DOI 10.1158/2159-8290.CD-11-0102; Gustafsson CM, 2016, ANNU REV BIOCHEM, V85, P133, DOI 10.1146/annurev-biochem-060815-014402; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Humpton TJ, 2019, CANCER DISCOV, V9, P1268, DOI 10.1158/2159-8290.CD-18-1409; Ide T, 2004, NAT CELL BIOL, V6, P351, DOI 10.1038/ncb1111; Im SS, 2011, CELL METAB, V13, P540, DOI 10.1016/j.cmet.2011.04.001; Janne PA, 2013, LANCET ONCOL, V14, P38, DOI 10.1016/S1470-2045(12)70489-8; Karachaliou N, 2013, CLIN LUNG CANCER, V14, P205, DOI 10.1016/j.cllc.2012.09.007; Kerr EM, 2018, FEBS J, V285, P28, DOI 10.1111/febs.14125; Kerr EM, 2016, NATURE, V531, P110, DOI 10.1038/nature16967; Knebel B, 2014, ARCH PHYSIOL BIOCHEM, V120, P216, DOI 10.3109/13813455.2014.973418; Kolde R., PHEATMAP PRETTY HEAT; Liberti MV, 2016, TRENDS BIOCHEM SCI, V41, P211, DOI 10.1016/j.tibs.2015.12.001; Madison BB, 2016, J LIPID RES, V57, P333, DOI 10.1194/jlr.C066712; Martinez-Reyes I, 2016, MOL CELL, V61, P199, DOI 10.1016/j.molcel.2015.12.002; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Min HY, 2018, BIOMOL THER, V26, P45, DOI 10.4062/biomolther.2017.211; Montal ED, 2015, MOL CELL, V60, P571, DOI 10.1016/j.molcel.2015.09.025; Mullard A, 2019, NAT REV DRUG DISCOV, V18, P887, DOI 10.1038/d41573-019-00195-5; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Pai JT, 1998, J BIOL CHEM, V273, P26138, DOI 10.1074/jbc.273.40.26138; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Park HJ, 2008, J CLIN INVEST, V118, P259, DOI 10.1172/JCI32011; Patra KC, 2013, CANCER CELL, V24, P213, DOI 10.1016/j.ccr.2013.06.014; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; R Core Team, 2019, R LANG ENV STAT COMP; Reed BD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000133; Rome S, 2008, PHYSIOL GENOMICS, V34, P327, DOI 10.1152/physiolgenomics.90211.2008; Rooney JP, 2015, METHODS MOL BIOL, V1241, P23, DOI 10.1007/978-1-4939-1875-1_3; Samatar AA, 2014, NAT REV DRUG DISCOV, V13, P928, DOI 10.1038/nrd4281; Shimano H, 2001, PROG LIPID RES, V40, P439, DOI 10.1016/S0163-7827(01)00010-8; Singh A, 2018, FASEB J, V32, P7018, DOI 10.1096/fj.201800204; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Spinelli JB, 2018, NAT CELL BIOL, V20, P745, DOI 10.1038/s41556-018-0124-1; Suda K, 2010, CANCER METAST REV, V29, P49, DOI 10.1007/s10555-010-9209-4; Sun Y, 2015, TUMOR BIOL, V36, P4133, DOI 10.1007/s13277-015-3047-5; Sunaga N, 2011, MOL CANCER THER, V10, P336, DOI 10.1158/1535-7163.MCT-10-0750; Tan ZQ, 2016, MOL CANCER THER, V15, P774, DOI 10.1158/1535-7163.MCT-15-0621; Tong XM, 2009, P NATL ACAD SCI USA, V106, P21660, DOI 10.1073/pnas.0911316106; Wen YA, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0330-6; White E, 2013, GENE DEV, V27, P2065, DOI 10.1101/gad.228122.113; Williams KJ, 2013, CANCER RES, V73, P2850, DOI 10.1158/0008-5472.CAN-13-0382-T; Young L, 2010, NAT PROTOC, V5, P929, DOI 10.1038/nprot.2010.43; Zhang J, 2017, ONCOTARGET, V8, P59008, DOI 10.18632/oncotarget.19779; Zhang J, 2016, ACTA BIOCH BIOPH SIN, V48, P11, DOI 10.1093/abbs/gmv118	65	7	7	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10574	10589		10.1096/fj.202000052R	http://dx.doi.org/10.1096/fj.202000052R		JUN 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32568455	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000543545400001
J	Zheng, QY; Xu, F; Yang, Y; Sun, DD; Zhong, Y; Wu, S; Li, GQ; Gao, WW; Wang, T; Xu, GL; Liang, SJ				Zheng, Quan-you; Xu, Feng; Yang, Yi; Sun, Dao-dong; Zhong, Yu; Wu, Shun; Li, Gui-qing; Gao, Wei-wu; Wang, Tao; Xu, Gui-lian; Liang, Shen-ju			C5a/C5aR1 mediates IMQ-induced psoriasiform skin inflammation by promoting IL-17A production from gamma delta-T cells	FASEB JOURNAL			English	Article						complement system; C5a; C5aR1; imiquimod; PI3K-Akt signaling; gamma delta-T cells	INTERLEUKIN-12/23 MONOCLONAL-ANTIBODY; COMPLEMENT ACTIVATION; MURINE MODEL; DOUBLE-BLIND; C5A; MECHANISMS; RECEPTOR; C3A; PATHOGENESIS; USTEKINUMAB	Psoriasis is a chronic relapsing inflammatory skin disease, affecting up to 3% of the global population. Accumulating evidence suggests that the complement system is involved in its pathogenesis. Our previous study revealed that the C5a/C5aR1 pathway is crucial for disease development. However, the underlying mechanisms remain largely unknown. To explore potential mechanisms, psoriatic skin lesions and histological changes were assessed following imiquimod (IMQ) cream treatment. Inflammatory cytokine expression was tested by real-time RT-PCR. Immunohistochemistry and flow cytometry were used to identify inflammatory cell infiltration and interleukin (IL-17A) IL-17A expression. A C5aR1 antagonist (C5aR1a) and PI3K inhibitor (wortmannin) were used for blocking experiments (both in vivo and in vitro) to explore the mechanism. C5a/C5aR1-pathway inhibition significantly attenuated psoriasis-like skin lesions with decreased epidermal hyperplasia, downregulated type 17-related inflammatory gene expression, and reduced IL-17A-producing gamma delta-T cell responses. Mechanistically, C5a/C5aR1 promoted the latter phenotype via PI3K-Akt signaling. Consistently, C5aR1 deficiency clearly ameliorated IMQ-induced chronic psoriasiform dermatitis, with a significant decrease in IL-17A expression. Finally, blocking C5aR1 signaling further decreased psoriasiform skin inflammation in IL-17-deficient mice. Results suggest that C5a/C5aR1 mediates experimental psoriasis and skin inflammation by upregulating IL-17A expression from gamma delta-T cells. Blocking C5a/C5aR1/IL-17A axis is expected to be a promising strategy for psoriasis treatment.	[Zheng, Quan-you; Sun, Dao-dong; Zhong, Yu] Army Med Univ, Southwest Hosp, Hosp 958, Dept Urol, Chongqing, Peoples R China; [Zheng, Quan-you; Xu, Feng; Li, Gui-qing; Gao, Wei-wu; Xu, Gui-lian] Army Med Univ, Dept Immunol Basical Med Coll, 30 Gaotanyan St, Chongqing 400038, Peoples R China; [Yang, Yi; Liang, Shen-ju] Army Med Univ, Daping Hosp, Dept Rheumatism & Immunol, 10 Changjiangzhi Rd, Chongqing 400042, Peoples R China; [Wu, Shun] Army Med Univ, Southwest Hosp, Dept Nephrol, Chongqing, Peoples R China; [Wang, Tao] Army Med Univ, Daping Hosp, Dept Gastroenterol, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University; Army Medical University; Army Medical University	Xu, GL (corresponding author), Army Med Univ, Dept Immunol Basical Med Coll, 30 Gaotanyan St, Chongqing 400038, Peoples R China.; Liang, SJ (corresponding author), Army Med Univ, Daping Hosp, Dept Rheumatism & Immunol, 10 Changjiangzhi Rd, Chongqing 400042, Peoples R China.	xuguilian@tmmu.edu.cn; shenju7890@163.com			National Natural Science Foundation of China [81873881, 81900628]; Natural Science Foundation of Chongqing [cstc2018jcyjAX0260]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Chongqing(Natural Science Foundation of Chongqing)	This work was supported by the National Natural Science Foundation of China (No. 81873881 and No. 81900628) and the Natural Science Foundation of Chongqing (cstc2018jcyjAX0260). The funders had no role in the design of the study, data collection and analysis, interpretation or the writing of this manuscript	Boehncke WH, 2015, LANCET, V386, P983, DOI 10.1016/S0140-6736(14)61909-7; Cai YH, 2011, IMMUNITY, V35, P596, DOI 10.1016/j.immuni.2011.08.001; Choudhry N, 2016, KIDNEY INT, V90, P540, DOI 10.1016/j.kint.2016.04.023; Di Cesare A, 2009, J INVEST DERMATOL, V129, P1339, DOI 10.1038/jid.2009.59; El Malki K, 2013, J INVEST DERMATOL, V133, P441, DOI 10.1038/jid.2012.318; Fleming CJ, 1996, CLIN EXP DERMATOL, V21, P415, DOI 10.1111/j.1365-2230.1996.tb00144.x; Fragoulis GE, 2016, ANNU REV MED, V67, P337, DOI 10.1146/annurev-med-051914-021944; Gaffen SL, 2014, NAT REV IMMUNOL, V14, P585, DOI 10.1038/nri3707; Gordon KB, 2016, NEW ENGL J MED, V375, P345, DOI 10.1056/NEJMoa1512711; Greb JE, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.82; Griffiths CEM, 2015, LANCET, V386, P541, DOI 10.1016/S0140-6736(15)60125-8; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; Hajishengallis G, 2017, NAT IMMUNOL, V18, P1288, DOI 10.1038/ni.3858; Han GC, 2011, IMMUNOLOGY, V133, P340, DOI 10.1111/j.1365-2567.2011.03445.x; Hawkes JE, 2017, J ALLERGY CLIN IMMUN, V140, P645, DOI 10.1016/j.jaci.2017.07.004; Huber-Lang M, 2006, NAT MED, V12, P682, DOI 10.1038/nm1419; KAPP A, 1985, ARCH DERMATOL RES, V277, P359, DOI 10.1007/BF00509233; Kim J, 2017, ANNU REV MED, V68, P255, DOI 10.1146/annurev-med-042915-103905; Kulig P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13466; Leonardi C, 2012, NEW ENGL J MED, V366, P1190, DOI 10.1056/NEJMoa1109997; Leonardi CL, 2008, LANCET, V371, P1665, DOI 10.1016/S0140-6736(08)60725-4; Li R, 2013, FASEB J, V27, P855, DOI 10.1096/fj.12-220509; Lowes MA, 2014, ANNU REV IMMUNOL, V32, P227, DOI 10.1146/annurev-immunol-032713-120225; Mabuchi T, 2011, J IMMUNOL, V187, P5026, DOI 10.4049/jimmunol.1101817; Mrowietz U, 2001, EXP DERMATOL, V10, P238, DOI 10.1034/j.1600-0625.2001.100403.x; Muenstermann M, 2019, VIRULENCE, V10, P677, DOI 10.1080/21505594.2019.1640035; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; OHKOHCHI K, 1988, TOHOKU J EXP MED, V154, P315, DOI 10.1620/tjem.154.315; OHKOHCHI K, 1985, BRIT J DERMATOL, V113, P189, DOI 10.1111/j.1365-2133.1985.tb02064.x; Pantelyushin S, 2012, J CLIN INVEST, V122, P2252, DOI 10.1172/JCI61862; Papp KA, 2008, LANCET, V371, P1675, DOI 10.1016/S0140-6736(08)60726-6; Papp KA, 2012, NEW ENGL J MED, V366, P1181, DOI 10.1056/NEJMoa1109017; Peng Q, 2012, J AM SOC NEPHROL, V23, P1474, DOI 10.1681/ASN.2011111072; Peng Q, 2009, J IMMUNOL, V183, P6058, DOI 10.4049/jimmunol.0804186; Qin L, 2016, AM J TRANSPLANT, V16, P2865, DOI 10.1111/ajt.13834; Ramirez-Valle F, 2015, P NATL ACAD SCI USA, V112, P8046, DOI 10.1073/pnas.1508990112; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Riol-Blanco L, 2014, NATURE, V510, P157, DOI 10.1038/nature13199; Rittirsch D, 2008, NAT MED, V14, P551, DOI 10.1038/nm1753; Rizzo HL, 2011, J IMMUNOL, V186, P1495, DOI 10.4049/jimmunol.1001001; Shibata S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8687; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; Wagner EF, 2010, NAT REV RHEUMATOL, V6, P704, DOI 10.1038/nrrheum.2010.157; Xu RN, 2016, CELL MOL IMMUNOL, V13, P103, DOI 10.1038/cmi.2014.136; Yu SL, 2019, J BIOL CHEM, V294, P8384, DOI 10.1074/jbc.RA118.006508; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zheng QY, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01866	47	4	4	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10590	10604		10.1096/fj.202000384R	http://dx.doi.org/10.1096/fj.202000384R		JUN 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32557852	hybrid			2022-12-28	WOS:000541761400001
J	Cao, ZX; Guo, CJ; Song, XMT; He, JL; Tan, L; Yu, S; Zhang, RQ; Peng, F; Peng, C; Li, YZ				Cao, Zhi-Xing; Guo, Chuan-Jie; Song, Xiaominting; He, Jun-Lin; Tan, Lu; Yu, Si; Zhang, Ruo-Qi; Peng, Fu; Peng, Cheng; Li, Yu-Zhi			Erlotinib is effective against FLT3-ITD mutant AML and helps to overcome intratumoral heterogeneity via targeting FLT3 and Lyn	FASEB JOURNAL			English	Article						AML; erlotinib; FLT3; intratumoral heterogeneity; Lyn	ACUTE MYELOID-LEUKEMIA; MINIMAL RESIDUAL DISEASE; THERAPEUTIC TARGET; PANCREATIC-CANCER; KINASE; CELLS; CHEMOTHERAPY; PROGRESSION; RESISTANCE; PATHWAY	Erlotinib has potential therapeutic effect on acute myeloid leukemia (AML) in patients, but the mechanism is not clear. Effective tumor biomarkers for erlotinib in the treatment of AML remain poorly defined. Here, we demonstrate that erlotinib in vitro significantly inhibits the growth of the FLT3-ITD mutant AML cell MV4-11 and Ba/F3-FLT3-ITD cell via targeting FLT3, a certified valid target for the effective treatment of AML. In vivo, oral administration of erlotinib at 100 mg/kg/day induced rapid MV4-11 tumor regression and significantly prolonged the survival time of bone marrow engraftment AML mice via inhibiting the FLT3 signal. Thus, the therapeutic benefits of erlotinib on AML are due to its ability to target FLT3. FLT3-ITD mutation is an effective biomarker for erlotinib during AML treatment. In addition, we also demonstrate that erlotinib inhibits the activity of AML cell KG-1 (no FLT3 expression) by targeting Lyn. Recently, single cell analysis demonstrated that intratumoral heterogeneity are one of the contributors in the relapse and FLT3 inhibitor resistance. Erlotinib could effectively inhibit the MV4-11 cells via targeting FLT3, and inhibit KG-1 cells via targeting Lyn. Therefore, Erlotinib also has the potential to overcome intratumoral heterogeneity via targeting FLT3 and Lyn.	[Cao, Zhi-Xing; Guo, Chuan-Jie; Song, Xiaominting; He, Jun-Lin; Tan, Lu; Yu, Si; Zhang, Ruo-Qi; Peng, Cheng; Li, Yu-Zhi] Chengdu Univ Tradit Chinese Med, Pharm Coll,Key Lab Systemat Res Dev & Utilizat Ch, Minist Educ,Key Lab Standardizat Chinese Herbal M, Key Lab Breeding Base Sichuan Prov & MOST Chengdu, Chengdu, Peoples R China; [Peng, Fu] Sichuan Univ, West China Sch Pharm, Chengdu, Peoples R China	Chengdu University of Traditional Chinese Medicine; Sichuan University	Peng, C; Li, YZ (corresponding author), Chengdu Univ Tradit Chinese Med, Coll Pharm, 1166 Liutai Rd, Chengdu 611137, Sichuan, Peoples R China.	pengchengchengdu@126.com; pengchengchengdu@126.com		Peng, Cheng/0000-0003-3303-906X	National Natural Science Foundation of China [81300437, 81403149, 81973189]; National Major Scientific and Technological Special Project of China [2017ZX09201001-008]; Sichuan Science and Technology Program [2018SZDZX0017]; Youth Scientific Research Fund of CDUTCM [ZRQN1764, ZRQN1770]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Major Scientific and Technological Special Project of China; Sichuan Science and Technology Program; Youth Scientific Research Fund of CDUTCM	This study was supported by the National Natural Science Foundation of China (81300437, 81403149, 81973189), National Major Scientific and Technological Special Project of China (2017ZX09201001-008), Sichuan Science and Technology Program (2018SZDZX0017). Youth Scientific Research Fund of CDUTCM (ZRQN1764, ZRQN1770).	Abou Dalle I, 2018, ACTA HAEMATOL-BASEL, V140, P30, DOI 10.1159/000490092; Ampasavate C, 2019, J CLIN LAB ANAL, V33, DOI 10.1002/jcla.22859; Boehrer S, 2008, BLOOD, V111, P2170, DOI 10.1182/blood-2007-07-100362; Chan G, 2007, BLOOD, V110, P1079, DOI 10.1182/blood-2007-01-069856; Dohner H, 2015, NEW ENGL J MED, V373, P1136, DOI 10.1056/NEJMra1406184; Donato NJ, 2003, BLOOD, V101, P690, DOI 10.1182/blood.V101.2.690; Dos Santos C, 2008, BLOOD, V111, P2269, DOI 10.1182/blood-2007-04-082099; Frolov A, 2007, CANCER BIOL THER, V6, P548, DOI 10.4161/cbt.6.4.3849; Ger M, 2018, ANTICANCER RES, V38, P5759, DOI 10.21873/anticanres.12914; Gilliland DG, 2002, BLOOD, V100, P1532, DOI 10.1182/blood-2002-02-0492; Giotopoulos G, 2018, CANCER CELL, V34, P533, DOI 10.1016/j.ccell.2018.09.004; Hahn CK, 2009, CANCER CELL, V16, P281, DOI 10.1016/j.ccr.2009.08.018; Harashima A, 2002, BLOOD, V100, P4440, DOI 10.1182/blood-2002-03-0864; Iida M, 2013, ONCOGENE, V32, P759, DOI 10.1038/onc.2012.90; Jongen-Lavrencic M, 2018, NEW ENGL J MED, V378, P1189, DOI 10.1056/NEJMoa1716863; Kindler T, 2010, BLOOD, V116, P5089, DOI 10.1182/blood-2010-04-261867; Kottaridis PD, 2001, BLOOD, V98, P1752, DOI 10.1182/blood.V98.6.1752; Levis MJ, 2018, BLOOD ADV, V2, P825, DOI 10.1182/bloodadvances.2018015925; Mann KM, 2016, NAT BIOTECHNOL, V34, P962, DOI 10.1038/nbt.3637; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; Okamoto M, 2007, LEUKEMIA, V21, P403, DOI 10.1038/sj.leu.2404547; Nguyen PH, 2016, CANCER CELL, V30, P610, DOI 10.1016/j.ccell.2016.09.007; Sayar H, 2015, LEUKEMIA RES, V39, P170, DOI 10.1016/j.leukres.2014.11.022; Schnittger S, 2002, BLOOD, V100, P59, DOI 10.1182/blood.V100.1.59; Sellar RS, 2018, NAT MED, V24, P904, DOI 10.1038/s41591-018-0114-7; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Sidaway Peter, 2018, Nat Rev Clin Oncol, V15, P532, DOI 10.1038/s41571-018-0061-8; Skrzypczynska KM, 2016, IMMUNITY, V45, P1232, DOI 10.1016/j.immuni.2016.10.013; Smith CC, 2017, BLOOD, V130, P48, DOI 10.1182/blood-2016-04-711820; Stone RM, 2017, NEW ENGL J MED, V377, P454, DOI 10.1056/NEJMoa1614359; Tada J, 1999, BLOOD, V93, P3723, DOI 10.1182/blood.V93.11.3723.411k02_3723_3735; Thepot S, 2014, LEUKEMIA RES, V38, P1430, DOI 10.1016/j.leukres.2014.09.014; Tornillo G, 2018, CELL REP, V25, P3674, DOI 10.1016/j.celrep.2018.11.103; Zhang QQ, 2019, J CANCER, V10, P1197, DOI 10.7150/jca.28908	34	3	3	5	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10182	10190		10.1096/fj.201902922RR	http://dx.doi.org/10.1096/fj.201902922RR		JUN 2020	9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32543003	Bronze			2022-12-28	WOS:000541638200001
J	Trindade-da-Silva, CA; Clemente-Napimoga, JT; Abdalla, HB; Rosa, SM; Ueira-Vieira, C; Morisseau, C; Verri, WA; Montalli, VAM; Hammock, BD; Napimoga, MH				Trindade-da-Silva, Carlos A.; Clemente-Napimoga, Juliana T.; Abdalla, Henrique B.; Rosa, Sergio Marcolino; Ueira-Vieira, Carlos; Morisseau, Christophe; Verri Jr, Waldiceu A.; Martins Montalli, Victor Angelo; Hammock, Bruce D.; Napimoga, Marcelo H.			Soluble epoxide hydrolase inhibitor, TPPU, increases regulatory T cells pathway in an arthritis model	FASEB JOURNAL			English	Article						rheumatoid arthritis; soluble epoxide hydrolase; TPPU; Th1; Th17; Treg	MODIFYING ANTIRHEUMATIC DRUGS; ENDOPLASMIC-RETICULUM STRESS; RHEUMATOID-ARTHRITIS; THERAPEUTIC TARGET; FATTY-ACID; TH17 CELLS; PAIN; INFLAMMATION; PREVALENCE; EXPRESSION	Epoxyeicosatrienoic acids (EET) and related epoxy fatty acids (EpFA) are endogenous anti-inflammatory compounds, which are converted by the soluble epoxide hydrolase (sEH) to dihydroxylethersatrienoic acids (DHETs) with lessened biological effects. Inhibition of sEH is used as a strategy to increase EET levels leading to lower inflammation. Rheumatoid arthritis is a chronic autoimmune disease that leads to destruction of joint tissues. This pathogenesis involves a complex interplay between the immune system, and environmental factors. Here, we investigate the effects of inhibiting sEH with 1-trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) urea (TPPU) on a collagen-induced arthritis model. The treatment with TPPU ameliorates hyperalgesia, edema, and decreases the expression of important pro-inflammatory cytokines of Th1 and Th17 profiles, while increasing Treg cells. Considering the challenges to control RA, this study provides robust data supporting that inhibition of the sEH is a promising target to treat arthritis.	[Trindade-da-Silva, Carlos A.; Clemente-Napimoga, Juliana T.; Abdalla, Henrique B.; Rosa, Sergio Marcolino; Martins Montalli, Victor Angelo; Napimoga, Marcelo H.] Inst Sao Leopoldo Mandic, Fac Sao Leopoldo Mandic, Lab Neuroimmune Interface Pain Res, R Jose Rocha Junqueira 13, BR-13045755 Campinas, SP, Brazil; [Ueira-Vieira, Carlos] Univ Fed Uberlandia, Inst Biotechnol, Lab Genet, Uberlandia, MG, Brazil; [Morisseau, Christophe; Hammock, Bruce D.] Univ Calif Davis, UC Davis Comprehens Canc Ctr, Dept Entomol & Hematol, Davis, CA 95616 USA; [Verri Jr, Waldiceu A.] State Univ Londrina UEL, Biol Sci Ctr, Dept Pathol Sci, Londrina, Parana, Brazil; [Hammock, Bruce D.] EicOsis LLC, Davis, CA USA	Faculdade Sao Leopoldo Mandic; Universidade Federal de Uberlandia; University of California System; University of California Davis; Universidade Estadual de Londrina	Napimoga, MH (corresponding author), Inst Sao Leopoldo Mandic, Fac Sao Leopoldo Mandic, Lab Neuroimmune Interface Pain Res, R Jose Rocha Junqueira 13, BR-13045755 Campinas, SP, Brazil.	marcelo.napimoga@gmail.com	Clemente-Napimoga, Juliana T/E-5163-2013; da Silva, Carlos Antonio Trindade/AAN-6561-2020; Abdalla, Henrique Ballassini/M-2565-2014; Napimoga, Marcelo/S-2434-2019; Montalli, Victor/E-7246-2013; WA, Verri/I-1330-2013; da Silva, Carlos Antonio Trindade/I-4250-2013	Clemente-Napimoga, Juliana T/0000-0003-1068-3039; da Silva, Carlos Antonio Trindade/0000-0002-5669-4190; Abdalla, Henrique Ballassini/0000-0002-7517-2830; Napimoga, Marcelo/0000-0003-4472-365X; Montalli, Victor/0000-0002-1927-7718; WA, Verri/0000-0003-2756-9283; da Silva, Carlos Antonio Trindade/0000-0002-5669-4190; Morisseau, Christophe/0000-0002-5672-6631	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2017/22334-9]; MCTI \ Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [302527/2019-2]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [001]; HHS \ NIH \ National Institute of Environmental Health Sciences (NIEHS) [R35 ES030443, P42ES04699]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); MCTI \ Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); HHS \ NIH \ National Institute of Environmental Health Sciences (NIEHS)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Grant/Award Number: 2017/22334-9; MCTI vertical bar Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Grant/Award Number: 302527/2019-2; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Grant/Award Number: 001; HHS vertical bar NIH vertical bar National Institute of Environmental Health Sciences (NIEHS), Grant/Award Number: R35 ES030443 and P42ES04699	Attias M, 2019, CLIN EXP IMMUNOL, V197, P36, DOI 10.1111/cei.13290; Bettaieb A, 2015, MOL PHARMACOL, V88, P281, DOI 10.1124/mol.114.097501; Borghi SM, 2018, J NUTR BIOCHEM, V53, P81, DOI 10.1016/j.jnutbio.2017.10.010; Carregaro V, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/9626427; Carregaro V, 2011, J IMMUNOL, V187, P4347, DOI 10.4049/jimmunol.1003404; Chatzidionysiou K, 2017, ANN RHEUM DIS, V76, P1102, DOI 10.1136/annrheumdis-2016-210711; Chen ZH, 2020, SHOCK, V53, P761, DOI 10.1097/SHK.0000000000001408; Dinarello CA, 2003, VACCINE, V21, pS24, DOI 10.1016/S0264-410X(03)00196-8; Dong RL, 2017, ONCOTARGET, V8, P50958, DOI 10.18632/oncotarget.17331; Faulkner J, 2015, J DIABETES METAB, V6, DOI 10.4172/2155-6156.1000555; Firestein GS, 2017, IMMUNITY, V46, P183, DOI 10.1016/j.immuni.2017.02.006; Harris TR, 2013, GENE, V526, P61, DOI 10.1016/j.gene.2013.05.008; Huh JR, 2012, EUR J IMMUNOL, V42, P2232, DOI 10.1002/eji.201242740; Inceoglu B, 2015, P NATL ACAD SCI USA, V112, P9082, DOI 10.1073/pnas.1510137112; Inceoglu B, 2012, P NATL ACAD SCI USA, V109, P11390, DOI 10.1073/pnas.1208708109; Kamali AN, 2019, MOL IMMUNOL, V105, P107, DOI 10.1016/j.molimm.2018.11.015; Kobayashi H, 2006, ARTHRITIS RHEUM-US, V54, P1132, DOI 10.1002/art.21754; Kodani SD, 2019, BIOCHIMIE, V159, P59, DOI 10.1016/j.biochi.2019.01.020; Kohler BM, 2019, J CLIN MED, V8, DOI 10.3390/jcm8070938; Kuo SJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176052; Loboda A, 2016, CELL MOL LIFE SCI, V73, P3221, DOI 10.1007/s00018-016-2223-0; McReynolds CB, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00533; Napimoga MH, 2018, J PERIODONTAL RES, V53, P743, DOI 10.1111/jre.12559; Nie H, 2013, NAT MED, V19, P322, DOI 10.1038/nm.3085; Oestreich KJ, 2012, TRENDS IMMUNOL, V33, P78, DOI 10.1016/j.it.2011.10.005; Oh JS, 2013, RHEUMATOL INT, V33, P381, DOI 10.1007/s00296-012-2365-9; Osterman C, 2015, AM J SPORT MED, V43, P1474, DOI 10.1177/0363546515570463; Otter SJ, 2010, CLIN RHEUMATOL, V29, P255, DOI 10.1007/s10067-009-1312-y; Park J, 2019, INT J FINANC STUD, V7, DOI 10.3390/ijfs7010010; Park J, 2018, AM J PUBLIC HEALTH, V108, P256, DOI [10.2105/AJPH.2017.304179, 10.2105/ajph.2017.304179]; Peres RS, 2015, P NATL ACAD SCI USA, V112, P2509, DOI 10.1073/pnas.1424792112; Rose TE, 2010, J MED CHEM, V53, P7067, DOI 10.1021/jm100691c; Ruiz-Miyazawa KW, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32334-0; Sakaguchi S, 2009, INT IMMUNOL, V21, P1105, DOI 10.1093/intimm/dxp095; Staurengo-Ferrari L, 2019, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01536; Su ZL, 2013, MOL MED REP, V8, P113, DOI 10.3892/mmr.2013.1476; Sultana S, 2018, IMMUNOL LETT, V196, P33, DOI 10.1016/j.imlet.2018.01.005; Trindade-da-Silva CA, 2017, J PHARMACOL EXP THER, V361, P408, DOI 10.1124/jpet.116.238113; Tsai HJ, 2010, EUR J PHARM SCI, V40, P222, DOI 10.1016/j.ejps.2010.03.018; Tu RR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23504-1; Valdes AM, 2018, J LIPID RES, V59, P1763, DOI 10.1194/jlr.P085118; Verri WA, 2010, ANN RHEUM DIS, V69, P1697, DOI 10.1136/ard.2009.122655; Wagner KM, 2017, PHARMACOL THERAPEUT, V180, P62, DOI 10.1016/j.pharmthera.2017.06.006; Xu D, 2008, P NATL ACAD SCI USA, V105, P10913, DOI 10.1073/pnas.0801898105; Xu DM, 2010, J IMMUNOL, V184, P2620, DOI 10.4049/jimmunol.0902685; Yao L, 2019, AM J PHYSIOL-GASTR L, V316, pG527, DOI 10.1152/ajpgi.00148.2018; Yin H, 2011, INT IMMUNOPHARMACOL, V11, P2112, DOI 10.1016/j.intimp.2011.09.004; Yu Q, 2014, CENT EUR J IMMUNOL, V39, P100, DOI 10.5114/ceji.2014.42133; Zarpelon AC, 2013, BRIT J PHARMACOL, V169, P90, DOI 10.1111/bph.12110; Zarpelon AC, 2016, FASEB J, V30, P54, DOI 10.1096/fj.14-267146	50	7	7	3	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9074	9086		10.1096/fj.202000415R	http://dx.doi.org/10.1096/fj.202000415R		MAY 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32400048	Green Published, hybrid			2022-12-28	WOS:000532213200001
J	Yang, F; Ma, HW; Butler, MR; Ding, XQ				Yang Fan; Ma Hongwei; Butler, Michael R.; Ding Xi-Qin			Potential contribution of ryanodine receptor 2 upregulation to cGMP/PKG signaling-induced cone degeneration in cyclic nucleotide-gated channel deficiency	FASEB JOURNAL			English	Article						cGMP; PKG signaling; CNG channel; cone photoreceptors; retinal degeneration; ryanodine receptor	ENDOPLASMIC-RETICULUM STRESS; OPTICAL COHERENCE TOMOGRAPHY; DEPENDENT PROTEIN-KINASE; CALCIUM-RELEASE CHANNELS; PHOTORECEPTOR DEGENERATION; ER STRESS; CNGB3-ASSOCIATED ACHROMATOPSIA; RETINAL DEGENERATION; PHOSPHORYLATION SITE; INDUCED APOPTOSIS	Photoreceptor cyclic nucleotide-gated (CNG) channels regulate Ca2+ influx in rod and cone photoreceptors. Mutations in cone CNG channel subunits CNGA3 and CNGB3 are associated with achromatopsia and cone dystrophies. Mice lacking functional cone CNG channel show endoplasmic reticulum (ER) stress-associated cone degeneration. The elevated cyclic guanosine monophosphate (cGMP)/cGMP-dependent protein kinase (PKG) signaling and upregulation of the ER Ca2+ channel ryanodine receptor 2 (RyR2) have been implicated in cone degeneration. This work investigates the potential contribution of RyR2 to cGMP/PKG signaling-induced ER stress and cone degeneration. We demonstrated that the expression and activity of RyR2 were highly regulated by cGMP/PKG signaling. Depletion of cGMP by deleting retinal guanylate cyclase 1 or inhibition of PKG using chemical inhibitors suppressed the upregulation of RyR2 in CNG channel deficiency. Depletion of cGMP or deletion of Ryr2 equivalently inhibited unfolded protein response/ER stress, activation of the CCAAT-enhancer-binding protein homologous protein, and activation of the cyclic adenosine monophosphate response element-binding protein, leading to early-onset cone protection. In addition, treatment with cGMP significantly enhanced Ryr2 expression in cultured photoreceptor-derived Weri-Rb1 cells. Findings from this work demonstrate the regulation of cGMP/PKG signaling on RyR2 in the retina and support the role of RyR2 upregulation in cGMP/PKG signaling-induced ER stress and photoreceptor degeneration.	[Yang Fan; Ma Hongwei; Butler, Michael R.; Ding Xi-Qin] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, 940 Stanton L Young Blvd,BMSB 553, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Ding, XQ (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, 940 Stanton L Young Blvd,BMSB 553, Oklahoma City, OK 73104 USA.	xi-qin-ding@ouhsc.edu			NEI NIH HHS [R01 EY027754] Funding Source: Medline; NIH HHS [P30EY021725] Funding Source: Medline	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Arguin G, 2007, J ENDOCRINOL, V192, P659, DOI 10.1677/JOE-06-0179; Bai GR, 2006, BIOCHEM BIOPH RES CO, V348, P1319, DOI 10.1016/j.bbrc.2006.07.208; Balogh A, 2014, APOPTOSIS, V19, P1080, DOI 10.1007/s10495-014-0986-z; Beltran WA, 2009, INVEST OPHTH VIS SCI, V50, P5355, DOI 10.1167/iovs.09-3741; Benali-Furet NL, 2005, ONCOGENE, V24, P4921, DOI 10.1038/sj.onc.1208673; Benkusky NA, 2007, CIRC RES, V101, P819, DOI 10.1161/CIRCRESAHA.107.153007; Biel M, 1999, P NATL ACAD SCI USA, V96, P7553, DOI 10.1073/pnas.96.13.7553; BOWES C, 1990, NATURE, V347, P677, DOI 10.1038/347677a0; Bround MJ, 2012, CARDIOVASC RES, V96, P372, DOI 10.1093/cvr/cvs260; Butler MR, 2017, J BIOL CHEM, V292, P11189, DOI 10.1074/jbc.M117.782326; Caron AZ, 2007, CELL CALCIUM, V42, P323, DOI 10.1016/j.ceca.2007.01.002; Carvalho LS, 2011, HUM MOL GENET, V20, P3161, DOI 10.1093/hmg/ddr218; Chao CC, 2012, J CELL BIOCHEM, V113, P1377, DOI 10.1002/jcb.24010; Ciani E, 2002, J NEUROCHEM, V82, P1282, DOI 10.1046/j.1471-4159.2002.01080.x; Daniele LL, 2005, INVEST OPHTH VIS SCI, V46, P2156, DOI 10.1167/iovs.04-1427; Ding XQ, 2009, HUM MOL GENET, V18, P4770, DOI 10.1093/hmg/ddp440; Dixit SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058655; Dong EH, 2017, MOL VIS, V23, P90; Duncan RS, 2010, MOLECULES, V15, P1168, DOI 10.3390/molecules15031168; Fahim AT, 2013, AM J OPHTHALMOL, V156, P1211, DOI 10.1016/j.ajo.2013.06.033; Farjo R, 2006, J CELL BIOL, V173, P59, DOI 10.1083/jcb.200509036; Fill M, 2002, PHYSIOL REV, V82, P893, DOI 10.1152/physrev.00013.2002; Francois F, 2000, FEBS LETT, V486, P281, DOI 10.1016/S0014-5793(00)02316-4; Genead MA, 2011, INVEST OPHTH VIS SCI, V52, P7298, DOI 10.1167/iovs.11-7762; Hamilton SL, 2005, CELL CALCIUM, V38, P253, DOI 10.1016/j.ceca.2005.06.037; Hong M, 2004, J BIOL CHEM, V279, P11354, DOI 10.1074/jbc.M309804200; Huang W, 2011, EXP EYE RES, V93, P700, DOI 10.1016/j.exer.2011.09.001; Isenoumi K, 2004, J PHARMACOL SCI, V95, P108, DOI 10.1254/jphs.95.108; Jhala US, 2003, GENE DEV, V17, P1575, DOI 10.1101/gad.1097103; Johannessen M, 2004, CELL SIGNAL, V16, P1211, DOI 10.1016/j.cellsig.2004.05.001; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; Kikuchi D, 2016, BIOCHEM BIOPH RES CO, V469, P243, DOI 10.1016/j.bbrc.2015.11.113; Kohl S, 1998, NAT GENET, V19, P257, DOI 10.1038/935; Kohl S, 2000, HUM MOL GENET, V9, P2107, DOI 10.1093/hmg/9.14.2107; Krizaj D, 2003, J PHYSIOL-LONDON, V547, P761, DOI 10.1113/jphysiol.2002.035683; Le YZ, 2004, MOL VIS, V10, P1011; Lee YY, 2013, CELL DEATH DIFFER, V20, P941, DOI 10.1038/cdd.2013.29; Li JZ, 2006, J BIOL CHEM, V281, P7260, DOI 10.1074/jbc.M509868200; Liang XF, 2015, BRIT J OPHTHALMOL, V99, P571, DOI 10.1136/bjophthalmol-2014-305432; Lin L, 2018, J CELL MOL MED, V22, P3489, DOI 10.1111/jcmm.13626; Liu Y, 2007, VISION RES, V47, P2314, DOI 10.1016/j.visres.2007.04.023; Lu YF, 1999, J NEUROSCI, V19, P10250; Luciani DS, 2009, DIABETES, V58, P422, DOI 10.2337/db07-1762; Ma HW, 2019, ENEURO, V6, DOI 10.1523/ENEURO.0119-19.2019; Ma HW, 2015, J BIOL CHEM, V290, P20880, DOI 10.1074/jbc.M115.641159; Ma HW, 2013, HUM MOL GENET, V22, P3906, DOI 10.1093/hmg/ddt245; Marchi S, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.45; Matveev AV, 2008, J NEUROCHEM, V106, P2042, DOI 10.1111/j.1471-4159.2008.05548.x; McClintock M, 2014, ADV EXP MED BIOL, V801, P551, DOI 10.1007/978-1-4614-3209-8_70; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Mekahli D, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004317; Michalakis S, 2005, INVEST OPHTH VIS SCI, V46, P1516, DOI 10.1167/iovs.04-1503; Michalakis S, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030749; Michalakis S, 2010, MOL THER, V18, P2057, DOI 10.1038/mt.2010.149; Murthy KS, 2003, AM J PHYSIOL-GASTR L, V284, pG221, DOI 10.1152/ajpgi.00401.2002; Nikonov SS, 2005, J GEN PHYSIOL, V125, P287, DOI 10.1085/jgp.200409208; Nishiguchi KM, 2005, HUM MUTAT, V25, P248, DOI 10.1002/humu.20142; Ozawa T, 2010, MOL MED REP, V3, P199, DOI [10.3892/mmr_000000240, 10.3892/mmr_00000240]; Periasamy M, 2007, MUSCLE NERVE, V35, P430, DOI 10.1002/mus.20745; Ramirez AI, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00214; Reusch JEB, 2002, J BIOL CHEM, V277, P1426, DOI 10.1074/jbc.M107923200; Santulli G, 2015, CURR MOL PHARMACOL, V8, P206, DOI 10.2174/1874467208666150507105105; Santulli G, 2015, J CLIN INVEST, V125, P1968, DOI 10.1172/JCI79273; Sen N, 2019, NEUROSCIENTIST, V25, P420, DOI 10.1177/1073858418816611; Shoshan-Barmatz V, 2007, EUR J NEUROSCI, V26, P3113, DOI 10.1111/j.1460-9568.2007.05931.x; Szado T, 2008, P NATL ACAD SCI USA, V105, P2427, DOI 10.1073/pnas.0711324105; TAKASAGO T, 1991, J BIOCHEM-TOKYO, V109, P163, DOI 10.1093/oxfordjournals.jbchem.a123339; TAKASAGO T, 1989, J BIOCHEM-TOKYO, V106, P872, DOI 10.1093/oxfordjournals.jbchem.a122945; Taylor CW, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004010; Thapa A, 2012, J BIOL CHEM, V287, P18018, DOI 10.1074/jbc.M112.342220; Thiadens AAHJ, 2010, INVEST OPHTH VIS SCI, V51, P5952, DOI 10.1167/iovs.10-5680; Thiadens AAHJ, 2009, OPHTHALMOLOGY, V116, P1984, DOI 10.1016/j.ophtha.2009.03.053; Varsanyi B, 2007, INVEST OPHTH VIS SCI, V48, P2249, DOI 10.1167/iovs.06-1173; Verkhratsky A, 2004, BIOL RES, V37, P693; WITCHER DR, 1991, J BIOL CHEM, V266, P11144; Wolfertstetter S, 2013, PHARMACEUTICALS, V6, P269, DOI 10.3390/ph6020269; Woodruff ML, 2007, J NEUROSCI, V27, P8805, DOI 10.1523/JNEUROSCI.2751-07.2007; Xu JH, 2013, J NEUROSCI, V33, P14939, DOI 10.1523/JNEUROSCI.0909-13.2013; Xu JH, 2011, INVEST OPHTH VIS SCI, V52, P3557, DOI 10.1167/iovs.10-6358; Xu XLL, 2009, CELL, V137, P1018, DOI 10.1016/j.cell.2009.03.051; Yang F, 2016, FASEB J, V30, P4313, DOI 10.1096/fj.201600715R; Yang RB, 1999, J NEUROSCI, V19, P5889, DOI 10.1523/JNEUROSCI.19-14-05889.1999; Yang YP, 2019, ENVIRON TOXICOL, V34, P1052, DOI 10.1002/tox.22776; Yoshida S, 2004, HUM MOL GENET, V13, P1487, DOI 10.1093/hmg/ddh160	84	3	3	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6335	6350		10.1096/fj.201901951RR	http://dx.doi.org/10.1096/fj.201901951RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32173907	Green Accepted			2022-12-28	WOS:000531325500025
J	Bi, CL; Fu, YL; Zhang, ZQ; Li, B				Bi, Changlong; Fu, Yili; Zhang, Zheqi; Li, Bo			Prostaglandin E2 confers protection against diabetic coronary atherosclerosis by stimulating M2 macrophage polarization via the activation of the CREB/BDNF/TrkB signaling pathway	FASEB JOURNAL			English	Article						CREB; BDNF; TrkB signaling pathway; diabetic coronary atherosclerosis; prostaglandin E2; M2 macrophage polarization	NEUROTROPHIC FACTOR; UP-REGULATION; CARDIOVASCULAR-DISEASE; GENE-EXPRESSION; BDNF; INFLAMMATION; BRAIN; INJURY	It has been documented that M2 macrophage polarization plays a suppressive role in atherosclerosis in diabetes mellitus (DM). In addition, prostaglandin E2 (PGE2) is implicated in the development of M2 macrophage polarization. Therefore, the study aimed to investigate the specific mechanism of PGE2 in M2 macrophage polarization in diabetic coronary atherosclerosis (DMAS). Initially, clinical samples were obtained and DMAS mouse model was established. The expression of BDNF was determined, and M1 and M2 macrophage polarizations were evaluated. Then, the levels of BDNF and PGE2 were modified in DMAS mice and the serum indicator, atherosclerotic plaque, lipid uptake by PBMCs, as well as M1 and M2 macrophage polarization were determined. Macrophages were isolated and the effects of PGE2 and the CREB/BDNF/TrkB signaling pathway on M2 macrophage polarization were explored. BDNF was downregulated and macrophages were differentiated into M1 in DMAS patients and mice. BDNF and PGE2 were observed to promote M2 macrophage polarization, where atherosclerotic plaque and lipid uptake by PBMCs were reduced, and DMAS was alleviated in mice. Overexpression of BDNF activated the CREB/BDNF/TrkB signaling pathway and stimulated M2 macrophage polarization in macrophages. PGE2 stimulated M2 macrophage polarization by inducing KLF4 via the activation of the CREB/BDNF/TrkB signaling pathway. This study demonstrates that PGE2 promotes M2 macrophage polarization by activating the CREB/BDNF/TrkB signaling pathway, thus alleviating DMAS.	[Bi, Changlong] Sun Yat Sen Univ, Affiliated Hosp 8, Dept Endocrinol, Shenzhen, Peoples R China; [Fu, Yili] Harbin Inst Technol, Sch Life Sci & Technol, Harbin, Peoples R China; [Fu, Yili] Harbin Inst Technol, State Key Lab Robot & Syst, Harbin, Peoples R China; [Zhang, Zheqi; Li, Bo] Harbin Med Univ, Dept Endocrinol, Affiliated Hosp 4, 37 Yiyuan St, Harbin 150001, Heilongjiang, Peoples R China	Sun Yat Sen University; Harbin Institute of Technology; Harbin Institute of Technology; Harbin Medical University	Li, B (corresponding author), Harbin Med Univ, Dept Endocrinol, Affiliated Hosp 4, 37 Yiyuan St, Harbin 150001, Heilongjiang, Peoples R China.	BobbyLL123@163.com			National Natural Science Foundation of China [81800739, 81871562]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (No. 81800739 & 81871562)	Ayuk SM, 2016, J PHOTOCH PHOTOBIO B, V161, P368, DOI 10.1016/j.jphotobiol.2016.05.027; Chatterjee T, 2019, FREE RADICAL BIO MED, V143, P309, DOI 10.1016/j.freeradbiomed.2019.07.034; Devaraj S, 2011, ARTERIOSCL THROM VAS, V31, P1397, DOI 10.1161/ATVBAHA.111.225508; Duarte PC, 2012, EXP NEUROL, V234, P466, DOI 10.1016/j.expneurol.2012.01.021; Fenyo IM, 2013, IMMUNOBIOLOGY, V218, P1376, DOI 10.1016/j.imbio.2013.06.005; Gong M, 2017, MED SCI MONIT BASIC, V23, P240, DOI 10.12659/MSMBR.904014; Gonzalez AA, 2017, AM J PHYSIOL-RENAL, V313, pF1038, DOI 10.1152/ajprenal.00194.2017; Hashimoto K, 2013, PROG NEUROBIOL, V100, P15, DOI 10.1016/j.pneurobio.2012.09.001; Hong JH, 2014, INT J CARDIOL, V176, P1405, DOI 10.1016/j.ijcard.2014.08.019; Hyam SR, 2013, EUR J PHARMACOL, V708, P21, DOI 10.1016/j.ejphar.2013.01.014; Ji XC, 2015, CELL MOL NEUROBIOL, V35, P881, DOI 10.1007/s10571-015-0182-x; Kim YG, 2014, CELL HOST MICROBE, V15, P95, DOI 10.1016/j.chom.2013.12.010; Krabbe KS, 2007, DIABETOLOGIA, V50, P431, DOI 10.1007/s00125-006-0537-4; Leal G, 2014, NEUROPHARMACOLOGY, V76, P639, DOI 10.1016/j.neuropharm.2013.04.005; Lino M, 2018, ARTERIOSCL THROM VAS, V38, P1878, DOI 10.1161/ATVBAHA.118.311238; Luan B, 2015, P NATL ACAD SCI USA, V112, P15642, DOI 10.1073/pnas.1519644112; Maiti Rituparna, 2007, Indian J Med Sci, V61, P292; Manni L, 2005, INT J CARDIOL, V102, P169, DOI 10.1016/j.ijcard.2004.10.041; Miao HS, 2018, J NEUROPHYSIOL, V120, P1307, DOI 10.1152/jn.00234.2018; Mokou M, 2019, EBIOMEDICINE, V41, P91, DOI 10.1016/j.ebiom.2019.02.040; Nakanishi M, 2013, SEMIN IMMUNOPATHOL, V35, P123, DOI 10.1007/s00281-012-0342-8; Navaratna D, 2011, DIABETES, V60, P1789, DOI 10.2337/db10-1371; Rasmussen P, 2009, EXP PHYSIOL, V94, P1062, DOI 10.1113/expphysiol.2009.048512; Ruffell D, 2009, P NATL ACAD SCI USA, V106, P17475, DOI 10.1073/pnas.0908641106; Suzuki A, 2011, J NEUROSCI, V31, P8786, DOI 10.1523/JNEUROSCI.3257-10.2011; Wang CCL, 2016, CIRCULATION, V133, P2459, DOI 10.1161/CIRCULATIONAHA.116.022194; Wang N, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00614; Wang Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115855; Yahagi K, 2017, ARTERIOSCL THROM VAS, V37, P191, DOI 10.1161/ATVBAHA.116.306256; Yoshii A, 2010, DEV NEUROBIOL, V70, P304, DOI 10.1002/dneu.20765; Zhao GF, 2016, FEBS LETT, V590, P1602, DOI 10.1002/1873-3468.12200	31	13	13	2	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					7360	7371		10.1096/fj.201902055R	http://dx.doi.org/10.1096/fj.201902055R		APR 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32350920				2022-12-28	WOS:000553673800001
J	Shen, T; Huang, ZH; Shi, CF; Pu, XF; Xu, XD; Wu, ZR; Ding, GP; Cao, LP				Shen, Tao; Huang, Zihang; Shi, Chengfei; Pu, Xiaofan; Xu, Xiaodong; Wu, Zhengrong; Ding, Guoping; Cao, Liping			Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK-mediated endoplasmic reticulum stress	FASEB JOURNAL			English	Article						apoptosis; endoplasmic reticulum stress; exosomes; p38 MAPK; pancreatic cancer; T lymphocytes	ACTIVATED PROTEIN-KINASE; INDUCED CELL-DEATH; VESICLES; PATHWAY; MICROVESICLES; INFILTRATION; PHOSPHATASES; EXPRESSION	Pancreatic cancer is the fourth most lethal malignancy and is characterized by poor immunogenicity. Pancreatic cancer cells have various strategies to suppress host immune response, evade immune defenses, and facilitate tumor growth and development. As a mode of long-range intercellular communication, cancer-derived exosomes contribute to impairment of the immune system. However, the mechanisms that induce changes in the activities of signal transduction pathways in immune cells, which are influenced by tumor-derived exosomes, are poorly understood. We (1) treated peripheral T lymphocytes with pancreatic cancer-derived exosomes, tagged CD63 with tdTomato, to trace exosome transfer from pancreatic cancer cells to T lymphocytes; (2) carried out a cytotoxicity assay of exosome-treated T lymphocytes using the Real Time Cellular Analysis system; (3) performed RNA sequencing and gene set enrichment analysis to explore the pivotal signaling pathway that mediates apoptosis in exosome-treated T lymphocytes; and (4) demonstrated the role of p38 mitogen-activated protein kinase (MAPK) and endoplasmic reticulum (ER) stress in exosome-induced T-lymphocyte apoptosis. In conclusion, these results indicate that pancreatic cancer cells secrete exosomes, which are taken up by T lymphocytes to activate p38 MAPK, and then induce ER stress-mediated apoptosis, ultimately causing immunosuppression.	[Shen, Tao; Huang, Zihang; Pu, Xiaofan; Xu, Xiaodong; Wu, Zhengrong; Ding, Guoping; Cao, Liping] Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Dept Gen Surg, Hangzhou, Peoples R China; [Shi, Chengfei] Wenzhou Med Univ, Wenling Hosp, Sch Med, Dept Gen Surg, Wenling, Peoples R China; [Cao, Liping] Zhejiang Univ, Innovat Ctr Minimally Invas Tech & Device, Hangzhou, Peoples R China	Zhejiang University; Wenzhou Medical University; Zhejiang University	Ding, GP; Cao, LP (corresponding author), Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Dept Gen Surg, Hangzhou, Peoples R China.	dinguop@zju.edu.cn; caolipingzju@zju.edu.cn		Xu, Xiaodong/0000-0002-5290-9705; cao, liping/0000-0003-4810-1495	Major Research Project of Science Technology, Department of Zhejiang Province [2019C03048]; National Natural Science Foundation of China [817, 02358]; Medical Science and Technology of Zhejiang Province [WKJ-ZJ-1824]; Zhejiang Traditional Chinese Medicine Research Fund Program [2019ZB071]	Major Research Project of Science Technology, Department of Zhejiang Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medical Science and Technology of Zhejiang Province; Zhejiang Traditional Chinese Medicine Research Fund Program	Major Research Project of Science Technology, Department of Zhejiang Province, Grant/Award Number: 2019C03048; National Natural Science Foundation of China, Grant/Award Number: 817 and 02358; Medical Science and Technology of Zhejiang Province, Grant/Award Number: WKJ-ZJ-1824; Zhejiang Traditional Chinese Medicine Research Fund Program, Grant/Award Number: 2019ZB071	Andreola G, 2002, J EXP MED, V195, P1303, DOI 10.1084/jem.20011624; Azmi AS, 2013, CANCER METAST REV, V32, P623, DOI 10.1007/s10555-013-9441-9; Buscail L, 2017, NAT REV GASTRO HEPAT, V14, P636, DOI 10.1038/nrgastro.2017.113; Clark CE, 2007, CANCER RES, V67, P9518, DOI 10.1158/0008-5472.CAN-07-0175; Darling NJ, 2014, BBA-MOL CELL RES, V1843, P2150, DOI 10.1016/j.bbamcr.2014.01.009; Emmrich J, 1998, DIGESTION, V59, P192, DOI 10.1159/000007488; Ene-Obong A, 2013, GASTROENTEROLOGY, V145, P1121, DOI 10.1053/j.gastro.2013.07.025; Finn OJ, 2012, ANN ONCOL, V23, P6, DOI 10.1093/annonc/mds256; Gajewski TF, 2013, NAT IMMUNOL, V14, P1014, DOI 10.1038/ni.2703; Hartwig W, 2013, LANCET ONCOL, V14, pE476, DOI 10.1016/S1470-2045(13)70172-4; Homma K, 2009, EXPERT OPIN THER TAR, V13, P653, DOI 10.1517/14728220902980249; Huber V, 2005, GASTROENTEROLOGY, V128, P1796, DOI 10.1053/j.gastro.2005.03.045; Ino Y, 2013, BRIT J CANCER, V108, P914, DOI 10.1038/bjc.2013.32; Keyse SM, 2000, CURR OPIN CELL BIOL, V12, P186, DOI 10.1016/S0955-0674(99)00075-7; Kim DS, 2010, BIOL PHARM BULL, V33, P545, DOI 10.1248/bpb.33.545; Kim JW, 2005, CLIN CANCER RES, V11, P1010; Ko J, 2017, ACS NANO, V11, P11182, DOI 10.1021/acsnano.7b05503; Laheru D, 2005, NAT REV CANCER, V5, P459, DOI 10.1038/nrc1630; Liu YS, 2007, NAT REV IMMUNOL, V7, P202, DOI 10.1038/nri2035; Melo SA, 2015, NATURE, V523, P177, DOI 10.1038/nature14581; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Morganti AG, 2010, ANN SURG ONCOL, V17, P194, DOI 10.1245/s10434-009-0762-4; Ozcan L, 2012, ANNU REV MED, V63, P317, DOI 10.1146/annurev-med-043010-144749; PAN BT, 1985, J CELL BIOL, V101, P942, DOI 10.1083/jcb.101.3.942; Park HS, 2011, BIOCHEM PHARMACOL, V82, P1110, DOI 10.1016/j.bcp.2011.07.085; Powolny A, 2003, J CELL BIOCHEM, V90, P1128, DOI 10.1002/jcb.10733; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Ricklefs FL, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar2766; Sarkar D, 2002, P NATL ACAD SCI USA, V99, P10054, DOI 10.1073/pnas.152327199; Scott DW, 2008, DNA CELL BIOL, V27, P607, DOI 10.1089/dna.2008.0773; Shen T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08479-9; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; Taylor DD, 2005, BRIT J CANCER, V92, P305, DOI 10.1038/sj.bjc.6602316; Terashima T, 2014, CANCER IMMUNOL IMMUN, V63, P479, DOI 10.1007/s00262-014-1529-8; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van den Boorn JG, 2013, ADV DRUG DELIVER REV, V65, P331, DOI 10.1016/j.addr.2012.06.011; van Niel G, 2006, J BIOCHEM, V140, P13, DOI 10.1093/jb/mvj128; von Bernstorff W, 2001, CLIN CANCER RES, V7, p925S; Wang MC, 2003, DEV CELL, V5, P811, DOI 10.1016/S1534-5807(03)00323-X; Zhang J, 2000, J EXP MED, V191, P1017, DOI 10.1084/jem.191.6.1017; Zhang J, 1999, J IMMUNOL, V162, P3819; Zomer Anoek, 2010, Commun Integr Biol, V3, P447, DOI 10.4161/cib.3.5.12339	45	36	36	4	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8442	8458		10.1096/fj.201902186R	http://dx.doi.org/10.1096/fj.201902186R		APR 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32350913	hybrid			2022-12-28	WOS:000553674200001
J	Gerner, MC; Ziegler, LS; Schmidt, RLJ; Krenn, M; Zimprich, F; Uyanik-Unal, K; Konstantopoulou, V; Derdak, S; Del Favero, G; Schwarzinger, I; Boztug, K; Schmetterer, KG				Gerner, Marlene C.; Ziegler, Liesa S.; Schmidt, Ralf L. J.; Krenn, Martin; Zimprich, Fritz; Uyanik-Uenal, Keziban; Konstantopoulou, Vassiliki; Derdak, Sophia; Del Favero, Giorgia; Schwarzinger, Ilse; Boztug, Kaan; Schmetterer, Klaus G.			The TGF-b/SOX4 axis and ROS-driven autophagy co-mediate CD39 expression in regulatory T-cells	FASEB JOURNAL			English	Article						autophagy; CD39; regulatory T-cells; immune tolerance; SOX4; TGF-b signaling	TGF-BETA; GENERATION; SOX4; METASTASIS; COMBINATION; MUTATIONS; INDUCTION; ADENOSINE; MECHANISM; RESPONSES	The ectonucleotidase CD39 on human regulatory T-cells (Treg) is an important immune regulator which is dysregulated in autoimmune diseases and cancer immunosuppression. We here define that CD39 expression on Treg is independent of the Treg-specific transcription factors FOXP3 and HELIOS and promoted by canonical TGF-b- and mTOR-signaling. Furthermore, the TGF-b mediated upregulation of CD39 is counteracted by reactive oxygen species (ROS)-driven autophagy. In line, CD39(+) peripheral blood Treg constitute a distinct lineage with low autophagic flux and absent ROS production. Patients with rare genetic defects in autophagy show supraphysiological levels of CD39(+) Treg, validating our observations in vivo. These biological processes rely on a distinct transcriptional program with CD39(+) Treg expressing low levels of two genes with putative involvement in autophagy, NEFL and PLAC8. Furthermore, the TGF-b downstream transcription factor SOX4 is selectively upregulated in CD39(+) Treg. Overexpression of SOX4 in Treg strongly increases CD39 expression, while Crispr/Cas9-mediated knockout of SOX4 in Treg has the opposing effect. Thus, we identify a crucial role of SOX4 in immune regulation and provide new insights involving the interplay of tolerogenic cues and autophagy in Treg.	[Gerner, Marlene C.; Ziegler, Liesa S.; Schmidt, Ralf L. J.; Schwarzinger, Ilse; Schmetterer, Klaus G.] Med Univ Vienna, Dept Lab Med, Waehringer Guertel 18-20, A-1090 Vienna, Austria; [Krenn, Martin; Zimprich, Fritz] Med Univ Vienna, Dept Neurol, Vienna, Austria; [Uyanik-Uenal, Keziban] Med Univ Vienna, Dept Surg, Vienna, Austria; [Konstantopoulou, Vassiliki] Med Univ Vienna, Dept Pediat, Vienna, Austria; [Derdak, Sophia] Med Univ Vienna, Core Facil Genom, Vienna, Austria; [Del Favero, Giorgia] Univ Vienna, Dept Food Chem & Toxicol, Fac Chem, Vienna, Austria; [Boztug, Kaan] Austrian Acad Sci, Res Ctr Mol Med, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; University of Vienna; Austrian Academy of Sciences	Schmetterer, KG (corresponding author), Med Univ Vienna, Dept Lab Med, Waehringer Guertel 18-20, A-1090 Vienna, Austria.	klaus.schmetterer@meduniwien.ac.at	Boztug, Kaan/AAM-4161-2021	Boztug, Kaan/0000-0001-8387-9185; Schmidt, Ralf/0000-0002-6697-0363; Krenn, Martin/0000-0003-3026-3082	Austrian Science Funds [P29654-B30]; Medical-Scientific Funds of the Mayor of the City of Vienna [15099, 18067]	Austrian Science Funds(Austrian Science Fund (FWF)); Medical-Scientific Funds of the Mayor of the City of Vienna	Austrian Science Funds, Grant/Award Number: P29654-B30; Medical-Scientific Funds of the Mayor of the City of Vienna, Grant/Award Number: 15099 and 18067	Abbas AK, 2013, NAT IMMUNOL, V14, P307, DOI 10.1038/ni.2554; Allard B, 2017, IMMUNOL REV, V276, P121, DOI 10.1111/imr.12528; Azad MB, 2009, ANTIOXID REDOX SIGN, V11, P777, DOI [10.1089/ars.2008.2270, 10.1089/ARS.2008.2270]; Bai AP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9819; Bergsland M, 2006, GENE DEV, V20, P3475, DOI 10.1101/gad.403406; Borsellino G, 2007, BLOOD, V110, P1225, DOI 10.1182/blood-2006-12-064527; BOVERIS A, 1975, FEBS LETT, V54, P311, DOI 10.1016/0014-5793(75)80928-8; Cai XY, 2016, ONCOL LETT, V12, P4080, DOI 10.3892/ol.2016.5189; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Del Favero G, 2018, TOXICOL LETT, V295, P424, DOI 10.1016/j.toxlet.2018.07.007; Derdak SV, 2006, P NATL ACAD SCI USA, V103, P13144, DOI 10.1073/pnas.0602283103; Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532; Dikic I, 2018, NAT REV MOL CELL BIO, V19, P349, DOI 10.1038/s41580-018-0003-4; Doulatov S, 2013, CELL STEM CELL, V13, P459, DOI 10.1016/j.stem.2013.09.002; Dulphy N, 2014, BRIT J HAEMATOL, V165, P722, DOI 10.1111/bjh.12774; Fang FQ, 2016, CELL REP, V14, P1218, DOI 10.1016/j.celrep.2016.01.002; Fletcher JM, 2009, J IMMUNOL, V183, P7602, DOI 10.4049/jimmunol.0901881; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Fournier PGJ, 2015, CANCER CELL, V27, P809, DOI 10.1016/j.ccell.2015.04.009; Friedman DJ, 2009, P NATL ACAD SCI USA, V106, P16788, DOI 10.1073/pnas.0902869106; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gerner MC, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00727; Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697; Gruenbacher G, 2016, CELL REP, V16, P444, DOI 10.1016/j.celrep.2016.06.009; Guo SJ, 2015, AUTOPHAGY, V11, P560, DOI 10.1080/15548627.2015.1017181; Haidar M, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00143; Hayes GM, 2015, AM J TRANSL RES, V7, P1181; Hilchey SP, 2009, J IMMUNOL, V183, P6157, DOI 10.4049/jimmunol.0900475; Hill JA, 2007, IMMUNITY, V27, P786, DOI 10.1016/j.immuni.2007.09.010; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Jacquin E, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01023; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kinsey C, 2014, CELL REP, V7, P1143, DOI 10.1016/j.celrep.2014.03.061; Kitoh A, 2009, IMMUNITY, V31, P609, DOI 10.1016/j.immuni.2009.09.003; Krenn M, 2018, J NEUROL, V265, P394, DOI 10.1007/s00415-017-8710-x; Kunzli BM, 2011, PURINERG SIGNAL, V7, P231, DOI 10.1007/s11302-011-9228-9; Kuwahara M, 2012, NAT IMMUNOL, V13, P778, DOI 10.1038/ni.2362; Labasi JM, 2002, J IMMUNOL, V168, P6436, DOI 10.4049/jimmunol.168.12.6436; Leone RD, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0360-8; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Long SA, 2008, J AUTOIMMUN, V30, P293, DOI 10.1016/j.jaut.2007.12.012; Loza MJ, 2011, CELL IMMUNOL, V271, P110, DOI 10.1016/j.cellimm.2011.06.010; Lu L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015150; Mandapathil M, 2009, CLIN CANCER RES, V15, P6348, DOI 10.1158/1078-0432.CCR-09-1143; Mauthe M, 2018, AUTOPHAGY, V14, P1435, DOI 10.1080/15548627.2018.1474314; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nascimbeni AC, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2016.475; Neuzillet C, 2014, ONCOTARGET, V5, P78, DOI 10.18632/oncotarget.1569; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Perrot I, 2019, CELL REP, V27, P2411, DOI 10.1016/j.celrep.2019.04.091; Phipson B, 2016, ANN APPL STAT, V10, P946, DOI 10.1214/16-AOAS920; Pietrocola F, 2016, CANCER CELL, V30, P147, DOI 10.1016/j.ccell.2016.05.016; Pollizzi KN, 2015, TRENDS IMMUNOL, V36, P13, DOI 10.1016/j.it.2014.11.005; Quinlan CL, 2011, J BIOL CHEM, V286, P31361, DOI 10.1074/jbc.M111.267898; Rao S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4056; Regateiro FS, 2011, EUR J IMMUNOL, V41, P2955, DOI 10.1002/eji.201141512; Rissiek A, 2015, J AUTOIMMUN, V58, P12, DOI 10.1016/j.jaut.2014.12.007; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Roth TL, 2018, NATURE, V559, P405, DOI 10.1038/s41586-018-0326-5; Schiavon V, 2019, P NATL ACAD SCI USA, V116, P6298, DOI 10.1073/pnas.1812471116; Schilham MW, 1997, EUR J IMMUNOL, V27, P1292, DOI 10.1002/eji.1830270534; Schmetterer KG, 2012, FASEB J, V26, P2253, DOI 10.1096/fj.11-193672; Schmetterer KG, 2011, J ALLERGY CLIN IMMUN, V127, P238, DOI 10.1016/j.jaci.2010.10.023; Sebastian M, 2016, J IMMUNOL, V196, P144, DOI 10.4049/jimmunol.1501704; Shen KL, 2020, WORLD J PEDIATR, V16, P232, DOI 10.1007/s12519-020-00362-4; Singha Prajjal K, 2014, Genes Cancer, V5, P320; STRASSER K, 2018, ONCOIMMUNOLOGY, V58, P1; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szczepanski MJ, 2009, CLIN CANCER RES, V15, P3325, DOI 10.1158/1078-0432.CCR-08-3010; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Underwood BR, 2010, HUM MOL GENET, V19, P3413, DOI 10.1093/hmg/ddq253; Waickman AT, 2012, IMMUNOL REV, V249, P43, DOI 10.1111/j.1600-065X.2012.01152.x; Yeh YM, 2013, INT J CANCER, V133, P867, DOI 10.1002/ijc.28086; Zarek PE, 2008, BLOOD, V111, P251, DOI 10.1182/blood-2007-03-081646; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328; ZHAO H, 2017, FRONT IMMUNOL, V8; Zhou YC, 2015, J CELL BIOCHEM, V116, P1007, DOI 10.1002/jcb.25055; Zhoua Q, 2009, AM J TRANSPLANT, V9, P2303, DOI 10.1111/j.1600-6143.2009.02777.x; Zumerle S, 2019, CELL REP, V27, P1, DOI 10.1016/j.celrep.2019.03.011	80	18	18	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8367	8384		10.1096/fj.201902664	http://dx.doi.org/10.1096/fj.201902664		APR 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32319705	Green Published, hybrid			2022-12-28	WOS:000527569200001
J	Liu, DL; Fu, XH; Wang, YG; Wang, XH; Wang, H; Wen, JL; Kang, NL				Liu, Donglian; Fu, Xinhui; Wang, Yuanguo; Wang, Xianghu; Wang, Hua; Wen, Jialing; Kang, Ningling			Protein diaphanous homolog 1 (Diaph1) promotes myofibroblastic activation of hepatic stellate cells by regulating Rab5a activity and TGF beta receptor endocytosis	FASEB JOURNAL			English	Article						cancer-associated fibroblasts; colorectal cancer; endosomal trafficking of receptors; IncuCyte Live-Cell Analysis; biotinylation	GROWTH-FACTOR; ACTIN; MEMBRANE; MDIA1; ADHESION; MICROENVIRONMENT; REORGANIZATION; TRANSPORT; FORMINS; GTPASE	TGF beta induces the differentiation of hepatic stellate cells (HSCs) into tumor-promoting myofibroblasts but underlying mechanisms remain incompletely understood. Because endocytosis of TGF beta receptor II (T beta RII), in response to TGF beta stimulation, is a prerequisite for TGF signaling, we investigated the role of protein diaphanous homolog 1 (known as Diaph1 or mDia1) for the myofibroblastic activation of HSCs. Using shRNA to knockdown Diaph1 or SMIFH2 to target Diaph1 activity of HSCs, we found that the inactivation of Diaph1 blocked internalization and intracellular trafficking of T beta RII and reduced SMAD3 phosphorylation induced by TGF beta 1. Mechanistic studies revealed that the N-terminal portion of Diaph1 interacted with both T beta RII and Rab5a directly and that Rab5a activity of HSCs was increased by Diaph1 overexpression and decreased by Diaph1 knockdown. Additionally, expression of Rab5aQ79L (active Rab5a mutant) increased whereas the expression of Rab5aS34N (inactive mutant) reduced the endosomal localization of T beta RII in HSCs compared to the expression of wild-type Rab5a. Functionally, TGF beta stimulation promoted HSCs to express tumor-promoting factors, and alpha-smooth muscle actin, fibronection, and CTGF, markers of myofibroblastic activation of HSCs. Targeting Diaph1 or Rab5a suppressed HSC activation and limited tumor growth in a tumor implantation mouse model. Thus, Dipah1 and Rab5a represent targets for inhibiting HSC activation and the hepatic tumor microenvironment.	[Liu, Donglian; Fu, Xinhui; Wang, Yuanguo; Wang, Xianghu; Wang, Hua; Wen, Jialing; Kang, Ningling] Univ Minnesota, Hormel Inst, Tumor Microenvironm & Metastasis Sect, 801 16th Ave NE, Austin, MN 55912 USA; [Liu, Donglian] Guangzhou Med Univ, Qingyuan Peoples Hosp, Affiliated Hosp 6, Inst Digest Dis, Qingyuan, Guangdong, Peoples R China; [Fu, Xinhui; Wen, Jialing] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Pathol, Guangzhou, Peoples R China	University of Minnesota System; Guangzhou Medical University; Sun Yat Sen University	Kang, NL (corresponding author), Univ Minnesota, Hormel Inst, Tumor Microenvironm & Metastasis Sect, 801 16th Ave NE, Austin, MN 55912 USA.	nkang@umn.edu	Wang, Xianghu/GZA-6149-2022		NIH [R01 CA160069]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	NIH grant R01 CA160069 to N. Kang.	Anders RA, 1998, J BIOL CHEM, V273, P23118, DOI 10.1074/jbc.273.36.23118; Barbieri MA, 2000, J CELL BIOL, V151, P539, DOI 10.1083/jcb.151.3.539; Brandt DT, 2007, J CELL BIOL, V178, P193, DOI 10.1083/jcb.200612071; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Colucci-Guyon E, 2005, CURR BIOL, V15, P2007, DOI 10.1016/j.cub.2005.09.051; Copeland JW, 2004, J BIOL CHEM, V279, P50250, DOI 10.1074/jbc.M404429200; Decker NK, 2008, AM J PATHOL, V173, P1002, DOI 10.2353/ajpath.2008.080158; Dou CW, 2018, GASTROENTEROLOGY, V154, P2209, DOI 10.1053/j.gastro.2018.02.015; Edlund S, 2002, MOL BIOL CELL, V13, P902, DOI 10.1091/mbc.01-08-0398; Fernandez-Borja M, 2005, J CELL SCI, V118, P2661, DOI 10.1242/jcs.02384; Fouraux MA, 2004, MOL BIOL CELL, V15, P611, DOI 10.1091/mbc.E03-05-0343; Hayes S, 2002, J CELL BIOL, V158, P1239, DOI 10.1083/jcb.200204088; Hinze C, 2018, BIOCHEM SOC T, V46, P565, DOI 10.1042/BST20170355; Hoffenberg S, 2000, J BIOL CHEM, V275, P24661, DOI 10.1074/jbc.M909600199; Kang NL, 2015, MOL CANCER RES, V13, P604, DOI 10.1158/1541-7786.MCR-14-0542; Kang NL, 2011, HEPATOLOGY, V54, P707, DOI 10.1002/hep.24384; Kang NL, 2010, AM J PATHOL, V177, P1888, DOI 10.2353/ajpath.2010.100187; Kim D, 2016, ONCOTARGET, V7, P17829, DOI 10.18632/oncotarget.7429; Koli KM, 1997, J BIOL CHEM, V272, P6423, DOI 10.1074/jbc.272.10.6423; Kozlov MM, 2004, J CELL BIOL, V167, P1011, DOI 10.1083/jcb.200410017; Levayer R, 2011, NAT CELL BIOL, V13, P529, DOI 10.1038/ncb2224; Lewkowicz E, 2008, J CELL BIOL, V183, P1287, DOI 10.1083/jcb.200807023; Li F, 2003, CURR BIOL, V13, P1335, DOI 10.1016/S0960-9822(03)00540-2; Lin YN, 2015, ONCOTARGET, V6, P18577, DOI 10.18632/oncotarget.4094; Liu CS, 2014, AM J PHYSIOL-GASTR L, V307, pG749, DOI 10.1152/ajpgi.00138.2014; Liu CS, 2013, J CLIN INVEST, V123, P1138, DOI 10.1172/JCI63836; Lynch ED, 1997, SCIENCE, V278, P1315, DOI 10.1126/science.278.5341.1315; Mei Y, 2017, BLOOD ADV, V1, P1650, DOI 10.1182/bloodadvances.2017007906; Mitchell H, 2004, MOL BIOL CELL, V15, P4166, DOI 10.1091/mbc.E04-03-0245; Narumiya S, 1997, FEBS LETT, V410, P68, DOI 10.1016/S0014-5793(97)00317-7; Paul A, 2008, CURR BIOL, V18, P9, DOI 10.1016/j.cub.2007.11.062; Rahimi RA, 2007, J CELL BIOCHEM, V102, P593, DOI 10.1002/jcb.21501; Rizvi SA, 2009, CHEM BIOL, V16, P1158, DOI 10.1016/j.chembiol.2009.10.006; Routray C, 2011, AM J PHYSIOL-CELL PH, V301, pC66, DOI 10.1152/ajpcell.00038.2011; Sandbo N, 2011, AM J PHYSIOL-LUNG C, V301, pL656, DOI 10.1152/ajplung.00166.2011; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Stritt S, 2016, BLOOD, V127, P2903, DOI 10.1182/blood-2015-10-675629; Tominaga T, 2000, MOL CELL, V5, P13, DOI 10.1016/S1097-2765(00)80399-8; Tu KS, 2015, HEPATOLOGY, V61, P361, DOI 10.1002/hep.27251; Wallar BJ, 2006, J BIOL CHEM, V281, P4300, DOI 10.1074/jbc.M510277200; Wang YG, 2019, HEPATOLOGY, V70, P1409, DOI 10.1002/hep.30668; Yang JC, 2019, DIS MARKERS, V2019, DOI 10.1155/2019/6716472; Zhu GY, 2004, NAT STRUCT MOL BIOL, V11, P975, DOI 10.1038/nsmb832; Zuidscherwoude M, 2019, PLATELETS, V30, P23, DOI 10.1080/09537104.2018.1481937	45	8	8	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					7345	7359		10.1096/fj.201903033R	http://dx.doi.org/10.1096/fj.201903033R		APR 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32304339	hybrid, Green Accepted			2022-12-28	WOS:000527389800001
J	Yang, CL; Shen, SN; Zheng, XL; Ye, K; Ge, H; Sun, YN; Lu, YF				Yang, Chengliang; Shen, Sining; Zheng, Xiaoli; Ye, Ke; Ge, Hong; Sun, Yanan; Lu, Yufei			Long non-coding RNA LINC00337 induces autophagy and chemoresistance to cisplatin in esophageal squamous cell carcinoma cells via upregulation of TPX2 by recruiting E2F4	FASEB JOURNAL			English	Article						autophagy; chemoresistance; esophageal squamous cell carcinoma; long non-coding RNA LINC00337; targeting protein for Xenopus kinesin-like protein 2	CANCER; PROLIFERATION; APOPTOSIS; INHIBITION; PROMOTES; GROWTH; STAGE	Esophageal cancer represents the eighth most frequently occurring cancer, as well as the sixth most widespread cause of cancer-related deaths. In recent years, accumulating evidence has implicated long non-coding RNAs in the progression of esophageal squamous cell carcinoma (ESCC). The aim of the present study was to investigate the potential involvement and underlying mechanisms of LINC00337 in ESCC. Expression patterns of LINC00337 and targeting protein for Xenopus kinesin-like protein 2 (TPX2) in ESCC tissues and cells were detected using RT-qPCR and immunohistochemical staining. Next, the interactions among LINC00337, E2F4, and TPX2 were identified using chromatin immunoprecipitation, dual-luciferase reporter, and RNA-binding protein immunoprecipitation assays, suggesting that LINC00337 could recruit E2F4 to enhance the transcription of TPX2. Thereafter, the regulatory roles of LINC00337 and TPX2 in ESCC were analyzed by altering the expression of LINC00337 or TPX2 in ESCC cells following treatment with cisplatin (DDP). The levels of autophagy-related proteins Beclin1 and LC3II/LC3I, viability, autophagy, apoptosis, and chemoresistance of ESCC cells to DDP were measured following transfection treatment with different plasmids. Additionally, the role of the LINC00337/E2F4/TPX2 axis was assessed in vivo by measuring tumor formation in nude mice. The results demonstrated that LINC00337 upregulated TPX2, consequently leading to elevated levels of Beclin1 and LC3II/LC3I, promoted cell viability and autophagy, while inhibiting apoptosis and chemosensitivity to DDP in ESCC. In sum, the current study evidenced that the overexpression of LINC00337 could potentially enhance ESCC cell autophagy and chemoresistance to DDP via the upregulation of TPX2 by recruiting E2F4. Thus, LINC00337 may serve as a potential candidate for the treatment of ESCC.	[Yang, Chengliang; Zheng, Xiaoli; Ye, Ke; Ge, Hong; Sun, Yanan; Lu, Yufei] Zhengzhou Univ, Dept Radiat Oncol, Affiliated Canc Hosp, 127 Dongming Rd, Zhengzhou 450008, Henan, Peoples R China; [Shen, Sining] Zhengzhou Univ, Dept Thorac Surg, Affiliated Canc Hosp, Zhengzhou, Peoples R China	Zhengzhou University; Zhengzhou University	Ge, H (corresponding author), Zhengzhou Univ, Dept Radiat Oncol, Affiliated Canc Hosp, 127 Dongming Rd, Zhengzhou 450008, Henan, Peoples R China.	proge_hong@163.com	YANG, CHENGLIANG/AAP-4080-2020					Cao HH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106007; Chen H, 2018, AM J CANCER RES, V8, P291; Chen YS, 2013, PATHOL RES PRACT, V209, P562, DOI 10.1016/j.prp.2013.06.006; Gao B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178760; Hsu PK, 2014, J GASTROENTEROL, V49, P1231, DOI 10.1007/s00535-013-0870-6; Hu B, 2019, AM J TRANSL RES, V11, P3238; Jia SL, 2019, INFECT GENET EVOL, V67, P88, DOI 10.1016/j.meegid.2018.10.027; Kim JA, 2017, CHIN CLIN ONCOL, V6, DOI 10.21037/cco.2017.09.05; Kondo Y, 2017, CANCER SCI, V108, P1927, DOI 10.1111/cas.13342; Lee BK, 2011, NUCLEIC ACIDS RES, V39, P3558, DOI 10.1093/nar/gkq1313; Li J, 2006, J SURG RES, V132, P112, DOI 10.1016/j.jss.2005.10.005; Liu DL, 2011, MED ONCOL, V28, P105, DOI 10.1007/s12032-009-9397-3; Liu HC, 2014, BIOMED PHARMACOTHER, V68, P833, DOI 10.1016/j.biopha.2014.08.008; Liu HC, 2013, BIOMED PHARMACOTHER, V67, P751, DOI 10.1016/j.biopha.2013.04.004; Liu JB, 2011, WORLD J GASTROENTERO, V17, P4917, DOI 10.3748/wjg.v17.i44.4917; Nakajima M, 2013, EXPERT OPIN PHARMACO, V14, P1345, DOI 10.1517/14656566.2013.801454; O'Donovan TR, 2011, AUTOPHAGY, V7, P509, DOI 10.4161/auto.7.5.15066; Okuda M, 2017, ONCOTARGET, V8, P34670, DOI 10.18632/oncotarget.16668; Pu Q, 2016, THORAC CANCER, V7, P348, DOI 10.1111/1759-7714.12317; Shi WH, 2015, TUMOR BIOL, V36, P2501, DOI 10.1007/s13277-014-2863-3; Spizzo R, 2012, ONCOGENE, V31, P4577, DOI 10.1038/onc.2011.621; Tang QS, 2013, CANCER LETT, V336, P325, DOI 10.1016/j.canlet.2013.03.023; Toshimitsu H, 2004, CANCER LETT, V211, P69, DOI 10.1016/j.canlet.2004.01.038; Wang CM, 2014, DIGEST DIS SCI, V59, P591, DOI 10.1007/s10620-013-2956-7; Wang XH, 2016, J TOXICOL ENV HEAL A, V79, P407, DOI 10.1080/15287394.2016.1176617; Wang YJ, 2016, TUMOR BIOL, V37, P925, DOI 10.1007/s13277-015-3890-4; Zang WQ, 2016, ONCOTARGET, V7, P19960, DOI 10.18632/oncotarget.6963; Zhang X, 2019, OSA CONTINUUM, V2, P1, DOI 10.1364/OSAC.2.000001	28	21	21	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6055	6069		10.1096/fj.201900731RR	http://dx.doi.org/10.1096/fj.201900731RR		APR 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32239565				2022-12-28	WOS:000522969200001
J	Karlsen, A; Soendenbroe, C; Malmgaard-Clausen, NM; Wagener, F; Moeller, CE; Senhaji, Z; Damberg, K; Andersen, JL; Schjerling, P; Kjaer, M; Mackey, AL				Karlsen, Anders; Soendenbroe, Casper; Malmgaard-Clausen, Nikolaj M.; Wagener, Frederik; Moeller, Casper Emil; Senhaji, Zouhir; Damberg, Kristine; Andersen, Jesper Lovind; Schjerling, Peter; Kjaer, Michael; Mackey, Abigail L.			Preserved capacity for satellite cell proliferation, regeneration, and hypertrophy in the skeletal muscle of healthy elderly men	FASEB JOURNAL			English	Article						heavy resistance training; human; myofiber necrosis; myogenic progenitor cells; in vivo myogenesis; Sarcopenia	MYOFIBER HYPERTROPHY; OLDER MEN; PROTEIN SUPPLEMENTATION; MYONUCLEAR ADDITION; FIBER HYPERTROPHY; RESISTANCE; EXERCISE; YOUNG; STRENGTH; ACTIVATION	Blunted muscle hypertrophy and impaired regeneration with aging have been partly attributed to satellite cell (SC) dysfunction. However, true muscle regeneration has not yet been studied in elderly individuals. To investigate this, muscle injury was induced by 200 electrically stimulated (ES) eccentric contractions of the vastus lateralis (VL) of one leg in seven young (20-31 years) and 19 elderly men (60-73 years). This was followed by 13 weeks of resistance training (RT) for both legs to investigate the capacity for hypertrophy. Muscle biopsies were collected Pre- and Post-RT, and 9 days after ES, for immunohistochemistry and RT-PCR. Hypertrophy was assessed by MRI, DEXA, and immunohistochemistry. Overall, surprisingly comparable responses were observed between the young and elderly. Nine days after ES, Pax7+ SC number had doubled (P < .05), alongside necrosis and substantial changes in expression of genes related to matrix, myogenesis, and innervation (P < .05). Post-RT, VL cross-sectional area had increased in both legs (15%, P < .05) and SCs/type II fiber had increased 2-4 times more with ES+RT vs RT alone (P < .001). Together these novel findings demonstrate "youthful" regeneration and hypertrophy responses in human elderly muscle. Furthermore, boosting SC availability in healthy elderly men does not enhance the subsequent muscle hypertrophy response to RT.	[Karlsen, Anders; Soendenbroe, Casper; Malmgaard-Clausen, Nikolaj M.; Wagener, Frederik; Moeller, Casper Emil; Senhaji, Zouhir; Damberg, Kristine; Andersen, Jesper Lovind; Schjerling, Peter; Kjaer, Michael; Mackey, Abigail L.] Bispebjerg Hosp, Inst Sports Med Copenhagen, Dept Orthopaed Surg M, Copenhagen, Denmark; [Karlsen, Anders; Soendenbroe, Casper; Malmgaard-Clausen, Nikolaj M.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Biomed Sci, Copenhagen, Denmark; [Karlsen, Anders; Soendenbroe, Casper; Malmgaard-Clausen, Nikolaj M.; Andersen, Jesper Lovind; Schjerling, Peter; Kjaer, Michael] Univ Copenhagen, Fac Hlth & Med Sci, Ctr Hlth Aging, Copenhagen, Denmark; [Mackey, Abigail L.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Biomed Sci, Ctr Hlth Aging,Xlab, Copenhagen, Denmark	University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; University of Copenhagen; University of Copenhagen	Mackey, AL (corresponding author), Bispebjerg Hosp, Inst Sports Med Copenhagen, Dept Orthopaed Surg M, Copenhagen, Denmark.	abigailmac@sund.ku.dk	Kjaer, Michael/W-6842-2019; Soendenbroe, Casper/ABG-2515-2021; Mackey, Abigail/D-1060-2009; Karlsen, Anders/S-6236-2019; Schjerling, Peter/F-6194-2011; Andersen, Jesper L/W-6813-2019	Kjaer, Michael/0000-0002-4582-8755; Soendenbroe, Casper/0000-0002-6579-5700; Mackey, Abigail/0000-0002-2017-4580; Karlsen, Anders/0000-0002-9356-1346; Schjerling, Peter/0000-0001-7138-3211; Sigvardsen, Casper Moller/0000-0002-9891-5721	Nordea Foundation (Healthy Aging Grant); Lundbeck Foundation [R303-2018-3427]; Danish Council for Independent Research; Danish Agency for Culture [FPK.2016-0023]; Bispebjerg Hospital; Danish Rheumatism Association [R160-A5113]; Faculty of Health and Medical Sciences at the University of Copenhagen; AP Moller Foundation for the Advancement of Medical Science	Nordea Foundation (Healthy Aging Grant); Lundbeck Foundation(Lundbeckfonden); Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Danish Agency for Culture; Bispebjerg Hospital; Danish Rheumatism Association; Faculty of Health and Medical Sciences at the University of Copenhagen; AP Moller Foundation for the Advancement of Medical Science	Funding from The Nordea Foundation (Healthy Aging Grant), The Lundbeck Foundation (R303-2018-3427), The Danish Council for Independent Research, Danish Agency for Culture (FPK.2016-0023), Bispebjerg Hospital, The AP Moller Foundation for the Advancement of Medical Science, The Danish Rheumatism Association (R160-A5113), and the Faculty of Health and Medical Sciences at the University of Copenhagen, is gratefully acknowledged.	Aagaard P, 2001, J PHYSIOL-LONDON, V534, P613, DOI 10.1111/j.1469-7793.2001.t01-1-00613.x; Agergaard J, 2015, NUTR METAB, V12, DOI 10.1186/s12986-015-0029-y; Bamman MM, 2007, J APPL PHYSIOL, V102, P2232, DOI 10.1152/japplphysiol.00024.2007; Bamman MM, 2018, CSH PERSPECT MED, V8, DOI 10.1101/cshperspect.a029751; Beaudart C, 2014, ARCH PUBLIC HEALTH, V72, DOI 10.1186/2049-3258-72-45; Bechshoft CJL, 2019, AM J PHYSIOL-CELL PH, V316, pC898, DOI 10.1152/ajpcell.00049.2019; Bellamy LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109739; Brook MS, 2016, J PHYSIOL-LONDON, V594, P7399, DOI 10.1113/JP272857; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Crameri RM, 2007, J PHYSIOL-LONDON, V583, P365, DOI 10.1113/jphysiol.2007.128827; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Dirks ML, 2017, J AM MED DIR ASSOC, V18, P608, DOI 10.1016/j.jamda.2017.02.006; Dreyer HC, 2006, MUSCLE NERVE, V33, P242, DOI 10.1002/mus.20461; Farup J, 2014, J APPL PHYSIOL, V117, P898, DOI 10.1152/japplphysiol.00261.2014; Gundersen K, 2008, J PHYSIOL-LONDON, V586, P2675, DOI 10.1113/jphysiol.2008.154369; Hakkinen K, 1998, J GERONTOL A-BIOL, V53, pB415, DOI 10.1093/gerona/53A.6.B415; Hardy D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147198; Heisterberg MF, 2018, J APPL PHYSIOL, V125, P1536, DOI 10.1152/japplphysiol.00106.2018; Joanisse S, 2016, FASEB J, V30, P3256, DOI 10.1096/fj.201600143RR; Karlsen A, 2020, MED SCI SPORT EXER, V52, P773, DOI 10.1249/MSS.0000000000002191; Karlsen A, 2019, ACTA PHYSIOL, V227, DOI 10.1111/apha.13271; Kosek DJ, 2006, J APPL PHYSIOL, V101, P531, DOI 10.1152/japplphysiol.01474.2005; Koulmann N, 2017, MUSCLE NERVE, V55, P91, DOI 10.1002/mus.25151; Leenders M, 2013, J GERONTOL A-BIOL, V68, P769, DOI 10.1093/gerona/gls241; Lepper C, 2011, DEVELOPMENT, V138, P3639, DOI 10.1242/dev.067595; LEXELL J, 1988, J NEUROL SCI, V84, P275, DOI 10.1016/0022-510X(88)90132-3; Mackey AL, 2016, FASEB J, V30, P2266, DOI 10.1096/fj.201500198R; McKay BR, 2012, FASEB J, V26, P2509, DOI 10.1096/fj.11-198663; Melnyk JA, 2009, EUR J APPL PHYSIOL, V105, P929, DOI 10.1007/s00421-008-0979-0; Mero AA, 2013, EUR J APPL PHYSIOL, V113, P641, DOI 10.1007/s00421-012-2466-x; Mertz KH, 2019, SCAND J MED SCI SPOR, V29, P1901, DOI 10.1111/sms.13524; Mitchell WK, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00260; Moore DR, 2018, EUR J APPL PHYSIOL, V118, P2225, DOI 10.1007/s00421-018-3954-4; Murach KA, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00635; Nederveen JP, 2017, AM J PHYSIOL-REG I, V312, pR85, DOI 10.1152/ajpregu.00221.2016; Olguin HC, 2004, DEV BIOL, V275, P375, DOI 10.1016/j.ydbio.2004.08.015; Olguin HC, 2007, J CELL BIOL, V177, P769, DOI 10.1083/jcb.200608122; Petrella JK, 2008, J APPL PHYSIOL, V104, P1736, DOI 10.1152/japplphysiol.01215.2007; Petrella JK, 2006, AM J PHYSIOL-ENDOC M, V291, pE937, DOI 10.1152/ajpendo.00190.2006; SADEH M, 1988, J NEUROL SCI, V87, P67, DOI 10.1016/0022-510X(88)90055-X; Shavlakadze T, 2010, BIOGERONTOLOGY, V11, P363, DOI 10.1007/s10522-009-9260-0; Snijders T, 2016, ACTA PHYSIOL, V216, P231, DOI 10.1111/apha.12609; Snijders T, 2017, J CACHEXIA SARCOPENI, V8, P267, DOI 10.1002/jcsm.12137; Snijders T, 2014, AGE, V36, DOI 10.1007/s11357-014-9699-z; Soendenbroe C, 2019, MUSCLE NERVE, V60, P453, DOI 10.1002/mus.26638; Sousa-Victor P, 2014, NATURE, V506, P316, DOI 10.1038/nature13013; Verdijk LB, 2014, AGE, V36, P545, DOI 10.1007/s11357-013-9583-2; Verdijk LB, 2009, J GERONTOL A-BIOL, V64, P332, DOI 10.1093/gerona/gln050	48	29	30	2	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6418	6436		10.1096/fj.202000196R	http://dx.doi.org/10.1096/fj.202000196R		MAR 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32167202				2022-12-28	WOS:000519869100001
J	Stoss, C; Laschinger, M; Wang, BC; Lu, M; Altmayr, F; Hartmann, D; Huser, N; Holzmann, B				Stoess, Christian; Laschinger, Melanie; Wang, Baocai; Lu, Miao; Altmayr, Felicitas; Hartmann, Daniel; Hueser, Norbert; Holzmann, Bernhard			TLR3 promotes hepatocyte proliferation after partial hepatectomy by stimulating uPA expression and the release of tissue-bound HGF	FASEB JOURNAL			English	Article						HGF; liver regeneration; stellate cells; TLR3; urokinase-type plasminogen activator	TOLL-LIKE RECEPTOR-3; GROWTH-FACTOR RECEPTOR; LIVER-REGENERATION; CELLS; INNATE; MET; RNA; RECOGNITION; ACTIVATION; NECROSIS	TLR3 is implicated in anti-viral immune responses, but may also act as a sensor of tissue damage in the absence of infection. Here, we provide evidence for an essential role of TLR3 in liver regeneration after an acute loss of tissue due to partial hepatectomy. Mice lacking TLR3 had a severe and sustained defect in the restoration of liver tissue with reduced liver-to-body weight ratios even after an extended recovery period of 2 weeks. Hepatocyte cell cycle progression into S phase was impaired in TLR3-deficient mice. Mechanistic analyses revealed that TLR3-deficient mice had markedly reduced systemic levels of active HGF, but had increased amounts of inactive tissue-bound HGF. Importantly, expression of uPA, which orchestrates the processing and release of HGF from the hepatic extracellular matrix, was reduced in regenerating livers of TLR3-deficient mice. In addition, expression of the HGF maturation factor HGFAC was transiently diminished in TLR3-deficient mice. In vitro, engagement of TLR3 directly stimulated expression of uPA by hepatic stellate cells. Thus, TLR3 supports liver regeneration through upregulation of uPA, which promotes the release of preformed HGF from extracellular matrix stores.	[Stoess, Christian; Laschinger, Melanie; Wang, Baocai; Lu, Miao; Altmayr, Felicitas; Hartmann, Daniel; Hueser, Norbert; Holzmann, Bernhard] Tech Univ Munich, Sch Med, Dept Surg, Ismaninger Str 22, D-81675 Munich, Germany	Technical University of Munich	Holzmann, B (corresponding author), Tech Univ Munich, Sch Med, Dept Surg, Ismaninger Str 22, D-81675 Munich, Germany.	bernhard.holzmann@tum.de		Stoess, Christian/0000-0002-0682-8808	Technical University of Munich	Technical University of Munich	Technical University of Munich	Alison MR, 2016, J PATHOL, V238, P371, DOI 10.1002/path.4667; Barbalat R, 2011, ANNU REV IMMUNOL, V29, P185, DOI 10.1146/annurev-immunol-031210-101340; Bernard JJ, 2012, NAT MED, V18, P1286, DOI 10.1038/nm.2861; Borowiak M, 2004, P NATL ACAD SCI USA, V101, P10608, DOI 10.1073/pnas.0403412101; Brentano F, 2005, ARTHRITIS RHEUM-US, V52, P2656, DOI 10.1002/art.21273; Campbell JS, 2006, J IMMUNOL, V176, P2522, DOI 10.4049/jimmunol.176.4.2522; Cavassani KA, 2008, J EXP MED, V205, P2609, DOI 10.1084/jem.20081370; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Crispe IN, 2016, J IMMUNOL, V196, P17, DOI 10.4049/jimmunol.1501668; DeLeve LD, 2013, J CLIN INVEST, V123, P1861, DOI 10.1172/JCI66025; Desmet CJ, 2012, NAT REV IMMUNOL, V12, P479, DOI 10.1038/nri3247; Dick FA, 2013, NAT REV MOL CELL BIO, V14, P297, DOI 10.1038/nrm3567; Estornes Y, 2012, CELL DEATH DIFFER, V19, P1482, DOI 10.1038/cdd.2012.22; Factor VM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012739; Faure-Dupuy S, 2018, J INNATE IMMUN, V10, P339, DOI 10.1159/000489966; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Feoktistova M, 2011, MOL CELL, V43, P449, DOI 10.1016/j.molcel.2011.06.011; He SD, 2011, P NATL ACAD SCI USA, V108, P20054, DOI 10.1073/pnas.1116302108; Huh CG, 2004, P NATL ACAD SCI USA, V101, P4477, DOI 10.1073/pnas.0306068101; Kaiser WJ, 2013, J BIOL CHEM, V288, P31268, DOI 10.1074/jbc.M113.462341; Kaiser WJ, 2005, J IMMUNOL, V174, P4942, DOI 10.4049/jimmunol.174.8.4942; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kocabayoglu P, 2016, LIVER INT, V36, P874, DOI 10.1111/liv.12933; Leyland H, 1996, HEPATOLOGY, V24, P1172, DOI 10.1002/hep.510240532; MARS WM, 1995, HEPATOLOGY, V21, P1695, DOI 10.1016/0270-9139(95)90477-8; Mei XP, 2011, NEUROSIGNALS, V19, P44, DOI 10.1159/000324293; Mitchell C, 2008, NAT PROTOC, V3, P1167, DOI 10.1038/nprot.2008.80; Modares NF, 2019, HEPATOLOGY, V70, P2075, DOI 10.1002/hep.30774; Mohammed FF, 2005, TRENDS CELL BIOL, V15, P555, DOI 10.1016/j.tcb.2005.08.009; Natarajan A, 2007, P NATL ACAD SCI USA, V104, P17081, DOI 10.1073/pnas.0704126104; Nelson AM, 2015, CELL STEM CELL, V17, P139, DOI 10.1016/j.stem.2015.07.008; Paranjpe S, 2007, HEPATOLOGY, V45, P1471, DOI 10.1002/hep.21570; Paranjpe S, 2016, HEPATOLOGY, V64, P1711, DOI 10.1002/hep.28721; Paranjpe S, 2010, AM J PATHOL, V176, P2669, DOI 10.2353/ajpath.2010.090605; Pediaditakis P, 2001, HEPATOLOGY, V34, P688, DOI 10.1053/jhep.2001.27811; Perales-Linares R, 2013, IMMUNOLOGY, V140, P153, DOI 10.1111/imm.12143; Riehle KJ, 2011, J GASTROEN HEPATOL, V26, P203, DOI 10.1111/j.1440-1746.2010.06539.x; Roselli HT, 1998, AM J PHYSIOL-GASTR L, V275, pG1472, DOI 10.1152/ajpgi.1998.275.6.G1472; Schulze S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29924-3; Schuppan D, 1998, GASTROENTEROLOGY, V114, P139, DOI 10.1016/S0016-5085(98)70642-0; Seki E, 2005, HEPATOLOGY, V41, P443, DOI 10.1002/hep.20603; Seo W, 2016, HEPATOLOGY, V64, P616, DOI 10.1002/hep.28644; Shimizu M, 2001, HEPATOLOGY, V33, P569, DOI 10.1053/jhep.2001.22650; Sun R, 2004, GASTROENTEROLOGY, V127, P1525, DOI 10.1053/j.gastro.2004.08.055; Sun R, 2006, HEPATOLOGY, V44, P955, DOI 10.1002/hep.21344; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Toscano F, 2013, J IMMUNOL, V190, P764, DOI 10.4049/jimmunol.1202173; Tsuchida T, 2017, NAT REV GASTRO HEPAT, V14, P397, DOI 10.1038/nrgastro.2017.38; Vaquero J, 2011, HEPATOLOGY, V54, P597, DOI 10.1002/hep.24420; WAKE K, 1971, AM J ANAT, V132, P429, DOI 10.1002/aja.1001320404; Wang L, 2012, J CLIN INVEST, V122, P1567, DOI 10.1172/JCI58789; Wilson CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083391; Zorde-Khvalevsky E, 2009, HEPATOLOGY, V50, P198, DOI 10.1002/hep.22973	54	5	5	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10387	10397		10.1096/fj.202000904R	http://dx.doi.org/10.1096/fj.202000904R		JUN 2020	11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32539223	hybrid			2022-12-28	WOS:000541802400001
J	Kuma, A; Wang, XNH; Klein, JD; Tan, L; Naqvi, N; Rianto, F; Huang, Y; Yu, MS; Sands, JM				Kuma, Akihiro; Wang, Xiaonan H.; Klein, Janet D.; Tan, Lin; Naqvi, Nawazish; Rianto, Fitra; Huang, Ying; Yu, Manshu; Sands, Jeff M.			Inhibition of urea transporter ameliorates uremic cardiomyopathy in chronic kidney disease	FASEB JOURNAL			English	Article						cardiac fibrosis; cardiovascular disease; dimethylthiourea; diuretics; hypertrophy	CONVERTING ENZYME-INHIBITORS; UT-A; CARDIOVASCULAR EVENTS; MYOCARDIAL-INFARCTION; ATRIAL-FIBRILLATION; CARDIAC FIBROSIS; RENAL-FUNCTION; HEART-FAILURE; HYPERTENSION; HYPERTROPHY	Uremic cardiomyopathy, characterized by hypertension, cardiac hypertrophy, and fibrosis, is a complication of chronic kidney disease (CKD). Urea transporter (UT) inhibition increases the excretion of water and urea, but the effect on uremic cardiomyopathy has not been studied. We tested UT inhibition by dimethylthiourea (DMTU) in 5/6 nephrectomy mice. This treatment suppressed CKD-induced hypertension and cardiac hypertrophy. In CKD mice, cardiac fibrosis was associated with upregulation of UT and vimentin abundance. Inhibition of UT suppressed vimentin amount. Left ventricular mass index in DMTU-treated CKD was less compared with non-treated CKD mice as measured by echocardiography. Nephrectomy was performed in UT-A1/A3 knockout (UT-KO) to further confirm our finding. UT-A1/A3 deletion attenuates the CKD-induced increase in cardiac fibrosis and hypertension. The amount of alpha-smooth muscle actin and tgf-beta were significantly less in UT-KO with CKD than WT/CKD mice. To study the possibility that UT inhibition could benefit heart, we measured the mRNA of renin and angiotensin-converting enzyme (ACE), and found both were sharply increased in CKD heart; DMTU treatment and UT-KO significantly abolished these increases. Conclusion: Inhibition of UT reduced hypertension, cardiac fibrosis, and improved heart function. These changes are accompanied by inhibition of renin and ACE.	[Kuma, Akihiro; Wang, Xiaonan H.; Klein, Janet D.; Rianto, Fitra; Huang, Ying; Yu, Manshu; Sands, Jeff M.] Emory Univ, Sch Med, Dept Med, Renal Div, 1639 Pierce Dr,WMB Rm 3313, Atlanta, GA 30322 USA; [Kuma, Akihiro] Univ Occupat & Environm Hlth, Sch Med, Dept Internal Med 2, Kitakyushu, Fukuoka, Japan; [Tan, Lin; Naqvi, Nawazish] Emory Univ, Sch Med, Dept Med, Div Cardiol, Atlanta, GA USA; [Yu, Manshu] Nanjing Univ Chinese Med, Renal Div, Affiliated Hosp, Nanjing, Peoples R China	Emory University; University of Occupational & Environmental Health - Japan; Emory University; Nanjing University of Chinese Medicine	Wang, XNH; Sands, JM (corresponding author), Emory Univ, Sch Med, Dept Med, Renal Div, 1639 Pierce Dr,WMB Rm 3313, Atlanta, GA 30322 USA.	xwang03@emory.edu; jeff.sands@emory.edu	Kuma, Akihiro/AAT-7155-2020; Rianto, Fitra/AAN-3056-2021	Kuma, Akihiro/0000-0002-4242-7921; Rianto, Fitra/0000-0002-6241-6816	NIH/NIDDK [R01 DK41707]; Japan Heart Foundation/Bayer Yakuhin Research Grant Abroad; American Heart Association Discover and Innovation Grants - Bayer Group [17IBDG33780000]	NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Japan Heart Foundation/Bayer Yakuhin Research Grant Abroad; American Heart Association Discover and Innovation Grants - Bayer Group	This work was supported by NIH/NIDDK grant R01 DK41707 to JMS; Japan Heart Foundation/Bayer Yakuhin Research Grant Abroad to AK; the American Heart Association Discover and Innovation Grants supported by Bayer Group (17IBDG33780000) to XHW The content is solely the responsibility of the authors and does not necessarily reflect the official views of the NIH, or the US Government	Aarabi S, 2007, FASEB J, V21, P3250, DOI 10.1096/fj.07-8218com; Ainscough JFX, 2009, CARDIOVASC RES, V81, P592, DOI 10.1093/cvr/cvn230; Darby IA, 2014, CLIN COSMET INV DERM, V7, P301, DOI 10.2147/CCID.S50046; De Mello WC, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00016; Doran JJ, 2006, AM J PHYSIOL-REG I, V290, pR1446, DOI 10.1152/ajpregu.00352.2004; Duchesne R, 2001, CIRC RES, V89, P139, DOI 10.1161/hh1401.093293; Efe O, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88409; Esteva-Font C, 2014, FASEB J, V28, P3878, DOI 10.1096/fj.14-253872; Fenton RA, 2005, J AM SOC NEPHROL, V16, P1583, DOI 10.1681/ASN.2005010031; Fenton RA, 2004, P NATL ACAD SCI USA, V101, P7469, DOI 10.1073/pnas.0401704101; Fenton RA, 2007, J AM SOC NEPHROL, V18, P679, DOI 10.1681/ASN.2006101108; Forrester SJ, 2018, PHYSIOL REV, V98, P1627, DOI 10.1152/physrev.00038.2017; GABBIANI G, 1971, EXPERIENTIA, V27, P549, DOI 10.1007/BF02147594; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Greene SJ, 2013, EUR J HEART FAIL, V15, P1401, DOI 10.1093/eurjhf/hft110; Gumprecht J, 2019, J HUM HYPERTENS, V33, P824, DOI 10.1038/s41371-019-0279-7; Healey JS, 2005, J AM COLL CARDIOL, V45, P1832, DOI 10.1016/j.jacc.2004.11.070; Ilori TO, 2013, AM J PHYSIOL-RENAL, V304, pF103, DOI 10.1152/ajprenal.00385.2012; Inoue H, 2005, AM J PHYSIOL-RENAL, V289, pF451, DOI 10.1152/ajprenal.00376.2004; Jin NN, 2019, MED SCI MONITOR, V25, P6605, DOI 10.12659/MSM.914877; Kennedy DJ, 2008, AM J PHYSIOL-RENAL, V294, pF450, DOI 10.1152/ajprenal.00472.2007; Kinugawa S, 2000, CIRC RES, V87, P392; Kitada K, 2017, J CLIN INVEST, V127, P1944, DOI 10.1172/JCI88532; Klein JD, 2016, J AM SOC NEPHROL, V27, P1448, DOI 10.1681/ASN.2014121267; Klein JD, 2012, PFLUG ARCH EUR J PHY, V464, P561, DOI 10.1007/s00424-012-1157-0; Kumagai K, 2003, J AM COLL CARDIOL, V41, P2197, DOI 10.1016/S0735-1097(03)00464-9; Laurino A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20194912; London GM, 2003, SEMIN DIALYSIS, V16, P85, DOI 10.1046/j.1525-139X.2003.16023.x; Marquez DF, 2015, EXPERT OPIN PHARMACO, V16, P2283, DOI 10.1517/14656566.2015.1079623; Messerli FH, 2018, J AM COLL CARDIOL, V71, P1474, DOI 10.1016/j.jacc.2018.01.058; Perkovic V, 2007, J AM SOC NEPHROL, V18, P2766, DOI 10.1681/ASN.2007020256; Romero C, 2015, NAT REV ENDOCRINOL, V11, P242, DOI 10.1038/nrendo.2015.6; Sands JM, 2004, CURR OPIN NEPHROL HY, V13, P525, DOI 10.1097/00041552-200409000-00008; Trespalacios FC, 2003, AM J KIDNEY DIS, V41, P1267, DOI 10.1016/S0272-6386(03)00359-7; United States Renal Data System, 2018, ANN DAT REP, V4, P79; von Lueder TG, 2015, CIRC-HEART FAIL, V8, P71, DOI 10.1161/CIRCHEARTFAILURE.114.001785; Wang B, 2019, THERANOSTICS, V9, P1864, DOI 10.7150/thno.29579; Wang B, 2017, J AM SOC NEPHROL, V28, P2632, DOI 10.1681/ASN.2016111213; Wang XNH, 2011, J AM SOC NEPHROL, V22, P2068, DOI 10.1681/ASN.2010121278; Wang XNH, 2009, KIDNEY INT, V76, P751, DOI 10.1038/ki.2009.260; Yamakawa H, 2000, AM J PHYSIOL-HEART C, V279, pH2939, DOI 10.1152/ajpheart.2000.279.6.H2939; Yeih DF, 2009, AM J PHYSIOL-HEART C, V297, pH1411, DOI 10.1152/ajpheart.01269.2008; Zoccali C, 2017, J AM SOC NEPHROL, V28, P2491, DOI 10.1681/ASN.2016121341	43	6	6	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8296	8309		10.1096/fj.202000214RR	http://dx.doi.org/10.1096/fj.202000214RR		MAY 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32367640	Green Accepted			2022-12-28	WOS:000530924800001
J	Griffiths, KK; Wang, AL; Wang, LF; Tracey, M; Kleiner, G; Quinzii, CM; Sun, LL; Yang, G; Perez-Zoghbi, JF; Licznerski, P; Yang, M; Jonas, EA; Levy, RJ				Griffiths, Keren K.; Wang, Aili; Wang, Lifei; Tracey, Matthew; Kleiner, Giulio; Quinzii, Catarina M.; Sun, Linlin; Yang, Guang; Perez-Zoghbi, Jose F.; Licznerski, Pawel; Yang, Mu; Jonas, Elizabeth A.; Levy, Richard J.			Inefficient thermogenic mitochondrial respiration due to futile proton leak in a mouse model of fragile X syndrome	FASEB JOURNAL			English	Article						coenzyme Q; Fmr1; Fragile X syndrome; mitochondria; permeability transition pore; proton leak; synaptogenesis; thermogenic; ubiquinone; uncoupled respiration	PERMEABILITY TRANSITION PORE; MENTAL-RETARDATION PROTEIN; BROWN ADIPOSE-TISSUE; BRAIN MITOCHONDRIA; ENERGY-METABOLISM; DENDRITIC SPINES; MESSENGER-RNAS; FMRP; EXPRESSION; AUTISM	Fragile X syndrome (FXS) is the leading known inherited intellectual disability and the most common genetic cause of autism. The full mutation results in transcriptional silencing of the Fmr1 gene and loss of fragile X mental retardation protein (FMRP) expression. Defects in neuroenergetic capacity are known to cause a variety of neurodevelopmental disorders. Thus, we explored the integrity of forebrain mitochondria in Fmr1 knockout mice during the peak of synaptogenesis. We found inefficient thermogenic respiration due to futile proton leak in Fmr1 KO mitochondria caused by coenzyme Q (CoQ) deficiency and an open cyclosporine-sensitive channel. Repletion of mitochondrial CoQ within the Fmr1 KO forebrain closed the channel, blocked the pathological proton leak, restored rates of protein synthesis during synaptogenesis, and normalized the key phenotypic features later in life. The findings demonstrate that FMRP deficiency results in inefficient oxidative phosphorylation during the neurodevelopment and suggest that dysfunctional mitochondria may contribute to the FXS phenotype.	[Griffiths, Keren K.; Wang, Aili; Wang, Lifei; Tracey, Matthew; Sun, Linlin; Yang, Guang; Perez-Zoghbi, Jose F.; Levy, Richard J.] Columbia Univ, Dept Anesthesiol, Med Ctr, PH5-534B,622 W 168th St, New York, NY 10032 USA; [Kleiner, Giulio; Quinzii, Catarina M.] Columbia Univ, Dept Neurol, Med Ctr, New York, NY USA; [Licznerski, Pawel; Jonas, Elizabeth A.] Yale Univ, Sch Med, Dept Internal Med, Sect Endocrinol, New Haven, CT 06510 USA; [Yang, Mu] Columbia Univ, Med Ctr, Inst Genom Med & Psychiat, New York, NY USA	Columbia University; Columbia University; Yale University; Columbia University	Levy, RJ (corresponding author), Columbia Univ, Dept Anesthesiol, Med Ctr, PH5-534B,622 W 168th St, New York, NY 10032 USA.	RL2740@cumc.columbia.edu	, WaNgtJ/AAR-7045-2020	Yang, Guang/0000-0002-5739-9126; Kleiner, Giulio/0000-0002-1830-3961; Tracey, Matthew/0000-0002-2487-5616; Licznerski, Pawel/0000-0003-2761-8428	National Institute of Neurological Disorders and Stroke (NINDS) [R01NS112706, R01NS081746, R37NS045876]; National Institute of Environmental Health Sciences (NIEHS) [P30 ES009089]; National Institute on Alcohol Abuse and Alcoholism (NIAAA) [R01AA027108]	National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute on Alcohol Abuse and Alcoholism (NIAAA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	National Institute of Neurological Disorders and Stroke (NINDS), Grant/Award Number: R01NS112706, R01NS112706, R01NS081746 and R37NS045876; National Institute of Environmental Health Sciences (NIEHS), Grant/Award Number: P30 ES009089; National Institute on Alcohol Abuse and Alcoholism (NIAAA), Grant/Award Number: R01AA027108	Acosta MJ, 2016, BBA-BIOENERGETICS, V1857, P1079, DOI 10.1016/j.bbabio.2016.03.036; Alavian KN, 2014, P NATL ACAD SCI USA, V111, P10580, DOI 10.1073/pnas.1401591111; Amo T, 2007, BIOCHEM J, V404, P345, DOI 10.1042/BJ20061609; Anderson CM, 2015, CELL REP, V10, P505, DOI 10.1016/j.celrep.2014.12.048; ARROYO ED, 2018, J NEUROSCI, V10, P1734; Aryal S, 2018, SCIENCE, V361, P648, DOI 10.1126/science.aau6450; Ascano M, 2012, NATURE, V492, P382, DOI 10.1038/nature11737; Bailey DB, 2017, PEDIATRICS, V139, pS216, DOI [10.1542/peds.2016-1159h, 10.1542/peds.2016-1159H]; Ballinger MA, 2017, AM J PHYSIOL-REG I, V312, pR301, DOI 10.1152/ajpregu.00314.2016; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Bonaccorso CM, 2015, INT J DEV NEUROSCI, V42, P15, DOI 10.1016/j.ijdevneu.2015.02.004; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cao RF, 2015, NAT NEUROSCI, V18, P855, DOI 10.1038/nn.4010; Cardoso S, 2013, J BIOENERG BIOMEMBR, V45, P397, DOI 10.1007/s10863-013-9503-2; Cirelli C, 2015, BIOL PSYCHIAT, V77, P1071, DOI 10.1016/j.biopsych.2014.12.017; Cruz-Martin A, 2010, J NEUROSCI, V30, P7793, DOI 10.1523/JNEUROSCI.0577-10.2010; D'Antoni S, 2020, BIOL CHEM, V401, P497, DOI 10.1515/hsz-2019-0221; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Divakaruni AS, 2011, PHYSIOLOGY, V26, P192, DOI 10.1152/physiol.00046.2010; Ferreiro-Barros CC, 2012, EINSTEIN-SAO PAULO, V10, P203, DOI 10.1590/S1679-45082012000200014; Fink BD, 2002, J BIOL CHEM, V277, P3918, DOI 10.1074/jbc.M107955200; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; Galvez R, 2005, AM J MED GENET A, V135A, P155, DOI 10.1002/ajmg.a.30709; Garre JM, 2017, NAT MED, V23, P714, DOI 10.1038/nm.4340; Gautier CA, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-22; Gholizadeh S, 2015, BRAIN RES, V1596, P22, DOI 10.1016/j.brainres.2014.11.023; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Greenblatt EJ, 2018, SCIENCE, V361, P709, DOI 10.1126/science.aas9963; Greenough WT, 2001, P NATL ACAD SCI USA, V98, P7101, DOI 10.1073/pnas.141145998; Hagerman RJ, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.65; Hansson MJ, 2003, BRAIN RES, V960, P99, DOI 10.1016/S0006-8993(02)03798-8; Hernandez-Camacho JD, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00044; Hom JR, 2011, DEV CELL, V21, P469, DOI 10.1016/j.devcel.2011.08.008; Hou Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076721; Hou Y, 2012, STEM CELLS, V30, P2535, DOI 10.1002/stem.1213; James AM, 2005, J BIOL CHEM, V280, P21295, DOI 10.1074/jbc.M501527200; Kazdoba TM, 2014, INTRACTABLE RARE DIS, V3, P118, DOI 10.5582/irdr.2014.01024; Kuzawa CW, 2014, P NATL ACAD SCI USA, V111, P13010, DOI 10.1073/pnas.1323099111; Lee C. P., 1993, V2, P41; Levy RJ, 2004, SHOCK, V21, P110, DOI 10.1097/01.shk.0000108400.56565.ab; Licitra F, 2014, MOL SYNDROMOL, V5, P180, DOI 10.1159/000362942; Lopez-Lluch G, 2019, NUTRITION, V57, P133, DOI 10.1016/j.nut.2018.05.020; Lumaban JG, 2015, HUM MOL GENET, V24, P2175, DOI 10.1093/hmg/ddu737; Magistretti PJ, 2015, NEURON, V86, P883, DOI 10.1016/j.neuron.2015.03.035; McKinney BC, 2005, AM J MED GENET B, V136B, P98, DOI 10.1002/ajmg.b.30183; Miyadera H, 2003, P NATL ACAD SCI USA, V100, P473, DOI 10.1073/pnas.0237315100; Mnatsakanyan N, 2017, J BIOENERG BIOMEMBR, V49, P13, DOI 10.1007/s10863-016-9652-1; Muddashetty RS, 2007, J NEUROSCI, V27, P5338, DOI 10.1523/JNEUROSCI.0937-07.2007; Nimchinsky EA, 2001, J NEUROSCI, V21, P5139, DOI 10.1523/JNEUROSCI.21-14-05139.2001; Osterweil EK, 2013, NEURON, V77, P243, DOI 10.1016/j.neuron.2012.01.034; Osterweil EK, 2010, J NEUROSCI, V30, P15616, DOI 10.1523/JNEUROSCI.3888-10.2010; Paxinos G, 2007, ATLAS DEV MOUSE BRAI; Perez MJ, 2017, DEV BIOL, V426, P1, DOI 10.1016/j.ydbio.2017.04.018; PETRONILLI V, 1994, BBA-BIOENERGETICS, V1187, P255, DOI 10.1016/0005-2728(94)90122-8; Petronilli V, 1999, BIOPHYS J, V76, P725, DOI 10.1016/S0006-3495(99)77239-5; PUMPHREY AM, 1960, BIOCHEM J, V76, P61, DOI 10.1042/bj0760061; Rangaraju V, 2019, CELL, V176, P73, DOI 10.1016/j.cell.2018.12.013; Rao VK, 2014, BBA-MOL BASIS DIS, V1842, P1267, DOI 10.1016/j.bbadis.2013.09.003; Rice D, 2000, ENVIRON HEALTH PERSP, V108, P511, DOI 10.2307/3454543; Riley C, 2017, PEDIATRICS, V139, pS207, DOI 10.1542/peds.2016-1159G; Rossignol DA, 2012, MOL PSYCHIATR, V17, P290, DOI 10.1038/mp.2010.136; Rumana CS, 1998, CRIT CARE MED, V26, P562, DOI 10.1097/00003246-199803000-00032; Scorrano L, 1997, J BIOL CHEM, V272, P12295, DOI 10.1074/jbc.272.19.12295; Sethna F, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14359; SHAHBAZIAN FM, 1987, INT J DEV NEUROSCI, V5, P39, DOI 10.1016/0736-5748(87)90046-3; SHAHBAZIAN FM, 1986, INT J DEV NEUROSCI, V4, P209, DOI 10.1016/0736-5748(86)90060-2; Singh K, 2007, MOL BIOL REP, V34, P173, DOI 10.1007/s11033-006-9032-8; Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058; Telford JE, 2010, J BIOL CHEM, V285, P8639, DOI 10.1074/jbc.M109.079780; Valenti D, 2014, NEUROSCI BIOBEHAV R, V46, P202, DOI 10.1016/j.neubiorev.2014.01.012; Veech RL, 2012, IUBMB LIFE, V64, P203, DOI 10.1002/iub.590; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Walter L, 2000, J BIOL CHEM, V275, P29521, DOI 10.1074/jbc.M004128200; Wang XY, 2011, J NEUROCHEM, V119, P1253, DOI 10.1111/j.1471-4159.2011.07525.x; Wang YG, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7511; Watson DJ, 2016, HIPPOCAMPUS, V26, P560, DOI 10.1002/hipo.22536; Weinert D, 2007, PHYSIOL BEHAV, V90, P246, DOI 10.1016/j.physbeh.2006.09.003; Weisz ED, 2018, HUM MOL GENET, V27, P95, DOI 10.1093/hmg/ddx387; Yan QJ, 2005, NEUROPHARMACOLOGY, V49, P1053, DOI 10.1016/j.neuropharm.2005.06.004; Yang G, 2010, NAT PROTOC, V5, P201, DOI 10.1038/nprot.2009.222; Yang M, 2012, J NEUROSCI, V32, P6525, DOI 10.1523/JNEUROSCI.6107-11.2012; Zhang XD, 2016, ELIFE, V5, DOI 10.7754/eLife.13374; Zheng JB, 2000, BRIT J PHARMACOL, V130, P1115, DOI 10.1038/sj.bjp.0703397; Ziosi M, 2017, EMBO MOL MED, V9, P96, DOI 10.15252/emmm.201606356	85	15	15	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					7404	7426		10.1096/fj.202000283RR	http://dx.doi.org/10.1096/fj.202000283RR		APR 2020	23	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32307754	Green Accepted, Bronze			2022-12-28	WOS:000527568000001
J	Chiu, YW; Hori, Y; Ebinuma, I; Sato, H; Hara, N; Ikeuchi, T; Tomita, T				Chiu, Yung Wen; Hori, Yukiko; Ebinuma, Ihori; Sato, Haruaki; Hara, Norikazu; Ikeuchi, Takeshi; Tomita, Taisuke			Identification of calcium and integrin-binding protein 1 as a novel regulator of production of amyloid beta peptide using CRISPR/Cas9-based screening system	FASEB JOURNAL			English	Article						Alzheimer disease; A beta; CIB1; gamma-secretase	ALZHEIMERS-DISEASE; SENILE PLAQUES; PRESENILIN; CIB1	The aberrant metabolism of amyloid beta peptide (A beta) has been implicated in the etiology of Alzheimer disease (AD). A beta is produced via the sequential cleavage of amyloid precursor protein (APP) by beta- and gamma-secretases. However, the precise regulatory mechanism of A beta generation still remains unclear. To gain a better understanding of the molecular mechanism of A beta production, we established a genetic screening method based on the CRISPR/Cas9 system to identify novel regulators of A beta production. We successfully identified calcium and integrin-binding protein 1 (CIB1) as a potential negative regulator of A beta production. The disruption of Cib1 significantly upregulated A beta levels. In addition, immunoprecipitation experiments demonstrated that CIB1 interacts with the gamma-secretase complex. Moreover, the disruption of Cib1 specifically reduced the cell-surface localization of mature Nicastrin (Nct), which is a component of the gamma-secretase complex, without changing the intrinsic activity of gamma-secretase. Finally, we confirmed using the single-cell RNA-seq data in human that CIB1 mRNA level in neuron was decreased in the early stage of AD. Taken together, our results indicate that CIB1 regulates A beta production via controlling the subcellular localization of gamma-secretase, suggesting CIB1 is involved in the development of AD.	[Chiu, Yung Wen; Hori, Yukiko; Ebinuma, Ihori; Sato, Haruaki; Tomita, Taisuke] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Neuropathol & Neurosci, Tokyo, Japan; [Hara, Norikazu; Ikeuchi, Takeshi] Niigata Univ, Brain Res Inst, Dept Mol Genet, Niigata, Japan	University of Tokyo; Niigata University	Tomita, T (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Neuropathol & Neurosci, Tokyo, Japan.	taisuke@mol.f.u-tokyo.ac.jp	Tomita, Taisuke/L-5427-2015	Tomita, Taisuke/0000-0002-0075-5943; Hara, Norikazu/0000-0001-8525-3469	Japan Agency for Medical Research and Development (AMED) [JP18dm0207014, JP20dm0207073]; Japan Society for the Promotion of Science (JSPS) [15H02492, 19H01015, 16K18871, 17J10935]	Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Japan Agency for Medical Research and Development (AMED), Grant/Award Number: JP18dm0207014 and JP20dm0207073; Japan Society for the Promotion of Science (JSPS), Grant/Award Number: 15H02492, 19H01015, 16K18871 and 17J10935	Bandyopadhyay C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003941; Bernstein HG, 2005, NEUROPATH APPL NEURO, V31, P314, DOI 10.1111/j.1365-2990.2005.00646.x; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; BRETSCHER MS, 1988, EMBO J, V7, P4087, DOI 10.1002/j.1460-2075.1988.tb03302.x; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Cai T, 2017, J NEUROSCI, V37, P12272, DOI 10.1523/JNEUROSCI.1628-17.2017; Castello MA, 2014, AGEING RES REV, V13, P10, DOI 10.1016/j.arr.2013.10.001; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; Gentry HR, 2005, J BIOL CHEM, V280, P8407, DOI 10.1074/jbc.M411515200; Gopalappa R, 2018, NUCLEIC ACIDS RES, V46, DOI 10.1093/nar/gky222; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Heineke J, 2010, NAT MED, V16, P872, DOI 10.1038/nm.2181; Herreman A, 2000, NAT CELL BIOL, V2, P461, DOI 10.1038/35017105; Holtzman DM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002369; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; Jarman KE, 2010, J BIOL CHEM, V285, P483, DOI 10.1074/jbc.M109.068395; Kanatsu K, 2018, J NEUROCHEM, V147, P110, DOI 10.1111/jnc.14477; Kanatsu K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4386; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Leisner TM, 2016, FASEB J, V30, P2640, DOI 10.1096/fj.201500073R; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Mathys H, 2019, NATURE, V570, P332, DOI 10.1038/s41586-019-1195-2; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Morohashi Y, 2006, J BIOL CHEM, V281, P14670, DOI 10.1074/jbc.M513012200; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sannerud R, 2016, CELL, V166, P193, DOI 10.1016/j.cell.2016.05.020; Sato C, 2008, J NEUROSCI, V28, P6264, DOI 10.1523/JNEUROSCI.1163-08.2008; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Stabler SM, 1999, J CELL BIOL, V145, P1277, DOI 10.1083/jcb.145.6.1277; Sun ZZ, 2018, MOL NEUROBIOL, V55, P3841, DOI 10.1007/s12035-017-0606-3; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Thinakaran G, 1998, NEUROBIOL DIS, V4, P438, DOI 10.1006/nbdi.1998.0171; Tomita T, 1999, J NEUROSCI, V19, P10627, DOI 10.1523/JNEUROSCI.19-24-10627.1999; Tomita T, 2017, METHOD ENZYMOL, V584, P185, DOI 10.1016/bs.mie.2016.10.033; Tomita T, 1997, P NATL ACAD SCI USA, V94, P2025, DOI 10.1073/pnas.94.5.2025; Tomita T, 2014, J BIOCHEM, V156, P195, DOI 10.1093/jb/mvu049; Watanabe N, 2005, J BIOL CHEM, V280, P41967, DOI 10.1074/jbc.M509066200	41	6	7	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					7661	7674		10.1096/fj.201902966RR	http://dx.doi.org/10.1096/fj.201902966RR		APR 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32307772	Bronze			2022-12-28	WOS:000526956600001
J	Wang, C; Pinar, AA; Widdop, RE; Hossain, MA; Bathgate, RAD; Denton, KM; Kemp-Harper, BK; Samuel, CS				Wang, Chao; Pinar, Anita A.; Widdop, Robert E.; Hossain, Mohammed A.; Bathgate, Ross A. D.; Denton, Kate M.; Kemp-Harper, Barbara K.; Samuel, Chrishan S.			The anti-fibrotic actions of relaxin are mediated through AT(2)R-associated protein phosphatases via RXFP1-AT(2)R functional crosstalk in human cardiac myofibroblasts	FASEB JOURNAL			English	Article						AT(2) receptor; cardiac fibrosis; myofibroblasts; phosphatases; RXFP1	II TYPE-2 RECEPTOR; GROWTH-FACTOR-BETA; TYROSINE-PHOSPHATASE; AT2 RECEPTOR; SIGNAL-TRANSDUCTION; AT(2) RECEPTORS; ANGIOTENSIN; HEART; INHIBITION; CELLS	Fibrosis is a hallmark of several cardiovascular diseases. The relaxin family peptide receptor 1 (RXFP1) agonist, relaxin, has rapidly occurring anti-fibrotic actions which are mediated through RXFP1 and angiotensin II receptor crosstalk on renal and cardiac myofibroblasts. Here, we investigated whether this would allow relaxin to indirectly activate angiotensin II type 2 receptor (AT(2)R)-specific signal transduction in primary human cardiac myofibroblasts (HCMFs). The anti-fibrotic effects of recombinant human relaxin (RLX; 16.8 nM) or the AT(2)R-agonist, Compound 21 (C21; 1 mu M), were evaluated in TGF-beta 1-stimulated HCMFs, in the absence or presence of an RXFP1 antagonist (1 mu M) or AT(2)R antagonist (0.1 mu M) to confirm RXFP1-AT(2)R crosstalk. Competition binding for RXFP1 was determined. Western blotting was performed to determine which AT(2)R-specific protein phosphatases were expressed by HCMFs; then, the anti-fibrotic effects of RLX and/or C21 were evaluated in the absence or presence of pharmacological inhibition (NSC95397 (1 mu M) for MKP-1; okadaic acid (10 nM) for PP2A) or siRNA-knockdown of these phosphatases after 72 hours. The RLX- or C21-induced increase in ERK1/2 and nNOS phosphorylation, and decrease in alpha-SMA (myofibroblast differentiation) and collagen-I expression by HCMFs was abrogated by pharmacological blockade of RXFP1 or the AT(2)R, confirming RXFP1-AT(2)R crosstalk in these cells. HCMFs were found to express AT(2)R-dependent MKP-1 and PP2A phosphatases, while pharmacological blockade or siRNA-knockdown of either phosphatase also abolished RLX and/or C21 signal transduction in HCMFs (all P < .05 vs RLX or C21 alone). These findings demonstrated that RLX can indirectly activate AT(2)R-dependent phosphatase activity in HCMFs by signaling through RXFP1-AT(2)R crosstalk, which have important therapeutic implications for its anti-fibrotic actions.	[Wang, Chao; Pinar, Anita A.; Widdop, Robert E.; Denton, Kate M.; Kemp-Harper, Barbara K.; Samuel, Chrishan S.] Monash Biomed Discovery Inst, Cardiovasc Dis Program, Clayton, Vic, Australia; [Wang, Chao; Pinar, Anita A.; Widdop, Robert E.; Kemp-Harper, Barbara K.; Samuel, Chrishan S.] Monash Univ, Dept Pharmacol, Clayton, Vic 3800, Australia; [Hossain, Mohammed A.; Bathgate, Ross A. D.] Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia; [Bathgate, Ross A. D.; Samuel, Chrishan S.] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic, Australia; [Denton, Kate M.] Monash Univ, Dept Physiol, Clayton, Vic, Australia	Monash University; Monash University; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Monash University	Kemp-Harper, BK; Samuel, CS (corresponding author), Monash Univ, Dept Pharmacol, Clayton, Vic 3800, Australia.	Barbara.kemp@monash.edu; chrishan.samuel@monash.edu	Bathgate, Ross/ABE-6471-2020	Bathgate, Ross/0000-0001-6301-861X; wang, chao/0000-0002-5898-9283; Denton, Kate/0000-0002-5929-4387	Department of Health \ National Health and Medical Research Council (NHMRC) [GNT1101552, GNT1100676, GNT1135837, GNT1136813, GNT1041766]	Department of Health \ National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	Department of Health vertical bar National Health and Medical Research Council (NHMRC), Grant/Award Number: GNT1101552, GNT1100676, GNT1135837, GNT1136813 and GNT1041766	AbdAlla S, 2001, J BIOL CHEM, V276, P39721, DOI 10.1074/jbc.M105253200; Baccari MC, 2008, CURR PROTEIN PEPT SC, V9, P638, DOI 10.2174/138920308786733921; Bathgate RAD, 2013, PHYSIOL REV, V93, P405, DOI 10.1152/physrev.00001.2012; Chow BSM, 2019, J AM SOC NEPHROL, V30, P2191, DOI 10.1681/ASN.2019060597; Chow BSM, 2014, KIDNEY INT, V86, P75, DOI 10.1038/ki.2013.518; Chow BSM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042714; Christie GR, 2005, MOL CELL BIOL, V25, P8323, DOI 10.1128/MCB.25.18.8323-8333.2005; Cowling RT, 2019, TRANSL RES, V209, P138, DOI 10.1016/j.trsl.2019.03.004; Cui TX, 2001, CARDIOVASC RES, V49, P863, DOI 10.1016/S0008-6363(00)00299-6; Dobaczewski M, 2011, J MOL CELL CARDIOL, V51, P600, DOI 10.1016/j.yjmcc.2010.10.033; Dubey NK, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061625; Everett AD, 1997, J MOL CELL CARDIOL, V29, P141, DOI 10.1006/jmcc.1996.0259; Fischer TA, 1998, AM J PHYSIOL-HEART C, V275, pH906, DOI 10.1152/ajpheart.1998.275.3.H906; Frangogiannis NG, 2019, MOL ASPECTS MED, V65, P70, DOI 10.1016/j.mam.2018.07.001; Gotz J, 1998, P NATL ACAD SCI USA, V95, P12370, DOI 10.1073/pnas.95.21.12370; Guo DQ, 2000, J BIOL CHEM, V275, P11216, DOI 10.1074/jbc.275.15.11216; Heeg MHJ, 2005, KIDNEY INT, V68, P96, DOI 10.1111/j.1523-1755.2005.00384.x; Horiuchi M, 1998, ENDOCR RES, V24, P307, DOI 10.3109/07435809809032610; Hossain MA, 2016, CHEM SCI, V7, P3805, DOI 10.1039/c5sc04754d; Hossain MA, 2011, BIOCHEMISTRY-US, V50, P1368, DOI 10.1021/bi1013968; Hossain MA, 2010, AMINO ACIDS, V39, P409, DOI 10.1007/s00726-009-0454-1; Jones ES, 2008, PHARMACOL THERAPEUT, V120, P292, DOI 10.1016/j.pharmthera.2008.08.009; KANG J, 1994, AM J PHYSIOL-CELL PH, V267, pC1389, DOI 10.1152/ajpcell.1994.267.5.C1389; Kiemer AK, 2002, CIRC RES, V90, P874, DOI 10.1161/01.RES.0000017068.58856.F3; Kocan M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02916-5; Koulis C, 2015, HYPERTENSION, V65, P1073, DOI 10.1161/HYPERTENSIONAHA.115.05204; Lange C, 2018, HYPERTENSION, V72, pE20, DOI 10.1161/HYPERTENSIONAHA.118.11168; Lehtonen JYA, 1999, MOL ENDOCRINOL, V13, P1051, DOI 10.1210/me.13.7.1051; Leonhardt J, 2017, HYPERTENSION, V69, P1128, DOI 10.1161/HYPERTENSIONAHA.116.08814; Li HG, 2002, CIRCULATION, V106, P2250, DOI 10.1161/01.CIR.0000035650.05921.50; Lim H, 2006, CELL MOL LIFE SCI, V63, P2584, DOI 10.1007/s00018-006-6085-8; LOKUTA AJ, 1994, J BIOL CHEM, V269, P4832; Martin B, 2019, MOL CELL ENDOCRINOL, V487, P45, DOI 10.1016/j.mce.2018.12.016; Matsubara H, 2001, BIOCHEM BIOPH RES CO, V282, P1085, DOI 10.1006/bbrc.2001.4695; Mirabito KM, 2014, AM J PHYSIOL-RENAL, V307, pF901, DOI 10.1152/ajprenal.00288.2014; Mookerjee I, 2009, FASEB J, V23, P1219, DOI 10.1096/fj.08-120857; NAKAJIMA M, 1995, P NATL ACAD SCI USA, V92, P10663, DOI 10.1073/pnas.92.23.10663; Ng HH, 2019, MOL CELL ENDOCRINOL, V487, P59, DOI 10.1016/j.mce.2019.01.015; Nouet S, 2000, TRENDS ENDOCRIN MET, V11, P1, DOI 10.1016/S1043-2760(99)00205-2; Porrello ER, 2011, CELL SIGNAL, V23, P1767, DOI 10.1016/j.cellsig.2011.06.011; Rompe F, 2010, HYPERTENSION, V55, P924, DOI 10.1161/HYPERTENSIONAHA.109.147843; Sampson AK, 2016, BRIT J PHARMACOL, V173, P729, DOI 10.1111/bph.13063; Samuel CS, 2017, BRIT J PHARMACOL, V174, P962, DOI 10.1111/bph.13529; Samuel CS, 2006, PHARMACOL THERAPEUT, V112, P529, DOI 10.1016/j.pharmthera.2005.05.012; Samuel CS, 2004, ENDOCRINOLOGY, V145, P4125, DOI 10.1210/en.2004-0209; Sarwar M, 2015, BRIT J PHARMACOL, V172, P1005, DOI 10.1111/bph.12964; Sarwar M, 2017, BRIT J PHARMACOL, V174, P933, DOI 10.1111/bph.13523; Sassoli C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063896; Saura M, 2005, CIRC RES, V97, P1115, DOI 10.1161/01.RES.0000191538.76771.66; Schinner E, 2017, FEBS OPEN BIO, V7, P550, DOI 10.1002/2211-5463.12202; Schutz S, 1996, AM J PATHOL, V149, P2067; Shabanpoor F, 2012, BIOCHEM BIOPH RES CO, V420, P253, DOI 10.1016/j.bbrc.2012.02.141; Singh RR, 2007, J PHYSIOL-LONDON, V579, P503, DOI 10.1113/jphysiol.2006.125773; Sumners C, 2019, ACTA PHYSIOL, V227, DOI 10.1111/apha.13280; Tyagi SC, 1998, CARDIOVASC PATHOL, V7, P153, DOI 10.1016/S1054-8807(97)00121-X; Unemori EN, 1996, J CLIN INVEST, V98, P2739, DOI 10.1172/JCI119099; Wang C, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00091; Wang Y, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00564; Wu XP, 2018, EXP CELL RES, V362, P17, DOI 10.1016/j.yexcr.2017.10.004; Yang J, 2012, J HYPERTENS, V30, P1176, DOI 10.1097/HJH.0b013e3283532099; Zenzmaier C, 2015, EXP CELL RES, V338, P162, DOI 10.1016/j.yexcr.2015.08.014	61	8	8	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8217	8233		10.1096/fj.201902506R	http://dx.doi.org/10.1096/fj.201902506R		APR 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32297670				2022-12-28	WOS:000526649400001
J	Yang, J; Asico, LD; Beitelshees, AL; Feranil, JB; Wang, XY; Jones, JE; Armando, I; Cuevas, SG; Schwartz, GL; Gums, JG; Chapman, AB; Turner, ST; Boerwinkle, E; Cooper-DeHoff, RM; Johnson, JA; Felder, RA; Weinman, EJ; Zeng, CY; Jose, PA; Villar, VM				Yang, Jian; Asico, Laureano D.; Beitelshees, Amber L.; Feranil, Jun B.; Wang, Xiaoyan; Jones, John E.; Armando, Ines; Cuevas, Santiago G.; Schwartz, Gary L.; Gums, John G.; Chapman, Arlene B.; Turner, Stephen T.; Boerwinkle, Eric; Cooper-DeHoff, Rhonda M.; Johnson, Julie A.; Felder, Robin A.; Weinman, Edward J.; Zeng, Chunyu; Jose, Pedro A.; Villar, Van Anthony M.			Sorting nexin 1 loss results in increased oxidative stress and hypertension	FASEB JOURNAL			English	Article						dopamine D-5 receptor; hypertension; oxidative stress; renal proximal tubule cells; sorting nexin 1	DOPAMINE-RECEPTOR REGULATION; OXYGEN SPECIES PRODUCTION; PROXIMAL TUBULE CELLS; BLOOD-PRESSURE; NADPH OXIDASE; MICE; ACTIVATION; EXPRESSION; PROMOTES; SODIUM	Acute renal depletion of sorting nexin 1 (SNX1) in mice results in blunted natriuretic response and hypertension due to impaired dopamine D-5 receptor (D5R) activity. We elucidated the molecular mechanisms for these phenotypes in Snx1(-/-) mice. These mice had increased renal expressions of angiotensin II type 1 receptor (AT(1)R), NADPH oxidase (NOX) subunits, D5R, and NaCl cotransporter. Basal reactive oxygen species (ROS), NOX activity, and blood pressure (BP) were also higher in Snx1(-/-) mice, which were normalized by apocynin, a drug that prevents NOX assembly. Renal proximal tubule (RPT) cells from hypertensive (HT) Euro-American males had deficient SNX1 activity, impaired D5R endocytosis, and increased ROS compared with cells from normotensive (NT) Euro-American males. siRNA-mediated depletion of SNX1 in RPT cells from NT subjects led to a blunting of D5R agonist-induced increase in cAMP production and decrease in Na+ transport, effects that were normalized by over-expression of SNX1. Among HT African-Americans, three of the 12 single nucleotide polymorphisms interrogated for the SNX1 gene were associated with a decrease in systolic BP in response to hydrochlorothiazide (HCTZ). The results illustrate a new paradigm for the development of hypertension and imply that the trafficking protein SNX1 may be a crucial determinant for hypertension and response to antihypertensive therapy.	[Yang, Jian] Chongqing Med Univ, Affiliated Hosp 3, Dept Clin Nutr, Chongqing 410020, Peoples R China; [Asico, Laureano D.; Feranil, Jun B.; Wang, Xiaoyan; Jones, John E.; Armando, Ines; Cuevas, Santiago G.; Weinman, Edward J.; Jose, Pedro A.; Villar, Van Anthony M.] Univ Maryland, Sch Med, Dept Med, Div Nephrol, Baltimore, MD 21201 USA; [Asico, Laureano D.; Wang, Xiaoyan; Armando, Ines; Cuevas, Santiago G.; Jose, Pedro A.; Villar, Van Anthony M.] George Washington Univ, Dept Med, Sch Med & Hlth Sci, Div Renal Dis & Hypertens, Washington, DC USA; [Beitelshees, Amber L.] Univ Maryland, Sch Med, Dept Med, Program Personalized & Genom Med,Div Endocrinol D, Baltimore, MD 21201 USA; [Schwartz, Gary L.; Turner, Stephen T.] Mayo Clin, Coll Med, Dept Internal Med, Div Nephrol & Hypertens, Rochester, MN USA; [Gums, John G.; Cooper-DeHoff, Rhonda M.; Johnson, Julie A.] Univ Florida, Coll Pharm, Ctr Pharmacogen, Dept Pharmacotherapy & Translat Res, Gainesville, FL USA; [Gums, John G.] Univ Florida, Coll Med, Dept Community Hlth & Family Med, Gainesville, FL USA; [Chapman, Arlene B.] Emory Univ, Sch Med, Dept Med, Renal Div, Atlanta, GA USA; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Human Genet & Inst Mol Med, Houston, TX 77030 USA; [Felder, Robin A.] Univ Virginia, Sch Med, Dept Pathol, Charlottesville, VA 22908 USA; [Weinman, Edward J.] Dept Vet Affairs, Baltimore, MD USA; [Zeng, Chunyu] Fujian Med Univ, Union Hosp, Fujian Heart Med Ctr, Dept Cardiol, Fuzhou 350001, Fujian, Peoples R China; [Zeng, Chunyu] Third Mil Med Univ, Daping Hosp, Dept Cardiol, Chongqing, Peoples R China; [Jose, Pedro A.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA	Chongqing Medical University; University System of Maryland; University of Maryland Baltimore; George Washington University; University System of Maryland; University of Maryland Baltimore; Mayo Clinic; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Emory University; University of Texas System; University of Texas Health Science Center Houston; University of Virginia; Fujian Medical University; Army Medical University; University System of Maryland; University of Maryland Baltimore	Yang, J (corresponding author), Chongqing Med Univ, Affiliated Hosp 3, Dept Clin Nutr, Chongqing 410020, Peoples R China.; Zeng, CY (corresponding author), Fujian Med Univ, Union Hosp, Fujian Heart Med Ctr, Dept Cardiol, Fuzhou 350001, Fujian, Peoples R China.	jianyang@hospital.cqmu.edu.cn; chunyuzeng01@163.com	Asico, Laureano/AAM-6321-2020; Cuevas, Santiago/AAG-4985-2021; Wang, Xiaoyan/GOK-1663-2022; Turner, Stephen/GXM-4654-2022; Asico, Laureano/F-5651-2016	Cuevas, Santiago/0000-0002-0832-5446; Wang, Xiaoyan/0000-0001-7406-5008; Asico, Laureano/0000-0002-4144-1887	National Institutes of Health [R37-HL023081, R01-DK039308, R01-HL092196, R01-DK090918, P01-HL068686, P01-HL074940]; National Natural Science Foundation of China [81570379, 81770425]; Natural Science Foundation Project of Chongqing [cstc2015jcyjA10060]; Key Program of The Third Affiliated Hospital of Chongqing Medical University [KY19024, DK-5581]; Research Service of the Department of Veterans Affairs; Norma E. Clauss Clinical Research Award by the National Institutes of Health Pharmacogenetics Research Network grant [U01-GM074492]; National Center for Advancing Translational Sciences [UL1-TR000064, UL1-TR000454, UL1-TR000135]; Mayo Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation Project of Chongqing(Natural Science Foundation of Chongqing); Key Program of The Third Affiliated Hospital of Chongqing Medical University; Research Service of the Department of Veterans Affairs(US Department of Veterans Affairs); Norma E. Clauss Clinical Research Award by the National Institutes of Health Pharmacogenetics Research Network grant; National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Mayo Foundation	We would like to acknowledge the help of Yen-Pei Chang, PhD, from the Departments of Medicine and Epidemiology & Public Health, and James A. Perry, PhD, from the Department of Medicine, University of Maryland School of Medicine for their assistance in the data analysis. This work was supported by the following grants: National Institutes of Health (R37-HL023081, R01-DK039308, R01-HL092196, R01-DK090918, P01-HL068686, and P01-HL074940), National Natural Science Foundation of China (81570379, 81770425), Natural Science Foundation Project of Chongqing (cstc2015jcyjA10060), Key Program of The Third Affiliated Hospital of Chongqing Medical University (KY19024), DK-5581 and funds from the Research Service of the Department of Veterans Affairs, and the Norma E. Clauss Clinical Research Award given to VAV by the National Kidney Foundation of Maryland. PEAR is supported by the National Institutes of Health Pharmacogenetics Research Network grant U01-GM074492 and the National Center for Advancing Translational Sciences under the award number UL1-TR000064 (University of Florida); UL1-TR000454 (Emory University) and UL1-TR000135 (Mayo Clinic) and funds from the Mayo Foundation. We are deeply saddened by the sudden loss of Dr Van Anthony M. Villar, and will keep him in our memories.	Armando I, 2014, FASEB J, V28, P1422, DOI 10.1096/fj.13-243840; Armando I, 2011, COMPR PHYSIOL, V1, P1075, DOI 10.1002/cphy.c100032; Asico L, 2011, J AM SOC NEPHROL, V22, P82, DOI 10.1681/ASN.2010050533; Botros FT, 2005, KIDNEY INT, V68, P2745, DOI 10.1111/j.1523-1755.2005.00745.x; CASARI G, 1995, HYPERTENSION, V25, P320, DOI 10.1161/01.HYP.25.3.320; Charpentier S, 1996, J BIOL CHEM, V271, P28071, DOI 10.1074/jbc.271.45.28071; Chen XC, 2014, BIOMED PHARMACOTHER, V68, P589, DOI 10.1016/j.biopha.2014.04.008; Coatmellec-Taglioni G, 2003, J PHARMACOL EXP THER, V305, P362, DOI 10.1124/jpet.102.045682; Diao ZY, 2017, FREE RADICAL BIO MED, V106, P80, DOI 10.1016/j.freeradbiomed.2017.02.021; Ennis RC, 2014, AM J PHYSIOL-RENAL, V307, pF1238, DOI 10.1152/ajprenal.00119.2014; Escano CS, 2009, AM J PHYSIOL-REG I, V297, pR1660, DOI 10.1152/ajpregu.00147.2009; Felder RA, 2002, P NATL ACAD SCI USA, V99, P3872, DOI 10.1073/pnas.062694599; Feng YY, 2019, J IMMUNOL, V202, P2546, DOI 10.4049/jimmunol.1800443; Gildea JJ, 2014, KIDNEY INT, V86, P118, DOI 10.1038/ki.2014.5; Haft CR, 1998, MOL CELL BIOL, V18, P7278, DOI 10.1128/MCB.18.12.7278; Heydorn A, 2004, FEBS LETT, V556, P276, DOI 10.1016/S0014-5793(03)01431-5; Hollon TR, 2002, J NEUROSCI, V22, P10801, DOI 10.1523/jneurosci.22-24-10801.2002; Huang HF, 2012, HYPERTENS RES, V35, P639, DOI 10.1038/hr.2012.11; Johnson JA, 2009, AM HEART J, V157, P442, DOI 10.1016/j.ahj.2008.11.018; Le TH, 2004, HYPERTENSION, V43, P445, DOI 10.1161/01.HYP.0000112423.28987.00; Li HW, 2008, J CLIN INVEST, V118, P2180, DOI 10.1172/JCI33637; Li LJ, 2013, AM J PHYSIOL-RENAL, V304, pF279, DOI 10.1152/ajprenal.00161.2012; Liu DM, 2008, CIRC RES, V103, P186, DOI 10.1161/CIRCRESAHA.108.179408; Lu QS, 2013, HYPERTENS RES, V36, P684, DOI 10.1038/hr.2013.9; Lum C, 2004, HYPERTENSION, V43, P79, DOI 10.1161/01.HYP.0000107401.72456.50; Natarajan A, 2010, J PHARMACOL EXP THER, V332, P640, DOI 10.1124/jpet.109.159871; Nguyen LN, 2006, CLIN CANCER RES, V12, P6952, DOI 10.1158/1078-0432.CCR-06-0317; Ogawa N, 2010, INT J HYPERTENS, V2010, DOI 10.4061/2010/790539; Radin MJ, 2003, MOL CELL BIOCHEM, V242, P57, DOI 10.1023/A:1021181527060; Rastogi R, 2017, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00301; Saad S, 2013, DIABETOLOGIA, V56, P1174, DOI 10.1007/s00125-013-2835-y; Schwarz DG, 2002, MOL BIOL CELL, V13, P3588, DOI 10.1091/mbc.E02-03-0145; Stocks T, 2012, HYPERTENSION, V59, P802, DOI 10.1161/HYPERTENSIONAHA.111.189258; Thompson D, 2011, TRAFFIC, V12, P644, DOI 10.1111/j.1600-0854.2011.01179.x; Villar VAM, 2013, FASEB J, V27, P1808, DOI 10.1096/fj.12-208439; Villar VM, 2013, J BIOL CHEM, V288, P152, DOI 10.1074/jbc.M112.428458; Wang SG, 2019, AUTOPHAGY, V15, P1954, DOI 10.1080/15548627.2019.1596486; Wang XY, 2010, HYPERTENSION, V55, P1431, DOI 10.1161/HYPERTENSIONAHA.109.148643; Wang Z, 2007, AM J PHYSIOL-HEART C, V292, pH2083, DOI 10.1152/ajpheart.00944.2006; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Wassmer T, 2007, J CELL SCI, V120, P45, DOI 10.1242/jcs.03302; Yang J, 2019, CLIN SCI, V133, P723, DOI 10.1042/CS20190034; Yang Y, 2012, FREE RADICAL BIO MED, V53, P437, DOI 10.1016/j.freeradbiomed.2012.05.015; Yang ZW, 2006, AM J PHYSIOL-REG I, V290, pR96, DOI 10.1152/ajpregu.00434.2005; Yang ZW, 2005, AM J PHYSIOL-HEART C, V288, pH55, DOI 10.1152/ajpheart.00627.2004; Yasunari K, 2000, CIRCULATION, V101, P2302, DOI 10.1161/01.CIR.101.19.2302; You YH, 2013, AM J PHYSIOL-RENAL, V304, pF840, DOI 10.1152/ajprenal.00511.2012; Zeng CY, 2006, CIRC RES, V99, P494, DOI 10.1161/01.RES.0000240500.96746.ec; Zhang MZ, 2011, J CLIN INVEST, V121, P2845, DOI 10.1172/JCI57324; Zou AP, 2001, HYPERTENSION, V37, P547, DOI 10.1161/01.HYP.37.2.547	50	7	7	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					7941	7957		10.1096/fj.201902448R	http://dx.doi.org/10.1096/fj.201902448R		APR 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32293069	Green Accepted			2022-12-28	WOS:000526103300001
J	Dungan, CM; Peck, BD; Walton, RG; Huang, ZY; Bamman, MM; Kern, PA; Peterson, CA				Dungan, Cory M.; Peck, Bailey D.; Walton, R. Grace; Huang, Zhengyan; Bamman, Marcas M.; Kern, Philip A.; Peterson, Charlotte A.			In vivo analysis of gamma H2AX+cells in skeletal muscle from aged and obese humans	FASEB JOURNAL			English	Article						DNA damage; postmitotic; satellite cells; senescence; gamma H2AX	DNA-DAMAGE RESPONSE; CELLULAR SENESCENCE; UP-REGULATION; HISTONE H2AX; FIBER TYPES; CELLS; P21; QUIESCENCE; PROLIFERATION; PROTEINS	Over the past 20 years, various identifiers of cellular senescence have been used to quantify the abundance of these cells in different tissues. These include classic markers such as p16, senescence-associated beta-gal, and gamma H2AX, in addition to more recent markers (Sudan Black B and HMGB1). In vivo data on the usefulness of these markers in skeletal muscle are very limited and inconsistent. In the present study, we attempted to identify senescent cells in frozen human skeletal muscle biopsies using these markers to determine the effects of age and obesity on senescent cell burden; however, we were only able to assess the abundance of DNA-damaged nuclei using gamma H2AX immunohistochemistry. The abundance of gamma H2AX+ cells, including satellite cells, was not higher in muscle from old compared to young individuals; however, gamma H2AX+ cells were higher with obesity. Additionally, terminally differentiated, postmitotic myofiber nuclei from obese individuals had elevated gamma H2AX abundance compared to muscle from lean individuals. Analyses of gene expression support the conclusion that the elevated DNA damage and the senescence-associated secretory phenotype are preferentially associated with obesity in skeletal muscle. These data implicate obesity as a larger contributor to DNA damage in skeletal muscle than aging; however, more sensitive senescence markers for human skeletal muscle are needed to determine if these cells are in fact senescent.	[Dungan, Cory M.; Peck, Bailey D.; Walton, R. Grace; Peterson, Charlotte A.] Univ Kentucky, Coll Hlth Sci, Dept Phys Therapy, 900 S Limestone,CTW 439, Lexington, KY 40536 USA; [Dungan, Cory M.; Peck, Bailey D.; Walton, R. Grace; Peterson, Charlotte A.] Univ Kentucky, Ctr Muscle Biol, Lexington, KY 40536 USA; [Huang, Zhengyan] Univ Kentucky, Coll Publ Hlth, Dept Biostat, Lexington, KY 40536 USA; [Bamman, Marcas M.] Univ Alabama Birmingham, Sch Med, Dept Cell Dev & Integrat Biol, Birmingham, AL USA; [Bamman, Marcas M.] Birmingham VA Med Ctr, Geriatr Res Educ & Clin Ctr, Birmingham, AL USA; [Kern, Philip A.] Univ Kentucky, Coll Med, Dept Internal Med Endocrinol, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Alabama System; University of Alabama Birmingham; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham; University of Kentucky	Peterson, CA (corresponding author), Univ Kentucky, Coll Hlth Sci, Dept Phys Therapy, 900 S Limestone,CTW 439, Lexington, KY 40536 USA.	cpete4@uky.edu			NIH [AG049806, AR060701]; CTSA [UL1 TR001998]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The authors thank Drs. Ying Liang and Cuiping Zhang for their assistance with the cell irradiation experiments, and Dr Kevin Murach for the thoughtful discussions about this project. This research was supported by NIH grants AG049806 to CAP, PAK and MMB, AR060701 to CAP, and CTSA grant UL1 TR001998.	Alcorta DA, 1996, P NATL ACAD SCI USA, V93, P13742, DOI 10.1073/pnas.93.24.13742; Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932; Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Barr AR, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14728; Bernadotte A, 2016, AGING-US, V8, P3, DOI 10.18632/aging.100871; Beyer I, 2012, CURR OPIN CLIN NUTR, V15, P12, DOI 10.1097/MCO.0b013e32834dd297; Bigot A, 2015, CELL REP, V13, P1172, DOI 10.1016/j.celrep.2015.09.067; Borodkina A, 2014, AGING-US, V6, P481, DOI 10.18632/aging.100673; Burd CE, 2013, CELL, V152, P340, DOI 10.1016/j.cell.2012.12.010; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Cazin C, 2017, JOVE-J VIS EXP, DOI 10.3791/56201; Chinzei N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125765; Coen PM, 2013, OBESITY, V21, P2362, DOI 10.1002/oby.20381; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Cousin W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063528; da Silva PFL, 2019, AGING CELL, V18, DOI 10.1111/acel.12848; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; El Gazzar M, 2009, MOL CELL BIOL, V29, P1959, DOI 10.1128/MCB.01862-08; Evangelou K, 2017, METHODS MOL BIOL, V1534, P111, DOI 10.1007/978-1-4939-6670-7_10; Fan J, 2007, J IMMUNOL, V178, P6573, DOI 10.4049/jimmunol.178.10.6573; Farr JN, 2016, J BONE MINER RES, V31, P1920, DOI 10.1002/jbmr.2892; Fernandez-Capetillo O, 2002, NAT CELL BIOL, V4, P993, DOI 10.1038/ncb884; Fontana L, 2007, DIABETES, V56, P1010, DOI 10.2337/db06-1656; Fortini P, 2012, CELL DEATH DIFFER, V19, P1741, DOI 10.1038/cdd.2012.53; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI21625, 10.1172/JCI20042162S]; Gardella S, 2002, EMBO REP, V3, P995, DOI 10.1093/embo-reports/kvf198; Gartel AL, 2002, MOL CANCER THER, V1, P639; GAUTHIER GF, 1966, J CELL BIOL, V28, P333, DOI 10.1083/jcb.28.2.333; Ghosh AK, 2012, J CELL PHYSIOL, V227, P493, DOI 10.1002/jcp.22783; Gorgoulis V, 2019, CELL, V179, P813, DOI 10.1016/j.cell.2019.10.005; HALEVY O, 1995, SCIENCE, V267, P1018, DOI 10.1126/science.7863327; Hawke TJ, 2003, AM J PHYSIOL-CELL PH, V285, pC1019, DOI 10.1152/ajpcell.00055.2003; He MY, 2019, AGING CELL, V18, DOI 10.1111/acel.13003; He ZY, 2016, SCI REP-UK, V6, DOI 10.1038/srep34558; Helman A, 2016, NAT MED, V22, P412, DOI 10.1038/nm.4054; Herwig R, 2016, NAT PROTOC, V11, P1889, DOI 10.1038/nprot.2016.117; Hu ZY, 2010, DIABETES, V59, P1312, DOI 10.2337/db09-1155; Ibler AEM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12064-1; Jeyapalan JC, 2007, MECH AGEING DEV, V128, P36, DOI 10.1016/j.mad.2006.11.008; Jurk D, 2012, AGING CELL, V11, P996, DOI 10.1111/j.1474-9726.2012.00870.x; Justice JN, 2018, J GERONTOL A-BIOL, V73, P939, DOI 10.1093/gerona/glx134; Kamburov A, 2013, NUCLEIC ACIDS RES, V41, pD793, DOI 10.1093/nar/gks1055; Karimian A, 2016, DNA REPAIR, V42, P63, DOI 10.1016/j.dnarep.2016.04.008; Kelly NA, 2018, MUSCLE NERVE, V57, pE52, DOI 10.1002/mus.25711; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kippin TE, 2005, GENE DEV, V19, P756, DOI 10.1101/gad.1272305; Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936; Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x; Lessard F, 2018, NAT CELL BIOL, V20, P789, DOI 10.1038/s41556-018-0127-y; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mann CJ, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-21; Marroncelli N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21835-7; Mecocci P, 1999, FREE RADICAL BIO MED, V26, P303, DOI 10.1016/S0891-5849(98)00208-1; Minamino T, 2009, NAT MED, V15, P1082, DOI 10.1038/nm.2014; Muniyappa R, 2008, AM J PHYSIOL-ENDOC M, V294, pE15, DOI 10.1152/ajpendo.00645.2007; Munoz-Canoves P, 2013, FEBS J, V280, P4131, DOI 10.1111/febs.12338; Murach KA, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12973; Murer A, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007039; Naderi J, 2009, AM J PATHOL, V175, P763, DOI 10.2353/ajpath.2009.081009; Ozcan S, 2016, AGING-US, V8, P1316, DOI 10.18632/aging.100971; Pedersen BK, 2001, J PHYSIOL-LONDON, V536, P329, DOI 10.1111/j.1469-7793.2001.0329c.xd; Perucca P, 2009, CELL CYCLE, V8, P105, DOI 10.4161/cc.8.1.7507; Renault V, 2002, AGING CELL, V1, P132, DOI 10.1046/j.1474-9728.2002.00017.x; Riballo E, 2004, MOL CELL, V16, P715, DOI 10.1016/j.molcel.2004.10.029; ROBERTS CJ, 1983, VET PATHOL, V20, P23, DOI 10.1177/030098588302000103; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Saito Y, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14734-x; Sapieha P, 2018, TRENDS CELL BIOL, V28, P595, DOI 10.1016/j.tcb.2018.03.003; Schafer MJ, 2016, DIABETES, V65, P1606, DOI 10.2337/db15-0291; Shefer G, 2006, DEV BIOL, V294, P50, DOI 10.1016/j.ydbio.2006.02.022; Shirakawa K, 2016, J CLIN INVEST, V126, P4626, DOI 10.1172/JCI88606; Sousa-Victor P, 2014, NATURE, V506, P316, DOI 10.1038/nature13013; van Velthoven CTJ, 2017, CELL REP, V21, P1994, DOI 10.1016/j.celrep.2017.10.037; Vaughan DE, 2017, ARTERIOSCL THROM VAS, V37, P1446, DOI 10.1161/ATVBAHA.117.309451; Verdijk LB, 2014, AGE, V36, P545, DOI 10.1007/s11357-013-9583-2; Wang CY, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000143; Wang CF, 2009, AGING CELL, V8, P311, DOI 10.1111/j.1474-9726.2009.00481.x; Wang HL, 2018, INT J MOL MED, V41, P3231, DOI 10.3892/ijmm.2018.3524; Wen Y, 2018, J APPL PHYSIOL, V124, P40, DOI 10.1152/japplphysiol.00762.2017; Weyemi U, 2012, ONCOGENE, V31, P1117, DOI 10.1038/onc.2011.327; Woo M, 2011, STEM CELLS DEV, V20, P1763, DOI 10.1089/scd.2010.0349; Yang C, 2018, AGING-US, V10, P1356, DOI 10.18632/aging.101472; Yousefzadeh MJ, 2020, AGING CELL, V19, DOI 10.1111/acel.13094; Yu H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23644-4; Zhang HB, 2016, SCIENCE, V352, P1436, DOI 10.1126/science.aaf2693; Zhang PM, 1999, GENE DEV, V13, P213, DOI 10.1101/gad.13.2.213	88	15	15	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					7018	7035		10.1096/fj.202000111RR	http://dx.doi.org/10.1096/fj.202000111RR		APR 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32246795	Green Accepted			2022-12-28	WOS:000523592300001
J	Kim, Y; Jang, YN; Kim, JY; Kim, N; Noh, S; Kim, H; Queenan, BN; Bellmore, R; Mun, JY; Park, H; Rah, JC; Pak, DTS; Lee, KJ				Kim, Yoonju; Jang, You-Na; Kim, Ji-Young; Kim, Nari; Noh, Seulgi; Kim, Hyeyeon; Queenan, Bridget N.; Bellmore, Ryan; Mun, Ji Young; Park, Hyungju; Rah, Jong Cheol; Pak, Daniel T. S.; Lee, Kea Joo			Microtubule-associated protein 2 mediates induction of long-term potentiation in hippocampal neurons	FASEB JOURNAL			English	Article						dendritic spine; electron microscopy; MAP2; synaptic plasticity	DENDRITIC SPINE MORPHOLOGY; AMPA RECEPTORS; NMDA RECEPTORS; STRUCTURAL PLASTICITY; BIDIRECTIONAL CONTROL; MAP2 PHOSPHORYLATION; SIGNALING PATHWAY; ACTIN; ACTIVATION; KINASE	Microtubule-associated protein (MAP) 2 has been perceived as a static cytoskeletal protein enriched in neuronal dendritic shafts. Emerging evidence indicates dynamic functions for various MAPs in activity-dependent synaptic plasticity. However, it is unclear how MAP2 is associated with synaptic plasticity mechanisms. Here, we demonstrate that specific silencing of high-molecular-weight MAP2 in vivo abolished induction of long-term potentiation (LTP) in the Schaffer collateral pathway of CA1 pyramidal neurons and in vitro blocked LTP-induced surface delivery of AMPA receptors and spine enlargement. In mature hippocampal neurons, we observed rapid translocation of a subpopulation of MAP2, present in dendritic shafts, to spines following LTP stimulation. Time-lapse confocal imaging showed that spine translocation of MAP2 was coupled with LTP-induced spine enlargement. Consistently, immunogold electron microscopy revealed that LTP stimulation of the Schaffer collateral pathway promoted MAP2 labeling in spine heads of CA1 neurons. This translocation depended on NMDA receptor activation and Ras-MAPK signaling. Furthermore, LTP stimulation led to an increase in surface-expressed AMPA receptors specifically in the neurons with MAP2 spine translocation. Altogether, this study indicates a novel role for MAP2 in LTP mechanisms and suggests that MAP2 participates in activity-dependent synaptic plasticity in mature hippocampal networks.	[Kim, Yoonju; Jang, You-Na; Noh, Seulgi; Mun, Ji Young; Lee, Kea Joo] Korea Brain Res Inst, Neural Circuits Res Grp, 61 Cheomdan Ro, Daegu 41062, South Korea; [Kim, Ji-Young; Kim, Hyeyeon; Park, Hyungju] Korea Brain Res Inst, Neurovasc Unit Res Grp, Daegu, South Korea; [Kim, Nari; Rah, Jong Cheol; Lee, Kea Joo] Korea Brain Res Inst, Ctr Cort Proc, Daegu, South Korea; [Queenan, Bridget N.; Bellmore, Ryan; Pak, Daniel T. S.] Georgetown Univ, Med Ctr, Dept Pharmacol & Physiol, Interdisciplinary Program Neurosci, Med Dent Bldg C405,3900 Reservoir Rd NW, Washington, DC 20057 USA; [Park, Hyungju; Rah, Jong Cheol; Lee, Kea Joo] DGIST, Dept Brain & Cognit Sci, Daegu, South Korea	Korea Brain Research Institute (KBRI); Korea Brain Research Institute (KBRI); Korea Brain Research Institute (KBRI); Georgetown University; Daegu Gyeongbuk Institute of Science & Technology (DGIST)	Lee, KJ (corresponding author), Korea Brain Res Inst, Neural Circuits Res Grp, 61 Cheomdan Ro, Daegu 41062, South Korea.; Pak, DTS (corresponding author), Georgetown Univ, Med Ctr, Dept Pharmacol & Physiol, Interdisciplinary Program Neurosci, Med Dent Bldg C405,3900 Reservoir Rd NW, Washington, DC 20057 USA.	Daniel.Pak@georgetown.edu; relaylee@kbri.re.kr		Kim, Yoonju/0000-0003-2657-2923; Rah, Jong-Cheol/0000-0003-3780-0522	Ministry of Science and ICT [20-BR-01-08, 20-BR-04-01, NRF-2017M3C7A1048086]; Ministry of Education [NRF-2015R1D1A1A01058889]; GUMC Pilot Project Grant	Ministry of Science and ICT(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Education; GUMC Pilot Project Grant	the KBRI Basic Research Programs funded by the Ministry of Science and ICT, Grant/Award Number: 20-BR-01-08 and 20-BR-04-01; the Korean NRF Basic Science Research Programs funded by the Ministry of Science and ICT, Grant/Award Number: NRF-2017M3C7A1048086; the Korean NRF Basic Science Research Programs funded by the Ministry of Education, Grant/Award Number: NRF-2015R1D1A1A01058889; the GUMC Pilot Project Grant	Andrieux A, 2002, GENE DEV, V16, P2350, DOI 10.1101/gad.223302; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; BERNHARDT R, 1984, J COMP NEUROL, V226, P203, DOI 10.1002/cne.902260205; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Bosch M, 2012, CURR OPIN NEUROBIOL, V22, P383, DOI 10.1016/j.conb.2011.09.002; Bosch M, 2014, NEURON, V82, P444, DOI 10.1016/j.neuron.2014.03.021; CACERES A, 1983, P NATL ACAD SCI-BIOL, V80, P1738, DOI 10.1073/pnas.80.6.1738; CACERES A, 1984, J NEUROSCI, V4, P394; Dehmelt L, 2004, J NEUROBIOL, V58, P18, DOI 10.1002/neu.10284; DYE RB, 1993, J BIOL CHEM, V268, P6847; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fiala JC, 2002, BRAIN RES REV, V39, P29, DOI 10.1016/S0165-0173(02)00158-3; Fink CC, 2002, CURR OPIN NEUROBIOL, V12, P293, DOI 10.1016/S0959-4388(02)00327-6; Fortin DA, 2010, J NEUROSCI, V30, P11565, DOI 10.1523/JNEUROSCI.1746-10.2010; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; GARNER CC, 1988, J CELL BIOL, V106, P779, DOI 10.1083/jcb.106.3.779; Gelinas JN, 2008, LEARN MEMORY, V15, P403, DOI 10.1101/lm.830008; GOEDERT M, 1991, TRENDS NEUROSCI, V14, P193, DOI 10.1016/0166-2236(91)90105-4; Greenough WT, 2001, P NATL ACAD SCI USA, V98, P7101, DOI 10.1073/pnas.141145998; Gu JP, 2008, J NEUROSCI, V28, P12120, DOI 10.1523/JNEUROSCI.2509-08.2008; HALPAIN S, 1990, NEURON, V5, P237, DOI 10.1016/0896-6273(90)90161-8; Harada A, 2002, J CELL BIOL, V158, P541, DOI 10.1083/jcb.200110134; Hu HL, 2008, J NEUROSCI, V28, P7847, DOI 10.1523/JNEUROSCI.1496-08.2008; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Jaworski J, 2009, NEURON, V61, P85, DOI 10.1016/j.neuron.2008.11.013; Jin SX, 2013, J BIOL CHEM, V288, P21703, DOI 10.1074/jbc.M113.471904; JOHNSON GVW, 1992, J NEUROSCI RES, V33, P505, DOI 10.1002/jnr.490330402; Kaech S, 1997, J NEUROSCI, V17, P9565; Kaech S, 2001, P NATL ACAD SCI USA, V98, P7086, DOI 10.1073/pnas.111146798; Kim Y, 2015, J BIOL CHEM, V290, P7323, DOI 10.1074/jbc.M114.634527; KINDLER S, 1990, J BIOL CHEM, V265, P19679; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; Lang C, 2004, P NATL ACAD SCI USA, V101, P16665, DOI 10.1073/pnas.0407581101; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; Lee KJ, 2013, NEURON, V77, P99, DOI 10.1016/j.neuron.2012.10.033; Liao DH, 1999, NAT NEUROSCI, V2, P37, DOI 10.1038/4540; Loveland KL, 1999, J BIOL CHEM, V274, P19261, DOI 10.1074/jbc.274.27.19261; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Marsden KM, 1996, J NEUROSCI, V16, P3265; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Moolman DL, 2004, J NEUROCYTOL, V33, P377, DOI 10.1023/B:NEUR.0000044197.83514.64; MORALES M, 1989, CELL TISSUE RES, V256, P447; Muly EC, 2004, CEREB CORTEX, V14, P1398, DOI 10.1093/cercor/bhh101; MURTHY ASN, 1983, EUR J BIOCHEM, V137, P37, DOI 10.1111/j.1432-1033.1983.tb07792.x; Orban PC, 1999, TRENDS NEUROSCI, V22, P38, DOI 10.1016/S0166-2236(98)01306-X; Otmakhov N, 2004, J NEUROPHYSIOL, V91, P1955, DOI 10.1152/jn.00941.2003; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; Park H, 2014, NEURON, V84, P1009, DOI 10.1016/j.neuron.2014.10.045; Park M, 2006, NEURON, V52, P817, DOI 10.1016/j.neuron.2006.09.040; Peris L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05869-z; Qin Y, 2005, GENE DEV, V19, P2000, DOI 10.1101/gad.342205; Quinlan EM, 1996, NEURON, V16, P357, DOI 10.1016/S0896-6273(00)80053-7; Quinlan EM, 1996, J NEUROSCI, V16, P7627; Racz B, 2004, J NEUROSCI, V24, P10310, DOI 10.1523/JNEUROSCI.2080-04.2004; SATTILARO RF, 1986, BIOCHEMISTRY-US, V25, P2003, DOI 10.1021/bi00356a025; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Skeberdis VA, 2006, NAT NEUROSCI, V9, P501, DOI 10.1038/nn1664; Snyder JP, 2001, P NATL ACAD SCI USA, V98, P5312, DOI 10.1073/pnas.051309398; Tao-Cheng JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118750; Valtschanoff JG, 2001, J NEUROSCI, V21, P1211; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071	63	18	19	0	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6965	6983		10.1096/fj.201902122RR	http://dx.doi.org/10.1096/fj.201902122RR		APR 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32237183	hybrid			2022-12-28	WOS:000522967700001
J	Parker, BL; Kiens, B; Wojtaszewski, JFP; Richter, EA; James, DE				Parker, Benjamin L.; Kiens, Bente; Wojtaszewski, Jorgen F. P.; Richter, Erik A.; James, David E.			Quantification of exercise-regulated ubiquitin signaling in human skeletal muscle identifies protein modification cross talk via NEDDylation	FASEB JOURNAL			English	Article						exercise; human skeletal muscle; isotopic labeling; mass spectrometry; NEDD8; proteomics; ubiquitin	RESISTANCE EXERCISE; PHOSPHORYLATION; EXPRESSION; DEGRADATION; METABOLISM; TURNOVER; REVEALS	The maintenance of muscle function is extremely important for whole body health and exercise is essential to this process. The ubiquitin-proteasome system (UPS) is required for muscle adaptation following exercise but little is known about acute posttranslational regulation and proteome remodeling during and after high-intensity exercise. Here, we used quantitative proteomics to study ubiquitin signaling dynamics in human skeletal muscle biopsies from healthy males before, during, and after a single bout of high-intensity exercise. Exercise resulted in a marked depletion of protein ubiquitylation in the vastus lateralis muscle consistent with proteasome activation. This was also associated with acute posttranslational modification of protein abundance. Integration of these data with phosphoproteomics identified co-regulated proximal modifications suggesting a cross talk between phosphorylation and ubiquitylation. We also identified additional protein modification cross talk and showed acute activation of protein NEDDylation. In vitro experiments revealed that cAMP-dependent activation of the proteasome requires NEDD8, an ubiquitin-like protein involved in protein NEDDylation, to maintain cellular protein ubiquitylation levels. Our data reveal the complexity of ubiquitin signaling and proteome remodeling in muscle during and after high-intensity exercise. We propose a model whereby exercise and the resulting cAMP signaling activate both the proteasome and ubiquitylation via NEDDylation to rapidly remove potentially damaged proteins.	[Parker, Benjamin L.; James, David E.] Univ Sydney, Charles Perkins Ctr, Sch Life & Environm Sci, Sydney, NSW, Australia; [Parker, Benjamin L.] Univ Melbourne, Dept Physiol, Ctr Muscle Res, Melbourne, Vic, Australia; [Kiens, Bente; Wojtaszewski, Jorgen F. P.; Richter, Erik A.] Univ Copenhagen, Sect Mol Physiol, Fac Sci, Dept Nutr Exercise & Sports, DK-2100 Copenhagen, Denmark; [James, David E.] Univ Sydney, Sch Med, Sydney, NSW, Australia	University of Sydney; University of Melbourne; University of Copenhagen; University of Sydney	Richter, EA (corresponding author), Univ Copenhagen, Sect Mol Physiol, Fac Sci, Dept Nutr Exercise & Sports, DK-2100 Copenhagen, Denmark.; James, DE (corresponding author), Univ Sydney, Charles Perkins Ctr D17, Sch Life & Environm Sci, Sydney, NSW 2006, Australia.	erichter@nexs.ku.dk; david.james@sydney.edu.au	Kiens, Bente/B-1375-2015; Richter, Erik A./N-4189-2014	Kiens, Bente/0000-0001-5705-5625; James, David/0000-0001-5946-5257; wojtaszewski, jorgen/0000-0001-8185-3408; Richter, Erik A./0000-0002-6850-3056				Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bilodeau PA, 2016, AM J PHYSIOL-CELL PH, V311, pC392, DOI 10.1152/ajpcell.00125.2016; BIOLO G, 1995, AM J PHYSIOL-ENDOC M, V268, pE514; Chen YW, 2010, THROMB HAEMOSTASIS, V104, P293, DOI 10.1160/TH09-09-0633; DOHM GL, 1985, FED PROC, V44, P348; DOHM GL, 1987, MED SCI SPORT EXER, V19, pS166; Enchev RI, 2015, NAT REV MOL CELL BIO, V16, P30, DOI 10.1038/nrm3919; Filipcik P, 2017, J MOL BIOL, V429, P1097, DOI 10.1016/j.jmb.2017.02.011; HARALAMBIE G, 1976, EUR J APPL PHYSIOL O, V36, P39, DOI 10.1007/BF00421632; Hoffman NJ, 2015, CELL METAB, V22, P922, DOI 10.1016/j.cmet.2015.09.001; Hutchins AP, 2013, MOL BIOL EVOL, V30, P1172, DOI 10.1093/molbev/mst022; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Lee JS, 2010, CELL, V142, P682, DOI 10.1016/j.cell.2010.08.011; Lokireddy S, 2015, P NATL ACAD SCI USA, V112, pE7176, DOI 10.1073/pnas.1522332112; Louis E, 2007, J APPL PHYSIOL, V103, P1744, DOI 10.1152/japplphysiol.00679.2007; Lydeard JR, 2013, EMBO REP, V14, P1050, DOI 10.1038/embor.2013.173; Malik ZA, 2013, PROTEOMES, V1, DOI 10.3390/proteomes1030290; Mansueto G, 2017, CELL METAB, V25, P182, DOI 10.1016/j.cmet.2016.11.003; Mir R, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00188-18; Nedergaard A, 2007, J APPL PHYSIOL, V103, P1513, DOI 10.1152/japplphysiol.01445.2006; Olsen LA, 2019, EUR J APPL PHYSIOL, V119, P333, DOI 10.1007/s00421-018-04061-x; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Palmisano G, 2010, NAT PROTOC, V5, P1974, DOI 10.1038/nprot.2010.167; Parikh H, 2008, AM J PHYSIOL-ENDOC M, V294, pE1152, DOI 10.1152/ajpendo.90255.2008; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Phillips SM, 2002, CAN J PHYSIOL PHARM, V80, P1045, DOI [10.1139/y02-134, 10.1139/Y02-134]; Phillips SM, 1997, AM J PHYSIOL-ENDOC M, V273, pE99, DOI 10.1152/ajpendo.1997.273.1.E99; Phillips SM, 1999, AM J PHYSIOL-ENDOC M, V276, pE118; Rose CM, 2016, CELL SYST, V3, P395, DOI 10.1016/j.cels.2016.08.009; Schafer MJ, 2016, DIABETES, V65, P1606, DOI 10.2337/db15-0291; Sheffield-Moore M, 2004, AM J PHYSIOL-ENDOC M, V287, pE513, DOI 10.1152/ajpendo.00334.2003; Shimizu K, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aah4117; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Swatek KN, 2016, CELL RES, V26, P399, DOI 10.1038/cr.2016.39; Taus T, 2011, J PROTEOME RES, V10, P5354, DOI 10.1021/pr200611n; THOMPSON HS, 1994, BIOCHEM BIOPH RES CO, V204, P1193, DOI 10.1006/bbrc.1994.2589; VerPlank JJS, 2019, P NATL ACAD SCI USA, V116, P4228, DOI 10.1073/pnas.1809254116; Werner C, 2009, CIRCULATION, V120, P2438, DOI 10.1161/CIRCULATIONAHA.109.861005; Wiley CD, 2019, CELL REP, V28, P3329, DOI 10.1016/j.celrep.2019.08.049; Willoughby DS, 2003, MED SCI SPORT EXER, V35, P2023, DOI 10.1249/01.MSS.0000099100.83796.77; Ye X, 2004, J BIOL CHEM, V279, P50110, DOI 10.1074/jbc.M409226200; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6	44	13	13	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5906	5916		10.1096/fj.202000075R	http://dx.doi.org/10.1096/fj.202000075R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32141134				2022-12-28	WOS:000530242100073
J	Ng, B; Dong, JR; Viswanathan, S; Widjaja, AA; Paleja, BS; Adami, E; Ko, NSJ; Wang, M; Lim, S; Tan, J; Chothani, SP; Albani, S; Schafer, S; Cook, SA				Ng, Benjamin; Dong, Jinrui; Viswanathan, Sivakumar; Widjaja, Anissa A.; Paleja, Bhairav S.; Adami, Eleonora; Ko, Nicole S. J.; Wang, Mao; Lim, Stella; Tan, Jessie; Chothani, Sonia P.; Albani, Salvatore; Schafer, Sebastian; Cook, Stuart A.			Fibroblast-specific IL11 signaling drives chronic inflammation in murine fibrotic lung disease	FASEB JOURNAL			English	Article						cytokine; fibrosis; fibroblast; signaling	PULMONARY-FIBROSIS; IL-11; CELL; EXPRESSION; INTERLEUKIN-11; PATHOGENESIS; BLEOMYCIN; SEVERITY; RECEPTOR; INJURY	Repetitive pulmonary injury causes fibrosis and inflammation that underlies chronic lung diseases such as idiopathic pulmonary fibrosis (IPF). Interleukin 11 (IL11) is important for pulmonary fibroblast activation but the contribution of fibroblast-specific IL11 activity to lung fibro-inflammation is not known. To address this gap in knowledge, we generated mice with loxP-flankedIl11ra1and deleted the IL11 receptor in adult fibroblasts (CKO mice). In the bleomycin (BLM) model of lung fibrosis, CKO mice had reduced fibrosis, lesser fibroblast ERK activation, and diminished immune cell STAT3 phosphorylation. Following BLM injury, acute inflammation in CKO mice was similar to controls but chronic immune infiltrates and pro-inflammatory gene activation, including NF-kB phosphorylation, were notably reduced. Therapeutic prevention of IL11 activity with neutralizing antibodies mirrored the effects of genetic deletion ofIl11ra1in fibroblasts. These data reveal a new function for IL11 in pro-inflammatory lung fibroblasts and highlight the important contribution of the stroma to inflammation in pulmonary disease.	[Ng, Benjamin; Tan, Jessie; Schafer, Sebastian] Natl Heart Ctr Singapore, Natl Heart Res Inst Singapore, Singapore, Singapore; [Ng, Benjamin; Dong, Jinrui; Viswanathan, Sivakumar; Widjaja, Anissa A.; Adami, Eleonora; Ko, Nicole S. J.; Wang, Mao; Lim, Stella; Tan, Jessie; Chothani, Sonia P.; Schafer, Sebastian] Duke Natl Univ Singapore Med Sch, Cardiovasc & Metab Disorders Program, Singapore, Singapore; [Paleja, Bhairav S.; Albani, Salvatore] SingHlth Duke NUS Acad Med Ctr, Translat Immunol Inst, Singapore, Singapore; [Cook, Stuart A.] Imperial Coll, Natl Heart & Lung Inst, London, England; [Cook, Stuart A.] MRC London Inst Med Sci, Hammersmith Hosp Campus, London, England	National Heart Centre Singapore; Imperial College London	Cook, SA (corresponding author), Duke Natl Univ Singapore Med Sch, 8 Coll Rd, Singapore 169857, Singapore.	stuart.cook@duke-nus.edu.sg		Paleja, Bhairav/0000-0003-3726-0167; Widjaja, Anissa/0000-0001-9404-7608	Medical Research Council [MC_U120085815] Funding Source: Medline; MRC [MC_U120085815] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aran D, 2019, NAT IMMUNOL, V20, P163, DOI 10.1038/s41590-018-0276-y; ASHCROFT T, 1988, J CLIN PATHOL, V41, P467, DOI 10.1136/jcp.41.4.467; Buechler MB, 2018, SEMIN IMMUNOL, V35, P48, DOI 10.1016/j.smim.2017.11.001; Chen HY, 2020, EXP MOL MED, V52, P130, DOI 10.1038/s12276-019-0371-7; Chen QS, 2005, J IMMUNOL, V174, P2305, DOI 10.4049/jimmunol.174.4.2305; Chew V, 2017, P NATL ACAD SCI USA, V114, pE5900, DOI 10.1073/pnas.1706559114; Croft AP, 2019, NATURE, V570, P246, DOI 10.1038/s41586-019-1263-7; Dakin SG, 2018, NAT REV RHEUMATOL, V14, P714, DOI 10.1038/s41584-018-0112-7; Desai O, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00043; Gregory AD, 2015, J LEUKOCYTE BIOL, V98, P143, DOI 10.1189/jlb.3HI1014-493R; Guzy RD, 2017, J BIOL CHEM, V292, P10364, DOI 10.1074/jbc.M117.791764; Heukels P, 2019, RESP MED, V147, P79, DOI 10.1016/j.rmed.2018.12.015; Homer RJ, 2011, ARCH PATHOL LAB MED, V135, P780, DOI 10.1043/2010-0296-RA.1; Joshi N, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00646-2019; Larson-Casey JL, 2016, IMMUNITY, V44, P582, DOI 10.1016/j.immuni.2016.01.001; Liang JR, 2016, NAT MED, V22, P1285, DOI 10.1038/nm.4192; Lim WW, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227505; Liu T, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.23; Lodyga M, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aao3469; Minshall E, 2000, J ALLERGY CLIN IMMUN, V105, P232, DOI 10.1016/S0091-6749(00)90070-8; Misharin AV, 2017, J EXP MED, V214, P2387, DOI 10.1084/jem.20162152; Ng B, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aaw1237; Noble PW, 2012, J CLIN INVEST, V122, P2756, DOI 10.1172/JCI60323; Parker JM, 2018, AM J RESP CRIT CARE, V197, P94, DOI 10.1164/rccm.201704-0784OC; Pedroza M, 2016, FASEB J, V30, P129, DOI 10.1096/fj.15-273953; Reyfman PA, 2019, AM J RESP CRIT CARE, V199, P1517, DOI 10.1164/rccm.201712-2410OC; Riehl DR, 2016, FASEB J, V30; Robb L, 1998, NAT MED, V4, P303, DOI 10.1038/nm0398-303; Schafer S, 2017, NATURE, V552, P110, DOI 10.1038/nature24676; SHEN AS, 1988, AM REV RESPIR DIS, V137, P564, DOI 10.1164/ajrccm/137.3.564; Smillie CS, 2019, CELL, V178, P714, DOI 10.1016/j.cell.2019.06.029; Smith RS, 1997, AM J PATHOL, V151, P317; Strikoudis A, 2019, CELL REP, V27, P3709, DOI 10.1016/j.celrep.2019.05.077; Takemasa A, 2012, EUR RESPIR J, V40, P1475, DOI 10.1183/09031936.00127011; Tan JN, 2017, J IMMUNOL, V198, P2269, DOI 10.4049/jimmunol.1600610; Tang WL, 1996, J CLIN INVEST, V98, P2845, DOI 10.1172/JCI119113; Wang JM, 1999, AM J PHYSIOL-LUNG C, V276, pL175, DOI 10.1152/ajplung.1999.276.1.L175; West NR, 2017, NAT MED, V23, P579, DOI 10.1038/nm.4307; Widjaja AA, 2019, GASTROENTEROLOGY, V157, P777, DOI 10.1053/j.gastro.2019.05.002; Xie T, 2018, CELL REP, V22, P3625, DOI 10.1016/j.celrep.2018.03.010; Zheng B, 2002, AM J PATHOL, V160, P1609, DOI 10.1016/S0002-9440(10)61108-X	41	26	26	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					11802	11815		10.1096/fj.202001045RR	http://dx.doi.org/10.1096/fj.202001045RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32656894	hybrid, Green Submitted			2022-12-28	WOS:000567002100038
J	Peng, YJ; Lu, JW; Liu, FC; Lee, CH; Lee, HS; Ho, YJ; Hsieh, TH; Wu, CC; Wang, CC				Peng, Yi-Jen; Lu, Jeng-Wei; Liu, Feng-Cheng; Lee, Chian-Her; Lee, Herng-Sheng; Ho, Yi-Jung; Hsieh, Tsung-Hsun; Wu, Chia-Chun; Wang, Chih-Chien			Astaxanthin attenuates joint inflammation induced by monosodium urate crystals	FASEB JOURNAL			English	Article						astaxanthin; inflammasome; inflammatory; monosodium urate; optical density (od)	NLRP3 INFLAMMASOME; GOUTY-ARTHRITIS; CAROTENOIDS; EXPRESSION; INHIBITORS; IMMUNITY; DISEASE; STRESS; SENSOR	Gouty arthritis is the one of the most painful arthritis and is caused by an inflammatory reaction. This study investigated whether astaxanthin (AXT), which has documented anti-inflammatory and antioxidant properties, exhibits protective effects against monosodium urate (MSU) crystal-induced inflammation. Cell viability of J774A.1 murine macrophages was assessed by AXT dose-dependent incubation by MTT assays, and expression levels of iNOS and COX-2 proteins as well as secretion of IL-1 beta were also analyzed under MSU crystals stimulation with or without AXT treatment. The production of inflammatory mediators was found to significantly decrease with AXT treatment, and the formation of the inflammasome complex was also attenuated when cells were co-stimulated with MSU crystals and AXT. Furthermore, we found that expression of the MAPK pathway was downregulated in J774A.1 cells. AXT also inhibited the induction of COX-2 and IL-6 in human chondrocytes and synovial fibroblasts by western blots. Finally, an MSU crystal intra-articular injection rat model for gouty arthritis was utilized in which treatment groups received 5-daily intraperitoneal injections of AXT prior to MSU crystal stimulation, or once intra-articular injections of AXT following MSU crystal stimulation for 6 hours. Results of synovitis score analysis revealed that inflammation was significantly attenuated in the group which received intraperitoneal AXT injection prior to MSU crystal stimulation compared to the group which received MSU only. These results indicate that AXT attenuates the effects of MSU crystal-induced inflammation by suppressing the production of pro-inflammatory cytokines and inflammatory mediators. Our findings that the anti-inflammatory activities of AXT may be beneficial in the treatment of MSU crystal-induced arthritis.	[Peng, Yi-Jen; Hsieh, Tsung-Hsun] Triserv Gen Hosp, Dept Pathol, Natl Def Med Ctr, Taipei, Taiwan; [Lu, Jeng-Wei] Natl Univ Singapore, Dept Biol Sci, Singapore, Singapore; [Liu, Feng-Cheng] Triserv Gen Hosp, Dept Med, Natl Def Med Ctr, Rheumatol Immunol & Allergy, Taipei, Taiwan; [Lee, Chian-Her] Taipei Med Univ, Taipei Med Univ Hosp, Coll Med, Dept Orthoped,Sch Med, Taipei, Taiwan; [Lee, Herng-Sheng] Kaohsiung Vet Gen Hosp, Dept Pathol & Lab Med, Kaohsiung, Taiwan; [Ho, Yi-Jung] Natl Def Med Ctr, Grad Inst Life Sci, Sch Pharm, Taipei, Taiwan; [Wu, Chia-Chun; Wang, Chih-Chien] Triserv Gen Hosp, Dept Orthoped, Natl Def Med Ctr, Taipei 114, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National University of Singapore; National Defense Medical Center; Tri-Service General Hospital; Taipei Medical University; Taipei Medical University Hospital; Kaohsiung Veterans General Hospital; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital	Wang, CC (corresponding author), Triserv Gen Hosp, Dept Orthoped, Natl Def Med Ctr, Taipei 114, Taiwan.	tsghcc@gmail.com		Lu, Jeng-Wei/0000-0003-2128-2046	Ministry of Science and Technology [MOST 107-2314-B-038-088, MOST 108-2314-B-038-082]; Tri-Service General Hospital, National Defense Medical Center [TSGH-C107-081, TSGH-C108-113, TSGH-D-10902]; Ministry of National Defense-Medical Affairs Bureau at Taiwan [MAB-106-006]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Tri-Service General Hospital, National Defense Medical Center; Ministry of National Defense-Medical Affairs Bureau at Taiwan	The authors' work was supported by grants from Ministry of Science and Technology (MOST 107-2314-B-038-088 and MOST 108-2314-B-038-082), Tri-Service General Hospital, National Defense Medical Center (TSGH-C107-081, TSGH-C108-113, and TSGH-D-10902), and Ministry of National Defense-Medical Affairs Bureau (MAB-106-006) at Taiwan.	Abderrazak A, 2015, REDOX BIOL, V4, P296, DOI 10.1016/j.redox.2015.01.008; Chen BF, 2019, ARTHRITIS RES THER, V21, DOI 10.1186/s13075-019-1974-z; Chew BP, 1999, ANTICANCER RES, V19, P5223; Choi HK, 2005, ANN INTERN MED, V143, P499, DOI 10.7326/0003-4819-143-7-200510040-00009; Choi HD, 2011, BRIT J NUTR, V105, P220, DOI 10.1017/S0007114510003454; Coleman JW, 2001, INT IMMUNOPHARMACOL, V1, P1397, DOI 10.1016/S1567-5769(01)00086-8; Crofford LJ, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4174; Dalbeth N, 2005, RHEUMATOLOGY, V44, P1090, DOI [10.1093/rheumatology/keh640, 10.1186/ar2952]; Dhanasekar C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145093; Fam AG, 2002, BRIT MED J, V325, P980, DOI 10.1136/bmj.325.7371.980; Fassett RG, 2011, MAR DRUGS, V9, P447, DOI 10.3390/md9030447; Fettelschoss A, 2011, P NATL ACAD SCI USA, V108, P18055, DOI 10.1073/pnas.1109176108; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Giroux M, 2000, J IMMUNOL, V165, P3985, DOI 10.4049/jimmunol.165.7.3985; Grebe A, 2018, CIRC RES, V122, P1722, DOI 10.1161/CIRCRESAHA.118.311362; Hochberg MC, 2005, CURR TOP MED CHEM, V5, P443, DOI 10.2174/1568026054201695; Jhang JJ, 2018, J AGR FOOD CHEM, V66, P765, DOI 10.1021/acs.jafc.7b05113; JYONOUCHI H, 1995, NUTR CANCER, V23, P171, DOI 10.1080/01635589509514373; Jyonouchi H, 2000, NUTR CANCER, V36, P59, DOI 10.1207/S15327914NC3601_9; Lee HS, 2009, OSTEOARTHR CARTILAGE, V17, P91, DOI 10.1016/j.joca.2008.05.010; Lionberger David R, 2010, J Pain Res, V3, P223, DOI 10.2147/JPR.S13238; Liu FC, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051453; Liu-Bryan R, 2010, IMMUNOL CELL BIOL, V88, P20, DOI 10.1038/icb.2009.93; Lopez-Castejon G, 2011, CYTOKINE GROWTH F R, V22, P189, DOI 10.1016/j.cytogfr.2011.10.001; Miyachi M, 2015, J CLIN BIOCHEM NUTR, V56, P171, DOI 10.3164/jcbn.14-109; Nakao R, 2010, ANTICANCER RES, V30, P2721; Nam JS, 2017, CHIN J NAT MEDICINES, V15, P561, DOI [10.1016/S1875-5364(17)30084-5, 10.3724/SP.J.1009.2017.00561]; Okai Y, 1996, INT J IMMUNOPHARMACO, V18, P753, DOI 10.1016/S0192-0561(97)85558-0; Park JS, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-18; Peng YJ, 2012, FREE RADICAL BIO MED, V52, P765, DOI 10.1016/j.freeradbiomed.2011.12.003; Perez-Ruiz F, 2015, ADV THER, V32, P31, DOI 10.1007/s12325-014-0175-z; Pope RM, 2007, ARTHRITIS RHEUM-US, V56, P3183, DOI 10.1002/art.22938; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; Schlesinger N, 2004, DRUGS, V64, P2399, DOI 10.2165/00003495-200464210-00003; Schroder K, 2010, SCIENCE, V327, P296, DOI 10.1126/science.1184003; Szekanecz Z, 2019, ARCH BIOCHEM BIOPHYS, V670, P82, DOI 10.1016/j.abb.2019.01.031; Tripathi DN, 2008, TOXICOLOGY, V248, P96, DOI 10.1016/j.tox.2008.03.015; Tripathi P, 2007, FEMS IMMUNOL MED MIC, V51, P443, DOI 10.1111/j.1574-695X.2007.00329.x; Yeh PT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146438; Zhang YF, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/9656270	40	10	11	1	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					11215	11226		10.1096/fj.202000558RR	http://dx.doi.org/10.1096/fj.202000558RR		JUL 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32648603	Bronze			2022-12-28	WOS:000547914000001
J	Jonker, SS; Giraud, GD; Chang, EI; Elman, MR; Louey, S				Jonker, Sonnet S.; Giraud, George D.; Chang, Eileen, I; Elman, Miriam R.; Louey, Samantha			Coronary vascular growth matches IGF-1-stimulated cardiac growth in fetal sheep	FASEB JOURNAL			English	Article						adenosine; angiogenesis; contracture; coronary autoregulation; developmental origins; nitric oxide	SMOOTH-MUSCLE-CELLS; MICROVASCULAR RAREFACTION; MYOCARDIAL FIBROSIS; ENDOTHELIAL-CELLS; HEART-FAILURE; FACTOR-I; IGF-I; PROLIFERATION; INSULIN; FLOW	As loss of contractile function in heart disease could often be mitigated by increased cardiomyocyte number, expansion of cardiomyocyte endowment paired with increased vascular supply is a desirable therapeutic goal. Insulin-like growth factor 1 (IGF-1) administration increases fetal cardiomyocyte proliferation and heart mass, but how fetal IGF-1 treatment affects coronary growth and function is unknown. Near-term fetal sheep underwent surgical instrumentation and were studied from 127 to 134 d gestation (term = 147 d), receiving either IGF-1 LR3 or vehicle. Coronary growth and function were interrogated using pressure-flow relationships, an episode of acute hypoxia with progressive blockade of adenosine receptors and nitric oxide synthase, and by modeling the determinants of coronary flow. The main findings were that coronary conductance was preserved on a per-gram basis following IGF-1 treatment, adenosine and nitric oxide contributed to hypoxia-mediated coronary vasodilation similarly in IGF-1-treated and Control fetuses, and the relationships between coronary flow and blood oxygen contents were similar between groups. We conclude that IGF-1-stimulated fetal myocardial growth is accompanied by appropriate expansion and function of the coronary vasculature. These findings support IGF-1 as a potential strategy to increase cardiac myocyte and coronary vascular endowment at birth.	[Jonker, Sonnet S.; Giraud, George D.; Chang, Eileen, I; Louey, Samantha] Oregon Hlth & Sci Univ, Ctr Dev Hlth, Knight Cardiovasc Inst, 3303 SW Bond Ave,CH14T, Portland, OR 97239 USA; [Giraud, George D.] VA Portland Hlth Care Syst, Div Cardiol, Portland, OR USA; [Elman, Miriam R.] Oregon Hlth & Sci Univ, Portland State Univ, Sch Publ Hlth, Portland, OR 97201 USA	Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System; Oregon Health & Science University; Portland State University	Jonker, SS (corresponding author), Oregon Hlth & Sci Univ, Ctr Dev Hlth, Knight Cardiovasc Inst, 3303 SW Bond Ave,CH14T, Portland, OR 97239 USA.	Jonker5@ohsu.edu	; Louey, Samantha/A-1381-2009	Chang, Eileen/0000-0002-3444-7260; Louey, Samantha/0000-0002-2628-0085; Jonker, Sonnet/0000-0002-1097-2562	HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [R01HD071068, P01HD034430]; HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) [T32HL094294]	HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI)	HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Grant/Award Number: R01HD071068 and P01HD034430; HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: T32HL094294	ANDERSON DF, 1985, J PHYSIOL-LONDON, V365, P29, DOI 10.1113/jphysiol.1985.sp015757; Bach LA, 2015, J MOL ENDOCRINOL, V54, pR1, DOI 10.1530/JME-14-0215; Back K, 2012, J ENDOCRINOL, V215, P89, DOI 10.1530/JOE-12-0261; Benjamin EJ, 2018, CIRCULATION, V137, pE67, DOI 10.1161/CIR.0000000000000558; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Burrell JH, 2003, ANAT REC PART A, V274A, P952, DOI 10.1002/ar.a.10110; Campbell DJ, 2015, CIRCULATION, V132, pE205, DOI 10.1161/CIRCULATIONAHA.115.016091; Charytan DM, 2018, KIDNEY INT, V93, P501, DOI 10.1016/j.kint.2017.07.025; Chattergoon NN, 2014, AM J PHYSIOL-HEART C, V307, pH1216, DOI 10.1152/ajpheart.00833.2013; Chien KR, 2019, NAT BIOTECHNOL, V37, P232, DOI 10.1038/s41587-019-0042-1; Chisalita SI, 2004, AM J PHYSIOL-ENDOC M, V286, pE896, DOI 10.1152/ajpendo.00327.2003; Coulombe KLK, 2014, ANNU REV BIOMED ENG, V16, P1, DOI 10.1146/annurev-bioeng-071812-152344; FLANAGAN MF, 1994, J AM COLL CARDIOL, V24, P1786, DOI 10.1016/0735-1097(94)90188-0; Goodwill AG, 2017, COMPR PHYSIOL, V7, P321, DOI 10.1002/cphy.c160016; HARDING JE, 1994, ENDOCRINOLOGY, V134, P1509, DOI 10.1210/en.134.3.1509; Huttenbach Y, 2001, CARDIOVASC PATHOL, V10, P119, DOI 10.1016/S1054-8807(01)00065-5; Jia GH, 2006, IMMUNOL CELL BIOL, V84, P422, DOI 10.1111/j.1440-1711.2006.01449.x; Jonker SS, 2016, J ENDOCRINOL, V228, pR1, DOI 10.1530/JOE-15-0309; Jonker SS, 2018, J ENDOCRINOL, V239, P253, DOI 10.1530/JOE-18-0382; Jonker SS, 2018, AM J PHYSIOL-HEART C, V315, pH1393, DOI 10.1152/ajpheart.00314.2018; Jonker SS, 2015, FASEB J, V29, P4346, DOI 10.1096/fj.15-272013; KAIJSER L, 1990, CLIN PHYSIOL, V10, P259, DOI 10.1111/j.1475-097X.1990.tb00094.x; KIM HD, 1992, J MOL CELL CARDIOL, V24, P949, DOI 10.1016/0022-2828(92)91862-Y; Li ZJ, 2017, BIOCHEM BIOPH RES CO, V487, P15, DOI 10.1016/j.bbrc.2017.03.055; Liu K, 2015, INT J MOL MED, V36, P817, DOI 10.3892/ijmm.2015.2277; LLANOS AJ, 1986, AM J OBSTET GYNECOL, V155, P893, DOI 10.1016/S0002-9378(86)80046-1; Massion P B, 2001, Curr Opin Crit Care, V7, P323, DOI 10.1097/00075198-200110000-00003; Mohammed SF, 2015, CIRCULATION, V131, P550, DOI 10.1161/CIRCULATIONAHA.114.009625; Nakagawa S, 2017, J R SOC INTERFACE, V14, DOI 10.1098/rsif.2017.0213; National Research Council (U.S.). Committee for the Update of the Guide for the Care and Use of Laboratory Animals. Institute for Laboratory Animal Research (U.S.) National Academies Press (U.S.), 2011, GUIDE CARE USE LAB A, pxxv; Nowak DG, 2008, J CELL SCI, V121, P3487, DOI 10.1242/jcs.016410; Porrello ER, 2008, CLIN EXP PHARMACOL P, V35, P1358, DOI 10.1111/j.1440-1681.2008.05036.x; Pries AR, 2017, EUR HEART J, V38, P478, DOI 10.1093/eurheartj/ehv760; Riksen Niels P, 2011, Handb Exp Pharmacol, P413, DOI 10.1007/978-3-642-13443-2_16; Robertson SS, 1996, DEV PSYCHOBIOL, V29, P667, DOI 10.1002/(SICI)1098-2302(199612)29:8<667::AID-DEV3>3.0.CO;2-R; Shinozuka N, 2000, AM J PHYSIOL-HEART C, V278, pH41, DOI 10.1152/ajpheart.2000.278.1.H41; Shuang T, 2018, BIOCHEM PHARMACOL, V149, P143, DOI 10.1016/j.bcp.2017.12.009; SUNDERJI SG, 1984, AM J OBSTET GYNECOL, V149, P408, DOI 10.1016/0002-9378(84)90155-8; Sundgren NC, 2003, AM J PHYSIOL-REG I, V285, pR1481, DOI 10.1152/ajpregu.00232.2003; Tarantini S, 2016, AGE, V38, P273, DOI 10.1007/s11357-016-9931-0; van de Hoef TP, 2012, J MOL CELL CARDIOL, V52, P786, DOI 10.1016/j.yjmcc.2011.07.025; Wagner BA, 2011, FREE RADICAL BIO MED, V51, P700, DOI 10.1016/j.freeradbiomed.2011.05.024; Wilburn AN, 2018, AM J PHYSIOL-REG I, V315, pR1038, DOI 10.1152/ajpregu.00198.2018; Xiao Y, 2018, CARDIOVASC TOXICOL, V18, P304, DOI 10.1007/s12012-017-9438-7; Zhu BH, 2001, ENDOCRINOLOGY, V142, P3598, DOI 10.1210/en.142.8.3598	45	2	2	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10041	10055		10.1096/fj.202000215R	http://dx.doi.org/10.1096/fj.202000215R		JUN 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32573852	Green Accepted, Bronze			2022-12-28	WOS:000543552400001
J	Younis, S; Naboulsi, R; Wang, X; Cao, XF; Larsson, M; Sargsyan, E; Bergsten, P; Welsh, N; Andersson, L				Younis, Shady; Naboulsi, Rakan; Wang, Xuan; Cao, Xiaofang; Larsson, Marten; Sargsyan, Ernest; Bergsten, Peter; Welsh, Nils; Andersson, Leif			The importance of the ZBED6-IGF2 axis for metabolic regulation in mouse myoblast cells	FASEB JOURNAL			English	Article						IGF2; mitochondria; myogenesis and gene editing; ZBED6	SKELETAL-MUSCLE; DIFFERENTIATION; GROWTH; MASS; RNA; CYCLE	The transcription factor ZBED6 acts as a repressor of Igf2 and affects directly or indirectly the transcriptional regulation of thousands of genes. Here, we use gene editing in mouse C2C12 myoblasts and show that ZBED6 regulates Igf2 exclusively through its binding site 5 '-GGCTCG-3 ' in intron 1 of Igf2. Deletion of this motif (Igf2(Delta GGCT)) or complete ablation of Zbed6 leads to similar to 20-fold upregulation of the IGF2 protein. Quantitative proteomics revealed an activation of Ras signaling pathway in both Z bed6(-/-) and Igf2(Delta GGCT) myoblasts, and a significant enrichment of mitochondrial membrane proteins among proteins showing altered expression in Z bed6(-/-)myoblasts. BothZbed6(-/-)andIgf2(Delta GGCT)myoblasts showed a faster growth rate and developed myotube hypertrophy. These cells exhibited an increased O-2 consumption rate, due to IGF2 upregulation. Transcriptome analysis revealed similar to 30% overlap between differentially expressed genes in Z bed6(-/-) and Igf2(Delta GGCT) myotubes, with an enrichment of upregulated genes involved in muscle development. In contrast, ZBED6-overexpression in myoblasts led to cell apoptosis, cell cycle arrest, reduced mitochondrial activities, and ceased myoblast differentiation. The similarities in growth and differentiation phenotypes observed in Z bed6(-/-)and Igf2(Delta GGCT) myoblasts demonstrates that ZBED6 affects mitochondrial activity and myogenesis largely through its regulation of IGF2 expression. This study adds new insights how the ZBED6-Igf2 axis affects muscle metabolism.	[Younis, Shady; Naboulsi, Rakan; Cao, Xiaofang; Larsson, Marten; Andersson, Leif] Uppsala Univ, Sci Life Lab, Dept Med Biochem & Microbiol, Box 582, SE-75123 Uppsala, Sweden; [Wang, Xuan; Sargsyan, Ernest; Bergsten, Peter; Welsh, Nils] Uppsala Univ, Dept Med Cell Biol, Sci Life Lab, Uppsala, Sweden; [Andersson, Leif] Swedish Univ Agr Sci, Dept Anim Breeding & Genet, Uppsala, Sweden; [Andersson, Leif] Texas A&M Univ, Dept Vet Integrat Biosci, College Stn, TX USA	Uppsala University; Uppsala University; Swedish University of Agricultural Sciences; Texas A&M University System; Texas A&M University College Station	Andersson, L (corresponding author), Uppsala Univ, Sci Life Lab, Dept Med Biochem & Microbiol, Box 582, SE-75123 Uppsala, Sweden.	leif.andersson@imbim.uu.se	Naboulsi, Rakan/GWM-4355-2022	Naboulsi, Rakan/0000-0002-3610-4341; Younis, Shady/0000-0002-4319-1738; Larsson, Marten/0000-0002-7855-9539	Knut och Alice Wallenbergs Stiftelse (Knut and Alice Wallenberg Foundation); Swedish Research Council	Knut och Alice Wallenbergs Stiftelse (Knut and Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission)	Knut och Alice Wallenbergs Stiftelse (Knut and Alice Wallenberg Foundation), Grant/Award Number: KAW Scholar; Swedish Research Council, Grant/Award Number: Radsprofessur	Ali MA, 2015, P NATL ACAD SCI USA, V112, P7743, DOI 10.1073/pnas.1509193112; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Arciuch VGA, 2012, ANTIOXID REDOX SIGN, V16, P1150, DOI 10.1089/ars.2011.4085; Barnes BR, 2004, J BIOL CHEM, V279, P38441, DOI 10.1074/jbc.M405533200; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Butter F, 2010, EMBO REP, V11, P305, DOI 10.1038/embor.2010.6; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Duguez S, 2004, EXP CELL RES, V299, P27, DOI 10.1016/j.yexcr.2004.05.017; Dunglison GF, 1999, MECH DEVELOP, V87, P11, DOI 10.1016/S0925-4773(99)00134-3; Filigheddu N, 2007, MOL BIOL CELL, V18, P986, DOI 10.1091/mbc.E06-05-0402; FLORINI JR, 1991, J BIOL CHEM, V266, P15917; HERZBERG NH, 1993, BIOCHIM BIOPHYS ACTA, V1181, P63, DOI 10.1016/0925-4439(93)90091-E; Hsu YC, 2016, SEMIN CELL DEV BIOL, V52, P119, DOI 10.1016/j.semcdb.2016.02.011; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Jiang LY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084578; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Lee KY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9054; Malmgren S, 2009, J BIOL CHEM, V284, P32395, DOI 10.1074/jbc.M109.026708; Markljung E, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000256; Naito Y, 2015, BIOINFORMATICS, V31, P1120, DOI 10.1093/bioinformatics/btu743; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; REHFELDT C, 1993, BIOSCIENCE REP, V13, P213, DOI 10.1007/BF01123503; Remels AHV, 2010, MOL CELL ENDOCRINOL, V315, P113, DOI 10.1016/j.mce.2009.09.029; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; STOCKDALE FE, 1992, DEV BIOL, V154, P284, DOI 10.1016/0012-1606(92)90068-R; Stohr G, 2011, RSC CHROMATOGR MONOG, P104, DOI 10.1039/9781849733144-00104; Tyanova S, 2016, NAT PROTOC, V11, P2301, DOI 10.1038/nprot.2016.136; Van Laere AS, 2003, NATURE, V425, P832, DOI 10.1038/nature02064; Velloso CP, 2008, BRIT J PHARMACOL, V154, P557, DOI 10.1038/bjp.2008.153; Wang X, 2019, FASEB J, V33, P88, DOI 10.1096/fj.201600835R; Wu LZ, 2001, NATURE, V414, P457, DOI 10.1038/35106593; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Younis S, 2018, P NATL ACAD SCI USA, V115, pE3808, DOI 10.1073/pnas.1722333115; Younis S, 2018, P NATL ACAD SCI USA, V115, pE2048, DOI 10.1073/pnas.1719278115	40	5	6	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10250	10266		10.1096/fj.201901321R	http://dx.doi.org/10.1096/fj.201901321R		JUN 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32557799	hybrid, Green Published			2022-12-28	WOS:000541805900001
J	Ferofontov, A; Vankova, P; Man, P; Giladi, M; Haitin, Y				Ferofontov, Alisa; Vankova, Pavla; Man, Petr; Giladi, Moshe; Haitin, Yoni			Conserved cysteine dioxidation enhances membrane interaction of human Cl(-)intracellular channel 5	FASEB JOURNAL			English	Article						CLIC; mass spectrometry; oligomerization; oxidation; X-ray crystallography	CHLORIDE-ION CHANNEL; SMALL-ANGLE SCATTERING; CRYSTAL-STRUCTURE; BIOLOGICAL MACROMOLECULES; MOLECULAR-CLONING; CLIC PROTEINS; SOLUBLE FORM; MUTATION; COMPLEXES; EXCHANGE	The human chloride intracellular channel (hCLIC) family is thought to transition between globular and membrane-associated forms by exposure of a hydrophobic surface. However, the molecular identity of this surface, and the triggering events leading to its exposure, remain elusive. Here, by combining biochemical and structural approaches, together with mass spectrometry (MS) analyses, we show that hCLIC5 is inherently flexible. X-ray crystallography revealed the existence of a globular conformation, while small-angle X-ray scattering showed additional elongated forms consisting of exposure of the conserved hydrophobic inter-domain interface to the bulk phase. Tryptophan fluorescence measurements demonstrated that the transition to the membrane-associated form is enhanced by the presence of oxidative environment and lipids. Using MS, we identified a dose-dependent oxidation of a highly conserved cysteine residue, known to play a key role in the structurally related omega-class of glutathione-S-transferases. Hydrogen/deuterium exchange MS analysis revealed that oxidation of this cysteine facilitates the exposure of the conserved hydrophobic inter-domain interface. Together, our results pinpoint an oxidation of a specific cysteine residue as a triggering mechanism initializing the molecular commitment for membrane interaction in the CLIC family.	[Ferofontov, Alisa; Giladi, Moshe; Haitin, Yoni] Tel Aviv Univ, Dept Physiol & Pharmacol, Sackler Sch Med, Tel Aviv, Israel; [Vankova, Pavla; Man, Petr] Czech Acad Sci, Div BioCeV, Inst Microbiol, Vestec, Czech Republic; [Vankova, Pavla] Charles Univ Prague, Fac Sci, Dept Biochem, Prague, Czech Republic; [Haitin, Yoni] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Charles University Prague; Tel Aviv University	Haitin, Y (corresponding author), Tel Aviv Univ, Dept Physiol & Pharmacol, Sackler Sch Med, Tel Aviv, Israel.	yhaitin@post.tau.ac.il	Man, Petr/H-2451-2014; Vaňková, Pavla/AAN-7392-2021; Haitin, Yoni/AAQ-4571-2021	Man, Petr/0000-0002-1485-2197; Vaňková, Pavla/0000-0001-8722-2586; Haitin, Yoni/0000-0002-1648-6792	Israel Science Foundation (ISF) [1721/16]; I-CORE program of the Planning and Budgeting Committee [1772/12]; Israel Science Foundation [1772/12]; Israel Cancer Research Fund (ICRF) [01214, 19202]; German-Israeli Foundation for Scientific Research and Development (GIF) [I-2425-418.13/2016]; EC [731077]; Czech Science Foundation (CSF) [19-16084S]; MEYS CZ [CZ.1.05/1.1.00/02.0109, LM2015043]	Israel Science Foundation (ISF)(Israel Science Foundation); I-CORE program of the Planning and Budgeting Committee; Israel Science Foundation(Israel Science Foundation); Israel Cancer Research Fund (ICRF); German-Israeli Foundation for Scientific Research and Development (GIF)(German-Israeli Foundation for Scientific Research and Development); EC(European CommissionEuropean Commission Joint Research Centre); Czech Science Foundation (CSF); MEYS CZ	Israel Science Foundation (ISF), Grant/Award Number: 1721/16; The I-CORE program of the Planning and Budgeting Committee and the Israel Science Foundation, Grant/Award Number: 1772/12; Israel Cancer Research Fund (ICRF), Grant/Award Number: 01214; Israel Cancer Research Fund (ICRF), Grant/Award Number: 19202; The German-Israeli Foundation for Scientific Research and Development (GIF), Grant/Award Number: I-2425-418.13/2016; EC vertical bar Horizon 2020 Framework Programme (H2020), Grant/Award Number: 731077; Czech Science Foundation (CSF), Grant/Award Number: 19-16084S; MEYS CZ funds, Grant/Award Number: CZ.1.05/1.1.00/02.0109, LM2015043	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Al Khamici H, 2016, MEMBRANES, V6, DOI 10.3390/membranes6040051; Argenzio E, 2016, J CELL SCI, V129, P4165, DOI 10.1242/jcs.189795; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Carlini V, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21041484; Carofino Brandi L, 2019, Oncotarget, V10, P7251, DOI 10.18632/oncotarget.27387; Cromer BA, 2007, J MOL BIOL, V374, P719, DOI 10.1016/j.jmb.2007.09.041; Dulhunty A, 2001, J BIOL CHEM, V276, P3319, DOI 10.1074/jbc.M007874200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Ferofontov A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25231-z; Filandr F, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10020242; Gagnon LH, 2006, J NEUROSCI, V26, P10188, DOI 10.1523/JNEUROSCI.2166-06.2006; Goodchild Sophia C, 2011, Biophys Rev, V3, P143, DOI 10.1007/s12551-011-0053-8; Goodchild SC, 2011, BIOCHEMISTRY-US, V50, P10887, DOI 10.1021/bi2012564; Goodchild SC, 2010, BIOCHEMISTRY-US, V49, P5278, DOI 10.1021/bi100111c; Goodchild SC, 2009, EUR BIOPHYS J BIOPHY, V39, P129, DOI 10.1007/s00249-009-0450-0; Harrop SJ, 2001, J BIOL CHEM, V276, P44993, DOI 10.1074/jbc.M107804200; Hernandez-Fernaud JR, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14206; Hofmann L, 2016, ANAL BIOCHEM, V499, P63, DOI 10.1016/j.ab.2016.01.016; Hossain KR, 2019, BBA-GEN SUBJECTS, V1863, P1243, DOI 10.1016/j.bbagen.2019.04.020; Jia NN, 2016, J CANCER RES THER, V12, P892, DOI 10.4103/0973-1482.154057; Kavan D, 2011, INT J MASS SPECTROM, V302, P53, DOI 10.1016/j.ijms.2010.07.030; Koch MHJ, 2003, Q REV BIOPHYS, V36, P147, DOI 10.1017/S0033583503003871; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Konermann L, 2011, CHEM SOC REV, V40, P1224, DOI 10.1039/c0cs00113a; Kulma M, 2019, TOXINS, V11, DOI 10.3390/toxins11080462; LANDRY D, 1993, J BIOL CHEM, V268, P14948; LANDRY DW, 1989, SCIENCE, V244, P1469, DOI 10.1126/science.2472007; Littler DR, 2010, PROTEINS, V78, P1594, DOI 10.1002/prot.22675; Littler DR, 2008, PROTEINS, V71, P364, DOI 10.1002/prot.21704; Littler DR, 2010, FEBS LETT, V584, P2093, DOI 10.1016/j.febslet.2010.01.027; Littler DR, 2005, FEBS J, V272, P4996, DOI 10.1111/j.1742-4658.2005.04909.x; Littler DR, 2004, J BIOL CHEM, V279, P9298, DOI 10.1074/jbc.M308444200; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Neveu B, 2016, HAEMATOLOGICA, V101, P1534, DOI 10.3324/haematol.2016.149740; Patel Sameer H, 2019, Cell Physiol Biochem, V53, P44, DOI 10.33594/000000193; Peretti M, 2015, BBA-BIOMEMBRANES, V1848, P2523, DOI 10.1016/j.bbamem.2014.12.012; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Potrzebowski W, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006641; Rao SG, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00096; Seco CZ, 2015, EUR J HUM GENET, V23, P189, DOI 10.1038/ejhg.2014.83; Singh H, 2006, BIOPHYS J, V90, P1628, DOI 10.1529/biophysj.105.072678; Singha B, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32885-2; Stoychev SH, 2009, BIOCHEMISTRY-US, V48, P8413, DOI 10.1021/bi9010607; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Suh KS, 2005, J INVEST DERM SYMP P, V10, P105, DOI 10.1111/j.1087-0024.2005.200402.x; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Takano K, 2012, HUM MOL GENET, V21, P4497, DOI 10.1093/hmg/dds292; Trcka F, 2019, MOL CELL PROTEOMICS, V18, P320, DOI 10.1074/mcp.RA118.001044; Valenzuela SM, 1997, J BIOL CHEM, V272, P12575, DOI 10.1074/jbc.272.19.12575; Valenzuela SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056948; Vivian JT, 2001, BIOPHYS J, V80, P2093, DOI 10.1016/S0006-3495(01)76183-8; Witham S, 2011, PROTEINS, V79, P2444, DOI 10.1002/prot.23065; ZHANG ZQ, 1993, PROTEIN SCI, V2, P522	58	1	1	2	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					9925	9940		10.1096/fj.202000399R	http://dx.doi.org/10.1096/fj.202000399R		JUN 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32725932	Bronze			2022-12-28	WOS:000541773000001
J	Schofield, ZV; Wu, MCL; Hansbro, PM; Cooper, MA; Woodruff, TM				Schofield, Zoe, V; Wu, Mike C. L.; Hansbro, Philip M.; Cooper, Matthew A.; Woodruff, Trent M.			Acetate protects against intestinal ischemia-reperfusion injury independent of its cognate free fatty acid 2 receptor	FASEB JOURNAL			English	Article						acetate; FFA2; ischemia-reperfusion injury; neutrophils	GUT MICROBIOTA; INFLAMMATORY RESPONSES; NEUTROPHIL RECRUITMENT; MESENTERIC ISCHEMIA; MECHANISMS; ALLOSTERISM; EXPERIENCES; INDUCTION; MEDIATORS; COMPONENT	Free fatty acid 2 receptor (FFA2) is highly expressed on neutrophils and, when activated by its cognate ligand acetate, generates potent anti-inflammatory activities. The roles of FFA2 and acetate have not been explored in ischemia-reperfusion injury (IRI). We therefore examined the function of FFA2 and the therapeutic potential of acetate to reduce tissue injury in an acute model of intestinal IRI. The superior mesenteric artery of wild-type (WT) and FFA2(-/-)mice was briefly occluded then reperfused following treatment with acetate or vehicle. The absence of FFA2 resulted in intestinal injury similar to that observed in WT mice, indicating a minimal causal role for FFA2 in this model. Acetate treatment to WT mice prior to ischemia profoundly protected the intestine from IRI-induced damage. Amelioration of IRI was also observed, although to a lesser extent, when acetate was administered to FFA2(-/-)mice demonstrating that certain protective effects of acetate were FFA2-independent. Remarkably, despite the lack of tissue damage following IRI, acetate-treated mice had markedly increased neutrophil infiltration to the reperfused intestine which was dependent on FFA2. These studies reveal a minimal causal role for FFA2 in intestinal IRI but highlight the novel therapeutic potential for acetate in the amelioration of ischemia-mediated tissue damage.	[Schofield, Zoe, V; Wu, Mike C. L.; Woodruff, Trent M.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia; [Schofield, Zoe, V; Cooper, Matthew A.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Hansbro, Philip M.] Centenary Inst, Ctr Inflammat, Sydney, NSW, Australia; [Hansbro, Philip M.] Univ Technol Sydney, Fac Sci, Ultimo, NSW, Australia	University of Queensland; University of Queensland; University of Sydney; Centenary Institute; University of Technology Sydney; University of Technology Sydney	Woodruff, TM (corresponding author), Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia.; Cooper, MA (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	m.cooper@uq.edu.au; t.woodruff@uq.edu.au	Woodruff, Trent/AAS-4629-2020; Hansbro, Phil/G-7486-2013; Woodruff, Trent M/B-4861-2009	Woodruff, Trent/0000-0003-1382-911X; Hansbro, Phil/0000-0002-4741-3035; Woodruff, Trent M/0000-0003-1382-911X; Schofield, Zoe/0000-0002-9065-0095	Department of Health \ National Health and Medical Research Council (NHMRC) [APP1082271, APP1086786, APP1079187, APP1175134]	Department of Health \ National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	Department of Health vertical bar National Health and Medical Research Council (NHMRC), Grant/Award Number: APP1082271, APP1086786, and APP1079187, APP1175134, APP1175134	Aoyama M, 2010, NUTRITION, V26, P653, DOI 10.1016/j.nut.2009.07.006; Arumugam TV, 2006, CLIN CHIM ACTA, V374, P33, DOI 10.1016/j.cca.2006.06.010; Arumugam TV, 2009, SHOCK, V32, P4, DOI 10.1097/SHK.0b013e318193e333; Awad AS, 2009, KIDNEY INT, V75, P689, DOI 10.1038/ki.2008.648; Bolisetty S, 2009, KIDNEY INT, V75, P674, DOI 10.1038/ki.2008.689; Braunersreuther V, 2012, CURR PHARM BIOTECHNO, V13, P97, DOI 10.2174/138920112798868782; de Oliveira THC, 2018, LAB INVEST, V98, P51, DOI 10.1038/labinvest.2017.90; Cerqueira Nereide Freire, 2005, Acta Cir. Bras., V20, P336, DOI 10.1590/S0102-86502005000400013; Chandrasekar B, 2000, FREE RADICAL BIO MED, V28, P1579, DOI 10.1016/S0891-5849(00)00273-2; Chen LW, 2008, SHOCK, V30, P563, DOI 10.1097/SHK.0b013e31816a3458; Chen Y, 2004, GUT, V53, P1772, DOI 10.1136/gut.2003.034868; CHIU CJ, 1970, ARCH SURG-CHICAGO, V101, P478; D'Souza WN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180190; Feuerstadt Paul, 2010, Curr Gastroenterol Rep, V12, P383, DOI 10.1007/s11894-010-0127-y; Geering B, 2011, CELL DEATH DIFFER, V18, P1457, DOI 10.1038/cdd.2011.75; Greenlee-Wacker MC, 2016, IMMUNOL REV, V273, P357, DOI 10.1111/imr.12453; Grommes J, 2011, MOL MED, V17, P293, DOI 10.2119/molmed.2010.00138; Grootjans J, 2010, AM J PATHOL, V176, P2283, DOI 10.2353/ajpath.2010.091069; Hamid H., 2010, PCT Int. Appl., Patent No. 2010066682; Hermann DM, 2018, THER ADV NEUROL DISO, V11, DOI 10.1177/1756286418798607; Hosios AM, 2014, CANCER METAB, V2, DOI 10.1186/s40170-014-0027-y; Jin R, 2010, J LEUKOCYTE BIOL, V87, P779, DOI 10.1189/jlb.1109766; Kalogeris T, 2012, INT REV CEL MOL BIO, V298, P229, DOI 10.1016/B978-0-12-394309-5.00006-7; Kamphorst JJ, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-23; Karkkainen JM, 2017, BEST PRACT RES CL GA, V31, P15, DOI 10.1016/j.bpg.2016.10.018; Kim MH, 2013, GASTROENTEROLOGY, V145, P396, DOI 10.1053/j.gastro.2013.04.056; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Kolaczkowska E, 2012, BLOOD, V120, P4455, DOI 10.1182/blood-2012-09-457226; Kucharzik T, 2005, GUT, V54, P1565, DOI 10.1136/gut.2004.061168; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; LEDER LD, 1970, BLUT, V21, P1, DOI 10.1007/BF01633225; Lembo PMC, 2002, NAT NEUROSCI, V5, P201, DOI 10.1038/nn815; Li SH, 2018, J IMMUNOL RES, V2018, DOI 10.1155/2018/7283703; Lu YZ, 2012, LAB INVEST, V92, P783, DOI 10.1038/labinvest.2012.11; Luther B, 2018, VISC MED, V34, P217, DOI 10.1159/000490318; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Mauler M, 2019, CIRCULATION, V139, P918, DOI 10.1161/CIRCULATIONAHA.118.033942; McCracken Jenna M, 2014, J Cell Death, V7, P15, DOI 10.4137/JCD.S11038; Meng D, 2016, AM J PHYSIOL-GASTR L, V311, pG744, DOI 10.1152/ajpgi.00090.2016; Milligan G, 2009, BRIT J PHARMACOL, V158, P146, DOI 10.1111/j.1476-5381.2009.00421.x; Mumy KL, 2009, CURR OPIN PHARMACOL, V9, P697, DOI 10.1016/j.coph.2009.10.004; Nastasi C, 2015, SCI REP-UK, V5, DOI 10.1038/srep16148; Pierro Agostino, 2004, Semin Pediatr Surg, V13, P11, DOI 10.1053/j.sempedsurg.2003.09.003; Rodrigues SF, 2010, CARDIOVASC RES, V87, P291, DOI 10.1093/cvr/cvq090; Sanada S, 2011, AM J PHYSIOL-HEART C, V301, pH1723, DOI 10.1152/ajpheart.00553.2011; Schofield ZV, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-36242-1; Schofield ZV, 2013, SHOCK, V40, P463, DOI 10.1097/SHK.0000000000000044; Selders GS, 2017, REGEN BIOMATER, V4, P55, DOI 10.1093/rb/rbw041; Sina C, 2009, J IMMUNOL, V183, P7514, DOI 10.4049/jimmunol.0900063; Smith NJ, 2011, MOL PHARMACOL, V80, P163, DOI 10.1124/mol.110.070789; Souza DG, 2003, J IMMUNOL, V170, P4759, DOI 10.4049/jimmunol.170.9.4759; STRIETER RM, 1992, AM J PATHOL, V141, P397; Tan J, 2014, ADV IMMUNOL, V121, P91, DOI 10.1016/B978-0-12-800100-4.00003-9; Tolhurst G, 2012, DIABETES, V61, P364, DOI 10.2337/db11-1019; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; van der Beek CM, 2017, NUTR REV, V75, P286, DOI 10.1093/nutrit/nuw067; Vieira AT, 2015, ARTHRITIS RHEUMATOL, V67, P1646, DOI 10.1002/art.39107; Vinolo MAR, 2011, J NUTR BIOCHEM, V22, P849, DOI 10.1016/j.jnutbio.2010.07.009; Vinolo MAR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021205; Vinolo MAR, 2009, CELL BIOCHEM FUNCT, V27, P48, DOI 10.1002/cbf.1533; Wagner E, 2010, NAT REV DRUG DISCOV, V9, P43, DOI 10.1038/nrd3011; Watanabe T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110441; Wu MY, 2018, CELL PHYSIOL BIOCHEM, V46, P1650, DOI 10.1159/000489241; Wu MCL, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00614; Wu MCL, 2013, P NATL ACAD SCI USA, V110, P9439, DOI 10.1073/pnas.1218815110	65	7	7	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10418	10430		10.1096/fj.202000960R	http://dx.doi.org/10.1096/fj.202000960R		JUN 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32725930	Bronze			2022-12-28	WOS:000541769800001
J	Ma, NA; Tie, CR; Yu, B; Zhang, W; Wan, J				Ma, Nana; Tie, Changrui; Yu, Bo; Zhang, Wei; Wan, Jun			Circular RNAs regulate its parental genes transcription in the AD mouse model using two methods of library construction	FASEB JOURNAL			English	Article						Alzheimer's disease (AD); APP; PS1 mouse; circRNA; library construction; RNA-sequencing	ALZHEIMERS-DISEASE; NONCODING RNAS; ANNOTATION; EXPRESSION; ABUNDANT; REVEALS	Circular RNA (circRNA) is an important class of noncoding RNA. Current, protocols to detected circRNAs have utilized nonpolyadenylated RNAs, ribosomal RNA-depleted RNA samples (rRNA- library), and rRNA-depleted RNA that has been treated with RNase R to digest linear RNA (rRNA- RNase R+ library). Accumulating evidence suggests the participation of circRNAs in Alzheimer's disease (AD)-associated pathophysiology, but the details remain largely unknown. Here, we elucidated the brain circRNAs profiles of AD-model and WT mice using two methods of library construction (rRNA- RNase R+ libraries and rRNA- libraries). We focused on the construction of libraries that best allow the identification of circRNAs from next-generation RNA sequencing data. We obtained a significantly higher abundance of circRNAs in the rRNA- RNase R+ libraries than in the rRNA- libraries. Additionally, the rRNA- RNase R+ libraries more clearly revealed differentially expressed circRNAs. We performed a correlation analysis between differentially expressed circRNAs and their parental genes and performed KEGG analysis of the parental genes to explore the role of circRNA in AD. Our results identified significantly dysregulated circRNAs and KEGG analysis revealed that the identified circRNAs are involved in regulating AD development from distinct origins, including cAMP signaling, MAPK signaling, insulin secretion, Axon guidance, Long-term potentiation, dopaminergic synapse, and ErBb signaling pathways. Following rigorous selection, we identified several important circRNAs and mRNAs and propose the circRNAs regulate parental gene transcription or affect variable splicing, which were discovered to be mainly involved in A beta production and cognitive performance (TRPC6) and neuronal differentiation and development (NME7). These newly identified circRNAs should serve as a valuable resource for the future development of potential biomarkers and therapeutic targets for AD.	[Ma, Nana; Tie, Changrui; Zhang, Wei; Wan, Jun] Hong Kong Univ Sci & Technol, Shenzhen Peking Univ, Biomed Res Inst, Shenzhen Key Lab Neuronal Struct Biol,Med Ctr, Shenzhen 518000, Peoples R China; [Yu, Bo] Hong Kong Univ Sci & Technol, Shenzhen Peking Univ, Biomed Res Inst, Shenzhen Key Lab Translat Med Dermatol,Med Ctr, Shenzhen, Peoples R China; [Yu, Bo] Peking Univ, Shenzhen Hosp, Dept Dermatol, Shenzhen, Peoples R China; [Zhang, Wei; Wan, Jun] Shenzhen Bay Lab, Greater Bay Biomed Innoctr, Shenzhen, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Peking University; Shenzhen Bay Laboratory	Zhang, W; Wan, J (corresponding author), Hong Kong Univ Sci & Technol, Shenzhen Peking Univ, Biomed Res Inst, Shenzhen Key Lab Neuronal Struct Biol,Med Ctr, Shenzhen 518000, Peoples R China.	zhangweispace@163.com; wanj@ust.hk			National Key R&D Program of China [2016YFA0501903]; National Natural Science Foundation of China (NSFC) [81673053]; Natural Scientific Foundation of Guangdong Province [2016A030312016]; Shenzhen Basic Research Grant [JCYJ20160229153100269, JCYJ20170411090739316, JCYJ20170815153617033, JCYJ20180507182657867, JCYJ20170306161450254, JCYJ20170306161807726]	National Key R&D Program of China; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Scientific Foundation of Guangdong Province; Shenzhen Basic Research Grant	National Key R&D Program of China Grant, Grant/Award Number: 2016YFA0501903; National Natural Science Foundation of China (NSFC), Grant/Award Number: 81673053; Natural Scientific Foundation of Guangdong Province, Grant/Award Number: 2016A030312016; Shenzhen Basic Research Grant, Grant/Award Number: JCYJ20160229153100269, JCYJ20170411090739316, JCYJ20170815153617033, JCYJ20180507182657867, JCYJ20170306161450254 and JCYJ20170306161807726	Bingol B, 2011, NEURON, V69, P22, DOI 10.1016/j.neuron.2010.11.006; Bishop NA, 2010, NATURE, V464, P529, DOI 10.1038/nature08983; Braunschweig U, 2014, GENOME RES, V24, P1774, DOI 10.1101/gr.177790.114; Canter RG, 2016, NATURE, V539, P187, DOI 10.1038/nature20412; Charalambous DC, 2013, CELL MOL LIFE SCI, V70, P335, DOI 10.1007/s00018-012-1108-0; De Strooper B, 2016, CELL, V164, P603, DOI 10.1016/j.cell.2015.12.056; Du WW, 2017, EUR HEART J, V38, P1402, DOI 10.1093/eurheartj/ehw001; Gao Y, 2018, BRIEF BIOINFORM, V19, P803, DOI 10.1093/bib/bbx014; Gruner H, 2016, SCI REP-UK, V6, DOI 10.1038/srep38907; Guarnerio J, 2016, CELL, V166, P1055, DOI 10.1016/j.cell.2016.07.035; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Holdt Lesca M, 2018, Noncoding RNA Res, V3, P75, DOI 10.1016/j.ncrna.2018.05.002; Huang S, 2017, GENOMICS, V109, P401, DOI 10.1016/j.ygeno.2017.06.005; Jeck WR, 2014, NAT BIOTECHNOL, V32, P453, DOI 10.1038/nbt.2890; Jeck WR, 2013, RNA, V19, P141, DOI 10.1261/rna.035667.112; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Legnini I, 2017, MOL CELL, V66, P22, DOI 10.1016/j.molcel.2017.02.017; Li ZY, 2015, NAT STRUCT MOL BIOL, V22, P256, DOI 10.1038/nsmb.2959; Lonskaya I, 2013, J ALZHEIMERS DIS, V33, P231, DOI 10.3233/JAD-2012-121141; Lu R, 2018, MOL PSYCHIATR, V23, P767, DOI 10.1038/mp.2017.136; Lukiw Walter J., 2013, Frontiers in Genetics, V4, P307, DOI [10.3389/fgene.2013.00307, 10.3389/fgene.2013.00077]; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Necsulea A, 2014, NATURE, V505, P635, DOI 10.1038/nature12943; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Qu SB, 2015, CANCER LETT, V365, P141, DOI 10.1016/j.canlet.2015.06.003; Rybak-Wolf A, 2015, MOL CELL, V58, P870, DOI 10.1016/j.molcel.2015.03.027; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Salzman J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003777; Salzman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030733; Sando R, 2019, SCIENCE, V363, P837, DOI 10.1126/science.aav7969; Schroeder J, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00501; Tatro ET, 2013, AM J GERIAT PSYCHIAT, V21, P461, DOI 10.1016/j.jagp.2012.09.005; Tay MLI, 2017, CURR BIOL, V27, P1062, DOI 10.1016/j.cub.2017.02.040; Tay Y, 2014, NATURE, V505, P344, DOI 10.1038/nature12986; Wang JF, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9876; Wang K, 2016, EUR HEART J, V37, P2602, DOI 10.1093/eurheartj/ehv713; Werfel S, 2016, J MOL CELL CARDIOL, V98, P103, DOI 10.1016/j.yjmcc.2016.07.007; Westholm JO, 2014, CELL REP, V9, P1966, DOI 10.1016/j.celrep.2014.10.062; Yang Y, 2017, CELL RES, V27, P626, DOI 10.1038/cr.2017.31; Zadori D, 2018, J ALZHEIMERS DIS, V62, P523, DOI 10.3233/JAD-170929; Zeng Y, 2017, THERANOSTICS, V7, P3842, DOI 10.7150/thno.19764; Zhang XP, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19102897; Zhang Y, 2013, MOL CELL, V51, P792, DOI 10.1016/j.molcel.2013.08.017	46	7	7	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10342	10356		10.1096/fj.201903157R	http://dx.doi.org/10.1096/fj.201903157R		JUN 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32530085	hybrid			2022-12-28	WOS:000541524800001
J	Schwefel, K; Spiegler, S; Kirchmaier, BC; Dellweg, PKE; Much, CD; Pane-Farre, J; Strom, TM; Riedel, K; Felbor, U; Rath, M				Schwefel, Konrad; Spiegler, Stefanie; Kirchmaier, Bettina C.; Dellweg, Patricia K. E.; Much, Christian D.; Pane-Farre, Jan; Strom, Tim M.; Riedel, Katharina; Felbor, Ute; Rath, Matthias			Fibronectin rescues aberrant phenotype of endothelial cells lacking either CCM1, CCM2 or CCM3	FASEB JOURNAL			English	Article						cerebral cavernous malformations; CRISPR; Cas9 genome editing; extracellular matrix	CEREBRAL CAVERNOUS MALFORMATIONS; VASCULAR MORPHOGENESIS; INTEGRIN ALPHA-5-BETA-1; EXTRACELLULAR-MATRIX; BINDING DOMAIN; RHO KINASE; MUTATIONS; PROTEINS; BARRIER; ANGIOGENESIS	Loss-of-function variants in CCM1/KRIT1, CCM2, and CCM3/PDCD10 are associated with autosomal dominant cerebral cavernous malformations (CCMs). CRISPR/Cas9-mediated CCM3 inactivation in human endothelial cells (ECs) has been shown to induce profound defects in cell-cell interaction as well as actin cytoskeleton organization. We here show that CCM3 inactivation impairs fibronectin expression and consequently leads to reduced fibers in the extracellular matrix. Despite the complexity and high molecular weight of fibronectin fibrils, our in vitro model allowed us to reveal that fibronectin supplementation restored aberrant spheroid formation as well as altered EC morphology, and suppressed actin stress fiber formation. Yet, fibronectin replacement neither enhanced the stability of tube-like structures nor inhibited the survival advantage of CCM3(-/-) ECs. Importantly, CRISPR/Cas9-mediated introduction of biallelic loss-of-function variants into either CCM1 or CCM2 demonstrated that the impaired production of a functional fibronectin matrix is a common feature of CCM1-, CCM2-, and CCM3-deficient ECs.	[Schwefel, Konrad; Spiegler, Stefanie; Dellweg, Patricia K. E.; Much, Christian D.; Felbor, Ute; Rath, Matthias] Univ Med Greifswald, Dept Human Genet, Fleischmannstr 43, D-17475 Greifswald, Germany; [Schwefel, Konrad; Spiegler, Stefanie; Dellweg, Patricia K. E.; Much, Christian D.; Felbor, Ute; Rath, Matthias] Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Genom, Greifswald, Germany; [Kirchmaier, Bettina C.] Goethe Univ Frankfurt, Inst Cell Biol & Neurosci, Frankfurt, Germany; [Kirchmaier, Bettina C.] Goethe Univ Frankfurt, Buchmann Inst Mol Life Sci, Frankfurt, Germany; [Pane-Farre, Jan; Riedel, Katharina] Ernst Moritz Arndt Univ Greifswald, Inst Microbiol, Dept Microbial Physiol & Mol Biol, Greifswald, Germany; [Strom, Tim M.] Tech Univ Munich, Inst Human Genet, Munich, Germany; [Strom, Tim M.] Helmholtz Zentrum Munchen, Inst Human Genet, Neuherberg, Germany; [Pane-Farre, Jan] Philipps Univ Marburg, Ctr Synthet Microbiol SYNMIKRO, Marburg, Germany; [Pane-Farre, Jan] Philipps Univ Marburg, Dept Chem, Marburg, Germany	Greifswald Medical School; Ernst Moritz Arndt Universitat Greifswald; Goethe University Frankfurt; Goethe University Frankfurt; Ernst Moritz Arndt Universitat Greifswald; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Philipps University Marburg; Philipps University Marburg	Rath, M (corresponding author), Univ Med Greifswald, Dept Human Genet, Fleischmannstr 43, D-17475 Greifswald, Germany.	matthias.rath@med.uni-greifswald.de		Rath, Matthias/0000-0002-7834-4650	Deutsche Forschungsgemeinschaft (DFG) [DFG RA2876/2-2]; Research Network Molecular Medicine of the University Medicine Greifswald [FOVB-2019-01]; Gerhard Domagk program of the University Medicine Greifswald	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Research Network Molecular Medicine of the University Medicine Greifswald; Gerhard Domagk program of the University Medicine Greifswald	Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: DFG RA2876/2-2; Research Network Molecular Medicine of the University Medicine Greifswald, Grant/Award Number: FOVB-2019-01; Gerhard Domagk program of the University Medicine Greifswald	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Auerbach R, 2003, CLIN CHEM, V49, P32, DOI 10.1373/49.1.32; Bauman E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18431-6; Bergametti F, 2005, AM J HUM GENET, V76, P42, DOI 10.1086/426952; Boon RA, 2010, BLOOD, V115, P2533, DOI 10.1182/blood-2009-06-228726; Borikova AL, 2010, J BIOL CHEM, V285, P11760, DOI 10.1074/jbc.C109.097220; Boulday G, 2011, J EXP MED, V208, P1835, DOI 10.1084/jem.20110571; Brenner KA, 2000, ONCOGENE, V19, P3156, DOI 10.1038/sj.onc.1203626; Burridge K, 2013, J CELL BIOL, V200, P9, DOI 10.1083/jcb.201210090; Carpentier GMM, 2012, 4 IMAGEJ USER DEV C, P198; Castro M, 2019, CIRC RES, V124, P1240, DOI 10.1161/CIRCRESAHA.118.314300; Cigoli MS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110438; Cseh B, 2010, J CELL SCI, V123, P3989, DOI 10.1242/jcs.073346; Cuttano R, 2016, EMBO MOL MED, V8, P6, DOI 10.15252/emmm.201505433; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; Denier C, 2004, AM J HUM GENET, V74, P326, DOI 10.1086/381718; Detter MR, 2018, CIRC RES, V123, P1143, DOI 10.1161/CIRCRESAHA.118.313970; Draheim KM, 2015, J CELL BIOL, V208, P987, DOI 10.1083/jcb.201407129; Draheim KM, 2014, J CELL SCI, V127, P701, DOI 10.1242/jcs.138388; Faurobert E, 2013, J CELL BIOL, V202, P545, DOI 10.1083/jcb.201303044; Fidalgo M, 2010, J CELL SCI, V123, P1274, DOI 10.1242/jcs.061341; Fischer A, 2013, TRENDS MOL MED, V19, P302, DOI 10.1016/j.molmed.2013.02.004; GILNAGEL A, 1995, EPILEPSY RES, V21, P27, DOI 10.1016/0920-1211(95)00005-U; Glading A, 2007, J CELL BIOL, V179, P247, DOI 10.1083/jcb.200705175; Goudreault M, 2009, MOL CELL PROTEOMICS, V8, P157, DOI 10.1074/mcp.M800266-MCP200; GUNEL M, 1995, P NATL ACAD SCI USA, V92, P6620, DOI 10.1073/pnas.92.14.6620; Hocking DC, 1998, J CELL BIOL, V141, P241, DOI 10.1083/jcb.141.1.241; Huveneers S, 2008, J CELL SCI, V121, P2452, DOI 10.1242/jcs.033001; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Jansen KA, 2017, SEMIN CELL DEV BIOL, V71, P75, DOI 10.1016/j.semcdb.2017.07.027; Jilkova ZM, 2014, BIOL OPEN, V3, P1228, DOI 10.1242/bio.201410132; Kim S, 2000, AM J PATHOL, V156, P1345, DOI 10.1016/S0002-9440(10)65005-5; Korff T, 1998, J CELL BIOL, V143, P1341, DOI 10.1083/jcb.143.5.1341; Koval M, 2010, AM J RESP CELL MOL, V42, P172, DOI 10.1165/rcmb.2008-0270OC; Laberge-le Couteulx S, 1999, NAT GENET, V23, P189, DOI 10.1038/13815; Lampugnani MG, 2010, J CELL SCI, V123, P1073, DOI 10.1242/jcs.059329; Liquori CL, 2003, AM J HUM GENET, V73, P1459, DOI 10.1086/380314; Liu WY, 2012, CNS NEUROSCI THER, V18, P609, DOI 10.1111/j.1755-5949.2012.00340.x; Liu WZ, 2013, MOL CELL, V49, P719, DOI 10.1016/j.molcel.2012.12.005; Liu YQ, 2004, FASEB J, V18, P457, DOI 10.1096/fj.03-0948com; Lopez-Ramirez MA, 2017, J EXP MED, V214, P3331, DOI 10.1084/jem.20171178; Lorenz L, 2018, NATURE, V562, P128, DOI 10.1038/s41586-018-0522-3; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Maddaluno L, 2013, NATURE, V498, P492, DOI 10.1038/nature12207; Malinyerno M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10707-x; Marchuk DA, 2003, HUM MOL GENET, V12, pR97, DOI 10.1093/hmg/ddg103; MCKEOWNLONGO PJ, 1985, J CELL BIOL, V100, P364, DOI 10.1083/jcb.100.2.364; NICOSIA RF, 1993, J CELL PHYSIOL, V154, P654, DOI 10.1002/jcp.1041540325; Otten C, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201809155; Perruzzi CA, 2003, J INVEST DERMATOL, V120, P1100, DOI 10.1046/j.1523-1747.2003.12236.x; Renz M, 2015, DEV CELL, V32, P181, DOI 10.1016/j.devcel.2014.12.016; Sabbagh MF, 2018, ELIFE, V7, DOI 10.7554/eLife.36187; Sahoo T, 1999, HUM MOL GENET, V8, P2325, DOI 10.1093/hmg/8.12.2325; Sarelius IH, 2015, TISSUE BARRIERS, V3, DOI 10.4161/21688370.2014.985954; Schneider H, 2011, J NEUROPATH EXP NEUR, V70, P417, DOI 10.1097/NEN.0b013e31821bc40e; Schwefel K, 2019, J CELL MOL MED, V23, P1771, DOI 10.1111/jcmm.14075; Senger DR, 1996, BBA-MOL CELL RES, V1314, P13, DOI 10.1016/S0167-4889(96)00067-5; Shenkar R, 2015, GENET MED, V17, P188, DOI 10.1038/gim.2014.97; Singh P, 2010, ANNU REV CELL DEV BI, V26, P397, DOI 10.1146/annurev-cellbio-100109-104020; Spiegler S, 2019, MOL GENET GENOM MED, V7, DOI 10.1002/mgg3.755; Spiegler S, 2018, MOL SYNDROMOL, V9, P60, DOI 10.1159/000486292; Stahl S, 2008, HUM MUTAT, V29, P709, DOI 10.1002/humu.20712; Stamatovic SM, 2015, ACTA NEUROPATHOL, V130, P731, DOI 10.1007/s00401-015-1479-z; Stemmer M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124633; Stockton RA, 2010, J EXP MED, V207, P881, DOI 10.1084/jem.20091258; Sun ZQ, 2016, J CELL BIOL, V215, P445, DOI 10.1083/jcb.201609037; Tilling T, 1998, J NEUROCHEM, V71, P1151; Tin A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06620-4; Turner CJ, 2017, ANGIOGENESIS, V20, P519, DOI 10.1007/s10456-017-9563-8; Voss K, 2007, NEUROGENETICS, V8, P249, DOI 10.1007/s10048-007-0098-9; Weber GF, 2011, J CELL SCI, V124, P1183, DOI 10.1242/jcs.064618; Wei S, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21020675; Whelan MC, 2003, J BIOL CHEM, V278, P327, DOI 10.1074/jbc.M207554200; Whitehead KJ, 2009, NAT MED, V15, P177, DOI 10.1038/nm.1911; Whitehead KJ, 2004, DEVELOPMENT, V131, P1437, DOI 10.1242/dev.01036; Wierzbicka-Patynowski I, 2003, J CELL SCI, V116, P3269, DOI 10.1242/jcs.00670; Wu MH, 2005, J PHYSIOL-LONDON, V569, P359, DOI 10.1113/jphysiol.2005.096537; Yoruk B, 2012, DEV BIOL, V362, P121, DOI 10.1016/j.ydbio.2011.12.006; Zhou HJ, 2016, NAT MED, V22, P1033, DOI 10.1038/nm.4169; Zhou ZN, 2016, NATURE, V532, P122, DOI 10.1038/nature17178; Zhou ZN, 2015, DEV CELL, V32, P168, DOI 10.1016/j.devcel.2014.12.009	81	4	4	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9018	9033		10.1096/fj.201902888R	http://dx.doi.org/10.1096/fj.201902888R		JUN 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32515053	hybrid			2022-12-28	WOS:000539691200001
J	Yang, YH; Lin, ZW; Cheng, JW; Ding, S; Mao, WW; Shi, S; Liang, BR; Jiang, LS				Yang, Yuehua; Lin, Zunwen; Cheng, Jiangwei; Ding, Sheng; Mao, Wei-wei; Shi, Sheng; Liang, Biru; Jiang, Leisheng			The roles of autophagy in osteogenic differentiation in rat ligamentum fibroblasts: Evidence and possible implications	FASEB JOURNAL			English	Article						autophagy; ligamentum fibroblasts; OPLL; osteogenic differentiation	POSTERIOR LONGITUDINAL LIGAMENT; MESENCHYMAL STEM-CELLS; OSSIFICATION; MINERALIZATION; SUSCEPTIBILITY; ASSOCIATION; OSTEOBLASTS; DETERMINES; EXPRESSION; APOPTOSIS	Autophagy, a macromolecular degradation process, plays a pivotal role in cell differentiation and survival. This study was designed to investigate the role of autophagy in the osteogenic differentiation in ligamentum fibroblasts. Rat ligamentum fibroblasts were isolated from the posterior longitudinal ligament and cultured in osteogenic induction medium. Ultrastructural analysis, immunofluorescence assay, western blot, flow cytometry, and lysosomal activity assessment were performed to determine the presence and activity of autophagy in the cells. The mineralization deposit and osteogenic gene expressions were evaluated to classify the association between autophagy activity and the bone formation ability of the spinal ligament cells. The influence of leptin and endothelin-1 on the autophagy activity was also evaluated. Our study demonstrated that autophagy was present and increased in the ligament cells under osteogenic induction. Inhibition of autophagy with either pharmacologic inhibitors (Bafilomycin A and 3-methyladenine) or Belcin1 (BECN1) knocking down weakened the mineralization capacity, decreased the gene expressions of COL1A1, osteocalcin (Ocn), and runt-related transcription factor 2 (Runx2) in the ligamentum fibroblasts and increased cell apoptosis. The Adenosine 5'-monophosphate (AMP)-activated protein kinase (AMPK)-BECN1 autophagic pathway was activated in the osteogenic differentiating ligamentum fibroblasts. Leptin significantly increased the autophagy activity in the ligament cells under osteogenic induction. These discoveries might improve our understanding for the mechanism of ossification of the posterior longitudinal ligament (OPLL) and provide new approaches on the prevention and treatment of this not uncommon disease.	[Yang, Yuehua; Jiang, Leisheng] Shanghai Jiao Tong Univ, Xinhua Hosp, Spine Ctr, Sch Med, 1665 Kongjiang Rd, Shanghai 200092, Peoples R China; [Yang, Yuehua; Liang, Biru] Southern Med Univ, Affiliated Hosp 5, Dept Orthopaed, Guangzhou, Guangdong, Peoples R China; [Lin, Zunwen; Cheng, Jiangwei] Nanchang Univ, Dept Orthoped Surg, Affiliated Hosp 1, Nanchang, Jiangxi, Peoples R China; [Ding, Sheng] Shanghai Jiao Tong Univ, Dept Stomatol, Sch Med, Xinhua Hosp, Shanghai, Peoples R China; [Mao, Wei-wei] Shanghai Jiao Tong Univ, Dept Pediat Neurosurg, Sch Med, Xinhua Hosp, Shanghai, Peoples R China; [Shi, Sheng] Tongji Univ, Shanghai Peoples Hosp 10, Sch Med, Dept Orthoped, Shanghai, Peoples R China	Shanghai Jiao Tong University; Southern Medical University - China; Nanchang University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Tongji University	Yang, YH; Jiang, LS (corresponding author), Shanghai Jiao Tong Univ, Xinhua Hosp, Spine Ctr, Sch Med, 1665 Kongjiang Rd, Shanghai 200092, Peoples R China.	yuesjtu@outlook.com; jiangleisheng@xinhuamed.com.cn	yang, yuehua/AHE-1426-2022; Shi, Sheng/AAF-8784-2020	yang, yuehua/0000-0001-7632-9871	National Natural Science Foundation of China [81501196, 81572092]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China, Grant/Award Number: 81501196 and 81572092	Asari T, 2012, BIOCHEM BIOPH RES CO, V417, P1193, DOI 10.1016/j.bbrc.2011.12.106; Boya P, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.146506; Chen HH, 2018, MOL MED REP, V17, P3267, DOI 10.3892/mmr.2017.8242; Chen S, 2018, EUR SPINE J, V27, P1757, DOI 10.1007/s00586-018-5663-4; Chen XH, 2018, STEM CELLS INT, V2018, DOI 10.1155/2018/9131397; Chen YT, 2011, SPINE, V36, pE1193, DOI 10.1097/BRS.0b013e3182053f58; Cheng M, 2018, INT J CLIN EXP PATHO, V11, P1610; Di YQ, 2021, AUTOPHAGY, V17, P1170, DOI 10.1080/15548627.2020.1752497; Feng B, 2018, J ORTHOP SURG RES, V13, DOI 10.1186/s13018-018-0864-4; Feng L, 2020, INT J MOL MED, V45, P1464, DOI 10.3892/ijmm.2020.4534; Guan JL, 2013, AUTOPHAGY, V9, P830, DOI 10.4161/auto.24132; Han IB, 2013, GENET MOL RES, V12, P4807, DOI 10.4238/2013.February.28.26; Harris L, 2018, SPINE, V43, pE545, DOI 10.1097/BRS.0000000000002401; Ho TT, 2017, NATURE, V543, P205, DOI 10.1038/nature21388; Ikeda Y, 2011, EUR SPINE J, V20, P1450, DOI 10.1007/s00586-011-1688-7; Iwasawa T, 2006, CALCIFIED TISSUE INT, V79, P422, DOI 10.1007/s00223-006-0147-7; Jaber FA, 2019, J CELL PHYSIOL, V234, P12105, DOI 10.1002/jcp.27071; Jia JJ, 2011, FASEB J, V25, P3366, DOI 10.1096/fj.11-182519; Jung KH, 2012, HEPATOLOGY, V56, P644, DOI 10.1002/hep.25699; Kim KH, 2014, GENET MOL RES, V13, P2240, DOI 10.4238/2014.March.31.4; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Kristjansson B, 2016, SPINE, V41, pE1, DOI 10.1097/BRS.0000000000001178; Lian WS, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0970-6; Nam DC, 2019, BIOMOL THER, V27, P342, DOI 10.4062/biomolther.2019.043; Nelson ER, 2012, J BURN CARE RES, V33, P463, DOI 10.1097/BCR.0b013e31825af547; Nollet M, 2014, AUTOPHAGY, V10, P1965, DOI 10.4161/auto.36182; Pantovic A, 2013, BONE, V52, P524, DOI 10.1016/j.bone.2012.10.024; Settembre C, 2008, GENE DEV, V22, P2645, DOI 10.1101/gad.1711308; Song YJ, 2013, CANCER LETT, V339, P70, DOI 10.1016/j.canlet.2013.07.021; Sotthibundhu A, 2018, CELL TISSUE RES, V374, P205, DOI 10.1007/s00441-018-2829-7; Steppan CM, 2000, REGUL PEPTIDES, V92, P73, DOI 10.1016/S0167-0115(00)00152-X; Sugita D, 2013, SPINE, V38, pE1388, DOI 10.1097/BRS.0b013e3182a40489; Suvorova II, 2019, CELL DEATH DISCOV, V5, DOI 10.1038/s41420-019-0137-y; Thomas N, 2019, CALCIFIED TISSUE INT, V105, P518, DOI 10.1007/s00223-019-00593-2; Vidoni C, 2019, CELL COMMUN SIGNAL, V17, DOI 10.1186/s12964-019-0414-7; WHITE MF, 1994, J BIOL CHEM, V269, P1; Whitehouse CA, 2010, P NATL ACAD SCI USA, V107, P12913, DOI 10.1073/pnas.0913058107; Wu WX, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107547; Wu XT, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10533; Xiao GZ, 2002, J BONE MINER RES, V17, P101, DOI 10.1359/jbmr.2002.17.1.101; Yan L, 2017, AGING DIS, V8, P570, DOI 10.14336/AD.2017.0201; Yang YH, 2013, APOPTOSIS, V18, P1363, DOI 10.1007/s10495-013-0867-x; Yang YH, 2014, BIOCHEM BIOPH RES CO, V451, P86, DOI 10.1016/j.bbrc.2014.07.069; Zahm AM, 2011, CELLS TISSUES ORGANS, V194, P274, DOI 10.1159/000324647	44	5	5	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					8876	8886		10.1096/fj.201903216RR	http://dx.doi.org/10.1096/fj.201903216RR		JUN 2020	11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32510740	Bronze			2022-12-28	WOS:000539575300001
J	Cartland, SP; Lin, RCY; Genner, S; Patil, MS; Martinez, GJ; Barraclough, JY; Gloss, B; Misra, A; Patel, S; Kavurma, MM				Cartland, Sian P.; Lin, Ruby C. Y.; Genner, Scott; Patil, Manisha S.; Martinez, Gonzalo J.; Barraclough, Jennifer Y.; Gloss, Brian; Misra, Ashish; Patel, Sanjay; Kavurma, Mary M.			Vascular transcriptome landscape of Trail(-/-) mice: Implications and therapeutic strategies for diabetic vascular disease	FASEB JOURNAL			English	Article						differentially expressed genes; transcriptome; TRAIL; vascular	APOPTOSIS-INDUCING-LIGAND; SMOOTH-MUSCLE-CELLS; HIGH-FAT DIET; NF-KAPPA-B; SP1 PHOSPHORYLATION; VSMC PROLIFERATION; INSULIN-RESISTANCE; DOPAMINE-RECEPTOR; P200 FAMILY; EXPRESSION	Circulating plasma TRAIL levels are suppressed in patients with cardiovascular and diabetic diseases. To identify novel targets in vascular metabolic diseases, genome-wide transcriptome of aortic tissue from Trail(-/-) versus Trail(+/+) mice were interrogated. We found 861 genes differentially expressed with TRAIL deletion. Gene enrichment analyses showed many of these genes were related to inflammation, cell-to-cell cytoskeletal interactions, and transcriptional modulation. We identified vascular protective and pathological gene clusters, with Ifi205 as the most significantly reduced vascular protective gene, whereas Glut1, the most significantly increased pathological gene with TRAIL deletion. We hypothesized that therapeutic targets could be devised from such integrated analysis and validated our findings from vascular tissues of diabetic mice. From the differentially expressed gene targets, enriched transcription factor (TF) and microRNA binding motifs were identified. The top two TFs were Elk1 and Sp1, with enrichment to eight gene targets common to both. miR-520d-3p and miR-377-3p were the top enriched microRNAs with TRAIL deletion; with four overlapping genes enriched for both microRNAs. Our findings offer an alternate in silico approach for therapeutic target identification and present a deeper understanding of gene signatures and pathways altered with TRAIL suppression in the vasculature.	[Cartland, Sian P.; Genner, Scott; Patil, Manisha S.; Barraclough, Jennifer Y.; Misra, Ashish; Patel, Sanjay; Kavurma, Mary M.] Heart Res Inst, Sydney, NSW, Australia; [Cartland, Sian P.; Lin, Ruby C. Y.; Patil, Manisha S.; Martinez, Gonzalo J.; Barraclough, Jennifer Y.; Misra, Ashish; Patel, Sanjay; Kavurma, Mary M.] Univ Sydney, Fac Med & Hlth, Sydney, NSW, Australia; [Lin, Ruby C. Y.] Univ New South Wales, Sch Med Sci, Sydney, NSW, Australia; [Lin, Ruby C. Y.; Martinez, Gonzalo J.; Gloss, Brian] Westmead Inst Med Res, Sydney, NSW, Australia; [Martinez, Gonzalo J.] Pontificia Univ Catolica Chile, Div Enfermedades Cardiovasc, Santiago, Chile; [Martinez, Gonzalo J.] Millennium Nucleus Cardiovasc Magnet Resonance, Santiago, Chile; [Barraclough, Jennifer Y.; Patel, Sanjay] Royal Prince Alfred Hosp, Dept Cardiol, Sydney, NSW, Australia	University of Sydney; Heart Research Institute; University of Sydney; University of New South Wales Sydney; University of Sydney; Westmead Institute for Medical Research; Pontificia Universidad Catolica de Chile; University of Sydney	Kavurma, MM (corresponding author), Univ Sydney, Heart Res Inst, 7 Eliza St, Newtown, NSW 2042, Australia.; Lin, RCY (corresponding author), Westmead Inst Med Res, 176 Hawkesbury Rd, Westmead, NSW 2145, Australia.	ruby.lin@sydney.edu.au; mary.kavurma@hri.org.au	Lin, Ruby CY/A-1636-2009	Lin, Ruby CY/0000-0003-4163-511X; Barraclough, jennifer/0000-0002-5093-9900; Gloss, Brian/0000-0001-7695-4394; Cartland, Sian/0000-0003-1723-2679				Adhikari N, 2011, ARTERIOSCL THROM VAS, V31, P86, DOI 10.1161/ATVBAHA.110.215004; Amenta F, 2000, CLIN EXP HYPERTENS, V22, P277, DOI 10.1081/CEH-100100077; Arik HO, 2013, MED SCI MONITOR, V19, P712, DOI [10.12659/MSM.889514, 10.12659/MSM.889304]; Asefa B, 2004, BLOOD CELL MOL DIS, V32, P155, DOI 10.1016/j.bcmd.2003.10.002; Azahri NSM, 2012, J CELL BIOCHEM, V113, P2597, DOI 10.1002/jcb.24135; Bernardo BC, 2016, J PHYSIOL-LONDON, V594, P5959, DOI 10.1113/JP272512; Bernardo BC, 2012, P NATL ACAD SCI USA, V109, P17615, DOI 10.1073/pnas.1206432109; Bisgin A, 2012, DIABETES RES CLIN PR, V96, pE84, DOI 10.1016/j.diabres.2012.02.028; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Cannavo A, 2016, J PHARMACOL EXP THER, V356, P503, DOI 10.1124/jpet.115.228411; Cartland SP, 2019, ISCIENCE, V12, P41, DOI 10.1016/j.isci.2018.12.037; Cartland SP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01721-4; Cartland SP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092952; Castells MC, 2001, NAT IMMUNOL, V2, P436, DOI 10.1038/87749; Cat AND, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21087-5; Chalmers JA, 2008, AM J PHYSIOL-REG I, V295, pR1529, DOI 10.1152/ajpregu.90572.2008; Chan J, 2010, CIRC RES, V106, P1061, DOI 10.1161/CIRCRESAHA.109.206029; Chen YB, 2019, ARTERIOSCL THROM VAS, V39, P1911, DOI 10.1161/ATVBAHA.119.312192; Chmielewski S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113318; Cholan PM, 2018, FREE RADICAL BIO MED, V126, P341, DOI 10.1016/j.freeradbiomed.2018.08.031; Cholan PM, 2017, ANTIOXIDANTS-BASEL, V6, DOI 10.3390/antiox6030056; Di Bartolo BA, 2011, DIABETOLOGIA, V54, P3157, DOI 10.1007/s00125-011-2308-0; Di Bartolo BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074211; Di Bartolo BA, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002527; Ehrlich S, 2003, CYTOKINE, V24, P244, DOI 10.1016/S1043-4666(03)00094-2; Falschlehner C, 2009, IMMUNOLOGY, V127, P145, DOI 10.1111/j.1365-2567.2009.03058.x; Fanger NA, 1999, J EXP MED, V190, P1155, DOI 10.1084/jem.190.8.1155; Freemerman AJ, 2014, J BIOL CHEM, V289, P7884, DOI 10.1074/jbc.M113.522037; Gaither K, 1999, J CLIN ENDOCR METAB, V84, P695, DOI 10.1210/jc.84.2.695; Galasso G, 2013, CIRC RES, V112, P1026, DOI 10.1161/CIRCRESAHA.111.300152; Gao F, 2010, AM J PHYSIOL-HEART C, V298, pH921, DOI 10.1152/ajpheart.00135.2009; Gariglio M, 2011, J INTERF CYTOK RES, V31, P159, DOI 10.1089/jir.2010.0106; Ghosh S, 2017, J IMMUNOL, V199, P3249, DOI 10.4049/jimmunol.1700823; Giudicelli W, 2005, NUCLEIC ACIDS RES, V33, pD256, DOI 10.1093/nar/gki010; Harith HH, 2016, J DIABETES, V8, P568, DOI 10.1111/1753-0407.12339; Harith HH, 2013, TRENDS ENDOCRIN MET, V24, P578, DOI 10.1016/j.tem.2013.07.001; Hoffmann O, 2007, J CLIN INVEST, V117, P2004, DOI 10.1172/JCI30356; Hsu PH, 2016, FEBS OPEN BIO, V6, P349, DOI 10.1002/2211-5463.12045; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang KN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089190; Hyvarinen K, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-709; Janssen EM, 2005, NATURE, V434, P88, DOI 10.1038/nature03337; Jones RD, 2013, DRUG METAB DISPOS, V41, P40, DOI 10.1124/dmd.112.048397; KASAHARA M, 1977, J BIOL CHEM, V252, P7384; Kavurma MM, 2008, BIOCHEM PHARMACOL, V75, P1441, DOI 10.1016/j.bcp.2007.10.020; Kavurma MM, 2008, J BIOL CHEM, V283, P7754, DOI 10.1074/jbc.M706927200; Kayagaki N, 1999, J IMMUNOL, V163, P1906; Kreth S, 2018, ANESTH ANALG, V126, P670, DOI 10.1213/ANE.0000000000002444; Lamhamedi-Cherradi SE, 2003, DIABETES, V52, P2274, DOI 10.2337/diabetes.52.9.2274; Leon-Villapalos J, 2005, BRIT J PLAST SURG, V58, P348, DOI 10.1016/j.bjps.2004.05.029; LEWIS JL, 1994, ANAT REC, V239, P55, DOI 10.1002/ar.1092390107; Li H, 2016, TRANSPORT RES REC, P92, DOI 10.3141/2575-10; Li R, 2014, 2014 2ND INTERNATIONAL CONFERENCE ON SYSTEMS AND INFORMATICS (ICSAI), P520, DOI 10.1109/ICSAI.2014.7009342; Li RF, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0209-0; Li Y, 2015, CLIN EXP HYPERTENS, V37, P288, DOI 10.3109/10641963.2014.960971; Lin RCY, 2010, ARTERIOSCL THROM VAS, V30, P724, DOI 10.1161/ATVBAHA.109.201988; Liu FH, 2014, MOL CELL ENDOCRINOL, V392, P80, DOI 10.1016/j.mce.2014.05.009; Liu WY, 2018, J CELL BIOCHEM, V119, P2124, DOI 10.1002/jcb.26374; Lu LL, 2013, J CELL PHYSIOL, V228, P251, DOI 10.1002/jcp.24133; Mann GE, 2003, PHYSIOL REV, V83, P183, DOI 10.1152/physrev.00022.2002; Mantovani A, 2016, CELL METAB, V24, P653, DOI 10.1016/j.cmet.2016.10.016; Martinez GJ, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002128; Massberg D, 2018, PHYSIOL REV, V98, P1739, DOI 10.1152/physrev.00013.2017; Moon DO, 2012, TOXICOL APPL PHARM, V259, P87, DOI 10.1016/j.taap.2011.12.010; Ng SF, 2014, FASEB J, V28, P1830, DOI 10.1096/fj.13-244046; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Nilsson M, 2007, NUCLEIC ACIDS RES, V35, P4858, DOI 10.1093/nar/gkm492; Nyman E, 2014, J BIOL CHEM, V289, P33215, DOI 10.1074/jbc.M114.608927; Oh YT, 2012, J BIOL CHEM, V287, P257, DOI 10.1074/jbc.M111.304006; Ooi JYY, 2017, RNA BIOL, V14, P500, DOI 10.1080/15476286.2016.1181251; Pati P, 2016, HYPERTENSION, V67, P661, DOI 10.1161/HYPERTENSIONAHA.115.06194; Pereira FA, 1999, GENE DEV, V13, P1037, DOI 10.1101/gad.13.8.1037; Richards J, 2014, LIFE SCI, V118, P255, DOI 10.1016/j.lfs.2014.03.028; Rothman A, 2017, PULM CIRC, V7, P455, DOI 10.1177/2045893217704206; Sarrazy V, 2016, CIRC RES, V118, P1062, DOI 10.1161/CIRCRESAHA.115.307599; Schoppet M, 2006, ATHEROSCLEROSIS, V184, P446, DOI 10.1016/j.atherosclerosis.2005.10.028; Secchiero P, 2004, CELL MOL LIFE SCI, V61, P1965, DOI 10.1007/s00018-004-4197-6; Secchiero P, 2004, NEOPLASIA, V6, P364, DOI 10.1593/neo.03421; Secchiero P, 2006, CIRCULATION, V114, P1522, DOI 10.1161/CIRCULATIONAHA.106.643841; Shantikumar S, 2012, CARDIOVASC RES, V93, P583, DOI 10.1093/cvr/cvr300; Song KM, 2000, J EXP MED, V191, P1095, DOI 10.1084/jem.191.7.1095; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tan NY, 2009, MOL CELL BIOL, V29, P2483, DOI 10.1128/MCB.01828-08; Thaker PH, 2006, NAT MED, V12, P939, DOI 10.1038/nm1447; Tornese G, 2014, ACTA DIABETOL, V51, P239, DOI 10.1007/s00592-013-0507-5; Tsokos GC, 2003, J CLIN INVEST, V112, P1315, DOI 10.1172/JCI200320297; Vogel H, 2012, HUM MOL GENET, V21, P3845, DOI 10.1093/hmg/dds213; Volpato S, 2011, ATHEROSCLEROSIS, V215, P452, DOI 10.1016/j.atherosclerosis.2010.11.004; Wang YL, 2010, AM J PHYSIOL-RENAL, V299, pF99, DOI 10.1152/ajprenal.00466.2009; Wu KK, 2005, ATHEROSCLEROSIS, V181, P251, DOI 10.1016/j.atherosclerosis.2005.01.029; Yang CH, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0530-7; Yang JJ, 2016, INT J CLIN EXP MED, V9, P5574; Yordy JS, 2000, ONCOGENE, V19, P6503, DOI 10.1038/sj.onc.1204036; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zauli G, 2010, DIABETES, V59, P1261, DOI 10.2337/db09-1771; Zhou SS, 2018, ACTA PHARMACOL SIN, V39, P1073, DOI 10.1038/aps.2018.30	97	4	4	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9547	9562		10.1096/fj.201902785R	http://dx.doi.org/10.1096/fj.201902785R		JUN 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32501591	Bronze			2022-12-28	WOS:000539541400001
J	Li, YH; Gu, JL; Ding, YH; Gao, HE; Li, YF; Sun, Y; He, M; Zhang, WS; Yin, JJ; Bai, CG; Gao, YD				Li, Yinghui; Gu, Jiali; Ding, Yahui; Gao, Huier; Li, Yafang; Sun, Yue; He, Mei; Zhang, Wenshan; Yin, Jingjing; Bai, Cuigai; Gao, Yingdai			A small molecule compound IX inhibits telomere and attenuates oncogenesis of drug-resistant leukemia cells	FASEB JOURNAL			English	Article						drug resistance; LSC; telomerase; Wnt pathway	CANCER STEM-CELLS; BCR-ABL; IMATINIB; CML; ASSOCIATION; PROGENITORS; EXPRESSION; SURVIVAL; AML	Drug resistance is a common obstacle in leukemia treatment and failing to eradicate leukemia stem cells is the main cause of leukemia relapse. Previous studies have demonstrated that telomerase activity is associated with deregulated self-renewal of leukemia stem cells (LSCs). Here, we identified a novel compound IX, an imatinib derivative with a replacement fragment of a telomerase inhibitor, which can effectively eradicate LSCs but had no influence on normal hematopoietic stem cells (HSCs) survival. We showed that compound IX can decrease the viability of drug-resistant K562/G cells and blast crisis CML primary patient cells. Besides, IX can affect LSC survival, inhibit the colony-forming ability, and reduce LSC frequency. In vivo results showed that IX can relieve the tumor burden in patient-derived xenograft (PDX) model and prolong the lifespan. We observed that compound IX can not only decrease telomerase activity, but also affect the alternative lengthening of telomeres. In addition, IX can inhibit both the canonical and non-canonical Wnt pathways. Our data suggested this novel compound IX as a promising candidate for drug-resistant leukemia therapy.	[Li, Yinghui; Gu, Jiali; Ding, Yahui; Gao, Huier; Li, Yafang; Sun, Yue; He, Mei; Zhang, Wenshan; Yin, Jingjing; Bai, Cuigai; Gao, Yingdai] Chinese Acad Med Sciences & Peking Union Med Coll, Inst Hematol & Blood Dis Hosp, Natl Clin Res Ctr Blood Dis,PUMC Dept Stem Cell, State Key Lab Expt Hematol,CAMS Key Lab Gene Ther, Tianjin 300020, Peoples R China; [Ding, Yahui] Nankai Univ, Coll Pharm, State Key Lab Med Chem Biol, Tianjin, Peoples R China; [Ding, Yahui] Nankai Univ, Coll Pharm, Tianjin Key Lab Mol Drug Res, Tianjin, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Nankai University; Nankai University	Bai, CG; Gao, YD (corresponding author), Chinese Acad Med Sciences & Peking Union Med Coll, Inst Hematol & Blood Dis Hosp, Natl Clin Res Ctr Blood Dis,PUMC Dept Stem Cell, State Key Lab Expt Hematol,CAMS Key Lab Gene Ther, Tianjin 300020, Peoples R China.; Bai, CG (corresponding author), Tianjin Int Joint Acad BioMed, High Throughput Mol Drug Discovery Ctr, Tianjin 300457, Peoples R China.	baicuigai@tjab.org; ydgao@ihcams.ac.cn			Ministry of Science and Technology of China [2016YFA0100600, 2017YFA0104900]; National Natural Science Foundation of China [NSFC 81870083, 81430004, 81421002, 81970105]; CAMS Innovation Fund for Medical Sciences [2016-I2M-3-008, 2016-I2M-1-017]; Tianjin Science and Technology Planning Project [18ZXXYSY00010]; Central Research Institutes [2019PT320017]; SKLEH-Pilot Research Grant	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAMS Innovation Fund for Medical Sciences; Tianjin Science and Technology Planning Project; Central Research Institutes; SKLEH-Pilot Research Grant	This work was supported by grants from the Ministry of Science and Technology of China (No. 2016YFA0100600 and 2017YFA0104900), the National Natural Science Foundation of China (NSFC 81870083, 81430004, 81421002, 81970105), CAMS Innovation Fund for Medical Sciences (No. 2016-I2M-3-008 and 2016-I2M-1-017), Tianjin Science and Technology Planning Project (No. 18ZXXYSY00010), Central Research Institutes (2019PT320017) and a SKLEH-Pilot Research Grant.	Baerlocher GM, 2003, ANN NY ACAD SCI, V996, P44, DOI 10.1111/j.1749-6632.2003.tb03231.x; Bashash D, 2012, CANCER INVEST, V30, P57, DOI 10.3109/07357907.2011.629378; Beurlet S, 2013, BLOOD, V122, P2864, DOI 10.1182/blood-2012-07-445635; Bojovic B, 2015, ONCOGENE, V34, P611, DOI 10.1038/onc.2013.603; Bryan TM, 1997, NAT MED, V3, P1271, DOI 10.1038/nm1197-1271; Copland M, 2006, BLOOD, V107, P4532, DOI 10.1182/blood-2005-07-2947; Corbett L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142794; Corbin AS, 2011, J CLIN INVEST, V121, P396, DOI 10.1172/JCI35721; Dong XJ, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-133; Drummond MW, 2007, STEM CELLS, V25, P1853, DOI 10.1634/stemcells.2007-0057; Elgehama A, 2016, CANCER LETT, V372, P82, DOI 10.1016/j.canlet.2015.12.014; EUSEBI V, 1989, SEMIN DIAGN PATHOL, V6, P146; Friedman KL, 2011, MOL CELL BIOL, V31, P2366, DOI 10.1128/MCB.05462-11; Gentles AJ, 2010, JAMA-J AM MED ASSOC, V304, P2706, DOI 10.1001/jama.2010.1862; Gregory MA, 2010, CANCER CELL, V18, P74, DOI 10.1016/j.ccr.2010.04.025; Hamilton A, 2012, BLOOD, V119, P1501, DOI 10.1182/blood-2010-12-326843; Henson JD, 2009, NAT BIOTECHNOL, V27, P1181, DOI 10.1038/nbt.1587; Hoffmeyer K, 2012, SCIENCE, V336, P1549, DOI 10.1126/science.1218370; Ishikawa F, 2007, NAT BIOTECHNOL, V25, P1315, DOI 10.1038/nbt1350; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Jorgensen HG, 2007, BLOOD, V109, P4016, DOI 10.1182/blood-2006-11-057521; Katoh M, 2017, INT J ONCOL, V51, P1357, DOI 10.3892/ijo.2017.4129; Kelland L, 2007, CLIN CANCER RES, V13, P4960, DOI 10.1158/1078-0432.CCR-07-0422; Kim JH, 2002, MOL CELLS, V13, P228; Kitagawa D, 2013, GENES CELLS, V18, P110, DOI 10.1111/gtc.12022; Konig H, 2008, BLOOD, V111, P2329, DOI 10.1182/blood-2007-05-092056; Li YT, 2016, BIOORG MED CHEM LETT, V26, P1419, DOI 10.1016/j.bmcl.2016.01.068; Lipinska N, 2017, CELL MOL LIFE SCI, V74, P4121, DOI 10.1007/s00018-017-2573-2; Makena MR, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20174242; Niu CC, 2013, LEUKEMIA RES, V37, P1532, DOI 10.1016/j.leukres.2013.07.013; Nusse R, 2017, CELL, V169, P985, DOI 10.1016/j.cell.2017.05.016; Ohyashiki JH, 2002, ONCOGENE, V21, P680, DOI 10.1038/sj.onc.1205075; Park JI, 2009, NATURE, V460, P66, DOI 10.1038/nature08137; Pukrop T, 2008, J MOL MED, V86, P259, DOI 10.1007/s00109-007-0266-2; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Shi SA, 2019, GENE, V683, P47, DOI 10.1016/j.gene.2018.10.014; Shin JS, 2012, PATHOLOGY, V44, P209, DOI 10.1097/PAT.0b013e3283511cd5; Somervaille TCP, 2006, CANCER CELL, V10, P257, DOI 10.1016/j.ccr.2006.08.020; Staal FJT, 2016, CANCERS, V8, DOI 10.3390/cancers8090078; Tan YF, 2019, PATHOL RES PRACT, V215, P546, DOI 10.1016/j.prp.2019.01.002; Toman O, 2016, ONCOL REP, V36, P1258, DOI 10.3892/or.2016.4945; Vicente-Duenas C, 2012, ONCOTARGET, V3, P261, DOI 10.18632/oncotarget.461; Wang YZ, 2010, SCIENCE, V327, P1650, DOI 10.1126/science.1186624; Yang TLB, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14766; Yu DM, 2016, CELL PHYSIOL BIOCHEM, V39, P2001, DOI 10.1159/000447896; Zhang K, 2017, CANCER RES, V77, P2534, DOI 10.1158/0008-5472.CAN-16-1887	47	2	3	2	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					8843	8857		10.1096/fj.201902651RR	http://dx.doi.org/10.1096/fj.201902651RR		MAY 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32433826	hybrid			2022-12-28	WOS:000535540600001
J	Gawlinski, D; Gawlinska, K; Frankowska, M; Filip, M				Gawlinski, Dawid; Gawlinska, Kinga; Frankowska, Malgorzata; Filip, Malgorzata			Maternal high-sugar diet changes offspring vulnerability to reinstatement of cocaine-seeking behavior: Role of melanocortin-4 receptors	FASEB JOURNAL			English	Article						cocaine self-administration; high-sugar diet; maternal diet; MC-4R; rat offspring	DORSOMEDIAL PREFRONTAL CORTEX; BASOLATERAL AMYGDALA; DORSAL HIPPOCAMPUS; NUCLEUS-ACCUMBENS; LOCOMOTOR SENSITIZATION; PERINATAL EXPOSURE; ETHANOL INTAKE; MENTAL-HEALTH; SUBSTANCE USE; NOSE-POKING	Maternal diet significantly influences the proper development of offspring in utero. Modifications of diet composition may lead to metabolic and mental disorders that may predispose offspring to a substance use disorder. We assessed the impact of a maternal high-sugar diet (HSD, rich in sucrose) consumed during pregnancy and lactation on the offspring phenotype in the context of the rewarding and motivational effects of cocaine and changes within the central melanocortin (MC) system. Using an intravenous cocaine self-administration model, we showed that maternal HSD leads to increased relapse of cocaine-seeking behavior in male offspring. In addition, we demonstrated that cocaine induces changes in the level of MC-4 receptors in the offspring brain, and these changes depend on maternal diet. These studies also reveal that an MC-4 receptor antagonist reduces the reinstatement of cocaine-seeking behavior, and offspring exposed to maternal HSD are more sensitive to its effects than offspring exposed to the maternal control diet. Taken together, the results suggest that a maternal HSD and MC-4 receptors play an important role in cocaine relapse.	[Gawlinski, Dawid; Gawlinska, Kinga; Frankowska, Malgorzata; Filip, Malgorzata] Polish Acad Sci, Maj Inst Pharmacol, Dept Drug Addict Pharmacol, Smetna St 12, PL-31343 Krakow, Poland	Polish Academy of Sciences; Maj Institute of Pharmacology of the Polish Academy of Sciences	Filip, M (corresponding author), Polish Acad Sci, Maj Inst Pharmacol, Dept Drug Addict Pharmacol, Smetna St 12, PL-31343 Krakow, Poland.	mal.fil@if-pan.krakow.pl	Gawliński, Dawid/ABB-3000-2020; Gawlińska, Kinga/AAJ-3232-2021	Gawliński, Dawid/0000-0002-9376-0564; Gawlińska, Kinga/0000-0001-7015-154X; Frankowska, Malgorzata/0000-0002-6646-6140	Narodowe Centrum Nauki (NCN) [UMO-2016/21/B/NZ4/00203]	Narodowe Centrum Nauki (NCN)(National Science Centre, Poland)	Narodowe Centrum Nauki (NCN), Grant/Award Number: UMO-2016/21/B/NZ4/00203	Adan RAH, 1997, PEPTIDES, V18, P1279, DOI 10.1016/S0196-9781(97)00078-8; Ahmed S, 2014, NEUROCHEM RES, V39, P815, DOI 10.1007/s11064-014-1274-6; Martinez JA, 2012, P NUTR SOC, V71, P276, DOI 10.1017/S0029665112000055; Alserda E, 2013, EUR J PHARMACOL, V719, P187, DOI 10.1016/j.ejphar.2013.04.052; Alvaro JD, 1996, MOL PHARMACOL, V50, P583; Alvaro JD, 2003, J PHARMACOL EXP THER, V304, P391, DOI 10.1124/jpet.102.040311; Avena NM, 2005, PHYSIOL BEHAV, V84, P359, DOI 10.1016/j.physbeh.2004.12.016; Baskin R, 2015, APPETITE, V91, P41, DOI 10.1016/j.appet.2015.03.017; Bassareo V, 2015, BEHAV BRAIN RES, V294, P215, DOI 10.1016/j.bbr.2015.08.006; Bassareo V, 2015, BEHAV BRAIN RES, V287, P200, DOI 10.1016/j.bbr.2015.03.056; Bello NT, 2002, NEUROREPORT, V13, P1575, DOI 10.1097/00001756-200208270-00017; Bocarsly ME, 2012, PHYSIOL BEHAV, V107, P568, DOI 10.1016/j.physbeh.2012.04.024; Colantuoni C, 2001, NEUROREPORT, V12, P3549, DOI 10.1097/00001756-200111160-00035; Cui H, 2013, GENES BRAIN BEHAV, V12, P658, DOI 10.1111/gbb.12057; Delaney-Black V, 2011, NEUROTOXICOL TERATOL, V33, P110, DOI 10.1016/j.ntt.2010.06.011; DESAI M, 2014, AM J OBSTET GYNECOL, V237, pE1, DOI DOI 10.1016/J.AJ0G.2014.03.025; Di Chiara G, 2007, CURR OPIN PHARMACOL, V7, P69, DOI 10.1016/j.coph.2006.11.003; Dietrich MO, 2012, NAT NEUROSCI, V15, P1108, DOI 10.1038/nn.3147; Farrell MR, 2018, PROG NEURO-PSYCHOPH, V87, P33, DOI 10.1016/j.pnpbp.2018.01.002; Frank DA, 2011, NEUROTOXICOL TERATOL, V33, P100, DOI 10.1016/j.ntt.2010.06.002; Fuchs RA, 2005, NEUROPSYCHOPHARMACOL, V30, P296, DOI 10.1038/sj.npp.1300579; Fuchs RA, 2007, EUR J NEUROSCI, V26, P487, DOI 10.1111/j.1460-9568.2007.05674.x; Girardet C, 2018, OBESITY, V26, P1849, DOI 10.1002/oby.22306; Gosnell BA, 2005, BRAIN RES, V1031, P194, DOI 10.1016/j.brainres.2004.10.037; Grimm JW, 2005, PHYSIOL BEHAV, V84, P73, DOI 10.1016/j.physbeh.2004.10.011; Hajnal A, 2004, AM J PHYSIOL-REG I, V286, pR31, DOI 10.1152/ajpregu.00282.2003; Hecht GS, 1998, BEHAV NEUROSCI, V112, P410, DOI 10.1037/0735-7044.112.2.410; Heindel JJ, 2015, CURR OPIN PEDIATR, V27, P248, DOI 10.1097/MOP.0000000000000191; Hsu R, 2005, EUR J NEUROSCI, V21, P2233, DOI 10.1111/j.1460-9568.2005.04038.x; Jacka FN, 2013, J AM ACAD CHILD PSY, V52, P1038, DOI 10.1016/j.jaac.2013.07.002; Jastrzebska J, 2015, BEHAV BRAIN RES, V293, P62, DOI 10.1016/j.bbr.2015.06.040; Johnson WG, 1999, AM J MED GENET, V88, P311, DOI 10.1002/(SICI)1096-8628(19990820)88:4<311::AID-AJMG6>3.3.CO;2-M; Jones KT, 2017, J NEUROCHEM, V140, P728, DOI 10.1111/jnc.13930; Kamat PK, 2014, METHODSX, V1, P102, DOI 10.1016/j.mex.2014.08.002; Karatayev O, 2015, ALCOHOL, V49, P479, DOI 10.1016/j.alcohol.2015.03.002; Keller RW, 1996, NEUROSCI LETT, V205, P153, DOI 10.1016/0304-3940(96)12409-5; Khoo SYS, 2017, GENES BRAIN BEHAV, V16, P185, DOI 10.1111/gbb.12328; Kokare DM, 2008, BRAIN RES, V1216, P53, DOI 10.1016/j.brainres.2008.03.064; Lee BR, 2013, NAT NEUROSCI, V16, P1644, DOI 10.1038/nn.3533; Lenoir M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000698; Li Yan-Qing, 2016, Shengli Xuebao, V68, P233, DOI 10.13294/j.aps.2016.0045; Lim BK, 2012, NATURE, V487, P183, DOI 10.1038/nature11160; Lindblom J, 2002, PHARMACOL BIOCHEM BE, V72, P491, DOI 10.1016/S0091-3057(02)00719-0; Lindblom J, 2002, PHARMACOL RES, V45, P119, DOI 10.1006/phrs.2001.0913; Lindblom J, 2001, NEUROREPORT, V12, P2155, DOI 10.1097/00001756-200107200-00022; Menting MD, 2019, NEUROSCI BIOBEHAV R, V98, P107, DOI 10.1016/j.neubiorev.2018.12.023; Minnes S, 2014, DRUG ALCOHOL DEPEN, V134, P201, DOI 10.1016/j.drugalcdep.2013.09.031; Morganstern I, 2013, PSYCHOPHARMACOLOGY, V230, P509, DOI 10.1007/s00213-013-3178-6; Navarro M, 2005, ALCOHOL CLIN EXP RES, V29, P949, DOI 10.1097/01.ALC.0000167740.19702.8C; Navarro M, 2003, NEUROPEPTIDES, V37, P338, DOI 10.1016/j.npep.2003.10.003; Nicholson JR, 2006, J PHARMACOL EXP THER, V317, P771, DOI 10.1124/jpet.105.097725; Ong ZY, 2011, FASEB J, V25, P2167, DOI 10.1096/fj.10-178392; Pandit R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121768; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Ploj K, 2002, BRAIN RES BULL, V59, P97, DOI 10.1016/S0361-9230(02)00844-4; Qi XL, 2015, ADDICT BIOL, V20, P324, DOI 10.1111/adb.12129; Rada P, 2005, NEUROSCIENCE, V134, P737, DOI 10.1016/j.neuroscience.2005.04.043; Richardson GA, 2019, DRUG ALCOHOL DEPEN, V195, P121, DOI 10.1016/j.drugalcdep.2018.10.033; Richardson NR, 1996, J NEUROSCI METH, V66, P1, DOI 10.1016/0165-0270(95)00153-0; Rocha BA, 2002, PSYCHOPHARMACOLOGY, V163, P221, DOI 10.1007/s00213-002-1140-0; Sanchez MS, 2001, CELL MOL NEUROBIOL, V21, P523, DOI 10.1023/A:1013871407464; Shelkar GP, 2015, ADDICT BIOL, V20, P302, DOI 10.1111/adb.12126; Spangler R, 2004, MOL BRAIN RES, V124, P134, DOI 10.1016/j.molbrainres.2004.02.013; Stefanik MT, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00213; Stewart J, 2008, PHILOS T R SOC B, V363, P3147, DOI 10.1098/rstb.2008.0084; Sullivan EL, 2015, HORM BEHAV, V76, P153, DOI 10.1016/j.yhbeh.2015.04.008; Vos TJ, 2004, J MED CHEM, V47, P1602, DOI 10.1021/jm034244g; Wells AM, 2011, LEARN MEMORY, V18, P693, DOI 10.1101/lm.2273111; Wirth MM, 2001, BRAIN RES, V897, P169, DOI 10.1016/S0006-8993(01)02087-X; Wolf ME, 2010, TRENDS NEUROSCI, V33, P391, DOI 10.1016/j.tins.2010.06.003	70	10	10	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9192	9206		10.1096/fj.202000163R	http://dx.doi.org/10.1096/fj.202000163R		MAY 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32421249	Bronze			2022-12-28	WOS:000533521600001
J	Ballout, RA; Sviridov, D; Bukrinsky, MI; Remaley, AT				Ballout, Rami A.; Sviridov, Dmitri; Bukrinsky, Michael I.; Remaley, Alan T.			The lysosome: A potential juncture between SARS-CoV-2 infectivity and Niemann-Pick disease type C, with therapeutic implications	FASEB JOURNAL			English	Article						angiotensin-converting enzyme-2 (ACE2); cathepsins; cholesterol; COVID-19; lipid rafts; lysosomal storage diseases; pandemic	ACUTE RESPIRATORY SYNDROME; TRANSPORT INHIBITOR U18666A; CATHEPSIN-L; SARS-CORONAVIRUS; EBOLA-VIRUS; CHOLESTEROL TRANSPORT; CELL ENTRY; FUNCTIONAL RECEPTOR; TISSUE DISTRIBUTION; ANTIVIRAL ACTIVITY	Drug repurposing is potentially the fastest available option in the race to identify safe and efficacious drugs that can be used to prevent and/or treat COVID-19. By describing the life cycle of the newly emergent coronavirus, SARS-CoV-2, in light of emerging data on the therapeutic efficacy of various repurposed antimicrobials undergoing testing against the virus, we highlight in this review a possible mechanistic convergence between some of these tested compounds. Specifically, we propose that the lysosomotropic effects of hydroxychloroquine and several other drugs undergoing testing may be responsible for their demonstrated in vitro antiviral activities against COVID-19. Moreover, we propose that Niemann-Pick disease type C (NPC), a lysosomal storage disorder, may provide new insights into potential future therapeutic targets for SARS-CoV-2, by highlighting key established features of the disorder that together result in an "unfavorable" host cellular environment that may interfere with viral propagation. Our reasoning evolves from previous biochemical and cell biology findings related to NPC, coupled with the rapidly evolving data on COVID-19. Our overall aim is to suggest that pharmacological interventions targeting lysosomal function in general, and those particularly capable of reversibly inducing transient NPC-like cellular and biochemical phenotypes, constitute plausible mechanisms that could be used to therapeutically target COVID-19.	[Ballout, Rami A.; Remaley, Alan T.] NHLBI, Lipoprot Metab Sect, Translat Vasc Med Branch, NIH, Bldg 10, Bethesda, MD 20892 USA; [Sviridov, Dmitri] Baker Heart & Diabet Inst, Lipoprot & Atherosclerosis Lab, Melbourne, Vic, Australia; [Bukrinsky, Michael I.] George Washington Univ, Sch Med & Hlth Sci, Dept Microbiol Immunol & Trop Med, Washington, DC 20052 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); George Washington University	Ballout, RA; Remaley, AT (corresponding author), NHLBI, Lipoprot Metab Sect, Translat Vasc Med Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	rami-ballout@hotmail.com; alan.remaley@nih.gov		Ballout, Rami A./0000-0002-7543-0895	Intramural Research Program of the National Heart, Lung, and Blood Institute (NHLBI) at the National Institutes of Health [HL006092]; National Heart, Lung, and Blood Institute (NHLBI) [R01-HL131473]; District of Columbia Center for AIDS Research (DC-CFAR), an NIH [P30-AI117970]	Intramural Research Program of the National Heart, Lung, and Blood Institute (NHLBI) at the National Institutes of Health; National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); District of Columbia Center for AIDS Research (DC-CFAR), an NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	RB and AR are supported by the Intramural Research Program of the National Heart, Lung, and Blood Institute (NHLBI) [HL006092] at the National Institutes of Health. MB and D.S are supported by a research grant from the National Heart, Lung, and Blood Institute (NHLBI) under award number [R01-HL131473]. MB is also supported by the District of Columbia Center for AIDS Research (DC-CFAR), an NIH-funded program [P30-AI117970]	Adedeji AO, 2014, ANTIMICROB AGENTS CH, V58, P4894, DOI 10.1128/AAC.02994-14; Ahmed SF, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12030254; Amritraj A, 2009, AM J PATHOL, V175, P2540, DOI 10.2353/ajpath.2009.081096; Ashoor R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082481; Bach G, 1999, CLIN CHIM ACTA, V280, P173, DOI 10.1016/S0009-8981(98)00183-1; Balzarini J, 2006, ANTIVIR RES, V72, P20, DOI 10.1016/j.antiviral.2006.03.005; Barcia-Macay M, 2008, J ANTIMICROB CHEMOTH, V61, P1288, DOI 10.1093/jac/dkn120; Baron SA, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105944; BEAUCHAMP D, 1992, ANTIMICROB AGENTS CH, V36, P2204, DOI 10.1128/AAC.36.10.2204; Berg RD, 2016, CELL, V165, P139, DOI 10.1016/j.cell.2016.02.034; Bertram S, 2013, J VIROL, V87, P6150, DOI 10.1128/JVI.03372-12; Bosch BJ, 2008, J VIROL, V82, P8887, DOI 10.1128/JVI.00415-08; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; Cenedella RJ, 2004, J LIPID RES, V45, P1232, DOI 10.1194/jlr.M300469-JLR200; Cermak S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167428; Chen PM, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-10; Chen YZ, 2014, SCI REP-UK, V4, DOI 10.1038/srep07242; Chung C, 2016, HUM MOL GENET, V25, P1434, DOI 10.1093/hmg/ddw025; Civra A, 2014, SCI REP-UK, V4, DOI 10.1038/srep07487; Cortegiani A, 2020, J CRIT CARE, V57, P279, DOI 10.1016/j.jcrc.2020.03.005; de Wit E, 2020, P NATL ACAD SCI USA, V117, P6771, DOI 10.1073/pnas.1922083117; Devlin C, 2010, TRAFFIC, V11, P601, DOI 10.1111/j.1600-0854.2010.01046.x; Doki T, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9010067; Elrick MJ, 2012, HUM MOL GENET, V21, P4876, DOI 10.1093/hmg/dds324; Fan H. H., 2020, CHIN MED J; Fineran Paul, 2016, Wellcome Open Res, V1, P18, DOI 10.12688/wellcomeopenres.10036.2; Folts CJ, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002583; Fraldi A, 2010, EMBO J, V29, P3607, DOI 10.1038/emboj.2010.237; Fu R, 2010, MOL GENET METAB, V101, P214, DOI 10.1016/j.ymgme.2010.06.018; Gabande-Rodriguez E, 2014, CELL DEATH DIFFER, V21, P864, DOI 10.1038/cdd.2014.4; Gao JJ, 2020, BIOSCI TRENDS, V14, P72, DOI 10.5582/bst.2020.01047; Garver WS, 2002, J LIPID RES, V43, P579; Gautret P, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.105949; Glende J, 2008, VIROLOGY, V381, P215, DOI 10.1016/j.virol.2008.08.026; GONZALEZNORIEGA A, 1980, J CELL BIOL, V85, P839, DOI 10.1083/jcb.85.3.839; Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570; Harrison C, 2020, NAT BIOTECHNOL, V38, P379, DOI 10.1038/d41587-020-00003-1; Hartshorn Kevan L, 2010, Front Biosci (Schol Ed), V2, P527; Heald-Sargent T, 2012, VIRUSES-BASEL, V4, P557, DOI 10.3390/v4040557; Heurich A, 2014, J VIROL, V88, P1293, DOI 10.1128/JVI.02202-13; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Holopainen JM, 2001, EUR J BIOCHEM, V268, P5851, DOI 10.1046/j.0014-2956.2001.02530.x; HOMEWOOD CA, 1972, NATURE, V235, P50, DOI 10.1038/235050a0; Huang IC, 2006, J BIOL CHEM, V281, P3198, DOI 10.1074/jbc.M508381200; Janac B, 2005, ANN NY ACAD SCI, V1048, P396, DOI 10.1196/annals.1342.048; Jelinek David, 2014, J Mol Biochem, V3, P14; Jensen K, 2012, N-S ARCH PHARMACOL, V385, P519, DOI 10.1007/s00210-011-0719-6; Kagedal K, 2001, BIOCHEM J, V359, P335, DOI 10.1042/0264-6021:3590335; Karypidou K, 2018, BIOORG MED CHEM LETT, V28, P3472, DOI 10.1016/j.bmcl.2018.09.019; Koo IC, 2008, P NATL ACAD SCI USA, V105, P710, DOI 10.1073/pnas.0708110105; Kosicek M, 2018, MOL CELL PROTEOMICS, V17, P631, DOI 10.1074/mcp.RA117.000129; Lawson PR, 2000, IMMUNOL REV, V173, P66, DOI 10.1034/j.1600-065X.2000.917308.x; Letko M, 2020, NAT MICROBIOL, V5, P562, DOI [10.1101/2020.01.22.915660, 10.1038/s41564-020-0688-y]; Li CF, 2017, IMMUNITY, V46, P446, DOI 10.1016/j.immuni.2017.02.012; Li Guangdi, 2020, Nat Rev Drug Discov, V19, P149, DOI 10.1038/d41573-020-00016-0; Li L, 2016, ARCH VIROL, V161, P1883, DOI 10.1007/s00705-016-2838-3; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; LINDLEY ER, 1993, BIOCHEM J, V290, P457, DOI 10.1042/bj2900457; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Liu SY, 2013, IMMUNITY, V38, P92, DOI 10.1016/j.immuni.2012.11.005; Liu Y, 2014, TOXICOLOGY, V320, P1, DOI 10.1016/j.tox.2014.02.014; Liu Y, 2014, JAMA OPHTHALMOL, V132, P226, DOI 10.1001/jamaophthalmol.2013.6030; Lloyd-Evans E, 2008, NAT MED, V14, P1247, DOI 10.1038/nm.1876; Long T, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13917-5; Lusa S, 2001, J CELL SCI, V114, P1893; Lyu JF, 2017, CANCER LETT, V409, P91, DOI 10.1016/j.canlet.2017.09.009; Mauthe M, 2018, AUTOPHAGY, V14, P1435, DOI 10.1080/15548627.2018.1474314; Mingo RM, 2015, J VIROL, V89, P2931, DOI 10.1128/JVI.03398-14; Moreno-Caceres J, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.294; multicenter collaboration group of Department of Science and Technology of Guangdong Province and Health Commission of Guangdong Province for chloroquine in the treatment of novel coronavirus pneumonia, 2020, Zhonghua Jie He He Hu Xi Za Zhi, V43, pE019, DOI [10.3760/cma.j.issn.1001-0939.2020.03.009, 10.3760/cma.j.issn.1001-0939.2020.0019]; Nujic K, 2012, CELL IMMUNOL, V279, P78, DOI 10.1016/j.cellimm.2012.09.007; Ou XY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15562-9; Pagler TA, 2007, J LIPID RES, V48, P2141, DOI 10.1194/jlr.M700056-JLR200; Patterson M, 2000, GENEREVIEWS, P1993; Pedersen NC, 2019, J FELINE MED SURG, V21, P271, DOI 10.1177/1098612X19825701; Porter FD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001417; Reinke LM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179177; Renna M, 2011, J CLIN INVEST, V121, P3554, DOI 10.1172/JCI46095; Rodriguez-Gil JL, 2020, J CLIN MED, V9, DOI 10.3390/jcm9010012; Roszell BR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067084; Roszell BR, 2012, AM J PHYSIOL-LUNG C, V302, pL919, DOI 10.1152/ajplung.00383.2011; SCHRIER DJ, 1986, J IMMUNOL, V137, P3284; Shah PP, 2010, MOL PHARMACOL, V78, P319, DOI 10.1124/mol.110.064261; Sheahan TP, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal3653; Shirato K, 2018, VIROLOGY, V517, P9, DOI 10.1016/j.virol.2017.11.012; Shivanna V, 2014, VIROLOGY, V464, P287, DOI 10.1016/j.virol.2014.07.025; Shulla A, 2011, J VIROL, V85, P873, DOI 10.1128/JVI.02062-10; Sillence DJ, 2013, MOL GENET METAB, V109, P194, DOI 10.1016/j.ymgme.2013.03.015; Simmons G, 2005, P NATL ACAD SCI USA, V102, P11876, DOI 10.1073/pnas.0505577102; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; SLATER AFG, 1993, PHARMACOL THERAPEUT, V57, P203, DOI 10.1016/0163-7258(93)90056-J; Takano T, 2019, VET RES, V50, DOI 10.1186/s13567-019-0625-3; Takano T, 2017, ANTIVIR RES, V145, P96, DOI 10.1016/j.antiviral.2017.07.022; TAYLOR MD, 1986, J MED CHEM, V29, P346, DOI 10.1021/jm00153a008; Tchesnokov EP, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11040326; Tellier E, 2006, EXP CELL RES, V312, P3969, DOI 10.1016/j.yexcr.2006.08.027; To KF, 2004, J PATHOL, V203, P740, DOI 10.1002/path.1597; Trinh MN, 2017, P NATL ACAD SCI USA, V114, P89, DOI 10.1073/pnas.1619571114; Vainio S, 2005, BIOCHEM J, V391, P465, DOI 10.1042/BJ20050460; Vincent MJ, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-69; Visentin S, 2013, J NEUROSCI, V33, P15388, DOI 10.1523/JNEUROSCI.0558-13.2013; Vitner EB, 2010, HUM MOL GENET, V19, P3583, DOI 10.1093/hmg/ddq273; Wang HL, 2008, CELL RES, V18, P290, DOI 10.1038/cr.2008.15; Wang ML, 2020, CELL RES, V30, P269, DOI 10.1038/s41422-020-0282-0; Warren TK, 2016, NATURE, V531, P381, DOI 10.1038/nature17180; Wilder-Smith A, 2020, LANCET INFECT DIS, V20, pE102, DOI 10.1016/S1473-3099(20)30129-8; Willard KA, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010020; Wu CR, 2020, ACTA PHARM SIN B, V10, P766, DOI 10.1016/j.apsb.2020.02.008; Wu JZ, 2003, J ANTIMICROB CHEMOTH, V52, P543, DOI 10.1093/jac/dkg405; Yang HY, 2017, GLIA, V65, P1728, DOI 10.1002/glia.23191; Yano T, 2015, FASEB J S, V29, P7771; Zaher NH, 2020, ACTA PHARMACEUT, V70, P145, DOI 10.2478/acph-2020-0024; Zarn JA, 2003, ENVIRON HEALTH PERSP, V111, P255, DOI 10.1289/ehp.5785; Zhang, 2020, TEICOPLANIN POTENTLY, DOI [10.1101/2020.02.05.935387, DOI 10.1101/2020.02.05.935387]; Zhang YH, 2019, VET MICROBIOL, V231, P129, DOI 10.1016/j.vetmic.2019.03.004; Zheng Y, 2018, J VIROL, V92, DOI 10.1128/JVI.01504-18; Zhong XZ, 2017, J BIOL CHEM, V292, P3445, DOI 10.1074/jbc.M116.743963; Zhou N, 2016, J BIOL CHEM, V291, P9218, DOI 10.1074/jbc.M116.716100; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	119	53	53	1	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					7253	7264		10.1096/fj.202000654R	http://dx.doi.org/10.1096/fj.202000654R		MAY 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32367579	Green Accepted, Green Submitted, Green Published			2022-12-28	WOS:000530303200001
J	Li, J; Li, X; Song, J; Yan, BX; Rock, SA; Jia, JH; Liu, JP; Wang, C; Weiss, T; Weiss, HL; Gao, TY; Alam, A; Evers, BM				Li, Jing; Li, Xian; Song, Jun; Yan, Baoxiang; Rock, Stephanie A.; Jia, Jianhang; Liu, Jinpeng; Wang, Chi; Weiss, Todd; Weiss, Heidi L.; Gao, Tianyan; Alam, Ashfaqul; Evers, B. Mark			Absence of neurotensin attenuates intestinal dysbiosis and inflammation by maintaining Mmp7/alpha-defensin axis in diet-induced obese mice	FASEB JOURNAL			English	Article						NF-kappa B; obesity; Paneth cells; PKC tau/lambda	NF-KAPPA-B; CELL ALPHA-DEFENSINS; CORE GUT MICROBIOME; PANETH CELLS; EPITHELIAL-CELLS; INTERLEUKIN-8 EXPRESSION; ANTIMICROBIAL PEPTIDES; BARRIER DYSFUNCTION; INNATE IMMUNITY; ENERGY-BALANCE	We previously reported that high levels of plasma neurotensin (NT), a gut hormone released from enteroendocrine cells of the small bowel, contribute to obesity and comorbid conditions. Gut microbiota has been implicated in the obesity development. Paneth cells are critical in maintaining gut microbiota composition and homeostasis by releasing antimicrobial proteins including alpha-defensins. The purpose of our current study was to determine the possible role of NT in gut microbiota composition and alpha-defensin gene expression associated with obesity. Here we show that the ratio of Firmicutes/Bacteroidetes (F/B ratio) and intestinal proinflammatory cytokines is significantly increased in NT+/+ mice fed with a high-fat diet (HFD) which were improved in NT-deficient mice. HFD disrupted the intestinal Mmp7/alpha-defensin axis, which was completely prevented in NT-/- mice. In addition, NT treatment inhibited DEFA5 expression and concurrent NF-kappa B activity, which was blocked by a pan PKC inhibitor (Go6983) or an inhibitor for atypical PKCs (CRT0066854). More importantly, the shRNA-mediated knockdown of atypical PKC tau reversed NT-attenuated DEFA5 expression and increased NF-kappa B activity. NT contributes to the HFD-induced disruption of gut microbiota composition and alpha-defensin expression. PKC tau/lambda plays a central role in NT-mediated alpha-defensin gene expression which might be mediated through the inhibition of NF-kappa B signaling pathways in Paneth cells.	[Li, Jing; Li, Xian; Song, Jun; Yan, Baoxiang; Rock, Stephanie A.; Evers, B. Mark] Univ Kentucky, Dept Surg, Lexington, KY USA; [Li, Jing; Li, Xian; Song, Jun; Yan, Baoxiang; Rock, Stephanie A.; Jia, Jianhang; Liu, Jinpeng; Wang, Chi; Weiss, Todd; Weiss, Heidi L.; Gao, Tianyan; Evers, B. Mark] Univ Kentucky, Markey Canc Ctr, CC140 Roach Bldg, Lexington, KY 40536 USA; [Alam, Ashfaqul] Univ Kentucky, Microbiol Immunol & Mol Genet, Lexington, KY USA	University of Kentucky; University of Kentucky; University of Kentucky	Evers, BM (corresponding author), Univ Kentucky, Markey Canc Ctr, CC140 Roach Bldg, Lexington, KY 40536 USA.	mark.evers@uky.edu			University of Kentucky Markey Cancer Center [P30 CA177558]; NIH [DK112034, R01 DK48498, K01 DK114391]	University of Kentucky Markey Cancer Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	University of Kentucky Markey Cancer Center, Grant/Award Number: P30 CA177558; NIH, Grant/Award Number: R01, DK112034, R01 DK48498 and K01 DK114391	Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; Adolph TE, 2013, NATURE, V503, P272, DOI 10.1038/nature12599; AMIR A, 2017, MSYSTEMS, V2, DOI [DOI 10.1128/MSYSTEMS.00191-16, 10.1128/mSystems.00191-16]; Ayabe T, 2002, J BIOL CHEM, V277, P5219, DOI 10.1074/jbc.M109410200; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Bakirtzi K, 2011, GASTROENTEROLOGY, V141, P1749, DOI 10.1053/j.gastro.2011.07.038; Ballance LT, 2006, PROG OCEANOGR, V69, P360, DOI 10.1016/j.pocean.2006.03.013; BARBER DL, 1991, AM J PHYSIOL, V261, pG497, DOI 10.1152/ajpgi.1991.261.3.G497; Barchetta I, 2018, J CLIN ENDOCR METAB, V103, P2253, DOI 10.1210/jc.2017-02751; Beisner J, 2014, AM J PHYSIOL-GASTR L, V307, pG487, DOI 10.1152/ajpgi.00347.2013; Luna-Ulloa LB, 2011, IUBMB LIFE, V63, P915, DOI 10.1002/iub.559; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bonnet D, 2018, ADV STEM CELL NICHES, V2, P77, DOI 10.1016/bs.asn.2017.12.002; Brodrick B, 2011, J BIOL CHEM, V286, P18515, DOI 10.1074/jbc.M111.229252; Buettner R, 2006, J MOL ENDOCRINOL, V36, P485, DOI 10.1677/jme.1.01909; CARRAWAY R, 1973, J BIOL CHEM, V248, P6854; Castagliuolo I, 1999, J CLIN INVEST, V103, P843, DOI 10.1172/JCI4217; CHUNG DH, 1992, GASTROENTEROLOGY, V103, P1254, DOI 10.1016/0016-5085(92)91512-3; Clevers HC, 2013, ANNU REV PHYSIOL, V75, P289, DOI 10.1146/annurev-physiol-030212-183744; Correa JD, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/373765; Coudronniere N, 2000, P NATL ACAD SCI USA, V97, P3394, DOI 10.1073/pnas.060028097; da Silva L, 2011, BBA-MOL CELL RES, V1813, P1863, DOI 10.1016/j.bbamcr.2011.06.018; Dicou E, 2004, J NEUROSCI RES, V78, P92, DOI 10.1002/jnr.20231; DOBNER PR, 1987, P NATL ACAD SCI USA, V84, P3516, DOI 10.1073/pnas.84.10.3516; Drewe J, 2008, J CLIN ENDOCR METAB, V93, P1964, DOI 10.1210/jc.2007-2238; Edgar RC., 2016, BIORXIV, DOI [10.1101/074161, DOI 10.1101/074161, 10.1101/2020.05.12.088096]; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Elphick DA, 2005, GUT, V54, P1802, DOI 10.1136/gut.2005.068601; EVERS BM, 1992, GASTROENTEROLOGY, V103, P86, DOI 10.1016/0016-5085(92)91099-P; Ferrand A, 2019, CELL MOL GASTROENTER, V7, P357, DOI 10.1016/j.jcmgh.2018.10.009; FERRIS CF, 1985, ENDOCRINOLOGY, V116, P1133, DOI 10.1210/endo-116-3-1133; FOGH J, 1977, J NATL CANCER I, V58, P209, DOI 10.1093/jnci/58.2.209; FUJIMURA M, 1989, GASTROENTEROLOGY, V96, P1502, DOI 10.1016/0016-5085(89)90518-0; Fuks G, 2018, MICROBIOME, V6, DOI 10.1186/s40168-017-0396-x; Gallo RL, 2012, NAT REV IMMUNOL, V12, P503, DOI 10.1038/nri3228; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; GOLDMAN R, 1983, FEBS LETT, V159, P63, DOI 10.1016/0014-5793(83)80417-7; Greicius G, 2018, P NATL ACAD SCI USA, V115, pE3173, DOI 10.1073/pnas.1713510115; Gschwendt M, 1996, FEBS LETT, V392, P77, DOI 10.1016/0014-5793(96)00785-5; Gui XY, 2001, GASTROENTEROLOGY, V120, P151, DOI 10.1053/gast.2001.20876; Guo XL, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/9474896; Hodin CM, 2011, J PATHOL, V225, P276, DOI 10.1002/path.2917; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Jumpertz R, 2011, AM J CLIN NUTR, V94, P58, DOI 10.3945/ajcn.110.010132; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; KISLAUSKIS E, 1988, J BIOL CHEM, V263, P4963; Koon HW, 2009, P NATL ACAD SCI USA, V106, P8766, DOI 10.1073/pnas.0903499106; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; LANGER P, 1991, HORM METAB RES, V23, P370, DOI 10.1055/s-2007-1003703; Law IKM, 2012, J BIOL CHEM, V287, P15066, DOI 10.1074/jbc.M111.327262; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Lee J, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/416036; LEMAIRE I, 1988, J IMMUNOL, V140, P2983; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li J, 2002, AM J PHYSIOL-GASTR L, V283, pG1197, DOI 10.1152/ajpgi.00177.2002; Li J, 2016, NATURE, V533, P411, DOI 10.1038/nature17662; Liu Y, 2012, J BIOL CHEM, V287, P20081, DOI 10.1074/jbc.M111.335463; Manco M, 2010, ENDOCR REV, V31, P817, DOI 10.1210/er.2009-0030; Melander O, 2012, JAMA-J AM MED ASSOC, V308, P1469, DOI 10.1001/jama.2012.12998; Miyashita Tadashi, 1992, Biological Signals, V1, P275; Moscat J, 2006, CELL DEATH DIFFER, V13, P702, DOI 10.1038/sj.cdd.4401823; Nakanishi Y, 2016, CELL REP, V16, P3297, DOI 10.1016/j.celrep.2016.08.054; OROURKE KP, 2016, BIO PROTOC, V6; Park KA, 2007, CARCINOGENESIS, V28, P71, DOI 10.1093/carcin/bgl094; Piliponsky AM, 2008, NAT MED, V14, P392, DOI 10.1038/nm1738; Qiao GL, 2008, MOL CELL BIOL, V28, P2470, DOI 10.1128/MCB.01505-07; Qiu S, 2017, GASTROENT RES PRACT, V2017, DOI 10.1155/2017/6456257; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Rosse C, 2010, NAT REV MOL CELL BIO, V11, P103, DOI 10.1038/nrm2847; Rozengurt E, 2002, EUR J SURG, V168, P23; Saetang J, 2018, MOL MED REP, V17, P1403, DOI 10.3892/mmr.2017.8038; SAKAMOTO T, 1988, SURG GYNECOL OBSTET, V166, P11; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schmitz ML, 2003, FASEB J, V17, P2187, DOI 10.1096/fj.02-1100rev; Schoenborn AA, 2019, GUT MICROBES, V10, P45, DOI 10.1080/19490976.2018.1474321; Shanahan MT, 2011, INFECT IMMUN, V79, P459, DOI 10.1128/IAI.00996-10; SIMOPOULOS C, 1989, GUT, V30, P600, DOI 10.1136/gut.30.5.600; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Stappenbeck TS, 2009, GASTROENTEROLOGY, V137, P30, DOI 10.1053/j.gastro.2009.05.013; Tan G, 2016, ONCOTARGET, V7, P63651, DOI 10.18632/oncotarget.11467; Tan G, 2015, SCI REP-UK, V5, DOI 10.1038/srep08383; Thaiss CA, 2018, SCIENCE, V362, P903, DOI 10.1126/science.aav6870; THEODORSSONNORHEIM E, 1983, ACTA PHYSIOL SCAND, V117, P439, DOI 10.1111/j.1748-1716.1983.tb00018.x; THOR K, 1982, GASTROENTEROLOGY, V83, P569; Turnbaugh PJ, 2009, J PHYSIOL-LONDON, V587, P4153, DOI 10.1113/jphysiol.2009.174136; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; van Es JH, 2005, NAT CELL BIOL, V7, P381, DOI 10.1038/ncb1240; Wan FY, 2010, CELL RES, V20, P24, DOI 10.1038/cr.2009.137; Wang XF, 2006, CLIN CANCER RES, V12, P5346, DOI 10.1158/1078-0432.CCR-06-0968; Wang XF, 2011, J BIOL CHEM, V286, P542, DOI 10.1074/jbc.M110.145664; Wehkamp J, 2008, MUCOSAL IMMUNOL, V1, pS67, DOI 10.1038/mi.2008.48; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; Xiao HL, 2017, CELL PHYSIOL BIOCHEM, V43, P2133, DOI 10.1159/000484232; Yu LCH, 2018, J BIOMED SCI, V25, DOI 10.1186/s12929-018-0483-8; Zhao DZ, 2006, PEPTIDES, V27, P2434, DOI 10.1016/j.peptides.2005.12.016; Zhao DZ, 2005, MOL PHARMACOL, V67, P2025, DOI 10.1124/mol.104.010801; Zhao DZ, 2003, AM J PHYSIOL-CELL PH, V284, pC1397, DOI 10.1152/ajpcell.00328.2002; Zhao DZ, 2001, J BIOL CHEM, V276, P44464, DOI 10.1074/jbc.M104942200	101	5	5	2	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8596	8610		10.1096/fj.201902374RR	http://dx.doi.org/10.1096/fj.201902374RR		MAY 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32359121	Green Accepted			2022-12-28	WOS:000530046900001
J	Kishimoto, T; Tomishige, N; Murate, M; Ishitsuka, R; Schaller, H; Mely, Y; Ueda, K; Kobayashi, T				Kishimoto, Takuma; Tomishige, Nario; Murate, Motohide; Ishitsuka, Reiko; Schaller, Hubert; Mely, Yves; Ueda, Kazumitsu; Kobayashi, Toshihide			Cholesterol asymmetry at the tip of filopodia during cell adhesion	FASEB JOURNAL			English	Article						ABCA1; Cdc42; cholesterol probe; lipid asymmetry	PERFRINGOLYSIN-O; PLASMA-MEMBRANE; APOA-I; ACTIVATES CDC42; LIPID STRUCTURE; DOMAINS; ABCA1; SPHINGOMYELIN; RECEPTOR; PROTEIN	During adhesion, cells develop filopodia to facilitate the attachment to the extracellular matrix. The small guanosine triphosphate (GTP)-binding protein, Cdc42, plays a central role in the formation of filopodia. It has been reported that Cdc42 activity is regulated by cholesterol (Chol). We examined Chol distribution in filopodia using Chol-binding domain 4 (D4) fragment of bacterial toxin, perfringolysin O that senses high membrane concentration of Chol. Our results indicate that fluorescent D4 was enriched at the tip of the outer leaflet of filopodia in the initiation phase of cell adhesion. This enrichment was accompanied by a defect of D4 labeling in the inner leaflet. Steady phase adhered cell experiment indicated that both Cdc42 and ATP-binding cassette transporter, ABCA1, were involved in the binding of D4 to the cell surface. Depletion of Chol activated Cdc42. Our results suggest that asymmetric distribution of Chol at the tip of filopodia induces activation of Cdc42, and thus, facilitates filopodia formation.	[Kishimoto, Takuma; Tomishige, Nario; Murate, Motohide; Ishitsuka, Reiko; Kobayashi, Toshihide] RIKEN, Lipid Biol Lab, Saitama, Japan; [Kishimoto, Takuma] Hokkaido Univ, Grad Sch Life Sci, Inst Med Genet, Div Mol Interact, Sapporo, Hokkaido, Japan; [Tomishige, Nario; Murate, Motohide; Mely, Yves; Kobayashi, Toshihide] Univ Strasbourg, CNRS, UMR 7021, Illkirch Graffenstaden 67401, France; [Schaller, Hubert] Univ Strasbourg, Inst Biol Mol Plantes, CNRS, UPR 2357, Strasbourg, France; [Ueda, Kazumitsu] Kyoto Univ, Div Appl Life Sci, Grad Sch Agr, Inst Integrated Cell Mat Sci, Kyoto, Japan	RIKEN; Hokkaido University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Kyoto University	Kobayashi, T (corresponding author), Univ Strasbourg, CNRS, UMR 7021, Illkirch Graffenstaden 67401, France.	kobayasi@riken.jp	KOBAYASHI, TOSHIHIDE/S-8313-2019; Kishimoto, Takuma/AAP-1813-2021	KOBAYASHI, TOSHIHIDE/0000-0002-4811-7270; Ueda, Kazumitsu/0000-0003-2980-6078; Murate, Motohide/0000-0001-5715-7947				Abe M, 2014, BBA-MOL CELL BIOL L, V1841, P720, DOI 10.1016/j.bbalip.2013.07.003; Abe M, 2012, MOL CELL BIOL, V32, P1396, DOI 10.1128/MCB.06113-11; Acimovic J, 2009, J CHROMATOGR B, V877, P2081, DOI 10.1016/j.jchromb.2009.05.050; Ahmed S, 2010, SEMIN CELL DEV BIOL, V21, P350, DOI 10.1016/j.semcdb.2009.11.008; Arakawa R, 2002, J BIOL CHEM, V277, P22426, DOI 10.1074/jbc.M202996200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Botelho RJ, 2000, J CELL BIOL, V151, P1353, DOI 10.1083/jcb.151.7.1353; Brachet A, 2015, J CELL BIOL, V208, P791, DOI 10.1083/jcb.201407122; Bustelo XR, 2007, BIOESSAYS, V29, P356, DOI 10.1002/bies.20558; Carquin M, 2014, J LIPID RES, V55, P1331, DOI 10.1194/jlr.M048538; Castellano F, 1999, CURR BIOL, V9, P351, DOI 10.1016/S0960-9822(99)80161-4; Chierico L, 2014, SCI REP-UK, V4, DOI 10.1038/srep06056; Das A, 2013, P NATL ACAD SCI USA, V110, P10580, DOI 10.1073/pnas.1309273110; Fessler MB, 2004, J BIOL CHEM, V279, P39989, DOI 10.1074/jbc.M401080200; Fraire-Zamora JJ, 2012, BIOCHEM BIOPH RES CO, V427, P478, DOI 10.1016/j.bbrc.2012.09.071; Gaus K, 2003, P NATL ACAD SCI USA, V100, P15554, DOI 10.1073/pnas.2534386100; Genest J, 2018, CURR OPIN LIPIDOL, V29, P36, DOI 10.1097/MOL.0000000000000470; Gupton Stephanie L, 2007, Sci STKE, V2007, pre5, DOI 10.1126/stke.4002007re5; Heijnen HFG, 2003, J THROMB HAEMOST, V1, P1161, DOI 10.1046/j.1538-7836.2003.00316.x; Heuck AP, 2000, MOL CELL, V6, P1233, DOI 10.1016/S1097-2765(00)00119-2; Iwamoto K, 2007, BIOPHYS J, V93, P1608, DOI 10.1529/biophysj.106.101584; Jacquemet G, 2015, CURR OPIN CELL BIOL, V36, P23, DOI 10.1016/j.ceb.2015.06.007; Jaksits S, 2004, J IMMUNOL, V173, P1628, DOI 10.4049/jimmunol.173.3.1628; Kheirollah A, 2014, J NEUROSCI RES, V92, P455, DOI 10.1002/jnr.23324; Kiyokawa E, 2005, J BIOL CHEM, V280, P24072, DOI 10.1074/jbc.M502244200; Kobayashi T, 2018, CURR BIOL, V28, pR386, DOI 10.1016/j.cub.2018.01.007; Liu SL, 2017, NAT CHEM BIOL, V13, P268, DOI [10.1038/NCHEMBIO.2268, 10.1038/nchembio.2268]; LOWRY RR, 1968, J LIPID RES, V9, P397; Lu R, 2008, ARTERIOSCL THROM VAS, V28, P1820, DOI 10.1161/ATVBAHA.108.169482; Maekawa M, 2014, J CELL SCI, V127, P4801, DOI 10.1242/jcs.150524; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; Mizuno H, 2011, CHEM SCI, V2, P1548, DOI 10.1039/c1sc00169h; Morozova KS, 2010, BIOPHYS J, V99, pL13, DOI 10.1016/j.bpj.2010.04.025; Murate M, 2015, J CELL SCI, V128, P1627, DOI 10.1242/jcs.163105; Nelson LD, 2008, J BIOL CHEM, V283, P4632, DOI 10.1074/jbc.M709483200; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Nofer JR, 2006, J LIPID RES, V47, P794, DOI 10.1194/jlr.M500502-JLR200; Nofer JR, 2003, J BIOL CHEM, V278, P53055, DOI 10.1074/jbc.M305673200; Ohno-Iwashita Y, 2004, ANAEROBE, V10, P125, DOI 10.1016/j.anaerobe.2003.09.003; Ohno-Iwashita Y, SUBCELL BIOCH, V51, P597; Oram JF, 2000, J BIOL CHEM, V275, P34508, DOI 10.1074/jbc.M006738200; Phillips MC, 2018, J LIPID RES, V59, P749, DOI 10.1194/jlr.R082313; ROBINSON JM, 1980, J CELL BIOL, V87, P562, DOI 10.1083/jcb.87.3.562; Sato SB, 2004, J BIOL CHEM, V279, P23790, DOI 10.1074/jbc.M313568200; Shimada Y, 2002, EUR J BIOCHEM, V269, P6195, DOI 10.1046/j.1432-1033.2002.03338.x; Sokolov A, 2010, J BIOL CHEM, V285, P29480, DOI 10.1074/jbc.M110.148254; Steck TL, 2018, TRAFFIC, V19, P750, DOI 10.1111/tra.12586; Surviladze Z., 2010, PROBE REPORTS NIH MO; Takahashi M, 2007, MOL BIOL CELL, V18, P2667, DOI 10.1091/mbc.E06-10-0924; Talbot CPJ, 2018, PROG LIPID RES, V69, P21, DOI 10.1016/j.plipres.2017.12.001; Tsukamoto K, 2001, BIOCHEM BIOPH RES CO, V287, P757, DOI 10.1006/bbrc.2001.5575; Venugopal S, 2016, J BIOL CHEM, V291, P26109, DOI 10.1074/jbc.M116.740928; Wang N, 2003, J CLIN INVEST, V111, P99, DOI 10.1172/JCI200316808; Westerterp M, 2014, CIRC RES, V114, P157, DOI 10.1161/CIRCRESAHA.114.300738; Wheeler G, 2011, BBA-BIOMEMBRANES, V1808, P634, DOI 10.1016/j.bbamem.2010.11.017; Xie C, 2011, J BIOL CHEM, V286, P35933, DOI 10.1074/jbc.M111.270199; Yokoyama K, 1997, EUR J BIOCHEM, V249, P450, DOI 10.1111/j.1432-1033.1997.00450.x; Zhang ZY, 2005, EXP GERONTOL, V40, P286, DOI 10.1016/j.exger.2005.01.011; Zhao GJ, 2012, MOL MED, V18, P149, DOI 10.2119/molmed.2011.00183	59	5	5	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6185	6197		10.1096/fj.201900065RR	http://dx.doi.org/10.1096/fj.201900065RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32162745	Bronze			2022-12-28	WOS:000531325500015
J	Jiao, N; Xu, DD; Qiu, K; Wang, LQ; Wang, L; Piao, XS; Yin, JD				Jiao, Ning; Xu, Doudou; Qiu, Kai; Wang, Liqi; Wang, Lu; Piao, Xiangshu; Yin, Jingdong			Restoring mitochondrial function and normalizing ROS-JNK/MAPK pathway exert key roles in glutamine ameliorating bisphenol A-induced intestinal injury	FASEB JOURNAL			English	Article						apoptosis; glutathione; intestinal mucosa; mitochondrial malfunction	SIGNAL-TRANSDUCTION; CELL PROLIFERATION; INDUCED APOPTOSIS; OXIDATIVE STRESS; HUMAN HEALTH; METABOLISM; BPA; DIFFERENTIATION; PATHOGENESIS; EXPOSURE	Bisphenol A (BPA) is toxic to the reproductive and nervous system, even carcinogenetic in humans and animals. However, few studies focused on effects of BPA on the intestinal tract. Here, we detected BPA-induced injuries on intestinal mucosa and explored a reliable approach to counteract BPA effects. C57BL/6J mice were gavage BPA or BPA accompanied with ingestion of 4% (w/w) of glutamine for 4-wks. In vitro, IEC-6 cells were treated with 0.4 mmol/L BPA for 6 hours mimicking acute injury and 0.2 mmol/L BPA for 12 hours followed with or without the inclusion of 4 mmol/L glutamine for 12 hours to determine cell renewal, mitochondrial function and ROS-JNK/MAPK pathway upon moderate BPA exposure. As results, BPA exposure caused severe intestinal injury, and disturbed intestinal epithelial cell proliferation and apoptosis, accompanied with mitochondrial malfunction and activated JNK/MAPK pathway as well. Notably, glutathione metabolism was implicated in BPA-induce injury. Glutamine could well rescue cell renewal and mitochondrial function from BPA exposure-induced injuries. In conclusion, we demonstrated impaired effect of BPA exposure on intestinal functions, which could be well counteracted by glutamine partly via restoring mitochondrial function and normalizing ROS-JNK/MAPK pathway. Thereby, we provided a novel application of glutamine to rescue intestinal injury.	[Jiao, Ning; Xu, Doudou; Qiu, Kai; Wang, Liqi; Wang, Lu; Piao, Xiangshu; Yin, Jingdong] China Agr Univ, Coll Anim Sci & Technol, State Key Lab Anim Nutr, Beijing 100193, Peoples R China	China Agricultural University	Yin, JD (corresponding author), China Agr Univ, Coll Anim Sci & Technol, State Key Lab Anim Nutr, Beijing 100193, Peoples R China.	yinjd@cau.edu.cn		Yin, Jingdong/0000-0003-4623-0568; Qiu, Kai/0000-0002-6575-5346	National Key Research and Development Program of China [2018YFD0500402, 2016YFD0700201]; 111 Project [B16044]	National Key Research and Development Program of China; 111 Project(Ministry of Education, China - 111 Project)	National Key Research and Development Program of China, Grant/Award Number: 2018YFD0500402 and 2016YFD0700201; 111 Project, Grant/Award Number: B16044	Agarwal S, 2016, J BIOL CHEM, V291, P15923, DOI 10.1074/jbc.M115.709493; Arthur JSC, 2013, NAT REV IMMUNOL, V13, P679, DOI 10.1038/nri3495; Barker N, 2014, NAT REV MOL CELL BIO, V15, P19, DOI 10.1038/nrm3721; Bauchart-Thevret C, 2009, NUTR RES REV, V22, P175, DOI 10.1017/S0954422409990138; Beutheu S, 2014, CLIN NUTR, V33, P694, DOI 10.1016/j.clnu.2013.09.003; Bhattacharyya A, 2014, PHYSIOL REV, V94, P329, DOI 10.1152/physrev.00040.2012; Board PG, 2013, BBA-GEN SUBJECTS, V1830, P3267, DOI 10.1016/j.bbagen.2012.11.019; Buckley A, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a029314; Circu ML, 2012, SEMIN CELL DEV BIOL, V23, P729, DOI 10.1016/j.semcdb.2012.03.014; Depeille P, 2015, NAT CELL BIOL, V17, P804, DOI 10.1038/ncb3175; Dobrzynska MM, 2013, DRUG CHEM TOXICOL, V36, P19, DOI 10.3109/01480545.2011.644561; EFSA, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.4278; Erler C, 2010, J PEDIATR NURS, V25, P400, DOI 10.1016/j.pedn.2009.05.006; Fehlberg S, 2002, BIOCHEM J, V362, P573, DOI 10.1042/0264-6021:3620573; Goodson WH, 2015, CARCINOGENESIS, V36, pS254, DOI 10.1093/carcin/bgv039; Hassani FV, 2017, FOOD CHEM TOXICOL, V107, P395, DOI 10.1016/j.fct.2017.07.007; Hu XM, 2019, GASTROENTEROLOGY, V156, P1098, DOI 10.1053/j.gastro.2018.11.033; Huang YQ, 2012, ENVIRON INT, V42, P91, DOI 10.1016/j.envint.2011.04.010; Huc L, 2012, TOXICOL IN VITRO, V26, P709, DOI 10.1016/j.tiv.2012.03.017; Indrieri A, 2012, AM J HUM GENET, V91, P942, DOI 10.1016/j.ajhg.2012.09.016; Jarvis MF, 2012, PAIN, V153, P1987, DOI 10.1016/j.pain.2012.05.020; Ji Y, 2018, J ANIM SCI BIOTECHNO, V9, DOI 10.1186/s40104-018-0253-1; Jiang Q, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122617; Jiao N, 2015, J NUTR, V145, P2258, DOI 10.3945/jn.115.217661; L'Huillier C, 2019, NUTRIENTS, V11, DOI 10.3390/nu11061348; Li JP, 2018, TOXICOLOGY, V396, P54, DOI 10.1016/j.tox.2018.02.004; Liu N, 2018, J NUTR, V148, P526, DOI 10.1093/jn/nxx062; McCubrey JA, 2006, ANTIOXID REDOX SIGN, V8, P1775, DOI 10.1089/ars.2006.8.1775; Miguel JC, 2017, J CELL SCI, V130, P90, DOI 10.1242/jcs.182584; Neurath MF, 2014, MUCOSAL IMMUNOL, V7, P6, DOI 10.1038/mi.2013.73; Odenwald MA, 2017, NAT REV GASTRO HEPAT, V14, P9, DOI 10.1038/nrgastro.2016.169; Okumura R, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.20; Ooe H, 2005, TOXICOL SCI, V88, P114, DOI 10.1093/toxsci/kfi278; Osaki LH, 2013, INT J MOL SCI, V14, P10143, DOI 10.3390/ijms140510143; Pal HC, 2015, BRIT J DERMATOL, V172, P354, DOI 10.1111/bjd.13513; Perez S, 2017, FREE RADICAL BIO MED, V104, P75, DOI 10.1016/j.freeradbiomed.2016.12.048; Qi SQ, 2014, REPROD TOXICOL, V50, P108, DOI 10.1016/j.reprotox.2014.10.013; Qu W, 2018, LIFE SCI, V208, P167, DOI 10.1016/j.lfs.2018.07.040; Rath E, 2018, NAT REV GASTRO HEPAT, V15, P497, DOI 10.1038/s41575-018-0021-x; Rezaie A, 2007, DIGEST DIS SCI, V52, P2015, DOI 10.1007/s10620-006-9622-2; Richter CA, 2007, REPROD TOXICOL, V24, P199, DOI 10.1016/j.reprotox.2007.06.004; Rochester JR, 2013, REPROD TOXICOL, V42, P132, DOI 10.1016/j.reprotox.2013.08.008; Ross AC, 2011, ANNU REV NUTR, V31, P65, DOI 10.1146/annurev-nutr-072610-145127; Rudel RA, 2011, ENVIRON HEALTH PERSP, V119, P914, DOI 10.1289/ehp.1003170; Sakurai T, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aao4874; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; Sonis ST, 2004, NAT REV CANCER, V4, P277, DOI 10.1038/nrc1318; St Clair RM, 2018, FEBS J, V285, P72, DOI 10.1111/febs.14313; Su ST, 2017, J NUTR BIOCHEM, V40, P86, DOI 10.1016/j.jnutbio.2016.10.010; Taniguchi K, 2015, NATURE, V519, P57, DOI 10.1038/nature14228; Tars K, 2014, J MED CHEM, V57, P2213, DOI 10.1021/jm401603e; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; Vandenberg LN, 2009, ENDOCR REV, V30, P75, DOI 10.1210/er.2008-0021; Vanheel H, 2014, GUT, V63, P262, DOI 10.1136/gutjnl-2012-303857; Wang B, 2016, J NUTR, V146, P501, DOI 10.3945/jn.115.224857; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; Winking H, 2004, CYTOGENET GENOME RES, V105, P251, DOI 10.1159/000078196; Wu GY, 2014, ANNU REV ANIM BIOSCI, V2, P387, DOI 10.1146/annurev-animal-022513-114113; Xia W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090443; Yang CD, 2014, MOL CELL, V56, P414, DOI 10.1016/j.molcel.2014.09.025; Yin L, 2017, TOXICOL APPL PHARM, V314, P98, DOI 10.1016/j.taap.2016.11.013; Zangar RC, 2004, TOXICOL APPL PHARM, V199, P316, DOI 10.1016/j.taap.2004.01.018; Zhao ZG, 2019, BIOMED PHARMACOTHER, V111, P901, DOI 10.1016/j.biopha.2019.01.007; Zhou MX, 2018, EBIOMEDICINE, V35, P345, DOI 10.1016/j.ebiom.2018.08.035	66	4	4	2	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					7442	7461		10.1096/fj.201902503R	http://dx.doi.org/10.1096/fj.201902503R		APR 2020	20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32285985	hybrid			2022-12-28	WOS:000526105900001
J	Truong, AT; Hamada, K; Yamada, Y; Guo, H; Kikkawa, Y; Okamoto, CT; MacKay, JA; Nomizu, M				Anh Tan Truong; Hamada, Keisuke; Yamada, Yuji; Guo, Hao; Kikkawa, Yamato; Okamoto, Curtis T.; MacKay, J. Andrew; Nomizu, Motoyoshi			Evaluation of extracellular matrix mimetic laminin bioactive peptide and elastin-like polypeptide	FASEB JOURNAL			English	Article						biomaterial; elastin-like polypeptide; laminin peptide; synthetic biology; tissue engineering	CELL; MEMBRANES; ALPHA-1	The extracellular matrix (ECM) is comprised of a large network of proteins that are essential for tissue development and repair. A bioactive RGD-containing peptide from laminin alpha 1 chain, A99 (AGTFALRGDNPQG), promotes strong cell attachment and has demonstrated utility in cell culture and tissue engineering. Various materials can be utilized as a scaffold for bioactive peptides; however, it may be advantageous to design materials that use bioconjugation strategies that do not affect bioactivity, generate homogenous products, and can be produced at scale. This report is the first to compare the methods for preparing chemically conjugated and recombinant A99 to elastin-like polypeptides (ELPs) as the scaffold and characterize the biological and cell attachment activity using human dermal fibroblasts (HDFs). ELPs are biocompatible protein-polymers that are also thermo-responsive. Below a lower critical solution temperature (LCST), they are highly soluble. Above the LCST, ELPs phase separate into a polymer-rich liquid, known as a coacervate. Both chemically conjugated and recombinant fusion between A99 and an ELP (A99-ELP-R) show dose-dependent cell attachment. In addition, coating above the LCST provides better cell spreading compared to coating at 4 degrees C. ELPs provide an excellent structural framework for deposition of bioactive peptides of the ECM, and their intrinsic biophysical properties make laminin peptide-ELPs promising biomaterials for cell culture and tissue engineering.	[Anh Tan Truong; Guo, Hao; Okamoto, Curtis T.; MacKay, J. Andrew] Univ Southern Calif, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, 1985 Zonal Ave, Los Angeles, CA 90089 USA; [Anh Tan Truong; Hamada, Keisuke; Yamada, Yuji; Kikkawa, Yamato; Nomizu, Motoyoshi] Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Clin Biochem, 1432-1 Horinouchi, Hachioji, Tokyo 1920392, Japan; [MacKay, J. Andrew] Univ Southern Calif, Dept Biomed Engn, Los Angeles, CA 90089 USA; [MacKay, J. Andrew] Univ Southern Calif, Dept Ophthalmol, Los Angeles, CA 90089 USA	University of Southern California; Tokyo University of Pharmacy & Life Sciences; University of Southern California; University of Southern California	MacKay, JA (corresponding author), Univ Southern Calif, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, 1985 Zonal Ave, Los Angeles, CA 90089 USA.; Nomizu, M (corresponding author), Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Clin Biochem, 1432-1 Horinouchi, Hachioji, Tokyo 1920392, Japan.	jamackay@usc.edu; nomizu@toyaku.ac.jp		Truong, Anh/0000-0003-1033-1666; Hamada, Keisuke/0000-0002-7774-0790; Yamada, Yuji/0000-0003-2338-6906	MEXT \ Japan Society for the Promotion of Science (JSPS) [PE18045]; JSPS KAKENHI [17K07180, 18K06637]	MEXT \ Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	MEXT vertical bar Japan Society for the Promotion of Science (JSPS), Grant/Award Number: PE18045; JSPS KAKENHIJSPS KAKENHI, Grant/Award Number: 17K07180 and 18K06637	Akter M, 2016, 2016 INTERNATIONAL CONFERENCE ON NETWORKING SYSTEMS AND SECURITY (NSYSS), P101; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Despanie J, 2016, J CONTROL RELEASE, V240, P93, DOI 10.1016/j.jconrel.2015.11.010; Dhandhukia JP, 2017, BIOCONJUGATE CHEM, V28, P2715, DOI 10.1021/acs.bioconjchem.7b00469; Dreher MR, 2008, J AM CHEM SOC, V130, P687, DOI 10.1021/ja0764862; Durbeej M, 2010, CELL TISSUE RES, V339, P259, DOI 10.1007/s00441-009-0838-2; Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820; Fujimori C, 2017, BIOPOLYMERS, V108, DOI 10.1002/bip.22983; Ho J, 2017, ADV WOUND CARE, V6, P191, DOI 10.1089/wound.2016.0723; Iorio V, 2015, ADV WOUND CARE, V4, P250, DOI 10.1089/wound.2014.0533; Janib SM, 2014, POLYM CHEM-UK, V5, P1614, DOI 10.1039/c3py00537b; Janib SM, 2014, BIOMACROMOLECULES, V15, P2347, DOI 10.1021/bm401622y; Jeon WB, 2011, J BIOMED MATER RES A, V97A, P152, DOI 10.1002/jbm.a.33041; Kakinoki S, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2014.00052; Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094; Lanza R, 2014, PRINCIPLES OF TISSUE ENGINEERING, 4TH EDITION, P1; Malinda KM, 1999, FASEB J, V13, P53, DOI 10.1096/fasebj.13.1.53; McDaniel JR, 2010, BIOMACROMOLECULES, V11, P944, DOI 10.1021/bm901387t; McGowan KA, 2000, MICROSC RES TECHNIQ, V51, P262, DOI 10.1002/1097-0029(20001101)51:3<262::AID-JEMT6>3.0.CO;2-V; Meyer DE, 1999, NAT BIOTECHNOL, V17, P1112, DOI 10.1038/15100; Mochizuki M, 2003, FASEB J, V17, P875, DOI 10.1096/fj.02-0564fje; Mochizuki M, 2007, BIOPOLYMERS, V88, P122, DOI 10.1002/bip.20684; Nettles DL, 2010, ADV DRUG DELIVER REV, V62, P1479, DOI 10.1016/j.addr.2010.04.002; Nomizu M, 1998, J BIOL CHEM, V273, P32491, DOI 10.1074/jbc.273.49.32491; Olczyk P, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/747584; Sasaki T, 2004, J CELL BIOL, V164, P959, DOI 10.1083/jcb.200401058; Tunggal P, 2000, MICROSC RES TECHNIQ, V51, P214, DOI 10.1002/1097-0029(20001101)51:3<214::AID-JEMT2>3.0.CO;2-J; Wilkins MR, 1999, METH MOL B, V112, P531; Yamada H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149474; Zhu JM, 2011, EXPERT REV MED DEVIC, V8, P607, DOI [10.1586/ERD.11.27, 10.1586/erd.11.27]; Zhu YX, 2018, P NATL ACAD SCI USA, V115, P6816, DOI 10.1073/pnas.1804262115	31	2	2	2	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6729	6740		10.1096/fj.201902794R	http://dx.doi.org/10.1096/fj.201902794R		APR 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32248607				2022-12-28	WOS:000523600600001
J	Darche, M; Cossutta, M; Caruana, L; Houppe, C; Gilles, ME; Habert, D; Guilloneau, X; Vignaud, L; Paques, M; Courty, J; Cascone, I				Darche, Marie; Cossutta, Melissande; Caruana, Laure; Houppe, Claire; Gilles, Maud-Emmanuelle; Habert, Damien; Guilloneau, Xavier; Vignaud, Lucile; Paques, Michel; Courty, Jose; Cascone, Ilaria			Antagonist of nucleolin, N6L, inhibits neovascularization in mouse models of retinopathies	FASEB JOURNAL			English	Article						angiogenesis; choroidal neovascularization (CNV); oxygen-induced retinopathy (OIR); vascular endothelial growth factor (VEGF); nucleolin	OXYGEN-INDUCED RETINOPATHY; ENDOTHELIAL GROWTH-FACTOR; CELL-SURFACE; MULTIVALENT PSEUDOPEPTIDES; CANCER; BINDING; NEUTRALIZATION; PLEIOTROPHIN; PROGRESSION; DELIVERY	Retinal vascular diseases (RVD) have been identified as a major cause of blindness worldwide. These pathologies, including the wet form of age-related macular degeneration, retinopathy of prematurity, and diabetic retinopathy are currently treated by intravitreal delivery of anti-vascular endothelial growth factor (VEGF) agents. However, repeated intravitreal injections can lead to ocular complications and resistance to these treatments. Thus, there is a need to find new targeted therapies. Nucleolin regulates the endothelial cell (EC) activation and angiogenesis. In previous studies, we designed a pseudopeptide, N6L, that binds the nucleolin and blocks the tumor angiogenesis. In this study, the effect of N6L was investigated in two experimental models of retinopathies including oxygen-induced retinopathy (OIR) and choroidal neovascularization (CNV). We found that in mouse OIR, intraperitoneal injection of N6L is delivered to activated ECs and induced a 50% reduction of pathological neovascularization. The anti-angiogenic effect of N6L has been tested in CNV model in which the systemic injection of N6L induced a 33% reduction of angiogenesis. This effect is comparable to those obtained with VEGF-trap, a standard of care drug for RVD. Interestingly, with preventive and curative treatments, neoangiogenesis is inhibited by 59%. Our results have potential interest in the development of new therapies targeting other molecules than VEGF for RVD.	[Darche, Marie; Cossutta, Melissande; Caruana, Laure; Houppe, Claire; Gilles, Maud-Emmanuelle; Habert, Damien; Courty, Jose; Cascone, Ilaria] Univ Paris Est Creteil, CNRS, CRRET Lab, ERL 9215, 61 Ave Gen Gaulle, F-94010 Creteil, France; [Darche, Marie; Paques, Michel] Sorbonne Univ, Inst Hosp Univ ForeSight, Ctr Hosp Natl Quinze Vingts, Clin Invest Ctr 1423, Paris, France; [Guilloneau, Xavier; Vignaud, Lucile] Sorbonne Univ, Inst Vis, CNRS, INSERM, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite Gustave-Eiffel; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHNO des Quinze-Vingts; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Cascone, I (corresponding author), Univ Paris Est Creteil, CNRS, CRRET Lab, ERL 9215, 61 Ave Gen Gaulle, F-94010 Creteil, France.	ilaria.cascone@u-pec.fr	Guillonneau, xavier/E-3995-2017; guillonneau, xavier/AAF-9495-2021	Guillonneau, xavier/0000-0001-7379-3935; guillonneau, xavier/0000-0001-7379-3935; COSSUTTA, Melissande/0000-0001-5460-8386				Al-Latayfeh M, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006411; Berger CM, 2015, BIOCHIMIE, V113, P78, DOI 10.1016/j.biochi.2015.03.023; Birmpas C, 2012, BMC CELL BIOL, V13, DOI 10.1186/1471-2121-13-32; Bishop P, 1996, EYE, V10, P664, DOI 10.1038/eye.1996.159; Campochiaro PA, 2014, OPHTHALMOLOGY, V121, P1783, DOI 10.1016/j.ophtha.2014.03.021; Campochiaro PA, 2010, OPHTHALMOLOGY, V117, P1102, DOI 10.1016/j.ophtha.2010.02.021; Christian S, 2003, J CELL BIOL, V163, P871, DOI 10.1083/jcb.200304132; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; Cossutta M, 2019, ARTERIOSCL THROM VAS, V39, P1843, DOI 10.1161/ATVBAHA.119.313021; De Cola A, 2018, CANCER LETT, V412, P272, DOI 10.1016/j.canlet.2017.10.038; Destouches D, 2012, J BIOL CHEM, V287, P43685, DOI 10.1074/jbc.M112.380402; Destouches D, 2011, CANCER RES, V71, P3296, DOI 10.1158/0008-5472.CAN-10-3459; Destouches D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002518; Dhez AC, 2018, J CELL PHYSIOL, V233, P4091, DOI 10.1002/jcp.26205; Diamantopoulou Z, 2017, ONCOTARGET, V8, P90108, DOI 10.18632/oncotarget.21441; Fuma S, 2017, SCI REP-UK, V7, DOI 10.1038/srep43509; Gilles ME, 2016, CANCER RES, V76, P7181, DOI 10.1158/0008-5472.CAN-16-0300; Gioelli N, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aah4807; Hovanessian AG, 2000, EXP CELL RES, V261, P312, DOI 10.1006/excr.2000.5071; Hovanessian AG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015787; Keane PA, 2012, J OPHTHALMOL, V2012, DOI 10.1155/2012/483034; Koutsioumpa M, 2013, J BIOL CHEM, V288, P343, DOI 10.1074/jbc.M112.387076; Leaderer D, 2016, EXP EYE RES, V145, P380, DOI 10.1016/j.exer.2016.02.009; Legrand D, 2004, EUR J BIOCHEM, V271, P303, DOI 10.1046/j.1432-1033.2003.03929.x; Montassar F, 2017, FASEB J, V31, P1107, DOI 10.1096/fj.201600351R; Ng DS, 2017, SCI REP-UK, V7, DOI 10.1038/srep45081; Olsen TW, 2017, OPHTHALMOLOGY, V124, pE68, DOI 10.1016/j.ophtha.2017.03.066; Peters S, 2007, CYTOKINE, V40, P144, DOI 10.1016/j.cyto.2007.09.001; Presta M, 2009, EUR CYTOKINE NETW, V20, P39, DOI 10.1684/ecn.2009.0155; Quiroz-Mercado J, 2016, GRAEF ARCH CLIN EXP, V254, P1753, DOI 10.1007/s00417-016-3409-8; Sader M., 2015, J NANOMEDICINE NANOT, V6, P310; Said EA, 2005, FEBS J, V272, P4646, DOI 10.1111/j.1742-4658.2005.04870.x; Sampat KM, 2010, CURR OPIN OPHTHALMOL, V21, P178, DOI 10.1097/ICU.0b013e328338679a; Sato T, 2015, OSLI RETINA, V46, P87, DOI 10.3928/23258160-20150101-16; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shao Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069552; Shi HB, 2007, BLOOD, V110, P2899, DOI 10.1182/blood-2007-01-064428; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Stahl A, 2010, INVEST OPHTH VIS SCI, V51, P2813, DOI 10.1167/iovs.10-5176; Storkebaum E, 2004, J CLIN INVEST, V113, P14, DOI 10.1172/JCI200420682; Storkebaum E, 2004, BIOESSAYS, V26, P943, DOI 10.1002/bies.20092; TAKE M, 1994, J BIOCHEM-TOKYO, V116, P1063, DOI 10.1093/oxfordjournals.jbchem.a124628; Tate A, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-197; Turck N, 2006, J CELL PHYSIOL, V206, P545, DOI 10.1002/jcp.20501; Van Bergen T, 2017, EXP EYE RES, V165, P136, DOI 10.1016/j.exer.2017.09.012; Wang WW, 2017, ANGIOGENESIS, V20, P479, DOI 10.1007/s10456-017-9557-6; Zhu XM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115523	47	8	8	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5851	5862		10.1096/fj.201901876R	http://dx.doi.org/10.1096/fj.201901876R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32141122	Bronze			2022-12-28	WOS:000530242100069
J	Hemker, SL; Cerqueira, DM; Bodnar, AJ; Cargill, KR; Clugston, A; Anslow, MJ; Sims-Lucas, S; Kostka, D; Ho, J				Hemker, Shelby L.; Cerqueira, Debora M.; Bodnar, Andrew J.; Cargill, Kasey R.; Clugston, Andrew; Anslow, Melissa J.; Sims-Lucas, Sunder; Kostka, Dennis; Ho, Jacqueline			Deletion of hypoxia-responsive microRNA-210 results in a sex-specific decrease in nephron number	FASEB JOURNAL			English	Article						apoptosis; kidney development; microRNA-210	GENE-EXPRESSION; BRANCHING MORPHOGENESIS; PLACENTAL INSUFFICIENCY; KIDNEY DEVELOPMENT; MAMMALIAN KIDNEY; MIR-210 EXPRESSION; FLASH; MOUSE; INDUCTION; GROWTH	Low nephron number results in an increased risk of developing hypertension and chronic kidney disease. Intrauterine growth restriction is associated with a nephron deficit in humans, and is commonly caused by placental insufficiency, which results in fetal hypoxia. The underlying mechanisms by which hypoxia impacts kidney development are poorly understood. microRNA-210 is the most consistently induced microRNA in hypoxia and is known to promote cell survival in a hypoxic environment. In this study, the role of microRNA-210 in kidney development was evaluated using a global microRNA-210 knockout mouse. A male-specific 35% nephron deficit in microRNA-210 knockout mice was observed. Wnt/beta -catenin signaling, a pathway crucial for nephron differentiation, was misregulated in male kidneys with increased expression of the canonical Wnt target lymphoid enhancer binding factor 1. This coincided with increased expression of caspase-8-associated protein 2, a known microRNA-210 target and apoptosis signal transducer. Together, these data are consistent with a sex-specific requirement for microRNA-210 in kidney development.	[Hemker, Shelby L.; Cerqueira, Debora M.; Bodnar, Andrew J.; Cargill, Kasey R.; Clugston, Andrew; Anslow, Melissa J.; Sims-Lucas, Sunder; Ho, Jacqueline] Univ Pittsburgh, Sch Med, Dept Pediat, Div Nephrol, Pittsburgh, PA 15261 USA; [Hemker, Shelby L.; Cerqueira, Debora M.; Bodnar, Andrew J.; Cargill, Kasey R.; Clugston, Andrew; Anslow, Melissa J.; Sims-Lucas, Sunder; Kostka, Dennis; Ho, Jacqueline] UPMC Childrens Hosp Pittsburgh, Rangos Res Ctr, 4401 Penn Ave, Pittsburgh, PA 15224 USA; [Clugston, Andrew; Kostka, Dennis] Univ Pittsburgh, Sch Med, Dept Dev Biol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ho, J (corresponding author), UPMC Childrens Hosp Pittsburgh, Rangos Res Ctr, 4401 Penn Ave, Pittsburgh, PA 15224 USA.	jacqueline.ho2@chp.edu	Cerqueira, Debora Malta/AAB-6204-2020; Cerqueira, Debora Malta/CAF-4323-2022; Ho, Jackie/AAP-1531-2021	Ho, Jackie/0000-0001-7115-1381; Hemker, Shelby/0000-0002-9135-7042; Clugston, Andrew/0000-0002-8521-9452; Cargill, Kasey/0000-0003-3082-1937	NICHD NIH HHS [K12 HD052892] Funding Source: Medline; NIDDK NIH HHS [R44 DK116370, T32 DK061296, K01 DK096996, P30 DK079307, R03 DK110503, F31 DK116338, R01 DK103776] Funding Source: Medline; NIGMS NIH HHS [R01 GM115836] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aisa MC, 2016, PEDIATR NEPHROL, V31, P2277, DOI 10.1007/s00467-016-3484-4; Alexander BT, 2003, HYPERTENSION, V41, P457, DOI 10.1161/01.HYP.0000053448.95913.3D; Alm-Kristiansen AH, 2008, ONCOGENE, V27, P4644, DOI 10.1038/onc.2008.105; Barcaroli D, 2006, P NATL ACAD SCI USA, V103, P14808, DOI 10.1073/pnas.0604227103; Bard JBL, 2002, BIOESSAYS, V24, P72, DOI 10.1002/bies.10024; Baschat AA, 2004, BJOG-INT J OBSTET GY, V111, P1031, DOI 10.1111/j.1471-0528.2004.00273.x; Basson MA, 2006, DEV BIOL, V299, P466, DOI 10.1016/j.ydbio.2006.08.051; Baum M, 2018, PEDIATR NEPHROL, V33, P409, DOI 10.1007/s00467-016-3359-8; Bavelloni A, 2017, ANTICANCER RES, V37, P6511, DOI 10.21873/anticanres.12107; Bernhardt WM, 2006, KIDNEY INT, V69, P114, DOI 10.1038/sj.ki.5000062; Bertram JF, 2011, PEDIATR NEPHROL, V26, P1529, DOI 10.1007/s00467-011-1843-8; Brown AC, 2015, DEV CELL, V34, P229, DOI 10.1016/j.devcel.2015.06.021; Cargill K, 2019, J AM SOC NEPHROL, V30, P1192, DOI 10.1681/ASN.2018111170; Cebrian C, 2014, CELL REP, V7, P127, DOI 10.1016/j.celrep.2014.02.033; Cerqueira DM, 2017, FASEB J, V31, P3540, DOI 10.1096/fj.201700010R; Chan YC, 2012, MICROCIRCULATION, V19, P215, DOI 10.1111/j.1549-8719.2011.00154.x; Charlton JR, 2014, PEDIATR NEPHROL, V29, P2299, DOI 10.1007/s00467-014-2758-y; Chung E, 2017, DEVELOPMENT, V144, P4530, DOI 10.1242/dev.156661; Chung E, 2016, DEVELOPMENT, V143, P3907, DOI 10.1242/dev.143503; Cosmi E, 2011, J PREGNANCY, V2011, DOI 10.1155/2011/364381; Costantini F, 2010, DEV CELL, V18, P698, DOI 10.1016/j.devcel.2010.04.008; Cullen-McEwen Luise A, 2012, Methods Mol Biol, V886, P109, DOI 10.1007/978-1-61779-851-1_10; Dotsch J, 2016, CURR OPIN PEDIATR, V28, P188, DOI 10.1097/MOP.0000000000000312; EKBLOM P, 1981, J CELL BIOL, V91, P1, DOI 10.1083/jcb.91.1.1; Freeburg PB, 2003, J AM SOC NEPHROL, V14, P927, DOI 10.1097/01.ASN.0000059308.82322.4F; Gagnon R, 2003, EUR J OBSTET GYN R B, V110, pS99, DOI 10.1016/S0301-2115(03)00179-9; Gan L, 2017, MEDICINE, V96, DOI [10.1097/MD.0000000000007515, 10.1097/md.0000000000007515]; Gao XB, 2005, DEVELOPMENT, V132, P5437, DOI 10.1242/dev.02095; Greijer AE, 2005, J PATHOL, V206, P291, DOI 10.1002/path.1778; Halt K, 2014, PEDIATR NEPHROL, V29, P737, DOI 10.1007/s00467-013-2733-z; Hartman HA, 2007, DEV BIOL, V310, P379, DOI 10.1016/j.ydbio.2007.08.021; Ho J, 2014, FRONT PEDIATR, V2, DOI 10.3389/fped.2014.00128; Ho J, 2012, J AM SOC NEPHROL, V23, P400, DOI 10.1681/ASN.2011080797; Ho J, 2011, J AM SOC NEPHROL, V22, P1053, DOI 10.1681/ASN.2010080841; Hodeify R, 2013, AM J PHYSIOL-RENAL, V304, pF875, DOI 10.1152/ajprenal.00590.2012; Hoy WE, 2005, J AM SOC NEPHROL, V16, P2557, DOI 10.1681/ASN.2005020172; Huang X, 2009, MOL CELL, V35, P856, DOI 10.1016/j.molcel.2009.09.006; Hughson M, 2006, KIDNEY INT, V69, P671, DOI 10.1038/sj.ki.5000041; Imai Y, 1999, NATURE, V398, P777, DOI 10.1038/19709; Ivan M, 2014, ADV EXP MED BIOL, V772, P205, DOI 10.1007/978-1-4614-5915-6_10; Karner CM, 2011, DEVELOPMENT, V138, P1247, DOI 10.1242/dev.057646; Kim HW, 2009, J BIOL CHEM, V284, P33161, DOI 10.1074/jbc.M109.020925; Kiriyama M, 2009, MOL CELL BIOL, V29, P4729, DOI 10.1128/MCB.00289-09; KLEIN G, 1988, DEVELOPMENT, V102, P749; Kobayashi A, 2005, DEVELOPMENT, V132, P2809, DOI 10.1242/dev.01858; Kobayashi A, 2008, CELL STEM CELL, V3, P169, DOI 10.1016/j.stem.2008.05.020; Krawczynski K, 2016, PLACENTA, V47, P113, DOI 10.1016/j.placenta.2016.09.007; Krieghoff E, 2007, CELL CYCLE, V6, P771, DOI 10.4161/cc.6.7.4046; Li TY, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/3565613; Lindstrom NO, 2018, J AM SOC NEPHROL, V29, P806, DOI 10.1681/ASN.2017080890; Little MH, 2007, GENE EXPR PATTERNS, V7, P680, DOI 10.1016/j.modgep.2007.03.002; Liu LL, 2017, MOL MED, V23, DOI 10.2119/molmed.2017.00013; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorenzen JM, 2011, CLIN J AM SOC NEPHRO, V6, P1540, DOI 10.2215/CJN.00430111; Ma QY, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071356; Marrone AK, 2014, J AM SOC NEPHROL, V25, P1440, DOI 10.1681/ASN.2013040390; McCormick RI, 2013, BRIT J CANCER, V108, P1133, DOI 10.1038/bjc.2013.56; Milovic-Holm K, 2007, EMBO J, V26, P391, DOI 10.1038/sj.emboj.7601504; Mugford JW, 2009, DEV BIOL, V333, P312, DOI 10.1016/j.ydbio.2009.06.043; Muralimanoharan S, 2015, INT J OBESITY, V39, P1274, DOI 10.1038/ijo.2015.45; Murawski IJ, 2010, ORGANOGENESIS, V6, P189, DOI 10.4161/org.6.3.12125; Nakagawa N, 2015, KIDNEY INT, V87, P1125, DOI 10.1038/ki.2014.406; Natoli TA, 2004, DEV BIOL, V268, P429, DOI 10.1016/j.ydbio.2003.12.033; Nyengaard JR, 1999, J AM SOC NEPHROL, V10, P1100; O'Brien LL, 2016, DEVELOPMENT, V143, P595, DOI 10.1242/dev.127175; O'Brien LL, 2014, SEMIN CELL DEV BIOL, V36, P31, DOI 10.1016/j.semcdb.2014.08.014; Park JS, 2007, DEVELOPMENT, V134, P2533, DOI 10.1242/dev.006155; Park KM, 2004, J BIOL CHEM, V279, P52282, DOI 10.1074/jbc.M407629200; Paterson MR, 2019, KIDNEY INT, V96, P1332, DOI 10.1016/j.kint.2019.07.017; Phua YL, 2019, AM J PHYSIOL-RENAL, V316, pF993, DOI 10.1152/ajprenal.00450.2018; Phua YL, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.218; Plisov S, 2005, J AM SOC NEPHROL, V16, P1632, DOI 10.1681/ASN.2004060476; Pulkkinen K, 2008, FEBS LETT, V582, P2397, DOI 10.1016/j.febslet.2008.05.048; Qin LM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-320; Ransick A, 2019, DEV CELL, V51, P293; Ricardo AC, 2019, J AM SOC NEPHROL, V30, P137, DOI 10.1681/ASN.2018030296; Rutledge EA, 2017, DEVELOPMENT, V144, P3177, DOI 10.1242/dev.149112; Rymer C, 2014, AM J PHYSIOL-RENAL, V307, pF337, DOI 10.1152/ajprenal.00208.2014; Samaan S, 2015, J MOL DIAGN, V17, P136, DOI 10.1016/j.jmoldx.2014.10.005; Schmidt-Ott KM, 2008, KIDNEY INT, V74, P1004, DOI 10.1038/ki.2008.322; Short KM, 2014, DEV CELL, V29, P188, DOI 10.1016/j.devcel.2014.02.017; Simard M, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-25; Steinhart Z, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.146589; Walton SL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08365-4; Walton SL, 2018, J PHYSIOL-LONDON, V596, P5873, DOI 10.1113/JP275918; Wilkinson LJ, 2015, KIDNEY INT, V87, P975, DOI 10.1038/ki.2014.394; Wu H, 2019, J AM SOC NEPHROL, V30, P2159; Yi CH, 2009, DEV CELL, V16, P21, DOI 10.1016/j.devcel.2008.12.012	88	4	4	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5782	5799		10.1096/fj.201902767R	http://dx.doi.org/10.1096/fj.201902767R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32141129	Green Accepted, Bronze			2022-12-28	WOS:000530242100064
J	Barbe, MF; Hilliard, BA; Amin, M; Harris, MY; Hobson, LJ; Cruz, GE; Popoff, SN				Barbe, Mary F.; Hilliard, Brendan A.; Amin, Mamta; Harris, Michele Y.; Hobson, Lucas J.; Cruz, Geneva E.; Popoff, Steven N.			Blocking CTGF/CCN2 reduces established skeletal muscle fibrosis in a rat model of overuse injury	FASEB JOURNAL			English	Article						CCN2; extracellular matrix; overuse injury; TGF-beta; work-related musculoskeletal disorders	TISSUE GROWTH-FACTOR; SENSORIMOTOR DECLINES; HEPATIC-FIBROSIS; HIGH-REPETITION; SUBSTANCE-P; CCN FAMILY; TGF-BETA; EXPRESSION; CTGF; PROTEIN	Tissue fibrosis is a hallmark of overuse musculoskeletal injuries and contributes to functional declines. We tested whether inhibition of CCN2 (cellular communication network factor 2, previously known as connective tissue growth factor, CTGF) using a specific antibody (termed FG-3019 or pamrevlumab) reduces established overuse-induced muscle fibrosis in a clinically relevant rodent model of upper extremity overuse injury. Young adult rats performed a high repetition high force (HRHF) reaching and lever-pulling task for 18 weeks, after first being shaped for 6 weeks to learn this operant task. Rats were then euthanized (HRHF-Untreated), or rested and treated for 6 weeks with FG-3019 (HRHF-Rest/FG-3019) or a human IgG as a vehicle control (HRHF-Rest/IgG). HRHF-Untreated and HRHF-Rest/IgG rats had higher muscle levels of several fibrosis-related proteins (TGF beta 1, CCN2, collagen types I and III, and FGF2), and higher muscle numbers of alpha SMA and pERK immunopositive cells, compared to control rats. Each of these fibrogenic changes was restored to control levels by the blocking of CCN2 signaling in HRHF-Rest/FG-3019 rats, as were HRHF task-induced increases in serum CCN2 and pro-collagen I intact N-terminal protein. Levels of cleaved CCN3, an antifibrotic protein, were lowered in HRHF-Untreated and HRHF-Rest/IgG rats, compared to control rats, yet elevated back to control levels in HRHF-Rest/FG-3019 rats. Significant grip strength declines observed in HRHF-Untreated and HRHF-Rest/IgG rats, were restored to control levels in HRHF-Rest/FG-3019 rats. These results are highly encouraging for use of FG-3019 for therapeutic treatment of persistent skeletal muscle fibrosis, such as those induced with chronic overuse.	[Barbe, Mary F.; Hilliard, Brendan A.; Amin, Mamta; Harris, Michele Y.; Hobson, Lucas J.; Cruz, Geneva E.; Popoff, Steven N.] Temple Univ, Lewis Katz Sch Med, Dept Anat & Cell Biol, 3500 North Broad St, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Barbe, MF (corresponding author), Temple Univ, Lewis Katz Sch Med, Dept Anat & Cell Biol, 3500 North Broad St, Philadelphia, PA 19140 USA.	mary.barbe@temple.edu		Barbe, Mary/0000-0002-5235-9803	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) of the National Institutes of Health (NIH) [AR056019]	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Research reported in this publication was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) of the National Institutes of Health (NIH) under Award Number AR056019. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health	Abdelmagid SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038359; Barbe MF, 2019, J MUSCULOSKEL NEURON, V19, P396; Barbe MF, 2019, J ORTHOP RES, V37, P2004, DOI 10.1002/jor.24337; Barbe MF, 2018, BONE, V110, P267, DOI 10.1016/j.bone.2018.02.014; Barbe MF, 2013, J AM ACAD ORTHOP SUR, V21, P644, DOI 10.5435/JAAOS-21-10-644; Barr AE, 2002, PHYS THER, V82, P173, DOI 10.1093/ptj/82.2.173; Bartel F, 2012, INT J GYNECOL PATHOL, V31, P405, DOI 10.1097/PGP.0b013e31824d1891; Bechtel W, 2010, NAT MED, V16, P544, DOI 10.1038/nm.2135; Bickelhaupt S, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djw339; Bove GM, 2019, PAIN, V160, P632, DOI 10.1097/j.pain.0000000000001443; Bove GM, 2016, J NEUROL SCI, V361, P168, DOI 10.1016/j.jns.2015.12.029; Brenner MC, 2016, PHARM RES-DORDR, V33, P1833, DOI 10.1007/s11095-016-1918-0; Brigstock DR, 1999, ENDOCR REV, V20, P189, DOI 10.1210/er.20.2.189; Choi J, 2013, J BIOL CHEM, V288, P23075, DOI 10.1074/jbc.M113.475418; Clark BD, 2004, J ORTHOP SPORT PHYS, V34, P244, DOI 10.2519/jospt.2004.34.5.244; Driscoll M, 2011, J BODYW MOV THER, V15, P335, DOI 10.1016/j.jbmt.2010.05.002; Fisher PW, 2015, J CELL COMMUN SIGNAL, V9, P37, DOI 10.1007/s12079-015-0263-0; Foglia B, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20112700; Frara N, 2018, CONNECT TISSUE RES, V59, P30, DOI 10.1080/03008207.2017.1297809; Morales MG, 2013, HUM MOL GENET, V22, P4938, DOI 10.1093/hmg/ddt352; Morales MG, 2011, J PATHOL, V225, P490, DOI 10.1002/path.2952; George J, 2007, GENE THER, V14, P790, DOI 10.1038/sj.gt.3302929; Gonzalez D, 2018, HUM MOL GENET, V27, P2913, DOI 10.1093/hmg/ddy204; Iannarone Victoria J., 2019, Journal of Biological Methods, V6, pe117, DOI 10.14440/jbm.2019.289; Ito Y, 2010, AM J PHYSIOL-RENAL, V299, pF545, DOI 10.1152/ajprenal.00120.2009; Jain NX, 2014, J MUSCULOSKEL NEURON, V14, P78; Kaasboll OJ, 2018, J BIOL CHEM, V293, P17953, DOI 10.1074/jbc.RA118.004559; Kietrys DM, 2011, J MOTOR BEHAV, V43, P465, DOI 10.1080/00222895.2011.627897; Kivela R, 2007, J APPL PHYSIOL, V103, P1395, DOI 10.1152/japplphysiol.00531.2007; Klinkhammer BM, 2017, ADV CHRONIC KIDNEY D, V24, P117, DOI 10.1053/j.ackd.2016.11.002; Kyurkchiev Stanimir, 2004, Cell Commun Signal, V2, P9, DOI 10.1186/1478-811X-2-9; Leask A, 2015, J CELL COMMUN SIGNAL, V9, P97, DOI 10.1007/s12079-015-0281-y; Lin N, 2011, AM J PHYSIOL-CELL PH, V301, pC469, DOI 10.1152/ajpcell.00452.2010; Lipson KE, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S24; Mahdy MAA, 2019, CELL TISSUE RES, V375, P575, DOI 10.1007/s00441-018-2955-2; Makino K, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1356-3; Mann CJ, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-21; Nakama LH, 2006, J ORTHOP RES, V24, P393, DOI 10.1002/jor.20053; NIOSH, 2011, NAT MAN AG JUN 2010; Ohara Yuuki, 2018, Oncotarget, V9, P18494, DOI 10.18632/oncotarget.24892; Pedersen BK, 2001, EXERC IMMUNOL REV, V7, P18; Pendurthi UR, 2005, CANCER RES, V65, P9705, DOI 10.1158/0008-5472.CAN-05-0982; Peng L, 2019, NEUROPEPTIDES, V76, DOI 10.1016/j.npep.2019.101941; Perbal B, 2001, J CLIN PATHOL-MOL PA, V54, P57, DOI 10.1136/mp.54.2.57; Perbal B, 2019, J CELL COMMUN SIGNAL, V13, P1, DOI 10.1007/s12079-019-00506-w; Perbal B, 2018, J CELL COMMUN SIGNAL, V12, P1, DOI 10.1007/s12079-018-0460-8; PICOZZI VJ, 2017, J CANC CLIN TRIALS, V2, P1; Rani S, 2010, J CELL PHYSIOL, V225, P152, DOI 10.1002/jcp.22208; Richeldi L, 2020, LANCET RESP MED, V8, P25, DOI 10.1016/S2213-2600(19)30262-0; Riser BL, 2015, J CELL COMMUN SIGNAL, V9, P327, DOI 10.1007/s12079-015-0309-3; Riser BL, 2009, AM J PATHOL, V174, P1725, DOI 10.2353/ajpath.2009.080241; Sakai N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05624-2; Sato S, 2000, J RHEUMATOL, V27, P149; Schild C, 2004, BBA-MOL CELL RES, V1691, P33, DOI 10.1016/j.bbamcr.2003.12.001; Sisco M, 2008, WOUND REPAIR REGEN, V16, P661, DOI 10.1111/j.1524-475X.2008.00416.x; Song JJ, 2007, J CELL PHYSIOL, V210, P398, DOI 10.1002/jcp.20850; Stauber WT, 1996, MUSCLE NERVE, V19, P423, DOI 10.1002/mus.880190402; Stauber WT, 2000, MUSCLE NERVE, V23, P1819, DOI 10.1002/1097-4598(200012)23:12<1819::AID-MUS4>3.0.CO;2-2; Su BY, 2001, J CLIN PATHOL-MOL PA, V54, P184, DOI 10.1136/mp.54.3.184; Tamura I, 2001, AM J PHYSIOL-CELL PH, V281, pC1524, DOI 10.1152/ajpcell.2001.281.5.C1524; Wang QJ, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-4; Wells AU, 2020, LANCET RESP MED, V8, P2, DOI 10.1016/S2213-2600(19)30339-X; Xin DL, 2017, BMC NEUROSCI, V18, DOI 10.1186/s12868-017-0354-3; Yang HW, 2010, ACTA OPHTHALMOL, V88, P652, DOI 10.1111/j.1755-3768.2009.01641.x; Zhang FQ, 2015, J BIOL CHEM, V290, P8232, DOI 10.1074/jbc.M114.623074; Zhao Z, 2015, IN VITRO CELL DEV-AN, V51, P941, DOI 10.1007/s11626-015-9914-y; Zoheiry Mona M, 2015, Electron Physician, V7, P1626, DOI 10.19082/1626; Zugel M, 2018, BRIT J SPORT MED, V52, P1497, DOI 10.1136/bjsports-2018-099308	68	25	25	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6554	6569		10.1096/fj.202000240RR	http://dx.doi.org/10.1096/fj.202000240RR		MAR 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32227398	hybrid, Green Published			2022-12-28	WOS:000522484900001
J	Gao, J; Dai, C; Yu, X; Yin, XB; Zhou, F				Gao, Jun; Dai, Chao; Yu, Xin; Yin, Xiang-Bao; Zhou, Fan			Long noncoding RNA LINC00324 exerts protumorigenic effects on liver cancer stem cells by upregulating fas ligand via PU box binding protein	FASEB JOURNAL			English	Article						fas ligand; hepatocellular carcinoma; liver cancer stem cells; long noncoding RNA LINC00324; PU box binding protein; transcription factor	HEPATOCELLULAR-CARCINOMA CELLS; PROMOTES PROLIFERATION; EXPRESSION; APOPTOSIS; ACTIVATION; PATHWAY; GROWTH; AXIS; HUR	Hepatocellular carcinoma (HCC) represents a major cause of cancer death, but the molecular mechanism for its development has not yet been well characterized. Long noncoding RNAs (lncRNAs) are involved in a wide range of biological processes via their roles as oncogenes or tumor suppressor genes. The present study aimed to elucidate the role of LINC00324 in HCC through its interaction with Fas ligand (FasL). Initially, microarray-based gene expression profiling of HCC was employed to identify differentially expressed genes. Next, the expression of LINC00324 in HCC tissues and liver cancer stem cell (LCSC) lines was examined using RT-qPCR. Then, the interaction among LINC00324, PU box binding protein (PU.1) and FasL was identified with RIP, ChIP and dual-luciferase reporter gene assays. The effect of LINC00324 on viability, proliferation, migration, invasion, and apoptosis as well as the tumorigenesis of transfected cells was examined with gain- and loss-of-function experiments. LINC00324 and FasL were highly expressed in HCC. LINC00324 regulated FasL expression via interaction with PU.1. Silencing of LINC00324 or FasL suppressed expression of stemness-related genes, cell viability, proliferation, migration, invasion, self-renewal, and tumorigenesis, but enhanced cell apoptosis. Taken together, LINC00324 promotes the expression of FasL through the recruitment of PU.1, which ultimately maintains the biological properties of LCSCs, thus, highlighting LINC00324 as a promising therapeutic candidate for HCC.	[Gao, Jun; Dai, Chao; Yu, Xin; Yin, Xiang-Bao; Zhou, Fan] Nanchang Univ, Affiliated Hosp 2, Dept Hepatobiliary & Pancreat Surg, 1 Mingde Rd, Nanchang 330006, Jiangxi, Peoples R China	Nanchang University	Zhou, F (corresponding author), Nanchang Univ, Affiliated Hosp 2, Dept Hepatobiliary & Pancreat Surg, 1 Mingde Rd, Nanchang 330006, Jiangxi, Peoples R China.	nczhoufan@hotmail.com			Key Foundation of Jiangxi Provincial Science and Technology Departement [20171ACB21064]; Youth Science Foundation of Jiangxi Provincial Science and Technology Department [20151BAB205105]; Jiangxi Provincial Science and Technology Planning Project [20141BBG70042]; Science Planning Project of Jiangxi Provincial Education Department [GJJ14049]	Key Foundation of Jiangxi Provincial Science and Technology Departement; Youth Science Foundation of Jiangxi Provincial Science and Technology Department; Jiangxi Provincial Science and Technology Planning Project; Science Planning Project of Jiangxi Provincial Education Department	Key Foundation of Jiangxi Provincial Science and Technology Departement, Grant/Award Number: 20171ACB21064; Youth Science Foundation of Jiangxi Provincial Science and Technology Department, Grant/Award Number: 20151BAB205105; Jiangxi Provincial Science and Technology Planning Project, Grant/Award Number: 20141BBG70042; Science Planning Project of Jiangxi Provincial Education Department, Grant/Award Number: GJJ14049	Aboelenein HR, 2017, GROWTH FACTORS, V35, P49, DOI 10.1080/08977194.2017.1345900; Braconi C, 2012, CURR CANCER DRUG TAR, V12, P1073; Bruix J, 2016, GASTROENTEROLOGY, V150, P835, DOI 10.1053/j.gastro.2015.12.041; Chandrashekar DS, 2017, NEOPLASIA, V19, P649, DOI 10.1016/j.neo.2017.05.002; Chen Y, 2019, J CELL PHYSIOL, V234, P606, DOI 10.1002/jcp.26803; Ding LJ, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101617; Dong YY, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0394-z; Dou CH, 2017, INT J ONCOL, V51, P1775, DOI 10.3892/ijo.2017.4159; Fang Jia-Ying, 2015, Asian Pac J Cancer Prev, V16, P1959; Feng YJ, 2019, BIOCHEM BIOPH RES CO, V513, P56, DOI 10.1016/j.bbrc.2019.03.079; Gao YZ, 2016, BIOCHEM BIOPH RES CO, V480, P348, DOI 10.1016/j.bbrc.2016.10.048; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gong J, 2018, CLIN LAB, V64, P1193, DOI 10.7754/Clin.Lab.2018.180136; Gu Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep18587; Li HY, 2015, ONCOTARGET, V6, P27847, DOI 10.18632/oncotarget.4443; Li JJ, 2015, GENET MOL RES, V14, P4150, DOI 10.4238/2015.April.27.30; Liu Q, 2017, ICERI PROC, P300; Luo P, 2017, CANCER BIOMARK, V18, P285, DOI 10.3233/CBM-160305; Ma YJ, 2016, DNA CELL BIOL, V35, P296, DOI 10.1089/dna.2015.3203; Militello G, 2017, BRIEF BIOINFORM, V18, P780, DOI 10.1093/bib/bbw053; Mohankumar S, 2016, BRIEF FUNCT GENOMICS, V15, P249, DOI 10.1093/bfgp/elv058; Nio K, 2015, J HEPATOL, V63, P1164, DOI 10.1016/j.jhep.2015.06.009; Pang SHM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01264; Parasramka Mansi A, 2016, Stem Cell Investig, V3, P1, DOI 10.3978/j.issn.2306-9759.2016.01.01; Rodriguez-Hernandez MA, 2019, J CELL PHYSIOL, V234, P692, DOI 10.1002/jcp.26855; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Song Li-Jie, 2015, Asian Pac J Cancer Prev, V16, P3667; Takahashi K, 2014, FEBS OPEN BIO, V4, P458, DOI 10.1016/j.fob.2014.04.007; Wang F, 2014, HEPATOLOGY, V60, P1278, DOI 10.1002/hep.27239; Wang MH, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0013-8; Wang WZ, 2013, LIFE SCI, V92, P352, DOI 10.1016/j.lfs.2013.01.013; Wang YY, 2015, CELL STEM CELL, V16, P413, DOI 10.1016/j.stem.2015.03.003; Wang Yong, 2012, Zhonghua Yi Xue Za Zhi, V92, P3434; Xiao CH, 2016, BIOSCI TRENDS, V10, P378, DOI 10.5582/bst.2016.01123; Yamashita T, 2013, J CLIN INVEST, V123, P1911, DOI 10.1172/JCI66024; Zhang SJ, 2017, INT J ONCOL, V50, P805, DOI 10.3892/ijo.2017.3855; Zhang YP, 2015, INT J CLIN EXP PATHO, V8, P15677; Zhu HF, 2015, MOL CANCER RES, V13, P809, DOI 10.1158/1541-7786.MCR-14-0241; Zhuang JL, 2017, THERANOSTICS, V7, P3053, DOI 10.7150/thno.19542; Zou ZG, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0758-8	40	18	18	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5800	5817		10.1096/fj.201902705RR	http://dx.doi.org/10.1096/fj.201902705RR		MAR 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32128906	Bronze			2022-12-28	WOS:000517935600001
J	Guo, W; Abou Ghayda, R; Schmidt, PJ; Fleming, MD; Bhasin, S				Guo, Wen; Abou Ghayda, Ramy; Schmidt, Paul J.; Fleming, Mark D.; Bhasin, Shalender			The role of iron in mediating testosterone's effects on erythropoiesis in mice	FASEB JOURNAL			English	Article						androgens; erythropoietin resistance; ineffective erythropoiesis; iron; iron deficiency	TRANSFERRIN RECEPTOR 2; CELL PRODUCTION; HEALTHY-YOUNG; DEFICIENCY; HEPCIDIN; MEN; ANEMIA; PROGENITORS; HEMOGLOBIN; ANDROGENS	Testosterone stimulates iron-dependent erythropoiesis and suppresses hepcidin. To clarify the role of iron in mediating testosterone's effects on erythropoiesis, we induced iron deficiency in mice by feeding low iron diet. Iron-replete and iron-deficient mice were treated weekly with testosterone propionate or vehicle for 3 weeks. Testosterone treatment increased red cell count in iron-replete mice, but, surprisingly, testosterone reduced red cell count in iron-deficient mice. Splenic stress erythropoiesis was stimulated in iron-deficient mice relative to iron-replete mice, and further increased by testosterone treatment, as indicated by the increase in red pulp area, the number of nucleated erythroblasts, and expression levels of TfR1, GATA1, and other erythroid genes. Testosterone treatment of iron-deficient mice increased the ratio of early-to-late erythroblasts in the spleen and bone marrow, and serum LDH level, consistent with ineffective erythropoiesis. In iron-deficient mice, erythropoietin levels were higher but erythropoietin-regulated genes were generally downregulated relative to iron-replete mice, suggesting erythropoietin resistance. Conclusion: Testosterone treatment stimulates splenic stress erythropoiesis in iron-replete as well as iron-deficient mice. However, testosterone worsens anemia in iron-deficient mice because of ineffective erythropoiesis possibly due to erythropoietin resistance associated with iron deficiency. Iron plays an important role in mediating testosterone's effects on erythropoiesis.	[Guo, Wen; Abou Ghayda, Ramy; Bhasin, Shalender] Harvard Med Sch, Res Program Mens Hlth Aging & Metab, Boston Claude D Pepper Older Amer Independence Ct, Brigham & Womens Hosp, Boston, MA 02115 USA; [Schmidt, Paul J.; Fleming, Mark D.] Harvard Med Sch, Dept Pathol, Boston Childrens Hosp, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School	Bhasin, S (corresponding author), Harvard Med Sch, Res Program Mens Hlth Aging & Metab, Boston Claude D Pepper Older Amer Independence Ct, Brigham & Womens Hosp, Boston, MA 02115 USA.	sbhasin@bwh.harvard.edu			HHS \ NIH \ National Institute on Aging (NIA) [AG031679]	HHS \ NIH \ National Institute on Aging (NIA)	HHS vertical bar NIH vertical bar National Institute on Aging (NIA), Grant/Award Number: AG031679	Alves Michelle Teodoro, 2015, Rev. Bras. Hematol. Hemoter., V37, P190, DOI 10.1016/j.bjhh.2015.02.001; Bachman E, 2014, J GERONTOL A-BIOL, V69, P725, DOI 10.1093/gerona/glt154; Bachman E, 2010, J CLIN ENDOCR METAB, V95, P4743, DOI 10.1210/jc.2010-0864; BESA EC, 1981, ENDOCRINOLOGY, V109, P1983; Bhasin S, 2005, J CLIN ENDOCR METAB, V90, P678, DOI 10.1210/jc.2004-1184; Bhasin S, 2001, AM J PHYSIOL-ENDOC M, V281, pE1172, DOI 10.1152/ajpendo.2001.281.6.E1172; Carrero JJ, 2012, NEPHROL DIAL TRANSPL, V27, P709, DOI 10.1093/ndt/gfr288; Cigarran S, 2017, NEFROLOGIA, V37, P526, DOI 10.1016/j.nefro.2017.03.014; Coviello AD, 2008, J CLIN ENDOCR METAB, V93, P914, DOI 10.1210/jc.2007-1692; Dousdampanis P, 2014, THER APHER DIAL, V18, P220, DOI 10.1111/1744-9987.12101; Ekart R, 2014, ARTIF ORGANS, V38, P598, DOI 10.1111/aor.12218; Forejtnikova H, 2010, BLOOD, V116, P5357, DOI 10.1182/blood-2010-04-281360; Gardner F H, 1973, Trans Am Clin Climatol Assoc, V84, P60; GARDNER FH, 1961, NEW ENGL J MED, V264, P103, DOI 10.1056/NEJM196101192640301; GARDNER FH, 1961, ARCH INTERN MED, V107, P846, DOI 10.1001/archinte.1961.03620060046007; Gibson JN, 2011, MAMM GENOME, V22, P556, DOI 10.1007/s00335-011-9344-4; GORIS H, 1990, EXP HEMATOL, V18, P400; Guo W, 2020, ANDROLOGY-US, V8, P82, DOI 10.1111/andr.12622; Guo W, 2016, ENDOCRINOLOGY, V157, P2937, DOI 10.1210/en.2016-1150; Guo W, 2014, J GERONTOL A-BIOL, V69, P505, DOI 10.1093/gerona/glt127; Guo W, 2013, AGING CELL, V12, P280, DOI 10.1111/acel.12052; HAURANI FI, 1967, AM J MED, V42, P151, DOI 10.1016/0002-9343(67)90013-7; JANSSON LT, 1985, BLOOD, V65, P959; KENNEDY BJ, 1966, CANCER, V19, P1205, DOI 10.1002/1097-0142(196609)19:9<1205::AID-CNCR2820190905>3.0.CO;2-V; KENNEDY BJ, 1957, NEW ENGL J MED, V256, P719, DOI 10.1056/NEJM195704182561601; KENNEDY BJ, 1962, ANN INTERN MED, V57, P917, DOI 10.7326/0003-4819-57-6-917; Khalil S, 2018, J EXP MED, V215, P661, DOI 10.1084/jem.20170396; Kina T, 2000, BRIT J HAEMATOL, V109, P280, DOI 10.1046/j.1365-2141.2000.02037.x; Koulnis M, 2011, JOVE-J VIS EXP, DOI 10.3791/2809; Latour C, 2014, HEPATOLOGY, V59, P683, DOI 10.1002/hep.26648; LEVENTHAL B, 1966, PEDIATRICS, V37, P62; Liu J, 2013, BLOOD, V121, pE43, DOI 10.1182/blood-2012-09-456079; Maggio M, 2013, ANDROLOGY-US, V1, P24, DOI 10.1111/j.2047-2927.2012.00009.x; Malgor L. A., 1998, Acta Physiologica Pharmacologica et Therapeutica Latinoamericana, V48, P99; Nai A, 2015, BLOOD, V125, P1170, DOI 10.1182/blood-2014-08-596254; NIJHOF W, 1993, EXP HEMATOL, V21, P496; PANTEL K, 1990, CELL TISSUE KINET, V23, P283, DOI 10.1111/j.1365-2184.1990.tb01125.x; RISHPONM.N, 1968, BLOOD, V31, P453, DOI 10.1182/blood.V31.4.453.453; Roy CN, 2017, JAMA INTERN MED, V177, P480, DOI 10.1001/jamainternmed.2016.9540; Schreiber T, 2006, SHOCK, V26, P271, DOI 10.1097/01.shk0000225856.32260.0d; Suzuki M, 2009, MOL CELL BIOL, V29, P1163, DOI 10.1128/MCB.01572-08; Suzuki N, 2003, BLOOD, V102, P3575, DOI 10.1182/blood-2003-04-1154; THOMSEN K, 1986, ACTA PAEDIATR SCAND, V75, P793, DOI 10.1111/j.1651-2227.1986.tb10292.x; Wallace DF, 2015, BRIT J HAEMATOL, V168, P891, DOI 10.1111/bjh.13225; Yanagisawa H, 2009, TOXICOL LETT, V191, P15, DOI 10.1016/j.toxlet.2009.07.024	45	4	4	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					11672	11684		10.1096/fj.202000920RR	http://dx.doi.org/10.1096/fj.202000920RR		JUL 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32667087	Bronze			2022-12-28	WOS:000553017500001
J	Weber, M; Mera, P; Casas, J; Salvador, J; Rodriguez, A; Alonso, S; Sebastian, D; Soler-Vazquez, MC; Montironi, C; Recalde, S; Fucho, R; Calderon-Dominguez, M; Mir, JF; Bartrons, R; Escola-Gil, JC; Sanchez-Infantes, D; Zorzano, A; Llorente-Cortes, V; Casals, N; Valenti, V; Fruhbeck, G; Herrero, L; Serra, D				Weber, Mineia; Mera, Paula; Casas, Josefina; Salvador, Javier; Rodriguez, Amaia; Alonso, Sergio; Sebastian, David; Carmen Soler-Vazquez, M.; Montironi, Carla; Recalde, Sandra; Fucho, Raquel; Calderon-Dominguez, Maria; Francesc Mir, Joan; Bartrons, Ramon; Carles Escola-Gil, Joan; Sanchez-Infantes, David; Zorzano, Antonio; Llorente-Cortes, Vicenta; Casals, Nuria; Valenti, Victor; Fruhbeck, Gema; Herrero, Laura; Serra, Dolors			Liver CPT1A gene therapy reduces diet-induced hepatic steatosis in mice and highlights potential lipid biomarkers for human NAFLD	FASEB JOURNAL			English	Article						AAV; CPT1A; fatty-acid oxidation; gene therapy; hepatic steatosis; lipid biomarker; obesity	CARNITINE PALMITOYLTRANSFERASE-I; INSULIN-RESISTANCE; UNCOUPLING PROTEIN-2; GASTRIC BYPASS; METABOLISM; EXPRESSION; AUTOPHAGY; OBESITY; SENSITIVITY; INHIBITION	The prevalence of nonalcoholic fatty liver disease (NAFLD) has increased drastically due to the global obesity pandemic but at present there are no approved therapies. Here, we aimed to revert high-fat diet (HFD)-induced obesity and NAFLD in mice by enhancing liver fatty acid oxidation (FAO). Moreover, we searched for potential new lipid biomarkers for monitoring liver steatosis in humans. We used adeno-associated virus (AAV) to deliver a permanently active mutant form of human carnitine palmitoyltransferase 1A (hCPT1AM), the key enzyme in FAO, in the liver of a mouse model of HFD-induced obesity and NAFLD. Expression of hCPT1AM enhanced hepatic FAO and autophagy, reduced liver steatosis, and improved glucose homeostasis. Lipidomic analysis in mice and humans before and after therapeutic interventions, such as hepatic AAV9-hCPT1AM administration and RYGB surgery, respectively, led to the identification of specific triacylglyceride (TAG) specie (C50:1) as a potential biomarker to monitor NAFFLD disease. To sum up, here we show for the first time that liver hCPT1AM gene therapy in a mouse model of established obesity, diabetes, and NAFLD can reduce HFD-induced derangements. Moreover, our study highlights TAG (C50:1) as a potential noninvasive biomarker that might be useful to monitor NAFLD in mice and humans.	[Weber, Mineia; Mera, Paula; Carmen Soler-Vazquez, M.; Recalde, Sandra; Fucho, Raquel; Calderon-Dominguez, Maria; Francesc Mir, Joan; Herrero, Laura; Serra, Dolors] Univ Barcelona, Inst Biomed Univ Barcelona IBUB, Sch Pharm & Food Sci, Dept Biochem & Physiol, Barcelona, Spain; [Mera, Paula; Salvador, Javier; Rodriguez, Amaia; Sanchez-Infantes, David; Casals, Nuria; Fruhbeck, Gema; Herrero, Laura; Serra, Dolors] Inst Salud Carlos III, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Madrid, Spain; [Casas, Josefina] CSIC, Dept Biol Chem, Res Unit BioAct Mol, Inst Adv Chem Catalonia IQAC, Barcelona, Spain; [Casas, Josefina] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Madrid, Spain; [Salvador, Javier] Clin Univ Navarra, Dept Endocrinol & Nutr, Pamplona, Spain; [Rodriguez, Amaia; Valenti, Victor; Fruhbeck, Gema] Clin Univ Navarra, Metab Res Lab, IdiSNA, Pamplona, Spain; [Alonso, Sergio] Germans Trias & Pujol Res Inst IGTP PMPPC, Program Predict & Personalized Med Canc, Canc Genet & Epigenet Grp, Campus Can Ruti, Barcelona, Spain; [Sebastian, David; Zorzano, Antonio] Univ Barcelona, Barcelona Inst Sci & Technol, Inst Res Biomed IRB Barcelona, Fac Biol,Dept Bioquim & Biomed Mol, Barcelona, Spain; [Sebastian, David; Carles Escola-Gil, Joan; Zorzano, Antonio] Inst Salud Carlos III, Ctr Invest Biomed Red Diabet & Enfermedades Metab, Madrid, Spain; [Montironi, Carla] Hosp Clin Barcelona, Pathol Dept, Barcelona, Spain; [Montironi, Carla] Univ Barcelona, IDIBAPS Hosp Clin, Liver Unit, Liver Canc Translat Res Lab, Barcelona, Spain; [Bartrons, Ramon] Univ Barcelona, Fac Med & Ciencies Salut, Dept Ciencies Fisiol, Barcelona, Spain; [Carles Escola-Gil, Joan] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, IIB St Pau, Barcelona, Spain; [Sanchez-Infantes, David] Germans Trias & Pujol Res Inst IGTP PMPPC, Campus Can Ruti, Barcelona, Spain; [Llorente-Cortes, Vicenta] CSIC, Biomed Res Inst St Pau IIB St Pau, Inst Biomed Res Barcelona IIBB, Barcelona, Spain; [Llorente-Cortes, Vicenta] Inst Hlth Carlos III, CIBERCV, Madrid, Spain; [Llorente-Cortes, Vicenta] CSIC ICCC, Cardiovasc Res Ctr, Barcelona, Spain; [Casals, Nuria] Univ Int Catalunya, Fac Med & Hlth Sci, Basic Sci Dept, Sant Cugat Del Valles, Spain; [Valenti, Victor] Clin Univ Navarra, Dept Surg, Pamplona, Spain	University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion y Desarrollo Pascual Vila (CID-CSIC); CSIC - Instituto de Quimica Avanzada de Cataluna (IQAC); CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Instituto de Salud Carlos III; University of Navarra; University of Navarra; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Instituto de Salud Carlos III; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas de Barcelona (IIBB); CIBER - Centro de Investigacion Biomedica en Red; CIBERCV; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institut Catala de Ciencies Cardiovasculars (ICCC); Universitat Internacional de Catalunya (UIC); University of Navarra	Serra, D (corresponding author), Univ Barcelona, Dept Biochem & Physiol, Sch Pharm & Food Sci, Av Joan XXIII 27-31, E-08028 Barcelona, Spain.	dserra@ub.edu	Sebastián, David/ABH-1574-2020; Soler-Vázquez, MCarmen/AAH-8811-2021; Herrero, Laura/ABH-7724-2020; Casas, Josefina/L-7934-2014; Alonso, Sergio/G-5145-2011; Escolà-Gil, Joan Carles/H-9522-2014; Calderon-Dominguez, Maria/AAU-3721-2020; Blattes, Minéia Weber/N-4805-2018; Alonso, Sergio/GVR-8346-2022	Soler-Vázquez, MCarmen/0000-0003-1430-5617; Herrero, Laura/0000-0003-4244-4673; Alonso, Sergio/0000-0001-6497-892X; Calderon-Dominguez, Maria/0000-0003-1797-3450; Blattes, Minéia Weber/0000-0001-5496-3679; valenti, victor/0000-0002-7074-2849; Sebastian, David/0000-0002-7260-3869; Montironi, Carla/0000-0002-1453-2193; Escola-Gil, Joan Carles/0000-0001-9021-2485; Recalde, Sandra/0000-0002-6174-0649	Ministry of Spain (MINECO) (European Regional Development Fund [ERDF]) [SAF2014-52223-C2-1-R, SAF201783813-C3-1-R, SAF2017-82813-C3-3R]; Ministry of Spain (MINECO) (Juan de la Cierva-Incorporacion research fellowship) [IJCI2016-28313]; Centro de Investigacion Biomedica en Red de Fisiopatologia de la Obesidad y la Nutricion (CIBEROBN) [CB06/03/0001]; Government of Catalonia [2014SGR465]; Instituto de Salud Carlos III [FISPI18/01584, FIS-PI17/00412, FIS PI18/01484, FIS17/01455, CP15/00106, CM19/00039]; European Regional Development Fund (ERDF); Fundacio La Marato de TV3 [201627-30, 201627-31]; European Foundation for the Study of Diabetes (EFSD)/Lilly and EFSD/Janssen-Rising Star; L'Oreal-UNESCO "For Women in Science"; Ciencia sem Fronteiras-CNPq [237976/2012-9]	Ministry of Spain (MINECO) (European Regional Development Fund [ERDF]); Ministry of Spain (MINECO) (Juan de la Cierva-Incorporacion research fellowship); Centro de Investigacion Biomedica en Red de Fisiopatologia de la Obesidad y la Nutricion (CIBEROBN); Government of Catalonia(Generalitat de Catalunya); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); European Regional Development Fund (ERDF)(European Commission); Fundacio La Marato de TV3; European Foundation for the Study of Diabetes (EFSD)/Lilly and EFSD/Janssen-Rising Star; L'Oreal-UNESCO "For Women in Science"; Ciencia sem Fronteiras-CNPq	We thank Gloria Gonzalez-Aseguinolaza for kindly supplying the EalbAATp promoter. Financial support statement: This study was supported by the Ministry of Spain (MINECO) (SAF2014-52223-C2-1-R to DS, SAF201783813-C3-1-R to DS and LH, SAF2017-82813-C3-3R to NC co-financed by the European Regional Development Fund [ERDF], a doctoral fellowship to JFM, and a Juan de la Cierva-Incorporacion research fellowship [IJCI2016-28313] to PM and DS), the Centro de Investigacion Biomedica en Red de Fisiopatologia de la Obesidad y la Nutricion (CIBEROBN) (CB06/03/0001 to DS), the Government of Catalonia (2014SGR465 to DS), Instituto de Salud Carlos III (FISPI18/01584 to VL-C, FIS-PI17/00412 to RB, FIS PI18/01484 to SA and FIS17/01455 to DS-I, Miguel Servet Fund CP15/00106 to DS-I and Rio Hortega grant (CM19/00039) to CM) and co-financed by the European Regional Development Fund (ERDF), Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM) to JC-EG, the Fundacio La Marato de TV3 (201627-30 to DS and 201627-31 to NC), the European Foundation for the Study of Diabetes (EFSD)/Lilly and EFSD/Janssen-Rising Star and L'Oreal-UNESCO "For Women in Science" research fellowships to LH, a doctoral fellowship from the Ciencia sem Fronteiras-CNPq (237976/2012-9) to MW. Figure 4F was created with BioRender.com.	Abu-Elheiga L, 2003, P NATL ACAD SCI USA, V100, P10207, DOI 10.1073/pnas.1733877100; Alexaki A, 2014, J LIPID RES, V55, P2521, DOI 10.1194/jlr.M051862; An J, 2004, NAT MED, V10, P268, DOI 10.1038/nm995; Arora T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126401; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brunt EM, 2004, SEMIN LIVER DIS, V24, P3; Escola-Gil JC, 2011, ARTERIOSCL THROM VAS, V31, P2493, DOI 10.1161/ATVBAHA.111.236075; Casteilla L, 2001, IUBMB LIFE, V52, P181, DOI 10.1080/15216540152845984; Cortez-Pinto H, 1999, GASTROENTEROLOGY, V116, P1184, DOI 10.1016/S0016-5085(99)70022-3; Dentin R, 2004, J BIOL CHEM, V279, P20314, DOI 10.1074/jbc.M312475200; Donello JE, 1998, J VIROL, V72, P5085, DOI 10.1128/JVI.72.6.5085-5092.1998; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; Ezquerro S, 2019, J CLIN ENDOCR METAB, V104, P21, DOI 10.1210/jc.2018-01171; Ferre P, 2004, DIABETES, V53, pS43, DOI 10.2337/diabetes.53.2007.S43; Fraser F, 1997, BIOCHEM J, V323, P711, DOI 10.1042/bj3230711; Gassaway BM, 2018, P NATL ACAD SCI USA, V115, pE8996, DOI 10.1073/pnas.1804379115; Graessler J, 2014, PHARMACOGENOMICS J, V14, P201, DOI 10.1038/tpj.2013.42; Ishigaki Y, 2005, DIABETES, V54, P322, DOI 10.2337/diabetes.54.2.322; Kahle M, 2015, MOL METAB, V4, P39, DOI 10.1016/j.molmet.2014.11.004; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; Kayser BD, 2017, INT J OBESITY, V41, P917, DOI 10.1038/ijo.2017.63; Kim S, 2015, COMMUN STAT APPL MET, V22, P665, DOI 10.5351/CSAM.2015.22.6.665; Kimmel AR, 2016, ANNU REV NUTR, V36, P471, DOI 10.1146/annurev-nutr-071813-105410; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kohjima M, 2007, INT J MOL MED, V20, P351; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Kramer MG, 2003, MOL THER, V7, P375, DOI 10.1016/S1525-0016(02)00060-6; Lee K, 2011, J BIOL CHEM, V286, P25655, DOI 10.1074/jbc.M111.228692; Martinez-Lopez N, 2015, ANNU REV NUTR, V35, P215, DOI 10.1146/annurev-nutr-071813-105336; Martinez-Sanchez N, 2017, CELL METAB, V26, P212, DOI 10.1016/j.cmet.2017.06.014; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McInnes L., 2018, ARXIV E PRINTS 1802; McInnes L., 2018, J OPEN SOURCE SOFTW, V3, P861, DOI [10.21105/joss.00861, DOI 10.21105/JOSS.00861]; Monsenego J, 2012, J HEPATOL, V56, P632, DOI 10.1016/j.jhep.2011.10.008; Morillas M, 2003, J BIOL CHEM, V278, P9058, DOI 10.1074/jbc.M209999200; Morillas M, 2001, J BIOL CHEM, V276, P45001, DOI 10.1074/jbc.M106920200; Morillas M, 2000, FEBS, VLett, P466; Nakamuta M, 2005, INT J MOL MED, V16, P631; Naso MF, 2017, BIODRUGS, V31, P317, DOI 10.1007/s40259-017-0234-5; NegreSalvayre A, 1997, FASEB J, V11, P809, DOI 10.1096/fasebj.11.10.9271366; Orellana-Gavalda JM, 2011, HEPATOLOGY, V53, P821, DOI 10.1002/hep.24140; Puri P, 2007, HEPATOLOGY, V46, P1081, DOI 10.1002/hep.21763; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Samuel VT, 2019, HEPATOLOGY, V70, P2217, DOI 10.1002/hep.30829; Sanyal Arun J, 2015, Trans Am Clin Climatol Assoc, V126, P271; Shilin Zhao A, 2019, PACKAGE HEATMAP3 TYP; Shon JC, 2015, J AGR FOOD CHEM, V63, P2919, DOI 10.1021/jf506216p; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Singh RK, 2012, INT J OPT, V2012, DOI [10.1155/2012/282041, 10.1155/2012/832086]; Skulachev VP, 1996, Q REV BIOPHYS, V29, P169, DOI 10.1017/S0033583500005795; Stefanovic-Racic M, 2008, AM J PHYSIOL-ENDOC M, V294, pE969, DOI 10.1152/ajpendo.00497.2007; TURINSKY J, 1990, J BIOL CHEM, V265, P16880; Ussher JR, 2010, DIABETES, V59, P2453, DOI 10.2337/db09-1293; VEERKAMP JH, 1986, BIOCHEM MED METAB B, V35, P248, DOI 10.1016/0885-4505(86)90080-0; Wei T, 2017, R PACKAGE CORRPLOT V; Woods A, 2017, CELL REP, V18, P3043, DOI 10.1016/j.celrep.2017.03.011; Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431; Zhang DY, 2010, CELL METAB, V11, P402, DOI 10.1016/j.cmet.2010.03.012	59	12	12	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					11816	11837		10.1096/fj.202000678R	http://dx.doi.org/10.1096/fj.202000678R		JUL 2020	22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32666604	hybrid, Green Published			2022-12-28	WOS:000553016800001
J	Pal, A; Al-Shaer, AE; Guesdon, W; Torres, MJ; Armstrong, M; Quinn, K; Davis, T; Reisdorph, N; Neufer, PD; Spangenburg, EE; Carroll, I; Bazine, RP; Halade, GV; Claria, J; Shaikh, SR				Pal, Anandita; Al-Shaer, Abrar E.; Guesdon, William; Torres, Maria J.; Armstrong, Michael; Quinn, Kevin; Davis, Traci; Reisdorph, Nichole; Neufer, P. Darrell; Spangenburg, Espen E.; Carroll, Ian; Bazine, Richard P.; Halade, Ganesh, V; Claria, Joan; Shaikh, Saame Raza			Resolvin E1 derived from eicosapentaenoic acid prevents hyperinsulinemia and hyperglycemia in a host genetic manner	FASEB JOURNAL			English	Article						diversity outbred mice; glucose; insulin; polyunsaturated fatty acids; specialized pro-resolving mediators	B-CELL ACTIVITY; INSULIN-RESISTANCE; ADIPOSE-TISSUE; DOCOSAHEXAENOIC ACID; LINOLEIC-ACID; INFLAMMATION; OBESITY; OMEGA-3-FATTY-ACIDS; ASSOCIATION; MICE	Eicosapentaenoic acid (EPA) has garnered attention after the success of the REDUCE-IT trial, which contradicted previous conclusions on EPA for cardiovascular disease risk. Here we first investigated EPA's preventative role on hyperglycemia and hyperinsulinemia. EPA ethyl esters prevented obesity-induced glucose intolerance, hyperinsulinemia, and hyperglycemia in C57BL/6J mice. Supporting NHANES analyses showed that fasting glucose levels of obese adults were inversely related to EPA intake. We next investigated how EPA improved murine hyperinsulinemia and hyperglycemia. EPA overturned the obesity-driven decrement in the concentration of 18-hydroxyeicosapentaenoic acid (18-HEPE) in white adipose tissue and liver. Treatment of obese inbred mice with RvE1, the downstream immunoresolvant metabolite of 18-HEPE, but not 18-HEPE itself, reversed hyperinsulinemia and hyperglycemia through the G-protein coupled receptor ERV1/ChemR23. To translate the findings, we determined if the effects of RvE1 were dependent on host genetics. RvE1's effects on hyperinsulinemia and hyperglycemia were divergent in diversity outbred mice that model human genetic variation. Secondary SNP analyses further confirmed extensive genetic variation in human RvE1/EPA-metabolizing genes. Collectively, the data suggest EPA prevents hyperinsulinemia and hyperglycemia, in part, through RvE1's activation of ERV1/ChemR23 in a host genetic manner. The studies underscore the need for personalized administration of RvE1 based on genetic/metabolic enzyme profiles.	[Pal, Anandita; Al-Shaer, Abrar E.; Davis, Traci; Carroll, Ian; Shaikh, Saame Raza] Univ North Carolina Chapel Hill, Gillings Sch Global Publ Hlth, Dept Nutr, 135 Dauer Dr, Chapel Hill, NC 27599 USA; [Pal, Anandita; Al-Shaer, Abrar E.; Davis, Traci; Carroll, Ian; Shaikh, Saame Raza] Univ North Carolina Chapel Hill, Sch Med, 135 Dauer Dr, Chapel Hill, NC 27599 USA; [Guesdon, William] East Carolina Univ, Dept Biochem & Mol Biol, Brody Sch Med, Greenville, NC 27858 USA; [Torres, Maria J.; Neufer, P. Darrell; Spangenburg, Espen E.] East Carolina Univ, Dept Physiol, East Carolina Diabet & Obes Inst, Greenville, NC 27858 USA; [Armstrong, Michael; Quinn, Kevin; Reisdorph, Nichole] Univ Colorado Denver, Dept Pharmaceut Sci, Anschutz Med Campus, Aurora, CO USA; [Bazine, Richard P.] Univ Toronto, Dept Nutr Sci, Toronto, ON, Canada; [Halade, Ganesh, V] Univ S Florida, Div Cardiovasc Sci, Dept Med, Tampa, FL 33620 USA; [Claria, Joan] Univ Barcelona, Hosp Clin, Dept Biochem & Mol Genet, Barcelona, Spain; [Guesdon, William] Kings Coll London, Sch Immunol & Microbial Sci, Guys Campus, London SE1 9RT, England; [Torres, Maria J.] Duke Univ, Duke Mol Physiol Inst, 300 North Duke St, Durham, NC 27701 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; East Carolina University; University of North Carolina; East Carolina University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Toronto; State University System of Florida; University of South Florida; University of Barcelona; Hospital Clinic de Barcelona; University of London; King's College London; Duke University	Shaikh, SR (corresponding author), Univ North Carolina Chapel Hill, Gillings Sch Global Publ Hlth, Dept Nutr, 135 Dauer Dr, Chapel Hill, NC 27599 USA.; Shaikh, SR (corresponding author), Univ North Carolina Chapel Hill, Sch Med, 135 Dauer Dr, Chapel Hill, NC 27599 USA.	shaikhsa@email.unc.edu	Torres, Maria/GVU-3391-2022; Reisdorph, Nichole/AAX-8774-2020; Pal, Anandita/ABC-9804-2021; Core, UNC Microbiome/AAB-3304-2022	Reisdorph, Nichole/0000-0002-0425-8012; Quinn, Kevin/0000-0002-3791-8128	NIH [R01AT008375, P30DK05635, R01AR066660, HL132989, HL144788, R01DK096907]; NIH/National Center for Research Resources [S10 RR026522-01A1]; Canadian Institutes of Health Research [303157]; Spanish Ministry of Economy and Science [SAF15-63674-R]; AGAUR Generalitat de Catalunya [2017SGR1449]; National Science Foundation Graduate Research Fellowship Program [1650116]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Spanish Ministry of Economy and Science(Spanish Government); AGAUR Generalitat de Catalunya(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)Generalitat de Catalunya); National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF))	This work was supported by NIH R01AT008375 (SRS), NIH P30DK05635 (SRS), NIH R01AR066660 (ES), NIH/National Center for Research Resources S10 RR026522-01A1 (NR), NIH R01DK096907 (PDN), Canadian Institutes of Health Research 303157 (RPB), NIH HL132989 (GVH), NIH HL144788 (GVH), SAF15-63674-R (Spanish Ministry of Economy and Science, JC), and 2017SGR1449 (AGAUR Generalitat de Catalunya, JC). This material is also based upon work supported by the National Science Foundation Graduate Research Fellowship Program under Grant No. 1650116 to AEA. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation	Ahluwalia N, 2016, ADV NUTR, V7, P121, DOI 10.3945/an.115.009258; Arita M, 2005, J EXP MED, V201, P713, DOI 10.1084/jem.20042031; Bhatt DL, 2019, NEW ENGL J MED, V380, P11, DOI 10.1056/NEJMoa1812792; Brown TJ, 2019, BMJ-BRIT MED J, V366, P14697, DOI [10.1136/bmj.14697, DOI 10.1136/BMJ.146971]; Caesar R, 2015, CELL METAB, V22, P658, DOI 10.1016/j.cmet.2015.07.026; Campbell EL, 2010, P NATL ACAD SCI USA, V107, P14298, DOI 10.1073/pnas.0914730107; Choque B, 2014, BIOCHIMIE, V96, P14, DOI 10.1016/j.biochi.2013.07.012; Churchill GA, 2012, MAMM GENOME, V23, P713, DOI 10.1007/s00335-012-9414-2; Claria J, 2012, J IMMUNOL, V189, P2597, DOI 10.4049/jimmunol.1201272; Crosslin DR, 2009, HUM GENET, V125, P217, DOI 10.1007/s00439-008-0619-0; Crouch MJ, 2019, J LEUKOCYTE BIOL, V106, P241, DOI 10.1002/JLB.3HI1017-405RR; Cruickshank-Quinn CI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101855; Delarue J, 2006, BRIT J NUTR, V95, P267, DOI 10.1079/BJN20051631; Elfaki I., 2018, ASIAN J PHARM CLIN R, V1, P55, DOI [10.22159/ajpcr.2018.v11i1.21657, DOI 10.22159/AJPCR.2018.V11I1.21657]; Elfaki Imadeldin, 2018, Asian Pac J Cancer Prev, V19, P2057; Fer M, 2008, ARCH BIOCHEM BIOPHYS, V471, P116, DOI 10.1016/j.abb.2008.01.002; Freire MO, 2017, J IMMUNOL, V198, P718, DOI 10.4049/jimmunol.1601543; Fromel T, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-012-0319-8; Gonzalez-Periz A, 2009, FASEB J, V23, P1946, DOI 10.1096/fj.08-125674; Goralski KB, 2007, J BIOL CHEM, V282, P28175, DOI 10.1074/jbc.M700793200; Hamlett ED, 2020, GLIA, V68, P1347, DOI 10.1002/glia.23779; Hamza M, 2019, CIRCULATION, V140; Helgadottir A, 2004, NAT GENET, V36, P233, DOI 10.1038/ng1311; Hellmann J, 2011, FASEB J, V25, P2399, DOI 10.1096/fj.10-178657; Herrera BS, 2015, INFECT IMMUN, V83, P792, DOI 10.1128/IAI.02444-14; Hoyo-Vadillo C., 2010, Health, V2, P1184, DOI 10.4236/health.2010.210174; Innes JK, 2018, PROSTAG LEUKOTR ESS, V132, P41, DOI 10.1016/j.plefa.2018.03.004; Jandacek RJ, 2017, HEALTHCARE-BASEL, V5, DOI 10.3390/healthcare5020025; Jung TW, 2019, CLIN EXP PHARMACOL P, V46, P898, DOI 10.1111/1440-1681.13131; Klingel SL, 2019, AM J CLIN NUTR, V110, P1502, DOI 10.1093/ajcn/nqz234; Kosaraju R, 2017, J IMMUNOL, V198, P4738, DOI 10.4049/jimmunol.1601031; Lalia AZ, 2016, NUTRIENTS, V8, DOI 10.3390/nu8060329; Coelho OGL, 2017, CRIT REV FOOD SCI, V57, P3614, DOI 10.1080/10408398.2015.1130016; Leiria LO, 2019, CELL METAB, V30, P768, DOI 10.1016/j.cmet.2019.07.001; Leng XL, 2018, BBA-BIOMEMBRANES, V1860, P1125, DOI 10.1016/j.bbamem.2018.01.002; Li PP, 2015, NAT MED, V21, P239, DOI 10.1038/nm.3800; Lopez-Vicario C, 2019, FASEB J, V33, P7072, DOI 10.1096/fj.201802587R; Lopez-Vicario C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15951-z; Magee P, 2012, J NUTR BIOCHEM, V23, P1440, DOI 10.1016/j.jnutbio.2011.09.005; Mahdi F, 2016, EXPLOR RES HYPOTHESI, V1, P42; Marchix J, 2020, J NUTR BIOCHEM, V75, DOI 10.1016/j.jnutbio.2019.108241; Mariani F, 2015, INFLAMM RES, V64, P85, DOI 10.1007/s00011-014-0792-7; Martinez-Fernandez L, 2017, FASEB J, V31, P2135, DOI 10.1096/fj.201600859R; Mason RP, 2020, ARTERIOSCL THROM VAS, V40, P1135, DOI 10.1161/ATVBAHA.119.313286; Naughton SS, 2016, PROSTAG OTH LIPID M, V125, P90, DOI 10.1016/j.prostaglandins.2016.06.003; Neuhofer A, 2013, DIABETES, V62, P1945, DOI 10.2337/db12-0828; Ozbayer C, 2018, PROSTAG LEUKOTR ESS, V137, P39, DOI 10.1016/j.plefa.2018.07.012; Pahlavani M, 2017, J NUTR BIOCHEM, V39, P101, DOI 10.1016/j.jnutbio.2016.08.012; Pinel A, 2016, J LIPID RES, V57, P1382, DOI 10.1194/jlr.M065458; Quinn KD, 2017, ALLERGY, V72, P1327, DOI 10.1111/all.13144; Sery O, 2016, J NEUROL SCI, V362, P27, DOI 10.1016/j.jns.2016.01.022; Sima C, 2018, CRIT REV IMMUNOL, V38, P343, DOI 10.1615/CritRevImmunol.2018026750; Sima C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13185-7; Souza PR, 2020, CIRC RES, V126, P75, DOI 10.1161/CIRCRESAHA.119.315506; Stark KD, 2016, PROG LIPID RES, V63, P132, DOI 10.1016/j.plipres.2016.05.001; Sumner LW, 2007, METABOLOMICS, V3, P211, DOI 10.1007/s11306-007-0082-2; Tang YN, 2013, DIABETES, V62, P618, DOI 10.2337/db12-0684; Teague H, 2014, J LIPID RES, V55, P1420, DOI 10.1194/jlr.M049809; Aung T, 2018, JAMA CARDIOL, V3, P225, DOI 10.1001/jamacardio.2017.5205; Titos E, 2016, J IMMUNOL, V197, P3360, DOI 10.4049/jimmunol.1502522; Westphal C, 2011, PROSTAG OTH LIPID M, V96, P99, DOI 10.1016/j.prostaglandins.2011.09.001; White PJ, 2014, NAT MED, V20, P664, DOI 10.1038/nm.3549; White PJ, 2010, DIABETES, V59, P3066, DOI 10.2337/db10-0054; Wittamer V, 2003, J EXP MED, V198, P977, DOI 10.1084/jem.20030382; Yamada Y, 2007, INT J MOL MED, V20, P703; Yang YH, 2013, J CHROMATOGR A, V1300, P217, DOI 10.1016/j.chroma.2013.04.030; Ying W, 2019, CELL METAB, V29, P457, DOI 10.1016/j.cmet.2018.12.003	67	29	30	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10640	10656		10.1096/fj.202000830R	http://dx.doi.org/10.1096/fj.202000830R		JUN 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32579292	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000544322500001
J	Qian, H; Cao, Y; Sun, JF; Zu, JN; Ma, L; Zhou, HZ; Tang, XL; Li, Y; Yu, HY; Zhang, MY; Bai, YL; Xu, CQ; Ishii, N; Hashimoto, T; Li, XG				Qian, Hua; Cao, Yan; Sun, Junfeng; Zu, Jianing; Ma, Liang; Zhou, Haizhou; Tang, Xianling; Li, Yan; Yu, Haiyang; Zhang, Mingyu; Bai, Yunlong; Xu, Chaoqian; Ishii, Norito; Hashimoto, Takashi; Li, Xiaoguang			Anti-human serum albumin autoantibody may be involved in the pathogenesis of autoimmune bullous skin diseases	FASEB JOURNAL			English	Article						anti-human serum albumin autoantibody; autoimmune bullous skin diseases; DNA damage-related signaling proteins; phospho-p38; skin lesion	C-TERMINAL DOMAIN; DNA-DAMAGE; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; INCREASED EXPRESSION; IGA AUTOANTIBODIES; NC16A DOMAIN; DIAGNOSIS; CANCER; ENZYME; ANTIBODIES	Although effective immunological diagnostic systems for autoimmune bullous skin diseases (AIBD) have been established, there are still unidentified cutaneous autoantigens. The purpose of this study is to investigative whether anti-human serum albumin (HSA) autoantibodies exist in AIBD sera and their potential pathogenesis. By immunoprecipitation-immunoblotting, immunofluorescence assay, anti-HSA autoantibodies could be detected in AIBD sera; by ELISAs, positive rates of AIBD sera for IgG and IgA anti-HSA autoantibodies were 29% and 34%, respectively. The IgG anti-HSA autoantibodies in ABID sera recognized a number of HSA antigen epitopes and therefore a polyclonal antibody against HSA were next employed to study its pathogenesis. In vitro cell and tissue culture models, anti-HSA antibody could influence DNA damage-related signaling proteins, via activation of phospho-p38 signaling pathway. This is the first report that an autoantibody may influence DNA damage-related signaling proteins. Statistical analyses also proved that anti-HSA autoantibodies were positively correlated with various known autoantibodies and clinical features of ABID patients. In summary, IgG and IgA autoantibodies to HSA may have diagnosis values for AIBD. DNA damage-related signaling proteins might be involved in the pathogenic role of anti-HSA autoantibodies in AIBD. Phospho-p38 signaling pathway is a potential target for treatment of AIBD positive for serum anti-HSA autoantibodies.	[Qian, Hua; Li, Xiaoguang] Nanchang Univ, Affiliated Dermatol Hosp, Dermatol Hosp Jiangxi Prov, Cent Lab,Dermatol Inst Jiangxi Prov, Nanchang, Jiangxi, Peoples R China; [Qian, Hua; Ma, Liang; Zhang, Mingyu; Bai, Yunlong; Hashimoto, Takashi; Li, Xiaoguang] Harbin Med Univ, Coll Pharm, Dept Pharmacol, Harbin, Peoples R China; [Qian, Hua; Ma, Liang; Zhang, Mingyu; Bai, Yunlong; Hashimoto, Takashi; Li, Xiaoguang] Heilongjiang Acad Med Sci, Harbin, Peoples R China; [Cao, Yan] Harbin Med Univ, Canc Hosp, Dept Urol, Harbin, Peoples R China; [Sun, Junfeng] Harbin Med Univ, Affiliated Hosp 1, Dept Cardiovasc Med, Harbin, Peoples R China; [Zu, Jianing] Harbin Med Univ, Affiliated Hosp 2, Dept Orthopaed, Harbin, Peoples R China; [Zhou, Haizhou] Harbin Med Univ, Affiliated Hosp 1, Dept Lab Diag, Harbin, Peoples R China; [Tang, Xianling] Harbin Med Univ, Affiliated Hosp 1, Eye Hosp, Harbin, Peoples R China; [Li, Yan] Harbin Med Univ, Ctr Endem Dis Control, Chinese Ctr Dis Control & Prevent, Harbin, Peoples R China; [Yu, Haiyang] Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Dept Ophthalmol, Hangzhou, Peoples R China; [Xu, Chaoqian] Mudanjiang Med Univ, Dept Pharmacol, Mudanjiang, Peoples R China; [Ishii, Norito] Kurume Univ, Sch Med, Dept Dermatol, Kurume, Fukuoka, Japan; [Ishii, Norito] Kurume Univ, Inst Cutaneous Cell Biol, Kurume, Fukuoka, Japan; [Hashimoto, Takashi] Osaka City Univ, Grad Sch Med, Dept Dermatol, Osaka, Japan	Nanchang University; Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University; Chinese Center for Disease Control & Prevention; Harbin Medical University; Zhejiang University; Mudanjiang Medical University; Kurume University; Kurume University; Osaka Metropolitan University	Li, XG (corresponding author), Nanchang Univ, Dermatol Hosp Jiangxi Prov, Dermatol Inst Jiangxi Prov, Cent Lab, 388 Yingbinbei Rd, Nanchang 330001, Jiangxi, Peoples R China.; Li, XG (corresponding author), Nanchang Univ, Affiliated Dermatol Hosp, 388 Yingbinbei Rd, Nanchang 330001, Jiangxi, Peoples R China.; Hashimoto, T (corresponding author), Osaka City Univ, Grad Sch Med, Dept Dermatol, Abeno Ku, 1-4-3 Asahimachi, Osaka 5458585, Japan.	hashyt@gmail.com; liqian0041@139.com	Zhang, mingyu/HGB-1069-2022		National Science and Technology Major Project [2018ZX10101003]; Natural Science Foundation of Heilongjiang Province of China [QC2016129]; Scientific Research Foundation of First Affiliated Hospital of Harbin Medical University, China [2017B013]; Ministry of Health Labour and Welfare, Japan [H24-038]; AMED, Japan [JP19lm0203007]	National Science and Technology Major Project; Natural Science Foundation of Heilongjiang Province of China(Natural Science Foundation of Heilongjiang Province); Scientific Research Foundation of First Affiliated Hospital of Harbin Medical University, China; Ministry of Health Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); AMED, Japan	The authors thank the patients for their participation. The authors also thank Dr Yoichiro Hamasaki and Dr Ken Igawa, Department of Dermatology, Dokkyo Medical University School of Medicine, for their kindly providing HE staining and direct IF results of the PNP patient. This work was supported by National Science and Technology Major Project (2018ZX10101003), the Natural Science Foundation of Heilongjiang Province of China (QC2016129), the Scientific Research Foundation of First Affiliated Hospital of Harbin Medical University (2017B013), China; and the Research on Measures for Intractable Diseases' Project: matching fund subsidy of Ministry of Health Labour and Welfare, Japan (H24-038), and AMED, Japan (JP19lm0203007).	Al-Shobaili HA, 2015, SAUDI MED J, V36, P1408, DOI 10.15537/smj.2015.12.12612; Amano S, 2000, J BIOL CHEM, V275, P22728, DOI 10.1074/jbc.M002345200; Anstey A, 2015, BRIT J DERMATOL, V173, pE23, DOI 10.1111/bjd.14162; Arif Z, 2018, INT J BIOL MACROMOL, V106, P1240, DOI 10.1016/j.ijbiomac.2017.08.122; BROWN LF, 1995, J INVEST DERMATOL, V104, P744, DOI 10.1111/1523-1747.ep12606974; Cai RQ, 2015, FASEB J, V29, P2749, DOI 10.1096/fj.14-265801; Cornaby C, 2015, IMMUNOL LETT, V163, P56, DOI 10.1016/j.imlet.2014.11.001; Curtin NJ, 2012, NAT REV CANCER, V12, P801, DOI 10.1038/nrc3399; Dainichi T, 2009, P NATL ACAD SCI USA, V106, P2800, DOI 10.1073/pnas.0809230106; De Bont R, 2004, MUTAGENESIS, V19, P169, DOI 10.1093/mutage/geh025; di Masi A, 2018, J INFECT DIS, V218, P1424, DOI 10.1093/infdis/jiy338; Egu DT, 2017, BRIT J DERMATOL, V177, P1612, DOI 10.1111/bjd.15721; Fanali G, 2012, MOL ASPECTS MED, V33, P209, DOI 10.1016/j.mam.2011.12.002; Fukumoto Y, 2014, J BIOL CHEM, V289, P12313, DOI 10.1074/jbc.M113.533752; Hashimoto T, 2016, BRIT J DERMATOL, V175, P953, DOI 10.1111/bjd.14692; Hashimoto T, 2001, ARCH DERMATOL, V137, P735; Hashimoto T, 2012, J PATHOL, V228, P1, DOI 10.1002/path.4062; Hayakawa T, 2016, EUR J DERMATOL, V26, P155, DOI 10.1684/ejd.2015.2719; Hayakawa T, 2014, OR SURG OR MED OR PA, V117, P483, DOI 10.1016/j.oooo.2013.12.402; Hou XW, 2017, FASEB J, V31, P3179, DOI 10.1096/fj.201601082R; Iida T, 2001, NEURO-ONCOLOGY, V3, P73, DOI 10.1093/neuonc/3.2.73; Ishii N, 2008, BRIT J DERMATOL, V158, P1151, DOI 10.1111/j.1365-2133.2008.08492.x; Ishii N, 2004, BRIT J DERMATOL, V150, P843, DOI 10.1111/j.1365-2133.2004.05933.x; Kanarek N, 2014, P NATL ACAD SCI USA, V111, pE702, DOI 10.1073/pnas.1322691111; Khan W. Z., 2015, IEEE COMMUNICATIONS, V17, P1, DOI DOI 10.2174/1389200216666151103115210; Khan WA, 2007, ARCH BIOCHEM BIOPHYS, V465, P293, DOI 10.1016/j.abb.2007.06.006; Lan YL, 2019, CELL BIOL TOXICOL, V35, P521, DOI 10.1007/s10565-019-09462-y; LENKEI R, 1977, J IMMUNOL METHODS, V16, P23, DOI 10.1016/0022-1759(77)90036-9; Leverkus M, 2001, BRIT J DERMATOL, V145, P998, DOI 10.1046/j.1365-2133.2001.04543.x; Li DH, 2002, MUTAT RES-GEN TOX EN, V513, P37, DOI 10.1016/S1383-5718(01)00291-1; Li X, 2014, BRIT J DERMATOL, V171, P1257, DOI 10.1111/bjd.13107; Li XG, 2016, EUR J DERMATOL, V26, P247, DOI 10.1684/ejd.2016.2772; Li XG, 2015, EUR J DERMATOL, V25, P418, DOI 10.1684/ejd.2015.2555; Li XD, 2015, METALL MATER TRANS E, V2, P1; Liu NA, 2015, FASEB J, V29, P2514, DOI 10.1096/fj.14-265546; Matsumura K, 1996, ARCH DERMATOL RES, V288, P507, DOI 10.1007/s004030050093; Mendez Christian M, 2005, Nutr Clin Pract, V20, P314, DOI 10.1177/0115426505020003314; Nie ZX, 1999, J INVEST DERMATOL, V112, P254, DOI 10.1046/j.1523-1747.1999.00501.x; Noble PW, 2016, NAT REV RHEUMATOL, V12, P429, DOI 10.1038/nrrheum.2016.23; Otten JV, 2014, CURR MOL MED, V14, P69, DOI 10.2174/15665240113136660079; Phadke M, 2011, BIOCHEM BIOPH RES CO, V411, P409, DOI 10.1016/j.bbrc.2011.06.165; Reddy R, 2014, AM J PHYSIOL-LUNG C, V286, pL658; Reichl S, 2004, BRIT J OPHTHALMOL, V88, P560, DOI 10.1136/bjo.2003.028225; Saalbach A, 2000, J INVEST DERMATOL, V115, P882, DOI 10.1046/j.1523-1747.2000.00104.x; Schmidt E, 2010, AUTOIMMUN REV, V10, P84, DOI 10.1016/j.autrev.2010.08.007; Shain SA, 2004, MOL CANCER RES, V2, P653; Shen Q, 2009, EXP CELL RES, V315, P1653, DOI 10.1016/j.yexcr.2009.03.007; Shiokawa M, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aaq0997; SUGI T, 1989, J CLIN INVEST, V84, P1050, DOI 10.1172/JCI114266; Tsuchisaka A, 2014, J INVEST DERMATOL, V134, P2283, DOI 10.1038/jid.2014.151; Tsuruta D, 2012, IMMUNOTHERAPY-UK, V4, P735, DOI [10.2217/IMT.12.67, 10.2217/imt.12.67]; Wei X, 2019, EXP EYE RES, V180, P174, DOI 10.1016/j.exer.2018.12.020; Yan Y, 2018, MOL MED REP, V17, P5233; Yasukochi A, 2016, ACTA DERM-VENEREOL, V96, P762, DOI 10.2340/00015555-2407; Zhou T, 2013, PATIENT PREFER ADHER, V7, P1207, DOI 10.2147/PPA.S53484	55	5	6	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8574	8595		10.1096/fj.201903247RR	http://dx.doi.org/10.1096/fj.201903247RR		MAY 2020	22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32369236				2022-12-28	WOS:000530304300001
J	Chu, WG; Wang, FD; Sun, ZC; Ma, SB; Wang, X; Han, WJ; Wang, F; Bai, ZT; Wu, SX; Freichel, M; Xie, RG; Luo, C				Chu, Wen-Guang; Wang, Fu-Dong; Sun, Zhi-Chuan; Ma, Sui-Bin; Wang, Xu; Han, Wen-Juan; Wang, Fei; Bai, Zhan-Tao; Wu, Sheng-Xi; Freichel, Marc; Xie, Rou-Gang; Luo, Ceng			TRPC1/4/5 channels contribute to morphine-induced analgesic tolerance and hyperalgesia by enhancing spinal synaptic potentiation and structural plasticity	FASEB JOURNAL			English	Article						long-term potentiation; opioid-induced tolerance and hyperalgesia; spinal cord; spine remodeling; TRPC1; 4; 5 channels	LONG-TERM POTENTIATION; KINASE-II-ALPHA; FUNCTIONAL PLASTICITY; SUBSTANTIA-GELATINOSA; TRPC CHANNELS; RECEPTOR; ACTIVATION; PAIN; MODULATION; NEURONS	Opioid analgesics remain the mainstay for managing intractable chronic pain, but their use is limited by detrimental side effects such as analgesic tolerance and hyperalgesia. Calcium-dependent synaptic plasticity is a key determinant in opiates tolerance and hyperalgesia. However, the exact substrates for this calcium-dependent synaptic plasticity in mediating these maladaptive processes are largely unknown. Canonical transient receptor potential 1, 4, and 5 (TRPC1, 4, 5) proteins assemble into heteromultimeric nonselective cation channels with high Ca2+ permeability and influence various neuronal functions. However, whether and how TRPC1/4/5 channels contribute to the development of opiates tolerance and hyperalgesia remains elusive. Here, we show that TRPC1/4/5 channels contribute to the generation of morphine tolerance and hyperalgesia. Chronic morphine exposure leads to upregulation of TRPC1/4/5 channels in the spinal cord. Spinally expressed TRPC1, TPRC4, and TRPC5 are required for chronic morphine-induced synaptic long-term potentiation (LTP) as well as remodeling of synaptic spines in the dorsal horn, thereby orchestrating functional and structural plasticity during the course of morphine-induced hyperalgesia and tolerance. These effects are attributed to TRPC1/4/5-mediated Ca2+ elevation in the spinal dorsal horn induced by chronic morphine treatment. This study identifies TRPC1/4/5 channels as a promising novel target to prevent the unwanted morphine tolerance and hyperalgesia.	[Chu, Wen-Guang; Wang, Fu-Dong; Sun, Zhi-Chuan; Ma, Sui-Bin; Wang, Xu; Han, Wen-Juan; Wang, Fei; Wu, Sheng-Xi; Xie, Rou-Gang; Luo, Ceng] Fourth Mil Med Univ, Sch Basic Med, Dept Neurobiol, Xian 710032, Peoples R China; [Wang, Fu-Dong] Fourth Mil Med Univ, Sch Basic Med, Regiment 4, Xian, Peoples R China; [Sun, Zhi-Chuan] Fourth Mil Med Univ, Tangdu Hosp, Dept Neurosurg, Xian, Peoples R China; [Wang, Xu; Bai, Zhan-Tao] Yanan Univ, Res Ctr Resource Polypeptide Drugs, Yanan, Peoples R China; [Wang, Xu; Bai, Zhan-Tao] Yanan Univ, Coll Life Sci, Yanan, Peoples R China; [Freichel, Marc] Heidelberg Univ, Inst Pharmacol, Heidelberg, Germany	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Yanan University; Yanan University; Ruprecht Karls University Heidelberg	Luo, C (corresponding author), Fourth Mil Med Univ, Sch Basic Med, Dept Neurobiol, Xian 710032, Peoples R China.	luoceng@fmmu.edu.cn		Xie, Rou-gang/0000-0001-7644-1492	Natural Science Foundation of China [31671088, 31471059, 81870867]; Natural Science Foundation of Shaanxi Province [2017ZDJC-01]; DFG-Forschergruppe [2289]; Collaborative Research Center [1118]; Transregional Collaborative Research Center [TR-SFB 152]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shaanxi Province(Natural Science Foundation of Shaanxi Province); DFG-Forschergruppe(German Research Foundation (DFG)); Collaborative Research Center; Transregional Collaborative Research Center	Natural Science Foundation of China, Grant/Award Number: 31671088, 31471059 and 81870867; Natural Science Foundation of Shaanxi Province, Grant/Award Number: 2017ZDJC-01; DFG-Forschergruppe, Grant/Award Number: 2289; Collaborative Research Center, Grant/Award Number: 1118; Transregional Collaborative Research Center, Grant/Award Number: TR-SFB 152	Abramowitz J, 2009, FASEB J, V23, P297, DOI 10.1096/fj.08-119495; ADVOKAT C, 1989, BEHAV NEUROSCI, V103, P1091, DOI 10.1037/0735-7044.103.5.1091; Alawi KM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02439-z; Alawi KM, 2017, ANN RHEUM DIS, V76, P252, DOI 10.1136/annrheumdis-2015-208886; Alessandri-Haber N, 2009, J NEUROSCI, V29, P6217, DOI 10.1523/JNEUROSCI.0893-09.2009; Anderson M, 2018, NEUROSCI BULL, V34, P194, DOI 10.1007/s12264-017-0139-9; Bhargava HN, 1997, BRAIN RES, V771, P343, DOI 10.1016/S0006-8993(97)00914-1; Blair NT, 2019, IUPHAR BPS GUIDE PHA, V2019; Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495; Broker-Lai J, 2017, EMBO J, V36, P2770, DOI 10.15252/embj.201696369; Chai ZY, 2017, CHANNELS, V11, P357, DOI 10.1080/19336950.2017.1324003; CHEN L, 1991, NEURON, V7, P319, DOI 10.1016/0896-6273(91)90270-A; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chen Y, 2010, J NEUROSCI, V30, P38, DOI 10.1523/JNEUROSCI.4346-09.2010; Corder G, 2017, NAT MED, V23, P164, DOI 10.1038/nm.4262; Dietrich A, 2005, MOL CELL BIOL, V25, P6980, DOI 10.1128/MCB.25.16.6980-6989.2005; Drdla R, 2009, SCIENCE, V325, P207, DOI 10.1126/science.1171759; Drdla-Schutting R, 2012, SCIENCE, V335, P235, DOI 10.1126/science.1211726; Elhabazi K, 2014, JOVE-J VIS EXP, DOI 10.3791/51264; Faber ESL, 2006, NEUROSCIENCE, V137, P781, DOI 10.1016/j.neuroscience.2005.09.027; Ferrini F, 2013, NAT NEUROSCI, V16, P183, DOI 10.1038/nn.3295; Fowler MA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000573; Freichel M, 2005, J PHYSIOL-LONDON, V567, P59, DOI 10.1113/jphysiol.2005.092999; Greka A, 2003, NAT NEUROSCI, V6, P837, DOI 10.1038/nn1092; Heinke B, 2011, J NEUROSCI, V31, P1313, DOI 10.1523/JNEUROSCI.4060-10.2011; Hong C, 2015, BRAIN, V138, P3030, DOI 10.1093/brain/awv188; Jeon JP, 2012, J BIOL CHEM, V287, P17029, DOI 10.1074/jbc.M111.326553; Jeon JP, 2008, BIOCHEM BIOPH RES CO, V377, P538, DOI 10.1016/j.bbrc.2008.10.012; Jin H, 2017, NEUROSCI LETT, V639, P138, DOI 10.1016/j.neulet.2016.12.062; Kohno T, 1999, J PHYSIOL-LONDON, V518, P803, DOI 10.1111/j.1469-7793.1999.0803p.x; Kuner R, 2017, NAT REV NEUROSCI, V18, DOI 10.1038/nrn.2017.5; Li MQ, 2012, CELL CALCIUM, V51, P486, DOI 10.1016/j.ceca.2012.04.014; Li Y, 2005, NATURE, V434, P894, DOI 10.1038/nature03477; Liang D, 2004, NEUROSCIENCE, V123, P769, DOI 10.1016/j.neuroscience.2003.10.007; Liu CH, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14335; Lu JN, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7820; Luo C, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001283; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Miller EC, 2012, MOL PHARMACOL, V82, P333, DOI 10.1124/mol.112.078162; Minard A, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7060052; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; Nakatsuka T, 2000, NEUROSCIENCE, V99, P549, DOI 10.1016/S0306-4522(00)00224-4; Phelan KD, 2012, MOL PHARMACOL, V81, P384, DOI 10.1124/mol.111.075341; Riccio A, 2014, J NEUROSCI, V34, P3653, DOI 10.1523/JNEUROSCI.2274-13.2014; Riccio A, 2009, CELL, V137, P761, DOI 10.1016/j.cell.2009.03.039; Robinson TE, 2002, SYNAPSE, V46, P271, DOI 10.1002/syn.10146; Roeckel LA, 2016, NEUROSCIENCE, V338, P160, DOI 10.1016/j.neuroscience.2016.06.029; Rowan MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093688; Rubaiy HN, 2019, BRIT J PHARMACOL, V176, P832, DOI 10.1111/bph.14578; Rubaiy HN, 2017, CHANNELS, V11, P362, DOI 10.1080/19336950.2017.1317485; Rubaiy HN, 2017, J BIOL CHEM, V292, P8158, DOI 10.1074/jbc.M116.773556; Russo SJ, 2010, TRENDS NEUROSCI, V33, P267, DOI 10.1016/j.tins.2010.02.002; Sandkuhler J, 2009, PHYSIOL REV, V89, P707, DOI 10.1152/physrev.00025.2008; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Shukla AK, 2010, J BIOL CHEM, V285, P30115, DOI 10.1074/jbc.M110.141549; Simmons SC, 2019, MOL BRAIN, V12, DOI 10.1186/s13041-019-0435-6; Simonetti M, 2013, NEURON, V77, P43, DOI 10.1016/j.neuron.2012.10.037; Stoicea N, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000015425; Stroh O, 2012, J NEUROSCI, V32, P5737, DOI 10.1523/JNEUROSCI.3753-11.2012; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; Thakur DP, 2016, P NATL ACAD SCI USA, V113, P1092, DOI 10.1073/pnas.1522294113; Wei H, 2015, NEUROSCI LETT, V608, P12, DOI 10.1016/j.neulet.2015.09.033; Weisberg DF, 2014, INT J DRUG POLICY, V25, P1124, DOI 10.1016/j.drugpo.2014.07.009; Westlund KN, 2014, NEUROSCIENCE, V262, P165, DOI 10.1016/j.neuroscience.2013.12.043; Xie Z, 2007, NEURON, V56, P640, DOI 10.1016/j.neuron.2007.10.005; Xu JT, 2014, J CLIN INVEST, V124, P592, DOI 10.1172/JCI70236; Yang HW, 2004, J NEUROPHYSIOL, V91, P1122, DOI 10.1152/jn.00735.2003; Zholos AV, 2014, HANDB EXP PHARMACOL, V222, P129, DOI 10.1007/978-3-642-54215-2_6; Zhou HY, 2010, J NEUROSCI, V30, P4460, DOI 10.1523/JNEUROSCI.5857-09.2010	69	6	6	3	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8526	8543		10.1096/fj.202000154RR	http://dx.doi.org/10.1096/fj.202000154RR		MAY 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32359120				2022-12-28	WOS:000530047900001
J	Przygrodzka, E; Sokolowska, G; Myszczynski, K; Krawczynski, K; Kaczmarek, MM				Przygrodzka, Emilia; Sokolowska, Gabriela; Myszczynski, Kamil; Krawczynski, Kamil; Kaczmarek, Monika M.			Clustered microRNAs: The molecular mechanism supporting the maintenance of luteal function during early pregnancy	FASEB JOURNAL			English	Article						estradiol; luteolysis; progesterone; prostaglandins	CORPUS-LUTEUM; TRANSCRIPTIONAL ACTIVATION; ESTROUS-CYCLE; EXPRESSION; GENES; PROGESTERONE; NUR77; PROSTAGLANDIN-F2-ALPHA; RECOGNITION; INVOLVEMENT	MicroRNAs (miRNAs) are recognized as the important regulators of ovarian function. However, little is known about the hormonal regulation of miRNA expression and the role of the specific miRNA-mRNA interactions in corpus luteum. Therefore, the present study was undertaken to determine: (a) the expression of miRNAs in the corpus luteum in early pregnancy vs regression; (b) the effect of conceptus and uterine signals in the expression of selected miRNAs; and (c) the role of specific miRNA-mRNA interactions in the molecular changes and secretory function of the corpus luteum in the pig. The results showed that the majority of miRNAs differentially expressed in the corpus luteum in early pregnancy vs regression belong to independent clusters (eg, miR-99b, miR-532), which are highly conserved among different animal species. The main conceptus signal in the pig (17 beta-estradiol) elevated the luteal expression of the miR-99b cluster and lowered the expression of NR4A1 and AKR1C1, the genes involved in corpus luteum regression. Furthermore, the delivery of miR-99b cluster mimics to luteal tissue concomitantly decreased NR4A1 and AKR1C1 expression and enhanced progesterone secretion. The present study demonstrated that conceptus signals can support the maintenance of luteal function during pregnancy by clustered miRNA-stimulated pathways, governing the expression of genes involved in luteal regression.	[Przygrodzka, Emilia; Sokolowska, Gabriela; Krawczynski, Kamil; Kaczmarek, Monika M.] Polish Acad Sci, Dept Hormonal Act Mech, Inst Anim Reprod & Food Res, Olsztyn, Poland; [Myszczynski, Kamil; Kaczmarek, Monika M.] Polish Acad Sci, Mol Biol Lab, Inst Anim Reprod & Food Res, Olsztyn, Poland; [Przygrodzka, Emilia] Univ Nebraska Med Ctr, Olson Ctr Womens Hlth, Dept Obstet & Gynecol, Omaha, NE USA; [Sokolowska, Gabriela] Med Univ Bialystok, Clin Res Ctr, Bialystok, Poland; [Krawczynski, Kamil] Polish Acad Sci, Mossakowski Med Res Ctr, Dept Neurochem, Warsaw, Poland	Polish Academy of Sciences; Institute of Animal Reproduction & Food Research of the Polish Academy of Sciences; Polish Academy of Sciences; Institute of Animal Reproduction & Food Research of the Polish Academy of Sciences; University of Nebraska System; University of Nebraska Medical Center; Medical University of Bialystok; Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences	Przygrodzka, E; Kaczmarek, MM (corresponding author), Polish Acad Sci, Inst Anim Reprod & Food Res, Tuwima 10 Str, PL-10748 Olsztyn, Poland.	e.bolzan@pan.olsztyn.pl; m.kaczmarek@pan.olsztyn.pl	KACZMAREK, Monika Marzena/AAS-2271-2020; PRZYGRODZKA, Emilia/H-7239-2017	KACZMAREK, Monika Marzena/0000-0002-8213-4381; PRZYGRODZKA, Emilia/0000-0003-4018-9023; Krawczynski, Kamil/0000-0001-5336-7525; Myszczynski, Kamil/0000-0002-3118-0900	Institute of Animal Reproduction and Food Research; Polish Academy of Science [GW10/2015]	Institute of Animal Reproduction and Food Research; Polish Academy of Science	The authors are grateful to K. Gromadzka-Hliwa, M. Romaniewicz, and P. Golder from the Institute of Animal Reproduction and Food Research, Polish Academy of Science for their excellent technical assistance in the laboratory. This research was supported by the statutory funds of the Institute of Animal Reproduction and Food Research, Polish Academy of Science (grant number-GW10/2015) and grant funded by KNOW (Leading National Research Centre) Scientific Consortium "Healthy Animal-Safe Food" (decision of Ministry of Science and Higher Education No. 05-1/KNOW2/2015; grant number-KNOW/2016/IRZiBZ/ESR3/01/4).	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Atli MO, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.094870; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bazer F. W., 1982, Control of pig reproduction, P227; BAZER FW, 1977, PROSTAGLANDINS, V14, P397, DOI 10.1016/0090-6980(77)90185-X; Bhat-Nakshatri P, 2009, NUCLEIC ACIDS RES, V37, P4850, DOI 10.1093/nar/gkp500; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Chekulaeva M, 2009, CURR OPIN CELL BIOL, V21, P452, DOI 10.1016/j.ceb.2009.04.009; Davis JS, 2002, FRONT BIOSCI-LANDMRK, V7, pD1949, DOI 10.2741/davis1; Duren RP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150450; Farberov S, 2018, BIOL REPROD, V98, P366, DOI 10.1093/biolre/iox167; Fiedler SD, 2008, BIOL REPROD, V79, P1030, DOI 10.1095/biolreprod.108.069690; FORD SP, 1982, J ANIM SCI, V55, P657, DOI 10.2527/jas1982.553657x; Geisert R D, 1990, J Reprod Fertil Suppl, V40, P293; Godoi PHC, 2016, J BIOL CHEM, V291, P14072, DOI 10.1074/jbc.M116.715235; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; GUTHRIE HD, 1972, ENDOCRINOLOGY, V91, P675, DOI 10.1210/endo-91-3-675; Helwak A, 2013, CELL, V153, P654, DOI 10.1016/j.cell.2013.03.043; Hong XM, 2008, ENDOCRINOLOGY, V149, P6207, DOI 10.1210/en.2008-0294; Hughes CK, 2019, BIOL REPROD, V100, P1581, DOI 10.1093/biolre/ioz037; Kim D, 2016, NAT GENET, V48, P1517, DOI 10.1038/ng.3694; Krawczynski K, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.123588; Krzymowski T, 2004, VET J, V168, P285, DOI 10.1016/j.tvjl.2003.10.010; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lai X., 2013, ENCY SYSTEMBIOL, P77; Lee SY, 2012, MOL CELL ENDOCRINOL, V362, P91, DOI 10.1016/j.mce.2012.05.015; Ma TH, 2011, J APPL GENET, V52, P481, DOI 10.1007/s13353-011-0055-z; Maalouf SW, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.135053; Maalouf SW, 2014, MOL CELL ENDOCRINOL, V398, P78, DOI 10.1016/j.mce.2014.10.005; McBride D, 2012, REPRODUCTION, V144, P221, DOI 10.1530/REP-12-0025; Mohammed BT, 2017, J CLIN ENDOCR METAB, V102, P2188, DOI 10.1210/jc.2017-00259; Oliveros J.C., 2007, INTERACTIVE TOOL COM; Otsuka M, 2008, J CLIN INVEST, V118, P1944, DOI 10.1172/JCI33680; Palomba S, 2015, J OVARIAN RES, V8, DOI 10.1186/s13048-015-0205-8; Przygrodzka E, 2016, REPRODUCTION, V151, P135, DOI 10.1530/REP-15-0332; Przygrodzka E, 2015, THERIOGENOLOGY, V83, P535, DOI 10.1016/j.theriogenology.2014.10.016; Przygrodzka E., 2017, LIFE CYCLE CORPUS LU, P227, DOI [10.1007/978-3-319-43238-0, DOI 10.1007/978-3-319-43238-0, DOI 10.1007/978-3-319-43238-0_12]; Przygrodzka E, 2014, REPROD BIOL, V14, P243, DOI 10.1016/j.repbio.2014.04.001; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Safe S, 2001, VITAM HORM, V62, P231, DOI 10.1016/S0083-6729(01)62006-5; Spencer TE, 2002, FRONT BIOSCI-LANDMRK, V7, pD1879, DOI 10.2741/spencer; Stefanczyk-Krzymowska S, 2006, PROSTAG OTH LIPID M, V81, P71, DOI 10.1016/j.prostaglandins.2006.07.004; Stocco CO, 2002, J BIOL CHEM, V277, P3293, DOI 10.1074/jbc.M110936200; Stocco CO, 2000, J BIOL CHEM, V275, P37202, DOI 10.1074/jbc.M006016200; Talbott H, 2017, MOL CELL ENDOCRINOL, V452, P93, DOI 10.1016/j.mce.2017.05.018; Waclawik A, 2007, J ENDOCRINOL, V194, P499, DOI 10.1677/JOE-07-0155; WILSON TE, 1993, MOL CELL BIOL, V13, P861, DOI 10.1128/MCB.13.2.861; Wiltbank Milo C, 2003, Reprod Biol Endocrinol, V1, P91, DOI 10.1186/1477-7827-1-91; YOON JK, 1994, MOL CELL BIOL, V14, P7731, DOI 10.1128/MCB.14.12.7731; Zhang PL, 1997, MOL ENDOCRINOL, V11, P891, DOI 10.1210/me.11.7.891; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047	53	3	4	1	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6582	6597		10.1096/fj.201903007RR	http://dx.doi.org/10.1096/fj.201903007RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32202349				2022-12-28	WOS:000531325500041
J	Zhu, HJ; Lan, LQ; Zhang, YX; Chen, QR; Zeng, YL; Luo, XF; Ren, JH; Chen, SZ; Xiao, M; Lin, KN; Chen, MM; Li, Q; Chen, YQ; Xu, JJ; Zheng, ZH; Chen, ZZ; Xie, YX; Hu, JD; Yang, T				Zhu, Haojie; Lan, Lingqiong; Zhang, Yuxin; Chen, Qiuru; Zeng, Yanling; Luo, Xiaofeng; Ren, Jinhua; Chen, Shaozhen; Xiao, Min; Lin, Kangni; Chen, Minmin; Li, Qian; Chen, Yongquan; Xu, Jingjing; Zheng, Zhihong; Chen, Zhizhe; Xie, Yongxin; Hu, Jianda; Yang, Ting			Epidermal growth factor stimulates exosomal microRNA-21 derived from mesenchymal stem cells to ameliorate aGVHD by modulating regulatory T cells	FASEB JOURNAL			English	Article						acute graft-versus-host disease; bone marrow-derived mesenchymal stem cells; epidermal growth factor; exosomes; microRNA-21; regulatory T cells	VERSUS-HOST-DISEASE; STROMAL CELLS; EGF; PROLIFERATION; PREVENTION; EXPRESSION; SIGNATURE; MIGRATION; MODEL; ROLES	Regulatory T cells (Tregs), a subset of CD4(+) T cells, may exert inhibitory effects on alloimmune responses including acute graft-versus-host disease (aGVHD), and several microRNAs are implicated in the pathophysiological process of GVHD. Therefore, we aimed in the present study to characterize the functional relevance of epidermal growth factor (EGF)-stimulated microRNA-21 (miR-21) in regulating bone marrow-derived mesenchymal stem cells (BMSCs) in a mouse model of aGVHD. We first isolated and cultured BMSCs and Tregs. Then, we examined effects of miR-21 knockdown or overexpression and EGF on cell activities of BMSCs and the expression of PTEN, Foxp3, AKT phosphorylation, and extent of c-jun phosphorylation by gain- and loss-of-function approaches. The results showed that miR-21 promoted the proliferation, invasion, and migration of BMSCs. Furthermore, miR-21 in BMSCs-derived exosomes inhibited PTEN, but enhanced AKT phosphorylation and Foxp3 expression in Tregs. In addition, EGF enhanced c-jun phosphorylation to elevate the miR-21 expression. Furthermore, EGF significantly increased the efficacy of BMSCs in a mouse model of aGVHD, manifesting in reduced IFN-gamma expression and lesser organ damage. Moreover, EGF treatment promoted the Foxp3 expression of Tregs in BMSCs-treated aGVHD mice. Taken together, EGF induced the BMSCs-derived exosomal miR-21 expression, which enhanced Foxp3 expression in Tregs, thereby improving the therapeutic effect of BMSCs on aGVHD.	[Zhu, Haojie; Lan, Lingqiong; Zhang, Yuxin; Chen, Qiuru; Zeng, Yanling; Luo, Xiaofeng; Ren, Jinhua; Chen, Shaozhen; Xiao, Min; Lin, Kangni; Chen, Minmin; Li, Qian; Chen, Yongquan; Xu, Jingjing; Zheng, Zhihong; Chen, Zhizhe; Hu, Jianda; Yang, Ting] Fujian Med Univ, Fujian Prov Key Lab Hematol, Union Hosp, Dept Hematol,Fujian Inst Hematol, 29 Xinquan Rd, Fuzhou 350001, Fujian, Peoples R China; [Lan, Lingqiong; Xie, Yongxin] Second Hosp Longyan, Dept Hematol, Longyan, Peoples R China	Fujian Medical University	Hu, JD; Yang, T (corresponding author), Fujian Med Univ, Fujian Prov Key Lab Hematol, Union Hosp, Dept Hematol,Fujian Inst Hematol, 29 Xinquan Rd, Fuzhou 350001, Fujian, Peoples R China.	drjiandahu@163.com; yang.hopeting@gmail.com			National Natural Science Foundation of China (NSFC) [81870138, 81570162, 81700131]; Fujian Provincial Healthy Commission and the Education Department of Fujian Province [2019-WJ24]; Fujian Province Department of Science Technology [2017Y9056, 2017Y9017, 2017Y9104, 2018Y0031, 2018J01312]; Startup Fund for scientific research Project of Fujian Medical University [2017XQ1047, 2017XQ2036]; Construction Project of Fujian Medical Center of Hematology [Min201704]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Fujian Provincial Healthy Commission and the Education Department of Fujian Province; Fujian Province Department of Science Technology; Startup Fund for scientific research Project of Fujian Medical University; Construction Project of Fujian Medical Center of Hematology	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81870138, 81570162 and 81700131; Fujian Provincial Healthy Commission and the Education Department of Fujian Province, Grant/Award Number: 2019-WJ24; Fujian Province Department of Science & Technology, Grant/Award Number: 2017Y9056, 2017Y9017, 2017Y9104, 2018Y0031 and 2018J01312; Startup Fund for scientific research Project of Fujian Medical University, Grant/Award Number: 2017XQ1047 and 2017XQ2036; Construction Project of Fujian Medical Center of Hematology, Grant/Award Number: Min201704	Arthur-Farraj PJ, 2017, CELL REP, V20, P2719, DOI 10.1016/j.celrep.2017.08.064; Bae JA, 2014, CLIN CANCER RES, V20, P4115, DOI 10.1158/1078-0432.CCR-13-2863; Cao L, 2017, BIOMED PHARMACOTHER, V93, P570, DOI 10.1016/j.biopha.2017.06.089; Chen YJ, 2016, TOXICOL APPL PHARM, V310, P98, DOI 10.1016/j.taap.2016.09.007; Cheng Q, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/9012152; Cooke KR, 1996, BLOOD, V88, P3230, DOI 10.1182/blood.V88.8.3230.bloodjournal8883230; Echevarria-Vargas IM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097094; Flowers MED, 2011, BLOOD, V117, P3214, DOI 10.1182/blood-2010-08-302109; Gimondi S, 2016, EXP HEMATOL, V44, P624, DOI 10.1016/j.exphem.2016.03.005; Guo XF, 2018, ONCOGENE, V37, P4239, DOI 10.1038/s41388-018-0261-9; Han ML, 2012, MOL CELL BIOCHEM, V363, P427, DOI 10.1007/s11010-011-1195-5; Hebert TL, 2009, J TISSUE ENG REGEN M, V3, P553, DOI 10.1002/term.198; Holtan SG, 2016, TRANSL RES, V167, P80, DOI 10.1016/j.trsl.2015.06.001; Hu Y, 2015, IMMUNOL CELL BIOL, V93, P753, DOI 10.1038/icb.2015.37; Jalapothu D, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00361; Kebriaei P, 2009, BIOL BLOOD MARROW TR, V15, P804, DOI 10.1016/j.bbmt.2008.03.012; Kern HB, 2012, DNA CELL BIOL, V31, P1403, DOI 10.1089/dna.2011.1469; Liu HZ, 2014, INT J MOL SCI, V15, P4007, DOI 10.3390/ijms15034007; Liu Yue-Jun, 2006, Zhonghua Nei Ke Za Zhi, V45, P835; Martin PJ, 2012, BIOL BLOOD MARROW TR, V18, P1150, DOI 10.1016/j.bbmt.2012.04.005; Messina C, 2008, BONE MARROW TRANSPL, V41, pS65, DOI 10.1038/bmt.2008.57; Nishikii H, 2016, BLOOD, V128, P2846, DOI 10.1182/blood-2016-06-723783; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Park JH, 2009, AM J PHYSIOL-CELL PH, V297, pC935, DOI 10.1152/ajpcell.00121.2009; Pierini A, 2016, BLOOD, V128, P866, DOI 10.1182/blood-2016-04-711275; Prasad VK, 2011, BIOL BLOOD MARROW TR, V17, P534, DOI 10.1016/j.bbmt.2010.04.014; Ranganathan P, 2012, BLOOD, V119, P4786, DOI 10.1182/blood-2011-10-387522; Rodrigues M, 2013, STEM CELLS, V31, P104, DOI 10.1002/stem.1215; Rouas R, 2009, EUR J IMMUNOL, V39, P1608, DOI 10.1002/eji.200838509; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Shi B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191616; Socie G, 2009, BLOOD, V114, P4327, DOI 10.1182/blood-2009-06-204669; Stickel N, 2014, BLOOD, V124, P2586, DOI 10.1182/blood-2014-04-569046; Tian Y, 2008, IMMUNOL INVEST, V37, P29, DOI 10.1080/08820130701410223; Wang L, 2016, STEM CELLS DEV, V25, P1874, DOI 10.1089/scd.2016.0107; Wu KN, 2009, CELL CYCLE, V8, P3601, DOI 10.4161/cc.8.21.9999; Wu TT, 2015, STEM CELLS, V33, P3281, DOI 10.1002/stem.2081; Xiao B, 2013, BLOOD, V122, P3365, DOI 10.1182/blood-2013-06-510586; Xu ZC, 2018, BIOCHEM BIOPH RES CO, V503, P146, DOI 10.1016/j.bbrc.2018.05.200; Yan XL, 2012, BREAST CANCER RES TR, V132, P153, DOI 10.1007/s10549-011-1577-0; Yuan HX, 2017, ONCOL LETT, V14, P3371, DOI 10.3892/ol.2017.6605; Zeng YL, 2017, ONCOTARGET, V8, P29161, DOI 10.18632/oncotarget.16254; Zhao QY, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1182-9; Zou XY, 2018, KIDNEY BLOOD PRESS R, V43, P152, DOI 10.1159/000487369	44	6	7	1	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					7372	7386		10.1096/fj.201900847RRRR	http://dx.doi.org/10.1096/fj.201900847RRRR		APR 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32314840				2022-12-28	WOS:000527568800001
J	Schruf, E; Schroeder, V; Le, HQ; Schonberger, T; Raedel, D; Stewart, EL; Fundel-Clemens, K; Bluhmki, T; Weigle, S; Schuler, M; Thomas, MJ; Heilker, R; Webster, MJ; Dass, M; Frick, M; Stierstorfer, B; Quast, K; Garnett, JP				Schruf, Eva; Schroeder, Victoria; Le, Huy Q.; Schoenberger, Tanja; Raedel, Dagmar; Stewart, Emily L.; Fundel-Clemens, Katrin; Bluhmki, Teresa; Weigle, Sabine; Schuler, Michael; Thomas, Matthew J.; Heilker, Ralf; Webster, Megan J.; Dass, Martin; Frick, Manfred; Stierstorfer, Birgit; Quast, Karsten; Garnett, James P.			Recapitulating idiopathic pulmonary fibrosis related alveolar epithelial dysfunction in a human iPSC-derived air-liquid interface model	FASEB JOURNAL			English	Article						alveolar epithelium; bronchiolization; induced pluripotent stem cells; IPF; pro-fibrotic milieu	BRONCHOALVEOLAR LAVAGE FLUID; PLURIPOTENT STEM-CELLS; CYTOKINE PROFILE; PROGENITOR CELLS; LUNG EPITHELIUM; LAMELLAR BODIES; IN-VITRO; DIFFERENTIATION; REPAIR; INTERLEUKIN-13	Idiopathic pulmonary fibrosis (IPF) is a fatal disease of unknown cause that is characterized by progressive fibrotic lung remodeling. An abnormal emergence of airway epithelial-like cells within the alveolar compartments of the lung, herein termed bronchiolization, is often observed in IPF. However, the origin of this dysfunctional distal lung epithelium remains unknown due to a lack of suitable human model systems. In this study, we established a human induced pluripotent stem cell (iPSC)-derived air-liquid interface (ALI) model of alveolar epithelial type II (ATII)-like cell differentiation that allows us to investigate alveolar epithelial progenitor cell differentiation in vitro. We treated this system with an IPF-relevant cocktail (IPF-RC) to mimic the pro-fibrotic cytokine milieu present in IPF lungs. Stimulation with IPF-RC during differentiation increases secretion of IPF biomarkers and RNA sequencing (RNA-seq) of these cultures reveals significant overlap with human IPF patient data. IPF-RC treatment further impairs ATII differentiation by driving a shift toward an airway epithelial-like expression signature, providing evidence that a pro-fibrotic cytokine environment can influence the proximo-distal differentiation pattern of human lung epithelial cells. In conclusion, we show for the first time, the establishment of a human model system that recapitulates aspects of IPF-associated bronchiolization of the lung epithelium in vitro.	[Schruf, Eva; Schroeder, Victoria; Le, Huy Q.; Stewart, Emily L.; Thomas, Matthew J.; Webster, Megan J.; Garnett, James P.] Boehringer Ingelheim Pharma GmbH & Co KG, Immunol & Resp Dis Res, Biberach, Germany; [Schoenberger, Tanja; Bluhmki, Teresa; Weigle, Sabine; Schuler, Michael; Heilker, Ralf; Frick, Manfred; Stierstorfer, Birgit] Boehringer Ingelheim Pharma GmbH & Co KG, Drug Discovery Sci, Biberach, Germany; [Raedel, Dagmar; Dass, Martin] Boehringer Ingelheim Pharma GmbH & Co KG, Nonclin Drug Safety, Biberach, Germany; [Fundel-Clemens, Katrin; Quast, Karsten] Boehringer Ingelheim Pharma GmbH & Co KG, Global Computat Biol, Biberach, Germany; [Garnett, James P.] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England	Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim; Newcastle University - UK	Garnett, JP (corresponding author), Boehringer Ingelheim Pharma GmbH & Co KG, Birkendorfer Str 65, D-88397 Biberach, Germany.	james.garnett@boehringer-ingelheim.com	Frick, Manfred/E-1374-2012; Le, Huy/AAW-4220-2021	Frick, Manfred/0000-0002-4763-1104; Le, Huy/0000-0002-0851-9320; Thomas, Matthew/0000-0003-3472-3904	Boehringer Ingelheim Pharma GmbH Co.KG; UK Medical Research Foundation Fellowship [MRF-091-0001-RG-GARNE]	Boehringer Ingelheim Pharma GmbH Co.KG(Boehringer Ingelheim); UK Medical Research Foundation Fellowship	Boehringer Ingelheim Pharma GmbH & Co.KG; UK Medical Research Foundation Fellowship, Grant/Award Number: MRF-091-0001-RG-GARNE	Agostini Carlo, 2006, Proc Am Thorac Soc, V3, P357, DOI 10.1513/pats.200601-010TK; Akram KM, 2013, EUR RESPIR J, V41, P683, DOI 10.1183/09031936.00213411; BARITUSSIO AG, 1981, BIOCHIM BIOPHYS ACTA, V666, P382, DOI 10.1016/0005-2760(81)90297-6; Barkauskas CE, 2013, J CLIN INVEST, V123, P3025, DOI 10.1172/JCI68782; Barlo NP, 2011, CLIN EXP IMMUNOL, V166, P346, DOI 10.1111/j.1365-2249.2011.04468.x; Bellanger AP, 2016, J IMMUNOL METHODS, V434, P61, DOI 10.1016/j.jim.2016.04.008; Bertoncello I, 2016, J CELL PHYSIOL, V231, P2582, DOI 10.1002/jcp.25404; Bingle CD, 2013, THORAX, V68, P1167, DOI 10.1136/thoraxjnl-2013-204179; Buendia-Roldan I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168552; Chambers Rachel C, 2015, Ann Am Thorac Soc, V12 Suppl 1, pS16, DOI 10.1513/AnnalsATS.201410-448MG; CHANDER A, 1986, J BIOL CHEM, V261, P6126; Chen YW, 2017, NAT CELL BIOL, V19, P542, DOI 10.1038/ncb3510; Chen Y, 2018, STEM CELLS DEV, V27, P1339, DOI 10.1089/scd.2018.0042; Evans CM, 2016, PHYSIOL REV, V96, P1567, DOI 10.1152/physrev.00004.2016; Firth AL, 2014, P NATL ACAD SCI USA, V111, pE1723, DOI 10.1073/pnas.1403470111; Gotoh S, 2014, STEM CELL REP, V3, P394, DOI 10.1016/j.stemcr.2014.07.005; Guiot J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171344; Hong GH, 2018, RESP RES, V19, DOI 10.1186/s12931-018-0863-3; Huang SXL, 2015, NAT PROTOC, V10, DOI 10.1038/nprot.2015.023; Huang SXL, 2014, NAT BIOTECHNOL, V32, P84, DOI 10.1038/nbt.2754; Jacob A, 2017, CELL STEM CELL, V21, P472, DOI 10.1016/j.stem.2017.08.014; Keenan AB, 2019, NUCLEIC ACIDS RES, V47, pW212, DOI 10.1093/nar/gkz446; KHOOR A, 1994, J HISTOCHEM CYTOCHEM, V42, P1187, DOI 10.1177/42.9.8064126; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; Knudsen L, 2017, CELL TISSUE RES, V367, P607, DOI 10.1007/s00441-016-2543-2; Kotton DN, 2014, NAT MED, V20, P822, DOI 10.1038/nm.3642; Kumar PA, 2011, CELL, V147, P525, DOI 10.1016/j.cell.2011.10.001; Kusko RL, 2016, AM J RESP CRIT CARE, V194, P948, DOI 10.1164/rccm.201510-2026OC; Lederer DJ, 2018, NEW ENGL J MED, V378, P1811, DOI 10.1056/NEJMra1705751; Lee CG, 2001, J EXP MED, V194, P809, DOI 10.1084/jem.194.6.809; Lee JU, 2017, BMC PULM MED, V17, DOI 10.1186/s12890-017-0380-z; Li L, 2015, CELL PHYSIOL BIOCHEM, V37, P1113, DOI 10.1159/000430236; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Lin LJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14602-7; Maher TM, 2017, LANCET RESP MED, V5, P946, DOI 10.1016/S2213-2600(17)30430-7; Mao P, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12288; McDonough JE, 2019, THORAX, V74, P132, DOI 10.1136/thoraxjnl-2018-211929; Meloni F, 2004, SARCOIDOSIS VASC DIF, V21, P111; Metsalu T, 2015, NUCLEIC ACIDS RES, V43, pW566, DOI 10.1093/nar/gkv468; Miller AJ, 2018, STEM CELL REP, V10, P101, DOI 10.1016/j.stemcr.2017.11.012; Moore BB, 2013, AM J RESP CELL MOL, V49, P167, DOI 10.1165/rcmb.2013-0094TR; Murray LA, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92192; Nabhan AN, 2018, SCIENCE, V359, P1118, DOI 10.1126/science.aam6603; Nikolic MZ, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.163485; Nikolic MZ, 2017, ELIFE, V6, DOI [10.7554/eLife.26575, 10.7554/eLife.26575.001]; Ochieng JK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107248; Park SW, 2009, J KOREAN MED SCI, V24, P614, DOI 10.3346/jkms.2009.24.4.614; Parker JM, 2018, AM J RESP CRIT CARE, V197, P94, DOI 10.1164/rccm.201704-0784OC; Passalacqua G, 2017, PULM PHARMACOL THER, V45, P95, DOI 10.1016/j.pupt.2017.05.007; Plantier L, 2011, THORAX, V66, P651, DOI 10.1136/thx.2010.151555; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Rawlins EL, 2009, CELL STEM CELL, V4, P525, DOI 10.1016/j.stem.2009.04.002; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rockich BE, 2013, P NATL ACAD SCI USA, V110, pE4456, DOI 10.1073/pnas.1311847110; de Carvalho ALRT, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.171652; Rosas IO, 2008, PLOS MED, V5, P623, DOI 10.1371/journal.pmed.0050093; Ryu JH, 2014, MAYO CLIN PROC, V89, P1130, DOI 10.1016/j.mayocp.2014.03.016; Sakai N, 2013, BBA-MOL BASIS DIS, V1832, P911, DOI 10.1016/j.bbadis.2013.03.001; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schruf E, 2019, RESP RES, V20, DOI 10.1186/s12931-019-1058-2; Seibold MA, 2018, ANN AM THORAC SOC, V15, pS98, DOI 10.1513/AnnalsATS.201711-868MG; Seibold MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058658; Seibold MA, 2011, NEW ENGL J MED, V364, P1503, DOI 10.1056/NEJMoa1013660; Selman M, 2001, RESP RES, V3, DOI 10.1186/rr175; Selman M, 2008, PLOS MED, V5, P373, DOI 10.1371/journal.pmed.0050062; Shi W, 2009, RESPIROLOGY, V14, P656, DOI 10.1111/j.1440-1843.2009.01565.x; Smirnova NF, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0404-x; Smith M, 2013, J CLIN PATHOL, V66, P896, DOI 10.1136/jclinpath-2013-201442; Sollner JF, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.185; Sokai A, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0280-9; Stahlman MT, 2007, J HISTOCHEM CYTOCHEM, V55, P71, DOI 10.1369/jhc.6A6962.2006; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sundarakrishnan A, 2018, ADV DRUG DELIVER REV, V129, P78, DOI 10.1016/j.addr.2017.12.013; Tasaka S, 2012, RESPIROLOGY, V17, P814, DOI 10.1111/j.1440-1843.2012.02182.x; Tompkins DH, 2011, AM J RESP CELL MOL, V45, P101, DOI 10.1165/rcmb.2010-0149OC; Treutlein B, 2014, NATURE, V509, P371, DOI 10.1038/nature13173; Van der Velden JL, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-123; Vasakova M, 2009, SCAND J IMMUNOL, V69, P268, DOI 10.1111/j.1365-3083.2008.02222.x; Weigle Sabine, 2019, Journal of Biological Methods, V6, pe115, DOI 10.14440/jbm.2019.285; Whitsett JA, 2011, AM J RESP CRIT CARE, V184, P401, DOI 10.1164/rccm.201103-0495PP; Winters NI, 2019, AM J MED SCI, V357, P374, DOI 10.1016/j.amjms.2019.01.010; Wong AP, 2012, NAT BIOTECHNOL, V30, P876, DOI 10.1038/nbt.2328; Xu XF, 2016, CLIN RESPIR J, V10, P133, DOI 10.1111/crj.12190; Xu Y, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.90558; Yamamoto Y, 2017, NAT METHODS, V14, P1097, DOI [10.1038/NMETH.4448, 10.1038/nmeth.4448]; Yang IV, 2013, THORAX, V68, P1114, DOI 10.1136/thoraxjnl-2012-202943; Zacharias WJ, 2018, NATURE, V555, P251, DOI 10.1038/nature25786; Zepp JA, 2017, CELL, V170, P1134, DOI 10.1016/j.cell.2017.07.034; Zhang YW, 2016, RESPIROLOGY, V21, P143, DOI 10.1111/resp.12659	90	14	15	2	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					7825	7846		10.1096/fj.201902926R	http://dx.doi.org/10.1096/fj.201902926R		APR 2020	22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32297676	Green Published, hybrid			2022-12-28	WOS:000526650100001
J	Miranda, HV; Chegao, A; Oliveira, MS; Gomes, BF; Enguita, FJ; Outeiro, TF				Miranda, Hugo Vicente; Chegao, Ana; Oliveira, Marcia S.; Gomes, Barbara Fernandes; Enguita, Francisco J.; Outeiro, Tiago Fleming			Hsp27 reduces glycation-induced toxicity and aggregation of alpha-synuclein	FASEB JOURNAL			English	Article						alpha-synuclein; glycation; Hsp27; neurodegeneration; Parkinson's disease	HEAT-SHOCK PROTEINS; B-CRYSTALLIN; PARKINSONS-DISEASE; NEURODEGENERATIVE DISORDERS; MOLECULAR CHAPERONES; ALZHEIMERS-DISEASE; CELL-DEATH; METHYLGLYOXAL; HEAT-SHOCK-PROTEIN-27; PHOSPHORYLATION	alpha-synuclein (aSyn) is a major player in Parkinson's disease and a group of other disorders collectively known as synucleinopathies, but the precise molecular mechanisms involved are still unclear. aSyn, as virtually all proteins, undergoes a series of posttranslational modifications during its lifetime, which can affect its biology and pathobiology. We recently showed that glycation of aSyn by methylglyoxal (MGO) potentiates its oligomerization and toxicity, induces dopaminergic neuronal cell loss in mice, and affects motor performance in flies. Small heat-shock proteins (sHsps) are molecular chaperones that facilitate the folding of proteins or target misfolded proteins for clearance. Importantly, sHsps were shown to prevent aSyn aggregation and cytotoxicity. Upon treating cells with increasing amounts of methylglyoxal, we found that the levels of Hsp27 decreased in a dose-dependent manner. Therefore, we hypothesized that restoring the levels of Hsp27 in glycating environments could alleviate the pathogenicity of aSyn. Consistently, we found that Hsp27 reduced MGO-induced aSyn aggregation in cells, leading to the formation of nontoxic aSyn species. Remarkably, increasing the levels of Hsp27 suppressed the deleterious effects induced by MGO. Our findings suggest that in glycating environments, the levels of Hsp27 are important for modulating the glycation-associated cellular pathologies in synucleinopathies.	[Miranda, Hugo Vicente; Chegao, Ana; Oliveira, Marcia S.; Gomes, Barbara Fernandes; Outeiro, Tiago Fleming] Univ Nova Lisboa, Fac Ciencias Med, Chron Dis Res Ctr, NOVA Med Sch,CEDOC, Lisbon, Portugal; [Enguita, Francisco J.] Univ Lisbon, Fac Med, Inst Med Mol Joao Lobo Antunes, Lisbon, Portugal; [Outeiro, Tiago Fleming] Univ Med Ctr Gottingen, Ctr Biostruct Imaging Neurodegenerat, Dept Expt Neurodegenerat, Gottingen, Germany; [Outeiro, Tiago Fleming] Max Planck Inst Expt Med, Gottingen, Germany; [Outeiro, Tiago Fleming] Newcastle Univ, Fac Med Sci, Translat & Clin Res Inst, Newcastle Upon Tyne, Tyne & Wear, England	Universidade Nova de Lisboa; Universidade de Lisboa; University of Gottingen; Max Planck Society; Newcastle University - UK	Miranda, HV (corresponding author), NOVA Med Sch, Chron Dis Res Ctr, CEDOC, Rua Camara Pestana 6,Edificio CEDOC II, P-1150082 Lisbon, Portugal.; Outeiro, TF (corresponding author), Univ Med Gottingen, Expt Neurodegenerat, Waldweg 33, D-37073 Gottingen, Germany.	hmvmiranda@nms.unl.pt; touteir@gwdg.de	Outeiro, Tiago/L-7351-2019; Chegão, Ana/AAX-7264-2020; Enguita, Francisco J./A-2347-2009; Miranda, Hugo Vicente/I-3525-2013; Chegao, Ana/Q-6557-2018	Outeiro, Tiago/0000-0003-1679-1727; Enguita, Francisco J./0000-0002-8072-8557; Miranda, Hugo Vicente/0000-0001-8065-9259; Chegao, Ana/0000-0003-2304-4121; Fernandes Gomes, Barbara/0000-0002-1512-6699	Fundacao para a Ciencia e Tecnologia [PTDC/NEU-OSD/5644/2014, EXPL/NEU-OSD/0606/2012, SFRH/BPD/109347/2015, PD/BD/136863/2018]; EU Joint Programme - Neurodegenerative Disease Research (JPND)	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); EU Joint Programme - Neurodegenerative Disease Research (JPND)	Fundacao para a Ciencia e Tecnologia, Grant/Award Number: PTDC/NEU-OSD/5644/2014, EXPL/NEU-OSD/0606/2012, SFRH/BPD/109347/2015, EXPL/NEU-OSD/0606/2012, PD/BD/136863/2018 and PTDC/NEU-OSD/5644/2014; EU Joint Programme - Neurodegenerative Disease Research (JPND)	Abisambra JF, 2010, J NEUROSCI, V30, P15374, DOI 10.1523/JNEUROSCI.3155-10.2010; Aquilina JA, 2013, J BIOL CHEM, V288, P13602, DOI 10.1074/jbc.M112.443812; Ardah MT, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00197; ARRIGO AP, 1988, EXP CELL RES, V175, P169, DOI 10.1016/0014-4827(88)90264-9; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Baraibar MA, 2012, PROG MOL BIOL TRANSL, V109, P249, DOI 10.1016/B978-0-12-397863-9.00007-9; Bartelt-Kirbach B, 2014, CELL STRESS CHAPERON, V19, P145, DOI [10.1007/s12192-013-0452-9, 10.1007/s12192-013-0465-4]; Bjorkdahl C, 2008, J NEUROSCI RES, V86, P1343, DOI 10.1002/jnr.21589; Braak H, 2001, ACTA NEUROPATHOL, V102, P449; Bruinsma IB, 2011, PROTEINS, V79, P2956, DOI 10.1002/prot.23152; Carra S, 2017, CELL STRESS CHAPERON, V22, P601, DOI 10.1007/s12192-017-0787-8; CHEN TS, 1989, P SOC EXP BIOL MED, V190, P399; Cox D, 2018, J BIOL CHEM, V293, P4486, DOI 10.1074/jbc.M117.813865; Cox D, 2017, CELL STRESS CHAPERON, V22, P589, DOI 10.1007/s12192-017-0785-x; Cox D, 2016, J BIOL CHEM, V291, P22618, DOI 10.1074/jbc.M116.739250; Daniele SG, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005965; de Oliveira RM, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2000374; Fauvet B, 2012, J BIOL CHEM, V287, P15345, DOI 10.1074/jbc.M111.318949; Gawlowski T, 2009, HORM METAB RES, V41, P594, DOI 10.1055/s-0029-1216374; Gomes RA, 2006, FEBS J, V273, P5273, DOI 10.1111/j.1742-4658.2006.05520.x; Goncalves S, 2013, MOL NEUROBIOL, V47, P1081, DOI 10.1007/s12035-013-8406-x; Guay J, 1997, J CELL SCI, V110, P357; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; Killinger BA, 2016, ANAL CHEM, V88, P4071, DOI 10.1021/acs.analchem.6b00419; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Konig A, 2018, J PARKINSON DIS, V8, P33, DOI 10.3233/JPD-171285; Kudva YC, 1997, FEBS LETT, V416, P117, DOI 10.1016/S0014-5793(97)01180-0; LAVOIE JN, 1993, J BIOL CHEM, V268, P24210; Lazaro DF, 2017, EXP NEUROL, V298, P162, DOI 10.1016/j.expneurol.2017.05.007; Lazaro DF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004741; Lee D, 2009, BBA-PROTEINS PROTEOM, V1794, P421, DOI 10.1016/j.bbapap.2008.11.016; Lee S, 2006, BIOCHEM BIOPH RES CO, V347, P527, DOI 10.1016/j.bbrc.2006.06.128; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; Marvian AT, 2019, J NEUROCHEM, V150, P535, DOI 10.1111/jnc.14707; Masaracchia C, 2019, BBA-PROTEINS PROTEOM, V1868, P140298; McLean PJ, 2002, J NEUROCHEM, V83, P846, DOI 10.1046/j.1471-4159.2002.01190.x; McLean PJ, 2001, NEUROSCIENCE, V104, P901, DOI 10.1016/S0306-4522(01)00113-0; McLean PJ, 2000, J NEURAL TRANSM-SUPP, P53; Mehlen P, 1997, J BIOL CHEM, V272, P31657, DOI 10.1074/jbc.272.50.31657; Mehlen P, 1997, BIOCHEM BIOPH RES CO, V241, P187, DOI 10.1006/bbrc.1997.7635; Michel PP, 2016, NEURON, V90, P675, DOI 10.1016/j.neuron.2016.03.038; Mymrikov EV, 2010, CELL STRESS CHAPERON, V15, P365, DOI 10.1007/s12192-009-0151-8; Nagaraj RH, 2003, BIOCHEMISTRY-US, V42, P10746, DOI 10.1021/bi034541n; Outeiro TF, 2006, BIOCHEM BIOPH RES CO, V351, P631, DOI 10.1016/j.bbrc.2006.10.085; Oya-Ito T, 2006, J CELL BIOCHEM, V99, P279, DOI 10.1002/jcb.20781; Oya-Ito T, 2011, BBA-MOL BASIS DIS, V1812, P769, DOI 10.1016/j.bbadis.2011.03.017; Padival AK, 2003, FEBS LETT, V551, P113, DOI 10.1016/S0014-5793(03)00874-3; Paul C, 2010, EXP CELL RES, V316, P1535, DOI 10.1016/j.yexcr.2010.03.006; Pinho R, 2019, HUM MOL GENET, V28, P31, DOI 10.1093/hmg/ddy326; RENKAWEK K, 1994, ACTA NEUROPATHOL, V87, P511; Renkawek K, 1999, NEUROREPORT, V10, P2273, DOI 10.1097/00001756-199908020-00009; RICHARD JP, 1993, BIOCHEM SOC T, V21, P549, DOI 10.1042/bst0210549; Rogalla T, 1999, J BIOL CHEM, V274, P18947, DOI 10.1074/jbc.274.27.18947; Saibil H, 2013, NAT REV MOL CELL BIO, V14, P630, DOI 10.1038/nrm3658; Sakamoto H, 2002, J BIOL CHEM, V277, P45770, DOI 10.1074/jbc.M207485200; Schalkwijk CG, 2006, FEBS LETT, V580, P1565, DOI 10.1016/j.febslet.2006.01.086; Schultz C, 2001, NEUROBIOL AGING, V22, P677, DOI 10.1016/S0197-4580(01)00229-9; Shachar T, 2011, MOVEMENT DISORD, V26, P1593, DOI 10.1002/mds.23774; Gadad BS, 2011, J ALZHEIMERS DIS, V24, P223, DOI 10.3233/JAD-2011-110182; Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Spillantini MG, 1998, NEUROSCI LETT, V251, P205, DOI 10.1016/s0304-3940(98)00504-7; Stamler R, 2005, J MOL BIOL, V353, P68, DOI 10.1016/j.jmb.2005.08.025; Sugiyama Y, 2000, J BIOL CHEM, V275, P1095, DOI 10.1074/jbc.275.2.1095; Treweek TM, 2015, CELL MOL LIFE SCI, V72, P429, DOI 10.1007/s00018-014-1754-5; van Heijst JWJ, 2006, CANCER LETT, V241, P309, DOI 10.1016/j.canlet.2005.10.042; van Montfort RLM, 2001, NAT STRUCT BIOL, V8, P1025, DOI 10.1038/nsb722; Vekrellis K, 2011, LANCET NEUROL, V10, P1041, DOI 10.1016/S1474-4422(11)70213-7; Vicente Miranda H, 2017, BRAIN, V140, P1399, DOI 10.1093/brain/awx056; Vicente Miranda H, 2016, MOVEMENT DISORD, V31, P782, DOI 10.1002/mds.26566; Vicente Miranda H, 2013, J NEUROCHEM, V126, P673, DOI 10.1111/jnc.12251; Vicente Miranda H, 2010, J PATHOL, V221, P13, DOI 10.1002/path.2682; Wales P, 2013, J PARKINSON DIS, V3, P415, DOI 10.3233/JPD-130216; Walther DM, 2015, CELL, V161, P919, DOI 10.1016/j.cell.2015.03.032; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Wilhelmus MMM, 2006, BRAIN RES, V1089, P67, DOI 10.1016/j.brainres.2006.03.058; Yerbury JJ, 2013, CELL STRESS CHAPERON, V18, P251, DOI 10.1007/s12192-012-0371-1; Zourlidou A, 2004, J NEUROCHEM, V88, P1439, DOI 10.1046/j.1471-4159.2003.02273.x	80	10	10	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6718	6728		10.1096/fj.201902936R	http://dx.doi.org/10.1096/fj.201902936R		APR 2020	11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32259355	Green Submitted, hybrid			2022-12-28	WOS:000525285600001
J	Dumbuya, H; Hafez, SY; Oancea, E				Dumbuya, Hawasatu; Hafez, Salwa Y.; Oancea, Elena			Cross talk between calcium and ROS regulate the UVA-induced melanin response in human melanocytes	FASEB JOURNAL			English	Article						calcium; human epidermal melanocytes; melanin; mitochondria; reactive oxygen species; ultraviolet radiation	HUMAN SKIN; MITOCHONDRIAL SUPEROXIDE; ENDOPLASMIC-RETICULUM; OXIDATIVE STRESS; SINGLET OXYGEN; IN-VITRO; LIGHT; PHOTOTRANSDUCTION; CONTACTS; CELL	Exposure to high doses of solar long wavelength ultraviolet radiation (UVA) damages human skin via reactive oxygen species (ROS). Whether physiological UVA doses also generate ROS that has an effect on the skin remains unknown. We previously showed that in human epidermal melanocytes UVA activates a G-protein coupled signaling pathway that leads to calcium mobilization and increased melanin. Here, we report that ROS generated by the UVA phototransduction pathway are critical cellular messengers required to augment melanin. Using simultaneous UVA exposure and live-cell imaging of primary human melanocytes, we found that physiological doses of UVA generate two spatiotemporally distinct sources of ROS: one upstream of the G-protein activation that potentiates calcium responses, and another source downstream of calcium, in the mitochondria (ROSmito). UVA-evoked signaling led to mitochondrial calcium uptake via mitochondrial calcium uniporter to promote ROS(mito)production leading to melanin synthesis. Our findings reveal a novel mechanism in which ROS function as signaling messengers necessary for melanin production, thus having a protective role in the UVA-induced skin response.	[Dumbuya, Hawasatu; Hafez, Salwa Y.; Oancea, Elena] Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA; [Hafez, Salwa Y.] King Saud bin Abdulaziz Univ Hlth Sci, Coll Med, Jeddah, Saudi Arabia; [Dumbuya, Hawasatu] LOreal USA, Res & Innovat, 133 Terminal Ave, Clark, NJ 07066 USA	Brown University; King Saud Bin Abdulaziz University for Health Sciences; L'Oreal Group	Oancea, E (corresponding author), Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA.	elena_oancea@brown.edu			NIAMS NIH HHS [R01 AR066318] Funding Source: Medline	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Agar NS, 2004, P NATL ACAD SCI USA, V101, P4954, DOI 10.1073/pnas.0401141101; Apalla Zoe, 2017, Dermatol Pract Concept, V7, P1, DOI 10.5826/dpc.0702a01; Ayoub MA, 2009, J BIOL CHEM, V284, P29136, DOI 10.1074/jbc.M109.042333; Baumler W, 2012, PHOTOCH PHOTOBIO SCI, V11, P107, DOI 10.1039/c1pp05142c; Baik LS, 2017, P NATL ACAD SCI USA, V114, P776, DOI 10.1073/pnas.1607989114; Bansaghi S, 2014, J BIOL CHEM, V289, P8170, DOI 10.1074/jbc.M113.504159; BASUMODAK S, 1993, CANCER RES, V53, P4505; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Bellono NW, 2014, J GEN PHYSIOL, V143, P203, DOI 10.1085/jgp.201311094; Bellono NW, 2013, P NATL ACAD SCI USA, V110, P2383, DOI 10.1073/pnas.1215555110; Bhatla N, 2015, NEURON, V85, P804, DOI 10.1016/j.neuron.2014.12.061; Booth DM, 2016, MOL CELL, V63, P240, DOI 10.1016/j.molcel.2016.05.040; Brenner M, 2008, PHOTOCHEM PHOTOBIOL, V84, P539, DOI 10.1111/j.1751-1097.2007.00226.x; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Buonocore G, 2010, SEMIN FETAL NEONAT M, V15, P186, DOI 10.1016/j.siny.2010.04.003; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Cocheme HM, 2008, J BIOL CHEM, V283, P1786, DOI 10.1074/jbc.M708597200; Collins Y, 2012, J CELL SCI, V125, P801, DOI 10.1242/jcs.098475; Csordas G, 2010, MOL CELL, V39, P121, DOI 10.1016/j.molcel.2010.06.029; Cui RT, 2007, CELL, V128, P853, DOI 10.1016/j.cell.2006.12.045; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; D'Mello SAN, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071144; D'Orazio J, 2013, INT J MOL SCI, V14, P12222, DOI 10.3390/ijms140612222; Daniele T, 2014, CURR BIOL, V24, P393, DOI 10.1016/j.cub.2014.01.007; DANPURE HJ, 1976, PHOTOCHEM PHOTOBIOL, V23, P171, DOI 10.1111/j.1751-1097.1976.tb07238.x; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Dikalova AE, 2010, CIRC RES, V107, P106, DOI 10.1161/CIRCRESAHA.109.214601; Dong ZW, 2017, MOL CELL, V65, P1014, DOI 10.1016/j.molcel.2017.01.032; Du EJ, 2016, ELIFE, V5, DOI 10.7554/eLife.18425; Emre Y, 2007, BIOCHEM J, V402, P271, DOI 10.1042/BJ20061430; Ermakova YG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6222; Fogle KJ, 2015, P NATL ACAD SCI USA, V112, P2245, DOI 10.1073/pnas.1416586112; Gong JK, 2017, CELL, V168, P325, DOI 10.1016/j.cell.2016.12.040; Han D, 2001, BIOCHEM J, V353, P411, DOI 10.1042/0264-6021:3530411; Hill K, 2009, CELL CALCIUM, V45, P155, DOI 10.1016/j.ceca.2008.08.001; Honigsmann H, 2002, PHOTODERMATOL PHOTO, V18, P75, DOI 10.1034/j.1600-0781.2002.180204.x; HONIGSMANN H, 1986, J INVEST DERMATOL, V87, P648, DOI 10.1111/1523-1747.ep12456326; Jenkins NC, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/908797; Kamer KJ, 2015, NAT REV MOL CELL BIO, V16, P545, DOI 10.1038/nrm4039; Leiter Ulrike, 2014, Adv Exp Med Biol, V810, P120; Maresca V, 2008, PIGM CELL MELANOMA R, V21, P200, DOI 10.1111/j.1755-148X.2007.00432.x; Marshall J, 2015, J BIOL CHEM, V290, P22030, DOI 10.1074/jbc.M115.662791; Matlib MA, 1998, J BIOL CHEM, V273, P10223, DOI 10.1074/jbc.273.17.10223; Mittler R, 2017, TRENDS PLANT SCI, V22, P11, DOI 10.1016/j.tplants.2016.08.002; Mouret S, 2006, P NATL ACAD SCI USA, V103, P13765, DOI 10.1073/pnas.0604213103; Muliyil S, 2014, DEV CELL, V28, P239, DOI 10.1016/j.devcel.2013.12.019; Muller FL, 2004, J BIOL CHEM, V279, P49064, DOI 10.1074/jbc.M407715200; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Natarajan VT, 2014, NAT CHEM BIOL, V10, P542, DOI [10.1038/NCHEMBIO.1548, 10.1038/nchembio.1548]; Natarajan VT, 2010, J INVEST DERMATOL, V130, P2781, DOI 10.1038/jid.2010.201; Owusu-Ansah E, 2009, NATURE, V461, P537, DOI 10.1038/nature08313; Pan Y, 2011, CELL METAB, V13, P668, DOI 10.1016/j.cmet.2011.03.018; PATHAK MA, 1962, NATURE, V193, P148, DOI 10.1038/193148a0; Premi S, 2015, SCIENCE, V347, P842, DOI 10.1126/science.1256022; Prosser BL, 2011, SCIENCE, V333, P1440, DOI 10.1126/science.1202768; Redmond RW, 2014, J INVEST DERMATOL, V134, P1083, DOI 10.1038/jid.2013.479; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412; Sage E, 2012, PHOTOCH PHOTOBIO SCI, V11, P74, DOI 10.1039/c1pp05219e; Sander CS, 2004, INT J DERMATOL, V43, P326, DOI 10.1111/j.1365-4632.2004.02222.x; Schmitz AL, 2014, CHEM BIOL, V21, P890, DOI 10.1016/j.chembiol.2014.06.003; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Shichida Y, 2009, PHILOS T R SOC B, V364, P2881, DOI 10.1098/rstb.2009.0051; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; Tal MC, 2009, P NATL ACAD SCI USA, V106, P2770, DOI 10.1073/pnas.0807694106; Tormos KV, 2011, CELL METAB, V14, P537, DOI 10.1016/j.cmet.2011.08.007; Tyrrell RM, 2012, PHOTOCH PHOTOBIO SCI, V11, P135, DOI 10.1039/c1pp05222e; Wang HT, 2010, P NATL ACAD SCI USA, V107, P12180, DOI 10.1073/pnas.1005244107; West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973; Wicks NL, 2011, CURR BIOL, V21, P1906, DOI 10.1016/j.cub.2011.09.047; Xu SH, 2014, DEV CELL, V31, P48, DOI 10.1016/j.devcel.2014.08.002; Yang W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000556; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592	74	8	8	2	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					11605	11623		10.1096/fj.201903024R	http://dx.doi.org/10.1096/fj.201903024R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32658369	Bronze			2022-12-28	WOS:000567002100025
J	Fang, Y; Liang, F; Yuan, RQ; Zhu, Q; Cai, SF; Chen, KR; Zhang, JY; Luo, XR; Chen, YS; Mo, DL				Fang, Ying; Liang, Feng; Yuan, Renqiang; Zhu, Qi; Cai, Shufang; Chen, Keren; Zhang, Junyan; Luo, Xiaorong; Chen, Yaosheng; Mo, Delin			High mobility group box 2 regulates skeletal muscle development through ribosomal protein S6 kinase 1	FASEB JOURNAL			English	Article						HMGB2; myogenesis	CELL-CYCLE; IN-VIVO; EXPRESSION; MYF5; HMGB2; PROLIFERATION; REGENERATION; MYOGENIN; MTOR; MRF4	HMGB2, a DNA-binding protein, highly expresses during embryogenesis and plays an important role in development of some organs and tissues. However, it remains to be further investigated weather HMGB2 influences muscle development. In this work, we identified HMGB2 as an essential factor in myogenesis. Compared to wild type (WT) mice, body weights of systemichmgb2homozygous knockout (hmgb2(-/-)) mice especially males were reduced. Diameter and cross-section area of tibialis anterior (TA) muscle fibers as well as expression of Myogenin and MyHC were all decreased inhmgb2(-/-)mice. CTX injury model revealed that HMGB2 was required for satellite cell proliferation and muscle regeneration. Moreover, HMGB2 interacted with S6K1 and regulated the kinase activity of S6K1 during cell proliferation. Knockdown and inactivation of S6K1 in C2C12 cells both resulted in impaired proliferation and differentiation. Furthermore, expression of cyclin D1 and Myf5 were both decreased when HMGB2 or S6K1 were knocked down and kinase activity of S6K1 was inhibited. These results indicate that HMGB2 is required for skeletal muscle development and regeneration, and HMGB2 maintains proliferation of myoblasts through regulating kinase activity of S6K1.	[Fang, Ying; Liang, Feng; Yuan, Renqiang; Zhu, Qi; Cai, Shufang; Chen, Keren; Zhang, Junyan; Luo, Xiaorong; Chen, Yaosheng; Mo, Delin] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou, Peoples R China	Sun Yat Sen University	Mo, DL (corresponding author), Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Higher Educ Mega Ctr, North Third Rd, Guangzhou 510006, Guangdong, Peoples R China.	modelin@mail.sysu.edu.cn	Liang, Feng/GZK-4305-2022; Liang, Fenghua/HHM-3798-2022	Mo, Delin/0000-0002-8738-4486	National Natural Science Foundation of China [31772565]; Sail Plan [2014YT02H042]; Key-Area Research and Development Program of Guangdong Province [2018B020203003]; Science and Technology Project of Guangdong Province [2014B020202001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sail Plan; Key-Area Research and Development Program of Guangdong Province; Science and Technology Project of Guangdong Province	This research was supported by the National Natural Science Foundation of China (31772565), Sail Plan (2014YT02H042), Key-Area Research and Development Program of Guangdong Province (2018B020203003), and the Science and Technology Project of Guangdong Province (2014B020202001).	Albini S, 2015, EMBO REP, V16, P1037, DOI 10.15252/embr.201540159; Asfour HA, 2018, EXP BIOL MED, V243, P118, DOI 10.1177/1535370217749494; Bentzinger CF, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008342; Bonisch C, 2012, NUCLEIC ACIDS RES, V40, P10719, DOI 10.1093/nar/gks865; Buckingham M, 2003, J ANAT, V202, P59, DOI 10.1046/j.1469-7580.2003.00139.x; Cai SF, 2020, CELL PROLIFERAT, V53, DOI 10.1111/cpr.12744; Campbell PA, 2013, STEM CELLS, V31, P1107, DOI 10.1002/stem.1365; Cheung K, 2016, MOL CELL PROTEOMICS, V15, P1658, DOI 10.1074/mcp.M115.056465; Cooper RN, 1999, J CELL SCI, V112, P2895; Franklin S, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014258; Gayraud-Morel B, 2012, J CELL SCI, V125, P1738, DOI 10.1242/jcs.097006; Ge YJ, 2011, J BIOL CHEM, V286, P35675, DOI 10.1074/jbc.M111.262881; Ge YJ, 2009, AM J PHYSIOL-CELL PH, V297, pC1434, DOI 10.1152/ajpcell.00248.2009; GROUNDS MD, 1992, CELL TISSUE RES, V267, P99, DOI 10.1007/BF00318695; Hamilton DL, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-37; He YH, 2017, ARTERIOSCL THROM VAS, V37, P717, DOI 10.1161/ATVBAHA.116.308210; Kassar-Duchossoy L, 2004, NATURE, V431, P466, DOI 10.1038/nature02876; Kikani CK, 2019, P NATL ACAD SCI USA, V116, P10382, DOI 10.1073/pnas.1804013116; Kitzmann M, 1998, J CELL BIOL, V142, P1447, DOI 10.1083/jcb.142.6.1447; Marabita M, 2016, CELL REP, V17, P501, DOI 10.1016/j.celrep.2016.09.020; Ohanna M, 2005, NAT CELL BIOL, V7, P286, DOI 10.1038/ncb1231; Panda AC, 2016, NUCLEIC ACIDS RES, V44, P2393, DOI 10.1093/nar/gkw023; RANTANEN J, 1995, LAB INVEST, V72, P341; Ronfani L, 2001, DEVELOPMENT, V128, P1265; Sato M, 2019, CIRC J, V83, P368, DOI 10.1253/circj.CJ-18-0925; Stros M, 2010, BBA-GENE REGUL MECH, V1799, P101, DOI 10.1016/j.bbagrm.2009.09.008; Taniguchi N, 2011, J BIOL CHEM, V286, P41489, DOI 10.1074/jbc.M111.236984; Tavares MR, 2015, LIFE SCI, V131, P1, DOI 10.1016/j.lfs.2015.03.001; Ustanina S, 2007, STEM CELLS, V25, P2006, DOI 10.1634/stemcells.2006-0736; Yi SA, 2016, MOL CELL, V62, P443, DOI 10.1016/j.molcel.2016.03.011; Yi X, 2017, BBA-MOL CELL RES, V1864, P697, DOI 10.1016/j.bbamcr.2017.01.012; Zammit PS, 2017, SEMIN CELL DEV BIOL, V72, P19, DOI 10.1016/j.semcdb.2017.11.011; Zhou XY, 2016, J CELL SCI, V129, P4305, DOI 10.1242/jcs.189944; Zhou Z, 2001, J MUSCLE RES CELL M, V22, P311, DOI 10.1023/A:1013133616449; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	35	1	1	2	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12367	12378		10.1096/fj.202001183R	http://dx.doi.org/10.1096/fj.202001183R		JUL 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32686868				2022-12-28	WOS:000553644500001
J	Ohno, M; Nishi, K; Hiraoka, Y; Niizuma, S; Matsuda, S; Iwasaki, H; Kimura, T; Nishi, E				Ohno, Mikiko; Nishi, Kiyoto; Hiraoka, Yoshinori; Niizuma, Shinichiro; Matsuda, Shintaro; Iwasaki, Hirotaka; Kimura, Takeshi; Nishi, Eiichiro			Nardilysin controls cardiac sympathetic innervation patterning through regulation of p75 neurotrophin receptor	FASEB JOURNAL			English	Article						ectodomain shedding; Heart; nardilysin; p75NTR; sympathetic nerve	NERVE GROWTH-FACTOR; MICE LACKING; TNF-ALPHA; HEART; ACTIVATION; EXPRESSION; NEURONS; TARGET; TRKA; NGF	Cardiac sympathetic innervation is critically involved in the regulation of circulatory dynamics. However, the molecular mechanism for the innervation patterning has remained elusive. Here, we demonstrate that nardilysin (NRDC,Nrdc), an enhancer of ectodomain shedding, regulates cardiac sympathetic innervation. Nardilysin-deficient (Nrdc(-/-)) mice show hypoplastic hearts, hypotension, bradycardia, and abnormal sympathetic innervation patterning. While the innervation of left ventricle (LV) of wild-type mice is denser in the subepicardium than in the subendocardium,Nrdc(-/-)LV lacks such a polarity and is uniformly and more abundantly innervated. At the molecular level, the full-length form of p75 neurotrophin receptor (p75(NTR),Ngfr) is increased inNrdc(-/-)LV due to the reduced ectodomain shedding of p75(NTR). Importantly, the reduction of p75(NTR)rescued the abnormal innervation phenotype ofNrdc(-/-)mice. Moreover, sympathetic neuron-specific, but not cardiomyocyte-specific deletion ofNrdcrecapitulated the abnormal innervation patterning ofNrdc(-/-)mice. In conclusion, neuronal nardilysin critically regulates cardiac sympathetic innervation and circulatory dynamics via modulation of p75(NTR).	[Ohno, Mikiko; Iwasaki, Hirotaka; Nishi, Eiichiro] Shiga Univ Med Sci, Dept Pharmacol, Seta Tsukinowa Cho, Otsu, Shiga 5202192, Japan; [Ohno, Mikiko; Nishi, Kiyoto; Matsuda, Shintaro; Kimura, Takeshi] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto, Japan; [Hiraoka, Yoshinori] Kobe Gakuin Univ, Fac Pharmaceut Sci, Div Clin Pharm, Kobe, Hyogo, Japan; [Niizuma, Shinichiro] Nihon Univ, Dept Med, Div Cardiol, Sch Med, Tokyo, Japan; [Nishi, Kiyoto] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA	Shiga University of Medical Science; Kyoto University; Kobe Gakuin University; Nihon University; University of Washington; University of Washington Seattle	Nishi, E (corresponding author), Shiga Univ Med Sci, Dept Pharmacol, Seta Tsukinowa Cho, Otsu, Shiga 5202192, Japan.	enishi@belle.shiga-med.ac.jp	Nishi, Eiichiro/A-8246-2019	Nishi, Eiichiro/0000-0002-8188-8026	Ministry of Education, Culture, Sports, Science and Technology (MEXT) [17H04048, 17K09575, 18H04694, 19K05958, 20H03449, 20K08445, 16H06280]; Takeda Science Foundation; Suzuken Memorial Foundation; Tohoku University	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Suzuken Memorial Foundation; Tohoku University	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Grant/Award Number: 17H04048, 17K09575, 18H04694, 19K05958, 20H03449, 20K08445 and 16H06280; Takeda Science Foundation; Suzuken Memorial Foundation; Tohoku University	Ben-Zvi A, 2007, J NEUROSCI, V27, P13000, DOI 10.1523/JNEUROSCI.3373-07.2007; Brinks H, 2010, J CARDIOVASC TRANSL, V3, P499, DOI 10.1007/s12265-010-9206-6; Brunet I, 2014, J CLIN INVEST, V124, P3230, DOI 10.1172/JCI75181; Chen PM, 2017, INT J CARDIOL, V243, P1, DOI 10.1016/j.ijcard.2017.04.047; CROWLEY C, 1994, CELL, V76, P1001, DOI 10.1016/0092-8674(94)90378-6; Ecker PM, 2006, AM J PHYSIOL-HEART C, V290, pH192, DOI 10.1152/ajpheart.00032.2005; Freeman K, 2014, J NEUROSCI METH, V221, P48, DOI 10.1016/j.jneumeth.2013.09.005; Fujii T, 2017, RMD OPEN, V3, DOI 10.1136/rmdopen-2017-000436; Fukuda K, 2015, CIRC RES, V116, P2005, DOI 10.1161/CIRCRESAHA.116.304679; Glebova NO, 2004, J NEUROSCI, V24, P743, DOI 10.1523/JNEUROSCI.4523-03.2004; Habecker BA, 2008, AUTON NEUROSCI-BASIC, V140, P40, DOI 10.1016/j.autneu.2008.03.002; Hasan W, 2013, ORGANOGENESIS, V9, P176, DOI 10.4161/org.24892; HASSANKHANI A, 1995, DEV BIOL, V169, P309, DOI 10.1006/dbio.1995.1146; Hiraoka Y, 2008, BIOCHEM BIOPH RES CO, V370, P154, DOI 10.1016/j.bbrc.2008.03.050; Hiraoka Y, 2007, J NEUROCHEM, V102, P1595, DOI 10.1111/j.1471-4159.2007.04685.x; Hiraoka Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4224; Honma Y, 2002, NEURON, V35, P267, DOI 10.1016/S0896-6273(02)00774-2; Ieda M, 2007, NAT MED, V13, P604, DOI 10.1038/nm1570; Ieda M, 2006, CIRCULATION, V114, P2351, DOI 10.1161/CIRCULATIONAHA.106.627588; Inuzuka Y, 2009, CIRCULATION, V120, P1695, DOI 10.1161/CIRCULATIONAHA.109.871137; Ishizu-Higashi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098017; Johnson JA, 2011, CLIN PHARMACOL THER, V89, P366, DOI 10.1038/clpt.2010.315; Kanda K, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.91316; Kanda K, 2012, EMBO MOL MED, V4, P396, DOI 10.1002/emmm.201200216; Kasai Y, 2017, CANCER SCI, V108, P910, DOI 10.1111/cas.13204; Kenchappa RS, 2010, J BIOL CHEM, V285, P20358, DOI 10.1074/jbc.M109.082834; Kenchappa RS, 2006, NEURON, V50, P219, DOI 10.1016/j.neuron.2006.03.011; Kisiswa L, 2013, NAT NEUROSCI, V16, P865, DOI 10.1038/nn.3430; Kuruvilla R, 2004, CELL, V118, P243, DOI 10.1016/j.cell.2004.06.021; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; Li J, 2012, J BIOL CHEM, V287, P10089, DOI 10.1074/jbc.M111.313965; Lockhart ST, 1997, J NEUROSCI, V17, P9573; Lorentz CU, 2013, EXP NEUROL, V249, P111, DOI 10.1016/j.expneurol.2013.08.015; Lorentz CU, 2010, AM J PHYSIOL-HEART C, V298, pH1652, DOI 10.1152/ajpheart.01128.2009; Majdan M, 1997, J NEUROSCI, V17, P6988; Matsushita N, 2004, J NEUROSCI RES, V78, P7, DOI 10.1002/jnr.20229; Moessler H, 1996, DEVELOPMENT, V122, P2415; Nam J, 2013, DEVELOPMENT, V140, P1475, DOI 10.1242/dev.087601; Nishi E, 2001, EMBO J, V20, P3342, DOI 10.1093/emboj/20.13.3342; Nishi E, 2006, J BIOL CHEM, V281, P31164, DOI 10.1074/jbc.M601316200; Nishi K, 2016, DIABETES, V65, P3015, DOI 10.2337/db16-0178; Noor N, 2011, J MOL CELL CARDIOL, V51, P534, DOI 10.1016/j.yjmcc.2010.11.005; Ohno M, 2014, NEUROBIOL AGING, V35, P213, DOI 10.1016/j.neurobiolaging.2013.07.014; Ohno M, 2009, NAT NEUROSCI, V12, P1506, DOI 10.1038/nn.2438; PARDINI BJ, 1989, J AUTONOM NERV SYST, V28, P193, DOI 10.1016/0165-1838(89)90146-X; Parrish DC, 2018, AM J PHYSIOL-HEART C, V314, pH415, DOI 10.1152/ajpheart.00300.2017; Rohrer H, 2011, EUR J NEUROSCI, V34, P1563, DOI 10.1111/j.1460-9568.2011.07860.x; Romi E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5058; SHELTON DL, 1984, P NATL ACAD SCI-BIOL, V81, P7951, DOI 10.1073/pnas.81.24.7951; Shen MJ, 2014, CIRC RES, V114, P1004, DOI 10.1161/CIRCRESAHA.113.302549; Susaki EA, 2014, CELL, V157, P726, DOI 10.1016/j.cell.2014.03.042; Tanaka M, 2008, KIDNEY INT, V73, P181, DOI 10.1038/sj.ki.5002626; Thireau J, 2008, EXP PHYSIOL, V93, P83, DOI 10.1113/expphysiol.2007.040733; Urra S, 2007, J BIOL CHEM, V282, P7606, DOI 10.1074/jbc.M610458200; YAGI T, 1993, ANAL BIOCHEM, V214, P70, DOI 10.1006/abio.1993.1458; Yan H, 2003, DEV DYNAM, V227, P395, DOI 10.1002/dvdy.10294; Yoh T, 2019, CLIN CANCER RES, V25, P619, DOI 10.1158/1078-0432.CCR-18-0124; Yoon SO, 1998, J NEUROSCI, V18, P3273	58	1	1	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					11624	11640		10.1096/fj.202000604R	http://dx.doi.org/10.1096/fj.202000604R		JUL 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32683751				2022-12-28	WOS:000553200300001
J	Mohandass, A; Krishnan, V; Gribkova, ED; Asuthkar, S; Baskaran, P; Nersesyan, Y; Hussain, Z; Wise, LM; George, RE; Stokes, N; Alexander, BM; Cohen, AM; Pavlov, EV; Llano, DA; Zhu, MX; Thyagarajan, B; Zakharian, E				Mohandass, Adithya; Krishnan, Vivek; Gribkova, Ekaterina D.; Asuthkar, Swapna; Baskaran, Padmamalini; Nersesyan, Yelena; Hussain, Zahir; Wise, Leslie M.; George, Robert E.; Stokes, Nadarra; Alexander, Brenda M.; Cohen, Alejandro M.; Pavlov, Evgeny, V; Llano, Daniel A.; Zhu, Michael X.; Thyagarajan, Baskaran; Zakharian, Eleonora			TRPM8 as the rapid testosterone signaling receptor: Implications in the regulation of dimorphic sexual and social behaviors	FASEB JOURNAL			English	Article						aggression; dopaminergic neurons; reward system; sexual Behavior; testosterone; transient receptor potential melastatin 8 (TRPM8) channel	ANDROGEN RECEPTOR; DOPAMINE TRANSMISSION; MICE LACKING; CHANNEL; PROTEIN; COLD; ESTROGEN; NEURONS; METABOLITES; DISRUPTION	Testosterone regulates dimorphic sexual behaviors in all vertebrates. However, the molecular mechanism underlying these behaviors remains unclear. Here, we report that a newly identified rapid testosterone signaling receptor, Transient Receptor Potential Melastatin 8 (TRPM8), regulates dimorphic sexual and social behaviors in mice. We found that, along with higher steroid levels in the circulation, TRPM8(-/-)male mice exhibit increased mounting frequency indiscriminate of sex, delayed sexual satiety, and increased aggression compared to wild-type controls, while TRPM8(-/-)females display an increased olfaction-exploratory behavior. Furthermore, neuronal responses to acute testosterone application onto the amygdala were attenuated in TRPM8(-/-)males but remained unchanged in females. Moreover, activation of dopaminergic neurons in the ventral tegmental area following mating was impaired in TRPM8(-/-)males. Together, these results demonstrate that TRPM8 regulates dimorphic sexual and social behaviors, and potentially constitutes a signalosome for mediation of sex-reward mechanism in males. Thus, deficiency of TRPM8 might lead to a delayed sexual satiety phenomenon.	[Mohandass, Adithya; Krishnan, Vivek; Baskaran, Padmamalini; Thyagarajan, Baskaran] Univ Wyoming, Coll Hlth Sci, Sch Pharm, Laramie, WY 82071 USA; [Gribkova, Ekaterina D.; Llano, Daniel A.] Univ Illinois, Neurosci Program, Dept Mol & Integrat Physiol, Urbana, IL USA; [Gribkova, Ekaterina D.; Llano, Daniel A.] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL USA; [Asuthkar, Swapna; Nersesyan, Yelena; Hussain, Zahir; Wise, Leslie M.; George, Robert E.; Stokes, Nadarra; Zakharian, Eleonora] Univ Illinois, Coll Med, Dept Canc Biol & Pharmacol, 1 Illini Dr, Peoria, IL 61605 USA; [Hussain, Zahir] Umm Al Qura Univ, Fac Med, Dept Physiol, Mecca, Saudi Arabia; [Alexander, Brenda M.] Univ Wyoming, Dept Anim Sci, Laramie, WY 82071 USA; [Cohen, Alejandro M.] Dalhousie Univ, Life Sci Res Inst, Biol Mass Spectrometry Core Facil, Fac Med, Halifax, NS, Canada; [Pavlov, Evgeny, V] NYU, Coll Dent, Dept Mol Pathobiol, New York, NY USA; [Zhu, Michael X.] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA	University of Wyoming; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Peoria; Umm Al Qura University; University of Wyoming; Dalhousie University; New York University; University of Texas System; University of Texas Health Science Center Houston	Zakharian, E (corresponding author), Univ Illinois, Coll Med, Dept Canc Biol & Pharmacol, 1 Illini Dr, Peoria, IL 61605 USA.; Thyagarajan, B (corresponding author), Univ Wyoming, Mol Signaling Lab, Sch Pharm, Dept 3375,1000 East Univ Ave, Laramie, WY 82071 USA.	Baskaran.Thyagarajan@uwyo.edu; zakharel@uic.edu		Baskaran, Padmamalini/0000-0001-8851-1486; Cohen, Alejandro/0000-0001-8646-8525; Gribkova, Ekaterina/0000-0001-8814-1585; Hussain, Zahir/0000-0003-4739-1865	National Science Foundation (NSF) [IOS-1922428]; HHS \ NIH \ National Institute of General Medical Sciences (NIGMS) [1P20GM103432-01]	National Science Foundation (NSF)(National Science Foundation (NSF)); HHS \ NIH \ National Institute of General Medical Sciences (NIGMS)	National Science Foundation (NSF), Grant/Award Number: IOS-1922428; HHS vertical bar NIH vertical bar National Institute of General Medical Sciences (NIGMS), Grant/Award Number: 1P20GM103432-01	Asaba A, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00231; Asuthkar S, 2014, ONCOGENE, V33, P1922, DOI 10.1038/onc.2013.151; Asuthkar S, 2017, ONCOTARGET, V8, P12877, DOI 10.18632/oncotarget.14178; Asuthkar S, 2015, ONCOTARGET, V6, P17221, DOI 10.18632/oncotarget.3948; Asuthkar S, 2015, J BIOL CHEM, V290, P2670, DOI 10.1074/jbc.M114.610873; Asuthkar S, 2015, J BIOL CHEM, V290, P2659, DOI 10.1074/jbc.M114.610824; Baird AD, 2007, J NEUROL NEUROSUR PS, V78, P1042, DOI 10.1136/jnnp.2006.107193; Balfour ME, 2004, NEUROPSYCHOPHARMACOL, V29, P718, DOI 10.1038/sj.npp.1300350; Balthazart J, 2011, ENDOCRINOLOGY, V152, P2937, DOI 10.1210/en.2011-0277; Beloate LN, 2016, J NEUROSCI, V36, P9949, DOI 10.1523/JNEUROSCI.0937-16.2016; BRONSON FH, 1979, Q REV BIOL, V54, P265, DOI 10.1086/411295; BULLITT E, 1990, J COMP NEUROL, V296, P517, DOI 10.1002/cne.902960402; Byers SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035538; Cao CK, 2013, CELL REP, V4, P302, DOI 10.1016/j.celrep.2013.06.022; Cornil CA, 2012, ENDOCRINOLOGY, V153, P2562, DOI 10.1210/en.2011-2159; Corre J, 2018, ELIFE, V7, DOI 10.7554/eLife.39945; DAMSMA G, 1992, BEHAV NEUROSCI, V106, P181, DOI 10.1037/0735-7044.106.1.181; Dong H.W., 2008, ALLEN REFERENCE ATLA; Ferretti A, 2005, NEUROIMAGE, V26, P1086, DOI 10.1016/j.neuroimage.2005.03.025; Foradori CD, 2008, FRONT NEUROENDOCRIN, V29, P169, DOI 10.1016/j.yfrne.2007.10.005; Gillies GE, 2014, NEUROSCIENCE, V282, P69, DOI 10.1016/j.neuroscience.2014.05.033; GORMAN DG, 1992, ARCH NEUROL-CHICAGO, V49, P308, DOI 10.1001/archneur.1992.00530270128029; Guo GX, 2020, MOL CELL ENDOCRINOL, V503, DOI 10.1016/j.mce.2019.110671; Hamson DK, 2004, NEUROSCIENCE, V127, P797, DOI 10.1016/j.neuroscience.2004.06.006; Hatanaka Y, 2015, BRAIN RES, V1621, P121, DOI 10.1016/j.brainres.2014.12.011; Honda S, 1998, BIOCHEM BIOPH RES CO, V252, P445, DOI 10.1006/bbrc.1998.9672; Huhtaniemi I, 2011, OXFORD TXB ENDOCRINO, P1347; Hull EM, 2007, HORM BEHAV, V52, P45, DOI 10.1016/j.yhbeh.2007.03.030; HULL EM, 1995, J NEUROSCI, V15, P7465; Ishihara Y, 2016, STEROIDS, V113, P71, DOI 10.1016/j.steroids.2016.06.004; Juntti SA, 2010, NEURON, V66, P260, DOI 10.1016/j.neuron.2010.03.024; Kelliher KR, 2009, ILAR J, V50, P28, DOI 10.1093/ilar.50.1.28; KEVETTER GA, 1981, J COMP NEUROL, V197, P99, DOI 10.1002/cne.901970108; KLING AS, 1993, BEHAV BRAIN RES, V56, P161, DOI 10.1016/0166-4328(93)90034-N; Kluver H, 1997, J NEUROPSYCH CLIN N, V9, P606; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Leypold BG, 2002, P NATL ACAD SCI USA, V99, P6376, DOI 10.1073/pnas.082127599; Lynch KS, 2006, HORM BEHAV, V49, P450, DOI 10.1016/j.yhbeh.2005.10.001; Lyng FM, 2000, BIOL REPROD, V63, P736, DOI 10.1095/biolreprod63.3.736; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Menegas W, 2015, ELIFE, V4, DOI 10.7554/eLife.10032; Mermelstein PG, 1996, J NEUROSCI, V16, P595; Morenilla-Palao C, 2014, CELL REP, V8, P1571, DOI 10.1016/j.celrep.2014.08.003; Ogawa S, 1998, ENDOCRINOLOGY, V139, P5058, DOI 10.1210/en.139.12.5058; Ordas P, 2021, J COMP NEUROL, V529, P234, DOI 10.1002/cne.24694; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; PFAUS JG, 1990, BRAIN RES, V530, P345, DOI 10.1016/0006-8993(90)91309-5; Putnam SK, 2003, HORM BEHAV, V44, P419, DOI 10.1016/j.yhbeh.2003.06.006; RICHERSON GB, 1995, EXP NEUROL, V131, P133, DOI 10.1016/0014-4886(95)90015-2; Rodriguez-Manzo G, 2011, BEHAV BRAIN RES, V217, P253, DOI 10.1016/j.bbr.2010.09.014; Sato SA, 2008, HORM BEHAV, V53, P647, DOI 10.1016/j.yhbeh.2008.01.010; Schellino R, 2016, SCI REP-UK, V6, DOI 10.1038/srep36063; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Sokolowski K, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00055; Soma M, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00282; Stoleru S, 2012, NEUROSCI BIOBEHAV R, V36, P1481, DOI 10.1016/j.neubiorev.2012.03.006; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; TEODORESCU D, 1989, INT J CONTROL, V50, P1577, DOI 10.1080/00207178908953452; TERZIAN H, 1955, NEUROLOGY, V5, P373, DOI 10.1212/WNL.5.6.373; Thompson RJ, 2005, United States Patent Application Publication Pub, Patent No. [US 2005/0245494, 20050245494]; Toda K, 2001, J ENDOCRINOL, V168, P455, DOI 10.1677/joe.0.1680455; Toda K, 2001, J ENDOCRINOL, V168, P217, DOI 10.1677/joe.0.1680217; Triemstra JL, 2005, NEUROPSYCHOPHARMACOL, V30, P1436, DOI 10.1038/sj.npp.1300685; Viant MR, 2000, NEUROSCIENCE, V99, P373, DOI 10.1016/S0306-4522(00)00167-6; WADDELL TG, 1980, J CHEM EDUC, V57, P341, DOI 10.1021/ed057p341; Xu XH, 2012, CELL, V148, P596, DOI 10.1016/j.cell.2011.12.018; Yuste R, 2011, COLD SPRING HARBOR P, V2011; Zakharian Eleonora, 2013, Methods Mol Biol, V998, P109, DOI 10.1007/978-1-62703-351-0_8; Zakharian E, 2010, J NEUROSCI, V30, P12526, DOI 10.1523/JNEUROSCI.3189-10.2010; Zakharian E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005404	70	13	15	2	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10887	10906		10.1096/fj.202000794R	http://dx.doi.org/10.1096/fj.202000794R		JUL 2020	20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32609392	Green Published, hybrid			2022-12-28	WOS:000547077200001
J	Tourki, B; Kain, V; Shaikh, SR; Leroy, X; Serhan, CN; Halade, GV				Tourki, Bochra; Kain, Vasundhara; Shaikh, Saame Raza; Leroy, Xavier; Serhan, Charles N.; Halade, Ganesh, V			Deficit of resolution receptor magnifies inflammatory leukocyte directed cardiorenal and endothelial dysfunction with signs of cardiomyopathy of obesity	FASEB JOURNAL			English	Article						obesogenic aging; non-resolving inflammation; inflammatory macrophage; kidney function	PRESERVED EJECTION FRACTION; HEART-FAILURE; MYOCARDIAL-INFARCTION; CARDIAC-FUNCTION; MACROPHAGES; CHANNELS; DISEASE; RISK	Chronic unresolved inflammation is the primary determinant of cardiovascular disease. Precise mechanisms that define the genesis of unresolved inflammation in heart failure with preserved ejection fraction (HFpEF) are of interest due to the obesity epidemic. To examine the obesity phenotype and its direct/indirect consequences, multiple approaches were employed using the lipoxin receptor (abbreviated as ALX) dysfunction mouse model. Indirect calorimetry analyses revealed that the deletion of ALX dysregulated energy metabolism driving toward age-related obesity. Heart function data suggest that obesity-prone ALX deficient mice had impaired myocardium strain. Comprehensive measurement of chemokines, extracellular matrix, and arrhythmogenic arrays confirmed the dysregulation of multiple ion channels gene expression with amplified inflammatory chemokines and cytokines response at the age of 4 months compared with WT counterparts. Quantitative analyses of leukocytes demonstrated an increase of proinflammatory Ly6C(hi)CCR2(+)macrophages in the spleen and heart at a steady-state resulting in an inflamed splenocardiac axis. Signs of subtle inflammation were marked with cardiorenal, endothelial defects with decreased CD31 and eNOS and an increased iNOS and COX2 expression. Thus, ALX receptor deficiency serves as an experimental model that defines multiple cellular and molecular mechanisms in HFpEF that could be a target for the development of HFpEF therapy in cardiovascular medicine.	[Tourki, Bochra; Kain, Vasundhara; Halade, Ganesh, V] Univ S Florida, Dept Med, Div Cardiovasc Sci, 546 Channelside Dr, Tampa, FL 33602 USA; [Shaikh, Saame Raza] Univ N Carolina, Dept Nutr, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27515 USA; [Shaikh, Saame Raza] Univ N Carolina, Sch Med, Chapel Hill, NC 27515 USA; [Leroy, Xavier] Domain Therapeut, Steinsoultz, France; [Serhan, Charles N.] Harvard Med Sch, Ctr Expt Therapeut & Reperfus Injury, Dept Anesthesiol Perioperat & Pain Med, Brigham & Womens Hosp, Boston, MA 02115 USA	State University System of Florida; University of South Florida; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Halade, GV (corresponding author), Univ S Florida, Dept Med, Div Cardiovasc Sci, 546 Channelside Dr, Tampa, FL 33602 USA.	ghalade@usf.edu	Kain, Vasundhara/AAL-7371-2021		National Institutes of Health [HL132989, HL144788, AT008375, GM038765]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	National Institutes of Health, Grant/Award Number: HL132989, HL144788, AT008375 and GM038765	Aizpurua AB, 2018, AM J PHYSIOL-HEART C, V315, pH1670, DOI 10.1152/ajpheart.00024.2018; Alberts P., 2006, CURR PROTOC NEUROSCI, V36, P9, DOI [10.1002/0471142301.ns0923ds36, DOI 10.1002/0471142301.NS0923DS36]; Alex L, 2018, AM J PHYSIOL-HEART C, V315, pH934, DOI 10.1152/ajpheart.00238.2018; Alpert CM, 2017, HEART FAIL REV, V22, P25, DOI 10.1007/s10741-016-9581-4; Altara R, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00160; Aromolaran AS, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00431; Barth AS, 2009, CIRC-ARRHYTHMIA ELEC, V2, P327, DOI 10.1161/CIRCEP.108.817320; Butler AA, 2010, DIABETES, V59, P323, DOI 10.2337/db09-1471; Carbone S, 2018, JACC-BASIC TRANSL SC, V3, P157, DOI 10.1016/j.jacbts.2018.01.004; Castellon X, 2016, AGING DIS, V7, DOI 10.14336/AD.2015.0803; Corminboeuf O, 2015, J MED CHEM, V58, P537, DOI 10.1021/jm501051x; Dehghani-Samani A, 2019, ACTA CARDIOL SIN, V35, P99, DOI 10.6515/ACS.201903_35(2).20181028A; Dunlay SM, 2017, NAT REV CARDIOL, V14, DOI 10.1038/nrcardio.2017.65; FIORE S, 1994, J EXP MED, V180, P253, DOI 10.1084/jem.180.1.253; Frasca D, 2017, FRONT IMMUNOL, V8, DOI [10.3389/fimmu.2017.01745, 10.3389/fimmu.2017.01003]; Ge YJ, 2020, FASEB J, V34, P6920, DOI 10.1096/fj.201903206R; Gorski PA, 2015, CELL METAB, V21, P183, DOI 10.1016/j.cmet.2015.01.005; Haass M, 2011, CIRC-HEART FAIL, V4, P324, DOI 10.1161/CIRCHEARTFAILURE.110.959890; Halade GV, 2019, METABOLISM, V96, P22, DOI 10.1016/j.metabol.2019.04.011; Halade GV, 2018, FASEB J, V32, P3717, DOI 10.1096/fj.201701173RR; Halade GV, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aao1818; Halade GV, 2018, AM J PHYSIOL-HEART C, V314, pH255, DOI 10.1152/ajpheart.00528.2017; Halade GV, 2016, AGING-US, V8, P2611, DOI 10.18632/aging.101077; Halade GV, 2013, AM J PHYSIOL-HEART C, V305, pH1830, DOI 10.1152/ajpheart.00224.2013; House AA, 2019, KIDNEY INT, V95, P1304, DOI 10.1016/j.kint.2019.02.022; Kain V, 2019, PHARMACOL RES, V146, DOI 10.1016/j.phrs.2019.104295; Kain V, 2018, AM J PHYSIOL-HEART C, V314, pH160, DOI 10.1152/ajpheart.00297.2017; Kain V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10441-8; Kain V, 2015, J MOL CELL CARDIOL, V84, P24, DOI 10.1016/j.yjmcc.2015.04.003; Kalucka J, 2017, PFLUG ARCH EUR J PHY, V469, P473, DOI 10.1007/s00424-017-1946-6; Kelly JP, 2015, J AM COLL CARDIOL, V65, P1668, DOI 10.1016/j.jacc.2015.03.043; Kjeldsen SE, 2019, HYPERTENSION; Lakdawala NK, 2010, CIRCULATION, V122, P527, DOI 10.1161/CIRCULATIONAHA.109.892240; Lazzerini PE, 2017, HEART, V103, P1821, DOI 10.1136/heartjnl-2016-311079; Lieve KV, 2017, INT J CARDIOL, V236, P187, DOI 10.1016/j.ijcard.2017.01.113; Masarone D, 2017, J CARDIOVASC DEV DIS, V4, DOI 10.3390/jcdd4010003; Matsushita K, 2020, KIDNEY INT, V97, P95, DOI 10.1016/j.kint.2019.06.022; Meyer Carola W, 2015, Curr Protoc Mouse Biol, V5, P205, DOI 10.1002/9780470942390.mo140216; NELSON MT, 1990, AM J PHYSIOL, V259, pC3; Odegaard JI, 2013, IMMUNITY, V38, P644, DOI 10.1016/j.immuni.2013.04.001; Ogna A, 2016, EUR J NUTR, V55, P1089, DOI 10.1007/s00394-015-0923-0; Packer M, 2018, JACC-HEART FAIL, V6, P633, DOI 10.1016/j.jchf.2018.01.009; de Heredia FP, 2012, P NUTR SOC, V71, P332, DOI 10.1017/S0029665112000092; Perretti M, 2002, NAT MED, V8, P1296, DOI 10.1038/nm786; Pieske B, 2019, EUR HEART J, V40, P3297, DOI 10.1093/eurheartj/ehz641; Premer Courtney, 2019, Mayo Clin Proc Innov Qual Outcomes, V3, P1, DOI 10.1016/j.mayocpiqo.2018.12.006; Redfield MM, 2017, NEW ENGL J MED, V376, P897, DOI 10.1056/NEJMc1615918; Remmerie A, 2018, CELL IMMUNOL, V330, P27, DOI 10.1016/j.cellimm.2018.01.020; Sabbatini AR, 2020, J AM COLL CARDIOL, V75, P1074, DOI 10.1016/j.jacc.2019.12.049; Sandmann S, 2001, J CARDIOVASC PHARM, V37, P64, DOI 10.1097/00005344-200101000-00008; Savji N, 2018, JACC-HEART FAIL, V6, P701, DOI 10.1016/j.jchf.2018.05.018; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Stunault MI, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/2426138; Tourki B, 2020, MOL METAB, V31, P138, DOI 10.1016/j.molmet.2019.10.008; Tripathy D, 2003, DIABETES, V52, P2882, DOI 10.2337/diabetes.52.12.2882; Upadhya B, 2017, HEART FAIL CLIN, V13, P485, DOI 10.1016/j.hfc.2017.02.005; Wang YG, 2010, J MOL CELL CARDIOL, V48, P619, DOI 10.1016/j.yjmcc.2010.01.009; Yang YB, 2014, OBESITY, V22, P2147, DOI 10.1002/oby.20811; Yanovski SZ, 2011, NEW ENGL J MED, V364, P987, DOI 10.1056/NEJMp1009229; Zannad F, 2018, CIRCULATION, V138, P929, DOI 10.1161/CIRCULATIONAHA.117.028814; Zhuang YW, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14728-9	61	12	12	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10560	10573		10.1096/fj.202000495RR	http://dx.doi.org/10.1096/fj.202000495RR		JUN 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32543720	Bronze, Green Accepted			2022-12-28	WOS:000541769300001
J	Summers, ME; Richmond, BW; Menon, S; Sheridan, RM; Kropski, JA; Majka, SA; Taketo, MM; Bastarache, JA; West, JD; De Langhe, S; Geraghty, P; Klemm, DJ; Chu, HW; Friedman, RS; Tao, YKK; Foronjy, RF; Majka, SM				Summers, Megan E.; Richmond, Bradley W.; Menon, Swapna; Sheridan, Ryan M.; Kropski, Jonathan A.; Majka, Sarah A.; Taketo, M. Mark; Bastarache, Julie A.; West, James D.; De Langhe, Stijn; Geraghty, Patrick; Klemm, Dwight J.; Chu, Hong Wei; Friedman, Rachel S.; Tao, Yuankai K.; Foronjy, Robert F.; Majka, Susan M.			Resident mesenchymal vascular progenitors modulate adaptive angiogenesis and pulmonary remodeling via regulation of canonical Wnt signaling	FASEB JOURNAL			English	Article						adaptive angiogenesis; emphysema; mesenchymal vascular progenitor cell; microvascular niche; Wnt signaling	ENDOTHELIAL GROWTH-FACTOR; SIDE POPULATION CELLS; STEM-CELLS; BETA-CATENIN; MOLECULAR-MECHANISMS; ARTERIAL STIFFNESS; LUNG; EMPHYSEMA; INJURY; VEGF	Adaptive angiogenesis is necessary for tissue repair, however, it may also be associated with the exacerbation of injury and development of chronic disease. In these studies, we demonstrate that lung mesenchymal vascular progenitor cells (MVPC) modulate adaptive angiogenesis via lineage trace, depletion of MVPC, and modulation of beta-catenin expression. Single cell sequencing confirmed MVPC as multipotential vascular progenitors, thus, genetic depletion resulted in alveolar simplification with reduced adaptive angiogenesis. Following vascular endothelial injury, Wnt activation in MVPC was sufficient to elicit an emphysema-like phenotype characterized by increased MLI, fibrosis, and MVPC driven adaptive angiogenesis. Lastly, activation of Wnt/beta-catenin signaling skewed the profile of human and murine MVPC toward an adaptive phenotype. These data suggest that lung MVPC drive angiogenesis in response to injury and regulate the microvascular niche as well as subsequent distal lung tissue architecture via Wnt signaling.	[Summers, Megan E.; Majka, Sarah A.; Chu, Hong Wei; Majka, Susan M.] Natl Jewish Hlth, Div Pulm Crit Care & Sleep Med, Dept Med, 1400 Jackson St,K810, Denver, CO 80206 USA; [Richmond, Bradley W.; Kropski, Jonathan A.; Bastarache, Julie A.; West, James D.] Vanderbilt Univ, Med Ctr, Dept Med, Div Allergy Pulm & Crit Care Med Cardiol, Nashville, TN USA; [Menon, Swapna; Tao, Yuankai K.] AnalyzeDat Consulting Serv, Pulm Vasc Res Inst Kochi, Ernakulam, India; [Sheridan, Ryan M.] Univ Colorado, Sch Med, RNA Biosci Initiat, Dept Biochem & Mol Genet, Aurora, CO USA; [Taketo, M. Mark] Kyoto Univ, Grad Sch Med, Div Expt Therapeut, Kyoto, Japan; [De Langhe, Stijn] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Geraghty, Patrick; Foronjy, Robert F.] SUNY Downstate Med Ctr, Div Pulm & Crit Care Med, Brooklyn, NY 11203 USA; [Klemm, Dwight J.] Univ Colorado, Dept Med Pulm & Crit Care Med, Aurora, CO USA; [Klemm, Dwight J.; Majka, Susan M.] Univ Colorado, Gates Ctr Regenerat Med & Stem Cell Biol, Aurora, CO USA; [Friedman, Rachel S.; Majka, Susan M.] Natl Jewish Hlth, Dept Biomed Res, Denver, CO USA; [Majka, Susan M.] Vanderbilt Univ, Biomed Engn, 221 Kirkland Hall, Nashville, TN 37235 USA	National Jewish Health; Vanderbilt University; University of Colorado System; University of Colorado Anschutz Medical Campus; Kyoto University; University of Alabama System; University of Alabama Birmingham; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; National Jewish Health; Vanderbilt University	Majka, SM (corresponding author), Natl Jewish Hlth, Div Pulm Crit Care & Sleep Med, Dept Med, 1400 Jackson St,K810, Denver, CO 80206 USA.	susanmajka@mac.com	menon, swapna/ABH-4241-2020; De Langhe, Stijn/ABH-6876-2020; menon, swapna/ABH-1717-2020; West, James/E-2960-2010	menon, swapna/0000-0002-0429-2472; De Langhe, Stijn/0000-0003-3867-4572; Sheridan, Ryan/0000-0003-4012-3147; West, James/0000-0002-6004-0202; Geraghty, Patrick/0000-0003-1647-5505	NIH [R01HL136449, R01HL116597]; National Center for Research Resources [UL1 RR024975-01]; National Center for Advancing Translational Sciences [2 UL1 TR000445-06]; University of Colorado [NCI P30 CA 46934-14, P30-CA046934 NCI]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); University of Colorado	This work was funded by grants to SM Majka from the NIH R01HL116597 and NIH R01HL136449. The project was also supported in part by the National Center for Research Resources, Grant UL1 RR024975-01 and is now at the National Center for Advancing Translational Sciences, Grant 2 UL1 TR000445-06. Experiments were performed using the University of Colorado Cancer Center Microarray Core (NCI P30 CA 46934-14) and Shared Flow Cytometry Resource (P30-CA046934 NCI).	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Akeson AL, 2000, DEV DYNAM, V217, P11, DOI 10.1002/(SICI)1097-0177(200001)217:1<11::AID-DVDY2>3.0.CO;2-L; Alford SK, 2010, P NATL ACAD SCI USA, V107, P7485, DOI 10.1073/pnas.0913880107; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Asakura A, 2002, EXP HEMATOL, V30, P1339, DOI 10.1016/S0301-472X(02)00954-2; Awad KS, 2016, PULM CIRC, V6, P285, DOI 10.1086/688034; BAARSMA HA, 2014, EUR RESPIR J S58, V44, P1835; Baarsma HA, 2017, J EXP MED, V214, P143, DOI 10.1084/jem.20160675; Baarsma HA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025450; Barr RG, 2007, AM J RESP CRIT CARE, V176, P1200, DOI 10.1164/rccm.200707-980OC; Bellusci S, 1997, DEVELOPMENT, V124, P53; Bingle L, 1997, MEDIAT INFLAMM, V6, P345, DOI 10.1080/09629359791488; Birdsey GM, 2015, DEV CELL, V32, P82, DOI 10.1016/j.devcel.2014.11.016; Bloodworth NC, 2018, CIRC RES, V123, pE51, DOI 10.1161/CIRCRESAHA.118.313397; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Case D, 2007, AM J PHYSIOL-LUNG C, V292, pL154, DOI 10.1152/ajplung.00192.2006; Chen CY, 2016, CELL ADHES MIGR, V10, P66, DOI 10.1080/19336918.2015.1108510; CHETTY A, 1995, EXP LUNG RES, V21, P889, DOI 10.3109/01902149509031769; Chilosi M, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-3; Chow K, 2013, PULM CIRC, V3, P31, DOI 10.4103/2045-8932.109912; Condliffe Robin, 2015, F1000Prime Rep, V7, P06, DOI 10.12703/P7-06; Corada M, 2010, DEV CELL, V18, P938, DOI 10.1016/j.devcel.2010.05.006; Cossu G, 2003, CURR OPIN GENET DEV, V13, P537, DOI 10.1016/j.gde.2003.08.001; Cottin V, 2011, ARTHRITIS RHEUM-US, V63, P295, DOI 10.1002/art.30077; Dell'Aringa M, 2018, METHODS MOL BIOL, V1799, P225, DOI 10.1007/978-1-4939-7896-0_17; Dikalov S, 2019, AM J PHYSIOL-HEART C, V316, pH639, DOI 10.1152/ajpheart.00595.2018; DiPietro LA, 2013, CURR OPIN RHEUMATOL, V25, P87, DOI 10.1097/BOR.0b013e32835b13b6; Dufourcq P, 2008, STEM CELLS, V26, P2991, DOI 10.1634/stemcells.2008-0372; El Agha E, 2017, CELL STEM CELL, V21, P166, DOI 10.1016/j.stem.2017.07.011; Ellis LV, 2020, DEV CELL, V52, P617, DOI 10.1016/j.devcel.2020.01.009; Fatima S, 2012, STEM CELLS, V30, P210, DOI 10.1002/stem.1002; Fernandez IE, 2012, LANCET, V380, P680, DOI 10.1016/S0140-6736(12)61144-1; Fong TAT, 1999, CANCER RES, V59, P99; Franco CA, 2009, CURR OPIN GENET DEV, V19, P476, DOI 10.1016/j.gde.2009.09.004; Gaskill C, 2017, PULM CIRC, V7, P108, DOI 10.1177/2045893217702346; Gaskill C, 2016, PULM CIRC, V6, P483, DOI 10.1086/688314; Gaskill CF, 2017, J CLIN INVEST, V127, P2262, DOI 10.1172/JCI88629; Gebb SA, 2000, DEV DYNAM, V217, P159, DOI 10.1002/(SICI)1097-0177(200002)217:2<159::AID-DVDY3>3.0.CO;2-9; Han HC, 2012, J VASC RES, V49, P185, DOI 10.1159/000335123; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Travisano SI, 2019, ELIFE, V8, DOI 10.7554/eLife.49977; Jeansson M, 2011, J CLIN INVEST, V121, P2278, DOI 10.1172/JCI46322; Jun D, 2011, STEM CELLS, V29, P725, DOI 10.1002/stem.604; Kam Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004580; Kasahara Y, 2000, J CLIN INVEST, V106, P1311, DOI 10.1172/JCI10259; Kestler HA, 2011, J CELL BIOL, V193, P431, DOI 10.1083/jcb.201103167; Kneidinger N, 2011, AM J RESP CRIT CARE, V183, P723, DOI 10.1164/rccm.200910-1560OC; Konigshoff M, 2010, AM J RESP CELL MOL, V42, P21, DOI 10.1165/rcmb.2008-0485TR; Kotch LE, 1999, DEV BIOL, V209, P254, DOI 10.1006/dbio.1999.9253; Kramann R, 2015, CELL STEM CELL, V16, P51, DOI 10.1016/j.stem.2014.11.004; Krock Bryan L, 2011, Genes Cancer, V2, P1117, DOI 10.1177/1947601911423654; Kumar A, 2017, CELL REP, V19, P1902, DOI 10.1016/j.celrep.2017.05.019; Kumar ME, 2014, SCIENCE, V346, P827, DOI 10.1126/science.1258810; Lee Chun Geun, 2011, Proc Am Thorac Soc, V8, P512, DOI 10.1513/pats.201102-018MW; Li RS, 2014, ARTERIOSCL THROM VAS, V34, P2268, DOI 10.1161/ATVBAHA.114.303345; Liu WH, 2013, CELL TRANSPLANT, V22, P1859, DOI 10.3727/096368912X657206; Loganathan K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0189433; Mack JJ, 2018, CURR OPIN HEMATOL, V25, P212, DOI 10.1097/MOH.0000000000000425; Majka S, 2006, AM J PHYSIOL-LUNG C, V290, pL1183, DOI 10.1152/ajplung.00175.2005; Marriott S, 2014, AM J PHYSIOL-CELL PH, V307, pC684, DOI 10.1152/ajpcell.00114.2014; Martin J, 2008, CYTOTHERAPY, V10, P140, DOI 10.1080/14653240801895296; Martowicz A, 2019, ARTERIOSCL THROM VAS, V39, P2273, DOI 10.1161/ATVBAHA.119.312749; McAllister DA, 2007, AM J RESP CRIT CARE, V176, P1208, DOI 10.1164/rccm.200707-1080OC; McGrath-Morrow SA, 2004, AM J RESP CELL MOL, V30, P635, DOI 10.1165/rcmb.2003-0049OC; Mendez JJ, 2015, BIOMATERIALS, V40, P61, DOI 10.1016/j.biomaterials.2014.11.011; Mofarrahi M, 2013, J APPL PHYSIOL, V114, P1309, DOI 10.1152/japplphysiol.00954.2012; Nagy JA, 2008, ANGIOGENESIS, V11, P109, DOI 10.1007/s10456-008-9099-z; Newcomb DC, 2013, THORAX, V68, P717, DOI 10.1136/thoraxjnl-2012-202404; Ng ML, 2018, WORLD J STEM CELLS, V10, P119, DOI 10.4252/wjsc.v10.i9.119; Nicolls MR, 2016, CURR OPIN ORGAN TRAN, V21, P279, DOI 10.1097/MOT.0000000000000307; Patel J, 2017, ONCOTARGET, V8, P84618, DOI 10.18632/oncotarget.21389; Patel J, 2017, CIRCULATION, V135, P786, DOI 10.1161/CIRCULATIONAHA.116.024754; Pepicelli CV, 1998, CURR BIOL, V8, P1083, DOI 10.1016/S0960-9822(98)70446-4; Pill Karoline, 2015, Cell Regen, V4, P8, DOI 10.1186/s13619-015-0025-8; Polosukhin VV, 2012, EXP LUNG RES, V38, P135, DOI 10.3109/01902148.2012.658595; Polverino F, 2018, PULM CIRC, V8, DOI 10.1177/2045894018758528; Rama N, 2015, NAT MED, V21, P483, DOI 10.1038/nm.3849; Rao S, 2007, DEVELOPMENT, V134, P4449, DOI 10.1242/dev.012187; Sabit R, 2007, AM J RESP CRIT CARE, V175, P1259, DOI 10.1164/rccm.200701-067OC; Schachtner SK, 2000, AM J RESP CELL MOL, V22, P157, DOI 10.1165/ajrcmb.22.2.3766; Schrimpf C, 2014, J VASC RES, V51, P247, DOI 10.1159/000365149; Secomb TW, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002983; Seimetz M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129327; Shu WG, 2002, DEVELOPMENT, V129, P4831; Smadja DM, 2010, ARTERIOSCL THROM VAS, V30, P2544, DOI 10.1161/ATVBAHA.110.213751; Summer R, 2007, AM J RESP CELL MOL, V37, P152, DOI 10.1165/rcmb.2006-0386OC; Suzuki M, 2008, INHAL TOXICOL, V20, P349, DOI 10.1080/08958370701866412 ; Tadjali M, 2006, STEM CELLS, V24, P1556, DOI 10.1634/stemcells.2005-0562; Tang KC, 2004, J APPL PHYSIOL, V97, P1559, DOI 10.1152/japplphysiol.00221.2004; Tanjore H, 2013, AM J RESP CRIT CARE, V187, P630, DOI 10.1164/rccm.201205-0972OC; Taraseviciene-Stewart L, 2001, FASEB J, V15, P427, DOI 10.1096/fj.00-0343com; THURLBEC.WM, 1967, AM REV RESPIR DIS, V95, P752; Tuder RM, 2003, AM J RESP CELL MOL, V29, P88, DOI 10.1165/rcmb.2002-0228OC; Vitali SH, 2014, PULM CIRC, V4, P619, DOI 10.1086/678508; Voehringer D, 2008, J IMMUNOL, V180, P4742, DOI 10.4049/jimmunol.180.7.4742; Wang RYR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022060; Xie T, 2018, CELL REP, V22, P3625, DOI 10.1016/j.celrep.2018.03.010; Xie T, 2016, J CLIN INVEST, V126, P3063, DOI 10.1172/JCI85328; Yin Y, 2008, DEV BIOL, V319, P426, DOI 10.1016/j.ydbio.2008.04.009; Ylikorkala A, 2001, SCIENCE, V293, P1323, DOI 10.1126/science.1062074; Yoshida T, 2010, NAT MED, V16, P767, DOI 10.1038/nm.2157; Yu N, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005095; Zhang WM, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-111; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	107	8	8	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10267	10285		10.1096/fj.202000629R	http://dx.doi.org/10.1096/fj.202000629R		JUN 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32533805	Green Published, hybrid			2022-12-28	WOS:000541525300001
J	Szabo, Z; Vainio, L; Lin, R; Swan, J; Hulmi, JJ; Rahtu-Korpela, L; Scrpi, R; Laitinen, M; Pasternack, A; Ritvos, O; Kerkela, R; Magga, J				Szabo, Zoltan; Vainio, Laura; Lin, Ruizhu; Swan, Julia; Hulmi, Juha J.; Rahtu-Korpela, Lea; Scrpi, Raisa; Laitinen, Mika; Pasternack, Arja; Ritvos, Olli; Kerkela, Risto; Magga, Johanna			Systemic blockade of ACVR2B ligands attenuates muscle wasting in ischemic heart failure without compromising cardiac function	FASEB JOURNAL			English	Article						activins; growth differentiation factors; myocardial infarction	ACTIVIN-A; MYOCARDIAL-INFARCTION; MYOSTATIN; CACHEXIA; HYPERTROPHY; INHIBITION; PROTEIN; MOUSE; MASS; FOLLISTATIN	Signaling through activin receptors regulates skeletal muscle mass and activin receptor 2B (ACVR2B) ligands are also suggested to participate in myocardial infarction (MI) pathology in the heart. In this study, we determined the effect of systemic blockade of ACVR2B ligands on cardiac function in experimental MI, and defined its efficacy to revert muscle wasting in ischemic heart failure (HF). Mice were treated with soluble ACVR2B decoy receptor (ACVR2B-Fc) to study its effect on post-MI cardiac remodeling and on later HF. Cardiac function was determined with echocardiography, and myocardium analyzed with histological and biochemical methods for hypertrophy and fibrosis. Pharmacological blockade of ACVR2B ligands did not rescue the heart from ischemic injury or alleviate post-MI remodeling and ischemic HF. Collectively, ACVR2B-Fc did not affect cardiomyocyte hypertrophy, fibrosis, angiogenesis, nor factors associated with cardiac regeneration except modification of certain genes involved in metabolism or cell growth/survival. ACVR2B-Fc, however, was able to reduce skeletal muscle wasting in chronic ischemic HF, accompanied by reduced LC3II as a marker of autophagy and increased mTOR signaling and Cited4 expression as markers of physiological hypertrophy in quadriceps muscle. Our results ascertain pharmacological blockade of ACVR2B ligands as a possible therapy for skeletal muscle wasting in ischemic HF. Pharmacological blockade of ACVR2B ligands preserved myofiber size in ischemic HF, but did not compromise cardiac function nor exacerbate cardiac remodeling after ischemic injury.	[Szabo, Zoltan; Vainio, Laura; Lin, Ruizhu; Swan, Julia; Rahtu-Korpela, Lea; Kerkela, Risto; Magga, Johanna] Univ Oulu, Dept Pharmacol & Toxicol, Res Unit Biomed, Oulu, Finland; [Lin, Ruizhu; Kerkela, Risto] Oulu Univ Hosp, Med Res Ctr Oulu, Oulu, Finland; [Lin, Ruizhu; Kerkela, Risto] Univ Oulu, Oulu, Finland; [Swan, Julia; Scrpi, Raisa; Magga, Johanna] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Hulmi, Juha J.] Univ Jyvaskyla, Neuromuscular Res Ctr, Fac Sport & Hlth Sci, Jyvaskyla, Finland; [Hulmi, Juha J.; Pasternack, Arja; Ritvos, Olli] Univ Helsinki, Dept Physiol, Fac Med, Helsinki, Finland; [Scrpi, Raisa] Univ Oulu, Fac Biochem & Mol Med, Oulu, Finland; [Laitinen, Mika] Univ Helsinki, Dept Med, Helsinki, Finland; [Laitinen, Mika] Helsinki Univ Hosp, Dept Med, Helsinki, Finland	University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Jyvaskyla; University of Helsinki; University of Oulu; University of Helsinki; University of Helsinki; Helsinki University Central Hospital	Magga, J (corresponding author), Dept Pharmacol & Toxicol, Res Unit Biomed, Aapistie 5B,POB 5000, Oulu 90220, Finland.	Johanna.Magga@oulu.fi	Ritvos, Olli/GWC-2442-2022	Pasternack, Arja/0000-0002-6088-4245; Serpi, Raisa/0000-0002-8207-4673; Szabo, Zoltan/0000-0003-0778-1113; Swan, Julia/0000-0002-8831-616X; Magga, Johanna/0000-0003-4688-9098	Academy of Finland (Suomen Akatemia) [268505, 297094, 275922]; Sydantutkimussaatio (Finnish Foundation for Cardiovascular Research)	Academy of Finland (Suomen Akatemia)(Academy of Finland); Sydantutkimussaatio (Finnish Foundation for Cardiovascular Research)	Academy of Finland (Suomen Akatemia), Grant/Award Number: 268505, 297094 and 275922; Sydantutkimussaatio (Finnish Foundation for Cardiovascular Research)	Bechir N, 2016, AM J PHYSIOL-ENDOC M, V310, pE539, DOI 10.1152/ajpendo.00370.2015; Bezzerides VJ, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.85904; Biesemann N, 2015, CELL TISSUE RES, V361, P779, DOI 10.1007/s00441-015-2139-2; Biesemann N, 2014, CIRC RES, V115, P296, DOI 10.1161/CIRCRESAHA.115.304185; Bostrom P, 2010, CELL, V143, P1072, DOI 10.1016/j.cell.2010.11.036; Castillero E, 2015, BIOCHEM BIOPH RES CO, V457, P106, DOI 10.1016/j.bbrc.2014.12.057; Chen Y, 2014, CYTOKINE, V69, P255, DOI 10.1016/j.cyto.2014.06.017; Dogra D, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01950-1; Dschietzig TB, 2014, CLIN CHIM ACTA, V433, P216, DOI 10.1016/j.cca.2014.03.021; Egerman MA, 2015, CELL METAB, V22, P164, DOI 10.1016/j.cmet.2015.05.010; Fang DYP, 2016, TRANSPLANT DIRECT, V2, DOI 10.1097/TXD.0000000000000601; Fulster S, 2013, EUR HEART J, V34, P512, DOI 10.1093/eurheartj/ehs381; Gao E, 2010, CIRC RES, V107, P1445, DOI 10.1161/CIRCRESAHA.110.223925; George I, 2010, EUR J HEART FAIL, V12, P444, DOI 10.1093/eurjhf/hfq039; Gruson D, 2011, EUR J HEART FAIL, V13, P734, DOI 10.1093/eurjhf/hfr024; Han HQ, 2013, INT J BIOCHEM CELL B, V45, P2333, DOI 10.1016/j.biocel.2013.05.019; Harper SC, 2018, CIRC RES, V123, P1220, DOI 10.1161/CIRCRESAHA.118.312955; Hedger MP, 2013, CYTOKINE GROWTH F R, V24, P285, DOI 10.1016/j.cytogfr.2013.03.003; Heineke J, 2010, CIRCULATION, V121, P419, DOI 10.1161/CIRCULATIONAHA.109.882068; Hu J, 2018, MOL MED REP, V17, P5074, DOI 10.3892/mmr.2018.8496; Hulmi JJ, 2018, J CACHEXIA SARCOPENI, V9, P417, DOI 10.1002/jcsm.12265; Hulmi JJ, 2013, AM J PHYSIOL-ENDOC M, V304, pE41, DOI 10.1152/ajpendo.00389.2012; Jackson MF, 2012, J ENDOCRINOL, V213, P263, DOI 10.1530/JOE-11-0455; Jamaiyar A, 2017, PHARMACOL THERAPEUT, V175, P28, DOI 10.1016/j.pharmthera.2017.02.032; Jones JE, 2018, CELL REP, V22, P1522, DOI 10.1016/j.celrep.2018.01.044; Kainulainen H, 2015, MOL CELL ENDOCRINOL, V399, P131, DOI 10.1016/j.mce.2014.10.001; Kleinbongard P, 2011, HEART FAIL REV, V16, P49, DOI 10.1007/s10741-010-9180-8; Latres E, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15153; Lee SJ, 2012, P NATL ACAD SCI USA, V109, pE2353, DOI 10.1073/pnas.1206410109; Li ZB, 2012, J CELL SCI, V125, P3957, DOI 10.1242/jcs.090365; Lim S, 2018, HEART LUNG CIRC, V27, P693, DOI 10.1016/j.hlc.2017.05.138; Magga J, 2019, MOL THER, V27, P600, DOI 10.1016/j.ymthe.2019.01.013; McMurray JJV, 2010, NEW ENGL J MED, V362, P228, DOI 10.1056/NEJMcp0909392; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron Alexandra C., 2010, Immunology Endocrine & Metabolic Agents in Medicinal Chemistry, V10, P217; Miyoshi T, 2009, CLIN CHIM ACTA, V401, P3, DOI 10.1016/j.cca.2008.10.027; Morissette MR, 2009, AGING CELL, V8, P573, DOI 10.1111/j.1474-9726.2009.00508.x; Morvan F, 2017, P NATL ACAD SCI USA, V114, P12448, DOI 10.1073/pnas.1707925114; Nissinen TA, 2016, SCI REP-UK, V6, DOI 10.1038/srep32695; Nissinen TA, 2018, J CACHEXIA SARCOPENI, V9, P514, DOI 10.1002/jcsm.12310; Oshima Y, 2009, CIRCULATION, V120, P1606, DOI 10.1161/CIRCULATIONAHA.109.872200; Palin NK, 2017, TRANSPL INT, V30, P96, DOI 10.1111/tri.12876; Pistilli EE, 2011, AM J PATHOL, V178, P1287, DOI 10.1016/j.ajpath.2010.11.071; Pollari E, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-74; Prabhu SD, 2016, CIRC RES, V119, P91, DOI 10.1161/CIRCRESAHA.116.303577; Rahimov F, 2011, PHYSIOL GENOMICS, V43, P398, DOI 10.1152/physiolgenomics.00223.2010; Relizani K, 2014, MOL THER, V22, P1423, DOI 10.1038/mt.2014.90; Roh JD, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aau8680; Ruas JL, 2012, CELL, V151, P1319, DOI 10.1016/j.cell.2012.10.050; Sako D, 2010, J BIOL CHEM, V285, P21037, DOI 10.1074/jbc.M110.114959; Sartori R, 2013, NAT GENET, V45, P1309, DOI 10.1038/ng.2772; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Smith C, 2004, J AM COLL CARDIOL, V44, P369, DOI 10.1016/j.jacc.2004.03.069; Souza TA, 2008, MOL ENDOCRINOL, V22, P2689, DOI 10.1210/me.2008-0290; Szabo Z, 2014, HYPERTENSION, V63, P1235, DOI 10.1161/HYPERTENSIONAHA.114.03279; Tamargo J, 2019, EXPERT OPIN INV DRUG, V28, P51, DOI 10.1080/13543784.2019.1551357; Tolonen AM, 2014, PHARMACOL RES PERSPE, V2, DOI 10.1002/prp2.56; Tuomainen T, 2017, EXP CELL RES, V360, P12, DOI 10.1016/j.yexcr.2017.03.052; Ueland T, 2013, EUR J HEART FAIL, V15, P747, DOI 10.1093/eurjhf/hft031; Vainio LE, 2019, JACC-BASIC TRANSL SC, V4, P83, DOI 10.1016/j.jacbts.2018.10.007; Vogel B, 2015, METHODSX, V2, P124, DOI 10.1016/j.mex.2015.02.007; von Haehling S, 2017, NAT REV CARDIOL, V14, P323, DOI 10.1038/nrcardio.2017.51; Wolfe RR, 2006, AM J CLIN NUTR, V84, P475, DOI 10.1093/ajcn/84.3.475; Yndestad A, 2004, CIRCULATION, V109, P1379, DOI 10.1161/01.CIR.0000120704.97934.41; Yndestad A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033038; Zhang C, 2012, DIABETOLOGIA, V55, P183, DOI 10.1007/s00125-011-2304-4; Zhou XL, 2010, CELL, V142, P531, DOI 10.1016/j.cell.2010.07.011	67	6	6	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					9911	9924		10.1096/fj.201903074RR	http://dx.doi.org/10.1096/fj.201903074RR		MAY 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32427381	Green Published, hybrid			2022-12-28	WOS:000535587500001
J	Machiela, E; Liontis, T; Dues, DJ; Rudich, PD; Traa, A; Wyman, L; Kaufman, C; Cooper, JF; Lew, L; Nadarajan, S; Senchuk, MM; Van Raamsdonk, JM				Machiela, Emily; Liontis, Thomas; Dues, Dylan J.; Rudich, Paige D.; Traa, Annika; Wyman, Leslie; Kaufman, Corah; Cooper, Jason F.; Lew, Leira; Nadarajan, Saravanapriah; Senchuk, Megan M.; Van Raamsdonk, Jeremy M.			Disruption of mitochondrial dynamics increases stress resistance through activation of multiple stress response pathways	FASEB JOURNAL			English	Article						C; elegans; genetics; mitochondria; mitochondrial dynamics; stress resistance	CAENORHABDITIS-ELEGANS; LIFE-SPAN; C. ELEGANS; OXIDATIVE STRESS; TRANSCRIPTION FACTOR; HEAT-SHOCK; PROTEIN; FISSION; MORPHOLOGY; FUSION	Mitochondria are dynamic organelles that can change shape and size depending on the needs of the cell through the processes of mitochondrial fission and fusion. In this work, we investigated the role of mitochondrial dynamics in organismal stress response. By using C. elegans as a genetic model, we could visualize mitochondrial morphology in a live organism with well-established stress assays and well-characterized stress response pathways. We found that disrupting mitochondrial fission (DRP1/drp-1) or fusion (OPA1/eat-3, MFN/fzo-1) genes caused alterations in mitochondrial morphology that impacted both mitochondrial function and physiologic rates. While both mitochondrial fission and mitochondrial fusion mutants showed increased sensitivity to osmotic stress and anoxia, surprisingly we found that the mitochondrial fusion mutants eat-3 and fzo-1 are more resistant to both heat stress and oxidative stress. In exploring the mechanism of increased stress resistance, we found that disruption of mitochondrial fusion genes resulted in the upregulation of multiple stress response pathways. Overall, this work demonstrates that disrupting mitochondrial dynamics can have opposite effects on resistance to different types of stress. Our results suggest that disruption of mitochondrial fusion activates multiple stress response pathways that enhance resistance to specific stresses.	[Machiela, Emily; Dues, Dylan J.; Wyman, Leslie; Kaufman, Corah; Cooper, Jason F.; Lew, Leira; Senchuk, Megan M.; Van Raamsdonk, Jeremy M.] Van Andel Res Inst, Ctr Neurodegenerat Sci, Lab Aging & Neurodegenerat Dis, Grand Rapids, MI USA; [Liontis, Thomas; Rudich, Paige D.; Traa, Annika; Van Raamsdonk, Jeremy M.] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada; [Liontis, Thomas; Rudich, Paige D.; Traa, Annika; Van Raamsdonk, Jeremy M.] McGill Univ, Res Inst, Hlth Ctr, Metab Disorders & Complicat Program, 1001 Decarie Blvd, Montreal, PQ, Canada; [Liontis, Thomas; Rudich, Paige D.; Traa, Annika; Van Raamsdonk, Jeremy M.] McGill Univ, Res Inst, Hlth Ctr, Brain Repair & Integrat Neurosci Program, 1001 Decarie Blvd, Montreal, PQ, Canada; [Nadarajan, Saravanapriah; Van Raamsdonk, Jeremy M.] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Van Raamsdonk, Jeremy M.] McGill Univ, Dept Med, Div Expt Med, Montreal, PQ, Canada	Van Andel Institute; McGill University; McGill University; McGill University; Harvard University; Harvard Medical School; McGill University	Van Raamsdonk, JM (corresponding author), McGill Univ, Res Inst, Hlth Ctr, Metab Disorders & Complicat Program, 1001 Decarie Blvd, Montreal, PQ, Canada.; Van Raamsdonk, JM (corresponding author), McGill Univ, Res Inst, Hlth Ctr, Brain Repair & Integrat Neurosci Program, 1001 Decarie Blvd, Montreal, PQ, Canada.	jeremy.vanraamsdonk@mcgill.ca	Machiela, Emily/AAB-2426-2021	Traa, Annika/0000-0002-9311-5696; Liontis, Thomas/0000-0003-3376-1511	National Institute of General Medical Sciences [R01 GM121756]; Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	National Institute of General Medical Sciences, Grant/Award Number: R01 GM121756; Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada	Archer SL, 2013, NEW ENGL J MED, V369, P2236, DOI 10.1056/NEJMra1215233; Breckenridge DG, 2009, CURR BIOL, V19, P768, DOI 10.1016/j.cub.2009.03.022; Burte F, 2015, NAT REV NEUROL, V11, P11, DOI 10.1038/nrneurol.2014.228; Byrne JJ, 2019, CELL MOL LIFE SCI, V76, P1967, DOI 10.1007/s00018-019-03024-5; Cooper JF, 2018, EXP NEUROL, V310, P58, DOI 10.1016/j.expneurol.2018.09.001; Cooper JF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16637-2; De Castro E, 2004, FREE RADICAL BIO MED, V37, P139, DOI 10.1016/j.freeradbiomed.2004.04.021; Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936; Detienne Giel, 2016, Worm, V5, pe1230585, DOI 10.1080/21624054.2016.1230585; Dues DJ, 2019, J GERONTOL A-BIOL, V74, P1206, DOI 10.1093/gerona/gly213; Dues DJ, 2017, FREE RADICAL BIO MED, V108, P362, DOI 10.1016/j.freeradbiomed.2017.04.004; Dues DJ, 2016, AGING-US, V8, P777, DOI 10.18632/aging.100939; Feng JL, 2001, DEV CELL, V1, P633, DOI 10.1016/S1534-5807(01)00071-5; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Frazier HN, 2009, CURR BIOL, V19, P859, DOI 10.1016/j.cub.2009.03.066; Hajdu-Cronin YM, 2004, GENETICS, V168, P1937, DOI 10.1534/genetics.104.028423; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Hwang AB, 2011, AGING-US, V3, P304, DOI 10.18632/aging.100292; Inoue H, 2005, GENE DEV, V19, P2278, DOI 10.1101/gad.1324805; Johnson D, 2010, MOL BIOL CELL, V21, P2191, DOI 10.1091/mbc.E09-10-0874; Kanazawa T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000022; Karbowski M, 2003, CELL DEATH DIFFER, V10, P870, DOI 10.1038/sj.cdd.4401260; Kaufman DM, 2015, CURR BIOL, V25, P2171, DOI 10.1016/j.cub.2015.06.062; Labbadia J, 2017, CELL REP, V21, P1481, DOI 10.1016/j.celrep.2017.10.038; Labrousse AM, 1999, MOL CELL, V4, P815, DOI 10.1016/S1097-2765(00)80391-3; Lakowski B, 1996, SCIENCE, V272, P1010, DOI 10.1126/science.272.5264.1010; Lamitina ST, 2004, AM J PHYSIOL-CELL PH, V286, pC785, DOI 10.1152/ajpcell.00381.2003; Liesa M, 2009, PHYSIOL REV, V89, P799, DOI 10.1152/physrev.00030.2008; Link CD, 1999, CELL STRESS CHAPERON, V4, P235, DOI 10.1379/1466-1268(1999)004<0235:DOOSRI>2.3.CO;2; Link CD, 2002, METHOD ENZYMOL, V353, P497; Lu BW, 2009, CURR NEUROL NEUROSCI, V9, P212, DOI 10.1007/s11910-009-0032-7; Luz AL, 2017, TOXICOLOGY, V387, P81, DOI 10.1016/j.tox.2017.05.018; Luz AL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130940; Machiela E, 2016, NEUROBIOL DIS, V96, P1, DOI 10.1016/j.nbd.2016.08.008; Maycotte P, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317698391; Mendenhall AR, 2006, GENETICS, V174, P1173, DOI 10.1534/genetics.106.061390; Nargund AM, 2012, SCIENCE, V337, P587, DOI 10.1126/science.1223560; Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019; Park HEH, 2017, MOL CELLS, V40, P90, DOI 10.14348/molcells.2017.0017; Rea SL, 2005, NAT GENET, V37, P894, DOI 10.1038/ng1608; Redpath CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069165; Regmi SG, 2014, AGING-US, V6, P118, DOI 10.18632/aging.100639; Rolland SG, 2013, P NATL ACAD SCI USA, V110, pE2967, DOI 10.1073/pnas.1303872110; Rolland SG, 2009, J CELL BIOL, V186, P525, DOI 10.1083/jcb.200905070; Schakel C, 2015, 8TH ACM INTERNATIONAL CONFERENCE ON PERVASIVE TECHNOLOGIES RELATED TO ASSISTIVE ENVIRONMENTS (PETRA 2015), DOI 10.1145/2769493.2769499; Senchuk MM, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2086; Senchuk MM, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007268; Tan FJ, 2008, J CELL SCI, V121, P3373, DOI 10.1242/jcs.032904; Tondera D, 2009, EMBO J, V28, P1589, DOI 10.1038/emboj.2009.89; Toyama EQ, 2016, SCIENCE, V351, P275, DOI 10.1126/science.aab4138; Tullet JMA, 2017, AGING CELL, V16, P1191, DOI 10.1111/acel.12627; van der Bliek AM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011072; van Horssen J, 2017, NEUROSCI LETT; Van Raamsdonk JM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000361; Van Raamsdonk JM, 2010, GENETICS, V185, P559, DOI 10.1534/genetics.110.115378; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Wu ZY, 2018, BMC BIOL, V16, DOI 10.1186/s12915-018-0615-3; Xu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038701; Yang W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000556; Yang W, 2010, AGING CELL, V9, P433, DOI 10.1111/j.1474-9726.2010.00571.x; Yoneda T, 2004, J CELL SCI, V117, P4055, DOI 10.1242/jcs.01275; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Zevian SC, 2014, METHODS, V68, P450, DOI 10.1016/j.ymeth.2014.04.015; Zhang PC, 2013, CELL METAB, V17, P85, DOI 10.1016/j.cmet.2012.12.013; Zhang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006348; Zorzano A, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00101; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	67	11	13	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8475	8492		10.1096/fj.201903235R	http://dx.doi.org/10.1096/fj.201903235R		MAY 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32385951	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000532119900001
J	He, TW; Wu, DP; He, L; Wang, X; Yang, B; Li, SF; Chen, YY; Wang, K; Chen, RQ; Liu, B; Zhang, LM; Rong, LM				He Tianwei; Wu Depeng; He Lei; Wang Xuan; Yang Bu; Li Shangfu; Chen Yuyong; Wang Kun; Chen Ruiqiang; Liu Bin; Zhang Liangming; Rong Limin			Casein kinase 1 epsilon facilitates cartilage destruction in osteoarthritis through JNK pathway	FASEB JOURNAL			English	Article						casein kinase 1 epsilon; c-Jun N-terminal kinase; osteoarthritis	CIRCADIAN CLOCK; TERMINAL KINASE; I EPSILON; KAPPA-B; EXPRESSION; WNT; ACTIVATION; PROTEIN; PHOSPHORYLATION; INHIBITION	Osteoarthritis (OA) is a high-morbidity skeletal disease worldwide and the exact mechanisms underlying OA pathogenesis are not fully understood. Casein kinase 1 epsilon (CK1 epsilon) is a serine/threonine protein kinase, but its relationship with OA is still unknown. We demonstrated that CK1 epsilon was upregulated in articular cartilage of human patients with OA and mice with experimentally induced OA. Activity of CK1 epsilon, demonstrated by analysis of phosphorylated substrates, was significantly elevated in interleukin (IL)-1 beta-induced OA-mimicking chondrocytes. CK1 epsilon inhibitor or CK1 epsilon short hairpin RNA (shRNA) partially blocked matrix metalloproteinase (MMP) expression by primary chondrocytes induced by IL-1 beta, and also inhibited cartilage destruction in knee joints of experimental OA model mice. Conversely, overexpression of CK1 epsilon promoted chondrocyte catabolism. Previous studies indicated that CK1 epsilon was involved in canonical Wnt/beta-catenin signaling and noncanonical Wnt/c-Jun N-terminal kinase (JNK) signaling pathway. Interestingly, the activity of JNK but not beta-catenin decreased after CK1 epsilon knockdown in IL-1 beta-treated chondrocytes in vitro, and JNK inhibition reduced MMP expression in chondrocytes overexpressing CK1 epsilon, which illustrated that CK1 epsilon-mediated OA was based on JNK pathway. In conclusion, our results demonstrate that CK1 epsilon promotes OA development, and inhibition of CK1 epsilon could be a potential strategy for OA treatment in the future.	[He Tianwei; Wu Depeng; He Lei; Wang Xuan; Yang Bu; Li Shangfu; Chen Yuyong; Chen Ruiqiang; Liu Bin; Zhang Liangming; Rong Limin] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Spine Surg, 600 Tianhe Rd, Guangzhou 510360, Peoples R China; [He Tianwei; Wu Depeng; He Lei; Wang Xuan; Yang Bu; Li Shangfu; Chen Yuyong; Chen Ruiqiang; Liu Bin; Zhang Liangming; Rong Limin] Guangdong Prov Ctr Qual Control Minimally Invas S, Guangzhou, Peoples R China; [He Tianwei; Wu Depeng; He Lei; Wang Xuan; Yang Bu; Li Shangfu; Chen Yuyong; Chen Ruiqiang; Liu Bin; Zhang Liangming; Rong Limin] Guangdong Prov Ctr Engn & Technol Res Minimally I, Guangzhou, Peoples R China; [Wang Kun] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Joint Surg & Orthoped Trauma, Guangzhou, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Zhang, LM; Rong, LM (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Dept Spine Surg, 600 Tianhe Rd, Guangzhou 510360, Peoples R China.	zhanglm36@mail.sysu.edu.cn; ronglm21@163.com		Rong, Limin/0000-0003-0373-7393				Baron R, 2013, NAT MED, V19, P179, DOI 10.1038/nm.3074; Bernatik O, 2011, J BIOL CHEM, V286, P10396, DOI 10.1074/jbc.M110.169870; Blom AB, 2009, ARTHRITIS RHEUM, V60, P501, DOI 10.1002/art.24247; Boulocher C, 2008, OSTEOARTHR CARTILAGE, V16, P470, DOI 10.1016/j.joca.2007.07.012; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; Bryja V, 2007, J CELL SCI, V120, P586, DOI 10.1242/jcs.03368; Casagolda D, 2010, J CELL SCI, V123, P2621, DOI 10.1242/jcs.067512; Cegielska A, 1998, J BIOL CHEM, V273, P1357, DOI 10.1074/jbc.273.3.1357; Chambers M, 2013, EXP CELL RES, V319, P1398, DOI 10.1016/j.yexcr.2013.04.010; Chiu YC, 2008, J CELL PHYSIOL, V215, P356, DOI 10.1002/jcp.21322; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Curto J, 2018, MOL ONCOL, V12, P611, DOI 10.1002/1878-0261.12184; del Valle-Perez B, 2011, MOL CELL BIOL, V31, P2877, DOI 10.1128/MCB.01466-10; Dudek M, 2016, J CLIN INVEST, V126, P365, DOI 10.1172/JCI82755; Felson DT, 2006, NEW ENGL J MED, V354, P841, DOI 10.1056/NEJMcp051726; Foldynova-Trantirkova S, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2581; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Gonzalez-Sancho JM, 2013, J BIOL CHEM, V288, P9428, DOI 10.1074/jbc.M112.448480; Gossan N, 2013, ARTHRITIS RHEUM-US, V65, P2334, DOI 10.1002/art.38035; GRAVES PR, 1993, J BIOL CHEM, V268, P6394; Gross SD, 1998, CELL SIGNAL, V10, P699, DOI 10.1016/S0898-6568(98)00042-4; Guo B, 2015, OSTEOARTHR CARTILAGE, V23, P1981, DOI 10.1016/j.joca.2015.02.020; Hinoi E, 2006, J BIOL CHEM, V281, P23632, DOI 10.1074/jbc.M512362200; Huang G, 2017, OSTEOARTHR CARTILAGE, V25, P1505, DOI 10.1016/j.joca.2017.05.018; Im GI, 2011, BIOTECHNOL LETT, V33, P1061, DOI 10.1007/s10529-010-0514-3; Kaucka M, 2013, CANCER RES, V73, P1491, DOI 10.1158/0008-5472.CAN-12-1752; Kobayashi M, 2005, ARTHRITIS RHEUM-US, V52, P128, DOI 10.1002/art.20776; Loeser RF, 2012, ARTHRITIS RHEUM-US, V64, P1697, DOI 10.1002/art.34453; Lories RJ, 2013, NAT REV RHEUMATOL, V9, P328, DOI 10.1038/nrrheum.2013.25; Matsu-ura T, 2016, MOL CELL, V64, P900, DOI 10.1016/j.molcel.2016.10.015; McKay RM, 2001, DEV BIOL, V235, P378, DOI 10.1006/dbio.2001.0307; Meng QJ, 2010, P NATL ACAD SCI USA, V107, P15240, DOI 10.1073/pnas.1005101107; Mengshol JA, 2000, ARTHRITIS RHEUM, V43, P801, DOI 10.1002/1529-0131(200004)43:4<801::AID-ANR10>3.0.CO;2-4; Mengshol JA, 2001, NUCLEIC ACIDS RES, V29, P4361, DOI 10.1093/nar/29.21.4361; Nusse R, 2017, CELL, V169, P985, DOI 10.1016/j.cell.2017.05.016; Pendas AM, 1997, GENOMICS, V40, P222, DOI 10.1006/geno.1996.4554; Radin EL, 2005, J RHEUMATOL, V32, P1136; Rivers A, 1998, J BIOL CHEM, V273, P15980, DOI 10.1074/jbc.273.26.15980; Ryu JH, 2006, J BIOL CHEM, V281, P22039, DOI 10.1074/jbc.M601804200; Su ZJ, 2018, P NATL ACAD SCI USA, V115, pE7522, DOI 10.1073/pnas.1802422115; Sun SW, 2018, BIOCHEM BIOPH RES CO, V506, P746, DOI 10.1016/j.bbrc.2018.10.134; Tao SC, 2017, THERANOSTICS, V7, P180, DOI 10.7150/thno.17133; Vinyoles M, 2017, ONCOGENE, V36, P429, DOI 10.1038/onc.2016.209; Yuan XL, 2014, OSTEOARTHR CARTILAGE, V22, P1077, DOI 10.1016/j.joca.2014.05.023; Zhu M, 2008, ARTHRITIS RHEUM-US, V58, P2053, DOI 10.1002/art.23614; Zhu M, 2009, J BONE MINER RES, V24, P12, DOI 10.1359/JBMR.080901	46	4	5	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6466	6478		10.1096/fj.201902672R	http://dx.doi.org/10.1096/fj.201902672R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32175635				2022-12-28	WOS:000531325500033
J	Liu, LJ; Dana, R; Yin, J				Liu Lingjia; Dana, Reza; Yin Jia			Sensory neurons directly promote angiogenesis in response to inflammation via substance P signaling	FASEB JOURNAL			English	Article						angiogenesis; corneal neovascularization; corneal nerves; dry eye disease; ocular surface inflammation; substance P	VIVO CONFOCAL MICROSCOPY; SUBBASAL CORNEAL NERVES; BLOOD-VESSELS; IN-VIVO; ENDOTHELIAL-CELLS; IMMUNE PRIVILEGE; GROWTH-FACTOR; EYE; RECEPTOR; HEALTH	Blood vessels and nerves travel together to supply most tissues in the body. However, there is a knowledge gap in the mechanisms underlying the direct regulation of angiogenesis by nerves. In the current study, we examined the regulation of angiogenesis by sensory nerves in response to inflammation using the cornea, a normally avascular and densely innervated ocular tissue, as a model. We used desiccating stress as an inflammatory stimulus in vivo and found that sub-basal and epithelial nerve densities in the cornea were reduced in dry eye disease (DED). We established a co-culture system of trigeminal ganglion sensory neurons and vascular endothelial cells (VEC) and found that neurons isolated from mice with DED directly promoted VEC proliferation and tube formation compared with normal controls. In addition, these neurons expressed and secreted higher levels of substance P (SP), a proinflammatory neuropeptide. SP potently promoted VEC activation in vitro and blockade of SP signaling with spantide I, an antagonist of SP receptor Neurokinin-1, significantly reduced corneal neovascularization in vivo. Spantide I and siRNA knockdown of SP abolished the promotion of VEC activation by DED neurons in vitro. Taken together, our data suggested that sensory neurons directly promote angiogenesis via SP signaling in response to inflammation in the cornea.	[Liu Lingjia; Dana, Reza; Yin Jia] Harvard Med Sch, Schepens Eye Res Inst Massachusetts Eye & Ear, 20 Staniford St, Boston, MA 02114 USA; [Liu Lingjia] Nankai Univ, Sch Med, Tianjin, Peoples R China	Harvard University; Harvard Medical School; Nankai University	Yin, J (corresponding author), Harvard Med Sch, Schepens Eye Res Inst Massachusetts Eye & Ear, 20 Staniford St, Boston, MA 02114 USA.	Jia_Yin@meei.harvard.edu			NEI NIH HHS [K12 EY016335, K08 EY031340, P30 EY003790] Funding Source: Medline	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Aggarwal S, 2018, AM J OPHTHALMOL, V196, P136, DOI 10.1016/j.ajo.2018.08.040; Azar Dimitri T, 2006, Trans Am Ophthalmol Soc, V104, P264; Barabino S, 2005, INVEST OPHTH VIS SCI, V46, P2766, DOI 10.1167/iovs.04-1326; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Basu S, 2004, CANCER RES, V64, P5551, DOI 10.1158/0008-5472.CAN-04-1600; Belmonte C, 2017, OCUL SURF, V15, P404, DOI 10.1016/j.jtos.2017.05.002; Benowitz LI, 2011, CURR OPIN NEUROL, V24, P577, DOI 10.1097/WCO.0b013e32834c208d; BEUERMAN RW, 1980, EXP NEUROL, V69, P196, DOI 10.1016/0014-4886(80)90154-5; Bignami F, 2014, INVEST OPHTH VIS SCI, V55, DOI 10.1167/iovs.14-14553; Binch ALA, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0889-6; Carmeliet P, 2003, NAT REV GENET, V4, P710, DOI 10.1038/nrg1158; Cattin AL, 2015, CELL, V162, P1127, DOI 10.1016/j.cell.2015.07.021; Chen YH, 2013, INVEST OPHTH VIS SCI, V54, P2457, DOI 10.1167/iovs.12-11121; Cho YK, 2014, CORNEA, V33, P621, DOI 10.1097/ICO.0000000000000107; Cruzat A, 2017, OCUL SURF, V15, P15, DOI 10.1016/j.jtos.2016.09.004; Cursiefen C, 2012, BRIT J OPHTHALMOL, V96, P3, DOI 10.1136/bjo.2011.204701; Dana R, 2019, AM J OPHTHALMOL, V202, P47, DOI 10.1016/j.ajo.2019.01.026; Ellenberg D, 2010, PROG RETIN EYE RES, V29, P208, DOI 10.1016/j.preteyeres.2010.01.002; Ferrari G, 2013, INVEST OPHTH VIS SCI, V54, P813, DOI 10.1167/iovs.11-8379; Francescone RA, 2011, JOVE-J VIS EXP, DOI 10.3791/3040; GARCIAHIRSCHFELD J, 1994, EXP EYE RES, V59, P597, DOI 10.1006/exer.1994.1145; GREENO EW, 1993, J EXP MED, V177, P1269, DOI 10.1084/jem.177.5.1269; GU XH, 1995, BRIT J DERMATOL, V132, P376, DOI 10.1111/j.1365-2133.1995.tb08670.x; He JC, 2019, INVEST OPHTH VIS SCI, V60, P2449, DOI 10.1167/iovs.18-26384; He MW, 2020, MOL MED REP, V21, P1163, DOI 10.3892/mmr.2020.10922; Hogg PJ, 2002, LANCET, V360, P1714, DOI 10.1016/S0140-6736(02)11726-0; Inomata T, 2017, CORNEA, V36, P491, DOI 10.1097/ICO.0000000000001127; Kheirkhah A, 2017, CORNEA, V36, P196, DOI 10.1097/ICO.0000000000001057; Kheirkhah A, 2015, OPHTHALMOLOGY, V122, P662, DOI 10.1016/j.ophtha.2014.11.006; Kodama-Takahashi A, 2018, CASE REP OPHTHALMOL, V2018, DOI 10.1155/2018/6815407; Kodati S, 2014, INVEST OPHTH VIS SCI, V55, P5871, DOI 10.1167/iovs.14-14481; Labbe A, 2013, INVEST OPHTH VIS SCI, V54, P5144, DOI 10.1167/iovs.13-12370; Labetoulle M, 2019, ACTA OPHTHALMOL, V97, P137, DOI 10.1111/aos.13844; Lambiase A, 2011, ARCH OPHTHALMOL-CHIC, V129, P981, DOI 10.1001/archophthalmol.2011.200; Lee J, 2018, TISSUE ENG REGEN MED, V15, P493, DOI 10.1007/s13770-018-0134-x; Malin SA, 2007, NAT PROTOC, V2, P152, DOI 10.1038/nprot.2006.461; Matsuyama A, 2017, BIOL PHARM BULL, V40, P396, DOI 10.1248/bpb.b16-00583; Mehta D, 2019, DERMATOLOGY, V235, P175, DOI 10.1159/000496538; Mistrova E, 2016, NEUROPEPTIDES, V58, P41, DOI 10.1016/j.npep.2015.12.005; Muller RT, 2015, INVEST OPHTH VIS SCI, V56, P4899, DOI 10.1167/iovs.15-16527; Muller LJ, 2003, EXP EYE RES, V76, P521, DOI 10.1016/S0014-4835(03)00050-2; Munoz M, 2014, AMINO ACIDS, V46, P1727, DOI 10.1007/s00726-014-1736-9; Munoz M, 2013, PEPTIDES, V48, P1, DOI 10.1016/j.peptides.2013.07.024; Neelam S, 2018, INVEST OPHTH VIS SCI, V59, P4738, DOI 10.1167/iovs.18-24894; Park JA, 2003, BIOCHEM BIOPH RES CO, V311, P247, DOI 10.1016/j.bbrc.2003.09.129; Patel DV, 2009, BRIT J OPHTHALMOL, V93, P853, DOI 10.1136/bjo.2008.150615; Paunicka KJ, 2015, AM J TRANSPLANT, V15, P1490, DOI 10.1111/ajt.13240; Pflugfelder SC, 2004, AM J OPHTHALMOL, V137, P337, DOI 10.1016/j.ajo.2003.10.036; Quinlan KL, 1999, J IMMUNOL, V162, P1656; Shaheen BS, 2014, SURV OPHTHALMOL, V59, P263, DOI 10.1016/j.survophthal.2013.09.002; Simsek C, 2019, INVEST OPHTH VIS SCI, V60, P615, DOI 10.1167/iovs.18-26318; Simsek C, 2018, INVEST OPHTH VIS SCI, V59, P1986, DOI 10.1167/iovs.17-23743; Stepp MA, 2017, GLIA, V65, P851, DOI 10.1002/glia.23102; Suvas S, 2017, J IMMUNOL, V199, P1543, DOI 10.4049/jimmunol.1601751; Twardy BS, 2011, INVEST OPHTH VIS SCI, V52, P8604, DOI 10.1167/iovs.11-8089; Ueno H, 2012, INVEST OPHTH VIS SCI, V53, P867, DOI 10.1167/iovs.11-8438; Ward NL, 2011, J DERMATOL SCI, V61, P14, DOI 10.1016/j.jdermsci.2010.11.004; Yu M, 2020, AM J PATHOL, V190, P125, DOI 10.1016/j.ajpath.2019.09.020; Zhong W, 2018, SURV OPHTHALMOL, V63, P453, DOI 10.1016/j.survophthal.2017.12.008; ZICHE M, 1991, LIFE SCI, V48, pPL7, DOI 10.1016/0024-3205(91)90417-A; ZICHE M, 1990, MICROVASC RES, V40, P264, DOI 10.1016/0026-2862(90)90024-L; ZICHE M, 1994, J CLIN INVEST, V94, P2036, DOI 10.1172/JCI117557	62	23	24	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6229	6243		10.1096/fj.201903236R	http://dx.doi.org/10.1096/fj.201903236R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32162744	Green Accepted, Bronze			2022-12-28	WOS:000531325500018
J	Hamard, L; Santoro, T; Allagnat, F; Meda, P; Nardelli-Haefliger, D; Alonso, F; Haefliger, JA				Hamard, Lauriane; Santoro, Tania; Allagnat, Florent; Meda, Paolo; Nardelli-Haefliger, Denise; Alonso, Florian; Haefliger, Jacques-Antoine			Targeting connexin37 alters angiogenesis and arteriovenous differentiation in the developing mouse retina	FASEB JOURNAL			English	Article						angiogenesis; connexin37; retina; vascular remodeling	GAP-JUNCTION PROTEINS; VASCULAR DEVELOPMENT; ENDOTHELIAL CONNEXINS; MICE LACKING; CX37; CELLS; CX40; MATURATION; SURVIVAL; INSIGHTS	Connexin37 (Cx37) forms intercellular channels between endothelial cells (EC), and contributes to coordinate the motor tone of vessels. We investigated the contribution of this protein during physiological angiogenesis. We show that, compared to WT littermates, mice lacking Cx37 (Cx37(-/-)) featured (i) a decreased extension of the superficial vascular plexus during the first 4 days after birth; (ii) an increased vascular density at the angiogenic front at P6, due to an increase in the proliferative rate of EC and in the sprouting of the venous compartment, as well as to a somewhat displaced position of tip cells; (iii) a decreased coverage of newly formed arteries and veins by mural cells; (iv) altered ERK-dependent endothelial cells proliferation through the EphB4 signaling pathway, which is involved in the specification of veins and arteries. In vitro studies documented that, in the absence of Cx37, human venous EC (HUVEC) released less platelet-derived growth factor (PDGF) and more Angiopoietin-2, two molecules involved in the recruitment of mural cells. Treatment of mice with DAPT, an inhibitor of the Notch pathway, decreased the expression of Cx37, and partially mimicked in WT retinas, the alterations observed in Cx37(-/-) mice. Thus, Cx37 contributes to (i) the early angiogenesis of retina, by interacting with the Notch pathway; (ii) the growth and maturation of neo-vessels, by modulating tip, stalk, and mural cells; (iii) the regulation of arteriovenous specification, thus, representing a novel target for treatments of retina diseases.	[Hamard, Lauriane; Santoro, Tania; Allagnat, Florent; Haefliger, Jacques-Antoine] Lausanne Univ Hosp, Dept Med, Lausanne, Switzerland; [Meda, Paolo] Univ Geneva, Med Ctr, Dept Cell Physiol & Metab, Geneva, Switzerland; [Nardelli-Haefliger, Denise] Lausanne Univ Hosp, Dept Urol, Lausanne, Switzerland; [Alonso, Florian] Univ Bordeaux, Ctr Rech Cardiothorac Bordeaux, INSERM, U1045, Bordeaux, France	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Geneva; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Haefliger, JA (corresponding author), Lausanne Univ Hosp, Dept Med, Lab Expt Med, Dept Biomed Sci, Bugnon 7a, CH-1005 Lausanne, Switzerland.	Jacques-Antoine.Haefliger@chuv.ch	Alonso, Florian/AAA-2776-2020; Allagnat, Florent/AAY-7188-2021	Alonso, Florian/0000-0002-6794-1513; Allagnat, Florent/0000-0001-6528-679X	Krebsliga Schweiz (Swiss Cancer League) [KFS-3796-02-2016]; Fonds De La Recherche Scientifique FNRS (FNRS) [31003A-175452/1]	Krebsliga Schweiz (Swiss Cancer League); Fonds De La Recherche Scientifique FNRS (FNRS)(Fonds de la Recherche Scientifique - FNRS)	Krebsliga Schweiz (Swiss Cancer League), Grant/Award Number: KFS-3796-02-2016; Fonds De La Recherche Scientifique FNRS (FNRS), Grant/Award Number: 31003A-175452/1	Allagnat F, 2017, CARDIOVASC RES, V113, P805, DOI 10.1093/cvr/cvx079; Alonso F, 2016, ONCOTARGET, V7, P14015, DOI 10.18632/oncotarget.7370; Alonso F, 2010, AM J PHYSIOL-HEART C, V299, pH1365, DOI 10.1152/ajpheart.00029.2010; Alonso F, 2010, CARDIOVASC RES, V87, P166, DOI 10.1093/cvr/cvq031; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Benton RL, 2008, J COMP NEUROL, V507, P1031, DOI 10.1002/cne.21570; Bosco D, 2011, PHYSIOL REV, V91, P1393, DOI 10.1152/physrev.00027.2010; Burt JM, 2008, AM J PHYSIOL-CELL PH, V295, pC1103, DOI 10.1152/ajpcell.299.2008; Cabral T, 2017, INT J RETINA VITREOU, V3, P1; Cai J, 2008, INVEST OPHTH VIS SCI, V49, P2163, DOI 10.1167/iovs.07-1206; Campochiaro PA, 2015, PROG RETIN EYE RES, V49, P67, DOI 10.1016/j.preteyeres.2015.06.002; Chung AS, 2011, ANNU REV CELL DEV BI, V27, P563, DOI 10.1146/annurev-cellbio-092910-154002; Cossutta M, 2019, ARTERIOSCL THROM VAS, V39, P1843, DOI 10.1161/ATVBAHA.119.313021; Crist AM, 2017, GENE EXPR PATTERNS, V23-24, P22, DOI 10.1016/j.gep.2017.01.002; Cuervo H, 2017, ANGIOGENESIS, V20, P655, DOI 10.1007/s10456-017-9570-9; Dhein S, 2015, N-S ARCH PHARMACOL, V388, P101, DOI 10.1007/s00210-014-1059-0; Ehling M, 2013, DEVELOPMENT, V140, P3051, DOI 10.1242/dev.093351; Fang JS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03076-4; Fang JS, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01742-7; Fang JS, 2012, J VASC RES, V49, P2, DOI 10.1159/000329616; Fang JS, 2011, AM J PHYSIOL-HEART C, V301, pH1872, DOI 10.1152/ajpheart.00683.2011; Gaengel K, 2009, ARTERIOSCL THROM VAS, V29, P630, DOI 10.1161/ATVBAHA.107.161521; Gartner C, 2012, PHARMACOL RES, V65, P347, DOI 10.1016/j.phrs.2011.11.012; Gridley T, 2007, DEVELOPMENT, V134, P2709, DOI 10.1242/dev.004184; Haefliger JA, 2017, ARTERIOSCL THROM VAS, V37, P2136, DOI 10.1161/ATVBAHA.117.310072; Hamelin R, 2009, CURR PROTEIN PEPT SC, V10, P18, DOI 10.2174/138920309787315167; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Hellstrom M, 2007, CELL ADHES MIGR, V1, P133, DOI 10.4161/cam.1.3.4978; Ivanova E, 2019, J COMP NEUROL, V527, P2675, DOI 10.1002/cne.24699; Kalna V, 2019, CIRC RES, V124, P1337, DOI 10.1161/CIRCRESAHA.118.313788; Klein R, 2012, DEVELOPMENT, V139, P4105, DOI 10.1242/dev.074997; Kuijper S, 2007, TRENDS CARDIOVAS MED, V17, P145, DOI 10.1016/j.tcm.2007.03.003; Lackmann M, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.115re2; Le Gal L, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.118.010823; Le Gal L, 2015, HYPERTENSION, V65, P910, DOI 10.1161/HYPERTENSIONAHA.114.04775; Le Gal L, 2014, HYPERTENSION, V63, P1198, DOI 10.1161/HYPERTENSIONAHA.113.02976; Li Z, 2018, EXP THER MED, V15, P1847, DOI 10.3892/etm.2017.5636; Meda P, 2018, BBA-BIOMEMBRANES, V1860, P124, DOI 10.1016/j.bbamem.2017.03.005; Meda P, 2016, SWISS MED WKLY, V146, DOI 10.4414/smw.2016.14365; Meens MJ, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0110-1; Meens MJ, 2015, CELL MOL LIFE SCI, V72, P2779, DOI 10.1007/s00018-015-1959-2; Nohata N, 2016, DEV BIOL, V411, P183, DOI 10.1016/j.ydbio.2016.02.005; Okamoto T, 2019, CANCERS, V11, DOI 10.3390/cancers11020237; Park HJ, 2006, STEM CELL REV, V2, P93, DOI 10.1007/s12015-006-0015-x; Peghaire C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12897-w; Pfenniger A, 2010, ARTERIOSCL THROM VAS, V30, P827, DOI 10.1161/ATVBAHA.109.200816; Phng LK, 2009, DEV CELL, V16, P196, DOI 10.1016/j.devcel.2009.01.015; Pitulescu ME, 2010, NAT PROTOC, V5, P1518, DOI 10.1038/nprot.2010.113; Sakabe M, 2017, P NATL ACAD SCI USA, V114, P10918, DOI 10.1073/pnas.1704030114; Sarrazin S, 2006, BBA-REV CANCER, V1765, P25, DOI 10.1016/j.bbcan.2005.08.004; Scheppke L, 2012, BLOOD, V119, P2149, DOI 10.1182/blood-2011-04-348706; Selbonne S, 2015, CELL MOL LIFE SCI, V72, P3999, DOI 10.1007/s00018-015-1972-5; Shawber CJ, 2004, BIOESSAYS, V26, P225, DOI 10.1002/bies.20004; Simon AM, 1997, NATURE, V385, P525, DOI 10.1038/385525a0; Simon AM, 2006, CELL COMMUN ADHES, V13, P61, DOI 10.1080/15419060600631748; Simon AM, 2002, DEV BIOL, V251, P206, DOI 10.1006/dbio.2002.0826; Slavi N, 2018, P NATL ACAD SCI USA, V115, pE5934, DOI 10.1073/pnas.1803907115; Stahl A, 2010, INVEST OPHTH VIS SCI, V51, P2813, DOI 10.1167/iovs.10-5176; Tahergorabi Z, 2012, INT J PREVENTIVE MED, V3, P827, DOI 10.4103/2008-7802.104853; Weinl C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107048; Wolf K, 2019, J VASC SURG, V69, P253, DOI 10.1016/j.jvs.2018.06.195; Yang D, 2016, ANGIOGENESIS, V19, P297, DOI 10.1007/s10456-016-9514-9	62	4	4	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8234	8249		10.1096/fj.202000257R	http://dx.doi.org/10.1096/fj.202000257R		APR 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32323401				2022-12-28	WOS:000528404900001
J	de Conti, A; Tryndyak, V; Willett, RA; Borowa-Mazgaj, B; Watson, A; Patton, R; Khare, S; Muskhelishvili, L; Olson, GR; Avigan, MI; Cerniglia, CE; Ross, SA; Sanyal, AJ; Beland, FA; Rusyn, I; Pogribny, IP				Conti, Aline; Tryndyak, Volodymyr; Willett, Rose A.; Borowa-Mazgaj, Barbara; Watson, Anna; Patton, Ralph; Khare, Sangeeta; Muskhelishvili, Levan; Olson, Greg R.; Avigan, Mark I.; Cerniglia, Carl E.; Ross, Sharon A.; Sanyal, Arun J.; Beland, Frederick A.; Rusyn, Ivan; Pogribny, Igor P.			Characterization of the variability in the extent of nonalcoholic fatty liver induced by a high-fat diet in the genetically diverse Collaborative Cross mouse model	FASEB JOURNAL			English	Article						Cd36; collaborative cross mice; gene expression; nonalcoholic fatty liver disease	ANIMAL-MODEL; PPAR-GAMMA; DISEASE; EXPRESSION; STEATOSIS; OBESITY; NASH; CD36	Interindividual variability and sexual dimorphisms in the development of nonalcoholic fatty liver disease (NAFLD) are still poorly understood. In the present study, male and female strains of Collaborative Cross (CC) mice were fed a high-fat and high-sucrose (HF/HS) diet or a control diet for 12 weeks to investigate interindividual- and sex-specific variations in the development of NAFLD. The severity of liver steatosis varied between sexes and individual strains and was accompanied by an elevation of serum markers of insulin resistance, including increases in total cholesterol, low-density lipoproteins, high-density lipoproteins, phospholipids, and glucose. The development of NAFLD was associated with overexpression of the critical fatty acid uptake and de novo lipogenesis genes Pparg, Mogat1, Cd36, Acaab1, Fabp2, and Gdf15 in male and female mice. The expression of Pparg, Mogat1, and Cd36 was positively correlated with liver triglycerides in male mice, and Mogat1 and Cd36 expression were positively correlated with liver triglycerides in female mice. Our results indicate the value of CC mice in combination with HF/HS diet-induced alterations as an approach to study the susceptibility and interindividual variabilities in the pathogenesis of nonalcoholic fatty liver and early nonalcoholic steatohepatitis at the population level, uncovering of susceptible and resistant cohorts, and identifying sex-specific molecular determinants of disease susceptibility.	[Conti, Aline; Tryndyak, Volodymyr; Willett, Rose A.; Borowa-Mazgaj, Barbara; Watson, Anna; Beland, Frederick A.; Pogribny, Igor P.] US FDA, Div Biochem Toxicol, Natl Ctr Toxicol Res, 3900 NCTR Rd, Jefferson, AR 72079 USA; [Patton, Ralph; Muskhelishvili, Levan; Olson, Greg R.] Toxicol Pathol Associates, Jefferson, AR USA; [Khare, Sangeeta; Cerniglia, Carl E.] US FDA, Div Microbiol, Natl Ctr Toxicol Res, Jefferson, AR USA; [Avigan, Mark I.] US FDA, Off Pharmacovigilance & Epidemiol, Ctr Drug Evaluat & Res, Silver Spring, MD USA; [Ross, Sharon A.] NCI, Div Canc Prevent, Bethesda, MD 20892 USA; [Sanyal, Arun J.] Virginia Commonwealth Univ, Dept Internal Med, Richmond, VA USA; [Rusyn, Ivan] Texas A&M Univ, Dept Vet Integrat Biosci, College Stn, TX USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Virginia Commonwealth University; Texas A&M University System; Texas A&M University College Station	Pogribny, IP (corresponding author), US FDA, Div Biochem Toxicol, Natl Ctr Toxicol Res, 3900 NCTR Rd, Jefferson, AR 72079 USA.	igor.pogribny@fda.hhs.gov		Willett, Rose/0000-0002-2081-8358; Rusyn, Ivan/0000-0001-9340-7384; Khare, SangeetA/0000-0002-9496-6636	HHS | U.S. Food and Drug Administration (FDA) [E7635.01]	HHS | U.S. Food and Drug Administration (FDA)(United States Department of Health & Human Services)	HHS | U.S. Food and Drug Administration (FDA), Grant/Award Number: E7635.01	Adolph TE, 2018, TRENDS IMMUNOL, V39, P712, DOI 10.1016/j.it.2018.05.002; Asgharpour A, 2016, J HEPATOL, V65, P579, DOI 10.1016/j.jhep.2016.05.005; Atamni HA, 2018, MAMM GENOME, V29, P471, DOI 10.1007/s00335-018-9768-1; Barrington WT, 2018, GENETICS, V208, P399, DOI 10.1534/genetics.117.300536; Bashiardes S, 2016, MOL METAB, V5, P782, DOI 10.1016/j.molmet.2016.06.003; Bedossa P, 2016, DIGEST DIS SCI, V61, P1348, DOI 10.1007/s10620-016-4062-0; Brunt EM, 2019, HEPATOLOGY, V70, P522, DOI 10.1002/hep.30418; Brunt EM, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.80; Castera L, 2019, GASTROENTEROLOGY, V156, P1264, DOI 10.1053/j.gastro.2018.12.036; Charlton M, 2011, AM J PHYSIOL-GASTR L, V301, pG825, DOI 10.1152/ajpgi.00145.2011; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Eslam M, 2018, J HEPATOL, V68, P268, DOI 10.1016/j.jhep.2017.09.003; Estes C, 2018, HEPATOLOGY, V67, P123, DOI 10.1002/hep.29466; Farrell G, 2019, HEPATOLOGY, V69, P2241, DOI 10.1002/hep.30333; Garcia-Monzon C, 2014, EUR J CLIN INVEST, V44, P65, DOI 10.1111/eci.12192; Golob-Schwarzi N, 2019, TRANSL ONCOL, V12, P256, DOI 10.1016/j.tranon.2018.10.010; Graupera I, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01709-0; Greenstein AW, 2017, J ENDOCRINOL, V232, P107, DOI 10.1530/JOE-16-0447; Hall AM, 2014, DIABETES, V63, P2284, DOI 10.2337/db13-1502; Hall AM, 2012, J LIPID RES, V53, P990, DOI 10.1194/jlr.P025536; Hayashi Y, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.4; Hui ST, 2018, HEPATOLOGY, V68, P2182, DOI 10.1002/hep.30113; Hui ST, 2015, ELIFE, V4, DOI 10.7554/eLife.05607; Inoue M, 2005, BIOCHEM BIOPH RES CO, V336, P215, DOI 10.1016/j.bbrc.2005.08.070; Ipsen DH, 2018, CELL MOL LIFE SCI, V75, P3313, DOI 10.1007/s00018-018-2860-6; Jahn D, 2019, BBA-MOL BASIS DIS, V1865, P943, DOI 10.1016/j.bbadis.2018.06.023; Jha P, 2018, CELL SYST, V6, P722, DOI 10.1016/j.cels.2018.05.016; Kaeppler SM, 1997, THEOR APPL GENET, V95, P384, DOI 10.1007/s001220050574; Leroux A, 2012, J HEPATOL, V57, P141, DOI 10.1016/j.jhep.2012.02.028; Li L, 2016, OBES REV, V17, P510, DOI 10.1111/obr.12407; Li ZZ, 2009, J BIOL CHEM, V284, P5637, DOI 10.1074/jbc.M807616200; Lima-Cabello E, 2011, CLIN SCI, V120, P239, DOI 10.1042/CS20100387; Lonardo A, 2019, HEPATOLOGY, V70, P1457, DOI 10.1002/hep.30626; Lu FB, 2018, EXPERT REV GASTROENT, V12, P491, DOI 10.1080/17474124.2018.1460202; NISHIMURA R, 1995, BIOTECH HISTOCHEM, V70, P28, DOI 10.3109/10520299509108313; Novo E, 2015, HISTOL HISTOPATHOL, V30, P1011, DOI 10.14670/HH-11-623; Pettinelli P, 2011, J CLIN ENDOCR METAB, V96, P1424, DOI 10.1210/jc.2010-2129; Pogribny IP, 2013, FASEB J, V27, P2233, DOI 10.1096/fj.12-227116; Salimova E, 2019, NPJ REGEN MED, V4, DOI 10.1038/s41536-019-0067-6; Santhekadur PK, 2018, J HEPATOL, V68, P230, DOI 10.1016/j.jhep.2017.10.031; Sanyal AJ, 2019, NAT REV GASTRO HEPAT, V16, P377, DOI 10.1038/s41575-019-0144-8; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schwenk RW, 2010, PROSTAG LEUKOTR ESS, V82, P149, DOI 10.1016/j.plefa.2010.02.029; Schwimmer JB, 2019, GASTROENTEROLOGY, V157, P1109, DOI 10.1053/j.gastro.2019.06.028; Sharpton SR, 2019, CLIN GASTROENTEROL H, V17, P296, DOI 10.1016/j.cgh.2018.08.065; Sheedfar F, 2014, AGING-US, V6, P281, DOI 10.18632/aging.100652; Silva AKS, 2018, CELL MOL LIFE SCI, V75, P2951, DOI 10.1007/s00018-018-2838-4; Teufel A, 2016, GASTROENTEROLOGY, V151, P513, DOI 10.1053/j.gastro.2016.05.051; Threadgill DW, 2011, ILAR J, V52, P24, DOI 10.1093/ilar.52.1.24; Valenti LVC, 2018, CURR PHARM DESIGN, V24, P4566, DOI 10.2174/1381612825666190119113836; Vilar-Gomez E, 2018, J HEPATOL, V68, P305, DOI 10.1016/j.jhep.2017.11.013; Wang P, 2019, GUT, V68, P1942, DOI 10.1136/gutjnl-2018-316691; Wang W, 2017, HEPATOLOGY, V66, P108, DOI 10.1002/hep.29129; Williams Valerie F, 2019, MSMR, V26, P2; Wong VWS, 2018, NAT REV GASTRO HEPAT, V15, P461, DOI 10.1038/s41575-018-0014-9; Younes R, 2019, SEMIN LIVER DIS, V39, P86, DOI 10.1055/s-0038-1677517; Younossi Z, 2019, HEPATOLOGY, V69, P2672, DOI 10.1002/hep.30251; Younossi ZM, 2019, J HEPATOL, V70, P531, DOI 10.1016/j.jhep.2018.10.033; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431; Zelber-Sagi S, 2014, LIVER INT, V34, pE128, DOI 10.1111/liv.12318	60	7	7	0	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					7773	7785		10.1096/fj.202000194R	http://dx.doi.org/10.1096/fj.202000194R		APR 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32304142	Green Accepted			2022-12-28	WOS:000526960300001
J	Couvineau, P; Llorens-cortes, C; Iturrioz, X				Couvineau, Pierre; Llorens-cortes, Catherine; Iturrioz, Xavier			Elabela/Toddler and apelin bind differently to the apelin receptor	FASEB JOURNAL			English	Article						apelin; APJ; Elabela; Toddler; G protein-coupled receptor; site-directed mutagenesis	FLUID HOMEOSTASIS; APJ RECEPTOR; LIGAND; RESIDUES; ELABELA; IDENTIFICATION; FRAGMENT	Like apelin (pE13F, K17F), Elabela/Toddler is an endogenous ligand of the apelin receptor playing a key role in cardiovascular development. Elabela/Toddler exists as peptide fragments of 32 (Q32P), 22 (K22P) and 11 (C11P) amino acids. In this study, we investigated the possible structural and functional similarities between these endogenous ligands. We performed in vitro pharmacological characterization and biased signaling analyses for apelin and Elabela/Toddler fragments in CHO cells, by assessing binding affinities, the inhibition of cyclic adenosine monophosphate (cAMP) production and the triggering of ss-arrestin 2 recruitment. We also performed Alanine scanning for Elabela/Toddler and structure-function studies based on site-directed mutagenesis of the rat and human apelin receptor, to compare the modes of binding of the different endogenous ligands. Alanine scanning of K22P showed that neither of its cysteine residues were involved in binding or in peptide activity and that its C-terminus carried the key pharmacophore for receptor binding and activation. We showed that Asp(282) and Asp(284) of rat and human apelin receptor, respectively, were not involved in Elabela/Toddler activity, whereas they are key residues for apelin binding and activity. We found that the structural features of Elabela/Toddler and apelin were different, resulting in different modes of binding of these endogenous ligands to the apelin receptor. These differences should be taken into account in the future development metabolically stable analogs of Elabela/Toddler and apelin as potential therapeutic tools for the treatment of cardiovascular diseases and water retention/hyponatremic disorders.	[Couvineau, Pierre; Llorens-cortes, Catherine; Iturrioz, Xavier] PSL Res Univ, Coll France, CIRB, INSERM,CNRS, Paris, France; [Couvineau, Pierre] Univ Montreal, IRIC, Montreal, PQ, Canada; [Couvineau, Pierre] Univ Montreal, Dept Biochem & Mol Med, Montreal, PQ, Canada	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Universite de Montreal; Universite de Montreal	Iturrioz, X (corresponding author), Coll France, Lab Cent Neuropeptides Regulat Body Fluid Homeost, CIRB, 11 Pl Marcelin Berthelot, F-75005 Paris, France.	xavier.iturrioz@college-de-france.fr	Iturrioz, Xavier/AAS-3555-2020; Llorens-Cortes, Catherine/E-5839-2016; ITURRIOZ, Xavier/Q-4406-2017	Iturrioz, Xavier/0000-0001-7143-8323; Llorens-Cortes, Catherine/0000-0002-7667-0401; ITURRIOZ, Xavier/0000-0001-7143-8323; Couvineau, Pierre/0000-0002-4905-7740	Institut National de la Sante et de la Recherche Medicale, the College de France; "Labex MemoLife" - French national "Programme des Investissements d'Avenir 2011-2012"	Institut National de la Sante et de la Recherche Medicale, the College de France; "Labex MemoLife" - French national "Programme des Investissements d'Avenir 2011-2012"(French National Research Agency (ANR))	This work was supported by the Institut National de la Sante et de la Recherche Medicale, the College de France. Pierre Couvineau was supported by a "Labex MemoLife," funded by the French national "Programme des Investissements d'Avenir 2011-2012." We would like to thank Dr Adrien Flahault for his contribution to our statistical analysis. We would like to thank Julie Sappa from Alex Edelman & Associates for the English editing. We would like to thank Dr Joanne Durgan (Babraham Institute, Cambridge, UK) and Dr Shane Wright Christopher (IRIC, Montreal, Canada) for manuscript reading.	Besserer-Offroy E, 2018, PHARMACOL RES, V131, P7, DOI 10.1016/j.phrs.2018.02.032; Boucher J, 2005, ENDOCRINOLOGY, V146, P1764, DOI 10.1210/en.2004-1427; Ceraudo E, 2014, J BIOL CHEM, V289, P24599, DOI 10.1074/jbc.M113.541698; Chen H, 2017, J AM SOC NEPHROL, V28, P2695, DOI 10.1681/ASN.2016111210; Chng SC, 2013, DEV CELL, V27, P672, DOI 10.1016/j.devcel.2013.11.002; Curtis MJ, 2018, BRIT J PHARMACOL, V175, P987, DOI 10.1111/bph.14153; De Mota N, 2000, NEUROENDOCRINOLOGY, V72, P400, DOI 10.1159/000054609; De Mota N, 2004, P NATL ACAD SCI USA, V101, P10464, DOI 10.1073/pnas.0403518101; Deng C, 2015, J BIOL CHEM, V290, P18261, DOI 10.1074/jbc.M115.648238; Fillion D, 2013, J BIOL CHEM, V288, P8187, DOI 10.1074/jbc.M112.442053; Flahault A, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00120; Galanth C, 2012, CURR PHARM DESIGN, V18, P789, DOI 10.2174/138161212799277770; Gerbier R, 2015, FASEB J, V29, P314, DOI 10.1096/fj.14-256339; Habata Y, 1999, BBA-MOL CELL RES, V1452, P25, DOI 10.1016/S0167-4889(99)00114-7; Helker CSM, 2015, ELIFE, V4, DOI 10.7554/eLife.06726; HJORTH SA, 1994, J BIOL CHEM, V269, P30953; Ho L, 2015, CELL STEM CELL, V17, P435, DOI 10.1016/j.stem.2015.08.010; Huang SYK, 2017, BBA-BIOMEMBRANES, V1859, P767, DOI 10.1016/j.bbamem.2017.01.028; Iturrioz X, 2010, J BIOL CHEM, V285, P32627, DOI 10.1074/jbc.M110.127167; Kawamata Y, 2001, BBA-MOL CELL RES, V1538, P162, DOI 10.1016/S0167-4889(00)00143-9; Ma YL, 2017, STRUCTURE, V25, P858, DOI 10.1016/j.str.2017.04.008; Medhurst AD, 2003, J NEUROCHEM, V84, P1162, DOI 10.1046/j.1471-4159.2003.01587.x; Messari SE, 2004, J NEUROCHEM, V90, P1290, DOI 10.1111/j.1471-4159.2004.02591.x; Murza A, 2016, J MED CHEM, V59, P2962, DOI 10.1021/acs.jmedchem.5b01549; ODOWD BF, 1993, GENE, V136, P355, DOI 10.1016/0378-1119(93)90495-O; Pauli A, 2014, SCIENCE, V343, P746, DOI 10.1126/science.1248636; Perjes A, 2016, BASIC RES CARDIOL, V111, DOI 10.1007/s00395-015-0521-6; Schioth HB, 2005, GEN COMP ENDOCR, V142, P94, DOI 10.1016/j.ygcen.2004.12.018; Shin K, 2019, AMINO ACIDS, V51, P395, DOI 10.1007/s00726-018-2674-8; Tatemoto K, 1998, BIOCHEM BIOPH RES CO, V251, P471, DOI 10.1006/bbrc.1998.9489; van der Westhuizen ET, 2014, MOL PHARMACOL, V85, P492, DOI 10.1124/mol.113.088880; Wang Z, 2015, SCI REP-UK, V5, DOI 10.1038/srep08170; Yang PR, 2017, CIRCULATION, V135, P1160, DOI 10.1161/CIRCULATIONAHA.116.023218; Yang PR, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00092; Zhou HP, 2000, ARCH BIOCHEM BIOPHYS, V373, P211, DOI 10.1006/abbi.1999.1555	35	5	5	1	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					7989	8000		10.1096/fj.201903029R	http://dx.doi.org/10.1096/fj.201903029R		APR 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32301550				2022-12-28	WOS:000526644000001
J	Seabright, AP; Fine, NHF; Barlow, JP; Lord, SO; Musa, I; Gray, A; Bryant, JA; Banzhaf, M; Lavery, GG; Hardie, DG; Hodson, DJ; Philp, A; Lai, YC				Seabright, Alex P.; Fine, Nicholas H. F.; Barlow, Jonathan P.; Lord, Samuel O.; Musa, Ibrahim; Gray, Alexander; Bryant, Jack A.; Banzhaf, Manuel; Lavery, Gareth G.; Hardie, D. Grahame; Hodson, David J.; Philp, Andrew; Lai, Yu-Chiang			AMPK activation induces mitophagy and promotes mitochondrial fission while activating TBK1 in a PINK1-Parkin independent manner	FASEB JOURNAL			English	Article						endogenous; mitophagy; skeletal muscle; tandem ubiquitin-binding entity (TUBE); ubiquitin	PINK1-DEPENDENT PHOSPHORYLATION; PARKIN; UBIQUITIN; PINK1; ULK1; MECHANISM; AUTOPHAGY; BINDING; IDENTIFICATION; TRANSLOCATION	Mitophagy is a key process regulating mitochondrial quality control. Several mechanisms have been proposed to regulate mitophagy, but these have mostly been studied using stably expressed non-native proteins in immortalized cell lines. In skeletal muscle, mitophagy and its molecular mechanisms require more thorough investigation. To measure mitophagy directly, we generated a stable skeletal muscle C2C12 cell line, expressing a mitophagy reporter construct (mCherry-green fluorescence protein-mtFIS1(101-152)). Here, we report that both carbonyl cyanide m-chlorophenyl hydrazone (CCCP) treatment and adenosine monophosphate activated protein kinase (AMPK) activation by 991 promote mitochondrial fission via phosphorylation of MFF and induce mitophagy by similar to 20%. Upon CCCP treatment, but not 991, ubiquitin phosphorylation, a read-out of PTEN-induced kinase 1 (PINK1) activity, and Parkin E3 ligase activity toward CDGSH iron sulfur domain 1 (CISD1) were increased. Although the PINK1-Parkin signaling pathway is active in response to CCCP treatment, we observed no change in markers of mitochondrial protein content. Interestingly, our data shows that TANK-binding kinase 1 (TBK1) phosphorylation is increased after both CCCP and 991 treatments, suggesting TBK1 activation to be independent of both PINK1 and Parkin. Finally, we confirmed in non-muscle cell lines that TBK1 phosphorylation occurs in the absence of PINK1 and is regulated by AMPK-dependent signaling. Thus, AMPK activation promotes mitophagy by enhancing mitochondrial fission (via MFF phosphorylation) and autophagosomal engulfment (via TBK1 activation) in a PINK1-Parkin independent manner.	[Seabright, Alex P.; Lord, Samuel O.; Musa, Ibrahim; Lai, Yu-Chiang] Univ Birmingham, Sch Sport Exercise & Rehabil Sci, Birmingham B15 2TT, W Midlands, England; [Fine, Nicholas H. F.; Lavery, Gareth G.; Hodson, David J.; Lai, Yu-Chiang] Univ Birmingham, Inst Metab & Syst Res, Birmingham, W Midlands, England; [Barlow, Jonathan P.; Lai, Yu-Chiang] Univ Birmingham, Mitochondrial Profiling Ctr, Birmingham, W Midlands, England; [Gray, Alexander; Hardie, D. Grahame] Univ Dundee, Sch Life Sci, Div Cell Signalling & Immunol, Dundee, Scotland; [Bryant, Jack A.; Banzhaf, Manuel] Univ Birmingham, Sch Biosci, Inst Microbiol & Infect, Birmingham, W Midlands, England; [Lavery, Gareth G.; Hodson, David J.] Birmingham Hlth Partners, Ctr Endocrinol Diabet & Metab, Birmingham, W Midlands, England; [Lavery, Gareth G.; Lai, Yu-Chiang] Univ Birmingham, MRC Versus Arthrit Ctr Musculoskeletal Ageing Res, Birmingham, W Midlands, England; [Hodson, David J.] Univ Birmingham, Ctr Membrane Prot & Receptors, Birmingham, W Midlands, England; [Philp, Andrew] Garvan Inst Med Res, Diabet & Metab Div, Sydney, NSW, Australia; [Philp, Andrew] UNSW Sydney, St Vincents Clin Sch, UNSW Med, Sydney, NSW, Australia	University of Birmingham; University of Birmingham; University of Birmingham; University of Dundee; University of Birmingham; University of Birmingham; University of Birmingham; Garvan Institute of Medical Research; University of New South Wales Sydney	Lai, YC (corresponding author), Univ Birmingham, Sch Sport Exercise & Rehabil Sci, Birmingham B15 2TT, W Midlands, England.	y.lai.1@bham.ac.uk	Musa, Ibrahim/GYJ-0462-2022; Lai, Yu-Chiang/AAR-8005-2021	Philp, Andrew/0000-0003-3860-4136; Banzhaf, Manuel/0000-0002-4682-1037; Gray, Alexander/0000-0001-9227-0363; Lai, Yu-Chiang/0000-0002-8254-3732; Bryant, Jack/0000-0002-7912-2144; Lord, Samuel/0000-0002-6241-7966; Fine, Nicholas/0000-0003-2343-8534	BBSRC; MRC Versus Arthritis Centre for Musculoskeletal Ageing Research; Wellcome Trust [204766/Z/16/Z, 104612/Z/14/Z]; MRC [MR/N00275X/1, MR/S025618/1]; Diabetes UK [17/0005681]; European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program [715884]; MRC [1854365] Funding Source: UKRI	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC Versus Arthritis Centre for Musculoskeletal Ageing Research(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Diabetes UK(Diabetes UK); European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program(European Research Council (ERC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors gratefully acknowledge Dr Ian Ganley (MRC protein phosphorylation and ubiquitylation unit, University of Dundee) for providing the mito-QC mitophagy reporter construct; Professor Richard Youle (National Institute of Health, Bethesda, USA) for providing the PINK1 knockout cell line; Professor Miratul Muqit for providing the PINK1 antibody; MRC PPU Reagents and Services for providing HALO-UBA<SUP>UBQLN1</SUP> TUBE construct for bacterial expression. The authors also acknowledge use of the Mitochondrial Profiling Centre, a core resource supported by the University of Birmingham. This study was supported by the BBSRC funded Midlands Integrative Biosciences Doctoral Training Partnership (MIBTP) and MRC Versus Arthritis Centre for Musculoskeletal Ageing Research. GGL was supported by a Wellcome Trust Senior Fellowship (104612/Z/14/Z). DGH was supported by an Investigator Award from the Wellcome Trust (204766/Z/16/Z). DJH was supported by MRC (MR/N00275X/1 and MR/S025618/1) and Diabetes UK (17/0005681) Project Grants. This project has received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (Starting Grant 715884 to DJH).	Affourtit C, 2009, METHOD ENZYMOL, V457, P405, DOI 10.1016/S0076-6879(09)05023-X; Allen GFG, 2013, EMBO REP, V14, P1127, DOI 10.1038/embor.2013.168; Bach M, 2011, BIOCHEM J, V440, P283, DOI 10.1042/BJ20101894; Bultot L, 2016, AM J PHYSIOL-ENDOC M, V311, pE706, DOI 10.1152/ajpendo.00237.2016; Burchell L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034748; Burman JL, 2017, J CELL BIOL, V216, P3231, DOI 10.1083/jcb.201612106; Carter HN, 2018, J PHYSIOL-LONDON, V596, P3567, DOI 10.1113/JP275998; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; Chen CCW, 2018, SKELET MUSCLE, V8, DOI 10.1186/s13395-018-0157-y; Chu CT, 2019, NEUROBIOL DIS, V122, P23, DOI 10.1016/j.nbd.2018.07.015; Denison SR, 2003, ONCOGENE, V22, P8370, DOI 10.1038/sj.onc.1207072; Ducommun S, 2015, CELL SIGNAL, V27, P978, DOI 10.1016/j.cellsig.2015.02.008; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Emmerich CH, 2015, BIOCHEM BIOPH RES CO, V466, P1, DOI 10.1016/j.bbrc.2015.08.109; Fogarty S, 2016, MOL CANCER RES, V14, P683, DOI 10.1158/1541-7786.MCR-15-0479; Fonseca TB, 2019, NATURE, V570, pE34, DOI 10.1038/s41586-019-1296-y; Heo JM, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aav0443; Heo JM, 2015, MOL CELL, V60, P7, DOI 10.1016/j.molcel.2015.08.016; Hernandez G, 2013, AUTOPHAGY, V9, P1852, DOI 10.4161/auto.26501; Hoffman NJ, 2015, CELL METAB, V22, P922, DOI 10.1016/j.cmet.2015.09.001; Hood DA, 2019, ANNU REV PHYSIOL, V81, P19, DOI 10.1146/annurev-physiol-020518-114310; Kane LA, 2014, J CELL BIOL, V205, P143, DOI 10.1083/jcb.201402104; Katayama H, 2011, CHEM BIOL, V18, P1042, DOI 10.1016/j.chembiol.2011.05.013; Kazlauskaite A, 2015, EMBO REP, V16, P939, DOI 10.15252/embr.201540352; Kazlauskaite A, 2014, BIOCHEM J, V460, P127, DOI 10.1042/BJ20140334; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kondapalli C, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120080; Koyano F, 2014, NATURE, V510, P162, DOI 10.1038/nature13392; Lai YC, 2015, EMBO J, V34, P2840, DOI 10.15252/embj.201591593; Lai YC, 2014, BIOCHEM J, V460, P363, DOI 10.1042/BJ20131673; Laker RC, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00520-9; Larabi A, 2013, CELL REP, V3, P734, DOI 10.1016/j.celrep.2013.01.034; Lazarou M, 2015, NATURE, V524, P309, DOI 10.1038/nature14893; Liu R, 2015, MOL BIOL CELL, V26, P4466, DOI 10.1091/mbc.E15-08-0591; Matsumoto G, 2015, HUM MOL GENET, V24, P4429, DOI 10.1093/hmg/ddv179; McWilliams TG, 2018, CELL METAB, V27, P439, DOI 10.1016/j.cmet.2017.12.008; McWilliams TG, 2017, CURR OPIN CELL BIOL, V45, P83, DOI 10.1016/j.ceb.2017.03.013; McWilliams TG, 2016, J CELL BIOL, V214, P333, DOI 10.1083/jcb.201603039; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Ordureau A, 2014, MOL CELL, V56, P360, DOI 10.1016/j.molcel.2014.09.007; Rakovic A, 2013, J BIOL CHEM, V288, P2223, DOI 10.1074/jbc.M112.391680; Richter B, 2016, P NATL ACAD SCI USA, V113, P4039, DOI 10.1073/pnas.1523926113; Shang LB, 2011, P NATL ACAD SCI USA, V108, P4788, DOI 10.1073/pnas.1100844108; Sun N, 2015, MOL CELL, V60, P685, DOI 10.1016/j.molcel.2015.10.009; Tian WL, 2015, FEBS LETT, V589, P1847, DOI 10.1016/j.febslet.2015.05.020; Toyama EQ, SCIENCE NEW YORK NY, V351, P275; Van Humbeeck C, 2011, J NEUROSCI, V31, P10249, DOI 10.1523/JNEUROSCI.1917-11.2011; Vargas JNS, 2019, MOL CELL, V74, P347, DOI 10.1016/j.molcel.2019.02.010; Villa E, 2018, TRENDS CELL BIOL, V28, P882, DOI 10.1016/j.tcb.2018.07.004; Villa E, 2017, CELL REP, V20, P2846, DOI 10.1016/j.celrep.2017.08.087; Wauer T, 2015, NATURE, V524, P370, DOI 10.1038/nature14879; Wild P, SCIENCE NEW YORK NY, V333, P228; Wilson RJ, 2019, MITOCHONDRION, V44, P20, DOI 10.1016/j.mito.2017.12.008; Yamano K, 2013, AUTOPHAGY, V9, P1758, DOI 10.4161/auto.24633; Zhao P, 2018, CELL, V172, P731, DOI 10.1016/j.cell.2018.01.007	56	55	55	3	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6284	6301		10.1096/fj.201903051R	http://dx.doi.org/10.1096/fj.201903051R		MAR 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32201986	Green Published, Green Accepted			2022-12-28	WOS:000521563300001
J	Pagella, P; Miran, S; Neto, E; Martin, I; Lamghari, M; Mitsiadis, TA				Pagella, Pierfrancesco; Miran, Shayee; Neto, Estrela; Martin, Ivan; Lamghari, Meriem; Mitsiadis, Thimios A.			Human dental pulp stem cells exhibit enhanced properties in comparison to human bone marrow stem cells on neurites outgrowth	FASEB JOURNAL			English	Article						human bone marrow stem cells; human dental pulp stem cells; innervation; microfluidics; neurotrophins; organs-on-chips; trigeminal ganglion	IN-VITRO; TRIGEMINAL NEURONS; AXON REGENERATION; SENSORY NEURONS; NERVOUS-SYSTEM; SPINAL-CORD; HOX; INNERVATION; REPAIR; TISSUE	Mesenchymal stem cells (MSCs) have the capacity to self-renew and differentiate into specific cell types and are, therefore, key players during tissue repair and regeneration. The use of MSCs for the regeneration of tissues in vivo is increasingly being explored and already constitutes a promising alternative to existing clinical treatments. MSCs also exert paracrine and trophic functions, including the promotion of innervation that plays fundamental roles in regeneration and in restoration of the function of organs. Human bone marrow stem cells (hBMSCs) and human dental pulp stem cells (hDPSCs) have been used in studies that aimed at the repair and/or regeneration of bone or other tissues of the craniofacial complex. However, the capabilities of hBMSCs and hDPSCs to elicit the growth of specific axons in order to reestablish functional innervation of the healing tissues are not known. Here, we compared the neurotrophic effects of hDPSCs and hBMSCs on trigeminal and dorsal root ganglia neurons using microfluidic organs-on-chips devices. We found that hDPSCs express significantly higher levels of neurotrophins than hBMSCs and consequently neurons cocultured with hDPSCs develop longer axons in the microfluidic co-culture system when compared to neurons cocultured with hBMSCs. Moreover, hDPSCs elicited the formation of extensive axonal networks and established close contacts with neurons, a phenomenon not observed in presence of hBMSCs. Taken together, these findings indicate that hDPSCs constitute a superior option for restoring the functionality of damaged craniofacial tissues, as they are able to support and promote extensive trigeminal innervation.	[Pagella, Pierfrancesco; Miran, Shayee; Mitsiadis, Thimios A.] Univ Zurich, Inst Oral Biol, Orofacial Dev & Regenerat, Ctr Dent Med, Plattenstr 11, CH-8032 Zurich, Switzerland; [Neto, Estrela; Lamghari, Meriem] Univ Porto, i3S, Porto, Portugal; [Neto, Estrela; Lamghari, Meriem] Univ Porto, Inst Biomed Engn INEB, Porto, Portugal; [Martin, Ivan] Univ Basel, Univ Hosp Basel, Dept Biomed, Basel, Switzerland	University of Zurich; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto; University of Basel	Pagella, P; Mitsiadis, TA (corresponding author), Univ Zurich, Inst Oral Biol, Orofacial Dev & Regenerat, Ctr Dent Med, Plattenstr 11, CH-8032 Zurich, Switzerland.	pierfrancesco.pagella@zzm.uzh.ch; thimios.mitsiadis@zzm.uzh.ch	Pagella, Pierfrancesco/ABA-3648-2020; Neto, Estrela C/M-2561-2013; Mitsiadis, Thimios/B-5564-2016; Lamghari, Meriem/K-2159-2013	Pagella, Pierfrancesco/0000-0001-6912-0957; Neto, Estrela C/0000-0003-2334-2292; Mitsiadis, Thimios/0000-0002-9812-9982; Lamghari, Meriem/0000-0002-2500-4548	Universitat Zurich (UZH)	Universitat Zurich (UZH)	Universitat Zurich (UZH)	Abbas OL, 2019, J INVEST SURG, V32, P477, DOI 10.1080/08941939.2018.1433254; Alge DL, 2010, J TISSUE ENG REGEN M, V4, P73, DOI 10.1002/term.220; BENEDETTI M, 1993, P NATL ACAD SCI USA, V90, P7859, DOI 10.1073/pnas.90.16.7859; BYERS MR, 1993, J DENT RES, V72, P613, DOI 10.1177/00220345930720031001; d'Aquino R, 2009, EUR CELLS MATER, V18, P75, DOI 10.22203/eCM.v018a07; Elsalanty ME, 2009, CRANIOMAX TRAUM REC, V2, P125, DOI 10.1055/s-0029-1215875; Fu Y, 2017, TISSUE ENG PART B-RE, V23, P515, DOI [10.1089/ten.TEB.2016.0365, 10.1089/ten.teb.2016.0365]; Giuliani A, 2013, STEM CELL TRANSL MED, V2, P316, DOI 10.5966/sctm.2012-0136; Gkiatas I, 2017, FRONT PHYS, V5, DOI 10.3389/fphy.2017.00044; Gonella MC, 2009, SEMIN NEUROL, V29, P36, DOI 10.1055/s-0028-1124021; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; HILDEBRAND C, 1995, PROG NEUROBIOL, V45, P165, DOI 10.1016/0301-0082(94)00045-J; Huang GTJ, 2009, J DENT RES, V88, P792, DOI 10.1177/0022034509340867; Huh D, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004249; Ichikawa H, 2004, ACTA HISTOCHEM, V106, P337, DOI 10.1016/j.acthis.2004.07.003; Ichikawa H, 2012, JPN DENT SCI REV, V48, P48, DOI 10.1016/j.jdsr.2011.10.001; Ingber DE, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.156125; Isobe Y, 2016, INT J ORAL MAX SURG, V45, P124, DOI 10.1016/j.ijom.2015.06.022; Jain A, 2018, CLIN PHARMACOL THER, V103, P332, DOI 10.1002/cpt.742; Jones RHB, 2010, AUST DENT J, V55, P112, DOI 10.1111/j.1834-7819.2010.01216.x; Knox SM, 2010, SCIENCE, V329, P1645, DOI 10.1126/science.1192046; Knox SM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2493; Kumar A, 2012, TRENDS NEUROSCI, V35, P691, DOI 10.1016/j.tins.2012.08.003; Kunimatsu R, 2018, BIOCHEM BIOPH RES CO, V501, P193, DOI 10.1016/j.bbrc.2018.04.213; La Noce M, 2014, EUR CELLS MATER, V28, P348, DOI 10.22203/eCM.v028a24; Leucht P, 2008, DEVELOPMENT, V135, P2845, DOI 10.1242/dev.023788; Lucas D, 2013, NAT MED, V19, P695, DOI 10.1038/nm.3155; Mallo M, 2010, DEV BIOL, V344, P7, DOI 10.1016/j.ydbio.2010.04.024; Martin I, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aat2189; Mead B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109305; Mead B, 2013, INVEST OPHTH VIS SCI, V54, P7544, DOI 10.1167/iovs.13-13045; Miran S, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/7231038; Mitsiadis TA, 2015, EUR CELLS MATER, V30, P248, DOI 10.22203/eCM.v030a17; Mitsiadis TA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01455-3; Neto EC, 2012, BONE, V50, pS113, DOI 10.1016/j.bone.2012.02.347; Neto E, 2016, J NEUROSCI, V36, P11573, DOI 10.1523/JNEUROSCI.1748-16.2016; Neto E, 2014, INTEGR BIOL-UK, V6, P586, DOI 10.1039/c4ib00035h; Nosrat IV, 2001, DEV BIOL, V238, P120, DOI 10.1006/dbio.2001.0400; Orsini G, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01102; Orsini G, 2018, AM J MED, V131, P1425, DOI 10.1016/j.amjmed.2018.05.042; Pagella P, 2015, EUR CELLS MATER, V29, P213, DOI 10.22203/eCM.v029a16; Pagella P, 2015, JOVE-J VIS EXP, DOI 10.3791/53114; Pagella P, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00326; Pagella P, 2014, CELL MOL LIFE SCI, V71, P2241, DOI 10.1007/s00018-013-1549-0; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Pediaditakis I, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00512; Picchi J, 2013, J CELL PHYSIOL, V228, P879, DOI 10.1002/jcp.24239; Prantil-Baun R., 2016, ANN REV PHARM TOXICO, V58, P37; Sacchetti B, 2016, STEM CELL REP, V6, P897, DOI 10.1016/j.stemcr.2016.05.011; Sakai K, 2012, J CLIN INVEST, V122, P80, DOI 10.1172/JCI59251; SANDSTEDT P, 1995, J ORAL MAXIL SURG, V53, P498, DOI 10.1016/0278-2391(95)90055-1; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sfriso R, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24273-7; Shibahara T, 2000, J ORAL MAXIL SURG, V58, P714, DOI 10.1053/joms.2000.7252; Smith GM, 2012, TRENDS NEUROSCI, V35, P156, DOI 10.1016/j.tins.2011.10.006; Song M, 2017, CELL TRANSPLANT, V26, P1001, DOI 10.3727/096368916X694391; Stone JB, 2016, NAT REV CLIN ONCOL, V13, P92, DOI 10.1038/nrclinonc.2015.152; Sullins JS, 2000, J ENDODONT, V26, P88, DOI 10.1097/00004770-200002000-00007; Susarla SM, 2005, J ORAL MAXIL SURG, V63, P1138, DOI 10.1016/j.joms.2005.04.021; Tamaki Y, 2013, ODONTOLOGY, V101, P121, DOI 10.1007/s10266-012-0075-0; Tollemar V, 2016, GENES DIS, V3, P56, DOI 10.1016/j.gendis.2015.09.004; Tomlinson RE, 2016, CELL REP, V16, P2723, DOI 10.1016/j.celrep.2016.08.002	62	19	19	2	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5499	5511		10.1096/fj.201902482R	http://dx.doi.org/10.1096/fj.201902482R		FEB 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32096581	Bronze, Green Accepted			2022-12-28	WOS:000517889200001
J	Jiang, YL; Wen, T; Yan, R; Kim, S; Stowell, SR; Wang, WY; Wang, YC; An, GY; Cummings, RD; Ju, TZ				Jiang, Yuliang; Wen, Tao; Yan, Rui; Kim, Suryun; Stowell, Sean R.; Wang, Wenyi; Wang, Yingchun; An, Guangyu; Cummings, Richard D.; Ju, Tongzhong			O-glycans on death receptors in cells modulate their sensitivity to TRAIL-induced apoptosis through affecting on their stability and oligomerization	FASEB JOURNAL			English	Article						Cosmc; O-glycosylation; STn antigen; Tn antigen; tumor cells	SIALYL-TN ANTIGEN; BREAST-CANCER CELLS; SURFACE EXPOSURE; CHAPERONE COSMC; SIALOSYL-TN; EXPRESSION; GLYCOSYLATION; PROTEIN; CARCINOMA; PROMOTES	The TNF-related apoptosis-inducing ligand (TRAIL) triggers apoptosis in cells by signaling through the O-glycosylated death receptors (DR4 and DR5), but the sensitivity to TRAIL-induced apoptosis of cells varies, and the attributes of this phenomenon are complex. Human carcinoma cells often express truncated O-glycans, Tn (GalNAc alpha 1-Ser/Thr), and Sialyl-Tn (Sia alpha 2-6GalNAc alpha 1-Ser/Thr, STn) on their surface glycoproteins, yet molecular mechanisms in terms of advantages for tumor cells to have these truncated O-glycans remain elusive. Normal extended O-glycan biosynthesis is regulated by a specific molecular chaperone Cosmc through assisting of the correct folding of Core 1 beta 3 Galactosyltransferase (T-synthase). Here, we use tumor cell lines harboring mutations inCosmc,and therefore expressing Tn and STn antigens to study the role of O-glycans in TRAIL-induced apoptosis. Expression of Tn and STn in tumor cells attenuates their sensitivity to TRAIL treatment; when transfected with wild-typeCosmc, these tumor cells thus express normal extended O-glycans and become more sensitive to TRAIL treatment. Mechanistically, Tn/STn antigens impair homo-oligomerization and stability of DR4 and DR5. These results represent the first mechanistic insight into how O-glycan structures on cell surface modulate their sensitivity to apoptotic stimuli, suggesting expression of Tn/STn may offer tumor cell survival advantages through altering DR4 and/or DR5 activity.	[Jiang, Yuliang; Wang, Wenyi; Wang, Yingchun; Cummings, Richard D.; Ju, Tongzhong] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Jiang, Yuliang; Wen, Tao; Yan, Rui; An, Guangyu] Capital Med Univ, Beijing Chao Yang Hosp, Dept Oncol, Beijing 100020, Peoples R China; [Kim, Suryun; Ju, Tongzhong] US FDA, Off Biotechnol Prod, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA; [Stowell, Sean R.] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA; [Cummings, Richard D.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Surg, CLS 11087-3 Blackfan Circle, Boston, MA 02115 USA	Emory University; Capital Medical University; US Food & Drug Administration (FDA); Emory University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	An, GY (corresponding author), Capital Med Univ, Beijing Chao Yang Hosp, Dept Oncol, Beijing 100020, Peoples R China.; Cummings, RD (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Surg, CLS 11087-3 Blackfan Circle, Boston, MA 02115 USA.; Ju, TZ (corresponding author), US FDA, Off Biotechnol Prod, Ctr Drug Evaluat & Res, OBP CDER, Bldg 52-72,Room 2120, Silver Spring, MD 20993 USA.	agybjcy@163.com; rcummin1@bidmc.harvard.edu; Tongzhong.ju@fda.hhs.gov	jiang, yu/HGU-0029-2022	Ju, Tongzhong/0000-0002-4429-1976	Georgia Research Alliance (GRA); NIH [U01CA168930]; National Natural Science Foundation of China [81572825, 81672338]; Beijing Natural Science Foundation [7172083]; U.S. Food and Drug Administration Intramural Research Funding	Georgia Research Alliance (GRA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); U.S. Food and Drug Administration Intramural Research Funding	This work was supported by Georgia Research Alliance (GRA) to TJ, NIH U01CA168930 to TJ and RDC., and by National Natural Science Foundation of China (81572825 to GA, 81672338 to TW) and Beijing Natural Science Foundation (7172083 to GA), and the U.S. Food and Drug Administration Intramural Research Funding to TJ.	Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Brockhausen I, 1999, BBA-GEN SUBJECTS, V1473, P67, DOI 10.1016/S0304-4165(99)00170-1; Brooks SA, 2000, HISTOL HISTOPATHOL, V15, P143, DOI 10.14670/HH-15.143; BROOKS SA, 1995, BRIT J CANCER, V71, P1033, DOI 10.1038/bjc.1995.199; Buskas T, 2009, CHEM COMMUN, P5335, DOI 10.1039/b908664c; Carlo-Stella C, 2007, CLIN CANCER RES, V13, P2313, DOI 10.1158/1078-0432.CCR-06-2774; Clancy L, 2005, P NATL ACAD SCI USA, V102, P18099, DOI 10.1073/pnas.0507329102; Crew VK, 2008, BRIT J HAEMATOL, V142, P657, DOI 10.1111/j.1365-2141.2008.07215.x; Davidson B, 2000, HUM PATHOL, V31, P1081, DOI 10.1053/hupa.2000.9776; Dias-Baruffi M, 2003, J BIOL CHEM, V278, P41282, DOI 10.1074/jbc.M306624200; Dufour F, 2017, CELL DEATH DIFFER, V24, P500, DOI 10.1038/cdd.2016.150; ENDO Y, 1976, J BIOCHEM-TOKYO, V80, P1; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Hofmann BT, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0386-1; Hymowitz SG, 2000, BIOCHEMISTRY-US, V39, P633, DOI 10.1021/bi992242l; Hymowitz SG, 1999, MOL CELL, V4, P563, DOI 10.1016/S1097-2765(00)80207-5; Ingale S, 2007, NAT CHEM BIOL, V3, P663, DOI 10.1038/nchembio.2007.25; INOUE M, 1990, OBSTET GYNECOL, V75, P1032; ITZKOWITZ SH, 1989, CANCER RES, V49, P197; ITZKOWITZ SH, 1990, CANCER-AM CANCER SOC, V66, P1960, DOI 10.1002/1097-0142(19901101)66:9<1960::AID-CNCR2820660919>3.0.CO;2-X; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Ju TZ, 2008, J CELL BIOL, V182, P531, DOI 10.1083/jcb.200711151; Ju TZ, 2008, CANCER RES, V68, P1636, DOI 10.1158/0008-5472.CAN-07-2345; Ju TZ, 2013, PROTEOM CLIN APPL, V7, P618, DOI 10.1002/prca.201300024; Ju TZ, 2005, NATURE, V437, P1252, DOI 10.1038/4371252a; Ju TZ, 2002, P NATL ACAD SCI USA, V99, P16613, DOI 10.1073/pnas.262438199; Ju TZ, 2002, J BIOL CHEM, V277, P169, DOI 10.1074/jbc.M109056200; Ju TZ, 2002, J BIOL CHEM, V277, P178, DOI 10.1074/jbc.M109060200; Julien S, 2006, GLYCOBIOLOGY, V16, P54, DOI 10.1093/glycob/cwj033; Kaiser A, 2009, ANGEW CHEM INT EDIT, V48, P7551, DOI 10.1002/anie.200902564; Kawaguchi T, 2006, BREAST CANCER RES TR, V98, P31, DOI 10.1007/s10549-005-9115-6; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Malhi H, 2006, ONCOGENE, V25, P7333, DOI 10.1038/sj.onc.1209765; Mellier G, 2010, MOL ASPECTS MED, V31, P93, DOI 10.1016/j.mam.2009.12.002; Mi RJ, 2012, J BIOL CHEM, V287, P41523, DOI 10.1074/jbc.M112.371989; Mongkolsapaya J, 1999, NAT STRUCT BIOL, V6, P1048; NOVOGRODSKY A, 1975, J IMMUNOL, V115, P1243; Pinho S, 2007, CANCER LETT, V249, P157, DOI 10.1016/j.canlet.2006.08.010; Posey AD, 2016, IMMUNITY, V45, P947, DOI 10.1016/j.immuni.2016.10.015; Radhakrishnan P, 2014, P NATL ACAD SCI USA, V111, pE4066, DOI 10.1073/pnas.1406619111; Reed JC, 2003, CANCER CELL, V3, P17, DOI 10.1016/S1535-6108(02)00241-6; Schietinger A, 2006, SCIENCE, V314, P304, DOI 10.1126/science.1129200; Screaton GR, 1997, CURR BIOL, V7, P693, DOI 10.1016/S0960-9822(06)00297-1; Secchiero P, 2003, CIRCULATION, V107, P2250, DOI 10.1161/01.CIR.0000062702.60708.C4; Secchiero P, 2004, CELL MOL LIFE SCI, V61, P1965, DOI 10.1007/s00018-004-4197-6; Sewell R, 2006, J BIOL CHEM, V281, P3586, DOI 10.1074/jbc.M511826200; Slee EA, 1996, BIOCHEM J, V315, P21, DOI 10.1042/bj3150021; Soares R, 1996, PATHOL RES PRACT, V192, P1181, DOI 10.1016/S0344-0338(96)80148-8; SPRINGER GF, 1989, MOL IMMUNOL, V26, P1, DOI 10.1016/0161-5890(89)90013-8; SPRINGER GF, 1984, SCIENCE, V224, P1198, DOI 10.1126/science.6729450; Stowell SR, 2007, BLOOD, V109, P219, DOI 10.1182/blood-2006-03-007153; Terasawa K, 1996, CANCER RES, V56, P2229; Thorburn A, 2008, DRUG RESIST UPDATE, V11, P17, DOI 10.1016/j.drup.2008.02.001; Wagner KW, 2007, NAT MED, V13, P1070, DOI 10.1038/nm1627; Walczak H, 2000, EXP CELL RES, V256, P58, DOI 10.1006/excr.2000.4840; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Wang SL, 2003, ONCOGENE, V22, P8628, DOI 10.1038/sj.onc.1207232; Wang YC, 2010, P NATL ACAD SCI USA, V107, P9228, DOI 10.1073/pnas.0914004107; Wu YH, 2012, J IMMUNOL, V188, P2914, DOI 10.4049/jimmunol.1102065; Xia LJ, 2004, J CELL BIOL, V164, P451, DOI 10.1083/jcb.200311112; Yoshida T, 2007, ONCOL REP, V18, P1239; Zhivotovsky B, 2006, CARCINOGENESIS, V27, P1939, DOI 10.1093/carcin/bgl035	63	15	15	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					11786	11801		10.1096/fj.201900053RR	http://dx.doi.org/10.1096/fj.201900053RR		JUL 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32692906				2022-12-28	WOS:000554623700001
J	Malik, S; Jang, W; Kim, JY; Kim, C				Malik, Sumira; Jang, Wijeong; Kim, Ji Young; Kim, Changsoo			Mechanisms ensuring robust repression of the Drosophila female germline stem cell maintenance factor Nanos via posttranscriptional regulation	FASEB JOURNAL			English	Article						Argonaute 1; Bag-of-marbles; Brain Tumor; Drosophila; germline stem cells; Mei-P26; Nanos; ovary; Pumilio	DIFFERENTIATION	During oogenesis in theDrosophilaovary, numerous translational regulators promote the self-renewal or differentiation of stem cells. An intriguing question is how these regulators combine to execute translational regulation. Here, we study mechanisms for the posttranscriptional regulation ofnos, a critical stem cell self-renewal factor in theDrosophilaovary; specifically, regulators that promote differentiation of the stem cell daughter. Previous studies showed that Bam, Bgcn, Mei-P26, and Sxl form a complex and repressnosexpression through thenos3 ' UTR. To further elucidate mechanistic processes of Nos translational regulation, we reconstitutednosrepression in culturedDrosophilacells. We identify Ago1 and Brat as new members, and show that Ago1 acts through miRNA binding sites in the proximal region of thenos3 ' UTR, whereas Sxl acts via an Sxl binding sequence in the distal region. Combining these findings with published reports, we propose that additional factors Bam, Bgcn, Mei-P26, and Brat are recruited tonosmRNAs through interaction with Ago1 and Sxl. These findings elucidate mechanisms ofnosregulation by diverse translational repressors.	[Malik, Sumira] Amity Univ Jharkhand, Amity Inst Biotechnol, Ranchi, Bihar, India; [Jang, Wijeong; Kim, Ji Young; Kim, Changsoo] Chonnam Natl Univ, Sch Biol Sci & Technol, Yongbong Ro 77, Gwangju 61186, South Korea	Chonnam National University	Kim, C (corresponding author), Chonnam Natl Univ, Sch Biol Sci & Technol, Yongbong Ro 77, Gwangju 61186, South Korea.	changkk2001@hanmail.net	Malik, Sumira/AIE-3977-2022	Malik, Sumira/0000-0001-5077-1493	National Research Foundation of Korea (NRF) [2018R1D1A1B07049100]; Chonnam National University (CNU) [2018-3496]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Chonnam National University (CNU)	National Research Foundation of Korea (NRF), Grant/Award Number: 2018R1D1A1B07049100; Chonnam National University (CNU), Grant/Award Number: 2018-3496	Behm-Ansmant I, 2006, COLD SPRING HARB SYM, V71, P523, DOI 10.1101/sqb.2006.71.013; Chau J, 2012, P NATL ACAD SCI USA, V109, P9465, DOI 10.1073/pnas.1120473109; Chau J, 2009, GENETICS, V182, P121, DOI 10.1534/genetics.109.100693; Fuller MT, 2007, SCIENCE, V316, P402, DOI 10.1126/science.1140861; Han KH, 1996, NUCLEIC ACIDS RES, V24, P4362, DOI 10.1093/nar/24.21.4362; Harris RE, 2011, DEV CELL, V20, P72, DOI 10.1016/j.devcel.2010.11.019; Joly W, 2013, STEM CELL REP, V1, P411, DOI 10.1016/j.stemcr.2013.09.007; Li Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058301; Li Y, 2012, DEVELOPMENT, V139, P1547, DOI 10.1242/dev.077412; Li Y, 2009, P NATL ACAD SCI USA, V106, P9304, DOI 10.1073/pnas.0901452106; Malik S, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20190099; Malik Sumira, 2017, Dev Reprod, V21, P449, DOI 10.12717/DR.2017.21.4.449; Neumuller RA, 2008, NATURE, V454, P241, DOI 10.1038/nature07014; Sgromo A, 2018, RNA, V24, P381, DOI 10.1261/rna.064584.117; Wang Z, 2004, SCIENCE, V303, P2016, DOI 10.1126/science.1093983	15	1	1	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					11421	11430		10.1096/fj.202000656R	http://dx.doi.org/10.1096/fj.202000656R		JUL 2020	10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32654316	Bronze			2022-12-28	WOS:000549275800001
J	Li, MT; Liu, BY; Yi, JJ; Yang, Y; Wang, JD; Zhu, WG; Luo, JY				Li, Meiting; Liu, Boya; Yi, Jingjie; Yang, Yang; Wang, Jiadong; Zhu, Wei-Guo; Luo, Jianyuan			MIB1-mediated degradation of WRN promotes cellular senescence in response to camptothecin treatment	FASEB JOURNAL			English	Article						aging; CPT; Mind bomb 1; protein stability; Werner syndrome protein	E3 UBIQUITIN LIGASE; SYNDROME PROTEIN; DNA-DAMAGE; TARGETS WRN; MIND BOMB; S-PHASE; TOPOISOMERASE; INHIBITORS; APOPTOSIS; REPAIR	Werner syndrome protein (WRN) plays critical roles in DNA replication, recombination, and repair, as well as transcription and cellular senescence. Ubiquitination and degradation of WRN have been reported, however, the E3 ubiquitin ligase of WRN is little known. Here, we identify mindbomb E3 ubiquitin protein ligase 1 (MIB1) as a novel E3 ubiquitin ligase for WRN protein. MIB1 physically interacts with WRN in vitro and in vivo and induces ubiquitination and degradation of WRN in the ubiquitin-proteasome pathway. Camptothecin (CPT) enhances the interaction between MIB1 and WRN, and promotes WRN degradation in a MIB1-dependent manner. In addition, CPT-induced cellular senescence is facilitated by the expression of MIB1 and attenuated by WRN expression. Our results show that MIB1-mediated degradation of WRN promotes cellular senescence and reveal a novel model executed by MIB1 and WRN to regulate cellular senescence.	[Li, Meiting; Liu, Boya; Luo, Jianyuan] Peking Univ, Hlth Sci Ctr, Ctr Med Genet, Dept Med Genet, Beijing, Peoples R China; [Yi, Jingjie] Columbia Univ, Inst Canc Genet, New York, NY USA; [Yang, Yang; Luo, Jianyuan] Peking Univ, Hlth Sci Ctr, Beijing Key Lab Prot Posttranslat Modificat & Cel, Dept Biochem & Mol Biol, Beijing, Peoples R China; [Wang, Jiadong] Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Inst Syst Biomed,Dept Radiat Med, Beijing, Peoples R China; [Zhu, Wei-Guo] Shenzhen Univ, Sch Med, Dept Biochem & Mol Biol, Shenzhen, Peoples R China	Peking University; Columbia University; Peking University; Peking University; Shenzhen University	Luo, JY (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Med Genet, Beijing, Peoples R China.	luojianyuan@bjmu.edu.cn	Luo, Jianyuan/ABI-7585-2020	Luo, Jianyuan/0000-0001-6057-2914	National Natural Science Foundation of China [81671389, 81874147, 81621063]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China, Grant/Award Number: 81671389, 81874147 and 81621063	Ammazzalorso F, 2010, EMBO J, V29, P3156, DOI 10.1038/emboj.2010.205; Berndt JD, 2011, J CELL BIOL, V194, P737, DOI 10.1083/jcb.201107021; Bohr VA, 2002, BIOGERONTOLOGY, V3, P89, DOI 10.1023/A:1015223917491; Chen JH, 2007, NUCLEIC ACIDS RES, V35, P7417, DOI 10.1093/nar/gkm681; Crabbe L, 2004, SCIENCE, V306, P1951, DOI 10.1126/science.1103619; Croteau DL, 2014, ANNU REV BIOCHEM, V83, P519, DOI 10.1146/annurev-biochem-060713-035428; Grandori C, 2003, GENE DEV, V17, P1569, DOI 10.1101/gad.1100303; Han ZY, 2002, J BIOL CHEM, V277, P17154, DOI 10.1074/jbc.M112401200; Hande KR, 1998, EUR J CANCER, V34, P1514, DOI 10.1016/S0959-8049(98)00228-7; Huang SR, 1998, NAT GENET, V20, P114, DOI 10.1038/2410; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; Jin YJ, 2002, J BIOL CHEM, V277, P46980, DOI 10.1074/jbc.M208585200; Kawabe Y, 2000, J BIOL CHEM, V275, P20963, DOI 10.1074/jbc.C000273200; Kusumoto R, 2007, MECH AGEING DEV, V128, P50, DOI 10.1016/j.mad.2006.11.010; Lebel M, 1998, P NATL ACAD SCI USA, V95, P13097, DOI 10.1073/pnas.95.22.13097; Lebel M, 2018, AGEING RES REV, V41, P82, DOI 10.1016/j.arr.2017.11.003; Li K, 2008, J BIOL CHEM, V283, P7590, DOI 10.1074/jbc.M709707200; Li K, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0012286, 10.1371/journal.pone.0010341]; Liu BY, 2019, ONCOGENE, V38, P2501, DOI 10.1038/s41388-018-0605-5; Lu H, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.168; Pichierri P, 2001, MOL BIOL CELL, V12, P2412, DOI 10.1091/mbc.12.8.2412; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; POOT M, 1992, EXP CELL RES, V202, P267, DOI 10.1016/0014-4827(92)90074-I; Shamanna Raghavendra A, 2017, F1000Res, V6, P1779, DOI 10.12688/f1000research.12110.1; Shamanna RA, 2016, ONCOTARGET, V7, P13269, DOI 10.18632/oncotarget.7906; Sidorova JM, 2008, CELL CYCLE, V7, P796, DOI 10.4161/cc.7.6.5566; Su FT, 2016, ONCOTARGET, V7, P46, DOI 10.18632/oncotarget.6659; Wang JD, 2013, MOL CELL, V52, P667, DOI 10.1016/j.molcel.2013.10.012; Yokote K, 2017, HUM MUTAT, V38, P7, DOI 10.1002/humu.23128; Zhang LG, 2009, AM J PHYSIOL-CELL PH, V297, pC1275, DOI 10.1152/ajpcell.00214.2009	30	7	7	2	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					11488	11497		10.1096/fj.202000268RRR	http://dx.doi.org/10.1096/fj.202000268RRR		JUL 2020	10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32652764	Bronze			2022-12-28	WOS:000548008700001
J	Rong, ZY; Cheng, BY; Zhong, L; Ye, XW; Li, X; Jia, L; Li, YF; Shue, F; Wang, N; Cheng, YY; Huang, XH; Liu, CC; Fryer, JD; Wang, X; Zhang, YW; Zheng, HH				Rong, Zhouyi; Cheng, Baoying; Zhong, Li; Ye, Xiaowen; Li, Xin; Jia, Lin; Li, Yanfang; Shue, Francis; Wang, Na; Cheng, Yiyun; Huang, Xiaohua; Liu, Chia-Chen; Fryer, John D.; Wang, Xin; Zhang, Yun-wu; Zheng, Honghua			Activation of FAK/Rac1/Cdc42-GTPase signaling ameliorates impaired microglial migration response to A beta(42)in triggering receptor expressed on myeloid cells 2 loss-of-function murine models	FASEB JOURNAL			English	Article						Alzheimer's disease; FAK; Rac1; Cdc42 pathway; microglia; migration; TREM2	FOCAL ADHESION KINASE; BASAL GANGLIA CALCIFICATION; TREM2 DEFICIENCY; GENETIC CAUSES; AMYLOID-BETA; BONE-CYSTS; ALZHEIMERS; RHO; DEMENTIA; CDC42	Mutation of Triggering receptor expressed on myeloid cells 2 (TREM2) impairs the response of microglia to amyloid-beta (A beta) pathology in Alzheimer's disease (AD), although the mechanism governing TREM2-regulated microglia recruitment to A beta plaques remains unresolved. Here, we confirm that TREM2 mutation attenuates microglial migration. Then, usingTrem2(-/-)mice and an R47H variant mouse model for AD generated for this study, we show that TREM2 deficiency or the AD-associated R47H mutation results in inhibition of FAK and Rac1/Cdc42-GTPase signaling critical for cell migration. Intriguingly, treatment with CN04, a Rac1/Cdc42-GTPase activator, partially enhances microglial migration in response to oligomeric A beta(42)inTrem2(-/-)or R47H microglia both in vitro and in vivo. Our study shows that the dysfunction of microglial migration in the AD-associated TREM2 R47H variant is caused by FAK/Rac1/Cdc42 signaling disruption, and that activation of this signaling ameliorates impaired microglial migration response to A beta(42), suggesting a therapeutic target for R47H-bearing patients with high risk of AD.	[Rong, Zhouyi; Cheng, Baoying; Zhong, Li; Ye, Xiaowen; Li, Xin; Jia, Lin; Li, Yanfang; Wang, Na; Cheng, Yiyun; Wang, Xin; Zhang, Yun-wu; Zheng, Honghua] Xiamen Univ, Inst Neurosci, Fujian Prov Key Lab Neurodegenerat Dis & Aging Re, Sch Med, Xiamen 361102, Peoples R China; [Li, Yanfang; Zheng, Honghua] Xiamen Univ, Shenzhen Res Inst, Shenzhen, Peoples R China; [Shue, Francis; Liu, Chia-Chen; Fryer, John D.] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Huang, Xiaohua; Zheng, Honghua] Xiamen Univ, Sch Med, Basic Med Sci, Xiamen, Peoples R China; [Wang, Xin] Xiamen Univ, State Key Lab Cellular Stress Biol, Xiamen, Peoples R China	Xiamen University; Xiamen University; Mayo Clinic; Xiamen University; Xiamen University	Zheng, HH (corresponding author), Xiamen Univ, Inst Neurosci, Fujian Prov Key Lab Neurodegenerat Dis & Aging Re, Sch Med, Xiamen 361102, Peoples R China.	honghua@zmu.edu.cn	li, yan/GTI-4638-2022	Zhong, Li/0000-0003-3815-6484; Shue, Francis/0000-0003-1659-1952; Zhang, Yun-wu/0000-0002-7152-7630; Huang, Xiaohua/0000-0003-4150-0477	National Natural Science Foundation of China [81771164, 91949129, 81870845, U1705285]; Fujian Educational Department [JZ160403]; Guangdong Natural Science Foundation [2016A030313821, 2017A030313604, 2018A030313158]; Xiamen University [SKLCSB2018KF017, SKLCSB2019KF014]; National Key Research and Development Program of China [2018YFC2000400, 2016YFC1305903]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fujian Educational Department; Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Xiamen University(Xiamen University); National Key Research and Development Program of China	National Natural Science Foundation of China, Grant/Award Number: 81771164, 91949129, 81870845 and U1705285; Fujian Educational Department, Grant/Award Number: JZ160403; Guangdong Natural Science Foundation, Grant/Award Number: 2016A030313821, 2017A030313604 and 2018A030313158; Xiamen University, Grant/Award Number: SKLCSB2018KF017 and SKLCSB2019KF014; National Key Research and Development Program of China, Grant/Award Number: 2018YFC2000400 and 2016YFC1305903	Bianchin MM, 2006, NEUROLOGY, V66, P615, DOI 10.1212/01.wnl.0000216105.11788.0f; Borroni B, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2013.09.017; Boulter E, 2010, NAT CELL BIOL, V12, P477, DOI 10.1038/ncb2049; Cady J, 2014, JAMA NEUROL, V71, P449, DOI 10.1001/jamaneurol.2013.6237; Cheng-Hathaway PJ, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0262-8; Choi I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9255; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; GERDES J, 1984, J IMMUNOL, V133, P1710; Giraldo M, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2013.02.016; Guerreiro R, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2013.06.005; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Guerreiro RJ, 2013, JAMA NEUROL, V70, P78, DOI 10.1001/jamaneurol.2013.579; Hickman SE, 2014, BIOCHEM PHARMACOL, V88, P495, DOI 10.1016/j.bcp.2013.11.021; Hildebrand JD, 1996, MOL CELL BIOL, V16, P3169; Jay TR, 2017, J NEUROSCI, V37, P637, DOI [10.1523/JNEUROSCI.2110-16.2017, 10.1523/JNEUROSCI.2110-16.2016]; Jay TR, 2015, J EXP MED, V212, P287, DOI 10.1084/jem.20142322; Jiang LZ, 2016, NEUROPHARMACOLOGY, V109, P216, DOI 10.1016/j.neuropharm.2016.06.017; Jiang LZ, 2016, MOL NEUROBIOL, V53, P1247, DOI 10.1007/s12035-015-9093-6; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Kang SS, 2018, HUM MOL GENET, V27, P211, DOI 10.1093/hmg/ddx366; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kleinberger G, 2017, EMBO J, V36, P1837, DOI 10.15252/embj.201796516; Klunemann HH, 2005, NEUROLOGY, V64, P1502, DOI 10.1212/01.WNL.0000160304.00003.CA; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lessard CB, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201809027; Liu CC, 2014, NEURON, V84, P63, DOI 10.1016/j.neuron.2014.08.048; LIU W, 1994, AM J PATHOL, V145, P48; Lively S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-75; Massol P, 1998, EMBO J, V17, P6219, DOI 10.1093/emboj/17.21.6219; Mazaheri F, 2017, EMBO REP, V18, P1186, DOI 10.15252/embr.201743922; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Myers JP, 2012, J CELL SCI, V125, P2918, DOI 10.1242/jcs.100107; N'Diaye EN, 2009, J CELL BIOL, V184, P215, DOI 10.1083/jcb.200808080; Palazzo AF, 2004, SCIENCE, V303, P836, DOI 10.1126/science.1091325; Parsons JT, 2000, ONCOGENE, V19, P5606, DOI 10.1038/sj.onc.1203877; Poliani PL, 2015, J CLIN INVEST, V125, P2161, DOI 10.1172/JCI77983; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Rayaprolu S, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-19; Ridley AJ, 2015, CURR OPIN CELL BIOL, V36, P103, DOI 10.1016/j.ceb.2015.08.005; Sadok Amine, 2014, Small GTPases, V5, pe29710, DOI 10.4161/sgtp.29710; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; Spiering D, 2011, CELL ADHES MIGR, V5, P170, DOI 10.4161/cam.5.2.14403; Sun XM, 2018, CHROMOSOMA, V127, P175, DOI 10.1007/s00412-018-0659-8; Ulland TK, 2018, NAT REV NEUROL, V14, P667, DOI 10.1038/s41582-018-0072-1; Ulland TK, 2017, CELL, V170, P649, DOI 10.1016/j.cell.2017.07.023; Vincent C, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-190; Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049; Xiang XY, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0280-6; Xiang XY, 2016, EMBO MOL MED, V8, P992, DOI 10.15252/emmm.201606370; Yeh FL, 2016, NEURON, V91, P328, DOI 10.1016/j.neuron.2016.06.015; Yuan P, 2016, NEURON, V90, P724, DOI 10.1016/j.neuron.2016.05.003; Zegers Mirjam M, 2014, Small GTPases, V5, pe28997, DOI 10.4161/sgtp.28997; Zhao YJ, 2018, NEURON, V97, P1023, DOI 10.1016/j.neuron.2018.01.031; Zheng HH, 2017, J NEUROSCI, V37, P1772, DOI 10.1523/JNEUROSCI.2459-16.2017; Zheng HH, 2016, NEUROBIOL AGING, V42, P132, DOI 10.1016/j.neurobiolaging.2016.03.004; Zhong L, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0247-7; Zhu W, 2010, J NEUROCHEM, V114, P386, DOI 10.1111/j.1471-4159.2010.06763.x	61	8	8	2	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10984	10997		10.1096/fj.202000550RR	http://dx.doi.org/10.1096/fj.202000550RR		JUL 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32613609				2022-12-28	WOS:000547079700001
J	Hesketh, SJ; Sutherland, H; Lisboa, PJ; Jarvis, JC; Burniston, JG				Hesketh, Stuart J.; Sutherland, Hazel; Lisboa, Paulo J.; Jarvis, Jonathan C.; Burniston, Jatin G.			Adaptation of rat fast-twitch muscle to endurance activity is underpinned by changes to protein degradation as well as protein synthesis	FASEB JOURNAL			English	Article						biosynthetic labeling; chronic stimulation; deuterium oxide; protein degradation; protein synthesis	HUMAN SKELETAL-MUSCLE; INDIVIDUAL PROTEINS; VASTUS-LATERALIS; TURNOVER RATES; IN-VIVO; EXERCISE; RESISTANCE; QUANTIFICATION; STIMULATION; EXPRESSION	Muscle adaptations to exercise are underpinned by alterations to the abundance of individual proteins, which may occur through a change either to the synthesis or degradation of each protein. We used deuterium oxide ((H2O)-H-2) labeling and chronic low-frequency stimulation (CLFS)in vivo to investigate the synthesis, abundance, and degradation of individual proteins during exercise-induced muscle adaptation. Independent groups of rats received CLFS (10 Hz, 24 h/d) and(2)H(2)O for 0, 10, 20, or 30 days. The extensor digitorum longus (EDL) was isolated from stimulated (Stim) and contralateral non-stimulated (Ctrl) legs. Proteomic analysis encompassed 38 myofibrillar and 46 soluble proteins and the rates of change in abundance, synthesis, and degradation were reported in absolute (ng/d) units. Overall, synthesis and degradation made equal contributions to the adaptation of the proteome, including instances where a decrease in protein-specific degradation primarily accounted for the increase in abundance of the protein.	[Hesketh, Stuart J.; Sutherland, Hazel; Jarvis, Jonathan C.; Burniston, Jatin G.] Liverpool John Moores Univ, Res Inst Sport & Exercise Sci, Liverpool, Merseyside, England; [Burniston, Jatin G.] Liverpool John Moores Univ, Liverpool Ctr Cardiovasc Sci, Liverpool, Merseyside, England; [Lisboa, Paulo J.] Liverpool John Moores Univ, Dept Appl Math, Liverpool, Merseyside, England	Liverpool John Moores University; Liverpool John Moores University; Liverpool John Moores University	Burniston, JG (corresponding author), Liverpool John Moores Univ, LCCS, RISES, Tom Reilly Bldg,Byrom St, Liverpool L3 3AF, Merseyside, England.	j.burniston@ljmu.ac.uk	Burniston, Jatin G/B-7833-2008	Burniston, Jatin G/0000-0001-7303-9318; Hesketh, Stuart/0000-0001-7855-2380; Sutherland, Hazel/0000-0002-5570-1379				Abu Hatoum O, 1998, MOL CELL BIOL, V18, P5670, DOI 10.1128/MCB.18.10.5670; Bowden-Davies K, 2015, PROTEOMICS, V15, P2342, DOI 10.1002/pmic.201400537; Burniston JG, 2008, BBA-PROTEINS PROTEOM, V1784, P1077, DOI 10.1016/j.bbapap.2008.04.007; Burniston JG, 2019, METH PHYS S, P171, DOI 10.1007/978-1-4939-9802-9_9; Burniston JG, 2014, PROTEOMICS, V14, P2339, DOI 10.1002/pmic.201400118; Burniston JG, 2011, EXPERT REV PROTEOMIC, V8, P361, DOI [10.1586/EPR.11.17, 10.1586/epr.11.17]; Busch R, 2006, BBA-GEN SUBJECTS, V1760, P730, DOI 10.1016/j.bbagen.2005.12.023; Camera DM, 2017, FASEB J, V31, P5478, DOI 10.1096/fj.201700531R; Cohen S, 2009, J CELL BIOL, V185, P1083, DOI 10.1083/jcb.200901052; Cunha TF, 2012, J APPL PHYSIOL, V112, P1839, DOI 10.1152/japplphysiol.00346.2011; Donoghue P, 2007, PROTEOMICS, V7, P3417, DOI 10.1002/pmic.200700262; Gerner C, 2002, MOL CELL PROTEOMICS, V1, P528, DOI 10.1074/mcp.M200026-MCP200; Gillies AR, 2011, MUSCLE NERVE, V44, P318, DOI 10.1002/mus.22094; He CC, 2012, NATURE, V481, P511, DOI 10.1038/nature10758; Hesketh S, 2016, PROTEOMES, V4, DOI 10.3390/proteomes4010012; Hoffman NJ, 2015, CELL METAB, V22, P922, DOI 10.1016/j.cmet.2015.09.001; HOLLOSZY JO, 1967, J BIOL CHEM, V242, P2278; Holloszy JO, 2016, J APPL PHYSIOL, V121, P831; Holloway KV, 2009, PROTEOMICS, V9, P5155, DOI 10.1002/pmic.200900068; Holmes WE, 2015, METHOD ENZYMOL, V561, P219, DOI 10.1016/bs.mie.2015.05.018; Holwerda AM, 2020, INT J SPORT NUTR EXE, V30, P153, DOI 10.1123/ijsnem.2019-0281; Jarvis JC, 1996, MUSCLE NERVE, V19, P1469, DOI 10.1002/(SICI)1097-4598(199611)19:11<1469::AID-MUS11>3.0.CO;2-O; Kosek DJ, 2006, J APPL PHYSIOL, V101, P531, DOI 10.1152/japplphysiol.01474.2005; Kristensen AR, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.47; Lang F, 2017, DIS MODEL MECH, V10, P881, DOI 10.1242/dmm.028910; Li L, 2012, MOL CELL PROTEOMICS, V11, DOI [10.1074/mcp.M111.010025, 10.1074/mcp.M111.014209]; Liu YS, 2016, CELL, V165, P535, DOI 10.1016/j.cell.2016.03.014; Makhnovskii PA, 2020, SCI REP, P1; Malik ZA, 2013, PROTEOMES, V1, DOI 10.3390/proteomes1030290; MAYNE CN, 1993, FEBS LETT, V327, P297, DOI 10.1016/0014-5793(93)81008-N; Nilsson A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12934-8; Okatsu K, 2015, J CELL BIOL, V209, P111, DOI 10.1083/jcb.201410050; Parker BL, 2020, FASEB J, V34, P5906, DOI 10.1096/fj.202000075R; Paulsen G, 2009, J APPL PHYSIOL, V107, P570, DOI 10.1152/japplphysiol.00209.2009; Pette D, 2002, J MUSCLE RES CELL M, V23, P215, DOI 10.1023/A:1020974710389; Pette D, 1991, Semin Thorac Cardiovasc Surg, V3, P101; Pette D, 2017, EUR J TRANSL MYOL, V27, P33, DOI 10.4081/ejtm.2017.6368; Phillips SM, 1997, AM J PHYSIOL-ENDOC M, V273, pE99, DOI 10.1152/ajpendo.1997.273.1.E99; SALMONS S, 1991, MED BIOL ENG COMPUT, V29, P554, DOI 10.1007/BF02442330; Schild M, 2015, J PROTEOMICS, V122, P119, DOI 10.1016/j.jprot.2015.03.028; Shankaran M, 2016, J CLIN INVEST, V126, P288, DOI 10.1172/JCI79639; Short KR, 2004, AM J PHYSIOL-ENDOC M, V286, pE92, DOI 10.1152/ajpendo.00366.2003; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200; Sollanek KJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171007; Srisawat K, 2020, PROTEOMICS, V20, DOI 10.1002/pmic.201900194; Stead CA, 2020, PROTEOMES, V8, DOI 10.3390/proteomes8020010; TERMIN A, 1992, EUR J BIOCHEM, V204, P569, DOI 10.1111/j.1432-1033.1992.tb16669.x; Tintignac LA, 2005, J BIOL CHEM, V280, P2847, DOI 10.1074/jbc.M411346200; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Wei LM, 2018, MOL CELL PROTEOMICS, V17, P148, DOI 10.1074/mcp.RA117.000124; Wilkinson SB, 2008, J PHYSIOL-LONDON, V586, P3701, DOI 10.1113/jphysiol.2008.153916; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]	52	7	7	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10398	10417		10.1096/fj.202000668RR	http://dx.doi.org/10.1096/fj.202000668RR		JUN 2020	20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32598083	Green Accepted, hybrid			2022-12-28	WOS:000546064900001
J	Hou, QH; Dong, YY; Yu, QH; Wang, B; Le, S; Guo, YM; Zhang, BK				Hou, Qihang; Dong, Yuanyang; Yu, Qinghua; Wang, Bo; Le, Shen; Guo, Yuming; Zhang, Bingkun			Regulation of the Paneth cell niche by exogenousL-arginine couples the intestinal stem cell function	FASEB JOURNAL			English	Article						5-FU; intestinal stem cell; L-arginine; organoids; Paneth cell; Wnt3a	SELF-RENEWAL; IN-VITRO; HOMEOSTASIS; METABOLISM	Although previous studies show that exogenous nutrients regulate the stem cell function, little is known about the effects ofL-arginine on intestinal stem cells (ISCs). In this study, we utilize mice, small intestinal (SI) organoids, and ISC-Paneth cell co-cultured models to clarify the role ofL-arginine in ISC function. We find that exogenousL-arginine is essential for ISCs proliferation and intestinal epithelial renewal. Our data show that Paneth cells, a critical component of the ISCs niche, augment the ISCs function in response toL-arginine. Moreover, enhanced the expression of Wnt3a in Paneth cells, which is a ligand of the Wnt/beta-catenin signaling pathway, mediates the effects ofL-arginine on ISCs function. Pre-treatment withL-arginine enhances the ISCs pool and protects the gut in response to injury provoked by murine tumor necrosis factor alpha (TNF-alpha) and 5-Fluorouracil (5-FU). Our findings establish that the regulation of Wnt3a in the Paneth cell niche by exogenousL-arginine couples ISCs function and favours a model in which the ISCs niche couples the nutrient levels to ISCs function.	[Hou, Qihang; Dong, Yuanyang; Wang, Bo; Guo, Yuming; Zhang, Bingkun] China Agr Univ, Coll Anim Sci & Technol, Dept Anim Nutr & Feed Sci, State Key Lab Anim Nutr, Beijing 100193, Peoples R China; [Yu, Qinghua] Nanjing Agr Univ, Coll Vet Med, MOE Joint Int Res Lab Anim Hlth & Food Safety, Nanjing, Peoples R China; [Le, Shen] Univ Chicago, Dept Surg, 5841 S Maryland Ave, Chicago, IL 60637 USA	China Agricultural University; Nanjing Agricultural University; University of Chicago	Zhang, BK (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Dept Anim Nutr & Feed Sci, State Key Lab Anim Nutr, Beijing 100193, Peoples R China.	bingkunzhang@126.com			State Key Laboratory of Animal Nutrition [2004DA125184]; NSFC | National Natural Science Foundation of China [31502024]; Nation Key R&D Program of China [2018YFD0500600]	State Key Laboratory of Animal Nutrition; NSFC | National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nation Key R&D Program of China	the State Key Laboratory of Animal Nutrition, Grant/Award Number: 2004DA125184; NSFC | National Natural Science Foundation of China, Grant/Award Number: 31502024; Nation Key R&D Program of China, Grant/Award Number: 2018YFD0500600	Agathocleous M, 2017, NATURE, V549, P476, DOI 10.1038/nature23876; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2014, NAT REV MOL CELL BIO, V15, P19, DOI 10.1038/nrm3721; Bertrand J, 2013, AMINO ACIDS, V45, P443, DOI 10.1007/s00726-012-1325-8; Beyaz S, 2018, NATURE, V560, pE26, DOI 10.1038/s41586-018-0187-y; Boger RH, 2001, ANNU REV PHARMACOL, V41, P79, DOI 10.1146/annurev.pharmtox.41.1.79; Cheng CW, 2019, CELL, V178, P1115, DOI 10.1016/j.cell.2019.07.048; Cimmino L, 2017, CELL, V170, P1079, DOI 10.1016/j.cell.2017.07.032; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Coburn LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033546; Dinesh OC, 2014, JPEN-PARENTER ENTER, V38, P973, DOI 10.1177/0148607113498906; Fan J, 2010, CLIN NUTR, V29, P124, DOI 10.1016/j.clnu.2009.07.005; Fotiadis C, 2007, ACTA CHIR BELG, V107, P192, DOI 10.1080/00015458.2007.11680039; Fritz JH, 2013, INFECT IMMUN, V81, P3500, DOI 10.1128/IAI.00789-13; Gregorieff A, 2005, GENE DEV, V19, P877, DOI 10.1101/gad.1295405; Hooper KM, 2017, J CROHNS COLITIS, V11, P118, DOI 10.1093/ecco-jcc/jjw127; Hou QH, 2018, CELL DEATH DIFFER, V25, P1657, DOI 10.1038/s41418-018-0070-2; Hou QH, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00599; Ireland H, 2004, GASTROENTEROLOGY, V126, P1236, DOI 10.1053/j.gastro.2004.03.020; Jiang HQ, 2012, CURR OPIN GENET DEV, V22, P354, DOI 10.1016/j.gde.2012.04.002; Meneses Andre M C, 2016, Vet Sci, V3, DOI 10.3390/vetsci3040031; Mihaylova MM, 2014, CELL STEM CELL, V14, P292, DOI 10.1016/j.stem.2014.02.008; Ananthakrishnan Ashwin N, 2013, Gastroenterol Hepatol (N Y), V9, P367; Morris SM, 2007, J NUTR, V137, p1602S, DOI 10.1093/jn/137.6.1602S; Passlack N, 2016, CYTOTECHNOLOGY, V68, P1949, DOI 10.1007/s10616-016-0008-9; Pentinmikko N, 2019, NATURE, V571, P398, DOI 10.1038/s41586-019-1383-0; Peregrina K, 2015, CARCINOGENESIS, V36, P25, DOI 10.1093/carcin/bgu221; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Simons BD, 2011, CELL, V145, P851, DOI 10.1016/j.cell.2011.05.033; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Tumanov AV, 2011, CELL HOST MICROBE, V10, P44, DOI 10.1016/j.chom.2011.06.002; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Ungaro F, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01331; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; Wang B, 2018, CELL STEM CELL, V22, P206, DOI 10.1016/j.stem.2017.12.017; Wu G, 2000, Curr Opin Clin Nutr Metab Care, V3, P59, DOI 10.1097/00075197-200001000-00010; Yilmaz OH, 2012, NATURE, V486, P490, DOI 10.1038/nature11163; Zhan Y, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.136; Zhou WJ, 2013, NATURE, V501, P107, DOI 10.1038/nature12416	40	7	7	5	26	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10299	10315		10.1096/fj.201902573RR	http://dx.doi.org/10.1096/fj.201902573RR		JUN 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32725957	Bronze			2022-12-28	WOS:000541773300001
J	Iwaki, A; Moriwaki, K; Sobajima, T; Taniguchi, M; Yoshimura, SI; Kunii, M; Kanda, S; Kamada, Y; Miyoshi, E; Harada, A				Iwaki, Ayano; Moriwaki, Kenta; Sobajima, Tomoaki; Taniguchi, Manabu; Yoshimura, Shin-ichiro; Kunii, Masataka; Kanda, Satoshi; Kamada, Yoshihiro; Miyoshi, Eiji; Harada, Akihiro			Loss of Rab6a in the small intestine causes lipid accumulation and epithelial cell death from lactation	FASEB JOURNAL			English	Article						cell polarity; membrane trafficking; Rab protein	MICROVILLUS INCLUSION DISEASE; APICAL PROTEIN LOCALIZATION; RETROGRADE TRANSPORT; GOLGI; ER; PATHWAY; TRAFFICKING; REVEALS; RAB11A; RAB8A	Intestinal epithelial cells (IECs) are not only responsible for the digestion and absorption of dietary substrates but also function as a first line of host defense against commensal and pathogenic luminal bacteria. Disruption of the epithelial layer causes malnutrition and enteritis. Rab6 is a small GTPase localized to the Golgi, where it regulates anterograde and retrograde transport by interacting with various effector proteins. Here, we generated mice with IEC-specific deletion of Rab6a (Rab6a( increment IEC) mice). While Rab6a(Delta IEC) mice were born at the Mendelian ratio, they started to show IEC death, inflammation, and bleeding in the small intestine shortly after birth, and these changes culminated in early postnatal death. We further found massive lipid accumulation in the IECs of Rab6a( increment IEC) neonates. In contrast to Rab6a( increment IEC) neonates, knockout embryos did not show any of these abnormalities. Lipid accumulation and IEC death became evident when Rab6a( increment IEC) embryos were nursed by a foster mother, suggesting that dietary milk-derived lipids accumulated in Rab6a-deficient IECs and triggered IEC death. These results indicate that Rab6a plays a crucial role in regulating the lipid transport and maintaining tissue integrity.	[Iwaki, Ayano; Moriwaki, Kenta; Sobajima, Tomoaki; Taniguchi, Manabu; Yoshimura, Shin-ichiro; Kunii, Masataka; Kanda, Satoshi; Harada, Akihiro] Osaka Univ, Dept Cell Biol, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan; [Iwaki, Ayano; Sobajima, Tomoaki; Kamada, Yoshihiro; Miyoshi, Eiji] Osaka Univ, Grad Sch Med, Dept Mol Biochem & Clin Invest, Suita, Osaka, Japan; [Moriwaki, Kenta] Toho Univ, Dept Biochem, Sch Med, Tokyo, Japan; [Sobajima, Tomoaki] Univ Oxford, Dept Biochem, Oxford, England	Osaka University; Osaka University; Toho University; University of Oxford	Moriwaki, K; Harada, A (corresponding author), Osaka Univ, Dept Cell Biol, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	kenta.moriwaki@med.toho-u.ac.jp; aharada@acb.med.osaka-u.ac.jp	Kamada, Yoshihiro/GQA-8854-2022; Kamada, Yoshihiro/AHC-1613-2022	Kamada, Yoshihiro/0000-0001-5485-902X; Kanda, Satoshi/0000-0002-1123-1205; Moriwaki, Kenta/0000-0002-8724-4715	Japan Society for the Promotion of Science KAKENHI [15H04668, 16H06280, 17H06422, 18H02594, 17K15547]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Japan Society for the Promotion of Science KAKENHI, Grant/Award Number: 15H04668, 16H06280, 17H06422, 18H02594 and 17K15547	Banfalvi G, 2017, APOPTOSIS, V22, P306, DOI 10.1007/s10495-016-1333-3; Bardin S, 2015, BIOL CELL, V107, P427, DOI 10.1111/boc.201400083; Blander JM, 2018, CURR OPIN GASTROEN, V34, P413, DOI 10.1097/MOG.0000000000000481; Coutelis JB, 2007, DEVELOPMENT, V134, P1419, DOI 10.1242/dev.02821; Echard A, 2000, MOL BIOL CELL, V11, P3819, DOI 10.1091/mbc.11.11.3819; Feng Q, 2017, J CELL SCI, V130, P2491, DOI 10.1242/jcs.201897; Fourriere L, 2019, J CELL BIOL, V218, P2215, DOI 10.1083/jcb.201805002; Garcia-Hernandez V, 2017, ANN NY ACAD SCI, V1397, P66, DOI 10.1111/nyas.13360; Gordon SM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40296-0; GRASLKRAUPP B, 1995, HEPATOLOGY, V21, P1465, DOI 10.1016/0270-9139(95)90071-3; Grigoriev I, 2007, DEV CELL, V13, P305, DOI 10.1016/j.devcel.2007.06.010; Han J, 2016, J LIPID RES, V57, P1329, DOI 10.1194/jlr.R067595; Homma Y, 2019, J CELL BIOL, V218, P2035, DOI 10.1083/jcb.201810134; Hussain MM, 2014, CURR OPIN LIPIDOL, V25, P200, DOI 10.1097/MOL.0000000000000084; Ikonen E, 2008, NAT REV MOL CELL BIO, V9, P125, DOI 10.1038/nrm2336; Iwanami N, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005828; Januschke J, 2007, DEVELOPMENT, V134, P3419, DOI 10.1242/dev.008078; Klunder LJ, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a027888; Leng CS, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000531; Mallard F, 2002, J CELL BIOL, V156, P653, DOI 10.1083/jcb.200110081; Mansbach CM, 2010, ANNU REV PHYSIOL, V72, P315, DOI 10.1146/annurev-physiol-021909-135801; Matanis T, 2002, NAT CELL BIOL, V4, P986, DOI 10.1038/ncb891; Miserey-Lenkei S, 2007, TRAFFIC, V8, P1385, DOI 10.1111/j.1600-0854.2007.00612.x; Mizuta R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080223; Neu J, 2011, NEW ENGL J MED, V364, P255, DOI 10.1056/NEJMra1005408; Odenwald MA, 2017, NAT REV GASTRO HEPAT, V14, P9, DOI 10.1038/nrgastro.2016.169; Opdam FJM, 2000, J CELL SCI, V113, P2725; Piccolis M, 2019, MOL CELL, V74, P32, DOI 10.1016/j.molcel.2019.01.036; Sato T, 2007, NATURE, V448, P366, DOI 10.1038/nature05929; Sato T, 2014, J CELL SCI, V127, P422, DOI 10.1242/jcs.136903; Schneeberger K, 2015, P NATL ACAD SCI USA, V112, P12408, DOI 10.1073/pnas.1516672112; Shafaq-Zadah M, 2016, NAT CELL BIOL, V18, P54, DOI 10.1038/ncb3287; Sobajima T, 2015, BIOL OPEN, V4, P86, DOI 10.1242/bio.20148532; Wallach D, 2014, NAT REV IMMUNOL, V14, P51, DOI 10.1038/nri3561; Weis VG, 2016, CELL MOL GASTROENTER, V2, P131, DOI 10.1016/j.jcmgh.2015.11.009; White J, 1999, J CELL BIOL, V147, P743, DOI 10.1083/jcb.147.4.743; Yoshimura S, 2004, J BIOCHEM, V135, P201, DOI 10.1093/jb/mvh024; Yu SY, 2014, EMBO J, V33, P1882, DOI 10.15252/embj.201487888; ZAHRAOUI A, 1989, J BIOL CHEM, V264, P12394; Zhen Y, 2015, J CELL SCI, V128, P3171, DOI 10.1242/jcs.166074	40	1	1	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9450	9465		10.1096/fj.202000028R	http://dx.doi.org/10.1096/fj.202000028R		JUN 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32496646	Bronze			2022-12-28	WOS:000538309300001
J	Wu, BL; Yuan, YC; Han, X; Wang, QC; Shang, HT; Liang, XT; Jing, H; Cheng, W				Wu, Bolin; Yuan, Yanchi; Han, Xue; Wang, Qiucheng; Shang, Haitao; Liang, Xitian; Jing, Hui; Cheng, Wen			Structure of LINC00511-siRNA-conjugated nanobubbles and improvement of cisplatin sensitivity on triple negative breast cancer	FASEB JOURNAL			English	Article						drug resistance; gene transfection; nanobubbles; RNA-Seq; triple negative breast cancer	RNA-SEQ; EXPRESSION; DELIVERY; RESISTANCE; KEGG	The drug resistance of triple negative breast cancer (TNBC) is considered as a major obstacle for the curative effect of chemotherapy. Long intergenic noncoding RNA 00511 (LINC00511) has been considered as a target gene of drug resistance. A novel theranostic agent loaded with LINC00511-siRNA to deliver siRNA was structured, and the responses of drug sensitivity in TNBC were detected. Next-generation high-throughput RNA sequencing (RNA-Seq) was performed to accurately analyze the differential expression of mRNAs and lncRNA targets after LINC00511-siRNA transfection with low-frequency ultrasound (LFUS). The LINC00511-siRNA conjugated nanobubble complexes showed appropriate characterization, with a mean diameter of 516.1 +/- 24.7 nm and a zeta potential of -38.05 +/- 0.24 mV. The transfection efficiency of nanobubble complexes was approximately 50% with LFUS. By RNA-Seq, the differential expressions of lncRNA transcripts and mRNA transcripts were identified, and then analyzed. The GO and KEGG enrichment analyses revealed the TNBC drug resistance related target genes and pathways. The combination of LFUS irradiation and nanobubble complexes is regarded as an efficient and safe method for siRNA transfection. The TNBC drug resistance occurs as a result of synergistic reactions between a variety of genes and a variety of pathways.	[Wu, Bolin; Yuan, Yanchi; Han, Xue; Wang, Qiucheng; Shang, Haitao; Liang, Xitian; Jing, Hui; Cheng, Wen] Harbin Med Univ, Dept Ultrasound, Canc Hosp, 150 Haping Rd, Harbin 150081, Heilongjiang, Peoples R China; [Wu, Bolin; Cheng, Wen] Harbin Med Univ, Dept Intervent Ultrasound, Canc Hosp, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University	Jing, H; Cheng, W (corresponding author), Harbin Med Univ, Dept Ultrasound, Canc Hosp, 150 Haping Rd, Harbin 150081, Heilongjiang, Peoples R China.	jinghui@hrbmu.edu.cn; chengwen@hrbmu.edu.cn	Jing, Hui/GXM-4109-2022	Jing, Hui/0000-0002-8389-8252	National Natural Science Foundation of China (NSFC) [81801709, 81873900]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81801709 and 81873900	Anastasiadi Z, 2017, UPDATES SURG, V69, P313, DOI 10.1007/s13304-017-0424-1; Barone I, 2020, SEMIN CANCER BIOL, V60, P274, DOI 10.1016/j.semcancer.2019.09.001; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012; Chen SY, 2018, GENE THER, V25, P497, DOI 10.1038/s41434-018-0036-5; Chen ZY, 2013, CARDIOVASC ULTRASOUN, V11, DOI 10.1186/1476-7120-11-11; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Frazee AC, 2015, NAT BIOTECHNOL, V33, P243, DOI 10.1038/nbt.3172; Gonzalez-Angulo AM, 2007, ADV EXP MED BIOL, V608, P1; Johnstone TC, 2016, CHEM REV, V116, P3436, DOI 10.1021/acs.chemrev.5b00597; Kaczmarek E, 2019, BREAST CANCER RES TR, V178, P505, DOI 10.1007/s10549-019-05423-5; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kang YJ, 2017, NUCLEIC ACIDS RES, V45, pW12, DOI 10.1093/nar/gkx428; Krupka TM, 2010, MOL PHARMACEUT, V7, P49, DOI 10.1021/mp9001816; Lee KL, 2019, CANCERS, V11, DOI 10.3390/cancers11091334; Liang XT, 2018, ONCOL LETT, V16, P2893, DOI 10.3892/ol.2018.8994; Lin MF, 2011, BIOINFORMATICS, V27, pI275, DOI 10.1093/bioinformatics/btr209; Liu L, 2019, EUR REV MED PHARMACO, V23, P7457, DOI 10.26355/eurrev_201909_18855; Liu YY, 2006, J CONTROL RELEASE, V114, P89, DOI 10.1016/j.jconrel.2006.05.018; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Meng L, 2019, ADV SCI, V6, DOI 10.1002/advs.201900557; Miansari M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47295-1; Moiseenko Fedor, 2017, F1000Res, V6, P288, DOI 10.12688/f1000research.10992.1; Omata D, 2019, J CONTROL RELEASE, V311, P65, DOI 10.1016/j.jconrel.2019.08.023; Poggio F, 2018, ANN ONCOL, V29, P1497, DOI 10.1093/annonc/mdy127; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Ren HX, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2365-3; Shang HT, 2019, DRUG DELIV, V26, P944, DOI 10.1080/10717544.2019.1667450; Sirsi SR, 2012, J CONTROL RELEASE, V157, P224, DOI 10.1016/j.jconrel.2011.09.071; Song QL, 2019, ADV MATER, V31, DOI 10.1002/adma.201903793; Sun L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt646; Sun SJ, 2018, NANOSCALE, V10, P19945, DOI 10.1039/c8nr03074j; Szablowski JO, 2019, ACCOUNTS CHEM RES, V52, P2427, DOI 10.1021/acs.accounts.9b00277; Tayier B, 2019, NANOSCALE, V11, P14757, DOI 10.1039/c9nr03402a; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tray N, 2019, CANCER TREAT REV, V79, DOI 10.1016/j.ctrv.2019.08.004; Wang HY, 2019, NANOSCALE, V11, P17018, DOI 10.1039/c9nr04655k; Wang X, 2019, NANO LETT, V19, P2251, DOI 10.1021/acs.nanolett.8b04632; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wayteck L, 2017, J CONTROL RELEASE, V267, P154, DOI 10.1016/j.jconrel.2017.08.002; Wein L, 2017, BREAST, V34, pS27, DOI 10.1016/j.breast.2017.06.023; Wu BL, 2019, FASEB J, V33, P14129, DOI 10.1096/fj.201900716RR; Wu BL, 2016, TUMOR BIOL, V37, P12113, DOI 10.1007/s13277-016-5082-2; Wu Q, 2019, J HEMATOL ONCOL, V12, DOI 10.1186/s13045-019-0778-6; Xu SP, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0696-6; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14	47	22	22	2	21	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9713	9726		10.1096/fj.202000481R	http://dx.doi.org/10.1096/fj.202000481R		JUN 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32497336				2022-12-28	WOS:000538309000001
J	Przanowska, RK; Sobierajska, E; Su, ZL; Jensen, K; Przanowski, P; Nagdas, S; Kashatus, JA; Kashatus, DF; Bhatnagar, S; Lukens, JR; Dutta, A				Przanowska, Roza K.; Sobierajska, Ewelina; Su, Zhangli; Jensen, Kate; Przanowski, Piotr; Nagdas, Sarbajeet; Kashatus, Jennifer A.; Kashatus, David F.; Bhatnagar, Sanchita; Lukens, John R.; Dutta, Anindya			miR-206 family is important for mitochondrial and muscle function, but not essential for myogenesis in vitro	FASEB JOURNAL			English	Article						miR-1a-1; miR-1a-2; myogenesis; myomiRs; skeletal muscle differentiation	CELL FATE; MOLECULAR REGULATION; DOWN-REGULATION; SATELLITE CELL; SKELETAL; DIFFERENTIATION; MICRORNAS; REGENERATION; EXPRESSION; MYOD	miR-206, miR-1a-1, and miR-1a-2 are induced during differentiation of skeletal myoblasts and promote myogenesis in vitro. miR-206 is required for skeletal muscle regeneration in vivo. Although this miRNA family is hypothesized to play an essential role in differentiation, a triple knock-out (tKO) of the three genes has not been done to test this hypothesis. We report that tKO C2C12 myoblasts generated using CRISPR/Cas9 method differentiate despite the expected derepression of the miRNA targets. Surprisingly, their mitochondrial function is diminished. tKO mice demonstrate partial embryonic lethality, most likely due to the role of miR-1a in cardiac muscle differentiation. Two tKO mice survive and grow normally to adulthood with smaller myofiber diameter, diminished physical performance, and an increase in PAX7 positive satellite cells. Thus, unlike other miRNAs important in other differentiation pathways, the miR-206 family is not absolutely essential for myogenesis and is instead a modulator of optimal differentiation of skeletal myoblasts.	[Przanowska, Roza K.; Sobierajska, Ewelina; Su, Zhangli; Jensen, Kate; Przanowski, Piotr; Bhatnagar, Sanchita; Dutta, Anindya] Univ Virginia, Sch Med, Dept Biochem & Mol Genet, POB 800733,1340 JPA Pinn Hall,Room 1240, Charlottesville, VA 22908 USA; [Nagdas, Sarbajeet; Kashatus, Jennifer A.; Kashatus, David F.] Univ Virginia, Sch Med, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22908 USA; [Bhatnagar, Sanchita] Univ Virginia, Sch Med, Dept Neurosci, Charlottesville, VA 22908 USA; [Lukens, John R.] Univ Virginia, Sch Med, Dept Neurosci, Ctr Brain Immunol & Glia, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia	Dutta, A (corresponding author), Univ Virginia, Sch Med, Dept Biochem & Mol Genet, POB 800733,1340 JPA Pinn Hall,Room 1240, Charlottesville, VA 22908 USA.	ad8q@virginia.edu	Przanowska, Roza/AFN-1810-2022	Su, Zhangli/0000-0001-6495-3351; Dutta, Anindya/0000-0002-4319-0073				Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anderson C, 2006, NUCLEIC ACIDS RES, V34, P5863, DOI 10.1093/nar/gkl743; Bhinge A, 2016, STEM CELLS, V34, P124, DOI 10.1002/stem.2233; Callis TE, 2007, DNA CELL BIOL, V26, P219, DOI 10.1089/dna.2006.0556; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen JF, 2010, J CELL BIOL, V190, P867, DOI 10.1083/jcb.200911036; Cheung TH, 2013, NAT REV MOL CELL BIO, V14, P329, DOI 10.1038/nrm3591; Choi WY, 2007, SCIENCE, V318, P271, DOI 10.1126/science.1147535; Cichewicz MA, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00655-17; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Delaloy C, 2010, CELL STEM CELL, V6, P323, DOI 10.1016/j.stem.2010.02.015; Dey BK, 2012, GENE DEV, V26, P2180, DOI 10.1101/gad.198085.112; Dey BK, 2011, MOL CELL BIOL, V31, P203, DOI 10.1128/MCB.01009-10; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dore LC, 2008, P NATL ACAD SCI USA, V105, P3333, DOI 10.1073/pnas.0712312105; Dugas JC, 2010, NEURON, V65, P597, DOI 10.1016/j.neuron.2010.01.027; El Haddad M, 2017, CELL MOL LIFE SCI, V74, P1923, DOI 10.1007/s00018-016-2445-1; Faridani OR, 2016, NAT BIOTECHNOL, V34, P1264, DOI 10.1038/nbt.3701; Friedman LM, 2009, P NATL ACAD SCI USA, V106, P7915, DOI 10.1073/pnas.0812446106; Gagan J, 2012, J BIOL CHEM, V287, P40360, DOI 10.1074/jbc.M112.378414; Garzon R, 2008, CURR OPIN HEMATOL, V15, P352, DOI 10.1097/MOH.0b013e328303e15d; Gebert D, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4031-9; Genovese NJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep41833; Goljanek-Whysall K, 2012, J CELL SCI, V125, P3590, DOI 10.1242/jcs.101758; HALEVY O, 1993, J CELL PHYSIOL, V154, P566, DOI 10.1002/jcp.1041540315; Heidersbach A, 2013, ELIFE, V2, DOI 10.7554/eLife.01323; Hirai H, 2010, J CELL BIOL, V191, P347, DOI 10.1083/jcb.201006025; Jackson SJ, 2013, DEVELOPMENT, V140, P1882, DOI 10.1242/dev.089649; Jean E, 2011, J CELL MOL MED, V15, P119, DOI 10.1111/j.1582-4934.2009.00942.x; Jiang AW, 2019, FASEB J, V33, P14083, DOI 10.1096/fj.201900502RRRR; Jiang H, 2008, BIOINFORMATICS, V24, P2395, DOI 10.1093/bioinformatics/btn429; Kassar-Duchossoy L, 2004, NATURE, V431, P466, DOI 10.1038/nature02876; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Koutsoulidou A, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-34; Kozomara A, 2019, NUCLEIC ACIDS RES, V47, pD155, DOI 10.1093/nar/gky1141; Krichevsky AM, 2006, STEM CELLS, V24, P857, DOI 10.1634/stemcells.2005-0441; Kwon C, 2005, P NATL ACAD SCI USA, V102, P18986, DOI 10.1073/pnas.0509535102; Lamarche E, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0032-z; Lattanzi L, 1998, J CLIN INVEST, V101, P2119, DOI 10.1172/JCI1505; Li H, 2009, J CLIN INVEST, V119, P3666, DOI 10.1172/JCI39832; Li Z, 2008, P NATL ACAD SCI USA, V105, P13906, DOI 10.1073/pnas.0804438105; Liu N, 2012, J CLIN INVEST, V122, P2054, DOI 10.1172/JCI62656; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; McCarthy JJ, 2011, EXERC SPORT SCI REV, V39, P150, DOI 10.1097/JES.0b013e31821c01e1; Mishima Y, 2009, GENE DEV, V23, P619, DOI 10.1101/gad.1760209; O'Rourke JR, 2007, DEV BIOL, V311, P359, DOI 10.1016/j.ydbio.2007.08.032; Ohana R, 2015, DEVELOPMENT, V142, P2487, DOI 10.1242/dev.121533; Olguin HC, 2012, J CELL MOL MED, V16, P1013, DOI 10.1111/j.1582-4934.2011.01348.x; Parker MH, 2003, NAT REV GENET, V4, P497, DOI 10.1038/nrg1109; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rao PK, 2006, P NATL ACAD SCI USA, V103, P8721, DOI 10.1073/pnas.0602831103; Rasmussen KD, 2010, J EXP MED, V207, P1351, DOI 10.1084/jem.20100458; Rosa A, 2009, DEV CELL, V16, P517, DOI 10.1016/j.devcel.2009.02.007; RUDNICKI MA, 1992, CELL, V71, P383, DOI 10.1016/0092-8674(92)90508-A; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; Sarkar S, 2010, MOL BIOL CELL, V21, P2138, DOI 10.1091/mbc.E10-01-0062; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Sokol NS, 2005, GENE DEV, V19, P2343, DOI 10.1101/gad.1356105; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sweetman D, 2008, DEV BIOL, V321, P491, DOI 10.1016/j.ydbio.2008.06.019; TAPSCOTT SJ, 1988, SCIENCE, V242, P405, DOI 10.1126/science.3175662; Townley-Tilson WHD, 2010, INT J BIOCHEM CELL B, V42, P1252, DOI 10.1016/j.biocel.2009.03.002; Vauchez K, 2009, MOL THER, V17, P1948, DOI 10.1038/mt.2009.204; Vella JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029226; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Vergara HM, 2018, DEV BIOL, V438, P94, DOI 10.1016/j.ydbio.2018.03.021; Wang CB, 2014, COGN NEUROSCI-UK, V5, P3, DOI 10.1080/17588928.2013.797388; Wang DM, 2013, NAT CELL BIOL, V15, P1153, DOI 10.1038/ncb2827; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Williams AH, 2009, SCIENCE, V326, P1549, DOI 10.1126/science.1181046; Wust S, 2018, CELL METAB, V27, P1026, DOI 10.1016/j.cmet.2018.02.022; Wystub K, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003793; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Yuasa K, 2008, CELL STRUCT FUNCT, V33, P163, DOI 10.1247/csf.08022; Zammit PS, 2006, J CELL SCI, V119, P1824, DOI 10.1242/jcs.02908; Zhang XR, 2014, CELL, V158, P607, DOI 10.1016/j.cell.2014.05.047; Zhao C, 2009, NAT STRUCT MOL BIOL, V16, P365, DOI 10.1038/nsmb.1576; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030; Zhu Y, 2013, NUCLEIC ACIDS RES, V41, P4129, DOI 10.1093/nar/gkt093	86	9	9	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					7687	7702		10.1096/fj.201902855RR	http://dx.doi.org/10.1096/fj.201902855RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32277852	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000553573700033
J	Paredes, J; Marvin, JC; Vaughn, B; Andarawis-Puri, N				Paredes, Juan; Marvin, Jason C.; Vaughn, Brenna; Andarawis-Puri, Nelly			Innate tissue properties drive improved tendon healing in MRL/MpJ and harness cues that enhance behavior of canonical healing cells	FASEB JOURNAL			English	Article						decellularization; extracellular matrix; MRL; MpJ; regeneration; tendon; therapeutics	EXTRACELLULAR-MATRIX; COLLAGEN FIBRILS; SKELETAL-MUSCLE; MRL MICE; GROWTH; FIBROMODULIN; REGENERATION; DECORIN; HYDROGEL; INJURY	Development of tendon therapeutics has been hindered by the lack of informative adult mammalian models of regeneration. Murphy Roth's Large (MRL/MpJ) mice exhibit improved healing following acute tendon injuries, but the driver of this regenerative healing response remains unknown. The tissue-specific attributes of this healing response, despite a shared systemic environment within the mouse, support the hypothesis of a tissue-driven mechanism for scarless healing. Our objective was to investigate the potential of MRL/MpJ tendon extracellular matrix (ECM)-derived coatings to regulate scar-mediated healing. We found that deviations in the composition of key structural proteins within MRL/MpJ vs C57Bl/6 tendons occur synergistically to mediate the improvements in structure and mechanics following a 1-mm midsubstance injury. Improvement in mechanical properties of healing MRL/MpJ vs C57Bl/6 tendons that were isolated from systemic contributions via organ culture, highlighted the innate tendon environment as the driver of scarless healing. Finally, we established that decellularized coatings derived from early-deposited MRL/MpJ tendon provisional extracellular matrix (provisional-ECM), can modulate canonical healing B6 tendon cell behavior by inducing morphological changes and increasing proliferation in vitro. This study supports that the unique compositional cues in MRL/MpJ provisional-ECM have the therapeutic capability to motivate canonically healing cells toward improved behavior; enhancing our ability to develop effective therapeutics.	[Paredes, Juan; Marvin, Jason C.; Vaughn, Brenna] Cornell Univ, Nancy E & Peter C Meinig Sch Biomed Engn, Ithaca, NY USA; [Andarawis-Puri, Nelly] Cornell Univ, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14850 USA; [Andarawis-Puri, Nelly] Hosp Special Surg, New York, NY 10021 USA	Cornell University; Cornell University	Andarawis-Puri, N (corresponding author), Cornell Univ, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14850 USA.	na424@cornell.edu	Marvin, Jason C./ADY-1804-2022; Marvin, Ph.D., Jason Chang/GZH-1204-2022	Marvin, Jason C./0000-0002-0741-595X; 	US National Institutes of Health (NIH) [NIAMS R01-AR068301, R01-AR052743]; NSF [GRFP DGE-1650441]	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF))	The authors acknowledge technical contributions from Dr Claudia Fischbach-Teschl (Cornell University) and Dr Benjamin Cosgrove (Cornell University) for access to their epifluorescence microscope and ChemiDoc MP imager, respectively. This work was supported by the US National Institutes of Health (NIH) Grants NIAMS R01-AR068301 and R01-AR052743 and NSF GRFP DGE-1650441.	Abdel-Wahab N, 2002, BIOCHEM J, V362, P643, DOI 10.1042/0264-6021:3620643; Al-Sadi Onays, 2011, Muscles Ligaments Tendons J, V1, P68; Andarawis-Puri N, 2018, J ORTHOP RES, V36, P3115, DOI 10.1002/jor.24133; Banes AJ, 1999, CLIN ORTHOP RELAT R, pS356; Beason DP, 2012, J BIOMECH, V45, P1550, DOI 10.1016/j.jbiomech.2012.02.022; Bi YM, 2007, NAT MED, V13, P1219, DOI 10.1038/nm1630; Blankenhorn EP, 2003, MAMM GENOME, V14, P250, DOI 10.1007/s00335-002-2222-3; Born AK, 2009, EUR CELLS MATER, V18, P49; Chen WCW, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600844; Christiansen DL, 2000, MATRIX BIOL, V19, P409, DOI 10.1016/S0945-053X(00)00089-5; Clark LD, 1998, CLIN IMMUNOL IMMUNOP, V88, P35, DOI 10.1006/clin.1998.4519; Colwell AS, 2006, WOUND REPAIR REGEN, V14, P81, DOI 10.1111/j.1524-475X.2005.00092.x; Costa MA, 2006, TISSUE ENG, V12, P1937, DOI 10.1089/ten.2006.12.1937; DeQuach JA, 2012, EUR CELLS MATER, V23, P400, DOI 10.22203/eCM.v023a31; Disser NP, 2019, FASEB J, V33, P12680, DOI 10.1096/fj.201901503R; Dunkman AA, 2014, ANN BIOMED ENG, V42, P619, DOI 10.1007/s10439-013-0915-2; Eriksen HA, 2002, J ORTHOPAED RES, V20, P1352, DOI 10.1016/S0736-0266(02)00064-5; Erisken C, 2013, TISSUE ENG PT A, V19, P519, DOI 10.1089/ten.tea.2012.0072; Fitzgerald J, 2008, OSTEOARTHR CARTILAGE, V16, P1319, DOI 10.1016/j.joca.2008.03.014; Franchi M, 2007, THESCIENTIFICWORLDJO, V7, P404, DOI 10.1100/TSW.2007.92; Gawriluk TR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11164; Gillies AR, 2011, TISSUE ENG PART C-ME, V17, P383, DOI [10.1089/ten.tec.2010.0438, 10.1089/ten.TEC.2010.0438]; Gilpin A, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/9831534; Heber-Katz E, 2004, WOUND REPAIR REGEN, V12, P384, DOI 10.1111/j.1067-1927.2004.012308.x; Heber-Katz E, 1999, SEMIN CELL DEV BIOL, V10, P415, DOI 10.1006/scdb.1999.0328; HILDEBRAND A, 1994, BIOCHEM J, V302, P527, DOI 10.1042/bj3020527; Honardoust D, 2012, J BURN CARE RES, V33, P218, DOI 10.1097/BCR.0b013e3182335980; Hoshiba T, 2010, EXPERT OPIN BIOL TH, V10, P1717, DOI 10.1517/14712598.2010.534079; Hussey GS, 2018, NAT REV MATER, V3, P159, DOI 10.1038/s41578-018-0023-x; Kannus P, 2000, SCAND J MED SCI SPOR, V10, P312, DOI 10.1034/j.1600-0838.2000.010006312.x; Lalley AL, 2015, J ORTHOP RES, V33, P1693, DOI 10.1002/jor.22928; Li YF, 2013, MATRIX BIOL, V32, P169, DOI 10.1016/j.matbio.2013.01.003; Marturano JE, 2014, ACTA BIOMATER, V10, P1370, DOI 10.1016/j.actbio.2013.11.024; Moon DK, 2006, J BIOMECH, V39, P3071, DOI 10.1016/j.jbiomech.2005.10.029; Paredes J, 2018, CONNECT TISSUE RES, V59, P472, DOI 10.1080/03008207.2018.1485665; Pokhai GG, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3194753; Poon CJ, 2013, ACTA BIOMATER, V9, P5609, DOI 10.1016/j.actbio.2012.11.003; Porzionato A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19124117; Rao N, 2017, ACS NANO, V11, P3851, DOI 10.1021/acsnano.7b00093; Richardson SH, 2007, MOL CELL BIOL, V27, P6218, DOI 10.1128/MCB.00261-07; Screen HRC, 2015, J ORTHOP RES, V33, P793, DOI 10.1002/jor.22818; Sereysky JB, 2013, INT J EXP PATHOL, V94, P293, DOI 10.1111/iep.12031; Singelyn JM, 2009, BIOMATERIALS, V30, P5409, DOI 10.1016/j.biomaterials.2009.06.045; Snedeker JG, 2017, ACTA BIOMATER, V63, P18, DOI 10.1016/j.actbio.2017.08.032; Subramanian A, 2018, ELIFE, V7, DOI 10.7554/eLife.38069; Svensson L, 1999, J BIOL CHEM, V274, P9636, DOI 10.1074/jbc.274.14.9636; Svensson RB, 2013, BIOPHYS J, V104, P2476, DOI 10.1016/j.bpj.2013.04.033; Taylor DA, 2018, ACTA BIOMATER, V74, P74, DOI 10.1016/j.actbio.2018.04.044; Ueno M, 2005, INVEST OPHTH VIS SCI, V46, P4097, DOI 10.1167/iovs.05-0548; Vorotnikova E, 2010, MATRIX BIOL, V29, P690, DOI 10.1016/j.matbio.2010.08.007; Wang L, 2014, J DENT RES, V93, P780, DOI 10.1177/0022034514541126; Xue AB, 2018, J BIOMED MATER RES A, V106, P805, DOI 10.1002/jbm.a.36279; Zhang L, 2013, TISSUE ENG PT A, V19, P1909, DOI [10.1089/ten.tea.2012.0622, 10.1089/ten.TEA.2012.0622]; Zheng Z, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.50; Zheng Z, 2016, AM J PATHOL, V186, P2824, DOI 10.1016/j.ajpath.2016.07.023	55	2	2	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8341	8356		10.1096/fj.201902825RR	http://dx.doi.org/10.1096/fj.201902825RR		APR 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32350938	Bronze, Green Accepted			2022-12-28	WOS:000553674600001
J	Wu, YW; Wu, B; Zhang, ZW; Lu, HM; Fan, C; Qi, Q; Gao, YZ; Li, H; Feng, CL; Zuo, JP; Tang, W				Wu, Yanwei; Wu, Bing; Zhang, Zongwang; Lu, Huimin; Fan, Chen; Qi, Qing; Gao, Yuanzhuo; Li, Heng; Feng, Chunlan; Zuo, Jianping; Tang, Wei			Heme protects intestinal mucosal barrier in DSS-induced colitis through regulating macrophage polarization in both HO-1-dependent and HO-1-independent way	FASEB JOURNAL			English	Article						IBD; M1; M2; ulcerative colitis	INFLAMMATORY-BOWEL-DISEASE; INDUCTION; RECOVERY; SUPPRESSION; EXPRESSION; RESPONSES; MONOCYTE; TARGETS; CELLS	Hemoglobin-derived heme was reported to play protective roles in hemorrhagic diseases by modulating the macrophages toward recovery. Mucosal bleeding is one of the pathological features of inflammatory bowel diseases (IBD). However, whether heme provides anti-inflammatory profiles in macrophages, thus contributing to the intestinal mucosal barrier protection, is unclear. In the current study, we investigated the beneficial effects of heme on DSS-induced colitis mice and explored the underlying mechanisms. In vivo, systemic heme supplementation by hemin injection relieved intestinal inflammation and remedied intestinal mucosal barrier damage by correcting abnormal intestinal macrophage polarization. In vitro, we confirmed the reciprocally regulating effects of hemin on M1/M2 macrophage polarization in BMDM. Intriguingly, with knockdown of HO-1, the inhibiting effects of hemin on M1 polarization were maintained, while the promoting effects on M2 polarization were reversed. Further research proved that hemin repressed the inflammatory profiles in macrophages through inhibiting the translocation of NF-kappa B p65 by disrupting IRF5-NF-kappa B p65 complex formation in Spi-C-dependent way. In conclusion, these results showed that the modification of colon tissue microenvironment with heme supplementation plays a protective role in DSS-induced colitis mice through regulating the macrophage polarization in both HO-1-dependent and HO-1-independent way, indicating a new choice to therapeutically modulate the macrophage function and prevent IBD.	[Wu, Yanwei; Wu, Bing; Lu, Huimin; Fan, Chen; Qi, Qing; Gao, Yuanzhuo; Li, Heng; Feng, Chunlan; Tang, Wei] Chinese Acad Sci, Lab Antiinflammat, Shanghai Inst Mat Med, 555 Zuchongzhi Rd, Shanghai 201203, Peoples R China; [Wu, Bing; Lu, Huimin; Gao, Yuanzhuo; Li, Heng; Zuo, Jianping; Tang, Wei] Univ Chinese Acad Sci, Sch Pharm, Beijing, Peoples R China; [Zhang, Zongwang] Shanghai Univ, Sch Life Sci, Shanghai, Peoples R China; [Zuo, Jianping] Chinese Acad Sci, Shanghai Inst Mat Med, Lab Immunopharmacol, State Key Lab Drug Res, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Shanghai University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Tang, W (corresponding author), Chinese Acad Sci, Lab Antiinflammat, Shanghai Inst Mat Med, 555 Zuchongzhi Rd, Shanghai 201203, Peoples R China.; Zuo, JP (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Lab Immunopharmacol, 555 Zuchongzhi Rd, Shanghai 201203, Peoples R China.	jpzuo@simm.ac.cn; tangwei@simm.ac.cn			National Natural Science Foundation of China (NSFC) [81673445, 81803543]; Shanghai Committee of Science and Technology [16431900300]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA12020107]; National Science & Technology Major Project [2017ZX09101002002-010]; Chinese Academy of Sciences [X2017ZX09101002-002-010]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Science & Technology Major Project; Chinese Academy of Sciences(Chinese Academy of Sciences)	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81673445 and 81803543; Shanghai Committee of Science and Technology, Grant/Award Number: 16431900300; Strategic Priority Research Program of the Chinese Academy of Sciences, Grant/Award Number: XDA12020107; National Science & Technology Major Project, Grant/Award Number: 2017ZX09101002002-010; Chinese Academy of Sciences, Grant/Award Number: X2017ZX09101002-002-010	Alam MZ, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00033; Amit I, 2016, NAT IMMUNOL, V17, P18, DOI 10.1038/ni.3325; Angele MK, 1999, ANN SURG, V229, P651, DOI 10.1097/00000658-199905000-00007; Angele MK, 2018, PNAS, V115, P8418; Bhattacharyya A, 2014, PHYSIOL REV, V94, P329, DOI 10.1152/physrev.00040.2012; Boyle JJ, 2009, AM J PATHOL, V174, P1097, DOI 10.2353/ajpath.2009.080431; Chang CF, 2018, J CLIN INVEST, V128, P607, DOI 10.1172/JCI95612; Chistiakov DA, 2017, IMMUNOBIOLOGY, V223, P101, DOI 10.1016/j.imbio.2017.10.005; Cho DI, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2013.135; Cholapranee A, 2017, ALIMENT PHARM THER, V45, P1291, DOI 10.1111/apt.14030; Dai Y, 2018, INVEST OPHTH VIS SCI, V59, P3952, DOI 10.1167/iovs.17-23327; Garton T, 2017, TRANSL STROKE RES, V8, P612, DOI 10.1007/s12975-017-0535-5; Gliem M, 2016, BBA-MOL BASIS DIS, V1862, P329, DOI 10.1016/j.bbadis.2015.11.004; Gupta J., 2014, BIOPROTOC, V4, pe1289, DOI [10.21769/BioProtoc.1289, DOI 10.21769/BIOPROTOC.1289]; Haldar M, 2014, CELL, V156, P1223, DOI 10.1016/j.cell.2014.01.069; Holleran G, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102020; Jaworski FM, 2017, CLIN CANCER RES, V23, P5135, DOI 10.1158/1078-0432.CCR-17-0112; Kitada S, 2017, J EXP MED, V214, P1313, DOI 10.1084/jem.20161076; Kuhl AA, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00613; Lavin Y, 2015, NAT REV IMMUNOL, V15, P731, DOI 10.1038/nri3920; Li H, 2019, BRIT J PHARMACOL, V176, P2209, DOI 10.1111/bph.14667; Lissner D, 2015, INFLAMM BOWEL DIS, V21, P1297, DOI 10.1097/MIB.0000000000000384; Mateus V, 2018, CLIN EXP GASTROENTER, V11, P325, DOI 10.2147/CEG.S166197; Min H, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0225-3; Moura FA, 2015, REDOX BIOL, V6, P617, DOI 10.1016/j.redox.2015.10.006; Na YR, 2019, NAT REV GASTRO HEPAT, V16, P531, DOI 10.1038/s41575-019-0172-4; Nakamichi I, 2005, J CLIN INVEST, V115, P3007, DOI 10.1172/JCI24912; Ng SC, 2017, LANCET, V390, P2769, DOI 10.1016/S0140-6736(17)32448-0; Oshima T, 2016, J GASTROENTEROL, V51, P768, DOI 10.1007/s00535-016-1207-z; Paine ER, 2014, GASTROENTEROL REP, V2, P161, DOI 10.1093/gastro/gou028; Rossi M, 2018, BIOCHEM BIOPH RES CO, V503, P2820, DOI 10.1016/j.bbrc.2018.08.046; Saliba DG, 2014, CELL REP, V8, P1308, DOI 10.1016/j.celrep.2014.07.034; Siegmund B, 2001, P NATL ACAD SCI USA, V98, P13249, DOI 10.1073/pnas.231473998; Takeda Y, 2004, CLIN EXP IMMUNOL, V138, P237, DOI 10.1111/j.1365-2249.2004.02594.x; Xiong HB, 1996, CELL IMMUNOL, V172, P118, DOI 10.1006/cimm.1996.0222; Yan F, 2012, AM J PHYSIOL-GASTR L, V302, pG504, DOI 10.1152/ajpgi.00312.2011; Yan YX, 2018, ACTA PHARMACOL SIN, V39, P1633, DOI 10.1038/aps.2017.185; Ying W, 2013, JOVE-J VIS EXP, DOI 10.3791/50323; Zhang LY, 2014, J BIOL CHEM, V289, P26847, DOI 10.1074/jbc.M114.590554; Zhong WW, 2010, J PEDIATR GASTR NUTR, V50, P132, DOI 10.1097/MPG.0b013e3181c61591	40	15	15	8	25	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8028	8043		10.1096/fj.202000313RR	http://dx.doi.org/10.1096/fj.202000313RR		APR 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32301543				2022-12-28	WOS:000526645200001
J	Girardet, L; Bernet, A; Calvo, E; Soulet, D; Joly-Beauparlant, C; Droit, A; Cyr, DG; Belleannee, C				Girardet, Laura; Bernet, Agathe; Calvo, Ezequiel; Soulet, Denis; Joly-Beauparlant, Charles; Droit, Arnaud; Cyr, Daniel G.; Belleannee, Clemence			Hedgehog signaling pathway regulates gene expression profile of epididymal principal cells through the primary cilium	FASEB JOURNAL			English	Article						epididymis; epithelial cells; immune response; inflammation; primary cilia	LINEAGE SPECIFICITY; EPITHELIAL-CELLS; BASAL-CELLS; CROSS-TALK; SECRETION; PROTEIN; MOUSE; DIFFERENTIATION; LIPOCALIN-2; INDUCTION	Primary cilia (PC) are organelles that sense and respond to dynamic changes of the extracellular milieu through the regulation of target genes. By using the epididymis as a model system, we determined the contribution of primary cilia in the regulation of epithelial cell functions through the transduction of the Hedgehog (Hh) signaling pathway. Both Sonic (SHH) and Indian Hedgehog (IHH) ligands were detected in epididymal epithelial cells by confocal microscopy and found secreted in the extracellular space. Gene expression profiling preformed on ciliated epithelial cells indicated that 153 and 1052 genes were differentially expressed following treatment with the Hh agonist SAG or the Hh antagonist cyclopamine (Cyclo), respectively. Strikingly, gene ontology analysis indicated that genes associated with immune response were the most affected following Hh modulation. The contribution of epididymal PC to canonical Hh pathway transduction was validated by ciliobrevin D treatment, which induced a significant decrease in PC length and a reduction in the expression Hh signaling targets. Such findings bring us closer to a molecular understanding of the subtle immune balance observed in some epithelia, including the epididymis and the intestine, which are organs featuring both tolerance toward autoimmune spermatozoa (or commensal bacteria) and defense against pathogens.	[Girardet, Laura; Bernet, Agathe; Calvo, Ezequiel; Cyr, Daniel G.; Belleannee, Clemence] Univ Laval, Fac Med, CHU Quebec Res Ctr CHUL, Dept Obstet Gynecol & Reprod, Quebec City, PQ, Canada; [Soulet, Denis] Univ Laval, Fac Pharm, CHU Quebec Res Ctr CHUL, Quebec City, PQ, Canada; [Joly-Beauparlant, Charles; Droit, Arnaud] Laval Univ, Fac Med, Computat Biol Lab Res Ctr, Quebec City, PQ, Canada; [Cyr, Daniel G.] Univ Quebec, INRS Inst Armand Frappier, Lab Reprod Toxicol, Laval, PQ, Canada	Laval University; Laval University; Laval University; University of Quebec; Institut national de la recherche scientifique (INRS)	Belleannee, C (corresponding author), Univ Laval, Fac Med, CHU Quebec Res Ctr CHUL, Dept Obstet Gynecol & Reprod, Quebec City, PQ, Canada.	Clemence.Belleannee@crchudequebec.ulaval.ca	Droit, Arnaud/AGZ-6283-2022; Cyr, Daniel/AIC-9460-2022	Droit, Arnaud/0000-0001-7922-790X; Soulet, Denis/0000-0002-0937-7061	CIHR operating grant; FRQS-Junior 1 salary award; CRDSI; RQR; CHU Foundation; FRQS-Junior 2 salary award; CIHR [84576]; FRQNT-Reseau de recherche en Reproduction	CIHR operating grant(Canadian Institutes of Health Research (CIHR)); FRQS-Junior 1 salary award; CRDSI; RQR; CHU Foundation; FRQS-Junior 2 salary award; CIHR(Canadian Institutes of Health Research (CIHR)); FRQNT-Reseau de recherche en Reproduction	This work was supported by a CIHR operating grant and an FRQS-Junior 1 salary award to CB. LG is recipient of CRDSI, RQR, and CHU Foundation fellowships. DS holds a FRQS-Junior 2 salary award. DGC is recipient of CIHR operating grant 84576 and funding from the FRQNT-Reseau de recherche en Reproduction.	ABE K, 1984, ARCH HISTOL JAPON, V47, P137, DOI 10.1679/aohc.47.137; Araki Y, 2002, J ANDROL, V23, P854; Arrighi S, 2013, TISSUE CELL, V45, P140, DOI 10.1016/j.tice.2012.10.003; Bangs FK, 2015, NAT CELL BIOL, V17, P113, DOI 10.1038/ncb3091; Bassols J, 2004, THERIOGENOLOGY, V62, P929, DOI 10.1016/j.theriogenology.2003.12.015; Battistone MA, 2020, J CELL SCI, V133, DOI 10.1242/jcs.233239; Beak JY, 2007, J BONE MINER RES, V22, P1234, DOI 10.1359/JBMR.070503; Belleannee C, 2015, ASIAN J ANDROL, V17, P730, DOI 10.4103/1008-682X.155532; Bernet A, 2018, HUM REPROD, V33, P1829, DOI 10.1093/humrep/dey276; Campbell C, 2016, J CELL SCI, V129, P3832, DOI 10.1242/jcs.183541; Caspary T, 2007, DEV CELL, V12, P767, DOI 10.1016/j.devcel.2007.03.004; Cervantes S, 2010, P NATL ACAD SCI USA, V107, P10109, DOI 10.1073/pnas.0909900107; Clark AM, 2000, BIOL REPROD, V63, P1825, DOI 10.1095/biolreprod63.6.1825; Cyr Daniel G, 2011, Spermatogenesis, V1, P325; Da Silva N, 2015, ASIAN J ANDROL, V17, P591, DOI 10.4103/1008-682X.153540; Donnelly JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075225; Dores C, 2017, CELL TISSUE RES, V368, P215, DOI 10.1007/s00441-016-2523-6; Drummond ML, 2018, J CELL BIOL, V217, P3255, DOI 10.1083/jcb.201703196; El Eit R, 2019, CANCER-AM CANCER SOC, V125, P2818, DOI 10.1002/cncr.32130; Ferent J, 2019, CELL REP, V29, P3356, DOI 10.1016/j.celrep.2019.11.015; Firestone AJ, 2012, NATURE, V484, P125, DOI 10.1038/nature10936; Girardet L, 2019, ANDROLOGY-US, V7, P588, DOI 10.1111/andr.12650; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Haidl G, 2008, ANDROLOGIA, V40, P92, DOI 10.1111/j.1439-0272.2007.00819.x; Hassounah NB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068521; HEDGES S, 1992, INFECT IMMUN, V60, P1295, DOI 10.1128/IAI.60.4.1295-1301.1992; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Joiner AM, 2015, J NEUROSCI, V35, P13761, DOI 10.1523/JNEUROSCI.1708-15.2015; Jung M, 2012, MOL CELL BIOL, V32, P3938, DOI 10.1128/MCB.00413-12; KINZLER KW, 1990, MOL CELL BIOL, V10, P634, DOI 10.1128/MCB.10.2.634; Kong JH, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.166892; Laner-Plamberger S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075317; Larkins CE, 2011, MOL BIOL CELL, V22, P4694, DOI 10.1091/mbc.E10-12-0994; Li CX, 2004, ONCOGENE, V23, P1608, DOI 10.1038/sj.onc.1207273; Li JY, 2018, DEV BIOL, V441, P191, DOI 10.1016/j.ydbio.2018.07.003; Mariani LE, 2016, MOL BIOL CELL, V27, P3780, DOI 10.1091/mbc.E16-03-0189; Mozzetti S, 2012, BIOCHEM PHARMACOL, V84, P1409, DOI 10.1016/j.bcp.2012.08.019; Nielsen BS, 1996, GUT, V38, P414, DOI 10.1136/gut.38.3.414; Pettigrew CA, 2014, MECH DEVELOP, V131, P137, DOI 10.1016/j.mod.2013.12.002; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ryan KE, 2012, J BIOL CHEM, V287, P17905, DOI 10.1074/jbc.R112.356006; Satir P, 2010, J CELL SCI, V123, P499, DOI 10.1242/jcs.050377; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schuppe HC, 2017, DTSCH ARZTEBL INT, V114, P339, DOI 10.3238/arztebl.2017.0339; Shi L, 2018, CELL BIOL TOXICOL, V34, P39, DOI 10.1007/s10565-017-9401-1; Shi T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013054; Shum WWC, 2011, J ANDROL, V32, P576, DOI 10.2164/jandrol.111.012971; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; Smith KD, 2007, INT J BIOCHEM CELL B, V39, P1776, DOI 10.1016/j.biocel.2007.07.003; Song JP, 2017, HYPERTENSION, V70, P324, DOI 10.1161/HYPERTENSIONAHA.117.09584; SUN EL, 1979, AM J ANAT, V154, P27, DOI 10.1002/aja.1001540104; Sun L, 2010, BRAIN BEHAV IMMUN, V24, P220, DOI 10.1016/j.bbi.2009.09.016; Tariki M, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.27; Todoric J, 2011, DIABETES, V60, P1668, DOI 10.2337/db10-1628; Tong CK, 2014, P NATL ACAD SCI USA, V111, P12438, DOI 10.1073/pnas.1321425111; Tukachinsky H, 2012, CELL REPORTS, V2, P308, DOI 10.1016/j.celrep.2012.07.010; Turner TT, 2006, J ANDROL, V27, P225, DOI 10.2164/jandrol.05114; Turner TT, 2004, J ANDROL, V25, P514; Walter J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043338; Wong SY, 2009, NAT MED, V15, P1055, DOI 10.1038/nm.2011; Zhao P, 2014, J BIOL CHEM, V289, P5960, DOI 10.1074/jbc.M113.532234	63	12	12	3	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					7593	7609		10.1096/fj.202000328R	http://dx.doi.org/10.1096/fj.202000328R		APR 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32283570				2022-12-28	WOS:000526115800001
J	Carvalho, KF; Machado, TS; Garcia, BM; Zangirolamo, AF; Macabelli, CH; Sugiyama, FHC; Grejo, MP; Neto, JDA; Tostes, K; Ribeiro, FKS; Sarapiao, FD; Pandey, AK; Nociti, RP; Tizioto, P; Coutinho, LL; Meirelles, FV; Guimaraes, FEG; Pernas, L; Seneda, MM; Chiaratti, MR				Carvalho, Karen F.; Machado, Thiago S.; Garcia, Bruna M.; Zangirolamo, Amanda F.; Macabelli, Carolina H.; Sugiyama, Fabricia H. C.; Grejo, Mateus P.; Neto, J. Djaci Augusto; Tostes, Katiane; Ribeiro, Fernanda K. S.; Sarapiao, Fabiana D.; Pandey, Anand K.; Nociti, Ricardo P.; Tizioto, Polyana; Coutinho, Luiz Lehman; Meirelles, Flavio V.; Guimaraes, Francisco E. G.; Pernas, Lena; Seneda, Marcelo M.; Chiaratti, Marcos R.			Mitofusin 1 is required for oocyte growth and communication with follicular somatic cells	FASEB JOURNAL			English	Article						folliculogenesis; mitochondria; MFN1; MFN2; oocyte; PI3K-Akt	MITOCHONDRIAL DYNAMICS; MOUSE OOCYTES; MEIOTIC MATURATION; IN-VITRO; 2 MFN2; FUSION; ACTIVATION; METABOLISM; FOLLICLES; FERTILIZATION	Mitochondrial function, largely regulated by the dynamics of this organelle, is inextricably linked to the oocyte health. In comparison with most somatic cells, mitochondria in oocytes are smaller and rounder in appearance, suggesting limited fusion. The functional implications of this distinct morphology, and how changes in the mitochondrial shape translate to mitochondrial function in oogenesis is little understood. We, therefore, asked whether the pro-fusion proteins mitofusins 1 (MFN1) and 2 (MFN2) are required for the oocyte development. Here we show that oocyte-specific deletion of Mfn1, but not Mfn2, prevents the oocyte growth and ovulation due to a block in folliculogenesis. We pinpoint the loss of oocyte growth and ovulation to impaired PI3K-Akt signaling and disrupted oocyte-somatic cell communication. In support, the double loss of Mfn1 and Mfn2 partially rescues the impaired PI3K-Akt signaling and defects in oocyte development secondary to the single loss of Mfn1. Together, this work demonstrates that the mitochondrial function influences the cellular signaling during the oocyte development, and highlights the importance of distinct, nonredundant roles of MFN1 and MFN2 in oogenesis.	[Carvalho, Karen F.; Garcia, Bruna M.; Macabelli, Carolina H.; Sugiyama, Fabricia H. C.; Grejo, Mateus P.; Neto, J. Djaci Augusto; Tostes, Katiane; Ribeiro, Fernanda K. S.; Pandey, Anand K.; Chiaratti, Marcos R.] Univ Fed Sao Carlos, Departamento Genet & Evolucao, Rod Washington Luis Km 235, BR-13565905 Sao Carlos, SP, Brazil; [Machado, Thiago S.; Meirelles, Flavio V.; Chiaratti, Marcos R.] Univ Sao Paulo, Fac Med Vet & Zootecnia, Sao Paulo, Brazil; [Zangirolamo, Amanda F.; Sarapiao, Fabiana D.; Seneda, Marcelo M.] Univ Estadual Londrina, Natl Inst Sci & Technol Dairy Prod Chain INCT LEI, Londrina, Parana, Brazil; [Pandey, Anand K.] Lala Lajpat Rai Univ Vet & Anim Sci, Coll et Sci, Hisar, Haryana, India; [Nociti, Ricardo P.; Meirelles, Flavio V.] Univ Sao Paulo, Fac Zootecnia & Engn Alimentos, Pirassununga, Brazil; [Tizioto, Polyana] NGS Solucoes Genom, Piracicaba, Brazil; [Coutinho, Luiz Lehman] Univ Sao Paulo, Escola Super Agr Luiz de Queiroz, Piracicaba, Brazil; [Guimaraes, Francisco E. G.] Univ Sao Paulo, Inst Fis Sao Carlos, Sao Carlos, Brazil; [Pernas, Lena] Max Planck Inst Biol Ageing, Cologne, Germany	Universidade Federal de Sao Carlos; Universidade de Sao Paulo; Universidade Estadual de Londrina; Lala Lajpat Rai University of Veterinary & Animal Sciences; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Max Planck Society	Chiaratti, MR (corresponding author), Univ Fed Sao Carlos, Departamento Genet & Evolucao, Rod Washington Luis Km 235, BR-13565905 Sao Carlos, SP, Brazil.	marcos.chiaratti@ufscar.br	Meirelles, Flavio V/B-5048-2010; Coutinho, Luiz L/C-8455-2012; Seneda, Marcelo/AAP-9031-2020; Chiaratti, Marcos/AAJ-3842-2021; Chiaratti, Marcos R/C-2727-2012	Meirelles, Flavio V/0000-0003-0372-4920; Coutinho, Luiz L/0000-0002-7266-8881; Chiaratti, Marcos R/0000-0001-8805-9469; Perecin Nociti, Ricardo/0000-0002-0831-5264; Martins Garcia, Bruna/0000-0002-2257-9370; Cavicchioli Sugiyama, Fabricia Heloisa/0000-0003-3964-7496; PANDEY, Dr. ANAND KUMAR/0000-0002-0747-5282	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2012/50231-6, 2017/058992, 2017/04372-0, 2016/11935-9, 2016/11942-5, 2016/07868-4, 2018/061193, 2009/54035-4, 2013/08135-2]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [001]; MCTI | Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [130496/2018-9, 472507/2012-5]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); MCTI | Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF))	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Grant/Award Number: 2012/50231-6, 2017/058992, 2017/04372-0, 2016/11935-9, 2016/11942-5, 2016/07868-4, 2018/061193, 2009/54035-4 and 2013/08135-2; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Grant/Award Number: Finance Code 001; MCTI | Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Grant/Award Number: 130496/2018-9 and 472507/2012-5	Adhikari D, 2012, PLOS ONE, V7, P1; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bradley J, 2019, INT J DEV BIOL, V63, P93, DOI 10.1387/ijdb.180355ks; CARROLL J, 1994, DEVELOPMENT, V120, P3507; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Chen KH, 2004, NAT CELL BIOL, V6, P872, DOI 10.1038/ncb1161; Chen KH, 2014, FASEB J, V28, P382, DOI 10.1096/fj.13-230037; Chiaratti MR, 2018, CELL BIOL INT, V42, P711, DOI 10.1002/cbin.10947; Chiaratti MR, 2011, REPROD BIOMED ONLINE, V22, P172, DOI 10.1016/j.rbmo.2010.10.011; Clarke HJ, 2018, WIRES DEV BIOL, V7, DOI 10.1002/wdev.294; Collado-Fernandez E, 2012, INT J DEV BIOL, V56, P799, DOI 10.1387/ijdb.120140ec; Coticchio G, 2015, HUM REPROD UPDATE, V21, P427, DOI 10.1093/humupd/dmv011; de Brito OM, 2009, MITOCHONDRION, V9, P222, DOI 10.1016/j.mito.2009.02.005; de Vries WN, 2000, GENESIS, V26, P110, DOI 10.1002/(SICI)1526-968X(200002)26:2<110::AID-GENE2>3.0.CO;2-8; Dietrich MO, 2013, CELL, V155, P188, DOI 10.1016/j.cell.2013.09.004; Dong JW, 1996, NATURE, V383, P531, DOI 10.1038/383531a0; El-Hayek S, 2018, METHODS MOL BIOL, V1818, P1, DOI 10.1007/978-1-4939-8603-3_1; Eppig JJ, 1996, BIOL REPROD, V54, P197, DOI 10.1095/biolreprod54.1.197; Fragouli E, 2015, SEMIN REPROD MED, V33, P401, DOI 10.1055/s-0035-1567821; Jagarlamudi K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006186; Jansen RPS, 1998, MOL CELL ENDOCRINOL, V145, P81, DOI 10.1016/S0303-7207(98)00173-7; Johnson MT, 2007, BIOL REPROD, V77, P2, DOI 10.1095/biolreprod.106.059899; Knight PG, 2006, REPRODUCTION, V132, P191, DOI 10.1530/rep.1.01074; Li C, 2013, FREE RADICAL BIO MED, V60, P29, DOI 10.1016/j.freeradbiomed.2013.01.013; Li J, 2010, P NATL ACAD SCI USA, V107, P10280, DOI 10.1073/pnas.1001198107; Liu Q, 2016, SCI REP-UK, V6, DOI 10.1038/srep30561; Liu XM, 2016, ONCOTARGET, V7, P1155, DOI 10.18632/oncotarget.6713; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma L, 2015, ONCOL LETT, V10, P3816, DOI 10.3892/ol.2015.3748; Macabelli CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093287; Machado TS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133650; Mishra P, 2014, NAT REV MOL CELL BIO, V15, P634, DOI 10.1038/nrm3877; Motta P M, 2000, Hum Reprod, V15 Suppl 2, P129; Nagy A., 2003, MANIPULATING MOUSE E, P764; Papanicolaou KN, 2012, CIRC RES, V111, P1012, DOI 10.1161/CIRCRESAHA.112.274142; PEDERSEN T, 1968, J REPROD FERTIL, V17, P555, DOI 10.1530/jrf.0.0170555; Ramos ES, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008085; Reddy P, 2008, SCIENCE, V319, P611, DOI 10.1126/science.1152257; Reynier P, 2001, MOL HUM REPROD, V7, P425, DOI 10.1093/molehr/7.5.425; Santos TA, 2006, FERTIL STERIL, V85, P584, DOI 10.1016/j.fertnstert.2005.09.017; Schneeberger M, 2013, CELL, V155, P172, DOI 10.1016/j.cell.2013.09.003; Schrepfer E, 2016, MOL CELL, V61, P683, DOI 10.1016/j.molcel.2016.02.022; Sebastian D, 2016, EMBO J, V35, P1677, DOI 10.15252/embj.201593084; Sebastian D, 2012, P NATL ACAD SCI USA, V109, P5523, DOI 10.1073/pnas.1108220109; Su YQ, 2009, SEMIN REPROD MED, V27, P32, DOI 10.1055/s-0028-1108008; Sugiura K, 2007, DEVELOPMENT, V134, P2593, DOI 10.1242/dev.006882; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Udagawa O, 2014, CURR BIOL, V24, P2451, DOI 10.1016/j.cub.2014.08.060; VANBLERKOM J, 1995, HUM REPROD, V10, P415, DOI 10.1093/oxfordjournals.humrep.a135954; Wai T, 2010, BIOL REPROD, V83, P52, DOI 10.1095/biolreprod.109.080887; Wakai T, 2014, MOL HUM REPROD, V20, P1090, DOI 10.1093/molehr/gau064; WASSARMAN PM, 1978, J MORPHOL, V156, P209, DOI 10.1002/jmor.1051560206; Yu YS, 2010, J CELL PHYSIOL, V224, P672, DOI 10.1002/jcp.22171; Zeng HT, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.118471; Zhang H, 2015, HUM REPROD UPDATE, V21, P779, DOI 10.1093/humupd/dmv037; Zhang H, 2014, CURR BIOL, V24, P2501, DOI 10.1016/j.cub.2014.09.023; Zhang JH, 2016, SCI REP-UK, V6, DOI 10.1038/srep30970; Zhao N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125680	61	15	16	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					7644	7660		10.1096/fj.201901761R	http://dx.doi.org/10.1096/fj.201901761R		APR 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32281181				2022-12-28	WOS:000526944600001
J	Hung, YW; Wang, Y; Lee, SL				Hung, Yu-Wen; Wang, Yun; Lee, Sheau-Ling			DPP-4 inhibitor reduces striatal microglial deramification after sensorimotor cortex injury induced by external force impact	FASEB JOURNAL			English	Article						controlled cortical impact; dorsolateral striatum; microglial ramification; sitagliptin; traumatic brain injury; vildagliptin	DIPEPTIDYL PEPTIDASE-4 INHIBITOR; BRAIN MITOCHONDRIAL-FUNCTION; TYPE-2 DIABETES-MELLITUS; COGNITIVE DEFICITS; RAT MODEL; VILDAGLIPTIN; SITAGLIPTIN; NEURODEGENERATION; POLYPEPTIDE; RELEASE	Dipeptidyl peptidase-4 inhibitors (or gliptins), a class of antidiabetic drugs, have recently been shown to have protective actions in the central nervous system. Their cellular and molecular mechanisms responsible for these effects are largely unknown. In the present study, two structurally different gliptins, sitagliptin and vildagliptin, were examined for their therapeutic actions in a controlled cortical impact (CCI) model of moderate traumatic brain injury (TBI) in mice. Early post-CCI treatment with sitagliptin, but not vildagliptin, significantly reduced body asymmetry, locomotor hyperactivity, and brain lesion volume. Sitagliptin attenuated post-CCI microglial deramification in the ipsilateral dorsolateral (DL) striatum, while vildagliptin had no effect. Sitagliptin also reduced striatal expression of galectin-3 and monocyte chemoattractant protein 1(MCP-1), and increased the cortical and striatal levels of the anti-inflammatory cytokine IL-10 on the ipsilateral side. These data support a differential protective effect of sitagliptin against TBI, possibly mediated by an anti-inflammatory effect in striatum to preserve connective network. Both sitagliptin and vildagliptin produced similar increases of active glucagon-like peptide-1 (GLP-1) in blood and brain. Increasing active GLP-1 may not be the sole molecular mechanisms for the neurotherapeutic effect of sitagliptin in TBI.	[Hung, Yu-Wen; Lee, Sheau-Ling] Natl Hlth Res Inst, Inst Cellular & Syst Med, 35 Keyan Rd, Zhunan Town 35053, Miaoli County, Taiwan; [Wang, Yun] Natl Hlth Res Inst, Ctr Neuropsychiat Res, Zhunan Town, Miaoli County, Taiwan	National Health Research Institutes - Taiwan; National Health Research Institutes - Taiwan	Lee, SL (corresponding author), Natl Hlth Res Inst, Inst Cellular & Syst Med, 35 Keyan Rd, Zhunan Town 35053, Miaoli County, Taiwan.	sllee@nhri.org.tw			National Health Research Institutes (NHRI) [06A1-CSPP10-014,07A1-CSPP10-014]; Taiwan Central Govement ST [06A1-NPSP06-034,07A1-NPSP11-034]	National Health Research Institutes (NHRI)(National Health Research Institutes - Taiwan); Taiwan Central Govement ST	National Health Research Institutes (NHRI), Grant/Award Number: 06A1-CSPP10-014,07A1-CSPP10-014; Taiwan Central Govement S&T, Grant/Award Number: 06A1-NPSP06-034,07A1-NPSP11-034	Abdelsalam RM, 2015, J NEUROCHEM, V133, P700, DOI 10.1111/jnc.13087; Ahren B, 2005, ENDOCRINOLOGY, V146, P2055, DOI 10.1210/en.2004-1174; Albert-Weissenberger Christiane, 2010, Exp Transl Stroke Med, V2, P16, DOI 10.1186/2040-7378-2-16; Atkins S, 2007, J PERIPHER NERV SYST, V12, P269, DOI 10.1111/j.1529-8027.2007.00148.x; Berger J. P., 2018, DIAB METAB, V1, pe2; Bonsack F, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00157; BORLONGAN CV, 1995, J NEUROSCI, V15, P5372; Brantley EC, 2010, TRANSL ONCOL, V3, P380, DOI 10.1593/tlo.10208; Budinich CS, 2013, PHARMACOL BIOCHEM BE, V108, P66, DOI 10.1016/j.pbb.2013.04.001; Burguillos MA, 2015, CELL REP, V10, P1626, DOI 10.1016/j.celrep.2015.02.012; Chen DY, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001128; Chen SC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28449-z; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Darsalia V, 2013, DIABETES, V62, P1289, DOI 10.2337/db12-0988; De Simoni S, 2018, BRAIN, V141, P148, DOI 10.1093/brain/awx309; DellaValle B, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00450; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Gault VA, 2015, DIABETES OBES METAB, V17, P403, DOI 10.1111/dom.12432; Gupta Vishal, 2011, Indian J Endocrinol Metab, V15, P298, DOI 10.4103/2230-8210.85583; Haage V, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0665-y; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Homsi S, 2010, J NEUROTRAUM, V27, P911, DOI 10.1089/neu.2009.1223; Ingberg E, 2015, BMC NEUROSCI, V16, DOI 10.1186/s12868-015-0189-8; Isik AT, 2017, DIABETES RES CLIN PR, V123, P192, DOI 10.1016/j.diabres.2016.12.010; Jain S, 2015, PHYSIOL BEHAV, V152, P182, DOI 10.1016/j.physbeh.2015.09.007; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kimbler DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041229; Kosaraju J, 2013, J PHARM PHARMACOL, V65, P1773, DOI 10.1111/jphp.12148; Kosaraju J, 2013, NEUROPHARMACOLOGY, V72, P291, DOI 10.1016/j.neuropharm.2013.04.008; Lankas GR, 2005, DIABETES, V54, P2988, DOI 10.2337/diabetes.54.10.2988; Li YZ, 2009, P NATL ACAD SCI USA, V106, P1285, DOI 10.1073/pnas.0806720106; Malkesman O, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00157; Manley NC, 2007, BRAIN RES, V1182, P138, DOI 10.1016/j.brainres.2007.08.092; MENTLEIN R, 1993, EUR J BIOCHEM, V214, P829, DOI 10.1111/j.1432-1033.1993.tb17986.x; Mentlein R, 1999, REGUL PEPTIDES, V85, P9, DOI 10.1016/S0167-0115(99)00089-0; Morrison H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13581-z; Morrison HW, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-4; Ogier M, 2017, J NEUROTRAUM, V34, P1645, DOI 10.1089/neu.2016.4741; Pintana H, 2013, J ENDOCRINOL, V218, P1, DOI 10.1530/JOE-12-0521; Pipatpiboon N, 2013, EUR J NEUROSCI, V37, P839, DOI 10.1111/ejn.12088; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Reichert F, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00090; Russell S, 2013, INT J CLIN PHARM-NET, V35, P159, DOI 10.1007/s11096-012-9729-9; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Siew JJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11441-0; Smith C, 2013, NEUROPATH APPL NEURO, V39, P654, DOI 10.1111/nan.12008; Stamatovic SM, 2005, J CEREBR BLOOD F MET, V25, P593, DOI 10.1038/sj.jcbfm.9600055; Tsai TH, 2015, J HYPERTENS, V33, P1001, DOI 10.1097/HJH.0000000000000529; Ewen T, 2013, CELL BIOCHEM BIOPHYS, V66, P337, DOI 10.1007/s12013-012-9453-z; Tziomalos K, 2015, DIABETES VASC DIS RE, V12, P463, DOI 10.1177/1479164115597867; Ujhelyi J, 2014, REGUL PEPTIDES, V194, P23, DOI 10.1016/j.regpep.2014.09.006; Van Waes V, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00021; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Viggiano D, 2008, BEHAV BRAIN RES, V194, P1, DOI 10.1016/j.bbr.2008.06.033; Willuhn I, 2003, EUR J NEUROSCI, V17, P1053, DOI 10.1046/j.1460-9568.2003.02525.x; Yip PK, 2017, SCI REP-UK, V7, DOI 10.1038/srep41689; Young K, 2018, JOVE-J VIS EXP, DOI 10.3791/57648; Yu FPS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20052-6	62	5	5	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6950	6964		10.1096/fj.201902818R	http://dx.doi.org/10.1096/fj.201902818R		APR 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32246809				2022-12-28	WOS:000523598500001
J	Nogimura, D; Mizushige, T; Taga, Y; Nagai, A; Shoji, S; Azuma, N; Kusubata, M; Adachi, SI; Yoshizawa, F; Kabuyama, Y				Nogimura, Dai; Mizushige, Takafumi; Taga, Yuki; Nagai, Akitoshi; Shoji, Sayo; Azuma, Nao; Kusubata, Masashi; Adachi, Shin-ichi; Yoshizawa, Fumiaki; Kabuyama, Yukihito			Prolyl-hydroxyproline, a collagen-derived dipeptide, enhances hippocampal cell proliferation, which leads to antidepressant-like effects in mice	FASEB JOURNAL			English	Article						corticosterone; depression; mental stress; neural stem cell; peptide	HUMAN BLOOD; NEUROTROPHIC FACTOR; VI PROTECTS; NGF LEVELS; NEUROGENESIS; DEPRESSION; PEPTIDES; IDENTIFICATION; BDNF; QUANTIFICATION	Depression has been a mental health issue worldwide. We previously reported that ginger-degraded collagen hydrolysate (GDCH) suppressed depression-like behavior in mice. Furthermore, prolyl-hydroxyproline (PO) and hydroxyprolyl-glycine (OG) were detected in the circulating blood after the oral administration of GDCH. In the present study, PO, but not OG, was detected in the cerebrospinal fluid of rats after the oral administration of GDCH, suggesting that PO is transported from blood to the brain. We then investigated the effects of PO and OG on the depression-like behavior of mice. The oral administration of PO significantly decreased depression-like behavior in the forced swim test. OG had no antidepressant-like effect. In addition, proline and hydroxyproline, components of PO, also had no antidepressant-like effect after their oral administration. PO significantly increased the gene expression of brain-derived neurotrophic factor and nerve growth factor in the hippocampus, and promoted the proliferation of neural progenitor cells in vivo and in vitro. PO also increased the dopamine concentration in the prefrontal cortex. Thus, PO-dependent regulation of neurotrophic function and neurotransmitter may be the mechanism for antidepressant-like behavior. Together, these results demonstrate that PO is an antidepressant bioactive peptide accompanying the proliferation of hippocampal neural progenitor cells.	[Nogimura, Dai; Mizushige, Takafumi; Nagai, Akitoshi; Shoji, Sayo; Azuma, Nao; Yoshizawa, Fumiaki; Kabuyama, Yukihito] Utsunomiya Univ, Sch Agr, 350 Minemachi, Utsunomiya, Tochigi 3218505, Japan; [Taga, Yuki; Kusubata, Masashi] Nippi Res Inst Biomatrix, Toride, Ibaraki, Japan; [Adachi, Shin-ichi] Utsunomiya Univ, Ctr Biosci Res & Educ, Utsunomiya, Tochigi, Japan; [Adachi, Shin-ichi] Kagoshima Womens Coll, Dept Human Life & Sci, 6-9 Korai Cho, Kagoshima, Kagoshima 8908565, Japan	Utsunomiya University; Utsunomiya University	Mizushige, T (corresponding author), Utsunomiya Univ, Sch Agr, 350 Minemachi, Utsunomiya, Tochigi 3218505, Japan.	mizushige@cc.utsunomiya-u.ac.jp	Taga, Yuki/I-2781-2019	Taga, Yuki/0000-0001-9100-758X	MEXT | Japan Society for the Promotion of Science (JSPS) [16K07731, 19K05927]	MEXT | Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	MEXT | Japan Society for the Promotion of Science (JSPS), Grant/Award Number: 16K07731 and 19K05927	Abdanipour A, 2015, NEUROL RES, V37, P117, DOI 10.1179/1743132814Y.0000000431; Anacker C, 2013, NEUROPSYCHOPHARMACOL, V38, P872, DOI 10.1038/npp.2012.253; Anacker C, 2011, PSYCHONEUROENDOCRINO, V36, P415, DOI 10.1016/j.psyneuen.2010.03.007; Cescon M, 2016, AGING-US, V8, P1083, DOI 10.18632/aging.100924; Chen TJ, 2016, J PHOTOCH PHOTOBIO B, V165, P34, DOI 10.1016/j.jphotobiol.2016.10.015; Cheng IH, 2011, NEUROSCIENCE, V183, P178, DOI 10.1016/j.neuroscience.2011.03.057; Cheng JS, 2009, NAT NEUROSCI, V12, P119, DOI 10.1038/nn.2240; Dailly E, 2004, FUND CLIN PHARMACOL, V18, P601, DOI 10.1111/j.1472-8206.2004.00287.x; Deltheil T, 2008, NEUROPHARMACOLOGY, V55, P1006, DOI 10.1016/j.neuropharm.2008.08.001; Eisch AJ, 2012, SCIENCE, V338, P72, DOI 10.1126/science.1222941; Filho CB, 2015, NEUROSCIENCE, V289, P367, DOI 10.1016/j.neuroscience.2014.12.048; Furukawa-Hibi Y, 2011, BEHAV BRAIN RES, V220, P271, DOI 10.1016/j.bbr.2011.02.003; Hanson ND, 2011, NEUROPSYCHOPHARMACOL, V36, P2589, DOI 10.1038/npp.2011.220; Hashimoto K, 2004, BRAIN RES REV, V45, P104, DOI 10.1016/j.brainresrev.2004.02.003; Hill AS, 2015, NEUROPSYCHOPHARMACOL, V40, P2368, DOI 10.1038/npp.2015.85; Hung YY, 2019, CELLS, V2, P9; Ichikawa S, 2010, INT J FOOD SCI NUTR, V61, P52, DOI 10.3109/09637480903257711; Iwai K, 2005, J AGR FOOD CHEM, V53, P6531, DOI 10.1021/jf050206p; Lagace DC, 2010, P NATL ACAD SCI USA, V107, P4436, DOI 10.1073/pnas.0910072107; Li HW, 2017, INT IMMUNOPHARMACOL, V53, P24, DOI 10.1016/j.intimp.2017.10.001; MacQueen GM, 2003, P NATL ACAD SCI USA, V100, P1387, DOI 10.1073/pnas.0337481100; MAISONPIERRE PC, 1990, NEURON, V5, P501, DOI 10.1016/0896-6273(90)90089-X; Malberg JE, 2005, CURR PHARM DESIGN, V11, P145, DOI 10.2174/1381612053382223; Mizushige T, 2019, J NUTR SCI VITAMINOL, V65, P251, DOI 10.3177/jnsv.65.251; Nasser A, 2014, NEUROSCI RES, V89, P44, DOI 10.1016/j.neures.2014.08.015; Onouchi T, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-21; Osawa Y, 2018, BIOMED RES-TOKYO, V39, P1, DOI 10.2220/biomedres.39.1; Park SC, 2019, CELL TISSUE RES, V377, P95, DOI 10.1007/s00441-019-03043-5; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Ricard-Blum S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004978; Sahay A, 2007, NAT NEUROSCI, V10, P1110, DOI 10.1038/nn1969; Shigemura Y, 2011, FOOD CHEM, V129, P1019, DOI 10.1016/j.foodchem.2011.05.066; Shinohara R, 2018, MOL PSYCHIATR, V23, P1717, DOI 10.1038/mp.2017.177; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; Sugihara F, 2012, J BIOSCI BIOENG, V113, P202, DOI 10.1016/j.jbiosc.2011.09.024; Taga Y, 2017, J AGR FOOD CHEM, V65, P9514, DOI 10.1021/acs.jafc.7b03714; Taga Y, 2016, J AGR FOOD CHEM, V64, P2962, DOI 10.1021/acs.jafc.6b00609; Taga Y, 2014, J AGR FOOD CHEM, V62, P12096, DOI 10.1021/jf5039597; Tanaka M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42099-9; Tanti A, 2010, BRIT J PHARMACOL, V159, P1187, DOI 10.1111/j.1476-5381.2009.00585.x; Tsutsui-Kimura I, 2017, J PHARMACOL SCI, V134, P181, DOI 10.1016/j.jphs.2017.06.004; Tunc-Ozcan E, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11641-8; Tzeng WY, 2013, PSYCHONEUROENDOCRINO, V38, P425, DOI 10.1016/j.psyneuen.2012.07.002; Uppal A, 2010, CURR PHARM DESIGN, V16, P4243, DOI 10.2174/138161210794519110; Xian YF, 2019, FASEB J, V33, P10393, DOI 10.1096/fj.201802743RR; Yamamoto Y, 2015, NEUROPEPTIDES, V51, P25, DOI 10.1016/j.npep.2015.04.002; Zague V, 2011, J MED FOOD, V14, P618, DOI 10.1089/jmf.2010.0085	47	10	10	1	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5715	5723		10.1096/fj.201902871R	http://dx.doi.org/10.1096/fj.201902871R		MAR 2020	9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32115749	hybrid			2022-12-28	WOS:000517933300001
J	Zhang, TT; Zhou, JW; Yue, HD; Du, CY; Xiao, ZT; Zhao, WD; Li, N; Wang, XD; Liu, XZ; Li, YJ; Geng, XW; Zhang, YW; Li, L; Tian, J				Zhang, Tingting; Zhou, Jianwei; Yue, Haodi; Du, Chunyan; Xiao, Ziting; Zhao, Wendi; Li, Na; Wang, Xiangdong; Liu, Xiaozhuan; Li, Yanjun; Geng, Xiwen; Zhang, Yuwei; Li, Li; Tian, Jian			Glycogen synthase kinase-3 beta promotes radiation-induced lung fibrosis by regulating beta-catenin/lin28 signaling network to determine type II alveolar stem cell transdifferentiation state	FASEB JOURNAL			English	Article						cell differentiation state; GSK-3 beta/TGF-beta 1/beta-catenin; lin28/let-7 relative ratios; radiation-induced lung fibrosis; type II alveolar epithelial stem cells	INHIBITION; LIN28; MAINTENANCE; SURFACTANT; ACTIVATION; EXPRESSION; REPAIR; ROLES	The role of type II alveolar epithelial stem cells (AEC II) for alveolar repair in radiation-induced lung fibrosis (RILF) remains largely unknown, mainly because of AEC II phenotype's spontaneous change in vitro. Cell differentiation status is determined by Lin28 and let-7 miRNAs in see-saw-pattern. Lin28, a repressor of let-7 and a stem cell marker, is activated by beta-catenin. The expression of beta-catenin is regulated by GSK-3 beta/TGF-beta 1 signaling. To understand the true role of AEC II in RILF, we freshly isolated primary AEC II directly from thoracically irradiated lungs. We then explored the expressions of cell phenotype markers and differentiation regulators in these isolated AEC II to analyze the correlation between GSK-3 beta/TGF-beta 1/beta-catenin signaling pathway, lin28/let-7 balance, and AEC II phenotypes at different injury phases following irradiation. Results showed that isolated single primary cells displayed AEC II ultrastructural features and proSP-C positive. The gene expressions of prosp-c (an AEC II biomarker) and hopx (an AEC I marker) significantly increased in isolated AEC II during injury repair phase (P < .05) but decreased at end-stage of injury, while mesenchymal markers increased in both isolated AEC II and irradiated lungs. mRNA levels of gsk-3 beta, tgf-beta 1, and beta-catenin increased in all irradiated AEC II, but more pronounced in the second half of injury phase (P < .001). Similarly, the expression of lin28 was also significantly elevated in isolated AEC II at the late phase (P < .001). Four let-7 miRNAs were significantly upregulated in all irradiated AEC II groups (P < .001). The time-dependent and highly consistent uptrends for four lin28/let-7 ratios in sorted AEC II contrasted to downtrends in irradiated lungs. In conclusion, RILF occurred when GSK-3 beta/TGF-beta 1 signaling increased beta-catenin levels, which led to the augmentation of AEC II population by elevated lin28/let-7 ratio and the transcription of profibrotic cytokines and factors, thereby inducing AEC II to undergo transdifferentiation into mesenchymal cells.	[Zhang, Tingting; Yue, Haodi; Wang, Xiangdong; Liu, Xiaozhuan; Li, Yanjun; Geng, Xiwen] Henan Univ, Peoples Hosp Zhengzhou Univ, Henan Prov Peoples Hosp, Ctr Clin Single Cell Biomed,Sch Clin Med, Zhengzhou, Peoples R China; [Zhou, Jianwei; Xiao, Ziting; Zhao, Wendi; Tian, Jian] Henan Univ, Zhengzhou Univ, Henan Prov Peoples Hosp, Dept Oncol,Sch Clin Med,Peoples Hosp, 7 Weiwu Rd, Zhengzhou 450003, Henan, Peoples R China; [Du, Chunyan] Zhengzhou Univ, Lab Anim Ctr, Sch Med Sci, Zhengzhou, Peoples R China; [Li, Na; Zhang, Yuwei] Henan Univ, Zhengzhou Univ, Henan Prov Peoples Hosp, Henan Prov Key Lab Kidney Dis & Immunol,Peoples H, Zhengzhou, Peoples R China; [Li, Li] Henan Univ, Zhengzhou Univ, Henan Prov Peoples Hosp, Dept Sci Res & Discipline Construct,Peoples Hosp, Zhengzhou, Peoples R China	Henan University; Zhengzhou University; Henan University; Zhengzhou University; Zhengzhou University; Henan University; Zhengzhou University; Henan University; Zhengzhou University	Tian, J (corresponding author), Henan Univ, Zhengzhou Univ, Henan Prov Peoples Hosp, Dept Oncol,Sch Clin Med,Peoples Hosp, 7 Weiwu Rd, Zhengzhou 450003, Henan, Peoples R China.	jacktian12@gmail.com			National Natural Science Foundation of China [81673097, 81801547]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China, Grant/Award Number: 81673097 and 81801547	Almeida C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053628; Baarsma HA, 2013, BRIT J PHARMACOL, V169, P590, DOI 10.1111/bph.12098; Cai WY, 2013, J CELL SCI, V126, P2877, DOI 10.1242/jcs.123810; Christofidou-Solomidou M, 2017, RADIAT RES, V188, P491, DOI 10.1667/RR14686.1; Dickey JS, 2011, RADIAT ENVIRON BIOPH, V50, P491, DOI 10.1007/s00411-011-0386-5; DOBBS LG, 1990, AM J PHYSIOL, V258, pL134, DOI 10.1152/ajplung.1990.258.4.L134; Fehrenbach H, 2001, RESP RES, V2, P33, DOI 10.1186/rr36; Gonzales LW, 2001, PEDIATR PATHOL MOL M, V20, P387, DOI 10.1080/15513810109168622; Guo R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066330; Henderson WR, 2010, P NATL ACAD SCI USA, V107, P14309, DOI 10.1073/pnas.1001520107; Jacobs KM, 2012, INT J CELL BIOL, V35, P1052; Liu H, 2013, ACTA PHARMACOL SIN, V34, P26; Liu XM, 2006, METHOD ENZYMOL, V419, P285, DOI 10.1016/S0076-6879(06)19012-6; Martin M, 2000, INT J RADIAT ONCOL, V47, P277, DOI 10.1016/S0360-3016(00)00435-1; McDaniel K, 2016, AM J PHYSIOL-GASTR L, V310, pG757, DOI 10.1152/ajpgi.00080.2016; Nam Y, 2011, CELL, V147, P1080, DOI 10.1016/j.cell.2011.10.020; Ota C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31214-x; Pandit KV, 2010, AM J RESP CRIT CARE, V182, P220, DOI 10.1164/rccm.200911-1698OC; Rice WR, 2002, AM J PHYSIOL-LUNG C, V283, pL256, DOI 10.1152/ajplung.00302.2001; Rogel MR, 2011, FASEB J, V25, P3873, DOI 10.1096/fj.10-170795; Selman M, 2020, CELL SIGNAL, V66, DOI 10.1016/j.cellsig.2019.109482; Shi J, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/3520581; Simone NL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006377; Singh SP, 2015, DIS MODEL MECH, V8, P931, DOI 10.1242/dmm.020511; Teo JL, 2010, ADV DRUG DELIVER REV, V62, P1149, DOI 10.1016/j.addr.2010.09.012; Tsialikas J, 2015, DEVELOPMENT, V142, P2397, DOI 10.1242/dev.117580; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; Yamashita T, 2007, CANCER RES, V67, P10831, DOI 10.1158/0008-5472.CAN-07-0908	28	4	5	2	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12466	12480		10.1096/fj.202001518	http://dx.doi.org/10.1096/fj.202001518		JUL 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32706136	hybrid			2022-12-28	WOS:000556097100001
J	Shi, LX; Chen, Q; Ge, XF				Shi, Lixia; Chen, Qing; Ge, Xiaofen			Long intergenic non-coding RNA 00337 confers progression of esophageal cancer by mediating microrna-145-dependent fscn1	FASEB JOURNAL			English	Article						esophageal cancer; FSCN1; invasion; long intergenic non-coding RNA; microRNA-145; migration; proliferation	SQUAMOUS-CELL CARCINOMA; EXPRESSION; PROLIFERATION; MIR-145; INVASION; ASSOCIATION; METASTASIS; MIGRATION; EPIDEMIOLOGY; HOTAIR	Long non-coding RNAs (lncRNAs) have been highlighted as prominent genetic modulators involved in multiple important biological processes of cancer cells, especially in esophageal cancer (EC). We tried to elucidate the potential role of LINC00337 in the progression of EC. Based on TCGA database analysis and Reverse transcription quantitative polymerase chain reaction determination, high expression of LINC00337 and FSCN1 was detected, while miR-145 exhibited a low expression in EC. LINC00337 was identified to bind to miR-145 to impair the miR-145-dependent FSCN1 inhibition. The underlying regulatory mechanisms were evaluated by transfection with LINC00337 overexpression plasmid, siRNA against LINC00337, miR-145 mimic, or anta-miR-145. Downregulation of LINC00337 results in increased Bax level, decreased FSCN1, Bcl-2, VEGF, and p53 levels, in addition to diminished cell proliferation, migration, invasion and tumor growth, with accelerated cell apoptosis by upregulating miR-145. Taken together, the findings obtained provided evidence suggesting that LINC00337 acts as a tumor promoter in EC, providing insight and advancements for EC treatment.	[Shi, Lixia; Chen, Qing] Linyi Peoples Hosp, Dept Gen Surg, Linyi, Shandong, Peoples R China; [Ge, Xiaofen] Linyi Peoples Hosp, Infect Dis Clin, 27 East Sect Jiefang Rd, Linyi 276000, Shandong, Peoples R China		Ge, XF (corresponding author), Linyi Peoples Hosp, Infect Dis Clin, 27 East Sect Jiefang Rd, Linyi 276000, Shandong, Peoples R China.	tanchengwangyaping@163.com						Akanuma N, 2014, BRIT J CANCER, V110, P189, DOI 10.1038/bjc.2013.676; Cao W, 2017, ORAL ONCOL, V65, P94, DOI 10.1016/j.oraloncology.2016.12.017; Chiyomaru T, 2010, BRIT J CANCER, V102, P883, DOI 10.1038/sj.bjc.6605570; Cui XB, 2016, ONCOTARGET, V7, P1777, DOI 10.18632/oncotarget.6499; Fu CR, 2014, BIOCHEM BIOPH RES CO, V446, P1197, DOI 10.1016/j.bbrc.2014.03.087; Fuse M, 2011, INT J ONCOL, V38, P1093, DOI 10.3892/ijo.2011.919; Ge XS, 2013, CANCER SCI, V104, P1675, DOI 10.1111/cas.12296; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Hamano R, 2011, CLIN CANCER RES, V17, P3029, DOI 10.1158/1078-0432.CCR-10-2532; Han YH, 2013, J SURG ONCOL, V107, P555, DOI 10.1002/jso.23264; Hayashi Y, 2011, CANCER SCI, V102, P1228, DOI 10.1111/j.1349-7006.2011.01910.x; Hu B, 2019, AM J TRANSL RES, V11, P3238; Hu LW, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0123-z; Kano M, 2010, INT J CANCER, V127, P2804, DOI 10.1002/ijc.25284; Lei HW, 2017, ACTA BIOCH BIOPH SIN, V49, P588, DOI 10.1093/abbs/gmx047; Liang Y, 2017, BIOSCIENCE REP, V37, DOI 10.1042/BSR20171019; Liu R., 2012, PLOS ONE, V7, DOI DOI 10.1371/journal.pone.0033987; Mao WM, 2011, ASIAN PAC J CANCER P, V12, P2461; Murakami K, 2010, ONCOLOGY-BASEL, V78, P62, DOI 10.1159/000292362; Napier KJ, 2014, WORLD J GASTRO ONCOL, V6, P112, DOI 10.4251/wjgo.v6.i5.112; Ng SY, 2012, EMBO J, V31, P522, DOI 10.1038/emboj.2011.459; Ortiz CM, 2010, DIAGN PATHOL, V5, DOI 10.1186/1746-1596-5-41; Pu Q, 2016, THORAC CANCER, V7, P348, DOI 10.1111/1759-7714.12317; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rojo AI, 2012, FREE RADICAL BIO MED, V52, P473, DOI 10.1016/j.freeradbiomed.2011.11.003; Tan VY, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-52; Wang F, 2013, ONKOLOGIE, V36, P754, DOI 10.1159/000356978; Wang GY, 2014, ONCOL REP, V31, P1839, DOI 10.3892/or.2014.3047; Wang TY, 2015, TUMOR BIOL, V36, P9733, DOI 10.1007/s13277-015-3743-1; Wei W, 2015, MED SCI MONITOR, V21, P3016, DOI 10.12659/MSM.894640; Wu BL, 2011, WORLD J GASTROENTERO, V17, P79, DOI 10.3748/wjg.v17.i1.79; Wu C, 2011, NAT GENET, V43, P679, DOI 10.1038/ng.849; Wu H, 2015, ONCOGENE, V34, P4723, DOI 10.1038/onc.2014.400; Xue M, 2016, CANCER SCI, V107, P18, DOI 10.1111/cas.12844; Zhang F, 2014, CANCER LETT, V342, P121, DOI 10.1016/j.canlet.2013.08.037; Zhang YW, 2013, WORLD J GASTROENTERO, V19, P5598, DOI 10.3748/wjg.v19.i34.5598; Zheng XX, 2016, ONCOL LETT, V12, P2357, DOI 10.3892/ol.2016.5026	37	3	3	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					11431	11443		10.1096/fj.202000470	http://dx.doi.org/10.1096/fj.202000470		JUL 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32654289	Bronze			2022-12-28	WOS:000549276700001
J	Zhang, Y; Yang, X; Yan, WC; Li, R; Ye, Q; You, LJ; Xie, WH; Mo, K; Fu, RF; Wang, YX; Chen, YF; Hou, H; Yang, Y; Birnbaumer, L; Di, Q; Li, XJ				Zhang, Ye; Yang, Xue; Yan, Wenchao; Li, Rui; Ye, Qian; You, Linjun; Xie, Wenhao; Mo, Kun; Fu, Ruifeng; Wang, Yanxiang; Chen, Yufei; Hou, Hui; Yang, Yong; Birnbaumer, Lutz; Di, Qin; Li, Xianjing			Thymopentin improves the survival of septic mice by promoting the production of 15-deoxy-prostaglandin J2 and activating the PPAR gamma signaling pathway	FASEB JOURNAL			English	Article						15-d-PGJ2; macrophage; PPAR gamma; thymopentin; sepsis	RECEPTOR-GAMMA; MACROPHAGES; SYNTHASE; LIGANDS; SEPSIS; INJURY; QUANTIFICATION; IDENTIFICATION; POLARIZATION; INFLAMMATION	Sepsis, a systemic inflammatory response syndrome (SIRS) caused by infection, is a major public health concern with limited therapeutic options. Infection disturbs the homeostasis of host, resulting in excessive inflammation and immune suppression. This has prompted the clinical use of immunomodulators to balance host response as an alternative therapeutic strategy. Here, we report that Thymopentin (TP5), a synthetic immunomodulator pentapeptide (Arg-Lys-Asp-Val-Tyr) with an excellent safety profile in the clinic, protects mice against cecal ligation and puncture (CLP)-induced sepsis, as shown by improved survival rate, decreased level of pro-inflammatory cytokines and reduced ratios of macrophages and neutrophils in spleen and peritoneum. Regarding mechanism, TP5 changed the characteristics of LPS-stimulated macrophages by increasing the production of 15-deoxy-Delta(12.14)-prostaelandin J2 (15-d-PGJ2). In addition, the improved effect of TP5 on survival rates was abolished by the peroxisome proliferator-activated receptor gamma (PPAR gamma) antagonist GW9662. Our results uncover the mechanism of the TP5 protective effects on CLP-induced sepsis and shed light on the development of TP5 as a therapeutic strategy for lethal systemic inflammatory disorders.	[Zhang, Ye; Yang, Xue; Yan, Wenchao; Li, Rui; Ye, Qian; You, Linjun; Xie, Wenhao; Mo, Kun; Fu, Ruifeng; Wang, Yanxiang; Chen, Yufei; Hou, Hui; Yang, Yong; Li, Xianjing] China Pharmaceut Univ, State Key Lab Nat Med, Ctr New Drug Safety Evaluat & Res, Nanjing 210009, Peoples R China; [Birnbaumer, Lutz] Catholic Univ Argentina, Inst Biomed Res BIOMED, C1107AFF, Buenos Aires, DF, Argentina; [Di, Qin] Nanjing Sport Inst, Sch Sports & Hlth, Nanjing 210014, Peoples R China	China Pharmaceutical University; Nanjing Sport Institute	Li, XJ (corresponding author), China Pharmaceut Univ, State Key Lab Nat Med, Ctr New Drug Safety Evaluat & Res, Nanjing 210009, Peoples R China.; Birnbaumer, L (corresponding author), Catholic Univ Argentina, Inst Biomed Res BIOMED, C1107AFF, Buenos Aires, DF, Argentina.; Di, Q (corresponding author), Nanjing Sport Inst, Sch Sports & Hlth, Nanjing 210014, Peoples R China.	birnbau1@gmail.com; sindyshu@163.com; xjl@cpu.edu.cn			Basic Research Program of Jiangsu Province [BK20170732]; National Natural Science Foundation of China [81703562, 81571984, 81703563]	Basic Research Program of Jiangsu Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Basic Research Program of Jiangsu Province, Grant/Award Number: BK20170732; National Natural Science Foundation of China, Grant/Award Number: 81703562, 81571984 and 81703563	A-Gonzalez N, 2018, CELL IMMUNOL, V330, P151, DOI 10.1016/j.cellimm.2018.05.005; Baek SH, 2000, J IMMUNOL, V164, P6359, DOI 10.4049/jimmunol.164.12.6359; Bell-Parikh LC, 2003, J CLIN INVEST, V112, P945, DOI 10.1172/JCI200318012; Ghosn EEB, 2010, P NATL ACAD SCI USA, V107, P2568, DOI 10.1073/pnas.0915000107; Cao H, 2008, ANAL BIOCHEM, V372, P41, DOI 10.1016/j.ab.2007.08.041; Cassado AD, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00225; CHEN K, 2014, PPAR RES, V2014, DOI DOI 10.1155/2014/215631; Chen W, 2013, MOL PLANT, V6, P1769, DOI 10.1093/mp/sst080; Cheng SC, 2016, NAT IMMUNOL, V17, P406, DOI 10.1038/ni.3398; Collin M, 2004, CRIT CARE MED, V32, P826, DOI 10.1097/01.CCM.0000114821.25573.E7; Cuzzocrea S, 2003, BRIT J PHARMACOL, V140, P366, DOI 10.1038/sj.bjp.0705419; Cuzzocrea S, 2003, BRIT J PHARMACOL, V138, P678, DOI 10.1038/sj.bjp.0705077; da Silva HB, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00480; Deutschman CS, 2014, IMMUNITY, V40, P464, DOI 10.1016/j.immuni.2014.04.001; Dioszeghy V, 2008, J IMMUNOL, V181, P6514, DOI 10.4049/jimmunol.181.9.6514; Eloranta ML, 1999, SCAND J IMMUNOL, V49, P391; Fan YZ, 2006, BBA-MOL CELL RES, V1763, P1059, DOI 10.1016/j.bbamcr.2006.07.004; FITZPATRICK FA, 1983, J BIOL CHEM, V258, P1713; Fujimura N, 2000, AM J RESP CRIT CARE, V162, P2159, DOI 10.1164/ajrccm.162.6.9912144; Gandhi UH, 2011, J BIOL CHEM, V286, P27471, DOI 10.1074/jbc.M111.260547; Harmon GS, 2011, CHEM REV, V111, P6321, DOI 10.1021/cr2001355; Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552; Kalbitz M, 2016, FASEB J, V30, P3997, DOI 10.1096/fj.201600728R; Kansanen E, 2009, FREE RADICAL BIO MED, V47, P1310, DOI 10.1016/j.freeradbiomed.2009.06.030; Kim SJ, 2016, BRIT J PHARMACOL, V173, P1045, DOI 10.1111/bph.13414; Li XS, 2015, 2015 INTERNATIONAL CONFERENCE ON INDUSTRIAL INFORMATICS - COMPUTING TECHNOLOGY, INTELLIGENT TECHNOLOGY, INDUSTRIAL INFORMATION INTEGRATION (ICIICII), P1, DOI 10.1109/ICIICII.2015.88; Li XJ, 2018, NAT REV MOL CELL BIO, V19, P563, DOI 10.1038/s41580-018-0029-7; Liu X, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01459; Liu YC, 2014, INT J BIOL SCI, V10, P520, DOI 10.7150/ijbs.8879; McCall CE, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.99292; Mills EL, 2018, NATURE, V556, P113, DOI 10.1038/nature25986; Nelson VL, 2018, GENE DEV, V32, P1035, DOI 10.1101/gad.312355.118; O'Neill LAJ, 2016, NAT REV IMMUNOL, V16, P553, DOI 10.1038/nri.2016.70; Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016; Pfalzgraff A, 2019, TRENDS PHARMACOL SCI, V40, P187, DOI 10.1016/j.tips.2019.01.001; Phan AT, 2017, IMMUNITY, V46, P714, DOI 10.1016/j.immuni.2017.04.016; Powell WS, 2003, J CLIN INVEST, V112, P828, DOI 10.1172/JCI200319796; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; Serhan CN, 2017, FASEB J, V31, P1273, DOI [10.1096/fj.201601222R, 10.1096/fj.201601222r]; Shiraki T, 2005, J BIOL CHEM, V280, P14145, DOI 10.1074/jbc.M500901200; Singh VK, 1998, IMMUNOL RES, V17, P345, DOI 10.1007/BF02786456; Thevenot EA, 2015, J PROTEOME RES, V14, P3322, DOI 10.1021/acs.jproteome.5b00354; Tsukahara T, 2012, PPAR RES, V2012, DOI 10.1155/2012/362361; van der Poll T, 2017, NAT REV IMMUNOL, V17, P407, DOI 10.1038/nri.2017.36; Ward PA, 2019, J LEUKOCYTE BIOL, V106, P187, DOI 10.1002/JLB.4MIR1118-425R; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034	47	1	1	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					11772	11785		10.1096/fj.202000467R	http://dx.doi.org/10.1096/fj.202000467R		JUL 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32652815	Green Published, Bronze			2022-12-28	WOS:000548007700001
J	Tai, YK; Ng, C; Purnamawati, K; Yap, JLY; Yin, JN; Wong, C; Patel, BK; Soong, PL; Pelczar, P; Frohlich, J; Beyer, C; Fong, CHH; Ramanan, S; Casarosa, M; Cerrato, CP; Foo, ZL; Selvan, RMP; Grishina, E; Degirmenci, U; Toh, SJ; Richards, PJ; Mirsaidi, A; Wuertz-Kozak, K; Chong, SY; Ferguson, SJ; Aguzzi, A; Monici, M; Sun, L; Drum, CL; Wang, JW; Franco-Obregon, A				Tai, Yee Kit; Ng, Charmaine; Purnamawati, Kristy; Yap, Jasmine Lye Yee; Yin, Jocelyn Naixin; Wong, Craig; Patel, Bharati Kadamb; Soong, Poh Loong; Pelczar, Pawel; Frohlich, Juerg; Beyer, Christian; Fong, Charlene Hui Hua; Ramanan, Sharanya; Casarosa, Marco; Cerrato, Carmine Pasquale; Foo, Zi Ling; Pannir Selvan, Rina Malathi; Grishina, Elina; Degirmenci, Ufuk; Toh, Shi Jie; Richards, Pete J.; Mirsaidi, Ali; Wuertz-Kozak, Karin; Chong, Suet Yen; Ferguson, Stephen J.; Aguzzi, Adriano; Monici, Monica; Sun, Lei; Drum, Chester L.; Wang, Jiong-Wei; Franco-Obregon, Alfredo			Magnetic fields modulate metabolism and gut microbiome in correlation withPgc-1 alpha expression: Follow-up to an in vitro magnetic mitohormetic study	FASEB JOURNAL			English	Article						brown adipose; mitochondria; muscle; PEMF; white adipose	SKELETAL-MUSCLE; INSULIN SENSITIVITY; ADIPOSE-TISSUE; MYOBLAST DIFFERENTIATION; MITOCHONDRIAL-FUNCTION; LIFE-SPAN; EXERCISE; EXPRESSION; CAPACITY; OBESITY	Exercise modulates metabolism and the gut microbiome. Brief exposure to low mT-range pulsing electromagnetic fields (PEMFs) was previously shown to accentuate in vitro myogenesis and mitochondriogenesis by activating a calcium-mitochondrial axis upstream of PGC-1 alpha transcriptional upregulation, recapitulating a genetic response implicated in exercise-induced metabolic adaptations. We compared the effects of analogous PEMF exposure (1.5 mT, 10 min/week), with and without exercise, on systemic metabolism and gut microbiome in four groups of mice: (a) no intervention; (b) PEMF treatment; (c) exercise; (d) exercise and PEMF treatment. The combination of PEMFs and exercise for 6 weeks enhanced running performance and upregulated muscular and adiposePgc-1 alpha transcript levels, whereas exercise alone was incapable of elevatingPgc-1 alpha levels. The gut microbiomeFirmicutes/Bacteroidetesratio decreased with exercise and PEMF exposure, alone or in combination, which has been associated in published studies with an increase in lean body mass. After 2 months, brief PEMF treatment alone increasedPgc-1 alpha and mitohormetic gene expression and after >4 months PEMF treatment alone enhanced oxidative muscle expression, fatty acid oxidation, and reduced insulin levels. Hence, short-term PEMF treatment was sufficient to instigate PGC-1 alpha-associated transcriptional cascades governing systemic mitohormetic adaptations, whereas longer-term PEMF treatment was capable of inducing related metabolic adaptations independently of exercise.	[Tai, Yee Kit; Ng, Charmaine; Purnamawati, Kristy; Yap, Jasmine Lye Yee; Yin, Jocelyn Naixin; Wong, Craig; Patel, Bharati Kadamb; Soong, Poh Loong; Fong, Charlene Hui Hua; Ramanan, Sharanya; Foo, Zi Ling; Pannir Selvan, Rina Malathi; Grishina, Elina; Toh, Shi Jie; Chong, Suet Yen; Drum, Chester L.; Wang, Jiong-Wei; Franco-Obregon, Alfredo] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Surg, NUHS Tower Block Level 8,1E Kent Ridge Rd, Singapore 119228, Singapore; [Tai, Yee Kit; Purnamawati, Kristy; Yap, Jasmine Lye Yee; Yin, Jocelyn Naixin; Wong, Craig; Soong, Poh Loong; Fong, Charlene Hui Hua; Ramanan, Sharanya; Foo, Zi Ling; Pannir Selvan, Rina Malathi; Grishina, Elina; Toh, Shi Jie; Franco-Obregon, Alfredo] Natl Univ Singapore, Biolon Currents Electromagnet Pulsing Syst Lab, BICEPS, Singapore, Singapore; [Pelczar, Pawel] Univ Basel, Ctr Transgen Models, Basel, Switzerland; [Pelczar, Pawel] Univ Zurich, Inst Lab Anim Sci, Zurich, Switzerland; [Frohlich, Juerg] Fields Work GmbH, Zurich, Switzerland; [Beyer, Christian] CSEM SA, Ctr Suisse Elect & Microtech, Neuchatel, Switzerland; [Casarosa, Marco] Univ Florence, Dept Expt & Clin Biomed Sci Mario Serio, Florence, Italy; [Casarosa, Marco] Swiss Fed Inst Technol, Inst Biomech, Zurich, Switzerland; [Cerrato, Carmine Pasquale] Karolinska Inst, Inst Environm Med, Stockholm, Sweden; [Degirmenci, Ufuk; Ferguson, Stephen J.; Franco-Obregon, Alfredo] ASTAR, Inst Mol & Cell Biol, Singapore, Singapore; [Richards, Pete J.; Mirsaidi, Ali; Wuertz-Kozak, Karin; Ferguson, Stephen J.] Univ Zurich, Competence Ctr Appl Biotechnol & Mol Med, Zurich, Switzerland; [Wuertz-Kozak, Karin] Rochester Inst Technol RIT, Dept Biomed Engn, Rochester, NY USA; [Wuertz-Kozak, Karin; Chong, Suet Yen; Drum, Chester L.; Wang, Jiong-Wei] Natl Univ Heart Ctr Singapore NUHCS, Cardiovasc Res Inst CVRI, Singapore, Singapore; [Aguzzi, Adriano] Univ Zurich, Inst Neuropathol, Zurich, Switzerland; [Monici, Monica] Univ Florence, Dept Expt & Clin Biomed Sci Mario Serio, ASA Res Div, ASAcampus JL, Florence, Italy; [Sun, Lei] DUKE NUS Grad Med Sch Singapore, Singapore, Singapore; [Wang, Jiong-Wei; Franco-Obregon, Alfredo] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore, Singapore; [Franco-Obregon, Alfredo] Natl Univ Singapore, IHealthtech, Inst Hlth Innovat & Technol, Singapore, Singapore	National University of Singapore; National University of Singapore; University of Basel; University of Zurich; Swiss Center for Electronics & Microtechnology (CSEM); University of Florence; Swiss Federal Institutes of Technology Domain; ETH Zurich; Karolinska Institutet; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); University of Zurich; Rochester Institute of Technology; University of Zurich; University of Florence; National University of Singapore; National University of Singapore; National University of Singapore	Franco-Obregon, A (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Surg, NUHS Tower Block Level 8,1E Kent Ridge Rd, Singapore 119228, Singapore.	suraf@nus.edu.sg	Degirmenci, Ufuk/AAS-9771-2021; Tai, Yee Kit/HCH-5864-2022; Cerrato, Carmine Pasquale/Y-5180-2019; Wang, Jiong-Wei/AAW-9118-2021; Tai, Yee Kit/AHB-6200-2022; Ferguson, Stephen J./A-4118-2012; Chong, Suet Yen/AAX-9483-2021; drum, chester/A-6089-2015; Wuertz-Kozak, Karin/G-3144-2012	Degirmenci, Ufuk/0000-0002-6192-7905; Cerrato, Carmine Pasquale/0000-0001-7769-6905; Wang, Jiong-Wei/0000-0001-7986-6082; Ferguson, Stephen J./0000-0003-0650-5889; Chong, Suet Yen/0000-0002-3627-4025; Ng, Charmaine/0000-0003-3026-0009; Tai, Yee Kit/0000-0003-0798-3575; drum, chester/0000-0001-6327-4584; Wuertz-Kozak, Karin/0000-0002-3281-4629; Aguzzi, Adriano/0000-0002-0344-6708	Lee Foundation, Singapore [N-176-000-045-001]; Institute for Health Innovation & Technology, iHealthtech (Microbiome in Health, Disease and Ageing), at the National University of Singapore [R-176-000-243-731]; Ministry of Education Academic Research Fund [R-722-000-018-112, MOE2018-T2-2-158]; European Space Agency Grant ESA-CORAGBF [4000113883]; Fondation Suisse de Recherche sur les Maladies Musculaires	Lee Foundation, Singapore; Institute for Health Innovation & Technology, iHealthtech (Microbiome in Health, Disease and Ageing), at the National University of Singapore; Ministry of Education Academic Research Fund; European Space Agency Grant ESA-CORAGBF(European Space Agency); Fondation Suisse de Recherche sur les Maladies Musculaires	We would like to acknowledge Professor Christian Wolfrum of the ETH Zurich, Department of Health Sciences and Technology for conducting the indirect calorimetry and blood analysis shown in Figure 1. We would also like to acknowledge Associate Professor Hyungwon Choi of the Department of Medicine of the NUS for helpful discussions on the statistical analytic methods employed in this study, particularly with reference to the utility and limitations of estimation plots used in Figures 2F,G, and S3.43 Mr Zac Goh, iHealthtech (NUS) designed the graphical abstract shown in Figure 7. Financial support for this study was awarded from the Lee Foundation, Singapore (N-176-000-045-001), the Institute for Health Innovation & Technology, iHealthtech (R-176-000-243-731, Microbiome in Health, Disease and Ageing), at the National University of Singapore and the Ministry of Education Academic Research Fund (R-722-000-018-112 or MOE2018-T2-2-158). This study was also partially funded by the European Space Agency Grant ESA-CORAGBF (4000113883) and the Fondation Suisse de Recherche sur les Maladies Musculaires.	Alfieri CM, 2007, AM J PHYSIOL-CELL PH, V292, pC1887, DOI 10.1152/ajpcell.00506.2006; Allen JM, 2018, MED SCI SPORT EXER, V50, P747, DOI [10.1249/MSS.0000000000001495, 10.1249/mss.0000000000001495]; Allen JM, 2015, J APPL PHYSIOL, V118, P1059, DOI 10.1152/japplphysiol.01077.2014; Armand AS, 2008, J BIOL CHEM, V283, P29004, DOI 10.1074/jbc.M801297200; Baj A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20061482; Bernlohr DA, 2014, DIABETES, V63, P2606, DOI 10.2337/db14-0638; Blachier F, 2009, AM J CLIN NUTR, V90, p814S, DOI 10.3945/ajcn.2009.27462S; Bressa C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171352; Brown WMC, 2015, SPORTS MED-OPEN, V1, DOI 10.1186/s40798-015-0032-x; Bull Matthew J, 2014, Integr Med (Encinitas), V13, P17; Calabria E, 2009, P NATL ACAD SCI USA, V106, P13335, DOI 10.1073/pnas.0812911106; Calvo JA, 2008, J APPL PHYSIOL, V104, P1304, DOI 10.1152/japplphysiol.01231.2007; Cani PD, 2018, GUT, V67, P1716, DOI 10.1136/gutjnl-2018-316723; Cani PD, 2019, NAT METAB, V1, P34, DOI 10.1038/s42255-018-0017-4; Cani PD, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01765; Castillo-Quan JI, 2012, DIS MODEL MECH, V5, P293, DOI 10.1242/dmm.009894; Cheng CF, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113447; Clark A, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00319; Clarke K.R., 2014, CHANGE MARINE COMMUN, V3; Clavel T, 2014, GUT MICROBES, V5, P544, DOI 10.4161/gmic.29331; Coleman V, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20901-4; Copps KD, 2012, DIABETOLOGIA, V55, P2565, DOI 10.1007/s00125-012-2644-8; Cox CS, 2018, CELL METAB, V28, P776, DOI 10.1016/j.cmet.2018.07.011; Crocetti S, 2014, CYTOM PART A, V85A, P525, DOI 10.1002/cyto.a.22461; Daniel H, 2014, ISME J, V8, P295, DOI 10.1038/ismej.2013.155; Dao MC, 2016, GUT, V65, P426, DOI 10.1136/gutjnl-2014-308778; de las Heras N, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01122; Ekmark M, 2003, J PHYSIOL-LONDON, V548, P259, DOI 10.1113/jphysiol.2002.036228; Erlich AT, 2018, AM J PHYSIOL-CELL PH, V314, pC62, DOI 10.1152/ajpcell.00162.2017; Fabbiano S, 2018, CELL METAB, V28, P907, DOI 10.1016/j.cmet.2018.08.005; Favaretto F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109540; Fedewa MV, 2018, SPORTS MED, V48, P1437, DOI 10.1007/s40279-018-0897-1; Forbes JD, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01081; Fraysse B, 2003, FASEB J, V17, P1916, DOI 10.1096/fj.02-1012fje; Frey N, 2008, J CLIN INVEST, V118, P3598, DOI 10.1172/JCI36277; Graf C, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20246159; Gupta VK, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01162; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; Heiss CN, 2018, J INNATE IMMUN, V10, P163, DOI 10.1159/000481519; Henique C, 2015, FASEB J, V29, P2473, DOI 10.1096/fj.14-257717; Ho J, 2019, NAT METHODS, V16, P565, DOI 10.1038/s41592-019-0470-3; Hoffmann C, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a029793; Houghton MJ, 2019, FASEB J, V33, P1887, DOI 10.1096/fj.201801209R; Hudson MB, 2013, INT J BIOCHEM CELL B, V45, P2173, DOI 10.1016/j.biocel.2013.06.029; Huh JY, 2018, ARCH PHARM RES, V41, P14, DOI 10.1007/s12272-017-0994-y; Jung S, 2014, INTEGR MED RES, V3, P155, DOI 10.1016/j.imr.2014.09.004; Kang CH, 2012, ANN NY ACAD SCI, V1271, P110, DOI 10.1111/j.1749-6632.2012.06738.x; Kuczynski Justin, 2012, Curr Protoc Microbiol, VChapter 1, DOI [10.1002/0471250953.bi1007s36, 10.1002/9780471729259.mc01e05s27]; Lahiri S, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aan5662; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Lee JH, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00042; Leick L, 2009, AM J PHYSIOL-ENDOC M, V297, pE92, DOI 10.1152/ajpendo.00076.2009; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li GL, 2017, CELL METAB, V26, P672, DOI 10.1016/j.cmet.2017.08.019; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lira VA, 2010, AM J PHYSIOL-ENDOC M, V299, pE145, DOI 10.1152/ajpendo.00755.2009; Liu ZH, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01687; Louis P, 2009, FEMS MICROBIOL LETT, V294, P1, DOI 10.1111/j.1574-6968.2009.01514.x; Mach N, 2017, J SPORT HEALTH SCI, V6, P179, DOI 10.1016/j.jshs.2016.05.001; Mansueto G, 2017, CELL METAB, V25, P182, DOI 10.1016/j.cmet.2016.11.003; Marchesi JR, 2016, GUT, V65, P330, DOI 10.1136/gutjnl-2015-309990; Martinez I, 2013, APPL ENVIRON MICROB, V79, P516, DOI 10.1128/AEM.03046-12; Martinez-Huenchullan SF, 2020, METABOLISM, V102, DOI 10.1016/j.metabol.2019.154008; Matulewicz N, 2017, J CLIN ENDOCR METAB, V102, P3040, DOI 10.1210/jc.2017-00597; Menni C, 2017, INT J OBESITY, V41, P1099, DOI 10.1038/ijo.2017.66; Mika A, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00026; Miller VJ, 2018, J NUTR METAB, V2018, DOI 10.1155/2018/5157645; Monda V, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/3831972; Morales S, 2007, AM J PHYSIOL-CELL PH, V292, pC553, DOI 10.1152/ajpcell.00096.2006; Mormeneo E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029985; Morrow RM, 2017, P NATL ACAD SCI USA, V114, P2705, DOI 10.1073/pnas.1700997114; Motiani P, 2017, DIABETES OBES METAB, V19, P1379, DOI 10.1111/dom.12947; Mottawea W, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13419; Mozhui K, 2010, J NEUROSCI, V30, P5357, DOI 10.1523/JNEUROSCI.5017-09.2010; Musci RV, 2019, SPORTS, V7, DOI 10.3390/sports7070170; Neis EPJG, 2015, NUTRIENTS, V7, P2930, DOI 10.3390/nu7042930; Oh HYP, 2019, FASEB J, V33, P9706, DOI 10.1096/fj.201802681RR; Parate D, 2020, STEM CELL RES THER, V11, DOI 10.1186/s13287-020-1566-5; Parate D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09892-w; Perroud J, 2017, J CELL SCI, V130, P3083, DOI 10.1242/jcs.198978; Petriz BA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-511; Petrosino JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148010; Pham TAN, 2014, CURR OPIN MICROBIOL, V17, P67, DOI 10.1016/j.mib.2013.12.002; Pontarelli Elizabeth M, 2013, Curr Gastroenterol Rep, V15, P340, DOI 10.1007/s11894-013-0340-6; Pradhan RN, 2017, OBES REV, V18, P65, DOI 10.1111/obr.12512; Ravussin Y, 2012, OBESITY, V20, P738, DOI 10.1038/oby.2011.111; Razzoli M, 2016, MOL METAB, V5, P19, DOI 10.1016/j.molmet.2015.10.005; Reese AT, 2018, MBIO, V9, DOI 10.1128/mBio.01294-18; Ristow M, 2014, DOSE-RESPONSE, V12, P288, DOI 10.2203/dose-response.13-035.Ristow; Roberts-Wilson TK, 2010, BBA-MOL CELL RES, V1803, P960, DOI 10.1016/j.bbamcr.2010.03.019; Robinson MM, 2017, CELL METAB, V25, P581, DOI 10.1016/j.cmet.2017.02.009; Ross D, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00595; Saint-Georges-Chaumet Y, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftv096; Scheele C, 2009, TRENDS ENDOCRIN MET, V20, P95, DOI 10.1016/j.tem.2008.12.002; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Sepa-Kishi DM, 2016, EXERC SPORT SCI REV, V44, P37, DOI 10.1249/JES.0000000000000068; Shin Ki Ok, 2015, J Exerc Nutrition Biochem, V19, P91, DOI 10.5717/jenb.2015.15061006; Sloan RP, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.010201; Stromsdorfer KL, 2016, CELL REP, V16, P1851, DOI 10.1016/j.celrep.2016.07.027; Suarez-Zamorano N, 2015, NAT MED, V21, P1497, DOI 10.1038/nm.3994; Supruniuk E, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00923; Tang BL, 2016, MOL CELLS, V39, P87, DOI 10.14348/molcells.2016.2318; Tomiyama AJ, 2019, ANNU REV PSYCHOL, V70, P703, DOI 10.1146/annurev-psych-010418-102936; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; van Wessel T, 2010, EUR J APPL PHYSIOL, V110, P665, DOI 10.1007/s00421-010-1545-0; Vargas-Mendoza N, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8060196; Villarroya F, 2017, NAT REV ENDOCRINOL, V13, P26, DOI 10.1038/nrendo.2016.136; Vina J, 2009, ADV DRUG DELIVER REV, V61, P1369, DOI 10.1016/j.addr.2009.06.006; Wang S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31353-1; WATFORD M, 1979, BIOCHEM J, V178, P589, DOI 10.1042/bj1780589; Weir HJ, 2017, CELL METAB, V26, P884, DOI 10.1016/j.cmet.2017.09.024; Wicks SE, 2015, P NATL ACAD SCI USA, V112, pE3300, DOI 10.1073/pnas.1418560112; Xia L, 2016, J PHYSIOL-LONDON, V594, P3111, DOI 10.1113/JP271705; Yap JLY, 2019, FASEB J, V33, P12853, DOI 10.1096/fj.201900057R; Zanou N, 2012, J BIOL CHEM, V287, P14524, DOI 10.1074/jbc.M112.341784; Zanou N, 2010, AM J PHYSIOL-CELL PH, V298, pC149, DOI 10.1152/ajpcell.00241.2009; Zietak M, 2016, CELL METAB, V23, P1216, DOI 10.1016/j.cmet.2016.05.001	118	13	13	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					11143	11167		10.1096/fj.201903005RR	http://dx.doi.org/10.1096/fj.201903005RR		JUL 2020	25	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32627872	Green Published, hybrid			2022-12-28	WOS:000547607100001
J	Li, GR; Schmitt, H; Johnson, WM; Lee, CY; Navarro, I; Cui, J; Fleming, T; Gomez-Caraballo, M; Elliott, MH; Sherwood, JM; Hauser, MA; Farsiu, S; Ethier, CR; Stamer, WD				Li, Guorong; Schmitt, Heather; Johnson, William M.; Lee, Chanyoung; Navarro, Iris; Cui, Jenny; Fleming, Todd; Gomez-Caraballo, Maria; Elliott, Michael H.; Sherwood, Joseph M.; Hauser, Michael A.; Farsiu, Sina; Ethier, C. Ross; Stamer, W. Daniel			Integral role for lysyl oxidase-like-1 in conventional outflow tissue function and behavior	FASEB JOURNAL			English	Article						crosslinking; elastin; extracellular matrix; fibrosis; intraocular pressure; Schlemm's canal	BLOOD-AQUEOUS BARRIER; OPEN-ANGLE GLAUCOMA; TRABECULAR MESHWORK; EXTRACELLULAR-MATRIX; INTRAOCULAR-PRESSURE; PSEUDOEXFOLIATION SYNDROME; CILIARY MUSCLE; LOXL1; CONNECTIONS; EXPRESSION	Lysyl oxidase-like-1 (LOXL1), a vital crosslinking enzyme in elastin fiber maintenance, is essential for the stability and strength of elastic vessels and tissues. Variants in the LOXL1 locus associate with a dramatic increase in risk of exfoliation syndrome (XFS), a systemic fibrillopathy, which often presents with ocular hypertension and exfoliation glaucoma (XFG). We examined the role of LOXL1 in conventional outflow function, the prime regulator of intraocular pressure (IOP). UsingLoxl1(-/-), Loxl1(+/-), andLoxl1(+/+)mice, we observed an inverse relationship between LOXL1 expression and IOP, which worsened with age. Elevated IOP inLoxl1(-/-)mice was associated with a larger globe, decreased ocular compliance, increased outflow facility, extracellular matrix (ECM) abnormalities, and dilated intrascleral veins, yet, no dilation of arteries or capillaries. Interestingly, in livingLoxl1(-/-)mouse eyes, Schlemm's canal (SC) was less susceptible to collapse when challenged with acute elevations in IOP, suggesting elevated episcleral venous pressure (EVP). Thus, LOXL1 expression is required for normal IOP control, while ablation results in altered ECM repair/homeostasis and conventional outflow physiology. Dilation of SC and distal veins, but not arteries, is consistent with key structural and functional roles for elastin in low-pressure vessels subjected to cyclical mechanical stress.	[Li, Guorong; Schmitt, Heather; Johnson, William M.; Navarro, Iris; Fleming, Todd; Gomez-Caraballo, Maria; Hauser, Michael A.; Farsiu, Sina; Stamer, W. Daniel] Duke Univ, Dept Ophthalmol, DUMC 3802,2608 Erwin Rd, Durham, NC 27705 USA; [Lee, Chanyoung; Ethier, C. Ross] Emory Univ, Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30322 USA; [Cui, Jenny] East Chapel Hill Sch, Chapel Hill, NC USA; [Elliott, Michael H.] Univ Oklahoma Hlth, Dept Ophthalmol & Physiol, Oklahoma City, OK USA; [Sherwood, Joseph M.] Imperial Coll London, Dept Bioengn, London, England; [Hauser, Michael A.] Duke Univ, Mol Physiol Inst, Durham, NC USA; [Farsiu, Sina; Stamer, W. Daniel] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA	Duke University; Emory University; University System of Georgia; Georgia Institute of Technology; University of Oklahoma System; University of Oklahoma Health Sciences Center; Imperial College London; Duke University; Duke University	Stamer, WD (corresponding author), Duke Univ, Dept Ophthalmol, DUMC 3802,2608 Erwin Rd, Durham, NC 27705 USA.; Ethier, CR (corresponding author), Emory Univ, Georgia Inst Technol, IBB, Dept Biomed Engn, 315 Ferst Dr,Room 2306, Atlanta, GA 30332 USA.	ross.ethier@bme.gatech.edu; dan.stamer@duke.edu	Sherwood, Joseph M/P-9619-2018	Sherwood, Joseph M/0000-0002-4402-9767; Ethier, Ross/0000-0001-6110-3052	HHS \ NIH \ National Eye Institute (NEI) [EY030124, EY030617, EY028608, EY005722]; BrightFocus Foundation (BrightFocus) [G2015100]; Research to Prevent Blindness (RPB); Georgia Research Alliance (GRA)	HHS \ NIH \ National Eye Institute (NEI); BrightFocus Foundation (BrightFocus)(BrightFocus Foundation); Research to Prevent Blindness (RPB)(Research to Prevent Blindness (RPB)); Georgia Research Alliance (GRA)	HHS vertical bar NIH vertical bar National Eye Institute (NEI), Grant/Award Number: EY030124, EY030617, EY028608 and EY005722; BrightFocus Foundation (BrightFocus), Grant/Award Number: G2015100; Research to Prevent Blindness (RPB), Grant/Award Number: unrestricted; Georgia Research Alliance (GRA), Grant/Award Number: unrestricted	Aboobakar IF, 2017, EXP EYE RES, V154, P88, DOI 10.1016/j.exer.2016.11.011; Acott TS, 2008, EXP EYE RES, V86, P543, DOI 10.1016/j.exer.2008.01.013; Alperin M, 2008, INT UROGYNECOL J, V19, P977, DOI 10.1007/s00192-008-0561-7; Behmoaras J, 2008, REJUV RES, V11, P883, DOI 10.1089/rej.2008.0760; Borel A, 2001, J BIOL CHEM, V276, P48944, DOI 10.1074/jbc.M109499200; Boussommier-Calleja A, 2015, INVEST OPHTH VIS SCI, V56, P8331, DOI 10.1167/iovs.15-17106; Elliott MH, 2016, SCI REP-UK, V6, DOI 10.1038/srep37127; Gabriela Espinosa M, 2018, J BIOMECH ENG, V140, P1; Ghasemi M, 2018, BIOMECH MODEL MECHAN, V17, P1757, DOI 10.1007/s10237-018-1054-3; Gottanka J, 1997, INVEST OPHTH VIS SCI, V38, P2435; Hendargo HC, 2013, BIOMED OPT EXPRESS, V4, P803, DOI 10.1364/BOE.4.000803; Huang QH, 2009, COMPUT MED IMAG GRAP, V33, P100, DOI 10.1016/j.compmedimag.2008.10.006; Kanthan GL, 2013, AM J OPHTHALMOL, V155, P83, DOI 10.1016/j.ajo.2012.07.002; Kasetti RB, 2018, J BIOL CHEM, V293, P9854, DOI 10.1074/jbc.RA118.002540; Khan TT, 2010, MOL VIS, V16, P2236; Kim J, 2017, J BIOMECH, V61, P199, DOI 10.1016/j.jbiomech.2017.07.011; Kimball EC, 2014, EXP EYE RES, V128, P129, DOI 10.1016/j.exer.2014.08.016; Kizhatil K, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001912; Kuchle M, 1996, GRAEF ARCH CLIN EXP, V234, P12, DOI 10.1007/BF00186513; Li GR, 2019, P NATL ACAD SCI USA, V116, P1714, DOI 10.1073/pnas.1814889116; Li GR, 2018, INVEST OPHTH VIS SCI, V59, P383, DOI 10.1167/iovs.17-23212; Li GR, 2016, EUR J PHARMACOL, V787, P20, DOI 10.1016/j.ejphar.2016.04.002; Li GR, 2014, MOL VIS, V20, P1695; Li GR, 2014, INVEST OPHTH VIS SCI, V55, P3737, DOI 10.1167/iovs.13-13700; Liu XQ, 2004, NAT GENET, V36, P178, DOI 10.1038/ng1297; Liu YT, 2008, INVEST OPHTH VIS SCI, V49, P3465, DOI 10.1167/iovs.08-1850; MACKAY EH, 1978, THORAX, V33, P335, DOI 10.1136/thx.33.3.335; Mariampillai A, 2008, OPT LETT, V33, P1530, DOI 10.1364/OL.33.001530; Millar JC, 2015, INVEST OPHTH VIS SCI, V56, P5764, DOI 10.1167/iovs.15-16720; Nave AH, 2014, ARTERIOSCL THROM VAS, V34, P1446, DOI 10.1161/ATVBAHA.114.303534; Norman RE, 2011, EXP EYE RES, V93, P4, DOI 10.1016/j.exer.2010.09.014; O'Callaghan J, 2017, EXPERT OPIN THER TAR, V21, P1037, DOI 10.1080/14728222.2017.1386174; Overby DR, 2014, INVEST OPHTH VIS SCI, V55, P3727, DOI 10.1167/iovs.13-13699; Park CY, 2016, INVEST OPHTH VIS SCI, V57, P1096, DOI 10.1167/iovs.15-17091; Pascual G, 2008, HISTOL HISTOPATHOL, V23, P179, DOI 10.14670/HH-23.179; Poole KM, 2014, BIOMED OPT EXPRESS, V5, P4118, DOI 10.1364/BOE.5.004118; Raghunathan VK, 2015, ACS BIOMATER SCI ENG, V1, P110, DOI 10.1021/ab500060r; Ritch R, 2008, PROG BRAIN RES, V173, P211, DOI 10.1016/S0079-6123(08)01115-1; RODRIGUEZ C, 2019, CELLS-BASEL, V8, P69499, DOI DOI 10.3390/CELLS8121483; Rohen J W, 1967, Albrecht Von Graefes Arch Klin Exp Ophthalmol, V172, P23, DOI 10.1007/BF00577152; ROHEN JW, 1981, INVEST OPHTH VIS SCI, V21, P574; Safari I, 2016, OPHTHALMIC RES, V56, P98, DOI 10.1159/000443508; Schlotzer-Schrehardt U, 2006, AM J OPHTHALMOL, V141, P921, DOI 10.1016/j.ajo.2006.01.047; Schlotzer-Schrehardt U, 2012, OPHTHALMOLOGY, V119, P1832, DOI 10.1016/j.ophtha.2012.03.015; Schlotzer-Schrehardt U, 2008, AM J PATHOL, V173, P1724, DOI 10.2353/ajpath.2008.080535; Schumacher S, 1999, ARCH OPHTHALMOL-CHIC, V117, P733; Sethi A, 2011, INVEST OPHTH VIS SCI, V52, P5240, DOI 10.1167/iovs.11-7287; Sherwood JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150694; Sherwood JM, 2019, FRONT BIOENG BIOTECH, V7, DOI 10.3389/fbioe.2019.00276; Sigal IA, 2005, INVEST OPHTH VIS SCI, V46, P4189, DOI 10.1167/iovs.05-0541; Stamer WD, 2017, EXP EYE RES, V158, P112, DOI 10.1016/j.exer.2016.07.009; Thomassin L, 2005, J BIOL CHEM, V280, P42848, DOI 10.1074/jbc.M506832200; Thorleifsson G, 2007, SCIENCE, V317, P1397, DOI 10.1126/science.1146554; Tjin G, 2017, DIS MODEL MECH, V10, P1301, DOI 10.1242/dmm.030114; Turner DC, 2019, INVEST OPHTH VIS SCI, V60, P2572, DOI 10.1167/iovs.19-26600; Vranka JA, 2015, EXP EYE RES, V133, P112, DOI 10.1016/j.exer.2014.07.014; Wang K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24165-w; Wang LL, 1999, OPHTHALMOLOGICA, V213, P387, DOI 10.1159/000027460; Wiederholt M, 2000, PROG RETIN EYE RES, V19, P271, DOI 10.1016/S1350-9462(99)00015-4; Wiggs JL, 2014, INVEST OPHTH VIS SCI, V55, P856, DOI 10.1167/iovs.13-13033; Wordinger Robert J, 2014, J Glaucoma, V23, pS55, DOI 10.1097/IJG.0000000000000127; Xin C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162048; Zadravec P, 2019, EXP EYE RES, V179, P115, DOI 10.1016/j.exer.2018.11.001; Zhang X, 2020, INVEST OPHTH VIS SCI, V61, DOI 10.1167/iovs.61.2.23; Zhao BH, 2012, J OBSTET GYNAECOL RE, V38, P925, DOI 10.1111/j.1447-0756.2011.01814.x; Zhou Y, 2013, J BIOMED RES, V27, P23, DOI 10.7555/JBR.27.20110142	66	11	11	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10762	10777		10.1096/fj.202000702RR	http://dx.doi.org/10.1096/fj.202000702RR		JUL 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32623782	Green Accepted			2022-12-28	WOS:000547518400001
J	Liu, XJ; Feng, B; Vats, A; Tang, H; Seibel, W; Swaroop, M; Tawa, G; Zheng, W; Byrne, L; Schurdak, M; Chen, YN				Liu, Xujie; Feng, Bing; Vats, Abhishek; Tang, Hong; Seibel, William; Swaroop, Manju; Tawa, Gregory; Zheng, Wei; Byrne, Leah; Schurdak, Mark; Chen, Yuanyuan			Pharmacological clearance of misfolded rhodopsin for the treatment ofRHO-associated retinitis pigmentosa	FASEB JOURNAL			English	Article						high-throughput screening; methotrexate; misfolded protein degradation	CILIARY NEUROTROPHIC FACTOR; PHOTORECEPTOR CELLS; RIBOZYME RESCUE; VISUAL FUNCTION; GENE-THERAPY; IN-VIVO; DEGRADATION; MUTATIONS; METHOTREXATE; SURVIVAL	Rhodopsin mutation and misfolding is a common cause of autosomal dominant retinitis pigmentosa (RP). Using a luciferase reporter assay, we undertook a small-molecule high-throughput screening (HTS) of 68, 979 compounds and identified nine compounds that selectively reduced the misfolded P23H rhodopsin without an effect on the wild type (WT) rhodopsin protein. Further, we found five of these compounds, including methotrexate (MTX), promoted P23H rhodopsin degradation that also cleared out other misfolded rhodopsin mutant proteins. We showed MTX increased P23H rhodopsin degradation via the lysosomal but not the proteasomal pathway. Importantly, one intravitreal injection (IVI) of 25 pmol MTX increased electroretinogram (ERG) response and rhodopsin level in the retinae ofRho(P23H/+)knock-in mice at 1 month of age. Additionally, four weekly IVIs increased the photoreceptor cell number in the retinae ofRho(P23H/+)mice compared to vehicle control. Our study indicates a therapeutic potential of repurposing MTX for the treatment of rhodopsin-associated RP.	[Liu, Xujie; Feng, Bing; Vats, Abhishek; Byrne, Leah; Chen, Yuanyuan] Univ Pittsburgh, Dept Ophthalmol, Pittsburgh, PA 15260 USA; [Liu, Xujie; Feng, Bing; Vats, Abhishek; Byrne, Leah; Chen, Yuanyuan] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA USA; [Tang, Hong; Seibel, William] Univ Cincinnati, Drug Discovery Ctr, Cincinnati, OH USA; [Seibel, William] Cincinnati Childrens Hosp Med Ctr, Oncol Dept, Cincinnati, OH 45229 USA; [Swaroop, Manju; Tawa, Gregory; Zheng, Wei] NIH, Natl Ctr Adv Translat Sci, Bldg 10, Bethesda, MD 20892 USA; [Schurdak, Mark] Univ Pittsburgh, Drug Discovery Inst, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Chen, YN (corresponding author), BST-3 Rm10043,3501 Fifth Ave, Pittsburgh, PA 15213 USA.	cheny1@pitt.edu	Zheng, Wei/GOE-5990-2022; Zheng, Wei/GQQ-8951-2022; Zheng, Wei/J-8889-2014	Zheng, Wei/0000-0003-1034-0757; Chen, Yuanyuan/0000-0001-9625-1610; Swaroop, Manju/0000-0002-0576-1664	NIH [EY024992]; CORE [EY008098]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CORE(Luxembourg National Research Fund)	NIH, Grant/Award Number: EY024992; CORE, Grant/Award Number: EY008098	Aguila M, 2014, HUM MOL GENET, V23, P2164, DOI 10.1093/hmg/ddt613; Ait-Ali N, 2015, CELL, V161, P817, DOI 10.1016/j.cell.2015.03.023; [Anonymous], CID4438424 NAT CTR B, P4438424; Athanasiou D, 2018, PROG RETIN EYE RES, V62, P1, DOI 10.1016/j.preteyeres.2017.10.002; Athanasiou Dimitra, 2017, Hum Mol Genet, V26, P4896, DOI 10.1093/hmg/ddx370; Auld D, 2004, ASSAY INTERFERENCE C; Auricchio A, 2017, HUM GENE THER, V28, P982, DOI 10.1089/hum.2017.164; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; BERSON EL, 1993, ARCH OPHTHALMOL-CHIC, V111, P761, DOI 10.1001/archopht.1993.01090060049022; Bok D, 2002, EXP EYE RES, V74, P719, DOI 10.1006/exer.2002.1176; Chen YY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04261-1; Chen YY, 2015, INVEST OPHTH VIS SCI, V56, P2553, DOI 10.1167/iovs.14-16298; Chen Yuanyuan, 2015, Methods Mol Biol, V1271, P369, DOI 10.1007/978-1-4939-2330-4_24; Chiang WC, 2015, MOL NEUROBIOL, V52, P679, DOI 10.1007/s12035-014-8881-8; Chow B. Y., 2013, SCI TRANSL MED, V5, P175; Dalkara D, 2016, HUM GENE THER, V27, P134, DOI 10.1089/hum.2015.147; Di Pierdomenico J, 2018, INVEST OPHTH VIS SCI, V59, P4392, DOI 10.1167/iovs.18-24621; Dryja TP, 2000, INVEST OPHTH VIS SCI, V41, P3124; DRYJA TP, 1990, NATURE, V343, P364, DOI 10.1038/343364a0; DRYJA TP, 1990, NEW ENGL J MED, V323, P1302, DOI 10.1056/NEJM199011083231903; El Gendy HA, 2016, J OPHTHALMOL, V2016, DOI 10.1155/2016/8501842; Fu YB, 2007, PFLUG ARCH EUR J PHY, V454, P805, DOI 10.1007/s00424-006-0194-y; Gorbatyuk M, 2007, VISION RES, V47, P1202, DOI 10.1016/j.visres.2006.11.026; HAROSI FI, 1975, J GEN PHYSIOL, V66, P357, DOI 10.1085/jgp.66.3.357; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hauswirth WW, 2008, HUM GENE THER, V19, P979, DOI 10.1089/hum.2008.107; Illing ME, 2002, J BIOL CHEM, V277, P34150, DOI 10.1074/jbc.M204955200; Kinoshita Junzo, 2018, Curr Protoc Mouse Biol, V8, P1, DOI 10.1002/cpmo.39; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Krebs MP, 2010, J MOL BIOL, V395, P1063, DOI 10.1016/j.jmb.2009.11.015; LaVail MM, 2000, P NATL ACAD SCI USA, V97, P11488, DOI 10.1073/pnas.210319397; Leveillard T, 2014, CR BIOL, V337, P207, DOI 10.1016/j.crvi.2013.12.002; Lewin AS, 1998, NAT MED, V4, P967, DOI 10.1038/nm0898-967; Liang FQ, 2001, MOL THER, V3, P241, DOI 10.1006/mthe.2000.0252; Lin JH, 2010, ADV EXP MED BIOL, V664, P115, DOI 10.1007/978-1-4419-1399-9_14; Lobanova ES, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04117-8; Lobanova ES, 2013, P NATL ACAD SCI USA, V110, P9986, DOI 10.1073/pnas.1305521110; Luo YHL, 2016, PROG RETIN EYE RES, V50, P89, DOI 10.1016/j.preteyeres.2015.09.003; Maeda A, 2019, ANNU REV GENOM HUM G, V20, P201, DOI 10.1146/annurev-genom-083118-015043; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Mendes HF, 2008, HUM MOL GENET, V17, P3043, DOI 10.1093/hmg/ddn202; Midorikawa R, 2010, J NEUROSCI, V30, P10703, DOI 10.1523/JNEUROSCI.2061-10.2010; Nakagawa S, 2016, RETINA-J RET VIT DIS, V36, P1340, DOI 10.1097/IAE.0000000000000904; Noorwez SM, 2003, J BIOL CHEM, V278, P14442, DOI 10.1074/jbc.M300087200; Opefi CA, 2013, J BIOL CHEM, V288, P33912, DOI 10.1074/jbc.M113.483032; Ozkan EB, 2013, INDIAN J OPHTHALMOL, V61, P329, DOI 10.4103/0301-4738.109518; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Parfitt DA, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.214; Peters JC, 2015, INVEST OPHTH VIS SCI, V56, P3860, DOI 10.1167/iovs.14-16220; Petrs-Silva H, 2012, ADV EXP MED BIOL, V723, P215, DOI 10.1007/978-1-4614-0631-0_29; Rosenblad A, 2009, STAT MED, V28, P360; Sahel J, 2010, DEV OPHTHALMOL, V47, P160, DOI 10.1159/000320079; Sakami S, 2011, J BIOL CHEM, V286, P10551, DOI 10.1074/jbc.M110.209759; Saliba RS, 2002, J CELL SCI, V115, P2907; Schlichtenbrede FC, 2003, GENE THER, V10, P523, DOI 10.1038/sj.gt.3301929; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P8840, DOI 10.1073/pnas.88.19.8840; Taylor SRJ, 2012, OPHTHALMOLOGY, V119, P878, DOI 10.1016/j.ophtha.2011.12.015; Taylor SRJ, 2009, OPHTHALMOLOGY, V116, P797, DOI 10.1016/j.ophtha.2008.10.033; Tochitsky I, 2015, CURR OPIN NEUROBIOL, V34, P74, DOI 10.1016/j.conb.2015.01.018; Vasireddy V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021193; Wang JG, 2017, NAT PROTOC, V12, P279, DOI 10.1038/nprot.2016.160; Wilson JH, 2003, MOL NEUROBIOL, V28, P149, DOI 10.1385/MN:28:2:149; Yao JY, 2018, AUTOPHAGY, V14, P1226, DOI 10.1080/15548627.2018.1463121; YOUNG RW, 1967, J CELL BIOL, V33, P61, DOI 10.1083/jcb.33.1.61; YOUNG RW, 1969, J CELL BIOL, V42, P392, DOI 10.1083/jcb.42.2.392; Zarbin M, 2016, TRENDS MOL MED, V22, P115, DOI 10.1016/j.molmed.2015.12.007; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zode GS, 2015, J CLIN INVEST, V125, P3303, DOI 10.1172/JCI82799	69	3	3	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10146	10167		10.1096/fj.202000282R	http://dx.doi.org/10.1096/fj.202000282R		JUN 2020	22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32536017	hybrid, Green Accepted			2022-12-28	WOS:000541515100001
J	Szostaczuk, N; van Schothorst, EM; Sanchez, J; Priego, T; Palou, M; Bekkenkamp-Grovenstein, M; Faustmann, G; Obermayer-Pietsch, B; Tiran, B; Roob, JM; Winklhofer-Roob, B; Keijer, J; Palou, A; Pico, C				Szostaczuk, Nara; van Schothorst, Evert M.; Sanchez, Juana; Priego, Teresa; Palou, Mariona; Bekkenkamp-Grovenstein, Melissa; Faustmann, Gernot; Obermayer-Pietsch, Barbara; Tiran, Beate; Roob, Johannes M.; Winklhofer-Roob, Brigitte; Keijer, Jaap; Palou, Andreu; Pico, Catalina			Identification of blood cell transcriptome-based biomarkers in adulthood predictive of increased risk to develop metabolic disorders using early life intervention rat models	FASEB JOURNAL			English	Article						gestational calorie restriction; metabolic health; metabolic programing; NPC1; PBMCs; predictive biomarkers	MODERATE CALORIC RESTRICTION; A(2) GROUP IIA; MONONUCLEAR-CELLS; ADIPOSE-TISSUE; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; SYMPATHETIC DRIVE; PREVENTS OBESITY; FOOD PREFERENCES; MICROARRAY DATA	Calorie restriction during gestation in rats has long-lasting adverse effects in the offspring. It induces metabolic syndrome-related alterations, which are partially reversed by leptin supplementation during lactation. We employed these conditions to identify transcript-based nutrient sensitive biomarkers in peripheral blood mononuclear cells (PBMCs) predictive of later adverse metabolic health. The best candidate was validated in humans. Transcriptome analysis of PBMCs from adult male Wistar rats of three experimental groups was performed: offspring of control dams (CON), and offspring of 20% calorie-restricted dams during gestation without (CR) and with leptin supplementation throughout lactation (CR-LEP). The expression of 401 genes was affected by gestational calorie restriction and reversed by leptin. The changes preceded metabolic syndrome-related phenotypic alterations. Of these genes, Npc1 mRNA levels were lower in CR vs CON, and normalized to CON in CR-LEP. In humans, NPC1 mRNA levels in peripheral blood cells (PBCs) were decreased in subjects with mildly impaired metabolic health compared to healthy subjects. Therefore, a set of potential transcript-based biomarkers indicative of a predisposition to metabolic syndrome-related alterations were identified, including NPC1, which was validated in humans. Low NPC1 transcript levels in PBCs are a candidate biomarker of increased risk for impaired metabolic health in humans.	[Szostaczuk, Nara; Sanchez, Juana; Priego, Teresa; Palou, Mariona; Palou, Andreu; Pico, Catalina] Univ Balearic Isl, CIBER Fisiopatol Obesidad & Nut CIBERobn, Grp Nutrigen & Obes, Lab Mol Biol Nutr & Biotechnol, Palma De Mallorca, Spain; [van Schothorst, Evert M.; Bekkenkamp-Grovenstein, Melissa; Keijer, Jaap] Wageningen Univ, Human & Anim Physiol, Wageningen, Netherlands; [Sanchez, Juana; Palou, Mariona; Palou, Andreu; Pico, Catalina] Inst Invest Sanit Illes Balears IdISBa, Palma De Mallorca, Spain; [Faustmann, Gernot; Winklhofer-Roob, Brigitte] Karl Franzens Univ Graz, Human Nutr & Metab Res & Training Ctr, Inst Mol Biosci, Graz, Austria; [Faustmann, Gernot; Roob, Johannes M.] Med Univ Graz, Dept Internal Med, Clin Div Nephrol, Graz, Austria; [Obermayer-Pietsch, Barbara] Med Univ Graz, Dept Internal Med, Div Endocrinol, Graz, Austria; [Tiran, Beate] Med Univ Graz, Clin Inst Med & Clin Lab Diagnost, Graz, Austria	CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Universitat de les Illes Balears; Wageningen University & Research; Institut Investigacio Sanitaria Illes Balears (IdISBa); University of Graz; Medical University of Graz; Medical University of Graz; Medical University of Graz	Palou, A (corresponding author), Univ Balearic Isl, Lab Mol Biol Nutr & Biotechnol Nutrigen, Cra Valldemossa Km 7-5, Palma De Mallorca 07122, Balearic Island, Spain.	andreu.palou@uib.es	Palou, Mariona/S-2098-2018; Palou, Andreu/K-9881-2014; Sanchez, Juana/K-9675-2014; Pico, Catalina/H-7115-2015	Palou, Mariona/0000-0001-9918-3764; Palou, Andreu/0000-0002-0295-4452; Sanchez, Juana/0000-0002-9176-8060; Pico, Catalina/0000-0001-6759-5844	EC \ Seventh Framework Programme (FP7) [244995]; Ministerio de Economia y Competitividad (MINECO) [AGL2015-67019-P]; Ministerio de Ciencia, innovacion y universidades [PGC2018-097436-B-I00]; Federal Ministry of Science, Research and Economy of Austria [BMWF651.483/0001-II/2/2010, BMWF-651.484/0001-II/2/2010]	EC \ Seventh Framework Programme (FP7); Ministerio de Economia y Competitividad (MINECO); Ministerio de Ciencia, innovacion y universidades; Federal Ministry of Science, Research and Economy of Austria	EC vertical bar Seventh Framework Programme (FP7), Grant/Award Number: 244995; Ministerio de Economia y Competitividad (MINECO), Grant/Award Number: AGL2015-67019-P; Ministerio de Ciencia, innovacion y universidades, Grant/Award Number: PGC2018-097436-B-I00; Federal Ministry of Science, Research and Economy of Austria, Grant/Award Number: BMWF651.483/0001-II/2/2010 and BMWF-651.484/0001-II/2/2010	Afman L, 2014, MOL NUTR FOOD RES, V58, P1708, DOI 10.1002/mnfr.201300559; Al-Daghri NM, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-140; Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; [Anonymous], 2019, DIABETES CARE, V42, pS1, DOI [10.2337/dc19-Sint01, 10.2337/dc19-SINT01]; Augustin R, 2004, J BIOL CHEM, V279, P16229, DOI 10.1074/jbc.M312226200; Caimari A, 2010, INT J OBESITY, V34, P831, DOI 10.1038/ijo.2010.17; Carobbio S, 2013, DIABETES, V62, P3697, DOI 10.2337/db12-1748; Casabiell X, 1997, J CLIN ENDOCR METAB, V82, P4270, DOI 10.1210/jc.82.12.4270; de Mello VDF, 2012, MOL NUTR FOOD RES, V56, P1160, DOI 10.1002/mnfr.201100685; DeBosch BJ, 2014, J BIOL CHEM, V289, P10989, DOI 10.1074/jbc.M113.527002; DeBosch BJ, 2012, ENDOCRINOLOGY, V153, P4181, DOI 10.1210/en.2012-1541; Denarie N, 2000, ATHEROSCLEROSIS, V148, P297, DOI 10.1016/S0021-9150(99)00276-2; Desai M, 2007, AM J PHYSIOL-REG I, V293, pR2306, DOI 10.1152/ajpregu.00783.2006; Diaz-Rua R, 2015, J NUTR BIOCHEM, V26, P398, DOI 10.1016/j.jnutbio.2014.11.013; Engelking LJ, 2004, J CLIN INVEST, V113, P1168, DOI 10.1172/JCI200420978; Ezzati M, 2017, LANCET, V390, P2627, DOI 10.1016/S0140-6736(17)32129-3; Faustmann G, 2016, BIOFACTORS, V42, P376, DOI 10.1002/biof.1281; Fletcher R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095598; Garcia AP, 2010, DIABETES OBES METAB, V12, P403, DOI 10.1111/j.1463-1326.2009.01174.x; Gertow K, 2004, DIABETOLOGIA, V47, P1118, DOI 10.1007/s00125-004-1417-4; Gluckman PD, 2005, MATERN CHILD NUTR, V1, P130, DOI 10.1111/j.1740-8709.2005.00020.x; Gorovits N, 2003, ENDOCRINOLOGY, V144, P1703, DOI 10.1210/en.2002-220968; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Hartford M, 2006, INT J CARDIOL, V108, P55, DOI 10.1016/j.ijcard.2005.04.004; Ikenasio-Thorpe BA, 2007, J ENDOCRINOL, V193, P31, DOI 10.1677/joe.1.07017; Iyer A, 2012, DIABETES, V61, P2320, DOI 10.2337/db11-1179; Jelinek D, 2011, HUM MOL GENET, V20, P312, DOI 10.1093/hmg/ddq466; Keijer J, 2010, MOL NUTR FOOD RES, V54, P240, DOI 10.1002/mnfr.200900304; KELLER H, 1993, P NATL ACAD SCI USA, V90, P2160, DOI 10.1073/pnas.90.6.2160; Kiani A, 2011, INT J ENDOCRINOL MET, V9, P409, DOI 10.5812/Kowsar.1726913X.3366; Konieczna J, 2015, INT J OBESITY, V39, P959, DOI 10.1038/ijo.2015.22; Konieczna J, 2014, GENES NUTR, V9, DOI 10.1007/s12263-013-0366-2; Konieczna J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081906; Kugiyama K, 1999, CIRCULATION, V100, P1280, DOI 10.1161/01.CIR.100.12.1280; Lamant M, 2006, J BIOL CHEM, V281, P36289, DOI 10.1074/jbc.M510861200; Levey AS, 2007, CLIN CHEM, V53, P766, DOI 10.1373/clinchem.2006.077180; Liu RX, 2017, DIABETES, V66, P935, DOI 10.2337/db16-0877; Mariman ECM, 2015, PHYSIOL GENOMICS, V47, P225, DOI 10.1152/physiolgenomics.00006.2015; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Musaad S, 2007, EPIDEMIOL REV, V29, P98, DOI 10.1093/epirev/mxm005; Oliver P, 2013, PFLUG ARCH EUR J PHY, V465, P459, DOI 10.1007/s00424-013-1246-8; Palou A, 2009, APPETITE, V52, P249, DOI 10.1016/j.appet.2008.09.013; Palou M, 2011, BRIT J NUTR, V106, P769, DOI 10.1017/S0007114511000973; Palou M, 2018, NUTR REV, V76, P875, DOI 10.1093/nutrit/nuy046; Palou M, 2012, J NUTR BIOCHEM, V23, P1627, DOI 10.1016/j.jnutbio.2011.11.005; Palou M, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-69; Palou M, 2010, ENDOCRINOLOGY, V151, P1030, DOI 10.1210/en.2009-0934; Patel KM, 2015, CIRC RES, V116, P789, DOI 10.1161/CIRCRESAHA.116.305811; Garcia AP, 2013, PEPTIDES, V39, P59, DOI 10.1016/j.peptides.2012.11.005; Garcia AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017313; Pavlovic Z, 2013, INT J MOL SCI, V14, P2529, DOI 10.3390/ijms14022529; Pellis L, 2003, PHYSIOL GENOMICS, V16, P99, DOI 10.1152/physiolgenomics.00111.2003; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Philip-Couderc P, 2003, HYPERTENSION, V41, P414, DOI 10.1161/01.HYP.0000057573.32425.95; Pico C, 2007, INT J OBESITY, V31, P1199, DOI 10.1038/sj.ijo.0803585; Pico C, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00436; Roder K, 2007, FEBS LETT, V581, P2715, DOI 10.1016/j.febslet.2007.05.022; Ruiz A, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00476; Sanchez J, 2017, INT J OBESITY, V41, P1481, DOI 10.1038/ijo.2017.132; Sanchez J, 2008, ENDOCRINOLOGY, V149, P733, DOI 10.1210/en.2007-0630; Sanchez J, 2012, J CLIN ENDOCR METAB, V97, pE648, DOI 10.1210/jc.2011-2209; Six DA, 2000, BBA-MOL CELL BIOL L, V1488, P1, DOI 10.1016/S1388-1981(00)00105-0; Smith EM, 2010, J LIPID RES, V51, P701, DOI 10.1194/jlr.M001404; Stark K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001948; Stein JH, 2008, J AM SOC ECHOCARDIOG, V21, P93, DOI 10.1016/j.echo.2007.11.011; Szostaczuk N, 2017, INT J OBESITY, V41, P360, DOI 10.1038/ijo.2016.241; Szostaczuk N, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00256; Turkieh A, 2014, J CLIN INVEST, V124, P2277, DOI 10.1172/JCI74668; van Schothorst EM, 2007, ANAL BIOCHEM, V363, P315, DOI 10.1016/j.ab.2007.01.016; Vickers MH, 2000, AM J PHYSIOL-ENDOC M, V279, pE83; Vitart V, 2008, NAT GENET, V40, P437, DOI 10.1038/ng.106; Wallace C, 2008, AM J HUM GENET, V82, P139, DOI 10.1016/j.ajhg.2007.11.001; Xing SC, 2015, CELL BIOCHEM BIOPHYS, V71, P1335, DOI 10.1007/s12013-014-0353-2; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15	74	6	6	2	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9003	9017		10.1096/fj.202000071RR	http://dx.doi.org/10.1096/fj.202000071RR		MAY 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32474969				2022-12-28	WOS:000538127700001
J	Shi, YR; Li, F; Wang, S; Wang, CL; Xie, Y; Zhou, J; Li, XX; Wang, BL				Shi, Yaru; Li, Fang; Wang, Shan; Wang, Changlan; Xie, Yan; Zhou, Jie; Li, Xiaoxia; Wang, Baoli			miR-196b-5p controls adipocyte differentiation and lipogenesis through regulating mTORC1 and TGF-beta signaling	FASEB JOURNAL			English	Article						adipogenesis; lipogenesis; mammalian target of rapamycin complex 1; microRNA; transforming growth factor-beta receptor 1; tuberous sclerosis 1	DIET-INDUCED OBESITY; PPAR-GAMMA; ADIPOSE-TISSUE; UP-REGULATION; EXPRESSION; INSULIN; ADIPOGENESIS; PROMOTES; GROWTH; PROLIFERATION	MicroRNAs have been reported to play a role in adipogenesis and obesity. This study was performed to investigate the role of miR-196b-5p in adipogenesis and the mechanism involved. The data revealed that miR-196b-5p expression increased in primary or established marrow stromal progenitor cells after adipogenic treatment. Supplementing miR-196b-5p in the progenitor cells stimulated adipogenic differentiation and lipogenesis, along with the induction of adipogenic and lipogenic factors. Conversely, inhibition of endogenous miR-196b-5p blocked adipogenesis and lipogenesis. Tuberous sclerosis 1 (Tsc1) and transforming growth factor-beta receptor 1 (TGFBR1) were demonstrated to be the direct target genes of miR-196b-5p. Supplementing miR-196b-5p activity in progenitor cells reduced the protein level of TSC1 and activated mammalian target of rapamycin complex 1 (mTORC1) signaling. We further demonstrated that the perturbation of TSC1 in progenitor cells altered the trend of adipogenic differentiation and lipogenesis. Overexpression of Tsc1 or inactivation of mTORC1 signaling attenuated the stimulation of adipogenic differentiation and lipogenesis by miR-196b-5p. Overexpression of Tgfbr1 also partially blocked the adipogenic effect of miR-196b-5p. Further investigations demonstrated that zinc finger E-box-binding homeobox 1 (ZEB1) transcriptionally upregulated miR-196b-5p expression. The current study suggests that miR-196b-5p promotes adipogenic differentiation and lipogenesis in progenitor cells through targeting TSC1 and TGFBR1 and therefore regulating mTORC1 and TGF-beta signaling.	[Shi, Yaru; Xie, Yan; Zhou, Jie; Wang, Baoli] Tianjin Med Univ, NHC Key Lab Hormones & Dev, Tianjin Key Lab Metab Dis, Chu Hsien I Mem Hosp, 6 Huan Rui Bei Rd, Tianjin 300134, Peoples R China; [Shi, Yaru; Xie, Yan; Zhou, Jie; Wang, Baoli] Tianjin Med Univ, Inst Endocrinol, 6 Huan Rui Bei Rd, Tianjin 300134, Peoples R China; [Li, Fang; Wang, Shan; Li, Xiaoxia] Tianjin Med Univ, Coll Basic Med Sci, Tianjin 300070, Peoples R China; [Wang, Changlan] Tianjin Med Univ, Gen Hosp, Div Endocrinol, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University	Wang, BL (corresponding author), Tianjin Med Univ, NHC Key Lab Hormones & Dev, Tianjin Key Lab Metab Dis, Chu Hsien I Mem Hosp, 6 Huan Rui Bei Rd, Tianjin 300134, Peoples R China.; Wang, BL (corresponding author), Tianjin Med Univ, Inst Endocrinol, 6 Huan Rui Bei Rd, Tianjin 300134, Peoples R China.; Li, XX (corresponding author), Tianjin Med Univ, Coll Basic Med Sci, Tianjin 300070, Peoples R China.	lixx@tmu.edu.cn; blwang@tmu.edu.cn			National Natural Science Foundation of China (NSFC) [81472040,81672116]; Natural Science Foundation of Tianjin City (Tianjin Natural Science Foundation) [18JCZDJC32200]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Tianjin City (Tianjin Natural Science Foundation)	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81472040,81672116; Natural Science Foundation of Tianjin City (Tianjin Natural Science Foundation), Grant/Award Number: 18JCZDJC32200	Ardestani A, 2018, TRENDS ENDOCRIN MET, V29, P737, DOI 10.1016/j.tem.2018.07.003; Cat AND, 2017, METHODS MOL BIOL, V1527, P283, DOI 10.1007/978-1-4939-6625-7_22; Chang GR, 2009, J PHARMACOL SCI, V109, P496, DOI 10.1254/jphs.08215FP; Chen CY, 2011, J CELL MOL MED, V15, P14, DOI 10.1111/j.1582-4934.2010.01219.x; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Ge J, 2014, CANCER CELL INT, V14, DOI 10.1186/s12935-014-0128-2; Gu CX, 2016, SCI REP-UK, V6, DOI 10.1038/srep38491; Gubelmann C, 2014, ELIFE, V3, DOI 10.7554/eLife.03346; Hagen RM, 2010, FEBS LETT, V584, P2689, DOI 10.1016/j.febslet.2010.04.004; Hausman Dorothy B., 2008, V456, P201, DOI 10.1007/978-1-59745-245-8_15; Holtrup B, 2017, ADIPOCYTE, V6, P224, DOI 10.1080/21623945.2017.1349042; Hou YY, 2016, ONCOL LETT, V11, P4013, DOI 10.3892/ol.2016.4491; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Jaeschke A, 2002, J CELL BIOL, V159, P217, DOI 10.1083/jcb.jcb.200206108; Janani C, 2015, DIABETES METAB SYND, V9, P46, DOI 10.1016/j.dsx.2014.09.015; Jin M, 2016, BIOCHEM BIOPH RES CO, V474, P76, DOI 10.1016/j.bbrc.2016.04.073; Kim SY, 2010, BIOCHEM BIOPH RES CO, V392, P323, DOI 10.1016/j.bbrc.2010.01.012; Kim YJ, 2009, J BONE MINER RES, V24, P816, DOI 10.1359/JBMR.081230; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Lee SW, 2016, J GASTRIC CANCER, V16, P221, DOI 10.5230/jgc.2016.16.4.221; Li CJ, 2015, J CLIN INVEST, V125, P1509, DOI 10.1172/JCI77716; Li N, 2016, ONCOL LETT, V11, P1745, DOI 10.3892/ol.2016.4141; Liang WC, 2015, J CELL BIOCHEM, V116, P2658, DOI 10.1002/jcb.25214; Liu SY, 2015, CELL PHYSIOL BIOCHEM, V36, P1552, DOI 10.1159/000430318; Menon S, 2014, CELL, V156, P771, DOI 10.1016/j.cell.2013.11.049; Ning XM, 2016, GENES-BASEL, V7, DOI 10.3390/genes7020005; Pang LX, 2016, J MOL ENDOCRINOL, V57, P33, DOI 10.1530/JME-16-0007; Polak P, 2008, CELL METAB, V8, P399, DOI 10.1016/j.cmet.2008.09.003; Potter CJ, 2002, NAT CELL BIOL, V4, P658, DOI 10.1038/ncb840; Shen LY, 2016, GENE, V575, P761, DOI 10.1016/j.gene.2015.09.060; Siersbaek R, 2012, TRENDS ENDOCRIN MET, V23, P56, DOI 10.1016/j.tem.2011.10.001; Siersbaek R, 2010, FEBS LETT, V584, P3242, DOI 10.1016/j.febslet.2010.06.010; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Tian LJ, 2017, GENE, V627, P32, DOI 10.1016/j.gene.2017.06.002; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Vienberg S, 2017, ACTA PHYSIOL, V219, P346, DOI 10.1111/apha.12681; Wang J, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.356; Zhang HH, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006189, 10.1371/journal.pone.0007826]; Zhang XM, 2016, OBESITY, V24, P1097, DOI 10.1002/oby.21467; Zhang X, 2015, SCI REP-UK, V5, DOI 10.1038/srep18118; Zhang YY, 2014, OBESITY, V22, P691, DOI 10.1002/oby.20528; Zhou J, 2015, INT J OBESITY, V39, P1282, DOI 10.1038/ijo.2015.43	45	5	6	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9207	9222		10.1096/fj.201901562RR	http://dx.doi.org/10.1096/fj.201901562RR		MAY 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32469097				2022-12-28	WOS:000538082100001
J	Krishna-K, K; Baby, N; Raghuraman, R; Navakkode, S; Behnisch, T; Sajikumar, S				Krishna-K, Kumar; Baby, Nimmi; Raghuraman, Radha; Navakkode, Sheeja; Behnisch, Thom; Sajikumar, Sreedharan			Regulation of aberrant proteasome activity re-establishes plasticity and long-term memory in an animal model of Alzheimer's disease	FASEB JOURNAL			English	Article						Alzheimer's disease; APP; PS1; hippocampus; long-term potentiation; proteasome; synaptic tagging; synaptic tagging and capture	KINASE-M-ZETA; PROTEIN-SYNTHESIS; LATE-PHASE; SYNAPTIC PLASTICITY; NEUROFIBRILLARY TANGLES; INHIBITOR MG132; UBIQUITIN; DEGRADATION; POTENTIATION; INVOLVEMENT	Reduced retrograde memory performance at the cognitive level and aggregation/deposition of amyloid beta (A beta) in the brain at the cellular level are some of the hallmarks of Alzheimer's Disease (AD). A molecular system that participates in the removal of proteins with an altered conformation is the Ubiquitin-Proteasome System (UPS). Impairments of the UPS in wild-type (WT) mice lead to defective clearance of A beta and prevent long-term plasticity of synaptic transmission. Here we show data whereby in contrast to WT mice, the inhibition of proteasome-mediated protein degradation in an animal model of AD by MG132 or lactacystin restores impaired activity-dependent synaptic plasticity and its associative interaction, synaptic tagging and capture (STC) in vitro, as well as associative long-term memory in vivo. This augmentation of synaptic plasticity and memory is mediated by the mTOR pathway and protein synthesis. Our data offer novel insights into the rebalancing of proteins relevant for synaptic plasticity which are regulated by UPS in AD-like animal models. In addition, the data provide evidence that proteasome inhibitors might be effective in reinstating synaptic plasticity and memory performance in AD, and therefore offer a new potential therapeutic option for AD treatment.	[Krishna-K, Kumar; Baby, Nimmi; Raghuraman, Radha; Navakkode, Sheeja; Sajikumar, Sreedharan] Natl Univ Singapore, Dept Physiol, Singapore 117597, Singapore; [Krishna-K, Kumar; Baby, Nimmi; Raghuraman, Radha; Sajikumar, Sreedharan] Natl Univ Singapore, Life Sci Inst, Neurobiol Programme, Singapore, Singapore; [Navakkode, Sheeja] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore; [Behnisch, Thom] Fudan Univ, State Key Lab Med Neurobiol, Inst Brain Sci, Shanghai, Peoples R China; [Behnisch, Thom] Fudan Univ, MOE Frontiers Ctr Brain Sci, Shanghai, Peoples R China; [Krishna-K, Kumar] Univ Tyumen, Sch Adv Studies, Tyumen, Russia; [Raghuraman, Radha] Brandeis Univ, Dept Biol, Waltham, MA 02254 USA	National University of Singapore; National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Fudan University; Fudan University; Tyumen State University; Brandeis University	Sajikumar, S (corresponding author), Natl Univ Singapore, Dept Physiol, Singapore 117597, Singapore.	phssks@nus.edu.sg	Behnisch, Thomas/G-3688-2018; BABY, NIMMI/AAK-2245-2020	Behnisch, Thomas/0000-0002-7842-3252; BABY, NIMMI/0000-0001-8344-8684; K, Krishna/0000-0001-6499-6917	National Medical Research Council [NMRC-CBRG-0099-2015, NMRC/OFIRG/0037/2017]; Ministry of Education - Singapore (MOE) [MOE2017-T3-1-002]	National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Ministry of Education - Singapore (MOE)(Ministry of Education, Singapore)	National Medical Research Council, Grant/Award Number: NMRC-CBRG-0099-2015 and NMRC/OFIRG/0037/2017; Ministry of Education - Singapore (MOE), Grant/Award Number: MOE2017-T3-1-002	Alzheimer A., 1907, ALLGEMEINE Z PSYCHIA, V64, P146, DOI DOI 10.1002/CA.980080612; Ballarini F, 2009, P NATL ACAD SCI USA, V106, P14599, DOI 10.1073/pnas.0907078106; Bekinschtein P, 2007, NEUROBIOL LEARN MEM, V87, P303, DOI 10.1016/j.nlm.2006.08.007; BERTONIFREDDARI C, 1989, PATHOL RES PRACT, V185, P799, DOI 10.1016/S0344-0338(89)80243-2; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Cai F, 2010, NEUROSCIENCE, V169, P1520, DOI 10.1016/j.neuroscience.2010.06.032; Chen BL, 2010, ACTA BIOCH BIOPH SIN, V42, P253, DOI 10.1093/abbs/gmq012; Chiang GG, 2005, J BIOL CHEM, V280, P25485, DOI 10.1074/jbc.M501707200; Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8; COLE GM, 1987, NEUROSCI LETT, V79, P207, DOI 10.1016/0304-3940(87)90698-7; Dang LF, 2014, INT J MOL MED, V33, P1083, DOI 10.3892/ijmm.2014.1678; Dasgupta A, 2017, P NATL ACAD SCI USA, V114, pE8741, DOI 10.1073/pnas.1711267114; Dong CG, 2008, LEARN MEMORY, V15, P335, DOI 10.1101/lm.984508; Dong CH, 2014, J NEUROSCI, V34, P3171, DOI 10.1523/JNEUROSCI.3291-13.2014; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Favit A, 2000, J NEUROCHEM, V75, P1258, DOI 10.1046/j.1471-4159.2000.0751258.x; Felsenberg J, 2014, J EXP BIOL, V217, P3441, DOI 10.1242/jeb.108142; Fonseca R, 2006, NEURON, V52, P239, DOI 10.1016/j.neuron.2006.08.015; Frey U, 1998, NEUROPHARMACOLOGY, V37, P545, DOI 10.1016/S0028-3908(98)00040-9; Graber TE, 2013, LEARN MEMORY, V20, P518, DOI 10.1101/lm.027664.112; Grunwald T, 1998, P NATL ACAD SCI USA, V95, P3193, DOI 10.1073/pnas.95.6.3193; Haynes KA, 2015, ACS CHEM NEUROSCI, V6, P695, DOI 10.1021/acschemneuro.5b00068; Hegde AN, 2004, PROG NEUROBIOL, V73, P311, DOI 10.1016/j.pneurobio.2004.05.005; Hegde AN, 2007, TRENDS NEUROSCI, V30, P587, DOI 10.1016/j.tins.2007.08.005; Hegde AN, 2017, NEUROBIOL LEARN MEM, V138, P98, DOI 10.1016/j.nlm.2016.09.003; Hong X., 2013, HUM MOL GENET, V23, P1056; Inden M, 2005, J PHARMACOL SCI, V97, P203, DOI 10.1254/jphs.FP0040525; Inoue S, 2009, CLIN EXP IMMUNOL, V156, P172, DOI 10.1111/j.1365-2249.2008.03872.x; Ji CY, 2017, METHOD CELL BIOL, V141, P229, DOI 10.1016/bs.mcb.2017.06.011; Karpova A, 2006, J NEUROSCI, V26, P4949, DOI 10.1523/JNEUROSCI.4573-05.2006; Keller JN, 2000, J NEUROCHEM, V75, P436, DOI 10.1046/j.1471-4159.2000.0750436.x; Knight RT, 1996, NATURE, V383, P256, DOI 10.1038/383256a0; Krishna K, 2016, J ALZHEIMERS DIS, V51, P783, DOI 10.3233/JAD-150838; Lafay-Chebassier C, 2005, J NEUROCHEM, V94, P215, DOI 10.1111/j.1471-4159.2005.03187.x; Li Q, 2017, P NATL ACAD SCI USA, V114, P5527, DOI 10.1073/pnas.1613700114; Li Q, 2016, CEREB CORTEX, V26, P2541, DOI 10.1093/cercor/bhv084; Li Q, 2014, CEREB CORTEX, V24, P353, DOI 10.1093/cercor/bhs315; Ling DSF, 2002, NAT NEUROSCI, V5, P295, DOI 10.1038/nn829; Ma T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012845; Moncada D, 2007, J NEUROSCI, V27, P7476, DOI 10.1523/JNEUROSCI.1083-07.2007; Moncada D, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/650780; Moncada D, 2017, NEUROBIOL LEARN MEM, V138, P226, DOI 10.1016/j.nlm.2016.06.003; MORI H, 1987, SCIENCE, V235, P1641, DOI 10.1126/science.3029875; Ortiz-Lazareno PC, 2008, IMMUNOLOGY, V124, P534, DOI 10.1111/j.1365-2567.2008.02806.x; PERRY G, 1987, P NATL ACAD SCI USA, V84, P3033, DOI 10.1073/pnas.84.9.3033; Popovic D, 2014, NAT MED, V20, P1242, DOI 10.1038/nm.3739; Puzzo Daniela, 2006, Current Alzheimer Research, V3, P179, DOI 10.2174/156720506777632871; Redondo RL, 2011, NAT REV NEUROSCI, V12, P17, DOI 10.1038/nrn2963; Romero-Granados R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028927; Sacktor TC, 2011, NAT REV NEUROSCI, V12, P9, DOI 10.1038/nrn2949; Sadoul R, 1996, EMBO J, V15, P3845, DOI 10.1002/j.1460-2075.1996.tb00758.x; Sajikumar S, 2005, J NEUROSCI, V25, P5750, DOI 10.1523/JNEUROSCI.1104-05.2005; Sajikumar S., 2019, J NEUROSCI, P2876; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Serrano P, 2005, J NEUROSCI, V25, P1979, DOI 10.1523/JNEUROSCI.5132-04.2005; Sharma M, 2015, SCI REP-UK, V5, DOI 10.1038/srep16616; Shetty MS, 2017, AGEING RES REV, V35, P22, DOI 10.1016/j.arr.2016.12.008; Shetty MS, 2017, AGING CELL, V16, P136, DOI 10.1111/acel.12537; Shetty MS, 2015, JOVE-J VIS EXP, DOI 10.3791/53008; Slipczuk L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006007; TERRY RD, 1963, J NEUROPATH EXP NEUR, V22, P629, DOI 10.1097/00005072-196310000-00005; Trinchese F, 2004, ANN NEUROL, V55, P801, DOI 10.1002/ana.20101; Tsokas P, 2015, SYNAPTIC TAGGING CAP, VSpringer, P99; Tsokas P, 2016, ELIFE, V5, DOI 10.7554/eLife.14846; Upadhya SC, 2006, NEUROCHEM INT, V48, P296, DOI 10.1016/j.neuint.2005.11.003; Valley CC, 2008, J MOL ENDOCRINOL, V40, P23, DOI 10.1677/JME-07-0067; Westphalen RI, 2003, J NEURAL TRANSM, V110, P1013, DOI 10.1007/s00702-003-0012-z; You J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048613; Yun D, 2018, NEUROPHARMACOLOGY, V133, P354, DOI 10.1016/j.neuropharm.2018.01.043	70	5	5	1	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9466	9479		10.1096/fj.201902844RR	http://dx.doi.org/10.1096/fj.201902844RR		MAY 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32459037				2022-12-28	WOS:000536294300001
J	van Faassen, H; Ryan, S; Henry, KA; Raphael, S; Yang, QL; Rossotti, MA; Brunette, E; Jiang, SS; Haqqani, AS; Sulea, T; MacKenzie, CR; Tanha, J; Hussack, G				van Faassen, Henk; Ryan, Shannon; Henry, Kevin A.; Raphael, Shalini; Yang, Qingling; Rossotti, Martin A.; Brunette, Eric; Jiang, Susan; Haqqani, Arsalan S.; Sulea, Traian; MacKenzie, C. Roger; Tanha, Jamshid; Hussack, Greg			Serum albumin-binding V(H)Hs with variable pH sensitivities enable tailored half-life extension of biologics	FASEB JOURNAL			English	Article						antibody; half-life; nanobody; pH sensitivity; serum albumin; single-domain antibody	DOMAIN ANTIBODIES; IN-VIVO; FUSION PROTEINS; RECOGNITION; SALMONELLA; STRATEGY; PHARMACOKINETICS; GENERATION; LIBRARIES; AFFINITY	Prolonged serum half-life is required for the efficacy of most protein therapeutics. One strategy for half-life extension is to exploit the long circulating half-life of serum albumin by incorporating a binding moiety that recognizes albumin. Here, we describe camelid single-domain antibodies (V(H)Hs) that bind the serum albumins of multiple species with moderate to high affinity at both neutral and endosomal pH and significantly extend the serum half-lives of multiple proteins in rats from minutes to days. We serendipitously identified an additional VHH (M75) that is naturally pH-sensitive: at endosomal pH, binding affinity for human serum albumin (HSA) was dramatically weakened and binding to rat serum albumin (RSA) was undetectable. Domain mapping revealed that M75 bound to HSA domain 1 and 2. Moreover, alanine scanning of HSA His residues suggested a critical role for His247, located in HSA domain 2, in M75 binding and its pH dependence. Isothermal titration calorimetry experiments were suggestive of proton-linked binding of M75 to HSA, with differing binding enthalpies observed for full-length HSA and an HSA domain 1-domain 2 fusion protein in which surface-exposed His residues were substituted with Ala. M75 conferred moderate half-life extension in rats, from minutes to hours, likely due to rapid dissociation from RSA during FcRn-mediated endosomal recycling in tandem with albumin conformational changes induced by M75 binding that prevented interaction with FcRn. Humanized V(H)Hs maintained in vivo half-life extension capabilities. These V(H)Hs represent a new set of tools for extending protein therapeutic half-life and one (M75) demonstrates a unique pH-sensitive binding interaction that can be exploited to achieve modest in vivo half-life.	[van Faassen, Henk; Ryan, Shannon; Henry, Kevin A.; Raphael, Shalini; Yang, Qingling; Rossotti, Martin A.; Brunette, Eric; Jiang, Susan; Haqqani, Arsalan S.; MacKenzie, C. Roger; Tanha, Jamshid; Hussack, Greg] Natl Res Council Canada, Human Hlth Therapeut Res Ctr, 100 Sussex Dr, Ottawa, ON K1A 0R6, Canada; [Henry, Kevin A.; Tanha, Jamshid] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Sulea, Traian] Natl Res Council Canada, Human Hlth Therapeut Res Ctr, Montreal, PQ, Canada	National Research Council Canada; University of Ottawa; National Research Council Canada	Hussack, G (corresponding author), Natl Res Council Canada, Human Hlth Therapeut Res Ctr, 100 Sussex Dr, Ottawa, ON K1A 0R6, Canada.	Greg.Hussack@nrc-cnrc.gc.ca						Adams R, 2016, MABS-AUSTIN, V8, P1336, DOI 10.1080/19420862.2016.1185581; Andersen JT, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1607; Blackler RJ, 2016, GLYCOBIOLOGY, V26, P181, DOI 10.1093/glycob/cwv093; Bonvin P, 2015, MABS-AUSTIN, V7, P294, DOI 10.1080/19420862.2015.1006993; Bostrom J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017887; BUNDLE DR, 1994, BIOCHEMISTRY-US, V33, P5172, DOI 10.1021/bi00183a022; Chaparro-Riggers J, 2012, J BIOL CHEM, V287, P11090, DOI 10.1074/jbc.M111.319764; Coppieters K, 2006, ARTHRITIS RHEUM-US, V54, P1856, DOI 10.1002/art.21827; CYGLER M, 1991, SCIENCE, V253, P442, DOI 10.1126/science.1713710; Dave E, 2016, MABS-AUSTIN, V8, P1319, DOI 10.1080/19420862.2016.1210747; Dennis MS, 2002, J BIOL CHEM, V277, P35035, DOI 10.1074/jbc.M205854200; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Farrington GK, 2014, FASEB J, V28, P4764, DOI 10.1096/fj.14-253369; FOOTE J, 1992, J MOL BIOL, V224, P487, DOI 10.1016/0022-2836(92)91010-M; Haqqani Arsalan S., 2008, V439, P241, DOI 10.1007/978-1-59745-188-8_17; Henry KA, 2015, PROTEIN ENG DES SEL, V28, P379, DOI 10.1093/protein/gzv039; Holt LJ, 2008, PROTEIN ENG DES SEL, V21, P283, DOI 10.1093/protein/gzm067; Hussack G, 2018, PLOS ONE, V13, DOI [10.1371/journal.pone.0208978, 10.1371/journal.pone.0298978]; Hussack G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028218; Hussack G, 2011, J BIOL CHEM, V286, P8961, DOI 10.1074/jbc.M110.198754; Igawa T, 2010, NAT BIOTECHNOL, V28, P1203, DOI 10.1038/nbt.1691; Jafari R, 2017, CURR MED CHEM, V24, P1228, DOI 10.2174/0929867324666170113112759; JONES PT, 1986, NATURE, V321, P522, DOI 10.1038/321522a0; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Knappik A, 2000, J MOL BIOL, V296, P57, DOI 10.1006/jmbi.1999.3444; Konning D, 2016, MAR BIOTECHNOL, V18, P161, DOI 10.1007/s10126-016-9690-z; Kontermann RE, 2016, EXPERT OPIN BIOL TH, V16, P903, DOI 10.1517/14712598.2016.1165661; Larsen Maja Thim, 2016, Mol Cell Ther, V4, P3, DOI 10.1186/s40591-016-0048-8; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Makrides SC, 1996, J PHARMACOL EXP THER, V277, P534; Mitragotri S, 2014, NAT REV DRUG DISCOV, V13, P655, DOI 10.1038/nrd4363; Moreno M, 2010, Patent No. [US 2010/0279937, 20100279937]; Muller MR, 2012, MABS-AUSTIN, V4, P673, DOI 10.4161/mabs.22242; Murase T, 2014, J BIOL CHEM, V289, P2331, DOI 10.1074/jbc.M113.505917; Murtaugh ML, 2011, PROTEIN SCI, V20, P1619, DOI 10.1002/pro.696; Nguyen A, 2006, PROTEIN ENG DES SEL, V19, P291, DOI 10.1093/protein/gzl011; Nilvebrant J, 2013, COMPUT STRUCT BIOTEC, V6, DOI 10.5936/csbj.201303009; Podust VN, 2016, J CONTROL RELEASE, V240, P52, DOI 10.1016/j.jconrel.2015.10.038; Schlapschy M, 2013, PROTEIN ENG DES SEL, V26, P489, DOI 10.1093/protein/gzt023; Schmidt MM, 2013, STRUCTURE, V21, P1966, DOI 10.1016/j.str.2013.08.022; Schroter C, 2015, MABS-AUSTIN, V7, P138, DOI 10.4161/19420862.2014.985993; Sircar A, 2011, J IMMUNOL, V186, P6357, DOI 10.4049/jimmunol.1100116; Sleep D, 2013, BBA-GEN SUBJECTS, V1830, P5526, DOI 10.1016/j.bbagen.2013.04.023; Smith BJ, 2001, BIOCONJUGATE CHEM, V12, P750, DOI 10.1021/bc010003g; Sola RJ, 2010, BIODRUGS, V24, P9, DOI 10.2165/11530550-000000000-00000; Steiner D, 2017, PROTEIN ENG DES SEL, V30, P583, DOI 10.1093/protein/gzx022; Strohl WR, 2015, BIODRUGS, V29, P215, DOI 10.1007/s40259-015-0133-6; Sulea T, 2020, MABS-AUSTIN, V12, DOI 10.1080/19420862.2019.1682866; Swierczewska M, 2015, EXPERT OPIN EMERG DR, V20, P531, DOI 10.1517/14728214.2015.1113254; Vincke C, 2009, J BIOL CHEM, V284, P3273, DOI 10.1074/jbc.M806889200; Walker A, 2010, PROTEIN ENG DES SEL, V23, P271, DOI 10.1093/protein/gzp091; Young NM, 2014, PROTEIN ENG DES SEL, V27, P383, DOI 10.1093/protein/gzu018; Zhang Jianbing, 2009, V525, P323, DOI 10.1007/978-1-59745-554-1_17; Zhang Y, 2010, COMPUT METH PROG BIO, V99, P306, DOI 10.1016/j.cmpb.2010.01.007	54	18	18	3	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8155	8171		10.1096/fj.201903231R	http://dx.doi.org/10.1096/fj.201903231R		APR 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32342547				2022-12-28	WOS:000529515800001
J	Li, FF; Zhao, HP; Li, GW; Zhang, SJ; Wang, RL; Tao, Z; Zheng, YM; Han, ZP; Liu, P; Ma, QF; Luo, YM				Li, Fangfang; Zhao, Haiping; Li, Guangwen; Zhang, Sijia; Wang, Rongliang; Tao, Zhen; Zheng, Yangmin; Han, Ziping; Liu, Ping; Ma, Qingfeng; Luo, Yumin			Intravenous antagomiR-494 lessens brain-infiltrating neutrophils by increasing HDAC2-mediated repression of multiple MMPs in experimental stroke	FASEB JOURNAL			English	Article						antagomiR-494; HDAC2; MMP; neutrophils; stroke	ISCHEMIC-STROKE; INHIBITION; MIGRATION; INVASION; NEUROPROTECTION; TRANSCRIPTION; MODULATION; ACTIVATION; EXPRESSION; PROTECTS	Neutrophil infiltration and phenotypic transformation are believed to contribute to neuronal damage in ischemic stroke. Emerging evidence suggests that histone deacetylase 2 (HDAC2) is an epigenetic regulator of inflammatory cells. Here, we aimed to investigate whether microRNA-494 (miR-494) affects HDAC2-mediated neutrophil infiltration and phenotypic shift. MiR-494 levels in neutrophils from acute ischemic stroke (AIS) patients were detected by real-time PCR. Chromatin Immunoprecipitation (ChIP)-Seq was performed to clarify which genes are the binding targets of HDAC2. Endothelial cells and cortical neurons were subjected to oxygen-glucose deprivation (OGD), transwell assay was conducted to examine neutrophil migration through endothelial cells, and neuronal injury was examined after stimulating with supernatant from antagomiR-494-treated neutrophils. C57BL/6J mice were subjected to transient middle cerebral artery occlusion (MCAO) and antagomiR-494 was injected through tail vein immediately after reperfusion, and neutrophil infiltration and phenotypic shift was examined. We found that the expression of miR-494 in neutrophils was significantly increased in AIS patients. HDAC2 targeted multiple matrix metalloproteinases (MMPs) and Fc-gamma receptor III (CD16) genes in neutrophils of AIS patients. Furthermore, antagomiR-494 repressed expression of multiple MMPs genes, including MMP7, MMP10, MMP13, and MMP16, which reduced the number of brain-infiltrating neutrophils by regulating HDAC2. AntagomiR-494 could also exert its neuroprotective role through inhibiting the shift of neutrophils toward pro-inflammatory N1 phenotype in vivo and in vitro. Taken together, miR-494 may serve as an alternative predictive biomarker of the outcome of AIS patients, and antagomiR-494 treatment decreases the expression of multiple MMPs and the infiltration of neutrophils and inhibits the shift of neutrophils into N1 phenotype partly by targeting HDAC2.	[Li, Fangfang; Zhao, Haiping; Li, Guangwen; Zhang, Sijia; Wang, Rongliang; Tao, Zhen; Zheng, Yangmin; Han, Ziping; Liu, Ping; Ma, Qingfeng; Luo, Yumin] Capital Med Univ, Inst Cerebrovasc Dis Res, Xuanwu Hosp, 45 Changchun St, Beijing 100053, Peoples R China; [Li, Fangfang; Zhao, Haiping; Li, Guangwen; Zhang, Sijia; Wang, Rongliang; Tao, Zhen; Zheng, Yangmin; Han, Ziping; Liu, Ping; Ma, Qingfeng; Luo, Yumin] Capital Med Univ, Dept Neurol, Xuanwu Hosp, 45 Changchun St, Beijing 100053, Peoples R China; [Zhao, Haiping; Wang, Rongliang; Tao, Zhen; Zheng, Yangmin; Han, Ziping; Luo, Yumin] Beijing Geriatr Med Res Ctr, Beijing, Peoples R China; [Zhao, Haiping; Wang, Rongliang; Tao, Zhen; Zheng, Yangmin; Han, Ziping; Luo, Yumin] Beijing Key Lab Translat Med Cerebrovasc Dis, Beijing, Peoples R China; [Luo, Yumin] Capital Med Univ, Beijing Inst Brain Disorders, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Capital Medical University	Luo, YM (corresponding author), Capital Med Univ, Inst Cerebrovasc Dis Res, Xuanwu Hosp, 45 Changchun St, Beijing 100053, Peoples R China.; Luo, YM (corresponding author), Capital Med Univ, Dept Neurol, Xuanwu Hosp, 45 Changchun St, Beijing 100053, Peoples R China.	yumin111@ccmu.edu.cn	zhao, haiping/I-1306-2014	zhao, Haiping/0000-0002-3244-1527	National Natural Science Foundation of China (NSFC) [81771413,81771412,81971222]; Natural Science Foundation of Beijing Municipality (Beijing Natural Science Foundation) [KZ201810025041]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Beijing Municipality (Beijing Natural Science Foundation)	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81771413,81771412,81971222; Natural Science Foundation of Beijing Municipality (Beijing Natural Science Foundation), Grant/Award Number: KZ201810025041	Biswas MHU, 2016, STEM CELL REP, V7, P316, DOI 10.1016/j.stemcr.2016.08.006; Campbell BCV, 2019, LANCET, V394, P139, DOI 10.1016/S0140-6736(19)31053-0; Certo M, 2015, PHARMACOL RES, V102, P298, DOI 10.1016/j.phrs.2015.10.009; Crosson CE, 2010, INVEST OPHTH VIS SCI, V51, P3639, DOI 10.1167/iovs.09-4538; Dodds JA, 2019, NEUROLOGY, V92, pE2784, DOI 10.1212/WNL.0000000000007653; Feigenson M, 2017, J BONE MINER RES, V32, P2453, DOI 10.1002/jbmr.3236; Gao CZ, 2008, MOL BIOL CELL, V19, P3020, DOI 10.1091/mbc.E07-11-1203; Garcia-Culebras A, 2019, STROKE, V50, P2922, DOI 10.1161/STROKEAHA.119.025085; Gill SE, 2016, AM J RESP CELL MOL, V55, P243, DOI 10.1165/rcmb.2015-0193OC; Han ZP, 2018, AGING DIS, V9, P235, DOI 10.14336/AD.2017.0328; He XW, 2019, ATHEROSCLEROSIS, V289, P36, DOI 10.1016/j.atherosclerosis.2019.08.002; Huang L, 2018, EXP NEUROL, V300, P41, DOI 10.1016/j.expneurol.2017.10.024; Cuartero MI, 2013, STROKE, V44, P3498, DOI 10.1161/STROKEAHA.113.002470; Jickling GC, 2015, J CEREBR BLOOD F MET, V35, P888, DOI 10.1038/jcbfm.2015.45; Jovin TG, 2015, NEW ENGL J MED, V372, P2296, DOI 10.1056/NEJMoa1503780; Lenglet S, 2014, THROMB HAEMOSTASIS, V112, P363, DOI 10.1160/TH14-01-0007; Li Y, 2018, NEOPLASIA, V20, P745, DOI 10.1016/j.neo.2018.03.008; Lin CY, 2015, ONCOTARGET, V6, P43081, DOI 10.18632/oncotarget.5638; Liu J, 2012, J CELL MOL MED, V16, P2379, DOI 10.1111/j.1582-4934.2012.01551.x; Ma FF, 2016, NEUROBIOL DIS, V91, P236, DOI 10.1016/j.nbd.2016.03.016; Ma H, 2014, INT J MOL SCI, V15, P10936, DOI 10.3390/ijms150610936; Mauler M, 2019, CIRCULATION, V139, P918, DOI 10.1161/CIRCULATIONAHA.118.033942; McCrary MR, 2019, FASEB J, V33, P10680, DOI 10.1096/fj.201900070R; McGrath JC, 2015, BRIT J PHARMACOL, V172, P3189, DOI 10.1111/bph.12955; Purroy A, 2018, ATHEROSCLEROSIS, V278, P124, DOI 10.1016/j.atherosclerosis.2018.09.022; Shi KB, 2019, LANCET NEUROL, V18, P1058, DOI 10.1016/S1474-4422(19)30078-X; Sonoda T, 2019, STROKE, V50, P1510, DOI 10.1161/STROKEAHA.118.023648; Swingler TE, 2010, BIOCHEM J, V427, P391, DOI 10.1042/BJ20091798; Tang CM, 2019, NANO LETT, V19, P4470, DOI 10.1021/acs.nanolett.9b01282; Venosa A, 2017, TOXICOL SCI, V157, P222, DOI 10.1093/toxsci/kfx032; Wang HZ, 2015, ONCOTARGETS THER, V8, P3211, DOI 10.2147/OTT.S79282; Wang H, 2019, CNS NEUROSCI THER, V25, P476, DOI 10.1111/cns.13074; Wang XH, 2010, CIRCULATION, V122, P1308, DOI 10.1161/CIRCULATIONAHA.110.964684; Xiong CX, 2019, FASEB J, V33, P8249, DOI 10.1096/fj.201801067RR; Zeidan-Chulia F, 2018, J PERIODONTAL RES, V53, P916, DOI 10.1111/jre.12583; Zhao HP, 2019, J CEREBR BLOOD F MET, V39, P2392, DOI 10.1177/0271678X19875201; Zhao HP, 2020, BRIT J PHARMACOL, V177, P128, DOI 10.1111/bph.14852; Zhao HW, 2021, J ASIAN NAT PROD RES, V23, P26, DOI 10.1080/10286020.2019.1700230	38	11	11	4	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6934	6949		10.1096/fj.201903127R	http://dx.doi.org/10.1096/fj.201903127R		APR 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32239566	Green Submitted			2022-12-28	WOS:000522968100001
J	Lim, D; Lee, S; Choi, MS; Han, JY; Seong, Y; Na, D; Kwon, YS; Lee, YS				Lim, Do-Hwan; Lee, Seungjae; Choi, Min-Seok; Han, Jee Yun; Seong, Youngmo; Na, Dokyun; Kwon, Young-Soo; Lee, Young Sik			The conserved microRNA miR-8-3p coordinates the expression of V-ATPase subunits to regulate ecdysone biosynthesis for Drosophila metamorphosis	FASEB JOURNAL			English	Article						Ago1; CLIP-seq; ecdysone; metamorphosis; microRNA; V-ATPase	PROTHORACIC GLAND; H+-ATPASE; MESENCHYMAL TRANSITION; VACUOLAR ATPASE; MIR-200 FAMILY; INDUCIBLE GENE; EARLY PUFF; BODY-SIZE; ENCODES 2; RECEPTOR	The steroid hormone ecdysone is the central regulator of insect metamorphosis, during which a growing, immature larva is remodeled, through pupal stages, to a reproductive adult. However, the underlying mechanisms of ecdysone-mediated metamorphosis remain to be fully elucidated. Here, we identified metamorphosis-associated microRNAs (miRNAs) and their potential targets by cross-linking immunoprecipitation coupled with deep sequencing of endogenous Argonaute 1 protein in Drosophila. Interestingly, miR-8-3p targeted five Vha genes encoding distinct subunits of vacuolar H+-ATPase (V-ATPase), which has a vital role in the organellar acidification. The expression of ecdysone-responsive miR-8-3p is normally downregulated during Drosophila metamorphosis, but temporary overexpression of miR-8-3p in the whole body at the end of larval development led to defects in metamorphosis and survival, hallmarks of aberrant ecdysone signaling. In addition, miR-8-3p was expressed in the prothoracic gland (PG), which produces and releases ecdysone in response to prothoracicotropic hormone (PTTH). Notably, overexpression of miR-8-3p or knockdown of its Vha targets in the PG resulted in larger than normal, ecdysone-deficient larvae that failed to develop into the pupal stage but could be rescued by ecdysone feeding. Moreover, these animals showed defective PTTH signaling with a concomitant decrease in the expression of ecdysone biosynthetic genes. We also demonstrated that the regulatory network between the conserved miR-8-3p/miR-200 family and V-ATPase was functional in human cells. Consequently, our data indicate that the coordinated regulation of V-ATPase subunits by miR-8-3p is involved in Drosophila metamorphosis by controlling the ecdysone biosynthesis.	[Lim, Do-Hwan; Lee, Seungjae; Choi, Min-Seok; Han, Jee Yun; Lee, Young Sik] Korea Univ, Coll Life Sci & Biotechnol, Seoul 02841, South Korea; [Lim, Do-Hwan; Lee, Seungjae; Choi, Min-Seok; Lee, Young Sik] Korea Univ, Inst Anim Mol Biotechnol, Seoul, South Korea; [Seong, Youngmo; Kwon, Young-Soo] Sejong Univ, Dept Biosci & Biotechnol, Seoul, South Korea; [Na, Dokyun] Chung Ang Univ, Sch Integrat Engn, Seoul, South Korea; [Lim, Do-Hwan] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Lee, Seungjae] Sloan Kettering Inst, Dept Dev Biol, New York, NY USA; [Han, Jee Yun] Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA USA	Korea University; Korea University; Sejong University; Chung Ang University; University of California System; University of California San Diego; Memorial Sloan Kettering Cancer Center; University of California System; University of California Los Angeles	Lee, YS (corresponding author), Korea Univ, Coll Life Sci & Biotechnol, Seoul 02841, South Korea.	ys-lee@korea.ac.kr	Lim, Dohwan/ABA-2685-2020	Lee, Seungjae/0000-0001-5626-9656; Lim, Do-Hwan/0000-0002-2054-1416; Lee, Seungjae/0000-0001-9081-2835	National Research Foundation of Korea (NRF) [NRF-2014R1A1A2058193]; Korea University (KU)	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea University (KU)	National Research Foundation of Korea (NRF), Grant/Award Number: NRF-2014R1A1A2058193; Korea University (KU)	Allan AK, 2005, PHYSIOL GENOMICS, V22, P128, DOI 10.1152/physiolgenomics.00233.2004; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BURTIS KC, 1990, CELL, V61, P85, DOI 10.1016/0092-8674(90)90217-3; Caldwell PE, 2005, CURR BIOL, V15, P1785, DOI 10.1016/j.cub.2005.09.011; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Cohen S, 2010, SEMIN CELL DEV BIOL, V21, P727, DOI 10.1016/j.semcdb.2010.07.004; DIBELLO PR, 1991, GENETICS, V129, P385; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Feng Xiangling, 2014, Cancer Lett, V344, P166, DOI 10.1016/j.canlet.2013.11.004; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Fulga TA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8279; Gibbens YY, 2011, DEVELOPMENT, V138, P2693, DOI 10.1242/dev.063412; Gilbert LI, 2002, ANNU REV ENTOMOL, V47, P883, DOI 10.1146/annurev.ento.47.091201.145302; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Gu S, 2009, NAT STRUCT MOL BIOL, V16, P144, DOI 10.1038/nsmb.1552; Hermle T, 2013, EMBO J, V32, P245, DOI 10.1038/emboj.2012.323; Hong JS, 2015, VET RES, V46, DOI 10.1186/s13567-015-0172-5; Hyun S, 2009, CELL, V139, P1096, DOI 10.1016/j.cell.2009.11.020; Jin H, 2012, GENE DEV, V26, P1427, DOI 10.1101/gad.192872.112; Karres JS, 2007, CELL, V131, P136, DOI 10.1016/j.cell.2007.09.020; KING RC, 1966, Z ZELLFORSCH MIK ANA, V73, P272, DOI 10.1007/BF00334868; Kissing S, 2015, J BIOL CHEM, V290, P14166, DOI 10.1074/jbc.M114.628891; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Kucherenko MM, 2012, EMBO J, V31, P4511, DOI 10.1038/emboj.2012.298; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee YS, 2009, NAT CELL BIOL, V11, P1150, DOI 10.1038/ncb1930; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim DH, 2019, INSECT MOL BIOL, V28, P444, DOI 10.1111/imb.12562; Lim DH, 2018, FASEB J, V32, P4519, DOI 10.1096/fj.201701185RR; Lim DH, 2013, J CELL BIOCHEM, V114, P418, DOI 10.1002/jcb.24379; Lorincz P, 2017, CELLS-BASEL, V6, DOI 10.3390/cells6030022; Lu YD, 2005, CANCER RES, V65, P6843, DOI 10.1158/0008-5472.CAN-04-3822; Martinez-Lopez N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3799; Maxson ME, 2014, J CELL SCI, V127, P4987, DOI 10.1242/jcs.158550; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Mijaljica D, 2011, AUTOPHAGY, V7, P666, DOI 10.4161/auto.7.6.15812; Mirth C, 2005, CURR BIOL, V15, P1796, DOI 10.1016/j.cub.2005.09.017; Moeller ME, 2013, DEVELOPMENT, V140, P4730, DOI 10.1242/dev.099739; Na D, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1091; Niwa YS, 2014, GENES GENET SYST, V89, P27, DOI 10.1266/ggs.89.27; Ohhara Y, 2015, P NATL ACAD SCI USA, V112, P1452, DOI 10.1073/pnas.1414966112; Pamarthy S, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0811-3; Parvy JP, 2014, DEVELOPMENT, V141, P3955, DOI 10.1242/dev.102020; Perdigao-Henriques R, 2016, ONCOGENE, V35, P158, DOI 10.1038/onc.2015.69; Pignoni F, 1997, DEVELOPMENT, V124, P271; Rewitz KF, 2009, SCIENCE, V326, P1403, DOI 10.1126/science.1176450; Riddiford LM, 2001, VITAM HORM, V60, P1; RIDDIFORD LM, 1993, AM ZOOL, V33, P340; Rusten TE, 2004, DEV CELL, V7, P179, DOI 10.1016/j.devcel.2004.07.005; Scott CC, 2011, BIOESSAYS, V33, P103, DOI 10.1002/bies.201000108; SEGRAVES WA, 1990, GENE DEV, V4, P204, DOI 10.1101/gad.4.2.204; Sennoune SR, 2004, CELL BIOCHEM BIOPHYS, V40, P185, DOI 10.1385/CBB:40:2:185; Sernpere LF, 2003, DEV BIOL, V259, P9, DOI 10.1016/S0012-1606(03)00208-2; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shimada-Niwa Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6778; Tang HL, 2013, CLIN CANCER RES, V19, P5602, DOI 10.1158/1078-0432.CCR-13-1326; Texada MJ, 2019, DEV CELL, V48, P659, DOI 10.1016/j.devcel.2019.01.007; Thummel CS, 1996, TRENDS GENET, V12, P306, DOI 10.1016/0168-9525(96)10032-9; Thummel CS, 2001, DEV CELL, V1, P453, DOI 10.1016/S1534-5807(01)00060-0; Walkiewicz MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005072; Wang JX, 2012, IEEE T NANOBIOSCI, V11, P386, DOI 10.1109/TNB.2012.2210907; Wu YC, 2012, DEV CELL, V23, P202, DOI 10.1016/j.devcel.2012.05.013; Yamanaka N, 2013, ANNU REV ENTOMOL, V58, P497, DOI 10.1146/annurev-ento-120811-153608; YAO TP, 1993, NATURE, V366, P476, DOI 10.1038/366476a0; YAO TP, 1992, CELL, V71, P63, DOI 10.1016/0092-8674(92)90266-F; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118	71	6	6	1	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6449	6465		10.1096/fj.201901516R	http://dx.doi.org/10.1096/fj.201901516R		MAR 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32196731				2022-12-28	WOS:000521550600001
J	Sorokin, AV; Karathanasis, SK; Yang, ZH; Freeman, L; Kotani, K; Remaley, AT				Sorokin, Alexander, V; Karathanasis, Sotirios K.; Yang, Zhi-Hong; Freeman, Lita; Kotani, Kazuhiko; Remaley, Alan T.			COVID-19-Associated dyslipidemia: Implications for mechanism of impaired resolution and novel therapeutic approaches	FASEB JOURNAL			English	Article						COVID-19; dyslipidemia; inflammation; lipoproteins; oxidation	HIGH-DENSITY-LIPOPROTEIN; APOLIPOPROTEIN-A-I; ANTIINFLAMMATORY PROPERTIES; AIRWAY INFLAMMATION; CHOLESTEROL EFFLUX; OXIDATIVE STRESS; HDL; DISEASE; INFECTION; COVID-19	The current coronavirus disease 2019 (COVID-19) pandemic presents a global challenge for managing acutely ill patients and complications from viral infection. Systemic inflammation accompanied by a "cytokine storm," hemostasis alterations and severe vasculitis have all been reported to occur with COVID-19, and emerging evidence suggests that dysregulation of lipid transport may contribute to some of these complications. Here, we aim to summarize the current understanding of the potential mechanisms related to COVID-19 dyslipidemia and propose possible adjunctive type therapeutic approaches that modulate lipids and lipoproteins. Specifically, we hypothesize that changes in the quantity and composition of high-density lipoprotein (HDL) that occurs with COVID-19 can significantly decrease the anti-inflammatory and anti-oxidative functions of HDL and could contribute to pulmonary inflammation. Furthermore, we propose that lipoproteins with oxidized phospholipids and fatty acids could lead to virus-associated organ damage via overactivation of innate immune scavenger receptors. Restoring lipoprotein function with ApoA-I raising agents or blocking relevant scavenger receptors with neutralizing antibodies could, therefore, be of value in the treatment of COVID-19. Finally, we discuss the role of omega-3 fatty acids transported by lipoproteins in generating specialized proresolving mediators and how together with anti-inflammatory drugs, they could decrease inflammation and thrombotic complications associated with COVID-19.	[Sorokin, Alexander, V; Karathanasis, Sotirios K.; Yang, Zhi-Hong; Freeman, Lita; Remaley, Alan T.] NHLBI, Lipoprot Metab Lab, Translat Vasc Med Branch, NIH, 10 Ctr Dr MSC 1454,Bldg 10,Magnuson CC,Room 5D-03, Bethesda, MD 20892 USA; [Karathanasis, Sotirios K.] NeoProgen, Baltimore, MD USA; [Kotani, Kazuhiko] Jichi Med Univ, Dept Clin Lab Med, Div Community & Family Med, Shimotsuke, Tochigi, Japan	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Jichi Medical University	Sorokin, AV; Remaley, AT (corresponding author), NHLBI, Lipoprot Metab Lab, Translat Vasc Med Branch, NIH, 10 Ctr Dr MSC 1454,Bldg 10,Magnuson CC,Room 5D-03, Bethesda, MD 20892 USA.	sorokinav2@nhlbi.nih.gov; alan.remaley@nih.gov	Sorokin, Alexander/AAG-1703-2021	Sorokin, Alexander/0000-0002-2291-4888	HHS \ NIH \ National Heart, Lung, and Blood Institute (NHLBI)	HHS \ NIH \ National Heart, Lung, and Blood Institute (NHLBI)	HHS vertical bar NIH vertical bar National Heart, Lung, and Blood Institute (NHLBI)	Acharjee S, 2013, J AM COLL CARDIOL, V62, P1826, DOI 10.1016/j.jacc.2013.07.051; Babin PJ, 1997, P NATL ACAD SCI USA, V94, P8622, DOI 10.1073/pnas.94.16.8622; Bacchetti T, 2013, BRIT J DERMATOL, V168, P984, DOI 10.1111/bjd.12144; Balzan S, 2018, LIFE SCI, V198, P79, DOI 10.1016/j.lfs.2018.02.024; Barlage S, 2001, J LIPID RES, V42, P281; Bergt C, 2003, ARTERIOSCL THROM VAS, V23, P1488, DOI 10.1161/01.ATV.0000090570.99836.9C; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; BREWER HB, 1983, ANN INTERN MED, V98, P623, DOI 10.7326/0003-4819-98-5-623; Cepkova Magda, 2006, J Intensive Care Med, V21, P119, DOI 10.1177/0885066606287045; Chen G, 2020, J CLIN INVEST, V130, P2620, DOI 10.1172/JCI137244; Chen L, 2020, CARDIOVASC RES, V116, P1097, DOI 10.1093/cvr/cvaa078; Cheng VCC, 2007, CLIN MICROBIOL REV, V20, P660, DOI 10.1128/CMR.00023-07; Dai CL, 2012, AM J RESP CELL MOL, V47, P186, DOI 10.1165/rcmb.2011-0322OC; Danser AHJ, 2020, HYPERTENSION, V75, P1382, DOI 10.1161/HYPERTENSIONAHA.120.15082; Das UN, 2020, ARCH MED RES, V51, P282, DOI 10.1016/j.arcmed.2020.03.004; Diaz JH, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa041; Driggin E, 2020, J AM COLL CARDIOL, V75, P2352, DOI 10.1016/j.jacc.2020.03.031; El Kebir D, 2012, P NATL ACAD SCI USA, V109, P14983, DOI 10.1073/pnas.1206641109; Farid AS, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-92; FEINGOLD KR, 1993, J CLIN ENDOCR METAB, V76, P1423, DOI 10.1210/jc.76.6.1423; Getz GS, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113479; Goeijenbier M, 2017, VACCINE, V35, P5095, DOI 10.1016/j.vaccine.2017.07.095; Goldstein MR, 2020, QJM-INT J MED, V113, P509, DOI 10.1093/qjmed/hcaa103; GORDON DJ, 1989, NEW ENGL J MED, V321, P1311; Gordon EM, 2019, J ALLERGY CLIN IMMUN, V144, P426, DOI 10.1016/j.jaci.2019.02.027; Han CY, 2006, ARTERIOSCL THROM VAS, V26, P1806, DOI 10.1161/01.ATV.0000227472.70734.ad; Han CY, 2016, J CLIN INVEST, V126, P266, DOI 10.1172/JCI83475; Hayashida K, 2005, CIRCULATION, V112, P812, DOI 10.1161/CIRCULATIONAHA.104.468397; He YE, 2020, J CARDIOVASC TRANSL, V13, P204, DOI 10.1007/s12265-019-09908-y; Homann J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143141; Hu X., 2020, LOW SERUM CHOLESTERO, DOI 10.2139/ssrn.3544826; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043; Iwai M, 2009, HYPERTENS RES, V32, P533, DOI 10.1038/hr.2009.74; Jin Y, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.119.012219; Jira W, 1998, CHEM PHYS LIPIDS, V91, P1, DOI 10.1016/S0009-3084(97)00095-9; Kabouridis PS, 2008, FEBS LETT, V582, P3711, DOI 10.1016/j.febslet.2008.10.006; Karathanasis SK, 2017, CLIN CHEM, V63, P196, DOI 10.1373/clinchem.2016.257725; Kendall AC, 2019, FASEB J, V33, P13014, DOI 10.1096/fj.201901501R; Khovidhunkit W, 2004, J LIPID RES, V45, P1169, DOI 10.1194/jlr.R300019-JLR200; Khovidhunkit W, 2001, J LIPID RES, V42, P967; Kingwell BA, 2014, NAT REV DRUG DISCOV, V13, P445, DOI 10.1038/nrd4279; Kockx M, 2018, J MOL MED, V96, P361, DOI 10.1007/s00109-018-1632-y; Koopal C, 2017, CURR OPIN ENDOCRINOL, V24, P133, DOI 10.1097/MED.0000000000000316; Kulminski AM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206873; Kypreos KE, 2007, BIOCHEM J, V403, P359, DOI 10.1042/BJ20061048; Leng ZK, 2020, AGING DIS, V11, P216, DOI 10.14336/AD.2020.0228; Levy BD, 2007, J IMMUNOL, V178, P496, DOI 10.4049/jimmunol.178.1.496; Li H, 2020, J INFECTION, V80, P646, DOI 10.1016/j.jinf.2020.03.035; Libby P, 2018, J AM COLL CARDIOL, V72, P2071, DOI 10.1016/j.jacc.2018.08.1043; Low-Kam C, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.009545; Lubrano V, 2008, LIPIDS, V43, P945, DOI 10.1007/s11745-008-3227-9; Lucero D, 2020, BBA-MOL CELL BIOL L, V1865, DOI 10.1016/j.bbalip.2019.158537; Madsen CM, 2019, CLIN CHEM, V65, P644, DOI 10.1373/clinchem.2018.299636; Marais AD, 2019, PATHOLOGY, V51, P165, DOI 10.1016/j.pathol.2018.11.002; Martinez-Martinez AB, 2020, NEUROBIOL DIS, V138, DOI 10.1016/j.nbd.2020.104809; Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0; Meyrelles SS, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-211; Mickleborough TD, 2009, CLIN NUTR, V28, P71, DOI 10.1016/j.clnu.2008.10.012; Moore JB, 2020, SCIENCE, V368, P473, DOI 10.1126/science.abb8925; Moraitis AG, 2015, J CLIN LIPIDOL, V9, P81, DOI 10.1016/j.jacl.2014.09.014; Morita M, 2013, CELL, V153, P112, DOI 10.1016/j.cell.2013.02.027; Morton AM, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.98045; Navab M, 2000, J LIPID RES, V41, P1481; Ortiz-Munoz G, 2014, BLOOD, V124, P2625, DOI 10.1182/blood-2014-03-562876; Ossoli A, 2019, ARTERIOSCL THROM VAS, V39, P915, DOI 10.1161/ATVBAHA.118.311987; Pamir N, 2016, J LIPID RES, V57, P246, DOI 10.1194/jlr.M063701; Panigrahy D, 2020, CANCER METAST REV, V39, P1, DOI [10.1007/s10555-020-09862-1, 10.1007/s10555-020-09889-4]; Pencina MJ, 2009, CIRCULATION, V119, P3078, DOI 10.1161/CIRCULATIONAHA.108.816694; Pham T, 2005, BIOCHEMISTRY-US, V44, P7577, DOI 10.1021/bi0472696; Pothineni NVK, 2017, J AM COLL CARDIOL, V69, P2759, DOI 10.1016/j.jacc.2017.04.010; Qin YG, 2020, CRYSTALS, V10, DOI 10.3390/cryst10040245; Rader DJ, 2009, J LIPID RES, V50, pS189, DOI 10.1194/jlr.R800088-JLR200; Raffai RL, 2003, J BIOL CHEM, V278, P11670, DOI 10.1074/jbc.M212873200; Riphagen S, 2020, LANCET, V395, P1607, DOI [10.1016/S0140-6736(20)31094-1, 10.1016/50140-6736(20)31094-1]; Ryoo S, 2011, ATHEROSCLEROSIS, V214, P279, DOI 10.1016/j.atherosclerosis.2010.10.044; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Skarpengland T, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.006479; Sluimer JC, 2008, J PATHOL, V215, P273, DOI 10.1002/path.2357; Soares MP, 2017, NAT REV IMMUNOL, V17, P83, DOI 10.1038/nri.2016.136; Sorokin AV, 2016, J NUTR BIOCHEM, V35, P58, DOI 10.1016/j.jnutbio.2016.05.012; Souza PR, 2020, CIRC RES, V126, P75, DOI 10.1161/CIRCRESAHA.119.315506; Stancel N, 2016, CLIN CHEM, V62, P320, DOI 10.1373/clinchem.2015.243923; Sun XJ, 2020, CYTOKINE GROWTH F R, V53, P38, DOI 10.1016/j.cytogfr.2020.04.002; Suzuki M, 2010, CIRCULATION, V122, P1919, DOI 10.1161/CIRCULATIONAHA.110.961193; Tang N, 2020, J THROMB HAEMOST, V18, P844, DOI 10.1111/jth.14768; Tay MZ, 2020, NAT REV IMMUNOL, V20, P363, DOI 10.1038/s41577-020-0311-8; Trinder M, 2020, ARTERIOSCL THROM VAS, V40, P267, DOI 10.1161/ATVBAHA.119.313381; van der Stoep M, 2014, CARDIOVASC RES, V103, P362, DOI 10.1093/cvr/cvu137; Van Lenten BJ, 2004, CIRCULATION, V110, P3252, DOI 10.1161/01.CIR.0000147232.75456.B3; Van Lenten BJ, 2001, CIRCULATION, V103, P2283; Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5; Verdoni L, 2020, LANCET, V395, P1771, DOI 10.1016/S0140-6736(20)31103-X; Walkey AJ, 2011, CRIT CARE MED, V39, P1322, DOI 10.1097/CCM.0b013e3182120829; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994; Xu H, 2020, INT J ORAL SCI, V12, DOI [10.1038/s41368-020-0074-x, 10.1038/s41368-020-0074-X]; Yamashita CM, 2014, RESPIRATION, V87, P416, DOI 10.1159/000358438; Yang ZH, 2020, NUTRIENTS, V12, DOI 10.3390/nu12030749; Zhang P, 2009, J INNATE IMMUN, V1, P358, DOI 10.1159/000161070; Zou X, 2020, FRONT MED-PRC, V14, P185, DOI 10.1007/s11684-020-0754-0	103	73	75	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					9843	9853		10.1096/fj.202001451	http://dx.doi.org/10.1096/fj.202001451		JUN 2020	11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32588493	Green Published			2022-12-28	WOS:000544290200001
J	Rebourcet, D; Mackay, R; Darbey, A; Curley, M; Jorgensen, A; Frederiksen, H; Mitchell, R; O'Shaughnessy, P; Nef, S; Smith, LB				Rebourcet, Diane; Mackay, Rosa; Darbey, Annalucia; Curley, Michael; Jorgensen, Anne; Frederiksen, Hanne; Mitchell, Rod T.; O'Shaughnessy, Peter; Nef, Serge; Smith, Lee B.			Ablation of the canonical testosterone production pathway via knockout of the steroidogenic enzyme HSD17B3, reveals a novel mechanism of testicular testosterone production	FASEB JOURNAL			English	Article						androgens; Leydig cell; testis; testosterone	LEYDIG-CELL DEVELOPMENT; SERTOLI-CELLS; 17-BETA-HYDROXYSTEROID-DEHYDROGENASE TYPE-3; MALE PSEUDOHERMAPHRODITISM; PROGRAMMING WINDOW; ANDROGEN; MOUSE; EXPRESSION; RATS; MASCULINIZATION	Male development, fertility, and lifelong health are all androgen-dependent. Approximately 95% of circulating testosterone is synthesized by the testis and the final step in this canonical pathway is controlled by the activity of the hydroxysteroid-dehydrogenase-17-beta-3 (HSD17B3). To determine the role of HSD17B3 in testosterone production and androgenization during male development and function we have characterized a mouse model lacking HSD17B3. The data reveal that developmental masculinization and fertility are normal in mutant males. Ablation of HSD17B3 inhibits hyperstimulation of testosterone production by hCG, although basal testosterone levels are maintained despite the absence of HSD17B3. Reintroduction of HSD17B3 via gene-delivery to Sertoli cells in adulthood partially rescues the adult phenotype, showing that, as in development, different cell-types in the testis are able to work together to produce testosterone. Together, these data show that HS17B3 acts as a rate-limiting-step for the maximum level of testosterone production by the testis but does not control basal testosterone production. Measurement of other enzymes able to convert androstenedione to testosterone identifies HSD17B12 as a candidate enzyme capable of driving basal testosterone production in the testis. Together, these findings expand our understanding of testosterone production in males.	[Rebourcet, Diane; Darbey, Annalucia; Smith, Lee B.] Univ Newcastle, Sch Environm & Life Sci, Callaghan, NSW 2308, Australia; [Mackay, Rosa; Curley, Michael; Mitchell, Rod T.; Smith, Lee B.] Univ Edinburgh, Ctr Reprod Hlth, Queens Med Res Inst, MRC, Edinburgh, Midlothian, Scotland; [Jorgensen, Anne] Univ Copenhagen, Rigshosp, Dept Growth & Reprod, Copenhagen, Denmark; [Jorgensen, Anne; Frederiksen, Hanne] Univ Copenhagen, Rigshosp, Int Ctr Res & Res Training Endocrine Disrupt Male, Copenhagen, Denmark; [O'Shaughnessy, Peter] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland; [Nef, Serge] Univ Geneva, Fac Med, Dept Genet Med & Dev, Geneva, Switzerland	University of Newcastle; University of Edinburgh; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Glasgow; University of Geneva	Smith, LB (corresponding author), Univ Newcastle, Sch Environm & Life Sci, Callaghan, NSW 2308, Australia.	L.B.Smith@newcastle.edu.au	Jørgensen, Anne/S-8681-2016; Frederiksen, Hanne/N-8632-2013; Nef, Serge/AAV-6445-2020	Jørgensen, Anne/0000-0002-6409-198X; Frederiksen, Hanne/0000-0002-3180-9879; Nef, Serge/0000-0001-5462-0676; Darbey, Annalucia/0000-0001-8541-5472; Smith, Lee/0000-0002-4103-3074	Department of Health | National Health and Medical Research Council (NHMRC) [APP1158344]; RCUK | Medical Research Council (MRC) [MR/N002970/1]; MRC [MR/N002970/1] Funding Source: UKRI	Department of Health | National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); RCUK | Medical Research Council (MRC); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Department of Health | National Health and Medical Research Council (NHMRC), Grant/Award Number: APP1158344; RCUK | Medical Research Council (MRC), Grant/Award Number: MR/N002970/1	Bellemare V, 2010, HORM MOL BIOL CLIN I, V2, P311, DOI 10.1515/HMBCI.2010.036; Blanchard PG, 2007, J ENDOCRINOL, V194, P449, DOI 10.1677/JOE-07-0144; Blomquist CH, 2002, J STEROID BIOCHEM, V81, P343, DOI 10.1016/S0960-0760(02)00117-6; Curley M, 2019, FASEB J, V33, P978, DOI 10.1096/fj.201800612R; Dean A, 2012, INT J ANDROL, V35, P330, DOI 10.1111/j.1365-2605.2011.01236.x; Djureinovic D, 2014, MOL HUM REPROD, V20, P476, DOI 10.1093/molehr/gau018; Dungan HM, 2006, ENDOCRINOLOGY, V147, P1154, DOI 10.1210/en.2005-1282; Fluck CE, 2011, AM J HUM GENET, V89, P201, DOI 10.1016/j.ajhg.2011.06.009; Galli-Tsinopoulou A, 2018, J CLIN RES PEDIATR E, V10, P74, DOI 10.4274/jcrpe.4829; GEISSLER WM, 1994, NAT GENET, V7, P34, DOI 10.1038/ng0594-34; Hakkarainen J, 2018, FASEB J, V32, P3229, DOI 10.1096/fj.201700921R; HICKEY GJ, 1989, ENDOCRINOLOGY, V125, P1673, DOI 10.1210/endo-125-3-1673; Jost A, 1973, Adv Biosci, V10, P3; JOST A, 1947, P SOC EXP BIOL MED, V66, P302, DOI 10.3181/00379727-66-16071; Kreisman MJ, 2017, ENDOCRINOLOGY, V158, P2884, DOI 10.1210/en.2017-00285; Lindqvist A, 2001, J CLIN ENDOCR METAB, V86, P921, DOI 10.1210/jc.86.2.921; Liu FJ, 2019, MOL CELL PROTEOMICS, V18, P1070, DOI 10.1074/mcp.RA119.001416; Luu-The V, 2006, MOL ENDOCRINOL, V20, P437, DOI 10.1210/me.2005-0058; Mahendroo M, 2004, MOL CELL ENDOCRINOL, V222, P113, DOI 10.1016/j.mce.2004.04.009; Mendonca BB, 2000, MEDICINE, V79, P299, DOI 10.1097/00005792-200009000-00003; Mendonca BB, 2017, J STEROID BIOCHEM, V165, P79, DOI 10.1016/j.jsbmb.2016.05.002; Mindnich R, 2005, J MOL ENDOCRINOL, V35, P305, DOI 10.1677/jme.1.01853; Mitchell RT, 2015, ENDOCRINOLOGY, V156, P24, DOI 10.1210/en.2014-1534; Moon YA, 2003, J BIOL CHEM, V278, P7335, DOI 10.1074/jbc.M211684200; O'Hara L, 2015, FASEB J, V29, P894, DOI 10.1096/fj.14-255729; O'Hara L, 2011, ENDOCRINOLOGY, V152, P718, DOI 10.1210/en.2010-0928; O'Shaughnessy PJ, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000002; O'Shaughnessy PJ, 2000, ENDOCRINOLOGY, V141, P2631, DOI 10.1210/en.141.7.2631; O'Shaughnessy PJ, 2002, J CELL SCI, V115, P3491; Ogawa N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092073; Rantakari P, 2010, ENDOCRINOLOGY, V151, P1893, DOI 10.1210/en.2009-0929; Rebourcet D, 2016, ENDOCRINOLOGY, V157, P2479, DOI 10.1210/en.2016-1156; Rebourcet D, 2014, DEVELOPMENT, V141, P2139, DOI 10.1242/dev.107029; Sakurai N, 2006, J STEROID BIOCHEM, V99, P174, DOI 10.1016/j.jsbmb.2006.01.010; Saloniemi T, 2009, MOL CELL ENDOCRINOL, V301, P163, DOI 10.1016/j.mce.2008.10.047; Sha J, 1996, BIOCHEM BIOPH RES CO, V222, P90, DOI 10.1006/bbrc.1996.0702; SHARPE RM, 1980, J REPROD FERTIL, V60, P359; SHARPE RM, 1983, MOL CELL ENDOCRINOL, V33, P131, DOI 10.1016/0303-7207(83)90162-4; Shima Y, 2013, MOL ENDOCRINOL, V27, P63, DOI 10.1210/me.2012-1256; Shores Molly M, 2014, Curr Sex Health Rep, V6, P235; Smith JT, 2005, ENDOCRINOLOGY, V146, P2976, DOI 10.1210/en.2005-0323; Soeborg T, 2017, CLIN CHIM ACTA, V468, P180, DOI 10.1016/j.cca.2017.03.002; Spitzer M, 2013, NAT REV ENDOCRINOL, V9, DOI [10.1038/nrendo.2013.73-c2, 10.1038/nrendo.2013.73]; Tajar A, 2010, J CLIN ENDOCR METAB, V95, P1810, DOI 10.1210/jc.2009-1796; Wei YH, 2019, MOL CELL PROTEOMICS, V18, P216, DOI 10.1074/mcp.RA117.000479; Welsh M, 2008, J CLIN INVEST, V118, P1479, DOI 10.1172/JCI34241; Welsh M, 2009, ENDOCRINOLOGY, V150, P2472, DOI 10.1210/en.2008-0529; Willems A, 2015, MOL REPROD DEV, V82, P626, DOI 10.1002/mrd.22506	48	21	23	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10373	10386		10.1096/fj.202000361R	http://dx.doi.org/10.1096/fj.202000361R		JUN 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32557858	Green Published, hybrid			2022-12-28	WOS:000544279700001
J	Teulings, NEWD; Garrud, TAC; Niu, YG; Skeffington, KL; Beck, C; Itani, N; Conlon, FG; Botting, KJ; Nicholas, LM; Ashmore, TJ; Blackmore, HL; Tong, W; Camm, EJ; Derks, JB; Logan, A; Murphy, MP; Ozanne, SE; Giussani, DA				Teulings, Noor E. W. D.; Garrud, Tessa A. C.; Niu, Youguo; Skeffington, Katie L.; Beck, Christian; Itani, Nozomi; Conlon, Fiona G.; Botting, Kimberley J.; Nicholas, Lisa M.; Ashmore, Thomas J.; Blackmore, Heather L.; Tong, Wen; Camm, Emily J.; Derks, Jan B.; Logan, Angela; Murphy, Michael P.; Ozanne, Susan E.; Giussani, Dino A.			Isolating adverse effects of glucocorticoids on the embryonic cardiovascular system	FASEB JOURNAL			English	Article						antenatal glucocorticoid therapy; cardiac function; cellular senescence; oxidative stress	DEXAMETHASONE TREATMENT; CARDIAC-FUNCTION; FETAL SHEEP; PRESSURE; HEART; BASAL; SENESCENCE; ENDOCRINE; MORTALITY; ADULTHOOD	Antenatal glucocorticoid therapy reduces mortality in the preterm infant, but evidence suggests off-target adverse effects on the developing cardiovascular system. Whether deleterious effects are direct on the offspring or secondary to alterations in uteroplacental physiology is unclear. Here, we isolated direct effects of glucocorticoids using the chicken embryo, a model system in which the effects on the developing heart and circulation of therapy can be investigated, independent of effects on the mother and/or the placenta. Fertilized chicken eggs were incubated and divided randomly into control (C) or dexamethasone (Dex) treatment at day 14 out of the 21-day incubation period. Combining functional experiments at the isolated organ, cellular and molecular levels, embryos were then studied close to term. Chicken embryos exposed to dexamethasone were growth restricted and showed systolic and diastolic dysfunction, with an increase in cardiomyocyte volume but decreased cardiomyocyte nuclear density in the left ventricle. Underlying mechanisms included a premature switch from tissue accretion to differentiation, increased oxidative stress, and activated signaling of cellular senescence. These findings, therefore, demonstrate that dexamethasone treatment can have direct detrimental off-target effects on the cardiovascular system in the developing embryo, which are independent of effects on the mother and/or placenta.	[Teulings, Noor E. W. D.; Nicholas, Lisa M.; Ashmore, Thomas J.; Blackmore, Heather L.; Ozanne, Susan E.] Univ Cambridge, Addenbrookes Hosp, Inst Metab Sci, Metab Res Labs, Cambridge, England; [Garrud, Tessa A. C.; Niu, Youguo; Skeffington, Katie L.; Beck, Christian; Itani, Nozomi; Conlon, Fiona G.; Botting, Kimberley J.; Tong, Wen; Camm, Emily J.; Giussani, Dino A.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EG, England; [Derks, Jan B.] Univ Med Ctr, Dept Perinatal Med, Utrecht, Netherlands; [Logan, Angela; Murphy, Michael P.] Univ Cambridge, Mitochondrial Biol Unit, Med Res Council, Cambridge, England; [Murphy, Michael P.] Univ Cambridge, Dept Med, Cambridge, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; Utrecht University; Utrecht University Medical Center; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Cambridge; University of Cambridge	Giussani, DA (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EG, England.	dag26@cam.ac.uk	Garrud, Tess/AAJ-2564-2021; Skeffington, Katie/AAJ-8756-2021	Garrud, Tess/0000-0002-7900-7939; Skeffington, Katie/0000-0001-5252-6459; Teulings, Noor/0000-0001-8176-179X; Tong, Wen/0000-0003-1647-4166; Nicholas, Lisa/0000-0003-1976-1953; Ozanne, Susan/0000-0001-8753-5144	British Heart Foundation [PG/14/5/30547, RG/17/8/32924, PG/10/99/28656] Funding Source: Medline; Medical Research Council [MC_U105663142] Funding Source: Medline; Wellcome Trust [110159, 110159/A/15/Z, 110158, 110158/Z/15/Z] Funding Source: Medline; MRC [MC_U105663142] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Adler A, 2010, NEONATOLOGY, V98, P73, DOI 10.1159/000275561; Aiken CE, 2013, REPRODUCTION, V145, pR1, DOI 10.1530/REP-11-0489; Bal MP, 2008, J APPL PHYSIOL, V104, P446, DOI 10.1152/japplphysiol.00951.2007; Botting KJ, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000531; Chapman K, 2013, PHYSIOL REV, V93, P1139, DOI 10.1152/physrev.00020.2012; CROWLEY P, 1990, BRIT J OBSTET GYNAEC, V97, P11, DOI 10.1111/j.1471-0528.1990.tb01711.x; Derks JB, 1997, J PHYSIOL-LONDON, V499, P217, DOI 10.1113/jphysiol.1997.sp021922; Figueroa JP, 2005, PEDIATR RES, V58, P510, DOI 10.1203/01.PDR.0000179410.57947.88; Fletcher AJW, 2002, J PHYSIOL-LONDON, V545, P649, DOI 10.1113/jphysiol.2001.015693; Fowden AL, 2015, EXP PHYSIOL, V100, P1477, DOI 10.1113/EP085212; Fowden AL, 1998, P NUTR SOC, V57, P113, DOI 10.1079/PNS19980017; Garrud TAC, 2019, TRENDS ENDOCRIN MET, V30, P258, DOI 10.1016/j.tem.2019.02.003; Gay MS, 2016, J PHARMACOL EXP THER, V358, P190, DOI 10.1124/jpet.116.234104; Gay MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125033; Guioli S, 2014, SEX DEV, V8, P227, DOI 10.1159/000358406; GUNDERSEN HJG, 1988, APMIS, V96, P379, DOI 10.1111/j.1699-0463.1988.tb05320.x; GUNDERSEN HJG, 1986, J MICROSC-OXFORD, V143, P3, DOI 10.1111/j.1365-2818.1986.tb02764.x; Itani N, 2018, J PHYSIOL-LONDON, V596, P2991, DOI 10.1113/JP274111; Iuchi T, 2003, CIRC RES, V92, P81, DOI 10.1161/01.RES.0000050588.35034.3C; Jellyman JK, 2004, AM J OBSTET GYNECOL, V190, P825, DOI 10.1016/j.ajog.2003.09.046; Jellyman JK, 2020, TRENDS MOL MED, V26, P170, DOI 10.1016/j.molmed.2019.09.005; Jobe AH, 1998, PEDIATRICS, V102, P1116, DOI 10.1542/peds.102.5.1116; Kelly BA, 2012, PEDIATRICS, V129, pE1282, DOI 10.1542/peds.2011-3175; KREAM J, 1983, J CLIN ENDOCR METAB, V56, P127, DOI 10.1210/jcem-56-1-127; Levkau B, 2008, CIRCULATION, V117, P1583, DOI 10.1161/CIRCULATIONAHA.107.734160; Li FQ, 1997, AM J PHYSIOL-REG I, V273, pR518, DOI 10.1152/ajpregu.1997.273.2.R518; Louey S, 2007, J PHYSIOL-LONDON, V580, P639, DOI 10.1113/jphysiol.2006.122200; McKinlay CJD, 2015, J DEV ORIG HLTH DIS, V6, P127, DOI 10.1017/S2040174414000579; Morrison JL, 2007, AM J PHYSIOL-REG I, V293, pR306, DOI 10.1152/ajpregu.00798.2006; Munoz-Espin D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Niu YG, 2013, J PHYSIOL-LONDON, V591, P5083, DOI 10.1113/jphysiol.2013.258210; Osterman H, 2015, AM J PHYSIOL-REG I, V309, pR1204, DOI 10.1152/ajpregu.00499.2014; Paolini M, 1997, BRIT J PHARMACOL, V122, P344, DOI 10.1038/sj.bjp.0701352; Pappas JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111135; Paradis AN, 2014, DRUG DISCOV TODAY, V19, P602, DOI 10.1016/j.drudis.2013.10.019; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; PETERSEN MC, 1980, EUR J CLIN PHARMACOL, V18, P245, DOI 10.1007/BF00563006; Puente BN, 2014, CELL, V157, P565, DOI 10.1016/j.cell.2014.03.032; Razaz N, 2015, OBSTET GYNECOL, V125, P288, DOI 10.1097/AOG.0000000000000629; Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036; Salem R, 2006, BRIT J ANAESTH, V97, P292, DOI 10.1093/bja/ael140; Sedmera D, 2003, J MOL CELL CARDIOL, V35, P301, DOI 10.1016/S0022-2828(03)00011-7; Skeffington KL, 2018, J DEV ORIG HLTH DIS, V9, P460, DOI 10.1017/S2040174418000247; Smith CA, 2001, J EXP ZOOL, V290, P691, DOI 10.1002/jez.1119; Tang JI, 2011, J HYPERTENS, V29, P282, DOI 10.1097/HJH.0b013e328340aa18; Thornburg K, 2011, PROG BIOPHYS MOL BIO, V106, P289, DOI 10.1016/j.pbiomolbio.2010.11.010; Tijsseling D, 2013, PEDIATR RES, V74, P639, DOI 10.1038/pr.2013.152; Whitworth JA, 2002, J HYPERTENS, V20, P1035, DOI 10.1097/00004872-200206000-00003; Zhang RG, 2005, DEV CELL, V8, P19, DOI 10.1016/j.devcel.2004.10.019	50	4	4	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9664	9677		10.1096/fj.202000697R	http://dx.doi.org/10.1096/fj.202000697R		JUN 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32502311	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000539540500001
J	Pan, ZN; Pan, MH; Sun, MH; Li, XH; Zhang, Y; Sun, SC				Pan, Zhen-Nan; Pan, Meng-Hao; Sun, Ming-Hong; Li, Xiao-Han; Zhang, Yu; Sun, Shao-Chen			RAB7 GTPase regulates actin dynamics for DRP1-mediated mitochondria function and spindle migration in mouse oocyte meiosis	FASEB JOURNAL			English	Article						actin; meiosis; oocyte; RAB7; spindle	CYTOSKELETAL ORGANIZATION; MATURATION; TRANSPORT; PROTEINS; FISSION; REARRANGEMENT; DIVISION	RAB7 is a small GTPase that belongs to the Rab family, and as a vesicle trafficking factor it is shown to regulate the transport to late endocytic compartments, autophagosome maturation and organelle function. In present study, we showed the critical roles of RAB7 GTPase on actin dynamics and mitochondria function in oocyte meiosis. RAB7 mainly accumulated at cortex and spindle periphery during oocyte maturation. RAB7 depletion caused the failure of polar body extrusion and asymmetric division, and Rab7 exogenous mRNA supplement could rescue the defects caused by RAB7 RNAi. Based on mass spectrometry analysis, we found that RAB7 associated with several actin nucleation factors and mitochondria-related proteins in oocytes. The depletion of RAB7 caused the decrease of actin dynamics, which further affected meiotic spindle migration to the oocyte cortex. In addition, we found that RAB7 could maintain mitochondrial membrane potential and the mitochondrial distribution in mouse oocytes, and this might be due to its effects on the phosphorylation of DRP1 at Ser616 domain. Taken together, our data indicated that RAB7 transported actin nucleation factor for actin polarization, which further affected the phosphorylation of DRP1 for mitochondria dynamics and the meiotic spindle migration in mouse oocytes.	[Pan, Zhen-Nan; Pan, Meng-Hao; Sun, Ming-Hong; Li, Xiao-Han; Zhang, Yu; Sun, Shao-Chen] Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing 210095, Peoples R China	Nanjing Agricultural University	Sun, SC (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing 210095, Peoples R China.	sunsc@njau.edu.cn			National Key Research and Development Program of China [2018YFC1003802, 2018YFC1004003]	National Key Research and Development Program of China	National Key Research and Development Program of China, Grant/Award Number: 2018YFC1003802 and 2018YFC1004003	Almonacid M, 2014, J CELL SCI, V127, P477, DOI 10.1242/jcs.142711; Azoury J, 2009, BIOL CELL, V101, P69, DOI 10.1042/BC20080003; Babayev E, 2015, CURR OPIN OBSTET GYN, V27, P175, DOI 10.1097/GCO.0000000000000164; Brunet S, 2011, HUM REPROD UPDATE, V17, P68, DOI 10.1093/humupd/dmq044; Cantalupo G, 2001, EMBO J, V20, P683, DOI 10.1093/emboj/20.4.683; Dalton CM, 2013, J CELL SCI, V126, P2955, DOI 10.1242/jcs.128744; Desai SP, 2013, BIOPHYS J, V104, P2077, DOI 10.1016/j.bpj.2013.03.025; Duan X, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14068-3; Duan X, 2019, BIOL REPROD, V100, P15, DOI 10.1093/biolre/ioy163; Duan X, 2018, BBA-MOL CELL RES, V1865, P455, DOI 10.1016/j.bbamcr.2017.11.016; Emmanuel M, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004666; Feng JX, 2019, FISH SHELLFISH IMMUN, V88, P1, DOI 10.1016/j.fsi.2019.02.053; FitzHarris G, 2007, DEV BIOL, V305, P133, DOI 10.1016/j.ydbio.2007.02.006; Frederick RL, 2007, TRAFFIC, V8, P1668, DOI 10.1111/j.1600-0854.2007.00644.x; Goody RS, 2017, BIOL CHEM, V398, P565, DOI 10.1515/hsz-2016-0274; Guerra F, 2016, CELLS-BASEL, V5, DOI 10.3390/cells5030034; Haile Y, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-016-0788-z; Hatch AL, 2016, MOL BIOL CELL, V27, P3109, DOI 10.1091/mbc.E16-03-0193; Holubcova Z, 2013, NAT CELL BIOL, V15, P937, DOI 10.1038/ncb2802; Hu CX, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010144; Hyttinen JMT, 2013, BBA-MOL CELL RES, V1833, P503, DOI 10.1016/j.bbamcr.2012.11.018; Jager S, 2004, J CELL SCI, V117, P4837, DOI 10.1242/jcs.01370; Jin RU, 2014, J CELL SCI, V127, P1018, DOI 10.1242/jcs.138776; Kjos I, 2018, BBA-MOL CELL RES, V1865, P1397, DOI 10.1016/j.bbamcr.2018.07.009; Korobova F, 2013, SCIENCE, V339, P464, DOI 10.1126/science.1228360; Landry MC, 2014, J BIOL CHEM, V289, P2230, DOI 10.1074/jbc.M113.516351; Levi M, 2011, MOL HUM REPROD, V17, P328, DOI 10.1093/molehr/gar025; Li Guangpu, 2015, Methods Mol Biol, V1298, P1, DOI 10.1007/978-1-4939-2569-8_1; Lopez-Domenech G, 2018, EMBO J, V37, P321, DOI 10.15252/embj.201696380; Loson OC, 2013, MOL BIOL CELL, V24, P659, DOI 10.1091/mbc.E12-10-0721; Ma RJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep23560; Manor U, 2015, ELIFE, V4, DOI 10.7554/eLife.08828; Mao LN, 2014, REPROD BIOMED ONLINE, V28, P284, DOI 10.1016/j.rbmo.2013.10.016; Mascia A, 2016, J CELL PHYSIOL, V231, P1695, DOI 10.1002/jcp.25267; Miller HE, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007005; Moore AS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12886; Pan MH, 2018, J CELL PHYSIOL, V233, P2270, DOI 10.1002/jcp.26099; Pan ZN, 2019, BIOL REPROD, V100, P711, DOI 10.1093/biolre/ioy217; Pfender S, 2011, CURR BIOL, V21, P955, DOI 10.1016/j.cub.2011.04.029; Qiu D, 2019, CELL CYCLE, V18, P1; Rehklau K, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.448; Sakane A, 2012, J BIOL CHEM, V287, P42455, DOI 10.1074/jbc.M112.383653; Shi P, 2019, J CELL SCI, V132, DOI 10.1242/jcs.226506; Sun Y, 2005, J BIOL CHEM, V280, P32356, DOI 10.1074/jbc.M414213200; Udagawa O, 2014, CURR BIOL, V24, P2451, DOI 10.1016/j.cub.2014.08.060; Van Blerkom J, 2007, MOL HUM REPROD, V13, P759, DOI 10.1093/molehr/gam068; Van Blerkom J, 2011, MITOCHONDRION, V11, P797, DOI 10.1016/j.mito.2010.09.012; Wickner W, 2008, NAT STRUCT MOL BIOL, V15, P658, DOI 10.1038/nsmb.1451; Wong YC, 2018, NATURE, V554, P382, DOI 10.1038/nature25486; Yang CS, 2019, NAT CELL BIOL, V21, P603, DOI 10.1038/s41556-019-0313-6; Yi KX, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0002; Zhang Y, 2019, MOL HUM REPROD, V25, P359, DOI 10.1093/molehr/gaz027; Zhang Y, 2014, CELL CYCLE, V13, P3390, DOI 10.4161/15384101.2014.952967; Zhu H, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.441	54	17	17	2	21	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9615	9627		10.1096/fj.201903013R	http://dx.doi.org/10.1096/fj.201903013R		MAY 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32472654				2022-12-28	WOS:000538118800001
J	Kim, JW; Im, I; Kim, H; Jeon, JS; Kang, EH; Jo, S; Chun, HS; Yoon, S; Kim, JH; Kim, SK; Park, HJ				Kim, Ji-Woo; Im, Ilkyun; Kim, Hyemin; Jeon, Jang Su; Kang, Eun-Hye; Jo, Seongyea; Chun, Hang-Suk; Yoon, Seokjoo; Kim, Jong-Hoon; Kim, Sang Kyum; Park, Han-Jin			Live-cell screening platform using human-induced pluripotent stem cells expressing fluorescence-tagged cytochrome P450 1A1	FASEB JOURNAL			English	Article						AHR; CRISPR-Cas9; high-content screening; toxicology	ARYL-HYDROCARBON RECEPTOR; KNOCKOUT MOUSE LINES; AH RECEPTOR; GENE; CANCER; CYP1A1; POLYMORPHISMS; INDUCTION; PROTEINS; LIGAND	Human-induced pluripotent stem cells (hiPSCs) are invaluable sources for drug screening and toxicity tests because of their differentiation potential and proliferative capacity. Recently, the CRISPR-Cas9-mediated homologous recombination system has enabled reporter knock-ins at desired loci in hiPSCs, and here, we generated a hiPSC reporter line expressing mCherry-tagged cytochrome P450 1A1 (CYP1A1), which can be utilized to screen for the modulators of aryl hydrocarbon receptor (AHR) in live cells. CYP1A1-mCherry hiPSCs exhibited typical characteristics of pluripotent stem cells such as marker expression, differentiation potential, and normal karyotype. After differentiation into hepatocyte-like cells (HLCs), CYP1A1-mCherry fusion protein was expressed and localized at the endoplasmic reticulum, and induced by AHR agonists. We obtained 23 hits modulating CYP1A1 expression from high-content screening with 241 hepatotoxicity chemicals and nuclear receptor ligands, and identified three upregulating chemicals and two downregulating compounds. Responses of hiPSC-HLCs against an AHR agonist were more similar to human primary hepatocytes than of HepG2 hepatocellular carcinoma cells. This platform has the advantages of live-cell screening without sacrificing cells (unlike previously available CYP1A1 reporter cell lines), as well as an indefinite supply of cells, and can be utilized in a wide range of screening related to AHR- and CYP1A1-associated diseases in desired cell types.	[Kim, Ji-Woo; Im, Ilkyun; Kim, Hyemin; Kang, Eun-Hye; Jo, Seongyea; Chun, Hang-Suk; Yoon, Seokjoo; Park, Han-Jin] Korea Inst Toxicol, Dept Predict Toxicol, Daejeon 34114, South Korea; [Jeon, Jang Su; Kim, Sang Kyum] Chungnam Natl Univ, Coll Pharm, Daejeon, South Korea; [Kang, Eun-Hye; Yoon, Seokjoo] Univ Sci & Technol, Sch Engn, Human & Environm Toxicol, Daejeon, South Korea; [Jo, Seongyea; Kim, Jong-Hoon] Korea Univ, Dept Biotechnol, Coll Life Sci & Biotechnol, Seoul, South Korea	Korea Institute of Toxicology; Chungnam National University; University of Science & Technology (UST); Korea University	Park, HJ (corresponding author), Korea Inst Toxicol, Dept Predict Toxicol, Daejeon 34114, South Korea.	hjpark@kitox.re.kr	Kim, Jong-Hoon/F-2504-2013	Kim, Jong-Hoon/0000-0003-3419-0538	National Research Foundation of Korea (NRF) [NRF-2017R1C1B2010444, NRF-2018M3A9H1021384]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	National Research Foundation of Korea (NRF), Grant/Award Number: NRF-2017R1C1B2010444 and NRF-2018M3A9H1021384	Barouki R, 2007, FEBS LETT, V581, P3608, DOI 10.1016/j.febslet.2007.03.046; Bersten DC, 2013, NAT REV CANCER, V13, P827, DOI 10.1038/nrc3621; Brignac-Huber LM, 2016, DRUG METAB DISPOS, V44, P1859, DOI 10.1124/dmd.115.068981; Byrne SM, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1246; Cauchi S, 2001, CARCINOGENESIS, V22, P1819, DOI 10.1093/carcin/22.11.1819; Chang JC, 2007, CLIN CANCER RES, V13, P1, DOI 10.1158/1078-0432.CCR-06-2405; Chen I, 1996, BIOCHEM PHARMACOL, V51, P1069, DOI 10.1016/0006-2952(96)00060-3; Ciolino HP, 2008, INT J CANCER, V122, P990, DOI 10.1002/ijc.23218; Corbett JL, 2019, FRONT MED-LAUSANNE, V6, DOI 10.3389/fmed.2019.00265; Denison MS, 2011, TOXICOL SCI, V124, P1, DOI 10.1093/toxsci/kfr218; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Elliott DA, 2011, NAT METHODS, V8, P1037, DOI [10.1038/NMETH.1740, 10.1038/nmeth.1740]; Frotschl R, 1998, CHEM RES TOXICOL, V11, P1447, DOI 10.1021/tx980164h; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gargaro M, 2016, AM J TRANSPLANT, V16, P2270, DOI 10.1111/ajt.13716; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Go RE, 2015, J STEROID BIOCHEM, V147, P24, DOI 10.1016/j.jsbmb.2014.11.003; Goldring C, 2017, HEPATOLOGY, V65, P710, DOI 10.1002/hep.28886; Goulburn AL, 2011, STEM CELLS, V29, P462, DOI 10.1002/stem.587; Gregersen N, 2010, METHODS MOL BIOL, V648, P3, DOI 10.1007/978-1-60761-756-3_1; Grskovic M, 2011, NAT REV DRUG DISCOV, V10, P915, DOI 10.1038/nrd3577; HANKINSON O, 1991, BIOCHIMIE, V73, P61, DOI 10.1016/0300-9084(91)90075-C; Hao N, 2013, BIOCHEM PHARMACOL, V86, P561, DOI 10.1016/j.bcp.2013.07.004; He GC, 2011, TOXICOL SCI, V123, P511, DOI 10.1093/toxsci/kfr189; Hosaka T, 2010, CANCER SCI, V101, P652, DOI 10.1111/j.1349-7006.2009.01454.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang S, 2015, SCI REP-UK, V5, DOI 10.1038/srep08022; Irion S, 2007, NAT BIOTECHNOL, V25, P1477, DOI 10.1038/nbt1362; Jackson MP, 2016, ESSAYS BIOCHEM, V60, P173, DOI 10.1042/EBC20160005; Kakarougkas A, 2014, BRIT J RADIOL, V87, DOI 10.1259/bjr.20130685; Kim HM, 2016, SCI REP-UK, V6, DOI 10.1038/srep21684; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Kolluri SK, 2017, ARCH TOXICOL, V91, P2497, DOI 10.1007/s00204-017-1981-2; Li Y, 2011, TOXICOL SCI, V124, P388, DOI 10.1093/toxsci/kfr235; Liu C, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.156166; McIntosh BE, 2010, ANNU REV PHYSIOL, V72, P625, DOI 10.1146/annurev-physiol-021909-135922; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Murray IA, 2014, NAT REV CANCER, V14, P801, DOI 10.1038/nrc3846; Nagy SR, 2002, TOXICOL SCI, V65, P200, DOI 10.1093/toxsci/65.2.200; Navas JM, 2004, LIFE SCI, V76, P699, DOI 10.1016/j.lfs.2004.09.015; Nebert D W, 1994, Prog Liver Dis, V12, P63; Nebert DW, 2013, MOL PHARMACOL, V84, P304, DOI 10.1124/mol.113.086637; NEBERT DW, 1991, PHARMACOGENETICS, V1, P68, DOI 10.1097/00008571-199111000-00003; Nebert DW, 1996, DNA CELL BIOL, V15, P273, DOI 10.1089/dna.1996.15.273; Nguyen LP, 2008, CHEM RES TOXICOL, V21, P102, DOI 10.1021/tx7001965; Nie YZ, 2018, EBIOMEDICINE, V35, P114, DOI 10.1016/j.ebiom.2018.08.014; O'Donnell EF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013128; Oesch-Bartlomowicz B, 2009, BIOCHEM PHARMACOL, V77, P627, DOI 10.1016/j.bcp.2008.10.017; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Oyama T, 2007, FRONT BIOSCI, V12, P4497, DOI 10.2741/2404; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Ramadoss P, 2004, MOL PHARMACOL, V66, P129, DOI 10.1124/mol.66.1.129; Ramme AP, 2019, FUTUR SCI OA, V5, DOI 10.2144/fsoa-2019-0065; Safe S, 2013, TOXICOL SCI, V135, P1, DOI 10.1093/toxsci/kft128; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sirenko O, 2016, ASSAY DRUG DEV TECHN, V14, P381, DOI 10.1089/adt.2016.729; Smith BW, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/2574152; Sogawa K, 1997, J BIOCHEM, V122, P1075; Stockinger B, 2014, ANNU REV IMMUNOL, V32, P403, DOI 10.1146/annurev-immunol-032713-120245; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Uno S, 2006, MOL PHARMACOL, V69, P1103, DOI 10.1124/mol.105.021501; Uno S, 2008, FREE RADICAL BIO MED, V44, P570, DOI 10.1016/j.freeradbiomed.2007.10.044; Werck-Reichhart D, 2000, GENOME BIOL, V1, P1, DOI DOI 10.1186/GB-2000-1-6-REVIEWS3003; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Wincent E, 2009, J BIOL CHEM, V284, P2690, DOI 10.1074/jbc.M808321200; Wong JMY, 2001, BIOCHEM BIOPH RES CO, V288, P990, DOI 10.1006/bbrc.2001.5861; Wourms MJ, 2015, CELL IMMUNOL, V295, P60, DOI 10.1016/j.cellimm.2015.02.012; Xie F, 2014, GENOME RES, V24, P1526, DOI 10.1101/gr.173427.114; Xue P, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00286; Zhao B, 2010, SCI CHINA CHEM, V53, P1010, DOI 10.1007/s11426-010-0142-8; Zwaka TP, 2003, NAT BIOTECHNOL, V21, P319, DOI 10.1038/nbt788	74	1	2	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9141	9155		10.1096/fj.201903110R	http://dx.doi.org/10.1096/fj.201903110R		MAY 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32421247				2022-12-28	WOS:000533521800001
J	Buch, BT; Halling, JF; Ringholm, S; Gudiksen, A; Kjobsted, R; Olsen, MA; Wojtaszewski, JFP; Pilegaard, H				Buch, Bjorg Thiellesen; Halling, Jens Frey; Ringholm, Stine; Gudiksen, Anders; Kjobsted, Rasmus; Olsen, Mette Algot; Wojtaszewski, Jorgen F. P.; Pilegaard, Henriette			Colchicine treatment impairs skeletal muscle mitochondrial function and insulin sensitivity in an age-specific manner	FASEB JOURNAL			English	Article						ADP sensitivity; aging; autophagy; ROS	OXIDATIVE STRESS; GLUCOSE-UTILIZATION; AUTOPHAGIC FLUX; GENE-EXPRESSION; H2O2 RELEASE; EX-VIVO; EXERCISE; PGC-1-ALPHA; RESISTANCE; DYSFUNCTION	The aim of the study was to investigate the impact of autophagy inhibition on skeletal muscle mitochondrial function and glucose homeostasis in young and aged mice. The transcriptional co-activator PGC-1 alpha regulates muscle oxidative phenotype which has been shown to be linked with basal autophagic capacity. Therefore, young and aged inducible muscle-specific PGC-1 alpha knockout (iMKO) mice and littermate lox/lox controls were used in three separate experiments performed after either saline or colchicine injections on two consecutive days: (1) Euthanization in the basal state obtaining skeletal muscle for mitochondrial respirometry, (2) whole body glucose tolerance test, and (3) in vivo insulin-stimulated 2-deoxyglucose (2-DG) uptake into skeletal muscle. Muscle PGC-1 alpha was not required for maintaining basal autophagy flux, regardless of age. Colchicine-induced inhibition of autophagy was associated with impairments of skeletal muscle mitochondrial function, including reduced ADP sensitivity and altered mitochondrial redox balance in both young and aged mice. Colchicine treatment reduced the glucose tolerance in aged, but not young mice, and similarly in iMKO and lox/lox mice. Colchicine reduced insulin-stimulated 2-DG uptake in soleus muscle in aged mice, independently of PGC-1 alpha, and without affecting insulin-regulated phosphorylation of proximal or distal mediators of insulin signaling. In conclusion, the results indicate that autophagy regulates the mitochondrial ADP sensitivity and redox balance as well as whole body glucose tolerance and skeletal muscle insulin sensitivity in aged mice, with no additional effects of inducible PGC-1 alpha deletion.	[Buch, Bjorg Thiellesen; Halling, Jens Frey; Ringholm, Stine; Gudiksen, Anders; Olsen, Mette Algot; Pilegaard, Henriette] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Kjobsted, Rasmus; Wojtaszewski, Jorgen F. P.] Univ Copenhagen, Dept Nutr Exercise & Sports, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Pilegaard, H (corresponding author), Univ Copenhagen, Dept Biol, Copenhagen, Denmark.	hpilegaard@bio.ku.dk	Kjøbsted, Rasmus/AAY-8228-2020; Halling, Jens Frey/H-4700-2015	Kjøbsted, Rasmus/0000-0002-0628-4994; wojtaszewski, jorgen/0000-0001-8185-3408; Halling, Jens Frey/0000-0002-8638-6746	Danish Council for Independent Research [4181-00078]; Augustinus Fonden (Augustinus Foundation); Danish Diabetes Academy	Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Augustinus Fonden (Augustinus Foundation); Danish Diabetes Academy	Danish Council for Independent Research, Grant/Award Number: 4181-00078; Augustinus Fonden (Augustinus Foundation); Danish Diabetes Academy	Ahlstrom P, 2017, J MOL ENDOCRINOL, V59, P339, DOI 10.1530/JME-17-0096; Ai H, 2003, AM J PHYSIOL-ENDOC M, V285, pE836, DOI 10.1152/ajpendo.00238.2002; Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; Birk JB, 2006, J PHYSIOL-LONDON, V577, P1021, DOI 10.1113/jphysiol.2006.120972; Boushel R, 2007, DIABETOLOGIA, V50, P790, DOI 10.1007/s00125-007-0594-3; Cannavino J, 2014, J PHYSIOL-LONDON, V592, P4575, DOI 10.1113/jphysiol.2014.275545; Capel F, 2005, MECH AGEING DEV, V126, P505, DOI 10.1016/j.mad.2004.11.001; Carter HN, 2018, J PHYSIOL-LONDON, V596, P3567, DOI 10.1113/JP275998; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Conley KE, 2000, J PHYSIOL-LONDON, V526, P203, DOI 10.1111/j.1469-7793.2000.t01-1-00203.x; DUDLEY GA, 1987, J BIOL CHEM, V262, P9109; Fazakerley DJ, 2018, J BIOL CHEM, V293, P7315, DOI 10.1074/jbc.RA117.001254; FERRE P, 1985, BIOCHEM J, V228, P103, DOI 10.1042/bj2280103; Finley LWS, 2012, P NATL ACAD SCI USA, V109, P2931, DOI 10.1073/pnas.1115813109; Fisher-Wellman KH, 2012, TRENDS ENDOCRIN MET, V23, P142, DOI 10.1016/j.tem.2011.12.008; Geng TY, 2010, AM J PHYSIOL-CELL PH, V298, pC572, DOI 10.1152/ajpcell.00481.2009; GIUGLIANO D, 1981, DIABETES, V30, P1008, DOI 10.2337/diabetes.30.12.1008; Goncalves RLS, 2015, J BIOL CHEM, V290, P209, DOI 10.1074/jbc.M114.619072; Halling JF, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12698; Halling JF, 2019, AM J PHYSIOL-ENDOC M, V317, pE513, DOI 10.1152/ajpendo.00059.2019; Halling JF, 2017, EXP GERONTOL, V96, P1, DOI 10.1016/j.exger.2017.05.020; Hancock CR, 2008, P NATL ACAD SCI USA, V105, P7815, DOI 10.1073/pnas.0802057105; Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785; Hey-Mogensen M, 2015, J PHYSIOL-LONDON, V593, P3991, DOI 10.1113/JP270204; Hoehn KL, 2009, P NATL ACAD SCI USA, V106, P17787, DOI 10.1073/pnas.0902380106; Holloway GP, 2018, CELL REP, V22, P2837, DOI 10.1016/j.celrep.2018.02.069; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Joseph AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069327; Ju JS, 2010, AUTOPHAGY, V6, P929, DOI 10.4161/auto.6.7.12785; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Kim YA, 2013, J PHYSIOL BIOCHEM, V69, P697, DOI 10.1007/s13105-013-0246-7; Larsen S, 2011, DIABETOLOGIA, V54, P1427, DOI 10.1007/s00125-011-2098-4; Larsen S, 2009, DIABETOLOGIA, V52, P1400, DOI 10.1007/s00125-009-1353-4; Leick L, 2010, EXP GERONTOL, V45, P336, DOI 10.1016/j.exger.2010.01.011; Li HG, 2017, EXP CELL RES, V354, P18, DOI 10.1016/j.yexcr.2017.03.023; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lira VA, 2013, FASEB J, V27, P4184, DOI 10.1096/fj.13-228486; Liu XL, 2015, METABOLISM, V64, P658, DOI 10.1016/j.metabol.2015.01.015; Liu Y, 2015, DIABETES, V64, P36, DOI 10.2337/db14-0267; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Ludzki A, 2015, DIABETES, V64, P2769, DOI 10.2337/db14-1838; Lundby C, 2005, EUR J APPL PHYSIOL, V95, P351, DOI 10.1007/s00421-005-0022-7; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; McCarthy JJ, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-8; MENZIES RA, 1971, J BIOL CHEM, V246, P2425; Miotto PM, 2018, DIABETES, V67, P2199, DOI 10.2337/db18-0417; Miotto PM, 2016, BIOCHEM J, V473, P2831, DOI 10.1042/BCJ20160373; Mogensen M, 2007, DIABETES, V56, P1592, DOI 10.2337/db06-0981; Morino K, 2005, J CLIN INVEST, V115, P3587, DOI 10.1172/JCI25151; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Olesen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032222; Perry CGR, 2012, J PHYSIOL-LONDON, V590, P5475, DOI 10.1113/jphysiol.2012.234682; Perry CGR, 2011, BIOCHEM J, V437, P215, DOI 10.1042/BJ20110366; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; Pilegaard H, 2000, AM J PHYSIOL-ENDOC M, V279, pE806; Quinlan CL, 2013, REDOX BIOL, V1, P304, DOI 10.1016/j.redox.2013.04.005; Rabol R, 2010, J CLIN ENDOCR METAB, V95, P857, DOI 10.1210/jc.2009-1844; Rodney GG, 2016, FREE RADICAL BIO MED, V98, P103, DOI 10.1016/j.freeradbiomed.2016.05.010; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Seiliez I, 2016, AUTOPHAGY, V12, P343, DOI 10.1080/15548627.2015.1117732; SHAH JH, 1978, DIABETES, V27, P925, DOI 10.2337/diabetes.27.9.925; SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771; Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102; Smith BK, 2013, J PHYSIOL-LONDON, V591, P6089, DOI 10.1113/jphysiol.2013.259226; SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Steinbusch LKM, 2010, AM J PHYSIOL-CELL PH, V298, pC1549, DOI 10.1152/ajpcell.00334.2009; Su ZD, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13114-4; Timmers S, 2016, DIABETES CARE, V39, P2211, DOI 10.2337/dc16-0499; Tonkonogi M, 2003, PFLUG ARCH EUR J PHY, V446, P261, DOI 10.1007/s00424-003-1044-9; TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0; Vainshtein A, 2015, AM J PHYSIOL-CELL PH, V308, pC710, DOI 10.1152/ajpcell.00380.2014; Vasilaki A, 2006, AGING CELL, V5, P109, DOI 10.1111/j.1474-9726.2006.00198.x; Venditti P, 1999, ARCH BIOCHEM BIOPHYS, V372, P315, DOI 10.1006/abbi.1999.1494; Wohlgemuth SE, 2010, EXP GERONTOL, V45, P138, DOI 10.1016/j.exger.2009.11.002; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269; Wu JJ, 2009, AGING-US, V1, P425, DOI 10.18632/aging.100038; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005; Zechner C, 2010, CELL METAB, V12, P633, DOI 10.1016/j.cmet.2010.11.008	82	8	8	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8653	8670		10.1096/fj.201903113RR	http://dx.doi.org/10.1096/fj.201903113RR		MAY 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32372536				2022-12-28	WOS:000530736400001
J	Xu, XQ; Wang, RL; Wu, R; Yan, WJ; Shi, TS; Jiang, Q; Shi, DQ				Xu, Xingquan; Wang, Rongliang; Wu, Rui; Yan, Wenjin; Shi, Tianshu; Jiang, Qing; Shi, Dongquan			Trehalose reduces bone loss in experimental biliary cirrhosis rats via ERK phosphorylation regulation by enhancing autophagosome formation	FASEB JOURNAL			English	Article						autophagosomes; ERK phosphorylation; osteoporosis in PBC; osteoclastogenesis; trehalose	CHOLESTATIC LIVER-DISEASE; HEPATIC OSTEODYSTROPHY; OSTEOPOROSIS; DIFFERENTIATION; METABOLISM; ETIDRONATE; OSTEOPENIA; RISK	Bone loss is a severe complication of primary biliary cirrhosis (PBC). Trehalose was intermittently administered in bile duct-ligated (BDL) male rats, a PBC-related osteoporosis model, for 4 weeks to reduce osteoporosis. Femoral bones were assessed ex vivo by micro computed tomography (CT) and histomorphometry. The potential mechanisms related to the reduction of osteoporosis were explored by evaluating the effect of trehalose on osteoblast autophagy, osteogenesis, osteoclastogenesis, and ERK phosphorylation. The results demonstrated that trehalose reduced osteoporosis of BDL rats and decreased osteoblast-mediated osteoclast differentiation by enhancing osteoblast autophagy to regulate osteoprotegerin (OPG) secretion. Hydroxychloroquine (HCQ) increased the expression of OPG and OPG/receptor activator genes for nuclear factor-kappa B ligand (RANKL) ratio, and reduced osteoblast-mediated osteoclastogenesis by inhibiting autophagy flux and inducing autophagosome formation. Furthermore, trehalose increased the phosphorylation of ERK1/2 in MC3T3-E1 cells, and the ERK inhibitor PD98059 reversed the upregulation of OPG gene and reduction of trehalose-induced osteoclastogeneis. The treatment with HCQ markedly increased the ERK phosphorylation. The correlation between autophagosome formation and ERK phosphorylation was confirmed in autophagy proteins (ATG) 4B or ATG5-deficient cells. Thus, trehalose could decrease osteoblast-mediated osteoclastogenesis and reduce PBC-related bone loss by regulating ERK phosphorylation via autophagosome formation.	[Xu, Xingquan; Wang, Rongliang; Wu, Rui; Yan, Wenjin; Shi, Tianshu; Jiang, Qing; Shi, Dongquan] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Dept Sports Med & Adult Reconstruct Surg, Nanjing Drum Tower Hosp,Affiliated Hosp,Med Sch, Nanjing, Peoples R China; [Xu, Xingquan; Wang, Rongliang; Wu, Rui; Yan, Wenjin; Shi, Tianshu; Jiang, Qing; Shi, Dongquan] Nanjing Univ, Joint Res Ctr Bone & Joint Dis, Model Anim Res Ctr MARC, Nanjing, Peoples R China	Nanjing University; Nanjing University	Jiang, Q; Shi, DQ (corresponding author), Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Dept Sports Med & Adult Reconstruct Surg, Drum Tower Hosp,Sch Med, 321 Zhongshan Rd, Nanjing 210008, Jiangsu, Peoples R China.	qingj@nju.edu.cn; shidongquan1215@163.com	shi, dongquan/ABH-3078-2021; Shi, Dongquan/ABG-6949-2021; shi, dongquan/AAE-9956-2020	shi, dongquan/0000-0002-4769-7816; 	National Science Foundation of China (NSFC) [81802196, 81572129]; Natural Science Foundation of Jiangsu Province [BK20180127]; Projects of International Cooperation and Exchanges NSFC [81420108021]; Key Program of NSFC [81730067]; Excellent Young Scholars NSFC [81622033]; Jiangsu Provincial Key Medical Center Foundation; Jiangsu Provincial Medical Outstanding Talent Foundation; Jiangsu Provincial Medical Youth Talent Foundation; Jiangsu Provincial Key Medical Talent Foundation	National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Projects of International Cooperation and Exchanges NSFC; Key Program of NSFC(National Natural Science Foundation of China (NSFC)); Excellent Young Scholars NSFC; Jiangsu Provincial Key Medical Center Foundation; Jiangsu Provincial Medical Outstanding Talent Foundation; Jiangsu Provincial Medical Youth Talent Foundation; Jiangsu Provincial Key Medical Talent Foundation	This study was supported by the National Science Foundation of China (NSFC, 81802196, 81572129), Natural Science Foundation of Jiangsu Province (BK20180127), Projects of International Cooperation and Exchanges NSFC (81420108021), Key Program of NSFC (81730067), Excellent Young Scholars NSFC (81622033), Jiangsu Provincial Key Medical Center Foundation, Jiangsu Provincial Medical Outstanding Talent Foundation, Jiangsu Provincial Medical Youth Talent Foundation, and Jiangsu Provincial Key Medical Talent Foundation.	Ackerman Z, 2002, LIVER, V22, P166, DOI 10.1046/j.0106-9543.2002.01566.x; Arai C, 2001, NUTR RES, V21, P993, DOI 10.1016/S0271-5317(01)00315-3; Belzile JP, 2016, J VIROL, V90, P1259, DOI 10.1128/JVI.02651-15; Beuers U, 2009, J HEPATOL, V51, P237, DOI 10.1016/j.jhep.2009.04.009; Boone RH, 2006, DIGEST DIS SCI, V51, P1103, DOI 10.1007/s10620-006-8015-x; Boyce BF, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2165; Castillo K, 2013, AUTOPHAGY, V9, P1308, DOI 10.4161/auto.25188; Chen XS, 2016, SCI REP-UK, V6, DOI 10.1038/srep19455; Dondorf F, 2017, WORLD J GASTROENTERO, V23, P4191, DOI 10.3748/wjg.v23.i23.4191; Dresner-Pollak R, 2008, GASTROENTEROLOGY, V134, P259, DOI 10.1053/j.gastro.2007.10.025; Endo Y, 2013, J CLIN PERIODONTOL, V40, P33, DOI 10.1111/jcpe.12032; Fan JY, 2017, CLIN RHEUMATOL, V36, P2565, DOI 10.1007/s10067-017-3844-x; Glass LM, 2016, GASTROENTEROL CLIN N, V45, P333, DOI 10.1016/j.gtc.2016.02.009; Goral V, 2010, WORLD J GASTROENTERO, V16, P1639, DOI 10.3748/wjg.v16.i13.1639; GUANABENS N, 1990, AM J GASTROENTEROL, V85, P1356; Guanabens N, 1997, GASTROENTEROLOGY, V113, P219, DOI 10.1016/S0016-5085(97)70098-2; Guanabens N, 2005, J HEPATOL, V42, P573, DOI 10.1016/j.jhep.2004.11.035; Guanabens N, 2010, GASTROENTEROLOGY, V138, P2348, DOI 10.1053/j.gastro.2010.02.016; Guichelaar MMJ, 2002, HEPATOLOGY, V36, P895, DOI 10.1053/jhep.2002.36357; Handzlik-Orlik G, 2016, THER ADV ENDOCRINOL, V7, P128, DOI 10.1177/2042018816641351; Heathcote EJ, 2000, HEPATOLOGY, V31, P1005, DOI 10.1053/he.2000.5984; Jaiswal RK, 2000, J BIOL CHEM, V275, P9645, DOI 10.1074/jbc.275.13.9645; Jeong YH, 2020, EVID-BASED COMPL ALT, V2020, DOI 10.1155/2020/1927017; Jin HM, 2019, FOOD FUNCT, V10, P6556, DOI 10.1039/c9fo00206e; Levy Cynthia, 2003, Curr Treat Options Gastroenterol, V6, P93, DOI 10.1007/s11938-003-0010-0; Li GC, 2018, J CELL PHYSIOL, V233, P7379, DOI 10.1002/jcp.26574; Liao CY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194418; Lindor KD, 2000, J HEPATOL, V33, P878, DOI 10.1016/S0168-8278(00)80118-X; Liu F, 2013, J BONE MINER RES, V28, P2414, DOI 10.1002/jbmr.1971; Lopez-Larramona G, 2011, WORLD J HEPATOL, V3, P300, DOI 10.4254/wjh.v3.i12.300; Lu ZY, 2017, MOL IMMUNOL, V87, P161, DOI 10.1016/j.molimm.2017.04.013; Luo TW, 2018, TOXICOL IN VITRO, V52, P60, DOI 10.1016/j.tiv.2018.06.001; Luxon Bruce A, 2011, Curr Gastroenterol Rep, V13, P40, DOI 10.1007/s11894-010-0166-4; Martinez-Lopez N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3799; Mathews S, 2014, J TISSUE ENG REGEN M, V8, P143, DOI 10.1002/term.1507; Nollet M, 2014, AUTOPHAGY, V10, P1965, DOI 10.4161/auto.36182; Pereira SP, 2004, ALIMENT PHARM THER, V19, P563, DOI 10.1111/j.1365-2036.2004.01890.x; Raszeja-Wyszomirska J, 2014, PRZ GASTROENTEROL, V9, P82, DOI 10.5114/pg.2014.42502; Rudic JS, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009146.pub2; Rusmini P, 2019, AUTOPHAGY, V15, P631, DOI 10.1080/15548627.2018.1535292; Sciarretta S, 2018, J AM COLL CARDIOL, V71, P1999, DOI 10.1016/j.jacc.2018.02.066; Selva C, 2013, J PHARM SCI-US, V102, P649, DOI 10.1002/jps.23398; Sergin I, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15750; Shen GY, 2018, CELL MOL LIFE SCI, V75, P2683, DOI 10.1007/s00018-018-2776-1; Shen MJ, 2018, CELL PHYSIOL BIOCHEM, V50, P1522, DOI 10.1159/000494651; Shiomi S, 1999, J GASTROENTEROL, V34, P241, DOI 10.1007/s005350050250; Solaymani-Dodaran M, 2006, GASTROENTEROLOGY, V131, P1752, DOI 10.1053/j.gastro.2006.09.012; STELLON AJ, 1987, HEPATOLOGY, V7, P137, DOI 10.1002/hep.1840070127; Weinreb M, 2004, J HEPATOL, V40, P385, DOI 10.1016/j.jhep.2003.11.032; Xu XQ, 2019, ANN TRANSL MED, V7, DOI 10.21037/atm.2019.05.73; Yang XX, 2018, BIOCONJUGATE CHEM, V29, P287, DOI 10.1021/acs.bioconjchem.7b00588; Yin YL, 2017, J ALZHEIMERS DIS, V59, P851, DOI 10.3233/JAD-170246; Zhang XC, 2018, INT J NANOMED, V13, P403, DOI 10.2147/IJN.S150875; Zhou ZH, 2020, EXP CELL RES, V388, DOI 10.1016/j.yexcr.2020.111857	54	10	10	2	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8402	8415		10.1096/fj.201902528RRR	http://dx.doi.org/10.1096/fj.201902528RRR		MAY 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32367591	hybrid			2022-12-28	WOS:000530738300001
J	Chamberlin, T; Thompson, V; Hillers-Ziemer, LE; Walton, BN; Arendt, LM				Chamberlin, Tamara; Thompson, Victoria; Hillers-Ziemer, Lauren E.; Walton, Brenna N.; Arendt, Lisa M.			Obesity reduces mammary epithelial cell TGF beta 1 activity through macrophage-mediated extracellular matrix remodeling	FASEB JOURNAL			English	Article						decorin; macrophages; mammary gland; obesity; transforming growth factor beta	TRANSFORMING-GROWTH-FACTOR; BODY-MASS INDEX; ELEVATED AROMATASE EXPRESSION; HUMAN ADIPOSE-TISSUE; FACTOR-BETA; BREAST-CANCER; STEM-CELLS; TGF-BETA; NEGATIVE REGULATION; RISK	Obesity is a risk factor for breast cancer in postmenopausal and high-risk premenopausal women. Changes within the obese breast microenvironment may increase breast cancer risk. Transforming growth factor beta-1 (TGF beta 1) is a major regulator of mammary epithelial stem/progenitor cells, and its activity is dysregulated under conditions of obesity. Using a high-fat diet model of obesity in mice and breast tissue from women, we observed that TGF beta 1 activity is reduced in breast epithelial cells in obesity. Breast ducts and lobules demonstrated increased decorin in the extracellular matrix (ECM) surrounding epithelial cells, and we observed that decorin and latent TGF beta 1 complexed together. Under conditions of obesity, macrophages expressed higher levels of decorin and were significantly increased in number surrounding breast epithelial cells. To investigate the relationship between macrophages and decorin expression, we treated obese mice with either IgG control or anti-F4/80 antibodies to deplete macrophages. Mice treated with anti-F4/80 antibodies demonstrated reduced decorin surrounding mammary ducts and enhanced TGF beta 1 activity within mammary epithelial cells. Given the role of TGF beta 1 as a tumor suppressor, reduced epithelial TGF beta 1 activity and enhanced TGF beta 1 within the ECM of obese mammary tissue may enhance breast cancer risk.	[Chamberlin, Tamara; Hillers-Ziemer, Lauren E.; Arendt, Lisa M.] Univ Wisconsin, Program Cellular & Mol Biol, Madison, WI USA; [Thompson, Victoria; Arendt, Lisa M.] Univ Wisconsin, Sch Vet Med, Dept Comparat Biosci, 2015 Linden Dr,Rm 4354A, Madison, WI 53706 USA; [Walton, Brenna N.; Arendt, Lisa M.] Univ Wisconsin, Program Mol & Environm Toxicol, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Arendt, LM (corresponding author), Univ Wisconsin, Sch Vet Med, Dept Comparat Biosci, 2015 Linden Dr,Rm 4354A, Madison, WI 53706 USA.	lmarendt@wisc.edu			National Cancer Institute (NCI) [R01 CA227542, P30 CA014520]; National Institutes of Health (NIH) [T32 OD010423]; Susan G. Komen (SGK) [CCR1532611]	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen (SGK)(Susan G. Komen Breast Cancer Foundation)	National Cancer Institute (NCI), Grant/Award Number: R01 CA227542 and P30 CA014520; National Institutes of Health (NIH), Grant/Award Number: T32 OD010423; Susan G. Komen (SGK), Grant/Award Number: CCR1532611	Afik R, 2016, J EXP MED, V213, P2315, DOI 10.1084/jem.20151193; Alessi MC, 2000, DIABETES, V49, P1374, DOI 10.2337/diabetes.49.8.1374; Arendt LM, 2013, CANCER RES, V73, P6080, DOI 10.1158/0008-5472.CAN-13-0926; ASSOIAN RK, 1987, P NATL ACAD SCI USA, V84, P6020, DOI 10.1073/pnas.84.17.6020; Barcellos-Hoff MH, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005474; Best J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162286; Biglia N, 2013, GYNECOL ENDOCRINOL, V29, P263, DOI 10.3109/09513590.2012.736559; Bolton K, 2008, INT J OBESITY, V32, P1113, DOI 10.1038/ijo.2008.41; Booth D, 2000, INT J CANCER, V86, P53, DOI 10.1002/(SICI)1097-0215(20000401)86:1<53::AID-IJC8>3.0.CO;2-Z; Boras-Granic K, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0487-6; Boulanger CA, 2001, ONCOGENE, V20, P2264, DOI 10.1038/sj.onc.1204312; Boulanger CA, 2005, ONCOGENE, V24, P552, DOI 10.1038/sj.onc.1208185; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Cecchini RS, 2012, CANCER PREV RES, V5, P583, DOI 10.1158/1940-6207.CAPR-11-0482; Chamberlin T, 2017, BREAST CANCER RES, V19, DOI 10.1186/s13058-017-0921-7; Costanza B, 2017, J CLIN MED, V6, DOI 10.3390/jcm6010007; Crawford SE, 1998, CELL, V93, P1159, DOI 10.1016/S0092-8674(00)81460-9; DANIEL CW, 1989, DEV BIOL, V135, P20, DOI 10.1016/0012-1606(89)90154-1; de la Durantaye M, 2014, J ORTHOP RES, V32, P279, DOI 10.1002/jor.22504; Desai VD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086865; Ewan KB, 2002, AM J PATHOL, V160, P2081, DOI 10.1016/S0002-9440(10)61158-3; Ewan KBR, 2005, AM J PATHOL, V167, P409, DOI 10.1016/S0002-9440(10)62985-9; Fain JN, 2005, METABOLISM, V54, P1546, DOI 10.1016/j.metabol.2005.05.024; Fang Lingling, 2015, J Proteomics Bioinform, V8, P133; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Gao CL, 2010, INT J MOL MED, V25, P71, DOI 10.3892/ijmm_00000315; Ginestier C, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1741; Hida K, 2000, J LIPID RES, V41, P1615; Hillers LE, 2018, NEOPLASIA, V20, P1161, DOI 10.1016/j.neo.2018.09.004; Horiguchi M, 2012, J BIOCHEM, V152, P321, DOI 10.1093/jb/mvs089; Iyengar NM, 2017, CANCER PREV RES, V10, P235, DOI 10.1158/1940-6207.CAPR-16-0314; KORDON EC, 1995, DEV BIOL, V168, P47, DOI 10.1006/dbio.1995.1060; Lee MJ, 2018, BBA-MOL BASIS DIS, V1864, P1160, DOI 10.1016/j.bbadis.2018.01.025; Lin D, 2016, BIOCHEM PHARMACOL, V119, P8, DOI 10.1016/j.bcp.2016.05.005; Lodyga M, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aao3469; Maxwell CA, 2008, CANCER RES, V68, P8304, DOI 10.1158/0008-5472.CAN-08-1212; Miyazono K, 2000, J CELL SCI, V113, P1101; Moses H, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003277; Murphy-Ullrich JE, 2000, CYTOKINE GROWTH F R, V11, P59, DOI 10.1016/S1359-6101(99)00029-5; Neuzillet C, 2015, PHARMACOL THERAPEUT, V147, P22, DOI 10.1016/j.pharmthera.2014.11.001; O'Brien J, 2010, J MAMMARY GLAND BIOL, V15, P353, DOI 10.1007/s10911-010-9185-x; Oda G, 2012, ONCOL REP, V28, P2003, DOI 10.3892/or.2012.2040; Phipps AI, 2008, CANCER EPIDEM BIOMAR, V17, P2078, DOI 10.1158/1055-9965.EPI-08-0206; Phipps AI, 2012, ANN EPIDEMIOL, V22, P340, DOI 10.1016/j.annepidem.2012.02.002; Prater MD, 2014, NAT CELL BIOL, V16, P942, DOI 10.1038/ncb3025; Reeves GK, 2007, BRIT MED J, V335, P1134, DOI 10.1136/bmj.39367.495995.AE; Rendra E, 2019, IMMUNOBIOLOGY, V224, P242, DOI 10.1016/j.imbio.2018.11.010; Rifkin DB, 2005, J BIOL CHEM, V280, P7409, DOI 10.1074/jbc.R400029200; ROBINSON SD, 1991, DEVELOPMENT, V113, P867; Russo L, 2018, IMMUNOLOGY, V155, P407, DOI 10.1111/imm.13002; Samad F, 1997, MOL MED, V3, P37, DOI 10.1007/BF03401666; Seo BR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010467; Shieh Y, 2019, BREAST CANCER RES, V21, DOI 10.1186/s13058-019-1129-9; Shoker BS, 1999, AM J PATHOL, V155, P1811, DOI 10.1016/S0002-9440(10)65498-3; Subbaramaiah K, 2012, CANCER DISCOV, V2, P356, DOI 10.1158/2159-8290.CD-11-0241; Subbaramaiah K, 2011, CANCER PREV RES, V4, P329, DOI 10.1158/1940-6207.CAPR-10-0381; Van Bockstal M, 2013, HISTOPATHOLOGY, V63, P520, DOI 10.1111/his.12188; Van Keymeulen A, 2017, CELL REP, V20, P1525, DOI 10.1016/j.celrep.2017.07.066; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; van't Land B, 2002, BRIT J CANCER, V87, P113, DOI 10.1038/sj.bjc.6600342; Varma V, 2008, DIABETES, V57, P432, DOI 10.2337/db07-0840; Voros G, 2005, ENDOCRINOLOGY, V146, P4545, DOI 10.1210/en.2005-0532; Walker RA, 2007, J PATHOL, V211, P232, DOI 10.1002/path.2079; Wang CH, 2017, CELL REP, V18, P2825, DOI 10.1016/j.celrep.2017.02.071; Wang YY, 2017, J AM SOC NEPHROL, V28, P2053, DOI 10.1681/ASN.2016050573; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; YAMAGUCHI Y, 1990, NATURE, V346, P281, DOI 10.1038/346281a0; Zarzynska JM, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/141747; Zhang W, 2018, ONCOTARGET, V9, P5480, DOI 10.18632/oncotarget.23869; Zhang Y, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a022145; Zhang Z, 2009, BURNS, V35, P527, DOI 10.1016/j.burns.2008.08.021	71	6	6	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8611	8624		10.1096/fj.202000228RR	http://dx.doi.org/10.1096/fj.202000228RR		MAY 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32359100	Green Published, hybrid			2022-12-28	WOS:000530047400001
J	He, JM; Ge, QW; Lin, ZH; Shen, WY; Lin, RB; Wu, JG; Wang, BY; Lu, YK; Chen, LY; Liu, XS; Zheng, WF; Zhang, Y; Wang, L; Wang, K; Wang, LJ; Zhuo, W; Chen, SJ				He, Jiamin; Ge, Qiwei; Lin, Zhenghua; Shen, Weiyi; Lin, Renbin; Wu, Jiaguo; Wang, Boya; Lu, Yunkun; Chen, Luyi; Liu, Xiaosun; Zheng, Wenfang; Zhang, Ying; Wang, Lan; Wang, Kan; Wang, Liangjing; Zhuo, Wei; Chen, Shujie			MiR-129-5p induces cell cycle arrest through modulating HOXC10/Cyclin D1 to inhibit gastric cancer progression	FASEB JOURNAL			English	Article						cell cycle; cyclin D1; gastric cancer; HOXC10; miR-129-5p	UP-REGULATION; HOX GENES; PROLIFERATION; EXPRESSION; ANGIOGENESIS; APOPTOSIS; AUTOPHAGY; SURVIVAL; INVASION	MicroRNAs (miRNAs) play important roles in posttranscriptional regulation and may serve as targets for the diagnosis and treatment of cancers. Nevertheless, a comprehensive understanding of miRNAs profiles in gastric cancer progression is still lacking. Here, we report that miR-129-5p is downregulated in gastric cancer by analyzing TCGA database (n = 41) and clinical tumor samples (n = 60). MiR-129-5p transfection suppressed gastric cancer cell proliferation through inducing G1 phase arrest in vitro and inhibit xenograft tumor growth in vivo. MiR-129-5p directly targeted the 3 ' untranslated regions (3 ' UTR) of HOXC10 mRNA and downregulated its expression. Importantly, miR-129-5p could reverse the oncogenic effect induced by HOXC10. We systemically screened the downstream target of HOXC10 by ChIP sequencing, and found that HOXC10 could transcriptionally regulate the expression of Cyclin D1 and facilitate G1/S cell cycle transition. Notably, high levels of HOXC10 and Cyclin D1 were related with poor prognosis of gastric cancer patients (n = 90). These findings reveal a novel role of miR-129-5p/HOXC10/Cyclin D1 axis in modulating cell cycle and gastric tumorigenesis, which might provide potential prognostic biomarkers and therapeutic targets for gastric cancer patients.	[He, Jiamin; Shen, Weiyi; Lin, Renbin; Wu, Jiaguo; Chen, Luyi; Zheng, Wenfang; Zhang, Ying; Wang, Lan; Wang, Kan; Chen, Shujie] Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Gastroenterol, Sch Med, Hangzhou 310016, Zhejiang, Peoples R China; [He, Jiamin; Ge, Qiwei; Lin, Zhenghua; Shen, Weiyi; Lin, Renbin; Wu, Jiaguo; Wang, Boya; Chen, Luyi; Zheng, Wenfang; Zhang, Ying; Wang, Lan; Wang, Kan; Wang, Liangjing; Zhuo, Wei; Chen, Shujie] Zhejiang Univ, Inst Gastroenterol, Hangzhou, Peoples R China; [Ge, Qiwei; Lin, Zhenghua; Wang, Liangjing] Zhejiang Univ, Dept Gastroenterol, Sch Med, Affiliated Hosp 2, Hangzhou 310009, Zhejiang, Peoples R China; [Wang, Boya] Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Pharm, Sch Med, Hangzhou, Peoples R China; [Lu, Yunkun; Zhuo, Wei] Zhejiang Univ, Dept Cell Biol, Sch Med, Hangzhou 310058, Zhejiang, Peoples R China; [Liu, Xiaosun] Zhejiang Univ, Affiliated Hosp 1, Dept Surg, Sch Med, Hangzhou, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University	Chen, SJ (corresponding author), Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Gastroenterol, Sch Med, Hangzhou 310016, Zhejiang, Peoples R China.; Wang, LJ (corresponding author), Zhejiang Univ, Dept Gastroenterol, Sch Med, Affiliated Hosp 2, Hangzhou 310009, Zhejiang, Peoples R China.; Zhuo, W (corresponding author), Zhejiang Univ, Dept Cell Biol, Sch Med, Hangzhou 310058, Zhejiang, Peoples R China.	wangljzju@zju.edu.cn; 0012049@zju.edu.cn; chenshujie77@zju.edu.cn		Lu, Yunkun/0000-0001-7605-1259; Zhuo, Wei/0000-0002-8251-4210	National Natural Science Foundation of China [31771540, 81802348, 81972276]; Natural Science Foundation of Zhejiang Province [LY18H160011, LYY19H310011]; Fundamental Research Funds for the Central Universities [2017QNA7005]; Zhejiang Provincial Medical and Health Science and Technology Project [2018KY464, 2018KY474]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Zhejiang Provincial Medical and Health Science and Technology Project	National Natural Science Foundation of China, Grant/Award Number: 31771540, 81802348 and 81972276; Natural Science Foundation of Zhejiang Province, Grant/Award Number: LY18H160011 and LYY19H310011; Fundamental Research Funds for the Central Universities, Grant/Award Number: 2017QNA7005; Zhejiang Provincial Medical and Health Science and Technology Project, Grant/Award Number: 2018KY464 and 2018KY474	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Cao JY, 2018, INT UROL NEPHROL, V50, P1811, DOI 10.1007/s11255-018-1959-x; Chen D, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00502; Chou WC, 2009, LEUKEMIA, V23, P1303, DOI 10.1038/leu.2009.25; Duarte HO, 2018, HELICOBACTER, V23, DOI 10.1111/hel.12523; Dubova EA, 2009, B EXP BIOL MED+, V148, P908, DOI 10.1007/s10517-010-0849-8; Feng XY, 2015, MOL BIOSYST, V11, P2946, DOI 10.1039/c5mb00253b; Geng ZH, 2016, AM J TRANSL RES, V8, P1886; Goetz MP, 2006, CLIN CANCER RES, V12, P2080, DOI 10.1158/1078-0432.CCR-05-1263; Huang YW, 2009, CANCER RES, V69, P9038, DOI 10.1158/0008-5472.CAN-09-1499; Li BW, 2017, CANCER LETT, V410, P212, DOI 10.1016/j.canlet.2017.09.035; Liu Q, 2018, BIOMED PHARMACOTHER, V105, P420, DOI 10.1016/j.biopha.2018.05.105; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035800; Ma Z, 2017, BIOCHEM BIOPH RES CO, V490, P309, DOI 10.1016/j.bbrc.2017.06.041; Morgan R, 2016, CURR MOL MED, V16, P322, DOI 10.2174/1566524016666160316145715; Ru Y, 2017, ONCOTARGET, V8, P73860, DOI 10.18632/oncotarget.18008; Sadik H, 2016, CANCER RES, V76, P4443, DOI 10.1158/0008-5472.CAN-16-0774; Seiler R, 2014, MODERN PATHOL, V27, P87, DOI 10.1038/modpathol.2013.125; Shah N, 2010, NAT REV CANCER, V10, P361, DOI 10.1038/nrc2826; Shen WF, 2001, MOL CELL BIOL, V21, P7509, DOI 10.1128/MCB.21.21.7509-7522.2001; Sun M, 2012, MOL CANCER THER, V11, P842, DOI 10.1158/1535-7163.MCT-11-1015; Tan ZY, 2018, THERANOSTICS, V8, P5143, DOI 10.7150/thno.27310; Wang QX, 2015, CELL PHYSIOL BIOCHEM, V35, P933, DOI 10.1159/000369750; Wang Q, 2018, BIOCHEM CELL BIOL, V96, P19, DOI 10.1139/bcb-2016-0254; Wang YF, 2018, CANCER BIOL THER, V19, P1162, DOI 10.1080/15384047.2018.1491497; Wu JJ, 2010, CELL CYCLE, V9, P1809, DOI 10.4161/cc.9.9.11535; Xie XK, 2018, ONCOTARGETS THER, V11, P473, DOI 10.2147/OTT.S143440; Yan L, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317706916; Yao S, 2018, BIOCHEM BIOPH RES CO, V501, P628, DOI 10.1016/j.bbrc.2018.05.019; You BR, 2017, MOL CARCINOGEN, V56, P2566, DOI 10.1002/mc.22701; Yu XC, 2013, GENE, V532, P87, DOI 10.1016/j.gene.2013.09.048; Zhai Y, 2007, CANCER RES, V67, P10163, DOI 10.1158/0008-5472.CAN-07-2056; Zheng B, 2012, ONCOGENE, V31, P4509, DOI 10.1038/onc.2011.581	34	16	17	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8544	8557		10.1096/fj.201903217R	http://dx.doi.org/10.1096/fj.201903217R		MAY 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32356314				2022-12-28	WOS:000530045700001
J	Contreras-Lopez, R; Elizondo-Vega, R; Paredes, MJ; Luque-Campos, N; Torres, MJ; Tejedor, G; Vega-Letter, AM; Figueroa-Valdes, A; Pradenas, C; Oyarce, K; Jorgensen, C; Khoury, M; Garcia-Robles, MD; Altamirano, C; Djouad, F; Luz-Crawford, P				Contreras-Lopez, Rafael; Elizondo-Vega, Roberto; Jose Paredes, Maria; Luque-Campos, Noymar; Torres, Maria Jose; Tejedor, Gautier; Maria Vega-Letter, Ana; Figueroa-Valdes, Aliosha; Pradenas, Carolina; Oyarce, Karina; Jorgensen, Christian; Khoury, Maroun; de los Angeles Garcia-Robles, Maria; Altamirano, Claudia; Djouad, Farida; Luz-Crawford, Patricia			HIF1 alpha-dependent metabolic reprogramming governs mesenchymal stem/stromal cell immunoregulatory functions	FASEB JOURNAL			English	Article						glycolytic; HIF1 alpha; immunomodulation; immunosuppression; metabolic reprogramming; metabolism; MSCs	STEM-CELLS; HIF-1-ALPHA EXPRESSION; THERAPEUTIC FUNCTION; ALPHA PROTEIN; HYPOXIA; PROMOTES; OSTEOGENESIS; ACTIVATION; KINASE; HIF-1	Hypoxia-inducible factor 1 alpha (HIF1 alpha), a regulator of metabolic change, is required for the survival and differentiation potential of mesenchymal stem/stromal cells (MSC). Its role in MSC immunoregulatory activity, however, has not been completely elucidated. In the present study, we evaluate the role of HIF1 alpha on MSC immunosuppressive potential. We show that HIF1 alpha silencing in MSC decreases their inhibitory potential on Th1 and Th17 cell generation and limits their capacity to generate regulatory T cells. This reduced immunosuppressive potential of MSC is associated with a metabolic switch from glycolysis to OXPHOS and a reduced capacity to express or produce some immunosuppressive mediators including Intercellular Adhesion Molecule (ICAM), IL-6, and nitric oxide (NO). Moreover, using the Delayed-Type Hypersensitivity murine model (DTH), we confirm, in vivo, the critical role of HIF1 alpha on MSC immunosuppressive effect. Indeed, we show that HIF1 alpha silencing impairs MSC capacity to reduce inflammation and inhibit the generation of pro-inflammatory T cells. This study reveals the pivotal role of HIF1 alpha on MSC immunosuppressive activity through the regulation of their metabolic status and identifies HIF1 alpha as a novel mediator of MSC immunotherapeutic potential.	[Contreras-Lopez, Rafael; Elizondo-Vega, Roberto; Jose Paredes, Maria; Luque-Campos, Noymar; Pradenas, Carolina; Luz-Crawford, Patricia] Univ Andes, Fac Med, Ctr Invest & Innovac Biomed, Lab Inmunol Celular & Mol, Santiago, Chile; [Elizondo-Vega, Roberto; de los Angeles Garcia-Robles, Maria] Univ Concepcion, Fac Ciencias Biol, Dept Biol Celular, Lab Biol Celular, Concepcion, Chile; [Torres, Maria Jose; Altamirano, Claudia] Pontificia Univ Catolica Valparaiso, Escuela Ingn Bioquim, Valparaiso, Chile; [Tejedor, Gautier; Jorgensen, Christian; Djouad, Farida] Univ Montpellier, INSERM, IRMB, Montpellier, France; [Maria Vega-Letter, Ana; Figueroa-Valdes, Aliosha; Khoury, Maroun] Consorcio Regenero, Cells Cells, Santiago, Chile; [Maria Vega-Letter, Ana; Figueroa-Valdes, Aliosha; Khoury, Maroun] Univ Andes, Fac Med, Lab Nanoregenerat Med, Santiago, Chile; [Oyarce, Karina] Univ San Sebastian, Fac Ciencias Salud, Concepcion, Chile	Universidad de los Andes - Chile; Universidad de Concepcion; Pontificia Universidad Catolica de Valparaiso; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universidad de los Andes - Chile; Universidad San Sebastian	Luz-Crawford, P (corresponding author), Univ Andes, Fac Med, Ctr Invest & Innovac Biomed, Lab Inmunol Celular & Mol, Santiago, Chile.; Djouad, F (corresponding author), Univ Montpellier, Hop St Eloi, INSERM U 1183, IRMB, 80 Ave Augustin Fliche, F-34295 Montpellier, France.	farida.djouad@inserm.fr; pluz@uandes.cl	Torres, Maria/GVU-3391-2022; Garcia-Robles, Maria/F-4900-2014; djouad, farida/P-1749-2017	djouad, farida/0000-0001-8248-6822; Figueroa Valdes, Aliosha Ivan/0000-0001-7431-5046; Khoury, Maroun/0000-0002-9965-6266; Oyarce, Karina/0000-0002-9591-3149; Contreras Lopez, Rafael/0000-0002-7221-5102; Luz Crawford, Patricia/0000-0003-0067-7743; Elizondo, Roberto/0000-0001-9790-0002	MINEDUC | Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) [11190690, 11160929, 21141173, 2191997, 80211, PC18S04-180032, 3190462, 1170852]; Fondo de Ayuda a la Investigacion (FAI), Universidad de los Andes; Vicerrectoria de Investigacion y desarrollo (VRID) [VRIDINICIACION 219.031.116-INI]; Agence Nationale de la Recherche (ANR) [ANR-18-CE18-0010-02, ANR-11-INSB-005]; Vicerrectoria de investigacion y desarrollo (VRID), Universidad de Concepcion [218.031.113-1]	MINEDUC | Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Fondo de Ayuda a la Investigacion (FAI), Universidad de los Andes; Vicerrectoria de Investigacion y desarrollo (VRID); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Vicerrectoria de investigacion y desarrollo (VRID), Universidad de Concepcion	MINEDUC | Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT), Grant/Award Number: FONDECYT INICIACION 11190690, FONDECYT INICIACION No 11160929, BECA DOCTORADO NACIONAL No 21141173, BECA DOCTORADO NACIONAL No 2191997, PROYECTO REDES No 80211, PROYECTO ECOSUD No PC18S04-180032, FONDECYT POSTDOCTORADO No 3190462 and FONDECYT REGULAR 1170852; Fondo de Ayuda a la Investigacion (FAI), Universidad de los Andes, Grant/Award Number: Venida profesor extranjero,2018; Vicerrectoria de Investigacion y desarrollo (VRID), Grant/Award Number: VRIDINICIACION 219.031.116-INI; Agence Nationale de la Recherche (ANR), Grant/Award Number: ANR-18-CE18-0010-02 and ANR-11-INSB-005; Vicerrectoria de investigacion y desarrollo (VRID), Universidad de Concepcion, Grant/Award Number: VRID-asociativo no 218.031.113-1	Antebi B, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-1007-x; Bader AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138477; Chowdhury A, 2018, CELL REP, V25, P561, DOI 10.1016/j.celrep.2018.09.057; Contreras RA, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/3162743; Dalloul A, 2013, METHODS MOL BIOL, V1035, P199, DOI 10.1007/978-1-62703-508-8_17; Djouad F, 2009, NAT REV RHEUMATOL, V5, P392, DOI 10.1038/nrrheum.2009.104; Dorronsoro A, 2014, EUR J IMMUNOL, V44, P480, DOI 10.1002/eji.201343668; Drela K, 2019, STEM CELLS INT, V2019, DOI 10.1155/2019/7012692; Foyt DA, 2019, ACTA BIOMATER, V89, P73, DOI 10.1016/j.actbio.2019.03.002; Gu QL, 2016, TOHOKU J EXP MED, V239, P287, DOI 10.1620/tjem.239.287; Hamann I, 2018, FASEB J, V32, P5104, DOI 10.1096/fj.201800360R; Hitosugi T, 2011, MOL CELL, V44, P864, DOI 10.1016/j.molcel.2011.10.015; Jung SN, 2008, CARCINOGENESIS, V29, P713, DOI 10.1093/carcin/bgn032; Killer MC, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0553-y; Kim DS, 2018, EBIOMEDICINE, V28, P261, DOI 10.1016/j.ebiom.2018.01.002; Kim DS, 2016, CELL STRESS CHAPERON, V21, P1089, DOI 10.1007/s12192-016-0733-1; Kim KW, 2017, EXP EYE RES, V164, P74, DOI 10.1016/j.exer.2017.08.008; Kurte M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00802; Luque-Campos N, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00798; Luz-Crawford P, 2016, ANN RHEUM DIS, V75, P2166, DOI 10.1136/annrheumdis-2015-208696; Luz-Crawford P, 2016, STEM CELLS, V34, P483, DOI 10.1002/stem.2254; Luz-Crawford P, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt216; Luz-Crawford P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045272; Martinez VG, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0659-2; Maumus M, 2013, BIOCHIMIE, V95, P2229, DOI 10.1016/j.biochi.2013.04.017; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Naji A, 2019, CELL MOL LIFE SCI, V76, P3323, DOI 10.1007/s00018-019-03125-1; Ngo DC, 2015, MOL BIOL REP, V42, P819, DOI 10.1007/s11033-015-3857-y; Niecknig H, 2012, FREE RADICAL RES, V46, P705, DOI 10.3109/10715762.2012.669041; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Ren GW, 2010, J IMMUNOL, V184, P2321, DOI 10.4049/jimmunol.0902023; Robins JC, 2005, BONE, V37, P313, DOI 10.1016/j.bone.2005.04.040; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Shum LC, 2016, STEM CELLS DEV, V25, P114, DOI 10.1089/scd.2015.0193; Stolze Ineke P, 2006, Novartis Found Symp, V272, P15; Varum S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020914; Vertelov G, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt153; Wagegg M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046483; Wobma Holly M, 2018, J Immunol Regen Med, V1, P45, DOI 10.1016/j.regen.2018.01.001; Xue CL, 2018, STEM CELLS DEV, V27, P456, DOI 10.1089/scd.2017.0296; Zhang YJ, 2015, CURR CHIN ECON REPOR, P33, DOI 10.1007/978-3-662-46205-8_2; Zhu CX, 2016, SCI REP-UK, V6, DOI 10.1038/srep35489; Zou D, 2011, CELL PROLIFERAT, V44, P234, DOI 10.1111/j.1365-2184.2011.00747.x	43	25	25	3	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8250	8264		10.1096/fj.201902232R	http://dx.doi.org/10.1096/fj.201902232R		APR 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32333618				2022-12-28	WOS:000529448500001
J	Yan, TT; Xiao, R; Lin, GA				Yan, Tiantian; Xiao, Rong; Lin, Guoan			Angiotensin-converting enzyme 2 in severe acute respiratory syndrome coronavirus and SARS-CoV-2: A double-edged sword?	FASEB JOURNAL			English	Review						COVID-19; renin-angiotensin system; SARS	FUNCTIONAL RECEPTOR; SARS CORONAVIRUS; ACE2; PROTEIN; SPIKE; NL63; EXPRESSION; PNEUMONIA; SYSTEM; ENTRY	Human angiotensin-converting enzyme 2 (ACE2) facilitates cellular entry of severe acute respiratory syndrome coronavirus (SARS-CoV) and SARS-CoV-2 as their common receptor. During infection, ACE2-expressing tissues become direct targets, resulting in serious pathological changes and progressive multiple organ failure or even death in severe cases. However, as an essential component of renin-angiotensin system (RAS), ACE2 confers protective effects in physiological circumstance, including maintaining cardiovascular homeostasis, fluid, and electrolyte balance. The absence of protective role of ACE2 leads to dysregulated RAS and thus acute changes under multiple pathological scenarios including SARS. This potentially shared mechanism may also be the molecular explanation for pathogenesis driven by SARS-CoV-2. We reasonably speculate several potential directions of clinical management including host-directed therapies aiming to restore dysregulated RAS caused by ACE2 deficiency. Enriched knowledge of ACE2 learned from SARS and COVID-19 outbreaks can provide, despite their inherent tragedy, informative clues for emerging pandemic preparedness.	[Yan, Tiantian; Xiao, Rong; Lin, Guoan] 990th Hosp Peoples Liberat Army, Mil Burn Ctr, Fengguang St 1, Zhumadian 463000, Henan, Peoples R China		Yan, TT; Lin, GA (corresponding author), 990th Hosp Peoples Liberat Army, Mil Burn Ctr, Fengguang St 1, Zhumadian 463000, Henan, Peoples R China.	tiantianyan27031@163.com; guoanlin169@163.com						A.Ke, 2020, bioRxiv, DOI 10.1101/2020.02.03.931766; Bosch BJ, 2014, CURR OPIN VIROL, V6, P55, DOI 10.1016/j.coviro.2014.03.011; Burrell LM, 2005, EUR HEART J, V26, P369, DOI 10.1093/eurheartj/ehi114; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Chen Y, 2020, BIOCHEM BIOPH RES CO, V525, P135, DOI 10.1016/j.bbrc.2020.02.071; Crackower MA, 2002, NATURE, V417, P822, DOI 10.1038/nature00786; Danser AHJ, 2020, HYPERTENSION, V75, P1382, DOI 10.1161/HYPERTENSIONAHA.120.15082; Diao Bo, 2020, DIAGNOSIS ACUTE RESP, DOI [DOI 10.1161/CIRCULATIONAHA.104.510461, 10.1101/2020.03.04.20031120]; Gaddam Ravinder Reddy, 2014, Inflammation & Allergy Drug Targets, V13, P224; Ge XY, 2013, NATURE, V503, P535, DOI 10.1038/nature12711; Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570; Hamming I, 2007, J PATHOL, V212, P1, DOI 10.1002/path.2162; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Hofmann H, 2005, P NATL ACAD SCI USA, V102, P7988, DOI 10.1073/pnas.0409465102; Hofmann H, 2004, TRENDS MICROBIOL, V12, P466, DOI 10.1016/j.tim.2004.08.008; Huang FM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4595; Imai Y, 2005, NATURE, V436, P112, DOI 10.1038/nature03712; Jia X., 2020, 2 THINGS COVID 19 MI, P2020020315, DOI [10.20944/preprints202002.0315.v1, DOI 10.20944/PREPRINTS202002.0315.V1]; Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267; Kuba K, 2006, J MOL MED, V84, P814, DOI 10.1007/s00109-006-0094-9; Kuba K, 2010, PHARMACOL THERAPEUT, V128, P119, DOI 10.1016/j.pharmthera.2010.06.003; Kuhn JH, 2004, CELL MOL LIFE SCI, V61, P2738, DOI 10.1007/s00018-004-4242-5; Letko M, 2020, NAT MICROBIOL, V5, P562, DOI [10.1101/2020.01.22.915660, 10.1038/s41564-020-0688-y]; Li F, 2005, SCIENCE, V309, P1864, DOI 10.1126/science.1116480; Li R, 2020, J INFECTION, V80, P469, DOI 10.1016/j.jinf.2020.02.013; Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Liang WH, 2020, NEW ENGL J MED, V382, P1708, DOI DOI 10.1038/s41586-020-2349-y; Liu J, 2020, J MED VIROL, V92, P491, DOI 10.1002/jmv.25709; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Michel N, 2005, CURR BIOL, V15, P714, DOI 10.1016/j.cub.2005.02.058; Perlot T, 2013, MICROBES INFECT, V15, P866, DOI 10.1016/j.micinf.2013.08.003; Pohlmann S, 2006, ADV EXP MED BIOL, V581, P281; Ruiz-Ortega M, 2006, NEPHROL DIAL TRANSPL, V21, P16, DOI 10.1093/ndt/gfi265; Schouten LRA, 2016, CRIT CARE MED, V44, P819, DOI [10.1097/CCM.0000000000001388, 10.1097/CCM.0000000000002008]; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585; World Health Organization, COR DIS 2019 SIT REP; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1126/science.abb2507, 10.1101/2020.02.11.944462]; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Wu KL, 2009, P NATL ACAD SCI USA, V106, P19970, DOI 10.1073/pnas.0908837106; Xu Zhe, 2020, Lancet Respir Med, V8, P420, DOI 10.1016/S2213-2600(20)30076-X; Yan YW, 2015, SCI CHINA LIFE SCI, V58, P208, DOI 10.1007/s11427-015-4814-7; Yang PH, 2014, SCI REP-UK, V4, DOI 10.1038/srep07027; Ye MH, 2006, J AM SOC NEPHROL, V17, P3067, DOI 10.1681/ASN.2006050423; Zhao Y., 2020, SINGLE CELL RNA EXPR, DOI 10.1101/2020.01.26.919985; Zheng YY, 2020, NAT REV CARDIOL, V17, P259, DOI 10.1038/s41569-020-0360-5; Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2951-z, 10.1038/s41586-020-2012-7]; Zisman LS, 2003, CIRCULATION, V108, P1707, DOI 10.1161/01.CIR.0000094734.67990.99; Zou Z, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4594	51	62	71	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6017	6026		10.1096/fj.202000782	http://dx.doi.org/10.1096/fj.202000782		APR 2020	10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32306452	Green Published			2022-12-28	WOS:000526956800001
J	Oh, KH; Sheoran, S; Richmond, JE; Kim, H				Oh, Kelly H.; Sheoran, Seema; Richmond, Janet E.; Kim, Hongkyun			Alcohol induces mitochondrial fragmentation and stress responses to maintain normal muscle function in Caenorhabditis elegans	FASEB JOURNAL			English	Article							UNFOLDED PROTEIN RESPONSE; SKELETAL-MUSCLE; UPR; MECHANISMS; RETICULUM; FUSION; COORDINATION; HOMEOSTASIS; ACTIVATION; RESISTANCE	Chronic excessive ethanol consumption has distinct toxic and adverse effects on a variety of tissues. In skeletal muscle, ethanol causes alcoholic myopathy, which is characterized by myofiber atrophy and the loss of muscle strength. Alcoholic myopathy is more prevalent than all inherited muscle diseases combined. Current evidence indicates that ethanol directly impairs muscle organization and function. However, the underlying mechanism by which ethanol causes toxicity in muscle is poorly understood. Here, we show that the nematode Caenorhabditis elegans exhibits the key features of alcoholic myopathy when exposed to ethanol. As in mammals, ethanol exposure impairs muscle strength and induces the expression of protective genes, including oxidative stress response genes. In addition, ethanol exposure causes the fragmentation of mitochondrial networks aligned with myofibril lattices. This ethanol-induced mitochondrial fragmentation is dependent on the mitochondrial fission factor DRP-1 (dynamin-related protein 1) and its receptor proteins on the outer mitochondrial membrane. Our data indicate that this fragmentation contributes to the activation of the mitochondrial unfolded protein response (UPR). We also found that robust, perpetual mitochondrial UPR activation effectively reduces muscle weakness caused by ethanol exposure. Our results strongly suggest that the modulation of mitochondrial stress responses may provide a method to ameliorate alcohol toxicity and damage to muscle.	[Oh, Kelly H.; Kim, Hongkyun] Rosalind Franklin Univ Med & Sci, Ctr Canc Cell Biol Immunol & Infect, Chicago Med Sch, Dept Cell Biol & Anat, N Chicago, IL 60064 USA; [Oh, Kelly H.; Kim, Hongkyun] Rosalind Franklin Univ Med & Sci, Sch Grad & Postdoctoral Studies, N Chicago, IL 60064 USA; [Sheoran, Seema; Richmond, Janet E.] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA	Chicago Medical School; Rosalind Franklin University Medical & Science; Rosalind Franklin University Medical & Science; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Oh, KH; Kim, H (corresponding author), Rosalind Franklin Univ Med & Sci, Ctr Canc Cell Biol Immunol & Infect, Chicago Med Sch, Dept Cell Biol & Anat, N Chicago, IL 60064 USA.	Kelly.oh@rosalindfranklin.edu; hongkyun.kim@rosalindfranklin.edu		Kim, Hongkyun/0000-0002-4879-7122; Sheoran, Seema/0000-0003-0227-856X; Oh, Kelly/0000-0001-8203-5247	HHS \ NIH \ National Institute of General Medical Sciences (NIGMS) [RO1GM125749]; HHS \ NIH \ National Institute on Alcohol Abuse and Alcoholism (NIAAA) [R21AA023940]	HHS \ NIH \ National Institute of General Medical Sciences (NIGMS); HHS \ NIH \ National Institute on Alcohol Abuse and Alcoholism (NIAAA)	HHS vertical bar NIH vertical bar National Institute of General Medical Sciences (NIGMS), Grant/Award Number: RO1GM125749; HHS vertical bar NIH vertical bar National Institute on Alcohol Abuse and Alcoholism (NIAAA), Grant/Award Number: R21AA023940	Alaimo JT, 2012, ALCOHOL CLIN EXP RES, V36, P1840, DOI 10.1111/j.1530-0277.2012.01799.x; Bennett CF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4483; Berendzen KM, 2016, CELL, V166, P1553, DOI 10.1016/j.cell.2016.08.042; Bolz DD, 2010, J BIOL CHEM, V285, P10832, DOI 10.1074/jbc.M109.091629; Cartoni R, 2005, J PHYSIOL-LONDON, V567, P349, DOI 10.1113/jphysiol.2005.092031; Eisner V, 2018, NAT CELL BIOL, V20, P755, DOI 10.1038/s41556-018-0133-0; Eisner V, 2017, P NATL ACAD SCI USA, V114, pE859, DOI 10.1073/pnas.1617288114; Eisner V, 2014, J CELL BIOL, V205, P179, DOI 10.1083/jcb.201312066; Estes KA, 2010, P NATL ACAD SCI USA, V107, P2153, DOI 10.1073/pnas.0914643107; Fernandez-Sola J, 2007, ALCOHOL CLIN EXP RES, V31, P1953, DOI 10.1111/j.1530-0277.2007.00530.x; Fiorese CJ, 2016, CURR BIOL, V26, P2037, DOI 10.1016/j.cub.2016.06.002; Gariani K, 2016, HEPATOLOGY, V63, P1190, DOI 10.1002/hep.28245; Giacomello M, 2020, NAT REV MOL CELL BIO, V21, P204, DOI 10.1038/s41580-020-0210-7; Haida M, 1998, ALCOHOL CLIN EXP RES, V22, p108S, DOI 10.1111/acer.1998.22.s3_part1.108s; Haynes CM, 2007, DEV CELL, V13, P467, DOI 10.1016/j.devcel.2007.07.016; Haynes CM, 2010, MOL CELL, V37, P529, DOI 10.1016/j.molcel.2010.01.015; Iser WB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017369; Kanazawa T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000022; Kaufman DM, 2015, CURR BIOL, V25, P2171, DOI 10.1016/j.cub.2015.06.062; Kim H, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0619-5; Kimball SR, 2018, ANNU REV NUTR, V38, P197, DOI 10.1146/annurev-nutr-071816-064642; Labrousse AM, 1999, MOL CELL, V4, P815, DOI 10.1016/S1097-2765(00)80391-3; Lamech LT, 2015, J CELL BIOL, V209, P781, DOI 10.1083/jcb.201503107; Lamitina Todd, 2006, V351, P127; Lebeau J, 2018, CELL REP, V22, P2827, DOI 10.1016/j.celrep.2018.02.055; Lehrbach NJ, 2016, ELIFE, V5, DOI 10.7554/eLife.17721; Lesanpezeshki L, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51608-9; Link CD, 2002, METHOD ENZYMOL, V353, P497; Liu Y, 2014, NATURE, V508, P406, DOI 10.1038/nature13204; Lowry J, 2015, G3-GENES GENOM GENET, V5, P2241, DOI 10.1534/g3.115.021451; Lu Y, 2011, P NATL ACAD SCI USA, V108, pE813, DOI 10.1073/pnas.1103218108; Ma DK, 2012, NEURON, V73, P925, DOI 10.1016/j.neuron.2011.12.037; Mai S, 2010, J CELL SCI, V123, P917, DOI 10.1242/jcs.059246; Melber A, 2018, CELL RES, V28, P281, DOI 10.1038/cr.2018.16; Merkwirth C, 2016, CELL, V165, P1209, DOI 10.1016/j.cell.2016.04.012; Much C, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006095; Nargund AM, 2015, MOL CELL, V58, P123, DOI 10.1016/j.molcel.2015.02.008; Nargund AM, 2012, SCIENCE, V337, P587, DOI 10.1126/science.1223560; Oh KH, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46615-9; Oh KH, 2013, P NATL ACAD SCI USA, V110, P19024, DOI 10.1073/pnas.1308866110; Oks O, 2018, GENETICS, V209, P457, DOI 10.1534/genetics.118.300863; Oliver DMA, 2019, J ALZHEIMERS DIS, V72, pS95, DOI 10.3233/JAD-190048; Palikaras K, 2015, NATURE, V521, P525, DOI 10.1038/nature14300; Pellegrino MW, 2014, NATURE, V516, P414, DOI 10.1038/nature13818; PREEDY VR, 1994, J PATHOL, V173, P309, DOI 10.1002/path.1711730405; Quiros PM, 2017, J CELL BIOL, V216, P2027, DOI 10.1083/jcb.201702058; Rauthan M, 2013, P NATL ACAD SCI USA, V110, P5981, DOI 10.1073/pnas.1218778110; Scott LL, 2017, GENETICS, V206, P1445, DOI 10.1534/genetics.116.193102; Sebastian D, 2012, P NATL ACAD SCI USA, V109, P5523, DOI 10.1073/pnas.1108220109; Shen QF, 2014, MOL BIOL CELL, V25, P145, DOI 10.1091/mbc.E13-09-0525; Shpilka T, 2018, NAT REV MOL CELL BIO, V19, P109, DOI 10.1038/nrm.2017.110; Simon L, 2017, ALCOHOL RES-CURR REV, V38, P207; Smyrnias I, 2019, J AM COLL CARDIOL, V73, P1795, DOI 10.1016/j.jacc.2018.12.087; Souza-Smith FM, 2016, AM J PHYSIOL-ENDOC M, V311, pE605, DOI 10.1152/ajpendo.00270.2016; Sudarikova YV, 1997, BIOCHEMISTRY-MOSCOW+, V62, P989; Tan FJ, 2008, J CELL SCI, V121, P3373, DOI 10.1242/jcs.032904; Tian Y, 2016, CELL, V165, P1197, DOI 10.1016/j.cell.2016.04.011; Urbano-Marquez A, 2004, MUSCLE NERVE, V30, P689, DOI 10.1002/mus.20168; URBANOMARQUEZ A, 1989, NEW ENGL J MED, V320, P409, DOI 10.1056/NEJM198902163200701; van der Bliek AM, 2017, GENETICS, V207, P843, DOI 10.1534/genetics.117.300262; Wang YT, 2019, AM J PHYSIOL-HEART C, V317, pH472, DOI 10.1152/ajpheart.00244.2019; Weimer Robby M., 2006, V351, P203; Yu R, 2019, EMBO J, V38, DOI 10.15252/embj.201899748	63	8	8	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8204	8216		10.1096/fj.201903166R	http://dx.doi.org/10.1096/fj.201903166R		APR 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32294300	Green Accepted, Green Submitted			2022-12-28	WOS:000526102900001
J	Sui, H; Tan, HS; Fu, J; Song, Q; Jia, R; Han, L; Lv, Y; Zhang, H; Zheng, D; Dong, LP; Wang, SP; Li, Q; Xu, HX				Sui, Hua; Tan, Hongsheng; Fu, Jie; Song, Qing; Jia, Ru; Han, Li; Lv, Yue; Zhang, Hong; Zheng, Dan; Dong, Liping; Wang, Songpo; Li, Qi; Xu, Hongxi			The active fraction of Garcinia yunnanensis suppresses the progression of colorectal carcinoma by interfering with tumorassociated macrophage-associated M2 macrophage polarization in vivo and in vitro	FASEB JOURNAL			English	Article						AOM; DSS-induced colitis-associated colorectal cancer; ApcMin; + mice; colorectal cancer; macrophage; prevention	OBLONGIFOLIN C; CANCER-CELLS; KAPPA-B; INFLAMMATION; PREVENTION; PROLIFERATION; TUMORIGENESIS; METASTASIS; APOPTOSIS; ASPIRIN	Colorectal cancer (CRC) is the third most common solid tumor worldwide and has shown resistance to several immunotherapies, particularly immune checkpoint blockade therapy, which is effective in many other types of cancer. Our previous studies indicated that the active fraction of Garcinia yunnanensis (YTE-17), had potent anticancer activities by regulating multiple signaling pathways. However, knowledge regarding the mechanism and effect of YTE-17 in the prevention of CRC is limited. This study tested the effects of YTE-17 on colon cancer development in vivo by using two murine models: the carcigenic azoxymethane/dextran sulfate sodium (AOM/DSS)-induced CRC model and a genetically induced model using Apc(Min/+) mice. Here, the tumor load, tumor number, histology, and even some oncogenes were used to evaluate the effect of YTE-17. The intragastric administration of YTE-17 for 12 weeks significantly decreased CRC incidence, tumor number and size, immunity, and some tumor-associated macrophage (TAM) markers, including CD206, Arg-1, IL-10, and TGF-beta. Importantly, the macrophages depletion by clodronate (CEL) also played a role in reducing the tumor burden and inhibiting tumor development, which were not affected by YTE-17 in the Apc(Min/+) mice. Moreover, the YTE-17 treatment attenuated CRC cell growth in a co-culture system in the presence of macrophages. Consistently, YTE-17 effectively reduced the tumor burden and macrophage infiltration and enhanced immunity in the AOM/DSS and Apc(Min/+) colon tumor models. Altogether, we demonstrate that macrophages in the microenvironment may contribute to the development and progression of CRC cells and propose YTE-17 as a new potential drug option for the treatment of CRC.	[Sui, Hua; Tan, Hongsheng; Han, Li; Lv, Yue; Zhang, Hong; Zheng, Dan; Dong, Liping; Xu, Hongxi] Shanghai Univ Tradit Chinese Med, Sch Pharm, 1200 Cai Lun Rd, Shanghai 201203, Peoples R China; [Sui, Hua; Song, Qing; Jia, Ru; Li, Qi] Shanghai Univ Tradit Chinese Med, Shuguang Hosp, Dept Med Oncol, 528 Zhang Rd, Shanghai 201203, Peoples R China; [Fu, Jie; Wang, Songpo] Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Dept Tradit Chinese Med, Sch Med, Shanghai, Peoples R China; [Li, Qi] Shanghai Univ Tradit Chinese Med, Acad Integrat Med, Shanghai, Peoples R China	Shanghai University of Traditional Chinese Medicine; Shanghai University of Traditional Chinese Medicine; Shanghai Jiao Tong University; Shanghai University of Traditional Chinese Medicine	Xu, HX (corresponding author), Shanghai Univ Tradit Chinese Med, Sch Pharm, 1200 Cai Lun Rd, Shanghai 201203, Peoples R China.; Li, Q (corresponding author), Shanghai Univ Tradit Chinese Med, Shuguang Hosp, Dept Med Oncol, 528 Zhang Rd, Shanghai 201203, Peoples R China.	qili@shutcm.edu.cn; xuhongxi88@gmail.com	Xu, Hongxi/AAC-2799-2020	Tan, Hongsheng/0000-0003-0921-5481; Xu, Hongxi/0000-0001-6238-4511	NSFC | National Natural Science Foundation of China-Yunnan Joint Fund (NSFC-Yunnan Joint Fund) [81830120, 81573805, 81573749, 81874399, 81703893, 81973438]; Science Foundation for Shanghai Committee of Science Project [16XD1403600, 19401972000, (2018-2020)-CCCX-2001-02]; National Major Scientific and Technological Special Project [2019ZX09301140]; National Natural Cultivation Project of Shuguang Hospital [SGKJ-201830]	NSFC | National Natural Science Foundation of China-Yunnan Joint Fund (NSFC-Yunnan Joint Fund); Science Foundation for Shanghai Committee of Science Project; National Major Scientific and Technological Special Project; National Natural Cultivation Project of Shuguang Hospital	NSFC | National Natural Science Foundation of China-Yunnan Joint Fund (NSFC-Yunnan Joint Fund), Grant/Award Number: 81830120, 81573805, 81573749, 81874399, 81703893 and 81973438; Science Foundation for Shanghai Committee of Science Project, Grant/Award Number: 16XD1403600, 19401972000 and ZY(2018-2020)-CCCX-2001-02; National Major Scientific and Technological Special Project, Grant/Award Number: 2019ZX09301140; National Natural Cultivation Project of Shuguang Hospital, Grant/Award Number: SGKJ-201830	Allavena P, 2008, CRIT REV ONCOL HEMAT, V66, P1, DOI 10.1016/j.critrevonc.2007.07.004; Andreotti F, 2017, INT J CARDIOL, V248, P394, DOI 10.1016/j.ijcard.2017.08.013; Bader JE, 2018, AM J PHYSIOL-GASTR L, V314, pG22, DOI 10.1152/ajpgi.00229.2017; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; Deng B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063777; Dorsam B, 2018, P NATL ACAD SCI USA, V115, pE4061, DOI 10.1073/pnas.1712345115; East JE, 2013, NAT REV GASTRO HEPAT, V10, P69, DOI 10.1038/nrgastro.2012.245; Feng BJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023221; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Gao C, 2015, XENOBIOTICA, V45, P578, DOI 10.3109/00498254.2015.1004205; Greten FR, 2019, IMMUNITY, V51, P27, DOI 10.1016/j.immuni.2019.06.025; Guo L, 2019, CANCER LETT, V452, P213, DOI 10.1016/j.canlet.2019.03.032; Guo MM, 2019, EMBO J, V38, DOI 10.15252/embj.2018100299; Kruse J, 2013, INT J COLORECTAL DIS, V28, P1337, DOI 10.1007/s00384-013-1703-z; Kwong LN, 2009, ADV EXP MED BIOL, V656, P85, DOI 10.1007/978-1-4419-1145-2_8; Le Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04567-0; Li H, 2017, ACTA PHARMACOL SIN, V38, P252, DOI 10.1038/aps.2016.101; Li Y, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0574-1; Lin XC, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-105; Lin YY, 2017, J ETHNOPHARMACOL, V209, P305, DOI 10.1016/j.jep.2017.08.011; Liu LQ, 2018, J AGR FOOD CHEM, V66, P4384, DOI 10.1021/acs.jafc.8b00710; Lu Y, 2015, MOL CELL BIOCHEM, V406, P263, DOI 10.1007/s11010-015-2444-9; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Missiaglia E, 2014, ANN ONCOL, V25, P1995, DOI 10.1093/annonc/mdu275; Munkholm P, 2003, ALIMENT PHARM THER, V18, P1, DOI 10.1046/j.1365-2036.18.s2.2.x; Na YR, 2019, NAT REV GASTRO HEPAT, V16, P531, DOI 10.1038/s41575-019-0172-4; Ni ZY, 2017, BRIT J CANCER, V117, P1621, DOI 10.1038/bjc.2017.319; Onizawa M, 2009, AM J PHYSIOL-GASTR L, V296, pG850, DOI 10.1152/ajpgi.00071.2008; Qiao X, 2017, MOLECULES, V22, DOI 10.3390/molecules22101593; Ren JZ, 2019, J CANCER RES CLIN, V145, P1111, DOI 10.1007/s00432-019-02883-6; Salmaninejad A, 2019, CELL ONCOL, V42, P591, DOI 10.1007/s13402-019-00453-z; Soncin I, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02834-8; Song XP, 2003, J IMMUNOL, V171, P6448, DOI 10.4049/jimmunol.171.12.6448; Sui H, 2017, CANCER LETT, V403, P86, DOI 10.1016/j.canlet.2017.05.013; Sui H, 2015, ONCOTARGET, V6, P25975, DOI 10.18632/oncotarget.4543; Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410; Szebeni GJ, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/9294018; Takahashi M, 2004, CANCER SCI, V95, P475, DOI 10.1111/j.1349-7006.2004.tb03235.x; Usman MW, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0849-6; van Leeuwen BL, 2008, CRIT REV ONCOL HEMAT, V67, P229, DOI 10.1016/j.critrevonc.2008.03.005; Wang D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09668-2; Wang LP, 2016, BIOORGAN MED CHEM, V24, P4120, DOI 10.1016/j.bmc.2016.06.054; Wang RQ, 2014, DRUG DISCOV THER, V8, P25, DOI 10.5582/ddt.8.25; Wilson JE, 2015, NAT MED, V21, P906, DOI 10.1038/nm.3908; Wu M, 2019, ACTA PHARMACOL SIN, V40, P929, DOI 10.1038/s41401-018-0167-7; Wu M, 2015, PHYTOMEDICINE, V22, P902, DOI 10.1016/j.phymed.2015.06.008; Xi Z, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.123; Xiao XW, 2014, P NATL ACAD SCI USA, V111, pE1211, DOI 10.1073/pnas.1321347111; Xu JJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10761; Yahaya MAF, 2019, J IMMUNOL RES, V2019, DOI 10.1155/2019/2368249; Zhang YC, 2018, BIOCHEM BIOPH RES CO, V506, P907, DOI 10.1016/j.bbrc.2018.10.136; Zhao HX, 2014, TOXICOL APPL PHARM, V279, P311, DOI 10.1016/j.taap.2014.07.001; Zheng XY, 2019, MOLECULES, V24, DOI 10.3390/molecules24071403; Zheng YY, 2012, PHOTOCHEM PHOTOBIOL, V88, P1083, DOI 10.1111/j.1751-1097.2012.01128.x	54	13	14	3	20	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					7387	7403		10.1096/fj.201903011R	http://dx.doi.org/10.1096/fj.201903011R		APR 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32283574	Bronze			2022-12-28	WOS:000526944200001
J	Xu, XX; Zhou, YG; Fu, BQ; Zhang, JH; Dong, ZJ; Zhang, XR; Shen, N; Sun, R; Tian, ZG; Wei, HM				Xu, Xiuxiu; Zhou, Yonggang; Fu, Binqing; Zhang, Jinghe; Dong, Zhongjun; Zhang, Xiaoren; Shen, Nan; Sun, Rui; Tian, Zhigang; Wei, Haiming			PBX1 promotes development of natural killer cells by binding directly to the Nfil3 promoter	FASEB JOURNAL			English	Article						homeodomain; NK cells; pre-NKP; rNKP	TRANSCRIPTION FACTOR E4BP4; DIFFERENTIAL REQUIREMENT; B-CELL; IDENTIFICATION; MAINTENANCE; HEXAPEPTIDE; EXPRESSION; LINEAGE; EXPORT; DNA	The transcription factor nuclear factor interleukin-3-regulated protein (NFIL3, also called E4BP4) is crucial for commitment of natural killer (NK) cells from common lymphoid progenitors (CLPs). However, the identity of the factor that can regulate NFIL3 directly during the NK-cell development is not known. Here, we reveal that pre-B-cell leukemia transcription factor 1 (PBX1) can upregulate the NFIL3 expression directly. We used conditional knockout mice in which PBX1 in hematopoietic cells was specifically absent. The number of NK-committed progenitor pre-NKP cells and rNKP cells was reduced significantly in the absence of PBX1, which was consistent with NFIL3 deficiency. Also, the NFIL3 expression in NK cells was decreased if PBX1 was absent. We demonstrated that PBX1 was bound directly to the promoter of Nfil3 and facilitated transcription. Upon knockout of the binding site of PBX1 in the Nfil3 promoter, mice showed fewer NK-precursor cells and NK cells, just like that observed in Nfil3 knockout mice. Furthermore, asparagine N286 in the homeodomain of PBX1 controlled the binding of PBX1 to the Nfil3 promoter. Collectively, these findings demonstrate that the transcription factor PBX1 promotes the early development of NK cells by upregulating the Nfil3 expression directly.	[Xu, Xiuxiu; Zhou, Yonggang; Fu, Binqing; Zhang, Jinghe; Sun, Rui; Tian, Zhigang; Wei, Haiming] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, CAS Key Lab Innate Immun & Chron Dis, Div Mol Med,Sch Life Sci, 443 Huangshan Rd, Hefei 230027, Peoples R China; [Xu, Xiuxiu; Zhou, Yonggang; Fu, Binqing; Zhang, Jinghe; Sun, Rui; Tian, Zhigang; Wei, Haiming] Univ Sci & Technol China, Inst Immunol, Hefei, Peoples R China; [Xu, Xiuxiu; Zhou, Yonggang; Fu, Binqing; Zhang, Jinghe; Sun, Rui; Tian, Zhigang; Wei, Haiming] Univ Sci & Technol China, Inst Immunol, Hefei, Peoples R China; [Zhou, Yonggang] Univ Sci & Technol China, Affiliated Hosp 1, Hefei, Peoples R China; [Dong, Zhongjun] Tsinghua Univ, Sch Med, Beijing, Peoples R China; [Zhang, Xiaoren] Chinese Acad Sci, Univ Chinese Acad Sci, Shanghai Inst Nutr & Hlth, Shanghai, Peoples R China; [Shen, Nan] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Shanghai Inst Rheumatol, Shanghai, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Tsinghua University; Chinese Academy of Sciences; Shanghai Institute of Nutrition & Health, CAS; University of Chinese Academy of Sciences, CAS; Shanghai Jiao Tong University	Tian, ZG; Wei, HM (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, CAS Key Lab Innate Immun & Chron Dis, Div Mol Med,Sch Life Sci, 443 Huangshan Rd, Hefei 230027, Peoples R China.	tzg@ustc.edu.cn; ustcwhm@ustc.edu.cn	Shen, Nan/AGK-6807-2022; Tian, Zhigang/J-3512-2013	xu, xiuxiu/0000-0002-2863-166X	National Key R&D Program of China [2018YFC1003900]; National Natural Science Foundation of China [81788101, 31900662]; China Postdoctoral Science Foundation [2018M640596]; Anhui provincial Natural Science Foundation [1908085QC101]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Anhui provincial Natural Science Foundation(Natural Science Foundation of Anhui Province)	We thank Prof. Tak Wah Mak (University of Toronto, Canada) for providing Nfil3<SUP>-/-</SUP> mice. This work was supported by National Key R&D Program of China (#2018YFC1003900) and the National Natural Science Foundation of China (#81788101, 31900662) and Project funded by China Postdoctoral Science Foundation (#2018M640596) and the Anhui provincial Natural Science Foundation (#1908085QC101).	Berthelsen J, 1999, GENE DEV, V13, P946, DOI 10.1101/gad.13.8.946; Carlyle JR, 1999, J IMMUNOL, V162, P5917; Carotta S, 2011, BLOOD, V117, P5449, DOI 10.1182/blood-2010-11-318956; Chung EY, 2007, IMMUNITY, V27, P952, DOI 10.1016/j.immuni.2007.11.014; Colucci F, 2001, BLOOD, V97, P2625, DOI 10.1182/blood.V97.9.2625; DiMartino JF, 2001, BLOOD, V98, P618, DOI 10.1182/blood.V98.3.618; Fathman JW, 2011, BLOOD, V118, P5439, DOI 10.1182/blood-2011-04-348912; Ficara F, 2008, CELL STEM CELL, V2, P484, DOI 10.1016/j.stem.2008.03.004; Firth MA, 2013, J EXP MED, V210, P2981, DOI 10.1084/jem.20130417; Fogel LA, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4232; Fu BQ, 2017, IMMUNITY, V47, P1100, DOI [10.1016/j.immuni.2017.11.018, 10.15585/mmwr.ss6904a1]; Gascoyne DM, 2009, NAT IMMUNOL, V10, P1118, DOI 10.1038/ni.1787; Habif G, 2019, CELL MOL IMMUNOL, V16, P415, DOI 10.1038/s41423-019-0224-2; Jeevan-Raj B, 2017, CELL REP, V20, P613, DOI 10.1016/j.celrep.2017.06.071; Kamizono S, 2009, J EXP MED, V206, P2977, DOI 10.1084/jem.20092176; Kilstrup-Nielsen C, 2003, EMBO J, V22, P89, DOI 10.1093/emboj/cdg010; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Kostrzewski T, 2018, J IMMUNOL, V200, P1370, DOI 10.4049/jimmunol.1700981; LaRonde-LeBlanc NA, 2003, GENE DEV, V17, P2060, DOI 10.1101/gad.1103303; Male V, 2014, J EXP MED, V211, P635, DOI 10.1084/jem.20132398; Morvan MG, 2016, NAT REV CANCER, V16, P7, DOI 10.1038/nrc.2015.5; Motomura Y, 2011, NAT IMMUNOL, V12, P450, DOI 10.1038/ni.2020; Nandakumar V, 2013, P NATL ACAD SCI USA, V110, pE3927, DOI 10.1073/pnas.1308888110; Piper DE, 1999, CELL, V96, P587, DOI 10.1016/S0092-8674(00)80662-5; Ramirez K, 2012, IMMUNITY, V36, P921, DOI 10.1016/j.immuni.2012.04.006; Sanyal M, 2007, BLOOD, V109, P4191, DOI 10.1182/blood-2006-10-054213; SCOTT MP, 1989, BIOCHIM BIOPHYS ACTA, V989, P25, DOI 10.1016/0304-419X(89)90033-4; Seillet C, 2014, J EXP MED, V211, P1733, DOI 10.1084/jem.20140145; Seillet C, 2014, J IMMUNOL, V192, P2667, DOI 10.4049/jimmunol.1302605; Selleri L, 2001, DEVELOPMENT, V128, P3543; Tang PMK, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14677; Van Kaer L, 2019, CELL MOL IMMUNOL, V16, P531, DOI 10.1038/s41423-019-0221-5; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Xu W, 2015, CELL REP, V10, P2043, DOI 10.1016/j.celrep.2015.02.057; Yang M, 2015, INT CONF MANIP MANU, P1, DOI 10.1109/3M-NANO.2015.7425476; Yokoyama WM, 2004, ANNU REV IMMUNOL, V22, P405, DOI 10.1146/annurev.immunol.22.012703.104711; Yu XF, 2014, ELIFE, V3, DOI 10.7554/eLife.04406	37	6	6	4	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6479	6492		10.1096/fj.202000121R	http://dx.doi.org/10.1096/fj.202000121R		MAR 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32190943				2022-12-28	WOS:000521550100001
J	Lim, SC; Jansson, PJ; Assinder, SJ; Maleki, S; Richardson, D; Kovacevic, Z				Lim, Syer C.; Jansson, Patric J.; Assinder, Stephen J.; Maleki, Sanaz; Richardson, Des R.; Kovacevic, Zaklina			Unique targeting of androgen-dependent and -independent AR signaling in prostate cancer to overcome androgen resistance	FASEB JOURNAL			English	Article						androgen receptor; androgen resistance; c-Jun; DpC; prostate cancer; PSA	DOWNSTREAM-REGULATED GENE-1; EPITHELIAL-MESENCHYMAL TRANSITION; METASTASIS SUPPRESSOR NDRG1; GROWTH-FACTOR RECEPTOR; IRON CHELATORS; UP-REGULATION; ANTITUMOR-ACTIVITY; TGF-BETA; IN-VITRO; INHIBITION	The androgen receptor (AR) is a major driver of prostate cancer (PCa) and a key therapeutic target for AR inhibitors (ie, Enzalutamide). However, Enzalutamide only inhibits androgen-dependent AR signaling, enabling intrinsic AR activationviaandrogen-independent pathways, leading to aggressive castration-resistant PCa (CRPC). We investigated the ability of novel anti-cancer agents, Dp44mT and DpC, to overcome androgen resistance. The effect of Dp44mT and DpC on androgen-dependent and independent AR signaling was assessed in androgen-dependent and -independent PCa cells using 2D- and 3D-tissue culture. The clinically trialed DpC was then examined in vivo and compared to Enzalutamide. These agents uniquely promote AR proteasomal degradation and inhibit AR transcription in PCa cells via the upregulation of c-Jun, potently reducing the AR target, prostate-specific antigen (PSA). These agents also inhibited the activation of key molecules in both androgen-dependent and independent AR signaling (ie, EGFR, MAPK, PI3K), which promote CRPC. The clinically trialed DpC also significantly inhibited PCa tumor growth, AR, and PSA expression in vivo, being more potent than Enzalutamide. DpC is a promising candidate for a unique, structurally distinct generation of AR inhibitors that simultaneously target both androgen-dependent and independent arms of AR signaling. No other therapies exhibit such comprehensive and potent AR suppression, which is critical for overcoming the development of androgen resistance.	[Lim, Syer C.; Kovacevic, Zaklina] Univ Sydney, Dept Pathol, Canc Metastasis & Tumour Microenvironm Program, Camperdown, NSW, Australia; [Lim, Syer C.; Jansson, Patric J.; Richardson, Des R.; Kovacevic, Zaklina] Univ Sydney, Dept Pathol, Mol Pharmacol & Pathol Program, Camperdown, NSW, Australia; [Assinder, Stephen J.] Univ Sydney, Discipline Physiol, Sch Med Sci, Camperdown, NSW, Australia; [Maleki, Sanaz] Univ Sydney, Sch Med Sci, Dept Pathol, Histopathol Lab, Camperdown, NSW, Australia; [Richardson, Des R.] Nagoya Univ, Grad Sch Med, Dept Pathol & Biol Responses, Nagoya, Aichi, Japan; [Richardson, Des R.] Griffith Univ, Griffith Inst Drug Discovery, Ctr Canc Cell Biol, Brisbane, Qld 4111, Australia; [Lim, Syer C.; Jansson, Patric J.; Richardson, Des R.; Kovacevic, Zaklina] Univ Sydney, Dept Pathol, Canc Drug Resistance & Stem Cell Program, Camperdown, NSW, Australia	University of Sydney; University of Sydney; University of Sydney; University of Sydney; Nagoya University; Griffith University; University of Sydney	Richardson, D (corresponding author), Griffith Univ, Griffith Inst Drug Discovery, Ctr Canc Cell Biol, Brisbane, Qld 4111, Australia.; Kovacevic, Z (corresponding author), Univ Sydney, Dept Pathol, Sydney, NSW 2006, Australia.	d.richardson@griffith.edu.au; zaklina.kovacevic@sydney.edu.au	Jansson, Patric/AAC-4221-2022; Lim, Syer Choon/AAN-7043-2021; Kovacevic, Zaklina/ABD-9581-2021	Jansson, Patric/0000-0002-9322-653X; Lim, Syer Choon/0000-0002-5648-9453; Kovacevic, Zaklina/0000-0002-4742-4690; Richardson, Des/0000-0002-5506-3274	Cure Cancer Australia Foundation (CCAF) [1086449]; Department of Health \ National Health and Medical Research Council (NHMRC) [1140447, APP1159596, APP1062607, APP1144456]; Cancer Institute NSW (Cancer Institute New South Wales) [CDF171126]; University of Sydney	Cure Cancer Australia Foundation (CCAF); Department of Health \ National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Cancer Institute NSW (Cancer Institute New South Wales); University of Sydney(University of Sydney)	Cure Cancer Australia Foundation (CCAF), Grant/Award Number: 1086449; Department of Health vertical bar National Health and Medical Research Council (NHMRC), Grant/Award Number: 1140447, APP1159596, APP1062607 and APP1144456; Cancer Institute NSW (Cancer Institute New South Wales), Grant/Award Number: CDF171126; University of Sydney	Alimirah F, 2007, NEOPLASIA, V9, P1152, DOI 10.1593/neo.07769; Bandyopadhyay S, 2003, CANCER RES, V63, P1731; Chen ZQ, 2012, J BIOL CHEM, V287, P17016, DOI 10.1074/jbc.M112.350470; Decker KF, 2012, NUCLEIC ACIDS RES, V40, P10765, DOI 10.1093/nar/gks888; Dehm SM, 2006, J CELL BIOCHEM, V99, P333, DOI 10.1002/jcb.20794; Denis LJ, 2000, SEMIN SURG ONCOL, V18, P52, DOI 10.1002/(SICI)1098-2388(200001/02)18:1<52::AID-SSU8>3.0.CO;2-6; Dixon KM, 2013, BRIT J CANCER, V108, P409, DOI 10.1038/bjc.2012.582; Evans MJ, 2011, PNAS, V108, P9678; Fang Z, 2012, J BIOL CHEM, V287, P2090, DOI 10.1074/jbc.M111.323303; Gao J, 2001, BLOOD, V98, P842, DOI 10.1182/blood.V98.3.842; Goldberg AL, 2012, J CELL BIOL, V199, P583, DOI 10.1083/jcb.201210077; Guo ZL, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0330-x; Ha S, 2013, ONCOGENE, V32, P3992, DOI 10.1038/onc.2012.412; Han YY, 2017, THERANOSTICS, V7, P1914, DOI 10.7150/thno.17852; Hsu CC, 2013, MOL CELL ENDOCRINOL, V372, P12, DOI 10.1016/j.mce.2013.03.004; IRVING H, 1953, J CHEM SOC, P3192, DOI 10.1039/jr9530003192; Jansson PJ, 2015, PHARMACOL RES, V100, P255, DOI 10.1016/j.phrs.2015.08.013; Kalinowski DS, 2005, PHARMACOL REV, V57, P547, DOI 10.1124/pr.57.4.2; Karantanos T, 2013, ONCOGENE, V32, P5501, DOI 10.1038/onc.2013.206; Kovacevic Z, 2006, CARCINOGENESIS, V27, P2355, DOI 10.1093/carcin/bgl146; Kovacevic Z, 2016, J BIOL CHEM, V291, P1029, DOI 10.1074/jbc.M115.689653; Kovacevic Z, 2013, ANTIOXID REDOX SIGN, V18, P874, DOI 10.1089/ars.2011.4273; Kovacevic Z, 2011, MOL PHARMACOL, V80, P598, DOI 10.1124/mol.111.073627; Lavoie JN, 1996, J BIOL CHEM, V271, P20608, DOI 10.1074/jbc.271.34.20608; Lee T, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000013; Leung JK, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00002; Li YL, 2015, INT J ONCOL, V47, P1001, DOI 10.3892/ijo.2015.3086; Liao RS, 2013, TRANSL ANDROL UROL, V2, P187, DOI 10.3978/j.issn.2223-4683.2013.09.07; Lin HK, 2002, EMBO J, V21, P4037, DOI 10.1093/emboj/cdf406; Lovejoy DB, 2012, J MED CHEM, V55, P7230, DOI 10.1021/jm300768u; Lui GYL, 2015, MOL PHARMACOL, V87, P543, DOI 10.1124/mol.114.096529; McCall P, 2008, BRIT J CANCER, V98, P1094, DOI 10.1038/sj.bjc.6604152; Menezes SV, 2019, J BIOL CHEM, V294, P4045, DOI 10.1074/jbc.RA118.006279; Menezes SV, 2017, J BIOL CHEM, V292, P12772, DOI 10.1074/jbc.R117.776393; Mukherjee R, 2011, BRIT J CANCER, V104, P1920, DOI 10.1038/bjc.2011.163; Park KC, 2020, J BIOL CHEM, V295, P481, DOI 10.1074/jbc.RA119.011341; Rao VA, 2009, CANCER RES, V69, P948, DOI 10.1158/0008-5472.CAN-08-1437; Rodriguez-Berriguete Gonzalo, 2012, J Signal Transduct, V2012, P169170, DOI 10.1155/2012/169170; Sanford M, 2013, DRUGS, V73, P1723, DOI 10.1007/s40265-013-0129-9; Sato N, 1997, J BIOL CHEM, V272, P17485, DOI 10.1074/jbc.272.28.17485; Saxena P, 2012, PROSTATE, V72, P769, DOI 10.1002/pros.21482; SCHER HI, 2009, J CLIN ONCOL, V27, P5011; Sharma A, 2017, MOL ONCOL, V11, P655, DOI 10.1002/1878-0261.12059; Sun J, 2013, MOL PHARMACOL, V83, P454, DOI 10.1124/mol.112.083097; Tu LC, 2007, MOL CELL PROTEOMICS, V6, P575, DOI 10.1074/mcp.M600249-MCP200; Vander Griend DJ, 2014, INT J BIOL SCI, V10, P627, DOI 10.7150/ijbs.8756; Veveris-Lowe TL, 2005, ENDOCR-RELAT CANCER, V12, P631, DOI 10.1677/erc.1.00958; Wangpu XZ, 2016, MOL PHARMACOL, V89, P521, DOI 10.1124/mol.115.103044; Watson PA, 2015, NAT REV CANCER, V15, P701, DOI 10.1038/nrc4016; Whitnall M, 2006, P NATL ACAD SCI USA, V103, P14901, DOI 10.1073/pnas.0604979103; Wu CT, 2007, P NATL ACAD SCI USA, V104, P12679, DOI 10.1073/pnas.0704940104; Xi RX, 2017, MOL PHARMACOL, V91, P499, DOI 10.1124/mol.116.107870; Xu YX, 2018, ONCOL LETT, V15, P7999, DOI 10.3892/ol.2018.8279; Yuan HQ, 2010, MOL CELL BIOCHEM, V339, P253, DOI 10.1007/s11010-010-0388-7; Yuan J, 2004, BLOOD, V104, P1450, DOI 10.1182/blood-2004-03-0868; Zhou ZD, 2010, FREE RADICAL BIO MED, V49, P1856, DOI 10.1016/j.freeradbiomed.2010.09.010	56	14	14	2	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					11511	11528		10.1096/fj.201903167R	http://dx.doi.org/10.1096/fj.201903167R		JUL 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32713076				2022-12-28	WOS:000555979500001
J	Wang, CD; Qi, XF; Zhou, X; Sun, JM; Cai, DQ; Lu, G; Chen, XF; Jiang, ZH; Yao, YG; Chan, WY; Zhao, H				Wang, Chengdong; Qi, Xufeng; Zhou, Xiang; Sun, Jianmin; Cai, Dongqing; Lu, Gang; Chen, Xiongfong; Jiang, Zhihua; Yao, Yong-Gang; Chan, Wai Yee; Zhao, Hui			RNA-Seq analysis on ets1 mutant embryos of Xenopus tropicalis identifies microseminoprotein beta gene 3 as an essential regulator of neural crest migration	FASEB JOURNAL			English	Article						cell migration; Ets1; Msmb3; neural crest	PROSTATE SECRETORY PROTEIN; TRANSCRIPTION FACTOR ETS1; 94 AMINO-ACIDS; BETA-MICROSEMINOPROTEIN; EXPRESSION; GENE; MUTATION; DISEASE; PROTOONCOGENE; ACTIVATION	The proto-oncogeneets1is highly expressed in the pre-migratory and migratory neural crest (NC), and has been implicated in the delamination and migration of the NC cells. To identify the downstream target genes of Ets1 in this process, we did RNA sequencing (RNA-Seq) on wild-type andets1mutantX. tropicalisembryos. A list of genes with significantly differential expression was obtained by analyzing the RNA-Seq data. We validated the RNA-Seq data by quantitative PCR, and examined the expression pattern of the genes identified from this assay with whole mount in situ hybridization. A majority of the identified genes showed expression in migrating NC. Among them, the expression ofmicroseminoprotein beta gene 3(msmb3) was positively regulated by Ets1 in bothX. laevisandX. tropicalis. Knockdown ofmsmb3with antisense morpholino oligonucleotides or disruption ofmsmb3by CRISPR/Cas9 both impaired the migratory streams of NC. Our study identifiedmsmb3as an Ets1 target gene and uncovered its function in maintaining neural crest migration pattern.	[Wang, Chengdong; Lu, Gang; Chan, Wai Yee; Zhao, Hui] Chinese Univ Hong Kong, Fac Med, Minist Educ, Key Lab Regenerat Med,Sch Biomed Sci, Room 620A,LKS Integrated Biomed Sci Bldg, Hong Kong, Peoples R China; [Qi, Xufeng; Cai, Dongqing] Jinan Univ, Dept Dev & Regenerat Biol, Key Lab Regenerat Med, Minist Educ, Guangzhou, Peoples R China; [Zhou, Xiang] Huazhong Agr Univ, Coll Anim Sci & Technol, Key Lab Agr Anim Genet Breeding & Reprod, Minist Educ, Wuhan, Peoples R China; [Sun, Jianmin] Ningxia Med Univ, Sch Basic Med Sci, Dept Pathogen Biol & Immunol, Yinchuan, Ningxia, Peoples R China; [Chen, Xiongfong] NCI, Adv Biomed Comp Ctr, NIH, Frederick, MD 21701 USA; [Jiang, Zhihua] Washington State Univ, Dept Anim Sci, Pullman, WA 99164 USA; [Jiang, Zhihua] Washington State Univ, Ctr Reprod Biol, Pullman, WA 99164 USA; [Yao, Yong-Gang] Chinese Acad Sci, Key Lab Anim Models & Human Dis Mech, Kunming, Yunnan, Peoples R China; [Yao, Yong-Gang] Chinese Acad Sci, Kunming Inst Zool, Kunming, Yunnan, Peoples R China; [Yao, Yong-Gang] Univ Chinese Acad Sci, Kunming Coll Life Sci, Kunming, Yunnan, Peoples R China; [Yao, Yong-Gang; Chan, Wai Yee; Zhao, Hui] Kunming Inst Zool Chinese Univ Hong Kong KIZ CUHK, Hong Kong, Peoples R China; [Chan, Wai Yee; Zhao, Hui] Chinese Univ Hong Kong, Hong Kong Branch, CAS Ctr Excellence Anim Evolut & Genet, Hong Kong, Peoples R China	Chinese University of Hong Kong; Jinan University; Huazhong Agricultural University; Ningxia Medical University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Washington State University; Washington State University; Chinese Academy of Sciences; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese University of Hong Kong	Zhao, H (corresponding author), Chinese Univ Hong Kong, Fac Med, Minist Educ, Key Lab Regenerat Med,Sch Biomed Sci, Room 620A,LKS Integrated Biomed Sci Bldg, Hong Kong, Peoples R China.	zhaohui@cuhk.edu.hk	Sun, Jianmin/AAX-5094-2021; Yao, Yong-Gang/AAH-2303-2021; Jiang, Zhihua/A-3378-2008; Chan, Wai Yee/R-7442-2018; Chan, Wai-Yee/ABE-3738-2020; Zhao, Hui/B-8429-2016	Sun, Jianmin/0000-0003-2327-4285; Yao, Yong-Gang/0000-0002-2955-0693; Jiang, Zhihua/0000-0003-1986-088X; Chan, Wai Yee/0000-0002-9714-0936; Zhao, Hui/0000-0001-8160-6415; Wang, Chengdong/0000-0001-9891-8765	Ministry of Science and Technology of China [2016YFE0204700]; Research Grants Council, University Grants Committee (RGC, UGC) [14167017, 14112618]; Bureau of International Cooperation, Chinese Academy of Sciences [152453KYSB20170031]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Research Grants Council, University Grants Committee (RGC, UGC); Bureau of International Cooperation, Chinese Academy of Sciences(Chinese Academy of Sciences)	Ministry of Science and Technology of China, Grant/Award Number: 2016YFE0204700; Research Grants Council, University Grants Committee (RGC, UGC), Grant/Award Number: 14167017 and 14112618; Bureau of International Cooperation, Chinese Academy of Sciences, Grant/Award Number: 152453KYSB20170031	Akkers Robert C, 2012, Methods Mol Biol, V917, P279, DOI 10.1007/978-1-61779-992-1_17; Alipov G, 2005, HISTOPATHOLOGY, V46, P202, DOI 10.1111/j.1365-2559.2005.02059.x; Aoki H, 2005, DEV DYNAM, V233, P407, DOI 10.1002/dvdy.20340; Betancur P, 2011, DEVELOPMENT, V138, P3689, DOI 10.1242/dev.057836; Betancur P, 2010, P NATL ACAD SCI USA, V107, P3570, DOI 10.1073/pnas.0906596107; Bjartell AS, 2007, CLIN CANCER RES, V13, P4130, DOI 10.1158/1078-0432.CCR-06-3031; BLOOM ML, 1994, P NATL ACAD SCI USA, V91, P10099, DOI 10.1073/pnas.91.21.10099; Calmont A, 2009, DEVELOPMENT, V136, P3173, DOI 10.1242/dev.028902; Dai W, 2014, CELL DEATH DIFFER, V21, P568, DOI 10.1038/cdd.2013.177; Dittmer J, 2015, SEMIN CANCER BIOL, V35, P20, DOI 10.1016/j.semcancer.2015.09.010; Dittmer Jurgen, 2003, Mol Cancer, V2, P29, DOI 10.1186/1476-4598-2-29; Edery P, 1996, NAT GENET, V12, P442, DOI 10.1038/ng0496-442; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Ferreira R, 2005, MOL CELL BIOL, V25, P1215, DOI 10.1128/MCB.25.4.1215-1227.2005; Gao ZG, 2010, DEVELOPMENT, V137, P1543, DOI 10.1242/dev.047696; Garde SV, 1999, PROSTATE, V38, P118, DOI 10.1002/(SICI)1097-0045(19990201)38:2<118::AID-PROS5>3.0.CO;2-G; Garrett-Sinha LA, 2013, CELL MOL LIFE SCI, V70, P3375, DOI 10.1007/s00018-012-1243-7; Girvan AR, 2005, UROLOGY, V65, P719, DOI 10.1016/j.urology.2004.10.058; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Hellsten U, 2010, SCIENCE, V328, P633, DOI 10.1126/science.1183670; Hou L, 2004, DEVELOPMENT, V131, P3239, DOI 10.1242/dev.01193; HYAKUTAKE H, 1993, PROSTATE, V22, P347, DOI 10.1002/pros.2990220409; Lee CG, 2012, J IMMUNOL, V188, P2244, DOI 10.4049/jimmunol.1101614; Lei Y, 2012, P NATL ACAD SCI USA, V109, P17484, DOI 10.1073/pnas.1215421109; Liao EC, 2000, DEVELOPMENT, V127, P5123; LILJA H, 1988, PROSTATE, V12, P29, DOI 10.1002/pros.2990120105; LIU AY, 1993, CANCER LETT, V74, P91, DOI 10.1016/0304-3835(93)90049-F; Ma JX, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.374; Marziali G, 2002, BLOOD CELL MOL DIS, V29, P553, DOI 10.1006/bcmd.2002.0595; Marziali G, 2002, ONCOGENE, V21, P7933, DOI 10.1038/sj.onc.1205925; Morita H, 2010, DEVELOPMENT, V137, P1315, DOI 10.1242/dev.043190; Nam RK, 2006, J UROLOGY, V175, P1291, DOI 10.1016/S0022-5347(05)00695-6; Nie SY, 2015, CARDIOVASC RES, V106, P67, DOI 10.1093/cvr/cvv043; NYE JA, 1992, GENE DEV, V6, P975, DOI 10.1101/gad.6.6.975; Osborne NJ, 2005, DEV DYNAM, V232, P939, DOI 10.1002/dvdy.20258; Plouhinec JL, 2014, DEV BIOL, V386, P461, DOI 10.1016/j.ydbio.2013.12.010; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Russell L, 2010, CYTOKINE, V51, P217, DOI 10.1016/j.cyto.2010.03.006; Saldana-Caboverde A, 2015, DEV BIOL, V407, P300, DOI 10.1016/j.ydbio.2015.04.012; Schachterle W, 2012, DEV BIOL, V361, P439, DOI 10.1016/j.ydbio.2011.10.023; SETH A, 1993, ONCOGENE, V8, P1783; Shaikhibrahim Z, 2011, ONCOL REP, V25, P1125, DOI 10.3892/or.2011.1156; Shi WL, 2015, J BIOL CHEM, V290, P577, DOI 10.1074/jbc.M114.591628; Tahtakran SA, 2003, GENE EXPR PATTERNS, V3, P455, DOI 10.1016/S1567-133X(03)00065-6; Theveneau E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001142; Tobin JL, 2008, P NATL ACAD SCI USA, V105, P6714, DOI 10.1073/pnas.0707057105; Vitelli F, 2002, HUM MOL GENET, V11, P915, DOI 10.1093/hmg/11.8.915; Wang CD, 2019, ZOOL RES, V40, P102, DOI 10.24272/j.issn.2095-8137.2018.064; Wang CD, 2015, J BIOL CHEM, V290, P21925, DOI 10.1074/jbc.M115.644864; Wei G, 2009, BLOOD, V114, P1123, DOI 10.1182/blood-2009-03-211391; Wu XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079975; Yang WL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000841	52	3	3	1	20	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12726	12738		10.1096/fj.202000603R	http://dx.doi.org/10.1096/fj.202000603R		JUL 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32713114	hybrid			2022-12-28	WOS:000556409300001
J	Padhan, DK; Sengupta, A; Patra, M; Ganguly, A; Mahata, SK; Sen, M				Padhan, Deepesh Kumar; Sengupta, Archya; Patra, Milan; Ganguly, Ananya; Mahata, Sushil Kumar; Sen, Malini			CCN6 regulates mitochondrial respiratory complex assembly and activity	FASEB JOURNAL			English	Article						chondrocyte; mitochondria; PPRD	GENE FAMILY; ARTHROPATHY; MUTATIONS; DYSPLASIA; PROTEINS; TISSUES	Cellular communication network factor 6 (CCN6) mutations are linked with Progressive Pseudo Rheumatoid Dysplasia (PPRD) a debilitating musculoskeletal disorder. The function of CCN6 and the mechanism of PPRD pathogenesis remain unclear. Accordingly, we focused on the functional characterization of CCN6 and CCN6 mutants. Using size exclusion chromatography and native polyacrylamide gel electrophoresis we demonstrated that CCN6 is present as a component of the mitochondrial respiratory complex in human chondrocyte lines. By means of siRNA-mediated transfection and electron microscopy we showed that moderate reduction in CCN6 expression decreases the RER- mitochondria inter-membrane distance. Parallel native PAGE, immunoblotting and Complex I activity assays furthermore revealed increase in both mitochondrial distribution of CCN6 and mitochondrial respiratory complex assembly/activity in CCN6 depleted cells. CCN6 mutants resembling those linked with PPRD, which were generated by CRISPR-Cas9 technology displayed low level of expression of mutant CCN6 protein and inhibited respiratory complex assembly/activity. Electron microscopy and MTT assay of the mutants revealed abnormal mitochondria and poor cell viability. Taken together, our results indicate that CCN6 regulates mitochondrial respiratory complex assembly/activity as part of the mitochondrial respiratory complex by controlling the proximity of RER with the mitochondria, and CCN6 mutations disrupt mitochondrial respiratory complex assembly/activity resulting in mitochondrial defects and poor cell viability.	[Padhan, Deepesh Kumar; Sengupta, Archya; Ganguly, Ananya; Sen, Malini] CSIR Indian Inst Chem Biol, Canc Biol & Inflammatory Disorder Div, 4 Raja SC Mullick Rd, Kolkata, W Bengal, India; [Patra, Milan] Hebrew Univ Jerusalem, Hadassah Med Sch, Jerusalem, Israel; [Mahata, Sushil Kumar] Univ Calif San Diego, VA San Diego Healthcare Syst, San Diego, CA 92103 USA	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Hebrew University of Jerusalem; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Sen, M (corresponding author), CSIR Indian Inst Chem Biol, Canc Biol & Inflammatory Disorder Div, 4 Raja SC Mullick Rd, Kolkata, W Bengal, India.	msen@iicb.res.in	Mahata, Sushil/AAF-8781-2021	Patra, Milan/0000-0001-6870-9938; Padhan, Deepesh Kumar/0000-0003-2159-5800	Department of Biotechnology, Government of India; Council of Scientific and Industrial Research (CSIR) fellowship from the Government of India; University Grants Commission from the Government of India; Department of Biotechnology, Govt. of India; Department of Veterans Affairs	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (CSIR) fellowship from the Government of India; University Grants Commission from the Government of India; Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India); Department of Veterans Affairs(US Department of Veterans Affairs)	LC-MS/MS was carried out in Mass Spectrometry Facility, UCSD, CA. Transmission Electron Microscopy was conducted at the Cellular & Molecular Medicine Electron Microscopy core Facility, UCSD. We thank J. Sengupta for the use of spectrophotometer and G. Ghosh for insightful comments. This work is supported by a grant from the Department of Biotechnology, Government of India and institutional funding. D. K. P and A.G are supported by the Council of Scientific and Industrial Research (CSIR) fellowship and the University Grants Commission fellowship respectively from the Government of India. A.S is supported by a research associate grant (DBT-RA Programme) from the Department of Biotechnology, Govt. of India. A research career scientist award from the Department of Veterans Affairs supports SKM.	Acin-Perez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021; Alawbathani S, 2018, CSH MOL CASE STUD, V4, DOI 10.1101/mcs.a002139; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; Dalal A, 2012, AM J MED GENET A, V158A, P2820, DOI 10.1002/ajmg.a.35620; Davis L, 2006, BIOCHEM BIOPH RES CO, V342, P259, DOI 10.1016/j.bbrc.2006.01.132; de Brito OM, 2010, EMBO J, V29, P2715, DOI 10.1038/emboj.2010.177; Diaz F, 2009, CURR PROTOC HUM GENE, V63; Ekbote AV, 2013, SEMIN ARTHRITIS RHEU, V42, P582, DOI 10.1016/j.semarthrit.2012.09.001; Engel J, 2004, INT J BIOCHEM CELL B, V36, P997, DOI 10.1016/j.biocel.2003.12.009; Gold VAM, 2017, EMBO REP, V18, P1786, DOI 10.15252/embr.201744261; Holbourn KP, 2008, TRENDS BIOCHEM SCI, V33, P461, DOI 10.1016/j.tibs.2008.07.006; Hurvitz JR, 1999, NAT GENET, V23, P94, DOI 10.1038/12699; Katsube K, 2009, DEV GROWTH DIFFER, V51, P55, DOI 10.1111/j.1440-169X.2009.01077.x; Koh CM, 2013, METHOD ENZYMOL, V529, P161, DOI 10.1016/B978-0-12-418687-3.00013-6; Lesnik C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6711; Liu LM, 2015, JOINT BONE SPINE, V82, P125, DOI 10.1016/j.jbspin.2014.10.005; Luo HY, 2015, GENE, V564, P35, DOI 10.1016/j.gene.2015.03.029; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; Milenkovic D, 2017, CELL METAB, V25, P765, DOI 10.1016/j.cmet.2017.03.009; Miller DS, 2007, BIOCHEM BIOPH RES CO, V355, P156, DOI 10.1016/j.bbrc.2007.01.114; Mimaki M, 2012, BBA-BIOENERGETICS, V1817, P851, DOI 10.1016/j.bbabio.2011.08.010; Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410; Moreno-Lastres D, 2012, CELL METAB, V15, P324, DOI 10.1016/j.cmet.2012.01.015; Pacheu-Grau D, 2018, CELL STRESS, V2, P184, DOI 10.15698/cst2018.07.147; Patra M, 2016, J CELL SCI, V129, P2841, DOI 10.1242/jcs.186247; Pennica D, 1998, P NATL ACAD SCI USA, V95, P14717, DOI 10.1073/pnas.95.25.14717; Perbal B, 2013, J CELL COMMUN SIGNAL, V7, P169, DOI 10.1007/s12079-013-0193-7; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Repudi SR, 2013, J CELL SCI, V126, P1650, DOI 10.1242/jcs.119859; Sailani MR, 2018, CSH MOL CASE STUD, V4, DOI 10.1101/mcs.a001990; Schutze Norbert, 2005, Cell Commun Signal, V3, P5, DOI 10.1186/1478-811X-3-5; Segarra NG, 2012, AM J MED GENET C, V160C, P217, DOI 10.1002/ajmg.c.31333; Sen M, 2004, ARTHRITIS RHEUM-US, V50, P488, DOI 10.1002/art.20005; Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058; Sun J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038643; Sunitha B, 2016, J NEUROCHEM, V138, P174, DOI 10.1111/jnc.13626; Takigawa M, 2003, J CELL PHYSIOL, V194, P256, DOI 10.1002/jcp.10206; van Meerloo J, 2011, METHODS MOL BIOL, V731, P237, DOI 10.1007/978-1-61779-080-5_20; Vincent AE, 2016, SCI REP-UK, V6, DOI 10.1038/srep30610; Wieckowski MR, 2009, NAT PROTOC, V4, P1582, DOI 10.1038/nprot.2009.151; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Yang X, 2013, JOINT BONE SPINE, V80, P650, DOI 10.1016/j.jbspin.2013.03.006	42	4	4	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12163	12176		10.1096/fj.202000405RR	http://dx.doi.org/10.1096/fj.202000405RR		JUL 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32686858				2022-12-28	WOS:000553645200001
J	Beedie, SL; Huang, PA; Harris, EM; Strope, JD; Mahony, C; Chau, CH; Vargesson, N; Figg, WD				Beedie, Shaunna L.; Huang, Phoebe A.; Harris, Emily M.; Strope, Jonathan D.; Mahony, Christopher; Chau, Cindy H.; Vargesson, Neil; Figg, William D.			Role of cereblon in angiogenesis and in mediating the antiangiogenic activity of immunomodulatory drugs	FASEB JOURNAL			English	Article						angiogenesis; argonaute-2; cereblon; endothelial cell; immunomodulatory drugs; SALL4	LIMB DEFECTS; THALIDOMIDE; LENALIDOMIDE; GENE; POMALIDOMIDE; TARGET; DEGRADATION; EXPRESSION; RESISTANCE; PROMOTES	Cereblon (CRBN) is a substrate recruiter element of the E3 cullin 4-RING ubiquitin ligase complex, and a binding target of immunomodulatory agents (IMiDs). CRBN is responsible for the pleiotropic effects of IMiDs, yet its function in angiogenesis and in mediating the antiangiogenic effects of IMiDs remains unclear. We investigated the role of CRBN in the angiogenic process and in propagating the antiangiogenic effects of IMiDs in vitro. siRNA-mediated CRBN knock down in human endothelial cells (HUVEC and HMVEC-L), did not affect endothelial cell proliferation, migration, or tube formation. Using CRBN-deficient mice, we further demonstrated that microvessal formation can occur independently of cereblon in the ex vivo mouse aortic ring model. The cereblon E3 ubiquitin ligase complex can recruit endothelial cell-specific factors, AGO2 (associated with angiogenesis), and SALL4 (associated with embryogenesis/angiogenesis), for ubiquitin-mediated degradation. Knockdown of CRBN caused a corresponding increase in AGO2 and SALL4 protein expression and IMiD treatment was able to rescue the siCRBN effect to increase the CRBN expression. These findings suggest one potential mechanism of action that likely involves a tightly coordinated regulation of CRBN with endothelial cell targets and highlight the need to further elucidate the mechanism(s), which could include cereblon-independent pathways, through which IMiDs exert their antiangiogenic effects.	[Beedie, Shaunna L.; Huang, Phoebe A.; Harris, Emily M.; Strope, Jonathan D.; Chau, Cindy H.; Figg, William D.] NCI, Mol Pharmacol Sect, Genitourinary Malignancies Branch, Ctr Canc Res,NIH, 9000 Rockville Pike,Bldg 10,Room 5A01, Bethesda, MD 20892 USA; [Beedie, Shaunna L.; Mahony, Christopher; Vargesson, Neil] Univ Aberdeen, Inst Med Sci, Sch Med Med Sci & Nutr, Aberdeen, Scotland	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Aberdeen	Figg, WD (corresponding author), NCI, Mol Pharmacol Sect, Genitourinary Malignancies Branch, Ctr Canc Res,NIH, 9000 Rockville Pike,Bldg 10,Room 5A01, Bethesda, MD 20892 USA.	figgw@mail.nih.gov		Strope, Jonathan/0000-0001-8247-8427; Mahony, Christopher/0000-0003-4487-2540; Vargesson, Neil/0000-0001-8027-114X; Figg, William/0000-0003-2428-5613	National Cancer Institut; National Institutes of Health [ZIA SC006538]; Wellcome Trust-NIH [098252/Z/12/Z]	National Cancer Institut(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust-NIH(Wellcome TrustUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	National Cancer Institut; National Institutes of Health, Grant/Award Number: ZIA SC006538; Wellcome Trust-NIH, Grant/Award Number: 098252/Z/12/Z	A Akuffo A, 2018, INTEGR CANC SCI THER, V5, P1; Akuffo AA, 2018, J BIOL CHEM, V293, P6187, DOI 10.1074/jbc.M117.816868; Asai T, 2008, BIOCHEM BIOPH RES CO, V368, P243, DOI 10.1016/j.bbrc.2008.01.074; Asatsuma-Okumura T, 2019, NAT CHEM BIOL, V15, P1077, DOI 10.1038/s41589-019-0366-7; Bavley CC, 2018, J NEUROSCI, V38, P2780, DOI 10.1523/JNEUROSCI.0599-17.2018; Bjorklund CC, 2015, BLOOD CANCER J, V5, DOI 10.1038/bcj.2015.66; Chamberlain PP, 2014, NAT STRUCT MOL BIOL, V21, P803, DOI 10.1038/nsmb.2874; Dennstedt E, 2011, METHODS MOL BIOL, V764, P215, DOI 10.1007/978-1-61779-188-8_14; Donovan KA, 2018, ELIFE, V7, DOI 10.7554/eLife.38430; Eichner R, 2016, NAT MED, V22, P735, DOI 10.1038/nm.4128; Eisener-Dorman AF, 2009, BRAIN BEHAV IMMUN, V23, P318, DOI 10.1016/j.bbi.2008.09.001; Feng GH, 2016, EMBO REP, V17, P1304, DOI 10.15252/embr.201541476; Fink EC, 2018, BLOOD, V132, P1535, DOI 10.1182/blood-2018-05-852798; Gandhi AK, 2014, BRIT J HAEMATOL, V164, P233, DOI 10.1111/bjh.12622; Gopalakrishnan R, 2016, ONCOGENE, V35, P1797, DOI 10.1038/onc.2015.245; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Kim HK, 2016, PFLUG ARCH EUR J PHY, V468, P1299, DOI 10.1007/s00424-016-1854-1; Kronke J, 2014, SCIENCE, V343, P301, DOI 10.1126/science.1244851; Kruger EA, 2000, BIOCHEM BIOPH RES CO, V268, P183, DOI 10.1006/bbrc.1999.2018; Lee KM, 2013, DIABETES, V62, P1855, DOI 10.2337/db12-1030; Li XJ, 2020, CRIT REV BIOCHEM MOL, V55, P33, DOI 10.1080/10409238.2020.1738331; Liu YB, 2015, FASEB J, V29, P4829, DOI 10.1096/fj.15-274050; Lopez-Girona A, 2012, LEUKEMIA, V26, P2326, DOI 10.1038/leu.2012.119; Lu G, 2014, SCIENCE, V343, P305, DOI 10.1126/science.1244917; Mahony C, 2018, J ANAT, V232, P568, DOI 10.1111/joa.12712; Mahony C, 2013, P NATL ACAD SCI USA, V110, P12703, DOI 10.1073/pnas.1307684110; Matyskiela ME, 2018, NAT CHEM BIOL, V14, P981, DOI 10.1038/s41589-018-0129-x; Matyskiela ME, 2016, NATURE, V535, P252, DOI 10.1038/nature18611; Ng SSW, 2003, CANCER RES, V63, P3189; Rajadhyaksha AM, 2012, BEHAV BRAIN RES, V226, P428, DOI 10.1016/j.bbr.2011.09.039; Sun JB, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.920851; Tan EMS, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00162; Therapontos C, 2009, P NATL ACAD SCI USA, V106, P8573, DOI 10.1073/pnas.0901505106; Vargesson N, 2019, J HAND SURG-EUR VOL, V44, P88, DOI 10.1177/1753193418805249; Vargesson N, 2015, BIRTH DEFECTS RES C, V105, P140, DOI 10.1002/bdrc.21096; Vargesson N, 2009, BIOESSAYS, V31, P1327, DOI 10.1002/bies.200900103; Wu S, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/1756-8722-7-40; Yamazaki H, 2016, CHEM RES TOXICOL, V29, P1279, DOI 10.1021/acs.chemrestox.6b00210; Zhu YX, 2013, LEUKEMIA LYMPHOMA, V54, P683, DOI 10.3109/10428194.2012.728597; Zhu YX, 2011, BLOOD, V118, P4771, DOI 10.1182/blood-2011-05-356063	40	8	8	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					11395	11404		10.1096/fj.201903060RR	http://dx.doi.org/10.1096/fj.201903060RR		JUL 2020	10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32677118	Green Accepted			2022-12-28	WOS:000552110900001
J	Kanakis, I; Alameddine, M; Scalabrin, M; van't Hof, RJ; Liloglou, T; Ozanne, SE; Goljanek-Whysall, K; Vasilaki, A				Kanakis, Ioannis; Alameddine, Moussira; Scalabrin, Mattia; van't Hof, Rob J.; Liloglou, Triantafillos; Ozanne, Susan E.; Goljanek-Whysall, Katarzyna; Vasilaki, Aphrodite			Low protein intake during reproduction compromises the recovery of lactation-induced bone loss in female mouse dams without affecting skeletal muscles	FASEB JOURNAL			English	Article						bone loss; lactation; microRNAs; protein restriction; recovery	MESENCHYMAL STEM-CELLS; OSTEOGENIC DIFFERENTIATION; ADIPOSE-TISSUE; DNA METHYLATION; MATERNAL CALCIUM; GENE-EXPRESSION; VITAMIN-D; PREGNANCY; METABOLISM; MASS	Lactation-induced bone loss occurs due to high calcium requirements for fetal growth but skeletal recovery is normally achieved promptly postweaning. Dietary protein is vital for fetus and mother but the effects of protein undernutrition on the maternal skeleton and skeletal muscles are largely unknown. We used mouse dams fed with normal (N, 20%) or low (L, 8%) protein diet during gestation and lactation and maintained on the same diets (NN, LL) or switched from low to normal (LN) during a 28 d skeletal restoration period post lactation. Skeletal muscle morphology and neuromuscular junction integrity was not different between any of the groups. However, dams fed the low protein diet showed extensive bone loss by the end of lactation, followed by full skeletal recovery in NN dams, partial recovery in LN and poor bone recovery in LL dams. Primary osteoblasts from low protein diet fed mice showed decreased in vitro bone formation and decreased osteogenic marker gene expression; promoter methylation analysis by pyrosequencing showed no differences inBmpr1a, Ptch1, Sirt1, Osx,andIgf1rosteoregulators, while miR-26a, -34a, and -125b expression was found altered in low protein fed mice. Therefore, normal protein diet is indispensable for maternal musculoskeletal health during the reproductive period.	[Kanakis, Ioannis; Alameddine, Moussira; Scalabrin, Mattia; van't Hof, Rob J.; Goljanek-Whysall, Katarzyna; Vasilaki, Aphrodite] Univ Liverpool, Inst Life Course & Med Sci, MRC Versus Arthrit Ctr Integrated Res Musculoskel, Liverpool, Merseyside, England; [Liloglou, Triantafillos] Univ Liverpool, Inst Translat Med, Dept Mol & Clin Canc Med, Liverpool, Merseyside, England; [Ozanne, Susan E.] Univ Cambridge, MRC Metab Dis Unit, Metab Res Labs, Cambridge, England; [Goljanek-Whysall, Katarzyna] NUI Galway, Sch Med, Dept Physiol, Galway, Ireland; [Scalabrin, Mattia] Univ Leeds, Sch Biomed Sci, Leeds, W Yorkshire, England	University of Liverpool; University of Liverpool; University of Cambridge; Ollscoil na Gaillimhe-University of Galway; University of Leeds	Kanakis, I; Vasilaki, A (corresponding author), Univ Liverpool, Inst Life Course & Med Sci, Fac Hlth & Life Sci, William Henry Duncan Bldg,6 West Derby St, Liverpool L7 8TX, Merseyside, England.	i.kanakis@liverpool.ac.uk; vasilaki@liverpool.ac.uk	Kanakis, Ioannis/N-7874-2019	Kanakis, Ioannis/0000-0001-6410-1482; Ozanne, Susan/0000-0001-8753-5144; Scalabrin, Mattia/0000-0001-6663-7088	RCUK \ Biotechnology and Biological Sciences Research Council (BBSRC) [BB/P008429/1]; BBSRC [BB/P008429/1] Funding Source: UKRI; MRC [MR/P020941/1] Funding Source: UKRI	RCUK \ Biotechnology and Biological Sciences Research Council (BBSRC); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	RCUK vertical bar Biotechnology and Biological Sciences Research Council (BBSRC), Grant/Award Number: BB/P008429/1	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Allard JS, 2009, MOL CELL ENDOCRINOL, V299, P58, DOI 10.1016/j.mce.2008.10.018; Ammann P, 2015, ENDOCRINOLOGY, V156, P419, DOI 10.1210/en.2014-1033; Ardeshirpour L, 2007, ENDOCRINOLOGY, V148, P3875, DOI 10.1210/en.2006-1467; Ardeshirpour L, 2015, ENDOCRINOLOGY, V156, P2762, DOI 10.1210/en.2015-1232; Bell AW, 2000, P NUTR SOC, V59, P119, DOI 10.1017/S0029665100000148; Bendre A, 2018, BONE, V106, P139, DOI 10.1016/j.bone.2017.10.018; Bowman BM, 2002, J BONE MINER RES, V17, P1954, DOI 10.1359/jbmr.2002.17.11.1954; Bueno-Vargas P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154120; Chen F, 2019, INT J ENV RES PUB HE, V16, P1, DOI DOI 10.3390/ijerph16142632; Chen S, 2014, MOL MED REP, V9, P1820, DOI 10.3892/mmr.2014.2024; Clowes EJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE564, DOI 10.1152/ajpendo.00198.2004; Clowes EJ, 2003, J ANIM SCI, V81, P753; Conigrave AD, 2008, ANNU REV NUTR, V28, P131, DOI 10.1146/annurev.nutr.28.061807.155328; Dang QJ, 2017, EXP THER MED, V14, P1633, DOI 10.3892/etm.2017.4708; Delgado-Calle Jesus, 2012, Biology (Basel), V1, P698, DOI 10.3390/biology1030698; Delgado-Calle J, 2012, J BONE MINER RES, V27, P926, DOI 10.1002/jbmr.1491; Delgado-Calle J, 2012, EPIGENETICS-US, V7, P83, DOI 10.4161/epi.7.1.18753; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Devlin M J, 2018, Bone Rep, V8, P204, DOI 10.1016/j.bonr.2018.04.003; Dweep H, 2015, NAT METHODS, V12, P697, DOI 10.1038/nmeth.3485; Elefteriou F, 2006, CELL METAB, V4, P441, DOI 10.1016/j.cmet.2006.10.010; Fan C, 2016, STEM CELL REP, V7, P236, DOI 10.1016/j.stemcr.2016.06.010; Ghayor C, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091446; Glatt V, 2007, J BONE MINER RES, V22, P1197, DOI 10.1359/JBMR.070507; Goettsch C, 2011, AM J PATHOL, V179, P1594, DOI 10.1016/j.ajpath.2011.06.016; Grieger JA, 2015, NUTRIENTS, V7, P153, DOI 10.3390/nu7010153; Hopkinson JM, 2000, J NUTR, V130, P777, DOI 10.1093/jn/130.4.777; Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107; Hu R, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.176099; Huang J, 2010, STEM CELLS, V28, P357, DOI 10.1002/stem.288; Jalabert A, 2016, DIABETOLOGIA, V59, P1049, DOI 10.1007/s00125-016-3882-y; Kanakis I, 2019, ARTHRITIS RHEUMATOL, V71, P571, DOI 10.1002/art.40765; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kang H, 2016, OSTEOPOROSIS INT, V27, P1493, DOI 10.1007/s00198-015-3381-x; Karlsson C, 2001, OSTEOPOROSIS INT, V12, P828, DOI 10.1007/s001980170033; Kelch S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16113-x; KENT GN, 1990, J BONE MINER RES, V5, P361, DOI 10.1002/jbmr.5650050409; Kim K, 2015, MOL CELLS, V38, P75, DOI 10.14348/molcells.2015.2241; Kirby BJ, 2011, J BONE MINER RES, V26, P1242, DOI 10.1002/jbmr.339; Kovacs CS, 2016, PHYSIOL REV, V96, P449, DOI 10.1152/physrev.00027.2015; Kovacs CS, 2012, ANNU REV NUTR, V32, P97, DOI 10.1146/annurev-nutr-071811-150742; Kovacs CS, 2011, ENDOCRIN METAB CLIN, V40, P795, DOI 10.1016/j.ecl.2011.08.002; Kovacs CS, 2006, ENDOCRIN METAB CLIN, V35, P21, DOI 10.1016/j.ecl.2005.09.004; Kovacs CS, 2005, J MAMMARY GLAND BIOL, V10, P105, DOI 10.1007/s10911-005-5394-0; Kovacs CS, 1997, ENDOCR REV, V18, P832, DOI 10.1210/er.18.6.832; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Krzeszinski JY, 2014, NATURE, V512, P431, DOI 10.1038/nature13375; Kuhla B, 2011, J PROTEOME RES, V10, P4252, DOI 10.1021/pr200425h; Laxman N, 2015, RNA, V21, P1433, DOI 10.1261/rna.049148.114; Li Y, 2015, MOL THER, V23, P1349, DOI 10.1038/mt.2015.101; Li Y, 2013, BIOMATERIALS, V34, P5048, DOI 10.1016/j.biomaterials.2013.03.052; Li Z, 2008, P NATL ACAD SCI USA, V105, P13906, DOI 10.1073/pnas.0804438105; LISSNER L, 1991, CALCIFIED TISSUE INT, V48, P319, DOI 10.1007/BF02556151; Liu P, 2016, SCI REP-UK, V6, DOI 10.1038/srep32112; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; Lu YY, 2017, NAT MED, V23, P1331, DOI 10.1038/nm.4424; Luzi E, 2008, J BONE MINER RES, V23, P287, DOI 10.1359/JBMR.071011; MacDonell R, 2016, BONEKEY REP, V5, DOI 10.1038/bonekey.2016.58; MELTON LJ, 1993, OSTEOPOROSIS INT, V3, P76, DOI 10.1007/BF01623377; Mercken EM, 2014, AGING CELL, V13, P787, DOI 10.1111/acel.12220; Mizuno Y, 2008, BIOCHEM BIOPH RES CO, V368, P267, DOI 10.1016/j.bbrc.2008.01.073; Mohri T, 2009, INT J CANCER, V125, P1328, DOI 10.1002/ijc.24459; Moody L, 2019, NUTRIENTS, V11, DOI 10.3390/nu11092075; Nishikawa K, 2015, NAT MED, V21, P281, DOI 10.1038/nm.3774; Olausson H, 2012, NUTR RES REV, V25, P40, DOI 10.1017/S0954422411000187; Paton LM, 2003, AM J CLIN NUTR, V77, P707, DOI 10.1093/ajcn/77.3.707; Patsch JM, 2011, METABOLISM, V60, P243, DOI 10.1016/j.metabol.2009.11.023; Pearson D, 2004, BONE, V34, P570, DOI 10.1016/j.bone.2003.11.005; Peterson CA, 2009, EUR J NUTR, V48, P84, DOI 10.1007/s00394-008-0765-0; Picke AK, 2018, BONE, V116, P120, DOI 10.1016/j.bone.2018.07.015; Prentice A, 2003, J NUTR, V133, p1693S, DOI 10.1093/jn/133.5.1693S; Cunha MCR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058872; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; Schulz TJ, 2016, DIABETOLOGIA, V59, P1769, DOI 10.1007/s00125-016-3990-8; Seeliger C, 2014, J BONE MINER RES, V29, P1718, DOI 10.1002/jbmr.2175; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shaw RJ, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl424; Sims NA, 2016, INT J BIOCHEM CELL B, V79, P14, DOI 10.1016/j.biocel.2016.08.003; Smith MS, 2002, FRONT NEUROENDOCRIN, V23, P225, DOI 10.1016/S0091-3022(02)00002-X; SOWERS M, 1993, JAMA-J AM MED ASSOC, V269, P3130, DOI 10.1001/jama.269.24.3130; Stephens Alexandre S, 2011, BMC Res Notes, V4, P410, DOI 10.1186/1756-0500-4-410; Su X, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.221; Taylor Sarah E B, 2014, Bonekey Rep, V3, P585, DOI 10.1038/bonekey.2014.80; Tencerova M, 2018, J BONE MINER RES, V33, P1154, DOI 10.1002/jbmr.3408; Thomas M, 2006, AM J OBSTET GYNECOL, V194, P937, DOI 10.1016/j.ajog.2005.05.032; TRAYHURN P, 1982, NATURE, V298, P59, DOI 10.1038/298059a0; Vajda EG, 2001, BIOL REPROD, V65, P689, DOI 10.1095/biolreprod65.3.689; van't Hof RJ, 2017, BONE, V99, P69, DOI 10.1016/j.bone.2017.03.051; van't Hof RJ, 2012, METHODS MOL BIOL, V816, P461, DOI 10.1007/978-1-61779-415-5_27; Vimalraj S, 2014, J CELL PHYSIOL, V229, P1236, DOI 10.1002/jcp.24557; Wang H, 2019, J BONE MINER RES, V34, P1169, DOI 10.1002/jbmr.3677; Wang HQ, 2017, CELL PHYSIOL BIOCHEM, V41, P530, DOI 10.1159/000457013; Wang Z, 2015, SCI REP-UK, V5, DOI 10.1038/srep15280; Wendelboe MH, 2016, BONE, V87, P27, DOI 10.1016/j.bone.2016.03.012; Wong N, 2015, NUCLEIC ACIDS RES, V43, pD146, DOI 10.1093/nar/gku1104; Woodrow JP, 2006, ENDOCRINOLOGY, V147, P4010, DOI 10.1210/en.2005-1616; Wysolmerski JJ, 2002, J MAMMARY GLAND BIOL, V7, P267, DOI 10.1023/A:1022800716196; Zeni SN, 1999, BONE, V25, P681, DOI 10.1016/S8756-3282(99)00228-8; Zhang Y, 2011, P NATL ACAD SCI USA, V108, P9863, DOI 10.1073/pnas.1018493108	101	3	3	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					11844	11859		10.1096/fj.202001131R	http://dx.doi.org/10.1096/fj.202001131R		JUL 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32652768	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000548010200001
J	Messner, M; Schmitt, S; Ardelt, MA; Frohlich, T; Muller, M; Pein, H; Huber-Cantonati, P; Ortler, C; Koenig, LM; Zobel, L; Koeberle, A; Arnold, GJ; Rothenfusser, S; Kiemer, AK; Gerbes, AL; Zischka, H; Vollmar, AM; Pachmayr, J				Messner, Martina; Schmitt, Sabine; Ardelt, Maximilian A.; Froehlich, Thomas; Mueller, Martin; Pein, Helmut; Huber-Cantonati, Petra; Ortler, Carina; Koenig, Lars M.; Zobel, Lena; Koeberle, Andreas; Arnold, Georg J.; Rothenfusser, Simon; Kiemer, Alexandra K.; Gerbes, Alexander L.; Zischka, Hans; Vollmar, Angelika M.; Pachmayr, Johanna			Metabolic implication of tigecycline as an efficacious second-line treatment for sorafenib-resistant hepatocellular carcinoma	FASEB JOURNAL			English	Article						antibiotics; electron acceptor auxotrophy; mitochondrial biogenesis; sorafenib resistance; tumor relapse	CANCER-CELLS; OXIDATIVE-PHOSPHORYLATION; MITOCHONDRIAL BIOGENESIS; ANTITUMOR-ACTIVITY; THERAPY; PROLIFERATION; TRANSLATION; INHIBITION; MITOPHAGY; RECEPTOR	Sorafenib represents the current standard of care for patients with advanced-stage hepatocellular carcinoma (HCC). However, acquired drug resistance occurs frequently during therapy and is accompanied by rapid tumor regrowth after sorafenib therapy termination. To identify the mechanism of this therapy-limiting growth resumption, we established robust sorafenib resistance HCC cell models that exhibited mitochondrial dysfunction and chemotherapeutic crossresistance. We found a rapid relapse of tumor cell proliferation after sorafenib withdrawal, which was caused by renewal of mitochondrial structures alongside a metabolic switch toward high electron transport system (ETS) activity. The translation-inhibiting antibiotic tigecycline impaired the biogenesis of mitochondrial DNA-encoded ETS subunits and limited the electron acceptor turnover required for glutamine oxidation. Thereby, tigecycline prevented the tumor relapse in vitro and in murine xenografts in vivo. These results offer a promising second-line therapeutic approach for advanced-stage HCC patients with progressive disease undergoing sorafenib therapy or treatment interruption due to severe adverse events.	[Messner, Martina; Mueller, Martin; Ortler, Carina; Zobel, Lena; Vollmar, Angelika M.] Ludwig Maximilians Univ LMU Munich, Dept Pharm, Pharmaceut Biol, Munich, Germany; [Messner, Martina; Ardelt, Maximilian A.; Huber-Cantonati, Petra; Pachmayr, Johanna] Paracelsus Med Univ, Inst Pharm, Ctr Publ Hlth, Salzburg, Austria; [Schmitt, Sabine; Zischka, Hans] Tech Univ Munich, Inst Toxicol & Environm Hyg, Sch Med, Munich, Germany; [Froehlich, Thomas; Arnold, Georg J.] Ludwig Maximilians Univ Munchen, Gene Ctr, Lab Funct Genome Anal LAFUGA, Munich, Germany; [Pein, Helmut; Koeberle, Andreas] Friedrich Schiller Univ Jena, Inst Pharm, Dept Pharmaceut Med Chem, Jena, Germany; [Koenig, Lars M.; Rothenfusser, Simon] Ludwig Maximilians Univ Munchen, Ctr Integrated Prot Sci Munich CIPS M, Univ Hosp, Div Clin Pharmacol, Munich, Germany; [Koeberle, Andreas] Univ Innsbruck, Michael Popp Res Inst, Innsbruck, Austria; [Kiemer, Alexandra K.] Saarland Univ, Dept Pharm, Pharmaceut Biol, Saarbrucken, Germany; [Gerbes, Alexander L.] Ludwig Maximilians Univ Munchen, Liver Ctr Munich, Univ Hosp, Dept Med 2, Munich, Germany; [Zischka, Hans] Helmholtz Zentrum Munchen, Inst Mol Toxicol & Pharmacol, Neuherberg, Germany	University of Munich; Paracelsus Private Medical University; Technical University of Munich; University of Munich; Friedrich Schiller University of Jena; University of Munich; University of Innsbruck; Saarland University; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Pachmayr, J (corresponding author), Paracelsus Med Univ, Inst Pharm, Strubergasse 21, A-5020 Salzburg, Austria.	johanna.pachmayr@pmu.ac.at	Kiemer, Alexandra K./I-9300-2012; Fröhlich, Thomas/C-6735-2011; Koeberle, Andreas/ABB-2356-2020; Zischka, Hans/M-1490-2017	Kiemer, Alexandra K./0000-0002-7224-9900; Fröhlich, Thomas/0000-0002-4709-3211; Koeberle, Andreas/0000-0001-6269-5088; Zischka, Hans/0000-0002-4047-1566; Konig, Lars/0000-0002-8348-7787	DFG [VO376/17-1]	DFG(German Research Foundation (DFG))	Prof. Angelika M. Vollmar was funded by the DFG (VO376/17-1)	Abdel-Aziz AK, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00718; Al-Rajabi R, 2015, J GASTROINTEST ONCOL, V6, P259, DOI 10.3978/j.issn.2078-6891.2015.005; Altman BJ, 2016, NAT REV CANCER, V16, P619, DOI 10.1038/nrc.2016.71; Archer SL, 2013, NEW ENGL J MED, V369, P2236, DOI 10.1056/NEJMra1215233; Birsoy K, 2015, CELL, V162, P540, DOI 10.1016/j.cell.2015.07.016; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bradford PA, 2005, CLIN INFECT DIS, V41, pS315, DOI 10.1086/431673; Bruix J, 2017, LANCET, V389, P56, DOI 10.1016/S0140-6736(16)32453-9; Bruix J, 2016, GASTROENTEROLOGY, V150, P835, DOI 10.1053/j.gastro.2015.12.041; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; CURI R, 1988, BIOCHEM J, V250, P383, DOI 10.1042/bj2500383; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Dudek J, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00090; Ebos JML, 2012, CLIN CANCER RES, V18, P3719, DOI 10.1158/1078-0432.CCR-12-1459; El-Khoueiry AB, 2017, LANCET, V389, P2492, DOI 10.1016/S0140-6736(17)31046-2; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Fan J, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.65; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Finkelmeier F, 2018, EXPERT REV ANTICANC, V18, P1169, DOI 10.1080/14737140.2018.1535315; Gardiner D, 2010, CLIN INFECT DIS, V50, P229, DOI 10.1086/648720; Gerbes A, 2018, GUT, V67, P380, DOI 10.1136/gutjnl-2017-315068; Glatzel DK, 2018, J LIPID RES, V59, P298, DOI 10.1194/jlr.M080101; HABER M, 1989, CANCER RES, V49, P5281; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Holz MS, 2013, MOL CANCER THER, V12, P173, DOI 10.1158/1535-7163.MCT-12-0532; Jia XF, 2016, FUND CLIN PHARMACOL, V30, P297, DOI 10.1111/fcp.12199; Jones RA, 2016, J CLIN INVEST, V126, P3739, DOI 10.1172/JCI81568; Kapanadze T, 2013, J HEPATOL, V59, P1007, DOI 10.1016/j.jhep.2013.06.010; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Koeberle A, 2013, P NATL ACAD SCI USA, V110, P2546, DOI 10.1073/pnas.1216182110; Kudo M, 2019, LIVER CANCER, V8, P221, DOI 10.1159/000501501; Kudo M, 2018, LANCET, V391, P1163, DOI 10.1016/S0140-6736(18)30207-1; Kudo M, 2017, LIVER CANCER, V6, P253, DOI 10.1159/000479573; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamb R, 2015, ONCOTARGET, V6, P4569, DOI 10.18632/oncotarget.3174; LeBleu VS, 2014, NAT CELL BIOL, V16, P992, DOI 10.1038/ncb3039; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Ma MKF, 2017, J HEPATOL, V67, P979, DOI 10.1016/j.jhep.2017.06.015; MANDERS EMM, 1992, J CELL SCI, V103, P857; Mullen AR, 2014, CELL REP, V7, P1679, DOI 10.1016/j.celrep.2014.04.037; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Pickles S, 2018, CURR BIOL, V28, pR170, DOI 10.1016/j.cub.2018.01.004; Raoul JL, 2018, CANCER TREAT REV, V68, P16, DOI 10.1016/j.ctrv.2018.05.006; SAGAN L, 1967, J THEOR BIOL, V14, P225, DOI 10.1016/0022-5193(67)90079-3; Scarpulla RC, 2006, J CELL BIOCHEM, V97, P673, DOI 10.1002/jcb.20743; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Shen YC, 2012, BRIT J CANCER, V108, P72; Skrtic M, 2011, CANCER CELL, V20, P674, DOI 10.1016/j.ccr.2011.10.015; Strumberg D, 2007, ONCOLOGIST, V12, P426, DOI 10.1634/theoncologist.12-4-426; Sugiura A, 2014, EMBO J, V33, P2142, DOI 10.15252/embj.201488104; Sullivan LB, 2015, CELL, V162, P552, DOI 10.1016/j.cell.2015.07.017; Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; van Malenstein H, 2013, CANCER LETT, V329, P74, DOI 10.1016/j.canlet.2012.10.021; Ventura-Clapier R, 2008, CARDIOVASC RES, V79, P208, DOI 10.1093/cvr/cvn098; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wheaton WW, 2014, ELIFE, V3, DOI 10.7554/eLife.02242; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Zhang L, 2013, TRENDS BIOCHEM SCI, V38, P612, DOI 10.1016/j.tibs.2013.10.001	62	5	6	2	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					11860	11882		10.1096/fj.202001128R	http://dx.doi.org/10.1096/fj.202001128R		JUL 2020	23	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32652772	Green Published, hybrid			2022-12-28	WOS:000548010700001
J	Qi, YY; Zhang, WK; Li, GQ; Niu, L; Zhang, YX; Tang, RF; Feng, G				Qi, Yiying; Zhang, Wenkan; Li, Guoqi; Niu, Lie; Zhang, Yuxiang; Tang, Ruofu; Feng, Gang			An oriented-collagen scaffold including Wnt5a promotes osteochondral regeneration and cartilage interface integration in a rabbit model	FASEB JOURNAL			English	Article						cartilage regeneration; integration; MSCs; oriented collagen; Wnt5a	MESENCHYMAL STEM-CELLS; IN-VITRO CHONDROGENESIS; ARTICULAR-CARTILAGE; CHONDROCYTE PROLIFERATION; GROWTH-FACTORS; REPAIR; DEFECTS; DIFFERENTIATION; HYPERTROPHY; DELIVERY	Articular cartilage regeneration remains a major challenge in orthopedics. Noncanonical Wnt5a is a particularly attractive growth factor in this context; Wnt5a inhibits chondrocyte hypertrophy but maintains chondrogenesis. We designed a novel, vertically oriented-collagen scaffold. The effect of Wnt5a on MSCs and chondrocytes and the therapeutic effects of the Wnt5a/oriented-collagen scaffold in terms of osteochondral repair and cartilage integration were evaluated. In vitro, the proliferation, migration, and differentiation of MSCs and chondrocytes treated with Wnt5a, and the mechanisms thereof, were assessed. mRNA microarray analysis was performed to compare the expression profiles of MSCs before and after Wnt5a treatment. In vivo, full-thickness cylindrical osteochondral defects (4 mm in diameter, 3 mm in depth) were created in the patellar grooves of 24 New Zealand white rabbits and implanted with oriented-collagen scaffolds (n = 8), Wnt5a/oriented-collagen scaffolds (n = 8), or nothing (n = 8). After 6 and 12 weeks, integration and tissue responses were evaluated. The proliferation, migration, chondrogenic differentiation, and extracellular matrix formation of/by MSCs and chondrocytes improved greatly after treatment with Wnt5a. Western blotting showed that the PI3K/AKT/JNK signaling pathway was activated. Microarray analysis revealed that the Wnt5a group exhibited a significant upregulation of the PI3K pathway. Reactome GSEA pathway interaction analysis revealed that such upregulation was associated with collagen and extracellular matrix formation. In vivo, the Wnt5a/oriented-collagen scaffold group exhibited optimal interface integration, cartilage regeneration, and collagenous fiber arrangement, accompanied by significantly increased glycosaminoglycan and collagen accumulations in the zones of regeneration and integration, compared to the other groups. Gene expression analysis showed that the levels of mRNAs encoding genes involved in cartilage formation were significantly increased in the Wnt5a/oriented, collagen scaffold group (allP < .05). Wnt5a promoted the proliferation, migration, and chondrogenic differentiation of MSCs and chondrocytes via the activation of the PI3K/AKT/JNK signaling pathway. The Wnt5a/oriented-collagen constructs enhanced the structure-specific regeneration of hyaline cartilage in a rabbit model and may be a promising treatment for the repair of human cartilage defects.	[Qi, Yiying; Zhang, Wenkan; Li, Guoqi; Zhang, Yuxiang; Tang, Ruofu; Feng, Gang] Zhejiang Univ, Affiliated Hosp 2, Dept Orthoped Surg, Sch Med, 88 Jiefang Rd, Hangzhou 310009, Zhejiang, Peoples R China; [Niu, Lie] Peoples Hosp Dongping Cty, Dept Orthoped Surg, Tai An, Shandong, Peoples R China	Zhejiang University	Feng, G (corresponding author), Zhejiang Univ, Affiliated Hosp 2, Dept Orthoped Surg, Sch Med, 88 Jiefang Rd, Hangzhou 310009, Zhejiang, Peoples R China.	gangfeng@zju.edu.cn			National Natural Science Foundation of China (NSFC) [81772325]; Natural Science Youth of China [81401779, 81601878, 81702662]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Youth of China	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81772325; Natural Science Youth of China, Grant/Award Number: 81401779, 81601878 and 81702662	Ahsan T, 1999, OSTEOARTHR CARTILAGE, V7, P29, DOI 10.1053/joca.1998.0160; Almeida HV, 2017, TISSUE ENG PT A, V23, P55, DOI [10.1089/ten.tea.2016.0055, 10.1089/ten.TEA.2016.0055]; Bhatt PM, 2014, ATHEROSCLEROSIS, V237, P155, DOI 10.1016/j.atherosclerosis.2014.08.027; Bos PK, 2002, ARTHRITIS RHEUM-US, V46, P976, DOI 10.1002/art.10208; Boushell MK, 2019, ANN NY ACAD SCI, V1442, P138, DOI 10.1111/nyas.14054; Bradley EW, 2010, MOL ENDOCRINOL, V24, P1581, DOI 10.1210/me.2010-0037; Caplan AI, 2005, TISSUE ENG, V11, P1198, DOI 10.1089/ten.2005.11.1198; Csaki C, 2008, ANN ANAT, V190, P395, DOI 10.1016/j.aanat.2008.07.007; de Mulder ELW, 2014, TISSUE ENG PT A, V20, P635, DOI 10.1089/ten.TEA.2013.0083; Dickinson SC, 2017, STEM CELLS, V35, P2280, DOI 10.1002/stem.2691; DiMicco MA, 2001, J ORTHOPAED RES, V19, P1105, DOI 10.1016/S0736-0266(01)00037-7; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ge XP, 2017, ARCH ORAL BIOL, V82, P171, DOI 10.1016/j.archoralbio.2017.06.019; Gibson JD, 2017, STEM CELL TRANSL MED, V6, P40, DOI 10.5966/sctm.2016-0020; Hartmann C, 2000, DEVELOPMENT, V127, P3141; Hasegawa D, 2015, J CELL PHYSIOL, V230, P2647, DOI 10.1002/jcp.24950; Hosseini-Farahabadi S, 2013, MATRIX BIOL, V32, P252, DOI 10.1016/j.matbio.2013.02.005; Huang G, 2017, OSTEOARTHR CARTILAGE, V25, P1505, DOI 10.1016/j.joca.2017.05.018; Huntley JS, 2005, J BONE JOINT SURG AM, V87A, P351, DOI 10.2106/JBJS.D.02086; Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801; Hunziker EB, 1998, J BONE JOINT SURG BR, V80B, P144, DOI 10.1302/0301-620X.80B1.7531; Hunziker EB, 2003, J BONE JOINT SURG AM, V85A, P85, DOI 10.2106/00004623-200300002-00011; Jeon JE, 2014, ANAT REC, V297, P26, DOI 10.1002/ar.22795; Jia SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145667; Jiang YZ, 2011, CELL TRANSPLANT, V20, P593, DOI 10.3727/096368910X532738; Kawakami Y, 1999, DEV GROWTH DIFFER, V41, P29; Khan I M, 2011, Eur Cell Mater, V22, P190; Kim J, 2010, J IMMUNOL, V185, P1274, DOI 10.4049/jimmunol.1000181; Kumawat K, 2013, FASEB J, V27, P1631, DOI 10.1096/fj.12-217539; Li Z, 2018, OSTEOARTHR CARTILAGE, V26, P966, DOI 10.1016/j.joca.2018.04.002; Mainil-Varlet P, 2003, J BONE JOINT SURG AM, V85A, P45, DOI 10.2106/00004623-200300002-00007; Mao GP, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-1004-0; Mohan N, 2011, TISSUE ENG PT A, V17, P2845, DOI 10.1089/ten.tea.2011.0135; Moretti M, 2005, J BIOMECH, V38, P1846, DOI 10.1016/j.jbiomech.2004.08.021; Mow V, 2002, ANNU REV BIOMED ENG, V4, P175, DOI 10.1146/annurev.bioeng.4.110701.120309; Osaki LH, 2013, INT J MOL SCI, V14, P10143, DOI 10.3390/ijms140510143; Oussedik S, 2015, ARTHROSCOPY, V31, P732, DOI 10.1016/j.arthro.2014.11.023; Pelttari K, 2006, ARTHRITIS RHEUM-US, V54, P3254, DOI 10.1002/art.22136; Qi YY, 2009, CELL TRANSPLANT, V18, P1161, DOI 10.3727/096368909X12483162197169; Redman SN, 2004, OSTEOARTHR CARTILAGE, V12, P106, DOI 10.1016/j.joca.2002.12.001; Sciore P, 1998, J ORTHOPAED RES, V16, P429, DOI 10.1002/jor.1100160406; Seol D, 2012, ARTHRITIS RHEUM-US, V64, P3626, DOI 10.1002/art.34613; SHAPIRO F, 1993, J BONE JOINT SURG AM, V75A, P532, DOI 10.2106/00004623-199304000-00009; Steinert AF, 2009, TISSUE ENG PT A, V15, P1127, DOI 10.1089/ten.tea.2007.0252; Van den Borne MPJ, 2007, OSTEOARTHR CARTILAGE, V15, P1397, DOI 10.1016/j.joca.2007.05.005; Vanden Berg-Foels WS, 2014, TISSUE ENG PART B-RE, V20, P28, DOI 10.1089/ten.TEB.2013.0100; Wang W, 2010, BIOMATERIALS, V31, P8964, DOI 10.1016/j.biomaterials.2010.08.018; Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211; Yamamoto K, 2016, MATRIX BIOL, V56, P57, DOI 10.1016/j.matbio.2016.03.007; Yang Q, 2008, BIOMATERIALS, V29, P2378, DOI 10.1016/j.biomaterials.2008.01.037; Yang YZ, 2003, DEVELOPMENT, V130, P1003, DOI 10.1242/dev.00324; Yeh JR, 2011, J CELL SCI, V124, P2357, DOI 10.1242/jcs.080903; Zhang W, 2013, BIOMATERIALS, V34, P713, DOI 10.1016/j.biomaterials.2012.10.027; Zhang YX, 2019, CYTOTHERAPY, V21, P856, DOI 10.1016/j.jcyt.2019.02.005	54	11	11	5	23	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					11115	11132		10.1096/fj.202000280R	http://dx.doi.org/10.1096/fj.202000280R		JUL 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32627881				2022-12-28	WOS:000547606600001
J	Lee, SW; Kim, HK; Naidansuren, P; Ham, KA; Choi, HS; Ahn, HY; Kim, M; Kang, DH; Kang, SW; Joe, YA				Lee, Seung-Woo; Kim, Hyun-Kyung; Naidansuren, Purevjargal; Ham, Kyung A.; Choi, Hong Seok; Ahn, Hyun-Young; Kim, Myungshin; Kang, Dong Hoon; Kang, Sang Won; Joe, Young Ae			Peroxidasin is essential for endothelial cell survival and growth signaling by sulfilimine crosslink-dependent matrix assembly	FASEB JOURNAL			English	Article							EXTRACELLULAR-MATRIX; COLLAGEN-IV; BASEMENT-MEMBRANE; MECHANISM; PROTEIN; IDENTIFICATION; PROLIFERATION; FIBRONECTIN; MUTATIONS; SCAFFOLDS	Peroxidasin (PXDN) has been reported to crosslink the C-terminal non-collagenous domains of collagen IV (Col IV) by forming covalent sulfilimine bond. Here, we explored the physiological role of PXDN and its mechanism of action in endothelial cell survival and growth. Silencing of PXDN using siRNAs decreased cell proliferation without increase of the number of detached cells and decreased cell viability under serum-starved condition with increased fragmented nuclei and caspase 3/7 activity. Conditioned medium (CM) containing wild-type PXDN restored the proliferation of PXDN-depleted cells, but CM containing mutant PXDN with deletion of either N-terminal extracellular matrix (ECM) motifs or peroxidase domain failed to restore PXDN function. Accordingly, anti-PXDN antibody [raised against IgC2 (3-4) subdomain within ECM motifs] and peroxidase inhibitor phloroglucinol prevented the rescue of the PXDN-depleted cells by PXDN-containing CM. PXDN depletion resulted in loss of sulfilimine crosslinks, and decreased dense fibrillar network assembly of not only Col IV, but also fibronectin and laminin like in Col IV knockdown. Exogenous PXDN-containing CM restored ECM assembly as well as proliferation of PXDN-depleted cells. Accordingly, purified recombinant PXDN protein restored the proliferation and ECM assembly, and prevented cell death of the PXDN-depleted cells. PXDN depletion also showed reduced growth factors-induced phosphorylation of FAK and ERK1/2. In addition, siPXDN-transfected cell-derived matrix failed to provide full ECM-mediated activation of FAK and ERK1/2. These results indicate that both the ECM motifs and peroxidase activity are essential for the cellular function of PXDN and that PXDN is crucial for ECM assembly for survival and growth signaling.	[Lee, Seung-Woo; Kim, Hyun-Kyung; Naidansuren, Purevjargal; Ham, Kyung A.; Choi, Hong Seok; Joe, Young Ae] Catholic Univ Korea, Canc Res Inst, Coll Med, 222 Banpo Daero, Seoul 06519, South Korea; [Lee, Seung-Woo; Kim, Hyun-Kyung; Naidansuren, Purevjargal; Ham, Kyung A.; Choi, Hong Seok; Joe, Young Ae] Catholic Univ Korea, Coll Med, Dept Med Life Sci, 222 Banpo Daero, Seoul 06519, South Korea; [Lee, Seung-Woo; Kim, Hyun-Kyung; Naidansuren, Purevjargal; Ham, Kyung A.; Choi, Hong Seok; Joe, Young Ae] Catholic Univ Korea, Coll Med, Canc Evolut Res Ctr, Seoul, South Korea; [Ham, Kyung A.; Choi, Hong Seok; Joe, Young Ae] Catholic Univ Korea, Dept Biomed & Hlth Sci, Seoul, South Korea; [Ahn, Hyun-Young] Catholic Univ Korea, Coll Med, Dept Gynecol, Div Maternal Fetal Med, Seoul, South Korea; [Kim, Myungshin] Catholic Univ Korea, Coll Med, Dept Lab Med, Seoul, South Korea; [Kang, Dong Hoon; Kang, Sang Won] Ewha Womans Univ, Dept Life Sci, Seoul, South Korea; [Kang, Dong Hoon; Kang, Sang Won] Ewha Womans Univ, Res Ctr Cell Homeostasis, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Ewha Womans University; Ewha Womans University	Joe, YA (corresponding author), Catholic Univ Korea, Canc Res Inst, Coll Med, 222 Banpo Daero, Seoul 06519, South Korea.; Joe, YA (corresponding author), Catholic Univ Korea, Coll Med, Dept Med Life Sci, 222 Banpo Daero, Seoul 06519, South Korea.	youngjoe@catholic.ac.kr			National Research Foundation of Korea - Korean Government [2016R1A2B2013712, NRF-313-2008-2-C00904, NRF-2012R1A5A2047939, NRF-2019R1H1A2080013]	National Research Foundation of Korea - Korean Government(National Research Foundation of KoreaKorean Government)	This work was supported by National Research Foundation of Korea grants funded by the Korean Government (2016R1A2B2013712, NRF-313-2008-2-C00904, NRF-2012R1A5A2047939, and NRF-2019R1H1A2080013)	AIDA Y, 1990, J IMMUNOL METHODS, V132, P191, DOI 10.1016/0022-1759(90)90029-U; Bhave G, 2012, NAT CHEM BIOL, V8, P784, DOI [10.1038/NCHEMBIO.1038, 10.1038/nchembio.1038]; Brizzi MF, 2012, CURR OPIN CELL BIOL, V24, P645, DOI 10.1016/j.ceb.2012.07.001; Cheng GJ, 2011, FREE RADICAL BIO MED, V51, P1445, DOI 10.1016/j.freeradbiomed.2011.07.002; Cheng GJ, 2008, FREE RADICAL BIO MED, V45, P1682, DOI 10.1016/j.freeradbiomed.2008.09.009; Chernousov MA, 1998, J CELL SCI, V111, P2763; Davies MJ, 2008, ANTIOXID REDOX SIGN, V10, P1199, DOI 10.1089/ars.2007.1927; Ero-Tolliver IA, 2015, J BIOL CHEM, V290, P21741, DOI 10.1074/jbc.M115.673996; Fidler AL, 2014, P NATL ACAD SCI USA, V111, P331, DOI 10.1073/pnas.1318499111; Gotenstein JR, 2010, DEVELOPMENT, V137, P3603, DOI 10.1242/dev.049189; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Khan K, 2011, AM J HUM GENET, V89, P464, DOI 10.1016/j.ajhg.2011.08.005; Khoshnoodi J, 2008, MICROSC RES TECHNIQ, V71, P357, DOI 10.1002/jemt.20564; Kim HK, 2003, BIOCHEM BIOPH RES CO, V304, P740, DOI 10.1016/S0006-291X(03)00656-9; Lazar E, 2015, FREE RADICAL BIO MED, V83, P273, DOI 10.1016/j.freeradbiomed.2015.02.015; McCall AS, 2014, CELL, V157, P1380, DOI 10.1016/j.cell.2014.05.009; Medfai H, 2019, CARDIOVASC RES, V115, P463, DOI 10.1093/cvr/cvy179; MEREDITH JE, 1993, MOL BIOL CELL, V4, P953, DOI 10.1091/mbc.4.9.953; Mouw JK, 2014, NAT REV MOL CELL BIO, V15, P771, DOI 10.1038/nrm3902; NELSON RE, 1994, EMBO J, V13, P3438, DOI 10.1002/j.1460-2075.1994.tb06649.x; Paumann-Page M, 2017, J BIOL CHEM, V292, P4583, DOI 10.1074/jbc.M117.775213; Peterfi Z, 2014, TRENDS BIOCHEM SCI, V39, P305, DOI 10.1016/j.tibs.2014.05.005; Peterfi Z, 2009, AM J PATHOL, V175, P725, DOI 10.2353/ajpath.2009.080693; Quint C, 2011, P NATL ACAD SCI USA, V108, P9214, DOI 10.1073/pnas.1019506108; Shi RZ, 2011, CARDIOVASC RES, V91, P27, DOI 10.1093/cvr/cvr042; Sirokmany G, 2018, REDOX BIOL, V16, P314, DOI 10.1016/j.redox.2018.03.009; Tapias LF, 2014, CURR OPIN ORGAN TRAN, V19, P145, DOI 10.1097/MOT.0000000000000051; Van Agtmael T, 2005, HUM MOL GENET, V14, P3161, DOI 10.1093/hmg/ddi348; Vanacore R, 2009, SCIENCE, V325, P1230, DOI 10.1126/science.1176811; Wijelath ES, 2006, CIRC RES, V99, P853, DOI 10.1161/01.RES.0000246849.17887.66; Yan XH, 2014, HUM MOL GENET, V23, P5597, DOI 10.1093/hmg/ddu274; Yurchenco PD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004911; Zheng YZ, 2018, ANN DIAGN PATHOL, V34, P161, DOI 10.1016/j.anndiagpath.2018.03.002	34	6	6	2	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10228	10241		10.1096/fj.201902899R	http://dx.doi.org/10.1096/fj.201902899R		JUN 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32543734	Bronze			2022-12-28	WOS:000546426300001
J	Saqib, F; Mujahid, K; Aslam, MA; Modhi, A; Moga, MA; Bobescu, E; Marceanu, L				Saqib, Fatima; Mujahid, Khizra; Aslam, Muhammad Arif; Modhi, Alotaibi; Moga, Marius Alexandru; Bobescu, Elena; Marceanu, Luigi			Ex vivo and in vivo studies of Viola tricolor Linn. as potential cardio protective and hypotensive agent: Inhibition of voltage-gated Ca++ ion channels	FASEB JOURNAL			English	Article						calcium channel blocker; cardiac depressant; histopathology; in vitro; in vivo; invasive blood pressure; Vasodilator; VDLCs	MYOCARDIAL INFARCTED RATS; ISOPROTERENOL; HYPERTROPHY; HYPERTENSION; EXTRACT; GEL	Viola tricolor Linn. is used as cardio-protective and anti-hypertensive agent in traditional medicine. Current study objective was to evaluate cardio-protective and hypotensive effects of Viola tricolor L. in vitro and in vivo studies. Viola tricolor L. crude extract (Vt.Cr) and its fractions (Aqueous and organic) were tested at rabbit atria and aorta coupled to Power Lab Data Acquisition System for cardio depressant and vasorelaxant effects in vitro whereas in vivo Blood Pressure was checked by invasive method in normotensive ketamine-diazepam anesthetized rats. Isoproterenol was employed for acute myocardial infarction (AMI) and left ventricular hypertrophy (LVH) development and cardioprotective effects of Vt.Cr were evaluated hemodynamically and histopathologically. Vt.Cr and its fractions decreased heart rate and contractile force in paired atria and relaxed Phenylephrine (1 mu M) and K+ (80 mM) stimulated contractions in aorta possibly mediated through Voltage dependent L-type calcium channels blockage supported by in vivo hypotensive action. In LVH, Vt.Cr lowered Angiotensin Converting Enzymes and renin, increased cyclic Guanosine Monophosphate and nitric oxide levels, decreased cardiomyocytes size and fibrosis attributed to Gallic acid as detected by High Performance Liquid Chromatography. Partial positive results were seen hemodynamically and histologically in AMI Viola tricolor L. showed vasorelaxant, cardio-relaxant, hypotensive, and cardio protective effect validating traditional practice in cardiovascular disorders.	[Saqib, Fatima; Mujahid, Khizra; Aslam, Muhammad Arif] Bahauddin Zakariya Univ, Fac Pharm, Multan, Pakistan; [Modhi, Alotaibi] Princess Nourah bint Abdulrahman Univ, Dept Biol, Coll Sci, Riyadh, Saudi Arabia; [Moga, Marius Alexandru; Bobescu, Elena; Marceanu, Luigi] Transilvania Univ Brasov, Fac Med, 56 Balcescu Nicolae St, Brasov 500019, Romania	Bahauddin Zakariya University; Princess Nourah bint Abdulrahman University; Transylvania University of Brasov	Bobescu, E (corresponding author), Transilvania Univ Brasov, Fac Med, 56 Balcescu Nicolae St, Brasov 500019, Romania.	elena.bobescu@gmail.com	MOGA, MARIUS ALEXANDRU/AHC-2310-2022; Aslam, Muhammad Arif/AAS-4577-2020; Bobescu, Elena/AAC-6840-2021; Bobescu, Elena/ABD-6951-2020	Aslam, Muhammad Arif/0000-0001-9747-658X; Bobescu, Elena/0000-0002-0945-9067	Deanship of Scientific Research at Princess Nourah bint Abdurrahman University through the Fast-track Research Funding Program	Deanship of Scientific Research at Princess Nourah bint Abdurrahman University through the Fast-track Research Funding Program(Princess Nourah bint Abdulrahman University)	This research was funded by the Deanship of Scientific Research at Princess Nourah bint Abdurrahman University through the Fast-track Research Funding Program	Aman Upaganlawar, 2011, Journal of Pharmacology and Toxicology, V6, P1; Ardjmand A, 2019, LIFE SCI, V227, P187, DOI 10.1016/j.lfs.2019.04.056; Bao D, 2015, DIS MODEL MECH, V8, P795, DOI 10.1242/dmm.021303; Cheng YL, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/274025; Doggrell SA, 1998, CARDIOVASC RES, V39, P89, DOI 10.1016/S0008-6363(98)00076-5; Fan Y, 2019, PHARMACOLOGY, V103, P291, DOI 10.1159/000496800; FOSTER RW, 1984, BRIT J PHARMACOL, V81, P499, DOI 10.1111/j.1476-5381.1984.tb10103.x; Ghorbani A, 2012, AFR J PHARM PHARMACO, V6, P2503, DOI 10.5897/AJPP10.721; Gilani AH, 2005, J ETHNOPHARMACOL, V98, P127, DOI 10.1016/j.jep.2005.01.017; Grzeszczuk M, 2016, ACTA SCI POL-HORTORU, V15, P109; Hellinger R, 2014, J ETHNOPHARMACOL, V151, P299, DOI 10.1016/j.jep.2013.10.044; Jahantab E., 2018, IRAN ADV HERB, V3, P12; Janbaz KH, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0697-1; Jin L., 2017, SCI REP-UK, V7, P1; Jin L, 2017, J HYPERTENS, V35, P1502, DOI 10.1097/HJH.0000000000001327; JIN LI, 2018, SCI REP-UK, V8, P1, DOI DOI 10.1038/S41598-018-27599-4; Kang N, 2015, ENVIRON TOXICOL PHAR, V39, P764, DOI 10.1016/j.etap.2015.02.006; Kim HY, 2011, J ETHNOPHARMACOL, V133, P315, DOI 10.1016/j.jep.2010.09.024; Kirichenko TV, 2016, PHYTOMEDICINE, V23, P1198, DOI 10.1016/j.phymed.2015.12.002; Lin PP, 2013, INT J MOL MED, V32, P1319, DOI 10.3892/ijmm.2013.1524; Loffredo FS, 2013, CELL, V153, P828, DOI 10.1016/j.cell.2013.04.015; Lu L, 2015, CELL BIOCHEM BIOPHYS, V72, P865, DOI 10.1007/s12013-015-0553-4; Meeran MFN, 2016, CHEM-BIOL INTERACT, V244, P159, DOI 10.1016/j.cbi.2015.12.006; Meeran MFN, 2012, EUR J PHARMACOL, V677, P116, DOI 10.1016/j.ejphar.2011.11.043; Mradu G., 2012, INT J PHARMACOGN PHY, V4, P162; Murugesan S, 2019, J ETHNOPHARMACOL, V237, P108, DOI 10.1016/j.jep.2019.03.049; NAGANO M, 1992, HYPERTENSION, V19, P708, DOI 10.1161/01.HYP.19.6.708; Ocaranza MP, 2002, J CARDIOVASC PHARM, V40, P246, DOI 10.1097/00005344-200208000-00010; Odigie IP, 2003, J ETHNOPHARMACOL, V86, P181, DOI 10.1016/S0378-8741(03)00078-3; Panda S, 2014, EUR J PHARMACOL, V723, P451, DOI 10.1016/j.ejphar.2013.10.049; Piana M, 2013, J ETHNOPHARMACOL, V150, P458, DOI 10.1016/j.jep.2013.08.040; Piana M, 2013, J CHROMATOGR SCI, V51, P406, DOI 10.1093/chromsci/bms155; Prince PSM, 2009, EUR J PHARMACOL, V615, P139, DOI 10.1016/j.ejphar.2009.05.003; Rahimi VB, 2019, IRAN J MED SCI, V44, P220; Ryu Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep34790; Saqib F, 2019, B LATINOAM CARIBE PL, V18, P204; Saqib F, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0837-7; Seguro Luis Fernando Bernal da Costa, 2009, Arq Bras Cardiol, V93, P652; Sudhakumari A., 2012, INT J BASIC MED SCI, V2, P53; Syed AA, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00510; Takami T, 2003, CLIN EXP HYPERTENS, V25, P525, DOI 10.1081/CEH-120025336; TSE J, 1979, ENDOCRINOLOGY, V105, P246, DOI 10.1210/endo-105-1-246; Vukics V, 2008, J CHROMATOGR SCI, V46, P823, DOI 10.1093/chromsci/46.9.823; Vukics V, 2009, ANTIOXIDANT FLAVONOI, P222; Witkowska-Banaszczak E, 2005, FITOTERAPIA, V76, P458, DOI 10.1016/j.fitote.2005.03.005; World Health Organization, 2019, SAN; YIN FCP, 1982, AM J PHYSIOL, V243, pH941, DOI 10.1152/ajpheart.1982.243.6.H941; Yoon Na Young, 2013, Fisheries and Aquatic Sciences, V16, P237, DOI 10.5657/FAS.2013.0237; Zhang GX, 2005, CARDIOVASC RES, V65, P230, DOI 10.1016/j.cardiores.2004.08.013	49	4	4	0	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9102	9119		10.1096/fj.202000658R	http://dx.doi.org/10.1096/fj.202000658R		MAY 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32475023				2022-12-28	WOS:000538126200001
J	Kang, ZF; Fan, RR				Kang Zhanfang; Fan Rongrong			PPAR alpha and NCOR/SMRT corepressor network in liver metabolic regulation	FASEB JOURNAL			English	Review						coregulators; liver metabolism; NCOR; nuclear receptors; PPAR	NUCLEAR RECEPTOR COREPRESSOR; THYROID-HORMONE RECEPTOR; TRANSCRIPTIONAL REPRESSION; CO-REPRESSORS; NONALCOHOLIC STEATOHEPATITIS; LIPID-METABOLISM; STRUCTURAL BASIS; SMRT; ACTIVATION; COMPLEX	Peroxisome proliferator-activated receptor alpha (PPAR alpha, NR1C1) belongs to a large family of ligand-dependent nuclear receptors (NRs). It is one of the best studied NRs which controls the lipid metabolism (mainly fatty acid oxidation) and inflammation, and has been a promising target for treating metabolic disorders such as fatty liver and cardiometabolic diseases. The function of PPAR alpha relies on its interaction with various coregulators upon different stimulating contexts, and, thereby, activates or represses its transcription targets in a gene-selective manner. Understanding the transcription factor and coregulator network underlying the PPAR alpha regulation is prerequisite to decipher its gene- and context-selectivity for designing better therapeutic ligands. In this review, we will summarize current knowledge of PPAR alpha coregulator network, with major focus on a relatively well-studied corepressor complex containing core subunits of nuclear receptor corepressor (NCOR or NCOR1), silencing mediator of retinoic acid and thyroid hormone receptor (SMRT or NCOR2), G-protein suppressor 2 (GPS2), transducin beta-like protein 1 (TBL1 or TBL1X), TBL-related 1 (TBLR1 or TBL1XR1), and the catalytic core of histone deacetylase 3 (HDAC3). We will mainly review the molecular events of the complex and sub-complexes in controlling the liver metabolism. We will also discuss the potential perturbation of the subunit expression in human livers during liver metabolic disorder progression which potentially defines the patient disease susceptibility and drug responses.	[Kang Zhanfang] Guangzhou Med Univ, Affiliated Hosp 6, Qingyuan Peoples Hosp, Dept Basic Med Res, Qingyuan, Peoples R China; [Fan Rongrong] Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden	Guangzhou Medical University; Karolinska Institutet	Fan, RR (corresponding author), Karolinska Inst, Dept Biosci & Nutr, NEO, S-14183 Huddinge, Sweden.	rongrong.fan@ki.se	Fan, Rongrong/AAG-2200-2019	Fan, Rongrong/0000-0002-5707-1497; Kang, Zhanfang/0000-0001-7010-8701	Swedish Research Council; Novo Nordisk Foundation; Center for Innovative Medicine (CIMED) Foundation; Diabetes Wellness Sverige Foundation; National Natural Science Foundation of China [81300680]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Center for Innovative Medicine (CIMED) Foundation; Diabetes Wellness Sverige Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	FR is supported by Swedish Research Council, Novo Nordisk Foundation, Center for Innovative Medicine (CIMED) Foundation and Diabetes Wellness Sverige Foundation. KZ is supported by the National Natural Science Foundation of China (81300680).	Alenghat T, 2008, NATURE, V456, P997, DOI 10.1038/nature07541; Astapova I, 2011, MOL ENDOCRINOL, V25, P212, DOI 10.1210/me.2010-0462; Astapova I, 2014, J CLIN INVEST, V124, P1976, DOI 10.1172/JCI73419; Astapovaa I, 2008, P NATL ACAD SCI USA, V105, P19544, DOI 10.1073/pnas.0804604105; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Bochkis IM, 2014, CELL REP, V9, P996, DOI 10.1016/j.celrep.2014.09.048; Bougarne N, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01769; Bougarne N, 2018, ENDOCR REV, V39, P760, DOI 10.1210/er.2018-00064; Cardamone MD, 2014, CELL REP, V8, P163, DOI 10.1016/j.celrep.2014.05.041; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; Cronet P, 2001, STRUCTURE, V9, P699, DOI 10.1016/S0969-2126(01)00634-7; Davalos-Salas M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13180-8; Devchand PR, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01093; Dowell P, 1999, J BIOL CHEM, V274, P15901, DOI 10.1074/jbc.274.22.15901; DREYER C, 1992, CELL, V68, P879, DOI 10.1016/0092-8674(92)90031-7; Fan RR, 2016, NAT MED, V22, P780, DOI 10.1038/nm.4114; Fang S, 2011, P NATL ACAD SCI USA, V108, P3412, DOI 10.1073/pnas.1017707108; Feng D, 2011, SCIENCE, V331, P1315, DOI 10.1126/science.1198125; Feng X, 2001, J BIOL CHEM, V276, P15066, DOI 10.1074/jbc.M011027200; Fozzatti L, 2011, P NATL ACAD SCI USA, V108, P17462, DOI 10.1073/pnas.1107474108; Galman C, 2008, CELL METAB, V8, P169, DOI 10.1016/j.cmet.2008.06.014; Gao ZG, 2006, J BIOL CHEM, V281, P4540, DOI 10.1074/jbc.M507784200; Giudici M, 2016, HANDB EXP PHARMACOL, V233, P95, DOI 10.1007/164_2015_5; Guenther MG, 2001, MOL CELL BIOL, V21, P6091, DOI 10.1128/MCB.21.18.6091-6101.2001; Hong F, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19082189; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Huang ZQ, 2019, FASEB J, V33, P1631, DOI 10.1096/fj.201801123R; Iershov A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09598-9; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Iroz A, 2017, CELL REP, V21, P403, DOI 10.1016/j.celrep.2017.09.065; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; Jakobsson T, 2009, MOL CELL, V34, P510, DOI 10.1016/j.molcel.2009.05.006; Janssen AWF, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1969-3; Jepsen K, 2000, CELL, V102, P753, DOI 10.1016/S0092-8674(00)00064-7; Jepsen K, 2007, NATURE, V450, P415, DOI 10.1038/nature06270; Jiang XT, 2014, J MOL ENDOCRINOL, V53, P191, DOI 10.1530/JME-14-0066; Jo YS, 2015, HEPATOLOGY, V62, P1606, DOI 10.1002/hep.27907; Juge-Aubry CE, 1999, J BIOL CHEM, V274, P10505, DOI 10.1074/jbc.274.15.10505; Karagianni P, 2015, BBA-MOL CELL BIOL L, V1851, P2, DOI 10.1016/j.bbalip.2014.05.001; Kersten S, 2014, MOL METAB, V3, P354, DOI 10.1016/j.molmet.2014.02.002; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim K, 2012, HEPATOLOGY, V55, P1727, DOI 10.1002/hep.25537; KLIEWER SA, 1994, P NATL ACAD SCI USA, V91, P7355, DOI 10.1073/pnas.91.15.7355; Knapp S, 2018, BRIT J CANCER, V118, P936, DOI 10.1038/s41416-018-0045-6; Krogsdam AM, 2002, BIOCHEM J, V363, P157, DOI 10.1042/0264-6021:3630157; Kulozik P, 2011, CELL METAB, V13, P389, DOI 10.1016/j.cmet.2011.02.011; Lefebvre P, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92264; Leuenberger N, 2009, J CLIN INVEST, V119, P3138, DOI 10.1172/JCI39019; Li H, 1997, MOL ENDOCRINOL, V11, P2025, DOI 10.1210/me.11.13.2025; Li HT, 2012, DIABETES, V61, P797, DOI 10.2337/db11-0846; Li PP, 2013, CELL, V155, P200, DOI 10.1016/j.cell.2013.08.054; Li PP, 2011, CELL, V147, P815, DOI 10.1016/j.cell.2011.09.050; Liang N, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09524-z; Liu MH, 2008, MOL ENDOCRINOL, V22, P1078, DOI 10.1210/me.2007-0547; Lundasen T, 2007, BIOCHEM BIOPH RES CO, V360, P437, DOI 10.1016/j.bbrc.2007.06.068; Minniti ME, 2020, HEPATOLOGY, V72, P656, DOI 10.1002/hep.31052; Mohammed H, 2016, NAT PROTOC, V11, P316, DOI 10.1038/nprot.2016.020; Montagner A, 2016, GUT, V65, P1202, DOI 10.1136/gutjnl-2015-310798; Mottis A, 2013, GENE DEV, V27, P819, DOI 10.1101/gad.214023.113; Mouchiroud L, 2014, CELL METAB, V20, P26, DOI 10.1016/j.cmet.2014.03.027; Musso G, 2016, NAT REV DRUG DISCOV, V15, P249, DOI 10.1038/nrd.2015.3; Nofsinger RR, 2008, P NATL ACAD SCI USA, V105, P20021, DOI 10.1073/pnas.0811012105; Oberoi J, 2011, NAT STRUCT MOL BIOL, V18, P177, DOI 10.1038/nsmb.1983; Ou-Yang Q, 2018, HEPATOLOGY, V67, P1071, DOI 10.1002/hep.29562; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Paumelle R, 2019, J HEPATOL, V70, P963, DOI 10.1016/j.jhep.2018.12.037; Pawlak M, 2015, J HEPATOL, V62, P720, DOI 10.1016/j.jhep.2014.10.039; Perissi V, 2004, CELL, V116, P511, DOI 10.1016/S0092-8674(04)00133-3; Pourcet B, 2010, J BIOL CHEM, V285, P5983, DOI 10.1074/jbc.M109.078311; Quagliarini F, 2019, MOL CELL, V76, P531, DOI 10.1016/j.molcel.2019.10.007; Rando G, 2016, ELIFE, V5, DOI 10.7554/eLife.11853; Ratziu V, 2016, GASTROENTEROLOGY, V150, P1147, DOI 10.1053/j.gastro.2016.01.038; Reilly SM, 2010, CELL METAB, V12, P643, DOI 10.1016/j.cmet.2010.11.007; Robinson-Rechavi M, 2001, TRENDS GENET, V17, P554, DOI 10.1016/S0168-9525(01)02417-9; Rodriguez MA, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4834-3; Rudraiah S, 2016, ANNU REV PHARMACOL, V56, P605, DOI 10.1146/annurev-pharmtox-010715-103209; Russell RC, 2014, CELL RES, V24, P42, DOI 10.1038/cr.2013.166; Saito T, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08829-3; Sanyal S, 2007, P NATL ACAD SCI USA, V104, P15665, DOI 10.1073/pnas.0706736104; Sengupta S, 2010, NATURE, V468, P1100, DOI 10.1038/nature09584; Shimizu H, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220717; Shimizu H, 2015, MOL CELL BIOL, V35, P555, DOI 10.1128/MCB.01208-14; Siersbaek R, 2017, MOL CELL, V66, P420, DOI 10.1016/j.molcel.2017.04.010; Sommars MA, 2019, ELIFE, V8, DOI 10.7554/eLife.43922; Sun Z, 2013, MOL CELL, V52, P769, DOI 10.1016/j.molcel.2013.10.022; Sun Z, 2012, NAT MED, V18, P934, DOI 10.1038/nm.2744; Toubal A, 2013, J CLIN INVEST, V123, P362, DOI 10.1172/JCI64052; Treuter E, 1998, MOL ENDOCRINOL, V12, P864, DOI 10.1210/me.12.6.864; Van Wyngene L, 2020, EMBO MOL MED, V12, DOI 10.15252/emmm.201911319; Venteclef N, 2010, GENE DEV, V24, P381, DOI 10.1101/gad.545110; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; Watson PJ, 2012, MOL CELL ENDOCRINOL, V348, P440, DOI 10.1016/j.mce.2011.08.033; Xu Eric H, 2003, Nucl Recept Signal, V1, pe004; Xu HE, 2001, P NATL ACAD SCI USA, V98, P13919, DOI 10.1073/pnas.241410198; Xu HE, 2002, NATURE, V415, P813, DOI 10.1038/415813a; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Yamamoto H, 2011, CELL, V147, P827, DOI 10.1016/j.cell.2011.10.017; Ye JP, 2013, DIABETES, V62, P685, DOI 10.2337/db12-1354; Yoo JY, 2012, MOL BIOL CELL, V23, P2943, DOI 10.1091/mbc.E11-11-0947; Yoon HG, 2005, MOL CELL BIOL, V25, P324, DOI 10.1128/MCB.25.1.324-335.2005; You SH, 2013, NAT STRUCT MOL BIOL, V20, P182, DOI 10.1038/nsmb.2476; You SH, 2010, MOL ENDOCRINOL, V24, P1359, DOI 10.1210/me.2009-0501; Yu C, 2005, J BIOL CHEM, V280, P13600, DOI 10.1074/jbc.M409468200; Zamir I, 1996, MOL CELL BIOL, V16, P5458; Zhang JS, 2002, MOL CELL, V9, P611, DOI 10.1016/S1097-2765(02)00468-9	106	16	16	2	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					8796	8809		10.1096/fj.202000055RR	http://dx.doi.org/10.1096/fj.202000055RR		MAY 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32396271	hybrid			2022-12-28	WOS:000532319700001
J	Cao, TF; Jiang, Y; Li, D; Sun, XL; Zhang, YY; Qin, LF; Tellides, G; Taylor, HS; Huang, YQ				Cao, Tiefeng; Jiang, Ying; Li, Da; Sun, Xiaoli; Zhang, Yuanyuan; Qin, Lingfeng; Tellides, George; Taylor, Hugh S.; Huang, Yingqun			H19/TET1 axis promotes TGF-beta signaling linked to endothelial-to-mesenchymal transition	FASEB JOURNAL			English	Article						atherosclerosis; cardiovascular; EndMT; epigenetic; LncRNA	METHYLATION GENOME-WIDE; SMOOTH-MUSCLE-CELLS; DNA METHYLATION; NEOINTIMA FORMATION; MASTER REGULATOR; H19; CONTRIBUTES; GROWTH; RECEPTOR; GENE	While emerging evidence suggests the link between endothelial activation of TGF-beta signaling, induction of endothelial-to-mesenchymal transition (EndMT), and cardiovascular disease (CVD), the molecular underpinning of this connection remains enigmatic. Here, we report aberrant expression of H19 lncRNA and TET1 in endothelial cells (ECs) of human atherosclerotic coronary arteries. Using primary human umbilical vein endothelial cells (HUVECs) and aortic endothelial cells (HAoECs) we show that TNF-alpha, a known risk factor for endothelial dysfunction and CVD, induces H19 expression which in turn activates TGF-beta signaling and EndMT via a TET1-dependent epigenetic mechanism. We also show that H19 regulates TET1 expression at the posttranscriptional level. Further, we provide evidence that this H19/TET1-mediated regulation of TGF-beta signaling and EndMT occurs in mouse pulmonary microvascular ECs in vivo under hyperglycemic conditions. We propose that endothelial activation of the H19/TET1 axis may play an important role in EndMT and perhaps CVD.	[Cao, Tiefeng; Jiang, Ying; Li, Da; Sun, Xiaoli; Zhang, Yuanyuan; Taylor, Hugh S.; Huang, Yingqun] Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06510 USA; [Cao, Tiefeng] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Gynecol & Obstet, Guangzhou, Peoples R China; [Jiang, Ying] Zhejiang Univ, Womens Hosp, Sch Med, Dept Obstet, Hangzhou, Peoples R China; [Li, Da] China Med Univ, Shengjing Hosp, Ctr Reprod Med, Dept Obstet & Gynecol, Shenyang, Peoples R China; [Sun, Xiaoli] Nantong Univ, Affiliated Hosp, Ctr Reprod Med, Dept Obstet & Gynecol, Nantong, Peoples R China; [Zhang, Yuanyuan] Nanjing Med Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Nanjing, Peoples R China; [Qin, Lingfeng; Tellides, George] Yale Univ, Sch Med, Dept Surg, New Haven, CT 06510 USA	Yale University; Sun Yat Sen University; Zhejiang University; China Medical University; Nantong University; Nanjing Medical University; Yale University	Huang, YQ (corresponding author), Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06510 USA.	Yingqun.huang@yale.edu			National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	Aisagbonhi O, 2011, DIS MODEL MECH, V4, P469, DOI 10.1242/dmm.006510; Akazawa Y, 2010, J HEPATOL, V52, P586, DOI 10.1016/j.jhep.2010.01.003; Cao TF, 2019, ONCOGENE, V38, P5356, DOI 10.1038/s41388-019-0808-4; Chen DH, 1999, CIRCULATION, V100, P849, DOI 10.1161/01.CIR.100.8.849; Chen PY, 2015, J CLIN INVEST, V125, P4514, DOI 10.1172/JCI82719; Chen PY, 2012, CELL REP, V2, P1684, DOI 10.1016/j.celrep.2012.10.021; CLARKE R, 1991, NEW ENGL J MED, V324, P1149, DOI 10.1056/NEJM199104253241701; Cooley BC, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3006927; DIPIETRO LA, 1994, J VASC RES, V31, P178, DOI 10.1159/000319585; El-Remessy AB, 2006, AM J PATHOL, V168, P235, DOI 10.2353/ajpath.2006.050500; Evrard SM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11853; Fabian MR, 2012, NAT STRUCT MOL BIOL, V19, P586, DOI 10.1038/nsmb.2296; Gao W, 2015, MUTAT RES-FUND MOL M, V772, P15, DOI 10.1016/j.mrfmmm.2014.12.009; Gao Y, 2014, NUCLEIC ACIDS RES, V42, P13799, DOI 10.1093/nar/gku1160; Geng TT, 2018, DIABETES, V67, P2183, DOI 10.2337/db18-0370; Ghazal S, 2015, EMBO MOL MED, V7, P996, DOI 10.15252/emmm.201505245; Greco S, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0926-5; Greissel A, 2015, THROMB HAEMOSTASIS, V114, P390, DOI 10.1160/TH14-10-0852; Han DKM, 1996, J CLIN INVEST, V97, P1276, DOI 10.1172/JCI118543; Hofmann P, 2019, CARDIOVASC RES, V115, P230, DOI 10.1093/cvr/cvy206; Hong L, 2018, EUR J CELL BIOL, V97, P493, DOI 10.1016/j.ejcb.2018.07.005; Iwasaki S, 2009, MOL CELL, V34, P58, DOI 10.1016/j.molcel.2009.02.010; Jeong D, 2016, J AM COLL CARDIOL, V67, P1556, DOI 10.1016/j.jacc.2016.01.030; Jiang YC, 2018, HEPATOL COMMUN, V2, P1356, DOI 10.1002/hep4.1252; Jimenez SA, 2016, MATRIX BIOL, V51, P26, DOI 10.1016/j.matbio.2016.01.012; Kallen AN, 2013, MOL CELL, V52, P101, DOI 10.1016/j.molcel.2013.08.027; Kessler T, 2015, CIRCULATION, V131, P1191, DOI 10.1161/CIRCULATIONAHA.114.014072; Khambhati J, 2018, ATHEROSCLEROSIS, V276, P1, DOI 10.1016/j.atherosclerosis.2018.07.007; KIM DK, 1994, J CLIN INVEST, V93, P355, DOI 10.1172/JCI116967; Kitao A, 2009, AM J PATHOL, V175, P616, DOI 10.2353/ajpath.2009.081061; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Lanahan AA, 2010, DEV CELL, V18, P713, DOI 10.1016/j.devcel.2010.02.016; Li DY, 2018, CIRCULATION, V138, P1551, DOI 10.1161/CIRCULATIONAHA.117.032184; Li P, 2016, CIRCULATION, V134, P1752, DOI 10.1161/CIRCULATIONAHA.116.017949; Li TY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02401-7; Liu RJ, 2013, CIRCULATION, V128, P2047, DOI 10.1161/CIRCULATIONAHA.113.002887; Maddaluno L, 2013, NATURE, V498, P492, DOI 10.1038/nature12207; Martinet C, 2016, DEVELOPMENT, V143, P962, DOI 10.1242/dev.131771; Meng XM, 2016, NAT REV NEPHROL, V12, P325, DOI 10.1038/nrneph.2016.48; Moonen JRAJ, 2015, CARDIOVASC RES, V108, P377, DOI 10.1093/cvr/cvv175; Moura R, 2007, ARTERIOSCL THROM VAS, V27, P2163, DOI 10.1161/ATVBAHA.107.151282; Murphy-Ullrich JE, 2018, MATRIX BIOL, V68-69, P28, DOI 10.1016/j.matbio.2017.12.009; Peng J, 2016, ONCOTARGET, V7, P76423, DOI 10.18632/oncotarget.13121; Piera-Velazquez S, 2011, AM J PATHOL, V179, P1074, DOI 10.1016/j.ajpath.2011.06.001; Popov D, 2001, MARC MALPIG SYMP SER, V7, P405; REED MJ, 1995, AM J PATHOL, V147, P1068; Ripoche MA, 1997, GENE DEV, V11, P1596, DOI 10.1101/gad.11.12.1596; Stenina-Adognravi O, 2014, MATRIX BIOL, V37, P69, DOI 10.1016/j.matbio.2014.02.001; Sun YL, 2019, J MOL CELL CARDIOL, V131, P66, DOI 10.1016/j.yjmcc.2019.04.004; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Thomas AA, 2019, DIABETOLOGIA, V62, P517, DOI 10.1007/s00125-018-4797-6; Uyy E, 2010, MICROVASC RES, V79, P154, DOI 10.1016/j.mvr.2009.11.008; Wesseling M, 2018, VASC PHARMACOL, V106, P1, DOI 10.1016/j.vph.2018.02.006; Wu XJ, 2017, NAT REV GENET, V18, P517, DOI 10.1038/nrg.2017.33; Yamashita S, 2008, CANCER RES, V68, P2112, DOI 10.1158/0008-5472.CAN-07-5282; Yan L, 2015, ONCOGENE, V34, P3076, DOI 10.1038/onc.2014.236; Yang Q, 2016, ANN BIOMED ENG, V44, P2218, DOI 10.1007/s10439-015-1491-4; Yang YY, 2019, AGING-US, V11, P10016, DOI 10.18632/aging.102388; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zhang N, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.120304; Zhang Z, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07611-z; Zhang ZW, 2016, J CLIN PATHOL, V69, P76, DOI 10.1136/jclinpath-2015-203275; Zhong T, 2017, ONCOGENE, V36, P2345, DOI 10.1038/onc.2016.391; Zhou JC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10221; Zuckerwise L, 2016, ONCOTARGET, V7, P38398, DOI 10.18632/oncotarget.9534	65	9	9	2	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8625	8640		10.1096/fj.202000073RRRRR	http://dx.doi.org/10.1096/fj.202000073RRRRR		MAY 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32374060	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000530737900001
J	Han, X; Guo, JL; You, YL; Zhan, JC; Huang, WD				Han, Xue; Guo, Jielong; You, Yilin; Zhan, Jicheng; Huang, Weidong			p-Coumaric acid prevents obesity via activating thermogenesis in brown adipose tissue mediated by mTORC1-RPS6	FASEB JOURNAL			English	Article						brown adipose tissue; mTORC1-RPS6; obesity; p-coumaric acid; thermogenesis	SASA-QUELPAERTENSIS; MAMMALIAN TARGET; LIPID-METABOLISM; FAT; GLUCOSE; MTOR; EXTRACT; WINE	Brown adipose tissue (BAT) has long been recognized as an energy-consuming organ and a possible target for combating metabolism disorder. Although numerous studies have demonstrated the ability of phytochemical phenolic acids to improve obesity by activating BAT, the underlying mechanism or mechanism therein remain obscure. In this study, diet-induced obese mice, genetically obese mice, and C3H10T1/2 cells were used to examine the effects of p-Coumaric acid (CA) on metabolism profiles. The results showed that CA prevented metabolic syndromes in the two mice models through the activation of BAT. This phenomenon was closely linked to the upregulation of uncoupling protein 1 (UCP1) and the accelerated burning of fatty acids and glucose, which consequently enhanced the energy expenditure and thermogenesis. Similar results were also obtained in vitro. Importantly, these effects were mediated by the mammalian target of rapamycin complex 1 (mTORC1)-RPS6 pathway. These findings reveal, to the best of our knowledge for the first time, the close correlation between mTORC1-RPS6 and BAT-mediated thermogenesis, and, in addition, the key role played by mTORC1-RPS6 in mediating phenolic acids-induced activation of BAT, thus preventing obesity.	[Han, Xue; Guo, Jielong; You, Yilin; Zhan, Jicheng; Huang, Weidong] China Agr Univ, Beijing Key Lab Viticulture & Enol, Coll Food Sci & Nutr Engn, Tsinghua East Rd 17, Beijing 100083, Peoples R China	China Agricultural University	You, YL; Zhan, JC; Huang, WD (corresponding author), China Agr Univ, Beijing Key Lab Viticulture & Enol, Coll Food Sci & Nutr Engn, Tsinghua East Rd 17, Beijing 100083, Peoples R China.	yilinyou@cau.edu.cn; zhanjicheng@cau.edu.cn; huanggwd@263.net	Zhan, Jicheng/ABF-8501-2021		National Natural Science Foundation of China [81900777]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China, Grant/Award Number: 81900777	Ambika S., 2013, BIOMEDICINE AGING PA, V3, P253, DOI DOI 10.1016/j.biomag.2013.09.004; Brown NF, 2007, METABOLISM, V56, P1500, DOI 10.1016/j.metabol.2007.06.016; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Catania C, 2011, INT J OBESITY, V35, P751, DOI 10.1038/ijo.2010.208; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Dann SG, 2007, TRENDS MOL MED, V13, P252, DOI 10.1016/j.molmed.2007.04.002; Din MU, 2018, CELL METAB, V28, P207, DOI 10.1016/j.cmet.2018.05.020; Ezzati M, 2017, LANCET, V390, P2627, DOI 10.1016/S0140-6736(17)32129-3; Fedorenko A, 2012, CELL, V151, P400, DOI 10.1016/j.cell.2012.09.010; Guo JL, 2019, ISCIENCE, V19, P676, DOI 10.1016/j.isci.2019.08.020; Han X, 2019, J FOOD SCI, V84, P3815, DOI 10.1111/1750-3841.14838; Han X, 2018, FOOD FUNCT, V9, P4366, DOI [10.1039/c8fo00978c, 10.1039/C8FO00978C]; Hanssen MJW, 2016, DIABETES, V65, P1179, DOI 10.2337/db15-1372; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Kang SW, 2013, FOOD CHEM TOXICOL, V59, P380, DOI 10.1016/j.fct.2013.06.033; Kim JH, 2013, BIOSCI BIOTECH BIOCH, V77, P1595, DOI 10.1271/bbb.130167; Kraemer FB, 2002, J LIPID RES, V43, P1585, DOI 10.1194/jlr.R200009-JLR200; Labbe SM, 2016, SCI REP-UK, V6, DOI 10.1038/srep37223; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Liu DX, 2016, J CLIN INVEST, V126, P1704, DOI 10.1172/JCI83532; Ma TT, 2019, FOOD FUNCT, V10, P1317, DOI 10.1039/c8fo02322k; Mele L, 2017, ADV NUTR, V8, P694, DOI 10.3945/an.117.015792; Pei KH, 2016, J SCI FOOD AGR, V96, P2952, DOI 10.1002/jsfa.7578; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; Ruvinsky I, 2005, GENE DEV, V19, P2199, DOI 10.1101/gad.351605; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Sun XY, 2020, FOOD RES INT, V127, DOI 10.1016/j.foodres.2019.108704; van Dorsten FA, 2010, MOL NUTR FOOD RES, V54, P897, DOI 10.1002/mnfr.200900212; Villarroya F, 2013, DIABETOLOGIA, V56, pS35; Whittle AJ, 2012, CELL, V149, P871, DOI 10.1016/j.cell.2012.02.066; Wipperman MF, 2019, AM J PATHOL, V189, P492, DOI 10.1016/j.ajpath.2018.11.013; Xie WD, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/903258; Yoon SA, 2013, BIOCHEM BIOPH RES CO, V432, P553, DOI 10.1016/j.bbrc.2013.02.067; You YL, 2018, J FUNCT FOODS, V41, P62, DOI 10.1016/j.jff.2017.12.025; You YL, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201700261; You YL, 2015, FOOD FUNCT, V6, P401, DOI 10.1039/c4fo00719k; Yuan XX, 2017, FASEB J, V31, P333, DOI [10.1096/fj.201600459RR, 10.1096/fj.201600459rr]; Yuan XX, 2016, SCI BULL, V61, P1498, DOI 10.1007/s11434-016-1051-9; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	39	17	17	6	22	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					7810	7824		10.1096/fj.202000333R	http://dx.doi.org/10.1096/fj.202000333R		APR 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32350925				2022-12-28	WOS:000553674000001
J	Davey, JR; Estevez, E; Thomson, RE; Whitham, M; Watt, KI; Hagg, A; Qian, HW; Henstridge, DC; Ludlow, H; Hedger, MP; McGee, SL; Coughlan, MT; Febbraio, MA; Gregorevic, P				Davey, Jonathan R.; Estevez, Emma; Thomson, Rachel E.; Whitham, Martin; Watt, Kevin I.; Hagg, Adam; Qian, Hongwei; Henstridge, Darren C.; Ludlow, Helen; Hedger, Mark P.; McGee, Sean L.; Coughlan, Melinda T.; Febbraio, Mark A.; Gregorevic, Paul			Intravascular Follistatin gene delivery improves glycemic control in a mouse model of type 2 diabetes	FASEB JOURNAL			English	Article						Activin; diabetes; Follistatin; gene therapy; skeletal muscle	BETA-CELL DEDIFFERENTIATION; ACTIVIN-A; INSULIN; EXPRESSION; APOPTOSIS; MASS; TRANSCRIPTION; MUTATION	Type 2 diabetes (T2D) manifests from inadequate glucose control due to insulin resistance, hypoinsulinemia, and deteriorating pancreatic beta -cell function. The pro-inflammatory factor Activin has been implicated as a positive correlate of severity in T2D patients, and as a negative regulator of glucose uptake by skeletal muscle, and of pancreatic beta -cell phenotype in mice. Accordingly, we sought to determine whether intervention with the Activin antagonist Follistatin can ameliorate the diabetic pathology. Here, we report that an intravenous Follistatin gene delivery intervention with tropism for striated muscle reduced the serum concentrations of Activin B and improved glycemic control in the db/db mouse model of T2D. Treatment reversed the hyperglycemic progression with a corresponding reduction in the percentage of glycated-hemoglobin to levels similar to lean, healthy mice. Follistatin gene delivery promoted insulinemia and abundance of insulin-positive pancreatic beta -cells, even when treatment was administered to mice with advanced diabetes, supporting a mechanism for improved glycemic control associated with maintenance of functional beta -cells. Our data demonstrate that single-dose intravascular Follistatin gene delivery can ameliorate the diabetic progression and improve prognostic markers of disease. These findings are consistent with other observations of Activin-mediated mechanisms exerting deleterious effects in models of obesity and diabetes, and suggest that interventions that attenuate Activin signaling could help further understanding of T2D and the development of novel T2D therapeutics.	[Davey, Jonathan R.; Thomson, Rachel E.; Watt, Kevin I.; Hagg, Adam; Qian, Hongwei; Gregorevic, Paul] Univ Melbourne, Dept Physiol, Ctr Muscle Res, Parkville, Vic 3010, Australia; [Davey, Jonathan R.; Estevez, Emma; Thomson, Rachel E.; Whitham, Martin; Watt, Kevin I.; Hagg, Adam; Qian, Hongwei; Gregorevic, Paul] Baker Heart & Diabet Inst, Melbourne, Vic, Australia; [Whitham, Martin] Univ Birmingham, Coll Life & Environm Sci, Edgbaston, England; [Watt, Kevin I.; Coughlan, Melinda T.] Monash Univ, Dept Diabet, Cent Clin Sch, Melbourne, Vic, Australia; [Hagg, Adam] Monash Univ, Dept Physiol, Clayton, Vic, Australia; [Henstridge, Darren C.] Univ Tasmania, Sch Hlth Sci, Launceston, Tas, Australia; [Ludlow, Helen] Oxford Brookes Univ, Sch Life Sci, Oxford, England; [Hedger, Mark P.] Hudson Inst Med Res, Clayton, Vic, Australia; [McGee, Sean L.] Deakin Univ, Sch Med, Waurn Ponds, Vic, Australia; [Febbraio, Mark A.] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic, Australia; [Gregorevic, Paul] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Gregorevic, Paul] Univ Washington, Dept Neurol, Seattle, WA 98195 USA	University of Melbourne; Baker Heart and Diabetes Institute; University of Birmingham; Monash University; Monash University; University of Tasmania; Oxford Brookes University; Hudson Institute of Medical Research; Deakin University; Monash University; Monash University; University of Washington; University of Washington Seattle	Gregorevic, P (corresponding author), Univ Melbourne, Dept Physiol, Ctr Muscle Res, Parkville, Vic 3010, Australia.	pgre@unimelb.edu.au	Hedger, Mark P/C-3495-2008; Watt, Kevin I./AAF-6703-2021; Gregorevic, Paul/AAH-6040-2021	Watt, Kevin I./0000-0001-7475-4487; Gregorevic, Paul/0000-0002-7418-8945; Whitham, Martin/0000-0002-0254-762X; Febbraio, Mark/0000-0002-9296-4418; Estevez, Emma/0000-0002-5125-2190; Hagg, Adam/0000-0001-7951-743X				Ashcroft FM, 2012, CELL, V148, P1160, DOI 10.1016/j.cell.2012.02.010; BAETENS D, 1978, DIABETES, V27, P1, DOI 10.2337/diabetes.27.1.1; Bertolino P, 2008, P NATL ACAD SCI USA, V105, P7246, DOI 10.1073/pnas.0801285105; Blum B, 2014, ELIFE, V3, DOI 10.7554/eLife.02809; Butler AE, 2003, DIABETES, V52, P2304, DOI 10.2337/diabetes.52.9.2304; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; Chen JL, 2014, FASEB J, V28, P1711, DOI 10.1096/fj.13-245894; Cinti F, 2016, J CLIN ENDOCR METAB, V101, P1044, DOI 10.1210/jc.2015-2860; Davey JR, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.85477; de Kretser DM, 1999, J ENDOCRINOL, V161, P195, DOI 10.1677/joe.0.1610195; DEFRONZO RA, 1985, J CLIN INVEST, V76, P149, DOI 10.1172/JCI111938; Dor Y, 2013, NEW ENGL J MED, V368, P572, DOI 10.1056/NEJMcibr1214034; Gao T, 2014, CELL METAB, V19, P259, DOI 10.1016/j.cmet.2013.12.002; Gregorevic P, 2004, NAT MED, V10, P828, DOI 10.1038/nm1085; Guo SL, 2013, J CLIN INVEST, V123, P3305, DOI 10.1172/JCI65390; Guo TQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004937; Han XQ, 2019, J CACHEXIA SARCOPENI, V10, P1241, DOI 10.1002/jcsm.12474; HUMMEL KP, 1966, SCIENCE, V153, P1127, DOI 10.1126/science.153.3740.1127; Ishida E, 2017, DIABETES, V66, P2092, DOI 10.2337/db16-1213; Izumiya Y, 2008, CELL METAB, V7, P159, DOI 10.1016/j.cmet.2007.11.003; Jha JC, 2014, J AM SOC NEPHROL, V25, P1237, DOI 10.1681/ASN.2013070810; Jones KL, 2007, P NATL ACAD SCI USA, V104, P16239, DOI 10.1073/pnas.0705971104; Kahn SE, 2014, LANCET, V383, P1068, DOI 10.1016/S0140-6736(13)62154-6; Kim-Muller JY, 2014, CELL METAB, V20, P593, DOI 10.1016/j.cmet.2014.08.012; Knight PG, 1996, J ENDOCRINOL, V148, P267, DOI 10.1677/joe.0.1480267; Kota J, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000112; Lassila M, 2004, J AM SOC NEPHROL, V15, P2125, DOI 10.1097/01.ASN.0000133025.23732.46; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Lin HM, 2009, J BIOL CHEM, V284, P12246, DOI 10.1074/jbc.M805379200; Ludlow H, 2009, CLIN ENDOCRINOL, V71, P867, DOI 10.1111/j.1365-2265.2009.03567.x; McPherron AC, 2012, DIABETES OBES METAB, V14, P279, DOI 10.1111/j.1463-1326.2011.01520.x; McPherron AC, 2002, J CLIN INVEST, V109, P595, DOI 10.1172/JCI200213562; Mendell JR, 2015, MOL THER, V23, P192, DOI 10.1038/mt.2014.200; Nakatani M, 2011, AM J PHYSIOL-ENDOC M, V300, pE543, DOI 10.1152/ajpendo.00430.2010; Page MM, 2018, FASEB J, V32, P1196, DOI [10.1096/fj.201700518R, 10.1096/fj.201700518r]; Ripoche D, 2016, MOL CELL BIOL, V36, P756, DOI 10.1128/MCB.00930-15; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Singh R, 2018, DIABET METAB SYND OB, V11, P65, DOI 10.2147/DMSO.S159315; Szabat M, 2010, DIABETOLOGIA, V53, P1680, DOI 10.1007/s00125-010-1758-0; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Tao RY, 2018, NAT MED, V24, P1058, DOI 10.1038/s41591-018-0048-0; Tersey SA, 2018, FASEB J, V32, P6150, DOI 10.1096/fj.201800150RR; Thompson TB, 2005, DEV CELL, V9, P535, DOI 10.1016/j.devcel.2005.09.008; Wang ZY, 2014, CELL METAB, V19, P872, DOI 10.1016/j.cmet.2014.03.010; Weir GC, 2004, DIABETES, V53, pS16, DOI 10.2337/diabetes.53.suppl_3.S16; Winbanks CE, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aac4976; Winbanks CE, 2012, J CELL BIOL, V197, P997, DOI 10.1083/jcb.201109091; Wu H, 2012, EXP DIABETES RES, DOI 10.1155/2012/410579; Zhang N, 2006, DIABETOLOGIA, V49, P506, DOI 10.1007/s00125-005-0095-1; Zhao CX, 2015, MOL THER, V23, P866, DOI 10.1038/mt.2015.29	52	4	4	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5697	5714		10.1096/fj.201802059RRR	http://dx.doi.org/10.1096/fj.201802059RRR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32141144	Bronze			2022-12-28	WOS:000530242100058
J	Basu, A; Dvorina, N; Baldwin, WM; Mazumder, B				Basu, Abhijit; Dvorina, Nina; Baldwin, William M., III; Mazumder, Barsanjit			High-fat diet-induced GAIT element-mediated translational silencing of mRNAs encoding inflammatory proteins in macrophage protects against atherosclerosis	FASEB JOURNAL			English	Article						atherosclerosis; GAIT; inflammation; L13a; translational control	LOW-DENSITY-LIPOPROTEIN; GAMMA-INTERFERON; PROMOTES ATHEROSCLEROSIS; STRUCTURAL ALIGNMENT; INITIATION-FACTOR; L13A; POLARIZATION; TRANSCRIPT; CELLS; PROLIFERATION	Previously, we identified a mechanism of inflammation control directed by ribosomal protein L13a and "GAIT" (Gamma Activated Inhibitor of Translation) elements in target mRNAs and showed that its elimination in myeloid cell-specific L13a knockout mice (L13a KO) increased atherosclerosis susceptibility and severity. Here, we investigated the mechanistic basis of this endogenous defense against atherosclerosis. We compared molecular and cellular aspects of atherosclerosis in high-fat diet (HFD)-fed L13a KO and intact (control) mice. HFD treatment of control mice induced release of L13a from 60S ribosome, formation of RNA-binding complex, and subsequent GAIT element-mediated translational silencing. Atherosclerotic plaques from HFD-treated KO mice showed increased infiltration of M1 type inflammatory macrophages. Macrophages from KO mice showed increased phagocytic activity and elevated expression of LDL receptor and pro-inflammatory mediators. NanoString analysis of the plaques from KO mice showed upregulation of a number of mRNAs encoding inflammatory proteins. Bioinformatics analysis suggests the presence of the potential GAIT elements in the 3 ' UTRs of several of these mRNAs. Macrophage induces L13a/GAIT-dependent translational silencing of inflammatory genes in response to HFD as an endogenous defense against atherosclerosis in ApoE(-/-) model.	[Basu, Abhijit; Mazumder, Barsanjit] Cleveland State Univ, Ctr Gene Regulat Hlth & Dis, Dept Biol Geol & Environm Sci, 2399 Euclid Ave,SR 261, Cleveland, OH 44115 USA; [Dvorina, Nina; Baldwin, William M., III] Cleveland Clin, Lerner Coll Med, Dept Inflammat & Immun, Cleveland, OH 44106 USA	University System of Ohio; Cleveland State University; Case Western Reserve University; Cleveland Clinic Foundation	Mazumder, B (corresponding author), Cleveland State Univ, Ctr Gene Regulat Hlth & Dis, Dept Biol Geol & Environm Sci, 2399 Euclid Ave,SR 261, Cleveland, OH 44115 USA.	b.mazumder@csuohio.edu			National Heart, Lung, and Blood Institute (NHLBI) [HL79164]; National Institute of Allergy and Infectious Diseases (NIAID) [AI087586]; Cleveland State University, Center for Gene Regulation in Health and Disease	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Cleveland State University, Center for Gene Regulation in Health and Disease	National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: HL79164; National Institute of Allergy and Infectious Diseases (NIAID), Grant/Award Number: AI087586; Cleveland State University, Center for Gene Regulation in Health and Disease	Aiello RJ, 1999, ARTERIOSCL THROM VAS, V19, P1518, DOI 10.1161/01.ATV.19.6.1518; Averill MM, 2012, ARTERIOSCL THROM VAS, V32, P223, DOI 10.1161/ATVBAHA.111.236927; Basu A, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx979; Basu A, 2014, ARTERIOSCL THROM VAS, V34, P533, DOI 10.1161/ATVBAHA.113.302573; BROWN MS, 1983, ANNU REV BIOCHEM, V52, P223, DOI 10.1146/annurev.bi.52.070183.001255; Chaudhuri S, 2007, RNA, V13, P2224, DOI 10.1261/rna.694007; Chinetti-Gbaguidi G, 2015, NAT REV CARDIOL, V12, P10, DOI 10.1038/nrcardio.2014.173; Doring Y, 2019, CIRCULATION, V139, P1338, DOI 10.1161/CIRCULATIONAHA.118.037953; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; ELLSWORTH JL, 1987, J BIOL CHEM, V262, P2316; Fava C, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00055; Gensel JC, 2017, SCI REP-UK, V7, DOI 10.1038/srep40144; Goel Reema, 2008, Arterioscler Thromb Vasc Biol, V28, P1996, DOI 10.1161/ATVBAHA.108.172270; GOLDSTEIN JL, 1979, P NATL ACAD SCI USA, V76, P333, DOI 10.1073/pnas.76.1.333; Golledge J, 2013, ARTERIOSCL THROM VAS, V33, P670, DOI 10.1161/ATVBAHA.112.301004; Gough PJ, 2006, J CLIN INVEST, V116, P59, DOI 10.1172/JCI25074; Gu L, 1998, MOL CELL, V2, P275, DOI 10.1016/S1097-2765(00)80139-2; Hao NB, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/948098; Havgaard JH, 2007, PLOS COMPUT BIOL, V3, P1896, DOI 10.1371/journal.pcbi.0030193; Havgaard JH, 2005, BIOINFORMATICS, V21, P1815, DOI 10.1093/bioinformatics/bti279; Ionita MG, 2010, ARTERIOSCL THROM VAS, V30, P1842, DOI 10.1161/ATVBAHA.110.209296; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Kapasi P, 2007, MOL CELL, V25, P113, DOI 10.1016/j.molcel.2006.11.028; Khallou-Laschet J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008852; Khyzha N, 2017, TRENDS MOL MED, V23, P332, DOI 10.1016/j.molmed.2017.02.004; KOO C, 1988, J CLIN INVEST, V81, P1332, DOI 10.1172/JCI113460; KOO C, 1986, J BIOL CHEM, V261, P1194; Kruth HS, 2002, J BIOL CHEM, V277, P34573, DOI 10.1074/jbc.M205059200; Leclercq A, 2007, J LEUKOCYTE BIOL, V82, P1420, DOI 10.1189/jlb.1106671; Leitinger N, 2013, ARTERIOSCL THROM VAS, V33, P1120, DOI 10.1161/ATVBAHA.112.300173; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Lin J, 2013, CELL REP, V3, P200, DOI 10.1016/j.celrep.2012.12.012; Maiellaro K, 2007, CARDIOVASC RES, V75, P640, DOI 10.1016/j.cardiores.2007.06.023; Mantovani A, 2009, ARTERIOSCL THROM VAS, V29, P1419, DOI 10.1161/ATVBAHA.108.180497; Mazumder B, 1999, MOL CELL BIOL, V19, P6898; Mazumder B, 2003, CELL, V115, P187, DOI 10.1016/S0092-8674(03)00773-6; Mazumder B, 2001, MOL CELL BIOL, V21, P6440, DOI 10.1128/MCB.21.19.6440-6449.2001; Moore KJ, 2013, NAT REV IMMUNOL, V13, P709, DOI 10.1038/nri3520; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Moore KJ, 2006, ARTERIOSCL THROM VAS, V26, P1702, DOI 10.1161/01.ATV.0000229218.97976.43; Moore KJ, 2005, J CLIN INVEST, V115, P2192, DOI 10.1172/JCI24061; Moos MPW, 2005, ARTERIOSCL THROM VAS, V25, P2386, DOI 10.1161/01.ATV.0000187470.31662.fe; Mukhopadhyay R, 2008, MOL CELL, V32, P371, DOI 10.1016/j.molcel.2008.09.019; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Nachtigal P, 2012, ATHEROSCLEROSIS, V224, P4, DOI 10.1016/j.atherosclerosis.2012.03.001; Naruko T, 2002, CIRCULATION, V106, P2894, DOI 10.1161/01.CIR.0000042674.89762.20; Nawaz A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00231-1; Oberoi R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137924; Ortega-Gomez A, 2013, EMBO MOL MED, V5, P661, DOI 10.1002/emmm.201202382; Poddar D, 2016, CELL MOL IMMUNOL, V13, P816, DOI 10.1038/cmi.2015.53; Poddar D, 2013, J IMMUNOL, V190, P3600, DOI 10.4049/jimmunol.1201933; Radhakrishnan A, 2016, J MOL BIOL, V428, P3558, DOI 10.1016/j.jmb.2016.05.025; Rajamaki K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011765; Ramel D, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01276; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Robbins CS, 2013, NAT MED, V19, P1166, DOI 10.1038/nm.3258; Robinet P, 2018, ARTERIOSCL THROM VAS, V38, P292, DOI 10.1161/ATVBAHA.117.309524; Sampath P, 2004, CELL, V119, P195, DOI 10.1016/j.cell.2004.09.030; Sampath P, 2003, MOL CELL BIOL, V23, P1509, DOI 10.1128/MCB.23.5.1509-1519.2003; Schrijvers DM, 2007, CARDIOVASC RES, V73, P470, DOI 10.1016/j.cardiores.2006.09.005; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Shi JY, 2018, METHODS MOL BIOL, V1784, P263, DOI 10.1007/978-1-4939-7837-3_24; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Soehnlein O, 2012, CIRC RES, V110, P875, DOI 10.1161/CIRCRESAHA.111.257535; Surra JC, 2010, J ATHEROSCLER THROMB, V17, P712; Tabas I, 2013, SCIENCE, V339, P166, DOI 10.1126/science.1230720; Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675; Torarinsson E, 2007, BIOINFORMATICS, V23, P926, DOI 10.1093/bioinformatics/btm049; Vyas K, 2009, MOL CELL BIOL, V29, P458, DOI 10.1128/MCB.00824-08; Wu MD, 2017, BLOOD, V129, P1415, DOI 10.1182/blood-2016-07-692673; Wu Q, ELIFE, V8, P45396; Ye Q, 2014, INFLAMMATION, V37, P555, DOI 10.1007/s10753-013-9769-x; Ye Q, 2009, INFLAMM RES, V58, P809, DOI 10.1007/s00011-009-0052-4; Yurdagul A, 2018, FRONT CARDIOVASC MED, V4, DOI 10.3389/fcvm.2017.00086; Zernecke A, 2010, CARDIOVASC RES, V86, P192, DOI 10.1093/cvr/cvp391	76	1	1	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6888	6906		10.1096/fj.201903119R	http://dx.doi.org/10.1096/fj.201903119R		MAR 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32232901	Bronze, Green Accepted			2022-12-28	WOS:000522487000001
J	Abner, EL; Elahi, FM; Jicha, GA; Mustapic, M; Al-Janabi, O; Kramer, JH; Kapogiannis, D; Goetzl, EJ				Abner, Erin L.; Elahi, Fanny M.; Jicha, Gregory A.; Mustapic, Maja; Al-Janabi, Omar; Kramer, Joel H.; Kapogiannis, Dimitrios; Goetzl, Edward J.			Endothelial-derived plasma exosome proteins in Alzheimer's disease angiopathy	FASEB JOURNAL			English	Article						amyloid; P-tau protein; prion cellular protein; small cerebral vascular disease	SMALL VESSEL DISEASE; CEREBRAL AMYLOID ANGIOPATHY; CEREBROVASCULAR-DISEASE; DEMENTIA; ATHEROSCLEROSIS; ASSOCIATION; EXPRESSION; ARTERIES; TAU	Small cerebral vascular disease (SCeVD) demonstrated by white matter hyperintensity (WMH) on MRI contributes to the development of dementia in Alzheimer's disease (AD), but it has not been possible to correlate onset, severity, or protein components of SCeVD with characteristics of WMH in living patients. Plasma endothelial-derived exosomes (EDEs) were enriched by two-step immunoabsorption from four groups of participants with no clinical evidence of cerebrovascular disease: cognitively normal (CN) without WMH (CN without SCeVD, n = 20), CN with SCeVD (n = 22), preclinical AD (pAD) + mild cognitive impairment (MCI) without SCeVD (pAD/MCI without SCeVD, n = 22), and pAD/MCI with SCeVD (n = 16) for ELISA quantification of cargo proteins. Exosome marker CD81-normalized EDE levels of the cerebrovascular-selective biomarkers large neutral amino acid transporter 1 (LAT-1), glucose transporter type 1 (Glut-1), and permeability-glycoprotein (p-GP, ABCB1) were similarly significantly higher in the CN with SCeVD and pAD/MCI with SCeVD groups than their corresponding control groups without SCeVD. CD81-normalized EDE levels of A beta 40 and A beta 42 were significantly higher in the pAD/MCI with SCeVD group but not in the CN with SCeVD group relative to controls without SCeVD. Levels of normal cellular prion protein (PrPc), a receptor for amyloid peptides, and phospho-181T-tau were higher in both CN and pAD/MCI with SCeVD groups than in the corresponding controls. High EDE levels of A beta 40, A beta 42, and phospho-181T-tau in patients with WMH suggesting SCeVD appear at the pre-clinical or MCI stage of AD and therapeutic lowering of neurotoxic peptide levels may delay progression of AD angiopathy.	[Abner, Erin L.; Jicha, Gregory A.; Al-Janabi, Omar] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; [Abner, Erin L.] Univ Kentucky, Dept Epidemiol, Lexington, KY USA; [Elahi, Fanny M.; Kramer, Joel H.] Univ Calif San Francisco, Dept Neurol, Memory & Aging Ctr, San Francisco, CA USA; [Jicha, Gregory A.] Univ Kentucky, Dept Neurol, Lexington, KY 40536 USA; [Mustapic, Maja; Kapogiannis, Dimitrios] NIA, Cellular & Mol Neurosci Sect, Lab Neurosci, Baltimore, MD 21224 USA; [Goetzl, Edward J.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Goetzl, Edward J.] Campus Jewish Living, San Francisco, CA USA	University of Kentucky; University of Kentucky; University of California System; University of California San Francisco; University of Kentucky; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of California System; University of California San Francisco	Goetzl, EJ (corresponding author), Univ Calif San Francisco, Geriatr Res Ctr, Dept Med, 1719 Broderick St, San Francisco, CA 94115 USA.	edward.goetzl@ucsf.edu	Mustapic, Maja/AAV-3212-2020; Kapogiannis, Dimitrios/AAW-4934-2020	Kapogiannis, Dimitrios/0000-0003-2181-3118; Elahi, Fanny/0000-0003-4663-4992; Mustapic, Maja/0000-0003-0511-2047	NIA-NIH [R01 AG042419, P30 AG028383]	NIA-NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	NIA-NIH, Grant/Award Number: R01 AG042419 and P30 AG028383	Al-Janabi OM, 2018, J ALZHEIMERS DIS, V66, P1095, DOI 10.3233/JAD-180663; Beach TG, 2007, ACTA NEUROPATHOL, V113, P13, DOI 10.1007/s00401-006-0136-y; Blair GW, 2016, J CEREBR BLOOD F MET, V36, P833, DOI 10.1177/0271678X16631756; Boado RJ, 1999, P NATL ACAD SCI USA, V96, P12079, DOI 10.1073/pnas.96.21.12079; Castle AR, 2017, FRONT MOL BIOSCI, V4, DOI 10.3389/fmolb.2017.00019; De Reuck J, 2011, EUR J NEUROL, V18, P913, DOI 10.1111/j.1468-1331.2010.03329.x; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Elahi FM, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00343; Ellis RJ, 1996, NEUROLOGY, V46, P1592, DOI 10.1212/WNL.46.6.1592; Esiri MM, 1999, LANCET, V354, P919, DOI 10.1016/S0140-6736(99)02355-7; Fiandaca MS, 2015, ALZHEIMERS DEMENT, V11, P600, DOI 10.1016/j.jalz.2014.06.008; Freeze WM, 2019, STROKE, V50, P328, DOI 10.1161/STROKEAHA.118.023788; Frey BM, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00238; Goetzl EJ, 2020, J NEUROTRAUM, V37, P382, DOI 10.1089/neu.2019.6711; Goetzl EJ, 2019, FASEB J, V33, P5082, DOI 10.1096/fj.201802319R; Goetzl EJ, 2017, FASEB J, V31, P3689, DOI 10.1096/fj.201700149; Goetzl EJ, 2015, ANN CLIN TRANSL NEUR, V2, P769, DOI 10.1002/acn3.211; Goetzl EJ, 2015, NEUROLOGY, V85, P40, DOI 10.1212/WNL.0000000000001702; Greenberg SM, 2020, NAT REV NEUROL, V16, P30, DOI 10.1038/s41582-019-0281-2; Huang CW, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19387-x; Iturria-Medina Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11934; Jarosz-Griffiths HH, 2019, J BIOL CHEM, V294, P7085, DOI 10.1074/jbc.RA118.005364; Kalaria RN, 2002, CEREBROVASC DIS, V13, P48, DOI 10.1159/000049150; Kramer Joel H, 2003, Cogn Behav Neurol, V16, P211, DOI 10.1097/00146965-200312000-00002; Love S, 2016, ACTA NEUROPATHOL, V131, P645, DOI 10.1007/s00401-015-1522-0; Merlini M, 2016, ACTA NEUROPATHOL, V131, P737, DOI 10.1007/s00401-016-1560-2; Nestor SM, 2017, ALZHEIMERS DEMENT, V13, P749, DOI 10.1016/j.jalz.2016.12.007; Nortley R, 2019, SCIENCE, V365, P250, DOI 10.1126/science.aav9518; Peres R, 2016, J CEREBR BLOOD F MET, V36, P681, DOI 10.1177/0271678X15625352; Roher AE, 2004, STROKE, V35, P2623, DOI 10.1161/01.STR.0000143317.70478.b3; Schelle J, 2019, ANN NEUROL, V86, P561, DOI 10.1002/ana.25562; Schinkel AH, 1999, ADV DRUG DELIVER REV, V36, P179, DOI 10.1016/S0169-409X(98)00085-4; Seidner G, 1998, NAT GENET, V18, P188, DOI 10.1038/ng0298-188; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Smith LM, 2019, J BIOL CHEM, V294, P6042, DOI 10.1074/jbc.RA118.006252; Snowdon DA, 2003, ANN INTERN MED, V139, P450, DOI 10.7326/0003-4819-139-5_Part_2-200309021-00014; Snowdon DA, 1997, JAMA-J AM MED ASSOC, V277, P813, DOI 10.1001/jama.277.10.813; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Traylor M, 2016, ANN NEUROL, V79, P739, DOI 10.1002/ana.24621; Whitehouse IJ, 2010, J ALZHEIMERS DIS, V22, P1023, DOI 10.3233/JAD-2010-101071; Wulf MA, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0375-5; You Y, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0680-z	42	12	13	1	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5967	5974		10.1096/fj.202000034R	http://dx.doi.org/10.1096/fj.202000034R		MAR 2020	8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32157747	Green Accepted			2022-12-28	WOS:000519868100001
J	Campos, JC; Baehr, LM; Ferreira, ND; Bozi, LHM; Andres, AM; Ribeiro, MAC; Gottlieb, RA; Bodine, SC; Ferreira, JCB				Campos, Juliane C.; Baehr, Leslie M.; Ferreira, Nikolas D.; Bozi, Luiz H. M.; Andres, Allen M.; Ribeiro, Marcio A. C.; Gottlieb, Roberta A.; Bodine, Sue C.; Ferreira, Julio C. B.			beta(2)-adrenoceptor activation improves skeletal muscle autophagy in neurogenic myopathy	FASEB JOURNAL			English	Article						G protein-coupled proteins; protein quality control; skeletal muscle diseases; therapy	UBIQUITIN-PROTEASOME; FORMOTEROL; RAT; HYPERTROPHY; DAMAGE; FLUX	beta(2)-adrenoceptor agonists improve autophagy and re-establish proteostasis in cardiac cells; therefore, suggesting autophagy as a downstream effector of beta(2)-adrenoceptor signaling pathway. Here, we used the pharmacological and genetic tools to determine the autophagy effect of sustained beta(2)-adrenoceptor activation in rodents with neurogenic myopathy, which display impaired skeletal muscle autophagic flux. Sustained beta(2)-adrenoceptor activation using Formoterol (10 mu g kg(-1) day(-1)), starting at the onset of neurogenic myopathy, prevents disruption of autophagic flux in skeletal muscle 14 days after sciatic nerve constriction. These changes are followed by reduction of the cytotoxic protein levels and increased skeletal muscle cross-sectional area and contractility properties. Of interest, sustained administration of Formoterol at lower concentration (1 mu g kg(-1) day(-1)) induces similar improvements in skeletal muscle autophagic flux and contractility properties in neurogenic myopathy, without affecting the cross-sectional area. Sustained pharmacological inhibition of autophagy using Chloroquine (50 mg kg(-1) day(-1)) abolishes the beneficial effects of beta(2)-adrenoceptor activation on the skeletal muscle proteostasis and contractility properties in neurogenic myopathy. Further supporting an autophagy mechanism for beta(2)-adrenoceptor activation, skeletal muscle-specific deletion of ATG7 blunts the beneficial effects of beta(2)-adrenoceptor on skeletal muscle proteostasis and contractility properties in neurogenic myopathy in mice. These findings suggest autophagy as a critical downstream effector of beta(2)-adrenoceptor signaling pathway in skeletal muscle.	[Campos, Juliane C.; Ferreira, Nikolas D.; Bozi, Luiz H. M.; Ribeiro, Marcio A. C.; Ferreira, Julio C. B.] Univ Sao Paulo, Inst Biomed Sci, Ave Prof Lineu Prestes 2415, BR-05508000 Sao Paulo, SP, Brazil; [Baehr, Leslie M.; Bodine, Sue C.] Univ Iowa, Dept Internal Med, Div Endocrinol & Metab, Iowa City, IA 52242 USA; [Andres, Allen M.; Gottlieb, Roberta A.] Cedars Sinai Heart Inst, Los Angeles, CA USA; [Andres, Allen M.; Gottlieb, Roberta A.] Cedars Sinai Med Ctr, Barbra Streisand Womens Heart Ctr, Los Angeles, CA 90048 USA; [Ferreira, Julio C. B.] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA	Universidade de Sao Paulo; University of Iowa; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Stanford University	Ferreira, JCB (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Ave Prof Lineu Prestes 2415, BR-05508000 Sao Paulo, SP, Brazil.	juliof@stanford.edu	Bozi, Luiz H M/K-5259-2012; Campos, Juliane/G-5997-2014; Ferreira, Julio Cesar Batista/AEU-0494-2022; Ferreira, Julio Cesar Batista/I-3177-2012; Bozi, Luiz/AAT-6126-2020; Ferreira, Julio/L-4687-2019	Bozi, Luiz H M/0000-0002-5698-1181; Campos, Juliane/0000-0003-0075-7209; Ferreira, Julio Cesar Batista/0000-0003-2694-239X; Ferreira, Julio Cesar Batista/0000-0003-2694-239X; Ribeiro, Marcio/0000-0002-8431-4968	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2012/14416-1, 2016/01633-5, 2017/16540-5, 2015/207835, 2015/50429-9, 2017/16694-2, 2018/18627-3]; MCTI | Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [407743/2018-9, 307934/20187, 303281/2015-4, 407306/2013-7]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [001]; Instituto Nacional de Ciencia e Tecnologia de Processos Redox em Biomedicina (INCT Redoxoma)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); MCTI | Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Instituto Nacional de Ciencia e Tecnologia de Processos Redox em Biomedicina (INCT Redoxoma)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Grant/Award Number: #2012/14416-1, #2016/01633-5 and #2017/16540-5 and #2015/207835, #2015/50429-9, #2017/16694-2 and #2018/18627-3; MCTI | Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Grant/Award Number: #407743/2018-9, #307934/20187, #303281/2015-4 and #407306/2013-7; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Grant/Award Number: Finance Code 001; Instituto Nacional de Ciencia e Tecnologia de Processos Redox em Biomedicina (INCT Redoxoma)	[Anonymous], 2016, J PHYSIOL-LONDON, DOI DOI 10.1113/JPHYSIOL.2014.282665; Aranguiz-Urroz P, 2011, BBA-MOL BASIS DIS, V1812, P23, DOI 10.1016/j.bbadis.2010.07.003; Asai M, 2009, J MOL CELL CARDIOL, V46, P452, DOI 10.1016/j.yjmcc.2008.11.001; Gomez-SanMiguel AB, 2016, AM J PHYSIOL-ENDOC M, V310, pE925, DOI 10.1152/ajpendo.00503.2015; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Brum PC, 2011, BRAZ J MED BIOL RES, V44, P827, DOI 10.1590/S0100-879X2011000900002; Brundtland GH, 2003, WHO TECH REP SER, V919, P1; Campos JC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30365-1; Campos JC, 2017, AUTOPHAGY, V13, P1304, DOI 10.1080/15548627.2017.1325062; Cunha TF, 2017, J APPL PHYSIOL, V122, P817, DOI 10.1152/japplphysiol.00182.2016; Cunha TF, 2012, J APPL PHYSIOL, V112, P1839, DOI 10.1152/japplphysiol.00346.2011; Ferreira JCB, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08276-6; Ferreira JCB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033175; Ferreira JCB, 2011, LIFE SCI, V88, P578, DOI 10.1016/j.lfs.2011.01.009; Ferreira JCB, 2010, EXP BIOL MED, V235, P497, DOI 10.1258/ebm.2009.009165; Glabe CG, 2004, TRENDS BIOCHEM SCI, V29, P542, DOI 10.1016/j.tibs.2004.08.009; Gomes KMS, 2014, CARDIOVASC RES, V103, P498, DOI 10.1093/cvr/cvu125; Goncalves DA, 2019, J CACHEXIA SARCOPENI, V10, P455, DOI 10.1002/jcsm.12395; Goodman CA, 2011, FASEB J, V25, P1028, DOI 10.1096/fj.10-168799; Grumati P, 2011, AUTOPHAGY, V7, P1415, DOI 10.4161/auto.7.12.17877; Hashem SI, 2017, J MOL CELL CARDIOL, V108, P86, DOI 10.1016/j.yjmcc.2017.05.007; Joassard OR, 2013, INT J BIOCHEM CELL B, V45, P2444, DOI 10.1016/j.biocel.2013.07.019; Ju JS, 2010, AUTOPHAGY, V6, P929, DOI 10.4161/auto.6.7.12785; Kadir R, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005919; Kline WO, 2007, J APPL PHYSIOL, V102, P740, DOI 10.1152/japplphysiol.00873.2006; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Lynch GS, 2008, PHYSIOL REV, V88, P729, DOI 10.1152/physrev.00028.2007; Ma XC, 2012, AUTOPHAGY, V8, P1394, DOI 10.4161/auto.21036; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; Mauthe M, 2018, AUTOPHAGY, V14, P1435, DOI 10.1080/15548627.2018.1474314; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Montuschi P, 2016, DRUG DISCOV TODAY, V21, P1820, DOI 10.1016/j.drudis.2016.07.009; Nalbandian A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122888; Nath S, 2014, NAT CELL BIOL, V16, P415, DOI 10.1038/ncb2940; PREEDY VR, 1983, BRIT J NUTR, V49, P517, DOI 10.1079/BJN19830060; Ramesh M, 2019, FASEB J, V33, P11857, DOI 10.1096/fj.201900807RR; Ryall JG, 2006, BRIT J PHARMACOL, V147, P587, DOI 10.1038/sj.bjp.0706669; Ryall JG, 2004, J PHYSIOL-LONDON, V555, P175, DOI 10.1113/jphysiol.2003.056770; Salazar-Degracia A, 2018, BIOCHIMIE, V149, P79, DOI 10.1016/j.biochi.2018.04.009; Shen A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03459-7; Sleeper MM, 2002, MED SCI SPORT EXER, V34, P643, DOI 10.1097/00005768-200204000-00013; SOLISCOHEN S, 1990, J ASTHMA, V27, P401, DOI 10.3109/02770909009073358; Souccar C, 2005, NEUROMUSCULAR DISORD, V15, P48, DOI 10.1016/j.nmd.2004.10.010; Sun YT, 2007, EMBO J, V26, P53, DOI 10.1038/sj.emboj.7601502; Ueta CB, 2018, CARDIOVASC RES, V114, P1006, DOI 10.1093/cvr/cvy070; Wang L, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.237; WATERLOW JC, 1984, Q J EXP PHYSIOL CMS, V69, P409, DOI 10.1113/expphysiol.1984.sp002829; Xiang Y, 2003, SCIENCE, V300, P1530, DOI 10.1126/science.1079206; Zhang FX, 2007, J BIOL CHEM, V282, P22460, DOI 10.1074/jbc.M702439200	50	7	7	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5628	5641		10.1096/fj.201902305R	http://dx.doi.org/10.1096/fj.201902305R		FEB 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32112488	Bronze			2022-12-28	WOS:000517910500001
J	Wang, CJ; Liu, QH; Huang, M; Zhou, QH; Zhang, XY; Zhang, JT; Xie, RH; Yu, YQ; Chen, S; Fan, JB; Chen, X				Wang, Chanjuan; Liu, Qinghua; Huang, Ming; Zhou, Qianghua; Zhang, Xiaoyu; Zhang, Jingtong; Xie, Ruihui; Yu, Yanqi; Chen, Shang; Fan, Jianbing; Chen, Xu			Loss of GATA6 expression promotes lymphatic metastasis in bladder cancer	FASEB JOURNAL			English	Article						bladder cancer; GATA6; lymphangiogenesis; metastasis; VEGF-C	GROWTH FACTOR-C; RADICAL CYSTECTOMY; VEGF-C; BREAST-CANCER; LYMPHANGIOGENESIS; METHYLATION; ANGIOGENESIS; CELLS; DNA	Lymph node metastasis is associated with tumor relapse and poor patient prognosis in bladder cancer. However, the mechanisms by which bladder carcinoma cells induce lymphangiogenesis and further promote metastasis in the lymphatic system remain unclear. Here, we show that the transcription factor GATA-binding factor 6 (GATA6) was substantially downregulated in bladder cancer via promoter hypermethylation. Low-level GATA6 expression significantly correlated with lymph node metastasis positivity and was able to predict earlier relapse and shorter survival of bladder cancer. Reconstitution of GATA6 inhibited lymphangiogenesis and lymph node metastasis in GATA6-low bladder cancer cells, while silencing of GATA6 rendered lymphatic metastasis in GATA6-high bladder cancer cells. Additionally, we demonstrated that GATA6 bound to the promoter of vascular endothelial growth factor (VEGF)-C, a lymphangiogenic factor, and acted as a transcriptional repressor. This GATA6/VEGF-C axis was essential for GATA6-mediated lymphatic metastasis. In bladder cancer patients, low GATA6 correlated with high VEGF-C and reduced overall survival. These findings indicate GATA6 as a pivotal regulator in the lymphatic dissemination of bladder cancer and suggest a new therapeutic target for the disease.	[Wang, Chanjuan; Zhang, Xiaoyu; Yu, Yanqi; Chen, Shang; Fan, Jianbing] Southern Med Univ, Sch Basic Med Sci, Dept Pathol, Guangzhou, Peoples R China; [Liu, Qinghua] Sun Yat Sen Univ, Dept Expt Res, Ctr Canc, Guangzhou, Peoples R China; [Huang, Ming; Zhou, Qianghua; Zhang, Jingtong; Xie, Ruihui; Chen, Xu] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Urol, Guangzhou 510120, Peoples R China; [Chen, Xu] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Guangzhou, Peoples R China	Southern Medical University - China; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Chen, X (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Urol, Guangzhou 510120, Peoples R China.; Fan, JB (corresponding author), Southern Med Univ, Dept Pathol, Guangzhou 510515, Peoples R China.	jianbingfan1115@smu.edu.cn; chenx457@mail.sysu.edu.cn	Zhang, xiaoyu/GXA-3206-2022	Chen, Xu/0000-0002-8425-036X	National Natural Science Foundation of China (NSFC) [81702523]; National Key Research and Development Program of China [2017YFC1309002]; Science and Technology Planning Project of Guangdong Province, China [2017B020226005]; Guangzhou Science and Technology Program key projects [201804010041]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Science and Technology Planning Project of Guangdong Province, China; Guangzhou Science and Technology Program key projects	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81702523; National Key Research and Development Program of China, Grant/Award Number: 2017YFC1309002; Science and Technology Planning Project of Guangdong Province, China, Grant/Award Number: 2017B020226005; Guangzhou Science and Technology Program key projects, Grant/Award Number: 201804010041	Achen MG, 2006, BRIT J CANCER, V94, P1355, DOI 10.1038/sj.bjc.6603120; Achen MG, 1998, P NATL ACAD SCI USA, V95, P548, DOI 10.1073/pnas.95.2.548; Amioka T, 2002, EUR J CANCER, V38, P1413, DOI 10.1016/S0959-8049(02)00106-5; [Anonymous], 2017, BJU INT, V120, P755, DOI [10.1111/bju.14045, DOI 10.1111/BJU.14045]; Berdik C, 2017, NATURE, V551, pS34, DOI 10.1038/551S34a; Capo-Chichi CD, 2009, MOL CELL BIOL, V29, P4766, DOI 10.1128/MCB.00087-09; Carrasco M, 2012, J CLIN INVEST, V122, P3504, DOI 10.1172/JCI63240; Chen X, 2019, CLIN CANCER RES, V25, P1389, DOI 10.1158/1078-0432.CCR-18-1656; Chen ZY, 2019, MOL THER, V27, P326, DOI 10.1016/j.ymthe.2018.12.015; Cheung WKC, 2013, CANCER CELL, V23, P725, DOI 10.1016/j.ccr.2013.04.009; De Carvalho DD, 2012, CANCER CELL, V21, P655, DOI 10.1016/j.ccr.2012.03.045; Dorin RP, 2011, EUR UROL, V60, P946, DOI 10.1016/j.eururo.2011.07.012; Faleiro I, 2017, ONCOTARGET, V8, P12484, DOI 10.18632/oncotarget.14226; Gu P, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1037-8; He W, 2018, J CLIN INVEST, V128, P861, DOI 10.1172/JCI96218; Hoque MO, 2006, JNCI-J NATL CANCER I, V98, P996, DOI 10.1093/jnci/djj265; Jeltsch M, 1997, SCIENCE, V276, P1423, DOI 10.1126/science.276.5317.1423; Jia YT, 2004, WORLD J GASTROENTERO, V10, P3261, DOI 10.3748/wjg.v10.i22.3261; Kandimalla R, 2012, EUR UROL, V61, P1245, DOI 10.1016/j.eururo.2012.01.011; Kluth LA, 2015, EUR UROL, V68, P238, DOI 10.1016/j.eururo.2015.01.032; Li QC, 2003, CHINESE MED J-PEKING, V116, P727; Liao CM, 2018, J CLIN INVEST, V128, P2944, DOI 10.1172/JCI96539; Liu H, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-018-1270-x; Mandriota SJ, 2001, EMBO J, V20, P672, DOI 10.1093/emboj/20.4.672; Martinelli P, 2017, GUT, V66, P1665, DOI 10.1136/gutjnl-2015-311256; Martinelli P, 2016, GUT, V65, P476, DOI 10.1136/gutjnl-2014-308042; May M, 2011, EUR UROL, V59, P712, DOI 10.1016/j.eururo.2011.01.030; Ding MX, 2006, WORLD J GASTROENTERO, V12, P4582, DOI 10.3748/wjg.v12.i28.4582; Miyata Y, 2006, CLIN CANCER RES, V12, P800, DOI 10.1158/1078-0432.CCR-05-1284; Nebbioso A, 2012, MOL ONCOL, V6, P657, DOI 10.1016/j.molonc.2012.09.004; Perera M, 2018, NAT REV UROL, V15, P686, DOI 10.1038/s41585-018-0066-1; Skobe M, 2001, NAT MED, V7, P192, DOI 10.1038/84643; Song YC, 2015, EXP MOL PATHOL, V99, P617, DOI 10.1016/j.yexmp.2015.10.005; Stacker SA, 2001, NAT MED, V7, P186, DOI 10.1038/84635; Stacker SA, 2002, NAT REV CANCER, V2, P573, DOI 10.1038/nrc863; Stacker SA, 2014, NAT REV CANCER, V14, P159, DOI 10.1038/nrc3677; Stein JP, 2001, J CLIN ONCOL, V19, P666, DOI 10.1200/JCO.2001.19.3.666; Tan HW, 2019, INT J CANCER, V145, P1860, DOI 10.1002/ijc.32248; Tarin TV, 2012, EUR UROL, V61, P1025, DOI 10.1016/j.eururo.2012.01.049; Whissell G, 2014, NAT CELL BIOL, V16, P695, DOI 10.1038/ncb2992; Zhao XD, 2018, FUTURE ONCOL, V14, P1741, DOI 10.2217/fon-2018-0064	41	12	12	2	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5754	5766		10.1096/fj.201903176R	http://dx.doi.org/10.1096/fj.201903176R		FEB 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32103545	Bronze			2022-12-28	WOS:000517906700001
J	Liu, J; Yu, CL; Doherty, TM; Akbari, O; Allard, P; Rehan, VK				Liu, Jie; Yu, Celia; Doherty, Terence M.; Akbari, Omid; Allard, Patrick; Rehan, Virender K.			Perinatal nicotine exposure-induced transgenerational asthma: Effects of reexposure in F1 gestation	FASEB JOURNAL			English	Article						cigarette smoke; epigenetics; pregnancy; methylation; multigenerational	EPIGENETIC INHERITANCE; MATERNAL SMOKING; TOBACCO SMOKING; TRANSMISSION; FETAL; PATTERNS	In a rat model, perinatal nicotine exposure results in an epigenetically driven multi- and trans-generationally transmitted asthmatic phenotype that tends to wane over successive generations. However, the effect of repeat nicotine exposure during the F1 (Filial 1) gestational period on the transmitted phenotype is unknown. Using a well-established rat model, we compared lung function, mesenchymal markers of airway reactivity, and global gonadal DNA methylation changes in F2 offspring in a sex-specific manner following perinatal exposure to nicotine in only the F0 gestation, in both F0 and F1 (F0/F1) gestations, and in neither (control group). Both F0 only and F0/F1 exposure groups showed an asthmatic phenotype, an effect that was more pronounced in the F0/F1 exposure group, especially in males. Testicular global DNA methylation increased, while ovarian global DNA methylation decreased in the F0/F1 exposed group. Since the offspring of smokers are more likely to smoke than the offspring of nonsmokers, this sets the stage for more severe asthma if both mother and grandmother had smoked during their pregnancies. Increased gonadal DNA methylation changes following nicotine reexposure in the F1 generation suggests that epigenetic mechanisms might well underlie the transgenerational inheritance of acquired phenotypic traits in general and nicotine-induced asthma in particular.	[Liu, Jie; Rehan, Virender K.] Harbor UCLA Med Ctr, Dept Pediat, Lundquist Inst Biomed Innovat, 1124 W Carson St, Torrance, CA 90502 USA; [Yu, Celia; Doherty, Terence M.] Harbor UCLA Med Ctr, Lundquist Inst Biomed Innovat, Torrance, CA 90502 USA; [Akbari, Omid] USC, Dept Mol Microbiol & Immunol, Keck Sch Med, Los Angeles, CA USA; [Allard, Patrick; Rehan, Virender K.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Allard, Patrick; Rehan, Virender K.] Univ Calif Los Angeles, Inst Soc & Genet, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of Southern California; University of Southern California Keck Hospital; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Rehan, VK (corresponding author), Harbor UCLA Med Ctr, Dept Pediat, Lundquist Inst Biomed Innovat, 1124 W Carson St, Torrance, CA 90502 USA.	vrehan@lundquist.org		Allard, Patrick/0000-0001-7765-1547	NIH [HL127137, HD071731, HL151769]; TRDRP [23RT-0018, 27IP-0050, T29IR0737]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); TRDRP	HL127137, HD071731, and HL151769 from the NIH and 23RT-0018, 27IP-0050, and T29IR0737 from the TRDRP	Accordini S, 2018, INT J EPIDEMIOL, V47, P1106, DOI 10.1093/ije/dyy031; Alberg AJ, 2014, AM J EPIDEMIOL, V179, P403, DOI 10.1093/aje/kwt335; BASSI JA, 1984, PEDIATR RES, V18, P127, DOI 10.1203/00006450-198402000-00002; Chen Q, 2016, NAT REV GENET, V17, P733, DOI 10.1038/nrg.2016.106; COLLINS MH, 1985, PEDIATR RES, V19, P408, DOI 10.1203/00006450-198519040-00018; Daxinger L, 2012, NAT REV GENET, V13, P153, DOI 10.1038/nrg3188; Dias BG, 2014, NAT NEUROSCI, V17, P89, DOI 10.1038/nn.3594; Dunn GA, 2011, ENDOCRINOLOGY, V152, P2228, DOI 10.1210/en.2010-1461; Erickson AC, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-102; Gilman SE, 2009, PEDIATRICS, V123, pE274, DOI 10.1542/peds.2008-2251; Gregory DJ, 2017, AM J PHYSIOL-LUNG C, V313, pL395, DOI 10.1152/ajplung.00035.2017; Heard E, 2014, CELL, V157, P95, DOI 10.1016/j.cell.2014.02.045; Holloway AC, 2006, ENDOCRINE, V30, P213, DOI 10.1385/ENDO:30:2:213; Iqbal K, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0619-z; Kahr MK, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2586-4; Kandel DB, 2015, AM J PUBLIC HEALTH, V105, pE63, DOI 10.2105/AJPH.2015.302775; Knudsen TM, 2018, J ALLERGY CLIN IMMUN, V142, P765, DOI [10.1016/j.jaci..2018.07.007, 10.1016/j.jaci.2018.07.007]; Li YF, 2005, CHEST, V127, P1232, DOI 10.1378/chest.127.4.1232; Liu J, 2015, AM J PHYSIOL-LUNG C, V308, pL788, DOI 10.1152/ajplung.00234.2014; Liu J, 2013, AM J RESP CELL MOL, V48, P53, DOI 10.1165/rcmb.2011-0344OC; Magnus MC, 2015, THORAX, V70, P237, DOI 10.1136/thoraxjnl-2014-206438; Maritz GS, 2011, INT J ENV RES PUB HE, V8, P875, DOI 10.3390/ijerph8030875; MARITZ GS, 1992, S AFR MED J, V81, P517; Martinez FD, 2016, NEW ENGL J MED, V375, P871, DOI 10.1056/NEJMra1603287; Matta SG, 2007, PSYCHOPHARMACOLOGY, V190, P269, DOI 10.1007/s00213-006-0441-0; McEvoy CT, 2017, PAEDIATR RESPIR REV, V21, P27, DOI 10.1016/j.prrv.2016.08.005; Melchior M, 2010, DRUG ALCOHOL DEPEN, V107, P257, DOI 10.1016/j.drugalcdep.2009.10.016; MONK M, 1987, DEVELOPMENT, V99, P371; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; Nguyen KH, 2016, PREV CHRONIC DIS, V13, DOI 10.5888/pcd13.160349; Pierce RA, 2002, AM J RESP CELL MOL, V26, P10, DOI 10.1165/ajrcmb.26.1.f225; Rehan VK, 2013, AM J PHYSIOL-LUNG C, V305, pL501, DOI 10.1152/ajplung.00078.2013; Rehan VK, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-129; Rehan VK, 2009, LUNG, V187, P281, DOI 10.1007/s00408-009-9158-2; Sekhon HS, 2001, AM J RESP CRIT CARE, V164, P989, DOI 10.1164/ajrccm.164.6.2011097; Seong KH, 2011, CELL, V145, P1049, DOI 10.1016/j.cell.2011.05.029; Singh SP, 2017, J IMMUNOL, V198, P3815, DOI 10.4049/jimmunol.1700014; Stoddard J, 1997, AM J PUBLIC HEALTH, V87, P205, DOI 10.2105/AJPH.87.2.205; Tong V. T., 2013, MMWR-MORBID MORTAL W, V62, P1	39	3	3	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					11444	11459		10.1096/fj.201902386R	http://dx.doi.org/10.1096/fj.201902386R		JUL 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32654256	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000549275000001
J	Shi, JP; Li, J				Shi, Jinping; Li, Juan			Neutrophil-targeted engineered prodrug nanoparticles for anti-inflammation	FASEB JOURNAL			English	Editorial Material						anti-inflammation; brain stroke; drug delivery; immune response; neutrophil; sepsis		Inflammation response is a defense to infection induced by invading pathogen or tissue injury. However, exaggerated inflammation may cause autoimmune or inflammatory disorders, such as acute respiratory distress syndrome, sepsis, stroke and rheumatoid arthritis. Anti-inflammatory agents and anti-cytokine therapy have been developed to inhibit inflammation pathways and neutralize cytokine storm, but the off-targeting delivery and damage in immune system cause systemic severe side-effect. Selective targeting, precise intracellular drug delivery and induced programed apoptosis of neutrophils may be a potential strategy to regulate the inflammatory responses for immune homeostasis. In this commentary, we summarized that the assembled engineering prodrug nanoparticles carrying doxorubicin via pH-responsive bonds that specifically target to and efficiently induce the apoptosis of activated neutrophils for anti-inflammation with high therapeutic efficacy and no systemically toxicity could be a promising strategy for neutrophil-mediated diseases.	[Shi, Jinping; Li, Juan] Beijing Inst Technol, Adv Res Inst Multidisciplinary Sci, Beijing 100081, Peoples R China	Beijing Institute of Technology	Li, J (corresponding author), Beijing Inst Technol, Adv Res Inst Multidisciplinary Sci, Beijing 100081, Peoples R China.	jli@bit.edu.cn			National Natural Science Foundation of China (NSFC) [21902012]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 21902012	Becher B, 2017, NAT REV IMMUNOL, V17, P49, DOI 10.1038/nri.2016.123; Cartwright JA, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00055; Dinarello CA, 2010, CELL, V140, P935, DOI 10.1016/j.cell.2010.02.043; Jaeger BN, 2012, J EXP MED, V209, P565, DOI 10.1084/jem.20111908; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Kotzin JJ, 2016, NATURE, V537, P239, DOI 10.1038/nature19346; Nauseef WM, 2014, NAT IMMUNOL, V15, P602, DOI 10.1038/ni.2921; Sekheri M, 2020, P NATL ACAD SCI USA, V117, P7971, DOI 10.1073/pnas.1920193117; Soehnlein O, 2017, NAT REV IMMUNOL, V17, P248, DOI 10.1038/nri.2017.10; Wang ZJ, 2014, NAT NANOTECHNOL, V9, P204, DOI [10.1038/NNANO.2014.17, 10.1038/nnano.2014.17]; Zhang CY, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax7964	11	3	3	3	23	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					9828	9831		10.1096/fj.202000978RR	http://dx.doi.org/10.1096/fj.202000978RR		JUL 2020	4	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32614469				2022-12-28	WOS:000547288800001
J	Cascarina, SM; Ross, ED				Cascarina, Sean M.; Ross, Eric D.			A proposed role for the SARS-CoV-2 nucleocapsid protein in the formation and regulation of biomolecular condensates	FASEB JOURNAL			English	Article						enveloped viruses; liquid-liquid phase separation; low-complexity domain; stress granule; viral capsid	LIQUID-PHASE-SEPARATION; HOST GENE-EXPRESSION; SARS-CORONAVIRUS; STRESS GRANULES; VIRUS-REPLICATION; INNATE IMMUNITY; NSP1; INTERFERON; INHIBITOR; PATHWAY	To date, the recently discovered SARS-CoV-2 virus has afflicted >6.9 million people worldwide and disrupted the global economy. Development of effective vaccines or treatments for SARS-CoV-2 infection will be aided by a molecular-level understanding of SARS-CoV-2 proteins and their interactions with host cell proteins. The SARS-CoV-2 nucleocapsid (N) protein is highly homologous to the N protein of SARS-CoV, which is essential for viral RNA replication and packaging into new virions. Emerging models indicate that nucleocapsid proteins of other viruses can form biomolecular condensates to spatiotemporally regulate N protein localization and function. Our bioinformatic analyses, in combination with pre-existing experimental evidence, suggest that the SARS-CoV-2 N protein is capable of forming or regulating biomolecular condensates in vivo by interaction with RNA and key host cell proteins. We discuss multiple models, whereby the N protein of SARS-CoV-2 may harness this activity to regulate viral life cycle and host cell response to viral infection.	[Cascarina, Sean M.; Ross, Eric D.] Colorado State Univ, Dept Biochem & Mol Biol, 1870 Campus Delivery, Ft Collins, CO 80523 USA	Colorado State University	Ross, ED (corresponding author), Colorado State Univ, Dept Biochem & Mol Biol, 1870 Campus Delivery, Ft Collins, CO 80523 USA.	Eric.Ross@colostate.edu		Cascarina, Sean/0000-0002-3054-2332	HHS \ NIH \ National Institute of General Medical Sciences (NIGMS) [R35GM130352]	HHS \ NIH \ National Institute of General Medical Sciences (NIGMS)	HHS vertical bar NIH vertical bar National Institute of General Medical Sciences (NIGMS), Grant/Award Number: R35GM130352	Alberti S, 2019, ANNU REV GENET, V53, P171, DOI 10.1146/annurev-genet-112618-043527; Alenquer M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09549-4; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Blanco-Melo D, 2020, CELL, V181, P1036, DOI 10.1016/j.cell.2020.04.026; Bolognesi B, 2016, CELL REP, V16, P222, DOI 10.1016/j.celrep.2016.05.076; Brocard M, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008250; Burke JM, 2020, J BIOL CHEM, V295, P1426, DOI 10.1074/jbc.RA119.011638; Cascarina SM, 2020, PLOS COMPUT BIOL, V16, DOI [10.1371/journal.pcbi.1007487, 10.1371/journal.pcbi.1007487.r001, 10.1371/journal.pcbi.1007487.r002, 10.1371/journal.pcbi.1007487.r003, 10.1371/journal.pcbi.1007487.r004]; Cascarina SM, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006256; Case LB, 2019, SCIENCE, V363, P1093, DOI 10.1126/science.aau6313; Chan CP, 2006, J VIROL, V80, P9279, DOI 10.1128/JVI.00659-06; Chan JFW, 2020, EMERG MICROBES INFEC, V9, P221, DOI 10.1080/22221751.2020.1719902; Chang CN, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0061196, 10.1371/journal.pone.0065045]; Chen CY, 2007, J MOL BIOL, V368, P1075, DOI 10.1016/j.jmb.2007.02.069; Cid-Samper F, 2018, CELL REP, V25, P3422, DOI 10.1016/j.celrep.2018.11.076; Cui L, 2015, J VIROL, V89, P9029, DOI 10.1128/JVI.01331-15; Dang YJ, 2006, J BIOL CHEM, V281, P32870, DOI 10.1074/jbc.M606149200; Devaraj SG, 2007, J BIOL CHEM, V282, P32208, DOI 10.1074/jbc.M704870200; FIOL CJ, 1987, J BIOL CHEM, V262, P14042; Fukuhara T, 2006, P NATL ACAD SCI USA, V103, P11329, DOI 10.1073/pnas.0604616103; Gaete-Argel A, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00336; Goldstein SA, 2017, J VIROL, V91, DOI 10.1128/JVI.02201-16; Gordon DE, 2020, NATURE, V583, P459, DOI 10.1038/s41586-020-2286-9; Grifoni A, 2020, CELL HOST MICROBE, V27, P671, DOI 10.1016/j.chom.2020.03.002; Guillen-Boixet J, 2020, CELL, V181, P346, DOI 10.1016/j.cell.2020.03.049; Guseva S, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz7095; Hackbart M, 2020, P NATL ACAD SCI USA, V117, P8094, DOI 10.1073/pnas.1921485117; Hatcher JM, 2018, CELL CHEM BIOL, V25, P460, DOI 10.1016/j.chembiol.2018.01.013; Heger-Stevic J, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007488; Heinrich BS, 2018, MBIO, V9, DOI 10.1128/mBio.02290-17; Hernandez-Vega A, 2017, CELL REP, V20, P2304, DOI 10.1016/j.celrep.2017.08.042; Hosmillo M, 2019, ELIFE, V8, DOI 10.7554/eLife.46681; Hou SM, 2017, J VIROL, V91, DOI 10.1128/JVI.00474-17; Hu Y, 2017, J VIROL, V91, DOI 10.1128/JVI.02143-16; Huang C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002433; Hur S, 2019, ANNU REV IMMUNOL, V37, P349, DOI 10.1146/annurev-immunol-042718-041356; Kamitani W, 2006, P NATL ACAD SCI USA, V103, P12885, DOI 10.1073/pnas.0603144103; Kamitani W, 2009, NAT STRUCT MOL BIOL, V16, P1134, DOI 10.1038/nsmb.1680; Kang SS, 2020, ACTA PHARM SIN B, V10, P1228, DOI 10.1016/j.apsb.2020.04.009; Karakama Y, 2010, ANTIMICROB AGENTS CH, V54, P3179, DOI 10.1128/AAC.00113-10; Khaperskyy DA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004217; Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922; Kim SSY, 2019, J BIOL CHEM, V294, P6430, DOI 10.1074/jbc.RA118.005868; Kopecky-Bromberg SA, 2007, J VIROL, V81, P548, DOI 10.1128/JVI.01782-06; Krahling V, 2009, J VIROL, V83, P2298, DOI 10.1128/JVI.01245-08; Law LMJ, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007798; Li D, 2020, APPL COMPOS MATER, V27, P1, DOI 10.1007/s10443-019-09791-5; Liu GQ, 2019, J VIROL, V93, DOI 10.1128/JVI.02299-18; Lokugamage KG, 2012, J VIROL, V86, P13598, DOI 10.1128/JVI.01958-12; Luo HB, 2005, FEBS LETT, V579, P2623, DOI 10.1016/j.febslet.2005.03.080; Manivannan P, 2020, J VIROL, V94, DOI 10.1128/JVI.00205-20; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; McBride R, 2014, VIRUSES-BASEL, V6, P2991, DOI 10.3390/v6082991; McSwiggen DT, 2019, ELIFE, V8, DOI 10.7554/eLife.47098; Monette A, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.03.084; Mu JF, 2020, SCI CHINA LIFE SCI, V63, P1413, DOI 10.1007/s11427-020-1692-1; Nakagawa K, 2018, J VIROL, V92, DOI 10.1128/JVI.00902-18; Narayananj K, 2008, J VIROL, V82, P4471, DOI 10.1128/JVI.02472-07; Neuman BW, 2006, J VIROL, V80, P7918, DOI 10.1128/JVI.00645-06; Ng CS, 2013, J VIROL, V87, P9511, DOI 10.1128/JVI.03248-12; Nikolic J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00102-9; Oh SW, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005444; Onomoto K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043031; Pakos-Zebrucka K, 2016, EMBO REP, V17, P1374, DOI 10.15252/embr.201642195; Peng TY, 2008, FEBS J, V275, P4152, DOI 10.1111/j.1742-4658.2008.06564.x; Piotrowska J, 2010, J VIROL, V84, P3654, DOI 10.1128/JVI.01320-09; Prescott EL, 2014, J VIROL, V88, P12599, DOI 10.1128/JVI.02029-14; Raaben M, 2007, CELL MICROBIOL, V9, P2218, DOI 10.1111/j.1462-5822.2007.00951.x; Rabouw HH, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005982; Reineke LC, 2015, MBIO, V6, DOI 10.1128/mBio.02486-14; Reineke LC, 2015, J VIROL, V89, P2575, DOI 10.1128/JVI.02791-14; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; Rozelle DK, 2014, MOL CELL BIOL, V34, P2003, DOI 10.1128/MCB.01630-13; Sanders DW, 2020, CELL, V181, P306, DOI 10.1016/j.cell.2020.03.050; Scholte FEM, 2015, J VIROL, V89, P4457, DOI 10.1128/JVI.03612-14; Shattuck JE, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11550-w; Simpson-Holley M, 2011, J VIROL, V85, P1581, DOI 10.1128/JVI.02247-10; Slaine PD, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9120388; Sola I, 2011, J VIROL, V85, P5136, DOI 10.1128/JVI.00195-11; Spiegel M, 2005, J VIROL, V79, P2079, DOI 10.1128/JVI.79.4.2079-2086.2005; Takamatsu Y, 2020, MBIO, V11, DOI 10.1128/mBio.02565-19; Tauber D, 2020, CELL, V180, P411, DOI 10.1016/j.cell.2019.12.031; Vernon RM, 2018, ELIFE, V7, DOI 10.7554/eLife.31486; Wang J, 2018, CELL, V174, P688, DOI 10.1016/j.cell.2018.06.006; Wathelet MG, 2007, J VIROL, V81, P11620, DOI 10.1128/JVI.00702-07; Weirich KL, 2017, P NATL ACAD SCI USA, V114, P2131, DOI 10.1073/pnas.1616133114; Wong HH, 2018, VIROLOGY, V515, P165, DOI 10.1016/j.virol.2017.12.028; Wu CH, 2009, J BIOL CHEM, V284, P5229, DOI 10.1074/jbc.M805747200; Yang PG, 2020, CELL, V181, P325, DOI 10.1016/j.cell.2020.03.046; Yoo JS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004012; Zhao L, 2012, CELL HOST MICROBE, V11, P607, DOI 10.1016/j.chom.2012.04.011; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	92	58	59	0	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					9832	9842		10.1096/fj.202001351	http://dx.doi.org/10.1096/fj.202001351		JUN 2020	11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32562316	Green Published			2022-12-28	WOS:000541814300001
J	Natali, EN; Principato, S; Ferlicca, F; Bianchi, F; Fontana, LE; Faleri, A; Pansegrau, W; Lo Surdo, P; Bartohai, E; Santini, L; Brune, B; Giusti, F; Veggi, D; Ferlenghi, I; Norais, N; Scarselli, M				Natali, Eriberto Noel; Principato, Silvia; Ferlicca, Francesca; Bianchi, Federica; Fontana, Lucia Eleonora; Faleri, Agnese; Pansegrau, Werner; Lo Surdo, Paola; Bartohai, Erika; Santini, Laura; Brune, Brunelia; Giusti, Fabiola; Veggi, Daniele; Ferlenghi, Ilaria; Norais, Nathalie; Scarselli, Maria			Synergic complement-mediated bactericidal activity of monoclonal antibodies with distinct specificity	FASEB JOURNAL			English	Article						bactericidal activity; monoclonal antibodies; Neisseria meningitidis; synergy	H-BINDING-PROTEIN; MENINGOCOCCAL SEROGROUP-B; MULTICOMPONENT VACCINE; PROTECTIVE ANTIGEN; MASS-SPECTROMETRY; EPITOPE DENSITY; TERMINAL DOMAIN; 4CMENB; NEUTRALIZATION; COMBINATIONS	The classical complement pathway is triggered when antigen-bound immunoglobulins bind to C1q through their Fc region. While C1q binds to a single Fc with low affinity, a higher avidity stable binding of two or more of C1q globular heads initiates the downstream reactions of the complement cascade ultimately resulting in bacteriolysis. Synergistic bactericidal activity has been demonstrated when monoclonal antibodies recognize nonoverlapping epitopes of the same antigen. The aim of the present work was to investigate the synergistic effect between antibodies directed toward different antigens. To this purpose, we investigated the bactericidal activity induced by combinations of monoclonal antibodies (mAbs) raised against factor H-binding protein (fHbp) and Neisserial Heparin-Binding Antigen (NHBA), two major antigens included in Bexsero, the vaccine against Meningococcus B, for prevention from this devastating disease in infants and adolescents. Collectively, our results show that mAbs recognizing different antigens can synergistically activate complement even when each single Mab is not bactericidal, reinforcing the evidence that cooperative immunity induced by antigen combinations can represent a remarkable added value of multicomponent vaccines. Our study also shows that the synergistic effect of antibodies is modulated by the nature of the respective epitopes, as well as by the antigen density on the bacterial cell surface.	[Natali, Eriberto Noel; Principato, Silvia; Ferlicca, Francesca; Bianchi, Federica; Fontana, Lucia Eleonora; Faleri, Agnese; Pansegrau, Werner; Lo Surdo, Paola; Bartohai, Erika; Santini, Laura; Brune, Brunelia; Giusti, Fabiola; Veggi, Daniele; Ferlenghi, Ilaria; Norais, Nathalie; Scarselli, Maria] GSK, Siena, Italy; [Natali, Eriberto Noel] Univ Florence, CERM, Dept Chem, Florence, Italy; [Principato, Silvia] Univ Siena, Dept Biol Sci, Siena, Italy; [Bianchi, Federica] GSK, Rockville, MD USA	GlaxoSmithKline; University of Florence; University of Siena; GlaxoSmithKline	Scarselli, M (corresponding author), GSK, Siena, Italy.	maria.x.scarselli@gsk.com			GlaxoSmithKline (GSK)	GlaxoSmithKline (GSK)(GlaxoSmithKline)	GlaxoSmithKline (GSK)	Arlaud GJ, 2001, IMMUNOL REV, V180, P136, DOI 10.1034/j.1600-065X.2001.1800112.x; Bambini S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065043; Beernink PT, 2008, INFECT IMMUN, V76, P4232, DOI 10.1128/IAI.00367-08; Beernink PT, 2015, MBIO, V6, DOI 10.1128/mBio.00842-15; Beernink PT, 2009, MOL IMMUNOL, V46, P1647, DOI 10.1016/j.molimm.2009.02.021; Biagini M, 2016, P NATL ACAD SCI USA, V113, P2714, DOI 10.1073/pnas.1521142113; Brier S, 2012, BIOCHEMISTRY-US, V51, P6738, DOI 10.1021/bi300656w; Cantini F, 2009, J BIOL CHEM, V284, P9022, DOI 10.1074/jbc.C800214200; Carr K, 2009, BIOMED CHROMATOGR, V23, P1108, DOI 10.1002/bmc.1231; Carr SA, 2014, MOL CELL PROTEOMICS, V13, P907, DOI 10.1074/mcp.M113.036095; Cendron L, 2011, ACTA CRYSTALLOGR F, V67, P531, DOI 10.1107/S1744309111006154; Chen ZC, 2009, INFECT IMMUN, V77, P3902, DOI 10.1128/IAI.00200-09; COOPER LJN, 1993, J IMMUNOL, V150, P2231; Degn SE, 2013, SCAND J IMMUNOL, V78, P181, DOI 10.1111/sji.12070; Diamant E, 2015, TOXINS, V7, P1854, DOI 10.3390/toxins7061854; Diebolder CA, 2014, SCIENCE, V343, P1260, DOI 10.1126/science.1248943; Donnelly J, 2010, P NATL ACAD SCI USA, V107, P19490, DOI 10.1073/pnas.1013758107; DUNCAN AR, 1988, NATURE, V332, P738, DOI 10.1038/332738a0; Esposito V, 2011, J BIOL CHEM, V286, P41767, DOI 10.1074/jbc.M111.289314; Faleri A, 2014, FASEB J, V28, P1644, DOI 10.1096/fj.13-239012; Giuliani M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22057-7; Giuliani MM, 2006, P NATL ACAD SCI USA, V103, P10834, DOI 10.1073/pnas.0603940103; Giuliani MM, 2010, VACCINE, V28, P5023, DOI 10.1016/j.vaccine.2010.05.014; Giuntini S, 2012, INFECT IMMUN, V80, P187, DOI 10.1128/IAI.05956-11; LACHMANN PJ, 1984, SPRINGER SEMIN IMMUN, V7, P143, DOI 10.1007/BF01893018; Lopez-Sagaseta J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02827-7; Malito E, 2016, BIOCHEM J, V473, P4699, DOI 10.1042/BCJ20160806; Maritan M, 2017, ACTA CRYSTALLOGR F, V73, P305, DOI 10.1107/S2053230X17006021; McIntosh EDG, 2015, VACCINE, V33, P4414, DOI 10.1016/j.vaccine.2015.07.019; Medini D, 2015, VACCINE, V33, P2629, DOI 10.1016/j.vaccine.2015.04.015; Miglietta R, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0346-3; Muzzi A, 2013, MBIO, V4, DOI 10.1128/mBio.00163-13; Nayak A, 2012, INNATE IMMUN-LONDON, V18, P350, DOI 10.1177/1753425910396252; Ngundi MM, 2012, CLIN VACCINE IMMUNOL, V19, P731, DOI 10.1128/CVI.05714-11; O'Ryan M, 2014, DRUGS, V74, P15, DOI 10.1007/s40265-013-0155-7; Oostindie SC, 2019, HAEMATOLOGICA, V104, P1841, DOI 10.3324/haematol.2018.207266; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Partridge E, 2017, VACCINE, V35, P4236, DOI 10.1016/j.vaccine.2017.06.020; Plested JS, 2009, CLIN VACCINE IMMUNOL, V16, P785, DOI 10.1128/CVI.00007-09; Pollara J, 2014, J VIROL, V88, P7715, DOI 10.1128/JVI.00156-14; Rossi R, 2016, INFECT IMMUN, V84, P1735, DOI 10.1128/IAI.01491-15; Seib KL, 2015, EXPERT REV VACCINES, V14, P841, DOI 10.1586/14760584.2015.1016915; Seib KL, 2011, INFECT IMMUN, V79, P970, DOI 10.1128/IAI.00891-10; Serruto D, 2012, VACCINE, V30, pB87, DOI 10.1016/j.vaccine.2012.01.033; Serruto D, 2010, P NATL ACAD SCI USA, V107, P3770, DOI 10.1073/pnas.0915162107; Thielens NM, 2017, MOL IMMUNOL, V89, P73, DOI 10.1016/j.molimm.2017.05.025; Ueha S, 2015, CANCER IMMUNOL RES, V3, P631, DOI 10.1158/2326-6066.CIR-14-0190; Valdez KPR, 2015, VIROLOGY, V475, P187, DOI 10.1016/j.virol.2014.11.011; VALIM YML, 1991, CLIN EXP IMMUNOL, V84, P1, DOI 10.1111/j.1365-2249.1991.tb08115.x; Vu DM, 2012, SCI REP-UK, V2, DOI 10.1038/srep00341; Vu DM, 2011, VACCINE, V29, P1968, DOI 10.1016/j.vaccine.2010.12.075; Wei H, 2014, DRUG DISCOV TODAY, V19, P95, DOI 10.1016/j.drudis.2013.07.019; Woo SR, 2012, CANCER RES, V72, P917, DOI 10.1158/0008-5472.CAN-11-1620	53	4	4	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10329	10341		10.1096/fj.201902795R	http://dx.doi.org/10.1096/fj.201902795R		JUN 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32725956	hybrid, Green Submitted			2022-12-28	WOS:000541771500001
J	Wang, JY; Kaplan, N; Wysocki, J; Yang, WD; Lu, K; Peng, H; Batlle, D; Lavker, RM				Wang, Junyi; Kaplan, Nihal; Wysocki, Jan; Yang, Wending; Lu, Kurt; Peng, Han; Batlle, Daniel; Lavker, Robert M.			The ACE2-deficient mouse: A model for a cytokine storm-driven inflammation	FASEB JOURNAL			English	Article						cornea; corneal epithelial cells; COVID-19; macrophages; SARS-CoV-2	ANGIOTENSIN-CONVERTING ENZYME-2; SARS CORONAVIRUS; ACE2; RECEPTOR; DYSFUNCTION; DELETION; STRESS; INJURY; MICE	Angiotensin converting enzyme 2 (ACE2) plays an important role in inflammation, which is attributable at least, in part, to the conversion of the pro-inflammatory angiotensin (Ang) II peptide into angiotensin 1-7 (Ang 1-7), a peptide which opposes the actions of AngII. ACE2 and AngII are present in many tissues but information on the cornea is lacking. We observed that mice deficient in theAce2gene (Ace2(-/-)), developed a cloudy cornea phenotype as they aged. Haze occupied the central cornea, accompanied by corneal edema and neovascularization. In severe cases with marked chronic inflammation, a cell-fate switch from a transparent corneal epithelium to a keratinized, stratified squamous, psoriasiform-like epidermis was observed. The stroma contained a large number of CD11c, CD68, and CD3 positive cells. Corneal epithelial debridement experiments in young ACE2-deficient mice showed normal appearing corneas, devoid of haze. We hypothesized, however, that these mice are "primed" for a corneal inflammatory response, which once initiated, would persist. In vitro studies reveal that interleukins (IL-1a, IL-1b), chemokines (CCL2, CXCL8), and TNF-alpha, are all significantly elevated, resulting in a cytokine storm-like phenotype. This phenotype could be partially rescued by treatment with the AngII type 1 receptor (AT1R) antagonist, losartan, suggesting that the observed effect was mediated by AngII acting on its main receptor. Since the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) utilizes human ACE2 as the receptor for entry with subsequent downregulation of ACE2, corneal inflammation in Ace2(-/-)mice may have a similar mechanism with that in COVID-19 patients. Thus the Ace2(-/-)cornea, because of easy accessibility, may provide an attractive model to explore the molecular mechanisms, immunological changes, and treatment modalities in patients with COVID-19.	[Wang, Junyi] Peoples Liberat Army Gen Hosp, Dept Ophthalmol, Ctr 1, Beijing, Peoples R China; [Wang, Junyi; Kaplan, Nihal; Yang, Wending; Lu, Kurt; Peng, Han; Lavker, Robert M.] Northwestern Univ, Dept Dermatol, 303 East Chicago Ave,Ward 9-124, Chicago, IL 60611 USA; [Wysocki, Jan; Batlle, Daniel] Northwestern Univ, Feinberg Sch Med, Dept Med Nephrol & Hypertens, Chicago, IL 60611 USA	Chinese People's Liberation Army General Hospital; Northwestern University; Northwestern University; Feinberg School of Medicine	Peng, H; Lavker, RM (corresponding author), Northwestern Univ, Dept Dermatol, 303 East Chicago Ave,Ward 9-124, Chicago, IL 60611 USA.; Batlle, D (corresponding author), Northwestern Univ, Dept Med Nephrol & Hypertens, 320 E Super St,Searle 10-511, Chicago, IL 60611 USA.	han-peng@northwestern.edu; d-batlle@northwestern.edu; r-lavker@northwestern.edu	wang, junyi/GYA-3213-2022		National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR075049]; National Institutes of Health [EY06769, EY017539, EY019463]; Dermatology Foundation; Eversight [AR064144, AR071168]; NIDDK [R01DK104785]; International Postdoctoral Exchange Fellowship Program [20180087]	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dermatology Foundation; Eversight; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); International Postdoctoral Exchange Fellowship Program	National Institute of Arthritis and Musculoskeletal and Skin Diseases, Grant/Award Number: AR075049; National Institutes of Health, Grant/Award Number: EY06769, EY017539 and EY019463; Dermatology Foundation research grant and Career Development; Eversight, Grant/Award Number: AR064144 and AR071168; NIDDK, Grant/Award Number: R01DK104785; International Postdoctoral Exchange Fellowship Program, Grant/Award Number: 20180087	AIELLO F, 2020, EYE 0518, DOI DOI 10.1038/S41433-020-0926-9; Batlle D, 2020, CLIN SCI, V134, P543, DOI 10.1042/CS20200163; Behrens EM, 2017, ARTHRITIS RHEUMATOL, V69, P1135, DOI 10.1002/art.40071; Bian F, 2015, INVEST OPHTH VIS SCI, V56, P4908, DOI 10.1167/iovs.15-16631; Burnier M, 2001, CIRCULATION, V103, P904, DOI 10.1161/01.CIR.103.6.904; Chen CH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06152-x; Crackower MA, 2002, NATURE, V417, P822, DOI 10.1038/nature00786; Desautels JD, 2020, OPHTHALMOL THER, V9, P371, DOI 10.1007/s40123-020-00254-w; Donoghue M, 2000, CIRC RES, V87, pE1, DOI 10.1161/01.res.87.5.e1; FERRARA JLM, 1993, TRANSPLANT P, V25, P1216; Gralinski LE, 2015, J PATHOL, V235, P185, DOI 10.1002/path.4454; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Gupta N, 2011, BRIT J OPHTHALMOL, V95, P194, DOI 10.1136/bjo.2009.173724; Gurley SB, 2008, EXP PHYSIOL, V93, P538, DOI 10.1113/expphysiol.2007.040014; Gurley SB, 2006, J CLIN INVEST, V116, P2218, DOI 10.1172/JCI16980; Guy JL, 2003, BIOCHEMISTRY-US, V42, P13185, DOI 10.1021/bi035268s; Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570; Hanff TC, 2020, CLIN INFECT DIS, V71, P870, DOI 10.1093/cid/ciaa329; Hui KPY, 2020, LANCET RESP MED, V8, P687, DOI 10.1016/S2213-2600(20)30193-4; Imai Y, 2005, NATURE, V436, P112, DOI 10.1038/nature03712; Israili ZH, 2000, J HUM HYPERTENS, V14, pS73, DOI 10.1038/sj.jhh.1000991; Jin HY, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0616-8; Kaplan N, 2020, FASEB J, V34, P525, DOI 10.1096/fj.201901512R; Kazama K, 2004, CIRC RES, V95, P1019, DOI 10.1161/01.RES.0000148637.85595.c5; Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267; Kusnadi A, 2019, IMMUNITY, V51, P241, DOI 10.1016/j.immuni.2019.06.005; Lee DW, 2014, BLOOD, V124, P188, DOI 10.1182/blood-2014-05-552729; Lgic R, 2018, EXP EYE RES, V166, P74; Li MY, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00662-x; Lin CI, 2018, INT J BIOL SCI, V14, P253, DOI 10.7150/ijbs.23489; Nakamura T, 2014, J CLIN INVEST, V124, P385, DOI 10.1172/JCI71488; Napoli PE, 2020, J CLIN MED, V9, DOI 10.3390/jcm9051269; Nita M, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/3164734; Oudit GY, 2003, TRENDS CARDIOVAS MED, V13, P93, DOI 10.1016/S1050-1738(02)00233-5; Park JK, 2016, J CELL BIOL, V215, P667, DOI 10.1083/jcb.201604032; Park SH, 2017, NAT IMMUNOL, V18, P1104, DOI 10.1038/ni.3818; Peng H, 2012, P NATL ACAD SCI USA, V109, P14030, DOI 10.1073/pnas.1111292109; Prestes TRR, 2017, CURR DRUG TARGETS, V18, P1301, DOI 10.2174/1389450117666160727142401; Serfozo P, 2020, HYPERTENSION, V75, P173, DOI 10.1161/HYPERTENSIONAHA.119.14071; Stepp MA, 2014, EXP EYE RES, V121, P178, DOI 10.1016/j.exer.2014.02.007; Suzuki Y, 2000, J NEPHROL, V13, pS101; Thomas MC, 2010, CIRC RES, V107, P888, DOI 10.1161/CIRCRESAHA.110.219279; Tikellis C, 2004, CURR EYE RES, V29, P419, DOI 10.1080/02713680490517944; Tipnis SR, 2000, J BIOL CHEM, V275, P33238, DOI 10.1074/jbc.M002615200; Tisoncik JR, 2012, MICROBIOL MOL BIOL R, V76, P16, DOI 10.1128/MMBR.05015-11; Tyburski JG, 2001, SURGERY, V130, P748, DOI 10.1067/msy.2001.118094; Vallabh NA, 2017, MITOCHONDRION, V36, P103, DOI 10.1016/j.mito.2017.05.009; Wilson SE, 2001, PROG RETIN EYE RES, V20, P625, DOI 10.1016/S1350-9462(01)00008-8; Wysocki J, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9120886; Wysocki J, 2014, PHYSIOL REP, V2, DOI 10.1002/phy2.264; Wysocki J, 2010, HYPERTENSION, V55, P90, DOI 10.1161/HYPERTENSIONAHA.109.138420; Xie L X, 2020, Zhonghua Yan Ke Za Zhi, V56, P250, DOI 10.3760/cma.j.cn112142-20200220-00091; Xu Z, 2020, LANCET RESP MED, V8, P420, DOI 10.1016/S2213-2600(20)30076-X; Yamamoto K, 2006, HYPERTENSION, V47, P718, DOI 10.1161/01.HYP.0000205833.89478.5b; Zhang B N, 2020, Zhonghua Yan Ke Za Zhi, V56, P438, DOI 10.3760/cma.j.cn112142-20200310-00170; Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2951-z, 10.1038/s41586-020-2012-7]; Zou KJ, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317695962	57	24	24	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10505	10515		10.1096/fj.202001020R	http://dx.doi.org/10.1096/fj.202001020R		JUN 2020	11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32725927	Green Published, Bronze			2022-12-28	WOS:000541770400001
J	Liu, QH; Huang, XJ; Li, QY; He, LX; Li, SQ; Chen, XF; Ouyang, Y; Wang, X; Lin, CY				Liu, Qinghua; Huang, Xinjian; Li, Qingyuan; He, Lixin; Li, Siqi; Chen, Xiangfu; Ouyang, Ying; Wang, Xi; Lin, Chuyong			Rhophilin-associated tail protein 1 promotes migration and metastasis in triple negative breast cancer via activation of RhoA	FASEB JOURNAL			English	Article						actin stress fibers; metastasis; RhoA; ROPN1; TNBC	GENE-EXPRESSION; BINDING-PROTEIN; TESTIS ANTIGEN; MOLECULAR PORTRAITS; ROPPORIN; CYTOSKELETON; REGULATOR; GTPASES	Triple negative breast cancer (TNBC) is the most aggressive breast cancer subtype with high motile and invasive capacity that contributes to metastasis. Understanding the mechanisms for the motility of TNBC might provide novel targetable vulnerabilities of the tumors. Herein, we find that Rhophilin-associated tail protein 1 (ROPN1) is selectively overexpressed in human TNBC cell lines and tissues. Overexpression of ROPN1 promotes, while silencing of ROPN1 inhibits the robust migration, invasion, and in vivo metastasis of TNBC cells. Moreover, we find that ROPN1 activates RhoA signaling via rhophilin-1 (RHPN1), leading to enhanced actin stress fibers formation in TNBC cells. RhoA signaling is demonstrated to be essential for ROPN1-mediated migration and metastasis of TNBC cells. Finally, we find that high levels of ROPN1 are significantly associated distant metastasis and predicted poor prognosis in patients with breast cancer. These findings reveal a novel mechanism for the high motility and metastasis of TNBC cells, suggesting that ROPN1 might be a potential prognostic marker and therapeutic target.	[Liu, Qinghua; Huang, Xinjian; He, Lixin; Chen, Xiangfu; Ouyang, Ying; Wang, Xi; Lin, Chuyong] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, Dept Expt Res, State Key Lab Oncol South China,Canc Ctr, Guangzhou, Peoples R China; [Huang, Xinjian; Li, Siqi; Wang, Xi] Sun Yat Sen Univ, Dept Breast Surg, Guangzhou, Peoples R China; [Li, Qingyuan] Univ Sydney, Sch Pharm, Sydney, NSW, Australia	State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; University of Sydney	Lin, CY (corresponding author), Sun Yat Sen Univ, Canc Ctr, State Key Lab Oncol Southern China, Dept Expt Res, Guangzhou 510060, Peoples R China.; Wang, X (corresponding author), Sun Yat Sen Univ, Canc Ctr, Dept Breast Surg, Guangzhou 510060, Peoples R China.	wangxi@sysucc.org.cn; Linchuyong999@gmail.com	Lin, Chuyong/AAA-9931-2020	Lin, Chuyong/0000-0003-4887-5386	National Natural Science Foundation of China [81672854, 81872383, 81772826, 81972459]; Science and Technology of Guangdong Province [2017A030306019]; Pearl River S&T Nova Program of Guangzhou [201710010163]; Fundamental Research Funds for the Central Universities [19ykzd45]; program for Excellent Talents in Cancer Centre [16zxyc01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology of Guangdong Province; Pearl River S&T Nova Program of Guangzhou; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); program for Excellent Talents in Cancer Centre	National Natural Science Foundation of China, Grant/Award Number: 81672854, 81872383, 81772826 and 81972459; Science and Technology of Guangdong Province, Grant/Award Number: 2017A030306019; Pearl River S&T Nova Program of Guangzhou, Grant/Award Number: 201710010163; Fundamental Research Funds for the Central Universities, Grant/Award Number: 19ykzd45; program for Excellent Talents in Cancer Centre, Grant/Award Number: 16zxyc01	Atanackovic D, 2011, AM J HEMATOL, V86, P918, DOI 10.1002/ajh.22141; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bon E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13648; Carey L, 2010, NAT REV CLIN ONCOL, V7, P683, DOI 10.1038/nrclinonc.2010.154; Chan CH, 2010, NAT CELL BIOL, V12, P457, DOI 10.1038/ncb2047; Chiriva-Internati M, 2011, J IMMUNOTHER, V34, P490, DOI 10.1097/CJI.0b013e31821ca76f; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Fiedler SE, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.105262; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Freeman SA, 2018, CELL, V172, P305, DOI 10.1016/j.cell.2017.12.023; Fujita A, 2000, J CELL SCI, V113, P103; Grimes SR, 2004, GENE, V343, P11, DOI 10.1016/j.gene.2004.08.021; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Jansen S, 2018, PHARMACOL THERAPEUT, V183, P1, DOI 10.1016/j.pharmthera.2017.09.002; Kimmins S, 2004, REPRODUCTION, V128, P5, DOI 10.1530/rep.1.00170; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Koedoot E, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11020-3; Lal MA, 2015, J AM SOC NEPHROL, V26, P647, DOI 10.1681/ASN.2013111195; Lambert AW, 2017, CELL, V168, P670, DOI 10.1016/j.cell.2016.11.037; Li ZF, 2007, INT J CANCER, V121, P1507, DOI 10.1002/ijc.22842; Liu JL, 2018, J PATHOL, V244, P71, DOI 10.1002/path.4995; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Mayer IA, 2014, CLIN CANCER RES, V20, P782, DOI 10.1158/1078-0432.CCR-13-0583; Nakamura K, 1999, FEBS LETT, V445, P9, DOI 10.1016/S0014-5793(99)00087-3; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Tam WL, 2013, NAT MED, V19, P1438, DOI 10.1038/nm.3336; Weigelt B, 2010, J PATHOL, V220, P263, DOI 10.1002/path.2648; Welch MD, 1997, CURR OPIN CELL BIOL, V9, P54, DOI 10.1016/S0955-0674(97)80152-4; Worzfeld T, 2012, J CLIN INVEST, V122, P1296, DOI 10.1172/JCI60568; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yao Y, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20190288	34	1	1	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					9959	9971		10.1096/fj.201903281R	http://dx.doi.org/10.1096/fj.201903281R		MAY 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32427399				2022-12-28	WOS:000533887700001
J	Rutkowsky, JM; Knotts, TA; Allen, PD; Pessah, IN; Ramsey, JJ				Rutkowsky, Jennifer M.; Knotts, Trina A.; Allen, Paul D.; Pessah, Isaac N.; Ramsey, Jon J.			Sex-specific alterations in whole body energetics and voluntary activity in heterozygous R163C malignant hyperthermia-susceptible mice	FASEB JOURNAL			English	Article						body composition; energy expendtiure; metabolic rate; physical activity; thermoneutral zone	SKELETAL-MUSCLE; ENERGY-EXPENDITURE; ADIPOSE-TISSUE; SUDDEN-DEATH; RYR1; THERMOGENESIS; PIGS	Malignant hyperthermia (MH) is characterized by induction of skeletal muscle hyperthermia in response to a dysregulated increase in myoplasmic calcium. Although altered energetics play a central role in MH, MH-susceptible humans and mouse models are often described as having no phenotype until exposure to a triggering agent. The purpose of this study was to determine the influence of the R163C ryanodine receptor 1 mutation, a common MH mutation in humans, on energy expenditure, and voluntary wheel running in mice. Energy expenditure was measured by indirect respiration calorimetry in wild-type (WT) and heterozygous R163C (HET) mice over a range of ambient temperatures. Energy expenditure adjusted for body weight or lean mass was increased (P < .05) in male, but not female, HET mice housed at 22 degrees C or when housed at 28 degrees C with a running wheel. In female mice, voluntary wheel running was decreased (P < .05) in the HET vs WT animals when analyzed across ambient temperatures. The thermoneutral zone was also widened in both male and female HET mice. The results of the study show that the R163C mutations alters energetics even at temperatures that do not typically induce MH.	[Rutkowsky, Jennifer M.; Knotts, Trina A.; Allen, Paul D.; Pessah, Isaac N.; Ramsey, Jon J.] Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, 1089 Vet Med Dr, Davis, CA 95616 USA; [Allen, Paul D.] Univ Leeds, Leeds Inst Biomed & Clin Sci, Leeds, W Yorkshire, England	University of California System; University of California Davis; University of Leeds	Ramsey, JJ (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, 1089 Vet Med Dr, Davis, CA 95616 USA.	jjramsey@ucdavis.edu			National Institutes of Health (NIH) [PO1AR052354]; UC Davis Mouse Metabolic Phenotyping Center [U2CDK092993]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UC Davis Mouse Metabolic Phenotyping Center	HHS vertical bar National Institutes of Health (NIH), Grant/Award Number: PO1AR052354; UC Davis Mouse Metabolic Phenotyping Center, Grant/Award Number: U2CDK092993	AALHUS JL, 1991, ANIM PROD, V52, P347, DOI 10.1017/S0003356100012873; Abreu-Vieira G, 2015, MOL METAB, V4, P461, DOI 10.1016/j.molmet.2015.03.001; Allard B, 2018, NEUROMUSCULAR DISORD, V28, P394, DOI 10.1016/j.nmd.2018.03.004; Assaad HI, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-0795-z; Bi JF, 2014, CELL METAB, V19, P861, DOI 10.1016/j.cmet.2014.03.028; BRITT BA, 1970, CAN ANAESTH SOC J, V17, P293, DOI 10.1007/BF03004694; Canato M, 2015, J MUSCLE RES CELL M, V36, P61, DOI 10.1007/s10974-014-9396-7; Cannon B, 2011, J EXP BIOL, V214, P242, DOI 10.1242/jeb.050989; Chang L, 2019, BRIT J ANAESTH, V122, P613, DOI 10.1016/j.bja.2019.02.010; Cully TR, 2018, P NATL ACAD SCI USA, V115, P8215, DOI 10.1073/pnas.1800490115; De Crescenzo V, 2012, P NATL ACAD SCI USA, V109, P610, DOI 10.1073/pnas.1115111108; DENBOROUGH MA, 1962, BRIT J ANAESTH, V34, P395, DOI 10.1093/bja/34.6.395; Dlamini N, 2013, NEUROMUSCULAR DISORD, V23, P540, DOI 10.1016/j.nmd.2013.03.008; Durham WJ, 2008, CELL, V133, P53, DOI 10.1016/j.cell.2008.02.042; Freymond D, 2000, ANESTHESIOLOGY, V93, P39, DOI 10.1097/00000542-200007000-00011; GIANNINI G, 1995, J CELL BIOL, V128, P893, DOI 10.1083/jcb.128.5.893; Giulivi C, 2011, J BIOL CHEM, V286, P99, DOI 10.1074/jbc.M110.153247; Gordon CJ, 2012, J THERM BIOL, V37, P654, DOI 10.1016/j.jtherbio.2012.08.004; Grievink H, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-10; Hartmann S, 1997, AM J VET RES, V58, P738; Islander G, 2007, ACTA ANAESTH SCAND, V51, P614, DOI 10.1111/j.1399-6576.2007.01293.x; Knoblauch M, 2013, SKELET MUSCLE, V3, DOI 10.1186/2044-5040-3-22; Kushnir A, 2010, FEBS LETT, V584, P1956, DOI 10.1016/j.febslet.2010.03.005; Lanner JT, 2012, NAT MED, V18, P244, DOI 10.1038/nm.2598; Lanner JT, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003996; Leach LM, 1996, J ANIM SCI, V74, P934; LUCKE JN, 1977, VET REC, V100, P45, DOI 10.1136/vr.100.3.45; Merritt A, 2017, BRIT J ANAESTH, V118, P533, DOI 10.1093/bja/aex042; Michelucci A, 2017, FASEB J, V31, P3649, DOI 10.1096/fj.201601292R; Miller DM, 2018, BRIT J ANAESTH, V121, P944, DOI 10.1016/j.bja.2018.06.028; Moreno CAI, 2019, ANESTHESIOLOGY, V131, P983, DOI 10.1097/ALN.0000000000002813; Periasamy M, 2017, DIABETES METAB J, V41, P327, DOI 10.4093/dmj.2017.41.5.327; Ramsey JJ, 2000, FREE RADICAL BIO MED, V29, P946, DOI 10.1016/S0891-5849(00)00417-2; Reddish FN, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18051024; Riazi S, 2018, ANESTHESIOLOGY, V128, P168, DOI 10.1097/ALN.0000000000001878; Rios E, 2010, J PHYSIOL SCI, V60, P81, DOI 10.1007/s12576-009-0069-z; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; Rouviere C, 2012, MUSCLE NERVE, V45, P586, DOI 10.1002/mus.22343; SCHOLANDER PF, 1950, BIOL BULL, V99, P237, DOI 10.2307/1538741; Smith IC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068924; Speakman JR, 2013, MOL METAB, V2, P5, DOI 10.1016/j.molmet.2012.10.002; TAKESHIMA H, 1994, NATURE, V369, P556, DOI 10.1038/369556a0; Thompson SJ, 2017, ANESTH ANALG, V125, P434, DOI 10.1213/ANE.0000000000002232; Yang TZ, 2006, ANESTHESIOLOGY, V105, P1164, DOI 10.1097/00000542-200612000-00016; Yuen B, 2012, FASEB J, V26, P1311, DOI 10.1096/fj.11-197582	45	2	2	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8721	8733		10.1096/fj.202000403	http://dx.doi.org/10.1096/fj.202000403		MAY 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32367593	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000530738200001
J	Choi, S; Singh, I; Singh, AK; Khan, M; Won, J				Choi, Seungho; Singh, Inderjit; Singh, Avtar K.; Khan, Mushfiquddin; Won, Jeseong			Asymmetric dimethylarginine exacerbates cognitive dysfunction associated with cerebrovascular pathology	FASEB JOURNAL			English	Article						actin stress fiber; Alzheimer's disease; asymmetric dimethylarginine (ADMA); brain endothelial barrier; endothelial nitric oxide synthase (eNOS); nitric oxide; vascular cognitive impairment and dementia (VCID)	NITRIC-OXIDE SYNTHASE; CEREBRAL VASOSPASM; S-NITROSOGLUTATHIONE; ENDOTHELIAL DYSFUNCTION; ENDOGENOUS INHIBITOR; BEHAVIORAL DEFICITS; PLASMA-LEVELS; BLOOD-FLOW; RAT MODEL; ADMA	Asymmetric dimethylarginine (ADMA), an endogenous inhibitor and uncoupler of nitric oxide synthase, has gained attention as a risk factor for cardiac disease, metabolic syndrome, and cerebrovascular disease. In this study, we investigated the role of systemic ADMA overburden in cerebromicrovascular pathology associated with cognitive dysfunction using APPSwDI transgenic mice expressing human beta-amyloid precursor protein Swedish (Tg-SwDI), a model of cerebrovascular beta-amyloidosis. To induce systemic overburden of ADMA, Tg-SwDI mice were treated with a daily dose of exogenous ADMA. ADMA treatment resulted in elevated ADMA levels in the blood and brain of Tg-SwDI mice. ADMA treatment induced the brain nitrosative stress and inflammation as well as enhanced the brain A beta deposition and cognitive impairment in Tg-SwDI mice. However, ADMA treatment had no such effects on wild type mice. ADMA treatment also exacerbated brain microvascular pathology in Tg-SwDI mice as observed by increased blood-brain barrier dysfunction, loss of tight junction proteins, increased endothelial stress fibers, and decreased microvessel density in the brain. In addition, similar observations were made in cultured human brain microvessel endothelial cells, where ADMA in the presence of VEGF-induced endothelial cell signaling for F-actin stress fiber inducing endothelial barrier dysfunction. Overall, these data document the potential role of ADMA in the cognitive pathology under conditions of cerebrovascular beta-amyloidosis.	[Choi, Seungho; Singh, Inderjit; Khan, Mushfiquddin] Med Univ South Carolina, Dept Pediat, 173 Ashley Ave,DCRI Room 509, Charleston, SC 29425 USA; [Singh, Inderjit] Ralph H Johnson Vet Adm Med Ctr, Res Serv, Charleston, SC USA; [Singh, Avtar K.; Won, Jeseong] Med Univ South Carolina, Dept Pathol & Lab Med, 173 Ashley Ave,DCRI Room 510, Charleston, SC 29425 USA; [Singh, Avtar K.] Ralph H Johnson Vet Adm Med Ctr, Pathol & Lab Med Serv, Charleston, SC USA	Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Singh, I (corresponding author), Med Univ South Carolina, Dept Pediat, 173 Ashley Ave,DCRI Room 509, Charleston, SC 29425 USA.; Won, J (corresponding author), Med Univ South Carolina, Dept Pathol & Lab Med, 173 Ashley Ave,DCRI Room 510, Charleston, SC 29425 USA.	singhi@musc.edu; wonj@musc.edu	Singh, Ashok/HGF-2506-2022; SINGH, ANIL KUMAR/M-4786-2017	SINGH, ANIL KUMAR/0000-0003-2933-4058	NIH HHS [NS037766] Funding Source: Medline; BLRD VA [I01 BX003401] Funding Source: Medline	NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BLRD VA		Achan V, 2003, ARTERIOSCL THROM VAS, V23, P1455, DOI 10.1161/01.ATV.0000081742.92006.59; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Alvarez XA, 2018, J ALZHEIMERS DIS, V63, P1003, DOI 10.3233/JAD-160477; Antoniades C, 2009, EUR HEART J, V30, P1142, DOI 10.1093/eurheartj/ehp061; Appel D, 2018, NEUROCRIT CARE, V29, P84, DOI 10.1007/s12028-018-0520-1; Atamer A, 2008, J INT MED RES, V36, P54, DOI 10.1177/147323000803600108; Bestermann WH, 2011, CARDIORENAL MED, V1, P211, DOI 10.1159/000332382; Borgeraas H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152029; Chen SF, 2012, INT J MOL SCI, V13, P15983, DOI 10.3390/ijms131215983; Choi S, 2019, NITRIC OXIDE-BIOL CH, V83, P51, DOI 10.1016/j.niox.2018.12.007; Fan R, 2007, J NEUROSCI, V27, P3057, DOI 10.1523/JNEUROSCI.4371-06.2007; Ganz T, 2017, DIABETES-METAB RES, V33, DOI 10.1002/dmrr.2836; Gaston Benjamin M, 2003, Mol Interv, V3, P253, DOI 10.1124/mi.3.5.253; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; He WL, 2016, REDOX BIOL, V9, P1, DOI 10.1016/j.redox.2016.05.002; Helman AM, 2016, BBA-MOL BASIS DIS, V1862, P975, DOI 10.1016/j.bbadis.2015.12.009; Jung CS, 2007, J NEUROSURG, V107, P945, DOI 10.3171/JNS-07/11/0945; Jung CS, 2012, NEUROSCI LETT, V524, P20, DOI 10.1016/j.neulet.2012.06.076; Jung CS, 2004, J NEUROSURG, V101, P836, DOI 10.3171/jns.2004.101.5.0836; Kajimoto H, 2012, KIDNEY INT, V81, P762, DOI 10.1038/ki.2011.476; Karbach S, 2014, CURR PHARM DESIGN, V20, P3579, DOI 10.2174/13816128113196660748; Khan M, 2006, NITRIC OXIDE-BIOL CH, V15, P114, DOI 10.1016/j.niox.2006.01.008; Khan M, 2016, BRAIN RES, V1630, P159, DOI 10.1016/j.brainres.2015.11.015; Khan M, 2012, J NEUROCHEM, V123, P86, DOI 10.1111/j.1471-4159.2012.07947.x; Khan M, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-32; Kielstein JT, 2006, STROKE, V37, P2024, DOI 10.1161/01.STR.0000231640.32543.11; Kocak H, 2011, J CLIN LAB ANAL, V25, P174, DOI 10.1002/jcla.20452; Konya Hiroyuki, 2015, World J Exp Med, V5, P110, DOI 10.5493/wjem.v5.i2.110; Kurtoglu E, 2014, ANGIOLOGY, V65, P788, DOI 10.1177/0003319713507333; Leiper JM, 1999, BIOCHEM J, V343, P209, DOI 10.1042/0264-6021:3430209; Li N, 2011, NEUROL RES, V33, P541, DOI 10.1179/016164111X13007856084403; Lu TM, 2004, AM J CARDIOL, V94, P157, DOI 10.1016/j.amjcard.2004.03.052; MACALLISTER RJ, 1994, BRIT J PHARMACOL, V112, P43, DOI 10.1111/j.1476-5381.1994.tb13026.x; Mahoney ER, 2019, MOL PSYCHIATR, P1; Marten-Lobenhoffer J, 2007, J NEUROSCI METH, V164, P155, DOI 10.1016/j.jneumeth.2007.04.005; Nishiyama Y, 2010, J NEUROL SCI, V290, P12, DOI 10.1016/j.jns.2009.12.020; OGAWA T, 1989, J BIOL CHEM, V264, P10205; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Palm F, 2007, AM J PHYSIOL-HEART C, V293, pH3227, DOI 10.1152/ajpheart.00998.2007; Prakash R, 2012, DIABETES, V61, P1533, DOI 10.2337/db11-1528; Ravi K, 2004, P NATL ACAD SCI USA, V101, P2619, DOI 10.1073/pnas.0300464101; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Seabra AB, 2007, BRIT J DERMATOL, V156, P814, DOI 10.1111/j.1365-2133.2006.07718.x; Snyder HM, 2015, ALZHEIMERS DEMENT, V11, P710, DOI 10.1016/j.jalz.2014.10.008; Suhardja A, 2004, NAT CLIN PRACT CARD, V1, P110, DOI 10.1038/ncpcardio0046; Takiuchi S, 2004, AM J HYPERTENS, V17, P802, DOI 10.1016/j.amjhyper.2004.05.005; Tang J, 2000, J BIOL CHEM, V275, P19866, DOI 10.1074/jbc.M000023200; Tran CTL, 2000, GENOMICS, V68, P101, DOI 10.1006/geno.2000.6262; Visser M, 2010, EUR J HEART FAIL, V12, P1274, DOI 10.1093/eurjhf/hfq158; Wahlstrom MR, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-98; Won JS, 2013, J ALZHEIMERS DIS, V34, P621, DOI 10.3233/JAD-121786; Xu F, 2007, NEUROSCIENCE, V146, P98, DOI 10.1016/j.neuroscience.2007.01.043; Xu Q, 2017, FREE RADICAL BIO MED, V109, P84, DOI 10.1016/j.freeradbiomed.2017.03.004; Yao Y, 2011, J CELL SCI, V124, P1486, DOI 10.1242/jcs.082834; Zafar MI, 2018, DIABETOL METAB SYNDR, V10, DOI 10.1186/s13098-018-0363-0	55	8	8	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6808	6823		10.1096/fj.201901318R	http://dx.doi.org/10.1096/fj.201901318R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32239698				2022-12-28	WOS:000531325500056
J	Divakaran, SJ; Srivastava, S; Jahagirdar, A; Rajendran, R; Sukhdeo, SV; Rajakumari, S				Divakaran, Soumya Jaya; Srivastava, Simran; Jahagirdar, Anusha; Rajendran, Rajprabu; Sukhdeo, Shinde Vijay; Rajakumari, Sona			Sesaminol induces brown and beige adipocyte formation through suppression of myogenic program	FASEB JOURNAL			English	Article						energy expenditure; myogenesis; thermogenesis	HIGH-FAT DIET; ADIPOSE-TISSUE; PPAR-GAMMA; ENERGY-EXPENDITURE; WHITE FAT; OBESITY; PRDM16; THERMOGENESIS; TRANSCRIPTION; ACTIVATION	Adipocytes are key players in maintaining energy homeostasis and are classified into two different categories: white and brown adipocytes. While white adipocytes store energy as triacylglycerols in lipid droplets, brown adipocytes combust excess chemical energy and release in the form of heat through uncoupled respiration. This characteristic phenomenon of brown fat attracts researchers and pharmacological industries to view brown fat as one of the potential therapeutic targets for obesity and associated metabolic disease. In the current study, we investigated the effect of a small molecule, sesaminol (SML) on brown fat activity and found that SML induces the thermogenic program in primary white adipocytes as well as chow diet fed mice. In particular, SML treatment to mice elevated mitochondrial complex proteins and the rate of oxygen consumption in brown and white fat. Administration of SML to high fat diet (HFD) challenged mice decreased weight gain, adiposity and cholesterol levels along with an increase of brown fat gene program in brown and white fat. Mechanistically, SML repressed the myogenic gene program in C2C12 myoblasts and increased all mitochondrial marker genes as appeared in brown adipose cells. Together, our results demonstrate that SML stimulates brown adipose function and protects mice against diet-induced weight gain.	[Divakaran, Soumya Jaya; Jahagirdar, Anusha; Rajakumari, Sona] Rajiv Gandhi Ctr Biotechnol, Cardiovasc Dis & Diabet Biol, Thiruvananthapuram, Kerala, India; [Srivastava, Simran; Rajendran, Rajprabu; Rajakumari, Sona] Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bengaluru 560012, Karnataka, India; [Sukhdeo, Shinde Vijay] Cent Food Technol Res Inst, CSIR, Lipid Ctr, Dept Lipid Sci, Mysuru, India	Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB); Indian Institute of Science (IISC) - Bangalore; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Food Technological Research Institute (CFTRI)	Rajakumari, S (corresponding author), Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bengaluru 560012, Karnataka, India.	sona@iisc.ac.in		Shinde, Vijay Sukhdeo/0000-0001-9351-8156				Ashakumary L, 1999, METABOLISM, V48, P1303, DOI 10.1016/S0026-0495(99)90272-X; Barbera MJ, 2001, J BIOL CHEM, V276, P1486, DOI 10.1074/jbc.M006246200; Berry DC, 2013, DEVELOPMENT, V140, P3939, DOI 10.1242/dev.080549; Bookout Angie L, 2003, Nucl Recept Signal, V1, pe012; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cannon B, 2011, J EXP BIOL, V214, P242, DOI 10.1242/jeb.050989; Cao WM, 2013, CELL BIOCHEM FUNCT, V31, P560, DOI 10.1002/cbf.2935; CUI JY, 1992, AM J PHYSIOL, V262, pR568, DOI 10.1152/ajpregu.1992.262.4.R568; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Das SK, 2011, SCIENCE, V333, P233, DOI 10.1126/science.1198973; Dempersmier J, 2015, MOL CELL, V57, P235, DOI 10.1016/j.molcel.2014.12.005; Gensch N, 2008, DEVELOPMENT, V135, P1597, DOI 10.1242/dev.019331; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Goldgof M, 2014, J BIOL CHEM, V289, P19341, DOI 10.1074/jbc.M114.568204; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; Monteiro EMH, 2014, NUTRIENTS, V6, P1931, DOI 10.3390/nu6051931; Hill JO, 2012, CIRCULATION, V126, P126, DOI 10.1161/CIRCULATIONAHA.111.087213; Ikeda S, 2003, J NUTR SCI VITAMINOL, V49, P270, DOI 10.3177/jnsv.49.270; Ji YW, 2012, J BIOL CHEM, V287, P24378, DOI 10.1074/jbc.M112.371807; Jin QH, 2014, MOL CELL BIOL, V34, P3746, DOI 10.1128/MCB.00622-14; Johnson AMF, 2013, CELL, V152, P673, DOI 10.1016/j.cell.2013.01.041; Kajimura S, 2009, NATURE, V460, P1154, DOI 10.1038/nature08262; Kang JG, 2012, DIABETES METAB J, V36, P13, DOI 10.4093/dmj.2012.36.1.13; Kapadia GJ, 2002, PHARMACOL RES, V45, P499, DOI 10.1006/phrs.2002.0992; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lee JE, 2013, ELIFE, V2, DOI 10.7554/eLife.01503; Lepper C, 2010, GENESIS, V48, P424, DOI 10.1002/dvg.20630; Liu XM, 2015, ENDOCRINOLOGY, V156, P2461, DOI 10.1210/en.2014-1598; Liu ZG, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201600717; Mele L, 2017, ADV NUTR, V8, P694, DOI 10.3945/an.117.015792; Milder IEJ, 2005, BRIT J NUTR, V93, P393, DOI 10.1079/BJN20051371; Misra A, 2008, J CLIN ENDOCR METAB, V93, pS9, DOI 10.1210/jc.2008-1595; Miyawaki T, 2009, J NUTR SCI VITAMINOL, V55, P87, DOI 10.3177/jnsv.55.87; NICHOLLS DG, 1984, PHYSIOL REV, V64, P1, DOI 10.1152/physrev.1984.64.1.1; Nolan Paul B, 2017, Prev Med Rep, V7, P211, DOI 10.1016/j.pmedr.2017.07.004; Ohno H, 2013, NATURE, V504, P163, DOI 10.1038/nature12652; Ohyama K, 2016, DIABETES, V65, P1410, DOI 10.2337/db15-0662; Park JH, 2013, DEV CELL, V26, P393, DOI 10.1016/j.devcel.2013.07.002; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Petruzzelli M, 2014, CELL METAB, V20, P433, DOI 10.1016/j.cmet.2014.06.011; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Rains TM, 2011, J NUTR BIOCHEM, V22, P1, DOI 10.1016/j.jnutbio.2010.06.006; Rajakumari S, 2013, CELL METAB, V17, P562, DOI 10.1016/j.cmet.2013.01.015; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; Rothwell N. J., 1982, METAB CLIN EXP, V34, P474; Schulz TJ, 2011, P NATL ACAD SCI USA, V108, P143, DOI 10.1073/pnas.1010929108; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Soukas A, 2001, J BIOL CHEM, V276, P34167, DOI 10.1074/jbc.M104421200; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Stanford KI, 2013, J CLIN INVEST, V123, P215, DOI 10.1172/JCI62308; Sun K, 2013, ENCY BIOL CHEM, P72; TONTONOZ P, 1994, NUCLEIC ACIDS RES, V22, P5628, DOI 10.1093/nar/22.25.5628; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; Tuck MK, 2009, J PROTEOME RES, V8, P113, DOI 10.1021/pr800545q; Villanueva CJ, 2013, CELL METAB, V17, P423, DOI 10.1016/j.cmet.2013.01.016; Wang S, 2015, BIOCHEM BIOPH RES CO, V466, P247, DOI 10.1016/j.bbrc.2015.09.018; Wang WS, 2014, P NATL ACAD SCI USA, V111, P14466, DOI 10.1073/pnas.1412685111; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Yoneshiro T, 2013, J CLIN INVEST, V123, P3404, DOI 10.1172/JCI67803; YOSHIOKA K, 1990, J NUTR SCI VITAMINOL, V36, P173, DOI 10.3177/jnsv.36.173; Zhang RJ, 2016, NUTR RES, V36, P1022, DOI 10.1016/j.nutres.2016.06.015	63	5	5	1	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6854	6870		10.1096/fj.201902124R	http://dx.doi.org/10.1096/fj.201902124R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32275102				2022-12-28	WOS:000531325500059
J	Hughes, KR; Schofield, Z; Dalby, MJ; Caim, S; Chalklen, L; Bernuzzi, F; Alcon-Giner, C; Le Gall, G; Watson, AJM; Hall, LJ				Hughes, Kevin R.; Schofield, Zoe; Dalby, Matthew J.; Caim, Shabhonam; Chalklen, Lisa; Bernuzzi, Federico; Alcon-Giner, Cristina; Le Gall, Gwenaelle; Watson, Alastair J. M.; Hall, Lindsay J.			The early life microbiota protects neonatal mice from pathological small intestinal epithelial cell shedding	FASEB JOURNAL			English	Article						antibiotics; cell shedding; early life; fecal microbiota transplant; inflammation; intestinal epithelium; metabolites; microbiota	ULCERATIVE-COLITIS; BARRIER FUNCTION; GUT MICROBIOME; EXPRESSION; DISEASE; MODEL	The early life gut microbiota plays a crucial role in regulating and maintaining the intestinal barrier, with disturbances in these communities linked to dysregulated renewal and replenishment of intestinal epithelial cells. Here we sought to determine pathological cell shedding outcomes throughout the postnatal developmental period, and which host and microbial factors mediate these responses. Surprisingly, neonatal mice (Day 14 and 21) were highly refractory to induction of cell shedding after intraperitoneal administration of liposaccharide (LPS), with Day 29 mice showing strong pathological responses, more similar to those observed in adult mice. These differential responses were not linked to defects in the cellular mechanisms and pathways known to regulate cell shedding responses. When we profiled microbiota and metabolites, we observed significant alterations. Neonatal mice had high relative abundances of Streptococcus, Escherichia, and Enterococcus and increased primary bile acids. In contrast, older mice were dominated by Candidatus Arthromitus, Alistipes, and Lachnoclostridium, and had increased concentrations of SCFAs and methyamines. Antibiotic treatment of neonates restored LPS-induced small intestinal cell shedding, whereas adult fecal microbiota transplant alone had no effect. Our findings further support the importance of the early life window for microbiota-epithelial interactions in the presence of inflammatory stimuli and highlights areas for further investigation.	[Hughes, Kevin R.; Schofield, Zoe; Dalby, Matthew J.; Caim, Shabhonam; Chalklen, Lisa; Bernuzzi, Federico; Alcon-Giner, Cristina; Le Gall, Gwenaelle; Hall, Lindsay J.] Quadram Inst Biosci, Gut Microbes & Hlth, Norwich, Norfolk, England; [Hughes, Kevin R.; Le Gall, Gwenaelle; Watson, Alastair J. M.; Hall, Lindsay J.] Univ East Anglia, Norwich Med Sch, Norwich, Norfolk, England; [Hughes, Kevin R.] Univ Nottingham, Res & Innovat, Nottingham, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia; University of Nottingham	Hall, LJ (corresponding author), Quadram Inst Biosci, Norwich NR4 7UQ, Norfolk, England.	Lindsay.Hall@quadram.ac.uk	Hall, Lindsay J/AAK-4993-2020; Le Gall, Gwenaelle/HDL-8283-2022	Hall, Lindsay J/0000-0001-8938-5709; Schofield, Zoe/0000-0002-9065-0095; Le Gall, Gwenaelle/0000-0002-1379-2196; Chalklen, Lisa/0000-0002-6162-9940	BBSRC [1652737, BBS/E/F/000PR10353, BBS/E/F/00044409, BBS/E/F/000PR10356, BBS/E/F/000PR10355] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/F/000PR10353, BBS/E/F/000PR10355, BBS/E/F/00044409, BBS/E/F/000PR10356, BBS/E/F/000PR10353, BB/R012490/1, BB/M011216/1, BB/J004529/1] Funding Source: Medline; Wellcome Trust [100974/C/13/Z, 100974] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome Trust)		Abdi K, 2012, J IMMUNOL, V188, P5981, DOI 10.4049/jimmunol.1102868; Alcon-Giner CDM, 2019, MICROBIOTA SUPPLEMEN, DOI [10.1101/698092, DOI 10.1101/698092]; Amenyogbe N, 2017, FRONT PEDIATR, V5, DOI 10.3389/fped.2017.00111; Andrews C, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01270; Are A, 2008, P NATL ACAD SCI USA, V105, P1943, DOI 10.1073/pnas.0711734105; Braun A, 2009, INFLAMM BOWEL DIS, V15, P1705, DOI 10.1002/ibd.20993; Chang YC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180025; Chelakkot C, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0126-x; d'Hennezel E, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00046-17; Danne C, 2017, CELL HOST MICROBE, V22, P733, DOI 10.1016/j.chom.2017.11.002; Derrien M, 2019, TRENDS MICROBIOL, V27, P997, DOI 10.1016/j.tim.2019.08.001; Dominguez-Bello MG, 2019, GUT, V68, P1108, DOI 10.1136/gutjnl-2018-317503; Ferretti P, 2018, CELL HOST MICROBE, V24, P133, DOI 10.1016/j.chom.2018.06.005; Foley MH, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007581; Fulde M, 2018, NATURE, V560, P489, DOI 10.1038/s41586-018-0395-5; Hedblom GA, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01991; Hegyi P, 2018, PHYSIOL REV, V98, P1983, DOI 10.1152/physrev.00054.2017; Hughes KR, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.160155; Hviid A, 2011, GUT, V60, P49, DOI 10.1136/gut.2010.219683; Jeon Seong Gyu, 2012, PLoS Pathog, V8, pe1002714, DOI 10.1371/journal.ppat.1002714; Jia W, 2018, NAT REV GASTRO HEPAT, V15, P111, DOI 10.1038/nrgastro.2017.119; Kennedy EA, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01534; LactMed, 2006, DRUGS LACT DAT; Lavelle A, 2015, GUT, V64, P1553, DOI 10.1136/gutjnl-2014-307873; Lim LG, 2014, INFLAMM BOWEL DIS, V20, P892, DOI 10.1097/MIB.0000000000000027; Martini E, 2017, CELL MOL GASTROENTER, V4, P33, DOI 10.1016/j.jcmgh.2017.03.007; Moschen AR, 2016, CELL HOST MICROBE, V19, P455, DOI 10.1016/j.chom.2016.03.007; O'Neill I, 2017, EMERG TOP LIFE SCI, V1, P333, DOI 10.1042/ETLS20170058; Pan WH, 2018, GENOME MED, V10, DOI 10.1186/s13073-018-0534-5; Park J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156334; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; POTTEN CS, 1990, DEVELOPMENT, V110, P1001; Potten CS, 1997, INT J EXP PATHOL, V78, P219, DOI 10.1046/j.1365-2613.1997.280362.x; Rahim MBHA, 2019, ACTA DIABETOL, V56, P493, DOI 10.1007/s00592-019-01312-x; Renz H, 2017, J ALLERGY CLIN IMMUN, V140, P24, DOI 10.1016/j.jaci.2017.05.015; Robertson RC, 2019, TRENDS MICROBIOL, V27, P131, DOI 10.1016/j.tim.2018.09.008; Schirmer M, 2018, CELL HOST MICROBE, V24, P600, DOI 10.1016/j.chom.2018.09.009; Schubert AM, 2015, MBIO, V6, DOI 10.1128/mBio.00974-15; Selma-Royo M, 2019, ADV EXP MED BIOL, V1125, P3, DOI 10.1007/5584_2018_312; Shao Y, 2019, NATURE, V574, P117, DOI 10.1038/s41586-019-1560-1; Shen ZH, 2018, WORLD J GASTROENTERO, V24, P5, DOI 10.3748/wjg.v24.i1.5; Sina C, 2009, J IMMUNOL, V183, P7514, DOI 10.4049/jimmunol.0900063; Steury MD, 2017, ADV IMMUNOL, V136, P227, DOI 10.1016/bs.ai.2017.05.003; Stewart CJ, 2018, NATURE, V562, P583, DOI 10.1038/s41586-018-0617-x; Sultan AA, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1394-6; Verdier J, 2012, INFLAMM BOWEL DIS, V18, P1260, DOI 10.1002/ibd.21905; WEISER MM, 1973, J BIOL CHEM, V248, P2536; Williams JM, 2015, VET PATHOL, V52, P445, DOI 10.1177/0300985814559404; Williams JM, 2013, DIS MODEL MECH, V6, P1388, DOI 10.1242/dmm.013284; Zhang JP, 2010, PEDIATR RES, V68, P479, DOI 10.1203/PDR.0b013e3181f90810; Zhuang L, 2019, GENOM PROTEOM BIOINF, V17, P13, DOI 10.1016/j.gpb.2018.10.002	51	14	16	2	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					7075	7088		10.1096/fj.202000042R	http://dx.doi.org/10.1096/fj.202000042R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32253791	Green Accepted, Green Submitted, hybrid, Green Published			2022-12-28	WOS:000531325500072
J	Sipila, P; Junnila, A; Hakkarainen, J; Huhtaniemi, R; Mairinoja, L; Zhang, FP; Strauss, L; Ohlsson, C; Kotaja, N; Huhtaniemi, I; Poutanen, M				Sipila, P.; Junnila, A.; Hakkarainen, J.; Huhtaniemi, R.; Mairinoja, L.; Zhang, F. P.; Strauss, L.; Ohlsson, C.; Kotaja, N.; Huhtaniemi, I.; Poutanen, M.			The lack of HSD17B3 in male mice results in disturbed Leydig cell maturation and endocrine imbalance akin to humans with HSD17B3 deficiency	FASEB JOURNAL			English	Article						disorder of sex development; Leydig cell maturation	17-BETA-HYDROXYSTEROID-DEHYDROGENASE 3 DEFICIENCY; LUTEINIZING-HORMONE RECEPTOR; MALE PSEUDOHERMAPHRODITISM; DEHYDROGENASE-DEFICIENCY; EXPRESSION; DIAGNOSIS; MODELS; TISSUE; GERM	Hydroxysteroid (17 beta) dehydrogenase type 3 (HSD17B3) deficiency causes a disorder of sex development in humans, where affected males are born with female-appearing external genitalia, but are virilized during puberty. The hormonal disturbances observed in the Hsd17b3 knockout mice (HSD17B3KO), generated in the present study, mimic those found in patients with HSD17B3 mutations. Identical to affected humans, serum T in the adult HSD17B3KO mice was within the normal range, while a striking increase was detected in serum A-dione concentration. This resulted in a marked reduction of the serum T/A-dione ratio, a diagnostic hallmark for the patients with HSD17B3 deficiency. However, unlike humans, male HSD17B3KO mice were born with normally virilized phenotype, but presenting with delayed puberty. In contrast to the current belief, data from HSD17B3KO mice show that the circulating T largely originates from the testes, indicating a strong compensatory mechanism in the absence of HSD17B3. The lack of testicular malignancies in HSD17B3KO mice supports the view that testis tumors in human patients are due to associated cryptorchidism. The HSD17B3KO mice presented also with impaired Leydig cell maturation and signs of undermasculinization in adulthood. The identical hormonal disturbances between HSD17B3 deficient knockout mice and human patients make the current mouse model valuable for understanding the mechanism of the patient phenotypes, as well as endocrinopathies and compensatory steroidogenic mechanisms in HSD17B3 deficiency.	[Sipila, P.; Junnila, A.; Hakkarainen, J.; Huhtaniemi, R.; Mairinoja, L.; Zhang, F. P.; Strauss, L.; Kotaja, N.; Huhtaniemi, I.; Poutanen, M.] Univ Turku, Res Ctr Integrat Physiol & Pharmacol, Inst Biomed, Kiinamyllynkatu 10, FI-20520 Turku, Finland; [Sipila, P.; Strauss, L.; Poutanen, M.] Univ Turku, Inst Biomed, TCDM, Turku, Finland; [Ohlsson, C.; Poutanen, M.] Gothenburg Univ, Sahlgrenska Acad, Inst Med, Gothenburg, Sweden; [Zhang, F. P.] Univ Helsinki, STEMM Res Program, Fac Med, GM Unit,Lab Anim Ctr, Helsinki, Finland	University of Turku; University of Turku; University of Gothenburg; University of Helsinki	Poutanen, M (corresponding author), Univ Turku, Res Ctr Integrat Physiol & Pharmacol, Inst Biomed, Kiinamyllynkatu 10, FI-20520 Turku, Finland.	matti.poutanen@utu.fi	Ohlsson, Claes/AGP-3544-2022; Ohlsson, Claes/HIR-6959-2022; Sipilä, Petra/GYE-3323-2022; Strauss, Leena/AAY-8824-2021	Ohlsson, Claes/0000-0002-9633-2805; Ohlsson, Claes/0000-0002-9633-2805; Sipila, Petra/0000-0001-8187-7143; Kotaja, Noora/0000-0003-1503-9170; Junnila, Arttu/0000-0002-1134-0962	Sigrid Juselius Foundation; Academy of Finland; Biocenter Finland	Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland); Biocenter Finland	Sigrid Juselius Foundation; Academy of Finland; Biocenter Finland	Andersson S, 1996, TRENDS ENDOCRIN MET, V7, P121, DOI 10.1016/1043-2760(96)00034-3; BAMBINO TH, 1981, ENDOCRINOLOGY, V108, P2142, DOI 10.1210/endo-108-6-2142; Bertelloni S., 2009, EXPERT REV ENDOCRINO, V4, P53, DOI [10.1586/17446651.4.1.53, DOI 10.1586/17446651.4.1.53]; Boehmer ALM, 1999, J CLIN ENDOCR METAB, V84, P4713, DOI 10.1210/jc.84.12.4713; Byers SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035538; Cheng L, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0029-0; Cools M, 2005, J CLIN ENDOCR METAB, V90, P5295, DOI 10.1210/jc.2005-0139; Corbould AM, 1998, J CLIN ENDOCR METAB, V83, P187, DOI 10.1210/jc.83.1.187; DAVIS S, 1980, J CLIN ENDOCR METAB, V51, P1293, DOI 10.1210/jcem-51-6-1293; ECKSTEIN B, 1989, J CLIN ENDOCR METAB, V68, P477, DOI 10.1210/jcem-68-2-477; Folsom LJ, 2019, MOL CELL ENDOCRINOL, V489, P3, DOI 10.1016/j.mce.2018.11.014; George MM, 2010, HORM RES PAEDIAT, V74, P229, DOI 10.1159/000318004; GOTOH M, 1984, UROL RES, V12, P159; HAAVISTO AM, 1993, ENDOCRINOLOGY, V132, P1687, DOI 10.1210/en.132.4.1687; Hakkarainen J, 2018, FASEB J, V32, P3229, DOI 10.1096/fj.201700921R; Hardy MP, 2005, CELL TISSUE RES, V322, P147, DOI 10.1007/s00441-005-0006-2; Hughes IA, 2006, ARCH DIS CHILD, V91, P554, DOI [10.1016/j.jpurol.2006.03.004, 10.1136/adc.2006.098319]; Huhtaniemi I, 2004, TURKISH J PEDIATR, V46, P28; Huhtaniemi R, 2018, AM J PATHOL, V188, P2890, DOI 10.1016/j.ajpath.2018.07.029; IMPERATOMCGINLEY J, 1979, J CLIN ENDOCR METAB, V49, P391, DOI 10.1210/jcem-49-3-391; Kilcoyne KR, 2014, P NATL ACAD SCI USA, V111, pE1924, DOI 10.1073/pnas.1320735111; KORENBROT CC, 1977, BIOL REPROD, V17, P298, DOI 10.1095/biolreprod17.2.298; Kotaja N, 2004, NAT METHODS, V1, P249, DOI 10.1038/nmeth1204-249; Kreisman MJ, 2017, ENDOCRINOLOGY, V158, P2884, DOI 10.1210/en.2017-00285; Mahendroo MS, 2001, ENDOCRINOLOGY, V142, P4652, DOI 10.1210/en.142.11.4652; Mendonca BB, 2000, MEDICINE, V79, P299, DOI 10.1097/00005792-200009000-00003; Mendonca BB, 1999, J CLIN ENDOCR METAB, V84, P802, DOI 10.1210/jc.84.2.802; Mendonca BB, 2017, J STEROID BIOCHEM, V165, P79, DOI 10.1016/j.jsbmb.2016.05.002; Nilsson ME, 2015, ENDOCRINOLOGY, V156, P2492, DOI 10.1210/en.2014-1890; Nokelainen P, 1996, EUR J BIOCHEM, V236, P482, DOI 10.1111/j.1432-1033.1996.00482.x; O'Hara L, 2015, FASEB J, V29, P894, DOI 10.1096/fj.14-255729; O'Shaughnessy PJ, 2000, ENDOCRINOLOGY, V141, P2631, DOI 10.1210/en.141.7.2631; Pakarinen P, 2002, ENDOCRINOLOGY, V143, P4477, DOI 10.1210/en.2002-220052; Rebourcet D, 2017, ENDOCRINOLOGY, V158, P2955, DOI 10.1210/en.2017-00196; ROSLER A, 1992, J STEROID BIOCHEM, V43, P989, DOI 10.1016/0960-0760(92)90327-F; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; Saloniemi T, 2012, J ENDOCRINOL, V212, P27, DOI 10.1530/JOE-11-0315; Shima Y, 2013, MOL ENDOCRINOL, V27, P63, DOI 10.1210/me.2012-1256; Steckelbroeck S, 1999, J NEUROENDOCRINOL, V11, P457; Teerds KJ, 2015, HUM REPROD UPDATE, V21, P310, DOI 10.1093/humupd/dmv008; van Casteren JIJ, 2000, BIOL REPROD, V62, P886, DOI 10.1095/biolreprod62.4.886; van den Driesche S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037064; Werner R, 2012, SEX DEV, V6, P161, DOI 10.1159/000336605; Yang ZW, 2017, J STEROID BIOCHEM, V174, P141, DOI 10.1016/j.jsbmb.2017.08.012; Zhang FP, 2001, MOL ENDOCRINOL, V15, P172, DOI 10.1210/me.15.1.172	45	4	4	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6111	6128		10.1096/fj.201902384R	http://dx.doi.org/10.1096/fj.201902384R		MAR 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32190925				2022-12-28	WOS:000521550400001
J	Chou, LY; Chen, CH; Lin, YH; Chuang, SC; Chou, HC; Lin, SY; Fu, YC; Chang, JK; Ho, ML; Wang, CZ				Chou, Liang-Yin; Chen, Chung-Hwan; Lin, Yi-Hsiung; Chuang, Shu-Chun; Chou, Hsin-Chiao; Lin, Sung-Yen; Fu, Yin-Chi; Chang, Je-Ken; Ho, Mei-Ling; Wang, Chau-Zen			Discoidin domain receptor 1 regulates endochondral ossification through terminal differentiation of chondrocytes	FASEB JOURNAL			English	Article						chondrocytes; DDR1; discoidin domain receptor 1; endochondral ossification; skeletal development	GROWTH-PLATE; RUNX2; BONE; CARTILAGE; PROLIFERATION; KINASE; MATRIX; OSTEOARTHRITIS; TRANSCRIPTION; EXPRESSION	Chondrocytes in growth plates are responsible for longitudinal growth in long bones during endochondral ossification. Discoidin domain receptor 1 (Ddr1) is expressed in chondrocytes, but the molecular mechanisms by which DDR1 regulates chondrocyte behaviors during the endochondral ossification process remain undefined. To elucidate Ddr1-mediate chondrocyte functions, we generated chondrocyte-specific Ddr1 knockout (CKO Delta Ddr1) mice in this study. The CKO Delta Ddr1 mice showed delayed development of the secondary ossification center and increased growth plate length in the hind limbs. In the tibial growth plate in CKO Delta Ddr1 mice, chondrocyte proliferation was reduced in the proliferation zone, and remarkable downregulation of Ihh, MMP13, and Col-X expression in chondrocytes resulted in decreased terminal differentiation in the hypertrophic zone. Furthermore, apoptotic chondrocytes were reduced in the growth plates of CKO Delta Ddr1 mice. We concluded that chondrocytes with Ddr1 knockout exhibit decreased proliferation, terminal differentiation, and apoptosis in growth plates, which delays endochondral ossification and results in short stature. We also demonstrated that Ddr1 regulates the Ihh/Gli1/Gli2/Col-X pathway to regulate chondrocyte terminal differentiation. These results indicate that Ddr1 is required for chondrocytes to regulate endochondral ossification in skeletal development.	[Chou, Liang-Yin; Chou, Hsin-Chiao; Lin, Sung-Yen; Fu, Yin-Chi; Ho, Mei-Ling; Wang, Chau-Zen] Kaohsiung Med Univ, Grad Inst Med, Coll Med, 100,Shih Chuan 1st Rd, Kaohsiung 807, Taiwan; [Chou, Liang-Yin; Chen, Chung-Hwan; Chuang, Shu-Chun; Chou, Hsin-Chiao; Lin, Sung-Yen; Fu, Yin-Chi; Chang, Je-Ken; Ho, Mei-Ling; Wang, Chau-Zen] Kaohsiung Med Univ, Orthopaed Res Ctr, Kaohsiung, Taiwan; [Chou, Liang-Yin; Chen, Chung-Hwan; Chuang, Shu-Chun; Chou, Hsin-Chiao; Lin, Sung-Yen; Fu, Yin-Chi; Chang, Je-Ken; Ho, Mei-Ling; Wang, Chau-Zen] Kaohsiung Med Univ, Regenerat Med & Cell Therapy Res Ctr, Kaohsiung, Taiwan; [Chen, Chung-Hwan; Lin, Sung-Yen; Fu, Yin-Chi; Ho, Mei-Ling] Kaohsiung Med Univ, Dept Orthoped, Coll Med, Kaohsiung, Taiwan; [Chen, Chung-Hwan; Lin, Sung-Yen; Chang, Je-Ken] Kaohsiung Med Univ, Kaohsiung Municipal Ta Tung Hosp, Dept Orthoped, Kaohsiung, Taiwan; [Chen, Chung-Hwan] Natl Sun Yat Sen Univ, Inst Med Sci & Technol, Kaohsiung, Taiwan; [Chen, Chung-Hwan; Chang, Je-Ken] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Adult Reconstruct Surg, Dept Orthoped, Kaohsiung, Taiwan; [Lin, Yi-Hsiung] Kaohsiung Med Univ, Dept Biotechnol, Kaohsiung, Taiwan; [Lin, Yi-Hsiung] Kaohsiung Med Univ Hosp, Dept Internal Med, Div Cardiol, Kaohsiung, Taiwan; [Lin, Yi-Hsiung] Kaohsiung Med Univ, Lipid Sci & Aging Res Ctr, Kaohsiung, Taiwan; [Ho, Mei-Ling; Wang, Chau-Zen] Kaohsiung Med Univ, Coll Med, Dept Physiol, 100,Shih Chuan 1st Rd, Kaohsiung 807, Taiwan; [Ho, Mei-Ling] Natl Sun Yat Sen Univ, Dept Marine Biotechnol & Resources, Kaohsiung, Taiwan; [Wang, Chau-Zen] Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital; National Sun Yat Sen University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; National Sun Yat Sen University; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Ho, ML; Wang, CZ (corresponding author), Kaohsiung Med Univ, Grad Inst Med, Coll Med, 100,Shih Chuan 1st Rd, Kaohsiung 807, Taiwan.; Ho, ML; Wang, CZ (corresponding author), Kaohsiung Med Univ, Coll Med, Dept Physiol, 100,Shih Chuan 1st Rd, Kaohsiung 807, Taiwan.	homelin@kmu.edu.tw; czwang@kmu.edu.tw	Chen, Chung-Hwan/D-4036-2009	Chen, Chung-Hwan/0000-0001-8941-4792; Ho, Mei-Ling/0000-0001-8064-8488; Chang, Je-Ken/0000-0001-8485-2574	Ministry of Science and Technology (MOST) [MOST108-2320-B-037-008, MOST108-2314-B-037-059-MY3]; Kaohsiung Medical University [KMU-TP-105B10, KMU-DK105009, KMU-TC108A02, KMU-TC108A02-1]	Ministry of Science and Technology (MOST)(Ministry of Science and Technology, China); Kaohsiung Medical University	Ministry of Science and Technology (MOST), Grant/Award Number: MOST108-2320-B-037-008 and MOST108-2314-B-037-059-MY3; Kaohsiung Medical University, Grant/Award Number: KMU-TP-105B10, KMU-DK105009, KMU-TC108A02 and KMU-TC108A02-1	Amano K, 2014, J BIOL CHEM, V289, P24898, DOI 10.1074/jbc.M114.570507; Borza CM, 2014, MATRIX BIOL, V34, P185, DOI 10.1016/j.matbio.2013.12.002; Bruderer M, 2014, EUR CELLS MATER, V28, P269, DOI 10.22203/eCM.v028a19; Chen HY, 2014, J BONE MINER RES, V29, P2653, DOI 10.1002/jbmr.2287; Chen L, 2001, HUM MOL GENET, V10, P457, DOI 10.1093/hmg/10.5.457; Chen S, 2015, GENES DIS, V2, P76, DOI 10.1016/j.gendis.2014.12.003; Dreier R, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3117; Harrington EK, 2010, ANAT REC, V293, P225, DOI 10.1002/ar.21072; Henry SP, 2012, J BONE MINER RES, V27, P2511, DOI 10.1002/jbmr.1696; Karp SJ, 2000, DEVELOPMENT, V127, P543; Kozhemyakina E, 2009, MOL CELL BIOL, V29, P5751, DOI 10.1128/MCB.00415-09; Kwon TG, 2011, J CELL BIOCHEM, V112, P3582, DOI 10.1002/jcb.23289; Labrador JP, 2001, EMBO REP, V2, P446, DOI 10.1093/embo-reports/kve094; Leitinger B, 2004, J MOL BIOL, V344, P993, DOI 10.1016/j.jmb.2004.09.089; Leitinger B, 2006, MATRIX BIOL, V25, P355, DOI 10.1016/j.matbio.2006.05.006; Leitinger B, 2014, INT REV CEL MOL BIO, V310, P39, DOI 10.1016/B978-0-12-800180-6.00002-5; Li YW, 2009, DEVELOPMENT, V136, P1083, DOI 10.1242/dev.023820; Loebel C, 2015, TISSUE ENG PT A, V21, P115, DOI [10.1089/ten.tea.2014.0096, 10.1089/ten.TEA.2014.0096]; Mackie EJ, 2008, INT J BIOCHEM CELL B, V40, P46, DOI 10.1016/j.biocel.2007.06.009; Mohan RR, 2001, EXP EYE RES, V72, P87, DOI 10.1006/exer.2000.0932; Nakamura E, 2006, DEV DYNAM, V235, P2603, DOI 10.1002/dvdy.20892; Ovchinnikov DA, 2000, GENESIS, V26, P145, DOI 10.1002/(SICI)1526-968X(200002)26:2<145::AID-GENE14>3.0.CO;2-C; PINES M, 1991, POULTRY SCI, V70, P1806, DOI 10.3382/ps.0701806; Pitsillides AA, 2011, NAT REV RHEUMATOL, V7, P654, DOI 10.1038/nrrheum.2011.129; Pratap J, 2005, MOL CELL BIOL, V25, P8581, DOI 10.1128/MCB.25.19.8581-8591.2005; Schminke B, 2014, CELL MOL LIFE SCI, V71, P1081, DOI 10.1007/s00018-013-1436-8; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Stanton LA, 2004, BIOCHEM J, V378, P53, DOI 10.1042/BJ20030874; Stickens D, 2004, DEVELOPMENT, V131, P5883, DOI 10.1242/dev.01461; Studer D, 2012, EUR CELLS MATER, V24, P118, DOI 10.22203/eCM.v024a09; Valiathan RR, 2012, CANCER METAST REV, V31, P295, DOI 10.1007/s10555-012-9346-z; Vogel WF, 2006, CELL SIGNAL, V18, P1108, DOI 10.1016/j.cellsig.2006.02.012; Whitaker AT, 2017, BIOL OPEN, V6, P358, DOI 10.1242/bio.021436; Yoshida CA, 2004, GENE DEV, V18, P952, DOI 10.1101/gad.1174704; Zhou G, 2006, P NATL ACAD SCI USA, V103, P19004, DOI 10.1073/pnas.0605170103	35	11	12	2	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5767	5781		10.1096/fj.201901852RR	http://dx.doi.org/10.1096/fj.201901852RR		MAR 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32128899	Bronze			2022-12-28	WOS:000517936400001
J	Das, S; Neelamegam, K; Peters, WN; Periyasamy, R; Pandey, KN				Das, Subhankar; Neelamegam, Kandasamy; Peters, Whitney N.; Periyasamy, Ramu; Pandey, Kailash N.			Depletion of cyclic-GMP levels and inhibition of cGMP-dependent protein kinase activate p21(Cip1)/p27(Kip1)pathways and lead to renal fibrosis and dysfunction	FASEB JOURNAL			English	Article						CDK blockers; cGMP; cGK; gene-targeting; natriuretic peptides; NPRA; renal fibrosis	ATRIAL-NATRIURETIC-PEPTIDE; SIGNAL-REGULATED KINASE; GROWTH-FACTOR-BETA; A GENE-KNOCKOUT; NF-KAPPA-B; SMOOTH-MUSCLE; MESANGIAL CELLS; DOWN-REGULATION; P27(KIP1) DEGRADATION; DIABETIC-NEPHROPATHY	Cell-cycle regulatory proteins (p21(Cip1)/p27(Kip1)) inhibit cyclin and cyclin-dependent kinase (CDK) complex that promotes fibrosis and hypertrophy. The present study examined the role of CDK blockers, p21(Cip1)/p27(Kip1)in the progression of renal fibrosis and dysfunction usingNpr1(encoding guanylyl cyclase/natriuretic peptide receptor-A, GC-A/NPRA) gene-knockout (0-copy;Npr1(-/-)), 2-copy (Npr1(+/+)), and 4-copy (Npr1(++/++)) mice treated with GC inhibitor, A71915 and cGMP-dependent protein kinase (cGK) inhibitor, (Rp-8-Br-cGMPS). A significant decrease in renal cGMP levels and cGK activity was observed in 0-copy mice and A71915- and Rp-treated 2-copy and 4-copy mice compared with controls. An increased phosphorylation of Erk1/2, p38, p21(Cip1), and p27(Kip1)occurred in 0-copy and A71915-treated 2-copy and 4-copy mice, while Rp treatment caused minimal changes than controls. Pro-inflammatory (TNF-alpha, IL-6) and pro-fibrotic (TGF-beta 1) cytokines were significantly increased in plasma and kidneys of 0-copy and A71915-treated 2-copy mice, but to lesser extent in 4-copy mice. Progressive renal pathologies, including fibrosis, mesangial matrix expansion, and tubular hypertrophy were observed in 0-copy and A71915-treated 2-copy and 4-copy mice, but minimally occurred in Rp-treated mice compared with controls. These results indicate thatNpr1has pivotal roles in inhibiting renal fibrosis and hypertrophy and exerts protective effects involving cGMP/cGK axis by repressing CDK blockers p21(Cip1)and p27(Kip1).	[Das, Subhankar; Neelamegam, Kandasamy; Peters, Whitney N.; Periyasamy, Ramu; Pandey, Kailash N.] Tulane Univ, Sch Med, Dept Physiol, Hlth Sci Ctr, 1430 Tulane Ave, New Orleans, LA 70112 USA	Tulane University	Pandey, KN (corresponding author), Tulane Univ, Sch Med, Dept Physiol, Hlth Sci Ctr, 1430 Tulane Ave, New Orleans, LA 70112 USA.	kpandey@tulane.edu	Neelamegam, Kandasamy/AAU-4746-2021		HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) [HL062147]	HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI)	HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: HL062147	Airhart N, 2003, J BIOL CHEM, V278, P38693, DOI 10.1074/jbc.M304098200; Al-Douahji M, 1999, KIDNEY INT, V56, P1691, DOI 10.1046/j.1523-1755.1999.00728.x; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Bretones G, 2015, BBA-GENE REGUL MECH, V1849, P506, DOI 10.1016/j.bbagrm.2014.03.013; BRONDELLO JM, 1995, ONCOGENE, V10, P1895; Browner NC, 2004, AM J PHYSIOL-CELL PH, V287, pC88, DOI 10.1152/ajpcell.00039.2004; Bryan PM, 2007, AM J PHYSIOL-RENAL, V292, pF1636, DOI 10.1152/ajprenal.00418.2006; Casteel DE, 2002, J BIOL CHEM, V277, P32003, DOI 10.1074/jbc.M112332200; Chang J, 2018, J PHYS CHEM LETT, V9, P881, DOI 10.1021/acs.jpclett.7b03417; Chang SH, 2004, AM J PHYSIOL-REG I, V287, pR950, DOI 10.1152/ajpregu.00639.2003; Chang TS, 2003, J BIOL CHEM, V278, P48092, DOI 10.1074/jbc.M309421200; Cheng MG, 1998, P NATL ACAD SCI USA, V95, P1091, DOI 10.1073/pnas.95.3.1091; Cheng XY, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/463740; Cui WP, 2014, AM J PHYSIOL-RENAL, V306, pF996, DOI 10.1152/ajprenal.00657.2013; Das S, 2012, PHYSIOL GENOMICS, V44, P430, DOI 10.1152/physiolgenomics.00147.2011; Das S, 2010, ENDOCRINOLOGY, V151, P5841, DOI 10.1210/en.2010-0655; Deguchi A, 2004, CANCER RES, V64, P3966, DOI 10.1158/0008-5472.CAN-03-3740; Delmas C, 2001, J BIOL CHEM, V276, P34958, DOI 10.1074/jbc.M101714200; Ernest S, 1996, AM J PHYSIOL-CELL PH, V270, pC910, DOI 10.1152/ajpcell.1996.270.3.C910; Geiselhoringer A, 2004, FEBS LETT, V575, P19, DOI 10.1016/j.febslet.2004.08.030; Gogulamudi VR, 2019, AM J PHYSIOL-RENAL, V316, pF1254, DOI 10.1152/ajprenal.00621.2018; Gudi T, 2002, J BIOL CHEM, V277, P37382, DOI 10.1074/jbc.M204491200; Hannken T, 2000, J AM SOC NEPHROL, V11, P1387, DOI 10.1681/ASN.V1181387; Hesabi B, 2012, CELL SIGNAL, V24, P1100, DOI 10.1016/j.cellsig.2012.01.006; Hofmann Franz, 2013, Methods Mol Biol, V1020, P17, DOI 10.1007/978-1-62703-459-3_2; Huang HC, 2000, KIDNEY INT, V58, P162, DOI 10.1046/j.1523-1755.2000.00151.x; Huang S, 2003, MOL CELL, V11, P1491, DOI 10.1016/S1097-2765(03)00180-1; Ishizuka S, 1999, BIOCHEM BIOPH RES CO, V254, P88, DOI 10.1006/bbrc.1998.9902; Jacob A, 2004, AM J PHYSIOL-CELL PH, V287, pC1077, DOI 10.1152/ajpcell.00477.2003; JAMALL IS, 1981, ANAL BIOCHEM, V112, P70, DOI 10.1016/0003-2697(81)90261-X; JOYCE NC, 1986, J CYCLIC NUCL PROT, V11, P191; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Kawada M, 1997, ONCOGENE, V15, P629, DOI 10.1038/sj.onc.1201228; Kiemer AK, 2002, CIRC RES, V90, P874, DOI 10.1161/01.RES.0000017068.58856.F3; Kuan CJ, 1998, J AM SOC NEPHROL, V9, P986; Kumar P, 2017, AM J PHYSIOL-RENAL, V313, pF781, DOI 10.1152/ajprenal.00166.2017; Levin ER, 1998, NEW ENGL J MED, V339, P321; Li YZ, 2012, AM J PHYSIOL-RENAL, V302, pF561, DOI 10.1152/ajprenal.00355.2011; Liu S, 2007, FREE RADICAL BIO MED, V42, P852, DOI 10.1016/j.freeradbiomed.2006.12.025; Lu ZM, 2010, CELL CYCLE, V9, P2342, DOI 10.4161/cc.9.12.11988; Maimaitiyiming H, 2013, AM J PHYSIOL-RENAL, V305, pF881, DOI 10.1152/ajprenal.00192.2013; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MISRAPRESS A, 1995, J BIOL CHEM, V270, P14587, DOI 10.1074/jbc.270.24.14587; Monkawa T, 2002, J AM SOC NEPHROL, V13, P1172, DOI 10.1097/01.ASN.0000013162.29833.45; Mortensen J, 2011, INFLAMM RES, V60, P299, DOI 10.1007/s00011-010-0268-3; Nishikimi T, 2009, REGUL PEPTIDES, V154, P44, DOI 10.1016/j.regpep.2009.02.006; NOGUCHI T, 1993, MOL CELL BIOL, V13, P5195, DOI 10.1128/MCB.13.9.5195; Oliver PM, 1998, P NATL ACAD SCI USA, V95, P2547, DOI 10.1073/pnas.95.5.2547; Oliver PM, 1997, P NATL ACAD SCI USA, V94, P14730, DOI 10.1073/pnas.94.26.14730; Pandey KN, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20163946; Pandey KN, 1999, ENDOCRINOLOGY, V140, P5112, DOI 10.1210/en.140.11.5112; Peng HM, 2001, HYPERTENSION, V37, P974, DOI 10.1161/01.HYP.37.3.974; Periyasamy R, 2019, PEPTIDES, V114, P17, DOI 10.1016/j.peptides.2019.03.001; Prieto Minolfa C, 2012, Int J Physiol Pathophysiol Pharmacol, V4, P128; Pumiglia KM, 1997, P NATL ACAD SCI USA, V94, P448, DOI 10.1073/pnas.94.2.448; Roovers K, 2000, BIOESSAYS, V22, P818, DOI 10.1002/1521-1878(200009)22:9<818::AID-BIES7>3.3.CO;2-Y; Sanches TR, 2012, AM J PHYSIOL-RENAL, V302, pF216, DOI 10.1152/ajprenal.00439.2010; Sauzeau V, 2003, J BIOL CHEM, V278, P9472, DOI 10.1074/jbc.M212776200; Schinner E, 2017, FEBS OPEN BIO, V7, P550, DOI 10.1002/2211-5463.12202; Schinner E, 2013, KIDNEY INT, V84, P1198, DOI 10.1038/ki.2013.219; Sebolt-Leopold JS, 1999, NAT MED, V5, P810, DOI 10.1038/10533; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Sharma GD, 2002, MOL CELL BIOCHEM, V233, P165, DOI 10.1023/A:1015882302796; Shi SJ, 2003, AM J PHYSIOL-RENAL, V285, pF694, DOI 10.1152/ajprenal.00097.2003; Shi SJ, 2001, AM J PHYSIOL-RENAL, V281, pF665, DOI 10.1152/ajprenal.2001.281.4.F665; SMITHIES O, 1994, P NATL ACAD SCI USA, V91, P3612, DOI 10.1073/pnas.91.9.3612; Somanna Naveen K, 2013, Int J Biochem Mol Biol, V4, P41; Sugimoto T, 1996, J BIOL CHEM, V271, P544, DOI 10.1074/jbc.271.1.544; SUN H, 1994, SCIENCE, V266, P285, DOI 10.1126/science.7939666; Tapia E, 2012, KIDNEY BLOOD PRESS R, V35, P273, DOI 10.1159/000334952; Tripathi S, 2012, MOL CELL BIOCHEM, V368, P47, DOI 10.1007/s11010-012-1341-8; Vellaichamy E, 2005, J BIOL CHEM, V280, P19230, DOI 10.1074/jbc.M411373200; Vellaichamy E, 2007, PHYSIOL GENOMICS, V31, P193, DOI 10.1152/physiolgenomics.00079.2007; Vellaichamy E, 2014, ENDOCRINOLOGY, V155, P1045, DOI 10.1210/en.2013-1416; Wang JJ, 2006, DIABETES, V55, P1678, DOI 10.2337/db05-1448; Wang SX, 2003, DIABETES, V52, P2144, DOI 10.2337/diabetes.52.8.2144; WOLF G, 1992, KIDNEY INT, V42, P647, DOI 10.1038/ki.1992.330; Wolf G, 2001, AM J PATHOL, V158, P1091, DOI 10.1016/S0002-9440(10)64056-4; Wolf G, 1997, AM J PHYSIOL-RENAL, V273, pF348, DOI 10.1152/ajprenal.1997.273.3.F348; Wolf G, 1998, KIDNEY INT, V53, P869, DOI 10.1046/j.1523-1755.1998.00829.x; Wolfertstetter S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126057; Yano T, 1998, LIFE SCI, V62, P2341, DOI 10.1016/S0024-3205(98)00215-X; Zaidi ARS, 2019, J CELL COMMUN SIGNAL, V13, P421, DOI 10.1007/s12079-018-0494-y; Zhao D, 2013, J HYPERTENS, V31, P134, DOI 10.1097/HJH.0b013e32835ac15f	84	8	9	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					11925	11943		10.1096/fj.202000754R	http://dx.doi.org/10.1096/fj.202000754R		JUL 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32686172	Green Published, hybrid			2022-12-28	WOS:000553642700001
J	Xian, WY; Wang, HM; Moretti, A; Laugwitz, KL; Flockerzi, V; Lipp, P				Xian, Wenying; Wang, Hongmei; Moretti, Alessandra; Laugwitz, Karl-Ludwig; Flockerzi, Veit; Lipp, Peter			Domain zipping and unzipping modulates TRPM4's properties in human cardiac conduction disease	FASEB JOURNAL			English	Article						cardiac conduction disease; calcium; S4-S5 linker; TRP domain; TRPM4	ION-CHANNEL; S4-S5 LINKER; TRPV1 STRUCTURES; VOLTAGE SENSOR; REVEAL; MUTATION; GAIN; ACTIVATION; BOX	The transient receptor potential melastatin 4 (TRPM4) is a Ca2+-activated nonselective cation channel linked to human cardiac diseases. The human mutation K914R within TRPM4's S4-S5 linker was identified in patients with atrioventricular block. During UV-flash-mediated Ca(2+)transients, TRPM4(K914R) generated a threefold augmented membrane current concomitant with 2 to 3-fold slowed down activation and deactivation kinetics resulting in excessive membrane currents during human cardiac action potentials. Mutagenesis of K914 paired with molecular modeling suggested the importance of the nanoscopic interface between the S4-S5 linker, the MHR4-, and TRP-domain as a major determinant for TRPM4's behavior. Rational mutagenesis of an interacting amino acid (R1062Q) in the TRP domain was able to offset K914R`s gain-of-function by zipping and unzipping of this nanoscopic interface. In conclusion, repulsion and attraction between the amino acids at positions 914 and 1062 alters the flexibility of the nanoscopic interface suggesting a zipping and unzipping mechanism that modulates TRPM4's functions. Pharmacological modulation of this intramolecular mechanism might represent a novel therapeutic strategy for the management of TRPM4-mediated cardiac diseases.	[Xian, Wenying; Lipp, Peter] Saarland Univ, Med Fac, Ctr Mol Signaling PZMS, Mol Cell Biol, D-66421 Homburg, Germany; [Wang, Hongmei; Flockerzi, Veit] Saarland Univ, Med Fac, Ctr Mol Signaling PZMS, Expt & Clin Pharmacol & Toxicol, Homburg, Germany; [Moretti, Alessandra; Laugwitz, Karl-Ludwig] Tech Univ Munich, Med Dept Cardiol 1, Klinikum Rechts Isar, Munich, Germany; [Moretti, Alessandra; Laugwitz, Karl-Ludwig] DZHK German Ctr Cardiovasc Res, Partner Site Munich Heart Alliance, Munich, Germany; [Wang, Hongmei] Southeast Univ, Sch Med, Dept Pharmacol, Nanjing, Peoples R China	Universitatsklinikum des Saarlandes; Universitatsklinikum des Saarlandes; Technical University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance; Southeast University - China	Lipp, P (corresponding author), Saarland Univ, Med Fac, Ctr Mol Signaling PZMS, Mol Cell Biol, D-66421 Homburg, Germany.	peter.lipp@uks.eu	wang, hongmei/HGT-7374-2022; Moretti, Alessandra/O-9271-2015	wang, hongmei/0000-0002-6975-9467; Moretti, Alessandra/0000-0001-5782-7832	Deutsche Forschungsgemeinschaft (DFG) [SFB TRR 152]; Alexander von Humboldt-Stiftung (Humboldt Foundation)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Alexander von Humboldt-Stiftung (Humboldt Foundation)(Alexander von Humboldt Foundation)	Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: SFB TRR 152; Alexander von Humboldt-Stiftung (Humboldt Foundation)	[Anonymous], 2014, J PHYS CHEM B; Autzen HE, 2018, SCIENCE, V359, P228, DOI 10.1126/science.aar4510; Bianchi B, 2018, FRONT PHYSIOL, V9, P873; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Chen Z., 2016, EUR HEART J, V38, P292; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gao Y, 2016, NATURE, V534, P347, DOI 10.1038/nature17964; Garcia-Sanz N, 2007, J NEUROSCI, V27, P11641, DOI 10.1523/JNEUROSCI.2457-07.2007; Gregorio-Teruel L, 2014, J GEN PHYSIOL, V143, P361, DOI 10.1085/jgp.201311070; Guo JT, 2017, NATURE, V552, P205, DOI 10.1038/nature24997; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hofmann L, 2017, CELL CALCIUM, V67, P156, DOI 10.1016/j.ceca.2017.04.002; Kremeyer B, 2010, NEURON, V66, P671, DOI 10.1016/j.neuron.2010.04.030; Kruse M, 2009, J CLIN INVEST, V119, P2737, DOI 10.1172/JCI38292; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Lin ZM, 2012, AM J HUM GENET, V90, P558, DOI 10.1016/j.ajhg.2012.02.006; Liu H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054131; Liu H, 2010, CIRC-CARDIOVASC GENE, V3, P374, DOI 10.1161/CIRCGENETICS.109.930867; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Nilius B, 2006, EMBO J, V25, P467, DOI 10.1038/sj.emboj.7600963; Nilius B, 2005, J BIOL CHEM, V280, P6423, DOI 10.1074/jbc.M411089200; Nilius B, 2003, J BIOL CHEM, V278, P30813, DOI 10.1074/jbc.M305127200; Nilius B, 2006, PFLUG ARCH EUR J PHY, V453, P313, DOI 10.1007/s00424-006-0088-z; Paulsen CE, 2015, NATURE, V520, P511, DOI 10.1038/nature14367; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Stallmeyer B, 2012, HUM MUTAT, V33, P109, DOI 10.1002/humu.21599; Teng JF, 2016, P NATL ACAD SCI USA, V113, P11847, DOI 10.1073/pnas.1613523113; Teng JF, 2015, P NATL ACAD SCI USA, V112, P3386, DOI 10.1073/pnas.1502366112; Valente P, 2011, FASEB J, V25, P1628, DOI 10.1096/fj.10-174433; Voets T, 2007, NAT CHEM BIOL, V3, P174, DOI 10.1038/nchembio862; Wang HJ, 2019, J INVEST DERMATOL, V139, P1089, DOI 10.1016/j.jid.2018.10.044; Winkler PA, 2017, NATURE, V552, P200, DOI 10.1038/nature24674; Xian WY, 2018, CELL REP, V24, P724, DOI 10.1016/j.celrep.2018.06.034; Zhou YY, 2018, P NATL ACAD SCI USA, V115, pE11864, DOI 10.1073/pnas.1813162115; Zima V, 2015, NEUROPHARMACOLOGY, V93, P294, DOI 10.1016/j.neuropharm.2015.02.018	35	4	4	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12114	12126		10.1096/fj.202000097RR	http://dx.doi.org/10.1096/fj.202000097RR		JUL 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32681584	Green Published, hybrid			2022-12-28	WOS:000552111300001
J	Zhang, N; Yang, K; Bai, J; Yi, J; Gao, CC; Zhao, JL; Liang, SQ; Wei, TX; Feng, L; Song, LQ; Han, H; Qin, HY				Zhang, Ni; Yang, Kui; Bai, Jian; Yi, Jing; Gao, Chunchen; Zhao, Junlong; Liang, Shiqian; Wei, Tiaoxia; Feng, Lei; Song, Liqiang; Han, Hua; Qin, Hongyan			Myeloid-specific blockade of Notch signaling alleviates murine pulmonary fibrosis through regulating monocyte-derived Ly6c(lo)MHCII(hi) alveolar macrophages recruitment and TGF-beta secretion	FASEB JOURNAL			English	Article						alveolar macrophages; Notch signaling; pulmonary; lung fibrosis; TGF-beta	INTERSTITIAL MACROPHAGES; LUNG; ACTIVATION; CELLS; LIVER; DIFFERENTIATION; INFLAMMATION; POLARIZATION; ONTOGENY; PATHWAY	Macrophages in lung, including resident alveolar macrophages (AMs) and interstitial macrophages (IMs), and monocyte-derived macrophages, play important roles in pulmonary fibrosis (PF), but mechanisms underlying their differential regulation remain unclear. Recombination signal-binding protein J kappa (RBP-J)-mediated Notch signaling regulates macrophage development and phenotype. Here, using bleomycin-induced fibrosis model combined with myeloid-specific RBP-J disruption (RBP-J(cKO)) mouse, we investigated the role of Notch signaling in macrophages during PF. Compared with the control, RBP-J(cKO) mice exhibited alleviated lung fibrosis as manifested by reduced collagen deposition and inflammation, and decreased TGF-beta production. FACS analysis suggested that decreased Ly6c(lo)MHCII(hi) AMs might make the major contribution to attenuated fibrogenesis in RBP-J(cKO) mice, probably by reduced inflammatory factor release and enhanced matrix metalloproteinases expression. Using clodronate-mediated macrophage depletion in RBP-J(ckO) mice, we demonstrated that embryonic-derived AMs play negligible role in lung fibrosis, which was further supported by adoptive transfer experiments. Moreover, on CCR2 knockout background, the effect of RBP-J deficiency on fibrogenesis was not elicited, suggesting that Notch regulated monocyte-derived AMs. Co-culture experiment showed that monocyte-derived AMs from RBP-J(cKO) mice exhibit reduced myofibroblast activation due to decreased TGF-beta secretion. In conclusion, monocyte-derived Ly6c(lo)MHCII(hi) AMs, which are regulated by RBP-J-mediated Notch signaling, play an essential role in lung fibrosis.	[Zhang, Ni; Yang, Kui; Bai, Jian; Yi, Jing; Gao, Chunchen; Zhao, Junlong; Liang, Shiqian; Wei, Tiaoxia; Feng, Lei; Han, Hua; Qin, Hongyan] Fourth Mil Med Univ, Dept Med Genet & Dev Biol, State Key Lab Canc Biol, Chang Le Xi St 169, Xian 710032, Peoples R China; [Zhang, Ni] Xian Med Univ, Dept Basic Med, Xian, Peoples R China; [Yang, Kui; Song, Liqiang] Fourth Mil Med Univ, Xijing Hosp, Dept Pulm & Crit Care Med, Xian, Peoples R China; [Han, Hua] Fourth Mil Med Univ, Dept Biochem & Mol Biol, Xian, Peoples R China	Air Force Military Medical University; Xi'an Medical University; Air Force Military Medical University; Air Force Military Medical University	Qin, HY (corresponding author), Fourth Mil Med Univ, Dept Med Genet & Dev Biol, State Key Lab Canc Biol, Chang Le Xi St 169, Xian 710032, Peoples R China.	hyqin@fmmu.edu.cn	Gao, Chunchen/HHN-8125-2022	han, hua/0000-0002-1872-9700; Zhao, Jun-Long/0000-0002-6148-5641	National Natural Science Foundation of China [81530018, 31970829, 81870216]; National Key R&D Program of China [2017YFC0908903]; Shaanxi Science and Technology Program [2020ZDLSF03-05]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; Shaanxi Science and Technology Program	National Natural Science Foundation of China, Grant/Award Number: 81530018, 31970829 and 81870216; National Key R&D Program of China, Grant/Award Number: 2017YFC0908903; Shaanxi Science and Technology Program, Grant/Award Number: 2020ZDLSF03-05	Aoyagi-Ikeda K, 2011, AM J RESP CELL MOL, V45, P136, DOI 10.1165/rcmb.2010-0140OC; Aran D, 2019, NAT IMMUNOL, V20, P163, DOI 10.1038/s41590-018-0276-y; Arora S, 2018, IMMUNOBIOLOGY, V223, P383, DOI 10.1016/j.imbio.2017.11.001; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Atabai K, 2009, J CLIN INVEST, V119, P3713, DOI 10.1172/JCI40053; Ballester-Lopez C, 2019, EBIOMEDICINE, V43, P562, DOI 10.1016/j.ebiom.2019.03.054; Bedoret D, 2009, J CLIN INVEST, V119, P3723, DOI 10.1172/JCI39717; Byrne AJ, 2016, TRENDS MOL MED, V22, P303, DOI 10.1016/j.molmed.2016.02.004; Byrne AJ, 2015, THORAX, V70, P1189, DOI 10.1136/thoraxjnl-2015-207020; Chakarov S, 2019, SCIENCE, V363, P1190, DOI 10.1126/science.aau0964; Chavez-Santoscoy AV, 2012, JOVE-J VIS EXP, DOI 10.3791/3883; Cho KW, 2014, CELL REP, V9, P605, DOI 10.1016/j.celrep.2014.09.004; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Epelman S, 2014, IMMUNITY, V41, P21, DOI 10.1016/j.immuni.2014.06.013; Gibbings SL, 2017, AM J RESP CELL MOL, V57, P66, DOI 10.1165/rcmb.2016-0361OC; Gibbings SL, 2015, BLOOD, V126, P1357, DOI 10.1182/blood-2015-01-624809; Gibbons MA, 2011, AM J RESP CRIT CARE, V184, P569, DOI 10.1164/rccm.201010-1719OC; Ginhoux F, 2016, IMMUNITY, V44, P439, DOI 10.1016/j.immuni.2016.02.024; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gu L, 2007, ACTA PHARMACOL SIN, V28, P382, DOI 10.1111/j.1745-7254.2007.00468.x; Guilliams M, 2017, NAT REV IMMUNOL, V17, P451, DOI 10.1038/nri.2017.42; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; He F, 2015, HEPATOLOGY, V61, P303, DOI 10.1002/hep.27394; Hendrix AY, 2017, PROG MOL BIOL TRANSL, V148, P1, DOI 10.1016/bs.pmbts.2017.04.004; Hu B, 2016, PHARMACOL RES, V108, P57, DOI 10.1016/j.phrs.2016.04.010; Huang F, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01327; Jakubzick CV, 2017, NAT REV IMMUNOL, V17, P349, DOI 10.1038/nri.2017.28; Ji WJ, 2014, J IMMUNOL METHODS, V403, P7, DOI 10.1016/j.jim.2013.11.012; Jiang YL, 2019, PROTEIN CELL, V10, P196, DOI 10.1007/s13238-018-0527-6; Kawano H, 2016, INT IMMUNOL, V28, P489, DOI 10.1093/intimm/dxw012; Kopf M, 2015, NAT IMMUNOL, V16, P36, DOI 10.1038/ni.3052; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Liu TJ, 2017, METHODS MOL BIOL, V1627, P27, DOI 10.1007/978-1-4939-7113-8_2; Ma PF, 2017, J HEPATOL, V67, P770, DOI 10.1016/j.jhep.2017.05.022; Martinez FJ, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.74; McCubbrey AL, 2018, AM J RESP CELL MOL, V58, P66, DOI 10.1165/rcmb.2017-0154OC; McQuattie-Pimentel AC, 2018, AM J RESP CELL MOL, V58, P5, DOI 10.1165/rcmb.2017-0328ED; Micallef L, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S5; Misharin AV, 2017, J EXP MED, V214, P2387, DOI 10.1084/jem.20162152; Misharin AV, 2013, AM J RESP CELL MOL, V49, P503, DOI 10.1165/rcmb.2013-0086MA; Moore BB, 2001, J IMMUNOL, V167, P4368, DOI 10.4049/jimmunol.167.8.4368; Richeldi L, 2017, LANCET, V389, P1941, DOI 10.1016/S0140-6736(17)30866-8; Sabatel C, 2017, IMMUNITY, V46, P457, DOI 10.1016/j.immuni.2017.02.016; Saito A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19082460; Shapouri-Moghaddam A, 2018, J CELL PHYSIOL, V233, P6425, DOI 10.1002/jcp.26429; Sun L, 2011, AM J PHYSIOL-LUNG C, V300, pL341, DOI 10.1152/ajplung.00122.2010; Suzuki T, 2014, NATURE, V514, P450, DOI 10.1038/nature13807; Tacke F, 2014, J HEPATOL, V60, P1090, DOI 10.1016/j.jhep.2013.12.025; Tang PMK, 2019, NAT REV NEPHROL, V15, P144, DOI 10.1038/s41581-019-0110-2; Tang YF, 2008, CIRC RES, V102, P661, DOI 10.1161/CIRCRESAHA.107.165134; Toussaint M, 2013, MUCOSAL IMMUNOL, V6, P485, DOI 10.1038/mi.2012.88; van de Laar L, 2016, IMMUNITY, V44, P755, DOI 10.1016/j.immuni.2016.02.017; Van Hoecke L, 2017, JOVE-J VIS EXP, DOI 10.3791/55398; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Wang YC, 2010, CANCER RES, V70, P4840, DOI 10.1158/0008-5472.CAN-10-0269; Watanabe S, 2019, J CLIN INVEST, V129, P2619, DOI 10.1172/JCI124615; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Xu HX, 2012, NAT IMMUNOL, V13, P642, DOI 10.1038/ni.2304; Ye YC, 2019, CANCER RES, V79, P4160, DOI 10.1158/0008-5472.CAN-18-1691; Yin DP, 2019, INT J MOL MED, V44, P1388, DOI 10.3892/ijmm.2019.4315; Zhang WJ, 2010, J IMMUNOL, V184, P6465, DOI 10.4049/jimmunol.0904016; Zhao JL, 2016, CANCER RES, V76, P1403, DOI 10.1158/0008-5472.CAN-15-2019; Zhou XF, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.00103-2018; Zigmond E, 2014, J IMMUNOL, V193, P344, DOI 10.4049/jimmunol.1400574	66	6	6	1	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					11168	11184		10.1096/fj.201903086RR	http://dx.doi.org/10.1096/fj.201903086RR		JUL 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32638441	Bronze			2022-12-28	WOS:000547533500001
J	Majali-Martinez, A; Hoch, D; Tam-Amersdorfer, C; Pollheimer, J; Glasner, A; Ghaffari-Tabrizi-Wizsy, N; Beristain, AG; Hiden, U; Dieber-Rotheneder, M; Desoye, G				Majali-Martinez, Alejandro; Hoch, Denise; Tam-Amersdorfer, Carmen; Pollheimer, Jurgen; Glasner, Andreas; Ghaffari-Tabrizi-Wizsy, Nassim; Beristain, Alexander G.; Hiden, Ursula; Dieber-Rotheneder, Martina; Desoye, Gernot			Matrix metalloproteinase 15 plays a pivotal role in human first trimester cytotrophoblast invasion and is not altered by maternal obesity	FASEB JOURNAL			English	Article						early pregnancy; placenta; trophoblasts; inflammation	NECROSIS-FACTOR-ALPHA; TROPHOBLAST INVASION; PLACENTAL DEVELOPMENT; CELL INVASION; HUMAN DECIDUA; EXPRESSION; MATRIX-METALLOPROTEINASE-9; INTERLEUKIN-10; IDENTIFICATION; PREGNANCY	Adequate anchoring of the placenta in the uterus through invasion of first trimester cytotrophoblasts (CTB) is required for a successful pregnancy. This process is mediated by matrix metalloproteinases (MMPs) and regulated by the maternal environment. Obesity is known to alter the intrauterine milieu and has been related to impaired invasion. We hypothesized that placental MMP15, a novel membrane-type MMP, is involved in CTB invasion and regulated by maternal obesity in early pregnancy. Thus, in this study MMP15 was immunolocalized to invasive extravillous and interstitial CTB. MMP15 silencing in chorionic villous explants using two different siRNAs reduced trophoblast outgrowth length (-35%,P <= .001 and -26%,P < .05) and area (-43%,P <= .001 and -36%,P <= .01) without altering trophoblast proliferation or apoptosis. Short-term treatment of primary first trimester trophoblasts with IL-6 (10 ng/mL), interleukin 10 (IL-10) (50 ng/mL), and tumor necrosis factor alpha (TNF-alpha) (10 ng/mL) did not affect MMP15 protein levels. Likewise, MMP15 mRNA and protein levels were unaltered between human first trimester placentas from control pregnancies vs those complicated with maternal obesity. Overall, our results suggest that the role of MMP15 in placental development and function in early pregnancy is limited to CTB invasion without being affected by short- and long-term inflammation.	[Majali-Martinez, Alejandro; Hoch, Denise; Hiden, Ursula; Dieber-Rotheneder, Martina; Desoye, Gernot] Med Univ Graz, Dept Obstet & Gynecol, Auenbruggerpl 14, A-8036 Graz, Austria; [Tam-Amersdorfer, Carmen; Ghaffari-Tabrizi-Wizsy, Nassim] Med Univ Graz, Otto Loewi Res Ctr, Div Immunol & Pathophysiol, Graz, Austria; [Pollheimer, Jurgen] Med Univ Vienna, Dept Obstet & Fetal Maternal Med, Vienna, Austria; [Glasner, Andreas] Femina Med Ctr, Graz, Austria; [Beristain, Alexander G.] Univ British Columbia, British Columbia Childrens Hosp, Res Inst, Vancouver, BC, Canada	Medical University of Graz; Medical University of Graz; Medical University of Vienna; BC Childrens Hospital; University of British Columbia	Hiden, U (corresponding author), Med Univ Graz, Dept Obstet & Gynecol, Auenbruggerpl 14, A-8036 Graz, Austria.	ursula.hiden@medunigraz.at	Ghaffari-Tabrizi-Wizsy, Nassim/J-7333-2017	Ghaffari-Tabrizi-Wizsy, Nassim/0000-0001-6696-8717; Beristain, Alexander/0000-0002-1117-6242; Hoch, Denise/0000-0002-7169-7007; Tam-Amersdorfer, Carmen/0000-0003-3123-6342; Majali-Martinez, Alejandro/0000-0002-9009-5810; Hiden, Ursula/0000-0001-8009-020X	Austrian Science Fund (FWF) [W1241]; Oesterreichische Nationalbank (OeNB) [14796]; Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN-2014-04466]; Herzfelder'sche Familienstiftung (Herzfelder Family Foundation) [00685]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Oesterreichische Nationalbank (OeNB); Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (NSERC); Herzfelder'sche Familienstiftung (Herzfelder Family Foundation)	Austrian Science Fund (FWF), Grant/Award Number: W1241; Oesterreichische Nationalbank (OeNB), Grant/Award Number: 14796; Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (NSERC), Grant/Award Number: RGPIN-2014-04466; Herzfelder'sche Familienstiftung (Herzfelder Family Foundation), Grant/Award Number: 00685	Abraham R, 2005, J BIOL CHEM, V280, P34123, DOI 10.1074/jbc.M508155200; Aghababaei M, 2015, PLACENTA, V36, pS11, DOI 10.1016/j.placenta.2014.12.016; Anacker J, 2011, MOL HUM REPROD, V17, P637, DOI 10.1093/molehr/gar033; Baltayeva J, 2020, BIOL REPROD, V102, P63, DOI 10.1093/biolre/ioz163; Bauer S, 2004, J CLIN ENDOCR METAB, V89, P812, DOI 10.1210/jc.2003-031351; Blaschitz A, 2000, PLACENTA, V21, P733, DOI 10.1053/plac.2000.0559; Bluher M, 2005, EXP CLIN ENDOCR DIAB, V113, P534, DOI 10.1055/s-2005-872851; Castellana B, 2018, IMMUNOL CELL BIOL, V96, P805, DOI 10.1111/imcb.12041; Catalano PM, 2017, BMJ-BRIT MED J, V356, DOI [10.1136/bmj.j1, 10.1136/bmj.j1631]; Champion H, 2012, MOL HUM REPROD, V18, P391, DOI 10.1093/molehr/gas010; Chen JJ, 2017, PROG MOL BIOL TRANSL, V148, P87, DOI 10.1016/bs.pmbts.2017.04.001; Cohen M, 2006, PLACENTA, V27, P783, DOI 10.1016/j.placenta.2005.08.006; Cui N, 2017, PROG MOL BIOL TRANSL, V147, P1, DOI 10.1016/bs.pmbts.2017.02.005; Forbes K, 2010, J ENDOCRINOL, V207, P1, DOI 10.1677/JOE-10-0174; Ghaffari-Tabrizi-Wizsy N, 2014, CELLS TISSUES ORGANS, V200, P181, DOI 10.1159/000381766; Handschuh K, 2007, ENDOCRINOLOGY, V148, P5011, DOI 10.1210/en.2007-0286; Hernandez-Barrantes S, 2002, SEMIN CANCER BIOL, V12, P131, DOI 10.1006/scbi.2001.0421; Hiden U, 2008, DIABETES, V57, P150, DOI 10.2337/db07-0903; Hiden U, 2013, AM J PATHOL, V182, P1563, DOI 10.1016/j.ajpath.2013.01.011; Hoch D, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21020468; Hoch D, 2019, MOL ASPECTS MED, V66, P21, DOI 10.1016/j.mam.2018.11.002; Howell KR, 2017, REPRODUCTION, V153, pR97, DOI [10.1530/REP-16-0495, 10.1530/rep-16-0495]; Huppertz B, 1998, CELL TISSUE RES, V291, P133; Isaka K, 2003, PLACENTA, V24, P53, DOI 10.1053/plac.2002.0867; Jauniaux E, 2000, AM J PATHOL, V157, P2111, DOI 10.1016/S0002-9440(10)64849-3; Kaufmann P, 2003, BIOL REPROD, V69, P1, DOI 10.1095/biolreprod.102.014977; Knofler M, 2019, CELL MOL LIFE SCI, V76, P3479, DOI 10.1007/s00018-019-03104-6; Knoefler Martin, 2013, Frontiers in Genetics, V4, P190, DOI 10.3389/fgene.2013.00190; KOVATS S, 1990, SCIENCE, V248, P220, DOI 10.1126/science.2326636; Lacroix MC, 2005, ENDOCRINOLOGY, V146, P2434, DOI 10.1210/en.2004-1550; Lash GE, 2005, BIOL REPROD, V73, P374, DOI 10.1095/biolreprod.105.040337; Lockwood CJ, 2008, BIOL REPROD, V78, P1064, DOI 10.1095/biolreprod.107.063743; Majali-Martinez A, 2017, HUM REPROD, V32, P46, DOI 10.1093/humrep/dew295; Majali-Martinez A, 2016, CELL ADHES MIGR, V10, P136, DOI 10.1080/19336918.2015.1110671; Maltepe E, 2015, ANNU REV CELL DEV BI, V31, P523, DOI 10.1146/annurev-cellbio-100814-125620; Morrison CJ, 2006, J BIOL CHEM, V281, P26528, DOI 10.1074/jbc.M603331200; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Pendeloski KPT, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12674; Perdu S, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.85560; Pollheimer J, 2014, PLACENTA, V35, pS57, DOI 10.1016/j.placenta.2013.10.012; Pollheimer J, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02597; Ray I, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00157; Seval Y, 2004, ACTA HISTOCHEM, V106, P353, DOI 10.1016/j.acthis.2004.07.005; Siwetz M, 2016, LAB INVEST, V96, P428, DOI 10.1038/labinvest.2015.159; Smith SD, 2016, HISTOL HISTOPATHOL, V31, P557, DOI 10.14670/HH-11-696; Strutz J, 2018, CLIN SCI, V132, P2437, DOI 10.1042/CS20180825; TAKINO T, 1995, J BIOL CHEM, V270, P23013, DOI 10.1074/jbc.270.39.23013; Vigano P, 2001, MOL HUM REPROD, V7, P971, DOI 10.1093/molehr/7.10.971; Wendremaire M, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.104844; Wright JK, 2010, BIOL REPROD, V83, P1036, DOI 10.1095/biolreprod.109.083246; Zhu Jia-Yu, 2012, Rev Obstet Gynecol, V5, pe137	51	6	6	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10720	10730		10.1096/fj.202000773R	http://dx.doi.org/10.1096/fj.202000773R		JUL 2020	11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32614494	Green Published, hybrid			2022-12-28	WOS:000547288900001
J	Macedo, F; Romanatto, T; de Assis, CG; Buis, A; Kowaltowski, AJ; Aguilaniu, H; da Cunha, FM				Macedo, Felipe; Romanatto, Talita; de Assis, Carolina Gomes; Buis, Alexia; Kowaltowski, Alicia J.; Aguilaniu, Hugo; da Cunha, Fernanda Marques			Lifespan-extending interventions enhance lipid-supported mitochondrial respiration inCaenorhabditis elegans	FASEB JOURNAL			English	Article						C; elegans; dietary restriction; lipid oxidation; longevity; mitochondrial metabolism	RESTRICTION-INDUCED LONGEVITY; DIETARY RESTRICTION; CAENORHABDITIS-ELEGANS; STARVATION; EFFICIENCY; AMPK; METABOLISM; MECHANISM; CAPACITY; MUSCLE	Dietary restriction and reduced reproduction have been linked to long lifespans in the vast majority of species tested. Although decreased mitochondrial mass and/or function are hallmarks of aging, little is known about the mechanisms by which these organelles contribute to physiological aging or to the effects of lifespan-extending interventions, particularly with respect to oxidative phosphorylation and energy production. Here, we employed the nematodeCaenorhabditis elegansto examine the effects of inhibition of germline proliferation and dietary restriction, both of which extend the lifespan ofC. elegans, on mitochondrial respiratory activity in whole animals and isolated organelles. We found that oxygen consumption rates and mitochondrial mass were reduced in wild-type (WT)C. eleganssubjected to bacterial deprivation (BD) compared with animals fed ad libitum (AL). In contrast, BD decreased the rate of oxygen uptake but not mitochondrial mass in germline-lessglp-1(e2144ts)mutants. Interestingly, mitochondria isolated from animals subjected to BD and/or inhibition of germline proliferation showed no differences in complex I-mediated respiratory activity compared to control mitochondria, whereas both interventions enhanced the efficiency with which mitochondria utilized lipids as respiratory substrates. Notably, the combination of BD and inhibition of germline proliferation further increased mitochondrial lipid oxidation compared to either intervention alone. We also detected a striking correlation between lifespan extension in response to BD and/or inhibition of germline proliferation and the capacity ofC. elegansto generate ATP from lipids. Our results thus suggest that the ability to oxidize lipids may be determinant in enhanced longevity.	[Macedo, Felipe; de Assis, Carolina Gomes; da Cunha, Fernanda Marques] Univ Fed Sao Paulo, Dept Bioquim, Escola Paulista Med, Rua 3 Maio 100, BR-04044020 Sao Paulo, SP, Brazil; [Romanatto, Talita; Kowaltowski, Alicia J.] Univ Sao Paulo, Inst Quim, Dept Bioquim, Sao Paulo, Brazil; [Buis, Alexia; Aguilaniu, Hugo] Inst Genom Fonct Lyon, Lyon, France; [Aguilaniu, Hugo] Inst Serrapilheira, Rua Dias Ferreira,78 S202, BR-22431050 Rio De Janeiro, RJ, Brazil; [Aguilaniu, Hugo] CNRS, Paris, France	Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Centre National de la Recherche Scientifique (CNRS)	da Cunha, FM (corresponding author), Univ Fed Sao Paulo, Dept Bioquim, Escola Paulista Med, Rua 3 Maio 100, BR-04044020 Sao Paulo, SP, Brazil.; Aguilaniu, H (corresponding author), Inst Serrapilheira, Rua Dias Ferreira,78 S202, BR-22431050 Rio De Janeiro, RJ, Brazil.	haguilaniu@gmail.com; fmcunha@unifesp.br	da Cunha, Fernanda M/G-3575-2012; Kowaltowski, Alicia J/H-8698-2012; DA CUNHA, FERNANDA MARQUES/AAY-4000-2020; de Assis, Carolina Gomes/AAM-5754-2021	da Cunha, Fernanda M/0000-0002-1583-5380; Gomes de Assis, Carolina/0000-0003-4753-503X	Brazilian Conselho Nacional de Pesquisa [401577/2013-9, 165640/2017-0]; Sao Paulo Research Foundation (FAPESP) [2013/07937-8, 2015/15526-3]; ERC [647003]	Brazilian Conselho Nacional de Pesquisa; Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); ERC(European Research Council (ERC)European Commission)	Brazilian Conselho Nacional de Pesquisa, Grant/Award Number: #401577/2013-9 and #165640/2017-0; Sao Paulo Research Foundation (FAPESP), Grant/Award Number: #2013/07937-8 and #2015/155263; ERC consolidator, Grant/Award Number: H2020/2014-2019-No 647003	Angelo G, 2009, SCIENCE, V326, P954, DOI 10.1126/science.1178343; Bishop NA, 2007, NATURE, V447, P545, DOI 10.1038/nature05904; Bourguignon A, 2017, J EXP BIOL, V220, P2445, DOI 10.1242/jeb.159087; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; BRENNER S, 1974, GENETICS, V77, P71; Castelein N, 2014, EXP GERONTOL, V56, P26, DOI 10.1016/j.exger.2014.02.009; Cerqueira FM, 2012, FREE RADICAL BIO MED, V52, P1236, DOI 10.1016/j.freeradbiomed.2012.01.011; Chaudhari SN, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00274-4; Choi JS, 2011, BIOCHEM BIOPH RES CO, V409, P308, DOI 10.1016/j.bbrc.2011.05.008; Elle Ida Coordt, 2012, Worm, V1, P26, DOI 10.4161/worm.19564; Ghazi A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000639; Goudeau J, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000599; Greer EL, 2007, CURR BIOL, V17, P1646, DOI 10.1016/j.cub.2007.08.047; Greer EL, 2009, AGING CELL, V8, P113, DOI 10.1111/j.1474-9726.2009.00459.x; Hansen M, 2013, CELL METAB, V17, P10, DOI 10.1016/j.cmet.2012.12.003; Harvald EB, 2017, CELL SYST, V5, P38, DOI 10.1016/j.cels.2017.06.004; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Jia KL, 2002, DEVELOPMENT, V129, P221; Kennedy JA, 1996, BIOCHEM PHARMACOL, V52, P273, DOI 10.1016/0006-2952(96)00204-3; Lamarche AMD, 2018, AGING CELL, V17, DOI 10.1111/acel.12713; Larance M, 2015, MOL CELL PROTEOMICS, V14, P1989, DOI 10.1074/mcp.M114.044289; Lopez-Lluch G, 2006, P NATL ACAD SCI USA, V103, P1768, DOI 10.1073/pnas.0510452103; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Lorenzini A, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00121; Luz AL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130940; Mair W, 2011, NATURE, V470, P404, DOI 10.1038/nature09706; Mallilankaraman K, 2012, NAT CELL BIOL, V14, P1336, DOI 10.1038/ncb2622; Miersch C, 2013, PHYSIOL GENOMICS, V45, P539, DOI 10.1152/physiolgenomics.00007.2013; Moroz N, 2014, AGING CELL, V13, P1075, DOI 10.1111/acel.12273; Morsci NS, 2016, J NEUROSCI, V36, P1373, DOI 10.1523/JNEUROSCI.2799-15.2016; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; NICHOLLS DG, 2013, BIOENERGETICS; O'Rourke EJ, 2013, NAT CELL BIOL, V15, P668, DOI 10.1038/ncb2741; Panowski SH, 2007, NATURE, V447, P550, DOI 10.1038/nature05837; Ramachandran PV, 2019, DEV CELL, V48, P685, DOI 10.1016/j.devcel.2018.12.022; Ratnappan R, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004829; SRERE PA, 1963, ACTA CHEM SCAND, V17, P129, DOI 10.3891/acta.chem.scand.17s-0129; Steinkraus KA, 2008, AGING CELL, V7, P394, DOI 10.1111/j.1474-9726.2008.00385.x; Sun N, 2016, MOL CELL, V61, P654, DOI 10.1016/j.molcel.2016.01.028; Tan KT, 2011, CELL METAB, V14, P390, DOI 10.1016/j.cmet.2011.06.019; Thondamal M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5879; Toei M, 2013, J BIOL CHEM, V288, P25717, DOI 10.1074/jbc.M113.482455; van der Bliek AM, 2017, GENETICS, V207, P843, DOI 10.1534/genetics.117.300262; VASINGTON FD, 1962, J BIOL CHEM, V237, P2670; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Weir HJ, 2017, CELL METAB, V26, P884, DOI 10.1016/j.cmet.2017.09.024; Wojtovich AP, 2008, BIOCHEM BIOPH RES CO, V376, P625, DOI 10.1016/j.bbrc.2008.09.043	47	1	1	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					9972	9981		10.1096/fj.201901880R	http://dx.doi.org/10.1096/fj.201901880R		JUL 2020	10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32609395				2022-12-28	WOS:000547078600001
J	Jiang, M; Wang, HM; Liu, ZF; Lin, LJ; Wang, L; Xie, MJ; Li, DY; Zhang, JB; Zhang, R				Jiang, Min; Wang, Haiming; Liu, Zifan; Lin, Lejian; Wang, Lin; Xie, Manjiang; Li, Danyang; Zhang, Jibin; Zhang, Ran			Endoplasmic reticulum stress-dependent activation of iNOS/NO-NF-kappa B signaling and NLRP3 inflammasome contributes to endothelial inflammation and apoptosis associated with microgravity	FASEB JOURNAL			English	Article						apoptosis; endoplasmic reticulum stress; endothelial cells; inflammation; microgravity	NITRIC-OXIDE SYNTHASE; CELL-ADHESION MOLECULE-1; SIMULATED MICROGRAVITY; IN-VIVO; CAROTID ARTERIES; OXIDATIVE STRESS; EXPRESSION; DYSFUNCTION; ANGIOGENESIS; SUPPRESSION	Exposure to microgravity results in vascular remodeling and cardiovascular dysfunction. To elucidate the mechanism involved in this condition, we investigated whether endoplasmic reticulum (ER) stress during simulated microgravity induced endothelial inflammation and apoptosis in human umbilical vein endothelial cells (HUVECs). Microgravity was simulated by clinorotation in the current study. We examined markers of ER stress, inducible nitric oxide (NO) synthase (iNOS)/NO content, proinflammatory cytokine production, nuclear factor kappa B (NF-kappa B)/I kappa B signaling, NLRP3 inflammasome, and detected apoptosis in HUVECs. We found that the levels of C/EBP homologous protein and glucose-regulated protein 78, pro-inflammatory cytokines (IL-6, TNF-alpha, IL-8, and IL-1 beta), and iNOS/NO content were upregulated by clinorotation. ER stress inhibition with tauroursodeoxycholic acid or 4-phenylbutyric acid and iNOS inhibition with 1400 W dramatically suppressed activation of the NF-kappa B/I kappa B pathway and the NLRP3 inflammasome, and decreased the production of pro-inflammatory cytokines. The increase of apoptosis in HUVECs during clinorotation was significantly suppressed by inhibiting ER stress, iNOS activity, NF-kappa B/I kappa B, and the NLRP3 inflammasome signaling pathway. Therefore, simulated microgravity causes ER stress in HUVECs, and subsequently activates iNOS/NO-NF-kappa B/I kappa B and the NLRP3 inflammasome signaling pathway, which have key roles in the induction of endothelial inflammation and apoptosis.	[Jiang, Min; Wang, Haiming; Liu, Zifan; Wang, Lin; Li, Danyang; Zhang, Jibin; Zhang, Ran] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 1, Dept Cardiol, 28 Fuxing Rd, Beijing 100853, Peoples R China; [Jiang, Min; Wang, Haiming; Liu, Zifan; Wang, Lin; Li, Danyang; Zhang, Jibin; Zhang, Ran] Med Sch Chinese PLA, 28 Fuxing Rd, Beijing 100853, Peoples R China; [Lin, Lejian] Chinese Peoples Liberat Army Gen Hosp, Dept Cardiol, Med Ctr 8, Beijing, Peoples R China; [Xie, Manjiang] Fourth Mil Med Univ, Minist Educ, Dept Aerosp Physiol, Xian, Peoples R China; [Xie, Manjiang] Fourth Mil Med Univ, Minist Educ, Key Lab Aerosp Med, Xian, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Air Force Military Medical University; Air Force Military Medical University	Zhang, R (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Med Ctr 1, Dept Cardiol, 28 Fuxing Rd, Beijing 100853, Peoples R China.; Zhang, R (corresponding author), Med Sch Chinese PLA, 28 Fuxing Rd, Beijing 100853, Peoples R China.	bjzhangran@126.com	Zhang, Ran/ABB-5587-2021	Jiang, Min/0000-0002-4952-1283	National Natural Science Foundation of China [81871516, 81571841, 81571840, 81772013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China, Grant/Award Number: 81871516, 81571841, 81571840 and 81772013	Beberashvili I, 2013, INT UROL NEPHROL, V45, P1703, DOI 10.1007/s11255-013-0436-9; Buchheim JI, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00085; Buravkova L, 2005, ACTA ASTRONAUT, V57, P67, DOI 10.1016/j.actaastro.2005.03.012; Capri M, 2019, FASEB J, V33, P5168, DOI 10.1096/fj.201801625R; Carlstrom M, 2019, J INTERN MED, V285, P2, DOI 10.1111/joim.12818; Chang TT, 2015, FASEB J, V29, P4122, DOI 10.1096/fj.15-275073; Chen XN, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/3462530; Childs BG, 2015, NAT MED, V21, P1424, DOI 10.1038/nm.4000; Connelly L, 2001, J IMMUNOL, V166, P3873, DOI 10.4049/jimmunol.166.6.3873; Cordero-Herrera I, 2019, P NATL ACAD SCI USA, V116, P217, DOI 10.1073/pnas.1809406115; Crucian BE, 2014, J INTERF CYTOK RES, V34, P778, DOI 10.1089/jir.2013.0129; Dai Y, 2019, CIRCULATION, V139, P1185, DOI 10.1161/CIRCULATIONAHA.118.033700; Demontis GC, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00547; Dimmeler S, 1997, NITRIC OXIDE-BIOL CH, V1, P275, DOI 10.1006/niox.1997.0133; Ding SJ, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9120850; Dittrich A, 2018, CELL PHYSIOL BIOCHEM, V45, P429, DOI 10.1159/000486920; Ebstein F, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02756; Garg AD, 2012, TRENDS MOL MED, V18, P589, DOI 10.1016/j.molmed.2012.06.010; Ghemrawi R, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7060063; Gliozzi M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20133294; Grenon SM, 2013, SCI REP-UK, V3, DOI 10.1038/srep01494; Griffoni C, 2011, J CELL BIOCHEM, V112, P265, DOI 10.1002/jcb.22921; Guo FJ, 2010, CELL SIGNAL, V22, P1818, DOI 10.1016/j.cellsig.2010.07.006; Guo HR, 2019, AGING-US, V11, P11659, DOI 10.18632/aging.102570; Hsieh YH, 2007, BIOCHEM BIOPH RES CO, V359, P643, DOI 10.1016/j.bbrc.2007.05.154; Hughson RL, 2018, NAT REV CARDIOL, V15, P167, DOI 10.1038/nrcardio.2017.157; Incalza MA, 2018, VASC PHARMACOL, V100, P1, DOI 10.1016/j.vph.2017.05.005; Kang CY, 2011, EUR J APPL PHYSIOL, V111, P2131, DOI 10.1007/s00421-011-1844-0; Kapitonova M Y, 2012, Malays J Pathol, V34, P103; Katsuyama K, 1998, ARTERIOSCL THROM VAS, V18, P1796, DOI 10.1161/01.ATV.18.11.1796; Kitamura M, 2009, ANTIOXID REDOX SIGN, V11, P2353, DOI 10.1089/ARS.2008.2391; Kruger M, 2019, ACTA ASTRONAUT, V159, P267, DOI 10.1016/j.actaastro.2019.03.074; Kruger Marcus, 2019, Cell Physiol Biochem, V52, P1039, DOI 10.33594/000000071; Li CF, 2019, APOPTOSIS, V24, P812, DOI 10.1007/s10495-019-01560-w; Li N, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01025; Liang B, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20246335; Liu F, 2020, BIOCHEM PHARMACOL, V174, DOI 10.1016/j.bcp.2020.113830; Liu H, 2015, CLIN EXP PHARMACOL P, V42, P510, DOI 10.1111/1440-1681.12381; Luo M, 2020, J CELL BIOCHEM, V121, P2994, DOI 10.1002/jcb.29556; Luo XJ, 2019, ARCH BIOCHEM BIOPHYS, V671, P203, DOI 10.1016/j.abb.2019.07.008; Ma J, 2003, J APPL PHYSIOL, V94, P83, DOI 10.1152/japplphysiol.00294.2002; Maamoun H, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20071658; Maier JAM, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/434803; Matsushita H, 2000, CIRC RES, V86, P974, DOI 10.1161/01.RES.86.9.974; Minamino T, 2010, CIRC RES, V107, P1071, DOI 10.1161/CIRCRESAHA.110.227819; Morbidelli L, 2005, BIOCHEM BIOPH RES CO, V334, P491, DOI 10.1016/j.bbrc.2005.06.124; Pavlakou P, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19103176; Peng L, 2015, BIOMED ENVIRON SCI, V28, P799, DOI [10.1016/S0895-3988(15)30110-0, 10.3967/bes2015.111]; Pfeilschifter J, 2002, NEPHROL DIAL TRANSPL, V17, P347, DOI 10.1093/ndt/17.3.347; QI S, 2017, OXID MED CELL LONGEV, V2017, DOI DOI 10.1155/2017/9738745; Siamwala JH, 2010, FEBS LETT, V584, P3415, DOI 10.1016/j.febslet.2010.06.039; Tsuchiya K, 2020, MICROBIOL IMMUNOL, V64, P252, DOI 10.1111/1348-0421.12771; Udi S, 2020, BRIT J PHARMACOL, V177, P110, DOI 10.1111/bph.14849; Versari S, 2007, BBA-MOL CELL RES, V1773, P1645, DOI 10.1016/j.bbamcr.2007.05.014; Versari S, 2013, FASEB J, V27, P4466, DOI 10.1096/fj.13-229195; Vorselen D, 2014, FASEB J, V28, P536, DOI 10.1096/fj.13-236356; Wang XY, 2018, MICROVASC RES, V119, P98, DOI 10.1016/j.mvr.2018.05.006; Wang YC, 2009, J CELL BIOCHEM, V107, P357, DOI 10.1002/jcb.22134; Wu F, 2008, J CELL PHYSIOL, V217, P207, DOI 10.1002/jcp.21495; Yoon SJ, 2015, BIOCHEM BIOPH RES CO, V463, P1184, DOI 10.1016/j.bbrc.2015.06.080; Zamora R, 2000, MOL MED, V6, P347, DOI 10.1007/BF03401781; Zhang LF, 2018, PHYSIOL REV, V98, P59, DOI 10.1152/physrev.00017.2016; Zhang R, 2008, J PHYSIOL SCI, V58, P67, DOI 10.2170/physiolsci.RP010707; Zhang R, 2014, FASEB J, V28, P2715, DOI 10.1096/fj.13-245654; Zhang R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095916; Zhang R, 2012, J PHYSIOL BIOCHEM, V68, P99, DOI 10.1007/s13105-011-0123-1; Zhang R, 2010, EXCLI J, V9, P195; Zhang R, 2009, J APPL PHYSIOL, V106, P251, DOI 10.1152/japplphysiol.01278.2007; Zhang X, 2014, NITRIC OXIDE-BIOL CH, V40, P10, DOI 10.1016/j.niox.2014.05.001; Zhuang T, 2019, CIRC RES, V125, P590, DOI 10.1161/CIRCRESAHA.118.314402; Zwart SR, 2017, FASEB J, V31, P3746, DOI 10.1096/fj.201700294	71	25	26	1	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10835	10849		10.1096/fj.202000734R	http://dx.doi.org/10.1096/fj.202000734R		JUN 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32592441				2022-12-28	WOS:000544413600001
J	Liu, BY; Chen, GF; He, QZ; Liu, MH; Gao, K; Cai, BL; Qu, JJ; Lin, SJ; Geng, AK; Li, SD; Wang, K; Mao, ZY; Wan, XP; Yan, Q				Liu, Binya; Chen, Guofang; He, Qizhi; Liu, Minhao; Gao, Kun; Cai, Bailian; Qu, Junjie; Lin, Shaojian; Geng, Anke; Li, Shuangdi; Wang, Kai; Mao, Zhiyong; Wan, Xiaoping; Yan, Qin			An HMGA2-p62-ER alpha axis regulates uterine leiomyomas proliferation	FASEB JOURNAL			English	Article						ER alpha; HMGA2; proliferation; p62/SQSTM1; uterine leiomyomas	ESTROGEN-RECEPTOR-ALPHA; UP-REGULATION; PROGESTERONE-RECEPTOR; CELL-PROLIFERATION; HMGA PROTEINS; STROMAL CELLS; IN-VITRO; GROWTH; EXPRESSION; AUTOPHAGY	Uterine leiomyomas (ULM) are a major public health issue contributing to high morbidity and poor pregnancy outcomes. However, its molecular pathogenesis is poorly understood. HMGA2-ULM is the second major subtype of human ULM and associates with large sizes, fast-growth, and high percentages of estrogen receptor a (ER alpha). As altered ER alpha expression plays a distinct role in ULM growth, here, we investigate a regulatory mechanism driving ULM growth via HMGA2 and ER alpha. We reveal a positive correlation of HMGA2 with ER alpha protein and demonstrate that HMGA2 promotes ULM cells proliferation via ER alpha. In addition, autophagy pathway and p62/ SQSTM1 (a selective autophagy receptor) are found to participate in the regulation of HMGA2 and ER alpha. Moreover, HMGA2 suppresses the transcription of p62 by binding to its promoter, meanwhile, p62 interacts with Ella, and inhibition of p62 increases ER alpha expression and enhances cell viability in ULM, suggesting a novel mechanism of the HMGA2-p62-ER alpha axis in ULM proliferation. Notably, rapamycM, a familiar autophagy agonist, reduces ER alpha levels and the proliferation ability of ULM cells. This study demonstrates a causal role of the HMGA2-p62-ER alpha axis in preventing autophagy and increasing ER alpha expression in HMGA2-ULM. Therefore, blocking HMGA2-p62-ER alpha axis and targeting autophagy pathway establish a roadmap toward HMGA2-ULM medical treatment.	[Liu, Binya; Liu, Minhao; Cai, Bailian; Qu, Junjie; Li, Shuangdi; Wan, Xiaoping; Yan, Qin] Tongji Univ, Sch Med, Shanghai Matern & Infant Hosp 1, Dept Gynecol, Shanghai 201204, Peoples R China; [Chen, Guofang; Gao, Kun; Wang, Kai] Tongji Univ, Sch Med, Shanghai Matern & Infant Hosp 1, Clin & Translat Res Ctr, Shanghai, Peoples R China; [He, Qizhi] Tongji Univ, Sch Med, Shanghai Matern & Infant Hosp 1, Dept Pathol, Shanghai, Peoples R China; [Lin, Shaojian] Tongji Univ, Sch Med, Shanghai, Peoples R China; [Geng, Anke; Mao, Zhiyong] Tongji Univ, Sch Life Sci & Technol, Shanghai Matern & Infant Hosp 1, Clin & Translat Res Ctr,Shanghai Key Lab Signalin, Shanghai, Peoples R China	Tongji University; Tongji University; Tongji University; Tongji University; Tongji University	Wan, XP; Yan, Q (corresponding author), Tongji Univ, Sch Med, Shanghai Matern & Infant Hosp 1, Dept Gynecol, Shanghai 201204, Peoples R China.	wanxiaoping@tongji.edu.cn; yanqin76@126.com		Mao, Zhiyong/0000-0002-5298-1918; Liu, Binya/0000-0003-1193-4821	National Natural Science Foundation of China (NSFC) [81601247, 81802960, 81672574, 81972438, 81502234]; Shanghai Clinical Medicine Field Projects of Science and Technology Innovation Action Program [17411951600]; Shanghai Municipal Medical and Health Discipline Construction Projects [2017ZZ02015]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Shanghai Clinical Medicine Field Projects of Science and Technology Innovation Action Program; Shanghai Municipal Medical and Health Discipline Construction Projects	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81601247, 81802960, 81672574, 81972438 and 81502234; Shanghai Clinical Medicine Field Projects of Science and Technology Innovation Action Program, Grant/Award Number: 17411951600; Shanghai Municipal Medical and Health Discipline Construction Projects, Grant/Award Number: 2017ZZ02015	Al-Hendy A, 2004, AM J OBSTET GYNECOL, V191, P1621, DOI 10.1016/j.ajog.2004.04.022; [Anonymous], 2017, CHIN J OBSTET GYNECO, V52, P793; Ashton KA, 2010, CANCER EPIDEMIOL, V34, P328, DOI 10.1016/j.canep.2010.03.005; Baird DD, 2003, AM J OBSTET GYNECOL, V188, P100, DOI 10.1067/mob.2003.99; Bakas P, 2008, FERTIL STERIL, V90, P1878, DOI 10.1016/j.fertnstert.2007.09.019; Barbarisi A, 2001, J CELL PHYSIOL, V186, P414, DOI 10.1002/1097-4652(2000)9999:999<000::AID-JCP1040>3.0.CO;2-E; Barth S, 2010, J PATHOL, V221, P117, DOI 10.1002/path.2694; Bebo BF, 2001, J IMMUNOL, V166, P2080, DOI 10.4049/jimmunol.166.3.2080; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Bertsch E, 2014, MODERN PATHOL, V27, P1144, DOI 10.1038/modpathol.2013.243; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Blin C, 1996, ENDOCRINOLOGY, V137, P2246, DOI 10.1210/en.137.6.2246; Bretschneider N, 2008, MOL ONCOL, V2, P182, DOI 10.1016/j.molonc.2008.05.004; Bulun SE, 2013, NEW ENGL J MED, V369, P1344, DOI 10.1056/NEJMra1209993; Burroughs KD, 2000, BIOL REPROD, V63, P1322, DOI 10.1095/biolreprod63.5.1322; BUTTRAM VC, 1981, FERTIL STERIL, V36, P433; Cardozo ER, 2012, AM J OBSTET GYNECOL, V206, DOI [10.1016/j.ajog.2011.12.002, 10.1016/j.ajog.2012.08.020]; Catherino WH, 2011, FERTIL STERIL, V95, P9, DOI 10.1016/j.fertnstert.2010.08.049; Cook KL, 2014, CLIN CANCER RES, V20, P3222, DOI 10.1158/1078-0432.CCR-13-3227; CRAMER SF, 1985, OBSTET GYNECOL, V66, P36; CRAMER SF, 1990, AM J CLIN PATHOL, V94, P435, DOI 10.1093/ajcp/94.4.435; Di X, 2008, HUM REPROD, V23, P1873, DOI 10.1093/humrep/den087; El Andaloussi A, 2017, CELL DEATH DISCOV, V3, DOI 10.1038/cddiscovery.2017.41; Esposito F, 2012, J CELL PHYSIOL, V227, P3749, DOI 10.1002/jcp.24087; Fusco A, 2007, NAT REV CANCER, V7, P899, DOI 10.1038/nrc2271; Gross G, 2000, AM J PHYSIOL-REG I, V278, pR1415, DOI 10.1152/ajpregu.2000.278.6.R1415; Gross KL, 2003, GENE CHROMOSOME CANC, V38, P68, DOI 10.1002/gcc.10240; Hassan MH, 2010, FERTIL STERIL, V93, P239, DOI 10.1016/j.fertnstert.2008.09.086; Helmke BM, 2011, MOL HUM REPROD, V17, P135, DOI 10.1093/molehr/gaq083; Hennig Y, 1997, CANCER GENET CYTOGEN, V96, P129, DOI 10.1016/S0165-4608(96)00283-X; Hodge JC, 2012, HUM MOL GENET, V21, P2312, DOI 10.1093/hmg/dds051; HOWE SR, 1995, ENDOCRINOLOGY, V136, P4996, DOI 10.1210/en.136.11.4996; Ishibashi H, 2005, CANCER RES, V65, P6450, DOI 10.1158/0008-5472.CAN-04-3087; Ishikawa H, 2010, ENDOCRINOLOGY, V151, P2433, DOI 10.1210/en.2009-1225; Jakimiuk AJ, 2004, FERTIL STERIL, V82, P1244, DOI 10.1016/j.fertnstert.2004.02.130; Galindo LJ, 2018, GYNECOL ONCOL, V150, P562, DOI 10.1016/j.ygyno.2018.07.007; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Karim MR, 2007, AUTOPHAGY, V3, P553, DOI 10.4161/auto.4615; Karras P, 2019, CANCER CELL, V35, P46, DOI 10.1016/j.ccell.2018.11.008; Kim BW, 2016, BMB REP, V49, P73, DOI 10.5483/BMBRep.2016.49.2.265; Kim S, 2014, ONCOL REP, V31, P1423, DOI 10.3892/or.2013.2936; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Kovacs KA, 2001, MOL HUM REPROD, V7, P1085, DOI 10.1093/molehr/7.11.1085; Kumar R, 2011, J REPROD IMMUNOL, V92, P88, DOI 10.1016/j.jri.2011.06.103; Kurita T, 2005, DIFFERENTIATION, V73, P313, DOI 10.1111/j.1432-0436.2005.00033.x; LINDER D, 1965, SCIENCE, V150, P67, DOI 10.1126/science.150.3692.67; Mao ZY, 2011, SCIENCE, V332, P1443, DOI 10.1126/science.1202723; Markowski DN, 2010, GENE CHROMOSOME CANC, V49, P661, DOI 10.1002/gcc.20777; Marsh EE, 2006, OBSTET GYN CLIN N AM, V33, P59, DOI 10.1016/j.ogc.2005.12.001; Mas A, 2015, MOL HUM REPROD, V21, P330, DOI 10.1093/molehr/gau114; Mas A, 2012, FERTIL STERIL, V98, P741, DOI 10.1016/j.fertnstert.2012.04.044; MASHAL RD, 1994, GENE CHROMOSOME CANC, V11, P1, DOI 10.1002/gcc.2870110102; McDonnel AC, 2005, CANCER LETT, V221, P49, DOI 10.1016/j.canlet.2004.09.011; Mehine M, 2016, P NATL ACAD SCI USA, V113, P1315, DOI 10.1073/pnas.1518752113; Mehine M, 2014, FERTIL STERIL, V102, P621, DOI 10.1016/j.fertnstert.2014.06.050; Mehine M, 2013, NEW ENGL J MED, V369, P43, DOI 10.1056/NEJMoa1302736; Mei J, 2015, HUM REPROD, V30, P1677, DOI 10.1093/humrep/dev100; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Nawas AF, 2019, J CELL BIOCHEM, V120, P1477, DOI 10.1002/jcb.27340; Ono M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036935; Park J, 2016, STEROIDS, V115, P177, DOI 10.1016/j.steroids.2016.09.011; Park SH, 2008, GYNECOL ENDOCRINOL, V24, P250, DOI 10.1080/09513590801893315; Parker WH, 2005, OBSTET GYNECOL, V105, P216, DOI 10.1097/01.AOG.0000150453.10906.b6; Peddada SD, 2008, P NATL ACAD SCI USA, V105, P19887, DOI 10.1073/pnas.0808188105; PORTER KB, 1995, BIOL REPROD, V52, P824, DOI 10.1095/biolreprod52.4.824; Quade BJ, 2003, CANCER RES, V63, P1351; Shen P, 2016, ONCOTARGET, V7, P48501, DOI 10.18632/oncotarget.10363; Shimomura Y, 1998, J CLIN ENDOCR METAB, V83, P2192, DOI 10.1210/jc.83.6.2192; Stewart EA, 2001, LANCET, V357, P293, DOI 10.1016/S0140-6736(00)03622-9; Sumitani H, 2000, ENDOCRINOLOGY, V141, P3852, DOI 10.1210/en.141.10.3852; Teyssier C, 2001, J BIOL CHEM, V276, P36361, DOI 10.1074/jbc.M101806200; Wang TS, 2007, GENE CHROMOSOME CANC, V46, P336, DOI 10.1002/gcc.20415; Wei Y, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1786-8; Wei Y, 2019, INT J BIOL SCI, V15, P942, DOI 10.7150/ijbs.30930; Wei Y, 2019, J STEROID BIOCHEM, V191, DOI 10.1016/j.jsbmb.2019.105380; Wu JJ, 2011, CANCER RES, V71, P349, DOI 10.1158/0008-5472.CAN-10-2550; Wu X, 2017, CANCER RES, V77, P6891, DOI 10.1158/0008-5472.CAN-17-1744; Xie J, 2018, GENE CHROMOSOME CANC, V57, P485, DOI 10.1002/gcc.22643; Xu XJ, 2004, GENE, V328, P143, DOI 10.1016/j.gene.2003.12.003; Yang F, 2017, INT J CANCER, V141, P986, DOI 10.1002/ijc.30789; Yang K, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1183-2; Yu LD, 2010, SEMIN REPROD MED, V28, P249, DOI 10.1055/s-0030-1251482; Zatloukal K, 2002, AM J PATHOL, V160, P255, DOI 10.1016/S0002-9440(10)64369-6	83	2	2	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10966	10983		10.1096/fj.202000520R	http://dx.doi.org/10.1096/fj.202000520R		JUN 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32592217				2022-12-28	WOS:000544411700001
J	Eggers, R; de Winter, F; Smit, L; Luimens, M; Muir, EM; Bradbury, EJ; Tannemaat, MR; Verhaagen, J				Eggers, Ruben; de Winter, Fred; Smit, Lotte; Luimens, Maruelle; Muir, Elizabeth M.; Bradbury, Elizabeth J.; Tannemaat, Martijn R.; Verhaagen, Joost			Combining timed GDNF and ChABC gene therapy to promote long-distance regeneration following ventral root avulsion and repair	FASEB JOURNAL			English	Article						axonal regeneration; chronic denervation; nerve damage; peripheral nerve	CHONDROITIN SULFATE PROTEOGLYCAN; IMPROVES FUNCTIONAL RECOVERY; PERIPHERAL-NERVE; NEUROTROPHIC FACTOR; SPINAL-CORD; AXONAL REGENERATION; MOTONEURON SURVIVAL; SCIATIC-NERVE; EXTRACELLULAR-MATRIX; VIRAL VECTOR	Ventral root avulsion leads to severe motoneuron degeneration and prolonged distal nerve denervation. After a critical period, a state of chronic denervation develops as repair Schwann cells lose their pro-regenerative properties and inhibitory factors such as CSPGs accumulate in the denervated nerve. In rats with ventral root avulsion injuries, we combined timed GDNF gene therapy delivered to the proximal nerve roots with the digestion of inhibitory CSPGs in the distal denervated nerve using sustained lentiviral-mediated chondroitinase ABC (ChABC) enzyme expression. Following reimplantation of lumbar ventral roots, timed GDNF-gene therapy enhanced motoneuron survival up to 45 weeks and improved axonal outgrowth, electrophysiological recovery, and muscle reinnervation. Despite a timed GDNF expression period, a subset of animals displayed axonal coils. Lentiviral delivery of ChABC enabled digestion of inhibitory CSPGs for up to 45 weeks in the chronically denervated nerve. ChABC gene therapy alone did not enhance motoneuron survival, but led to improved muscle reinnervation and modest electrophysiological recovery during later stages of the regeneration process. Combining GDNF treatment with digestion of inhibitory CSPGs did not have a significant synergistic effect. This study suggests a delicate balance exists between treatment duration and concentration in order to achieve therapeutic effects.	[Eggers, Ruben; de Winter, Fred; Smit, Lotte; Luimens, Maruelle; Tannemaat, Martijn R.; Verhaagen, Joost] Royal Acad Arts & Sci, Lab Neuroregenerat, Netherlands Inst Neurosci, An Inst, Meibergdreef 47, NL-1105 BA Amsterdam, Netherlands; [Muir, Elizabeth M.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England; [Bradbury, Elizabeth J.] Kings Coll London, Regenerat Grp, Inst Psychiat Psychol & Neurosci IoPPN, Wolfson Ctr Age Related Dis, London, England; [Tannemaat, Martijn R.] Leiden Univ, Dept Neurol, Med Ctr, Leiden, Netherlands; [Verhaagen, Joost] Vrije Univ Amsterdam, Dept Mol & Cellular Neurobiol, Ctr Neurogen & Cognit Res, Amsterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); University of Cambridge; University of London; King's College London; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Vrije Universiteit Amsterdam	Eggers, R (corresponding author), Royal Acad Arts & Sci, Lab Neuroregenerat, Netherlands Inst Neurosci, An Inst, Meibergdreef 47, NL-1105 BA Amsterdam, Netherlands.	r.eggers@nin.knaw.nl	eggers, ruben/B-8937-2008; De Winter, Fred/AAZ-8671-2020; Tannemaat, Martijn/S-3445-2016	eggers, ruben/0000-0001-7017-0791; De Winter, Fred/0000-0002-3042-2429; Bradbury, Elizabeth/0000-0003-4252-0234; Tannemaat, Martijn/0000-0003-2929-0390	Wings for Life (Wings for Life International) [WFLNL17-16]; International Spinal Research Trust (Spinal Research) [TRI004_3]	Wings for Life (Wings for Life International); International Spinal Research Trust (Spinal Research)	Wings for Life (Wings for Life International), Grant/Award Number: WFLNL17-16; International Spinal Research Trust (Spinal Research), Grant/Award Number: TRI004_3	Bartus K, 2014, J NEUROSCI, V34, P4822, DOI 10.1523/JNEUROSCI.4369-13.2014; Bergerot A, 2004, EXP NEUROL, V187, P359, DOI 10.1016/j.expneurol.2004.02.003; Blits B, 2004, EXP NEUROL, V189, P303, DOI 10.1016/j.expneurol.2004.05.014; Boyer RB, 2015, J SURG RES, V193, P969, DOI 10.1016/j.jss.2014.09.023; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; BRAUNEWELL KH, 1995, EUR J NEUROSCI, V7, P792, DOI 10.1111/j.1460-9568.1995.tb00682.x; Burnside ER, 2018, BRAIN, V141, P2362, DOI 10.1093/brain/awy158; Chu TH, 2009, J NEUROPATH EXP NEUR, V68, P94, DOI 10.1097/NEN.0b013e31819344a9; Ee XP, 2017, BIOTECHNOL BIOENG, V114, P2121, DOI 10.1002/bit.26335; Eggers R, 2010, EXP NEUROL, V223, P207, DOI 10.1016/j.expneurol.2009.07.021; Eggers R, 2008, MOL CELL NEUROSCI, V39, P105, DOI 10.1016/j.mcn.2008.05.018; Eggers R, 2019, EXP NEUROL, V321, DOI 10.1016/j.expneurol.2019.113037; Eggers R, 2019, BRAIN, V142, P295, DOI 10.1093/brain/awy340; Eggers R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071076; FU SY, 1995, J NEUROSCI, V15, P3886; FUNAKOSHI H, 1993, J CELL BIOL, V123, P455, DOI 10.1083/jcb.123.2.455; Galtrey CM, 2007, BRAIN, V130, P926, DOI 10.1093/brain/awl372; GIANNINI C, 1990, J NEUROPATH EXP NEUR, V49, P550, DOI 10.1097/00005072-199011000-00002; Graham JP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155981; Grimpe B, 2005, MOL CELL NEUROSCI, V28, P18, DOI 10.1016/j.mcn.2004.06.010; Groves ML, 2005, EXP NEUROL, V195, P278, DOI 10.1016/j.expneurol.2005.04.007; Gu HY, 2005, EXP NEUROL, V192, P89, DOI 10.1016/j.expneurol.2004.10.019; Gu YM, 1997, DEV NEUROSCI-BASEL, V19, P255, DOI 10.1159/000111214; Guo WL, 2019, NEURAL REGEN RES, V14, P328, DOI 10.4103/1673-5374.244796; Hallin RG, 1999, EXP BRAIN RES, V124, P304, DOI 10.1007/s002210050627; HENDERSON CE, 1994, SCIENCE, V266, P1062, DOI 10.1126/science.7973664; Hoke A, 2006, NAT CLIN PRACT NEURO, V2, P448, DOI 10.1038/ncpneuro0262; Hoyng SA, 2014, GENE THER, V21, P549, DOI 10.1038/gt.2014.22; Hoyng SA, 2014, EXP NEUROL, V261, P578, DOI 10.1016/j.expneurol.2014.08.002; Jessen KR, 2019, GLIA, V67, P421, DOI 10.1002/glia.23532; KOLIATSOS VE, 1994, J COMP NEUROL, V342, P35, DOI 10.1002/cne.903420105; Krekoski CA, 2001, J NEUROSCI, V21, P6206, DOI 10.1523/JNEUROSCI.21-16-06206.2001; Li H, 2015, SCI REP-UK, V5, DOI 10.1038/srep14923; LI LX, 1995, P NATL ACAD SCI USA, V92, P9771, DOI 10.1073/pnas.92.21.9771; Loew R, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-81; Marquardt LM, 2015, TISSUE ENG PT A, V21, P2852, DOI [10.1089/ten.tea.2015.0311, 10.1089/ten.TEA.2015.0311]; Moon LDF, 2001, NAT NEUROSCI, V4, P465, DOI 10.1038/87415; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Pajenda G, 2014, EXP NEUROL, V261, P367, DOI 10.1016/j.expneurol.2014.05.019; RISLING M, 1992, BRAIN RES, V570, P27, DOI 10.1016/0006-8993(92)90559-R; Ronchi G, 2017, J NEUROSURG, V127, P843, DOI 10.3171/2016.9.JNS16140; Roney IJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep27697; Ruven C, 2018, J NEUROPATH EXP NEUR, V77, P325, DOI 10.1093/jnen/nly009; Sabatier MJ, 2012, J NEUROPHYSIOL, V107, P747, DOI 10.1152/jn.00887.2011; Santos D, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/4969523; Santosa KB, 2013, MUSCLE NERVE, V47, P213, DOI 10.1002/mus.23490; Sarhane KA, 2019, NEUROTHERAPEUTICS, V16, P1283, DOI 10.1007/s13311-019-00745-0; Shakhbazau A, 2013, J CONTROL RELEASE, V172, P841, DOI 10.1016/j.jconrel.2013.10.004; Sivak WN, 2017, J TISSUE ENG REGEN M, V11, P733, DOI 10.1002/term.1970; Sulaiman OAR, 2009, NEUROSURGERY, V65, pA105, DOI 10.1227/01.NEU.0000358537.30354.63; Sulaiman W, 2013, OCHSNER J, V13, P100; Tannemaat MR, 2008, EUR J NEUROSCI, V28, P1467, DOI 10.1111/j.1460-9568.2008.06452.x; Tom VJ, 2009, J NEUROSCI, V29, P14881, DOI 10.1523/JNEUROSCI.3641-09.2009; TONA A, 1993, J HISTOCHEM CYTOCHEM, V41, P593, DOI 10.1177/41.4.8450198; TRUPP M, 1995, J CELL BIOL, V130, P137, DOI 10.1083/jcb.130.1.137; Tsui CC, 2010, J NEUROSCI, V30, P5149, DOI 10.1523/JNEUROSCI.5246-09.2010; Udina E, 2010, EXP NEUROL, V223, P143, DOI 10.1016/j.expneurol.2009.08.026; Urlinger S, 2000, P NATL ACAD SCI USA, V97, P7963, DOI 10.1073/pnas.130192197; Wang ZZ, 2018, J NEUROSCI METH, V308, P183, DOI 10.1016/j.jneumeth.2018.08.002; Wu WT, 2003, J NEUROTRAUM, V20, P603, DOI 10.1089/089771503767168528; WU WT, 1993, NEUROSCI LETT, V153, P121, DOI 10.1016/0304-3940(93)90303-3; YAMAGATA T, 1968, J BIOL CHEM, V243, P1523; Yang LJS, 2006, P NATL ACAD SCI USA, V103, P11057, DOI 10.1073/pnas.0604613103; Yuan QJ, 2000, NEUROREPORT, V11, P2237, DOI 10.1097/00001756-200007140-00035; Zahavi EE, 2015, J CELL SCI, V128, P1241, DOI 10.1242/jcs.167544; Zhang Y, 2013, J CRANIOFAC SURG, V24, P2153, DOI 10.1097/01.SCS.0000436700.65891.3b; Zhou LH, 2006, J NEUROTRAUM, V23, P920, DOI 10.1089/neu.2006.23.920; Zuo J, 2002, EXP NEUROL, V176, P221, DOI 10.1006/exnr.2002.7922; Zuo J, 1998, J NEUROBIOL, V34, P41, DOI 10.1002/(SICI)1097-4695(199801)34:1<41::AID-NEU4>3.3.CO;2-4	69	2	2	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10605	10622		10.1096/fj.202000559R	http://dx.doi.org/10.1096/fj.202000559R		JUN 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32543730	Green Published, hybrid			2022-12-28	WOS:000541638800001
J	Jaen, RI; Fernandez-Velasco, M; Terron, V; Sanchez-Garcia, S; Zaragoza, C; Canales-Bueno, N; Val-Blasco, A; Vallejo-Cremades, MT; Bosca, L; Prieto, P				Jaen, Rafael I.; Fernandez-Velasco, Maria; Terron, Veronica; Sanchez-Garcia, Sergio; Zaragoza, Carlos; Canales-Bueno, Natalia; Val-Blasco, Almudena; Vallejo-Cremades, Maria Teresa; Bosca, Lisardo; Prieto, Patricia			BML-111 treatment prevents cardiac apoptosis and oxidative stress in a mouse model of autoimmune myocarditis	FASEB JOURNAL			English	Article						inflammation; lipoxin; myocarditis; oxidative stress; resolution	ISCHEMIA-REPERFUSION INJURY; PRO-RESOLVING MEDIATORS; ACUTE LUNG INJURY; RECEPTOR AGONIST; SIGNALING PATHWAY; DOWN-REGULATION; HEART-FAILURE; A(4) RECEPTOR; LIPOXIN; PEPTIDE	Myocarditis is an inflammation of the myocardium that can progress to a more severe phenotype of dilated cardiomyopathy (DCM). Three main harmful factors determine this progression: inflammation, cell death, and oxidative stress. Lipoxins and their derivatives are endogenous proresolving mediators that induce the resolution of the inflammatory process. This study aims to determine whether these mediators play a protective role in a murine model of experimental autoimmune myocarditis (EAM) by treating with the lipoxin A(4)analog BML-111. We observed that EAM mice presented extensive infiltration areas that correlated with higher levels of inflammatory and cardiac damage markers. Both parameters were significantly reduced in BML-treated EAM mice. Consistently, cardiac dysfunction, hypertrophy, and emerging fibrosis detected in EAM mice was prevented by BML-111 treatment. At the molecular level, we demonstrated that treatment with BML-111 hampered apoptosis and oxidative stress induction by EAM. Moreover, both in vivo and in vitro studies revealed that these beneficial effects were mediated by activation of Nrf2 pathway through CaMKK2-AMPK alpha kinase pathway. Altogether, our data indicate that treatment with the lipoxin derivative BML-111 effectively alleviates EAM outcome and prevents cardiac dysfunction, thus, underscoring the therapeutic potential of lipoxins and their derivatives to treat myocarditis and other inflammatory cardiovascular diseases.	[Jaen, Rafael I.; Terron, Veronica; Sanchez-Garcia, Sergio; Bosca, Lisardo; Prieto, Patricia] Ctr Mixto CSIC UAM, Inst Invest Biomed Alberto Sols, Arturo Duperier 4, Madrid 28029, Spain; [Jaen, Rafael I.; Fernandez-Velasco, Maria; Zaragoza, Carlos; Bosca, Lisardo; Prieto, Patricia] Inst Salud Carlos III ISCIII, CIBER Enfermedades Cardiovasc CIBER CV, Madrid, Spain; [Fernandez-Velasco, Maria; Terron, Veronica; Canales-Bueno, Natalia; Val-Blasco, Almudena; Vallejo-Cremades, Maria Teresa] Hosp Univ La Paz IdiPAZ, Inst Invest, Madrid, Spain; [Zaragoza, Carlos] Univ Francisco de Vitoria, Serv Cardiol, Hosp Univ Ramon y Cajal, Inst Ramon y Cajal Invest Sanitaria IRYCIS, Madrid, Spain; [Vallejo-Cremades, Maria Teresa] Hosp Univ La Paz, Unidad Imagen & Inmunohistoquim, Fdn Invest Biomed, Madrid, Spain; [Prieto, Patricia] Univ Complutense Madrid, Dept Farmacol Farmacognosia & Bot, Fac Farm, Plaza Ramon y Cajal S-N, Madrid 28040, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); CIBER - Centro de Investigacion Biomedica en Red; CIBERCV; Hospital Universitario La Paz; Hospital Universitario Ramon y Cajal; Universidad Francisco de Vitoria; Hospital Universitario La Paz; Complutense University of Madrid	Bosca, L (corresponding author), Ctr Mixto CSIC UAM, Inst Invest Biomed Alberto Sols, Arturo Duperier 4, Madrid 28029, Spain.; Prieto, P (corresponding author), Univ Complutense Madrid, Dept Farmacol Farmacognosia & Bot, Fac Farm, Plaza Ramon y Cajal S-N, Madrid 28040, Spain.	lbosca@iib.uam.es; patriciaprieto@ucm.es	velasco, maria fernandez/AAO-5062-2021; Zaragoza, Carlos/AAH-9275-2019; Prieto, Patricia/ABG-8343-2020	Prieto, Patricia/0000-0001-6943-7663; Zaragoza, Carlos/0000-0002-1706-8592; Inigo Jaen, Rafael/0000-0002-7298-2125; VAL BLASCO, ALMUDENA/0000-0001-7029-2895; Sanchez-Garcia, Sergio/0000-0002-3332-7603	Ministerio de Economia y Competitividad (MINECO) [SAF2017-82436R]; Comunidad de Madrid [S2017/BMD-3686]; Fundacion Ramon Areces (Ramon Areces Foundation) [CIVP18A3864]; MINECO \ Instituto de Salud Carlos III (ISCIII) [CIBER CV-CB11/00222]	Ministerio de Economia y Competitividad (MINECO); Comunidad de Madrid(Comunidad de Madrid); Fundacion Ramon Areces (Ramon Areces Foundation); MINECO \ Instituto de Salud Carlos III (ISCIII)	Ministerio de Economia y Competitividad (MINECO), Grant/Award Number: SAF2017-82436R; Comunidad de Madrid, Grant/Award Number: S2017/BMD-3686; Fundacion Ramon Areces (Ramon Areces Foundation), Grant/Award Number: CIVP18A3864; MINECO vertical bar Instituto de Salud Carlos III (ISCIII), Grant/Award Number: CIBER CV-CB11/00222	ARETZ HT, 1987, HUM PATHOL, V18, P619; Basil MC, 2016, NAT REV IMMUNOL, V16, P51, DOI 10.1038/nri.2015.4; Blyszczuk P, 2016, EUR HEART J, V38; Carreno JE, 2006, REV ESP CARDIOL, V59, P473, DOI 10.1016/S1885-5857(06)60796-2; Chandrasekharan JA, 2015, J INFLAMM RES, V8, P181, DOI 10.2147/JIR.S90380; Chen HM, 2014, INFLAMMATION, V37, P1078, DOI 10.1007/s10753-014-9831-3; Chen XQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067120; Cheng X, 2016, FREE RADICAL BIO MED, V93, P52, DOI 10.1016/j.freeradbiomed.2016.01.026; da Costa RM, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00382; El Kebir D, 2008, J LEUKOCYTE BIOL, V84, P600, DOI 10.1189/jlb.1107765; Fairweather D.L., 2017, HDB SYSTEMIC AUTOIMM, V14, P1; Fontes JA, 2015, CYTOKINE, V74, P62, DOI 10.1016/j.cyto.2014.12.024; Fung G, 2016, CIRC RES, V118, P496, DOI 10.1161/CIRCRESAHA.115.306573; Garcia RA, 2019, JACC-BASIC TRANSL SC, V4, P905, DOI 10.1016/j.jacbts.2019.07.005; Gehlken C, 2018, HEART FAIL CLIN, V14, P75, DOI 10.1016/j.hfc.2017.08.009; Han X, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/9303606; Hirakawa H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119360; Joo MS, 2016, MOL CELL BIOL, V36, P1931, DOI 10.1128/MCB.00118-16; Kania G, 2009, CIRC RES, V105, P462, DOI 10.1161/CIRCRESAHA.109.196287; Kong X, 2017, EXP THER MED, V14, P2284, DOI 10.3892/etm.2017.4787; Liu HZ, 2018, RESP RES, V19, DOI 10.1186/s12931-018-0937-2; Liu XC, 2017, INFORMATION SCIENCE AND ELECTRONIC ENGINEERING, P1; Liu YF, 2012, INT IMMUNOL, V24, P605, DOI 10.1093/intimm/dxs056; Long C S, 2001, Heart Fail Rev, V6, P81; Mason JW, 2003, CARDIOVASC RES, V60, P5, DOI 10.1016/S0008-6363(03)00437-1; Matzinger M, 2020, REDOX BIOL, V29, DOI 10.1016/j.redox.2019.101393; McArthur S, 2020, J CLIN INVEST, V130, P1156, DOI 10.1172/JCI124635; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Parkinson John F., 2006, Inflammation & Allergy Drug Targets, V5, P91, DOI 10.2174/187152806776383125; Patriki D, 2018, JACC-HEART FAIL, V6, P573, DOI 10.1016/j.jchf.2018.03.002; Posso SV, 2018, INT IMMUNOPHARMACOL, V56, P330, DOI 10.1016/j.intimp.2018.01.045; Prieto P, 2010, CELL DEATH DIFFER, V17, P1179, DOI 10.1038/cdd.2009.220; Qi D, 2015, TRENDS ENDOCRIN MET, V26, P422, DOI 10.1016/j.tem.2015.05.010; Qin CX, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14232; Reina-Couto M, 2014, EUR J CLIN INVEST, V44, P527, DOI 10.1111/eci.12265; Sakamoto K, 2006, AM J PHYSIOL-ENDOC M, V290, pE780, DOI 10.1152/ajpendo.00443.2005; Sergeeva IA, 2013, BBA-MOL BASIS DIS, V1832, P2403, DOI 10.1016/j.bbadis.2013.07.003; Serhan CN, 2011, CURR TOP MED CHEM, V11, P629; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Sevigny MB, 2006, FEBS LETT, V580, P6533, DOI 10.1016/j.febslet.2006.10.073; Shi Y, 2017, EUR REV MED PHARMACO, V21, P1850; SHIVERICK KT, 1975, BIOCHIM BIOPHYS ACTA, V393, P124, DOI 10.1016/0005-2795(75)90222-6; Tada Y, 2016, CURR PHARM DESIGN, V22, P450, DOI 10.2174/1381612822666151222160559; Tanaka T, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016295; Tojkander S, 2018, CELL REP, V24, P11, DOI 10.1016/j.celrep.2018.06.011; Tonelli C, 2018, ANTIOXID REDOX SIGN, V29, P1727, DOI 10.1089/ars.2017.7342; Tsutsui H, 2011, AM J PHYSIOL-HEART C, V301, pH2181, DOI 10.1152/ajpheart.00554.2011; Tu WJ, 2019, AGING DIS, V10, P637, DOI 10.14336/AD.2018.0513; Val-Blasco A, 2017, J AM COLL CARDIOL, V69, P423, DOI 10.1016/j.jacc.2016.10.073; Wang Y, 2018, BIOCHEM BIOPH RES CO, V506, P130, DOI 10.1016/j.bbrc.2018.09.092; Watanabe Kenichi, 2011, Inflammation & Allergy Drug Targets, V10, P218; Wu SH, 2017, MOL MED REP, V15, P1682, DOI 10.3892/mmr.2017.6195; Wu SH, 2016, INFLAMMATION, V39, P611, DOI 10.1007/s10753-015-0286-y; Yang SB, 2019, CELL SIGNAL, V60, P146, DOI 10.1016/j.cellsig.2019.05.002; Zhang L, 2008, INFLAMM RES, V57, P157, DOI 10.1007/s00011-007-7141-z; Zhang L, 2018, CURR MED SCI, V38, P997, DOI 10.1007/s11596-018-1975-1; Zhao QF, 2014, HEART VESSELS, V29, P667, DOI 10.1007/s00380-013-0418-y	57	10	10	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10531	10546		10.1096/fj.202000611R	http://dx.doi.org/10.1096/fj.202000611R		JUN 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32543747	Green Submitted, Bronze			2022-12-28	WOS:000541639100001
J	Chen, R; Zeng, Z; Zhang, YY; Cao, C; Liu, HM; Li, W; Wu, Y; Xia, ZY; Ma, DQ; Meng, QT				Chen, Rong; Zeng, Zi; Zhang, Yun-yan; Cao, Chen; Liu, Hui-min; Li, Wei; Wu, Yang; Xia, Zhong-yuan; Ma, Daqing; Meng, Qing-tao			Ischemic postconditioning attenuates acute kidney injury following intestinal ischemia-reperfusion through Nrf2-regulated autophagy, anti-oxidation, and anti-inflammation in mice	FASEB JOURNAL			English	Article						acute kidney injury; autophagy; intestinal ischemia-reperfusion; ischemic postconditioning; Nrf2; HO-1 pathway	ACUTE LUNG INJURY; CEREBRAL-ISCHEMIA; CARDIAC-SURGERY; NRF2; PROTECTS; DAMAGE; DEFENSE; CANCER; RATS	Intestinal ischemia-reperfusion (IIR) often occurs during and following major cardiovascular or gut surgery and causes significant organ including kidney injuries. This study was to investigate the protective effect of intestinal ischemic postconditioning (IPo) on IIR-induced acute kidney injury (AKI) and the underling cellular signaling mechanisms with focus on the Nrf2/HO-1. Adult C57BL/6J mice were subjected to IIR with or without IPo. IIR was established by clamping the superior mesenteric artery (SMA) for 45 minutes followed by 120 minutes reperfusion. Outcome measures were: (i) Intestinal and renal histopathology; (ii) Renal function; (iii) Cellular signaling changes; (iv) Oxidative stress and inflammatory responses. IPo significantly attenuated IIR-induced kidney injury. Furthermore, IPo significantly increased both nuclear Nrf2 and HO-1 expression in the kidney, upregulated autophagic flux, inhibited IIR-induced inflammation and reduced oxidative stress. The protective effect of IPo was abolished by the administration of Nrf2 inhibitor (Brusatol) or Nrf2 siRNA. Conversely, a Nrf2 activator t-BHQ has a similar protective effect to that of IPo. Our data indicate that IPo protects the kidney injury induced by IIR, which was likely mediated through the Nrf2/HO-1 cellular signaling activation.	[Chen, Rong; Zeng, Zi; Zhang, Yun-yan; Liu, Hui-min; Li, Wei; Wu, Yang; Xia, Zhong-yuan; Meng, Qing-tao] Wuhan Univ, Dept Anesthesiol, Renmin Hosp, Wuhan 430060, Peoples R China; [Cao, Chen] 3rd Hosp Wuhan, Dept Endocrinol, Wuhan, Peoples R China; [Ma, Daqing] Imperial Coll London, Chelsea & Westminster Hosp, Div Anaesthet Pain Med & Intens Care, Dept Surg & Canc,Fac Med, London, England	Wuhan University; Imperial College London	Meng, QT (corresponding author), Wuhan Univ, Dept Anesthesiol, Renmin Hosp, Wuhan 430060, Peoples R China.	mengqingtao2018@126.com	Ma, Daqing/GLT-2735-2022	Ma, Daqing/0000-0003-1235-0537; xia, zhongyuan/0000-0002-5807-9554	National Natural Science Foundation of China (NSFC) [81671948, 81400698, 81401574]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (NSFC) (grand number 81671948, 81400698, 81401574)	Bell RM, 2014, EUR HEART J, V35, P138, DOI 10.1093/eurheartj/eht478; Chapple SJ, 2012, INT J BIOCHEM CELL B, V44, P1315, DOI 10.1016/j.biocel.2012.04.021; Chen R, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/6954764; CHIU CJ, 1970, ARCH SURG-CHICAGO, V101, P478; Decuypere JP, 2015, AM J KIDNEY DIS, V66, P699, DOI 10.1053/j.ajkd.2015.05.021; Diez ER, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20235927; Guo C, 2017, MOL NEUROBIOL, V54, P833, DOI 10.1007/s12035-016-9690-z; He F, 2020, CARCINOGENESIS, V41, P405, DOI 10.1093/carcin/bgaa039; Hess DC, 2015, NAT REV NEUROL, V11, DOI 10.1038/nrneurol.2015.223; Hobel S, 2010, J GENE MED, V12, P287, DOI 10.1002/jgm.1431; Jeong WS, 2006, ANTIOXID REDOX SIGN, V8, P99, DOI 10.1089/ars.2006.8.99; Jiang Y, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/843721; Kazantzidou D, 2010, MINERVA CHIR, V65, P515; Levy JMM, 2017, NAT REV CANCER, V17, P528, DOI 10.1038/nrc.2017.53; Li N, 2004, J IMMUNOL, V173, P3467, DOI 10.4049/jimmunol.173.5.3467; Li S, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9040354; Liu L, 2013, WORLD J GASTROENTERO, V19, P9439, DOI 10.3748/wjg.v19.i48.9439; Liu TQ, 2015, FREE RADICAL BIO MED, V81, P170, DOI 10.1016/j.freeradbiomed.2014.10.509; Souza JRM, 2008, ARQ BRAS CARDIOL, V90, P94, DOI 10.1590/S0066-782X2008000200004; Meng QT, 2017, INT J MOL MED, V40, P1731, DOI 10.3892/ijmm.2017.3170; Meng QT, 2016, LAB INVEST, V96, P1087, DOI 10.1038/labinvest.2016.87; Myles PS, 2019, BRIT J ANAESTH, V122, P726, DOI 10.1016/j.bja.2019.01.010; Ologunde R, 2014, INT UROL NEPHROL, V46, P2337, DOI 10.1007/s11255-014-0766-2; Pac-Soo CK, 2015, BRIT J ANAESTH, V114, P204, DOI 10.1093/bja/aeu302; Piantadosi CA, 2008, FREE RADICAL BIO MED, V45, P562, DOI 10.1016/j.freeradbiomed.2008.05.013; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Ren DM, 2011, P NATL ACAD SCI USA, V108, P1433, DOI 10.1073/pnas.1014275108; Shih AY, 2005, J NEUROSCI, V25, P10321, DOI 10.1523/JNEUROSCI.4014-05.2005; Shokeir AA, 2014, ACTA PHYSIOL, V210, P342, DOI 10.1111/apha.12164; Spandou E, 2006, NEPHROL DIAL TRANSPL, V21, P330, DOI 10.1093/ndt/gfi177; Stiermaier T, 2019, CIRC RES, V124, P1482, DOI 10.1161/CIRCRESAHA.118.314500; Tan KP, 2008, FREE RADICAL BIO MED, V45, P1663, DOI 10.1016/j.freeradbiomed.2008.09.010; Teke Z, 2008, AM J SURG, V195, P861, DOI 10.1016/j.amjsurg.2007.06.025; Vaziri ND, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114881; Venditti P, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21062173; Vollmar B, 2011, LANGENBECK ARCH SURG, V396, P13, DOI 10.1007/s00423-010-0727-x; Xiao LY, 2020, PHYTOMEDICINE, V70, DOI 10.1016/j.phymed.2020.153219; Yun N, 2014, FREE RADICAL BIO MED, V68, P168, DOI 10.1016/j.freeradbiomed.2013.12.014; Yurdakan G, 2012, KAOHSIUNG J MED SCI, V28, P16, DOI 10.1016/j.kjms.2011.06.030; Zarbock A, 2017, ANESTHESIOLOGY, V126, P787, DOI 10.1097/ALN.0000000000001598; Zarbock A, 2015, JAMA-J AM MED ASSOC, V313, P2133, DOI 10.1001/jama.2015.4189; Zhang MH, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/463815; Zhang YX, 2011, ANTIOXID REDOX SIGN, V15, P2867, DOI 10.1089/ars.2010.3685; Zhao HL, 2019, BRIT J ANAESTH, V123, P519, DOI 10.1016/j.bja.2019.05.041; Zhao HL, 2017, AM J PHYSIOL-LUNG C, V312, pL155, DOI 10.1152/ajplung.00449.2016; Zhao HL, 2013, FASEB J, V27, P4076, DOI 10.1096/fj.13-232173; Zhao HP, 2014, STROKE, V45, P2417, DOI 10.1161/STROKEAHA.114.006135; Zhao QF, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/231351; Zhao ZQ, 2010, CARDIOVASC DRUG THER, V24, P265, DOI 10.1007/s10557-010-6240-1; Zhong ZY, 2016, CELL, V166, P288, DOI 10.1016/j.cell.2016.05.051; Zhou B, 2017, CLIN SCI, V131, P1161, DOI 10.1042/CS20170052	51	9	9	2	23	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					8887	8901		10.1096/fj.202000274R	http://dx.doi.org/10.1096/fj.202000274R		JUN 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32519766				2022-12-28	WOS:000541521500001
J	Zhang, CY; Hu, JW; Wang, WS; Sun, Y; Sun, K				Zhang, Chuyue; Hu, Jingwen; Wang, Wangsheng; Sun, Yun; Sun, Kang			HMGB1-induced aberrant autophagy contributes to insulin resistance in granulosa cells in PCOS	FASEB JOURNAL			English	Article						High mobility group box 1; autophagy; insulin resistance; polycystic ovary syndrome; granulosa cell	POLYCYSTIC-OVARY-SYNDROME; PROGESTERONE PRODUCTION; HMGB1; WOMEN; OBESITY; INFLAMMATION; PREVALENCE; METABOLISM; HORMONE; RELEASE	Insulin resistance (IR) disrupts ovarian functions in polycystic ovary syndrome (PCOS). The contributing factors remains elusive. High mobility group box 1 (HMGB1), a damage-associated molecular pattern molecule, has been shown to be related to IR and autophagy, respectively, in peripheral tissues. Here, we investigated whether increased HMGB1 contributes to IR in granulosa cells of PCOS patients via induction of aberrant autophagy. Results showed that HMGB1 abundance in the follicular fluid was significantly increased with enhanced autophagy in granulosa cells in PCOS patients with IR. HMGB1 exacerbated autophagy in granulosa cells as evinced by increased LC3B II/I ratio and ATG7 as well as decreased p62, the markers for autophagy. Concurrently, HMGB1 impaired insulin sensitivities by attenuating the abundance of insulin receptor substrate-1, Akt phosphorylation, GLUT4 translocation, and glucose uptake in granulosa cells, which were reversed by blocking autophagy pathways with siRNA-mediated knockdown of ATG7 or with chloroquine and bafilomycin A1, the lysosome inhibitors. In conclusion, our results indicate that increased HMGB1 contributes to IR development in granulosa cells of PCOS patients, which is associated with exacerbation of autophagy by HMGB1. Control of HMGB1 production may be benefical for the improvement of insulin sensitivity in granulosa cells in PCOS.	[Zhang, Chuyue; Hu, Jingwen; Wang, Wangsheng; Sun, Yun; Sun, Kang] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Ctr Reprod Med, Shanghai 200135, Peoples R China; [Zhang, Chuyue; Hu, Jingwen; Wang, Wangsheng; Sun, Yun; Sun, Kang] Shanghai Key Lab Assisted Reprod & Reprod Genet, Shanghai, Peoples R China	Shanghai Jiao Tong University	Sun, Y; Sun, K (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Ctr Reprod Med, Shanghai 200135, Peoples R China.	syun163@163.com; sungangrenji@sjtu.edu.cn	Wang, Wang-sheng/E-9811-2017	Wang, Wang-sheng/0000-0003-1429-9237; Sun, Kang/0000-0003-2727-141X	National Key R&D Program of China [2017YFC1001403]; National Natural Science Foundation of China [81571499, 81771648]; Program of Shanghai Academic Research Leader in Shanghai Municipal Commission of Health and Family Planning [2017BR015]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of Shanghai Academic Research Leader in Shanghai Municipal Commission of Health and Family Planning	This work was supported by National Key R&D Program of China (2017YFC1001403); National Natural Science Foundation of China (81571499, 81771648); Program of Shanghai Academic Research Leader in Shanghai Municipal Commission of Health and Family Planning (2017BR015).	Alebic MS, 2014, ENDOCRINE, V47, P625, DOI 10.1007/s12020-014-0182-5; Andersson UG, 2004, J INTERN MED, V255, P318, DOI 10.1111/j.1365-2796.2003.01304.x; Baptiste CG, 2010, J STEROID BIOCHEM, V122, P42, DOI 10.1016/j.jsbmb.2009.12.010; Bhattacharya D, 2018, EXCLI J, V17, P709, DOI 10.17179/excli2018-1353; Chen XW, 2013, J MOL ENDOCRINOL, V50, pR21, DOI 10.1530/JME-12-0247; Choi JY, 2010, FERTIL STERIL, V93, P2532, DOI 10.1016/j.fertnstert.2009.11.021; Choi J, 2011, FERTIL STERIL, V95, P1482, DOI 10.1016/j.fertnstert.2010.06.006; Cirillo F, 2020, GYNECOL ENDOCRINOL, V36, P588, DOI 10.1080/09513590.2020.1725967; Cirillo F, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00879; Cirillo F, 2019, GYNECOL ENDOCRINOL, V35, P842, DOI 10.1080/09513590.2019.1599349; Coffler MS, 2003, J CLIN ENDOCR METAB, V88, P5624, DOI 10.1210/jc.2003-030745; Dagon Y, 2015, METABOLISM, V64, P655, DOI 10.1016/j.metabol.2015.03.002; DAIN LB, 1991, FERTIL STERIL, V55, P1093; Dang X, 2017, ENDOCRINOLOGY, V158, P3281, DOI 10.1210/en.2017-00029; DeUgarte CM, 2005, FERTIL STERIL, V83, P1454, DOI 10.1016/j.fertnstert.2004.11.070; Dhindsa G, 2004, J Postgrad Med, V50, P140; Diamanti-Kandarakis E, 2012, ENDOCR REV, V33, P981, DOI 10.1210/er.2011-1034; Escobar-Morreale HF, 2004, J CLIN ENDOCR METAB, V89, P806, DOI 10.1210/jc.2003-031365; Feng HH, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/1936386; Gonzalez F, 2006, J CLIN ENDOCR METAB, V91, P1508, DOI 10.1210/jc.2005-2327; Gonzalez F, 2012, STEROIDS, V77, P300, DOI 10.1016/j.steroids.2011.12.003; Gunasekaran MK, 2016, ADIPOCYTE, V5, P384, DOI 10.1080/21623945.2016.1245818; Guzman-Ruiz R, 2014, INT J OBESITY, V38, P1545, DOI 10.1038/ijo.2014.36; Hackbart KS, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.113.107862; Kang R, 2013, CLIN CANCER RES, V19, P4046, DOI 10.1158/1078-0432.CCR-13-0495; Klionsky DJ, 2008, AUTOPHAGY, V4, P740, DOI 10.4161/auto.6398; Kobayashi S, 2015, BIOL PHARM BULL, V38, P1098, DOI 10.1248/bpb.b15-00096; Kosacka J, 2015, MOL CELL ENDOCRINOL, V409, P21, DOI 10.1016/j.mce.2015.03.015; Li D, 2018, REPRODUCTION, V155, P85, DOI 10.1530/REP-17-0499; Li G, 2016, INT J MOL MED, V37, P99, DOI 10.3892/ijmm.2015.2410; Li M, 2002, J CLIN ENDOCR METAB, V87, P4088, DOI 10.1210/jc.2002-020363; Li XX, 2019, FASEB J, V33, P11303, DOI 10.1096/fj.201802829R; Lin Y, 1997, HUM REPROD, V12, P2469, DOI 10.1093/humrep/12.11.2469; Liu L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178236; March WA, 2010, HUM REPROD, V25, P544, DOI 10.1093/humrep/dep399; Maruthini D, 2014, HUM REPROD, V29, P2302, DOI 10.1093/humrep/deu187; Mellor KM, 2011, J MOL CELL CARDIOL, V50, P1035, DOI 10.1016/j.yjmcc.2011.03.002; Nestler John E., 1997, Human Reproduction (Oxford), V12, P53; Orisaka M, 2009, J OVARIAN RES, V2, DOI 10.1186/1757-2215-2-9; Qi J, 2018, J CLIN ENDOCR METAB, V103, P2457, DOI 10.1210/jc.2017-02459; Rice S, 2005, HUM REPROD, V20, P373, DOI 10.1093/humrep/deh609; Rotterdam E-S, 2003, FERTIL STERIL, V81, P19; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Seow KM, 2007, HUM REPROD, V22, P1003, DOI 10.1093/humrep/del466; Shi YY, 2012, NAT GENET, V44, P1020, DOI 10.1038/ng.2384; Sun XF, 2014, AUTOPHAGY, V10, P1873, DOI 10.4161/auto.32184; Tang D, 2010, ONCOGENE, V29, P5299, DOI 10.1038/onc.2010.261; Tang DL, 2010, J CELL BIOL, V190, P881, DOI 10.1083/jcb.200911078; Valley MP, 2016, ANAL BIOCHEM, V505, P43, DOI 10.1016/j.ab.2016.04.010; Vgontzas AN, 2006, METABOLISM, V55, P1076, DOI 10.1016/j.metabol.2006.04.002; Wang WS, 2019, CLIN SCI, V133, P515, DOI 10.1042/CS20180950; Wang YA, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/2543268; Yamamoto S, 2018, CELL REP, V23, P3286, DOI 10.1016/j.celrep.2018.05.032; Young JM, 2010, REPRODUCTION, V140, P489, DOI 10.1530/REP-10-0094; Yu L, 2008, AUTOPHAGY, V4, P567, DOI 10.4161/auto.5902; Zhang CY, 2018, HUM REPROD, V33, P2096, DOI 10.1093/humrep/dey292; Zhou JW, 2019, INT J BIOL SCI, V15, P726, DOI 10.7150/ijbs.30369; Zhu QL, 2016, J CLIN ENDOCR METAB, V101, P2168, DOI 10.1210/jc.2015-3899	58	13	13	3	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9563	9574		10.1096/fj.202000605RR	http://dx.doi.org/10.1096/fj.202000605RR		MAY 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32469087				2022-12-28	WOS:000538082700001
J	Tsou, PS; Sawalha, AH				Tsou, Pei-Suen; Sawalha, Amr H.			Glycoprotein nonmetastatic melanoma protein B: A key mediator and an emerging therapeutic target in autoimmune diseases	FASEB JOURNAL			English	Review						autoimmunity; GPNMB; lupus; osteoactivin; vasculitis	WIDE DNA METHYLATION; FORMATION IN-VIVO; DC-HIL; ADIPOSE-TISSUE; OSTEOBLAST DIFFERENTIATION; OSTEOCLAST DIFFERENTIATION; TRANSGENIC EXPRESSION; TRANSCRIPTION FACTORS; PROGNOSTIC INDICATOR; MMP-3 EXPRESSION	The glycoprotein nonmetastatic melanoma protein B (GPNMB, also known as osteoactivin) is highly expressed in many cell types and regulates the homeostasis in various tissues. In different physiological contexts, it functions as a melanosome-associated protein, membrane-bound surface receptor, soluble ligand, or adhesion molecule. Therefore, GPNMB is involved in cell differentiation, migration, inflammation, metabolism, and neuroprotection. Because of its various involvement in different physiological conditions, GPNMB has been implicated in many diseases, including cancer, neurological disorders, and more recently immune-mediated diseases. This review summarizes the regulation and function of GPNMB in normal physiology, and discusses the involvement of GPNMB in disease conditions with a particular focus on its potential role and therapeutic implications in autoimmunity.	[Tsou, Pei-Suen] Univ Michigan, Dept Internal Med, Div Rheumatol, Ann Arbor, MI 48109 USA; [Sawalha, Amr H.] Univ Pittsburgh, Sch Med, Dept Pediat, Div Rheumatol,UPMC Childrens Hosp Pittsburgh, Pittsburgh, PA 15261 USA; [Sawalha, Amr H.] Univ Pittsburgh, Sch Med, Dept Med, Div Rheumatol & Clin Immunol, Pittsburgh, PA 15213 USA; [Sawalha, Amr H.] Univ Pittsburgh, Sch Med, Lupus Ctr Excellence, Pittsburgh, PA USA	University of Michigan System; University of Michigan; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Sawalha, AH (corresponding author), Univ Pittsburgh, Sch Med, Div Pediat Rheumatol, UPMC Childrens Hosp Pittsburgh, 4401 Penn Ave, Pittsburgh, PA 15224 USA.	asawalha@pitt.edu			National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health [R01 AR070148]	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health grant number R01 AR070148.	Abdelmagid SM, 2008, EXP CELL RES, V314, P2334, DOI 10.1016/j.yexcr.2008.02.006; Abdelmagid SM, 2007, J CELL PHYSIOL, V210, P26, DOI 10.1002/jcp.20841; Abdelmagid SM, 2015, J BIOL CHEM, V290, P20128, DOI 10.1074/jbc.M114.624270; Abdelmagid SM, 2014, AM J PATHOL, V184, P697, DOI 10.1016/j.ajpath.2013.11.031; Abe H, 2007, BIOCHEM BIOPH RES CO, V356, P610, DOI 10.1016/j.bbrc.2007.03.035; Akiyoshi H, 2010, J IMMUNOL, V184, P3554, DOI 10.4049/jimmunol.0903250; Altorok N, 2015, ANN RHEUM DIS, V74, P1612, DOI 10.1136/annrheumdis-2014-205303; Anderson MG, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-30; [Anonymous], 2020, HUMAN PROTEIN ATLAS; Arazi A, 2019, NAT IMMUNOL, V20, P902, DOI 10.1038/s41590-019-0398-x; Arosarena OA, 2018, J CELL PHYSIOL, V233, P409, DOI 10.1002/jcp.25900; Ashktorab H, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4903-7; Athwal VS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-36037-4; Baba M, 2019, MOL CANCER RES, V17, P1613, DOI 10.1158/1541-7786.MCR-18-1235; Bachner Dietmar, 2002, Brain Res Gene Expr Patterns, V1, P159; Bao G, 2016, EXP BIOL MED, V241, P1968, DOI 10.1177/1535370216654224; Bethunaickan R, 2011, J IMMUNOL, V186, P4994, DOI 10.4049/jimmunol.1003010; Bhaskaran M, 2012, PHYSIOL GENOMICS, V44, P970, DOI 10.1152/physiolgenomics.00145.2011; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Chen C, 2018, CANCER RES, V78, P6424, DOI 10.1158/0008-5472.CAN-18-0599; Choi MS, 2015, BRIT J NUTR, V113, P867, DOI 10.1017/S0007114515000100; Chung JS, 2007, J IMMUNOL, V179, P5778, DOI 10.4049/jimmunol.179.9.5778; Chung JS, 2014, J INVEST DERMATOL, V134, P2784, DOI 10.1038/jid.2014.254; Chung JS, 2014, J IMMUNOL, V192, P2576, DOI 10.4049/jimmunol.1301857; Chung JS, 2013, IMMUNOLOGY, V138, P173, DOI 10.1111/imm.12027; Chung JS, 2011, BLOOD, V117, P3382, DOI 10.1182/blood-2010-08-302034; Chung JS, 2009, J IMMUNOL, V183, P5190, DOI 10.4049/jimmunol.0901319; Chung JS, 2009, EUR J IMMUNOL, V39, P965, DOI 10.1002/eji.200838990; Coit P, 2013, J AUTOIMMUN, V43, P78, DOI 10.1016/j.jaut.2013.04.003; Dolcino M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128262; DSOUZA SE, 1991, TRENDS BIOCHEM SCI, V16, P246, DOI 10.1016/0968-0004(91)90096-E; Frara N, 2016, J CELL PHYSIOL, V231, P72, DOI 10.1002/jcp.25020; FUJIWARA KT, 1993, ONCOGENE, V8, P2371; Furochi H, 2007, FEBS LETT, V581, P5743, DOI 10.1016/j.febslet.2007.11.036; Gabriel TL, 2014, DIABETES, V63, P3310, DOI 10.2337/db13-1720; Gong XM, 2019, NAT METAB, V1, P570, DOI 10.1038/s42255-019-0065-4; Gutknecht M, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0099-5; Hoashi T, 2010, FASEB J, V24, P1616, DOI 10.1096/fj.09-151019; Hong SB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015793; Hu XF, 2013, J CELL BIOCHEM, V114, P2729, DOI 10.1002/jcb.24621; Huang JJ, 2012, BRAIN BEHAV, V2, P85, DOI 10.1002/brb3.39; Huttenrauch M, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0612-3; Jing H, 2002, STRUCTURE, V10, P1453, DOI 10.1016/S0969-2126(02)00840-7; Katayama A, 2015, SCI REP-UK, V5, DOI 10.1038/srep16920; Kobayashi M, 2019, CLIN CANCER RES, V25, P828, DOI 10.1158/1078-0432.CCR-18-0330; Kong XF, 2019, ANN RHEUM DIS, V78, P1388, DOI 10.1136/annrheumdis-2019-215567; Kramer G, 2016, FEBS OPEN BIO, V6, P902, DOI 10.1002/2211-5463.12078; Kuan CT, 2006, CLIN CANCER RES, V12, P1970, DOI 10.1158/1078-0432.CCR-05-2797; Kumagai K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143413; Kumari K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39122-4; Levy C, 2006, TRENDS MOL MED, V12, P406, DOI 10.1016/j.molmed.2006.07.008; Li B, 2010, FASEB J, V24, P4767, DOI 10.1096/fj.10-154757; Li H, 2019, HISTOL HISTOPATHOL, V34, P803, DOI 10.14670/HH-18-084; Li YJ, 2020, J CELL PHYSIOL, V235, P2071, DOI 10.1002/jcp.29107; Li YN, 2014, APMIS, V122, P140, DOI 10.1111/apm.12107; Lin AF, 2016, NAT CELL BIOL, V18, P213, DOI 10.1038/ncb3295; Liu FX, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1146-8; Loftus SK, 2009, PIGM CELL MELANOMA R, V22, P99, DOI 10.1111/j.1755-148X.2008.00518.x; Maric G, 2015, ONCOGENE, V34, P5494, DOI 10.1038/onc.2015.8; Maric G, 2019, ONCOGENE, V38, P5294, DOI 10.1038/s41388-019-0793-7; Metz RL, 2005, CELL CYCLE, V4, P315; Mo JS, 2003, J EXP MED, V197, P1335, DOI 10.1084/jem.20022041; Mokarram P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007012; Moloney EB, 2018, NEUROBIOL DIS, V120, P1, DOI 10.1016/j.nbd.2018.08.013; Moussa FM, 2014, J CELL BIOCHEM, V115, P1243, DOI 10.1002/jcb.24760; Murata K, 2015, J NEUROCHEM, V132, P583, DOI 10.1111/jnc.13010; Murugesan V, 2018, BLOOD CELL MOL DIS, V68, P47, DOI 10.1016/j.bcmd.2016.12.002; Nakano Y, 2014, NEUROSCIENCE, V277, P123, DOI 10.1016/j.neuroscience.2014.06.065; Naor D, 1997, ADV CANCER RES, V71, P241, DOI 10.1016/S0065-230X(08)60101-3; Narasaraju T, 2015, AM J RESP CELL MOL, V52, P253, DOI 10.1165/rcmb.2013-0021OC; Neal ML, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1100-1; Okita Y, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aak9397; Ono Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep23241; Oyewumi MO, 2016, ONCOTARGET, V7, P13932, DOI 10.18632/oncotarget.7323; Pahl MV, 2010, CLIN J AM SOC NEPHRO, V5, P56, DOI 10.2215/CJN.03390509; Patel-Chamberlin M, 2011, KIDNEY INT, V79, P1138, DOI 10.1038/ki.2011.28; Ramachandran P, 2012, P NATL ACAD SCI USA, V109, pE3186, DOI 10.1073/pnas.1119964109; Ren FF, 2020, J CELL PHYSIOL, V235, P2738, DOI 10.1002/jcp.29177; Ripoll VM, 2008, GENE, V413, P32, DOI 10.1016/j.gene.2008.01.014; Ripoll VM, 2007, J IMMUNOL, V178, P6557, DOI 10.4049/jimmunol.178.10.6557; Rose A, 2008, CANCER RES, V68, P3681; Rose AAN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012093; Rose AAN, 2010, CLIN CANCER RES, V16, P2147, DOI 10.1158/1078-0432.CCR-09-1611; Ruan WM, 2014, INT J CLIN EXP MED, V7, P4857; Safadi FF, 2002, J CELL BIOCHEM, V84, P12, DOI 10.1002/jcb.1259; Sasaki F, 2015, MOL MED REP, V12, P7503, DOI 10.3892/mmr.2015.4408; Sayed M, 2014, STEM CELL RES, V13, P12, DOI 10.1016/j.scr.2014.04.002; Scholer J, 2015, J BIOL CHEM, V290, P8154, DOI 10.1074/jbc.M114.615922; Sheng MHC, 2008, FEBS LETT, V582, P1451, DOI 10.1016/j.febslet.2008.03.030; Sheng MHC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035280; Shi FY, 2014, J MOL NEUROSCI, V54, P234, DOI 10.1007/s12031-014-0280-0; Shikano S, 2001, J BIOL CHEM, V276, P8125, DOI 10.1074/jbc.M008539200; Singh M, 2012, J CELL PHYSIOL, V227, P390, DOI 10.1002/jcp.22791; Smuczek B, 2017, EXP CELL RES, V358, P323, DOI 10.1016/j.yexcr.2017.07.005; Sondag GR, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.78; Tanaka H, 2012, SCI REP-UK, V2, DOI 10.1038/srep00573; Terasawa K, 2016, BIOCHEM BIOPH RES CO, V479, P489, DOI 10.1016/j.bbrc.2016.09.093; Theos AC, 2013, PIGM CELL MELANOMA R, V26, DOI 10.1111/pcmr.12084; Tian F, 2012, ONCOL RES, V20, P341, DOI 10.3727/096504013X13657689382851; Tomihari M, 2010, CANCER RES, V70, P5778, DOI 10.1158/0008-5472.CAN-09-2538; Tomihari M, 2009, EXP DERMATOL, V18, P586, DOI 10.1111/j.1600-0625.2008.00830.x; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Wang YL, 2015, INT J CLIN EXP PATHO, V8, P6498; WETERMAN MAJ, 1995, INT J CANCER, V60, P73, DOI 10.1002/ijc.2910600111; Xie R, 2019, CANCER SCI, V110, P2237, DOI 10.1111/cas.14076; Yang CF, 2018, AM J HUM GENET, V102, P219, DOI 10.1016/j.ajhg.2017.12.012; Yang M, 2018, CELL COMMUN SIGNAL, V16, DOI 10.1186/s12964-018-0242-1; Yu B, 2018, J INVEST DERMATOL, V138, P219, DOI 10.1016/j.jid.2017.08.034; Yu B, 2016, J CELL BIOCHEM, V117, P1511, DOI 10.1002/jcb.25394; Zambonelli P, 2016, ANIM GENET, V47, P306, DOI 10.1111/age.12413; Zhang F, 2019, NAT IMMUNOL, V20, P928, DOI 10.1038/s41590-019-0378-1; Zhang P, 2013, BMB REP, V46, P364, DOI 10.5483/BMBRep.2013.46.7.250; Zhang P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042955; Zhang YX, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317699119; Zhou LT, 2017, CELL IMMUNOL, V316, P53, DOI 10.1016/j.cellimm.2017.03.006; Zhu SC, 2019, J MOL NEUROSCI, V69, P643, DOI 10.1007/s12031-019-01411-y	116	9	9	3	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					8810	8823		10.1096/fj.202000651	http://dx.doi.org/10.1096/fj.202000651		MAY 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32445534	Green Published, Green Accepted			2022-12-28	WOS:000535460100001
J	Voth, S; Gwin, M; Francis, CM; Balczon, R; Frank, DW; Pittet, JF; Wagener, BM; Moser, SA; Alexeyev, M; Housley, N; Audia, JP; Piechocki, S; Madera, K; Simmons, A; Crawford, I; Stevens, T				Voth, Sarah; Gwin, Meredith; Francis, Christopher Michael; Balczon, Ron; Frank, Dara W.; Pittet, Jean-Francois; Wagener, Brant M.; Moser, Stephen A.; Alexeyev, Mikhail; Housley, Nicole; Audia, Jonathon P.; Piechocki, Scott; Madera, Kayla; Simmons, Autumn; Crawford, Iichacla; Stevens, Troy			Virulent Pseudomonas aeruginosa infection converts antimicrobial amyloids into cytotoxic prions	FASEB JOURNAL			English	Article						amyloid beta (A beta); exoenzyme Y (ExoY); nosocomial pneumonia; prion; tau (tau)	VENTILATOR-ASSOCIATED PNEUMONIA; NUCLEOTIDYL CYCLASE; ALZHEIMERS-DISEASE; A-BETA; ALAMAR BLUE; EXOENZYME Y; TAU; OLIGOMERS; PEPTIDE; EXOY	Pseudomonas aeruginosa infection elicits the production of cytotoxic amyloids from lung endothelium, yet molecular mechanisms of host-pathogen interaction that underlie the amyloid production are not well understood. We examined the importance of type III secretion system (T3SS) effectors in the production of cytotoxic amyloids. P aeruginosa possessing a functional T3SS and effectors induced the production and release of cytotoxic amyloids from lung endothelium, including beta amyloid, and tau. T3SS effector intoxication was sufficient to generate cytotoxic amyloid release, yet intoxication with exoenzyme Y (ExoY) alone or together with exoenzymes S and T (ExoS/T/Y) generated the most virulent amyloids. Infection with lab and clinical strains engendered cytotoxic amyloids that were capable of being propagated in endothelial cell culture and passed to naive cells, indicative of a prion strain. Conversely, T3SS-incompetent P aeruginosa infection produced non-cytotoxic amyloids with antimicrobial properties. These findings provide evidence that (1) endothelial intoxication with ExoY is sufficient to elicit self-propagating amyloid cytotoxins during infection, (2) pulmonary endothelium contributes to innate immunity by generating antimicrobial amyloids in response to bacterial infection, and (3) ExoY contributes to the virulence arsenal of P aeruginosa through the subversion of endothelial amyloid host-defense to promote a lung endothelial-derived cytotoxic proteinopathy.	[Voth, Sarah; Gwin, Meredith; Francis, Christopher Michael; Alexeyev, Mikhail; Piechocki, Scott; Madera, Kayla; Simmons, Autumn; Crawford, Iichacla; Stevens, Troy] Univ S Alabama, Coll Med, Dept Physiol & Cell Biol, Mobile, AL 36688 USA; [Voth, Sarah; Gwin, Meredith; Francis, Christopher Michael; Balczon, Ron; Alexeyev, Mikhail; Audia, Jonathon P.; Stevens, Troy] Univ S Alabama, Coll Med, Ctr Lung Biol, Mobile, AL 36688 USA; [Balczon, Ron] Univ S Alabama, Coll Med, Dept Biochem & Mol Biol, Mobile, AL 36688 USA; [Frank, Dara W.] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA; [Pittet, Jean-Francois; Wagener, Brant M.] Univ Alabama Birmingham, Birmingham Sch Med, Dept Anesthesiol & Perioperat Med, Birmingham, AL USA; [Moser, Stephen A.] Univ Alabama Birmingham, Birmingham Sch Med, Dept Pathol, Birmingham, AL USA; [Housley, Nicole; Audia, Jonathon P.] Univ S Alabama, Coll Med, Dept Microbiol & Immunol, Mobile, AL 36688 USA; [Stevens, Troy] Univ S Alabama, Coll Med, Dept Internal Med, Mobile, AL 36688 USA	University of South Alabama; University of South Alabama; University of South Alabama; Medical College of Wisconsin; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of South Alabama; University of South Alabama	Stevens, T (corresponding author), Univ S Alabama, Coll Med, Dept Physiol & Cell Biol, Mobile, AL 36688 USA.	tstevens@southalabama.edu	Voth, Sarah B./AGJ-8666-2022	Voth, Sarah B./0000-0003-3796-7154	HHS \ NIH \ National Heart, Lung, and Blood Institute (NHLBI) [HL140182, HL66299, HL135003, HL60024, HL118334, HL136869, F31HL147512-01]; American Heart Association (AHA) [19PRE34380166]	HHS \ NIH \ National Heart, Lung, and Blood Institute (NHLBI); American Heart Association (AHA)(American Heart Association)	HHS vertical bar NIH vertical bar National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: HL140182, HL66299, HL135003, HL60024, HL118334, HL136869 and F31HL147512-01; American Heart Association (AHA), Grant/Award Number: 19PRE34380166	Aoyagi A, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aat8462; Azimi S, 2016, GMS HYG INFECT CONTR, V11, DOI 10.3205/dgkh000264; Balczon R, 2018, JOVE-J VIS EXP, DOI 10.3791/57447; Balczon R, 2017, FASEB J, V31, P2785, DOI 10.1096/fj.201601042RR; Beckert U, 2014, BIOCHEM BIOPH RES CO, V451, P497, DOI 10.1016/j.bbrc.2014.07.134; Beckert U, 2014, BIOCHEM BIOPH RES CO, V450, P870, DOI 10.1016/j.bbrc.2014.06.088; Benson MA, 2010, CLIN CHIM ACTA, V411, P190, DOI 10.1016/j.cca.2009.10.025; Castillo-Carranza DL, 2017, AGING DIS, V8, P257, DOI 10.14336/AD.2017.0112; Chan WW, 2016, CLIN MICROBIOLOGY PR, DOI [10.1128/9781555818814, DOI 10.1128/9781555818814]; Chen GF, 2017, ACTA PHARMACOL SIN, V38, P1205, DOI 10.1038/aps.2017.28; Cowan CM, 2012, BIOCHEM SOC T, V40, P693, DOI 10.1042/BST20120135; Danin PE, 2015, RESP CARE, V60, P21, DOI 10.4187/respcare.02722; Deane R, 2009, CNS NEUROL DISORD-DR, V8, P16, DOI 10.2174/187152709787601867; Dick A, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-432; Dueholm MS, 2013, MICROBIOLOGYOPEN, V2, P365, DOI 10.1002/mbo3.81; Eimer WA, 2018, NEURON, V99, P56, DOI 10.1016/j.neuron.2018.06.030; Ercan E, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0229-1; Feltman H, 2001, MICROBIOL-SGM, V147, P2659, DOI 10.1099/00221287-147-10-2659; FinckBarbancon V, 1997, MOL MICROBIOL, V25, P547, DOI 10.1046/j.1365-2958.1997.4891851.x; Forloni G, 2018, J ALZHEIMERS DIS, V62, P1261, DOI 10.3233/JAD-170819; Frank DW, 2002, J INFECT DIS, V186, P64, DOI 10.1086/341069; Gil-Perotin S, 2012, CRIT CARE, V16, DOI 10.1186/cc11357; Giles K, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a023499; Glabe CG, 2004, TRENDS BIOCHEM SCI, V29, P542, DOI 10.1016/j.tibs.2004.08.009; Gosztyla ML, 2018, J ALZHEIMERS DIS, V62, P1495, DOI 10.3233/JAD-171133; Grochowska KM, 2017, EMBO REP, V18, P962, DOI 10.15252/embr.201643519; Hamid R, 2004, TOXICOL IN VITRO, V18, P703, DOI 10.1016/j.tiv.2004.03.012; Hauser AR, 2009, NAT REV MICROBIOL, V7, P654, DOI 10.1038/nrmicro2199; He CX, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00239-17; He WL, 1999, BIOCHEMISTRY-US, V38, P10871, DOI 10.1021/bi990563r; Hetz C, 2002, P NATL ACAD SCI USA, V99, P2696, DOI 10.1073/pnas.052709699; Howie AJ, 2008, LAB INVEST, V88, P232, DOI 10.1038/labinvest.3700714; Ibanez J, 2016, J INTENSIVE CARE MED, V31, P34, DOI 10.1177/0885066614523918; Intile PJ, 2014, J BACTERIOL, V196, P357, DOI 10.1128/JB.01199-13; Jenkins CEM, 2019, PERFORMANCE STANDARD; Jeon J, 2017, FEBS J, V284, P3392, DOI 10.1111/febs.14199; Karhu J, 2011, ACTA ANAESTH SCAND, V55, P1254, DOI 10.1111/j.1399-6576.2011.02535.x; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kloth C, 2018, TOXINS, V10, DOI 10.3390/toxins10050185; Kobayashi N, 2008, BIOCONTROL SCI, V13, P49, DOI 10.4265/bio.13.49; Kollef MH, 2014, CRIT CARE MED, V42, P2178, DOI 10.1097/CCM.0000000000000510; Kumar DKV, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1059; Kumar S, 2011, AGING-US, V3, P803, DOI 10.18632/aging.100362; Lasagna-Reeves CA, 2012, FASEB J, V26, P1946, DOI 10.1096/fj.11-199851; Lathe R, 2017, J ALZHEIMERS DIS REP, V1, P263, DOI 10.3233/ADR-170037; Lin MT, 2018, AM J RESP CRIT CARE, V198, P1575, DOI 10.1164/rccm.201801-0060LE; Luo JH, 2016, J BIOL CHEM, V291, P16485, DOI 10.1074/jbc.R116.714576; Marden JN, 2013, P NATL ACAD SCI USA, V110, P15055, DOI 10.1073/pnas.1307217110; Melsen WG, 2013, LANCET INFECT DIS, V13, P665, DOI 10.1016/S1473-3099(13)70081-1; Mietelska-Porowska A, 2014, INT J MOL SCI, V15, P4671, DOI 10.3390/ijms15034671; Mikkelsen ME, 2012, AM J RESP CRIT CARE, V185, P1307, DOI 10.1164/rccm.201111-2025OC; Miklossy J, 2016, J ALZHEIMERS DIS, V53, P1459, DOI 10.3233/JAD-160451; Ming L, 2015, INT J CLIN EXP MED, V8, P5806; Moir RD, 2018, ALZHEIMERS DEMENT, V14, P1602, DOI 10.1016/j.jalz.2018.06.3040; Morrow KA, 2015, AM J PHYSIOL-LUNG C, V309, pL1199, DOI 10.1152/ajplung.00165.2015; Morrow KA, 2017, HANDB EXP PHARMACOL, V238, P67, DOI 10.1007/164_2016_5003; Morrow KA, 2016, AM J PHYSIOL-LUNG C, V310, P1337, DOI 10.1152/ajplung.00103.2015; Mroczko B, 2018, J NEURAL TRANSM, V125, P177, DOI 10.1007/s00702-017-1820-x; Naini SMA, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/151979; Nguyen K, 2016, J PHYS CHEM B, V120, P2187, DOI 10.1021/acs.jpcb.5b12235; O'Brien RJ, 2011, ANNU REV NEUROSCI, V34, P185, DOI 10.1146/annurev-neuro-061010-113613; Ochoa CD, 2012, J BIOL CHEM, V287, P25407, DOI 10.1074/jbc.M111.301440; Ow SY, 2014, PROTEIN SCI, V23, P1315, DOI 10.1002/pro.2524; Park SC, 2016, BIOCHEM BIOPH RES CO, V478, P924, DOI 10.1016/j.bbrc.2016.08.052; Pascoal TA, 2017, ALZHEIMERS DEMENT, V13, P644, DOI 10.1016/j.jalz.2016.11.005; Pauwels K, 2012, J BIOL CHEM, V287, P5650, DOI 10.1074/jbc.M111.264473; Portelius E, 2006, J PROTEOME RES, V5, P1010, DOI 10.1021/pr050475v; PRUSINER SB, 1983, CELL, V35, P349, DOI 10.1016/0092-8674(83)90168-X; Prusiner SB, 2013, ANNU REV GENET, V47, P601, DOI 10.1146/annurev-genet-110711-155524; Ramirez-Estrada S, 2016, INFECT DRUG RESIST, V9, P7, DOI 10.2147/IDR.S50669; Rampersad SN, 2012, SENSORS-BASEL, V12, P12347, DOI 10.3390/s120912347; Rapoport M, 2002, P NATL ACAD SCI USA, V99, P6364, DOI 10.1073/pnas.092136199; Realegeno S, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005705; Reichhardt C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140388; Rodrigues ME, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170433; Romero D, 2014, INT MICROBIOL, V17, P65, DOI 10.2436/20.1501.01.208; Sato H, 2004, MOL MICROBIOL, V53, P1279, DOI 10.1111/j.1365-2958.2004.04194.x; Sayner SL, 2004, CIRC RES, V95, P196, DOI 10.1161/01.RES.0000134922.25721.d9; Schwartz K, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002744; Seifert R, 2017, HANDB EXP PHARMACOL, V238, P3, DOI 10.1007/164_2016_5005; Sengupta U, 2016, EBIOMEDICINE, V6, P42, DOI 10.1016/j.ebiom.2016.03.035; Shaver CM, 2004, INFECT IMMUN, V72, P6969, DOI 10.1128/IAI.72.12.6969-6977.2004; Shima K, 2010, MED MICROBIOL IMMUN, V199, P283, DOI 10.1007/s00430-010-0162-1; Soscia SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009505; Spitzer P, 2016, SCI REP-UK, V6, DOI 10.1038/srep32228; Stevens TC, 2014, AM J PHYSIOL-LUNG C, V306, pL915, DOI 10.1152/ajplung.00135.2013; Tsay TB, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0417-5; Tumbarello M, 2013, INTENS CARE MED, V39, P682, DOI 10.1007/s00134-013-2828-9; Vallis AJ, 1999, INFECT IMMUN, V67, P2040; Xue C, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.160696; Yahr TL, 1998, P NATL ACAD SCI USA, V95, P13899, DOI 10.1073/pnas.95.23.13899; Zhou Yizhou, 2013, Methods Mol Biol, V966, P53, DOI 10.1007/978-1-62703-245-2_4	92	15	15	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9156	9179		10.1096/fj.202000051RRR	http://dx.doi.org/10.1096/fj.202000051RRR		MAY 2020	24	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32413239	Green Published, Green Accepted			2022-12-28	WOS:000533181500001
J	Yim, TW; Perling, D; Polcz, M; Komalavilas, P; Brophy, C; Cheung-Flynn, J				Yim, Tsz Wing; Perling, Daniel; Polcz, Monica; Komalavilas, Padmini; Brophy, Colleen; Cheung-Flynn, Joyce			A cell permeant phosphopeptide mimetic of Niban inhibits p38 MAPK and restores endothelial function after injury	FASEB JOURNAL			English	Article						endothelial dysfunction; kinase inhibitor; Niban; p38 MAPK; vascular	ENDOPLASMIC-RETICULUM STRESS; ACTIVATED PROTEIN-KINASE; SUBFAILURE OVERSTRETCH INJURY; P2X7 RECEPTOR; SIGNALING PATHWAYS; VASCULAR-RESPONSE; EXTRACELLULAR ATP; BLOOD-VESSELS; ORGAN DAMAGE; IN-VITRO	Vascular injury leads to membrane disruption, ATP release, and endothelial dysfunction. Increases in the phosphorylation of p38 mitogen-activated protein kinase (p38 MAPK) and decreases in the phosphorylation of Niban, a protein implicated in ER stress and apoptosis, are associated with vascular injury. A cell permeant phosphopeptide mimetic of Niban (NiPp) was generated. The effects of NiPp in restoring endothelial function were determined ex vivo using intact rat aortic tissue (RA) after pharmacological activation of p38 MAPK and also in multiple clinically relevant injury models. Anisomycin (Aniso) increased p38 MAPK phosphorylation and reduced endothelial-dependent relaxation in RA. Treatment with NiPp prevented Ansio-induced reduction in endothelial function and increases in p38 MAPK phosphorylation. NiPp treatment also restored endothelial function after stretch injury (subfailure stretch), treatment with acidic Normal Saline (NS), and P2X7R activation with 2 '(3 ')-O-(4-Benzoylbenzoyl)adenosine 5 '-triphosphate (BzATP). Aged, diseased, human saphenous vein (HSV) remnants obtained from patients undergoing coronary bypass surgical procedures have impaired endothelial function. Treatment of these HSV segments with NiPp improved endothelial-dependent relaxation. Kinome screening experiments indicated that NiPp inhibits p38 MAPK. These data demonstrate that p38 MAPK and Niban signaling have a role in endothelial function, particularly in response to injury. Niban may represent an endogenous regulator of p38 MAPK activation. The NiPp peptide may serve as an experimental tool to further elucidate p38 MAPK regulation and as a potential therapeutic for endothelial dysfunction.	[Yim, Tsz Wing; Perling, Daniel; Polcz, Monica; Komalavilas, Padmini; Brophy, Colleen; Cheung-Flynn, Joyce] Vanderbilt Univ, Dept Surg, 1211 Med Ctr Dr, Nashville, TN 37232 USA; [Komalavilas, Padmini; Brophy, Colleen] VA Tennessee Valley Healthcare Syst, Nashville, TN USA	Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Cheung-Flynn, J (corresponding author), Vanderbilt Univ, Dept Surg, 1211 Med Ctr Dr, Nashville, TN 37232 USA.	joyce.cheung-flynn@vumc.org			National Institutes of Health [R01HL70715-09, R01HL105731-01]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	National Institutes of Health, Grant/Award Number: R01HL70715-09 and R01HL105731-01	Abebe W, 2010, EPMA J, V1, P32, DOI 10.1007/s13167-010-0012-7; Behr TM, 2001, CIRCULATION, V104, P1292, DOI 10.1161/hc3601.094275; Brown KA, 2007, ARTERIOSCL THROM VAS, V27, P1941, DOI 10.1161/ATVBAHA.107.146852; BURD JF, 1973, CLIN CHIM ACTA, V46, P223, DOI 10.1016/0009-8981(73)90174-5; Chao CC, 2012, J CELL BIOCHEM, V113, P1377, DOI 10.1002/jcb.24010; Cheriyan J, 2011, CIRCULATION, V123, P515, DOI 10.1161/CIRCULATIONAHA.110.971986; Cheung-Flynn J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220893; Chiu JJ, 2011, PHYSIOL REV, V91, P327, DOI 10.1152/physrev.00047.2009; Coulthard LR, 2009, TRENDS MOL MED, V15, P369, DOI 10.1016/j.molmed.2009.06.005; Crimi E, 2012, J CRIT CARE, V27, P108, DOI 10.1016/j.jcrc.2011.06.001; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Di Virgilio F, 2017, IMMUNITY, V47, P15, DOI 10.1016/j.immuni.2017.06.020; Dong L, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020278; Donnelly-Roberts DL, 2004, J PHARMACOL EXP THER, V308, P1053, DOI 10.1124/jpet.103.059600; DUBYAK GR, 1993, AM J PHYSIOL, V265, pC577, DOI 10.1152/ajpcell.1993.265.3.C577; Dubyak GR, 2002, AM J PHYSIOL-CELL PH, V282, pC242, DOI 10.1152/ajpcell.00522.2001; Eagle S, 2011, AM SURGEON, V77, P922; Evstafieva AG, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191107; Feng X, 2019, CELL DEATH DISCOV, V5, DOI 10.1038/s41420-019-0167-5; Fischer-Colbrie R, 2005, CURR PROTEIN PEPT SC, V6, P373, DOI 10.2174/1389203054546334; Franceschini A, 2015, FASEB J, V29, P2450, DOI 10.1096/fj.14-268714; FRESHNEY NW, 1994, CELL, V78, P1039, DOI 10.1016/0092-8674(94)90278-X; Galan M, 2014, BBA-MOL CELL RES, V1843, P1063, DOI 10.1016/j.bbamcr.2014.02.009; Gustin JA, 2004, AM J PHYSIOL-CELL PH, V286, pC547, DOI 10.1152/ajpcell.00332.2002; Guth CM, 2017, J SURG RES, V216, P80, DOI 10.1016/j.jss.2017.03.025; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Harskamp RE, 2014, JAMA SURG, V149, P798, DOI 10.1001/jamasurg.2014.87; Ho A, 2001, CANCER RES, V61, P474; Hocking KM, 2011, J VASC SURG, V53, P454, DOI 10.1016/j.jvs.2010.09.010; Icli B, 2019, FASEB J, V33, P5599, DOI 10.1096/fj.201802063RR; Ji HT, 2012, EMBO REP, V13, P554, DOI 10.1038/embor.2012.53; Jia LX, 2015, J PATHOL, V236, P373, DOI 10.1002/path.4534; Ju HS, 2002, J PHARMACOL EXP THER, V301, P15, DOI 10.1124/jpet.301.1.15; Ju HS, 2003, J PHARMACOL EXP THER, V307, P932, DOI 10.1124/jpet.103.057422; King EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053936; KOGA T, 1989, HYPERTENSION, V14, P542, DOI 10.1161/01.HYP.14.5.542; KOH JY, 1987, J NEUROSCI METH, V20, P83, DOI 10.1016/0165-0270(87)90041-0; Komalavilas P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188069; Kyriakis JM, 1996, BIOESSAYS, V18, P567, DOI 10.1002/bies.950180708; Li FD, 2014, JAMA SURG, V149, P655, DOI 10.1001/jamasurg.2013.5067; Lum H, 1999, AM J PHYSIOL-CELL PH, V277, pC580, DOI 10.1152/ajpcell.1999.277.3.C580; Luo WF, 2017, PURINERG SIGNAL, V13, P579, DOI 10.1007/s11302-017-9585-0; Luo WF, 2016, FRONT BIOENG BIOTECH, V4, DOI 10.3389/fbioe.2016.00075; Majima S, 2000, JPN J CANCER RES, V91, P869, DOI 10.1111/j.1349-7006.2000.tb01027.x; Malek AM, 1998, STROKE, V29, P2631, DOI 10.1161/01.STR.29.12.2631; Mayr M, 2000, FASEB J, V14, P261, DOI 10.1096/fasebj.14.2.261; McGeachie MJ, 2018, J ALLERGY CLIN IMMUN, V142, P1479, DOI 10.1016/j.jaci.2017.11.059; Niaudet C, 2017, CELL SIGNAL, V33, P10, DOI 10.1016/j.cellsig.2017.02.001; Nozima BH, 2019, ENDOCR-RELAT CANCER, V26, P227, DOI 10.1530/ERC-17-0530; Ohashi N, 2000, ARTERIOSCL THROM VAS, V20, P2521, DOI 10.1161/01.ATV.20.12.2521; Osgood MJ, 2014, J VASC SURG, V60, P202, DOI 10.1016/j.jvs.2013.06.004; Ottesen AH, 2019, CIRC-ARRHYTHMIA ELEC, V12, DOI 10.1161/CIRCEP.118.007045; Pallmann N, 2019, ONCOGENE, V38, P6301, DOI 10.1038/s41388-019-0879-2; Semler MW, 2018, NEW ENGL J MED, V378, P829, DOI 10.1056/NEJMoa1711584; Srinivasan B, 2015, JALA-J LAB AUTOM, V20, P107, DOI 10.1177/2211068214561025; Stone JD, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00409; Sun GD, 2007, BIOCHEM BIOPH RES CO, V360, P181, DOI 10.1016/j.bbrc.2007.06.021; TESFAMARIAM B, 1991, J CLIN INVEST, V87, P1643, DOI 10.1172/JCI115179; Ungvari Z, 2018, CIRC RES, V123, P849, DOI 10.1161/CIRCRESAHA.118.311378; Varghese GP, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.003031; Ward B, 2009, J PEPT SCI, V15, P668, DOI 10.1002/psc.1168; Williams SB, 1998, CIRCULATION, V97, P1695, DOI 10.1161/01.CIR.97.17.1695; Wise ES, 2015, SURGERY, V158, P537, DOI 10.1016/j.surg.2015.03.036; Yuki R, 2015, J CELL BIOCHEM, V116, P954, DOI 10.1002/jcb.25046; Zamaraeva MV, 2005, CELL DEATH DIFFER, V12, P1390, DOI 10.1038/sj.cdd.4401661; Zhang CH, 2008, BASIC RES CARDIOL, V103, P398, DOI 10.1007/s00395-008-0733-0	67	3	3	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9180	9191		10.1096/fj.201902745R	http://dx.doi.org/10.1096/fj.201902745R		MAY 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32396246	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000532318400001
J	Lin, S; Song, SZ; Sun, R; Zhang, MB; Du, YT; Zhang, DD; Xu, WH; Wang, HB				Lin, Sen; Song, Suzhen; Sun, Rong; Zhang, Mingbao; Du, Yating; Zhang, Dongdong; Xu, Weihua; Wang, Hongbo			Oncogenic circular RNA Hsa-circ-000684 interacts with microRNA-186 to upregulate ZEB1 in gastric cancer	FASEB JOURNAL			English	Article						angiogenesis; circular RNA hsa-circ-000684; gastric cancer; microRNA-186; ZEB1	MESENCHYMAL TRANSITION; DOWN-REGULATION; CELL; PROLIFERATION; EXPRESSION; PROMOTES; METASTASIS; MIR-15A; PROFILE	Circular RNAs (circRNAs) function as modulators of microRNAs (miRNAs) and are often involved in cancer progression. This study aims to investigate the underlying mechanism by which circRNA hsa-circ-000684 promotes the progression of gastric cancer (GC). Expression of hsa-circ-000684 and that of ZEB1 mRNA were elevated while microRNA-186 (miR-186) expression was downregulated in GC cell lines and clinical tissues. In addition, the effects of hsa-circ-000684 on the proliferation, migration, invasion, and tube formation of GC cells were examined through gain-and loss-of-function experiments. Furthermore, we introduced tumor xenografts into nude mice to better understand these effects in vivo. Either knockdown of hsa-circ-000684 or upregulation of miR-186 inhibited GC cell proliferation, migration, invasion, and tube formation in vitro, and reduced the xenograft tumor growth in nude mice. Moreover, we found that hsa-circ-000684 and ZEB1 directly bound to miR-186. Hsa-circ-000684 increased the expression of ZEB1 by binding to miR-186. The tumor suppressive effects of hsa-circ-000684 knockdown were reversed by inhibition of miR-186. Collectively, our data show that hsa-circ-000684 reduces the miR-186 expression which leads to an increase in the ZEB1 expression and, consequently, promotion of GC progression.	[Lin, Sen; Zhang, Mingbao; Du, Yating; Zhang, Dongdong; Xu, Weihua; Wang, Hongbo] Shandong Univ, Dept Digest Dis, Hosp 2, 247 Beiyuan St, Jinan 250033, Shandong, Peoples R China; [Song, Suzhen] Shandong Univ Tradit Chinese Med, Dept Internal Med, Jinan, Peoples R China; [Sun, Rong] Shandong Univ, Hosp 2, Cent Lab, Jinan, Peoples R China	Shandong University; Shandong University of Traditional Chinese Medicine; Shandong University	Wang, HB (corresponding author), Shandong Univ, Dept Digest Dis, Hosp 2, 247 Beiyuan St, Jinan 250033, Shandong, Peoples R China.	wanghongbo_d@163.com			Major Program of National Nature Significant Drug Discovery National Key Technologies Program of China during the 11th Five-Year Plan Period [2009ZX09502-015]; National Major Fundamental Research Program of China [2009CB522802]; Traditional Chinese Medicine Pharmacology and Toxicology Expert from Taishan Scholar Project of Shandong Province [ts201511107]	Major Program of National Nature Significant Drug Discovery National Key Technologies Program of China during the 11th Five-Year Plan Period; National Major Fundamental Research Program of China; Traditional Chinese Medicine Pharmacology and Toxicology Expert from Taishan Scholar Project of Shandong Province	the Major Program of National Nature Significant Drug Discovery National Key Technologies Program of China during the 11th Five-Year Plan Period, Grant/Award Number: 2009ZX09502-015; the National Major Fundamental Research Program of China, Grant/Award Number: 2009CB522802; Traditional Chinese Medicine Pharmacology and Toxicology Expert from Taishan Scholar Project of Shandong Province, Grant/Award Number: ts201511107	Bian YZ, 2019, CANCER BIOL THER, V20, P886, DOI 10.1080/15384047.2019.1579959; Cai JC, 2013, CANCER RES, V73, P756, DOI 10.1158/0008-5472.CAN-12-2651; Cao G, 2018, ONCOTARGETS THER, V11, P6153, DOI 10.2147/OTT.S175428; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Dang RY, 2017, BIOCHEM BIOPH RES CO, V490, P104, DOI 10.1016/j.bbrc.2017.05.164; Dang Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09076-6; Ebbesen KK, 2016, BBA-GENE REGUL MECH, V1859, P163, DOI 10.1016/j.bbagrm.2015.07.007; Guo XB, 2017, AM J CANCER RES, V7, P2234; Guo YM, 2019, BIOMED PHARMACOTHER, V118, DOI 10.1016/j.biopha.2019.109255; Huang TH, 2018, CANCER BIOMARK, V21, P221, DOI 10.3233/CBM-170670; Jia BQ, 2012, MOL CELL BIOCHEM, V366, P223, DOI 10.1007/s11010-012-1299-6; Krejs GJ, 2010, DIGEST DIS, V28, P600, DOI 10.1159/000320277; Li JL, 2018, ARCH BIOCHEM BIOPHYS, V640, P53, DOI 10.1016/j.abb.2018.01.002; Li Y, 2017, CANCER LETT, V411, P64, DOI 10.1016/j.canlet.2017.09.006; Liu L, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.35; Liu LJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148774; Nienhuser H, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010043; Okugawa Y, 2012, J SURG ONCOL, V106, P280, DOI 10.1002/jso.22142; Ouyang YM, 2019, J CELL PHYSIOL, V234, P10458, DOI 10.1002/jcp.27714; Shan F, 2016, CANCER LETT, V380, P598, DOI 10.1016/j.canlet.2015.12.023; Shao YF, 2017, CANCER MED-US, V6, P1173, DOI 10.1002/cam4.1055; Shi YQ, 2010, J SURG ONCOL, V101, P687, DOI 10.1002/jso.21455; Sun HD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27837-9; Sun WJ, 2019, J CELL BIOCHEM, V120, P10001, DOI 10.1002/jcb.28283; Terzuoli E, 2016, ONCOTARGET, V7, P44350, DOI 10.18632/oncotarget.10051; Wang MQ, 2019, GENE, V700, P110, DOI 10.1016/j.gene.2019.03.043; Wang Y, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0766-4; Wu S, 2019, J CELL PHYSIOL, V234, P19059, DOI 10.1002/jcp.28545; Xie HJ, 2016, ONCOTARGET, V7, P26680, DOI 10.18632/oncotarget.8589; Xue YJ, 2019, MED SCI MONITOR, V25, P1663, DOI 10.12659/MSM.912338; Zare Ali, 2019, Iranian Biomedical Journal, V23, P338, DOI 10.29252/.23.5.338; Zhong ZY, 2016, SCI REP-UK, V6, DOI 10.1038/srep30919; Zhu X, 2016, ONCOGENE, V35, P323, DOI 10.1038/onc.2015.84; Zou QY, 2018, J CELL BIOCHEM, V119, P2189, DOI 10.1002/jcb.26380	34	17	17	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8187	8203		10.1096/fj.201903246R	http://dx.doi.org/10.1096/fj.201903246R		MAY 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32388910				2022-12-28	WOS:000532112400001
J	Horii, Y; Nakaya, M; Ohara, H; Nishihara, H; Watari, K; Nagasaka, A; Nakaya, T; Sugiura, Y; Okuno, T; Koga, T; Tanaka, A; Yokomizo, T; Kurose, H				Horii, Yuma; Nakaya, Michio; Ohara, Hiroki; Nishihara, Hiroaki; Watari, Kenji; Nagasaka, Akiomi; Nakaya, Takeo; Sugiura, Yuki; Okuno, Toshiaki; Koga, Tomoaki; Tanaka, Akira; Yokomizo, Takehiko; Kurose, Hitoshi			Leukotriene B-4 receptor 1 exacerbates inflammation following myocardial infarction	FASEB JOURNAL			English	Article						inflammation; leukotriene b4 receptor 1; myocardial infarction	CHRONIC HEART-FAILURE; ISCHEMIA-REPERFUSION; MECHANISMS; BLT1; ATHEROSCLEROSIS; RECRUITMENT; ANTAGONIST; THERAPY; RUPTURE; INJURY	Leukotriene B-4 receptor 1 (BLT1), a high-affinity G-protein-coupled receptor for leukotriene B4 (LTB4), is expressed on various inflammatory cells and plays critical roles in several inflammatory diseases. In myocardial infarction (MI), various inflammatory cells are known to be recruited to the infarcted area, but the function of BLT1 in MI is poorly understood. Here, we investigated the role of BLT1 in MI and the therapeutic effect of a BLT1 antagonist, ONO-4057, on MI. Mice with infarcted hearts showed increased BLT1 expression and LTB4 levels. BLT1-knockout mice with infarcted hearts exhibited attenuated leukocyte infiltration, proinflammatory cytokine production, and cell death, which led to reduced mortality and improved cardiac function after MI. Bone-marrow transplantation studies showed that BLT1 expressed on bone marrow-derived cells was responsible for the exacerbation of inflammation in infarcted hearts. Furthermore, ONO-4057 administration attenuated the inflammatory responses in hearts surgically treated for MI, which resulted in reduced mortality and improved cardiac function after MI. Our study demonstrated that BLT1 contributes to excessive inflammation after MI and could represent a new therapeutic target for MI.	[Horii, Yuma; Nakaya, Michio; Ohara, Hiroki; Nishihara, Hiroaki; Watari, Kenji; Nagasaka, Akiomi; Kurose, Hitoshi] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol & Toxicol, Fukuoka, Japan; [Nakaya, Michio] Japan Agcy Med Res & Dev, AHED PRIME, Tokyo, Japan; [Nakaya, Takeo; Tanaka, Akira] Jichi Med Univ, Dept Pathol, Shimotsuke, Tochigi, Japan; [Sugiura, Yuki] Keio Univ, Dept Biochem, Sch Med, Tokyo, Japan; [Okuno, Toshiaki; Koga, Tomoaki; Yokomizo, Takehiko] Juntendo Univ, Grad Sch Med, Dept Biochem, Tokyo, Japan	Kyushu University; Jichi Medical University; Keio University; Juntendo University	Nakaya, M; Kurose, H (corresponding author), Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol & Toxicol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	nakaya@phar.kyushu-u.ac.jp; hikurose@phar.kyushu-u.ac.jp			Japan Agency for Medical Research and Development (AMED) [JP20gm5810030, JP19fk0210029, JP19am0101091]; MEXT | Japan Society for the Promotion of Science (JSPS) [19J20083]; Ono Medical Research Foundation; Takeda Science Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; SENSHIN Medical Research Foundation; Shimabara Science Promotion Foundation; Senri Life Science Foundation; KAKENHI [17H03984, 17H05510, 17H01525];  [25116716]	Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); MEXT | Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ono Medical Research Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation); Shimabara Science Promotion Foundation; Senri Life Science Foundation; KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); 	Japan Agency for Medical Research and Development (AMED), Grant/Award Number: JP20gm5810030; Japan Agency for Medical Research and Development (AMED), Grant/Award Number: JP19fk0210029; MEXT | Japan Society for the Promotion of Science (JSPS), Grant/Award Number: 19J20083; Grants-in-Aid for Scientific Research on Innovative Areas, Grant/Award Number: 25116716; Ono Medical Research Foundation; Takeda Science Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; SENSHIN Medical Research Foundation; Shimabara Science Promotion Foundation; Senri Life Science Foundation; Japan Agency for Medical Research and Development (AMED), Grant/Award Number: JP19am0101091; Grants-in-Aid for Scientific Research (KAKENHI), Grant/Award Number: 17H03984, 17H05510 and 17H01525	Abbate A, 2013, AM J CARDIOL, V111, P1394, DOI 10.1016/j.amjcard.2013.01.287; Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4; Blomer N, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0367-8; Bujak M, 2008, AM J PATHOL, V173, P57, DOI 10.2353/ajpath.2008.070974; Chung ES, 2003, CIRCULATION, V107, P3133, DOI 10.1161/01.CIR.0000077913.60364.D2; de Hoog VC, 2015, CARDIOVASC RES, V108, P367, DOI 10.1093/cvr/cvv224; Dick SA, 2016, CIRC RES, V119, P159, DOI 10.1161/CIRCRESAHA.116.308030; Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5; Frangogiannis NG, 2012, CIRC RES, V110, P159, DOI 10.1161/CIRCRESAHA.111.243162; FUSTER V, 1990, CIRCULATION, V82, P47; Gijon MA, 2007, J LIPID RES, V48, P716, DOI 10.1194/jlr.M600508-JLR200; Gupta K, 2018, J MOL CELL CARDIOL, V118, P26, DOI 10.1016/j.yjmcc.2018.03.003; Gurung P, 2015, AM J PATHOL, V185, P17, DOI 10.1016/j.ajpath.2014.08.025; HAHN RA, 1990, J PHARMACOL EXP THER, V253, P58; Haribabu B, 2000, J EXP MED, V192, P433, DOI 10.1084/jem.192.3.433; Hikiji H, 2009, P NATL ACAD SCI USA, V106, P21294, DOI 10.1073/pnas.0905209106; Huang SB, 2018, BRIT J PHARMACOL, V175, P1377, DOI 10.1111/bph.14155; IVERSEN L, 1994, ARCH DERMATOL RES, V286, P261, DOI 10.1007/BF00387598; Kim ND, 2006, J EXP MED, V203, P829, DOI 10.1084/jem.20052349; KISHIKAWA K, 1992, PROSTAGLANDINS, V44, P261, DOI 10.1016/0090-6980(92)90002-B; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Liu JQ, 2016, CLIN MED INSIGHTS-CA, V10, P79, DOI 10.4137/CMC.S33164; Luedde M, 2014, CARDIOVASC RES, V103, P206, DOI 10.1093/cvr/cvu146; Mann DL, 2004, CIRCULATION, V109, P1594, DOI 10.1161/01.CIR.0000124490.27666.B2; Marchetti C, 2014, J CARDIOVASC PHARM, V63, P316, DOI 10.1097/FJC.0000000000000053; Matsunobu T, 2013, J LIPID RES, V54, P2979, DOI 10.1194/jlr.M037754; MCGEE JE, 1986, P NATL ACAD SCI USA, V83, P1349, DOI 10.1073/pnas.83.5.1349; Miyahara N, 2005, J IMMUNOL, V174, P4979, DOI 10.4049/jimmunol.174.8.4979; Newton K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006049; Noiri E, 2000, P NATL ACAD SCI USA, V97, P823, DOI 10.1073/pnas.97.2.823; Peters-Golden M, 2007, NEW ENGL J MED, V357, P1841, DOI 10.1056/NEJMra071371; Riccioni G, 2008, J LEUKOCYTE BIOL, V84, P1374, DOI 10.1189/jlb.0808476; Rinaldo-Matthis A, 2010, BIOCHIMIE, V92, P676, DOI 10.1016/j.biochi.2010.01.010; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Sasaki F, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.96902; Sasaki F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185133; Subbarao K, 2004, ARTERIOSCL THROM VAS, V24, P369, DOI 10.1161/01.ATV.0000110503.16605.15; Sun M, 2004, CIRCULATION, V110, P3221, DOI 10.1161/01.CIR.0000147233.10318.23; Swirski FK, 2013, SCIENCE, V339, P161, DOI 10.1126/science.1230719; Terawaki K, 2005, J IMMUNOL, V175, P4217, DOI 10.4049/jimmunol.175.7.4217; Toldo S, 2013, EXP PHYSIOL, V98, P734, DOI 10.1113/expphysiol.2012.069831; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; White HD, 2008, LANCET, V372, P570, DOI 10.1016/S0140-6736(08)61237-4; Yan XX, 2013, J MOL CELL CARDIOL, V62, P24, DOI 10.1016/j.yjmcc.2013.04.023; Yokomizo T, 2000, J EXP MED, V192, P421, DOI 10.1084/jem.192.3.421; Yokomizo T, 1997, NATURE, V387, P620, DOI 10.1038/42506; Yokomizo T, 2001, J BIOL CHEM, V276, P12454, DOI 10.1074/jbc.M011361200; Yokomizo T, 2018, J CLIN INVEST, V128, P2691, DOI 10.1172/JCI97946	50	9	9	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8749	8763		10.1096/fj.202000041R	http://dx.doi.org/10.1096/fj.202000041R		MAY 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32385915	hybrid			2022-12-28	WOS:000532120900001
J	Guo, YX; Wang, JY; Zhou, KC; Lv, JQ; Wang, L; Gao, S; Keller, ET; Zhang, ZS; Wang, Q; Yao, Z				Guo, Yaxiu; Wang, Jingyu; Zhou, Kaichen; Lv, Junqiang; Wang, Lei; Gao, Shan; Keller, Evan T.; Zhang, Zhi-Song; Wang, Quan; Yao, Zhi			Cytotoxic necrotizing factor 1 promotes bladder cancer angiogenesis through activating RhoC	FASEB JOURNAL			English	Article						angiogenesis; bladder cancer; cytotoxic necrotizing factor 1; RhoC; uropathogenic Escherichia coli	ESCHERICHIA-COLI; EXPRESSION; HYPOXIA; HIF-1; VEGF; HIF-1-ALPHA; METASTASIS; CARCINOMA; TRANSCRIPTION; PROGRESSION	Uropathogenic Escherichia coli (UPEC), a leading cause of urinary tract infections, is associated with prostate and bladder cancers. Cytotoxic necrotizing factor 1 (CNF1) is a key UPEC toxin; however, its role in bladder cancer is unknown. In the present study, we found CNF1 induced bladder cancer cells to secrete vascular endothelial growth factor (VEGF) through activating Ras homolog family member C (RhoC), leading to subsequent angiogenesis in the bladder cancer microenvironment. We then investigated that CNF1-mediated RhoC activation modulated the stabilization of hypoxia-inducible factor 1 alpha (HIF1 alpha) to upregulate the VEGF. We demonstrated in vitro that active RhoC increased heat shock factor 1 (HSF1) phosphorylation, which induced the heat shock protein 90 alpha (HSP90 alpha) expression, leading to stabilization of HIF1 alpha. Active RhoC elevated HSP90 alpha, HIF1 alpha, VEGF expression, and angiogenesis in the human bladder cancer xenografts. In addition, HSP90 alpha, HIF1 alpha, and VEGF expression were also found positively correlated with the human bladder cancer development. These results provide a potential mechanism through which UPEC contributes to bladder cancer progression, and may provide potential therapeutic targets for bladder cancer.	[Guo, Yaxiu; Wang, Jingyu; Zhou, Kaichen; Lv, Junqiang; Wang, Quan; Yao, Zhi] Tianjin Med Univ, Key Lab Immune Microenvironm & Dis, Tianjin Key Lab Cellular & Mol Immunol, Dept Immunol,Educ Minist China,Sch Basic Med Sci, Tianjin 300070, Peoples R China; [Wang, Lei; Gao, Shan; Zhang, Zhi-Song] Nankai Univ, Collaborat Innovat Ctr Biotherapy, Tianjin Key Lab Mol Drug Res, State Key Lab Med Chem Biol, Tianjin, Peoples R China; [Wang, Lei; Gao, Shan; Zhang, Zhi-Song] Nankai Univ, Collaborat Innovat Ctr Biotherapy, Tianjin Key Lab Mol Drug Res, Coll Pharm, Tianjin, Peoples R China; [Keller, Evan T.] Univ Michigan, Dept Urol, Ann Arbor, MI 48109 USA; [Yao, Zhi] Tianjin Med Univ, 2011 Collaborat Innovat Ctr Tianjin Med Epigenet, Tianjin, Peoples R China	Tianjin Medical University; Nankai University; Nankai University; University of Michigan System; University of Michigan; Tianjin Medical University	Wang, Q; Yao, Z (corresponding author), Tianjin Med Univ, Key Lab Immune Microenvironm & Dis, Tianjin Key Lab Cellular & Mol Immunol, Dept Immunol,Educ Minist China,Sch Basic Med Sci, Tianjin 300070, Peoples R China.; Zhang, ZS (corresponding author), Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300350, Peoples R China.; Zhang, ZS (corresponding author), Nankai Univ, Coll Pharm, Collaborat Innovat Ctr Biotherapy, Tianjin 300350, Peoples R China.; Zhang, ZS (corresponding author), Nankai Univ, Tianjin Key Lab Mol Drug Res, Tianjin 300350, Peoples R China.	zzs@nankai.edu.cn; wangquan@tmu.edu.cn; yaozhi@tmu.edu.cn			National Natural Science Foundation of China [31970133, 81672740, 81572882]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China, Grant/Award Number: 31970133, 81672740 and 81572882	Bae SH, 2004, BIOCHEM BIOPH RES CO, V324, P394, DOI 10.1016/j.bbrc.2004.09.068; Bien J, 2012, INT J NEPHROL, V2012, DOI 10.1155/2012/681473; Boellmann F, 2004, P NATL ACAD SCI USA, V101, P4100, DOI 10.1073/pnas.0304768101; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Cathcart J, 2015, GENES DIS, V2, P26, DOI 10.1016/j.gendis.2014.12.002; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Clough E, 2016, METHODS MOL BIOL, V1418, P93, DOI 10.1007/978-1-4939-3578-9_5; del Pulgar TG, 2005, BIOESSAYS, V27, P602, DOI 10.1002/bies.20238; Doye A, 2002, CELL, V111, P553, DOI 10.1016/S0092-8674(02)01132-7; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Fabbri A, 2010, TOXINS, V2, P283, DOI [10.3390/toxins2020283, 10.3390/toxins2020282]; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Griner EM, 2015, MOL CANCER RES, V13, P483, DOI 10.1158/1541-7786.MCR-14-0420; Guo YX, 2017, J PATHOL, V243, P208, DOI 10.1002/path.4940; Hoeppner LH, 2015, J CELL SCI, V128, P3556, DOI 10.1242/jcs.167601; Jochmanova I, 2013, JNCI-J NATL CANCER I, V105, P1270, DOI 10.1093/jnci/djt201; Kamai T, 2003, CLIN CANCER RES, V9, P2632; Karlsson R, 2009, BBA-REV CANCER, V1796, P91, DOI 10.1016/j.bbcan.2009.03.003; Koh MY, 2008, TRENDS BIOCHEM SCI, V33, P526, DOI 10.1016/j.tibs.2008.08.002; Lang S, 2017, ONCOTARGET, V8, P87364, DOI 10.18632/oncotarget.20957; Lee JS, 2016, BMB REP, V49, P607, DOI 10.5483/BMBRep.2016.49.11.145; Li ZB, 2005, EMBO REP, V6, P373, DOI 10.1038/sj.embor.7400377; Liu N, 2007, J MOL MED-JMM, V85, P1149, DOI 10.1007/s00109-007-0217-y; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Matsumoto K, 2014, J BIOCHEM, V156, P1, DOI 10.1093/jb/mvu031; Mitsumori K, 1999, J INFECT DIS, V180, P1378, DOI 10.1086/314976; Nielubowicz GR, 2010, NAT REV UROL, V7, P430, DOI 10.1038/nrurol.2010.101; Prodromou C, 2016, BIOCHEM J, V473, P2439, DOI 10.1042/BCJ20160005; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Schmidt G, 1997, NATURE, V387, P725, DOI 10.1038/42735; Semenza GL, 2000, J APPL PHYSIOL, V88, P1474, DOI 10.1152/jappl.2000.88.4.1474; Semenza GL, 2002, TRENDS MOL MED, V8, pS62, DOI 10.1016/S1471-4914(02)02317-1; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 2000, CRIT REV BIOCHEM MOL, V35, P71, DOI 10.1080/10409230091169186; Shao RJ, 2004, FEBS LETT, V569, P293, DOI 10.1016/j.febslet.2004.05.079; Shen KH, 2016, CANCER SCI, V107, P1390, DOI 10.1111/cas.13016; Simons BW, 2015, J PATHOL, V235, P478, DOI 10.1002/path.4472; Tang ZF, 2017, NUCLEIC ACIDS RES, V45, pW98, DOI 10.1093/nar/gkx247; Tanimoto K, 2000, EMBO J, V19, P4298, DOI 10.1093/emboj/19.16.4298; Tolg C, 2011, LAB INVEST, V91, P825, DOI 10.1038/labinvest.2010.197; van Golen KL, 2002, CLIN EXP METASTAS, V19, P301, DOI 10.1023/A:1015518114931; van Golen KL, 2000, NEOPLASIA, V2, P418, DOI 10.1038/sj.neo.7900115; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Volanis D, 2011, J BUON, V16, P511; Wang W, 2008, CANCER SCI, V99, P2012, DOI 10.1111/j.1349-7006.2008.00902.x; Wenandy L, 2008, CANCER IMMUNOL IMMUN, V57, P1871, DOI 10.1007/s00262-008-0517-2; Wu SR, 2013, CANCER RES, V73, P1787, DOI 10.1158/0008-5472.CAN-12-0366; Wu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048917; Xie SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054493; Yang H, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01987; Yang J, 2014, CELL MOL IMMUNOL, V11, P285, DOI 10.1038/cmi.2014.6; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498; Zaravinos A, 2012, ONCOL REP, V28, P1159, DOI 10.3892/or.2012.1948; Zhao Y, 2010, GYNECOL ONCOL, V116, P563, DOI 10.1016/j.ygyno.2009.11.015; Zhao ZH, 2015, WORLD J GASTROENTERO, V21, P905, DOI 10.3748/wjg.v21.i3.905	56	11	12	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					7927	7940		10.1096/fj.201903266RR	http://dx.doi.org/10.1096/fj.201903266RR		APR 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32314833	Green Published			2022-12-28	WOS:000527569100001
J	Liu, WW; Wei, SZ; Huang, GD; Liu, LB; Gu, C; Shen, Y; Wang, XH; Xia, ST; Xie, AM; Hu, LF; Wang, F; Liu, CF				Liu, Wen-Wen; Wei, Shi-Zhuang; Huang, Guo-Dong; Liu, Lu-Bing; Gu, Chao; Shen, Yun; Wang, Xian-Hui; Xia, Shu-Ting; Xie, An-Mu; Hu, Li-Fang; Wang, Fen; Liu, Chun-Feng			BMAL1 regulation of microglia-mediated neuroinflammation in MPTP-induced Parkinson's disease mouse model	FASEB JOURNAL			English	Article						circadian rhythm; dopaminergic neurons; neuroinflammation; nonmotor symptoms	NF-KAPPA-B; CIRCADIAN-RHYTHMS; NONMOTOR SYMPTOMS; SLEEP; DYSFUNCTION; COMPONENT; CLOCK; EXPRESSION; DEMENTIA; MICE	Dysfunction of the circadian rhythm is one of most common nonmotor symptoms in Parkinson's disease (PD), but the molecular role of the circadian rhythm in PD is unclear. We here showed that inactivation of brain and muscle ARNT-like 1 (BMAL1) in 1-methyl-4-phenyl-1,2,4,5-tetrahydropyridine (MPTP)-treated mice resulted in obvious motor functional deficit, loss of dopaminergic neurons (DANs) in the substantia nigra pars compacta (SNpc), decrease of dopamine (DA) transmitter, and increased activation of microglia and astrocytes in the striatum. Time on the rotarod or calorie consumption, and food and water intake were reduced in the Bmal1(-/-) mice after MPTP treatment, suggesting that absence of Bmal1 may exacerbate circadian and PD motor function. We observed a significant reduction of DANs (similar to 35%) in the SNpc, the tyrosine hydroxylase protein level in the striatum (similar to 60%), the DA (similar to 22%), and 3,4-dihydroxyphenylacetic acid content (similar to 29%), respectively, in MPTP-treated Bmal1(-/-) mice. Loss of Bmal1 aggravated the inflammatory reaction both in vivo and in vitro. These findings suggest that BMAL1 may play an essential role in the survival of DANs and maintain normal function of the DA signaling pathway via regulating microglia-mediated neuroinflammation in the brain.	[Liu, Wen-Wen; Gu, Chao; Shen, Yun; Wang, Xian-Hui; Liu, Chun-Feng] Soochow Univ, Dept Neurol, Affiliated Hosp 2, 1055 Sanxiang Rd, Suzhou 215004, Peoples R China; [Liu, Wen-Wen; Gu, Chao; Shen, Yun; Wang, Xian-Hui; Liu, Chun-Feng] Soochow Univ, Suzhou Clin Res Ctr Neurol Dis, Affiliated Hosp 2, 1055 Sanxiang Rd, Suzhou 215004, Peoples R China; [Liu, Wen-Wen; Wei, Shi-Zhuang; Liu, Lu-Bing; Gu, Chao; Xia, Shu-Ting; Hu, Li-Fang; Wang, Fen; Liu, Chun-Feng] Soochow Univ, Jiangsu Key Lab Neuropsychiat Dis, 199 Renai Rd, Suzhou 215123, Peoples R China; [Liu, Wen-Wen; Wei, Shi-Zhuang; Liu, Lu-Bing; Gu, Chao; Xia, Shu-Ting; Hu, Li-Fang; Wang, Fen; Liu, Chun-Feng] Soochow Univ, Inst Neurosci, 199 Renai Rd, Suzhou 215123, Peoples R China; [Huang, Guo-Dong] Harvard Med Sch, Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA; [Wang, Xian-Hui] Soochow Univ, Peoples Hosp Taicang 1, Dept Neurol, Taicang Affiliated Hosp, Taicang, Peoples R China; [Xie, An-Mu] Qingdao Univ, Dept Neurol, Affiliated Hosp, Qingdao, Peoples R China	Soochow University - China; Soochow University - China; Soochow University - China; Soochow University - China; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Soochow University - China; Qingdao University	Liu, CF (corresponding author), Soochow Univ, Dept Neurol, Affiliated Hosp 2, 1055 Sanxiang Rd, Suzhou 215004, Peoples R China.; Liu, CF (corresponding author), Soochow Univ, Suzhou Clin Res Ctr Neurol Dis, Affiliated Hosp 2, 1055 Sanxiang Rd, Suzhou 215004, Peoples R China.; Wang, F (corresponding author), Soochow Univ, Jiangsu Key Lab Neuropsychiat Dis, 199 Renai Rd, Suzhou 215123, Peoples R China.; Wang, F (corresponding author), Soochow Univ, Inst Neurosci, 199 Renai Rd, Suzhou 215123, Peoples R China.	wangfen_1982@126.com; liuchunfeng@suda.edu.cn			National Natural Science Foundation of China (NSFC) [91649114, 81671250, 81801253]; Jiangsu Science and Technology Department [BE2018658]; Jiangsu Provincial Commission of Health and Family Planning [ZDXKB2016022]; Natural Science Research of Jiangsu Higher Education Institutions of China [19KJB180007]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Jiangsu Science and Technology Department; Jiangsu Provincial Commission of Health and Family Planning; Natural Science Research of Jiangsu Higher Education Institutions of China	National Natural Science Foundation of China (NSFC), Grant/Award Number: 91649114, 81671250 and 81801253; Jiangsu Science and Technology Department, Grant/Award Number: BE2018658; Jiangsu Provincial Commission of Health and Family Planning, Grant/Award Number: ZDXKB2016022; Natural Science Research of Jiangsu Higher Education Institutions of China, Grant/Award Number: 19KJB180007	Aryal B, 2019, BMB REP, V52, P250, DOI 10.5483/BMBRep.2019.52.4.204; Baeuerle PA, 1997, ADV IMMUNOL, V65, P111, DOI 10.1016/S0065-2776(08)60742-7; Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; Breen DP, 2014, JAMA NEUROL, V71, P589, DOI 10.1001/jamaneurol.2014.65; Buhr Ethan D, 2013, Handb Exp Pharmacol, P3, DOI 10.1007/978-3-642-25950-0_1; Cai Y, 2010, EUR J NEUROL, V17, P550, DOI 10.1111/j.1468-1331.2009.02848.x; Campos Costa Ines, 2013, Am J Neurodegener Dis, V2, P228; Caplan IF, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00417; Cassone VM, 1988, J BIOL RHYTHM, V3, P71, DOI 10.1177/074873048800300106; Curtis AM, 2015, P NATL ACAD SCI USA, V112, P7231, DOI 10.1073/pnas.1501327112; Dardente H, 2007, CHRONOBIOL INT, V24, P195, DOI 10.1080/07420520701283693; Early JO, 2018, P NATL ACAD SCI USA, V115, pE8460, DOI 10.1073/pnas.1800431115; Garfinkel D, 1997, ARCH GERONTOL GERIAT, V24, P223, DOI 10.1016/S0167-4943(96)00754-6; Ghosh A, 2007, P NATL ACAD SCI USA, V104, P18754, DOI 10.1073/pnas.0704908104; Goldman SM, 2014, ANNU REV PHARMACOL, V54, P141, DOI 10.1146/annurev-pharmtox-011613-135937; He Q, 2017, GLIA, V65, P1251, DOI 10.1002/glia.23153; JACKSONLEWIS V, 1995, NEURODEGENERATION, V4, P257, DOI 10.1016/1055-8330(95)90015-2; Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045; Jiang X, 2018, TRANSL NEURODEGENER, V7, DOI 10.1186/s40035-018-0131-y; Joshi YB, 2014, HUM MOL GENET, V23, P6894, DOI 10.1093/hmg/ddu412; Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206; Kudo T, 2011, EXP NEUROL, V232, P66, DOI 10.1016/j.expneurol.2011.08.003; Kurtis MM, 2013, PARKINSONISM RELAT D, V19, P1152, DOI 10.1016/j.parkreldis.2013.07.026; Lauretti E, 2017, MOL PSYCHIATR, V22, P280, DOI 10.1038/mp.2016.47; Long-Smith CM, 2009, PROG NEUROBIOL, V89, P277, DOI 10.1016/j.pneurobio.2009.08.001; Lu XL, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0661-0; McGeer PL, 2008, MOVEMENT DISORD, V23, P474, DOI 10.1002/mds.21751; MCGEER PL, 1988, NEUROLOGY, V38, P1285, DOI 10.1212/WNL.38.8.1285; Mieda M, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00055; Musiek ES, 2016, SCIENCE, V354, P1004, DOI 10.1126/science.aah4968; Olanow CW, 2012, MOVEMENT DISORD, V27, P666, DOI 10.1002/mds.25019; ONeill LAJ, 1997, TRENDS NEUROSCI, V20, P252, DOI 10.1016/S0166-2236(96)01035-1; Pang SYY, 2019, TRANSL NEURODEGENER, V8, DOI 10.1186/s40035-019-0165-9; Paschos GK, 2012, NAT MED, V18, P1768, DOI 10.1038/nm.2979; Patel SA, 2014, ANTIOXID REDOX SIGN, V20, P2997, DOI 10.1089/ars.2013.5671; Richards J, 2013, AM J PHYSIOL-REG I, V304, pR1053, DOI 10.1152/ajpregu.00066.2013; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Schenck CH, 2013, SLEEP MED, V14, P744, DOI 10.1016/j.sleep.2012.10.009; Sen CK, 1996, FASEB J, V10, P709, DOI 10.1096/fasebj.10.7.8635688; Sharma S, 2013, NEUROCHEM INT, V63, P201, DOI 10.1016/j.neuint.2013.06.005; Sterniczuk R, 2013, CURR ALZHEIMER RES, V10, P767, DOI 10.2174/15672050113109990134; Surace MJ, 2012, CELL MOL LIFE SCI, V69, P2409, DOI 10.1007/s00018-012-1015-4; SWAAB DF, 1985, BRAIN RES, V342, P37, DOI 10.1016/0006-8993(85)91350-2; Tholfsen LK, 2015, NEUROLOGY, V85, P162, DOI 10.1212/WNL.0000000000001737; Todorova Antoniya, 2014, Pract Neurol, V14, P310, DOI 10.1136/practneurol-2013-000741; Wang Y, 2019, J NEUROSURG, V130, P1680, DOI 10.3171/2018.1.JNS171552; Willison LD, 2013, EXP NEUROL, V243, P57, DOI 10.1016/j.expneurol.2013.01.014; Wu DL, 2016, ELIFE, V5, DOI 10.7554/eLife.18790; Yang ZT, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf3006; Zhang ZX, 2005, LANCET, V365, P595, DOI 10.1016/S0140-6736(05)70801-1	50	28	28	4	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6570	6581		10.1096/fj.201901565RR	http://dx.doi.org/10.1096/fj.201901565RR		APR 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32246801				2022-12-28	WOS:000523593200001
J	Xue, YF; Guo, CZ; Hu, F; Zhu, WY; Mao, SY				Xue, Yanfeng; Guo, Changzheng; Hu, Fan; Zhu, Weiyun; Mao, Shengyong			Undernutrition-induced lipid metabolism disorder triggers oxidative stress in maternal and fetal livers using a model of pregnant sheep	FASEB JOURNAL			English	Article						antioxidant capacity; BHBA; mother and fetus; NEFAs; PPARA; RXRA signaling	FATTY-ACIDS ACTIVATE; B SIGNALING PATHWAY; INSULIN-RESISTANCE; MALONALDEHYDE; PATHOGENESIS; DISEASE	This study aimed to evaluate the oxidative status and antioxidant capacity in maternal and fetal livers upon undernutrition as well as the connection between oxidative stress and lipid metabolism disorder. Ten ewes, who were pregnant for 115 days, were restricted to a 30% level of ad libitum feed intake to develop an undernourished model, while another 10 pregnant ewes were fed normally as controls. Undernutrition induced severe lipid metabolism disorder and oxidative stress in blood, maternal liver, and fetal liver. RNA-sequencing data displayed that antioxidant capacity was changed and antioxidant genes were downregulated in maternal and fetal livers of the undernourished model. Non-esterified fatty acids (NEFAs) and beta-hydroxybutyrate (BHBA) levels showed a positive correlation with oxidative indices and negative correlation with the expression of antioxidant genes both in maternal and fetal livers. Primary hepatocytes experiments confirmed that both high levels of NEFAs and BHBA could elicit oxidative stress and decrease antioxidant capacity, and the peroxisome proliferator-activated receptor alpha (PPARA)/retinoid X receptor alpha (RXRA) signaling pathway played a vital role in enhancing antioxidant capacity and relieving oxidative stress. In conclusion, maternal undernutrition induced lipid metabolism disorder, which downregulated antioxidant genes, decreased antioxidant activity, and further triggered oxidative stress both in maternal and fetal livers. Activation of PPARA/RXRA signaling could enhance antioxidant capacity and mitigate oxidative stress. Our findings contribute to protecting the pregnant mother and her fetus from oxidative stress.	[Xue, Yanfeng; Guo, Changzheng; Hu, Fan; Zhu, Weiyun; Mao, Shengyong] Nanjing Agr Univ, Coll Anim Sci & Technol, Jiangsu Key Lab Gastrointestinal Nutr & Anim Hlth, Lab Gastrointestinal Microbiol, Weigang 1, Nanjing 210095, Peoples R China; [Xue, Yanfeng; Guo, Changzheng; Hu, Fan; Zhu, Weiyun; Mao, Shengyong] Nanjing Agr Univ, Natl Expt Teaching Demonstrat Ctr Anim Sci, Natl Ctr Int Res Anim Gut Nutr, Nanjing, Peoples R China	Nanjing Agricultural University; Nanjing Agricultural University	Mao, SY (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, Jiangsu Key Lab Gastrointestinal Nutr & Anim Hlth, Lab Gastrointestinal Microbiol, Weigang 1, Nanjing 210095, Peoples R China.	maoshengyong@njau.edu.cn			National Key Research and Development Program of China [2016YFD0501200]	National Key Research and Development Program of China	National Key Research and Development Program of China, Grant/Award Number: 2016YFD0501200	Allen Matthew, 1994, Clinical Materials, V16, P189; Barazzoni R, 2012, DIABETOLOGIA, V55, P773, DOI 10.1007/s00125-011-2396-x; BERTICS SJ, 1992, J DAIRY SCI, V75, P1914, DOI 10.3168/jds.S0022-0302(92)77951-X; Bickers DR, 2006, J INVEST DERMATOL, V126, P2565, DOI 10.1038/sj.jid.5700340; Davis JE, 2009, HORM METAB RES, V41, P523, DOI 10.1055/s-0029-1202852; Del Rio D, 2005, NUTR METAB CARDIOVAS, V15, P316, DOI 10.1016/j.numecd.2005.05.003; EIFAR AH, 2010, J AM SCI, V6, P742; Forbes JM, 2008, DIABETES, V57, P1446, DOI 10.2337/db08-0057; HARTMAN PE, 1983, ENVIRON MUTAGEN, V5, P603, DOI 10.1002/em.2860050409; Henchcliffe C, 2008, NAT CLIN PRACT NEURO, V4, P600, DOI 10.1038/ncpneuro0924; Iwersen M, 2013, J DAIRY SCI, V96, P7719, DOI 10.3168/jds.2013-7121; Li XW, 2013, CELL BIOCHEM BIOPHYS, V67, P1157, DOI 10.1007/s12013-013-9629-1; Li XW, 2012, MOL CELL BIOCHEM, V359, P385, DOI 10.1007/s11010-011-1032-x; LOFFLER G, 1988, PHYSL CHEM; MacNee W, 2001, EUR J PHARMACOL, V429, P195, DOI 10.1016/S0014-2999(01)01320-6; Mantena SK, 2008, FREE RADICAL BIO MED, V44, P1259, DOI 10.1016/j.freeradbiomed.2007.12.029; Marnett LJ, 1999, MUTAT RES-FUND MOL M, V424, P83, DOI 10.1016/S0027-5107(99)00010-X; Moore K, 1998, FREE RADICAL RES, V28, P659, DOI 10.3109/10715769809065821; Poulsen LL, 2012, SEMIN CELL DEV BIOL, V23, P631, DOI 10.1016/j.semcdb.2012.01.003; PRYOR WA, 1975, J ORG CHEM, V40, P3615, DOI 10.1021/jo00912a038; Pyper Sean R, 2010, Nucl Recept Signal, V8, pe002, DOI 10.1621/nrs.08002; Reddy JK, 2001, ANNU REV NUTR, V21, P193, DOI 10.1146/annurev.nutr.21.1.193; Riserus U, 2008, DIABETES, V57, P332, DOI 10.2337/db07-1318; Roberts CK, 2006, METABOLISM, V55, P928, DOI 10.1016/j.metabol.2006.02.022; Robertson Graham, 2001, American Journal of Physiology, V281, pG1135; Shi XX, 2015, J STEROID BIOCHEM, V145, P103, DOI 10.1016/j.jsbmb.2014.10.014; Shi XX, 2014, CELL PHYSIOL BIOCHEM, V33, P920, DOI 10.1159/000358664; Smith MA, 2000, BBA-MOL BASIS DIS, V1502, P139, DOI 10.1016/S0925-4439(00)00040-5; Song YX, 2014, APOPTOSIS, V19, P984, DOI 10.1007/s10495-014-0982-3; Xu TL, 2018, J AGR FOOD CHEM, V66, P6281, DOI 10.1021/acs.jafc.8b01439; Xue YF, 2019, ANIMAL, V13, P992, DOI 10.1017/S1751731118002136; Xue YF, 2019, FASEB J, V33, P9990, DOI 10.1096/fj.201900406R; Xue YF, 2018, METABOLITES, V8, DOI 10.3390/metabo8040085; Zhang ZG, 2012, VET J, V191, P323, DOI 10.1016/j.tvjl.2011.01.008	34	10	10	4	21	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6508	6520		10.1096/fj.201902537R	http://dx.doi.org/10.1096/fj.201902537R		MAR 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32232897				2022-12-28	WOS:000522486900001
J	Cui, P; Zhang, P; Zhang, YM; Sun, LH; Cui, GH; Guo, X; Wang, H; Zhang, XW; Shi, Y; Yu, ZD				Cui, Peng; Zhang, Ping; Zhang, Yanmin; Sun, Lihua; Cui, Guanghui; Guo, Xin; Wang, He; Zhang, Xiaowei; Shi, Yu; Yu, Zhendong			HIF-1 alpha/Actl6a/H3K9ac axis is critical for pluripotency and lineage differentiation of human induced pluripotent stem cells	FASEB JOURNAL			English	Article						differentiation potential; epigenetics; hypoxia-inducible factor 1 alpha; pluripotency maintenance; regenerative medicine	GLYCOLYTIC METABOLISM; SELF-RENEWAL; CHROMATIN; ROLES; ACETYLATION; MECHANISM; BAF53A; OXYGEN; ESBAF; STATE	Pluripotent stem cells (PSCs) are important models for analyzing cellular metabolism and individual development. As a hypoxia-inducible factor subunit, HIF-1 alpha plays an important role in maintaining the pluripotency of PSCs under hypoxic conditions. However, the mechanisms underlying the self-renewal and pluripotency maintenance of human induced pluripotent stem cells (hiPSCs) via regulating HIF-1 alpha largely remain elusive. In this study, we found that disrupting the expression of HIF-1 alpha reduced self-renewal and pluripotency of hiPSCs. Additionally, HIF-1 alpha-knockdown led to lower mitochondrial membrane potential (Delta psi(m)) and higher reactive oxygen species production in hiPSCs. However, HIF-1 alpha-overexpression increased ATP content in hiPSCs, while the role of HIF-1 alpha-knockdown was opposite. The embryoid body (EB) and teratoma formation assays showed that HIF-1 alpha-knockdown promoted endoderm differentiation and development in vitro and in vivo. In terms of the underlying molecular mechanisms, HIF-1 alpha-knockdown inhibited the expression of Actl6a and histone H3K9ac acetylation (H3K9ac). Actl6a knockdown reduced the expression of H3K9ac and the pluripotency of hiPSCs, and also affected endoderm differentiation. These data suggest that hindering HIF-1 alpha expression causes the changes in mitochondrial properties and metabolic disorders in hiPSCs. Furthermore, HIF-1 alpha affects hiPSC pluripotency, and germ layer differentiation via Actl6a and histone acetylation.	[Cui, Peng; Zhang, Yanmin; Cui, Guanghui; Guo, Xin; Yu, Zhendong] Peking Univ, Shenzhen Hosp, Shenzhen Peking Univ Hong Kong Univ Sci & Technol, Cent Lab, Shenzhen, Peoples R China; [Zhang, Ping; Sun, Lihua] Peking Univ, Shenzhen Hosp, Shenzhen Peking Univ Hong Kong Univ Sci & Technol, Dept Hematol, Shenzhen, Peoples R China; [Wang, He] Peking Univ, Shenzhen Hosp, Shenzhen Peking Univ Hong Kong Univ Sci & Technol, Dept Lab Med, Shenzhen, Peoples R China; [Zhang, Xiaowei] Peking Univ, Sch Basic Med Sci, Beijing, Peoples R China; [Shi, Yu] Peking Univ, Shenzhen Hosp, Shenzhen Peking Univ Hong Kong Univ Sci & Technol, Dept Res & Teaching, Shenzhen, Peoples R China	Hong Kong University of Science & Technology; Peking University; Hong Kong University of Science & Technology; Peking University; Hong Kong University of Science & Technology; Peking University; Peking University; Hong Kong University of Science & Technology; Peking University	Shi, Y; Yu, ZD (corresponding author), Peking Univ, Shenzhen Hosp, Shenzhen Peking Univ Hong Kong Univ Sci & Technol, Shenzhen 518000, Peoples R China.	shiyu@pkuszh.com; dongboyaa@pkuszh.com	zhang, xiaowei/GQH-5387-2022		China Postdoctoral Science Foundation [2019M652993]; Natural Science Foundation of Guangdong Province (Guangdong Natural Science Foundation) [2019A1515011432]; Shenzhen Science and Technology Innovation Commission [JCYJ20170816105345191]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Natural Science Foundation of Guangdong Province (Guangdong Natural Science Foundation)(National Natural Science Foundation of Guangdong Province); Shenzhen Science and Technology Innovation Commission	China Postdoctoral Science Foundation, Grant/Award Number: 2019M652993; Natural Science Foundation of Guangdong Province (Guangdong Natural Science Foundation), Grant/Award Number: 2019A1515011432; Shenzhen Science and Technology Innovation Commission, Grant/Award Number: JCYJ20170816105345191	Atlasi Y, 2017, NAT REV GENET, V18, DOI 10.1038/nrg.2017.57; Axelson H, 2005, SEMIN CELL DEV BIOL, V16, P554, DOI 10.1016/j.semcdb.2005.03.007; Bao XM, 2013, CELL STEM CELL, V12, P193, DOI 10.1016/j.stem.2012.12.014; Cabarcas SM, 2011, INT J CANCER, V129, P2315, DOI 10.1002/ijc.26312; Cliff TS, 2017, CELL STEM CELL, V21, P502, DOI 10.1016/j.stem.2017.08.018; Ding JJ, 2015, CELL STEM CELL, V16, P653, DOI 10.1016/j.stem.2015.04.001; Doege CA, 2012, NATURE, V488, P652, DOI 10.1038/nature11333; Edupuganti RR, 2017, STEM CELL REP, V9, P1291, DOI 10.1016/j.stemcr.2017.08.021; Ezashi T, 2005, P NATL ACAD SCI USA, V102, P4783, DOI 10.1073/pnas.0501283102; Fazzio TG, 2008, CELL, V134, P162, DOI 10.1016/j.cell.2008.05.031; Folmes CDL, 2011, CELL METAB, V14, P264, DOI 10.1016/j.cmet.2011.06.011; Gaspar-Maia A, 2009, NATURE, V460, P863, DOI 10.1038/nature08212; Gintant G, 2017, CELL STEM CELL, V21, P14, DOI 10.1016/j.stem.2017.06.005; Gu W, 2016, CELL STEM CELL, V19, P476, DOI 10.1016/j.stem.2016.08.008; Harvey A, 2019, STEM CELL REP, V13, P573, DOI 10.1016/j.stemcr.2019.09.003; Ho L, 2009, P NATL ACAD SCI USA, V106, P5181, DOI 10.1073/pnas.0812889106; Huan F, 2016, MOL CELL BIOL, V36, P1900, DOI 10.1128/MCB.00055-16; Keenen B, 2009, J CELL PHYSIOL, V219, P1, DOI 10.1002/jcp.21654; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krasteva V, 2012, BLOOD, V120, P4720, DOI 10.1182/blood-2012-04-427047; Landry J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000241; Lu WS, 2015, STEM CELLS, V33, P1782, DOI 10.1002/stem.2000; Mandal S, 2011, STEM CELLS, V29, P486, DOI 10.1002/stem.590; Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007; Morrison SJ, 2000, J NEUROSCI, V20, P7370; Moussaieff A, 2015, CELL METAB, V21, P392, DOI 10.1016/j.cmet.2015.02.002; Mu XP, 2015, CELL REPROGRAM, V17, P259, DOI 10.1089/cell.2014.0102; Nascimento CHV, 2019, FASEB J, V33, P13435, DOI 10.1096/fj.201900722R; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Novershtern N, 2011, NAT CELL BIOL, V13, P886, DOI 10.1038/ncb2311; Panopoulos AD, 2012, CELL RES, V22, P168, DOI 10.1038/cr.2011.177; Park SJ, 2017, STEM CELLS DEV, V26, P734, DOI 10.1089/scd.2016.0320; Prigione A, 2014, STEM CELLS, V32, P364, DOI 10.1002/stem.1552; Qiao YB, 2015, J BIOL CHEM, V290, P2508, DOI 10.1074/jbc.M114.603761; Ryall JG, 2015, CELL STEM CELL, V17, P651, DOI 10.1016/j.stem.2015.11.012; Saladi SV, 2010, STEM CELL REV REP, V6, P62, DOI 10.1007/s12015-010-9120-y; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Suda T, 2011, CELL STEM CELL, V9, P298, DOI 10.1016/j.stem.2011.09.010; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takubo K, 2012, INT J HEMATOL, V95, P478, DOI 10.1007/s12185-012-1071-4; Takubo K, 2010, CELL STEM CELL, V7, P391, DOI 10.1016/j.stem.2010.06.020; Trisciuoglio D, 2018, STEM CELLS INT, V2018, DOI 10.1155/2018/8908751; Wan WB, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/382530; Wanet A, 2015, STEM CELLS DEV, V24, P1957, DOI 10.1089/scd.2015.0117; Wang L, 2014, CELL STEM CELL, V14, P575, DOI 10.1016/j.stem.2014.02.013; Wang Y, 2011, CELL STEM CELL, V8, P399, DOI 10.1016/j.stem.2011.02.006; Wang Y, 2019, FASEB J, V33, P13398, DOI 10.1096/fj.201901366R; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323; Yoshida Y, 2009, CELL STEM CELL, V5, P237, DOI 10.1016/j.stem.2009.08.001; Zhang Y, 2018, FASEB J, V32, P1891, DOI 10.1096/fj.201700626RR; Zhong XY, 2019, CELL METAB, V29, P979, DOI 10.1016/j.cmet.2018.11.007; Zhou WY, 2012, EMBO J, V31, P2103, DOI 10.1038/emboj.2012.71; Zhu B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14362-4; Zhu SY, 2010, CELL STEM CELL, V7, P651, DOI 10.1016/j.stem.2010.11.015	55	9	10	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5740	5753		10.1096/fj.201902829RR	http://dx.doi.org/10.1096/fj.201902829RR		FEB 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32112486	hybrid			2022-12-28	WOS:000517911700001
J	Tedesco, E; Benetti, F; Pezzani, R				Tedesco, Erik; Benetti, Federico; Pezzani, Raffaele			In vitro evaluation of different organic matrices used to modulate silicon bioavailability	FASEB JOURNAL			English	Article						choline; collagen; maltodextrins; orthosilicic acid; silicon	STABILIZED ORTHOSILICIC ACID; DIGESTION MODEL; ORAL INTAKE; HAIR; BIOACCESSIBILITY; ABSORPTION; RETENTION; WOMEN; FOOD; SKIN	Silicon (Si) has numerous health properties. It is an element of the extracellular matrix; it is involved in collagen synthesis, bone mineralization, and immune system modulation; and it reduces metal accumulation in Alzheimer's disease and the risk of atherosclerosis. Given its poor intestinal absorption, Si is ingested in the form of orthosilicic acid (OSA) to promote its bioavailability. The aim of this work was to compare different commercial dietary supplements containing stabilized OSA to ascertain their bioaccessibility, bioavailability, and safety in a model of human intestinal epithelium. Biocompatibility with the glycocalyx was also investigated. Supplements containing collagen, maltodextrins, and choline as OSA stabilizers were analyzed. Bioaccessibility was explored by means of an in vitro digestive process. Bioavailability was investigated using a Caco2 cell line alone, or co-culturing with a HT29-MTX cell line. The safety of the compounds tested (in terms of intestinal epithelium integrity) was judged on the grounds of MTS assay, transepithelial electrical resistance, and apparent permeability. The three formulations were also tested in a Caco2 cell model of intestinal glycocalyx Si retention. The choline-formulated OSA formulation outperformed the maltodextrin-stabilized supplement, with a Si bioavailability about 14 times higher (P < .05). The choline-formulated OSA formulation increased cell permeability, with consequent intestinal epithelium disruption. The supplements' absorption and bioavailability (and harmfulness) differed considerably, depending on the OSA stabilizer involved. Of the three formulations tested, the collagen-formulated OSA represents the best Si dietary supplement.	[Tedesco, Erik; Benetti, Federico] ECAMRICERT SRL, ECSIN European Ctr Sustainable Impact Nanotechnol, Padua, Italy; [Pezzani, Raffaele] Univ Padua, Dept Med DIMED, Endocrinol Unit, Padua, Italy; [Pezzani, Raffaele] AIROB Assoc Italiana Ric Oncol Base, Padua, Italy	University of Padua	Pezzani, R (corresponding author), Univ Padua, Dept Med, Endocrinol Unit, Via Osped 105, I-35128 Padua, Italy.	raffaele.pezzani@unipd.it						Barel A, 2005, ARCH DERMATOL RES, V297, P147, DOI 10.1007/s00403-005-0584-6; de Araujo LA, 2016, AN BRAS DERMATOL, V91, P331, DOI 10.1590/abd1806-4841.20163986; Domingo JL, 2011, NUTR REV, V69, P41, DOI 10.1111/j.1753-4887.2010.00360.x; Geusens P, 2017, BMC MUSCULOSKEL DIS, V18, DOI 10.1186/s12891-016-1370-7; Hall JE, TXB MED PHYSL; Jin Hong, 2016, Drug Metab Lett, V10, P161; Martin Keith R, 2013, Met Ions Life Sci, V13, P451, DOI 10.1007/978-94-007-7500-8_14; Natoli M, 2012, TOXICOL IN VITRO, V26, P1243, DOI 10.1016/j.tiv.2012.03.009; Nielsen FH, 2014, J TRACE ELEM MED BIO, V28, P379, DOI 10.1016/j.jtemb.2014.06.024; Oomen AG, 2003, ARCH ENVIRON CON TOX, V44, P281, DOI 10.1007/s00244-002-1278-0; Perez-Granados A M, 2002, J Nutr Health Aging, V6, P154; Reffitt DM, 1999, J INORG BIOCHEM, V76, P141, DOI 10.1016/S0162-0134(99)00126-9; Spector TD, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-85; Sripanyakorn S, 2005, NUTR BULL, V30, P222, DOI 10.1111/j.1467-3010.2005.00507.x; Sripanyakorn S, 2009, BRIT J NUTR, V102, P825, DOI 10.1017/S0007114509311757; Van Dyck K, 1999, FRESEN J ANAL CHEM, V363, P541, DOI 10.1007/s002160051243; Versantvoort CHM, 2005, FOOD CHEM TOXICOL, V43, P31, DOI 10.1016/j.fct.2004.08.007; Walczak AP, 2013, NANOTOXICOLOGY, V7, P1198, DOI 10.3109/17435390.2012.726382; Wickett RR, 2007, ARCH DERMATOL RES, V299, P499, DOI 10.1007/s00403-007-0796-z; Younes M, 2018, EFSA J, V16, DOI 10.2903/j.efsa.2018.5294	20	4	4	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12229	12238		10.1096/fj.202000060RR	http://dx.doi.org/10.1096/fj.202000060RR		JUL 2020	10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32681588	hybrid			2022-12-28	WOS:000552140600001
J	Horii, N; Hasegawa, N; Fujie, S; Uchida, M; Iemitsu, M				Horii, Naoki; Hasegawa, Natsuki; Fujie, Shumpei; Uchida, Masataka; Iemitsu, Motoyuki			Resistance exercise-induced increase in muscle 5 alpha-dihydrotestosterone contributes to the activation of muscle Akt/mTOR/p70S6K-and Akt/AS160/GLUT4-signaling pathways in type 2 diabetic rats	FASEB JOURNAL			English	Article						androgen; diabetes; exercise; glucose metabolism; muscle protein synthesis	SEX STEROID-HORMONES; SKELETAL-MUSCLE; IMPROVES HYPERGLYCEMIA; PROTEIN-SYNTHESIS; GLYCEMIC CONTROL; STEROIDOGENESIS; HYPERTROPHY; INSULIN; DHEA; DEHYDROEPIANDROSTERONE	Effects of increase in muscle 5 alpha-dihydrotestosterone (DHT) levels caused by resistance exercise on regulation of mammalian target of rapamycin (mTOR)- and glucose transporter 4 (GLUT4)-signaling pathways in type 2 diabetic rats were assessed. Twenty-week-old type 2 diabetic rats were randomly divided into the resting control, immediately, 1 hour, or 3 hours after resistance exercise, with or without the pretreatment of 5 alpha-reductase inhibitor. Immediately or 1 hour after exercise, levels of 5 alpha-reductase and DHT as well as phosphorylation levels of AMP-activated protein kinase (AMPK), TBC1 domain family member 1 (TBC1D1), and protein kinase B (Akt) in muscle were significantly elevated. Phosphorylation of muscle Akt substrate of 160 kDa (AS160) and translocation levels of GLUT4 at 1 and 3 hours after resistance exercise were significantly elevated. Additionally, resistance exercise significantly activated the phosphorylation of muscle mTOR immediately, and at 1 and 3 hours and of p70 ribosomal S6 kinase (p70S6K) at 1 and 3 hours. However, pretreatment with the 5 alpha-reductase inhibitor significantly attenuated the exercise-induced activation of Akt/mTOR/p70S6K and Akt/AS160/GLUT4 signaling, but did not affect AMPK/TBC1D1/GLUT4 signaling. These findings suggest that resistance exercise-induced increase in muscle DHT synthesis may contribute to activation of Akt/mTOR/p70S6K- and Akt/AS160/GLUT4 signaling pathways in type 2 diabetic rats.	[Horii, Naoki; Fujie, Shumpei; Uchida, Masataka; Iemitsu, Motoyuki] Ritsumeikan Univ, Fac Sport & Hlth Sci, 1-1-1 Nojihigashi, Kusatsu, Shiga 5258577, Japan; [Horii, Naoki] Japan Soc Promot Sci, Chiyoda Ku, Tokyo, Japan; [Hasegawa, Natsuki] Ritsumeikan Univ, Res Org Sci & Technol, Kusatsu, Japan	Ritsumeikan University; Japan Society for the Promotion of Science; Ritsumeikan University	Iemitsu, M (corresponding author), Ritsumeikan Univ, Fac Sport & Hlth Sci, 1-1-1 Nojihigashi, Kusatsu, Shiga 5258577, Japan.	iemitsu@fc.ritsumei.ac.jp			MEXT \ Japan Society for the Promotion of Science (JSPS) [17H02182, 19K22828]; Yamaha Motor Foundation for Sports	MEXT \ Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Yamaha Motor Foundation for Sports	MEXT vertical bar Japan Society for the Promotion of Science (JSPS), Grant/Award Number: #17H02182 and #19K22828; Yamaha Motor Foundation for Sports	Aizawa K, 2008, J APPL PHYSIOL, V104, P67, DOI 10.1152/japplphysiol.00558.2007; Aizawa K, 2007, AM J PHYSIOL-ENDOC M, V292, pE577, DOI 10.1152/ajpendo.00367.2006; Aizawa K, 2010, STEROIDS, V75, P219, DOI 10.1016/j.steroids.2009.12.002; Al-Trad B, 2017, PHYTOTHER RES, V31, P1910, DOI 10.1002/ptr.5936; Almurdhi MM, 2016, DIABETES CARE, V39, P441, DOI 10.2337/dc15-0995; Aymerich MS, 2001, INVEST OPHTH VIS SCI, V42, P3287; Bacchi E, 2012, DIABETES CARE, V35, P676, DOI 10.2337/dc11-1655; Bauer ER, 2008, APMIS, V108, P838; Brook MS, 2015, FASEB J, V29, P4485, DOI 10.1096/fj.15-273755; Church TS, 2010, JAMA-J AM MED ASSOC, V304, P2253, DOI 10.1001/jama.2010.1710; Damas F, 2016, J PHYSIOL-LONDON, V594, P5209, DOI 10.1113/JP272472; Fogle RH, 2007, J CLIN ENDOCR METAB, V92, P3040, DOI 10.1210/jc.2007-0581; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Henricsson M, 1996, ACTA OPHTHALMOL SCAN, V74, P523; Horii N, 2018, FASEB J, V32, P3547, DOI 10.1096/fj.201700772RRR; Horii N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165689; Hornberger TA, 2004, CAN J APPL PHYSIOL, V29, P16, DOI 10.1139/h04-002; Kido K, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12907; Labrie F, 2005, J ENDOCRINOL, V187, P169, DOI 10.1677/joe.1.06264; Mumford PW, 2018, J APPL PHYSIOL, V125, P486, DOI 10.1152/japplphysiol.00768.2017; Nooron N, 2017, BIOCHEM BIOPH RES CO, V494, P101, DOI 10.1016/j.bbrc.2017.10.075; Pollanen E, 2015, AGING CELL, V14, P236, DOI 10.1111/acel.12309; Pollanen E, 2011, AGING CELL, V10, P650, DOI 10.1111/j.1474-9726.2011.00701.x; Ritz E, 1999, AM J KIDNEY DIS, V34, P795, DOI 10.1016/S0272-6386(99)70035-1; Ryder JW, 2001, ACTA PHYSIOL SCAND, V171, P249, DOI 10.1046/j.1365-201x.2001.00827.x; Sato K, 2014, J STEROID BIOCHEM, V143, P152, DOI 10.1016/j.jsbmb.2014.02.020; Sato K, 2009, ACTA PHYSIOL, V197, P217, DOI 10.1111/j.1748-1716.2009.02011.x; Sato K, 2008, AM J PHYSIOL-ENDOC M, V294, pE961, DOI 10.1152/ajpendo.00678.2007; Sato K, 2017, FASEB J, V31, P793, DOI 10.1096/fj.201600874R; Sato K, 2013, J DIABETES METAB, V4, DOI 10.4172/2155-6156.1000239; Sato K, 2014, FASEB J, V28, P1891, DOI 10.1096/fj.13-245480; Sato K, 2011, AM J PHYSIOL-ENDOC M, V301, pE274, DOI 10.1152/ajpendo.00564.2010; Sigal RJ, 2007, ANN INTERN MED, V147, P357, DOI 10.7326/0003-4819-147-6-200709180-00005; Srikanthan P, 2011, J CLIN ENDOCR METAB, V96, P2898, DOI 10.1210/jc.2011-0435; Strasser B, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/805217; Umpierre D, 2013, DIABETOLOGIA, V56, P242, DOI 10.1007/s00125-012-2774-z; Wu M, 2017, MOL CANCER THER, V16, P57, DOI 10.1158/1535-7163.MCT-16-0419; Xu TS, 2004, J STEROID BIOCHEM, V92, P447, DOI 10.1016/j.jsbmb.2004.07.008; Yang ZY, 2014, SPORTS MED, V44, P487, DOI 10.1007/s40279-013-0128-8; Yoshioka M, 2006, J MOL ENDOCRINOL, V36, P247, DOI 10.1677/jme.1.01964; Zeng FX, 2017, BIOL SPORT, V34, P313, DOI 10.5114/biolsport.2017.69818	41	7	7	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					11047	11057		10.1096/fj.201903223RR	http://dx.doi.org/10.1096/fj.201903223RR		JUL 2020	11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32627878				2022-12-28	WOS:000547606200001
J	Wang, JY; Kaplan, N; Wang, SJ; Yang, WD; Wang, LQ; He, CC; Peng, H				Wang, Junyi; Kaplan, Nihal; Wang, Sijia; Yang, Wending; Wang, Liqiang; He, Congcong; Peng, Han			Autophagy plays a positive role in induction of epidermal proliferation	FASEB JOURNAL			English	Article						Beclin 1; imiquimod; psoriasis; PBK; skin	KERATINOCYTE HYPERPROLIFERATION; CELL-PROLIFERATION; PSORIASIS; INFLAMMATION; STRESS; EXPRESSION; PROTEIN; MIGRATION; REVEALS; NUDC	Autophagy is a multistage catabolic process that mediates stress responses. However, the role of autophagy in epidermal proliferation, particularly under conditions when the epidermis becomes "activated" (hyperproliferative), remains unclear. We have shown that inhibition of Beclin 1, a key activator in the initiation phase of autophagy, attenuates imiquimod (IMQ)-induced epidermal hyperplasia in adult mice as well as naturally occurring hyperproliferation in neonatal mouse epidermis. Inhibition of Beclin 1 did not change the levels of several key inflammatory molecules or the numbers of immune cells in lesional skins. This indicates that autophagy does not affect inflammatory regulators in IMQ-treated mouse skin. Bioinformatic analysis combined with gene expression quantitative assays, revealed that a deficiency in autophagy decreases the expression of PDZ Binding Kinase (PBK), a regulator of the cell cycle, in mouse epidermis and human epidermal keratinocytes (HEKs). Interestingly, the decrease in PBK results in inhibition of proliferation in HEKs and such reduced proliferation can be rescued by activation of p38, the downstream signaling of PBK. Collectively, autophagy plays a positive role in epidermal proliferation, which is in part via regulating PBK expression.	[Wang, Junyi; Kaplan, Nihal; Yang, Wending; Peng, Han] Northwestern Univ, Dept Dermatol, Feinberg Sch Med, 303 E Chicago Ave, Chicago, IL 60611 USA; [Wang, Junyi; Wang, Liqiang] Peoples Liberat Army Gen Hosp, Dept Ophthalmol, Ctr 1, Beijing, Peoples R China; [Wang, Sijia] Southern Med Univ, Nanfang Hosp, Dept Dermatol, Guangzhou, Peoples R China; [He, Congcong] Northwestern Univ, Dept Cell & Mol Biol, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Chinese People's Liberation Army General Hospital; Southern Medical University - China; Northwestern University; Feinberg School of Medicine	Peng, H (corresponding author), Northwestern Univ, Dept Dermatol, Feinberg Sch Med, 303 E Chicago Ave, Chicago, IL 60611 USA.	han-peng@northwestern.edu	wang, junyi/GYA-3213-2022		Dermatology Foundation (DF); HHS | National Institutes of Health (NIH) [DK094980]; American Federation for Aging Research (AFAR); Eversight	Dermatology Foundation (DF); HHS | National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Federation for Aging Research (AFAR); Eversight	Dermatology Foundation (DF); Eversight; HHS | National Institutes of Health (NIH), Grant/Award Number: DK094980; American Federation for Aging Research (AFAR)	Akinduro O, 2016, J INVEST DERMATOL, V136, P1460, DOI 10.1016/j.jid.2016.03.016; Angelastro JM, 2003, J NEUROSCI, V23, P4590; Angelastro JM, 2006, ONCOGENE, V25, P907, DOI 10.1038/sj.onc.1209116; Archer NK, 2017, J INVEST DERMATOL, V137, P2257, DOI 10.1016/j.jid.2017.08.026; Arican O, 2005, MEDIAT INFLAMM, P273, DOI 10.1155/MI.2005.273; Aumais JP, 2003, J CELL SCI, V116, P1991, DOI 10.1242/jcs.00412; Ayllon V, 2007, ONCOGENE, V26, P3451, DOI 10.1038/sj.onc.1210142; Blumenberg Miroslav, 2007, Expert Rev Dermatol, V2, P763, DOI 10.1586/17469872.2.6.763; Boehncke WH, 2015, LANCET, V386, P983, DOI 10.1016/S0140-6736(14)61909-7; Busse D, 2014, J INVEST DERMATOL, V134, P2823, DOI 10.1038/jid.2014.273; Cao Y, 2007, CELL RES, V17, P839, DOI 10.1038/cr.2007.78; Chen Y, 2013, EXP CELL RES, V319, P142, DOI 10.1016/j.yexcr.2012.09.004; Chowdhari S, 2016, CELL SIGNAL, V28, P25, DOI 10.1016/j.cellsig.2015.10.015; Clarke R, 2012, CANCER RES, V72, P1321, DOI 10.1158/0008-5472.CAN-11-3213; Cordoro KM, 2017, J AM ACAD DERMATOL, V77, P417, DOI 10.1016/j.jaad.2017.05.017; Dangelmaier C, 2000, EUR J BIOCHEM, V267, P2283, DOI 10.1046/j.1432-1327.2000.01235.x; Dash S, 2020, SEMIN CELL DEV BIOL, V101, P20, DOI 10.1016/j.semcdb.2019.07.015; Douroudis K, 2012, ACTA DERM-VENEREOL, V92, P85, DOI 10.2340/00015555-1183; Eskelinen EL, 2009, BBA-MOL CELL RES, V1793, P664, DOI 10.1016/j.bbamcr.2008.07.014; Filomeni G, 2015, CELL DEATH DIFFER, V22, P377, DOI 10.1038/cdd.2014.150; Fuhriman JM, 2018, J INVEST DERMATOL, V138, P864, DOI 10.1016/j.jid.2017.10.029; Gaudet S, 2000, P NATL ACAD SCI USA, V97, P5167, DOI 10.1073/pnas.090102397; Gazel A, 2008, J CELL PHYSIOL, V215, P292, DOI 10.1002/jcp.21394; Girolomoni Giampiero, 2002, Curr Opin Investig Drugs, V3, P1590; Ha HL, 2014, P NATL ACAD SCI USA, V111, pE3422, DOI 10.1073/pnas.1400513111; Haines JD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145843; Harper EG, 2009, J INVEST DERMATOL, V129, P2175, DOI 10.1038/jid.2009.65; He CC, 2012, NATURE, V481, P511, DOI 10.1038/nature10758; He CC, 2010, CURR OPIN CELL BIOL, V22, P140, DOI 10.1016/j.ceb.2010.01.001; Ichihara A, 2011, BRIT J DERMATOL, V165, P1003, DOI 10.1111/j.1365-2133.2011.10497.x; Jensen PJ, 1999, J INVEST DERMATOL, V112, P240, DOI 10.1046/j.1523-1747.1999.00494.x; Jia HY, 2016, INT J MOL MED, V37, P359, DOI 10.3892/ijmm.2015.2445; Kaplan N, 2020, FASEB J, V34, P525, DOI 10.1096/fj.201901512R; Kaplan N, 2019, INVEST OPHTH VIS SCI, V60, P3570, DOI 10.1167/iovs.19-27656; Kim Grace K, 2010, J Clin Aesthet Dermatol, V3, P32; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Langkilde A, 2013, BRIT J DERMATOL, V169, P677, DOI 10.1111/bjd.12352; LAVKER R M, 1970, Journal of Cell Biology, V44, P501, DOI 10.1083/jcb.44.3.501; LAVKER RM, 1974, J MORPHOL, V142, P365, DOI 10.1002/jmor.1051420402; Lee DD, 2009, J CELL PHYSIOL, V220, P427, DOI 10.1002/jcp.21784; Lee HM, 2011, J IMMUNOL, V186, P1248, DOI 10.4049/jimmunol.1001954; Loukil A, 2014, J CELL SCI, V127, P2145, DOI 10.1242/jcs.139188; Mahil SK, 2016, J INVEST DERMATOL, V136, P2251, DOI 10.1016/j.jid.2016.06.618; Mathiassen SG, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00051; McKnight NC, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004626; Michalak-Stoma A, 2013, DIS MARKERS, V2013, DOI 10.1155/2013/856056; Miller Lloyd S, 2008, Adv Dermatol, V24, P71; Moos S, 2019, J INVEST DERMATOL, V139, P1110, DOI 10.1016/j.jid.2019.01.006; Naik S, 2017, NATURE, V550, P475, DOI 10.1038/nature24271; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Nakagawa Y, 2014, J DERMATOL SCI, V76, P264, DOI 10.1016/j.jdermsci.2014.10.006; Nishino M, 2006, CURR BIOL, V16, P1414, DOI 10.1016/j.cub.2006.05.052; Noguchi S, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-018-0279-0; Palombo R, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.201; Pan HF, 2013, CYTOKINE GROWTH F R, V24, P51, DOI 10.1016/j.cytogfr.2012.07.002; Park JK, 2016, J CELL BIOL, V215, P667, DOI 10.1083/jcb.201604032; Peng H, 2015, STEM CELLS, V33, P1642, DOI 10.1002/stem.1962; Peng H, 2012, P NATL ACAD SCI USA, V109, P14030, DOI 10.1073/pnas.1111292109; Qiang L, 2017, AUTOPHAGY, V13, P2086, DOI 10.1080/15548627.2017.1380757; Qiang L, 2014, P NATL ACAD SCI USA, V111, P9241, DOI 10.1073/pnas.1322913111; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Rong YG, 2012, NAT CELL BIOL, V14, P924, DOI 10.1038/ncb2557; Rong YG, 2011, P NATL ACAD SCI USA, V108, P7826, DOI 10.1073/pnas.1013800108; Sa SM, 2007, J IMMUNOL, V178, P2229, DOI 10.4049/jimmunol.178.4.2229; Senft D, 2015, TRENDS BIOCHEM SCI, V40, P141, DOI 10.1016/j.tibs.2015.01.002; Tian R, 2016, INFLAMMATION, V39, P1387, DOI 10.1007/s10753-016-0370-y; Tsuchihara K, 2005, CANCER RES, V65, P6685, DOI 10.1158/0008-5472.CAN-04-4223; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; Wang SJ, 2018, J INVEST DERMATOL, V138, P1481, DOI 10.1016/j.jid.2018.02.002; WILSON C, 1994, DIFFERENTIATION, V55, P127, DOI 10.1046/j.1432-0436.1994.5520127.x; Yu XL, 2015, FASEB J, V29, P394, DOI 10.1096/fj.14-252841; Yun DH, 2009, EXP MOL MED, V41, P17, DOI 10.3858/emm.2009.41.1.003; Zhang JH, 2019, INT J BIOL SCI, V15, P1962, DOI 10.7150/ijbs.35440; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Zhou T, 2003, DEV CELL, V5, P127, DOI 10.1016/S1534-5807(03)00186-2; Zibert JR, 2010, J DERMATOL SCI, V58, P177, DOI 10.1016/j.jdermsci.2010.03.004	77	6	6	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10657	10667		10.1096/fj.202000770RR	http://dx.doi.org/10.1096/fj.202000770RR		JUN 2020	11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32598088	Bronze, Green Accepted			2022-12-28	WOS:000546063100001
J	Li, XY; Kim, SE; Chen, TY; Wang, J; Yang, X; Tabib, T; Tan, JN; Guo, B; Fung, S; Zhao, J; Sembrat, J; Rojas, M; Shiva, S; Lafyatis, R; Croix, CS; Alder, JK; Di, YP; Kass, DJ; Zhang, YZ				Li, Xiaoyun; Kim, Sharon E.; Chen, Ting-Yun; Wang, Juan; Yang, Xia; Tabib, Tracy; Tan, Jiangning; Guo, Brandon; Fung, Sonia; Zhao, Jing; Sembrat, John; Rojas, Mauricio; Shiva, Sruti; Lafyatis, Robert; St. Croix, Claudette; Alder, Jonathan K.; Di, Y. Peter; Kass, Daniel J.; Zhang, Yingze			Toll interacting protein protects bronchial epithelial cells from bleomycin-induced apoptosis	FASEB JOURNAL			English	Article						apoptosis; autophagy; basal cells; idiopathic pulmonary fibrosis; lung epithelial cells; TOLLIP	IDIOPATHIC PULMONARY-FIBROSIS; MUC5B PROMOTER POLYMORPHISM; INTRACELLULAR TRAFFICKING; GENETIC-DISEASE; RISK-FACTOR; AUTOPHAGY; SUSCEPTIBILITY; ASSOCIATION; INJURY; PINK1	Idiopathic pulmonary fibrosis (IPF) is characterized by altered epithelial cell phenotypes, which are associated with myofibroblast accumulation in the lung. Atypical alveolar epithelial cells in IPF express molecular markers of airway epithelium. Polymorphisms within and around Toll interacting protein (TOLLIP) are associated with the susceptibility to IPF and mortality. However, the functional role of TOLLIP in IPF is unknown. Using lung tissues from IPF and control subjects, we showed that expression ofTOLLIPgene in the lung parenchyma is globally lower in IPF compared to controls. Lung cells expressing significant levels ofTOLLIPinclude macrophages, alveolar type II, and basal cells. TOLLIP protein expression is lower in the parenchyma of IPF lungs but is expressed in the atypical epithelial cells of the distal fibrotic regions. Using overexpression and silencing approaches, we demonstrate that TOLLIP protects cells from bleomycin-induced apoptosis using primary bronchial epithelial cells and BEAS-2B cells. The protective effects are mediated by reducing mitochondrial reactive oxygen species (ROS) levels and upregulating autophagy. Therefore, global downregulation of theTOLLIPgene in IPF lungs may predispose injured lung epithelial cells to apoptosis and to the development of IPF.	[Li, Xiaoyun; Kim, Sharon E.; Chen, Ting-Yun; Wang, Juan; Yang, Xia; Tan, Jiangning; Guo, Brandon; Fung, Sonia; Sembrat, John; Rojas, Mauricio; Alder, Jonathan K.; Kass, Daniel J.; Zhang, Yingze] Univ Pittsburgh, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA USA; [Li, Xiaoyun; Kim, Sharon E.; Chen, Ting-Yun; Wang, Juan; Yang, Xia; Tan, Jiangning; Guo, Brandon; Fung, Sonia; Sembrat, John; Rojas, Mauricio; Alder, Jonathan K.; Kass, Daniel J.; Zhang, Yingze] Univ Pittsburgh, Dorothy P & Richard P Simmons Ctr Interstitial Lu, Pittsburgh, PA USA; [Chen, Ting-Yun] Natl Cheng Kung Univ, Inst Allied Hlth Sci, Tainan, Taiwan; [Wang, Juan; Yang, Xia] Tianjin Med Univ, Dept Pulm Med, Tianjin, Peoples R China; [Tabib, Tracy; Lafyatis, Robert] Univ Pittsburgh, Div Rheumatol & Clin Immunol, Pittsburgh, PA USA; [Zhao, Jing] Ohio State Univ, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Shiva, Sruti] Univ Pittsburgh, Vasc Med Inst, Pittsburgh, PA USA; [Shiva, Sruti] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA; [St. Croix, Claudette] Univ Pittsburgh, Ctr Biol Imaging, Pittsburgh, PA USA; [Di, Y. Peter] Univ Pittsburgh, Dept Environm & Occupat Hlth, Pittsburgh, PA USA; [Zhang, Yingze] Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Cheng Kung University; Tianjin Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Ohio; Ohio State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Zhang, YZ (corresponding author), Univ Pittsburgh, Sch Medicine, Div Pulm, Allergy,Crit Care Med, NW628 MUH,3459 Fifth Ave, Pittsburgh, PA 15213 USA.	zhangy@upmc.edu	Di, Yuanpu Peter/H-4191-2016	Di, Yuanpu Peter/0000-0003-2028-2087	Dorothy P. and Richard P. Simmons Center for Interstitial Lung Disease; Violet Rippy Research Fund; Young Investigator Grant from the Pulmonary Fibrosis Foundation	Dorothy P. and Richard P. Simmons Center for Interstitial Lung Disease; Violet Rippy Research Fund; Young Investigator Grant from the Pulmonary Fibrosis Foundation	This project was supported in part by the Dorothy P. and Richard P. Simmons Center for Interstitial Lung Disease, the Violet Rippy Research Fund, and a Young Investigator Grant from the Pulmonary Fibrosis Foundation (YZ)	Alder JK, 2008, P NATL ACAD SCI USA, V105, P13051, DOI 10.1073/pnas.0804280105; Alder JK, 2015, CHEST, V147, P1361, DOI 10.1378/chest.14-1947; An CH, 2012, AM J PHYSIOL-LUNG C, V303, pL748, DOI 10.1152/ajplung.00102.2012; Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157; Ashrafi G, 2013, CELL DEATH DIFFER, V20, P31, DOI 10.1038/cdd.2012.81; Baker B, 2015, J BIOL CHEM, V290, P6670, DOI 10.1074/jbc.M114.611442; Baumgartner KB, 1997, AM J RESP CRIT CARE, V155, P242, DOI 10.1164/ajrccm.155.1.9001319; Bingol B, 2014, NATURE, V510, P370, DOI 10.1038/nature13418; Brissoni B, 2006, CURR BIOL, V16, P2265, DOI 10.1016/j.cub.2006.09.062; Bueno M, 2015, J CLIN INVEST, V125, P521, DOI 10.1172/JCI74942; Chilosi M, 2002, LAB INVEST, V82, P1335, DOI 10.1097/01.LAB.0000032380.82232.67; Cronkhite JT, 2008, AM J RESP CRIT CARE, V178, P729, DOI 10.1164/rccm.200804-550OC; Devor DC, 2000, AM J PHYSIOL-CELL PH, V279, pC461, DOI 10.1152/ajpcell.2000.279.2.C461; Djavaheri-Mergny M, 2010, ONCOGENE, V29, P1717, DOI 10.1038/onc.2009.519; Evans CM, 2016, PHYSIOL REV, V96, P1567, DOI 10.1152/physrev.00004.2016; Fang EF, 2016, CELL METAB, V24, P566, DOI 10.1016/j.cmet.2016.09.004; Fingerlin TE, 2013, NAT GENET, V45, P613, DOI 10.1038/ng.2609; Hancock LA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07768-9; Jablonski RP, 2017, FASEB J, V31, P2520, DOI 10.1096/fj.201601077R; Jenkins G, 2018, THORAX, V73, P485, DOI 10.1136/thoraxjnl-2017-211220; Kasper M, 1996, HISTOL HISTOPATHOL, V11, P463; Katayama H, 2011, CHEM BIOL, V18, P1042, DOI 10.1016/j.chembiol.2011.05.013; Keskitalo S, 2019, NPJ GENOM MED, V4, DOI 10.1038/s41525-019-0088-5; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; King TE, 2001, AM J RESP CRIT CARE, V164, P1025, DOI 10.1164/ajrccm.164.6.2001056; Koyano F, 2014, NATURE, V510, P162, DOI 10.1038/nature13392; Kusko RL, 2016, AM J RESP CRIT CARE, V194, P948, DOI 10.1164/rccm.201510-2026OC; Lawson WE, 2008, AM J PHYSIOL-LUNG C, V294, pL1119, DOI 10.1152/ajplung.00382.2007; Lazarou M, 2015, NATURE, V524, P309, DOI 10.1038/nature14893; Lee VY, 2005, AM J PHYSIOL-LUNG C, V289, pL521, DOI 10.1152/ajplung.00340.2004; Liang JR, 2016, NAT MED, V22, P1285, DOI 10.1038/nm.4192; Lu KF, 2014, AUTOPHAGY, V10, P2381, DOI 10.4161/15548627.2014.981919; Maillard MH, 2014, INFLAMM BOWEL DIS, V20, P660, DOI 10.1097/MIB.0000000000000006; Maitra U, 2012, J IMMUNOL, V189, P1014, DOI 10.4049/jimmunol.1200857; Marino G, 2014, NAT REV MOL CELL BIO, V15, P81, DOI 10.1038/nrm3735; Martinez J, 2018, CURR OPIN IMMUNOL, V55, P54, DOI 10.1016/j.coi.2018.09.011; McDonough JE, 2019, THORAX, V74, P132, DOI 10.1136/thoraxjnl-2018-211929; Moore C, 2019, AM J RESP CRIT CARE, V200, P199, DOI 10.1164/rccm.201810-1891OC; Morse C, 2019, EUR RESPIR J, V54, DOI 10.1183/13993003.02441-2018; Mukherjee S, 2014, CELL SIGNAL, V26, P2674, DOI 10.1016/j.cellsig.2014.08.009; Mukhopadhyay S, 2014, APOPTOSIS, V19, P555, DOI 10.1007/s10495-014-0967-2; MYERS JL, 1988, AM J PATHOL, V132, P102; MYERS JL, 1988, CHEST, V94, P1309, DOI 10.1378/chest.94.6.1309; Noth I, 2013, LANCET RESP MED, V1, P309, DOI 10.1016/S2213-2600(13)70045-6; Peljto AL, 2013, JAMA-J AM MED ASSOC, V309, P2232, DOI 10.1001/jama.2013.5827; Plantier L, 2011, THORAX, V66, P651, DOI 10.1136/thx.2010.151555; Prasse A, 2019, AM J RESP CRIT CARE, V199, P622, DOI 10.1164/rccm.201712-2551OC; Richards TJ, 2012, AM J PHYSIOL-LUNG C, V302, pL746, DOI 10.1152/ajplung.00319.2011; Roy MG, 2014, NATURE, V505, P412, DOI 10.1038/nature12807; Sarraf SA, 2013, NATURE, V496, P372, DOI 10.1038/nature12043; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schwartz DA, 2018, ANN AM THORAC SOC, V15, pS192, DOI 10.1513/AnnalsATS.201802-144AW; Seibold MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058658; Seibold MA, 2011, NEW ENGL J MED, V364, P1503, DOI 10.1056/NEJMoa1013660; Sekine S, 2020, J BIOCHEM, V167, P217, DOI 10.1093/jb/mvz069; Selman M, 2003, AM J RESP CELL MOL, V29, pS93; Selman Moises, 2006, Proc Am Thorac Soc, V3, P364, DOI 10.1513/pats.200601-003TK; Shah JA, 2019, MUCOSAL IMMUNOL, V12, P1382, DOI 10.1038/s41385-019-0196-7; Sisson TH, 2010, AM J RESP CRIT CARE, V181, P254, DOI 10.1164/rccm.200810-1615OC; Slebos DJ, 2007, AM J RESP CELL MOL, V36, P409, DOI 10.1165/rcmb.2006-0214OC; Smith LJ, 2010, PAEDIATR RESPIR REV, V11, P135, DOI 10.1016/j.prrv.2009.12.006; Stuart BD, 2015, NAT GENET, V47, P512, DOI 10.1038/ng.3278; Sun N, 2017, NAT PROTOC, V12, P1576, DOI 10.1038/nprot.2017.060; Tan HW, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080842; Tanaka A, 2012, AM J RESP CELL MOL, V46, P507, DOI 10.1165/rcmb.2009-0415OC; Thannickal Victor J, 2006, Proc Am Thorac Soc, V3, P350, DOI 10.1513/pats.200601-001TK; Wang Y, 2009, AM J HUM GENET, V84, P52, DOI 10.1016/j.ajhg.2008.11.010; Whitsett JA, 2018, ANN AM THORAC SOC, V15, pS143, DOI 10.1513/AnnalsATS.201802-128AW; Xu Y, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.90558; Yanagihara T, 2019, EUR RESPIR REV, V28, DOI 10.1183/16000617.0029-2019; Yuan T, 2019, STEM CELL REP, V12, P1041, DOI 10.1016/j.stemcr.2019.04.003; Zhang GL, 2002, J BIOL CHEM, V277, P7059, DOI 10.1074/jbc.M109537200; Zhang YZ, 2011, NEW ENGL J MED, V364, P1576, DOI 10.1056/NEJMc1013504; Zhu L, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.388009; Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001	76	16	16	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					9884	9898		10.1096/fj.201902636RR	http://dx.doi.org/10.1096/fj.201902636RR		JUN 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32596871	Green Accepted, Bronze			2022-12-28	WOS:000546047800001
J	Bishop, CA; Schulze, MB; Klaus, S; Weitkunat, K				Bishop, Christopher A.; Schulze, Matthias B.; Klaus, Susanne; Weitkunat, Karolin			The branched-chain amino acids valine and leucine have differential effects on hepatic lipid metabolism	FASEB JOURNAL			English	Article						fatty acid metabolism; leucine; liver; OCFA; valine	DAIRY PRODUCT INTAKE; INSULIN SENSITIVITY; FATTY-ACIDS; ODD-CHAIN; PPAR-ALPHA; GLUCOSE-METABOLISM; IMPROVES GLUCOSE; PROTEIN; SUPPLEMENTATION; OBESE	Dairy intake, as a source of branched-chain amino acids (BCAA), has been linked to a lower incidence of type-2-diabetes and increased circulating odd-chain fatty acids (OCFA). To understand this connection, we aimed to investigate differences in BCAA metabolism of leucine and valine, a possible source of OCFA, and their role in hepatic metabolism. Male mice were fed a high-fat diet supplemented with leucine and valine for 1 week and phenotypically characterized with a focus on lipid metabolism. Mouse primary hepatocytes were treated with the BCAA or a Ppar alpha activator WY-14643 to systematically examine direct hepatic effects and their mechanisms. Here, we show that only valine supplementation was able to increase hepatic and circulating OCFA levels via two pathways; a PPAR alpha-dependent induction of alpha-oxidation and an increased supply of propionyl-CoA for de novo lipogenesis. Meanwhile, we were able to confirm leucine-mediated effects on the inhibition of food intake and transport of fatty acids, as well as induction of S6 ribosomal protein phosphorylation. Taken together, these data illustrate differential roles of the BCAA in lipid metabolism and provide preliminary evidence that exclusively valine contributes to the endogenous formation of OCFA which is important for a better understanding of these metabolites in metabolic health.	[Bishop, Christopher A.; Klaus, Susanne; Weitkunat, Karolin] German Inst Human Nutr Potsdam Rehbruecke DIfE, Dept Physiol Energy Metab, Arthur Scheunert Allee 114-116, D-14558 Nuthetal, Germany; [Bishop, Christopher A.; Schulze, Matthias B.; Klaus, Susanne] Univ Potsdam, Inst Nutr Sci, Nuthetal, Germany; [Schulze, Matthias B.] German Inst Human Nutr Potsdam Rehbruecke DIfE, Dept Mol Epidemiol, Nuthetal, Germany	Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); University of Potsdam; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE)	Weitkunat, K (corresponding author), German Inst Human Nutr Potsdam Rehbruecke DIfE, Dept Physiol Energy Metab, Arthur Scheunert Allee 114-116, D-14558 Nuthetal, Germany.	Karolin.Weitkunat@dife.de	Schulze, Matthias B/AAH-6906-2021; Klaus, Susanne/P-9299-2018	Schulze, Matthias B/0000-0002-0830-5277; Bishop, Christopher/0000-0003-2247-3602; Klaus, Susanne/0000-0001-8726-185X	Deutsche Forschungsgemeinschaft (DFG) [WE6488/1-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: WE6488/1-1	Akiyama Taro E, 2005, Curr Diab Rep, V5, P45, DOI 10.1007/s11892-005-0067-3; Al-Majdoub M, 2017, DIABETES METAB, V43, P475, DOI 10.1016/j.diabet.2016.12.008; Anthony TG, 2001, J NUTR, V131, P1171, DOI 10.1093/jn/131.4.1171; Arakawa M, 2011, ENDOCR J, V58, P161, DOI 10.1507/endocrj.K10E-221; Bianchi G, 2005, CURR OPIN CLIN NUTR, V8, P83, DOI 10.1097/00075197-200501000-00013; Binder E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074705; BLOMMAART EFC, 1995, J BIOL CHEM, V270, P2320, DOI 10.1074/jbc.270.5.2320; Brunetta HS, 2018, AMINO ACIDS, V50, P1663, DOI 10.1007/s00726-018-2658-8; Chan SMH, 2013, DIABETES, V62, P2095, DOI 10.2337/db12-1397; Chu RY, 2004, MOL CELL BIOL, V24, P6288, DOI 10.1128/MCB.24.14.6288-6297.2004; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; Crown SB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145850; Dongol B, 2007, J LIPID RES, V48, P1781, DOI 10.1194/jlr.M700119-JLR200; Forouhi NG, 2014, LANCET DIABETES ENDO, V2, P810, DOI 10.1016/S2213-8587(14)70146-9; Franklin MP, 2017, DIABETES, V66, P2112, DOI 10.2337/db16-1519; Freudenberg A, 2013, AMINO ACIDS, V44, P519, DOI 10.1007/s00726-012-1363-2; Freudenberg A, 2012, J NUTR BIOCHEM, V23, P1524, DOI 10.1016/j.jnutbio.2011.10.005; Guerre-Millo M, 2000, J BIOL CHEM, V275, P16638, DOI 10.1074/jbc.275.22.16638; Guillou Herve, 2008, V49, P3, DOI 10.1007/978-1-4020-8831-5_1; Halton TL, 2004, J AM COLL NUTR, V23, P373, DOI 10.1080/07315724.2004.10719381; Higuchi N, 2011, J CELL BIOCHEM, V112, P30, DOI 10.1002/jcb.22688; Ijichi C, 2003, BIOCHEM BIOPH RES CO, V303, P59, DOI 10.1016/S0006-291X(03)00295-X; Jenkins B, 2017, MOLECULES, V22, DOI 10.3390/molecules22101718; Jenkins B, 2015, MOLECULES, V20, P2425, DOI 10.3390/molecules20022425; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Klaus S, 2005, J NUTR, V135, P1854, DOI 10.1093/jn/135.8.1854; Layman DK, 2006, J NUTR, V136, p319S, DOI 10.1093/jn/136.1.319S; Li CH, 2003, J BIOL CHEM, V278, P2853, DOI 10.1074/jbc.M210577200; Li HL, 2012, AM J PHYSIOL-ENDOC M, V303, pE1234, DOI 10.1152/ajpendo.00198.2012; Li WC, 2010, METHODS MOL BIOL, V633, P185, DOI 10.1007/978-1-59745-019-5_13; Lotta LA, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002179; Macotela Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021187; Matthan NR, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000764; Meijer AJ, 2004, BIOCHEM BIOPH RES CO, V313, P397, DOI 10.1016/j.bbrc.2003.07.012; Nepokroeff C M, 1975, Methods Enzymol, V35, P37, DOI 10.1016/0076-6879(75)35136-7; Newgard CB, 2012, CELL METAB, V15, P606, DOI 10.1016/j.cmet.2012.01.024; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Nilsson M, 2007, AM J CLIN NUTR, V85, P996, DOI 10.1093/ajcn/85.4.996; O'Connor LM, 2014, DIABETOLOGIA, V57, P909, DOI 10.1007/s00125-014-3176-1; Pertiwi K, 2019, NUTR METAB, V16, DOI 10.1186/s12986-019-0407-y; Proud CG, 2002, EUR J BIOCHEM, V269, P5338, DOI 10.1046/j.1432-1033.2002.03292.x; Santaren ID, 2014, AM J CLIN NUTR, V100, P1532, DOI 10.3945/ajcn.114.092544; Veiga FM, 2017, BIOCHIMIE, V140, P106, DOI 10.1016/j.biochi.2017.07.003; Sluijs I, 2012, AM J CLIN NUTR, V96, P382, DOI 10.3945/ajcn.111.021907; Solon-Biet SM, 2019, NAT METAB, V1, P532, DOI 10.1038/s42255-019-0059-2; Son SM, 2019, CELL METAB, V29, P192, DOI 10.1016/j.cmet.2018.08.013; Suryawan A, 1998, AM J CLIN NUTR, V68, P72, DOI 10.1093/ajcn/68.1.72; Titchenell PM, 2017, TRENDS ENDOCRIN MET, V28, P497, DOI 10.1016/j.tem.2017.03.003; Tournissac Marine, 2018, Alzheimers Dement (N Y), V4, P677, DOI 10.1016/j.trci.2018.10.005; Vessby B, 2013, BRIT J NUTR, V110, P871, DOI 10.1017/S0007114512005934; Vlaeminck B, 2006, ANIM FEED SCI TECH, V131, P389, DOI 10.1016/j.anifeedsci.2006.06.017; Weitkunat K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06447-x; Weitkunat K, 2017, AM J CLIN NUTR, V105, P1544, DOI 10.3945/ajcn.117.152702; Weitkunat K, 2016, MOL NUTR FOOD RES, V60, P2611, DOI 10.1002/mnfr.201600305; Weitkunat K, 2015, J NUTR BIOCHEM, V26, P929, DOI 10.1016/j.jnutbio.2015.03.010; Westerterp-Plantenga MS, 2009, ANNU REV NUTR, V29, P21, DOI 10.1146/annurev-nutr-080508-141056; Xiao F, 2014, METABOLISM, V63, P841, DOI 10.1016/j.metabol.2014.03.006; Xiao F, 2011, DIABETES, V60, P746, DOI 10.2337/db10-1246; Yakoob MY, 2016, CIRCULATION, V133, P1645, DOI 10.1161/CIRCULATIONAHA.115.018410; Yan X, 2018, MOL METAB, V18, P15, DOI 10.1016/j.molmet.2018.10.003; Yang JC, 2010, NUTR REV, V68, P270, DOI 10.1111/j.1753-4887.2010.00282.x; Ye JM, 2001, DIABETES, V50, P411, DOI 10.2337/diabetes.50.2.411; Yoshizawa F, 2013, BIOSCI BIOTECH BIOCH, V77, P839, DOI 10.1271/bbb.120737; Zarfeshani A, 2014, CLIN EPIGENETICS, V6, DOI 10.1186/1868-7083-6-27; Zhang YY, 2007, DIABETES, V56, P1647, DOI 10.2337/db07-0123	65	18	19	8	25	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9727	9739		10.1096/fj.202000195R	http://dx.doi.org/10.1096/fj.202000195R		JUN 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32506644	Green Published			2022-12-28	WOS:000539607600001
J	Qu, FN; Palte, IC; Gontarz, PM; Zhang, B; Guilak, F				Qu, Feini; Palte, Ilan C.; Gontarz, Paul M.; Zhang, Bo; Guilak, Farshid			Transcriptomic analysis of bone and fibrous tissue morphogenesis during digit tip regeneration in the adult mouse	FASEB JOURNAL			English	Article						amputation; blastema; osteogenesis; regenerative medicine; RNA-seq; wound repair	GENE-EXPRESSION; ROLES; DIFFERENTIATION; AMPUTATION; CELLS; FETAL; MSX1	Humans have limited regenerative potential of musculoskeletal tissues following limb or digit loss. The murine digit has been used to study mammalian regeneration, where stem/progenitor cells (the "blastema") completely regenerate the digit tip after distal, but not proximal, amputation. However, the molecular mechanisms responsible for this response remain to be determined. Here, we evaluated the spatiotemporal formation of bone and fibrous tissues after level-dependent amputation of the murine terminal phalanx and quantified the transcriptome of the repair tissue. Distal (regenerative) and proximal (non-regenerative) amputations showed significant differences in temporal gene expression and tissue regrowth over time. Genes that direct skeletal system development and limb morphogenesis are transiently upregulated during blastema formation and differentiation, including distal Hox genes. Overall, our results suggest that digit tip regeneration is controlled by a gene regulatory network that recapitulates aspects of limb development, and that failure to activate this developmental program results in fibrotic wound healing.	[Qu, Feini; Palte, Ilan C.; Guilak, Farshid] Washington Univ, Dept Orthopaed Surg, Couch Biomed Res Bldg,Room 3121,Campus Box 8233, St Louis, MO 63110 USA; [Qu, Feini; Palte, Ilan C.; Gontarz, Paul M.; Zhang, Bo; Guilak, Farshid] Washington Univ, Ctr Regenerat Med, St Louis, MO 63110 USA; [Qu, Feini; Palte, Ilan C.; Guilak, Farshid] Shriners Hosp Children St Louis, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL)	Guilak, F (corresponding author), Washington Univ, Dept Orthopaed Surg, Couch Biomed Res Bldg,Room 3121,Campus Box 8233, St Louis, MO 63110 USA.	guilak@wustl.edu			National Institutes of Health [T32 AR060719, F32 AR074895, R25 DA027995, AG15768, AG46927, P30 AR073752, P30 AR074992]; Arthritis Foundation; Nancy Taylor Foundation for Chronic Diseases; Shriners Hospitals for Children	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthritis Foundation; Nancy Taylor Foundation for Chronic Diseases; Shriners Hospitals for Children	This work was supported by the National Institutes of Health (T32 AR060719 and F32 AR074895 to F. Qu, R25 DA027995 to B. Zhang, AG15768 and AG46927 to F. Guilak, P30 AR073752, P30 AR074992), the Arthritis Foundation, the Nancy Taylor Foundation for Chronic Diseases, and the Shriners Hospitals for Children	Agrawal V, 2011, TISSUE ENG PT A, V17, P2435, DOI [10.1089/ten.TEA.2011.0036, 10.1089/ten.tea.2011.0036]; Avouac J, 2012, ARTHRITIS RHEUM-US, V64, P1642, DOI 10.1002/art.33501; Bauer O, 2015, MOL CELL BIOL, V35, P1097, DOI 10.1128/MCB.01106-14; Carr MJ, 2019, CELL STEM CELL, V24, P240, DOI 10.1016/j.stem.2018.10.024; Chadwick RB, 2007, WOUND REPAIR REGEN, V15, P275, DOI 10.1111/j.1524-475X.2007.00216.x; Chamberlain CS, 2017, WOUND REPAIR REGEN, V25, P443, DOI 10.1111/wrr.12544; Chen Y, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.46; Cheng CH, 2013, PHYSIOL GENOMICS, V45, P409, DOI 10.1152/physiolgenomics.00142.2012; Corada M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3609; Dawson LA, 2018, WOUND REPAIR REGEN, V26, P263, DOI 10.1111/wrr.12666; Dawson LA, 2017, REGENERATION, V4, P140, DOI 10.1002/reg2.81; Fernando WA, 2011, DEV BIOL, V350, P301, DOI 10.1016/j.ydbio.2010.11.035; FromentalRamain C, 1996, DEVELOPMENT, V122, P2997; Gabory A, 2009, DEVELOPMENT, V136, P3413, DOI 10.1242/dev.036061; Gerber T, 2018, SCIENCE, V362, P421, DOI 10.1126/science.aaq0681; Giannandrea M, 2014, DIS MODEL MECH, V7, P193, DOI 10.1242/dmm.012062; Han M, 2008, DEV BIOL, V315, P125, DOI 10.1016/j.ydbio.2007.12.025; Han MJ, 2003, DEVELOPMENT, V130, P5123, DOI 10.1242/dev.00710; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang YH, 2015, 2015 12TH WEB INFORMATION SYSTEM AND APPLICATION CONFERENCE (WISA), P3, DOI [10.1109/WISA.2015.16, 10.1109/PPC.2015.7296864]; Johnson GL, 2020, DEV CELL, V52, P525, DOI 10.1016/j.devcel.2020.01.026; Johnston APW, 2016, CELL STEM CELL, V19, P433, DOI 10.1016/j.stem.2016.06.002; Komori T, 2010, ADV EXP MED BIOL, V658, P43, DOI 10.1007/978-1-4419-1050-9_5; Kuijper S, 2005, DEV BIOL, V285, P533, DOI 10.1016/j.ydbio.2005.06.017; Lehoczky JA, 2011, P NATL ACAD SCI USA, V108, P20609, DOI 10.1073/pnas.1118017108; Leigh ND, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07604-0; Li XY, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00855; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu QC, 2018, INFLAMMATION, V41, P896, DOI 10.1007/s10753-018-0744-4; Marrero L, 2017, REGENERATION, V4, P69, DOI 10.1002/reg2.75; Martin TJ, 2009, CRIT REV EUKAR GENE, V19, P73, DOI 10.1615/CritRevEukarGeneExpr.v19.i1.40; Meyer MB, 2014, J BIOL CHEM, V289, P16016, DOI 10.1074/jbc.M114.552216; Miller MJ, 2017, CONTEMP CLIN TRIALS, V55, P10, DOI 10.1016/j.cct.2017.01.008; Mu XD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059105; Neufeld Daniel A., 1995, Wound Repair and Regeneration, V3, P461, DOI 10.1046/j.1524-475X.1995.30410.x; Nik AM, 2016, DEV BIOL, V415, P14, DOI 10.1016/j.ydbio.2016.05.013; Owings MF, 1998, VITAL HLTH STAT, V139, P1; Pineault KM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11100-4; Qu FN, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01955-w; Qu FN, 2015, BIOMATERIALS, V39, P85, DOI 10.1016/j.biomaterials.2014.10.067; REGINELLI AD, 1995, DEVELOPMENT, V121, P1065; Rinkevich Y, 2015, DEV DYNAM, V244, P641, DOI 10.1002/dvdy.24265; Rinkevich Y, 2014, P NATL ACAD SCI USA, V111, P9846, DOI 10.1073/pnas.1410097111; Rinkevich Y, 2011, NATURE, V476, P409, DOI 10.1038/nature10346; Rux DR, 2016, DEV CELL, V39, P653, DOI 10.1016/j.devcel.2016.11.008; Sheeba CJ, 2017, CURR TOP DEV BIOL, V122, P355, DOI 10.1016/bs.ctdb.2016.08.009; Sheth R, 2016, CELL REP, V17, P2913, DOI 10.1016/j.celrep.2016.11.039; Simkin J, 2017, DEVELOPMENT, V144, P3907, DOI 10.1242/dev.150086; Simkin J, 2015, REGENERATION, V2, P106, DOI 10.1002/reg2.34; Stadler HS, 2001, DEVELOPMENT, V128, P4177; Storer MA, 2020, DEV CELL, V52, P509, DOI 10.1016/j.devcel.2019.12.004; Taghiyar L, 2017, J BIOL CHEM, V292, P10520, DOI 10.1074/jbc.M116.774265; Takeo M, 2013, NATURE, V499, P228, DOI 10.1038/nature12214; ten Berge D, 1998, DEVELOPMENT, V125, P3831; Varma P, 2014, PHYS MED REH CLIN N, V25, P1, DOI 10.1016/j.pmr.2013.09.001; Villavicencio-Lorini P, 2010, J CLIN INVEST, V120, P1994, DOI 10.1172/JCI41554; Volk SW, 2011, CELLS TISSUES ORGANS, V194, P25, DOI 10.1159/000322399; Wu YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054764; Yu L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08278-4; Yu L, 2010, DEVELOPMENT, V137, P551, DOI 10.1242/dev.042424; Zakany J, 1999, CELL TISSUE RES, V296, P19, DOI 10.1007/s004410051262	61	6	6	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9740	9754		10.1096/fj.202000330R	http://dx.doi.org/10.1096/fj.202000330R		JUN 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32506623	Green Submitted, Green Accepted			2022-12-28	WOS:000539605700001
J	Cai, J; Wang, DM; Liang, SL; Peng, JR; Zhao, FQ; Liu, JX				Cai, Jie; Wang, Diming; Liang, Shulin; Peng, Jinrong; Zhao, Fengqi; Liu, Jianxin			Excessive supply of glucose elicits an NF-kappa B2-dependent glycolysis in lactating goat mammary glands	FASEB JOURNAL			English	Article						coexpression; glycolysis; lactation; mammary gland; NF-kappa B; transcriptome	NF-KAPPA-B; EPITHELIAL-CELLS; GANODERIC ACID; DNA-REPAIR; AVAILABILITY; METABOLISM; EXPRESSION; ROLES; DIET; P53	During lactation, an improper glucose supply often threatens mammary gland (MG) health. However, information is limited on the metabolic trajectories and molecules that regulate lactating MGs with an excessive glucose supply. Based on the network analysis of transcriptome and microRNAs, we found that the oversupply of glucose-induced severe glucose metabolic disorders in MGs of lactating goats, shifting lactose synthesis to acute fermentative glycolysis which caused increased flux of glucose metabolism into lactate. Moreover, NF-kappa B2 played a key role in regulating glycolysis, exhibiting a metabolic shift when MGs had an excessive supply of glucose. In primary mammary epithelial cells, fermentative glycolysis, and intracellular concentration of reactive oxygen species (ROS) were reduced by ganoderic acid A through blocking NF-kappa B2, while activation of NF-kappa B2 with phorbol myristate acetate (PMA) upregulated fermentative glycolysis and increased cellular ROS accumulation under excessive glucose. Thus, we established an NF-kappa B2-targeting method to reform the metabolic shift toward glycolysis caused by glucose oversupply by integrating NF-kappa B2 blockade and intracellular ROS scavenging.	[Cai, Jie; Wang, Diming; Liang, Shulin; Peng, Jinrong; Zhao, Fengqi; Liu, Jianxin] Zhejiang Univ, Inst Dairy Sci, Coll Anim Sci, Minist Educ,Key Lab Mol Anim Nutr, Hangzhou, Zhejiang, Peoples R China; [Zhao, Fengqi] Univ Vermont, Dept Anim & Vet Sci, Burlington, VT USA	Zhejiang University; University of Vermont	Liu, JX (corresponding author), Zhejiang Univ, Minist Educ, Key Lab Mol Anim Nutr, Hangzhou, Zhejiang, Peoples R China.	liujx@zju.edu.cn			National Nature Science Foundation of China [31930107]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	The National Nature Science Foundation of China, Grant/Award Number: 31930107	Akers M. R., 2002, LACTATION MAMMARY GL, P88; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Cai J, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01467; Cao FR, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00101; Cao YX, 2003, J MAMMARY GLAND BIOL, V8, P215, DOI 10.1023/A:1025905008934; Cerella C, 2014, BIOCHEM PHARMACOL, V92, P22, DOI 10.1016/j.bcp.2014.07.005; Chang MS, 2005, CELL SIGNAL, V17, P299, DOI 10.1016/j.cellsig.2004.07.008; Cui Y, 2016, MED SCI MONITOR, V22, P4699, DOI 10.12659/MSM.896772; Elo LL, 2007, BIOINFORMATICS, V23, P2096, DOI 10.1093/bioinformatics/btm309; Elswood J, 2021, AUTOPHAGY, V17, P420, DOI 10.1080/15548627.2020.1720427; Epstein T, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-7; Diaz FE, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/1218297; Farabegoli F, 2012, EUR J PHARM SCI, V47, P729, DOI 10.1016/j.ejps.2012.08.012; Gill BS, 2018, INTERDISCIP SCI, V10, P233, DOI 10.1007/s12539-016-0182-7; Giugliano D, 2006, J AM COLL CARDIOL, V48, P677, DOI 10.1016/j.jacc.2006.03.052; Guan YJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep10372; Ho E, 2002, P NATL ACAD SCI USA, V99, P16770, DOI 10.1073/pnas.222679399; Ideker Trey, 2002, Bioinformatics, V18 Suppl 1, pS233; Ingman WV, 2014, J MAMMARY GLAND BIOL, V19, P161, DOI 10.1007/s10911-014-9325-9; Kumar S, 2014, INT J CANCER, V134, P2798, DOI 10.1002/ijc.28623; Lapierre H, 2007, P CORN NUTR C FEED M; Lemosquet S, 2002, AM J PHYSIOL-REG I, V282, pR464, DOI 10.1152/ajpregu.2002.282.2.R464; Lemosquet S, 2009, J DAIRY SCI, V92, P3244, DOI 10.3168/jds.2008-1610; Li JJ, 2006, PROTEIN PEPTIDE LETT, V13, P391, DOI 10.2174/092986606775974339; Li Q, 2015, TOXICOL APPL PHARM, V289, P133, DOI 10.1016/j.taap.2015.09.025; Liao YX, 2019, NUCLEIC ACIDS RES, V47, pW199, DOI 10.1093/nar/gkz401; Liu BH, 2010, BIOINFORMATICS, V26, P2637, DOI 10.1093/bioinformatics/btq471; Liu HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066092; Liu ZD, 2018, EUR J PHARMACOL, V824, P72, DOI 10.1016/j.ejphar.2018.01.026; Luo MH, 2010, ANTIOXID REDOX SIGN, V12, P1247, DOI 10.1089/ars.2009.2698; Martinez-Outschoorn UE, 2013, CELL CYCLE, V12, P2580, DOI 10.4161/cc.25510; Mathias PCF, 2014, EUR J NUTR, V53, P711, DOI 10.1007/s00394-014-0654-7; Nikolayeva O, 2014, METHODS MOL BIOL, V1150, P45, DOI 10.1007/978-1-4939-0512-6_3; Purup S, 2012, ANIMAL, V6, P423, DOI 10.1017/S1751731111002540; Rao Xiayu, 2013, Biostat Bioinforma Biomath, V3, P71; Sala G, 2016, NEUROTOXICOLOGY, V54, P161, DOI 10.1016/j.neuro.2016.04.018; Santos JM, 2019, NUTR CANC, V22, P1; SCHULZEOSTHOFF K, 1995, BIOCHEM PHARMACOL, V50, P735, DOI 10.1016/0006-2952(95)02011-Z; Seyfried TN, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-7; Shi HP, 2014, ANIM SCI J, V85, P735, DOI 10.1111/asj.12206; Sun SC, 2017, NAT REV IMMUNOL, V17, P545, DOI 10.1038/nri.2017.52; Tarazona A, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12010016; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Voutilainen M, 2012, P NATL ACAD SCI USA, V109, P5744, DOI 10.1073/pnas.1110627109; Wang Y, 2019, MICROB PATHOGENESIS, V128, P390, DOI 10.1016/j.micpath.2019.01.038; Wang ZY, 2019, IMMUNOL LETT, V206, P1, DOI 10.1016/j.imlet.2018.11.014; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wu TY, 2020, NUTRIENTS, V12, DOI 10.3390/nu12020578; Xie H, 2009, MOL CANCER THER, V8, P626, DOI 10.1158/1535-7163.MCT-08-1049; Yang JL, 2018, ONCOTARGET, V9, P1063, DOI 10.18632/oncotarget.23148; Yang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079729; Yeung SJ, 2008, CELL MOL LIFE SCI, V65, P3981, DOI 10.1007/s00018-008-8224-x; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang YL, 2015, COMPUT MATH METHOD M, V2015, DOI 10.1155/2015/621264; Zhao K, 2012, ANIMAL, V6, P488, DOI 10.1017/S1751731111001893; Zhu J, 2018, CHEM-BIOL INTERACT, V290, P77, DOI 10.1016/j.cbi.2018.05.014	57	2	3	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8671	8685		10.1096/fj.201903088R	http://dx.doi.org/10.1096/fj.201903088R		MAY 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32359096				2022-12-28	WOS:000530048100001
J	Zhu, NN; Lu, MJ; Chen, YQ; Jin, XJ; Zhou, X; Wei, HW; Liu, XQ; Duan, LS; Yin, L; Guo, JR				Zhu, Na-Na; Lu, Ming-Jun; Chen, Yong-Quan; Jin, Xiao-Ju; Zhou, Xun; Wei, Han-Wei; Liu, Xiao-Qian; Duan, Li-Shuang; Yin, Lei; Guo, Jian-Rong			Autologous blood transfusion stimulates wound healing in diabetic mice through activation of the HIF-1 alpha pathway by improving the blood preservation solution	FASEB JOURNAL			English	Article						autologous blood transfusion; diabetes; HIF-1 alpha; improved blood preservation solution; wound healing	PROMOTES ANGIOGENESIS; IN-VIVO; EXPRESSION; HIF-1; SURGERY; CELLS	Transfusion of autologous blood is a timesaving, convenient, safe, and effective therapy from a clinical perspective, and often employed for the treatment of diabetic patients. Stabilization of HIF-1 alpha has been widely reported to be a critical factor in the improvement of wound healing in diabetes. Therefore, our study reveals the roles of improved autologous blood in wound healing in diabetes, through autologous blood transfusion in a mouse model. Initially, BALB/c mice were subjected to streptozotocin for diabetic mouse model establishment. Diabetic mice were transfused with improved or standard autologous blood in perfusion culture system. Roles of improved autologous blood in mediating HIF-1 alpha pathway were determined by measuring expression of VEGF, EGF, HIF-1 alpha, and HSP-90. In order to assess the detailed regulatory mechanism of improved autologous blood in perspective of wound healing, cell proliferation, migration and cell cycle, fibroblasts isolated from diabetic mice were transfected with HIF-1 alpha siRNA. Mice transfused with improved autologous blood exhibited increased levels of CD31 and alpha-SMA in skin tissues, and reduced TNF-alpha, IL-1 beta, and IL-6 levels, indicating that improved autologous blood promoted wound healing ability and reduced the release of inflammatory factors. Diabetic mice transfused with improved autologous blood presented activated HIF-1 alpha pathway. The survival rate, proliferation, and migration of fibroblasts were elevated via activation of the HIF-1 alpha pathway. Taken together, improved blood preservation solution could enhance the oxygen carrying capacity of red blood cells and wound healing in mice with diabetes, which is achieved through regulation of HIF-1 alpha pathway.	[Zhu, Na-Na; Lu, Ming-Jun; Zhou, Xun; Liu, Xiao-Qian; Duan, Li-Shuang; Yin, Lei; Guo, Jian-Rong] Second Mil Med Univ, Gongli Hosp, Dept Anesthesiol, 219 Miaopu Rd, Shanghai 200135, Peoples R China; [Chen, Yong-Quan; Jin, Xiao-Ju; Wei, Han-Wei] Wannan Med Coll, Yijishan Hosp, Dept Anesthesiol, Wuhu, Peoples R China; [Zhou, Xun; Guo, Jian-Rong] Ningxia Med Univ, Gongli Hosp, Shanghai Pudong New Area Training Base, Shanghai, Peoples R China	Naval Medical University; Wannan Medical College; Ningxia Medical University	Guo, JR (corresponding author), Second Mil Med Univ, Gongli Hosp, Dept Anesthesiol, 219 Miaopu Rd, Shanghai 200135, Peoples R China.	g_jianrong@yeah.net						Badr G, 2016, J CELL PHYSIOL, V231, P2159, DOI 10.1002/jcp.25328; Chen QY, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/9726503; Deppe J, 2016, ARCH TOXICOL, V90, P1141, DOI 10.1007/s00204-015-1549-y; Dumont LJ, 2009, TRANSFUSION, V49, P458, DOI 10.1111/j.1537-2995.2008.02038.x; FONG YM, 1994, AM J SURG, V167, P256, DOI 10.1016/0002-9610(94)90087-6; Galeano M, 2004, DIABETES, V53, P2509, DOI 10.2337/diabetes.53.9.2509; Guo JR, 2018, CELL COMMUN SIGNAL, V16, DOI 10.1186/s12964-018-0290-6; Heun Y, 2017, MOL THER, V25, P1616, DOI 10.1016/j.ymthe.2017.04.007; Khamaisi M, 2017, DIABETES-METAB RES, V33, DOI 10.1002/dmrr.2929; Lacci Kathleen M., 2010, Yale Journal of Biology and Medicine, V83, P1; Li SL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171081; Ma HS, 2016, CHIN J TRAUMATOL, V19, P371, DOI 10.1016/j.cjtee.2016.04.007; Mace KA, 2007, WOUND REPAIR REGEN, V15, P636, DOI 10.1111/j.1524-475X.2007.00278.x; Mao ZG, 2016, SCI REP-UK, V6, DOI 10.1038/srep20084; Marrotte EJ, 2010, J CLIN INVEST, V120, P4207, DOI 10.1172/JCI36858; Morgan TM, 2013, UROL ONCOL-SEMIN ORI, V31, P871, DOI 10.1016/j.urolonc.2011.07.012; Pawaskar A, 2017, KNEE SURG SPORT TR A, V25, P2957, DOI 10.1007/s00167-016-4116-z; Pesce M, 2013, EUR CYTOKINE NETW, V24, P1, DOI 10.1684/ecn.2013.0332; Piccin A, 2015, BLOOD TRANSFUS, V14, P1; Piccin A, 2017, BLOOD TRANSFUS, V15, P1, DOI DOI 10.2450/2016.0058-16; Piccin A, 2017, TRANSFUSION, V57, P2220, DOI 10.1111/trf.14205; Piccin A, 2016, REGEN MED, V11, P459, DOI 10.2217/rme-2016-0031; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Shabbir A, 2015, STEM CELLS DEV, V24, P1635, DOI 10.1089/scd.2014.0316; Shen KK, 2012, BIOCHEM PHARMACOL, V84, P784, DOI 10.1016/j.bcp.2012.05.024; Sugimoto T, 2014, BLOOD TRANSFUS-ITALY, V12, pS209, DOI 10.2450/2013.0271-12; Sunkari VG, 2015, WOUND REPAIR REGEN, V23, P98, DOI 10.1111/wrr.12253; Suthar M, 2017, J BIOMED SCI, V24, DOI 10.1186/s12929-017-0324-1; Vishwakarma S, 2017, INDIAN J HEMATOL BLO, V33, P293, DOI 10.1007/s12288-016-0715-6; Vogler M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069128; Wang CG, 2018, ACTA PHARMACOL SIN, V39, P393, DOI 10.1038/aps.2017.161; Wang H, 2017, ONCOTARGET, V8; Wang HY, 2016, ONCOTARGET, V7, P20193, DOI 10.18632/oncotarget.7935; Zhang JJ, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0306-2; Zhou J, 2016, BRAZ J MED BIOL RES, V49, DOI [10.1590/1414-431X20165493, 10.1590/1414-431x20165493]	35	3	4	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6038	6054		10.1096/fj.201900324RRR	http://dx.doi.org/10.1096/fj.201900324RRR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32202355				2022-12-28	WOS:000531325500006
J	Dong, XM; Zhao, K; Zheng, WW; Xu, CW; Zhang, MJ; Yin, RH; Gao, R; Tang, LJ; Liu, JF; Chen, H; Zhan, YQ; Yu, M; Ge, CH; Gao, HY; Li, X; Luo, T; Ning, HM; Yang, XM; Li, CY				Dong, Xiao-Ming; Zhao, Ke; Zheng, Wei-Wei; Xu, Cheng-Wang; Zhang, Mei-Jiang; Yin, Rong-Hua; Gao, Rui; Tang, Liu-jun; Liu, Jin-Fang; Chen, Hui; Zhan, Yi-Qun; Yu, Miao; Ge, Chang-Hui; Gao, Hui-Ying; Li, Xiu; Luo, Teng; Ning, Hong-Mei; Yang, Xiao-Ming; Li, Chang-Yan			EDAG mediates Hsp70 nuclear localization in erythroblasts and rescues dyserythropoiesis in myelodysplastic syndrome	FASEB JOURNAL			English	Article						dyserythropoiesis; EDAG; Hsp70; myelodysplastic syndrome; nuclear localization	ERYTHROID-DIFFERENTIATION; PROTEIN; CELLS; EXPRESSION; GATA1; ERYTHROPOIESIS; IDENTIFICATION; PROLIFERATION; PROGENITORS; ACTIVATION	During human erythroid maturation, Hsp70 translocates into the nucleus and protects GATA-1 from caspase-3 cleavage. Failure of Hsp70 to localize to the nucleus was found in Myelodysplastic syndrome (MDS) erythroblasts and can induce dyserythropoiesis, with arrest of maturation and death of erythroblasts. However, the mechanism of the nuclear trafficking of Hsp70 in erythroblasts remains unknown. Here, we found the hematopoietic transcriptional regulator, EDAG, to be a novel binding partner of Hsp70 that forms a protein complex with Hsp70 and GATA-1 during human normal erythroid differentiation. EDAG overexpression blocked the cytoplasmic translocation of Hsp70 induced by EPO deprivation, inhibited GATA-1 degradation, thereby promoting erythroid maturation in an Hsp70-dependent manner. Furthermore, in myelodysplastic syndrome (MDS) patients with dyserythropoiesis, EDAG is dramatically down-regulated, and forced expression of EDAG has been found to restore the localization of Hsp70 in the nucleus and elevate the protein level of GATA-1 to a significant extent. In addition, EDAG rescued the dyserythropoiesis of MDS patients by increasing erythroid differentiation and decreasing cell apoptosis. This study demonstrates the molecular mechanism of Hsp70 nuclear sustaining during erythroid maturation and establishes that EDAG might be a suitable therapeutic target for dyserythropoiesis in MDS patients.	[Dong, Xiao-Ming; Zhao, Ke; Zheng, Wei-Wei; Xu, Cheng-Wang; Zhang, Mei-Jiang; Yin, Rong-Hua; Gao, Rui; Tang, Liu-jun; Liu, Jin-Fang; Chen, Hui; Zhan, Yi-Qun; Yu, Miao; Gao, Hui-Ying; Luo, Teng; Yang, Xiao-Ming; Li, Chang-Yan] Beijing Inst Lifeom, Beijing Proteome Res Ctr, State Key Lab Prote, Beijing, Peoples R China; [Dong, Xiao-Ming; Zhang, Mei-Jiang; Yang, Xiao-Ming] Tianjin Univ, Sch Chem Engn & Technol, Dept Pharmaceut Engn, Tianjin, Peoples R China; [Dong, Xiao-Ming] Shaanxi Normal Univ, Coll Life Sci, Xian, Peoples R China; [Ge, Chang-Hui] Beijing Inst Radiat Med, Dept Expt Hematol & Biochem, Beijing, Peoples R China; [Li, Xiu; Yang, Xiao-Ming; Li, Chang-Yan] Anhui Med Univ, Sch Postgrad, Hefei, Peoples R China; [Ning, Hong-Mei] Chinese Peoples Liberat Army Gen Hosp, Dept Hematopoiet Stem Cell Transplantat, Med Ctr 5, Beijing, Peoples R China	Tianjin University; Shaanxi Normal University; Anhui Medical University; Chinese People's Liberation Army General Hospital; Fifth Medical Center of Chinese PLA General Hospital	Ning, HM (corresponding author), 307 Hosp PLA, Dept Hematopoiet Stem Cell Transplantat, Beijing 100071, Peoples R China.; Yang, XM; Li, CY (corresponding author), Beijing Inst Lifeom, State Key Lab Prote, 27 Taiping Rd, Beijing 100850, Peoples R China.	ninghongmei72@sina.com; xiaomingyang@sina.com; fmmli@163.com		Dong, xiao-ming/0000-0003-2413-8541	Ministry of Science and Technology of the People's Republic of China [2017YFA0103400]; National Natural Science Foundation of China [81222005, 81770108, 30570781]; National Center for Protein Sciences [SKLP-K201802, SKLP-O20180, 4]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Center for Protein Sciences	Ministry of Science and Technology of the People's Republic of China, Grant/Award Number: 2017YFA0103400; National Natural Science Foundation of China, Grant/Award Number: 81222005, 81770108 and 30570781; National Center for Protein Sciences, Grant/Award Number: SKLP-K201802, SKLP-O20180 and 4	Ahn SG, 2005, BIOCHEM J, V392, P145, DOI 10.1042/BJ20050412; Ali AM, 2018, BLOOD ADV, V2, P1393, DOI 10.1182/bloodadvances.2018018440; An LL, 2005, LEUKEMIA, V19, P1499, DOI 10.1038/sj.leu.2403808; Arlet JB, 2016, EXPERT REV PROTEOMIC, V13, P983, DOI 10.1080/14789450.2016.1240622; Arlet JB, 2014, NATURE, V514, P242, DOI 10.1038/nature13614; Bresnick EH, 2012, NUCLEIC ACIDS RES, V40, P5819, DOI 10.1093/nar/gks281; Claessens YE, 2002, BLOOD, V99, P1594, DOI 10.1182/blood.V99.5.1594; CLARK WELG, 1947, NATURE, V159, P579; Ding YL, 2010, J CELL BIOCHEM, V110, P866, DOI 10.1002/jcb.22597; FREEMAN BC, 1995, EMBO J, V14, P2281, DOI 10.1002/j.1460-2075.1995.tb07222.x; Frisan E, 2012, BLOOD, V119, P1532, DOI 10.1182/blood-2011-03-343475; Gyan E, 2008, LEUKEMIA, V22, P1864, DOI 10.1038/leu.2008.172; Han X, 2017, BLOOD, V129, P226, DOI 10.1182/blood-2016-09-739268; Kose S, 2014, BBA-GEN SUBJECTS, V1840, P2953, DOI 10.1016/j.bbagen.2014.04.022; Kose S, 2012, CELL, V149, P578, DOI 10.1016/j.cell.2012.02.058; Kruger A, 2002, DEV DYNAM, V223, P414, DOI 10.1002/dvdy.10067; Li CY, 2007, LEUKEMIA, V21, P2277, DOI 10.1038/sj.leu.2404901; Li CY, 2008, BBA-GENE REGUL MECH, V1779, P606, DOI 10.1016/j.bbagrm.2008.06.004; Li CY, 2004, CELL DEATH DIFFER, V11, P1299, DOI 10.1038/sj.cdd.4401490; Lu J, 2001, ACTA BIOCH BIOPH SIN, V33, P641; MERCHAV S, 1991, LEUKEMIA, V5, P340; PELHAM HRB, 1984, EMBO J, V3, P3095, DOI 10.1002/j.1460-2075.1984.tb02264.x; Peters MJ, 2018, BIOL OPEN, V7, DOI 10.1242/bio.035576; Raghavachari N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006484; Ribeil JA, 2007, NATURE, V445, P102, DOI 10.1038/nature05378; Shulga N, 1999, J BIOL CHEM, V274, P16501, DOI 10.1074/jbc.274.23.16501; Tehranchi R, 2005, BLOOD, V106, P247, DOI 10.1182/blood-2004-12-4649; Tsukahara F, 2004, J BIOL CHEM, V279, P8867, DOI 10.1074/jbc.M308848200; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; WELCH WJ, 1984, J BIOL CHEM, V259, P4501; Wurtz T, 2001, EXP CELL RES, V263, P236, DOI 10.1006/excr.2000.5114; Yang LV, 2006, LEUKEMIA, V20, P417, DOI 10.1038/sj.leu.2404105; Yang LV, 2001, MECH DEVELOP, V104, P105, DOI 10.1016/S0925-4773(01)00376-8; Zhang MJ, 2012, FEBS J, V279, P2848, DOI 10.1111/j.1742-4658.2012.08663.x; Zhao K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190794; Zheng WW, 2014, STEM CELLS, V32, P2278, DOI 10.1002/stem.1723	36	6	7	2	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8416	8427		10.1096/fj.201902946R	http://dx.doi.org/10.1096/fj.201902946R		APR 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32350948	Bronze			2022-12-28	WOS:000553674400001
J	Wang, HZ; Li, SX; Dai, QX; Gonzalez, A; Tran, ON; Sun, HY; DeFronzo, RA; Dean, DD; Yeh, CK; Chen, XD				Wang, Hanzhou; Li, Shengxian; Dai, Qiuxia; Gonzalez, Aaron; Tran, Olivia N.; Sun, Haiyan; DeFronzo, Ralph A.; Dean, David D.; Yeh, Chih-Ko; Chen, Xiao-Dong			Culture on a native bone marrow-derived extracellular matrix restores the pancreatic islet basement membrane, preserves islet function, and attenuates islet immunogenicity	FASEB JOURNAL			English	Article						extracellular matrix; immune tolerance; insulin secretion; pancreatic islets; vascular endothelial cells	COLLAGEN-VI; ANIMAL-MODELS; TRANSPLANTATION; CELLS; REGENERATION; EXPRESSION; IMPACT; NICHE	Islet transplantation in man is limited by multiple factors including islet availability, islet cell damage caused by collagenase during isolation, maintenance of islet function between isolation and transplantation, and allograft rejection. In this study, we describe a new approach for preparing islets that enhances islet function in vitro and reduces immunogenicity. The approach involves culture on native decellularized 3D bone marrow-derived extracellular matrix (3D-ECM), which contains many of the matrix components present in pancreas, prior to islet transplantation. Compared to islets cultured on tissue culture plastic (TCP), islets cultured on 3D-ECM exhibited greater attachment, higher survival rate, increased insulin content, and enhanced glucose-stimulated insulin secretion. In addition, culture of islets on 3D-ECM promoted recovery of vascular endothelial cells within the islets and restored basement membrane-related proteins (eg, fibronectin and collagen type VI). More interestingly, culture on 3D-ECM also selectively decontaminated islets of "passenger" cells (co-isolated with the islets) and restored basement membrane-associated type VI collagen, which were associated with an attenuation in islet immunogenicity. These results demonstrate that this novel approach has promise for overcoming two major issues in human islet transplantation: (a) poor yield of islets from donated pancreas tissue and (b) the need for life-long immunosuppression.	[Wang, Hanzhou; Li, Shengxian; Dai, Qiuxia; Gonzalez, Aaron; Tran, Olivia N.; Dean, David D.; Yeh, Chih-Ko; Chen, Xiao-Dong] Univ Texas Hlth Sci Ctr San Antonio, Dept Comprehens Dent, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA; [Li, Shengxian] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Endocrinol, Shanghai, Peoples R China; [Gonzalez, Aaron; Tran, Olivia N.; Dean, David D.; Chen, Xiao-Dong] Univ Texas San Antonio, Dept Biomed Engn, San Antonio, TX USA; [Sun, Haiyan] Acad Mil Med Sci, Affiliated Hosp, Dept Stomatol, Beijing, Peoples R China; [DeFronzo, Ralph A.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Diabet Div, San Antonio, TX 78229 USA; [Yeh, Chih-Ko; Chen, Xiao-Dong] South Texas Vet Hlth Care Syst, Dept Vet Affairs, San Antonio, TX USA	University of Texas System; University of Texas Health San Antonio; Shanghai Jiao Tong University; University of Texas System; University of Texas at San Antonio (UTSA); Academy of Military Medical Sciences - China; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Chen, XD (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Comprehens Dent, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	chenx4@uthscsa.edu	Li, Shengxian/AFT-2979-2022	Yeh, Chih-Ko/0000-0001-6611-9942; Chen, Xiao-Dong/0000-0003-1602-806X; Dean, David/0000-0002-4512-9065	San Antonio Medical Foundation; VA Merit Review	San Antonio Medical Foundation; VA Merit Review(US Department of Veterans Affairs)	San Antonio Medical Foundation; VA Merit Review	Atchison NA, 2010, LANGMUIR, V26, P14081, DOI 10.1021/la101264h; BALLINGER WF, 1972, SURGERY, V72, P175; BANK HL, 1988, IN VITRO CELL DEV B, V24, P266; Barton FB, 2012, DIABETES CARE, V35, P1436, DOI 10.2337/dc12-0063; Block TJ, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0688-x; Bogdani M, 2012, CURR DIABETES REP, V14, P552, DOI 10.1007/s11892-014-0552-7; Brehm MA, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007757; Carter JD, 2009, BIOL PROCED ONLINE, V11, P3, DOI 10.1007/s12575-009-9021-0; Chen HA, 2009, GENE DEV, V23, P975, DOI 10.1101/gad.1742509; Chen PW, 2015, ACTA NEUROPATHOL, V129, P97, DOI 10.1007/s00401-014-1369-9; Chen XD, 2007, J BONE MINER RES, V22, P1943, DOI 10.1359/JBMR.070725; Daoud J, 2010, BIOMATERIALS, V31, P1676, DOI 10.1016/j.biomaterials.2009.11.057; Graham ML, 2015, EUR J PHARMACOL, V759, P221, DOI 10.1016/j.ejphar.2015.02.054; Groulx JF, 2011, MATRIX BIOL, V30, P195, DOI 10.1016/j.matbio.2011.03.002; Hatlapatka K, 2009, AM J PHYSIOL-ENDOC M, V297, pE315, DOI 10.1152/ajpendo.90981.2008; Hughes SJ, 2006, TRANSPLANTATION, V81, P423, DOI 10.1097/01.tp.0000197482.91227.df; HUTTON JC, 1989, DIABETOLOGIA, V32, P271, DOI 10.1007/BF00265542; Irving-Rodgers HF, 2014, CELL TRANSPLANT, V23, P59, DOI 10.3727/096368912X659880; King A, 2016, BIOCHEM PHARMACOL, V99, P1, DOI 10.1016/j.bcp.2015.08.108; LACY P E, 1980, Diabetes, V29, P93; Lai YL, 2010, STEM CELLS DEV, V19, P1095, DOI 10.1089/scd.2009.0217; Marinkovic M, 2016, MATRIX BIOL, V52-54, P426, DOI 10.1016/j.matbio.2016.01.004; Nakashima Y, 2018, ISLETS, V10, DOI 10.1080/19382014.2018.1460294; Nikolova G, 2006, DEV CELL, V10, P397, DOI 10.1016/j.devcel.2006.01.015; Noguchi H, 2015, CELL MED, V8, P25, DOI 10.3727/215517915X689047; RABINOVITCH A, 1982, DIABETES, V31, P48, DOI 10.2337/diab.31.4.S48; Riopel M, 2014, FRONT BIOSCI-LANDMRK, V19, P77, DOI 10.2741/4196; Ryan EA, 2005, DIABETES, V54, P2060, DOI 10.2337/diabetes.54.7.2060; SELAWRY H, 1978, DIABETES, V27, P625, DOI 10.2337/diab.27.6.625; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Sorokin L, 2010, NAT REV IMMUNOL, V10, P712, DOI 10.1038/nri2852; Stendahl JC, 2009, CELL TRANSPLANT, V18, P1, DOI 10.3727/096368909788237195; Sun Y, 2011, FASEB J, V25, P1474, DOI 10.1096/fj.10-161497; Swift S M, 1996, Transpl Immunol, V4, P169, DOI 10.1016/S0966-3274(96)80012-8; Urciuolo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2964; Willenborg M, 2012, AM J PHYSIOL-ENDOC M, V303, pE223, DOI 10.1152/ajpendo.00010.2012	36	4	4	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8044	8056		10.1096/fj.201902893R	http://dx.doi.org/10.1096/fj.201902893R		APR 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32307751	hybrid, Green Accepted			2022-12-28	WOS:000527383500001
J	Zhang, JX; Ding, Y; Jiang, DX; Xie, JG; Liu, YM; Ma, JC; Mu, Y; Zhang, XX; Yu, CP; Zhang, Y; Yi, X; Zhou, ZQ; Fang, L; Shen, S; Yang, YX; Cheng, K; Zhuang, R; Zhang, Y				Zhang, Jinxue; Ding, Yong; Jiang, Dongxu; Xie, Jiangang; Liu, Yongming; Ma, Jingchang; Mu, Yang; Zhang, Xuexin; Yu, Chaoping; Zhang, Yun; Yi, Xin; Zhou, Ziqing; Fang, Liang; Shen, Shen; Yang, Yixin; Cheng, Kun; Zhuang, Ran; Zhang, Yuan			Deficiency of platelet adhesion molecule CD226 causes megakaryocyte development and platelet hyperactivity	FASEB JOURNAL			English	Article						activation; CD226; megakaryocyte; nitric oxide; platelet	LIFE-SPAN; ACTIVATION; CELLS; BINDING; PROTEIN; SYSTEM; INJURY; FORMS; MODEL; MICE	This study used constitutive CD226 gene knockout (KO) mice as a model to investigate the functions and mechanisms of CD226 in megakaryocyte (MK) maturation and platelet activation. Although CD226 deficiency did not cause MK polyploidization or platelet granule abnormalities, increased MK counts were detected in the femora bone marrow (BM) and spleen of CD226 KO mice. Particularly, CD226 KO mice have a more extensive membrane system in MKs and platelets than wild-type (WT) mice. We also demonstrated that CD226 KO mice displayed increased platelet counts, shortened bleeding time, and enhanced platelet aggregation. CD226 KO platelets had an increased mature platelet ratio compared to the control platelets. In addition, the observed reduction in bleeding time may be due to decreased nitric oxide (NO) production in the platelets. Platelet-specific CD226-deficient mice showed similar increased MK counts, shortened bleeding time, enhanced platelet aggregation, and decreased NO production in platelets. Furthermore, we performed middle cerebral artery occlusion-reperfusion surgery on WT and CD226 KO mice to explore the potential effect of CD226 on acute ischemia-reperfusion injury; the results revealed that CD226 deficiency led to significantly increased infarct area. Thus, CD226 is a promising candidate for the treatment of thrombotic disorders.	[Zhang, Jinxue; Ding, Yong; Liu, Yongming; Yi, Xin] Fourth Mil Med Univ, Orthoped Dept Tangdu Hosp, Xian, Peoples R China; [Jiang, Dongxu; Ma, Jingchang; Mu, Yang; Zhang, Xuexin; Zhang, Yun; Zhou, Ziqing; Fang, Liang; Shen, Shen; Yang, Yixin; Zhuang, Ran] Fourth Mil Med Univ, Dept Immunol, 169 West Changle Rd, Xian 710032, Shaanxi, Peoples R China; [Xie, Jiangang; Yu, Chaoping] Fourth Mil Med Univ, Dept Emergency, Xian, Peoples R China; [Cheng, Kun; Zhuang, Ran] Fourth Mil Med Univ, Transplant Immunol Lab, Xian, Peoples R China; [Zhang, Yuan] Northwestern Polytech Univ, Inst Med Res, 127 West Youyi Rd, Xian 710072, Shaanxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Northwestern Polytechnical University	Zhuang, R (corresponding author), Fourth Mil Med Univ, Dept Immunol, 169 West Changle Rd, Xian 710032, Shaanxi, Peoples R China.; Zhang, Y (corresponding author), Northwestern Polytech Univ, Inst Med Res, 127 West Youyi Rd, Xian 710072, Shaanxi, Peoples R China.	fmmuzhr@fmmu.edu.cn; zhangyuan_nwpu@nwpu.edu.cn	Zhuang, Ran/I-7336-2019	Zhuang, Ran/0000-0002-3614-0422	Natural Science Foundation of China [81671575, 81871258, 81771705]; Natural Science Basic Research Plan in Shaanxi Province of China [2017JM8066]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Basic Research Plan in Shaanxi Province of China	This investigation was supported by the Natural Science Foundation of China (No. 81671575, No. 81871258 and No. 81771705) and Natural Science Basic Research Plan in Shaanxi Province of China (Program No. 2017JM8066)	Arumugam TV, 2004, AM J PHYSIOL-HEART C, V287, pH2555, DOI 10.1152/ajpheart.00588.2004; Behrens K, 2018, GROWTH FACTORS, V36, P89, DOI 10.1080/08977194.2018.1498487; Brunini TMC, 2003, PFLUG ARCH EUR J PHY, V445, P547, DOI 10.1007/s00424-002-0978-7; Cataltepe O, 2012, NEUROPATH APPL NEURO, V38, P400, DOI 10.1111/j.1365-2990.2011.01237.x; Chan CJ, 2010, J IMMUNOL, V184, P902, DOI 10.4049/jimmunol.0903225; Chen CY, 2018, BRAIN BEHAV IMMUN, V69, P255, DOI 10.1016/j.bbi.2017.11.019; Csongradi E, 2011, THROMB HAEMOSTASIS, V106, P683, DOI 10.1160/TH11-01-0030; Decouture B, 2015, BLOOD, V126, P1823, DOI 10.1182/blood-2015-02-631044; Dhall S, 2016, ADV WOUND CARE, V5, P421, DOI 10.1089/wound.2016.0687; Du X, 2018, P NATL ACAD SCI USA, V115, pE11731; Freedman JE, 1997, J CLIN INVEST, V100, P350, DOI 10.1172/JCI119540; Garraud O, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00070; Gavins FNE, 2011, BLOOD, V117, P4125, DOI 10.1182/blood-2010-08-301366; Gieger C, 2011, NATURE, V480, P201, DOI 10.1038/nature10659; Gkaliagkousi E, 2007, CIRC RES, V101, P654, DOI 10.1161/CIRCRESAHA.107.158410; Gkaliagkousi E, 2011, FRONT BIOSCI-LANDMRK, V16, P1873, DOI 10.2741/3828; Gokhin DS, 2010, J CELL BIOL, V189, P95, DOI 10.1083/jcb.201001125; Hata R, 1998, J CEREBR BLOOD F MET, V18, P367, DOI 10.1097/00004647-199804000-00004; Ho-Tin-Noe B, 2018, BLOOD, V131, P277, DOI 10.1182/blood-2017-06-742676; Italiano JE, 2003, J THROMB HAEMOST, V1, P1174, DOI 10.1046/j.1538-7836.2003.00290.x; Jarvis GE, 2012, J THROMB HAEMOST, V10, P268, DOI 10.1111/j.1538-7836.2011.04567.x; Kojima H, 2003, J BIOL CHEM, V278, P36748, DOI 10.1074/jbc.M300702200; Kostyak JC, 2012, BLOOD, V119, P838, DOI 10.1182/blood-2011-04-346098; Lakshmikanth T, 2009, J CLIN INVEST, V119, P1251, DOI 10.1172/JCI36022; Lebois M, 2016, PLATELETS, V27, P497, DOI 10.3109/09537104.2016.1161739; Li TT, 2015, BRIT J PHARMACOL, V172, P3904, DOI 10.1111/bph.13178; Li Y., 2012, ADV HEMATOL, V2012; Ma DC, 2005, EUR J HAEMATOL, V74, P228, DOI 10.1111/j.1600-0609.2004.00345.x; MEHTA JL, 1995, J LAB CLIN MED, V125, P370; Piguet PF, 2001, EUR J CELL BIOL, V80, P171, DOI 10.1078/0171-9335-00147; Queen LR, 2003, DIABETOLOGIA, V46, P1474, DOI 10.1007/s00125-003-1219-0; Raghavachari N, 2007, CIRCULATION, V115, P1551, DOI 10.1161/CIRCULATIONAHA.106.658641; Rajendran S, 2008, CARDIOVASC DRUG THER, V22, P193, DOI 10.1007/s10557-008-6098-7; Ralston KJ, 2004, J BIOL CHEM, V279, P33816, DOI 10.1074/jbc.M401040200; Romaniuk MA, 2012, FASEB J, V26, P2788, DOI 10.1096/fj.11-197541; Rossaint J, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02712; Sahu I, 2017, FASEB J, V31, P3439, DOI 10.1096/fj.201601211R; Schulze H, 2006, BLOOD, V107, P3868, DOI 10.1182/blood-2005-07-2755; SCOTT JL, 1989, J BIOL CHEM, V264, P13475; Senchenkova EY, 2013, AM J PATHOL, V183, P173, DOI 10.1016/j.ajpath.2013.03.014; Tahara-Hanaoka S, 2004, INT IMMUNOL, V16, P533, DOI 10.1093/intimm/dxh059; Xiong P, 2015, IMMUNOLOGY, V146, P369, DOI 10.1111/imm.12516; Xu XHR, 2016, THROMB J, V14, DOI 10.1186/s12959-016-0100-6; Zeng DF, 2018, J THROMB HAEMOST, V16, P1843, DOI 10.1111/jth.14214; Zhang JX, 2019, MOL IMMUNOL, V107, P123, DOI 10.1016/j.molimm.2019.01.013; Zhou Bo, 2018, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V34, P309	46	3	4	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6871	6887		10.1096/fj.201902142R	http://dx.doi.org/10.1096/fj.201902142R		APR 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32248623				2022-12-28	WOS:000523600800001
J	Chen, JL; Liang, LN; Li, Y; Zhang, YX; Zhang, MD; Yang, TT; Meng, F; Lai, XW; Li, CP; He, JC; He, MA; Xu, QR; Li, Q; Law, PY; Loh, HH; Pei, DQ; Sun, H; Zheng, H				Chen, Jinlong; Liang, Lining; Li, Yuan; Zhang, Yixin; Zhang, Mengdan; Yang, Tingting; Meng, Fei; Lai, Xiaowei; Li, Changpeng; He, Jingcai; He, Meiai; Xu, Qiaoran; Li, Qian; Law, Ping-Yee; Loh, Horace H.; Pei, Duanqing; Sun, Hao; Zheng, Hui			Naloxone regulates the differentiation of neural stem cells via a receptor-independent pathway	FASEB JOURNAL			English	Article						morphine; naloxone; neural stem cells; neurogenesis; receptor-independent; Tet1	ADULT HIPPOCAMPAL NEUROGENESIS; PROLIFERATION; MORPHINE; MODULATION; CULTURES; OPIATES; MODELS	The abilities of opioids to activate downstream signaling pathways normally depend on the binding between opioids and their receptors. However, opioids may also function in a receptor-independent manner, especially in neural stem cells (NSCs) in which the expression of opioid receptors and endogenous opioid agonists is low. When two opioids, morphine and naloxone, were used during the early stage of NSC differentiation, increased neurogenesis was observed. However, naloxone methiodide, a membrane impenetrable analog of naloxone, did not affect the NSC differentiation. The abilities of morphine and naloxone to facilitate neurogenesis were also observed in opioid receptor-knockout NSCs. Therefore, morphine and naloxone promote neurogenesis in a receptor-independent manner at least during the early stage. In addition, the receptor-independent functions of opioids were not observed in methylcytosine dioxygenase ten-eleven translocation 1 (Tet1) knockout NSCs. When the expression of opioid receptors increased and the expression of Tet1 decreased during the late stage of NSC differentiation, morphine, but not naloxone, inhibited neurogenesis via traditional receptor-dependent and miR181a-Prox1-Notch-related pathway. In summary, the current results demonstrated the time-dependent effects of opioids during the differentiation of NSCs and provided additional insight on the complex functions of opioids.	[Chen, Jinlong; Liang, Lining; Li, Yuan; Zhang, Yixin; Zhang, Mengdan; Yang, Tingting; Meng, Fei; Lai, Xiaowei; Li, Changpeng; He, Jingcai; He, Meiai; Xu, Qiaoran; Li, Qian; Pei, Duanqing; Sun, Hao; Zheng, Hui] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangzhou Med Univ, CAS Key Lab Regenerat Biol,Joint Sch Life Sci, 190 Kaiyuan Ave, Guangzhou 510530, Peoples R China; [Chen, Jinlong; Liang, Lining; Li, Yuan; Zhang, Yixin; Zhang, Mengdan; Yang, Tingting; Meng, Fei; Lai, Xiaowei; Li, Changpeng; He, Jingcai; He, Meiai; Xu, Qiaoran; Loh, Horace H.; Pei, Duanqing; Sun, Hao; Zheng, Hui] Guangzhou Regenerat Med & Hlth Guangdong Lab, Guangzhou, Peoples R China; [Chen, Jinlong; Liang, Lining; Li, Yuan; Zhang, Yixin; Zhang, Mengdan; Yang, Tingting; Meng, Fei; Lai, Xiaowei; Li, Changpeng; He, Jingcai; He, Meiai; Xu, Qiaoran; Pei, Duanqing; Sun, Hao; Zheng, Hui] Guangdong Prov Key Lab Stem Cell & Regenerat Med, Guangzhou, Peoples R China; [Chen, Jinlong; Zhang, Yixin; Zhang, Mengdan; Yang, Tingting; Meng, Fei; Lai, Xiaowei; He, Meiai; Xu, Qiaoran; Pei, Duanqing; Sun, Hao; Zheng, Hui] Univ Chinese Acad Sci, Beijing, Peoples R China; [Law, Ping-Yee; Loh, Horace H.] Univ Minnesota, Dept Pharmacol, 3-249 Millard Hall, Minneapolis, MN 55455 USA; [Pei, Duanqing; Zheng, Hui] Chinese Acad Sci, Inst Stem Cell & Regenerat, Beijing, Peoples R China	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Guangzhou Medical University; Guangzhou Regenerative Medicine & Health Guangdong Laboratory (Bioisland Laboratory); Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Minnesota System; University of Minnesota Twin Cities; Chinese Academy of Sciences	Sun, H; Zheng, H (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangzhou Med Univ, CAS Key Lab Regenerat Biol,Joint Sch Life Sci, 190 Kaiyuan Ave, Guangzhou 510530, Peoples R China.	sun_hao@gibh.ac.cn; zheng_hui@gibh.ac.cn	Chen, Jinlong/GLT-0135-2022	Li, Qian/0000-0003-4347-7311				Chen JN, 2013, KNOWL-BASED SYST, V45, P1, DOI 10.1016/j.knosys.2013.01.031; Chien GL, 1999, BASIC RES CARDIOL, V94, P136, DOI 10.1007/s003950050136; Chu J, 2008, CELL SIGNAL, V20, P1616, DOI 10.1016/j.cellsig.2008.05.004; DUTTAROY A, 1995, ANESTHESIOLOGY, V82, P1226, DOI 10.1097/00000542-199505000-00018; Eisch AJ, 2006, HIPPOCAMPUS, V16, P271, DOI 10.1002/hipo.20161; Eisch AJ, 2000, P NATL ACAD SCI USA, V97, P7579, DOI 10.1073/pnas.120552597; He SW, 2019, CELL DISCOV, V5, DOI 10.1038/s41421-018-0074-6; Holmes MM, 2002, BEHAV NEUROSCI, V116, P160, DOI 10.1037//0735-7044.116.1.160; Hutchins AP, 2017, NUCLEIC ACIDS RES, V45, P2354, DOI 10.1093/nar/gkx054; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Khurshid N, 2010, FASEB J, V24, P3681, DOI 10.1096/fj.09-146746; Koch T, 2005, MOL PHARMACOL, V67, P280, DOI 10.1124/mol.104.004994; Law PY, 1999, J PHARMACOL EXP THER, V289, P607; Leuner B, 2006, HIPPOCAMPUS, V16, P216, DOI 10.1002/hipo.20153; Lewis SS, 2012, J PAIN, V13, P498, DOI 10.1016/j.jpain.2012.02.005; Li W, 2014, BIOL PSYCHIAT, V76, P775, DOI 10.1016/j.biopsych.2014.05.013; Liang L., CELL REPORTS; Liu XP, 2013, NAT CELL BIOL, V15, P829, DOI 10.1038/ncb2765; Persson AI, 2003, EUR J NEUROSCI, V17, P1159, DOI 10.1046/j.1460-9568.2003.02538.x; Persson AI, 2003, MOL CELL NEUROSCI, V23, P360, DOI 10.1016/S1044-7431(03)00061-7; Risso D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-480; Schuller AGP, 1999, NAT NEUROSCI, V2, P151, DOI 10.1038/5706; Willner D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103043; Winocur G, 2006, HIPPOCAMPUS, V16, P296, DOI 10.1002/hipo.20163; Xu C, 2015, STEM CELLS, V33, P2762, DOI 10.1002/stem.2055; Xu C, 2014, STEM CELLS, V32, P2961, DOI 10.1002/stem.1774; Zhang RR, 2013, CELL STEM CELL, V13, P237, DOI 10.1016/j.stem.2013.05.006; Zhang Yue, 2016, ScientificWorldJournal, V2016, P2601264, DOI 10.1155/2016/2601264; Zheng H, 2008, P NATL ACAD SCI USA, V105, P9421, DOI 10.1073/pnas.0802253105; Zheng H, 2008, MOL PHARMACOL, V73, P178, DOI 10.1124/mol.107.039842; Zheng H, 2013, NEUROPSYCHOPHARMACOL, V38, P770, DOI 10.1038/npp.2012.242; Zheng H, 2010, J NEUROSCI, V30, P8102, DOI 10.1523/JNEUROSCI.6069-09.2010	32	5	6	2	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5917	5930		10.1096/fj.201902873R	http://dx.doi.org/10.1096/fj.201902873R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32154623	Bronze			2022-12-28	WOS:000530242100074
J	Tang, BY; Li, X; Maretzky, T; Perez-Aguilar, JM; McIlwain, D; Xie, YF; Zheng, YF; Mak, TW; Weinstein, H; Blobel, CP				Tang, Beiyu; Li, Xue; Maretzky, Thorsten; Perez-Aguilar, Jose Manuel; McIlwain, David; Xie, Yifang; Zheng, Yufang; Mak, Tak W.; Weinstein, Harel; Blobel, Carl P.			Substrate-selective protein ectodomain shedding by ADAM17 and iRhom2 depends on their juxtamembrane and transmembrane domains	FASEB JOURNAL			English	Article						ADAM17 (a disintegrin and metalloprotease 17); EGFR (epidermal growth factor receptor); iRhom1/2 (inactive Rhomboid like protein 1/2); Rhbdf1/2 (rhomboid family member 1/2); TGF alpha (transforming growth factor alpha); TNF alpha (tumor necrosis factor alpha)	NECROSIS-FACTOR-ALPHA; EGF-RECEPTOR; MOLECULAR SWITCH; DISINTEGRIN; PHOSPHORYLATION; ACTIVATION; ENZYME; METALLOPROTEINASE; INTERLEUKIN-6; INFLAMMATION	The metalloprotease ADAM17 (a disintegrin and metalloprotease 17) regulates EGF-receptor and TNF alpha signaling, thereby not only protecting the skin and intestinal barrier, but also contributing to autoimmunity. ADAM17 can be rapidly activated by many stimuli through its transmembrane domain (TMD), with the seven membrane-spanning inactive Rhomboids (iRhom) 1 and 2 implicated as candidate regulatory partners. However, several alternative models of ADAM17 regulation exist that do not involve the iRhoms, such as regulation through disulfide bond exchange or through interaction with charged phospholipids. Here, we report that a non-activatable mutant of ADAM17 with the TMD of betacellulin (BTC) can be rescued by restoring residues from the ADAM17 TMD, but only in Adam17(-/-) cells, which contain iRhoms, not in iRhom1/2(-/-) cells. We also provide the first evidence that the extracellular juxtamembrane domains (JMDs) of ADAM17 and iRhom2 regulate the stimulation and substrate selectivity of ADAM17. Interestingly, a point mutation in the ADAM17 JMD identified in a patient with Tetralogy of Fallot, a serious heart valve defect, affects the substrate selectivity of ADAM17 toward Heparin-binding epidermal growth factor like growth factor (HB-EGF), a crucial regulator of heart valve development in mice. These findings provide new insights into the regulation of ADAM17 through an essential interaction with the TMD1 and JMD1 of iRhom2.	[Tang, Beiyu; Li, Xue; Blobel, Carl P.] Hosp Special Surg, Arthrit & Tissue Degenerat Program, 535 E 70th St, New York, NY 10021 USA; [Tang, Beiyu] Weill Cornell Med, Dept Pharmacol, New York, NY USA; [Li, Xue] Weill Cornell Med, Dept Biochem Cellular & Mol Biol, New York, NY USA; [Maretzky, Thorsten] Univ Iowa, Inflammat Program, Iowa City, IA USA; [Maretzky, Thorsten] Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Perez-Aguilar, Jose Manuel; Weinstein, Harel; Blobel, Carl P.] Weill Cornell Med, Dept Physiol Biophys & Syst Biol, New York, NY USA; [Perez-Aguilar, Jose Manuel] Meritorious Autonomous Univ Puebla BUAP, Sch Chem Sci, Puebla, Mexico; [McIlwain, David] Stanford Univ, Dept Microbiol & Immunol, Baxter Lab Stem Cell Biol, Stanford, CA 94305 USA; [McIlwain, David; Mak, Tak W.] Univ Hlth Network, Campbell Family Inst Breast Canc Res, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Xie, Yifang; Zheng, Yufang] Fudan Univ, Inst Reprod & Dev, State Key Lab Genet Engn, Obstet & Gynecol Hosp,Sch Life Sci, Shanghai, Peoples R China; [Xie, Yifang; Zheng, Yufang] Fudan Univ, Collaborat Innovat Ctr Genet & Dev, Key Lab Reprod Regulat NPFPC, Shanghai, Peoples R China; [Xie, Yifang; Zheng, Yufang] Fudan Univ, Inst Biomed Sci, Shanghai, Peoples R China; [Blobel, Carl P.] Tech Univ Munich, Inst Adv Study, Garching, Germany	Cornell University; Cornell University; University of Iowa; University of Iowa; Cornell University; Stanford University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Fudan University; Fudan University; Fudan University; Technical University of Munich	Blobel, CP (corresponding author), Weill Cornell Med, Hosp Special Surg, 535 East 70th, New York, NY 10021 USA.	blobelc@hss.edu	WEINSTEIN, HAREL/O-8245-2019; Maretzky, Thorsten/AEN-1915-2022; Zheng, Yufang/F-1091-2011; Maretzky, Thorsten/GSN-2981-2022	WEINSTEIN, HAREL/0000-0003-3473-9818; Maretzky, Thorsten/0000-0003-1282-6080; Zheng, Yufang/0000-0002-0488-2624; Xie, Yifang/0000-0002-5501-4018	HHS | National Institutes of Health (NIH) [R01 GM64750, R35 GM134907]	HHS | National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	HHS | National Institutes of Health (NIH), Grant/Award Number: R01 GM64750 and R35 GM134907	Adrain C, 2012, SCIENCE, V335, P225, DOI 10.1126/science.1214400; Ardito CM, 2012, CANCER CELL, V22, P304, DOI 10.1016/j.ccr.2012.07.024; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Blaydon DC, 2011, NEW ENGL J MED, V365, P1502, DOI 10.1056/NEJMoa1100721; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Cavadas M, 2017, CELL REP, V21, P745, DOI 10.1016/j.celrep.2017.09.074; Chalaris A, 2010, J EXP MED, V207, P1617, DOI 10.1084/jem.20092366; Doedens JR, 2003, BIOCHEM BIOPH RES CO, V308, P331, DOI 10.1016/S0006-291X(03)01381-0; Dusterhoft S, 2015, BIOCHEMISTRY-US, V54, P5791, DOI 10.1021/acs.biochem.5b00497; Dusterhoft S, 2014, J BIOL CHEM, V289, P16336, DOI 10.1074/jbc.M114.557322; Dusterhoft S, 2013, J AM CHEM SOC, V135, P5776, DOI 10.1021/ja400340u; Franzke CW, 2012, J EXP MED, V209, P1105, DOI 10.1084/jem.20112258; Garbers C, 2018, NAT REV DRUG DISCOV, V17, P395, DOI 10.1038/nrd.2018.45; Gooz P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033350; Grieve AG, 2017, ELIFE, V6, DOI 10.7554/eLife.23968; Grotzinger J, 2017, BBA-MOL CELL RES, V1864, P2088, DOI 10.1016/j.bbamcr.2017.05.024; Gschwind A, 2003, EMBO J, V22, P2411, DOI 10.1093/emboj/cdg231; Horiuchi K, 2007, J IMMUNOL, V179, P2686, DOI 10.4049/jimmunol.179.5.2686; Horiuchi K, 2007, MOL BIOL CELL, V18, P176, DOI 10.1091/mbc.E06-01-0014; Inoue A, 2012, NAT METHODS, V9, P1021, DOI [10.1038/nmeth.2172, 10.1038/NMETH.2172]; Inoue A, 2011, EMBO J, V30, P4248, DOI 10.1038/emboj.2011.296; Issuree PDA, 2013, J CLIN INVEST, V123, P928, DOI 10.1172/JCI66168; Jackson LF, 2003, EMBO J, V22, P2704, DOI 10.1093/emboj/cdg264; Kawaguchi N, 2007, J CELL SCI, V120, P943, DOI 10.1242/jcs.03403; Krossa S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19429-4; Kunzel U, 2018, ELIFE, V7, DOI 10.7554/eLife.35012; Lambrecht BN, 2018, NAT REV IMMUNOL, V18, P745, DOI 10.1038/s41577-018-0068-5; Le Gall SM, 2010, J CELL SCI, V123, P3913, DOI 10.1242/jcs.069997; Le Gall SM, 2009, MOL BIOL CELL, V20, P1785, DOI 10.1091/mbc.E08-11-1135; Li X, 2017, J CELL SCI, V130, P868, DOI 10.1242/jcs.196436; Li X, 2015, P NATL ACAD SCI USA, V112, P6080, DOI 10.1073/pnas.1505649112; Maretzky T, 2013, P NATL ACAD SCI USA, V110, P11433, DOI 10.1073/pnas.1302553110; Maretzky T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1232; McIlwain DR, 2012, SCIENCE, V335, P229, DOI 10.1126/science.1214448; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Murphy G, 2008, NAT REV CANCER, V8, P929, DOI 10.1038/nrc2459; Oikonomidi I, 2018, ELIFE, V7, DOI 10.7554/eLife.35032; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Reiss K, 2017, BBA-MOL CELL RES, V1864, P2082, DOI 10.1016/j.bbamcr.2017.06.006; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Sahin U, 2007, FEBS LETT, V581, P41, DOI 10.1016/j.febslet.2006.11.074; Scheller J, 2014, SEMIN IMMUNOL, V26, P2, DOI 10.1016/j.smim.2013.11.002; Scheller J, 2011, TRENDS IMMUNOL, V32, P380, DOI 10.1016/j.it.2011.05.005; Schlondorff J, 2000, BIOCHEM J, V347, P131, DOI 10.1042/0264-6021:3470131; Schwarz J, 2013, BBA-MOL CELL RES, V1833, P3355, DOI 10.1016/j.bbamcr.2013.10.005; Seegar TCM, 2017, CELL, V171, P1638, DOI 10.1016/j.cell.2017.11.014; Siggs OM, 2012, BLOOD, V119, P5769, DOI 10.1182/blood-2012-03-417949; Sommer A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11523; Soond SM, 2005, J CELL SCI, V118, P2371, DOI 10.1242/jcs.02357; Urban S, 2001, CELL, V107, P173, DOI 10.1016/S0092-8674(01)00525-6; Weber S, 2012, DEVELOPMENT, V139, P3693, DOI 10.1242/dev.076398; Willems SH, 2010, BIOCHEM J, V428, P439, DOI 10.1042/BJ20100179; Xie YF, 2019, CLIN SCI, V133, P225, DOI 10.1042/CS20180842; Xu PL, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002689; Xu PL, 2010, MOL CELL, V37, P551, DOI 10.1016/j.molcel.2010.01.034; Zunke F, 2017, BBA-MOL CELL RES, V1864, P2059, DOI 10.1016/j.bbamcr.2017.07.001	56	14	14	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					4956	4969		10.1096/fj.201902649R	http://dx.doi.org/10.1096/fj.201902649R		FEB 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32103528	Green Accepted, Bronze			2022-12-28	WOS:000517907200001
J	Strong, MD; Hart, MD; Tang, TZ; Ojo, BA; Wu, L; Nacke, MR; Agidew, WT; Hwang, HJ; Hoyt, PR; Bettaieb, A; Clarke, SL; Smith, BJ; Stoecker, BJ; Lucas, EA; Lin, DB; Chowanadisai, W				Strong, Morgan D.; Hart, Matthew D.; Tang, Tony Z.; Ojo, Babajide A.; Wu, Lei; Nacke, Mariah R.; Agidew, Workneh T.; Hwang, Hong J.; Hoyt, Peter R.; Bettaieb, Ahmed; Clarke, Stephen L.; Smith, Brenda J.; Stoecker, Barbara J.; Lucas, Edralin A.; Lin, Dingbo; Chowanadisai, Winyoo			Role of zinc transporter ZIP12 in susceptibility-weighted brain magnetic resonance imaging (MRI) phenotypes and mitochondrial function	FASEB JOURNAL			English	Article						metal homeostasis; mitochondria; neurite outgrowth; neurodegeneration; nutrigenomics	ALPHA-SYNUCLEIN OVEREXPRESSION; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; IRON ACCUMULATION; MISSENSE VARIANT; TRANSGENIC MICE; GENE VARIANTS; COMPLEX-I; NEURODEGENERATION; DYSFUNCTION	Brain zinc dysregulation is linked to many neurological disorders. However, the mechanisms regulating brain zinc homeostasis are poorly understood. We performed secondary analyses of brain MRI GWAS and exome sequencing data from adults in the UK Biobank. Coding ZIP12 polymorphisms in zinc transporter ZIP12 (SLC39A12)were associated with altered brain susceptibility weighted MRI (swMRI). Conditional and joint association analyses revealed independent GWAS signals in linkage disequilibrium with 2 missense ZIP12 polymorphisms, rs10764176 and rs72778328, with reduced zinc transport activity. ZIP12 rare coding variants predicted to be deleterious were associated with similar impacts on brain swMRI. In Neuro-2a cells, ZIP12 deficiency by short hairpin RNA (shRNA) depletion or CRISPR/Cas9 genome editing resulted in impaired mitochondrial function, increased superoxide presence, and detectable protein carbonylation. Inhibition of Complexes I and IV of the electron transport chain reduced neurite outgrowth in ZIP12 deficient cells. Transcriptional coactivator PGC-1 alpha, mitochondrial superoxide dismutase (SOD2), and chemical antioxidants alpha-tocopherol, MitoTEMPO, and MitoQ restored neurite extension impaired by ZIP12 deficiency. Mutant forms of alpha-synuclein and tau linked to familial Parkinson's disease and frontotemporal dementia, respectively, reduced neurite outgrowth in cells deficient in ZIP12. Zinc and ZIP12 may confer resilience against neurological diseases or premature aging of the brain.	[Strong, Morgan D.; Hart, Matthew D.; Tang, Tony Z.; Ojo, Babajide A.; Wu, Lei; Nacke, Mariah R.; Agidew, Workneh T.; Clarke, Stephen L.; Smith, Brenda J.; Stoecker, Barbara J.; Lucas, Edralin A.; Lin, Dingbo; Chowanadisai, Winyoo] Oklahoma State Univ, Dept Nutr Sci, 301 Human Sci, Stillwater, OK 74078 USA; [Hwang, Hong J.; Hoyt, Peter R.] Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA; [Bettaieb, Ahmed] Univ Tennessee, Dept Nutr, Knoxville, TN 37996 USA	Oklahoma State University System; Oklahoma State University - Stillwater; Oklahoma State University System; Oklahoma State University - Stillwater; University of Tennessee System; University of Tennessee Knoxville	Chowanadisai, W (corresponding author), Oklahoma State Univ, Dept Nutr Sci, 301 Human Sci, Stillwater, OK 74078 USA.	winyoo.chowanadisai@okstate.edu	Wu, Lei/GLV-1137-2022	Wu, Lei/0000-0002-6070-1998; Smith, Brenda/0000-0002-7296-8534; Lin, Dingbo/0000-0002-7441-8210; , Stephen/0000-0001-8313-9638; Hoyt, Peter/0000-0002-2767-0923	Oklahoma Center for the Advancement of Science and Technology (OCAST) [HR16-060]; Office of the Vice President of Research at Oklahoma State University; Oklahoma Agricultural Experiment Station (OAES) [OKL03053]; National Science Foundation (NSF) [DBI 1626257, OCI 1531128, OCI 1039829]; Niblack Foundation; Oak Ridge National Laboratory	Oklahoma Center for the Advancement of Science and Technology (OCAST); Office of the Vice President of Research at Oklahoma State University; Oklahoma Agricultural Experiment Station (OAES); National Science Foundation (NSF)(National Science Foundation (NSF)); Niblack Foundation; Oak Ridge National Laboratory(United States Department of Energy (DOE))	Oklahoma Center for the Advancement of Science and Technology (OCAST), Grant/Award Number: HR16-060; Office of the Vice President of Research at Oklahoma State University; Oklahoma Agricultural Experiment Station (OAES), Grant/Award Number: OKL03053; National Science Foundation (NSF), Grant/Award Number: DBI 1626257, OCI 1531128 and OCI 1039829; Niblack Foundation; Oak Ridge National Laboratory	Adlard PA, 2008, NEURON, V59, P43, DOI 10.1016/j.neuron.2008.06.018; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; ALI SF, 1994, SYNAPSE, V18, P27, DOI 10.1002/syn.890180105; Alizadeh BZ, 2009, NEUROBIOL AGING, V30, P330, DOI 10.1016/j.neurobiolaging.2007.05.026; Anazi S, 2017, MOL PSYCHIATR, V22, P615, DOI 10.1038/mp.2016.113; Aoun M, 2015, INT J BIOCHEM CELL B, V63, P25, DOI 10.1016/j.biocel.2015.01.018; Atkinson A, 2010, J BIOL CHEM, V285, P19450, DOI 10.1074/jbc.M110.109793; Baldauf L, 2019, NEUROSCI LETT, V713, DOI 10.1016/j.neulet.2019.134521; Barco A, 2002, CELL, V108, P689, DOI 10.1016/S0092-8674(02)00657-8; BarKalifa R, 2009, EUR J PHARMACOL, V618, P15, DOI 10.1016/j.ejphar.2009.07.019; BARTZOKIS G, 1994, BIOL PSYCHIAT, V35, P480, DOI 10.1016/0006-3223(94)90047-7; Bartzokis G, 1999, MAGN RESON IMAGING, V17, P213, DOI 10.1016/S0730-725X(98)00155-6; Bartzokis G, 2010, J ALZHEIMERS DIS, V20, P333, DOI 10.3233/JAD-2010-1368; Belaidi AA, 2016, J NEUROCHEM, V139, P179, DOI 10.1111/jnc.13425; Benyamin B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5926; Besecker B, 2008, AM J PHYSIOL-LUNG C, V294, pL1127, DOI 10.1152/ajplung.00057.2008; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Blankenhaus B, 2019, MOL METAB, V24, P64, DOI 10.1016/j.molmet.2019.03.008; Bly M, 2006, SCHIZOPHR RES, V81, P321, DOI 10.1016/j.schres.2005.07.039; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bonanni L, 2006, J NEUROSCI, V26, P6851, DOI 10.1523/JNEUROSCI.5444-05.2006; Boycott KM, 2015, AM J HUM GENET, V97, P886, DOI 10.1016/j.ajhg.2015.11.002; Brand MD, 2010, EXP GERONTOL, V45, P466, DOI 10.1016/j.exger.2010.01.003; Burdette SC, 2001, J AM CHEM SOC, V123, P7831, DOI 10.1021/ja010059l; Carrera N, 2012, BIOL PSYCHIAT, V71, P169, DOI 10.1016/j.biopsych.2011.09.032; Chen LA, 2015, J NEUROSCI, V35, P890, DOI 10.1523/JNEUROSCI.0089-14.2015; Chen P, 2015, J NEUROCHEM, V134, P601, DOI 10.1111/jnc.13170; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Choi EK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21464-0; Chowanadisai W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111535; Chowanadisai W, 2013, P NATL ACAD SCI USA, V110, P9903, DOI 10.1073/pnas.1222142110; Chowanadisai W, 2010, J BIOL CHEM, V285, P142, DOI 10.1074/jbc.M109.030130; Chowanadisai W, 2006, J BIOL CHEM, V281, P39699, DOI 10.1074/jbc.M605821200; Cirulli ET, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14288-y; Corniola RS, 2008, BRAIN RES, V1237, P52, DOI 10.1016/j.brainres.2008.08.040; Correia SC, 2012, ADV EXP MED BIOL, V724, P205, DOI 10.1007/978-1-4614-0653-2_16; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; Cummins N, 2019, EMBO J, V38, DOI 10.15252/embj.201899360; Dallabona C, 2016, BRAIN, V139, P782, DOI 10.1093/brain/awv392; David DC, 2005, J BIOL CHEM, V280, P23802, DOI 10.1074/jbc.M500356200; Desler Claus, 2012, J Aging Res, V2012, P192503, DOI 10.1155/2012/192503; Devi L, 2008, J BIOL CHEM, V283, P9089, DOI 10.1074/jbc.M710012200; Di Giovanni S, 2006, EMBO J, V25, P4084, DOI 10.1038/sj.emboj.7601292; Dusi S, 2014, AM J HUM GENET, V94, P11, DOI 10.1016/j.ajhg.2013.11.008; Eide DJ, 2004, PFLUG ARCH EUR J PHY, V447, P796, DOI 10.1007/s00424-003-1074-3; Elliott LT, 2018, NATURE, V562, P210, DOI 10.1038/s41586-018-0571-7; Fadista J, 2016, EUR J HUM GENET, V24, P1202, DOI 10.1038/ejhg.2015.269; Fang EF, 2014, CELL, V157, P882, DOI 10.1016/j.cell.2014.03.026; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Finkelstein DI, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0456-2; Frohnert BI, 2013, ADV NUTR, V4, P157, DOI 10.3945/an.112.003319; Furlong RA, 2000, BIOCHEM J, V346, P577, DOI 10.1042/0264-6021:3460577; GEYER CA, 1988, J COMPUT ASSIST TOMO, V12, P40, DOI 10.1097/00004728-198801000-00006; Gholap DS, 2010, ANAL CHIM ACTA, V664, P19, DOI 10.1016/j.aca.2010.01.052; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Giunta C, 2008, AM J HUM GENET, V82, P1290, DOI 10.1016/j.ajhg.2008.05.001; Glusman G, 2011, BIOINFORMATICS, V27, P3216, DOI 10.1093/bioinformatics/btr540; Hagemeier J, 2018, NEUROIMAGE-CLIN, V17, P530, DOI 10.1016/j.nicl.2017.11.003; Haller G, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06705-0; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Hayflick S.J., 2018, HDB CLIN NEUROLOGY, V147, P293, DOI [10.1016/b978-0-444-63233-3.00019-1, DOI 10.1016/B978-0-444-63233-3.00019-1]; Hayflick SJ, 2006, AM J NEURORADIOL, V27, P1230; Hill BG, 2009, BIOCHEM J, V424, P99, DOI 10.1042/BJ20090934; Hingwala DR, 2013, CLIN RADIOL, V68, pE338, DOI 10.1016/j.crad.2012.12.003; Hoover BR, 2010, NEURON, V68, P1067, DOI 10.1016/j.neuron.2010.11.030; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Hwang PM, 2001, NAT MED, V7, P1111, DOI 10.1038/nm1001-1111; Invernizzi F, 2013, HUM MUTAT, V34, P1619, DOI 10.1002/humu.22441; Jurgens Caroline K, 2010, PLoS Curr, V2, DOI 10.1371/currents.RRN1173; Kamens J, 2015, NUCLEIC ACIDS RES, V43, pD1152, DOI 10.1093/nar/gku893; Kanda T, 2016, JPN J RADIOL, V34, P258, DOI 10.1007/s11604-016-0532-8; Kartikasalwah Al, 2010, Biomed Imaging Interv J, V6, pe6, DOI 10.2349/biij.6.1.e6; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kim Y, 2019, ANTIOXID REDOX SIGN, V31, P275, DOI 10.1089/ars.2018.7606; Kmita K, 2015, P NATL ACAD SCI USA, V112, P5685, DOI 10.1073/pnas.1424353112; Kury S, 2002, NAT GENET, V31, P239, DOI 10.1038/ng913; Langley J, 2017, MOVEMENT DISORD, V32, P441, DOI 10.1002/mds.26883; Lee JH, 2011, J MOV DISORD, V4, P60, DOI 10.14802/jmd.11012; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li DL, 2016, GASTROENTEROLOGY, V151, P724, DOI 10.1053/j.gastro.2016.06.051; Li HL, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.169797; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; Liang XQ, 2015, J BIOTECHNOL, V208, P44, DOI 10.1016/j.jbiotec.2015.04.024; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lin JD, 2002, J BIOL CHEM, V277, P1645, DOI 10.1074/jbc.C100631200; Liu CL, 2015, J MAGN RESON IMAGING, V42, P23, DOI [10.3969/j.issn.1001-2400.2015.01.004, 10.1002/jmri.24768]; Loh PR, 2015, NAT GENET, V47, P284, DOI 10.1038/ng.3190; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu Q., 2016, ER GOLGI APPARATUS, V8, P35; Luo S, 2018, NEUROL SCI, V39, P1049, DOI 10.1007/s10072-018-3324-3; Machiela MJ, 2015, BIOINFORMATICS, V31, P3555, DOI 10.1093/bioinformatics/btv402; Mattson MP, 1999, J NEUROSCI RES, V56, P8, DOI 10.1002/(SICI)1097-4547(19990401)56:1<8::AID-JNR2>3.3.CO;2-7; Mehemed TM, 2013, AM J NEURORADIOL, V34, pE72, DOI 10.3174/ajnr.A3571; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Miranda JG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049371; Mocchegiani E, 2005, PROG NEUROBIOL, V75, P367, DOI 10.1016/j.pneurobio.2005.04.005; Monsalve M, 2000, MOL CELL, V6, P307, DOI 10.1016/S1097-2765(00)00031-9; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; MUTISYA EM, 1994, J NEUROCHEM, V63, P2179; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ning Z, 2017, AM J HUM GENET, V101, P903, DOI 10.1016/j.ajhg.2017.09.027; Ojo B, 2016, J NUTR, V146, P1483, DOI 10.3945/jn.115.226688; Perfeito R, 2014, MOL CELL NEUROSCI, V62, P51, DOI 10.1016/j.mcn.2014.08.002; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Popp MW, 2016, CELL, V165, P1319, DOI 10.1016/j.cell.2016.05.053; Qin WP, 2009, ARCH NEUROL-CHICAGO, V66, P352, DOI 10.1001/archneurol.2008.588; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Riley LG, 2017, J INHERIT METAB DIS, V40, P261, DOI 10.1007/s10545-016-0010-6; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Roelofs BA, 2015, FREE RADICAL BIO MED, V86, P250, DOI 10.1016/j.freeradbiomed.2015.05.032; Rose S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085436; Sampietro M, 2001, NEUROBIOL AGING, V22, P563, DOI 10.1016/S0197-4580(01)00219-6; Scarr E, 2016, NPJ SCHIZOPHR, V2, DOI 10.1038/npjschz.2016.2; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scott I, 2014, J BIOL CHEM, V289, P2864, DOI 10.1074/jbc.M113.521641; Sensi SL, 2003, P NATL ACAD SCI USA, V100, P6157, DOI 10.1073/pnas.1031598100; Sheng ZH, 2014, J CELL BIOL, V204, P1087, DOI 10.1083/jcb.201312123; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Stefanatos R, 2018, FEBS LETT, V592, P743, DOI 10.1002/1873-3468.12902; Stevens DA, 2015, P NATL ACAD SCI USA, V112, P11696, DOI 10.1073/pnas.1500624112; Stevens JC, 2010, PLOS ONE, V5, pA8, DOI 10.1371/journal.pone.0009541; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sudmant PH, 2015, NATURE, V526, P75, DOI 10.1038/nature15394; Szabados T, 2004, BEHAV BRAIN RES, V154, P31, DOI 10.1016/j.bbr.2004.01.016; Tsushima Y, 2006, CURR PROBL DIAGN RAD, V35, P140, DOI 10.1067/j.cpradiol.2006.04.002; Tuschl K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11601; Wang DF, 2018, SCIENCE, V362, P333, DOI 10.1126/science.aao1797; Wang K, 2002, AM J HUM GENET, V71, P66, DOI 10.1086/341125; Wolansky LJ, 1999, AM J NEURORADIOL, V20, P1653; Wu L, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201600576; Wu Z, 2009, J MAGN RESON IMAGING, V29, P177, DOI 10.1002/jmri.21617; Yan MH, 2013, FREE RADICAL BIO MED, V62, P90, DOI 10.1016/j.freeradbiomed.2012.11.014; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Yang X, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14868-x; Zarb Y, 2019, BRAIN, V142, P885, DOI 10.1093/brain/awz032; Zhang G, 2018, J MOL CELL CARDIOL, V118, P169, DOI 10.1016/j.yjmcc.2018.03.019; Zhao L, 2015, NATURE, V524, P356, DOI 10.1038/nature14620; Zhyvoloup A, 2003, J BIOL CHEM, V278, P50316, DOI 10.1074/jbc.M307763200	139	6	6	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12702	12725		10.1096/fj.202000772R	http://dx.doi.org/10.1096/fj.202000772R		JUL 2020	24	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32716562	Bronze			2022-12-28	WOS:000556423800001
J	Juiz, N; Elkaoutari, A; Bigonnet, M; Gayet, O; Roques, J; Nicolle, R; Iovanna, J; Dusetti, N				Juiz, Natalia; Elkaoutari, Abdessamad; Bigonnet, Martin; Gayet, Odile; Roques, Julie; Nicolle, Remy; Iovanna, Juan; Dusetti, Nelson			Basal-like and classical cells coexist in pancreatic cancer revealed by single-cell analysis on biopsy-derived pancreatic cancer organoids from the classical subtype	FASEB JOURNAL			English	Article						combinational barcoding; intra-tumor heterogeneity; single-cell analysis; transcriptomics	EXPRESSION; TUMOR; TRANSCRIPTOMICS; MODELS	Pancreatic ductal adenocarcinoma (PDAC) is composed of stromal, immune, and cancerous epithelial cells. Transcriptomic analysis of the epithelial compartment allows classification into different phenotypic subtypes as classical and basal-like. However, little is known about the intra-tumor heterogeneity particularly in the epithelial compartment. Growing evidences suggest that this phenotypic segregation is not so precise and different cancerous cell types may coexist in a single tumor. To test this hypothesis, we performed single-cell transcriptomic analyses using combinational barcoding exclusively on epithelial cells from six different classical PDAC patients obtained by Endoscopic Ultrasound (EUS) with Fine Needle Aspiration (FNA). To purify the epithelial compartment, PDAC were grown as biopsy-derived pancreatic cancer organoids. Single-cell transcriptomic analysis allowed the identification of four main cell clusters present in different proportions in all tumors. Remarkably, although all these tumors were classified as classical, one cluster present in all corresponded to a basal-like phenotype. These results reveal an unanticipated high heterogeneity of pancreatic cancers and demonstrate that basal-like cells, which have a highly aggressive phenotype, are more widespread than expected.	[Juiz, Natalia; Elkaoutari, Abdessamad; Bigonnet, Martin; Gayet, Odile; Roques, Julie; Iovanna, Juan; Dusetti, Nelson] Aix Marseille Univ, Ctr Rech Cancerol Marseille, Inst Paoli Calmettes, CNRS,CRCM,Inserm, Marseille, France; [Nicolle, Remy] Ligue Natl Canc, Programme Cartes Identite Tumeurs CIT, Paris, France; [Iovanna, Juan] Inst Paoli Calmettes, Parc Sci & Technol Luminy,163 Ave Luminy, F-13288 Marseille, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC)	Iovanna, J; Dusetti, N (corresponding author), Inst Paoli Calmettes, Parc Sci & Technol Luminy,163 Ave Luminy, F-13288 Marseille, France.; Iovanna, J; Dusetti, N (corresponding author), Aix Marseille Univ, Ctr Rech Cancerol Marseille CRCM, INSERM U1068, CNRS UMR 7258, Parc Sci & Technol Luminy,163 Ave Luminy, F-13288 Marseille, France.	juan.iovanna@inserm.fr; nelson.dusetti@inserm.fr	EL KAOUTARI, Abdessamad/AAR-8318-2021; Dusetti, Nelson/O-7919-2017; Nicolle, Rémy/P-7983-2019	EL KAOUTARI, Abdessamad/0000-0003-2334-3121; Dusetti, Nelson/0000-0002-6161-8483; Nicolle, Rémy/0000-0001-8084-1173	INCa [2018-078, 2018-079]; Canceropole PACA; Amidex Foundation; Fondation de France; INSERM; La Ligue Contre le Cancer	INCa(Institut National du Cancer (INCA) France); Canceropole PACA(Region Grand-Est); Amidex Foundation; Fondation de France(Fondation de France); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); La Ligue Contre le Cancer(Ligue nationale contre le cancer)	This work was supported by INCa (Grants number 2018-078 and 2018-079), Canceropole PACA, Amidex Foundation, Fondation de France, La Ligue Contre le Cancer, and INSERM. Authors thank Christopher Pin for critically reading the manuscript.	Bailey P, 2016, NATURE, V531, P47, DOI 10.1038/nature16965; BEAVO JA, 1995, PHYSIOL REV, V75, P725, DOI 10.1152/physrev.1995.75.4.725; Boj SF, 2015, CELL, V160, P324, DOI 10.1016/j.cell.2014.12.021; Brazovskaja A, 2019, CURR OPIN BIOTECH, V55, P167, DOI 10.1016/j.copbio.2018.11.002; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Cao JY, 2019, NATURE, V566, P496, DOI 10.1038/s41586-019-0969-x; Cao JY, 2017, SCIENCE, V357, P661, DOI 10.1126/science.aam8940; Collisson EA, 2019, NAT REV GASTRO HEPAT, V16, P207, DOI 10.1038/s41575-019-0109-y; Dijk F, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-56826-9; Escudero-Esparza A, 2016, ONCOTARGET, V7, P76920, DOI 10.18632/oncotarget.12729; Hayashi A, 2020, NAT CANCER, V1, P59, DOI 10.1038/s43018-019-0010-1; He CB, 2016, APMIS, V124, P169, DOI 10.1111/apm.12480; He ZY, 2019, J CELL PHYSIOL, V234, P19582, DOI 10.1002/jcp.28557; Klein AM, 2015, CELL, V161, P1187, DOI 10.1016/j.cell.2015.04.044; Li YL, 2015, ONCOTARGET, V6, P27641, DOI 10.18632/oncotarget.4737; Lomberk G, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11812-7; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Maziveyi M, 2017, ONCOTARGET, V8, P48471, DOI 10.18632/oncotarget.17265; Moffitt RA, 2015, NAT GENET, V47, P1168, DOI 10.1038/ng.3398; Nicolle R, 2017, CELL REP, V21, P2458, DOI 10.1016/j.celrep.2017.11.003; Parekh S, 2018, GIGASCIENCE, V7, DOI 10.1093/gigascience/giy059; Peng JY, 2019, CELL RES, V29, P725, DOI 10.1038/s41422-019-0195-y; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/nmeth.2639, 10.1038/NMETH.2639]; Porta C, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00064; Qiu XJ, 2017, NAT METHODS, V14, P979, DOI [10.1038/NMETH.4402, 10.1038/nmeth.4402]; Rashid NU, 2020, CLIN CANCER RES, V26, P82, DOI 10.1158/1078-0432.CCR-19-1467; Rosenberg AB, 2018, SCIENCE, V360, P176, DOI 10.1126/science.aam8999; Satelli A, 2011, CELL MOL LIFE SCI, V68, P3033, DOI 10.1007/s00018-011-0735-1; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Tan F, 2014, HDB NEUROTOXICITY, P1825; Tiriac H, 2019, CURR OPIN GENET DEV, V54, P7, DOI 10.1016/j.gde.2019.02.003; Tuveson D, 2019, SCIENCE, V364, P952, DOI 10.1126/science.aaw6985; Vara-Perez M, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8050493; Vasioukhin Valeri, 2012, Subcell Biochem, V60, P379, DOI 10.1007/978-94-007-4186-7_16; Yachida S, 2013, ONCOGENE, V32, P5253, DOI 10.1038/onc.2013.29; Yamada Y, 2018, CANCER SCI, V109, P2919, DOI 10.1111/cas.13722; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Yu X, 2017, CELL PROLIFERAT, V50, DOI 10.1111/cpr.12329; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zeng WW, 2020, FRONT BIOSCI-LANDMRK, V25, P564, DOI 10.2741/4821	40	44	44	1	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12214	12228		10.1096/fj.202000363RR	http://dx.doi.org/10.1096/fj.202000363RR		JUL 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32686876	Green Submitted			2022-12-28	WOS:000553642800001
J	Jin, T; Chen, RY; Shao, MS; Yang, X; Ma, L; Wang, FF				Jin, Tao; Chen, Ruyan; Shao, Mingshuo; Yang, Xiao; Ma, Lan; Wang, Feifei			Dorsal hippocampus- and ACC-projecting medial septum neurons differentially contribute to the recollection of episodic-like memory	FASEB JOURNAL			English	Article						anterior cingulate cortex; dorsal hippocampus; episodic-like memory; medial septum	ANTERIOR CINGULATE; VENTRAL HIPPOCAMPUS; CHOLINERGIC NEURONS; TEMPORAL-ORDER; CORTEX; RECOGNITION; INCREASES; NETWORK; ACETYLCHOLINE; TRANSMISSION	Episodic memory refers to the recollection of previous experiences containing specific temporal, spatial, and emotional information. The ability to recollect episodic memory requires coordination of multiple brain regions, including the hippocampus (HPC) and the cingulate cortex. While the afferents into HPC and cingulate cortex that orchestrate the episodic memory remain unclear. The medial septum (MS), one of the anatomical location of cholinergic centers, innervates not only the dorsal HPC (dHPC), but also the cingulate and entorhinal cortices. By using "What-Where-When" episodic-like memory (ELM) behavioral model and viral tracing, we found that MS neurons projected to dHPC and anterior cingulate cortex (ACC), which exerted distinct impacts on ELM recollection. Chemogenetic inhibition of the dHPC-projecting MS neurons disrupted "What-Where-When" ELM recollection as well as object location, object-in-place, and recency recognition memories recollection, while chemogenetic inhibition of the ACC-projecting MS neurons only disrupted "What-Where-When" ELM recollection. Moreover, neither dHPC- nor ACC-projecting MS neurons were involved in novel object recognition memory recollection or locomotor activity. Immunostaining showed that ACC- and dHPC-projecting MS neurons are partially overlapped populations. These findings reveal an unsuspected division of ELM processing and provide the potential mechanism that the recollection of episodic memory need the coordination of MS neurons projecting to dHPC and ACC.	[Jin, Tao; Chen, Ruyan; Shao, Mingshuo; Yang, Xiao; Ma, Lan; Wang, Feifei] Fudan Univ, Inst Brain Sci, Sch Basic Med Sci, State Key Lab Med Neurobiol, 138 Yixueyuan Rd, Shanghai, Peoples R China; [Jin, Tao; Chen, Ruyan; Shao, Mingshuo; Yang, Xiao; Ma, Lan; Wang, Feifei] Fudan Univ, Inst Brain Sci, Sch Basic Med Sci, MOE Frontiers Ctr Brain Sci, 138 Yixueyuan Rd, Shanghai, Peoples R China	Fudan University; Fudan University	Wang, FF (corresponding author), Fudan Univ, Inst Brain Sci, Sch Basic Med Sci, State Key Lab Med Neurobiol, 138 Yixueyuan Rd, Shanghai, Peoples R China.; Wang, FF (corresponding author), Fudan Univ, Inst Brain Sci, Sch Basic Med Sci, MOE Frontiers Ctr Brain Sci, 138 Yixueyuan Rd, Shanghai, Peoples R China.	ffwang@fudan.edu.cn			Natural Science Foundation of China [31930046, 31671042, 31871021]; Shanghai Municipal Science and Technology Major Project; ZJ Lab [2018SHZDZX01]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Science and Technology Major Project; ZJ Lab	This work was supported by grants from the Natural Science Foundation of China (31930046 to L.M., 31671042 & 31871021 to F.W), Shanghai Municipal Science and Technology Major Project and ZJ Lab (2018SHZDZX01 to L.M and F.W.).	Aggleton JP, 2001, PHILOS T R SOC B, V356, P1467, DOI 10.1098/rstb.2001.0946; Aleman A, 1999, AM J PSYCHIAT, V156, P1358; Backman L, 2004, J INTERN MED, V256, P195, DOI 10.1111/j.1365-2796.2004.01386.x; Barker GRI, 2007, J NEUROSCI, V27, P2948, DOI 10.1523/JNEUROSCI.5289-06.2007; Barker GRI, 2017, NAT NEUROSCI, V20, P242, DOI 10.1038/nn.4472; Barker GRI, 2011, J NEUROSCI, V31, P10721, DOI 10.1523/JNEUROSCI.6413-10.2011; Bian XL, 2019, J NEUROSCI, V39, P5728, DOI 10.1523/JNEUROSCI.2739-18.2019; Bienkowski MS, 2018, NAT NEUROSCI, V21, P1628, DOI 10.1038/s41593-018-0241-y; Bierman EJM, 2005, AM J GERIAT PSYCHIAT, V13, P686, DOI 10.1176/appi.ajgp.13.8.686; Binder S, 2015, PROG NEUROBIOL, V130, P71, DOI 10.1016/j.pneurobio.2015.04.002; Chung YC, 2004, BRAIN RES, V1023, P54, DOI 10.1016/j.brainres.2004.07.009; Dere E, 2005, NEUROBIOL LEARN MEM, V84, P214, DOI 10.1016/j.nlm.2005.07.002; Dere E, 2010, BEHAV BRAIN RES, V215, P162, DOI 10.1016/j.bbr.2010.03.017; Desikan S, 2018, P NATL ACAD SCI USA, V115, pE2644, DOI 10.1073/pnas.1716531115; Dickerson BC, 2010, NEUROPSYCHOPHARMACOL, V35, P86, DOI 10.1038/npp.2009.126; Dougherty KD, 1998, BRAIN RES, V810, P59, DOI 10.1016/S0006-8993(98)00870-1; Easton A, 2009, HIPPOCAMPUS, V19, P837, DOI 10.1002/hipo.20567; Ebitz RB, 2016, NAT NEUROSCI, V19, P1278, DOI 10.1038/nn.4387; Eichenbaum H, 2017, NAT REV NEUROSCI, V18, P547, DOI 10.1038/nrn.2017.74; Elzinga BM, 2002, J AFFECT DISORDERS, V70, P1, DOI 10.1016/S0165-0327(01)00351-2; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Fellini L, 2013, J NEUROSCI, V33, P1038, DOI 10.1523/JNEUROSCI.2280-12.2013; Graham NL, 2004, J NEUROL NEUROSUR PS, V75, P61; Guo BL, 2019, NAT NEUROSCI, V22, P1223, DOI 10.1038/s41593-019-0445-9; Hermans D, 2008, DEPRESS ANXIETY, V25, P787, DOI 10.1002/da.20326; Inostroza M, 2013, J NEUROSCI, V33, P17749, DOI 10.1523/JNEUROSCI.0957-13.2013; Joo HR, 2018, NAT REV NEUROSCI, V19, P744, DOI 10.1038/s41583-018-0077-1; King DR, 2015, J NEUROSCI, V35, P1763, DOI 10.1523/JNEUROSCI.3219-14.2015; Layton B, 2002, J NEUROPSYCH CLIN N, V14, P254, DOI 10.1176/appi.neuropsych.14.3.254; Lu NN, 2018, CEREB CORTEX, V28, P2391, DOI 10.1093/cercor/bhx141; Manseau F, 2005, J PHYSIOL-LONDON, V566, P865, DOI 10.1113/jphysiol.2005.089664; Meda KS, 2019, NEURON, V102, P944, DOI 10.1016/j.neuron.2019.03.042; MITCHELL DB, 1990, PSYCHOL AGING, V5, P264, DOI 10.1037/0882-7974.5.2.264; Moscovitch M, 2016, ANNU REV PSYCHOL, V67, P105, DOI 10.1146/annurev-psych-113011-143733; Newman EL, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00024; Panoz-Brown D, 2018, CURR BIOL, V28, P1628, DOI 10.1016/j.cub.2018.04.006; Pause BM, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00033; Powell AL, 2017, EUR J NEUROSCI, V45, P1451, DOI 10.1111/ejn.13577; Rainville P, 1997, SCIENCE, V277, P968, DOI 10.1126/science.277.5328.968; Ren J, 2011, NEURON, V69, P445, DOI 10.1016/j.neuron.2010.12.038; Robinson J, 2016, J NEUROSCI, V36, P3016, DOI 10.1523/JNEUROSCI.2141-15.2016; Roy DS, 2017, CELL, V170, P1000, DOI 10.1016/j.cell.2017.07.013; Sarafyazd M, 2019, SCIENCE, V364, P652, DOI 10.1126/science.aav8911; Saur TX, 2016, J NEUROGENET, V30, P297, DOI 10.1080/01677063.2016.1229779; Sun YJ, 2019, NAT NEUROSCI, V22, P1857, DOI 10.1038/s41593-019-0496-y; Sweeney P, 2017, P NATL ACAD SCI USA, V114, P13816, DOI 10.1073/pnas.1707228114; Takacs VT, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05136-1; Ting JT, 2014, METHODS MOL BIOL, V1183, P221, DOI 10.1007/978-1-4939-1096-0_14; Tulving E, 2002, ANNU REV PSYCHOL, V53, P1, DOI 10.1146/annurev.psych.53.100901.135114; Unal G, 2018, BRAIN STRUCT FUNCT, V223, P2409, DOI 10.1007/s00429-018-1626-0; Wang DV, 2016, J NEUROSCI, V36, P10663, DOI 10.1523/JNEUROSCI.1042-16.2016; Wang ZL, 2020, BIOL PSYCHIAT, V87, P979, DOI 10.1016/j.biopsych.2019.10.009; Watrous AJ, 2013, NAT NEUROSCI, V16, P349, DOI 10.1038/nn.3315; Winters BD, 2004, J NEUROSCI, V24, P5901, DOI 10.1523/JNEUROSCI.1346-04.2004; Zhou HC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06295-x	55	2	2	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					11741	11753		10.1096/fj.202000398R	http://dx.doi.org/10.1096/fj.202000398R		JUL 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32652689	hybrid			2022-12-28	WOS:000548008400001
J	Wan, SS; Pan, YM; Yang, WJ; Rao, ZQ; Yang, YN				Wan, Shan-Shan; Pan, Yu-Miao; Yang, Wan-Ju; Rao, Zhuo-Qun; Yang, Yan-Ning			Inhibition of EZH2 alleviates angiogenesis in a model of corneal neovascularization by blocking FoxO3a-mediated oxidative stress	FASEB JOURNAL			English	Article						angiogenesis; cornea; enhancer of zeste homolog 2; oxidative stress	NF-KAPPA-B; CELLS; MAINTENANCE	Enhancer of zeste homolog 2 (EZH2), a well-known methyltransferase, mediates histone H3 lysine 27 trimethylation (H3K27me3) and plays a vital role in ophthalmological disease. However, its role in corneal neovascularization (CoNV) remains unclear. In vitro and in vivo models were assessed in hypoxia-stimulated angiogenesis and in a mouse model of alkali burn-induced CoNV. Human umbilical vein endothelial cells (HUVECs) were cultured under hypoxic conditions and different reoxygenation times to identify the molecular mechanisms involved in this process. In this study, we found that EZH2 was positively related to corneal alkali burn-induced injury. Inhibition of EZH2 with 3-Deazaneplanocin A (DZNeP) alleviated corneal injury, including oxidative stress and neovascularization in vivo. Similarly, inhibition of EZH2 with either DZNeP or small interfering RNA (siRNA) exerted an inhibitory effect on hypoxia/reoxygenation (H/R)-induced oxidative stress and angiogenesis in HUVECs. Moreover, our study revealed that ablation of reactive oxygen species (ROS) with N-acetyl-cysteine suppressed angiogenesis in HUVECs exposed to H/R stimulation. Furthermore, Forkhead-box protein O3a (FoxO3a), which was positively associated with ROS production and angiogenesis, was elevated during H/R. This effect could be reversed through the suppression of the transcription activity of EZH2 with DZNeP or siRNA. In addition, the PI3K/Akt pathway, which is the upstream of FoxO3a, was activated in both DZNeP-treated mice and EZH2-inhibited HUVECs. Collectively, our results demonstrated that the inhibition of EZH2 alleviated corneal angiogenesis by inhibiting FoxO3a-dependent ROS production through the PI3K/Akt signaling pathway. These findings indicate that EZH2 may be a valuable therapeutic target for CoNV.	[Wan, Shan-Shan; Pan, Yu-Miao; Yang, Wan-Ju; Rao, Zhuo-Qun; Yang, Yan-Ning] Wuhan Univ, Dept Ophthalmol, Renmin Hosp, Wuhan 430060, Peoples R China	Wuhan University	Yang, YN (corresponding author), Wuhan Univ, Dept Ophthalmol, Renmin Hosp, Wuhan 430060, Peoples R China.	ophyyn@163.com		Yang, Wanju/0000-0002-3071-2805	National Natural Science Foundation of China (NSFC) [81370986, 81770899, 81070708]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81370986, 81770899 and 81070708	Ambati BK, 2006, NATURE, V443, P993, DOI 10.1038/nature05249; Anderson C, 2014, JOVE-J VIS EXP, DOI 10.3791/51159; Aurora AB, 2010, BLOOD, V116, P475, DOI 10.1182/blood-2009-07-232132; Avedschmidt SE, 2016, INVEST OPHTH VIS SCI, V57, P6242, DOI 10.1167/iovs.16-20463; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Bao B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050165; Chang JH, 2001, CURR OPIN OPHTHALMOL, V12, P242, DOI 10.1097/00055735-200108000-00002; Cursiefen C, 2004, J CLIN INVEST, V113, P1040, DOI 10.1172/JCI200420465; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Fu YC, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20180552; Fujimura N, 2018, DEV BIOL, V433, P47, DOI 10.1016/j.ydbio.2017.11.004; Gao M, 2016, FREE RADICAL BIO MED, V92, P39, DOI 10.1016/j.freeradbiomed.2016.01.005; Iida A, 2015, DEV NEUROBIOL, V75, P947, DOI 10.1002/dneu.22261; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Kubota M, 2011, INVEST OPHTH VIS SCI, V52, P427, DOI 10.1167/iovs.10-6167; Liu H, 2019, REDOX BIOL, V24, DOI 10.1016/j.redox.2019.101195; Liu W, 2020, CELL MOL LIFE SCI, V77, P651, DOI 10.1007/s00018-019-03297-w; Mitic T, 2015, MOL THER, V23, P32, DOI 10.1038/mt.2014.163; Mukwaya A, 2016, SCI REP-UK, V6, DOI 10.1038/srep32137; Nakao S, 2018, FASEB J, V32, P143, DOI 10.1096/fj.201601229R; Qazi Y, 2010, BRAIN RES BULL, V81, P198, DOI 10.1016/j.brainresbull.2009.05.019; Raju I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067126; Rogers MS, 2007, NAT PROTOC, V2, P2545, DOI 10.1038/nprot.2007.368; Saika S, 2005, AM J PATHOL, V166, P1405, DOI 10.1016/S0002-9440(10)62358-9; Shi WZ, 2019, BIOCHEM BIOPH RES CO, V516, P285, DOI 10.1016/j.bbrc.2019.05.181; Shoham A, 2008, FREE RADICAL BIO MED, V45, P1047, DOI 10.1016/j.freeradbiomed.2008.07.021; Tsou PS, 2019, P NATL ACAD SCI USA, V116, P3695, DOI 10.1073/pnas.1813006116; Wen Q, 2012, NEUROGENETICS, V13, P105, DOI 10.1007/s10048-012-0320-2; Wing MR, 2013, SEMIN NEPHROL, V33, P363, DOI 10.1016/j.semnephrol.2013.05.008; Zhang XP, 2018, FASEB J, V32, P3782, DOI 10.1096/fj.201701074RR; Zheng SJ, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0349-8	31	9	9	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10168	10181		10.1096/fj.201902814RRR	http://dx.doi.org/10.1096/fj.201902814RRR		JUN 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32562311				2022-12-28	WOS:000541813700001
J	Kong, J; Kim, S				Kong, Jiwon; Kim, Sunghoon			Cell-based analysis of pairwise interactions between the components of the multi-tRNA synthetase complex	FASEB JOURNAL			English	Article						aminoacyl-tRNA synthetase; macromolecular complex; mammalian multi-tRNA synthetase complex; ribosome; tRNA	AMINOACYL-TRANSFER-RNA; PROTEIN INTERACTIONS; TRANSLATION; ELONGATION; REVEALS; ASSOCIATION; RIBOSOMES; REPORTER; DOMAIN; FORMS	Cytoplasmic aminoacyl-tRNA synthetases (ARSs) are organized into multi-tRNA synthetase complexes (MSCs), from Archaea to mammals. An evolutionary conserved role of the MSCs is enhancement of aminoacylation by forming stable associations of the ARSs and tRNAs. In mammals, a single macromolecular MSC exists, which is composed of eight cytoplasmic ARSs, for nine amino acids, and three scaffold proteins. Consequently, nearly half of aminoacyl-tRNA efflux becomes concentrated at the MSC. Stable supply of aminoacyl-tRNA to the ribosome is, therefore, considered to be a major role of the mammalian MSC. Furthermore, the mammalian MSC also serves as a reservoir for releasable components with noncanonical functions. In this study, a split-luciferase complementation system was applied to investigate the configuration of the MSC in live mammalian cells. Multiplex interconnections between the components were simplified into binary protein-protein interactions, and pairwise comparison of the interactions reconstituted a framework consistent with previousin vitrostudies. Reversibility of the split-luciferase reporter binding demonstrated convertible organization of the mammalian MSC, including interferon gamma (IFN gamma)-stimulated glutamyl-prolyl-tRNA synthetase 1 (EPRS1) release, as well as the cooperation with the ribosome bridged by the tRNAs. The cell-based analysis provided an improved understanding of the flexible framework of the mammalian MSC in physiological conditions.	[Kong, Jiwon; Kim, Sunghoon] Seoul Natl Univ, Coll Pharm, Med Bioconvergence Res Ctr, Seoul 08826, South Korea; [Kim, Sunghoon] Yonsei Univ, Gangnam Severance Hosp, Coll Pharm, Med Bioconvergence Res Ctr, Incheon 21983, South Korea; [Kim, Sunghoon] Yonsei Univ, Gangnam Severance Hosp, Coll Med, Incheon 21983, South Korea; [Kong, Jiwon] Seoul Natl Univ, Coll Pharm, Seoul 08826, South Korea	Seoul National University (SNU); Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Seoul National University (SNU)	Kim, S (corresponding author), Yonsei Univ, Gangnam Severance Hosp, Coll Pharm, Med Bioconvergence Res Ctr, Incheon 21983, South Korea.; Kim, S (corresponding author), Yonsei Univ, Gangnam Severance Hosp, Coll Med, Incheon 21983, South Korea.	sunghoonkim@yonsei.ac.kr	Kong, Jiwon/GXH-5761-2022	Kong, Jiwon/0000-0003-3990-5619	National Research Foundation - Ministry of Science and ICT (MSIT) of Korea [NRF-M3A6A4-2010-0029785]	National Research Foundation - Ministry of Science and ICT (MSIT) of Korea	This work was supported by the Global Frontier Project grant (NRF-M3A6A4-2010-0029785) of National Research Foundation funded by the Ministry of Science and ICT (MSIT) of Korea.	Azad T, 2014, ANAL BIOANAL CHEM, V406, P5541, DOI 10.1007/s00216-014-7980-8; AZZAM ME, 1973, P NATL ACAD SCI USA, V70, P3866, DOI 10.1073/pnas.70.12.3866; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P11288, DOI 10.1073/pnas.96.20.11288; Cho HY, 2015, J BIOL CHEM, V290, P29313, DOI 10.1074/jbc.M115.690867; Choi JW, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001351; David A, 2011, J BIOL CHEM, V286, P20688, DOI 10.1074/jbc.M110.209452; Dias J, 2013, J BIOL CHEM, V288, P23979, DOI 10.1074/jbc.M113.489922; Dixon AS, 2016, ACS CHEM BIOL, V11, P400, DOI 10.1021/acschembio.5b00753; Fang PF, 2011, P NATL ACAD SCI USA, V108, P8239, DOI 10.1073/pnas.1100224108; Fu YY, 2014, P NATL ACAD SCI USA, V111, P15084, DOI 10.1073/pnas.1408836111; Godinic V, 2007, FEBS J, V274, P2788, DOI 10.1111/j.1742-4658.2007.05812.x; Godinic-Mikulcic V, 2011, J BIOL CHEM, V286, P3396, DOI 10.1074/jbc.M110.168526; Guo M, 2008, P NATL ACAD SCI USA, V105, P2331, DOI 10.1073/pnas.0712072105; GUPTA RS, 1977, CELL, V10, P61, DOI 10.1016/0092-8674(77)90140-4; Hahn H, 2019, IUCRJ, V6, P958, DOI 10.1107/S2052252519010790; Hall MP, 2012, ACS CHEM BIOL, V7, P1848, DOI 10.1021/cb3002478; Hausmann CD, 2007, NUCLEIC ACIDS RES, V35, P6094, DOI 10.1093/nar/gkm534; Hei ZF, 2019, J BIOL CHEM, V294, P4775, DOI 10.1074/jbc.RA118.006356; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Kaminska M, 2009, J BIOL CHEM, V284, P13746, DOI 10.1074/jbc.M900480200; Kang T, 2012, J MOL BIOL, V423, P475, DOI 10.1016/j.jmb.2012.07.020; Kim DG, 2014, NAT CHEM BIOL, V10, P29, DOI [10.1038/nchembio.1381, 10.1038/NCHEMBIO.1381]; Kwon NH, 2011, P NATL ACAD SCI USA, V108, P19635, DOI 10.1073/pnas.1103922108; Kyriacou SV, 2008, MOL CELL, V29, P419, DOI 10.1016/j.molcel.2007.11.038; Laschet C, 2019, J BIOL CHEM, V294, P4079, DOI 10.1074/jbc.RA118.006231; MartinNieto J, 1997, J CELL SCI, V110, P955; Moreland JL, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-21; Moulinier L, 2001, EMBO J, V20, P5290, DOI 10.1093/emboj/20.18.5290; Negrutskii BS, 1999, J BIOL CHEM, V274, P4545, DOI 10.1074/jbc.274.8.4545; Ofir-Birin Y, 2013, MOL CELL, V49, P30, DOI 10.1016/j.molcel.2012.10.010; Park BJ, 2005, CELL, V120, P209, DOI 10.1016/j.cell.2004.11.054; Praetorius-Ibba M, 2007, J BIOL CHEM, V282, P3680, DOI 10.1074/jbc.M609988200; Raina M, 2012, FEBS LETT, V586, P2232, DOI 10.1016/j.febslet.2012.05.039; Ray PS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098493; Rho SB, 1999, P NATL ACAD SCI USA, V96, P4488, DOI 10.1073/pnas.96.8.4488; Sampath P, 2004, CELL, V119, P195, DOI 10.1016/j.cell.2004.09.030; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schneider-Poetsch T, 2010, NAT CHEM BIOL, V6, P209, DOI 10.1038/NCHEMBIO.304; Simos G, 1996, EMBO J, V15, P5437, DOI 10.1002/j.1460-2075.1996.tb00927.x; Simos G, 1998, MOL CELL, V1, P235, DOI 10.1016/S1097-2765(00)80024-6; SIVARAM P, 1990, P NATL ACAD SCI USA, V87, P3665, DOI 10.1073/pnas.87.10.3665; STAPULIONIS R, 1995, P NATL ACAD SCI USA, V92, P7158, DOI 10.1073/pnas.92.16.7158; Yaremchuk A, 2000, ACTA CRYSTALLOGR D, V56, P197, DOI 10.1107/S0907444999015504; Zhou HH, 2013, NATURE, V494, P121, DOI 10.1038/nature11774	44	3	3	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10476	10488		10.1096/fj.202000418R	http://dx.doi.org/10.1096/fj.202000418R		JUN 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32539228	hybrid			2022-12-28	WOS:000541800100001
J	Fang, WQ; Deng, ZY; Benadjaoud, F; Yang, DF; Yang, CZ; Shi, GP				Fang, Wenqian; Deng, Zhiyong; Benadjaoud, Feriel; Yang, Dafeng; Yang, Chongzhe; Shi, Guo-Ping			Regulatory T cells promote adipocyte beiging in subcutaneous adipose tissue	FASEB JOURNAL			English	Article						epididymal white adipose tissue; gonadal white adipose tissue; macrophage polarization; regulatory T cell; subcutaneous adipose tissue; uncoupling protein-1	NICOTINAMIDE RIBOSIDE; THERMOGENIC ADIPOCYTES; METABOLIC HOMEOSTASIS; FAT DEVELOPMENT; BROWN; ACTIVATION; DISTINCT; POPULATION; GLUCOSE; ENERGY	Regulatory T cells (Tregs) play essential roles in obesity and diabetes. Here, we report a role of Tregs in enhancing beta 3-adrenergic receptor agonist CL316243 (CL)-stimulated thermogenic program in subcutaneous adipose tissue (SAT), but not in visceral fat. CL treatment for 7 days increased SAT adipocyte beiging and thermogenic gene expression in male or female mice. Adoptive transfer of Tregs enhanced this CL activity. Such Treg activity lost in male epididymal white adipose tissue (eWAT) and female gonadal gWAT. Adipocyte culture yielded the same conclusion. Tregs enhanced the expression of CL-induced thermogenic genes in SAT from male and female mice. This activity of Tregs reduced or disappeared in adipocytes from eWAT or gWAT. Both CL and Tregs induced much higher UCP-1 (uncoupling protein-1) expression in SAT from females than that from males. A mechanistic study demonstrated a role of Tregs in suppressing the expression of M1 macrophage markers (Tnfa, Il6, iNos, Ip10) and promoting the expression of M2 macrophage markers (Mrc1, Arg1, Il10) in bone-marrow-derived macrophages or in SAT from male or female mice. In female mice with pre-established obesity, Treg adoptive transfer reduced the gWAT weight in 2 weeks. Together with CL treatment, Treg adoptive transfer reduced the SAT weight and further improved CL-induced glucose metabolism and insulin sensitivity in female obese mice, but did not affect CL-induced body weight loss in male or female obese mice. This study revealed a predominant role of Tregs in female mice in promoting adipocyte beiging and thermogenesis in SAT, in part by slanting M2 macrophage polarization.	[Fang, Wenqian; Deng, Zhiyong; Benadjaoud, Feriel; Yang, Dafeng; Shi, Guo-Ping] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Fang, Wenqian; Deng, Zhiyong; Benadjaoud, Feriel; Yang, Dafeng; Shi, Guo-Ping] Harvard Med Sch, Boston, MA 02115 USA; [Fang, Wenqian] Shanghai Univ, Cardiac Regenerat & Ageing Lab, Sch Life Sci, Inst Cardiovasc Sci, Shanghai, Peoples R China; [Deng, Zhiyong; Yang, Chongzhe] South China Univ Technol, Natl Key Clin Specialty, Guangzhou Peoples Hosp 1, Dept Geriatr,Sch Med, Guangzhou, Peoples R China	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Shanghai University; South China University of Technology	Yang, CZ (corresponding author), Guangzhou First Peoples Hosp, Dept Geriatr, 1 Panfu Rd,Pansong Bldg 7, Guangzhou 510180, Guangdong, Peoples R China.; Shi, GP (corresponding author), Brigham & Womens Hosp, Cardiovasc Med, 77 Ave Louis Pasteur,NRB-7, Boston, MA 02115 USA.	eyyangchongzhe@scut.edu.cn; gshi@bwh.harvard.edu	Yang, Dafeng/HIK-2106-2022; Shi, Guoping/AAI-9946-2021	Yang, Dafeng/0000-0002-8320-8215; Fang, Wenqian/0000-0001-8929-6423; Yang, Chongzhe/0000-0002-0338-8245	National Heart, Lung, and Blood Institute (NHLBI) [HL123568, HL60942]; National Institute of Neurological Disorders and Stroke (NINDS) [AG063839]	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: HL123568 and HL60942; National Institute of Neurological Disorders and Stroke (NINDS), Grant/Award Number: AG063839	Arpaia N, 2015, CELL, V162, P1078, DOI 10.1016/j.cell.2015.08.021; Bacher P, 2016, CELL, V167, P1067, DOI 10.1016/j.cell.2016.09.050; Brestoff JR, 2015, CELL, V161, P146, DOI 10.1016/j.cell.2015.02.022; Brestoff JR, 2015, NATURE, V519, P242, DOI 10.1038/nature14115; Canto C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022; Cereijo R, 2018, CELL METAB, V28, P750, DOI 10.1016/j.cmet.2018.07.015; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Chu DT, 2016, J PHYSIOL BIOCHEM, V73, P315, DOI 10.1007/s13105-017-0567-z; Chu DT, 2017, BIOCHIMIE, V138, P102, DOI 10.1016/j.biochi.2017.04.017; Chu DT, 2017, J PHYSIOL BIOCHEM, V73, P1, DOI 10.1007/s13105-016-0536-y; Chu DT, 2014, J BIOL CHEM, V289, P18478, DOI 10.1074/jbc.M114.555821; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Fried SK, 2015, OBESITY, V23, P1345, DOI 10.1002/oby.21133; Grinberg-Bleyer Y, 2017, CELL, V170, P1096, DOI 10.1016/j.cell.2017.08.004; Hao L, 2018, J PHARMACOL EXP THER, V365, P467, DOI 10.1124/jpet.117.246256; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Jiang YW, 2017, ELIFE, V6, DOI 10.7554/eLife.30329; Kalin S, 2017, CELL METAB, V26, P475, DOI 10.1016/j.cmet.2017.08.008; Kajimura S, 2014, ANNU REV PHYSIOL, V76, P225, DOI 10.1146/annurev-physiol-021113-170252; Khan NA, 2014, EMBO MOL MED, V6, P721, DOI 10.1002/emmm.201403943; Kim SN, 2016, BIOL SEX DIFFER, V7, DOI 10.1186/s13293-016-0121-7; Klein J, 1999, J BIOL CHEM, V274, P34795, DOI 10.1074/jbc.274.49.34795; Lee MW, 2015, CELL, V160, P74, DOI 10.1016/j.cell.2014.12.011; Lee P, 2014, CELL METAB, V19, P302, DOI 10.1016/j.cmet.2013.12.017; Lee YH, 2012, CELL METAB, V15, P480, DOI 10.1016/j.cmet.2012.03.009; Liu PS, 2015, ADIPOCYTE, V4, P146, DOI 10.4161/21623945.2014.981428; Liu PS, 2015, ADIPOCYTE, V4, P123, DOI 10.4161/21623945.2014.981438; Merlin J, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00249; Min SY, 2016, NAT MED, V22, P312, DOI 10.1038/nm.4031; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; Ooi JD, 2017, NATURE, V545, P243, DOI 10.1038/nature22329; Peirce V, 2014, NATURE, V510, P76, DOI 10.1038/nature13477; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Qiu YF, 2014, CELL, V157, P1292, DOI 10.1016/j.cell.2014.03.066; Rao RR, 2014, CELL, V157, P1279, DOI 10.1016/j.cell.2014.03.065; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; Rosenwald M, 2013, NAT CELL BIOL, V15, P659, DOI 10.1038/ncb2740; Sakamoto T, 2016, AM J PHYSIOL-ENDOC M, V310, pE676, DOI 10.1152/ajpendo.00028.2015; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Sidossis L, 2015, J CLIN INVEST, V125, P478, DOI 10.1172/JCI78362; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Tiemessen MM, 2007, P NATL ACAD SCI USA, V104, P19446, DOI 10.1073/pnas.0706832104; Traba J, 2015, J CLIN INVEST, V125, P4592, DOI 10.1172/JCI83260; Trammell SAJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep26933; Tseng YH, 2004, MOL CELL BIOL, V24, P1918, DOI 10.1128/MCB.24.5.1918-1929.2004; Varghese M, 2017, ADV EXP MED BIOL, V1043, P65, DOI 10.1007/978-3-319-70178-3_5; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wang H, 2016, CELL METAB, V24, P835, DOI 10.1016/j.cmet.2016.10.005; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Ying W, 2013, JOVE-J VIS EXP, DOI 10.3791/50323; Zeng Q, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02075; Zheng XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063967; Zhou Y, 2015, CELL METAB, V22, P1045, DOI 10.1016/j.cmet.2015.09.013	54	10	11	4	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9755	9770		10.1096/fj.201902518R	http://dx.doi.org/10.1096/fj.201902518R		JUN 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32510702				2022-12-28	WOS:000539575900001
J	Ruan, QT; Yazdani, N; Reed, ER; Beierle, JA; Peterson, LP; Luttik, KP; Szumlinski, KK; Johnson, WE; Ash, PEA; Wolozin, B; Bryant, CD				Ruan, Qiu T.; Yazdani, Necma; Reed, Eric R.; Beierle, Jacob A.; Peterson, Lucy P.; Luttik, Kimberly P.; Szumlinski, Karen K.; Johnson, William E.; Ash, Peter E. A.; Wolozin, Benjamin; Bryant, Camron D.			5 ' UTR variants in the quantitative trait gene Hnrnph1 support reduced 5 ' UTR usage and hnRNP H protein as a molecular mechanism underlying reduced methamphetamine sensitivity	FASEB JOURNAL			English	Article						alternative splicing; functional variants; positional cloning; psychostimulant; RNA binding protein; untranslated regions	RECEPTOR 1 REGULATION; REGULATE ANXIETY; EXPRESSION; METHYLGLYOXAL; 5'-UTR	We previously identified a 210 kb region on chromosome 11 (50.37-50.58 Mb, mm10) containing two protein-coding genes (Hnrnph1, Rufy1) that was necessary for reduced methamphetamine-induced locomotor activity in C57BL/6J congenic mice harboring DBA/2J polymorphisms. Gene editing of a small deletion in the first coding exon supported Hnrnph1 as a quantitative trait gene. We have since shown that Hnrnph1 mutants also exhibit reduced methamphetamine-induced reward, reinforcement, and dopamine release. However, the quantitative trait variants (QTVs) that modulate Hnrnph1 function at the molecular level are not known. Nine single nucleotide polymorphisms and seven indels distinguish C57BL/6J from DBA/2J within Hnrnph1, including four variants within the 5 ' untranslated region (UTR). Here, we show that a 114 kb introgressed region containing Hnrnph1 and Rufy1 was sufficient to cause a decrease in MA-induced locomotor activity. Gene-level transcriptome analysis of striatal tissue from 114 kb congenics vs Hnrnph1 mutants identified a nearly perfect correlation of fold-change in expression for those differentially expressed genes that were common to both mouse lines, indicating functionally similar effects on the transcriptome and behavior. Exon-level analysis (including noncoding exons) revealed decreased 5 ' UTR usage of Hnrnph1 and immunoblot analysis identified a corresponding decrease in hnRNP H protein in 114 kb congenic mice. Molecular cloning of the Hnrnph1 5 ' UTR containing all four variants (but none of them individually) upstream of a reporter induced a decrease in reporter signal in both HEK293 and N2a cells, thus, identifying a set of QTVs underlying molecular regulation of Hnrnph1.	[Ruan, Qiu T.; Yazdani, Necma; Beierle, Jacob A.; Luttik, Kimberly P.; Bryant, Camron D.] Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut & Psychiat, Lab Addict Genet, Boston, MA 02118 USA; [Ruan, Qiu T.; Yazdani, Necma; Beierle, Jacob A.; Peterson, Lucy P.; Bryant, Camron D.] Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Biomol Pharmacol Training Program, Boston, MA 02118 USA; [Ruan, Qiu T.; Yazdani, Necma; Beierle, Jacob A.; Bryant, Camron D.] Boston Univ, Sch Med, Transformat Training Program Addict Sci, Boston, MA 02118 USA; [Reed, Eric R.] Boston Univ, PhD Program Bioinformat, Boston, MA USA; [Szumlinski, Karen K.] Univ Calif Santa Barbara, Neurosci Res Inst, Dept Psychol & Brain Sci Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Johnson, William E.] Boston Univ, Sch Med, Dept Med Computat Biomed, Boston, MA 02118 USA; [Ash, Peter E. A.; Wolozin, Benjamin] Boston Univ, Sch Med, Lab Neurodegenerat, Dept Pharmacol & Expt Therapeut & Neurol, Boston, MA 02118 USA	Boston University; Boston University; Boston University; Boston University; University of California System; University of California Santa Barbara; Boston University; Boston University	Bryant, CD (corresponding author), Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, 72 E Concord St L-616, Boston, MA 02118 USA.; Bryant, CD (corresponding author), Boston Univ, Sch Med, Dept Psychiat, 72 E Concord St L-616, Boston, MA 02118 USA.	camron@bu.edu	Szumlinski, Karen K./J-9617-2015; Bryant, Camron D/J-2408-2015	Szumlinski, Karen K./0000-0003-1078-1077; Bryant, Camron D/0000-0003-4505-5809; Beierle, Jacob/0000-0001-6517-7614; Ruan, Qiu/0000-0002-7136-1079	National Institute on Drug Abuse (NIDA) [R01DA039168, F31DA40324]; National Institute of General Medical Sciences (NIGMS) [T32GM008541]; Burroughs Wellcome Fund (BWF) [1011479]; National Institute on Aging (NIA) [5R01AG050471-05, 1RF1AG056318-01A1]	National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Burroughs Wellcome Fund (BWF)(Burroughs Wellcome Fund); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	National Institute on Drug Abuse (NIDA), Grant/Award Number: R01DA039168 and F31DA40324; National Institute of General Medical Sciences (NIGMS), Grant/Award Number: T32GM008541; Burroughs Wellcome Fund (BWF), Grant/Award Number: 1011479; National Institute on Aging (NIA), Grant/Award Number: 5R01AG050471-05 and 1RF1AG056318-01A1	Aldridge GM, 2008, J NEUROSCI METH, V172, P250, DOI 10.1016/j.jneumeth.2008.05.003; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; Araujo PR, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/475731; Bryant CD, 2018, MOLECULAR-GENETIC AND STATISTICAL TECHNIQUES FOR BEHAVIORAL AND NEURAL RESEARCH, P165, DOI 10.1016/B978-0-12-804078-2.00008-8; Bryant CD, 2012, NEUROPSYCHOPHARMACOL, V37, P1026, DOI 10.1038/npp.2011.287; Bryant CD, 2011, ANN NY ACAD SCI, V1245, P31, DOI 10.1111/j.1749-6632.2011.06325.x; Bryant CD, 2009, PSYCHOPHARMACOLOGY, V203, P703, DOI 10.1007/s00213-008-1417-z; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Chatterjee S, 2009, BIOL CELL, V101, P251, DOI 10.1042/BC20080104; Chen E. Y., 2013, BIOINFORMATICS, V14, P5; Chick JM, 2016, NATURE, V534, P500, DOI 10.1038/nature18270; Cook KB, 2011, NUCLEIC ACIDS RES, V39, pD301, DOI 10.1093/nar/gkq1069; Dassi E, 2017, FRONT MOL BIOSCI, V4, DOI 10.3389/fmolb.2017.00067; de Guglielmo G, 2018, PHARMACOL BIOCHEM BE, V167, P36, DOI 10.1016/j.pbb.2018.03.001; DEMINIERE JM, 1989, NEUROSCI BIOBEHAV R, V13, P141, DOI 10.1016/S0149-7634(89)80023-5; DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274; Dickson PE, 2016, PSYCHOPHARMACOLOGY, V233, P701, DOI 10.1007/s00213-015-4147-z; Distler MG, 2013, EPILEPSIA, V54, P649, DOI 10.1111/epi.12121; Distler MG, 2012, J CLIN INVEST, V122, P2306, DOI 10.1172/JCI61319; Dvir S, 2013, P NATL ACAD SCI USA, V110, pE2792, DOI 10.1073/pnas.1222534110; Fisette JF, 2010, RNA, V16, P228, DOI 10.1261/rna.1890310; Fogger SA, 2019, J ADDICT NURS, V30, P219, DOI 10.1097/JAN.0000000000000298; Gelernter J, 2014, MOL PSYCHIATR, V19, P717, DOI 10.1038/mp.2013.99; Gilda JE, 2013, ANAL BIOCHEM, V440, P186, DOI 10.1016/j.ab.2013.05.027; Goldberg LR, 2017, GENES BRAIN BEHAV, V16, P725, DOI 10.1111/gbb.12397; Harkness JH, 2015, NEUROPSYCHOPHARMACOL, V40, P2175, DOI 10.1038/npp.2015.61; Hovatta I, 2005, NATURE, V438, P662, DOI 10.1038/nature04250; Huelga SC, 2012, CELL REP, V1, P167, DOI 10.1016/j.celrep.2012.02.001; Iakoubova OA, 2001, GENOMICS, V74, P89, DOI 10.1006/geno.2000.6497; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jensen Kevin P, 2016, Mol Neuropsychiatry, V2, P37, DOI 10.1159/000444755; Kim Y, 2014, NUCLEIC ACIDS RES, V42, P485, DOI 10.1093/nar/gkt864; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Kumar V, 2013, SCIENCE, V342, P1508, DOI 10.1126/science.1245503; Loftis JM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220270; McMurray KMJ, 2018, MOL PSYCHIATR, V23, P384, DOI 10.1038/mp.2017.14; McMurray KMJ, 2016, BEHAV BRAIN RES, V301, P119, DOI 10.1016/j.bbr.2015.12.026; McMurray KMJ, 2017, ADDICT BIOL, V22, P381, DOI 10.1111/adb.12333; Miner NB, 2017, NEUROTOXICOLOGY, V63, P57, DOI 10.1016/j.neuro.2017.09.006; Mulligan MK, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00188; Nelson EC, 2016, MOL PSYCHIATR, V21, P608, DOI 10.1038/mp.2015.102; Parker CC, 2012, GENES BRAIN BEHAV, V11, P52, DOI 10.1111/j.1601-183X.2011.00747.x; Pierce RC, 2018, NEUROPSYCHOPHARMACOL, V43, P1471, DOI 10.1038/s41386-018-0008-x; Reed C, 2018, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00993; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Ruan QT, 2020, J NEUROSCI, V40, P107, DOI 10.1523/JNEUROSCI.1808-19.2019; Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shi X, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152581; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Stafford AM, 2019, ELIFE, V8, DOI 10.7554/eLife.46472; Steri M, 2018, WIRES RNA, V9, DOI 10.1002/wrna.1474; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Vogel C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.59; Williams R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004649; WISE RA, 1987, PSYCHOL REV, V94, P469, DOI 10.1037/0033-295X.94.4.469; Xu J, 2014, J NEUROSCI, V34, P11048, DOI 10.1523/JNEUROSCI.3986-13.2014; Yalcin B, 2012, MAMM GENOME, V23, P719, DOI 10.1007/s00335-012-9409-z; Yazdani N, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005713; Zhou ZF, 2013, P NATL ACAD SCI USA, V110, P16963, DOI 10.1073/pnas.1309839110	61	7	8	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9223	9244		10.1096/fj.202000092R	http://dx.doi.org/10.1096/fj.202000092R		MAY 2020	22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32401417	Green Submitted, Green Accepted			2022-12-28	WOS:000532216500001
J	Markovic, MA; Srikrishnaraj, A; Tsang, D; Brubaker, PL				Markovic, Melanie A.; Srikrishnaraj, Arjuna; Tsang, Derek; Brubaker, Patricia L.			Requirement for the intestinal epithelial insulin-like growth factor-1 receptor in the intestinal responses to glucagon-like peptide-2 and dietary fat	FASEB JOURNAL			English	Article						APOC3; CD36; enterocyte; FATP-4; GLP-2; MTP; Western diet	ACID TRANSPORT; CHYLOMICRON PRODUCTION; LIPID ABSORPTION; CD36; MICE; LOCALIZATION; DEFICIENCY; RESISTANCE; EXPRESSION; SECRETION	The intestinal hormone, glucagon-like peptide-2 (GLP-2), enhances the enterocyte chylomicron production. However, GLP-2 is known to require the intestinal-epithelial insulin-like growth factor-1 receptor (IE-IGF-1R) for its other actions to increase intestinal growth and barrier function. The role of the IE-IGF-1R in enterocyte lipid handling was thus tested in the GLP-2 signaling pathway, as well as in response to a Western diet (WD). IE-IGF-1R knockout (KO) and control mice were treated for 11 days with h(GLY(2))GLP-2 or fed a WD for 18 weeks followed by a duodenal fat tolerance test with C-14-labeled triolein. Human Caco-2BBE cells were treated with an IGF-1R antagonist or signaling inhibitors to determine triglyceride-associated protein expression. The IE-IGF-1R was required for GLP-2-induced increases in CD36 and FATP-4 in chow-fed mice, and for expression in vitro; FATP-4 also required PI3K/Akt. Although WD-fed IE-IGF-1R KO mice demonstrated normal CD36 expression, the protein was incorrectly localized 2h post-duodenal fat administration. IE-IGF-1R KO also prevented the WD-induced increase in MTP and decrease in APOC3, increased jejunal mucosal C-14-fat accumulation, and elevated plasma triglyceride and C-14-fat levels. Collectively, these studies elucidate new roles for the IE-IGF-1R in enterocyte lipid handling, under basal conditions and in response to GLP-2 and WD-feeding.	[Markovic, Melanie A.; Srikrishnaraj, Arjuna; Tsang, Derek; Brubaker, Patricia L.] Univ Toronto, Dept Physiol, Rm 3366 Med Sci Bldg,1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada; [Brubaker, Patricia L.] Univ Toronto, Dept Med, Toronto, ON, Canada	University of Toronto; University of Toronto	Brubaker, PL (corresponding author), Univ Toronto, Dept Physiol, Rm 3366 Med Sci Bldg,1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	p.brubaker@utoronto.ca		Srikrishnaraj, Arjuna/0000-0002-7828-2779				Alexander AN, 2001, AM J PHYSIOL-GASTR L, V280, pG222, DOI 10.1152/ajpgi.2001.280.2.G222; Bjerknes M, 2001, P NATL ACAD SCI USA, V98, P12497, DOI 10.1073/pnas.211278098; Brubaker PL, 2018, COMPR PHYSIOL, V8, P1185, DOI 10.1002/cphy.c170055; Brubaker PL, 1997, AM J PHYSIOL-ENDOC M, V272, pE1050, DOI 10.1152/ajpendo.1997.272.6.E1050; Buttet M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145626; Coburn CT, 2000, J BIOL CHEM, V275, P32523, DOI 10.1074/jbc.M003826200; Crawley SW, 2014, CELL, V157, P433, DOI 10.1016/j.cell.2014.01.067; Dash S, 2014, GASTROENTEROLOGY, V147, P1275, DOI 10.1053/j.gastro.2014.08.037; Desmarchelier C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-84; Dong CX, 2014, ENDOCRINOLOGY, V155, P370, DOI 10.1210/en.2013-1871; Drover VA, 2005, J CLIN INVEST, V115, P1290, DOI 10.1172/JCI200521514; Dube PE, 2008, ENDOCRINOLOGY, V149, P291, DOI 10.1210/en.2007-0561; Dube PE, 2006, GASTROENTEROLOGY, V131, P589, DOI 10.1053/j.gastro.2006.05.055; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Feingold KR, 2000, EFFECT ENDOCRINE DIS; Glatz JFC, 2010, PHYSIOL REV, V90, P367, DOI 10.1152/physrev.00003.2009; Griffin E, 2001, NAT MED, V7, P840, DOI 10.1038/89969; Haidari M, 2002, J BIOL CHEM, V277, P31646, DOI 10.1074/jbc.M200544200; Hernandez V. S. J., 2009, AM J PHYSIOL-GASTR L, V296, P782; Hsieh J, 2015, ENDOCRINOLOGY, V156, P3538, DOI 10.1210/EN.2015-1110; Hsieh J, 2009, GASTROENTEROLOGY, V137, P997, DOI 10.1053/j.gastro.2009.05.051; Hussain MM, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-14; Hussain MM, 2003, J LIPID RES, V44, P22, DOI 10.1194/jlr.R200014-JLR200; Jain SS, 2015, FEBS LETT, V589, P2769, DOI 10.1016/j.febslet.2015.08.010; Jeppesen PB, 2015, CURR OPIN ENDOCRINOL, V22, P14, DOI 10.1097/MED.0000000000000120; Kappeler L, 2008, PLOS BIOL, V6, P2144, DOI 10.1371/journal.pbio.0060254; Khalifeh-Soltani A, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.87418; Kraus D., 2015, BIO PROTOC, V5, pe1375; Kumar NS, 1999, AM J PHYSIOL-GASTR L, V276, pG378, DOI 10.1152/ajpgi.1999.276.2.G378; Kuwasako T, 2003, DIABETES CARE, V26, P1647, DOI 10.2337/diacare.26.5.1647-a; Larsson M, 2013, J BIOL CHEM, V288, P33997, DOI 10.1074/jbc.M113.495366; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lobo MVT, 2001, J HISTOCHEM CYTOCHEM, V49, P1253, DOI 10.1177/002215540104901007; Markovic MA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49510-5; Masuda D, 2009, J LIPID RES, V50, P999, DOI 10.1194/jlr.P700032-JLR200; Meier JJ, 2006, GASTROENTEROLOGY, V130, P44, DOI 10.1053/j.gastro.2005.10.004; MEYER JH, 1974, AM J PHYSIOL, V226, P1178; Milger K, 2006, J CELL SCI, V119, P4678, DOI 10.1242/jcs.03280; Nakae J, 2001, ENDOCR REV, V22, P818, DOI 10.1210/edrv.22.6.0452; Nauli AM, 2006, GASTROENTEROLOGY, V131, P1197, DOI 10.1053/j.gastro.2006.08.012; Nelson DW, 2008, AM J PHYSIOL-REG I, V294, pR1175, DOI 10.1152/ajpregu.00238.2007; Nelson DW, 2014, J BIOL CHEM, V289, P17338, DOI 10.1074/jbc.M114.555961; Nelson DW, 2011, J LIPID RES, V52, P1723, DOI 10.1194/jlr.M016840; Orskov C, 2005, REGUL PEPTIDES, V124, P105, DOI 10.1016/j.regpep.2004.07.009; Petit V, 2007, J LIPID RES, V48, P278, DOI 10.1194/jlr.M600283-JLR200; Poirier H, 1996, EUR J BIOCHEM, V238, P368, DOI 10.1111/j.1432-1033.1996.0368z.x; Rowland KJ, 2011, GASTROENTEROLOGY, V141, P2166, DOI 10.1053/j.gastro.2011.09.014; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; Stahl A, 2004, PFLUG ARCH EUR J PHY, V447, P722, DOI 10.1007/s00424-003-1106-z; Stahl A, 1999, MOL CELL, V4, P299, DOI 10.1016/S1097-2765(00)80332-9; Thi TTT, 2011, J BIOL CHEM, V286, P25201, DOI 10.1074/jbc.M111.233551; Thorne RF, 2010, BBA-MOL CELL RES, V1803, P1298, DOI 10.1016/j.bbamcr.2010.07.002; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; ULLRICH A, 1986, EMBO J, V5, P2503, DOI 10.1002/j.1460-2075.1986.tb04528.x; ULLRICH A, 1985, NATURE, V313, P756, DOI 10.1038/313756a0; Wang F, 2014, PHYSIOL REP, V2, DOI 10.1002/phy2.247; WATANABE S, 1988, AM J PHYSIOL, V254, pG837, DOI 10.1152/ajpgi.1988.254.6.G837; Xiao CT, 2019, DIABETES OBES METAB, V21, P2535, DOI 10.1111/dom.13839; Xiao CT, 2018, TRENDS ENDOCRIN MET, V29, P151, DOI 10.1016/j.tem.2017.12.001; Yusta B, 2000, GASTROENTEROLOGY, V119, P744, DOI 10.1053/gast.2000.16489; Zhu JB, 2009, J LIPID RES, V50, P1080, DOI 10.1194/jlr.M800555-JLR200	61	5	6	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6628	6640		10.1096/fj.202000169R	http://dx.doi.org/10.1096/fj.202000169R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32212202	Bronze			2022-12-28	WOS:000531325500044
J	Shivshankar, P; Li, YD; Mueller-Ortiz, SL; Wetsel, RA				Shivshankar, Pooja; Li, Yi-Dong; Mueller-Ortiz, Stacey L.; Wetsel, Rick A.			In response to complement anaphylatoxin peptides C3a and C5a, human vascular endothelial cells migrate and mediate the activation of B-cells and polarization of T-cells	FASEB JOURNAL			English	Article						B-cell and T-cells; C3a and C5a; C3aR and C5aR1; complement; lymphocyte endothelial interaction; vascular endothelial cells	SMOOTH-MUSCLE CELLS; CELLULAR EXPRESSION; CYTOKINE PRODUCTION; GROWTH-FACTOR; STEM-CELLS; RECEPTOR; ADHESION; GENE; MACROPHAGES; PROMOTER	The vascular endothelium has been discovered in the past several years to be important in shaping the cellular immune response. During the immune response the vascular endothelium is constantly perturbed by biologically potent molecules, including the complement activation peptides, C3a and C5a. Despite the importance of C3a and C5a in inflammation and immunity, their role in modulating lymphocyte function via activation of vascular endothelial cells is unknown. Accordingly, we investigated the regulated expression of the C3a and C5a receptors (complement anaphylatoxin C3a receptor [C3aR] and complement anaphylatoxin C5a receptor 1 [C5aR1]) on human umbilical vascular endothelial cells (HUVECs) and examined how C3a or C5a activation of HUVECs affects the activation and polarization of lymphatic cells. Our findings demonstrated that C3a and C5a increase C3aR and C5aR1 expression by HUVECs as well as directing their cellular transmigration and spreading through transwell filters. Moreover, C3a- or C5a-stimulated endothelial cells: (1) caused activation of B-lymphoblasts with significant increase in Fas Ligand (CD95L) (FasL), CD69, and IL-R1 expression, and (2) skewed T-lymphoblast cells toward a Th1 subtype, (CD4(+)/CCR5(+)) that correlated with significant increase of IFN-gamma. Collectively, these data indicate that C3a and C5a signaling is important in the activation and polarization of lymphocytes as they traffic through the vascular endothelium during the immune response.	[Shivshankar, Pooja; Li, Yi-Dong; Mueller-Ortiz, Stacey L.; Wetsel, Rick A.] Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med, Res Ctr Immunol & Autoimmune Dis, McGovern Med Sch, Houston, TX 77030 USA; [Wetsel, Rick A.] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Biochem & Mol Biol, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Wetsel, RA (corresponding author), Brown Fdn Inst Mol Med, 1825 Pressler St,Suite 430A, Houston, TX 77030 USA.	Rick.A.Wetsel@uth.tmc.edu			National Institutes of Health Public Service [RO1 AI025011]; Hans J. Muller-Eberhard and Irma Gigli Distinguished Chair in Immunology	National Institutes of Health Public Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hans J. Muller-Eberhard and Irma Gigli Distinguished Chair in Immunology	This work was supported by a National Institutes of Health Public Service Grant RO1 AI025011 (to RAW). Support was also provided by the Hans J. Muller-Eberhard and Irma Gigli Distinguished Chair in Immunology	Basta M, 2003, NAT MED, V9, P431, DOI 10.1038/nm836; Bellows-Peterson ML, 2012, J MED CHEM, V55, P4159, DOI 10.1021/jm201609k; Carman CV, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00603; Chen Hong-Chen, 2004, V294, P15; Debefve E, 2011, LASER SURG MED, V43, P696, DOI 10.1002/lsm.21115; Denton MD, 1999, J EXP MED, V190, P555, DOI 10.1084/jem.190.4.555; Dorosz SA, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/737310; Drouin SM, 2001, J IMMUNOL, V166, P2025, DOI 10.4049/jimmunol.166.3.2025; Ebert J, 2018, BLOOD, V131, P2161, DOI 10.1182/blood-2017-09-807040; Erbilgin A, 2013, ARTERIOSCL THROM VAS, V33, P2509, DOI 10.1161/ATVBAHA.113.301989; Foreman KE, 1996, INFLAMMATION, V20, P1, DOI 10.1007/BF01487740; FOREMAN KE, 1994, J CLIN INVEST, V94, P1147, DOI 10.1172/JCI117430; Gerdes N, 2002, J EXP MED, V195, P245, DOI 10.1084/jem.20011022; HAVILAND DL, 1995, J IMMUNOL, V154, P1861; Hunt JR, 2005, MOL IMMUNOL, V42, P1405, DOI 10.1016/j.molimm.2005.01.002; Hwang MS, 2019, J CELL SCI, V132, DOI 10.1242/jcs.219352; Jagels MA, 2000, IMMUNOPHARMACOLOGY, V46, P209, DOI 10.1016/S0162-3109(99)00178-2; Kao WT, 2008, ANTICANCER RES, V28, P2109; Kildsgaard J, 2000, J IMMUNOL, V165, P5406, DOI 10.4049/jimmunol.165.10.5406; Laudes IJ, 2002, J IMMUNOL, V169, P5962, DOI 10.4049/jimmunol.169.10.5962; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Liu BY, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-111; Mahajan SD, 2015, IMMUNOLOGY, V146, P130, DOI 10.1111/imm.12489; Martin CB, 2005, J IMMUNOL, V175, P3123, DOI 10.4049/jimmunol.175.5.3123; Michaelis UR, 2014, CELL MOL LIFE SCI, V71, P4131, DOI 10.1007/s00018-014-1678-0; Monsinjon T, 2003, FASEB J, V17, P1003, DOI 10.1096/fj.02-0737com; MURPHY HS, 1992, AM J PHYSIOL, V263, pL51, DOI 10.1152/ajplung.1992.263.1.L51; Nakanishi K, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00763; Nilsen EM, 1998, GUT, V42, P635, DOI 10.1136/gut.42.5.635; Noronha AM, 2009, J LEUKOCYTE BIOL, V86, P1007, DOI 10.1189/jlb.0309203; Nourshargh S, 2014, IMMUNITY, V41, P694, DOI 10.1016/j.immuni.2014.10.008; Oliveira SDS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023547; Orrem HL, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02035; Palmer E, 2012, MOL IMMUNOL, V52, P88, DOI 10.1016/j.molimm.2012.04.012; Pober JS, 2012, TRENDS IMMUNOL, V33, P49, DOI 10.1016/j.it.2011.09.006; Reis ES, 2018, NAT REV IMMUNOL, V18, P5, DOI 10.1038/nri.2017.97; Sartain SE, 2018, J BIOL CHEM, V293, P7195, DOI 10.1074/jbc.RA118.002639; Schaefer M, 2005, J BIOL CHEM, V280, P42113, DOI 10.1074/jbc.M508146200; Schraufstatter IU, 2015, WORLD J STEM CELLS, V7, P1090, DOI 10.4252/wjsc.v7.i8.1090; Schraufstatter IU, 2009, J IMMUNOL, V182, P3827, DOI 10.4049/jimmunol.0803055; Schraufstatter IU, 2002, J IMMUNOL, V169, P2102, DOI 10.4049/jimmunol.169.4.2102; Shrestha B, 2010, J IMMUNOL, V184, P4819, DOI 10.4049/jimmunol.0903063; Tan JQ, 1997, J IMMUNOL, V158, P475; Treudler R, 1996, ARCH DERMATOL, V132, P1323, DOI 10.1001/archderm.132.11.1323; Trouw LA, 2017, NAT REV RHEUMATOL, V13, DOI 10.1038/nrrheum.2017.125; Turner NA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121994; Turner NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059372; Urban D, 2011, BIOCHEM BIOPH RES CO, V404, P448, DOI 10.1016/j.bbrc.2010.11.142; Van Beek J, 2000, EXP NEUROL, V161, P373, DOI 10.1006/exnr.1999.7273; Vazquez MI, 2015, CYTOKINE, V74, P318, DOI 10.1016/j.cyto.2015.02.007; Wang JJ, 2015, WORLD J DIABETES, V6, P726, DOI 10.4239/wjd.v6.i5.726; Wetsel RA, 2000, CONT IMMUN, V9, P113; WETSEL RA, 1995, CURR OPIN IMMUNOL, V7, P48, DOI 10.1016/0952-7915(95)80028-X; Whiteside SK, 2018, TRENDS IMMUNOL, V39, P1021, DOI 10.1016/j.it.2018.10.003; Young MR, 2012, CANCER IMMUNOL IMMUN, V61, P1609, DOI 10.1007/s00262-012-1335-0; Yves L, 2017, MOL IMMUNOL, V84, P51, DOI 10.1016/j.molimm.2016.11.013; Zhang T, 2017, J IMMUNOL RES, V2017, DOI 10.1155/2017/6073961	57	5	7	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					7540	7560		10.1096/fj.201902397R	http://dx.doi.org/10.1096/fj.201902397R		APR 2020	21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32301538				2022-12-28	WOS:000526643300001
J	Song, M; Yang, Q; Zhang, FL; Chen, L; Su, H; Yang, XH; He, HW; Liu, FF; Zheng, JS; Ling, MF; Lai, XM; Zhu, XT; Wang, LN; Gao, P; Shu, G; Jiang, QY; Wang, SB				Song, Min; Yang, Qiang; Zhang, Fenglin; Chen, Lin; Su, Han; Yang, Xiaohua; He, Haiwen; Liu, Fangfang; Zheng, Jisong; Ling, Mingfa; Lai, Xumin; Zhu, Xiaotong; Wang, Lina; Gao, Ping; Shu, Gang; Jiang, Qingyan; Wang, Songbo			Hyodeoxycholic acid (HDCA) suppresses intestinal epithelial cell proliferation through FXR-PI3K/AKT pathway, accompanied by alteration of bile acids metabolism profiles induced by gut bacteria	FASEB JOURNAL			English	Article						bile acids metabolism profiles; FXR-PI3K; AKT; gut bacteria; hyodeoxycholic acid (HDCA); intestinal epithelial cell proliferation	MUCOSAL INJURY; MICROBIOTA; ACTIVATION; GALLSTONES; APOPTOSIS	Bile acids (BAs) have been implicated in regulation of intestinal epithelial signaling and function. This study aimed to investigate the effects of hyodeoxycholic acid (HDCA) on intestinal epithelial cell proliferation and explore the underlying mechanisms. IPEC-J2 cells and weaned piglets were treated with HDCA and the contributions of cellular signaling pathways, BAs metabolism profiles and gut bacteria were assessed. In vitro, HDCA suppressed IPEC-J2 proliferation via the BAs receptor FXR but not TGR5. In addition, HDCA inhibited the PI3K/AKT pathway, while knockdown of FXR or constitutive activation of AKT eliminated the inhibitory effects of HDCA, suggesting that FXR-dependent inhibition of PI3K/AKT pathway was involved in HDCA-suppressed IPEC-J2 proliferation. In vivo, dietary HDCA inhibited intestinal expression of proliferative markers and PI3K/AKT pathway in weaned piglets. Meanwhile, HDCA altered the BAs metabolism profiles, with decrease in primary BA and increase in total and secondary BAs in feces, and reduction of conjugated BAs in serum. Furthermore, HDCA increased abundance of the gut bacteria associated with BAs metabolism, and thereby induced BAs profiles alternation, which might indirectly contribute to HDCA-suppressed cell proliferation. Together, HDCA suppressed intestinal epithelial cell proliferation through FXR-PI3K/AKT signaling pathway, accompanied by alteration of BAs metabolism profiles induced by gut bacteria.	[Song, Min; Yang, Qiang; Zhang, Fenglin; Chen, Lin; Su, Han; Yang, Xiaohua; He, Haiwen; Liu, Fangfang; Zheng, Jisong; Ling, Mingfa; Lai, Xumin; Zhu, Xiaotong; Wang, Lina; Gao, Ping; Shu, Gang; Jiang, Qingyan; Wang, Songbo] South China Agr Univ, Coll Anim Sci, Guangdong Lab Lingnan Modern Agr, Guangdong Prov Key Lab Anim Nutr Control, Guangzhou 510642, Peoples R China; [Song, Min; Yang, Qiang; Zhang, Fenglin; Chen, Lin; Su, Han; Yang, Xiaohua; He, Haiwen; Liu, Fangfang; Zheng, Jisong; Ling, Mingfa; Lai, Xumin; Zhu, Xiaotong; Wang, Lina; Gao, Ping; Shu, Gang; Jiang, Qingyan; Wang, Songbo] South China Agr Univ, Natl Engn Res Ctr Breeding Swine Ind, Guangzhou, Peoples R China; [Song, Min; Yang, Qiang; Zhang, Fenglin; Chen, Lin; Su, Han; Yang, Xiaohua; He, Haiwen; Liu, Fangfang; Zheng, Jisong; Ling, Mingfa; Lai, Xumin; Zhu, Xiaotong; Wang, Lina; Gao, Ping; Shu, Gang; Jiang, Qingyan; Wang, Songbo] South China Agr Univ, ALLTECH SCAU Anim Nutr Control Res Alliance, Guangzhou, Peoples R China	South China Agricultural University; South China Agricultural University; South China Agricultural University	Jiang, QY; Wang, SB (corresponding author), South China Agr Univ, Coll Anim Sci, Guangdong Lab Lingnan Modern Agr, Guangdong Prov Key Lab Anim Nutr Control, Guangzhou 510642, Peoples R China.	qyjiang@scau.edu.cn; songbowang@scau.edu.cn			National Natural Science Foundation of China [31672508, 31972636, 31790411]; National Key Research and Development Program of China [2017YFD0500501]; South China Agricultural University Doctoral Innovative Talent Cultivation Program [CX2019N006]; Guangdong Key areas Research and Development Project [2019B020218001]; Guangdong Provincial Promotion Project on Preservation and Utilization of Local Breed of Livestock and Poultry	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; South China Agricultural University Doctoral Innovative Talent Cultivation Program; Guangdong Key areas Research and Development Project; Guangdong Provincial Promotion Project on Preservation and Utilization of Local Breed of Livestock and Poultry	National Natural Science Foundation of China, Grant/Award Number: 31672508, 31972636 and 31790411; National Key Research and Development Program of China, Grant/Award Number: 2017YFD0500501; South China Agricultural University Doctoral Innovative Talent Cultivation Program, Grant/Award Number: CX2019N006; Guangdong Key areas Research and Development Project, Grant/Award Number: 2019B020218001; Guangdong Provincial Promotion Project on Preservation and Utilization of Local Breed of Livestock and Poultry	Ahmad TR, 2019, NAT REV ENDOCRINOL, V15, P701, DOI 10.1038/s41574-019-0266-7; Bergstrom KSB, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005108; Carbajo-Pescador S, 2019, DIS MODEL MECH, V12, DOI 10.1242/dmm.039206; Chen ZG, 2018, MOLECULES, V23, DOI 10.3390/molecules23082012; Chevre R, 2018, TRENDS ENDOCRIN MET, V29, P686, DOI 10.1016/j.tem.2018.08.002; COHEN BI, 1988, LIPIDS, V23, P220, DOI 10.1007/BF02535461; Dossa AY, 2016, AM J PHYSIOL-GASTR L, V310, pG81, DOI 10.1152/ajpgi.00065.2015; Fang W, 2018, J ANIM SCI, V96, P4743, DOI 10.1093/jas/sky327; Fu T, 2019, CELL, V176, P1098, DOI 10.1016/j.cell.2019.01.036; Guo J, 2017, INT J MOL MED, V40, P1435, DOI 10.3892/ijmm.2017.3120; Hu FF, 2019, GENE, V700, P96, DOI 10.1016/j.gene.2019.03.051; Huang FJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12896-x; Ishizuka S, 2012, BIOMED RES-TOKYO, V33, P159, DOI 10.2220/biomedres.33.159; Jahnel J, 2014, DRUG METAB DISPOS, V42, P1423, DOI 10.1124/dmd.114.058065; Ji CG, 2017, TRANSL RES, V182, P88, DOI 10.1016/j.trsl.2016.12.001; Jia W, 2018, NAT REV GASTRO HEPAT, V15, P111, DOI 10.1038/nrgastro.2017.119; Kakiyama G, 2013, J HEPATOL, V58, P949, DOI 10.1016/j.jhep.2013.01.003; Lin H, 2019, J AGR FOOD CHEM, V67, P3624, DOI 10.1021/acs.jafc.9b00249; MahmoudianDehkordi S, 2019, ALZHEIMERS DEMENT, V15, P76, DOI 10.1016/j.jalz.2018.07.217; Malisova L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082086; Martinot E, 2017, MOL ASPECTS MED, V56, P2, DOI 10.1016/j.mam.2017.01.006; Meng YY, 2017, J AGR FOOD CHEM, V65, P95, DOI 10.1021/acs.jafc.6b04878; Molinaro A, 2018, TRENDS ENDOCRIN MET, V29, P31, DOI 10.1016/j.tem.2017.11.002; Powell AA, 2001, BIOCHEM J, V356, P481, DOI 10.1042/0264-6021:3560481; Qi XY, 2019, NAT MED, V25, P1225, DOI 10.1038/s41591-019-0509-0; Ridlon JM, 2015, ACTA PHARM SIN B, V5, P99, DOI 10.1016/j.apsb.2015.01.006; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; Schneider KM, 2018, J HEPATOL, V68, P1083, DOI 10.1016/j.jhep.2017.11.025; Seekatz AM, 2018, ANAEROBE, V53, P64, DOI 10.1016/j.anaerobe.2018.04.001; Sehayek E, 2001, J LIPID RES, V42, P1250; Shih DM, 2013, FASEB J, V27, P3805, DOI 10.1096/fj.12-223008; SINGHAL AK, 1984, J LIPID RES, V25, P539; Sukhotnik I, 2007, J SURG RES, V143, P379, DOI 10.1016/j.jss.2007.02.002; Sun LY, 2019, CANCER BIOL THER, V20, P1017, DOI 10.1080/15384047.2019.1595277; Theriot CM, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00045-15; Toledo A, 2004, DIGEST DIS SCI, V49, P1664, DOI 10.1023/B:DDAS.0000043383.96077.99; Trudeau MP, 2018, FRONT VET SCI, V5, DOI 10.3389/fvets.2018.00196; Uchiyama K, 2018, J IMMUNOL RES, V2018, DOI 10.1155/2018/7270486; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; Vergauwen H., 2015, IMPACT FOOD BIOACTIV, P125; Wahlstrom A, 2016, CELL METAB, V24, P41, DOI 10.1016/j.cmet.2016.05.005; Wang DQH, 2003, AM J PHYSIOL-GASTR L, V285, pG494, DOI 10.1152/ajpgi.00156.2003; Wang K, 2019, CELL REP, V26, P222, DOI 10.1016/j.celrep.2018.12.028; Wang SB, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201600746; Watanabe S, 2014, LIPIDS, V49, P963, DOI 10.1007/s11745-014-3947-y; Winston JA, 2020, GUT MICROBES, V11, P158, DOI 10.1080/19490976.2019.1674124; Xie R, 2013, J CEREBR BLOOD F MET, V33, P1875, DOI 10.1038/jcbfm.2013.132; Xiong F, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02209; Yamaguchi J, 2004, SURGERY, V135, P215, DOI 10.1016/j.surg.2003.08.025; Zeng HW, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20051214; Zeng HW, 2015, J NUTR BIOCHEM, V26, P1022, DOI 10.1016/j.jnutbio.2015.04.007; Zheng P, 2016, MOL PSYCHIATR, V21, P786, DOI 10.1038/mp.2016.44; Zhou WN, 2018, EXP BIOL MED, V243, P911, DOI 10.1177/1535370218785152	53	17	23	2	30	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					7103	7117		10.1096/fj.201903244R	http://dx.doi.org/10.1096/fj.201903244R		APR 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32246800				2022-12-28	WOS:000525013300001
J	Colecraft, HM; Khanna, R				Colecraft, Henry M.; Khanna, Rajesh			The 2019 FASEB Science Research Conference on Ion Channel Regulation: Molecules to Disease, July 7-12, 2019, Lisbon, Portugal	FASEB JOURNAL			English	Article							MODULATION		[Colecraft, Henry M.] Columbia Univ, Vagelos Coll Phys & Surg, Dept Physiol & Cellular Biophys, New York, NY 10027 USA; [Colecraft, Henry M.] Columbia Univ, Vagelos Coll Phys & Surg, Dept Pharmacol, New York, NY 10027 USA; [Khanna, Rajesh] Univ Arizona, Coll Med, Dept Pharmacol, Tucson, AZ 85724 USA; [Khanna, Rajesh] Univ Arizona, Coll Med, Dept Anesthesiol, Tucson, AZ USA; [Khanna, Rajesh] Univ Arizona Hlth Sci, Ctr Innovat Brain Sci, Tucson, AZ USA	Columbia University; Columbia University; University of Arizona; University of Arizona; University of Arizona; University of Arizona Health Sciences	Colecraft, HM (corresponding author), Columbia Univ, Vagelos Coll Phys & Surg, Dept Physiol & Cellular Biophys, New York, NY 10027 USA.; Colecraft, HM (corresponding author), Columbia Univ, Vagelos Coll Phys & Surg, Dept Pharmacol, New York, NY 10027 USA.; Khanna, R (corresponding author), Univ Arizona, Coll Med, Dept Pharmacol, Tucson, AZ 85724 USA.	hc2405@cumc.columbia.edu; rkhanna@email.arizona.edu			NINDS NIH HHS [R13 NS111788] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ashcroft FM, 2017, TRENDS ENDOCRIN MET, V28, P377, DOI 10.1016/j.tem.2017.02.003; Carter BC, 2011, J NEUROPHYSIOL, V105, P860, DOI 10.1152/jn.01056.2010; Clatot J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02262-0; Do MTH, 2003, NEURON, V39, P109, DOI 10.1016/S0896-6273(03)00360-X; Dustrude ET, 2016, P NATL ACAD SCI USA, V113, pE8443, DOI 10.1073/pnas.1610531113; Francois-Moutal L, 2018, CHANNELS, V12, P219, DOI 10.1080/19336950.2018.1491244; Kabir ZD, 2017, NEUROTHERAPEUTICS, V14, P588, DOI 10.1007/s13311-017-0532-0; Lolicato M, 2017, NATURE, V547, P364, DOI 10.1038/nature22988; Nicoli ER, 2019, AM J HUM GENET, V104, P1127, DOI 10.1016/j.ajhg.2019.04.008; Pereira V., 2018, WELLCOME OPEN RES, V3, P101; Saponaro A, 2018, ELIFE, V7, DOI 10.7554/eLife.35753; Yang L, 2019, J CLIN INVEST, V129, P647, DOI 10.1172/JCI123878	12	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					4828	4831		10.1096/fj.202000367	http://dx.doi.org/10.1096/fj.202000367			4	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32157730	Green Accepted, Bronze			2022-12-28	WOS:000530242100003
J	Song, JH; Wang, CJ; Long, DL; Li, ZG; You, LS; Brand-Saberi, B; Wang, G; Yang, XS				Song, Jinhuan; Wang, Chaojie; Long, Denglu; Li, Ziguang; You, Lingsen; Brand-Saberi, Beate; Wang, Guang; Yang, Xuesong			Dysbacteriosis-induced LPS elevation disturbs the development of muscle progenitor cells by interfering with retinoic acid signaling	FASEB JOURNAL			English	Article						gut microbiota dysbiosis; LPS; myogenesis; retinoic acid signaling; somitogenesis	INTRAUTERINE FETAL-DEATH; REGULATORY FACTORS MYF5; SKELETAL-MUSCLE; GUT DYSBIOSIS; CHICK-EMBRYO; IN-VIVO; DIFFERENTIATION; SOMITOGENESIS; EXPRESSION; MYOGENESIS	Whether myogenesis is affected by the maternal gut dysbacteriosis still remains ambiguous. In this study, first we show the elevated level of lipopolysaccharides (LPS) in a gut microbiota dysbiosis mouse model. Second, we demonstrate that the diameter of muscle fibers, limb development, and somitogenesis were inhibited in both the gut microbiota dysbiosis and LPS exposed mice and chicken embryos. These might be due to LPS disturbed the cell survival and key genes which regulate the somitogenesis and myogenesis. RNA sequencing and subsequent validation experiments verified that retinoic acid (RA) signaling perturbation was mainly responsible for the aberrant somite formation and differentiation. Subsequently, we found that LPS-induced reactive oxygen species (ROS generation and antioxidant genes such as Nrf2, AKR1B10) contributed to the above -mentioned interference with RA signaling. These findings highlight that the gut microbiota homeostasis is also involved in regulating the development of muscle progenitor cells during pregnancy.	[Song, Jinhuan; Wang, Chaojie; Long, Denglu; Li, Ziguang; You, Lingsen; Wang, Guang; Yang, Xuesong] Jinan Univ, Int Joint Lab Embryon Dev & Prenatal Med, Div Histol & Embryol, Guangzhou 510632, Peoples R China; [Brand-Saberi, Beate] Ruhr Univ Bochum, Inst Anat, Dept Anat & Mol Embryol, Bochum, Germany; [Yang, Xuesong] Jinan Univ, Minist Educ, Key Lab Regenerat Med, Guangzhou, Peoples R China	Jinan University; Ruhr University Bochum; Jinan University	Wang, G; Yang, XS (corresponding author), Jinan Univ, Int Joint Lab Embryon Dev & Prenatal Med, Div Histol & Embryol, Guangzhou 510632, Peoples R China.	wangguang7453@126.com; yang_xuesong@126.com	Brand-Saberi, Beate/GVT-9451-2022; Wang, Guang/AAC-4624-2019		National Natural Science Foundation of China (NSFC) [31771331, 31971108]; National College Students Innovation and Entrepreneurship Training Program [CX18044, CX2019098]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National College Students Innovation and Entrepreneurship Training Program	National Natural Science Foundation of China (NSFC), Grant/Award Number: 31771331 and 31971108; National College Students Innovation and Entrepreneurship Training Program, Grant/Award Number: CX18044 and CX2019098	Aisemberg J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056161; Aleshukina A. V., 2012, Zhurnal Mikrobiologii Epidemiologii i Immunobiologii, P74; Alexander C, 2001, J ENDOTOXIN RES, V7, P167, DOI 10.1179/096805101101532675; Awad N, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2011.01.030; Bayha E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005845; BUMCROT DA, 1995, CURR BIOL, V5, P612, DOI 10.1016/S0960-9822(95)00123-0; Carapuco M, 2005, GENE DEV, V19, P2116, DOI 10.1101/gad.338705; Chal J, 2017, DEVELOPMENT, V144, P2104, DOI 10.1242/dev.151035; Chapman SC, 2001, DEV DYNAM, V220, P284, DOI 10.1002/1097-0177(20010301)220:3<284::AID-DVDY1102>3.0.CO;2-5; Cheng X, 2019, J CELL PHYSIOL, V234, P2593, DOI 10.1002/jcp.27025; Chkhaidze I G, 1998, Zh Mikrobiol Epidemiol Immunobiol, P12; Collins JJP, 2012, AM J PHYSIOL-LUNG C, V303, pL778, DOI 10.1152/ajplung.00280.2011; Duester Gregg, 2007, Birth Defects Research, V81, P84, DOI 10.1002/bdrc.20092; Emoto Y, 2005, DEV BIOL, V278, P415, DOI 10.1016/j.ydbio.2004.11.023; FAN CM, 1994, CELL, V79, P1175, DOI 10.1016/0092-8674(94)90009-4; Galli LM, 2008, DEV DYNAM, V237, P1862, DOI 10.1002/dvdy.21585; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Hay AJ, 2016, ADV APPL MICROBIOL, V96, P43, DOI 10.1016/bs.aambs.2016.07.019; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Huang RL, 2014, STEM CELLS DEV, V23, P277, DOI 10.1089/scd.2013.0345; Iimura T, 2009, CURR TOP DEV BIOL, V88, P201, DOI 10.1016/S0070-2153(09)88007-1; Jaiswal YK, 2009, FERTIL STERIL, V91, P2095, DOI 10.1016/j.fertnstert.2008.04.050; Joint FAO/WHO Expert Committee on Food Additives, 2009, TOX EV CERT VET DRUG; Kablar B, 2003, DEV BIOL, V258, P307, DOI 10.1016/S0012-1606(03)00139-8; Kam RKT, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-11; Kohmura Y, 2000, MICROBIOL IMMUNOL, V44, P897, DOI 10.1111/j.1348-0421.2000.tb02581.x; Kurita N, 2017, J NEUROL SCI, V381, P875, DOI 10.1016/j.jns.2017.08.2466; Lee ASJ, 2013, DEV DYNAM, V242, P1043, DOI 10.1002/dvdy.23998; Lin CY, 2006, DEV BIOL, V299, P594, DOI 10.1016/j.ydbio.2006.08.042; Long Y, 2018, CELL CYCLE, V17, P1757, DOI 10.1080/15384101.2018.1496743; Misske J, 2007, PEDIATR CARDIOL, V28, P263, DOI 10.1007/s00246-006-0109-x; Musumeci G, 2015, ACTA HISTOCHEM, V117, P313, DOI 10.1016/j.acthis.2015.02.011; Naiche LA, 2011, P NATL ACAD SCI USA, V108, P4018, DOI 10.1073/pnas.1007417108; Niederreither K, 1997, MECH DEVELOP, V62, P67, DOI 10.1016/S0925-4773(96)00653-3; Nuriel-Ohayon M, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01031; Olivera-Martinez I, 2000, DEVELOPMENT, V127, P4611; Penning TM, 2017, CHEM RES TOXICOL, V30, P162, DOI 10.1021/acs.chemrestox.6b00319; Perry RJ, 2016, NATURE, V534, P213, DOI 10.1038/nature18309; Pitt JA, 1997, REPROD TOXICOL, V11, P771, DOI 10.1016/S0890-6238(97)00060-9; Porte S, 2013, CHEM-BIOL INTERACT, V202, P186, DOI 10.1016/j.cbi.2012.11.014; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rashidi H, 2009, BIOESSAYS, V31, P459, DOI 10.1002/bies.200800168; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; Rogers GB, 2016, MOL PSYCHIATR, V21, P738, DOI 10.1038/mp.2016.50; Serino M, 2014, CURR CARDIOL REP, V16, DOI 10.1007/s11886-014-0540-1; Smith CA, 1995, TERATOLOGY, V52, P333, DOI 10.1002/tera.1420520604; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Straley ME, 2014, PLACENTA, V35, P533, DOI 10.1016/j.placenta.2014.06.001; TAM PPL, 1981, J EMBRYOL EXP MORPH, V65, P103; Trajkovski M, 2016, NATURE, V534, P185, DOI 10.1038/534185a; Vadiveloo PK, 2001, BBA-MOL CELL RES, V1539, P140, DOI 10.1016/S0167-4889(01)00102-1; Vasyutina E, 2005, GENE DEV, V19, P2187, DOI 10.1101/gad.346205; Vattemi G, 2005, NEUROPATH APPL NEURO, V31, P45, DOI 10.1111/j.1365-2990.2004.00602.x; Wang HJ, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085484, 10.1371/journal.pone.0097917]; Ward L, 2018, DEV BIOL, V439, P3, DOI 10.1016/j.ydbio.2018.04.005; Ruiz FX, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00058; Xu DX, 2007, TOXICOLOGY, V234, P167, DOI 10.1016/j.tox.2007.02.010; Yang Y, 2014, DIS MODEL MECH, V7, P1131, DOI 10.1242/dmm.016428; Yusuf F, 2006, DEV DYNAM, V235, P3007, DOI 10.1002/dvdy.20951; Zammit PS, 2017, SEMIN CELL DEV BIOL, V72, P19, DOI 10.1016/j.semcdb.2017.11.011; Zhang P, 2018, CELL PHYSIOL BIOCHEM, V49, P2483, DOI 10.1159/000493874; Zhang P, 2017, TOXICOL LETT, V281, P53, DOI 10.1016/j.toxlet.2017.09.010; Zhang YJ, 2015, INT J MOL SCI, V16, P7493, DOI 10.3390/ijms16047493; Zhao K, 2014, EUR J PHARMACOL, V737, P57, DOI 10.1016/j.ejphar.2014.05.011	64	7	7	0	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6837	6853		10.1096/fj.201902965R	http://dx.doi.org/10.1096/fj.201902965R		MAR 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32223025				2022-12-28	WOS:000522485900001
J	Ng, HP; Kim, GD; Chan, ER; Dunwoodie, SL; Mahabeleshwar, GH				Hang Pong Ng; Kim, Gun-Dong; Chan, E. Ricky; Dunwoodie, Sally L.; Mahabeleshwar, Ganapati H.			CITED2 limits pathogenic inflammatory gene programs in myeloid cells	FASEB JOURNAL			English	Article						CITED2; inflammation; innate immunity; macrophage	CREB-BINDING-PROTEIN; KAPPA-B; HEART; IDENTIFICATION; RECOGNITION; RESOLUTION; RECEPTORS	Monocyte-derived macrophages are the major innate immune cells that provide the first line of cellular defense against infections or injuries. These recruited macrophages at the site of inflammation are exposed to a broad range of cytokines that categorically incite a robust pro-inflammatory response. However, macrophage pro-inflammatory activation must be under exquisite control to avert unbridled inflammation. Thus, endogenous mechanisms must exist that rigorously preserve macrophage quiescence and yet, allow nimble pro-inflammatory macrophage response with precise spatiotemporal control. Herein, we identify the CBP/p300-interacting transactivator with glutamic acid/aspartic acid-rich carboxyl-terminal domain 2 (CITED2) as a critical intrinsic negative regulator of inflammation, which broadly attenuates pro-inflammatory gene programs in macrophages. Our in vivo studies revealed that myeloid-CITED2 deficiency significantly heightened macrophages and neutrophils recruitment to the site of inflammation. Our integrated transcriptomics and gene set enrichment analysis (GSEA) studies uncovered that CITED2 deficiency broadly enhances NF kappa B targets, IFN gamma/IFN alpha responses, and inflammatory response gene expression in macrophages. Using complementary gain- and loss-of-function studies, we observed that CITED2 overexpression attenuate and CITED2 deficiency elevate LPS-induced NF kappa B transcriptional activity and NF kappa B-p65 recruitment to target gene promoter in macrophages. More importantly, blockade of NF kappa B signaling completely reversed elevated pro-inflammatory gene expression in macrophages. Collectively, our findings show that CITED2 restrains NF kappa B activation and curtails broad pro-inflammatory gene programs in myeloid cells.	[Hang Pong Ng; Kim, Gun-Dong; Mahabeleshwar, Ganapati H.] Case Western Reserve Univ, Sch Med, Dept Pathol, 2103 Cornell Rd,Room WRB5527, Cleveland, OH 44106 USA; [Chan, E. Ricky] Case Western Reserve Univ, Sch Med, Cleveland Inst Computat Biol, Cleveland, OH 44106 USA; [Dunwoodie, Sally L.] Victor Chang Cardiac Res Inst, Sydney, NSW, Australia; [Dunwoodie, Sally L.] UNSW Sydney, Sydney, NSW, Australia; [Mahabeleshwar, Ganapati H.] Case Western Reserve Univ, Sch Med, Cardiovasc Res Inst, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Victor Chang Cardiac Research Institute; University of New South Wales Sydney; Case Western Reserve University	Mahabeleshwar, GH (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pathol, 2103 Cornell Rd,Room WRB5527, Cleveland, OH 44106 USA.	ghm4@case.edu			HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) [HL126626, HL141423]; Crohn's and Colitis Foundation of America (CCFA) [421904]	HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI); Crohn's and Colitis Foundation of America (CCFA)	HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: HL126626 and HL141423; Crohn's and Colitis Foundation of America (CCFA), Grant/Award Number: 421904	Bamforth SD, 2004, NAT GENET, V36, P1189, DOI 10.1038/ng1446; Bamforth SD, 2001, NAT GENET, V29, P469, DOI 10.1038/ng768; Bhattacharya S, 1999, GENE DEV, V13, P64, DOI 10.1101/gad.13.1.64; Chen Y, 2007, BLOOD, V110, P2889, DOI 10.1182/blood-2007-01-066316; Chu WT, 2020, P NATL ACAD SCI USA, V117, P5595, DOI 10.1073/pnas.1915333117; Das A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00022; De Guzman RN, 2004, J BIOL CHEM, V279, P3042, DOI 10.1074/jbc.M310348200; Fitzgerald KA, 2020, CELL, V180, P1044, DOI 10.1016/j.cell.2020.02.041; Floro KL, 2011, HUM MOL GENET, V20, P1097, DOI 10.1093/hmg/ddq554; Freedman SJ, 2003, NAT STRUCT BIOL, V10, P504, DOI 10.1038/nsb936; Ganesh SK, 2009, NAT GENET, V41, P1191, DOI 10.1038/ng.466; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Gordon S, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0392-4; Kim GD, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00452-17; Kopf M, 2015, NAT IMMUNOL, V16, P36, DOI 10.1038/ni.3052; Li YP, 1999, ANTIOXID REDOX SIGN, V1, P97, DOI 10.1089/ars.1999.1.1-97; LIN YZ, 1995, J BIOL CHEM, V270, P14255, DOI 10.1074/jbc.270.24.14255; Metsalu T, 2015, NUCLEIC ACIDS RES, V43, pW566, DOI 10.1093/nar/gkv468; Mukherjee SP, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001647; Newson J, 2014, BLOOD, V124, P1748, DOI 10.1182/blood-2014-03-562710; Platanitis E, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02542; Preis JI, 2006, GENESIS, V44, P579, DOI 10.1002/dvg.20251; Qu X, 2007, EMBO J, V26, P4445, DOI 10.1038/sj.emboj.7601883; Segal BH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009631; Sperling S, 2005, HUM MUTAT, V26, P575, DOI 10.1002/humu.20262; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Swamydas Muthulekha, 2015, Curr Protoc Immunol, V110, DOI 10.1002/0471142735.im0320s110; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tien ES, 2004, J BIOL CHEM, V279, P24053, DOI 10.1074/jbc.M401489200; Varma TK, 2002, CLIN DIAGN LAB IMMUN, V9, P530, DOI 10.1128/CDLI.9.3.530-543.2002; Volcik KA, 2004, AM J MED GENET A, V126A, P324, DOI 10.1002/ajmg.a.20578; Weninger WJ, 2005, DEVELOPMENT, V132, P1337, DOI 10.1242/dev.01696; West AP, 2006, ANNU REV CELL DEV BI, V22, P409, DOI 10.1146/annurev.cellbio.21.122303.115827; Withington SL, 2006, DEV BIOL, V294, P67, DOI 10.1016/j.ydbio.2006.02.025; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Zhao J, 2006, J BIOL CHEM, V281, P10073, DOI 10.1074/jbc.M507788200	36	5	5	2	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12100	12113		10.1096/fj.202000864R	http://dx.doi.org/10.1096/fj.202000864R		JUL 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32697413	Green Published, hybrid			2022-12-28	WOS:000554917800001
J	Mao, ZF; Ouyang, SH; Zhang, QY; Wu, YP; Wang, GE; Tu, LF; Luo, Z; Li, WX; Kurihara, H; Li, YF; He, RR				Mao, Zhong-Fu; Ouyang, Shu-Hua; Zhang, Qiong-Yi; Wu, Yan-Ping; Wang, Guo-En; Tu, Long-Fang; Luo, Zhuo; Li, Wei-Xi; Kurihara, Hiroshi; Li, Yi-Fang; He, Rong-Rong			New insights into the effects of caffeine on adult hippocampal neurogenesis in stressed mice: Inhibition of CORT-induced microglia activation	FASEB JOURNAL			English	Article						caffeine; neurogenesis; depression; stress; inflammation	NEURAL STEM-CELLS; SUBVENTRICULAR ZONE; NEUROTROPHIC FACTOR; DENTATE GYRUS; TNF-ALPHA; HPA-AXIS; IMPAIRED NEUROGENESIS; ADRENAL-STEROIDS; SUBGRANULAR ZONE; CHRONIC EXPOSURE	Chronic stress-evoked depression has been implied to associate with the decline of adult hippocampal neurogenesis. Caffeine has been known to combat stress-evoked depression. Herein, we aim to investigate whether the protective effect of caffeine on depression is related with improving adult hippocampus neurogenesis and explore the mechanisms. Mouse chronic water immersion restraint stress (CWIRS) model, corticosterone (CORT)-established cell stress model, a coculture system containing CORT-treated BV-2 cells and hippocampal neural stem cells (NSCs) were utilized. Results showed that CWIRS caused obvious depressive-like disorders, abnormal 5-HT signaling, and elevated-plasma CORT levels. Notably, microglia activation-evoked brain inflammation and inhibited neurogenesis were also observed in the hippocampus of stressed mice. In comparison, intragastric administration of caffeine (10 and 20 mg/kg, 28 days) significantly reverted CWIRS-induced depressive behaviors, neurogenesis recession and microglia activation in the hippocampus. Further evidences from bothin vivoandin vitromechanistic experiments demonstrated that caffeine treatment significantly suppressed microglia activationviathe A2AR/MEK/ERK/NF-kappa B signaling pathway. The results suggested that CORT-induced microglia activation contributes to stress-mediated neurogenesis recession. The antidepression effect of caffeine was associated with unlocking microglia activation-induced neurogenesis inhibition.	[Mao, Zhong-Fu; Ouyang, Shu-Hua; Zhang, Qiong-Yi; Wu, Yan-Ping; Wang, Guo-En; Tu, Long-Fang; Luo, Zhuo; Kurihara, Hiroshi; Li, Yi-Fang; He, Rong-Rong] Jinan Univ, Guangdong Engn Res Ctr Chinese Med & Dis Suscepti, Guangzhou 510632, Peoples R China; [Mao, Zhong-Fu; Ouyang, Shu-Hua; Zhang, Qiong-Yi; Wu, Yan-Ping; Wang, Guo-En; Tu, Long-Fang; Luo, Zhuo; Kurihara, Hiroshi; Li, Yi-Fang; He, Rong-Rong] Jinan Univ, Coll Pharm, Guangdong Prov Key Lab Pharmacodynam Constituent, Guangzhou, Peoples R China; [Mao, Zhong-Fu; Ouyang, Shu-Hua; Zhang, Qiong-Yi; Wu, Yan-Ping; Wang, Guo-En; Tu, Long-Fang; Luo, Zhuo; Kurihara, Hiroshi; Li, Yi-Fang; He, Rong-Rong] Jinan Univ, Int Cooperat Lab Tradit Chinese Med Modernizat &, Chinese Minist Educ MOE, Coll Pharm, Guangzhou, Peoples R China; [Li, Wei-Xi] Yunnan Univ Tradit Chinese Med, Sch Tradit Chinese Pharm, Kunming, Yunnan, Peoples R China; [Li, Yi-Fang] Univ Hong Kong, Sch Biomed Sci, Hong Kong, Peoples R China	Jinan University; Jinan University; Jinan University; Yunnan University of Chinese Medicine; University of Hong Kong	Li, YF; He, RR (corresponding author), Jinan Univ, Guangdong Engn Res Ctr Chinese Med & Dis Suscepti, Guangzhou 510632, Peoples R China.	rongronghe@jnu.edu.cn; rongronghe66@163.com		HE, Rong-Rong/0000-0001-5505-5672	Natural Science Foundation of China [U1801284, 81573675, 81622050, 81874341, 81873209, 81673709]; National Key Research and Development Program of China [2017YFC1700404]; Local Innovative and Research Teams Project of Guangdong Pearl River Talents Program [2017BT01Y036, GDUPS (2019)]; Guangdong Science and Technology Foundation for Distinguished Young Scholars [2017A030306004]; Program of Hong Kong Scholar [XJ2016017]; Science and Technology Program of Guangzhou [201903010062]; Youth Top-notch Talent Support Program of Guangdong Province [2016TQ03R586]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Local Innovative and Research Teams Project of Guangdong Pearl River Talents Program; Guangdong Science and Technology Foundation for Distinguished Young Scholars; Program of Hong Kong Scholar; Science and Technology Program of Guangzhou; Youth Top-notch Talent Support Program of Guangdong Province	Natural Science Foundation of China, Grant/Award Number: U1801284, 81573675, 81622050, 81874341, 81873209 and 81673709; National Key Research and Development Program of China, Grant/Award Number: 2017YFC1700404; Local Innovative and Research Teams Project of Guangdong Pearl River Talents Program, Grant/Award Number: 2017BT01Y036 and GDUPS (2019); Guangdong Science and Technology Foundation for Distinguished Young Scholars, Grant/Award Number: 2017A030306004; Program of Hong Kong Scholar, Grant/Award Number: XJ2016017; Science and Technology Program of Guangzhou, Grant/Award Number: 201903010062; Youth Top-notch Talent Support Program of Guangdong Province, Grant/Award Number: 2016TQ03R586	Al-Mayyahi RS, 2018, MOL CELL NEUROSCI, V86, P30, DOI 10.1016/j.mcn.2017.11.006; Alonso R, 2004, MOL PSYCHIATR, V9, P278, DOI 10.1038/sj.mp.4001464; Bagga P, 2016, NEUROCHEM INT, V92, P25, DOI 10.1016/j.neuint.2015.11.006; Banasr M, 2004, NEUROPSYCHOPHARMACOL, V29, P450, DOI 10.1038/sj.npp.1300320; Barrientos RM, 2003, NEUROSCIENCE, V121, P847, DOI 10.1016/S0306-4522(03)00564-5; Batalha VL, 2016, SCI REP-UK, V6, DOI 10.1038/srep31493; BOCCHINI V, 1992, J NEUROSCI RES, V31, P616, DOI 10.1002/jnr.490310405; Brummelte S, 2010, NEUROSCIENCE, V168, P680, DOI 10.1016/j.neuroscience.2010.04.023; Brunet JF, 2004, GLIA, V46, P8, DOI 10.1002/glia.10348; CAMERON HA, 1994, NEUROSCIENCE, V61, P203, DOI 10.1016/0306-4522(94)90224-0; Castren E, 2010, DEV NEUROBIOL, V70, P289, DOI 10.1002/dneu.20758; Chen G, 2000, J NEUROCHEM, V75, P1729, DOI 10.1046/j.1471-4159.2000.0751729.x; Chen KQ, 2006, J BIOL CHEM, V281, P3651, DOI 10.1074/jbc.M508125200; Chen NN, 2016, NEUROCHEM RES, V41, P3052, DOI 10.1007/s11064-016-2024-8; Costa MS, 2008, NEUROCHEM INT, V53, P89, DOI 10.1016/j.neuint.2008.06.006; Das S, 2008, J NEUROSCI RES, V86, P1199, DOI 10.1002/jnr.21585; Di Lorenzo A, 2016, MOL NUTR FOOD RES, V60, P566, DOI 10.1002/mnfr.201500567; Drew Michael R., 2007, CNS & Neurological Disorders-Drug Targets, V6, P205, DOI 10.2174/187152707780619353; Duan WJ, 2016, FREE RADICAL BIO MED, V95, P230, DOI 10.1016/j.freeradbiomed.2016.03.022; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Endesfelder S, 2018, NEUROTOX RES, V34, P173, DOI 10.1007/s12640-018-9872-8; Evanson NK, 2010, ENDOCRINOLOGY, V151, P4811, DOI 10.1210/en.2010-0285; Fotakis G, 2006, TOXICOL LETT, V160, P171, DOI 10.1016/j.toxlet.2005.07.001; Frank MG, 2014, PSYCHONEUROENDOCRINO, V40, P191, DOI 10.1016/j.psyneuen.2013.11.006; Fredholm BB, 1999, PHARMACOL REV, V51, P83; Ghoneim FM, 2015, INT J CLIN EXP PATHO, V8, P7710; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Goshen I, 2008, MOL PSYCHIATR, V13, P717, DOI 10.1038/sj.mp.4002055; Gotlib IH, 2008, BIOL PSYCHIAT, V63, P847, DOI 10.1016/j.biopsych.2007.10.008; GOULD E, 1991, J COMP NEUROL, V313, P479, DOI 10.1002/cne.903130308; GOULD E, 1992, J NEUROSCI, V12, P3642; Gourley SL, 2008, BIOL PSYCHIAT, V63, P353, DOI 10.1016/j.biopsych.2007.07.016; Guo WX, 2012, NAT PROTOC, V7, P2005, DOI 10.1038/nprot.2012.123; Han ME, 2007, BIOCHEM BIOPH RES CO, V356, P976, DOI 10.1016/j.bbrc.2007.03.086; He BP, 2002, J NEUROIMMUNOL, V128, P31, DOI 10.1016/S0165-5728(02)00141-8; Hemish J, 2003, J BIOL CHEM, V278, P42321, DOI 10.1074/jbc.M308192200; Horie N, 2008, CELL MOL NEUROBIOL, V28, P833, DOI 10.1007/s10571-007-9237-y; Jacobs BL, 2000, MOL PSYCHIATR, V5, P262, DOI 10.1038/sj.mp.4000712; Jans LAW, 2007, MOL PSYCHIATR, V12, P522, DOI 10.1038/sj.mp.4001920; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Kang CH, 2012, FOOD CHEM TOXICOL, V50, P4270, DOI 10.1016/j.fct.2012.08.041; Kelly KA, 2012, J NEUROCHEM, V122, P995, DOI 10.1111/j.1471-4159.2012.07864.x; Kempermann G, 2002, BIPOLAR DISORD, V4, P17, DOI 10.1034/j.1399-5618.2002.40101.x; Khisti RT, 2000, PHARMACOL BIOCHEM BE, V67, P137, DOI 10.1016/S0091-3057(00)00300-2; Kikusui T, 2009, PSYCHONEUROENDOCRINO, V34, P762, DOI 10.1016/j.psyneuen.2008.12.009; Kim JJ, 2002, NAT REV NEUROSCI, V3, P453, DOI 10.1038/nrn849; Koo JW, 2010, P NATL ACAD SCI USA, V107, P2669, DOI 10.1073/pnas.0910658107; Kubera M, 2011, PROG NEURO-PSYCHOPH, V35, P744, DOI 10.1016/j.pnpbp.2010.08.026; Kyritsis N, 2012, SCIENCE, V338, P1353, DOI 10.1126/science.1228773; Laurent C, 2016, MOL PSYCHIATR, V21, P97, DOI 10.1038/mp.2014.151; Lee J, 2002, J NEUROCHEM, V82, P1367, DOI 10.1046/j.1471-4159.2002.01085.x; Liu MY, 2018, NAT PROTOC, V13, P1686, DOI 10.1038/s41596-018-0011-z; Liu QS, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201600910; Lu KT, 2015, PFLUG ARCH EUR J PHY, V467, P1651, DOI 10.1007/s00424-014-1588-x; Lucassen PJ, 2013, TRENDS NEUROSCI, V36, P621, DOI 10.1016/j.tins.2013.08.002; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Mirescu C, 2006, HIPPOCAMPUS, V16, P233, DOI 10.1002/hipo.20155; Mitani H, 2006, PROG NEURO-PSYCHOPH, V30, P531, DOI 10.1016/j.pnpbp.2005.11.021; Mizoguchi K, 2003, NEUROSCIENCE, V119, P887, DOI 10.1016/S0306-4522(03)00105-2; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Murray F, 2008, EUR J PHARMACOL, V583, P115, DOI 10.1016/j.ejphar.2008.01.014; Odaka H, 2016, NEUROSCI RES, V113, P28, DOI 10.1016/j.neures.2016.07.002; Pedersen TKH, 2000, ANAL CHIM ACTA, V413, P63, DOI 10.1016/S0003-2670(00)00812-6; Sahu S, 2013, EXP NEUROL, V248, P470, DOI 10.1016/j.expneurol.2013.07.021; Shen FX, 2014, STROKE, V45, P2101, DOI 10.1161/STROKEAHA.114.005115; Shi WZ, 2014, BIOCHEM BIOPH RES CO, V447, P95, DOI 10.1016/j.bbrc.2014.03.112; Shioda N, 2008, NEUROSCIENCE, V155, P876, DOI 10.1016/j.neuroscience.2008.05.056; Sierra A, 2010, CELL STEM CELL, V7, P483, DOI 10.1016/j.stem.2010.08.014; Smith KA, 1997, LANCET, V349, P915, DOI 10.1016/S0140-6736(96)07044-4; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; Song HJ, 2002, NAT NEUROSCI, V5, P438, DOI 10.1038/nn844; STERU L, 1987, PROG NEURO-PSYCHOPH, V11, P659; TAKAHASHI T, 1992, J NEUROCYTOL, V21, P185, DOI 10.1007/BF01194977; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Wadhwa M, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00049; Walton NM, 2006, GLIA, V54, P815, DOI 10.1002/glia.20419; Wang MJ, 2002, EUR J NEUROSCI, V16, P2103, DOI 10.1046/j.1460-9568.2002.02290.x; Wang W, 2003, J NEUROCHEM, V84, P189, DOI 10.1046/j.1471-4159.2003.01544.x; Wentz CT, 2009, NEUROPHARMACOLOGY, V56, P994, DOI 10.1016/j.neuropharm.2009.02.002; Yirmiya R, 2011, BRAIN BEHAV IMMUN, V25, P181, DOI 10.1016/j.bbi.2010.10.015; Yu HY, 2016, MOL NEUROBIOL, V53, P6786, DOI 10.1007/s12035-015-9597-0; Zhang XD, 2004, EXP NEUROL, V186, P112, DOI 10.1016/j.expneurol.2003.10.022; Zhao J, 2006, GLIA, V53, P304, DOI 10.1002/glia.20283	85	14	16	5	20	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10998	11014		10.1096/fj.202000146RR	http://dx.doi.org/10.1096/fj.202000146RR		JUL 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32619083				2022-12-28	WOS:000547909600001
J	Menegaz, RA; Ladd, SH; Organ, JM				Menegaz, Rachel A.; Ladd, Summer H.; Organ, Jason M.			Craniofacial allometry in the OIM(-/-)mouse model of osteogenesis imperfecta	FASEB JOURNAL			English	Article						3D geometric morphometrics; brittle bone disease; malocclusions; midface hypoplasia; scaling; type I collagen	BONE; MICE	Osteogenesis imperfecta (OI) is a skeletal disorder characterized by the impaired synthesis of type I collagen (Col1). This study tests the hypothesis that the craniofacial phenotype of severe OI is linked to an overall reduction in body size. 3D landmark data were collected from mu CT scans of adult OIM(-/-)and wild-type (WT) mice and used to calculate centroid sizes (CS) and interlandmark distances (ILDs). To remove the effect of body size, ILDs were scaled against craniomandibular lengths and CS. Mann-WhitneyUtests were used to compare CS and absolute/scaled ILDs between genotypes. OIM(-/-)mice are smaller than their WT littermates in body mass, craniomandibular CS, and absolute ILDs including skull, basicranial, palatal, mandibular, and toothrow lengths. When linear distances are scaled to CS, OIM(-/-)mice have a relatively short midface, short nasal bones, tall mandibular corpora, and long mandibular toothrows. Results underscore the importance of size and scaling in morphometric analyses. The deleterious effect of Col1 mutations on global skeletal dimensions combined with localized morphometric changes may underlie the facial phenotype seen in human patients with severe OI. Attempts to identify these localized changes should first account for the restricted growth and small body sizes present in individuals with OI.	[Menegaz, Rachel A.; Ladd, Summer H.] Univ North Texas, Hlth Sci Ctr, Ctr Anat Sci, 3500 Camp Bowie Blvd, Ft Worth, TX 76107 USA; [Organ, Jason M.] Indiana Univ Sch Med, Dept Anat Cell Biol & Physiol, Indianapolis, IN 46202 USA	University of North Texas System; University of North Texas Denton; University of North Texas Health Science Center; Indiana University System; Indiana University Bloomington	Menegaz, RA (corresponding author), Univ North Texas, Hlth Sci Ctr, Ctr Anat Sci, 3500 Camp Bowie Blvd, Ft Worth, TX 76107 USA.	rachel.menegaz@unthsc.edu	Menegaz, Rachel/ABA-2446-2020	Menegaz, Rachel/0000-0002-7261-7873; Organ, Jason/0000-0001-8462-0271	Indiana University (IU) Collaborative Research Grant; Ralph W. and Grace M. Showalter Research Trust Fund (Showalter Research Trust)	Indiana University (IU) Collaborative Research Grant; Ralph W. and Grace M. Showalter Research Trust Fund (Showalter Research Trust)	Indiana University (IU) Collaborative Research Grant; Ralph W. and Grace M. Showalter Research Trust Fund (Showalter Research Trust)	Cheung MS, 2011, J BONE MINER RES, V26, P405, DOI 10.1002/jbmr.220; Eimar H, 2016, J DENT RES, V95, P761, DOI 10.1177/0022034516637045; Enagonio E, 2014, OSTEOGENSIS IMPERFEC, P271; Enderli TA, 2016, ORTHOP RES REV, V8, P41, DOI 10.2147/ORR.S85198; Forlino A, 2011, NAT REV ENDOCRINOL, V7, P540, DOI 10.1038/nrendo.2011.81; Gentry BA, 2010, MATRIX BIOL, V29, P638, DOI 10.1016/j.matbio.2010.06.006; Harrington J, 2014, PEDIATR CLIN N AM, V61, P1243, DOI 10.1016/j.pcl.2014.08.010; Hartsfield JK, 2006, SEMIN ORTHOD, V12, P254, DOI DOI 10.1053/J.SODO.2006.08.004; Huber MA, 2007, ORAL SURG ORAL MED O, V103, P314, DOI 10.1016/j.tripleo.2006.10.003; Jain M, 2019, GENET MED, V21, P275, DOI 10.1038/s41436-018-0045-1; Kayukawa H, 1992, J Clin Pediatr Dent, V16, P162; Klingenberg CP, 2016, DEV GENES EVOL, V226, P113, DOI 10.1007/s00427-016-0539-2; LANDIS WJ, 1995, BONE, V16, P533, DOI 10.1016/8756-3282(95)00076-P; Lund AM, 1999, ARCH DIS CHILD, V80, P524, DOI 10.1136/adc.80.6.524; Maga AM, 2016, J AM ASSOC LAB ANIM, V55, P131; Martin Elizabeth, 2007, Curr Osteoporos Rep, V5, P91; McBride DJ, 1997, J MOL BIOL, V270, P275, DOI 10.1006/jmbi.1997.1106; Mullick R, 1998, ANN M SOC COMP APPL; Nakamura A, 2013, ANGLE ORTHOD, V83, P749, DOI 10.2319/083012-698.1; O'Connell AC, 1999, ORAL SURG ORAL MED O, V87, P189, DOI 10.1016/S1079-2104(99)70272-6; Phillips CL, 2000, BONE, V27, P219, DOI 10.1016/S8756-3282(00)00311-2; PROSCHEL P, 1988, J PROSTHET DENT, V59, P617, DOI 10.1016/0022-3913(88)90082-0; Rizkallah J, 2013, AM J ORTHOD DENTOFAC, V143, P336, DOI 10.1016/j.ajodo.2012.10.016; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SCHWARTZ S, 1984, ORAL SURG ORAL MED O, V57, P161, DOI 10.1016/0030-4220(84)90206-8; SILLENCE DO, 1979, J MED GENET, V16, P101, DOI 10.1136/jmg.16.2.101; Somerville JN, 2004, CALCIFIED TISSUE INT, V74, P469, DOI 10.1007/s00223-003-0101-x; Waltimo-Siren J, 2005, AM J MED GENET A, V133A, P142, DOI 10.1002/ajmg.a.30523; West-Eberhard MJ, 1993, DEV PLASTICITY EVOLU; Xu H, 2020, DEV DYNAM, V249, P884, DOI 10.1002/dvdy.166; Zelditch M. L., 2004, GEOMETRIC MORPHOMETR	31	1	1	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10850	10859		10.1096/fj.202000715R	http://dx.doi.org/10.1096/fj.202000715R		JUN 2020	10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32592291	Bronze			2022-12-28	WOS:000544413300001
J	Uematsu, M; Kita, Y; Shimizu, T; Shindou, H				Uematsu, Masaaki; Kita, Yoshihiro; Shimizu, Takao; Shindou, Hideo			Multiplex fatty acid imaging inside cells by Raman microscopy	FASEB JOURNAL			English	Article						lipid droplet; spectral unmixing; triacylglycerol	EXTRACTION; ENZYMES; INHIBITORS; MEMBRANES	Visualizing intracellular fatty acids (including free and esterified form) is very useful for understanding how and where such molecules are incorporated, stored, and metabolized within cells. However, techniques of imaging multiple intracellular fatty acids have been limited by their small size, making it difficult to label and track without changing their biological and biophysical characteristics. Here, we present a new method for simultaneously visualizing up to five atomically labeled intracellular fatty acid species. For this, we utilized the distinctive Raman spectra depending on the labeling patterns and created a new, extensible opensource software to perform by-pixel analysis of extracting original spectra from mixed ones. Our multiplex imaging method revealed that fatty acids with more double bonds tend to concentrate more efficiently at lipid droplets. This novel approach contributes to reveal not only the spatial dynamics of fatty acids, but also of any other metabolites inside cells.	[Uematsu, Masaaki; Kita, Yoshihiro; Shimizu, Takao; Shindou, Hideo] Natl Ctr Global Hlth & Med, Dept Lipid Signaling, Tokyo, Japan; [Uematsu, Masaaki; Kita, Yoshihiro; Shimizu, Takao] Univ Tokyo, Grad Sch Med, Dept Lipid, Tokyo, Japan; [Kita, Yoshihiro] Univ Tokyo, Grad Sch Med, Life Sci Core Facil, Tokyo, Japan; [Shimizu, Takao] Inst Microbial Chem, Tokyo, Japan; [Shindou, Hideo] Univ Tokyo, Grad Sch Med, Dept Lipid Sci, Tokyo, Japan	National Center for Global Health & Medicine - Japan; University of Tokyo; University of Tokyo; University of Tokyo	Uematsu, M; Shindou, H (corresponding author), Natl Ctr Global Hlth & Med, Dept Lipid Signaling, Shinjuku Ku, 1-21-1 Toyama, Tokyo 1628655, Japan.	ucmatsu@m.u-tokyo.ac.jp; hshindou@ri.ncgm.go.jp	Shimizu, Takao/AAV-7052-2021	Uematsu, Masaaki/0000-0002-0197-8401	Japan Agency for Medical Research and Development (AMED) [19gm0910011, 19cm0106116, JP19fk0210041]; MEXT \ Japan Society for the Promotion of Science (JSPS) [18J21897]; Takeda Science Foundation	Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); MEXT \ Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF))	Japan Agency for Medical Research and Development (AMED), Grant/Award Number: 19gm0910011, 19cm0106116 and JP19fk0210041; MEXT vertical bar Japan Society for the Promotion of Science (JSPS), Grant/Award Number: 18J21897; Takeda Science Foundation	Ando J, 2015, P NATL ACAD SCI USA, V112, P4558, DOI 10.1073/pnas.1418088112; Baron VO, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10234-z; Bennet M, 2014, BIOPHYS J, V106, pL17, DOI 10.1016/j.bpj.2014.01.002; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Cao JS, 2011, J BIOL CHEM, V286, P41838, DOI 10.1074/jbc.M111.245456; Chiu LD, 2017, SCI REP, V7, P1; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; Futatsugi K, 2015, J MED CHEM, V58, P7173, DOI 10.1021/acs.jmedchem.5b01006; Hu FH, 2018, NAT METHODS, V15, P194, DOI [10.1038/NMETH.4578, 10.1038/nmeth.4578]; Huang WE, 2004, ANAL CHEM, V76, P4452, DOI 10.1021/ac049753k; Itabe H, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-017-0473-y; Ivashov VA, 2013, BBA-MOL CELL BIOL L, V1831, P282, DOI 10.1016/j.bbalip.2012.09.017; Jamieson LE, 2018, SPECTROCHIM ACTA A, V197, P30, DOI 10.1016/j.saa.2018.01.064; Vaquero JJ, 2015, ANNU REV BIOMED ENG, V17, P385, DOI 10.1146/annurev-bioeng-071114-040723; Kaiser RD, 1998, BBA-BIOMEMBRANES, V1375, P13, DOI 10.1016/S0005-2736(98)00127-8; Milger K, 2006, J CELL SCI, V119, P4678, DOI 10.1242/jcs.03280; Okada M, 2012, P NATL ACAD SCI USA, V109, P28, DOI 10.1073/pnas.1107524108; Palma BF, 2008, SENSORS-BASEL, V8, P3624, DOI 10.3390/s8063624; Rompp A, 2013, HISTOCHEM CELL BIOL, V139, P759, DOI 10.1007/s00418-013-1097-6; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shimizu T, 2009, ANNU REV PHARMACOL, V49, P123, DOI 10.1146/annurev.pharmtox.011008.145616; Shimura M, 2016, FASEB J, V30, P4149, DOI 10.1096/fj.201600569R; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; Stein SE, 1999, J AM SOC MASS SPECTR, V10, P770, DOI 10.1016/S1044-0305(99)00047-1; Stiebing C, 2014, ANAL BIOANAL CHEM, V406, P7037, DOI 10.1007/s00216-014-7927-0; Tatenaka Y, 2019, BIOCHEMISTRY-US, V58, P499, DOI 10.1021/acs.biochem.8b01071; Tsugawa H, 2015, NAT METHODS, V12, P523, DOI 10.1038/nmeth.3393; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Wei L, 2017, NATURE, V544, P465, DOI 10.1038/nature22051; Yen CLE, 2008, J LIPID RES, V49, P2283, DOI 10.1194/jlr.R800018-JLR200; You S., 2016, SCI REP-UK, V6, P1; Zimmermann R, 2008, NEUROPHARMACOLOGY, V1383, P1383	32	6	6	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10357	10372		10.1096/fj.202000514R	http://dx.doi.org/10.1096/fj.202000514R		JUN 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32592240	hybrid			2022-12-28	WOS:000544412400001
J	Choudhury, M; Yin, XQ; Schaefbauer, KJ; Kang, JH; Roy, B; Kottom, TJ; Limper, AH; Leof, EB				Choudhury, Malay; Yin, Xueqian; Schaefbauer, Kyle J.; Kang, Jeong-Han; Roy, Bhaskar; Kottom, Theodore J.; Limper, Andrew H.; Leof, Edward B.			SIRT7-mediated modulation of glutaminase 1 regulates TGF-beta-induced pulmonary fibrosis	FASEB JOURNAL			English	Article						bleomycin; FOXO4; GLS1; glutamine metabolism; pulmonary fibrosis; SIRT7; TGF-beta signaling	GROWTH-FACTOR-BETA; RECEPTOR; GLUTAMINOLYSIS; METABOLISM; EXPRESSION; GLUTAMATE; CANCER; ACTIVATION; MECHANISMS; RESPONSES	In the current work we show that the profibrotic actions of TGF-beta are mediated, at least in part, through a metabolic maladaptation in glutamine metabolism and how the inhibition of glutaminase 1 (GLS1) reverses pulmonary fibrosis. GLS1 was found to be highly expressed in fibrotic vs normal lung fibroblasts and the expression of profibrotic targets, cell migration, and soft agar colony formation stimulated by TGF-beta required GLS1 activity. Moreover, knockdown of SMAD2 or SMAD3 as well as inhibition of PI3K, mTORC2, and PDGFR abrogated the induction of GLS1 by TGF-beta. We further demonstrated that the NAD-dependent protein deacetylase, SIRT7, and the FOXO4 transcription factor acted as endogenous brakes for GLS1 expression, which are inhibited by TGF-beta. Lastly, administration of the GLS1 inhibitor CB-839 attenuated bleomycin-induced pulmonary fibrosis. Our study points to an exciting and unexplored connection between epigenetic and transcriptional processes that regulate glutamine metabolism and fibrotic development in a TGF-beta-dependent manner.	[Choudhury, Malay; Yin, Xueqian; Schaefbauer, Kyle J.; Kang, Jeong-Han; Kottom, Theodore J.; Limper, Andrew H.; Leof, Edward B.] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Thorac Dis Res Unit,Div Pulm & Crit Care Med, Rochester, MN 55905 USA; [Roy, Bhaskar] Mayo Clin, Coll Med, Div Gastroenterol & Hepatol, Rochester, MN USA; [Yin, Xueqian] Mayo Clin, Coll Med, Dept Mol Med, Rochester, MN USA; [Kang, Jeong-Han] Mayo Clin, Coll Med, Dept Lab Med & Pathol, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Choudhury, M; Limper, AH (corresponding author), Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Thorac Dis Res Unit,Div Pulm & Crit Care Med, Rochester, MN 55905 USA.	Choudhury.Malay@mayo.edu; limper.andrew@mayo.edu	Kang, Jeong-Han/J-3541-2019	Kang, Jeong-Han/0000-0002-9693-0696; Choudhury, Malay/0000-0003-3051-9084	HHS | NIH | National Institute of General Medical Sciences (NIGMS) [GM-54200, GM-55816]	HHS | NIH | National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	HHS | NIH | National Institute of General Medical Sciences (NIGMS), Grant/Award Number: GM-54200 and GM-55816	Akamata K, 2016, ONCOTARGET, V7, P69321, DOI 10.18632/oncotarget.12504; Altman BJ, 2016, NAT REV CANCER, V16, P619, DOI 10.1038/nrc.2016.71; Andrianifahanana M, 2013, FASEB J, V27, P4444, DOI 10.1096/fj.12-224907; Andrianifahanana M, 2010, CANCER RES, V70, P7421, DOI 10.1158/0008-5472.CAN-10-0232; BASSING CH, 1994, SCIENCE, V263, P87, DOI 10.1126/science.8272871; BERGSTROM J, 1974, J APPL PHYSIOL, V36, P693, DOI 10.1152/jappl.1974.36.6.693; Bernard K, 2018, J BIOL CHEM, V293, P1218, DOI 10.1074/jbc.RA117.000444; Canestaro WJ, 2016, CHEST, V149, P756, DOI 10.1016/j.chest.2015.11.013; Coloff JL, 2016, CELL METAB, V23, P867, DOI 10.1016/j.cmet.2016.03.016; Csibi A, 2013, CELL, V153, P840, DOI 10.1016/j.cell.2013.04.023; Cui HC, 2019, AM J RESP CELL MOL, V61, P492, DOI 10.1165/rcmb.2019-0051OC; CURTHOYS NP, 1995, ANNU REV NUTR, V15, P133, DOI 10.1146/annurev.nu.15.070195.001025; Daniels CE, 2004, J CLIN INVEST, V114, P1308, DOI 10.1175/JCI200419603; Derynck R, 1998, CELL, V95, P737, DOI 10.1016/S0092-8674(00)81696-7; dos Reis LM, 2019, J BIOL CHEM, V294, P9342, DOI 10.1074/jbc.RA119.008180; Duran RV, 2012, MOL CELL, V47, P349, DOI 10.1016/j.molcel.2012.05.043; Elliott RL, 2005, J CLIN ONCOL, V23, P2078, DOI 10.1200/JCO.2005.02.047; Eng CH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000911; Esnault S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170207; Fernandez Isis E, 2012, Proc Am Thorac Soc, V9, P111, DOI 10.1513/pats.201203-023AW; Foskett AM, 2014, AM J PHYSIOL-LUNG C, V306, pL120, DOI 10.1152/ajplung.00240.2013; Galan-Cobo A, 2019, CANCER RES, V79, P3251, DOI 10.1158/0008-5472.CAN-18-3527; Ge J, 2018, AM J RESP CELL MOL, V58, P378, DOI 10.1165/rcmb.2017-0238OC; Gregory MA, 2019, CLIN CANCER RES, V25, P4079, DOI 10.1158/1078-0432.CCR-18-3223; Grinde MT, 2019, BREAST CANCER RES, V21, DOI 10.1186/s13058-019-1141-0; Gross MI, 2014, MOL CANCER THER, V13, P890, DOI 10.1158/1535-7163.MCT-13-0870; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Jacque N, 2015, BLOOD, V126, P1346, DOI 10.1182/blood-2015-01-621870; Jeong SM, 2013, CANCER CELL, V23, P450, DOI 10.1016/j.ccr.2013.02.024; Jin L, 2016, ONCOGENE, V35, P3619, DOI 10.1038/onc.2015.447; Jin LT, 2015, CANCER CELL, V27, P257, DOI 10.1016/j.ccell.2014.12.006; Kang JH, 2017, J CLIN INVEST, V127, P2541, DOI 10.1172/JCI88696; Katt WP, 2012, MOL CANCER THER, V11, P1269, DOI 10.1158/1535-7163.MCT-11-0942; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; Kurotsu S, 2014, J PHARMACOL EXP THER, V350, P79, DOI 10.1124/jpet.114.213009; Lee JS, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.404; Lee YZ, 2014, ONCOTARGET, V5, P6087, DOI 10.18632/oncotarget.2173; LEOF EB, 1986, P NATL ACAD SCI USA, V83, P2453, DOI 10.1073/pnas.83.8.2453; Li J, 2019, CELL BIOL INT, V43, P921, DOI 10.1002/cbin.11182; LIN HY, 1992, CELL, V68, P775, DOI 10.1016/0092-8674(92)90152-3; Liu PS, 2017, NAT IMMUNOL, V18, P985, DOI 10.1038/ni.3796; Liu RQ, 2019, CANCER LETT, V443, P34, DOI 10.1016/j.canlet.2018.11.030; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Michaeloudes C, 2011, AM J PHYSIOL-LUNG C, V300, pL295, DOI 10.1152/ajplung.00134.2010; MOREADITH RW, 1984, J BIOL CHEM, V259, P6215; Morimoto-Tomita M, 2002, J BIOL CHEM, V277, P49175, DOI 10.1074/jbc.M205131200; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Nakerakanti Sashidhar, 2012, Open Rheumatol J, V6, P156, DOI 10.2174/1874312901206010156; Orkin SH, 2011, CELL, V145, P835, DOI 10.1016/j.cell.2011.05.019; Pilewski JM, 2005, AM J PATHOL, V166, P399, DOI 10.1016/S0002-9440(10)62263-8; Prud'homme GJ, 2007, LAB INVEST, V87, P1077, DOI 10.1038/labinvest.3700669; Raghu G, 2015, AM J RESP CRIT CARE, V191, P252, DOI 10.1164/rccm.201411-2044ED; Rahimi RA, 2009, CANCER RES, V69, P84, DOI 10.1158/0008-5472.CAN-08-2146; Roberts AB, 2003, P NATL ACAD SCI USA, V100, P8621, DOI 10.1073/pnas.1633291100; Ross S, 2008, INT J BIOCHEM CELL B, V40, P383, DOI 10.1016/j.biocel.2007.09.006; RUBIN AL, 1990, CANCER RES, V50, P2832; Sanjabi S, 2005, GENE DEV, V19, P2138, DOI 10.1101/gad.1329805; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shah R, 2019, CANCER RES, V79, P1799, DOI 10.1158/0008-5472.CAN-18-1500; Sosulski ML, 2017, J GERONTOL A-BIOL, V72, P595, DOI 10.1093/gerona/glw151; Steele MP, 2013, ANNU REV MED, V64, P265, DOI 10.1146/annurev-med-042711-142004; Todd NW, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-11; van der Horst A, 2004, J BIOL CHEM, V279, P28873, DOI 10.1074/jbc.M401138200; van der Vos KE, 2012, AUTOPHAGY, V8, P1862, DOI 10.4161/auto.22152; Verhoeven D, 2009, VIROLOGY, V390, P151, DOI 10.1016/j.virol.2009.05.004; Wang DC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166423; Wei J, 2015, ARTHRITIS RHEUMATOL, V67, P1323, DOI 10.1002/art.39061; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Wilkes MC, 2003, MOL CELL BIOL, V23, P8878, DOI 10.1128/MCB.23.23.8878-8889.2003; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; WU MC, 1978, INT J CANCER, V22, P728, DOI 10.1002/ijc.2910220615; Wyman AE, 2018, CURR RHEUMATOL REP, V20, DOI 10.1007/s11926-018-0724-6; Wyman AE, 2017, AM J PHYSIOL-LUNG C, V312, pL945, DOI 10.1152/ajplung.00473.2016; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Xiang LS, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-018-1291-5; Xin ZL, 2018, AGEING RES REV, V41, P42, DOI 10.1016/j.arr.2017.11.002; Yang J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41523-4; Yuneva M, 2007, J CELL BIOL, V178, P93, DOI 10.1083/jcb.200703099; Zerr P, 2016, ANN RHEUM DIS, V75, P226, DOI 10.1136/annrheumdis-2014-205740; Zhai XX, 2017, MOL MED REP, V15, P3467, DOI 10.3892/mmr.2017.6437; Zhang J, 2014, MOL CELL, V56, P205, DOI 10.1016/j.molcel.2014.08.018; Zhang L, 2013, TRENDS BIOCHEM SCI, V38, P612, DOI 10.1016/j.tibs.2013.10.001; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	86	14	15	3	19	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					8920	8940		10.1096/fj.202000564R	http://dx.doi.org/10.1096/fj.202000564R		JUN 2020	21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32519817	Bronze			2022-12-28	WOS:000541521900001
J	Lewis, A; McCrossan, ZA; Manville, RW; Popa, MO; Cuello, LG; Goldstein, SAN				Lewis, Anthony; McCrossan, Zoe A.; Manville, Rian W.; Popa, M. Oana; Cuello, Luis G.; Goldstein, Steve A. N.			TOK channels use the two gates in classical K(+)channels to achieve outward rectification	FASEB JOURNAL			English	Article						Aspergillus; Candida; Cryptococcus; gating; potassium; selectivity	C-TYPE INACTIVATION; YEAST K+ CHANNEL; POTASSIUM-CHANNEL; PLASMA-MEMBRANE; SELECTIVITY FILTER; PORE DOMAINS; KILLER TOXIN; CRYSTAL-STRUCTURE; LEAK CHANNEL; ION	TOKs are outwardly rectifying K(+)channels in fungi with two pore-loops and eight transmembrane spans. Here, we describe the TOKs from four pathogens that cause the majority of life-threatening fungal infections in humans. These TOKs pass large currents only in the outward direction like the canonical isolate fromSaccharomyces cerevisiae(ScTOK), and distinct from other K(+)channels. ScTOK, AfTOK1 (Aspergillus fumigatus), and H99TOK (Cryptococcus neoformans grubii) are K+-selective and pass current above the K(+)reversal potential. CaTOK (Candida albicans) and CnTOK (Cryptococcus neoformans neoformans) pass both K(+)and Na(+)and conduct above a reversal potential reflecting the mixed permeability of their selectivity filter. Mutations in CaTOK and ScTOK at sites homologous to those that open the internal gates in classical K(+)channels are shown to produce inward TOK currents. A favored model for outward rectification is proposed whereby the reversal potential determines ion occupancy, and thus, conductivity, of the selectivity filter gate that is coupled to an imperfectly restrictive internal gate, permitting the filter to sample ion concentrations on both sides of the membrane.	[Lewis, Anthony] Univ Portsmouth, Sch Pharm & Biomed Sci, Portsmouth, Hants, England; [McCrossan, Zoe A.] Univ Southampton, NIHR Evaluat Trials & Studies Coordinating Ctr NE, Southampton, Hants, England; [Manville, Rian W.] Univ Brighton, Sch Pharm & Biomol Sci, Brighton, E Sussex, England; [Popa, M. Oana] Univ Sussex, Sch Life Sci, Sussex Drug Discovery Ctr, Brighton, E Sussex, England; [Cuello, Luis G.] Texas Tech Univ, Hlth Sci Ctr, Dept Cell Physiol & Mol Biophys, Ctr Membrane Prot Res, Lubbock, TX 79430 USA; [Goldstein, Steve A. N.] Univ Calif Irvine, Dept Physiol & Biophys, Sch Med, Samueli Coll Hlth Sci, Irvine, CA 92717 USA; [Goldstein, Steve A. N.] Univ Calif Irvine, Dept Pediat, Sch Med, Samueli Coll Hlth Sci, Irvine, CA 92717 USA	University of Portsmouth; University of Southampton; University of Brighton; University of Sussex; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; University of California System; University of California Irvine; University of California System; University of California Irvine	Goldstein, SAN (corresponding author), Univ Calif Irvine, Dept Physiol & Biophys, Sch Med, Susan & Henry Samueli Coll Hlth Sci, Irvine, CA 92697 USA.; Goldstein, SAN (corresponding author), Univ Calif Irvine, Dept Pediat, Sch Med, Susan & Henry Samueli Coll Hlth Sci, Irvine, CA 92697 USA.; Lewis, A (corresponding author), Univ Portsmouth, Sch Pharm & Biomed Sci, Inst Biol & Biomed Sci, Portsmouth PO1 2DT, Hants, England.	anthony.lewis@port.ac.uk; sgoldst2@uci.edu	; Goldstein, Steven A./E-9817-2015	Manville, Rian/0000-0002-0057-3541; Goldstein, Steven A./0000-0001-5207-5061; Popa, Mariana Oana/0000-0002-2766-6801	HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS) [RO1NS58505]; HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) [RO1HL61657]; Biotechnology and Biological Sciences Research Council [BB/J006114/1]; HHS NIH National Institute of General Medical Sciences (NIGMS) [RO1GM097159]; BBSRC [BB/J006114/1] Funding Source: UKRI	HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS); HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); HHS NIH National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS), Grant/Award Number: RO1NS58505; HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: RO1HL61657; Biotechnology and Biological Sciences Research Council, Grant/Award Number: BB/J006114/1; HHS NIH National Institute of General Medical Sciences (NIGMS), Grant/Award Number: RO1GM097159	Ahmed A, 1999, CELL, V99, P283, DOI 10.1016/S0092-8674(00)81659-1; Ando H, 2005, J GEN PHYSIOL, V126, P529, DOI 10.1085/jgp.200509377; Aryal P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5377; Baev D, 2003, INFECT IMMUN, V71, P3251, DOI 10.1128/IAI.71.6.3251-3260.2003; Bagriantsev SN, 2011, EMBO J, V30, P3594, DOI 10.1038/emboj.2011.230; Ben Soussia I, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08710-3; Ben-Abu Y, 2009, NAT STRUCT MOL BIOL, V16, P71, DOI 10.1038/nsmb.1525; Berneche S, 2005, STRUCTURE, V13, P591, DOI 10.1016/j.str.2004.12.019; Bertl A, 1998, J MEMBRANE BIOL, V162, P67, DOI 10.1007/s002329900343; Bichet D, 2006, P NATL ACAD SCI USA, V103, P14355, DOI 10.1073/pnas.0606660103; Brettmann JB, 2015, P NATL ACAD SCI USA, V112, P15366, DOI 10.1073/pnas.1515965112; Brohawn SG, 2013, P NATL ACAD SCI USA, V110, P2129, DOI 10.1073/pnas.1218950110; Brohawn SG, 2012, SCIENCE, V335, P436, DOI 10.1126/science.1213808; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Brown S, 2008, CELL PHYSIOL BIOCHEM, V22, P601, DOI 10.1159/000185544; Coonen L, 2020, BIOPHYS J, V118, P2612, DOI 10.1016/j.bpj.2020.03.032; Cuello LG, 2017, ELIFE, V6, DOI 10.7554/eLife.28032; Cuello LG, 2010, NATURE, V466, P272, DOI 10.1038/nature09136; Cuello LG, 2010, NATURE, V466, P203, DOI 10.1038/nature09153; DEMO SD, 1992, BIOPHYS J, V61, P639, DOI 10.1016/S0006-3495(92)81869-6; Diaz-Franulic I, 2015, J GEN PHYSIOL, V146, P133, DOI 10.1085/jgp.201411353; Dong YY, 2015, SCIENCE, V347, P1256, DOI 10.1126/science.1261512; Flynn GE, 2001, NEURON, V30, P689, DOI 10.1016/S0896-6273(01)00324-5; Goldstein SAN, 1998, J MOL MED-JMM, V76, P13, DOI 10.1007/s109-1998-8100-0; Goldstein SAN, 1996, P NATL ACAD SCI USA, V93, P13256, DOI 10.1073/pnas.93.23.13256; Guerrero-Galan C, 2018, ENVIRON MICROBIOL, V20, P1873, DOI 10.1111/1462-2920.14122; Heer FT, 2017, ELIFE, V6, DOI 10.7554/eLife.25844.001; Iwamoto M, 2011, J NEUROSCI, V31, P12180, DOI 10.1523/JNEUROSCI.1377-11.2011; Jensen MO, 2013, J GEN PHYSIOL, V141, P619, DOI 10.1085/jgp.201210820; Jia ZG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05970-3; Jiang YX, 2000, J GEN PHYSIOL, V115, P269, DOI 10.1085/jgp.115.3.269; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; KETCHUM KA, 1995, NATURE, V376, P690, DOI 10.1038/376690a0; Kopfer DA, 2014, SCIENCE, V346, P352, DOI 10.1126/science.1254840; Kollewe A, 2009, J GEN PHYSIOL, V134, P53, DOI 10.1085/jgp.200910235; Labro AJ, 2018, P NATL ACAD SCI USA, V115, P5426, DOI 10.1073/pnas.1800559115; Lengyel M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197622; Lesage F, 1996, EMBO J, V15, P1004, DOI 10.1002/j.1460-2075.1996.tb00437.x; Lesage F, 1996, J BIOL CHEM, V271, P4183; Li J, 2018, J GEN PHYSIOL, V150, P1408, DOI 10.1085/jgp.201812082; Lolicato M, 2014, NEURON, V84, P1198, DOI 10.1016/j.neuron.2014.11.017; LOPEZBARNEO J, 1993, RECEPTOR CHANNEL, V1, P61; Loukin SH, 1999, BIOPHYS J, V77, P3060, DOI 10.1016/S0006-3495(99)77137-7; Loukin SH, 2002, P NATL ACAD SCI USA, V99, P1926, DOI 10.1073/pnas.042538599; Loukin SH, 1997, EMBO J, V16, P4817, DOI 10.1093/emboj/16.16.4817; Ma XY, 2011, J BIOL CHEM, V286, P39813, DOI 10.1074/jbc.M111.264788; Maresova L, 2006, FEMS YEAST RES, V6, P1039, DOI 10.1111/j.1567-1364.2006.00140.x; Matulef K, 2016, STRUCTURE, V24, P750, DOI 10.1016/j.str.2016.02.021; Matulef K, 2013, P NATL ACAD SCI USA, V110, P17886, DOI 10.1073/pnas.1314356110; MILLER C, 1982, BIOPHYS J, V38, P227, DOI 10.1016/S0006-3495(82)84552-9; Morais-Cabral JH, 2001, NATURE, V414, P37, DOI 10.1038/35102000; Nishida M, 2007, EMBO J, V26, P4005, DOI 10.1038/sj.emboj.7601828; Pan AC, 2011, J GEN PHYSIOL, V138, P571, DOI 10.1085/jgp.201110670; Piechotta PL, 2011, EMBO J, V30, P3607, DOI 10.1038/emboj.2011.268; Prole DL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042404; Rajan S, 2005, CELL, V121, P37, DOI 10.1016/j.cell.2005.01.019; Rapedius M, 2012, CHANNELS, V6, P473, DOI 10.4161/chan.22153; Roberts SK, 2003, EUKARYOT CELL, V2, P181, DOI 10.1128/EC.2.1.181-190.2003; Roller A, 2005, PFLUG ARCH EUR J PHY, V451, P362, DOI 10.1007/s00424-005-1418-2; Roller A, 2008, PFLUG ARCH EUR J PHY, V456, P883, DOI 10.1007/s00424-008-0446-0; Schewe M, 2016, CELL, V164, P937, DOI 10.1016/j.cell.2016.02.002; Sesti F, 2001, CELL, V105, P637, DOI 10.1016/S0092-8674(01)00376-2; Sesti F, 2001, BIOPHYS J, V80, p446A; Shiraki Y, 2006, J MED MICROBIOL, V55, P1175, DOI 10.1099/jmm.0.46632-0; Squeo RF, 1998, J AM ACAD DERMATOL, V39, P379, DOI 10.1016/S0190-9622(98)70396-2; Thompson AN, 2009, NAT STRUCT MOL BIOL, V16, P1317, DOI 10.1038/nsmb.1703; Tilegenova C, 2019, P NATL ACAD SCI USA, V116, P16829, DOI 10.1073/pnas.1901888116; Tsukamoto H, 2018, J BIOL CHEM, V293, P6969, DOI 10.1074/jbc.RA118.001817; Ye S, 2010, NAT STRUCT MOL BIOL, V17, P1019, DOI 10.1038/nsmb.1865; Yellen G, 1998, Q REV BIOPHYS, V31, P239, DOI 10.1017/S0033583598003448; Zheng J, 1997, J GEN PHYSIOL, V110, P101, DOI 10.1085/jgp.110.2.101; ZHOU XL, 1995, FEBS LETT, V373, P170, DOI 10.1016/0014-5793(95)01035-D; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009; Zilberberg N, 2001, NEURON, V32, P635, DOI 10.1016/S0896-6273(01)00503-7	74	1	1	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					8902	8919		10.1096/fj.202000545R	http://dx.doi.org/10.1096/fj.202000545R		JUN 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32519783	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000539526300001
J	Shannon, AH; Elder, CT; Lu, GY; Su, G; Mast, A; Salmon, MD; Montgomery, WG; Spinosa, MD; Upchurch, GR; Sharma, AK				Shannon, Alexander H.; Elder, Craig T.; Lu, Guanyi; Su, Gang; Mast, Alexis; Salmon, Morgan D.; Montgomery, William G.; Spinosa, Michael D.; Upchurch, Gilbert R., Jr.; Sharma, Ashish K.			Pharmacologic inhibition of transient receptor channel vanilloid 4 attenuates abdominal aortic aneurysm formation	FASEB JOURNAL			English	Article						abdominal aortic aneurysms; aortic smooth muscle cells; endothelial cells; inflammation; TRPV4 channels	TRP CHANNELS; PRACTICE GUIDELINES; ACTIVATION; MODEL; INFLAMMATION; PROGRESSION; EXPRESSION; MORTALITY; DILATION; ARTERIAL	Abdominal aortic aneurysm (AAA) formation is characterized by inflammation, leukocyte infiltration, and vascular remodeling. This study investigates the role of TRPV4 channels, which are transmembrane calcium channels that can regulate vascular tone, in modulating AAA formation. The elastase-treatment model of AAA in C57BL6 (WT) mice and Angiotensin II treatment model in ApoE(-/-) mice were used to confirm our hypotheses. The administration of a specific TRPV4 antagonist, GSK2193874, in elastase-treated WT mice and in AngII-treated ApoE(-/-) mice caused a significant attenuation of aortic diameter, decrease in pro-inflammatory cytokines (IL-1 beta, IL-6, IL-17, MCP-1, MIP-1 alpha, MIP-2, RANTES, and TNF-alpha), inflammatory cell infiltration (CD3 + T cells, macrophages, and neutrophils), elastic fiber disruption, and an increase in smooth muscle cell alpha-actin expression compared to untreated mice. Similarly, elastase-treated TRPV4(-/-) mice had a significant decrease in AAA formation, aortic inflammation, and vascular remodeling compared to elastase-treated WT mice on Day 14. In vitro studies demonstrated that the inhibition of TRPV4 channels mitigates aortic smooth muscle cell-dependent inflammatory cytokine production as well as decreases neutrophil transmigration through aortic endothelial cells. Therefore, our results suggest that TRPV4 antagonism can attenuate aortic inflammation and remodeling via decreased smooth muscle cell activation and neutrophil transendothelial migration during AAA formation.	[Shannon, Alexander H.; Salmon, Morgan D.; Montgomery, William G.; Spinosa, Michael D.] Univ Virginia, Dept Surg, Charlottesville, VA USA; [Elder, Craig T.; Lu, Guanyi; Su, Gang; Mast, Alexis; Upchurch, Gilbert R., Jr.; Sharma, Ashish K.] Univ Florida, Dept Surg, POB 100128, Gainesville, FL 32610 USA	University of Virginia; State University System of Florida; University of Florida	Sharma, AK (corresponding author), Univ Florida, Dept Surg, POB 100128, Gainesville, FL 32610 USA.	ashish.sharma@surgery.ufl.edu		Sharma, Ashish/0000-0002-1234-6039	National Institutes of Health [RO1 HL081629, RO1 HL138931]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	National Institutes of Health, Grant/Award Number: RO1 HL081629 and RO1 HL138931	Anguita E, 2017, BBA-MOL CELL RES, V1864, P915, DOI 10.1016/j.bbamcr.2016.10.022; Azar D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192032; BICKERSTAFF LK, 1982, SURGERY, V92, P1103; Brady AR, 2004, CIRCULATION, V110, P16, DOI 10.1161/01.CIR.0000133279.07468.9F; Brophy C M, 1991, Ann Vasc Surg, V5, P229, DOI 10.1007/BF02329378; Cao RY, 2010, FRONT PHARMACOL, V1, DOI 10.3389/fphar.2010.00009; Chaikof EL, 2018, J VASC SURG, V67, P2, DOI 10.1016/j.jvs.2017.10.044; Chaikof EL, 2009, J VASC SURG, V50, P880, DOI 10.1016/j.jvs.2009.07.001; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Colonnello JS, 2003, J VASC SURG, V38, P138, DOI 10.1016/S0741-5214(03)00125-3; Cullen JM, 2019, J VASC SURG, V70, P252, DOI 10.1016/j.jvs.2018.09.057; Earley S, 2005, CIRC RES, V97, P1270, DOI 10.1161/01.RES.0000194321.60300.d6; Earley S, 2009, AM J PHYSIOL-HEART C, V297, pH1096, DOI 10.1152/ajpheart.00241.2009; Fashandi AZ, 2018, SURGERY, V163, P397, DOI 10.1016/j.surg.2017.10.003; Firth AL, 2007, BBA-MOL BASIS DIS, V1772, P895, DOI 10.1016/j.bbadis.2007.02.009; FREESTONE T, 1995, ARTERIOSCL THROM VAS, V15, P1145, DOI 10.1161/01.ATV.15.8.1145; Freichel M, 2001, NAT CELL BIOL, V3, P121, DOI 10.1038/35055019; Ihara M, 1999, HYPERTENSION, V33, P1399, DOI 10.1161/01.HYP.33.6.1399; Johnston WF, 2014, CIRCULATION, V130, pS51, DOI 10.1161/CIRCULATIONAHA.113.006800; Johnston WF, 2013, ARTERIOSCL THROM VAS, V33, P294, DOI 10.1161/ATVBAHA.112.300432; Karthikesalingam A, 2014, LANCET, V383, P963, DOI 10.1016/S0140-6736(14)60109-4; Laser A, 2012, J SURG RES, V178, P1038, DOI 10.1016/j.jss.2012.04.073; Lederle FA, 2000, ARCH INTERN MED, V160, P1425, DOI 10.1001/archinte.160.10.1425; Lu GY, 2017, J VASC SURG, V66, P232, DOI 10.1016/j.jvs.2016.07.105; Mittal M, 2017, CIRC RES, V121, P1081, DOI 10.1161/CIRCRESAHA.117.311747; Moll FL, 2011, EUR J VASC ENDOVASC, V41, pS1, DOI 10.1016/j.ejvs.2010.09.011; NEWMAN KM, 1994, CIRCULATION, V90, P224; Nilius B, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-218; Nordon IM, 2011, NAT REV CARDIOL, V8, P92, DOI 10.1038/nrcardio.2010.180; Norman PE, 2004, BRIT MED J, V329, P1259, DOI 10.1136/bmj.38272.478438.55; Orandi BJ, 2014, CURRENT SURG THERAPY, P777; Pope NH, 2016, FASEB J, V30, P4192, DOI 10.1096/fj.201600144RR; Pope NH, 2015, ANN THORAC SURG, V100, P1620, DOI 10.1016/j.athoracsur.2015.05.009; Powell JT, 1998, LANCET, V352, P1649; Sharma AK, 2016, ARTERIOSCL THROM VAS, V36, P908, DOI 10.1161/ATVBAHA.116.307373; Sharma AK, 2012, CIRCULATION, V126, pS38, DOI 10.1161/CIRCULATIONAHA.111.083451; Shimizu K, 2006, ARTERIOSCL THROM VAS, V26, P987, DOI 10.1161/01.ATV.0000214999.12921.4f; Sonkusare SK, 2012, SCIENCE, V336, P597, DOI 10.1126/science.1216283; Spinosa M, 2018, CIRCULATION, V138; Spinosa M, 2018, FASEB J, V32, P6038, DOI 10.1096/fj.201701138RR; Sullivan MN, 2013, AM J PHYSIOL-CELL PH, V305, pC999, DOI 10.1152/ajpcell.00273.2013; Thorneloe KS, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004276; Tykocki T, 2015, ASIAN J NEUROSURG, V2, P1031; VanderLaan PA, 2005, J LIPID RES, V46, P829, DOI 10.1194/jlr.R500003-JLR200; Watanabe H, 2002, J BIOL CHEM, V277, P47044, DOI 10.1074/jbc.M208277200; Yang XR, 2006, AM J PHYSIOL-LUNG C, V290, pL1267, DOI 10.1152/ajplung.00515.2005; Yin J, 2008, CIRC RES, V102, P966, DOI 10.1161/CIRCRESAHA.107.168724; Yoshida T, 2006, NAT CHEM BIOL, V2, P596, DOI 10.1038/nchembio821; Yue ZC, 2015, AM J PHYSIOL-HEART C, V308, pH157, DOI 10.1152/ajpheart.00457.2014; Zhang DX, 2011, J CARDIOVASC PHARM, V57, P133, DOI 10.1097/FJC.0b013e3181fd35d1; Zhang DX, 2009, HYPERTENSION, V53, P532, DOI 10.1161/HYPERTENSIONAHA.108.127100; Zhang P, 2018, HYPERTENSION, V71, P134, DOI 10.1161/HYPERTENSIONAHA.117.09767; Zhang Z, 2012, CIRC RES, V111, P1137, DOI 10.1161/CIRCRESAHA.112.273755	53	3	3	3	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9787	9801		10.1096/fj.202000251R	http://dx.doi.org/10.1096/fj.202000251R		JUN 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32506673	Bronze, Green Accepted			2022-12-28	WOS:000539604700001
J	Zhang, XN; Yu, Y; Bai, B; Wang, T; Zhao, JH; Zhang, N; Zhao, YJ; Wang, XP; Wang, B				Zhang, Xiaonan; Yu, Yang; Bai, Bin; Wang, Tao; Zhao, Jiahui; Zhang, Na; Zhao, Yanjiao; Wang, Xipeng; Wang, Bing			PTPN22 interacts with EB1 to regulate T-cell receptor signaling	FASEB JOURNAL			English	Article						autoimmune diseases; protein interactions; TCR signaling pathway; tyrosine phosphatase	LYMPHOID TYROSINE PHOSPHATASE; MICROTUBULE DYNAMIC INSTABILITY; END BINDING-PROTEINS; RHEUMATOID-ARTHRITIS; SH2 DOMAIN; ASSOCIATION; POLYMORPHISM; VARIANT; KINASE; ACTIVATION	The PTPN22 gene encoding the Lyp/Pep protein tyrosine phosphatase is a negative regulator of T-cell receptor (TCR) signaling. Recent studies have shown that phosphorylation of end-binding protein 1 (EB1) is associated with the TCR activation. In this study, using 2-hybrid and mass spectrometry analyses, we identified EB1 as a protein associated with PTPN22. Furthermore, we discovered that EB1 specifically bound to the P1 domain of PTPN22 by competing with CSK, and the variant PTPN22-R620W does not affect the association with EB1, which is instrumental with respect to the regulation of TCR signaling. In addition, PTPN22 dephosphorylates EB1 at tyrosine-247 (Y247), which decreases the expression of the T-cell activation markers CD25 and CD69 and the phosphorylation levels of the TCR molecules ZAP-70, LAT, and Erk, leading to the eventual downregulation of the transcription factor NFAT and reduced the levels of secreted IL-2. The findings of this study provide new insights into the TCR signaling and the T-cell immune response, which are important for clarifying the mechanism of PTPN22-related autoimmune diseases.	[Zhang, Xiaonan; Yu, Yang; Bai, Bin; Wang, Tao; Zhao, Jiahui; Zhang, Na; Zhao, Yanjiao; Wang, Xipeng; Wang, Bing] Northeastern Univ, Inst Biochem & Mol Biol, Coll Life & Hlth Sci, Shenyang 110169, Peoples R China	Northeastern University - China	Wang, B (corresponding author), Northeastern Univ, Inst Biochem & Mol Biol, Coll Life & Hlth Sci, Shenyang 110169, Peoples R China.	wangbing@mail.neu.edu.cn		Wang, Tao/0000-0001-7087-4596; wang, bing/0000-0002-6549-8837; zhang, xiaonan/0000-0002-2229-7242	National Natural Science Foundation of China (NSFC) [31670770, 2016YFC1302402, 31370784]; LiaoNing Revitalization Talents Program [XLYC 1902063]; Fundamental Research Funds for the Central Universityies of China [N141008001, N162004006, N172008008]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); LiaoNing Revitalization Talents Program; Fundamental Research Funds for the Central Universityies of China	National Natural Science Foundation of China (NSFC), Grant/Award Number: 31670770, 2016YFC1302402 and 31370784; LiaoNing Revitalization Talents Program, Grant/Award Number: XLYC 1902063; Fundamental Research Funds for the Central Universityies of China, Grant/Award Number: N141008001, N162004006 and N172008008	Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Azarenko O, 2008, CARCINOGENESIS, V29, P2360, DOI 10.1093/carcin/bgn241; Bae SC, 2018, CELL MOL BIOL, V64, P46, DOI 10.14715/cmb/2018.64.5.7; Bayley R, 2015, ANN RHEUM DIS, V74, P1588, DOI 10.1136/annrheumdis-2013-204796; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Bieling P, 2008, J CELL BIOL, V183, P1223, DOI 10.1083/jcb.200809190; Bjelic S, 2012, J STRUCT BIOL, V177, P160, DOI 10.1016/j.jsb.2011.11.010; Bottini N, 2004, NAT GENET, V36, P337, DOI 10.1038/ng1323; Bottini N, 2014, ANNU REV IMMUNOL, V32, P83, DOI 10.1146/annurev-immunol-032713-120249; Cemerski S, 2008, IMMUNITY, V29, P414, DOI 10.1016/j.immuni.2008.06.014; Chen J, 2014, PROTEIN CELL, V5, P795, DOI 10.1007/s13238-014-0081-9; Chen L, 1999, COLD SPRING HARB SYM, V64, P527, DOI 10.1101/sqb.1999.64.527; Chen M, 2019, EXP CELL RES, V384, DOI 10.1016/j.yexcr.2019.111618; Cloutier JF, 1999, J EXP MED, V189, P111, DOI 10.1084/jem.189.1.111; Davidson D, 1997, J BIOL CHEM, V272, P23455, DOI 10.1074/jbc.272.37.23455; Gjorloff-Wingren A, 1999, EUR J IMMUNOL, V29, P3845, DOI 10.1002/(SICI)1521-4141(199912)29:12<3845::AID-IMMU3845>3.0.CO;2-U; Gouveia SM, 2010, INT REV CEL MOL BIO, V285, P1, DOI 10.1016/S1937-6448(10)85001-4; Heneberg P, 2015, INT ARCH ALLERGY IMM, V166, P189, DOI 10.1159/000380853; Heward JM, 2007, J CLIN ENDOCR METAB, V92, P685, DOI 10.1210/jc.2006-2064; Honnappa S, 2009, CELL, V138, P366, DOI 10.1016/j.cell.2009.04.065; Kodama A, 2003, CELL, V115, P343, DOI 10.1016/S0092-8674(03)00813-4; Kyogoku C, 2004, AM J HUM GENET, V75, P504, DOI 10.1086/423790; Lee JU, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02747; Manjarrez-Orduno N, 2012, NAT GENET, V44, P1227, DOI 10.1038/ng.2439; Manna T, 2008, BIOCHEMISTRY-US, V47, P779, DOI 10.1021/bi701912g; Martin-Cofreces NB, 2012, EMBO J, V31, P4140, DOI 10.1038/emboj.2012.242; MATTHEWS RJ, 1992, MOL CELL BIOL, V12, P2396, DOI 10.1128/MCB.12.5.2396; Mimori-Kiyosue Y, 2005, J CELL BIOL, V168, P141, DOI 10.1083/jcb.200405094; Mognol GP, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.97; Nehlig A, 2017, CELL MOL LIFE SCI, V74, P2381, DOI 10.1007/s00018-017-2476-2; Niu KW, 2017, SCI REP-UK, V7, DOI 10.1038/srep44809; Pedersen AK, 2004, BIOCHEM J, V378, P421, DOI 10.1042/BJ20030565; Perri V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175784; Ran JE, 2017, ONCOTARGET, V8, P9858, DOI 10.18632/oncotarget.14222; Serebriiskii IG, 2000, ANAL BIOCHEM, V285, P1, DOI 10.1006/abio.2000.4672; Smyth D, 2004, DIABETES, V53, P3020, DOI 10.2337/diabetes.53.11.3020; Steinmetz MO, 2008, TRENDS BIOCHEM SCI, V33, P535, DOI 10.1016/j.tibs.2008.08.006; Sun JP, 2003, J BIOL CHEM, V278, P12406, DOI 10.1074/jbc.M212491200; Tirnauer JS, 2000, J CELL BIOL, V149, P761, DOI 10.1083/jcb.149.4.761; Triplett TA, 2012, EUR J IMMUNOL, V42, P1893, DOI 10.1002/eji.201242444; van Oene M, 2005, ARTHRITIS RHEUM-US, V52, P1993, DOI 10.1002/art.21123; Vang T, 2012, NAT CHEM BIOL, V8, P437, DOI [10.1038/NCHEMBIO.916, 10.1038/nchembio.916]; Veillette A, 2002, ANNU REV IMMUNOL, V20, P669, DOI 10.1146/annurev.immunol.20.081501.130710; Wang B, 2001, MOL CELL BIOL, V21, P1077, DOI 10.1128/MCB.21.4.1077-1088.2001; Wang B, 2008, CELL, V133, P1080, DOI 10.1016/j.cell.2008.04.042; Wang WQ, 2004, J BIOL CHEM, V279, P30459, DOI 10.1074/jbc.M402217200; WEISS A, 1993, CELL, V73, P209, DOI 10.1016/0092-8674(93)90221-B; Wen Y, 2004, NAT CELL BIOL, V6, P820, DOI 10.1038/ncb1160; Wu JS, 2006, J BIOL CHEM, V281, P11002, DOI 10.1074/jbc.M600498200; Yu X, 2007, P NATL ACAD SCI USA, V104, P19767, DOI 10.1073/pnas.0706233104; Zhang JY, 2011, NAT GENET, V43, P902, DOI 10.1038/ng.904; Zhang YJ, 2016, THERANOSTICS, V6, P2129, DOI 10.7150/thno.16356; Zhang ZY, 2003, PROG NUCLEIC ACID RE, V73, P171, DOI 10.1016/S0079-6603(03)01006-7; Zyss D, 2011, J CELL BIOL, V195, P781, DOI 10.1083/jcb.201106025	54	5	5	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					8959	8974		10.1096/fj.201902811RR	http://dx.doi.org/10.1096/fj.201902811RR		MAY 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32469452	Green Submitted			2022-12-28	WOS:000538083000001
J	Giudetti, AM; Di Bonaventura, MVM; Ferramosca, A; Longo, S; Di Bonaventura, EM; Friuli, M; Romano, A; Gaetani, S; Cifani, C				Giudetti, Anna Maria; Micioni Di Bonaventura, Maria Vittoria; Ferramosca, Alessandra; Longo, Serena; Micioni Di Bonaventura, Emanuela; Friuli, Marzia; Romano, Adele; Gaetani, Silvana; Cifani, Carlo			Brief daily access to cafeteria-style diet impairs hepatic metabolism even in the absence of excessive body weight gain in rats	FASEB JOURNAL			English	Article						body weight; cafeteria diet; de novo lipogenesis; insulin signaling; obesity	DIACYLGLYCEROL ACYLTRANSFERASE; FATTY-ACID; INSULIN-RESISTANCE; SIGNALING PATHWAY; ENERGY DENSITY; FOOD-INTAKE; LIVER; OBESITY; LIPOGENESIS; EXPRESSION	Numerous nutritional approaches aimed at reducing body weight have been developed as a strategy to reduce obesity. Most of these interventions rely on reducing caloric intake or limiting calories access to a few hours per day. In this work, we analyzed the effects of the extended (24 hours/day) or restricted (1 hour/day) access to a cafeteria-style (CAF) diet, on rat body weight and hepatic lipid metabolism, with respect to control rats (CTR) fed with a standard chow diet. The body weight gain of restricted-fed rats was not different from CTR, despite the slightly higher total caloric intake, but resulted significantly lower than extended-fed rats, which showed a CAF diet-induced obesity and a dramatically higher total caloric intake. However, both CAF-fed groups of rats showed, compared to CTR, unhealthy serum and hepatic parameters such as higher serum glucose level, lower HDL values, and increased hepatic triacylglycerol and cholesterol amount. The hepatic expression and activity of key enzymes of fatty acid synthesis, acetyl-CoA carboxylase (ACC), and fatty acid synthase (FAS), was similarly reduced in both CAF-fed groups of rats with respect to CTR. Anyway, while in extended-fed rats this reduction was associated to a long-term mechanism involving sterol regulatory element-binding protein-1 (SREBP-1), in restricted-fed animals a short-term mechanism based on PKA and AMPK activation occurred in the liver. Furthermore, hepatic fatty acid oxidation (FAO) and oxidative stress resulted significantly increased in extended, but not in restricted-fed rats, as compared to CTR. Overall, these results demonstrate that although limiting the total caloric intake might successfully fight obesity development, the nutritional content of the diet is the major determinant for the health status.	[Giudetti, Anna Maria; Ferramosca, Alessandra; Longo, Serena] Univ Salento, Dept Biol & Environm Sci & Technol, Via Monteroni, I-73100 Lecce, Italy; [Micioni Di Bonaventura, Maria Vittoria; Micioni Di Bonaventura, Emanuela; Cifani, Carlo] Univ Camerino, Sch Pharm, Pharmacol Unit, Camerino, Italy; [Friuli, Marzia; Romano, Adele; Gaetani, Silvana] Sapienza Univ Rome, Dept Physiol & Pharmacol V Erspamer, Piazzale Aldo Moro 5, I-00185 Rome, Italy	University of Salento; University of Camerino; Sapienza University Rome	Giudetti, AM (corresponding author), Univ Salento, Dept Biol & Environm Sci & Technol, Via Monteroni, I-73100 Lecce, Italy.; Gaetani, S (corresponding author), Sapienza Univ Rome, Dept Physiol & Pharmacol V Erspamer, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	anna.giudetti@unisalento.it; silvana.gaetani@uniroma1.it	Giudetti, Anna Maria/ABF-4049-2021; Ferramosca, Alessandra/B-8801-2015; Micioni Di Bonaventura, Maria Vittoria/AAC-5447-2022; Longo, Serena/AHI-0456-2022	Ferramosca, Alessandra/0000-0002-8251-9652; Micioni Di Bonaventura, Maria Vittoria/0000-0002-8044-1206; Micioni Di Bonaventura, Emanuela/0000-0001-8484-7513; LONGO, SERENA/0000-0001-8595-1259; ROMANO, ADELE/0000-0003-3874-2627; Friuli, Marzia/0000-0001-7481-3424	Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) [2012JTX3KL - PRIN 2012]	Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR))	Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR), Grant/Award Number: 2012JTX3KL - PRIN 2012	Arble DM, 2009, OBESITY, V17, P2100, DOI 10.1038/oby.2009.264; Azzout-Marniche D, 2000, BIOCHEM J, V350, P389, DOI 10.1042/0264-6021:3500389; Bartus M, 2005, PHARMACOL REP, V57, P127; Boone LR, 2011, J LIPIDS, V2011, DOI 10.1155/2011/101242; Carillon J, 2013, FREE RADICAL BIO MED, V65, P254, DOI 10.1016/j.freeradbiomed.2013.06.022; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Cases S, 2001, J BIOL CHEM, V276, P38870, DOI 10.1074/jbc.M106219200; Choi CS, 2007, J BIOL CHEM, V282, P22678, DOI 10.1074/jbc.M704213200; Cifani C, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00266; Cifani C, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00187; CORTON JM, 1994, CURR BIOL, V4, P315, DOI 10.1016/S0960-9822(00)00070-1; Cottone P, 2008, NEUROPSYCHOPHARMACOL, V33, P524, DOI 10.1038/sj.npp.1301430; Czech MP, 2013, DIABETOLOGIA, V56, P949, DOI 10.1007/s00125-013-2869-1; D'Addario C, 2014, NEUROSCI BIOBEHAV R, V47, P203, DOI 10.1016/j.neubiorev.2014.08.008; Di Bonaventura MVM, 2020, NUTRIENTS, V12, DOI 10.3390/nu12030623; Di Bonaventura MVM, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201700403; Di Bonaventura MVM, 2013, PSYCHOPHARMACOLOGY, V228, P53, DOI 10.1007/s00213-013-3013-0; Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280; Ferramosca A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038797; Ferre P, 2007, HORM RES, V68, P72, DOI 10.1159/000100426; Gao YF, 2015, J AGR FOOD CHEM, V63, P6019, DOI 10.1021/acs.jafc.5b01238; GEELEN MJH, 1980, DIABETES, V29, P1006, DOI 10.2337/diab.29.12.1006; Giudetti AM, 2005, EUR J NUTR, V44, P33, DOI 10.1007/s00394-004-0489-8; Giudetti AM, 2003, BRIT J NUTR, V90, P887, DOI 10.1079/BJN2003977; Giudetti AM, 2019, FASEB J, V33, P1428, DOI 10.1096/fj.201801130R; Giudetti AM, 2019, BBA-MOL CELL BIOL L, V1864, P344, DOI 10.1016/j.bbalip.2018.12.011; Gnoni A, 2019, IUBMB LIFE, V71, P863, DOI 10.1002/iub.2014; Gomez-Smith M, 2016, PHYSIOL BEHAV, V167, P382, DOI 10.1016/j.physbeh.2016.09.029; Guillet-Deniau I, 2002, DIABETES, V51, P1722, DOI 10.2337/diabetes.51.6.1722; Hebestreit A, 2014, EUR J NUTR, V53, P673, DOI 10.1007/s00394-013-0575-x; HENIN N, 1995, FASEB J, V9, P541, DOI 10.1096/fasebj.9.7.7737463; Higa Talita S, 2014, Int J Physiol Pathophysiol Pharmacol, V6, P47; Johnson AR, 2016, BIOCHEM BIOPH RES CO, V473, P545, DOI 10.1016/j.bbrc.2016.03.113; Johnson PM, 2010, NAT NEUROSCI, V13, P635, DOI 10.1038/nn.2519; Leigh SJ, 2019, JOVE-J VIS EXP, DOI 10.3791/60262; LINDBERG RA, 1995, AM J HYPERTENS, V8, P1001, DOI 10.1016/0895-7061(95)00183-2; Lu M, 2006, AM J PHYSIOL-CELL PH, V290, pC1477, DOI 10.1152/ajpcell.00374.2005; Maeda AS, 2018, NUTRIENTS, V10, DOI 10.3390/nu10111571; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Munday MR, 2002, BIOCHEM SOC T, V30, P1059, DOI 10.1042/bst0301059; Muoio DM, 1999, BIOCHEM J, V338, P783, DOI 10.1042/0264-6021:3380783; Peng IC, 2012, AM J PHYSIOL-ENDOC M, V302, pE1560, DOI 10.1152/ajpendo.00504.2011; Pucci M, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00523; Ren CJ, 2015, INT J BIOL MACROMOL, V72, P951, DOI 10.1016/j.ijbiomac.2014.09.060; ROTHWELL NJ, 1983, BIOSCIENCE REP, V3, P217, DOI 10.1007/BF01122453; Sampey BP, 2011, OBESITY, V19, P1109, DOI 10.1038/oby.2011.18; Saper CB, 2002, NEURON, V36, P199, DOI 10.1016/S0896-6273(02)00969-8; Shafat A, 2009, APPETITE, V52, P34, DOI 10.1016/j.appet.2008.07.004; Stanca E, 2013, BBA-MOL BASIS DIS, V1832, P2019, DOI 10.1016/j.bbadis.2013.07.005; Titchenell PM, 2016, CELL METAB, V23, P1154, DOI 10.1016/j.cmet.2016.04.022; Vergara D, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00544; Yen CLE, 2008, J LIPID RES, V49, P2283, DOI 10.1194/jlr.R800018-JLR200; Yuan LY, 2009, MOL ASPECTS MED, V30, P29, DOI 10.1016/j.mam.2008.08.003; Zhang XD, 2010, ACTA PHARMACOL SIN, V31, P1470, DOI 10.1038/aps.2010.104	54	8	8	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9358	9371		10.1096/fj.201902757R	http://dx.doi.org/10.1096/fj.201902757R		MAY 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32463138				2022-12-28	WOS:000536309100001
J	Branton, SA; Ghorbani, A; Bolt, BN; Fifield, H; Berghuis, LM; Larijani, M				Branton, Sarah A.; Ghorbani, Atefeh; Bolt, Brittany N.; Fifield, Heather; Berghuis, Lesley M.; Larijani, Mani			Activation-induced cytidine deaminase can target multiple topologies of double-stranded DNA in a transcription-independent manner	FASEB JOURNAL			English	Article						breathing DNA structures; cytidine deamination; genome mutagenesis; RNA polymerase	CLASS-SWITCH RECOMBINATION; B-CELL GENOME; SOMATIC HYPERMUTATION; IMMUNOGLOBULIN GENES; SUPER-ENHANCERS; RGYW MOTIFS; CHAIN GENES; IN-VIVO; AID; POLYMERASE	Activation-induced cytidine deaminase (AID) mutates immunoglobulin genes and acts genome-wide. AID targets robustly transcribed genes, and purified AID acts on single-stranded (ss) but not double-stranded (ds) DNA oligonucleotides. Thus, it is believed that transcription is the generator of ssDNA for AID. Previous cell-free studies examining the relationship between transcription and AID targeting have employed a bacterial colony count assay wherein AID reverts an antibiotic resistance stop codon in plasmid substrates, leading to colony formation. Here, we established a novel assay where kb-long dsDNA of varying topologies is incubated with AID, with or without transcription, followed by direct sequencing. This assay allows for an unselected and in-depth comparison of mutation frequency and pattern of AID targeting in the absence of transcription or across a range of transcription dynamics. We found that without transcription, AID targets breathing ssDNA in supercoiled and, to a lesser extent, in relaxed dsDNA. The most optimal transcription only modestly enhanced AID action on supercoiled dsDNA in a manner dependent on RNA polymerase speed. These data suggest that the correlation between transcription and AID targeting may reflect transcription leading to AID-accessible breathing ssDNA patches naturally occurring in de-chromatinized dsDNA, as much as being due to transcription directly generating ssDNA.	[Branton, Sarah A.; Ghorbani, Atefeh; Bolt, Brittany N.; Fifield, Heather; Berghuis, Lesley M.; Larijani, Mani] Mem Univ Newfoundland, Dept Biomed Sci, Program Immunol & Infect Dis, Fac Med, St John, NF, Canada; [Larijani, Mani] Simon Fraser Univ, Dept Mol Biol & Biochem, Fac Sci, Burnaby, BC V5A 1S6, Canada	Memorial University Newfoundland; Simon Fraser University	Larijani, M (corresponding author), Simon Fraser Univ, Dept Mol Biol & Biochem, Fac Sci, Burnaby, BC V5A 1S6, Canada.	mani_larijani@sfu.ca			Gouvernement du Canada | CIHR | Institute of Infection and Immunity (III) [MOP111132]; Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (NSERC) [2015-047960]; International Development Research Centre (IDRC) [108405-001]	Gouvernement du Canada | CIHR | Institute of Infection and Immunity (III)(Canadian Institutes of Health Research (CIHR)); Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (NSERC); International Development Research Centre (IDRC)	Gouvernement du Canada | CIHR | Institute of Infection and Immunity (III), Grant/Award Number: MOP111132; Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (NSERC), Grant/Award Number: 2015-047960; International Development Research Centre (IDRC), Grant/Award Number: 108405-001	Abdouni HS, 2018, MOL IMMUNOL, V93, P94, DOI 10.1016/j.molimm.2017.11.012; Altan-Bonnet G, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLEtt.90.138101; Alvarez-Prado AF, 2018, J EXP MED, V215, P761, DOI 10.1084/jem.20171738; Basu U, 2011, CELL, V144, P353, DOI 10.1016/j.cell.2011.01.001; Besmer E, 2006, MOL CELL BIOL, V26, P4378, DOI 10.1128/MCB.02375-05; BETZ AG, 1994, CELL, V77, P239, DOI 10.1016/0092-8674(94)90316-6; Borzooee F, 2019, NEW BIOTECHNOL, V51, P67, DOI 10.1016/j.nbt.2019.02.006; Boursier L, 2004, MOL IMMUNOL, V40, P1273, DOI 10.1016/j.molimm.2003.11.026; Bransteitter R, 2004, J BIOL CHEM, V279, P51612, DOI 10.1074/jbc.M408135200; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Canugovi C, 2009, FASEB J, V23, P34, DOI 10.1096/fj.08-115352; Chaudhuri J, 2004, NATURE, V430, P992, DOI 10.1038/nature02821; Chelico L, 2006, NAT STRUCT MOL BIOL, V13, P392, DOI 10.1038/nsmb1086; Chelico L, 2009, PHILOS T R SOC B, V364, P583, DOI 10.1098/rstb.2008.0195; Choudhary M, 2018, INT REV IMMUNOL, V37, P37, DOI 10.1080/08830185.2017.1369980; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; CLARKE SH, 1985, J EXP MED, V161, P687, DOI 10.1084/jem.161.4.687; Cline J, 1996, NUCLEIC ACIDS RES, V24, P3546, DOI 10.1093/nar/24.18.3546; Conticello SG, 2008, MOL CELL, V31, P474, DOI 10.1016/j.molcel.2008.07.009; Conticello SG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-229; Das C, 2010, TRENDS BIOCHEM SCI, V35, P476, DOI 10.1016/j.tibs.2010.04.001; DAYN A, 1992, NUCLEIC ACIDS RES, V20, P5991, DOI 10.1093/nar/20.22.5991; Diamond CP, 2019, BBA-GEN SUBJECTS, V1863, DOI 10.1016/j.bbagen.2019.129415; Dickerson SK, 2003, J EXP MED, V197, P1291, DOI 10.1084/jem.20030481; Dorner T, 1998, EUR J IMMUNOL, V28, P3384; Duvvuri B, 2012, IMMUNOGENETICS, V64, P481, DOI 10.1007/s00251-012-0607-3; Fei JY, 2013, P NATL ACAD SCI USA, V110, P17173, DOI 10.1073/pnas.1316493110; Foster SJ, 1999, EUR J IMMUNOL, V29, P4011, DOI 10.1002/(SICI)1521-4141(199912)29:12<4011::AID-IMMU4011>3.0.CO;2-W; Foster SJ, 1999, EUR J IMMUNOL, V29, P3122, DOI 10.1002/(SICI)1521-4141(199910)29:10<3122::AID-IMMU3122>3.3.CO;2-F; Fugmann SD, 2003, NAT IMMUNOL, V4, P429, DOI 10.1038/ni0503-429; Fukita Y, 1998, IMMUNITY, V9, P105, DOI 10.1016/S1074-7613(00)80592-0; Gelmez MY, 2017, IMMUNOL INVEST, V46, P433, DOI 10.1080/08820139.2017.1288241; Goyenechea B, 1997, EMBO J, V16, P3987, DOI 10.1093/emboj/16.13.3987; Honjo T, 2002, NAT IMMUNOL, V3, P800, DOI 10.1038/ni0902-800; Honjo T, 2012, ADV CANCER RES, V113, P1, DOI 10.1016/B978-0-12-394280-7.00001-4; Hu WJ, 2015, P NATL ACAD SCI USA, V112, P5791, DOI 10.1073/pnas.1506167112; Huang JB, 2000, J MOL BIOL, V303, P347, DOI 10.1006/jmbi.2000.4150; Keim C, 2013, GENE DEV, V27, P1, DOI 10.1101/gad.200014.112; Kim N, 2012, NAT REV GENET, V13, P204, DOI 10.1038/nrg3152; King JJ, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00351; King JJ, 2015, STRUCTURE, V23, P615, DOI 10.1016/j.str.2015.01.016; Kleinstein SH, 2003, J IMMUNOL, V171, P4639, DOI 10.4049/jimmunol.171.9.4639; Kodgire P, 2013, J EXP MED, V210, P1481, DOI 10.1084/jem.20121523; Kodgire P, 2012, MOL CELL BIOL, V32, P2030, DOI 10.1128/MCB.06722-11; Kotani A, 2007, P NATL ACAD SCI USA, V104, P1616, DOI 10.1073/pnas.0610732104; Kouzine F, 2013, NAT STRUCT MOL BIOL, V20, P396, DOI 10.1038/nsmb.2517; Krasilnikov AS, 1999, J MOL BIOL, V292, P1149, DOI 10.1006/jmbi.1999.3117; Kuetche VK, 2016, J THEOR BIOL, V401, P15, DOI 10.1016/j.jtbi.2016.04.026; Lada AG, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-47; Larijani M, 2005, MOL IMMUNOL, V42, P599, DOI 10.1016/j.molimm.2004.09.007; Larijani M, 2005, IMMUNOGENETICS, V56, P840, DOI 10.1007/s00251-004-0748-0; Larijani M, 2007, MOL CELL BIOL, V27, P8038, DOI 10.1128/MCB.01046-07; Larijani M, 2007, MOL CELL BIOL, V27, P20, DOI 10.1128/MCB.00824-06; Larijani M, 2012, SEMIN IMMUNOL, V24, P255, DOI 10.1016/j.smim.2012.05.003; LEBECQUE SG, 1990, J EXP MED, V172, P1717, DOI 10.1084/jem.172.6.1717; Ling L L, 1991, PCR Methods Appl, V1, P63; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; Longerich S, 2006, CURR OPIN IMMUNOL, V18, P164, DOI 10.1016/j.coi.2006.01.008; MacCarthy T, 2009, P NATL ACAD SCI USA, V106, P8629, DOI 10.1073/pnas.0903803106; Mak CH, 2013, J BIOL CHEM, V288, P29786, DOI 10.1074/jbc.M113.506550; MANDLER R, 1993, J EXP MED, V178, P1577, DOI 10.1084/jem.178.5.1577; Martin A, 2002, NAT REV IMMUNOL, V2, P605, DOI 10.1038/nri858; Martin A, 2002, NATURE, V415, P802, DOI 10.1038/nature714; Martomo SA, 2005, J IMMUNOL, V174, P7787, DOI 10.4049/jimmunol.174.12.7787; Matsushita M, 2017, YONAGO ACTA MED, V60, P145, DOI 10.33160/yam.2017.09.002; McInerney Peter, 2014, Mol Biol Int, V2014, P287430, DOI 10.1155/2014/287430; Meng FL, 2014, CELL, V159, P1538, DOI 10.1016/j.cell.2014.11.014; Methot SP, 2017, ADV IMMUNOL, V133, P37, DOI 10.1016/bs.ai.2016.11.002; Mu YX, 2018, MOL CELL ONCOL, V5, DOI 10.1080/23723556.2018.1432259; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Muramatsu Masamichi, 2007, Adv Immunol, V94, P1, DOI 10.1016/S0065-2776(06)94001-2; Nambu Y, 2003, SCIENCE, V302, P2137, DOI 10.1126/science.1092481; Naughton C, 2013, NAT STRUCT MOL BIOL, V20, P387, DOI 10.1038/nsmb.2509; Nowak U, 2011, NAT IMMUNOL, V12, P160, DOI 10.1038/ni.1977; Odegard VH, 2006, NAT REV IMMUNOL, V6, P573, DOI 10.1038/nri1896; Pannunzio NR, 2017, MOL CELL, V68, P901, DOI 10.1016/j.molcel.2017.11.011; Parsa JY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002518; Pasqualucci L, 2008, NAT GENET, V40, P108, DOI 10.1038/ng.2007.35; Pavri R, 2010, CELL, V143, P122, DOI 10.1016/j.cell.2010.09.017; Peters A, 1996, IMMUNITY, V4, P57, DOI 10.1016/S1074-7613(00)80298-8; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Pham P, 2019, NUCLEIC ACIDS RES, V47, P10815, DOI 10.1093/nar/gkz821; Pilzecker B, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00438; Pinaud E, 2001, IMMUNITY, V15, P187, DOI 10.1016/S1074-7613(01)00181-9; Potapov V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169774; Qian J, 2014, CELL, V159, P1524, DOI 10.1016/j.cell.2014.11.013; Qiao Q, 2017, MOL CELL, V67, P361, DOI 10.1016/j.molcel.2017.06.034; Quinlan EM, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00077-17; Rada C, 2001, EMBO J, V20, P4570, DOI 10.1093/emboj/20.16.4570; Rajagopal D, 2009, J EXP MED, V206, P1237, DOI 10.1084/jem.20082514; RAJEWSKY K, 1987, SCIENCE, V238, P1088, DOI 10.1126/science.3317826; Ramiro AR, 2003, NAT IMMUNOL, V4, P452, DOI 10.1038/ni920; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Robbiani DF, 2013, ANNU REV PATHOL-MECH, V8, P79, DOI 10.1146/annurev-pathol-020712-164004; Robbiani DF, 2009, MOL CELL, V36, P631, DOI 10.1016/j.molcel.2009.11.007; Robbiani DF, 2008, CELL, V135, P1028, DOI 10.1016/j.cell.2008.09.062; Rodriguez-Cortez VC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07380-9; ROTHENFLUH HS, 1993, EUR J IMMUNOL, V23, P2152, DOI 10.1002/eji.1830230916; Sheinin MY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3579; Shen HM, 2005, MOL CELL BIOL, V25, P10815, DOI 10.1128/MCB.25.24.10815-10821.2005; Shen HM, 2004, P NATL ACAD SCI USA, V101, P12997, DOI 10.1073/pnas.0404974101; Shen HM, 2009, J EXP MED, V206, P1057, DOI 10.1084/jem.20082678; SHERMOEN AW, 1991, CELL, V67, P303, DOI 10.1016/0092-8674(91)90182-X; Singh AK, 2019, MOL IMMUNOL, V116, P63, DOI 10.1016/j.molimm.2019.10.002; Sohail A, 2003, NUCLEIC ACIDS RES, V31, P2990, DOI 10.1093/nar/gkg464; Spencer J, 1999, J IMMUNOL, V162, P6596; Storb U, 1998, CURR TOP MICROBIOL, V229, P11; Storb U, 1998, IMMUNOL REV, V162, P153; Storb U, 1999, COLD SPRING HARB SYM, V64, P227, DOI 10.1101/sqb.1999.64.227; Storb U, 2014, ADV IMMUNOL, V122, P253, DOI 10.1016/B978-0-12-800267-4.00007-9; Storck S, 2011, CURR OPIN IMMUNOL, V23, P337, DOI 10.1016/j.coi.2011.02.002; Teater M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02595-w; von Hippel PH, 2013, BIOPOLYMERS, V99, P923, DOI 10.1002/bip.22347; Willmann KL, 2012, J EXP MED, V209, P2099, DOI 10.1084/jem.20112145; XU LX, 1993, P NATL ACAD SCI USA, V90, P3705, DOI 10.1073/pnas.90.8.3705; Xue KM, 2006, J EXP MED, V203, P2085, DOI 10.1084/jem.20061067; Yamane A, 2011, NAT IMMUNOL, V12, P62, DOI 10.1038/ni.1964; Yu KF, 2005, MOL CELL BIOL, V25, P1730, DOI 10.1128/MCB.25.5.1730-1736.2005; Yu KF, 2003, NAT IMMUNOL, V4, P442, DOI 10.1038/ni919; ZHANG J, 1993, EMBO J, V12, P3529, DOI 10.1002/j.1460-2075.1993.tb06027.x	121	8	9	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9245	9268		10.1096/fj.201903036RR	http://dx.doi.org/10.1096/fj.201903036RR		MAY 2020	24	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32437054				2022-12-28	WOS:000535480800001
J	Prigent, A; Chapelet, G; de Lataillade, AD; Outlier, T; Durieu, E; Bourreille, A; Duchalais, E; Hardonniere, K; Neunlist, M; Noble, W; Kercline-Romer, S; Derkinderen, P; Rolli-Derkinderen, M				Prigent, Alice; Chapelet, Guillaume; de Lataillade, Adrien De Guilliem; Outlier, Thibauld; Durieu, Emilie; Bourreille, Arnaud; Duchalais, Emilie; Hardonniere, Kevin; Neunlist, Michel; Noble, Wendy; Kercline-Romer, Saadia; Derkinderen, Pascal; Rolli-Derkinderen, Malvyne			Tau accumulates in Crohn's disease gut	FASEB JOURNAL			English	Article						alpha-synuclein; Crohn's disease; enteric nervous system; Nrf2; Tau	ENTERIC NERVOUS-SYSTEM; ALPHA-SYNUCLEIN; PARKINSONS-DISEASE; CASPASE-CLEAVAGE; PROTEIN; AGGREGATION; NEURONS	A sizeable body of evidence has recently emerged to suggest that gastrointestinal (GI) inflammation might be involved in the development of Parkinson's disease (PD). There is now strong epidemiological and genetical evidence linking PD to inflammatory bowel diseases and we recently demonstrated that the neuronal protein alpha-synuclein, which is critically involved in PD pathophysiology, is upregulated in inflamed segments of Crohn's colon. The microtubule associated protein tau is another neuronal protein critically involved in neurodegenerative disorders but, in contrast to alpha-synuclein, no data are available about its expression and phosphorylation patterns in inflammatory bowel diseases. Here, we examined the expression levels of tau isoforms, their phosphorylation profile and truncation in colon biopsy specimens from 16 Crohn's disease (CD) and 6 ulcerative colitis (UC) patients and compared them to samples from 16 controls. Additional experiments were performed in full thickness segments of colon of five CD and five control subjects, in primary cultures of rat enteric neurons and in nuclear factor erythroid 2-related factor (Nrf2) knockout mice. Our results show the upregulation of two main human tau isoforms in the enteric nervous system (ENS) in CD but not in UC. This upregulation was not transcriptionally regulated but instead likely resulted from a decrease in protein clearance via an Nrf2 pathway. Our findings, which provide the first detailed characterization of tau in CD, suggest that the key proteins involved in neurodegenerative disorders such as alpha-synuclein and tau, might also play a role in CD.	[Prigent, Alice; Chapelet, Guillaume; de Lataillade, Adrien De Guilliem; Outlier, Thibauld; Durieu, Emilie; Bourreille, Arnaud; Duchalais, Emilie; Neunlist, Michel; Derkinderen, Pascal; Rolli-Derkinderen, Malvyne] Univ Nantes, IMAD, Enter Nervous Syst Gut & Brain Dis, Inserm,TENS, Nantes, France; [Chapelet, Guillaume] CHU Nantes, Clin Gerontol Dept, Nantes, France; [de Lataillade, Adrien De Guilliem; Derkinderen, Pascal] CHU Nantes, Dept Neurol, Nantes, France; [Hardonniere, Kevin; Kercline-Romer, Saadia] Univ Paris Saclay, Inflammat Microbiome & Immunosurveillance, INSERM, Chatenay Malabry, France; [Noble, Wendy] Kings Coll London, Inst Psychiat Psychol & Neurosci, Maurice Wohl Clin Neurosci Inst, Dept Basic & Clin Neurosci, London, England	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of London; King's College London	Derkinderen, P (corresponding author), Univ Nantes, INSERM, U1235 Nantes, TENS,Enter Nervous Syst Gut & Brain Dis,IMAD, 1 Rue Gaston Veil, F-44035 Nantes, France.	pascal.derkinderen@chu-nantes.fr	Hardonnière, Kévin/ABH-2844-2020; Noble, Wendy/C-3756-2009	Noble, Wendy/0000-0002-7898-4295; Hardonniere, Kevin/0000-0002-4866-8937; Kerdine-Romer, Saadia/0000-0003-3313-952X	centre d'entraide et de coordination des associations de parkinsoniens (CECAP); Parkinsonien de Vendee (FFGP)	centre d'entraide et de coordination des associations de parkinsoniens (CECAP); Parkinsonien de Vendee (FFGP)	This work was supported by centre d'entraide et de coordination des associations de parkinsoniens (CECAP) and Parkinsonien de Vendee (FFGP) to AP, AGL, and PD.	Nguyen APT, 2018, HUM MOL GENET, V27, P120, DOI 10.1093/hmg/ddx389; Aronov S, 2002, J CELL SCI, V115, P3817, DOI 10.1242/jcs.00058; Bailey RM, 2013, ACTA NEUROPATHOL, V126, P809, DOI 10.1007/s00401-013-1188-4; Belai A, 1997, GUT, V40, P767, DOI 10.1136/gut.40.6.767; Bellezza I, 2018, BBA-MOL CELL RES, V1865, P721, DOI 10.1016/j.bbamcr.2018.02.010; Bottner M, 2012, NEUROBIOL DIS, V48, P474, DOI 10.1016/j.nbd.2012.07.018; Brierley SM, 2014, NAT REV GASTRO HEPAT, V11, P611, DOI 10.1038/nrgastro.2014.103; BRION JP, 1986, LANCET, V2, P1098, DOI 10.1016/S0140-6736(86)90495-2; Chesser AS, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00122; Corbille AG, 2017, NEUROSCI LETT, V641, P81, DOI 10.1016/j.neulet.2017.01.050; Derkinderen P, 2011, NEUROLOGY, V77, P1761, DOI 10.1212/WNL.0b013e318236ef60; Dugger BN, 2019, NEUROSCI LETT, V696, P132, DOI 10.1016/j.neulet.2018.12.031; DVORAK AM, 1993, ANN SURG, V217, P260, DOI 10.1097/00000658-199303000-00008; Fenyi A, 2019, NEUROBIOL DIS, V129, P38, DOI 10.1016/j.nbd.2019.05.002; Galvin JE, 2001, ARCH NEUROL-CHICAGO, V58, P186, DOI 10.1001/archneur.58.2.186; Gamblin TC, 2003, P NATL ACAD SCI USA, V100, P10032, DOI 10.1073/pnas.1630428100; Geboes K, 1998, NEUROGASTROENT MOTIL, V10, P189, DOI 10.1046/j.1365-2982.1998.00102.x; GREENBERG SG, 1990, P NATL ACAD SCI USA, V87, P5827, DOI 10.1073/pnas.87.15.5827; Guerreiro PS, 2016, MOL NEUROBIOL, V53, P3124, DOI 10.1007/s12035-015-9209-z; Guo T, 2017, ACTA NEUROPATHOL, V133, P665, DOI 10.1007/s00401-017-1707-9; Henderson MX, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0836-x; Hui KY, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aai7795; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Jo C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4496; Johnson ME, 2019, TRENDS NEUROSCI, V42, P4, DOI 10.1016/j.tins.2018.09.007; Kruger U, 2012, NEUROBIOL AGING, V33, P2291, DOI 10.1016/j.neurobiolaging.2011.11.009; Lakhan SE, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-37; Lasagna-Reeves CA, 2012, FASEB J, V26, P1946, DOI 10.1096/fj.11-199851; Lebouvier T, 2010, NEUROGASTROENT MOTIL, V22, pE11, DOI 10.1111/j.1365-2982.2009.01368.x; Lin JC, 2016, INFLAMM BOWEL DIS, V22, P1049, DOI 10.1097/MIB.0000000000000735; Lionnet A, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0568-3; LITTAUER UZ, 1986, P NATL ACAD SCI USA, V83, P7162, DOI 10.1073/pnas.83.19.7162; Liu C, 2016, J BIOL CHEM, V291, P8173, DOI 10.1074/jbc.M115.641902; Melrose HL, 2010, NEUROBIOL DIS, V40, P503, DOI 10.1016/j.nbd.2010.07.010; Meyer V, 2014, BIOCHEMISTRY-US, V53, P5804, DOI 10.1021/bi501050g; Newman J, 2005, ACTA NEUROPATHOL, V110, P135, DOI 10.1007/s00401-005-1027-3; OEHMICHEN M, 1977, DIGESTION, V15, P482, DOI 10.1159/000198039; Preterrea C, 2015, J PARKINSON DIS, V5, P765, DOI 10.3233/JPD-150670; Prigent A, 2019, J NEUROCHEM, V148, P746, DOI 10.1111/jnc.14656; Prigent A, 2019, ACTA NEUROPATHOL, V137, P359, DOI 10.1007/s00401-018-1943-7; Rissman RA, 2004, J CLIN INVEST, V114, P121, DOI 10.1172/JCI200420640; Rolli-Derkinderen M, 2020, J NEUROL, V267, P2207, DOI 10.1007/s00415-019-09321-0; Rousseaux MWC, 2016, ELIFE, V5, DOI 10.7554/eLife.19809; Schneider J, 2001, NEUROGASTROENT MOTIL, V13, P255, DOI 10.1046/j.1365-2982.2001.00265.x; Sengupta U, 2015, BIOL PSYCHIAT, V78, P672, DOI 10.1016/j.biopsych.2014.12.019; Spillantini MG, 1998, TRENDS NEUROSCI, V21, P428, DOI 10.1016/S0166-2236(98)01337-X; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Torres J, 2017, LANCET, V389, P1741, DOI 10.1016/S0140-6736(16)31711-1; Wang R, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/4703253; Weimers P, 2019, INFLAMM BOWEL DIS, V25, P111, DOI 10.1093/ibd/izy190; Zhang HQ, 2019, FREE RADICAL BIO MED, V145, P33, DOI 10.1016/j.freeradbiomed.2019.09.016; Zhu F, 2019, DIGEST LIVER DIS, V51, P38, DOI 10.1016/j.dld.2018.09.017	52	12	12	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9285	9296		10.1096/fj.202000414R	http://dx.doi.org/10.1096/fj.202000414R		MAY 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32436623	Green Submitted			2022-12-28	WOS:000535481500001
J	Aviv, A				Aviv, Abraham			Telomeres and COVID-19	FASEB JOURNAL			English	Article						COVID-19; lymphopenia; Telomeres; T cells	T-CELL; LENGTH; EXPRESSION; PNEUMONIA; IMMUNITY; CANCER; SPAN; SARS	The medical, public health, and scientific communities are grappling with monumental imperatives to contain COVID-19, develop effective vaccines, identify efficacious treatments for the infection and its complications, and find biomarkers that detect patients at risk of severe disease. The focus of this communication is on a potential biomarker, short telomere length (TL), that might serve to identify patients more likely to die from the SARS-CoV-2 infection, regardless of age. The common thread linking these patients is lymphopenia, which largely reflects a decline in the numbers of CD4/CD8 T cells but not B cells. These findings are consistent with data that lymphocyte TL dynamics impose a limit on T-cell proliferation. They suggest that T-cell lymphopoiesis might stall in individuals with short TL who are infected with SARS-CoV-2.	[Aviv, Abraham] Rutgers State Univ, New Jersey Med Sch, Ctr Human Dev & Aging, Newark, NJ USA	Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center	Aviv, A (corresponding author), Rutgers State Univ, New Jersey Med Sch, Ctr Human Dev & Aging, Room F-464 MSB, Newark, NJ 07103 USA.	avivab@njms.rutgers.edu			NIH [R01 HL134840, U01AG066529]; Norwegian Research Council (NFR) [ES562296]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Norwegian Research Council (NFR)(Research Council of Norway)	A. Aviv current telomere research is funded by the NIH (R01 HL134840 and U01AG066529) and the Norwegian Research Council (NFR) ES562296	AlGhatrif M, 2020, JAMA CARDIOL, V5, P747, DOI 10.1001/jamacardio.2020.1329; ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114; Aubert G, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002696; Aviv A, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2016.0436; Aviv A, 2017, TRENDS CANCER, V3, P253, DOI 10.1016/j.trecan.2017.02.005; Benetos A, 2018, CIRC RES, V122, P616, DOI 10.1161/CIRCRESAHA.117.311751; de Jesus BB, 2011, AGING CELL, V10, P604, DOI 10.1111/j.1474-9726.2011.00700.x; Bialek S, 2020, MMWR-MORBID MORTAL W, V69, P422, DOI 10.15585/mmwr.mm6914e4; Blackburn Elizabeth H, 2011, Cold Spring Harb Perspect Biol, V3, DOI 10.1101/cshperspect.a003558; Booth CM, 2003, JAMA-J AM MED ASSOC, V289, P2801, DOI 10.1001/jama.289.21.JOC30885; Brouilette S, 2003, ARTERIOSCL THROM VAS, V23, P842, DOI 10.1161/01.ATV.0000067426.96344.32; Carter R, 2002, CLIN MICROBIOL REV, V15, P564, DOI 10.1128/CMR.15.4.564-594.2002; Chen G, 2020, J CLIN INVEST, V130, P2620, DOI 10.1172/JCI137244; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Cohen J., 2020, SCIENCE, DOI [10.1126/science.abc5422, DOI 10.1126/SCIENCE.ABC5422]; Danser AHJ, 2020, HYPERTENSION, V75, P1382, DOI 10.1161/HYPERTENSIONAHA.120.15082; Diao B, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00827; Dingli D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000345; DOBZHANSKY T, 1973, AM BIOL TEACH, V35, P125, DOI 10.2307/4444260; Dong YY, 2020, PEDIATRICS, V145, DOI 10.1542/peds.2020-0702; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; Factor-Litvak P, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3927; Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1574, DOI 10.1001/jama.2020.5394; Hansen MEB, 2016, HUM MOL GENET, V25, P2324, DOI 10.1093/hmg/ddw070; Harley CB, 2011, REJUV RES, V14, P45, DOI 10.1089/rej.2010.1085; He FJ, 1998, HYPERTENSION, V32, P820, DOI 10.1161/01.HYP.32.5.820; Hjelmborg JB, 2015, J MED GENET, V52, P297, DOI 10.1136/jmedgenet-2014-102736; Hodes RJ, 2002, NAT REV IMMUNOL, V2, P699, DOI 10.1038/nri890; Horvath K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36923-x; Hunt SC, 2008, AGING CELL, V7, P451, DOI 10.1111/j.1474-9726.2008.00397.x; Joy DA, 2003, SCIENCE, V300, P318, DOI 10.1126/science.1081449; Kimura M, 2010, EXP HEMATOL, V38, P854, DOI 10.1016/j.exphem.2010.06.010; Ko JH, 2016, J INFECTION, V73, P468, DOI 10.1016/j.jinf.2016.08.005; Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685; Liu WJ, 2017, ANTIVIR RES, V137, P82, DOI 10.1016/j.antiviral.2016.11.006; Lu Q, 2020, J MED VIROL, V92, P564, DOI 10.1002/jmv.25740; Martens UM, 2002, BRIT J HAEMATOL, V119, P810, DOI 10.1046/j.1365-2141.2002.03910.x; Min CK, 2016, SCI REP-UK, V6, DOI 10.1038/srep25359; Misiti S, 2000, MOL CELL BIOL, V20, P3764, DOI 10.1128/MCB.20.11.3764-3771.2000; Molgora Brenda, 2013, Cells, V2, P57, DOI 10.3390/cells2010057; Mollica L, 2009, J GERONTOL A-BIOL, V64, P965, DOI 10.1093/gerona/glp065; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Nanni S, 2002, J CLIN INVEST, V110, P219, DOI 10.1172/JCI200215552; Napoli PE, 2020, J CLIN MED, V9, DOI 10.3390/jcm9041138; Parri N, 2020, NEW ENGL J MED, V383, P187, DOI 10.1056/NEJMc2007617; Parrish CR, 2008, MICROBIOL MOL BIOL R, V72, P457, DOI 10.1128/MMBR.00004-08; Patrick M, 2019, CELL IMMUNOL, V345, DOI 10.1016/j.cellimm.2019.103989; Patrick MS, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01993; Shepherd BE, 2004, EXP HEMATOL, V32, P1040, DOI 10.1016/j.exphem.2004.07.023; Sidorov I, 2009, EXP HEMATOL, V37, P514, DOI 10.1016/j.exphem.2008.11.009; SLAGBOOM PE, 1994, AM J HUM GENET, V55, P876; Steenstrup T, 2017, AGING-US, V9, P1130, DOI 10.18632/aging.101216; Stone RC, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006144; Van Blerkom LM, 2003, YEARB PHYS ANTHROPOL, V46, P14, DOI 10.1002/ajpa.10384; VAZIRI H, 1994, P NATL ACAD SCI USA, V91, P9857, DOI 10.1073/pnas.91.21.9857; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585; Weng NP, 1997, IMMUNOL REV, V160, P43, DOI 10.1111/j.1600-065X.1997.tb01026.x; White NJ, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2509-9; WHO, 2019, REP WHO CHIN JOINT M; World Health Organization, 2018, THIS YEARS WORLD MAL; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Yancy CW, 2020, JAMA-J AM MED ASSOC, V323, P1891, DOI 10.1001/jama.2020.6548; Zhang JJ, 2020, ALLERGY, V75, P1730, DOI 10.1111/all.14238; Zheng HY, 2020, CELL MOL IMMUNOL, V17, P541, DOI 10.1038/s41423-020-0401-3	64	36	36	1	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					7247	7252		10.1096/fj.202001025	http://dx.doi.org/10.1096/fj.202001025		MAY 2020	6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32427393	Green Published, Green Accepted			2022-12-28	WOS:000533887200001
J	Li, T; Yu, Y; Song, YR; Li, XC; Lan, DY; Zhang, P; Xiao, YJ; Xing, YF				Li, Tao; Yu, Ying; Song, Yarong; Li, Xuechao; Lan, Dongyang; Zhang, Peng; Xiao, Yajun; Xing, Yifei			Activation of BDNF/TrkB pathway promotes prostate cancer progression via induction of epithelial-mesenchymal transition and anoikis resistance	FASEB JOURNAL			English	Article						anoikis resistance; BDNF; epithelial-mesenchymal transition; prostate cancer; TrkB	NEUROTROPHIC FACTOR ACTIVATION; SELECTIVE INHIBITOR; TRUNCATED TRKB; KINASE; EXPRESSION; RECEPTORS; AKT; EMT; ADENOCARCINOMA; SUPPRESSION	Prostate cancer (PCa) is one of the most common malignant diseases in male worldwide, yet, the molecular mechanisms involved in PCa progression are still poorly understood. This study aimed to investigate the roles of the brain-derived neurotrophic factor/tropomyosin receptor kinase B (BDNF/TrkB) pathway in PCa progression. It was demonstrated by immunohistochemical analysis that both BDNF and TrkB were overexpressed in PCa tissues and elevated TrkB expression was tightly related with lymph node metastasis and advanced stage of PCa. In vitro studies showed that stimulation with rhBDNF or overexpression of TrkB in PCa cells promoted cell migration, invasion, and anoikis resistance. Overexpression of TrkB also resulted in epithelial-mesenchymal transition (EMT)-like transformation in cell morphology, whereas RNA interference-mediated TrkB depletion caused reversion of EMT. Further investigation demonstrated that protein kinase B (AKT) was responsible for BDNF/TrkB signaling-induced pro-migratory and pro-invasive effects, EMT, and anoikis resistance. Finally, in vivo studies confirmed that enhanced TrkB expression facilitated tumor growth, whereas downregulation of TrkB suppressed tumor growth. Our findings illustrate that BDNF/TrkB pathway is crucial for PCa progression, which may provide a novel therapeutic strategy for the treatment of advanced PCa.	[Li, Tao; Yu, Ying; Song, Yarong; Li, Xuechao; Lan, Dongyang; Zhang, Peng; Xiao, Yajun; Xing, Yifei] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Urol, 1277 Jiefang Ave, Wuhan 430022, Peoples R China; [Li, Tao] Southeast Univ, Sch Med, Zhongda Hosp, Dept Urol, Nanjing, Peoples R China; [Li, Xuechao] Wuhan Cent Hosp, Dept Urol, Wuhan, Peoples R China; [Lan, Dongyang] Zhengzhou Univ, Affiliated Hosp 1, Dept Urol, Zhengzhou, Henan, Peoples R China; [Zhang, Peng] Wuhan Univ, Zhongnan Hosp, Dept Urol, Wuhan, Peoples R China	Huazhong University of Science & Technology; Southeast University - China; Zhengzhou University; Wuhan University	Xing, YF (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Urol, 1277 Jiefang Ave, Wuhan 430022, Peoples R China.	yifei_xing@163.com		Zhang, Peng/0000-0002-9967-1597	National Natural Science Foundation of China [81272847, 81772751, 81974399]; Program for New Century Excellent Talents in University [NCET-13-0239]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	National Natural Science Foundation of China, Grant/Award Number: 81272847, 81772751 and 81974399; Program for New Century Excellent Talents in University, Grant/Award Number: NCET-13-0239	Bardelli A, 2003, SCIENCE, V300, P949, DOI 10.1126/science.1082596; BEHRENS J, 1991, EXP SUPPL, V59, P109; Bronzetti E, 2008, ONCOL REP, V19, P969; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; DAVIS PD, 1992, J MED CHEM, V35, P177, DOI 10.1021/jm00079a024; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Douma S, 2004, NATURE, V430, P1034, DOI 10.1038/nature02765; Eide FF, 1996, J NEUROSCI, V16, P3123; ELLIOTT LH, 1990, BIOCHEM BIOPH RES CO, V171, P148, DOI 10.1016/0006-291X(90)91369-4; Fenner BM, 2012, CYTOKINE GROWTH F R, V23, P15, DOI 10.1016/j.cytogfr.2012.01.002; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Fujikawa H, 2012, J GASTROENTEROL, V47, P775, DOI 10.1007/s00535-012-0532-0; Ghosh PM, 2003, CURR DRUG METAB, V4, P487, DOI 10.2174/1389200033489226; Gong YX, 2014, CANCERS, V6, P1298, DOI 10.3390/cancers6031298; Jaboin J, 2002, CANCER RES, V62, P6756; Kim MS, 2015, ONCOTARGET, V6, P40158, DOI 10.18632/oncotarget.5522; Kreisberg JI, 2004, CANCER RES, V64, P5232, DOI 10.1158/0008-5472.CAN-04-0272; Kupferman ME, 2010, ONCOGENE, V29, P2047, DOI 10.1038/onc.2009.486; Kuzniewska B, 2013, MOL CELL BIOL, V33, P2149, DOI 10.1128/MCB.00008-13; Lam CT, 2011, CLIN CANCER RES, V17, P3123, DOI 10.1158/1078-0432.CCR-10-2802; Malik SN, 2002, CLIN CANCER RES, V8, P1168; Marchetti A, 2008, HUM MUTAT, V29, P609, DOI 10.1002/humu.20707; MATSUMOTO K, 1995, CANCER RES, V55, P1798; MIDDLEMAS DS, 1991, MOL CELL BIOL, V11, P143, DOI 10.1128/MCB.11.1.143; Miknyoczki SJ, 1999, INT J CANCER, V81, P417, DOI 10.1002/(SICI)1097-0215(19990505)81:3<417::AID-IJC16>3.0.CO;2-6; Montanari M, 2017, ONCOTARGET, V8, P35376, DOI 10.18632/oncotarget.15686; Nakamura K, 2006, CANCER RES, V66, P4249, DOI 10.1158/0008-5472.CAN-05-2789; Okugawa Y, 2013, BRIT J CANCER, V108, P121, DOI 10.1038/bjc.2012.499; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Paschalis A, 2019, EUR UROL, V76, P469, DOI 10.1016/j.eururo.2019.06.030; Patani N, 2011, CANCER CELL INT, V11, DOI 10.1186/1475-2867-11-23; Pearse RN, 2005, BLOOD, V105, P4429, DOI 10.1182/blood-2004-08-3096; Prakash YS, 2014, PHARMACOL THERAPEUT, V143, P74, DOI 10.1016/j.pharmthera.2014.02.006; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Ricci A, 2001, AM J RESP CELL MOL, V25, P439, DOI 10.1165/ajrcmb.25.4.4470; Ricci A, 2013, CELL CYCLE, V12, P1696, DOI 10.4161/cc.24759; Sakamoto S, 2010, MOL ASPECTS MED, V31, P205, DOI 10.1016/j.mam.2010.02.001; Simpson CD, 2008, CANCER LETT, V272, P177, DOI 10.1016/j.canlet.2008.05.029; Stoilov P, 2002, BIOCHEM BIOPH RES CO, V290, P1054, DOI 10.1006/bbrc.2001.6301; Taddei ML, 2012, J PATHOL, V226, P380, DOI 10.1002/path.3000; TAPLEY P, 1992, ONCOGENE, V7, P371; Tejeda GS, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201809950; Thiele CJ, 2009, CLIN CANCER RES, V15, P5962, DOI 10.1158/1078-0432.CCR-08-0651; Wang ZW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173335; Weeraratna AT, 2000, PROSTATE, V45, P140, DOI 10.1002/1097-0045(20001001)45:2<140::AID-PROS8>3.0.CO;2-#; Xu DF, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0930-6; Xu WT, 2015, CELL ADHES MIGR, V9, P317, DOI 10.1080/19336918.2015.1016686; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; Yu XH, 2008, CANCER SCI, V99, P543, DOI 10.1111/j.1349-7006.2007.00722.x; Zhang SY, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-43	51	19	19	2	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9087	9101		10.1096/fj.201802159RRR	http://dx.doi.org/10.1096/fj.201802159RRR		MAY 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32390303				2022-12-28	WOS:000532276800001
J	Zhang, X; Zhan, YT; Lin, WJ; Zhao, F; Guo, CJ; Chen, YJ; Du, MG; Li, DN; Zhang, LQ; An, W; Wang, HR; Xie, P				Zhang, Xin; Zhan, Yutao; Lin, Wenjun; Zhao, Fei; Guo, Chaojing; Chen, Yujiao; Du, Mengge; Li, Dongnian; Zhang, Lingqiang; An, Wei; Wang, Hong-Rui; Xie, Ping			Smurf1 aggravates non-alcoholic fatty liver disease by stabilizing SREBP-1c in an E3 activity-independent manner	FASEB JOURNAL			English	Article						high-fat diet; liver steatosis; ubiquitination	UBIQUITIN LIGASE SMURF1; HEPATIC LIPID-METABOLISM; CELL POLARITY; PHOSPHORYLATION; DEGRADATION; INHIBITION; ACTIVATION; FAMILY	Non-alcoholic fatty liver disease (NAFLD) is one of the most common liver disorders which are characterized by the accumulation of excessive lipid in hepatocytes. The precise pathogenesis of NAFLD is very complicated and remains largely unknown. Smad ubiquitination regulatory factor 1 (Smurf1) is crucial for numerous processes including bone homeostasis, embryogenesis, and pathogenic autophagy. In this study, we found that liver steatosis was alleviated in Smurf1-deficient mice fed with high-fat diet (HFD) for 19 weeks. The deletion of Smurf1 reduced the accumulation of lipid droplets and triglycerides in hepatocytes. The stability of sterol regulatory element-binding protein-1c (SREBP-1c), a key transcription factor that mediates de novo lipogenesis, was markedly reduced in Smurf1-deficient mice. The mechanistic study showed that Smurf1 interacts with SREBP-1c and protects SREBP-1c from ubiquitination and degradation by preventing the binding of SREBP-1c to its ubiquitin E3 ligase Fbw7a. Thus, our study presented an E3 ligase catalytic activity-independent function of Smurf1 in the fatty liver development.	[Zhang, Xin; Wang, Hong-Rui] Xiamen Univ, Innovat Ctr Cell Biol, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen, Peoples R China; [Zhan, Yutao; Lin, Wenjun; Chen, Yujiao; Du, Mengge; An, Wei; Xie, Ping] Capital Med Univ, Dept Cell Biol, Municipal Lab Liver Protect & Regulat Regenerat, 10 Xitoutiao, Beijing 100069, Peoples R China; [Zhan, Yutao; Lin, Wenjun; Zhao, Fei; Li, Dongnian] Capital Med Univ, Beijing Tongren Hosp, Dept Gastroenterol, Beijing, Peoples R China; [Guo, Chaojing; Zhang, Lingqiang] Beijing Inst Life, Natl Ctr Prot Sci Beijing, State Key Lab Prote, Beijing, Peoples R China	Xiamen University; Capital Medical University; Capital Medical University	An, W; Xie, P (corresponding author), Capital Med Univ, Dept Cell Biol, Municipal Lab Liver Protect & Regulat Regenerat, 10 Xitoutiao, Beijing 100069, Peoples R China.; Wang, HR (corresponding author), Xiamen Univ, Sch Life Sci, State Key Lab Cellular Stress Biol, D301,Huang Chao Yang Bldg, Xiamen 361102, Fujian, Peoples R China.	anwei@ccmu.edu.cn; wanghr@xmu.edu.cn; xiep@ccmu.edu.cn	An, wei/AGZ-8037-2022		NSFC | National Natural Science Foundation of China [81570515, U1605222]; National Natural Science Foundation of China-Yunnan Joint Fund [31970742]; Beijing Higher Education Young Elite Teacher Project [CITTCD201704097]	NSFC | National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China-Yunnan Joint Fund(National Natural Science Foundation of China (NSFC)); Beijing Higher Education Young Elite Teacher Project	NSFC | National Natural Science Foundation of China, Grant/Award Number: 81570515 and U1605222; National Natural Science Foundation of China-Yunnan Joint Fund, Grant/Award Number: 31970742; Beijing Higher Education Young Elite Teacher Project, Grant/Award Number: CIT&TCD201704097	Arai T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32586-w; Chen H, 2016, BBA-GENE REGUL MECH, V1859, P1459, DOI 10.1016/j.bbagrm.2016.07.010; Chen YH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04815-3; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Dong SX, 2013, CELL METAB, V18, P380, DOI 10.1016/j.cmet.2013.08.012; Frades I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124544; Franco LH, 2017, CELL HOST MICROBE, V21, P59, DOI [10.1016/j.chom.2017.08.005, 10.1016/j.chom.2016.11.002]; Fu L, 2019, SEMIN CANCER BIOL, VS1044-579X, P30423; Giandomenico V, 2003, MOL CELL BIOL, V23, P2587, DOI 10.1128/MCB.23.7.2587-2599.2003; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hu F, 2018, FASEB J, V32, P4627, DOI 10.1096/fj.201701480R; Kawano Y, 2013, J GASTROENTEROL, V48, P434, DOI 10.1007/s00535-013-0758-5; Li S, 2016, ONCOGENE, V35, P642, DOI 10.1038/onc.2015.123; Lin P, 2017, PHARMACOGN MAG, V13, P245, DOI 10.4103/0973-1296.204563; Lu KF, 2008, NAT CELL BIOL, V10, P994, DOI 10.1038/ncb1760; Moon YA, 2017, ENDOCRINOL METAB, V32, P6, DOI 10.3803/EnM.2017.32.1.6; Narimatsu M, 2009, CELL, V137, P295, DOI 10.1016/j.cell.2009.02.025; Nie J, 2010, J BIOL CHEM, V285, P22816, DOI 10.1074/jbc.M110.126920; Ponugoti B, 2010, J BIOL CHEM, V285, P33959, DOI 10.1074/jbc.M110.122978; Punga T, 2006, J BIOL CHEM, V281, P25278, DOI 10.1074/jbc.M604983200; Shimano H, 1997, J CLIN INVEST, V99, P846, DOI 10.1172/JCI119248; Sohn JW, 2015, BMB REP, V48, P229, DOI 10.5483/BMBRep.2015.48.4.272; Sundqvist A, 2005, CELL METAB, V1, P379, DOI 10.1016/j.cmet.2005.04.010; Walker AK, 2010, GENE DEV, V24, P1403, DOI 10.1101/gad.1901210; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Wei JW, 2014, J CLIN INVEST, V124, P1781, DOI 10.1172/JCI72323; Xie P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4733; Xiong P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6330; Xu X, 2013, SEMIN LIVER DIS, V33, P301, DOI 10.1055/s-0033-1358523; Yamashita M, 2005, CELL, V121, P101, DOI 10.1016/j.cell.2005.01.035; Zhan YT, 2017, EXP CELL RES, V355, P40, DOI 10.1016/j.yexcr.2017.03.033; Zhao XP, 2012, J CLIN INVEST, V122, P2417, DOI 10.1172/JCI61462; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293	34	7	7	0	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					7631	7643		10.1096/fj.201902952RR	http://dx.doi.org/10.1096/fj.201902952RR		APR 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32301540				2022-12-28	WOS:000526642700001
J	Watanabe, Y; Watanabe, K; Fujioka, D; Nakamura, K; Nakamura, T; Uematsu, M; Bachschmid, MM; Matsui, R; Kugiyama, K				Watanabe, Yosuke; Watanabe, Kazuhiro; Fujioka, Daisuke; Nakamura, Kazuto; Nakamura, Takamitsu; Uematsu, Manabu; Bachschmid, Markus M.; Matsui, Reiko; Kugiyama, Kiyotaka			Protein S-glutathionylation stimulate adipogenesis by stabilizing C/EBP beta in 3T3L1 cells	FASEB JOURNAL			English	Article						CCAAT enhancer-binding protein; glutaredoxin-1; reactive oxygen species; S-glutathionylation	ADIPOCYTE DIFFERENTIATION; OXIDATIVE STRESS; MICE LACKING; E3 LIGASE; OBESITY; UBIQUITIN; INHIBITOR; ISCHEMIA; DELETION; CYSTEINE	Reactive oxygen species (ROS) increase during adipogenesis and in obesity. Oxidants react with cysteine residues of proteins to form glutathione (GSH) adducts, S-glutathionylation, that are selectively removed by glutaredoxin-1 (Glrx). We have previously reported that Glrx knockout mice had increased protein S-glutathionylation and developed obesity by an unknown mechanism. In this study, we demonstrated that 3T3L1 adipocytes differentiation increased ROS and protein S-glutathionylation. Glrx ablation elevated protein S-glutathionylation and lipid content in 3T3L1 cells. Glrx replenishment decreased the lipid content of Glrx KO 3T3L1 cells. Glrx KO also increased protein expression and protein S-glutathionylation of the adipogenic transcription factor CCAAT enhancer-binding protein (C/EBP) beta. Protein S-glutathionylation decreased the interaction of C/EBP beta and protein inhibitor of activated STAT (PIAS) 1, a small ubiquitin-related modifier E3 ligase that facilitates C/EBP beta degradation. Experiments with truncated mutant C/EBP beta demonstrated that PIAS1 interacted with the liver-enriched inhibitory protein (LIP) region of C/EBP beta. Furthermore, mass spectrometry analysis identified protein S-glutathionylation of Cys201 and Cys296 in the LIP region of C/EBP beta. The C201S, C296S double-mutant C/EBP beta prevented protein S-glutathionylation and preserved the interaction with PIAS1. In summary, Glrx ablation stimulated 3T3L1 cell differentiation and adipogenesis via increased protein S-glutathionylation of C/EBP beta, stabilizing and increasing C/EBP beta protein levels.	[Watanabe, Yosuke; Watanabe, Kazuhiro; Fujioka, Daisuke; Nakamura, Kazuto; Nakamura, Takamitsu; Uematsu, Manabu; Kugiyama, Kiyotaka] Univ Yamanashi, Dept Internal Med 2, Chuo Ku, Shimokato 1110, Yamanashi 4003898, Japan; [Bachschmid, Markus M.; Matsui, Reiko] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Dept Med,Vasc Biol Sect, Boston, MA 02118 USA	University of Yamanashi; Boston University	Watanabe, Y (corresponding author), Univ Yamanashi, Dept Internal Med 2, Chuo Ku, Shimokato 1110, Yamanashi 4003898, Japan.	yosuke@yamanashi.ac.jp			NHLBI NIH HHS [R01 HL133013] Funding Source: Medline; NIDDK NIH HHS [R01 DK103750] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Anathy V, 2018, NAT MED, V24, P1128, DOI 10.1038/s41591-018-0090-y; Berndsen CE, 2014, NAT STRUCT MOL BIOL, V21, P301, DOI 10.1038/nsmb.2780; Carvalho AN, 2016, FEBS LETT, V590, P1455, DOI 10.1002/1873-3468.12177; Chang YC, 2013, EMBO MOL MED, V5, P1165, DOI 10.1002/emmm.201302679; Cho H, 2012, MOL CELL, V46, P495, DOI 10.1016/j.molcel.2012.03.009; Chrestensen CA, 2000, J BIOL CHEM, V275, P26556, DOI 10.1074/jbc.M004097200; Fruh SM, 2017, J AM ASSOC NURSE PRA, V29, pS3, DOI 10.1002/2327-6924.12510; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI21625, 10.1172/JCI20042162S]; Guo L, 2015, J BIOL CHEM, V290, P755, DOI 10.1074/jbc.R114.619957; Han CY, 2012, J BIOL CHEM, V287, P10379, DOI 10.1074/jbc.M111.304998; Han YH, 2010, INT J MOL MED, V25, P657, DOI 10.3892/ijmm_00000389; Hausman D B, 2001, Obes Rev, V2, P239, DOI 10.1046/j.1467-789X.2001.00042.x; Herrmann J, 2007, CIRC RES, V100, P1276, DOI 10.1161/01.RES.0000264500.11888.f0; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Kendig EL, 2011, TOXICOL APPL PHARM, V257, P338, DOI 10.1016/j.taap.2011.09.017; Klein EA, 2011, JAMA-J AM MED ASSOC, V306, P1549, DOI 10.1001/jama.2011.1437; Kobayashi T, 2010, CARDIOVASC RES, V85, P785, DOI 10.1093/cvr/cvp342; Lee H, 2009, J BIOL CHEM, V284, P10601, DOI 10.1074/jbc.M808742200; Liu Y, 2013, MOL CELL BIOL, V33, P4606, DOI 10.1128/MCB.00723-13; Luedde T, 2004, HEPATOLOGY, V40, P356, DOI 10.1002/hep.20333; Millward CA, 2007, DIABETES, V56, P161, DOI 10.2337/db06-0310; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Shao D, 2017, ANTIOXID REDOX SIGN, V27, P313, DOI 10.1089/ars.2016.6716; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; Tormos KV, 2011, CELL METAB, V14, P537, DOI 10.1016/j.cmet.2011.08.007; Unamuno X, 2018, EUR J CLIN INVEST, V48, DOI 10.1111/eci.12997; Vigilanza P, 2011, J CELL PHYSIOL, V226, P2016, DOI 10.1002/jcp.22542; Watanabe Y, 2016, CIRC J, V80, P1278, DOI 10.1253/circj.CJ-16-0317; Watanabe Y, 2016, P NATL ACAD SCI USA, V113, P6011, DOI 10.1073/pnas.1524198113; Watanabe Y, 2013, CARDIOVASC RES, V97, P282, DOI 10.1093/cvr/cvs333; Youn JY, 2014, DIABETES, V63, P2344, DOI 10.2337/db13-0719; Zhang YY, 2011, MOL BIOL CELL, V22, P2165, DOI 10.1091/mbc.E10-11-0912	32	10	10	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5827	5837		10.1096/fj.201902575R	http://dx.doi.org/10.1096/fj.201902575R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32141127	Bronze, Green Accepted			2022-12-28	WOS:000530242100067
J	Huang, J; Bao, D; Lei, CT; Tang, H; Zhang, CY; Su, H; Zhang, C				Huang, Jing; Bao, Dian; Lei, Chun-Tao; Tang, Hui; Zhang, Chun-Yun; Su, Hua; Zhang, Chun			Selenoprotein T protects against cisplatin-induced acute kidney injury through suppression of oxidative stress and apoptosis	FASEB JOURNAL			English	Article						catalase; malondialdehyde; Nox4; reactive oxygen species; superoxide dismutase	FIBROBLAST ACTIVATION; CELLS; MECHANISMS; EXPRESSION; MOUSE	Previously, selenoprotein T (SelT) expression was shown to be induced in nervous, endocrine, and metabolic tissues during ontogenetic and regenerative processes. However, whether SelT plays a critical role in renal diseases remains unclear. Here, we explored the role of SelT in cisplatin-induced acute kidney injury (AKI). Results revealed that SelT was highly expressed in renal tubules, but its expression was significantly reduced in cisplatin-induced AKI. Importantly, knocking down of SelT expression in kidney cells in vitro resulted in cisplatin-induced cell apoptosis, as indicated by the elevation of cleaved-PARP and Bax expression, Caspase-3 activity, and number of TUNEL-positive cells. Moreover, SelT silencing-induced reactive oxygen species (ROS) production, accompanied by a decrease in intracellular superoxide dismutase (SOD) and catalase (CAT) activity and increase in malondialdehyde (MDA) content. Notably, the protein and mRNA levels of Nox4 were increased in response to SelT downregulation. Furthermore, suppression of Nox4 expression by GKT137831 partially alleviated SelT knockdown-induced ROS generation and cell apoptosis in cisplatin-treated kidney cells. Taken together, our findings provide the first evidence that SelT protects against cisplatin-induced AKI by suppression of oxidative stress and apoptosis.	[Huang, Jing; Bao, Dian; Lei, Chun-Tao; Tang, Hui; Zhang, Chun-Yun; Su, Hua; Zhang, Chun] Huazhong Univ Sci & Technol, Dept Nephrol, Union Hosp, Tongji Med Coll, Wuhan 430022, Peoples R China	Huazhong University of Science & Technology	Zhang, C (corresponding author), Huazhong Univ Sci & Technol, Dept Nephrol, Union Hosp, Tongji Med Coll, Wuhan 430022, Peoples R China.	drzhangchun@hust.edu.cn			National Natural Science Foundation of China [81961138007, 81974096, 81770711, 81522010, 81873602, 81800610, 81700603]; National Key R&D Program of China [2018YFC1314000]; Program for HUST Academic Frontier Youth Team [2017QYTD20]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; Program for HUST Academic Frontier Youth Team	This study was supported by the National Natural Science Foundation of China (No. 81961138007, No. 81974096, No. 81770711, No. 81522010, No. 81873602, No. 81800610, and No. 81700603), National Key R&D Program of China (2018YFC1314000), and Program for HUST Academic Frontier Youth Team (2017QYTD20).	Agarwal A, 2016, J AM SOC NEPHROL, V27, P1288, DOI 10.1681/ASN.2015070740; Anouar Y, 2018, FREE RADICAL BIO MED, V127, P145, DOI 10.1016/j.freeradbiomed.2018.05.076; Boukhzar L, 2016, ANTIOXID REDOX SIGN, V24, P557, DOI 10.1089/ars.2015.6478; Chen BD, 2017, BIOCHEM BIOPH RES CO, V490, P1326, DOI 10.1016/j.bbrc.2017.07.023; Chen BD, 2010, AM J PHYSIOL-CELL PH, V298, pC1170, DOI 10.1152/ajpcell.00223.2009; Dennis JM, 2017, NUTRIENTS, V9, DOI 10.3390/nu9070718; Ferguson AD, 2006, J BIOL CHEM, V281, P3536, DOI 10.1074/jbc.M511386200; Goldar Samira, 2015, Asian Pac J Cancer Prev, V16, P2129; Grumolato L, 2003, ENDOCRINOLOGY, V144, P2368, DOI 10.1210/en.2002-0106; Grumolato L, 2008, FASEB J, V22, P1756, DOI 10.1096/fj.06-075820; Hashem RM, 2016, EXP BIOL MED, V241, P1250, DOI 10.1177/1535370216636719; Holditch SJ, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20123011; Ishimoto Y, 2018, CLIN EXP PHARMACOL P, V45, P1097, DOI 10.1111/1440-1681.13018; Jan R, 2019, ADV PHARM BULL, V9, P205, DOI 10.15171/apb.2019.024; Jeong BY, 2018, J ANTIMICROB CHEMOTH, V73, P962, DOI 10.1093/jac/dkx479; Jeong BY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191034; Jin YX, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0948-3; Kaushal GP, 2016, KIDNEY INT, V89, P779, DOI 10.1016/j.kint.2015.11.021; Kishi S, 2019, J CLIN INVEST, V129, P4797, DOI 10.1172/JCI122313; Li JZ, 2014, KIDNEY INT, V86, P86, DOI 10.1038/ki.2013.559; Liu BC, 2018, KIDNEY INT, V93, P568, DOI 10.1016/j.kint.2017.09.033; Liu XD, 2014, MED SCI MONITOR, V20, P2705, DOI 10.12659/MSM.893078; LiuG Sun Y, 2008, BIOCHEM BIOPH RES CO, V370, P651, DOI DOI 10.1016/j.bbrc.2008.04.031; Madrigal-Matute J, 2015, FREE RADICAL BIO MED, V86, P352, DOI 10.1016/j.freeradbiomed.2015.06.001; Manohar S, 2018, J NEPHROL, V31, P15, DOI 10.1007/s40620-017-0392-z; Mukhopadhyay P, 2012, FREE RADICAL BIO MED, V52, P497, DOI 10.1016/j.freeradbiomed.2011.11.001; Ozkok A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/967826; Prevost G, 2013, ENDOCRINOLOGY, V154, P3796, DOI 10.1210/en.2013-1167; Ratliff BB, 2016, ANTIOXID REDOX SIGN, V25, P119, DOI 10.1089/ars.2016.6665; Rocca C, 2018, ACTA PHYSIOL, V223, DOI 10.1111/apha.13067; Samaranayake GJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01269-x; Sedeek M, 2013, J AM SOC NEPHROL, V24, P1512, DOI 10.1681/ASN.2012111112; Shakeri A, 2019, PHARMACOL RES, V146, DOI 10.1016/j.phrs.2019.104335; Susantitaphong P, 2013, CLIN J AM SOC NEPHRO, V8, P1482, DOI 10.2215/CJN.00710113; Tang H, 2016, AM J PHYSIOL-RENAL, V311, pF207, DOI 10.1152/ajprenal.00600.2015; Tanguy Y, 2011, ENDOCRINOLOGY, V152, P4322, DOI 10.1210/en.2011-1246; Yang L, 2015, LANCET, V386, P1465, DOI 10.1016/S0140-6736(15)00344-X; Ye C, 2017, AM J PHYSIOL-RENAL, V312, pF760, DOI 10.1152/ajprenal.00528.2016; Young JJ, 2010, BIOCHEM BIOPH RES CO, V392, P363, DOI 10.1016/j.bbrc.2010.01.026; Yu XW, 2018, EBIOMEDICINE, V36, P266, DOI 10.1016/j.ebiom.2018.09.031	40	10	11	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					11983	11996		10.1096/fj.202000180RR	http://dx.doi.org/10.1096/fj.202000180RR		JUL 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32686857				2022-12-28	WOS:000553642300001
J	Slivka, A; Rink, C; Paoletto, D; Sen, CK				Slivka, Andrew; Rink, Cameron; Paoletto, David; Sen, Chandan K.			Platelet function in stroke/transient ischemic attack patients treated with tocotrienol	FASEB JOURNAL			English	Article						aspirin resistance; clinical trial; nutrition; vitamin E	ASPIRIN RESISTANCE; STROKE PREVENTION; FUNCTION TESTS; AGGREGOMETRY; NONRESPONDER; CLOPIDOGREL; PREVALENCE; OUTCOMES	The purpose of this study was to characterize the effects of tocotrienol form of vitamin E (TCT) on platelet function in patients with stroke or transient ischemic attack (TIA). A double blind, randomized, single center phase II clinical trial was conducted comparing placebo (PBO) and 400 and 800 mg TCT daily for a year in 150 patients with a sentinel ischemic stroke or TIA event in the prior 6 months. Platelet function was measured at baseline and then, at 3 month intervals for a year, using light transmission aggregometry. The incidence of aspirin resistance in aspirin-treated patients or platelet inhibition in patients on clopidogrel alone was compared between the three treatment groups. Results showed that in patients taking aspirin and clopidogrel, the incidence of aspirin resistance was significantly decreased from 40% in PBO-treated patients to 9% in the 400 mg TCT group and 25% in the TCT 800 mg group (P = .03). In conclusion, patients on aspirin and clopidogrel had a higher incidence of aspirin resistance than all patients treated with aspirin alone and TCT decreased the frequency of aspirin resistance in this group.	[Slivka, Andrew] Ohio State Univ, Dept Neurol, Wexner Med Ctr, Columbus, OH 43210 USA; [Rink, Cameron] Ohio State Univ, Dept Neurosurg, Wexner Med Ctr, Columbus, OH 43210 USA; [Paoletto, David; Sen, Chandan K.] Ohio State Univ, Dept Surg, Wexner Med Ctr, Columbus, OH 43210 USA; [Sen, Chandan K.] Indiana Univ Sch Med, Dept Surg, Indianapolis, IN 46202 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Indiana University System; Indiana University Bloomington	Sen, CK (corresponding author), Indiana Univ Sch Med, Dept Surg, Indiana Ctr Regenerat Med & Engn, 975 W Walnut St,Med Res Lib Bldg,Suite 454, Indianapolis, IN 46202 USA.	cksen@iu.edu	Rink, Cameron/AAA-4484-2021	Sen, Chandan/0000-0003-3151-5202	National Institute of Neurological Disorders and Stroke (NINDS) [NS042617]; Government of Malaysia	National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Government of Malaysia	Supported in part by the National Institute of Neurological Disorders and Stroke (NINDS) NS042617 and the Government of Malaysia	Amarenco P, 2006, NEW ENGL J MED, V355, P549; Azmin S, 2013, EXCLI J, V12, P907; Breet NJ, 2010, JAMA-J AM MED ASSOC, V303, P754, DOI 10.1001/jama.2010.181; Dalen JE, 2007, AM J MED, V120, P1, DOI 10.1016/j.amjmed.2006.08.023; Depta JP, 2012, STROKE, V43, P2376, DOI 10.1161/STROKEAHA.112.655084; Gengo F, 2016, J CLIN PHARMACOL, V56, P414, DOI 10.1002/jcph.608; Gengo FM, 2008, J CLIN PHARMACOL, V48, P335, DOI 10.1177/0091270007313324; GROTEMEYER KH, 1993, THROMB RES, V71, P397, DOI 10.1016/0049-3848(93)90164-J; Grundmann K, 2003, J NEUROL, V250, P63, DOI 10.1007/s00415-003-0954-y; Gum PA, 2003, J AM COLL CARDIOL, V41, P961, DOI 10.1016/S0735-1097(02)03014-0; Halawani SHM, 2011, THROMB HAEMOSTASIS, V106, P240, DOI 10.1160/TH11-01-0045; Hart RG, 1999, ANN INTERN MED, V131, P492, DOI 10.7326/0003-4819-131-7-199910050-00003; Hensley K, 2004, FREE RADICAL BIO MED, V36, P1, DOI 10.1016/j.freeradbiomed.2003.10.009; Kent DM, 2008, NEW ENGL J MED, V359, P1287, DOI 10.1056/NEJMe0806806; Lev EI, 2006, J AM COLL CARDIOL, V47, P27, DOI 10.1016/j.jacc.2005.08.058; Lordkipanidze M, 2007, EUR HEART J, V28, P1702, DOI 10.1093/eurheartj/ehm226; McGrath E, 2011, CEREBROVASC DIS, V32, P22, DOI 10.1159/000324629; PARKER RA, 1993, J BIOL CHEM, V268, P11230; PEARCE BC, 1992, J MED CHEM, V35, P3595, DOI 10.1021/jm00098a002; Qureshi AA, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-58; Schwartz KA, 2005, AM J CARDIOL, V95, P973, DOI 10.1016/j.amjcard.2004.12.038; Sen CK, 2007, VITAM HORM, V76, P203, DOI 10.1016/S0083-6729(07)76008-9; Stejskal D, 2006, EUR J INTERN MED, V17, P349, DOI 10.1016/j.ejim.2006.01.006; Velik-Salchner C, 2008, ANESTH ANALG, V107, P1798, DOI 10.1213/ane.0b013e31818524c1	24	3	3	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					11838	11843		10.1096/fj.201902216RR	http://dx.doi.org/10.1096/fj.201902216RR		JUL 2020	6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32686874	Green Accepted			2022-12-28	WOS:000553643800001
J	Zhang, PF; Huang, Y; Liang, X; Li, D; Jiang, L; Yang, X; Zhu, M; Gou, HF; Gong, YL; Wei, YQ; Li, Q; Wang, W				Zhang, Peng-Fei; Huang, Yong; Liang, Xiao; Li, Dan; Jiang, Lin; Yang, Xiao; Zhu, Min; Gou, Hong-Feng; Gong, You-Ling; Wei, Yu-Quan; Li, Qiu; Wang, Wei			Enhancement of the antitumor effect of HER2-directed CAR-T cells through blocking epithelial-mesenchymal transition in tumor cells	FASEB JOURNAL			English	Article						adoptive cell transfer; chimeric antigen receptor; epithelial-mesenchymal transition; solid tumor	TGF-BETA; SOLID TUMORS; INHIBITOR; RESISTANCE; EFFICACY; THERAPY; EMT; EXPRESSION; CHALLENGES; RECEPTORS	The efficacy of chimeric antigen receptor T (CAR-T) cell therapy in solid tumors is far from satisfactory. In this study, we investigated the influence of epithelial-mesenchymal transition (EMT) on the antitumor effect of CAR-T cells and explored the potential efficacy of combining CAR-T cells with inhibitors targeting EMT. We successfully induced EMT in tumor cells with TGF-beta 1, and the antitumor effect of HER2-directed CAR-T cells was significantly suppressed by EMT. Upregulation of PD-L1 was observed in tumor cells undergoing EMT, and change in PD-L1 expression during the EMT process was dependent on the MEK/ERK and PI3K/Akt pathways. Inhibition of the TGF-beta 1 pathway could block the EMT process in tumor cells and restore their susceptibility to HER2-directed CAR-T cells in vitro. In addition, targeting the TGF-beta 1 pathway significantly enhanced the antitumor effect of HER2-directed CAR-T cells in vivo. Our findings suggest that blocking EMT could potently enhance the antitumor effect of CAR-T cells, which provides a promising approach to improving the therapeutic efficacy of CAR-T cell therapy in solid tumors.	[Zhang, Peng-Fei; Liang, Xiao; Gou, Hong-Feng; Gong, You-Ling; Wei, Yu-Quan; Li, Qiu] Sichuan Univ, West China Hosp, Dept Med Oncol, Ctr Canc,State Key Lab Biotherapy, Chengdu, Peoples R China; [Huang, Yong; Li, Dan; Jiang, Lin; Yang, Xiao; Zhu, Min; Wei, Yu-Quan; Li, Qiu; Wang, Wei] Sichuan Univ, West China Hosp, Collaborat Innovat Ctr Biotherapy, State Key Lab Biotherapy, Chengdu, Peoples R China	Sichuan University; Sichuan University	Wang, W (corresponding author), Sichuan Univ, West China Hosp, Collaborat Innovat Ctr Biotherapy, State Key Lab Biotherapy, Chengdu, Peoples R China.; Li, Q (corresponding author), Sichuan Univ, West China Hosp, Dept Med Oncol, Ctr Canc, Chengdu, Peoples R China.	weiwang@scu.edu.cn; weiwang@scu.edu.cn		liang, xiao/0000-0003-0330-7027	National Key RD Project [2016YFC1303403]; National Natural and Scientific Foundation of China [81572981, 81672397]; National High-tech RD program [2014AA020704]; Key Scientific and Technological Foundation in Sichuan Province [17ZDZX0037]	National Key RD Project; National Natural and Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); National High-tech RD program(National High Technology Research and Development Program of China); Key Scientific and Technological Foundation in Sichuan Province	National Key R&D Project, Grant/Award Number: 2016YFC1303403; National Natural and Scientific Foundation of China, Grant/Award Number: 81572981 and 81672397; National High-tech R&D program, Grant/Award Number: 2014AA020704; Key Scientific and Technological Foundation in Sichuan Province, Grant/Award Number: 17ZDZX0037	Abken H, 2015, IMMUNOTHERAPY-UK, V7, P535, DOI [10.2217/IMT.15.15, 10.2217/imt.15.15]; Akalay I, 2013, CANCER RES, V73, P2418, DOI 10.1158/0008-5472.CAN-12-2432; Alcantara M, 2018, LEUKEMIA, V32, P2307, DOI 10.1038/s41375-018-0285-8; Bach PB, 2017, JAMA-J AM MED ASSOC, V318, P1861, DOI 10.1001/jama.2017.15218; Beatty GL, 2016, PHARMACOL THERAPEUT, V166, P30, DOI 10.1016/j.pharmthera.2016.06.010; Beatty GL, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/21624011.2014.970027; Cerwenka A, 1999, MICROBES INFECT, V1, P1291, DOI 10.1016/S1286-4579(99)00255-5; Cheng GZ, 2007, CANCER RES, V67, P1979, DOI 10.1158/0008-5472.CAN-06-1479; David CJ, 2016, CELL, V164, P1015, DOI 10.1016/j.cell.2016.01.009; Di SM, 2016, SCI CHINA LIFE SCI, V59, P360, DOI 10.1007/s11427-016-5025-6; Ghobadi A, 2018, CURR RES TRANSL MED, V66, P43, DOI 10.1016/j.retram.2018.03.005; Ghorashian S, 2015, BRIT J HAEMATOL, V169, P463, DOI 10.1111/bjh.13340; GREENBURG G, 1982, J CELL BIOL, V95, P333, DOI 10.1083/jcb.95.1.333; Hoseini SS, 2017, CANCER LETT, V399, P44, DOI 10.1016/j.canlet.2017.04.013; Hu BL, 2017, CELL REP, V20, P3025, DOI 10.1016/j.celrep.2017.09.002; Hutzen B, 2017, MOL THER-ONCOLYTICS, V7, P17, DOI 10.1016/j.omto.2017.09.001; Kakarla S, 2013, MOL THER, V21, P1611, DOI 10.1038/mt.2013.110; Katsuno Y, 2013, CURR OPIN ONCOL, V25, P76, DOI 10.1097/CCO.0b013e32835b6371; Kloss CC, 2018, MOL THER, V26, P1855, DOI 10.1016/j.ymthe.2018.05.003; Koneru M, 2015, ONCOIMMUNOLOGY, V4, DOI 10.4161/2162402X.2014.994446; Lamers CHJ, 2016, BIOCHEM SOC T, V44, P951, DOI 10.1042/BST20160037; Lee CH, 2010, BRIT J DERMATOL, V163, P1238, DOI 10.1111/j.1365-2133.2010.09971.x; Li XC, 2017, IMMUNOL LETT, V183, P86, DOI 10.1016/j.imlet.2017.01.010; Marie-Egyptienne DT, 2013, CANCER LETT, V341, P63, DOI 10.1016/j.canlet.2012.11.019; Moon EK, 2014, CLIN CANCER RES, V20, P4262, DOI 10.1158/1078-0432.CCR-13-2627; Nantajit D, 2015, J CANCER RES CLIN, V141, P1697, DOI 10.1007/s00432-014-1840-y; Ninomiya S, 2015, BLOOD, V125, P3905, DOI 10.1182/blood-2015-01-621474; Ohori M, 2005, BIOCHEM BIOPH RES CO, V336, P357, DOI 10.1016/j.bbrc.2005.08.082; Parry RV, 2005, MOL CELL BIOL, V25, P9543, DOI 10.1128/MCB.25.21.9543-9553.2005; Pastushenko I, 2018, NATURE, V556, P463, DOI 10.1038/s41586-018-0040-3; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Rafiq S, 2018, NAT BIOTECHNOL, V36, P847, DOI 10.1038/nbt.4195; Santamaria PG, 2017, MOL ONCOL, V11, P718, DOI 10.1002/1878-0261.12091; Shang YL, 2013, CURR CANCER DRUG TAR, V13, P915, DOI 10.2174/15680096113136660097; Shi SJ, 2015, ONCOTARGET, V6, P11652, DOI 10.18632/oncotarget.3457; Sidaway Peter, 2016, Nat Rev Clin Oncol, V13, P530, DOI 10.1038/nrclinonc.2016.125; Siddiquee K, 2007, P NATL ACAD SCI USA, V104, P7391, DOI 10.1073/pnas.0609757104; Thistlethwaite FC, 2017, CANCER IMMUNOL IMMUN, V66, P1425, DOI 10.1007/s00262-017-2034-7; Tojo M, 2005, CANCER SCI, V96, P791, DOI 10.1111/j.1349-7006.2005.00103.x; Tu E, 2014, CYTOKINE GROWTH F R, V25, P423, DOI 10.1016/j.cytogfr.2014.07.014; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Watanabe K, 2015, J IMMUNOL, V194, P911, DOI 10.4049/jimmunol.1402346; Wiercinska E, 2011, BREAST CANCER RES TR, V128, P657, DOI 10.1007/s10549-010-1147-x; Wing A, 2018, CANCER IMMUNOL RES, V6, P605, DOI 10.1158/2326-6066.CIR-17-0314; Woods K, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00367; Xu W, 2014, SCAND J IMMUNOL, V80, P71, DOI 10.1111/sji.12177; Yamamura S, 2012, INT J CANCER, V130, P20, DOI 10.1002/ijc.25961; Yang AD, 2006, CLIN CANCER RES, V12, P4147, DOI 10.1158/1078-0432.CCR-06-0038; Ye X, 2015, TRENDS CELL BIOL, V25, P675, DOI 10.1016/j.tcb.2015.07.012; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; Yue CY, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2018.1438111	51	4	4	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					11185	11199		10.1096/fj.202000080RR	http://dx.doi.org/10.1096/fj.202000080RR		JUL 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32645243				2022-12-28	WOS:000548043700001
J	Kock, A; Bergqvist, F; Steinmetz, J; Elfman, LHM; Korotkova, M; Johnsen, JI; Jakobsson, PJ; Kogner, P; Larsson, K				Kock, Anna; Bergqvist, Filip; Steinmetz, Julia; Elfman, Lotta H. M.; Korotkova, Marina; Johnsen, John Inge; Jakobsson, Per-Johan; Kogner, Per; Larsson, Karin			Establishment of an in vitro 3D model for neuroblastoma enables preclinical investigation of combined tumor-stroma drug targeting	FASEB JOURNAL			English	Article						cancer; microsomal prostaglandin E synthase-1; mPGES-1; multicellular tumor spheroids; PGE(2)	PROSTAGLANDIN E-2; CANCER; GROWTH; EXPRESSION; HALLMARKS; MICROENVIRONMENT; REPOPULATION; ACTIVATION; APOPTOSIS; CELLS	The majority of anti-cancer therapies target the proliferating tumor cells, while the tumor stroma, principally unaffected, survives, and provide a niche for surviving tumor cells. Combining tumor cell and stroma-targeting therapies thus have a potential to improve patient outcome. The neuroblastoma stroma contains cancer-associated fibroblasts expressing microsomal prostaglandin E synthase-1 (mPGES-1). mPGES-1-derived prostaglandin E-2(PGE(2)) is known to promote tumor growth through increased proliferation and survival of tumor cells, immune suppression, angiogenesis, and therapy resistance, and we, therefore, hypothesize that mPGES-1 constitutes an interesting stromal target. Here, we aimed to develop a relevant in vitro model to study combination therapies. Co-culturing of neuroblastoma and fibroblast cells in 3D tumor spheroids mimic neuroblastoma tumors with regard to the cyclooxygenase/mPGES-1/PGE(2)pathway. Using the spheroid model, we show that the inhibition of fibroblast-derived mPGES-1 enhanced the cytotoxic effect of doxorubicin and vincristine and significantly reduced tumor cell viability and spheroid growth. Cyclic treatment with vincristine in combination with an mPGES-1 inhibitor abrogated cell repopulation. Moreover, inhibition of mPGES-1 potentiated the cytotoxic effect of vincristine on established neuroblastoma allografts in mice. In conclusion, we established a 3D neuroblastoma model, highlighting the potential of combining stromal targeting of mPGES-1 with tumor cell targeting drugs like vincristine.	[Kock, Anna; Elfman, Lotta H. M.; Johnsen, John Inge; Kogner, Per] Karolinska Univ Hosp, Karolinska Inst, Dept Childrens & Womens Hlth, Childhood Canc Res Unit, Stockholm, Sweden; [Bergqvist, Filip; Steinmetz, Julia; Korotkova, Marina; Jakobsson, Per-Johan; Larsson, Karin] Karolinska Univ Hosp, Karolinska Inst, Dept Med, Rheumatol Unit, Visionsgatan 18,CMM L8-02, SE-17176 Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Larsson, K (corresponding author), Karolinska Univ Hosp, Karolinska Inst, Dept Med, Rheumatol Unit, Visionsgatan 18,CMM L8-02, SE-17176 Stockholm, Sweden.	karin.larsson@ki.se	Larsson, Karin/AAO-7701-2021; Jakobsson, Per-Johan/ABC-5594-2021	Johnsen, John Inge/0000-0003-1277-812X; Bergqvist, Filip/0000-0002-0075-6751; Larsson, Karin/0000-0002-6403-2736	Barncancerfonden (Swedish Childhood Cancer Foundation) [TJ2017-0040, PR2018-0055, PR2017-0122, PROF2019-0001, TJ2019-0111, NCP2016-0021, TJ2016-0058, PR2015-0098]; Cancerfonden (Swedish Cancer Society) [CAN 2016/739]; Cancerforeningen i Stockholm (Cancer Society in Stockholm) [171073]; Innovative Medicines Initiative (IMI) [115766]; Marta och Gunnar V. Philipsons Stiftelse; Reumatikerforbundet (Svenska Reumatikerforbundet) [R-755861]; Kung Gustaf V:s 80-arsfond; Vetenskapsradet (VR) [2015-03955, 2017-01391, 201702577]; Stiftelsen for strategisk forskning	Barncancerfonden (Swedish Childhood Cancer Foundation); Cancerfonden (Swedish Cancer Society)(Swedish Cancer Society); Cancerforeningen i Stockholm (Cancer Society in Stockholm); Innovative Medicines Initiative (IMI); Marta och Gunnar V. Philipsons Stiftelse; Reumatikerforbundet (Svenska Reumatikerforbundet); Kung Gustaf V:s 80-arsfond; Vetenskapsradet (VR)(Swedish Research Council); Stiftelsen for strategisk forskning	Barncancerfonden (Swedish Childhood Cancer Foundation), Grant/Award Number: TJ2017-0040,PR2018-0055 and PR2017-0122,PROF2019-0001,TJ2019-0111,NCP2016-0021,TJ2016-0058,PR2015-0098; Cancerfonden (Swedish Cancer Society), Grant/Award Number: CAN 2016/739; Cancerforeningen i Stockholm (Cancer Society in Stockholm), Grant/Award Number: 171073; Innovative Medicines Initiative (IMI), Grant/Award Number: 115766; Marta och Gunnar V. Philipsons Stiftelse, Grant/Award Number: n.a.; Reumatikerforbundet (Svenska Reumatikerforbundet), Grant/Award Number: R-755861; Kung Gustaf V:s 80-arsfond, Grant/Award Number: n.a; Vetenskapsradet (VR), Grant/Award Number: 2015-03955,2017-01391,201702577; Stiftelsen for strategisk forskning, Grant/Award Number: n.a	Bergqvist F, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00636; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Borriello L, 2016, CANCER LETT, V380, P304, DOI 10.1016/j.canlet.2015.11.017; Brocard E, 2015, ONCOTARGET, V6, P6840, DOI 10.18632/oncotarget.3160; Buchanan FG, 2003, J BIOL CHEM, V278, P35451, DOI 10.1074/jbc.M302474200; Correia AL, 2012, DRUG RESIST UPDATE, V15, P39, DOI 10.1016/j.drup.2012.01.006; Cortez E, 2014, SEMIN CANCER BIOL, V25, P3, DOI 10.1016/j.semcancer.2013.12.010; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Esposito MR, 2017, J BIOMED SCI, V24, DOI 10.1186/s12929-017-0319-y; Fukuda R, 2003, CANCER RES, V63, P2330; Greenhough A, 2009, CARCINOGENESIS, V30, P377, DOI 10.1093/carcin/bgp014; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hangai S, 2016, P NATL ACAD SCI USA, V113, P3844, DOI 10.1073/pnas.1602023113; Huang Q, 2011, NAT MED, V17, P860, DOI 10.1038/nm.2385; Johnsen JI, 2004, CANCER RES, V64, P7210, DOI 10.1158/0008-5472.CAN-04-1795; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Kalluri R, 2016, NAT REV CANCER, V16, P582, DOI 10.1038/nrc.2016.73; Kenny HA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7220; Kimlin LC, 2013, MOL CARCINOGEN, V52, P167, DOI 10.1002/mc.21844; Kock A, 2018, EBIOMEDICINE, V32, P84, DOI 10.1016/j.ebiom.2018.05.008; Kurtova AV, 2015, NATURE, V517, P209, DOI 10.1038/nature14034; Larsson K, 2019, BRIT J PHARMACOL, V176, P4625, DOI 10.1111/bph.14827; Larsson K, 2015, P NATL ACAD SCI USA, V112, P8070, DOI 10.1073/pnas.1424355112; Leclerc P, 2013, PROSTAG OTH LIPID M, V107, P26, DOI 10.1016/j.prostaglandins.2013.09.001; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Matthay KK, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.78; Miyoshi H, 2017, EMBO J, V36, P5, DOI 10.15252/embj.201694660; Ozen G, 2017, BR J PHARM; Pai R, 2002, GASTROENTEROLOGY, V122, pA240; Pai R, 2001, BIOCHEM BIOPH RES CO, V286, P923, DOI 10.1006/bbrc.2001.5494; Park JR, 2013, PEDIATR BLOOD CANCER, V60, P985, DOI 10.1002/pbc.24433; Pietras K, 2010, EXP CELL RES, V316, P1324, DOI 10.1016/j.yexcr.2010.02.045; Rasmuson A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029331; Sasaki Y, 2017, PROSTAG OTH LIPID M, V133, P49, DOI 10.1016/j.prostaglandins.2017.05.001; Sheng HM, 1998, CANCER RES, V58, P362; Sheng HM, 2001, GASTROENTEROLOGY, V120, pA494; Unger C, 2014, ADV DRUG DELIVER REV, V79-80, P50, DOI 10.1016/j.addr.2014.10.015; Valkenburg KC, 2018, NAT REV CLIN ONCOL, V15, P366, DOI 10.1038/s41571-018-0007-1; Zanoni M, 2016, SCI REP-UK, V6, DOI 10.1038/srep19103; Zelenay S, 2015, CELL, V162, P1257, DOI 10.1016/j.cell.2015.08.015; Zhang J, 2013, PHARMACOL THERAPEUT, V137, P200, DOI 10.1016/j.pharmthera.2012.10.003	41	9	9	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					11101	11114		10.1096/fj.202000684R	http://dx.doi.org/10.1096/fj.202000684R		JUL 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32623799	hybrid			2022-12-28	WOS:000547549500001
J	Yamane, M; Sato, S; Shimizu, E; Shibata, S; Hayano, M; Yaguchi, T; Kamijuku, H; Ogawa, M; Suzuki, T; Mukai, S; Shimmura, S; Okano, H; Takeuchi, T; Kawakami, Y; Ogawa, Y; Tsubota, K				Yamane, Mio; Sato, Shinri; Shimizu, Eisuke; Shibata, Shinsuke; Hayano, Motoshi; Yaguchi, Tomonori; Kamijuku, Hajime; Ogawa, Mamoru; Suzuki, Takanori; Mukai, Shin; Shimmura, Shigeto; Okano, Hideyuki; Takeuchi, Tsutomu; Kawakami, Yutaka; Ogawa, Yoko; Tsubota, Kazuo			Senescence-associated secretory phenotype promotes chronic ocular graft-vs-host disease in mice and humans	FASEB JOURNAL			English	Article						chronic ocular graft-vs-host disease; lacrimal glands; senescence-associated secretory phenotype; senolytic treatment; stress-induced senescence	STEM-CELL TRANSPLANTATION; RENIN-ANGIOTENSIN SYSTEM; STROMAL FIBROBLASTS; BCL-2 FAMILY; DRY EYE; CANCER; EXPRESSION; LEUKEMIA; INSIGHTS; MODEL	Chronic graft-vs-host disease (cGVHD) is a multifactorial inflammatory disease that affects patients undergoing hematopoietic stem cell transplantation. Multiple organs, including the lacrimal glands (LGs), are negatively affected by cGVHD and lose function due to the resultant fibrosis. An abnormal immune response is thought to be a major factor in the development of chronic ocular GVHD, which is currently treated primarily with immunosuppressive therapies. However, all the treatments yield unsatisfactory outcomes, and additional treatment strategies are needed. To meet this unmet medical need, we aimed to elucidate an additional pathway of chronic ocular GVHD. Our findings suggest a potential association between chronic ocular GVHD pathogenesis and stress-induced cellular senescence through the senescence-associated secretory phenotype (SASP). Senescent cells produce cytokines and chemokines, such as IL-6 and CXCL9. Indeed, senescent cell accumulation was presumably associated with cGVHD development in LGs, as evidenced by the improvement in LGs after the selective elimination of senescent cells (senolysis) with ABT-263. Results in the sclerodermatous cGVHD mouse model suggest that inhibiting the major components of the SASP, including IL-6 and CXCL9, with senolytics is a potential novel strategy for treating cGVHD-affected LGs. Taken together, our results indicate a potential association between the SASP and cGVHD development in LGs and suggest that targeted senolytic treatment may be a new therapeutic option for this disease.	[Yamane, Mio; Sato, Shinri; Shimizu, Eisuke; Hayano, Motoshi; Ogawa, Mamoru; Suzuki, Takanori; Shimmura, Shigeto; Ogawa, Yoko; Tsubota, Kazuo] Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan; [Shibata, Shinsuke] Keio Univ, Sch Med, Electron Microscope Lab, Tokyo, Japan; [Yaguchi, Tomonori; Kawakami, Yutaka] Keio Univ, Sch Med, Inst Adv Med Res, Div Cellular Signaling, Tokyo, Japan; [Kamijuku, Hajime] Keio Univ, Sch Med, Dept Internal Med, Div Cardiol, Tokyo, Japan; [Mukai, Shin] Harvard Med Sch, Brigham & Womens Hosp, Ctr Interdisciplinary Cardiovasc Sci, Boston, MA 02115 USA; [Okano, Hideyuki] Keio Univ, Dept Physiol, Sch Med, Tokyo, Japan; [Takeuchi, Tsutomu] Keio Univ, Sch Med, Dept Internal Med, Div Rheumatol, Tokyo, Japan	Keio University; Keio University; Keio University; Keio University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Keio University; Keio University	Ogawa, Y; Tsubota, K (corresponding author), Keio Univ, Sch Med, Dept Ophthalmol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	yoko@z7.keio.jp; tsubota@z3.keio.jp	Takeuchi, Tsutomu/AFM-8316-2022; Ogawa, Yoko/AAV-1932-2021	Ogawa, Yoko/0000-0002-2906-9621; Ogawa, Mamoru/0000-0003-3416-9843; Hayano, Motoshi/0000-0001-6453-2741	Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) by Japan Agency for Medical Research and Development (AMED) [JP178dm0207001, JP178dm0207002]; Japanese Ministry of Education, Science, Sports, Culture and Technology [26462668, 18K09421]; Program for the Advancement of Research in Core Projects under Keio University's Longevity Initiative (KGRI); JSR Corporation	Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) by Japan Agency for Medical Research and Development (AMED); Japanese Ministry of Education, Science, Sports, Culture and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Program for the Advancement of Research in Core Projects under Keio University's Longevity Initiative (KGRI); JSR Corporation(JSR Corporation)	Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) by Japan Agency for Medical Research and Development (AMED), Grant/Award Number: JP178dm0207002; Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) by Japan Agency for Medical Research and Development (AMED), Grant/Award Number: JP178dm0207001; Japanese Ministry of Education, Science, Sports, Culture and Technology, Grant/Award Number: 26462668 and 18K09421; Program for the Advancement of Research in Core Projects under Keio University's Longevity Initiative (KGRI) to K. T. and M. H.; Academic Development Project Grant-in-Aid by JSR Corporation 2019 to E. S.	BARAK V, 1995, LEUKEMIA LYMPHOMA, V17, P169, DOI 10.3109/10428199509051718; Beatty GL, 2009, CLIN CANCER RES, V15, P4944, DOI 10.1158/1078-0432.CCR-08-3332; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Chang JH, 2016, NAT MED, V22, P78, DOI 10.1038/nm.4010; Chiche A, 2017, CELL STEM CELL, V20, P407, DOI 10.1016/j.stem.2016.11.020; Ciceri F, 2008, BLOOD, V112, P3574, DOI 10.1182/blood-2008-02-140095; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Cui YJ, 2013, INT J MOL SCI, V14, P4094, DOI 10.3390/ijms14024094; Duque GA, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00491; Ferrara JLM, 2009, LANCET, V373, P1550, DOI 10.1016/S0140-6736(09)60237-3; He SH, 2017, CELL, V169, P1000, DOI 10.1016/j.cell.2017.05.015; Holtan SG, 2014, BLOOD, V124, P363, DOI 10.1182/blood-2014-01-514786; Hornsby PJ, 2010, CELLULAR SENESCENCE AND TUMOR SUPPRESSION, P85, DOI 10.1007/978-1-4419-1075-2_4; Inamoto Y, 2011, CURR OPIN HEMATOL, V18, P414, DOI 10.1097/MOH.0b013e32834ba87d; Jankovic D, 2013, J EXP MED, V210, P1899, DOI 10.1084/jem.20130084; Kawai M, 2013, SCI REP-UK, V3, DOI 10.1038/srep02455; Kawakami K, 2017, BIOCHEM BIOPH RES CO, V485, P468, DOI 10.1016/j.bbrc.2017.02.047; Kitko CL, 2014, BLOOD, V123, P786, DOI 10.1182/blood-2013-08-520072; Kothari AN, 2016, J CLIN MED, V5, DOI 10.3390/jcm5040039; Lee SJ, 2017, BLOOD, V129, P30, DOI 10.1182/blood-2016-07-686642; MacDonald KPA, 2017, BLOOD, V129, P13, DOI 10.1182/blood-2016-06-686618; Malaquin N, 2016, EXP GERONTOL, V82, P39, DOI 10.1016/j.exger.2016.05.010; Malaquin N, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00094; Min Chang-Ki, 2011, Korean J Hematol, V46, P80, DOI 10.5045/kjh.2011.46.2.80; Minamino T, 2009, NAT MED, V15, P1082, DOI 10.1038/nm.2014; MUKAI S, 2017, SCI REP UK, V7; Munir SZ, 2017, OPTOMETRY VISION SCI, V94, P545, DOI 10.1097/OPX.0000000000001071; Ogawa Y, 1999, BRIT J OPHTHALMOL, V83, P1125, DOI 10.1136/bjo.83.10.1125; Ogawa Y, 2003, INVEST OPHTH VIS SCI, V44, P1888, DOI 10.1167/iovs.02-0699; Ogawa Y, 2001, INVEST OPHTH VIS SCI, V42, P111; OGAWA Y, 2013, SCI REP UK, V3; Ogawa Y, 2007, INVEST OPHTH VIS SCI, V48, P1079, DOI 10.1167/iovs.06-0601; Ogawa Y, 2016, ELIFE, V5, DOI 10.7554/eLife.09394; Ogawa Yoko, 2010, Cornea, V29 Suppl 1, pS68; Ogawa Y, 2009, AM J PATHOL, V175, P2372, DOI 10.2353/ajpath.2009.090318; Ohtani N, 2007, P NATL ACAD SCI USA, V104, P15034, DOI 10.1073/pnas.0706949104; Pazolli E, 2012, CANCER RES, V72, P2251, DOI 10.1158/0008-5472.CAN-11-3386; Perez VL, 2016, BIOL BLOOD MARROW TR, V22, P1765, DOI 10.1016/j.bbmt.2016.07.012; Riemens A, 2010, CURR OPIN OPHTHALMOL, V21, P485, DOI 10.1097/ICU.0b013e32833eab64; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sene A, 2013, CELL METAB, V17, P549, DOI 10.1016/j.cmet.2013.03.009; Shirakawa K, 2016, J CLIN INVEST, V126, P4626, DOI 10.1172/JCI88606; Shoemaker AR, 2008, CLIN CANCER RES, V14, P3268, DOI 10.1158/1078-0432.CCR-07-4622; Socie G, 2014, BLOOD, V124, P374, DOI 10.1182/blood-2014-01-514752; Sun YC, 2015, BIOL BLOOD MARROW TR, V21, P1687, DOI 10.1016/j.bbmt.2015.05.020; Tawara I, 2011, CLIN CANCER RES, V17, P77, DOI 10.1158/1078-0432.CCR-10-1198; Toussaint Olivier, 2002, TheScientificWorldJOURNAL, V2, P230; Tvedt THA, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00667; Uchibori T, 2017, CYTOKINE, V90, P88, DOI 10.1016/j.cyto.2016.11.006; van Deursen JM, 2014, NATURE, V509, P439, DOI 10.1038/nature13193; Wang WJ, 2017, ONCOTARGET, V8, P64520, DOI 10.18632/oncotarget.17327; Yaguchi S, 2015, CORNEA, V34, pS142, DOI 10.1097/ICO.0000000000000586; Yaguchi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064724; Yaguchi S, 2012, INVEST OPHTH VIS SCI, V53, P5416, DOI 10.1167/iovs.12-9891; Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347; Zhang Y, 2002, J IMMUNOL, V168, P3088, DOI 10.4049/jimmunol.168.6.3088; Zhu Y, 2016, AGING CELL, V15, P428, DOI 10.1111/acel.12445	59	14	14	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10778	10800		10.1096/fj.201900218R	http://dx.doi.org/10.1096/fj.201900218R		JUL 2020	23	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32619061	hybrid, Green Published			2022-12-28	WOS:000547517800001
J	Sun, C; Zhang, H; Wang, X; Liu, XH				Sun, Chao; Zhang, Han; Wang, Xiang; Liu, Xinhui			Ligamentum flavum fibrosis and hypertrophy: Molecular pathways, cellular mechanisms, and future directions	FASEB JOURNAL			English	Review						extracellular matrix; fibroblasts; fibrosis; ligamentum flavum; TGF-beta 1	LUMBAR SPINAL STENOSIS; TISSUE GROWTH-FACTOR; FACET JOINT TISSUE; MATRIX METALLOPROTEINASES; INCREASED EXPRESSION; CONNECTIVE-TISSUE; CANAL STENOSIS; LYSOPHOSPHATIDIC ACID; TGF-BETA; EXTRACELLULAR-MATRIX	Hypertrophy of ligamentum flavum (LF), along with disk protrusion and facet joints degeneration, is associated with the development of lumbar spinal canal stenosis (LSCS). Of note, LF hypertrophy is deemed as an important cause of LSCS. Histologically, fibrosis is proved to be the main pathology of LF hypertrophy. Despite the numerous studies explored the mechanisms of LF fibrosis at the molecular and cellular levels, the exact mechanism remains unknown. It is suggested that pathophysiologic stimuli such as mechanical stress, aging, obesity, and some diseases are the causative factors. Then, many cytokines and growth factors secreted by LF cells and its surrounding tissues play different roles in activating the fibrotic response. Here, we summarize the current status of detailed knowledge available regarding the causative factors, pathology, molecular and cellular mechanisms implicated in LF fibrosis and hypertrophy, also focusing on the possible avenues for anti-fibrotic strategies.	[Sun, Chao; Zhang, Han; Wang, Xiang; Liu, Xinhui] Nanjing Med Univ, Affiliated Jiangning Hosp, Dept Spine Surg, Nanjing 211100, Peoples R China	Nanjing Medical University	Liu, XH (corresponding author), Nanjing Med Univ, Affiliated Jiangning Hosp, Dept Spine Surg, Nanjing 211100, Peoples R China.	drsunchao@163.com; Professorlxh2010@163.com			National Natural Science Foundation of China (NSFC) [81802198]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81802198	Abbas J, 2010, SPINE, V35, P1225, DOI 10.1097/BRS.0b013e3181bfca15; Abdel-Meguid EM, 2008, NEUROSCIENCES, V13, P11; Aigner T, 2001, ARTHRITIS RHEUM-US, V44, P2777, DOI 10.1002/1529-0131(200112)44:12<2777::AID-ART465>3.0.CO;2-H; Altinkaya N, 2011, SPINE, V36, pE1093, DOI 10.1097/BRS.0b013e318203e2b5; Altun I, 2017, ASIAN SPINE J, V11, P71, DOI 10.4184/asj.2017.11.1.71; Amudong A, 2017, J INT MED RES, V45, P2036, DOI 10.1177/0300060517711308; Anekstein Y, 2010, ISR MED ASSOC J, V12, P16; Araujo FA, 2010, BIOMED PHARMACOTHER, V64, P29, DOI 10.1016/j.biopha.2009.03.003; Asadian L, 2016, CLIN MED INSIGHTS-EN, V9, DOI 10.4137/CMED.S39035; Bagnato G, 2017, EUR RESPIR REV, V26, DOI 10.1183/16000617.0125-2016; Balkowiec M, 2018, MOL MED REP, V18, P3123, DOI 10.3892/mmr.2018.9303; Basalyga DM, 2004, CIRCULATION, V110, P3480, DOI 10.1161/01.CIR.0000148367.08413.E9; Baum J, 2011, J CARDIOVASC PHARM, V57, P376, DOI 10.1097/FJC.0b013e3182116e39; Botwin Kenneth P, 2003, Phys Med Rehabil Clin N Am, V14, P1, DOI 10.1016/S1047-9651(02)00063-3; BRADHAM DM, 1991, J CELL BIOL, V114, P1285, DOI 10.1083/jcb.114.6.1285; Brigstock DR, 1999, ENDOCR REV, V20, P189, DOI 10.1210/er.20.2.189; Cao YL, 2016, INT J MOL MED, V38, P391, DOI 10.3892/ijmm.2016.2631; Capogna G, 1997, INT J OBSTET ANESTH, V6, P97, DOI 10.1016/S0959-289X(97)80005-2; D'Arpino MC, 2018, CELL BIOL INT, V42, P443, DOI 10.1002/cbin.10916; Chao YH, 2012, CONNECT TISSUE RES, V53, P407, DOI 10.3109/03008207.2012.679368; Chao YH, 2012, CONNECT TISSUE RES, V53, P422, DOI 10.3109/03008207.2012.685132; Chen DQ, 2018, TRENDS PHARMACOL SCI, V39, P937, DOI 10.1016/j.tips.2018.09.002; Chen JW, 2016, J SPINAL CORD MED, V39, P450, DOI 10.1080/10790268.2016.1141470; Chen JW, 2014, DIS MARKERS, V2014, P1, DOI 10.1155/2014/786543; Chen MH, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-238; Chen YT, 2011, SPINE, V36, pE1193, DOI 10.1097/BRS.0b013e3182053f58; Cheng ZY, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020581; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; Chu PS, 2013, HEPATOLOGY, V58, P337, DOI 10.1002/hep.26351; Chung AWY, 2007, CIRC RES, V101, P512, DOI 10.1161/CIRCRESAHA.107.157776; Colwell AS, 2005, PLAST RECONSTR SURG, V115, P204, DOI 10.1097/01.PRS.0000138252.51581.22; Cui GY, 2011, J ORTHOP SCI, V16, P785, DOI 10.1007/s00776-011-0135-2; Cui N, 2017, PROG MOL BIOL TRANSL, V147, P1, DOI 10.1016/bs.pmbts.2017.02.005; Cutroneo KR, 2007, WOUND REPAIR REGEN, V15, pS54, DOI 10.1111/j.1524-475X.2007.00226.x; DAGOSTINO AN, 1992, CLIN NEUROPATHOL, V11, P147; Dario AB, 2015, SPINE J, V15, P1106, DOI 10.1016/j.spinee.2015.02.001; Dean RG, 2005, J HISTOCHEM CYTOCHEM, V53, P1245, DOI 10.1369/jhc.4A6560.2005; Dechsupa S, 2018, PEERJ, V6, DOI 10.7717/peerj.5381; Dolivo DM, 2018, CELL MOL LIFE SCI, V75, P3663, DOI 10.1007/s00018-018-2880-2; ENKER P, 1994, CLIN ORTHOP RELAT R, P90; Feng YL, 2020, MED RES REV, V40, P54, DOI 10.1002/med.21596; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Forcina L, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8030232; Frangogiannis NG, 2015, CURR OPIN CARDIOL, V30, P240, DOI 10.1097/HCO.0000000000000158; Frank S, 1996, J BIOL CHEM, V271, P10188, DOI 10.1074/jbc.271.17.10188; Fukui D, 2015, EUR SPINE J, V24, P2085, DOI 10.1007/s00586-014-3537-y; FUKUYAMA S, 1995, J SPINAL DISORD, V8, P126; Gorelik L, 2002, NAT REV IMMUNOL, V2, P46, DOI 10.1038/nri704; Haig AJ, 2012, PM&R, V4, P23, DOI 10.1016/j.pmrj.2011.07.023; Hangai M, 2008, SPINE J, V8, P732, DOI 10.1016/j.spinee.2007.07.392; Hansson T, 2009, EUR SPINE J, V18, P679, DOI 10.1007/s00586-009-0919-7; Harris L, 2018, SPINE, V43, pE545, DOI 10.1097/BRS.0000000000002401; Hayashi K, 2019, SPINE, V44, pE1172, DOI 10.1097/BRS.0000000000003089; Hayashi K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13360-w; Holbourn KP, 2008, TRENDS BIOCHEM SCI, V33, P461, DOI 10.1016/j.tibs.2008.07.006; Honsawek S, 2013, INT ORTHOP, V37, P1387, DOI 10.1007/s00264-013-1864-y; Hu HH, 2020, AGEING RES REV, V60, DOI 10.1016/j.arr.2020.101063; Hu HH, 2018, CHEM-BIOL INTERACT, V292, P76, DOI 10.1016/j.cbi.2018.07.008; Hu W, 2019, BMC MUSCULOSKEL DIS, V20, DOI 10.1186/s12891-019-2825-4; Hu WH, 2019, FASEB J, V33, P532, DOI 10.1096/fj.201800750R; Hughes CCW, 2008, CURR OPIN HEMATOL, V15, P204, DOI 10.1097/MOH.0b013e3282f97dbc; Hur JW, 2017, EUR SPINE J, V26, P2021, DOI 10.1007/s00586-017-4981-2; Hur JW, 2015, NEUROSURGERY, V77, P274, DOI 10.1227/NEU.0000000000000755; Igarashi A, 2004, SPINE, V29, P2091, DOI 10.1097/01.brs.0000141265.55411.30; Igarashi A, 2007, J ORTHOP SCI, V12, P154, DOI 10.1007/s00776-006-1105-y; Jablonski RP, 2017, FASEB J, V31, P2520, DOI 10.1096/fj.201601077R; Jafarinejad-Farsangi S, 2016, INT J DERMATOL, V55, P1259, DOI 10.1111/ijd.13308; Jeon ES, 2010, BBA-MOL CELL BIOL L, V1801, P1205, DOI 10.1016/j.bbalip.2010.08.003; Jirathanathornnukul N, 2016, J INVEST MED, V64, P882, DOI 10.1136/jim-2015-000024; Jun JI, 2011, NAT REV DRUG DISCOV, V10, P945, DOI 10.1038/nrd3599; Jung MY, 2018, FASEB J, V32, P3803, DOI 10.1096/fj.201701187R; Kamita M, 2015, PROTEOMICS, V15, P1622, DOI 10.1002/pmic.201400442; Kang JD, 1996, SPINE, V21, P271, DOI 10.1097/00007632-199602010-00003; Kang YM, 2014, J SPINAL DISORD TECH, V27, P382, DOI 10.1097/BSD.0b013e3182a26532; Karavelioglu E, 2016, J BACK MUSCULOSKELET, V29, P771, DOI 10.3233/BMR-160688; KAWAHARA E, 1991, VIRCHOWS ARCH A, V419, P373, DOI 10.1007/BF01605070; Kendall RT, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00123; Kim HJ, 2007, ASIAN SPINE J, V1, P8, DOI 10.4184/asj.2007.1.1.8; Kim MG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143961; Kolte VS, 2015, ASIAN SPINE J, V9, P245, DOI 10.4184/asj.2015.9.2.245; Kong W, 2008, MOL CELL BIOL, V28, P6773, DOI 10.1128/MCB.00941-08; Kular L, 2011, BIOCHIMIE, V93, P377, DOI 10.1016/j.biochi.2010.11.010; Kumar I, 2009, BRIT J SURG, V96, P1484, DOI 10.1002/bjs.6778; Kusano K, 1998, ENDOCRINOLOGY, V139, P1338, DOI 10.1210/en.139.3.1338; Lakemeier S, 2013, J SPINAL DISORD TECH, V26, P400, DOI 10.1097/BSD.0b013e3182495b88; Lakemeier S, 2012, ACTA NEUROCHIR, V154, P359, DOI 10.1007/s00701-011-1206-z; Landstrom M, 2019, FASEB J, V33, P13064, DOI 10.1096/fj.201902632; Lee HW, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221798; Lee SY, 2015, ASIAN SPINE J, V9, P818, DOI 10.4184/asj.2015.9.5.818; Letterio JJ, 1998, ANNU REV IMMUNOL, V16, P137, DOI 10.1146/annurev.immunol.16.1.137; Li C, 2014, INFLAMM BOWEL DIS, V20, P1250, DOI 10.1097/MIB.0000000000000043; Lohr M, 2011, ACTA NEUROCHIR, V153, P134, DOI 10.1007/s00701-010-0839-7; Lotan R, 2008, J SPINAL DISORD TECH, V21, P247, DOI 10.1097/BSD.0b013e31813707af; Lu Changhuai, 2019, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V33, P883, DOI 10.7507/1002-1892.201812016; Luo JQ, 2017, J ORTHOP RES, V35, P1058, DOI 10.1002/jor.23302; Lyu X, 2019, THER ADV CHRONIC DIS, V10, DOI 10.1177/2040622319862697; Ma CX, 2019, THER ADV CHRONIC DIS, V10, DOI 10.1177/2040622319868383; Manna I, 2018, FASEB J, V32, P4241, DOI 10.1096/fj.201701533R; Maruf MH, 2019, SPINE J, V19, P1739, DOI 10.1016/j.spinee.2019.06.001; Meng XM, 2016, NAT REV NEPHROL, V12, P325, DOI 10.1038/nrneph.2016.48; Miyauchi A, 2017, EUR SPINE J, V26, P382, DOI 10.1007/s00586-016-4640-z; Mohr J, 2019, FASEB J, V33, P5887, DOI 10.1096/fj.201801875RR; Moon HJ, 2012, SPINE, V37, pE147, DOI 10.1097/BRS.0b013e3182269b19; Mori T, 2017, SPINE SURG RELAT RES, V1, P211, DOI 10.22603/ssrr.1.2017-0023; MULLER W, 1994, Z GERONTOL, V27, P328; Munns JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128321; Murata H, 2004, J CELL BIOCHEM, V92, P715, DOI 10.1002/jcb.20090; Nagai T, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3142; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; NAKAMURA T, 1990, J SPINAL DISORD, V3, P288; Nakamura T, 2015, EUR SPINE J, V24, P2001, DOI 10.1007/s00586-015-3835-z; Nakamura T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085542; Nakatani T, 2002, J ORTHOP RES, V20, P1380, DOI 10.1016/S0736-0266(02)00046-3; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Oates PJ, 2002, INT REV NEUROBIOL, V50, P325; Oh IS, 2013, CONNECT TISSUE RES, V54, P380, DOI 10.3109/03008207.2013.848199; Oh IS, 2009, SPINE, V34, pE552, DOI 10.1097/BRS.0b013e3181aa0232; Okuda T, 2004, SPINE, V29, P1689, DOI 10.1097/01.BRS.0000132510.25378.8C; Pakshir P, 2018, MATRIX BIOL, V68-69, P81, DOI 10.1016/j.matbio.2018.01.019; Park J B, 2001, Spine (Phila Pa 1976), V26, pE492, DOI 10.1097/00007632-200111010-00007; Park JB, 2005, J BONE JOINT SURG AM, V87A, P2750, DOI 10.2106/JBJS.E.00251; Park JO, 2013, J SPINAL DISORD TECH, V26, pE6, DOI 10.1097/BSD.0b013e3182698501; Park JB, 2009, CLIN ORTHOP SURG, V1, P81, DOI 10.4055/cios.2009.1.2.81; Patroi I, 2003, J AM ACAD DERMATOL, V48, P846, DOI 10.1067/mjd.2003.452; Perbal B, 2004, LANCET, V363, P62, DOI 10.1016/S0140-6736(03)15172-0; Pinchuk I V, 2010, Curr Gastroenterol Rep, V12, P310, DOI 10.1007/s11894-010-0135-y; Polo M., 1997, Journal of Burn Care and Rehabilitation, V18, P477, DOI 10.1097/00004630-199711000-00002; POSTACCHINI F, 1994, SPINE, V19, P917, DOI 10.1097/00007632-199404150-00009; Rai D, 2010, P NATL ACAD SCI USA, V107, P3111, DOI 10.1073/pnas.0910667107; Ramazani Y, 2018, MATRIX BIOL, V68-69, P44, DOI 10.1016/j.matbio.2018.03.007; Rancoule C, 2017, ONCOTARGET, V8, P43543, DOI 10.18632/oncotarget.16672; Rancoule C, 2014, BBA-MOL CELL BIOL L, V1841, P88, DOI 10.1016/j.bbalip.2013.10.003; Rancoule C, 2011, EXPERT OPIN INV DRUG, V20, P657, DOI 10.1517/13543784.2011.566864; Rhett JM, 2008, TRENDS BIOTECHNOL, V26, P173, DOI 10.1016/j.tibtech.2007.12.007; Rispoli R, 2010, NEURORADIOL J, V23, P347, DOI 10.1177/197140091002300316; Roach KM, 2020, BRIT J PHARMACOL, V177, P1003, DOI 10.1111/bph.14939; Roberts DD, 2017, ANTIOXID REDOX SIGN, V27, P771, DOI 10.1089/ars.2017.7308; Rosenkranz S, 2004, CARDIOVASC RES, V63, P423, DOI 10.1016/j.cardiores.2004.04.030; Ruiz-Fernandez C, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20082030; Safak AA, 2010, CLIN ANAT, V23, P79, DOI 10.1002/ca.20883; Sairyo K, 2005, SPINE, V30, P2649, DOI 10.1097/01.brs.0000188117.77657.ee; Sairyo K, 2007, SPINE, V32, pE340, DOI 10.1097/01.brs.0000263407.25009.6e; Saito T, 2017, AM J PATHOL, V187, P2831, DOI 10.1016/j.ajpath.2017.08.020; Saito T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169717; Sakai N, 2013, FASEB J, V27, P1830, DOI 10.1096/fj.12-219378; Sakai Y, 2017, J ORTHOP SCI, V22, P27, DOI 10.1016/j.jos.2016.08.007; Sakamaki T, 2009, ARCH ORTHOP TRAUM SU, V129, P1415, DOI 10.1007/s00402-009-0849-1; Sato N, 2018, J MED INVESTIG, V65, P85, DOI 10.2152/jmi.65.85; Schneider DJ, 2012, FASEB J, V26, P503, DOI 10.1096/fj.11-186098; Schrader PK, 1999, EUR SPINE J, V8, P323, DOI 10.1007/s005860050181; Schroeder GD, 2016, J AM ACAD ORTHOP SUR, V24, P843, DOI 10.5435/JAAOS-D-15-00034; Setter SM, 2003, ANN PHARMACOTHER, V37, P1858, DOI 10.1345/aph.1D002; Shafaq N, 2012, J SPINAL DISORD TECH, V25, P107, DOI 10.1097/BSD.0b013e31820bb76e; Shah M, 2019, CUREUS, V11, DOI 10.7759/cureus.5691; Shemesh S, 2018, EUR SPINE J, V27, P1614, DOI 10.1007/s00586-017-5315-0; Shu DY, 2017, PROG RETIN EYE RES, V60, P44, DOI 10.1016/j.preteyeres.2017.08.001; Sidon E, 2019, J CELL BIOCHEM, V120, P11716, DOI 10.1002/jcb.28451; Siebert E, 2009, NAT REV NEUROL, V5, P392, DOI 10.1038/nrneurol.2009.90; Silva MJ, 2020, FASEB J, V34, P1970, DOI 10.1096/fj.201902109R; Specchia N, 2001, J ORTHOP RES, V19, P294, DOI 10.1016/S0736-0266(00)00026-7; Splettstosser A, 2017, WORLD J RADIOL, V9, P223, DOI 10.4329/wjr.v9.i5.223; STERNBERG M, 1985, DIABETES METAB, V11, P27; Stetler-Stevenson WG, 1999, J CLIN INVEST, V103, P1237, DOI 10.1172/JCI6870; Sturm A, 1999, GASTROENTEROLOGY, V117, P368, DOI 10.1053/gast.1999.0029900368; Sudhir G, 2019, CLIN NEUROL NEUROSUR, V182, P19, DOI 10.1016/j.clineuro.2019.04.023; Sueyoshi T, 2011, AMYLOID, V18, P165, DOI 10.3109/13506129.2011.582197; Sueyoshi T, 2011, HUM PATHOL, V42, P1259, DOI 10.1016/j.humpath.2010.11.017; Sugimoto K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200872; Sun C, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20171214; Sun C, 2017, BIOCHEM BIOPH RES CO, V490, P1106, DOI 10.1016/j.bbrc.2017.06.182; Sun C, 2017, INT J CLIN EXP PATHO, V10, P1356; Sun YW, 2018, EUR J PHARMACOL, V822, P199, DOI 10.1016/j.ejphar.2018.01.027; Sziksz E, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/764641; Szpalski M, 2003, EUR SPINE J, V12, pS170, DOI 10.1007/s00586-003-0612-1; Takashima H, 2018, SPINE SURG RELAT RES, V2, P263, DOI 10.22603/ssrr.2017-0069; Takeuchi-Yorimoto A, 2016, TOXICOL LETT, V258, P159, DOI 10.1016/j.toxlet.2016.06.012; Tammi R, 2005, J INVEST DERMATOL, V124, P898, DOI 10.1111/j.0022-202X.2005.23697.x; Viejo-Fuertes D, 1998, SURG RADIOL ANAT, V20, P171, DOI 10.1007/s00276-998-0171-6; Wan Q, 2019, AGING-US, V11, P9616, DOI 10.18632/aging.102408; Wang RZ, 2020, FASEB J, V34, P3554, DOI 10.1096/fj.201902096R; Wang Z, 2008, J SPINAL CORD MED, V31, P279, DOI 10.1080/10790268.2008.11760723; Weiler C, 2002, EUR SPINE J, V11, P308, DOI 10.1007/s00586-002-0472-0; Weiskirchen R, 2019, MOL ASPECTS MED, V65, P2, DOI 10.1016/j.mam.2018.06.003; Westermark P, 2014, UPSALA J MED SCI, V119, P223, DOI 10.3109/03009734.2014.895786; Xu YQ, 2016, SPINE, V41, P275, DOI 10.1097/BRS.0000000000001226; Xue JX, 2010, ONCOL REP, V24, P1515, DOI 10.3892/or_00001013; Yabe Y, 2016, J ORTHOP RES, V34, P1241, DOI 10.1002/jor.23130; Yabe Y, 2015, SPINE, V40, P429, DOI 10.1097/BRS.0000000000000795; YAHIA LH, 1990, SPINE, V15, P262, DOI 10.1097/00007632-199004000-00002; Yamahata H, 2017, J ORTHOP SCI, V22, P190, DOI 10.1016/j.jos.2016.11.005; Yan B, 2018, CELL PHYSIOL BIOCHEM, V48, P293, DOI 10.1159/000491729; Yanagisawa A, 2015, MODERN PATHOL, V28, P201, DOI 10.1038/modpathol.2014.102; Yayama T, 2005, CLIN EXP RHEUMATOL, V23, P637; Yayama T, 2008, CLIN RHEUMATOL, V27, P597, DOI 10.1007/s10067-007-0754-3; Ye S, 2019, J ORTHOP RES, V37, P2634, DOI 10.1002/jor.24425; Yin Q, 2019, ADV EXP MED BIOL, V1165, P365, DOI 10.1007/978-981-13-8871-2_17; YOSHIDA M, 1992, SPINE, V17, P1353, DOI 10.1097/00007632-199211000-00015; Yoshiiwa T, 2016, ASIAN SPINE J, V10, P1132, DOI 10.4184/asj.2016.10.6.1132; Yoshio Y, 2004, KIDNEY INT, V66, P1677, DOI 10.1111/j.1523-1755.2004.00935.x; Yu F, 2019, AGING-US, V11, P10454, DOI 10.18632/aging.102469; Yu SZ, 2017, MOL MED REP, V16, P7692, DOI 10.3892/mmr.2017.7543; Yucetas SC, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000015192; Zhang K, 2017, CLIN SPINE SURG, V30, pE189, DOI 10.1097/BSD.0000000000000048; Zhang Q, 2019, J CELL BIOCHEM, V120, P3401, DOI 10.1002/jcb.27611; Zhang Y, 2010, SPINE, V35, pE1479, DOI 10.1097/BRS.0b013e3181f3d2df; Zhong ZM, 2011, J ORTHOP RES, V29, P1592, DOI 10.1002/jor.21431; Zhong ZM, 2009, YONSEI MED J, V50, P375, DOI 10.3349/ymj.2009.50.3.375; Zhou TJ, 2018, CELL PHYSIOL BIOCHEM, V45, P1472, DOI 10.1159/000487574; Zurier RB, 2016, FASEB J, V30, P3682, DOI 10.1096/fj.201600646R	209	25	25	4	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					9854	9868		10.1096/fj.202000635R	http://dx.doi.org/10.1096/fj.202000635R		JUL 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32608536				2022-12-28	WOS:000547079000001
J	Xue, YL; Razafsky, D; Hodzic, D; Kefalov, VJ				Xue, Yunlu; Razafsky, David; Hodzic, Didier; Kefalov, Vladimir J.			Mislocalization of cone nuclei impairs cone function in mice	FASEB JOURNAL			English	Article						cone photoreceptor; dark adaptation; LINC complex; nucleus migration; retinal degeneration; retina electrophysiology	RETINAL VISUAL CYCLE; PHOTORECEPTORS; PHOTOTRANSDUCTION; BINDING; ROD; EVOLUTION; PROTEINS; SEGMENTS; CELLS	The nuclei of cone photoreceptors are located on the apical side of the outer nuclear layer (ONL) in vertebrate retinas. However, the functional role of this evolutionarily conserved localization of cone nuclei is unknown. We previously showed that Linkers of the Nucleoskeleton to the Cytoskeleton (LINC complexes) are essential for the apical migration of cone nuclei during development. Here, we developed an efficient genetic strategy to disrupt cone LINC complexes in mice. Experiments with animals from both sexes revealed that disrupting cone LINC complexes resulted in mislocalization of cone nuclei to the basal side of ONL in mouse retina. This, in turn, disrupted cone pedicle morphology, and appeared to reduce the efficiency of synaptic transmission from cones to bipolar cells. Although we did not observe other developmental or phototransduction defects in cones with mislocalized nuclei, their dark adaptation was impaired, consistent with a deficiency in chromophore recycling. These findings demonstrate that the apical localization of cone nuclei in the ONL is required for the timely dark adaptation and efficient synaptic transmission in cone photoreceptors.	[Xue, Yunlu] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Xue, Yunlu] Harvard Med Sch, Dept Ophthalmol, Boston, MA 02115 USA; [Razafsky, David; Hodzic, Didier; Kefalov, Vladimir J.] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Washington University (WUSTL)	Xue, YL (corresponding author), Harvard Med Sch, Dept Genet, Boston, MA 02115 USA.	yunlu_xue@hms.harvard.edu	Xue, Yunlu/AAJ-8433-2021	Xue, Yunlu/0000-0002-2088-9826	HHS \ NIH \ National Eye Institute (NEI) [K99EY030951, EY025696, EY027387, EY022632]	HHS \ NIH \ National Eye Institute (NEI)	HHS vertical bar NIH vertical bar National Eye Institute (NEI), Grant/Award Number: K99EY030951, EY025696, EY027387 and EY022632	Alexopoulou AN, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-2; Bringmann A, 2019, ANAT HISTOL EMBRYOL, V48, P177, DOI 10.1111/ahe.12432; Calvert PD, 2000, P NATL ACAD SCI USA, V97, P13913, DOI 10.1073/pnas.250478897; Crisp M, 2006, J CELL BIOL, V172, P41, DOI 10.1083/jcb.200509124; Cuenca N, 2002, J NEUROCYTOL, V31, P649, DOI 10.1023/A:1025791512555; DICKSON DH, 1979, EXP EYE RES, V29, P45, DOI 10.1016/0014-4835(79)90165-9; Fain GL, 2010, CURR BIOL, V20, pR114, DOI 10.1016/j.cub.2009.12.006; Hoang QV, 2002, VISUAL NEUROSCI, V19, P395, DOI 10.1017/S0952523802194028; ISHIKAWA M, 1987, CELL TISSUE RES, V249, P241; Kolb H., 1995, WEBVISION ORG RETINA; Kolesnikov AV, 2012, JOVE-J VIS EXP, DOI 10.3791/3424; Kolesnikov AV, 2011, J NEUROSCI, V31, P7900, DOI 10.1523/JNEUROSCI.0438-11.2011; Lagman D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121330; Lamb TD, 2004, PROG RETIN EYE RES, V23, P307, DOI 10.1016/j.preteyeres.2004.03.001; Lamb TD, 2007, NAT REV NEUROSCI, V8, P960, DOI 10.1038/nrn2283; Le YZ, 2006, MOL VIS, V12, P389; Lei K, 2009, P NATL ACAD SCI USA, V106, P10207, DOI 10.1073/pnas.0812037106; Lombardi ML, 2011, JOVE-J VIS EXP, DOI 10.3791/3087; Lopez-Lopez R, 2008, CELL TISSUE RES, V332, P13, DOI 10.1007/s00441-007-0572-6; Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; Morshedian A, 2015, CURR BIOL, V25, P484, DOI 10.1016/j.cub.2014.12.031; Rajgor D, 2013, EXPERT REV MOL MED, V15, DOI 10.1017/erm.2013.6; Razafsky D, 2015, JOVE-J VIS EXP, DOI 10.3791/53318; Razafsky D, 2014, GENESIS, V52, P359, DOI 10.1002/dvg.22755; Razafsky D, 2014, ADV EXP MED BIOL, V773, P471, DOI 10.1007/978-1-4899-8032-8_21; Razafsky D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047180; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Rich KA, 1997, J COMP NEUROL, V388, P47; Roux KJ, 2009, P NATL ACAD SCI USA, V106, P2194, DOI 10.1073/pnas.0808602106; Sato S, 2017, VISUAL NEUROSCI, V34, DOI 10.1017/S0952523817000013; Sosa BA, 2012, CELL, V149, P1035, DOI 10.1016/j.cell.2012.03.046; Stewart-Hutchinson PJ, 2008, EXP CELL RES, V314, P1892, DOI 10.1016/j.yexcr.2008.02.022; STOCKTON RA, 1989, J GEN PHYSIOL, V93, P101, DOI 10.1085/jgp.93.1.101; Vinberg F, 2014, VISION RES, V101, P108, DOI 10.1016/j.visres.2014.06.003; Wachtmeister L, 1998, PROG RETIN EYE RES, V17, P485, DOI 10.1016/S1350-9462(98)00006-8; Wang JS, 2014, J NEUROSCI, V34, P11212, DOI 10.1523/JNEUROSCI.1245-14.2014; Wang JS, 2009, NAT NEUROSCI, V12, P295, DOI 10.1038/nn.2258; Xue YL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02549-8; Xue YL, 2015, SCI REP-UK, V5, DOI 10.1038/srep17616; Xue YL, 2015, J CLIN INVEST, V125, P727, DOI 10.1172/JCI79651; Yang SH, 2011, HUM MOL GENET, V20, P3537, DOI 10.1093/hmg/ddr266; Yau KW, 2009, CELL, V139, P246, DOI 10.1016/j.cell.2009.09.029; Zhang HB, 2008, J NEUROSCI, V28, P4008, DOI 10.1523/JNEUROSCI.0317-08.2008; Zhou ZC, 2012, J BIOL CHEM, V287, P5317, DOI 10.1074/jbc.M111.304543	44	1	1	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10242	10249		10.1096/fj.202000568R	http://dx.doi.org/10.1096/fj.202000568R		JUN 2020	8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32539195	Bronze, Green Accepted			2022-12-28	WOS:000541801100001
J	Dohrmann, M; Makhoul, S; Gross, K; Krause, M; Pillitteri, D; von Auer, C; Walter, U; Lutz, J; Volf, I; Kehrel, BE; Jurk, K				Doehrmann, Mareike; Makhoul, Stephanie; Gross, Kathrin; Krause, Manuela; Pillitteri, Danielle; von Auer, Charis; Walter, Ulrich; Lutz, Jens; Volf, Ivo; Kehrel, Beate E.; Jurk, Kerstin			CD36-fibrin interaction propagates FXI-dependent thrombin generation of human platelets	FASEB JOURNAL			English	Article						adhesion molecules; coagulation; factor XI; inflammation; scavenger receptors	COAGULATION-FACTOR XI; BLOOD-COAGULATION; FIBRIN; CD36; ACTIVATION; RECEPTOR; BINDING; THROMBOSPONDIN; ADHESION; FAMILY	Thrombin converts fibrinogen to fibrin and activates blood and vascular cells in thrombo-inflammatory diseases. Platelets are amplifiers of thrombin formation when activated by leukocyte- and vascular cell-derived thrombin. CD36 on platelets acts as sensitizer for molecules with damage-associated molecular patterns, thereby increasing platelet reactivity. Here, we investigated the role of CD36 in thrombin-generation on human platelets, including selected patients with advanced chronic kidney disease (CKD). Platelets deficient in CD36 or blocked by anti-CD36 antibody FA6.152 showed impaired thrombin generation triggered by thrombin in calibrated automated thrombography. Using platelets with congenital function defects, blocking antibodies, pharmacological inhibitors, and factor-depleted plasma, CD36-sensitive thrombin generation was dependent on FXI, fibrin, and platelet signaling via GPIb alpha and SFKs. CD36-deficiency or blocking suppressed thrombin-induced platelet alpha IIb beta 3 activation, granule exocytosis, binding of adhesion proteins and FV, FVIII, FIX, FX, but not anionic phospholipid exposure determined by flow cytometry. CD36 ligated specifically soluble fibrin, which recruited distinct coagulation factors via thiols. Selected patients with CKD showed elevated soluble fibrin plasma levels and enhanced thrombin-induced thrombin generation, which was normalized by CD36 blocking. Thus, CD36 is an important amplifier of platelet-dependent thrombin generation when exposure of anionic phospholipids is limited. This pathway might contribute to hypercoagulability in CKD.	[Doehrmann, Mareike; Makhoul, Stephanie; Gross, Kathrin; Walter, Ulrich; Jurk, Kerstin] Johannes Gutenberg Univ Mainz, Ctr Thrombosis & Hemostasis CTH, Univ Med Ctr, Langenbeckstr 1, D-55131 Mainz, Germany; [Krause, Manuela; Pillitteri, Danielle] Deutsch Klin Diagnost HELIOS Klin, Wiesbaden, Germany; [von Auer, Charis] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Med 3, Mainz, Germany; [Lutz, Jens] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Med 1, Sect Nephrol, Mainz, Germany; [Lutz, Jens] Gemeinschaftsklinikum Mittelrhein, Sect Nephrol & Infect Dis, Med Clin, Koblenz, Germany; [Volf, Ivo] Med Univ Vienna, Ctr Physiol & Pharmacol, Vienna, Austria; [Kehrel, Beate E.; Jurk, Kerstin] Univ Munster, Dept Anesthesiol Intens Care & Pain Med, Expt & Clin Hemostasis, Munster, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Medical University of Vienna; University of Munster	Jurk, K (corresponding author), Johannes Gutenberg Univ Mainz, Ctr Thrombosis & Hemostasis CTH, Univ Med Ctr, Langenbeckstr 1, D-55131 Mainz, Germany.	kerstin.jurk@unimedizin-mainz.de	Jurk, Kerstin/AAT-7768-2020		German Federal Ministry of Education and Research (BMBF) [01EO1003, 01EO1503]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	German Federal Ministry of Education and Research (BMBF), Grant/Award Number: 01EO1003 and 01EO1503	Alshehri OM, 2015, BLOOD, V126, P1601, DOI 10.1182/blood-2015-04-641654; ASCH AS, 1987, J CLIN INVEST, V79, P1054, DOI 10.1172/JCI112918; Assinger A, 2010, ATHEROSCLEROSIS, V212, P153, DOI 10.1016/j.atherosclerosis.2010.05.010; Borissoff JI, 2011, NEW ENGL J MED, V364, P1746, DOI 10.1056/NEJMra1011670; Burkhart JM, 2012, BLOOD, V120, pE73, DOI 10.1182/blood-2012-04-416594; Dormann D, 2000, BLOOD, V96, P2469, DOI 10.1182/blood.V96.7.2469.h8002469_2469_2478; ENDEMANN G, 1993, J BIOL CHEM, V268, P11811; Gilbert GE, 2015, BLOOD, V126, P1237, DOI 10.1182/blood-2015-01-620245; Heemskerk JWM, 2013, J THROMB HAEMOST, V11, P2, DOI 10.1111/jth.12045; Hemker HC, 2003, PATHOPHYSIOL HAEMO T, V33, P4, DOI 10.1159/000071636; Herczenik E, 2007, ARTERIOSCL THROM VAS, V27, P1657, DOI 10.1161/ATVBAHA.107.143479; Jurk K, 2011, J THROMB HAEMOST, V9, P2278, DOI 10.1111/j.1538-7836.2011.04509.x; Jurk K, 2003, FASEB J, V17, P1490, DOI 10.1096/fj.02-0830fje; Jurk K, 2010, THROMB HAEMOSTASIS, V103, P1053, DOI 10.1160/TH09-10-0689; Keularts IMLW, 2001, THROMB HAEMOSTASIS, V85, P1060, DOI 10.1055/s-0037-1615964; KIEFFER N, 1989, BIOCHEM J, V262, P835, DOI 10.1042/bj2620835; Korporaal SJA, 2007, ARTERIOSCL THROM VAS, V27, P2476, DOI 10.1161/ATVBAHA.107.150698; Kossmann S, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah4923; Kravtsov DV, 2009, BLOOD, V114, P452, DOI 10.1182/blood-2009-02-203604; Kuijpers MJE, 2014, ARTERIOSCL THROM VAS, V34, P1187, DOI 10.1161/ATVBAHA.113.302917; Loroch S, 2017, THROMB HAEMOSTASIS, V117, P556, DOI 10.1160/TH16-07-0515; Lutz J, 2017, PLATELETS THROMBOTIC, P1183; Maas C, 2018, BLOOD, V131, P1903, DOI 10.1182/blood-2017-04-569111; Mackman N, 2007, ARTERIOSCL THROM VAS, V27, P1687, DOI 10.1161/ATVBAHA.107.141911; Makhoul S, 2019, CELL COMMUN SIGNAL, V17, DOI 10.1186/s12964-019-0428-1; Mammadova-Bach E, 2015, BLOOD, V126, P683, DOI 10.1182/blood-2015-02-629717; Meijers JCM, 2000, NEW ENGL J MED, V342, P696, DOI 10.1056/NEJM200003093421004; Monroe DM, 2006, ARTERIOSCL THROM VAS, V26, P41, DOI 10.1161/01.ATV.0000193624.28251.83; Montague SJ, 2018, BLOOD ADV, V2, P240, DOI 10.1182/bloodadvances.2017011171; Niemann S, 2004, CIRCULATION, V110, P193, DOI 10.1161/01.CIR.0000134486.93030.E7; Ninivaggi M, 2012, CLIN CHEM, V58, P1252, DOI 10.1373/clinchem.2012.184077; PARKER RI, 1987, BLOOD, V70, P1589; Podoplelova NA, 2016, BLOOD, V128, P1745, DOI 10.1182/blood-2016-02-696898; Podrez EA, 2002, J BIOL CHEM, V277, P38503, DOI 10.1074/jbc.M203318200; Podrez EA, 2007, NAT MED, V13, P1086, DOI 10.1038/nm1626; Roberts W, 2010, BLOOD, V116, P4297, DOI 10.1182/blood-2010-01-265561; Salomon O, 2008, BLOOD, V111, P4113, DOI 10.1182/blood-2007-10-120139; Silverstein RL, 2009, CLIN LIPIDOL, V4, P767, DOI 10.2217/CLP.09.57; Swieringa F, 2018, RES PRACT THROMB HAE, V2, P450, DOI 10.1002/rth2.12107; TUSZYNSKI GP, 1985, J BIOL CHEM, V260, P2240; Wang YM, 2014, J CLIN INVEST, V124, P2160, DOI 10.1172/JCI70966; Wielders SJH, 2004, ARTERIOSCL THROM VAS, V24, P1138, DOI 10.1161/01.ATV.0000128125.80559.9c; Xie LJ, 2001, J EXP MED, V193, P1341, DOI 10.1084/jem.193.12.1341; Yang MA, 2018, BLOOD ADV, V2, P2848, DOI 10.1182/bloodadvances.2018025411; Yang M, 2017, BLOOD, V129, P2917, DOI 10.1182/blood-2016-11-750133; Zilberman-Rudenko J, 2016, ARTERIOSCL THROM VAS, V36, P510, DOI 10.1161/ATVBAHA.115.307034; Zwicker JI, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.125851	48	10	10	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9337	9357		10.1096/fj.201903189R	http://dx.doi.org/10.1096/fj.201903189R		MAY 2020	21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32463151				2022-12-28	WOS:000538058900001
J	Zhou, Q; Li, J; Yue, W; Li, A; Meng, TG; Lei, WL; Fan, LH; Ouyang, YC; Schatten, H; Wang, ZB; Su, QY				Zhou, Qian; Li, Jian; Yue, Wei; Li, Ang; Meng, Tie-Gang; Lei, Wen-Long; Fan, Li-Hua; Ouyang, Ying-Chun; Schatten, Heide; Wang, Zhen-Bo; Su, Qing-Yuan			Cell division cycle 23 is required for mouse oocyte meiotic maturation	FASEB JOURNAL			English	Article						aneuploidy; Cdc23; chromosome; meiosis; oocyte	ANAPHASE-PROMOTING COMPLEX; SPINDLE ASSEMBLY CHECKPOINT; LOCALIZATION; MEIOSIS; APC/C; YEAST; MAD1; PROMETAPHASE; KINETOCHORES; CHROMOSOMES	Precise regulation of chromosome segregation during oocyte meiosis is of vital importance to mammalian reproduction. Anaphase promoting complex/cyclosome (APC/C) is reported to play an important role in metaphase-to-anaphase transition. Here we report that cell division cycle 23 (Cdc23, also known as APC8) plays a critical role in regulating the oocyte chromosome separation. Cdc23 localized on the meiotic spindle, and microinjection of Cdc23 siRNA caused decreased ratios of metaphase-to-anaphase transition. Loss of Cdc23 resulted in abnormal spindles, misaligned chromosomes, errors of homologous chromosome segregation, and production of aneuploid oocytes. Further study showed that inactivation of spindle assembly checkpoint and degradation of Cyclin B1 and securin were disturbed after Cdc23 knockdown. Furthermore, we found that inhibiting spindle assembly checkpoint protein Msp1 partly rescued the decreased polar body extrusion and reduced the accumulation of securin in Cdc23 knockdown oocytes. Taken together, our data demonstrate that Cdc23 is required for the chromosome segregation through regulating the spindle assembly checkpoint activity, and cyclin B1 and securin degradation in meiotic mouse oocytes.	[Zhou, Qian; Li, Jian; Yue, Wei; Li, Ang; Meng, Tie-Gang; Lei, Wen-Long; Fan, Li-Hua; Ouyang, Ying-Chun; Wang, Zhen-Bo; Su, Qing-Yuan] Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China; [Zhou, Qian; Yue, Wei; Lei, Wen-Long; Fan, Li-Hua; Wang, Zhen-Bo; Su, Qing-Yuan] Univ Chinese Acad Sci, Beijing, Peoples R China; [Li, Jian] Peking Univ, Shenzhen Peking Univ, Hong Kong Univ Sci & Technol, Shenzhen Hosp,Med Ctr,Dept Reprod Med, Shenzhen, Peoples R China; [Schatten, Heide] Univ Missouri, Dept Vet Pathobiol, Columbia, MO USA	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Hong Kong University of Science & Technology; Peking University; University of Missouri System; University of Missouri Columbia	Wang, ZB; Su, QY (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China.	wangzb@ioz.ac.cn; sunqy@ioz.ac.cn		Zhou, Qian/0000-0001-7274-6053	National Natural Science Foundation of China [31530049, 31871504, 31601201]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (31530049, 31871504, 31601201).	Acquaviva C, 2006, J CELL SCI, V119, P2401, DOI 10.1242/jcs.02937; Brooker AS, 2014, METHODS MOL BIOL, V1170, P229, DOI 10.1007/978-1-4939-0888-2_11; Chang LF, 2015, NATURE, V522, P450, DOI 10.1038/nature14471; Chang LF, 2014, NATURE, V513, P388, DOI 10.1038/nature13543; Cheslock PS, 2005, NAT GENET, V37, P756, DOI 10.1038/ng1588; Collin P, 2013, NAT CELL BIOL, V15, P1378, DOI 10.1038/ncb2855; Fan H.-Y., 2019, OVARY, V3rd ed., P181, DOI [10.1016/B978-0-12-813209-8.00012-1, DOI 10.1016/B978-0-12-813209-8.00012-1]; Goshima G, 2000, CELL, V100, P619, DOI 10.1016/S0092-8674(00)80699-6; Gregan J, 2003, MOL BIOL CELL, V14, P3876, DOI 10.1091/mbc.E03-02-0090; Gui LM, 2013, DEV CELL, V25, P43, DOI 10.1016/j.devcel.2013.02.008; Hagting A, 2002, J CELL BIOL, V157, P1125, DOI 10.1083/jcb.200111001; Harper JW, 2002, GENE DEV, V16, P2179, DOI 10.1101/gad.1013102; Hart EA, 2002, CURR GENET, V41, P342, DOI 10.1007/s00294-002-0316-9; Herbert M, 2003, NAT CELL BIOL, V5, P1023, DOI 10.1038/ncb1062; Hewitt L, 2010, J CELL BIOL, V190, P25, DOI 10.1083/jcb.201002133; Homer H, 2013, REPRODUCTION, V146, pR61, DOI 10.1530/REP-13-0163; Huang JY, 2007, J CELL SCI, V120, P1990, DOI 10.1242/jcs.006833; IRNIGER S, 1995, CELL, V81, P269, DOI 10.1016/0092-8674(95)90337-2; Kudo NR, 2009, J CELL SCI, V122, P2686, DOI 10.1242/jcs.035287; LAMB JR, 1994, EMBO J, V13, P4321, DOI 10.1002/j.1460-2075.1994.tb06752.x; Ledan E, 2001, DEV BIOL, V232, P400, DOI 10.1006/dbio.2001.0188; Lee J-K, 2003, PNAS, V100, P6; Li M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007701; Marston AL, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00109; Melloy PG, 2004, GENETICS, V167, P1079, DOI 10.1534/genetics.103.025478; NEWLON CS, 1975, CELL, V5, P423; Pal M, 2007, J CELL SCI, V120, P3238, DOI 10.1242/jcs.004762; Polanski Z, 1998, DEVELOPMENT, V125, P4989; Reis A, 2007, NAT CELL BIOL, V9, P1192, DOI 10.1038/ncb1640; Sebestova J, 2012, CELL CYCLE, V11, P3011, DOI 10.4161/cc.21398; So C, 2019, SCIENCE, V364, P1252, DOI 10.1126/science.aat9557; Sun SC, 2012, HUM REPROD UPDATE, V18, P60, DOI 10.1093/humupd/dmr044; Toda K, 2012, CELL DIV, V7, DOI 10.1186/1747-1028-7-4; Tunquist BJ, 2003, J CELL BIOL, V163, P1231, DOI 10.1083/jcb.200306153; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Xu RY, 2019, NEW PHYTOL, V224, P229, DOI 10.1111/nph.16014; Zachariae W, 1996, MOL BIOL CELL, V7, P791, DOI 10.1091/mbc.7.5.791; Zachariae W, 1998, SCIENCE, V279, P1216, DOI 10.1126/science.279.5354.1216; Zeng XM, 1999, J CELL BIOL, V146, P415, DOI 10.1083/jcb.146.2.415; Zhang D, 2005, BIOL REPROD, V72, P58, DOI 10.1095/biolreprod.104.032987; Zhang D, 2004, BIOL REPROD, V71, P740, DOI 10.1095/biolreprod.104.028282; Zhang LS, 2011, ENDOCR-RELAT CANCER, V18, P731, DOI 10.1530/ERC-11-0181; Zhang ZG, 2010, J MOL BIOL, V397, P1316, DOI 10.1016/j.jmb.2010.02.045	43	1	1	1	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					8990	9002		10.1096/fj.202000131R	http://dx.doi.org/10.1096/fj.202000131R		MAY 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32449168				2022-12-28	WOS:000535406900001
J	Choi, H; Bae, SJ; Choi, G; Lee, H; Son, T; Kim, JG; An, S; Lee, HS; Seo, JH; Kwon, HB; Jeon, S; Oh, GT; Surh, YJ; Kim, KW				Choi, Hoon; Bae, Sung-Jin; Choi, Garam; Lee, Hyunseung; Son, Taekwon; Kim, Jeong-Gyun; An, Sunho; Lee, Hye Shin; Seo, Ji Hae; Kwon, Hyouk-Bum; Jeon, Sejin; Oh, Goo Taeg; Surh, Young-Joon; Kim, Kyu-Won			Ninjurin1 deficiency aggravates colitis development by promoting M1 macrophage polarization and inducing microbial imbalance	FASEB JOURNAL			English	Article						dysbiosis; homeostasis; inflammatory bowel disease; inflammation; M2 macrophages	INFLAMMATORY-BOWEL-DISEASE; ADHESION MOLECULE; SYSTEM; RECEPTOR; RECOGNITION; METABOLITES; PLASTICITY; DYSBIOSIS; ANXIETY; CELLS	Disruption of colonic homeostasis caused by aberrant M1/M2 macrophage polarization and dysbiosis contributes to inflammatory bowel disease (IBD) pathogenesis. However, the molecular factors mediating colonic homeostasis are not well characterized. Here, we found that Ninjurin1 (Ninj1) limits colon inflammation by regulating macrophage polarization and microbiota composition under homeostatic conditions and during colitis development. Ninj1 deletion in mice induced hypersusceptibility to colitis, with increased prevalence of colitogenic Prevotellaceae strains and decreased immunoregulatory Lachnospiraceae strains. Upon co-housing (CoH) with WT mice, Ninj1(-/-) mice showed increased Lachnospiraceae and decreased Prevotellaceae abundance, with subsequent improvement of colitis. Under homeostatic conditions, M1 macrophage frequency was higher in the Ninj1(-/-) mouse colons than wild-type (WT) mouse colons, which may contribute to increased basal colonic inflammation and microbial imbalance. Following colitis induction, Ninj1 expression was increased in macrophages; meanwhile Ninj1(-/-) mice showed severe colitis development and impaired recovery, associated with decreased M2 macrophages and escalated microbial imbalance. In vitro, Ninj1 knockdown in mouse and human macrophages activated M1 polarization and restricted M2 polarization. Finally, the transfer of WT macrophages ameliorated severe colitis in Ninj1(-/-) mice. These findings suggest that Ninj1 mediates colonic homeostasis by modulating M1/M2 macrophage balance and preventing extensive dysbiosis, with implications for IBD prevention and therapy.	[Choi, Hoon; Choi, Garam; Lee, Hyunseung; Son, Taekwon; Kim, Jeong-Gyun; An, Sunho; Lee, Hye Shin; Surh, Young-Joon; Kim, Kyu-Won] Seoul Natl Univ, Coll Pharm, Seoul 08826, South Korea; [Choi, Hoon; Choi, Garam; Lee, Hyunseung; Son, Taekwon; Kim, Jeong-Gyun; An, Sunho; Lee, Hye Shin; Surh, Young-Joon; Kim, Kyu-Won] Seoul Natl Univ, Res Inst Pharmaceut Sci, Seoul 08826, South Korea; [Bae, Sung-Jin] Pusan Natl Univ, Korean Med Res Ctr Hlth Aging, Yangsan, South Korea; [Seo, Ji Hae] Keimyung Univ, Sch Med, Dept Biochem, Daegu, South Korea; [Kwon, Hyouk-Bum] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27515 USA; [Jeon, Sejin; Oh, Goo Taeg] Ewha Womans Univ, Dept Life Sci, Seoul, South Korea; [Kim, Kyu-Won] Seoul Natl Univ, Crop Biotechnol Inst, GreenBio Sci & Technol, Pyeongchang, South Korea	Seoul National University (SNU); Seoul National University (SNU); Pusan National University; Keimyung University; University of North Carolina; University of North Carolina Chapel Hill; Ewha Womans University; Seoul National University (SNU)	Kim, KW (corresponding author), Seoul Natl Univ, Coll Pharm, Seoul 08826, South Korea.; Kim, KW (corresponding author), Seoul Natl Univ, Res Inst Pharmaceut Sci, Seoul 08826, South Korea.	qwonkim@snu.ac.kr	Oh, Goo Taeg/AAQ-9995-2021; Bae, Sung-Jin/AAX-9144-2021; Jeon, Sejin/GRJ-6826-2022; Jeon, Sejin/GWU-7864-2022	Bae, Sung-Jin/0000-0001-8975-0876	Global Core Research Center Program [2011-0030001]; Midcareer Researcher Program [2018R1A2B6001590]; Bio & Medical Technology Development Program [2015M3A9E6028949]; Young Researcher Program [2020R1C1C1003703]; National Research Foundation of Korea [NRF]; Ministry of Science, ICT and Future Planning [MSIP]; Ministry of Science and ICT [MSIT]	Global Core Research Center Program; Midcareer Researcher Program; Bio & Medical Technology Development Program; Young Researcher Program; National Research Foundation of Korea [NRF](National Research Foundation of Korea); Ministry of Science, ICT and Future Planning [MSIP]; Ministry of Science and ICT [MSIT]	Global Core Research Center Program, Grant/Award Number: 2011-0030001; Midcareer Researcher Program, Grant/Award Number: 2018R1A2B6001590; Bio & Medical Technology Development Program, Grant/Award Number: 2015M3A9E6028949; Young Researcher Program, Grant/Award Number: 2020R1C1C1003703; National Research Foundation of Korea [NRF]; Ministry of Science, ICT and Future Planning [MSIP] or Ministry of Science and ICT [MSIT]	Ahn BJ, 2014, J BIOL CHEM, V289, P3328, DOI 10.1074/jbc.M113.498212; Araki T, 1997, J BIOL CHEM, V272, P21373, DOI 10.1074/jbc.272.34.21373; Araki T, 1996, NEURON, V17, P353, DOI 10.1016/S0896-6273(00)80166-X; Araki T, 2000, J NEUROSCI, V20, P187, DOI 10.1523/JNEUROSCI.20-01-00187.2000; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Bae SJ, 2019, EXP MOL MED, V51, DOI 10.1038/s12276-018-0201-3; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Bernardo D, 2018, MUCOSAL IMMUNOL, V11, P1114, DOI 10.1038/s41385-018-0030-7; Carvalho FA, 2012, CELL HOST MICROBE, V12, P139, DOI 10.1016/j.chom.2012.07.004; Chang PV, 2014, P NATL ACAD SCI USA, V111, P2247, DOI 10.1073/pnas.1322269111; Chen L, 2017, NAT IMMUNOL, V18, P541, DOI 10.1038/ni.3690; Cho SJ, 2013, P NATL ACAD SCI USA, V110, P9362, DOI 10.1073/pnas.1221242110; Couturier-Maillard A, 2013, J CLIN INVEST, V123, P700, DOI 10.1172/JCI62236; Ding J, 2018, BIOCHEM BIOPH RES CO, V505, P1180, DOI 10.1016/j.bbrc.2018.09.184; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Gallo RL, 2012, NAT REV IMMUNOL, V12, P503, DOI 10.1038/nri3228; Handley SA, 2016, CELL HOST MICROBE, V19, P323, DOI 10.1016/j.chom.2016.02.010; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; HUME DA, 1984, ANAT REC, V210, P503, DOI 10.1002/ar.1092100311; Hunter MM, 2010, GASTROENTEROLOGY, V138, P1395, DOI 10.1053/j.gastro.2009.12.041; Ifergan I, 2011, ANN NEUROL, V70, P751, DOI 10.1002/ana.22519; Isidro RA, 2016, AM J PHYSIOL-GASTR L, V311, pG59, DOI 10.1152/ajpgi.00123.2016; Jennewein C, 2015, AM J RESP CELL MOL, V53, P656, DOI 10.1165/rcmb.2014-0354OC; Ji J, 2016, SCI REP-UK, V6, DOI 10.1038/srep24838; Kaufmann SHE, 2016, IMMUNITY, V44, P476, DOI 10.1016/j.immuni.2016.02.014; Kim TS, 2019, AUTOPHAGY, V15, P1356, DOI 10.1080/15548627.2019.1582743; Kny M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216987; Kostic AD, 2014, GASTROENTEROLOGY, V146, P1489, DOI 10.1053/j.gastro.2014.02.009; Le H, 2017, MOL NEUROBIOL, V54, P7353, DOI 10.1007/s12035-016-0207-6; Lee HJ, 2009, CELL DEATH DIFFER, V16, P1395, DOI 10.1038/cdd.2009.78; Levy M, 2017, NAT REV IMMUNOL, V17, P219, DOI 10.1038/nri.2017.7; Li G, 2019, AGING-US, V11, P8526, DOI 10.18632/aging.102336; Li L, 2015, CELL DEATH DIFFER, V22, P1081, DOI 10.1038/cdd.2014.212; Lin YL, 2014, CELL MOL IMMUNOL, V11, P355, DOI 10.1038/cmi.2014.15; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; Mengaud J, 1996, CELL, V84, P923, DOI 10.1016/S0092-8674(00)81070-3; MOOLENBEEK C, 1981, LAB ANIM, V15, P57, DOI 10.1258/002367781780958577; Mottawea W, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13419; Na YR, 2019, NAT REV GASTRO HEPAT, V16, P531, DOI 10.1038/s41575-019-0172-4; Nahon S, 2012, INFLAMM BOWEL DIS, V18, P2086, DOI 10.1002/ibd.22888; Nava GM, 2011, ISME J, V5, P627, DOI 10.1038/ismej.2010.161; Postler TS, 2017, CELL METAB, V26, P110, DOI 10.1016/j.cmet.2017.05.008; RELMAN D, 1990, CELL, V61, P1375, DOI 10.1016/0092-8674(90)90701-F; Robertson SJ, 2018, TRENDS IMMUNOL, V39, P992, DOI 10.1016/j.it.2018.10.004; Roszer T, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/816460; Schmitter T, 2004, J EXP MED, V199, P35, DOI 10.1084/jem.20030204; Shin MW, 2016, INT J ONCOL, V48, P821, DOI 10.3892/ijo.2015.3296; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Siegmund B, 2001, P NATL ACAD SCI USA, V98, P13249, DOI 10.1073/pnas.231473998; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Tang C, 2018, NAT IMMUNOL, V19, P755, DOI 10.1038/s41590-018-0134-y; Thevaranjan N, 2018, CELL HOST MICROBE, V23, P570, DOI 10.1016/j.chom.2018.03.006; Tye H, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06125-0; Walters WA, 2014, FEBS LETT, V588, P4223, DOI 10.1016/j.febslet.2014.09.039; Wang JJ, 2017, CELL SIGNAL, V35, P231, DOI 10.1016/j.cellsig.2017.04.011; Woo JK, 2016, ONCOTARGET, V7, P29592, DOI 10.18632/oncotarget.9020; Yang HJ, 2017, P NATL ACAD SCI USA, V114, P11500, DOI 10.1073/pnas.1711814114; Zeng MY, 2017, MUCOSAL IMMUNOL, V10, P18, DOI 10.1038/mi.2016.75; Zhou X, 2019, CELL REP, V27, P1176, DOI 10.1016/j.celrep.2019.03.028	62	9	9	3	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8702	8720		10.1096/fj.201902753R	http://dx.doi.org/10.1096/fj.201902753R		MAY 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32385864				2022-12-28	WOS:000532122000001
J	Lee, YJ; Ting, WH; Yang, YW; Lin, CJ; Hsieh, YT; Huang, CY; Lo, FS; Chu, CC; Lin, CL; Lin, WS; Lai, TS				Lee, Yann-Jinn; Ting, Wei-Hsin; Yang, Yi-Wen; Lin, Cheng-Jui; Hsieh, Yu-Ting; Huang, Chi-Yu; Lo, Fu-Sung; Chu, Chen-Chung; Lin, Chiung-Ling; Lin, Wen-Shan; Lai, Thung-S.			HLA-DQ genotype and biochemical characterization of anti-transglutaminase 2 antibodies in patients with type 1 diabetes mellitus in Taiwan	FASEB JOURNAL			English	Article						autoantibodies; celiac disease; Gliadin; Gluten; HLA-DQB1 genotyping; transglutaminase 2	CELIAC-DISEASE; TISSUE TRANSGLUTAMINASE; AUTOANTIBODIES; BINDING; RISK; PREVALENCE; GENETICS; DOMAINS; SURFACE	Human Leukocyte Antigen (HLA)-DQ2 and HLA-DQ8 are genetic risk factors for Type 1 Diabetes Mellitus (T1DM) and Celiac disease (CD) in Caucasians, but their association with Taiwanese Han population is unknown. We screened 532 Taiwanese T1DM patients for CD biomarkers including anti-tissue transglutaminase (TGM2), anti-gliadin and anti-neoepitope antibodies (Abs), sequencing DQB1 genotypes, and characterized the TGM2 Abs. We report that 3.76% of Taiwanese patients had TGM2-Abs and all had no CD's symptoms. In contrast to Caucasian's CD patients, DQ2/DQ8 only constituted 4/5 of TGM2-Abs positive patients, while the other 1/5 patients belonged to different HLA genotypes. Either anti-gliadin or anti-neoepitope Abs coexisted with 3/4 of TGM2-Abs positive patients that were likely due to gluten-ingestion, while the cause of TGM2-Abs production for other 1/4 of patients was unknown. Purified anti-TGM2 IgA (TGA) and anti-TGM2 IgG (TGG) could bind on endothelial cells surface, recognized native better than denatured forms of TGM2, and TGA inhibited TGM2's transamidation activity by up to 80% but TGG had no effects. Epitope mapping of all TGM2-Abs positive sera demonstrated that TGM2-Abs had heterogeneity in specificities. This is the first study on the differences between Taiwanese Han group and Caucasian in HLA genotypes and properties of TGM2-Abs.	[Lee, Yann-Jinn; Yang, Yi-Wen; Hsieh, Yu-Ting; Lai, Thung-S.] MacKay Med Coll, Inst Biomed Sci, New Taipei, Taiwan; [Lee, Yann-Jinn; Ting, Wei-Hsin; Huang, Chi-Yu] MaKkay Med Coll, Dept Med, New Taipei, Taiwan; [Lee, Yann-Jinn; Ting, Wei-Hsin; Huang, Chi-Yu] MacKay Childrens Hosp, Dept Pediat Endocrinol, Taipei, Taiwan; [Lee, Yann-Jinn; Chu, Chen-Chung; Lin, Chiung-Ling; Lin, Wen-Shan] MacKay Mem Hosp Tamsui Dist, Dept Med Res, New Taipei, Taiwan; [Lee, Yann-Jinn] Taipei Med Univ, Sch Med, Dept Pediat, Coll Med, Taipei, Taiwan; [Ting, Wei-Hsin; Lin, Cheng-Jui; Huang, Chi-Yu] MacKay Jr Coll Med Nursing & Management, Taipei, Taiwan; [Lin, Cheng-Jui] Mackay Mem Hosp, Div Nephrol, Dept Internal Med, Taipei, Taiwan; [Hsieh, Yu-Ting] MacKay Mem Hosp, Dept Clin Lab, Taipei, Taiwan; [Lo, Fu-Sung] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Lo, Fu-Sung] Chang Gung Mem Hosp, Dept Pediat, Taoyuan, Taiwan	Mackay Medical College; Taipei Medical University; Mackay Junior College of Medicine, Nursing & Management; Mackay Memorial Hospital; Mackay Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital	Lai, TS (corresponding author), MacKay Med Coll, Inst Biomed Sci, New Taipei, Taiwan.	lai00002@mmc.edu.tw			MacKay Memorial Hospital [MMH104, MMH105, MMH106, MMH E-105-07]; MacKay Medical College [1022D03, 1012A08, 1041B14, 1041C01]	MacKay Memorial Hospital; MacKay Medical College	MacKay Memorial Hospital, Grant/Award Number: MMH104, MMH105, MMH106 and MMH E-105-07; MacKay Medical College, Grant/Award Number: 1022D03, 1012A08, 1041B14 and 1041C01	Abadie V, 2011, ANNU REV IMMUNOL, V29, P493, DOI 10.1146/annurev-immunol-040210-092915; American Diabetes Association, 2020, Diabetes Care, V43, pS163, DOI 10.2337/dc20-S013; Araya M, 2015, NUTRIENTS, V7, P4955, DOI 10.3390/nu7064955; Bao F, 1999, J AUTOIMMUN, V13, P143, DOI 10.1006/jaut.1999.0303; Bodd M, 2012, HUM IMMUNOL, V73, P376, DOI 10.1016/j.humimm.2012.01.016; Byrne G, 2007, GUT, V56, P336, DOI 10.1136/gut.2006.092908; Caputo I, 2009, AMINO ACIDS, V36, P693, DOI 10.1007/s00726-008-0120-z; Cardoso I, 2017, AMINO ACIDS, V49, P489, DOI 10.1007/s00726-016-2296-y; Cardoso I, 2015, FEBS J, V282, P2063, DOI 10.1111/febs.13276; Choung RS, 2019, GASTROENTEROLOGY, V156, P582, DOI 10.1053/j.gastro.2018.10.025; Ciclitira Paul J., 2005, Molecular Aspects of Medicine, V26, P421, DOI 10.1016/j.mam.2005.05.001; Comerford R, 2012, J PEDIATR GASTR NUTR, V55, P445, DOI 10.1097/MPG.0b013e318251419f; Datta S, 2007, BIOCHEMISTRY-US, V46, P14819, DOI 10.1021/bi701422h; DeMelo EN, 2015, CAN J DIABETES, V39, P513, DOI 10.1016/j.jcjd.2015.06.006; Dieterich W, 2003, GUT, V52, P1562, DOI 10.1136/gut.52.11.1562; Esposito C, 2002, GUT, V51, P177, DOI 10.1136/gut.51.2.177; Fasano A, 2003, ARCH INTERN MED, V163, P286, DOI 10.1001/archinte.163.3.286; Ferrara F, 2010, CLIN EXP IMMUNOL, V159, P217, DOI 10.1111/j.1365-2249.2009.04054.x; Fesus L, 2002, TRENDS BIOCHEM SCI, V27, P534, DOI 10.1016/S0968-0004(02)02182-5; Halttunen T, 1999, GASTROENTEROLOGY, V116, P566, DOI 10.1016/S0016-5085(99)70178-2; Iversen R, 2013, J IMMUNOL, V190, P5981, DOI 10.4049/jimmunol.1300183; Jabs A, 1999, J MOL BIOL, V286, P291, DOI 10.1006/jmbi.1998.2459; Karell K, 2003, HUM IMMUNOL, V64, P469, DOI 10.1016/S0198-8859(03)00027-2; Kiraly R, 2008, DOCTOR PHILOS, P1; Kurppa K, 2014, GASTROENTEROLOGY, V147, P610, DOI 10.1053/j.gastro.2014.05.003; Lai TS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16342-0; Lai TS, 2017, AMINO ACIDS, V49, P501, DOI 10.1007/s00726-016-2270-8; Lai TS, 2013, FRONT BIOSCI-LANDMRK, V18, P504, DOI 10.2741/4117; Lai TS, 1996, J BIOL CHEM, V271, P31191, DOI 10.1074/jbc.271.49.31191; Lebwohl B, 2018, LANCET, V391, P70, DOI 10.1016/S0140-6736(17)31796-8; Lerner A, 2016, J IMMUNOL METHODS, V429, P15, DOI 10.1016/j.jim.2015.12.006; LIBLAU RS, 1992, APMIS, V100, P709, DOI 10.1111/j.1699-0463.1992.tb03988.x; Liu E, 2014, NEW ENGL J MED, V371, P42, DOI 10.1056/NEJMoa1313977; Liu SP, 2002, P NATL ACAD SCI USA, V99, P2743, DOI 10.1073/pnas.042454899; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Lundin KEA, 2015, NAT REV GASTRO HEPAT, V12, P507, DOI 10.1038/nrgastro.2015.136; McConoughey SJ, 2010, EMBO MOL MED, V2, P349, DOI 10.1002/emmm.201000084; Monsuur AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002270; Moustakas AK, 2000, INT IMMUNOL, V12, P1157, DOI 10.1093/intimm/12.8.1157; Myrsky E, 2008, CLIN EXP IMMUNOL, V152, P111, DOI 10.1111/j.1365-2249.2008.03600.x; Peracchi M, 2002, AM J GASTROENTEROL, V97, P2850; Pinkas DM, 2007, PLOS BIOL, V5, P2788, DOI 10.1371/journal.pbio.0050327; Rauhavirta Tiina, 2019, Clin Rev Allergy Immunol, V57, P23, DOI 10.1007/s12016-016-8557-4; Seissler J, 2001, CLIN EXP IMMUNOL, V125, P216, DOI 10.1046/j.1365-2249.2001.01584.x; Simon-Vecsei Z, 2012, P NATL ACAD SCI USA, V109, P431, DOI 10.1073/pnas.1107811108; SLAUGHTER TF, 1992, ANAL BIOCHEM, V205, P166, DOI 10.1016/0003-2697(92)90594-W; Sollid LM, 2005, CLIN GASTROENTEROL H, V3, P843, DOI 10.1016/S1542-3565(05)00532-X; Tinto N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138324; TODD JA, 1987, NATURE, V329, P599, DOI 10.1038/329599a0; Wang HL, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001779	50	2	2	2	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8459	8474		10.1096/fj.202000269R	http://dx.doi.org/10.1096/fj.202000269R		MAY 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32362042	hybrid			2022-12-28	WOS:000530050400001
J	Roche, JA; Roche, R				Roche, Joseph A.; Roche, Renuka			A hypothesized role for dysregulated bradykinin signaling in COVID-19 respiratory complications	FASEB JOURNAL			English	Article						bradykinin; bradykinin receptor; coronavirus; icatibant; inflammation; injury	B-2 RECEPTOR ANTAGONIST; ENZYME 2 ACE2; HEREDITARY ANGIOEDEMA; ICATIBANT; INHIBITORS; HYPERRESPONSIVENESS; EOSINOPHILIA; ATTACKS; CELLS; TRIAL	As of April 20, 2020, over time, the COVID-19 pandemic has resulted in 157 970 deaths out of 2 319 066 confirmed cases, at a Case Fatality Rate of similar to 6.8%. With the pandemic rapidly spreading, and health delivery systems being overwhelmed, it is imperative that safe and effective pharmacotherapeutic strategies are rapidly explored to improve survival. In this paper, we use established and emerging evidence to propose a testable hypothesis that, a vicious positive feedback loop of des-Arg(9)-bradykinin- and bradykinin-mediated inflammation -> injury -> inflammation, likely precipitates life threatening respiratory complications in COVID-19. Through our hypothesis, we make the prediction that the FDA-approved molecule, icatibant, might be able to interrupt this feedback loop and, thereby, improve the clinical outcomes. This hypothesis could lead to basic, translational, and clinical studies aimed at reducing COVID-19 morbidity and mortality.	[Roche, Joseph A.] Wayne State Univ, Eugene Applebaum Coll Pharm & Hlth Sci, 259 Mack Ave, Detroit, MI 48201 USA; [Roche, Renuka] Eastern Michigan Univ, Coll Hlth & Human Serv, Ypsilanti, MI 48197 USA	Wayne State University; Eastern Michigan University	Roche, JA (corresponding author), Wayne State Univ, Eugene Applebaum Coll Pharm & Hlth Sci, 259 Mack Ave, Detroit, MI 48201 USA.	joseph.roche@wayne.edu			Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University	Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University	Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University (EACPHS, WSU)	Al-Shamlan F, 2019, RESP RES, V20, DOI 10.1186/s12931-019-1060-8; Allen TC, 2014, ARCH PATHOL LAB MED, V138, P266, DOI 10.5858/arpa.2013-0182-RA; American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS), 2020, COVID 19 AN REP TOOL, V2020; Bas M, 2015, NEW ENGL J MED, V372, P418, DOI 10.1056/NEJMoa1312524; Bhatraju PK, 2020, NEW ENGL J MED, V382, P2012, DOI 10.1056/NEJMoa2004500; Breil I, 1997, ACTA PHYSIOL SCAND, V159, P189, DOI 10.1046/j.1365-201X.1997.549324000.x; Brown NJ, 1996, CLIN PHARMACOL THER, V60, P8, DOI 10.1016/S0009-9236(96)90161-7; Cabrini DA, 1997, EUR J PHARMACOL, V331, P31, DOI 10.1016/S0014-2999(97)01010-8; Cadnapaphornchai MA, 2004, AM J PHYSIOL-RENAL, V286, pF875, DOI 10.1152/ajprenal.00243.2003; Charignon D, 2012, EXPERT OPIN PHARMACO, V13, P2233, DOI 10.1517/14656566.2012.723692; Chen J, 2010, J VIROL, V84, P1289, DOI 10.1128/JVI.01281-09; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Copaken D, 2020, MY WHOLE HOUSEHOLD H, V2020; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Duchene J, 2009, CURR OPIN PHARMACOL, V9, P125, DOI 10.1016/j.coph.2008.11.011; Farkas H, 2011, CLIN COSMET INVESTI, V4, P61, DOI 10.2147/CCID.S10322; FARMER SG, 1992, BRIT J PHARMACOL, V107, P653, DOI 10.1111/j.1476-5381.1992.tb14502.x; Fung TS, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00296; Gainer JV, 1996, J ALLERGY CLIN IMMUN, V98, P283, DOI 10.1016/S0091-6749(96)70151-3; Gane SB, 2020, RHINOLOGY, V58, P299, DOI 10.4193/Rhin20.114; GAVRAS I, 1992, KIDNEY INT, V42, P1020, DOI 10.1038/ki.1992.383; Gibbs CR, 1999, BRIT J CLIN PHARMACO, V48, P861; Giwa Al, 2020, Emerg Med Pract, V22, P1; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Hudey SN, 2017, J ALLER CL IMM-PRACT, V5, P610, DOI 10.1016/j.jaip.2017.03.017; Ingelheim B, 2014, SAFETY TOLERABILITY; Ingelheim B, 2010, SAFETY TOLERABILITY; Jia HP, 2016, SHOCK, V46, P239, DOI 10.1097/SHK.0000000000000633; Johns Hopkins University and Medicine, 2020, RAC DAT TRANSP STAT, V2020; Krahling V, 2009, J VIROL, V83, P2298, DOI 10.1128/JVI.01245-08; Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267; Leeb-Lundberg LMF, 2005, PHARMACOL REV, V57, P27, DOI 10.1124/pr.57.1.2; Lim Yvonne Xinyi, 2016, Diseases, V4, DOI 10.3390/diseases4030026; Lumry WR, 2011, ANN ALLERG ASTHMA IM, V107, P529, DOI 10.1016/j.anai.2011.08.015; Maas C, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02046; Manolis AJ, 2010, HYPERTENS RES, V33, P772, DOI 10.1038/hr.2010.82; Mo P., 2020, CLIN INFECT DIS, DOI [10.1093/cid/ciaa270, DOI 10.1093/CID/CIAA270]; Molinaro G, 2006, KIDNEY INT, V70, P1823, DOI 10.1038/sj.ki.5001873; Molinaro G, 2002, J PHARMACOL EXP THER, V303, P232, DOI 10.1124/jpet.102.038067; Moreau ME, 2005, J PHARMACOL SCI, V99, P6, DOI 10.1254/jphs.SRJ05001X; Murray J, 2020, THIS REALLY HURTS MA, V2020; Murugesan P, 2016, J INFECT DIS, V213, P532, DOI 10.1093/infdis/jiv426; NEILDWYER G, 1989, J HUM HYPERTENS, V3, P169; Perricone C, 2011, ALLERGY, V66, P149, DOI 10.1111/j.1398-9995.2010.02453.x; RHALEB NE, 1992, EUR J PHARMACOL, V210, P115, DOI 10.1016/0014-2999(92)90661-M; Saule C, 2013, CLIN EXP ALLERGY, V43, P475, DOI 10.1111/cea.12055; Shafiq A, 2020, INT J BREAST CANCER, V2020, DOI 10.1155/2020/4824813; Sodhi CP, 2018, AM J PHYSIOL-LUNG C, V314, pL17, DOI 10.1152/ajplung.00498.2016; Tom B, 2002, BRIT J PHARMACOL, V137, P276, DOI 10.1038/sj.bjp.0704862; Turner P, 2001, J ALLERGY CLIN IMMUN, V107, P105, DOI 10.1067/mai.2001.111145; Walter LA, 2020, WEST J EMERG MED, V21, P507, DOI 10.5811/westjem.2020.4.47536; Wan YS, 2020, J VIROL, V94, DOI 10.1128/JVI.02015-19; Wang DW, 2020, J COASTAL RES, P1, DOI [10.2112/JCR-SI109-001.1, 10.1001/jama.2020.1585]; Woodard-Grice AV, 2010, PHARMACOGENET GENOM, V20, P532, DOI 10.1097/FPC.0b013e32833d3acb; World Health Organization (WHO), 2020, WHO HLTH EM DASHB WH, V2020; World Health Organization (WHO), OFF LAB US MED COVID, V2020; Yan CH, 2020, INT FORUM ALLERGY RH, V10, P806, DOI 10.1002/alr.22579; Yancy CW, 2020, JAMA-J AM MED ASSOC, V323, P1891, DOI 10.1001/jama.2020.6548; Yeung YS, 2008, VIROLOGY, V371, P32, DOI 10.1016/j.virol.2007.09.016; Zanichelli A, 2017, ALLERGY, V72, P994, DOI 10.1111/all.13103	60	79	79	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					7265	7269		10.1096/fj.202000967	http://dx.doi.org/10.1096/fj.202000967		MAY 2020	5	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32359101	Green Published			2022-12-28	WOS:000530047600001
J	Googins, MR; Woghiren-Afegbua, AO; Calderon, M; St Croix, CM; Kiselyov, KI; VanDemark, AP				Googins, Matthew R.; Woghiren-Afegbua, Aigbirhemwen O.; Calderon, Michael; St Croix, Claudette M.; Kiselyov, Kirill I.; VanDemark, Andrew P.			Structural and functional divergence of GDAP1 from the glutathione S-transferase superfamily	FASEB JOURNAL			English	Article						ganglioside-induced differentiation-associated protein 1; mitochondria; oxidative stress; structural biology; X-ray crystallography	MARIE-TOOTH-DISEASE; DIFFERENTIATION-ASSOCIATED PROTEIN-1; PI CLASS GLUTATHIONE; ETHACRYNIC-ACID; 3-DIMENSIONAL STRUCTURE; THERMODYNAMIC ANALYSIS; I-TASSER; BINDING; GENE; P1-1	Mutations in ganglioside-induced differentiation-associated protein 1 (GDAP1) alter mitochondrial morphology and result in several subtypes of the inherited peripheral neuropathy Charcot-Marie-Tooth disease; however, the mechanism by which GDAP1 functions has remained elusive. GDAP1 contains primary sequence homology to the GST superfamily; however, the question of whether GDAP1 is an active GST has not been clearly resolved. Here, we present biochemical evidence, suggesting that GDAP1 has lost the ability to bind glutathione without a loss of substrate binding activity. We have revealed that the alpha-loop, located within the H-site motif is the primary determinant for substrate binding. Using structural data of GDAP1, we have found that critical residues and configurations in the G-site which canonically interact with glutathione are altered in GDAP1, rendering it incapable of binding glutathione. Last, we have found that the overexpression of GDAP1 in HeLa cells results in a mitochondrial phenotype which is distinct from oxidative stress-induced mitochondrial fragmentation. This phenotype is dependent on the presence of the transmembrane domain, as well as a unique hydrophobic domain that is not found in canonical GSTs. Together, we data point toward a non-enzymatic role for GDAP1, such as a sensor or receptor.	[Googins, Matthew R.; Woghiren-Afegbua, Aigbirhemwen O.; Kiselyov, Kirill I.; VanDemark, Andrew P.] Univ Pittsburgh, Dept Biol Sci, 4249 Fifth Ave, Pittsburgh, PA 15260 USA; [Calderon, Michael; St Croix, Claudette M.] Univ Pittsburgh, Ctr Biol Imaging, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	VanDemark, AP (corresponding author), Univ Pittsburgh, Dept Biol Sci, 4249 Fifth Ave, Pittsburgh, PA 15260 USA.	andyv@pitt.edu	St Croix, Claudette/AAA-3338-2022	Kiselyov, Kirill/0000-0001-6683-2895; VanDemark, Andrew/0000-0003-3424-4831	NIH HHS [S10 OD021540] Funding Source: Medline; NINDS NIH HHS [R21 NS094860] Funding Source: Medline; HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS) [NS094860] Funding Source: Medline; HHS | NIH | NIH Office of the Director (OD) [1S10OD021540] Funding Source: Medline	NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS); HHS | NIH | NIH Office of the Director (OD)		Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andujar-Sanchez M, 2005, BIOCHEMISTRY-US, V44, P1174, DOI 10.1021/bi0483110; Barneo-Munoz M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005115; Baxter RV, 2002, NAT GENET, V30, P21, DOI 10.1038/ng796; CAMERON AD, 1995, STRUCTURE, V3, P717, DOI 10.1016/S0969-2126(01)00206-4; Cassereau J, 2011, EXP NEUROL, V227, P31, DOI 10.1016/j.expneurol.2010.09.006; Claramunt R, 2005, J MED GENET, V42, P358, DOI 10.1136/jmg.2004.022178; Coblentz J, 2014, BIOCHEM J, V457, P361, DOI 10.1042/BJ20130647; Cuesta A, 2002, NAT GENET, V30, P22, DOI 10.1038/ng798; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Estela A, 2011, J BIOL CHEM, V286, P36777, DOI 10.1074/jbc.M111.260042; Gonzalez-Sanchez P, 2017, SCI REP-UK, V7, DOI 10.1038/srep42993; Grahn E, 2006, ACTA CRYSTALLOGR D, V62, P197, DOI 10.1107/S0907444905039296; Hauck AK, 2016, J LIPID RES, V57, P1976, DOI 10.1194/jlr.R066597; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Hayes JD, 1998, CHEM-BIOL INTERACT, V112, P51, DOI 10.1016/S0009-2797(97)00151-8; Helmich KE, 2016, J BIOL CHEM, V291, P5234, DOI 10.1074/jbc.M115.694307; Huber N, 2016, SCI REP-UK, V6, DOI 10.1038/srep36930; Huber N, 2013, EMBO REP, V14, P545, DOI 10.1038/embor.2013.56; Juarez P, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/171636; Kazamel M, 2015, J NEUROL, V262, P801, DOI 10.1007/s00415-014-7490-9; KOONIN EV, 1994, PROTEIN SCI, V3, P2045, DOI 10.1002/pro.5560031117; Kukic I, 2013, BIOCHEM J, V451, P155, DOI 10.1042/BJ20121506; Laura M, 2019, CURR OPIN NEUROL, V32, P641, DOI 10.1097/WCO.0000000000000735; Marco A, 2004, MOL BIOL EVOL, V21, P176, DOI 10.1093/molbev/msh013; Martin AM, 2015, COLOMB MEDICA, V46, P194; Moreau NG, 2012, GAIT POSTURE, V35, P154, DOI 10.1016/j.gaitpost.2011.08.027; Murphy SM, 2012, J NEUROL NEUROSUR PS, V83, P706, DOI 10.1136/jnnp-2012-302451; Niemann A, 2005, J CELL BIOL, V170, P1067, DOI 10.1083/jcb.200507087; Niemann A, 2014, BRAIN, V137, P668, DOI 10.1093/brain/awt371; Niemann A, 2009, NEUROBIOL DIS, V36, P509, DOI 10.1016/j.nbd.2009.09.011; Noack R, 2012, HUM MOL GENET, V21, P150, DOI 10.1093/hmg/ddr450; Oakley A, 2011, DRUG METAB REV, V43, P138, DOI 10.3109/03602532.2011.558093; Oakley AJ, 1997, BIOCHEMISTRY-US, V36, P576, DOI 10.1021/bi962316i; Oakley AJ, 1997, FEBS LETT, V419, P32, DOI 10.1016/S0014-5793(97)01424-5; Ortiz-Salmeron E, 2003, J BIOL CHEM, V278, P46938, DOI 10.1074/jbc.M305043200; Ortiz-Salmeron E, 2001, BBA-PROTEIN STRUCT M, V1548, P106, DOI 10.1016/S0167-4838(01)00224-2; Ortiz-Salmeron E, 2001, EUR J BIOCHEM, V268, P4307, DOI 10.1046/j.1432-1327.2001.02349.x; Pakhrin PS, 2018, J NEUROL, V265, P637, DOI 10.1007/s00415-018-8743-9; Pedrola L, 2005, HUM MOL GENET, V14, P1087, DOI 10.1093/hmg/ddi121; Pedrola L, 2008, J CELL MOL MED, V12, P679, DOI 10.1111/j.1582-4934.2007.00158.x; Pla-Martin D, 2013, NEUROBIOL DIS, V55, P140, DOI 10.1016/j.nbd.2013.03.010; Quesada-Soriano I, 2011, J MOL RECOGNIT, V24, P220, DOI 10.1002/jmr.1040; Quesada-Soriano I, 2009, PROTEIN SCI, V18, P2454, DOI 10.1002/pro.253; REINEMER P, 1991, EMBO J, V10, P1997, DOI 10.1002/j.1460-2075.1991.tb07729.x; Rossor AM, 2016, MUSCLE NERVE, V53, P972, DOI 10.1002/mus.25124; Rossor AM, 2013, NAT REV NEUROL, V9, P562, DOI 10.1038/nrneurol.2013.179; Rzepnikowska W, 2018, ACTA NEUROBIOL EXP, V78, P1, DOI 10.21307/ane-2018-002; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Senderek J, 2003, BRAIN, V126, P642, DOI 10.1093/brain/awg068; Shield AJ, 2006, BIOCHEM BIOPH RES CO, V347, P859, DOI 10.1016/j.bbrc.2006.06.189; Sivera R, 2013, NEUROLOGY, V81, P1617, DOI 10.1212/WNL.0b013e3182a9f56a; Sivera R, 2010, J PERIPHER NERV SYST, V15, P334, DOI 10.1111/j.1529-8027.2010.00286.x; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tian MY, 2012, PLANT J, V72, P1027, DOI 10.1111/tpj.12016; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Wagner KM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005160; Yang JY, 2016, PROTEINS, V84, P233, DOI 10.1002/prot.24918; Yang Jianyi, 2015, Curr Protoc Bioinformatics, V52, DOI 10.1002/0471250953.bi0508s52; Yang JY, 2015, NUCLEIC ACIDS RES, V43, pW174, DOI 10.1093/nar/gkv342; Zis P, 2017, J PERIPHER NERV SYST, V22, P224, DOI 10.1111/jns.12222	61	6	6	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					7192	7207		10.1096/fj.202000110R	http://dx.doi.org/10.1096/fj.202000110R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32274853	Green Accepted			2022-12-28	WOS:000531325500080
J	Shen, Y; Liu, WW; Zhang, X; Shi, JG; Jiang, S; Zheng, LS; Qin, Y; Liu, B; Shi, JH				Shen, Yang; Liu, Wen-wen; Zhang, Xiu; Shi, Jian-guo; Jiang, Shan; Zheng, Lishuang; Qin, Yan; Liu, Bin; Shi, Jian-hong			TRAF3 promotes ROS production and pyroptosis by targeting ULK1 ubiquitination in macrophages	FASEB JOURNAL			English	Article						cell death; inflammasome; macrophages; mitochondrial; reactive oxygen species	KAPPA-B; INFLAMMASOME ACTIVATION; KINASE; MITOCHONDRIA; STIMULATION; COMPLEX	Disrupted mitochondrial function and reactive oxygen species (ROS) generation cause cellular damage and oxidative stress-induced macrophage inflammatory cell death. It remains unclear how mitochondrial dysfunction relates to inflammasome activation and pyroptotic cell death. In this study, we demonstrated that tumor necrosis factor receptor-associated factor 3 (TRAF3) regulates mitochondrial ROS production and promotes TLR agonist LPS plus nigericin (LPS/Ng)-induced inflammasome and pyroptosis in mouse primary macrophages and human monocyte THP-1 cells. Co-IP assays confirmed that TRAF3 forms a complex with TRAF2 and cIAP1 and mediates ubiquitin and degradation of Unc-51 like autophagy activating kinase 1 (ULK1). Moreover, knockdown of ULK1 in THP-1 cells significantly promoted LPS/Ng-induced inflammasome by activating caspase 1 and mature IL-1 beta. Apoptosis inducing factor (AIF) translocation from mitochondrial to nuclear was observed in ULK1-deficient THP-1 cells under LPS/Ng stimulation, which mediates LPS/Ng-induced cell death in ULK1 deficient macrophages. In conclusion, this study identified a novel role of TRAF3 in regulation of ULK1 ubiquitination and inflammasome signaling and provided molecular mechanisms by which ubiquitination of ULK1 controls mitochondrial ROS production, inflammasome activity, and AIF-dependent pyroptosis.	[Shen, Yang; Liu, Wen-wen; Zhang, Xiu; Jiang, Shan; Zheng, Lishuang; Qin, Yan; Liu, Bin; Shi, Jian-hong] Hebei Univ, Hebei Key Lab Canc Radiotherapy & Chemotherapy, Affiliated Hosp, Cent Lab, 212 Yuhua East Rd, Baoding 071000, Peoples R China; [Shi, Jian-guo] Chinese Peoples Liberat Army, Dept Urinary Surg, Army Hosp 82, Baoding, Peoples R China	Hebei University	Shi, JH (corresponding author), Hebei Univ, Hebei Key Lab Canc Radiotherapy & Chemotherapy, Affiliated Hosp, Cent Lab, 212 Yuhua East Rd, Baoding 071000, Peoples R China.	shijianhong@hbu.edu.cn	Shi, Jian-hong/AAP-5703-2021; Shi, Jian-hong/AAF-6078-2019	Shi, Jian-hong/0000-0003-2232-1000; 				Adam C, 2017, J INVEST DERMATOL, V137, P367, DOI 10.1016/j.jid.2016.10.003; Back M, 2019, NAT REV CARDIOL, V16, P389, DOI 10.1038/s41569-019-0169-2; Canli O, 2017, CANCER CELL, V32, P869, DOI 10.1016/j.ccell.2017.11.004; Daskalaki MG, 2019, MAR DRUGS, V17, DOI 10.3390/md17020097; Delavallee L, 2011, IUBMB LIFE, V63, P221, DOI 10.1002/iub.432; Dewaele M, 2010, AUTOPHAGY, V6, P838, DOI 10.4161/auto.6.7.12113; El-Kenawi A, 2017, CANCER CELL, V32, P727, DOI 10.1016/j.ccell.2017.11.015; Fujita K, 2019, J CLIN MED, V8, DOI 10.3390/jcm8020201; Guan K, 2015, J IMMUNOL, V194, P4880, DOI 10.4049/jimmunol.1402851; Guven-Maiorov E, 2016, BBA-GEN SUBJECTS, V1860, P2646, DOI 10.1016/j.bbagen.2016.05.021; Harris J, 2018, MITOCHONDRION, V41, P2, DOI 10.1016/j.mito.2017.10.009; Hine AM, 2019, J IMMUNOL, V203, P593, DOI 10.4049/jimmunol.1900345; Immanuel CN, 2019, AM J PHYSIOL-LUNG C, V316, pL418, DOI 10.1152/ajplung.00199.2018; Jin J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6930; Banos-Hernandez CJ, 2019, CLIN RHEUMATOL, V38, P1643, DOI 10.1007/s10067-019-04459-8; Joshi A, 2016, CELL DEATH DIFFER, V23, P216, DOI 10.1038/cdd.2015.88; Korzenik J, 2019, ALIMENT PHARM THER, V50, P289, DOI 10.1111/apt.15370; Li CG, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01409; Li XM, 2002, NATURE, V416, P345, DOI 10.1038/416345a; Liao GX, 2004, J BIOL CHEM, V279, P26243, DOI 10.1074/jbc.M403286200; Liu YT, 2018, INT J ONCOL, V53, P1332, DOI 10.3892/ijo.2018.4463; Mascarenhas DPA, 2019, METHODS MOL BIOL, V1921, P305, DOI 10.1007/978-1-4939-9048-1_20; Matsuzawa A, 2005, NAT IMMUNOL, V6, P587, DOI 10.1038/ni1200; Miao EA, 2011, IMMUNOL REV, V243, P206, DOI 10.1111/j.1600-065X.2011.01044.x; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; O'Meara TR, 2018, MICROB CELL, V5, P566, DOI 10.15698/mic2018.12.662; O'Meara TR, 2018, MBIO, V9, DOI 10.1128/mBio.01581-18; Riestra AM, 2019, J INNATE IMMUN, V11, P86, DOI 10.1159/000493585; Ruan HH, 2016, BIOCHEM BIOPH RES CO, V478, P618, DOI 10.1016/j.bbrc.2016.07.116; Shi JH, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01849; Siu KL, 2019, FASEB J, V33, P8865, DOI 10.1096/fj.201802418R; Stefan-Lifshitz M, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.126663; Su Y, 2018, INFLAMMATION, V41, P1384, DOI 10.1007/s10753-018-0786-7; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Van Erp AC, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/7120962; Vargas JNS, 2019, MOL CELL, V74, P347, DOI 10.1016/j.molcel.2019.02.010; Wang JY, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007105; Wang YF, 2019, J MOL CELL BIOL, V11, P1069, DOI 10.1093/jmcb/mjz020; Wu WX, 2014, EMBO REP, V15, P566, DOI 10.1002/embr.201438501; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Xu MM, 2019, FREE RADICAL RES, V53, P780, DOI 10.1080/10715762.2019.1630735; Zachari M, 2017, ESSAYS BIOCHEM, V61, P585, DOI 10.1042/EBC20170021; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676; Zong X, 2019, J IMMUNOL, V202, P567, DOI 10.4049/jimmunol.1801151	44	16	16	6	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					7144	7159		10.1096/fj.201903073R	http://dx.doi.org/10.1096/fj.201903073R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32275117	hybrid			2022-12-28	WOS:000531325500077
J	Shimizu, A; Zankov, DP; Sato, A; Komeno, M; Toyoda, F; Yamazaki, S; Makita, T; Noda, T; Ikawa, M; Asano, Y; Miyashita, Y; Takashima, S; Morita, H; Ishikawa, T; Makita, N; Hitosugi, M; Matsuura, H; Ohno, S; Horie, M; Ogita, H				Shimizu, Akio; Zankov, Dimitar P.; Sato, Akira; Komeno, Masahiro; Toyoda, Futoshi; Yamazaki, Satoru; Makita, Toshinori; Noda, Taichi; Ikawa, Masahito; Asano, Yoshihiro; Miyashita, Yohei; Takashima, Seiji; Morita, Hiroshi; Ishikawa, Taisuke; Makita, Naomasa; Hitosugi, Masahito; Matsuura, Hiroshi; Ohno, Seiko; Horie, Minoru; Ogita, Hisakazu			Identification of transmembrane protein 168 mutation in familial Brugada syndrome	FASEB JOURNAL			English	Article						fatal ventricular arrhythmia; sodium channel; ubiquitination	SUDDEN CARDIAC DEATH; ST SEGMENT ELEVATION; READ ALIGNMENT; FRAMEWORK; CELLS; ABNORMALITIES; EPIDEMIOLOGY; GENETICS; INSIGHTS; AFADIN	Brugada syndrome (BrS) is an inherited channelopathy responsible for almost 20% of sudden cardiac deaths in patients with nonstructural cardiac diseases. Approximately 70% of BrS patients, the causative gene mutation(s) remains unknown. In this study, we used whole exome sequencing to investigate candidate mutations in a family clinically diagnosed with BrS. A heterozygous 1616G>A substitution (R539Q mutation) was identified in the transmembrane protein 168 (TMEM168) gene of symptomatic individuals. Similar to endogenous TMEM168, both TMEM168 wild-type (WT) and mutant proteins that were ectopically induced in HL-1 cells showed nuclear membrane localization. A significant decrease in Na+ current and Na(v)1.5 protein expression was observed in HL-1 cardiomyocytes expressing mutant TMEM168. Ventricular tachyarrhythmias and conduction disorders were induced in the heterozygous Tmem168 1616G>A knock-in mice by pharmacological stimulation, but not in WT mice. Na+ current was reduced in ventricular cardiomyocytes isolated from the Tmem168 knock-in heart, and Na(v)1.5 expression was also impaired. This impairment was dependent on increased Nedd4-2 binding to Na(v)1.5 and subsequent ubiquitination. Collectively, our results show an association between the TMEM168 1616G>A mutation and arrhythmogenesis in a family with BrS.	[Shimizu, Akio; Zankov, Dimitar P.; Sato, Akira; Komeno, Masahiro; Ogita, Hisakazu] Shiga Univ Med Sci, Dept Biochem & Mol Biol, Div Mol Med Biochem, Seta Tsukinowa Cho, Otsu, Shiga 5202192, Japan; [Zankov, Dimitar P.; Ohno, Seiko] Natl Cerebral & Cardiovasc Ctr, Dept Biosci & Genet, Suita, Osaka, Japan; [Toyoda, Futoshi; Matsuura, Hiroshi] Shiga Univ Med Sci, Dept Physiol, Div Cell Physiol, Otsu, Shiga, Japan; [Yamazaki, Satoru] Natl Cerebral & Cardiovasc Ctr, Dept Mol Pharmacol, Suita, Osaka, Japan; [Makita, Toshinori] Osaka Red Cross Hosp, Dept Cardiovasc Ctr, Div Cardiac Electrophysiol, Osaka, Japan; [Noda, Taichi; Ikawa, Masahito] Osaka Univ, Anim Resource Ctr Infect Dis, Res Inst Microbial Dis, Suita, Osaka, Japan; [Asano, Yoshihiro] Osaka Univ, Dept Cardiovasc Med, Grad Sch Med, Suita, Osaka, Japan; [Miyashita, Yohei] Osaka Univ, Dept Legal Med, Grad Sch Med, Suita, Osaka, Japan; [Takashima, Seiji] Osaka Univ, Dept Med Biochem, Grad Sch Med, Suita, Osaka, Japan; [Morita, Hiroshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cardiovasc Therapeut, Okayama, Japan; [Ishikawa, Taisuke; Makita, Naomasa] Natl Cerebral & Cardiovasc Ctr, Omics Res Ctr, Suita, Osaka, Japan; [Hitosugi, Masahito] Shiga Univ Med Sci, Dept Legal Med, Otsu, Shiga, Japan; [Ohno, Seiko; Horie, Minoru] Shiga Univ Med Sci, Ctr Epidemiol Res Asia, Otsu, Shiga, Japan	Shiga University of Medical Science; National Cerebral & Cardiovascular Center - Japan; Shiga University of Medical Science; National Cerebral & Cardiovascular Center - Japan; Osaka Red Cross Hospital; Osaka University; Osaka University; Osaka University; Osaka University; Okayama University; National Cerebral & Cardiovascular Center - Japan; Shiga University of Medical Science; Shiga University of Medical Science	Ogita, H (corresponding author), Shiga Univ Med Sci, Dept Biochem & Mol Biol, Div Mol Med Biochem, Seta Tsukinowa Cho, Otsu, Shiga 5202192, Japan.	hogita@belle.shiga-med.ac.jp	ikawa, masahito/A-5315-2009; Horie, Minoru/ABG-7128-2020; NODA, Taichi/K-1785-2018	ikawa, masahito/0000-0001-9859-6217; NODA, Taichi/0000-0003-0260-7861; Miyashita, Yohei/0000-0002-1739-4734; Ogita, Hisakazu/0000-0001-6750-1668				Ackerman MJ, 2011, HEART RHYTHM, V8, P1308, DOI [10.1016/j.hrthm.2011.05.020, 10.1093/europace/eur245]; Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; Aida T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0653-x; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Antzelevitch C, 2016, J ARRYTHM, V32, P315, DOI 10.1016/j.joa.2016.07.002; Baskin B, 2013, HUM GENET, V132, P1245, DOI 10.1007/s00439-013-1323-2; Boukens BJ, 2014, J PHYSIOL-LONDON, V592, P4613, DOI 10.1113/jphysiol.2014.279380; Brayson D, 2017, NUCLEUS-PHILA, V8, P17, DOI 10.1080/19491034.2016.1260798; BRUGADA P, 1992, J AM COLL CARDIOL, V20, P1391, DOI 10.1016/0735-1097(92)90253-J; Campuzano O, 2014, FORENSIC SCI INT, V245, P30, DOI 10.1016/j.forsciint.2014.10.004; Campuzano O, 2010, GENET MED, V12, P260, DOI 10.1097/GIM.0b013e3181d81636; Casini S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20205033; Chen QY, 1998, NATURE, V392, P293, DOI 10.1038/32675; Chockalingam Priya, 2014, Indian Heart J, V66 Suppl 1, pS49, DOI 10.1016/j.ihj.2013.11.008; Choi Y, 2015, BIOINFORMATICS, V31, P2745, DOI 10.1093/bioinformatics/btv195; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Cock PJA, 2010, NUCLEIC ACIDS RES, V38, P1767, DOI 10.1093/nar/gkp1137; Deo R, 2012, CIRCULATION, V125, P620, DOI 10.1161/CIRCULATIONAHA.111.023838; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Derangeon M, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00210; Fernandez-Falgueras A, 2017, BIOLOGY-BASEL, V6, DOI 10.3390/biology6010007; Gourraud JB, 2017, ARCH CARDIOVASC DIS, V110, P188, DOI 10.1016/j.acvd.2016.09.009; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Juang JMJ, 2016, J ARRYTHM, V32, P418, DOI 10.1016/j.joa.2016.07.012; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kuo CC, 2002, J GEN PHYSIOL, V120, P159, DOI 10.1085/jgp.20018536; Lang D, 2011, JOVE-J VIS EXP, DOI 10.3791/3275; Le Scouarnec S, 2015, HUM MOL GENET, V24, P2757, DOI 10.1093/hmg/ddv036; Leoni AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009298; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lieve KVV, 2015, EUROPACE, V17, P1, DOI 10.1093/europace/euv105; Liu H, 2007, J MOL CELL CARDIOL, V42, P760, DOI 10.1016/j.yjmcc.2006.10.013; Lopshire JC, 2006, CIRCULATION, V114, P1134, DOI 10.1161/CIRCULATIONAHA.106.647933; Ma XL, 2017, SCI REP-UK, V7, DOI 10.1038/srep42244; Marionneau C, 2015, J MOL CELL CARDIOL, V82, P36, DOI 10.1016/j.yjmcc.2015.02.013; Martin CA, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120072; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Miyazaki T, 1996, J AM COLL CARDIOL, V27, P1061, DOI 10.1016/0735-1097(95)00613-3; Murakoshi N, 2013, CIRC J, V77, P2419, DOI 10.1253/circj.CJ-13-1129; Nademanee K, 2015, J AM COLL CARDIOL, V66, P1976, DOI 10.1016/j.jacc.2015.08.862; Omatsu-Kanbe M, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13688; Pang XL, 2016, HYPERTENSION, V68, P630, DOI 10.1161/HYPERTENSIONAHA.116.07357; Probst V, 2009, CIRC-CARDIOVASC GENE, V2, P552, DOI 10.1161/CIRCGENETICS.109.853374; Rizzo S, 2012, CARDIOVASC RES, V95, P409, DOI 10.1093/cvr/cvs219; Savio-Galimberti E, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00124; Sidik NP, 2009, EUROPACE, V11, P650, DOI 10.1093/europace/eup079; Sieira J, 2017, EUR HEART J, V38, P3029, DOI 10.1093/eurheartj/ehx490; Siragam V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109128; Tse G, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00467; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; van Bemmelen MX, 2004, CIRC RES, V95, P284, DOI 10.1161/01.RES.0000136816.05109.89; van Berlo JH, 2005, J MOL MED, V83, P79, DOI 10.1007/s00109-004-0589-1; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Yao JA, 1999, CARDIOVASC RES, V44, P132, DOI 10.1016/S0008-6363(99)00154-6; Zankov DP, 2017, CIRC J, V81, P1862, DOI 10.1253/circj.CJ-17-0394; Zankov DP, 2017, SCI REP-UK, V7, DOI 10.1038/srep39335; Zhang YM, 2014, AM J PHYSIOL-HEART C, V306, pH1553, DOI 10.1152/ajpheart.00459.2013; Zwerger M, 2013, HUM MOL GENET, V22, P2335, DOI 10.1093/hmg/ddt079	60	2	2	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6399	6417		10.1096/fj.201902991R	http://dx.doi.org/10.1096/fj.201902991R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32175648				2022-12-28	WOS:000531325500029
J	Wang, YF; Hao, YL; Zhao, YY; Huang, YT; Lai, DW; Du, T; Wan, XH; Zhu, YF; Liu, ZJ; Wang, Y; Wang, NP; Zhang, P				Wang Yinfang; Hao Yilong; Zhao Yuanyuan; Huang Yitong; Lai Dongwu; Du Tao; Wan Xiaohong; Zhu Yuefeng; Liu Zongjun; Wang Ying; Wang Nanping; Zhang Peng			TRIM28 and TRIM27 are required for expressions of PDGFR beta and contractile phenotypic genes by vascular smooth muscle cells	FASEB JOURNAL			English	Article						contractile phenotype; SRF; TRIM27; TRIM28; VSMCs	FAMILY PROTEINS; RECEPTOR; TRANSCRIPTION; DIFFERENTIATION; REGULATOR; ATHEROSCLEROSIS; ACTIVATION; ROLES; MYC; SRF	Vascular smooth muscle cells (VSMCs) in the normal arterial media continually express contractile phenotypic markers which are reduced dramatically in response to injury. Tripartite motif-containing proteins are a family of scaffold proteins shown to regulate gene silencing, cell growth, and differentiation. We here investigated the biological role of tripartite motif-containing 28 (TRIM28) and tripartite motif-containing 27 (TRIM27) in VSMCs. We observed that siRNA-mediated knockdown of TRIM28 and TRIM27 inhibited platelet-derived growth factor (PDGF)-induced migration in human VSMCs. Both TRIM28 and TRIM27 can regulate serum response element activity and were required for maintaining the contractile gene expression in human VSMCs. At the same time, TRIM28 and TRIM27 knockdown reduced the expression of PDGF receptor-beta (PDGFR beta) and the phosphorylation of its downstream signaling components. Immunoprecipitation showed that TRIM28 formed complexes with TRIM27 through its N-terminal RING-B boxes-Coiled-Coil domain. Furthermore, TRIM28 and TRIM27 were shown to be upregulated and mediate the VSMC contractile marker gene and PDGFR beta expression in differentiating human bone marrow mesenchymal stem cells. In conclusion, we identified that TRIM28 and TRIM27 cooperatively maintain the endogenous expression of PDGFR beta and contractile phenotype of human VSMCs.	[Wang Yinfang; Hao Yilong; Zhao Yuanyuan; Huang Yitong; Zhang Peng] Shanghai Univ Tradit Chinese Med, Putuo Hosp, Cent Lab, Shanghai, Peoples R China; [Wang Yinfang; Liu Zongjun; Zhang Peng] Shanghai Univ Tradit Chinese Med, Putuo Hosp, Dept Cardiovasc Med, Shanghai, Peoples R China; [Lai Dongwu; Zhu Yuefeng] Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Cardiovasc Med & Vasc Surg, Sch Med, Hangzhou, Peoples R China; [Du Tao] Tongji Univ, Sch Med, Shanghai East Hosp, Dept Gastrointestinal Surg, Shanghai, Peoples R China; [Wan Xiaohong; Zhang Peng] Anhui Med Univ, Shanghai Putuo Cent Sch Clin Med, Hefei, Peoples R China; [Wang Ying] Mayo Clin, Dept Biochem & Mol Biol, Jacksonville, FL 32224 USA; [Wang Nanping] Dalian Med Univ, Adv Inst Med Sci, Dalian, Peoples R China	Shanghai University of Traditional Chinese Medicine; Shanghai University of Traditional Chinese Medicine; Zhejiang University; Tongji University; Anhui Medical University; Mayo Clinic; Dalian Medical University	Zhang, P (corresponding author), Shanghai Univ Tradit Chinese Med, Putuo Hosp, Cent Lab, Shanghai, Peoples R China.; Wang, NP (corresponding author), Dalian Med Univ, Adv Inst Med Sci, Dalian, Peoples R China.	nanpingwang2003@yahoo.com; zhangnep@hotmail.com		Wang, Nanping/0000-0002-8528-8132				Bennett MR, 2016, CIRC RES, V118, P692, DOI 10.1161/CIRCRESAHA.115.306361; Cai J, 2018, FASEB J, V32, P5238, DOI 10.1096/fj.201700473RR; Chappell J, 2016, CIRC RES, V119, P1313, DOI 10.1161/CIRCRESAHA.116.309799; Chintalgattu V, 2010, J CLIN INVEST, V120, P472, DOI 10.1172/JCI39434; Czerwinska P, 2017, J BIOMED SCI, V24, DOI 10.1186/s12929-017-0374-4; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Ganster RW, 2001, P NATL ACAD SCI USA, V98, P8638, DOI 10.1073/pnas.151239498; Hackzell A, 2002, J BIOL CHEM, V277, P39769, DOI 10.1074/jbc.M204483200; Han M, 2006, AM J PHYSIOL-CELL PH, V291, pC50, DOI 10.1152/ajpcell.00524.2005; Hatakeyama S, 2017, TRENDS BIOCHEM SCI, V42, P297, DOI 10.1016/j.tibs.2017.01.002; Herquel B, 2011, P NATL ACAD SCI USA, V108, P8212, DOI 10.1073/pnas.1101544108; Horita H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10830; Itoh S, 2001, J MOL CELL CARDIOL, V33, P95, DOI 10.1006/jmcc.2000.1279; Iyengar S, 2011, J BIOL CHEM, V286, P26267, DOI 10.1074/jbc.R111.252569; Jiang Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03852-2; Kato T, 2014, CELL REP, V7, P1156, DOI 10.1016/j.celrep.2014.03.068; Kim TS, 2010, DIS MODEL MECH, V3, P752, DOI 10.1242/dmm.004689; King KE, 2003, J BIOL CHEM, V278, P11661, DOI 10.1074/jbc.M211337200; Lacolley P, 2017, CARDIOVASC RES, V113, P120, DOI 10.1093/cvr/cvw253; Levitzki A, 2005, CARDIOVASC RES, V65, P581, DOI 10.1016/j.cardiores.2004.08.008; Li ZB, 2003, EMBO J, V22, P1857, DOI 10.1093/emboj/cdg173; Lyu Q, 2018, ARTERIOSCL THROM VAS, V38, P2184, DOI 10.1161/ATVBAHA.118.311171; Molander C, 2001, MOL BIOL REP, V28, P223, DOI 10.1023/A:1015701232589; Nakamura S, 2010, J BIOL CHEM, V285, P37314, DOI 10.1074/jbc.M110.180786; Oster SK, 2000, MOL CELL BIOL, V20, P6768, DOI 10.1128/MCB.20.18.6768-6778.2000; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Panek RL, 1997, ARTERIOSCL THROM VAS, V17, P1283, DOI 10.1161/01.ATV.17.7.1283; Ross JJ, 2006, J CLIN INVEST, V116, P3139, DOI 10.1172/JCI28184; Tsankov AM, 2015, NATURE, V518, P344, DOI 10.1038/nature14233; Walsh K, 2001, Z Kardiol, V90 Suppl 3, P12; Wang YF, 2017, FASEB J, V31, P2026, DOI 10.1096/fj.201600988RR; Wang YF, 2015, INT J BIOCHEM CELL B, V69, P225, DOI 10.1016/j.biocel.2015.10.026; Wang ZG, 2004, NATURE, V428, P185, DOI 10.1038/nature02382; Wanjare M, 2013, CARDIOVASC RES, V97, P321, DOI 10.1093/cvr/cvs315; Wetterskog D, 2009, MOL CANCER RES, V7, P2031, DOI 10.1158/1541-7786.MCR-08-0501; Woo SY, 2007, J BIOL CHEM, V282, P25604, DOI 10.1074/jbc.M704343200; Xie CQ, 2011, ARTERIOSCL THROM VAS, V31, P1485, DOI 10.1161/ATVBAHA.110.221101; Zhang HX, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05796-z; Zhang QJ, 2002, ARTERIOSCL THROM VAS, V22, P2030, DOI 10.1161/01.ATV.0000042206.98651.15; Zhuang XJ, 2016, CELL CYCLE, V15, P2576, DOI 10.1080/15384101.2016.1174796	41	5	5	2	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6271	6283		10.1096/fj.201902828RR	http://dx.doi.org/10.1096/fj.201902828RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32162409	Bronze			2022-12-28	WOS:000531325500021
J	Liao, C; Pang, N; Liu, ZJ; Lei, L				Liao, Chen; Pang, Nan; Liu, Zhaojun; Lei, Lei			Transient inhibition of rDNA transcription in donor cells improves ribosome biogenesis and preimplantation development of embryos derived from somatic cell nuclear transfer	FASEB JOURNAL			English	Article						cx5461; mTOR inhibitor; nucleolar rebuilding; rDNA transcription; SCNT	RNA GENES; SCNT EMBRYOS; NUCLEOLAR; EXPRESSION	Ribosomal DNA (rDNA) transcription is a limiting step in ribosome biogenesis, crucial for protein synthesis and cell growth-especially at the early stages of embryonic development-and is regulated in a mammalian target of rapamycin (mTOR)-dependent manner. Our previous report demonstrated that treatment with mTOR inhibitors during artificial embryonic activation improved the development of embryos derived from somatic cell nuclear transfer (SCNT). We hypothesize that inhibition of ribosome biogenesis in somatic cells facilitates reactivation of embryonic nucleolar establishment and ribosome biogenesis in SCNT embryos. Herein, we show that mTOR inhibitors suppressed ribosome biogenesis in somatic cells, and more importantly, improved development potential of SCNT embryos (blastocyst rate, 34% vs 24%). SCNT embryos derived from drug-treated somatic cells exhibited higher levels of 47S, 18S, and 5S rRNAs, upstream binding factor (UBF) mRNA, ribosomal protein S6; they also improved the rebuilding of the nucleolar ultrastructure. In addition, treatment of donor cells with the RNA polymerase I (Pol I) inhibitor cx5461 caused similar effects on SCNT embryos. These results indicated that transient inhibition of rDNA transcription in donor cells facilitated the establishment of functional nucleoli and improved preimplantation development of SCNT embryos.	[Liao, Chen; Pang, Nan; Liu, Zhaojun; Lei, Lei] Harbin Med Univ, Dept Histol & Embryol, Harbin 150081, Peoples R China	Harbin Medical University	Lei, L (corresponding author), Harbin Med Univ, Dept Histol & Embryol, Harbin 150081, Peoples R China.	leiys2002@yahoo.com	liu, zhao/GXV-6141-2022	Lei, Lei/0000-0001-5372-8749; Liao, Chen/0000-0003-1759-4178	National Natural Science Foundation of China (NSFC) [31671545]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 31671545	Bai GY, 2018, ZYGOTE, V26, P24, DOI 10.1017/S0967199417000673; Baran V, 2003, ZYGOTE, V11, P271, DOI 10.1017/S0967199403002326; Baran V, 2002, BIOL REPROD, V66, P534, DOI 10.1095/biolreprod66.2.534; Brombin A, 2015, CURR OPIN GENET DEV, V34, P61, DOI 10.1016/j.gde.2015.07.006; Chauvin C, 2014, ONCOGENE, V33, P474, DOI 10.1038/onc.2012.606; Chung YG, 2015, CELL STEM CELL, V17, P758, DOI 10.1016/j.stem.2015.10.001; Donati G, 2012, CANCER RES, V72, P1602, DOI 10.1158/0008-5472.CAN-11-3992; Drygin D, 2011, CANCER RES, V71, P1418, DOI 10.1158/0008-5472.CAN-10-1728; Drygin D, 2010, ANNU REV PHARMACOL, V50, P131, DOI 10.1146/annurev.pharmtox.010909.105844; Eckardt S, 2004, ANIM REPROD SCI, V82-3, P97, DOI 10.1016/j.anireprosci.2004.04.017; ENGEL W, 1977, HUM GENET, V38, P57, DOI 10.1007/BF00295808; Grummt I, 1999, PROG NUCLEIC ACID RE, V62, P109; Grummt I, HUM MOL GEN, V16, pR21; Hai T, 2011, CELL REPROGRAM, V13, P47, DOI 10.1089/cell.2010.0042; Iadevaia V, 2012, NUCLEIC ACIDS RES, V40, P2527, DOI 10.1093/nar/gkr1040; Kanka J, 1999, MOL REPROD DEV, V52, P253, DOI 10.1002/(SICI)1098-2795(199903)52:3&lt;253::AID-MRD2&gt;3.0.CO;2-N; King WA, 1996, MOL REPROD DEV, V44, P499, DOI 10.1002/(SICI)1098-2795(199608)44:4&lt;499::AID-MRD10&gt;3.0.CO;2-U; Laurincik J, 2007, ADV EXP MED BIOL, V591, P84; Lin CJ, 2014, DEV CELL, V30, P268, DOI 10.1016/j.devcel.2014.06.022; Mayer C, 2006, ONCOGENE, V25, P6384, DOI 10.1038/sj.onc.1209883; Moss T, 2007, CELL MOL LIFE SCI, V64, P29, DOI 10.1007/s00018-006-6278-1; Murano K, 2008, MOL CELL BIOL, V28, P3114, DOI 10.1128/MCB.02078-07; Russell J, 2005, TRENDS BIOCHEM SCI, V30, P87, DOI 10.1016/j.tibs.2004.12.008; Sanij E, 2015, GENOME RES, V25, P201, DOI 10.1101/gr.176115.114; Santoro R, 2001, MOL CELL, V8, P719, DOI 10.1016/S1097-2765(01)00317-3; Schlesinger S, 2009, GENE DEV, V23, P2437, DOI 10.1101/gad.544509; Shen XH, 2015, SCI REP-UK, V5, DOI 10.1038/srep17829; Simonsson S, 2004, NAT CELL BIOL, V6, P984, DOI 10.1038/ncb1176; Sirri V, 2008, HISTOCHEM CELL BIOL, V129, P13, DOI 10.1007/s00418-007-0359-6; Song YR, 2014, PROTEIN CELL, V5, P382, DOI 10.1007/s13238-014-0034-3; SPECTOR DL, 1984, CHROMOSOMA, V90, P139, DOI 10.1007/BF00292451; Svarcova O, 2009, MOL REPROD DEV, V76, P132, DOI 10.1002/mrd.20936; Tschochner H, 2003, TRENDS CELL BIOL, V13, P255, DOI 10.1016/S0962-8924(03)00054-0; Zhai YH, 2018, MOL REPROD DEV, V85, P26, DOI 10.1002/mrd.22935; Zhao QS, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0369-1; Zheng Z, 2012, J BIOL CHEM, V287, P19949, DOI 10.1074/jbc.M112.355099; Zhou C, 2019, FASEB J, V33, P4638, DOI 10.1096/fj.201801887R	37	3	3	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8283	8295		10.1096/fj.202000025RR	http://dx.doi.org/10.1096/fj.202000025RR		APR 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32323360				2022-12-28	WOS:000528405000001
J	Zhou, Z; Cui, D; Sun, MH; Huang, JL; Deng, Z; Han, BM; Sun, XW; Xia, SJ; Sun, F; Shi, F				Zhou, Zheng; Cui, Di; Sun, Meng-Hao; Huang, Jing-Lang; Deng, Zheng; Han, Bang-Min; Sun, Xiao-Wen; Xia, Shu-Jie; Sun, Feng; Shi, Fei			CAFs-derived MFAP5 promotes bladder cancer malignant behavior through NOTCH2/HEY1 signaling	FASEB JOURNAL			English	Article						bladder cancer; CAFs; gene regulation; MFAP5; NOTCH2 signaling	RENAL-CELL CARCINOMA; TUMOR MICROENVIRONMENT; GLYCOPROTEIN-2 MAGP-2; NOTCH; PROGRESSION; EXPRESSION; FIBROBLASTS; RECURRENCE; IDENTIFICATION; PROLIFERATION	Cancer-associated fibroblasts (CAFs) are an important component of the tumor microenvironment and contribute to tumor cell proliferation and metastasis. Microfibrillar-associated protein 5 (MFAP5), a component of elastic microfibers and an oncogenic protein in several types of tumors, is secreted by CAFs. However, the role of MFAP5 in the bladder cancer remains unclear. Here, we report that MFAP5 is upregulated in bladder cancer and is associated with poor patient survival. Downregulation of MFAP5 in CAFs led to an impairment in proliferation and invasion of bladder cancer cells. Luciferase reporter assays and electrophoretic mobility shift assays (EMSA) showed QKI directly downregulates MFAP5 in CAFs. In addition, CAFs-derived MFAP5 led to an activation of the NOTCH2/HEY1 signaling pathway through direct interaction with the NOTCH2 receptor, thereby stimulating the N2ICD release. RNA-sequencing revealed that MFAP5-mediated PI3K-AKT signaling activated the DLL4/NOTCH2 pathway axis in bladder cancer. Moreover, downregulation of NOTCH2 by short hairpin RNA or the inactivating anti-body NRR2Mab was able to reverse the adverse effects of MFAP5 stimulation in vitro and in vivo. Together, these results demonstrate CAFs-derived MFAP5 promotes the bladder cancer proliferation and metastasis and provides new insight for targeting CAFs as novel diagnostic and therapeutic strategy.	[Zhou, Zheng] Nanjing Med Univ, Shanghai Gen Hosp, Dept Urol, Shanghai, Peoples R China; [Cui, Di; Sun, Meng-Hao; Huang, Jing-Lang; Deng, Zheng; Han, Bang-Min; Sun, Xiao-Wen; Xia, Shu-Jie; Sun, Feng; Shi, Fei] Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Dept Urol, Sch Med, 100 Haining Rd, Shanghai 200080, Peoples R China; [Cui, Di; Han, Bang-Min; Sun, Xiao-Wen; Xia, Shu-Jie; Sun, Feng; Shi, Fei] Shanghai Jiao Tong Univ, Inst Urol, Shanghai, Peoples R China	Nanjing Medical University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Sun, F; Shi, F (corresponding author), Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Dept Urol, Sch Med, 100 Haining Rd, Shanghai 200080, Peoples R China.	sfsunfeng1987@163.com; shifei191859@126.com			National Natural Science Foundation of China (NSFC) [81602252]; Shanghai Municipal Education Commission; Shanghai Education Development Foundation [16CG10]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); Shanghai Education Development Foundation	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81602252; Shanghai Municipal Education Commission; Shanghai Education Development Foundation, Grant/Award Number: #16CG10	Albig AR, 2008, MICROVASC RES, V76, P7, DOI 10.1016/j.mvr.2008.01.001; Albig Allan R., 2007, Angiogenesis, V10, P197, DOI 10.1007/s10456-007-9075-z; Alexandroff AB, 1999, LANCET, V353, P1689, DOI 10.1016/S0140-6736(98)07422-4; Andersen P, 2012, TRENDS CELL BIOL, V22, P257, DOI 10.1016/j.tcb.2012.02.003; Bocchicchio S, 2019, J CELL PHYSIOL, V234, P22130, DOI 10.1002/jcp.28775; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Bryan RT, 2013, BJU INT, V112, P169, DOI 10.1111/bju.12032; Caolo V, 2010, J BIOL CHEM, V285, P40681, DOI 10.1074/jbc.M110.176065; Deford P, 2016, EXP CELL RES, V341, P84, DOI 10.1016/j.yexcr.2016.01.011; Deng Z, 2019, TOXICOL APPL PHARM, V366, P83, DOI 10.1016/j.taap.2019.01.022; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fu X, 2015, INT J ORAL MAX SURG, V44, P562, DOI 10.1016/j.ijom.2014.10.001; Galarneau A, 2005, NAT STRUCT MOL BIOL, V12, P691, DOI 10.1038/nsmb963; Gibson MA, 1998, J HISTOCHEM CYTOCHEM, V46, P871, DOI 10.1177/002215549804600802; Gibson MA, 1999, J BIOL CHEM, V274, P13060, DOI 10.1074/jbc.274.19.13060; Goriki A, 2018, NAT REV UROL, V15, P345, DOI 10.1038/s41585-018-0005-1; Greife A, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-628; Guo CL, 2017, THERANOSTICS, V7, P775, DOI 10.7150/thno.17237; Gutierrez A, 2007, CANCER CELL, V12, P411, DOI 10.1016/j.ccr.2007.10.027; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Hanssen E, 2004, J BIOL CHEM, V279, P29185, DOI 10.1074/jbc.M313672200; Hayashi T, 2016, CLIN CANCER RES, V22, P2981, DOI 10.1158/1078-0432.CCR-15-2360; Herrera M, 2013, CANCER SCI, V104, P437, DOI 10.1111/cas.12096; Kharaishvili G, 2014, CANCER CELL INT, V14, DOI 10.1186/1475-2867-14-41; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; LeBleu VS, 2018, DIS MODEL MECH, V11, DOI 10.1242/dmm.029447; Leung CS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6092; Liu TY, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00060; Miyake M, 2016, NEOPLASIA, V18, P636, DOI 10.1016/j.neo.2016.08.002; Miyamoto A, 2006, J BIOL CHEM, V281, P10089, DOI 10.1074/jbc.M600298200; Miyazaki J, 2017, INT J UROL, V24, P730, DOI 10.1111/iju.13376; Mok SC, 2009, CANCER CELL, V16, P521, DOI 10.1016/j.ccr.2009.10.018; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Pagie S, 2018, CELL COMMUN SIGNAL, V16, DOI 10.1186/s12964-017-0214-x; Paulsson J, 2014, SEMIN CANCER BIOL, V25, P61, DOI 10.1016/j.semcancer.2014.02.006; Principe S, 2018, J PROTEOME RES, V17, P2045, DOI 10.1021/acs.jproteome.7b00925; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Rampias T, 2014, NAT MED, V20, P1199, DOI 10.1038/nm.3678; Ranganathan P, 2011, NAT REV CANCER, V11, P338, DOI 10.1038/nrc3035; Sandri S, 2016, PHARMACOL RES, V111, P523, DOI 10.1016/j.phrs.2016.07.017; Shi F, 2020, J CANCER, V11, P1359, DOI 10.7150/jca.36083; Shi F, 2019, J CELL MOL MED, V23, P6578, DOI 10.1111/jcmm.14481; Sylvester RJ, 2006, EUR UROL, V49, P466, DOI 10.1016/j.eururo.2005.12.031; Tsujino T, 2007, CLIN CANCER RES, V13, P2082, DOI 10.1158/1078-0432.CCR-06-2191; van Rhijn BWG, 2009, EUR UROL, V56, P430, DOI 10.1016/j.eururo.2009.06.028; Verhelst J, 2015, JOVE-J VIS EXP, DOI 10.3791/52871; Vivacqua A, 2019, CANCERS, V11, DOI 10.3390/cancers11030412; Wang S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06568-5; Weber CE, 2012, SURG ONCOL, V21, P172, DOI 10.1016/j.suronc.2011.09.001; Wu ZG, 2018, BIOCHEM BIOPH RES CO, V498, P495, DOI 10.1016/j.bbrc.2018.03.007; Yamamizu K, 2010, J CELL BIOL, V189, P325, DOI 10.1083/jcb.200904114; Yuan X, 2015, CANCER LETT, V369, P20, DOI 10.1016/j.canlet.2015.07.048; Zeegers MPA, 2000, CANCER-AM CANCER SOC, V89, P630, DOI 10.1002/1097-0142(20000801)89:3<630::AID-CNCR19>3.0.CO;2-Q; Zhang JH, 2011, J BIOL CHEM, V286, P8055, DOI 10.1074/jbc.M110.192641; Zhang RL, 2016, CELL CYCLE, V15, P3094, DOI 10.1080/15384101.2016.1235103	55	11	13	1	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					7970	7988		10.1096/fj.201902659R	http://dx.doi.org/10.1096/fj.201902659R		APR 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32293074	hybrid			2022-12-28	WOS:000526103700001
J	Zaugg, J; Melhem, H; Huang, X; Wegner, M; Baumann, M; Surbek, D; Korner, M; Albrecht, C				Zaugg, Jonas; Melhem, Hassan; Huang, Xiao; Wegner, Malgorzata; Baumann, Marc; Surbek, Daniel; Korner, Meike; Albrecht, Christiane			Gestational diabetes mellitus affects placental iron homeostasis: Mechanism and clinical implications	FASEB JOURNAL			English	Article						antioxidant treatment; autophagy; DMT1; ferroportin; immunohistochemistry; iron uptake; oxidative stress; placenta; transferrin receptor; trophoblast cells; ZIP8	PROTECTS TROPHOBLAST CELLS; TRANSPORTER DMT1; PREGNANT-WOMEN; SUPPLEMENTATION; METABOLISM; SELENIUM; STRESS; ASSAY; EXPRESSION; HEPCIDIN	Clinical studies suggest that pregnant women with elevated iron levels are more vulnerable to develop gestational diabetes mellitus (GDM), but the causes and underlying mechanisms are unknown. We hypothesized that hyperglycemia induces cellular stress responses leading to dysregulated placental iron homeostasis. Hence, we compared the expression of genes/proteins involved in iron homeostasis in placentae from GDM and healthy pregnancies (n = 11 each). RT-qPCR and LC-MS/MS analyses revealed differential regulation of iron transporters/receptors (DMT1/FPN1/ZIP8/TfR1), iron sensors (IRP1), iron regulators (HEPC), and iron oxidoreductases (HEPH/Zp). To identify the underlying mechanisms, we adapted BeWo trophoblast cells to normoglycemic (N), hyperglycemic (H), and hyperglycemic-hyperlipidemic (HL) conditions and assessed Fe3+-uptake, expression patterns, and cellular pathways involving oxidative stress (OS), ER-stress, and autophagy. H and HL induced alterations in cellular morphology, differential iron transporter expression, and reduced Fe3+-uptake confirming the impact of hyperglycemia on iron transport observed in GDM patients. Pathway analysis and rescue experiments indicated that dysregulated OS and disturbed autophagy processes contribute to the reduced placental iron transport under hyperglycemic conditions. These adaptations could represent a protective mechanism preventing the oxidative damage for both fetus and placenta caused by highly oxidative iron. In pregnancies with risk for GDM, antioxidant treatment, and controlled iron supplementation could help to balance placental OS levels protecting mother and fetus from impaired iron homeostasis.	[Zaugg, Jonas; Melhem, Hassan; Huang, Xiao; Wegner, Malgorzata; Albrecht, Christiane] Univ Bern, Inst Biochem & Mol Med, Buhlstr 28, CH-3012 Bern, Switzerland; [Zaugg, Jonas; Melhem, Hassan; Huang, Xiao; Wegner, Malgorzata; Albrecht, Christiane] Univ Bern, Swiss Natl Ctr Competence Res NCCR TransCure, Bern, Switzerland; [Baumann, Marc; Surbek, Daniel] Univ Hosp, Dept Obstet & Gynaecol, Bern, Switzerland; [Korner, Meike] Pathol Laenggasse, Bern, Switzerland	University of Bern; University of Bern; University of Bern; University Hospital of Bern	Albrecht, C (corresponding author), Univ Bern, Inst Biochem & Mol Med, Buhlstr 28, CH-3012 Bern, Switzerland.	christiane.albrecht@ibmm.unibe.ch		Surbek, Daniel/0000-0001-7705-1584; Zaugg, Jonas/0000-0002-3153-2806	Swiss National Centre of Competence in Research, NCCR TransCure, University of Bern, Switzerland; Swiss National Science Foundation (SNSF) [310030_149958]; Graduate School for Cellular and Biomedical Sciences (GCB), University of Bern, Switzerland	Swiss National Centre of Competence in Research, NCCR TransCure, University of Bern, Switzerland; Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); Graduate School for Cellular and Biomedical Sciences (GCB), University of Bern, Switzerland	This study was supported by the Swiss National Centre of Competence in Research, NCCR TransCure, University of Bern, Switzerland, and the Swiss National Science Foundation (SNSF) (Grant No. 310030_149958). JZ was supported by the Graduate School for Cellular and Biomedical Sciences (GCB), University of Bern, Switzerland.	Afkhami-Ardekani M, 2009, J DIABETES COMPLICAT, V23, P194, DOI 10.1016/j.jdiacomp.2007.11.006; Avagliano L, 2017, PLACENTA, V55, P90, DOI 10.1016/j.placenta.2017.05.002; Basevi V, 2011, DIABETES CARE, V34, P1887, DOI 10.2337/dc11-s011; Bo S, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.04.049; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Cao JY, 2016, CELL MOL LIFE SCI, V73, P2195, DOI 10.1007/s00018-016-2194-1; Chong WS, 2005, HUM REPROD, V20, P3532, DOI 10.1093/humrep/dei246; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; DeSisto CL, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130415; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Escher C, 2012, PROTEOMICS, V12, P1111, DOI 10.1002/pmic.201100463; Foot NJ, 2008, BLOOD, V112, P4268, DOI 10.1182/blood-2008-04-150953; Frewen Barbara, 2007, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1307s20; Fuqua BK, 2018, CELL MOL GASTROENTER, V6, P405, DOI 10.1016/j.jcmgh.2018.06.006; Gambling L, 2001, BIOCHEM J, V356, P883, DOI 10.1042/0264-6021:3560883; Huang X, 2013, PLACENTA, V34, P544, DOI 10.1016/j.placenta.2013.03.011; Huang X, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4518-z; Jain A, 2010, J BIOL CHEM, V285, P22576, DOI 10.1074/jbc.M110.118976; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Khera A, 2013, PLACENTA, V34, P594, DOI 10.1016/j.placenta.2013.04.010; Khera A, 2017, BIOL TRACE ELEM RES, V177, P394, DOI 10.1007/s12011-016-0870-5; Koenig MD, 2014, NUTRIENTS, V6, P3062, DOI 10.3390/nu6083062; Kopp MC, 2018, ELIFE, V7, DOI 10.7554/eLife.30257; Kurutas EB, 2016, NUTR J, V15, DOI 10.1186/s12937-016-0186-5; Lam-Yuk-Tseung S, 2006, BIOCHEMISTRY-US, V45, P2294, DOI 10.1021/bi052307m; Lappas M, 2011, ANTIOXID REDOX SIGN, V15, P3061, DOI 10.1089/ars.2010.3765; Levine RL, 1983, METHOD ENZYMOL, V2009, P1; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Orecchio A, 2014, GYNECOL ENDOCRINOL, V30, P561, DOI 10.3109/09513590.2013.879853; Papanikolaou G, 2005, TOXICOL APPL PHARM, V202, P199, DOI 10.1016/j.taap.2004.06.021; Peuchant E, 2004, CLIN BIOCHEM, V37, P293, DOI 10.1016/j.clinbiochem.2003.12.005; Potter TM, 2011, METHODS MOL BIOL, V697, P181, DOI 10.1007/978-1-60327-198-1_19; Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378; Rawal S, 2017, DIABETOLOGIA, V60, P249, DOI 10.1007/s00125-016-4149-3; Riemer J, 2004, ANAL BIOCHEM, V331, P370, DOI 10.1016/j.ab.2004.03.049; Roverso M, 2019, METALLOMICS, V11, P676, DOI [10.1039/c8mt00331a, 10.1039/C8MT00331A]; Sinha S, 2004, J BIOL CHEM, V279, P41294, DOI 10.1074/jbc.M406514200; Stirm L, 2018, J CLIN ENDOCR METAB, V103, P3299, DOI 10.1210/jc.2018-00397; Turker C, 2010, P 13 INT C EXTENDING, P717, DOI DOI 10.1145/1739041.1739135; van Santen S, 2013, CLIN CHEM LAB MED, V51, P1395, DOI 10.1515/cclm-2012-0576; Vecchi C, 2009, SCIENCE, V325, P877, DOI 10.1126/science.1176639; Wilkinson N, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00176; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Xiaoqiu Xiao PS, 2014, J MOL BIOMARK DIAGN, V5, P13, DOI [10.4172/2155-9929.1000205, DOI 10.4172/2155-9929.1000205]; Yung HW, 2016, DIABETOLOGIA, V59, P2240, DOI 10.1007/s00125-016-4040-2; Zachara BA, 2018, ADV CLIN CHEM, V86, P157, DOI 10.1016/bs.acc.2018.05.004; Zein S, 2015, J TRACE ELEM MED BIO, V30, P220, DOI 10.1016/j.jtemb.2014.09.004; Ziaei S, 2007, BJOG-INT J OBSTET GY, V114, P684, DOI 10.1111/j.1471-0528.2007.01325.x	48	11	11	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					7311	7329		10.1096/fj.201903054R	http://dx.doi.org/10.1096/fj.201903054R		APR 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32285992	hybrid			2022-12-28	WOS:000526106100001
J	Ou, MH; Zhao, HD; Ji, GX; Zhao, X; Zhang, Q				Ou, Minghui; Zhao, Huidong; Ji, Guoxin; Zhao, Xin; Zhang, Qian			Long noncoding RNA MALAT1 contributes to pregnancy-induced hypertension development by enhancing oxidative stress and inflammation through the regulation of the miR-150-5p/ET-1 axis	FASEB JOURNAL			English	Article						endothelial cells; endothelin-1; metastasis-associated lung adenocarcinoma transcript 1; microRNA-150-5p; NF-kappa B pathway; pregnancy-induced hypertension; smooth muscle cells	SMOOTH-MUSCLE-CELLS; ENDOTHELIN RECEPTOR; PROLIFERATION; MICRORNA-150; PREECLAMPSIA; MIGRATION	Metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) has been identified previously in the pathogenesis of hypertension and some gestational diseases. However, the biological functions of MALAT1 in pregnancy-induced hypertension (PIH) are still poorly understood. Herein, we aim to explore the functional relevance of MALAT1 in PIH and to explain the potential underlying mechanisms. We found that the levels of ET-1 and MALAT1 were upregulated and that of miR-150-5p were downregulated in the serum of pregnant women with PIH and the aortic endothelial cells (ECs) of reduced uterine perfusion pressure (RUPP)-induced rat models. In aortic ECs, MALAT1 could competitively bind to miR-150-5p to upregulate the expression of ET-1. The MALAT1/miR-150-5p/ET-1 axis regulated the expression of endothelin B receptor (ETBR) in aortic ECs leading to oxidative stress imbalance and increased the release of proinflammatory cytokines (IL-18 and IL-1 beta), which concurrently activated the NF-kappa B pathway to regulate the ETBR expression and to stimulate smooth muscle cell (SMC) contraction. Furthermore, silencing MALAT1 could alleviate the hypertensive symptoms of RUPP-induced rat models. Taken conjointly, the upregulation of MALAT1 can reduce the expression of ET-1 by competitively binding to miR-150-5p, which enhances the expression of ETBR via the activation of the NF-kappa B pathway in SMCs, thus exacerbating the hypertensive symptoms in the RUPP-induced rat models.	[Ou, Minghui] Qingdao Municipal Hosp, Dept Vasc Surg, Qingdao, Peoples R China; [Zhao, Huidong; Ji, Guoxin; Zhao, Xin; Zhang, Qian] Qingdao Municipal Hosp, Dept Obstet, 1 Jiaozhou Rd, Qingdao 266011, Shandong, Peoples R China	Qingdao Municipal Hospital; Qingdao Municipal Hospital	Zhang, Q (corresponding author), Qingdao Municipal Hosp, Dept Obstet, 1 Jiaozhou Rd, Qingdao 266011, Shandong, Peoples R China.	zhangqian6368@sina.com			General Projects of National Natural Science Foundation of China-the Function and Regulation Mechanism of ETBR in Aortic Endothelium and Smooth Muscle Cells in Pregnancy-Induced Hypertension [81871187]; Regional Projects of the National Natural Science Foundation of China-Correlation Analysis Between Endothelin Receptor and Pregnancy-Induced Hypertension and Abnormal Blood Pressure Regulation [81460239]; Natural Science Foundation Project of Ningxia Province-Correlation Analysis Between Anastomotic Regional Blood Flow Velocity and Intimal Hyperplasia after Revascularization [NZ17195]; Qingdao Outstanding Health Professional Development Fund	General Projects of National Natural Science Foundation of China-the Function and Regulation Mechanism of ETBR in Aortic Endothelium and Smooth Muscle Cells in Pregnancy-Induced Hypertension; Regional Projects of the National Natural Science Foundation of China-Correlation Analysis Between Endothelin Receptor and Pregnancy-Induced Hypertension and Abnormal Blood Pressure Regulation; Natural Science Foundation Project of Ningxia Province-Correlation Analysis Between Anastomotic Regional Blood Flow Velocity and Intimal Hyperplasia after Revascularization; Qingdao Outstanding Health Professional Development Fund	This study was supported by the General Projects of National Natural Science Foundation of China-the Function and Regulation Mechanism of ETBR in Aortic Endothelium and Smooth Muscle Cells in Pregnancy-Induced Hypertension (No. 81871187), the Regional Projects of the National Natural Science Foundation of China-Correlation Analysis Between Endothelin Receptor and Pregnancy-Induced Hypertension and Abnormal Blood Pressure Regulation (No. 81460239), and the Natural Science Foundation Project of Ningxia Province-Correlation Analysis Between Anastomotic Regional Blood Flow Velocity and Intimal Hyperplasia after Revascularization (No. NZ17195), and Qingdao Outstanding Health Professional Development Fund.	Ananth CV, 2010, EPIDEMIOLOGY, V21, P118, DOI 10.1097/EDE.0b013e3181c297af; Anguiano L, 2015, J CLIN MED, V4, P1171, DOI 10.3390/jcm4061171; Caldeira-Dias M, 2018, PREGNANCY HYPERTENS, V12, P75, DOI 10.1016/j.preghy.2018.03.001; Chen HY, 2015, INT J CLIN EXP PATHO, V8, P12718; Chen MT, 2017, BIOMED PHARMACOTHER, V93, P861, DOI 10.1016/j.biopha.2017.07.028; George EM, 2012, HYPERTENSION, V60, P507, DOI 10.1161/HYPERTENSIONAHA.112.194845; George EM, 2011, AM J HYPERTENS, V24, P964, DOI 10.1038/ajh.2011.99; Gerstung M, 2007, AM J NEPHROL, V27, P294, DOI 10.1159/000101999; Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928; He Q, 2018, NUTR METAB CARDIOVAS, V28, P1285, DOI 10.1016/j.numecd.2018.09.002; He XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081437; Jia XQ, 2018, EXP THER MED, V16, P3793, DOI 10.3892/etm.2018.6668; Kappers MHW, 2010, HYPERTENSION, V56, P675, DOI 10.1161/HYPERTENSIONAHA.109.149690; Khanam F, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-2046-0; Kobayashi M, 2005, J ATHEROSCLER THROMB, V12, P138, DOI 10.5551/jat.12.138; Kowalczyk A, 2015, ARCH IMMUNOL THER EX, V63, P41, DOI 10.1007/s00005-014-0310-1; Kurabayashia T, 2013, MATURITAS, V75, P227, DOI 10.1016/j.maturitas.2013.04.002; Lankhorst S, 2014, ANTIOXID REDOX SIGN, V20, P135, DOI 10.1089/ars.2013.5244; Li QF, 2009, AM J PHYSIOL-CELL PH, V297, pC1424, DOI 10.1152/ajpcell.00324.2009; Liu JY, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.466; Lu CQ, 2018, PREGNANCY HYPERTENS, V14, P68, DOI 10.1016/j.preghy.2018.06.008; Luo XY, 2018, CELL BIOL INT, V42, P1170, DOI 10.1002/cbin.10985; Mazzuca MQ, 2014, HYPERTENSION, V64, P632, DOI 10.1161/HYPERTENSIONAHA.114.03315; Ou MH, 2014, J CELL PHYSIOL, V229, P489, DOI 10.1002/jcp.24469; Park HS, 2019, REPROD BIOMED ONLINE, V39, P187, DOI 10.1016/j.rbmo.2019.03.207; Patsch C, 2015, NAT CELL BIOL, V17, P994, DOI 10.1038/ncb3205; Rautureau Y, 2012, CURR OPIN NEPHROL HY, V21, P128, DOI 10.1097/MNH.0b013e32834f0092; Rhodes CJ, 2013, AM J RESP CRIT CARE, V187, P294, DOI 10.1164/rccm.201205-0839OC; Small EM, 2011, NATURE, V469, P336, DOI 10.1038/nature09783; Tai LW, 2018, NEUROSCIENCE, V384, P139, DOI 10.1016/j.neuroscience.2018.05.024; Wang J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169206; Wang YNZ, 2016, HYPERTENSION, V68, P736, DOI 10.1161/HYPERTENSIONAHA.116.07259; Yang JM, 2018, MOLECULES, V23, DOI 10.3390/molecules23061274; Yeligar S, 2009, J IMMUNOL, V183, P5232, DOI 10.4049/jimmunol.0901084; Yu B, 2018, THERANOSTICS, V8, P3654, DOI 10.7150/thno.26024; Zhang Y, 2019, CELL BIOSCI, V9, DOI 10.1186/s13578-019-0302-2; Zhao XD, 2018, MOL MED REP, V18, P705, DOI 10.3892/mmr.2018.9070; Zhou X, 2015, SCI REP-UK, V5, DOI 10.1038/srep10071; Zhuo YF, 2017, CLIN CHEM LAB MED, V55, P38, DOI 10.1515/cclm-2016-0056	39	19	21	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6070	6085		10.1096/fj.201902280R	http://dx.doi.org/10.1096/fj.201902280R		APR 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32246794				2022-12-28	WOS:000523593500001
J	Xu, Y; Xie, MM; Xue, JS; Xiang, L; Li, YL; Xiao, J; Xiao, GR; Wang, HL				Xu, Yi; Xie, Mengmeng; Xue, Jinsong; Xiang, Ling; Li, Yali; Xiao, Jie; Xiao, Guiran; Wang, Hui-Li			EGCG ameliorates neuronal and behavioral defects by remodeling gut microbiota and TotM expression in Drosophila models of Parkinson's disease	FASEB JOURNAL			English	Article						Lactobacillus plantarum; mitochondria; PINK1(B9); rotenone	MITOCHONDRIAL DYSFUNCTION; ALPHA-SYNUCLEIN; PINK1; HOMEOSTASIS; BRAIN; EPIGALLOCATECHIN-3-GALLATE; POLYPHENOLS; METABOLISM; MITOPHAGY; PROTECTS	Parkinson's disease (PD) is the second most common neurodegenerative disease. Eigallocatechin-3-gallate (EGCG), the major polyphenol in green tea, is known to exert a beneficial effect on PD patients. Although some mechanisms were suggested to underlie this intervention, it remains unknown if the EGCG-mediated protection was achieved by remodeling gut microbiota. In the present study, 0.1 mM or 0.5 mM EGCG was administered to the Drosophila melanogaster with PINK1 (PTEN induced putative kinase 1) mutations, a prototype PD model, and their behavioral performances, as well as neuronal/mitochondrial morphology (only for 0.5 mM EGCG treatment) were determined. According to the results, the mutant PINK1(B9) flies exhibited dopaminergic, survival, and behavioral deficits, which were rescued by EGCG supplementation. Meanwhile, EGCG resulted in profound changes in gut microbial compositions in PINK1(B9) flies, restoring the abundance of a set of bacteria. Notably, EGCG protection was blunted when gut microbiota was disrupted by antibiotics. We further isolated four bacterial strains from fly guts and the supplementation of individual Lactobacillus plantarum or Acetobacter pomorum strain exacerbated the neuronal and behavioral dysfunction of PD flies, which could not be rescued by EGCG. Transcriptomic analysis identified TotM as the central gene responding to EGCG or microbial manipulations. Genetic ablation of TotM blocked the recovery activity of EGCG, suggesting that EGCG-mediated protection warrants TotM. Apart from familial form, EGCG was also potent in improving sporadic PD symptoms induced by rotenone treatment, wherein gut microbiota shared regulatory roles. Together, our results suggest the relevance of the gut microbiota-TotM pathway in EGCG-mediated neuroprotection, providing insight into indirect mechanisms underlying nutritional intervention of Parkinson's disease.	[Xu, Yi; Xie, Mengmeng; Xue, Jinsong; Xiang, Ling; Li, Yali; Xiao, Jie; Xiao, Guiran; Wang, Hui-Li] Hefei Univ Technol, Sch Food & Bioengn, 420 Feicui Rd, Hefei 230009, Anhui, Peoples R China	Hefei University of Technology	Xu, Y; Wang, HL (corresponding author), Hefei Univ Technol, Sch Food & Bioengn, 420 Feicui Rd, Hefei 230009, Anhui, Peoples R China.	xuyi@hfut.edu.cn; wanghl@hfut.edu.cn	wang, huimin/HDM-8421-2022; wang, hui/GRS-4730-2022					Abd El Mohsen MM, 2002, FREE RADICAL BIO MED, V33, P1693, DOI 10.1016/S0891-5849(02)01137-1; Aho VTE, 2019, EBIOMEDICINE, V44, P691, DOI 10.1016/j.ebiom.2019.05.064; Baenas N, 2019, GENES NUTR, V14, DOI 10.1186/s12263-019-0641-y; Bieschke J, 2010, P NATL ACAD SCI USA, V107, P7710, DOI 10.1073/pnas.0910723107; Bingol B, 2014, NATURE, V510, P370, DOI 10.1038/nature13418; Brun S, 2006, GENES CELLS, V11, P397, DOI 10.1111/j.1365-2443.2006.00953.x; Chen AYY, 2018, NEUROBIOL DIS, V114, P153, DOI 10.1016/j.nbd.2018.03.003; Chen J, 2017, FASEB J, V31, P5234, DOI 10.1096/fj.201700011R; Chen M, 2015, NEUROSCIENCE, V286, P383, DOI 10.1016/j.neuroscience.2014.12.003; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Coulom H, 2004, J NEUROSCI, V24, P10993, DOI 10.1523/JNEUROSCI.2993-04.2004; de Cossio LF, 2017, BRAIN BEHAV IMMUN, V64, P33, DOI 10.1016/j.bbi.2016.12.022; Doktor B, 2018, ACTA NEUROBIOL EXP, V78, P231, DOI 10.21307/ane-2018-021; Dragicevic N, 2011, J ALZHEIMERS DIS, V26, P507, DOI 10.3233/JAD-2011-101629; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Ekengren S, 2001, BIOCHEM BIOPH RES CO, V284, P998, DOI 10.1006/bbrc.2001.5067; Gan RY, 2018, CRIT REV FOOD SCI, V58, P924, DOI 10.1080/10408398.2016.1231168; Hewitt VL, 2017, CURR TOP DEV BIOL, V121, P173, DOI 10.1016/bs.ctdb.2016.07.005; Ho L, 2019, J NUTR BIOCHEM, V64, P170, DOI 10.1016/j.jnutbio.2018.10.019; Hsieh CH, 2016, CELL STEM CELL, V19, P709, DOI 10.1016/j.stem.2016.08.002; Jimenez-Del-Rio M, 2010, NEUROCHEM RES, V35, P227, DOI 10.1007/s11064-009-0046-1; Jin SM, 2012, J CELL SCI, V125, P795, DOI 10.1242/jcs.093849; Johnson ME, 2018, NEUROTOXICOLOGY, V65, P174, DOI 10.1016/j.neuro.2018.02.013; Julienne H, 2017, NEUROBIOL DIS, V104, P15, DOI 10.1016/j.nbd.2017.04.014; Kemp C, 2013, J IMMUNOL, V190, P650, DOI 10.4049/jimmunol.1102486; Klein P, 2014, EMBO J, V33, P341, DOI 10.1002/embj.201284290; Kohri T, 2001, J AGR FOOD CHEM, V49, P1042, DOI 10.1021/jf0011236; Lee KA, 2013, CELL, V153, P797, DOI 10.1016/j.cell.2013.04.009; Liu S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001237; Lorenzen N, 2014, J BIOL CHEM, V289, P21299, DOI 10.1074/jbc.M114.554667; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Matheoud D, 2019, NATURE, V571, P565, DOI 10.1038/s41586-019-1405-y; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Mi YS, 2017, FASEB J, V31, P4998, DOI 10.1096/fj.201700400RR; Most J, 2017, EUR J CLIN NUTR, V71, P1040, DOI 10.1038/ejcn.2017.89; Natsume M, 2004, FREE RADICAL RES, V38, P1341, DOI 10.1080/10715760400022087; Ng CH, 2012, J NEUROSCI, V32, P14311, DOI 10.1523/JNEUROSCI.0499-12.2012; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Pickrell AM, 2015, NEURON, V85, P257, DOI 10.1016/j.neuron.2014.12.007; Pietrucci D, 2019, PARKINSONISM RELAT D, V65, P124, DOI 10.1016/j.parkreldis.2019.06.003; Remely M, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/3079148; Renaud J, 2015, REJUV RES, V18, P257, DOI 10.1089/rej.2014.1639; Ryu JH, 2008, SCIENCE, V319, P777, DOI 10.1126/science.1149357; Sampson TR, 2016, CELL, V167, P1469, DOI 10.1016/j.cell.2016.11.018; Si HW, 2019, FASEB J, V33, P965, DOI [10.1096/fj.201800554RR, 10.1096/fj.201800554rr]; Singh NA, 2016, NUTR J, V15, DOI 10.1186/s12937-016-0179-4; Steenbergen L, 2015, BRAIN BEHAV IMMUN, V48, P258, DOI 10.1016/j.bbi.2015.04.003; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Tefit MA, 2017, J EXP BIOL, V220, P900, DOI 10.1242/jeb.151522; Tufi R, 2014, NAT CELL BIOL, V16, P157, DOI 10.1038/ncb2901; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Weinreb O, 2013, FREE RADICAL BIO MED, V62, P52, DOI 10.1016/j.freeradbiomed.2013.01.017; Whitworth AJ, 2005, P NATL ACAD SCI USA, V102, P8024, DOI 10.1073/pnas.0501078102; Wu SC, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00040-6; Wu ZH, 2018, EXP GERONTOL, V113, P10, DOI 10.1016/j.exger.2018.09.014	55	18	18	7	26	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5931	5950		10.1096/fj.201903125RR	http://dx.doi.org/10.1096/fj.201903125RR			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32157731	hybrid			2022-12-28	WOS:000530242100075
J	Yellamilli, A; Ren, Y; McElmurry, RT; Lambert, JP; Gross, P; Mohsin, S; Houser, SR; Elrod, JW; Tolar, J; Garry, DJ; van Berlo, JH				Yellamilli, Amritha; Ren, Yi; McElmurry, Ron T.; Lambert, Jonathan P.; Gross, Polina; Mohsin, Sadia; Houser, Steven R.; Elrod, John W.; Tolar, Jakub; Garry, Daniel J.; van Berlo, Jop H.			Abcg2-expressing side population cells contribute to cardiomyocyte renewal through fusion	FASEB JOURNAL			English	Article						cardiac regeneration; cardiomyocyte proliferation; fusion; side population	BINDING CASSETTE TRANSPORTER; CARDIAC PROGENITOR CELLS; HEMATOPOIETIC STEM-CELLS; MYOCARDIAL-INFARCTION; C-KIT(+) CELLS; HEART-FAILURE; ABCG2; REGENERATION; EXPRESSION; MYOCYTES	The adult mammalian heart has a limited regenerative capacity. Therefore, identification of endogenous cells and mechanisms that contribute to cardiac regeneration is essential for the development of targeted therapies. The side population (SP) phenotype has been used to enrich for stem cells throughout the body; however, SP cells isolated from the heart have been studied exclusively in cell culture or after transplantation, limiting our understanding of their function in vivo. We generated a new Abcg2-driven lineage-tracing mouse model with efficient labeling of SP cells. Labeled SP cells give rise to terminally differentiated cells in bone marrow and intestines. In the heart, labeled SP cells give rise to lineage-traced cardiomyocytes under homeostatic conditions with an increase in this contribution following cardiac injury. Instead of differentiating into cardiomyocytes like proposed cardiac progenitor cells, cardiac SP cells fuse with preexisting cardiomyocytes to stimulate cardiomyocyte cell cycle reentry. Our study is the first to show that fusion between cardiomyocytes and non-cardiomyocytes, identified by the SP phenotype, contribute to endogenous cardiac regeneration by triggering cardiomyocyte cell cycle reentry in the adult mammalian heart.	[Yellamilli, Amritha; Ren, Yi; Garry, Daniel J.; van Berlo, Jop H.] Univ Minnesota, Sch Med, Lillehei Heart Inst, Minneapolis, MN 55455 USA; [Yellamilli, Amritha; van Berlo, Jop H.] Univ Minnesota, Sch Med, Dept Integrat Biol & Physiol, Minneapolis, MN 55455 USA; [Yellamilli, Amritha; McElmurry, Ron T.; Tolar, Jakub; van Berlo, Jop H.] Univ Minnesota, Sch Med, Stem Cell Inst, Minneapolis, MN 55455 USA; [McElmurry, Ron T.; Tolar, Jakub] Univ Minnesota, Sch Med, Dept Pediat, Minneapolis, MN 55455 USA; [Lambert, Jonathan P.; Elrod, John W.] Temple Univ, Lewis Katz Sch Med, Ctr Translat Med, Philadelphia, PA 19122 USA; [Gross, Polina; Mohsin, Sadia; Houser, Steven R.] Temple Univ, Lewis Katz Sch Med, Cardiovasc Res Ctr, Philadelphia, PA 19122 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	van Berlo, JH (corresponding author), Univ Minnesota, Dept Med, Lillehei Heart Inst, 2231 6th St SE, Minneapolis, MN 55455 USA.	jvanberl@umn.edu	Lambert, Jonathan/P-1766-2018	Lambert, Jonathan/0000-0001-7048-6841; Elrod, John/0000-0003-3925-2224; Tolar, Jakub/0000-0002-0957-4380	National Institutes of Health [HL112852, HL130072]; MSTP [T32GM008244]; Hartwell Foundation; Minnesota Regenerative Medicine Initiative	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MSTP; Hartwell Foundation; Minnesota Regenerative Medicine Initiative	National Institutes of Health, Grant/Award Number: HL112852 and HL130072; MSTP, Grant/Award Number: T32GM008244; The Hartwell Foundation; Minnesota Regenerative Medicine Initiative	Alfakir M, 2012, INT J CARDIOL, V156, P133, DOI 10.1016/j.ijcard.2010.10.025; Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bergmann O, 2015, CELL, V161, P1566, DOI 10.1016/j.cell.2015.05.026; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bollini S, 2014, STEM CELLS DEV, V23, P1719, DOI 10.1089/scd.2014.0019; Brooks WW, 2009, COMPARATIVE MED, V59, P339; Chen ZM, 2017, CIRCULATION, V136, P2359, DOI 10.1161/CIRCULATIONAHA.117.030137; Chiong M, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.130; Darwich AS, 2014, DRUG METAB DISPOS, V42, P2016, DOI 10.1124/dmd.114.058404; Deb A, 2003, CIRCULATION, V107, P1247, DOI 10.1161/01.CIR.0000061910.39145.F0; Dekaney CM, 2005, GASTROENTEROLOGY, V129, P1567, DOI 10.1053/j.gastro.2005.08.011; Dey D, 2013, CIRC RES, V112, P1253, DOI 10.1161/CIRCRESAHA.112.300779; Epelman S, 2014, IMMUNITY, V40, P91, DOI 10.1016/j.immuni.2013.11.019; Epstein JA, 2019, JAMA CARDIOL, V4, P95, DOI 10.1001/jamacardio.2018.4435; Ergen Aysegul V, 2013, Methods Mol Biol, V946, P151, DOI 10.1007/978-1-62703-128-8_10; Eschenhagen T, 2017, CIRCULATION, V136, P680, DOI 10.1161/CIRCULATIONAHA.117.029343; Fatima S, 2012, STEM CELLS, V30, P210, DOI 10.1002/stem.1002; Fioret BA, 2014, CELL REP, V8, P229, DOI 10.1016/j.celrep.2014.06.004; Garbern JC, 2013, CELL STEM CELL, V12, P689, DOI 10.1016/j.stem.2013.05.008; Golebiewska A, 2011, CELL STEM CELL, V8, P136, DOI 10.1016/j.stem.2011.01.007; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Gundewar S, 2007, AM J PHYSIOL-HEART C, V293, pH2462, DOI 10.1152/ajpheart.00392.2007; He LJ, 2017, NAT MED, V23, P1488, DOI 10.1038/nm.4437; Hierlihy AM, 2002, FEBS LETT, V530, P239, DOI 10.1016/S0014-5793(02)03477-4; Higashikuni Y, 2010, ARTERIOSCL THROM VAS, V30, P2128, DOI 10.1161/ATVBAHA.110.211755; Hong KU, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096725; Horsey AJ, 2016, BIOCHEM SOC T, V44, P824, DOI 10.1042/BST20160014; Hsieh PCH, 2007, NAT MED, V13, P970, DOI 10.1038/nm1618; Jackson KA, 2001, J CLIN INVEST, V107, P1395, DOI 10.1172/JCI12150; Kretzschmar K, 2018, P NATL ACAD SCI USA, V115, pE12245, DOI 10.1073/pnas.1805829115; Krishnamurthy P, 2006, ANNU REV PHARMACOL, V46, P381, DOI 10.1146/annurev.pharmtox.46.120604.141238; Leach JP, 2017, NATURE, V550, P260, DOI 10.1038/nature24045; Li Y, 2018, CIRCULATION, V138, P793, DOI 10.1161/CIRCULATIONAHA.118.034250; Liang SX, 2010, INT J CARDIOL, V138, P40, DOI 10.1016/j.ijcard.2008.08.032; Liu QZ, 2016, CELL RES, V26, P119, DOI 10.1038/cr.2015.143; Luongo TS, 2017, NATURE, V545, P93, DOI 10.1038/nature22082; Martin CM, 2004, DEV BIOL, V265, P262, DOI 10.1016/j.ydbio.2003.09.028; Matsuura K, 2004, J CELL BIOL, V167, P351, DOI 10.1083/jcb.200312111; Meissner K, 2006, J HISTOCHEM CYTOCHEM, V54, P215, DOI 10.1369/jhc.5A6750.2005; Min YL, 2018, P NATL ACAD SCI USA, V115, pE8430, DOI 10.1073/pnas.1800526115; Mouquet F, 2005, CIRC RES, V97, P1090, DOI 10.1161/01.RES.0000194330.66545.f5; Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446; Nakada Y, 2017, NATURE, V541, P222, DOI 10.1038/nature20173; Noseda M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7930; Nygren JM, 2004, NAT MED, V10, P494, DOI 10.1038/nm1040; O'Connell Timothy D, 2007, Methods Mol Biol, V357, P271; Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100; Okabe K, 2014, CELL, V159, P584, DOI 10.1016/j.cell.2014.09.025; Oyama T, 2007, J CELL BIOL, V176, P329, DOI 10.1083/jcb.200603014; Parsons SA, 2004, J BIOL CHEM, V279, P26192, DOI 10.1074/jbc.M313800200; Pfister O, 2005, CIRC RES, V97, P52, DOI 10.1161/01.RES.0000173297.53793.fa; Pfister O, 2008, CIRC RES, V103, P825, DOI 10.1161/CIRCRESAHA.108.174615; Pfister O, 2010, METHODS MOL BIOL, V660, P53, DOI 10.1007/978-1-60761-705-1_4; Sanganalmath SK, 2013, CIRC RES, V113, P810, DOI 10.1161/CIRCRESAHA.113.300219; Sawamiphak S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01555-8; Senyo SE, 2013, NATURE, V493, P433, DOI 10.1038/nature11682; Solbach TF, 2008, N-S ARCH PHARMACOL, V377, P231, DOI 10.1007/s00210-008-0279-6; Sultana N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9701; Tzahor E, 2017, SCIENCE, V356, P1035, DOI 10.1126/science.aam5894; Unno K, 2012, CIRC RES, V110, P1355, DOI 10.1161/CIRCRESAHA.111.243014; van Berlo JH, 2016, CIRC RES, V118, P17, DOI 10.1161/CIRCRESAHA.115.307934; van Berlo JH, 2014, NAT MED, V20, P1386, DOI 10.1038/nm.3764; van Berlo JH, 2014, NATURE, V509, P337, DOI 10.1038/nature13309; van Empel VPM, 2005, CARDIOVASC RES, V67, P21, DOI 10.1016/j.cardiores.2005.04.012; von Furstenberg RJ, 2014, STEM CELL RES, V12, P364, DOI 10.1016/j.scr.2013.10.012; Wallner M, 2016, CIRC RES, V119, P865, DOI 10.1161/CIRCRESAHA.116.308687; Wu JMF, 2015, CIRC RES, V116, P633, DOI 10.1161/CIRCRESAHA.116.304564; Yellamilli A, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00102; Zhou S, 2002, P NATL ACAD SCI USA, V99, P12339, DOI 10.1073/pnas.192276999; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	71	6	6	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5642	5657		10.1096/fj.201902105R	http://dx.doi.org/10.1096/fj.201902105R		FEB 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32100368	Green Submitted, Green Accepted			2022-12-28	WOS:000517898300001
J	Nam, TS; Park, DR; Rah, SY; Woo, TG; Chung, HT; Brenner, C; Kim, UH				Nam, Tae-Sik; Park, Dae-Ryoung; Rah, So-Young; Woo, Tae-Gyu; Chung, Hun Taeg; Brenner, Charles; Kim, Uh-Hyun			Interleukin-8 drives CD38 to form NAADP from NADP(+)and NAAD in the endolysosomes to mobilize Ca(2+)and effect cell migration	FASEB JOURNAL			English	Article						calcium; cell migration; nicotinamide adenine dinucleotide; signal transduction	ADENINE-DINUCLEOTIDE PHOSPHATE; CYCLIC ADP-RIBOSE; NICOTINIC-ACID; NAD(+); CA2+; CAMP	Nicotinic acid adenine dinucleotide phosphate (NAADP) is the most potent Ca(2+)mobilizing second messenger whose formation has remained elusive. In vitro, CD38-mediated NAADP synthesis requires an acidic pH and a nonphysiological concentration of nicotinic acid (NA). We discovered that CD38 catalyzes synthesis of NAADP by exchanging the nicotinamide moiety of nicotinamide adenine dinucleotide phosphate (NADP(+)) for the NA group of nicotinic acid adenine dinucleotide (NAAD) inside endolysosomes of interleukin 8 (IL8)-treated lymphokine-activated killer (LAK) cells. Upon IL8 stimulation, cytosolic NADP(+)is transported to acidified endolysosomes via connexin 43 (Cx43) and gated by cAMP-EPAC-RAP1-PP2A signaling. CD38 then performs a base-exchange reaction with the donor NA group deriving from NAAD, produced by newly described endolysosomal activities of NA phosphoribosyltransferase (NAPRT) and NMN adenyltransferase (NMNAT) 3. Thus, the membrane organization of endolysosomal CD38, a signal-mediated transport system for NADP(+)and luminal NAD(+)biosynthetic enzymes integrate signals from a chemokine and cAMP to specify the spatiotemporal mobilization of Ca(2+)to drive cell migration.	[Nam, Tae-Sik; Park, Dae-Ryoung; Rah, So-Young; Woo, Tae-Gyu; Kim, Uh-Hyun] Chonbuk Natl Univ, Med Sch, Dept Biochem, Jeonju 561182, South Korea; [Nam, Tae-Sik; Park, Dae-Ryoung; Rah, So-Young; Woo, Tae-Gyu; Kim, Uh-Hyun] Chonbuk Natl Univ, Med Sch, Natl Creat Res Lab Signaling Ca2, Jeonju, South Korea; [Chung, Hun Taeg] Univ Ulsan, Dept Biol Sci, Ulsan, South Korea; [Brenner, Charles] Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA	Jeonbuk National University; Jeonbuk National University; University of Ulsan; University of Iowa	Kim, UH (corresponding author), Chonbuk Natl Univ, Med Sch, Dept Biochem, Jeonju 561182, South Korea.; Brenner, C (corresponding author), Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA.	charles-brenner@uiowa.edu; uhkim@chonbuk.ac.kr	Brenner, Charles/D-6339-2014	Brenner, Charles/0000-0002-4955-3226; Rah, So-Young/0000-0002-0255-1960	National Research Foundation of Korea (NRF) [2012R1A3A2026453, 2014R1A6A1030318]; Roy J. Carver Trust	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Roy J. Carver Trust	National Research Foundation of Korea (NRF), Grant/Award Number: 2012R1A3A2026453, 2014R1A6A1030318 and 2012R1A3A2026453; Roy J. Carver Trust	Aarhus R, 1995, J BIOL CHEM, V270, P30327, DOI 10.1074/jbc.270.51.30327; Ai X, 2005, CIRC RES, V96, P54, DOI 10.1161/01.RES.0000152325.07495.5a; Almahariq M, 2013, MOL PHARMACOL, V83, P122, DOI 10.1124/mol.112.080689; Berger F, 2005, J BIOL CHEM, V280, P36334, DOI 10.1074/jbc.M508660200; Bieganowski P, 2003, J BIOL CHEM, V278, P33049, DOI 10.1074/jbc.M302257200; Bogan KL, 2008, ANNU REV NUTR, V28, P115, DOI 10.1146/annurev.nutr.28.061807.155443; Bruzzone S, 2001, FASEB J, V15, P10; Cancela JM, 1999, NATURE, V398, P74, DOI 10.1038/18032; Churchill GC, 2003, CURR BIOL, V13, P125, DOI 10.1016/S0960-9822(03)00002-2; Churchill GC, 2002, CELL, V111, P703, DOI 10.1016/S0092-8674(02)01082-6; Fujita T, 2005, CELL SIGNAL, V17, P167, DOI 10.1016/j.cellsig.2004.06.008; Graeff R, 2002, BIOCHEM J, V367, P163, DOI 10.1042/BJ20020644; Graeff RM, 1998, J BIOL CHEM, V273, P118, DOI 10.1074/jbc.273.1.118; Guse AH, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.144re10; Hara N, 2007, J BIOL CHEM, V282, P24574, DOI 10.1074/jbc.M610357200; Hong K, 2008, J BIOL CHEM, V283, P23129, DOI 10.1074/jbc.M800478200; Kato Y, 2015, ARTERIOSCL THROM VAS, V35, P2617, DOI 10.1161/ATVBAHA.115.306534; KIM UH, 1993, BIOCHIM BIOPHYS ACTA, V1178, P121, DOI 10.1016/0167-4889(93)90001-6; LEE HC, 1995, J BIOL CHEM, V270, P9060, DOI 10.1074/jbc.270.16.9060; Lorraine C, 2015, BIOCHEM SOC T, V43, P482, DOI 10.1042/BST20150034; Park DR, 2019, FASEB J, V33, P3404, DOI 10.1096/fj.201800235R; Park KH, 2013, J BIOL CHEM, V288, P35548, DOI 10.1074/jbc.M113.489278; Rah SY, 2015, SCI REP-UK, V5, DOI 10.1038/srep10741; Rah SY, 2010, J BIOL CHEM, V285, P21877, DOI 10.1074/jbc.M109.066290; Rah SY, 2005, J BIOL CHEM, V280, P2888, DOI 10.1074/jbc.M409592200; Ring S, 2015, J IMMUNOL, V194, P3735, DOI 10.4049/jimmunol.1401434; Stransky L, 2016, PHYSIOL REV, V96, P1071, DOI 10.1152/physrev.00035.2015; Tong L, 2009, J BIOL CHEM, V284, P11256, DOI 10.1074/jbc.M809790200; Trammell SAJ, 2013, COMPUT STRUCT BIOTEC, V4, DOI 10.5936/csbj.201301012; Vasudevan SR, 2008, BIOCHEM J, V411, P63, DOI 10.1042/BJ20071616; Wiggins HL, 2010, BIOTECHNIQUES, V48, P120, DOI 10.2144/000113353; Wilson HL, 1998, BIOCHEM J, V331, P837, DOI 10.1042/bj3310837; Xu YQ, 2012, J BIOL CHEM, V287, P26409, DOI 10.1074/jbc.M112.352229; Yamamoto M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147037; Yen MC, 2009, CLIN CANCER RES, V15, P641, DOI 10.1158/1078-0432.CCR-08-1988; Yoshino J, 2013, METHODS MOL BIOL, V1077, P203, DOI 10.1007/978-1-62703-637-5_14; Zhang ZQ, 2000, ANAL BIOCHEM, V285, P163, DOI 10.1006/abio.2000.4701; Zhao YJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002700	38	13	13	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12565	12576		10.1096/fj.202001249R	http://dx.doi.org/10.1096/fj.202001249R		JUL 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32717131				2022-12-28	WOS:000556425100001
J	Malik, R; Corrales, C; Linsenmeier, M; Alalami, H; Sepanj, N; Bitan, G				Malik, Ravinder; Corrales, Christian; Linsenmeier, Miriam; Alalami, Huda; Sepanj, Niki; Bitan, Gal			Examination of SOD1 aggregation modulators and their effect on SOD1 enzymatic activity as a proxy for potential toxicity	FASEB JOURNAL			English	Article						Proteinopathies; amyloid; enzyme activity; Thioflavin T; therapeutic index	ZINC SUPEROXIDE-DISMUTASE; AMYLOIDOGENIC PROTEINS; COPPER; INHIBITORS; MICE; MECHANISM	Small-molecule inhibitors of abnormal protein self-assembly are promising candidates for developing therapy against proteinopathies. Such compounds have been examined primarily as inhibitors of amyloid beta-protein (A beta), whereas testing of inhibitors of other amyloidogenic proteins has lagged behind. An important issue with screening compound libraries is that although an inhibitor suitable for therapy must be both effective and nontoxic, typical screening focuses on efficacy, whereas safety typically is tested at a later stage using cells and/or animals. In addition, typical thioflavin T (ThT)-fluorescence-based screens use the final fluorescence value as a readout, potentially missing important kinetic information. Here, we examined potential inhibitors of superoxide dismutase 1 (SOD1) using ThT-fluorescence including the different phases of fluorescence change and added a parallel screen of SOD1 activity as a potential proxy for compound toxicity. Some compounds previously reported to inhibit other amyloidogenic proteins also inhibited SOD1 aggregation at low micromolar concentrations, whereas others were ineffective. Analysis of the lag phase and exponential slope added important information that could help exclude false-positive or false-negative results. SOD1 was highly resistant to inhibition of its activity, and therefore, did not have the necessary sensitivity to serve as a proxy for examining potential toxicity.	[Malik, Ravinder; Corrales, Christian; Linsenmeier, Miriam; Alalami, Huda; Sepanj, Niki; Bitan, Gal] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Bitan, Gal] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA; [Bitan, Gal] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Linsenmeier, Miriam] Swiss Fed Inst Technol, Dept Chem & Appl Biosci, Inst Chem & Bioengn, Vladimir Prelog Weg 1-5-10, CH-8093 Zurich, Switzerland	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Swiss Federal Institutes of Technology Domain; ETH Zurich	Bitan, G (corresponding author), Gordon Neurosci Res Bldg 451, Los Angeles, CA 90095 USA.	gbitan@mednet.ucla.edu	Bitan, Gal/U-2204-2019	Bitan, Gal/0000-0001-7046-3754	HHS \ NIH \ National Institute on Aging (NIA) [R01AG050721]; RGK Foundation [20143057]	HHS \ NIH \ National Institute on Aging (NIA); RGK Foundation	HHS vertical bar NIH vertical bar National Institute on Aging (NIA), Grant/Award Number: R01AG050721; RGK Foundation, Grant/Award Number: 20143057	Abdolvahabi A, 2017, ACS CHEM NEUROSCI, V8, P1378, DOI 10.1021/acschemneuro.7b00029; Abdolvahabi A, 2016, ACS CHEM NEUROSCI, V7, P799, DOI 10.1021/acschemneuro.6b00048; Andrich K, 2015, ADV EXP MED BIOL, V863, P139, DOI 10.1007/978-3-319-18365-7_7; Anzai I, 2016, FRONT MOL BIOSCI, V3, DOI 10.3389/fmolb.2016.00040; Atlasi RS, 2018, ACS CHEM BIOL, V13, P2794, DOI 10.1021/acschembio.8b00729; Biancalana M, 2010, BBA-PROTEINS PROTEOM, V1804, P1405, DOI 10.1016/j.bbapap.2010.04.001; Bitan G, 2019, PROG MOL BIOL TRANSL, V168, P277, DOI 10.1016/bs.pmbts.2019.07.010; Brennan RE, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0430-8; Bunton-Stasyshyn RKA, 2015, NEUROSCIENTIST, V21, P519, DOI 10.1177/1073858414561795; Cantu-Medellin N, 2013, REDOX BIOL, V1, P353, DOI 10.1016/j.redox.2013.05.002; Chattopadhyay M, 2008, P NATL ACAD SCI USA, V105, P18663, DOI 10.1073/pnas.0807058105; Core Team R, 2013, R LANG ENV STAT COMP; Dong XW, 2016, CHEM SCI, V7, P6251, DOI 10.1039/c6sc01272h; Doucette PA, 2004, J BIOL CHEM, V279, P54558, DOI 10.1074/jbc.M409744200; Eisele YS, 2015, NAT REV DRUG DISCOV, V14, P759, DOI 10.1038/nrd4593; Flora Gagan, 2012, Interdiscip Toxicol, V5, P47, DOI 10.2478/v10102-012-0009-2; GETZOFF ED, 1983, NATURE, V306, P287, DOI 10.1038/306287a0; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Knowles TPJ, 2009, SCIENCE, V326, P1533, DOI 10.1126/science.1178250; Lang L, 2015, P NATL ACAD SCI USA, V112, P9878, DOI 10.1073/pnas.1503328112; Liu TY, 2012, CHEMMEDCHEM, V7, P359, DOI 10.1002/cmdc.201100585; Malik R, 2019, J BIOL CHEM, V294, P3501, DOI 10.1074/jbc.RA118.005940; Metrick MA, 2020, ACTA NEUROPATHOL COM, V8, DOI 10.1186/s40478-020-0887-z; Metrick MA, 2019, P NATL ACAD SCI USA, V116, P23029, DOI 10.1073/pnas.1909322116; MISRA HP, 1979, J BIOL CHEM, V254, P1623; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Palhano FL, 2013, J AM CHEM SOC, V135, P7503, DOI 10.1021/ja3115696; Rahimi F, 2016, DEVELOPING THERAPEUTICS FOR ALZHEIMER'S DISEASE: PROGRESS AND CHALLENGES, P97, DOI 10.1016/B978-0-12-802173-6.00006-X; Rodriguez JA, 2002, J BIOL CHEM, V277, P15932, DOI 10.1074/jbc.M112088200; Sakellariou GK, 2018, ANTIOXID REDOX SIGN, V28, P275, DOI 10.1089/ars.2017.7249; Sangwan S, 2017, P NATL ACAD SCI USA, V114, P8770, DOI 10.1073/pnas.1705091114; Sato M, 2013, J BIOL CHEM, V288, P23212, DOI 10.1074/jbc.M113.464222; Schrader T, 2016, CHEM COMMUN, V52, P11318, DOI 10.1039/c6cc04640a; Sehati S, 2011, FREE RADICAL BIO MED, V50, P1591, DOI 10.1016/j.freeradbiomed.2011.03.004; Sheng YW, 2012, CURR TOP MED CHEM, V12, P2560; Somwar R, 2011, P NATL ACAD SCI USA, V108, P16375, DOI 10.1073/pnas.1113554108; Sutherland MW, 1997, FREE RADICAL RES, V27, P283, DOI 10.3109/10715769709065766; Sweeney P, 2017, TRANSL NEURODEGENER, V6, DOI 10.1186/s40035-017-0077-5; Talbiersky P, 2008, J AM CHEM SOC, V130, P9824, DOI 10.1021/ja801441j; Toichi K, 2013, J BIOL CHEM, V288, P4970, DOI 10.1074/jbc.M112.414235; Tokuda E, 2018, BBA-MOL BASIS DIS, V1864, P2119, DOI 10.1016/j.bbadis.2018.03.015; Weissmann N, 2000, AM J PHYSIOL-LUNG C, V279, pL683, DOI 10.1152/ajplung.2000.279.4.L683; ZOLNIEROWICZ S, 1988, BIOCHEM INT, V17, P303	44	3	3	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					11957	11969		10.1096/fj.202000948R	http://dx.doi.org/10.1096/fj.202000948R		JUL 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32701214	Green Published, Green Accepted			2022-12-28	WOS:000555048200001
J	Seidl, MD; Fels, B; Kranick, D; Sternberg, A; Grimm, K; Stumpel, FT; Pluteanu, F; Schulte, JS; Heinick, A; Kojima, N; Endo, S; Huge, A; Stoll, M; Muller, FU				Seidl, Matthias D.; Fels, Benedikt; Kranick, Daniel; Sternberg, Alexandra; Grimm, Kristina; Stuempel, Frank T.; Pluteanu, Florentina; Schulte, Jan S.; Heinick, Alexander; Kojima, Nobuhiko; Endo, Shogo; Huge, Andreas; Stoll, Monika; Mueller, Frank U.			Induction of ICER is superseded by smICER, challenging the impact of ICER under chronic beta-adrenergic stimulation	FASEB JOURNAL			English	Article						cyclic AMP (cAMP); gene regulation; heart; transcription factors	CAMP EARLY REPRESSOR; RESPONSE ELEMENT MODULATOR; CREM GENE; TRANSCRIPTIONAL REGULATION; NUCLEAR-FACTOR; T-CELLS; EXPRESSION; REGULATOR; APOPTOSIS; PROMOTER	ICER (inducible cAMP early repressor) isoforms are transcriptional repressors encoded by theCrem(cAMP responsive element modulator) gene. They were linked to the regulation of a multitude of cellular processes and pathophysiological mechanisms. Here, we show for the first time that two independent induction patterns for CREM repressor isoforms exist in the heart, namely for ICER and smICER (small ICER), which are induced in response to beta-adrenergic stimulation in a transient- and saturation-like manner, respectively. This time-shifted induction pattern, driven by two internal promoters in theCremgene, leads to the predominant transcription ofsmIcerafter prolonged beta-adrenergic stimulation. Using an ICER knockout mouse model with preserved smICER induction, we show that the transient-like induction ofIceritself has minor effects on gene regulation, cardiac hypertrophy or contractile function in the heart. We conclude that the functions previously linked to ICER may be rather attributed to smICER, also beyond the cardiac background.	[Seidl, Matthias D.; Fels, Benedikt; Kranick, Daniel; Sternberg, Alexandra; Grimm, Kristina; Stuempel, Frank T.; Pluteanu, Florentina; Schulte, Jan S.; Heinick, Alexander; Mueller, Frank U.] Univ Munster, Inst Pharmacol & Toxicol, Domagkstr 12, D-48149 Munster, Germany; [Kojima, Nobuhiko] Toyo Univ, Fac Life Sci, Gunma, Japan; [Endo, Shogo] Tokyo Metropolitan Inst Gerontol, Aging Neurosci Res Team, Tokyo, Japan; [Huge, Andreas; Stoll, Monika] Univ Munster, Fac Med, Core Facil Genomik, Munster, Germany	University of Munster; Toyo University; Tokyo Metropolitan Institute of Gerontology; University of Munster	Seidl, MD (corresponding author), Univ Munster, Inst Pharmacol & Toxicol, Domagkstr 12, D-48149 Munster, Germany.	seidl@uni-muenster.de	Pluteanu, Florentina/R-8630-2018	Pluteanu, Florentina/0000-0003-0743-0129; Heinick, Alexander/0000-0002-3770-105X	Deutsche Forschungsgemeinschaft [Mu1376/11-1, Mu1376/11-3]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Deutsche Forschungsgemeinschaft, Grant/Award Number: Mu1376/11-1 and Mu1376/11-3	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Behr R, 2000, MOL HUM REPROD, V6, P967, DOI 10.1093/molehr/6.11.967; Bieganska K, 2012, NEUROBIOL DIS, V45, P701, DOI 10.1016/j.nbd.2011.10.015; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Borlikova G, 2009, MOL NEUROBIOL, V40, P73, DOI 10.1007/s12035-009-8072-1; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Catz SD, 2001, ONCOGENE, V20, P7342, DOI 10.1038/sj.onc.1204926; Chiappini F, 2013, MOL CELL ENDOCRINOL, V365, P84, DOI 10.1016/j.mce.2012.09.006; Daniel PB, 2000, ENDOCRINOLOGY, V141, P3923, DOI 10.1210/en.141.11.3923; DELMAS V, 1992, P NATL ACAD SCI USA, V89, P4226, DOI 10.1073/pnas.89.10.4226; Ding B, 2005, P NATL ACAD SCI USA, V102, P14771, DOI 10.1073/pnas.0506489102; Ding B, 2005, CIRCULATION, V111, P2469, DOI 10.1161/01.CIR.0000165128.39715.87; Don J, 2002, MOL CELL ENDOCRINOL, V187, P115, DOI 10.1016/S0303-7207(01)00696-7; Favre D, 2011, DIABETOLOGIA, V54, P2337, DOI 10.1007/s00125-011-2165-x; Feng JX, 2012, NAT PROTOC, V7, P1728, DOI 10.1038/nprot.2012.101; Folco EJ, 1997, BIOCHEM J, V328, P37; FOULKES NS, 1991, CELL, V64, P739, DOI 10.1016/0092-8674(91)90503-Q; Gellersen B, 1997, MOL ENDOCRINOL, V11, P97, DOI 10.1210/me.11.1.97; Gellersen B, 2002, MOL HUM REPROD, V8, P965, DOI 10.1093/molehr/8.11.965; Green TA, 2006, J NEUROSCI, V26, P8235, DOI 10.1523/JNEUROSCI.0880-06.2006; Heinick A, 2015, FASEB J, V29, P3773, DOI 10.1096/fj.14-269837; Huang WC, 2013, BIOINFORMATICS, V29, P3097, DOI 10.1093/bioinformatics/btt520; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Inada A, 2004, MOL CELL BIOL, V24, P2831, DOI 10.1128/MCB.24.7.2831-2841.2004; Jaspers S, 2007, J ANDROL, V28, P59, DOI 10.2164/jandrol.106.000976; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kojima N, 2008, J NEUROSCI, V28, P6459, DOI 10.1523/JNEUROSCI.0412-08.2008; Kosir R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031798; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Ma D, 2009, EUR J PHARMACOL, V602, P348, DOI 10.1016/j.ejphar.2008.11.002; Martianov I, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-530; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Mioduszewska B, 2003, J NEUROCHEM, V87, P1313, DOI 10.1046/j.1471-4159.2003.02116.x; MOLINA CA, 1993, CELL, V75, P875, DOI 10.1016/0092-8674(93)90532-U; Monaco L, 2004, INT J ANDROL, V27, P322, DOI 10.1111/j.1365-2605.2004.00494.x; Muller FU, 1998, FASEB J, V12, P1191; Muller FU, 2005, J BIOL CHEM, V280, P6906, DOI 10.1074/jbc.M407864200; Myers R, 2015, CIRC-ARRHYTHMIA ELEC, V8, P942, DOI 10.1161/CIRCEP.114.002162; Nervina JM, 2003, BONE, V32, P483, DOI 10.1016/S8756-3282(03)00056-5; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rauen T, 2013, TRENDS MOL MED, V19, P262, DOI 10.1016/j.molmed.2013.02.001; Rauen T, 2011, J BIOL CHEM, V286, P32366, DOI 10.1074/jbc.M111.245811; SassoneCorsi P, 1995, ANNU REV CELL DEV BI, V11, P355, DOI 10.1146/annurev.cellbio.11.1.355; Schulte JS, 2016, BASIC RES CARDIOL, V111, DOI 10.1007/s00395-016-0532-y; Seidl MD, 2017, CIRC-ARRHYTHMIA ELEC, V10, DOI 10.1161/CIRCEP.117.005075; Seidl MD, 2014, FASEB J, V28, P143, DOI 10.1096/fj.13-231977; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tomita H, 2003, CIRC RES, V93, P12, DOI 10.1161/01.RES.0000079794.57578.F1; Vaeth M, 2011, P NATL ACAD SCI USA, V108, P2480, DOI 10.1073/pnas.1009463108; Xiang H, 2006, MOL CELL BIOL, V26, P8599, DOI 10.1128/MCB.01062-06; Xu WD, 2012, CELL IMMUNOL, V276, P10, DOI 10.1016/j.cellimm.2012.04.008; Yan C, 2007, CIRC RES, V100, P489, DOI 10.1161/01.RES.0000258451.44949.d7; Yan C, 2007, CIRC RES, V100, P510, DOI 10.1161/01.RES.0000259045.49371.9c	54	1	1	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					11272	11291		10.1096/fj.201902301RR	http://dx.doi.org/10.1096/fj.201902301RR		JUN 2020	20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32602979	hybrid			2022-12-28	WOS:000546040800001
J	Rolicka, A; Guo, Y; Zapater, AG; Tariq, K; Quin, J; Vintermist, A; Sadeghifar, F; Arsenian-Henriksson, M; Farrants, AKO				Rolicka, Anna; Guo, Yuan; Ganez Zapater, Antoni; Tariq, Kanwal; Quin, Jaclyn; Vintermist, Anna; Sadeghifar, Fatemeh; Arsenian-Henriksson, Marie; Ostlund Farrants, Ann-Kristin			The chromatin-remodeling complexes B-WICH and NuRD regulate ribosomal transcription in response to glucose	FASEB JOURNAL			English	Article						CHD4; chromatin remodeling; c-MYC; ribosomal genes; TTF-1; WSTF	RNA-POLYMERASE-I; EPIGENETIC REGULATION; TIF-IA; GENES; DNA; BIOGENESIS; NORC; REPRESSION; EXPRESSION; PROMOTER	Regulation of ribosomal transcription is under tight control from environmental stimuli, and this control involves changes in the chromatin structure. The underlying mechanism of how chromatin changes in response to nutrient and energy supply in the cell is still unclear. The chromatin-remodeling complex B-WICH is involved in activating the ribosomal transcription, and we show here that knock down of the B-WICH component WSTF results in cells that do not respond to glucose. The promoter is less accessible, and RNA pol I and its transcription factors SL1/TIF-1B and RRN3/TIF-1A, as well as the proto-oncogene c-MYC and the activating deacetylase SIRT7 do not bind upon glucose stimulation. In contrast, the repressive chromatin state that forms after glucose deprivation is reversible, and RNA pol I factors are recruited. WSTF knock down results in an accumulation of the ATPase CHD4, a component of the NuRD chromatin remodeling complex, which is responsible for establishing a repressive poised state at the promoter. The TTF-1, which binds and affect the binding of the chromatin complexes, is important to control the association of activating chromatin component UBF. We suggest that B-WICH is required to allow for a shift to an active chromatin state upon environmental stimulation, by counteracting the repressive state induced by the NuRD complex.	[Rolicka, Anna; Guo, Yuan; Ganez Zapater, Antoni; Tariq, Kanwal; Quin, Jaclyn; Vintermist, Anna; Sadeghifar, Fatemeh; Ostlund Farrants, Ann-Kristin] Stockholm Univ, Dept Mol Biosci, Wenner Gren Inst, Arrhenius Lab F4, SE-10691 Stockholm, Sweden; [Arsenian-Henriksson, Marie] Karolinska Inst, Dept Microbiol Tumor & Cell Biol MTC, Biomedicum B7, Stockholm, Sweden; [Rolicka, Anna] Warsaw Univ Life Sci, Fac Anim Sci, Dept Genet & Anim Breeding, SGGW, Warsaw, Poland; [Sadeghifar, Fatemeh] Hakim Sabzevari Univ, Dept Sci, Sabzevar, Iran	Stockholm University; Karolinska Institutet; Warsaw University of Life Sciences	Farrants, AKO (corresponding author), Stockholm Univ, Dept Mol Biosci, Wenner Gren Inst, Arrhenius Lab F4, SE-10691 Stockholm, Sweden.	anki.ostlund@su.se	Henriksson, Marie Arsenian/F-5010-2015	Ganez Zapater, Antoni/0000-0002-6852-4834; Arsenian Henriksson, Marie/0000-0001-6376-7792; Tariq, Kanwal/0000-0003-4810-2076	Carl Tryggers stiftelse for vetenskaplig forskning [CTS15:568]; Magnus Bergvalls Stiftelse; Department of Molecular Biosciences, the Wenner-Gren Institute, Stockholm University	Carl Tryggers stiftelse for vetenskaplig forskning; Magnus Bergvalls Stiftelse; Department of Molecular Biosciences, the Wenner-Gren Institute, Stockholm University	Carl Tryggers stiftelse for vetenskaplig forskning (CTS15:568) and Magnus Bergvalls Stiftelse. Funding for open access charge: Department of Molecular Biosciences, the Wenner-Gren Institute, Stockholm University.	Anosova I, 2015, NUCLEIC ACIDS RES, V43, P5208, DOI 10.1093/nar/gkv365; Arabi A, 2005, NAT CELL BIOL, V7, P303, DOI 10.1038/ncb1225; Blattner C, 2011, GENE DEV, V25, P2093, DOI 10.1101/gad.17363311; Brown SE, 2007, MOL CELL BIOL, V27, P4938, DOI 10.1128/MCB.01880-06; Cavellan E, 2006, J BIOL CHEM, V281, P16264, DOI 10.1074/jbc.M600233200; Chen SF, 2013, MOL CELL, V52, P303, DOI 10.1016/j.molcel.2013.10.010; Cus R, 2006, GENE EXPR PATTERNS, V6, P340, DOI 10.1016/j.modgep.2005.10.001; Engel C, 2017, CELL, V169, P120, DOI 10.1016/j.cell.2017.03.003; Engel C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12129; Ford E, 2006, GENE DEV, V20, P1075, DOI 10.1101/gad.1399706; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Grob A, 2009, J CELL SCI, V122, P489, DOI 10.1242/jcs.042382; Grummt I, 2013, BBA-GENE REGUL MECH, V1829, P393, DOI 10.1016/j.bbagrm.2012.10.004; Hamdane N, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004505; Hannan KM, 2013, BBA-GENE REGUL MECH, V1829, P342, DOI 10.1016/j.bbagrm.2012.10.014; Hoppe S, 2009, P NATL ACAD SCI USA, V106, P17781, DOI 10.1073/pnas.0909873106; Hung SS, 2017, GENE, V612, P36, DOI 10.1016/j.gene.2016.12.015; Jin R, 2016, BBA-REV CANCER, V1866, P189, DOI 10.1016/j.bbcan.2016.09.003; Koch S, 2014, CELL CYCLE, V13, P2029, DOI 10.4161/cc.29018; Kusnadi EP, 2015, GENE, V556, P27, DOI 10.1016/j.gene.2014.11.010; Lee D, 2017, P NATL ACAD SCI USA, V114, pE3424, DOI 10.1073/pnas.1701978114; Lessard F, 2012, NUCLEIC ACIDS RES, V40, P5357, DOI 10.1093/nar/gks198; Lessard F, 2010, MOL CELL, V38, P539, DOI 10.1016/j.molcel.2010.03.015; Li JW, 2006, EMBO J, V25, P5735, DOI 10.1038/sj.emboj.7601454; Ling T, 2013, BIOCHEM BIOPH RES CO, V437, P101, DOI 10.1016/j.bbrc.2013.06.045; Low JKK, 2016, J BIOL CHEM, V291, P15853, DOI 10.1074/jbc.M115.707018; Lu XJ, 1998, GENOMICS, V54, P241, DOI 10.1006/geno.1998.5578; Manelyte L, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004157; Mars JC, 2018, G3-GENES GENOM GENET, V8, P303, DOI 10.1534/g3.117.300225; Mayer C, 2006, MOL CELL, V22, P351, DOI 10.1016/j.molcel.2006.03.028; Moss T, 2007, CELL MOL LIFE SCI, V64, P29, DOI 10.1007/s00018-006-6278-1; Moss T, 2019, CHROMOSOME RES, V27, P31, DOI 10.1007/s10577-018-09603-9; Murayama A, 2008, CELL, V133, P627, DOI 10.1016/j.cell.2008.03.030; Nemeth A, 2004, NUCLEIC ACIDS RES, V32, P4091, DOI 10.1093/nar/gkh732; Nemeth A, 2008, EMBO J, V27, P1255, DOI 10.1038/emboj.2008.57; Percipalle P, 2006, EMBO REP, V7, P525, DOI 10.1038/sj.embor.7400657; Philimonenko VV, 2004, NAT CELL BIOL, V6, P1165, DOI 10.1038/ncb1190; Pilsl M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12126; Sadeghifar F, 2015, NUCLEIC ACIDS RES, V43, P4477, DOI 10.1093/nar/gkv312; Salminen A, 2009, BIOCHEM BIOPH RES CO, V378, P6, DOI 10.1016/j.bbrc.2008.11.023; Sanij E, 2009, EPIGENETICS-US, V4, P274, DOI 10.4161/epi.4.6.9449; Santoro R, 2005, MOL CELL BIOL, V25, P2539, DOI 10.1128/MCB.25.7.2539-2546.2005; Sarshad A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003397; Sharifi S, 2018, ANNU REV BIOCHEM, V87, P51, DOI 10.1146/annurev-biochem-062917-012612; Shen MQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057667; Shiue CN, 2009, ONCOGENE, V28, P1833, DOI 10.1038/onc.2009.21; Shiue CN, 2014, NUCLEIC ACIDS RES, V42, P5505, DOI 10.1093/nar/gku183; Tsai YC, 2012, MOL CELL PROTEOMICS, V11, P60, DOI 10.1074/mcp.A111.015156; Vintermist A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019184; von Walden F, 2012, AM J PHYSIOL-CELL PH, V302, pC1523, DOI 10.1152/ajpcell.00460.2011; White RJ, 2008, TRENDS GENET, V24, P622, DOI 10.1016/j.tig.2008.10.003; Xie WB, 2012, P NATL ACAD SCI USA, V109, P8161, DOI 10.1073/pnas.1201262109; Yang LX, 2015, CELL CYCLE, V14, P3613, DOI 10.1080/15384101.2015.1100777; Yang LX, 2013, MOL CELL BIOL, V33, P3835, DOI 10.1128/MCB.00476-13; Yuan XJ, 2007, MOL CELL, V27, P585, DOI 10.1016/j.molcel.2007.06.021; Zhao ZL, 2018, GENE DEV, V32, P836, DOI 10.1101/gad.311688.118; Zhao ZL, 2016, NUCLEIC ACIDS RES, V44, P8144, DOI 10.1093/nar/gkw496; Zhao ZL, 2016, CELL REP, V14, P1876, DOI 10.1016/j.celrep.2016.01.073; Zhou YG, 2002, EMBO J, V21, P4632, DOI 10.1093/emboj/cdf460; Zillner K, 2013, NUCLEIC ACIDS RES, V41, P5251, DOI 10.1093/nar/gkt218	60	1	1	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10818	10834		10.1096/fj.202000411R	http://dx.doi.org/10.1096/fj.202000411R		JUN 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32598531	hybrid			2022-12-28	WOS:000546063500001
J	Lisewski, U; Kohncke, C; Schleussner, L; Purfurst, B; Lee, SM; De Silva, AM; Manville, RW; Abbott, GW; Roepke, TK				Lisewski, Ulrike; Koehncke, Clemens; Schleussner, Leonhard; Purfuerst, Bettina; Lee, Soo Min; De Silva, Angele M.; Manville, Rian W.; Abbott, Geoffrey W.; Roepke, Torsten K.			Hypochlorhydria reduces mortality in heart failure caused by Kcne2 gene deletion	FASEB JOURNAL			English	Article						dilated cardiomyopathy; heart failure; KCNE; microbiome; potassium channel	FORMS POTASSIUM CHANNELS; GENOME-WIDE ASSOCIATION; PROTON-PUMP INHIBITORS; CARDIAC-ARRHYTHMIA; DILATED CARDIOMYOPATHY; MYOCARDIAL-INFARCTION; BETA-SUBUNIT; DISEASE; MINK; MUTATIONS	Heart failure (HF) is an increasing global health crisis, affecting 40 million people and causing 50% mortality within 5 years of diagnosis. A fuller understanding of the genetic and environmental factors underlying HF, and novel therapeutic approaches to address it, are urgently warranted. Here, we discovered that cardiac-specific germline deletion in mice of potassium channel beta subunit-encodingKcne2(Kcne2(CS-/-)) causes dilated cardiomyopathy and terminal HF (median longevity, 28 weeks). Mice with globalKcne2deletion (Kcne2(Glo-/-)) exhibit multiple HF risk factors, yet, paradoxically survived over twice as long asKcne2(CS-/-)mice. GlobalKcne2deletion, which inhibits gastric acid secretion, reduced the relative abundance of species within Bacteroidales, a bacterial order that positively correlates with increased lifetime risk of human cardiovascular disease. Strikingly, the proton-pump inhibitor omeprazole similarly altered the microbiome and delayed terminal HF inKcne2(CS-/-)mice, increasing survival 10-fold at 44 weeks. Thus, genetic or pharmacologic induction of hypochlorhydria and decreased gut Bacteroidales species are associated with lifespan extension in a novel HF model.	[Lisewski, Ulrike; Koehncke, Clemens; Schleussner, Leonhard; Roepke, Torsten K.] Expt & Clin Res Ctr, Berlin, Germany; [Koehncke, Clemens] Campus Virchow Univ Med Berlin, Dept Cardiol, Berlin, Germany; [Purfuerst, Bettina] Max Delbruck Ctr Mol Med, Electron Microscopy Core Facil, Berlin, Germany; [Lee, Soo Min; De Silva, Angele M.; Manville, Rian W.; Abbott, Geoffrey W.] Univ Calif Irvine, Sch Med, Dept Physiol & Biophys, Bioelect Lab, Irvine, CA 92697 USA; [Roepke, Torsten K.] Charite Univ Med Berlin, Dept Cardiol & Angiol, Campus Mitte, Berlin, Germany; [Roepke, Torsten K.] Klinikum Niederlausitz, Clin Internal Med Cardiol, Senftenberg, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of California System; University of California Irvine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Roepke, TK (corresponding author), Klinikum Niederlausitz, Clin Internal Med Cardiol, Senftenberg, Germany.; Abbott, GW (corresponding author), Univ Calif Irvine, Dept Physiol & Biophys, Sch Med, Room D337,Med Sci 1, Irvine, CA 92697 USA.	abbottg@uci.edu; torsten.roepke@gmx.net		Manville, Rian/0000-0002-0057-3541	Deutsche Forschungsgemeinschaft; Fritz-Thyssen-Stiftung; intramural ECRC funding; US National Institutes of Health [GM115189, GM130377, DK041544]; UC Irvine Microbiome Initiative Pilot Project Award	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fritz-Thyssen-Stiftung; intramural ECRC funding; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UC Irvine Microbiome Initiative Pilot Project Award	The Deutsche Forschungsgemeinschaft, Fritz-Thyssen-Stiftung, and intramural ECRC funding (to TKR), US National Institutes of Health (GM115189, GM130377, and DK041544 to GWA), and a UC Irvine Microbiome Initiative Pilot Project Award (to GWA) supported this work	Abbott GW, 2015, GENE, V569, P162, DOI 10.1016/j.gene.2015.06.061; Abbott GW, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005025; Abbott GW, 2013, EXPERT REV CLIN PHAR, V6, P49, DOI [10.1586/ECP.12.76, 10.1586/ecp.12.76]; Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; Abbott GW, 2001, CELL, V104, P217, DOI 10.1016/S0092-8674(01)00207-0; Adelborg K, 2018, CLIN EPIDEMIOL, V10, P521, DOI 10.2147/CLEP.S162909; Arimatsu K, 2014, SCI REP-UK, V4, DOI 10.1038/srep04828; Bendahhou S, 2005, CARDIOVASC RES, V67, P529, DOI 10.1016/j.cardiores.2005.02.014; Blaich A, 2012, J BIOL CHEM, V287, P22616, DOI 10.1074/jbc.M112.357921; Bundhun PK, 2017, BMC CARDIOVASC DISOR, V17, DOI 10.1186/s12872-016-0453-6; Burton-Freeman BM, 2016, ADV NUTR, V7, P44, DOI 10.3945/an.115.009639; Calmettes G, 2015, J MOL CELL CARDIOL, V78, P107, DOI 10.1016/j.yjmcc.2014.09.020; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; COHN JN, 1986, NEW ENGL J MED, V314, P1547, DOI 10.1056/NEJM198606123142404; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Furukawa T, 2001, J MOL BIOL, V313, P775, DOI 10.1006/jmbi.2001.5053; Garcia-Mazcorro JF, 2018, J MICROBIOL BIOTECHN, V28, P1247, DOI 10.4014/jmb.1803.03020; Garcia-Mazcorro JF, 2012, FEMS MICROBIOL ECOL, V80, P624, DOI 10.1111/j.1574-6941.2012.01331.x; Gavillet B, 2006, CIRC RES, V99, P407, DOI 10.1161/01.RES.0000237466.13252.5e; Goetze JP, 2016, INT J CARDIOL, V209, P37, DOI 10.1016/j.ijcard.2016.02.038; Gordon E, 2008, CARDIOVASC RES, V77, P98, DOI 10.1093/cvr/cvm030; Grossini E, 2011, J APPL PHYSIOL, V110, P95, DOI 10.1152/japplphysiol.00625.2010; Hojo M, 2018, DIGEST DIS SCI, V63, P2940, DOI 10.1007/s10620-018-5122-4; Houser SR, 2012, CIRC RES, V111, P131, DOI 10.1161/RES.0b013e3182582523; Hu ZY, 2016, CARDIOVASC RES, V110, P227, DOI 10.1093/cvr/cvw048; Hu ZY, 2014, CIRC-CARDIOVASC GENE, V7, P33, DOI 10.1161/CIRCGENETICS.113.000315; Kanda VA, 2011, BIOPHYS J, V101, P1354, DOI 10.1016/j.bpj.2011.08.015; Kanda VA, 2011, BIOPHYS J, V101, P1364, DOI 10.1016/j.bpj.2011.08.014; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Kelly TN, 2016, CIRC RES, V119, P956, DOI 10.1161/CIRCRESAHA.116.309219; Kohncke C, 2013, JOVE-J VIS EXP, DOI 10.3791/50145; Kuwahara K, 2012, J PHARMACOL SCI, V119, P198, DOI 10.1254/jphs.12R04CP; Lee SM, 2017, FASEB J, V31, P2674, DOI 10.1096/fj.201601347; Lee SM, 2016, SCI REP-UK, V6, DOI 10.1038/srep23118; Lee SM, 2015, J MOL CELL CARDIOL, V87, P148, DOI 10.1016/j.yjmcc.2015.08.013; Lewis A, 2004, J BIOL CHEM, V279, P7884, DOI 10.1074/jbc.M310501200; Lisewski U, 2008, J EXP MED, V205, P2369, DOI 10.1084/jem.20080897; Liu WJ, 2014, J MOL CELL CARDIOL, V72, P208, DOI 10.1016/j.yjmcc.2014.03.013; McCrossan ZA, 2009, J MEMBRANE BIOL, V228, P1, DOI 10.1007/s00232-009-9154-8; Mongue-Din H, 2007, PFLUG ARCH EUR J PHY, V454, P165, DOI 10.1007/s00424-006-0197-8; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Neyroud N, 1997, NAT GENET, V15, P186, DOI 10.1038/ng0297-186; Onda K, 2017, HYPERTENSION, V69, P457, DOI 10.1161/HYPERTENSIONAHA.116.08408; Lazaro AMP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169826; Qu JH, 2004, J BIOL CHEM, V279, P43497, DOI 10.1074/jbc.M405018200; Radicke S, 2006, CARDIOVASC RES, V71, P695, DOI 10.1016/j.cardiores.2006.06.017; Reynolds A, 2019, LANCET, V393, P434, DOI 10.1016/S0140-6736(18)31809-9; Roepke TK, 2006, VASC PHARMACOL, V44, P90, DOI 10.1016/j.vph.2005.07.013; Roepke TK, 2008, FASEB J, V22, P3648, DOI 10.1096/fj.08-110171; Roepke TK, 2006, J BIOL CHEM, V281, P23740, DOI 10.1074/jbc.M604155200; Roepke TK, 2011, FASEB J, V25, P4264, DOI 10.1096/fj.11-187609; Roepke TK, 2011, FASEB J, V25, P727, DOI 10.1096/fj.10-173682; Roepke TK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011451; Roepke TK, 2009, NAT MED, V15, P1186, DOI 10.1038/nm.2029; Roger VL, 2013, CIRC RES, V113, P646, DOI 10.1161/CIRCRESAHA.113.300268; Sabater-Lleal M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104082; Saito T, 2015, EUR HEART J, V36, P724, DOI 10.1093/eurheartj/ehu404; Sesti F, 2000, P NATL ACAD SCI USA, V97, P10613, DOI 10.1073/pnas.180223197; Splawski I, 1997, NAT GENET, V17, P338, DOI 10.1038/ng1197-338; STEVENSON WG, 1993, CIRCULATION, V88, P2953, DOI 10.1161/01.CIR.88.6.2953; Szpakowicz A, 2015, POL ARCH MED WEWN, V125, P240, DOI 10.20452/pamw.2780; Tinel N, 2000, EMBO J, V19, P6326, DOI 10.1093/emboj/19.23.6326; Vaduganathan M, 2016, AM J MED, V129, P1002, DOI 10.1016/j.amjmed.2016.03.042; Wakil SM, 2016, ATHEROSCLEROSIS, V245, P62, DOI 10.1016/j.atherosclerosis.2015.11.019; Walters W, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00009-15; Wang F, 2015, J MICROBIOL BIOTECHN, V25, P1195, DOI 10.4014/jmb.1410.10014; WANG Q, 1995, CELL, V80, P805, DOI 10.1016/0092-8674(95)90359-3; Xie Y, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l1580; Yoshihisa A, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.005110; Zhang M, 2001, CIRC RES, V88, P1012, DOI 10.1161/hh1001.090839; Zhao XY, 2005, WORLD J GASTROENTERO, V11, P3405, DOI 10.3748/wjg.v11.i22.3405; Ziaeian B, 2016, NAT REV CARDIOL, V13, P368, DOI 10.1038/nrcardio.2016.25	72	2	2	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10699	10719		10.1096/fj.202000013RR	http://dx.doi.org/10.1096/fj.202000013RR		JUN 2020	21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32584506	Bronze, Green Accepted			2022-12-28	WOS:000544342900001
J	Chen, Y; Cai, GH; Xia, B; Wang, X; Zhang, CC; Xie, BC; Shi, XC; Liu, H; Lu, JF; Zhang, RX; Zhu, MQ; Liu, M; Yang, SZ; Yang, ZD; Chu, XY; Khan, R; Wang, YL; Wu, JW				Chen Yan; Cai Guo He; Xia Bo; Wang Xin; Zhang Cong Cong; Xie Bao Cai; Shi Xiao Chen; Liu Huan; Lu Jun Feng; Zhang Rui Xin; Zhu Meng Qing; Liu Min; Yang Shi Zhen; Yang Zhang Dan; Chu Xin Yi; Khan, Rajwali; Wang Yong Liang; Wu Jiang Wei			Mitochondrial aconitase controls adipogenesis through mediation of cellular ATP production	FASEB JOURNAL			English	Article						cell differentiation; mitochondrial metabolism; TCA cycle	TRICARBOXYLIC-ACID CYCLE; WHITE ADIPOSE-TISSUE; ADIPOCYTE DIFFERENTIATION; DYSFUNCTION; BIOGENESIS; OBESITY; MICE; LIPOGENESIS; DEFICIENCY; METABOLISM	Mitochondrial aconitase (Aco2) catalyzes the conversion of citrate to isocitrate in the TCA cycle, which produces NADH and FADH2, driving synthesis of ATP through OXPHOS. In this study, to explore the relationship between adipogenesis and mitochondrial energy metabolism, we hypothesize that Aco2 may play a key role in the lipid synthesis. Here, we show that overexpression of Aco2 in 3T3-L1 cells significantly increased lipogenesis and adipogenesis, accompanied by elevated mitochondrial biogenesis and ATP production. However, when ATP is depleted by rotenone, an inhibitor of the respiratory chain, the promotive role of Aco2 in adipogenesis is abolished. In contrast to Aco2 overexpression, deficiency of Aco2 markedly reduced lipogenesis and adipogenesis, along with the decreased mitochondrial biogenesis and ATP production. Supplementation of isocitrate efficiently rescued the inhibitory effect of Aco2 deficiency. Similarly, the restorative effect of isocitrate was abolished in the presence of rotenone. Together, these results show that Aco2 sustains normal adipogenesis through mediating ATP production, revealing a potential mechanistic link between TCA cycle enzyme and lipid synthesis. Our work suggest that regulation of adipose tissue mitochondria function may be a potential way for combating abnormal adipogenesis related diseases such as obesity and lipodystrophy.	[Chen Yan; Cai Guo He; Xia Bo; Wang Xin; Zhang Cong Cong; Xie Bao Cai; Shi Xiao Chen; Liu Huan; Lu Jun Feng; Zhang Rui Xin; Zhu Meng Qing; Liu Min; Yang Shi Zhen; Yang Zhang Dan; Chu Xin Yi; Khan, Rajwali; Wang Yong Liang; Wu Jiang Wei] Northwest A&F Univ, Key Lab Anim Genet Breeding & Reprod Shaanxi Prov, Coll Anim Sci & Technol, Yangling 712100, Shaanxi, Peoples R China	Northwest A&F University - China	Wu, JW (corresponding author), Northwest A&F Univ, Key Lab Anim Genet Breeding & Reprod Shaanxi Prov, Coll Anim Sci & Technol, Yangling 712100, Shaanxi, Peoples R China.	wujiangwei@nwafu.edu.cn	Zhu, Mengqing/GLT-5795-2022; Lu, Junfeng/AFN-9843-2022; Liu, Huan/HIK-2282-2022; Khan, Rajwali/N-2609-2019	Zhu, Mengqing/0000-0001-9422-6550; Lu, Junfeng/0000-0002-2640-8595; Khan, Rajwali/0000-0001-5191-3457; xie, baocai/0000-0003-0611-0131				Aljohani A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52339-7; Bardella C, 2012, MOL CELL BIOL, V32, P3081, DOI 10.1128/MCB.06160-11; Bissonnette S, 2018, AM J CLIN NUTR, V108, P62, DOI 10.1093/ajcn/nqy070; Bouwkamp CG, 2018, NEUROL-GENET, V4, DOI 10.1212/NXG.0000000000000223; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Chen CM, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112480; Choo HJ, 2006, DIABETOLOGIA, V49, P784, DOI 10.1007/s00125-006-0170-2; Chow HM, 2019, J CELL BIOL, V218, P909, DOI 10.1083/jcb.201806197; Cummins TD, 2014, AM J PHYSIOL-ENDOC M, V307, pE262, DOI 10.1152/ajpendo.00271.2013; Dahlman I, 2006, DIABETES, V55, P1792, DOI 10.2337/db05-1421; Danson MJ, 2001, METHOD ENZYMOL, V331, P3; DeVisser A, 2011, NEUROBIOL DIS, V44, P161, DOI 10.1016/j.nbd.2011.06.005; Du D, 2018, J PROTEOME RES, V17, P2092, DOI 10.1021/acs.jproteome.8b00028; Fernandes J, 2015, BIOCHEMISTRY-US, V54, P4008, DOI 10.1021/acs.biochem.5b00375; Figarola JL, 2013, INT J MOL MED, V31, P1166, DOI 10.3892/ijmm.2013.1313; Fortier M, 2005, J LIPID RES, V46, P1860, DOI 10.1194/jlr.M500081-JLR200; Gaspari M, 2004, BBA-BIOENERGETICS, V1659, P148, DOI 10.1016/j.bbabio.2004.10.003; Gesta S, 2011, P NATL ACAD SCI USA, V108, P2771, DOI 10.1073/pnas.1019704108; Hada K, 2019, J BIOL CHEM, V294, P3091, DOI 10.1074/jbc.RA118.004726; Han J, 2016, J LIPID RES, V57, P1329, DOI 10.1194/jlr.R067595; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Heinonen S, 2015, DIABETES, V64, P3135, DOI 10.2337/db14-1937; Hock MB, 2009, ANNU REV PHYSIOL, V71, P177, DOI 10.1146/annurev.physiol.010908.163119; Hresko RC, 1998, J BIOL CHEM, V273, P20658, DOI 10.1074/jbc.273.32.20658; Jiang HC, 2017, CELL METAB, V26, P686, DOI 10.1016/j.cmet.2017.08.016; Jung SJ, 2015, FEBS LETT, V589, P822, DOI 10.1016/j.febslet.2015.02.015; Kaaman M, 2007, DIABETOLOGIA, V50, P2526, DOI 10.1007/s00125-007-0818-6; Kusminski CM, 2012, TRENDS ENDOCRIN MET, V23, P435, DOI 10.1016/j.tem.2012.06.004; Levin K, 2001, DIABETOLOGIA, V44, P824; Li S, 2016, BBA-BIOENERGETICS, V1857, P643, DOI 10.1016/j.bbabio.2016.03.009; Liu QF, 2019, FEBS LETT, V593, P2118, DOI 10.1002/1873-3468.13509; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Luo B, 2007, J CHROMATOGR A, V1147, P153, DOI 10.1016/j.chroma.2007.02.034; Metodiev MD, 2014, J MED GENET, V51, P834, DOI 10.1136/jmedgenet-2014-102532; Mills EL, 2018, NATURE, V556, P113, DOI 10.1038/nature25986; Moreno M, 2015, FASEB J, V29, P1529, DOI 10.1096/fj.14-258996; Munnich A, 2008, NAT GENET, V40, P1148, DOI 10.1038/ng1008-1148; Ogden CL, 2016, JAMA-J AM MED ASSOC, V315, P2292, DOI 10.1001/jama.2016.6361; Osellame LD, 2012, BEST PRACT RES CL EN, V26, P711, DOI 10.1016/j.beem.2012.05.003; Przybyla-Zawislak B, 1999, GENETICS, V152, P153; Putti R, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00109; Rogge MM, 2009, BIOL RES NURS, V10, P356, DOI 10.1177/1099800408329408; Rong JX, 2007, DIABETES, V56, P1751, DOI 10.2337/db06-1135; Shi XR, 2008, J BIOL CHEM, V283, P30658, DOI 10.1074/jbc.M800510200; SLAUGHTER CA, 1977, ANN HUM GENET, V40, P385; Spiegel K, 2012, AM J HUM GENET, V90, P518, DOI 10.1016/j.ajhg.2012.01.009; Tejerina S, 2009, J CELL SCI, V122, P145, DOI 10.1242/jcs.027508; Ugrankar R, 2019, DEV CELL, V50, P557, DOI 10.1016/j.devcel.2019.07.021; Weinberg SE, 2015, IMMUNITY, V42, P406, DOI 10.1016/j.immuni.2015.02.002; Wiles MV, 2015, MAMM GENOME, V26, P501, DOI 10.1007/s00335-015-9565-z; Wilson-Fritch L, 2003, MOL CELL BIOL, V23, P1085, DOI 10.1128/MCB.23.3.1085-1094.2003; Wu JW, 2012, ENDOCRINOLOGY, V153, P2198, DOI 10.1210/en.2011-1518; Yang H, 2016, DIABETES, V65, P3396, DOI 10.2337/db16-0136; Yin X, 2014, J CLIN ENDOCR METAB, V99, pE209, DOI 10.1210/jc.2013-3042; Zhu CT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047584; Zorzano A, 2009, INT J BIOCHEM CELL B, V41, P1846, DOI 10.1016/j.biocel.2009.02.004	56	6	6	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6688	6702		10.1096/fj.201903224RR	http://dx.doi.org/10.1096/fj.201903224RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32212192				2022-12-28	WOS:000531325500048
J	Raz, Y; van den Akker, EB; Roest, T; Riaz, M; van de Rest, O; Suchiman, HED; Lakenberg, N; Stassen, SA; van Putten, M; Feskens, EJM; Reinders, MJT; Goeman, J; Beekman, M; Raz, V; Slagboom, PE				Raz, Yotam; van den Akker, Erik B.; Roest, Tijmen; Riaz, Muhammad; van de Rest, Ondine; Suchiman, H. Eka D.; Lakenberg, Nico; Stassen, Stefanie A.; van Putten, Maaike; Feskens, Edith J. M.; Reinders, Marcel J. T.; Goeman, Jelle; Beekman, Marian; Raz, Vered; Slagboom, Pieternella Eline			A data-driven methodology reveals novel myofiber clusters in older human muscles	FASEB JOURNAL			English	Article						bioinformatics; clustering; fibertyping; human; muscle; muscle health; myofiber; myosin heavy chain; RNA-sequencing; sarcomere	SKELETAL-MUSCLE; SARCOPLASMIC-RETICULUM; PROTEASOMAL ACTIVITY; ISOFORMS; FIBERS; SLOW; MEN	Skeletal muscles control posture, mobility and strength, and influence whole-body metabolism. Muscles are built of different types of myofibers, each having specific metabolic, molecular, and contractile properties. Fiber classification is, therefore, regarded the key for understanding muscle biology, (patho-) physiology. The expression of three myosin heavy chain (MyHC) isoforms, MyHC-1, MyHC-2A, and MyHC-2X, marks myofibers in humans. Typically, myofiber classification is performed by an eye-based histological analysis. This classical approach is insufficient to capture complex fiber classes, expressing more than one MyHC-isoform. We, therefore, developed a methodological procedure for high-throughput characterization of myofibers on the basis of multiple isoforms. The mean fluorescence intensity of the three most abundant MyHC isoforms was measured per myofiber in muscle biopsies of 56 healthy elderly adults, and myofiber classes were identified using computational biology tools. Unsupervised clustering revealed the existence of six distinct myofiber clusters. A comparison with the visual assessment of myofibers using the same images showed that some of these myofiber clusters could not be detected or were frequently misclassified. The presence of these six clusters was reinforced by RNA expressions levels of sarcomeric genes. In addition, one of the clusters, expressing all three MyHC isoforms, correlated with histological measures of muscle health. To conclude, this methodological procedure enables deep characterization of the complex muscle heterogeneity. This study opens opportunities to further investigate myofiber composition in comparative studies.	[Raz, Yotam; van den Akker, Erik B.; Roest, Tijmen; Suchiman, H. Eka D.; Lakenberg, Nico; Beekman, Marian; Slagboom, Pieternella Eline] Leiden Univ, Med Ctr, Sect Mol Epidemiol, NL-2300 RC Leiden, Netherlands; [van den Akker, Erik B.; Reinders, Marcel J. T.] Leiden Univ, Med Ctr, Leiden Computat Biol Ctr, Leiden, Netherlands; [van den Akker, Erik B.; Reinders, Marcel J. T.] Delft Univ Technol, Delft Bioinformat Lab, Delft, Netherlands; [Riaz, Muhammad; van Putten, Maaike; Raz, Vered] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands; [van de Rest, Ondine; Feskens, Edith J. M.] Wageningen Univ & Res, Div Human Nutr, Wageningen, Netherlands; [Stassen, Stefanie A.] Leiden Univ, Med Ctr, Sect Gerontol & Geriatr, Leiden, Netherlands; [Goeman, Jelle] Leiden Univ, Med Ctr, Dept Med Stat, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Delft University of Technology; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Wageningen University & Research; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	van den Akker, EB (corresponding author), Leiden Univ, Med Ctr, Sect Mol Epidemiol, NL-2300 RC Leiden, Netherlands.	e.b.van_den_akker@lumc.nl	Feskens, Edith/ABI-1446-2020; Goeman, Jelle/AAT-1300-2020; Suchiman, H. Eka D./F-5024-2017	Feskens, Edith/0000-0001-5819-2488; Goeman, Jelle/0000-0003-4283-0259; van Putten, Maaike/0000-0002-0683-8897; Suchiman, H. Eka D./0000-0002-7168-5516; raz, vered/0000-0003-3152-1952	European Union's Seventh Framework Programme [259679]; Netherlands Consortium for Healthy Aging [050-060-810]; Netherlands Genomics Initiative, Netherlands Organization for Scientific Research (NWO); BMRI-NL, a Research Infrastructure financed by the Dutch government [NWO 184.021.007]; French Muscular Dystrophy Association (AFM-Telethon) [21160]; Leiden University Medical Center	European Union's Seventh Framework Programme(European Commission); Netherlands Consortium for Healthy Aging; Netherlands Genomics Initiative, Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); BMRI-NL, a Research Infrastructure financed by the Dutch government; French Muscular Dystrophy Association (AFM-Telethon); Leiden University Medical Center	The research leading to these results has received funding from the European Union's Seventh Framework Programme (FP7/2007-2011) under grant agreement number 259679. This study was supported by the Netherlands Consortium for Healthy Aging (grant 050-060-810), in the framework of the Netherlands Genomics Initiative, Netherlands Organization for Scientific Research (NWO); by BBMRI-NL, a Research Infrastructure financed by the Dutch government (NWO 184.021.007) to PES and EJMF This study was also supported by French Muscular Dystrophy Association (AFM-Telethon), grant 21160 to VR YR received funding from the Leiden University Medical Center, in the framework of the MD/PhD-track.	Andersen JL, 1999, MUSCLE NERVE, V22, P449, DOI 10.1002/(SICI)1097-4598(199904)22:4<449::AID-MUS4>3.3.CO;2-U; Andersen JL, 1999, J APPL PHYSIOL, V86, P455, DOI 10.1152/jappl.1999.86.2.455; Bloemberg D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035273; Bonder MJ, 2017, NAT GENET, V49, P131, DOI 10.1038/ng.3721; BOROSHATFALUDY S, 1986, EUR J APPL PHYSIOL O, V55, P334, DOI 10.1007/BF02343809; Chemello F, 2019, CELL REP, V26, P3784, DOI 10.1016/j.celrep.2019.02.105; Ciciliot S, 2013, INT J BIOCHEM CELL B, V45, P2191, DOI 10.1016/j.biocel.2013.05.016; Engel WK, 2015, BBA-MOL BASIS DIS, V1852, P563, DOI 10.1016/j.bbadis.2014.11.015; ENGEL WK, 1970, ARCH NEUROL-CHICAGO, V22, P97, DOI 10.1001/archneur.1970.00480200003001; Francioli LC, 2014, NAT GENET, V46, P818, DOI 10.1038/ng.3021; Frontera WR, 2000, J APPL PHYSIOL, V88, P1321; Gehlert S, 2012, EUR J APPL PHYSIOL, V112, P2393, DOI 10.1007/s00421-011-2209-4; GIACOMEL.F, 1967, NATURE, V213, P679, DOI 10.1038/213679a0; Giordani L, 2019, MOL CELL, V74, P609, DOI 10.1016/j.molcel.2019.02.026; Gregorevic P, 2008, MUSCLE NERVE, V37, P104, DOI 10.1002/mus.20877; Hu X, 2017, SKELET MUSCLE, V7, DOI 10.1186/s13395-017-0143-9; Kim J, 2014, METHODS MOL BIOL, V1213, P245, DOI 10.1007/978-1-4939-1453-1_20; KLITGAARD H, 1990, ACTA PHYSIOL SCAND, V140, P41, DOI 10.1111/j.1748-1716.1990.tb08974.x; Kragstrup TW, 2011, SCAND J MED SCI SPOR, V21, P749, DOI 10.1111/j.1600-0838.2011.01377.x; LEXELL J, 1995, J GERONTOL A-BIOL, V50, P11; Mackey AL, 2009, MUSCLE NERVE, V40, P455, DOI 10.1002/mus.21369; MARIN P, 1994, DIABETES CARE, V17, P382, DOI 10.2337/diacare.17.5.382; MIDRIO M, 1992, PFLUG ARCH EUR J PHY, V420, P446, DOI 10.1007/BF00374618; Murgia M, 2017, CELL REP, V19, P2396, DOI 10.1016/j.celrep.2017.05.054; Nigro V, 2015, BBA-MOL BASIS DIS, V1852, P585, DOI 10.1016/j.bbadis.2014.07.023; Ogata T, 1997, ANAT REC, V248, P214; Olie CS, 2019, ISCIENCE, V12, P318, DOI 10.1016/j.isci.2019.01.024; Purves-Smith FM, 2014, EXERC SPORT SCI REV, V42, P45, DOI 10.1249/JES.0000000000000012; Raz V, 2019, FASEB J, V33, P4046, DOI 10.1096/fj.201801714R; Raz V, 2018, FASEB J, V32, P1579, DOI 10.1096/fj.201700861R; Raz V, 2017, J CACHEXIA SARCOPENI, V8, P798, DOI 10.1002/jcsm.12211; Raz Y, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00236; Riaz M, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006031; Robinson MM, 2017, CELL METAB, V25, P581, DOI 10.1016/j.cmet.2017.02.009; Rowan SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029082; Sawano S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166080; SCHIAFFINO S, 1994, J APPL PHYSIOL, V77, P493, DOI 10.1152/jappl.1994.77.2.493; Schutte BAM, 2016, SCI REP-UK, V6, DOI 10.1038/srep38980; SIMONEAU JA, 1995, FASEB J, V9, P1091, DOI 10.1096/fasebj.9.11.7649409; Strucksberg KH, 2010, ANAL BIOCHEM, V399, P225, DOI 10.1016/j.ab.2009.12.026; Tiku V, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16083; Zhernakova DV, 2017, NAT GENET, V49, P139, DOI 10.1038/ng.3737	42	4	4	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5525	5537		10.1096/fj.201902350R	http://dx.doi.org/10.1096/fj.201902350R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32141137	Green Published, hybrid			2022-12-28	WOS:000530242100046
J	Porebska, A; Rozycka, M; Holubowicz, R; Szewczuk, Z; Ozyhar, A; Dobryszycki, P				Porebska, Aleksandra; Rozycka, Miroslawa; Holubowicz, Rafal; Szewczuk, Zbigniew; Ozyhar, Andrzej; Dobryszycki, Piotr			Functional derivatives of human dentin matrix protein 1 modulate morphology of calcium carbonate crystals	FASEB JOURNAL			English	Article						biomineralization; intrinsically disordered proteins; otoconia	SEDIMENTATION-VELOCITY; POSITIONAL VERTIGO; IN-VITRO; DMP1; GENE; IDENTIFICATION; OSTEOPONTIN; STARMAKER; OTOCONIA; COLLAGEN	Dentin matrix protein 1 (DMP1) is an acidic, extracellular matrix protein essential for biomineralization of calcium phosphate, in bone and dentin. It is proteolytically processed into two fragments, 44K and 56K. Recently, the presence of DMP1 was noticed in inner ear, specifically in otoconia, which are calcium carbonate biominerals involved in sensing of balance. In this study, the solution structure and biomineralization activity of otoconial 44K and 56K fragments toward calcium carbonate were investigated. The results of analytical ultracentrifugation, circular dichroism, and gel filtration indicated that DMP1 fragments are disordered in solution. Notably, 56K formed oligomers in the presence of calcium ions. It was also observed that both fragments influenced the crystal growth by in vitro biomineralization assay and scanning electron microscopy. In addition, they sequester the calcium ions during the calcite formation. Calcium carbonate crystals precipitated in vitro changed their size and shape in the presence of DMP1 fragments. Oligomerization propensity of 56K may significantly enhance this function. Our study indicates that intrinsically disordered DMP1 has a previously unknown regulatory function for biomineralization of otoconia.	[Porebska, Aleksandra; Rozycka, Miroslawa; Holubowicz, Rafal; Ozyhar, Andrzej; Dobryszycki, Piotr] Wroclaw Univ Sci & Technol, Fac Chem, Dept Biochem Mol Biol & Biotechnol, Wybrzeze Wyspianskiego 27, PL-50370 Wroclaw, Poland; [Szewczuk, Zbigniew] Univ Wroclaw, Fac Chem, Wroclaw, Poland	Wroclaw University of Science & Technology; University of Wroclaw	Dobryszycki, P (corresponding author), Wroclaw Univ Sci & Technol, Fac Chem, Dept Biochem Mol Biol & Biotechnol, Wybrzeze Wyspianskiego 27, PL-50370 Wroclaw, Poland.	piotr.dobryszycki@pwr.edu.pl	Szewczuk, Zbigniew/A-2243-2013; Rozycka, Miroslawa/V-4541-2018	Dobryszycki, Piotr/0000-0001-5522-2557; Holubowicz, Rafal/0000-0002-2555-2069; Rozycka, Miroslawa/0000-0002-8008-6689; Porebska, Aleksandra/0000-0001-6804-1341	Narodowe Centrum Nauki (NCN) [UMO-2015/19/B/ST10/02148]; Polish Ministry of Science and Higher Education	Narodowe Centrum Nauki (NCN)(National Science Centre, Poland); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	Narodowe Centrum Nauki (NCN), Grant/Award Number: UMO-2015/19/B/ST10/02148; Polish Ministry of Science and Higher Education	Addadi L, 2003, ADV MATER, V15, P959, DOI 10.1002/adma.200300381; Agrawal Y, 2009, ARCH INTERN MED, V169, P938, DOI 10.1001/archinternmed.2009.66; Aizenberg J, 1996, Connect Tissue Res, V34, P255, DOI 10.3109/03008209609005269; Albeck S, 1996, CONNECT TISSUE RES, V35, P365, DOI 10.3109/03008209609029213; Andrews P, 1970, Methods Biochem Anal, V18, P1, DOI 10.1002/9780470110362.ch1; Baht GS, 2008, MATRIX BIOL, V27, P600, DOI 10.1016/j.matbio.2008.06.004; Bajoghli B, 2009, DEV DYNAM, V238, P2860, DOI 10.1002/dvdy.22093; BALOH RW, 1987, NEUROLOGY, V37, P371, DOI 10.1212/WNL.37.3.371; BEGG GE, 2001, CURR PROTOC PROTEIN, P7; Boskey AL, 2016, MATRIX BIOL, V52-54, P43, DOI 10.1016/j.matbio.2016.01.007; Brautigam CA, 2015, METHOD ENZYMOL, V562, P109, DOI 10.1016/bs.mie.2015.05.001; Buck M, 1998, Q REV BIOPHYS, V31, P297, DOI 10.1017/S003358359800345X; Byun H, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39830-x; Carteret C, 2009, CRYST GROWTH DES, V9, P807, DOI 10.1021/cg800368u; Chaturvedi SK, 2019, AAPS J, V21, DOI 10.1208/s12248-019-0307-0; Chen YY, 2019, MINERALS-BASEL, V9, DOI 10.3390/min9020068; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Correia JJ, 2015, METHOD ENZYMOL, V562, P49, DOI 10.1016/bs.mie.2015.06.042; Culik RM, 2014, J PHYS CHEM B, V118, P11455, DOI 10.1021/jp508056w; Deans MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012765; Dimitriou R, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-66; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; EHRLICH H, 2017, EXTREME BIOMIMETICS, P1; Ehrlich H, 2011, ADV FUNCT MATER, V21, P3473, DOI 10.1002/adfm.201100749; Ehrlich H, 2010, INT GEOL REV, V52, P661, DOI 10.1080/00206811003679521; Ehrlich H, 2010, CHEM MATER, V22, P1462, DOI 10.1021/cm9026607; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; Forman-Kay JD, 2013, STRUCTURE, V21, P1492, DOI 10.1016/j.str.2013.08.001; GADD GM, 2004, MINERAL MAG, V68, P718; George A., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P308; Gericke A, 2010, J DENT RES, V89, P355, DOI 10.1177/0022034510363250; Gilbert PUPA, 2019, P NATL ACAD SCI USA, V116, P17659, DOI 10.1073/pnas.1902273116; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; He G, 2003, NAT MATER, V2, P552, DOI 10.1038/nmat945; He G, 2005, BIOCHEMISTRY-US, V44, P16140, DOI 10.1021/bi051045l; He G, 2004, J BIOL CHEM, V279, P11649, DOI 10.1074/jbc.M309296200; He G, 2003, CONNECT TISSUE RES, V44, P240, DOI 10.1080/03008200390181726; Holubowicz R, 2017, FEBS J, V284, P4278, DOI 10.1111/febs.14308; Hong MN, 2015, CRYST GROWTH DES, V15, P129, DOI 10.1021/cg501001r; Hua QX, 1998, BIOCHEMISTRY-US, V37, P5858, DOI 10.1021/bi9800808; Huang BZ, 2008, CALCIFIED TISSUE INT, V82, P401, DOI 10.1007/s00223-008-9140-7; Huang F, 2012, BIOCOMPUT-PAC SYM, P128; Huss D, 2003, J NEUROSCI METH, V125, P129, DOI 10.1016/S0165-0270(03)00048-7; Ibsen CJS, 2016, CHEM MATER, V28, P8550, DOI 10.1021/acs.chemmater.6b01088; Irvine G B, 2001, Curr Protoc Cell Biol, VChapter 5, DOI 10.1002/0471143030.cb0505s06; Kalmar L, 2012, BONE, V51, P528, DOI 10.1016/j.bone.2012.05.009; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Kniep R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175769; Kniep R, 2015, PURE APPL CHEM, V87, P719, DOI 10.1515/pac-2015-0201; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee SH, 2010, J CLIN NEUROL, V6, P51, DOI 10.3988/jcn.2010.6.2.51; Lim R, 2016, HEARING RES, V338, P9, DOI 10.1016/j.heares.2016.02.004; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Lundberg YW, 2015, DEV DYNAM, V244, P239, DOI 10.1002/dvdy.24195; LUNDBERG YW, 2012, OTOLARYNGOLOGY; Lv K, 2010, INT J BIOL SCI, V6, P537; Moreland KT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095333; Morinobu M, 2003, J BONE MINER RES, V18, P1706, DOI 10.1359/jbmr.2003.18.9.1706; Ni M, 2008, SURF INTERFACE ANAL, V40, P1356, DOI 10.1002/sia.2904; Poznar M, 2017, BBA-PROTEINS PROTEOM, V1865, P1358, DOI 10.1016/j.bbapap.2017.08.019; Qin CL, 2006, J BIOL CHEM, V281, P8034, DOI 10.1074/jbc.M512964200; Qin CL, 2003, J BIOL CHEM, V278, P34700, DOI 10.1074/jbc.M305315200; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; ROSS MD, 1984, PHILOS T ROY SOC B, V304, P445, DOI 10.1098/rstb.1984.0038; Rozycka M, 2019, CHEM-EUR J, V25, P12740, DOI 10.1002/chem.201902157; Rozycka M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114308; Salvay Andres G, 2012, Methods Mol Biol, V896, P91, DOI 10.1007/978-1-4614-3704-8_6; Scheffer DI, 2015, J NEUROSCI, V35, P6366, DOI 10.1523/JNEUROSCI.5126-14.2015; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schuck P., 2015, BASIC PRINCIPLES ANA; Silvent J, 2013, J MOL EVOL, V76, P59, DOI 10.1007/s00239-013-9539-2; SKINNER HCW, 2013, TREATISE GEOCHEMISTR, V10, P105; Sollner C, 2003, SCIENCE, V302, P282, DOI 10.1126/science.1088443; Sreerama N, 2004, METHOD ENZYMOL, V383, P318; Staines KA, 2012, J ENDOCRINOL, V214, P241, DOI 10.1530/JOE-12-0143; STOCK A, 1987, FEBS LETT, V220, P8, DOI 10.1016/0014-5793(87)80866-9; Su JT, 2013, BIOCHEM J, V453, P179, DOI 10.1042/BJ20130285; Sun Y, 2011, J DENT RES, V90, P619, DOI 10.1177/0022034510397839; Tartaix PH, 2004, J BIOL CHEM, V279, P18115, DOI 10.1074/jbc.M314114200; Tcherkasskaya O, 2001, PROTEINS, V44, P244, DOI 10.1002/prot.1089; Thomas ORB, 2019, FEBS J, V286, P66, DOI 10.1111/febs.14715; Tohse H, 2008, FEBS J, V275, P2512, DOI 10.1111/j.1742-4658.2008.06400.x; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Tompa P, 2005, FEBS LETT, V579, P3346, DOI 10.1016/j.febslet.2005.03.072; TOMPA P, 2009, STRUCTURE FUNCTION I, P33; Uversky Vladimir N, 2012, Methods Mol Biol, V896, P179, DOI 10.1007/978-1-4614-3704-8_11; Uversky VN, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/568068; Uversky VN, 2009, PROTEIN J, V28, P305, DOI 10.1007/s10930-009-9201-4; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Vassileva-Atanassova A, 1999, J BIOTECHNOL, V69, P63, DOI 10.1016/S0168-1656(98)00207-7; Villarreal-Ramirez E, 2017, BONE, V95, P65, DOI 10.1016/j.bone.2016.10.028; von Brevern M, 2015, J VESTIBUL RES-EQUIL, V25, P105, DOI 10.3233/VES-150553; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Wilkins MR, 1999, METH MOL B, V112, P531; Wojtas M, 2015, BIOCHEMISTRY-US, V54, P6525, DOI 10.1021/acs.biochem.5b00933; Wojtas M, 2012, ADVANCED TOPICS IN BIOMINERALIZATION, P3; Wojtas M, 2012, CRYST GROWTH DES, V12, P158, DOI 10.1021/cg200905f; Wysokowski M, 2018, AM MINERAL, V103, P665, DOI 10.2138/am-2018-6429; Xu YF, 2016, GENESIS, V54, P613, DOI 10.1002/dvg.22990; Xu YF, 2010, DEV DYNAM, V239, P2659, DOI 10.1002/dvdy.22405; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Yamakoshi Y, 2018, JPN DENT SCI REV, V54, P183, DOI 10.1016/j.jdsr.2018.03.006; Zhao HY, 2013, ANAL BIOCHEM, V437, P104, DOI 10.1016/j.ab.2013.02.011; Zhao X, 2008, JARO-J ASSOC RES OTO, V9, P191, DOI 10.1007/s10162-008-0117-z; Zhao X, 2007, DEV BIOL, V304, P508, DOI 10.1016/j.ydbio.2007.01.013; Zoraghi R, 2005, J BIOL CHEM, V280, P12051, DOI 10.1074/jbc.M413611200	108	6	6	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6147	6165		10.1096/fj.201901999R	http://dx.doi.org/10.1096/fj.201901999R		MAR 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32190922	hybrid			2022-12-28	WOS:000521549900001
J	Opheim, GL; Holme, AM; Holm, MB; Michelsen, TM; Zahid, SM; Roland, MCP; Henriksen, T; Haugen, G				Opheim, Gun Lisbet; Holme, Ane Moe; Holm, Maia Blomhoff; Michelsen, Trond Melbye; Zahid, Saba Muneer; Roland, Marie Cecilie Paasche; Henriksen, Tore; Haugen, Guttorm			The impact of umbilical vein blood flow and glucose concentration on blood flow distribution to the fetal liver and systemic organs in healthy pregnancies	FASEB JOURNAL			English	Article						fetal glucose supply; fetal liver blood flow; fetal-maternal glucose gradient; maternal nutritional status	DUCTUS-VENOSUS; PULSATILITY INDEX; REFERENCE RANGES; GROWTH; METABOLISM; CIRCULATION; 2ND-HALF; FETUSES	Glucose is a major energy substrate for the fetus, including liver, heart, and brain metabolism. The umbilical vein (UV) blood flow supplies the fetal liver directly from the placenta, whereas a fraction is shunted via ductus venosus (DV) to the fetal systemic circulation bypassing the fetal liver. We hypothesized UV glucose concentration to be a major regulator of the distribution of glucose supply between the fetal liver and DV, and explored the influence of maternal metabolic status on this distribution. We included 124 healthy women with normal singleton pregnancies, scheduled for elective cesarean section. UV and DV blood flow measurements were performed by Doppler ultrasound immediately before, and blood samples were obtained during surgery. UV blood flow was significantly correlated with DV blood flow, liver blood flow, and the DV shunting fraction, while UV glucose concentration was not. For normal-weight mothers, the maternal-fetal glucose gradient was positively correlated with DV shunting fraction, and negatively with liver blood flow. For the fetuses of the overweight mothers no such correlation was found. This indicates that within the normal physiological range the human fetus makes adaptations of blood flow to ensure individual needs related to the offered maternal energy supply.	[Opheim, Gun Lisbet; Zahid, Saba Muneer; Haugen, Guttorm] Oslo Univ Hosp, Dept Fetal Med, Rikshosp, Sognsvannsveien 20,POB 4950 Nydalen, N-0424 Oslo, Norway; [Opheim, Gun Lisbet; Michelsen, Trond Melbye; Roland, Marie Cecilie Paasche] Oslo Univ Hosp, Norwegian Advisory Unit Womens Hlth, Rikshosp, Oslo, Norway; [Opheim, Gun Lisbet; Michelsen, Trond Melbye; Zahid, Saba Muneer; Henriksen, Tore; Haugen, Guttorm] Univ Oslo, Inst Clin Med, Oslo, Norway; [Holme, Ane Moe; Holm, Maia Blomhoff; Michelsen, Trond Melbye; Roland, Marie Cecilie Paasche; Henriksen, Tore] Oslo Univ Hosp, Dept Obstet, Rikshosp, Oslo, Norway	University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; National Hospital Norway	Opheim, GL (corresponding author), Oslo Univ Hosp, Dept Fetal Med, Rikshosp, Sognsvannsveien 20,POB 4950 Nydalen, N-0424 Oslo, Norway.	glopheim@gmail.com			Norwegian National Advisory Unit on Women's Health; South-Eastern Norway Regional Health Authority	Norwegian National Advisory Unit on Women's Health; South-Eastern Norway Regional Health Authority	The Norwegian National Advisory Unit on Women's Health (to GLO, TMM, and MPR) and the South-Eastern Norway Regional Health Authority (to AMH, MBH, and TMM) provided financial support to conduct the research. The funders had no involvement in the study design, data collection, analyses, or interpretation. Furthermore, they were not involved in the writing or the decision to publish this paper	Acharya G, 2005, AM J OBSTET GYNECOL, V192, P937, DOI 10.1016/j.ajog.2004.09.019; BATTAGLIA FC, 1978, PHYSIOL REV, V58, P499, DOI 10.1152/physrev.1978.58.2.499; Bellotti M, 2004, AM J OBSTET GYNECOL, V190, P1347, DOI 10.1016/j.ajog.2003.11.018; Brown JM, 2019, J CLIN INVEST, V129, P3035, DOI 10.1172/JCI130904; Catalano PM, 2017, BMJ-BRIT MED J, V356, DOI [10.1136/bmj.j1, 10.1136/bmj.j1631]; Catalano PM, 2009, DIABETES CARE, V32, P1076, DOI 10.2337/dc08-2077; CHIBA Y, 1992, No To Hattatsu, V24, P136; du Plessis AJ, 2009, CLIN PERINATOL, V36, P531, DOI 10.1016/j.clp.2009.07.002; Ebbing C, 2007, ULTRASOUND OBST GYN, V30, P287, DOI 10.1002/uog.4088; Ebbing C, 2011, ULTRASOUND OBST GYN, V38, P303, DOI 10.1002/uog.9046; EDELSTONE DI, 1978, CIRC RES, V42, P426, DOI 10.1161/01.RES.42.3.426; Godfrey KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041759; Haugen G, 2005, CIRC RES, V96, P12, DOI 10.1161/01.RES.0000152391.45273.A2; Haugen G, 2004, ULTRASOUND OBST GYN, V24, P599, DOI 10.1002/uog.1744; Haugen G, 2014, ACTA OBSTET GYN SCAN, V93, P778, DOI 10.1111/aogs.12419; HAY WW, 1991, P NUTR SOC, V50, P321, DOI 10.1079/PNS19910042; Holme AM, 2017, JOVE-J VIS EXP, DOI 10.3791/55847; Holme AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117084; Houin SS, 2015, AM J PHYSIOL-ENDOC M, V308, pE306, DOI 10.1152/ajpendo.00396.2014; Ikenoue S, 2017, AM J OBSTET GYNECOL, V217, DOI 10.1016/j.ajog.2017.04.022; Johnsen SL, 2006, EUR J OBSTET GYN R B, V127, P172, DOI 10.1016/j.ejogrb.2005.10.004; Kalhan S, 2000, SEMIN PERINATOL, V24, P94, DOI 10.1053/sp.2000.6360; Kessler J, 2007, ULTRASOUND OBST GYN, V30, P52, DOI 10.1002/uog.4054; Kessler J, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.038; Kessler J, 2009, PEDIATR RES, V66, P113, DOI 10.1203/PDR.0b013e3181a29077; Kiserud T, 2006, ULTRASOUND OBST GYN, V28, P143, DOI 10.1002/uog.2784; Kiserud T, 2000, AM J OBSTET GYNECOL, V182, P147, DOI 10.1016/S0002-9378(00)70504-7; Kiserud T, 1998, ULTRASOUND MED BIOL, V24, P1301, DOI 10.1016/S0301-5629(98)00131-8; Kiserud T, 1998, ULTRASOUND OBST GYN, V11, P419, DOI 10.1046/j.1469-0705.1998.11060419.x; KISERUD T, 1994, ULTRASOUND MED BIOL, V20, P225, DOI 10.1016/0301-5629(94)90062-0; Lund A, 2019, MATERNAL DIABETES ME; MARI G, 1989, AM J OBSTET GYNECOL, V160, P698, DOI 10.1016/S0002-9378(89)80063-8; Michelsen TM, 2019, J CLIN ENDOCR METAB, V104, P873, DOI 10.1210/jc.2018-01154; Mizuno K, 2017, HEPATOL RES, V47, P160, DOI 10.1111/hepr.12760; Nyberg MK, 2010, ULTRASOUND OBST GYN, V36, P718, DOI 10.1002/uog.7701; Opheim GL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216176; Petersen MC, 2017, NAT REV ENDOCRINOL, V13, P572, DOI 10.1038/nrendo.2017.80; Poisson J, 2017, J HEPATOL, V66, P212, DOI 10.1016/j.jhep.2016.07.009; Roland MCP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039324; Sewell MF, 2007, J REPROD MED, V52, P907; Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059; Sjogren K, 1999, P NATL ACAD SCI USA, V96, P7088, DOI 10.1073/pnas.96.12.7088; Skjaerven R, 2000, AM J OBSTET GYNECOL, V183, P689, DOI 10.1067/mob.2000.106590; Tchirikov M, 2006, ULTRASOUND OBST GYN, V27, P452, DOI 10.1002/uog.2747; Tchirikov M, 2002, PLACENTA, V23, pS153, DOI 10.1053/plac.2002.0810; WLADIMIROFF JW, 1987, OBSTET GYNECOL, V69, P705; WLADIMIROFF JW, 1986, BRIT J OBSTET GYNAEC, V93, P471, DOI 10.1111/j.1471-0528.1986.tb08656.x	47	7	8	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12481	12491		10.1096/fj.202000766R	http://dx.doi.org/10.1096/fj.202000766R		JUL 2020	11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32729124	Green Published			2022-12-28	WOS:000556799000001
J	Muppala, S; Rahman, MT; Krukovets, I; Verbovetskiy, D; Pluskota, E; Fleischman, A; Vince, DG; Plow, EF; Stenina-Adognravi, O				Muppala, Santoshi; Rahman, Mohammed Tanjimur; Krukovets, Irene; Verbovetskiy, Dmitriy; Pluskota, Elzbieta; Fleischman, Aaron; Vince, D. Geoffrey; Plow, Edward F.; Stenina-Adognravi, Olga			The P387 thrombospondin-4 variant promotes accumulation of macrophages in atherosclerotic lesions	FASEB JOURNAL			English	Article						atherosclerosis; extracellular matrix; macrophage; matricellular proteins; thrombospondin-4	MYOCARDIAL-INFARCTION; A387P POLYMORPHISM; EXPRESSION; ASSOCIATION; PREDICTION; MATRIX; GENES; RISK	Thrombospondin-4 (TSP4) is a pro-angiogenic protein that has been implicated in tissue remodeling and local vascular inflammation. TSP4 and, in particular, its SNP variant, P387 TSP4, have been associated with cardiovascular disease. Macrophages are central to initiation and resolution of inflammation and development of atherosclerotic lesions, but the effects of the P387 TSP4 on macrophages remain essentially unknown. We examined the effects of the P387 TSP4 variant on macrophages in cell culture andin vivoin a murine model of atherosclerosis. Furthermore, the levels and distributions of the two TSP4 variants were assessed in human atherosclerotic arteries. InApoE(-)(/-)/P387-TSP4 knock-in mice, lesions size measured by Oil Red O did not change, but the lesions accumulated more macrophages than lesions bearing A387 TSP4. The levels of inflammatory markers were increased in lesions ofApoE(-)(/)(-)/P387-TSP4 knock-in mice compared toApoE(-)(/)(-)mice. Lesions in human arteries from individuals carrying the P387 variant had higher levels of TSP4 and higher macrophage accumulation. P387 TSP4 was more active in supporting adhesion of cultured human and mouse macrophages in experiments using recombinant TSP4 variants and in cells derived from P387-TSP4 knock-in mice. TSP4 supports the adhesion of macrophages and their accumulation in atherosclerotic lesions without changing the size of lesions. P387 TSP4 is more active in supporting these pro-inflammatory events in the vascular wall, which may contribute to the increased association of P387 TSP4 with cardiovascular disease.	[Muppala, Santoshi; Rahman, Mohammed Tanjimur; Krukovets, Irene; Verbovetskiy, Dmitriy; Pluskota, Elzbieta; Plow, Edward F.; Stenina-Adognravi, Olga] Cleveland Clin, Dept Cardiovasc & Metab Sci, 9500 Euclid Ave,NB50-78, Cleveland, OH 44195 USA; [Fleischman, Aaron; Vince, D. Geoffrey] Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation	Stenina-Adognravi, O (corresponding author), Cleveland Clin, Dept Cardiovasc & Metab Sci, 9500 Euclid Ave,NB50-78, Cleveland, OH 44195 USA.	stenino@ccf.org			National Institutes of Health [R01 HL117216, R01 CA177771]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health [R01 HL117216 to OSA and EFP, R01 CA177771 to OSA]	Adams J, 2004, INT J BIOCHEM CELL B, V36, P960, DOI 10.1016/j.biocel.2004.02.009; ADAMS J, 1993, CURR BIOL, V3, P188, DOI 10.1016/0960-9822(93)90270-X; Adams JC, 2018, CURR TOP DEV BIOL, V130, P39, DOI 10.1016/bs.ctdb.2018.02.003; Adams JC, 2011, CSH PERSPECT BIOL, V3, DOI [10.1101/cshperspect.a009712, 10.1016/j.biocel.2004.01.004]; Amici SA, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01593; Andersson D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070699; Armstrong LC, 2003, MATRIX BIOL, V22, P63, DOI 10.1016/S0945-053X(03)00005-2; Benner EJ, 2013, NATURE, V497, P369, DOI 10.1038/nature12069; Bentley AA, 2010, MOL BIOL EVOL, V27, P2187, DOI 10.1093/molbev/msq107; Cho JY, 2011, CLIN CANCER RES, V17, P1850, DOI 10.1158/1078-0432.CCR-10-2180; Cingolani OH, 2011, CIRC RES, V109, P1410, DOI 10.1161/CIRCRESAHA.111.256743; Cui JX, 2006, AM HEART J, V152, DOI 10.1016/j.ahj.2006.06.002; Cui JX, 2004, ARTERIOSCL THROM VAS, V24, pE183, DOI 10.1161/01.ATV.0000147304.67100.ee; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; D'Errico M, 2009, EUR J CANCER, V45, P461, DOI 10.1016/j.ejca.2008.10.032; Eroglu C, 2009, CELL, V139, P380, DOI 10.1016/j.cell.2009.09.025; Forster S, 2011, MODERN PATHOL, V24, P1390, DOI 10.1038/modpathol.2011.99; Frolova EG, 2014, MATRIX BIOL, V37, P35, DOI 10.1016/j.matbio.2014.02.003; Frolova EG, 2012, FASEB J, V26, P2363, DOI 10.1096/fj.11-190728; Frolova EG, 2010, CIRC RES, V107, P1313, DOI 10.1161/CIRCRESAHA.110.232371; Girard F, 2014, MOL CELL NEUROSCI, V61, P176, DOI 10.1016/j.mcn.2014.06.010; Gu WD, 2019, ARTERIOSCL THROM VAS, V39, P1055, DOI 10.1161/ATVBAHA.119.312399; Kato T. Y. A., 2003, CIRCULATION, V108, pIV; Kirk JA, 2016, J MOL CELL CARDIOL, V90, P102, DOI 10.1016/j.yjmcc.2015.12.009; LAWLER JW, 1978, J BIOL CHEM, V253, P8609; Lawler PR, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006627; Lopez-Dee Z, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/296069; Lynch JM, 2012, CELL, V149, P1257, DOI 10.1016/j.cell.2012.03.050; Ma XJ, 2004, CANCER CELL, V5, P607, DOI 10.1016/j.ccr.2004.05.015; McCarthy JJ, 2004, J MED GENET, V41, P334, DOI 10.1136/jmg.2003.016584; Mosher DF, 2012, MATRIX BIOL, V31, P155, DOI 10.1016/j.matbio.2012.01.003; Muppala S, 2017, ONCOGENE, V36, P5189, DOI 10.1038/onc.2017.140; Muppala S, 2015, ARTERIOSCL THROM VAS, V35, P1975, DOI 10.1161/ATVBAHA.115.305912; Orecchioni M, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01084; Peter MR, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/767185; Pluskota E, 2005, BLOOD, V106, P3970, DOI 10.1182/blood-2005-03-1292; Rahman MT, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2237-2; Reed AEM, 2013, VIRCHOWS ARCH, V463, P535, DOI 10.1007/s00428-013-1468-3; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Stenina OI, 2005, FASEB J, V19, P1893, DOI 10.1096/fj.05-3712fje; Stenina OI, 2003, CIRCULATION, V108, P1514, DOI 10.1161/01.CIR.0000089085.76320.4E; Su F, 2017, ONCOTARGET, V8, P23277, DOI 10.18632/oncotarget.15054; Tan FL, 2002, P NATL ACAD SCI USA, V99, P11387, DOI 10.1073/pnas.162370099; Tinajero MG, 2020, AM J PATHOL, V190, P520, DOI 10.1016/j.ajpath.2019.10.021; Toledo-Flores D, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43765-8; TOLSMA SS, 1993, J CELL BIOL, V122, P497, DOI 10.1083/jcb.122.2.497; Topol EJ, 2001, CIRCULATION, V104, P2641, DOI 10.1161/hc4701.100910; Turashvili G, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-55; Wessel J, 2004, AM HEART J, V147, P905, DOI 10.1016/j.ahj.2003.12.013; Wilsgaard T, 2015, CIRC-CARDIOVASC GENE, V8, P363, DOI 10.1161/CIRCGENETICS.113.000630; Yamada Y, 2002, NEW ENGL J MED, V347, P1916, DOI 10.1056/NEJMoa021445; Yang F, 2020, CARDIOVASC RES, V116, P211, DOI 10.1093/cvr/cvz044; Yang HJ, 2016, J MOL NEUROSCI, V60, P517, DOI 10.1007/s12031-016-0845-1	53	1	1	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					11529	11545		10.1096/fj.201901434RRRR	http://dx.doi.org/10.1096/fj.201901434RRRR		JUL 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32686880	Green Submitted			2022-12-28	WOS:000553643200001
J	Jia, P; Pan, TY; Xu, SJ; Fang, Y; Song, NN; Guo, M; Liang, YR; Xu, XL; Ding, XQ				Jia, Ping; Pan, Tianyi; Xu, Sujuan; Fang, Yi; Song, Nana; Guo, Man; Liang, Yiran; Xu, Xialian; Ding, Xiaoqiang			Depletion of miR-21 in dendritic cells aggravates renal ischemia-reperfusion injury	FASEB JOURNAL			English	Article						acute kidney injury; dendritic cell; inflammation; microRNAs	CONTRIBUTES; PROTECTION	Dendritic cells (DCs) play an important role in the pathophysiology of renal ischemia-reperfusion injury (IRI). The mechanisms underlying DCs phenotypic modulation and their function are not fully understood. In this study, we examined the effect of miR-21 on the phenotypic modulation of DCs in vitro and in vivo, and further investigated the impact of miR-21-overexpression DC or miR-21-deficient DC on renal IRI. We found that treatment with hypoxia/reoxygenation (H/R) suppressed miR-21 expression in bone marrow-derived dendritic cells (BMDCs), and significantly increased the percentage of mature DCs (CD11c(+)/MHC-II+/CD80(+)). Using a selection of microRNA mimics, we successfully induced the upregulation of miR-21 in BMDCs, which induced immature DC phenotype and an anti-inflammatory DC response. However, deletion of miR-21 in BMDCs promoted maturation of DCs under H/R. Adoptive transfer of miR-21-overexpression BMDCs could alleviate renal IR-induced pro-inflammatory cytokines production and acute kidney injury (AKI). Mice with miR-21 deficiency in DCs subjected to renal IR showed more severe renal dysfunction and inflammatory response compared with wild-type mice. In addition, chemokine C receptor 7 (CCR7), a surface marker of mature DC, was a target gene of miR-21, and silencing of CCR7 in BMDCs led to reduced mature DCs under H/R. In conclusion, our findings highlight miR-21 as a key regulator of DCs subset phenotype and a potential therapeutic target in renal IRI.	[Jia, Ping; Pan, Tianyi; Xu, Sujuan; Fang, Yi; Song, Nana; Guo, Man; Liang, Yiran; Xu, Xialian; Ding, Xiaoqiang] Fudan Univ, Zhongshan Hosp, Div Nephrol, 180 Fenglin Rd, Shanghai 200032, Peoples R China; [Jia, Ping; Ding, Xiaoqiang] Kidney & Blood Purificat Lab Shanghai, Shanghai, Peoples R China; [Pan, Tianyi] Shanghai Med Assoc, Shanghai, Peoples R China; [Ding, Xiaoqiang] Shanghai Med Ctr Kidney, Shanghai, Peoples R China; [Ding, Xiaoqiang] Kidney & Dialysis Inst Shanghai, Shanghai, Peoples R China; [Ding, Xiaoqiang] Hemodialysis Qual Control Ctr Shanghai, Shanghai, Peoples R China	Fudan University	Ding, XQ (corresponding author), Fudan Univ, Zhongshan Hosp, Div Nephrol, 180 Fenglin Rd, Shanghai 200032, Peoples R China.	ding.xiaoqiang@zs-hospital.sh.cn			Science and Technology Commission of Shanghai Municipality (STCSM) [14DZ2260200]; National Natural Science Foundation of China [81430015, 81670614, 81870466]	Science and Technology Commission of Shanghai Municipality (STCSM)(Science & Technology Commission of Shanghai Municipality (STCSM)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Science and Technology Commission of Shanghai Municipality (STCSM), Grant/Award Number: 14DZ2260200; National Natural Science Foundation of China, Grant/Award Number: 81430015, 81670614 and 81870466	Ardavin C, 2001, TRENDS IMMUNOL, V22, P691, DOI 10.1016/S1471-4906(01)02059-2; Awuah D, 2019, J IMMUNOL, V203, P148, DOI 10.4049/jimmunol.1801108; Bajwa A, 2016, J AM SOC NEPHROL, V27, P1076, DOI 10.1681/ASN.2015010095; Hashimi ST, 2009, BLOOD, V114, P404, DOI 10.1182/blood-2008-09-179150; Hu J, 2011, IMMUNOLOGY, V132, P307, DOI 10.1111/j.1365-2567.2010.03396.x; Jia P, 2017, CRIT CARE MED, V45, pE703, DOI 10.1097/CCM.0000000000002363; Jia P, 2013, ANESTHESIOLOGY, V119, P621, DOI 10.1097/ALN.0b013e318298e5f1; Karrich JJ, 2013, BLOOD, V122, P3001, DOI 10.1182/blood-2012-12-475087; Kim BS, 2005, TRANSPLANTATION, V79, P1370, DOI 10.1097/01.TP.0000158355.83327.62; Kim MG, 2010, NEPHROL DIAL TRANSPL, V25, P2908, DOI 10.1093/ndt/gfq183; Li L, 2012, J CLIN INVEST, V122, P3931, DOI 10.1172/JCI63170; Liu F, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00947; Lotze MT, 2007, IMMUNOL REV, V220, P60, DOI 10.1111/j.1600-065X.2007.00579.x; Morelli AE, 2007, NAT REV IMMUNOL, V7, P610, DOI 10.1038/nri2132; Okusa Mark D, 2012, Trans Am Clin Climatol Assoc, V123, P54; Reis M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02538; Schutt CR, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0255-7; Sheedy FJ, 2008, ANN RHEUM DIS, V67, P50, DOI 10.1136/ard.2008.100289; Sheedy FJ, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00019; Song NN, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00790; White LE, 2012, INT J NEPHROL, V2012, DOI 10.4061/2012/505197; Xu XL, 2012, KIDNEY INT, V82, P1167, DOI 10.1038/ki.2012.241	22	8	8	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					11729	11740		10.1096/fj.201903222RR	http://dx.doi.org/10.1096/fj.201903222RR		JUL 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32667078	Bronze			2022-12-28	WOS:000553017100001
J	Li, BE; Lee, WC; Song, C; Ye, L; Abel, ED; Long, FX				Li, Boer; Lee, Wen-Chih; Song, Chao; Ye, Ling; Abel, E. Dale; Long, Fanxin			Both aerobic glycolysis and mitochondrial respiration are required for osteoclast differentiation	FASEB JOURNAL			English	Article						aerobic glycolysis; bone; metabolism; osteoclast; oxidative phosphorylation	BONE-RESORPTION; BIOGENESIS	Excessive bone resorption over bone formation is the root cause for bone loss leading to osteoporotic fractures. Development of new antiresorptive therapies calls for a holistic understanding of osteoclast differentiation and function. Although much has been learned about the molecular regulation of osteoclast biology, little is known about the metabolic requirement and bioenergetics during osteoclastogenesis. Here, we report that glucose metabolism through oxidative phosphorylation (OXPHOS) is the predominant bioenergetic pathway to support osteoclast differentiation. Meanwhile, increased lactate production from glucose, known as aerobic glycolysis when oxygen is abundant, is also critical for osteoclastogenesis. Genetic deletion of Glut1 in osteoclast progenitors reduces aerobic glycolysis without compromising OXPHOS, but nonetheless diminishes osteoclast differentiation in vitro. Glut1 deficiency in the progenitors leads to osteopetrosis due to fewer osteoclasts specifically in the female mice. Thus, Glut1-mediated glucose metabolism through both lactate production and OXPHOS is necessary for normal osteoclastogenesis.	[Li, Boer; Ye, Ling] Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu, Peoples R China; [Li, Boer; Lee, Wen-Chih; Long, Fanxin] Washington Univ, Sch Med, Dept Orthopaed Surg, St Louis, MO USA; [Lee, Wen-Chih; Song, Chao; Long, Fanxin] Childrens Hosp Philadelphia, Translat Res Program Pediat Orthopaed, Philadelphia, PA 19104 USA; [Abel, E. Dale] Univ Iowa, Carver Coll Med, Div Endocrinol & Metab, Fraternal Order Eagles Diabet Res Ctr, Iowa City, IA USA; [Long, Fanxin] Univ Penn, Dept Orthopaed Surg, Philadelphia, PA 19104 USA	Sichuan University; Washington University (WUSTL); University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Iowa; University of Pennsylvania	Long, FX (corresponding author), Childrens Hosp Philadelphia, Translat Res Program Pediat Orthopaed, Philadelphia, PA 19104 USA.	longf1@email.chop.edu		Abel, E. Dale/0000-0001-5290-0738	China Scholarship Council [201506240134]; NIH [R01 DK111212, P30 AR057235]; Washington University Musculoskeletal Research Center	China Scholarship Council(China Scholarship Council); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Washington University Musculoskeletal Research Center	China Scholarship Council, Grant/Award Number: 201506240134; NIH, Grant/Award Number: R01 DK111212 and P30 AR057235; Washington University Musculoskeletal Research Center	Ahn H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153886; Almeida M, 2017, PHYSIOL REV, V97, P135, DOI 10.1152/physrev.00033.2015; Arnett TR, 2018, BONE, V115, P25, DOI 10.1016/j.bone.2017.12.021; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Indo Y, 2013, J BONE MINER RES, V28, P2392, DOI 10.1002/jbmr.1976; Ishii K, 2009, NAT MED, V15, P259, DOI 10.1038/nm.1910; Jin ZX, 2014, CELL METAB, V20, P483, DOI 10.1016/j.cmet.2014.07.011; Karner CM, 2018, BONE, V115, P2, DOI 10.1016/j.bone.2017.08.008; Kim JM, 2007, CELL PHYSIOL BIOCHEM, V20, P935, DOI 10.1159/000110454; Mai V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020647; McHugh KP, 2000, J CLIN INVEST, V105, P433, DOI 10.1172/JCI8905; Miyazaki T, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.385369; Novack DV, 2003, J EXP MED, V198, P771, DOI 10.1084/jem.20030116; Ramchand SK, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00505; Sims Natalie A, 2014, Bonekey Rep, V3, P481, DOI 10.1038/bonekey.2013.215; Spencer JA, 2014, NATURE, V508, P269, DOI 10.1038/nature13034; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Williams JP, 1997, BIOCHEM BIOPH RES CO, V235, P646, DOI 10.1006/bbrc.1997.6795; Zeng R, 2015, J BONE MINER RES, V30, P2287, DOI 10.1002/jbmr.2584; Zhang Y, 2018, J BONE MINER RES, V33, P1114, DOI 10.1002/jbmr.3398	21	15	16	13	48	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					11058	11067		10.1096/fj.202000771R	http://dx.doi.org/10.1096/fj.202000771R		JUL 2020	10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32627870				2022-12-28	WOS:000547605500001
J	Yao, L; Wells, M; Wu, XW; Xu, Y; Zhang, L; Xiong, W				Yao, Lei; Wells, Marta; Wu, Xiongwu; Xu, Yan; Zhang, Li; Xiong, Wei			Membrane cholesterol dependence of cannabinoid modulation of glycine receptor	FASEB JOURNAL			English	Article						cannabinoid; cholesterol; glycine receptor	NEUROPATHIC PAIN; GABA(A) RECEPTOR; ALPHA-1; POTENTIATION; MUTATIONS; CHANNEL; TARGET	Cannabinoids exert therapeutic effects on several diseases such as chronic pain and startle disease by targeting glycine receptors (GlyRs). Our previous studies have shown that cannabinoids target a serine residue at position 296 in the third transmembrane helix of the alpha 1/alpha 3 GlyR. This site is located on the outside of the ion channel protein at the lipid interface where the cholesterol concentrates. However, whether membrane cholesterol regulates cannabinoid-GlyR interaction remains unknown. Here, we show that GlyRs are closely associated with cholesterol/caveolin-rich domains at subcellular levels. Membrane cholesterol reduction significantly inhibits cannabinoid potentiation of glycine-activated currents in cultured spinal neurons and in HEK 293T cells expressing alpha 1/alpha 3 GlyRs. Such inhibition is fully rescued by cholesterol replenishment in a concentration-dependent manner. Molecular docking calculations further reveal that cholesterol regulates cannabinoid enhancement of GlyR function through both direct and indirect mechanisms. Taken together, these findings suggest that cholesterol is critical for the cannabinoid-GlyR interaction in the cell membrane.	[Yao, Lei; Xiong, Wei] Univ Sci & Technol China, Affiliated Hosp 1, Inst Aging & Brain Disorders, Div Life Sci & Med,Hefei Natl Lab Phys Sci Micros, Hefei, Peoples R China; [Wells, Marta; Xu, Yan] Univ Pittsburgh, Sch Med, Dept Anesthesiol, Pittsburgh, PA 15261 USA; [Wu, Xiongwu] NHLBI, NIH, Bldg 10, Bethesda, MD 20892 USA; [Zhang, Li] NIAAA, Lab Integrat Neurosci, NIH, Bethesda, MD 20892 USA; [Xiong, Wei] Chinese Acad Sci, Ctr Excellence Brain Sci & Intelligence Technol, Shanghai, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Chinese Academy of Sciences	Zhang, L (corresponding author), NIAAA, Lab Integrat Neurosci, NIH, Bethesda, MD 20892 USA.; Xiong, W (corresponding author), Univ Sci & Technol China, Div Life Sci & Med, Hefei 230026, Anhui, Peoples R China.	lzhang@mail.nih.gov; wxiong@ustc.edu.cn		Wells, Marta/0000-0001-6800-134X	National Natural Science Foundation of China [91849206, 91649121, 91942315]; Chinese Academy of Sciences [XDPB1005]; Key Research Program of Frontier Science [ZDBS-LY-SM002]; CAS Interdisciplinary Innovation Team [JCTD-2018-20]; National Key R&D Program of China [2016YFC1300500-2]; Fundamental Research Funds for the Central Universities, Users with Excellence Program/Project of Hefei Science Center CAS [2019HSC-UE006]; US National Institutes of Health [T32EB009403, R37GM049202]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Key Research Program of Frontier Science; CAS Interdisciplinary Innovation Team; National Key R&D Program of China; Fundamental Research Funds for the Central Universities, Users with Excellence Program/Project of Hefei Science Center CAS; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	National Natural Science Foundation of China, Grant/Award Number: 91849206, 91649121 and 91942315; Chinese Academy of Sciences, Grant/Award Number: XDPB1005; Key Research Program of Frontier Science, Grant/Award Number: ZDBS-LY-SM002; CAS Interdisciplinary Innovation Team, Grant/Award Number: JCTD-2018-20; National Key R&D Program of China, Grant/Award Number: 2016YFC1300500-2; Fundamental Research Funds for the Central Universities, Users with Excellence Program/Project of Hefei Science Center CAS, Grant/Award Number: 2019HSC-UE006; US National Institutes of Health, Grant/Award Number: T32EB009403 and R37GM049202	Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Atakan Z, 2012, THER ADV PSYCHOPHARM, V2, P241, DOI 10.1177/2045125312457586; Barrantes FJ, 2007, J NEUROCHEM, V103, P72, DOI 10.1111/j.1471-4159.2007.04719.x; Bruses JL, 2001, J NEUROSCI, V21, P504, DOI 10.1523/JNEUROSCI.21-02-00504.2001; Chung SK, 2010, J NEUROSCI, V30, P9612, DOI 10.1523/JNEUROSCI.1763-10.2010; Davies PA, 2011, CURR OPIN PHARMACOL, V11, P75, DOI 10.1016/j.coph.2011.01.010; Dong XP, 2002, ANESTH ANALG, V95, P907, DOI 10.1097/00000539-200210000-00021; Ferraro NA, 2018, ANAL CHEM, V90, P2508, DOI 10.1021/acs.analchem.7b03639; Frank C, 2004, FEBS LETT, V566, P25, DOI 10.1016/j.febslet.2004.03.113; Harvey RJ, 2004, SCIENCE, V304, P884, DOI 10.1126/science.1094925; Hub JS, 2010, J AM CHEM SOC, V132, P13251, DOI 10.1021/ja102133x; James VM, 2013, NEUROBIOL DIS, V52, P137, DOI 10.1016/j.nbd.2012.12.001; Killestein J, 2016, NEW ENGL J MED, V374, P94, DOI 10.1056/NEJMc1512758; Kirsch C, 2003, BIOCHEM PHARMACOL, V65, P843, DOI 10.1016/S0006-2952(02)01654-4; Lara CO, 2019, ACS CHEM NEUROSCI, V10, P2551, DOI 10.1021/acschemneuro.9b00050; Levitan I, 2010, SUBCELL BIOCHEM, V51, P509, DOI 10.1007/978-90-481-8622-8_19; Lu HC, 2016, BIOL PSYCHIAT, V79, P516, DOI 10.1016/j.biopsych.2015.07.028; Lu JP, 2018, NEUROPHARMACOLOGY, V133, P224, DOI 10.1016/j.neuropharm.2018.01.041; Lynch JW, 2009, NEUROPHARMACOLOGY, V56, P303, DOI 10.1016/j.neuropharm.2008.07.034; Mowrey DD, 2013, STRUCTURE, V21, P1897, DOI 10.1016/j.str.2013.07.014; Nothdurfter C, 2013, INT J NEUROPSYCHOPH, V16, P1361, DOI 10.1017/S146114571200140X; Nurmikko TJ, 2007, PAIN, V133, P210, DOI 10.1016/j.pain.2007.08.028; Olsen RW, 2018, NEUROPHARMACOLOGY, V136, P10, DOI 10.1016/j.neuropharm.2018.01.036; Sooksawate T, 2001, NEUROPHARMACOLOGY, V40, P178, DOI 10.1016/S0028-3908(00)00159-3; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Wells MM, 2015, J MED CHEM, V58, P2958, DOI 10.1021/jm501873p; Wennberg CL, 2012, J AM CHEM SOC, V134, P5351, DOI 10.1021/ja211929h; Xiong W, 2011, NEUROSCIENCE, V184, P28, DOI 10.1016/j.neuroscience.2011.03.066; Xiong W, 2014, NAT NEUROSCI, V17, P232, DOI 10.1038/nn.3615; Xiong W, 2012, J EXP MED, V209, P1121, DOI 10.1084/jem.20120242; Xiong W, 2012, J NEUROSCI, V32, P5200, DOI 10.1523/JNEUROSCI.6347-11.2012; Xiong W, 2011, NAT CHEM BIOL, V7, P296, DOI 10.1038/nchembio.552; Yevenes GE, 2011, BRIT J PHARMACOL, V164, P224, DOI 10.1111/j.1476-5381.2011.01471.x; Zeilhofer HU, 2012, PHYSIOL REV, V92, P193, DOI 10.1152/physrev.00043.2010; Zheng H, 2012, J LIPID RES, V53, P1153, DOI 10.1194/jlr.M024455	35	11	11	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10920	10930		10.1096/fj.201903093R	http://dx.doi.org/10.1096/fj.201903093R		JUL 2020	11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32608538	Green Accepted			2022-12-28	WOS:000547077800001
J	Clarkson-Townsend, DA; Kennedy, E; Everson, TM; Deyssenroth, MA; Burt, AA; Hao, K; Chen, J; Lardue, MT; Marsit, CJ				Clarkson-Townsend, Danielle A.; Kennedy, Elizabeth; Everson, Todd M.; Deyssenroth, Maya A.; Burt, Amber A.; Hao, Ke; Chen, Jia; Lardue, Machelle T.; Marsit, Carmen J.			Seasonally variant gene expression in full-term human placenta	FASEB JOURNAL			English	Article						BHLHE40; circadian; photoperiod; rhythmicity; transcriptome	CIRCADIAN-RHYTHMS; BIRTH; MELATONIN; HYPOXIA; ASSOCIATION; PHOTOPERIOD; MECHANISMS; RISK	Seasonal exposures influence human health and development. The placenta, as a mediator of the maternal and fetal systems and a regulator of development, is an ideal tissue to understand the biological pathways underlying relationships between season of birth and later life health outcomes. Here, we conducted a differential expression (DE) analysis of season of birth in full-term human placental tissue to evaluate whether the placenta may be influenced by seasonal cues. Of the analyzed transcripts, 583 displayed DE between summer and winter births (False Discovery Rate [FDR]q < .05); among these,BHLHE40,MIR210HG, andHILPDAhad increased expression among winter births (BonferroniP < .05). Enrichment analyses of the seasonally variant genes between summer and winter births indicated overrepresentation of transcription factors HIF1A, VDR, and CLOCK, among others, and of GO term pathways related to ribosomal activity and infection. Additionally, a cosinor analysis found rhythmic expression for approximately 11.9% of all 17 664 analyzed placental transcripts. These results suggest that the placenta responds to seasonal cues and add to the growing body of evidence that the placenta acts as a peripheral clock, which may provide a molecular explanation for the extensive associations between season of birth and health outcomes.	[Clarkson-Townsend, Danielle A.; Kennedy, Elizabeth; Everson, Todd M.; Burt, Amber A.; Marsit, Carmen J.] Emory Univ, Rollins Sch Publ Hlth, Gangarosa Dept Environm Hlth, 1518 Clifton Rd, Atlanta, GA 30322 USA; [Deyssenroth, Maya A.; Chen, Jia] Icahn Sch Med Mt Sinai, Dept Environm Med & Publ Hlth, New York, NY 10029 USA; [Hao, Ke] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Lardue, Machelle T.] Atlanta VA Healthcare Syst, Tenter Visual & Neurocognit Rehabil, Decatur, GA USA; [Lardue, Machelle T.] Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA; [Lardue, Machelle T.] Emory Univ, Atlanta, GA 30322 USA	Emory University; Rollins School Public Health; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University System of Georgia; Georgia Institute of Technology; Emory University	Marsit, CJ (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Gangarosa Dept Environm Hlth, 1518 Clifton Rd, Atlanta, GA 30322 USA.	Carmen.J.Marsit@Emory.edu		(Clarkson-Townsend) Wallace, Danielle/0000-0001-7033-2172; Deyssenroth, Maya/0000-0003-2913-2392; Marsit, Carmen/0000-0003-4566-150X	HHS | NIH | National Institute of Environmental Health Sciences (NIEHS) [R01ES022223, T32 ES012870, R24ES025145, P30 ES019776]; HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [F31 HD097918]; U.S. Department of Veterans Affairs (VA) [RX003134]	HHS | NIH | National Institute of Environmental Health Sciences (NIEHS); HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); U.S. Department of Veterans Affairs (VA)(US Department of Veterans Affairs)	HHS | NIH | National Institute of Environmental Health Sciences (NIEHS), Grant/Award Number: R01ES022223, T32 ES012870, R24ES025145 and P30 ES019776; HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Grant/Award Number: F31 HD097918; U.S. Department of Veterans Affairs (VA), Grant/Award Number: RX003134	Appleton AA, 2016, PAEDIATR PERINAT EP, V30, P367, DOI 10.1111/ppe.12294; Benita Y, 2009, NUCLEIC ACIDS RES, V37, P4587, DOI 10.1093/nar/gkp425; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boland MR, 2015, J AM MED INFORM ASSN, V22, P1042, DOI 10.1093/jamia/ocv046; BUJA A, 1992, MULTIVAR BEHAV RES, V27, P509, DOI 10.1207/s15327906mbr2704_2; Cangul H, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-27; Christakos S, 2016, PHYSIOL REV, V96, P365, DOI 10.1152/physrev.00014.2015; Clarkson-Townsend DA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215745; Currie J, 2013, P NATL ACAD SCI USA, V110, P13228, DOI 10.1073/pnas.1307582110; Darrow LA, 2009, EPIDEMIOLOGY, V20, P699, DOI 10.1097/EDE.0b013e3181a66e96; Day FR, 2015, HELIYON, V1, DOI 10.1016/j.heliyon.2015.e00031; De Jong S, 2014, HUM MOL GENET, V23, P2721, DOI 10.1093/hmg/ddt665; Deyssenroth MA, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3878-0; Disanto G, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-69; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Doblhammer G, 2001, P NATL ACAD SCI USA, V98, P2934, DOI 10.1073/pnas.041431898; Dopico XC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8000; Fiddes B, 2014, J NEUROL, V261, P1851, DOI 10.1007/s00415-014-7241-y; Frigato E, 2009, BIOCHEM BIOPH RES CO, V378, P108, DOI 10.1016/j.bbrc.2008.11.006; Goldman BD, 2001, J BIOL RHYTHM, V16, P283, DOI 10.1177/074873001129001980; GRAY TK, 1979, SCIENCE, V204, P1311, DOI 10.1126/science.451538; Honma S, 2002, NATURE, V419, P841, DOI 10.1038/nature01123; Horvat F, 2018, LIFE SCI ALLIANCE, V1, DOI 10.26508/lsa.201800084; Ietta F, 2006, BIOL REPROD, V75, P112, DOI 10.1095/biolreprod.106.051557; Kato Y, 2014, CURR TOP DEV BIOL, V110, P339, DOI 10.1016/B978-0-12-405943-6.00010-5; Kim SH, 2013, CANCER LETT, V341, P159, DOI 10.1016/j.canlet.2013.07.028; Klingberg E, 2015, ENDOCRINE, V49, P800, DOI 10.1007/s12020-015-0548-3; Klingenspor M, 1996, FEBS LETT, V399, P290, DOI 10.1016/S0014-5793(96)01343-9; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Lanoix D, 2008, J PINEAL RES, V45, P50, DOI 10.1111/j.1600-079X.2008.00555.x; Lanoix D, 2012, J PINEAL RES, V53, P417, DOI 10.1111/j.1600-079X.2012.01012.x; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Leek JT, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku864; Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Lockett GA, 2016, ALLERGY, V71, P1314, DOI 10.1111/all.12882; Lofgren E, 2007, J VIROL, V81, P5429, DOI 10.1128/JVI.01680-06; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Ludwig N, 2019, RNA BIOL, V16, P1034, DOI 10.1080/15476286.2019.1612217; Mandel Y, 2008, OPHTHALMOLOGY, V115, P686, DOI 10.1016/j.ophtha.2007.05.040; Mark PJ, 2017, J BIOL RHYTHM, V32, P534, DOI 10.1177/0748730417728671; Morey JS, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3020-8; Myung J, 2012, J NEUROSCI, V32, P8900, DOI 10.1523/JNEUROSCI.5586-11.2012; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Peek CB, 2017, CELL METAB, V25, P86, DOI 10.1016/j.cmet.2016.09.010; Peng RD, 2005, AM J EPIDEMIOL, V161, P585, DOI 10.1093/aje/kwi075; Qiu CF, 2016, INT J MOL EPIDEMIOL, V7, P32; Rashid H, 2017, TROP MED HEALTH, V45, DOI 10.1186/s41182-016-0041-6; Rytkonen KT, 2020, REPRODUCTION, V160, P39, DOI 10.1530/REP-19-0615; Sachs, 2015, TOOLS ESTIMATING PRE; Shi GS, 2019, NEURON, V103, P1044, DOI 10.1016/j.neuron.2019.07.026; Song MS, 2017, BIOCHEM J, V474, P1603, DOI 10.1042/BCJ20160759; Stevenson TJ, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1453; Tackenberg MC, 2018, NEURAL PLAST, V2018, DOI 10.1155/2018/8217345; Takahashi JS, 2017, NAT REV GENET, V18, P164, DOI 10.1038/nrg.2016.150; TONG YL, 1976, BIOMETRICS, V32, P85, DOI 10.2307/2529340; Voellenkle C, 2016, SCI REP-UK, V6, DOI 10.1038/srep24141; Waddell BJ, 2012, PLACENTA, V33, P533, DOI 10.1016/j.placenta.2012.03.008; Walton JC, 2011, FRONT NEUROENDOCRIN, V32, P303, DOI 10.1016/j.yfrne.2010.12.003; Watson PE, 2007, EUR J CLIN NUTR, V61, P1271, DOI 10.1038/sj.ejcn.1602644; Watt KEN, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006187; Wehr TA, 1997, J BIOL RHYTHM, V12, P518, DOI 10.1177/074873049701200605; Zhang R, 2014, P NATL ACAD SCI USA, V111, P16219, DOI 10.1073/pnas.1408886111; Zhang YW, 2007, CELL CYCLE, V6, P507, DOI 10.4161/cc.6.5.3928	65	7	8	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10431	10442		10.1096/fj.202000291R	http://dx.doi.org/10.1096/fj.202000291R		JUN 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32574425	Green Submitted, Green Accepted			2022-12-28	WOS:000543552500001
J	Kang, D; Jung, SH; Lee, GH; Lee, S; Park, HJ; Ko, YG; Kim, YN; Lee, JS				Kang, Donghee; Jung, Seung Hee; Lee, Gun-Hee; Lee, Seongju; Park, Heon Joo; Ko, Young-Gyu; Kim, Yong-Nyun; Lee, Jae-Seon			Sulfated syndecan 1 is critical to preventing cellular senescence by modulating fibroblast growth factor receptor endocytosis	FASEB JOURNAL			English	Article						cellular senescence; endocytosis; heparan sulfation; SDC1; FGFR1	HEPARAN-SULFATE; MEDIATED ENDOCYTOSIS; PLASMA-MEMBRANE; PROTEOGLYCANS; APOPTOSIS; BINDING; REQUIREMENTS; REGULATORS; INTEGRIN; TARGET	Cellular senescence can be triggered by various intrinsic and extrinsic stimuli. We previously reported that silencing of 3 '-phosphoadenosine 5 '-phosphosulfate synthetase 2 (PAPSS2) induces cellular senescence through augmented fibroblast growth factor receptor 1 (FGFR1) signaling. However, the exact molecular mechanism connecting heparan sulfation and cellular senescence remains unclear. Here, we investigated the potential involvement of heparan sulfate proteoglycans (HSPGs) in augmented FGFR1 signaling and cellular senescence. Depletion of several types of HSPGs revealed that cells depleted of syndecan 1 (SDC1) exhibited typical senescence phenotypes, and those depleted of PAPSS2-, SDC1-, or heparan sulfate 2-O sulfotransferase 1 (HS2ST1) showed decreased FGFR1 internalization along with hyperresponsiveness to and prolonged activation of fibroblast growth factor 2 (FGF2)-stimulated FGFR1- v-akt murine thymoma viral oncogene homolog (AKT) signaling. Clathrin- and caveolin-mediated FGFR1 endocytosis contributed to cellular senescence through the FGFR1-AKT-p53-p21 signaling pathway. Dynasore treatment triggered senescence phenotypes, augmented FGFR1-AKT-p53-p21 signaling, and decreased SDC1 expression. Finally, the replicatively and prematurely senescent cells were characterized by decreases of SDC1 expression and FGFR1 internalization, and an increase in FGFR1-AKT-p53-p21 signaling. Together, our results demonstrate that properly sulfated SDC1 plays a critical role in preventing cellular senescence through the regulation of FGFR1 endocytosis.	[Kang, Donghee; Jung, Seung Hee; Lee, Gun-Hee; Lee, Jae-Seon] Inha Univ, Coll Med, Dept Mol Med, Incheon 22212, South Korea; [Kang, Donghee; Jung, Seung Hee; Lee, Gun-Hee; Lee, Seongju; Park, Heon Joo; Lee, Jae-Seon] Inha Univ, Coll Med, Med Res Ctr, Incheon, South Korea; [Lee, Seongju] Inha Univ, Coll Med, Dept Anat, Incheon, South Korea; [Park, Heon Joo] Inha Univ, Coll Med, Dept Microbiol, Incheon, South Korea; [Ko, Young-Gyu] Korea Univ, Div Life Sci, Seoul, South Korea; [Kim, Yong-Nyun] Natl Canc Ctr, Div Translat Sci, Goyang, South Korea	Inha University; Inha University; Inha University; Inha University; Korea University; National Cancer Center - Korea (NCC)	Lee, JS (corresponding author), Inha Univ, Coll Med, Dept Mol Med, Incheon 22212, South Korea.	jaeslee@inha.ac.kr	Lee, Seongju/AHE-8571-2022		National Research Foundation [2014R1A5A2009392, 2020R1A2B5B02002375]	National Research Foundation	National Research Foundation, Grant/Award Number: 2014R1A5A2009392 and 2020R1A2B5B02002375	Ai XB, 2003, J CELL BIOL, V162, P341, DOI 10.1083/jcb.200212083; Akl MR, 2016, ONCOTARGET, V7, P44735, DOI 10.18632/oncotarget.8203; Alcorta DA, 1996, P NATL ACAD SCI USA, V93, P13742, DOI 10.1073/pnas.93.24.13742; Auciello G, 2013, J CELL SCI, V126, P613, DOI 10.1242/jcs.116228; AVIEZER D, 1994, J BIOL CHEM, V269, P114; Axelsson J, 2012, BLOOD, V120, P1742, DOI 10.1182/blood-2012-03-417139; Belleudi F, 2007, TRAFFIC, V8, P1854, DOI 10.1111/j.1600-0854.2007.00651.x; Belting M, 2003, TRENDS BIOCHEM SCI, V28, P145, DOI 10.1016/S0968-0004(03)00031-8; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Chen LL, 2018, MOL CELLS, V41, P853, DOI 10.14348/molcells.2018.0103; Citores L, 1999, MOL BIOL CELL, V10, P3835, DOI 10.1091/mbc.10.11.3835; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Couchman JR, 2010, ANNU REV CELL DEV BI, V26, P89, DOI 10.1146/annurev-cellbio-100109-104126; Couchman JR, 2003, NAT REV MOL CELL BIO, V4, P926, DOI 10.1038/nrm1257; Deguchi Y, 2002, J NEUROCHEM, V83, P381, DOI 10.1046/j.1471-4159.2002.01129.x; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Echtermeyer F, 2011, CARDIOVASC RES, V92, P123, DOI 10.1093/cvr/cvr149; Elfenbein A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002495; Feng L, 2012, J CELL PHYSIOL, V227, P2480, DOI 10.1002/jcp.22984; Ferreras C, 2012, J BIOL CHEM, V287, P36132, DOI 10.1074/jbc.M112.384875; Gleizes PE, 1996, EUR J CELL BIOL, V71, P144; Hacker U, 2005, NAT REV MOL CELL BIO, V6, P530, DOI 10.1038/nrm1681; Harada E, 2017, ONCOTARGET, V8, P24741, DOI 10.18632/oncotarget.15799; Hassan H, 2013, FEBS J, V280, P2216, DOI 10.1111/febs.12111; Haugsten EM, 2008, MOL BIOL CELL, V19, P3390, DOI 10.1091/mbc.E07-12-1219; Hernandez-Segura A, 2018, TRENDS CELL BIOL, V28, P436, DOI 10.1016/j.tcb.2018.02.001; Hinze C, 2018, J CELL SCI, V131, DOI 10.1242/jcs.216804; Ishikawa T, 2010, EXP CELL RES, V316, P951, DOI 10.1016/j.yexcr.2009.12.013; Jung SH, 2016, CELL DEATH DIFFER, V23, P417, DOI 10.1038/cdd.2015.107; Kwak IH, 2004, CANCER RES, V64, P572, DOI 10.1158/0008-5472.CAN-03-1856; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Lecot P, 2016, BRIT J CANCER, V114, P1180, DOI 10.1038/bjc.2016.115; Liu SY, 2012, BIOCHEM BIOPH RES CO, V419, P656, DOI 10.1016/j.bbrc.2012.02.069; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; MALI M, 1993, J BIOL CHEM, V268, P24215; Marchese C, 1998, J CELL SCI, V111, P3517; Matsuo I, 2013, CURR OPIN GENET DEV, V23, P399, DOI 10.1016/j.gde.2013.02.004; Miaczynska M, 2008, J CELL BIOL, V180, P7, DOI 10.1083/jcb.200711073; Mundhenke C, 2002, AM J PATHOL, V160, P185, DOI 10.1016/S0002-9440(10)64362-3; Munoz-Espin D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823; Nugent MA, 2000, INT J BIOCHEM CELL B, V32, P115, DOI 10.1016/S1357-2725(99)00123-5; Ornitz DM, 2000, BIOESSAYS, V22, P108, DOI 10.1002/(SICI)1521-1878(200002)22:2<108::AID-BIES2>3.0.CO;2-M; Park JS, 2001, FASEB J, V15, P1625, DOI 10.1096/fj.00-0723fje; Pye DA, 2000, GLYCOBIOLOGY, V10, P1183, DOI 10.1093/glycob/10.11.1183; Rajarajacholan UK, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001502; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; Rapraeger AC, 2013, FEBS J, V280, P2194, DOI 10.1111/febs.12134; Scita G, 2010, NATURE, V463, P464, DOI 10.1038/nature08910; Sharpless NE, 2015, NAT REV CANCER, V15, P397, DOI 10.1038/nrc3960; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Steinfeld R, 1996, J CELL BIOL, V133, P405, DOI 10.1083/jcb.133.2.405; Stephen JR, 2006, CELL MOL LIFE SCI, V63, P1823; Takahashi A, 2012, MOL CELL, V45, P123, DOI 10.1016/j.molcel.2011.10.018; Tkachenko E, 2005, CIRC RES, V96, P488, DOI 10.1161/01.RES.0000159708.71142.c8; Zhang Z, 2001, J BIOL CHEM, V276, P41921, DOI 10.1074/jbc.M106608200; Zwick E, 2001, ENDOCR-RELAT CANCER, V8, P161, DOI 10.1677/erc.0.0080161	58	12	12	2	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10316	10328		10.1096/fj.201902714R	http://dx.doi.org/10.1096/fj.201902714R		JUN 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32530114	Bronze			2022-12-28	WOS:000541523700001
J	Gkika, D; Lolignier, S; Grolez, GP; Bavencoffe, A; Shapovalov, G; Gordienko, D; Kondratskyi, A; Meleine, M; Prival, L; Chapuy, E; Etienne, M; Eschalier, A; Shuba, Y; Skryma, R; Busserolles, J; Prevarskaya, N				Gkika, Dimitra; Lolignier, Stephane; Grolez, Guillaume P.; Bavencoffe, Alexis; Shapovalov, Georges; Gordienko, Dmitri; Kondratskyi, Artem; Meleine, Mathieu; Prival, Laetitia; Chapuy, Eric; Etienne, Monique; Eschalier, Alain; Shuba, Yaroslav; Skryma, Roman; Busserolles, Jerome; Prevarskaya, Natalia			Testosterone-androgen receptor: The steroid link inhibiting TRPM8-mediated cold sensitivity	FASEB JOURNAL			English	Article						hormone; ion channel; sensory neurons; thermosensation; transient receptor potential	PRIMARY SENSORY NEURONS; PREGNENOLONE SULFATE; BINDING GLOBULIN; TRPM8 CHANNEL; CA2+ CHANNEL; PROTEIN; AGE; EXPRESSION; SENSATION; ESTRADIOL	Recent studies have revealed gender differences in cold perception, and pointed to a possible direct action of testosterone (TST) on the cold-activated TRPM8 (Transient Receptor Potential Melastatin Member 8) channel. However, the mechanisms by which TST influences TRPM8-mediated sensory functions remain elusive. Here, we show that TST inhibits TRPM8-mediated mild-cold perception through the noncanonical engagement of the Androgen Receptor (AR). Castration of both male rats and mice increases sensitivity to mild cold, and this effect depends on the presence of intact TRPM8 and AR. TST in nanomolar concentrations suppresses whole-cell TRPM8-mediated currents and single-channel activity in native dorsal root ganglion (DRG) neurons and HEK293 cells co-expressing recombinant TRPM8 and AR, but not TRPM8 alone. AR cloned from rat DRGs shows no difference from standard AR. However, biochemical assays and confocal imaging reveal the presence of AR on the cell surface and its interaction with TRPM8 in response to TST, leading to an inhibition of channel activity.	[Gkika, Dimitra; Grolez, Guillaume P.; Bavencoffe, Alexis; Shapovalov, Georges; Gordienko, Dmitri; Kondratskyi, Artem; Shuba, Yaroslav; Skryma, Roman; Prevarskaya, Natalia] Univ Lille, INSERM, U1003, PHYCEL Physiol Cellulaire, Lille, France; [Lolignier, Stephane; Meleine, Mathieu; Prival, Laetitia; Chapuy, Eric; Etienne, Monique; Eschalier, Alain; Busserolles, Jerome] Univ Clermont Auvergne, INSERM, Neurodol, Clermont Ferrand, France; [Lolignier, Stephane; Meleine, Mathieu; Prival, Laetitia; Chapuy, Eric; Etienne, Monique; Eschalier, Alain; Busserolles, Jerome] Inst Analgesia, Fac Med, Clermont Ferrand, France; [Kondratskyi, Artem; Shuba, Yaroslav] Bogomoletz Inst Physiol NASU, Dept Neuromuscular Physiol, Kiev, Ukraine	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA); National Academy of Sciences Ukraine; A.A. Bogomoletz Institute of Physiology	Gkika, D (corresponding author), Univ Lille, INSERM, Dept Biol,U1003, Lab Physiol Cellulaire,Fac Sci & Technol, Batiment SN3, F-59655 Villeneuve Dascq, France.	dimitra.gkika@univ-lille.fr	Guillaume, Grolez/N-5087-2019; Grolez, Guillaume/U-5356-2018; Lolignier, Stéphane/K-1281-2015; Gkika, Dimitra/S-3054-2019; Busserolles, Jerome/AAJ-1196-2020; Shuba, Yaroslav/AAT-6758-2021	Guillaume, Grolez/0000-0002-7603-0797; Grolez, Guillaume/0000-0002-7603-0797; Lolignier, Stéphane/0000-0001-5407-4986; Gkika, Dimitra/0000-0001-8612-0836; Bavencoffe, Alexis Guillaume/0000-0001-5659-5988; Kondratskyi, Artem/0000-0003-3290-0524				Asuthkar S, 2015, ONCOTARGET, V6, P17221, DOI 10.18632/oncotarget.3948; Asuthkar S, 2015, J BIOL CHEM, V290, P2670, DOI 10.1074/jbc.M114.610873; Asuthkar S, 2015, J BIOL CHEM, V290, P2659, DOI 10.1074/jbc.M114.610824; Bain DL, 2007, ANNU REV PHYSIOL, V69, P201, DOI 10.1146/annurev.physiol.69.031905.160308; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Bidaux G, 2005, ENDOCR-RELAT CANCER, V12, P367, DOI 10.1677/erc.1.00969; Bourinet E, 2005, EMBO J, V24, P315, DOI 10.1038/sj.emboj.7600515; Cao G, 2009, J BIOL CHEM, V284, P14788, DOI 10.1074/jbc.M808752200; Caudle RM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176753; Chen SC, 2004, BRAIN RES, V1027, P196, DOI 10.1016/j.brainres.2004.08.053; Chodon D, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-212; Colburn RW, 2007, NEURON, V54, P379, DOI 10.1016/j.neuron.2007.04.017; De Gendt K, 2004, P NATL ACAD SCI USA, V101, P1327, DOI 10.1073/pnas.0308114100; Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024; DOELAND HJ, 1989, MUSCLE NERVE, V12, P712, DOI 10.1002/mus.880120903; Fernandez JA, 2011, J GEN PHYSIOL, V137, P173, DOI 10.1085/jgp.201010498; Freeman MR, 2005, TRENDS ENDOCRIN MET, V16, P273, DOI 10.1016/j.tem.2005.06.002; GATENBECK L, 1987, SCAND J UROL NEPHROL, V21, P139, DOI 10.3109/00365598709180309; Gkika D, 2010, ONCOGENE, V29, P4611, DOI 10.1038/onc.2010.210; Gotmar A, 2008, CLIMACTERIC, V11, P304, DOI 10.1080/13697130802249769; Harju EL, 2002, SOMATOSENS MOT RES, V19, P61, DOI 10.1080/08990220120113057; Hensel H, 1981, Monogr Physiol Soc, V38, P1; HRYB DJ, 1985, BIOCHEM BIOPH RES CO, V128, P432, DOI 10.1016/0006-291X(85)91697-3; Irnaten M, 2008, CELL CALCIUM, V44, P441, DOI 10.1016/j.ceca.2008.02.007; JANSSEN PAJ, 1963, ARZNEIMITTEL-FORSCH, V13, P502; Karashima Y, 2009, P NATL ACAD SCI USA, V106, P1273, DOI 10.1073/pnas.0808487106; Keast JR, 1998, NEUROREPORT, V9, P4137, DOI 10.1097/00001756-199812210-00025; Kondrats'kyi A P, 2009, Fiziol Zh, V55, P91; KRUPENKO SA, 1994, J STEROID BIOCHEM, V51, P115, DOI 10.1016/0960-0760(94)90122-8; Kubo T, 2017, EXP ANIM TOKYO, V66, P337, DOI 10.1538/expanim.17-0028; Lavery DN, 2005, BIOCHEM J, V391, P449, DOI 10.1042/BJ20050872; Li CL, 2016, CELL RES, V26, P83, DOI 10.1038/cr.2015.149; Limonta P, 2003, FRONT NEUROENDOCRIN, V24, P279, DOI 10.1016/j.yfrne.2003.10.003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Majeed Y, 2011, BRIT J PHARMACOL, V162, P1509, DOI 10.1111/j.1476-5381.2010.01136.x; Majeed Y, 2012, CELL CALCIUM, V51, P1, DOI 10.1016/j.ceca.2011.09.005; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Miehe S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035393; Morenilla-Palao C, 2014, CELL REP, V8, P1571, DOI 10.1016/j.celrep.2014.08.003; Morenilla-Palao C, 2009, J BIOL CHEM, V284, P9215, DOI 10.1074/jbc.M807228200; Noel J, 2009, EMBO J, V28, P1308, DOI 10.1038/emboj.2009.57; Noguchi W, 2013, J UROLOGY, V189, P1975, DOI 10.1016/j.juro.2012.10.014; Pinchenko VO, 2005, BBA-GEN SUBJECTS, V1724, P1, DOI 10.1016/j.bbagen.2005.04.008; Potkanowicz ES, 2003, AVIAT SPACE ENVIR MD, V74, P1157; STAHL F, 1984, EXP CLIN ENDOCRINOL, V84, P277, DOI 10.1055/s-0029-1210399; Stirling CMA, 2005, IMMUNOLOGY, V114, P542, DOI 10.1111/j.1365-2567.2004.02121.x; Svartberg J, 2003, J CLIN ENDOCR METAB, V88, P3099, DOI 10.1210/jc.2002-021878; Thebault S, 2005, J BIOL CHEM, V280, P39423, DOI 10.1074/jbc.M503544200; Thomas P, 2019, ENDOCRINOLOGY, V160, P772, DOI 10.1210/en.2018-00987; Usoskin D, 2015, NAT NEUROSCI, V18, P145, DOI 10.1038/nn.3881; Van Coppenolle F, 2001, AM J PHYSIOL-ENDOC M, V280, pE120, DOI 10.1152/ajpendo.2001.280.1.E120; Vriens J, 2014, NAT REV NEUROSCI, V15, P573, DOI 10.1038/nrn3784; Wagner TFJ, 2008, NAT CELL BIOL, V10, P1421, DOI 10.1038/ncb1801; Yin Y, 2019, SCIENCE, V363, P945, DOI 10.1126/science.aav9334; Yin Y, 2018, SCIENCE, V359, P237, DOI 10.1126/science.aan4325; Zhang L, 2004, CANCER RES, V64, P8365, DOI 10.1158/0008-5472.CAN-04-2146; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	57	8	8	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					7483	7499		10.1096/fj.201902270R	http://dx.doi.org/10.1096/fj.201902270R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32277850	hybrid, Green Published			2022-12-28	WOS:000553573700021
J	Pan, YL; Sun, YL; Wang, YL; Mang, ZP				Pan, Yinlai; Sun, Yulong; Wang, Yilei; Mang, Ziping			Barcode sequence could be a good target for developing a species-specific anti-parasite agent based on CRISPR-Cas9	FASEB JOURNAL			English	Article						CRISPR-Cas9; Cryptocaryon irritans; DNA barcode; quantitative real-time PCR; species-specific anti-parasitic drug	CRYPTOCARYON-IRRITANS CILIOPHORA; ORANGE-SPOTTED GROUPER; RNA-GUIDED ENDONUCLEASE; EPINEPHELUS-COIOIDES; PROTECTIVE IMMUNITY; MOLECULAR-CLONING; PARASITE; CILIATE; LIFE; IMMUNIZATION	Parasitic infections are a severe issue in many regions of the world. We assume that if a chemical can destroy a DNA barcode sequence, then this chemical could be developed as a species-specific parasiticidal agent. To test this hypothesis, we designed sgRNAs that target the sequences of both a DNA barcode (ITS-2) and a control (5.8S rDNA) in Cryptocaryon irritans. In in vivo tests, we found that exposure to Cas9 mRNA mixed with sgRNAs was able to significantly reduce the hatching rate of tomont and the survival rate of theront. Quantitative Real-time PCR demonstrated that the DNAs of tomont and theront exposed to sgRNAs and Cas9 mRNA were significantly disrupted, no matter whether they were exposed to a single sgRNA or a mixture of two sgRNAs. DNA sequencing also suggested the test group that was exposed to a single sgRNA mixed with Cas9-induced mutation at sgRNA targeted fragments and the test group exposed to two sgRNAs combined with Cas9-induced deletion of large pieces. The findings and principles provided by this study contribute to the development of novel nucleic acid therapeutic drugs for cryptocaryoniasis and other parasitic diseases and provide insight into the development of species-specific parasiticidal agents.	[Pan, Yinlai; Sun, Yulong; Mang, Ziping] Fujian Agr & Forestry Univ, Coll Anim Sci, Fuzhou 350002, Fujian, Peoples R China; [Pan, Yinlai; Mang, Ziping] Fujian Agr & Forestry Univ, Inst Oceanol, Key Lab Marine Biotechnol Fujian Prov, Fuzhou, Peoples R China; [Sun, Yulong] Fujian Agr & Forestry Univ, Coll Life Sci, Fuzhou, Peoples R China; [Wang, Yilei] Jimei Univ, Coll Fisheries, Xiamen, Peoples R China; [Wang, Yilei; Mang, Ziping] State Key Lab Large Yellow Croaker Breeding, Ningde, Peoples R China	Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University; Jimei University	Mang, ZP (corresponding author), Fujian Agr & Forestry Univ, Coll Anim Sci, Fuzhou 350002, Fujian, Peoples R China.	zhangziping@hotmail.com			Major Projects of Industry-University Cooperation in Science and Technology of Department of Science and Technology of Fujian Province [2017N5002]; Municipal University (Institute) Science and Technology Cooperation Project of Fuzhou Science and Technology Bureau [2018-G-43]; Research Fund of State Key Laboratory of Large Yellow Croaker Breeding [LYC2018RS05]; Special Fund for Marine Economic Development of Fujian Province [ZHHY-2019-3]; 13th Five-year Plan on Fuzhou Marine Economic Innovation and Development Demonstration City Project [FZHJ17]	Major Projects of Industry-University Cooperation in Science and Technology of Department of Science and Technology of Fujian Province; Municipal University (Institute) Science and Technology Cooperation Project of Fuzhou Science and Technology Bureau; Research Fund of State Key Laboratory of Large Yellow Croaker Breeding; Special Fund for Marine Economic Development of Fujian Province; 13th Five-year Plan on Fuzhou Marine Economic Innovation and Development Demonstration City Project	This research was funded by Major Projects of Industry-University Cooperation in Science and Technology of Department of Science and Technology of Fujian Province (2017N5002), Municipal University (Institute) Science and Technology Cooperation Project of Fuzhou Science and Technology Bureau (2018-G-43), Research Fund of State Key Laboratory of Large Yellow Croaker Breeding (LYC2018RS05), Special Fund for Marine Economic Development of Fujian Province (ZHHY-2019-3), 13th Five-year Plan on Fuzhou Marine Economic Innovation and Development Demonstration City Project (FZHJ17).	Adams A, 2019, FISH SHELLFISH IMMUN, V90, P210, DOI 10.1016/j.fsi.2019.04.066; Agnew P, 2000, MICROBES INFECT, V2, P891, DOI 10.1016/S1286-4579(00)00389-0; [Anonymous], J MICROBIOL EXP, DOI DOI 10.1007/s00436-007-0766-6; [Anonymous], SUISANZOSHOKU; [Anonymous], 1937, SUISANGAKUKAI HO; [Anonymous], KAIYO MON; [Anonymous], DRUM CROAKER, DOI DOI 10.1126/science.1247997; Bai JS, 2008, PARASITOL RES, V102, P307, DOI 10.1007/s00436-007-0766-6; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Beneke T, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170095; Bondad-Reantaso MG, 2005, VET PARASITOL, V132, P249, DOI 10.1016/j.vetpar.2005.07.005; BURGESS PJ, 1995, FISH SHELLFISH IMMUN, V5, P459, DOI 10.1006/fsim.1995.0043; COLORNI A, 1987, AQUACULTURE, V67, P236, DOI 10.1016/0044-8486(87)90041-X; Colorni Angelo, 1997, Aquarium Sciences and Conservation, V1, P217, DOI 10.1023/A:1018360323287; Crampton A, 2007, INFECT GENET EVOL, V7, P664, DOI 10.1016/j.meegid.2007.06.004; Crawford ED, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178163; Dalby B, 2004, METHODS, V33, P95, DOI 10.1016/j.ymeth.2003.11.023; Dan XM, 2013, FISH SHELLFISH IMMUN, V34, P885, DOI 10.1016/j.fsi.2012.12.011; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Dickerson HW, 2006, FISH DISEASES AND DISORDERS, VOL 1: PROTOZOAN AND METAZOAN INFECTIONS, 2ND EDITION, P116, DOI 10.1079/9780851990156.0116; Gang SS, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006675; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Geary TG, 2012, CURR OPIN INFECT DIS, V25, P709, DOI 10.1097/QCO.0b013e328359f04a; Good MF, 2004, IMMUNOL REV, V201, P254, DOI 10.1111/j.0105-2896.2004.00178.x; Goto T, 2015, AQUACULTURE, V435, P173, DOI 10.1016/j.aquaculture.2014.09.007; Hatanaka A, 2008, PARASITOLOGY, V135, P1043, DOI 10.1017/S0031182008004617; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hewitson JP, 2014, EXPERT REV VACCINES, V13, P473, DOI 10.1586/14760584.2014.893195; Hirazawa N, 2003, AQUACULTURE, V223, P1, DOI 10.1016/S0044-8486(03)00167-4; Hirazawa N, 2001, AQUACULTURE, V198, P219, DOI 10.1016/S0044-8486(01)00503-8; Hoang TTT, 2011, ENVIRON SCI POLLUT R, V18, P835, DOI 10.1007/s11356-011-0475-7; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Huang XH, 2012, EXP PARASITOL, V130, P189, DOI 10.1016/j.exppara.2012.01.012; HUFF JA, 1981, AQUACULTURE, V22, P181, DOI 10.1016/0044-8486(81)90144-7; Isah MB, 2016, PARASITOLOGY, V143, P1219, DOI 10.1017/S0031182016000718; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kawano F, 2012, AQUACULTURE, V344, P35, DOI 10.1016/j.aquaculture.2012.02.028; Kawano F, 2012, AQUACULTURE, V330, P1, DOI 10.1016/j.aquaculture.2011.11.037; Keene JD, 2002, MOL CELL, V9, P1161, DOI 10.1016/S1097-2765(02)00559-2; Kress WJ, 2008, P NATL ACAD SCI USA, V105, P2761, DOI 10.1073/pnas.0800476105; Li YW, 2012, FISH SHELLFISH IMMUN, V32, P476, DOI 10.1016/j.fsi.2011.11.021; Li YW, 2011, FISH SHELLFISH IMMUN, V30, P1230, DOI 10.1016/j.fsi.2011.04.012; Luo XC, 2008, PARASITOL RES, V102, P1269, DOI 10.1007/s00436-008-0904-9; Luo XC, 2007, FISH SHELLFISH IMMUN, V22, P427, DOI 10.1016/j.fsi.2006.04.011; Ma R, 2017, PARASITOLOGY, V144, P720, DOI [10.1017/S0031182016002651, 10.1017/s0031182016002651]; MATTHEWS BF, 1993, J FISH DIS, V16, P339, DOI 10.1111/j.1365-2761.1993.tb00867.x; Minet C, 2018, INFECT GENET EVOL, V63, P326, DOI 10.1016/j.meegid.2018.02.030; Misumi I, 2012, PARASITOL RES, V110, P363, DOI 10.1007/s00436-011-2500-7; Misumi I, 2011, FISH SHELLFISH IMMUN, V30, P1152, DOI 10.1016/j.fsi.2011.03.004; Mo ZQ, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1919-1; Mo ZQ, 2015, FISH SHELLFISH IMMUN, V43, P142, DOI 10.1016/j.fsi.2014.12.023; Okazaki T, 2012, INT CONF EMERG TR, P253, DOI 10.1109/ICETET.2012.44; Peng D, 2015, MBIO, V6, DOI 10.1128/mBio.02097-14; Picon-Camacho SM, 2011, DIS AQUAT ORGAN, V94, P167, DOI 10.3354/dao02315; Priya TAJ, 2012, VACCINE, V30, P893, DOI 10.1016/j.vaccine.2011.11.102; Seng LeongTak, 2006, Aqua Culture Asia Pacific, V2, P14; Shen B, 2014, MBIO, V5, DOI 10.1128/mBio.01114-14; Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/NMETH.2857, 10.1038/nmeth.2857]; Shrivastava R, 2019, MSPHERE, V4, DOI 10.1128/mSphere.00450-19; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Vinayak S, 2015, NATURE, V523, P477, DOI 10.1038/nature14651; Wang GX, 2009, AQUACULTURE, V297, P38, DOI 10.1016/j.aquaculture.2009.09.012; Watanabe Y, 2019, AQUACULTURE, V512, DOI 10.1016/j.aquaculture.2019.734311; WILKIE DW, 1969, CALIF FISH GAME, V55, P227; Xing HL, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0327-y; Yambot AV, 2006, AQUACULTURE, V260, P1, DOI 10.1016/j.aquaculture.2006.05.055; YANG RZ, 1988, ECON BOT, V42, P376, DOI 10.1007/BF02860162; Yoshinaga T, 2001, FISH PATHOL, V36, P231, DOI 10.3147/jsfp.36.231; Yu C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098282; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zheng J, 2015, INT J PARASITOL, V45, P141, DOI 10.1016/j.ijpara.2014.09.003	73	4	4	1	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9393	9404		10.1096/fj.202000118RR	http://dx.doi.org/10.1096/fj.202000118RR		MAY 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32474999				2022-12-28	WOS:000538126600001
J	Lu, LH; Yakoumatos, L; Ren, JL; Duan, XX; Zhou, HX; Gu, Z; Mohammed, M; Uriarte, SM; Liang, S; Scott, DA; Lamont, RJ; Wang, HZ				Lu, Lanhai; Yakoumatos, Lan; Ren, Junling; Duan, Xiaoxian; Zhou, Huaxin; Gu, Zhen; Mohammed, Muddasir; Uriarte, Silvia M.; Liang, Shuang; Scott, David A.; Lamont, Richard J.; Wang, Huizhi			JAK3 restrains inflammatory responses and protects against periodontal disease through Wnt3a signaling	FASEB JOURNAL			English	Article						inflammation; JAK3; P; gingivalis; ubiquitination; Wnt3	PORPHYROMONAS-GINGIVALIS; WNT/BETA-CATENIN; BETA-CATENIN; STEM-CELLS; IN-VITRO; IMMUNE; ACTIVATION; INHIBITION; TOLERANCE; PATHWAY	Homeostasis between pro- and anti- inflammatory responses induced by bacteria is critical for the maintenance of health. In the oral cavity, pro-inflammatory mechanisms induced by pathogenic bacteria are well-established; however, the anti-inflammatory responses that act to restrain innate responses remain poorly characterized. Here, we demonstrate that infection with the periodontal pathogen Porphyromonas gingivalis enhances the activity of Janus kinase 3 (JAK3) in innate immune cells, and subsequently phospho-inactivates Nedd4-2, an ubiquitin E3 ligase. In turn, Wingless-INT (Wnt) 3 (Wnt3) ubiquitination is decreased, while total protein levels are enhanced, leading to a reduction in pro-inflammatory cytokine levels. In contrast, JAK3 or Wnt3a inhibition robustly enhances nuclear factor kappa-light-chain-enhancer of activated B cells activity and the production of pro-inflammatory cytokines in P. gingivalis-stimulated innate immune cells. Moreover, using gain- and loss-of-function approaches, we demonstrate that downstream molecules of Wnt3a signaling, including Dvl3 and beta-catenin, are responsible for the negative regulatory role of Wnt3a. In addition, using an in vivo P. gingivalis-mediated periodontal disease model, we show that JAK3 inhibition enhances infiltration of inflammatory cells, reduces expression of Wnt3a and Dvl3 in P. gingivalis-infected gingival tissues, and increases disease severity. Together, our results reveal a new anti-inflammatory role for JAK3 in innate immune cells and show that the underlying signaling pathway involves Nedd4-2-mediated Wnt3a ubiquitination.	[Lu, Lanhai; Yakoumatos, Lan; Ren, Junling; Gu, Zhen; Mohammed, Muddasir; Uriarte, Silvia M.; Liang, Shuang; Scott, David A.; Lamont, Richard J.; Wang, Huizhi] Univ Louisville, Sch Dent, Dept Oral Immunol & Infect Dis, Louisville, KY 40292 USA; [Lu, Lanhai] Univ Louisville, Sch Med, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA; [Ren, Junling; Wang, Huizhi] Virginia Commonwealth Univ, Dept Oral & Craniofacial Mol Biol, VCU Sch Dent, Richmond, VA 23298 USA; [Duan, Xiaoxian] Univ Louisville, Dept Microbiol & Immunol, Sch Med, Louisville, KY 40292 USA; [Zhou, Huaxin] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Uriarte, Silvia M.] Univ Louisville, Sch Med, Dept Med, Louisville, KY 40292 USA	University of Louisville; University of Louisville; Virginia Commonwealth University; University of Louisville; Indiana University System; Indiana University Bloomington; University of Louisville	Wang, HZ (corresponding author), Virginia Commonwealth Univ, Sch Dent, VCU Philips Inst Oral Hlth Res Oral & Craniofacia, Perkinson Bldg,Room 4152,521 N 11th St, Richmond, VA 23298 USA.; Lamont, RJ; Wang, HZ (corresponding author), Univ Louisville, Sch Dent, Oral Immunol & Infect Dis, 501 S Preston St, Louisville, KY 40292 USA.	rich.lamont@louisville.edu; wangh3@vcu.edu	Scott, David/GYU-8656-2022	Scott, David A./0000-0003-1007-2756	HHS \ NIH \ National Institute of Dental and Craniofacial Research (NIDCR) [DE 026727, DE 017921, DE012505, DE 011111, DE 017680, DE026963, DE 025388, DE 024509]; HHS \ NIH \ National Institute of General Medical Sciences (NIGMS) [GM 125504]	HHS \ NIH \ National Institute of Dental and Craniofacial Research (NIDCR); HHS \ NIH \ National Institute of General Medical Sciences (NIGMS)	HHS vertical bar NIH vertical bar National Institute of Dental and Craniofacial Research (NIDCR), Grant/Award Number: DE 026727, DE 017921, DE012505, DE 011111, DE 017680, DE026963, DE 025388 and DE 024509; HHS vertical bar NIH vertical bar National Institute of General Medical Sciences (NIGMS), Grant/Award Number: GM 125504	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Adamowicz K, 2012, MOL MED, V18, P1190, DOI 10.2119/molmed.2012.00180; Axmann R, 2009, ARTHRITIS RHEUM-US, V60, P2747, DOI 10.1002/art.24781; Baccala R, 2009, NAT REV RHEUMATOL, V5, P448, DOI 10.1038/nrrheum.2009.136; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Brown J, 2011, J DENT RES, V90, P417, DOI 10.1177/0022034510381264; Burns E, 2006, J IMMUNOL, V177, P8296, DOI 10.4049/jimmunol.177.12.8296; Castro-Rojas CM, 2020, TRANSPLANTATION, V104, P1058, DOI 10.1097/TP.0000000000002917; Chan DW, 2006, GASTROENTEROLOGY, V131, P1218, DOI 10.1053/j.gastro.2006.07.020; Cheng Q, 2011, MOL CELL BIOL, V31, P4951, DOI 10.1128/MCB.05553-11; Damsky W, 2017, J AM ACAD DERMATOL, V76, P736, DOI 10.1016/j.jaad.2016.12.005; Danese S, 2019, GUT, V68, P1893, DOI 10.1136/gutjnl-2019-318448; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; Duan YL, 2007, LAB INVEST, V87, P613, DOI 10.1038/labinvest.3700545; Fernando ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099050; GABAY C, 2006, ARTHRITIS RES THE S2, V8; Gatica-Andrades M, 2017, BLOOD ADV, V1, P1274, DOI 10.1182/bloodadvances.2017006163; Ghoreschi K, 2009, IMMUNOL REV, V228, P273, DOI 10.1111/j.1600-065X.2008.00754.x; Hajishengallis G, 2012, MOL ORAL MICROBIOL, V27, P409, DOI 10.1111/j.2041-1014.2012.00663.x; Hajishengallis G, 2014, EUR J IMMUNOL, V44, P328, DOI 10.1002/eji.201344202; Herath TDK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058496; Ishikawa M, 2013, BBA-MOL BASIS DIS, V1832, P2035, DOI 10.1016/j.bbadis.2013.07.012; Jang J, 2017, SCI REP-UK, V7, DOI 10.1038/srep41612; Kany S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20236008; Kim HJ, 2004, J IMMUNOL, V172, P4948, DOI 10.4049/jimmunol.172.8.4948; Kim H, 2015, CELL REP, V11, P1151, DOI 10.1016/j.celrep.2015.04.048; Konkel JE, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01403; Lamont RJ, 2018, NAT REV MICROBIOL, V16, P745, DOI 10.1038/s41579-018-0089-x; Leonard WJ, 2019, IMMUNITY, V50, P832, DOI 10.1016/j.immuni.2019.03.028; Li YJ, 2019, J IMMUNOL, V202, P2044, DOI 10.4049/jimmunol.1801286; Li Y, 2014, MOL IMMUNOL, V59, P128, DOI 10.1016/j.molimm.2014.02.002; Lin J, 2014, INFECT IMMUN, V82, P4127, DOI 10.1128/IAI.02084-14; Liu JQ, 2017, J DENT SCI, V12, P220, DOI 10.1016/j.jds.2016.11.006; Liu WL, 2004, J BIOL CHEM, V279, P18748, DOI 10.1074/jbc.M311227200; Liu XY, 2010, FEBS LETT, V584, P911, DOI 10.1016/j.febslet.2010.01.024; Maekawa T, 2014, CELL HOST MICROBE, V15, P768, DOI 10.1016/j.chom.2014.05.012; Manicassamy S, 2010, SCIENCE, V329, P849, DOI 10.1126/science.1188510; MCCARTY KS, 1985, ARCH PATHOL LAB MED, V109, P716; Mishra J, 2013, J BIOL CHEM, V288, P31795, DOI 10.1074/jbc.M113.504126; Murray PJ, 2012, NAT IMMUNOL, V13, P916, DOI 10.1038/ni.2391; Nakayama M, 2015, J BIOL CHEM, V290, P5190, DOI 10.1074/jbc.M114.591610; Natarajan S, 2008, J IMMUNOL, V181, P8402, DOI 10.4049/jimmunol.181.12.8402; Nativel B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16190-y; Neumann J, 2010, FASEB J, V24, P4599, DOI 10.1096/fj.10-160994; NGUYEN LK, 2013, CELL COMMUN SIGNAL, V11; OLSEN I, 2016, J ORAL MICROBIOL, V8; Arroyo JP, 2011, J AM SOC NEPHROL, V22, P1707, DOI 10.1681/ASN.2011020132; Pesu M, 2005, IMMUNOL REV, V203, P127, DOI 10.1111/j.0105-2896.2005.00220.x; Rajendran P, 2018, J CELL PHYSIOL, V233, P6458, DOI 10.1002/jcp.26479; REMMELE W, 1987, PATHOLOGE, V8, P138; Schaale K, 2011, EUR J CELL BIOL, V90, P553, DOI 10.1016/j.ejcb.2010.11.004; Schulte W, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/165974; Schwartz DM, 2017, NAT REV DRUG DISCOV, V16, P843, DOI 10.1038/nrd.2017.201; Shan MM, 2013, SCIENCE, V342, P447, DOI 10.1126/science.1237910; Stacey KB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034041; Sun J, 2005, AM J PHYSIOL-GASTR L, V289, pG129, DOI 10.1152/ajpgi.00515.2004; Tanaka Y, 2015, J BIOCHEM, V158, P173, DOI 10.1093/jb/mvv069; Tsuchida S, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071476; Uraguchi M, 2004, J DENT RES, V83, P327, DOI 10.1177/154405910408300411; Vazirpanah N, 2019, ANN RHEUM DIS, V78, P663, DOI 10.1136/annrheumdis-2018-214656; Villasenor T, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00050; Wang GQ, 2019, NEUROSCIENCE, V415, P135, DOI 10.1016/j.neuroscience.2019.06.038; Wang HZ, 2016, INFLAMM RES, V65, P61, DOI 10.1007/s00011-015-0891-0; Wang HZ, 2014, INFECT IMMUN, V82, P4118, DOI 10.1128/IAI.02000-14; Wang HZ, 2013, J IMMUNOL, V191, P1164, DOI 10.4049/jimmunol.1203084; Wang J, 2013, INFLAMMATION, V36, P1393, DOI 10.1007/s10753-013-9679-y; Wang SH, 2017, ONCOGENE, V36, P1503, DOI 10.1038/onc.2016.317; Weichhart T, 2008, IMMUNITY, V29, P565, DOI 10.1016/j.immuni.2008.08.012; Wittmann M, 1999, BLOOD, V94, P1717, DOI 10.1182/blood.V94.5.1717.417k21_1717_1726; Yang DQ, 2020, MOL IMMUNOL, V118, P153, DOI 10.1016/j.molimm.2019.12.013; Yoshida H, 2012, BIOCHEM BIOPH RES CO, V418, P234, DOI 10.1016/j.bbrc.2011.12.156; Zhang H, 2018, CIRCULATION, V137, P1934, DOI 10.1161/CIRCULATIONAHA.117.030423	73	9	9	2	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9120	9140		10.1096/fj.201902697RR	http://dx.doi.org/10.1096/fj.201902697RR		MAY 2020	21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32433819	Green Accepted			2022-12-28	WOS:000535541600001
J	van Patot, MCT				van Patot, Martha C. Tissot			The Nobel Mabel. The woman who discovered that low oxygen stimulates hemoglobin production	FASEB JOURNAL			English	Article						altitude; history; hypoxia; oxygen; women	CARBONIC-ACID PRESSURE; HYDROCHLORIC-ACID; BLOOD; ORIGIN	The research of Mabel Purefoy FitzGerald (1872-1973) was recently recognized by Sir Peter Ratcliffe in his public lecture at the awarding of the Nobel Prize in Physiology or Medicine as a critical step in the recent delineation of the oxygen sensing pathway. This brief article offers a tantalizing glimpse into the life of a woman whose scientific career spanned four countries, worked with eminent scientists and clinicians including Haldane and Osler, and published important physiologic discoveries. Her accomplishments and astounding life were lost to history for more than one hundred years and it is time to bring her back. When this diminutive and proper English woman set out on her own to the wild and remote mining towns of Colorado, little did she know that this would be the moment for which she would be remembered in her long, productive research career and ludicrous struggle to become a physician more than a century ago. Hers is an extraordinary tale of privilege, hardship, discrimination, shocking perseverance, and grand adventure.	[van Patot, Martha C. Tissot] Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Clin Sci, Ft Collins, CO 80524 USA	Colorado State University	van Patot, MCT (corresponding author), Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Clin Sci, Ft Collins, CO 80524 USA.	marthatissot@me.com		Tissot van Patot, Martha/0000-0002-2934-366X	Physiological Society (UK) Paton Prize Bursary	Physiological Society (UK) Paton Prize Bursary	Funding information Work funded in part by The Physiological Society (UK) Paton Prize Bursary 2014	Fitzgerald MP, 1905, J PHYSIOL-LONDON, V32, P486; FitzGerald MP, 1910, P R SOC LOND B-CONTA, V82, P346, DOI 10.1098/rspb.1910.0026; Fitzgerald MP, 1910, P R SOC LOND B-CONTA, V83, P56, DOI 10.1098/rspb.1910.0067; Fitzgerald MP, 1910, J PATHOL BACTERIOL, V14, P328, DOI 10.1002/path.1700140305; Fitzgerald MP, 1906, P R SOC LOND B-CONTA, V78, P88, DOI 10.1098/rspb.1906.0051; Fitzgerald MP, 1913, PHILOS T R SOC LON B, V203, P351, DOI 10.1098/rstb.1913.0008; FitzGerald MP, 1914, P R SOC LOND B-CONTA, V88, P248, DOI 10.1098/rspb.1914.0072; FitzGerald MP, 1902, CONTRIBUTIONS U LAB, P1	8	0	0	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					7222	7224		10.1096/fj.202000128R	http://dx.doi.org/10.1096/fj.202000128R		MAY 2020	3	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32358870				2022-12-28	WOS:000530046000001
J	Leermakers, PA; Remels, AHV; Zonneveld, MI; Rouschop, KMA; Schols, AMWJ; Gosker, HR				Leermakers, Pieter A.; Remels, Alexander H. V.; Zonneveld, Marijke I.; Rouschop, Kasper M. A.; Schols, Annemie M. W. J.; Gosker, Harry R.			Iron deficiency-induced loss of skeletal muscle mitochondrial proteins and respiratory capacity; the role of mitophagy and secretion of mitochondria-containing vesicles	FASEB JOURNAL			English	Article						extracellular vesicles; mitochondrial clearance; myotubes; iron depletion	QUALITY-CONTROL; INDUCTION; AUTOPHAGY; ANEMIA; ENZYMES	Iron homeostasis is essential for mitochondrial function, and iron deficiency has been associated with skeletal muscle weakness and decreased exercise capacity in patients with different chronic disorders. We hypothesized that iron deficiency-induced loss of skeletal muscle mitochondria is caused by increased mitochondrial clearance. To study this, C2C12 myotubes were subjected to the iron chelator deferiprone. Mitochondrial parameters and key constituents of mitophagy pathways were studied in presence or absence of pharmacological autophagy inhibition or knockdown of mitophagy-related proteins. Furthermore, it was explored if mitochondria were present in extracellular vesicles (EV). Iron chelation resulted in an increase in BCL2/Adenovirus E1B 19 kDa protein-interacting protein 3 (BNIP3) and BNIP3-like gene and protein levels, and the appearance of mitochondria encapsulated by lysosome-like vesicular structures in myotubes. Moreover, mitochondria were secreted via EV. These changes were associated with cellular mitochondrial impairments. These impairments were unaltered by autophagy inhibition, knockdown of mitophagy-related proteins BNIP3 and BNIP3L, or knockdown of their upstream regulator hypoxia-inducible factor 1 alpha. In conclusion, mitophagy is not essential for development of iron deficiency-induced reductions in mitochondrial proteins or respiratory capacity. The secretion of mitochondria-containing EV could present an additional pathway via which mitochondria can be cleared from iron chelation-exposed myotubes.	[Leermakers, Pieter A.; Schols, Annemie M. W. J.; Gosker, Harry R.] Maastricht Univ, Med Ctr, Dept Resp Med, NUTRIM Sch Nutr & Translat Res Metab, POB 5800, Maastricht 6202 AZ, Netherlands; [Remels, Alexander H. V.] Maastricht Univ, Med Ctr, Dept Pharmacol & Toxicol, NUTRIM Sch Nutr & Translat Res Metab, Maastricht, Netherlands; [Zonneveld, Marijke I.; Rouschop, Kasper M. A.] Maastricht Univ, Med Ctr, Dept Radiotherapy, GROW Sch Oncol & Dev Biol, Maastricht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University	Gosker, HR (corresponding author), Maastricht Univ, Med Ctr, Dept Resp Med, NUTRIM Sch Nutr & Translat Res Metab, POB 5800, Maastricht 6202 AZ, Netherlands.	h.gosker@maastrichtuniversity.nl	Leermakers, Pieter/AAY-1341-2021	Leermakers, Pieter/0000-0002-0145-742X; Rouschop, Kasper/0000-0002-4208-5415; Zonneveld, Marijke/0000-0002-7200-5199; Gosker, Harry/0000-0002-7659-0225				ACKRELL BAC, 1984, J BIOL CHEM, V259, P53; Allen GFG, 2013, EMBO REP, V14, P1127, DOI 10.1038/embor.2013.168; Barberan-Garcia A, 2015, RESPIROLOGY, V20, P1089, DOI 10.1111/resp.12591; Bellot G, 2009, MOL CELL BIOL, V29, P2570, DOI 10.1128/MCB.00166-09; Boyer-Guittaut M, 2014, AUTOPHAGY, V10, P986, DOI 10.4161/auto.28390; CARTIER LJ, 1986, J BIOL CHEM, V261, P3827; DAVIES KJA, 1984, AM J PHYSIOL, V246, pE535, DOI 10.1152/ajpendo.1984.246.6.E535; Davis CHO, 2014, P NATL ACAD SCI USA, V111, P9633, DOI 10.1073/pnas.1404651111; Eisner V, 2014, J CELL BIOL, V205, P179, DOI 10.1083/jcb.201312066; Eiyama A, 2015, CURR OPIN CELL BIOL, V33, P95, DOI 10.1016/j.ceb.2015.01.002; Esteva S, 2008, J ANAT, V212, P836, DOI 10.1111/j.1469-7580.2008.00908.x; EVANS TC, 1985, BIOCHEM MED METAB B, V34, P93, DOI 10.1016/0006-2944(85)90065-1; Falchi AM, 2013, HISTOCHEM CELL BIOL, V139, P221, DOI 10.1007/s00418-012-1045-x; Forterre A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084153; Galy B, 2010, CELL METAB, V12, P194, DOI 10.1016/j.cmet.2010.06.007; HAGLER L, 1981, AM J CLIN NUTR, V34, P2169, DOI 10.1093/ajcn/34.10.2169; Keulers TG, 2015, RADIOTHER ONCOL, V116, P417, DOI 10.1016/j.radonc.2015.06.023; Kim S, 2018, CELL PHYSIOL BIOCHEM, V48, P1829, DOI 10.1159/000492505; Kurz T, 2011, INT J BIOCHEM CELL B, V43, P1686, DOI 10.1016/j.biocel.2011.08.016; Lazarou M, 2015, NATURE, V524, P309, DOI 10.1038/nature14893; Lotvall J, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.26913; MACDONALD VW, 1985, J LAB CLIN MED, V105, P11; Matsuda N, 2016, J BIOCHEM, V159, P379, DOI 10.1093/jb/mvv125; Nagi M, 2016, AUTOPHAGY, V12, P1259, DOI 10.1080/15548627.2016.1183080; OHIRA Y, 1987, AM J PHYSIOL, V253, pC639, DOI 10.1152/ajpcell.1987.253.5.C639; Okuyama S, 2016, ASIA-PAC INT SYM ELE, P50, DOI 10.1109/APEMC.2016.7522776; Palikaras K, 2014, EXP GERONTOL, V56, P182, DOI 10.1016/j.exger.2014.01.021; Phinney DG, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9472; Romanello V, 2016, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00422; Schiavi A, 2015, CURR BIOL, V25, P1810, DOI 10.1016/j.cub.2015.05.059; Slot IGM, 2016, J CELL PHYSIOL, V231, P377, DOI 10.1002/jcp.25083; Stotland A, 2015, BBA-MOL CELL RES, V1853, P2802, DOI 10.1016/j.bbamcr.2014.12.041; Stugiewicz M, 2016, EUR J HEART FAIL, V18, P762, DOI 10.1002/ejhf.467; Tkaczyszyn M, 2018, J CACHEXIA SARCOPENI, V9, P547, DOI 10.1002/jcsm.12282; Van Deun J, 2017, NAT METHODS, V14, P228, DOI 10.1038/nmeth.4185; Van Deun J, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.24858; Wang XY, 2016, NEUROBIOL AGING, V47, P168, DOI 10.1016/j.neurobiolaging.2016.07.025; Watson A, 2016, CELL SIGNAL, V28, P412, DOI 10.1016/j.cellsig.2016.01.014; Wei HF, 2015, BBA-MOL CELL RES, V1853, P2784, DOI 10.1016/j.bbamcr.2015.03.013; WILLIS WT, 1987, J APPL PHYSIOL, V62, P2442, DOI 10.1152/jappl.1987.62.6.2442; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200	41	20	20	2	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6703	6717		10.1096/fj.201901815R	http://dx.doi.org/10.1096/fj.201901815R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32202346	Green Published, hybrid			2022-12-28	WOS:000531325500049
J	Liu, ZF; Ji, JF; Jiang, XF; Shao, T; Fan, DD; Jiang, XH; Lin, AF; Xiang, LX; Shao, JZ				Liu, Zhi-fei; Ji, Jian-fei; Jiang, Xiao-feng; Shao, Tong; Fan, Dong-dong; Jiang, Xin-hang; Lin, Ai-fu; Xiang, Li-xin; Shao, Jian-zhong			Characterization of cGAS homologs in innate and adaptive mucosal immunities in zebrafish gives evolutionary insights into cGAS-STING pathway	FASEB JOURNAL			English	Article						cGAMP; IFN; IgZ; NF-kappa B	CYCLIC GMP-AMP; DNA SENSOR CGAS; KAPPA-B ACTIVATION; SIGNALING PATHWAYS; SCAVENGER RECEPTOR; HUMORAL IMMUNITY; TELEOST FISH; MECHANISM; SYNTHASE; DINUCLEOTIDE	Cyclic GMP-AMP synthase (cGAS) is one of the most-characterized cytoplasmic DNA sensors in humans and other mammals. However, knowledge about cGAS homologs in nonmammalian species remains limited. In this study, we report the molecular and functional identification of two cGAS homologs, namely, DrcGASa and DrcGASb, from a zebrafish (Danio rerio) model. DrcGASa and DrcGASb share the same overall conservative structural architectures and functional domains/residues to mammalian cGASs. Both homologs synthesized a 2'3'-cGAMP isomer but not a 3'3'-cGAMP isomer via oligomerization in response to DNA stimulation. Overexpression of DrcGASa/b in HEK293T cells and zebrafish embryos significantly activated NF-kappa B and IFN-I signaling pathways in a STING-dependent manner. Knockdown of DrcGASa or DrSTING impaired such activations, thereby reducing the host innate immunity against bacterial and viral infections. DrcGASa, but not DrcGASb, was involved in immunoglobulin Z-mediated mucosal immunity in gill-associated lymphoid tissue, suggesting differential functions between the two DrcGASs. This reaction was associated with the DrcGAS-DrSTING-IFN phi 1 signaling axis in GALT's gamma delta T cells. Our findings provide experimental evidence that a modern cGAS-STING pathway that mainly participates in IFN-mediated immunity originated from teleost fish based on the functional constraint of cGAS and STING proteins during vertebrate evolution.	[Liu, Zhi-fei; Ji, Jian-fei; Jiang, Xiao-feng; Shao, Tong; Fan, Dong-dong; Jiang, Xin-hang; Lin, Ai-fu; Xiang, Li-xin; Shao, Jian-zhong] Zhejiang Univ, Coll Life Sci, Key Lab Cell & Gene Engn Zhejiang Prov, 866 YuHangTang Rd, Hangzhou 310058, Peoples R China; [Shao, Jian-zhong] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China	Zhejiang University; Qingdao National Laboratory for Marine Science & Technology	Shao, JZ (corresponding author), Zhejiang Univ, Coll Life Sci, Key Lab Cell & Gene Engn Zhejiang Prov, 866 YuHangTang Rd, Hangzhou 310058, Peoples R China.	shaojz@zju.edu.cn		Jiang, Xiaofeng/0000-0002-6691-9816	National Natural Science Foundation of China [31572641, 31630083]; National Key Research and Development Program of China [2018YFD0900503, 2018YFD0900505]; Stem Cell and Translational Research, the National Key Research and Development Program of China [2016YFA0101001]; Open Fund of the Laboratory for Marine Biology and Biotechnology, Qingdao National Laboratory for Marine Science and Technology, Qingdao, China [OF2017NO02]; Open Funding Project of the State Key Laboratory of Bioreactor Engineering; Zhejiang Major Special Program of Breeding [2016C02055-4]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Stem Cell and Translational Research, the National Key Research and Development Program of China; Open Fund of the Laboratory for Marine Biology and Biotechnology, Qingdao National Laboratory for Marine Science and Technology, Qingdao, China; Open Funding Project of the State Key Laboratory of Bioreactor Engineering; Zhejiang Major Special Program of Breeding	National Natural Science Foundation of China, Grant/Award Number: 31572641 and 31630083; the National Key Research and Development Program of China, Grant/Award Number: 2018YFD0900503 and 2018YFD0900505; Stem Cell and Translational Research, the National Key Research and Development Program of China, Grant/Award Number: 2016YFA0101001; the Open Fund of the Laboratory for Marine Biology and Biotechnology, Qingdao National Laboratory for Marine Science and Technology, Qingdao, China, Grant/Award Number: OF2017NO02; the Open Funding Project of the State Key Laboratory of Bioreactor Engineering and the Zhejiang Major Special Program of Breeding, Grant/Award Number: 2016C02055-4	ABDILLAHI H, 1987, FEMS MICROBIOL LETT, V48, P367, DOI 10.1016/0378-1097(87)90077-2; Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; Biacchesi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047737; Biacchesi S, 2009, J VIROL, V83, P7815, DOI 10.1128/JVI.00404-09; Civril F, 2013, NATURE, V498, P332, DOI 10.1038/nature12305; Collins AC, 2015, CELL HOST MICROBE, V17, P820, DOI 10.1016/j.chom.2015.05.005; Diner EJ, 2013, CELL REP, V3, P1355, DOI 10.1016/j.celrep.2013.05.009; Fang R, 2017, J IMMUNOL, V199, P3222, DOI 10.4049/jimmunol.1700699; Feng W, 2016, J IMMUNOL, V197, P151, DOI 10.4049/jimmunol.1502334; Gao DX, 2015, P NATL ACAD SCI USA, V112, pE5699, DOI 10.1073/pnas.1516465112; Gao P, 2013, CELL, V153, P1094, DOI 10.1016/j.cell.2013.04.046; Gentili M, 2019, CELL REP, V26, P2377, DOI 10.1016/j.celrep.2019.01.105; Gong YF, 2009, J IMMUNOL, V182, P7749, DOI 10.4049/jimmunol.0804370; Gu YF, 2011, J IMMUNOL, V187, P2514, DOI 10.4049/jimmunol.1003457; Gui X, 2019, NATURE, V567, P262, DOI 10.1038/s41586-019-1006-9; Guo DY, 2016, J IMMUNOL, V197, P3198, DOI 10.4049/jimmunol.1600438; Hu YL, 2010, MOL IMMUNOL, V47, P738, DOI 10.1016/j.molimm.2009.10.010; Kato K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076983; Kranzusch PJ, 2015, MOL CELL, V59, P891, DOI 10.1016/j.molcel.2015.07.022; Kranzusch PJ, 2014, CELL, V158, P1011, DOI 10.1016/j.cell.2014.07.028; Kuchta K, 2009, NUCLEIC ACIDS RES, V37, P7701, DOI 10.1093/nar/gkp854; Li JY, 2018, J IMMUNOL, V201, P1946, DOI 10.4049/jimmunol.1800498; Li X, 2013, IMMUNITY, V39, P1019, DOI 10.1016/j.immuni.2013.10.019; Liang QM, 2014, CELL HOST MICROBE, V15, P228, DOI 10.1016/j.chom.2014.01.009; Liu HP, 2018, NATURE, V563, P131, DOI 10.1038/s41586-018-0629-6; Luecke S, 2017, EMBO REP, V18, P1707, DOI 10.15252/embr.201744017; Ma JX, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01327; Mann CCD, 2016, SCI REP-UK, V6, DOI 10.1038/srep27498; Margolis SR, 2017, TRENDS IMMUNOL, V38, P733, DOI 10.1016/j.it.2017.03.004; Martin M, 2018, CELL REP, V23, P3537, DOI 10.1016/j.celrep.2018.05.029; Meng FS, 2016, GENE DEV, V30, P1086, DOI 10.1101/gad.277533.116; Meng Z, 2012, J IMMUNOL, V189, P4024, DOI 10.4049/jimmunol.1201244; Novotna B, 2019, J MED CHEM, V62, P10676, DOI 10.1021/acs.jmedchem.9b01062; Pari M, 2007, FEBS J, V274, P3462, DOI 10.1111/j.1742-4658.2007.05878.x; Rolf J, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21010105; Ryo S, 2010, DEV COMP IMMUNOL, V34, P1183, DOI 10.1016/j.dci.2010.06.012; Shao T, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01204; Shi W, 2019, J IMMUNOL, V203, P2425, DOI 10.4049/jimmunol.1900458; Shu C, 2014, CYTOKINE GROWTH F R, V25, P641, DOI 10.1016/j.cytogfr.2014.06.006; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tao JL, 2017, J IMMUNOL, V198, P3627, DOI 10.4049/jimmunol.1601909; Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007; Wan Feng, 2016, Front Immunol, V7, P675, DOI 10.3389/fimmu.2016.00675; Wang J, 2015, MOL IMMUNOL, V65, P436, DOI 10.1016/j.molimm.2015.02.002; Whiteley AT, 2019, NATURE, V567, P194, DOI 10.1038/s41586-019-0953-5; Wu XM, 2014, NUCLEIC ACIDS RES, V42, P8243, DOI 10.1093/nar/gku569; Xia PY, 2016, PROTEIN CELL, V7, P777, DOI 10.1007/s13238-016-0320-3; Xie W, 2019, P NATL ACAD SCI USA, V116, P11946, DOI 10.1073/pnas.1905013116; Xiong R, 2012, J IMMUNOL, V188, P2653, DOI 10.4049/jimmunol.1100959; Xu XG, 2016, J IMMUNOL, V196, P1686, DOI 10.4049/jimmunol.1501736; Xu Z, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10728; Yang H, 2017, P NATL ACAD SCI USA, V114, pE4612, DOI 10.1073/pnas.1705499114; Zhang CG, 2019, NATURE, V567, P394, DOI 10.1038/s41586-019-1000-2; Zhang N, 2017, DEV COMP IMMUNOL, V70, P94, DOI 10.1016/j.dci.2017.01.001; Zhang X, 2014, CELL REP, V6, P421, DOI 10.1016/j.celrep.2014.01.003; Zhang X, 2013, MOL CELL, V51, P226, DOI 10.1016/j.molcel.2013.05.022; Zhang YA, 2010, NAT IMMUNOL, V11, P827, DOI 10.1038/ni.1913; Zhu LY, 2014, J IMMUNOL, V192, P2699, DOI 10.4049/jimmunol.1301312	59	11	12	1	31	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					7786	7809		10.1096/fj.201902833R	http://dx.doi.org/10.1096/fj.201902833R		APR 2020	24	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32285982				2022-12-28	WOS:000526106000001
J	Bravo-Caparros, I; Ruiz-Cantero, MC; Perazzoli, G; Cronin, SJF; Vela, JM; Hamed, MF; Penninger, JM; Baeyens, JM; Cobos, EJ; Nieto, FR				Bravo-Caparros, Inmaculada; Carmen Ruiz-Cantero, M.; Perazzoli, Gloria; Cronin, Shane J. F.; Vela, Jose M.; Hamed, Mohamed F.; Penninger, Josef M.; Baeyens, Jose M.; Cobos, Enrique J.; Nieto, Francisco R.			Sigma-1 receptors control neuropathic pain and macrophage infiltration into the dorsal root ganglion after peripheral nerve injury	FASEB JOURNAL			English	Article						ATF3; CCL2; IL-6; neuroinflammation; spared nerve injury	SENSORY NEURONS; SPINAL-CORD; MECHANICAL ALLODYNIA; IMMUNE CELLS; EXPRESSION; CCL2; ANTAGONIST; INDUCTION; BEHAVIOR; BD1047	Neuron-immune interaction in the dorsal root ganglia (DRG) plays a pivotal role in the neuropathic pain development after nerve injury. Sigma-1 receptor (Sig-1R) is expressed by DRG neurons but its role in neuropathic pain is not fully understood. We investigated the effect of peripheral Sig-1R on neuroinflammation in the DRG after spared (sciatic) nerve injury (SNI) in mice. Nerve injury induced a decrease in NeuN staining along with the nuclear eccentricity and ATF3 expression in the injured DRG. Sig-1R was present in all DRG neurons examined, and after SNI this receptor translocated to the periphery of the soma and the vicinity of the nucleus, especially in injured ATF3 + neurons. In WT mice, injured DRG produced the chemokine CCL2, and this was followed by massive infiltration of macrophages/monocytes, which clustered mainly around sensory neurons with translocated Sig-1R, accompanied by robust IL-6 increase and mechanical allodynia. In contrast, Sig-1R knockout (Sig-1R-KO) mice showed reduced levels of CCL2, decreased macrophage/monocyte infiltration into DRG, and less IL-6 and neuropathic mechanical allodynia after SNI. Our findings point to an important role of peripheral Sig-1R in sensory neuron-macrophage/monocyte communication in the DRG after peripheral nerve injury; thus, these receptors may contribute to the neuropathic pain phenotype.	[Bravo-Caparros, Inmaculada; Carmen Ruiz-Cantero, M.; Baeyens, Jose M.; Cobos, Enrique J.; Nieto, Francisco R.] Univ Granada, Sch Med, Dept Pharmacol, Granada 18016, Spain; [Bravo-Caparros, Inmaculada; Carmen Ruiz-Cantero, M.; Baeyens, Jose M.; Cobos, Enrique J.; Nieto, Francisco R.] Univ Granada, Inst Neurosci, Biomed Res Ctr, Granada, Spain; [Bravo-Caparros, Inmaculada; Carmen Ruiz-Cantero, M.; Perazzoli, Gloria; Baeyens, Jose M.; Cobos, Enrique J.; Nieto, Francisco R.] Inst Invest Biosanitaria IBS GRANADA, Granada, Spain; [Perazzoli, Gloria] Univ Granada, Sch Med, Dept Human Anat & Embryol, Granada, Spain; [Cronin, Shane J. F.; Penninger, Josef M.] Inst Mol Biotechnol, Vienna, Austria; [Vela, Jose M.] Esteve, Drug Discovery & Preclin Dev, Barcelona, Spain; [Hamed, Mohamed F.] Mansoura Univ, Dept Pathol, Fac Vet Med, Mansoura, Egypt; [Penninger, Josef M.] Univ British Columbia, Life Sci Inst, Dept Med Genet, Vancouver, BC, Canada; [Cobos, Enrique J.] Teofilo Hernando Inst Drug Discovery, Madrid, Spain	University of Granada; University of Granada; Instituto de Investigacion Biosanitaria IBS Granada; University of Granada; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Esteve; Egyptian Knowledge Bank (EKB); Mansoura University; University of British Columbia	Cobos, EJ; Nieto, FR (corresponding author), Univ Granada, Sch Med, Dept Pharmacol, Granada 18016, Spain.	ejcobos@ugr.es; fnieto@ugr.es	Baeyens, Jose M/G-2590-2016; Ruiz-Cantero, M Carmen/Z-1911-2019; Cobos, Enrique J/E-9077-2016; López, Francisco Nieto/AAS-2144-2021; Penninger, Josef M/I-6860-2013; López, Francisco Nieto/AEX-2949-2022	Baeyens, Jose M/0000-0001-7168-0523; Cobos, Enrique J/0000-0003-1308-6264; López, Francisco Nieto/0000-0001-9555-0651; Penninger, Josef M/0000-0002-8194-3777; López, Francisco Nieto/0000-0001-9555-0651; Ruiz Cantero/0000-0001-6968-0946				Abadias M, 2013, BRIT J CLIN PHARMACO, V75, P103, DOI 10.1111/j.1365-2125.2012.04333.x; Borsook D, 2013, ANN SURG, V257, P403, DOI 10.1097/SLA.0b013e3182701a7b; Bourquin AF, 2006, PAIN, V122, P14, DOI 10.1016/j.pain.2005.10.036; Bravo-Caparros I, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00613; Bruna J, 2018, NEUROTHERAPEUTICS, V15, P178, DOI 10.1007/s13311-017-0572-5; Castany S, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00222; Castany S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22217-9; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Choi SR, 2016, BIOL PHARM BULL, V39, P1922, DOI 10.1248/bpb.b16-00326; Cobos EJ, 2018, CELL REP, V22, P1301, DOI 10.1016/j.celrep.2018.01.006; Cobos EJ, 2013, CURR NEUROPHARMACOL, V11, P560, DOI 10.2174/1570159X113119990041; Colloca L, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.2; Collombet JM, 2006, NEUROSCI LETT, V398, P337, DOI 10.1016/j.neulet.2006.01.029; de la Puente B, 2009, PAIN, V145, P294, DOI 10.1016/j.pain.2009.05.013; Deacon R, 2012, JOVE-J VIS EXP, DOI 10.3791/2607; Deacon RMJ, 2006, NAT PROTOC, V1, P118, DOI 10.1038/nprot.2006.19; Decosterd I, 2000, PAIN, V87, P149, DOI 10.1016/S0304-3959(00)00276-1; Duan W, 2016, MOL NEUROBIOL, V53, P1637, DOI 10.1007/s12035-015-9122-5; Finnerup NB, 2015, LANCET NEUROL, V14, P162, DOI 10.1016/S1474-4422(14)70251-0; Gris G, 2016, SCI REP-UK, V6, DOI 10.1038/srep24591; Hewson DW, 2018, ANAESTHESIA, V73, P51, DOI 10.1111/anae.14140; Hu GL, 2016, SCI REP-UK, V6, DOI 10.1038/srep31851; Jay GW, 2014, DM-DIS MON, V60, P6, DOI 10.1016/j.disamonth.2013.12.001; Jeong YC, 2015, BRAIN RES BULL, V119, P93, DOI 10.1016/j.brainresbull.2015.07.006; Ji RR, 2016, SCIENCE, V354, P572, DOI 10.1126/science.aaf8924; Johnson IP, 2013, NEUROSCIENCE, V228, P163, DOI 10.1016/j.neuroscience.2012.10.015; Kang DW, 2016, SCI REP-UK, V6, DOI 10.1038/srep37850; Kourrich S, 2017, HANDB EXP PHARMACOL, V244, P109, DOI 10.1007/164_2017_8; Kwon MJ, 2015, J NEUROSCI, V35, P15934, DOI 10.1523/JNEUROSCI.1924-15.2015; Kwon MJ, 2013, J NEUROSCI, V33, P15095, DOI 10.1523/JNEUROSCI.0278-13.2013; Laedermann CJ, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-19; Lindborg JA, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1222-5; Liu CC, 2016, BRAIN BEHAV IMMUN, V53, P96, DOI 10.1016/j.bbi.2015.11.004; Liu DY, 2018, EXP NEUROL, V308, P90, DOI 10.1016/j.expneurol.2018.07.002; Entrena JM, 2009, PAIN, V143, P252, DOI 10.1016/j.pain.2009.03.011; MATTHEWS MR, 1972, PROC R SOC SER B-BIO, V181, P43, DOI 10.1098/rspb.1972.0040; Mavlyutov TA, 2016, NEUROSCIENCE, V331, P148, DOI 10.1016/j.neuroscience.2016.06.030; Merlos M, 2017, HANDB EXP PHARMACOL, V244, P131, DOI 10.1007/164_2017_9; Montilla-Garcia A, 2018, NEUROPHARMACOLOGY, V135, P328, DOI 10.1016/j.neuropharm.2018.03.025; Niemi JP, 2013, J NEUROSCI, V33, P16236, DOI 10.1523/JNEUROSCI.3319-12.2013; Nieto FR, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-11; North RY, 2019, BRAIN, V142, P1215, DOI 10.1093/brain/awz063; Puntener U, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-146; Nieto FR, 2012, J PAIN, V13, P1107, DOI 10.1016/j.jpain.2012.08.006; Raoof R, 2018, RHEUMATOLOGY, V57, P429, DOI 10.1093/rheumatology/kex308; Roh DH, 2008, ANESTHESIOLOGY, V109, P879, DOI 10.1097/ALN.0b013e3181895a83; Romero L, 2012, BRIT J PHARMACOL, V166, P2289, DOI 10.1111/j.1476-5381.2012.01942.x; Sanchez-Fernandez C, 2017, ADV EXP MED BIOL, V964, P109, DOI 10.1007/978-3-319-50174-1_9; Sanchez-Fernandez C, 2014, J PHARMACOL EXP THER, V348, P32, DOI 10.1124/jpet.113.208272; Scholz J, 2007, NAT NEUROSCI, V10, P1361, DOI 10.1038/nn1992; Sheahan Tayler D, 2017, Neurobiol Pain, V2, P1, DOI 10.1016/j.ynpai.2017.09.001; Shepherd AJ, 2018, FRONT BEHAV NEUROSCI, V12, DOI 10.3389/fnbeh.2018.00124; Smith ES, 2018, J NEUROL, V265, P231, DOI 10.1007/s00415-017-8641-6; Su TP, 2016, TRENDS PHARMACOL SCI, V37, P262, DOI 10.1016/j.tips.2016.01.003; Su TP, 2010, TRENDS PHARMACOL SCI, V31, P557, DOI 10.1016/j.tips.2010.08.007; Tsai SYA, 2015, P NATL ACAD SCI USA, V112, pE6562, DOI 10.1073/pnas.1518894112; Tsujino H, 2000, MOL CELL NEUROSCI, V15, P170, DOI 10.1006/mcne.1999.0814; Urban R, 2011, PAIN, V152, P990, DOI 10.1016/j.pain.2010.12.003; Vallejo R, 2013, PAIN PHYSICIAN, V16, pE601; Van Steenwinckel J, 2011, J NEUROSCI, V31, P5865, DOI 10.1523/JNEUROSCI.5986-10.2011; van Waarde A, 2011, BEHAV BRAIN RES, V221, P543, DOI 10.1016/j.bbr.2009.12.043; Vega-Avelaira D, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-70; Wang CH, 2010, NEUROSCI LETT, V475, P48, DOI 10.1016/j.neulet.2010.03.044; Wang XL, 2018, NEUROSCI LETT, V668, P164, DOI 10.1016/j.neulet.2018.02.002; White FA, 2005, P NATL ACAD SCI USA, V102, P14092, DOI 10.1073/pnas.0503496102; Wiberg R, 2018, NEUROREPORT, V29, P779, DOI 10.1097/WNR.0000000000001031; Wong GT, 2002, NEUROPEPTIDES, V36, P230, DOI 10.1054/npep.2002.0905; Zhou YQ, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0607-6; Zhu SS, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/265056; Zhu X, 2014, J PAIN, V15, P516, DOI 10.1016/j.jpain.2014.01.492; Zigrnond RE, 2019, PROG NEUROBIOL, V173, P102, DOI 10.1016/j.pneurobio.2018.12.001; Zimmermann M, 2001, EUR J PHARMACOL, V429, P23, DOI 10.1016/S0014-2999(01)01303-6	72	29	32	2	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5951	5966		10.1096/fj.201901921R	http://dx.doi.org/10.1096/fj.201901921R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32157739				2022-12-28	WOS:000530242100076
J	Li, Y; Zhang, T; Tian, WJ; Hu, HJ; Xin, ZF; Ma, XJ; Ye, CY; Hang, K; Han, XG; Zhao, J; Li, WX				Li, Yan; Zhang, Ting; Tian, Wenjia; Hu, Hejia; Xin, Zengfeng; Ma, Xiaojing; Ye, Chenyi; Hang, Kai; Han, Xiuguo; Zhao, Jie; Li, Weixu			Loss of TIMP3 expression induces inflammation, matrix degradation, and vascular ingrowth in nucleus pulposus: A new mechanism of intervertebral disc degeneration	FASEB JOURNAL			English	Article						inflammation; matrix degradation; nucleus pulposus; TIMP3; vascular ingrowth	ENDOTHELIAL-CELL PROLIFERATION; AGE-RELATED-CHANGES; TISSUE INHIBITOR; GROWTH; ANGIOGENESIS; RECEPTORS; ENZYMES; INNERVATION; FEATURES; SMAD2/3	Low back pain (LBP) is one of the most common complains in orthopedic outpatient department and intervertebral disc degeneration (IDD) is one of the most important reasons of LBP. The mechanisms of IDD contain a complex biochemical cascade which includes inflammation, vascular ingrowth, and results in degradation of matrix. In our study, we used both in vitro and in vivo models to investigate the relation between tissue inhibitor of metalloproteinase-3 (TIMP3) expression and IDD. Loss of TIMP3 expression was found in degenerative intervertebral disc (IVD), this change of expression was closely related with the dephosphorylation of smad2/3. Overexpression of TIMP3 significantly inhibited the release of TNF-alpha and matrix degradation induced by Lipopolysaccharide. Vascular ingrowth was also suppressed by TIMP3 in the in vitro and in vivo models. Further, animal experiments confirmed that the degeneration of IVD was reduced after overexpression of TIMP3 in nucleus pulposus. Taken together, our results indicated TIMP-3 might play an important role in the pathogenesis of IDD and therefore be a potential therapeutic target in the future.	[Li, Yan; Hu, Hejia; Xin, Zengfeng; Ye, Chenyi; Hang, Kai; Li, Weixu] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Orthoped Surg, 88 Jiefang Rd, Hangzhou 310009, Zhejiang, Peoples R China; [Li, Yan; Hu, Hejia; Xin, Zengfeng; Ye, Chenyi; Hang, Kai; Li, Weixu] Zhejiang Univ, Orthoped Res Inst, Hangzhou, Peoples R China; [Zhang, Ting] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Radiotherapy, Hangzhou, Peoples R China; [Tian, Wenjia] Zhejiang Chinese Med Univ, Affiliated Hosp 1, Dept Endocrinol, Hangzhou, Peoples R China; [Ma, Xiaojing] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Pathol, Hangzhou, Peoples R China; [Han, Xiuguo; Zhao, Jie] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Shanghai Key Lab Orthopaed Implants,Dept Orthopae, Shanghai, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang Chinese Medical University; Zhejiang University; Shanghai Jiao Tong University	Li, WX (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Orthoped Surg, 88 Jiefang Rd, Hangzhou 310009, Zhejiang, Peoples R China.	zrlwx@zju.edu.cn			National Natural Science Foundation of China (NSFC) [81802228]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81802228	Andersson GBJ, 1999, LANCET, V354, P581, DOI 10.1016/S0140-6736(99)01312-4; Bachmeier BE, 2007, ANN NY ACAD SCI, V1096, P44, DOI 10.1196/annals.1397.069; Binch ALA, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0416-1; Boos N, 2002, SPINE, V27, P2631, DOI 10.1097/00007632-200212010-00002; Chen T, 2018, MED SCI MONITOR, V24, P6456, DOI 10.12659/MSM.910636; Chen YY, 2014, ANGIOGENESIS, V17, P207, DOI 10.1007/s10456-013-9389-y; Das AM, 2016, EUR J CANCER, V53, P135, DOI 10.1016/j.ejca.2015.09.014; Das AM, 2014, ANGIOGENESIS, V17, P163, DOI 10.1007/s10456-013-9385-2; DePalma MJ, 2011, PAIN MED, V12, P224, DOI 10.1111/j.1526-4637.2010.01045.x; Ellman MB, 2012, GENE, V505, P283, DOI 10.1016/j.gene.2012.06.004; Freemont AJ, 1997, LANCET, V350, P178, DOI 10.1016/S0140-6736(97)02135-1; Freemont AJ, 2002, J PATHOL, V197, P286, DOI 10.1002/path.1108; Griffith JF, 2007, SPINE, V32, pE708, DOI 10.1097/BRS.0b013e31815a59a0; Hashimoto G, 2001, FEBS LETT, V494, P192, DOI 10.1016/S0014-5793(01)02323-7; Huang M, 2012, J ORTHOP RES, V30, P267, DOI 10.1002/jor.21507; Igarashi T, 2000, SPINE, V25, P2975, DOI 10.1097/00007632-200012010-00003; Johnson WEB, 2002, ARTHRITIS RHEUM-US, V46, P2658, DOI 10.1002/art.10585; KAUPPILA LI, 1995, J BONE JOINT SURG AM, V77A, P26, DOI 10.2106/00004623-199501000-00004; Kepler CK, 2013, SPINE J, V13, P318, DOI 10.1016/j.spinee.2012.12.003; Kwon WK, 2017, OSTEOARTHR CARTILAGE, V25, P1738, DOI 10.1016/j.joca.2017.06.003; Le Maitre CL, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2275; Le Maitre CL, 2004, J PATHOL, V204, P47, DOI 10.1002/path.1608; Lee JM, 2011, J ORTHOP RES, V29, P265, DOI 10.1002/jor.21210; Leivonen SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057474; Li GJ, 2017, MOL MED REP, V15, P1981, DOI 10.3892/mmr.2017.6240; Li Y, 2016, BIOCHEM BIOPH RES CO, V469, P507, DOI 10.1016/j.bbrc.2015.12.020; Liu Y, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/7189854; Mohammed FF, 2004, NAT GENET, V36, P969, DOI 10.1038/ng1413; Pockert AJ, 2009, ARTHRITIS RHEUM-US, V60, P482, DOI 10.1002/art.24291; Qi JH, 2003, NAT MED, V9, P407, DOI 10.1038/nm846; Schafers Maria, 2007, Expert Rev Neurother, V7, P1613, DOI 10.1586/14737175.7.11.1613; SCHWARZER AC, 1995, SPINE, V20, P1878, DOI 10.1097/00007632-199509000-00007; Smookler DS, 2006, J IMMUNOL, V176, P721, DOI 10.4049/jimmunol.176.2.721; Tsuji T, 2007, SPINE, V32, P849, DOI 10.1097/01.brs.0000259804.39881.62; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; WALTENBERGER J, 1994, J BIOL CHEM, V269, P26988; Wang CB, 2014, COGN NEUROSCI-UK, V5, P3, DOI 10.1080/17588928.2013.797388; Wang X, 2014, ARCH BIOCHEM BIOPHYS, V564, P229, DOI 10.1016/j.abb.2014.09.009; Wuertz K, 2013, GLOB SPINE J, V3, P175, DOI 10.1055/s-0033-1347299; Zhu YH, 2017, J CELL MOL MED, V21, P1781, DOI 10.1111/jcmm.13099	40	5	6	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5483	5498		10.1096/fj.201902364RR	http://dx.doi.org/10.1096/fj.201902364RR		FEB 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32107793	Bronze			2022-12-28	WOS:000517909800001
J	Kim, GD; Lee, JH; Song, SM; Kim, SW; Han, JS; Shin, SP; Park, BC; Park, TS				Kim, Gap-Don; Lee, Jeong Hyo; Song, Sumin; Kim, Seo Woo; Han, Ji Seon; Shin, Seung Pyo; Park, Byung-Chul; Park, Tae Sub			Generation of myostatin-knockout chickens mediated by D10A-Cas9 nickase	FASEB JOURNAL			English	Article						chicken; D10A-Cas9; muscle; myostatin; nickase; off-target	EFFICIENT GENERATION; GENE KNOCKOUT; PIGS; HYPERTROPHY; HYPERPLASIA; MUTATIONS; CATTLE; CAS9; MICE	Many studies have been conducted to improve economically important livestock traits such as feed efficiency and muscle growth. Genome editing technologies represent a major advancement for both basic research and agronomic biotechnology development. The clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 technical platform is a powerful tool used to engineer specific targeted loci. However, the potential occurrence of off-target effects, including the cleavage of unintended targets, limits the practical applications of Cas9-mediated genome editing. In this study, to minimize the off-target effects of this technology, we utilized D10A-Cas9 nickase to generate myostatin-knockout (MSTN KO) chickens via primordial germ cells. D10A-Cas9 nickase (Cas9n)-mediated MSTN KO chickens exhibited significantly larger skeletal muscles in the breast and leg. Degrees of skeletal muscle hypertrophy and hyperplasia induced by myostatin deletion differed by sex and muscle type. The abdominal fat deposition was dramatically lower in MSTN KO chickens than in wild-type chickens. Our results demonstrate that the D10A-Cas9 technical platform can facilitate precise and efficient targeted genome engineering and may broaden the range of applications for genome-edited chickens in practical industrialization and as animal models of human diseases.	[Kim, Gap-Don; Song, Sumin; Kim, Seo Woo; Han, Ji Seon; Park, Byung-Chul; Park, Tae Sub] Seoul Natl Univ, Grad Sch Int Agr Technol, Pyeongchang Gun 25354, Gangwon Do, South Korea; [Kim, Gap-Don; Lee, Jeong Hyo; Shin, Seung Pyo; Park, Byung-Chul; Park, Tae Sub] Seoul Natl Univ, Inst Green Bio Sci & Technol, Pyeongchang Gun, South Korea; [Park, Byung-Chul] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Park, BC; Park, TS (corresponding author), Seoul Natl Univ, Grad Sch Int Agr Technol, Pyeongchang Gun 25354, Gangwon Do, South Korea.	bcpark@snu.ac.kr; taesubpark@snu.ac.kr		Lee, Jeong Hyo/0000-0002-1848-5347	RDA, Korea [PJ01334801]	RDA, Korea	RDA, Korea, Grant/Award Number: PJ01334801	Bastiaansen JWM, 2018, GENET SEL EVOL, V50, DOI 10.1186/s12711-018-0389-7; Bhattacharya TK, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44217-z; Carlson DF, 2016, NAT BIOTECHNOL, V34, P479, DOI 10.1038/nbt.3560; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cui XX, 2011, NAT BIOTECHNOL, V29, P64, DOI 10.1038/nbt.1731; Dimitrov L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154303; Dou TF, 2018, MOL BIOL REP, V45, P511, DOI 10.1007/s11033-018-4187-7; Gao YP, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-016-1144-4; Hauschild J, 2011, P NATL ACAD SCI USA, V108, P12013, DOI 10.1073/pnas.1106422108; Kang JD, 2017, RSC ADV, V7, P12541, DOI 10.1039/c6ra28579a; Lee JH, 2017, ASIAN AUSTRAL J ANIM, V30, P743, DOI 10.5713/ajas.16.0695; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; Meuwissen T, 2013, ANNU REV ANIM BIOSCI, V1, P221, DOI 10.1146/annurev-animal-031412-103705; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Nishi M, 2002, BIOCHEM BIOPH RES CO, V293, P247, DOI 10.1016/S0006-291X(02)00209-7; Oishi I, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28438-2; Oishi I, 2016, SCI REP-UK, V6, DOI 10.1038/srep23980; Park TS, 2019, FASEB J, V33, P1188, DOI 10.1096/fj.201800784R; Park TS, 2014, P NATL ACAD SCI USA, V111, P12716, DOI 10.1073/pnas.1410555111; Peng H, 2016, SCI REP-UK, V6, DOI 10.1038/srep22000; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/NMETH.2857, 10.1038/nmeth.2857]; Stern CD, 2005, DEV CELL, V8, P9, DOI 10.1016/j.devcel.2004.11.018; Sung YH, 2013, NAT BIOTECHNOL, V31, P23, DOI 10.1038/nbt.2477; Wang KK, 2015, SCI REP-UK, V5, DOI 10.1038/srep16623; Whitworth KM, 2016, NAT BIOTECHNOL, V34, P20, DOI 10.1038/nbt.3434; Zhou XQ, 2015, CELL MOL LIFE SCI, V72, P1175, DOI 10.1007/s00018-014-1744-7; Zhu XL, 2000, FEBS LETT, V474, P71, DOI 10.1016/S0014-5793(00)01570-2	31	29	32	1	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5688	5696		10.1096/fj.201903035R	http://dx.doi.org/10.1096/fj.201903035R		FEB 2020	9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32100378	hybrid			2022-12-28	WOS:000517898700001
J	Laitakari, A; Huttunen, R; Kuvaja, P; Hannuksela, P; Szabo, Z; Heikkila, M; Kerkela, R; Myllyharju, J; Dimova, EY; Serpi, R; Koivunen, P				Laitakari, Anna; Huttunen, Riikka; Kuvaja, Paula; Hannuksela, Pauliina; Szabo, Zoltan; Heikkila, Minna; Kerkela, Risto; Myllyharju, Johanna; Dimova, Elitsa Y.; Serpi, Raisa; Koivunen, Peppi			Systemic long-term inactivation of hypoxia-inducible factor prolyl 4-hydroxylase 2 ameliorates aging-induced changes in mice without affecting their life span	FASEB JOURNAL			English	Article						anemia; HCC; hypoxia response; metabolism	CORONARY-HEART-DISEASE; SERUM URIC-ACID; CELL-PROLIFERATION; ROXADUSTAT FG-4592; ENDOTHELIAL-CELLS; PHD2; ACTIVATION; INHIBITION; MORTALITY; PROTECTS	Hypoxia inactivates hypoxia-inducible factor (HIF) prolyl 4-hydroxylases (HIF-P4Hs), which stabilize HIF and upregulate genes to restore tissue oxygenation. HIF-P4Hs can also be inhibited by small molecules studied in clinical trials for renal anemia. Knowledge of systemic long-term inactivation of HIF-P4Hs is limited but crucial, since HIF overexpression is associated with cancers. We aimed to determine the effects of systemic genetic inhibition of the most abundant isoenzyme HIF prolyl 4-hydroxylase-2 (HIF-P4H-2)/PHD2/EglN1 on life span and tissue homeostasis in aged mice. Our data showed no difference between wild-type and HIF-P4H-2-deficient mice in the average age reached. There were several differences, however, in the primary causes of death and comorbidities, the HIF-P4H-2-deficient mice having less inflammation, liver diseases, including cancer, and myocardial infarctions, and not developing anemia. No increased cancer incidence was observed due to HIF-P4H-2-deficiency. These data suggest that chronic inactivation of HIF-P4H-2 is not harmful but rather improves the quality of life in senescence.	[Laitakari, Anna; Huttunen, Riikka; Hannuksela, Pauliina; Heikkila, Minna; Myllyharju, Johanna; Dimova, Elitsa Y.; Serpi, Raisa; Koivunen, Peppi] Univ Oulu, Oulu Ctr Cell Matrix Res, Fac Biochem & Mol Med, Bioctr Oulu, Aapistie 7C, FIN-90014 Oulu, Finland; [Kuvaja, Paula] Univ Oulu, Oulu Univ Hosp, Med Res Ctr Oulu, Canc & Translat Med Res Unit, Oulu, Finland; [Kuvaja, Paula] Oulu Univ Hosp, Dept Pathol, Oulu, Finland; [Szabo, Zoltan; Kerkela, Risto] Univ Oulu, Dept Pharmacol & Toxicol, Res Unit Biomed, Oulu, Finland	University of Oulu; University of Oulu; University of Oulu; University of Oulu	Koivunen, P (corresponding author), Univ Oulu, Oulu Ctr Cell Matrix Res, Fac Biochem & Mol Med, Bioctr Oulu, Aapistie 7C, FIN-90014 Oulu, Finland.	peppi.koivunen@oulu.fi		Szabo, Zoltan/0000-0003-0778-1113; Serpi, Raisa/0000-0002-8207-4673	Academy of Finland (Suomen Akatemia) [266719, 308009, 296498, 251314]; Sigrid Juseliuksen Saatio (Sigrid Juselius Stiftelse); Finnish Cancer Foundation; Jane ja Aatos Erkon Saatio (JAE); FibroGen (FibroGen Inc.)	Academy of Finland (Suomen Akatemia)(Academy of Finland); Sigrid Juseliuksen Saatio (Sigrid Juselius Stiftelse); Finnish Cancer Foundation; Jane ja Aatos Erkon Saatio (JAE); FibroGen (FibroGen Inc.)	Academy of Finland (Suomen Akatemia), Grant/Award Number: 266719, 308009, 296498 and 251314; Sigrid Juseliuksen Saatio (Sigrid Juselius Stiftelse); Finnish Cancer Foundation; Jane ja Aatos Erkon Saatio (J & AE); FibroGen (FibroGen Inc.)	Acker T, 2005, CANCER CELL, V8, P131, DOI 10.1016/j.ccr.2005.07.003; Amiiants V I, 1997, Klin Med (Mosk), V75, P26; Andersen S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023847; Austad SN, 2016, CELL METAB, V23, P1022, DOI 10.1016/j.cmet.2016.05.019; Bagherniya M, 2018, AGEING RES REV, V47, P183, DOI 10.1016/j.arr.2018.08.004; Blouw B, 2003, CANCER CELL, V4, P133, DOI 10.1016/S1535-6108(03)00194-6; Bogaerts E, 2016, EXCLI J, V15, P687, DOI 10.17179/excli2016-607; Callicott RJ, 2006, COMPARATIVE MED, V56, P17; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chang AM, 2003, AM J PHYSIOL-ENDOC M, V284, pE7, DOI 10.1152/ajpendo.00366.2002; Chen N, 2017, NEPHROL DIAL TRANSPL, V32, P1373, DOI 10.1093/ndt/gfx011; Dai ZY, 2016, CIRCULATION, V133, P2447, DOI 10.1161/CIRCULATIONAHA.116.021494; Dhillon S, 2019, DRUGS, V79, P563, DOI 10.1007/s40265-019-01077-1; Di Conza G, 2017, CELL REP, V18, P2836, DOI 10.1016/j.celrep.2017.02.081; Dovell F, 2018, EUR J CANCER PREV, V27, P399, DOI [10.1097/cej.0000000000000440, 10.1097/CEJ.0000000000000440]; Durkin M.E., 2013, BIOPROTOC, V3, pE908, DOI DOI 10.21769/BioProtoc.908; Ezzati M, 2012, J EPIDEMIOL COMMUN H, V66, DOI 10.1136/jech.2010.112938; Faeh D, 2009, CIRCULATION, V120, P495, DOI 10.1161/CIRCULATIONAHA.108.819250; Farese RV, 1996, P NATL ACAD SCI USA, V93, P6393, DOI 10.1073/pnas.93.13.6393; Flamme I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111838; Folgueras AR, 2018, CIRC RES, V123, P905, DOI 10.1161/CIRCRESAHA.118.312204; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Guralnik Jack M, 2005, Hematology Am Soc Hematol Educ Program, P528; Haase VH, 2017, HEMODIAL INT, V21, pS110, DOI 10.1111/hdi.12567; Hawley JA, 2018, CELL METAB, V27, P962, DOI 10.1016/j.cmet.2018.04.014; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; Hwang AB, 2012, CURR GENOMICS, V13, P519, DOI 10.2174/138920212803251427; Hyvarinen J, 2010, J BIOL CHEM, V285, P13646, DOI 10.1074/jbc.M109.084855; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kaelin William G Jr, 2017, Trans Am Clin Climatol Assoc, V128, P298; Karsikas S, 2016, J MOL MED, V94, P301, DOI 10.1007/s00109-015-1349-0; Kerkela R, 2013, MOL CELL BIOL, V33, P3321, DOI 10.1128/MCB.00432-13; Klotzsche-von Ameln A, 2011, CANCER RES, V71, P3306, DOI 10.1158/0008-5472.CAN-10-3838; Koivunen P, 2018, TRENDS MOL MED, V24, P1021, DOI 10.1016/j.molmed.2018.10.004; Koivunen P, 2016, PHARMACOL RES, V114, P265, DOI 10.1016/j.phrs.2016.11.003; Koivunen P, 2012, NATURE, V483, P485, DOI 10.1038/nature10898; Kozlova N, 2017, ONCOTARGET, V8, P9885, DOI 10.18632/oncotarget.14241; Kuchnio A, 2015, CELL REP, V12, P992, DOI 10.1016/j.celrep.2015.07.010; Laitakari A, 2019, REDOX BIOL, V22, DOI 10.1016/j.redox.2019.101145; Laitala A, 2012, BLOOD, V120, P3336, DOI 10.1182/blood-2012-07-441824; Li Z, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000179; Liu ZW, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00477; Loenarz C, 2011, EMBO REP, V12, P63, DOI 10.1038/embor.2010.170; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Mack FA, 2003, CANCER CELL, V3, P75, DOI 10.1016/S1535-6108(02)00240-4; McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63; Minamishima YA, 2008, BLOOD, V111, P3236, DOI 10.1182/blood-2007-10-117812; MIRRAKHIMOV MM, 1991, KARDIOLOGIYA, V31, P8; MKRTCHYAN RI, 1989, KARDIOLOGIYA, V29, P22; Myllyharju J, 2008, ANN MED, V40, P402, DOI 10.1080/07853890801986594; Myllymaki MNM, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00529-16; Nath B, 2011, HEPATOLOGY, V53, P1526, DOI 10.1002/hep.24256; Olson E, 2014, VASC MED, V19, P473, DOI 10.1177/1358863X14557151; Provenzano R, 2016, CLIN J AM SOC NEPHRO, V11, P982, DOI 10.2215/CJN.06890615; Provenzano R, 2016, AM J KIDNEY DIS, V67, P912, DOI 10.1053/j.ajkd.2015.12.020; Rahtu-Korpela L, 2016, ARTERIOSCL THROM VAS, V36, P608, DOI 10.1161/ATVBAHA.115.307136; Rahtu-Korpela L, 2014, DIABETES, V63, P3324, DOI 10.2337/db14-0472; Rankin EB, 2009, MOL CELL BIOL, V29, P4527, DOI 10.1128/MCB.00200-09; Salminen A, 2012, AGING-US, V4, P166, DOI 10.18632/aging.100444; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schito L, 2016, TRENDS CANCER, V2, P758, DOI 10.1016/j.trecan.2016.10.016; Semenza GL, 2009, PHYSIOLOGY, V24, P97, DOI 10.1152/physiol.00045.2008; Snyder JM, 2016, VET PATHOL, V53, P233, DOI 10.1177/0300985815610391; Song LP, 2008, ONCOGENE, V27, P519, DOI 10.1038/sj.onc.1210670; Strasak AM, 2007, CANCER CAUSE CONTROL, V18, P1021, DOI 10.1007/s10552-007-9043-3; Takeda K, 2008, BLOOD, V111, P3229, DOI 10.1182/blood-2007-09-114561; Tao YF, 2016, INT J BIOCHEM CELL B, V77, P129, DOI 10.1016/j.biocel.2016.05.022; Veniant MM, 1998, J CLIN INVEST, V102, P1559, DOI 10.1172/JCI4164; Voss JD, 2013, INT J OBESITY, V37, P1407, DOI 10.1038/ijo.2013.5; Xie C, 2017, NAT MED, V23, P1298, DOI 10.1038/nm.4412; Yeh TL, 2017, CHEM SCI, V8, P7651, DOI 10.1039/c7sc02103h; Zhao G, 2013, ATHEROSCLEROSIS, V231, P61, DOI 10.1016/j.atherosclerosis.2013.08.023	73	6	6	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5590	5609		10.1096/fj.201902331R	http://dx.doi.org/10.1096/fj.201902331R		FEB 2020	20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32100354	Green Submitted, Bronze			2022-12-28	WOS:000517899100001
J	Zheng, SS; Ma, MQ; Li, ZW; Hao, Y; Li, H; Fu, PH; Jin, SW				Zheng, Sisi; Ma, Minqi; Li, Zhongwang; Hao, Yu; Li, Hui; Fu, Panhan; Jin, Shengwei			Posttreatment of Maresin1 Inhibits NLRP3 inflammasome activation via promotion of NLRP3 ubiquitination	FASEB JOURNAL			English	Article						Maresin1; NLRP3 inflammasome; ubiquitination	METABOLIC-DISORDER; DEUBIQUITINATION; DEGRADATION; MECHANISMS; DIVERSITY; DISEASE	Maresin1 is a potent lipid mediator exhibiting potential anti-inflammatory activity in a variety of inflammatory diseases, however, the underlying mechanisms remain poorly understood. Excessive activation of NLRP3 inflammasome has been established in multiple inflammatory diseases. Here, we show that Maresin1 dose-dependently inhibited the NLRP3 inflammasome activation and subsequent caspase-1 activation and IL-1 beta secretion. This inhibitory effect could be reversed by KH7 and H89, the inhibitors of the cAMP-PKA signaling pathway. Activation of PKA kinase induced by Maresin1 led to the K63-linked ubiquitination of NLRP3 in macrophages. Maresin1 attenuated serum IL-1 beta secretion through inhibition of NLRP3 inflammasome in vivo using Nlrp3-deficient mouse models of lipopolysaccharide (LPS)-induced sepsis. Maresin1 also repressed MSU-induced peritonitis. This study suggests that Maresin1 is an inhibitor of NLRP3 inflammasome activation and can be used clinically in the treatment of NLRP3 inflammasome-driven inflammatory diseases.	[Zheng, Sisi; Ma, Minqi; Li, Zhongwang; Hao, Yu; Li, Hui; Fu, Panhan; Jin, Shengwei] Wenzhou Med Univ, Dept Anesthesia & Crit Care, Affiliated Hosp 2, 109 Xueyuan Rd, Wenzhou 325027, Zhejiang, Peoples R China	Wenzhou Medical University	Fu, PH; Jin, SW (corresponding author), Wenzhou Med Univ, Dept Anesthesia & Crit Care, Affiliated Hosp 2, 109 Xueyuan Rd, Wenzhou 325027, Zhejiang, Peoples R China.; Fu, PH; Jin, SW (corresponding author), Wenzhou Med Univ, Yuying Childrens Hosp, 109 Xueyuan Rd, Wenzhou 325027, Zhejiang, Peoples R China.	fupanhan213@126.com; jinshengwei69@163.com		Hao, Yu/0000-0002-8351-1206; Jin, Shengwei/0000-0002-4734-8114	Nation Natural Science Foundation [81870065, 81901983, 81570076]; Natural Science Foudation of Zhejiang Province [LQ19H150001, LQ20H150003]	Nation Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Natural Science Foudation of Zhejiang Province	This work was supported by grants from the Nation Natural Science Foundation (NO.81870065, NO. 81901983 and 81570076) of China and the Natural Science Foudation of Zhejiang Province (LQ19H150001 and LQ20H150003).	Baker PJ, 2017, PHYSIOL REV, V97, P1165, DOI 10.1152/physrev.00026.2016; Beilharz M, 2016, METHODS MOL BIOL, V1417, P145, DOI 10.1007/978-1-4939-3566-6_9; Chateigner-Boutin AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089620; Chen Y, 2019, PEDIATR RES, V86, P692, DOI 10.1038/s41390-019-0418-4; Claria J, 2013, AM J PHYSIOL-CELL PH, V304, pC1141, DOI 10.1152/ajpcell.00351.2012; Dalli J, 2013, FASEB J, V27, P2573, DOI 10.1096/fj.13-227728; Danielski LG, 2020, INFLAMMATION, V43, P24, DOI 10.1007/s10753-019-01124-9; Fattori V, 2019, BRIT J PHARMACOL, V176, P1728, DOI 10.1111/bph.14647; Gu JQ, 2018, LAB INVEST, V98, P715, DOI 10.1038/s41374-018-0031-x; Guarda G, 2011, IMMUNITY, V34, P213, DOI 10.1016/j.immuni.2011.02.006; Guo CS, 2016, IMMUNITY, V45, P802, DOI 10.1016/j.immuni.2016.09.008; Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893; Gurung P, 2015, TRENDS MOL MED, V21, P193, DOI 10.1016/j.molmed.2014.11.008; Han S, 2015, J BIOL CHEM, V290, P18124, DOI 10.1074/jbc.M115.645549; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Hoss F, 2018, METHODS MOL BIOL, V1714, P149, DOI 10.1007/978-1-4939-7519-8_10; Juliana C, 2012, J BIOL CHEM, V287, P36617, DOI 10.1074/jbc.M112.407130; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Lee GS, 2012, NATURE, V492, P123, DOI 10.1038/nature11588; Li RD, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/3798465; Malhotra S, 2015, BRAIN, V138, P644, DOI 10.1093/brain/awu388; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Mishra BB, 2013, NAT IMMUNOL, V14, P52, DOI 10.1038/ni.2474; Neudecker V, 2017, J EXP MED, V214, P1737, DOI 10.1084/jem.20160462; Py BF, 2013, MOL CELL, V49, P331, DOI 10.1016/j.molcel.2012.11.009; Qiu Y, 2019, DRUG DES DEV THER, V13, P739, DOI 10.2147/DDDT.S188654; Sandall CF, 2019, ARCH BIOCHEM BIOPHYS, V670, P43, DOI 10.1016/j.abb.2019.02.020; Serhan CN, 2009, J EXP MED, V206, P15, DOI 10.1084/jem.20081880; Sharma D, 2016, J CELL BIOL, V213, P617, DOI 10.1083/jcb.201602089; Shi CS, 2012, NAT IMMUNOL, V13, P255, DOI 10.1038/ni.2215; Song H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13727; Song NS, 2018, BIOCHEM PHARMACOL, V150, P243, DOI 10.1016/j.bcp.2018.02.009; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Wan P, 2019, FASEB J, V33, P5793, DOI 10.1096/fj.201801681R; Yan YQ, 2015, CELL, V160, P62, DOI 10.1016/j.cell.2014.11.047; Yan YQ, 2013, IMMUNITY, V38, P1154, DOI 10.1016/j.immuni.2013.05.015; Yang T, 2019, BRIT J ANAESTH, V122, P350, DOI 10.1016/j.bja.2018.10.062; Zamani P, 2020, PROG BIOPHYS MOL BIO, V150, P50, DOI 10.1016/j.pbiomolbio.2019.05.004; Zhang J, 2017, COMPOS COMMUN, V4, P1, DOI 10.1016/j.coco.2017.02.005; Zhong YJ, 2020, MOL IMMUNOL, V122, P80, DOI 10.1016/j.molimm.2020.03.020; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	42	7	8	5	23	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					11944	11956		10.1096/fj.202000665RR	http://dx.doi.org/10.1096/fj.202000665RR		JUL 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32667092	Bronze			2022-12-28	WOS:000553018500001
J	Su, CC; Ho, WT; Peng, FT; Gao, CM; Jou, TS; Wang, IJ				Su, Chien-Chia; Ho, Wei-Ting; Peng, Fu-Ti; Gao, Chia-Mao; Jou, Tzuu-Shuh; Wang, I-Jong			Exploring a peptidomimetic approach of N-cadherin in modulating fibroblast growth factor receptor signaling for corneal endothelial regeneration	FASEB JOURNAL			English	Article						basic fibroblast growth factor; endothelial mesenchymal transition; FGFR; N-cadherin; beta-catenin	EPITHELIAL-MESENCHYMAL TRANSITION; BETA-CATENIN; MATRIX METALLOPROTEINASE-2; NEURITE OUTGROWTH; CELL ADHESION; CLEAVAGE; PROLIFERATION; EXPRESSION; CAM; PHOSPHORYLATION	Endothelial rejection and a critical shortage of corneal transplants present an unmet medical need in corneal regeneration research area. Although basic fibroblast growth factor (bFGF) is a potent mitogenic factor for corneal ex vivo expansion, it is also a morphogen eliciting unfavorable endothelial-mesenchymal transition (EnMT) of corneal endothelial cells. A pharmacological reagent that retains the beneficial proliferative effect while lacking the EnMT effect of bFGF would be of great potential in corneal regeneration. In present study, we demonstrated that bFGF not only activated the canonical fibroblast growth factor receptor 1 (FGFR1) tyrosine kinase pathway, but also further upregulated matrix metalloproteinase activity to cleave N-cadherin into N-terminus and C-terminus fragments, which activated the classical FGFR1 tyrosine kinase pathway and a cryptic beta-catenin pathway to affect corneal proliferation and EnMT, respectively. We generated the synthetic peptides resembling a critical motif in the ectodomain of N-cadherin and found these peptides enhanced downstream proliferative signaling of FGFR1 but without seemingly EnMT effect. The potential of these peptides can be demonstrated on both ex vivo cell culture and in vivo rat cryo-injury model. Our study indicated this peptidomimetic approach of N-cadherin can stimulate corneal regeneration and offer a promising therapeutic option to treat corneal endothelial dysfunction.	[Su, Chien-Chia; Peng, Fu-Ti; Gao, Chia-Mao; Wang, I-Jong] Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei, Taiwan; [Su, Chien-Chia; Jou, Tzuu-Shuh; Wang, I-Jong] Natl Taiwan Univ, Inst Clin Med, Taipei, Taiwan; [Su, Chien-Chia; Jou, Tzuu-Shuh; Wang, I-Jong] Natl Taiwan Univ, Coll Med, Taipei, Taiwan; [Ho, Wei-Ting] Far Eastern Mem Hosp, Dept Ophthalmol, New Taipei, Taiwan; [Jou, Tzuu-Shuh] Natl Taiwan Univ, Coll Med, Ctr Precis Med, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; Far Eastern Memorial Hospital; National Taiwan University	Jou, TS; Wang, IJ (corresponding author), Natl Taiwan Univ, Inst Clin Med, Taipei, Taiwan.	jouts@ntu.edu.tw; ijong@ms8.hinet.net		Wang, I-Jong/0000-0002-3045-0614; Su, Chien-Chia/0000-0002-9220-7599; JOU, TZUU-SHUH/0000-0003-4341-5137	Ministry of Science and Technology, Taiwan (MOST) [107-3017-F-002-002, 105-2314-B-002-033, 106-2314-B-002-130-MY3, 106-2314-B-002-124-MY3]; National Taiwan University Hospital (NTUH) [103-CGN12, 106-S3502, 106-N3680, 107-M4045, 107-A140]	Ministry of Science and Technology, Taiwan (MOST)(Ministry of Science and Technology, Taiwan); National Taiwan University Hospital (NTUH)	Ministry of Science and Technology, Taiwan (MOST), Grant/Award Number: 107-3017-F-002-002, 105-2314-B-002-033, 106-2314-B-002-130-MY3 and 106-2314-B-002-124-MY3; National Taiwan University Hospital (NTUH), Grant/ Award Number: 103-CGN12, 106-S3502, 106-N3680, 107-M4045 and 107-A140	Aisagbonhi O, 2011, DIS MODEL MECH, V4, P469, DOI 10.1242/dmm.006510; BATES AK, 1986, CURR EYE RES, V5, P363, DOI 10.3109/02713688609025174; Blake DA, 1997, INVEST OPHTH VIS SCI, V38, P1119; Cavallaro U, 2001, NAT CELL BIOL, V3, P650, DOI 10.1038/35083041; Derycke L, 2006, CLIN EXP METASTAS, V23, P187, DOI 10.1007/s10585-006-9029-7; Doherty P, 1996, MOL CELL NEUROSCI, V8, P99, DOI 10.1006/mcne.1996.0049; Doherty P, 2000, MOL CELL NEUROSCI, V16, P283, DOI 10.1006/mcne.2000.0907; Dwivedi A, 2009, CARDIOVASC RES, V81, P178, DOI 10.1093/cvr/cvn278; ENGELMANN K, 1988, INVEST OPHTH VIS SCI, V29, P1656; Eto H, 2012, LAB INVEST, V92, P214, DOI 10.1038/labinvest.2011.127; Gao H, 2011, MOL VIS, V17, P3406; Hartland SN, 2009, LIVER INT, V29, P966, DOI 10.1111/j.1478-3231.2009.02070.x; Ho WT, 2015, AM J PATHOL, V185, P2158, DOI 10.1016/j.ajpath.2015.04.005; HOFFER KJ, 1979, AM J OPHTHALMOL, V87, P252, DOI 10.1016/0002-9394(79)90156-9; Holnthoner W, 2006, BIOCHEM BIOPH RES CO, V342, P725, DOI 10.1016/j.bbrc.2006.02.011; Hoppenreijs VPT, 1996, SURV OPHTHALMOL, V41, P155, DOI 10.1016/S0039-6257(96)80005-1; Hsu CC, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2846-4; Kohutek ZA, 2009, J NEUROSCI, V29, P4605, DOI 10.1523/JNEUROSCI.5126-08.2009; Lee HT, 2004, J BIOL CHEM, V279, P32325, DOI 10.1074/jbc.M405208200; Lee HT, 2003, MOL VIS, V9, P624; Lee HT, 2003, INVEST OPHTH VIS SCI, V44, P1521, DOI 10.1167/iovs.02-0637; Lee JG, 2006, EXP EYE RES, V83, P1309, DOI 10.1016/j.exer.2006.04.007; Lee JG, 2011, INVEST OPHTH VIS SCI, V52, P8216, DOI 10.1167/iovs.11-8213; LIAW CW, 1990, EMBO J, V9, P2701, DOI 10.1002/j.1460-2075.1990.tb07456.x; Marambaud P, 2003, CELL, V114, P635, DOI 10.1016/j.cell.2003.08.008; MAURICE DM, 1972, J PHYSIOL-LONDON, V221, P43, DOI 10.1113/jphysiol.1972.sp009737; Miyamoto Takeshi, 2010, Cornea, V29 Suppl 1, pS52; Mohammadi M, 1998, EMBO J, V17, P5896, DOI 10.1093/emboj/17.20.5896; Niessen CM, 2011, PHYSIOL REV, V91, P691, DOI 10.1152/physrev.00004.2010; Nistico P, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011908; Okabe T, 2003, J BIOL CHEM, V278, P9920, DOI 10.1074/jbc.M208872200; Onguchi T, 2009, AM J PATHOL, V174, P1564, DOI 10.2353/ajpath.2009.080452; Orlichenko LS, 2008, CLIN EXP METASTAS, V25, P593, DOI 10.1007/s10585-008-9143-9; Peh GSL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028310; Peh GSL, 2011, TRANSPLANTATION, V91, P811, DOI 10.1097/TP.0b013e3182111f01; Radisky ES, 2010, J MAMMARY GLAND BIOL, V15, P201, DOI 10.1007/s10911-010-9177-x; Reiss K, 2005, EMBO J, V24, P742, DOI 10.1038/sj.emboj.7600548; RIECK P, 1995, EXP CELL RES, V220, P36, DOI 10.1006/excr.1995.1289; Roy O, 2015, INVEST OPHTH VIS SCI, V56, P1228, DOI 10.1167/iovs.14-16166; Sapienza P, 2004, EUR J VASC ENDOVASC, V28, P89, DOI 10.1016/j.ejvs.2004.02.022; Shoval I, 2007, DEVELOPMENT, V134, P491, DOI 10.1242/dev.02742; Su CC, 2015, MOL VIS, V21, P633; Suyama K, 2002, CANCER CELL, V2, P301, DOI 10.1016/S1535-6108(02)00150-2; Uemura K, 2006, BIOCHEM BIOPH RES CO, V345, P951, DOI 10.1016/j.bbrc.2006.04.157; Uria JA, 1998, AM J PATHOL, V153, P91, DOI 10.1016/S0002-9440(10)65549-6; Utton MA, 2001, J NEUROCHEM, V76, P1421, DOI 10.1046/j.1471-4159.2001.00140.x; WILLIAMS EJ, 1994, NEURON, V13, P583, DOI 10.1016/0896-6273(94)90027-2; Williams EJ, 2001, J BIOL CHEM, V276, P43879, DOI 10.1074/jbc.M105876200; Williams H, 2010, CARDIOVASC RES, V87, P137, DOI 10.1093/cvr/cvq042; Wu M, 2014, J CELL BIOCHEM, V115, P1692, DOI 10.1002/jcb.24832; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Zhang J, 2015, EXP EYE RES, V130, P97, DOI 10.1016/j.exer.2014.10.023; Zhao Y, 2016, BMC CELL BIOL, V17, DOI 10.1186/s12860-016-0101-0; Zhu YT, 2008, INVEST OPHTH VIS SCI, V49, P3879, DOI 10.1167/iovs.08-1693	54	2	2	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					11698	11713		10.1096/fj.201902525RR	http://dx.doi.org/10.1096/fj.201902525RR		JUL 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32654299	Bronze			2022-12-28	WOS:000549273200001
J	Ozbaki-Yagan, N; Liu, XN; Bodnar, AJ; Ho, J; Butterworth, MB				Ozbaki-Yagan, Nejla; Liu, Xiaoning; Bodnar, Andrew J.; Ho, Jacqueline; Butterworth, Michael Bruce			Aldosterone-induced microRNAs act as feedback regulators of mineralocorticoid receptor signaling in kidney epithelia	FASEB JOURNAL			English	Article						steroid hormone; mineralocorticoid receptor; kidney collecting duct; epithelial sodium channel	CARDIOVASCULAR-DISEASE; SODIUM-TRANSPORT; COLLECTING DUCT; DISTINCT ROLES; BLOOD-PRESSURE; HYPERTENSION; BIOGENESIS; SYSTEM; SGK1; PHOSPHORYLATION	The final steps in the Renin-Angiotensin-Aldosterone signaling System (RAAS) involve binding of the corticosteroid hormone, aldosterone to its mineralocorticoid receptor (MR). The bound MR interacts with response elements to induce or repress the transcription of aldosterone-regulated genes. A well characterized aldosterone-induced gene is the serum and glucocorticoid-induced kinase (SGK1), which acts downstream to increase sodium transport in distal kidney nephron epithelial cells. The role of microRNAs (miRs) induced by extended aldosterone stimulation in regulating MR and SGK1 has not been reported. In these studies, miRs predicted to bind to the 3MODIFIER LETTER PRIME-UTR of mouse MR were profiled by qRT-PCR after aldosterone stimulation. The miR-466a/b/c/e family was upregulated in mouse kidney cortical collecting duct epithelial cells. A luciferase reporter assay confirmed miR-466 binding to both MR and SGK1 3MODIFIER LETTER PRIME-UTRs. Inhibition of miR-466 increased MR and SGK1 mRNA and protein levels. Inhibiting miR-466b and preventing its upregulation after aldosterone stimulation increased amiloride-sensitive sodium transport and sensitivity to aldosterone stimulation. In vivo upregulation of miR-466 was confirmed in distal nephrons of mice on low Na(+)diets. Repression of MR and SGK1 by aldosterone-induced miRs may represent a negative feedback loop that contributes to a form of aldosterone escape in vivo.	[Ozbaki-Yagan, Nejla; Liu, Xiaoning; Butterworth, Michael Bruce] Univ Pittsburgh, Dept Cell Biol, Pittsburgh, PA USA; [Bodnar, Andrew J.; Ho, Jacqueline] Univ Pittsburgh, Dept Pediat, Div Nephrol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Butterworth, MB (corresponding author), Univ Pittsburgh, Sch Med, Dept Cell Biol, S314 BST,200 Lothrop St, Pittsburgh, PA 15261 USA.	michael7@pitt.edu	Ho, Jackie/AAP-1531-2021	Ho, Jackie/0000-0001-7115-1381	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [DK102843, DK103776]	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Grant/Award Number: DK102843 and DK103776	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Antes LM, 1998, SEMIN NEPHROL, V18, P31; Baluta Monica, 2004, Rom J Intern Med, V42, P277; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Batkai S, 2012, CURR HYPERTENS REP, V14, P79, DOI 10.1007/s11906-011-0235-6; Berger S, 2000, KIDNEY INT, V57, P1295, DOI 10.1046/j.1523-1755.2000.00965.x; Breving K, 2010, INT J BIOCHEM CELL B, V42, P1316, DOI 10.1016/j.biocel.2009.09.016; Briet M, 2010, NAT REV NEPHROL, V6, P261, DOI 10.1038/nrneph.2010.30; Butterworth MB, 2019, VITAM HORM, V109, P69, DOI 10.1016/bs.vh.2018.09.002; Butterworth MB, 2018, CURR OPIN NEPHROL HY, V27, P390, DOI 10.1097/MNH.0000000000000440; Butterworth MB, 2015, AM J PHYSIOL-CELL PH, V308, pC521, DOI 10.1152/ajpcell.00026.2015; Chen LJ, 2015, INT J HYPERTENS, V2015, DOI 10.1155/2015/896861; Chrysant SG, 2010, AM J CARDIOVASC DRUG, V10, P315, DOI 10.2165/11538850-000000000-00000; Chua JH, 2009, CURR OPIN MOL THER, V11, P189; Coccheri S, 2007, DRUGS, V67, P997, DOI 10.2165/00003495-200767070-00005; de Seigneux S, 2008, J BIOL CHEM, V283, P25671, DOI 10.1074/jbc.M803812200; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; Edinger RS, 2014, J AM SOC NEPHROL, V25, P2445, DOI 10.1681/ASN.2013090931; Edinger RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046593; Engeli S, 2006, CONTRIB NEPHROL, V151, P122, DOI 10.1159/000095324; Faresse N, 2012, FASEB J, V26, P4373, DOI 10.1096/fj.12-209924; Fejes-Toth G, 1998, P NATL ACAD SCI USA, V95, P2973, DOI 10.1073/pnas.95.6.2973; Felmeden D C, 2000, J Renin Angiotensin Aldosterone Syst, V1, P240, DOI 10.3317/jraas.2000.036; Fitzgerald MA, 2011, J AM ACAD NURSE PRAC, V23, P239, DOI 10.1111/j.1745-7599.2010.00589.x; Forstemann K, 2007, CELL, V130, P287, DOI 10.1016/j.cell.2007.05.056; Grad Y, 2003, MOL CELL, V11, P1253, DOI 10.1016/S1097-2765(03)00153-9; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Hattangady NG, 2012, MOL CELL ENDOCRINOL, V350, P151, DOI 10.1016/j.mce.2011.07.034; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Ilatovskaya DV, 2019, EBIOMEDICINE, V40, P663, DOI 10.1016/j.ebiom.2019.01.006; Ismail H, 2010, CURR DIABETES REP, V10, P32, DOI 10.1007/s11892-009-0081-y; Jacobs ME, 2016, AM J PHYSIOL-RENAL, V310, pF1251, DOI 10.1152/ajprenal.00024.2016; Jansen PM, 2009, J HYPERTENS, V27, P680, DOI 10.1097/HJH.0b013e32832810ed; Jaskiewicz L, 2008, CURR TOP MICROBIOL, V320, P77; Jiang F, 2005, GENE DEV, V19, P1674, DOI 10.1101/gad.1334005; Kim VN, 2005, MOL CELLS, V19, P1; Kim YK, 2007, EMBO J, V26, P775, DOI 10.1038/sj.emboj.7601512; Komukai K, 2010, FUND CLIN PHARMACOL, V24, P687, DOI 10.1111/j.1472-8206.2010.00854.x; Lakkis J, 2003, CURR HYPERTENS REP, V5, P408, DOI 10.1007/s11906-003-0087-9; Lang F, 2014, NEPHRON PHYSIOL, V128, P1, DOI 10.1159/000368263; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Lin DH, 2014, AM J PHYSIOL-RENAL, V306, pF53, DOI 10.1152/ajprenal.00349.2013; Liu XN, 2017, J CELL PHYSIOL, V232, P1306, DOI 10.1002/jcp.25599; Liu XH, 2012, MOL CELL, V46, P507, DOI 10.1016/j.molcel.2012.03.010; Luo Y, 2014, BBA-GENE REGUL MECH, V1839, P97, DOI 10.1016/j.bbagrm.2013.12.005; Meneton P, 2000, J AM SOC NEPHROL, V11, pS135; Monticone S, 2018, LANCET DIABETES ENDO, V6, P41, DOI 10.1016/S2213-8587(17)30319-4; Nogueira EF, 2009, MOL CELL ENDOCRINOL, V302, P230, DOI 10.1016/j.mce.2008.08.024; Nossent AY, 2011, AM J HYPERTENS, V24, P999, DOI 10.1038/ajh.2011.92; Ohno Y, 2018, HYPERTENSION, V71, P530, DOI 10.1161/HYPERTENSIONAHA.117.10263; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Ouar Z, 1998, KIDNEY INT, V53, P59, DOI 10.1046/j.1523-1755.1998.00721.x; Pacurari M, 2015, INT J INFLAMM, V2015, DOI 10.1155/2015/101527; Papademetriou V, 2009, AM HEART J, V157, pS24, DOI 10.1016/j.ahj.2009.04.006; Parreira RC, 2017, CLIN SCI, V131, P2813, DOI 10.1042/CS20171398; Poulsen SB, 2018, PHYSIOL GENOMICS, V50, P343, DOI 10.1152/physiolgenomics.00084.2017; Rayner B, 2008, J CLIN PATHOL, V61, P825, DOI 10.1136/jcp.2007.053264; Rossi GP, 2008, TRENDS ENDOCRIN MET, V19, P88, DOI 10.1016/j.tem.2008.01.006; Sciarretta S, 2009, CLIN SCI, V116, P467, DOI 10.1042/CS20080390; Shibata S, 2013, CELL METAB, V18, P660, DOI 10.1016/j.cmet.2013.10.005; Sokol SI, 2004, NEUROLOGY, V63, P208, DOI 10.1212/01.WNL.0000130360.21618.D0; Sontheimer EJ, 2004, SCIENCE, V305, P1409, DOI 10.1126/science.1103076; Sowers JR, 2009, ANN INTERN MED, V150, P776, DOI 10.7326/0003-4819-150-11-200906020-00005; Spat A, 2004, PHYSIOL REV, V84, P489, DOI 10.1152/physrev.00030.2003; Strazzullo P, 2003, HYPERTENSION, V41, P1000, DOI 10.1161/01.HYP.0000066844.63035.3A; Tang GL, 2005, TRENDS BIOCHEM SCI, V30, P106, DOI 10.1016/j.tibs.2004.12.007; Tomaschitz A, 2010, NAT REV ENDOCRINOL, V6, P83, DOI 10.1038/nrendo.2009.263; Trionfini P, 2015, NAT REV NEPHROL, V11, P23, DOI 10.1038/nrneph.2014.202; Vallon V, 2005, AM J PHYSIOL-REG I, V288, pR4, DOI 10.1152/ajpregu.00369.2004; Verrey F, 2003, CELL PHYSIOL BIOCHEM, V13, P21, DOI 10.1159/000070246; Verrey F, 2000, KIDNEY INT, V57, P1277, DOI 10.1046/j.1523-1755.2000.00962.x; Vijayaraghavan K, 2011, CARDIOL CLIN, V29, P137, DOI 10.1016/j.ccl.2010.11.003; Volpe M, 2010, J CLIN HYPERTENS, V12, P277, DOI 10.1111/j.1751-7176.2009.00253.x; Willenberg HS, 2008, HORM METAB RES, V40, P435, DOI 10.1055/s-2008-1065336; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Wong N, 2015, NUCLEIC ACIDS RES, V43, pD146, DOI 10.1093/nar/gku1104; Wulff P, 2002, J CLIN INVEST, V110, P1263, DOI 10.1172/JCI200215696	83	8	8	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					11714	11728		10.1096/fj.201902254RR	http://dx.doi.org/10.1096/fj.201902254RR		JUL 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32652691	Green Accepted, Bronze			2022-12-28	WOS:000548009500001
J	Anoz-Carbonell, E; Rivero, M; Polo, V; Velazquez-Campoy, A; Medina, M				Anoz-Carbonell, Ernesto; Rivero, Maribel; Polo, Victor; Velazquez-Campoy, Adrian; Medina, Milagros			Human riboflavin kinase: Species-specific traits in the biosynthesis of the FMN cofactor	FASEB JOURNAL			English	Article						calorimetry; kinetics limiting step; ligand binding and cooperativity; pre-steady-state kinetics; product inhibition; riboflavin kinase; therapeutic target	FAD SYNTHETASE; ANTIBIOTICS ROSEOFLAVIN; CRYSTAL-STRUCTURE; LIGAND-BINDING; FLAVOKINASE; CYCLE; METABOLISM; PROTEINS; FEATURES; REVEALS	Human riboflavin kinase (HsRFK) catalyzes vitamin B-2(riboflavin) phosphorylation to flavin mononucleotide (FMN), obligatory step in flavin cofactor synthesis.HsRFK expression is related to protection from oxidative stress, amyloid-beta toxicity, and some malignant cancers progression. Its downregulation alters expression profiles of clock-controlled metabolic-genes and destroys flavins protection on stroke treatments, while its activity reduction links to protein-energy malnutrition and thyroid hormones decrease. We explored specific features of the mechanisms underlying the regulation ofHsRFK activity, showing that both reaction products regulate it through competitive inhibition. Fast-kinetic studies show that despiteHsRFK binds faster and preferably the reaction substrates, the complex holding both products is kinetically most stable. An intricate ligand binding landscape with all combinations of substrates/products competing with the catalytic complex and exhibiting moderate cooperativity is also presented. These data might contribute to better understanding the molecular bases of pathologies coursing with aberrantHsRFK availability, and envisage that interaction with its client-apoproteins might favor FMN release. Finally,HsRFK parameters differ from those of the so far evaluated bacterial counterparts, reinforcing the idea of species-specific mechanisms in RFK catalysis. These observations supportHsRFK as potential therapeutic target because of its key functions, while also envisage bacterial RFK modules as potential antimicrobial targets.	[Anoz-Carbonell, Ernesto; Rivero, Maribel; Velazquez-Campoy, Adrian; Medina, Milagros] Univ Zaragoza, Fac Ciencias, Dept Bioquim & Biol Mol & Celular, Pedro Cerbuna 12, E-50009 Zaragoza, Spain; [Anoz-Carbonell, Ernesto; Polo, Victor; Velazquez-Campoy, Adrian; Medina, Milagros] Univ Zaragoza, Inst Biocomputac & Fis Sistemas Complejos, GBsC CSIC & BIFI IQFR Joint Units, Zaragoza, Spain; [Polo, Victor] Univ Zaragoza, Dept Quim Fis, Zaragoza, Spain; [Velazquez-Campoy, Adrian] Fdn ARAID, Diputac Gen Aragon, Zaragoza, Spain; [Velazquez-Campoy, Adrian] Aragon Inst Hlth Res IIS Aragon, Zaragoza, Spain; [Velazquez-Campoy, Adrian] Biomed Res Networking Ctr Liver & Digest Dis CIBE, Madrid, Spain	University of Zaragoza; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); University of Zaragoza; University of Zaragoza; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD	Medina, M (corresponding author), Univ Zaragoza, Fac Ciencias, Dept Bioquim & Biol Mol & Celular, Pedro Cerbuna 12, E-50009 Zaragoza, Spain.	mmedina@unizar.es	Medina, Milagros/F-8310-2012; Velazquez-Campoy, Adrian/E-7946-2012	Medina, Milagros/0000-0001-8743-0182; Velazquez-Campoy, Adrian/0000-0001-5702-4538; Anoz-Carbonell, Ernesto/0000-0002-6649-9153; /0000-0001-5823-7965	Spanish Ministry of Economy, Industry and Competitiveness [BIO2016-75183-P]; Spanish Ministry of Science and Innovation [PID2019-103901GB-I00]; Government of AragonFEDER [E35_20R]	Spanish Ministry of Economy, Industry and Competitiveness(Spanish Government); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Government of AragonFEDER	Spanish Ministry of Economy, Industry and Competitiveness, Grant/Award Number: BIO2016-75183-P AEI/FEDER; Spanish Ministry of Science and Innovation, Grant/Award Number: PID2019-103901GB-I00 AEI/FEDER; Government of AragonFEDER, Grant/Award Number: E35_20R	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Barile M, 2000, EUR J BIOCHEM, V267, P4888, DOI 10.1046/j.1432-1327.2000.01552.x; Barile M, 2016, J INHERIT METAB DIS, V39, P545, DOI 10.1007/s10545-016-9950-0; Barile M, 2013, CURR PHARM DESIGN, V19, P2649, DOI 10.2174/1381612811319140014; Bauer S, 2003, J MOL BIOL, V326, P1463, DOI 10.1016/S0022-2836(03)00059-7; Bollen YJM, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2010; Capo-chichi CD, 1999, AM J CLIN NUTR, V69, P672; Capo-chichi CD, 2000, AM J CLIN NUTR, V71, P978; Chen X, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14525-4; DeLano W.L., 2002, CCP4 NEWSL PROTEIN C, V40, P82; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Frago S, 2009, J BIOL CHEM, V284, P6610, DOI 10.1074/jbc.M808142200; Giancaspero TA, 2015, FRONT CHEM, V3, DOI 10.3389/fchem.2015.00030; Herguedas B, 2015, ACTA CRYSTALLOGR D, V71, P2526, DOI 10.1107/S1399004715019641; Herguedas B, 2010, J MOL BIOL, V400, P218, DOI 10.1016/j.jmb.2010.05.018; Hirano A, 2017, CELL REP, V19, P255, DOI 10.1016/j.celrep.2017.03.041; Hirano G, 2011, INT J ONCOL, V38, P893, DOI 10.3892/ijo.2011.938; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jin C, 2017, BIOL PHARM BULL, V40, P1990, DOI 10.1248/bpb.b17-00292; Karthikeyan S, 2003, BIOCHEMISTRY-US, V42, P12532, DOI 10.1021/bi035450t; Karthikeyan S, 2003, STRUCTURE, V11, P265, DOI 10.1016/S0969-2126(03)00024-8; Lans I, 2018, BIOPHYS J, V115, P988, DOI 10.1016/j.bpj.2018.08.011; LEE SS, 1985, ARCH BIOCHEM BIOPHYS, V237, P197, DOI 10.1016/0003-9861(85)90269-3; LEE SS, 1983, J NUTR, V113, P2274, DOI 10.1093/jn/113.11.2274; Lienhart WD, 2013, ARCH BIOCHEM BIOPHYS, V535, P150, DOI 10.1016/j.abb.2013.02.015; Marcuello C, 2013, BBA-PROTEINS PROTEOM, V1834, P665, DOI 10.1016/j.bbapap.2012.12.013; Martinez-Julvez M, 2012, METHODS MOL BIOL, V796, P53, DOI [10.1007/978-1-61779-334-9_4, 10.1590/2236-463320120403]; Martinez-Julvez M, 2009, BIOPHYS J, V96, P4966, DOI 10.1016/j.bpj.2009.02.061; Matern A, 2016, J BACTERIOL, V198, P3233, DOI 10.1128/JB.00388-16; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Patel MV, 2020, ENZYME MICROB TECH, V133, DOI 10.1016/j.enzmictec.2019.109455; Pedrolli DB, 2011, BIOCHEM PHARMACOL, V82, P1853, DOI 10.1016/j.bcp.2011.08.029; Sebastian M, 2019, J MOL BIOL, V431, P2762, DOI 10.1016/j.jmb.2019.05.029; Sebastian M, 2018, J ENZYM INHIB MED CH, V33, P842, DOI 10.1080/14756366.2018.1461857; Sebastian M, 2017, J ENZYM INHIB MED CH, V33, P241, DOI 10.1080/14756366.2017.1411910; Sebastian M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07716-5; Sebastian M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07875-5; Serrano A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00402-6; Serrano A, 2013, CURR PHARM DESIGN, V19, P2637, DOI 10.2174/1381612811319140013; Serrano A, 2013, CELL BIOCHEM BIOPHYS, V65, P57, DOI 10.1007/s12013-012-9403-9; Solovieva IM, 2003, BIOCHEMISTRY-MOSCOW+, V68, P177, DOI 10.1023/A:1022645327972; Torchetti EM, 2011, FEBS J, V278, P4435, DOI 10.1111/j.1742-4658.2011.08368.x; Vega S, 2015, METHODS, V76, P99, DOI 10.1016/j.ymeth.2014.09.010; Velazquez-Campoy A, 2006, BIOPHYS J, V91, P1887, DOI 10.1529/biophysj.106.086561; Vogt AD, 2012, BIOCHEMISTRY-US, V51, P5894, DOI 10.1021/bi3006913; Walsh CT, 2013, NAT PROD REP, V30, P175, DOI 10.1039/c2np20069d; YAMADA Y, 1990, ARCH BIOCHEM BIOPHYS, V278, P125, DOI 10.1016/0003-9861(90)90240-Y; Yazdanpanah B, 2009, NATURE, V460, P1159, DOI 10.1038/nature08206; Yruela I, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-311; Zou YX, 2012, CNS NEUROSCI THER, V18, P834, DOI 10.1111/j.1755-5949.2012.00379.x	50	8	8	0	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10871	10886		10.1096/fj.202000566R	http://dx.doi.org/10.1096/fj.202000566R		JUL 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32649804	Bronze, Green Published			2022-12-28	WOS:000547915300001
J	Niu, LZ; Zheng, ZW; Xue, QJ; Cheng, HJ; Liu, Y; Wang, HL; Hu, XY; Zhang, AN, AN; Liu, B; Xu, XW				Niu, Lizhu; Zheng, Zhiwei; Xue, Qianjing; Cheng, Huijun; Liu, Ying; Wang, Huanling; Hu, Xueying; Zhang, Anding; Liu, Bang; Xu, Xuewen			Two coupled mutations abolished the binding of CEBPB to the promoter of CXCL14 that displayed an antiviral effect on PRRSV by activating IFN signaling	FASEB JOURNAL			English	Article						antiviral; CEBPB; CXCL14; interferon; PRRSV	RESPIRATORY SYNDROME VIRUS; GENE-EXPRESSION; CHEMOKINE CXCL14; HOST RESPONSE; IN-VITRO; CELL; IL-10; BRAK; BRAK/CXCL14; INFECTION	Porcine reproductive and respiratory syndrome (PRRS) is the most economically important infectious disease of pigs worldwide. Our previous study revealed that Tongcheng (TC) pigs display higher resistance to PRRS than Largewhite (LW) pigs, but the genetic mechanism remains unknown. Here, we first confirmed that CXCL14 was downregulated in lungs and porcine alveolar macrophages (PAMs) responding to PRRS virus (PRRSV) infection, but the decline in LW pigs was more obvious than that in TC pigs. Then, we found that the overexpression of CXCL14 activated type-I interferon (IFN-I) signaling by upregulating interferon beta (IFNB), which plays a major role in the antiviral effect. To further decipher the mechanism underlying its differential expression, we characterized the core promoter of CXCL14 as being located from -145 to 276 bp of the transcription start site (TSS) and identified two main haplotypes that displayed significant differential transcriptional activities. We further identified two coupled point mutations that altered the binding status of CEBPB and were responsible for the differential expression in TC and LW pigs. The regulatory effect of CEBPB on CXCL14 was further confirmed by RNA interference (RNAi) and chromatin immunoprecipitation (ChIP), providing crucial clues for deciphering the mechanism of CXCL14 downregulation in unusual conditions. The present study revealed the potential antiviral effect of CXCL14, occurring via activation of interferon signaling, and suggested that CXCL14 contributes to the PRRS resistance of TC pigs.	[Niu, Lizhu; Zheng, Zhiwei; Xue, Qianjing; Cheng, Huijun; Liu, Ying; Wang, Huanling; Liu, Bang; Xu, Xuewen] Huazhong Agr Univ, Minist Educ, Key Lab Agr Anim Genet Breeding & Reprod, Wuhan 430070, Peoples R China; [Niu, Lizhu; Zheng, Zhiwei; Xue, Qianjing; Cheng, Huijun; Liu, Ying; Wang, Huanling; Liu, Bang; Xu, Xuewen] Huazhong Agr Univ, Coll Anim Sci & Technol, Wuhan 430070, Peoples R China; [Niu, Lizhu; Zheng, Zhiwei; Xue, Qianjing; Liu, Ying; Hu, Xueying; Zhang, Anding; Liu, Bang; Xu, Xuewen] Cooperat Innovat Ctr Sustainable Pig Prod, Wuhan, Peoples R China; [Niu, Lizhu; Wang, Huanling] Huazhong Agr Univ, Coll Fishery, Key Lab Freshwater Anim Breeding, Wuhan, Peoples R China; [Liu, Bang; Xu, Xuewen] Minist Agr & Rural Affairs, Key Lab Swine Genet & Breeding, Wuhan, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University; Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs	Xu, XW (corresponding author), Huazhong Agr Univ, Minist Educ, Key Lab Agr Anim Genet Breeding & Reprod, Wuhan 430070, Peoples R China.; Xu, XW (corresponding author), Huazhong Agr Univ, Coll Anim Sci & Technol, Wuhan 430070, Peoples R China.	xuewen_xu@mail.hzau.edu.cn			National Natural Science Foundation of China (NSFC) [31930104, 31872326]; NSFC \ Young Scientists Fund [31601920]; National Key Technology RD Program [2015BAD03B02]; Fundamental Research Funds for the central Universities [2662015QC039]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NSFC \ Young Scientists Fund(National Natural Science Foundation of China (NSFC)); National Key Technology RD Program(National Key Technology R&D Program); Fundamental Research Funds for the central Universities(Fundamental Research Funds for the Central Universities)	National Natural Science Foundation of China (NSFC), Grant/Award Number: 31930104; National Natural Science Foundation of China (NSFC), Grant/Award Number: 31872326; NSFC vertical bar Young Scientists Fund, Grant/Award Number: 31601920; National Key Technology R&D Program, Grant/Award Number: 2015BAD03B02; Fundamental Research Funds for the central Universities, Grant/Award Number: 2662015QC039	Akdis CA, 2001, IMMUNOLOGY, V103, P131, DOI 10.1046/j.1365-2567.2001.01235.x; Albina E, 1998, J INTERF CYTOK RES, V18, P485, DOI 10.1089/jir.1998.18.485; Alejo A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04098-8; Banisadr G, 2011, J NEUROCHEM, V119, P1173, DOI 10.1111/j.1471-4159.2011.07509.x; Boddicker N, 2012, J ANIM SCI, V90, P1733, DOI 10.2527/jas.2011-4464; Boddicker NJ, 2014, ANIM GENET, V45, P48, DOI 10.1111/age.12079; Cain DW, 2013, J IMMUNOL, V191, P4665, DOI 10.4049/jimmunol.1300581; Cao XT, 2000, J IMMUNOL, V165, P2588, DOI 10.4049/jimmunol.165.5.2588; Cicchini L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03295-7; Cicchini L, 2016, MBIO, V7, DOI 10.1128/mBio.00270-16; CONZELMANN KK, 1993, VIROLOGY, V193, P329, DOI 10.1006/viro.1993.1129; Dai C, 2015, J IMMUNOL, V194, P5980, DOI 10.4049/jimmunol.1402634; Diaz I, 2006, VIROLOGY, V351, P249, DOI 10.1016/j.virol.2006.03.046; Frick IM, 2011, J IMMUNOL, V187, P4300, DOI 10.4049/jimmunol.1004179; Gutsch R, 2011, J BIOL CHEM, V286, P22716, DOI 10.1074/jbc.M110.152538; Herrero C, 2003, J IMMUNOL, V171, P5034, DOI 10.4049/jimmunol.171.10.5034; Hromas R, 1999, BIOCHEM BIOPH RES CO, V255, P703, DOI 10.1006/bbrc.1999.0257; Hu CY, 2013, INT J ONCOL, V43, P1487, DOI 10.3892/ijo.2013.2078; Hu XY, 2006, IMMUNITY, V24, P563, DOI 10.1016/j.immuni.2006.02.014; Ikoma T, 2012, BIOCHEM BIOPH RES CO, V420, P217, DOI 10.1016/j.bbrc.2012.01.157; Komori R, 2010, BIOMED RES-TOKYO, V31, P123, DOI 10.2220/biomedres.31.123; Kurth I, 2001, J EXP MED, V194, P855, DOI 10.1084/jem.194.6.855; LaMarca HL, 2010, STEM CELLS, V28, P535, DOI 10.1002/stem.297; Lamkin DM, 2019, BRAIN BEHAV IMMUN, V80, P839, DOI 10.1016/j.bbi.2019.05.034; Lande R, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09683-z; Lee E, 2020, TOXICOL APPL PHARM, V386, DOI 10.1016/j.taap.2019.114828; Lee SM, 2004, VET IMMUNOL IMMUNOP, V102, P217, DOI 10.1016/j.vetimm.2004.09.009; Liang W, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071475; Liang W, 2016, VIRUS RES, V215, P84, DOI 10.1016/j.virusres.2016.02.004; Lin KZ, 2014, MOL MED REP, V10, P1561, DOI 10.3892/mmr.2014.2343; Liu YW, 2003, J IMMUNOL, V171, P821, DOI 10.4049/jimmunol.171.2.821; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu J, 2016, J INFLAMM-LOND, V13, DOI 10.1186/s12950-015-0109-9; Lunney JK, 2010, VIRUS RES, V154, P161, DOI 10.1016/j.virusres.2010.08.004; Meuter S, 2008, CYTOKINE, V44, P248, DOI 10.1016/j.cyto.2008.08.009; Nakayama Y, 2019, J CELL PHYSIOL, V234, P11474, DOI 10.1002/jcp.27804; Niu JJ, 2016, ONCOTARGET, V7, P76169, DOI 10.18632/oncotarget.12732; Ojeda AF, 2017, DEV BIOL, V423, P77, DOI 10.1016/j.ydbio.2017.01.008; Overend C, 2007, J GEN VIROL, V88, P925, DOI 10.1099/vir.0.82585-0; Pertea M, 2016, NAT PROTOC, V11, P1650, DOI 10.1038/nprot.2016.095; Ruffell D, 2009, P NATL ACAD SCI USA, V106, P17475, DOI 10.1073/pnas.0908641106; Shirato K, 2004, J MED VIROL, V74, P507, DOI 10.1002/jmv.20205; Shurin GV, 2005, J IMMUNOL, V174, P5490, DOI 10.4049/jimmunol.174.9.5490; Sleeman MA, 2000, INT IMMUNOL, V12, P677, DOI 10.1093/intimm/12.5.677; Starnes T, 2006, EXP HEMATOL, V34, P1101, DOI 10.1016/j.exphem.2006.05.015; Suradhat S, 2003, J GEN VIROL, V84, P453, DOI 10.1099/vir.0.18698-0; TANAKA T, 1995, CELL, V80, P353, DOI 10.1016/0092-8674(95)90418-2; Wang J, 2009, INT IMMUNOL, V21, P227, DOI 10.1093/intimm/dxn143	48	2	2	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					11257	11271		10.1096/fj.202000477R	http://dx.doi.org/10.1096/fj.202000477R		JUL 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32648265	hybrid			2022-12-28	WOS:000547913300001
J	Son, YS; Ki, SJ; Thanavel, R; Kim, JJ; Lee, MO; Kim, J; Jung, CR; Han, TS; Cho, HS; Ryu, CM; Kim, SH; Park, DS; Son, MY				Son, Ye Seul; Ki, Soo Jin; Thanavel, Rajangam; Kim, Jong-Jin; Lee, Mi-Ok; Kim, Janghwan; Jung, Cho-Rok; Han, Tae-Su; Cho, Hyun-Soo; Ryu, Choong-Min; Kim, Sang-Heon; Park, Doo-Sang; Son, Mi-Young			Maturation of human intestinal organoids in vitro facilitates colonization by commensal lactobacilli by reinforcing the mucus layer	FASEB JOURNAL			English	Article						colonization; host-microbe interaction; human intestinal organoid; lactobacilli; microinjection; mucus	ENTERICA SEROVAR TYPHIMURIUM; BARRIER; DISEASE; HOST; MICROBIOME; MODEL; BIFIDOBACTERIA; DISRUPTION; INTEGRITY; HEALTH	Lactobacilli, which are probiotic commensal bacteria that mainly reside in the human small intestine, have attracted attention for their ability to exert health-promoting effects and beneficially modulate host immunity. However, host epithelial-commensal bacterial interactions are still largely unexplored because of limited access to human small intestinal tissues. Recently, we described an in vitro maturation technique for generating adult-like, mature human intestinal organoids (hIOs) from human pluripotent stem cells (hPSCs) that closely resemble the in vivo tissue structure and cellular diversity. Here, we established an in vitro human model to study the response to colonization by commensal bacteria using luminal microinjection into mature hIOs, allowing for the direct examination of epithelial-bacterial interactions.Lactobacillus reuteriandLactobacillus plantarumwere more likely to survive and colonize when microinjected into the lumen of mature hIOs than when injected into immature hIOs, as determined by scanning electron microscopy, colony formation assay, immunofluorescence, and real-time imaging withLplantarumexpressing red fluorescent protein. The improved mature hIO-based host epithelium system resulted from enhanced intestinal epithelial integrity via upregulation of mucus secretion and tight junction proteins. Our study indicates that mature hIOs are a physiologically relevant in vitro model system for studying commensal microorganisms.	[Son, Ye Seul; Ki, Soo Jin; Kim, Jong-Jin; Lee, Mi-Ok; Kim, Janghwan; Jung, Cho-Rok; Han, Tae-Su; Cho, Hyun-Soo; Ryu, Choong-Min; Park, Doo-Sang; Son, Mi-Young] KRIBB, 125 Gwahangno, Daejeon 34141, South Korea; [Son, Ye Seul; Kim, Jong-Jin; Lee, Mi-Ok; Kim, Janghwan; Jung, Cho-Rok; Cho, Hyun-Soo; Ryu, Choong-Min; Park, Doo-Sang; Son, Mi-Young] Korea Univ Sci & Technol UST, KRIBB Sch Biosci, Daejeon, South Korea; [Ki, Soo Jin; Park, Doo-Sang] Korea Res Inst Biosci & Biotechnol, Biol Resource Ctr, Korean Collect Type Cultures, Jeongeup, South Korea; [Thanavel, Rajangam; Kim, Sang-Heon] KIST, Ctr Biomat, Seoul 02792, South Korea; [Kim, Sang-Heon] UST, KIST Sch, Dept Biomed Engn, Daejeon, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of Science & Technology (UST); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Institute of Science & Technology (KIST); Korea Institute of Science & Technology (KIST); University of Science & Technology (UST)	Park, DS; Son, MY (corresponding author), KRIBB, 125 Gwahangno, Daejeon 34141, South Korea.; Kim, SH (corresponding author), KIST, Ctr Biomat, Seoul 02792, South Korea.	skimbrc@kist.re.kr; dspark@kribb.re.kr; myson@kribb.re.kr		, cho-rok/0000-0002-4474-6563	National Research Foundation of Korea (NRF) [NRF-2018M3A9H3023077]; Korea Research Institute of Bioscience and Biotechnology Research Initiative Program; Rural Development Administration (RDA) [PJ015049]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea Research Institute of Bioscience and Biotechnology Research Initiative Program; Rural Development Administration (RDA)(Rural Development Administration (RDA), Republic of Korea)	National Research Foundation of Korea (NRF), Grant/Award Number: NRF-2018M3A9H3023077; Korea Research Institute of Bioscience and Biotechnology Research Initiative Program; Rural Development Administration (RDA), Grant/Award Number: PJ015049	Aurora M, 2016, DEV BIOL, V420, P230, DOI 10.1016/j.ydbio.2016.06.006; Blutt SE, 2018, CELL MOL GASTROENTER, V5, P241, DOI 10.1016/j.jcmgh.2017.12.001; Cannon JP, 2005, EUR J CLIN MICROBIOL, V24, P31, DOI 10.1007/s10096-004-1253-y; Carabotti M, 2015, ANN GASTROENTEROL, V28, P203; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Castillo NA, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-177; Dethlefsen L, 2006, TRENDS ECOL EVOL, V21, P517, DOI 10.1016/j.tree.2006.06.013; Donaldson GP, 2016, NAT REV MICROBIOL, V14, P20, DOI 10.1038/nrmicro3552; Dowarah R, 2017, ANIM NUTR, V3, P1, DOI 10.1016/j.aninu.2016.11.002; Dutta D, 2017, TRENDS MOL MED, V23, P393, DOI 10.1016/j.molmed.2017.02.007; Fasciano AC, 2019, MICROBIOL SPECTR, V7, DOI 10.1128/microbiolspec.BAI-0013-2019; Finkbeiner SR, 2015, STEM CELL REP, V4, P1140, DOI 10.1016/j.stemcr.2015.04.010; Forbester JL, 2015, INFECT IMMUN, V83, P2926, DOI 10.1128/IAI.00161-15; Fuochi V, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01403; Groschwitz KR, 2009, J ALLERGY CLIN IMMUN, V124, P3, DOI 10.1016/j.jaci.2009.05.038; Heeney DD, 2018, CURR OPIN BIOTECH, V49, P140, DOI 10.1016/j.copbio.2017.08.004; Hill DR, 2017, ELIFE, V6, DOI 10.7554/eLife.29132; Holloway EM, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.166173; Hooper LV, 1999, P NATL ACAD SCI USA, V96, P9833, DOI 10.1073/pnas.96.17.9833; In JG, 2016, NAT REV GASTRO HEPAT, V13, P633, DOI 10.1038/nrgastro.2016.142; Jung KB, 2019, J CLIN MED, V8, DOI 10.3390/jcm8070976; Jung KB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05450-8; Jung KB, 2018, FASEB J, V32, P111, DOI 10.1096/fj.201700504R; Kaiko GE, 2014, TRENDS IMMUNOL, V35, P538, DOI 10.1016/j.it.2014.08.002; Karve SS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178966; Kho ZY, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01835; Kim JS, 2018, INT J SYST EVOL MICR, V68, P3118, DOI 10.1099/ijsem.0.002949; Lee H, 2020, THERANOSTICS, V10, P5048, DOI 10.7150/thno.41534; Lee MO, 2019, J BIOL ENG, V13, DOI 10.1186/s13036-019-0139-6; Leslie JL, 2015, INFECT IMMUN, V83, P138, DOI 10.1128/IAI.02561-14; Linden SK, 2008, MUCOSAL IMMUNOL, V1, P183, DOI 10.1038/mi.2008.5; McCracken KW, 2014, NATURE, V516, P400, DOI 10.1038/nature13863; Milani C, 2017, MICROBIOL MOL BIOL R, V81, DOI 10.1128/MMBR.00036-17; Nakamura T, 2019, INT IMMUNOL, V31, P13, DOI 10.1093/intimm/dxy065; Nilsson HE, 2014, J MOL BIOL, V426, P2567, DOI 10.1016/j.jmb.2014.04.027; Pearce SC, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01584; Peng LY, 2007, PEDIATR RES, V61, P37, DOI 10.1203/01.pdr.0000250014.92242.f3; Perea D, 2017, EMBO J, V36, P3029, DOI 10.15252/embj.201696247; Rajangam T, 2016, TISSUE ENG PART C-ME, V22, P679, DOI [10.1089/ten.tec.2016.0037, 10.1089/ten.TEC.2016.0037]; Ruff WE, 2015, TRENDS MOL MED, V21, P233, DOI 10.1016/j.molmed.2015.02.006; Sacchetti L, 2020, CLIN CHEM LAB MED, V58, P340, DOI 10.1515/cclm-2019-0657; SCHEPPACH W, 1994, GUT, V35, pS35, DOI 10.1136/gut.35.1_Suppl.S35; Schroeder BO, 2019, GASTROENTEROL REP, V7, P3, DOI 10.1093/gastro/goy052; Sengupta R, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/237921; Servin AL, 2004, FEMS MICROBIOL REV, V28, P405, DOI 10.1016/j.femsre.2004.01.003; Sheng YH, 2011, GUT, V60, P1661, DOI 10.1136/gut.2011.239194; Simpson MR, 2018, J DAIRY SCI, V101, P889, DOI 10.3168/jds.2017-13411; Son YS, 2019, STEM CELLS DEV, V28, P438, DOI 10.1089/scd.2018.0181; Soto A, 2014, J PEDIATR GASTR NUTR, V59, P78, DOI 10.1097/MPG.0000000000000347; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691; Tafazoli F, 2003, INFECT IMMUN, V71, P872, DOI 10.1128/IAI.71.2.872-881.2003; Tailford LE, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00081; Tamburini S, 2016, NAT MED, V22, P713, DOI 10.1038/nm.4142; Wallis K, 2007, BRIT J HOSP MED, V68, P11, DOI 10.12968/hmed.2007.68.1.22648; Wickstrom C, 2009, MICROBIOL-SGM, V155, P2866, DOI 10.1099/mic.0.030536-0; Wilson SS, 2015, MUCOSAL IMMUNOL, V8, P352, DOI 10.1038/mi.2014.72; Yu Linda Chia-Hui, 2012, World J Gastrointest Pathophysiol, V3, P27, DOI 10.4291/wjgp.v3.i1.27; Yu M, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.125166; Zotta T, 2017, J APPL MICROBIOL, V122, P857, DOI 10.1111/jam.13399	59	18	19	3	20	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					9899	9910		10.1096/fj.202000063R	http://dx.doi.org/10.1096/fj.202000063R		JUN 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32602623				2022-12-28	WOS:000546040200001
J	Huang, CC; Li, JF; Zhang, XT; Xiong, TF; Ye, J; Yu, J; Gui, YT				Huang, Chenchen; Li, Jianfa; Zhang, Xiaoting; Xiong, Tiefu; Ye, Jing; Yu, Jing; Gui, Yaoting			The miR-140-5p/KLF9/KCNQ1 axis promotes the progression of renal cell carcinoma	FASEB JOURNAL			English	Article						KCNQ1; KLF9; miR-140-5p; proliferation; invasion; metastasis; renal cell carcinoma	KRUPPEL-LIKE FACTORS; DOWN-REGULATION; COLORECTAL-CANCER; SUPPRESSES; PROLIFERATION; METASTASIS; GROWTH; KLF9; TRANSCRIPTION; EXPRESSION	Although renal cell carcinoma (RCC) is a common malignant urological cancer, its pathogenesis remains unclear. Previous studies have indicated that miR-140-5p acts as a tumor suppressor in various tumors, including bladder cancer, hepatocellular carcinoma, and gastric cancer, but its biological function in RCC remains unknown. In the present study, we found that miR-140-5p was upregulated in RCC tissues, whereas Kruppel-like factor 9 (KLF9) was downregulated and correlated inversely with miR-140-5p in RCC tissues. miR-140-5p promoted the proliferation, migration, and invasion of RCC cells in vitro, and knockdown of miR-140-5p significantly suppressed tumor growth and lung metastasis in nude mouse model of RCC. We also found that miR-140-5p significantly suppressed the expression of KLF9 by binding to the 3MODIFIER LETTER PRIME-UTR of KLF9 mRNA and that KLF9, as a transcription factor, upregulates KCNQ1 (also called K(v)7.1 and K(v)LQT1) expression by binding to the site (-841/-827) in the KCNQ1 promoter region in RCC cells. Moreover, forced expression of KCNQ1 decreased the growth and metastasis of RCC cells. These results suggest that the miR-140-5p/KLF9/KCNQ1 axis functions as a key signaling pathway in RCC progression and metastasis and represents a potential target of RCC therapies.	[Huang, Chenchen; Li, Jianfa; Xiong, Tiefu; Ye, Jing; Gui, Yaoting] Anhui Med Univ, Guangdong & Shenzhen Key Lab Male Reprod Med & Ge, Peking Univ, Shenzhen Hosp,Clin Coll, Shenzhen 518036, Peoples R China; [Huang, Chenchen; Gui, Yaoting] Anhui Med Univ, Hefei, Peoples R China; [Zhang, Xiaoting] Shenzhen Baoan Dist Songgang Peoples Hosp, Shenzhen, Peoples R China; [Yu, Jing] Peking Univ, Dept Lab Med, Shenzhen Hosp, Shenzhen 518036, Peoples R China	Anhui Medical University; Peking University; Anhui Medical University; Peking University	Gui, YT (corresponding author), Anhui Med Univ, Guangdong & Shenzhen Key Lab Male Reprod Med & Ge, Peking Univ, Shenzhen Hosp,Clin Coll, Shenzhen 518036, Peoples R China.; Yu, J (corresponding author), Peking Univ, Dept Lab Med, Shenzhen Hosp, Shenzhen 518036, Peoples R China.	jing_yu2004@aliyun.com; guiyaoting2007@aliyun.com	gui, yaoting/GLT-3684-2022		National Key Research Program of China [2019YFA09006003]; Guangdong Foundation of Nature Science [2020A1515010067]; Guangdong Key Laboratory of Male Reproductive Medicine and Genetics [2017B030314074]; Shenzhen Project of Science and Technology [JCYJ20170413100245260]	National Key Research Program of China; Guangdong Foundation of Nature Science; Guangdong Key Laboratory of Male Reproductive Medicine and Genetics; Shenzhen Project of Science and Technology	We thank our researchers for their hard work and reviewers for their valuable advice. This study was supported by the grants from the National Key Research Program of China (2019YFA09006003), the Guangdong Foundation of Nature Science (2020A1515010067), the Guangdong Key Laboratory of Male Reproductive Medicine and Genetics (2017B030314074) and the Shenzhen Project of Science and Technology (JCYJ20170413100245260).	[Anonymous], 2018, Cancer Res, V78, P1371, DOI 10.1158/0008-5472.CAN-17-3848; [Anonymous], 2002, PDQ CANC INFORM SUMM; Bai XY, 2018, CANCER LETT, V412, P224, DOI 10.1016/j.canlet.2017.10.027; Barata PC, 2017, CA-CANCER J CLIN, V67, P507, DOI 10.3322/caac.21411; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bhayadia R, 2018, J CLIN ONCOL, V36, P1007, DOI 10.1200/JCO.2017.75.2204; Brown AR, 2015, CARCINOGENESIS, V36, P946, DOI 10.1093/carcin/bgv104; Chen XY, 2014, CLIN CANCER RES, V20, P2617, DOI 10.1158/1078-0432.CCR-13-3224; den Uil SH, 2016, BRIT J CANCER, V115, P1565, DOI 10.1038/bjc.2016.376; Fan HY, 2018, BIOCHEM BIOPH RES CO, V503, P3100, DOI 10.1016/j.bbrc.2018.08.099; Fang Z, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0708-6; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gao Y, 2017, CANCER RES, V77, P330, DOI 10.1158/0008-5472.CAN-16-0348; Hammond SM, 2015, ADV DRUG DELIVER REV, V87, P3, DOI 10.1016/j.addr.2015.05.001; Haraguchi T, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp040; Hollingsworth JM, 2007, CANCER-AM CANCER SOC, V109, P1763, DOI 10.1002/cncr.22600; Huang SY, 2015, CANCER LETT, V356, P547, DOI 10.1016/j.canlet.2014.10.007; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Kang L, 2008, PATHOL INT, V58, P334, DOI 10.1111/j.1440-1827.2008.02233.x; Lei W, 2018, BMC CANCER, V18, DOI [10.1186/S12885-018-4460-0, 10.1186/s12885-018-4460-0]; Li Q, 2014, ONCOGENE, V33, P2589, DOI 10.1038/onc.2013.226; Li WL, 2014, CELL PHYSIOL BIOCHEM, V34, P1466, DOI 10.1159/000366351; Li Y, 2019, FASEB J, V33, P7915, DOI 10.1096/fj.201802531R; Lopez-Beltran A, 2006, EUR UROL, V49, P798, DOI 10.1016/j.eururo.2005.11.035; Lu XJ, 2015, TUMOR BIOL, V36, P533, DOI 10.1007/s13277-015-3127-6; Mannava S, 2012, BLOOD, V119, P1450, DOI 10.1182/blood-2011-04-346676; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; Pabona JMP, 2009, J ENDOCRINOL, V200, P63, DOI 10.1677/JOE-08-0383; Pabona JMP, 2012, J CLIN ENDOCR METAB, V97, pE376, DOI 10.1210/jc.2011-2562; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Qiao F, 2016, MOL CARCINOGEN, V55, P280, DOI 10.1002/mc.22277; Rapetti-Mauss R, 2017, P NATL ACAD SCI USA, V114, P4159, DOI 10.1073/pnas.1702913114; Scobie KN, 2009, J NEUROSCI, V29, P9875, DOI 10.1523/JNEUROSCI.2260-09.2009; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Simmen FA, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-41; Simmen RCM, 2010, J ENDOCRINOL, V204, P223, DOI 10.1677/JOE-09-0329; Sun JB, 2014, CANCER LETT, V355, P25, DOI 10.1016/j.canlet.2014.09.022; Tetreault MP, 2013, NAT REV CANCER, V13, P701, DOI 10.1038/nrc3582; Than BLN, 2014, ONCOGENE, V33, P3861, DOI 10.1038/onc.2013.350; Thomas JS, 2015, CRIT REV ONCOL HEMAT, V96, P527, DOI 10.1016/j.critrevonc.2015.07.009; Wang ML, 2016, INT J CANCER, V139, P65, DOI 10.1002/ijc.29978; Wolfson Benjamin, 2014, World J Stem Cells, V6, P591, DOI 10.4252/wjsc.v6.i5.591; Wu L, 2008, MOL CELL, V29, P1, DOI 10.1016/j.molcel.2007.12.010; Yang H, 2013, HEPATOLOGY, V58, P205, DOI 10.1002/hep.26315; Ying MY, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.588988; Ying MY, 2011, STEM CELLS, V29, P20, DOI 10.1002/stem.561; Zhang QH, 2015, ARCH GYNECOL OBSTET, V291, P377, DOI 10.1007/s00404-014-3405-3; Zhao WC, 2016, INT J ONCOL, V49, P1001, DOI 10.3892/ijo.2016.3609	48	10	10	3	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10623	10639		10.1096/fj.202000088RR	http://dx.doi.org/10.1096/fj.202000088RR		JUN 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32596959	hybrid			2022-12-28	WOS:000546048200001
J	Chen, X; Chen, S; Shen, TR; Yang, WQ; Chen, Q; Zhang, PW; You, YR; Sun, XY; Xu, HH; Tang, Y; Mi, JX; Yang, Y; Ling, WH				Chen, Xu; Chen, Shen; Shen, Tianran; Yang, Wenqi; Chen, Qian; Zhang, Peiwen; You, Yiran; Sun, Xiaoyuan; Xu, Huihui; Tang, Yi; Mi, Jiaxin; Yang, Yan; Ling, Wenhua			Adropin regulates hepatic glucose production via PP2A/AMPK pathway in insulin-resistant hepatocytes	FASEB JOURNAL			English	Article						AMPK; diabetes; gluconeogenesis; obesity	ACTIVATED PROTEIN-KINASE; CATALYTIC SUBUNIT; TRANSCRIPTION; AMPK; GLUCONEOGENESIS; CREB; METABOLISM; LIVER; ADIPONECTIN; DISRUPTION	Adropin as a secretory peptide has shown a protective role on the disorders of glucose and lipid metabolism. However, the role and mechanism of this peptide on the hepatic glucose production has remained unclear. Adropin knockout (KO) mice were generated to explore its effects on the enhanced hepatic glucose production in obesity. We found that compared to wild-type (WT) mice, adropin-KO mice developed the unbalanced enhanced hepatic glucose production in advance of the whole-body insulin resistance (IR) by high-fat diet (HFD). Mechanistically, adropin dissociated CREB-CRTC2 and FoxO1-PGC1 alpha complex and reduced their binding to the promoters of G6Pase and PEPCK to decrease glucose production in IR. However, these effects were not observed in insulin-sensitive hepatocytes. Furthermore, in IR hepatocytes, dampened AMPK signaling was re-activated by adropin treatment via inhibition of PP2A. To further authenticate AMPK role in vivo, we administrated HFD-fed mice with AAV8-CA AMPK alpha and found that AMPK activation functionally restored the aberrant glucose production and IR induced by adropin-deficiency. This study provides evidence that adropin activates the AMPK pathway via inhibition of PP2A and decreases the liver glucose production in IR context. Therefore, adropin may represent a novel target for the prevention and treatment of diabetes.	[Chen, Xu; Chen, Qian; Zhang, Peiwen; You, Yiran; Sun, Xiaoyuan; Xu, Huihui; Tang, Yi; Mi, Jiaxin; Yang, Yan; Ling, Wenhua] Sun Yat Sen Univ, Dept Nutr, Sch Publ Hlth, North Campus,74 Zhongshan Rd 2, Guangzhou 510080, Guangdong, Peoples R China; [Chen, Xu; Chen, Qian; Zhang, Peiwen; You, Yiran; Sun, Xiaoyuan; Xu, Huihui; Tang, Yi; Mi, Jiaxin; Yang, Yan; Ling, Wenhua] Guangdong Prov Key Lab Food Nutr & Hlth, Guangzhou, Peoples R China; [Chen, Shen] Sun Yat Sen Univ, Sch Publ Hlth, Dept Toxicol, Guangzhou, Peoples R China; [Shen, Tianran] Guangdong Pharmaceut Univ, Sch Publ Hlth, Dept Nutr, Guangzhou, Peoples R China; [Yang, Wenqi] Guangzhou Inst Phys Educ, Lab Ctr Sport Sci & Med, Guangzhou, Peoples R China; [Chen, Qian] Sun Yat Sen Mem Hosp, Dept Cardiol, Guangzhou, Peoples R China; [Yang, Yan] Sun Yat Sen Univ, Sch Publ Hlth Shenzhen, Guangzhou, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Guangdong Pharmaceutical University; Guangzhou Sport University; Sun Yat Sen University; Sun Yat Sen University	Ling, WH (corresponding author), Sun Yat Sen Univ, Dept Nutr, Sch Publ Hlth, North Campus,74 Zhongshan Rd 2, Guangzhou 510080, Guangdong, Peoples R China.	lingwh@mail.sysu.edu.cn	Lang, Ming/HIK-0758-2022; yang, yang/GWB-9426-2022	Chen, Shen/0000-0001-8640-4492	National Natural Science Foundation of China (NSFC) [81730090]; Major Projects of Guangzhou Health Collaborative Innovation [201604020002]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Major Projects of Guangzhou Health Collaborative Innovation	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81730090; Major Projects of Guangzhou Health Collaborative Innovation, Grant/Award Number: 201604020002	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Andreelli F, 2006, ENDOCRINOLOGY, V147, P2432, DOI 10.1210/en.2005-0898; Ayala JE, 1999, DIABETES, V48, P1885, DOI 10.2337/diabetes.48.9.1885; Barthel A, 2002, ENDOCRINOLOGY, V143, P3183, DOI 10.1210/endo.143.8.8792; Chen X, 2019, REDOX BIOL, V21, DOI 10.1016/j.redox.2018.101068; Cokorinos EC, 2017, CELL METAB, V25, P1147, DOI 10.1016/j.cmet.2017.04.010; Erion DM, 2013, J BIOL CHEM, V288, P16167, DOI 10.1074/jbc.M113.460246; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Fu A, 2008, CELL CYCLE, V7, P3823, DOI 10.4161/cc.7.24.7241; Galbo T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027424; Gao S, 2019, J BIOL CHEM, V294, P13366, DOI 10.1074/jbc.RA119.008967; Garcia-Rocha M, 2001, BIOCHEM J, V357, P17, DOI 10.1042/0264-6021:3570017; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Haeusler RA, 2010, J BIOL CHEM, V285, P35245, DOI 10.1074/jbc.C110.175851; Hasenour CM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170382; Hatting M, 2018, ANN NY ACAD SCI, V1411, P21, DOI 10.1111/nyas.13435; Jeon SM, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.81; Joseph BK, 2015, J BIOL CHEM, V290, P10588, DOI 10.1074/jbc.M114.626259; Kumar KG, 2012, OBESITY, V20, P1394, DOI 10.1038/oby.2012.31; Kumar KG, 2008, CELL METAB, V8, P468, DOI 10.1016/j.cmet.2008.10.011; Lee JM, 2010, J BIOL CHEM, V285, P32182, DOI 10.1074/jbc.M110.134890; Lucidi P, 2018, CURR DIABETES REP, V18, DOI 10.1007/s11892-018-1065-6; Madiraju AK, 2014, NATURE, V510, P542, DOI 10.1038/nature13270; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Oh KJ, 2013, BMB REP, V46, P567, DOI 10.5483/BMBRep.2013.46.12.248; Petersen MC, 2017, NAT REV ENDOCRINOL, V13, P572, DOI 10.1038/nrendo.2017.80; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Ravnskjaer K, 2006, J MOL ENDOCRINOL, V36, P289, DOI 10.1677/jme.1.01965; Russo L, 2018, IMMUNOLOGY, V155, P407, DOI 10.1111/imm.13002; Scott JW, 2008, CHEM BIOL, V15, P1220, DOI 10.1016/j.chembiol.2008.10.005; Seidell JC, 2000, BRIT J NUTR, V83, pS5, DOI 10.1017/S000711450000088X; Sharabi K, 2015, MOL ASPECTS MED, V46, P21, DOI 10.1016/j.mam.2015.09.003; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Viollet B, 2006, J PHYSIOL-LONDON, V574, P41, DOI 10.1113/jphysiol.2006.108506; Wang YG, 2010, P NATL ACAD SCI USA, V107, P3087, DOI 10.1073/pnas.0914897107; Wang YG, 2009, NATURE, V460, P534, DOI 10.1038/nature08111; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Xian L, 2015, AGING-US, V7, P223, DOI 10.18632/aging.100725; Yadav H, 2017, J BIOL CHEM, V292, P3420, DOI 10.1074/jbc.M116.764910; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Zhang M, 2012, MOL CELL ENDOCRINOL, V363, P122, DOI 10.1016/j.mce.2012.08.006	41	17	17	1	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10056	10072		10.1096/fj.202000115RR	http://dx.doi.org/10.1096/fj.202000115RR		JUN 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32579277	Bronze			2022-12-28	WOS:000544324100001
J	Heinick, A; Pluteanu, F; Hermes, C; Klemme, A; Domnik, M; Husser, X; Gerke, V; Schmitz, W; Muller, FU				Heinick, Alexander; Pluteanu, Florentina; Hermes, Christina; Klemme, Andre; Domnik, Manuel; Husser, Xenia; Gerke, Volker; Schmitz, Wilhelm; Mueller, Frank U.			Annexin A4 N-terminal peptide inhibits adenylyl cyclase 5 and limits beta-adrenoceptor-mediated prolongation of cardiac action potential	FASEB JOURNAL			English	Article						calcium current; cardiomyocytes; co-immunoprecipitation; cyclic AMP; FRET	HEART-FAILURE; CRYSTAL-STRUCTURE; VI; OVEREXPRESSION; IDENTIFICATION; DISRUPTION; COMPLEX; LOCALIZATION; ASSOCIATION; MODULATION	Adenylyl cyclases (AC) are essential for the normal and pathophysiological response of many cells. In cardiomyocytes, the predominant AC isoforms are AC5 and AC6. Specific AC5 inhibition was suggested as an option for the treatment of heart failure potentially advantageous over beta-blockers. We previously reported an interaction between the calcium-binding protein annexin A4 (ANXA4) and AC5 in human embryonic kidney 293 (HEK293) cells and an inhibition of cyclic adenosine monophosphate (cAMP) production in cardiomyocytes. Here, we investigated whether ANXA4 is able to differentiate between AC5 and AC6. In transfected HEK293 cells, ANXA4 specifically co-immunoprecipitated with AC5 and not with AC6, via its N-terminal domain. Both ANXA4 and a peptide comprising the ANXA4 N-terminal sequence (A4N(1-22)) decreased the cAMP production in AC5 and not in AC6 expressing cells. In line with ACs inhibition, in myocytes from ANXA4-deficient mice, beta-adrenoceptor (beta AR) stimulation led to a higher increase of the L-type calcium current (I-CaL) and to an excessive action potential duration (APD) prolongation as compared to wild-type cardiomyocytes. This enhanced response was reversed in the presence of A4N(1-22)peptide likely via specific AC5 inhibition. We conclude that via the N-terminal domain ANXA4 inhibits AC5 not AC6, and that A4N(1-22)as a specific AC5 inhibitor could serve as a novel therapeutic tool for the treatment of AC5-linked diseases.	[Heinick, Alexander; Pluteanu, Florentina; Hermes, Christina; Klemme, Andre; Domnik, Manuel; Husser, Xenia; Schmitz, Wilhelm; Mueller, Frank U.] Univ Munster, Inst Pharmacol & Toxicol, Munster, Germany; [Gerke, Volker] Univ Munster, Ctr Mol Biol Inflammat, Inst Med Biochem, Munster, Germany; [Gerke, Volker] Univ Munster, Interdisciplinary Clin Res Ctr, Munster, Germany	University of Munster; University of Munster; University of Munster	Muller, FU (corresponding author), Westfalische Wilhelms Univ Munster, Inst Pharmacol & Toxicol, Domagkstr 12, D-48149 Munster, Germany.	mullerf@uni-muenster.de	Pluteanu, Florentina/R-8630-2018	Pluteanu, Florentina/0000-0003-0743-0129; Heinick, Alexander/0000-0002-3770-105X	IZKF Munster [Mu1/011/17]; DFG [Mu1376/11-3, CRC1348/A07]	IZKF Munster; DFG(German Research Foundation (DFG))	IZKF Munster, Grant/Award Number: Mu1/011/17; DFG, Grant/Award Number: Mu1376/11-3 and CRC1348/A07	Antoni FA, 2006, NEUROCHEM RES, V31, P287, DOI 10.1007/s11064-005-9019-1; Antoons G, 2007, J PHYSIOL-LONDON, V579, P147, DOI 10.1113/jphysiol.2006.124222; Ayala-Sanmartin J, 2008, BBA-BIOMEMBRANES, V1778, P472, DOI 10.1016/j.bbamem.2007.11.004; Babij P, 1998, CIRC RES, V83, P668, DOI 10.1161/01.RES.83.6.668; Baldwin TA, 2018, J CARDIOVASC DEV DIS, V5, DOI 10.3390/jcdd5010002; Baran I, 2007, J CHEM INF MODEL, V47, P464, DOI 10.1021/ci600404q; Bers DM, 2001, EXCITATION CONTRACTI; Brachvogel B, 2003, MOL CELL BIOL, V23, P2907, DOI 10.1128/MCB.23.8.2907-2913.2003; Camors E, 2005, CARDIOVASC RES, V65, P793, DOI 10.1016/j.cardiores.2004.11.010; CONCHA NO, 1993, SCIENCE, V261, P1321, DOI 10.1126/science.8362244; De Lorenzo MS, 2014, AGING CELL, V13, P102, DOI 10.1111/acel.12152; DeGeorge BR, 2007, J CLIN INVEST, V117, P86, DOI 10.1172/JCI30476; DIAZMUNOZ M, 1990, J BIOL CHEM, V265, P15894; Ellerkmann RK, 2003, NEUROSCIENCE, V119, P323, DOI 10.1016/S0306-4522(03)00168-4; Gao MH, 1999, CIRCULATION, V99, P1618, DOI 10.1161/01.CIR.99.12.1618; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Gottle M, 2009, J PHARMACOL EXP THER, V329, P1156, DOI 10.1124/jpet.109.150953; Guellich A, 2014, PFLUG ARCH EUR J PHY, V466, P1163, DOI 10.1007/s00424-014-1515-1; Guellich A, 2010, AM J PHYSIOL-HEART C, V299, pH707, DOI 10.1152/ajpheart.00148.2010; GunteskiHamblin AM, 1996, AM J PHYSIOL-HEART C, V270, pH1091, DOI 10.1152/ajpheart.1996.270.3.H1091; HALL SA, 1995, J AM COLL CARDIOL, V25, P1154, DOI 10.1016/0735-1097(94)00543-Y; Hammond HK, 2016, JAMA CARDIOL, V1, P163, DOI 10.1001/jamacardio.2016.0008; Hawkins TE, 1999, MOL CELL BIOL, V19, P8028; Heinick A, 2015, FASEB J, V29, P3773, DOI 10.1096/fj.14-269837; Herr C, 2001, MOL CELL BIOL, V21, P4119, DOI 10.1128/MCB.21.13.4119-4128.2001; Hill MD, 2012, LANCET NEUROL, V11, P942, DOI 10.1016/S1474-4422(12)70225-9; Kim KS, 2007, GENES BRAIN BEHAV, V6, P120, DOI 10.1111/j.1601-183X.2006.00238.x; Lai L, 2013, CIRCULATION, V127, P1692, DOI 10.1161/CIRCULATIONAHA.112.001212; Li BL, 2003, J BIOL CHEM, V278, P43276, DOI 10.1074/jbc.M306361200; Lowes BD, 2002, NEW ENGL J MED, V346, P1357, DOI 10.1056/NEJMoa012630; Lujan HL, 2016, AUTON NEUROSCI-BASIC, V201, P24, DOI 10.1016/j.autneu.2016.08.017; Matteo RG, 2000, CARDIOVASC RES, V45, P961, DOI 10.1016/S0008-6363(99)00409-5; Okumura S, 2003, P NATL ACAD SCI USA, V100, P9986, DOI 10.1073/pnas.1733772100; Okumura S, 2007, CIRCULATION, V116, P1776, DOI 10.1161/CIRCULATIONAHA.107.698662; Penny WF, 2018, AM HEART J, V201, P111, DOI 10.1016/j.ahj.2018.04.005; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pieske B, 2004, EUR HEART J SUPPL, V6, pD66, DOI 10.1016/j.ehjsup.2004.05.019; Piljic A, 2006, MOL BIOL CELL, V17, P3318, DOI 10.1091/mbc.E06-01-0041; Pluteanu F, 2009, AM J PHYSIOL-HEART C, V297, pH1304, DOI 10.1152/ajpheart.00528.2009; Ravassa S, 2007, EUR HEART J, V28, P2785, DOI 10.1093/eurheartj/ehm370; Rety S, 1999, NAT STRUCT BIOL, V6, P89; Sadana R, 2009, NEUROSIGNALS, V17, P5, DOI 10.1159/000166277; Schulte JS, 2012, AM J PHYSIOL-HEART C, V302, pH1998, DOI 10.1152/ajpheart.00057.2011; Seidl MD, 2017, CIRC-ARRHYTHMIA ELEC, V10, DOI 10.1161/CIRCEP.117.005075; SOBOTA A, 1990, BIOCHEM BIOPH RES CO, V172, P1067, DOI 10.1016/0006-291X(90)91555-7; Song GJ, 1998, J MOL CELL CARDIOL, V30, P443, DOI 10.1006/jmcc.1997.0608; Sugano Y, 2011, BIOCHEM BIOPH RES CO, V405, P349, DOI 10.1016/j.bbrc.2010.12.113; Tang T, 2010, J AM COLL CARDIOL, V55, P1476, DOI 10.1016/j.jacc.2009.11.066; Trouve P, 1999, AM J PHYSIOL-HEART C, V276, pH1159, DOI 10.1152/ajpheart.1999.276.4.H1159; Vatner SF, 2013, AM J PHYSIOL-HEART C, V305, pH1, DOI 10.1152/ajpheart.00080.2013; Walther A, 2000, MOL CELL, V5, P831, DOI 10.1016/S1097-2765(00)80323-8; Watts VJ, 2005, PHARMACOL THERAPEUT, V106, P405, DOI 10.1016/j.pharmthera.2004.12.005; Willshaw A, 2004, FEBS LETT, V559, P13, DOI 10.1016/S0014-5793(03)01513-8; Zhao ZH, 2015, AM J PHYSIOL-HEART C, V308, pH240, DOI 10.1152/ajpheart.00630.2014	55	6	6	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10489	10504		10.1096/fj.201902094RR	http://dx.doi.org/10.1096/fj.201902094RR		JUN 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32579290	hybrid			2022-12-28	WOS:000544323500001
J	Colucci, S; Colaianni, G; Brunetti, G; Ferranti, F; Mascetti, G; Mori, G; Grano, M				Colucci, Silvia; Colaianni, Graziana; Brunetti, Giacomina; Ferranti, Francesca; Mascetti, Gabriele; Mori, Giorgio; Grano, Maria			Irisin prevents microgravity-induced impairment of osteoblast differentiation in vitro during the space flight CRS-14 mission	FASEB JOURNAL			English	Article						irisin; ISS; microgravity; osteoblasts	BONE; EXERCISE; SPACEFLIGHT; MYOKINE; MUSCLE	Understanding molecular mechanisms responsible for bone cells unbalance in microgravity would allow the development of better countermeasures for astronauts, and eventually advancing terrestrial osteoporosis treatments. We conduct a unique investigation by using a controlled 3D in vitro cell model to mimic the bone microenvironment in microgravity aboard the SpaceX Dragon cargo ferry to the ISS. Osteoblasts (OBs), osteoclasts (OCs), and endothelial cells (ECs), seeded on Skelite discs, were cultured w/ or w/o rec-Irisin and exposed to 14 days of microgravity in the eOSTEO hardware. Gene expression analysis was assessed, and results were compared to ground controls treated within identical payloads. Our results show that the microgravity-induced downregulation of mRNA levels of genes encoding for OB key transcription factors (Atf4-75%,P RunX2-87%,P < .001,Osterix-95%,P < .05 vs ground) and proteins (Collagen I-84%,P Osteoprotegerin-94%,P < .05) were prevented by irisin. Despite it was not effective in preventing Trap and Cathepsin K mRNA increase, irisin induced a 2.8-fold increase of Osteoprotegerin (P < .05) that might act for reducing osteoclastogenesis in microgravity. Our results provide evidence that irisin supports OB differentiation and activity in microgravity and it might represent a countermeasure to prevent bone loss in astronauts.	[Colucci, Silvia; Brunetti, Giacomina] Univ Bari, Dept Basic Med Sci Neurosci & Sense Organs, Bari, Italy; [Colaianni, Graziana; Grano, Maria] Univ Bari, Dept Emergency & Organ Transplantat, Piazza Giulio Cesare 11, I-70124 Bari, Italy; [Ferranti, Francesca; Mascetti, Gabriele] Italian Space Agcy ASI, Rome, Italy; [Mori, Giorgio] Univ Foggia, Dept Clin & Expt Med, Foggia, Italy	Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; Agenzia Spaziale Italiana (ASI); University of Foggia	Grano, M (corresponding author), Univ Bari, Dept Emergency & Organ Transplantat, Piazza Giulio Cesare 11, I-70124 Bari, Italy.	maria.grano@uniba.it	Mori, Giorgio/P-1370-2014	Mori, Giorgio/0000-0001-6731-0247	ERISTO by ESA; ASI	ERISTO by ESA; ASI(Agenzia Spaziale Italiana (ASI))	ERISTO by ESA; ASI	Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Cazzaniga A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/857934; Chim SM, 2013, CYTOKINE GROWTH F R, V24, P297, DOI 10.1016/j.cytogfr.2013.03.008; Colaianni G, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/902186; Colaianni G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02557-8; Colaianni G, 2015, P NATL ACAD SCI USA, V112, P12157, DOI 10.1073/pnas.1516622112; Drake MT, 2017, ENDOCR REV, V38, P325, DOI 10.1210/er.2015-1114; Guignandon A, 2014, FASEB J, V28, P4077, DOI 10.1096/fj.14-249714; Halleen JM, 2006, CLIN LAB, V52, P499; Hamidouche Z, 2008, FASEB J, V22, P3813, DOI 10.1096/fj.08-106302; Hayman AR, 2008, AUTOIMMUNITY, V41, P218, DOI 10.1080/08916930701694667; Hofbauer LC, 1999, EUR J ENDOCRINOL, V141, P195, DOI 10.1530/eje.0.1410195; HughesFulford M, 1996, EXP CELL RES, V224, P103, DOI 10.1006/excr.1996.0116; Lang TF, 2006, J BONE MINER RES, V21, P1224, DOI 10.1359/JBMR.060509; LeBlanc A, 2013, OSTEOPOROSIS INT, V24, P2105, DOI 10.1007/s00198-012-2243-z; LittlewoodEvans A, 1997, BONE, V20, P81, DOI 10.1016/S8756-3282(96)00351-1; Lu JL, 2016, ONCOTARGET, V7, P37471, DOI 10.18632/oncotarget.9650; McCarthy EF, 2011, SKELETAL RADIOL, V40, P661, DOI 10.1007/s00256-011-1100-z; Nabavi N, 2011, BONE, V49, P965, DOI 10.1016/j.bone.2011.07.036; Pang H, 2013, BIOCHEM BIOPH RES CO, V430, P729, DOI 10.1016/j.bbrc.2012.11.081; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Shackelford LC, 2004, J APPL PHYSIOL, V97, P119, DOI 10.1152/japplphysiol.00741.2003; Storlino G, 2020, J BONE MINER RES, V35, P766, DOI 10.1002/jbmr.3944; Tamma R, 2009, FASEB J, V23, P2549, DOI 10.1096/fj.08-127951; Tesch PA, 2005, EUR J APPL PHYSIOL, V93, P463, DOI 10.1007/s00421-004-1236-9; Veeriah V, 2019, CALCIFIED TISSUE INT, V104, P344, DOI 10.1007/s00223-018-0496-z; Xiao GZ, 2005, J BIOL CHEM, V280, P30689, DOI 10.1074/jbc.M500750200; Xu HJ, 2017, BIOCHIMIE, V138, P184, DOI 10.1016/j.biochi.2017.04.015; Yang XL, 2004, J BIOL CHEM, V279, P47109, DOI 10.1074/jbc.M410010200; Yu SB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007583	30	21	23	4	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10096	10106		10.1096/fj.202000216R	http://dx.doi.org/10.1096/fj.202000216R		JUN 2020	11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32539174	Bronze			2022-12-28	WOS:000543403200001
J	Debnath, M; Banerjee, M; Berk, M				Debnath, Monojit; Banerjee, Moinak; Berk, Michael			Genetic gateways to COVID-19 infection: Implications for risk, severity, and outcomes	FASEB JOURNAL			English	Article						ACE; COVID-19; cytokine storm; genetics; HLA; immunity; SARS-CoV-2	ACUTE RESPIRATORY SYNDROME; ANGIOTENSIN-CONVERTING ENZYME-2; CLASS-II; HLA-A; RECEPTOR; SARS; ALLELES; RESISTANCE; ACE2; ASSOCIATION	The dynamics, such as transmission, spatial epidemiology, and clinical course of Coronavirus Disease-2019 (COVID-19) have emerged as the most intriguing features and remain incompletely understood. The genetic landscape of an individual in particular, and a population in general seems to play a pivotal role in shaping the above COVID-19 dynamics. Considering the implications of host genes in the entry and replication of SARS-CoV-2 and in mounting the host immune response, it appears that multiple genes might be crucially involved in the above processes. Herein, we propose three potentially important genetic gateways to COVID-19 infection; these could explain at least in part the discrepancies of its spread, severity, and mortality. The variations within Angiotensin-converting enzyme 2 (ACE2) gene might constitute the first genetic gateway, influencing the spatial transmission dynamics of COVID-19. The Human Leukocyte Antigen locus, a master regulator of immunity against infection seems to be crucial in influencing susceptibility and severity of COVID-19 and can be the second genetic gateway. The genes regulating Toll-like receptor and complement pathways and subsequently cytokine storm induced exaggerated inflammatory pathways seem to underlie the severity of COVID-19, and such genes might represent the third genetic gateway. Host-pathogen interaction is a complex event and some additional genes might also contribute to the dynamics of COVID-19. Overall, these three genetic gateways proposed here might be the critical host determinants governing the risk, severity, and outcome of COVID-19. Genetic variations within these gateways could be key in influencing geographical discrepancies of COVID-19.	[Debnath, Monojit] Natl Inst Mental Hlth & Neurosci, Dept Human Genet, Bangalore, Karnataka, India; [Banerjee, Moinak] Rajiv Gandhi Ctr Biotechnol, Human Mol Genet Lab, Thiruvananthapuram, India; [Berk, Michael] Deakin Univ, IMPACT Inst Mental & Phys Hlth & Clin Translat, Sch Med, Barwon Hlth, Geelong, Vic, Australia; [Berk, Michael] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Dept Psychiat & Orygen, Natl Ctr Excellence Youth Mental Hlth, Melbourne, Vic, Australia	National Institute of Mental Health & Neurosciences - India; Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB); Deakin University; Florey Institute of Neuroscience & Mental Health; Orygen, The National Centre of Excellence in Youth Mental Health; University of Melbourne	Debnath, M (corresponding author), Natl Inst Mental Hlth & Neurosci NIMHANS, Dept Human Genet, Hosur Rd, Bangalore 560029, Karnataka, India.	monozeet@gmail.com	Banerjee, Moinak/X-4471-2018; Debnath, Monojit/G-2725-2010; Berk, Michael/M-7891-2013	Banerjee, Moinak/0000-0002-0842-0398; Berk, Michael/0000-0002-5554-6946	NHMRC Senior Principal Research Fellowship [1156072]	NHMRC Senior Principal Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	MB is supported by a NHMRC Senior Principal Research Fellowship (1156072). Dr Sangeeta Maity critically read the first draft and provided some opinions, which were helpful in improving the content of this manuscript. The authors are grateful to Dr Maity.	Ahmed SF, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12030254; Alicia SM, 2020, SWISS MED WKLY, V150, DOI 10.4414/smw.2020.20248; Blackwell JM, 2009, CLIN MICROBIOL REV, V22, P370, DOI 10.1128/CMR.00048-08; Campbell Katie M, 2020, bioRxiv, DOI 10.1101/2020.03.30.016931; Cao K, 2004, TISSUE ANTIGENS, V63, P293, DOI 10.1111/j.0001-2815.2004.00192.x; Cao YN, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-0147-1; Chakraborty C, 2020, J MED VIROL, V92, P2314, DOI 10.1002/jmv.25997; Chen Y., 2020, ASIANS OTHER RACES E, DOI [10.20944/preprints202002.0258.v1, DOI 10.20944/PREPRINTS202002.0258.V1]; Chen YMA, 2006, J CLIN MICROBIOL, V44, P359, DOI 10.1128/JCM.44.2.359-365.2006; Chong WP, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-82; Cox ED, 2001, TRANSPLANTATION, V72, P720, DOI 10.1097/00007890-200108270-00027; Ehlers A, 2000, GENOME RES, V10, P1968, DOI 10.1101/gr.10.12.1968; Fang CY, 2009, BLOOD, V114, P1005, DOI 10.1182/blood-2009-01-198283; FLOCH F, 1976, ANN INST PASTEUR IMM, VC127, P173; Gaddam Ravinder Reddy, 2014, Inflammation & Allergy Drug Targets, V13, P224; Gao T., 2020, HIGHLY PATHOGENIC CO, DOI 10.1101/2020.03.29.20041962; Giamarellos-Bourboulis EJ, 2020, CELL HOST MICROBE, V27, P992, DOI 10.1016/j.chom.2020.04.009; Gonzalez-Galarza FF, 2015, NUCLEIC ACIDS RES, V43, pD784, DOI 10.1093/nar/gku1166; Gralinski LE, 2018, MBIO, V9, DOI 10.1128/mBio.01753-18; Gralinski LE, 2017, G3-GENES GENOM GENET, V7, P1653, DOI 10.1534/g3.117.041434; GRANT WB, 2020, NUTRIENTS, V12, DOI [DOI 10.3390/NU12040988, 10.3390/nu12040988]; Gursel M, 2020, ALLERGY, V75, P1815, DOI 10.1111/all.14345; Herold T., 2020, J ALLERGY CLIN IMMUN, DOI 10.1101/2020.04.01.20047381; Hilton HG, 2017, CELL REP, V19, P1394, DOI 10.1016/j.celrep.2017.04.059; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Hoffmann SC, 2002, AM J TRANSPLANT, V2, P560, DOI 10.1034/j.1600-6143.2002.20611.x; Hofmann H, 2004, BIOCHEM BIOPH RES CO, V319, P1216, DOI 10.1016/j.bbrc.2004.05.114; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Huang X, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-201; Hussain M, 2020, J MED VIROL, V92, P1580, DOI 10.1002/jmv.25832; Keicho N, 2009, HUM IMMUNOL, V70, P527, DOI 10.1016/j.humimm.2009.05.006; Lechien JR, 2020, EUR ARCH OTO-RHINO-L, V277, P2251, DOI 10.1007/s00405-020-05965-1; Lee Chloe H, 2020, F1000Res, V9, P145, DOI 10.12688/f1000research.22507.2; Li MY, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00662-x; Li Q, 2020, MOL GENET GENOM MED, V8, DOI 10.1002/mgg3.1344; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Lin Marie, 2003, BMC Med Genet, V4, P9, DOI 10.1186/1471-2350-4-9; Lips P, 2019, EUR J ENDOCRINOL, V180, pP23, DOI 10.1530/EJE-18-0736; Manchanda Parmeet Kaur, 2005, Asian Pac J Cancer Prev, V6, P541; Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0; Middleton D, 2000, HUM IMMUNOL, V61, P1048, DOI 10.1016/S0198-8859(00)00178-6; Milinski M, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2889; Moein ST, 2020, INT FORUM ALLERGY RH, V10, P944, DOI 10.1002/alr.22587; Ng MHL, 2004, J INFECT DIS, V190, P515, DOI 10.1086/421523; Nguyen A, 2020, J VIROL, DOI [10.1128/JVI.00510-20, DOI 10.1128/JVI.00510-20]; Ozato K, 2002, BIOTECHNIQUES, P66; Patel VB, 2012, CIRC RES, V110, P1322, DOI 10.1161/CIRCRESAHA.112.268029; Patin E, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000448; Rivas, 2020, INITIAL REV ANAL COV, P1, DOI [10.20944/preprints202003.0356.v1, DOI 10.20944/PREPRINTS202003.0356.V1]; Romero-Lopez JP, 2020, RES SQUARE, DOI [10.21203/rs.3.rs-25844/v1, DOI 10.21203/RS.3.RS-25844/V1]; Saxena A, 2019, HLA, V93, P16, DOI 10.1111/tan.13447; Secundo L, 2015, P NATL ACAD SCI USA, V112, P8750, DOI 10.1073/pnas.1424826112; Shea MK, 2009, EUR J CLIN NUTR, V63, P458, DOI 10.1038/sj.ejcn.1602959; Sibilio L, 2008, J BIOL CHEM, V283, P1267, DOI 10.1074/jbc.M708068200; Srinivas L, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0569-8; Stawiski E.W., 2020, BIORXIV, DOI [10.1101/2020.04.07.024752, DOI 10.1101/2020.04.07.024752]; Stoermer KA, 2011, VIROLOGY, V411, P362, DOI 10.1016/j.virol.2010.12.045; Tang F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002183; Tetro JA, 2020, MICROBES INFECT, V22, P72, DOI 10.1016/j.micinf.2020.02.006; Thomas MC, 2010, CIRC RES, V107, P888, DOI 10.1161/CIRCRESAHA.110.219279; Tian C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00257-5; Totura AL, 2015, MBIO, V6, DOI 10.1128/mBio.00638-15; Tsao YP, 2006, BIOCHEM BIOPH RES CO, V344, P63, DOI 10.1016/j.bbrc.2006.03.152; Wan YS, 2020, J VIROL, V94, DOI 10.1128/JVI.02015-19; Wang BM, 2004, BLOOD, V104, P200, DOI 10.1182/blood-2003-11-4072; Wang LM, 1999, INT J LEPROSY, V67, P403; Wang MY, 2019, CLIN IMMUNOL, V208, DOI 10.1016/j.clim.2019.108259; Wang SF, 2011, VIRAL IMMUNOL, V24, P421, DOI 10.1089/vim.2011.0024; Xiong P, 2008, INT J IMMUNOGENET, V35, P69, DOI 10.1111/j.1744-313X.2007.00741.x; Yancy CW, 2020, JAMA-J AM MED ASSOC, V323, P1891, DOI 10.1001/jama.2020.6548; Yang J, 2020, INT J INFECT DIS, V94, P91, DOI 10.1016/j.ijid.2020.03.017; Younger RM, 2001, GENOME RES, V11, P519, DOI 10.1101/gr.GR-1603R; Zayet S, 2021, INFECTION, V49, P361, DOI 10.1007/s15010-020-01442-3; Zhao M, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105982	74	64	67	1	20	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					8787	8795		10.1096/fj.202001115R	http://dx.doi.org/10.1096/fj.202001115R		JUN 2020	9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32525600	Green Published			2022-12-28	WOS:000541522700001
J	Liu, ZH; Lee, SJ; Park, S; Konstantopoulos, K; Glunde, K; Chen, Y; Barman, I				Liu, Zhenhui; Lee, Se Jong; Park, Seungman; Konstantopoulos, Konstantinos; Glunde, Kristine; Chen, Yun; Barman, Ishan			Cancer cells display increased migration and deformability in pace with metastatic progression	FASEB JOURNAL			English	Article						amoeboid movement; breast cancer metastasis; isogenic cell lines; mechanotyping; microchannel migration	CONFINEMENT; TRANSITION; MECHANISMS; ADHESION; INVASION	In this study, we explored the relation between metastatic states vs the capacity of confined migration, amoeboid transition, and cellular stiffness. We compared across an isogenic panel of human breast cancer cells derived from MDA-MB-231 cells. It was observed that cells after lung metastasis have the fastest migration and lowest stiffness, with a significantly higher capacity to transition into an amoeboid mode. Our findings illustrate that metastasis is a selective process favoring motile and softer cells. Moreover, the observation that circulating tumor cells resemble the parental cell line, but not lung-metastatic cells, suggests that cells with higher deformability and motility are likely selected during extravasation and colonization.	[Liu, Zhenhui; Park, Seungman; Chen, Yun; Barman, Ishan] Johns Hopkins Univ, Dept Mech Engn, Baltimore, MD 21218 USA; [Lee, Se Jong; Konstantopoulos, Konstantinos] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD USA; [Park, Seungman; Konstantopoulos, Konstantinos; Chen, Yun] Johns Hopkins Univ, Johns Hopkins Inst NanoBioTechnol, Baltimore, MD USA; [Park, Seungman; Chen, Yun] Johns Hopkins Univ, Ctr Cell Dynam, Baltimore, MD USA; [Konstantopoulos, Konstantinos] Johns Hopkins Univ, Johns Hopkins Phys Sci Oncol Ctr, Baltimore, MD USA; [Konstantopoulos, Konstantinos] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD USA; [Konstantopoulos, Konstantinos; Barman, Ishan] Johns Hopkins Univ, Dept Oncol, Baltimore, MD USA; [Glunde, Kristine; Barman, Ishan] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Div Canc Imaging Res, Baltimore, MD USA; [Glunde, Kristine] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	Chen, Y; Barman, I (corresponding author), Johns Hopkins Univ, Dept Mech Engn, Baltimore, MD 21218 USA.	yan.chen@jhu.edu; ibarman@jhu.edu	Chen, Yun/AAB-2132-2020	Chen, Yun/0000-0001-6917-7814	National Institute of Biomedical Imaging and Bioengineering (NIBIB) [2-P41-EB015871-31]; National Institute of General Medical Sciences (NIGMS) [DP2GM128198]; National Cancer Institute [R01 CA183804, R01 CA213428, R01 CA213492]; Maryland Stem Cell Research Fund [2018-MSCRFF-4276]	National Institute of Biomedical Imaging and Bioengineering (NIBIB)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Maryland Stem Cell Research Fund	National Institute of Biomedical Imaging and Bioengineering (NIBIB), Grant/Award Number: 2-P41-EB015871-31; National Institute of General Medical Sciences (NIGMS), Grant/Award Number: DP2GM128198; National Cancer Institute, Grant/Award Number: R01 CA183804,, R01 CA213428, and R01 CA213492; Maryland Stem Cell Research Fund, Grant/Award Number: 2018-MSCRFF-4276	Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028; Balzer EM, 2012, FASEB J, V26, P4045, DOI 10.1096/fj.12-211441; Byun S, 2013, P NATL ACAD SCI USA, V110, P7580, DOI 10.1073/pnas.1218806110; Chabottaux V, 2009, J CELL MOL MED, V13, P4002, DOI 10.1111/j.1582-4934.2009.00764.x; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chen JJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep19304; Cheung KJ, 2013, CELL, V155, P1639, DOI 10.1016/j.cell.2013.11.029; Cidado J, 2016, ONCOTARGET, V7, P6281, DOI 10.18632/oncotarget.7057; Cross SE, 2007, NAT NANOTECHNOL, V2, P780, DOI 10.1038/nnano.2007.388; Edelstein Arthur D, 2014, J Biol Methods, V1; Fisher JK, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2166509; Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908; Friedl P, 2012, NAT CELL BIOL, V14, P777, DOI 10.1038/ncb2548; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Guan XM, 2015, ACTA PHARM SIN B, V5, P402, DOI 10.1016/j.apsb.2015.07.005; Hung WC, 2013, J CELL BIOL, V202, P807, DOI 10.1083/jcb.201302132; Innocenti M, 2018, CELL ADHES MIGR, V12, P401, DOI 10.1080/19336918.2018.1448352; Irianto J, 2017, CURR BIOL, V27, P210, DOI 10.1016/j.cub.2016.11.049; Lee G, 2019, ACS BIOMATER SCI ENG, V5, P3735, DOI 10.1021/acsbiomaterials.8b01230; Liu YJ, 2015, CELL, V160, P659, DOI 10.1016/j.cell.2015.01.007; Mack GS, 2010, NAT BIOTECHNOL, V28, P214, DOI 10.1038/nbt0310-214; Mandriota N, 2019, NAT MATER, V18, P1071, DOI 10.1038/s41563-019-0391-7; Mathieu E, 2016, LAB CHIP, V16, P3304, DOI 10.1039/c6lc00860g; Obenauf AC, 2015, TRENDS CANCER, V1, P76, DOI 10.1016/j.trecan.2015.07.009; Padmanaban V, 2019, NATURE, V573, P439, DOI 10.1038/s41586-019-1526-3; Paluch EK, 2013, CURR OPIN CELL BIOL, V25, P582, DOI 10.1016/j.ceb.2013.05.005; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Pankova K, 2010, CELL MOL LIFE SCI, V67, P63, DOI 10.1007/s00018-009-0132-1; Patsialou Antonia, 2013, Intravital, V2, pe25294; Rizwan A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29330-9; Salbreux G, 2012, TRENDS CELL BIOL, V22, P536, DOI 10.1016/j.tcb.2012.07.001; Sosale NG, 2015, BLOOD, V125, P542, DOI 10.1182/blood-2014-06-585299; Stroka KM, 2014, CELL, V157, P611, DOI 10.1016/j.cell.2014.02.052; Swaminathan V, 2011, CANCER RES, V71, P5075, DOI 10.1158/0008-5472.CAN-11-0247; Tong ZQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029211; Weigelin Bettina, 2012, Intravital, V1, P32, DOI 10.4161/intv.21223; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Wu PH, 2018, NAT METHODS, V15, P491, DOI 10.1038/s41592-018-0015-1; Xu WW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046609; Yankaskas CL, 2019, NAT BIOMED ENG, V3, P452, DOI 10.1038/s41551-019-0400-9; ZIEMANN F, 1994, BIOPHYS J, V66, P2210, DOI 10.1016/S0006-3495(94)81017-3	41	15	15	2	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9307	9315		10.1096/fj.202000101RR	http://dx.doi.org/10.1096/fj.202000101RR		MAY 2020	9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32463148	Bronze, Green Accepted			2022-12-28	WOS:000536309500001
J	Iljas, JD; Homer, HA				Iljas, Juvita D.; Homer, Hayden A.			Sirt3 is dispensable for oocyte quality and female fertility in lean and obese mice	FASEB JOURNAL			English	Article						mitochondria; obesity; oocytes; oxidative stress; sirtuins	OXIDATIVE STRESS; SIRT3-DEPENDENT DEACETYLATION; CALORIE RESTRICTION; MATERNAL OBESITY; PROTEIN; MITOCHONDRIA; PROMETAPHASE; METABOLISM; MECHANISMS	Mammalian oocytes rely heavily on mitochondrial oxidative phosphorylation (OXPHOS) for generating ATP. However, mitochondria are also the primary source of damaging reactive oxygen species (ROS). Mitochondrial de-regulation, therefore, underpins poor oocyte quality associated with conditions such as obesity and aging. The mitochondrial sirtuin, Sirt3, is critical for mitochondrial respiration and redox regulation. Interestingly, however, Sirt3 knockout (Sirt3(-/-)) mice do not exhibit systemic compromise under basal conditions, only doing so under stressed conditions such as high-fat diet (HFD)-induced obesity. Mouse oocytes depleted of Sirt3 exhibit increased ROS in vitro, but it is unknown whether Sirt3 is necessary for female fertility in vivo. Here, we test this for the first time by investigating ovarian follicular reserve, oocyte maturation (including detailed spindle assembly and chromosome segregation), and female fertility in Sirt3(-/-) females. We find that under basal conditions, young Sirt3(-/-) females exhibit no defects in any parameters. Surprisingly, all parameters also remain intact following HFD-induced obesity. Despite markedly increased ROS levels in HFD Sirt3(-/-) oocytes, ATP levels nevertheless remain normal. Our data support that ATP is sustained in vivo through increased mitochondrial mass possibly secondary to compensatory upregulation of another sirtuin, Sirt1, which has overlapping functions with Sirt3.	[Iljas, Juvita D.; Homer, Hayden A.] Univ Queensland, Christopher Chen Oocyte Biol Res Lab, Clin Res Ctr, Brisbane, Qld 4029, Australia	University of Queensland	Homer, HA (corresponding author), Univ Queensland, Christopher Chen Oocyte Biol Res Lab, Clin Res Ctr, Brisbane, Qld 4029, Australia.	h.homer@uq.edu.au						Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Babayev E, 2015, CURR OPIN OBSTET GYN, V27, P175, DOI 10.1097/GCO.0000000000000164; Brenmoehl J, 2013, MITOCHONDRION, V13, P755, DOI 10.1016/j.mito.2013.04.002; Buso A, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00474; Busse E, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52921-z; Chowdhury MKH, 2017, SCI REP-UK, V7, DOI 10.1038/srep40159; Ciarlo E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04263-x; Dalton CM, 2013, J CELL SCI, V126, P2955, DOI 10.1242/jcs.128744; de Paula WBM, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0263; EPPIG JJ, 1976, J EXP ZOOL, V198, P375, DOI 10.1002/jez.1401980311; Figueira TR, 2013, ANTIOXID REDOX SIGN, V18, P2029, DOI 10.1089/ars.2012.4729; Grindler NM, 2013, MOL HUM REPROD, V19, P486, DOI 10.1093/molehr/gat026; Gui LM, 2013, DEV CELL, V25, P43, DOI 10.1016/j.devcel.2013.02.008; Gui LM, 2012, DEVELOPMENT, V139, P1941, DOI 10.1242/dev.078352; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Han LS, 2017, J PINEAL RES, V63, DOI 10.1111/jpi.12431; Hebert AS, 2013, MOL CELL, V49, P186, DOI 10.1016/j.molcel.2012.10.024; Hill CM, 2016, AGING CELL, V15, P509, DOI 10.1111/acel.12467; Hirschey MD, 2011, MOL CELL, V44, P177, DOI 10.1016/j.molcel.2011.07.019; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Homer H, 2009, SCIENCE, V326, P991, DOI 10.1126/science.1175326; Igosheva N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010074; Johnson MT, 2007, BIOL REPROD, V77, P2, DOI 10.1095/biolreprod.106.059899; Kawamura Y, 2010, J CLIN INVEST, V120, P2817, DOI 10.1172/JCI42020; Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023; Liu XH, 2017, CELL CYCLE, V16, P1302, DOI 10.1080/15384101.2017.1320004; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Lombard DB, 2014, GERONTOLOGY, V60, P56, DOI 10.1159/000354382; Lukinavicius G, 2014, NAT METHODS, V11, P731, DOI [10.1038/NMETH.2972, 10.1038/nmeth.2972]; Luzzo KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049217; May-Panloup P, 2016, HUM REPROD UPDATE, V22, P725, DOI 10.1093/humupd/dmw028; PEDERSEN T, 1968, J REPROD FERTIL, V17, P555, DOI 10.1530/jrf.0.0170555; Pillai VB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7656; Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015; Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002; Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162; Tao RD, 2010, MOL CELL, V40, P893, DOI 10.1016/j.molcel.2010.12.013; Tilly Jonathan L, 2003, Reprod Biol Endocrinol, V1, P11, DOI 10.1186/1477-7827-1-11; Toyooka Y, 2000, MECH DEVELOP, V93, P139, DOI 10.1016/S0925-4773(00)00283-5; Verdin E, 2010, TRENDS BIOCHEM SCI, V35, P669, DOI 10.1016/j.tibs.2010.07.003; Wai T, 2010, BIOL REPROD, V83, P52, DOI 10.1095/biolreprod.109.080887; Wei Z, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06510-9; Winnik S, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-013-0399-0; Yang W, 2016, CELL, V167, P985, DOI 10.1016/j.cell.2016.10.016; Yu W, 2012, J BIOL CHEM, V287, P14078, DOI 10.1074/jbc.M112.355206; Zhang L, 2015, CELL CYCLE, V14, P2959, DOI 10.1080/15384101.2015.1026517; Zhou CX, 2019, J CELL SCI, V132, DOI 10.1242/jcs.233379	47	14	14	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6641	6653		10.1096/fj.202000153R	http://dx.doi.org/10.1096/fj.202000153R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32212196				2022-12-28	WOS:000531325500045
J	Meyerowitz, EA; Vannier, AGL; Friesen, MGN; Schoenfeld, S; Gelfand, JA; Callahan, MV; Kim, AY; Reeves, PM; Poznansky, MC				Meyerowitz, Eric A.; Vannier, Augustin G. L.; Friesen, Morgan G. N.; Schoenfeld, Sara; Gelfand, Jeffrey A.; Callahan, Michael V.; Kim, Arthur Y.; Reeves, Patrick M.; Poznansky, Mark C.			Rethinking the role of hydroxychloroquine in the treatment of COVID-19	FASEB JOURNAL			English	Review						coronavirus; COV-SARS-2; immunology; immune; SARS	SYSTEMIC-LUPUS-ERYTHEMATOSUS; RESPIRATORY SYNDROME CORONAVIRUS; ANTIMALARIAL-DRUGS; RHEUMATOID-ARTHRITIS; CHLOROQUINE; PNEUMONIA; RISK; CHEMOPROPHYLAXIS; INFECTIONS; AUTOPHAGY	There are currently no proven or approved treatments for coronavirus disease 2019 (COVID-19). Early anecdotal reports and limited in vitro data led to the significant uptake of hydroxychloroquine (HCQ), and to lesser extent chloroquine (CQ), for many patients with this disease. As an increasing number of patients with COVID-19 are treated with these agents and more evidence accumulates, there continues to be no high-quality clinical data showing a clear benefit of these agents for this disease. Moreover, these agents have the potential to cause harm, including a broad range of adverse events including serious cardiac side effects when combined with other agents. In addition, the known and potent immunomodulatory effects of these agents which support their use in the treatment of auto-immune conditions, and provided a component in the original rationale for their use in patients with COVID-19, may, in fact, undermine their utility in the context of the treatment of this respiratory viral infection. Specifically, the impact of HCQ on cytokine production and suppression of antigen presentation may have immunologic consequences that hamper innate and adaptive antiviral immune responses for patients with COVID-19. Similarly, the reported in vitro inhibition of viral proliferation is largely derived from the blockade of viral fusion that initiates infection rather than the direct inhibition of viral replication as seen with nucleoside/tide analogs in other viral infections. Given these facts and the growing uncertainty about these agents for the treatment of COVID-19, it is clear that at the very least thoughtful planning and data collection from randomized clinical trials are needed to understand what if any role these agents may have in this disease. In this article, we review the datasets that support or detract from the use of these agents for the treatment of COVID-19 and render a data informed opinion that they should only be used with caution and in the context of carefully thought out clinical trials, or on a case-by-case basis after rigorous consideration of the risks and benefits of this therapeutic approach.	[Meyerowitz, Eric A.; Vannier, Augustin G. L.; Friesen, Morgan G. N.; Gelfand, Jeffrey A.; Callahan, Michael V.; Kim, Arthur Y.; Reeves, Patrick M.; Poznansky, Mark C.] Massachusetts Gen Hosp MGH, Div Infect Dis, Boston, MA USA; [Meyerowitz, Eric A.; Vannier, Augustin G. L.; Friesen, Morgan G. N.; Schoenfeld, Sara; Gelfand, Jeffrey A.; Callahan, Michael V.; Kim, Arthur Y.; Reeves, Patrick M.; Poznansky, Mark C.] Harvard Med Sch HMS, Bldg 149,13th St, Boston, MA 02129 USA; [Vannier, Augustin G. L.; Friesen, Morgan G. N.; Gelfand, Jeffrey A.; Callahan, Michael V.; Reeves, Patrick M.; Poznansky, Mark C.] MGH, Vaccine & Immunotherapy Ctr VIC, Boston, MA USA; [Schoenfeld, Sara] MGH, Div Allergy Immunol & Rheumatol, Boston, MA USA; [Callahan, Michael V.] US Dept HHS, Publ Hlth Preparedness & Response, Washington, DC 20201 USA	Harvard University; Massachusetts General Hospital	Poznansky, MC (corresponding author), Harvard Med Sch HMS, Bldg 149,13th St, Boston, MA 02129 USA.; Poznansky, MC (corresponding author), Massachusetts Gen Hosp MGH, Vaccine & Immunotherapy Ctr, Div Infect Dis Med, Bldg 149,13th St, Boston, MA 02129 USA.	mpoznansky@mgh.harvard.edu	Reeves, Patrick/I-1066-2018	Reeves, Patrick/0000-0001-8202-0723; Vannier, Augustin/0000-0002-9467-0480				Accapezzato D, 2005, J EXP MED, V202, P817, DOI 10.1084/jem.20051106; Aguiar JA, 2020, GENE EXPRESSION SITU; An J, 2015, J IMMUNOL, V194, P4089, DOI 10.4049/jimmunol.1402793; Bernatsky S, 2007, RHEUMATOLOGY, V46, P1157, DOI 10.1093/rheumatology/kem076; Borba EF, 2012, RHEUMATOLOGY, V51, P1061, DOI 10.1093/rheumatology/ker427; Borba MGS, 2020, CHLOROQUINE DIPHOSPH, DOI [10.1101/2020.04.07.20056424, 10.1101/ 2020.04.07.20056424., DOI 10.1101/2020.04.07.20056424]; BRADLEYMOORE AM, 1985, ANN TROP MED PARASIT, V79, P563, DOI 10.1080/00034983.1985.11811963; Cao XT, 2020, NAT REV IMMUNOL, V20, P269, DOI 10.1038/s41577-020-0308-3; Chen Jun, 2020, Zhejiang Da Xue Xue Bao Yi Xue Ban, V49, P215, DOI 10.3785/j.issn.1008-9292.2020.03.03; Chen X., 2020, RESTORATION LEUKOMON, DOI 10.1101/2020.03.03.20030437; Chopra A, 2014, ARTHRITIS RHEUMATOL, V66, P319, DOI 10.1002/art.38221; Collins KP, 2018, J PHARMACOL EXP THER, V365, P447, DOI 10.1124/jpet.117.245639; Concordia Pharmaceuticals, 2017, PLAQ HYDR SULF TABL; Cong Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194868; de Wilde AH, 2014, ANTIMICROB AGENTS CH, V58, P4875, DOI 10.1128/AAC.03011-14; Di Trani L, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-39; Durcan L, 2015, J RHEUMATOL, V42, P2092, DOI 10.3899/jrheum.150379; Fung TS, 2019, ANNU REV MICROBIOL, V73, P529, DOI 10.1146/annurev-micro-020518-115759; Gao JJ, 2020, BIOSCI TRENDS, V14, P72, DOI 10.5582/bst.2020.01047; Garulli B, 2008, CLIN VACCINE IMMUNOL, V15, P1497, DOI 10.1128/CVI.00166-08; Gautret P, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.105949; Gautret P, 2020, TRAVEL MED INFECT DI, V34, DOI 10.1016/j.tmaid.2020.101663; GILLES HM, 1983, T ROY SOC TROP MED H, V77, P24, DOI 10.1016/0035-9203(83)90005-6; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Guo T, 2020, JAMA CARDIOL, V5, P811, DOI 10.1001/jamacardio.2020.1017; Ibrahim IM, 2020, J INFECTION, V80, P554, DOI 10.1016/j.jinf.2020.02.026; Jang CH, 2006, RHEUMATOLOGY, V45, P703, DOI 10.1093/rheumatology/kei282; Keyaerts E, 2004, BIOCHEM BIOPH RES CO, V323, P264, DOI 10.1016/j.bbrc.2004.08.085; KLEMPNER MS, 1983, J CLIN INVEST, V72, P1793, DOI 10.1172/JCI111139; Kollaritsch H, 1997, J INFECT DIS, V175, P871, DOI 10.1086/513984; LAAKSONEN AL, 1974, SCAND J RHEUMATOL, V3, P103, DOI 10.3109/03009747409115809; Lane, 2020, SAFETY HYDROXYCHLORO, DOI 10.1101/2020.04.08.20054551; Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504; Lim HS, 2009, ANTIMICROB AGENTS CH, V53, P1468, DOI 10.1128/AAC.00339-08; Liu K, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-019-0132-8; Lokugamage Kumari G, 2020, bioRxiv, DOI 10.1101/2020.03.07.982264; Ly A, 2019, CELL REP, V29, P2257, DOI 10.1016/j.celrep.2019.10.087; Mahevas M, 2020, NO EVIDENCE CLIN EFF, P1; Maringer K, 2014, CYTOKINE GROWTH F R, V25, P669, DOI 10.1016/j.cytogfr.2014.08.004; Mizumoto K, 2020, EMERG INFECT DIS, V26, P1251, DOI 10.3201/eid2606.200233; Mocholi E, 2018, CELL REP, V24, P1136, DOI 10.1016/j.celrep.2018.06.065; Molina JM, 2020, MED MAL INFECT; MORRISON LA, 1986, IMMUNOL RES, V5, P294, DOI 10.1007/BF02935502; multicenter collaboration group of Department of Science and Technology of Guangdong Province and Health Commission of Guangdong Province for chloroquine in the treatment of novel coronavirus pneumonia, 2020, Zhonghua Jie He He Hu Xi Za Zhi, V43, pE019, DOI [10.3760/cma.j.issn.1001-0939.2020.03.009, 10.3760/cma.j.issn.1001-0939.2020.0019]; Munster T, 2002, ARTHRITIS RHEUM-US, V46, P1460, DOI 10.1002/art.10307; Murugan R, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aap8029; Oh S, 2016, BIOCHEM BIOPH RES CO, V474, P345, DOI 10.1016/j.bbrc.2016.04.105; Ooi EE, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-39; PAFFENBARGER RS, 1994, MED SCI SPORT EXER, V26, P857; Paton NI, 2011, LANCET INFECT DIS, V11, P677, DOI 10.1016/S1473-3099(11)70065-2; Popert A J, 1976, Rheumatol Rehabil, V15, P235, DOI 10.1093/rheumatology/15.3.235; Rainsford KD, 2015, INFLAMMOPHARMACOLOGY, V23, P231, DOI 10.1007/s10787-015-0239-y; Rokni M, 2020, REV MED VIROL, V30, DOI 10.1002/rmv.2107; Savarino A, 2003, LANCET INFECT DIS, V3, P722, DOI 10.1016/S1473-3099(03)00806-5; Schrezenmeier E, 2020, NAT REV RHEUMATOL, V16, P155, DOI 10.1038/s41584-020-0372-x; Sheahan T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000240; Siddiqi HK, 2020, J HEAR LUNG TRANSPLA; Smitten AL, 2008, J RHEUMATOL, V35, P387; Tang N, 2020, J THROMB HAEMOST, V18, P844, DOI 10.1111/jth.14768; Tang W., 2020, HYDROXYCHLOROQUINE P, DOI [10.1101/2020.04.10.20060558, DOI 10.1101/2020.04.10.20060558]; Taylor MA, 2000, J IMMUNOL, V165, P5048, DOI 10.4049/jimmunol.165.9.5048; TETT SE, 1989, BRIT J CLIN PHARMACO, V27, P771, DOI 10.1111/j.1365-2125.1989.tb03439.x; Thevarajan I, 2020, NAT MED, V26, P453, DOI 10.1038/s41591-020-0819-2; Tu YF, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21072657; Verity R, 2020, ESTIMATES SEVERITY C, DOI DOI 10.1101/2020.03.09.20033357; Vincent MJ, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-69; Voss A, 2020, OFFICIAL STATEMENT I; Wan YS, 2020, J VIROL, V94, DOI 10.1128/JVI.02015-19; Wang DW, 2020, J COASTAL RES, P1, DOI [10.2112/JCR-SI109-001.1, 10.1001/jama.2020.1585]; [王科雯 Wang Kewen], 2020, [测绘通报, Bulletin of Surveying and Mapping], P1; Wang ML, 2020, CELL RES, V30, P269, DOI 10.1038/s41422-020-0282-0; Wolfe F, 2006, ARTHRITIS RHEUM-US, V54, P628, DOI 10.1002/art.21568; Wu JM, 2022, CRIT REV FOOD SCI, V62, P783, DOI [10.1038/s41591-020-0822-7, 10.1080/10408398.2020.1828813]; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Yang J, 2018, J RHEUMATOL, V45, P818, DOI 10.3899/jrheum.170737; Yao X, 2020, CLIN INFECT DIS; Yazdany J, 2020, ANN INTERN MED, V172, P754, DOI 10.7326/M20-1334; Zamora LD, 2020, INT J RHEUM DIS, V23, P197, DOI 10.1111/1756-185X.13725; Zhang, 2020, EFFICACY HYDROXYCHLO, P7, DOI [10.1101/.20040758, 10.1101/2020.03.22.20040758, DOI 10.1101/2020.03.22.20040758]; Zheng HY, 2020, CELL MOL IMMUNOL, V17, P541, DOI 10.1038/s41423-020-0401-3; Zheng MJ, 2020, CELL MOL IMMUNOL, V17, P533, DOI 10.1038/s41423-020-0402-2; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	82	73	78	0	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6027	6037		10.1096/fj.202000919	http://dx.doi.org/10.1096/fj.202000919		APR 2020	11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32350928	Green Published			2022-12-28	WOS:000529982100001
J	Jin, K; Ma, YJ; Manrique-Caballero, CL; Li, H; Emlet, DR; Li, SN; Baty, CJ; Wen, XY; Kim-Campbell, N; Frank, A; Menchikova, EV; Pastor-Soler, NM; Hallows, KR; Jackson, EK; Shiva, S; Pinsky, MR; Zuckerbraun, BS; Kellum, JA; Gomez, H				Jin, Kui; Ma, Yujie; Manrique-Caballero, Carlos L.; Li, Hui; Emlet, David R.; Li, Shengnan; Baty, Catherine J.; Wen, Xiaoyan; Kim-Campbell, Nahmah; Frank, Alicia; Menchikova, Elizabeth, V; Pastor-Soler, Nuria M.; Hallows, Kenneth R.; Jackson, Edwin K.; Shiva, Sruti; Pinsky, Michael R.; Zuckerbraun, Brian S.; Kellum, John A.; Gomez, Hernando			Activation of AMP-activated protein kinase during sepsis/inflammation improves survival by preserving cellular metabolic fitness	FASEB JOURNAL			English	Article						AMPK; metabolism; mitochondria; Sirt3; tubular epithelial cell	ACUTE KIDNEY INJURY; OXIDATIVE STRESS; MITOCHONDRIAL BIOGENESIS; SKELETAL-MUSCLE; SEVERE SEPSIS; RESCUES MICE; METFORMIN; INHIBITION; AUTOPHAGY; GROWTH	The purpose was to determine the role of AMPK activation in the renal metabolic response to sepsis, the development of sepsis-induced acute kidney injury (AKI) and on survival. In a prospective experimental study, 167 10- to 12-week-old C57BL/6 mice underwent cecal ligation and puncture (CLP) and human proximal tubule epithelial cells (TEC; HK2) were exposed to inflammatory mix (IM), a combination of lipopolysaccharide (LPS) and high mobility group box 1 (HMGB1). Renal/TEC metabolic fitness was assessed by monitoring the expression of drivers of oxidative phosphorylation (OXPHOS), the rates of utilization of OXPHOS/glycolysis in response to metabolic stress, and mitochondrial function by measuring O-2 consumption rates (OCR) and the membrane potential (Delta psi(m)). Sepsis/IM resulted in AKI, increased mortality, and in renal AMPK activation 6-24 hours after CLP/IM. Pharmacologic activation of AMPK with 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR) or metformin during sepsis improved the survival, while AMPK inhibition with Compound C increased mortality, impaired mitochondrial respiration, decreased OCR, and disrupted TEC metabolic fitness. AMPK-driven protection was associated with increased Sirt 3 expression and restoration of metabolic fitness. Renal AMPK activation in response to sepsis/IM is an adaptive mechanism that protects TEC, organs, and the host by preserving mitochondrial function and metabolic fitness likely through Sirt3 signaling.	[Jin, Kui] Anhui Prov Hosp, Dept Crit Care, Hefei, Peoples R China; [Ma, Yujie] Air Force Med Ctr, Dept Crit Care Med, Beijing, Peoples R China; [Manrique-Caballero, Carlos L.; Emlet, David R.; Wen, Xiaoyan; Kim-Campbell, Nahmah; Frank, Alicia; Pastor-Soler, Nuria M.; Hallows, Kenneth R.; Pinsky, Michael R.; Zuckerbraun, Brian S.; Kellum, John A.; Gomez, Hernando] Univ Pittsburgh, Ctr Crit Care Nephrol, Dept Crit Care Med, CRISMA Ctr, Pittsburgh, PA 15213 USA; [Li, Hui; Pastor-Soler, Nuria M.; Hallows, Kenneth R.] Univ Southern Calif, Div Nephrol & Hypertens, Keck Sch Med, Los Angeles, CA 90007 USA; [Li, Hui; Pastor-Soler, Nuria M.; Hallows, Kenneth R.] Univ Southern Calif, USC UKRO Kidney Res Ctr, Dept Med, Keck Sch Med, Los Angeles, CA 90007 USA; [Li, Shengnan] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Anesthesiol, Wuhan, Peoples R China; [Baty, Catherine J.] Univ Pittsburgh, Dept Med, Renal Electrolyte Div, Pittsburgh, PA 15213 USA; [Menchikova, Elizabeth, V; Jackson, Edwin K.; Shiva, Sruti] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA; [Shiva, Sruti; Gomez, Hernando] Univ Pittsburgh, Vasc Med Inst, Pittsburgh, PA 15213 USA; [Zuckerbraun, Brian S.] Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Southern California; University of Southern California; Huazhong University of Science & Technology; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Gomez, H (corresponding author), Univ Pittsburgh, Ctr Crit Care Ncphrol, Dept Crit Care Med, Sch Med, 3347 Forbes Ave,Suite 220,Rm 207, Pittsburgh, PA 15213 USA.	gomezh@upmc.edu	Kellum, John A/HCH-2944-2022; Kellum, John/AAP-3072-2020; ma, yujie/GYA-3957-2022; Gomez, Hernando/ABB-4589-2020	Kellum, John A/0000-0003-1995-2653; Kellum, John/0000-0003-1995-2653; Hallows, Kenneth/0000-0002-2964-2440	National Institutes of Health [1K12HL109068-02, 1K08GM117310-01A1, DK079307, HL109002]; kidney imaging and cellular physiology cores of the Pittsburgh Center for Kidney Research [P30 DK079307, S10 OD021627, R01 DK075048]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); kidney imaging and cellular physiology cores of the Pittsburgh Center for Kidney Research	This work was supported by the National Institutes of Health grants 1K12HL109068-02 (HG) and 1K08GM117310-01A1 (HG), DK079307 (EKJ), and HL109002 (EKJ). We are grateful for support from the kidney imaging and cellular physiology cores of the Pittsburgh Center for Kidney Research (P30 DK079307 and S10 OD021627), R01 DK075048 (KRH), P30 DK079307 (The Pittsburgh Center for Kidney Research; NMPS, KRH, EJ). HG served one time only on the Edwards LifeSciences advisory board in January 2017 and received a onetime honorarium	Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Angele MK, 2014, VIRULENCE, V5, P12, DOI 10.4161/viru.26982; Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; [Anonymous], CRIT CARE MED; Arad M, 2007, CIRC RES, V100, P474, DOI 10.1161/01.RES.0000258446.23525.37; Avalos JL, 2005, MOL CELL, V17, P855, DOI 10.1016/j.molcel.2005.02.022; Benziane B, 2009, AM J PHYSIOL-CELL PH, V297, pC1554, DOI 10.1152/ajpcell.00010.2009; Canto C, 2010, CELL METAB, V11, P213, DOI 10.1016/j.cmet.2010.02.006; Cao Y, 2015, FEBS J, V282, P3799, DOI 10.1111/febs.13379; Carchman E, 2010, J AM COLL SURGEONS, V211, pS48, DOI 10.1016/j.jamcollsurg.2010.06.125; Cardenes N, 2014, BLOOD, V123, P2864, DOI 10.1182/blood-2013-09-529420; Chen LY, 2018, OSTEOARTHR CARTILAGE, V26, P1539, DOI 10.1016/j.joca.2018.07.004; Cherry AD, 2015, ANTIOXID REDOX SIGN, V22, P965, DOI 10.1089/ars.2014.6200; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; Cottet-Rousselle C, 2011, CYTOM PART A, V79A, P405, DOI 10.1002/cyto.a.21061; EHRENBERG B, 1988, BIOPHYS J, V53, P785, DOI 10.1016/S0006-3495(88)83158-8; Escobar DA, 2015, J SURG RES, V194, P262, DOI 10.1016/j.jss.2014.10.009; FARKAS DL, 1989, BIOPHYS J, V56, P1053, DOI 10.1016/S0006-3495(89)82754-7; Faubert B, 2013, CELL METAB, V17, P113, DOI 10.1016/j.cmet.2012.12.001; Fu JR, 2012, J BIOL CHEM, V287, P24460, DOI 10.1074/jbc.M112.382226; Goodpaster BH, 2017, CELL METAB, V25, P1027, DOI 10.1016/j.cmet.2017.04.015; Gowans GJ, 2013, CELL METAB, V18, P556, DOI 10.1016/j.cmet.2013.08.019; Gras V, 2006, DIABETES METAB, V32, P147, DOI 10.1016/S1262-3636(07)70261-6; Guan XY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107729; Guo LP, 2013, J IMMUNOL, V190, P3620, DOI 10.4049/jimmunol.1102975; Hardie DG, 2011, BIOCHEM SOC T, V39, P1, DOI 10.1042/BST0390001; Hotchkiss RS, 1999, CRIT CARE MED, V27, P1230, DOI 10.1097/00003246-199907000-00002; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Jackson EK, 2017, J NEUROCHEM, V141, P676, DOI 10.1111/jnc.14018; Kalender A, 2010, CELL METAB, V11, P390, DOI 10.1016/j.cmet.2010.03.014; Kang HM, 2014, NAT MED, V21, P1; Kautza B, 2015, NITRIC OXIDE-BIOL CH, V51, P7, DOI 10.1016/j.niox.2015.09.006; Kelley DE, 1999, AM J PHYSIOL-ENDOC M, V277, pE1130; Kellum JA, 2007, ARCH INTERN MED, V167, P1655, DOI 10.1001/archinte.167.15.1655; Kellum JA, 2016, AM J RESP CRIT CARE, V193, P281, DOI 10.1164/rccm.201505-0995OC; Kinaan M, 2015, MED PRIN PRACT, V24, P401, DOI 10.1159/000381643; Kisfalvi K, 2013, PANCREAS, V42, P781, DOI 10.1097/MPA.0b013e31827aec40; Kong XX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011707; Lancel S, 2009, J PHARMACOL EXP THER, V329, P641, DOI 10.1124/jpet.108.148049; Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185; Lemasters JJ, 2007, METHOD CELL BIOL, V80, P283, DOI 10.1016/S0091-679X(06)80014-2; Lerolle N, 2010, INTENS CARE MED, V36, P471, DOI 10.1007/s00134-009-1723-x; Li W, 2015, LAB INVEST, V95, P635, DOI 10.1038/labinvest.2015.44; MacGarvey NC, 2012, AM J RESP CRIT CARE, V185, P851, DOI 10.1164/rccm.201106-1152OC; Morigi M, 2015, J CLIN INVEST, V125, P715, DOI 10.1172/JCI77632; Murugan R, 2011, NAT REV NEPHROL, V7, P209, DOI 10.1038/nrneph.2011.13; Nishino Y, 2004, CARDIOVASC RES, V61, P610, DOI 10.1016/j.cardiores.2003.10.022; Opal SM, 2016, SHOCK, V45, P411, DOI 10.1097/SHK.0000000000000528; Pias EK, 2003, J BIOL CHEM, V278, P13294, DOI 10.1074/jbc.M208670200; Quoilin C, 2014, BBA-BIOENERGETICS, V1837, P1790, DOI 10.1016/j.bbabio.2014.07.005; Rabinovitch RC, 2017, CELL REP, V21, P1, DOI 10.1016/j.celrep.2017.09.026; Ranhotra HS, 2009, MOL CELL BIOCHEM, V332, P59, DOI 10.1007/s11010-009-0174-6; Rasola A, 2001, CYTOMETRY, V45, P151, DOI 10.1002/1097-0320(20011001)45:2<151::AID-CYTO1157>3.0.CO;2-I; Ren J, 2016, J MOL CELL CARDIOL, V93, P18, DOI 10.1016/j.yjmcc.2016.02.002; RYAN MJ, 1994, KIDNEY INT, V45, P48, DOI 10.1038/ki.1994.6; Schmidt C, 2007, CRIT CARE MED, V35, P2110, DOI 10.1097/01.ccm.0000281447.22966.8b; Takasu O, 2013, AM J RESP CRIT CARE, V187, P509, DOI 10.1164/rccm.201211-1983OC; Thong FSL, 2007, DIABETES, V56, P414, DOI 10.2337/db06-0900; Tran M, 2011, J CLIN INVEST, V121, P4003, DOI 10.1172/JCI58662; Tran MT, 2016, NATURE, V531, P528, DOI 10.1038/nature17184; Tsoyi K, 2011, BRIT J PHARMACOL, V162, P1498, DOI 10.1111/j.1476-5381.2010.01126.x; Vachharajani VT, 2014, J LEUKOCYTE BIOL, V96, P785, DOI 10.1189/jlb.3MA0114-034RR; Wald R, 2009, JAMA-J AM MED ASSOC, V302, P1179, DOI 10.1001/jama.2009.1322; Wang LS, 2013, POLYMER COMPOSITES, VOL 2, P13; Wang Z, 2012, AM J PATHOL, V180, P505, DOI 10.1016/j.ajpath.2011.10.011; Wu SB, 2012, BBA-MOL BASIS DIS, V1822, P233, DOI 10.1016/j.bbadis.2011.09.014; Xie W, 2017, MED SCI MONITOR, V23, P29, DOI 10.12659/MSM.898710; Zhan M, 2013, KIDNEY INT, V83, P568, DOI 10.1038/ki.2012.441; Zhang XH, 2017, FASEB J, V31, P4382, DOI 10.1096/fj.201601096RRR	69	23	25	0	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					7036	7057		10.1096/fj.201901900R	http://dx.doi.org/10.1096/fj.201901900R		APR 2020	22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32246808				2022-12-28	WOS:000523598200001
J	Stenina-Adognravi, O; Murphy-Ullrich, J				Stenina-Adognravi, Olga; Murphy-Ullrich, Joanne			The 2019 FASEB Science Research Conference on Matricellular Proteins in Inflammation and Tissue Remodeling, July 14-19, 2019, Lisbon, Portugal	FASEB JOURNAL			English	Article									[Stenina-Adognravi, Olga] Cleveland State Univ, Dept Cardiovasc & Metab Sci, Cleveland Clin, Lerner Coll Med, 9500 Euclid Ave, Cleveland, OH 44115 USA; [Murphy-Ullrich, Joanne] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA	Case Western Reserve University; Cleveland Clinic Foundation; University System of Ohio; Cleveland State University; University of Alabama System; University of Alabama Birmingham	Stenina-Adognravi, O (corresponding author), Cleveland State Univ, Dept Cardiovasc & Metab Sci, Cleveland Clin, Lerner Coll Med, 9500 Euclid Ave, Cleveland, OH 44115 USA.	steinino@ccf.org			NHLBI NIH HHS [R13 HL147539] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))			0	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					4825	4827		10.1096/fj.202000364	http://dx.doi.org/10.1096/fj.202000364			3	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32167185				2022-12-28	WOS:000530242100002
J	Singh, A				Singh, Amandeep			Expanding the Horizon of Recombination Repair in Mycobacteria: Identification and Characterization of Novel Proteins	FASEB JOURNAL			English	Meeting Abstract	Experimental Biology Meeting	APR 21-25, 2018	Amer Assoc Anatomists, San Diego, CA	Amer Physiol Soc, Amer Soc Biochemistry & Mol Biol, Amer Soc Investigat Pathol, Amer Soc Pharmacol & Experimental Therapeut	Amer Assoc Anatomists										Department of Biotechnology, India	Department of Biotechnology, India(Department of Biotechnology (DBT) India)	Department of Biotechnology, India		0	1	1	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	1		S		lb1								1	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GL2VX	32504469				2022-12-28	WOS:000436985002370
J	Kim, HY; Kwon, WY; Park, JB; Lee, MH; Oh, YJ; Suh, S; Baek, YH; Jeong, JS; Yoo, YH				Kim, Hye Young; Kwon, Woo Young; Park, Joon Beom; Lee, Mi Hwa; Oh, Yoo Jin; Suh, SungHwan; Baek, Yang Hyun; Jeong, Jin Sook; Yoo, Young Hyun			Hepatic STAMP2 mediates recombinant FGF21-induced improvement of hepatic iron overload in nonalcoholic fatty liver disease	FASEB JOURNAL			English	Article						hepatic steatosis; insulin resistance; iron exporter; iron homeostasis	HEPATOCELLULAR-CARCINOMA; INSULIN-RESISTANCE; SEX-DIFFERENCES; STEAP PROTEINS; CELLULAR IRON; STEATOHEPATITIS; FERROPORTIN; HOMEOSTASIS; STEATOSIS; HYPERFERRITINEMIA	Although previous studies have shown that the administration of fibroblast growth factor 21 (FGF21) reverses hepatic steatosis, the mechanism by which FGF21 exerts a therapeutic effect on nonalcoholic fatty liver disease (NAFLD) is not yet entirely understood. We previously demonstrated that hepatic six transmembrane protein of prostate 2 (STAMP2) may represent a suitable target for NAFLD. We investigated the mechanism underlying the therapeutic effect of recombinant FGF21 on NAFLD, focusing on the involvement of hepatic STAMP2. In this study, we used human nonalcoholic steatosis patient pathology samples, C57BL/6 mice for a high-fat diet (HFD)-induced in vivo NAFLD model, and used human primary hepatocytes and HepG2 cells for oleic acid (OA)-induced in vitro NAFLD model. We observed that recombinant FGF21 treatment ameliorated hepatic steatosis and insulin resistance through the upregulation of STAMP2 expression. We further observed hepatic iron overload (HIO) and reduced iron exporter, ferroportin expression in the liver samples obtained from human NAFLD patients, and HFD-induced NAFLD mice and in OA-treated HepG2 cells. Importantly, recombinant FGF21 improved HIO through the hepatic STAMP2-mediated upregulation of ferroportin expression. Our data suggest that hepatic STAMP2 may represent a suitable therapeutic intervention target for FGF21-induced improvement of NAFLD accompanying HIO.	[Kim, Hye Young; Kwon, Woo Young; Park, Joon Beom; Lee, Mi Hwa; Oh, Yoo Jin; Yoo, Young Hyun] Dong A Univ, Dept Anat & Cell Biol, Coll Med, Busan 49201, South Korea; [Suh, SungHwan] Dong A Univ, Dept Endocrinol, Coll Med, Busan, South Korea; [Baek, Yang Hyun] Dong A Univ, Dept Gastroenterol, Coll Med, Busan, South Korea; [Jeong, Jin Sook] Dong A Univ, Coll Med, Dept Pathol, Busan, South Korea	Dong A University; Dong A University; Dong A University; Dong A University	Yoo, YH (corresponding author), Dong A Univ, Dept Anat & Cell Biol, Coll Med, Busan 49201, South Korea.	yhyoo@dau.ac.kr			National Research Foundation of Korea - Korea government [NRF-2019R1A2C2002266, NRF-2019R1C1C1002274, NRF-2016R1A5A2007009]	National Research Foundation of Korea - Korea government(National Research Foundation of KoreaKorean Government)	This work was supported by the National Research Foundation of Korea grant funded by the Korea government (No. NRF-2019R1A2C2002266, NRF-2019R1C1C1002274, NRF-2016R1A5A2007009).	Abedini A, 2007, IMMUNOL CELL BIOL, V85, P399, DOI 10.1038/sj.icb.7100107; Aigner E, 2008, AM J CLIN NUTR, V87, P1374, DOI 10.1093/ajcn/87.5.1374; Anderson ER, 2013, COMPR PHYSIOL, V3, P315, DOI 10.1002/cphy.c120016; BACON BR, 1990, HEPATOLOGY, V11, P127, DOI 10.1002/hep.1840110122; Boga S, 2015, J GASTROINTEST LIVER, V24, P293, DOI 10.15403/jgld.2014.1121.243.hak; Britton LJ, 2016, WORLD J GASTROENTERO, V22, P8112, DOI 10.3748/wjg.v22.i36.8112; Chen XL, 2014, ENDOCRINE, V47, P372, DOI 10.1007/s12020-014-0230-1; Chitturi S, 2002, HEPATOLOGY, V36, P142, DOI 10.1053/jhep.2002.33892; Chukijrungroat N, 2017, AM J PHYSIOL-ENDOC M, V313, pE203, DOI 10.1152/ajpendo.00076.2017; Datz C, 2017, MINERVA ENDOCRINOL, V42, P173, DOI 10.23736/S0391-1977.16.02565-7; Datz C, 2013, EUR J CLIN INVEST, V43, P215, DOI 10.1111/eci.12032; Deguti MM, 2003, BRAZ J MED BIOL RES, V36, P739, DOI 10.1590/S0100-879X2003000600009; Dongiovanni P, 2011, J HEPATOL, V55, P920, DOI 10.1016/j.jhep.2011.05.008; Drakesmith H, 2015, CELL METAB, V22, P777, DOI 10.1016/j.cmet.2015.09.006; Duseja A, 2005, WORLD J GASTROENTERO, V11, P393, DOI 10.3748/wjg.v11.i3.393; Ebe H, 2019, MOD RHEUMATOL, V29, P714, DOI 10.1080/14397595.2018.1484415; Fargion S, 2001, AM J GASTROENTEROL, V96, P2448, DOI 10.1111/j.1572-0241.2001.04052.x; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Fernandez-Real JM, 1998, DIABETES CARE, V21, P62, DOI 10.2337/diacare.21.1.62; George DK, 1998, GASTROENTEROLOGY, V114, P311, DOI 10.1016/S0016-5085(98)70482-2; Graham RM, 2007, WORLD J GASTROENTERO, V13, P4725, DOI 10.3748/wjg.v13.i35.4725; Harrison-Findik DD, 2010, WORLD J HEPATOL, V2, P302, DOI 10.4254/wjh.v2.i8.302; Iwasa M, 2010, HEPATOL RES, V40, P1188, DOI 10.1111/j.1872-034X.2010.00724.x; Kim HY, 2015, J HEPATOL, V63, P477, DOI 10.1016/j.jhep.2015.01.025; Knutson MD, 2007, NUTR REV, V65, P335, DOI 10.1301/nr.2007.jul.335-340; Kong WN, 2014, BIOL TRACE ELEM RES, V160, P258, DOI 10.1007/s12011-014-0051-3; Murali AR, 2018, HEPATOL RES, V48, pE30, DOI 10.1111/hepr.12921; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Oh YJ, 2018, MOL PHARMACOL, V94, P1401, DOI 10.1124/mol.118.113217; Ohgami RS, 2006, BLOOD, V108, P1388, DOI 10.1182/blood-2006-02-003681; Olynyk JK, 2005, AM J GASTROENTEROL, V100, P837, DOI 10.1111/j.1572-0241.2005.41287.x; Olynyk JK, 2009, CLIN GASTROENTEROL H, V7, P359, DOI 10.1016/j.cgh.2008.11.010; Pietrangelo Antonello, 2016, J Hepatol, V65, P226, DOI 10.1016/j.jhep.2016.01.037; Qiao B, 2012, CELL METAB, V15, P918, DOI 10.1016/j.cmet.2012.03.018; Scarl RT, 2017, J ENDOCRINOL, V234, pR123, DOI 10.1530/JOE-16-0594; Sikkeland J, 2016, MOL CELL ENDOCRINOL, V425, P26, DOI 10.1016/j.mce.2016.02.013; Sorrentino P, 2009, J HEPATOL, V50, P351, DOI 10.1016/j.jhep.2008.09.011; Starley BQ, 2010, HEPATOLOGY, V51, P1820, DOI 10.1002/hep.23594; Sumida Y, 2003, J HEPATOL, V38, P32, DOI 10.1016/S0168-8278(02)00331-8; Valenti L, 2007, AM J GASTROENTEROL, V102, P1251, DOI 10.1111/j.1572-0241.2007.01192.x; Waki H, 2007, CELL, V129, P451, DOI 10.1016/j.cell.2007.04.022; Ward DM, 2012, BBA-MOL CELL RES, V1823, P1426, DOI 10.1016/j.bbamcr.2012.03.004; Wellen KE, 2007, CELL, V129, P537, DOI 10.1016/j.cell.2007.02.049; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Younossi ZM, 1999, HEPATOLOGY, V30, P847, DOI 10.1002/hep.510300407; Younossi ZM, 2019, J HEPATOL, V70, P531, DOI 10.1016/j.jhep.2018.10.033; Zhu SL, 2016, MOL CELL BIOCHEM, V420, P107, DOI 10.1007/s11010-016-2774-2; Zhu SL, 2014, ACTA BIOCH BIOPH SIN, V46, P1041, DOI 10.1093/abbs/gmu097	48	9	10	2	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12354	12366		10.1096/fj.202000790R	http://dx.doi.org/10.1096/fj.202000790R		JUL 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32721044				2022-12-28	WOS:000556062000001
J	Zhao, H; Jiang, N; Han, YC; Yang, M; Gao, P; Xiong, XF; Xiong, S; Zeng, LF; Xiao, Y; Wei, L; Li, L; Li, CR; Yang, JF; Tang, CY; Xiao, L; Liu, FY; Liu, Y; Sun, L				Zhao, Hao; Jiang, Na; Han, Yachun; Yang, Ming; Gao, Peng; Xiong, Xiaofen; Xiong, Shan; Zeng, Lingfeng; Xiao, Ying; Wei, Ling; Li, Li; Li, Chenrui; Yang, Jinfei; Tang, Chengyuan; Xiao, Li; Liu, Fuyou; Liu, Yu; Sun, Lin			Aristolochic acid induces renal fibrosis by arresting proximal tubular cells in G2/M phase mediated by HIF-1 alpha	FASEB JOURNAL			English	Article						aristolochic acid nephropathy; G2/M arrest; HIF-1 alpha; p21; renal fibrosis	HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; KIDNEY-DISEASE; CYCLE ARREST; NEPHROPATHY; INJURY; INDUCTION; PROLIFERATION; EXPRESSION; P21; HIF	Renal tubulointerstitial fibrosis (TIF) is a common pathological feature of aristolochic acid (AA) nephropathy (AAN). G2/M arrest of proximal tubular cells (PTCs) is implicated in renal fibrosis of AAN, but the upstream regulatory molecule remains unknown. Hypoxia inducible factor-1 alpha (HIF-1 alpha) promotes renal fibrosis in kidney disease, but the role of HIF-1 alpha in AAN is unclear. Evidence shows that HIF-1 alpha and p21, a known inducer of cellular G2/M arrest, are closely related to each other. To investigate the role of HIF-1 alpha in renal fibrosis of AAN and its effects on p21 expression and PTCs G2/M arrest, mice with HIF-1 alpha gene knockout PTCs (PT-HIF-1 alpha-KO) were generated, and AAN was induced by AA. In vitro tests were conducted on the human PTCs line HK-2 and primary mouse PTCs. HIF-1 alpha and p21 expression, fibrogenesis, and G2/M arrest of PTCs were determined. Results showed that HIF-1 alpha was upregulated in the kidneys of wild-type (WT) AAN mice, accompanied by p21 upregulation, PTCs G2/M arrest and renal fibrosis, and these alterations were reversed in PT-HIF-1 alpha-KO AAN mice. Similar results were observed in HK-2 cells and were further confirmed in primary PTCs from PT-HIF-1 alpha-KO and WT mice. Inhibiting p21 in HK-2 cells and primary PTCs did not change the expression of HIF-1 alpha, but G2/M arrest and fibrogenesis were reduced. These data indicate that HIF-1 alpha plays a key role in renal fibrosis in AAN by inducing PTCs G2/M arrest modulated through p21. HIF-1 alpha may serve as a potential therapeutic target for AAN.	[Zhao, Hao; Jiang, Na; Han, Yachun; Yang, Ming; Gao, Peng; Xiong, Xiaofen; Xiong, Shan; Zeng, Lingfeng; Xiao, Ying; Wei, Ling; Li, Li; Li, Chenrui; Yang, Jinfei; Tang, Chengyuan; Xiao, Li; Liu, Fuyou; Liu, Yu; Sun, Lin] Cent South Univ, Xiangya Hosp 2, Hunan Key Lab Kidney Dis & Blood Purificat, Dept Nephrol, 139 Renmin Middle Rd, Changsha 410011, Hunan, Peoples R China	Central South University	Liu, Y; Sun, L (corresponding author), Cent South Univ, Xiangya Hosp 2, Hunan Key Lab Kidney Dis & Blood Purificat, Dept Nephrol, 139 Renmin Middle Rd, Changsha 410011, Hunan, Peoples R China.	rory0423@163.com; sunlin@csu.edu.cn			NSFC \ National Natural Science Foundation of China [81570622]; NSFC \ Key Programme [81730018]; National Key R&D program of China [2018YFC1314002]	NSFC \ National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NSFC \ Key Programme; National Key R&D program of China	NSFC vertical bar National Natural Science Foundation of China, Grant/Award Number: 81570622; NSFC vertical bar Key Programme, Grant/Award Number: 81730018; National Key R&D program of China, Grant/Award Number: 2018YFC1314002	Bach A, 2010, ANTIOXID REDOX SIGN, V13, P437, DOI 10.1089/ars.2009.3000; Ball MK, 2014, AM J RESP CRIT CARE, V189, P314, DOI 10.1164/rccm.201302-0302OC; Baudoux T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23565-2; Bonventre JV, 2014, KIDNEY INT SUPPL, V4, P39, DOI 10.1038/kisup.2014.8; Canaud G, 2015, NEPHROL DIAL TRANSPL, V30, P575, DOI 10.1093/ndt/gfu230; Chen YY, 2010, ONCOL REP, V24, P141, DOI 10.3892/or_00000839; Cho YS, 2008, BBA-MOL CELL RES, V1783, P323, DOI 10.1016/j.bbamcr.2007.11.017; Crosio C, 2002, MOL CELL BIOL, V22, P874, DOI 10.1128/MCB.22.3.874-885.2002; Dai XY, 2016, ONCOTARGET, V7, P10841, DOI 10.18632/oncotarget.7460; Debelle FD, 2008, KIDNEY INT, V74, P158, DOI 10.1038/ki.2008.129; Eckardt Kai-Uwe, 2005, Kidney Int Suppl, pS46; Fischer M, 2016, NUCLEIC ACIDS RES, V44, P164, DOI 10.1093/nar/gkv927; Gokmen MR, 2013, ANN INTERN MED, V158, P469, DOI 10.7326/0003-4819-158-6-201303190-00006; Gunaratnam L, 2009, J AM SOC NEPHROL, V20, P1877, DOI 10.1681/ASN.2008070804; Han JY, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00648; Higgins DF, 2007, J CLIN INVEST, V117, P3810, DOI 10.1172/JCI30487; Huang M, 2018, CELL SIGNAL, V51, P139, DOI 10.1016/j.cellsig.2018.08.002; Jadot I, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020297; Jeong W, 2018, THERIOGENOLOGY, V115, P9, DOI 10.1016/j.theriogenology.2018.04.016; Karimian A, 2016, DNA REPAIR, V42, P63, DOI 10.1016/j.dnarep.2016.04.008; Kawakami T, 2014, KIDNEY INT SUPPL, V4, P107, DOI 10.1038/kisup.2014.20; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Kimura K, 2008, AM J PHYSIOL-RENAL, V295, pF1023, DOI 10.1152/ajprenal.90209.2008; Lin SL, 2005, J AM SOC NEPHROL, V16, P2702, DOI 10.1681/ASN.2005040435; Liu J, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18050950; Liu KH, 2013, CANCER LETT, V340, P22, DOI 10.1016/j.canlet.2013.06.024; Liu LM, 2019, J MOL CELL BIOL, V11, P371, DOI 10.1093/jmcb/mjy042; Marin DE, 2018, N-S ARCH PHARMACOL, V391, P1147, DOI 10.1007/s00210-018-1538-9; Nayak BK, 2016, DIABETES, V65, P1387, DOI 10.2337/db15-0519; Reginster F, 1997, NEPHROL DIAL TRANSPL, V12, P81, DOI 10.1093/ndt/12.1.81; Richard DE, 2000, J BIOL CHEM, V275, P26765; Salnikow K, 2000, CANCER RES, V60, P5630; Sandau KB, 2001, J BIOL CHEM, V276, P39805, DOI 10.1074/jbc.M107689200; Stiehl DP, 2002, FEBS LETT, V512, P157, DOI 10.1016/S0014-5793(02)02247-0; VANHERWEGHEM JL, 1993, LANCET, V341, P387, DOI 10.1016/0140-6736(93)92984-2; Wen YJ, 2008, TRANSL RES, V152, P38, DOI 10.1016/j.trsl.2008.05.002; Wu HL, 2007, J CLIN INVEST, V117, P2847, DOI 10.1172/JCI31008; Xiao L, 2017, REDOX BIOL, V11, P297, DOI 10.1016/j.redox.2016.12.022; Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144; Yang SK, 2017, REDOX BIOL, V13, P482, DOI 10.1016/j.redox.2017.07.002; Zhang Y, 2019, AGING-US, V11, P2241, DOI 10.18632/aging.101911; Zhou L, 2010, AM J PHYSIOL-RENAL, V298, pF1006, DOI 10.1152/ajprenal.00675.2009; Zhu SH, 2010, FORENSIC SCI INT, V199, pE5, DOI 10.1016/j.forsciint.2010.02.003	43	9	9	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12599	12614		10.1096/fj.202000949R	http://dx.doi.org/10.1096/fj.202000949R		JUL 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32706145	hybrid			2022-12-28	WOS:000556097300001
J	Wan, XY; Zhu, XD; Wang, H; Feng, Y; Zhou, WH; Liu, PH; Shen, WY; Zhang, LL; Liu, LM; Li, TL; Diao, DJ; Yang, F; Zhao, Q; Chen, L; Ren, J; Yan, S; Li, J; Yu, CH; Ju, ZY				Wan, Xingyong; Zhu, Xudong; Wang, Hu; Feng, Ye; Zhou, Weihua; Liu, Peihao; Shen, Weiyan; Zhang, Lingling; Liu, Leiming; Li, Tangliang; Diao, Daojun; Yang, Fan; Zhao, Qi; Chen, Li; Ren, Jian; Yan, Sheng; Li, Jing; Yu, Chaohui; Ju, Zhenyu			PGC1 alpha protects against hepatic steatosis and insulin resistance via enhancing IL10-mediated anti-inflammatory response	FASEB JOURNAL			English	Article						hepatic steatosis; IL-10; inflammation; insulin resistance; PGC1 alpha	PROLIFERATOR-ACTIVATED RECEPTOR; FATTY LIVER-DISEASE; MITOCHONDRIAL BIOGENESIS; COACTIVATOR; PGC-1-ALPHA; METABOLISM; GLUCONEOGENESIS; DYSFUNCTION	Inflammatory responses are pivotal incidences in hepatic metabolic derangements. However, the underlying mechanism remains elusive. The present study aimed to evaluate the role of peroxisome proliferator-activated receptor-gamma, coactivator 1 alpha (PGC1 alpha) in IL10-mediated anti-inflammatory response, and its role in hepatic steatosis and insulin resistance. Hepatocyte-specific PGC1 alpha knock-in (LivPGC1 alpha) mice and the control mice were fed high-fat diet (HFD) for 8 weeks. IL-10 neutralizing antibody was injected into the liver of PGC1 alpha mice. A variety of biological and histological approaches were applied to assess hepatic function. We demonstrated that hepatic PGC1 alpha expression was significantly reduced in mice fed HFD. LivPGC1 alpha livers exhibited enhanced gene expressions involving mitochondrial function, and favored an accelerated lipid metabolism upon HFD. Meanwhile, LivPGC1 alpha mice revealed improved hepatic steatosis and insulin resistance. Mechanistically, PGC1 alpha bound and activated the promotor region of IL-10, thereby attenuating inflammatory response in the liver. Administration of IL10 neutralizing antibody to LivPGC1 alpha mice abolished PGC1 alpha-mediated anti-inflammatory effects in mice. Further, IL-10 neutralizing antibody intervention aggravated hepatic steatosis and insulin resistance in LivPGC1 alpha mice. Taken together, our data indicated that hepatic-specific overexpression of PGC1 alpha exerts a beneficial role in the regulation of hepatic steatosis and insulin resistance via enhancing IL10-mediated anti-inflammatory response. Pharmacological activation of PGC1 alpha-IL10 axis may be promising for the treatment of fatty liver diseases.	[Wan, Xingyong; Feng, Ye; Zhou, Weihua; Liu, Peihao; Yu, Chaohui] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Gastroenterol, Hangzhou 310003, Peoples R China; [Zhu, Xudong; Wang, Hu; Zhang, Lingling; Li, Tangliang; Ju, Zhenyu] Hangzhou Normal Univ, Inst Ageing Res, Sch Med, Hangzhou 311121, Peoples R China; [Zhou, Weihua] Sanmen Peoples Hosp, Dept Pathol, Taizhou, Peoples R China; [Shen, Weiyan; Liu, Leiming; Diao, Daojun; Yang, Fan; Ju, Zhenyu] Jinan Univ, Inst Aging & Regenerat Med, Minist Educ, Key Lab Regenerat Med, Guangzhou 510632, Peoples R China; [Zhao, Qi; Chen, Li; Ren, Jian] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Canc Ctr, Guangzhou, Peoples R China; [Yan, Sheng] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Hepatobiliary Surg, Hangzhou, Peoples R China; [Li, Jing] Capital Med Univ, Beijing Chao Yang Hosp, Dept Endocrinol, Beijing, Peoples R China	Zhejiang University; Hangzhou Normal University; Jinan University; State Key Lab Oncology South China; Sun Yat Sen University; Zhejiang University; Capital Medical University	Yu, CH (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Gastroenterol, Hangzhou 310003, Peoples R China.; Zhu, XD (corresponding author), Hangzhou Normal Univ, Inst Ageing Res, Sch Med, Hangzhou 311121, Peoples R China.; Ju, ZY (corresponding author), Jinan Univ, Inst Aging & Regenerat Med, Minist Educ, Key Lab Regenerat Med, Guangzhou 510632, Peoples R China.	xzhu2013@163.com; xzhu2013@163.com; zhenyuju@163.com	zhang, lingling/HDM-2189-2022; Zhao, Qi/X-7899-2019	Zhao, Qi/0000-0002-8683-6145; Zhu, Xudong/0000-0002-0873-6800	National Natural Science Foundation of China [81700511, 91749203, 81525010, 81570523, 81400221]; National Key R&D Program of China [2016YFA0100602, 2017YFA0103302]; Program for Guangdong Introducing Innovative and Enterpreneurial Teams [2017ZT07S347]; Innovative Team Program of Guangzhou Regenerative Medicine and Health Guangdong Laboratory [2018GZR110103002]; National Key Research and Development Program of China [2017YFC0908900]; Opening Project of Key Laboratory of Integrative Chinese and Western Medicine for the Diagnosis and Treatment of Circulatory Diseases of Zhejiang Province [2C32003]; Hangzhou Normal University [PF14002004017]; Natural science foundation of Zhejiang province [LY20H030004]; Zhejiang Medical Science and Technology project [2017193668]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; Program for Guangdong Introducing Innovative and Enterpreneurial Teams; Innovative Team Program of Guangzhou Regenerative Medicine and Health Guangdong Laboratory; National Key Research and Development Program of China; Opening Project of Key Laboratory of Integrative Chinese and Western Medicine for the Diagnosis and Treatment of Circulatory Diseases of Zhejiang Province; Hangzhou Normal University; Natural science foundation of Zhejiang province(Natural Science Foundation of Zhejiang Province); Zhejiang Medical Science and Technology project	This work is supported by National Natural Science Foundation of China (grants #91749203 and 81525010), National Key R&D Program of China (2016YFA0100602, 2017YFA0103302), the Program for Guangdong Introducing Innovative and Enterpreneurial Teams (2017ZT07S347), Innovative Team Program of Guangzhou Regenerative Medicine and Health Guangdong Laboratory (2018GZR110103002) to ZJ; National Key Research and Development Program of China (grant #2017YFC0908900) and National Natural Science Foundation of China (grants #81570523) to CY; the Opening Project of Key Laboratory of Integrative Chinese and Western Medicine for the Diagnosis and Treatment of Circulatory Diseases of Zhejiang Province (No. 2C32003), the National Natural Science Foundation of China (grant #81400221) and Hangzhou Normal University (PF14002004017) to XZ; National Natural Science Foundation of China (grant #81700511) and Natural science foundation of Zhejiang province (grant LY20H030004) Zhejiang Medical Science and Technology project (grant #2017193668) to XW.	Agudelo LZ, 2014, CELL, V159, P33, DOI 10.1016/j.cell.2014.07.051; Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41; Arensdorf Angela M., 2013, Frontiers in Genetics, V4, P188, DOI 10.3389/fgene.2013.00188; Barroso WA, 2018, EUR J NUTR, V57, P1891, DOI 10.1007/s00394-017-1472-5; Barry JC, 2016, SCI REP-UK, V6, DOI 10.1038/srep21244; Bellafante E, 2013, HEPATOLOGY, V57, P1343, DOI 10.1002/hep.26222; Besse-Patin A, 2019, P NATL ACAD SCI USA, V116, P4285, DOI 10.1073/pnas.1815150116; Besse-Patin A, 2017, GASTROENTEROLOGY, V152, P243, DOI 10.1053/j.gastro.2016.09.017; Chawla A, 2001, NAT MED, V7, P48, DOI 10.1038/83336; Cheng AW, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2238; Cintra DE, 2008, J HEPATOL, V48, P628, DOI 10.1016/j.jhep.2007.12.017; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Guo XX, 2014, AM J PATHOL, V184, P1017, DOI 10.1016/j.ajpath.2013.12.012; Handschin C, 2007, GENE DEV, V21, P770, DOI 10.1101/gad.1525107; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; LeBleu VS, 2014, NAT CELL BIOL, V16, P992, DOI 10.1038/ncb3039; Lelliott CJ, 2007, ARTERIOSCL THROM VAS, V27, P2707, DOI 10.1161/ATVBAHA.107.155739; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Liu C, 2007, NATURE, V447, P477, DOI 10.1038/nature05767; Lustig Y, 2011, GENE DEV, V25, P1232, DOI 10.1101/gad.2054711; Madeshiya AK, 2017, J GENET, V96, P53, DOI 10.1007/s12041-016-0738-7; Morris EM, 2012, AM J PHYSIOL-GASTR L, V303, pG979, DOI 10.1152/ajpgi.00169.2012; Paredes-Turrubiarte G, 2016, CLIN EXP MED, V16, P193, DOI 10.1007/s10238-015-0347-4; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Russell LK, 2004, CIRC RES, V94, P525, DOI 10.1161/01.RES.0000117088.36577.EB; Ryan SD, 2013, CELL, V155, P1351, DOI 10.1016/j.cell.2013.11.009; Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787; Saltiel AR, 2017, J CLIN INVEST, V127, P1, DOI [10.1172/JCI92035, 10.1172/jci92035]; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Sen N, 2011, MOL CELL, V44, P621, DOI 10.1016/j.molcel.2011.08.044; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Tran MT, 2016, NATURE, V531, P528, DOI 10.1038/nature17184; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431; Zhu XD, 2019, CIRC RES, V125, P707, DOI 10.1161/CIRCRESAHA.119.315529	38	8	9	8	40	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10751	10761		10.1096/fj.201902476R	http://dx.doi.org/10.1096/fj.201902476R		JUL 2020	11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32633848	Bronze			2022-12-28	WOS:000547554700001
J	Dragunas, G; Woest, ME; Nijboer, S; Bos, ST; van Asselt, J; de Groot, AP; Vohlidalova, E; Vermeulen, CJ; Ditz, B; Vonk, JM; Koppelman, GH; van den Berge, M; ten Hacken, NHT; Timens, W; Munhoz, CD; Prakash, YS; Gosens, R; Kistemaker, LEM				Dragunas, Guilherme; Woest, Manon E.; Nijboer, Susan; Bos, Sophie T.; van Asselt, Janet; de Groot, Anne P.; Vohlidalova, Eva; Vermeulen, Corneel J.; Ditz, Benedikt; Vonk, Judith M.; Koppelman, Gerard H.; van den Berge, Maarten; ten Hacken, Nick H. T.; Timens, Wim; Munhoz, Carolina D.; Prakash, Y. S.; Gosens, Reinoud; Kistemaker, Loes E. M.			Cholinergic neuroplasticity in asthma driven by TrkB signaling	FASEB JOURNAL			English	Article						asthma; lung innervation; neuroplasticity; neurotrophins	NEUROTROPHIC FACTOR; AIRWAY HYPERRESPONSIVENESS; GENOMEWIDE ASSOCIATION; ALLERGEN EXPOSURE; LUNG-SLICE; TIOTROPIUM; RECEPTORS; INNERVATION; DYSFUNCTION; EXPRESSION	Parasympathetic neurons in the airways control bronchomotor tone. Increased activity of cholinergic neurons are mediators of airway hyperresponsiveness (AHR) in asthma, however, mechanisms are not elucidated. We describe remodeling of the cholinergic neuronal network in asthmatic airways driven by brain-derived neurotrophic factor (BDNF) and Tropomyosin receptor kinase B (TrkB). Human bronchial biopsies were stained for cholinergic marker vesicular acetylcholine transporter (VAChT). Human lung gene expression and single nucleotide polymorphisms (SNP) in neuroplasticity-related genes were compared between asthma and healthy patients. Wild-type (WT) and mutated TrkB knock-in mice (Ntrk2tm1Ddg/J) with impaired BDNF signaling were chronically exposed to ovalbumin (OVA). Neuronal VAChT staining and airway narrowing in response to electrical field stimulation in precision cut lung slices (PCLS) were assessed. Increased cholinergic fibers in asthmatic airway biopsies was found, paralleled by increased TrkB gene expression in human lung tissue, and SNPs in the NTRK2 [TrkB] and BDNF genes linked to asthma. Chronic allergen exposure in mice resulted in increased density of cholinergic nerves, which was prevented by inhibiting TrkB. Increased nerve density resulted in AHR in vivo and in increased nerve-dependent airway reactivity in lung slices mediated via TrkB. These findings show cholinergic neuroplasticity in asthma driven by TrkB signaling and suggest that the BDNF-TrkB pathway may be a potential target.	[Dragunas, Guilherme; Woest, Manon E.; Nijboer, Susan; Bos, Sophie T.; van Asselt, Janet; de Groot, Anne P.; Vohlidalova, Eva; Gosens, Reinoud; Kistemaker, Loes E. M.] Univ Groningen, Dept Mol Pharmacol, A Deusinglaan 1, NL-9713 AV Groningen, Netherlands; [Dragunas, Guilherme; Woest, Manon E.; Nijboer, Susan; Bos, Sophie T.; van Asselt, Janet; de Groot, Anne P.; Vohlidalova, Eva; Vermeulen, Corneel J.; Ditz, Benedikt; Vonk, Judith M.; Koppelman, Gerard H.; van den Berge, Maarten; ten Hacken, Nick H. T.; Timens, Wim; Gosens, Reinoud; Kistemaker, Loes E. M.] Univ Groningen, Univ Med Ctr Groningen, GRIAC Res Inst, Groningen, Netherlands; [Dragunas, Guilherme; Munhoz, Carolina D.] Univ Sao Paulo, Dept Pharmacol, Sao Paulo, Brazil; [Vermeulen, Corneel J.; Ditz, Benedikt; van den Berge, Maarten; ten Hacken, Nick H. T.] Univ Med Ctr Groningen, Dept Pulm Dis, Groningen, Netherlands; [Vonk, Judith M.] Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Koppelman, Gerard H.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Dept Pediat Pulmonol & Pediat Allergol, Groningen, Netherlands; [Timens, Wim] Univ Med Ctr Groningen, Dept Pathol, Groningen, Netherlands; [Prakash, Y. S.] Mayo Clin, Dept Anesthesiol & Perioperat Med, Rochester, MN USA	University of Groningen; University of Groningen; Universidade de Sao Paulo; University of Groningen; University of Groningen; University of Groningen; University of Groningen; Mayo Clinic	Dragunas, G (corresponding author), Univ Groningen, Dept Mol Pharmacol, A Deusinglaan 1, NL-9713 AV Groningen, Netherlands.	g.dragunas@rug.nl	Timens, Wim/K-5570-2013; Munhoz, Carolina/N-7219-2014	Timens, Wim/0000-0002-4146-6363; Dragunas, Guilherme/0000-0001-6560-8402; Klaskova, Eva/0000-0002-6984-1268; van den Berge, Maarten/0000-0002-9336-7340; de Groot, Anne Pieta/0000-0002-5956-8608; Prakash, Y S/0000-0002-2968-224X; Koppelman, Gerard/0000-0001-8567-3252; Vermeulen, Corneel/0000-0002-3280-1414; Munhoz, Carolina/0000-0002-8656-5234; Gosens, Reinoud/0000-0002-5595-152X	NHLBI NIH HHS [R01 HL088029] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alberti P, 2020, NEUROPHARMACOLOGY, V164, DOI 10.1016/j.neuropharm.2019.107905; Aven L, 2014, FASEB J, V28, P897, DOI 10.1096/fj.13-238212; BARNES PJ, 1986, AM REV RESPIR DIS, V134, P1289; BARNES PJ, 1986, LANCET, V1, P242; Barrios J, 2018, CURR ALLERGY ASTHM R, V18, DOI 10.1007/s11882-018-0765-y; Braun A, 2004, BRIT J PHARMACOL, V141, P431, DOI 10.1038/sj.bjp.0705638; Britt RD, 2019, FASEB J, V33, P3024, DOI 10.1096/fj.201801002R; Broekema M, 2010, RESP MED, V104, P1254, DOI 10.1016/j.rmed.2010.03.030; Broekema M, 2011, AM J RESP CRIT CARE, V183, P310, DOI 10.1164/rccm.201003-0494OC; Bryan SA, 2000, LANCET, V356, P2149, DOI 10.1016/S0140-6736(00)03497-8; Casarosa P, 2009, J PHARMACOL EXP THER, V330, P660, DOI 10.1124/jpet.109.152470; Case DT, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00765-4; Chew AD, 2008, EUR RESPIR J, V31, P532, DOI 10.1183/09031936.00079307; Donovan C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074101; Drake MG, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aar8477; Ekman M, 2017, AUTON NEUROSCI-BASIC, V205, P41, DOI 10.1016/j.autneu.2017.03.004; Flood-Page P, 2007, AM J RESP CRIT CARE, V176, P1062, DOI 10.1164/rccm.200701-085OC; FRYER AD, 1991, J APPL PHYSIOL, V71, P2255, DOI 10.1152/jappl.1991.71.6.2255; Fryer AD, 1998, AM J RESP CRIT CARE, V158, pS154, DOI 10.1164/ajrccm.158.supplement_2.13tac120; Gallart-Palau X, 2014, FASEB J, V28, P3618, DOI 10.1096/fj.13-248583; (GINA) G. I. for A, 2018, GINA REP GLOB BURD A; KAGEYAMA N, 1995, EUR RESPIR J, V8, P752; Kerstjens HAM, 2016, RESP MED, V117, P198, DOI 10.1016/j.rmed.2016.06.013; Kerstjens HAM, 2015, LANCET RESP MED, V3, P367, DOI 10.1016/S2213-2600(15)00031-4; Kerstjens HAM, 2012, NEW ENGL J MED, V367, P1198, DOI 10.1056/NEJMoa1208606; Kistemaker LEM, 2019, PHYSIOLOGY, V34, P283, DOI 10.1152/physiol.00050.2018; Kistemaker LEM, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0327-6; Kistemaker LEM, 2015, EUR RESPIR J, V46, P1489, DOI 10.1183/13993003.00413-2015; Kistemaker LEM, 2015, THORAX, V70, P668, DOI 10.1136/thoraxjnl-2014-205731; Kistemaker LEM, 2014, AM J RESP CELL MOL, V50, P690, DOI 10.1165/rcmb.2013-0220OC; Larsen GL, 2017, AM J PHYSIOL-CELL PH, V266, pL263; Leal G, 2014, NEUROPHARMACOLOGY, V76, P639, DOI 10.1016/j.neuropharm.2013.04.005; Leus NGJ, 2016, BIOCHEM PHARMACOL, V108, P58, DOI 10.1016/j.bcp.2016.03.010; Mazzone SB, 2002, CURR OPIN PHARMACOL, V2, P220, DOI 10.1016/S1471-4892(02)00151-0; McAlexander MA, 2015, RESP PHYSIOL NEUROBI, V212, P20, DOI 10.1016/j.resp.2015.03.007; MCCAIG DJ, 1987, BRIT J PHARMACOL, V92, P809, DOI 10.1111/j.1476-5381.1987.tb11385.x; Melgert BN, 2004, AM J RESP CELL MOL, V30, P880, DOI 10.1165/rcmb.2003-0178OC; Modarresi F, 2012, NAT BIOTECHNOL, V30, P453, DOI 10.1038/nbt.2158; Nieuwenhuis MA, 2016, ALLERGY, V71, P1712, DOI 10.1111/all.12990; Nieuwenhuis MAE, 2017, ALLERGY, V72, P792, DOI 10.1111/all.13062; Nockher WA, 2006, J ALLERGY CLIN IMMUN, V117, P67, DOI 10.1016/j.jaci.2005.08.029; Pan J, 2010, AM J RESP CELL MOL, V43, P452, DOI 10.1165/rcmb.2009-0130OC; Postma DS, 1998, AM J RESP CRIT CARE, V158, pS187, DOI 10.1164/ajrccm.158.supplement_2.13tac170; Prakash YS, 2014, PHARMACOL THERAPEUT, V143, P74, DOI 10.1016/j.pharmthera.2014.02.006; Ricci A, 2004, AM J RESP CELL MOL, V30, P12, DOI 10.1165/rcmb.2002-0110OC; Rosner SR, 2014, AM J RESP CELL MOL, V50, P876, DOI 10.1165/rcmb.2013-0166MA; Salvany S, 2019, FASEB J, V33, P7833, DOI 10.1096/fj.201802329R; Schleputz M, 2011, J APPL PHYSIOL, V110, P545, DOI 10.1152/japplphysiol.00409.2010; Szefler S, 2000, NEW ENGL J MED, V343, P1054; Talbot S, 2020, J ALLERGY CLIN IMMUN, V145, P1693, DOI 10.1016/j.jaci.2020.01.003; Tu NH, 2017, EUR J NEUROSCI, V46, P2096, DOI 10.1111/ejn.13647; Undem BJ, 2014, J ALLERGY CLIN IMMUN, V133, P1521, DOI 10.1016/j.jaci.2013.11.027; Van Dijk E. M., 2017, FRONT PHYSIOL, V7, P1; Vohra PK, 2013, BBA-MOL CELL RES, V1833, P2953, DOI 10.1016/j.bbamcr.2013.07.019; Wang JR, 2018, INTL CONF POWER SYST, P2825, DOI 10.1109/POWERCON.2018.8602236; Watanabe T, 2015, AM J RESP CELL MOL, V53, P844, DOI 10.1165/rcmb.2015-0015OC	56	9	9	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					7703	7717		10.1096/fj.202000170R	http://dx.doi.org/10.1096/fj.202000170R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32277855	Green Published, hybrid			2022-12-28	WOS:000553573700034
J	Hao, WJ; Wang, J; Zhang, YH; Wang, CX; Xia, L; Zhang, WH; Zafar, M; Kang, JY; Wang, RX; Bohio, AA; Pan, L; Zeng, XL; Wei, M; Boldogh, I; Ba, XQ				Hao, Wenjing; Wang, Jing; Zhang, Yuanhang; Wang, Chenxin; Xia, Lan; Zhang, Wenhe; Zafar, Muhammad; Kang, Ju-Yong; Wang, Ruoxi; Ali Bohio, Ameer; Pan, Lang; Zeng, Xianlu; Wei, Min; Boldogh, Istvan; Ba, Xueqing			Enzymatically inactive OGG1 binds to DNA and steers base excision repair toward gene transcription	FASEB JOURNAL			English	Article						8-oxoG; OGG1; oxidative stress; pro-inflammatory gene expression	HUMAN 8-OXOGUANINE DNA; REDOX REGULATION; GLYCOSYLASE 1; G-QUADRUPLEX; TNF-ALPHA; RECOGNITION; DAMAGE; 8-OXO-7,8-DIHYDROGUANINE; 8-HYDROXYGUANINE; ACCUMULATION	8-Oxoguanine DNA glycosylase1 (OGG1)-initiated base excision repair (BER) is the primary pathway to remove the pre-mutagenic 8-oxo-7,8-dihydroguanine (8-oxoG) from DNA. Recent studies documented 8-oxoG serves as an epigenetic-like mark and OGG1 modulates gene expression in oxidatively stressed cells. For this new role of OGG1, two distinct mechanisms have been proposed: one is coupled to base excision, while the other only requires substrate binding of OGG1--both resulting in conformational adjustment in the adjacent DNA sequences providing access for transcription factors to their cis-elements. The present study aimed to examine if BER activity of OGG1 is required for pro-inflammatory gene expression. To this end, Ogg1/OGG1 knockout/depleted cells were transfected with constructs expressing wild-type (wt) and repair-deficient mutants of OGG1. OGG1's promoter enrichment, oxidative state, and gene expression were examined. Results showed that TNF alpha exposure increased levels of oxidatively modified cysteine(s) of wt OGG1 without impairing its association with promoter and facilitated gene expression. The excision deficient K249Q mutant was even a more potent activator of gene expression; whereas, mutant OGG1 with impaired substrate recognition/binding was not. These data suggested the interaction of OGG1 with its substrate at regulatory regions followed by conformational adjustment in the adjacent DNA is the primary mode to modulate inflammatory gene expression.	[Hao, Wenjing; Zhang, Yuanhang; Wang, Chenxin; Xia, Lan; Zhang, Wenhe; Zafar, Muhammad; Kang, Ju-Yong; Wang, Ruoxi; Ali Bohio, Ameer; Zeng, Xianlu; Wei, Min; Ba, Xueqing] Northeast Normal Univ, Key Lab Mol Epignt, Minist Educ, Changchun, Peoples R China; [Hao, Wenjing; Zhang, Yuanhang; Wang, Chenxin; Xia, Lan; Zhang, Wenhe; Zafar, Muhammad; Wang, Ruoxi; Ali Bohio, Ameer; Pan, Lang; Zeng, Xianlu; Wei, Min; Ba, Xueqing] Northeast Normal Univ, Sch Life Sci, Changchun, Peoples R China; [Wang, Jing] Jilin Univ, Dept Resp Med, China Japan Union Hosp, Changchun, Peoples R China; [Kang, Ju-Yong] Kim Il Sung Univ, Fac Life Sci, Pyongyang, North Korea; [Wang, Ruoxi] Shandong Normal Univ, Coll Life Sci, Inst Biomed Sci, Key Lab Anim Resistance Biol Shandong Prov, Jinan, Peoples R China; [Pan, Lang; Boldogh, Istvan] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA	Northeast Normal University - China; Northeast Normal University - China; Jilin University; Shandong Normal University; University of Texas System; University of Texas Medical Branch Galveston	Ba, XQ (corresponding author), Northeast Normal Univ, Minist Educ, Key Lab Mol Epigenet, Sch Life Sci, 5268 Renmin St, Changchun 130024, Jilin, Peoples R China.	baxq755@nenu.edu.cn		Pan, Lang/0000-0003-2324-2144	National Natural Science Foundation of China (NSFC) [31571339, 31970686, 31900557]; program for Introducing Talent to Universities [B07017]; National Institute of Environmental Health Sciences (NIEHS) [RO1 ES018948]; National Institute of Allergy and Infectious Diseases (NIAID) [AI062885]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); program for Introducing Talent to Universities; National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 31571339, 31970686 and 31900557; the program for Introducing Talent to Universities, Grant/Award Number: B07017; National Institute of Environmental Health Sciences (NIEHS), Grant/Award Number: RO1 ES018948; National Institute of Allergy and Infectious Diseases (NIAID), Grant/Award Number: AI062885	Allgayer J, 2016, NUCLEIC ACIDS RES, V44, P7267, DOI 10.1093/nar/gkw473; Amente S, 2010, ONCOGENE, V29, P3691, DOI 10.1038/onc.2010.120; Arai T, 2006, TOXICOLOGY, V221, P179, DOI 10.1016/j.tox.2006.01.004; Audebert M, 2000, NUCLEIC ACIDS RES, V28, P2672, DOI 10.1093/nar/28.14.2672; Ba XQ, 2018, REDOX BIOL, V14, P669, DOI 10.1016/j.redox.2017.11.008; Ba XQ, 2014, J IMMUNOL, V192, P2384, DOI 10.4049/jimmunol.1302472; Banerjee A, 2005, NATURE, V434, P612, DOI 10.1038/nature03458; Bjoras M, 2002, J MOL BIOL, V317, P171, DOI 10.1006/jmbi.2002.5400; Bjoras M, 1997, EMBO J, V16, P6314, DOI 10.1093/emboj/16.20.6314; Bohio AA, 2019, J IMMUNOL, V203, P1521, DOI 10.4049/jimmunol.1801616; Boiteux S, 2017, FREE RADICAL BIO MED, V107, P179, DOI 10.1016/j.freeradbiomed.2016.11.042; Bravard A, 2006, MOL CELL BIOL, V26, P7430, DOI 10.1128/MCB.00624-06; Bravard A, 2010, MUTAT RES-FUND MOL M, V685, P61, DOI 10.1016/j.mrfmmm.2009.09.013; Bruner SD, 2000, NATURE, V403, P859, DOI 10.1038/35002510; Bruner SD, 2000, COLD SPRING HARB SYM, V65, P103, DOI 10.1101/sqb.2000.65.103; Cadet J, 2010, FREE RADICAL BIO MED, V49, P9, DOI 10.1016/j.freeradbiomed.2010.03.025; Cividini F, 2016, J BIOL CHEM, V291, P26515, DOI 10.1074/jbc.M116.754481; D'Onofrio G, 1999, ANN NY ACAD SCI, V870, P81, DOI 10.1111/j.1749-6632.1999.tb08867.x; Dalhus B, 2011, STRUCTURE, V19, P117, DOI 10.1016/j.str.2010.09.023; Dherin C, 1999, NUCLEIC ACIDS RES, V27, P4001, DOI 10.1093/nar/27.20.4001; Donley N, 2015, ACS CHEM BIOL, V10, P2334, DOI 10.1021/acschembio.5b00452; Fleming AM, 2019, NUCLEIC ACIDS RES, V47, P5049, DOI 10.1093/nar/gkz207; Fleming AM, 2018, BIOCHEMISTRY-US, V57, P991, DOI 10.1021/acs.biochem.7b01172; Fleming AM, 2017, ACS CHEM BIOL, V12, P2417, DOI 10.1021/acschembio.7b00636; Fleming AM, 2017, P NATL ACAD SCI USA, V114, P2604, DOI 10.1073/pnas.1619809114; Friedberg EC, 2003, NATURE, V421, P436, DOI 10.1038/nature01408; Gautier C, 2000, CURR OPIN GENET DEV, V10, P656, DOI 10.1016/S0959-437X(00)00144-1; German P, 2013, DNA REPAIR, V12, P856, DOI 10.1016/j.dnarep.2013.06.006; Giese B, 2002, ANNU REV BIOCHEM, V71, P51, DOI 10.1146/annurev.biochem.71.083101.134037; Hao WJ, 2018, REDOX BIOL, V18, P43, DOI 10.1016/j.redox.2018.06.002; HART RW, 1974, P NATL ACAD SCI USA, V71, P2169, DOI 10.1073/pnas.71.6.2169; Izumi T, 2003, TOXICOLOGY, V193, P43, DOI 10.1016/S0300-483X(03)00289-0; Karahalil B, 2012, HUM EXP TOXICOL, V31, P981, DOI 10.1177/0960327112444476; KASAI H, 1986, CARCINOGENESIS, V7, P1849, DOI 10.1093/carcin/7.11.1849; Ke YS, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8091047; Ke YS, 2019, CELL MOL LIFE SCI, V76, P3283, DOI 10.1007/s00018-019-03120-6; Klungland A, 1999, P NATL ACAD SCI USA, V96, P13300, DOI 10.1073/pnas.96.23.13300; Koval VV, 2014, ACTA NATURAE, V6, P52, DOI 10.32607/20758251-2014-6-3-52-65; Kumar P, 2011, NUCLEIC ACIDS RES, V39, P8005, DOI 10.1093/nar/gkr536; Kuznetsova AA, 2014, BBA-GEN SUBJECTS, V1840, P387, DOI 10.1016/j.bbagen.2013.09.035; Li GP, 2012, FREE RADICAL BIO MED, V52, P392, DOI 10.1016/j.freeradbiomed.2011.10.490; Liu LL, 2012, HUM IMMUNOL, V73, P439, DOI 10.1016/j.humimm.2012.02.002; Mabley JG, 2004, FASEB J, V18, P290, DOI 10.1096/fj.04-2278fje; Minowa O, 2000, P NATL ACAD SCI USA, V97, P4156, DOI 10.1073/pnas.050404497; Morreall J, 2015, DNA REPAIR, V26, P15, DOI 10.1016/j.dnarep.2014.11.007; Nash HM, 1997, CHEM BIOL, V4, P693, DOI 10.1016/S1074-5521(97)90225-8; Neeley WL, 2006, CHEM RES TOXICOL, V19, P491, DOI 10.1021/tx0600043; Noren Hooten N, 2011, J BIOL CHEM, V286, P44679, DOI 10.1074/jbc.M111.255869; Pan L, 2017, SCI REP-UK, V7, DOI 10.1038/srep43297; Pan L, 2016, J BIOL CHEM, V291, P25553, DOI 10.1074/jbc.M116.751453; Pastukh V, 2015, AM J PHYSIOL-LUNG C, V309, pL1367, DOI 10.1152/ajplung.00236.2015; Perillo B, 2008, SCIENCE, V319, P202, DOI 10.1126/science.1147674; Radak Z, 2010, FREE RADICAL BIO MED, V49, P587, DOI 10.1016/j.freeradbiomed.2010.05.008; Ruchko MV, 2009, FREE RADICAL BIO MED, V46, P352, DOI 10.1016/j.freeradbiomed.2008.09.038; Saito I, 1995, Nucleic Acids Symp Ser, P191; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034; Seifermann M, 2017, DNA REPAIR, V58, P13, DOI 10.1016/j.dnarep.2017.08.005; Sen CK, 1996, FASEB J, V10, P709, DOI 10.1096/fasebj.10.7.8635688; Silvia TA, 2004, DNA REPAIR, V3, P483, DOI 10.1016/j.dnarep.2004.01.003; Svilar D, 2011, ANTIOXID REDOX SIGN, V14, P2491, DOI 10.1089/ars.2010.3466; Tezel G, 2008, PROG BRAIN RES, V173, P409, DOI 10.1016/S0079-6123(08)01128-X; Touati E, 2006, HELICOBACTER, V11, P494, DOI 10.1111/j.1523-5378.2006.00442.x; Tyugashev TE, 2019, J PHYS CHEM B, V123, P4878, DOI 10.1021/acs.jpcb.9b02949; van der Kemp PA, 2004, NUCLEIC ACIDS RES, V32, P570, DOI 10.1093/nar/gkh224; Visnes T, 2018, SCIENCE, V362, P834, DOI 10.1126/science.aar8048; Wallace SS, 2014, DNA REPAIR, V19, P14, DOI 10.1016/j.dnarep.2014.03.030; Wang RX, 2018, CELL MOL LIFE SCI, V75, P3741, DOI 10.1007/s00018-018-2887-8; Yang D, 2007, EXP EYE RES, V85, P462, DOI 10.1016/j.exer.2007.06.013; Zhou PT, 2015, MED ONCOL, V32, DOI 10.1007/s12032-014-0472-z	70	14	14	2	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					7427	7441		10.1096/fj.201902243R	http://dx.doi.org/10.1096/fj.201902243R		MAY 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32378256	Green Published, hybrid			2022-12-28	WOS:000530924600001
J	Feger, M; Ewendt, F; Menzel, M; Hocher, B; Foeller, M				Feger, Martina; Ewendt, Franz; Menzel, Matthias; Hocher, Berthold; Foeller, Michael			Endothelin receptor B controls the production of fibroblast growth factor 23	FASEB JOURNAL			English	Article						ET-1; klotho; phosphate; vitamin D	REGULATES FGF23 PRODUCTION; VITAMIN-D; EXPRESSION; PHOSPHATE; KLOTHO; TRAJECTORIES; INFLAMMATION; DYSFUNCTION; ANTAGONISTS; TARGET	Endothelin-1 (ET-1) is a member of the endothelin family of peptide hormones first discovered as endothelium-derived mediators regulating vascular tone. ET-1 also regulates the proliferation and differentiation of bone cells that synthesize fibroblast growth factor 23 (FGF23). FGF23 is a hormone controlling renal phosphate and vitamin D metabolism. Here, we studied the role of ET-1 and endothelin receptor B (ETB) for FGF23 production. Fgf23 gene expression was studied in IDG-SW3 bone cells by quantitative RT-PCR. ETB-expressing (etb(+/+)) and rescued ETB-deficient mice (etb(-/-)) were studied in metabolic cages. Their serum FGF23, PTH, and 1,25(OH)(2)D-3 concentrations were determined by ELISA, serum and urinary phosphate and Ca2+ by photometric methods. ET-1 and ETB agonist sarafotoxin 6c suppressed Fgf23 mRNA in IDG-SW3 cells. Serum C-terminal and intact FGF23 as well as bone Fgf23 mRNA levels were significantly higher in etb(-/-) mice than in etb(+/+) mice. Renal phosphate excretion was significantly higher in etb(-/-) mice despite lower phosphate levels. In addition, etb(-/-) animals exhibited calciuria and a significantly higher serum 1,25(OH)(2)D-3 concentration compared to etb(+/+) mice. In conclusion, ETB-dependent ET-1 signaling is a potent suppressor of FGF23 formation. This effect is likely to be of clinical relevance given the use of endothelin receptor antagonists in various diseases.	[Feger, Martina; Foeller, Michael] Univ Hohenheim, Dept Physiol, Garbenstr 30, Stuttgart 70599, Germany; [Ewendt, Franz] Martin Luther Univ Halle Wittenberg, Inst Agr & Nutr Sci, Halle, Saale, Germany; [Menzel, Matthias] Fraunhofer Inst Microstruct Mat & Syst IMWS, Halle, Saale, Germany; [Hocher, Berthold] Heidelberg Univ, Univ Med Ctr Mannheim, Dept Med Nephrol Endocrinol Rheumatol 5, Mannheim, Germany	University Hohenheim; Martin Luther University Halle Wittenberg; Fraunhofer Gesellschaft; Ruprecht Karls University Heidelberg	Foeller, M (corresponding author), Univ Hohenheim, Dept Physiol, Garbenstr 30, Stuttgart 70599, Germany.	michael.foeller@uni-hohenheim.de		Ewendt, Franz/0000-0003-0604-2140				Agoro R, 2018, FASEB J, V32, P3752, DOI 10.1096/fj.201700667R; Andrukhova O, 2014, EMBO J, V33, P229, DOI 10.1002/embj.201284188; Bar L, 2019, FEBS LETT, V593, P1879, DOI 10.1002/1873-3468.13494; Bar L, 2018, P NATL ACAD SCI USA, V115, P5804, DOI 10.1073/pnas.1800160115; Ben-Dov IZ, 2007, J CLIN INVEST, V117, P4003, DOI 10.1172/JCI32409; Bohm F, 2007, CARDIOVASC RES, V76, P8, DOI 10.1016/j.cardiores.2007.06.004; Chen B, 2019, EBIOMEDICINE, V49, P118, DOI 10.1016/j.ebiom.2019.10.040; Chonchol M, 2016, J AM SOC NEPHROL, V27, P227, DOI 10.1681/ASN.2014101009; Clouthier DE, 2010, AM J MED GENET A, V152A, P2962, DOI 10.1002/ajmg.a.33568; Correale M, 2018, VASC HEALTH RISK MAN, V14, P253, DOI 10.2147/VHRM.S133921; Daryadel A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51577-z; Daryadel A, 2018, PFLUG ARCH EUR J PHY, V470, P1569, DOI 10.1007/s00424-018-2171-7; David V, 2016, KIDNEY INT, V89, P135, DOI 10.1038/ki.2015.290; Durlacher-Betzer K, 2018, KIDNEY INT, V94, P315, DOI 10.1016/j.kint.2018.02.026; Emma F, 2018, KIDNEY INT, V94, P846, DOI 10.1016/j.kint.2018.08.022; Erben RG, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00267; Erben RG, 2017, BONE, V100, P62, DOI 10.1016/j.bone.2016.09.010; Faul C, 2018, KIDNEY INT, V94, P7, DOI 10.1016/j.kint.2018.03.024; Faul C, 2017, BONE, V100, P69, DOI 10.1016/j.bone.2016.10.001; Faul C, 2011, J CLIN INVEST, V121, P4393, DOI 10.1172/JCI46122; Fitzpatrick EA, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00320; FOZARD JR, 1992, BRIT J PHARMACOL, V105, P744, DOI 10.1111/j.1476-5381.1992.tb09049.x; Francis C, 2016, CURR OPIN NEPHROL HY, V25, P325, DOI 10.1097/MNH.0000000000000232; Glosse P, 2018, KIDNEY INT, V94, P491, DOI 10.1016/j.kint.2018.03.006; Gohar EY, 2017, AM J PHYSIOL-RENAL, V313, pF666, DOI 10.1152/ajprenal.00639.2016; Hanudel MR, 2019, NEPHROL DIAL TRANSPL, V34, P2057, DOI 10.1093/ndt/gfy189; Heerspink HJL, 2019, LANCET, V393, P1937, DOI 10.1016/S0140-6736(19)30772-X; Hu MC, 2019, PFLUG ARCH EUR J PHY, V471, P99, DOI 10.1007/s00424-018-2238-5; Isakova T, 2018, J AM SOC NEPHROL, V29, P579, DOI 10.1681/ASN.2017070772; Isakova T, 2011, KIDNEY INT, V79, P1370, DOI 10.1038/ki.2011.47; Johnson MG, 2014, CONNECT TISSUE RES, V55, P113, DOI 10.3109/03008207.2014.923866; Jovanovich A, 2019, AM J NEPHROL, V49, P263, DOI 10.1159/000497445; Kaludjerovic J, 2017, FASEB J, V31, P2050, DOI 10.1096/fj.201601036R; Kandalaft LE, 2009, CLIN CANCER RES, V15, P4521, DOI 10.1158/1078-0432.CCR-08-0543; Kendrick J, 2011, ADV CHRONIC KIDNEY D, V18, P113, DOI 10.1053/j.ackd.2010.12.003; Kohan DE, 2014, KIDNEY INT, V86, P896, DOI 10.1038/ki.2014.143; Kristianto J, 2017, ENDOCRIN METAB CLIN, V46, P51, DOI 10.1016/j.ecl.2016.09.014; Kuro-o M, 2013, NAT REV NEPHROL, V9, P650, DOI 10.1038/nrneph.2013.111; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Lavi-Moshayoff V, 2010, AM J PHYSIOL-RENAL, V299, pF882, DOI 10.1152/ajprenal.00360.2010; Leifheit-Nestler M, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00278; Masuyama R, 2006, J CLIN INVEST, V116, P3150, DOI 10.1172/JCI29463; Quaschning T, 2005, J HYPERTENS, V23, P979, DOI 10.1097/01.hjh.0000166838.55688.7e; Schnedl C, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/358086; SEMLER DE, 1995, J PHARMACOL EXP THER, V272, P1052; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Sin A, 2015, OSTEOARTHR CARTILAGE, V23, P516, DOI 10.1016/j.joca.2014.11.002; Singh S, 2016, KIDNEY INT, V90, P985, DOI 10.1016/j.kint.2016.05.019; Smith ER, 2019, CELL MOL LIFE SCI, V76, P4705, DOI 10.1007/s00018-019-03241-y; Smith ER, 2012, J CLIN ENDOCR METAB, V97, P3357, DOI 10.1210/jc.2012-1811; Spichtig D, 2014, KIDNEY INT, V85, P1340, DOI 10.1038/ki.2013.526; Stohr R, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00351; Tagliabracci VS, 2014, P NATL ACAD SCI USA, V111, P5520, DOI 10.1073/pnas.1402218111; Wright JD, 2019, FASEB J, V33, P9182, DOI 10.1096/fj.201900321R	54	2	2	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6262	6270		10.1096/fj.201903109R	http://dx.doi.org/10.1096/fj.201903109R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32157737				2022-12-28	WOS:000531325500020
J	Kilicarslan, M; de Weijer, BA; Sjodin, KS; Aryal, P; ter Horst, KW; Cakir, H; Romijn, JA; Ackermans, MT; Janssen, IM; Berends, FJ; van de Laar, AW; Houdijk, AP; Kahn, BB; Serlie, MJ				Kilicarslan, Murat; de Weijer, Barbara A.; Simonyte Sjodin, Kotryna; Aryal, Pratik; ter Horst, Kasper W.; Cakir, Hamit; Romijn, Johannes A.; Ackermans, Mariette T.; Janssen, Ignace M.; Berends, Frits J.; van de Laar, Arnold W.; Houdijk, Alexander P.; Kahn, Barbara B.; Serlie, Mireille J.			RBP4 increases lipolysis in human adipocytes and is associated with increased lipolysis and hepatic insulin resistance in obese women	FASEB JOURNAL			English	Article						endogenous glucose production; inflammation; insulin resistance; lipolysis; obesity; RBP4	RETINOL-BINDING-PROTEIN; ADIPOSE-TISSUE INFLAMMATION; FATTY LIVER-DISEASE; CIRCULATING RBP4; SERUM; RETINOL-BINDING-PROTEIN-4; SENSITIVITY; METABOLISM; EXPRESSION; HEPATOCYTES	Retinol-binding protein-4 (RBP4) is elevated in serum and adipose tissue (AT) in obesity-induced insulin resistance and correlates inversely with insulin-stimulated glucose disposal. But its role in insulin-mediated suppression of lipolysis, free fatty acids (FFA), and endogenous glucose production (EGP) in humans is unknown. RBP4 mRNA or protein levels were higher in liver, subcutaneous adipose tissue (SAT), and visceral adipose tissue (VAT) in morbidly obese subjects undergoing Roux-en-Y gastric bypass surgery compared to lean controls undergoing elective laparoscopic cholecystectomy. RBP4 mRNA expression in SAT correlated with the expression of several macrophage and other inflammation markers. Serum RBP4 levels correlated inversely with glucose disposal and insulin-mediated suppression of lipolysis, FFA, and EGP. Mechanistically, RBP4 treatment of human adipocytes in vitro directly stimulated basal lipolysis. Treatment of adipocytes with conditioned media from RBP4-activated macrophages markedly increased basal lipolysis and impaired insulin-mediated lipolysis suppression. RBP4 treatment of macrophages increased TNF alpha production. These data suggest that elevated serum or adipose tissue RBP4 levels in morbidly obese subjects may cause hepatic and systemic insulin resistance by stimulating basal lipolysis and by activating macrophages in adipose tissue, resulting in release of pro-inflammatory cytokines that impair lipolysis suppression. While we have demonstrated this mechanism in human adipocytes in vitro, and correlations from our flux studies in humans strongly support this, further studies are needed to determine whether this mechanism explains RBP4-induced insulin resistance in humans.	[Kilicarslan, Murat; de Weijer, Barbara A.; ter Horst, Kasper W.; Romijn, Johannes A.; Serlie, Mireille J.] Amsterdam Univ Med Ctr, Dept Endocrinol & Metab, Amsterdam, Netherlands; [Simonyte Sjodin, Kotryna; Aryal, Pratik; Kahn, Barbara B.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Div Endocrinol Diabet & Metab, Boston, MA 02115 USA; [Cakir, Hamit; Houdijk, Alexander P.] Northwest Clin, Dept Surg, Alkmaar, Netherlands; [Ackermans, Mariette T.] Amsterdam Univ Med Ctr, Lab Endocrinol, Clin Chem, Amsterdam, Netherlands; [Janssen, Ignace M.; Berends, Frits J.] Rijnstate Hosp, Dept Surg, Arnhem, Netherlands; [van de Laar, Arnold W.] Spaarne Hosp, Dept Surg, Hoofddorp, Netherlands	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Rijnstate Hospital; Spaarne Hospital	Serlie, MJ (corresponding author), Amsterdam Univ Med Ctr, AMC, Dept Endocrinol & Metab, Meibergdreef 9, Amsterdam 1105AZ, Netherlands.; Kahn, BB (corresponding author), Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, 330 Brookline Ave,CLS 747, Boston, MA 02215 USA.	bkahn@bidmc.harvard.edu; m.j.serlie@amsterdamumc.nl	Simonyté Sjödin, Kotryna/CAF-5168-2022; Simonyté Sjödin, Kotryna/CAI-1642-2022	Simonyté Sjödin, Kotryna/0000-0002-1323-9913; Simonyté Sjödin, Kotryna/0000-0002-1323-9913; Aryal, Pratik/0000-0001-6443-8974				Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc10-S062, 10.2337/dc13-S067, 10.2337/dc12-s064, 10.2337/dc11-S062]; Balagopal P, 2007, J CLIN ENDOCR METAB, V92, P1971, DOI 10.1210/jc.2006-2712; Bianconcini A, 2009, INT J BIOCHEM CELL B, V41, P2189, DOI 10.1016/j.biocel.2009.04.011; Cawthorn WP, 2008, FEBS LETT, V582, P117, DOI 10.1016/j.febslet.2007.11.051; Chavez AO, 2009, AM J PHYSIOL-ENDOC M, V296, pE758, DOI 10.1152/ajpendo.90737.2008; Choi SM, 2010, MOL CELL BIOL, V30, P5009, DOI 10.1128/MCB.00797-10; de Weijer BA, 2013, OBESITY, V21, P1143, DOI 10.1002/oby.20220; Deng ZB, 2009, DIABETES, V58, P2498, DOI 10.2337/db09-0216; DIXON JL, 1987, J CELL PHYSIOL, V130, P14, DOI 10.1002/jcp.1041300104; Fedders R, 2018, J BIOL CHEM, V293, P15269, DOI 10.1074/jbc.RA118.004294; FINEGOOD DT, 1987, DIABETES, V36, P914, DOI 10.2337/diabetes.36.8.914; Gao D, 2014, AM J PHYSIOL-ENDOC M, V307, pE289, DOI 10.1152/ajpendo.00430.2013; Graham TE, 2007, DIABETOLOGIA, V50, P814, DOI 10.1007/s00125-006-0557-0; Graham TE, 2006, NEW ENGL J MED, V354, P2552, DOI 10.1056/NEJMoa054862; Grant RW, 2015, AM J PHYSIOL-ENDOC M, V309, pE205, DOI 10.1152/ajpendo.00053.2015; Johansson H, 2008, CANCER RES, V68, P9512, DOI 10.1158/0008-5472.CAN-08-0553; Kloeting N, 2007, CELL METAB, V6, P79, DOI 10.1016/j.cmet.2007.06.002; Kotnik P, 2011, EUR J ENDOCRINOL, V165, P703, DOI 10.1530/EJE-11-0431; LAURELL S, 1966, CLIN CHIM ACTA, V13, P317, DOI 10.1016/0009-8981(66)90210-5; Lee MJ, 2014, METHOD ENZYMOL, V538, P49, DOI 10.1016/B978-0-12-800280-3.00004-9; Lee MJ, 2012, AM J PHYSIOL-ENDOC M, V303, pE1126, DOI 10.1152/ajpendo.00228.2012; Lee SA, 2016, HEPATOLOGY, V64, P1534, DOI 10.1002/hep.28659; Liu Y, 2016, J CLIN ENDOCR METAB, V101, P4338, DOI 10.1210/jc.2016-1320; Ma X, 2016, DIABETOLOGIA, V59, P354, DOI 10.1007/s00125-015-3807-1; Moraes-Vieira PM, 2016, DIABETES, V65, P1317, DOI 10.2337/db15-1696; Moraes-Vieira PM, 2014, CELL METAB, V19, P512, DOI 10.1016/j.cmet.2014.01.018; Morigny P, 2016, BIOCHIMIE, V125, P259, DOI 10.1016/j.biochi.2015.10.024; Munkhtulga L, 2010, OBESITY, V18, P1006, DOI 10.1038/oby.2009.358; Norseen J, 2012, MOL CELL BIOL, V32, P2010, DOI 10.1128/MCB.06193-11; Perry RJ, 2015, CELL, V160, P745, DOI 10.1016/j.cell.2015.01.012; Preitner F, 2009, AM J PHYSIOL-ENDOC M, V297, pE1420, DOI 10.1152/ajpendo.00362.2009; Ribel-Madsen R, 2009, DIABETES, V58, P54, DOI 10.2337/db08-1019; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; Shepherd PR, 1999, NEW ENGL J MED, V341, P248, DOI 10.1056/NEJM199907223410406; Shin DJ, 2012, NUCLEIC ACIDS RES, V40, P11499, DOI 10.1093/nar/gks932; SMITH JE, 1978, CELL, V15, P865, DOI 10.1016/0092-8674(78)90271-4; STEELE R, 1959, ANN NY ACAD SCI, V82, P420, DOI 10.1111/j.1749-6632.1959.tb44923.x; Tan BK, 2007, J CLIN ENDOCR METAB, V92, P2764, DOI 10.1210/jc.2007-0091; Tan Y, 2011, BBA-MOL CELL BIOL L, V1811, P1045, DOI 10.1016/j.bbalip.2011.09.011; ter Horst KW, 2015, INT J OBESITY, V39, P1703, DOI 10.1038/ijo.2015.125; Terra X, 2013, OBESITY, V21, P170, DOI 10.1002/oby.20233; Thompson SJ, 2017, DIABETES, V66, P58, DOI 10.2337/db16-0286; van Hoek M, 2008, DIABETOLOGIA, V51, P1423, DOI 10.1007/s00125-008-1042-8; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Yang YQ, 2008, ENDOCRINE, V33, P261, DOI 10.1007/s12020-008-9085-7; Yao-Borengasser A, 2007, J CLIN ENDOCR METAB, V92, P2590, DOI 10.1210/jc.2006-0816; Yore MM, 2012, DIABETES, V61, pA423; Zemany L, 2015, DIABETES, V64, P1603, DOI 10.2337/db14-0970	48	22	23	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6099	6110		10.1096/fj.201901979RR	http://dx.doi.org/10.1096/fj.201901979RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32167208	hybrid, Green Published			2022-12-28	WOS:000531325500010
J	Mensah, SA; Nersesyan, AA; Harding, IC; Lee, CI; Tan, XF; Banerjee, S; Niedre, M; Torchilin, VP; Ebong, EE				Mensah, Solomon A.; Nersesyan, Alina A.; Harding, Ian C.; Lee, Claire I.; Tan, Xuefei; Banerjee, Selina; Niedre, Mark; Torchilin, Vladimir P.; Ebong, Eno E.			Flow-regulated endothelial glycocalyx determines metastatic cancer cell activity	FASEB JOURNAL			English	Article						disturbed flow; endothelial cells; glycocalyx; intercellular interactions; metastatic cancer cells	CIRCULATING TUMOR-CELLS; DISTURBED FLOW; NEUTROPHIL ADHESION; HUMAN BREAST; INFLAMMATION; EXPRESSION; MODEL; ATHEROSCLEROSIS; DYSFUNCTION; PROGRESSION	Cancer metastasis and secondary tumor initiation largely depend on circulating tumor cell (CTC) and vascular endothelial cell (EC) interactions by incompletely understood mechanisms. Endothelial glycocalyx (GCX) dysfunction may play a significant role in this process. GCX structure depends on vascular flow patterns, which are irregular in tumor environments. This work presents evidence that disturbed flow (DF) induces GCX degradation, leading to CTC homing to the endothelium, a first step in secondary tumor formation. A 2-fold greater attachment of CTCs to human ECs was found to occur under DF conditions, compared to uniform flow (UF) conditions. These results corresponded to an approximately 50% decrease in wheat germ agglutinin (WGA)-labeled components of the GCX under DF conditions, vs UF conditions, with undifferentiated levels of CTC-recruiting E-selectin under DF vs UF conditions. Confirming the role of the GCX, neuraminidase induced the degradation of WGA-labeled GCX under UF cell culture conditions or in Balb/C mice and led to an over 2-fold increase in CTC attachment to ECs or Balb/C mouse lungs, respectively, compared to untreated conditions. These experiments confirm that flow-induced GCX degradation can enable metastatic CTC arrest. This work, therefore, provides new insight into pathways of secondary tumor formation.	[Mensah, Solomon A.; Nersesyan, Alina A.; Harding, Ian C.; Lee, Claire I.; Niedre, Mark; Ebong, Eno E.] Northeastern Univ, Dept Bioengn, Boston, MA 02115 USA; [Tan, Xuefei; Niedre, Mark] Northeastern Univ, Dept Elect & Comp Engn, Boston, MA 02115 USA; [Banerjee, Selina; Ebong, Eno E.] Northeastern Univ, Dept Chem Engn, 360 Huntington Ave,313 Snell Engn Bldg, Boston, MA 02115 USA; [Torchilin, Vladimir P.] Northeastern Univ, Dept Pharmaceut Sci, Boston, MA 02115 USA; [Ebong, Eno E.] Albert Einstein Coll Med, Neurosci Dept, New York, NY USA	Northeastern University; Northeastern University; Northeastern University; Northeastern University; Yeshiva University	Ebong, EE (corresponding author), Northeastern Univ, Dept Chem Engn, 360 Huntington Ave,313 Snell Engn Bldg, Boston, MA 02115 USA.	e.ebong@northeastern.edu		Mensah, Solomon/0000-0002-3444-4932; Banerjee, Selina/0000-0001-7927-2372	NHLBI NIH HHS [K01 HL125499, R01 HL124315] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aceto N, 2014, CELL, V158, P1110, DOI 10.1016/j.cell.2014.07.013; Asaad A, 2018, CHIRURGIA-BUCHAREST, V113, P712, DOI 10.21614/chirurgia.113.5.712; Barthel SR, 2007, EXPERT OPIN THER TAR, V11, P1473, DOI 10.1517/14728222.11.11.1473; BOSMANN HB, 1974, P NATL ACAD SCI USA, V71, P1833, DOI 10.1073/pnas.71.5.1833; Brabletz T, 2001, P NATL ACAD SCI USA, V98, P10356, DOI 10.1073/pnas.171610498; Buchanan CF, 2014, CELL ADHES MIGR, V8, P517, DOI 10.4161/19336918.2014.970001; Burke-Gaffney A, 2012, CRIT CARE, V16, DOI 10.1186/cc11239; Cancel LM, 2016, ATHEROSCLEROSIS, V252, P136, DOI 10.1016/j.atherosclerosis.2016.07.930; Cegan M, 2017, FOLIA HISTOCHEM CYTO, V55, P107, DOI 10.5603/FHC.a2017.0015; Chappell D, 2009, BASIC RES CARDIOL, V104, P78, DOI 10.1007/s00395-008-0749-5; Charoenphol P, 2012, J BIOMECH, V45, P2822, DOI 10.1016/j.jbiomech.2012.08.035; Chen QS, 2013, MEDIAT INFLAMM, V2013, DOI [10.1155/2013/928315, 10.1155/2013/434010]; Cheng MJ, 2020, ANN BIOMED ENG, V48, P1941, DOI 10.1007/s10439-020-02474-4; Cheng MJ, 2019, INT J NANOMED, V14, P319, DOI 10.2147/IJN.S184455; Chien S, 2008, ANN BIOMED ENG, V36, P554, DOI 10.1007/s10439-007-9426-3; Chiu JJ, 2011, PHYSIOL REV, V91, P327, DOI 10.1152/physrev.00047.2009; Clark AG, 2015, CURR OPIN CELL BIOL, V36, P13, DOI 10.1016/j.ceb.2015.06.004; Cooper S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202526; De Souza LM, 2017, CANCER LETT, V392, P60, DOI 10.1016/j.canlet.2017.01.023; Disibio G, 2008, ARCH PATHOL LAB MED, V132, P931, DOI 10.1043/1543-2165(2008)132[931:MPOCRF]2.0.CO;2; Ebong EE, 2011, ARTERIOSCL THROM VAS, V31, P1908, DOI 10.1161/ATVBAHA.111.225268; Fan J, 2016, ANN BIOMED ENG, V44, P2189, DOI 10.1007/s10439-015-1517-y; Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Fu BMM, 2018, ADV EXP MED BIOL, V1097, P201, DOI 10.1007/978-3-319-96445-4_11; Gava F, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4148-5; Giantsos-Adams KM, 2013, CELL MOL BIOENG, V6, P160, DOI 10.1007/s12195-013-0273-z; Goel S, 2011, PHYSIOL REV, V91, P1071, DOI 10.1152/physrev.00038.2010; Gouverneur M, 2006, J INTERN MED, V259, P393, DOI 10.1111/j.1365-2796.2006.01625.x; Gouverneur M, 2006, AM J PHYSIOL-HEART C, V290, pH458, DOI 10.1152/ajpheart.00592.2005; Guo P, 2014, BIOMECH MODEL MECHAN, V13, P537, DOI 10.1007/s10237-013-0515-y; Harding IC, 2019, BIORHEOLOGY, V56, P131, DOI 10.3233/BIR-180205; Harding IC, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1721-2; Hartmann C, 2018, PHYS MED BIOL, V63, DOI 10.1088/1361-6560/aa98f9; Hashizume H, 2000, AM J PATHOL, V156, P1363, DOI 10.1016/S0002-9440(10)65006-7; Huang J, 2004, J BIOL CHEM, V279, P44915, DOI 10.1074/jbc.M407039200; Huang RB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031874; Ishikawa T, 2011, BIOMED MICRODEVICES, V13, P159, DOI 10.1007/s10544-010-9481-7; Johansson PI, 2011, ANN SURG, V254, P194, DOI 10.1097/SLA.0b013e318226113d; Kline TL, 2011, CELLS TISSUES ORGANS, V194, P431, DOI 10.1159/000323482; Kobayashi H, 2007, CURR MED CHEM, V14, P377, DOI 10.2174/092986707779941032; Koo A, 2013, AM J PHYSIOL-CELL PH, V304, pC137, DOI 10.1152/ajpcell.00187.2012; Korshunov VA, 2003, ARTERIOSCL THROM VAS, V23, P2185, DOI 10.1161/01.ATV.0000103120.06092.14; KU DN, 1985, ARTERIOSCLEROSIS, V5, P293, DOI 10.1161/01.ATV.5.3.293; Kundra P, 2019, INDIAN J ANAESTH, V63, P6, DOI 10.4103/ija.IJA_751_18; Kurzelewski M, 2005, J PHYSIOL PHARMACOL, V56, P163; Lambert AW, 2017, CELL, V168, P670, DOI 10.1016/j.cell.2016.11.037; Lee AM, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00108; Li YT, 2019, ELIFE, V8, DOI 10.7554/eLife.47642; Lipowsky HH, 2015, BIORHEOLOGY, V52, P433, DOI 10.3233/BIR-15063; Manni A, 2005, CLIN EXP METASTAS, V22, P255, DOI 10.1007/s10585-005-8480-1; Markovic S, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.3.035005; Markovic S, 2013, CYTOM PART A, V83, P1113, DOI 10.1002/cyto.a.22397; McDonald KK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167576; Mensah SA, 2019, AICHE J, V65, DOI 10.1002/aic.16634; Mitra R, 2018, TRANSL MED COMMUN, V3, P1; Nakajima H, 2017, CELL CYCLE, V16, P1893, DOI 10.1080/15384101.2017.1364324; Nam D, 2009, AM J PHYSIOL-HEART C, V297, pH1535, DOI 10.1152/ajpheart.00510.2009; Nishitani S, 2018, CHEMISTRYOPEN, V7, P513, DOI 10.1002/open.201800071; Okegawa T, 2004, ACTA BIOCHIM POL, V51, P445; Patil R, 2019, J BIOMED OPT, V24, DOI 10.1117/1.JBO.24.8.085004; Pera V, 2017, J BIOMED OPT, V22, DOI 10.1117/1.JBO.22.3.037004; Prall F, 2007, HISTOPATHOLOGY, V50, P151, DOI 10.1111/j.1365-2559.2006.02551.x; Rai S, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0223-9; Rehm M, 2007, CIRCULATION, V116, P1896, DOI 10.1161/CIRCULATIONAHA.106.684852; Reitsma S, 2007, PFLUG ARCH EUR J PHY, V454, P345, DOI 10.1007/s00424-007-0212-8; Rocha HNM, 2018, LIFE SCI, V209, P103, DOI 10.1016/j.lfs.2018.08.002; Sarangapani KK, 2011, J BIOL CHEM, V286, P9567, DOI 10.1074/jbc.M110.196485; SCHENGRUND CL, 1973, J BIOL CHEM, V248, P4424; Schmidt EP, 2012, NAT MED, V18, P1217, DOI 10.1038/nm.2843; Singh A, 2007, J AM SOC NEPHROL, V18, P2885, DOI 10.1681/ASN.2007010119; Song JW, 2017, J PHARMACOL EXP THER, V361, P115, DOI 10.1124/jpet.116.239509; Stojak M, 2018, PHARMACOL RES, V136, P160, DOI 10.1016/j.phrs.2018.09.005; Sukhikh GT, 2016, PLACENTA, V43, P69, DOI 10.1016/j.placenta.2016.05.002; Sullivan TM, 2002, J VASC SURG, V36, P143, DOI 10.1067/mva.2002.122878; Sung BH, 2007, CELL BIOCHEM FUNCT, V25, P585, DOI 10.1002/cbf.1361; Takeishi N, 2016, AM J PHYSIOL-HEART C, V311, pH395, DOI 10.1152/ajpheart.00241.2016; Tan XF, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40143-2; Townsley MI, 2012, COMPR PHYSIOL, V2, P675, DOI 10.1002/cphy.c100081; van den Berg BM, 2006, AM J PHYSIOL-HEART C, V290, pH915, DOI 10.1152/ajpheart.00051.2005; Vlodavsky I, 2008, CONNECT TISSUE RES, V49, P207, DOI 10.1080/03008200802143281; Wang LP, 2016, BIOCHEM BIOPH RES CO, V478, P669, DOI 10.1016/j.bbrc.2016.08.005; Yin M, 2017, ONCOTARGET, V8, P88232, DOI 10.18632/oncotarget.21088; Zeng Y, 2014, AM J PHYSIOL-HEART C, V306, pH363, DOI 10.1152/ajpheart.00687.2013; Zhou JT, 2017, ONCOTARGET, V8, P25713, DOI 10.18632/oncotarget.14879	85	12	12	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6166	6184		10.1096/fj.201901920R	http://dx.doi.org/10.1096/fj.201901920R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32167209	Green Accepted, Bronze			2022-12-28	WOS:000531325500014
J	Wang, W; Allard, BA; Pottorf, TS; Wang, HH; Vivian, JL; Tran, PV				Wang Wei; Allard, Bailey A.; Pottorf, Tana S.; Wang, Henry H.; Vivian, Jay L.; Tran, Pamela V.			Genetic interaction of mammalian IFT-A paralogs regulates cilia disassembly, ciliary entry of membrane protein, Hedgehog signaling, and embryogenesis	FASEB JOURNAL			English	Article						development; mouse embryonic fibroblasts; mouse model; primary cilia	INTRAFLAGELLAR TRANSPORT; COMPLEX; TRANSDUCTION; TRAFFICKING; ACTIVATION; BBSOME	Primary cilia are sensory organelles that are essential for eukaryotic development and health. These antenna-like structures are synthesized by intraflagellar transport protein complexes, IFT-B and IFT-A, which mediate bidirectional protein trafficking along the ciliary axoneme. Here using mouse embryonic fibroblasts (MEF), we investigate the ciliary roles of two mammalian orthologues of Chlamydomonas IFT-A gene, IFT139, namely Thm1 (also known as Ttc21b) and Thm2 (Ttc21a). Thm1 loss causes perinatal lethality, and Thm2 loss allows survival into adulthood. At E14.5, the number of Thm1;Thm2 double mutant embryos is lower than that for a Mendelian ratio, indicating deletion of Thm1 and Thm2 causes mid-gestational lethality. We examined the ciliary phenotypes of mutant MEF. Thm1-mutant MEF show decreased cilia assembly, increased cilia disassembly, shortened primary cilia, a retrograde IFT defect for IFT and BBS proteins, and reduced ciliary entry of membrane-associated proteins. Thm1-mutant cilia also show a retrograde transport defect for the Hedgehog transducer, Smoothened, and an impaired response to Smoothened agonist, SAG. Thm2-null MEF show normal ciliary dynamics and Hedgehog signaling, but additional loss of a Thm1 allele impairs response to SAG. Further, Thm1;Thm2 double-mutant MEF show enhanced cilia disassembly, and increased impairment of INPP5E ciliary import. Thus, Thm1 and Thm2 have unique and redundant roles in MEF. Thm1 regulates cilia assembly, and alone and together with Thm2, regulates cilia disassembly, ciliary entry of membrane-associated protein, Hedgehog signaling, and embryogenesis. These findings shed light on mechanisms underlying Thm1-, Thm2- or IFT-A-mediated ciliopathies.	[Wang Wei; Allard, Bailey A.; Pottorf, Tana S.; Wang, Henry H.; Tran, Pamela V.] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Jared Grantham Kidney Inst, 3901 Rainbow Blvd,MS 3038, Kansas City, KS 66160 USA; [Vivian, Jay L.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Tran, PV (corresponding author), Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Jared Grantham Kidney Inst, 3901 Rainbow Blvd,MS 3038, Kansas City, KS 66160 USA.	ptran@kumc.edu	Pottorf, Tana/AAP-2801-2021	Pottorf, Tana/0000-0001-9410-6110	NCI NIH HHS [P30 CA168524] Funding Source: Medline; NICHD NIH HHS [U54 HD090216] Funding Source: Medline; NIDDK NIH HHS [R01 DK103033, P30 DK106912] Funding Source: Medline; NIGMS NIH HHS [P30 GM122731] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bai CB, 2002, DEVELOPMENT, V129, P4753; Brown JM, 2014, BIOSCIENCE, V64, P1126, DOI 10.1093/biosci/biu174; Chang CF, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006351; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Davis EE, 2011, NAT GENET, V43, P189, DOI 10.1038/ng.756; Driver AM, 2017, J DEV BIOL, V5, DOI 10.3390/jdb5040018; Eguether T, 2014, DEV CELL, V31, P279, DOI 10.1016/j.devcel.2014.09.011; Fu WX, 2016, CELL REP, V17, P1505, DOI 10.1016/j.celrep.2016.10.018; Goetz SC, 2009, METHOD CELL BIOL, V94, P199, DOI 10.1016/S0091-679X(08)94010-3; Herron BJ, 2002, NAT GENET, V30, P185, DOI 10.1038/ng812; Hirano T, 2017, MOL BIOL CELL, V28, P429, DOI 10.1091/mbc.E16-11-0813; Iomini C, 2009, GENETICS, V183, P885, DOI 10.1534/genetics.109.101915; Jacobs DT, 2016, DIS MODEL MECH, V9, P789, DOI 10.1242/dmm.025791; Jin H, 2010, CELL, V141, P1208, DOI 10.1016/j.cell.2010.05.015; Keeling J, 2016, CELLS-BASEL, V5, DOI 10.3390/cells5010006; Liew GM, 2014, DEV CELL, V31, P265, DOI 10.1016/j.devcel.2014.09.004; Liu WJ, 2019, AM J HUM GENET, V104, P738, DOI 10.1016/j.ajhg.2019.02.020; Lu H, 2015, DEV BIOL, V397, P225, DOI 10.1016/j.ydbio.2014.11.009; Mirvis M, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000381; Mirvis M, 2018, BIOCHEM J, V475, P2329, DOI 10.1042/BCJ20170453; Mukhopadhyay S, 2010, GENE DEV, V24, P2180, DOI 10.1101/gad.1966210; Phua SC, 2017, CELL, V168, P264, DOI 10.1016/j.cell.2016.12.032; Picariello T, 2019, J CELL SCI, V132, DOI 10.1242/jcs.220749; Plotnikova OV, 2009, METHOD CELL BIOL, V94, P137, DOI 10.1016/S0091-679X(08)94007-3; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; Spalluto C, 2013, FEBS OPEN BIO, V3, P334, DOI 10.1016/j.fob.2013.08.002; Stottmann RW, 2009, DEV BIOL, V335, P166, DOI 10.1016/j.ydbio.2009.08.023; Tobin JL, 2009, GENET MED, V11, P386, DOI 10.1097/GIM.0b013e3181a02882; Tran PV, 2008, NAT GENET, V40, P403, DOI 10.1038/ng.105; Tran PV, 2014, J AM SOC NEPHROL, V25, P2201, DOI 10.1681/ASN.2013070735; Zhang QH, 2011, P NATL ACAD SCI USA, V108, P20678, DOI 10.1073/pnas.1113220108; Zhu B, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006627	32	9	9	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6369	6381		10.1096/fj.201902611R	http://dx.doi.org/10.1096/fj.201902611R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32167205	Green Submitted, Green Accepted			2022-12-28	WOS:000531325500027
J	Ghosh, R; Wood-Kaczmar, A; Dobson, L; Smith, EJ; Sirinathsinghji, EC; Kriston-Vizi, J; Hargreaves, IP; Heaton, R; Herrmann, F; Abramov, AY; Lam, AJ; Heales, SJ; Ketteler, R; Bates, GP; Andre, R; Tabrizi, SJ				Ghosh, Rhia; Wood-Kaczmar, Alison; Dobson, Lucianne; Smith, Edward J.; Sirinathsinghji, Eva C.; Kriston-Vizi, Janos; Hargreaves, Iain P.; Heaton, Robert; Herrmann, Frank; Abramov, Andrey Y.; Lam, Amanda J.; Heales, Simon J.; Ketteler, Robin; Bates, Gillian P.; Andre, Ralph; Tabrizi, Sarah J.			Expression of mutant exon 1 huntingtin fragments in human neural stem cells and neurons causes inclusion formation and mitochondrial dysfunction	FASEB JOURNAL			English	Article						aggregation; Huntington's; mitochondria; model; respiration	CELLULAR TOXICITY; SKELETAL-MUSCLE; CAG REPEAT; DISEASE; PROTEIN; AGGREGATION; METABOLISM; NUCLEAR; MODEL; DEATH	Robust cellular models are key in determining pathological mechanisms that lead to neurotoxicity in Huntington's disease (HD) and for high throughput pre-clinical screening of potential therapeutic compounds. Such models exist but mostly comprise non-human or non-neuronal cells that may not recapitulate the correct biochemical milieu involved in pathology. We have developed a new human neuronal cell model of HD, using neural stem cells (ReNcell VM NSCs) stably transduced to express exon 1 huntingtin (HTT) fragments with variable length polyglutamine (polyQ) tracts. Using a system with matched expression levels of exon 1 HTT fragments, we investigated the effect of increasing polyQ repeat length on HTT inclusion formation, location, neuronal survival, and mitochondrial function with a view to creating an in vitro screening platform for therapeutic screening. We found that expression of exon 1 HTT fragments with longer polyQ tracts led to the formation of intra-nuclear inclusions in a polyQ length-dependent manner during neurogenesis. There was no overt effect on neuronal viability, but defects of mitochondrial function were found in the pathogenic lines. Thus, we have a human neuronal cell model of HD that may recapitulate some of the earliest stages of HD pathogenesis, namely inclusion formation and mitochondrial dysfunction.	[Ghosh, Rhia; Wood-Kaczmar, Alison; Dobson, Lucianne; Smith, Edward J.; Sirinathsinghji, Eva C.; Bates, Gillian P.; Andre, Ralph; Tabrizi, Sarah J.] UCL, Huntingtons Dis Ctr, Dept Neurodegenerat Dis, UCL Queen Sq Inst Neurol, London WC1N 3BG, England; [Kriston-Vizi, Janos; Ketteler, Robin] UCL, MRC Lab Mol Cell Biol, London, England; [Hargreaves, Iain P.; Heaton, Robert] Liverpool John Moores Univ, Sch Pharm, Liverpool, Merseyside, England; [Herrmann, Frank] Evotec AG, Hamburg, Germany; [Abramov, Andrey Y.] Univ Coll London, Dept Clin & Movement Neurosci, UCL Queen Sq Inst Neurol, London, Germany; [Lam, Amanda J.; Heales, Simon J.] Natl Hosp Neurol & Neurosurg, Neurometab Unit, London, Germany	University of London; University College London; MRC Laboratory Molecular Biology; University of London; University College London; Liverpool John Moores University; Evotec	Tabrizi, SJ (corresponding author), UCL, Huntingtons Dis Ctr, Dept Neurodegenerat Dis, UCL Queen Sq Inst Neurol, London WC1N 3BG, England.	s.tabrizi@ucl.ac.uk	Abramov, Andrey Y/H-9053-2012; Kriston-Vizi, Janos/L-6021-2013; Bates, Gillian/E-1146-2012	Abramov, Andrey Y/0000-0002-7646-7235; Kriston-Vizi, Janos/0000-0002-0149-145X; Bates, Gillian/0000-0002-4041-6305; Tabrizi, Sarah/0000-0003-2716-2045	Takeda Pharmaceutical Company (Takeda Pharmaceutical Co., Ltd.); RCUK \ Medical Research Council (MRC) [MR/L02053X/1, MR/M02492X/1, MC_U12266B]; MRC [UKDRI-1008/1, UKDRI-1008/2, MR/L02053X/1, MR/M02492X/1, MR/K023268/1] Funding Source: UKRI	Takeda Pharmaceutical Company (Takeda Pharmaceutical Co., Ltd.); RCUK \ Medical Research Council (MRC); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Takeda Pharmaceutical Company (Takeda Pharmaceutical Co., Ltd.); RCUK vertical bar Medical Research Council (MRC), Grant/Award Number: MR/L02053X/1, MR/M02492X/1 and LMCB; MC_U12266B	An MC, 2012, CELL STEM CELL, V11, P253, DOI 10.1016/j.stem.2012.04.026; ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; [Anonymous], 2018, R LANG ENV STAT COMP; Antoniou M, 2003, GENOMICS, V82, P269, DOI 10.1016/S0888-7543(03)00107-1; Apostol BL, 2003, P NATL ACAD SCI USA, V100, P5950, DOI 10.1073/pnas.2628045100; Barbaro BA, 2015, HUM MOL GENET, V24, P913, DOI 10.1093/hmg/ddu504; Bayram-Weston Z, 2012, BRAIN RES BULL, V88, P104, DOI 10.1016/j.brainresbull.2011.07.009; Clemens LE, 2015, BRAIN, V138, P3632, DOI 10.1093/brain/awv290; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Donato R, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-36; Duncan AJ, 2005, CLIN CHEM, V51, P2380, DOI 10.1373/clinchem.2005.054643; Gandhi S, 2009, MOL CELL, V33, P627, DOI 10.1016/j.molcel.2009.02.013; Germain PL, 2017, STEM CELL REP, V8, P1784, DOI 10.1016/j.stemcr.2017.05.012; Gouarne C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081528; Grima JC, 2017, NEURON, V94, P93, DOI 10.1016/j.neuron.2017.03.023; Guedes-Dias P, 2016, NEUROBIOL DIS, V90, P51, DOI 10.1016/j.nbd.2015.09.008; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; Hamilton J, 2015, HUM MOL GENET, V24, P4862, DOI 10.1093/hmg/ddv209; Hargreaves IP, 1999, J INHERIT METAB DIS, V22, P925, DOI 10.1023/A:1005643508075; Hatefi Y, 1978, Methods Enzymol, V53, P21; HD iPSC Consortium, 2012, CELL STEM CELL, V11, P264, DOI 10.1016/j.stem.2012.04.027; Ho LW, 2001, J MED GENET, V38, P450, DOI 10.1136/jmg.38.7.450; Hughes A., 2014, HUNTINGTONS DIS; Ismailoglu I, 2014, DEV BIOL, V391, P230, DOI 10.1016/j.ydbio.2014.04.005; Jacquard C, 2006, FASEB J, V20, P1021, DOI 10.1096/fj.05-5085fje; Kim YH, 2015, NAT PROTOC, V10, P985, DOI 10.1038/nprot.2015.065; Kim YE, 2016, MOL CELL, V63, P951, DOI 10.1016/j.molcel.2016.07.022; King T.E., 1967, METHODS ENZYMOL, P216, DOI DOI 10.1016/0076-6879(67)10043-8; Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X; Ko J, 2018, HUM MOL GENET, V27, P2330, DOI 10.1093/hmg/ddy141; Labbadia J, 2012, BRAIN, V135, P1180, DOI 10.1093/brain/aws022; Labbadia J, 2011, J CLIN INVEST, V121, P3306, DOI 10.1172/JCI57413; Li H, 2003, HUM MOL GENET, V12, P2021, DOI 10.1093/hmg/ddg218; Lopez LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011897; Lou S, 2016, HUM MOL GENET, V25, P2813, DOI 10.1093/hmg/ddw138; Lu BX, 2013, FASEB J, V27, P1820, DOI 10.1096/fj.12-219220; Macdonald D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096854; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Mejia EM, 2016, LIPIDS, V51, P561, DOI 10.1007/s11745-015-4110-0; Miller J, 2010, J NEUROSCI, V30, P10541, DOI 10.1523/JNEUROSCI.0146-10.2010; Nekooki-Machida Y, 2009, P NATL ACAD SCI USA, V106, P9679, DOI 10.1073/pnas.0812083106; Neueder A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01510-z; Park SH, 2013, CELL, V154, P134, DOI 10.1016/j.cell.2013.06.003; Polyzos AA, 2017, MECH AGEING DEV, V161, P181, DOI 10.1016/j.mad.2016.09.003; Rahman S, 2001, J PEDIATR-US, V139, P456, DOI 10.1067/mpd.2001.117575; Ramdzan YM, 2017, CELL REP, V19, P919, DOI 10.1016/j.celrep.2017.04.029; Ross CA, 2011, LANCET NEUROL, V10, P83, DOI 10.1016/S1474-4422(10)70245-3; Sahoo B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155747; Sathasivam K, 2013, P NATL ACAD SCI USA, V110, P2366, DOI 10.1073/pnas.1221891110; Schaffar G, 2004, MOL CELL, V15, P95, DOI 10.1016/j.molcel.2004.06.029; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Selak MA, 2000, PEDIATR NEUROL, V23, P54, DOI 10.1016/S0887-8994(00)00145-4; SIMPSON JR, 1993, EXP NEUROL, V121, P57, DOI 10.1006/exnr.1993.1071; Woerner AC, 2016, SCIENCE, V351, P173, DOI 10.1126/science.aad2033; Wood-Kaczmar A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002455; Yang SH, 2008, NATURE, V453, P921, DOI 10.1038/nature06975; Ye CF, 2008, NEUROSCI LETT, V442, P63, DOI 10.1016/j.neulet.2008.05.119	58	12	12	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8139	8154		10.1096/fj.201902277RR	http://dx.doi.org/10.1096/fj.201902277RR		APR 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32329133	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000529446100001
J	Macaulay, AD; Allais, A; FitzHarris, G				Macaulay, Angus D.; Allais, Adelaide; FitzHarris, Greg			Chromosome dynamics and spindle microtubule establishment in mouse embryos	FASEB JOURNAL			English	Article						embryo; error correction; mitosis; spindle	AURORA C; SEGREGATION; CENTROSOME; MECHANISMS; MOSAICISM; MTOCS; CONSEQUENCES; ORGANIZATION; INHERITANCE; ANEUPLOIDY	Chromosome segregation errors in mammalian embryos are common and jeopardize embryo health. Here, we perform for the first time 4-Dimensional imaging and tracking of chromosomes and centromeres through each preimplantation mitotic cell division in mouse embryos to define the normal dynamics of chromosome segregation. We show that a microtubule (MT)-dependent inward movement of chromosomes occurs at the time of nuclear envelope breakdown (NEBD), particularly in the earliest cell divisions, to position chromosomes prior to spindle assembly. Establishment of a rudimentary metaphase plate occurs immediately after NEBD, and is followed by a progressive alignment and biorientation of mitotic chromosomes. Stable end-on kinetochore-MT attachments form rapidly and attachment errors are uncommon. Altogether our data describe a rapid and efficient spindle assembly pathway that apparently minimizes the need for canonical MT attachment error correction in normally dividing embryos.	[Macaulay, Angus D.; Allais, Adelaide; FitzHarris, Greg] Ctr Rech Ctr Hosp Univ Montreal, 900 St Denis St, Montreal, PQ H2X 3H8, Canada; [FitzHarris, Greg] Univ Montreal, Dept OBGYN, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal	FitzHarris, G (corresponding author), Ctr Rech Ctr Hosp Univ Montreal, 900 St Denis St, Montreal, PQ H2X 3H8, Canada.	greg.fitzharris@umontreal.ca		Macaulay, Angus/0000-0001-8638-5068	Gouvernement du Canada \ CIHR \ Institute of Human Development, Child and Youth Health (IHDCYH); Gouvernement du Canada \ Natural Sciences and Engineering Research Council of Canada (NSERC); Fondation Jean-Louis Levesque (Fondation J Louis Levesque)	Gouvernement du Canada \ CIHR \ Institute of Human Development, Child and Youth Health (IHDCYH); Gouvernement du Canada \ Natural Sciences and Engineering Research Council of Canada (NSERC); Fondation Jean-Louis Levesque (Fondation J Louis Levesque)	Gouvernement du Canada vertical bar CIHR vertical bar Institute of Human Development, Child and Youth Health (IHDCYH); Gouvernement du Canada vertical bar Natural Sciences and Engineering Research Council of Canada (NSERC); Fondation Jean-Louis Levesque (Fondation J Louis Levesque)	Ajduk A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09526-1; Beaudouin J, 2002, CELL, V108, P83, DOI 10.1016/S0092-8674(01)00627-4; Bennabi I, 2016, J CELL BIOL, V215, P611, DOI 10.1083/jcb.201607062; Bolton H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11165; Booth AJR, 2019, ELIFE, V8, DOI 10.7554/eLife.46902; Cimini D, 2001, J CELL BIOL, V153, P517, DOI 10.1083/jcb.153.3.517; Compton DA, 2000, ANNU REV BIOCHEM, V69, P95, DOI 10.1146/annurev.biochem.69.1.95; Courtois A, 2012, J CELL BIOL, V198, P357, DOI 10.1083/jcb.201202135; Davydenko O, 2013, J CELL BIOL, V202, P221, DOI 10.1083/jcb.201303019; Delattre M, 2004, J CELL SCI, V117, P1619, DOI 10.1242/jcs.01128; DELHANTY JDA, 1993, HUM MOL GENET, V2, P1183, DOI 10.1093/hmg/2.8.1183; Fernandez-Miranda G, 2011, DEVELOPMENT, V138, P2661, DOI 10.1242/dev.066381; Gregan J, 2011, TRENDS CELL BIOL, V21, P374, DOI 10.1016/j.tcb.2011.01.003; GUETHHALLONET C, 1993, J CELL SCI, V105, P157; Heald R, 2015, J CELL BIOL, V211, P1103, DOI 10.1083/jcb.201510015; Howe K, 2013, CELL CYCLE, V12, P1616, DOI 10.4161/cc.24755; Kitajima TS, 2011, CELL, V146, P568, DOI 10.1016/j.cell.2011.07.031; Lampson MA, 2017, BIOLOGY-BASEL, V6, DOI 10.3390/biology6010001; Lara-Gonzalez P, 2012, CURR BIOL, V22, pR966, DOI 10.1016/j.cub.2012.10.006; Lenart P, 2005, NATURE, V436, P812, DOI 10.1038/nature03810; Luksza M, 2013, DEV BIOL, V382, P48, DOI 10.1016/j.ydbio.2013.07.029; Magidson V, 2011, CELL, V146, P555, DOI 10.1016/j.cell.2011.07.012; Michel L, 2004, P NATL ACAD SCI USA, V101, P4459, DOI 10.1073/pnas.0306069101; Michel LS, 2001, NATURE, V409, P355, DOI 10.1038/35053094; Mihajlovic AI, 2018, CURR BIOL, V28, pR895, DOI 10.1016/j.cub.2018.06.057; Miyanari Y, 2013, NAT STRUCT MOL BIOL, V20, P1321, DOI 10.1038/nsmb.2680; Mogessie B, 2017, SCIENCE, V357, DOI 10.1126/science.aal1647; MUNNE S, 1994, BIOL REPROD, V51, P373, DOI 10.1095/biolreprod51.3.373; Munne S, 2017, FERTIL STERIL, V108, P62, DOI 10.1016/j.fertnstert.2017.05.002; Musacchio A, 2015, CURR BIOL, V25, pR1002, DOI 10.1016/j.cub.2015.08.051; Nakagawa S, 2017, CURR BIOL, V27, P1040, DOI 10.1016/j.cub.2017.02.025; Nakagawa S, 2016, METHODS MOL BIOL, V1457, P217, DOI 10.1007/978-1-4939-3795-0_16; Paim LMG, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12772-8; Reichmann J, 2018, SCIENCE, V361, P189, DOI 10.1126/science.aar7462; Salmon ED, 2005, PHILOS T R SOC B, V360, P553, DOI 10.1098/rstb.2004.1610; SCHATTEN G, 1994, DEV BIOL, V165, P299, DOI 10.1006/dbio.1994.1256; Schindler K, 2012, P NATL ACAD SCI USA, V109, pE2215, DOI 10.1073/pnas.1120517109; Schuh M, 2007, CELL, V130, P484, DOI 10.1016/j.cell.2007.06.025; Sikora-Polaczek M, 2006, BIOL REPROD, V74, P734, DOI 10.1095/biolreprod.105.047092; Taylor TH, 2014, HUM REPROD UPDATE, V20, P571, DOI 10.1093/humupd/dmu016; Thompson SL, 2011, P NATL ACAD SCI USA, V108, P17974, DOI 10.1073/pnas.1109720108; Thompson SL, 2010, CURR BIOL, V20, pR285, DOI 10.1016/j.cub.2010.01.034; Tsichlaki E, 2016, SCI REP-UK, V6, DOI 10.1038/srep28040; Vazquez-Diez C, 2019, CURR BIOL, V29, P865, DOI 10.1016/j.cub.2018.12.042; Vazquez-Diez C, 2018, REPRODUCTION, V155, pR63, DOI 10.1530/REP-17-0569; Vazquez-Diez C, 2016, P NATL ACAD SCI USA, V113, P626, DOI 10.1073/pnas.1517628112; Yamagata K, 2013, CELL CYCLE, V12, P157, DOI 10.4161/cc.23052	47	2	2	4	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8057	8067		10.1096/fj.201902947R	http://dx.doi.org/10.1096/fj.201902947R		APR 2020	11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32329130				2022-12-28	WOS:000529446900001
J	Wu, D; Fan, Y; Liu, SZ; Woollam, MD; Sun, X; Murao, E; Zha, RR; Prakash, R; Park, C; Siegel, AP; Liu, J; Agarwal, M; Li, BY; Yokota, H				Wu, Di; Fan, Yao; Liu, Shengzhi; Woollam, Mark D.; Sun, Xun; Murao, Eiji; Zha, Rongrong; Prakash, Rahul; Park, Charles; Siegel, Amanda P.; Liu, Jing; Agarwal, Mangilal; Li, Bai-Yan; Yokota, Hiroki			Loading-induced antitumor capability of murine and human urine	FASEB JOURNAL			English	Article						breast cancer; CD105; cholesterol; CSF1; dopamine; loading; Lrp5; melatonin; TCGA; tumor progression; urine	DOPAMINERGIC ACTIVITY; CANCER; EXERCISE; CELL; METASTASIS; ACTIVATION; MODEL	While urine has been considered as a useful bio-fluid for health monitoring, its dynamic changes to physical activity are not well understood. We examined urine's possible antitumor capability in response to medium-level, loading-driven physical activity. Urine was collected from mice subjected to 5-minute skeletal loading and human individuals before and after 30-minute step aerobics. Six cancer cell lines (breast, prostate, and pancreas) and a mouse model of the mammary tumor were employed to evaluate the effect of urine. Compared to urine collected prior to loading, urine collected post-activity decreased the cellular viability, proliferation, migration, and invasion of tumor cells, as well as tumor weight in the mammary fat pad. Detection of urinary volatile organic compounds and ELISA assays showed that the loading-conditioned urine reduced cholesterol and elevated dopamine and melatonin. Immunohistochemical fluorescent images presented upregulation of the rate-limiting enzymes for the production of dopamine and melatonin in the brain. Molecular analysis revealed that the antitumor effect was linked to the reduction in molecular vinculin-linked molecular force as well as the downregulation of the Lrp5-CSF1-CD105 regulatory axis. Notably, the survival rate for the high expression levels of Lrp5, CSF1, and CD105 in tumor tissues was significantly lowered in the Cancer Genome Atlas database. Collectively, this study revealed that 5- or 10-minute loading-driven physical activity was sufficient to induce the striking antitumor effect by activating the neuronal signaling and repressing cholesterol synthesis. The result supported the dual role of loading-conditioned urine as a potential tumor suppressor and a source of diagnostic biomarkers.	[Wu, Di; Fan, Yao; Sun, Xun; Zha, Rongrong; Li, Bai-Yan; Yokota, Hiroki] Harbin Med Univ, Sch Pharm, Dept Pharmacol, 157 Baojian Rd, Harbin 150081, Peoples R China; [Wu, Di; Fan, Yao; Liu, Shengzhi; Sun, Xun; Murao, Eiji; Zha, Rongrong; Prakash, Rahul; Yokota, Hiroki] Indiana Univ Purdue Univ, Dept Biomed Engn, Indianapolis, IN 46202 USA; [Woollam, Mark D.; Siegel, Amanda P.] Indiana Univ Purdue Univ, Dept Chem & Chem Biol, Indianapolis, IN 46202 USA; [Woollam, Mark D.; Siegel, Amanda P.; Agarwal, Mangilal; Yokota, Hiroki] Indiana Univ Purdue Univ, Integrat Nanosyst Dev Inst, Indianapolis, IN 46202 USA; [Murao, Eiji] Mie Univ, Grad Sch Engn, Tsu, Mie, Japan; [Park, Charles; Liu, Jing] Indiana Univ Purdue Univ, Dept Phys, Indianapolis, IN 46202 USA; [Liu, Jing; Yokota, Hiroki] Indiana Univ, Sch Med, Simon Canc Res Ctr, Indianapolis, IN USA; [Yokota, Hiroki] Indiana Univ, Sch Med, Indiana Ctr Musculoskeletal Hlth, Indianapolis, IN USA	Harbin Medical University; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Mie University; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Li, BY; Yokota, H (corresponding author), Harbin Med Univ, Sch Pharm, Dept Pharmacol, 157 Baojian Rd, Harbin 150081, Peoples R China.; Yokota, H (corresponding author), IUPUI, Dept Biomed Engn, 723 West Michigan St,SL220, Indianapolis, IN 46202 USA.	liby@ems.hrbmu.edu.cn; hyokota@iupui.edu	Siegel, Amanda/AAR-7871-2020	Liu, Jing/0000-0002-4912-4560	National Institute of Health [R03 CA238555]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	National Institute of Health, Grant/Award Number: R01 AR52144; National Institute of Health, Grant/Award Number: R03 CA238555	Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Armstrong JA, 2007, KIDNEY INT, V71, P384, DOI 10.1038/sj.ki.5002057; ARMSTRONG JA, 1971, WATER LIFE TREATISE; Becker GJ, 2016, AM J KIDNEY DIS, V67, P954, DOI 10.1053/j.ajkd.2015.11.011; Bouatra S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073076; Bower JE, 2000, J CLIN ONCOL, V18, P743, DOI 10.1200/JCO.2000.18.4.743; CHEN A, 2018, SCI REP UK, V8; Chen X, 2019, RNA BIOL, V16, P1249, DOI 10.1080/15476286.2019.1624470; Cheng BH, 2009, BRAIN RES, V1286, P25, DOI 10.1016/j.brainres.2009.06.060; Church WH, 2014, NEUROSCI LETT, V571, P1, DOI 10.1016/j.neulet.2014.04.016; Dethlefsen C, 2017, CANCER RES, V77, P4894, DOI 10.1158/0008-5472.CAN-16-3125; Dethlefsen C, 2017, BREAST CANCER RES TR, V162, P399, DOI 10.1007/s10549-017-4129-4; Dethlefsen C, 2016, BREAST CANCER RES TR, V159, P469, DOI 10.1007/s10549-016-3970-1; Ewens A, 2005, ANTICANCER RES, V25, P3905; Fan Y, 2020, BONE RES, V8, DOI 10.1038/s41413-020-0083-6; Feng XJ, 2020, PROG LIPID RES, V77, DOI 10.1016/j.plipres.2019.101006; GERALD MC, 1978, NEUROPHARMACOLOGY, V17, P703, DOI 10.1016/0028-3908(78)90083-7; Gogtay NJ, 2002, DRUG SAFETY, V25, P1005, DOI 10.2165/00002018-200225140-00003; Grashoff C, 2010, NATURE, V466, P263, DOI 10.1038/nature09198; HEYES MP, 1985, LIFE SCI, V36, P671, DOI 10.1016/0024-3205(85)90172-9; Ji LL, 2006, ANN NY ACAD SCI, V1067, P425, DOI 10.1196/annals.1354.061; Jing Hui-Feng, 2017, Zhongguo Ying Yong Sheng Li Xue Za Zhi, V33, P252, DOI 10.12047/j.cjap.5395.2017.062; Jones AJ, 2017, FASEB J, V31; KASPRZAK A, 2018, INT J MOL SCI, V19; Kolouri S, 2017, J EVID-BASED INTEGR, V22, P232, DOI 10.1177/2156587216641828; Lelekakis M, 1999, CLIN EXP METASTAS, V17, P163, DOI 10.1023/A:1006689719505; Li FJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42132-x; Liao HW, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20082044; LIEBER M, 1975, INT J CANCER, V15, P741, DOI 10.1002/ijc.2910150505; Lindsay A, 2017, SPORTS MED, V47, P11, DOI 10.1007/s40279-016-0558-1; Ma N, 2020, MED RES REV, V40, P606, DOI 10.1002/med.21628; Muzio L, 2016, BEHAV BRAIN RES, V311, P392, DOI 10.1016/j.bbr.2016.05.063; Nayak MG, 2015, INDIAN J PALLIAT CAR, V21, P349, DOI 10.4103/0973-1075.164893; Niziolek PJ, 2012, BONE, V51, P459, DOI 10.1016/j.bone.2012.05.023; Pedersen BK, 2006, SCAND J MED SCI SPOR, V16, P3, DOI 10.1111/j.1600-0838.2006.00520.x; Picke AK, 2018, BONE, V116, P120, DOI 10.1016/j.bone.2018.07.015; Qiu F, 2018, HYPERTENS RES, V41, P718, DOI 10.1038/s41440-018-0066-9; RASTOGI S, 2011, EVID-BASED COMPL ALT, V2011; Romli F, 2017, INTEGR CANCER THER, V16, P540, DOI 10.1177/1534735416656051; Ruegsegger G. N., 2018, Cold Spring Harbor Perspectives in Biology, V10, pa029694; Rundqvist H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067579; Runegaard AH, 2019, PHARMACOL REV, V71, P123, DOI 10.1124/pr.117.013995; Savica V, 2011, J NEPHROL, V24, pS123, DOI 10.5301/JN.2011.6463; Schernhammer ES, 2005, J NATL CANCER I, V97, P1084, DOI 10.1093/jnci/dji190; Segal R, 2017, CURR ONCOL, V24, pE290, DOI 10.3747/co.24.3619; Stranahan AM, 2010, NEUROBIOL AGING, V31, P1937, DOI 10.1016/j.neurobiolaging.2008.10.016; Tai S, 2011, PROSTATE, V71, P1668, DOI 10.1002/pros.21383; Tai SY, 2016, SCI REP-UK, V6, DOI 10.1038/srep29606; Tang ZF, 2017, NUCLEIC ACIDS RES, V45, pW98, DOI 10.1093/nar/gkx247; Vaidya ADB, 2018, J AYURVEDA INTEGR ME, V9, P221, DOI 10.1016/j.jaim.2017.09.005; Wang LQ, 2019, FASEB J, V33, P13710, DOI 10.1096/fj.201901388R; Wang LQ, 2018, INT J ONCOL, V53, P1001, DOI 10.3892/ijo.2018.4481; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; Watanabe M, 2002, YAKUGAKU ZASSHI, V122, P429, DOI 10.1248/yakushi.122.429; Wong WWL, 2002, LEUKEMIA, V16, P508, DOI 10.1038/sj.leu.2402476; Woollam M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38920-0; Xu WX, 2015, CELL SIGNAL, V27, P2332, DOI 10.1016/j.cellsig.2015.08.014; Yadav VK, 2008, CELL, V135, P825, DOI 10.1016/j.cell.2008.09.059	58	8	8	2	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					7578	7592		10.1096/fj.202000096R	http://dx.doi.org/10.1096/fj.202000096R		APR 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32293076	Green Submitted, Green Accepted			2022-12-28	WOS:000526103400001
J	Zhou, MJ; Xu, XH; Wang, H; Yang, GY; Yang, ML; Zhao, XY; Guo, HL; Song, JL; Zheng, HT; Zhu, ZM; Li, L				Zhou, Mengjiao; Xu, Xiaohui; Wang, Han; Yang, Gangyi; Yang, Mengliu; Zhao, Xinyi; Guo, Huilin; Song, Jinlin; Zheng, Hongting; Zhu, Zhiming; Li, Ling			Effect of central JAZF1 on glucose production is regulated by the PI3K-Akt-AMPK pathway	FASEB JOURNAL			English	Article						hepatic glucose production; hypothalamus; insulin signaling; JAZF1	ACTIVATED PROTEIN-KINASE; GENOME-WIDE ASSOCIATION; K-ATP CHANNELS; INSULIN SENSITIVITY; HYPOTHALAMIC NEURONS; ENERGY HOMEOSTASIS; HEPATIC STEATOSIS; BRAIN; MICE; GENES	The role of central juxtaposed with another zinc finger gene 1 (JAZF1) in glucose regulation remains unclear. Here, we activated mediobasal hypothalamus (MBH) JAZF1 in high-fat diet (HFD)-fed rats by an adenovirus expressing JAZF1 (Ad-JAZF1). We evaluated the changes in the hypothalamic insulin receptor (InsR)-PI3K-Akt-AMPK pathway and hepatic glucose production (HGP). To investigate the impact of MBH Ad-JAZF1 on HGP, we activated MBH JAZF1 in the presence or absence of ATP-dependent potassium (K-ATP) channel inhibition, hepatic branch vagotomy (HVG), or an AMPK activator (AICAR). In HFD-fed rats, MBH Ad-JAZF1 decreased body weight and food intake, and inhibited HGP by increasing hepatic insulin signaling. Under insulin stimulation, MBH Ad-JAZF1 increased InsR and Akt phosphorylation, and phosphatidylinositol 3, 4, 5-trisphosphate (PIP3) formation; however, AMPK phosphorylation was decreased in the hypothalamus. The positive effect of MBH JAZF1 on hepatic insulin signaling and HGP was prevented by treatment with a K-ATP channel inhibitor or HVG. The metabolic impact of hypothalamic JAZF1 was also blocked by MBH AICAR. Ad-JAZF1 treatment in SH-SY5Y cells resulted in an elevation of InsR and Akt phosphorylation following insulin stimulation. Our findings show that hypothalamic JAZF1 regulates HGP via the InsR-PI3K-Akt-AMPK pathway and K-ATP channels.	[Zhou, Mengjiao; Wang, Han; Yang, Mengliu; Li, Ling] Chongqing Med Univ, Coll Lab Med, Dept Clin Biochem, Key Lab Lab Med Diagnost,Minist Educ, Chongqing, Peoples R China; [Zhou, Mengjiao; Song, Jinlin] Chongqing Med Univ, Coll Stomatol, Chongqing Key Lab Oral Dis & Biomed Sci, Chongqing, Peoples R China; [Xu, Xiaohui; Yang, Gangyi; Zhao, Xinyi; Guo, Huilin] Chongqing Med Univ, Affiliated Hosp 2, Dept Endocrinol, Chongqing, Peoples R China; [Yang, Mengliu] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia; [Zheng, Hongting] Third Mil Med Univ, Xinqiao Hosp, Dept Endocrinol, Chongqing, Peoples R China; [Zhu, Zhiming] Third Mil Med Univ, Daping Hosp, Chongqing Inst Hypertens, Dept Hypertens & Endocrinol, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; University of Queensland; Army Medical University; Army Medical University	Li, L (corresponding author), Chongqing Med Univ, Coll Lab Med, Dept Clin Biochem, Key Lab Diagnost Med,Minist Educ, Chongqing 400016, Peoples R China.	liling@cqmu.edu.cn	Song, Jin/HHS-8731-2022	Zhou, Mengjiao/0000-0002-4446-4742	National Natural Science Foundation of China (NSFC) [81270913, 81670755, 81600558, 81070640]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81270913, 81670755, 81600558 and 81070640	Abraham MA, 2014, MOL METAB, V3, P202, DOI 10.1016/j.molmet.2013.11.007; An Ping, 2009, BMC Proc, V3 Suppl 7, pS71; Barahona MJ, 2018, GLIA, V66, P592, DOI 10.1002/glia.23267; Belgardt BF, 2008, CELL METAB, V7, P291, DOI 10.1016/j.cmet.2008.01.006; Boden G, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac4765; Caspi L, 2007, CELL METAB, V6, P99, DOI 10.1016/j.cmet.2007.07.005; Chang TJ, 2009, DIABETOLOGIA, V52, P1112, DOI 10.1007/s00125-009-1337-4; Cheung GWC, 2009, CELL METAB, V10, P99, DOI 10.1016/j.cmet.2009.07.005; Claret M, 2007, J CLIN INVEST, V117, P2325, DOI 10.1172/JCI31516; Contreras C, 2014, CELL REP, V9, P366, DOI 10.1016/j.celrep.2014.08.057; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; de Moura RF, 2016, INT J OBESITY, V40, P471, DOI 10.1038/ijo.2015.188; Dunn-Meynell AA, 2002, DIABETES, V51, P2056, DOI 10.2337/diabetes.51.7.2056; Gupta A, 2011, NEUROPHARMACOLOGY, V60, P910, DOI 10.1016/j.neuropharm.2011.01.033; Hill JW, 2009, ENDOCRINOLOGY, V150, P4874, DOI 10.1210/en.2009-0454; Ho MM, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-10; Inquimbert P, 2013, JOVE-J VIS EXP, DOI 10.3791/50313; Jang WY, 2014, BIOCHEM BIOPH RES CO, V444, P296, DOI 10.1016/j.bbrc.2013.12.094; Kang HS, 2011, DIABETES, V60, P177, DOI 10.2337/db10-0628; Karschin C, 1997, FEBS LETT, V401, P59, DOI 10.1016/S0014-5793(96)01438-X; Knight CM, 2017, DIABETES, V60, P2671; Konner AC, 2007, CELL METAB, V5, P438, DOI 10.1016/j.cmet.2007.05.004; Kovacic S, 2003, J BIOL CHEM, V278, P39422, DOI 10.1074/jbc.M305371200; Lam CKL, 2011, DIABETES, V60, P107, DOI 10.2337/db10-0994; Lam TKT, 2005, NAT MED, V11, P320, DOI 10.1038/nm1201; Lam TKT, 2007, NAT MED, V13, P171, DOI 10.1038/nm1540; Lam TKT, 2010, NAT MED, V16, P392, DOI 10.1038/nm0410-392; Lee SJ, 2018, MOL METAB, V11, P33, DOI 10.1016/j.molmet.2018.03.008; Li L, 2011, MOL MED, V17, P1168, DOI 10.2119/molmed.2011.00051; Li L, 2011, METABOLISM, V60, P523, DOI 10.1016/j.metabol.2010.04.021; Li XQ, 2014, INT J CARDIOL, V177, P100, DOI 10.1016/j.ijcard.2014.09.007; Li Y, 2020, METABOLISM, V103, DOI 10.1016/j.metabol.2019.154029; Lin YF, 2008, NEUROSCIENCE, V152, P371, DOI 10.1016/j.neuroscience.2008.01.003; Lopez M, 2018, EUR J CLIN INVEST, V48, DOI 10.1111/eci.12996; Luo X, 2016, INT J OBESITY, V40, P947, DOI 10.1038/ijo.2016.24; Matsuhisa M, 2000, METABOLISM, V49, P11, DOI 10.1016/S0026-0495(00)90538-9; Ming GF, 2014, BIOCHEM BIOPH RES CO, V445, P673, DOI 10.1016/j.bbrc.2014.02.088; Mountjoy PD, 2007, EXP PHYSIOL, V92, P311, DOI 10.1113/expphysiol.2006.036004; Muse ED, 2004, J CLIN INVEST, V114, P232, DOI 10.1172/JCI200421270; Nakajima T, 2004, NUCLEIC ACIDS RES, V32, P4194, DOI 10.1093/nar/gkh741; Nectow AR, 2017, CELL REP, V19, P655, DOI 10.1016/j.celrep.2017.03.048; Obici S, 2003, ENDOCRINOLOGY, V144, P5172, DOI 10.1210/en.2003-0999; Paranjape SA, 2011, AM J PHYSIOL-ENDOC M, V301, pE978, DOI 10.1152/ajpendo.00304.2011; Pocai A, 2005, CELL METAB, V1, P53, DOI 10.1016/j.cmet.2004.11.001; Pocai A, 2005, NATURE, V434, P1026, DOI 10.1038/nature03439; Quaresma PGF, 2017, INT J OBESITY, V41, P268, DOI 10.1038/ijo.2016.174; Ruderman NB, 2013, J CLIN INVEST, V123, P2764, DOI 10.1172/JCI67227; Spanswick D, 1997, NATURE, V390, P521, DOI 10.1038/37379; Spanswick D, 2000, NAT NEUROSCI, V3, P757, DOI 10.1038/77660; Sun Q, 2009, ANN MED, V41, P311, DOI 10.1080/07853890902729760; Turner N, 2013, DIABETOLOGIA, V56, P1638, DOI 10.1007/s00125-013-2913-1; Wei Q, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0923-0; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Wu DD, 2014, DIABETES, V63, P1234, DOI 10.2337/db13-0899; Xu Y, 2010, NAT NEUROSCI, V13, P1457, DOI 10.1038/nn.2664; Yang CS, 2010, DIABETES, V59, P2435, DOI 10.2337/db10-0221; Yang ML, 2012, DIABETES, V61, P1959, DOI 10.2337/db11-1755; Yuan L, 2015, INT J OBESITY, V39, P949, DOI 10.1038/ijo.2015.5; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zhang Q, 2013, DIABETES, V62, P2230, DOI 10.2337/db12-1050	60	7	7	2	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					7058	7074		10.1096/fj.201901836RR	http://dx.doi.org/10.1096/fj.201901836RR		APR 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32275331	hybrid			2022-12-28	WOS:000525000400001
J	Zhou, Y; Xia, XB; Yang, EZ; Wang, YW; Marra, KG; Ethier, CR; Schuman, JS; Du, YQ				Zhou, Yi; Xia, Xiaobo; Yang, Enzhi; Wang, Yiwen; Marra, Kacey G.; Ethier, C. Ross; Schuman, Joel S.; Du, Yiqin			Adipose-derived stem cells integrate into trabecular meshwork with glaucoma treatment potential	FASEB JOURNAL			English	Article						adipose stem cells; differentiation; homing; integration; trabecular meshwork	OPEN-ANGLE GLAUCOMA; OCULAR HYPERTENSION TREATMENT; LINKED ACTIN NETWORKS; IN-VITRO; INTRAOCULAR-PRESSURE; TISSUE; OUTFLOW; TRANSPLANTATION; INDUCTION; MODEL	The trabecular meshwork (TM) is an ocular tissue that maintains intraocular pressure (IOP) within a physiologic range. Glaucoma patients have reduced TM cellularity and, frequently, elevated IOP. To establish a stem cell-based approach to restoring TM function and normalizing IOP, human adipose-derived stem cells (ADSCs) were induced to differentiate to TM cells in vitro. These ADSC-TM cells displayed a TM cell-like genotypic profile, became phagocytic, and responded to dexamethasone stimulation, characteristic of TM cells. After transplantation into naive mouse eyes, ADSCs and ADSC-TM cells integrated into the TM tissue, expressed TM cell markers, and maintained normal IOP, outflow facility, and extracellular matrix. Cell migration and affinity results indicated that the chemokine pair CXCR4/SDF1 may play an important role in ADSC-TM cell homing. Our study demonstrates the possibility of applying autologous or allogeneic ADSCs and ADSC-TM cells as a potential treatment to restore TM structure and function in glaucoma.	[Zhou, Yi; Yang, Enzhi; Wang, Yiwen; Du, Yiqin] Univ Pittsburgh, Dept Ophthalmol, 910 EEINS,203 Lothrop St, Pittsburgh, PA 15213 USA; [Zhou, Yi; Xia, Xiaobo; Wang, Yiwen] Cent South Univ, Xiangya Hosp, Dept Ophthalmol, Changsha, Peoples R China; [Marra, Kacey G.] Univ Pittsburgh, Dept Plast Surg & Bioengn, Pittsburgh, PA 15213 USA; [Marra, Kacey G.; Du, Yiqin] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15213 USA; [Ethier, C. Ross] Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA; [Ethier, C. Ross] Emory Univ, Atlanta, GA 30322 USA; [Schuman, Joel S.] NYU, Dept Ophthalmol, Sch Med, 550 1St Ave, New York, NY 10016 USA; [Du, Yiqin] Univ Pittsburgh, Dept Dev Biol, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Central South University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Georgia; Georgia Institute of Technology; Emory University; New York University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Du, YQ (corresponding author), Univ Pittsburgh, Dept Ophthalmol, 910 EEINS,203 Lothrop St, Pittsburgh, PA 15213 USA.	duy@upmc.edu	DU, YIQIN/AAO-1566-2020; Schuman, Joel/K-7304-2012	DU, YIQIN/0000-0002-4330-0957; Schuman, Joel/0000-0002-8885-3766; Xia, Xiaobo/0000-0003-1720-7860; Ethier, Ross/0000-0001-6110-3052; Xia, Xiaobo/0000-0002-2785-3391; Zhou, Yi/0000-0002-2493-7434	HHS \ NIH \ National Eye Institute (NEI) [EY025643, EY025286, P30-EY008098]; Eye and Ear Foundation of Pittsburgh; Research to Prevent Blindness (RPB)	HHS \ NIH \ National Eye Institute (NEI); Eye and Ear Foundation of Pittsburgh; Research to Prevent Blindness (RPB)(Research to Prevent Blindness (RPB))	HHS vertical bar NIH vertical bar National Eye Institute (NEI), Grant/Award Number: EY025643, EY025286 and P30-EY008098; Eye and Ear Foundation of Pittsburgh; Research to Prevent Blindness (RPB); an anonymous philanthropic donation	Abu-Hassan DW, 2015, STEM CELLS, V33, P751, DOI 10.1002/stem.1885; Aksu AE, 2008, ANN PLAS SURG, V60, P306, DOI 10.1097/SAP.0b013e3180621ff0; Albersen M, 2013, SEX MED-UK, V1, P3, DOI 10.1002/sm2.1; Aliancy J, 2017, OPHTHALMOL THER, V6, P221, DOI 10.1007/s40123-017-0094-6; ALVARADO J, 1984, OPHTHALMOLOGY, V91, P564; Alvarado JA, 2005, BRIT J OPHTHALMOL, V89, P1500, DOI 10.1136/bjo.2005.081307; Baetz NW, 2009, EXP EYE RES, V89, P95, DOI 10.1016/j.exer.2009.02.018; Bill A, 2003, J GLAUCOMA, V12, P88, DOI 10.1097/00061198-200302000-00017; Braunger BM, 2014, INVEST OPHTH VIS SCI, V55, P7499, DOI 10.1167/iovs.14-14872; Brunner S, 2009, FASEB J, V23, P351, DOI 10.1096/fj.08-109462; BULLER C, 1990, INVEST OPHTH VIS SCI, V31, P2156; Camras LJ, 2014, INVEST OPHTH VIS SCI, V55, P814, DOI 10.1167/iovs.13-13091; CLARK AF, 1994, INVEST OPHTH VIS SCI, V35, P281; Clark AF, 2001, INVEST OPHTH VIS SCI, V42, P1769; Ding QJ, 2014, INVEST OPHTH VIS SCI, V55, P7065, DOI 10.1167/iovs.14-14800; Du YQ, 2007, INVEST OPHTH VIS SCI, V48, P5038, DOI 10.1167/iovs.07-0587; Du YQ, 2013, INVEST OPHTH VIS SCI, V54, P1450, DOI 10.1167/iovs.12-11056; Du YQ, 2012, INVEST OPHTH VIS SCI, V53, P1566, DOI 10.1167/iovs.11-9134; Du YQ, 2010, MOL VIS, V16, P2680; Du YQ, 2009, STEM CELLS, V27, P1635, DOI 10.1002/stem.91; Dudas JR, 2008, J CRANIOFAC SURG, V19, P360, DOI 10.1097/SCS.0b013e318163e17b; Fautsch MP, 2006, INVEST OPHTH VIS SCI, V47, P213, DOI 10.1167/iovs.05-0334; Filla MS, 2009, INVEST OPHTH VIS SCI, V50, P5723, DOI 10.1167/iovs.08-3215; Frese L, 2016, TRANSFUS MED HEMOTH, V43, P268, DOI 10.1159/000448180; Funderburgh ML, 2005, FASEB J, V19, P1371, DOI 10.1096/fj.04-2770fje; Gong H, 2016, GLAUCOMA RES CLIN AD, P17; Gonzalez P, 2006, EXP EYE RES, V82, P959, DOI 10.1016/j.exer.2005.10.006; Gordon MO, 2002, ARCH OPHTHALMOL-CHIC, V120, P714; Heijl A, 2002, ARCH OPHTHALMOL-CHIC, V120, P1268, DOI 10.1001/archopht.120.10.1268; Janssen SF, 2013, PROG RETIN EYE RES, V37, P31, DOI 10.1016/j.preteyeres.2013.09.001; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; Keller KE, 2018, EXP EYE RES, V171, P164, DOI 10.1016/j.exer.2018.03.001; Keller Kate E, 2013, J Ocul Biol, V1, P3; Kelley MJ, 2009, EXP EYE RES, V88, P747, DOI 10.1016/j.exer.2008.10.024; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Kumar A, 2018, INVEST OPHTH VIS SCI, V59, P3728, DOI 10.1167/iovs.18-23824; Last JA, 2011, INVEST OPHTH VIS SCI, V52, P2147, DOI 10.1167/iovs.10-6342; Lei YA, 2011, INVEST OPHTH VIS SCI, V52, P1865, DOI 10.1167/iovs.10-6019; LUTJENDRECOLL E, 1986, EXP EYE RES, V42, P457, DOI 10.1016/0014-4835(86)90005-9; Manuguerra-Gagne R, 2013, STEM CELLS, V31, P1136, DOI 10.1002/stem.1364; McGowan SL, 2007, MOL VIS, V13, P1984; Mysinger MM, 2012, P NATL ACAD SCI USA, V109, P5517, DOI 10.1073/pnas.1120431109; Petit I, 2002, NAT IMMUNOL, V3, P687, DOI 10.1038/ni813; Prum Bruce E Jr, 2016, Ophthalmology, V123, pP41, DOI 10.1016/j.ophtha.2015.10.053; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Rao VP, 2007, BIODRUGS, V21, P167, DOI 10.2165/00063030-200721030-00004; ROHEN JW, 1993, EXP EYE RES, V56, P683, DOI 10.1006/exer.1993.1085; Shaul ME, 2010, DIABETES, V59, P1171, DOI 10.2337/db09-1402; Snider EJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30834-7; Stamer WD, 2017, EXP EYE RES, V158, P112, DOI 10.1016/j.exer.2016.07.009; Stamer WD, 2013, INVEST OPHTH VIS SCI, V54, P2100, DOI 10.1167/iovs.12-11298; STAMER WD, 1994, INVEST OPHTH VIS SCI, V35, P3867; Stamer WD, 1995, CURR EYE RES, V14, P1095, DOI 10.3109/02713689508995815; Tamm ER, 2009, EXP EYE RES, V88, P648, DOI 10.1016/j.exer.2009.02.007; Tanna AP, 2018, OPHTHALMOLOGY, V125, P1741, DOI 10.1016/j.ophtha.2018.04.040; Tay CY, 2012, STEM CELLS DEV, V21, P1381, DOI 10.1089/scd.2011.0655; Tchernychev B, 2010, P NATL ACAD SCI USA, V107, P22255, DOI 10.1073/pnas.1009633108; Vranka JA, 2015, EXP EYE RES, V133, P112, DOI 10.1016/j.exer.2014.07.014; Waldner M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01642; Wang K, 2017, EXP EYE RES, V158, P3, DOI 10.1016/j.exer.2016.07.011; Wang RF, 2015, J GLAUCOMA, V24, P51, DOI 10.1097/IJG.0b013e3182952213; Weinreb RN, 2016, OPHTHALMOLOGY, V123, P965, DOI 10.1016/j.ophtha.2016.01.019; Whikehart D, 2005, MOL VIS, V11, P816; Wu LW, 2019, FASEB J, V33, P2388, DOI 10.1096/fj.201800658R; Wu XX, 2014, J IMMUNOL, V192, P3409, DOI 10.4049/jimmunol.1302436; Yuan Y, 2013, INVEST OPHTH VIS SCI, V54, P6502, DOI 10.1167/iovs.13-12447; Yun HM, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0227-z; Yun HM, 2016, J OCUL PHARMACOL TH, V32, P253, DOI 10.1089/jop.2016.0005; Yun HM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107446; Zheng B, 2006, TISSUE ENG, V12, P1891, DOI 10.1089/ten.2006.12.1891; Zhu W, 2017, INVEST OPHTH VIS SCI, V58, P2054, DOI 10.1167/iovs.16-20672; Zhu W, 2016, P NATL ACAD SCI USA, V113, pE3492, DOI 10.1073/pnas.1604153113; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	73	10	10	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					7160	7177		10.1096/fj.201902326R	http://dx.doi.org/10.1096/fj.201902326R		APR 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32259357	Green Accepted			2022-12-28	WOS:000525284800001
J	Tojo, K; Tamada, N; Nagamine, Y; Yazawa, T; Ota, S; Goto, T				Tojo, Kentaro; Tamada, Nao; Nagamine, Yusuke; Yazawa, Takuya; Ota, Shuhei; Goto, Takahisa			Enhancement of glycolysis by inhibition of oxygen-sensing prolyl hydroxylases protects alveolar epithelial cells from acute lung injury	FASEB JOURNAL			English	Article						ARDS; energy metabolism; prolyl-hydroxylase inhibitors; hypoxia-inducible factor 1; cell death	GLYCATION END-PRODUCTS; NF-KAPPA-B; CAPILLARY BARRIER; HYPOXIA; RECEPTOR; DEATH; INFLAMMATION; MACROPHAGES; DYSFUNCTION; HIF-1-ALPHA	Cellular bioenergetic failure caused by mitochondrial dysfunction is a key process of alveolar epithelial injury during acute respiratory distress syndrome (ARDS). Prolyl hydroxylases (PHDs) act as cellular oxygen sensors, and their inhibition activates hypoxia-inducible factor (HIF), resulting in enhanced cellular glycolytic activity, which could compensate for impaired mitochondrial function and protect alveolar epithelial cells from ARDS. Here, we evaluated the effects of pharmacological PHD inhibition with dimethyloxalylglycine (DMOG) on alveolar epithelial cell injury using in vitro and in vivo ARDS models. We established an in vitro model of alveolar epithelial injury mimicking ARDS by adding isolated neutrophils and LPS to cultured MLE12 alveolar epithelial cells. DMOG treatment protected MLE12 cells from neutrophil-LPS-induced ATP decline and cell death. Knockdown of HIF-1 alpha or inhibition of glycolysis abolished the protective effect of DMOG, suggesting that it was exerted by HIF-1-dependent enhancement of glycolysis. Additionally, intratracheal DMOG administration to mice protected the alveolar epithelial barrier and improved arterial oxygenation, preventing ATP decline during LPS-induced lung injury. In summary, enhancement of glycolysis by PHD inhibition is a potential therapeutic approach for ARDS, protecting alveolar epithelial cells from bioenergetic failure and cell death.	[Tojo, Kentaro; Tamada, Nao; Nagamine, Yusuke; Ota, Shuhei; Goto, Takahisa] Yokohama City Univ, Grad Sch Med, Dept Anesthesiol & Crit Care Med, Yokohama, Kanagawa, Japan; [Yazawa, Takuya] Dokkyo Med Univ, Dept Pathol, Mibu, Tochigi, Japan	Yokohama City University; Dokkyo Medical University	Tojo, K (corresponding author), Yokohama City Univ, Grad Sch Med, Dept Anesthesiol & Crit Care Med, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	ktojo-cib@umin.net	Tojo, Kentaro/Q-5569-2019	Tojo, Kentaro/0000-0002-1194-8636	Japan Society for the Promotion of Science [15K20054, 16K11414]; Grants-in-Aid for Scientific Research [16K11414] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors thank Yoji Andrew Minamishima (Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan) and Tomoko Oyaizu-Toramaru (Keio University School of Medicine, Tokyo, Japan) for advising on the manuscript and Yuki Yuba and Akiko Adachi (both from the Graduate School of Medicine, Yokohama City University) for technical assistance. This work was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (15K20054 to K.T., 16K11414 to S.O.). The authors declare no conflicts of interest.	Abdul-Hafez A, 2009, FASEB J, V23, P1655, DOI 10.1096/fj.08-114611; Abraham E, 2003, CRIT CARE MED, V31, pS195, DOI 10.1097/01.CCM.0000057843.47705.E8; Amulic B, 2012, ANNU REV IMMUNOL, V30, P459, DOI 10.1146/annurev-immunol-020711-074942; Bhattacharya J, 2013, ANNU REV PHYSIOL, V75, P593, DOI 10.1146/annurev-physiol-030212-183756; Chabot F, 1998, EUR RESPIR J, V11, P745; Chan MC, 2016, MOL ASPECTS MED, V47-48, P54, DOI 10.1016/j.mam.2016.01.001; Chida J, 2012, ANAL CHIM ACTA, V727, P8, DOI 10.1016/j.aca.2012.03.022; Constantinou C, 2009, CURR CANCER DRUG TAR, V9, P717, DOI 10.2174/156800909789271512; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Cummins EP, 2008, GASTROENTEROLOGY, V134, P156, DOI 10.1053/j.gastro.2007.10.012; Cummins EP, 2006, P NATL ACAD SCI USA, V103, P18154, DOI 10.1073/pnas.0602235103; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Eckle T, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001665; Eltzschig HK, 2014, NAT REV DRUG DISCOV, V13, P852, DOI 10.1038/nrd4422; Eltzschig HK, 2012, NEW ENGL J MED, V367, P2322, DOI 10.1056/NEJMra1205750; Fong GH, 2008, CELL DEATH DIFFER, V15, P635, DOI 10.1038/cdd.2008.10; Grommes J, 2011, MOL MED, V17, P293, DOI 10.2119/molmed.2010.00138; Gupta N, 2017, AM J KIDNEY DIS, V69, P815, DOI 10.1053/j.ajkd.2016.12.011; Hamid R, 2004, TOXICOL IN VITRO, V18, P703, DOI 10.1016/j.tiv.2004.03.012; Hams E, 2011, SHOCK, V36, P295, DOI 10.1097/SHK.0b013e318225ad7e; Hart ML, 2011, J IMMUNOL, V186, P4367, DOI 10.4049/jimmunol.0903617; Heller AR, 2007, EUR J ANAESTH, V24, P258, DOI 10.1017/S026502150600144X; Herold S, 2013, AM J PHYSIOL-LUNG C, V305, pL665, DOI 10.1152/ajplung.00232.2013; Hill P, 2008, J AM SOC NEPHROL, V19, P39, DOI 10.1681/ASN.2006090998; Hoegl S, 2015, J IMMUNOL, V195, P1815, DOI 10.4049/jimmunol.1401957; Islam MN, 2012, NAT MED, V18, P759, DOI 10.1038/nm.2736; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kao SJ, 2007, J CARDIOVASC PHARM, V50, P333, DOI 10.1097/FJC.0b013e3180cbd18a; Karmouty-Quintana H, 2015, FASEB J, V29, P50, DOI 10.1096/fj.14-260182; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kong TQ, 2006, FASEB J, V20, P2242, DOI 10.1096/fj.06-6419com; Kramer G, 2004, CANCER RES, V64, P1751, DOI 10.1158/0008-5472.CAN-03-2455; Luo Yi, 2001, Curr Protoc Immunol, VChapter 3, DOI 10.1002/0471142735.im0320s22; Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST; Maxwell PH, 2016, NAT REV NEPHROL, V12, P157, DOI 10.1038/nrneph.2015.193; McClendon J, 2017, AM J PATHOL, V187, P1772, DOI 10.1016/j.ajpath.2017.04.012; Moslehi J, 2010, CIRCULATION, V122, P1004, DOI 10.1161/CIRCULATIONAHA.109.922427; Nagamine Y, 2016, AM J RESP CELL MOL, V55, P878, DOI 10.1165/rcmb.2015-0266OC; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Oyaizu-Toramaru T, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00248-17; Peyssonnaux C, 2007, J IMMUNOL, V178, P7516, DOI 10.4049/jimmunol.178.12.7516; Philip K, 2017, FASEB J, V31, P4745, DOI 10.1096/fj.201700219R; Schneider M, 2010, GASTROENTEROLOGY, V138, P1143, DOI 10.1053/j.gastro.2009.09.057; Scholz CC, 2013, P NATL ACAD SCI USA, V110, P18490, DOI 10.1073/pnas.1309718110; Semenza GL, 2011, COLD SH Q B, V76, P347, DOI 10.1101/sqb.2011.76.010678; Su X, 2009, AM J PHYSIOL-LUNG C, V297, pL1, DOI 10.1152/ajplung.90546.2008; Suhara T, 2015, P NATL ACAD SCI USA, V112, P11642, DOI 10.1073/pnas.1515872112; Taniguchi CM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008523; TeSlaa T, 2014, METHOD ENZYMOL, V542, P91, DOI 10.1016/B978-0-12-416618-9.00005-4; Uchida T, 2006, AM J RESP CRIT CARE, V173, P1008, DOI 10.1164/rccm.200509-1477OC; Vanden Berghe T, 2014, NAT REV MOL CELL BIO, V15, P134, DOI 10.1038/nrm3737; Wang HM, 2008, EUR SURG RES, V40, P305, DOI 10.1159/000121471; Yamazaki R, 2017, FASEB J, V31, P3359, DOI 10.1096/fj.201601357R	54	20	21	2	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					2258	2268		10.1096/fj.201700888R	http://dx.doi.org/10.1096/fj.201700888R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	32172532				2022-12-28	WOS:000429051400043
J	Go, YM; Zhang, J; Fernandes, J; Litwin, C; Chen, R; Wensel, TG; Jones, DP; Cai, JY; Chen, Y				Go, Young-Mi; Zhang, Jing; Fernandes, Jolyn; Litwin, Christopher; Chen, Rui; Wensel, Theodore G.; Jones, Dean P.; Cai, Jiyang; Chen, Yan			MTOR-initiated metabolic switch and degeneration in the retinal pigment epithelium	FASEB JOURNAL			English	Article						aging; AMD; lipid; metabolism; Mtor	MACULAR DEGENERATION; LIFE-SPAN; DOCOSAHEXAENOIC ACID; GEOGRAPHIC ATROPHY; MECHANISTIC TARGET; FATTY-ACIDS; MOUSE MODEL; RAPAMYCIN; GROWTH; CELLS	The retinal pigment epithelium (RPE) is a particularly vulnerable tissue to age-dependent degeneration. Over the life span, the RPE develops an expanded endo-lysosomal compartment to maintain the high efficiency of phagocytosis and degradation of photoreceptor outer segments (POS) necessary for photoreceptor survival. As the assembly and activation of the mechanistic target of rapamycin complex 1 (mTORC1) occur on the lysosome surface, increased lysosome mass with aging leads to higher mTORC1 activity. The functional consequences of hyperactive mTORC1 in the RPE are unclear. In the current study, we used integrated high-resolution metabolomic and genomic approaches to examine mice with RPE-specific deletion of the tuberous sclerosis 1 (Tsc1) gene which encodes an upstream suppressor of mTORC1. Our data show that RPE cells with constitutively high mTORC1 activity were reprogramed to be hyperactive in glucose and lipid metabolism. Lipolysis was suppressed, mitochondrial carnitine shuttle was inhibited, while genes involved in fatty acid (FA) biosynthesis were upregulated. The metabolic changes occurred prior to structural changes of RPE and retinal degeneration. These findings have revealed cellular events and intrinsic mechanisms that contribute to lipid accumulation in the RPE cells during aging and age-related degeneration.	[Go, Young-Mi; Fernandes, Jolyn; Jones, Dean P.] Emory Univ, Dept Med, Atlanta, GA 30322 USA; [Zhang, Jing; Cai, Jiyang; Chen, Yan] Univ Texas Med Branch, Dept Ophthalmol, Galveston, TX 77555 USA; [Fernandes, Jolyn] Univ Oklahoma, Hlth Sci Ctr, Dept Pediat, Oklahoma City, OK 73190 USA; [Litwin, Christopher; Chen, Yan] Univ Oklahoma, Dean McGee Eye Inst, Hlth Sci Ctr, 608 Stanton L Young Blvd DMEI PB 027, Oklahoma City, OK 73104 USA; [Chen, Rui] Baylor Coll Med, Dept Genet, Houston, TX 77030 USA; [Chen, Rui; Wensel, Theodore G.] Baylor Coll Med, Dept Biochem, Houston, TX 77030 USA; [Cai, Jiyang] Univ Oklahoma, Dept Physiol, Hlth Sci Ctr, Oklahoma City, OK 73104 USA; [Chen, Yan] Univ Oklahoma, Dept Biochem, Hlth Sci Ctr, Oklahoma City, OK 73104 USA	Emory University; University of Texas System; University of Texas Medical Branch Galveston; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Baylor College of Medicine; Baylor College of Medicine; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Chen, Y (corresponding author), Univ Oklahoma, Dean McGee Eye Inst, Hlth Sci Ctr, 608 Stanton L Young Blvd DMEI PB 027, Oklahoma City, OK 73104 USA.	yan-chen@ouhsc.edu	FERNANDES, JOLYN/J-4034-2019	FERNANDES, JOLYN/0000-0002-4100-5815; Litwin, Christopher/0000-0001-6833-454X	NIH [R01EY026999, R01EY 028773, R01EY025218, R01-026545]; NIEHS [R01ES023485, NIHS10 OD018006]; BrightFocus Foundation [M2017186]; Welch Foundation [Q0035]; NIH/NEI grant [P30EY027125]; Research to Prevent Blindness	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); BrightFocus Foundation(BrightFocus Foundation); Welch Foundation(The Welch Foundation); NIH/NEI grant; Research to Prevent Blindness(Research to Prevent Blindness (RPB))	This work was supported by NIH grants R01EY026999 (YC), R01EY 028773 (JC), R01EY025218 (TGW), R01-026545 (TGW), NIEHS grants R01ES023485 (DPJ and YMG) and NIHS10 OD018006 (DPJ), BrightFocus Foundation grants M2017186 (YC), and Welch Foundation Q0035 (TGW). The authors will like to acknowledge the Oklahoma University Health Science Center (OUHSC) Vision Research Facilities for the Live Animal Imaging Core, Genotyping Core and Cellular Imaging Core services. The cores are supported by NIH/NEI grant P30EY027125 to Dr Michelle C. Callegan and an unrestricted grant from Research to Prevent Blindness to the Dean McGee Eye Institute. We also will like to thank the Molecular Biology and Cytometry Research Shared Resource at OUHSC which provided the Metabolic Analysis of Live Cells service.	Adijanto J, 2014, EXP EYE RES, V126, P77, DOI 10.1016/j.exer.2014.01.015; Adijanto J, 2014, J BIOL CHEM, V289, P20570, DOI 10.1074/jbc.M114.565457; Benador IY, 2019, CELL METAB, V29, P827, DOI 10.1016/j.cmet.2019.02.011; Benchorin G, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2218; Bjedov I, 2010, CELL METAB, V11, P35, DOI 10.1016/j.cmet.2009.11.010; BODENSTEIN L, 1987, DEV BIOL, V121, P205, DOI 10.1016/0012-1606(87)90153-9; Bove J, 2011, NAT REV NEUROSCI, V12, P437, DOI 10.1038/nrn3068; Caccamo A, 2010, J BIOL CHEM, V285, P13107, DOI 10.1074/jbc.M110.100420; Chen C, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000559; CHEN HM, 1993, EXP EYE RES, V57, P369, DOI 10.1006/exer.1993.1136; Chen L, 2020, RETINA-J RET VIT DIS, V40, P618, DOI 10.1097/IAE.0000000000002657; Chen M, 2016, AGING CELL, V15, P436, DOI 10.1111/acel.12447; Chen Y, 2010, INVEST OPHTH VIS SCI, V51, P5314, DOI 10.1167/iovs.10-5280; Cheng SY, 2020, P NATL ACAD SCI USA, V117, P13094, DOI 10.1073/pnas.2000339117; Choudhary M, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.131928; Combadiere C, 2007, J CLIN INVEST, V117, P2920, DOI 10.1172/JCI31692; Du JH, 2016, P NATL ACAD SCI USA, V113, P14710, DOI 10.1073/pnas.1604572113; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Fritsche LG, 2016, NAT GENET, V48, P134, DOI 10.1038/ng.3448; Gambril JA, 2019, INVEST OPHTH VIS SCI, V60, P2481, DOI 10.1167/iovs.19-26949; Gilliam JC, 2012, CELL, V151, P1029, DOI 10.1016/j.cell.2012.10.038; Go YM, 2015, TOXICOL SCI, V148, P531, DOI 10.1093/toxsci/kfv198; Go YM, 2015, AM J PHYSIOL-REG I, V308, pR62, DOI 10.1152/ajpregu.00278.2014; Golestaneh N, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-1101-8; GORDON WC, 1992, CURR EYE RES, V11, P73, DOI 10.3109/02713689209069169; Griffiths B, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-3; Guo ZX, 2016, ASIAN AUSTRAL J ANIM, V29, P1646, DOI 10.5713/ajas.15.0660; Handa JT, 2017, BBA-MOL CELL BIOL L, V1862, P430, DOI 10.1016/j.bbalip.2016.07.013; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; He LZ, 2014, AM J PATHOL, V184, P1660, DOI 10.1016/j.ajpath.2014.02.007; Huang JC, 2019, THERANOSTICS, V9, P1170, DOI 10.7150/thno.26281; Iacovelli J, 2011, INVEST OPHTH VIS SCI, V52, P1378, DOI 10.1167/iovs.10-6347; Im SS, 2009, MOL CELL BIOL, V29, P5974, DOI 10.1128/MCB.01236-09; Kanow MA, 2017, ELIFE, V6, DOI 10.7554/eLife.28899; Kaur G, 2018, P NATL ACAD SCI USA, V115, P9014, DOI 10.1073/pnas.1805039115; Kim JY, 2013, CELL, V154, P365, DOI 10.1016/j.cell.2013.06.012; Klein R, 2014, AM J OPHTHALMOL, V158, P513, DOI 10.1016/j.ajo.2014.05.027; Kurihara T, 2016, ELIFE, V5, DOI 10.7554/eLife.14319; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Landowski M, 2019, P NATL ACAD SCI USA, V116, P3703, DOI 10.1073/pnas.1814014116; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Li SZ, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003123; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mannick JB, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aaq1564; Mannick JB, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009892; Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; Menon S, 2014, CELL, V156, P771, DOI 10.1016/j.cell.2013.11.049; Miller JW, 2013, AM J OPHTHALMOL, V155, P1, DOI 10.1016/j.ajo.2012.10.018; Mitter SK, 2014, AUTOPHAGY, V10, P1989, DOI 10.4161/auto.36184; Muniz-Feliciano L, 2017, AUTOPHAGY, V13, P2072, DOI 10.1080/15548627.2017.1380124; Muoio DM, 2012, CELL METAB, V15, P764, DOI 10.1016/j.cmet.2012.04.005; Nussenblatt RB, 2010, RETINA-J RET VIT DIS, V30, P1579, DOI 10.1097/IAE.0b013e3181e7978e; Petrou PA, 2015, INVEST OPHTH VIS SCI, V56, P330, DOI 10.1167/iovs.14-15877; Puchalska P, 2017, CELL METAB, V25, P262, DOI 10.1016/j.cmet.2016.12.022; Punzo C, 2009, NAT NEUROSCI, V12, P44, DOI 10.1038/nn.2234; Randle P J, 1978, Biochem Soc Symp, P47; Ratnapriya R, 2019, NAT GENET, V51, P606, DOI 10.1038/s41588-019-0351-9; Ricoult SJH, 2013, EMBO REP, V14, P242, DOI 10.1038/embor.2013.5; Rudolf M, 2009, J HISTOCHEM CYTOCHEM, V57, P731, DOI 10.1369/jhc.2009.953448; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; SanGiovanni JP, 2008, ARCH OPHTHALMOL-CHIC, V126, P1274, DOI 10.1001/archopht.126.9.1274; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Schymanski EL, 2014, ENVIRON SCI TECHNOL, V48, P2097, DOI 10.1021/es5002105; Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221; Shang P, 2017, AGING CELL, V16, P349, DOI 10.1111/acel.12561; Shin Y, 2018, BBA-MOL BASIS DIS, V1864, P2420, DOI 10.1016/j.bbadis.2018.04.014; Souied EH, 2013, OPHTHALMOLOGY, V120, P1619, DOI 10.1016/j.ophtha.2013.01.005; Spaide RF, 2018, SURV OPHTHALMOL, V63, P782, DOI 10.1016/j.survophthal.2018.05.005; Storti F, 2019, ELIFE, V8, DOI 10.7554/eLife.45100; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Swarup A, 2019, AM J PHYSIOL-CELL PH, V316, pC121, DOI 10.1152/ajpcell.00410.2018; Tyni T, 2002, PEDIATR RES, V52, P595, DOI 10.1203/01.PDR.0000030874.20888.2D; Uppal K, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-15; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; Wang L, 2009, INVEST OPHTH VIS SCI, V50, P870, DOI 10.1167/iovs.08-2376; Wang YJ, 2012, APOPTOSIS, V17, P1144, DOI 10.1007/s10495-012-0750-1; Wilkinson JE, 2012, AGING CELL, V11, P675, DOI 10.1111/j.1474-9726.2012.00832.x; Wong WT, 2013, INVEST OPHTH VIS SCI, V54, P2941, DOI 10.1167/iovs.13-11650; Wu JJ, 2013, CELL REP, V4, P913, DOI 10.1016/j.celrep.2013.07.030; Yip CK, 2010, MOL CELL, V38, P768, DOI 10.1016/j.molcel.2010.05.017; Yu B, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aag3315; Yu B, 2014, INVEST OPHTH VIS SCI, V55, P8638, DOI 10.1167/iovs.14-14758; Yu TW, 2013, J PROTEOME RES, V12, P1419, DOI 10.1021/pr301053d; Zechner R, 2012, CELL METAB, V15, P279, DOI 10.1016/j.cmet.2011.12.018; Zhao C, 2011, J CLIN INVEST, V121, P369, DOI 10.1172/JCI44303; Zhao ZY, 2017, FASEB J, V31, P4903, DOI 10.1096/fj.201700533R; Zhao ZY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019456; Zigler JS, 2011, J CELL SCI, V124, P523, DOI 10.1242/jcs.078790; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025; Zweifel SA, 2010, OPHTHALMOLOGY, V117, P303, DOI 10.1016/j.ophtha.2009.07.014	91	14	14	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12502	12520		10.1096/fj.202000612R	http://dx.doi.org/10.1096/fj.202000612R		JUL 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32721041	Green Accepted			2022-12-28	WOS:000556063300001
J	Zhao, TF; Xu, K; Wu, QH; Wang, CG; Xiao, SN; Li, HYZ; He, T; Wang, LL; Li, FC; Chen, QX				Zhao, Tengfei; Xu, Kan; Wu, Qionghua; Wang, Chenggui; Xiao, Shining; Li, Heyangzi; He, Teng; Wang, Linlin; Li, Fangcai; Chen, Qixin			Duraplasty of PHBV/PLA/Col membranes promotes axonal regeneration by inhibiting NLRP3 complex and M1 macrophage polarization in rats with spinal cord injury	FASEB JOURNAL			English	Article						duraplasty after decompression; inflammasome; macrophage; PHBV; PLA; Col membranes; polarization; spinal cord injury	EARLY SURGICAL DECOMPRESSION; DURAL SUBSTITUTE; NANOFIBROUS SCAFFOLDS; NEUROTROPHIC FACTORS; LOCOMOTOR FUNCTION; REPAIR; MODEL; FABRICATION; PRESSURE; EFFICACY	Duraplasty after decompression decreases the lesion size and scar formation, promoting better functional recovery, but the underlying mechanism has not been clarified. Here, we fabricated a series of poly(hydroxybutyrate-co-hydroxyvalerate)/polylactic acid/collagen (PHBV/PLA/Col) membranes and cultured them with VSC4.1 motor neurons. The material characteristics and in vitro biological characteristics were evaluated. In the subcutaneous implantation test, PHBV/PLA/COl scaffolds supported the cellular infiltration, microvasculature formation, and decreased CD86-positive macrophage aggregation. Following contusion spinal cord injury at T10 in Sprague-Dawley rats, durotomy was performed with allograft dura mater or PHBV/PLA or PHBV/PLA/Col membranes. At 3 days post-injury, Western blot assay showed decreased the expression of the NLRP3, ASC, cleaved-caspase-1, IL-1 beta, TNF-alpha, and CD86 expression but increased the expression of CD206. Immunofluorescence demonstrated that duraplasty with PHBV/PLA/Col membranes reduced the infiltration of CD86-positive macrophages in the lesion site, decreased the glial fibrillary acidic protein expression, and increased the expression of NF-200. Moreover, duraplasty with PHBV/PLA/Col membranes improved locomotor functional recovery at 8 weeks post-injury. Thus, duraplasty with PHBV/PLA/Col membranes decreased the glial scar formation and promoted axon growth by inhibiting inflammasome activation and modulating macrophage polarization in acute spinal cord injury.	[Zhao, Tengfei; Xu, Kan; Wu, Qionghua; Wang, Chenggui; Xiao, Shining; Li, Fangcai; Chen, Qixin] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Orthoped Surg, 88 Jiefang Rd, Hangzhou 310009, Peoples R China; [Li, Heyangzi; He, Teng; Wang, Linlin] Zhejiang Univ, Dept Basic Med Sci, Sch Med, Hangzhou, Peoples R China; [Li, Heyangzi; He, Teng; Wang, Linlin] Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Orthopaed, Sch Med, Hangzhou, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Li, FC; Chen, QX (corresponding author), Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Orthoped Surg, 88 Jiefang Rd, Hangzhou 310009, Peoples R China.	2505004@zju.edu.cn; zrcqx@zju.edu.cn			National Natural Science Foundation of China [81401011, 81772379, 81972096, 81972138]; Natural Science Foundation of Zhejiang, China [LY20H060009]; Medical Science and Technology Project of Zhejiang, China [2017KY364, 2017ZD017]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang, China(Natural Science Foundation of Zhejiang Province); Medical Science and Technology Project of Zhejiang, China	This research was financially supported by the National Natural Science Foundation of China (grant nos. 81401011, 81772379, 81972096, and 81972138), the Natural Science Foundation of Zhejiang, China (grant no. LY20H060009), and the Medical Science and Technology Project of Zhejiang, China (grant nos. 2017KY364 and 2017ZD017).	Azzam D, 2018, WORLD NEUROSURG, V113, P244, DOI 10.1016/j.wneu.2018.01.115; Bao F, 2012, J NEUROTRAUM, V29, P1626, DOI 10.1089/neu.2011.2190; Bejjani GK, 2007, J NEUROSURG, V106, P1028, DOI 10.3171/jns.2007.106.6.1028; Bradbury EJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11707-7; BRADLEY KC, 1970, J NEUROL NEUROSUR PS, V33, P387, DOI 10.1136/jnnp.33.3.387; Camlar M, 2019, WORLD NEUROSURG, V126, pE288, DOI 10.1016/j.wneu.2019.02.043; Clark AK, 2006, J NEUROCHEM, V99, P868, DOI 10.1111/j.1471-4159.2006.04126.x; Ecker RD, 2011, J NEUROSURG, V115, P124, DOI 10.3171/2011.2.JNS101490; Finn MA, 2011, J NEUROSURG-SPINE, V15, P422, DOI 10.3171/2011.5.SPINE10851; Gallagher MJ, 2019, J NEUROTRAUM, V36, P919, DOI 10.1089/neu.2018.5961; Gao ST, 2019, LIFE SCI, V237, DOI 10.1016/j.lfs.2019.116978; Gensel JC, 2015, BRAIN RES, V1619, P1, DOI 10.1016/j.brainres.2014.12.045; Hajiali H, 2018, J MATER CHEM B, V6, P930, DOI 10.1039/c7tb02969a; Harvey AR, 2015, BRAIN RES, V1619, P36, DOI 10.1016/j.brainres.2014.10.049; Harwell DM, 2016, SPINE, V41, pE524, DOI 10.1097/BRS.0000000000001306; He LM, 2009, POLYMER, V50, P4128, DOI 10.1016/j.polymer.2009.06.025; He Y, 2014, J MATER SCI-MATER M, V25, P561, DOI 10.1007/s10856-013-5073-4; Hodgetts SI, 2017, VITAM HORM, V104, P405, DOI 10.1016/bs.vh.2016.11.007; Hoell T, 2007, ACTA NEUROCHIR, V149, P1259, DOI 10.1007/s00701-007-1414-8; Hu MY, 2019, CNS NEUROSCI THER, V25, P1299, DOI 10.1111/cns.13262; Iannotti C, 2006, J NEUROTRAUM, V23, P853, DOI 10.1089/neu.2006.23.853; Jalan D, 2017, J NEUROSURG-SPINE, V26, P62, DOI 10.3171/2016.6.SPINE16343; Jiang W, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0980-9; Jones CF, 2012, SPINE, V37, pE890, DOI 10.1097/BRS.0b013e3182553d1d; Katoh H, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00248; Knopp U, 2005, ACTA NEUROCHIR, V147, P877, DOI 10.1007/s00701-005-0552-0; Leonard AV, 2015, J NEUROTRAUM, V32, P397, DOI 10.1089/neu.2014.3543; Li HYZ, 2019, THERANOSTICS, V9, P2017, DOI 10.7150/thno.29400; Li HY, 2004, BIOMATERIALS, V25, P5473, DOI 10.1016/j.biomaterials.2003.12.052; Li M, 2000, NEUROSCIENCE, V99, P333, DOI 10.1016/S0306-4522(00)00173-1; Li X, 2019, BIOMATERIALS, V197, P20, DOI 10.1016/j.biomaterials.2019.01.012; Li Yiping, 2014, Front Biol (Beijing), V9, P127; Liang HS, 2012, J BIOMED MATER RES B, V100B, P2131, DOI 10.1002/jbm.b.32778; Malliti M, 2004, NEUROSURGERY, V54, P599, DOI 10.1227/01.NEU.0000108640.45371.1A; Mohtaram NK, 2015, J MATER CHEM B, V3, P7974, DOI 10.1039/c5tb00871a; Smith JS, 2010, J BONE JOINT SURG AM, V92A, P1206, DOI 10.2106/JBJS.I.00740; Vaccari JPD, 2016, J NEUROCHEM, V136, P39, DOI 10.1111/jnc.13036; Vaccari JPD, 2012, J NEUROSCI, V32, P3058, DOI 10.1523/JNEUROSCI.4930-11.2012; von Wild KRH, 1999, SURG NEUROL, V52, P418, DOI 10.1016/S0090-3019(99)00125-1; Wang YW, 2007, BIOMATERIALS, V28, P4619, DOI 10.1016/j.biomaterials.2007.07.006; Winestone JS, 2012, J NEUROSURG-SPINE, V16, P195, DOI 10.3171/2011.10.SPINE11377; Xu H, 2015, ACS APPL MATER INTER, V7, P8706, DOI 10.1021/acsami.5b00996; Yamada K, 2002, J NEUROSURG, V96, P731, DOI 10.3171/jns.2002.96.4.0731; Yamada K, 1997, J NEUROSURG, V86, P1012, DOI 10.3171/jns.1997.86.6.1012; Yu FB, 2015, J BIOMATER APPL, V30, P311, DOI 10.1177/0885328215589205; Zhang J, 2016, J ORTHOP SURG RES, V11, DOI 10.1186/s13018-016-0369-y; Zhang Y, 2019, NANOSCALE, V11, P6315, DOI 10.1039/c8nr09818b; Zhao TF, 2018, J BIOMED NANOTECHNOL, V14, P1921, DOI 10.1166/jbn.2018.2622	48	4	5	5	24	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12147	12162		10.1096/fj.202000190RR	http://dx.doi.org/10.1096/fj.202000190RR		JUL 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32686873				2022-12-28	WOS:000553645000001
J	Shao, S; Zhao, L; An, GL; Zhang, LX; Jing, X; Luo, MN; Li, W; Meng, D; Ning, Q; Zhao, XH; Lei, JJ				Shao, Shan; Zhao, Lin; An, Gaili; Zhang, Lingxiao; Jing, Xin; Luo, Minna; Li, Wei; Meng, Du; Ning, Qian; Zhao, Xinhan; Lei, Jianjun			Metformin suppresses HIF-1 alpha expression in cancer-associated fibroblasts to prevent tumor-stromal cross talk in breast cancer	FASEB JOURNAL			English	Article						cancer-associated fibroblasts; hypoxia-inducible factor-1 alpha; metformin; phospho-AMPK; tumor microenvironment	ACTIVATED PROTEIN-KINASE; MICROENVIRONMENTAL REGULATION; TUMORIGENESIS; PROGRESSION; METASTASIS; ALPHA	The tumor microenvironment (TME) is a crucial factor in cancer progression. In breast cancer, cancer-associated fibroblasts (CAFs) and the derived stromal components have been recognized as comprising the majority of the pathological structure of the TME. In this study, we show that metformin (Met), a diabetes drug, transforms CAFs in the TME. Met disrupts tumor-stromal cross talk by preventing breast cancer cell transforming growth factor-beta (TGF-beta) signaling and the production of stromal-derived factor-1 (SDF-1) and interleukin-8 (IL-8) by CAFs. The suppression of bidirectional signaling between tumor cells and CAFs by Met is attributed to increased phospho-AMP kinase (p-AMPK) levels. By upregulating p-AMPK in CAFs, Met induces prolyl hydroxylases (PHDs), leading to the degradation of hypoxia-inducible factor-1 alpha (HIF-1 alpha) in CAFs. Moreover, interruption of HIF-1 alpha-driven SDF-1 signaling in CAFs by Met leads to decreased breast cancer cell invasion. These findings suggest that Met may be used to target tumor-promoting signaling between CAFs and breast cancer cells in the TME.	[Shao, Shan; Zhao, Lin; Zhang, Lingxiao; Jing, Xin; Zhao, Xinhan] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Oncol, 277 West Yanta Rd, Xian 710061, Shaanxi, Peoples R China; [An, Gaili] Shaanxi Prov Peoples Hosp, Dept Oncol, Xian, Peoples R China; [Luo, Minna] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Hematol, Xian, Peoples R China; [Li, Wei; Lei, Jianjun] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, 277 West Yanta Rd, Xian 710061, Shaanxi, Peoples R China; [Meng, Du] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Radiat Oncol, Xian, Peoples R China; [Ning, Qian] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Resp & Crit Care Med, Xian, Peoples R China	Xi'an Jiaotong University; Xi'an Medical University; Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University	Zhao, XH (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Oncol, 277 West Yanta Rd, Xian 710061, Shaanxi, Peoples R China.; Lei, JJ (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, 277 West Yanta Rd, Xian 710061, Shaanxi, Peoples R China.	zhaoxinhanprof@163.com; JianjunLei@xjtufh.edu.cn			National Natural Science Foundation of China (NSFC) [81502066, 81702908]; Natural Science Foundation of Shaanxi Province [2019JM-115, 2018JQ8030]; Fundamental Research Funds of the Central Universities [xzy012019090, xjj2018117]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shaanxi Province(Natural Science Foundation of Shaanxi Province); Fundamental Research Funds of the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by grants from the National Natural Science Foundation of China (NSFC) (No. 81502066, 81702908), the Natural Science Foundation of Shaanxi Province (2019JM-115, 2018JQ8030), and the Fundamental Research Funds of the Central Universities (xzy012019090, xjj2018117).	Casazza A, 2014, ONCOGENE, V33, P1743, DOI 10.1038/onc.2013.121; Corsello SM, 2017, NAT MED, V23, P405, DOI 10.1038/nm.4306; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; David JM, 2016, VACCINES-BASEL, V4, DOI 10.3390/vaccines4030022; DeCensi A, 2010, CANCER PREV RES, V3, P1451, DOI 10.1158/1940-6207.CAPR-10-0157; Duan WX, 2017, CANCER LETT, V385, P225, DOI 10.1016/j.canlet.2016.10.019; Fernandez-Nogueira P, 2019, CLIN CANCER RES, V26, P1448; Gascard P, 2016, GENE DEV, V30, P1002, DOI 10.1101/gad.279737.116; Han SS, 2019, THER ADV MED ONCOL, V11, DOI 10.1177/1758835919875851; Hart PC, 2019, CELL REP, V29, P4086, DOI 10.1016/j.celrep.2019.11.079; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Karagiannis GS, 2012, MOL CANCER RES, V10, P1403, DOI 10.1158/1541-7786.MCR-12-0307; Kenny HA, 2014, J CLIN INVEST, V124, P4614, DOI 10.1172/JCI74778; Lei JJ, 2014, CANCER LETT, V347, P129, DOI 10.1016/j.canlet.2014.02.003; Lord SR, 2020, BRIT J CANCER, V122, P258, DOI 10.1038/s41416-019-0665-5; Marushima H, 2011, INT J ONCOL, V39, P1327, DOI 10.3892/ijo.2011.1142; McMahon S, 2006, J BIOL CHEM, V281, P24171, DOI 10.1074/jbc.M604507200; Nieman KM, 2013, BBA-MOL CELL BIOL L, V1831, P1533, DOI 10.1016/j.bbalip.2013.02.010; Peng M, 2017, CANCER TREAT REV, V54, P24, DOI 10.1016/j.ctrv.2017.01.005; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Romero IL, 2015, CLIN CANCER RES, V21, P680, DOI 10.1158/1078-0432.CCR-14-2198; Shin HS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05836-6; Siegel RL, 2020, CA-CANCER J CLIN, V70, P7, DOI [10.3322/caac.21601, 10.3322/caac.21590]; Sleire L, 2017, PHARMACOL RES, V124, P74, DOI 10.1016/j.phrs.2017.07.013; Werb Z, 2015, CANCER J, V21, P250, DOI 10.1097/PPO.0000000000000127; Xu S, 2018, MOL CANCER THER, V17, P1291, DOI 10.1158/1535-7163.MCT-17-0927; Yan Q, 2007, MOL CELL BIOL, V27, P2092, DOI 10.1128/MCB.01514-06; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505	30	12	12	2	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10860	10870		10.1096/fj.202000951RR	http://dx.doi.org/10.1096/fj.202000951RR		JUN 2020	11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32592239	hybrid			2022-12-28	WOS:000544412000001
J	Hwang, HS; Lee, MH; Kim, HA				Hwang, Hyun Sook; Lee, Mi Hyun; Kim, Hyun Ah			TGF-beta 1-induced expression of collagen type II and ACAN is regulated by 4E-BP1, a repressor of translation	FASEB JOURNAL			English	Article						4E-BP1; cartilage matrix; osteoarthritis; protein translation; TGF-beta 1	MESENCHYMAL STEM-CELLS; TGF-BETA; PROTEIN-SYNTHESIS; SMAD3 GENE; CHONDROCYTE; MTOR; MECHANISMS; INHIBITOR; DIFFERENTIATION; CHONDROGENESIS	Eukaryotic initiation factor 4E (eIF4E)-binding protein 1 (4E-BP1) binds eIF4E and represses protein translation by displacing it from the mRNA. In this study, we investigated the influence of 4E-BP1 translational apparatus on the regulation of transforming growth factor-beta 1 (TGF-beta 1)-induced anabolic signaling in chondrocytes. The level of 4E-BP1 expression was significantly higher in human OA cartilage than normal cartilage. TGF-beta 1 increased total protein synthesis, including aggrecan (ACAN) and collagen type II (Col II), together with activation of Akt/mTOR signaling pathway. mTOR silencing significantly suppressed ACAN and Col II expressions through decreasing TGF-beta 1-induced phosphorylation of 4E-BP1. On the contrary, 4E-BP1 knockdown promoted total protein synthesis but suppressed Col II and ACAN expressions with decreased expression of Smad2/3 and Smad4 and increased expression of inhibitory Smad6 and Smad7. TGF-beta 1 suppressed the interaction of 4E-BP1 and eIF4E and subsequently enhanced protein synthesis. Furthermore, 4E-BP1 regulated translation levels of inhibitory Smads, which decreased the accumulation of nuclear Smad2/3 complexes on the promoter of ACAN and Col II genes, subsequently affecting transcription of ACAN and Col II. These results demonstrated that TGF-beta 1-modulated phosphorylation of 4EBP1 plays a role in the expression of Col II and ACAN through differential alteration of Smad signaling pathway.	[Hwang, Hyun Sook; Lee, Mi Hyun; Kim, Hyun Ah] Hallym Univ, Dept Internal Med, Div Rheumatol, Sacred Heart Hosp, 896 Pyungchon, Anyang 14068, Kyunggi, South Korea; [Hwang, Hyun Sook; Lee, Mi Hyun; Kim, Hyun Ah] Hallym Univ, Inst Skeletal Aging, Chunchon, South Korea	Hallym University; Hallym University	Kim, HA (corresponding author), Hallym Univ, Dept Internal Med, Div Rheumatol, Sacred Heart Hosp, 896 Pyungchon, Anyang 14068, Kyunggi, South Korea.	kimha@hallym.ac.kr			National Research Foundation of Korea [2017R1A2B2001881]; Hallym University Research Fund	National Research Foundation of Korea(National Research Foundation of Korea); Hallym University Research Fund	The National Research Foundation of Korea, Grant/Award Number: 2017R1A2B2001881; Hallym University Research Fund	Abreu RD, 2009, MOL BIOSYST, V5, P1512, DOI 10.1039/b908315d; Aref-Eshghi E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097786; Avdulov S, 2004, CANCER CELL, V5, P553, DOI 10.1016/j.ccr.2004.05.024; Azar R, 2008, CELL MOL LIFE SCI, V65, P3110, DOI 10.1007/s00018-008-8418-2; Bhat M, 2015, NAT REV DRUG DISCOV, V14, P261, DOI 10.1038/nrd4505; Chen CG, 2012, ARTHRITIS RHEUM-US, V64, P3278, DOI 10.1002/art.34566; De Benedetti A, 2004, ONCOGENE, V23, P3189, DOI 10.1038/sj.onc.1207545; Estrada KD, 2013, DEV BIOL, V382, P375, DOI 10.1016/j.ydbio.2013.08.021; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Furumatsu T, 2013, J BIOMECH, V46, P1508, DOI 10.1016/j.jbiomech.2013.03.028; Gingras AC, 2001, GENE DEV, V15, P2852; Hwang HS, 2019, OSTEOARTHR CARTILAGE, V27, P833, DOI 10.1016/j.joca.2019.01.006; Iwai T, 2008, J BIOL CHEM, V283, P27154, DOI 10.1074/jbc.M801175200; Jiang LY, 2013, RHEUMATOL INT, V33, P1763, DOI 10.1007/s00296-012-2593-z; Katsara O, 2017, ARTHRITIS RHEUMATOL, V69, P586, DOI 10.1002/art.39947; Lang CH, 2007, AM J PHYSIOL-ENDOC M, V293, pE453, DOI 10.1152/ajpendo.00204.2007; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee MC, 2015, BONE JOINT J, V97B, P924, DOI 10.1302/0301-620X.97B7.35852; Li C, 2014, BIOCHEM BIOPH RES CO, V450, P646, DOI 10.1016/j.bbrc.2014.06.030; Loeser RF, 2012, ARTHRITIS RHEUM-US, V64, P1697, DOI 10.1002/art.34453; Lu J, 2017, MOL THER, V25, P2676, DOI 10.1016/j.ymthe.2017.08.009; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Mercer PF, 2016, THORAX, V71, P701, DOI 10.1136/thoraxjnl-2015-207429; Qin XY, 2016, CELL CYCLE, V15, P781, DOI 10.1080/15384101.2016.1151581; Qureshi HY, 2007, CELL SIGNAL, V19, P1643, DOI 10.1016/j.cellsig.2007.02.007; REDINI F, 1991, BIOCHIM BIOPHYS ACTA, V1093, P196, DOI 10.1016/0167-4889(91)90123-F; Remy I, 2004, NAT CELL BIOL, V6, P358, DOI 10.1038/ncb1113; Ruoff R, 2016, P NATL ACAD SCI USA, V113, P7545, DOI 10.1073/pnas.1605451113; Schaeffer V, 2010, AM J NEPHROL, V31, P189, DOI 10.1159/000268954; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Valdes AM, 2010, ARTHRITIS RHEUM-US, V62, P2347, DOI 10.1002/art.27530; van de Laar IMBH, 2011, NAT GENET, V43, P121, DOI 10.1038/ng.744; van der Kraan PM, 2009, OSTEOARTHR CARTILAGE, V17, P1539, DOI 10.1016/j.joca.2009.06.008; van der Kraan PM, 2017, NAT REV RHEUMATOL, V13, P155, DOI 10.1038/nrrheum.2016.219; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Wang LF, 2006, J BIOL CHEM, V281, P24293, DOI 10.1074/jbc.M603566200; Watanabe H, 2001, J BIOL CHEM, V276, P14466, DOI 10.1074/jbc.M005724200; Whitaker AT, 2017, BIOL OPEN, V6, P358, DOI 10.1242/bio.021436; Woodcock HV, 2019, NAT COMMUN, V10, DOI [10.1038/s41467-020-18621-3, 10.1038/s41467-018-07858-8]; Xia P, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0733-9; Yang X, 2001, J CELL BIOL, V153, P35, DOI 10.1083/jcb.153.1.35; Yoon HJ, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0599-x; Zhen GH, 2013, NAT MED, V19, P704, DOI 10.1038/nm.3143	44	5	5	1	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9531	9546		10.1096/fj.201903003R	http://dx.doi.org/10.1096/fj.201903003R		JUN 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32485037				2022-12-28	WOS:000538169700001
J	Roseman, GP; Wu, B; Wadolkowski, MA; Harris, DA; Millhauser, GL				Roseman, Graham P.; Wu, Bei; Wadolkowski, Mark A.; Harris, David A.; Millhauser, Glenn L.			Intrinsic toxicity of the cellular prion protein is regulated by its conserved central region	FASEB JOURNAL			English	Article						cellular studies; electrophysiology; neurodeneration; nuclear magnetic resonance; prion	ALPHA-CLEAVAGE; OCTAREPEAT DOMAIN; FULL-LENGTH; COPPER; PRP; DISEASE; COORDINATION; EXPRESSION; MECHANISM; RECEPTOR	The conserved central region (CR) of PrP (c) has been hypothesized to serve as a passive linker connecting the protein's toxic N-terminal and globular C-terminal domains. Yet, deletion of the CR causes neonatal fatality in mice, implying the CR possesses a protective function. The CR encompasses the regulatory alpha-cleavage locus, and additionally facilitates a regulatory metal ion-promoted interaction between the PrP (c) N- and C-terminal domains. To elucidate the role of the CR and determine why CR deletion generates toxicity, we designed PrP (c) constructs wherein either the cis-interaction or alpha-cleavage are selectively prevented. These constructs were interrogated using nuclear magnetic resonance, electrophysiology, and cell viability assays. Our results demonstrate the CR is not a passive linker and the native sequence is crucial for its protective role over the toxic N-terminus, irrespective of alpha-cleavage or the cis-interaction. Additionally, we find that the CR facilitates homodimerization of PrP (c), attenuating the toxicity of the N-terminus.	[Roseman, Graham P.; Wadolkowski, Mark A.; Millhauser, Glenn L.] Univ Calif Santa Cruz, Dept Chem & Biochem, 1156 High St,Phys Sci Bldg 265, Santa Cruz, CA 95060 USA; [Wu, Bei; Harris, David A.] Boston Univ, Sch Med, Dept Biochem, 72 E Concord St,Silvio Conte Bldg K,Room K206, Boston, MA 02118 USA	University of California System; University of California Santa Cruz; Boston University	Millhauser, GL (corresponding author), Univ Calif Santa Cruz, Dept Chem & Biochem, 1156 High St,Phys Sci Bldg 265, Santa Cruz, CA 95060 USA.; Harris, DA (corresponding author), Boston Univ, Sch Med, Dept Biochem, 72 E Concord St,Silvio Conte Bldg K,Room K206, Boston, MA 02118 USA.	daharris@bu.edu; glennm@ucsc.edu		Millhauser, Glenn/0000-0003-2442-7220	NIH [R35 GM131781, S10 OD024980, S10 OD018455, R01 NS065244]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	NIH, Grant/Award Number: R35 GM131781, S10 OD024980, S10 OD018455 and R01 NS065244	Aguzzi A, 2008, ANNU REV NEUROSCI, V31, P439, DOI 10.1146/annurev.neuro.31.060407.125620; Aronoff-Spencer E, 2000, BIOCHEMISTRY-US, V39, P13760, DOI 10.1021/bi001472t; Barmada S, 2004, NEUROBIOL DIS, V16, P527, DOI 10.1016/j.nbd.2004.05.005; Baumann F, 2007, EMBO J, V26, P538, DOI 10.1038/sj.emboj.7601510; Biasini E, 2013, J NEUROSCI, V33, P2408, DOI 10.1523/JNEUROSCI.3406-12.2013; Biasini E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033472; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; Burns CS, 2003, BIOCHEMISTRY-US, V42, P6794, DOI 10.1021/bi027138+; Chattopadhyay M, 2005, J AM CHEM SOC, V127, P12647, DOI 10.1021/ja053254z; Chen SG, 2010, J BIOL CHEM, V285, P26377, DOI 10.1074/jbc.M110.145516; Chen XY, 2013, ADV DRUG DELIVER REV, V65, P1357, DOI 10.1016/j.addr.2012.09.039; Christensen HM, 2010, AM J PATHOL, V176, P2695, DOI 10.2353/ajpath.2010.091007; Christensen HM, 2009, J NEUROCHEM, V108, P44, DOI 10.1111/j.1471-4159.2008.05719.x; Coleman BM, 2014, J VIROL, V88, P2690, DOI 10.1128/JVI.02720-13; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Collins S, 2001, J CLIN NEUROSCI, V8, P387, DOI 10.1054/jocn.2001.0919; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Evans EGB, 2017, PROG MOL BIOL TRANSL, V150, P35, DOI 10.1016/bs.pmbts.2017.06.005; Evans EGB, 2016, STRUCTURE, V24, P1057, DOI 10.1016/j.str.2016.04.017; Fioriti L, 2005, MOL CELL NEUROSCI, V28, P165, DOI 10.1016/j.mcn.2004.09.006; Gasperini L, 2015, ANTIOXID REDOX SIGN, V22, P772, DOI 10.1089/ars.2014.6032; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Goniotaki D, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006733; Herrmann US, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004662; Hornemann S, 1997, FEBS LETT, V413, P277, DOI 10.1016/S0014-5793(97)00921-6; KITAMOTO T, 1986, ANN NEUROL, V20, P204, DOI 10.1002/ana.410200205; Kuffer A, 2016, NATURE, V536, P464, DOI 10.1038/nature19312; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Li AM, 2007, EMBO J, V26, P548, DOI 10.1038/sj.emboj.7601507; Liang JJ, 2012, PRION, V6, DOI 10.4161/pri.22511; Liang JJ, 2012, J BIOL CHEM, V287, P16510, DOI 10.1074/jbc.M112.360891; Markham KA, 2019, BIOPHYS J, V116, P610, DOI 10.1016/j.bpj.2019.01.005; Martinez J, 2015, SCI REP-UK, V5, DOI 10.1038/srep13623; Massignan T, 2011, METHODS, V53, P214, DOI 10.1016/j.ymeth.2010.11.005; Massignan T, 2010, J BIOL CHEM, V285, P7752, DOI 10.1074/jbc.M109.064949; MASTERS CL, 1981, BRAIN, V104, P559, DOI 10.1093/brain/104.3.559; McDonald AJ, 2019, STRUCTURE, V27, P907, DOI 10.1016/j.str.2019.03.008; McDonald AJ, 2017, PRION, V11, P388, DOI 10.1080/19336896.2017.1384894; McDonald AJ, 2014, PRION, V8, P183, DOI 10.4161/pri.28796; McDonald AJ, 2014, J BIOL CHEM, V289, P803, DOI 10.1074/jbc.M113.502351; Mehrabian M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114594; Millhauser GL, 2007, ANNU REV PHYS CHEM, V58, P299, DOI 10.1146/annurev.physchem.58.032806.104657; Minikel EV, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad5169; Oliveira-Martins JB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009107; Peralta OA, 2009, PRION, V3, P161, DOI 10.4161/pri.3.3.9772; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Pushie MJ, 2011, METALLOMICS, V3, P206, DOI 10.1039/c0mt00037j; Rambold AS, 2008, EMBO J, V27, P1974, DOI 10.1038/emboj.2008.122; Sales N, 1998, EUR J NEUROSCI, V10, P2464, DOI 10.1046/j.1460-9568.1998.00258.x; Sangeetham SB, 2018, J MOL BIOL, V430, P2784, DOI 10.1016/j.jmb.2018.05.027; SCHATZL HM, 1995, J MOL BIOL, V245, P362, DOI 10.1006/jmbi.1994.0030; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; Solomon IH, 2012, PRION, V6, P40, DOI 10.4161/pri.6.1.18627; Solomon IH, 2011, J BIOL CHEM, V286, P14724, DOI 10.1074/jbc.M110.214973; Solomon IH, 2010, J BIOL CHEM, V285, P26719, DOI 10.1074/jbc.M110.134619; Sonati T, 2013, NATURE, V501, P102, DOI 10.1038/nature12402; Spevacek AR, 2013, STRUCTURE, V21, P236, DOI 10.1016/j.str.2012.12.002; Stys PK, 2012, J PHYSIOL-LONDON, V590, P1357, DOI 10.1113/jphysiol.2011.225276; Thakur AK, 2011, J BIOL CHEM, V286, P38533, DOI 10.1074/jbc.M111.265645; Turnbaugh JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025675; Um JW, 2013, NEURON, V79, P887, DOI 10.1016/j.neuron.2013.06.036; Walter ED, 2007, J AM CHEM SOC, V129, P15440, DOI 10.1021/ja077146j; Watt NT, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00041; Watt NT, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2135; Westergard L, 2007, BBA-MOL BASIS DIS, V1772, P629, DOI 10.1016/j.bbadis.2007.02.011; Westergard L, 2011, J BIOL CHEM, V286, P44234, DOI 10.1074/jbc.M111.286195; Westergard L, 2011, J NEUROSCI, V31, P14005, DOI 10.1523/JNEUROSCI.1243-11.2011; Wu B, 2017, ELIFE, V6, DOI 10.7554/eLife.23473; Wusten KA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32581-1; You HT, 2012, P NATL ACAD SCI USA, V109, P1737, DOI 10.1073/pnas.1110789109; Yusa S, 2012, VIRUSES-BASEL, V4, P3109, DOI 10.3390/v4113109	72	1	1	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8734	8748		10.1096/fj.201902749RR	http://dx.doi.org/10.1096/fj.201902749RR		MAY 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32385908	Green Accepted			2022-12-28	WOS:000532114000001
J	Bruschi, M; Santucci, L; Petretto, A; Bartolocci, M; Marchisio, M; Ghiggeri, GM; Verrina, E; Ramenghi, LA; Panfoli, I; Candiano, G				Bruschi, Maurizio; Santucci, Laura; Petretto, Andrea; Bartolocci, Martina; Marchisio, Marco; Ghiggeri, Gian Marco; Verrina, Enrico; Ramenghi, Luca A.; Panfoli, Isabella; Candiano, Giovanni			Association between maternal omega-3 polyunsaturated fatty acids supplementation and preterm delivery: A proteomic study	FASEB JOURNAL			English	Article						docosahexaenoic acids; eicosapentaenoic acids; glutathione synthetase; microvesicles; premature birth	ATP-SYNTHASE; PERMEABILITY TRANSITION; CHAIN; MITOCHONDRIA; METABOLISM; PREVENTION; SURFACE; BRAIN; BIRTH	Maternal nutrition during pregnancy influences offspring health. Dietary supplementation of pregnant women with (n-3) long-chain polyunsaturated fatty acids (PUFA) was shown to exert beneficial effects on offspring, through yet unknown mechanisms. Here, we conducted a dietary intervention study on a cohort of 10 women diagnosed with threatened preterm labor with a nutritional integration with eicosapentaenoic and docosahexaenoic acids. Microvesicles (MV) isolated form arterial cord blood of the treated cohort offspring and also of a randomized selection of 10 untreated preterm and 12 term newborns, were characterized by dynamic light scattering and analyzed by proteomic and statistical analysis. Glutathione synthetase was the protein bearing the highest discrimination ability between cohorts. ELISA assay showed that glutathione synthetase was more abundant in cord blood from untreated preterm compared to the other conditions. Assay of free SH-groups showed that serum of preterm subjects was oxidized. Data suggest that preterm suffer from oxidative stress, which was lower in the treated cohort. This study confirms that MV are a representative sample of the individual status and the efficacy of dietary intervention with PUFA in human pregnancy in terms of lowered inflammatory status, increased gestational age and weight at birth.	[Bruschi, Maurizio; Santucci, Laura; Ghiggeri, Gian Marco; Candiano, Giovanni] IRCCS Ist Giannina Gaslini, Lab Mol Nephrol, Genoa, Italy; [Petretto, Andrea; Bartolocci, Martina] IRCCS Ist Giannina Gaslini, Core Facil Clin Prote & Metabol, Genoa, Italy; [Marchisio, Marco] Univ G DAnnunzio, Sch Med & Hlth Sci, Dept Med & Aging Sci, Chieti, Italy; [Ghiggeri, Gian Marco; Verrina, Enrico] IRCCS Ist Giannina Gaslini, UO Nephrol Dialysis & Transplantat, Genoa, Italy; [Ramenghi, Luca A.] IRCCS Ist Giannina Gaslini, Neonatal Intens Care Unit, Genoa, Italy; [Panfoli, Isabella] Univ Genoa, Dipartimento Farm DIFAR, Vle Benedetto XV 3, Genoa 16132, Italy	University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS Istituto Giannina Gaslini; G d'Annunzio University of Chieti-Pescara; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa	Panfoli, I (corresponding author), Univ Genoa, Dipartimento Farm DIFAR, Vle Benedetto XV 3, Genoa 16132, Italy.	panfoli@difar.unige.it	Bruschi, Maurizio/E-7090-2016; Bartolucci, Martina/AAA-6582-2019; Verrina, Enrico/AAA-7317-2020	Bruschi, Maurizio/0000-0001-6036-1500; Bartolucci, Martina/0000-0001-5289-4219; 				Aoyama K, 2013, INT J MOL SCI, V14, P21021, DOI 10.3390/ijms141021021; Arakaki N, 2007, FEBS LETT, V581, P3405, DOI 10.1016/j.febslet.2007.06.041; Bartolucci M, 2015, NEUROCHEM RES, V40, P2230, DOI 10.1007/s11064-015-1712-0; Bennet L, 2018, J REPROD IMMUNOL, V125, P45, DOI 10.1016/j.jri.2017.11.003; Berman SB, 2000, EXP NEUROL, V164, P415, DOI 10.1006/exnr.2000.7438; Bohning D, 2015, METHOD INFORM MED, V54, P382, DOI 10.3414/ME15-04-0004; Bruschi M, 2018, PROTEOM CLIN APPL, V12, DOI 10.1002/prca.201700082; Buonocore G, 2002, PEDIATR RES, V52, P46, DOI 10.1203/01.PDR.0000016664.46604.01; Calder PC, 2007, PROSTAG LEUKOTR ESS, V77, P327, DOI 10.1016/j.plefa.2007.10.015; Calzia D, 2015, BRIT J PHARMACOL, V172, P3890, DOI 10.1111/bph.13173; Chang HY, 2012, CANCER RES, V72, P4696, DOI 10.1158/0008-5472.CAN-12-0567; Coumans FAW, 2017, CIRC RES, V120, P1632, DOI 10.1161/CIRCRESAHA.117.309417; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; da Silva EN, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2016-000242; Davis S, 2017, J PROTEOME RES, V16, P1288, DOI 10.1021/acs.jproteome.6b00915; Fedorova I, 2006, PROSTAG LEUKOTR ESS, V75, P271, DOI 10.1016/j.plefa.2006.07.006; Gandhi S, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/428010; Giorlandino Claudio, 2013, J Prenat Med, V7, P42; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Jung KH, 2007, CANCER BIOTHER RADIO, V22, P704, DOI 10.1089/cbr.2007.369; Kar S, 2016, EUR J OBSTET GYN R B, V198, P40, DOI 10.1016/j.ejogrb.2015.11.033; Khairallah RJ, 2010, J PHARMACOL EXP THER, V335, P155, DOI 10.1124/jpet.110.170605; Kidd PM, 2005, ALTERN MED REV, V10, P268; Kulak NA, 2014, NAT METHODS, V11, P319, DOI [10.1038/NMETH.2834, 10.1038/nmeth.2834]; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lattka E, 2010, CLIN NUTR, V29, P277, DOI 10.1016/j.clnu.2009.11.005; Lee LK, 2013, J NUTR BIOCHEM, V24, P803, DOI 10.1016/j.jnutbio.2012.04.014; Liu Y, 2013, INT J MOL MED, V32, P607, DOI 10.3892/ijmm.2013.1419; Lu SC, 2013, BBA-GEN SUBJECTS, V1830, P3143, DOI 10.1016/j.bbagen.2012.09.008; Lu SC, 2009, MOL ASPECTS MED, V30, P42, DOI 10.1016/j.mam.2008.05.005; Mallol R, 2012, ANAL BIOANAL CHEM, V402, P2407, DOI 10.1007/s00216-011-5705-9; Mangiullo R, 2008, BBA-BIOENERGETICS, V1777, P1326, DOI 10.1016/j.bbabio.2008.08.003; Manuck TA., 2016, AM J OBSTET GYNECOL, V215; Mayurasakorn K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160870; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Morris JH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-436; Muralidharan-Chari V, 2010, J CELL SCI, V123, P1603, DOI 10.1242/jcs.064386; Ozsurekci Y, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/2768365; Panfoli I, 2018, EXPERT REV PROTEOMIC, V15, P801, DOI 10.1080/14789450.2018.1528149; Panfoli I, 2016, FASEB J, V30, P1416, DOI 10.1096/fj.15-279679; Romero R, 2014, SCIENCE, V345, P760, DOI 10.1126/science.1251816; Saste MD, 1998, J NUTR, V128, P740, DOI 10.1093/jn/128.4.740; Schmitz G, 2008, PROG LIPID RES, V47, P147, DOI 10.1016/j.plipres.2007.12.004; Sima C, 2018, CRIT REV IMMUNOL, V38, P343, DOI 10.1615/CritRevImmunol.2018026750; Stockwin LH, 2006, J PROTEOME RES, V5, P2996, DOI 10.1021/pr0601739; van Zijl MD, 2016, INT J WOMENS HEALTH, V8, P633, DOI 10.2147/IJWH.S89317; Velzing-Aarts FV, 2001, PROSTAG LEUKOTR ESS, V65, P51, DOI 10.1054/plef.2001.0288; Wen M, 2018, FOOD FUNCT, V9, P2184, DOI [10.1039/c7fo01815k, 10.1039/C7FO01815K]; Zhang WT, 2011, FRONT BIOSCI-LANDMRK, V16, P2653, DOI 10.2741/3878	49	5	8	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6322	6334		10.1096/fj.201900738RR	http://dx.doi.org/10.1096/fj.201900738RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32162735				2022-12-28	WOS:000531325500024
J	Cassina, L; Chiaravalli, M; Boletta, A				Cassina, Laura; Chiaravalli, Marco; Boletta, Alessandra			Increased mitochondrial fragmentation in polycystic kidney disease acts as a modifier of disease progression	FASEB JOURNAL			English	Article						cellular respiration; Mdivi-1; mitochondrial fragmentation; polycystic kidney disease	METABOLISM; ACTIVATION; OXIDATION; DYNAMICS; FISSION	Autosomal dominant polycystic kidney disease (ADPKD) is a common monogenic disorder, characterized by bilateral renal cyst formation. Multiple pathways are de-regulated in cystic epithelia offering good opportunities for therapy. Others and we have previously reported that metabolic reprogramming, including alterations of the TCA cycle, are prominent features of ADPKD. Several lines of evidence suggest that mitochondrial impairment might be responsible for the metabolic alterations. Here, we performed morphologic and morphometric evaluation of mitochondria by TEM in an orthologous mouse model of PKD caused by mutations in the Pkd1 gene (Ksp-Cre;Pkd1(flox/-)). Furthermore, we measured mitochondrial respiration by COX and SDH enzymatic activity in situ. We found several alterations including reduced mitochondrial mass, altered structure and fragmentation of the mitochondrial network in cystic epithelia of Ksp-Cre;Pkd1(flox/-) mice. At the molecular level, we found reduced expression of the pro-fusion proteins OPA1 and MFN1 and up-regulation of the pro-fission protein DRP1. Importantly, administration of Mdivi-1, which interferes with DRP1 rescuing mitochondrial fragmentation, significantly reduced kidney/body weight, cyst formation, and improved renal function in Ksp-Cre;Pkd1(flox/-) mice. Our data indicate that impaired mitochondrial structure and function play a role in disease progression, and that their improvement can significantly modify the course of the disease.	[Cassina, Laura; Chiaravalli, Marco; Boletta, Alessandra] IRCCS San Raffaele Sci Inst, Div Genet & Cell Biol, Mol Basis Cyst Kidney Disorders Unit, Via Olgettina 58, I-20132 Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Boletta, A (corresponding author), IRCCS San Raffaele Sci Inst, Div Genet & Cell Biol, Mol Basis Cyst Kidney Disorders Unit, Via Olgettina 58, I-20132 Milan, Italy.	boletta.alessandra@hsr.it	Cassina, Laura/AAN-3804-2020	Cassina, Laura/0000-0002-7350-3069	PKD Foundation (PKDF) [PKD-218G18A]; Associazione Italiana Rene Policistico (AIRP)	PKD Foundation (PKDF); Associazione Italiana Rene Policistico (AIRP)	PKD Foundation (PKDF), Grant/Award Number: PKD-218G18A; Associazione Italiana Rene Policistico (AIRP)	Bhargava P, 2017, NAT REV NEPHROL, V13, P629, DOI 10.1038/nrneph.2017.107; Bordt EA, 2017, DEV CELL, V40, P583, DOI 10.1016/j.devcel.2017.02.020; Brand CS, 2018, CELL SIGNAL, V50, P48, DOI 10.1016/j.cellsig.2018.06.012; Brooks C, 2009, J CLIN INVEST, V119, P1275, DOI 10.1172/JCI37829; Cai J, 2018, GENE DEV, V32, P781, DOI 10.1101/gad.315127.118; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Gaeggeler HP, 2005, J AM SOC NEPHROL, V16, P878, DOI 10.1681/ASN.2004121110; Hajarnis S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14395; Harris PC, 2009, ANNU REV MED, V60, P321, DOI 10.1146/annurev.med.60.101707.125712; Ishimoto Y, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00337-17; Iuso A, 2017, METHODS MOL BIOL, V1567, P217, DOI 10.1007/978-1-4939-6824-4_13; Kuo IY, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aat7397; Lakhia R, 2018, AM J PHYSIOL-RENAL, V314, pF122, DOI 10.1152/ajprenal.00352.2017; Lin CC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20856-6; Manczak M, 2019, HUM MOL GENET, V28, P177, DOI 10.1093/hmg/ddy335; Menezes LF, 2016, EBIOMEDICINE, V5, P183, DOI 10.1016/j.ebiom.2016.01.027; Mishra P, 2016, J CELL BIOL, V212, P379, DOI 10.1083/jcb.201511036; Nigro EA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53061-0; Padovano V, 2018, NAT REV NEPHROL, V14, P678, DOI 10.1038/s41581-018-0051-1; Padovano V, 2017, MOL BIOL CELL, V28, P261, DOI 10.1091/mbc.E16-08-0597; Podrini C, 2020, CELL SIGNAL, V68, DOI 10.1016/j.cellsig.2019.109495; Podrini C, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0200-x; Rappold PM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6244; Rogers GW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021746; Rossi A, 2019, BBA-MOL CELL RES, V1866, P1068, DOI 10.1016/j.bbamcr.2018.10.016; Rowe I, 2014, NEPHROL DIAL TRANSPL, V29, P1480, DOI 10.1093/ndt/gft521; Rowe I, 2013, NAT MED, V19, P488, DOI 10.1038/nm.3092; Sciacco M, 1996, Methods Enzymol, V264, P509, DOI 10.1016/S0076-6879(96)64045-2; Shao XL, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000016444.90348.50; Shibazaki S, 2008, HUM MOL GENET, V17, P1505, DOI 10.1093/hmg/ddn039; Sumida M, 2015, J AM SOC NEPHROL, V26, P2378, DOI 10.1681/ASN.2014080750; Torres VE, 2007, LANCET, V369, P1287, DOI 10.1016/S0140-6736(07)60601-1; Wang WJ, 2012, CELL METAB, V15, P186, DOI 10.1016/j.cmet.2012.01.009; Wodarczyk C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007137	34	14	15	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6493	6507		10.1096/fj.201901739RR	http://dx.doi.org/10.1096/fj.201901739RR		APR 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32239723	hybrid			2022-12-28	WOS:000523590100001
J	Han, JYS; Kinoshita, J; Bisetto, S; Bell, BA; Nowak, RA; Peachey, NS; Philp, NJ				Han, John Y. S.; Kinoshita, Junzo; Bisetto, Sara; Bell, Brent A.; Nowak, Romana A.; Peachey, Neal S.; Philp, Nancy J.			Role of monocarboxylate transporters in regulating metabolic homeostasis in the outer retina: Insight gained from cell-specific Bsg deletion	FASEB JOURNAL			English	Article						basigin; lactate; monocarboxylate transporters; photoreceptors; retina; RPE	PIGMENT EPITHELIUM; PLASMA-MEMBRANE; MCT3 GENE; EXPRESSION; CONE; ROD; PHOTORECEPTORS; BASIGIN; LACTATE; DEGENERATION	The neural retina metabolizes glucose through aerobic glycolysis generating large amounts of lactate. Lactate flux into and out of cells is regulated by proton-coupled monocarboxylate transporters (MCTs), which are encoded by members of the Slc16a family. MCT1, MCT3, and MCT4 are expressed in the retina and require association with the accessory protein basigin, encoded by Bsg, for maturation and trafficking to the plasma membrane. Bsg(-/-) mice have severely reduced electroretinograms (ERGs) and progressive photoreceptor degeneration, which is presumed to be driven by metabolic dysfunction resulting from loss of MCTs. To understand the basis of the Bsg(-/-) phenotype, we generated mice with conditional deletion of Bsg in rods (Rod Delta Bsg), cones (Cone increment Bsg), or retinal pigment epithelial cells (RPE Delta Bsg). Rod Delta Bsg mice showed a progressive loss of photoreceptors, while Cone Delta Bsg mice did not display a degenerative phenotype. The RPE Delta Bsg mice developed a distinct phenotype characterized by severely reduced ERG responses as early as 4 weeks of age. The loss of lactate transporters from the RPE most closely resembled the phenotype of the Bsg(-/-) mouse, suggesting that the regulation of lactate levels in the RPE and the subretinal space is essential for the viability and function of photoreceptors.	[Han, John Y. S.; Bisetto, Sara; Philp, Nancy J.] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, 1020 Locust St, Philadelphia, PA 19107 USA; [Kinoshita, Junzo; Peachey, Neal S.] Cleveland Clin, Cole Eye Inst, Cleveland, OH 44106 USA; [Bell, Brent A.] Univ Penn, Dept Ophthalmol, Philadelphia, PA 19104 USA; [Nowak, Romana A.] Univ Illinois, Anim Sci, Urbana, IL USA; [Peachey, Neal S.] Louis Stokes Cleveland VA Med Ctr, Cleveland, OH USA; [Peachey, Neal S.] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Dept Ophthalmol, Cleveland, OH 44106 USA; [Kinoshita, Junzo] Daiichi Sankyo Co Ltd, Med Safety Res Labs, Tokyo, Japan	Jefferson University; Cleveland Clinic Foundation; University of Pennsylvania; University of Illinois System; University of Illinois Urbana-Champaign; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Case Western Reserve University; Cleveland Clinic Foundation; Daiichi Sankyo Company Limited	Philp, NJ (corresponding author), Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, 1020 Locust St, Philadelphia, PA 19107 USA.; Peachey, NS (corresponding author), Louis Stokes Cleveland VA Med Ctr, Res Serv 151, 10701 East Blvd, Cleveland, OH 44106 USA.	neal.peachey@va.gov; Nancy.Philp@jefferson.edu	Peachey, Neal/G-5533-2010	Peachey, Neal/0000-0002-4419-7226; Philp, Nancy/0000-0001-7028-0448; Han, John/0000-0003-4200-5128	HHS \ NIH \ National Eye Institute (NEI) [R01 EY12042, P30 EY025585]; U.S. Department of Veterans Affairs (VA) [I01 BX002340]; HHS \ NIH \ National Institute on Alcohol Abuse and Alcoholism (NIAAA) [T32AA007463]	HHS \ NIH \ National Eye Institute (NEI); U.S. Department of Veterans Affairs (VA)(US Department of Veterans Affairs); HHS \ NIH \ National Institute on Alcohol Abuse and Alcoholism (NIAAA)	HHS vertical bar NIH vertical bar National Eye Institute (NEI), Grant/Award Number: R01 EY12042; HHS vertical bar NIH vertical bar National Eye Institute (NEI), Grant/Award Number: P30 EY025585; U.S. Department of Veterans Affairs (VA), Grant/Award Number: I01 BX002340; HHS vertical bar NIH vertical bar National Institute on Alcohol Abuse and Alcoholism (NIAAA), Grant/Award Number: T32AA007463	Adijanto J, 2014, EXP EYE RES, V126, P77, DOI 10.1016/j.exer.2014.01.015; Adijanto J, 2012, CURR TOP MEMBR, V70, P275, DOI 10.1016/B978-0-12-394316-3.00009-0; Ait-Ali N, 2015, CELL, V161, P817, DOI 10.1016/j.cell.2015.03.023; Akimoto M, 2004, INVEST OPHTH VIS SCI, V45, P42, DOI 10.1167/iovs.03-0804; Bell BA, 2019, EXP EYE RES, V185, DOI 10.1016/j.exer.2019.05.012; Bell BA, 2015, EXP EYE RES, V135, P192, DOI 10.1016/j.exer.2015.04.009; Bell BA, 2014, EXP EYE RES, V127, P280, DOI 10.1016/j.exer.2014.01.001; Bisetto S, 2019, ISCIENCE, V22, P507, DOI 10.1016/j.isci.2019.11.041; Bisetto S, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00324; BRETON ME, 1994, INVEST OPHTH VIS SCI, V35, P295; Caceres PS, 2020, CURR OPIN CELL BIOL, V62, P37, DOI 10.1016/j.ceb.2019.08.001; Castorino JJ, 2011, TRAFFIC, V12, P483, DOI 10.1111/j.1600-0854.2010.01155.x; Chang B, 2002, VISION RES, V42, P517, DOI 10.1016/S0042-6989(01)00146-8; Chang B, 2006, INVEST OPHTH VIS SCI, V47, P5017, DOI 10.1167/iovs.05-1468; Chen M, 2016, AGING CELL, V15, P436, DOI 10.1111/acel.12447; Chinchore Y, 2017, ELIFE, V6, DOI 10.7554/eLife.25946; Contreras-Baeza Y, 2019, J BIOL CHEM, V294, P20135, DOI 10.1074/jbc.RA119.009093; Daniele LL, 2008, AM J PHYSIOL-CELL PH, V295, pC451, DOI 10.1152/ajpcell.00124.2008; Du JH, 2016, J BIOL CHEM, V291, P4698, DOI 10.1074/jbc.M115.698985; Fisel P, 2018, CTS-CLIN TRANSL SCI, V11, P352, DOI 10.1111/cts.12551; Flynn E, 2014, INVEST OPHTH VIS SCI, V55, P5643, DOI 10.1167/iovs.14-14136; FULTON AB, 1978, VISION RES, V18, P785, DOI 10.1016/0042-6989(78)90118-9; Gallagher SM, 2007, CANCER RES, V67, P4182, DOI 10.1158/0008-5472.CAN-06-3184; Gao XR, 2019, HUM MOL GENET, V28, P1162, DOI 10.1093/hmg/ddy422; Goto Y, 1995, DOC OPHTHALMOL, V91, P147, DOI 10.1007/BF01203694; Hamann S, 2003, EXP EYE RES, V76, P493, DOI 10.1016/S0014-4835(02)00329-9; Hood Donald C., 1996, Documenta Ophthalmologica, V92, P253, DOI 10.1007/BF02584080; Hoppe G, 2016, P NATL ACAD SCI USA, V113, pE2516, DOI 10.1073/pnas.1523005113; Hori K, 2000, INVEST OPHTH VIS SCI, V41, P3128; Iacovelli J, 2011, INVEST OPHTH VIS SCI, V52, P1378, DOI 10.1167/iovs.10-6347; Iommarini L, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00286; Issa PC, 2013, INVEST OPHTH VIS SCI, V54, P5602, DOI 10.1167/iovs.13-11688; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Joyal JS, 2018, PROG RETIN EYE RES, V64, P131, DOI 10.1016/j.preteyeres.2017.11.002; Kanow MA, 2017, ELIFE, V6, DOI 10.7554/eLife.28899; Kim JW, 2016, DEV CELL, V37, P520, DOI 10.1016/j.devcel.2016.05.023; Kirk P, 2000, EMBO J, V19, P3896, DOI 10.1093/emboj/19.15.3896; Kurihara T, 2016, ELIFE, V5, DOI 10.7554/eLife.14319; Kurihara T, 2012, J CLIN INVEST, V122, P4213, DOI 10.1172/JCI65157; Lee YJ, 2012, NATURE, V487, P443, DOI 10.1038/nature11314; Leveillard T, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030762; Li S, 2005, GENESIS, V41, P73, DOI 10.1002/gene.20097; Lindsay KJ, 2014, P NATL ACAD SCI USA, V111, P15579, DOI 10.1073/pnas.1412441111; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Muramatsu T, 2016, J BIOCHEM, V159, P481, DOI 10.1093/jb/mvv127; Ochrietor JD, 2003, INVEST OPHTH VIS SCI, V44, P4086, DOI 10.1167/iovs.02-0995; Ochrietor JD, 2002, VISION RES, V42, P447, DOI 10.1016/S0042-6989(01)00236-X; Peachey NS, 2018, ADV EXP MED BIOL, V1074, P375, DOI 10.1007/978-3-319-75402-4_46; PEACHEY NS, 1989, VISION RES, V29, P263, DOI 10.1016/0042-6989(89)90075-8; Perkins GA, 2003, MOL VIS, V9, P60; Petit L, 2018, CELL REP, V23, P2629, DOI 10.1016/j.celrep.2018.04.111; Philp NJ, 2003, INVEST OPHTH VIS SCI, V44, P1716, DOI 10.1167/iovs.02-0287; Philp NJ, 2003, INVEST OPHTH VIS SCI, V44, P1305, DOI 10.1167/iovs.02-0552; Philp NJ, 2001, AM J PHYSIOL-CELL PH, V280, pC1319, DOI 10.1152/ajpcell.2001.280.5.C1319; Philp NJ, 1998, AM J PHYSIOL, V274, P1824; POITRYYAMATE CL, 1995, J NEUROSCI, V15, P5179; Rajala A, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0712-9; Rajala A, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0296-4; Rosafio K, 2016, NEUROSCIENCE, V317, P108, DOI 10.1016/j.neuroscience.2015.12.052; Rosell A, 2014, P NATL ACAD SCI USA, V111, P2966, DOI 10.1073/pnas.1323779111; Schmidt N, 2017, NEURON, V96, P827, DOI 10.1016/j.neuron.2017.09.038; Silagi ES, 2019, J BONE MINER RES, P1; Swarup A, 2019, AM J PHYSIOL-CELL PH, V316, pC121, DOI 10.1152/ajpcell.00410.2018; Tanner LB, 2018, CELL SYST, V7, P49, DOI 10.1016/j.cels.2018.06.003; Ullah MS, 2006, J BIOL CHEM, V281, P9030, DOI 10.1074/jbc.M511397200; Wei H, 2016, EXP EYE RES, V145, P450, DOI 10.1016/j.exer.2015.09.015; Wilson DF, 2015, AM J PHYSIOL-ENDOC M, V308, pE506, DOI 10.1152/ajpendo.00544.2014; Wubben TJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18098-z; Xu XP, 2000, EXP NEUROL, V163, P207, DOI 10.1006/exnr.2000.7370; Yoon H, 1999, GENOMICS, V60, P366, DOI 10.1006/geno.1999.5926; Yu DY, 2006, INVEST OPHTH VIS SCI, V47, P1109, DOI 10.1167/iovs.05-1118; Zhao C, 2011, J CLIN INVEST, V121, P369, DOI 10.1172/JCI44303	72	11	11	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5401	5419		10.1096/fj.201902961R	http://dx.doi.org/10.1096/fj.201902961R		FEB 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32112484	Bronze, Green Accepted			2022-12-28	WOS:000517912600001
J	Kohler, A; Morgelin, M; Gebauer, JM; Ocal, S; Imhof, T; Koch, M; Nagata, K; Paulsson, M; Zaucke, F; Baumann, U; Sengle, G				Koehler, Anna; Morgelin, Matthias; Gebauer, Jan M.; Oecal, Sinan; Imhof, Thomas; Koch, Manuel; Nagata, Kazuhiro; Paulsson, Mats; Zaucke, Frank; Baumann, Ulrich; Sengle, Gerhard			New specific HSP47 functions in collagen subfamily chaperoning	FASEB JOURNAL			English	Article						collagen; collagen XVII; FACIT; HSP47; MACIT	MOLECULAR CHAPERONE; TRIPLE-HELIX; ENDOPLASMIC-RETICULUM; RECOGNITION; PROTEIN; CARTILAGE; ACID; PH; MICROFIBRILS; EXPRESSION	Although collagens are the most abundant proteins implicated in various disease pathways, essential mechanisms required for their proper folding and assembly are poorly understood. Heat-shock protein 47 (HSP47), an ER-resident chaperone, was mainly reported to fulfill key functions in folding and secretion of fibrillar collagens by stabilizing pro-collagen triple-helices. In this study, we demonstrate unique functions of HSP47 for different collagen subfamilies. Our results show that HSP47 binds to the N-terminal region of procollagen I and is essential for its secretion. However, HSP47 ablation does not majorly impact collagen VI secretion, but its lateral assembly. Moreover, specific ablation ofHsp47in murine keratinocytes revealed a new role for the transmembrane collagen XVII triple-helix formation. Incompletely folded collagen XVII C-termini protruding from isolated HSP47 null keratinocyte membrane vesicles could be fully restored upon the application of recombinant HSP47. Thus, our study expands the current view regarding the client repertoire and function of HSP47, as well as emphasizes its importance for transmembrane collagen folding.	[Koehler, Anna; Imhof, Thomas; Paulsson, Mats; Sengle, Gerhard] Univ Cologne, Ctr Biochem, Fac Med, Joseph Stelzmann Str 52, D-50931 Cologne, Germany; [Morgelin, Matthias] Lund Univ, Div Infect Med, Dept Clin Sci, Lund, Sweden; [Morgelin, Matthias] Colzyx AB, Lund, Sweden; [Gebauer, Jan M.; Oecal, Sinan; Baumann, Ulrich] Univ Cologne, Inst Biochem, Fac Math & Nat Sci, Zulpicher Str 47, D-50674 Cologne, Germany; [Imhof, Thomas; Koch, Manuel] Univ Cologne, Inst Dent Res & Oral Musculoskeletal Biol, Med Fac, Cologne, Germany; [Nagata, Kazuhiro] Kyoto Sangyo Univ, Inst Prot Dynam, Kyoto, Japan; [Paulsson, Mats; Sengle, Gerhard] Cologne Ctr Musculoskeletal Biomech CCMB, Cologne, Germany; [Paulsson, Mats] Univ Cologne, Cluster Excellence Cellular Stress Responses Agin, Cologne, Germany; [Paulsson, Mats; Sengle, Gerhard] Ctr Mol Med Cologne CMMC, Cologne, Germany; [Zaucke, Frank] Friedrichsheim gGmbh, Orthoped Univ Hosp, Dr Rolf M Schwiete Res Unit Osteoarthritis, Frankfurt, Germany; [Sengle, Gerhard] Univ Cologne, Univ Hosp Cologne, Fac Med, Dept Pediat & Adolescent Med, Cologne, Germany	University of Cologne; Lund University; University of Cologne; University of Cologne; Kyoto Sangyo University; University of Cologne; University of Cologne; University of Cologne	Sengle, G (corresponding author), Univ Cologne, Ctr Biochem, Fac Med, Joseph Stelzmann Str 52, D-50931 Cologne, Germany.; Baumann, U (corresponding author), Univ Cologne, Inst Biochem, Fac Math & Nat Sci, Zulpicher Str 47, D-50674 Cologne, Germany.; Zaucke, F (corresponding author), Friedrichsheim gGmbH, Orthopad Univ Klin, Orthoped Univ Hosp, Dr Rolf M Schwiete Res Unit Osteoarthritis, Marienburgstr 2, D-60528 Frankfurt, Germany.	Frank.Zaucke@friedrichsheim.de; ubaumann@uni-koeln.de; gsengle@uni-koeln.de	Zaucke, Frank/E-2077-2012; Baumann, Ulrich/B-1220-2013; Koch, Manuel/AAG-9914-2021; Zaucke, Frank/AAT-2688-2021; Gebauer, Jan/C-3085-2009	Koch, Manuel/0000-0002-2962-7814; Gebauer, Jan/0000-0002-3989-4748	Deutsche Forschungsgemeinschaft (DFG) [73111208, FOR2722/B1,B2]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: 73111208 and FOR2722/B1,B2,C2,D2	Abdillahi SM, 2018, J IMMUNOL, V201, P1007, DOI 10.4049/jimmunol.1700602; Agarwal P, 2012, J BIOL CHEM, V287, P22549, DOI 10.1074/jbc.M111.335935; BASCHONG W, 1990, J ELECTRON MICR TECH, V14, P313, DOI 10.1002/jemt.1060140405; BJORNSSON S, 1981, BIOCHEM J, V197, P249; Blaschke UK, 2000, J BIOL CHEM, V275, P10370, DOI 10.1074/jbc.275.14.10370; Bober M, 2010, J INNATE IMMUN, V2, P160, DOI 10.1159/000232587; Christiansen HE, 2010, AM J HUM GENET, V86, P389, DOI 10.1016/j.ajhg.2010.01.034; CHU ML, 1988, J BIOL CHEM, V263, P18601; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Drogemuller C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000579; Findlay JWA, 2007, AAPS J, V9, pE260, DOI 10.1208/aapsj0902029; Forlino A, 2016, LANCET, V387, P1657, DOI 10.1016/S0140-6736(15)00728-X; Gara SK, 2011, MATRIX BIOL, V30, P248, DOI 10.1016/j.matbio.2011.03.006; Hafner M, 2004, GENESIS, V38, P176, DOI 10.1002/gene.20016; Hansen U, 2003, J BIOL CHEM, V278, P37352, DOI 10.1074/jbc.M304325200; HAYASHI T, 1973, J BIOCHEM-TOKYO, V73, P999, DOI 10.1093/oxfordjournals.jbchem.a130184; Hirako Y, 1996, J BIOL CHEM, V271, P13739, DOI 10.1074/jbc.271.23.13739; Ishida Y, 2006, MOL BIOL CELL, V17, P2346, DOI 10.1091/mbc.E05-11-1065; Ishikawa Y, 2016, P NATL ACAD SCI USA, V113, pE6036, DOI 10.1073/pnas.1609571113; Ishikawa Y, 2014, J BIOL CHEM, V289, P18189, DOI 10.1074/jbc.M114.561944; KADLER KE, 1987, J BIOL CHEM, V262, P15696; Knupp C, 2001, EMBO J, V20, P372, DOI 10.1093/emboj/20.3.372; Koch M, 2006, J BIOL CHEM, V281, P21546, DOI 10.1074/jbc.M604131200; Koide T, 2006, J BIOL CHEM, V281, P3432, DOI 10.1074/jbc.M509707200; Koide T, 2006, J BIOL CHEM, V281, P11177, DOI 10.1074/jbc.M601369200; Koide T, 2002, J BIOL CHEM, V277, P6178, DOI 10.1074/jbc.M106497200; Koide T, 2000, J BIOL CHEM, V275, P27957; LIAN JB, 1973, BIOCHIM BIOPHYS ACTA, V328, P193, DOI 10.1016/0005-2795(73)90345-0; Lindert U, 2015, J BIOL CHEM, V290, P17679, DOI 10.1074/jbc.M115.661025; Maass T, 2016, J BIOL CHEM, V291, P5247, DOI 10.1074/jbc.M115.705160; Mao JR, 2001, J CLIN INVEST, V107, P1063, DOI 10.1172/JCI12881; Masago Y, 2012, J CELL SCI, V125, P1118, DOI 10.1242/jcs.089748; Nagai N, 2000, J CELL BIOL, V150, P1499, DOI 10.1083/jcb.150.6.1499; NATSUME T, 1994, J BIOL CHEM, V269, P31224; Oecal S, 2016, J BIOL CHEM, V291, P12612, DOI 10.1074/jbc.M115.706069; Ono T, 2012, J BIOL CHEM, V287, P6810, DOI 10.1074/jbc.M111.280248; Ratanavaraporn J, 2008, J BIOMAT SCI-POLYM E, V19, P945, DOI 10.1163/156856208784613505; SPISSINGER T, 1995, MATRIX BIOL, V14, P499, DOI 10.1016/0945-053X(95)90007-1; Tasab M, 2000, EMBO J, V19, P2204, DOI 10.1093/emboj/19.10.2204; Tasab M, 2002, J BIOL CHEM, V277, P35007, DOI 10.1074/jbc.M202782200; Terajima M, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008196; Widmer C, 2012, P NATL ACAD SCI USA, V109, P13243, DOI 10.1073/pnas.1208072109; Wilson DG, 2011, J CELL BIOL, V193, P935, DOI 10.1083/jcb.201007162; Zwolanek D, 2014, BIOCHEM J, V459, P217, DOI 10.1042/BJ20130642	44	9	9	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12040	12052		10.1096/fj.202000570R	http://dx.doi.org/10.1096/fj.202000570R		JUL 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32716577				2022-12-28	WOS:000556424000001
J	Li, Q; Huyan, T; Cai, SN; Huang, QP; Zhang, MZ; Peng, HR; Zhang, YJ; Liu, NJ; Zhang, W				Li, Qi; Huyan, Ting; Cai, Suna; Huang, Qiuping; Zhang, Mengzhao; Peng, Hourong; Zhang, Yujun; Liu, Ningjing; Zhang, Wei			The role of exosomal miR-375-3p: A potential suppressor in bladder cancer via the Wnt/beta-catenin pathway	FASEB JOURNAL			English	Article						bladder cancer; exosomes; FZD8; miR-375-3p; Wnt/beta-catenin pathway	EXTRACELLULAR VESICLES; CERVICAL-CANCER; CARCINOMA-CELLS; LUNG-CANCER; EXPRESSION; PROLIFERATION; BIOGENESIS; AUTOPHAGY; INVASION; SECRETION	miR-375-3p is a significantly downregulated miRNA in bladder cancer (BC). However, its role in BC regulation is still unclear. In this study, we reported that miR-375-3p overexpression inhibited proliferation and migration and promoted apoptosis in BC cells. Frizzled-8 (FZD8) gene is identified as the direct miR-375-3p targeting gene. miR-375-3p blocks the Wnt/beta-catenin pathway and downstream molecules Cyclin D1 and c-Myc by inhibiting the expression of FZD8 directly, it could increase caspase 1 and caspase 3 expression and promote T24 cell apoptosis as well. miR-375-3p also showed a significant inhibitory effect in vivo in bladder tumor-bearing nude mice, as demonstrated by the reduced tumor volume and Ki67 proliferation index in tumor tissue. Collectively, miR-375-3p is a suppressor of BC that inhibits proliferation and metastasis, and promotes apoptosis in BC cells as well as suppresses tumor growth in a T24 xenograft mouse model, which could be used as a potential therapeutic approach for BC in future.	[Li, Qi; Huyan, Ting; Cai, Suna; Huang, Qiuping; Peng, Hourong; Zhang, Yujun; Liu, Ningjing] Northwestern Polytech Univ, Sch Life Sci, Key Lab Space Biosci & Space Biotechnol, 127 YouyiXilu, Xian 710072, Shaanxi, Peoples R China; [Huyan, Ting] Northwestern Polytech Univ, Inst Flexible Elect, Xian, Peoples R China; [Zhang, Mengzhao] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Urol, Xian, Peoples R China; [Zhang, Wei] Zhengzhou Univ, Henan Prov Peoples Hosp, Peoples Hosp, Dept Anesthesiol, Zhengzhou, Peoples R China	Northwestern Polytechnical University; Northwestern Polytechnical University; Xi'an Jiaotong University; Zhengzhou University	Huyan, T (corresponding author), Northwestern Polytech Univ, Sch Life Sci, Key Lab Space Biosci & Space Biotechnol, 127 YouyiXilu, Xian 710072, Shaanxi, Peoples R China.	huyanting@nwpu.edu.cn		Huyan, Ting/0000-0002-8739-1600	Natural Science Basic Research Program of Shaanxi [2019JM360, 2019JM046]; National Natural Science Foundation of China [81502465, 31500688, 31800781]; China Postdoctoral Science Foundation [2020M673491]; National Training Program of Innovation and Entrepreneurship for Undergraduates [201910699168]	Natural Science Basic Research Program of Shaanxi; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Training Program of Innovation and Entrepreneurship for Undergraduates	Natural Science Basic Research Program of Shaanxi, Grant/Award Number: 2019JM360 and 2019JM046; National Natural Science Foundation of China, Grant/Award Number: 81502465, 31500688 and 31800781; China Postdoctoral Science Foundation Funded Project, Grant/Award Number: 2020M673491; National Training Program of Innovation and Entrepreneurship for Undergraduates, Grant/Award Number: 201910699168	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Akers JC, 2013, J NEURO-ONCOL, V113, P1, DOI 10.1007/s11060-013-1084-8; Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Anastasiadis A, 2012, THER ADV UROL, V4, P13, DOI 10.1177/1756287211431976; Anding AL, 2015, CURR TOP DEV BIOL, V114, P67, DOI 10.1016/bs.ctdb.2015.07.012; Baumgart S, 2017, ONCOTARGET, V8, P58278, DOI 10.18632/oncotarget.17619; Boyd JL, 2015, CURR BIOL, V25, P772, DOI 10.1016/j.cub.2015.01.041; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Brown AL, 2019, J ORAL PATHOL MED, V48, P840, DOI 10.1111/jop.12894; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Chang Y, 2012, GASTROENTEROLOGY, V143, P177, DOI 10.1053/j.gastro.2012.04.009; Chen FK, 2018, CANCER BIOL THER, V19, P1139, DOI 10.1080/15384047.2018.1480888; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Deng SZ, 2020, CANCER GENE THER, V27, P203, DOI 10.1038/s41417-019-0079-9; Du JH, 2015, SCI REP-UK, V5, DOI 10.1038/srep16163; Fan YP, 2017, MOL THER-NUCL ACIDS, V7, P181, DOI 10.1016/j.omtn.2017.03.010; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Giallombardo M, 2016, JOVE-J VIS EXP, DOI 10.3791/53900; Grayson M, 2017, NATURE, V551, pS33, DOI 10.1038/551S33a; Hall MC, 2007, J UROLOGY, V178, P2314, DOI 10.1016/j.juro.2007.09.003; He SM, 2019, PATHOL RES PRACT, V215, DOI 10.1016/j.prp.2019.03.004; He XX, 2012, ONCOGENE, V31, P3357, DOI 10.1038/onc.2011.500; Hristov M, 2004, BLOOD, V104, P2761, DOI 10.1182/blood-2003-10-3614; Ji H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110314; Jin XC, 2017, CLIN CANCER RES, V23, P5311, DOI 10.1158/1078-0432.CCR-17-0577; Jin Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144187; Kaufman DS, 2009, LANCET, V374, P239, DOI 10.1016/S0140-6736(09)60491-8; Keller S, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-86; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Kowal J, 2014, CURR OPIN CELL BIOL, V29, P116, DOI 10.1016/j.ceb.2014.05.004; Kumar S, 2018, CANCERS, V10, DOI 10.3390/cancers10110443; Lee YR, 2019, INT J CANCER, V144, P1444, DOI 10.1002/ijc.31931; Li C, 2019, P NATL ACAD SCI USA, V116, P4548, DOI 10.1073/pnas.1813802116; Li GF, 2019, NEOPLASMA, V66, P350, DOI 10.4149/neo_2018_180714N484; Li LN, 2018, ONCOL LETT, V16, P3319, DOI 10.3892/ol.2018.9011; Li Q, 2019, MOL DIAGN THER, V23, P579, DOI 10.1007/s40291-019-00410-4; Li QJ, 2017, CANCER LETT, V402, P166, DOI 10.1016/j.canlet.2017.05.029; Li WH, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0706-8; Lin J, 2016, TUMOR BIOL, V37, P15835, DOI 10.1007/s13277-016-5410-6; Liu G, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0917-7; Liu JN, 2019, CELL PROLIFERAT, V52, DOI 10.1111/cpr.12648; Liu SL, 2016, EUR REV MED PHARMACO, V20, P3223; Liu ZH, 2019, EUR REV MED PHARMACO, V23, P3799, DOI 10.26355/eurrev_201905_17806; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ng L, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080826; Nolte-'t Hoen E, 2016, P NATL ACAD SCI USA, V113, P9155, DOI 10.1073/pnas.1605146113; Oltra E, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00194; Ou HH, 2019, CANCER SCI, V110, P1169, DOI 10.1111/cas.13949; Pan C, 2018, MOL ONCOL, V12, P1935, DOI 10.1002/1878-0261.12371; PROUT GR, 1992, J UROLOGY, V148, P1413, DOI 10.1016/S0022-5347(17)36924-0; Shen ZY, 2014, EXP THER MED, V7, P1757, DOI 10.3892/etm.2014.1627; Sheng B, 2017, BIOMED PHARMACOTHER, V86, P254, DOI 10.1016/j.biopha.2016.11.147; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Spanjer AIR, 2016, THORAX, V71, P312, DOI 10.1136/thoraxjnl-2015-206958; Terasaki H, 2002, INT J MOL MED, V9, P107; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery C, 2018, J EXTRACELL VESICLES, V7, DOI 10.1080/20013078.2018.1535750; Tkach M, 2016, CELL, V164, P1226, DOI 10.1016/j.cell.2016.01.043; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang FF, 2011, AM J PATHOL, V179, P2580, DOI 10.1016/j.ajpath.2011.07.037; Wang Y, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0556-9; Weston WW, 2019, BIODRUGS, V33, P137, DOI 10.1007/s40259-019-00338-5; Woolbright BL, 2018, UROL ONCOL-SEMIN ORI, V36, P327, DOI 10.1016/j.urolonc.2018.04.010; Wu QW, 2018, ONCOL REP, V39, P1461, DOI 10.3892/or.2018.6177; Xu H, 2019, EXP THER MED, V17, P1509, DOI 10.3892/etm.2018.7106; Xu LL, 2016, ONCOTARGET, V7, P40644, DOI 10.18632/oncotarget.9811; Xu LL, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-714; Yan JW, 2014, INT J CANCER, V135, P1011, DOI 10.1002/ijc.28563; Yang QW, 2017, ONCOTARGET, V8, P78989, DOI 10.18632/oncotarget.20742; Yang YZ, 2019, ACTA PHARMACOL SIN, V40, P879, DOI 10.1038/s41401-018-0194-4; Yang Y, 2018, MOL CARCINOGEN, V57, P842, DOI 10.1002/mc.22805; Ye CW, 2019, PATHOL RES PRACT, V215, DOI 10.1016/j.prp.2019.152478; Yoda S, 2014, LUNG CANCER, V85, P366, DOI 10.1016/j.lungcan.2014.06.009; Yoshii S, 2019, CANCER SCI, V110, P2396, DOI 10.1111/cas.14084; Yu X, 2016, INT J GYNECOL CANCER, V26, P851, DOI 10.1097/IGC.0000000000000711; Zhang HD, 2018, EPIGENOMICS-UK, V10, P1499, DOI 10.2217/epi-2017-0151; Zhao PX, 2018, ACTA BIOMATER, V72, P248, DOI 10.1016/j.actbio.2018.03.022; Zhao X, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000012632	80	18	18	1	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12177	12196		10.1096/fj.202000347R	http://dx.doi.org/10.1096/fj.202000347R		JUL 2020	20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32716585				2022-12-28	WOS:000556424800001
J	Wu, PF; Bhore, N; Lee, YL; Chou, JY; Chen, YW; Wu, PY; Hsu, WM; Lee, H; Huang, YS; Lu, PJ; Liao, YF				Wu, Po-Fan; Bhore, Noopur; Lee, Yen-Lurk; Chou, Ju-Yun; Chen, Yun-Wen; Wu, Pei-Yi; Hsu, Wen-Ming; Lee, Hsinyu; Huang, Yi-Shuian; Lu, Pei-Jung; Liao, Yung-Feng			Phosphatidylinositol-4-phosphate 5-kinase type 1 alpha attenuates A beta production by promoting non-amyloidogenic processing of amyloid precursor protein	FASEB JOURNAL			English	Article						Alzheimer's disease; amyloid precursor protein; amyloid-beta; phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	PLASMA-MEMBRANE; GAMMA-SECRETASE; I-ALPHA; PTDINS(4,5)P-2 SYNTHESIS; MOUSE MODEL; DISEASE; KINASE; APP; 4,5-BISPHOSPHATE; BINDING	Alzheimer's disease (AD) is characterized by a chronic decline in cognitive function and is pathologically typified by cerebral deposition of amyloid-beta peptide (A beta). The production of A beta is mediated by sequential proteolysis of amyloid precursor protein (APP) by beta- and gamma-secretases, and has been implicated as the essential determinant of AD pathology. Previous studies have demonstrated that the level of phosphatidylinositol-4,5-bisphosphate [PI(4,5)P2] in the membrane may potentially modulate A beta production. Given that PI(4,5)P2 is produced by type 1 phosphatidylinositol-4-phosphate 5-kinases (PIP5Ks), we sought to determine whether the level of PIP5K type I alpha (PIP5K1A) can affect production of A beta by modulating the lipid composition of the membrane. Using a HEK-derived cell line that constitutively expresses yellow fluorescent protein-tagged APP (APP-YFP), we demonstrated that overexpression of PIP5K1A results in significant enhancement of non-amyloidogenic APP processing and a concomitant suppression of the amyloidogenic pathway, leading to a marked decrease in secreted A beta. Consistently, cells overexpressing PIP5K1A exhibited a significant redistribution of APP-YFP from endosomal compartments to the cell surface. Our findings suggest that PIP5K1A may play a critical role in governing A beta production by modulating membrane distribution of APP, and as such, the pathway may be a valuable therapeutic target for AD.	[Wu, Po-Fan; Bhore, Noopur; Chou, Ju-Yun; Chen, Yun-Wen; Wu, Pei-Yi; Liao, Yung-Feng] Acad Sinica, Inst Cellular & Organism Biol, ICOB 238,128 Sec 2 Acad Rd, Taipei 11529, Taiwan; [Wu, Po-Fan; Bhore, Noopur; Huang, Yi-Shuian; Lu, Pei-Jung; Liao, Yung-Feng] Natl Cheng Kung Univ, TIGP Interdisciplinary Neurosci, Taipei, Taiwan; [Wu, Po-Fan; Bhore, Noopur; Lee, Yen-Lurk; Huang, Yi-Shuian; Lu, Pei-Jung; Liao, Yung-Feng] Acad Sinica, Taipei, Taiwan; [Lee, Yen-Lurk; Huang, Yi-Shuian] Natl Yang Ming Univ, TIGP Mol Med, Taipei, Taiwan; [Lee, Yen-Lurk; Huang, Yi-Shuian] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Hsu, Wen-Ming] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Dept Surg, Coll Med, Taipei, Taiwan; [Lee, Hsinyu] Natl Taiwan Univ, Dept Life Sci, Taipei, Taiwan; [Lu, Pei-Jung] Natl Cheng Kung Univ, Grad Inst Clin Med, Tainan, Taiwan	Academia Sinica - Taiwan; National Cheng Kung University; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Cheng Kung University	Liao, YF (corresponding author), Acad Sinica, Inst Cellular & Organism Biol, ICOB 238,128 Sec 2 Acad Rd, Taipei 11529, Taiwan.	yliao@sinica.edu.tw	Huang, Yi-Shuian/P-2824-2018	Huang, Yi-Shuian/0000-0001-9000-7748; HSU, WEN-MING/0000-0002-5145-9538	National Core Facility Program for Biotechnology Grants by National Science Council (NSC) [100-2319-B-001-002]; Ministry of Science and Technology, Taiwan [MOST 107-2320-B-001-019, MOST 108-2320-B-001-009]; Academia Sinica; Program for Translational Innovation of Biopharmaceutical Development-Technology Supporting Platform Axis [AS-KPQ-106-TSPA]; Ministry of Science and Technology [MOST 108-3114-Y-001-002, MOST 109-0210-01-18-02]; Academia Sinica [AS-SUMMIT-109]	National Core Facility Program for Biotechnology Grants by National Science Council (NSC); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Academia Sinica(Academia Sinica - Taiwan); Program for Translational Innovation of Biopharmaceutical Development-Technology Supporting Platform Axis; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Academia Sinica(Academia Sinica - Taiwan)	We thank Dr Chi-Hon Lee for generous support. We thank the Core Facility of the Institute of Cellular and Organismic Biology, Academia Sinica, for technical support. RNAi reagents were obtained from the National RNAi Core Facility located at the Institute of Molecular Biology/Genomic Research Center, Academia Sinica, supported by National Core Facility Program for Biotechnology Grants provided by National Science Council (NSC) Grant 100-2319-B-001-002. We thank Dr Marcus Calkins for critical reading of the manuscript. This study was supported by Ministry of Science and Technology, Taiwan Grants (MOST 107-2320-B-001-019 and MOST 108-2320-B-001-009 to Y.-FL); the Academia Sinica (Y.-FL); the Program for Translational Innovation of Biopharmaceutical Development-Technology Supporting Platform Axis [Grant No. AS-KPQ-106-TSPA, to Y.-FL (NP7)]. Additional funding was provided by Academia Sinica [AS-SUMMIT-109] and Ministry of Science and Technology [MOST 108-3114-Y-001-002 and/or MOST 109-0210-01-18-02].	Aikawa Y, 2003, J CELL BIOL, V162, P647, DOI 10.1083/jcb.200212142; Andersen OM, 2005, P NATL ACAD SCI USA, V102, P13461, DOI 10.1073/pnas.0503689102; Araki Y, 2003, J BIOL CHEM, V278, P49448, DOI 10.1074/jbc.M306024200; Barber WA, 2010, J THROID RES, V2010, DOI 10.4061/2010/840469; Benjannet S, 2001, J BIOL CHEM, V276, P10879, DOI 10.1074/jbc.M009899200; Brazil DP, 2001, TRENDS BIOCHEM SCI, V26, P657, DOI 10.1016/S0968-0004(01)01958-2; Burns A, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b158; Carrodus NL, 2014, JOVE-J VIS EXP, DOI 10.3791/51139; Chao WT, 2010, J CELL BIOL, V190, P247, DOI 10.1083/jcb.200911110; Chatah NEH, 2001, J BIOL CHEM, V276, P34059, DOI 10.1074/jbc.M104917200; Cheng HP, 2009, J BIOL CHEM, V284, P1373, DOI 10.1074/jbc.M806380200; Coppolino MG, 2002, J BIOL CHEM, V277, P43849, DOI 10.1074/jbc.M209046200; D'Angelo G, 2007, NATURE, V449, P62, DOI 10.1038/nature06097; Di Paolo G, 2004, NATURE, V431, P415, DOI 10.1038/nature02896; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Doughman RL, 2003, J BIOL CHEM, V278, P23036, DOI 10.1074/jbc.M211397200; Flammang B, 2012, J ALZHEIMERS DIS, V30, P145, DOI 10.3233/JAD-2012-112186; Fuentealba RA, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-14; Funakoshi Y, 2011, J CELL PHYSIOL, V226, P888, DOI 10.1002/jcp.22482; Ravetti MG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010153; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; Hammond GRV, 2009, BIOCHEM J, V422, P23, DOI 10.1042/BJ20090428; Hicks DA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00189; Ho A, 2004, P NATL ACAD SCI USA, V101, P2548, DOI 10.1073/pnas.0308655100; Honda A, 1999, CELL, V99, P521, DOI 10.1016/S0092-8674(00)81540-8; Huang TY, 2016, J NEUROSCI, V36, P7996, DOI 10.1523/JNEUROSCI.0206-16.2016; Irie F, 2005, NAT CELL BIOL, V7, P501, DOI 10.1038/ncb1252; Ishihara H, 1998, J BIOL CHEM, V273, P8741, DOI 10.1074/jbc.273.15.8741; Ji C, 2017, CELL REP, V20, P1409, DOI 10.1016/j.celrep.2017.07.041; Kang MS, 2013, J BIOL CHEM, V288, P20868, DOI 10.1074/jbc.M112.445734; Kapoor A, 2010, J ALZHEIMERS DIS, V22, P423, DOI 10.3233/JAD-2010-100531; Kisseleva M, 2005, MOL CELL BIOL, V25, P3956, DOI 10.1128/MCB.25.10.3956-3966.2005; Landman N, 2006, P NATL ACAD SCI USA, V103, P19524, DOI 10.1073/pnas.0604954103; Lee JH, 2003, J BIOL CHEM, V278, P47025, DOI 10.1074/jbc.M300503200; Leslie NR, 2001, CHEM REV, V101, P2365, DOI 10.1021/cr000091i; Mak LH, 2011, ACS CHEM BIOL, V6, P1382, DOI 10.1021/cb2003187; McIntire LBJ, 2012, J NEUROSCI, V32, P15271, DOI 10.1523/JNEUROSCI.2034-12.2012; McKeever PM, 2017, NEUROBIOL AGING, V57, P104, DOI 10.1016/j.neurobiolaging.2017.05.014; Mendez MF, 2012, ARCH MED RES, V43, P677, DOI 10.1016/j.arcmed.2012.11.009; Micucci F, 2008, BLOOD, V111, P4165, DOI 10.1182/blood-2007-08-108886; Nelson CD, 2008, J BIOL CHEM, V283, P21093, DOI 10.1074/jbc.M800431200; Osawa S, 2008, J BIOL CHEM, V283, P19283, DOI 10.1074/jbc.M705954200; Osenkowski P, 2008, J BIOL CHEM, V283, P22529, DOI 10.1074/jbc.M801925200; Padron D, 2003, J CELL BIOL, V162, P693, DOI 10.1083/jcb.200302051; Pietrzik CU, 2002, EMBO J, V21, P5691, DOI 10.1093/emboj/cdf568; Plociennikowska A, 2015, J CELL SCI, V128, P4096, DOI 10.1242/jcs.173104; Prestwich GD, 2004, CHEM BIOL, V11, P619, DOI 10.1016/j.chembiol.2004.03.025; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Riddell DR, 2001, J LIPID RES, V42, P998; Saito Y, 2008, J BIOL CHEM, V283, P35763, DOI 10.1074/jbc.M801353200; Sano Y, 2006, J BIOL CHEM, V281, P37853, DOI 10.1074/jbc.M609312200; Santarius M, 2006, BIOCHEM J, V398, P1, DOI 10.1042/BJ20060565; Shin N, 2008, J CELL SCI, V121, P1252, DOI 10.1242/jcs.016709; Spoelgen R, 2006, J NEUROSCI, V26, P418, DOI 10.1523/JNEUROSCI.3882-05.2006; Sun M, 2016, NEUROBIOL DIS, V93, P1, DOI 10.1016/j.nbd.2016.03.022; Sun Y, 2013, DEV CELL, V25, P144, DOI 10.1016/j.devcel.2013.03.010; Szymanska E, 2009, EXP CELL RES, V315, P981, DOI 10.1016/j.yexcr.2009.01.023; Tall E, 1997, BIOCHEMISTRY-US, V36, P7239, DOI 10.1021/bi9702288; Thinakaran VB-P, 2014, SCI TRANS MED, V6, P1; Thong FSL, 2005, PHYSIOLOGY, V20, P271, DOI 10.1152/physiol.00017.2005; Tsai MT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09633-z; van den Bout I, 2009, J CELL SCI, V122, P3837, DOI 10.1242/jcs.056127; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Vetrivel KS, 2009, J BIOL CHEM, V284, P3793, DOI 10.1074/jbc.M808920200; Vicinanza M, 2008, EMBO J, V27, P2457, DOI 10.1038/emboj.2008.169; Vos T, 2016, LANCET, V388, P1545, DOI [10.1016/S0140-6736(16)31678-6, 10.1016/S0140-6736(16)31012-1]; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; Wenk GL, 2003, J CLIN PSYCHIAT, V64, P7; Yamaguchi H, 2010, CANCER SCI, V101, P1632, DOI 10.1111/j.1349-7006.2010.01574.x; Yang M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063049; Zhu L, 2015, P NATL ACAD SCI USA, V112, P11965, DOI 10.1073/pnas.1510011112; Zhu L, 2013, J BIOL CHEM, V288, P32050, DOI 10.1074/jbc.M113.504365	72	0	0	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12127	12146		10.1096/fj.202000113R	http://dx.doi.org/10.1096/fj.202000113R		JUL 2020	20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32686865				2022-12-28	WOS:000553644100001
J	Fu, M; Barlow-Anacker, AJ; Kuruvilla, KP; Bowlin, GL; Seidel, CW; Trainor, PA; Gosain, A				Fu, Ming; Barlow-Anacker, Amanda J.; Kuruvilla, Korah P.; Bowlin, Gary L.; Seidel, Christopher W.; Trainor, Paul A.; Gosain, Ankush			37/67-laminin receptor facilitates neural crest cell migration during enteric nervous system development	FASEB JOURNAL			English	Article						development; extracellular matrix; Hirschsprung disease; neural crest	KDA LAMININ RECEPTOR; HIRSCHSPRUNG-DISEASE; TYROSINE KINASE; BINDING-PROTEIN; EXPRESSION; MUTATION; THERAPY; NEURONS; GENE; GUT	Enteric nervous system (ENS) development is governed by interactions between neural crest cells (NCC) and the extracellular matrix (ECM). Hirschsprung disease (HSCR) results from incomplete NCC migration and failure to form an appropriate ENS. Prior studies implicate abnormal ECM in NCC migration failure. We performed a comparative microarray of the embryonic distal hindgut of wild-type andEdnrB(NCC-/-)mice that model HSCR and identified laminin-beta 1 as upregulated inEdnrB(NCC-/-)colon. We identified decreased expression of 37/67 kDa laminin receptor (LAMR), which binds laminin-beta 1, in human HSCR myenteric plexus andEdnrB(NCC-/-)NCC. Using a combination of in vitro gut slice cultures and ex vivo organ cultures, we determined the mechanistic role of LAMR in NCC migration. We found that enteric NCC express LAMR, which is downregulated in human and murine HSCR. Binding of LAMR by the laminin-beta 1 analog YIGSR promotes NCC migration. Silencing of LAMR abrogated these effects. Finally, applying YIGSR to E13.5EdnrB(NCC-/-)colon explants resulted in 80%-100% colonization of the hindgut. This study adds LAMR to the large list of receptors through which NCC interact with their environment during ENS development. These results should be used to inform ongoing integrative, regenerative medicine approaches to HSCR.	[Fu, Ming; Kuruvilla, Korah P.; Gosain, Ankush] Univ Tennessee, Ctr Hlth Sci, Dept Surg, Div Pediat Surg, Memphis, TN 38163 USA; [Barlow-Anacker, Amanda J.] Univ Wisconsin, Dept Surg, Sch Med & Publ Hlth, Madison, WI USA; [Bowlin, Gary L.] Univ Memphis, Dept Biomed Engn, Memphis, TN 38152 USA; [Seidel, Christopher W.; Trainor, Paul A.] Stowers Inst Med Res, Kansas City, MO USA; [Trainor, Paul A.] Univ Kansas, Dept Anat & Cell Biol, Sch Med, Kansas City, KS USA; [Gosain, Ankush] Childrens Fdn Res Inst, Le Bonheur Childrens Hosp, 50 N Dunlap St,Room 320, Memphis, TN 38105 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Wisconsin System; University of Wisconsin Madison; University of Memphis; Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Gosain, A (corresponding author), Childrens Fdn Res Inst, Le Bonheur Childrens Hosp, 50 N Dunlap St,Room 320, Memphis, TN 38105 USA.	agosain@uthsc.edu	Pushpamangalam Kuruvilla, Korah/AFS-1915-2022	Pushpamangalam Kuruvilla, Korah/0000-0001-5722-7562; Trainor, Paul/0000-0003-2774-3624	National Institutes of Health, USA [DK098271, DK114543, DK125047]; American College of Surgeons, USA; Mary Shainberg Neuroscience Research Fund; Stowers Institute for Medical Research	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American College of Surgeons, USA; Mary Shainberg Neuroscience Research Fund; Stowers Institute for Medical Research	This work was supported by the National Institutes of Health, USA [DK098271 to AG, DK114543 to AG, DK125047 to AG]; American College of Surgeons, USA [George HA Clowes Career Development Award to AG]; Mary Shainberg Neuroscience Research Fund [to AG]; and the Stowers Institute for Medical Research [to PAT].	Akbareian SE, 2013, DEV BIOL, V382, P446, DOI 10.1016/j.ydbio.2013.08.006; Asai N, 2006, DEVELOPMENT, V133, P4507, DOI 10.1242/dev.02616; Barlow A, 2003, NEURON, V40, P905, DOI 10.1016/S0896-6273(03)00730-X; Becker L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059452; Bi JJ, 2017, MOL CELL BIOCHEM, V435, P175, DOI 10.1007/s11010-017-3066-1; Breau MA, 2006, DEVELOPMENT, V133, P1725, DOI 10.1242/dev.02346; Breau MA, 2009, DEVELOPMENT, V136, P2791, DOI 10.1242/dev.031419; Broders-Bondon F, 2012, DEV BIOL, V364, P178, DOI 10.1016/j.ydbio.2012.02.001; Burns AJ, 2016, DEV BIOL, V417, P229, DOI 10.1016/j.ydbio.2016.04.001; Buto S, 1998, J CELL BIOCHEM, V69, P244, DOI 10.1002/(SICI)1097-4644(19980601)69:3<244::AID-JCB2>3.0.CO;2-R; Carlomagno F, 1996, EMBO J, V15, P2717, DOI 10.1002/j.1460-2075.1996.tb00632.x; Chalazonitis A, 1997, J NEUROBIOL, V33, P118, DOI 10.1002/(SICI)1097-4695(199708)33:2<118::AID-NEU2>3.0.CO;2-5; Cheng LS, 2017, PEDIATR RES, V81, P838, DOI 10.1038/pr.2017.4; Cheng LS, 2016, J PEDIATR SURG, V51, P1834, DOI 10.1016/j.jpedsurg.2016.08.001; Chevalier NR, 2016, SCI REP-UK, V6, DOI 10.1038/srep20927; Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R; Cooper JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162104; DiGiacomo V, 2016, BIOL REV, V91, P288, DOI 10.1111/brv.12170; Druckenbrod NR, 2008, GENESIS, V46, P396, DOI 10.1002/dvg.20415; Druckenbrod NR, 2009, DEVELOPMENT, V136, P3195, DOI 10.1242/dev.031302; Edery P, 1996, NAT GENET, V12, P442, DOI 10.1038/ng0496-442; Fattahi F, 2016, NATURE, V531, P105, DOI 10.1038/nature16951; Fujimura Y, 2005, BIOCHEM BIOPH RES CO, V336, P674, DOI 10.1016/j.bbrc.2005.08.146; Furness JB, 2012, NAT REV GASTRO HEPAT, V9, P286, DOI 10.1038/nrgastro.2012.32; Gosain A, 2016, PEDIATR SURG INT, V32, P313, DOI 10.1007/s00383-016-3862-9; Gosain A, 2015, CURR OPIN PEDIATR, V27, P364, DOI 10.1097/MOP.0000000000000210; Goto A, 2013, J NEUROSCI, V33, P4901, DOI 10.1523/JNEUROSCI.4828-12.2013; HARRISON MW, 1986, AM J SURG, V152, P49, DOI 10.1016/0002-9610(86)90138-8; Heuckeroth RO, 2018, NAT REV GASTRO HEPAT, V27, P1; Heuckeroth RO, 2018, NAT REV GASTRO HEPAT, V15, P152, DOI 10.1038/nrgastro.2017.149; Hotta R, 2013, J CLIN INVEST, V123, P1182, DOI 10.1172/JCI65963; Ivanchuk SM, 1996, HUM MOL GENET, V5, P2023, DOI 10.1093/hmg/5.12.2023; Iwashita T, 2003, SCIENCE, V301, P972, DOI 10.1126/science.1085649; Jovanovic K, 2015, EXPERT OPIN THER PAT, V25, P567, DOI 10.1517/13543776.2015.1014802; Lake JI, 2013, AM J PHYSIOL-GASTR L, V305, pG1, DOI 10.1152/ajpgi.00452.2012; LANDOWSKI TH, 1995, BIOCHEMISTRY-US, V34, P11276, DOI 10.1021/bi00035a037; Lee HO, 2003, DEV BIOL, V259, P162, DOI 10.1016/S0012-1606(03)00160-X; Levin DE, 2012, CURR OPIN PEDIATR, V24, P365, DOI 10.1097/MOP.0b013e328352ec19; Li AW, 2008, WORLD J PEDIATR, V4, P135, DOI 10.1007/s12519-008-0027-5; McCallion AS, 2001, PIGM CELL RES, V14, P161, DOI 10.1034/j.1600-0749.2001.140305.x; Meyers ML, 2016, FETAL DIAGN THER, V40, P235, DOI 10.1159/000371742; Mograbi B, 2001, J BIOL CHEM, V276, P45307, DOI 10.1074/jbc.M101220200; Montuori N, 2016, TRANSL MED UNISA, V15, P8; Nagy N, 2006, DEV BIOL, V293, P203, DOI 10.1016/j.ydbio.2006.01.032; Nagy N, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.160317; Nagy N, 2017, SEMIN CELL DEV BIOL, V66, P94, DOI 10.1016/j.semcdb.2017.01.006; Nagy N, 2009, DEV BIOL, V330, P263, DOI 10.1016/j.ydbio.2009.03.025; Nelson J, 2008, BIOSCIENCE REP, V28, P33, DOI 10.1042/BSR20070004; Nishida S, 2018, BIOCHEM BIOPH RES CO, V495, P1461, DOI 10.1016/j.bbrc.2017.11.184; Oharazawa H, 2005, OPHTHALMIC RES, V37, P191, DOI 10.1159/000086595; PARIKH DH, 1992, GASTROENTEROLOGY, V102, P1236; PARIKH DH, 1992, J PEDIATR SURG, V27, P991, DOI 10.1016/0022-3468(92)90545-I; Pesapane A, 2017, CURR PHARM DESIGN, V23, P4745, DOI 10.2174/1381612823666170710125332; Pesapane A, 2015, ONCOTARGET, V6, P18116, DOI 10.18632/oncotarget.4016; POMERANZ HD, 1991, J COMP NEUROL, V313, P625, DOI 10.1002/cne.903130408; POMERANZ HD, 1993, DEV BIOL, V156, P341, DOI 10.1006/dbio.1993.1082; PUFFENBERGER EG, 1994, CELL, V79, P1257, DOI 10.1016/0092-8674(94)90016-7; ROMANOV V, 1994, CELL ADHES COMMUN, V2, P201, DOI 10.3109/15419069409004438; ROMANOV VI, 1995, BIOCHEM BIOPH RES CO, V208, P637, DOI 10.1006/bbrc.1995.1386; Rothman TP, 1996, DEV BIOL, V178, P498, DOI 10.1006/dbio.1996.0234; Sarnataro D, 2016, SCI REP-UK, V6, DOI 10.1038/srep24457; Soret R, 2015, J CLIN INVEST, V125, P4483, DOI 10.1172/JCI83178; Stamp LA, 2017, GASTROENTEROLOGY, V152, P1407, DOI 10.1053/j.gastro.2017.01.005; Stamp LA, 2017, AM J PHYSIOL-GASTR L, V312, pG348, DOI 10.1152/ajpgi.00018.2017; Suh HN, 2010, AM J PHYSIOL-CELL PH, V298, pC1159, DOI 10.1152/ajpcell.00496.2009; Taraviras S, 1999, DEVELOPMENT, V126, P2785; Workman MJ, 2017, NAT MED, V23, P49, DOI 10.1038/nm.4233; Zaitoun I, 2013, NEUROGASTROENT MOTIL, V25, pE233, DOI 10.1111/nmo.12083	68	3	3	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10931	10947		10.1096/fj.202000699R	http://dx.doi.org/10.1096/fj.202000699R		JUN 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32592286	Bronze, Green Accepted			2022-12-28	WOS:000544412900001
J	Huang, CW; Chang, YH; Lee, HH; Wu, JY; Huang, JX; Chung, YH; Hsu, ST; Chow, LP; Wei, KC; Huang, FT				Huang, Chiun-Wei; Chang, Yu-Hsuan; Lee, Hsuan-Hung; Wu, Jing-Yi; Huang, Jia-Xing; Chung, Yi-Hsiu; Hsu, Shih-Ting; Chow, Lu-Ping; Wei, Kuo-Chen; Huang, Feng-Ting			Irisin, an exercise myokine, potently suppresses tumor proliferation, invasion, and growth in glioma	FASEB JOURNAL			English	Article						cell invasion; exercise; glioblastoma; irisin; TFPI-2; tumor targeting	FACTOR PATHWAY INHIBITOR-2; CELL LUNG-CANCER; PHYSICAL-ACTIVITY; MOLECULAR-MECHANISMS; SIGNALING PATHWAY; EXPRESSION; MIGRATION; PROGRESSION; ADIPOCYTES; FAT	Glioblastoma multiforme is the most common and aggressive glial tumor with poor prognosis. Importantly, effective treatment options for glioblastoma are unmet needs. Obesity and low physical activity have been linked with a high risk of cancer, and exercise is related to delayed cancer development and progression. Epidemiological studies have revealed a correlation between exercise and the survival rate of patients with glioblastoma. Nevertheless, the mechanisms by which exercise exerts its anticancer effects in glioblastoma remain unclear. Here, we found that irisin, an exercise-induced myokine, induced G(2)/M cell cycle arrest and increased p21 levels in glioblastoma cells, leading to the inhibition of cell proliferation. In addition, irisin inhibited glioblastoma cell invasion by upregulating TFPI-2 and even reversed the aggressive tumor phenotype promoted by co-cultivation with cancer-associated adipocytes. Furthermore, irisin retarded xenograft glioblastoma tumor growth, and radiolabeled irisin demonstrated specific tumor-targeting capability in vivo. Therefore, this study identified one potential molecular mechanism by which exercise prevents cancer progression via irisin. Intriguingly, irisin has the potential to be developed as a molecular imaging and therapeutic anticancer agent.	[Huang, Chiun-Wei; Chung, Yi-Hsiu; Hsu, Shih-Ting] Chang Gung Mem Hosp, Ctr Adv Mol Imaging & Translat CAMIT, Taoyuan, Taiwan; [Chang, Yu-Hsuan; Lee, Hsuan-Hung; Wu, Jing-Yi; Huang, Jia-Xing; Huang, Feng-Ting] Natl Taiwan Univ, Coll Life Sci, Dept Biochem Sci & Technol, AC2-414,1,Sec 4,Roosevelt Rd, Taipei 106, Taiwan; [Chow, Lu-Ping] Natl Taiwan Univ, Coll Med, Grad Inst Biochem & Mol Biol, Taipei, Taiwan; [Wei, Kuo-Chen] Chang Gung Mem Hosp, Dept Neurosurg, Taoyuan, Taiwan; [Wei, Kuo-Chen] Chang Gung Univ, Sch Med, Taoyuan, Taiwan	Chang Gung Memorial Hospital; National Taiwan University; National Taiwan University; Chang Gung Memorial Hospital; Chang Gung University	Huang, FT (corresponding author), Natl Taiwan Univ, Coll Life Sci, Dept Biochem Sci & Technol, AC2-414,1,Sec 4,Roosevelt Rd, Taipei 106, Taiwan.	fthuang@ntu.edu.tw		Wei, Kuochen/0000-0003-3505-2196	National Taiwan University (NTU) [108L7866, 109L7866]; Ministry of Science and Technology, Taiwan (MOST) [107-2314-B-182A-149-MY3]	National Taiwan University (NTU)(National Taiwan UniversityNanyang Technological University); Ministry of Science and Technology, Taiwan (MOST)(Ministry of Science and Technology, Taiwan)	National Taiwan University (NTU), Grant/Award Number: 108L7866 and 109L7866; Ministry of Science and Technology, Taiwan (MOST), Grant/Award Number: 107-2314-B-182A-149-MY3	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Aoi W, 2013, GUT, V62, P882, DOI 10.1136/gutjnl-2011-300776; Aroui S, 2016, CHEM-BIOL INTERACT, V244, P195, DOI 10.1016/j.cbi.2015.12.011; Ballard-Barbash R, 2012, JNCI-J NATL CANCER I, V104, P815, DOI 10.1093/jnci/djs207; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Cao L, 2010, CELL, V142, P52, DOI 10.1016/j.cell.2010.05.029; Chen GH, 2017, J PHARMACOL SCI, V134, P59, DOI 10.1016/j.jphs.2017.04.003; Choi YK, 2013, DIABETES RES CLIN PR, V100, P96, DOI 10.1016/j.diabres.2013.01.007; Chung YH, 2014, MOL PHARMACEUT, V11, P3904, DOI 10.1021/mp500296n; Cormie P, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00085; Dirat B, 2011, CANCER RES, V71, P2455, DOI 10.1158/0008-5472.CAN-10-3323; Gannon NP, 2015, INT J CANCER, V136, pE197, DOI 10.1002/ijc.29142; Gessler F, 2011, NEUROSCI LETT, V497, P49, DOI 10.1016/j.neulet.2011.04.027; Gleeson M, 2011, NAT REV IMMUNOL, V11, P607, DOI 10.1038/nri3041; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Hojman P, 2018, CELL METAB, V27, P10, DOI 10.1016/j.cmet.2017.09.015; Hojman P, 2011, AM J PHYSIOL-ENDOC M, V301, pE504, DOI 10.1152/ajpendo.00520.2010; Huang CW, 2017, THERANOSTICS, V7, P4013, DOI 10.7150/thno.19304; Hudis CA, 2014, BRIT J CANCER, V110, P829, DOI 10.1038/bjc.2014.12; Jedrychowski MP, 2015, CELL METAB, V22, P734, DOI 10.1016/j.cmet.2015.08.001; Khandekar MJ, 2011, NAT REV CANCER, V11, P886, DOI 10.1038/nrc3174; Kim H, 2018, CELL, V175, P1756, DOI 10.1016/j.cell.2018.10.025; Konduri SD, 2001, ONCOGENE, V20, P6938, DOI 10.1038/sj.onc.1204847; Lanir N, 2003, SEMIN THROMB HEMOST, V29, P175, DOI 10.1055/s-2003-38833; Liu JY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33229-w; Martin-Caballero J, 2001, CANCER RES, V61, P6234; McTiernan A, 2008, NAT REV CANCER, V8, P205, DOI 10.1038/nrc2325; Moore SC, 2009, CANCER RES, V69, P8349, DOI 10.1158/0008-5472.CAN-09-1669; Nieman KM, 2011, NAT MED, V17, P1498, DOI 10.1038/nm.2492; Pagliara V, 2014, BBA-MOL CELL RES, V1843, P2631, DOI 10.1016/j.bbamcr.2014.07.008; Park J, 2014, NAT REV ENDOCRINOL, V10, P455, DOI 10.1038/nrendo.2014.94; Pedersen L, 2016, CELL METAB, V23, P554, DOI 10.1016/j.cmet.2016.01.011; Penas-Prado M, 2012, HAND CLINIC, V105, P485, DOI 10.1016/B978-0-444-53502-3.00004-5; Qian QA, 2010, CANCER INVEST, V28, P661, DOI 10.3109/07357901003735634; Rao CN, 2001, CLIN CANCER RES, V7, P570; Ren FH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135544; Shao L, 2017, BIOCHEM BIOPH RES CO, V485, P598, DOI 10.1016/j.bbrc.2016.12.084; Shi Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep14901; Sierko E, 2007, SEMIN THROMB HEMOST, V33, P653, DOI 10.1055/s-2007-991532; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; Wang HL, 2014, CANCER BIOTHER RADIO, V29, P166, DOI 10.1089/cbr.2014.1608; Wekesa A, 2015, PROSTATE CANCER P D, V18, P197, DOI 10.1038/pcan.2015.9; Wojtukiewicz MZ, 2003, THROMB HAEMOSTASIS, V90, P140; Wolin KY, 2011, BRIT J CANCER, V104, P882, DOI 10.1038/sj.bjc.6606045; Wrann CD, 2013, CELL METAB, V18, P649, DOI 10.1016/j.cmet.2013.09.008; Zebisch K, 2012, ANAL BIOCHEM, V425, P88, DOI 10.1016/j.ab.2012.03.005; Zhang Y, 2009, CANCER RES, V69, P5259, DOI 10.1158/0008-5472.CAN-08-3444; Zhang Y, 2014, DIABETES, V63, P514, DOI 10.2337/db13-1106	50	11	11	3	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9678	9693		10.1096/fj.202000573RR	http://dx.doi.org/10.1096/fj.202000573RR		MAY 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32469121				2022-12-28	WOS:000538082300001
J	Luo, J; Zhang, BY; Lyu, ZY; Wu, YT; Zhang, Y; Guo, XF				Luo, Jun; Zhang, Boyue; Lyu, Ziyu; Wu, Yuting; Zhang, Yue; Guo, Xiaofeng			Single amino acid change at position 255 in rabies virus glycoprotein decreases viral pathogenicity	FASEB JOURNAL			English	Article						glycoprotein; mutation; pathogenicity; rabies virus; vaccine	ATTENUATED RECOMBINANT RABIES; PROTECTIVE IMMUNE-RESPONSE; FUSION ACTIVITY; CLONED CDNA; SITE-III; VIRULENCE; GENE; MUTATIONS; VACCINE; STRAIN	Previous studies have indicated that the amino acid at position 333 in the glycoprotein (G) is closely related to rabies virus (RABV) pathogenicity. However, whether there are other amino acid residues in G that relate to pathogenicity remain unclear. The aim of this study is to find new amino acid residues in G that could strongly reduce RABV pathogenicity. The present study found that the pathogenicity of a virulent strain was strongly attenuated when the amino acid glycine (Gly) replaced the aspartic acid (Asp) at position 255 in G (D255G) as intracranial (i.c.) infection with this D255G mutant virus did not cause death in adult mice. The indexes of neurotropism of the D255G mutant strain and the parent GD-SH-01 are 0.72 and 10.0, respectively, which indicate that the D255G mutation decreased the neurotropism of RABV. In addition, the D255G mutation significantly decreased RABV replication in the mouse brain. Furthermore, the D255G mutation enhanced the immune response in mice, which contributed to the clearance of RABV after infection. The Asp255 -> Gly255 mutation was genetically stable in vitro and in vivo. In this study, we describe a new referenced amino acid site in G that relates to the pathogenicity of RABV.	[Luo, Jun; Zhang, Boyue; Lyu, Ziyu; Wu, Yuting; Zhang, Yue; Guo, Xiaofeng] South China Agr Univ, Coll Vet Med, 483 Wushan Rd, Guangzhou 510642, Peoples R China	South China Agricultural University	Guo, XF (corresponding author), South China Agr Univ, Coll Vet Med, 483 Wushan Rd, Guangzhou 510642, Peoples R China.	xfguo@scau.edu.cn			National Natural Science Foundation of China (NSFC) [31772742]; National Key Research and Development Program of China [2016YFD0500400]; Natural Science Foundation of Guangdong Province (Guangdong Natural Science Foundation) [2015A03031103]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Natural Science Foundation of Guangdong Province (Guangdong Natural Science Foundation)(National Natural Science Foundation of Guangdong Province)	National Natural Science Foundation of China (NSFC), Grant/Award Number: 31772742; National Key Research and Development Program of China, Grant/Award Number: 2016YFD0500400; Natural Science Foundation of Guangdong Province (Guangdong Natural Science Foundation), Grant/Award Number: 2015A03031103	Albertini AAV, 2012, VIRUSES-BASEL, V4, P117, DOI 10.3390/v4010117; Chopy D, 2011, J NEUROVIROL, V17, P353, DOI 10.1007/s13365-011-0041-6; Cliquet F, 1998, J IMMUNOL METHODS, V212, P79, DOI 10.1016/S0022-1759(97)00212-3; Coulon P, 1998, J VIROL, V72, P273, DOI 10.1128/JVI.72.1.273-278.1998; Desmezieres E, 2003, VIRUS RES, V91, P181, DOI 10.1016/S0168-1702(02)00267-8; DIALLO A, 1986, ANN RECH VET, V17, P3; DIETZSCHOLD B, 1985, J VIROL, V56, P12, DOI 10.1128/JVI.56.1.12-18.1985; DIETZSCHOLD B, 1983, P NATL ACAD SCI-BIOL, V80, P70, DOI 10.1073/pnas.80.1.70; DIETZSCHOLD B, 1982, J VIROL, V44, P595, DOI 10.1128/JVI.44.2.595-602.1982; Evans JS, 2018, J GEN VIROL, V99, P169, DOI 10.1099/jgv.0.000998; Faber M, 2005, J VIROL, V79, P14141, DOI 10.1128/JVI.79.22.14141-14148.2005; Faber M, 2004, P NATL ACAD SCI USA, V101, P16328, DOI 10.1073/pnas.0407289101; Faber M, 2002, J VIROL, V76, P3374, DOI 10.1128/JVI.76.7.3374-3381.2002; Faber M, 2009, P NATL ACAD SCI USA, V106, P11300, DOI 10.1073/pnas.0905640106; FREDERICKSEN BL, 1995, J VIROL, V69, P1435, DOI 10.1128/JVI.69.3.1435-1443.1995; Gaudin Y, 1999, J GEN VIROL, V80, P1221, DOI 10.1099/0022-1317-80-5-1221; Gaudin Y, 1997, J VIROL, V71, P3742, DOI 10.1128/JVI.71.5.3742-3750.1997; GAUDIN Y, 1992, VIROLOGY, V187, P627, DOI 10.1016/0042-6822(92)90465-2; Ghanem A, 2016, VIRUS RES, V216, P41, DOI 10.1016/j.virusres.2015.05.023; Gnanadurai CW, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004023; Guo YD, 2019, VIRUS RES, V263, P217, DOI 10.1016/j.virusres.2019.02.006; Hooper DC, 1998, J VIROL, V72, P3711, DOI 10.1128/JVI.72.5.3711-3719.1998; Huang JH, 2017, ANTIVIR RES, V141, P1, DOI 10.1016/j.antiviral.2017.01.022; Inoue K, 2003, J VIROL METHODS, V107, P229, DOI 10.1016/S0166-0934(02)00249-5; ITO H, 1994, MICROBIOL IMMUNOL, V38, P479, DOI 10.1111/j.1348-0421.1994.tb01812.x; Ito N, 2001, J VIROL, V75, P9121, DOI 10.1128/JVI.75.19.9121-9128.2001; KAPLAN MM, 1975, J IMMUNOL, V114, P1761; Kuang Y, 2009, VIRUS RES, V144, P18, DOI 10.1016/j.virusres.2009.03.014; Kuzmina NA, 2013, VIRUS GENES, V47, P305, DOI 10.1007/s11262-013-0952-9; LAFAY F, 1994, VACCINE, V12, P317, DOI 10.1016/0264-410X(94)90095-7; Lafay F, 1996, J GEN VIROL, V77, P339, DOI 10.1099/0022-1317-77-2-339; LENTZ TL, 1982, SCIENCE, V215, P182, DOI 10.1126/science.7053569; Liu XH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087105; Luo J, 2019, VACCINE, V37, P7478, DOI 10.1016/j.vaccine.2019.09.077; Luo J, 2018, ARCH VIROL, V163, P1889, DOI 10.1007/s00705-018-3808-8; Luo J, 2017, VACCINE, V35, P938, DOI 10.1016/j.vaccine.2016.12.069; Luo J, 2016, VACCINE, V34, P4392, DOI 10.1016/j.vaccine.2016.07.020; Luo J, 2016, VIRUS GENES, V52, P379, DOI 10.1007/s11262-016-1313-2; Luo YW, 2013, INFECT GENET EVOL, V17, P147, DOI 10.1016/j.meegid.2013.03.046; McGettigan JP, 2003, J VIROL, V77, P237, DOI 10.1128/JVI.77.1.237-244.2003; Mebatsion T, 2001, J VIROL, V75, P11496, DOI 10.1128/JVI.75.23.11496-11502.2001; Mei MZ, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00120; Morimoto K, 1999, J VIROL, V73, P510, DOI 10.1128/JVI.73.1.510-518.1999; Morimoto K, 2000, J NEUROVIROL, V6, P373, DOI 10.3109/13550280009018301; Nakagawa K, 2017, VACCINE, V35, P5622, DOI 10.1016/j.vaccine.2017.08.050; Ohara S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080245; Phares TW, 2006, J IMMUNOL, V176, P7666, DOI 10.4049/jimmunol.176.12.7666; Pulmanausahakul R, 2008, J VIROL, V82, P2330, DOI 10.1128/JVI.02327-07; SCHNELL MJ, 1994, EMBO J, V13, P4195, DOI 10.1002/j.1460-2075.1994.tb06739.x; Schutsky K, 2013, J VIROL, V87, P1834, DOI 10.1128/JVI.02589-12; SEIF I, 1985, J VIROL, V53, P926, DOI 10.1128/JVI.53.3.926-934.1985; Shuai L, 2015, ANTIVIR RES, V121, P9, DOI 10.1016/j.antiviral.2015.06.011; Takayama-Ito M, 2006, VIRUS RES, V115, P169, DOI 10.1016/j.virusres.2005.08.004; Takayama-Ito M, 2004, J NEUROVIROL, V10, P131, DOI 10.1080/13550280490279799; Takayama-Ito M, 2006, VIRUS RES, V119, P208, DOI 10.1016/j.virusres.2006.01.014; Tao LH, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-454; Tao LH, 2010, J VIROL, V84, P8926, DOI 10.1128/JVI.00787-10; Thoulouze MI, 1998, J VIROL, V72, P7181, DOI 10.1128/JVI.72.9.7181-7190.1998; Tian Q, 2017, VIRUS GENES, V53, P573, DOI 10.1007/s11262-017-1458-7; Tuffereau C, 1998, EMBO J, V17, P7250, DOI 10.1093/emboj/17.24.7250; TUFFEREAU C, 1989, VIROLOGY, V172, P206, DOI 10.1016/0042-6822(89)90122-0; Virojanapirom P, 2012, ARCH VIROL, V157, P2201, DOI 10.1007/s00705-012-1402-z; Wang JL, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007189; Wu XF, 2008, VIRUS RES, V131, P95, DOI 10.1016/j.virusres.2007.07.018; WUNNER WH, 1988, REV INFECT DIS, V10, pS771; Yang FL, 2020, CELL HOST MICROBE, V27, P441, DOI 10.1016/j.chom.2019.12.012; Yang Y, 2015, J VIROL, V89, P2157, DOI 10.1128/JVI.02092-14; Zhang GQ, 2013, VET MICROBIOL, V162, P601, DOI 10.1016/j.vetmic.2012.11.031; Zhao L, 2009, J VIROL, V83, P11808, DOI 10.1128/JVI.01346-09	69	5	5	3	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9650	9663		10.1096/fj.201902577R	http://dx.doi.org/10.1096/fj.201902577R		MAY 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32469133				2022-12-28	WOS:000538081700001
J	Rao, GT; Murphy, B; Dey, A; Dwivedi, SKD; Zhang, YS; Roy, RV; Chakraborty, P; Bhattacharya, R; Mukherjee, P				Rao, Geeta; Murphy, Brennah; Dey, Anindya; Dwivedi, Shailendra Kumar Dhar; Zhang, Yushan; Roy, Ram Vinod; Chakraborty, Prabir; Bhattacharya, Resham; Mukherjee, Priyabrata			Cystathionine beta synthase regulates mitochondrial dynamics and function in endothelial cells	FASEB JOURNAL			English	Article						endothelial cells; mitochondrial dynamics; mitophagy; mitochondrial fusion; mitochondrial fission	HYDROGEN-SULFIDE; ENDOPLASMIC-RETICULUM; OXIDATIVE STRESS; RESPIRATORY CAPACITY; CROSS-TALK; AUTOPHAGY; BNIP3; FISSION; PROTEIN; FUSION	Mutations in the human cystathionine beta synthase (CBS) gene are known to cause endothelial dysfunction responsible for cardiovascular and neurovascular diseases. CBS is the predominant hydrogen sulfide (H2S)-producing enzyme in endothelial cells (ECs). Recently, H2S was shown to attenuate ROS and improve mitochondrial function. Mitochondria are metabolic organelles that actively transform their ultrastructure to mediate their function. Therefore, we questioned whether perturbation of CBS/H2S activity could drive mitochondrial dysfunction via mitochondrial dynamics in ECs. Here we demonstrate that silencing CBS induces mitochondria fragmentation, attenuates efficient oxidative phosphorylation, and decreases EC function. Mechanistically, CBS silencing significantly elevates ROS production, thereby leading to reduced mitofusin 2 (MFN2) expression, decouple endoplasmic reticulum-mitochondria contacts, increased mitochondria fission, enhanced receptor-mediated mitophagy, and increased EC death. These defects were significantly rescued by the treatment of H2S donors. Taken together our data highlights a novel signaling axis that mechanistically links CBS with mitochondrial function and ER-mitochondrial tethering and could be considered as a new therapeutic approach for the intervention of EC dysfunction-related pathologies.	[Rao, Geeta; Murphy, Brennah; Zhang, Yushan; Roy, Ram Vinod; Chakraborty, Prabir; Mukherjee, Priyabrata] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK USA; [Rao, Geeta; Murphy, Brennah; Zhang, Yushan; Roy, Ram Vinod; Chakraborty, Prabir; Bhattacharya, Resham; Mukherjee, Priyabrata] Univ Oklahoma, Hlth Sci Ctr, Peggy & Charles Stephenson Canc Ctr, Oklahoma City, OK USA; [Dey, Anindya; Dwivedi, Shailendra Kumar Dhar; Bhattacharya, Resham] Univ Oklahoma, Hlth Sci Ctr, Dept Obstet & Gynecol, Oklahoma City, OK USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Bhattacharya, R (corresponding author), OUHSC, Peggy & Charles Stephenson Canc Ctr, Dept Obstet & Gynecol, 975 NE 10th St,BRC 1409B, Oklahoma City, OK 73104 USA.; Mukherjee, P (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Pathol,Coll Med, Expt Pathol,Peggy & Charles Stephenson Endowed Ch, 975 NE 10th St,BRC 1409A, Oklahoma City, OK 73104 USA.; Mukherjee, P (corresponding author), Univ Oklahoma, Stephenson Canc Ctr, 975 NE 10th St,BRC 1409A, Oklahoma City, OK 73104 USA.	Resham-Bhattacharya@ouhsc.edu; Priyabrata-Mukherjee@ouhsc.edu			National Institutes of Health [1R01 CA220237-01A1, 2CA136494, CA213278, CA157481, 1R01HL120585]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	National Institutes of Health, Grant/Award Number: 1R01 CA220237-01A1, 2CA136494, CA213278, CA157481 and 1R01HL120585	Albertini E, 2012, AGING-US, V4, P664, DOI 10.18632/aging.100491; Beard RS, 2011, AM J PHYSIOL-HEART C, V300, pH13, DOI 10.1152/ajpheart.00598.2010; Bhattacharyya S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079167; Brattstrom L, 2000, AM J CLIN NUTR, V72, P315; Chakraborty PK, 2018, FASEB J, V32, P4145, DOI 10.1096/fj.201701095R; Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529; Chen G, 1997, J EXP MED, V186, P1975, DOI 10.1084/jem.186.12.1975; Chen G, 1999, J BIOL CHEM, V274, P7, DOI 10.1074/jbc.274.1.7; Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032; De Bock K, 2013, CELL, V154, P651, DOI 10.1016/j.cell.2013.06.037; Dey A, 2018, MOL CANCER THER, V17, P39, DOI 10.1158/1535-7163.MCT-17-0574; Dhingra A, 2017, FREE RADICAL BIO MED, V112, P411, DOI 10.1016/j.freeradbiomed.2017.08.010; Dhingra R, 2014, P NATL ACAD SCI USA, V111, pE5537, DOI 10.1073/pnas.1414665111; Ding WX, 2012, BIOL CHEM, V393, P547, DOI 10.1515/hsz-2012-0119; Filadi R, 2018, PHARMACOL RES, V128, P42, DOI 10.1016/j.phrs.2018.01.003; Frank M, 2012, BBA-MOL CELL RES, V1823, P2297, DOI 10.1016/j.bbamcr.2012.08.007; Friedman JR, 2014, NATURE, V505, P335, DOI 10.1038/nature12985; Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385; Fu M, 2012, P NATL ACAD SCI USA, V109, P2943, DOI 10.1073/pnas.1115634109; Ghavami S, 2010, CELL RES, V20, P314, DOI 10.1038/cr.2009.129; Goldman SJ, 2010, MITOCHONDRION, V10, P309, DOI 10.1016/j.mito.2010.01.005; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Gomez-Suaga P, 2017, AUTOPHAGY, V13, P1250, DOI 10.1080/15548627.2017.1317913; Guo K, 2001, CELL DEATH DIFFER, V8, P367, DOI 10.1038/sj.cdd.4400810; Hamacher-Brady A, 2007, CELL DEATH DIFFER, V14, P146, DOI 10.1038/sj.cdd.4401936; Hanna RA, 2012, J BIOL CHEM, V287, P19094, DOI 10.1074/jbc.M111.322933; Huang H, 2017, EMBO J, V36, P2334, DOI 10.15252/embj.201695518; Incalza MA, 2018, VASC PHARMACOL, V100, P1, DOI 10.1016/j.vph.2017.05.005; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kalucka J, 2018, CELL METAB, V28, P881, DOI 10.1016/j.cmet.2018.07.016; Kevil CG, 2000, AM J PHYSIOL-CELL PH, V279, pC21, DOI 10.1152/ajpcell.2000.279.1.C21; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kudchodkar SB, 2009, REV MED VIROL, V19, P359, DOI 10.1002/rmv.630; Liesa M, 2013, CELL METAB, V17, P491, DOI 10.1016/j.cmet.2013.03.002; MacIntosh GC, 2011, AUTOPHAGY, V7, P662, DOI 10.4161/auto.7.6.15447; Marchi S, 2018, CELL CALCIUM, V69, P62, DOI 10.1016/j.ceca.2017.05.003; Marcu R, 2017, ADV EXP MED BIOL, V982, P371, DOI 10.1007/978-3-319-55330-6_21; Matsumoto G, 2011, MOL CELL, V44, P279, DOI 10.1016/j.molcel.2011.07.039; MCCULLY KS, 1969, AM J PATHOL, V56, P111; McLelland GL, 2018, ELIFE, V7, DOI 10.7554/eLife.32866; Mishra P, 2016, J CELL BIOL, V212, P379, DOI 10.1083/jcb.201511036; Mishra P, 2014, CELL METAB, V19, P630, DOI 10.1016/j.cmet.2014.03.011; MIYAZONO Y, 2018, SCI REP UK, V8; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Moody BF, 2011, MED GAS RES, V1, DOI 10.1186/2045-9912-1-3; Murphy B, 2019, FASEB J, V33, P13098, DOI 10.1096/fj.201901304R; Mustafi SB, 2016, FASEB J, V30, P4042, DOI 10.1096/fj.201600321R; Nakao A, 2009, J CLIN BIOCHEM NUTR, V44, P1, DOI 10.3164/jcbn.08-193R; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Naon D, 2016, P NATL ACAD SCI USA, V113, P11249, DOI 10.1073/pnas.1606786113; Ney PA, 2015, BBA-MOL CELL RES, V1853, P2775, DOI 10.1016/j.bbamcr.2015.02.022; Nicholls DG, 2009, BIOCHEM SOC T, V37, P1385, DOI 10.1042/BST0371385; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Papapetropoulos A, 2009, P NATL ACAD SCI USA, V106, P21972, DOI 10.1073/pnas.0908047106; Potente M, 2017, ANNU REV PHYSIOL, V79, P43, DOI 10.1146/annurev-physiol-021115-105134; Rambold AS, 2011, P NATL ACAD SCI USA, V108, P10190, DOI 10.1073/pnas.1107402108; Reef S, 2006, MOL CELL, V22, P463, DOI 10.1016/j.molcel.2006.04.014; Safiedeen Z, 2017, ANTIOXID REDOX SIGN, V26, P15, DOI 10.1089/ars.2016.6771; Saha S, 2016, FASEB J, V30, P441, DOI 10.1096/fj.15-278648; Sanchis-Gomar F, 2014, NEW ENGL J MED, V370, P1073, DOI 10.1056/NEJMc1316254; Santel A, 2003, J CELL SCI, V116, P2763, DOI 10.1242/jcs.00479; Schoors S, 2015, NATURE, V520, P192, DOI 10.1038/nature14362; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Szabo C, 2013, P NATL ACAD SCI USA, V110, P12474, DOI 10.1073/pnas.1306241110; Szabo C, 2011, BRIT J PHARMACOL, V164, P853, DOI 10.1111/j.1476-5381.2010.01191.x; Tanida I, 2011, ANTIOXID REDOX SIGN, V14, P2201, DOI 10.1089/ars.2010.3482; Teng HJ, 2013, P NATL ACAD SCI USA, V110, P12679, DOI 10.1073/pnas.1308487110; Toyama EQ, 2016, SCIENCE, V351, P275, DOI 10.1126/science.aab4138; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Valente AJ, 2017, ACTA HISTOCHEM, V119, P315, DOI 10.1016/j.acthis.2017.03.001; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Wai T, 2016, TRENDS ENDOCRIN MET, V27, P105, DOI 10.1016/j.tem.2015.12.001; Wang CN, 2014, ANTIOXID REDOX SIGN, V21, P2192, DOI 10.1089/ars.2013.5682; Wang MJ, 2010, ANTIOXID REDOX SIGN, V12, P1065, DOI 10.1089/ars.2009.2945; Weiss N, 2002, ARTERIOSCL THROM VAS, V22, P34, DOI 10.1161/hq1201.100456; Whiteman M, 2004, J NEUROCHEM, V90, P765, DOI 10.1111/j.1471-4159.2004.02617.x; Wong BW, 2017, NATURE, V542, P49, DOI 10.1038/nature21028; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Yap S, 2000, SEMIN THROMB HEMOST, V26, P335, DOI 10.1055/s-2000-8100; Yasuda M, 1998, J BIOL CHEM, V273, P12415, DOI 10.1074/jbc.273.20.12415; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697; Yu QJ, 2017, ADV EXP MED BIOL, V967, P373, DOI 10.1007/978-3-319-63245-2_24; Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103; Zhang J, 2009, CELL DEATH DIFFER, V16, P939, DOI 10.1038/cdd.2009.16; Zhu YY, 2013, J BIOL CHEM, V288, P1099, DOI 10.1074/jbc.M112.399345	88	14	14	3	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9372	9392		10.1096/fj.202000173R	http://dx.doi.org/10.1096/fj.202000173R		MAY 2020	21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32463541	Green Accepted			2022-12-28	WOS:000536309800001
J	Hui, SC; Huang, L; Wang, XL; Zhu, XH; Zhou, M; Chen, MT; Yi, L; Mi, MT				Hui, Suocheng; Huang, Li; Wang, Xiaolan; Zhu, Xiaohui; Zhou, Min; Chen, Mengting; Yi, Long; Mi, Mantian			Capsaicin improves glucose homeostasis by enhancing glucagon-like peptide-1 secretion through the regulation of bile acid metabolism via the remodeling of the gut microbiota in male mice	FASEB JOURNAL			English	Article						bile acids; capsaicin; GLP-1; gut microbiota; type 2 diabetes	SEX-DIFFERENCES; IMPACT; ENERGY; GLP-1	Mounting evidence has linked dietary capsaicin (CAP) consumption to the improvement of glucose homeostasis; however, the underlying mechanisms still need to be further elucidated. Male mice were fed a high-fat diet (HFD) with CAP administration for 8 weeks, gut microbiota, bile acid (BA) profiles and markers for BA, and glucose metabolism were investigated. CAP improved glucose homeostasis partially by enhancing the secretion of glucagon-like peptide 1 (GLP-1). The gut microbiota was remodeled by CAP and was characterized by the increased abundance of Bacteroides genera, which is related with lithocholic acid (LCA) production. LCA is an endogenous agonist of Takeda G-protein coupled receptor 5 (TGR5); it may enhance GLP-1 secretion in intestinal L cells. Meanwhile, antibiotics experiment abolished the effects of CAP on glucose homeostasis and microbiota transplantation experiments demonstrated that the CAP-induced beneficial effects were transferable, indicating that the effects of CAP on glucose homeostasis were largely dependent on the gut microbiota. Additionally, we further identified that the improvements induced by CAP were attenuated by the antagonist of GLP-1 receptor, indicating that the activation of GLP-1 signaling contributes to the CAP-induced improvement in glucose homeostasis.	[Hui, Suocheng; Huang, Li; Wang, Xiaolan; Zhu, Xiaohui; Zhou, Min; Chen, Mengting; Yi, Long; Mi, Mantian] Third Mil Med Univ, Chongqing Med Nutr Res Ctr, Chongqing Key Lab Nutr & Food Safety, Res Ctr Nutr & Food Safety,Inst Mil Prevent Med, Chongqing 400038, Peoples R China	Army Medical University	Mi, MT (corresponding author), Third Mil Med Univ, Chongqing Med Nutr Res Ctr, Chongqing Key Lab Nutr & Food Safety, Res Ctr Nutr & Food Safety,Inst Mil Prevent Med, Chongqing 400038, Peoples R China.	mi_mt2009@hotmail.com		Mi, Mantian/0000-0002-7213-2155	National Natural Science Foundation of China [81673157]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China, Grant/Award Number: 81673157	Albaugh VL, 2019, GASTROENTEROLOGY, V156, P1041, DOI 10.1053/j.gastro.2018.11.017; Anhe FF, 2019, GUT, V68, P453, DOI 10.1136/gutjnl-2017-315565; Baggio LL, 2008, GASTROENTEROLOGY, V134, P1137, DOI 10.1053/j.gastro.2008.01.017; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Beli E, 2018, DIABETES, V67, P1867, DOI 10.2337/db18-0158; Buteau J, 2008, DIABETES METAB, V34, pS73, DOI 10.1016/S1262-3636(08)73398-6; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen MT, 2019, MOL NUTR FOOD RES, V63, DOI 10.1002/mnfr.201800612; Chen MT, 2020, CLIN NUTR, V39, P1264, DOI 10.1016/j.clnu.2019.05.020; Chen ML, 2016, MBIO, V7, DOI 10.1128/mBio.02210-15; Chiang JYL, 2009, J LIPID RES, V50, P1955, DOI 10.1194/jlr.R900010-JLR200; Cotillard A, 2013, NATURE, V500, P585, DOI 10.1038/nature12480; DeMars MD, 2018, FASEB J, V32; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; FISHER MM, 1973, CAN MED ASSOC J, V109, P190; Flores R, 2012, EUR J CLIN INVEST, V42, P848, DOI 10.1111/j.1365-2362.2012.02660.x; Fuchs CD, 2018, GUT, V67, P1683, DOI 10.1136/gutjnl-2017-314553; Galman C, 2011, J INTERN MED, V270, P580, DOI 10.1111/j.1365-2796.2011.02466.x; Grasset E, 2017, CELL METAB, V26, P278, DOI 10.1016/j.cmet.2017.06.003; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; Gupta R, 2009, CURR DRUG TARGETS, V10, P71, DOI 10.2174/138945009787122860; HIRANO S, 1982, J LIPID RES, V23, P1152; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Hui SC, 2019, MOL NUTR FOOD RES, V63, DOI 10.1002/mnfr.201900608; Kang C, 2017, MBIO, V8, DOI [10.1128/mBio.00470-17, 10.1128/mbio.00470-17, 10.1128/mBio.00900-17]; Kaur A, 2015, DIABETES, V64, P1168, DOI [10.2337/db14-0716, 10.2337/db15-0518]; Lan K, 2016, ANAL CHEM, V88, P7041, DOI 10.1021/acs.analchem.6b00573; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Naghavi M, 2017, LANCET, V390, P1151, DOI 10.1016/S0140-6736(17)32152-9; Nakamura A, 2010, J DIABETES INVEST, V1, P208, DOI 10.1111/j.2040-1124.2010.00046.x; NAUCK M, 1986, DIABETOLOGIA, V29, P46, DOI 10.1007/BF02427280; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; Pathak P, 2018, HEPATOLOGY, V68, P1574, DOI 10.1002/hep.29857; Patriti A, 2004, OBES SURG, V14, P840, DOI 10.1381/0960892041590818; Phelps T, 2019, BIOL SEX DIFFER, V10, DOI 10.1186/s13293-019-0265-3; Scrocchi LA, 1996, NAT MED, V2, P1254, DOI 10.1038/nm1196-1254; Sharma SK, 2013, EUR J PHARMACOL, V720, P55, DOI 10.1016/j.ejphar.2013.10.053; Sun LL, 2018, NAT MED, V24, P1919, DOI 10.1038/s41591-018-0222-4; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; Tolhurst G, 2012, DIABETES, V61, P364, DOI 10.2337/db11-1019; Wahlstrom A, 2016, CELL METAB, V24, P41, DOI 10.1016/j.cmet.2016.05.005; Wang PJ, 2012, DIABETES, V61, P2155, DOI 10.2337/db11-1503; Wang XW, 2011, J CLIN ENDOCR METAB, V96, P885, DOI 10.1210/jc.2010-2061; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Xie GX, 2015, J PROTEOME RES, V14, P850, DOI 10.1021/pr500920q; Yasir M, 2015, NUTR DIABETES, V5, DOI 10.1038/nutd.2015.3; Zeng XL, 2019, ANTIOXID REDOX SIGN, V30, P163, DOI 10.1089/ars.2017.7172; Zheng Y, 2018, NAT REV ENDOCRINOL, V14, P88, DOI 10.1038/nrendo.2017.151	51	16	17	0	37	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8558	8573		10.1096/fj.201902618RR	http://dx.doi.org/10.1096/fj.201902618RR		MAY 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32359008				2022-12-28	WOS:000530046700001
J	Zhu, ZW; Peng, XF; Li, XP; Tu, T; Yang, H; Teng, S; Zhang, W; Xing, ZH; Tang, JJ; Hu, XQ; Fang, ZF; Zhou, SH				Zhu, Zhaowei; Peng, Xiaofan; Li, Xuping; Tu, Tao; Yang, Hui; Teng, Shuai; Zhang, Wei; Xing, Zhenhua; Tang, Jianjun; Hu, Xinqun; Fang, Zhenfei; Zhou, Shenghua			HMGB1 impairs endothelium-dependent relaxation in diabetes through TLR4/eNOS pathway	FASEB JOURNAL			English	Article						diabetes; endothelium-dependent relaxation; glycyrrhizin acid; HMGB1	NITRIC-OXIDE SYNTHASE; RECEPTOR 4; MURINE MODEL; DYSFUNCTION; ACTIVATION; INJURY; CONTRIBUTES; MICE	Endothelium-dependent relaxation (EDR) is an initial key step leading to various vascular complications in patients with diabetes. However, the underlying mechanism of EDR impairment in diabetes is not fully understood. Present study defined the role of high-mobility group protein (HMGB1) in EDR related to diabetes. Serum level of HMGB1 was increased in diabetic patients and in db/db mice. Serum HMGB1 level was also positively correlated with HbA1c and negatively correlated with nitric oxide (NO) in diabetic patients. Results from wire myograph showed that recombinant HMGB1 (rHMGB1) was capable of impairing EDR of aortas from wild-type (WT) mice by an eNOS-dependent mechanism. Consistently, HMGB1 inhibitor glycyrrhizin acid (GA) decreased the serum level of HMGB1 and rescued EDR impairment partly in db/db mice. Furthermore, rHMGB1 mediated EDR impairment was abolished in aortas of TLR4(-/-) mice. In addition, high-glucose-induced HMGB1 upregulation and secretion in endothelial cells. In conclusion, HMGB1 contributes to the EDR impairment through TLR4/eNOS pathway in the setting of diabetes. GA as the HMGB1 inhibitor could attenuate EDR impairment in an animal model of diabetes.	[Zhu, Zhaowei; Peng, Xiaofan; Li, Xuping; Tu, Tao; Yang, Hui; Teng, Shuai; Xing, Zhenhua; Tang, Jianjun; Hu, Xinqun; Fang, Zhenfei; Zhou, Shenghua] Cent South Univ, Xiangya Hosp 2, Cardiovasc Dept, Middle Ren Min Rd 139, Changsha 410011, Hunan, Peoples R China; [Zhang, Wei] Wake Forest Univ, Sch Med, Dept Internal Med, Winston Salem, NC 27101 USA	Central South University; Wake Forest University	Zhou, SH (corresponding author), Cent South Univ, Xiangya Hosp 2, Cardiovasc Dept, Middle Ren Min Rd 139, Changsha 410011, Hunan, Peoples R China.	zhoushenghua@csu.edu.cn	zhou, sheng/GYJ-6012-2022		National Natural Science Foundation of China (NSFC) [81600248, 81670269]; Natural Science Foundation of Hunan Province (Hunan Provincial Natural Science Foundation) [2018JJ3744, 2018JJ2563]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hunan Province (Hunan Provincial Natural Science Foundation)	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81600248 and 81670269; Natural Science Foundation of Hunan Province (Hunan Provincial Natural Science Foundation), Grant/Award Number: 2018JJ3744 and 2018JJ2563	Andersson U, 2018, SEMIN IMMUNOL, V38, P40, DOI 10.1016/j.smim.2018.02.011; Arrigo T, 2013, EUR J ENDOCRINOL, V168, P631, DOI 10.1530/EJE-13-0037; Bauer EM, 2013, J BIOL CHEM, V288, P1365, DOI 10.1074/jbc.M112.434142; Benhamou Y, 2014, ARTHRITIS RHEUMATOL, V66, P3210, DOI 10.1002/art.38785; Cefalu WT, 2019, DIABETES CARE, V42, pS13, DOI 10.2337/dc19-S002; Chen J, 2012, ATHEROSCLEROSIS, V224, P332, DOI 10.1016/j.atherosclerosis.2012.07.020; Chiesa ST, 2019, EUR HEART J, V40, P3559, DOI 10.1093/eurheartj/ehz114; Donath MY, 2019, NAT REV IMMUNOL, V19, P734, DOI 10.1038/s41577-019-0213-9; Frank MG, 2015, BRAIN BEHAV IMMUN, V48, P1, DOI 10.1016/j.bbi.2015.03.010; Hernanz R, 2015, BRIT J PHARMACOL, V172, P3159, DOI 10.1111/bph.13117; Idelman G, 2015, REDOX BIOL, V5, P398, DOI 10.1016/j.redox.2015.06.008; Jiang RZ, 2014, J IMMUNOL, V193, P5000, DOI 10.4049/jimmunol.1303445; Kang R, 2017, CELL RES, V27, P916, DOI 10.1038/cr.2017.51; Kaur R, 2018, CARDIOVASC DIABETOL, V17, DOI 10.1186/s12933-018-0763-3; Kim F, 2007, CIRC RES, V100, P1589, DOI 10.1161/CIRCRESAHA.106.142851; Kraehling JR, 2016, CIRC RES, V118, P48, DOI 10.1161/CIRCRESAHA.115.307767; Lee JH, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0260-0; Li H, 2019, THERANOSTICS, V9, P1909, DOI 10.7150/thno.30578; Liang CF, 2013, ARTERIOSCL THROM VAS, V33, P777, DOI 10.1161/ATVBAHA.112.301087; Musumeci D, 2014, PHARMACOL THERAPEUT, V141, P347, DOI 10.1016/j.pharmthera.2013.11.001; Pellegrini L, 2019, PHARMACOL THERAPEUT, V196, P160, DOI 10.1016/j.pharmthera.2018.12.005; Rask-Madsen C, 2013, CELL METAB, V17, P20, DOI 10.1016/j.cmet.2012.11.012; Reaven PD, 2019, NEW ENGL J MED, V380, P2215, DOI 10.1056/NEJMoa1806802; Sachdev U, 2013, J VASC SURG, V58, P460, DOI 10.1016/j.jvs.2012.11.071; Szasz T, 2016, DIABETES, V65, P3754, DOI 10.2337/db16-0480; Tang DL, 2011, ANTIOXID REDOX SIGN, V14, P1315, DOI 10.1089/ars.2010.3356; Vanhoutte PM, 2016, CIRC RES, V119, P375, DOI 10.1161/CIRCRESAHA.116.306531; Vellecco V, 2016, DIABETES OBES METAB, V18, P1236, DOI 10.1111/dom.12750; Wang H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136564; Yanai H, 2012, TRENDS IMMUNOL, V33, P633, DOI 10.1016/j.it.2012.10.005; Yang S, 2014, J LEUKOCYTE BIOL, V95, P563, DOI 10.1189/jlb.0713412; Yazji I, 2013, P NATL ACAD SCI USA, V110, P9451, DOI 10.1073/pnas.1219997110; Youn JH, 2008, J IMMUNOL, V180, P5067, DOI 10.4049/jimmunol.180.7.5067; Zhao DD, 2013, INT J CARDIOL, V168, P1559, DOI 10.1016/j.ijcard.2012.12.073; Zheng Y, 2018, NAT REV ENDOCRINOL, V14, P88, DOI 10.1038/nrendo.2017.151; Zhu ZW, 2020, J VASC INTERV RADIOL, V31, P42, DOI 10.1016/j.jvir.2019.09.017	36	13	13	4	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8641	8652		10.1096/fj.202000242R	http://dx.doi.org/10.1096/fj.202000242R		MAY 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32359123				2022-12-28	WOS:000530046500001
J	Kovacs, D; Maresca, V; Flori, E; Mastrofrancesco, A; Picardo, M; Cardinali, G				Kovacs, Daniela; Maresca, Vittoria; Flori, Enrica; Mastrofrancesco, Arianna; Picardo, Mauro; Cardinali, Giorgia			Bovine colostrum induces the differentiation of human primary keratinocytes	FASEB JOURNAL			English	Article						cutaneous homeostasis; EGFR-PI3K signaling pathway; filaggrin	GROWTH-FACTOR RECEPTOR; SKIN BARRIER; FACTOR-BB; IMMUNOGLOBULIN CONCENTRATIONS; CORNIFIED ENVELOPE; CALCIUM REGULATION; DIABETIC ULCERS; CELL-DEATH; CROSS-TALK; FACTOR-I	Bovine colostrum, the first milk secreted by the mammary glands of cows shortly after they have given birth, provides a natural source of bioactive substances helpful to promote tissue development and repair, and to maintain a healthy immune system. Owing to its properties, the use of colostrum in the treatment of human diseases is under investigation. We evaluated the biological activity of colostrum on human primary keratinocytes, focusing on its effects with regard to a proliferation/differentiation balance. Using cellular and molecular approaches, we showed that colostrum favors a cell cycle withdrawal by increasing the expression of p21/WAF1 and p27/KIP1. It also promotes the transition of keratinocytes from a proliferating to a differentiating state, as assessed by a decrease in keratin 5 and an increase in keratin 16. We demonstrated the ability of colostrum to induce the expression of early and late differentiation markers (keratin 1, involucrin, and filaggrin) and the synthesis of caspase 14 and bleomycin hydrolase, the two main enzymes involved in filaggrin maturation. Moreover, we showed that bovine colostrum is able to promote keratinocyte stratification and terminal differentiation not only in two-dimensional (2D), but also in a more physiological system of three-dimensional (3D) skin equivalents. Finally, we demonstrated that colostrum stimulates cell differentiation through the PI3K/PLC-gamma 1/PKC alpha pathways mainly associated to tyrosine kinase receptors. These results suggest the possibility to benefit from colostrum properties for the treatment of skin diseases characterized by altered differentiation and perturbed barrier function.	[Kovacs, Daniela; Maresca, Vittoria; Flori, Enrica; Mastrofrancesco, Arianna; Picardo, Mauro; Cardinali, Giorgia] IRCCS, Cutaneous Physiopathol & Integrated Ctr Metabol R, San Gallicano Dermatol Inst, Via Elio Chianesi 53, Rome 00144, Italy	IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG)	Cardinali, G (corresponding author), IRCCS, Cutaneous Physiopathol & Integrated Ctr Metabol R, San Gallicano Dermatol Inst, Via Elio Chianesi 53, Rome 00144, Italy.	giorgia.cardinali@ifo.gov.it	kovacs, daniela/H-4418-2014; maresca, vittoria/J-3272-2016; Flori, Enrica/H-4417-2014; Cardinali, Giorgia/H-1814-2016; Picardo, Mauro/A-6978-2011; Mastrofrancesco, Arianna/K-2433-2018	kovacs, daniela/0000-0003-1873-0549; maresca, vittoria/0000-0001-9239-6978; Flori, Enrica/0000-0002-9275-1041; Cardinali, Giorgia/0000-0002-7527-9451; Picardo, Mauro/0000-0003-4899-6639; Mastrofrancesco, Arianna/0000-0003-1231-3832				Barrientos S, 2014, WOUND REPAIR REGEN, V22, P569, DOI 10.1111/wrr.12205; BERGHARD A, 1990, J BIOL CHEM, V265, P21086; Berlanga-Acosta J., 2011, J CARCINOG MUTAGEN, V2, P100; Bernot KM, 2002, J INVEST DERMATOL, V119, P1137, DOI 10.1046/j.1523-1747.2002.19518.x; Bikle DD, 2012, EXPERT REV ENDOCRINO, V7, P461, DOI 10.1586/EEM.12.34; Blum JW, 2000, LIVEST PROD SCI, V66, P151, DOI 10.1016/S0301-6226(00)00222-0; Borowiec AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077507; BOYCE ST, 1983, J INVEST DERMATOL, V81, pS33, DOI 10.1111/1523-1747.ep12540422; BROWN GL, 1989, NEW ENGL J MED, V321, P76, DOI 10.1056/NEJM198907133210203; BROWN RL, 1994, J SURG RES, V56, P562, DOI 10.1006/jsre.1994.1090; Cairangzhuoma, 2013, BIOSCI BIOTECH BIOCH, V77, P992, DOI 10.1271/bbb.120942; Cairangzhuoma, 2013, J DAIRY SCI, V96, P1347, DOI 10.3168/jds.2012-5701; Campbell P, 2014, J INVEST DERMATOL, V134, P2570, DOI 10.1038/jid.2014.164; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Chanprapaph K, 2014, DERMAT RES PRACT, V2014, DOI 10.1155/2014/734249; Cheng XP, 2010, CELL, V141, P331, DOI 10.1016/j.cell.2010.03.013; DAUGHADAY WH, 1989, ENDOCR REV, V10, P68, DOI 10.1210/edrv-10-1-68; Denecker G, 2008, J CELL BIOL, V180, P451, DOI 10.1083/jcb.200709098; Denning MF, 2000, EXP DERMATOL, V9, P192, DOI 10.1034/j.1600-0625.2000.009003192.x; DIGNASS AU, 1993, GASTROENTEROLOGY, V105, P1323, DOI 10.1016/0016-5085(93)90136-Z; Doillon CJ, 2011, INT WOUND J, V8, P280, DOI 10.1111/j.1742-481X.2011.00783.x; Eckhart L, 2013, BBA-MOL CELL RES, V1833, P3471, DOI 10.1016/j.bbamcr.2013.06.010; Elfstrand L, 2010, HIV AIDS-RES PALLIAT, V2, P219, DOI 10.2147/HIV.S13191; Elsholz F, 2014, EUR J DERMATOL, V24, P650, DOI 10.1684/ejd.2014.2452; Franzke CW, 2012, J EXP MED, V209, P1105, DOI 10.1084/jem.20112258; Fry MJ, 2001, BREAST CANCER RES, V3, P304, DOI 10.1186/bcr312; Gauthier SF, 2006, LAIT, V86, P99, DOI 10.1051/lait:2005048; HENNINGS H, 1980, CELL, V19, P245, DOI 10.1016/0092-8674(80)90406-7; Henry J, 2012, FRONT BIOSCI-LANDMRK, V17, P1517, DOI 10.2741/4001; Hill DS, 2015, MOL CANCER THER, V14, P2665, DOI 10.1158/1535-7163.MCT-15-0394; Hironaka T, 1997, J DAIRY SCI, V80, P488, DOI 10.3168/jds.S0022-0302(97)75961-7; Holcmann M, 2015, MOL CELL ONCOL, V2, DOI 10.1080/23723556.2015.1004969; Jaschke E, 1999, INT J DERMATOL, V38, P380, DOI 10.1046/j.1365-4362.1999.00665.x; Kehoe SI, 2007, J DAIRY SCI, V90, P4108, DOI 10.3168/jds.2007-0040; Kelly Gregory S, 2003, Altern Med Rev, V8, P378; Korhonen H, 2000, BRIT J NUTR, V84, pS135; Korhonen HJ, 2013, CELL MOL BIOL, V59, P12, DOI 10.1170/T943; Kovacs D, 2010, BRIT J DERMATOL, V163, P1020, DOI 10.1111/j.1365-2133.2010.09946.x; Kovacs D, 2012, J INVEST DERMATOL, V132, P1196, DOI 10.1038/jid.2011.457; Kovacs D, 2009, GROWTH FACTORS, V27, P448, DOI 10.3109/08977190903211077; Kshirsagar AY, 2015, J CLIN DIAGN RES, V9, pPC1, DOI 10.7860/JCDR/2015/12004.5739; Kypriotou M, 2012, EXP DERMATOL, V21, P643, DOI 10.1111/j.1600-0625.2012.01472.x; Lamb R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052494; Li LW, 1996, J INVEST DERMATOL, V106, P254, DOI 10.1111/1523-1747.ep12340654; Lichtenberger BM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005886; Matus CE, 2008, BRIT J DERMATOL, V159, P792, DOI 10.1111/j.1365-2133.2008.08784.x; Pakkanen R, 1997, INT DAIRY J, V7, P285, DOI 10.1016/S0958-6946(97)00022-8; PAMMI M, 2015, COCHRANE DB SYST REV, V20, P7137; Pan XO, 2013, CURR OPIN CELL BIOL, V25, P47, DOI 10.1016/j.ceb.2012.10.018; Pendaries V, 2014, J INVEST DERMATOL, V134, P2938, DOI 10.1038/jid.2014.259; PLAYFORD RJ, 1995, GUT, V37, P595, DOI 10.1136/gut.37.5.595; Playford RJ, 2000, AM J CLIN NUTR, V72, P5; Playford RJ, 1999, GUT, V44, P653, DOI 10.1136/gut.44.5.653; POUMAY Y, 1995, J INVEST DERMATOL, V104, P271, DOI 10.1111/1523-1747.ep12612810; Proksch E, 2008, EXP DERMATOL, V17, P1063, DOI 10.1111/j.1600-0625.2008.00786.x; Purup S, 2007, J DAIRY RES, V74, P58, DOI 10.1017/S0022029906002093; Rathe M, 2014, NUTR REV, V72, P237, DOI 10.1111/nure.12089; ROBSON MC, 1992, ANN PLAS SURG, V29, P193, DOI 10.1097/00000637-199209000-00001; ROGERS ML, 1995, J DAIRY RES, V62, P501, DOI 10.1017/S0022029900031198; Sacerdote P, 2013, J DAIRY SCI, V96, P1745, DOI 10.3168/jds.2012-5928; Sandilands A, 2009, J CELL SCI, V122, P1285, DOI 10.1242/jcs.033969; Sch?tz, 2017, SCI REP, V7, P1, DOI [10.1038/s41598-017-17164-w, DOI 10.1038/S41598-017-17164-W]; SHING Y, 1987, MOL ENDOCRINOL, V1, P335, DOI 10.1210/mend-1-5-335; Smiell JM, 1999, WOUND REPAIR REGEN, V7, P335, DOI 10.1046/j.1524-475X.1999.00335.x; Solomons NW, 2002, EUR J CLIN NUTR, V56, pS24, DOI 10.1038/sj.ejcn.1601480; Son ED, 2015, CLIN EXP DERMATOL, V40, P247, DOI 10.1111/ced.12520; Sponseller JK, 2015, J INFECT DIS, V211, P1334, DOI 10.1093/infdis/jiu605; Szabo S, 1996, BAILLIERE CLIN GAST, V115, P273; Takayama Y, 2001, BIOSCI BIOTECH BIOCH, V65, P2776, DOI 10.1271/bbb.65.2776; THOMPSON JF, 1994, GASTROENTEROLOGY, V107, P1278, DOI 10.1016/0016-5085(94)90528-2; Torre C, 2006, J NUTR, V136, p2058S, DOI 10.1093/jn/136.7.2058S; Tyler JW, 1999, AM J VET RES, V60, P1136; VACHER PY, 1993, MILCHWISSENSCHAFT, V48, P423; Wakita N, 1999, J BIOL CHEM, V274, P37285, DOI 10.1074/jbc.274.52.37285; Walker A, 2010, J PEDIATR-US, V156, pS3, DOI 10.1016/j.jpeds.2009.11.021; Wieman TJ, 1998, DIABETES CARE, V21, P822, DOI 10.2337/diacare.21.5.822; Xie ZJ, 2007, J BIOL CHEM, V282, P8695, DOI 10.1074/jbc.M609135200; Xie ZJ, 2010, BIOCHEM BIOPH RES CO, V397, P296, DOI 10.1016/j.bbrc.2010.05.103; Xie ZJ, 2005, MOL BIOL CELL, V16, P3236, DOI 10.1091/mbc.E05-02-0109	79	7	7	0	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6302	6321		10.1096/fj.201900103RRR	http://dx.doi.org/10.1096/fj.201900103RRR			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32157742				2022-12-28	WOS:000531325500023
J	Fernandez-Gonzalo, R; Tesch, PA; Lundberg, TR; Alkner, BA; Rullman, E; Gustafsson, T				Fernandez-Gonzalo, Rodrigo; Tesch, Per A.; Lundberg, Tommy R.; Alkner, Bjorn A.; Rullman, Eric; Gustafsson, Thomas			Three months of bed rest induce a residual transcriptomic signature resilient to resistance exercise countermeasures	FASEB JOURNAL			English	Article						atrophy; microarray; muscle wasting; unloading	HUMAN SKELETAL-MUSCLE; FLYWHEEL RESISTIVE EXERCISE; SIMULATED MICROGRAVITY; CONCURRENT EXERCISE; VASTUS LATERALIS; CIRCADIAN CLOCK; DISUSE ATROPHY; MESSENGER-RNA; BONE LOSS; EXPRESSION	This study explored the muscle genome-wide response to long-term unloading (84-day bed rest) in 21 men. We hypothesized that a part of the bed rest-induced gene expression signature would be resilient to a concurrent flywheel resistance exercise (RE) countermeasure. Using DNA microarray technology analyzing 35 345 gene-level probe-sets, we identified 335 annotated probe-sets that were downregulated, and 315 that were upregulated after bed rest (P < .01). Besides a predictable differential expression of genes and pathways related to mitochondria (downregulation; false-discovery rates (FDR) <1E-04), ubiquitin system (upregulation; FDR = 3E-02), and skeletal muscle energy metabolism and structure (downregulation; FDR <= 3E-03), 84-day bed rest also altered circadian rhythm regulation (upregulation; FDR = 3E-02). While most of the bed rest-induced changes were counteracted by RE, 209 transcripts were resilient to the exercise countermeasure. Genes upregulated after bed rest were particularly resistant to training (P < .001 vs downregulated, non-reversed genes). Specifically, "Translation Factors," "Proteasome Degradation," "Cell Cycle," and "Nucleotide Metabolism" pathways were not normalized by RE. This study provides an unbiased high-throughput transcriptomic signature of one of the longest unloading periods in humans to date. Classical disuse-related changes in structural and metabolic genes/pathways were identified, together with a novel upregulation of circadian rhythm transcripts. In the context of previous bed rest campaigns, the latter seemed to be related to the duration of unloading, suggesting the transcriptomic machinery continues to adapt throughout extended disuse periods. Despite that the RE training offset most of the bed rest-induced muscle-phenotypic and transcriptomic alterations, we contend that the human skeletal muscle also displays a residual transcriptomic signature of unloading that is resistant to an established exercise countermeasure.	[Fernandez-Gonzalo, Rodrigo; Lundberg, Tommy R.; Rullman, Eric; Gustafsson, Thomas] Karolinska Inst, Dept Lab Med, Div Clin Physiol, Alfred Nobels Alle 8, S-14152 Stockholm, Sweden; [Fernandez-Gonzalo, Rodrigo; Lundberg, Tommy R.; Rullman, Eric; Gustafsson, Thomas] Karolinska Univ Hosp, Unit Clin Physiol, Stockholm, Sweden; [Tesch, Per A.] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; [Alkner, Bjorn A.] Reg Jonkoping Cty, Dept Orthopaed, Eksjo, Sweden; [Alkner, Bjorn A.] Linkoping Univ, Dept Biomed & Clin Sci, Linkoping, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Linkoping University	Fernandez-Gonzalo, R (corresponding author), Karolinska Inst, Dept Lab Med, Div Clin Physiol, Alfred Nobels Alle 8, S-14152 Stockholm, Sweden.; Fernandez-Gonzalo, R (corresponding author), Karolinska Univ Hosp, ANA Futura, Unit Clin Physiol, Alfred Nobels Alle 8, S-14152 Stockholm, Sweden.	rodrigo.gonzalo@ki.se	Alkner, Björn/AHC-5835-2022; Lundberg, Tommy/AAV-6205-2020	Lundberg, Tommy/0000-0002-6818-6230; Fernandez-Gonzalo, Rodrigo/0000-0003-2816-9855	Swedish National Space Agency; European Space Agency (ESA); Swedish National Center for Research in Sports	Swedish National Space Agency; European Space Agency (ESA)(European Space Agency); Swedish National Center for Research in Sports	Swedish National Space Agency; European Space Agency (ESA); Swedish National Center for Research in Sports	ADAMS GR, 1994, AVIAT SPACE ENVIR MD, V65, P1116; Alibegovic AC, 2010, AM J PHYSIOL-ENDOC M, V299, pE752, DOI 10.1152/ajpendo.00590.2009; Alkner BA, 2004, EUR J APPL PHYSIOL, V93, P294, DOI 10.1007/s00421-004-1172-8; Bengtsson H., 2008, 745 U CAL DEP STAT; Berg HE, 1997, J APPL PHYSIOL, V82, P182, DOI 10.1152/jappl.1997.82.1.182; Beyfuss K, 2018, REDOX REP, V23, P100, DOI 10.1080/13510002.2017.1416773; Bostrom J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188772; CAPRI A, 2004, J GRAVIT PHYSL, V11, P83; Chen YW, 2007, PHYSIOL GENOMICS, V31, P510, DOI 10.1152/physiolgenomics.00115.2006; Chopard A, 2009, PHYSIOL GENOMICS, V38, P291, DOI 10.1152/physiolgenomics.00036.2009; Cotter JA, 2015, MED SCI SPORT EXER, V47, P990, DOI 10.1249/MSS.0000000000000483; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Damas F, 2018, EUR J APPL PHYSIOL, V118, P2607, DOI 10.1007/s00421-018-3984-y; ESA-CNES-NASDA, 2003, FIN REP SIM MISS AB; Gabriel BM, 2019, NAT REV ENDOCRINOL, V15, P197, DOI 10.1038/s41574-018-0150-x; Gallagher P, 2005, ACTA PHYSIOL SCAND, V185, P61, DOI 10.1111/j.1365-201X.2005.01457.x; Gustafsson T, 2005, J APPL PHYSIOL, V98, P2137, DOI 10.1152/japplphysiol.01402.2004; Hans JM, 2007, AM J PHYSIOL-REG I, V293, pR1722, DOI 10.1152/ajpregu.00292.2007; HATHER BM, 1992, J APPL PHYSIOL, V72, P1493, DOI 10.1152/jappl.1992.72.4.1493; Irimia JM, 2017, J APPL PHYSIOL, V122, P96, DOI 10.1152/japplphysiol.00521.2016; Jones SW, 2004, FASEB J, V18, P1025, DOI 10.1096/fj.03-1228fje; Kandasamy K, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r3; Kim J, 2017, J EXERC REHABIL, V13, P621, DOI 10.12965/jer.1735072.536; Kivela R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13124; Krijthe JH, 2015, T DISTRIBUTED STOCHA; Urso M, 2006, J APPL PHYSIOL, V101, P1136, DOI 10.1152/japplphysiol.00180.2006; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lundberg TR, 2014, ACTA PHYSIOL, V212, P142, DOI 10.1111/apha.12310; Mahmassani ZS, 2019, J APPL PHYSIOL, V126, P894, DOI 10.1152/japplphysiol.00811.2018; Nakao R, 2015, CHRONOBIOL INT, V32, P486, DOI 10.3109/07420528.2014.1003350; Nielsen RO, 2015, MLTJ-MUSCLE LIGAMENT, V5, P305, DOI 10.11138/mltj/2015.5.4.305; Ogawa T, 2006, MUSCLE NERVE, V34, P463, DOI 10.1002/mus.20611; Perrin L, 2018, ELIFE, V7, DOI 10.7554/eLife.34114; Phillips SM, 2014, J PHYSIOL-LONDON, V592, P5341, DOI 10.1113/jphysiol.2014.273615; Ramakrishnan S. N., 2006, NUCL RECEPT SIGNALIN, V4, pe009; Raue U, 2012, J APPL PHYSIOL, V112, P1625, DOI 10.1152/japplphysiol.00435.2011; Reeves ND, 2005, J APPL PHYSIOL, V98, P2278, DOI 10.1152/japplphysiol.01266.2004; Reid MB, 2014, J PHYSIOL-LONDON, V592, P5345, DOI 10.1113/jphysiol.2014.279406; Rittweger J, 2005, BONE, V36, P1019, DOI 10.1016/j.bone.2004.11.014; Rittweger J, 2007, EUR J APPL PHYSIOL, V100, P427, DOI 10.1007/s00421-007-0443-6; Rullman E, 2018, AM J PHYSIOL-REG I, V315, pR799, DOI 10.1152/ajpregu.00452.2017; Rullman E, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12753; Safikhani Z, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01153-8; Salanova M, 2015, SCI REP-UK, V5, DOI 10.1038/srep17027; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Schroder EA, 2013, EXERC SPORT SCI REV, V41, P224, DOI 10.1097/JES.0b013e3182a58a70; Shavlakadze T, 2013, AM J PHYSIOL-CELL PH, V305, pC26, DOI 10.1152/ajpcell.00027.2013; Slenter DN, 2018, NUCLEIC ACIDS RES, V46, pD661, DOI 10.1093/nar/gkx1064; Stuart CA, 2016, AM J PHYSIOL-CELL PH, V310, pC381, DOI 10.1152/ajpcell.00317.2015; Tesch PA, 2008, J APPL PHYSIOL, V105, P902, DOI 10.1152/japplphysiol.90558.2008; Trappe S, 2007, J APPL PHYSIOL, V103, P1242, DOI 10.1152/japplphysiol.00560.2007; Trappe Scott, 2002, J Gravit Physiol, V9, pP323; Trappe S, 2009, J APPL PHYSIOL, V106, P1159, DOI 10.1152/japplphysiol.91578.2008; Tsika RW, 2008, J BIOL CHEM, V283, P36154, DOI 10.1074/jbc.M807461200; van der Maaten L, 2014, J MACH LEARN RES, V15, P3221; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Vernikos J, 2010, GERONTOLOGY, V56, P157, DOI 10.1159/000252852; Watanabe Y, 2004, J BONE MINER RES, V19, P1771, DOI 10.1359/JBMR.040811; Wolff G, 2012, MED SCI SPORT EXER, V44, P1663, DOI 10.1249/MSS.0b013e318255cf4c; Wu H, 2000, EMBO J, V19, P1963, DOI 10.1093/emboj/19.9.1963; Zambon AC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r61	61	20	21	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					7958	7969		10.1096/fj.201902976R	http://dx.doi.org/10.1096/fj.201902976R		APR 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32293758	hybrid, Green Published			2022-12-28	WOS:000526103900001
J	Zhang, WW; Xie, RQ; Zhang, XD; Lee, LTO; Zhang, HJ; Yang, MH; Peng, B; Zheng, J				Zhang, Wenwen; Xie, Ruiqiang; Zhang, Xiaohua Douglas; Lee, Leo Tsz On; Zhang, Hongjie; Yang, Menghua; Peng, Bo; Zheng, Jun			Organism dual RNA-seq reveals the importance of BarA/UvrY in Vibrio parahaemolyticus virulence	FASEB JOURNAL			English	Article						C; elegans; organism dual RNA-Seq; BarA; UvrY; V; parahaemolyticus; virulence factor	III SECRETION SYSTEMS; CAENORHABDITIS-ELEGANS; C. ELEGANS; FUNCTIONAL-CHARACTERIZATION; SALMONELLA-TYPHIMURIUM; 2-COMPONENT SYSTEM; PROTEIN; HOST; INFECTION; PATHOGEN	Elucidation of host-pathogen interaction is essential for developing effective strategies to combat bacterial infection. Dual RNA-Seq using cultured cells or tissues/organs as the host of pathogen has emerged as a novel strategy to understand the responses concurrently from both pathogen and host at cellular level. However, bacterial infection mostly causes systematic responses from the host at organism level where the interplay is urgently to be understood but inevitably being neglected by the current practice. Here, we developed an approach that simultaneously monitor the genome-wide infection-linked transcriptional alterations in both pathogenic Vibrio parahaemolyticus and the infection host nematode Caenorhabditis elegans. Besides the dynamic alterations in transcriptomes of both C. elegans and V. parahaemolyticus during infection, we identify a two-component system, BarA/UvrY, that is important for virulence in host. BarA/UvrY not only controls the virulence factors in V. parahaemolyticus including Type III and Type VI secretion systems, but also attenuates innate immune responses in C. elegans, including repression on the MAP kinase-mediated cascades. Thus, our study exemplifies the use of dual RNA-Seq at organism level to uncover previously unrecognized interplay between host and pathogen.	[Zhang, Wenwen; Xie, Ruiqiang; Zhang, Xiaohua Douglas; Lee, Leo Tsz On; Zhang, Hongjie; Zheng, Jun] Univ Macau, Fac Hlth Sci, Macau, Peoples R China; [Yang, Menghua] Zhejiang A&F Univ, Coll Anim Sci & Technol, Key Lab Appl Technol Green Ecohlth Anim Husb Zhej, Hangzhou, Peoples R China; [Peng, Bo] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China; [Peng, Bo] Sun Yat Sen Univ, Sch Life Sci, Guangzhou, Peoples R China; [Zheng, Jun] Univ Macau, Inst Translat Med, Macau, Peoples R China	University of Macau; Zhejiang A&F University; Qingdao National Laboratory for Marine Science & Technology; Sun Yat Sen University; University of Macau	Zheng, J (corresponding author), Univ Macau, Fac Hlth Sci, Macau, Peoples R China.	Junzheng@um.edu.mo	Zheng, Jun/AAN-4698-2020	Zheng, Jun/0000-0001-6329-4518	Research Committee of the University of Macau [MYRG2016-00073-FHS, MYRG2016-00199-FHS, MYRG2019-000050-FHS]; Macau Science and Technology Development Fund [FDCT/066/2015/A2, FDCT/0058/2018/A2, FDCT/0113/2019/A2]; NIH Office of Research Infrastructure Programs [P40 OD010440]	Research Committee of the University of Macau; Macau Science and Technology Development Fund; NIH Office of Research Infrastructure Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Prof. Garry Wong from Faculty of Health Sciences, University of Macau, for his critical review and comments. We acknowledge the Research Committee of the University of Macau (Grant No.: MYRG2016-00073-FHS, MYRG2016-00199-FHS and MYRG2019-000050-FHS) and the Macau Science and Technology Development Fund (Grant No.: FDCT/066/2015/A2, FDCT/0058/2018/A2 and FDCT/0113/2019/A2) for providing financial support for this research. Some strains of C. elegans were provided by the CGC, which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440).	Aagesen AM, 2013, APPL ENVIRON MICROB, V79, P3303, DOI 10.1128/AEM.00314-13; Aballay A, 2000, CURR BIOL, V10, P1539, DOI 10.1016/S0960-9822(00)00830-7; Alegado RA, 2008, CELL MICROBIOL, V10, P1259, DOI 10.1111/j.1462-5822.2008.01124.x; Alper S, 2007, MOL CELL BIOL, V27, P5544, DOI 10.1128/MCB.02070-06; Alteri CJ, 2012, MBIO, V3, DOI 10.1128/mBio.00365-12; Aprianto R, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1054-5; Babitzke P, 2007, CURR OPIN MICROBIOL, V10, P156, DOI 10.1016/j.mib.2007.03.007; Baddal B, 2015, MBIO, V6, DOI 10.1128/mBio.01765-15; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Burdette DL, 2008, P NATL ACAD SCI USA, V105, P12497, DOI 10.1073/pnas.0802773105; Cambi A, 2009, CURR BIOL, V19, pR375, DOI 10.1016/j.cub.2009.03.032; Cheesman HK, 2016, G3-GENES GENOM GENET, V6, P541, DOI 10.1534/g3.115.025650; Cloney R, 2016, NAT REV GENET, V17, DOI 10.1038/nrg.2016.15; Damron FH, 2016, SCI REP-UK, V6, DOI 10.1038/srep39172; Dhakal BK, 2006, BIOCHEM BIOPH RES CO, V346, P751, DOI 10.1016/j.bbrc.2006.05.168; Dorman MJ, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02686; Durai S, 2011, J MICROBIOL BIOTECHN, V21, P1026, DOI 10.4014/jmb.1102.02006; Ermolaeva Maria, 2013, Commun Integr Biol, V6, pe26926, DOI 10.4161/cib.26926; Ermolaeva MA, 2014, SEMIN IMMUNOL, V26, P303, DOI 10.1016/j.smim.2014.04.005; Evans EA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000175; Fan XC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn535; Feng LH, 2015, CELL, V160, P228, DOI 10.1016/j.cell.2014.11.051; Finn R, 2014, FEMS MICROBIOL LETT, V350, P65, DOI 10.1111/1574-6968.12323; Fletcher M, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1007830; Flotho A, 2013, ANNU REV BIOCHEM, V82, P357, DOI 10.1146/annurev-biochem-061909-093311; Gooderham WJ, 2009, FEMS MICROBIOL REV, V33, P279, DOI 10.1111/j.1574-6976.2008.00135.x; Heeb S, 2001, MOL PLANT MICROBE IN, V14, P1351, DOI 10.1094/MPMI.2001.14.12.1351; Hensel M, 1999, MOL MICROBIOL, V32, P275, DOI 10.1046/j.1365-2958.1999.01345.x; Huang LX, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00619; Jaskolska M, 2018, NUCLEIC ACIDS RES, V46, P10619, DOI 10.1093/nar/gky717; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; KISHISHITA M, 1992, APPL ENVIRON MICROB, V58, P2449, DOI 10.1128/AEM.58.8.2449-2457.1992; Krachler AM, 2011, J BIOL CHEM, V286, P38939, DOI 10.1074/jbc.M111.291377; Kuehn MJ, 2005, GENE DEV, V19, P2645, DOI 10.1101/gad.1299905; Kulkarni PR, 2006, NUCLEIC ACIDS RES, V34, P3361, DOI 10.1093/nar/gkl439; Letchumanan V, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00705; Liberati NT, 2004, P NATL ACAD SCI USA, V101, P6593, DOI 10.1073/pnas.0308625101; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lublin AL, 2007, DEV BIOL, V303, P635, DOI 10.1016/j.ydbio.2006.12.004; Matlawska-Wasowska K, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-329; Mey AR, 2015, MBIO, V6, DOI 10.1128/mBio.01064-15; Moy TI, 2006, P NATL ACAD SCI USA, V103, P10414, DOI 10.1073/pnas.0604055103; O'Rourke D, 2006, GENOME RES, V16, P1005, DOI 10.1101/gr.50823006; Pan XL, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00083; Papenfort K, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00091; Park KS, 2004, INFECT IMMUN, V72, P6659, DOI 10.1128/IAI.72.11.6659-6665.2004; Peleg AY, 2008, P NATL ACAD SCI USA, V105, P14585, DOI 10.1073/pnas.0805048105; Philippe N, 2004, PLASMID, V51, P246, DOI 10.1016/j.plasmid.2004.02.003; Raghunath P, 2015, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00805; Romeo T, 2013, ENVIRON MICROBIOL, V15, P313, DOI 10.1111/j.1462-2920.2012.02794.x; Saliba AE, 2017, CURR OPIN MICROBIOL, V35, P78, DOI 10.1016/j.mib.2017.01.001; Salomon D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061086; Sawabe T, 2006, LETT APPL MICROBIOL, V43, P514, DOI 10.1111/j.1472-765X.2006.01992.x; Shimohata T, 2010, J MED INVESTIG, V57, P179, DOI 10.2152/jmi.57.179; Song T, 2008, MOL MICROBIOL, V70, P100, DOI 10.1111/j.1365-2958.2008.06392.x; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Stewart BJ, 2003, J BACTERIOL, V185, P4508, DOI 10.1128/JB.185.15.4508-4518.2003; Subramanian G, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006877; Surana P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186622; Tabara H, 1999, DEVELOPMENT, V126, P1; Tissenbaum HA, 2012, J GERONTOL A-BIOL, V67, P503, DOI 10.1093/gerona/gls088; Trosky JE, 2004, J BIOL CHEM, V279, P51953, DOI 10.1074/jbc.M407001200; Urano F, 2002, J CELL BIOL, V158, P639, DOI 10.1083/jcb.200203086; Vaitkevicius K, 2006, P NATL ACAD SCI USA, V103, P9280, DOI 10.1073/pnas.0601754103; Westermann AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006033; Westermann AJ, 2016, NATURE, V529, P496, DOI 10.1038/nature16547; Westermann AJ, 2012, NAT REV MICROBIOL, V10, P618, DOI 10.1038/nrmicro2852; Wingett Steven W, 2018, F1000Res, V7, P1338, DOI 10.12688/f1000research.15931.2; Winter SE, 2010, NATURE, V467, P426, DOI 10.1038/nature09415; Wolf T, 2018, CURR OPIN MICROBIOL, V42, P7, DOI 10.1016/j.mib.2017.09.001; Yanagihara I, 2010, J BIOL CHEM, V285, P16267, DOI 10.1074/jbc.M109.074526; Yu Y, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00168; Zhang LL, 2013, CURR OPIN MICROBIOL, V16, P70, DOI 10.1016/j.mib.2013.02.002; Zhang LL, 2012, CELL REP, V1, P453, DOI 10.1016/j.celrep.2012.04.004; Zhang QH, 2016, DEV COMP IMMUNOL, V55, P159, DOI 10.1016/j.dci.2015.10.021; Zhang RY, 2017, Q REV BIOPHYS, V50, DOI 10.1017/S0033583517000075; Zheng J, 2005, INFECT IMMUN, V73, P4127, DOI 10.1128/IAI.73.7.4127-4137.2005; Zhou XH, 2013, CELL REP, V3, P1690, DOI 10.1016/j.celrep.2013.03.039	80	5	5	17	32	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					7561	7577		10.1096/fj.201902630R	http://dx.doi.org/10.1096/fj.201902630R		APR 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32281204				2022-12-28	WOS:000526117700001
J	Berner, DK; Wessolowski, L; Armbrust, F; Schneppenheim, J; Schlepckow, K; Koudelka, T; Scharfenberg, F; Lucius, R; Tholey, A; Kleinberger, G; Haass, C; Arnold, P; Becker-Pauly, C				Berner, Dennis Kristopher; Wessolowski, Luisa; Armbrust, Fred; Schneppenheim, Janna; Schlepckow, Kai; Koudelka, Tomas; Scharfenberg, Franka; Lucius, Ralph; Tholey, Andreas; Kleinberger, Gernot; Haass, Christian; Arnold, Philipp; Becker-Pauly, Christoph			Meprin beta cleaves TREM2 and controls its phagocytic activity on macrophages	FASEB JOURNAL			English	Article						ADAM10; Alzheimer's disease; cell surface protein; meprin beta; metalloprotease; phagocytosis; protein-protein interaction; TREM2	MYELOID CELLS-2 TREM2; METALLOPROTEASE MEPRIN; ALZHEIMERS-DISEASE; INFLAMMATORY RESPONSES; ALPHA-SUBUNIT; AMYLOID-BETA; ECTODOMAIN; MICROGLIA; RECEPTOR; VARIANTS	The triggering receptor expressed on myeloid cells 2 (TREM2) is a multifunctional surface protein that affects survival, migration, and phagocytic capacity of myeloid cells. Soluble TREM2 levels were found to be increased in early stages of sporadic and familial Alzheimer's disease (AD) probably reflecting a defensive microglial response to some initial brain damage. The disintegrin and metalloproteases (ADAM) 10 and 17 were identified as TREM2 sheddases. We demonstrate that meprin beta is a direct TREM2 cleaving enzyme using ADAM10/17 deficient HEK293 cells. LC-MS/MS analysis of recombinant TREM2 incubated with meprin beta revealed predominant cleavage between Arg136 and Asp137, distant to the site identified for ADAM10/17. We further demonstrate that the metalloprotease meprin beta cleaves TREM2 on macrophages concomitant with decreased levels of soluble TREM2 in the serum of Mep1b(-/-) mice compared to WT controls. Isolated BMDMs from Mep1b(-/-) mice showed significantly increased full-length TREM2 levels and enhanced phagocytosis efficiency compared to WT cells. The diminished constitutive shedding of TREM2 on meprin beta deficient macrophages could be rescued by ADAM stimulation through LPS treatment. Our data provide evidence that meprin beta is a TREM2 sheddase on macrophages and suggest that multiple proteases may be involved in the generation of soluble TREM2.	[Berner, Dennis Kristopher; Wessolowski, Luisa; Armbrust, Fred; Scharfenberg, Franka; Becker-Pauly, Christoph] Univ Kiel, Biochem Inst, Unit Degrad Protease Web, Kiel, Germany; [Schneppenheim, Janna; Lucius, Ralph; Arnold, Philipp] Univ Kiel, Anat Inst, Kiel, Germany; [Schlepckow, Kai; Haass, Christian] German Ctr Neurodegenerat Dis DZNE, Munich, Germany; [Koudelka, Tomas; Tholey, Andreas] Univ Kiel, Inst Expt Med, Systemat Prote & Bioanalyt, Kiel, Germany; [Kleinberger, Gernot; Haass, Christian] Ludwig Maximilians Univ Munchen, Biomed Ctr, Biochem, Munich, Germany; [Kleinberger, Gernot; Haass, Christian] Munich Cluster Syst Neurol, Munich, Germany	University of Kiel; University of Kiel; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Kiel; University of Munich	Becker-Pauly, C (corresponding author), Christian Albrechts Univ Kiel, Unit Degrad Protease Web, Biochem Inst, Otto Hahn Pl 9, D-24118 Kiel, Germany.	cbeckerpauly@biochem.uni-kiel.de	Becker-Pauly, Christoph/B-7569-2011; Scharfenberg, Franka/AAS-9798-2021		Deutsche Forschungsgemeinschaft (DFG) [125440785 SFB877 A9/A15, 125440785 SFB877 Z2, 125440785 SFB877 A13, BE 4086/2-2, EXC 1010 SyNergy, HA1737/16-1, FOR2290]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: 125440785 SFB877 A9/A15, 125440785 SFB877 Z2, 125440785 SFB877 A13, BE 4086/2-2, EXC 1010 SyNergy, HA1737/16-1 and FOR2290	Arnold P, 2017, SCI REP-UK, V7, DOI 10.1038/srep44053; Becker C, 2003, BIOL CHEM, V384, P825, DOI 10.1515/BC.2003.092; Becker-Pauly C, 2007, J INVEST DERMATOL, V127, P1115, DOI 10.1038/sj.jid.5700675; Becker-Pauly C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009233; Bedau T, 2017, ONCOTARGET, V8, P54873, DOI 10.18632/oncotarget.18966; Bedau T, 2017, FASEB J, V31, P1226, DOI 10.1096/fj.201601113R; Bien J, 2012, J BIOL CHEM, V287, P33304, DOI 10.1074/jbc.M112.395608; Broder C, 2013, BIOCHEM J, V450, P253, DOI 10.1042/BJ20121751; Charles JF, 2008, INFECT IMMUN, V76, P2439, DOI 10.1128/IAI.00115-08; Colonna M, 2016, NAT REV NEUROSCI, V17, P201, DOI 10.1038/nrn.2016.7; Crisman JM, 2004, J IMMUNOL, V172, P4510, DOI 10.4049/jimmunol.172.7.4510; Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668; Daws MR, 2003, J IMMUNOL, V171, P594, DOI 10.4049/jimmunol.171.2.594; Feuerbach D, 2017, NEUROSCI LETT, V660, P109, DOI 10.1016/j.neulet.2017.09.034; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Hahn D, 2003, J BIOL CHEM, V278, P42829, DOI 10.1074/jbc.M211169200; Herzog Christian, 2016, Biochem Biophys Rep, V8, P146, DOI 10.1016/j.bbrep.2016.08.019; Jay TR, 2015, J EXP MED, V212, P287, DOI 10.1084/jem.20142322; Jefferson T, 2013, CELL MOL LIFE SCI, V70, P309, DOI 10.1007/s00018-012-1106-2; Jiang T, 2016, NEUROBIOL AGING, V42, DOI 10.1016/j.neurobiolaging.2016.02.023; Jin SC, 2014, HUM MOL GENET, V23, P5838, DOI 10.1093/hmg/ddu277; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Keiffer TR, 2014, J BIOL CHEM, V289, P7580, DOI 10.1074/jbc.M113.546309; Kleinberger G, 2017, EMBO J, V36, P1837, DOI 10.15252/embj.201796516; Kleinberger G, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009093; Li YJ, 2014, INT IMMUNOPHARMACOL, V18, P77, DOI 10.1016/j.intimp.2013.11.004; N'Diaye EN, 2009, J CELL BIOL, V184, P215, DOI 10.1083/jcb.200808080; Norman LP, 2003, MOL CELL BIOL, V23, P1221, DOI 10.1128/MCB.23.4.1221-1230.2003; Parhizkar S, 2019, NAT NEUROSCI, V22, P191, DOI 10.1038/s41593-018-0296-9; Riethmueller S, 2016, SCI REP-UK, V6, DOI 10.1038/srep25550; Schlepckow K, 2017, EMBO MOL MED, V9, P1356, DOI 10.15252/emmm.201707672; Schonherr C, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0084-5; Schutte A, 2014, P NATL ACAD SCI USA, V111, P12396, DOI 10.1073/pnas.1407597111; Sirkis DW, 2017, MOL BIOL CELL, V28, P2723, DOI 10.1091/mbc.E17-06-0423; Suarez-Calvet M, 2016, EMBO MOL MED, V8, P466, DOI 10.15252/emmm.201506123; Thornton P, 2017, EMBO MOL MED, V9, P1366, DOI 10.15252/emmm.201707673; Ulland TK, 2018, NAT REV NEUROL, V14, P667, DOI 10.1038/s41582-018-0072-1; Vazeille E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021199; Wichert R, 2017, CELL REP, V21, P2090, DOI 10.1016/j.celrep.2017.10.087; Wu K, 2015, J EXP MED, V212, P681, DOI 10.1084/jem.20141732; Wunderlich P, 2013, J BIOL CHEM, V288, P33027, DOI 10.1074/jbc.M113.517540; Xiang XY, 2016, EMBO MOL MED, V8, P992, DOI 10.15252/emmm.201606370; Yeh FL, 2017, TRENDS MOL MED, V23, P512, DOI 10.1016/j.molmed.2017.03.008; Yeh FL, 2016, NEURON, V91, P328, DOI 10.1016/j.neuron.2016.06.015; Zhao YJ, 2018, NEURON, V97, P1023, DOI 10.1016/j.neuron.2018.01.031; Zhao YH, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00140; Zhong L, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00204; Zhong L, 2017, J EXP MED, V214, P597, DOI 10.1084/jem.20160844; Zhong L, 2015, J BIOL CHEM, V290, P15866, DOI 10.1074/jbc.M115.645986	49	13	13	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6675	6687		10.1096/fj.201902183R	http://dx.doi.org/10.1096/fj.201902183R		APR 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32237095	hybrid			2022-12-28	WOS:000522967100001
J	Acosta-Iborra, B; Tiana, M; Maeso-Alonso, L; Hernandez-Sierra, R; Herranz, G; Santamaria, A; Rey, C; Luna, R; Puente-Santamaria, L; Marques, MM; Marin, MC; del Peso, L; Jimenez, B				Acosta-Iborra, Barbara; Tiana, Maria; Maeso-Alonso, Laura; Hernandez-Sierra, Rosana; Herranz, Gonzalo; Santamaria, Andrea; Rey, Carlos; Luna, Raquel; Puente-Santamaria, Laura; Marques, Margarita M.; Marin, Maria C.; del Peso, Luis; Jimenez, Benilde			Hypoxia compensates cell cycle arrest with progenitor differentiation during angiogenesis	FASEB JOURNAL			English	Article						angiogenesis; embryoid bodies; endothelial proliferation; hypoxia; stem cells	PAS DOMAIN PROTEIN-1; INDUCIBLE FACTORS; TRANSCRIPTION FACTOR; ENDOTHELIAL-CELLS; GENE-EXPRESSION; PROLIFERATION; HIF-2-ALPHA; HIF-1-ALPHA; HIF; GROWTH	Angiogenesis, the main mechanism that allows vascular expansion for tissue regeneration or disease progression, is often triggered by an imbalance between oxygen consumption and demand. Here, by analyzing changes in the transcriptomic profile of endothelial cells (ECs) under hypoxia we uncovered that the repression of cell cycle entry and DNA replication stand as central responses in the early adaptation of ECs to low oxygen tension. Accordingly, hypoxia imposed a restriction in S-phase in ECs that is mediated by Hypoxia-Inducible Factors. Our results indicate that the induction of angiogenesis by hypoxia in Embryoid Bodies generated from murine Stem Cells is accomplished by the compensation of decreased S-phase entry in mature ECs and differentiation of progenitor cells. This conditioning most likely allows an optimum remodeling of the vascular network. Identification of the molecular underpinnings of cell cycle arrest by hypoxia would be relevant for the design of improved strategies aimed to suppress angiogenesis in pathological contexts where hypoxia is a driver of neovascularization.	[Acosta-Iborra, Barbara; Tiana, Maria; Hernandez-Sierra, Rosana; Herranz, Gonzalo; Santamaria, Andrea; Rey, Carlos; Luna, Raquel; Puente-Santamaria, Laura; del Peso, Luis; Jimenez, Benilde] Univ Autonoma Madrid, Inst Invest Biomed Alberto Sols CSIC UAM, Dept Bioquim, C Arturo Duperier 4, Madrid 28029, Spain; [Tiana, Maria; del Peso, Luis; Jimenez, Benilde] Hosp Univ La Paz, IdiPaz, Inst Invest Sanitaria, Madrid, Spain; [Tiana, Maria; del Peso, Luis; Jimenez, Benilde] Inst Salud Carlos III, CIBER Enfermedades Resp CIBERES, Madrid, Spain; [Maeso-Alonso, Laura; Marin, Maria C.] Univ Leon, Inst Biomed, Dept Biol Mol, Lab Diferenciac Celular & Diseno Modelos Celulare, Leon, Spain; [Marques, Margarita M.] Univ Leon, Inst Desarrollo Ganadero & Sanidad Anim, Dept Prod Anim, Lab Diferenciac Celular & Diseno Modelos Celulare, Leon, Spain; [Tiana, Maria] CNIC, Madrid, Spain; [Herranz, Gonzalo; Rey, Carlos] Ctr Biol Mol Severo Ochoa CSIC UAM, Madrid, Spain; [Luna, Raquel] Evotec France SAS, Toulouse, France	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Hospital Universitario La Paz; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; Universidad de Leon; Universidad de Leon; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Evotec	Jimenez, B (corresponding author), Univ Autonoma Madrid, Inst Invest Biomed Alberto Sols CSIC UAM, Dept Bioquim, C Arturo Duperier 4, Madrid 28029, Spain.	bjimenez@iib.uam.es	rey, carlos/Y-9185-2019; tiana, maria/G-4240-2016; Puente-Santamaria, Laura/GWM-4342-2022; Puente-Santamaria, Laura/AFV-5649-2022; del Peso, Luis/K-9391-2014; Maeso-Alonso, Laura/AAH-2571-2021; Cuenca, Benilde Jimenez/K-9959-2014; Tiana, María/AAA-1868-2020; Acosta-Iborra, Barbara/L-5570-2013	tiana, maria/0000-0003-0678-1154; Puente-Santamaria, Laura/0000-0001-9034-4576; Puente-Santamaria, Laura/0000-0001-9034-4576; del Peso, Luis/0000-0003-4014-5688; Tiana, María/0000-0003-0678-1154; Acosta-Iborra, Barbara/0000-0002-1517-114X; Rey Serra, Carlos/0000-0001-7635-0056; Jimenez Cuenca, Benilde/0000-0002-1806-6636; Maeso Alonso, Laura/0000-0001-7805-3792	Ministerio de Ciencia e Innovacion (MICINN) [SAF2014-53819-R, SAF2017-88771R, SAF2015-71381-R]; Consejeria de Educacion, Junta de Castilla y Leon (Ministry of Education, Government of Castile-Leon) [LE021P17]	Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Consejeria de Educacion, Junta de Castilla y Leon (Ministry of Education, Government of Castile-Leon)	Ministerio de Ciencia e Innovacion (MICINN), Grant/Award Number: SAF2014-53819-R, SAF2017-88771R and SAF2015-71381-R; Consejeria de Educacion, Junta de Castilla y Leon (Ministry of Education, Government of Castile-Leon), Grant/Award Number: LE021P17	Batie M, 2018, BIOMEDICINES, V6, DOI 10.3390/biomedicines6020047; Betsholtz C, 2016, NATURE, V529, P160, DOI 10.1038/nature16866; Biswas S, 2010, P NATL ACAD SCI USA, V107, P6976, DOI 10.1073/pnas.1001653107; Bunce C, 2016, CURR TOP DEV BIOL, V116, P153, DOI 10.1016/bs.ctdb.2015.10.001; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Casazza A, 2014, ONCOGENE, V33, P1743, DOI 10.1038/onc.2013.121; Centanin L, 2008, DEV CELL, V14, P547, DOI 10.1016/j.devcel.2008.01.020; Choudhry H, 2018, CELL METAB, V27, P281, DOI 10.1016/j.cmet.2017.10.005; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Draoui N, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170219; Ema M, 1997, P NATL ACAD SCI USA, V94, P4273, DOI 10.1073/pnas.94.9.4273; Fernandez-Alonso R, 2015, CELL DEATH DIFFER, V22, P1287, DOI 10.1038/cdd.2014.214; Fernandez-Barral A, 2014, NEOPLASIA, V16, P529, DOI 10.1016/j.neo.2014.06.001; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; Gardner LB, 2001, J BIOL CHEM, V276, P7919, DOI 10.1074/jbc.M010189200; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Germain S, 2010, CURR OPIN HEMATOL, V17, P245, DOI 10.1097/MOH.0b013e32833865b9; Goda N, 2003, MOL CELL BIOL, V23, P359, DOI 10.1128/MCB.23.1.359-369.2003; Gordan JD, 2007, CANCER CELL, V11, P335, DOI 10.1016/j.ccr.2007.02.006; Hogenesch JB, 1997, J BIOL CHEM, V272, P8581, DOI 10.1074/jbc.272.13.8581; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Huang H, 2017, EMBO J, V36, P2334, DOI 10.15252/embj.201695518; Hubbi ME, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003417; Humar R, 2002, FASEB J, V16, DOI 10.1096/fj.01-0658com; Jain RK, 2014, CANCER CELL, V26, P605, DOI 10.1016/j.ccell.2014.10.006; Jakobsson L, 2007, J CELL BIOL, V177, P751, DOI 10.1083/jcb.200701146; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kearney JB, 2002, BLOOD, V99, P2397, DOI 10.1182/blood.V99.7.2397; Koh MY, 2012, TRENDS BIOCHEM SCI, V37, P364, DOI 10.1016/j.tibs.2012.06.004; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Koshiji M, 2004, EMBO J, V23, P1949, DOI 10.1038/sj.emboj.7600196; KUEHN MR, 1987, NATURE, V326, P295, DOI 10.1038/326295a0; Kusumbe AP, 2014, NATURE, V507, P323, DOI 10.1038/nature13145; Lee SW, 2012, EMBO MOL MED, V4, P924, DOI 10.1002/emmm.201101107; Lim SH, 2013, DEVELOPMENT, V140, P3079, DOI 10.1242/dev.091744; Martin-Lopez M, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.432; Mazzone M, 2009, CELL, V136, P839, DOI 10.1016/j.cell.2009.01.020; Ning W, 2004, PHYSIOL GENOMICS, V18, P70, DOI 10.1152/physiolgenomics.00221.2003; Noguera-Troise I, 2006, NATURE, V444, P1032, DOI 10.1038/nature05355; Oladipupo SS, 2011, BLOOD, V117, P4142, DOI 10.1182/blood-2010-09-307538; Peters DG, 2006, PHYSIOL GENOMICS, V26, P99, DOI 10.1152/physiolgenomics.00152.2005; Pontes-Quero S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09875-7; Potente M, 2017, ANNU REV PHYSIOL, V79, P43, DOI 10.1146/annurev-physiol-021115-105134; Rey S, 2017, TRENDS CANCER, V3, P529, DOI 10.1016/j.trecan.2017.05.002; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Salama R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134645; Scheurer SB, 2004, PROTEOMICS, V4, P1737, DOI 10.1002/pmic.200300689; Schito L, 2016, TRENDS CANCER, V2, P758, DOI 10.1016/j.trecan.2016.10.016; Semenza GL, 2014, ANNU REV PATHOL-MECH, V9, P47, DOI 10.1146/annurev-pathol-012513-104720; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Serra H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8935; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Skuli N, 2012, J CLIN INVEST, V122, P1427, DOI 10.1172/JCI57322; Skuli N, 2009, BLOOD, V114, P469, DOI 10.1182/blood-2008-12-193581; Tang N, 2004, CANCER CELL, V6, P485, DOI 10.1016/j.ccr.2004.09.026; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; Tiana M, 2018, NUCLEIC ACIDS RES, V46, P120, DOI 10.1093/nar/gkx951; Torres-Capelli M, 2016, SCI REP-UK, V6, DOI 10.1038/srep25357; Tsang KM, 2017, STEM CELL REP, V9, P796, DOI 10.1016/j.stemcr.2017.07.001; Wiesener MS, 1998, BLOOD, V92, P2260, DOI 10.1182/blood.V92.7.2260.2260_2260_2268; Wilhelm K, 2016, NATURE, V529, P216, DOI 10.1038/nature16498; Wong BW, 2017, EMBO J, V36, P2187, DOI 10.15252/embj.201696150; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zudaire E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027385	64	3	3	1	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6654	6674		10.1096/fj.201903082R	http://dx.doi.org/10.1096/fj.201903082R		MAR 2020	21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32223018	Green Submitted, Bronze			2022-12-28	WOS:000522485300001
J	Chen, ZL; Haus, JM; Chen, L; Wu, SC; Urao, N; Koh, TJ; Minshall, RD				Chen, Zhenlong; Haus, Jacob M.; Chen, Lin; Wu, Stephanie C.; Urao, Norifumi; Koh, Timothy J.; Minshall, Richard D.			CCL28-induced CCR10/eNOS interaction in angiogenesis and skin wound healing	FASEB JOURNAL			English	Article						angiogenesis; CCL28; CCR10; eNOS; wound healing	NITRIC-OXIDE SYNTHASE; ENDOTHELIAL GROWTH-FACTOR; ACTIVATION; CELLS; ENOS; RECEPTOR; BINDING; CCL28; IDENTIFICATION; CONTRIBUTES	Chemokines and their receptors play important roles in vascular homeostasis, development, and angiogenesis. Little is known regarding the molecular signaling mechanisms activated by CCL28 chemokine via its primary receptor CCR10 in endothelial cells (ECs). Here, we test the hypothesis that CCL28/CCR10 signaling plays an important role in regulating skin wound angiogenesis through endothelial nitric oxide synthase (eNOS)-dependent Src, PI3K, and MAPK signaling. We observed nitric oxide (NO) production in human primary ECs stimulated with exogenous CCL28, which also induced direct binding of CCR10 and eNOS resulting in inhibition of eNOS activity. Knockdown of CCR10 with siRNA lead to reduced eNOS expression and tube formation suggesting the involvement of CCR10 in EC angiogenesis. Based on this interaction, we engineered a myristoylated 7 amino acid CCR10-binding domain (Myr-CBD7) peptide and showed that this can block eNOS interaction with CCR10, but not with calmodulin, resulting in upregulation of eNOS activity. Importantly, topical administration of Myr-CBD7 peptide on mouse dermal wounds not only blocked CCR10-eNOS interaction, but also enhanced expression of eNOS, CD31, and IL-4 with reduction of CCL28 and IL-6 levels associated with improved wound healing. These results point to a potential therapeutic strategy to upregulate NO bioavailability, enhance angiogenesis, and improve wound healing by disrupting CCL28-activated CCR10-eNOS interaction.	[Chen, Zhenlong; Minshall, Richard D.] Univ Illinois, Dept Anesthesiol, 835 S Wolcott Ave M-C 868, Chicago, IL 60612 USA; [Haus, Jacob M.; Urao, Norifumi; Koh, Timothy J.] Univ Illinois, Dept Kinesiol & Nutr, Chicago, IL USA; [Chen, Lin] Univ Illinois, Dept Periodont, Chicago, IL USA; [Chen, Lin; Urao, Norifumi; Koh, Timothy J.] Univ Illinois, Ctr Wound Healing & Tissue Regenerat, Chicago, IL USA; [Wu, Stephanie C.] Rosalind Franklin Univ Med & Sci, Dr William M Scholl Coll Podiatr Med, CLEAR, N Chicago, IL USA; [Minshall, Richard D.] Univ Illinois, Dept Pharmacol, 835 S Wolcott Ave M-C 868, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Rosalind Franklin University Medical & Science; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Chen, ZL; Minshall, RD (corresponding author), Univ Illinois, Dept Anesthesiol, 835 S Wolcott Ave M-C 868, Chicago, IL 60612 USA.; Minshall, RD (corresponding author), Univ Illinois, Dept Pharmacol, 835 S Wolcott Ave M-C 868, Chicago, IL 60612 USA.	zlchen@uic.edu; rminsh@uic.edu	Chen, Zhenlong/AAQ-9578-2021; Chen, Lin/AAW-8207-2020	Chen, Lin/0000-0001-8530-2363; Koh, Timothy/0000-0001-6549-7060	National Institutes of Health [P01 HL60678, R01 HL125356, R01 HL083298, UL1 RR029879]; American Diabetes Association [1-14-JF-32]; University of Illinois at Chicago Chancellor's Translational Research Initiative	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); University of Illinois at Chicago Chancellor's Translational Research Initiative	This work was supported in part by National Institutes of Health grants P01 HL60678, R01 HL125356 and R01 HL083298, and UL1 RR029879, American Diabetes Association grant 1-14-JF-32, and the University of Illinois at Chicago Chancellor's Translational Research Initiative. Myr-CBD peptides are protected under United States Patent and Trademark Office (USPTO) application number 62879717.	Alkaitis Matthew S, 2012, Curr Heart Fail Rep, V9, P200, DOI 10.1007/s11897-012-0097-5; Baig MS, 2015, J EXP MED, V212, P1725, DOI 10.1084/jem.20140654; Balaji S, 2015, ADV WOUND CARE, V4, P660, DOI 10.1089/wound.2014.0564; BARBUL A, 1990, SURGERY, V108, P331; Blanchet X, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00175; Bonnefoy-Berard N, 2004, BBA-MOL CELL RES, V1644, P159, DOI 10.1016/j.bbamcr.2003.10.014; BREDT DS, 1990, NATURE, V347, P768, DOI 10.1038/347768a0; Bunemann E, 2018, EUR J MED RES, V23, DOI 10.1186/s40001-017-0299-0; Cao S, 2001, J BIOL CHEM, V276, P14249, DOI 10.1074/jbc.M006258200; Chen ZL, 2018, MOL BIOL CELL, V29, P1190, DOI 10.1091/mbc.E17-01-0049; Chen ZL, 2015, ANN RHEUM DIS, V74, P1898, DOI 10.1136/annrheumdis-2013-204530; Chen Z, 2013, J IMMUNOL, V190, P5256, DOI 10.4049/jimmunol.1201675; Chen ZL, 2012, MOL BIOL CELL, V23, P1388, DOI 10.1091/mbc.E11-09-0811; Chignalia AZ, 2015, AM J PATHOL, V185, P1251, DOI 10.1016/j.ajpath.2015.01.022; Curnock AP, 2002, IMMUNOLOGY, V105, P125, DOI 10.1046/j.1365-2567.2002.01345.x; Daff S, 2010, NITRIC OXIDE-BIOL CH, V23, P1, DOI 10.1016/j.niox.2010.03.001; Facciabene A, 2011, NATURE, V475, P226, DOI 10.1038/nature10169; Fernandez A, 2001, J NATL CANCER I, V93, P208, DOI 10.1093/jnci/93.3.208; Forstermann U, 2006, CIRCULATION, V113, P1708, DOI 10.1161/CIRCULATIONAHA.105.602532; Galvez BG, 2005, J BIOL CHEM, V280, P1292, DOI 10.1074/jbc.M408673200; Garcia-Cardena G, 1998, NATURE, V392, P821, DOI 10.1038/33934; Gosain A, 2004, WORLD J SURG, V28, P321, DOI 10.1007/s00268-003-7397-6; GOSINK EC, 1993, AM J PHYSIOL, V265, pC1620, DOI 10.1152/ajpcell.1993.265.6.C1620; Heiss C, 2015, ANTIOXID REDOX SIGN, V22, P1230, DOI 10.1089/ars.2014.6158; Jayathilaka G, 2007, J BIOMOL TECH, V18, P46; Jetten N, 2014, ANGIOGENESIS, V17, P109, DOI 10.1007/s10456-013-9381-6; KIRK SJ, 1993, SURGERY, V114, P155; Kobayashi K, 2014, ARTERIOSCL THROM VAS, V34, P1716, DOI 10.1161/ATVBAHA.114.303890; Koh TJ, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001943; Kroncke KD, 1998, CLIN EXP IMMUNOL, V113, P147; Lee PC, 1999, AM J PHYSIOL-HEART C, V277, pH1600, DOI 10.1152/ajpheart.1999.277.4.H1600; Lee SJ, 2006, AM J PHYSIOL-HEART C, V291, pH2836, DOI 10.1152/ajpheart.00113.2006; Li Q, 2015, J HYPERTENS, V33, P1128, DOI 10.1097/HJH.0000000000000587; Liu ZJ, 2008, ANTIOXID REDOX SIGN, V10, P1869, DOI 10.1089/ars.2008.2121; Mahmoud AM, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12895; MARCHESE A, 1994, GENOMICS, V23, P609, DOI 10.1006/geno.1994.1549; Masckauchan T. Nestor H., 2005, Angiogenesis, V8, P43, DOI 10.1007/s10456-005-5612-9; Mathieu D, 2006, Int J Low Extrem Wounds, V5, P233, DOI 10.1177/1534734606294450; Mirza R, 2009, AM J PATHOL, V175, P2454, DOI 10.2353/ajpath.2009.090248; Moncada S., 2006, V176, P213; Murad F, 2004, BIOSCIENCE REP, V24, P452, DOI 10.1007/s10540-005-2741-8; Murohara T, 1998, J CLIN INVEST, V101, P2567, DOI 10.1172/JCI1560; Namba T, 2003, CIRCULATION, V108, P2250, DOI 10.1161/01.CIR.0000093190.53478.78; NATHAN C, 1992, FASEB J, V6, P3051, DOI 10.1096/fasebj.6.12.1381691; Novak ML, 2013, J LEUKOCYTE BIOL, V93, P875, DOI 10.1189/jlb.1012512; Pan JL, 2000, J IMMUNOL, V165, P2943, DOI 10.4049/jimmunol.165.6.2943; Papapetropoulos A, 1997, J CLIN INVEST, V100, P3131, DOI 10.1172/JCI119868; Petrai I, 2008, INT J BIOCHEM CELL B, V40, P1764, DOI 10.1016/j.biocel.2008.01.008; Rees PA, 2015, ADV WOUND CARE, V4, P687, DOI 10.1089/wound.2014.0568; Ribatti D, 2009, ANGIOGENESIS, V12, P101, DOI 10.1007/s10456-008-9125-1; Ridiandries A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19103217; Ridiandries A, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17111856; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Schaffer MR, 1996, J SURG RES, V63, P237, DOI 10.1006/jsre.1996.0254; Stallmeyer B, 2002, NITRIC OXIDE-BIOL CH, V6, P168, DOI 10.1006/niox.2001.0407; Stamatovic SM, 2006, J IMMUNOL, V177, P2651, DOI 10.4049/jimmunol.177.4.2651; Su YC, 2014, CURR PHARM DESIGN, V20, P3514, DOI 10.2174/13816128113196660752; Takahashi S, 2003, J BIOL CHEM, V278, P9339, DOI 10.1074/jbc.M212651200; Thomas GD, 2001, JAMA-J AM MED ASSOC, V285, P2055, DOI 10.1001/jama.285.16.2055; VENEMA RC, 1995, J BIOL CHEM, V270, P14705, DOI 10.1074/jbc.270.24.14705; Venema RC, 1996, J BIOL CHEM, V271, P6435, DOI 10.1074/jbc.271.11.6435; Wang W, 2000, J BIOL CHEM, V275, P22313, DOI 10.1074/jbc.M001461200; White GE, 2013, PHARMACOL REV, V65, P47, DOI 10.1124/pr.111.005074; Wietecha MS, 2013, ADV WOUND CARE, V2, P81, DOI 10.1089/wound.2011.0348; Witte MB, 2002, BRIT J SURG, V89, P1594, DOI 10.1046/j.1365-2168.2002.02263.x; Witte MB, 2000, NITRIC OXIDE-BIOL CH, V4, P572, DOI 10.1006/niox.2000.0307; Xiong N, 2012, PROTEIN CELL, V3, P571, DOI 10.1007/s13238-012-2927-3; Yang JY, 2018, EXP CELL RES, V363, P262, DOI 10.1016/j.yexcr.2018.01.016; Yu J, 2005, P NATL ACAD SCI USA, V102, P10999, DOI 10.1073/pnas.0501444102; Zhao Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146451	70	3	4	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5838	5850		10.1096/fj.201902060R	http://dx.doi.org/10.1096/fj.201902060R		MAR 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32124475	Bronze, Green Accepted			2022-12-28	WOS:000517934400001
J	Wang, KH; Vorontsova, I; Hoshino, M; Uesugi, K; Yagi, N; Hall, JE; Schilling, TF; Pierscionek, BK				Wang, Kehao; Vorontsova, Irene; Hoshino, Masato; Uesugi, Kentaro; Yagi, Naoto; Hall, James E.; Schilling, Thomas F.; Pierscionek, Barbara K.			Optical development in the zebrafish eye lens	FASEB JOURNAL			English	Article						eye lens; ocular development; vision; zebrafish	GRADIENT REFRACTIVE-INDEX; AFRICAN CICHLID FISH; CRYSTALLINE LENS; SPHERICAL-ABERRATION; ZONES; SHAPE; QUALITY; GROWTH; MOUSE	The optics of the eye is the key to a functioning visual system. The exact nature of the correlation between ocular optics and eye development is not known because of the paucity of knowledge about the growth of a key optical element, the eye lens. The sophisticated optics of the lens and its gradient of refractive index provide the superior optical quality that the eye needs and which, it is thought, has a major influence on the development of proper visual function. The nature of a gradient refractive index lens, however, renders accurate measurements of its development difficult to make and has been the reason why the influence of lens growth on visual function remains largely unknown. Novel imaging techniques have made it possible to investigate growth of the eye lens in the zebrafish. This study shows measurements using X-ray Talbot interferometry of three-dimensional gradient index profiles in eye lenses of zebrafish from late larval to adult stages. The zebrafish lens shows evidence of a gradient of refractive index from the earliest stages measured and its growth suggests an apparent coincidence between periods of rapid increase in refractive index in the lens nucleus and increased expression of a particular crystallin protein group.	[Wang, Kehao; Pierscionek, Barbara K.] Nottingham Trent Univ, Sch Sci & Technol, Nottingham NG11 8NS, England; [Vorontsova, Irene; Hall, James E.] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92717 USA; [Vorontsova, Irene; Schilling, Thomas F.] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92717 USA; [Hoshino, Masato; Uesugi, Kentaro; Yagi, Naoto] Japan Synchrotron Radiat Res Inst Spring 8, Sayo, Hyogo, Japan; [Pierscionek, Barbara K.] Staffordshire Univ, Sch Life Sci & Educ, Stafford, England	Nottingham Trent University; University of California System; University of California Irvine; University of California System; University of California Irvine; Japan Synchrotron Radiation Research Institute; Staffordshire University	Pierscionek, BK (corresponding author), Nottingham Trent Univ, Sch Sci & Technol, Nottingham NG11 8NS, England.	barbara.pierscionek@staffs.ac.uk	Pierscionek, Barbara/AAK-5760-2021		SPring-8 synchrotron [2016A1096, 2017A1197, 2018A1105]; Royal Society [IE160996]; Fight for Sight UK [1319/1320]; National Institutes of Health [R01 EY05661]; Zeiss Meditec AG	SPring-8 synchrotron; Royal Society(Royal Society of London); Fight for Sight UK; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Zeiss Meditec AG	SPring-8 synchrotron, Grant/Award Number: 2016A1096, 2017A1197 and 2018A1105; Royal Society, Grant/Award Number: IE160996; Zeiss Meditec AG; Fight for Sight UK, Grant/Award Number: 1319/1320; National Institutes of Health, Grant/Award Number: R01 EY05661	AXELROD D, 1988, VISION RES, V28, P57, DOI 10.1016/S0042-6989(88)80006-3; Bahrami M, 2014, EXP EYE RES, V124, P93, DOI 10.1016/j.exer.2014.05.009; BARER R, 1954, Q J MICROSC SCI, V95, P399; Bassnett S, 2017, PROG RETIN EYE RES, V60, P181, DOI 10.1016/j.preteyeres.2017.04.001; Birkenfeld J, 2014, INVEST OPHTH VIS SCI, V55, P2599, DOI 10.1167/iovs.14-14201; Birkenfeld J, 2013, VISION RES, V86, P27, DOI 10.1016/j.visres.2013.04.004; CAMPBELL MCW, 1984, VISION RES, V24, P409, DOI 10.1016/0042-6989(84)90039-7; Collery RF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110699; Easter SS, 1996, DEV BIOL, V180, P646; FAGERHOLM PP, 1981, EXP EYE RES, V33, P615, DOI 10.1016/S0014-4835(81)80101-7; FERNALD RD, 1983, NATURE, V301, P618, DOI 10.1038/301618a0; Garner LF, 2001, VISION RES, V41, P973, DOI 10.1016/S0042-6989(01)00011-6; Greiling TMS, 2008, SEMIN CELL DEV BIOL, V19, P94, DOI 10.1016/j.semcdb.2007.10.011; Greiling TMS, 2012, INT REV CEL MOL BIO, V296, P1, DOI 10.1016/B978-0-12-394307-1.00001-1; Hoshino M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025140; Hoshino M, 2010, AIP CONF PROC, V1266, P57, DOI 10.1063/1.3478199; Jackson JM, 2016, SCI REP-UK, V6, DOI 10.1038/srep33585; Jagger WS, 1996, VISION RES, V36, P2623, DOI 10.1016/0042-6989(95)00328-2; Jones CE, 2004, MAGN RESON IMAGING, V22, P211, DOI 10.1016/j.mri.2003.07.005; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; KORETZ JF, 1994, VISION RES, V34, P2955, DOI 10.1016/0042-6989(94)90267-4; Kozlowski TM, 2019, VISION RES, V162, P29, DOI 10.1016/j.visres.2019.06.008; Kozlowski TM, 2019, EXP EYE RES, V181, P1, DOI 10.1016/j.exer.2018.12.013; Kroger RHH, 2001, VISION RES, V41, P549, DOI 10.1016/S0042-6989(00)00283-2; KROGER RHH, 1994, VISION RES, V34, P1815, DOI 10.1016/0042-6989(94)90306-9; Lim JC, 2009, INVEST OPHTH VIS SCI, V50, P4304, DOI 10.1167/iovs.09-3435; Momose A, 2005, JPN J APPL PHYS 1, V44, P6355, DOI 10.1143/JJAP.44.6355; Momose A, 2003, JPN J APPL PHYS 2, V42, pL866, DOI 10.1143/JJAP.42.L866; PIERSCIONEK B, 1987, VISION RES, V27, P1539, DOI 10.1016/0042-6989(87)90162-3; Pierscionek B K, 1995, J Am Optom Assoc, V66, P739; Pierscionek B, 2015, ONCOTARGET, V6, P30532, DOI 10.18632/oncotarget.5762; Pierscionek BK, 2012, PROG RETIN EYE RES, V31, P332, DOI 10.1016/j.preteyeres.2012.03.001; Pierscionek BK, 2003, EXP EYE RES, V77, P639, DOI 10.1016/S0014-4835(03)00221-5; PIERSCIONEK BK, 1989, VISION RES, V29, P1759, DOI 10.1016/0042-6989(89)90158-2; Schilling Thomas F., 2002, P59; SIVAK JG, 1983, INVEST OPHTH VIS SCI, V24, P1162; Soules KA, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-12; Vendra VPR, 2016, BBA-GEN SUBJECTS, V1860, P333, DOI 10.1016/j.bbagen.2015.06.007; Verma Y, 2007, APPL PHYS B-LASERS O, V87, P607, DOI 10.1007/s00340-007-2689-4; Vihtelic TS, 2005, MOL VIS, V11, P1083; Vorontsova I, 2019, JOVE-J VIS EXP, DOI 10.3791/59528; Vorontsova I, 2018, INVEST OPHTH VIS SCI, V59, P2869, DOI 10.1167/iovs.18-24044; Wages P, 2013, MOL VIS, V19, P408; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE	44	9	9	2	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5552	5562		10.1096/fj.201902607R	http://dx.doi.org/10.1096/fj.201902607R		FEB 2020	11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32103543	Green Submitted, hybrid			2022-12-28	WOS:000517906400001
J	Suresh, S; Lee, J; Noguchi, CT				Suresh, Sukanya; Lee, Jeeyoung; Noguchi, Constance T.			Erythropoietin signaling in osteoblasts is required for normal bone formation and for bone loss during erythropoietin-stimulated erythropoiesis	FASEB JOURNAL			English	Article						bone remodeling; EPO; osteoblast differentiation; osteocyte; trabecular	ESTROGEN-RECEPTOR; PROLIFERATION; HEALTH; ALPHA; MICE	Erythropoietin (EPO) regulates erythropoiesis by binding to erythropoietin receptor (Epor) on erythroid progenitor cells. Epor is also expressed on bone forming osteoblasts and bone loss accompanies EPO-stimulated erythropoiesis in mice. Mice with Epor restricted to erythroid tissue exhibit reduced bone and increased marrow adipocytes; in contrast, transgenic mice (Tg) with osteoblastic-specific deletion ofEporexhibit reduced trabecular bone with age without change in marrow adipocytes. By 12 weeks, male Tg mice had 22.2% and female Tg mice had 29.6% reduced trabecular bone volume (BV) compared to controls. EPO administration (1200 U/kg) for 10 days reduced trabecular bone in control mice but not in Tg mice. There were no differences in numbers of osteoblasts, osteoclasts, and marrow adipocytes in Tg mice, suggesting independence of EPO signaling in mature osteoblasts, osteoclasts, and adipocytes. Female Tg mice had increased number of dying osteocytes and male Tg mice had a trend for more empty lacunae. Osteogenic cultures from Tg mice had reduced differentiation and mineralization with reducedAlplandRunx2transcripts. In conclusion, endogenous EPO-Epor signaling in osteoblasts is important in bone remodeling, particularly trabecular bone and endogenous Epor expression in osteoblasts is required for bone loss accompanying EPO-stimulated erythropoiesis.	[Suresh, Sukanya; Lee, Jeeyoung; Noguchi, Constance T.] NIDDK, Mol Med Branch, NIH, Bldg 10,Room 9N319,10 Ctr Dr,MSC 1822, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Noguchi, CT (corresponding author), NIDDK, Mol Med Branch, NIH, Bldg 10,Room 9N319,10 Ctr Dr,MSC 1822, Bethesda, MD 20892 USA.	connien@niddk.nih.gov			National Institute of Diabetes and Digestive and Kidney Diseases; National Institutes of Health (NIH), USA	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health (NIH), USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	National Institute of Diabetes and Digestive and Kidney Diseases; National Institutes of Health (NIH), USA	Adhami MD, 2015, J BONE MINER RES, V30, P71, DOI 10.1002/jbmr.2321; Beleslin-Cokic BB, 2004, BLOOD, V104, P2073, DOI 10.1182/blood-2004-02-0744; Boyce BF, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2165; Canalis E, 2013, J BIOL CHEM, V288, P25614, DOI 10.1074/jbc.M113.470492; Delgado-Calle Jesus, 2015, Curr Mol Biol Rep, V1, P157; Elefteriou F, 2011, BONE, V49, P1242, DOI 10.1016/j.bone.2011.08.021; Garcia P, 2011, J ORTHOP RES, V29, P165, DOI 10.1002/jor.21219; Guo LH, 2014, CLIN EXP MED, V14, P69, DOI 10.1007/s10238-012-0220-7; Hiram-Bab S, 2015, FASEB J, V29, P1890, DOI 10.1096/fj.14-259085; Kondoh S, 2014, BONE, V60, P68, DOI 10.1016/j.bone.2013.12.005; Kristjansdottir HL, 2020, J BONE MINER RES, V35, P298, DOI 10.1002/jbmr.3900; Maatta JA, 2013, FASEB J, V27, P478, DOI 10.1096/fj.12-213587; McKenzie J, 2019, J BONE MINER RES, V34, P1660, DOI 10.1002/jbmr.3742; Ogilvie M, 2000, J BIOL CHEM, V275, P39754, DOI 10.1074/jbc.M004999200; Orimo Hideo, 2010, Journal of Nippon Medical School, V77, P4; Ott C, 2015, MOL MED, V21, P803, DOI 10.2119/molmed.2015.00192; Rankin EB, 2012, CELL, V149, P63, DOI 10.1016/j.cell.2012.01.051; Rauner M, 2016, J BONE MINER RES, V31, P1877, DOI 10.1002/jbmr.2857; Shu L, 2015, CALCIFIED TISSUE INT, V96, P313, DOI 10.1007/s00223-015-9954-z; Singbrant S, 2011, BLOOD, V117, P5631, DOI 10.1182/blood-2010-11-320564; Suresh S, 2019, BONE RES, V7, DOI 10.1038/s41413-019-0060-0; Teng RF, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1526; Wan L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102010; Wang L, 2013, DIABETES, V62, P4122, DOI 10.2337/db13-0518; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593; Zhang YY, 2017, FASEB J, V31, P2661, DOI 10.1096/fj.201601223RRR; Zhang YY, 2014, INT J MOL SCI, V15, P10296, DOI 10.3390/ijms150610296	27	12	12	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					11685	11697		10.1096/fj.202000888R	http://dx.doi.org/10.1096/fj.202000888R		JUL 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32671900	Green Accepted, Bronze			2022-12-28	WOS:000552018100001
J	Yang, JH; Liu, H; Han, S; Fu, ZR; Wang, JY; Chen, Y; Wang, LM				Yang, Jinghui; Liu, Hao; Han, Shu; Fu, Zhiren; Wang, Jiyuan; Chen, Yu; Wang, Liming			Melatonin pretreatment alleviates renal ischemia-reperfusion injury by promoting autophagic flux via TLR4/MyD88/MEK/ERK/mTORC1 signaling	FASEB JOURNAL			English	Article						autophagy; ischemia-reperfusion injury; melatonin	OXIDATIVE STRESS; INHIBITOR; PROTECTS; MTORC1; BCL-2; ROS	Autophagy is an important mechanism for cellular homeostasis and survival during pathologic stress conditions in the kidney, such as ischemia-reperfusion (IR) injury. In this study, renal IR was induced in female C57BL/6 mice after melatonin administration. Renal function, histological damage, inflammatory infiltration, cytokine production, oxidative stress, antioxidant capacity, autophagy changing, apoptosis levels, and autophagy-associated intracellular signaling pathway were assessed to evaluate the impact of antecedent melatonin treatment on IR-induced renal injury. The administration of melatonin resulted in significantly preserved renal function, and the protective effect was associated with ameliorated oxidative stress, limited pro-inflammatory cytokine production, and neutrophil and macrophage infiltration. Moreover, autophagic flux was increased after melatonin administration while the apoptosis levels were decreased in the melatonin-pretreated mice. Using TAK-242 and CRX-527, we confirmed that MyD88-dependent TLR4 and MEK/ERK/mTORC1 signaling participated in melatonin-induced autophagy in IR mice. Collectively, our results provide novel evidence that antecedent melatonin treatment provides protection for the kidney against IR injury by enhancing autophagy, as regulated by the TLR4/MyD88/MEK/ERK/mTORC1 signaling pathway. Therefore, melatonin preconditioning offers a potential therapeutic approach to prevent renal IR injury related to various clinical conditions.	[Yang, Jinghui; Liu, Hao; Han, Shu; Fu, Zhiren; Wang, Jiyuan; Chen, Yu; Wang, Liming] Second Mil Med Univ, Dept Organ Transplantat, Shanghai ChangZheng Hosp, 415 Fengyang Rd, Shanghai 200003, Peoples R China	Naval Medical University	Chen, Y; Wang, LM (corresponding author), Second Mil Med Univ, Dept Organ Transplantat, Shanghai ChangZheng Hosp, 415 Fengyang Rd, Shanghai 200003, Peoples R China.	chenyu8@smmu.edu.cn; limingwangmail@163.com	Yang, Jinghui/ABH-5641-2020		National Natural Science Foundation of China (NSFC) [81671577]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81801590; National Natural Science Foundation of China (NSFC), Grant/Award Number: 81671577	Aghaei M, 2019, J CELL PHYSIOL, V234, P16768, DOI 10.1002/jcp.28345; Boga JA, 2019, J PINEAL RES, V66, DOI 10.1111/jpi.12534; Chamanara M, 2019, INFLAMMOPHARMACOLOGY, V27, P361, DOI 10.1007/s10787-018-0523-8; Cho JH, 2019, EXP NEUROL, V320, DOI 10.1016/j.expneurol.2019.112983; Erlich S, 2007, AUTOPHAGY, V3, P561, DOI 10.4161/auto.4713; Fonseca BD, 2011, J BIOL CHEM, V286, P27111, DOI 10.1074/jbc.M111.260794; Garcia MM, 2020, EUR J PHARMACOL, V874, DOI 10.1016/j.ejphar.2020.172975; Gul-Kahraman K, 2019, J PINEAL RES, V67, DOI 10.1111/jpi.12589; Hardeland R, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20051223; Jancso G, 2016, CLIN HEMORHEOL MICRO, V63, P217, DOI 10.3233/CH-152038; Kar R, 2018, JBMR PLUS, V3; Kuriakose S, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02673; Kurusu T, 2017, J PLANT RES, V130, P491, DOI 10.1007/s10265-017-0934-4; Lester SN, 2014, J MOL BIOL, V426, P1246, DOI 10.1016/j.jmb.2013.11.024; Li YL, 2019, NEUROCHEM RES, V44, P2007, DOI 10.1007/s11064-019-02838-w; Li ZL, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0518-9; Liu H, 2019, BIOCHEM BIOPH RES CO, V519, P227, DOI 10.1016/j.bbrc.2019.08.162; Liu HZ, 2018, RESP RES, V19, DOI 10.1186/s12931-018-0937-2; Ma ZQ, 2017, CELL MOL LIFE SCI, V74, P3989, DOI 10.1007/s00018-017-2618-6; Molteni M, 2018, INT J INFLAMM, V2018, DOI 10.1155/2018/2859135; Nakagawa S, 2012, EUR J PHARMACOL, V696, P143, DOI 10.1016/j.ejphar.2012.09.010; Ono Y, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-57714-3; Panah F, 2019, TRANSPL IMMUNOL, V57, DOI 10.1016/j.trim.2019.101241; Quera-Salva MA, 2018, ENCEPHALE, V44, P548, DOI 10.1016/j.encep.2018.06.005; Rabanal-Ruiz Y, 2017, ESSAYS BIOCHEM, V61, P565, DOI 10.1042/EBC20170027; Su H, 2019, ADV EXP MED BIOL, V1165, P585, DOI 10.1007/978-981-13-8871-2_29; Tang CY, 2018, AUTOPHAGY, V14, P880, DOI 10.1080/15548627.2017.1405880; Tang TT, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0378-3; Wang Y, 2018, PHARMAZIE, V73, P396, DOI 10.1691/ph.2018.7509; Wu L, 2019, BASIC RES CARDIOL, V114, DOI 10.1007/s00395-019-0747-9; Wu YP, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02185; Xu HD, 2019, ADV EXP MED BIOL, V1206, P109, DOI 10.1007/978-981-15-0602-4_5; Yang JH, 2015, BIOCHEM BIOPH RES CO, V467, P704, DOI 10.1016/j.bbrc.2015.10.080; Yang JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106892; Yang JF, 2015, IEEE C EVOL COMPUTAT, P1, DOI 10.1109/CEC.2015.7256867; Yang S, 2018, MED SCI MONITOR, V24, P3804, DOI 10.12659/MSM.907734; Zhang Y, 2019, J PINEAL RES, V66, DOI 10.1111/jpi.12542; Zhao HL, 2018, EBIOMEDICINE, V28, P31, DOI 10.1016/j.ebiom.2018.01.025; Zhou H, 2018, J PINEAL RES, V65, DOI 10.1111/jpi.12503; Zhou H, 2018, J PINEAL RES, V64, DOI 10.1111/jpi.12471; Zhu XX, 2019, J CACHEXIA SARCOPENI, V10, P378, DOI 10.1002/jcsm.12377	41	15	16	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12324	12337		10.1096/fj.202001252R	http://dx.doi.org/10.1096/fj.202001252R		JUL 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32662527	hybrid			2022-12-28	WOS:000553028700001
J	Prado, DS; Veras, FP; Ferreira, RG; Damasceno, LEA; Melo, PH; Zamboni, DS; Cunha, TM; Cunha, FQ; Alves-Filho, JC				Prado, Douglas Silva; Veras, Flavio P.; Ferreira, Raphael Gomes; Damasceno, Luis Eduardo Alves; Melo, Paulo Henrique; Zamboni, Dario Simoes; Cunha, Thiago Mattar; Cunha, Fernando Queiroz; Alves-Filho, Jose Carlos			NLRP12 controls arthritis severity by acting as a checkpoint inhibitor of Th17 cell differentiation	FASEB JOURNAL			English	Article						autoimmune disease; STAT3; T cell; inflammation; NLR	NF-KAPPA-B; ANTI-INTERLEUKIN-17 MONOCLONAL-ANTIBODY; CONTAINING APAF1-LIKE PROTEIN; COLLAGEN-INDUCED ARTHRITIS; ANTIGEN-INDUCED ARTHRITIS; RHEUMATOID-ARTHRITIS; REGULATES ACTIVATION; COLON INFLAMMATION; HOST-DEFENSE; PATHWAYS	Nucleotide oligomerization domain (NOD)-like receptor-12 (NLRP12) has emerged as a negative regulator of inflammation. It is well described that the Th17 cell population increases in patients with early Rheumatoid Arthritis (RA), which correlates with the disease activity. Here, we investigated the role of NLRP12 in the differentiation of Th17 cells and the development of experimental arthritis, using the antigen-induced arthritis (AIA) murine model. We found thatNlrp12(-/)(-)mice develop severe arthritis characterized by an exacerbated Th17-mediated inflammatory response with increases in the articular hyperalgesia, knee joint swelling, and neutrophil infiltration. Adoptive transfer ofNlrp12(-/)(-)cells into WT mice recapitulated the hyperinflammatory response seen inNlrp12(-/)(-)mice and the treatment with anti-IL-17A neutralizing antibody abrogated arthritis development inNlrp12(-/)(-)mice, suggesting that NLRP12 works as an inhibitor of Th17 cell differentiation. Indeed, Th17 cell differentiation markedly increases inNlrp12(-/-)T cells cultured under the Th17-skewing condition. Mechanistically, we found that NLRP12 negatively regulates IL-6-induced phosphorylation of STAT3 in T cells. Finally, pharmacological inhibition of STAT3 reduced Th17 cell differentiation and abrogated hyperinflammatory arthritis observed inNlrp12(-/)(-)mice. Thus, we described a novel role for NLRP12 as a checkpoint inhibitor of Th17 cell differentiation, which controls the severity of experimental arthritis.	[Prado, Douglas Silva; Veras, Flavio P.; Ferreira, Raphael Gomes; Damasceno, Luis Eduardo Alves; Melo, Paulo Henrique; Zamboni, Dario Simoes; Cunha, Thiago Mattar; Cunha, Fernando Queiroz; Alves-Filho, Jose Carlos] Univ Sao Paulo, Ribeirao Preto Med Sch, CRID, Ctr Res Inflammatory Dis, Ribeirao Preto, Brazil; [Prado, Douglas Silva; Veras, Flavio P.; Ferreira, Raphael Gomes; Damasceno, Luis Eduardo Alves; Melo, Paulo Henrique; Cunha, Thiago Mattar; Cunha, Fernando Queiroz; Alves-Filho, Jose Carlos] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Pharmacol, Ave Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP, Brazil; [Zamboni, Dario Simoes] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Cell Biol, Ribeirao Preto, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Alves-Filho, JC (corresponding author), Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Pharmacol, Ave Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP, Brazil.	jcafilho@usp.br	Cunha, Thiago M/B-7729-2012; Alves-Filho, Jose Carlos/B-5814-2008; Veras, Flávio Protásio/AAD-6274-2021; Cunha, Fernando Q/M-3090-2014; Zamboni, Dario S/D-3024-2012; Damasceno, Luis Eduardo Alves/GPK-5616-2022	Cunha, Thiago M/0000-0003-1084-0065; Alves-Filho, Jose Carlos/0000-0002-9918-8714; Zamboni, Dario S/0000-0002-7856-7512; Damasceno, Luis Eduardo Alves/0000-0003-2833-9244; Ferreira, Raphael/0000-0002-1199-937X; De Melo, Paulo/0000-0001-8911-1142; Cunha, Fernando Queiroz/0000-0003-4755-1670; Protasio Veras, Flavio/0000-0002-6222-4064; Mattar Cunha, Thiago/0000-0002-7855-3700; Prado, Douglas da Silva/0000-0003-4594-1851	FAPESP [2013/08216-2, 2016/05377-3]; CNPq [430823/2018-5]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	FAPESP, Grant/Award Number: 2013/08216-2 and 2016/05377-3; CNPq, Grant/Award Number: 430823/2018-5	Allen IC, 2012, IMMUNITY, V36, P742, DOI 10.1016/j.immuni.2012.03.012; Asquith DL, 2009, EUR J IMMUNOL, V39, P2040, DOI 10.1002/eji.200939578; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Borghini S, 2011, ARTHRITIS RHEUM-US, V63, P830, DOI 10.1002/art.30170; BRACKERTZ D, 1977, ARTHRITIS RHEUM, V20, P841, DOI 10.1002/art.1780200314; Caruso R, 2014, IMMUNITY, V41, P898, DOI 10.1016/j.immuni.2014.12.010; Chabaud M, 1999, ARTHRITIS RHEUM-US, V42, P963, DOI 10.1002/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E; Chen GY, 2011, J IMMUNOL, V186, P7187, DOI 10.4049/jimmunol.1100412; Chen Z, 2006, P NATL ACAD SCI USA, V103, P8137, DOI 10.1073/pnas.0600666103; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Geboes L, 2009, ARTHRITIS RHEUM-US, V60, P390, DOI 10.1002/art.24220; Genovese MC, 2010, ARTHRITIS RHEUM-US, V62, P929, DOI 10.1002/art.27334; Genovese MC, 2014, ARTHRITIS RHEUMATOL, V66, P1693, DOI 10.1002/art.38617; Gharagozloo M, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7090119; Gharagozloo M, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0414-5; Guerrero ATG, 2006, PHARMACOL BIOCHEM BE, V84, P244, DOI 10.1016/j.pbb.2006.05.008; Gullick NJ, 2013, CLIN EXP IMMUNOL, V174, P292, DOI 10.1111/cei.12167; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jeru I, 2008, P NATL ACAD SCI USA, V105, P1614, DOI 10.1073/pnas.0708616105; Jeru I, 2011, ARTHRITIS RHEUM-US, V63, P2142, DOI 10.1002/art.30378; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Kimura A, 2007, P NATL ACAD SCI USA, V104, P12099, DOI 10.1073/pnas.0705268104; Kirkham BW, 2006, ARTHRITIS RHEUM, V54, P1122, DOI 10.1002/art.21749; Kolly L, 2009, J IMMUNOL, V183, P4003, DOI 10.4049/jimmunol.0802173; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Krauss JL, 2015, P NATL ACAD SCI USA, V112, P10455, DOI 10.1073/pnas.1500196112; Lawlor KE, 2001, ARTHRITIS RHEUM, V44, P442, DOI 10.1002/1529-0131(200102)44:2<442::AID-ANR63>3.0.CO;2-M; Le Maitre CL, 2005, ARTHRITIS RES THER, V7, pR732, DOI 10.1186/ar1732; Leipe J, 2020, RHEUMATOLOGY, V59, P2754, DOI 10.1093/rheumatology/kez660; Leipe J, 2010, ARTHRITIS RHEUM-US, V62, P2876, DOI 10.1002/art.27622; Lich JD, 2007, J IMMUNOL, V178, P1256, DOI 10.4049/jimmunol.178.3.1256; Lukens JR, 2015, IMMUNITY, V42, P654, DOI 10.1016/j.immuni.2015.03.006; Macaluso F, 2007, EXP DERMATOL, V16, P692, DOI 10.1111/j.1600-0625.2007.00589.x; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Manji GA, 2002, J BIOL CHEM, V277, P11570, DOI 10.1074/jbc.M112208200; Nakae S, 2003, J IMMUNOL, V171, P6173, DOI 10.4049/jimmunol.171.11.6173; Nickdel MB, 2009, ANN RHEUM DIS, V68, P1059, DOI 10.1136/ard.2008.089300; Pinto LG, 2010, PAIN, V148, P247, DOI 10.1016/j.pain.2009.11.006; Qin HW, 2009, J IMMUNOL, V183, P97, DOI 10.4049/jimmunol.0801986; Rathinam VAK, 2016, CELL, V165, P792, DOI 10.1016/j.cell.2016.03.046; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; Shen H, 2009, ARTHRITIS RHEUM-US, V60, P1647, DOI 10.1002/art.24568; Taira TM, 2019, J DENT RES, V98, P476, DOI 10.1177/0022034518820289; Toma C, 2010, J IMMUNOL, V184, P5287, DOI 10.4049/jimmunol.0903536; Udden SMN, 2019, ELIFE, V8, DOI 10.7554/eLife.40396; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Veras FP, 2015, SCI REP, V5, P1; Wang L, 2002, J BIOL CHEM, V277, P29874, DOI 10.1074/jbc.M203915200; Wang L, 2020, PROCEEDINGS OF THE 18TH USENIX CONFERENCE ON FILE AND STORAGE TECHNOLOGIES, P1; Wanke F, 2018, J MOL MED, V96, P819, DOI 10.1007/s00109-018-1662-5; Weissmann G, 2006, BULL HOSP JT DIS, V64, P12; Williams KL, 2005, J BIOL CHEM, V280, P39914, DOI 10.1074/jbc.M502820200; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Zaki MH, 2011, CANCER CELL, V20, P649, DOI 10.1016/j.ccr.2011.10.022	55	4	5	2	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10907	10919		10.1096/fj.202000795R	http://dx.doi.org/10.1096/fj.202000795R		JUL 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32632939				2022-12-28	WOS:000547553800001
J	Zhang, C; Zhang, XY; Wang, JH; Di, F; Xue, YX; Lin, XD; Zhang, Y; Zhang, H; Zhang, Z; Gu, YT				Zhang, Cai; Zhang, Xiaoyi; Wang, Jiahong; Di, Fan; Xue, Yixue; Lin, Xiangdan; Zhang, Ying; Zhang, Hong; Zhang, Zhou; Gu, Yanting			Lnc00462717 regulates the permeability of the blood-brain tumor barrier through interaction with PTBP1 to inhibit the miR-186-5p/Occludin signaling pathway	FASEB JOURNAL			English	Article						blood-brain tumor barrier (BTB); Lnc00462717; MiR-186-5p; Occludin; permeability; PTBP1	GLIOBLASTOMA; PROLIFERATION; TRANSPORT	Blood-brain tumor barrier (BTB) severely restricts the efficient delivery of chemotherapeutic drugs into brain tumor tissue, which is a critical obstacle for glioma treatment. Recently, long noncoding RNAs (lncRNAs) have shown as regulation factors of numerous biological processes. In this study, we identified that Lnc00462717 was upregulated in glioma endothelial cells (GECs), and that knockdown of Lnc00462717 significantly increased the BTB permeability. Both bioinformatics and RNA immunoprecipitation (RIP) results revealed that Lnc00462717 interacts with polypyrimidine tract binding protein (PTBP1). Moreover, overexpression of PTBP1 significantly reversed the increase in BTB permeability caused by siLnc00462717. Furthermore, the binding sites between miR-186 and PTBP1 as well as between miR-186 and 3'UTR of Occludin mRNA were confirmed by RIP and luciferase assays, respectively. And the interaction of Lnc00462717 and PTBP1 significantly facilitated the binding of PTBP1 to 3'UTR of Occludin mRNA and then blocked the miR-186-5p-induced downregulation of Occludin. In addition, we identified that knockdown of Lnc00462717 or overexpression of miR-186-5p increased the accumulation of doxorubicin (Dox) in brain glioma via the ultrafast liquid chromatography-mass spectrometry system (UFLC-MS/MS system) and decreased the intracranial glioma volume in BALB/c nude mice. Taken together, these results show a novel molecular pathway in BTB that may provide a potential innovative strategy for glioma therapy.	[Zhang, Cai; Zhang, Xiaoyi; Wang, Jiahong; Zhang, Ying; Zhang, Hong; Zhang, Zhou; Gu, Yanting] Shenyang Pharmaceut Univ, Life Sci & Biopharmaceut Inst, Dept Physiol, Shenyang, Peoples R China; [Di, Fan] Gen Hosp Northern Theater Command, Dept Neurosurg, Shenyang, Peoples R China; [Xue, Yixue] China Med Univ, Dept Neurobiol, Coll Basic Med, Shenyang, Peoples R China; [Lin, Xiangdan] Grad Sch Jinzhou Med Univ, Jinzhou, Peoples R China	Shenyang Pharmaceutical University; China Medical University	Zhang, Z; Gu, YT (corresponding author), Shenyang Pharmaceut Univ, Sch Life Sci & Biopharmaceut, 103 Culture Rd, Shenyang 110016, Peoples R China.	zzhouzhang@163.com; guyanting@syphu.edu.cn			National Natural Science Foundation of China (NSFC) [81773289]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81773289	Awan HM, 2017, GENOM PROTEOM BIOINF, V3, P53; Bracken CP, 2016, NAT REV GENET, V17, P719, DOI 10.1038/nrg.2016.134; Dong SS, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1103-5; Fellner S, 2002, J CLIN INVEST, V110, P1309, DOI 10.1172/JCI200215451; Feng HX, 2019, EXP MOL PATHOL, V108, P105, DOI 10.1016/j.yexmp.2019.04.007; Gu YT, 2019, FASEB J, V33, P441, DOI 10.1096/fj.201800095RR; Guil S, 2015, TRENDS BIOCHEM SCI, V40, P248, DOI 10.1016/j.tibs.2015.03.001; Guo JQ, 2017, BBA-MOL BASIS DIS, V1863, P2240, DOI 10.1016/j.bbadis.2017.02.005; Izquierdo JM, 2005, MOL CELL, V19, P475, DOI 10.1016/j.molcel.2005.06.015; Jia P, 2016, CANCER LETT, V381, P359, DOI 10.1016/j.canlet.2016.08.009; Kim J, 2016, NUCLEIC ACIDS RES, V44, P2378, DOI 10.1093/nar/gkw017; Kim SS, 2018, NUCLEIC ACIDS RES, V46, P1424, DOI 10.1093/nar/gkx1221; Komarova Y, 2010, ANNU REV PHYSIOL, V72, P463, DOI 10.1146/annurev-physiol-021909-135833; Lapointe S, 2018, LANCET, V392, P432, DOI 10.1016/S0140-6736(18)30990-5; Li JL, 2018, ARCH BIOCHEM BIOPHYS, V640, P53, DOI 10.1016/j.abb.2018.01.002; Li Mengfeng, 2013, Cancers (Basel), V5, P1306, DOI 10.3390/cancers5041306; Li YI, 2015, GENOME RES, V25, P1, DOI 10.1101/gr.181990.114; Liu HM, 2017, BIOMATERIALS, V121, P130, DOI 10.1016/j.biomaterials.2017.01.001; Ma J, 2015, BIOCHIM BIOPHYS ACTA, V1859, P324; Mr L, 2017, FRONT PLANT SCI, V8, P1631; Pries AR, 2010, NAT REV CANCER, V10, P587, DOI 10.1038/nrc2895; Rosas-Hernandez H., 2018, HDB DEV NEUROTOXICOL, P229, DOI DOI 10.1016/C2015-0-04830-4; Troy A, 2012, J CLIN INVEST, V122, P3837, DOI 10.1172/JCI66645; van Tellingen O, 2015, DRUG RESIST UPDATE, V19, P1, DOI 10.1016/j.drup.2015.02.002; Wang AQ, 2017, BIOCHEM BIOPH RES CO, V485, P513, DOI 10.1016/j.bbrc.2017.02.015; Wang FC, 2017, CELL MOL NEUROBIOL, V37, P1433, DOI 10.1007/s10571-017-0474-4; Weller M, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.17; Xie ZC, 2019, AM J TRANSL RES, V11, P4922; Zhang L.Y., 2019, NAT COMMUN, V10, P1, DOI DOI 10.1007/s00294019-00994-8; Zhang L, 2017, HEPATOLOGY, V65, P604, DOI 10.1002/hep.28882; Zhu Y, 2016, J CONTROL RELEASE, V233, P29, DOI 10.1016/j.jconrel.2016.05.014	31	7	9	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					9941	9958		10.1096/fj.202000045R	http://dx.doi.org/10.1096/fj.202000045R		JUL 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32623796	hybrid			2022-12-28	WOS:000547518800001
J	Lau, YCC; Ding, JA; Simental, A; Mirzoyan, H; Lee, W; Diamante, GY; Cely, I; Tran, M; Morselli, M; Dang, J; Kaczor-Urbanowicz, KE; Sayre, J; Stiles, L; Yang, X; Pellegrini, M; Fiala, M				Lau, Yik Chai Charles; Ding, Jessica Aliyah; Simental, Aracely; Mirzoyan, Hayk; Lee, William; Diamante, Graciel Young; Cely, Ingrid; Tran, Michelle; Morselli, Marco; Dang, Johnny; Kaczor-Urbanowicz, Karolina Elzbieta; Sayre, James; Stiles, Linsey; Yang, Xia; Pellegrini, Matteo; Fiala, Milan			Omega-3 fatty acids increase OXPHOS energy for immune therapy of Alzheimer disease patients	FASEB JOURNAL			English	Article						amyloid-beta; citric acid cycle; glycolysis; mild cognitive impairment; omega-3 fatty acids; phagocytosis	MILD COGNITIVE IMPAIRMENT; AMYLOID-BETA; MACROPHAGES; BRAIN; SUPPLEMENTATION; OMEGA-3; IMMUNOTHERAPY; CLEARANCE; DAMAGE; MODEL	Sporadic late-onset Alzheimer disease (LOAD) preceded by mild cognitive impairment (MCI) is the most common type of dementia. Long-term studies of immunity to pathogenic amyloid-beta (A beta) in LOAD are lacking. Innate immunity of LOAD patients is malfunctioning in phagocytosis and degradation of A beta and LOAD patients' macrophage transcriptome and metabolome are deregulated. We previously showed omega-3 fatty acid (omega-3)-mediated repair of unfolded protein response and here we show much broader transcriptomic effects. omega-3 treatment in vitro and omega-3 supplementation by the drink Smartfish (SMF) in vivo increased the transcripts of the genes and pathways of immunity, glycolysis, tricarboxylic acid cycle, OX-PHOS, nicotinamide dinucleotide (NAD(+)) synthesis, and reversed the defects in A beta phagocytosis. In both peripheral blood mononuclear cells (PBMC) and macrophages, omega-3 increased ATP-linked oxygen consumption rate (OCR) and omega-3 with carnitine was superior to omega-3. omega-3 treatment in vitro and supplementation by the omega-3 drink SMF in vivo rescued macrophage phagocytosis when glycolysis or glycosylation were blocked. omega-3 provide flexible energy for immune clearance of the brain throughout the diurnal cycle, even in hypo- or hyper-glycemia. In certain LOAD patients, omega-3 may delay progression to dementia.	[Lau, Yik Chai Charles; Simental, Aracely; Mirzoyan, Hayk; Lee, William; Tran, Michelle; Dang, Johnny; Kaczor-Urbanowicz, Karolina Elzbieta; Fiala, Milan] Univ Calif Los Angeles, Sch Dent & Med, Div Oral Biol & Oral Med, Los Angeles, CA 90095 USA; [Lau, Yik Chai Charles; Simental, Aracely; Mirzoyan, Hayk; Lee, William; Tran, Michelle; Morselli, Marco; Dang, Johnny; Pellegrini, Matteo; Fiala, Milan] Univ Calif Los Angeles, Sch Life Sci, Dept Mol Cell & Dev Biol, 3000D Terasaki Life Sci Bldg, Los Angeles, CA 90095 USA; [Ding, Jessica Aliyah; Diamante, Graciel Young; Cely, Ingrid; Yang, Xia] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA; [Kaczor-Urbanowicz, Karolina Elzbieta; Yang, Xia] Univ Calif Los Angeles, Inst Quantitat & Computat Biosci, Los Angeles, CA 90095 USA; [Sayre, James] Univ Calif Los Angeles, Sch Publ Hlth, Los Angeles, CA 90095 USA; [Stiles, Linsey] Univ Calif Los Angeles, Sch Med, Mitochondrial & Metab Core, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Fiala, M (corresponding author), Univ Calif Los Angeles, Sch Life Sci, Dept Mol Cell & Dev Biol, 3000D Terasaki Life Sci Bldg, Los Angeles, CA 90095 USA.	fiala@mednet.ucla.edu	Morselli, Marco/AAF-3182-2019	Morselli, Marco/0000-0003-3351-5791	NIH [5PO1GM099134-03]; Smartfish company to UCLA [R01 DK104363]; American Diabetes Association Postdoctoral Fellowship	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Smartfish company to UCLA; American Diabetes Association Postdoctoral Fellowship(American Diabetes Association)	This study was supported by the NIH grant 5PO1GM099134-03 to M.P. and a grant from Smartfish company to UCLA. XY is supported by R01 DK104363. GD is supported by American Diabetes Association Postdoctoral Fellowship.	Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Birks J, 2006, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001190.pub2, 10.1002/14651858.CD001190.pub3]; Butterfield DA, 2019, NAT REV NEUROSCI, V20, P148, DOI 10.1038/s41583-019-0132-6; Cribbs DH, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-179; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Famenini S, 2017, FASEB J, V31, P148, DOI 10.1096/fj.201600677RR; Fang EF, 2017, TRENDS MOL MED, V23, P899, DOI 10.1016/j.molmed.2017.08.001; Fiala M, 2002, EUR J CLIN INVEST, V32, P360, DOI 10.1046/j.1365-2362.2002.00994.x; Fiala M, 2007, P NATL ACAD SCI USA, V104, P12849, DOI 10.1073/pnas.0701267104; Fiala M, 2018, J ALZHEIMERS DIS, V62, P1013, DOI 10.3233/JAD-170579; Flannery PJ, 2019, MOL CELL NEUROSCI, V98, P109, DOI 10.1016/j.mcn.2019.06.009; Freund-Levi Y, 2006, ARCH NEUROL-CHICAGO, V63, P1402, DOI 10.1001/archneur.63.10.1402; Gordon BA, 2018, LANCET NEUROL, V17, P241, DOI 10.1016/S1474-4422(18)30028-0; Hou YJ, 2018, P NATL ACAD SCI USA, V115, pE1876, DOI 10.1073/pnas.1718819115; Krashia P, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11928-w; Liang WS, 2008, P NATL ACAD SCI USA, V105, P4441, DOI 10.1073/pnas.0709259105; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; Olivera-Perez HM, 2017, FASEB J, V31, P4359, DOI 10.1096/fj.201700290R; Persidsky Y, 1997, J IMMUNOL, V158, P3499; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Prinz M, 2017, NAT IMMUNOL, V18, P385, DOI 10.1038/ni.3703; Quinn JF, 2010, JAMA-J AM MED ASSOC, V304, P1903, DOI 10.1001/jama.2010.1510; Rapalino O, 1998, NAT MED, V4, P814, DOI 10.1038/nm0798-814; Ren HX, 2017, FASEB J, V31, P282, DOI 10.1096/fj.201600896; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Schwartz M, 2017, SCIENCE, V357, P254, DOI 10.1126/science.aai8231; Shechter R, 2013, IMMUNITY, V38, P555, DOI 10.1016/j.immuni.2013.02.012; Sonntag KC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14420-x; Swerdlow RH, 2018, J ALZHEIMERS DIS, V62, P1403, DOI 10.3233/JAD-170585; Tramutola A, 2017, BRAIN RES BULL, V133, P88, DOI 10.1016/j.brainresbull.2016.06.005; Venegas C, 2019, FASEB J, V33, P13075, DOI 10.1096/fj.201900439; Zaghi J, 2009, ACTA NEUROPATHOL, V117, P111, DOI 10.1007/s00401-008-0481-0	33	4	4	2	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					9982	9994		10.1096/fj.202000669RR	http://dx.doi.org/10.1096/fj.202000669RR		JUL 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32614485				2022-12-28	WOS:000547288700001
J	Venturini, C; Ben Zakour, NL; Bowring, B; Morales, S; Cole, R; Kovach, Z; Branston, S; Kettle, E; Thomson, N; Iredell, JR				Venturini, Carola; Ben Zakour, Nouri L.; Bowring, Bethany; Morales, Sandra; Cole, Robert; Kovach, Zsuzsanna; Branston, Steven; Kettle, Emma; Thomson, Nicholas; Iredell, Jonathan R.			Fine capsule variation affects bacteriophage susceptibility inKlebsiella pneumoniaeST258	FASEB JOURNAL			English	Article						bacteriophages; capsular locus; Klebsiella pneumoniaeST258; multidrug resistance	KLEBSIELLA-PNEUMONIAE; PHYLOGENETIC ANALYSIS; RESISTANCE; DIVERSITY; EMERGENCE; VIRULENCE; PLASMIDS; PROTEIN; VERSION; THREAT	Multidrug resistant (MDR) carbapenemase-producing (CP)Klebsiella pneumoniae, belonging to clonal group CG258, is capable of causing severe disease in humans and is classified as an urgent threat by health agencies worldwide. Bacteriophages are being actively explored as therapeutic alternatives to antibiotics. In an effort to define a robust experimental approach for effective selection of lytic viruses for therapy, we have fully characterized the genomes of 18 Kumoniaetarget strains and tested them against novel lytic bacteriophages (n = 65). The genomes ofK pneumoniaecarryingbla(NDM)andbla(KPC)were sequenced and CG258 isolates selected for bacteriophage susceptibility testing. The localK pneumoniaeCG258 population was dominated by sequence type ST258 clade 1 (86%) with variations in capsular locus (cps) and prophage content. CG258-specific bacteriophages primarily targeted the capsule, but successful infection is also likely blocked in some by immunity conferred by existing prophages. Five tailed bacteriophages againstK pneumoniaeST258 clade 1 were selected for further characterization. Our findings show that effective control ofK pneumoniaeCG258 with bacteriophage will require mixes of diverse lytic viruses targeting relevantcpsvariants and allowing for variable prophage content. These insights will facilitate identification and selection of therapeutic bacteriophage candidates against this serious pathogen.	[Venturini, Carola; Ben Zakour, Nouri L.; Bowring, Bethany; Iredell, Jonathan R.] Westmead Inst Med Res WIMR, Ctr Infect Dis & Microbiol, Westmead, NSW 2145, Australia; [Venturini, Carola; Ben Zakour, Nouri L.; Iredell, Jonathan R.] Univ Sydney, Sydney Med Sch, Sch Med, Sydney, NSW, Australia; [Morales, Sandra; Cole, Robert; Kovach, Zsuzsanna; Branston, Steven] AmpliPhi Australia Pty Ltd, Brookvale, NSW, Australia; [Kettle, Emma] Westmead Inst Med Res, Westmead Res Hub Electron Microscope Core Facil, Westmead, NSW, Australia; [Thomson, Nicholas] Wellcome Trust Sanger Inst, Wellcome Genome Campus, Cambridge, England; [Thomson, Nicholas] London Sch Hyg & Trop Med, London, England; [Iredell, Jonathan R.] Westmead Hosp, Western Sydney Local Hlth Dist WSLHD, Sydney, NSW, Australia	University of Sydney; University of Sydney; Westmead Institute for Medical Research; Wellcome Trust Sanger Institute; University of London; London School of Hygiene & Tropical Medicine; University of Sydney	Venturini, C; Iredell, JR (corresponding author), Westmead Inst Med Res WIMR, Ctr Infect Dis & Microbiol, Westmead, NSW 2145, Australia.	carola.venturini@sydney.edu.au; jonathan.iredell@sydney.edu.au	Venturini, Carola/G-6642-2018; BEN ZAKOUR, Nouri/B-9338-2011	Venturini, Carola/0000-0003-2370-8661; Morales, PhD, Sandra/0000-0001-7085-2864; BEN ZAKOUR, Nouri/0000-0002-6949-1755	National Health and Medical Research Council (NHMRC) [GRP1107322]; Westmead Research Hub; Cancer Institute New South Wales; NHMRC; Ian Potter Foundation	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Westmead Research Hub; Cancer Institute New South Wales; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Ian Potter Foundation	This project was funded by the National Health and Medical Research Council (NHMRC; GRP1107322). The Westmead Scientific Platforms are supported by the Westmead Research Hub, the Cancer Institute New South Wales, the NHMRC and the Ian Potter Foundation	Abedon Stephen T, 2011, Bacteriophage, V1, P66; Abedon Stephen T, 2011, Bacteriophage, V1, P46, DOI 10.4161/bact.1.1.13980; Adriaenssens EM, 2015, VIROLOGY, V477, P144, DOI 10.1016/j.virol.2014.10.016; Agyekum A, 2016, DIAGN MICR INFEC DIS, V84, P328, DOI 10.1016/j.diagmicrobio.2015.12.010; Alcantar-Curiel MD, 2013, VIRULENCE, V4, P129, DOI 10.4161/viru.22974; Arndt D, 2016, NUCLEIC ACIDS RES, V44, pW16, DOI 10.1093/nar/gkw387; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; BARTON BM, 1995, ANAL BIOCHEM, V226, P235, DOI 10.1006/abio.1995.1220; Bell JM, 2016, COMM DIS INTELL, V42, pS2209; Bengoechea JA, 2019, FEMS MICROBIOL REV, V43, P123, DOI 10.1093/femsre/fuy043; Bradford PA, 2004, CLIN INFECT DIS, V39, P55, DOI 10.1086/421495; Brettin T, 2015, SCI REP-UK, V5, DOI 10.1038/srep08365; Chan BK, 2013, FUTURE MICROBIOL, V8, P769, DOI [10.2217/FMB.13.47, 10.2217/fmb.13.47]; Chevallet M, 2006, NAT PROTOC, V1, P1852, DOI 10.1038/nprot.2006.288; Ciacci N, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10090482; Clokie MRJ, 2009, METHODS PROTOCOLS, V1; Croucher NJ, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1196; Cumby N, 2015, MOL MICROBIOL, V96, P437, DOI 10.1111/mmi.12918; Deleo FR, 2014, P NATL ACAD SCI USA, V111, P4988, DOI 10.1073/pnas.1321364111; DOMENICO P, 1989, INFECT IMMUN, V57, P3778, DOI 10.1128/IAI.57.12.3778-3782.1989; Dorman MJ, 2018, MBIO, V9, DOI 10.1128/mBio.01863-18; Fajardo-Lubian A, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007218; Follador R, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000073; Fronzes R, 2008, EMBO J, V27, P2271, DOI 10.1038/emboj.2008.155; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; Holt KE, 2015, P NATL ACAD SCI USA, V112, pE3574, DOI 10.1073/pnas.1501049112; Hsu CR, 2016, SCI REP-UK, V6, DOI 10.1038/srep31946; Hsu CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070092; Jacob JT, 2013, MMWR-MORBID MORTAL W, V62, P165; Kesik-Szeloch A, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-100; Khater F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116215; Ko KS, 2017, VIRULENCE, V8, P485, DOI 10.1080/21505594.2016.1240862; Kos V, 2010, J BIOL CHEM, V285, P19668, DOI 10.1074/jbc.M110.122598; Kwong JC, 2018, PEERJ, V6, DOI 10.7717/peerj.4210; Lam MMC, 2018, MICROB GENOMICS, V4, DOI 10.1099/mgen.0.000196; Lam MCC, 2018, KLEBORATE COMPREHENS; Latka A, 2017, APPL MICROBIOL BIOT, V101, P3103, DOI 10.1007/s00253-017-8224-6; Ly-Chatain MH, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00051; Majkowska-Skrobek G, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02517; Merabishvili M, 2018, METHODS MOL BIOL, V1693, P99, DOI 10.1007/978-1-4939-7395-8_9; Nobrega FL, 2018, NAT REV MICROBIOL, V16, P760, DOI 10.1038/s41579-018-0070-8; Nordmann P, 2009, LANCET INFECT DIS, V9, P228, DOI 10.1016/S1473-3099(09)70054-4; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Page AJ, 2015, BIOINFORMATICS, V31, P3691, DOI 10.1093/bioinformatics/btv421; Pal S, 2019, MICROBIOL-SGM, V165, P891, DOI 10.1099/mic.0.000827; Pan YJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep15573; Partridge SR, 2015, INT J ANTIMICROB AG, V45, P130, DOI 10.1016/j.ijantimicag.2014.10.006; Pires DP, 2016, APPL MICROBIOL BIOT, V100, P2141, DOI 10.1007/s00253-015-7247-0; Pitout JDD, 2015, ANTIMICROB AGENTS CH, V59, P5873, DOI 10.1128/AAC.01019-15; Pitt ME, 2018, MICROB GENOMICS, V4, DOI 10.1099/mgen.0.000158; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589; Shoma S, 2014, DIAGN MICR INFEC DIS, V78, P93, DOI 10.1016/j.diagmicrobio.2013.08.001; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Sullivan MJ, 2011, BIOINFORMATICS, V27, P1009, DOI 10.1093/bioinformatics/btr039; Thiry D, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11050411; Thomsen MCF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157718; Villa L, 2010, J ANTIMICROB CHEMOTH, V65, P2518, DOI 10.1093/jac/dkq347; World Health Organization, 2016, ANTIMICROBIAL RESIST; Wyres KL, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000102; Wyres KL, 2015, GENOME BIOL EVOL, V7, P1267, DOI 10.1093/gbe/evv062	60	5	5	2	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10801	10817		10.1096/fj.201902735R	http://dx.doi.org/10.1096/fj.201902735R		JUN 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32598522	hybrid			2022-12-28	WOS:000546064400001
J	Tengeler, AC; Gart, E; Wiesmann, M; Arnoldussen, IAC; van Duyvenvoorde, W; Hoogstad, M; Dederen, PJ; Verweij, V; Geenen, B; Kozicz, T; Kleemann, R; Morrison, MC; Kiliaan, AJ				Tengeler, Anouk C.; Gart, Eveline; Wiesmann, Maximilian; Arnoldussen, Ilse A. C.; van Duyvenvoorde, Wim; Hoogstad, Marloes; Dederen, Pieter J.; Verweij, Vivienne; Geenen, Bram; Kozicz, Tamas; Kleemann, Robert; Morrison, Martine C.; Kiliaan, Amanda J.			Propionic acid and not caproic acid, attenuates nonalcoholic steatohepatitis and improves (cerebro) vascular functions in obese Ldlr(-/-).Leiden mice	FASEB JOURNAL			English	Article						cerebral vasoreactivity; cognition; liver fibrosis; neuroimaging; obesity	CHAIN FATTY-ACIDS; DIET-INDUCED OBESITY; COGNITIVE IMPAIRMENT; SOCIAL-BEHAVIOR; BRAIN STRUCTURE; INSULIN; MODEL; RATS; QUANTIFICATION; METABOLISM	The obesity epidemic increases the interest to elucidate impact of short-chain fatty acids on metabolism, obesity, and the brain. We investigated the effects of propionic acid (PA) and caproic acid (CA) on metabolic risk factors, liver and adipose tissue pathology, brain function, structure (by MRI), and gene expression, during obesity development in Ldlr(-/-).Leiden mice. Ldlr(-/-).Leiden mice received 16 weeks either a high-fat diet (HFD) to induce obesity, or chow as reference group. Next, obese HFD-fed mice were treated 12 weeks with (a) HFD + CA (CA), (b) HFD + PA (PA), or (c) a HFD-control group. PA reduced the body weight and systolic blood pressure, lowered fasting insulin levels, and reduced HFD-induced liver macrovesicular steatosis, hypertrophy, inflammation, and collagen content. PA increased the amount of glucose transporter type 1-positive cerebral blood vessels, reverted cerebral vasoreactivity, and HFD-induced effects in microstructural gray and white matter integrity of optic tract, and somatosensory and visual cortex. PA and CA also reverted HFD-induced effects in functional connectivity between visual and auditory cortex. However, PA mice were more anxious in open field, and showed reduced activity of synaptogenesis and glutamate regulators in hippocampus. Therefore, PA treatment should be used with caution even though positive metabolic, (cerebro) vascular, and brain structural and functional effects were observed.	[Tengeler, Anouk C.; Wiesmann, Maximilian; Arnoldussen, Ilse A. C.; Hoogstad, Marloes; Dederen, Pieter J.; Verweij, Vivienne; Geenen, Bram; Kozicz, Tamas; Kleemann, Robert; Kiliaan, Amanda J.] Radboud Univ Nijmegen, Dept Anat, Donders Inst Brain Cognit & Behav, Preclin Imaging Ctr,Med Ctr, Nijmegen, Netherlands; [Gart, Eveline; van Duyvenvoorde, Wim; Morrison, Martine C.] Netherlands Org Appl Sci Res TNO, Dept Metab Hlth Res, Leiden, Netherlands; [Gart, Eveline; Morrison, Martine C.] Wageningen Univ, Human & Anim Physiol, Wageningen, Netherlands; [Kozicz, Tamas] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN USA; [Kleemann, Robert] Leiden Univ, Dept Vasc Surg, Med Ctr, Leiden, Netherlands	Radboud University Nijmegen; Wageningen University & Research; Mayo Clinic; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Kiliaan, AJ (corresponding author), Radboud Univ Nijmegen, Dept Anat, Donders Inst Brain Cognit & Behav, Preclin Imaging Ctr PRIME,Med Ctr, Geert Grootepl Noord 21, NL-6525 EZ Nijmegen, Netherlands.	Amanda.Kiliaan@radboudumc.nl	Gart, Eveline/AFI-8480-2022; Geenen, Bram/D-9659-2016; Morrison, Martine C./C-3168-2014; Wiesmann, Maximilian/AAW-1627-2021; Kiliaan, Amanda J/D-8778-2012; Gart, Eveline/AAF-4105-2022	Gart, Eveline/0000-0002-7713-2381; Geenen, Bram/0000-0001-7838-3097; Morrison, Martine C./0000-0003-4996-943X; Wiesmann, Maximilian/0000-0002-1412-398X; Gart, Eveline/0000-0002-7713-2381	TNO Early Research Program 'Body Brain Interactions'	TNO Early Research Program 'Body Brain Interactions'	We thank the bio-technicians at TNO Metabolic Health Research and at the Animal Research Facility of the Radboud university medical center for taking excellent care of the mice. We also thank Andor Veltien, Sjaak van Asten, and Tim Emmerzaal for their great scientific support. This study was supported by the TNO Early Research Program 'Body Brain Interactions'.	Akpa MM, 2010, LIPIDS, V45, P997, DOI 10.1007/s11745-010-3465-5; Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Arnoldussen IAC, 2017, INT J OBESITY, V41, P935, DOI 10.1038/ijo.2017.52; Arnoldussen IAC, 2016, J NUTR BIOCHEM, V30, P177, DOI 10.1016/j.jnutbio.2015.12.011; Bartolomaeus H, 2019, CIRCULATION, V139, P1407, DOI 10.1161/CIRCULATIONAHA.118.036652; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bindels LB, 2012, BRIT J CANCER, V107, P1337, DOI 10.1038/bjc.2012.409; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Burhans MS, 2019, COMPR PHYSIOL, V9, P1, DOI 10.1002/cphy.c170040; Chambers E, 2015, P NUTR SOC, V74; Chambers Edward S, 2018, Curr Nutr Rep, V7, P198, DOI 10.1007/s13668-018-0248-8; Choeiri C, 2002, NEUROSCIENCE, V111, P19, DOI 10.1016/S0306-4522(01)00619-4; Daikhin Y, 2000, J NUTR, V130, p1026S, DOI 10.1093/jn/130.4.1026S; de Mello AH, 2018, LIFE SCI, V192, P26, DOI 10.1016/j.lfs.2017.11.019; de Montgolfier O, 2019, GEROSCIENCE, V41, P511, DOI 10.1007/s11357-019-00070-6; De Vadder F, 2014, CELL, V156, P84, DOI 10.1016/j.cell.2013.12.016; DEMIGNE C, 1995, BRIT J NUTR, V74, P209, DOI 10.1079/BJN19950124; den Besten G, 2015, DIABETES, V64, P2398, DOI 10.2337/db14-1213; Deng J, 2014, CARDIOVASC RES, V103, P473, DOI 10.1093/cvr/cvu154; Deutsch C, 2009, MICROVASC RES, V78, P100, DOI 10.1016/j.mvr.2009.04.004; Emmerzaal TL, 2018, J ALZHEIMERS DIS, V66, P75, DOI 10.3233/JAD-180337; Foley KA, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0087072, 10.1371/journal.pone.0108413]; Friedman SL, 2018, NAT MED, V24, P908, DOI 10.1038/s41591-018-0104-9; Galarraga M, 2012, J LIPID RES, V53, P2791, DOI 10.1194/jlr.D023788; Giles JM, 2018, J AM ASS LAB ANIM SC; Harsan LA, 2010, NMR BIOMED, V23, P884, DOI 10.1002/nbm.1496; Hurr C, 2017, EXP PHYSIOL, V102, P1300, DOI 10.1113/EP086446; Jais A, 2016, CELL, V165, P882, DOI 10.1016/j.cell.2016.03.033; Janssen AJM, 2007, CLIN CHEM, V53, P729, DOI 10.1373/clinchem.2006.078873; Janssen CIF, 2015, J NUTR BIOCHEM, V26, P24, DOI 10.1016/j.jnutbio.2014.08.002; Jennings JR, 2009, NEUROIMAGE, V47, P914, DOI 10.1016/j.neuroimage.2009.04.072; Kilkenny C, 2012, VET CLIN PATH, V41, P27, DOI 10.1111/j.1939-165X.2012.00418.x; Kitade H, 2017, NUTRIENTS, V9, DOI 10.3390/nu9040387; Li M, 2018, EUR J PHARMACOL, V831, P52, DOI 10.1016/j.ejphar.2018.05.003; Liang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075290; Liang WF, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0109757, 10.1371/journal.pone.0090827]; Lin HV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035240; Lopez OL, 2003, ARCH NEUROL-CHICAGO, V60, P1394, DOI 10.1001/archneur.60.10.1394; Lowenstein JM, 1969, METHOD ENZYMOL, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; MacFabe DF, 2007, BEHAV BRAIN RES, V176, P149, DOI 10.1016/j.bbr.2006.07.025; MacFabe DF, 2011, BEHAV BRAIN RES, V217, P47, DOI 10.1016/j.bbr.2010.10.005; Rodriguez MM, 2015, SCI REP-UK, V5, DOI 10.1038/srep14600; Medic N, 2019, INT J OBESITY, V43, P523, DOI 10.1038/s41366-018-0269-9; Morrison MC, 2018, HEPATOL COMMUN, V2, P1513, DOI 10.1002/hep4.1270; Mulder P, 2016, INT J OBESITY, V40, P675, DOI 10.1038/ijo.2015.226; Natarajan N, 2016, PHYSIOL GENOMICS, V48, P826, DOI 10.1152/physiolgenomics.00089.2016; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Ou XW, 2015, J MAGN RESON IMAGING, V42, P1205, DOI 10.1002/jmri.24912; Pannacciulli N, 2006, NEUROIMAGE, V31, P1419, DOI 10.1016/j.neuroimage.2006.01.047; Patrone V, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00200; Paxinos G, 2001, PAXINOS FRANKLINS MO, V4th; Pernold K, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211063; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Renna NF, 2013, INT J HYPERTENS, V2013, DOI 10.1155/2013/808353; Rial SA, 2018, MOLECULES, V23, DOI 10.3390/molecules23092315; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sekar S, 2013, PSYCHOPHARMACOLOGY, V227, P479, DOI 10.1007/s00213-013-2966-3; Seravalle G, 2017, PHARMACOL RES, V122, P1, DOI 10.1016/j.phrs.2017.05.013; Shams S, 2019, DEV PSYCHOBIOL, V61, P688, DOI 10.1002/dev.21825; Shultz SR, 2008, NEUROPHARMACOLOGY, V54, P901, DOI 10.1016/j.neuropharm.2008.01.013; Sorop O, 2017, CARDIOVASC RES, V113, P1035, DOI 10.1093/cvr/cvx093; Takai A, 2020, BMC GASTROENTEROL, V20, DOI 10.1186/s12876-020-01194-2; Tedelind S, 2007, WORLD J GASTROENTERO, V13, P2826, DOI 10.3748/wjg.v13.i20.2826; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; Uranga RM, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00513; van Bloemendaal L, 2016, METAB BRAIN DIS, V31, P621, DOI 10.1007/s11011-016-9792-3; Vani K, 2017, J HISTOCHEM CYTOCHEM, V65, P463, DOI 10.1369/0022155417714208; Wagner J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221455; Wah DTO, 2019, PHYSIOL BEHAV, V199, P35, DOI 10.1016/j.physbeh.2018.11.003; Wiesmann M, 2017, J CEREBR BLOOD F MET, V37, P2396, DOI 10.1177/0271678X16667364; Wiesmann M, 2017, THERANOSTICS, V7, P1277, DOI 10.7150/thno.18509; Wiesmann M, 2017, THERANOSTICS, V7, P493, DOI 10.7150/thno.17559; WRIGHT RS, 1990, P SOC EXP BIOL MED, V195, P26, DOI 10.3181/00379727-195-43113; Wu H, 2016, NEUROSCIENCE, V322, P221, DOI 10.1016/j.neuroscience.2016.02.043; Xu H, 2016, J ENDOCRINOL, V229, P133, DOI 10.1530/JOE-15-0409; Zerbi V, 2014, J NEUROSCI, V34, P13963, DOI 10.1523/JNEUROSCI.0684-14.2014; Zerbi V, 2014, NEUROBIOL AGING, V35, P600, DOI 10.1016/j.neurobiolaging.2013.09.038	79	16	16	2	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9575	9593		10.1096/fj.202000455R	http://dx.doi.org/10.1096/fj.202000455R		MAY 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32472598	Green Published			2022-12-28	WOS:000538118400001
J	Nederveen, JP; Joanisse, S; Thomas, ACQ; Snijders, T; Manta, K; Bell, KE; Phillips, SM; Kumbhare, D; Parise, G				Nederveen, Joshua P.; Joanisse, Sophie; Thomas, Aaron C. Q.; Snijders, Tim; Manta, Katherine; Bell, Kirsten E.; Phillips, Stuart M.; Kumbhare, Dinesh; Parise, Gianni			Age-related changes to the satellite cell niche are associated with reduced activation following exercise	FASEB JOURNAL			English	Article						basal lamina; muscle stem cells; Pax7; satellite cell niche	FAST SKELETAL-MUSCLE; EXTRACELLULAR-MATRIX; IV COLLAGEN; CONNECTIVE-TISSUE; IN-VITRO; SENESCENCE; MICE; FIBROBLASTS; LAMININ; YOUNG	Skeletal muscle satellite cell (SC) function and responsiveness is regulated, in part, through interactions within the niche, in which they reside. Evidence suggests that structural changes occur in the SC niche as a function of aging. In the present study, we investigated the impact of aging on SC niche properties. Muscle biopsies were obtained from the vastus lateralis of healthy young (YM; 21 +/- 1 yr; n = 10) and older men (OM; 68 +/- 1 yr; n = 16) at rest. A separate group of OM performed a single bout of resistance exercise and additional muscle biopsies were taken 24 and 48 hours post-exercise; this was performed before and following 12 wks of combined exercise training (OM-Ex; 73 +/- 1; n = 24). Muscle SC niche measurements were assessed using high resolution immunofluorescent confocal microscopy. Type II SC niche laminin thickness was greater in OM (1.86 +/- 0.06 mu m) as compared to YM (1.55 +/- 0.09 mu m, P < .05). The percentage of type II-associated SC that were completely surrounded by laminin was greater in OM (13.6%+/- 4.2%) as compared to YM (3.5%+/- 1.5%; P < .05). In non-surrounded SC, the proportion of active MyoD(+)/Pax7(+) SC were higher compared to surrounded SC (P < .05) following a single bout of exercise. This "incarceration" of the SC niche by laminin appears with aging and may inhibit SC activation in response to exercise.	[Nederveen, Joshua P.; Joanisse, Sophie; Thomas, Aaron C. Q.; Snijders, Tim; Manta, Katherine; Bell, Kirsten E.; Phillips, Stuart M.; Parise, Gianni] McMaster Univ, Dept Kinesiol, Hamilton, ON L8S 4L8, Canada; [Snijders, Tim] Maastricht Univ, Med Ctr, NUTRIM Sch Nutr & Translat Res Metab, Human Biol, Maastricht, Netherlands; [Kumbhare, Dinesh] Toronto Rehabil Inst, Toronto, ON, Canada	McMaster University; Maastricht University; Maastricht University Medical Centre (MUMC); University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto Rehabilitation Institute	Parise, G (corresponding author), McMaster Univ, Dept Kinesiol, Hamilton, ON L8S 4L8, Canada.	pariseg@mcmaster.ca	Phillips, Stuart/B-2343-2009	Phillips, Stuart/0000-0002-1956-4098; Joanisse, Sophie/0000-0001-9983-9401	Natural Sciences and Engineering Research Council of Canada; McMaster University	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); McMaster University	Natural Sciences and Engineering Research Council of Canada; McMaster University	ALNAQEEB MA, 1984, J ANAT, V139, P677; Baghdadi MB, 2018, NATURE, V557, P714, DOI 10.1038/s41586-018-0144-9; Bell KE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181387; Bentzinger CF, 2013, EMBO REP, V14, P1062, DOI 10.1038/embor.2013.182; Bentzinger CF, 2013, CELL STEM CELL, V12, P75, DOI 10.1016/j.stem.2012.09.015; Bonnemann CG, 2011, NAT REV NEUROL, V7, P379, DOI 10.1038/nrneurol.2011.81; Bonnemann CG, 2004, CURR OPIN NEUROL, V17, P529; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Candiello J, 2010, MATRIX BIOL, V29, P402, DOI 10.1016/j.matbio.2010.03.004; Carlson ME, 2008, NATURE, V454, P528, DOI 10.1038/nature07034; Chang NC, 2016, TRENDS MOL MED, V22, P479, DOI 10.1016/j.molmed.2016.04.002; Christov C, 2007, MOL BIOL CELL, V18, P1397, DOI 10.1091/mbc.E06-08-0693; Feru J, 2016, EUR J DERMATOL, V26, P350, DOI 10.1684/ejd.2016.2782; Fry CS, 2015, NAT MED, V21, P76, DOI 10.1038/nm.3710; Garcia-Prat L, 2016, NATURE, V529, P37, DOI 10.1038/nature16187; Garg K, 2016, J APPL PHYSIOL, V121, P1053, DOI 10.1152/japplphysiol.00594.2016; Goetsch KP, 2013, J MUSCLE RES CELL M, V34, P333, DOI 10.1007/s10974-013-9364-7; Goetsch KP, 2011, MATRIX BIOL, V30, P109, DOI 10.1016/j.matbio.2010.10.009; GOLDNER JACQUES, 1938, AMER JOUR PATH, V14, P237; Hadler-Olsen E, 2015, J CELL PHYSIOL, V230, P160, DOI 10.1002/jcp.24694; Harburger DS, 2009, J CELL SCI, V122, P159, DOI 10.1242/jcs.018093; Hindle AG, 2009, J EXP BIOL, V212, P790, DOI 10.1242/jeb.025387; Joanisse S, 2016, FASEB J, V30, P3256, DOI 10.1096/fj.201600143RR; Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015; Jones DL, 2008, NAT REV MOL CELL BIO, V9, P11, DOI 10.1038/nrm2319; Kadi F, 2004, MUSCLE NERVE, V29, P120, DOI 10.1002/mus.10510; Kjaer M, 2004, PHYSIOL REV, V84, P649, DOI 10.1152/physrev.00031.2003; KOVANEN V, 1988, COLLAGEN REL RES, V8, P145; KOVANEN V, 1987, CELL TISSUE RES, V248, P247; Kragstrup TW, 2011, SCAND J MED SCI SPOR, V21, P749, DOI 10.1111/j.1600-0838.2011.01377.x; KUHL U, 1984, DIFFERENTIATION, V28, P164, DOI 10.1111/j.1432-0436.1984.tb00279.x; Labat-Robert J, 2003, PATHOL BIOL, V51, P563, DOI 10.1016/j.patbio.2003.09.006; Lacraz G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136217; Lampe AK, 2005, J MED GENET, V42, P673, DOI 10.1136/jmg.2002.002311; Lepper C, 2011, DEVELOPMENT, V138, P3639, DOI 10.1242/dev.067595; LEXELL J, 1988, J NEUROL SCI, V84, P275, DOI 10.1016/0022-510X(88)90132-3; Liu D, 2007, CANCER RES, V67, P3117, DOI 10.1158/0008-5472.CAN-06-3452; Lu PF, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005058; Mann CJ, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-21; Marguerat S, 2012, TRENDS GENET, V28, P560, DOI 10.1016/j.tig.2012.07.003; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; McCarthy JJ, 2011, DEVELOPMENT, V138, P3657, DOI 10.1242/dev.068858; MCCARTHY R A, 1991, International Journal of Developmental Biology, V35, P437; McKay BR, 2012, FASEB J, V26, P2509, DOI 10.1096/fj.11-198663; MITSUI Y, 1976, EXP CELL RES, V100, P147, DOI 10.1016/0014-4827(76)90336-0; Morrison J, 2000, LAB INVEST, V80, P881, DOI 10.1038/labinvest.3780092; Nederveen JP, 2015, ACTA PHYSIOL, V215, P177, DOI 10.1111/apha.12601; Nederveen JP, 2018, J PHYSIOL-LONDON, V596, P1063, DOI 10.1113/JP275155; Nederveen JP, 2016, J CACHEXIA SARCOPENI, V7, P547, DOI 10.1002/jcsm.12105; Nilwik R, 2013, EXP GERONTOL, V48, P492, DOI 10.1016/j.exger.2013.02.012; Patton BL, 1999, NEUROMUSCULAR DISORD, V9, P423, DOI 10.1016/S0960-8966(99)00033-4; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; Pijuan J, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00107; Ramaswamy KS, 2011, J PHYSIOL-LONDON, V589, P1195, DOI 10.1113/jphysiol.2010.201921; Rayagiri SS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03425-3; Rebalka IA, 2018, AM J PHYSIOL-CELL PH, V315, pC714, DOI 10.1152/ajpcell.00195.2017; Ryall JG, 2008, BIOGERONTOLOGY, V9, P213, DOI 10.1007/s10522-008-9131-0; Sadaie M, 2015, MOL BIOL CELL, V26, P2971, DOI 10.1091/mbc.E15-01-0003; Sambasivan R, 2011, DEVELOPMENT, V138, P3647, DOI 10.1242/dev.067587; Sanes JR, 2003, J BIOL CHEM, V278, P12601, DOI 10.1074/jbc.R200027200; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Snijders T, 2019, J PHYSIOL-LONDON, V597, P105, DOI 10.1113/JP276260; Snijders T, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00283; Snijders T, 2014, AGE, V36, DOI 10.1007/s11357-014-9699-z; SNOW MH, 1977, CELL TISSUE RES, V185, P399; Sousa-Victor P, 2014, NATURE, V506, P316, DOI 10.1038/nature13013; Sprenger CCT, 2008, NEOPLASIA, V10, P1350, DOI 10.1593/neo.08746; Stein GH, 1999, MOL CELL BIOL, V19, P2109; Thomas K, 2015, CONNECT TISSUE RES, V56, P1, DOI 10.3109/03008207.2014.947369; Trensz F, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0030-1; Urciuolo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2964; Vazquez F, 1996, MATURITAS, V25, P209, DOI 10.1016/S0378-5122(96)01066-3; Verdijk LB, 2007, AM J PHYSIOL-ENDOC M, V292, pE151, DOI 10.1152/ajpendo.00278.2006; Verdijk LB, 2014, AGE, V36, P545, DOI 10.1007/s11357-013-9583-2	74	7	7	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					8975	8989		10.1096/fj.201900787R	http://dx.doi.org/10.1096/fj.201900787R		MAY 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32463134	Green Accepted			2022-12-28	WOS:000536309700001
J	Chen, KH; Chen, J; Wang, L; Yang, J; Xiao, F; Wang, XY; Yuan, JJ; Wang, LM; He, YN				Chen, Kehong; Chen, Jia; Wang, Ling; Yang, Jie; Xiao, Fei; Wang, Xianyue; Yuan, Junjie; Wang, Limin; He, Yani			Parkin ubiquitinates GATA4 and attenuates the GATA4/GAS1 signaling and detrimental effects on diabetic nephropathy	FASEB JOURNAL			English	Article						diabetic nephropathy; GATA4; Parkin; renal tubular epithelial cells; ubiquitination	TUBULAR EPITHELIAL-CELLS; RENAL-FUNCTION DECLINE; CELLULAR SENESCENCE; ACCELERATED SENESCENCE; INJURY; MITOPHAGY; PROMOTES; DISEASE; GAS1; DEGRADATION	Renal tubular injury contributes to the progression of diabetic nephropathy (DN). This study explored the role and mechanisms of E3-ubiquitin ligase Parkin in the renal tubular injury of DN. We found that Parkin expression gradually decreased and was inversely associated with IL-6, TGF-beta 1, and GATA4 expression in the kidney during the progression of DN. Parkin over-expression (OE) reduced inflammation, fibrosis, premature senescence of renal tubular epithelial cells (RTECs), and improved renal function while Parkin knockout (KO) had opposite effects in DN mice. Parkin-OE decreased GATA4 protein, but not its mRNA transcripts in the kidney of DN mice and high glucose (HG)-treated RTECs. Immunoprecipitation indicated that Parkin directly interacted with GATA4 in DN kidney. Parkin-OE enhanced GATA4 ubiquitination. Furthermore, Parkin-KO upregulated growth arrest-specific gene 1 (GAS1) expression in renal tubular tissues of DN mice and GATA4-OE enhanced the HG-upregulated GAS1 expression in RTECs. Conversely, GAS1-OE mitigated the effect of Parkin-OE on HG-induced P21, IL-6, and TGF-beta 1 expression in RTECs. These results indicate that Parkin inhibits the progression of DN by promoting GATA4 ubiquitination and downregulating the GATA4/GAS1 signaling to inhibit premature senescence, inflammation, and fibrosis in DN mice. Thus, these findings uncover new mechanisms underlying the action of Parkin during the process of DN.	[Chen, Kehong; Chen, Jia; Wang, Ling; Yang, Jie; Xiao, Fei; Wang, Xianyue; Yuan, Junjie; Wang, Limin; He, Yani] Army Med Univ, Daping Hosp, Dept Nephrol, Chongqing 400042, Peoples R China	Army Medical University	He, YN (corresponding author), Army Med Univ, Daping Hosp, Dept Nephrol, Chongqing 400042, Peoples R China.	heynmail@163.com			NSFC | National Natural Science Foundation of China [81670661, 81770731]; 12th Five-year Science Foundation [AWS14C003]; National Science and Technology Support Plan [2015BAI12B06, 2016YFC1305501]	NSFC | National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 12th Five-year Science Foundation; National Science and Technology Support Plan	NSFC | National Natural Science Foundation of China, Grant/Award Number: 81670661 and 81770731; 12th Five-year Science Foundation, Grant/Award Number: AWS14C003; National Science and Technology Support Plan, Grant/Award Number: 2015BAI12B06 and 2016YFC1305501	Braun H, 2012, J AM SOC NEPHROL, V23, P1467, DOI 10.1681/ASN.2011100967; Carroll RG, 2014, CELL REP, V9, P1538, DOI 10.1016/j.celrep.2014.10.046; Cassidy LD, 2015, SCIENCE, V349, P1448, DOI 10.1126/science.aad2501; Checler F, 2017, AUTOPHAGY, V13, P2004, DOI 10.1080/15548627.2017.1363950; Chen KH, 2019, FASEB J, V33, P4571, DOI 10.1096/fj.201801749RRR; Chen KH, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0127-z; Chen KH, 2013, INT J BIOCHEM CELL B, V45, P932, DOI 10.1016/j.biocel.2013.02.009; D'Onofrio N, 2016, FREE RADICAL BIO MED, V96, P211, DOI 10.1016/j.freeradbiomed.2016.04.013; Fakhruddin S, 2017, J DIABETES RES, V2017, DOI 10.1155/2017/8379327; Freund A, 2011, EMBO J, V30, P1536, DOI 10.1038/emboj.2011.69; Gao YG, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02283-2; Grimaldo L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185289; Hadjadj S, 2016, DIABETOLOGIA, V59, P208, DOI 10.1007/s00125-015-3785-3; He AB, 2011, P NATL ACAD SCI USA, V108, P5632, DOI 10.1073/pnas.1016959108; Hwang S, 2017, J DIABETES COMPLICAT, V31, P1704, DOI 10.1016/j.jdiacomp.2017.08.009; Joo-Ho S, 2016, CELL, V144, P689; Ka SM, 2007, J AM SOC NEPHROL, V18, P1777, DOI 10.1681/ASN.2006080901; Kang C, 2015, SCIENCE, V349, DOI 10.1126/science.aaa5612; Kann M, 2015, DEVELOPMENT, V142, P1254, DOI 10.1242/dev.119735; Kitada K, 2014, J DIABETES COMPLICAT, V28, P604, DOI 10.1016/j.jdiacomp.2014.05.010; Kovalchuke L, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47952-5; LANG EK, 1992, RADIOLOGY, V182, P703, DOI 10.1148/radiology.182.3.1535883; Lee SB, 2015, MOL CELL, V60, P21, DOI 10.1016/j.molcel.2015.08.011; Li W, 2017, ENDOCRINOLOGY, V158, P2155, DOI 10.1210/en.2016-1970; Lin QS, 2019, REDOX BIOL, V26, DOI 10.1016/j.redox.2019.101254; Liu J, 2015, AM J PHYSIOL-CELL PH, V308, pC621, DOI 10.1152/ajpcell.00096.2014; Liu J, 2012, TRANSL RES, V159, P454, DOI 10.1016/j.trsl.2011.11.008; Long J, 2008, J BIOL CHEM, V283, P5427, DOI 10.1074/jbc.M704973200; Magri CJ, 2009, EUR J INTERN MED, V20, P551, DOI 10.1016/j.ejim.2008.12.012; Marmary Y, 2016, CANCER RES, V76, P1170, DOI 10.1158/0008-5472.CAN-15-1671; Martinelli DC, 2007, CELL CYCLE, V6, P2650, DOI 10.4161/cc.6.21.4877; Mazzucco AE, 2017, GENE DEV, V31, P1933, DOI 10.1101/gad.304857.117; Meyer TW, 2003, KIDNEY INT, V63, P774, DOI 10.1046/j.1523-1755.2003.00795.x; Pickrell AM, 2015, NEURON, V85, P257, DOI 10.1016/j.neuron.2014.12.007; Qin W, 2011, J AM SOC NEPHROL, V22, P1462, DOI 10.1681/ASN.2010121308; Rana A, 2013, P NATL ACAD SCI USA, V110, P8638, DOI 10.1073/pnas.1216197110; Schena FP, 2005, J AM SOC NEPHROL, V16, pS30, DOI 10.1681/ASN.2004110970; Stebel M, 2000, FEBS LETT, V481, P152, DOI 10.1016/S0014-5793(00)02004-4; Tang CY, 2018, AUTOPHAGY, V14, P880, DOI 10.1080/15548627.2017.1405880; TANNER GA, 1989, KIDNEY INT, V36, P1050, DOI 10.1038/ki.1989.300; Verzola D, 2008, AM J PHYSIOL-RENAL, V295, pF1563, DOI 10.1152/ajprenal.90302.2008; Vilchez D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6659; Wang Y, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1152-2; Winklhofer KF, 2014, TRENDS CELL BIOL, V24, P332, DOI 10.1016/j.tcb.2014.01.001; Xiao L, 2017, REDOX BIOL, V11, P297, DOI 10.1016/j.redox.2016.12.022; Yang JR, 2017, J AM SOC NEPHROL, V28, P532, DOI 10.1681/ASN.2016010009; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797; Zhao CY, 2017, EXP CELL RES, V350, P390, DOI 10.1016/j.yexcr.2016.12.015; Zhu JQ, 2018, AM J TRANSL RES, V10, P4163	49	4	5	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					8858	8875		10.1096/fj.202000053R	http://dx.doi.org/10.1096/fj.202000053R		MAY 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32436607	hybrid			2022-12-28	WOS:000535480300001
J	Liu, T; Woo, JAA; Bukhari, MZ; LePochat, P; Chacko, A; Selenica, MLB; Yan, Y; Kotsiviras, P; Buosi, SC; Zhao, XY; Kang, DVE				Liu, Tian; Woo, Jung-A A.; Bukhari, Mohammed Zaheen; LePochat, Patrick; Chacko, Ann; Selenica, Maj-Linda B.; Yan, Yan; Kotsiviras, Peter; Buosi, Sara Cazzaro; Zhao, Xingyu; Kang, David E.			CHCHD10-regulated OPA1-mitofilin complex mediates TDP-43-induced mitochondrial phenotypes associated with frontotemporal dementia	FASEB JOURNAL			English	Article						CHCHD10; frontotemporal dementia; mitofilin; OPA1; TDP-43	AMYOTROPHIC-LATERAL-SCLEROSIS; CHCHD10 MUTATIONS; CONTACT SITE; TAU PATHOLOGY; MICOS COMPLEX; IN-VIVO; TDP-43; DISEASE; ALS; GENE	Mutations in CHCHD10, a gene coding for a mitochondrial protein, are implicated in ALS-FTD spectrum disorders, which are pathologically characterized by transactive response DNA binding protein 43 kDa (TDP-43) accumulation. While both TDP-43 and CHCHD10 mutations drive mitochondrial pathogenesis, mechanisms underlying such phenotypes are unclear. Moreover, despite the disruption of the mitochondrial mitofilin protein complex at cristae junctions in patient fibroblasts bearing the CHCHD10(S59L) mutation, the role of CHCHD10 variants in mitofilin-associated protein complexes in brain has not been examined. Here, we utilized novel CHCHD10 transgenic mouse variants (WT, R15L, & S59L), TDP-43 transgenic mice, FTLD-TDP patient brains, and transfected cells to assess the interplay between CHCHD10 and TDP-43 on mitochondrial phenotypes. We show that CHCHD10 mutations disrupt mitochondrial OPA1-mitofilin complexes in brain, associated with impaired mitochondrial fusion and respiration. Likewise, CHCHD10 levels and OPA1-mitofilin complexes are significantly reduced in brains of FTLD-TDP patients and TDP-43 transgenic mice. In cultured cells, CHCHD10 knockdown results in OPA1-mitofilin complex disassembly, while TDP-43 overexpression also reduces CHCHD10, promotes OPA1-mitofilin complex disassembly via CHCHD10, and impairs mitochondrial fusion and respiration, phenotypes that are rescued by wild type (WT) CHCHD10. These results indicate that disruption of CHCHD10-regulated OPA1-mitofilin complex contributes to mitochondrial abnormalities in FTLD-TDP and suggest that CHCHD10 restoration could ameliorate mitochondrial dysfunction in FTLD-TDP.	[Liu, Tian; Woo, Jung-A A.; Bukhari, Mohammed Zaheen; LePochat, Patrick; Chacko, Ann; Yan, Yan; Kotsiviras, Peter; Buosi, Sara Cazzaro; Zhao, Xingyu; Kang, David E.] USF Hlth Morsani Coll Med, Byrd Alzheimers Ctr & Res Inst, Tampa, FL 33613 USA; [Liu, Tian; Bukhari, Mohammed Zaheen; LePochat, Patrick; Chacko, Ann; Yan, Yan; Kotsiviras, Peter; Buosi, Sara Cazzaro; Zhao, Xingyu; Kang, David E.] USF Hlth Morsani Coll Med, Dept Mol Med, Tampa, FL USA; [Woo, Jung-A A.] USF Hlth Morsani Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL USA; [Selenica, Maj-Linda B.] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY USA; [Kang, David E.] James A Haley Vet Adm Hosp, Tampa, FL USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; University of Kentucky; US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital	Liu, T; Kang, DVE (corresponding author), USF Hlth Morsani Coll Med, Byrd Alzheimers Ctr & Res Inst, Tampa, FL 33613 USA.	tianliu@usf.edu; dkang@usf.edu		Woo, Jung A/0000-0002-9194-1361; Kang, David E./0000-0002-7132-821X	Foundation for the National Institutes of Health (FNIH) [1RF1AG053060-01A1, 5R01NS073899]; U.S. Department of Veterans Affairs (VA) [1 I01 BX002478-01A1]; Florida Department of Health [8AZ29]	Foundation for the National Institutes of Health (FNIH); U.S. Department of Veterans Affairs (VA)(US Department of Veterans Affairs); Florida Department of Health	Foundation for the National Institutes of Health (FNIH), Grant/Award Number: 1RF1AG053060-01A1 and 5R01NS073899; U.S. Department of Veterans Affairs (VA), Grant/Award Number: 1 I01 BX002478-01A1; Florida Department of Health, Grant/Award Number: 8AZ29	Alami NH, 2014, NEURON, V81, P536, DOI 10.1016/j.neuron.2013.12.018; Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298; Anderson CJ, 2019, ACTA NEUROPATHOL, V138, P103, DOI 10.1007/s00401-019-01989-y; Aras S, 2013, NUCLEIC ACIDS RES, V41, P2255, DOI 10.1093/nar/gks1454; Auranen M, 2015, NEUROL-GENET, V1, DOI 10.1212/NXG.0000000000000003; Bannwarth S, 2014, BRAIN, V137, P2329, DOI 10.1093/brain/awu138; Borthwick GM, 1999, ANN NEUROL, V46, P787, DOI 10.1002/1531-8249(199911)46:5<787::AID-ANA17>3.0.CO;2-8; Brockmann SJ, 2018, HUM MOL GENET, V27, P706, DOI 10.1093/hmg/ddx436; Burstein SR, 2018, HUM MOL GENET, V27, P160, DOI 10.1093/hmg/ddx397; Callegari S, 2019, J MOL BIOL, V431, P2835, DOI 10.1016/j.jmb.2019.05.015; Cho B, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15754; Colombrita C, 2009, J NEUROCHEM, V111, P1051, DOI 10.1111/j.1471-4159.2009.06383.x; Darshi M, 2011, J BIOL CHEM, V286, P2918, DOI 10.1074/jbc.M110.171975; Davis SA, 2018, NEUROSCI LETT, V678, P8, DOI 10.1016/j.neulet.2018.04.053; Del Dotto V, 2017, CELL REP, V19, P2557, DOI 10.1016/j.celrep.2017.05.073; Delettre C, 2001, HUM GENET, V109, P584, DOI 10.1007/s00439-001-0633-y; Feneberg E, 2018, MOL NEUROBIOL, V55, P7789, DOI 10.1007/s12035-018-0947-6; Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Friedman JR, 2015, ELIFE, V4, DOI 10.7554/eLife.07739; Genin EC, 2019, ACTA NEUROPATHOL, V138, P123, DOI 10.1007/s00401-019-01988-z; Genin EC, 2018, NEUROBIOL DIS, V119, P159, DOI 10.1016/j.nbd.2018.07.027; Genin EC, 2016, EMBO MOL MED, V8, P58, DOI 10.15252/emmm.201505496; Glytsou C, 2016, CELL REP, V17, P3024, DOI 10.1016/j.celrep.2016.11.049; Guarani V, 2015, ELIFE, V4, DOI 10.7554/eLife.06265; Harner M, 2011, EMBO J, V30, P4356, DOI 10.1038/emboj.2011.379; Huang HP, 2019, HUM MOL GENET, V28, P3880, DOI 10.1093/hmg/ddz218; Huynen MA, 2016, BBA-MOL CELL RES, V1863, P91, DOI 10.1016/j.bbamcr.2015.10.009; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Jiang TC, 2019, DIS MODEL MECH, V12, DOI 10.1242/dmm.038109; Johnson JO, 2014, BRAIN, V137, DOI 10.1093/brain/awu265; Joshi AU, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708166; Kaurov I, 2018, CURR BIOL, V28, P3393, DOI 10.1016/j.cub.2018.09.008; Lee MK, 2002, P NATL ACAD SCI USA, V99, P8968, DOI 10.1073/pnas.132197599; Li H, 2016, CELL DEATH DIFFER, V23, P380, DOI 10.1038/cdd.2015.102; Li Q, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7183; Liu W, 2020, CELL DEATH DIFFER, V10, P1038; Lomen-Hoerth C, 2002, NEUROLOGY, V59, P1077, DOI 10.1212/WNL.59.7.1077; Lu JS, 2012, BRAIN RES BULL, V89, P185, DOI 10.1016/j.brainresbull.2012.09.005; MacVicar T, 2016, J CELL SCI, V129, P2297, DOI 10.1242/jcs.159186; Malka F, 2005, EMBO REP, V6, P853, DOI 10.1038/sj.embor.7400488; Meng H, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15500; Muller K, 2014, BRAIN, V137, DOI 10.1093/brain/awu227; Muyderman H, 2014, BRIT J PHARMACOL, V171, P2191, DOI 10.1111/bph.12476; Penttila S, 2015, ANN NEUROL, V77, P163, DOI 10.1002/ana.24319; Pham AH, 2012, GENESIS, V50, P833, DOI 10.1002/dvg.22050; Purandare N, 2018, J BIOL CHEM, V293, P6517, DOI 10.1074/jbc.RA117.001073; Rampelt H, 2017, BBA-MOL CELL RES, V1864, P737, DOI 10.1016/j.bbamcr.2016.05.020; Smith EF, 2019, NEUROSCI LETT, V710, DOI 10.1016/j.neulet.2017.06.052; Song ZY, 2009, MOL BIOL CELL, V20, P3525, DOI 10.1091/mbc.E09-03-0252; Stoica R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4996; Straub IR, 2018, HUM MOL GENET, V27, P178, DOI 10.1093/hmg/ddx393; SU C, 1994, ANAL BIOCHEM, V223, P93, DOI 10.1006/abio.1994.1552; Wai T, 2015, SCIENCE, V350, DOI 10.1126/science.aad0116; Wang P, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1007947; Wang WZ, 2016, NAT MED, V22, P869, DOI 10.1038/nm.4130; Wang WZ, 2013, HUM MOL GENET, V22, P4706, DOI 10.1093/hmg/ddt319; Wils H, 2010, P NATL ACAD SCI USA, V107, P3858, DOI 10.1073/pnas.0912417107; Woo JA, 2017, HUM MOL GENET, V26, P3973, DOI 10.1093/hmg/ddx284; Woo JAA, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0359-9; Woo JAA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15558; Wu X, 2018, J CELL BIOL, V217, P139, DOI 10.1083/jcb.201702125; Xu YF, 2010, J NEUROSCI, V30, P10851, DOI 10.1523/JNEUROSCI.1630-10.2010; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Zhang M, 2015, BRAIN, V138, DOI 10.1093/brain/awv082	66	9	9	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8493	8509		10.1096/fj.201903133RR	http://dx.doi.org/10.1096/fj.201903133RR		MAY 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32369233	Green Accepted			2022-12-28	WOS:000530303800001
J	Abid, N; Embola, J; Tryfonos, Z; Bercher, J; Ashton, SV; Khalil, A; Thilaganathan, B; Cartwright, JE; Whitley, GS				Abid, Naila; Embola, Joan; Tryfonos, Zoe; Bercher, Julia; Ashton, Sandra V.; Khalil, Asma; Thilaganathan, Baskaran; Cartwright, Judith E.; Whitley, Guy S.			Regulation of stanniocalcin-1 secretion by BeWo cells and first trimester human placental tissue from normal pregnancies and those at increased risk of developing preeclampsia	FASEB JOURNAL			English	Article						first trimester; hypoxia; placenta; stanniocalcin-1; trophoblasts	MESSENGER-RNA EXPRESSION; DIBUTYRYL-CAMP; TRANSCRIPTION; MITOCHONDRIA; ACTIVATION; HORMONE; PATHWAY; GROWTH; INJURY	Stanniocalcin-1 (STC-1) is a multi-functional glycosylated peptide present in the plasma of healthy women postpartum and increased further in pregnancies complicated by preeclampsia. Although the STC-1 gene is expressed by the placenta what regulates its secretion and from which cells at the feto-maternal interface is unknown. Here, we demonstrate for the first time that the syncytiotrophoblast and cytotrophoblast are a major site of STC-1 protein expression in first trimester placental tissue. Further, in response to low oxygen, first trimester chorionic villous tissue from pregnancies at increased risk of developing preeclampsia secreted significantly more STC-1 than normal tissue under the same conditions. Using the human trophoblast cell line BeWo we have shown that low oxygen increased the secretion of STC-1 but it required co-stimulation with the Adenosine-3', 5'-cyclic monophosphate (cAMP) analogue, 8-Bromo adenosine-3', 5'-cyclic monophosphate cAMP (8 Br-cAMP) to reach significance. Inhibition of Hypoxia inducible factor 2 alpha (HIF-2 alpha) and the Phosphatidylinositol-3 kinase (PI3-Kinase)/AKT/Serum and glucocorticoid-induced kinase-1(SGK-1) pathway resulted in significant inhibition of STC-1 secretion. As both low oxygen and cAMP are known to play a central role in placental function, their regulation of STC-1 points to a potentially important role in the maintenance of a normal healthy pregnancy and we would hypothesize that it may act to protect against prolonged placental hypoxia seen in preeclampsia.	[Abid, Naila; Embola, Joan; Tryfonos, Zoe; Bercher, Julia; Ashton, Sandra V.; Khalil, Asma; Thilaganathan, Baskaran; Cartwright, Judith E.; Whitley, Guy S.] St Georges Univ London, Mol & Clin Sci Res Inst, Ctr Vasc Biol, Cranmer Terrace, London SW17 0RE, England; [Ashton, Sandra V.; Khalil, Asma; Thilaganathan, Baskaran] St Georges Univ Hosp NHS Fdn Trust, Fetal Med Unit, London, England	St Georges University London	Cartwright, JE; Whitley, GS (corresponding author), St Georges Univ London, Mol & Clin Sci Res Inst, Ctr Vasc Biol, Cranmer Terrace, London SW17 0RE, England.	jcartwri@sgul.ac.uk; gwhitley@sgul.ac.uk	Whitley, Guy/A-9300-2019	Whitley, Guy/0000-0002-9670-3004	Medical Research Council [MR/M02184X/1] Funding Source: Medline; MRC [MR/M02184X/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aghajanova L, 2016, FERTIL STERIL, V106, P681, DOI 10.1016/j.fertnstert.2016.05.023; Brown MA, 2001, HYPERTENS PREGNANCY, V20, pIX, DOI 10.1081/PRG-100104165; Burton GJ, 2009, PLACENTA, V30, P473, DOI 10.1016/j.placenta.2009.02.009; Chang ACM, 2003, ENDOCR-RELAT CANCER, V10, P359, DOI 10.1677/erc.0.0100359; CHANG ACM, 1995, MOL CELL ENDOCRINOL, V112, P241, DOI 10.1016/0303-7207(95)03601-3; Chang ACM, 2015, CLIN EXP METASTAS, V32, P15, DOI 10.1007/s10585-014-9687-9; Cindrova-Davies T, 2015, MOL HUM REPROD, V21, P296, DOI 10.1093/molehr/gau105; Ellard JP, 2007, MOL CELL ENDOCRINOL, V264, P90, DOI 10.1016/j.mce.2006.10.008; Flugel D, 2007, MOL CELL BIOL, V27, P3253, DOI 10.1128/MCB.00015-07; Forbes K, 2009, PLACENTA, V30, P124, DOI 10.1016/j.placenta.2008.10.003; Garcia-Morales V, 2017, BIOCHEM PHARMACOL, V145, P94, DOI 10.1016/j.bcp.2017.09.004; He J, 2015, EXP CELL RES, V331, P164, DOI 10.1016/j.yexcr.2014.09.024; Highet AR, 2015, EUR J CELL BIOL, V94, P589, DOI 10.1016/j.ejcb.2015.10.004; Hollis B, 2001, ULTRASOUND OBST GYN, V18, P593, DOI 10.1046/j.0960-7692.2001.00544.x; Juhanson P, 2016, J CLIN ENDOCR METAB, V101, P4799, DOI 10.1210/jc.2016-1873; Kim LC, 2017, ONCOGENE, V36, P2191, DOI 10.1038/onc.2016.363; Kim YS, 2009, CANCER LETT, V276, P102, DOI 10.1016/j.canlet.2008.10.034; Kloverpris S, 2015, J BIOL CHEM, V290, P21915, DOI 10.1074/jbc.M115.650143; Law AYS, 2010, MOL CELL ENDOCRINOL, V314, P118, DOI 10.1016/j.mce.2009.07.007; Leslie K, 2015, AM J PATHOL, V185, P2731, DOI 10.1016/j.ajpath.2015.06.020; Li L, 2008, MOL CELL ENDOCRINOL, V283, P96, DOI 10.1016/j.mce.2007.11.028; Liu GZ, 2010, JNCI-J NATL CANCER I, V102, P812, DOI 10.1093/jnci/djq127; Ma X, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0421-4; Martinez F, 1997, ENDOCRINOLOGY, V138, P2172, DOI 10.1210/en.138.5.2172; Maulik D, 2006, CLIN OBSTET GYNECOL, V49, P219, DOI 10.1097/00003081-200606000-00005; Meidan R, 2013, REPROD FERT DEVELOP, V25, P343, DOI 10.1071/RD12139; Mohammadipoor A, 2016, TRANSL RES, V177, P127, DOI 10.1016/j.trsl.2016.06.011; Mohlin S, 2015, CANCER RES, V75, P4617, DOI 10.1158/0008-5472.CAN-15-0708; Paciga M, 2004, ENDOCRINOLOGY, V145, P4204, DOI 10.1210/en.2003-1613; Salnikow K, 2003, CANCER RES, V63, P3524; Sanada S, 2004, CIRCULATION, V110, P51, DOI 10.1161/01.CIR.0000133390.12306.C7; Schmidt KM, 2017, ONCOTARGET, V8, P24491, DOI 10.18632/oncotarget.15524; Sheikh-Hamad D, 2003, AM J PHYSIOL-HEART C, V285, pH442, DOI 10.1152/ajpheart.01071.2002; Thilaganathan B, 2019, HYPERTENSION, V73, P522, DOI 10.1161/HYPERTENSIONAHA.118.11191; Toschi A, 2008, J BIOL CHEM, V283, P34495, DOI 10.1074/jbc.C800170200; Trindade DM, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-57; Uuskula L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049248; Wallace AE, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.121566; Wallace EM, 2016, CANCER RES, V76, P5491, DOI 10.1158/0008-5472.CAN-16-0473; Weedon-Fekjraer MS, 2012, PLACENTA, V33, pS87, DOI 10.1016/j.placenta.2011.11.003; WICE B, 1990, EXP CELL RES, V186, P306, DOI 10.1016/0014-4827(90)90310-7; Wolfrum S, 2004, ARTERIOSCL THROM VAS, V24, P1842, DOI 10.1161/01.ATV.0000142813.33538.82; Wong CKC, 2002, J ENDOCRINOL, V173, P199, DOI 10.1677/joe.0.1730199; Yeung HY, 2005, ENDOCRINOLOGY, V146, P4951, DOI 10.1210/en.2005-0365; Zhang KZ, 2000, P NATL ACAD SCI USA, V97, P3637, DOI 10.1073/pnas.070045897	45	3	3	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6086	6098		10.1096/fj.201902426R	http://dx.doi.org/10.1096/fj.201902426R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32162740	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000531325500009
J	Shin, NR; Bose, S; Wang, JH; Nam, YD; Song, EJ; Lim, DW; Kim, HB; Lim, YS; Choi, HS; Kim, H				Shin, Na Rae; Bose, Shambhunath; Wang, Jing-Hua; Nam, Young-Do; Song, Eun-Ji; Lim, Dong-Woo; Kim, Hee-Bok; Lim, Yun-Sung; Choi, Han Seok; Kim, Hojun			Chemically or surgically induced thyroid dysfunction altered gut microbiota in rat models	FASEB JOURNAL			English	Article						gut microbiota; hyperthyroidism; hypothyroidism; thyroid function; thyroidectomy	YERSINIA-ENTEROCOLITICA; OBESITY; AUTOIMMUNITY; ASSOCIATION	Thyroid hormones are essential for the regulation of energy homeostasis and metabolic processes. However, the relationship between thyroid function and host gut microbial communities is not properly understood. To determine whether and how gut microbiota is associated with thyroid function, metagenomics analysis of the bacterial population in fecal samples of rat models of hyperthyroidism (induced by levothyroxine) and hypothyroidism (induced by propylthiouracil or thyroidectomy) was conducted through 16S rRNA gene sequencing. Our results revealed that all thyroid dysfunction models were definitely established and gut microbial composition varied according to different thyroid functional status. The relative abundance of Ruminococcus was significantly higher in the hyperthyroidism group (HE) vs both the normal and hypothyroidism groups (HO) while S24-7 was significantly higher in the HO group. The population of Prevotellaceae and Prevotella were significantly lower in the HO group vs the normal. Firmicutes and Oscillospira were significantly higher in the SHO (surgery-induced hypothyroidism) group, while Prevotellaceae and Prevotella showed lower abundance in the SHO group than the SHAM group. Present results suggest that thyroid functions may have the potential to influence the profile of gut microbiota and could be used as foundation to investigate interaction mechanism between thyroid and gut microbiome.	[Shin, Na Rae; Wang, Jing-Hua; Kim, Hojun] Dongguk Univ, Dept Rehabil Med Korean Med, Goyang, South Korea; [Bose, Shambhunath] NosQuest, Seongnam Si, South Korea; [Nam, Young-Do; Song, Eun-Ji] Korea Food Res Inst, Res Grp Gut Microbiome, Wanju Gun, South Korea; [Nam, Young-Do; Song, Eun-Ji] Korea Univ Sci & Technol, Dept Food Biotechnol, Wonju, South Korea; [Lim, Dong-Woo] Dongguk Univ, Coll Korean Med, Dept Pathol, Goyang, South Korea; [Kim, Hee-Bok; Lim, Yun-Sung] Dongguk Univ, Dept Otorhinolaryngol Head & Neck Surg, Dongguk Ro 32, Goyang, Gyeonggi Do, South Korea; [Choi, Han Seok] Dongguk Univ, Dept Endocrinol, Dongguk Ro 32, Goyang, Gyeonggi Do, South Korea	Dongguk University; Korea Food Research Institute (KFRI); Dongguk University; Dongguk University; Dongguk University	Kim, H (corresponding author), Dongguk Univ, Dept Rehabil Med Korean Med, Goyang, South Korea.; Lim, YS (corresponding author), Dongguk Univ, Dept Otorhinolaryngol Head & Neck Surg, Dongguk Ro 32, Goyang, Gyeonggi Do, South Korea.; Choi, HS (corresponding author), Dongguk Univ, Dept Endocrinol, Dongguk Ro 32, Goyang, Gyeonggi Do, South Korea.	splash1@hanmail.net; hschoi402@dumc.or.kr; kimklar@dongguk.ac.kr	Song, Eun-Ji/HDO-8376-2022; Wang, Jing-hua/AAO-2350-2020; Lim, Dongwoo/GLU-0640-2022	Wang, Jing-hua/0000-0002-2034-7429; 	National Research Foundation (NRF) [NRF2019R1A2B5B01070365]; Main Research Program of the Korea Food Research Institute (KFRI) [E0170602-02]	National Research Foundation (NRF); Main Research Program of the Korea Food Research Institute (KFRI)	National Research Foundation (NRF), Grant/Award Number: NRF2019R1A2B5B01070365; Main Research Program of the Korea Food Research Institute (KFRI), Grant/Award Number: E0170602-02	ARSCOTT P, 1992, J CLIN ENDOCR METAB, V75, P295, DOI 10.1210/jc.75.1.295; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Barcena C, 2019, NAT MED, V25, P1234, DOI 10.1038/s41591-019-0504-5; Biondi B, 2010, J CLIN ENDOCR METAB, V95, P3614, DOI 10.1210/jc.2010-1245; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Brent GA, 2012, J CLIN INVEST, V122, P3035, DOI 10.1172/JCI60047; BYFIELD PGH, 1989, J ENDOCRINOL, V121, P571, DOI 10.1677/joe.0.1210571; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Conley MN, 2016, PEERJ, V4, DOI 10.7717/peerj.1854; Cooper DS, 2012, LANCET, V379, P1142, DOI 10.1016/S0140-6736(11)60276-6; Corapcioglu D, 2002, THYROID, V12, P613, DOI 10.1089/105072502320288483; Hage MP, 2012, J THROID RES, V2012, DOI 10.1155/2012/590648; Hoshi N, 2007, ENDOCRINOLOGY, V148, P4251, DOI 10.1210/en.2006-0490; Ishaq HM, 2018, INT J BIOL SCI, V14, P1558, DOI 10.7150/ijbs.24151; Jiang WW, 2015, SCI REP-UK, V5, DOI 10.1038/srep08096; Johnson BM, 2020, J AUTOIMMUN, V108, DOI 10.1016/j.jaut.2020.102420; Kim Seong-Mo, 2012, Evid Based Complement Alternat Med, V2012, P578497, DOI 10.1155/2012/578497; Knudsen N, 2005, J CLIN ENDOCR METAB, V90, P4019, DOI 10.1210/jc.2004-2225; Kohling HL, 2017, CLIN IMMUNOL, V183, P63, DOI 10.1016/j.clim.2017.07.001; Lauritano EC, 2007, J CLIN ENDOCR METAB, V92, P4180, DOI 10.1210/jc.2007-0606; Limonard EJ, 2012, SCI WORLD J, P1, DOI 10.1100/2012/548796; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; MKGarg NM, 2017, PRINC PRACT THYROID, V22, P3; Mullur R, 2014, PHYSIOL REV, V94, P355, DOI 10.1152/physrev.00030.2013; National Research Council, 1996, GUIDE CARE USE LAB A, V7th ed., P140, DOI [10.17226/5140, DOI 10.17226/5140]; Nilsson M, 2017, DEVELOPMENT, V144, P2123, DOI 10.1242/dev.145615; Okamoto M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080801; Pearson K, 1909, Science, V30, P23, DOI 10.1126/science.30.757.23; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Reinehr T, 2010, MOL CELL ENDOCRINOL, V316, P165, DOI 10.1016/j.mce.2009.06.005; Salam MH A, 2015, BASIC SCI MED, V4, P12; Sari R, 2003, CLIN ENDOCRINOL, V59, P258, DOI 10.1046/j.1365-2265.2003.01836.x; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; SHENKMAN L, 1976, ANN INTERN MED, V85, P735, DOI 10.7326/0003-4819-85-6-735; Shin NR, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02271; Taylor PN, 2013, J CLIN ENDOCR METAB, V98, P3562, DOI 10.1210/jc.2013-1315; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Varian B, 2014, J OBES WEIGHT LOSS T, V4; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Vilsboll T, 2004, DIABETOLOGIA, V47, P357, DOI 10.1007/s00125-004-1342-6; Vrieze A, 2010, DIABETOLOGIA, V53, P606, DOI 10.1007/s00125-010-1662-7; Wang J, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086117, 10.1371/journal.pone.0101358]; WENZEL BE, 1988, LANCET, V1, P56; Zheng P, 2016, MOL PSYCHIATR, V21, P786, DOI 10.1038/mp.2016.44; Zhou L, 2014, CURR MICROBIOL, V69, P675, DOI 10.1007/s00284-014-0640-6	47	7	7	2	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8686	8701		10.1096/fj.201903091RR	http://dx.doi.org/10.1096/fj.201903091RR		MAY 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32356337				2022-12-28	WOS:000530007100001
J	Verschuren, EHJ; Rigalli, JP; Castenmiller, C; Rohrbach, MU; Bindels, RJM; Peters, DJM; Arjona, FJ; Hoenderop, JGJ				Verschuren, Eric H. J.; Rigalli, Juan P.; Castenmiller, Charlotte; Rohrbach, Meike U.; Bindels, Rene J. M.; Peters, Dorien J. M.; Arjona, Francisco J.; Hoenderop, Joost G. J.			Pannexin-1 mediates fluid shear stress-sensitive purinergic signaling and cyst growth in polycystic kidney disease	FASEB JOURNAL			English	Article						ATP; fluid shear stress; pannexin-1; polycystin-1; purinergic signaling	ATP RELEASE; EPITHELIAL-CELLS; MOUSE MODEL; INHIBITION; EXPRESSION; SECRETION; RECEPTOR; PATHWAY; ADPKD; MECHANOSENSATION	Tubular ATP release is regulated by mechanosensation of fluid shear stress (FSS). Polycystin-1/polycystin-2 (PC1/PC2) functions as a mechanosensory complex in the kidney. Extracellular ATP is implicated in polycystic kidney disease (PKD), where PC1/PC2 is dysfunctional. This study aims to provide new insights into the ATP signaling under physiological conditions and PKD. Microfluidics, pharmacologic inhibition, and loss-of-function approaches were combined to assess the ATP release in mouse distal convoluted tubule 15 (mDCT15) cells. Kidney-specific Pkd1 knockout mice (iKsp-Pkd1(-/-)) and zebrafish pkd2 morphants (pkd2-MO) were as models for PKD. FSS-exposed mDCT15 cells displayed increased ATP release. Pannexin-1 inhibition and knockout decreased FSS-modulated ATP release. In iKsp-Pkd1(-/-) mice, elevated renal pannexin-1 mRNA expression and urinary ATP were observed. In Pkd1(-/-) mDCT15 cells, elevated ATP release was observed upon the FSS mechanosensation. In these cells, increased pannexin-1 mRNA expression was observed. Importantly, pannexin-1 inhibition in pkd2-MO decreased the renal cyst growth. Our results demonstrate that pannexin-1 channels mediate ATP release into the tubular lumen due to pro-urinary flow. We present pannexin-1 as novel therapeutic target to prevent the renal cyst growth in PKD.	[Verschuren, Eric H. J.; Rigalli, Juan P.; Castenmiller, Charlotte; Rohrbach, Meike U.; Bindels, Rene J. M.; Arjona, Francisco J.; Hoenderop, Joost G. J.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Physiol, Nijmegen, Netherlands; [Peters, Dorien J. M.] Leiden Univ, Dept Human Genet, Med Ctr, Leiden, Netherlands	Radboud University Nijmegen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Hoenderop, JGJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Physiol 286, Radboud Inst Mol Life Sci, POB 9101, NL-6500 HB Nijmegen, Netherlands.	Joost.Hoenderop@radboudumc.nl	Rigalli, Juan Pablo/E-2099-2018; Peters, Dorien/AFH-8507-2022; Rohrbach, Meike Ursula/AAP-5772-2020; Verschuren, Eric H.J./AAX-6774-2020	Rigalli, Juan Pablo/0000-0003-4168-9396; Peters, Dorien/0000-0001-6974-7143; Castenmiler, Charlotte/0000-0001-7608-7390	Dutch Kidney Foundation [15OP03]	Dutch Kidney Foundation	We thank Dr Omar AZ Tutakhel, Charlotte Roosendaal, Marieke Schultink, and Milou Fransen for their support and acknowledge Dr Erwin van Wijk and Dr Gert Flik for providing the facilities for zebrafish experimentation. This study is supported by grants from the Dutch Kidney Foundation (15OP03) to DJM Peters and RJM Bindels, and from the Netherlands Organization for Scientific Research (NWO VICI 016.130.668) to JGJ Hoenderop. JP Rigalli is supported by the Radboud Excellence Initiative from the Radboud University (Nijmegen, The Netherlands).	Abed AB, 2015, CELL MOL LIFE SCI, V72, P2869, DOI 10.1007/s00018-015-1964-5; [Anonymous], 2016, EFSA J, V8, P1853, DOI [10.2903/j.efsa.2010.1853., DOI 10.2903/J.EFSA.2010.1853]; Arkhipov SN, 2019, AM J PHYSIOL-RENAL, V317, pF1649, DOI 10.1152/ajprenal.00395.2019; Arkhipov SN, 2019, BIOCHEM BIOPH RES CO, V513, P166, DOI 10.1016/j.bbrc.2019.03.177; Ballou Lisa M, 2008, J Chem Biol, V1, P27, DOI 10.1007/s12154-008-0003-5; Bergmann C, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0047-y; Bergmann C, 2015, PEDIATR NEPHROL, V30, P15, DOI 10.1007/s00467-013-2706-2; Bhaskaracharya A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093058; Boehlke C, 2010, NAT CELL BIOL, V12, P1115, DOI 10.1038/ncb2117; Burnstock G, 2014, PURINERG SIGNAL, V10, P103, DOI 10.1007/s11302-013-9395-y; Cao Y, 2009, P NATL ACAD SCI USA, V106, P21819, DOI 10.1073/pnas.0911987106; Chang MY, 2011, J AM SOC NEPHROL, V22, P1696, DOI 10.1681/ASN.2010070728; Chebib FT, 2015, NAT REV NEPHROL, V11, P451, DOI 10.1038/nrneph.2015.39; Chin TY, 2010, AUTOPHAGY, V6, P1139, DOI 10.4161/auto.6.8.13564; Dalagiorgou G, 2010, INT J BIOCHEM CELL B, V42, P1610, DOI 10.1016/j.biocel.2010.06.017; Edwards ME, 2018, CLIN J AM SOC NEPHRO, V13, P1153, DOI 10.2215/CJN.01520218; Faria D, 2009, PFLUG ARCH EUR J PHY, V457, P1373, DOI 10.1007/s00424-008-0606-2; Gilder AL, 2018, TRAFFIC, V19, P933, DOI 10.1111/tra.12612; Haeussler M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1012-2; Hanner F, 2012, AM J PHYSIOL-RENAL, V303, pF1454, DOI 10.1152/ajprenal.00206.2011; Hanner F, 2010, AM J PHYSIOL-REG I, V298, pR1143, DOI 10.1152/ajpregu.00808.2009; Happe H, 2014, NAT REV NEPHROL, V10, P587, DOI 10.1038/nrneph.2014.137; Happe H, 2013, KIDNEY INT, V83, P1099, DOI 10.1038/ki.2013.13; Hechler B, 2006, J PHARMACOL EXP THER, V316, P556, DOI 10.1124/jpet.105.094037; Helal I, 2011, CLIN J AM SOC NEPHRO, V6, P2439, DOI 10.2215/CJN.01010211; Hovater MB, 2008, PURINERG SIGNAL, V4, P109, DOI 10.1007/s11302-008-9102-6; Hovater MB, 2008, PURINERG SIGNAL, V4, P155, DOI 10.1007/s11302-007-9072-0; Ilatovskaya DV, 2016, AM J PHYSIOL-RENAL, V311, pF1135, DOI 10.1152/ajprenal.00406.2016; Jang KJ, 2011, INTEGR BIOL-UK, V3, P134, DOI 10.1039/c0ib00018c; Jang KJ, 2010, LAB CHIP, V10, P36, DOI 10.1039/b907515a; Jansen RS, 2014, ARTERIOSCL THROM VAS, V34, P1985, DOI 10.1161/ATVBAHA.114.304017; Jensen MEJ, 2007, J AM SOC NEPHROL, V18, P2062, DOI 10.1681/ASN.2006070700; Ko B, 2012, AM J PHYSIOL-RENAL, V303, pF700, DOI 10.1152/ajprenal.00139.2012; Kraus A, 2016, PURINERG SIGNAL, V12, P687, DOI 10.1007/s11302-016-9532-5; Kunnen SJ, 2018, BIOMED PHARMACOTHER, V108, P1123, DOI 10.1016/j.biopha.2018.07.178; Leipziger J, 2003, AM J PHYSIOL-RENAL, V284, pF419, DOI 10.1152/ajprenal.00075.2002; Low SH, 2006, DEV CELL, V10, P57, DOI 10.1016/j.devcel.2005.12.005; Maddalo D, 2014, NATURE, V516, P423, DOI 10.1038/nature13902; Markowitz GS, 1999, AM J PHYSIOL-RENAL, V277, pF17, DOI 10.1152/ajprenal.1999.277.1.F17; Matsuzaki Y, 2005, J INVEST DERMATOL, V125, P900, DOI 10.1111/j.0022-202X.2005.23897.x; Meijer E, 2018, JAMA-J AM MED ASSOC, V320, P2010, DOI 10.1001/jama.2018.15870; Mohammed SG, 2018, FASEB J, V32, P3653, DOI 10.1096/fj.201701228R; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Ong ACM, 2015, LANCET, V385, P1993, DOI 10.1016/S0140-6736(15)60907-2; Palygin O, 2018, PURINERG SIGNAL, V14, P485, DOI 10.1007/s11302-018-9632-5; Perico N, 2010, J AM SOC NEPHROL, V21, P1031, DOI 10.1681/ASN.2009121302; Peters DJM, 1999, J PATHOL, V188, P439, DOI 10.1002/(SICI)1096-9896(199908)188:4<439::AID-PATH367>3.0.CO;2-P; Poudel N, 2019, NEPHRON, V143, P158, DOI 10.1159/000501278; Praetorius HA, 2009, ACTA PHYSIOL, V197, P241, DOI 10.1111/j.1748-1716.2009.02002.x; Praetorius HA, 2008, J PHYSIOL-LONDON, V586, P2669, DOI 10.1113/jphysiol.2008.155085; Praetorius HA, 2010, ANNU REV PHYSIOL, V72, P377, DOI 10.1146/annurev-physiol-021909-135825; Praetorius HA, 2009, PURINERG SIGNAL, V5, P433, DOI 10.1007/s11302-009-9146-2; Ramanathan A, 2009, P NATL ACAD SCI USA, V106, P22229, DOI 10.1073/pnas.0912074106; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rangan G, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00218; Rodat-Despoix L, 2013, CELL CALCIUM, V53, P327, DOI 10.1016/j.ceca.2013.02.002; Rowe I, 2013, NAT MED, V19, P488, DOI 10.1038/nm.3092; Schreiber R, 2019, J AM SOC NEPHROL, V30, P228, DOI 10.1681/ASN.2018010039; Schwiebert EM, 2002, AM J PHYSIOL-RENAL, V282, pF763, DOI 10.1152/ajprenal.0337.2000; Shibazaki S, 2008, HUM MOL GENET, V17, P1505, DOI 10.1093/hmg/ddn039; Shillingford JM, 2006, P NATL ACAD SCI USA, V103, P5466, DOI 10.1073/pnas.0509694103; Shirley DG, 2009, PURINERG SIGNAL, V5, P501, DOI 10.1007/s11302-009-9152-4; Sipos A, 2009, J AM SOC NEPHROL, V20, P1724, DOI 10.1681/ASN.2008101099; Solini A, 2015, J AM SOC NEPHROL, V26, P1007, DOI 10.1681/ASN.2014070721; Stoessel A, 2010, AM J PHYSIOL-RENAL, V298, pF216, DOI 10.1152/ajprenal.00295.2009; Sun ZX, 2004, DEVELOPMENT, V131, P4085, DOI 10.1242/dev.01240; Svenningsen P, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00292; Torres VE, 2017, NEW ENGL J MED, V377, P1930, DOI 10.1056/NEJMoa1710030; Turner CM, 2004, CELLS TISSUES ORGANS, V178, P168, DOI 10.1159/000082247; Tutakhel OAZ, 2016, AM J PHYSIOL-RENAL, V310, pF204, DOI 10.1152/ajprenal.00429.2015; Verschuren EHJ, 2019, FASEB J, V33, P5034, DOI 10.1096/fj.201802094R; Verschuren EHJ, 2018, AM J PHYSIOL-RENAL, V315, pF537, DOI 10.1152/ajprenal.00622.2017; Waikar SS, 2010, KIDNEY INT, V78, P486, DOI 10.1038/ki.2010.165; Wang JJ, 2013, J GEN PHYSIOL, V141, P649, DOI 10.1085/jgp.201310966; Ward CJ, 1996, P NATL ACAD SCI USA, V93, P1524, DOI 10.1073/pnas.93.4.1524; Weinbaum S, 2011, CELL MOL BIOENG, V4, P510, DOI 10.1007/s12195-011-0179-6; Weinbaum S, 2010, AM J PHYSIOL-RENAL, V299, pF1220, DOI 10.1152/ajprenal.00453.2010; Wildman SS, 2003, AM J PHYSIOL-RENAL, V285, pF1168, DOI 10.1152/ajprenal.00171.2003; Wilson PD, 1999, J AM SOC NEPHROL, V10, P218; Xu C, 2009, AM J PHYSIOL-RENAL, V296, pF1464, DOI 10.1152/ajprenal.90542.2008; Xu GM, 2003, J BIOL CHEM, V278, P1457, DOI 10.1074/jbc.M209996200; Zheng X, 2016, ELIFE, V5, DOI [10.7554/eLife.18638, 10.7554/eLife.13374]	82	7	7	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6382	6398		10.1096/fj.201902901R	http://dx.doi.org/10.1096/fj.201902901R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32159259	Green Published, hybrid			2022-12-28	WOS:000531325500028
J	Yin, HS; Li, WN; Chatterjee, S; Xiong, XK; Saha, P; Yechoor, V; Ma, K				Yin Hongshan; Li Weini; Chatterjee, Somik; Xiong Xuekai; Saha, Pradip; Yechoor, Vijay; Ma Ke			Metabolic-sensing of the skeletal muscle clock coordinates fuel oxidation	FASEB JOURNAL			English	Article						circadian clock; skeletal muscle; glucose metabolism; fatty acid metabolism; hepatic steatosis	PERIPHERAL CIRCADIAN CLOCKS; FATTY-ACID OXIDATION; ARNT-LIKE 1; INSULIN SENSITIVITY; GLUCOSE-INTOLERANCE; MECHANISMS; PATHWAYS; RECEPTOR; BMAL1; BRAIN	Circadian clock confers temporal control in metabolism, with its disruption leading to the development of insulin resistance. Metabolic substrate utilization in skeletal muscle is coordinated with diurnal nutrient cycles. However, whether the molecular clock is involved in this coordination is largely unknown. Using a myocyte-selective genetic ablation mouse model of the essential clock activator Bmal1, here we identify muscle-intrinsic clock as a sensor of feeding cues to orchestrate skeletal muscle oxidation required for global nutrient flux. Bmal1 in skeletal muscle responds robustly to feeding in vivo and insulin induces its expression. Muscle Bmal1 deficiency impaired the transcriptional control of glucose metabolic pathway, resulting in markedly attenuated glucose utilization and fasting hyperglycemia. Notably, the loss of Bmal1 response to feeding abolished fasting-to-feeding metabolic fuel switch from fatty acids to glucose in skeletal muscle, leading to the activation of energy-sensing pathways for fatty acid oxidation. These altered metabolic substrate oxidations in Bmal1-deficient muscle ultimately depleted circulating lipid levels that prevented hepatic steatosis. Collectively, our findings highlight the key role of the metabolic-sensing function of skeletal muscle clock in partitioning nutrient flux between muscle and liver to maintain whole-body lipid and glucose homeostasis.	[Yin Hongshan] Hebei Med Univ, Dept Cardiol, Affiliated Hosp 3, Shijiazhuang, Hebei, Peoples R China; [Li Weini; Xiong Xuekai; Ma Ke] Beckman Res Inst City Hope, Dept Diabet Complicat & Metab, Duarte, CA 91010 USA; [Chatterjee, Somik; Saha, Pradip] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Yechoor, Vijay] Univ Pittsburgh, Dept Med, Diabet & Beta Cell Biol Ctr, Div Endocrinol Diabet & Metab, Pittsburgh, PA USA	Hebei Medical University; City of Hope; Beckman Research Institute of City of Hope; Baylor College of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ma, K (corresponding author), Beckman Res Inst City Hope, Dept Diabet Complicat & Metab, Duarte, CA 91010 USA.	kema@coh.org	Yechoor, Vijay/AAX-3244-2021; Chatterjee, Somik/P-1581-2016	Chatterjee, Somik/0000-0001-6869-4019	NIDDK NIH HHS [R01 DK097160, R01 DK112794] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abu-Elheiga L, 2001, SCIENCE, V291, P2613, DOI 10.1126/science.1056843; Andrews JL, 2010, P NATL ACAD SCI USA, V107, P19090, DOI 10.1073/pnas.1014523107; Asher G, 2010, CELL, V142, P943, DOI 10.1016/j.cell.2010.08.016; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Buxton OM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003200; Caruso M, 1997, J BIOL CHEM, V272, P7290, DOI 10.1074/jbc.272.11.7290; Chatterjee S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41059-7; Chatterjee S, 2013, J CELL SCI, V126, P2213, DOI 10.1242/jcs.120519; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; de Lange P, 2007, FASEB J, V21, P3431, DOI 10.1096/fj.07-8527rev; DEFRONZO RA, 1981, DIABETES, V30, P1000, DOI 10.2337/diab.30.12.1000; Dyar KA, 2018, CELL, V174, P1571, DOI 10.1016/j.cell.2018.08.042; Dyar KA, 2014, MOL METAB, V3, P29, DOI 10.1016/j.molmet.2013.10.005; Dyar KA, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005886; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Fujita Y, 1998, DIABETOLOGIA, V41, P1459, DOI 10.1007/s001250051092; Glund S, 2012, DIABETOLOGIA, V55, P2044, DOI 10.1007/s00125-012-2554-9; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Guo BY, 2012, FASEB J, V26, P3453, DOI 10.1096/fj.12-205781; Harfmann BD, 2016, SKELET MUSCLE, V6, DOI 10.1186/s13395-016-0082-x; Hodge BA, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0039-5; Karatsoreos IN, 2011, P NATL ACAD SCI USA, V108, P1657, DOI 10.1073/pnas.1018375108; Kim JK, 2000, J CLIN INVEST, V105, P1791, DOI 10.1172/JCI8305; Kinouchi K, 2018, CELL REP, V25, P3299, DOI 10.1016/j.celrep.2018.11.077; KRAEGEN EW, 1985, AM J PHYSIOL, V248, pE353; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Lee J, 2013, MOL CELL BIOL, V33, P2327, DOI 10.1128/MCB.01421-12; Ma K, 2002, J BIOL CHEM, V277, P34658, DOI 10.1074/jbc.C200362200; Ma K, 2006, J CLIN INVEST, V116, P1102, DOI 10.1172/JCI25604; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; McDearmon EL, 2006, SCIENCE, V314, P1304, DOI 10.1126/science.1132430; Meng ZX, 2017, MOL CELL, V66, P332, DOI 10.1016/j.molcel.2017.04.007; Miller BH, 2007, P NATL ACAD SCI USA, V104, P3342, DOI 10.1073/pnas.0611724104; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Nam D., 2014, EXP CELL RES; Nam D, 2015, J CELL SCI, V128, P1835, DOI 10.1242/jcs.167643; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Roche TE, 2007, CELL MOL LIFE SCI, V64, P830, DOI 10.1007/s00018-007-6380-z; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; Stenvers DJ, 2019, NAT REV ENDOCRINOL, V15, P75, DOI 10.1038/s41574-018-0122-1; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Sugden Mary C., 2006, Archives of Physiology and Biochemistry, V112, P139, DOI 10.1080/13813450600935263; Sugden MC, 2001, BIOCHEM SOC T, V29, P272, DOI 10.1042/0300-5127:0290272; Takahashi JS, 2017, NAT REV GENET, V18, P164, DOI 10.1038/nrg.2016.150; Wende AR, 2005, MOL CELL BIOL, V25, P10684, DOI 10.1128/MCB.25.24.10684-10694.2005; Woldt E, 2013, NAT MED, V19, P1039, DOI 10.1038/nm.3213; Xu WQ, 2019, MOL CELL ENDOCRINOL, V482, P1, DOI 10.1016/j.mce.2018.12.001; ZURLO F, 1990, J CLIN INVEST, V86, P1423, DOI 10.1172/JCI114857; Zvonic S, 2006, DIABETES, V55, P962, DOI 10.2337/diabetes.55.04.06.db05-0873	51	8	11	2	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6613	6627		10.1096/fj.201903226RR	http://dx.doi.org/10.1096/fj.201903226RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32212194	Green Accepted			2022-12-28	WOS:000531325500043
J	Perli, E; Pisano, A; Pignataro, MG; Campese, AF; Pelullo, M; Genovese, I; de Turris, V; Ghelli, AM; Cerbelli, B; Giordano, C; Colotti, G; Morea, V; d'Amati, G				Perli, Elena; Pisano, Annalinda; Pignataro, Maria Gemma; Campese, Antonio Francesco; Pelullo, Maria; Genovese, Ilaria; de Turris, Valeria; Ghelli, Anna Maria; Cerbelli, Bruna; Giordano, Carla; Colotti, Gianni; Morea, Veronica; d'Amati, Giulia			Exogenous peptides are able to penetrate human cell and mitochondrial membranes, stabilize mitochondrial tRNA structures, and rescue severe mitochondrial defects	FASEB JOURNAL			English	Article						mitochondrial (mt) diseases; mitochondrial targeting; rescuing peptides; transfer RNA (tRNA) point mutations	SYNTHETASE; MUTATIONS; GENOMES; MODEL	Mutations in mitochondrial transfer RNA (mt-tRNA) genes are responsible for a wide range of syndromes, for which no effective treatment is available. We previously reported that transfection of the nucleotide sequence encoding for the 16-residue beta 32_33 peptide from mitochondrial leucyl-tRNA synthetase ameliorates the cell phenotype caused by the mitochondrial tRNA mutations. In this work, we demonstrated that both the beta 32_33 peptide linked with the known (L)-Phe-(D)-Arg-(L)-Phe-(L)-Lys (FrFK) mitochondrial penetrating sequence and, strikingly, the beta 32_33 peptide per se, are able to penetrate both the plasma and mitochondrial membranes and exert the rescuing activity when exogenously administered to cells bearing the mutations m.3243A > G and m.8344A > G. These mutations are responsible for the most common and severe mt-tRNA-related diseases. In addition, we dissected the molecular determinants of constructs activity by showing that both the order of amino acids along the sequence and presence of positive charges are essential determinants of the peptide activity in cells and mt-tRNA structures stabilization in vitro. In view of future in vivo studies, this information may be required to design of beta 32_33 peptide-mimetic derivatives. The beta 32_33 and FrFK-beta 32_33 peptides are, therefore, promising molecules for the development of therapeutic agents against diseases caused by the mt-tRNA point mutations.	[Perli, Elena; Pisano, Annalinda; Pignataro, Maria Gemma; Giordano, Carla] Sapienza Univ Rome, Dept Radiol Oncol & Pathol Sci, Rome, Italy; [Campese, Antonio Francesco] Sapienza Univ Rome, Dept Mol Med, Rome, Italy; [Pelullo, Maria; de Turris, Valeria] Ist Italiano Tecnol, Ctr Life Nano Sci Sapienza, Rome, Italy; [Genovese, Ilaria] Sapienza Univ Rome, Dept Biochem Sci A Rossi Fanelli, Rome, Italy; [Ghelli, Anna Maria] Univ Bologna, Dept Pharm & Biotechnol FABIT, Bologna, Italy; [Cerbelli, Bruna] Sapienza Univ, Dept Med Surg Sci & Biotechnol, Latina, Italy; [Colotti, Gianni; Morea, Veronica] Natl Res Council Italy, Inst Mol Biol & Pathol, Rome, Italy; [d'Amati, Giulia] Sapienza Univ Rome, Ist Pasteur Italia Fdn Cenci Bolognetti, Dept Radiol Oncol & Pathol Sci, Rome, Italy	Sapienza University Rome; Sapienza University Rome; Istituto Italiano di Tecnologia - IIT; Sapienza University Rome; University of Bologna; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Sapienza University Rome	d'Amati, G (corresponding author), Sapienza Univ Rome, Dept Radiol Oncol & Pathol Sci, Policlin Umberto I, Viale Regina Elena 324, I-00161 Rome, Italy.; Morea, V (corresponding author), Sapienza Univ Rome, Natl Res Council Italy, Inst Mol Biol & Pathol, Dept Biochem Sci A Rossi Fanelli, Piazzale Aldo Moro 5, I-00161 Rome, Italy.	veronica.morea@cnr.it; giulia.damati@uniroma1.it	Genovese, Ilaria/AAK-3403-2021; Pelullo, Maria/AFE-7902-2022; Morea, Veronica/AAS-6881-2020; GIORDANO, Carla/L-5657-2015; Colotti, Gianni/D-2015-2010	Morea, Veronica/0000-0003-2566-3049; GENOVESE, Ilaria/0000-0002-1981-750X; GIORDANO, Carla/0000-0002-3716-4303; Colotti, Gianni/0000-0002-9913-0635	AFM-Telethon (French Muscular Dystrophy Association) [20607]; Istituto Pasteur-Fondazione Cenci Bolognetti (Cenci Bolognetti Foundation); Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) [2017483NH8_005]; Mitocon Italy [2018-02]	AFM-Telethon (French Muscular Dystrophy Association); Istituto Pasteur-Fondazione Cenci Bolognetti (Cenci Bolognetti Foundation); Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR)); Mitocon Italy	AFM-Telethon (French Muscular Dystrophy Association), Grant/Award Number: 20607; Istituto Pasteur-Fondazione Cenci Bolognetti (Cenci Bolognetti Foundation), Grant/Award Number: Anna Tramontano; Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR), Grant/Award Number: 2017483NH8_005 to Veronica Morea; Mitocon Italy, Grant/Award Number: 2018-02 to Annalinda Pisano	Bacman SR, 2018, NAT MED, V24, P1696, DOI 10.1038/s41591-018-0166-8; Bacman SR, 2013, NAT MED, V19, P1111, DOI 10.1038/nm.3261; Bredenoord AL, 2017, SCIENCE, V355, DOI 10.1126/science.aaf9414; Campese AF, 2009, INT IMMUNOL, V21, P727, DOI 10.1093/intimm/dxp042; Carelli V, 2002, BBA-MOL BASIS DIS, V1588, P7, DOI 10.1016/S0925-4439(02)00097-2; Craven L, 2017, ANNU REV GENOM HUM G, V18, P257, DOI 10.1146/annurev-genom-091416-035426; Di Micco P, 2014, BBA-MOL CELL RES, V1843, P3065, DOI 10.1016/j.bbamcr.2014.09.011; Dutta D, 2017, TRENDS MOL MED, V23, P393, DOI 10.1016/j.molmed.2017.02.007; Gammage PA, 2018, NAT MED, V24, P1691, DOI 10.1038/s41591-018-0165-9; Gammage PA, 2014, EMBO MOL MED, V6, P458, DOI 10.1002/emmm.201303672; Hirano M, 2018, ESSAYS BIOCHEM, V62, P467, DOI 10.1042/EBC20170114; Horton KL, 2008, CHEM BIOL, V15, P375, DOI 10.1016/j.chembiol.2008.03.015; Hue THD, 2014, EMBO MOL MED, V6, P183, DOI 10.1002/emmm.201303202; Inak G, 2017, STEM CELLS, V35, P1655, DOI 10.1002/stem.2637; Jean SR, 2016, ACCOUNTS CHEM RES, V49, P1893, DOI 10.1021/acs.accounts.6b00277; KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480; Kirino Y, 2004, P NATL ACAD SCI USA, V101, P15070, DOI 10.1073/pnas.0405173101; Ma H, 2015, NATURE, V524, P234, DOI 10.1038/nature14546; Mahon KP, 2007, CHEM BIOL, V14, P923, DOI 10.1016/j.chembiol.2007.07.011; McDonnell MT, 2004, EUR J HUM GENET, V12, P778, DOI 10.1038/sj.ejhg.5201216; Meseguer S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06553-w; Nightingale H, 2016, BRAIN, V139, P1633, DOI 10.1093/brain/aww081; Pello R, 2008, HUM MOL GENET, V17, P4001, DOI 10.1093/hmg/ddn303; Perli E, 2016, HUM MOL GENET, V25, P903, DOI 10.1093/hmg/ddv619; Perli E, 2014, EMBO MOL MED, V6, P169, DOI 10.1002/emmm.201303198; Rasband WS, 2018, IMAGEJ; Rorbach J, 2008, NUCLEIC ACIDS RES, V36, P3065, DOI 10.1093/nar/gkn147; Rossmanith W, 1998, FEBS LETT, V433, P269, DOI 10.1016/S0014-5793(98)00928-4; Shi Y, 2017, NAT REV DRUG DISCOV, V16, P115, DOI 10.1038/nrd.2016.245; Tomcin S, 2014, INT J NANOMED, V9, P5471, DOI 10.2147/IJN.S70908; Yarham JW, 2010, WIRES RNA, V1, P304, DOI 10.1002/wrna.27; Yasukawa T, 2001, EMBO J, V20, P4794, DOI 10.1093/emboj/20.17.4794	32	3	3	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					7675	7686		10.1096/fj.201903270R	http://dx.doi.org/10.1096/fj.201903270R		APR 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32304340				2022-12-28	WOS:000527389300001
J	Li, XQ; Zhang, CB; Liu, LY; Gu, MJ				Li, Xiangqi; Zhang, Chaobao; Liu, Lianyong; Gu, Mingjun			Existing bitter medicines for fighting 2019-nCoV-associated infectious diseases	FASEB JOURNAL			English	Article						2019-nCoV; coronavirus; COVID-19; cytokine storm; infectious disease; type 2 taste receptors (TAS2Rs)	TASTE RECEPTORS; CHEMOSENSORY CELLS; TYPE-2 IMMUNITY; T2R38; EXPRESSION; 2019-NCOV; ACTIVATE; HEALTH; VIRUS; DRUGS	The sudden outbreak of COVID-19 has led to more than seven thousand deaths. Unfortunately, there are no specific drugs available to cure this disease. Type 2 taste receptors (TAS2Rs) may play an important role in host defense mechanisms. Based on the idea of host-directed therapy (HDT), we performed a negative co-expression analysis using big data of 60 000 Affymetrix expression arrays and 5000 TCGA data sets to determine the functions of TAS2R10, which can be activated by numerous bitter substances. Excitingly, we found that the main functions of TAS2R10 involved controlling infectious diseases caused by bacteria, viruses, and parasites, suggesting that TAS2R10 is a key trigger of host defense pathways. To quickly guide the clinical treatment of 2019-nCoV, we searched currently available drugs that are agonists of TAS2Rs. We identified many cheap, available, and safe medicines, such as diphenidol, quinine, chloroquine, artemisinin, chlorpheniramine, yohimbine, and dextromethorphan, which may target the most common symptoms caused by 2019-nCoV. We suggest that a cocktail-like recipe of existing bitter drugs may help doctors to fight this catastrophic disease and that the general public may drink or eat bitter substances, such as coffee, tea, or bitter vegetables, to reduce the risk of infection.	[Li, Xiangqi; Gu, Mingjun] Second Mil Med Univ, Shanghai Gongli Hosp, Dept Endocrinol, Shanghai 200135, Peoples R China; [Zhang, Chaobao] Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, CAS Ctr Excellence Mol Cell Sci, Univ Chinese Acad Sci,State Key Lab Mol Biol, Shanghai, Peoples R China; [Liu, Lianyong] Punan Hosp Pudong New Dist, Dept Endocrinol, Shanghai, Peoples R China	Naval Medical University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS	Li, XQ (corresponding author), Second Mil Med Univ, Shanghai Gongli Hosp, Dept Endocrinol, Shanghai 200135, Peoples R China.	lixq@sibs.ac.cn			Pudong Health and Family Planning Commission of Shanghai [PWZxk2017-07, PWZzk2017-29, PWRI2018-02]; Pudong New Area Science and Technology Commission [PKJ2019-Y21]; China Postdoctoral Science Foundation [2019M651615, 2018229]	Pudong Health and Family Planning Commission of Shanghai; Pudong New Area Science and Technology Commission; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	Pudong Health and Family Planning Commission of Shanghai, Grant/Award Number: PWZxk2017-07, PWZzk2017-29 and PWRI2018-02; Pudong New Area Science and Technology Commission, Grant/Award Number: PKJ2019-Y21; China Postdoctoral Science Foundation, Grant/Award Number: 2019M651615 and 2018229	An J, 2017, ANNU REV MED, V68, P317, DOI 10.1146/annurev-med-043015-123453; Avau B, 2016, ACTA PHYSIOL, V216, P407, DOI 10.1111/apha.12621; Bassetti M, 2020, EUR J CLIN INVEST, V50, DOI 10.1111/eci.13209; Behrens M, 2013, SEMIN CELL DEV BIOL, V24, P215, DOI 10.1016/j.semcdb.2012.08.006; Bogoch II, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa008; Bortolotti M, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00486; Brockhoff A, 2007, J AGR FOOD CHEM, V55, P6236, DOI 10.1021/jf070503p; Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9; Channappanavar R, 2017, SEMIN IMMUNOPATHOL, V39, P529, DOI 10.1007/s00281-017-0629-x; Chen M, 2018, HUM GENOMICS, V12, DOI 10.1186/s40246-018-0133-y; Chen YW, 2013, NEUROSCI LETT, V552, P62, DOI 10.1016/j.neulet.2013.07.030; Clark AA, 2012, FASEB J, V26, P4827, DOI 10.1096/fj.12-215087; Cohen NA, 2017, LARYNGOSCOPE, V127, P44, DOI 10.1002/lary.26198; Elewa H, 2017, EUR J DRUG METAB PH, V42, P745, DOI 10.1007/s13318-016-0399-1; Grassin-Delyle S, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01267; Guo CH, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0273-8; Hatzimouratidis K, 2005, DRUGS, V65, P1621, DOI 10.2165/00003495-200565120-00003; Ho WE, 2014, PHARMACOL THERAPEUT, V142, P126, DOI 10.1016/j.pharmthera.2013.12.001; Howitt MR, 2016, SCIENCE, V351, P1329, DOI 10.1126/science.aaf1648; Huang C, 2020, CHINA LANCET; Jing FM, 2013, J PHARM PHARMACOL, V65, P847, DOI 10.1111/jphp.12041; Kohl S, 2013, J AGR FOOD CHEM, V61, P53, DOI 10.1021/jf303146h; Lee E E, 2001, Am J Clin Dermatol, V2, P27, DOI 10.2165/00128071-200102010-00005; Lee RJ, 2015, CELL MOL LIFE SCI, V72, P217, DOI 10.1007/s00018-014-1736-7; Lee RJ, 2014, AM J RHINOL ALLERGY, V28, P366, DOI 10.2500/ajra.2014.28.4077; Lee RJ, 2014, J CLIN INVEST, V124, P1393, DOI 10.1172/JCI72094; Lee RJ, 2012, J CLIN INVEST, V122, P4145, DOI 10.1172/JCI64240; Lei WW, 2018, P NATL ACAD SCI USA, V115, P5552, DOI 10.1073/pnas.1720758115; Levit A, 2014, FASEB J, V28, P1181, DOI 10.1096/fj.13-242594; Li DY, 2014, MOL BIOL EVOL, V31, P303, DOI 10.1093/molbev/mst219; Liyanage Chamari R D G, 2014, BMJ Case Rep, V2014, DOI 10.1136/bcr-2014-204424; Lu HZ, 2020, BIOSCI TRENDS, V14, P69, DOI 10.5582/bst.2020.01020; Lu P, 2017, J GEN PHYSIOL, V149, P181, DOI 10.1085/jgp.201611637; Luo XC, 2019, P NATL ACAD SCI USA, V116, P5564, DOI 10.1073/pnas.1812901116; Meyerhof W, 2005, REV PHYSIOL BIOCH P, V154, P37, DOI 10.1007/s10254-005-0041-0; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Nguyen L, 2016, PHARMACOL THERAPEUT, V159, P1, DOI 10.1016/j.pharmthera.2016.01.016; Oritani S, 2017, HUM CELL, V30, P106, DOI 10.1007/s13577-016-0151-9; Parry J, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m351; Phan LT, 2020, NEW ENGL J MED, V382, P872, DOI 10.1056/NEJMc2001272; Plantone D, 2018, CLIN DRUG INVEST, V38, P653, DOI 10.1007/s40261-018-0656-y; Quezada SM, 2018, EXPERT REV GASTROENT, V12, P1183, DOI 10.1080/17474124.2018.1545574; Rao M, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00962; Savarin C, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.03022; Seo Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176851; Sharifi-Rad M, 2018, PHYTOTHER RES, V32, P2131, DOI 10.1002/ptr.6157; Shimokawa T, 2020, EUR J PHARMACOL, V871, DOI 10.1016/j.ejphar.2020.172917; Sloan VS, 2019, DRUGS-REAL WOR OUTC, V6, P47, DOI 10.1007/s40801-019-0152-6; Tekin HG, 2015, TURK PEDIATR ARSIVI, V50, P248, DOI 10.5152/TurkPediatriArs.2015.1360; Tran HTT, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02949; Vliegenthart R, 2018, ARCH DIS CHILD-FETAL, V103, pF523, DOI 10.1136/archdischild-2017-313556; Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9; Wang ML, 2020, CELL RES, V30, P269, DOI 10.1038/s41422-020-0282-0; Wong JP, 2017, FUTURE MED CHEM, V9, P169, DOI 10.4155/fmc-2016-0181; Yang CC, 1998, J TOXICOL-CLIN TOXIC, V36, P33, DOI 10.3109/15563659809162581; Zhang L, 2015, FORENSIC SCI MED PAT, V11, P570, DOI 10.1007/s12024-015-9709-1; Zhang T, 2020, SCI CHINA LIFE SCI, V63, P737, DOI 10.1007/s11427-019-9550-4; Zheng X, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12505-x; Zumla A, 2020, LANCET, V395, pE35, DOI 10.1016/S0140-6736(20)30305-6; Zumla A, 2016, NAT REV DRUG DISCOV, V15, P327, DOI 10.1038/nrd.2015.37	60	31	33	2	19	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6008	6016		10.1096/fj.202000502	http://dx.doi.org/10.1096/fj.202000502		APR 2020	9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32281695	Green Published			2022-12-28	WOS:000526117200001
J	Cholak, E; Bugge, K; Khondker, A; Gauger, K; Pedraz-Cuesta, E; Pedersen, ME; Bucciarelli, S; Vestergaard, B; Pedersen, SF; Rheinstadter, MC; Langkilde, AE; Kragelund, BB				Cholak, Ersoy; Bugge, Katrine; Khondker, Adree; Gauger, Kimmie; Pedraz-Cuesta, Elena; Pedersen, Morten Enghave; Bucciarelli, Saskia; Vestergaard, Bente; Pedersen, Stine F.; Rheinstadter, Maikel C.; Langkilde, Annette Eva; Kragelund, Birthe B.			Avidity within the N-terminal anchor drives alpha-synuclein membrane interaction and insertion	FASEB JOURNAL			English	Article						alpha-synuclein; aSN; avidity; IDP; membrane interaction; N-acetylation; NMR; XRD	PARKINSONS-DISEASE; PHOSPHOLIPID-BINDING; FUSION PEPTIDE; EXTENDED-HELIX; NMR; DYNAMICS; PHOSPHORYLATION; ACETYLATION; BIOPHYSICS; INTERPLAY	In the brain, alpha-synuclein (aSN) partitions between free unbound cytosolic and membrane bound forms modulating both its physiological and pathological role and complicating its study due to structural heterogeneity. Here, we use an interdisciplinary, synergistic approach to characterize the properties of aSN:lipid mixtures, isolated aSN:lipid co-structures, and aSN in mammalian cells. Enabled by the isolation of the membrane-bound state, we show that within the previously described N-terminal membrane anchor, membrane interaction relies both on an N-terminal tail (NTT) head group layer insertion of 14 residues and a folded-upon-binding helix at the membrane surface. Both binding events must be present; if, for example, the NTT insertion is lost, the membrane affinity of aSN is severely compromised and formation of aSN:lipid co-structures hampered. In mammalian cells, compromised cooperativity results in lowered membrane association. Thus, avidity within the N-terminal anchor couples N-terminal insertion and helical surface binding, which is crucial for aSN membrane interaction and cellular localization, and may affect membrane fusion.	[Cholak, Ersoy; Bucciarelli, Saskia; Vestergaard, Bente; Langkilde, Annette Eva] Univ Copenhagen, Dept Drug Design & Pharmacol, Univ Pk 2, DK-2100 Copenhagen, Denmark; [Bugge, Katrine; Kragelund, Birthe B.] Univ Copenhagen, Linderstrom Lang Ctr Prot Sci, Struct Biol & NMR Lab, DK-2200 Copenhagen N, Denmark; [Bugge, Katrine; Kragelund, Birthe B.] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Khondker, Adree; Rheinstadter, Maikel C.] McMaster Univ, Dept Phys & Astron, ABB-241 1280 Main St West, Hamilton, ON, Canada; [Gauger, Kimmie; Pedraz-Cuesta, Elena; Pedersen, Stine F.] Univ Copenhagen, Dept Biol, Sect Cell Biol & Physiol, Copenhagen, Denmark; [Pedersen, Morten Enghave] Fida Biosyst ApS, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; McMaster University; University of Copenhagen	Langkilde, AE (corresponding author), Univ Copenhagen, Dept Drug Design & Pharmacol, Univ Pk 2, DK-2100 Copenhagen, Denmark.; Kragelund, BB (corresponding author), Univ Copenhagen, Linderstrom Lang Ctr Prot Sci, Struct Biol & NMR Lab, DK-2200 Copenhagen N, Denmark.; Rheinstadter, MC (corresponding author), McMaster Univ, Dept Phys & Astron, ABB-241 1280 Main St West, Hamilton, ON, Canada.	rheinstadter@mcmaster.ca; annette.langkilde@sund.ku.dk; bbk@bio.ku.dk	Rheinstadter, Maikel C/D-5322-2009; Bugge, Katrine/C-5790-2015	Rheinstadter, Maikel C/0000-0002-0558-7475; Bugge, Katrine/0000-0002-6286-6243; Bucciarelli, Saskia/0000-0001-7612-223X; Langkilde, Annette Eva/0000-0003-2467-4205; Vestergaard, Bente/0000-0001-8011-6414; cholak, ersoy/0000-0003-1172-5683	Novo Nordisk Foundation [NNF15OC0016670]; Lundbeck Foundation; Canada Foundation for Innovation; Natural Sciences and Engineering Research Council of Canada; McMaster University	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); McMaster University	The Novo Nordisk Foundation, Grant/Award Number: NNF15OC0016670; The Lundbeck Foundation, Grant/Award Number: BRAINSTRUC; Canada Foundation for Innovation; Natural Sciences and Engineering Research Council of Canada; McMaster University	Albertson K, 2018, POL PRESS SHORT, P1; Allison JR, 2009, J AM CHEM SOC, V131, P18314, DOI 10.1021/ja904716h; Alsop RJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep22425; Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Auluck PK, 2010, ANNU REV CELL DEV BI, V26, P211, DOI 10.1146/annurev.cellbio.042308.113313; Barrett MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034357; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Bartels T, 2010, BIOPHYS J, V99, P2116, DOI 10.1016/j.bpj.2010.06.035; Binolfi A, 2012, BIOCHEM SOC T, V40, P950, DOI 10.1042/BST20120096; Bodner CR, 2010, BIOCHEMISTRY-US, V49, P862, DOI 10.1021/bi901723p; Bodner CR, 2009, J MOL BIOL, V390, P775, DOI 10.1016/j.jmb.2009.05.066; Chandra S, 2003, J BIOL CHEM, V278, P15313, DOI 10.1074/jbc.M213128200; CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033; Cholak E, 2019, BIOCHEMISTRY-US, V58, P5052, DOI 10.1021/acs.biochem.9b00925; Christel S, 2015, PROTOCOL EXCHANGE, DOI [10.1038/protex.2015.032, DOI 10.1038/PROTEX.2015.032]; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Diao JJ, 2013, ELIFE, V2, DOI 10.7554/eLife.00592; Dikiy I, 2014, J BIOL CHEM, V289, P3652, DOI 10.1074/jbc.M113.512459; Durrer P, 1996, J BIOL CHEM, V271, P13417, DOI 10.1074/jbc.271.23.13417; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Fakhree MAA, 2018, J PHYS CHEM LETT, V9, P1249, DOI 10.1021/acs.jpclett.8b00092; Ferreon ACM, 2009, P NATL ACAD SCI USA, V106, P5645, DOI 10.1073/pnas.0809232106; Fusco G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12563; Fusco G, 2016, SCI REP-UK, V6, DOI 10.1038/srep27125; Fusco G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4827; Galvagnion C, 2017, J PARKINSON DIS, V7, P433, DOI 10.3233/JPD-171103; Georgieva ER, 2008, J AM CHEM SOC, V130, P12856, DOI 10.1021/ja804517m; Georgieva ER, 2010, J BIOL CHEM, V285, P28261, DOI 10.1074/jbc.M110.157214; Gorbatenko A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39733-x; Haxholm GW, 2015, BIOCHEM J, V468, P495, DOI 10.1042/BJ20141243; Hellstrand E, 2013, ACS CHEM NEUROSCI, V4, P1339, DOI 10.1021/cn400066t; Hendus-Altenburger R, 2014, CURR TOP MEMBR, V73, P69, DOI 10.1016/B978-0-12-800223-0.00002-5; Hopkins JB, 2017, J APPL CRYSTALLOGR, V50, P1545, DOI 10.1107/S1600576717011438; HORTH M, 1991, EMBO J, V10, P2747, DOI 10.1002/j.1460-2075.1991.tb07823.x; Iyer A, 2016, J BIOL CHEM, V291, P21110, DOI 10.1074/jbc.M116.726612; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; Jao CC, 2008, P NATL ACAD SCI USA, V105, P19666, DOI 10.1073/pnas.0807826105; Jensen MB, 2011, J BIOL CHEM, V286, P42603, DOI 10.1074/jbc.M111.271130; Jiang ZP, 2015, J PHYS CHEM B, V119, P4812, DOI 10.1021/jp512499r; Johnson Matthew, 2013, Methods Mol Biol, V981, P193, DOI 10.1007/978-1-62703-305-3_15; Jucker M, 2013, NATURE, V501, P45, DOI 10.1038/nature12481; Kellie JF, 2014, SCI REP-UK, V4, DOI 10.1038/srep05797; Khondker A, 2018, ACS INFECT DIS, V4, P926, DOI 10.1021/acsinfecdis.7b00156; Khondker A, 2017, BIOPHYS J, V113, P2016, DOI 10.1016/j.bpj.2017.09.013; Knowles TPJ, 2009, SCIENCE, V326, P1533, DOI 10.1126/science.1178250; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kucerka N, 2012, J PHYS CHEM B, V116, P232, DOI 10.1021/jp208920h; Lashuel HA, 2013, NAT REV NEUROSCI, V14, P38, DOI 10.1038/nrn3406; Lee JC, 2007, J PHYS CHEM B, V111, P2107, DOI 10.1021/jp068604y; Lins L, 2008, BBA-BIOMEMBRANES, V1778, P1537, DOI 10.1016/j.bbamem.2008.04.006; Lins L, 2008, J PEPT SCI, V14, P416, DOI 10.1002/psc.971; Lokappa SB, 2011, J BIOL CHEM, V286, P21450, DOI 10.1074/jbc.M111.224055; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; Nakamura K, 2012, J BIOL CHEM, V287, P25478, DOI 10.1074/jbc.M112.365783; Nielsen SS, 2009, J APPL CRYSTALLOGR, V42, P959, DOI 10.1107/S0021889809023863; Nuscher B, 2004, J BIOL CHEM, V279, P21966, DOI 10.1074/jbc.M401076200; O'Leary EI, 2018, J BIOL CHEM, V293, P11195, DOI 10.1074/jbc.RA118.002780; Orekhov VY, 2011, PROG NUCL MAG RES SP, V59, P271, DOI 10.1016/j.pnmrs.2011.02.002; Orthaber D, 2000, J APPL CRYSTALLOGR, V33, P218, DOI 10.1107/S0021889899015216; Pacheco CR, 2015, J NEUROCHEM, V132, P731, DOI 10.1111/jnc.13060; Paleologou KE, 2010, J NEUROSCI, V30, P3184, DOI 10.1523/JNEUROSCI.5922-09.2010; Pedersen ME, 2019, ANAL CHEM, V91, P4975, DOI 10.1021/acs.analchem.9b00537; Pedraz-Cuesta E, 2016, MOL ENDOCRINOL, V30, P693, DOI 10.1210/me.2015-1299; Perrin RJ, 2001, J BIOL CHEM, V276, P41958, DOI 10.1074/jbc.M105022200; Pfefferkorn CM, 2012, BIOPHYS J, V102, P613, DOI 10.1016/j.bpj.2011.12.051; Pfefferkorn CM, 2012, BBA-BIOMEMBRANES, V1818, P162, DOI 10.1016/j.bbamem.2011.07.032; Pranke IM, 2011, J CELL BIOL, V194, P88, DOI 10.1083/jcb.201011118; Relini A, 2009, CHEM PHYS LIPIDS, V158, P1, DOI 10.1016/j.chemphyslip.2008.11.003; Reverter David, 2009, V497, P225, DOI 10.1007/978-1-59745-566-4_15; Roberts-Galbraith RH, 2010, CELL CYCLE, V9, P4091, DOI 10.4161/cc.9.20.13587; Robotta M, 2017, J AM CHEM SOC, V139, P4254, DOI 10.1021/jacs.6b05335; Robotta M, 2011, CHEMPHYSCHEM, V12, P267, DOI 10.1002/cphc.201000815; Shahmoradian SH, 2019, NAT NEUROSCI, V22, P1099, DOI 10.1038/s41593-019-0423-2; Shental-Bechor D, 2007, BIOPHYS J, V93, P1858, DOI 10.1529/biophysj.106.103812; Shvadchak VV, 2011, FEBS LETT, V585, P3513, DOI 10.1016/j.febslet.2011.10.006; Snead David, 2014, Exp Neurobiol, V23, P292, DOI 10.5607/en.2014.23.4.292; Sorensen CS, 2019, P NATL ACAD SCI USA, V116, P23124, DOI 10.1073/pnas.1904813116; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Surguchov A, 2015, INT REV CEL MOL BIO, V320, P103, DOI 10.1016/bs.ircmb.2015.07.007; Terada M, 2018, J BIOL CHEM, V293, P13910, DOI 10.1074/jbc.RA118.001862; Ullman O, 2011, J AM CHEM SOC, V133, P19536, DOI 10.1021/ja208657z; Ulmer TS, 2005, J BIOL CHEM, V280, P43179, DOI 10.1074/jbc.M507624200; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; Uversky VN, 2009, CURR PROTEIN PEPT SC, V10, P483, DOI 10.2174/138920309789351921; Vamvaca K, 2009, J MOL BIOL, V389, P413, DOI 10.1016/j.jmb.2009.03.021; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Xicoy H, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8010027; Zhou Z, 2000, BIOPHYS J, V78, P2418, DOI 10.1016/S0006-3495(00)76785-3	89	13	13	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					7462	7482		10.1096/fj.202000107R	http://dx.doi.org/10.1096/fj.202000107R		APR 2020	21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32277854	Green Published, hybrid			2022-12-28	WOS:000525001100001
J	Parashar, K; Schulte, F; Hardt, M; Baker, OJ				Parashar, Kaustubh; Schulte, Fabian; Hardt, Markus; Baker, Olga J.			Sex-mediated elevation of the specialized pro-resolving lipid mediator levels in a Sjogren's syndrome mouse model	FASEB JOURNAL			English	Article						hyposalivation; resolvins; RvD1; salivary gland; Sjogren's syndrome; SPM	ALX/FPR2 RECEPTOR; INFLAMMATION; D1; RESOLUTION; MECHANISMS; INHIBITORS; LIPOXINS; EPA; E1	Our previous results showed that the specialized pro-resolving mediator (SPM) Resolvin D1 (RvD1) promotes resolution of inflammation in salivary glands in non-obese diabetic (NOD)/ShiLtJ, a mouse model for Sjogren's syndrome (SS). Additionally, mice lacking the RvD1 receptor ALX/FPR2 show defective innate and adaptive immune responses in salivary glands. Particularly, ALX/FPR2 KO mice exhibit exacerbated inflammation in their salivary glands in response to systemic LPS treatment. Moreover, female ALX/FPR2 KO mice show increased autoantibody production and loss of salivary gland function with age. Together, these studies suggest that an underlying SPM dysregulation could be contributing to SS progression. Therefore, we investigated whether SPM production is altered in NOD/ShiLtJ using metabololipidomics and enzyme-linked immunosorbent assay (ELISA). Our results demonstrate that SPM levels were broadly elevated in plasma collected from NOD/ShiLtJ female mice after disease onset, whereas these drastic changes did not occur in male mice. Moreover, gene expression of enzymes involved in SPM biosynthesis were altered in submandibular glands (SMG) from NOD/ShiLtJ female mice after disease onset, with 5-LOX and 12/15-LOX being downregulated and upregulated, respectively. Despite this dysregulation, the abundances of the SPM products of these enzymes (ie, RvD1 and RvD2) were unaltered in freshly isolated SMG cells suggesting that other cell populations (eg, lymphocytes) may be responsible for the overabundance of SPMs that we observed. The elevation of SPMs noted here appeared to be sex mediated, meaning that it was observed only in one sex (females). Given that SS primarily affects females (roughly 90% of diagnosed cases), these results may provide some insights into the mechanisms underlying the observed sexual dimorphism.	[Parashar, Kaustubh; Baker, Olga J.] Univ Utah, Sch Dent, 383 Colorow Dr,Room 289A, Salt Lake City, UT 84108 USA; [Schulte, Fabian; Hardt, Markus] Forsyth Inst, Dept Appl Oral Sci, Cambridge, MA USA; [Hardt, Markus] Harvard Sch Dent Med, Dept Dev Biol, Boston, MA USA	Utah System of Higher Education; University of Utah; Harvard University; Forsyth Institute; Harvard University; Harvard School of Dental Medicine	Baker, OJ (corresponding author), Univ Utah, Sch Dent, 383 Colorow Dr,Room 289A, Salt Lake City, UT 84108 USA.	olga.baker@hsc.utah.edu	Hardt, Markus/M-8569-2019	Hardt, Markus/0000-0002-2300-216X	National Institute of Dental and Craniofacial Research (NIDCR) [R01DE027884]	National Institute of Dental and Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	National Institute of Dental and Craniofacial Research (NIDCR), Grant/Award Number: R01DE027884	Aliberti J, 2002, NAT IMMUNOL, V3, P76, DOI 10.1038/ni745; Ambrosi A, 2015, CURR OPIN RHEUMATOL, V27, P468, DOI 10.1097/BOR.0000000000000195; Antoniazzi RP, 2009, J PERIODONTOL, V80, P429, DOI [10.1902/jop.2009.080350, 10.1902/jop.2009.080350 ]; Arita M, 2005, J EXP MED, V201, P713, DOI 10.1084/jem.20042031; Arnardottir HH, 2016, J IMMUNOL, V197, P2362, DOI 10.4049/jimmunol.1502268; Barr JY, 2018, IMMUNOLOGY, V155, P225, DOI 10.1111/imm.12948; Benabdoune H, 2016, INFLAMM RES, V65, P635, DOI 10.1007/s00011-016-0946-x; Bhavsar PK, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-71; Brandt JE, 2015, BIOL SEX DIFFER, V6, DOI 10.1186/s13293-015-0037-7; Chiang N, 2017, MOL ASPECTS MED, V58, P114, DOI 10.1016/j.mam.2017.03.005; Colas RA, 2018, INFECT IMMUN, V86, DOI 10.1128/IAI.00688-17; Colas RA, 2014, AM J PHYSIOL-CELL PH, V307, pC39, DOI 10.1152/ajpcell.00024.2014; Cornec D, 2014, J AUTOIMMUN, V51, P109, DOI 10.1016/j.jaut.2014.02.006; Dean S, 2019, RHEUMATOLOGY, V58, P1285, DOI 10.1093/rheumatology/kez072; Dona M, 2008, BLOOD, V112, P848, DOI 10.1182/blood-2007-11-122598; Easley Justin T, 2015, J Rheum Dis Treat, V1; Eickmeier O, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171249; FOX HS, 1992, J EXP MED, V175, P1409, DOI 10.1084/jem.175.5.1409; Hamilton JA, 2017, CURR ATHEROSCLER REP, V19, DOI 10.1007/s11883-017-0696-4; Hasturk H, 2006, FASEB J, V20, P401, DOI 10.1096/fj.05-4724fje; Hasturk H, 2007, J IMMUNOL, V179, P7021, DOI 10.4049/jimmunol.179.10.7021; Herrera BS, 2008, BRIT J PHARMACOL, V155, P1214, DOI 10.1038/bjp.2008.367; Hodges RR, 2017, MUCOSAL IMMUNOL, V10, P46, DOI 10.1038/mi.2016.33; Holdgate Nicholas, 2016, F1000Res, V5, DOI 10.12688/f1000research.8352.1; Hsiao HM, 2015, AM J PATHOL, V185, P3189, DOI 10.1016/j.ajpath.2015.08.008; Imgenberg-Kreuz J, 2018, CLIN IMMUNOL, V196, P12, DOI 10.1016/j.clim.2018.04.004; Jin YP, 2009, INVEST OPHTH VIS SCI, V50, P4743, DOI 10.1167/iovs.08-2462; Kain V, 2015, J MOL CELL CARDIOL, V84, P24, DOI 10.1016/j.yjmcc.2015.04.003; Kazani S, 2013, J ALLERGY CLIN IMMUN, V132, P547, DOI 10.1016/j.jaci.2013.01.058; Kiripolsky J, 2017, CLIN IMMUNOL, V182, P4, DOI 10.1016/j.clim.2017.04.003; Krishnamoorthy S, 2010, P NATL ACAD SCI USA, V107, P1660, DOI 10.1073/pnas.0907342107; Lopez-Vicario C, 2016, EUR J PHARMACOL, V785, P133, DOI 10.1016/j.ejphar.2015.03.092; Luo X, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00745; Makino S, 1981, Jikken Dobutsu, V30, P137; Martini AC, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0540-8; Miyata J, 2019, ALLERGY, V74, P1113, DOI 10.1111/all.13726; Miyata J, 2013, J ALLERGY CLIN IMMUN, V131, P353, DOI 10.1016/j.jaci.2012.07.048; Navarini L, 2018, J IMMUNOL RES, V2018, DOI 10.1155/2018/5264195; Nelson JW, 2014, AM J PHYSIOL-CELL PH, V306, pC178, DOI 10.1152/ajpcell.00284.2013; Odusanwo O, 2012, AM J PHYSIOL-CELL PH, V302, pC1331, DOI 10.1152/ajpcell.00207.2011; Pace S, 2017, J CLIN INVEST, V127, P3167, DOI 10.1172/JCI92885; Psianou K, 2018, AUTOIMMUN REV, V17, P1053, DOI 10.1016/j.autrev.2018.05.005; Qin BD, 2015, ANN RHEUM DIS, V74, P1983, DOI 10.1136/annrheumdis-2014-205375; Rischmueller M, 2016, BEST PRACT RES CL RH, V30, P189, DOI 10.1016/j.berh.2016.04.003; Rogerio AP, 2012, J IMMUNOL, V189, P1983, DOI 10.4049/jimmunol.1101665; Serhan CN, 2008, BRIT J PHARMACOL, V153, pS200, DOI 10.1038/sj.bjp.0707489; Serhan CN, 2008, ANNU REV PATHOL-MECH, V3, P279, DOI 10.1146/annurev.pathmechdis.3.121806.151409; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; Serhan CN, 2017, MOL ASPECTS MED, V58, P1, DOI 10.1016/j.mam.2017.03.001; Serhan CN, 2017, FASEB J, V31, P1273, DOI [10.1096/fj.201601222R, 10.1096/fj.201601222r]; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Serhan CN, 2005, PROSTAG LEUKOTR ESS, V73, P141, DOI 10.1016/j.plefa.2005.05.002; Serhan CN, 2004, LIPIDS, V39, P1125, DOI 10.1007/s11745-004-1339-7; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; SERHAN CN, 1987, PROSTAGLANDINS, V34, P201, DOI 10.1016/0090-6980(87)90243-7; Spite M, 2014, CELL METAB, V19, P21, DOI 10.1016/j.cmet.2013.10.006; Takano T, 1997, J EXP MED, V185, P1693, DOI 10.1084/jem.185.9.1693; Voigt A, 2015, BIOL OPEN, V4, P1410, DOI 10.1242/bio.013771; Voulgarelis M, 2010, NAT REV RHEUMATOL, V6, P529, DOI 10.1038/nrrheum.2010.118; Wang CY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02593-4; Wang CS, 2018, AM J PATHOL, V188, P1555, DOI 10.1016/j.ajpath.2018.04.003; Wang CS, 2016, SCI REP-UK, V6, DOI 10.1038/srep24244; Wang SB, 2012, FASEB J, V26, P1506, DOI 10.1096/fj.11-198036; Wang XZ, 2015, ALZHEIMERS DEMENT, V11, P40, DOI 10.1016/j.jalz.2013.12.024; Wu SH, 2009, AM J PATHOL, V174, P115, DOI 10.2353/ajpath.2009.080671; Yang Rong, 2011, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1426s95	66	11	11	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					7733	7744		10.1096/fj.201902196R	http://dx.doi.org/10.1096/fj.201902196R		APR 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32277856	Green Accepted, Bronze			2022-12-28	WOS:000525003900001
J	James-Allan, LB; Rosario, FJ; Barner, K; Lai, A; Guanzon, D; McIntyre, HD; Lappas, M; Powell, TL; Salomon, C; Jansson, T				James-Allan, Laura B.; Rosario, Frederick J.; Barner, Kelsey; Lai, Andrew; Guanzon, Dominic; McIntyre, H. David; Lappas, Martha; Powell, Theresa L.; Salomon, Carlos; Jansson, Thomas			Regulation of glucose homeostasis by small extracellular vesicles in normal pregnancy and in gestational diabetes	FASEB JOURNAL			English	Article						exosomes; glucose intolerance; insulin resistance; islets of Langerhans; skeletal muscle	PLACENTAL GROWTH-HORMONE; SEVERE INSULIN-RESISTANCE; POTENTIAL ROLE; EXOSOMES; MICE; LACTOGEN; CIRCULATION; BIOACTIVITY; ADAPTATION; EXPRESSION	The mechanisms underpinning maternal metabolic adaptations to a healthy pregnancy and in gestational diabetes mellitus (GDM) remain poorly understood. We hypothesized that small extracellular vesicles (sEVs) isolated from healthy pregnant women promote islet glucose-stimulated insulin secretion (GSIS) and peripheral insulin resistance in nonpregnant mice and that sEVs from GDM women fail to stimulate insulin secretion and cause exacerbated insulin resistance. Small EVs were isolated from plasma of nonpregnant, healthy pregnant, and GDM women at 24-28 weeks of gestation. We developed a novel approach in nonpregnant mice involving a mini-osmotic pump for continuous 4-day jugular venous infusion of sEVs and determined their effects on glucose tolerance in vivo and islets and skeletal muscle in vitro. Fasting insulin was elevated in mice infused with pregnant sEVs as compared to sEVs from nonpregnant and GDM women. Mice infused with sEVs from GDM women developed glucose intolerance. GSIS was increased in mice infused with healthy pregnancy sEVs compared to mice receiving nonpregnant sEVs. GSIS and muscle basal insulin signaling, and insulin responsiveness were attenuated in mice infused with GDM sEVs. sEVs represent a novel mechanism regulating maternal glucose homeostasis in pregnancy and we speculate that altered sEV content contributes to the development of GDM.	[James-Allan, Laura B.; Rosario, Frederick J.; Barner, Kelsey; Jansson, Thomas] Univ Colorado, Dept Obstet Gynecol, Div Reprod Sci, Anschutz Med Campus, Aurora, CO USA; [Lai, Andrew; Guanzon, Dominic; McIntyre, H. David; Salomon, Carlos] Univ Queensland, Fac Med & Biomed Sci, Royal Brisbane & Womens Hosp, Exosome Biol Lab,Ctr Clin Diagnost,UQ Ctr Clin Re, Herston, Qld, Australia; [McIntyre, H. David] Univ Queensland, Fac Med, Mater Hlth Serv, South Brisbane, Qld, Australia; [McIntyre, H. David] Univ Queensland, Fac Med, Mater Med Res Inst, South Brisbane, Qld, Australia; [Lappas, Martha] Univ Melbourne, Dept Obstet & Gynecol, Melbourne, Vic, Australia; [Powell, Theresa L.] Univ Colorado, Dept Pediat, Sect Neonatal, Anschutz Med Campus, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Royal Brisbane & Women's Hospital; University of Queensland; Mater Health Services; University of Queensland; Mater Research; University of Queensland; University of Melbourne; University of Colorado System; University of Colorado Anschutz Medical Campus	James-Allan, LB (corresponding author), Univ Colorado, Dept Obstet & Gynecol, Anschutz Med Campus,12700 East 19th Ave, Aurora, CO 80045 USA.; Salomon, C (corresponding author), Univ Queensland, Exosome Biol Lab, Ctr Clin Diagnost, UQ Ctr Clin Res,Royal Brisbane Hosp,Fac Med, Bldg 71-918, Herston, Qld 4029, Australia.	laura.james-allan@cuanschutz.edu; c.salomongallo@uq.edu.au	James-Allan, Laura/GLU-1853-2022; McIntyre, Harold D/F-1888-2010; Salomon, Carlos/L-2167-2013	James-Allan, Laura/0000-0002-4372-6149; McIntyre, Harold D/0000-0001-8819-5794; Salomon, Carlos/0000-0003-4474-0046				Adam S, 2017, PLACENTA, V54, P83, DOI 10.1016/j.placenta.2016.12.001; ALEXANDER I, 1982, BRIT J OBSTET GYNAEC, V89, P241, DOI 10.1111/j.1471-0528.1982.tb03623.x; Aswad H, 2014, DIABETOLOGIA, V57, P2155, DOI 10.1007/s00125-014-3337-2; Baeyens L, 2016, DIABETES OBES METAB, V18, P63, DOI 10.1111/dom.12716; Barbour LA, 2004, ENDOCRINOLOGY, V145, P1144, DOI 10.1210/en.2003-1297; Barbour LA, 2002, AM J OBSTET GYNECOL, V186, P512, DOI 10.1067/mob.2002.121256; Barbour LA, 2007, DIABETES CARE, V30, pS112, DOI 10.2337/dc07-s202; Barr SM, 2011, BJOG-INT J OBSTET GY, V118, P1008; Boyle KE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106872; BRELJE TC, 1994, DIABETES, V43, P263, DOI 10.2337/diabetes.43.2.263; Catalano PM, 2006, BJOG-INT J OBSTET GY, V113, P1126, DOI 10.1111/j.1471-0528.2006.00989.x; Colino J, 2007, INFECT IMMUN, V75, P220, DOI 10.1128/IAI.01217-06; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Dareen A, 2016, END SOC 98 ANN M EXP; Delorme-Axford E, 2013, P NATL ACAD SCI USA, V110, P12048, DOI 10.1073/pnas.1304718110; Dugas C, 2017, OBESITY FACTS, V10, P396, DOI 10.1159/000477407; Elfeky O, 2017, PLACENTA, V50, P60, DOI 10.1016/j.placenta.2016.12.020; Gonzalez C, 2000, J ENDOCRINOL, V166, P283, DOI 10.1677/joe.0.1660283; Gorczynski RM, 2016, CANCER MED-US, V5, P325, DOI 10.1002/cam4.575; Guay C, 2017, DIABETES OBES METAB, V19, P137, DOI 10.1111/dom.13027; Handwerger S, 2000, J PEDIATR ENDOCR MET, V13, P343, DOI 10.1515/JPEM.2000.13.4.343; Imai T, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.26238; Jayabalan N, 2019, PROTEOMICS, V19, DOI 10.1002/pmic.201800164; Jin J, 2018, AM J REPROD IMMUNOL, V79, DOI 10.1111/aji.12788; Kanguru L, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.23987; Kim C, 2014, DIABETIC MED, V31, P292, DOI 10.1111/dme.12382; Lacroix MC, 2002, PLACENTA, V23, pS87, DOI 10.1053/plac.2002.0811; Lain KY, 2007, CLIN OBSTET GYNECOL, V50, P938, DOI 10.1097/GRF.0b013e31815a5494; Margolis L, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000363; Mitchell MD, 2015, AM J OBSTET GYNECOL, V213, pS173, DOI 10.1016/j.ajog.2015.07.001; Morales-Prieto DM, 2013, J REPROD IMMUNOL, V97, P51, DOI 10.1016/j.jri.2012.11.001; Nair S, 2018, CLIN SCI, V132, P2451, DOI 10.1042/CS20180487; Ouyang YS, 2016, PLACENTA, V47, P86, DOI 10.1016/j.placenta.2016.09.008; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Pettitt DJ, 2008, DIABETES CARE, V31, P2126, DOI 10.2337/dc08-0769; Poirier C, 2017, CURR DIABETES REP, V17, DOI 10.1007/s11892-017-0856-5; Poola-Kella S, 2018, REV RECENT CLIN TRIA, V13, P5, DOI 10.2174/1574887112666170911124806; Raimondo S, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0086-x; Rice GE, 2015, J CLIN ENDOCR METAB, V100, pE1280, DOI 10.1210/jc.2015-2270; Salomon C, 2017, J CLIN ENDOCR METAB, V102, P3182, DOI 10.1210/jc.2017-00672; Salomon C, 2016, DIABETES, V65, P598, DOI 10.2337/db15-0966; Salomon C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098667; Salomon C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079636; Santovito D, 2014, J CLIN ENDOCR METAB, V99, pE1681, DOI 10.1210/jc.2013-3843; Sarker S, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-204; SIDERI M, 1983, BRIT J OBSTET GYNAEC, V90, P771, DOI 10.1111/j.1471-0528.1983.tb09309.x; Sonagra Amit D, 2014, J Clin Diagn Res, V8, pCC01, DOI 10.7860/JCDR/2014/10068.5081; Sorenson RL, 1997, HORM METAB RES, V29, P301, DOI 10.1055/s-2007-979040; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun L, 2016, CYTOTHERAPY, V18, P413, DOI 10.1016/j.jcyt.2015.11.018; Takahashi Y, 2013, J BIOTECHNOL, V165, P77, DOI 10.1016/j.jbiotec.2013.03.013; Thery C, 2018, J EXTRACELL VESICLES, V7, DOI 10.1080/20013078.2018.1535750; Yang CJ, 2012, EUR J IMMUNOL, V42, P1778, DOI 10.1002/eji.201141978; Zhu XH, 2017, J EXTRACELL VESICLES, V6, DOI 10.1080/20013078.2017.1324730; Zhu YY, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-015-0699-x	56	30	30	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5724	5739		10.1096/fj.201902522RR	http://dx.doi.org/10.1096/fj.201902522RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32154621	Bronze			2022-12-28	WOS:000530242100060
J	Zhao, J; Sun, Y; Lin, H; Chou, FJ; Xiao, Y; Jin, RA; Cai, XJ; Chang, CS				Zhao, Jie; Sun, Yin; Lin, Hui; Chou, Fuju; Xiao, Yao; Jin, Ren'an; Cai, Xiujun; Chang, Chawnshang			Olaparib and enzalutamide synergistically suppress HCC progression via the AR-mediated miR-146a-5p/BRCA1 signaling	FASEB JOURNAL			English	Article						androgen receptor; enzalutamide; hepatocellular carcinoma; olaparib; synergistic effect	UNRESECTABLE HEPATOCELLULAR-CARCINOMA; PROSTATE-CANCER; ANTIANDROGEN THERAPY; DNA-DAMAGE; REPAIR; SORAFENIB; MIR-146A; GENES; PATHOGENESIS; INHIBITION	Hepatocellular carcinoma (HCC) is one of most common cancers worldwide, however, the treatment for advanced HCC remains unsatisfactory. We focused on the function of the androgen receptor (AR) in HCC and tried to find new treatment strategy based on antiandrogen enzalutamide (Enz). Here, we found that olaparib, a FDA-approved PARP inhibitor, could enhance the cytotoxicity in HCC cells with a lower BRCA1 expression, and suppressing the AR with either Enz or AR-shRNA could further increase the olaparib sensitivity to better suppress the HCC cell growth via a synergistic mechanism that may involve suppressing the expression of BRCA1 and other DNA damage response (DDR) genes. Mechanism studies revealed that Enz/AR signaling might transcriptionally regulate the miR-146a-5p expression via binding to the Androgen Response Elements on its 5 ' promoter region, which could then lead to suppress the homologous recombination-related BRCA1 expression via direct binding to the mRNA 3 ' UTR. Preclinical studies using an in vivo mouse model also demonstrated that combining Enz plus olaparib led to better suppression of the HCC progression. Together, these in vitro/in vivo data suggest that combining Enz and olaparib may help in the development of a novel therapy to better suppress the HCC progression.	[Zhao, Jie; Lin, Hui; Jin, Ren'an; Cai, Xiujun] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Gen Surg,Innovat Ctr Minimally Invas Tech &, Hangzhou 310016, Peoples R China; [Zhao, Jie; Lin, Hui; Jin, Ren'an; Cai, Xiujun] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Urol,Innovat Ctr Minimally Invas Tech & Devi, Hangzhou, Peoples R China; [Zhao, Jie; Sun, Yin; Chou, Fuju; Xiao, Yao; Jin, Ren'an; Chang, Chawnshang] Univ Rochester, Med Ctr, Dept Pathol, George Whipple Lab Canc Res, Rochester, NY 14642 USA; [Zhao, Jie; Sun, Yin; Chou, Fuju; Xiao, Yao; Jin, Ren'an; Chang, Chawnshang] Univ Rochester, Med Ctr, Dept Urol, George Whipple Lab Canc Res, Rochester, NY 14642 USA; [Zhao, Jie; Sun, Yin; Chou, Fuju; Xiao, Yao; Jin, Ren'an; Chang, Chawnshang] Univ Rochester, Med Ctr, Wilmot Canc Inst, Rochester, NY 14642 USA; [Chang, Chawnshang] China Med Univ Hosp, Sex Hormone Res Ctr, Taichung, Taiwan	Zhejiang University; Zhejiang University; University of Rochester; University of Rochester; University of Rochester; China Medical University Taiwan; China Medical University Hospital - Taiwan	Cai, XJ (corresponding author), Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Gen Surg,Innovat Ctr Minimally Invas Tech &, Hangzhou 310016, Peoples R China.; Chang, CS (corresponding author), Univ Rochester, Med Ctr, Dept Pathol, George Whipple Lab Canc Res, Rochester, NY 14642 USA.; Chang, CS (corresponding author), Univ Rochester, Med Ctr, Dept Urol, George Whipple Lab Canc Res, Rochester, NY 14642 USA.; Chang, CS (corresponding author), Univ Rochester, Med Ctr, Wilmot Canc Inst, Rochester, NY 14642 USA.	srrsh_cxj@zju.edu.cn; chang@urmc.rochester.edu	Xiao, Yao/AEX-1775-2022	Xiao, Yao/0000-0002-4638-4148; Chang, Chawnshang/0000-0001-8510-3516	NCI NIH HHS [R01 CA156700] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Asim M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00393-y; Bandiera S, 2016, J VIROL, V90, P6387, DOI 10.1128/JVI.00619-16; Beer TM, 2014, NEW ENGL J MED, V371, P424, DOI 10.1056/NEJMoa1405095; Brechot C, 2004, GASTROENTEROLOGY, V127, pS56, DOI 10.1053/j.gastro.2004.09.016; Chen CF, 2010, HEPATOLOGY, V52, P1690, DOI 10.1002/hep.23847; CHOU TC, 1994, JNCI-J NATL CANCER I, V86, P1517, DOI 10.1093/jnci/86.20.1517; Cui YJ, 2016, ONCOL RES, V23, P275, DOI 10.3727/096504016X14562725373798; Di Maio M, 2006, ANN NY ACAD SCI, V1089, P252, DOI 10.1196/annals.1386.007; El-Amm J, 2013, CLIN MED INSIGHTS-ON, V7, P235, DOI 10.4137/CMO.S11670; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Fautrel A, 2005, J HEPATOL, V43, P288, DOI 10.1016/j.jhep.2005.02.020; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Fujimoto A, 2012, NAT GENET, V44, P760, DOI 10.1038/ng.2291; Garcia AI, 2011, EMBO MOL MED, V3, P279, DOI 10.1002/emmm.201100136; Grimaldi C, 1998, J CLIN ONCOL, V16, P411, DOI 10.1200/JCO.1998.16.2.411; GUPTA S, 1988, J CLIN GASTROENTEROL, V10, P651, DOI 10.1097/00004836-198812000-00016; Hu QM, 2018, ONCOL REP, V39, P3015, DOI 10.3892/or.2018.6391; Huang J, 2012, NAT GENET, V44, P1117, DOI 10.1038/ng.2391; Kudo M, 2018, LANCET, V391, P1163, DOI 10.1016/S0140-6736(18)30207-1; Lacona JR, 2019, WIRES RNA, V10, DOI 10.1002/wrna.1533; Li Y., 2010, CANCER RES, V70, P5703, DOI [10.1158/1538-7445.AM10-5703, DOI 10.1158/1538-7445.AM10-5703]; Li YL, 2016, ONCOTARGET, V7, P59287, DOI 10.18632/oncotarget.11040; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Llovet JM, 2015, NAT REV CLIN ONCOL, V12, P408, DOI [10.1038/nrclinonc.2015.103, 10.1038/nrclinonc.2015.121]; Ma CL, 2008, GASTROENTEROLOGY, V135, P947, DOI 10.1053/j.gastro.2008.05.046; Mateo J, 2015, NEW ENGL J MED, V373, P1697, DOI 10.1056/NEJMoa1506859; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Polkinghorn WR, 2013, CANCER DISCOV, V3, P1245, DOI 10.1158/2159-8290.CD-13-0172; Robson M, 2017, NEW ENGL J MED, V377, P523, DOI 10.1056/NEJMoa1706450; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; Sasaki H, 2016, CLIN GENITOURIN CANC, V14, pE493, DOI 10.1016/j.clgc.2016.04.002; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Sun Q, 2014, PROSTATE, V74, P1613, DOI 10.1002/pros.22878; Tangkijvanich P, 2004, WORLD J GASTROENTERO, V10, P1547, DOI 10.3748/wjg.v10.i11.1547; Wang C, 2016, BRIT J CANCER, V115, P1548, DOI 10.1038/bjc.2016.367; Warde P, 2011, LANCET, V378, P2104, DOI 10.1016/S0140-6736(11)61095-7; Wu MH, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001143; Xu JJ, 2016, EBIOMEDICINE, V12, P55, DOI 10.1016/j.ebiom.2016.07.013; Yang SF, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/153867	42	6	7	2	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5877	5891		10.1096/fj.201903045RR	http://dx.doi.org/10.1096/fj.201903045RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32134529	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000530242100071
J	Schulze, A; Kleinau, G; Neumann, S; Scheerer, P; Schoneberg, T; Bruser, A				Schulze, Annelie; Kleinau, Gunnar; Neumann, Susanne; Scheerer, Patrick; Schoeneberg, Torsten; Brueser, Antje			The intramolecular agonist is obligate for activation of glycoprotein hormone receptors	FASEB JOURNAL			English	Article						G protein-coupled receptors; glycoprotein hormone receptors; hormone receptors; tethered agonist; thyroid-stimulating hormone	FOLLICLE-STIMULATING-HORMONE; HUMAN THYROTROPIN RECEPTOR; TSH RECEPTOR; EXTRACELLULAR DOMAIN; HINGE REGION; CONSTITUTIVE ACTIVATION; TRANSMEMBRANE DOMAIN; SMALL-MOLECULE; INTRACELLULAR LOOP; LUTROPIN-RECEPTOR	In contrast to most rhodopsin-like G protein-coupled receptors, the glycoprotein hormone receptors (GPHR) have a large extracellular N-terminus for hormone binding. The hormones do not directly activate the transmembrane domain but mediate their action via a, thus, far only partially knownTetheredAgonisticLIgand (TALI). The existence of such an intramolecular agonist was initially indicated by site-directed mutation studies and activating peptides derived from the extracellular hinge region. It is still unknown precisely howTALIis involved in intramolecular signal transmission. We combined systematic mutagenesis studies at the luteinizing hormone receptor and the thyroid-stimulating hormone receptor (TSHR), stimulation with a drug-like agonist (E2) of the TSHR, and structural homology modeling to unravel the functional and structural properties defining theTALIregion. Here, we report thatTALI(a) is predisposed to constitutively activate GPHR, (b) can by itself rearrange GPHR into a fully active conformation, (c) stabilizes active GPHR conformation, and (d) is not involved in activation of the TSHR by E2. In the active state conformation,TALIforms specific interactions between the N-terminus and the transmembrane domain. We show that stabilization of an active state is dependent onTALI,including activation by hormones and constitutively activating mutations.	[Schulze, Annelie; Schoeneberg, Torsten; Brueser, Antje] Univ Leipzig, Rudolf Schonheimer Inst Biochem, Med Fac, Mol Biochem, Johannisallee 30, D-04103 Leipzig, Germany; [Kleinau, Gunnar; Scheerer, Patrick] Charite Univ Med Berlin, Berlin Inst Hlth, Inst Med Phys & Biophys, Grp Prot Xray Crystallog & Signal Transduct, Berlin, Germany; [Kleinau, Gunnar; Scheerer, Patrick] Free Univ Berlin, Berlin, Germany; [Kleinau, Gunnar; Scheerer, Patrick] Humboldt Univ, Berlin, Germany; [Neumann, Susanne] NIDDK, Lab Endocrinol & Receptor Biol, NIH, Bethesda, MD 20892 USA	Leipzig University; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Schoneberg, T (corresponding author), Univ Leipzig, Rudolf Schonheimer Inst Biochem, Med Fac, Mol Biochem, Johannisallee 30, D-04103 Leipzig, Germany.	schoberg@medizin.uni-leipzig.de	Kleinau, Gunnar/GPX-6330-2022; Neumann, Susanne/GPK-6035-2022; Schulze, Annelie/AAP-2021-2021	Schulze, Annelie/0000-0002-8722-4984; Scheerer, Patrick/0000-0001-5028-2075	Deutsche Forschungsgemeinschaft (DFG) [CRC1365-A03, BR 5108/1, CRC1078-B6, CRC1423]; HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [Z01 DK011006]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: BR 5108/1; Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: CRC1078-B6; Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: CRC1423; Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: CRC1365-A03; HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Grant/Award Number: Z01 DK011006	Agrawal G, 2009, J BIOL CHEM, V284, P2636, DOI 10.1074/jbc.M808199200; Allen MD, 2011, FASEB J, V25, P3687, DOI 10.1096/fj.11-188961; Alvarez CA, 1999, ENDOCRINOLOGY, V140, P1775, DOI 10.1210/en.140.4.1775; Angelova K, 2002, ENDOCRINE, V19, P147, DOI 10.1385/ENDO:19:2:147; Angelova K, 2008, MOL ENDOCRINOL, V22, P126, DOI 10.1210/me.2007-0352; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Biebermann H, 1998, FASEB J, V12, P1461, DOI 10.1096/fasebj.12.14.1461; Biebermann H, 2001, J CLIN ENDOCR METAB, V86, P4429, DOI 10.1210/jc.86.9.4429; Bruser A, 2016, J BIOL CHEM, V291, P508, DOI 10.1074/jbc.M115.701102; Bruysters M, 2008, J BIOL CHEM, V283, P25821, DOI 10.1074/jbc.M804395200; Chen CR, 2012, ENDOCRINOLOGY, V153, P5058, DOI 10.1210/en.2012-1376; Chen CR, 2003, ENDOCRINOLOGY, V144, P1324, DOI 10.1210/en.2002-0005; Claus M, 2005, ENDOCRINOLOGY, V146, P5197, DOI 10.1210/en.2005-0713; deRoux N, 1996, J CLIN ENDOCR METAB, V81, P4229, DOI 10.1210/jc.81.12.4229; Duprez L, 1997, FEBS LETT, V409, P469, DOI 10.1016/S0014-5793(97)00532-2; Fan QR, 2005, NATURE, V433, P269, DOI 10.1038/nature03206; Godbole A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00357-2; Gruters A, 1998, J CLIN ENDOCR METAB, V83, P1431, DOI 10.1210/jc.83.5.1431; Jaeschke H, 2006, ENDOCRINOLOGY, V147, P1753, DOI 10.1210/en.2005-1138; Jaeschke H, 2008, CELL MOL LIFE SCI, V65, P4028, DOI 10.1007/s00018-008-8530-3; Jaquette J, 2002, MOL CELL ENDOCRINOL, V194, P211, DOI 10.1016/S0303-7207(02)00220-4; Jaschke H, 2006, J BIOL CHEM, V281, P9841, DOI 10.1074/jbc.C600014200; Jiang XL, 2014, MOL CELL ENDOCRINOL, V382, P424, DOI 10.1016/j.mce.2013.08.021; Jiang XL, 2012, P NATL ACAD SCI USA, V109, P12491, DOI 10.1073/pnas.1206643109; Karges B, 2005, MOL ENDOCRINOL, V19, P2086, DOI 10.1210/me.2004-0378; Kleinau G, 2004, J BIOL CHEM, V279, P51590, DOI 10.1074/jbc.M404748200; Kleinau G, 2008, FASEB J, V22, P2798, DOI 10.1096/fj.07-104711; Kleinau G, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00086; Kleinau Gunnar, 2014, Adv Pharmacol, V70, P81, DOI 10.1016/B978-0-12-417197-8.00003-1; Kleinau G, 2013, ENDOCR REV, V34, P691, DOI 10.1210/er.2012-1072; Kleinau G, 2010, FASEB J, V24, P2347, DOI 10.1096/fj.09-149146; Kleinau G, 2010, HUM MUTAT, V31, pE1519, DOI 10.1002/humu.21265; Kleinau G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009745; Kleinau G, 2009, ENDOCR REV, V30, P133, DOI 10.1210/er.2008-0044; Koehl A, 2018, NATURE, V558, P547, DOI 10.1038/s41586-018-0219-7; Kopp P, 1997, J CLIN INVEST, V100, P1634, DOI 10.1172/JCI119687; Krause G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052920; Kreuchwig A, 2013, MOL ENDOCRINOL, V27, P1357, DOI 10.1210/me.2013-1115; Krumm BE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8895; Laugwitz KL, 1996, P NATL ACAD SCI USA, V93, P116, DOI 10.1073/pnas.93.1.116; Liu Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016335; Ma YL, 2017, STRUCTURE, V25, P858, DOI 10.1016/j.str.2017.04.008; Majumdar R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040291; Marcinkowski P, 2019, MOL PHARMACOL, V96, P452, DOI 10.1124/mol.119.116947; Miller RL, 2015, STRUCTURE, V23, P2291, DOI 10.1016/j.str.2015.07.024; Mizutori Y, 2008, MOL ENDOCRINOL, V22, P1171, DOI 10.1210/me.2007-0407; Mueller S, 2006, J BIOL CHEM, V281, P31638, DOI 10.1074/jbc.M604770200; Mueller S, 2009, J BIOL CHEM, V284, P16317, DOI 10.1074/jbc.M109.005710; Neumann S, 2005, ENDOCRINOLOGY, V146, P477, DOI 10.1210/en.2004-1045; Neumann S, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00105; Neumann S, 2009, P NATL ACAD SCI USA, V106, P12471, DOI 10.1073/pnas.0904506106; Nurwakagari P, 2007, J MOL ENDOCRINOL, V38, P259, DOI 10.1677/jme.1.02160; Parma J, 1997, J CLIN ENDOCR METAB, V82, P2695, DOI 10.1210/jc.82.8.2695; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Ryu KS, 1996, J BIOL CHEM, V271, P7301, DOI 10.1074/jbc.271.13.7301; Sanders J, 2003, LANCET, V362, P126, DOI 10.1016/S0140-6736(03)13866-4; Sanders J, 2007, THYROID, V17, P395, DOI 10.1089/thy.2007.0034; Sangkuhl K, 2002, J BIOL CHEM, V277, P47748, DOI 10.1074/jbc.M203491200; Schaarschmidt J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111570; Schoneberg T, 2016, PHARMACOL RES, V108, P9, DOI 10.1016/j.phrs.2016.03.027; Schoneberg T, 1998, HUM MUTAT, V12, P196, DOI 10.1002/(SICI)1098-1004(1998)12:3<196::AID-HUMU7>3.0.CO;2-F; Schulz A, 1999, MOL ENDOCRINOL, V13, P181, DOI 10.1210/me.13.2.181; Smith BR, 2007, THYROID, V17, P923, DOI 10.1089/thy.2007.0239; Sohn J, 2002, J BIOL CHEM, V277, P50165, DOI 10.1074/jbc.M207646200; Stavrou SS, 1998, J CLIN ENDOCR METAB, V83, P2091, DOI 10.1210/jc.83.6.2091; Troppmann B, 2013, HUM REPROD UPDATE, V19, P583, DOI 10.1093/humupd/dmt023; VanSande J, 1996, MOL CELL ENDOCRINOL, V119, P161, DOI 10.1016/0303-7207(96)03804-X; Vlaeminck-Guillem V, 2002, MOL ENDOCRINOL, V16, P736, DOI 10.1210/me.16.4.736; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Zeng HW, 2001, J BIOL CHEM, V276, P3451, DOI 10.1074/jbc.M007488200; Zhang M, 2000, ENDOCRINOLOGY, V141, P3514, DOI 10.1210/en.141.9.3514; ZHANG ML, 1995, BIOCHEM BIOPH RES CO, V211, P205, DOI 10.1006/bbrc.1995.1797; Zhang R, 1996, J BIOL CHEM, V271, P5755, DOI 10.1074/jbc.271.10.5755	73	6	6	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					11243	11256		10.1096/fj.202000100R	http://dx.doi.org/10.1096/fj.202000100R		JUL 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32648604	hybrid, Green Accepted			2022-12-28	WOS:000547914900001
J	Plewes, MR; Krause, C; Talbott, HA; Przygrodzka, E; Wood, JR; Cupp, A; Davis, JS				Plewes, Michele R.; Krause, Crystal; Talbott, Heather A.; Przygrodzka, Emilia; Wood, Jennifer R.; Cupp, Andrea; Davis, John S.			Trafficking of cholesterol from lipid droplets to mitochondria in bovine luteal cells: Acute control of progesterone synthesis	FASEB JOURNAL			English	Article						corpus luteum; hormone sensitive lipase; protein kinase A; steroidogenesis; luteinizing hormone	HORMONE-SENSITIVE LIPASE; ACUTE REGULATORY PROTEIN; ADIPOSE TRIGLYCERIDE LIPASE; HIGH-DENSITY-LIPOPROTEIN; CORPUS-LUTEUM; SPATIAL-DISTRIBUTION; LUTEINIZING-HORMONE; LATERAL MOBILITY; ESTER HYDROLASE; FISH-OIL	The corpus luteum is a transient endocrine gland that synthesizes and secretes the steroid hormone, progesterone, which is vital for establishment and maintenance of pregnancy. Luteinizing hormone (LH) via activation of protein kinase A (PKA) acutely stimulates luteal progesterone synthesis via a complex process, converting cholesterol via a series of enzymatic reactions, into progesterone. Lipid droplets in steroidogenic luteal cells store cholesterol in the form of cholesterol esters, which are postulated to provide substrate for steroidogenesis. Early enzymatic studies showed that hormone sensitive lipase (HSL) hydrolyzes luteal cholesterol esters. In this study, we tested whether HSL is a critical mediator of the acute actions of LH on luteal progesterone production. Using LH-responsive bovine small luteal cells our results reveal that LH, forskolin, and 8-Br cAMP-induced PKA-dependent phosphorylation of HSL at Ser563 and Ser660, events known to promote HSL activity. Small molecule inhibition of HSL activity and siRNA-mediated knock down of HSL abrogated LH-induced progesterone production. Moreover, western blotting and confocal microscopy revealed that LH stimulates phosphorylation and translocation of HSL to lipid droplets. Furthermore, LH increased trafficking of cholesterol from the lipid droplets to the mitochondria, which was dependent on both PKA and HSL activation. Taken together, these findings identify a PKA/HSL signaling pathway in luteal cells in response to LH and demonstrate the dynamic relationship between PKA, HSL, and lipid droplets in luteal progesterone synthesis.	[Plewes, Michele R.; Krause, Crystal; Talbott, Heather A.; Przygrodzka, Emilia; Davis, John S.] Univ Nebraska Med Ctr, Olson Ctr Womens Hlth, Dept Obstet & Gynecol, Omaha, NE 68198 USA; [Wood, Jennifer R.; Cupp, Andrea] Univ Nebraska, Dept Anim Sci, A224k, Lincoln, NE USA; [Plewes, Michele R.; Davis, John S.] Vet Affairs Nebraska Western Iowa Hlth Care Syst, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Lincoln; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Nebraska-Western Iowa Health Care System	Davis, JS (corresponding author), Univ Nebraska Med Ctr, Olson Ctr Womens Hlth, 983255 Nebraska Med Ctr, Omaha, NE 68198 USA.	jsdavis@unmc.edu	Wood, Jennifer R/S-3213-2019; PRZYGRODZKA, Emilia/H-7239-2017	Wood, Jennifer R/0000-0001-9337-5837; Talbott, Heather/0000-0002-6140-9059; Davis, John/0000-0003-3468-4079; PRZYGRODZKA, Emilia/0000-0003-4018-9023	NIH [R01 HD087402, R01HD092263]; USDA, NIFA [2017-67015-26450, 2014-67011-22280, 2018-08068]; Department of Veterans Affairs [I01 BX004272]; Olson Center for Women's Health; Center for Cellular Signaling National Health Institutes [CoBRE-P30GM106397]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA, NIFA(United States Department of Agriculture (USDA)); Department of Veterans Affairs(US Department of Veterans Affairs); Olson Center for Women's Health; Center for Cellular Signaling National Health Institutes	This project was supported by NIH grants R01 HD087402 and R01HD092263 to JSD, ASC and JRW; USDA, NIFA Grants 2017-67015-26450 to JSD and ASC, 2014-67011-22280 to HAT, and 2018-08068 to MRP; the Department of Veterans Affairs I01 BX004272 to JSD; the Olson Center for Women's Health; and the use of microscope was supported by Center for Cellular Signaling CoBRE-P30GM106397 National Health Institutes.	[Anonymous], 2019, STATPEARLS; Anthonsen MW, 1998, J BIOL CHEM, V273, P215, DOI 10.1074/jbc.273.1.215; Bickel PE, 2009, BBA-MOL CELL BIOL L, V1791, P419, DOI 10.1016/j.bbalip.2009.04.002; Bochem AE, 2013, J LIPID RES, V54, P1698, DOI 10.1194/jlr.P033449; Brasaemle DL, 2016, CURRENT PROTOCOLS CE, V72, P1; CARR BR, 1982, FERTIL STERIL, V38, P303; Christenson Lane K, 2003, Reprod Biol Endocrinol, V1, P90, DOI 10.1186/1477-7827-1-90; COOK KG, 1982, EUR J BIOCHEM, V125, P245, DOI 10.1111/j.1432-1033.1982.tb06675.x; DAVIS JS, 1987, J BIOL CHEM, V262, P8515; DAYA S, 1988, AM J OBSTET GYNECOL, V158, P225, DOI 10.1016/0002-9378(88)90127-5; Ding YB, 2012, ACTA BIOCH BIOPH SIN, V44, P394, DOI 10.1093/abbs/gms008; Escary JL, 1998, ARTERIOSCL THROM VAS, V18, P991, DOI 10.1161/01.ATV.18.6.991; GARTON AJ, 1988, FEBS LETT, V229, P68, DOI 10.1016/0014-5793(88)80799-3; GRUMMER RR, 1988, J ANIM SCI, V66, P3160; HANSEL W, 1991, J REPROD FERTIL, P77; Holm C, 2003, BIOCHEM SOC T, V31, P1120, DOI 10.1042/BST0311120; HOLST LS, 1994, FEBS LETT, V355, P125, DOI 10.1016/0014-5793(94)01185-0; Hu J, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-47; Itabe H, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-017-0473-y; Khanthusaeng V, 2016, ACTA HISTOCHEM, V118, P553, DOI 10.1016/j.acthis.2016.05.007; Kohen P, 2003, J CLIN ENDOCR METAB, V88, P3421, DOI 10.1210/jc.2002-021916; Kraemer FB, 2004, MOL ENDOCRINOL, V18, P549, DOI 10.1210/me.2003-0179; Kraemer FB, 2007, MOL CELL ENDOCRINOL, V265, P42, DOI 10.1016/j.mce.2006.12.001; Kraemer FB, 2006, NUTR METAB, V3, DOI 10.1186/1743-7075-3-12; Li D, 2008, DIABETES, V57, P635, DOI 10.2337/db07-0717; Lobo MVT, 2009, J HISTOCHEM CYTOCHEM, V57, P51, DOI 10.1369/jhc.2008.951996; Manna PR, 2013, J BIOL CHEM, V288, P8505, DOI 10.1074/jbc.M112.417873; Manna PR, 2009, MOL HUM REPROD, V15, P321, DOI 10.1093/molehr/gap025; Mao DG, 2013, MOL ENDOCRINOL, V27, P2066, DOI 10.1210/me.2013-1274; Marsh J M, 1975, Adv Cyclic Nucleotide Res, V6, P137; Meidan, 2017, LIFE CYCLE CORPUS LU, P57, DOI DOI 10.1007/978-3-319-43238-0_4; Meidan R., 2016, LIFE CYCLE CORPUS LU; Miller WL, 2017, J STEROID BIOCHEM, V165, P18, DOI 10.1016/j.jsbmb.2016.03.009; Miller WL, 1995, J STEROID BIOCHEM, V55, P607, DOI 10.1016/0960-0760(95)00212-X; Minkkila A, 2009, CHEMMEDCHEM, V4, P1253, DOI 10.1002/cmdc.200900137; Miyoshi H, 2008, J CELL BIOCHEM, V105, P1430, DOI 10.1002/jcb.21964; Mottillo EP, 2007, AM J PHYSIOL-ENDOC M, V293, pE1188, DOI 10.1152/ajpendo.00051.2007; Murphy DJ, 1999, TRENDS BIOCHEM SCI, V24, P109, DOI 10.1016/S0968-0004(98)01349-8; Niswender GD, 2002, REPRODUCTION, V123, P333, DOI 10.1530/rep.0.1230333; Olzmann JA, 2019, NAT REV MOL CELL BIO, V20, P137, DOI 10.1038/s41580-018-0085-z; OSHEA JD, 1989, J REPROD FERTIL, V85, P483, DOI 10.1530/jrf.0.0850483; Osuga J, 2000, P NATL ACAD SCI USA, V97, P787, DOI 10.1073/pnas.97.2.787; PATE JL, 1982, MOL CELL ENDOCRINOL, V28, P551, DOI 10.1016/0303-7207(82)90146-0; Petan T, 2018, MOLECULES, V23, DOI 10.3390/molecules23081941; Plewes MR, 2018, DOMEST ANIM ENDOCRIN, V63, P38, DOI 10.1016/j.domaniend.2017.12.001; Plewes MR, 2017, DOMEST ANIM ENDOCRIN, V60, P9, DOI 10.1016/j.domaniend.2017.02.001; Plewes MR, 2017, DOMEST ANIM ENDOCRIN, V58, P39, DOI 10.1016/j.domaniend.2016.08.001; Plewes MR, 2017, BBA-BIOMEMBRANES, V1859, P2413, DOI 10.1016/j.bbamem.2017.09.012; Rapoport R, 1998, BBA-GEN SUBJECTS, V1380, P133, DOI 10.1016/S0304-4165(97)00136-0; Romereim SM, 2017, DATA BRIEF, V10, P335, DOI 10.1016/j.dib.2016.11.093; Romereim SM, 2017, MOL CELL ENDOCRINOL, V439, P379, DOI 10.1016/j.mce.2016.09.029; Roy L, 2009, ENDOCRINOLOGY, V150, P5036, DOI 10.1210/en.2009-0771; Rueda BR, 2000, BIOL REPROD, V62, P269, DOI 10.1095/biolreprod62.2.269; Schweiger M, 2006, J BIOL CHEM, V281, P40236, DOI 10.1074/jbc.M608048200; SEIFART K, 1965, FED PROC, V24, P320; Sekiya M, 2008, J LIPID RES, V49, P1829, DOI 10.1194/jlr.M800198-JLR200; Shen WJ, 2016, EXP CELL RES, V340, P209, DOI 10.1016/j.yexcr.2015.11.024; Shen WJ, 2003, J BIOL CHEM, V278, P43870, DOI 10.1074/jbc.M303934200; SMALL CA, 1989, FEBS LETT, V247, P205, DOI 10.1016/0014-5793(89)81335-3; Stocco DM, 1997, BIOL REPROD, V56, P328, DOI 10.1095/biolreprod56.2.328; STRALFORS P, 1984, P NATL ACAD SCI-BIOL, V81, P3317, DOI 10.1073/pnas.81.11.3317; STRAUSS JF, 1977, J LIPID RES, V18, P246; Talbott HA, 2020, SCI REPORTS; Taurin S, 2008, AM J PHYSIOL-CELL PH, V294, pC1169, DOI 10.1152/ajpcell.00096.2008; VAUGHAN M, 1964, J BIOL CHEM, V239, P401; Wang H, 2009, J BIOL CHEM, V284, P32116, DOI 10.1074/jbc.M109.006726; Watt MJ, 2006, AM J PHYSIOL-ENDOC M, V290, pE500, DOI 10.1152/ajpendo.00361.2005; Wiltbank MC, 2012, ANIM REPROD, V9, P242; WILTBANK MC, 1991, J REPROD FERTIL, P65	69	6	7	1	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10731	10750		10.1096/fj.202000671R	http://dx.doi.org/10.1096/fj.202000671R		JUL 2020	20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32614098	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000547288600001
J	Sanjo, H; Yao, T; Katagiri, K; Sato, T; Matsumura, T; Komeya, M; Yamanaka, H; Yao, M; Matsuhisa, A; Asayama, Y; Ikeda, K; Kano, K; Aoki, J; Arita, M; Ogawa, T				Sanjo, Hiroyuki; Yao, Tatsuma; Katagiri, Kumiko; Sato, Takuya; Matsumura, Takafumi; Komeya, Mitsuru; Yamanaka, Hiroyuki; Yao, Masahiro; Matsuhisa, Akio; Asayama, Yuta; Ikeda, Kazutaka; Kano, Kuniyuki; Aoki, Junken; Arita, Makoto; Ogawa, Takehiko			Antioxidant vitamins and lysophospholipids are critical for inducing mouse spermatogenesis under organ culture conditions	FASEB JOURNAL			English	Article						ascorbic acid; chemically defined medium; glutathione; lysophospholipids; meiosis; organ culture; spermatogenesis; testis; alpha-tocopherol	FOLLICLE-STIMULATING-HORMONE; LYSOPHOSPHATIDIC ACID; SPERM PRODUCTION; E-DEFICIENCY; SERUM; PHOSPHOLIPIDS; MATURATION; FERTILITY; TURNOVER; TISSUES	In vitro mouse spermatogenesis using a classical organ culture method became possible by supplementing basal culture medium with only the product of bovine serum albumin purified by chromatography (AlbuMAX), which indicated that AlbuMAX contained every chemical factor necessary for mouse spermatogenesis. However, since the identity of these factors was unclear, improvements in culture media and our understanding of the nutritional and signal substances required for spermatogenesis were hindered. In the present study, chemically defined media (CDM) without AlbuMAX was used to evaluate each supplementary factor and their combinations for the induction of spermatogenesis. Similar to in vivo conditions, retinoic acid, triiodothyronine (T-3), and testosterone (T) were needed. Based on differences in spermatogenic competence between AlbuMAX, fetal bovine serum, and adult bovine serum, we identified alpha-tocopherol, which strongly promoted spermatogenesis when combined with ascorbic acid and glutathione. Differences were also observed in the abilities of lipids extracted from AlbuMAX using two different methods to induce spermatogenesis. This led to the identification of lysophospholipids, particularly lysophosphatidylcholine, lysophosphatidic acid, and lysophosphatidylserine, as important molecules for spermatogenesis. New CDM formulated based on these results induced and promoted spermatogenesis as efficiently as AlbuMAX-containing medium. In vitro spermatogenesis with CDM may provide a unique experimental system for research on spermatogenesis that cannot be performed in in vivo experiments.	[Sanjo, Hiroyuki; Komeya, Mitsuru; Yamanaka, Hiroyuki; Yao, Masahiro; Ogawa, Takehiko] Yokohama City Univ, Grad Sch Med, Dept Urol, Yokohama, Kanagawa, Japan; [Sanjo, Hiroyuki; Katagiri, Kumiko; Sato, Takuya; Matsumura, Takafumi; Ogawa, Takehiko] Yokohama City Univ, Inst Mol Med & Life Sci, Lab Biopharmaceut & Regenerat Sci, Assoc Med Sci, Yokohama, Kanagawa, Japan; [Yao, Tatsuma; Matsuhisa, Akio; Asayama, Yuta] Fuso Pharmaceut Ind Ltd, Res & Dev Ctr, Osaka, Japan; [Ikeda, Kazutaka; Arita, Makoto] RIKEN Ctr Integrat Med Sci, Lab Metabolom, Yokohama, Kanagawa, Japan; [Ikeda, Kazutaka; Arita, Makoto] Yokohama City Univ, Grad Sch Med Life Sci, Cellular & Mol Epigenet Lab, Yokohama, Kanagawa, Japan; [Ikeda, Kazutaka] Kazusa DNA Res Inst, Kisarazu, Japan; [Kano, Kuniyuki; Aoki, Junken] Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi, Japan; [Arita, Makoto] Keio Univ, Grad Sch Pharmaceut Sci, Div Physiol Chem & Metab, Tokyo, Japan	Yokohama City University; Yokohama City University; Fuso Pharmaceutical Industries, Ltd.; RIKEN; Yokohama City University; Kazusa DNA Research Institute; Tohoku University; Keio University	Ogawa, T (corresponding author), Yokohama City Univ, Assoc Med Sci, Lab Biopharmaceut & Regenerat Sci, Inst Mol Med & Life Sci,Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	ogawa@yokohama-cu.ac.jp	Sato, Takuya/F-8251-2017	Sato, Takuya/0000-0002-6198-2234; Yao, Tatsuma/0000-0002-0974-0625; Kano, Kuniyuki/0000-0002-4539-5750; Arita, Makoto/0000-0001-9902-0463	MEXT \ Japan Science and Technology Agency (JST) [18H05546, 15H05897]; Japan Agency for Medical Research and Development (AMED)	MEXT \ Japan Science and Technology Agency (JST); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	MEXT vertical bar Japan Science and Technology Agency (JST), Grant/Award Number: 18H05546 and 15H05897; Japan Agency for Medical Research and Development (AMED)	Aikawa S, 2015, J BIOCHEM, V157, P81, DOI 10.1093/jb/mvu077; Aoyagi R, 2017, J LIPID RES, V58, P2229, DOI 10.1194/jlr.D077123; Arkoun B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116660; Baker DL, 2001, ANAL BIOCHEM, V292, P287, DOI 10.1006/abio.2001.5063; Bensoussan K, 1998, J ANDROL, V19, P266; BETTGER WJ, 1981, P NATL ACAD SCI-BIOL, V78, P5588, DOI 10.1073/pnas.78.9.5588; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BURTON GW, 1982, LANCET, V2, P327; Carr AC, 1999, AM J CLIN NUTR, V69, P1086; CHESSEBEUF M, 1984, IN VITRO CELL DEV B, V20, P780; Dierich A, 1998, P NATL ACAD SCI USA, V95, P13612, DOI 10.1073/pnas.95.23.13612; Dumont L, 2016, MOL HUM REPROD, V22, P819, DOI 10.1093/molehr/gaw063; GALLAHER WR, 1973, BIOCHEM BIOPH RES CO, V52, P1252, DOI 10.1016/0006-291X(73)90635-9; Gohbara A, 2010, BIOL REPROD, V83, P261, DOI 10.1095/biolreprod.110.083899; Hishikawa D, 2014, J LIPID RES, V55, P799, DOI 10.1194/jlr.R046094; Holsberger DR, 2005, BIOL REPROD, V73, P396, DOI 10.1095/biolreprod.105.041426; ISCOVE NN, 1980, EXP CELL RES, V126, P121, DOI 10.1016/0014-4827(80)90476-0; Isoler-Alcaraz J, 2017, REPROD BIOL ENDOCRIN, V15, DOI 10.1186/s12958-017-0305-y; Kanatsu-Shinohara M, 2011, BIOL REPROD, V84, P97, DOI 10.1095/biolreprod.110.086462; Kihara Y, 2015, EXP CELL RES, V333, P171, DOI 10.1016/j.yexcr.2014.11.020; Komeya M, 2018, REPROD MED BIOL, V17, P407, DOI 10.1002/rmb2.12225; Komeya M, 2016, SCI REP-UK, V6, DOI 10.1038/srep21472; Kubota H, 2004, BIOL REPROD, V71, P722, DOI 10.1095/biolreprod.104.029207; Kumar TR, 1997, NAT GENET, V15, P201, DOI 10.1038/ng0297-201; Martinovitch P. N., 1937, Nature London, V139, P413, DOI 10.1038/139413a0; Mason KE, 1933, AM J ANAT, V52, P153, DOI 10.1002/aja.1000520202; Moudgal NR, 1998, HUM REPROD, V13, P916, DOI 10.1093/humrep/13.4.916; Nakamura N, 2017, BIRTH DEFECTS RES, V109, P465, DOI 10.1002/bdr2.1002; Nakanishi T, 1999, FEBS LETT, V449, P277, DOI 10.1016/S0014-5793(99)00433-0; Nakanishi T, 2001, DEV BIOL, V237, P222, DOI 10.1006/dbio.2001.0353; Nguyen LN, 2014, NATURE, V509, P503, DOI 10.1038/nature13241; NIKI E, 1987, CHEM PHYS LIPIDS, V44, P227, DOI 10.1016/0009-3084(87)90052-1; Niki E, 2004, ACCOUNTS CHEM RES, V37, P45, DOI 10.1021/ar030069m; Ohta H, 2009, BIOL REPROD, V80, P511, DOI 10.1095/biolreprod.108.073270; Okudaira M, 2014, J LIPID RES, V55, P2178, DOI 10.1194/jlr.D048439; Olcott HS, 1937, J AM CHEM SOC, V59, P1008, DOI 10.1021/ja01285a013; PACKER JE, 1979, NATURE, V278, P737, DOI 10.1038/278737a0; Packer L., 1997, Vitamin C in health and disease., P95; PASTERNA.CA, 1970, BIOCHEM J, V119, P481, DOI 10.1042/bj1190481; Sanjo H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192884; Sato T, 2013, NAT PROTOC, V8, P2098, DOI 10.1038/nprot.2013.138; Sato T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1478; Sato T, 2011, NATURE, V471, P504, DOI 10.1038/nature09850; Sharpe Richard M., 1994, P1363; SINGH J, 1995, ENDOCRINOLOGY, V136, P5311, DOI 10.1210/en.136.12.5311; Wang RS, 2009, ENDOCR REV, V30, P119, DOI 10.1210/er.2008-0025; WARREN L, 1968, J CELL BIOL, V37, P729, DOI 10.1083/jcb.37.3.729; Wauthier E, 2008, METHOD CELL BIOL, V86, P137, DOI 10.1016/S0091-679X(08)00008-3; WINKLER BS, 1994, FREE RADICAL BIO MED, V17, P333, DOI 10.1016/0891-5849(94)90019-1; Ye XQ, 2008, BIOL REPROD, V79, P328, DOI 10.1095/biolreprod.108.068783; Yokonishi Tetsuhiro, 2016, Reproductive Medicine and Biology, V15, P21, DOI 10.1007/s12522-015-0218-4; Yokonishi Tetsuhiro, 2013, Methods Mol Biol, V927, P479	53	7	7	3	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9480	9497		10.1096/fj.202000245R	http://dx.doi.org/10.1096/fj.202000245R		MAY 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32474967				2022-12-28	WOS:000538126800001
J	Tsai, SH; Hsu, LA; Tsai, HY; Yeh, YH; Lu, CY; Chen, PC; Wang, JC; Chiu, YL; Lin, CY; Hsu, YJ				Tsai, Shih-Hung; Hsu, Lung-An; Tsai, Hsiao-Ya; Yeh, Yung-Hsin; Lu, Cheng-Yo; Chen, Po-Chuan; Wang, Jen-Chun; Chiu, Yi-Lin; Lin, Chih-Yuan; Hsu, Yu-Juei			Aldehyde dehydrogenase 2 protects against abdominal aortic aneurysm formation by reducing reactive oxygen species, vascular inflammation, and apoptosis of vascular smooth muscle cells	FASEB JOURNAL			English	Article						4-hydroxy-2-nonenal; abdominal aortic aneurysm; aldehyde dehydrogenase 2; angiotensin II; reactive oxygen species	GENOMICS DATA SETS; ANGIOTENSIN-II; OXIDATIVE STRESS; ALCOHOL-CONSUMPTION; LIPID-PEROXIDATION; ACTIVATION; ALDH2; INJURY; EXPRESSION; PATHOPHYSIOLOGY	Mitochondrial aldehyde dehydrogenase 2 (ALDH2) is an enzyme that detoxifies aldehydes by converting them to carboxylic acids. ALDH2 deficiency is known to increase oxidative stress. Increased oxidative stress plays a pivotal role in abdominal aortic aneurysm (AAA) pathogenesis. Reactive oxygen species (ROS) promote degradation of the extracellular matrix (ECM) and vascular smooth muscle cell (VSMC) apoptosis. Reducing oxidative stress by an ALDH2 activator could have therapeutic potential for limiting AAA development. We hypothesized that ALDH2 deficiency could increase the risk for AAA by decreasing ROS elimination and that an ALDH2 activator could provide an alternative option for AAA treatment. The National Center for Biotechnology (NCBI) Gene Expression Omnibus (GEO) database was used. Human aortic smooth muscle cells (HASMCs) were used for the in vitro experiments. Gene-targeted ALDH2*2 KI knock-in mice on a C57BL/6J background and apolipoprotein E knockout (ApoE KO) mice were obtained. An animal model of AAA was constructed using osmotic minipumps to deliver 1000 ng/kg/min angiotensin II (AngII) for 28 days. Patients with AAA had significantly lower ALDH2 expression levels than normal subjects. ALDH2*2 KI mice were susceptible to AngII administration, exhibiting significantly increased AAA incidence rates and increased aortic diameters. Alda-1, an ALDH2 activator, reduced AngII-induced ROS production, NF-kB activation, and apoptosis in HASMCs. Alda-1 attenuated AngII-induced aneurysm formation and decreased aortic expansion in ApoE KO mice. We concluded that ALDH2 deficiency is associated with the development of AAAs in humans and a murine disease model. ALDH2 deficiency increases susceptibility to AngII-induced AAA formation by attenuating anti-ROS effects and increasing VSMC apoptosis and vascular inflammation. Alda-1 was shown to attenuate the progression of experimental AAA in a murine model.	[Tsai, Shih-Hung; Tsai, Hsiao-Ya; Lu, Cheng-Yo; Chen, Po-Chuan; Wang, Jen-Chun] Triserv Gen Hosp, Natl Def Med Ctr, Dept Emergency Med, Taipei, Taiwan; [Tsai, Shih-Hung] Natl Def Med Ctr, Grad Inst Physiol, Dept Physiol & Biophys, Taipei, Taiwan; [Hsu, Lung-An; Yeh, Yung-Hsin] Chang Gung Univ, Cardiovasc Dept, Chang Gung Mem Hosp, Taoyuan, Taiwan; [Hsu, Lung-An; Yeh, Yung-Hsin] Chang Gung Univ, Sch Med, Taoyuan, Taiwan; [Wang, Jen-Chun] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan; [Chiu, Yi-Lin] Natl Def Med Ctr, Dept Biochem, Taipei, Taiwan; [Lin, Chih-Yuan] Triserv Gen Hosp, Natl Def Med Ctr, Dept Surg, Div Cardiovasc Surg, Taipei, Taiwan; [Hsu, Yu-Juei] Triserv Gen Hosp, Natl Def Med Ctr Taipei, Dept Internal Med, Div Nephrol, 325,Sec 2,Cheng Kung Rd, Taipei 11490, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; National Yang Ming Chiao Tung University; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital	Hsu, YJ (corresponding author), Triserv Gen Hosp, Natl Def Med Ctr Taipei, Dept Internal Med, Div Nephrol, 325,Sec 2,Cheng Kung Rd, Taipei 11490, Taiwan.	yujuei@mail2000.com.tw	Chiu, Yilin/ABC-3746-2021; Yeh, Yung-Hsin/ABD-9351-2021	Chiu, Yilin/0000-0002-1827-6924; Tsai, Hsaio Ya/0000-0002-5704-507X	Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan [TSGH-C107-47, TSGH-C108-67, TSGH-D-109071]; Ministry of Science and Technology [MOST 107 2314-B-016071-MY2, MOST 107-2314-B-016-061, MOST 108-2314-B-016-047-MY3]; Ministry of National DefenseMedical Affairs Bureau [MAB-C107-013, MAB-C108-018, MAB-109-035, CHNDMC108-30, CHNDMC-109-16]	Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of National DefenseMedical Affairs Bureau	This study was supported by grants from Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan (TSGH-C107-47, TSGH-C108-67, and TSGH-D-109071), the Ministry of Science and Technology (MOST 107 2314-B-016071-MY2, MOST 107-2314-B-016-061 and MOST 108-2314-B-016-047-MY3) and the Ministry of National DefenseMedical Affairs Bureau (MAB-C107-013, MAB-C108-018, MAB-109-035, CHNDMC108-30, and CHNDMC-109-16)	Abdul-Hussien H, 2010, J VASC SURG, V51, P1479, DOI 10.1016/j.jvs.2010.01.057; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Baxter BT, 2008, CIRCULATION, V117, P1883, DOI 10.1161/CIRCULATIONAHA.107.735274; Biros E, 2015, ONCOTARGET, V6, P12984, DOI 10.18632/oncotarget.3848; Bradley MA, 2010, FREE RADICAL BIO MED, V48, P1570, DOI 10.1016/j.freeradbiomed.2010.02.016; Budas GR, 2009, TRENDS CARDIOVAS MED, V19, P158, DOI 10.1016/j.tcm.2009.09.003; Byon CH, 2016, REDOX BIOL, V9, P244, DOI 10.1016/j.redox.2016.08.015; Chen CH, 2008, SCIENCE, V321, P1493, DOI 10.1126/science.1158554; Chen CH, 2014, PHYSIOL REV, V94, P1, DOI 10.1152/physrev.00017.2013; Chen CH, 2010, CARDIOVASC RES, V88, P51, DOI 10.1093/cvr/cvq192; Choi H, 2011, J AM SOC HYPERTENS, V5, P154, DOI 10.1016/j.jash.2011.02.005; Cohen G, 2013, FREE RADICAL BIO MED, V65, P978, DOI 10.1016/j.freeradbiomed.2013.08.163; Cuccurullo C, 2006, ARTERIOSCL THROM VAS, V26, P2716, DOI 10.1161/01.ATV.0000249630.02085.12; Daugherty A, 2000, J CLIN INVEST, V105, P1605, DOI 10.1172/JCI7818; Daugherty A, 2011, J ZHEJIANG UNIV-SC B, V12, P624, DOI 10.1631/jzus.B1101002; Emeto TI, 2016, CLIN SCI, V130, P301, DOI 10.1042/CS20150547; Ge W, 2011, FREE RADICAL BIO MED, V51, P1736, DOI 10.1016/j.freeradbiomed.2011.08.002; Gong DX, 2019, INTERACT CARDIOV TH, V28, P79, DOI 10.1093/icvts/ivy204; Gross ER, 2015, ANNU REV PHARMACOL, V55, P107, DOI 10.1146/annurev-pharmtox-010814-124915; Gu Q, 2014, EXP GERONTOL, V56, P37, DOI 10.1016/j.exger.2014.02.014; Guo YJ, 2010, ATHEROSCLEROSIS, V211, P545, DOI 10.1016/j.atherosclerosis.2010.03.030; Guo YL, 2015, BBA-MOL BASIS DIS, V1852, P319, DOI 10.1016/j.bbadis.2014.05.017; Han SA, 2017, ANN VASC SURG, V41, P135, DOI 10.1016/j.avsg.2016.08.044; Hao PP, 2011, CAN J NEUROL SCI, V38, P500, DOI 10.1017/S0317167100011938; Haskett D, 2012, J BIOMECH, V45, P772, DOI 10.1016/j.jbiomech.2011.11.017; Hinterseher I, 2011, ARTERIOSCL THROM VAS, V31, P1653, DOI 10.1161/ATVBAHA.111.227652; Hu XY, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15027822; Jin SF, 2015, P NATL ACAD SCI USA, V112, P9088, DOI 10.1073/pnas.1510757112; Kim J, 2017, J BIOMED SCI, V24, DOI [10.1186/s12929-017-0338-8, 10.12653/jecd.2017.24.1.0033]; Kwon HJ, 2014, HEPATOLOGY, V60, P146, DOI 10.1002/hep.27036; Lapenna D, 2015, ATHEROSCLEROSIS, V238, P190, DOI 10.1016/j.atherosclerosis.2014.11.028; Lederle FA, 2013, ANN INTERN MED, V159, P852, DOI 10.7326/0003-4819-159-12-201312170-00012; Lee SJ, 2008, FREE RADICAL BIO MED, V45, P1487, DOI 10.1016/j.freeradbiomed.2008.08.022; Li SY, 2004, J BIOL CHEM, V279, P11244, DOI 10.1074/jbc.M308011200; Lu QL, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10116-0; Ma H, 2011, EUR HEART J, V32, P1025, DOI 10.1093/eurheartj/ehq253; Mali VR, 2014, FREE RADICAL RES, V48, P251, DOI 10.3109/10715762.2013.864761; Martorell S, 2016, ARTERIOSCL THROM VAS, V36, P1587, DOI 10.1161/ATVBAHA.116.307530; Meijer CA, 2013, ANN INTERN MED, V159, P815, DOI 10.7326/0003-4819-159-12-201312170-00007; Pan C, 2016, ONCOTARGET, V7, P35562, DOI 10.18632/oncotarget.9384; Pan GD, 2018, EUR J PHARMACOL, V839, P76, DOI 10.1016/j.ejphar.2018.09.021; Panisello-Rosello A, 2018, WORLD J GASTROENTERO, V24, P2984, DOI 10.3748/wjg.v24.i27.2984; Parry DJ, 2010, J VASC SURG, V52, P145, DOI 10.1016/j.jvs.2010.02.279; Peshkova IO, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13017-4; Piechota-Polanczyk A, 2012, EUR J VASC ENDOVASC, V44, P133, DOI 10.1016/j.ejvs.2012.04.020; Pincemail J, 2018, CURR DRUG TARGETS, V19, P1256, DOI 10.2174/1389450118666170918164601; Ruef T, 2001, BASIC RES CARDIOL, V96, P143, DOI 10.1007/s003950170064; Satoh K, 2009, NAT MED, V15, P649, DOI 10.1038/nm.1958; Schneider C, 2008, J BIOL CHEM, V283, P15539, DOI 10.1074/jbc.R800001200; Sidloff D, 2014, CIRCULATION, V129, P747, DOI 10.1161/CIRCULATIONAHA.113.005457; Spencer SM, 2017, BRIT J SURG, V104, P1756, DOI 10.1002/bjs.10674; Stachowicz A, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001329; Stackelberg O, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.004725; Stewart MJ, 1996, J INVEST MED, V44, P42; Sun LH, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002067; Sung YH, 2014, METHODS, V69, P85, DOI 10.1016/j.ymeth.2014.02.009; Tsai SH, 2018, J VASC SURG, V68, p72S, DOI 10.1016/j.jvs.2017.09.042; van der Pluijm I, 2018, CARDIOVASC RES, V114, P1776, DOI 10.1093/cvr/cvy150; Vasiliou Vasilis, 2005, Human Genomics, V2, P138; Wang CM, 2015, J CARDIOVASC PHARM, V66, P285, DOI 10.1097/FJC.0000000000000276; Wang F, 2016, SCI CHINA LIFE SCI, V59, P940, DOI 10.1007/s11427-015-0277-8; Wang YX, 2019, BRIT J PHARMACOL, V176, P282, DOI 10.1111/bph.14515; Wilhite SE, 2012, METHODS MOL BIOL, V802, P41, DOI 10.1007/978-1-61779-400-1_3; Wimborne HJ, 2019, FREE RADICAL BIO MED, V145, P136, DOI 10.1016/j.freeradbiomed.2019.09.026; Wood AM, 2018, LANCET, V391, P1513, DOI 10.1016/S0140-6736(18)30134-X; Xiao Q, 1996, J CLIN INVEST, V98, P2027, DOI 10.1172/JCI119007; Xu L, 2018, INT HEART J, V59, P689, DOI 10.1536/ihj.17-165; Xu T, 2017, REDOX BIOL, V11, P286, DOI 10.1016/j.redox.2016.12.019; Zambelli VO, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009539; Zhang L, 2018, EBIOMEDICINE, V27, P247, DOI 10.1016/j.ebiom.2017.12.002; Zhang P, 2011, BIOMED PHARMACOTHER, V65, P590, DOI 10.1016/j.biopha.2009.12.001; Zhang YM, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-40; Zhang YM, 2011, PHARMACOL THERAPEUT, V132, P86, DOI 10.1016/j.pharmthera.2011.05.008; Zhong HQ, 2015, REDOX BIOL, V4, P193, DOI 10.1016/j.redox.2014.12.011; Zhong SS, 2019, J CLIN INVEST, V129, P252, DOI 10.1172/JCI122064; Zhong ZB, 2016, TRANSPL INT, V29, P98, DOI 10.1111/tri.12675; Zhu QK, 2017, CLIN SCI, V131, P1123, DOI 10.1042/CS20170074	77	13	15	5	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9498	9511		10.1096/fj.201902550RRR	http://dx.doi.org/10.1096/fj.201902550RRR		MAY 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32463165				2022-12-28	WOS:000536309300001
J	Daftarian, N; Zandi, S; Piryaie, G; Zarif, MN; Pirmardan, ER; Yamaguchi, M; Nejad, QB; Hasanpour, H; Samiei, S; Pfister, IB; Soheili, ZS; Nakao, S; Barakat, A; Garweg, JG; Ahmadieh, H; Hafezi-Moghadam, A				Daftarian, Narsis; Zandi, Souska; Piryaie, Golbarg; Zarif, Mahin Nikougoftar; Pirmardan, Ehsan Ranaei; Yamaguchi, Muneo; Nejad, Qurban Behzadian; Hasanpour, Hossein; Samiei, Shahram; Pfister, Isabel B.; Soheili, Zahra-Soheila; Nakao, Shintaro; Barakat, Aliaa; Garweg, Justus G.; Ahmadieh, Hamid; Hafezi-Moghadam, Ali			Peripheral blood CD163(+) monocytes and soluble CD163 in dry and neovascular age-related macular degeneration	FASEB JOURNAL			English	Article						AMD pathogenesis; CD206; choroidal neovascularization (CNV); M1; M2 differentiation; macrophage polarization	COMPLEMENT FACTOR-H; BRUCHS MEMBRANE; MACROPHAGES; VARIANT; SUSCEPTIBILITY; IDENTIFICATION; POLARIZATION; POLYMORPHISM; EXPRESSION; BIOMARKERS	Macrophages are the main infiltrating immune cells in choroidal neovascularization (CNV), a hallmark of the human wet, or neovascular age-related macular degeneration (AMD). Due to their plasticity and ability to adapt to the local microenvironment in a tissue-dependent manner, macrophages display polar functional phenotypes characterized by their cell surface markers and their cytokine profiles. We found accumulation of hemoglobin-scavenging cluster of differentiation 163 (CD163)(+) macrophages in laser-induced CNV lesions and higher expression of CD163(+) monocytes in the peripheral blood on day 7 post injury in mice. In comparison, CD80(+) macrophages did not differ with laser-injury in young or aged mice and did not significantly change in the peripheral blood of CNV mice. We examined the percentages of CD163(+), CD206(+), and CD80(+) monocytes in the peripheral blood of patients with wet AMD, patients with dry AMD, and in age-matched individuals without AMD as controls. Percentages of peripheral blood CD163(+) monocytes in both dry AMD (P < .001) and wet AMD (P < .05) were higher than in age-matched non-AMD controls, while there was no difference between the groups in the percentages of peripheral CD206(+) and CD80(+) monocytes. Further, serum level of soluble CD163 (sCD163) was elevated only in patients with wet AMD (P < .05). An examination of 40 cytokine levels across the study groups revealed that anti-VEGF treated patients with wet AMD, who showed no exudative signs on the day of blood drawing had a cytokine profile that was similar to that of non-AMD individuals. These results indicate that CD163 could be further evaluated for its potential as a useful marker of disease activity in patients with neovascular AMD. Future studies will address the origin and potential mechanistic role of CD163(+) macrophages in wet AMD pathologies of angiogenesis and leakage of blood components.	[Daftarian, Narsis; Zandi, Souska; Pirmardan, Ehsan Ranaei; Barakat, Aliaa; Ahmadieh, Hamid; Hafezi-Moghadam, Ali] Brigham & Womens Hosp, Mol Biomarkers Nanoimaging Lab, 75 Francis St, Boston, MA 02115 USA; [Daftarian, Narsis; Pirmardan, Ehsan Ranaei; Barakat, Aliaa; Ahmadieh, Hamid; Hafezi-Moghadam, Ali] Harvard Med Sch, Dept Radiol, Boston, MA 02115 USA; [Daftarian, Narsis] Shahid Beheshti Univ Med Sci, Ocular Tissue Engn Res Ctr, Tehran, Iran; [Zandi, Souska; Pfister, Isabel B.; Garweg, Justus G.] Lindenhofspital, Rotkreuz & Berner Augenklin, Swiss Eye Inst, Bern, Switzerland; [Zandi, Souska; Garweg, Justus G.] Univ Bern, Bern Univ Hosp, Dept Ophthalmol, Inselspital, Bern, Switzerland; [Piryaie, Golbarg; Ahmadieh, Hamid] Shahid Beheshti Univ Med Sci, Ophthalm Res Ctr, Tehran, Iran; [Zarif, Mahin Nikougoftar; Samiei, Shahram] High Inst Res & Educ Transfus Med, Blood Transfus Res Ctr, Tehran, Iran; [Yamaguchi, Muneo; Nakao, Shintaro] Kyushu Univ, Grad Sch Med Sci, Dept Ophthalmol, Fukuoka, Japan; [Nejad, Qurban Behzadian; Hasanpour, Hossein] Shahid Beheshti Univ Med Sci, Negah Specialty Ophthalm Res Ctr, Tehran, Iran; [Soheili, Zahra-Soheila] Natl Inst Genet Engn & Biotechnol, Inst Med Biotechnol, Dept Mol Med, Tehran, Iran	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Shahid Beheshti University Medical Sciences; University of Bern; University Hospital of Bern; Shahid Beheshti University Medical Sciences; Kyushu University; Shahid Beheshti University Medical Sciences	Hafezi-Moghadam, A (corresponding author), Brigham & Womens Hosp, Mol Biomarkers Nanoimaging Lab MBNI, 75 Francis St,Thorn Res Bldg, Boston, MA 02115 USA.	ahm@bwh.harvard.edu	Hasanpour, Hossein/HGF-0571-2022; Pirmardan, Ehsan Ranaei/AAG-3914-2021; Daftarian, Narsis/AAW-5803-2020; Soheili, Zahra-Soheila/W-8316-2018; Ahmadieh, Hamid/M-4853-2017	Daftarian, Narsis/0000-0001-5846-8739; Soheili, Zahra-Soheila/0000-0003-1292-465X; Ahmadieh, Hamid/0000-0002-8139-2661; Hasanpour, Hossein/0000-0002-1090-1166; Zandi, Souska/0000-0001-9351-4278; Ranaei Pirmardan, Ehsan/0000-0002-6848-5839	Juvenile Diabetes Research Foundation (JDRF) Innovation award; Malaysian Palm Oil Board (MPOB)	Juvenile Diabetes Research Foundation (JDRF) Innovation award; Malaysian Palm Oil Board (MPOB)	This work was supported by Juvenile Diabetes Research Foundation (JDRF) Innovation award (AHM) and the Malaysian Palm Oil Board (MPOB).	Bronkhorst IHG, 2011, INVEST OPHTH VIS SCI, V52, P643, DOI 10.1167/iovs.10-5979; Cao XG, 2011, PATHOL INT, V61, P528, DOI 10.1111/j.1440-1827.2011.02695.x; Costantini A, 2018, AGING-US, V10, P1268, DOI 10.18632/aging.101465; Droste A, 1999, BIOCHEM BIOPH RES CO, V256, P110, DOI 10.1006/bbrc.1999.0294; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Etzerodt A, 2010, J LEUKOCYTE BIOL, V88, P1201, DOI 10.1189/jlb.0410235; Garweg JG, 2019, ACTA OPHTHALMOL, V97, pE580, DOI 10.1111/aos.13998; Garweg JG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182571; Grunin M, 2012, INVEST OPHTH VIS SCI, V53, P5292, DOI 10.1167/iovs.11-9165; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Ikram MK, 2013, DIABETES CARE, V36, P750, DOI 10.2337/dc12-1554; ISHIBASHI T, 1987, INVEST OPHTH VIS SCI, V28, P1116; Jabs DA, 2019, AM J OPHTHALMOL, V199, P230, DOI 10.1016/j.ajo.2018.12.002; Jones K, 2013, CLIN CANCER RES, V19, P731, DOI 10.1158/1078-0432.CCR-12-2693; Kauppinen A, 2016, CELL MOL LIFE SCI, V73, P1765, DOI 10.1007/s00018-016-2147-8; Kelly J, 2007, J CLIN INVEST, V117, P3421, DOI 10.1172/JCI32430; KILLINGSWORTH MC, 1990, EYE, V4, P613, DOI 10.1038/eye.1990.86; Kim S, 2019, MOL VIS, V25, P129; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; Krohne TU, 2010, INVEST OPHTH VIS SCI, V51, P553, DOI 10.1167/iovs.09-3755; Lad EM, 2015, GRAEF ARCH CLIN EXP, V253, P1941, DOI 10.1007/s00417-015-3094-z; Lechner J, 2015, SCI REP-UK, V5, DOI 10.1038/srep16754; Liu F, 2016, MOL VIS, V22, P352; Mettu PS, 2012, MOL ASPECTS MED, V33, P376, DOI 10.1016/j.mam.2012.04.006; Parkner T, 2012, DIABETOLOGIA, V55, P1856, DOI 10.1007/s00125-012-2533-1; Patel M, 2008, SEMIN IMMUNOPATHOL, V30, P97, DOI 10.1007/s00281-008-0112-9; PENFOLD PL, 1985, GRAEF ARCH CLIN EXP, V223, P69, DOI 10.1007/BF02150948; Peng XN, 2018, EXP EYE RES, V176, P88, DOI 10.1016/j.exer.2018.06.030; Rath M, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00532; Seddon JM, 2006, OPHTHALMOLOGY, V113, P260, DOI 10.1016/j.ophtha.2005.11.001; Singh A, 2013, OPHTHALMOLOGY, V120, P1029, DOI 10.1016/j.ophtha.2012.11.002; Skeie JM, 2009, EYE, V23, P747, DOI 10.1038/eye.2008.206; Spindler J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203337; Stout RD, 2004, J LEUKOCYTE BIOL, V76, P509, DOI 10.1189/jlb.0504272; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811; Zandi S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214674; Zandi S, 2016, INVEST OPHTH VIS SCI, V57, P6320, DOI 10.1167/iovs.16-20657; Zandi S, 2015, CELL REP, V10, P1173, DOI 10.1016/j.celrep.2015.01.050; Zareparsi S, 2005, AM J HUM GENET, V77, P149, DOI 10.1086/431426	43	4	4	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8001	8011		10.1096/fj.201901902RR	http://dx.doi.org/10.1096/fj.201901902RR		APR 2020	11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32333612	Bronze			2022-12-28	WOS:000529448100001
J	Hope, S; Naerland, T; Hoiland, AL; Torske, T; Malt, E; Abrahamsen, T; Nerhus, M; Wedervang-Resell, K; Lonning, V; Johannessen, J; Steen, NE; Agartz, I; Stenberg, N; Hundhausen, T; Morkrid, L; Andreassen, OA				Hope, Sigrun; Naerland, Terje; Hoiland, Anne Lise; Torske, Tonje; Malt, Eva; Abrahamsen, Tore; Nerhus, Mari; Wedervang-Resell, Kirsten; Lonning, Vera; Johannessen, Jade; Steen, Nils Eiel; Agartz, Ingrid; Stenberg, Nina; Hundhausen, Thomas; Morkrid, Lars; Andreassen, Ole A.			Higher vitamin B12 levels in neurodevelopmental disorders than in healthy controls and schizophrenia A comparison among participants between 2 and 53 years	FASEB JOURNAL			English	Article						autism; cobalamin; hypercobalaminemia; intellectual disability; TCN1	FOLATE RECEPTOR AUTOANTIBODIES; AUTISM SPECTRUM DISORDER; COGNITIVE IMPAIRMENT; EUROPEAN ADOLESCENTS; REFERENCE INTERVALS; SERUM VITAMIN-B12; DEFICIENCY; CHILDREN; MARKERS; ASSOCIATION	Recent studies suggest that both high and low levels of vitamin B12 (vitB12) may have negative health impacts. We measured VitB12 in patients with the Neurodevelopmental disorders (ND) (n = 222), comprised of Autism Spectrum Disorders, specific Developmental disorders, and Intellectual Disability (aged 2-53 years), schizophrenia (n = 401), and healthy controls (HC) (n = 483). Age-and gender-adjusted vitB12 z-scores were calculated by comparisons with a reference population (n = 76 148). We found higher vitB12 in ND (median 420 pmol/L, mean z-score: 0.30) than in HC (316 pmol/L, z-score: 0.06, P < .01) and schizophrenia (306 pmol/L, z-score: -0.02, P < .001), which was significant after adjusting for age, gender, vitB12 supplement, folate, hemoglobin, leukocytes, liver, and kidney function (P < .02). In ND, 20% (n = 44) had vitB12 above 650 pmol/L, and 1% (n = 3) had below 150 pmol/L (common reference limits). In 6.3% (n = 14) of ND, vitB12 was above 2SD of mean in the age-and gender-adjusted reference population, which was more frequent than in HC (n = 8, 1.6%), OR: 4.0, P = .001. Low vitB12 was equally frequent as in HC, and vitB12 z-scores were equal across the age groups. To conclude, vitB12 was higher in ND than in HC and schizophrenia, suggesting a specific feature of ND, which warrants further studies to investigate the underlying mechanisms.	[Hope, Sigrun; Naerland, Terje; Nerhus, Mari; Wedervang-Resell, Kirsten; Lonning, Vera; Steen, Nils Eiel; Agartz, Ingrid; Andreassen, Ole A.] Oslo Univ Hosp Ulleval, Dept Neuro Habilitat, Oslo, Norway; [Hope, Sigrun] Univ Oslo, Norwegian Ctr Mental Disorders Res, Inst Clin Med, NORMENT, Oslo, Norway; [Naerland, Terje] Oslo Univ Hosp, Natl Competence Ctr Neurodev Disorders & Hypersom, Oslo, Norway; [Hoiland, Anne Lise] Trondheim Reg & Univ Hosp, St Olays Hosp, Dept Pediat, Trondheim, Norway; [Hoiland, Anne Lise] Norwegian Univ Sci & Technol, Fac Med & Hlth Sci, Reg Ctr Child & Youth Mental Hlth & Child Welf, Dept Mental Hlth, Trondheim, Norway; [Torske, Tonje] Vestre Viken Hosp Trust, Div Mental Hlth & Addict, Drammen, Norway; [Malt, Eva; Nerhus, Mari; Lonning, Vera] Akershus Univ Hosp, Div Mental Hlth, Lorenskog, Norway; [Malt, Eva; Abrahamsen, Tore] Univ Oslo, Inst Clin Med, Oslo, Norway; [Abrahamsen, Tore] Oslo Univ Hosp, Dept Pediat, Oslo, Norway; [Wedervang-Resell, Kirsten; Steen, Nils Eiel; Stenberg, Nina; Andreassen, Ole A.] Oslo Univ Hosp Ulleval, Div Mental Hlth & Addict, Oslo, Norway; [Johannessen, Jade] Autism Soc Norway, Oslo, Norway; [Agartz, Ingrid] Diakonhjemmet Hosp, Dept Psychiat Res, Oslo, Norway; [Hundhausen, Thomas] Univ Agder, Dept Nat Sci, Kristiansand, Norway; [Hundhausen, Thomas] Sorlandet Hosp Trust, Dept Lab Med, Kristiansand, Norway; [Morkrid, Lars] Oslo Univ Hosp, Dept Med Biochem, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University of Oslo; University of Oslo; University of Oslo; University of Oslo; Diakonhjemmet Hospital; University of Agder; University of Oslo	Hope, S (corresponding author), Univ Oslo, Ctr Psychosis Res, Inst Clin Med, NORMENT, Oslo, Norway.	sigrun.hope@ous-hf.no	Steen, Nils Eiel/GRO-6284-2022; Andreassen, Ole A./AAY-7531-2020	Steen, Nils Eiel/0000-0001-6442-1179; Naerland, Terje/0000-0001-9175-4286; Wedervang-Resell, Kirsten/0000-0002-2856-5412; Hope, Sigrun/0000-0003-0115-5285	Norges Forskningsrad (Forskningsradet) [223273]; KG Jebsen stiftelsen	Norges Forskningsrad (Forskningsradet); KG Jebsen stiftelsen	Norges Forskningsrad (Forskningsradet) Grant number 213694, Norges Forskningsrad (Forskningsradet) Grant number 223273, KG Jebsen stiftelsen.	Adams JB, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-34; Akkouh IA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30898-5; Al-Farsi YM, 2013, NUTRITION, V29, P537, DOI 10.1016/j.nut.2012.09.014; Allen LH, 2009, AM J CLIN NUTR, V89, p693S, DOI 10.3945/ajcn.2008.26947A; Andres E, 2013, QJM-INT J MED, V106, P505, DOI 10.1093/qjmed/hct051; Andrew T, 2013, BRIT J NUTR, V110, P1672, DOI 10.1017/S0007114513000974; Aparicio-Ugarriza R, 2015, CLIN CHEM LAB MED, V53, P1149, DOI 10.1515/cclm-2014-0784; Arendt JFB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045979; Bailey D, 2013, CLIN CHEM, V59, P1393, DOI 10.1373/clinchem.2013.204222; Bala KA, 2016, EUR REV MED PHARMACO, V20, P923; Bellerose J, 2016, JIMD REP, V29, P19, DOI 10.1007/8904_2015_517; Cao B, 2016, SCHIZOPHR RES, V172, P216, DOI 10.1016/j.schres.2016.01.050; Christensen EI, 2013, NEPHROL DIAL TRANSPL, V28, P274, DOI 10.1093/ndt/gfs565; Dror DK, 2008, NUTR REV, V66, P250, DOI 10.1111/j.1753-4887.2008.00031.x; Frye RE, 2013, MOL PSYCHIATR, V18, P369, DOI 10.1038/mp.2011.175; Frye RE, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00080; Gonzalez-Gross M, 2012, NUTR RES, V32, P817, DOI 10.1016/j.nutres.2012.09.016; Grove J, 2019, NAT GENET, V51, P431, DOI 10.1038/s41588-019-0344-8; Guest J, 2015, NUTR NEUROSCI, V18, P355, DOI 10.1179/1476830515Y.0000000041; GUNDUZ M, 2017, J NEUROL EXP NEUROSC, V2, P4; HUNDHAUSEN T, 2016, NORD C CLIN BIOCH; Iglesia I, 2014, NUTR RES, V34, P199, DOI 10.1016/j.nutres.2014.01.006; James SJ, 2009, AM J CLIN NUTR, V89, P425, DOI 10.3945/ajcn.2008.26615; Keene KL, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00112; MARKS PW, 2009, HEMATOLOGY BASIC PRI, P439; Masalha R, 2001, ISRAEL MED ASSOC J, V3, P701; Melnyk S, 2012, J AUTISM DEV DISORD, V42, P367, DOI 10.1007/s10803-011-1260-7; Misra UK, 2017, MOL NEUROBIOL, V54, P1278, DOI 10.1007/s12035-016-9736-2; Modabbernia A, 2017, MOL AUTISM, V8, DOI 10.1186/s13229-017-0121-4; Mollehave LT, 2017, EUR J CLIN NUTR, V71, P1054, DOI 10.1038/ejcn.2017.97; Moore E, 2012, INT PSYCHOGERIATR, V24, P541, DOI 10.1017/S1041610211002511; Morkrid L, 2015, CLIN CHEM, V61, P760, DOI 10.1373/clinchem.2014.235564; Nielsen MJ, 2012, NAT REV GASTRO HEPAT, V9, P345, DOI 10.1038/nrgastro.2012.76; Nongmaithem SS, 2017, HUM MOL GENET, V26, P2551, DOI [10.1093/hmg/ddx156, 10.1093/hmg/ddx071]; Pisula W, 2014, MED HYPOTHESES, V83, P488, DOI 10.1016/j.mehy.2014.08.007; Raghavan R, 2018, PAEDIATR PERINAT EP, V32, P100, DOI 10.1111/ppe.12414; Ramaekers VT, 2007, NEUROPEDIATRICS, V38, P276, DOI 10.1055/s-2008-1065354; Ramaekers VT, 2013, MOL PSYCHIATR, V18, P270, DOI 10.1038/mp.2012.22; Remacha AF, 2014, INT J LAB HEMATOL, V36, P92, DOI 10.1111/ijlh.12131; Reynolds A, 2012, PEDIATRICS, V130, pS154, DOI 10.1542/peds.2012-0900M; Rietsema WJ, 2014, J AM GERIATR SOC, V62, P1611, DOI 10.1111/jgs.12966; Riglin L, 2017, LANCET PSYCHIAT, V4, P57, DOI 10.1016/S2215-0366(16)30406-0; Sandin S, 2017, JAMA-J AM MED ASSOC, V318, P1182, DOI 10.1001/jama.2017.12141; SAVORY DJ, 1990, ANN CLIN BIOCHEM, V27, P99, DOI 10.1177/000456329002700201; Schendel DE, 2016, JAMA PEDIATR, V170, P243, DOI 10.1001/jamapediatrics.2015.3935; Schmidt-Kastner R, 2012, MOL PSYCHIATR, V17, P1194, DOI 10.1038/mp.2011.183; Schork AJ, 2019, NAT NEUROSCI, V22, P353, DOI 10.1038/s41593-018-0320-0; Schwettmann L, 2015, CLIN LAB, V61, P1095, DOI 10.7754/Clin.Lab.2015.150112; Sequeira JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152249; Sequeira JM, 2013, CLIN CHEM LAB MED, V51, P545, DOI 10.1515/cclm-2012-0577; Shibata K, 2014, NUTR METAB INSIGHTS, V7, P61, DOI 10.4137/NMI.S17245; Shipton MJ, 2015, CLIN MED, V15, P145, DOI 10.7861/clinmedicine.15-2-145; Steward-Scott E, 2014, J PEDIATR NURS, V29, P107, DOI 10.1016/j.pedn.2013.12.009; Veasey SC, 2013, SLEEP, V36, P1471, DOI 10.5665/sleep.3038; Zinck JWR, 2015, AM J CLIN NUTR, V101, P1295, DOI 10.3945/ajcn.115.107219	55	4	4	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8114	8124		10.1096/fj.201900855RRR	http://dx.doi.org/10.1096/fj.201900855RRR		APR 2020	11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32323402	Bronze			2022-12-28	WOS:000528405100001
J	Park, YJ; Kim, TS; Kim, EH; Kim, HD; Kim, J				Park, Yong Jun; Kim, Tae-Sung; Kim, Eun-Ho; Kim, Hag Dong; Kim, Joon			Ribosomal protein S3 is a novel negative regulator of non-homologous end joining repair of DNA double-strand breaks	FASEB JOURNAL			English	Article						DNA-PK; extra-ribosomal function; Ku; NHEJ; rpS3	HOMOLOGOUS RECOMBINATION; DAMAGE RESPONSE; CELL-DEATH; RPS3; PHOSPHORYLATION; APOPTOSIS; ENDONUCLEASE; NUCLEOLUS; INTERACTS; COMPLEX	DNA double-strand breaks (DSBs) are one of the most serious types of DNA damage. However, multiple repair pathways are present in cells to ensure rapid and appropriate repair of DSBs. Pathway selection depends on several factors including cell type, cell cycle phase, and damage severity. Ribosomal protein S3 (rpS3), a component of the 40S small ribosomal subunit, is a multi-functional protein primarily involved in protein synthesis. rpS3 is also involved in the mediation of various extra-ribosomal pathways, including DNA damage processing and the stress response. Here, we report that rpS3 is a novel negative regulator of non-homologous end joining (NHEJ)-mediated repair of DSBs. We found that rpS3 interacts with the Ku heterodimers of the DNA-dependent protein kinase (DNA-PK) complex and slows down NHEJ ligation reactions, ultimately triggering p53-dependent cell death following treatment with high-dose ionizing radiation. After DSB formation, DNA-PK phosphorylates rpS3, which consequently reduces the binding of rpS3 to the Ku complex. We hypothesized that rpS3 may play a role in DSB repair by repressing NHEJ, while inducing other repair pathways, and by initiating DSB-induced cell death in response to severe DNA damage.	[Park, Yong Jun; Kim, Tae-Sung; Kim, Eun-Ho; Kim, Joon] Korea Univ, Div Life Sci, Lab Biochem, Seoul 02841, South Korea; [Kim, Hag Dong; Kim, Joon] Korea Univ, HAEL Lab, Seoul, South Korea	Korea University; Korea University	Kim, J (corresponding author), Korea Univ, Div Life Sci, Lab Biochem, Seoul 02841, South Korea.	joonkim@korea.ac.kr			National Research Foundation of Korea (NRF) [2017R1E1A1A01074101]; Korea University (KU) [2019S1A5A2A03050121]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea University (KU)	National Research Foundation of Korea (NRF), Grant/Award Number: 2017R1E1A1A01074101; Korea University (KU), Grant/Award Number: 2019S1A5A2A03050121	Ahn JY, 2000, CANCER RES, V60, P5934; Boulon S, 2010, MOL CELL, V40, P216, DOI 10.1016/j.molcel.2010.09.024; Brandsma Inger, 2012, Genome Integr, V3, P9, DOI 10.1186/2041-9414-3-9; Chen JJ, 1999, CANCER RES, V59, p1752S; Chen LC, 2008, J BIOL CHEM, V283, P7713, DOI 10.1074/jbc.M710245200; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Costantini S, 2007, DNA REPAIR, V6, P712, DOI 10.1016/j.dnarep.2006.12.007; Fell VL, 2015, MUTAT RES-REV MUTAT, V763, P15, DOI 10.1016/j.mrrev.2014.06.002; Gao XF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000708; Golomb L, 2014, FEBS LETT, V588, P2571, DOI 10.1016/j.febslet.2014.04.014; Han SH, 2017, ONCOL LETT, V13, P3681, DOI 10.3892/ol.2017.5906; Hara S, 2004, CELL DEATH DIFFER, V11, P853, DOI 10.1038/sj.cdd.4401428; Hegde V, 2004, BIOCHEMISTRY-US, V43, P14211, DOI 10.1021/bi049234b; Hegde V, 2009, MUTAT RES-FUND MOL M, V666, P16, DOI 10.1016/j.mrfmmm.2009.03.005; Howard SM, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004943; Jang CY, 2012, BIOCHEM BIOPH RES CO, V421, P474, DOI 10.1016/j.bbrc.2012.04.020; Jang CY, 2004, FEBS LETT, V560, P81, DOI 10.1016/S0014-5793(04)00074-2; Jeggo P, 2007, ONCOGENE, V26, P7717, DOI 10.1038/sj.onc.1210868; Kass EM, 2010, FEBS LETT, V584, P3703, DOI 10.1016/j.febslet.2010.07.057; Kelley MR, 2000, DNA CELL BIOL, V19, P149, DOI 10.1089/104454900314537; Kim HD, 2011, ONCOGENE, V30, P3317, DOI 10.1038/onc.2011.47; KIM J, 1995, J BIOL CHEM, V270, P13620, DOI 10.1074/jbc.270.23.13620; Kim SH, 2005, BIOCHEM BIOPH RES CO, V328, P962, DOI 10.1016/j.bbrc.2005.01.045; Kim Y, 2013, BBA-MOL CELL RES, V1833, P2943, DOI 10.1016/j.bbamcr.2013.07.015; Kysela B, 2003, J BIOL CHEM, V278, P22466, DOI 10.1074/jbc.M303273200; Lees-Miller SP, 2003, BIOCHIMIE, V85, P1161, DOI 10.1016/j.biochi.2003.10.011; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Lindstrom MS, 2018, ONCOGENE, V37, P2351, DOI 10.1038/s41388-017-0121-z; Lord CJ, 2012, NATURE, V481, P287, DOI 10.1038/nature10760; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; Mao ZY, 2008, DNA REPAIR, V7, P1765, DOI 10.1016/j.dnarep.2008.06.018; Merritt AJ, 1997, ONCOGENE, V14, P2759, DOI 10.1038/sj.onc.1201126; Ohnishi T, 2009, MUTAT RES-FUND MOL M, V669, P8, DOI 10.1016/j.mrfmmm.2009.06.010; Patil AV, 2017, J BIOL CHEM, V292, P4313, DOI 10.1074/jbc.M116.764324; Pierce AJ, 2001, GENE DEV, V15, P3237, DOI 10.1101/gad.946401; Radyuk SN, 2006, FREE RADICAL BIO MED, V41, P757, DOI 10.1016/j.freeradbiomed.2006.05.021; Reinhardt HC, 2009, CURR OPIN CELL BIOL, V21, P245, DOI 10.1016/j.ceb.2009.01.018; Roos WP, 2006, TRENDS MOL MED, V12, P440, DOI 10.1016/j.molmed.2006.07.007; Seong KM, 2012, FEBS LETT, V586, P356, DOI 10.1016/j.febslet.2011.12.030; Smeaton MB, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm974; Sonoda E, 2006, DNA REPAIR, V5, P1021, DOI 10.1016/j.dnarep.2006.05.022; Suzuki A, 2012, CANCER SCI, V103, P632, DOI 10.1111/j.1349-7006.2012.02219.x; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Wan FY, 2007, CELL, V131, P927, DOI 10.1016/j.cell.2007.10.009; Wan FY, 2011, NAT IMMUNOL, V12, P335, DOI 10.1038/ni.2007; Wang B, 2001, J RADIAT RES, V42, P1, DOI 10.1269/jrr.42.1; Wyman C, 2006, ANNU REV GENET, V40, P363, DOI 10.1146/annurev.genet.40.110405.090451; Yadavilli S, 2009, DNA REPAIR, V8, P1215, DOI 10.1016/j.dnarep.2009.07.003	48	6	6	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8102	8113		10.1096/fj.201903245R	http://dx.doi.org/10.1096/fj.201903245R		APR 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32297663				2022-12-28	WOS:000526651100001
J	Amano, K; Okuzaki, D; Aikawa, T; Kogo, M				Amano, Katsuhiko; Okuzaki, Daisuke; Aikawa, Tomonao; Kogo, Mikihiko			Indian hedgehog in craniofacial neural crest cells links to skeletal malocclusion by regulating associated cartilage formation and gene expression	FASEB JOURNAL			English	Article						Indian hedgehog; mandibular angle cartilage; nasal cartilage; neural crest cell; RNA-Seq analysis	GROWTH-PLATE; TEMPOROMANDIBULAR-JOINT; CONDITIONAL DELETION; IHH; DIFFERENTIATION; MUTATIONS; ROLES	The frontal craniofacial skeleton derived from neural crest cells is vital for facial structure and masticatory functions. The exact role of Indian hedgehog (Ihh) in facial and masticatory development has not been fully explored. In this study, we generated craniofacial neural crest cells-specific Ihh deletion mice (Wnt1-Cre;Ihh(fl/fl);Tomato(fl/+)) and found the gradual dwarfism without perinatal lethality. Morphological and histological analyses revealed unambiguous craniofacial phenotypes in mutants, where we observed skeletal malocclusion accompanied by markedly hypoplastic nasomaxillary complex and reversed incisor occlusion. Both the replacement of nasal concha cartilage by turbinate bones and the endochondral ossification of nasal septum ethmoid bone were substantially delayed. We also observed hypoplastic mandibles in mutants where the mandibular ramus was unexpectedly the most affected. Both the condylar process and mandibular angle cartilages were distorted. However, dental examination showed no significant changes in teeth and dentition. Finally, a comprehensive RNA sequence analysis utilizing condylar cartilage identified Ihh-associated gene network including several cell cycle genes and 16 genes related to the extracellular matrix, sulfate transporters, transcription factors, receptors, a ciliogenesis factor, and an adhesion molecule. Our data provide direct in vivo evidence that Ihh plays crucial roles in midface and masticatory system formation, likely by activating key genes.	[Amano, Katsuhiko; Aikawa, Tomonao; Kogo, Mikihiko] Osaka Univ, Grad Sch Dent, Dept Oral & Maxillofacial Surg 1, 1-8 Yamadaoka, Suita, Osaka 5650871, Japan; [Okuzaki, Daisuke] Osaka Univ, Microbial Dis Res Inst, Genome Informat Res Ctr, Suita, Osaka, Japan	Osaka University; Osaka University	Amano, K (corresponding author), Osaka Univ, Grad Sch Dent, Dept Oral & Maxillofacial Surg 1, 1-8 Yamadaoka, Suita, Osaka 5650871, Japan.	k-tenno@dent.osaka-u.ac.jp	Okuzaki, Daisuke/AAN-5641-2020; Kogo, Mikihiko/ABD-7080-2020; Aikawa, Tomonao/AAV-2302-2021	Okuzaki, Daisuke/0000-0002-4552-783X; Kogo, Mikihiko/0000-0002-4556-2491; Aikawa, Tomonao/0000-0001-6906-6874	MEXT | Japan Society for the Promotion of Science (JSPS) [16K20572]; Takeda Medical Research Foundation	MEXT | Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Medical Research Foundation	MEXT | Japan Society for the Promotion of Science (JSPS), Grant/Award Number: 16K20572; Takeda Medical Research Foundation	Abzhanov A, 2007, DEVELOPMENT, V134, P3133, DOI 10.1242/dev.002709; Amano K, 2015, J BONE MINER RES, V30, P2262, DOI 10.1002/jbmr.2582; Amano K, 2014, J BIOL CHEM, V289, P24898, DOI 10.1074/jbc.M114.570507; Bren-Mattison Y, 2011, DEV BIOL, V356, P486, DOI 10.1016/j.ydbio.2011.06.002; da Fontoura CSG, 2015, J DENT RES, V94, P913, DOI 10.1177/0022034515581643; Gao B, 2001, NAT GENET, V28, P386, DOI 10.1038/ng577; Hellemans J, 2003, AM J HUM GENET, V72, P1040, DOI 10.1086/374318; Kurio N, 2018, MATRIX BIOL, V67, P15, DOI 10.1016/j.matbio.2018.02.011; Lanske B, 1996, SCIENCE, V273, P663, DOI 10.1126/science.273.5275.663; Lewis AE, 2013, DEV BIOL, V379, P229, DOI 10.1016/j.ydbio.2013.04.026; Noden DM, 2005, J ANAT, V207, P575, DOI 10.1111/j.1469-7580.2005.00473.x; Ochiai T, 2010, J DENT RES, V89, P349, DOI 10.1177/0022034510363078; Razzaque MS, 2005, J PATHOL, V207, P453, DOI 10.1002/path.1870; Shibukawa Y, 2007, DEV DYNAM, V236, P426, DOI 10.1002/dvdy.21036; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Uribe LMM, 2015, ORTHOD CRANIOFAC RES, V18, P91, DOI 10.1111/ocr.12083; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Wei X, 2016, J DENT RES, V95, P1221, DOI 10.1177/0022034516651823; Yang L, 2016, CELL TISSUE RES, V364, P105, DOI 10.1007/s00441-015-2306-5; Young B, 2006, DEV BIOL, V299, P272, DOI 10.1016/j.ydbio.2006.07.028	20	6	6	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6791	6807		10.1096/fj.201903269R	http://dx.doi.org/10.1096/fj.201903269R		MAR 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32223017	Bronze			2022-12-28	WOS:000522485600001
J	Lu, QX; Scott, PA; Vukmanic, EV; Kaplan, HJ; Dean, DC; Li, QT				Lu, Qingxian; Scott, Patrick A.; Vukmanic, Eric V.; Kaplan, Henry J.; Dean, Douglas C.; Li, Qiutang			Yap1 is required for maintenance of adult RPE differentiation	FASEB JOURNAL			English	Article						dedifferentiation; EMT; eye; knockout; RPE65; Wnt/beta-catenin	RETINAL-PIGMENT EPITHELIUM; HIPPO SIGNALING PATHWAY; TRANSGENIC SWINE MODEL; ORGAN SIZE CONTROL; BETA-CATENIN; MESENCHYMAL TRANSITION; CELL-PROLIFERATION; ALPHA-CATENIN; PROTEIN RPE65; STEM-CELLS	Nuclear YAP1 plays a critical role in regulation of stem cell proliferation, tissue regeneration, and organ size in many types of epithelia. Due to rapid turnover of most epithelial cell types, the cytoplasmic function of YAP1 in epithelial cells has not been well studied. The retinal pigment epithelium (RPE) is a highly polarized epithelial cell type maintained at a senescence state, and offers an ideal cell model to study the active role of YAP1 in maintenance of the adult epithelial phenotype. Here, we show that the cytoplasmic function of YAP1 is essential to maintain adult RPE differentiation. Knockout of Yap1 in the adult mouse RPE caused cell depolarization and tight junction breakdown, and led to inhibition of RPE65 expression, diminishment of RPE pigments, and retraction of microvilli and basal infoldings. These changes in RPE further prompted the loss of adjacent photoreceptor outer segments and photoreceptor death, which eventually led to decline of visual function in older mice between 6 and 12 months of age. Furthermore, nuclear beta-catenin and its activity were significantly increased in mutant RPE. These results suggest that YAP1 plays an important role in active inhibition of Wnt/beta-catenin signaling, and is essential for downregulation of beta-catenin nuclear activity and prevention of dedifferentiation of adult RPE.	[Lu, Qingxian; Scott, Patrick A.; Vukmanic, Eric V.; Kaplan, Henry J.; Dean, Douglas C.; Li, Qiutang] Univ Louisville, Sch Med, Dept Ophthalmol & Visual Sci, 301 East Muhammad Ali Blvd, Louisville, KY 40202 USA	University of Louisville	Li, QT (corresponding author), Univ Louisville, Sch Med, Dept Ophthalmol & Visual Sci, 301 East Muhammad Ali Blvd, Louisville, KY 40202 USA.	q.li@louisville.edu			HHS | NIH | National Eye Institute (NEI) [EY027033]	HHS | NIH | National Eye Institute (NEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	HHS | NIH | National Eye Institute (NEI), Grant/Award Number: EY027033	Asaoka Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097365; Azzolin L, 2014, CELL, V158, P157, DOI 10.1016/j.cell.2014.06.013; Barry ER, 2013, CURR OPIN CELL BIOL, V25, P247, DOI 10.1016/j.ceb.2012.12.006; Buchholz DE, 2009, STEM CELLS, V27, P2427, DOI 10.1002/stem.189; Burke JM, 2008, PROG RETIN EYE RES, V27, P579, DOI 10.1016/j.preteyeres.2008.08.002; Cabochette P, 2015, ELIFE, V4, DOI 10.7554/eLife.08488; Chan SW, 2011, J BIOL CHEM, V286, P7018, DOI 10.1074/jbc.C110.212621; Chen HC, 2012, LAB INVEST, V92, P676, DOI 10.1038/labinvest.2011.201; de Castro JPF, 2014, INVEST OPHTH VIS SCI, V55, P2460, DOI 10.1167/iovs.13-13724; Defoe DM, 2007, MOL VIS, V13, P273; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Elbediwy A, 2016, DEVELOPMENT, V143, P1674, DOI 10.1242/dev.133728; Fujimura N, 2009, DEV BIOL, V334, P31, DOI 10.1016/j.ydbio.2009.07.002; HAMEL CP, 1993, J NEUROSCI RES, V34, P414, DOI 10.1002/jnr.490340406; Iacovelli J, 2011, INVEST OPHTH VIS SCI, V52, P1378, DOI 10.1167/iovs.10-6347; Idelson M, 2009, CELL STEM CELL, V5, P396, DOI 10.1016/j.stem.2009.07.002; Jiang Q, 2009, BIOCHEM BIOPH RES CO, V384, P114, DOI 10.1016/j.bbrc.2009.04.070; Kim JY, 2016, DEV BIOL, V419, P336, DOI 10.1016/j.ydbio.2016.09.001; Kodaka M, 2015, CELL MOL LIFE SCI, V72, P285, DOI 10.1007/s00018-014-1742-9; Lee Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04757-w; Liu YQ, 2009, INVEST OPHTH VIS SCI, V50, P5080, DOI 10.1167/iovs.08-2911; Mahoney JE, 2014, DEV CELL, V30, P137, DOI 10.1016/j.devcel.2014.06.003; Manes G, 1998, FEBS LETT, V423, P133, DOI 10.1016/S0014-5793(98)00081-7; Miesfeld JB, 2015, DEVELOPMENT, V142, P3021, DOI 10.1242/dev.119008; Mo JS, 2014, EMBO REP, V15, P642, DOI 10.15252/embr.201438638; Murase S, 2002, NEURON, V35, P91, DOI 10.1016/S0896-6273(02)00764-X; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nazari H, 2015, PROG RETIN EYE RES, V48, P1, DOI 10.1016/j.preteyeres.2015.06.004; Noel JM, 2012, EXP EYE RES, V97, P137, DOI 10.1016/j.exer.2011.12.018; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Piccolo S, 2014, PHYSIOL REV, V94, P1287, DOI 10.1152/physrev.00005.2014; Robinson BS, 2011, CURR BIOL, V21, pR890, DOI 10.1016/j.cub.2011.09.019; Roura S, 1999, J BIOL CHEM, V274, P36734, DOI 10.1074/jbc.274.51.36734; Sambandam SAT, 2015, J INVEST DERMATOL, V135, P1621, DOI 10.1038/jid.2015.42; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Scott PA, 2014, INVEST OPHTH VIS SCI, V55, P2452, DOI 10.1167/iovs.13-13723; Silvis MR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001823; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Tamiya S, 2010, INVEST OPHTH VIS SCI, V51, P2755, DOI 10.1167/iovs.09-4725; Ulsamer A, 2012, J BIOL CHEM, V287, P5164, DOI 10.1074/jbc.M111.322123; Umazume K, 2014, AM J PATHOL, V184, P1419, DOI 10.1016/j.ajpath.2014.01.022; Varelas X, 2014, DEVELOPMENT, V141, P1614, DOI 10.1242/dev.102376; Wang WQ, 2011, J BIOL CHEM, V286, P4364, DOI 10.1074/jbc.C110.205401; Westenskow P, 2009, DEVELOPMENT, V136, P2505, DOI 10.1242/dev.032136; Wolf G, 2005, NUTR REV, V63, P97, DOI 10.1111/j.1753-4887.2005.tb00127.x; Yoshida K, 2004, ANAT EMBRYOL, V208, P145, DOI 10.1007/s00429-004-0382-5; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Zhang HY, 2011, P NATL ACAD SCI USA, V108, P2270, DOI 10.1073/pnas.1019603108; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303; Zhao B, 2011, GENE DEV, V25, P51, DOI 10.1101/gad.2000111; Zhao B, 2010, J CELL SCI, V123, P4001, DOI 10.1242/jcs.069070; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210; Zhao R, 2014, DEV CELL, V30, P151, DOI 10.1016/j.devcel.2014.06.004	54	2	2	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6757	6768		10.1096/fj.201903234R	http://dx.doi.org/10.1096/fj.201903234R		MAR 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32223016	Green Accepted, Bronze			2022-12-28	WOS:000522486200001
J	Lamothe, SM; Hulbert, M; Guo, J; Li, WT; Yang, TH; Zhang, ST				Lamothe, Shawn M.; Hulbert, Maggie; Guo, Jun; Li, Wentao; Yang, Tonghua; Zhang, Shetuan			Glycosylation stabilizes hERG channels on the plasma membrane by decreasing proteolytic susceptibility	FASEB JOURNAL			English	Article						potassium channel; electrophysiology; post-translational modification	ISCHEMIA-REPERFUSION INJURY; CELL-SURFACE EXPRESSION; POTASSIUM CHANNEL; SIALIC-ACID; I-KR; MOLECULAR DETERMINANTS; LINKED GLYCOSYLATION; CONGENITAL DISORDERS; CARDIAC-ARRHYTHMIA; SERINE PROTEASES	The human ether-a-go-go related gene (hERG)-encoded channel hERG undergoes N-linked glycosylation at position 598, which is located in the unusually long S5-pore linker of the channel. In other work we have demonstrated that hERG is uniquely susceptible to proteolytic cleavage at the S5-pore linker by proteinase K (PK) and calpain (CAPN). The scorpion toxin BeKm-1, which binds to the S5-pore linker of hERG, protects hERG from such cleavage. In the present study, our data revealed that, compared with normal glycosylated hERG channels, nonglycosylated hERG channels were significantly more susceptible to cleavage by extracellular PK. Furthermore, the protective effect of BeKm-1 on hERG from PK-cleavage was lost when glycosylation of hERG was inhibited. The inactivation-deficient mutant hERG channels S620T and S631A were resistant to PK cleavage, and inhibition of glycosylation rendered both mutants susceptible to PK cleavage. Compared with normal glycosylated channels, nonglycosylated hERG channels were also more susceptible to cleavage mediated by CAPN, which was present in the medium of human embryonic kidney cells under normal culture conditions. Inhibition of CAPN resulted in an increase of nonglycosylated hERG current. In summary, our results revealed that N-linked glycosylation protects hERG against protease-mediated degradation and thus contributes to hERG channel stability on the plasma membrane.	[Lamothe, Shawn M.; Hulbert, Maggie; Guo, Jun; Li, Wentao; Yang, Tonghua; Zhang, Shetuan] Queens Univ, Dept Biomed & Mol Sci, 18 Stuart St, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Zhang, ST (corresponding author), Queens Univ, Dept Biomed & Mol Sci, 18 Stuart St, Kingston, ON K7L 3N6, Canada.	shetuan.zhang@queensu.ca		Zhang, Shetuan/0000-0002-2297-0193	Canadian Institutes of Health Research Open Operating Grants Program [MOP-72911]	Canadian Institutes of Health Research Open Operating Grants Program(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research Open Operating Grants Program (MOP-72911; to S.Z.). The authors declare no conflicts of interest.	Al-Owain M, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-7; Bate C, 2016, J BIOL CHEM, V291, P17093, DOI 10.1074/jbc.M116.731117; BERKOWITZ SD, 1988, BLOOD, V72, P1790; BERNARD BA, 1982, J BIOL CHEM, V257, P8549; Cheung PY, 2000, CIRCULATION, V101, P1833, DOI 10.1161/01.CIR.101.15.1833; Chohan PK, 2006, CARDIOVASC RES, V69, P152, DOI 10.1016/j.cardiores.2005.07.016; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Donaldson SH, 2002, J BIOL CHEM, V277, P8338, DOI 10.1074/jbc.M105044200; FEDERICI AB, 1984, J CLIN INVEST, V74, P2049, DOI 10.1172/JCI111628; Ficker E, 1998, CIRC RES, V82, P386, DOI 10.1161/01.RES.82.3.386; Footitt EJ, 2009, J INHERIT METAB DIS, V32, pS313, DOI 10.1007/s10545-009-1262-1; Freeman LC, 2000, J MEMBRANE BIOL, V177, P65, DOI 10.1007/s002320001100; Freeze HH, 2006, NAT REV GENET, V7, P537, DOI 10.1038/nrg1894; Garg V, 2011, MOL PHARMACOL, V80, P630, DOI 10.1124/mol.111.073809; Gehrmann J, 2003, CARDIOL YOUNG, V13, P345, DOI 10.1017/S1047951103000702; Gerlach AC, 2010, MOL PHARMACOL, V77, P58, DOI 10.1124/mol.109.059543; Gong QM, 2002, AM J PHYSIOL-HEART C, V283, pH77, DOI 10.1152/ajpheart.00008.2002; GOROG P, 1985, J PATHOL, V146, P205, DOI 10.1002/path.1711460307; Guo J, 2009, J CLIN INVEST, V119, P2745, DOI 10.1172/JCI39027; Gustina AS, 2011, J GEN PHYSIOL, V137, P315, DOI 10.1085/jgp.201010582; HAMMOND C, 1994, P NATL ACAD SCI USA, V91, P913, DOI 10.1073/pnas.91.3.913; Hogan-Cann A, 2016, BBA-BIOMEMBRANES, V1858, P1082, DOI 10.1016/j.bbamem.2016.02.012; Jiang M, 2005, J PHYSIOL-LONDON, V569, P75, DOI 10.1113/jphysiol.2005.093682; Keating MT, 2001, CELL, V104, P569, DOI 10.1016/S0092-8674(01)00243-4; Khanna R, 2001, J BIOL CHEM, V276, P34028, DOI 10.1074/jbc.M105248200; Kranz C, 2007, AM J MED GENET A, V143A, P1371, DOI 10.1002/ajmg.a.31791; Lakhal S, 2011, J BIOL CHEM, V286, P4090, DOI 10.1074/jbc.M110.173096; Lamothe SM, 2017, FASEB J, V31, P5068, DOI 10.1096/fj.201700255R; Lamothe SM, 2016, J BIOL CHEM, V291, P20387, DOI 10.1074/jbc.M116.743138; Manganas LN, 2001, P NATL ACAD SCI USA, V98, P14055, DOI 10.1073/pnas.241403898; Massaeli H, 2010, CIRC RES, V106, P1072, DOI 10.1161/CIRCRESAHA.109.215970; Muller AL, 2013, INT J CARDIOL, V164, P39, DOI 10.1016/j.ijcard.2012.01.103; Petrecca K, 1999, J PHYSIOL-LONDON, V515, P41, DOI 10.1111/j.1469-7793.1999.041ad.x; PRIVES JM, 1980, P NATL ACAD SCI-BIOL, V77, P5263, DOI 10.1073/pnas.77.9.5263; Radaev S, 2001, J BIOL CHEM, V276, P16478, DOI 10.1074/jbc.M100351200; Rajamani S, 2006, AM J PHYSIOL-HEART C, V290, pH1278, DOI 10.1152/ajpheart.00777.2005; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; SANTACRUZTOLOZA L, 1994, BIOCHEMISTRY-US, V33, P5607, DOI 10.1021/bi00184a033; SARENEVA T, 1995, BIOCHEM J, V308, P9, DOI 10.1042/bj3080009; Schwetz TA, 2010, BBA-BIOMEMBRANES, V1798, P367, DOI 10.1016/j.bbamem.2009.11.018; Shi G, 1999, J MEMBRANE BIOL, V168, P265, DOI 10.1007/s002329900515; Szklarczyk A, 2008, FASEB J, V22, P3757, DOI 10.1096/fj.07-101402; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Tseng GN, 2007, BIOPHYS J, V92, P3524, DOI 10.1529/biophysj.106.097360; Watanabe I, 2004, J BIOL CHEM, V279, P8879, DOI 10.1074/jbc.M309802200; Watanabe I, 2007, BRAIN RES, V1144, P1, DOI 10.1016/j.brainres.2007.01.092; Zhou ZF, 1998, BIOPHYS J, V74, P230, DOI 10.1016/S0006-3495(98)77782-3	47	7	7	1	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					1933	1943		10.1096/fj.201700832R	http://dx.doi.org/10.1096/fj.201700832R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	32172531				2022-12-28	WOS:000429051400016
J	Ogawa, M; Ishihara, T; Isobe, Y; Kato, T; Kuba, K; Imai, Y; Uchino, Y; Tsubota, K; Arita, M				Ogawa, Mamoru; Ishihara, Tomoaki; Isobe, Yosuke; Kato, Taiga; Kuba, Keiji; Imai, Yumiko; Uchino, Yuichi; Tsubota, Kazuo; Arita, Makoto			Eosinophils promote corneal wound healing via the 12/15-lipoxygenase pathway	FASEB JOURNAL			English	Article						alox15; corneal wound healing; eosinophils; lipid mediator; lipoxygenase; metabolomics	LIPID MEDIATORS; RESOLUTION; RESOLVINS; SIGNALS; 17-HDHA	Lipid mediators play important roles in regulating inflammatory responses and tissue homeostasis. Since 12/15-lipoxygenase (12/15-LOX)-derived lipid mediators such as lipoxin A(4)(LXA(4)) and protectin D1 (PD1) protect against corneal epithelial cell damage, the major cell types that express 12/15-LOX and contribute to the corneal wound healing process are of particular interest. Here, we found that eosinophils were the major cell type expressing 12/15-LOX during the corneal wound healing process. Eosinophils were recruited into the conjunctiva after corneal epithelium wounding, and eosinophil-deficient and/or eosinophil-specific 12/15-LOX knockout mice showed delayed corneal wound healing compared with wild-type mice. Liquid chromatography-tandem mass spectrometry (LC-MS/MS)-based mediator lipidomics revealed that a series of 12/15-LOX-derived mediators were significantly decreased in eosinophil-deficient mice and topical application of 17-hydroxydocosahexaenoic acid (17-HDoHE), a major 12/15-LOX-derived product, restored the phenotype. These results indicate that 12/15-LOX-expressing eosinophils, by locally producing pro-resolving mediators, significantly contribute to the corneal wound healing process in the eye.	[Ogawa, Mamoru; Ishihara, Tomoaki; Isobe, Yosuke; Kato, Taiga; Arita, Makoto] RIKEN Ctr Integrat Med Sci IMS, Lab Metabol, Yokohama, Kanagawa, Japan; [Ogawa, Mamoru; Uchino, Yuichi; Tsubota, Kazuo] Keio Univ, Dept Ophthalmol, Sch Med, Tokyo, Japan; [Kuba, Keiji] Akita Univ, Dept Biochem & Metab Sci, Grad Sch Med, Akita, Japan; [Imai, Yumiko] Natl Inst Biomed Innovat Hlth & Nutr NIBIOHN, Lab Regulat Intractable Infect Dis, Osaka, Japan; [Arita, Makoto] Keio Univ, Grad Sch Pharmaceut Sci, Div Physiol Chem & Metab, Tokyo, Japan; [Arita, Makoto] Yokohama City Univ, Grad Sch Med Life Sci, Cellular & Mol Epigenet Lab, Yokohama, Kanagawa, Japan	RIKEN; Keio University; Akita University; Keio University; Yokohama City University	Arita, M (corresponding author), RIKEN Ctr Integrat Med Sci IMS, Lab Metabol, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	makoto.arita@riken.jp	Imai, Yumiko/GXW-1144-2022	Arita, Makoto/0000-0001-9902-0463; Ogawa, Mamoru/0000-0003-3416-9843	Japan Society for the Promotion of Science [KAKENHI JP15H05897, 15H05898, 20H00495]; Keio University; RIKEN Junior Research Associate Program; Keio University Doctorate Student Grant-In-Aid Program	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Keio University; RIKEN Junior Research Associate Program; Keio University Doctorate Student Grant-In-Aid Program	Japan Society for the Promotion of Science, Grant/Award Number: KAKENHI JP15H05897, 15H05898 and 20H00495; Keio University; RIKEN Junior Research Associate Program; Keio University Doctorate Student Grant-In-Aid Program	Ariel A, 2003, J IMMUNOL, V170, P6266, DOI 10.4049/jimmunol.170.12.6266; Carion TW, 2018, FASEB J, V32, P5026, DOI 10.1096/fj.201701502R; Chiu CY, 2012, INFLAMM RES, V61, P967, DOI 10.1007/s00011-012-0489-8; Doyle AD, 2013, J LEUKOCYTE BIOL, V94, P17, DOI 10.1189/jlb.0213089; Eghrari AO, 2015, PROG MOL BIOL TRANSL, V134, P7, DOI 10.1016/bs.pmbts.2015.04.001; Fukuda Ken, 2010, Cornea, V29 Suppl 1, pS62; Goh YPS, 2013, P NATL ACAD SCI USA, V110, P9914, DOI 10.1073/pnas.1304046110; Gronert K, 2005, J BIOL CHEM, V280, P15267, DOI 10.1074/jbc.M410638200; Heredia JE, 2013, CELL, V153, P376, DOI 10.1016/j.cell.2013.02.053; Holland EJ, 2015, CORNEA, V34, pS9, DOI 10.1097/ICO.0000000000000534; Iwamoto S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13122-8; Kenchegowda S, 2011, INVEST OPHTH VIS SCI, V52, P2240, DOI 10.1167/iovs.10-6199; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Ljubimov AV, 2015, PROG RETIN EYE RES, V49, P17, DOI 10.1016/j.preteyeres.2015.07.002; Marcheselli VL, 2003, J BIOL CHEM, V278, P43807, DOI 10.1074/jbc.M305841200; Masterson JC, 2015, GUT, V64, P1236, DOI 10.1136/gutjnl-2014-306998; Neuhofer A, 2013, DIABETES, V62, P1945, DOI 10.2337/db12-0828; Ogawa Mamoru, 2018, Journal of Biological Methods, V5, pe102, DOI 10.14440/jbm.2018.237; Ramon S, 2014, J IMMUNOL, V193, P6031, DOI 10.4049/jimmunol.1302795; Rosenberg HF, 2013, NAT REV IMMUNOL, V13, P9, DOI 10.1038/nri3341; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; TSUBOTA K, 1991, CORNEA, V10, P525, DOI 10.1097/00003226-199111000-00011; Weller PF, 2017, NAT REV IMMUNOL, V17, P746, DOI 10.1038/nri.2017.95; Xu ZZ, 2011, BRIT J PHARMACOL, V164, P274, DOI 10.1111/j.1476-5381.2011.01348.x; Yamada T, 2011, FASEB J, V25, P561, DOI 10.1096/fj.10-170027; Yamaguchi T, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aan3638; Zieske JD, 2000, INVEST OPHTH VIS SCI, V41, P1346	27	9	9	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12492	12501		10.1096/fj.202000483R	http://dx.doi.org/10.1096/fj.202000483R		JUL 2020	10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32721046	hybrid			2022-12-28	WOS:000556061500001
J	Rexius-Hall, ML; Khalil, NN; Andres, AM; McCain, ML				Rexius-Hall, Megan L.; Khalil, Natalie N.; Andres, Allen M.; McCain, Megan L.			Mitochondrial division inhibitor 1 (mdivi-1) increases oxidative capacity and contractile stress generated by engineered skeletal muscle	FASEB JOURNAL			English	Article						contractility; Drp1; mitochondria; myotube; sarcomere	MICROMOLDED GELATIN HYDROGELS; STEM-CELL; IN-VIVO; FISSION CONTRIBUTES; DRP1; DYSFUNCTION; DYNAMICS; LENGTH; DIFFERENTIATION; FUSION	In skeletal muscle fibers, mitochondria are densely packed adjacent to myofibrils because adenosine triphosphate (ATP) is needed to fuel sarcomere shortening. However, despite this close physical and biochemical relationship, the effects of mitochondrial dynamics on skeletal muscle contractility are poorly understood. In this study, we analyzed the effects of Mitochondrial Division Inhibitor 1 (mdivi-1), an inhibitor of mitochondrial fission, on the structure and function of both mitochondria and myofibrils in skeletal muscle tissues engineered on micromolded gelatin hydrogels. Treatment with mdivi-1 did not alter myotube morphology, but did increase the mitochondrial turbidity and oxidative capacity, consistent with reduced mitochondrial fission. Mdivi-1 also significantly increased basal, twitch, and tetanus stresses, as measured using the Muscular Thin Film (MTF) assay. Finally, mdivi-1 increased sarcomere length, potentially due to mdivi-1-induced changes in mitochondrial volume and compression of myofibrils. Together, these results suggest that mdivi-1 increases contractile stress generation, which may be caused by an increase in maximal respiration and/or sarcomere length due to increased volume of individual mitochondria. These data reinforce that mitochondria have both biochemical and biomechanical roles in skeletal muscle and that mitochondrial dynamics can be manipulated to alter muscle contractility.	[Rexius-Hall, Megan L.; Khalil, Natalie N.; McCain, Megan L.] Univ Southern Calif, Dept Biomed Engn, USC Viterbi Sch Engn, Lab Living Syst Engn, Los Angeles, CA 90007 USA; [Andres, Allen M.] Cedars Sinai Med Ctr, Smidt Heart Inst, Los Angeles, CA 90048 USA; [Andres, Allen M.] Cedars Sinai Med Ctr, Barbra Streisand Womens Heart Ctr, Los Angeles, CA 90048 USA; [McCain, Megan L.] Univ Southern Calif, Keck Sch Med USC, Dept Stem Cell Biol & Regenerat Med, Los Angeles, CA 90007 USA; [Andres, Allen M.] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA	University of Southern California; Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of Southern California; University of California System; University of California San Diego	McCain, ML (corresponding author), USC Viterbi Sch Engn, Dept Biomed Engn, Lab Living Syst Engn, 1042 Downey Way,DRB 140, Los Angeles, CA 90089 USA.	mlmccain@usc.edu		Khalil, Natalie/0000-0003-1209-2718	American Heart Association (AHA) [15SDG23230013, 16SDG29950005]; Rose Hills Foundation; USC Viterbi School of Engineering; USC Women in Science and Engineering; ALS Association [18-IIA-401]	American Heart Association (AHA)(American Heart Association); Rose Hills Foundation; USC Viterbi School of Engineering; USC Women in Science and Engineering; ALS Association	American Heart Association (AHA), Grant/Award Number: 15SDG23230013 and 16SDG29950005; Rose Hills Foundation, Grant/Award Number: Innovator Grant Program; USC Viterbi School of Engineering, Grant/Award Number: N/A; USC Women in Science and Engineering, Grant/Award Number: N/A; ALS Association, Grant/Award Number: 18-IIA-401	Abdelmoez AM, 2020, AM J PHYSIOL-CELL PH, V318, pC615, DOI 10.1152/ajpcell.00540.2019; Arribat Y, 2019, ACTA PHYSIOL, V225, DOI 10.1111/apha.13179; Baek SH, 2017, J NEUROSCI, V37, P5099, DOI 10.1523/JNEUROSCI.2385-16.2017; Bettadapur A, 2016, SCI REP-UK, V6, DOI 10.1038/srep28855; Bloemberg D, 2016, DATA BRIEF, V7, P634, DOI 10.1016/j.dib.2016.02.070; Bordt EA, 2017, DEV CELL, V40, P583, DOI 10.1016/j.devcel.2017.02.020; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Chal J, 2017, DEVELOPMENT, V144, P2104, DOI 10.1242/dev.151035; Chen Yu, 2016, Shengli Xuebao, V68, P669, DOI 10.13294/j.aps.2016.0079; Collins TJ, 2002, EMBO J, V21, P1616, DOI 10.1093/emboj/21.7.1616; Cunniff B, 2014, REDOX BIOL, V3, P79, DOI 10.1016/j.redox.2014.11.003; De Palma C, 2010, CELL DEATH DIFFER, V17, P1684, DOI 10.1038/cdd.2010.48; Denes LT, 2019, SKELET MUSCLE, V9, DOI 10.1186/s13395-019-0203-4; Dorn GW, 2015, GENE DEV, V29, P1981, DOI 10.1101/gad.269894.115; Du AP, 2008, DEV BIOL, V318, P236, DOI 10.1016/j.ydbio.2008.03.011; Fang D, 2016, SCI REP-UK, V6, DOI 10.1038/srep31462; Forni MF, 2016, STEM CELLS, V34, P743, DOI 10.1002/stem.2248; Gan XQ, 2014, BBA-MOL BASIS DIS, V1842, P220, DOI 10.1016/j.bbadis.2013.11.009; Giacomotto J, 2013, HUM MOL GENET, V22, P4562, DOI 10.1093/hmg/ddt302; Gilhus NE, 2015, LANCET NEUROL, V14, P1023, DOI 10.1016/S1474-4422(15)00145-3; Givvimani S, 2015, INT J CARDIOL, V187, P325, DOI 10.1016/j.ijcard.2015.03.352; Gokhin DS, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00375; Groen EJN, 2018, NAT REV NEUROL, V14, P214, DOI 10.1038/nrneurol.2018.4; Grosberg A, 2011, LAB CHIP, V11, P4165, DOI 10.1039/c1lc20557a; Guiraud S, 2015, ANNU REV GENOM HUM G, V16, P281, DOI 10.1146/annurev-genom-090314-025003; Hall AE, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.91; Hardiman O, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.71; He B, 2009, CURR OPIN CELL BIOL, V21, P900, DOI 10.1016/j.ceb.2009.08.008; Hickmann FH, 2015, BBA-BIOENERGETICS, V1847, P620, DOI 10.1016/j.bbabio.2015.04.003; Hirschy A, 2006, DEV BIOL, V289, P430, DOI 10.1016/j.ydbio.2005.10.046; Hogue A, 2018, CELL DEATH DISCOV, V4, DOI 10.1038/s41420-018-0042-9; HOLLOSZY JO, 1984, J APPL PHYSIOL, V56, P831, DOI 10.1152/jappl.1984.56.4.831; Ikeda Y, 2015, CIRC RES, V116, P264, DOI 10.1161/CIRCRESAHA.116.303356; Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907; Jheng HF, 2012, MOL CELL BIOL, V32, P309, DOI 10.1128/MCB.05603-11; Kaasik A, 2010, CARDIOVASC RES, V87, P83, DOI 10.1093/cvr/cvq039; Kageyama Y, 2012, J CELL BIOL, V197, P535, DOI 10.1083/jcb.201110034; Kasahara A, 2013, SCIENCE, V342, P734, DOI 10.1126/science.1241359; Khacho M, 2016, CELL STEM CELL, V19, P232, DOI 10.1016/j.stem.2016.04.015; Kim B, 2013, AM J PHYSIOL-REG I, V305, pR927, DOI 10.1152/ajpregu.00502.2012; Kim DI, 2016, BBA-MOL CELL RES, V1863, P2820, DOI 10.1016/j.bbamcr.2016.09.003; Kim HJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep15962; Kim JE, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00301; LIEBER RL, 1994, J NEUROPHYSIOL, V71, P874, DOI 10.1152/jn.1994.71.3.874; Luo G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082112; Magalon K, 2016, NEUROPHARMACOLOGY, V111, P293, DOI 10.1016/j.neuropharm.2016.09.009; Maganaris CN, 2003, CLIN ANAT, V16, P215, DOI 10.1002/ca.10064; Manczak M, 2019, HUM MOL GENET, V28, P177, DOI 10.1093/hmg/ddy335; Marsboom G, 2012, CIRC RES, V110, P1484, DOI 10.1161/CIRCRESAHA.111.263848; McCain ML, 2014, BIOMATERIALS, V35, P5462, DOI 10.1016/j.biomaterials.2014.03.052; McCarron JG, 2013, J VASC RES, V50, P357, DOI 10.1159/000353883; Mishra P, 2015, CELL METAB, V22, P1033, DOI 10.1016/j.cmet.2015.09.027; Mitra K, 2009, P NATL ACAD SCI USA, V106, P11960, DOI 10.1073/pnas.0904875106; Nesmith AP, 2016, J CELL BIOL, V215, P47, DOI 10.1083/jcb.201603111; Niu F, 2019, WORLD NEUROSURG, V122, pE1090, DOI 10.1016/j.wneu.2018.10.236; Nozaki T, 2001, CARDIOVASC PATHOL, V10, P125, DOI 10.1016/S1054-8807(01)00071-0; Ogata T, 1997, ANAT REC, V248, P214; OGATA T, 1985, CELL TISSUE RES, V241, P251, DOI 10.1007/BF00217168; Ong SB, 2010, CIRCULATION, V121, P2012, DOI 10.1161/CIRCULATIONAHA.109.906610; Pajcini KV, 2010, CELL STEM CELL, V7, P198, DOI 10.1016/j.stem.2010.05.022; Pasqualin C, 2016, AM J PHYSIOL-CELL PH, V311, pC277, DOI 10.1152/ajpcell.00094.2016; Piquereau J, 2012, CARDIOVASC RES, V94, P408, DOI 10.1093/cvr/cvs117; Qin D, 2010, NAT PROTOC, V5, P491, DOI 10.1038/nprot.2009.234; Rangwala SM, 2010, J BIOL CHEM, V285, P22619, DOI 10.1074/jbc.M110.125401; Rassier DE, 1999, J APPL PHYSIOL, V86, P1445, DOI 10.1152/jappl.1999.86.5.1445; Rehman J, 2012, FASEB J, V26, P2175, DOI 10.1096/fj.11-196543; Rossignol R, 2004, CANCER RES, V64, P985, DOI 10.1158/0008-5472.CAN-03-1101; Ruiz A, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00003; Salabei JK, 2013, REDOX BIOL, V1, P542, DOI 10.1016/j.redox.2013.10.011; Sanger JW, 2002, CLIN ORTHOP RELAT R, pS153, DOI 10.1097/01.blo.0000031973.69509.21; Schiavone M, 2017, PHARMACOL RES, V125, P122, DOI 10.1016/j.phrs.2017.09.001; Schwarz K, 2014, INT J CARDIOL, V171, P134, DOI 10.1016/j.ijcard.2013.12.014; Sharp WW, 2014, FASEB J, V28, P316, DOI 10.1096/fj.12-226225; Silva RD, 2005, MOL MICROBIOL, V58, P824, DOI 10.1111/j.1365-2958.2005.04868.x; Steketee MB, 2012, INVEST OPHTH VIS SCI, V53, P7402, DOI 10.1167/iovs.12-10298; Suh GC, 2017, METHODS MOL BIOL, V1668, P147, DOI 10.1007/978-1-4939-7283-8_11; Tanner MJ, 2017, AM J PHYSIOL-HEART C, V312, pH515, DOI 10.1152/ajpheart.00499.2016; Troncoso R, 2014, CELL CYCLE, V13, P2281, DOI 10.4161/cc.29272; Vazquez-Martin A, 2012, AGING-US, V4, P393, DOI 10.18632/aging.100465; Vendelin M, 2005, AM J PHYSIOL-CELL PH, V288, pC757, DOI 10.1152/ajpcell.00281.2004; Wakabayashi J, 2009, J CELL BIOL, V186, P805, DOI 10.1083/jcb.200903065; WALKER SM, 1974, ANAT RECORD, V178, P63, DOI 10.1002/ar.1091780107; Wan YY, 2014, ONCOL REP, V32, P619, DOI 10.3892/or.2014.3235; Wang G, 2014, NAT MED, V20, P616, DOI 10.1038/nm.3545; WANG YP, 1995, J MOL CELL CARDIOL, V27, P1235, DOI 10.1016/S0022-2828(05)82385-5; Westermann B, 2012, BBA-BIOENERGETICS, V1817, P1833, DOI 10.1016/j.bbabio.2012.02.033; Xu FL, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0210-x; Yu J, 2017, ACTA PHYSIOL, V220, P83, DOI 10.1111/apha.12812; Yu TZ, 2018, LIFE SCI, V200, P6, DOI 10.1016/j.lfs.2018.02.031; Yu TZ, 2016, J PHYSIOL-LONDON, V594, P7419, DOI 10.1113/JP272885; Zhang B, 2013, CANCER RES, V73, P6700, DOI 10.1158/0008-5472.CAN-13-1411; Zick M, 2009, BBA-MOL CELL RES, V1793, P5, DOI 10.1016/j.bbamcr.2008.06.013	92	5	5	2	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					11562	11576		10.1096/fj.201901039RR	http://dx.doi.org/10.1096/fj.201901039RR		JUL 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32652761	Bronze			2022-12-28	WOS:000548006900001
J	Lutz, A; Jung, DI; Diem, K; Fauler, M; Port, F; Gottschalk, K; Felder, E				Lutz, Anngrit; Jung, Dominik; Diem, Kathrin; Fauler, Michael; Port, Fabian; Gottschalk, Kay; Felder, Edward			Acute effects of cell stretch on keratin filaments in A549 lung cells	FASEB JOURNAL			English	Article						desmosome; mechanical resilience; phosphorylation; strain	SIGNAL-REGULATED KINASE; INTERMEDIATE-FILAMENTS; MECHANICAL-PROPERTIES; SHEAR-STRESS; VISCOELASTIC PROPERTIES; PHOSPHORYLATION; PROTEIN; NETWORKS; STRAIN; REORGANIZATION	Keratin filaments (KFs) comprise the intermediate filaments of epithelial cells and are well known for their cytoprotective properties and their mechanical resilience. Although, several studies have demonstrated KFs' remarkable tensile properties relatively little is known about acute implications of mechanical stretch on KFs in living cells. This includes structural effects on the KFs and their higher level assembly structures as well as posttranslational response mechanisms to possibly modify KF's properties. We subjected simple epithelial A549 lung cells to 30% unidirectional stretch and already after 10 seconds we observed morphological changes of the KF-network as well as structural effects on their desmosomal anchor sites-both apparently caused by the tensile strain. Interestingly, the effect on the desmosomes was attenuated after 30 seconds of cell stretch with a concomitant increase in phosphorylation of keratin8-S432, keratin18-S53, and keratin18-S34 without an apparent increase in keratin solubility. When mimicking the phosphorylation of keratin18-S34 the stretch-induced effect on the desmosomes could be diminished and probing the cell surface with atomic force microscopy showed a lowered elastic modulus. We conclude that the stretch-induced KF phosphorylation affects KF's tensile properties, probably to lower the mechanical load on strained desmosomal cell-cell contacts, and hence, preserve epithelial integrity.	[Lutz, Anngrit; Jung, Dominik; Diem, Kathrin; Fauler, Michael; Felder, Edward] Ulm Univ, Dept Gen Physiol, Ulm, Germany; [Port, Fabian; Gottschalk, Kay] Ulm Univ, Dept Expt Phys, Ulm, Germany	Ulm University; Ulm University	Felder, E (corresponding author), Ulm Univ, Dept Gen Physiol, Ulm, Germany.	edward.felder@uni-ulm.de			Deutsche Forschungsgemeinschaft (DFG) [GRK2203]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: GRK2203	Arentz G, 2012, ISRN MOL BIOL, V2012, P1; Beil M, 2003, NAT CELL BIOL, V5, P803, DOI 10.1038/ncb1037; Breslin JW, 2003, AM J PHYSIOL-HEART C, V284, pH92, DOI 10.1152/ajpheart.00330.2002; Busch T, 2012, J CELL SCI, V125, P2148, DOI 10.1242/jcs.080127; Charrier EE, 2016, METHOD ENZYMOL, V568, P35, DOI 10.1016/bs.mie.2015.09.009; Colburn ZT, 2018, J CELL SCI, V131, DOI 10.1242/jcs.214593; Cowan KJ, 2003, J EXP BIOL, V206, P1107, DOI 10.1242/jeb.00220; Deek J, 2016, ACTA BIOMATER, V43, P218, DOI 10.1016/j.actbio.2016.07.010; Deschner J, 2003, CURR OPIN CLIN NUTR, V6, P289, DOI 10.1097/01.mco.0000068964.34812.2b; Felder E, 2008, AM J PHYSIOL-LUNG C, V295, pL849, DOI 10.1152/ajplung.00503.2007; Flitney EW, 2009, FASEB J, V23, P2110, DOI 10.1096/fj.08-124453; Fois G, 2013, FASEB J, V27, P1322, DOI 10.1096/fj.12-215632; Fudge D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002327; Gerstmair A, 2009, J APPL PHYSIOL, V107, P613, DOI 10.1152/japplphysiol.00012.2009; Haines RL, 2012, J CELL SCI, V125, P3923, DOI 10.1242/jcs.099655; Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823; Herrmann H, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a018242; Huang HD, 2004, AM J PHYSIOL-CELL PH, V287, pC1, DOI 10.1152/ajpcell.00559.2003; Hughes-Fulford Millie, 2004, Sci STKE, V2004, pRE12; Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098; Iqbal J, 2005, BIOCHEM BIOPH RES CO, V328, P751, DOI 10.1016/j.bbrc.2004.12.087; Jaitovich A, 2008, J BIOL CHEM, V283, P25348, DOI 10.1074/jbc.M801635200; JANMEY PA, 1991, J CELL BIOL, V113, P155, DOI 10.1083/jcb.113.1.155; Jo H, 1997, J BIOL CHEM, V272, P1395, DOI 10.1074/jbc.272.2.1395; Kim HJ, 2015, BIOMOL THER, V23, P301, DOI 10.4062/biomolther.2015.032; Kim S, 2007, GENE DEV, V21, P1581, DOI 10.1101/gad.1552107; Ku NO, 1998, EMBO J, V17, P1892, DOI 10.1093/emboj/17.7.1892; Ku NO, 2004, J CELL BIOL, V166, P479, DOI 10.1083/jcb.200402051; KU NO, 1994, J CELL BIOL, V127, P161, DOI 10.1083/jcb.127.1.161; Liao J, 1997, J BIOL CHEM, V272, P17565, DOI 10.1074/jbc.272.28.17565; Lidsky M, 2014, J BIOL CHEM, V289, P27714, DOI 10.1074/jbc.M113.532432; LIEBER M, 1976, INT J CANCER, V17, P62, DOI 10.1002/ijc.2910170110; Magin TM, 2007, EXP CELL RES, V313, P2021, DOI 10.1016/j.yexcr.2007.03.005; Nafeey S, 2016, J STRUCT BIOL, V194, P415, DOI 10.1016/j.jsb.2016.03.023; Omary MB, 2006, TRENDS BIOCHEM SCI, V31, P383, DOI 10.1016/j.tibs.2006.05.008; Perrett RM, 2013, J BIOL CHEM, V288, P21001, DOI 10.1074/jbc.M113.455345; Price AJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07523-0; Prina-Mello A, 2018, TISSUE CELL, V50, P15, DOI 10.1016/j.tice.2017.11.003; Qin Z, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/42/425101; Qin Z, 2010, J BIOMECH, V43, P15, DOI 10.1016/j.jbiomech.2009.09.004; Ridge KM, 2005, J BIOL CHEM, V280, P30400, DOI 10.1074/jbc.M504239200; Ruwhof C, 2000, CARDIOVASC RES, V47, P23, DOI 10.1016/S0008-6363(00)00076-6; Sanghvi-Shah R, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00081; Sawant MS, 2017, INT REV CEL MOL BIO, V330, P171, DOI 10.1016/bs.ircmb.2016.09.005; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sivaramakrishnan S, 2009, MOL BIOL CELL, V20, P2673; Sivaramakrishnan S, 2008, P NATL ACAD SCI USA, V105, P889, DOI 10.1073/pnas.0710728105; Snider NT, 2014, NAT REV MOL CELL BIO, V15, P163, DOI 10.1038/nrm3753; Song SL, 2016, PHARM BIOL, V54, P732, DOI 10.3109/13880209.2015.1073333; Thamilselvan V, 2004, GASTROENTEROLOGY, V126, P8, DOI 10.1053/j.gastro.2003.10.078; Toivola DM, 2010, TRENDS CELL BIOL, V20, P79, DOI 10.1016/j.tcb.2009.11.004; Wagner OI, 2007, EXP CELL RES, V313, P2228, DOI 10.1016/j.yexcr.2007.04.025; Woll S, 2007, J CELL BIOL, V177, P795, DOI 10.1083/jcb.200703174; Yamada S, 2003, J STRUCT BIOL, V143, P45, DOI 10.1016/S1047-8477(03)00101-1; Yi HY, 2013, HISTOCHEM CELL BIOL, V140, P65, DOI 10.1007/s00418-013-1105-x; Yoon M, 1998, J CELL BIOL, V143, P147, DOI 10.1083/jcb.143.1.147	56	3	3	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					11227	11242		10.1096/fj.201903160RR	http://dx.doi.org/10.1096/fj.201903160RR		JUL 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32632966				2022-12-28	WOS:000547911700001
J	Wu, L; Niu, ZF; Hu, XL; Liu, HL; Li, S; Chen, L; Zheng, DH; Liu, Z; Liu, TT; Xu, FQ; Manyande, A; Wang, J; Xia, HC				Wu, Liang; Niu, Zhanfeng; Hu, Xulei; Liu, Huili; Li, Shuang; Chen, Lei; Zheng, Danhao; Liu, Zhuang; Liu, Taotao; Xu, Fuqiang; Manyande, Anne; Wang, Jie; Xia, Hechun			Regional cerebral metabolic levels and turnover in awake rats after acute or chronic spinal cord injury	FASEB JOURNAL			English	Article						brain regions; metabolic kinetics; neurotransmitters; NMR; spinal cord injury	BRAIN ENERGY-METABOLISM; IN-VIVO; MITOCHONDRIAL TRANSPLANTATION; FUNCTIONAL RECOVERY; GLUTAMATE; EXPRESSION; CORTEX; BIOENERGETICS; PLASTICITY; PATTERNS	Spinal cord injury (SCI) is a common cause of disability, which often leads to sensorimotor cortex dysfunction above the spinal injury site. However, the cerebral regional effects on metabolic information after SCI have been little studied. Here, adult Sprague-Dawley rats were divided into acute and chronic treatment groups and sham groups with day-matched periods. The Basso, Beatte, and Bresnahan scores method were utilized to evaluate the changes in behaviors during the recovery of the animals, and the metabolic information was measured with the(1)H-observed/C-13-edited NMR method. Total metabolic concentrations in every region were almost similar in both treated groups. However, the metabolic kinetics in most regions in the acute group were significantly altered (P < .05), particularly in the cortical area, thalamus and medulla (P < .01). After long-term recovery, some metabolic kinetics were recovered, especially in the temporal cortex, occipital cortex, and medulla. The metabolic kinetic changes revealed the alteration of metabolism and neurotransmission in different brain regions after SCI, which present evidence for the alternation of brain glucose oxidation. Therefore, this shows the significant influence of SCI on cerebral function and neuroscience research. This study also provides the theoretical basis for clinical therapy after SCI, such as mitochondrial transplantation.	[Wu, Liang; Niu, Zhanfeng; Hu, Xulei; Xia, Hechun] Ningxia Med Univ, Dept Neurosurg, Gen Hosp, Yinchuan 750004, Ningxia, Peoples R China; [Wu, Liang; Liu, Huili; Li, Shuang; Chen, Lei; Zheng, Danhao; Liu, Zhuang; Xu, Fuqiang; Wang, Jie] Chinese Acad Sci, State Key Lab Magnet Resonance & Atom & Mol Phys, Innovat Acad Precis Measurement Sci & Technol, Key Lab Magnet Resonance Biol Syst,Wuhan Inst Phy, Wuhan 430071, Hubei, Peoples R China; [Wu, Liang; Hu, Xulei] Ningxia Key Lab Cerebrocranial Dis, Yinchuan, Ningxia, Peoples R China; [Wu, Liang; Hu, Xulei] Ningxia Med Univ, Sch Clin Med, Yinchuan, Ningxia, Peoples R China; [Liu, Huili; Zheng, Danhao; Liu, Zhuang; Xu, Fuqiang; Wang, Jie] Univ Chinese Acad Sci, Beijing, Peoples R China; [Liu, Taotao] Peking Univ, Dept Anesthesiol, Hosp 3, Beijing, Peoples R China; [Manyande, Anne] Univ West London, Sch Human & Social Sci, London, England; [Wang, Jie] 2nd Hosp Shijiazhuang, Hebei Prov Key Lab Basic Med Diabet, Shijiazhuang, Hebei, Peoples R China; [Xia, Hechun] Ningxia Med Univ, Ningxia Human Stem Cell Res Inst, Gen Hosp, Yinchuan, Ningxia, Peoples R China	Ningxia Medical University; Chinese Academy of Sciences; Ningxia Medical University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Peking University; Ningxia Medical University	Xia, HC (corresponding author), Ningxia Med Univ, Dept Neurosurg, Gen Hosp, Yinchuan 750004, Ningxia, Peoples R China.; Wang, J (corresponding author), Chinese Acad Sci, State Key Lab Magnet Resonance & Atom & Mol Phys, Innovat Acad Precis Measurement Sci & Technol, Key Lab Magnet Resonance Biol Syst,Wuhan Inst Phy, Wuhan 430071, Hubei, Peoples R China.	jie.wang@wipm.ac.cn; xhechun@nyfy.com.cn		Wang, Jie/0000-0002-2997-3450; xu, fu qiang/0000-0002-4382-9797	Key Research Projects of Ningxia Hui Autonomous Region [2018BCG01002]; National Natural Science Foundation of China [31771193, 81760449]; Natural Science Foundation of Ningxia [NZ16127]; Youth Innovation Promotion Association of Chinese Academy of Sciences [Y6Y0021004]	Key Research Projects of Ningxia Hui Autonomous Region; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Ningxia; Youth Innovation Promotion Association of Chinese Academy of Sciences	This work was supported by grants from Key Research Projects of Ningxia Hui Autonomous Region (2018BCG01002), the National Natural Science Foundation of China (31771193,81760449), the Natural Science Foundation of Ningxia (NZ16127), and the Youth Innovation Promotion Association of Chinese Academy of Sciences (Y6Y0021004).	Ahmad M, 2016, PHARMACOL BIOCHEM BE, V145, P45, DOI 10.1016/j.pbb.2016.04.003; Ahuja CS, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.18; Baek A, 2017, CELL TRANSPLANT, V26, P1286, DOI 10.1177/0963689717715822; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Bonizzato M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05282-6; Burnside ER, 2018, BRAIN, V141, P2362, DOI 10.1093/brain/awy158; Dahlberg LS, 2018, NEUROSCI BIOBEHAV R, V90, P272, DOI 10.1016/j.neubiorev.2018.04.018; de Graaf RA, 2003, NMR BIOMED, V16, P339, DOI 10.1002/nbm.847; Deelchand DK, 2009, J MAGN RESON, V196, P157, DOI 10.1016/j.jmr.2008.11.001; Dieterle F, 2006, ANAL CHEM, V78, P4281, DOI 10.1021/ac051632c; Dulin JN, 2013, J NEUROSCI, V33, P652, DOI 10.1523/JNEUROSCI.6128-11.2013; Emir UE, 2012, NMR BIOMED, V25, P152, DOI 10.1002/nbm.1727; Endo T, 2007, BRAIN, V130, P2951, DOI 10.1093/brain/awm237; ERECINSKA M, 1990, PROG NEUROBIOL, V35, P245, DOI 10.1016/0301-0082(90)90013-7; Escartin C, 2006, J NEUROCHEM, V99, P393, DOI 10.1111/j.1471-4159.2006.04083.x; Freund P, 2013, LANCET NEUROL, V12, P873, DOI 10.1016/S1474-4422(13)70146-7; Frigon A, 2006, PROG BRAIN RES, V157, P231, DOI 10.1016/S0079-6123(06)57016-5; Furkiewicz MT, 2007, NEUROREHAB NEURAL RE, V21, P527, DOI 10.1177/1545968307301872; Gollihue JL, 2018, J NEUROTRAUM, V35, P1800, DOI 10.1089/neu.2017.5605; Goryawala MZ, 2016, NMR BIOMED, V29, P1108, DOI 10.1002/nbm.3575; Grabher P, 2015, ANN NEUROL, V78, P751, DOI 10.1002/ana.24508; Gustin SM, 2014, PAIN, V155, P1027, DOI 10.1016/j.pain.2014.02.008; Henderson LA, 2011, J NEUROSCI, V31, P2630, DOI 10.1523/JNEUROSCI.2717-10.2011; Hirata A, 2009, J NEUROPHYSIOL, V102, P437, DOI 10.1152/jn.00277.2009; Humanes-Valera D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069655; Huo ZG, 2020, NEUROBIOL AGING, V86, P123, DOI 10.1016/j.neurobiolaging.2019.10.014; Jacyna J, 2019, TALANTA, V202, P572, DOI 10.1016/j.talanta.2019.05.039; LENZ FA, 1987, PAIN, V31, P225, DOI 10.1016/0304-3959(87)90038-8; Likavcanova K, 2008, MAGN RESON MED, V59, P499, DOI 10.1002/mrm.21504; Liu TT, 2020, NEUROSCI BULL, V36, P25, DOI 10.1007/s12264-019-00414-4; Liu TT, 2017, BBA-MOL BASIS DIS, V1863, P1222, DOI 10.1016/j.bbadis.2017.03.011; Liu Y, 2017, CHEMOMETR INTELL LAB, V162, P142, DOI 10.1016/j.chemolab.2017.01.005; Long YC, 2011, J APPL PHYSIOL, V110, P1204, DOI 10.1152/japplphysiol.00686.2010; Lyons DN, 2018, J NEUROTRAUM, V35, P2435, DOI 10.1089/neu.2018.5663; Magon S, 2015, J NEUROSCI, V35, P13800, DOI 10.1523/JNEUROSCI.2154-15.2015; Manohar A, 2017, ELIFE, V6, DOI 10.7554/eLife.23532; Martinez-Reyes I, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13668-3; McCully JD, 2017, MITOCHONDRION, V34, P127, DOI 10.1016/j.mito.2017.03.004; Oyinbo CA, 2011, ACTA NEUROBIOL EXP, V71, P281; Pacak CA, 2015, BIOL OPEN, V4, P622, DOI 10.1242/bio.201511478; Patel SP, 2014, EXP NEUROL, V257, P95, DOI 10.1016/j.expneurol.2014.04.026; Patel SP, 2010, J NEUROCHEM, V114, P291, DOI 10.1111/j.1471-4159.2010.06764.x; Patel SP, 2009, J NEUROSCI RES, V87, P130, DOI 10.1002/jnr.21814; Perruchoud D, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/4/041001; Ramadan S, 2013, NMR BIOMED, V26, P1630, DOI 10.1002/nbm.3045; Scandola M, 2019, J NEUROTRAUM, V36, P2028, DOI 10.1089/neu.2018.6123; Scholpa NE, 2017, J PHARMACOL EXP THER, V363, P303, DOI 10.1124/jpet.117.244806; Sibson NR, 1998, P NATL ACAD SCI USA, V95, P316, DOI 10.1073/pnas.95.1.316; SIESJO BK, 1978, J NEURAL TRANSM, P17; Sonnewald U, 2003, NMR BIOMED, V16, P424, DOI 10.1002/nbm.837; Tam S, 2010, NEUROSURGERY, V67, pE863, DOI 10.1227/01.NEU.0000374848.86299.17; Tkac I, 2003, MAGN RESON MED, V50, P24, DOI 10.1002/mrm.10497; Vera-Portocarrero LP, 2002, BRAIN RES, V927, P104, DOI 10.1016/S0006-8993(01)03329-7; Wang J, 2010, J NEUROCHEM, V113, P1447, DOI 10.1111/j.1471-4159.2010.06684.x; Waxman SG, 2006, TRENDS NEUROSCI, V29, P207, DOI 10.1016/j.tins.2006.02.003; Wrigley PJ, 2009, CEREB CORTEX, V19, P224, DOI 10.1093/cercor/bhn072	56	6	6	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10547	10559		10.1096/fj.202000447R	http://dx.doi.org/10.1096/fj.202000447R		JUN 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32592196	hybrid, Green Accepted			2022-12-28	WOS:000544411200001
J	Liu, QR; Cui, P; Zheng, K; Wang, JJ; Jiang, W; Liu, GY; Hao, JW; Liu, HJ				Liu, Qingrong; Cui, Pan; Zheng, Kai; Wang, Junjie; Jiang, Wei; Liu, Guiyou; Hao, Junwei; Liu, Haijie			SERPINA1gene expression in whole blood links the rs6647 variant G allele to an increased risk of large artery atherosclerotic stroke	FASEB JOURNAL			English	Article						expression quantitative trait loci; large artery atherosclerotic stroke; rs6647; SERPINA1; whole blood	GENE-EXPRESSION; ISCHEMIC-STROKE; DISEASE; CONTRIBUTE; EQTLS	The rs6647 variant G allele inSERPINA1gene was reported to be associated with the risk of large artery atherosclerotic stroke (LAS), however, the mechanism remains unclear. Here, we performed a functional annotation of the rs6647 variant by using the software HaploReg version 4.1 (HaploReg v4.1). Next, the expression quantitative trait loci (eQTLs) analysis of multiple datasets was conducted for determining the association between the rs6647 andSERPINA1expression in various tissues. Then, a case-control gene expression analysis was done using two independent ischemic stroke (IS) gene expression datasets. Finally,SERPINA1expression in whole blood samples from 8 LAS patients and 14 healthy persons were compared. The functional annotation suggested that the rs6647 regulates gene expression in multiple human tissues especially in brain and blood. The eQTLs analysis revealed a significant association of the rs6647 G allele with increased expression ofSERPINA1gene only in whole blood. Compared with the controls, there was an increased expression ofSERPINA1gene in whole blood in both IS patients and LAS patients.SERPINA1gene expression in whole blood bridges the rs6647 variant G allele with increased LAS risk, providing new insights into the mechanisms underlying role of the rs6647 in determining LAS risk.	[Liu, Qingrong; Hao, Junwei] Shanxi Med Univ, Minist Educ, Key Lab Cellular Physiol, 56 Xinjiannan Rd, Taiyuan, Shanxi, Peoples R China; [Liu, Qingrong; Hao, Junwei] Shanxi Med Univ, Dept Physiol, 56 Xinjiannan Rd, Taiyuan, Shanxi, Peoples R China; [Cui, Pan; Zheng, Kai; Wang, Junjie; Jiang, Wei; Hao, Junwei] Tianjin Med Univ Gen Hosp, Dept Neurol, Tianjin, Peoples R China; [Liu, Guiyou; Hao, Junwei; Liu, Haijie] Capital Med Univ, Dept Neurol, Xuanwu Hosp, 45 Changchun St, Beijing, Peoples R China	Shanxi Medical University; Shanxi Medical University; Tianjin Medical University; Capital Medical University	Hao, JW (corresponding author), Shanxi Med Univ, Minist Educ, Key Lab Cellular Physiol, 56 Xinjiannan Rd, Taiyuan, Shanxi, Peoples R China.; Hao, JW (corresponding author), Shanxi Med Univ, Dept Physiol, 56 Xinjiannan Rd, Taiyuan, Shanxi, Peoples R China.; Liu, HJ (corresponding author), Capital Med Univ, Dept Neurol, Xuanwu Hosp, 45 Changchun St, Beijing, Peoples R China.	haojunwei@vip.163.com; haijieliu@163.com			National Natural Science Foundation of China (NSFC) [81825008, 81571600, 81701189, 81801197]; Natural Science Foundation of Tianjin City (Tianjin Natural Science Foundation) [17JCZDJC35500, 19JCQNJC10500]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Tianjin City (Tianjin Natural Science Foundation)	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81825008, 81571600, 81701189 and 81801197; Natural Science Foundation of Tianjin City (Tianjin Natural Science Foundation), Grant/Award Number: 17JCZDJC35500 and 19JCQNJC10500	Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Barr TL, 2010, NEUROLOGY, V75, P1009, DOI 10.1212/WNL.0b013e3181f2b37f; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Chauhan G, 2016, LANCET NEUROL, V15, P695, DOI [10.1016/S1474-4422(16)00102-2, 10.1016/s1474-4422(16)00102-2]; Hu Y, 2017, NEUROL SCI, V38, P1255, DOI 10.1007/s10072-017-2959-9; Inouye M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002907; Liu G, 2018, J ALZHEIMERS DIS, V61, P1077, DOI 10.3233/JAD-170468; Liu GY, 2017, MOL NEUROBIOL, V54, P6820, DOI 10.1007/s12035-016-0208-5; Liu GY, 2017, J ALZHEIMERS DIS, V58, P1121, DOI 10.3233/JAD-170005; Liu GY, 2017, P NATL ACAD SCI USA, V114, pE906, DOI [10.1073/pnas.1618520114, 10.1073/pnas.1712127114]; Liu GY, 2016, P NATL ACAD SCI USA, V113, pE6321, DOI 10.1073/pnas.1614369113; Liu GY, 2015, P NATL ACAD SCI USA, V112, pE3975, DOI 10.1073/pnas.1509048112; Lloyd-Jones LR, 2017, AM J HUM GENET, V100, P228, DOI 10.1016/j.ajhg.2016.12.008; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Malik R, 2017, P NATL ACAD SCI USA, V114, P3613, DOI 10.1073/pnas.1616301114; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Mozaffarian D, 2016, CIRCULATION, V133, P187, DOI 10.1161/CIRCULATIONAHA.115.018585; NINDS S, 2016, LANCET NEUROL, V0015; Ong CT, 2011, NAT REV GENET, V12, P283, DOI 10.1038/nrg2957; Ramasamy A, 2014, NAT NEUROSCI, V17, P1418, DOI 10.1038/nn.3801; Shlyueva D, 2014, NAT REV GENET, V15, P272, DOI 10.1038/nrg3682; Stamova B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102550; Traylor M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004469; Traylor M, 2012, LANCET NEUROL, V11, P951, DOI 10.1016/S1474-4422(12)70234-X; Ward LD, 2016, NUCLEIC ACIDS RES, V44, pD877, DOI 10.1093/nar/gkv1340; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Zhang Y, 2018, J NEUROL SCI, V390, P162, DOI 10.1016/j.jns.2018.04.037; Zou FG, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002707	28	4	4	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10107	10116		10.1096/fj.201903197R	http://dx.doi.org/10.1096/fj.201903197R		JUN 2020	10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32725952	Bronze			2022-12-28	WOS:000541772000001
J	Lin, EW; Brady, GF; Kwan, R; Nesvizhskii, AI; Omary, MB				Lin, Eric W.; Brady, Graham F.; Kwan, Raymond; Nesvizhskii, Alexey, I; Omary, M. Bishr			Genotype-phenotype analysis of LMNA-related diseases predicts phenotype-selective alterations in lamin phosphorylation	FASEB JOURNAL			English	Article						intermediate filaments; laminopathy; mutation; post-translational modifications	DILATED CARDIOMYOPATHY; NUCLEAR LAMINA; MUTATION; DATABASE; INHIBITION; IDENTIFICATION; LAMINOPATHIES; LOCALIZATION; ACTIVATION; PROTEINS	Laminopathies are rare diseases associated with mutations in LMNA, which encodes nuclear lamin A/C. LMNA variants lead to diverse tissue-specific phenotypes including cardiomyopathy, lipodystrophy, myopathy, neuropathy, progeria, bone/skin disorders, and overlap syndromes. The mechanisms underlying these heterogeneous phenotypes remain poorly understood, although post-translational modifications, including phosphorylation, are postulated as regulators of lamin function. We catalogued all known lamin A/C human mutations and their associated phenotypes, and systematically examined the putative role of phosphorylation in laminopathies. In silico prediction of specific LMNA mutant-driven changes to lamin A phosphorylation and protein structure was performed using machine learning methods. Some of the predictions we generated were validated via assessment of ectopically expressed wild-type and mutant LMNA. Our findings indicate phenotype- and mutant-specific alterations in lamin phosphorylation, and that some changes in phosphorylation may occur independently of predicted changes in lamin protein structure. Therefore, therapeutic targeting of phosphorylation in the context of laminopathies will likely require mutant- and kinase-specific approaches.	[Lin, Eric W.; Brady, Graham F.; Kwan, Raymond; Omary, M. Bishr] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Lin, Eric W.; Brady, Graham F.; Omary, M. Bishr] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Kwan, Raymond; Omary, M. Bishr] Rutgers State Univ, Ctr Adv Biotechnol & Med, 679 Hoes Lane West,Room 206, Piscataway, NJ 08854 USA; [Nesvizhskii, Alexey, I] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Nesvizhskii, Alexey, I] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Rutgers State University New Brunswick; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Omary, MB (corresponding author), Rutgers State Univ, Ctr Adv Biotechnol & Med, 679 Hoes Lane West,Room 206, Piscataway, NJ 08854 USA.	bishr.omary@rutgers.edu			National Institutes of Health (NIH) [R01 DK47918, R01 GM094231, P30 DK034933]; American Liver Foundation	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Liver Foundation	National Institutes of Health (NIH), Grant/Award Number: R01 DK47918, R01 GM094231 and P30 DK034933; American Liver Foundation	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ahn J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11684-x; Ao Y, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav5078; Bateman A, 2019, NUCLEIC ACIDS RES, V47, pD506, DOI 10.1093/nar/gky1049; Bera M, 2016, SCI REP-UK, V6, DOI 10.1038/srep27879; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bertrand AT, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9040844; Boudreau E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045918; Brady GF, 2018, GASTROENTEROLOGY, V154, P1602, DOI 10.1053/j.gastro.2018.03.026; Brady GF, 2018, HEPATOLOGY, V67, P1710, DOI 10.1002/hep.29522; Buljan M, 2018, MOL SYST BIOL, V14, DOI 10.15252/msb.20177974; Butin-Israeli V, 2012, TRENDS GENET, V28, P464, DOI 10.1016/j.tig.2012.06.001; Capell BC, 2006, NAT REV GENET, V7, P940, DOI 10.1038/nrg1906; Cenni V, 2005, J MED GENET, V42, P214, DOI 10.1136/jmg.2004.026112; Chamcheu JC, 2016, EXP DERMATOL, V25, P183, DOI 10.1111/exd.12893; Chatzifrangkeskou M, 2018, HUM MOL GENET, V27, P3060, DOI 10.1093/hmg/ddy215; Chen L, 2018, J BIOMED RES, V32, P314, DOI 10.7555/JBR.32.20180003; Choi JC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003875; Delvecchio CJ, 2008, J ENDOCRINOL, V197, P121, DOI 10.1677/JOE-07-0525; Dhe-Paganon S, 2002, J BIOL CHEM, V277, P17381, DOI 10.1074/jbc.C200038200; Dinkel H, 2011, NUCLEIC ACIDS RES, V39, pD261, DOI 10.1093/nar/gkq1104; DUBOSE AJ, 2018, P NATL ACAD SCI USA, V115; Elzeneini E, 2017, J CELL BIOL, V216, P2607, DOI 10.1083/jcb.201707090; Fryxell KJ, 2005, MOL BIOL EVOL, V22, P650, DOI 10.1093/molbev/msi043; Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313; HEALD R, 1990, CELL, V61, P579, DOI 10.1016/0092-8674(90)90470-Y; Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823; Herrmann H, 2002, J STRUCT BIOL, V137, P82, DOI 10.1006/jsbi.2002.4466; Herrmann H, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a018242; Hicks S, 2011, HUM MUTAT, V32, P661, DOI 10.1002/humu.21490; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Hu JF, 2014, BIOINFORMATICS, V30, P141, DOI 10.1093/bioinformatics/btt627; Hubner S, 2006, J CELL BIOCHEM, V98, P810, DOI 10.1002/jcb.20791; Ishiyama A, 2018, HUM GENOME VAR, V5, DOI 10.1038/s41439-018-0018-6; Kelley JB, 2011, MOL CELL BIOL, V31, P3378, DOI 10.1128/MCB.05087-11; Kochin V, 2014, J CELL SCI, V127, P2683, DOI 10.1242/jcs.141820; Kwan R, 2017, CELL MOL GASTROENTER, V4, P365, DOI 10.1016/j.jcmgh.2017.06.005; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Martelli AM, 2002, J CELL BIOCHEM, V86, P320, DOI 10.1002/jcb.10227; Mitsuhashi H, 2010, J CELL SCI, V123, P3893, DOI 10.1242/jcs.072157; Muchir A, 2007, J CLIN INVEST, V117, P1282, DOI 10.1172/JCI29042; Muchir A, 2014, BIOCHEM BIOPH RES CO, V452, P958, DOI 10.1016/j.bbrc.2014.09.020; Muchir A, 2012, HUM MOL GENET, V21, P4325, DOI 10.1093/hmg/dds265; Muchir A, 2012, CARDIOVASC RES, V93, P311, DOI 10.1093/cvr/cvr301; Muchir A, 2009, HUM MOL GENET, V18, P241, DOI 10.1093/hmg/ddn343; Naetar N, 2017, J CELL SCI, V130, P2087, DOI 10.1242/jcs.203430; Omary MB, 2006, TRENDS BIOCHEM SCI, V31, P383, DOI 10.1016/j.tibs.2006.05.008; PEJAVER V, MUTPRED2 INFERRING M; Peri S, 2003, GENOME RES, V13, P2363, DOI 10.1101/gr.1680803; PETER M, 1990, CELL, V61, P591, DOI 10.1016/0092-8674(90)90471-P; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Raharjo WH, 2001, J CELL SCI, V114, P4447; Rodrigues CHM, 2018, NUCLEIC ACIDS RES, V46, pW350, DOI 10.1093/nar/gky300; Scharner J, 2010, BIOCHEM SOC T, V38, P257, DOI 10.1042/BST0380257; Sim NL, 2012, NUCLEIC ACIDS RES, V40, pW452, DOI 10.1093/nar/gks539; Simon DN, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7050044; Simon DN, 2013, CHROMOSOMA, V122, P13, DOI 10.1007/s00412-013-0399-8; Simon DN, 2013, MOL BIOL CELL, V24, P342, DOI 10.1091/mbc.E12-07-0527; Snider NT, 2014, NAT REV MOL CELL BIO, V15, P163, DOI 10.1038/nrm3753; Sporrer M, 2019, EBIOMEDICINE, V44, P502, DOI 10.1016/j.ebiom.2019.04.062; Stenson PD, 2017, HUM GENET, V136, P665, DOI 10.1007/s00439-017-1779-6; Strnad P, 2011, J CELL SCI, V124, P4221, DOI 10.1242/jcs.089516; Sylvius N, 2008, EXP CELL RES, V314, P2362, DOI 10.1016/j.yexcr.2008.04.017; Szeverenyi I, 2008, HUM MUTAT, V29, P351, DOI 10.1002/humu.20652; Thompson LJ, 1997, J BIOL CHEM, V272, P29693, DOI 10.1074/jbc.272.47.29693; Torvaldson E, 2015, NUCLEUS-PHILA, V6, P166, DOI 10.1080/19491034.2015.1017167; Wadhwa R., 2018, J OPEN SOURCE SOFTW, V3, P1008, DOI DOI 10.21105/JOSS.01008; Wagih O, 2015, NAT METHODS, V12, P531, DOI 10.1038/nmeth.3396; Wang DL, 2017, BIOINFORMATICS, V33, P3909, DOI 10.1093/bioinformatics/btx496; Wu W, 2014, HUM MOL GENET, V23, P1, DOI 10.1093/hmg/ddt387; Wu W, 2011, CIRCULATION, V123, P53, DOI 10.1161/CIRCULATIONAHA.110.970673; Wu W, 2010, BBA-MOL BASIS DIS, V1802, P632, DOI 10.1016/j.bbadis.2010.04.001; Young SG, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005229	73	5	5	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9051	9073		10.1096/fj.202000500R	http://dx.doi.org/10.1096/fj.202000500R		MAY 2020	23	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32413188	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000533180700001
J	Chen, CD; Rudy, MA; Zeldich, E; Abraham, CR				Chen, Ci-Di; Rudy, Melissa A.; Zeldich, Ella; Abraham, Carmela R.			A method to specifically activate the Klotho promoter by using zinc finger proteins constructed from modular building blocks and from naturally engineered Egr1 transcription factor backbone	FASEB JOURNAL			English	Article						aging; Alzheimer's disease; cancer; kidney disease; neurodegeneration; transcription factor	GENE-EXPRESSION; COGNITION; KIDNEY; MODEL; MICE; RNA; METHYLATION; REPRESSION; MORTALITY; COMPLEX	There is an unmet need for treatments for diseases associated with aging. The antiaging, life-extending, and cognition-enhancing protein Klotho is neuroprotective due to its anti-inflammatory, antioxidative, and pro-myelinating effects. In addition, Klotho is also a tumor suppressor and has beneficial roles in multiple organs. Klotho is downregulated as part of the aging process. Thus, upregulating Klotho in the brain may lead to novel therapeutics to people suffering or at risk for neurodegenerative diseases such as Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis, and demyelinating diseases such as multiple sclerosis. We attempted to upregulate Klotho for its beneficial effects in the brain and elsewhere. Here, we describe a method to specifically activate Klotho gene expression. To accomplish this task, we designed zinc finger proteins (ZFPs) targeting within -300 bps of the human Klotho promoter. We designed the ZPF constructs either de novo from modular building blocks, or modified sequences from the natural endogenous Egr1 transcription factor backbone structure. Egr1 is known to upregulate Klotho expression. We tested the transcriptional activation effects of these ZFPs in a dual luciferase coincidence reporter system under the control of 4-kb promoter of human Klotho in stable HEK293 cells and in HK-2 cells that express Klotho protein endogenously. We found that the best ZFPs are the de novo designed ones targeting -250 bps of Klotho promoter and one of the Egr1-binding sites. We further enhanced Klotho's activation using p65-Rta transcriptional activation domains in addition to VP64. These upregulation approaches could be useful for studying Klotho's protective effects and designing Klotho boosting therapeutics for future in vivo experiments.	[Chen, Ci-Di; Rudy, Melissa A.; Zeldich, Ella; Abraham, Carmela R.] Klogene Therapeut Inc, Boston, MA 02118 USA		Chen, CD (corresponding author), Klogene Therapeut Inc, Boston, MA 02118 USA.	cidichen@bu.edu		Rudy, Melissa/0000-0003-0165-5669	small business innovation research (SBIR) [1R44 AG053084]; NIH-NIA	small business innovation research (SBIR)(United States Department of Agriculture (USDA)); NIH-NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a small business innovation research (SBIR) grant 1R44 AG053084 from NIH-NIA to Klogene Therapeutics, Inc.	Abraham CR, 2016, VITAM HORM, V101, P215, DOI 10.1016/bs.vh.2016.02.004; Anamizu Y, 2005, ACTA NEUROPATHOL, V109, P457, DOI 10.1007/s00401-004-0971-7; Beerli RR, 2000, J BIOL CHEM, V275, P32617, DOI 10.1074/jbc.M005108200; Beerli RR, 2002, NAT BIOTECHNOL, V20, P135, DOI 10.1038/nbt0202-135; Blancafort P, 2004, MOL PHARMACOL, V66, P1361, DOI 10.1124/mol.104.002758; Bloch L, 2009, FEBS LETT, V583, P3221, DOI 10.1016/j.febslet.2009.09.009; Brobey RK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139914; Chen CD, 2007, P NATL ACAD SCI USA, V104, P19796, DOI 10.1073/pnas.0709805104; Chen CD, 2018, J MOL NEUROSCI, V64, P175, DOI 10.1007/s12031-017-1011-0; Cheng MF, 2015, ACTA NEUROBIOL EXP, V75, P60; Choi BH, 2010, GENE, V450, P121, DOI 10.1016/j.gene.2009.11.004; Chtarto A, 2007, EXP NEUROL, V204, P387, DOI 10.1016/j.expneurol.2006.11.014; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Das AT, 2016, CURR GENE THER, V16, P156, DOI 10.2174/1566523216666160524144041; Dubal DB, 2015, J NEUROSCI, V35, P2358, DOI 10.1523/JNEUROSCI.5791-12.2015; Dubal DB, 2014, CELL REP, V7, P1065, DOI 10.1016/j.celrep.2014.03.076; Duce JA, 2008, GLIA, V56, P106, DOI 10.1002/glia.20593; Durai S, 2005, NUCLEIC ACIDS RES, V33, P5978, DOI 10.1093/nar/gki912; ElrodErickson M, 1996, STRUCTURE, V4, P1171, DOI 10.1016/S0969-2126(96)00125-6; GASHLER AL, 1993, MOL CELL BIOL, V13, P4556, DOI 10.1128/MCB.13.8.4556; Haussler MR, 2016, VITAM HORM, V100, P165, DOI 10.1016/bs.vh.2015.11.005; Haussler MR, 2012, REV ENDOCR METAB DIS, V13, P57, DOI 10.1007/s11154-011-9199-8; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Jamieson AC, 2003, NAT REV DRUG DISCOV, V2, P361, DOI 10.1038/nrd1087; King GD, 2012, AGE, V34, P1405, DOI 10.1007/s11357-011-9315-4; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Kuro-O M, 2012, CURR OPIN NEPHROL HY, V21, P362, DOI 10.1097/MNH.0b013e32835422ad; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Mandell JG, 2006, NUCLEIC ACIDS RES, V34, pW516, DOI 10.1093/nar/gkl209; Marcais C, 2017, J CLIN ENDOCR METAB, V102, P3154, DOI 10.1210/jc.2017-00104; Masso A, 2018, MOL PSYCHIATR, V23, DOI 10.1038/mp.2017.211; Masso A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143623; Masuda H, 2005, MECH AGEING DEV, V126, P1274, DOI 10.1016/j.mad.2005.07.007; Matsumura Y, 1998, BIOCHEM BIOPH RES CO, V242, P626, DOI 10.1006/bbrc.1997.8019; Nagai T, 2002, FASEB J, V16, P50, DOI 10.1096/fj.02-0448fje; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; Perveez M, 2015, MOL BIOL RES COMMUN, V4, P217; Pollock R, 2002, NAT BIOTECHNOL, V20, P729, DOI 10.1038/nbt0702-729; Polstein LR, 2014, METHODS MOL BIOL, V1148, P89, DOI 10.1007/978-1-4939-0470-9_7; Qu YP, 2013, CLIN CHIM ACTA, V424, P53, DOI 10.1016/j.cca.2013.05.002; Rubinek T, 2012, BREAST CANCER RES TR, V133, P649, DOI 10.1007/s10549-011-1824-4; RUSSO MW, 1993, MOL CELL BIOL, V13, P6858, DOI 10.1128/MCB.13.11.6858; Seibert E, 2017, CLIN NEPHROL, V87, P173, DOI 10.5414/CN108970; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Wehling-Henricks M, 2016, HUM MOL GENET, V25, P2465, DOI 10.1093/hmg/ddw111; Yamagishi T, 2001, HYPERTENS RES, V24, P705, DOI 10.1291/hypres.24.705; Yamazaki Y, 2010, BIOCHEM BIOPH RES CO, V398, P513, DOI 10.1016/j.bbrc.2010.06.110; Zeldich E, 2019, J MOL NEUROSCI, V69, P264, DOI 10.1007/s12031-019-01356-2; Zeldich E, 2015, J MOL NEUROSCI, V57, P185, DOI 10.1007/s12031-015-0598-2; Zeldich E, 2014, J BIOL CHEM, V289, P24700, DOI 10.1074/jbc.M114.567321; Zhang Q, 2017, KIDNEY INT, V91, P144, DOI 10.1016/j.kint.2016.07.040	52	2	2	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					7234	7246		10.1096/fj.202000171R	http://dx.doi.org/10.1096/fj.202000171R		APR 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32347987	Bronze, Green Accepted			2022-12-28	WOS:000529968700001
J	Rivas, J; Diaz, N; Silva, I; Morales, D; Lavanderos, B; Alvarez, A; Saldias, MP; Pulgar, E; Cruz, P; Maureira, D; Flores, G; Colombo, A; Blanco, C; Contreras, HR; Jana, F; Gallegos, I; Concha, ML; Vergara-Jaque, A; Poblete, H; Gonzalez, W; Varela, D; Trimmer, JS; Caceres, M; Cerda, O				Rivas, Jose; Diaz, Nicolas; Silva, Ian; Morales, Danna; Lavanderos, Boris; Alvarez, Alhejandra; Paz Saldias, Maria; Pulgar, Eduardo; Cruz, Pablo; Maureira, Diego; Flores, Guillermo; Colombo, Alicia; Blanco, Constanza; Contreras, Hector R.; Jana, Fabian; Gallegos, Ivan; Concha, Miguel L.; Vergara-Jaque, Ariela; Poblete, Horacio; Gonzalez, Wendy; Varela, Diego; Trimmer, James S.; Caceres, Monica; Cerda, Oscar			KCTD5, a novel TRPM4-regulatory protein required for cell migration as a new predictor for breast cancer prognosis	FASEB JOURNAL			English	Article						cell migration; KCTD proteins; TRP channels	CATION CHANNEL TRPM4; PROSTATE-CANCER; MICROARRAY ANALYSIS; SURFACE EXPRESSION; IDENTIFICATION; FAMILY; DOMAIN; BIOMARKERS; DOCKING; SIGNAL	Transient receptor potential melastatin 4 (TRPM4) is a Ca2+-activated nonselective cationic channel that regulates cell migration and contractility. Increased TRPM4 expression has been related to pathologies, in which cytoskeletal rearrangement and cell migration are altered, such as metastatic cancer. Here, we identify the K+ channel tetramerization domain 5 (KCTD5) protein, a putative adaptor of cullin3 E3 ubiquitin ligase, as a novel TRPM4-interacting protein. We demonstrate that KCTD5 is a positive regulator of TRPM4 activity by enhancing its Ca2+ sensitivity. We show that through its effects on TRPM4 that KCTD5 promotes cell migration and contractility. Finally, we observed that both TRPM4 and KCTD5 expression are increased in distinct patterns in different classes of breast cancer tumor samples. Together, these data support that TRPM4 activity can be regulated through expression levels of either TRPM4 or KCTD5, not only contributing to increased understanding of the molecular mechanisms involved on the regulation of these important ion channels, but also providing information that could inform treatments based on targeting these distinct molecules that define TRPM4 activity.	[Rivas, Jose; Diaz, Nicolas; Silva, Ian; Lavanderos, Boris; Alvarez, Alhejandra; Paz Saldias, Maria; Cruz, Pablo; Maureira, Diego; Flores, Guillermo; Blanco, Constanza; Caceres, Monica; Cerda, Oscar] Univ Chile, Fac Med, Inst Biomed Sci ICBM, Program Cellular & Mol Biol, Santiago, Chile; [Rivas, Jose; Diaz, Nicolas; Silva, Ian; Morales, Danna; Lavanderos, Boris; Alvarez, Alhejandra; Paz Saldias, Maria; Cruz, Pablo; Maureira, Diego; Blanco, Constanza; Vergara-Jaque, Ariela; Poblete, Horacio; Gonzalez, Wendy; Varela, Diego; Caceres, Monica; Cerda, Oscar] Millennium Nucleus Ion Channel Associated Dis MiN, Santiago, Chile; [Rivas, Jose; Jana, Fabian] Univ Aysen, Dept Ciencias Salud, Coyhaique, Chile; [Morales, Danna; Varela, Diego] Univ Chile, Fac Med, Inst Biomed Sci ICBM, Program Physiol & Biophys, Santiago, Chile; [Pulgar, Eduardo; Concha, Miguel L.] Univ Chile, Fac Med, Inst Biomed Sci ICBM, Program Anat & Dev Biol, Santiago, Chile; [Colombo, Alicia; Contreras, Hector R.; Gallegos, Ivan] Univ Chile, Fac Med, Dept Oncol Bas Clin, Santiago, Chile; [Colombo, Alicia; Gallegos, Ivan] Univ Chile, Hosp Clin Univ Chile, Dept Anat Patol, Santiago, Chile; [Jana, Fabian; Caceres, Monica; Cerda, Oscar] Wound Repair Treatment & Hlth WoRTH Initiat, Santiago, Chile; [Concha, Miguel L.] Biomed Neurosci Inst, Santiago, Chile; [Concha, Miguel L.] Ctr Gerosci Brain Hlth & Metab, Santiago, Chile; [Concha, Miguel L.] Millennium Nucleus Phys Act Matter, Santiago, Chile; [Vergara-Jaque, Ariela; Poblete, Horacio] Univ Talca, Multidisciplinary Sci Nucleus, Talca, Chile; [Vergara-Jaque, Ariela; Poblete, Horacio; Gonzalez, Wendy] Univ Talca, Fac Engn, Ctr Bioinformat & Mol Simulat CBSM, Talca, Chile; [Trimmer, James S.] Univ Calif Davis, Dept Physiol & Membrane Biol, Sch Med, Davis, CA 95616 USA	Universidad de Chile; Universidad de Chile; Universidad de Chile; Universidad de Chile; Universidad de Chile; Universidad de Talca; Universidad de Talca; University of California System; University of California Davis	Cerda, O (corresponding author), Univ Chile, Fac Med, Inst Biomed Sci ICBM, Program Cellular & Mol Biol, Santiago, Chile.	oscarcerda@uchile.cl	Contreras, Hector/CAE-9087-2022; Poblete, Horacio N/E-4974-2012; Colombo, Alicia/AAD-5178-2021; Jaña, Fabián/D-9364-2017; Poblete, Horacio/J-9781-2012; Concha, Miguel/I-2551-2013	Poblete, Horacio N/0000-0003-2650-3565; Jaña, Fabián/0000-0001-7786-4569; Contreras, Hector/0000-0003-4012-2662; Cerda, Oscar/0000-0003-2873-5722; Cruz, Pablo/0000-0002-1389-2162; Concha, Miguel/0000-0003-3353-9398; Pulgar, Eduardo/0000-0001-9569-062X	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) [1160518, 11170291, 11170223, 1171155, 1190806, 1160900, 1181263]; Iniciativa Cientifica Milenio	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Iniciativa Cientifica Milenio	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT), Grant/Award Number: 1160518, 11170291, 11170223, 1171155, 1190806, 1160900 and 1181263; Iniciativa Cientifica Milenio	Albarran L, 2016, SCI REP-UK, V6, DOI 10.1038/srep24452; Alvarez A, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00450; Ashida S, 2004, CANCER RES, V64, P5963, DOI 10.1158/0008-5472.CAN-04-0020; Barbet G, 2008, NAT IMMUNOL, V9, P1148, DOI 10.1038/ni.1648; Bayon Y, 2008, FEBS J, V275, P3900, DOI 10.1111/j.1742-4658.2008.06537.x; Berg KD, 2016, VIRCHOWS ARCH, V468, P345, DOI 10.1007/s00428-015-1880-y; Blanco C, 2019, FASEB J, V33, P9434, DOI 10.1096/fj.201900136R; Brockmann M, 2017, NATURE, V546, P307, DOI 10.1038/nature22376; Caceres M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130540; Cerda O, 2015, PFLUG ARCH EUR J PHY, V467, P1723, DOI 10.1007/s00424-014-1610-3; Cheng H, 2007, CELL CALCIUM, V41, P51, DOI 10.1016/j.ceca.2006.04.032; Colombo A, 2013, DEVELOPMENT, V140, P3997, DOI 10.1242/dev.091934; Corey DR, 2001, GENOME BIOL, V2; Dementieva IS, 2009, J MOL BIOL, V387, P175, DOI 10.1016/j.jmb.2009.01.030; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Duffy MJ, 2017, EUR J CANCER, V75, P284, DOI 10.1016/j.ejca.2017.01.017; Earley S, 2004, CIRC RES, V95, P922, DOI 10.1161/01.RES.0000147311.54833.03; Essner JJ, 2005, DEVELOPMENT, V132, P1247, DOI 10.1242/dev.01663; Fotia AB, 2004, J BIOL CHEM, V279, P28930, DOI 10.1074/jbc.M402820200; Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473; Fritzius T, 2017, J NEUROSCI, V37, P1162, DOI 10.1523/JNEUROSCI.2181-16.2016; Garcia-Sanz N, 2007, J NEUROSCI, V27, P11641, DOI 10.1523/JNEUROSCI.2457-07.2007; Gerzanich V, 2009, NAT MED, V15, P185, DOI 10.1038/nm.1899; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Guinamard R, 2010, PHYSIOLOGY, V25, P155, DOI 10.1152/physiol.00004.2010; Guo JT, 2017, NATURE, V552, P205, DOI 10.1038/nature24997; Hasegawa T, 2013, HUM PATHOL, V44, P1271, DOI 10.1016/j.humpath.2012.10.013; Haydaroglu A, 2013, PRINCIPLES PRACTICE; He HB, 2018, FEBS LETT, V592, P2334, DOI 10.1002/1873-3468.13104; Hopf TA, 2014, ELIFE, V3, DOI 10.7554/eLife.03430; Kim SY, 2017, RADIOLOGY, V284, P354, DOI 10.1148/radiol.2017162348; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Kodama Y, 2010, BIOTECHNIQUES, V49, P793, DOI 10.2144/000113519; Kruse M, 2014, CURR OPIN PHARMACOL, V15, P68, DOI 10.1016/j.coph.2013.12.003; Kruse M, 2009, J CLIN INVEST, V119, P2737, DOI 10.1172/JCI38292; Launay P, 2002, CELL, V109, P397, DOI 10.1016/S0092-8674(02)00719-5; Lehmann BD, 2014, J PATHOL, V232, P142, DOI 10.1002/path.4280; Li LP, 2016, SCI REP-UK, V6, DOI 10.1038/srep20460; Liu H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054131; Liu H, 2010, CIRC-CARDIOVASC GENE, V3, P374, DOI 10.1161/CIRCGENETICS.109.930867; Liu PB, 2006, CANCER RES, V66, P4011, DOI 10.1158/0008-5472.CAN-05-3055; Liu ZP, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-45; Mizoguchi T, 2008, DEVELOPMENT, V135, P2521, DOI 10.1242/dev.020107; Mizuno H, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-18; Narayan G, 2007, GENE CHROMOSOME CANC, V46, P373, DOI 10.1002/gcc.20418; Nilius B, 2006, EMBO J, V25, P467, DOI 10.1038/sj.emboj.7600963; Nilius B, 2005, J BIOL CHEM, V280, P6423, DOI 10.1074/jbc.M411089200; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pfeiffenberger C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003003; Rajalu M, 2015, NEUROPHARMACOLOGY, V88, P145, DOI 10.1016/j.neuropharm.2014.08.020; Rakha EA, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2607; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Ross-Adams H, 2015, EBIOMEDICINE, V2, P1133, DOI 10.1016/j.ebiom.2015.07.017; Roulot A, 2016, ANN BIOL CLIN-PARIS, V74, P653, DOI 10.1684/abc.2016.1192; Rutz N, 2015, BIOCHEM BIOPH RES CO, V464, P922, DOI 10.1016/j.bbrc.2015.07.069; Sagredo AI, 2019, J CELL PHYSIOL, V234, P2037, DOI 10.1002/jcp.27371; Sagredo AI, 2018, MOL ONCOL, V12, P151, DOI 10.1002/1878-0261.12100; Sakaguchi T, 2006, DEVELOPMENT, V133, P4063, DOI 10.1242/dev.02581; Schattling B, 2012, NAT MED, V18, P1805, DOI 10.1038/nm.3015; Schinke EN, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-120; Schwake M, 2001, J BIOL CHEM, V276, P12049, DOI 10.1074/jbc.M010642200; Schwenk J, 2010, NATURE, V465, P231, DOI 10.1038/nature08964; Shimizu T, 2009, CELL CALCIUM, V45, P226, DOI 10.1016/j.ceca.2008.10.005; Shyu YJ, 2006, BIOTECHNIQUES, V40, P61, DOI 10.2144/000112036; Singh J, 2006, CANCER LETT, V237, P298, DOI 10.1016/j.canlet.2005.06.008; Sozucan Y., 2015, Experimental Oncology, V37, P208; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Stavropoulos N, 2011, NEURON, V72, P964, DOI 10.1016/j.neuron.2011.12.003; Suguro M, 2006, CANCER SCI, V97, P868, DOI 10.1111/j.1349-7006.2006.00267.x; Syam N, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00052; Turashvili G, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00227; van Bemmelen MX, 2004, CIRC RES, V95, P284, DOI 10.1161/01.RES.0000136816.05109.89; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Wang HJ, 2019, J INVEST DERMATOL, V139, P1089, DOI 10.1016/j.jid.2018.10.044; Weber KS, 2010, J IMMUNOL, V185, P2836, DOI 10.4049/jimmunol.1000880; Wegierski T, 2006, EMBO J, V25, P5659, DOI 10.1038/sj.emboj.7601429; Woo SK, 2013, J BIOL CHEM, V288, P36409, DOI 10.1074/jbc.M113.530584; Woo S, 2012, J CELL BIOL, V198, P941, DOI 10.1083/jcb.201203012; Young JA, 2011, J BIOL CHEM, V286, P6521, DOI 10.1074/jbc.M110.172288; Zurek N, 2011, TRAFFIC, V12, P28, DOI 10.1111/j.1600-0854.2010.01134.x	81	20	20	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					7847	7865		10.1096/fj.201901195RRR	http://dx.doi.org/10.1096/fj.201901195RRR		APR 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32301552				2022-12-28	WOS:000526644900001
J	Cheng, FY; Su, SY; Zhu, XF; Jia, X; Tian, HM; Zhai, XG; Guan, W; Zhou, YJ				Cheng, Fangyun; Su, Shengyan; Zhu, Xiaofei; Jia, Xin; Tian, Haimeng; Zhai, Xuguang; Guan, Wei; Zhou, Yajun			Leptin promotes methionine adenosyltransferase 2A expression in hepatic stellate cells by the downregulation of E2F-4 via the beta-catenin pathway	FASEB JOURNAL			English	Article						hyperleptinemia; liver fibrosis; methylation; obesity; signaling transduction	BINDING PROTEIN-1C EXPRESSION; GAMMA GENE-EXPRESSION; LIVER FIBROSIS; IN-VIVO; INHIBITION; ACTIVATION; CONTRIBUTES; INDUCTION; PHENOTYPE; MEDIATE	Most obese patients develop hyperleptinaemia. Leptin, mainly produced by adipocytes, demonstrates a promotional role in liver fibrosis. Hepatic stellate cell (HSC) activation, a key step in liver fibrogenesis, requires global reprogramming of gene expression. The remodeling of DNA methylation is a mechanism of the epigenetic regulation of gene expression. The biosynthesis of S-adenosylmethionine, a principle biological methyl donor, is catalyzed by methionine adenosyltransferase (MAT) such as MATII which has been shown to promote HSC activation in vitro. This study was mainly aimed to determine the effect of leptin on MAT2A expression (the catalytic subunit of MATII) in HSCs. Results showed that MAT2A knockdown reduced leptin-induced HSC activation and liver fibrosis in the leptin-deficient mouse model. Leptin promoted MAT2A expression in HSCs and increased MAT2A promoter activity. The axis of the beta-catenin pathway/E2F-4 mediated the effect of leptin on MAT2A expression. Leptin-induced beta-catenin signaling reduced E2F-4 expression and thus abated E2F-4 binding to MAT2A promoter at a site around -2779 bp, leading to an increase in the MAT2A promoter activity. These data might shed more light on the mechanisms responsible for liver fibrogenesis in obese patients with hyperleptinaemia.	[Cheng, Fangyun; Su, Shengyan; Jia, Xin; Tian, Haimeng; Zhai, Xuguang; Zhou, Yajun] Nantong Univ, Coll Med, Dept Biochem & Mol Biol, Qi Xiou Rd 19, Nantong 226001, Jiangsu, Peoples R China; [Zhu, Xiaofei; Guan, Wei] Nantong Univ, Sch Pharm, Dept Pharmacol, Nantong, Peoples R China	Nantong University; Nantong University	Zhou, YJ (corresponding author), Nantong Univ, Coll Med, Dept Biochem & Mol Biol, Qi Xiou Rd 19, Nantong 226001, Jiangsu, Peoples R China.	zhouyajun6464@hotmail.com			National Natural Science Foundation of China (NSFC) [81570553]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81570553	Akhmetshina A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1734; Aleffi S, 2005, HEPATOLOGY, V42, P1339, DOI 10.1002/hep.20965; Cai SP, 2016, MOL IMMUNOL, V80, P58, DOI 10.1016/j.molimm.2016.11.002; Cao Q, 2007, J HEPATOL, V46, P124, DOI 10.1016/j.jhep.2006.07.027; Choi SS, 2010, J BIOL CHEM, V285, P36551, DOI 10.1074/jbc.M110.168542; Elinav E, 2009, HEPATOLOGY, V49, P278, DOI 10.1002/hep.22584; Galli A, 2002, GASTROENTEROLOGY, V122, P1924, DOI 10.1053/gast.2002.33666; Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246; Honda H, 2002, HEPATOLOGY, V36, P12, DOI 10.1053/jhep.2002.33684; Hsu J, 2016, CELL CYCLE, V15, P3183, DOI 10.1080/15384101.2016.1234551; Jia XW, 2011, CELL BIOL INT, V35, P697, DOI 10.1042/CBI20100298; Lee BK, 2011, NUCLEIC ACIDS RES, V39, P3558, DOI 10.1093/nar/gkq1313; Liuzzi A, 1999, INT J OBESITY, V23, P1066, DOI 10.1038/sj.ijo.0801036; Mato JM, 2007, HEPATOLOGY, V45, P1306, DOI 10.1002/hep.21650; McCullough AJ, 1999, HEPATOLOGY, V29, P1328, DOI 10.1002/hep.510290451; Page A, 2016, J HEPATOL, V64, P661, DOI 10.1016/j.jhep.2015.11.024; Petrov N, 2012, STEM CELLS DEV, V21, P589, DOI 10.1089/scd.2011.0048; Qiao HW, 2016, BBA-MOL BASIS DIS, V1862, P2186, DOI 10.1016/j.bbadis.2016.09.001; Ramani K, 2008, HEPATOLOGY, V47, P521, DOI 10.1002/hep.22064; Ramani K, 2010, HEPATOLOGY, V51, P986, DOI 10.1002/hep.23411; Ratziu V, 2000, GASTROENTEROLOGY, V118, P1117, DOI 10.1016/S0016-5085(00)70364-7; Rezvani M, 2016, CELL STEM CELL, V18, P809, DOI 10.1016/j.stem.2016.05.005; Stefanovic A, 2008, DIABETES RES CLIN PR, V79, P156, DOI 10.1016/j.diabres.2007.07.019; Tomasi ML, 2013, EXP CELL RES, V319, P1902, DOI 10.1016/j.yexcr.2013.04.005; Tsukamoto H, 2005, ALCOHOL CLIN EXP RES, V29, p132S, DOI 10.1097/01.alc.0000189279.92602.f0; Yan KF, 2012, MOL MED, V18, P10, DOI 10.2119/molmed.2011.00243; Yochum GS, 2007, J BIOL CHEM, V282, P871, DOI 10.1074/jbc.M609391200; Zhai XG, 2013, BRIT J PHARMACOL, V169, P197, DOI 10.1111/bph.12114; Zhang W, 2013, INT J BIOCHEM CELL B, V45, P736, DOI 10.1016/j.biocel.2012.12.019; Zhang X, 2019, INT C COMP SUPP COOP, P10, DOI 10.1109/CSCWD.2019.8791924; Zhou Q, 2014, BBA-MOL BASIS DIS, V1842, P2367, DOI 10.1016/j.bbadis.2014.10.001; Zhou YJ, 2010, MOL CELL ENDOCRINOL, V323, P193, DOI 10.1016/j.mce.2010.03.005; Zhou YJ, 2009, MOL CELL BIOCHEM, V325, P131, DOI 10.1007/s11010-009-0027-3	33	9	12	2	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5578	5589		10.1096/fj.201903021RR	http://dx.doi.org/10.1096/fj.201903021RR		FEB 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32108965				2022-12-28	WOS:000517910100001
J	Zhao, ZH; Ma, JY; Meng, TG; Wang, ZB; Yue, W; Zhou, Q; Li, S; Feng, X; Hou, Y; Schatten, H; Ou, XH; Sun, QY				Zhao, Zheng-Hui; Ma, Jun-Yu; Meng, Tie-Gang; Wang, Zhen-Bo; Yue, Wei; Zhou, Qian; Li, Sen; Feng, Xie; Hou, Yi; Schatten, Heide; Ou, Xiang-Hong; Sun, Qing-Yuan			Single-cell RNA sequencing reveals the landscape of early female germ cell development	FASEB JOURNAL			English	Article						developmental trajectory; meiosis initiation; oocyte; scRNA-seq	PRIMORDIAL FOLLICLE; FATE SPECIFICATION; DNA METHYLATION; MOUSE; DIFFERENTIATION; TROPHECTODERM; SUBUNIT; GENES; TAF4B; CDX2	Meiosis initiation is a crucial step for the production of haploid gametes, which occurs from anterior to posterior in fetal ovaries. The asynchrony of the transition from mitosis to meiosis results in heterogeneity in the female germ cell populations, which limits the studies of meiosis initiation and progression at a higher resolution level. To dissect the process of meiosis initiation, we investigated the transcriptional profiles of 19 363 single germ cells collected from E12.5, E14.5, and E16.5 mouse fetal ovaries. Clustering analysis identified seven groups and defined dozens of corresponding transcription factors, providing a global view of cellular differentiation from primordial germ cells toward meiocytes. Furthermore, we explored the dynamics of gene expression within the developmental trajectory with special focus on the critical state of meiosis. We found that meiosis initiation occurs as early as E12.5 and the cluster of oogonia_4 is the critical state between mitosis and meiosis. Our data provide key insights into the transcriptome features of peri-meiotic female germ cells, which offers new information not only on meiosis initiation and progression but also on screening pathogenic mutations in meiosis-associated diseases.	[Zhao, Zheng-Hui; Meng, Tie-Gang; Wang, Zhen-Bo; Yue, Wei; Zhou, Qian; Hou, Yi; Sun, Qing-Yuan] Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing, Peoples R China; [Zhao, Zheng-Hui; Wang, Zhen-Bo; Yue, Wei; Zhou, Qian] Univ Chinese Acad Sci, Coll Life Sci, Beijing, Peoples R China; [Ma, Jun-Yu; Meng, Tie-Gang; Li, Sen; Feng, Xie; Ou, Xiang-Hong; Sun, Qing-Yuan] Guangdong Second Prov Gen Hosp, Fertil Preservat Lab, Reprod Med Ctr, Guangzhou, Peoples R China; [Schatten, Heide] Univ Missouri, Dept Vet Pathobiol, Columbia, MO USA	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Missouri System; University of Missouri Columbia	Ou, XH; Sun, QY (corresponding author), Guangdong Second Prov Gen Hosp, Fertil Preservat Lab, Reprod Med Ctr, Guangzhou, Peoples R China.	ouxianghong2003@163.com; sunqy@ioz.ac.cn	Zhao, Zhenghui/AAY-6120-2020		National R&D program of China [2018YFA0107701]; National Natural Science Foundation of China (NSFC) [31801245]; Key Research & Development Program of Guangzhou Regenerative Medicine and Health Guangdong Laboratory [2019GZR110104001]	National R&D program of China; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Key Research & Development Program of Guangzhou Regenerative Medicine and Health Guangdong Laboratory	National R&D program of China, Grant/Award Number: 2018YFA0107701; National Natural Science Foundation of China (NSFC), Grant/Award Number: 31801245; Key Research & Development Program of Guangzhou Regenerative Medicine and Health Guangdong Laboratory, Grant/Award Number: 2019GZR110104001	Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; BORUM K, 1961, EXP CELL RES, V24, P495, DOI 10.1016/0014-4827(61)90449-9; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Coto E, 2018, HUM IMMUNOL, V79, P494, DOI 10.1016/j.humimm.2018.03.008; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Falender AE, 2005, DEV BIOL, V288, P405, DOI 10.1016/j.ydbio.2005.09.038; Falender AE, 2005, GENE DEV, V19, P794, DOI 10.1101/gad.1290105; Guo HS, 2017, CELL RES, V27, P165, DOI 10.1038/cr.2016.128; Handel MA, 2010, NAT REV GENET, V11, P124, DOI 10.1038/nrg2723; Jiang H, 2011, CELL, V144, P513, DOI 10.1016/j.cell.2011.01.020; Jin KX, 2016, DEV NEUROBIOL, V76, P900, DOI 10.1002/dneu.22365; Kerr JB, 2012, MOL CELL, V48, P343, DOI 10.1016/j.molcel.2012.08.017; Korostowski L, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002956; Le Bouffant R, 2011, DEVELOPMENT, V138, P5393, DOI 10.1242/dev.068452; Lesch BJ, 2013, P NATL ACAD SCI USA, V110, P16061, DOI 10.1073/pnas.1315204110; McInnes L., 2018, J OPEN SOURCE SOFTW, V3, P861, DOI [10.21105/joss.00861, DOI 10.21105/JOSS.00861]; Nagaoka SI, 2020, SCIENCE, V367, P1089, DOI 10.1126/science.aaw4115; Ng HH, 2011, NAT CELL BIOL, V13, P490, DOI 10.1038/ncb0511-490; Ng JH, 2013, DEV CELL, V24, P324, DOI 10.1016/j.devcel.2012.12.011; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Onodera K, 2016, BLOOD, V128, P508, DOI 10.1182/blood-2016-02-698118; Pepling ME, 2006, GENESIS, V44, P622, DOI 10.1002/dvg.20258; Qiu XJ, 2017, NAT METHODS, V14, P979, DOI [10.1038/NMETH.4402, 10.1038/nmeth.4402]; Relaix F, 1998, NAT GENET, V18, P287, DOI 10.1038/ng0398-287; Sachs M, 2013, CELL REP, V3, P1777, DOI 10.1016/j.celrep.2013.04.032; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Savory JGA, 2014, DEV BIOL, V395, P199, DOI 10.1016/j.ydbio.2014.09.013; Savory JGA, 2009, DEVELOPMENT, V136, P4099, DOI 10.1242/dev.041582; Smallwood SA, 2012, TRENDS GENET, V28, P33, DOI 10.1016/j.tig.2011.09.004; Soh YQS, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005531; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Thornton BR, 2003, NAT CELL BIOL, V5, P1090, DOI 10.1038/ncb1066; Wang J-J, 2019, TRANSCRIPTOME LANDSC; Wang L, 2014, CELL, V157, P979, DOI 10.1016/j.cell.2014.04.017; Wen L, 2019, MOL CELL, V76, P320, DOI 10.1016/j.molcel.2019.08.025; Xu YL, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0991-1; Xue Y, 1998, EMBO J, V17, P1996, DOI 10.1093/emboj/17.7.1996; Yokobayashi S, 2013, NATURE, V495, P236, DOI 10.1038/nature11918; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zhao L, 2017, DEV BIOL, V423, P46, DOI 10.1016/j.ydbio.2017.01.013	41	23	23	5	32	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12634	12645		10.1096/fj.202001034RR	http://dx.doi.org/10.1096/fj.202001034RR		JUL 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32716582	Green Submitted			2022-12-28	WOS:000556418400001
J	Cheng, WJ; Gu, MJ; Ye, F; Zhang, YD; Zhong, QP; Dong, HF; Liu, R; Jiang, H				Cheng, Wen-Jun; Gu, Meng-Jie; Ye, Feng; Zhang, Yao-Dan; Zhong, Qin-Ping; Dong, Hui-Fen; Liu, Rong; Jiang, Hong			Prohibitin 1 (PHB1) controls growth and development and regulates proliferation and apoptosis inSchistosoma japonicum	FASEB JOURNAL			English	Article						dsRNA; growth and reproductive maturation; in vivo; RNA interference; vitellaria	BLOOD FLUKE DEVELOPMENT; SCHISTOSOMA-JAPONICUM; CANCER-CELLS; MANSONI; REPRODUCTION; SURVIVAL; GENES; MICE; RNA; PCR	Schistosomiasis is a zoonotic parasitic disease caused by the trematode blood flukes of the genusSchistosoma. The prodigious egg output of females is the main cause of the disease in definitive hosts, while the female worm relies on continuous pairing with the male worm to fuel the growth and maturation of the reproductive organs and egg production. Prohibitin, which contains the functionally interdependent PHB1 and PHB2 subunits in human and some other species, has been proposed to participate in the cell proliferation and apoptosis regulation in mammals. However, little is known about the function of PHB homolog in the growth and reproductive development of schistosomes. Here, we reported the Phb1 gene that was structurally and evolutionarily conserved inSchistosoma japonicumwhen compared with that of other species fromCaenorhabditis elegansto human. Real-time PCR detected thatSjPhb1was highly transcribed in the vitellaria of female worms.SjPhb1knockdown achieved through the dsRNA-mediated RNAi in vivo resulted in retarded growth, decreased pairing, and fecundity in adult worms, as well as attenuated pathogenicity or virulence of worms to their hosts. Cell proliferation and apoptosis examination found decreased cell proliferation and increased cell apoptosis inSjPhb1dsRNA-treated worms. Therefore, our study provides the first characterization ofS. japonicumPHB1 and reveals its fundamental role in the regulation of growth and development ofS. japonicumby specific dsRNA-mediated RNAi in vivo. Our findings prompt for a promising molecular of schistosomes that can be targeted to effectively retard the growth and development of the schistosomes.	[Cheng, Wen-Jun; Gu, Meng-Jie; Ye, Feng; Zhang, Yao-Dan; Zhong, Qin-Ping; Dong, Hui-Fen; Liu, Rong; Jiang, Hong] Wuhan Univ, Sch Basic Med Sci, Wuhan 430071, Peoples R China	Wuhan University	Liu, R; Jiang, H (corresponding author), Wuhan Univ, Sch Basic Med Sci, Wuhan 430071, Peoples R China.	liurong19840901@whu.edu.cn; jiangh@whu.edu.cn	Liu, Rong/ABE-3102-2020	Liu, Rong/0000-0003-2561-348X	Special Project for Schistosomiasis Control of Health and Family Planning Commission of Hubei Province [WJ2017X002]; Natural Science Foundation of Hubei Province [2017CFB239]; Fundamental Research Funds for the Central Universities"of China [2042017kf0033]	Special Project for Schistosomiasis Control of Health and Family Planning Commission of Hubei Province; Natural Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province); Fundamental Research Funds for the Central Universities"of China(Fundamental Research Funds for the Central Universities)	Special Project for Schistosomiasis Control of Health and Family Planning Commission of Hubei Province, Grant/Award Number: WJ2017X002; Natural Science Foundation of Hubei Province, Grant/Award Number: 2017CFB239; Fundamental Research Funds for the Central Universities"of China, Grant/Award Number: 2042017kf0033	AMIRI P, 1992, NATURE, V356, P604, DOI 10.1038/356604a0; Artal-Sanz M, 2009, TRENDS ENDOCRIN MET, V20, P394, DOI 10.1016/j.tem.2009.04.004; Artal-Sanz M, 2009, NATURE, V461, P793, DOI 10.1038/nature08466; Assare RK, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1290; Blank RB, 2006, J INFECT DIS, V194, P1609, DOI 10.1086/508896; Chen JC, 2005, PLANT J, V44, P16, DOI 10.1111/j.1365-313X.2005.02505.x; Cheng YL, 2008, PARASITOL RES, V102, P1129, DOI 10.1007/s00436-008-0880-0; Chowdhury I, 2016, J MOL ENDOCRINOL, V56, P325, DOI 10.1530/JME-15-0278; Chowdhury Indrajit, 2012, Front Biosci (Elite Ed), V4, P690; Collins JJ, 2013, NATURE, V494, P476, DOI 10.1038/nature11924; Costain AH, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.03042; Davies SJ, 2004, INT J PARASITOL, V34, P27, DOI 10.1016/j.ijpara.2003.10.010; Davies SJ, 2001, SCIENCE, V294, P1358, DOI 10.1126/science.1064462; Ding H, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2453-5; Djehal A, 2018, EUR J MED CHEM, V155, P880, DOI 10.1016/j.ejmech.2018.06.052; ERASMUS DA, 1980, EXP PARASITOL, V50, P171, DOI 10.1016/0014-4894(80)90018-1; ERASMUS DA, 1975, EXP PARASITOL, V38, P240, DOI 10.1016/0014-4894(75)90027-2; Galanti SE, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001509; Gamble SC, 2007, ONCOGENE, V26, P1757, DOI 10.1038/sj.onc.1209967; Hahnel S, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00170; Han HX, 2013, PARASITOL INT, V62, P100, DOI 10.1016/j.parint.2012.09.008; He B, 2011, ENDOCRINOLOGY, V152, P1047, DOI 10.1210/en.2010-0732; HE YX, 1980, ACTA ZOOL SINICA, V26, P32; He YX, 2001, TRENDS PARASITOL, V17, P320, DOI 10.1016/S1471-4922(01)01904-3; Hotez PJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002865; Jupe ER, 1996, CELL GROWTH DIFFER, V7, P871; Knobloch J, 2007, EXP PARASITOL, V117, P318, DOI 10.1016/j.exppara.2007.04.006; Kurtev V, 2004, J BIOL CHEM, V279, P24834, DOI 10.1074/jbc.M312300200; Lamb EW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000892; Lewis F., 2001, CURRENT PROTOCOLS IM; Lewis FA, 2014, ADV EXP MED BIOL, V766, P47, DOI 10.1007/978-1-4939-0915-5_3; Li J, 2018, BIOCHEM BIOPH RES CO, V503, P1004, DOI 10.1016/j.bbrc.2018.06.109; Liang Y, 2012, MOL MED REP, V5, P1087, DOI 10.3892/mmr.2012.752; Liu JT, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006654; Liu R, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00274; Liu R, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00440; Liu R, 2013, EXP PARASITOL, V135, P64, DOI 10.1016/j.exppara.2013.05.016; Liu S, 2012, MOL BIOCHEM PARASIT, V182, P75, DOI 10.1016/j.molbiopara.2011.12.007; Liu YF, 2012, MOL MED REP, V6, P1288, DOI 10.3892/mmr.2012.1105; Liu Y, 2012, EURASIP J ADV SIG PR, DOI 10.1186/1687-6180-2012-210; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MCCLUNG JK, 1989, BIOCHEM BIOPH RES CO, V164, P1316, DOI 10.1016/0006-291X(89)91813-5; McManus DP, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0013-8; Merkwirth C, 2008, GENE DEV, V22, P476, DOI 10.1101/gad.460708; Mishra S, 2006, J CELL MOL MED, V10, P353, DOI 10.1111/j.1582-4934.2006.tb00404.x; Mishra S, 2010, FEBS J, V277, P3937, DOI 10.1111/j.1742-4658.2010.07809.x; MOLONEY NA, 1982, PARASITE IMMUNOL, V4, P431, DOI 10.1111/j.1365-3024.1982.tb00454.x; Nation CS, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0007951; Nijtmans LGJ, 2002, CELL MOL LIFE SCI, V59, P143, DOI 10.1007/s00018-002-8411-0; Nijtmans LGJ, 2000, EMBO J, V19, P2444, DOI 10.1093/emboj/19.11.2444; Nistor A, 2006, BMC CLIN PATHOL, V6, DOI 10.1186/1472-6890-6-2; Panvichian R, 2015, BIOMED RES INT, V2015, DOI DOI 10.1155/2015/381602; Pearce EJ, 2002, NAT REV IMMUNOL, V2, P499, DOI 10.1038/nri843; Peng YT, 2015, APOPTOSIS, V20, P1135, DOI 10.1007/s10495-015-1143-z; RUPPEL A, 1990, PARASITOLOGY, V101, P23, DOI 10.1017/S0031182000079701; Sanz MA, 2003, J BIOL CHEM, V278, P32091, DOI 10.1074/jbc.M304877200; Saule P, 2002, J PARASITOL, V88, P849, DOI 10.1645/0022-3395(2002)088[0849:EVOHTA]2.0.CO;2; Skelly PJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004246; Sun J, 2014, PARASITOL RES, V113, P881, DOI 10.1007/s00436-013-3719-2; Tang HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054432; Tang JJ, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/753483; Tebeje BM, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1799-4; Thuaud F, 2013, CHEM BIOL, V20, P316, DOI 10.1016/j.chembiol.2013.02.006; Van Aken O, 2007, PLANT J, V52, P850, DOI 10.1111/j.1365-313X.2007.03276.x; Wang JP, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000254; Wang JP, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14693; Wilson RA, 2009, PARASITOLOGY, V136, P1581, DOI 10.1017/S0031182009005708; Wolowczuk I, 1999, INFECT IMMUN, V67, P4183, DOI 10.1128/IAI.67.8.4183-4190.1999; Xu YJ, 2016, J MOL CELL BIOL, V8, P282, DOI 10.1093/jmcb/mjw018; Yang B, 2019, J CANCER, V10, P1616, DOI 10.7150/jca.28218; Yang F, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1549-6; You H, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003730; Zhang L, 2012, ASIAN PAC J CANCER P, V13, P3803, DOI 10.7314/APJCP.2012.13.8.3803; Zhang Y, 2014, CELL MOL BIOL, V60, P26; Zhong N, 2015, TUMOR BIOL, V36, P1221, DOI 10.1007/s13277-014-2742-y	75	3	3	1	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					11030	11046		10.1096/fj.201902787RRR	http://dx.doi.org/10.1096/fj.201902787RRR		JUL 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32627884				2022-12-28	WOS:000547607200001
J	Calhoun, PJ; Phan, AV; Taylor, JD; James, CC; Padget, RL; Zeitz, MJ; Smyth, JW				Calhoun, Patrick J.; Phan, Allen, V; Taylor, Jordan D.; James, Carissa C.; Padget, Rachel L.; Zeitz, Michael J.; Smyth, James W.			Adenovirus targets transcriptional and posttranslational mechanisms to limit gap junction function	FASEB JOURNAL			English	Article						adenovirus; connexin; gap junction; myocarditis; beta-catenin	BETA-CATENIN; INTERCELLULAR COMMUNICATION; ZONULA OCCLUDENS-1; CONNEXIN43 PHOSPHORYLATION; PROTEIN CONNEXIN-43; VIRAL MYOCARDITIS; IN-VITRO; EXPRESSION; CELLS; P53	Adenoviruses are responsible for a spectrum of pathogenesis including viral myocarditis. The gap junction protein connexin43 (Cx43, gene nameGJA1) facilitates rapid propagation of action potentials necessary for each heartbeat. Gap junctions also propagate innate and adaptive antiviral immune responses, but how viruses may target these structures is not understood. Given this immunological role of Cx43, we hypothesized that gap junctions would be targeted during adenovirus type 5 (Ad5) infection. We find reduced Cx43 protein levels due to decreasedGJA1mRNA transcripts dependent upon beta-catenin transcriptional activity during Ad5 infection, with early viral protein E4orf1 sufficient to induce beta-catenin phosphorylation. Loss of gap junction function occurs prior to reduced Cx43 protein levels with Ad5 infection rapidly inducing Cx43 phosphorylation events consistent with altered gap junction conductance. Direct Cx43 interaction with ZO-1 plays a critical role in gap junction regulation. We find loss of Cx43/ZO-1 complexing during Ad5 infection by co-immunoprecipitation and complementary studies in human induced pluripotent stem cell derived-cardiomyocytes reveal Cx43 gap junction remodeling by reduced ZO-1 complexing. These findings reveal specific targeting of gap junction function by Ad5 leading to loss of intercellular communication which would contribute to dangerous pathological states including arrhythmias in infected hearts.	[Calhoun, Patrick J.; James, Carissa C.; Padget, Rachel L.; Zeitz, Michael J.; Smyth, James W.] VTC, Fralin Biomed Res Inst, 2 Riverside Circle, Roanoke, VA 24016 USA; [Calhoun, Patrick J.; Smyth, James W.] Virginia Tech, Dept Biol Sci, Blacksburg, VA USA; [Phan, Allen, V; Taylor, Jordan D.; Smyth, James W.] Virginia Tech, Carillon Sch Med, Roanoke, VA USA; [James, Carissa C.; Padget, Rachel L.] Virginia Tech, Grad Program Translat Biol Med & Hlth, Blacksburg, VA USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Smyth, JW (corresponding author), VTC, Fralin Biomed Res Inst, 2 Riverside Circle, Roanoke, VA 24016 USA.	smythj@vtc.vt.edu		Smyth, James/0000-0003-4246-7904	American Heart Association [18PRE33960573] Funding Source: Medline; NHLBI NIH HHS [R01 HL132236, F31 HL140909, F31 HL152649] Funding Source: Medline	American Heart Association(American Heart Association); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ablasser A, 2013, NATURE, V503, P530, DOI 10.1038/nature12640; Agullo-Pascual E, 2014, CARDIOVASC RES, V104, P371, DOI 10.1093/cvr/cvu195; Ai ZW, 2000, J CLIN INVEST, V105, P161, DOI 10.1172/JCI7798; Alonso F, 2010, CARDIOVASC RES, V87, P166, DOI 10.1093/cvr/cvq031; ARANY Z, 1994, CELL, V77, P799, DOI 10.1016/0092-8674(94)90127-9; Babica P, 2016, METHODS MOL BIOL, V1437, P133, DOI 10.1007/978-1-4939-3664-9_9; Barker RJ, 2002, CIRC RES, V90, P317, DOI 10.1161/hh0302.104471; Basu R, 2016, J VIROL, V90, P2586, DOI 10.1128/JVI.02420-15; Bauer A, 2000, EMBO J, V19, P6121, DOI 10.1093/emboj/19.22.6121; Beardslee MA, 1998, CIRC RES, V83, P629, DOI 10.1161/01.RES.83.6.629; BLAIR GE, 1989, VIRUS RES, V14, P339, DOI 10.1016/0168-1702(89)90026-9; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; BONDESSON M, 1992, EMBO J, V11, P3347, DOI 10.1002/j.1460-2075.1992.tb05413.x; Bowles NE, 2003, J AM COLL CARDIOL, V42, P466, DOI 10.1016/S0735-1097(03)00648-X; BRACIALE TJ, 1987, IMMUNOL REV, V98, P95, DOI 10.1111/j.1600-065X.1987.tb00521.x; Bridges RG, 2016, MBIO, V7, DOI 10.1128/mBio.02184-15; Bruce AF, 2008, CARDIOVASC RES, V77, P757, DOI 10.1093/cvr/cvm083; Castellano P, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00122; Chandrasekaran A, 2019, J VIROL, V93, DOI 10.1128/JVI.00569-19; Chen Q, 2016, NATURE, V533, P493, DOI 10.1038/nature18268; Cooper LT, 2009, NEW ENGL J MED, V360, P1526, DOI 10.1056/NEJMra0800028; Dennert R, 2008, EUR HEART J, V29, P2073, DOI 10.1093/eurheartj/ehn296; Dobner T, 1996, SCIENCE, V272, P1470, DOI 10.1126/science.272.5267.1470; Dunn CA, 2014, J CELL SCI, V127, P455, DOI 10.1242/jcs.142497; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; FALLON RF, 1981, J CELL BIOL, V90, P521, DOI 10.1083/jcb.90.2.521; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Fang L, 2016, CANCER RES, V76, P891, DOI 10.1158/0008-5472.CAN-15-1519; Ferrari R, 2014, CELL HOST MICROBE, V16, P663, DOI 10.1016/j.chom.2014.10.004; Fischer NO, 2001, J VIROL METHODS, V91, P157, DOI 10.1016/S0166-0934(00)00260-3; Frese KK, 2003, ONCOGENE, V22, P710, DOI 10.1038/sj.onc.1206151; Fung G, 2016, CIRC RES, V118, P496, DOI 10.1161/CIRCRESAHA.115.306573; Gauntt CJ, 1995, EUR HEART J, V16, P56, DOI 10.1093/eurheartj/16.suppl_O.56; Giepmans BNG, 2001, J BIOL CHEM, V276, P8544, DOI 10.1074/jbc.M005847200; Goldsmith KT, 1998, VIROLOGY, V248, P406, DOI 10.1006/viro.1998.9293; Green Maurice, 2006, Curr Protoc Microbiol, VChapter 14, DOI 10.1002/9780471729259.mc14c01s00; Gutstein DE, 2001, CIRC RES, V88, P333, DOI 10.1161/01.RES.88.3.333; Hale TK, 1999, J BIOL CHEM, V274, P23777, DOI 10.1074/jbc.274.34.23777; Hermeking H, 1997, MOL CELL, V1, P3, DOI 10.1016/S1097-2765(00)80002-7; Herve JC, 2012, BBA-BIOMEMBRANES, V1818, P1844, DOI 10.1016/j.bbamem.2011.12.009; Hsiao HJ, 2010, ARCH VIROL, V155, P1107, DOI 10.1007/s00705-010-0693-1; Hunter AW, 2005, MOL BIOL CELL, V16, P5686, DOI 10.1091/mbc.E05-08-0737; James CC, 2018, MOL BIOL CELL, V29, P797, DOI 10.1091/mbc.E17-06-0406; Jogler C, 2006, J VIROL, V80, P3549, DOI 10.1128/JVI.80.7.3549-3558.2006; Johansen D, 2011, CELL PHYSIOL BIOCHEM, V28, P103, DOI 10.1159/000331719; Kanagaratnam P, 2002, J AM COLL CARDIOL, V39, P116, DOI 10.1016/S0735-1097(01)01710-7; Kearney MT, 2001, POSTGRAD MED J, V77, P4, DOI 10.1136/pmj.77.903.4; Koester-Patzlaff C, 2007, BRAIN RES, V1184, P316, DOI 10.1016/j.brainres.2007.09.062; Kostin S, 2007, J CELL MOL MED, V11, P892, DOI 10.1111/j.1582-4934.2007.00063.x; Laird DW, 2005, BBA-BIOMEMBRANES, V1711, P172, DOI 10.1016/j.bbamem.2004.09.009; LAIRD DW, 1995, J CELL BIOL, V131, P1193, DOI 10.1083/jcb.131.5.1193; Lampe PD, 2000, J CELL BIOL, V149, P1503, DOI 10.1083/jcb.149.7.1503; Li MWM, 2009, P NATL ACAD SCI USA, V106, P10213, DOI 10.1073/pnas.0901700106; Liao CK, 2013, TOXICOLOGY, V314, P11, DOI 10.1016/j.tox.2013.08.001; Lim BK, 2008, J CLIN INVEST, V118, P2758, DOI 10.1172/JCI34777; Lisewski U, 2008, J EXP MED, V205, P2369, DOI 10.1084/jem.20080897; Ma B, 2015, J CELL SCI, V128, P2430, DOI 10.1242/jcs.168542; MARTINO TA, 1994, CIRC RES, V74, P182, DOI 10.1161/01.RES.74.2.182; McCarthy MK, 2016, VIROLOGY, V498, P57, DOI 10.1016/j.virol.2016.08.009; McCarthy MK, 2015, J VIROL, V89, P468, DOI 10.1128/JVI.02077-14; Moreno AP, 2007, PROG BIOPHYS MOL BIO, V94, P107, DOI 10.1016/j.pbiomolbio.2007.03.004; Nagasawa K, 2006, J CELL PHYSIOL, V208, P123, DOI 10.1002/jcp.20647; Neijssen J, 2005, NATURE, V434, P83, DOI 10.1038/nature03290; Nimlamool W, 2015, MOL BIOL CELL, V26, P2755, DOI 10.1091/mbc.E14-06-1105; O'Shea CC, 2005, CELL CYCLE, V4, P883, DOI 10.4161/cc.4.7.1791; OELZE I, 1995, J VIROL, V69, P4489, DOI 10.1128/JVI.69.7.4489-4494.1995; Oyamada M, 2013, BBA-BIOMEMBRANES, V1828, P118, DOI 10.1016/j.bbamem.2011.12.031; Pankuweit S, 2013, HEART FAIL REV, V18, P683, DOI 10.1007/s10741-012-9357-4; Park DJ, 2007, CELL COMMUN ADHES, V14, P211, DOI 10.1080/15419060701755958; Patel SJ, 2009, P NATL ACAD SCI USA, V106, P12867, DOI 10.1073/pnas.0809292106; Poelzing S, 2004, AM J PHYSIOL-HEART C, V287, pH1762, DOI 10.1152/ajpheart.00346.2004; Querido E, 2001, GENE DEV, V15, P3104, DOI 10.1101/gad.926401; RAYCHAUDHURI P, 1987, EMBO J, V6, P4073, DOI 10.1002/j.1460-2075.1987.tb02753.x; Rhett JM, 2011, MOL BIOL CELL, V22, P1516, DOI 10.1091/mbc.E10-06-0548; Richards TS, 2004, J CELL BIOL, V167, P555, DOI 10.1083/jcb.200404142; SARNOW P, 1982, CELL, V28, P387, DOI 10.1016/0092-8674(82)90356-7; Sato PY, 2011, CIRC RES, V109, P193, DOI 10.1161/CIRCRESAHA.111.247023; Savon C, 2008, J CLIN VIROL, V43, P152, DOI 10.1016/j.jcv.2008.05.012; Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Segretain D, 2004, BIOCHIMIE, V86, P241, DOI 10.1016/j.biochi.2004.05.003; Sharma A, 2014, CIRC RES, V115, P556, DOI 10.1161/CIRCRESAHA.115.303810; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Singh D, 2005, J BIOL CHEM, V280, P30416, DOI 10.1074/jbc.M506799200; Sirnes S, 2009, BIOCHEM BIOPH RES CO, V382, P41, DOI 10.1016/j.bbrc.2009.02.141; Smyth JW, 2014, TRAFFIC, V15, P684, DOI 10.1111/tra.12169; Smyth JW, 2013, CELL REP, V5, P611, DOI 10.1016/j.celrep.2013.10.009; Solan JL, 2007, J CELL BIOL, V179, P1301, DOI 10.1083/jcb.200707060; Solan JL, 2007, J MEMBRANE BIOL, V217, P35, DOI 10.1007/s00232-007-9035-y; Solan JL, 2014, FEBS LETT, V588, P1423, DOI 10.1016/j.febslet.2014.01.049; Soria C, 2010, NATURE, V466, P1076, DOI 10.1038/nature09307; Spagnol G, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061562; Suomalainen M, 2001, EMBO J, V20, P1310, DOI 10.1093/emboj/20.6.1310; Tago K, 2000, GENE DEV, V14, P1741; Takemaru KI, 2003, NATURE, V422, P905, DOI 10.1038/nature01570; Taurin S, 2006, J BIOL CHEM, V281, P9971, DOI 10.1074/jbc.M508778200; Teodoro JG, 1997, J VIROL, V71, P3620, DOI 10.1128/JVI.71.5.3620-3627.1997; Teunissen BEJ, 2004, CARDIOVASC RES, V62, P246, DOI 10.1016/j.cardiores.2003.12.011; TOWNSEND ARM, 1986, CELL, V44, P959, DOI 10.1016/0092-8674(86)90019-X; Toyofuku T, 1998, J BIOL CHEM, V273, P12725, DOI 10.1074/jbc.273.21.12725; UNWIN PNT, 1980, NATURE, V283, P545, DOI 10.1038/283545a0; Valenta T, 2012, EMBO J, V31, P2714, DOI 10.1038/emboj.2012.150; van der Heyden MAG, 1998, J CELL SCI, V111, P1741; Vozzi C, 1999, J MOL CELL CARDIOL, V31, P991, DOI 10.1006/jmcc.1999.0937; Warn-Cramer BJ, 1998, J BIOL CHEM, V273, P9188, DOI 10.1074/jbc.273.15.9188; WarnCramer BJ, 1996, J BIOL CHEM, V271, P3779; Wei CJ, 2005, J BIOL CHEM, V280, P19925, DOI 10.1074/jbc.M412921200; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; YEW PR, 1994, GENE DEV, V8, P190, DOI 10.1101/gad.8.2.190; YEW PR, 1992, NATURE, V357, P82, DOI 10.1038/357082a0; Yousuf MA, 2016, BIOCHEMISTRY-US, V55, P5938, DOI 10.1021/acs.biochem.6b00858; Yue P, 2006, CELL PHYSIOL BIOCHEM, V17, P129, DOI 10.1159/000092074; Zeitz MJ, 2019, CELL REP, V27, P2737, DOI 10.1016/j.celrep.2019.04.114; Zemljic-Harpf AE, 2014, J CELL SCI, V127, P1104, DOI 10.1242/jcs.143743; Zhang F, 2005, CIRC RES, V96, P950, DOI 10.1161/01.RES.0000165867.95291.7b; Zhang SS, 2011, P NATL ACAD SCI USA, V108, P13576, DOI 10.1073/pnas.1106911108; Zhang YM, 2005, J VIROL, V79, P12125, DOI 10.1128/JVI.79.19.12125-12131.2005; Zhao LM, 2019, J MOL CELL CARDIOL, V135, P90, DOI 10.1016/j.yjmcc.2019.08.007; Zheng YT, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005415; ZINKERNA.RM, 1974, NATURE, V248, P701, DOI 10.1038/248701a0	120	3	3	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9694	9712		10.1096/fj.202000667R	http://dx.doi.org/10.1096/fj.202000667R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32485054	Green Accepted, Bronze			2022-12-28	WOS:000546308400061
J	Ni, DJ; Ai, ZY; Munoz-Sandoval, D; Suresh, R; Ellis, PR; Chen, YQ; Sharp, PA; Butterworth, PJ; Yu, Z; Corpe, CP				Ni, Dejiang; Ai, Zeyi; Munoz-Sandoval, Diana; Suresh, Reshma; Ellis, Peter R.; Chen Yuqiong; Sharp, Paul A.; Butterworth, Peter J.; Yu, Zhi; Corpe, Christopher P.			Inhibition of the facilitative sugar transporters (GLUTs) by tea extracts and catechins	FASEB JOURNAL			English	Article						catechins; facilitative glucose transporters (GLUTs); glucose uptake; sodium-dependent glucose transporter (SGLT1); tea extract	DECREASE GLUCOSE-UPTAKE; GREEN TEA; BRUSH-BORDER; BLACK TEA; DIABETES-MELLITUS; POLYPHENOLS; EXPRESSION; METABOLISM; ABSORPTION; INTESTINE	Tea polyphenolics have been suggested to possess blood glucose lowering properties by inhibiting sugar transporters in the small intestine and improving insulin sensitivity. In this report, we studied the effects of teas and tea catechins on the small intestinal sugar transporters, SGLT1 and GLUTs (GLUT1, 2 and 5). Green tea extract (GT), oolong tea extract (OT), and black tea extract (BT) inhibited glucose uptake into the intestinal Caco-2 cells with GT being the most potent inhibitor (IC50: 0.077 mg/mL), followed by OT (IC50: 0.136 mg/mL) and BT (IC50: 0.56 mg/mL). GT and OT inhibition of glucose uptake was partial non-competitive, with an inhibitor constant (K-i) = 0.0317 and 0.0571 mg/mL, respectively, whereas BT was pure non-competitive,K-i = 0.36 mg/mL. Oocytes injected to express small intestinal GLUTs were inhibited by teas, but SGLT1 was not. Furthermore, catechins present in teas were the predominant inhibitor of glucose uptake into Caco-2 cells, and gallated catechins the most potent: CG > ECG > EGCG >= GCG when compared to the non-gallated catechins (C, EC, GC, and EGC). In Caco-2 cells, individual tea catechins reduced the SGLT1 gene, but not protein expression levels. In contrast, GLUT2 gene and protein expression levels were reduced after 2 hours exposure to catechins but increased after 24 hours. These in vitro studies suggest teas containing catechins may be useful dietary supplements capable of blunting postprandial glycaemia in humans, including those with or at risk to Type 2 diabetes mellitus.	[Ni, Dejiang; Ai, Zeyi; Chen Yuqiong; Yu, Zhi] Huazhong Agr Univ, Key Lab Hort Plant Biol, Minist Educ, Wuhan, Peoples R China; [Ni, Dejiang; Ellis, Peter R.; Butterworth, Peter J.] Kings Coll London, Dept Biochem & Nutr, Fac Life Sci & Med, London, England; [Ai, Zeyi] Jiangsu Acad Agr Sci, Inst Leisure Agr, Nanjing, Peoples R China; [Munoz-Sandoval, Diana; Suresh, Reshma; Sharp, Paul A.; Corpe, Christopher P.] Kings Coll London, Fac Life Sci & Med, Dept Nutr Sci, Franklin Wilkins Bldg,150 Stamford St, London SE1 9NH, England	Huazhong Agricultural University; University of London; King's College London; Jiangsu Academy of Agricultural Sciences; University of London; King's College London	Corpe, CP (corresponding author), Kings Coll London, Fac Life Sci & Med, Dept Nutr Sci, Franklin Wilkins Bldg,150 Stamford St, London SE1 9NH, England.	Christopher.corpe@kcl.ac.uk		Sharp, Paul Anthony/0000-0003-3400-6702; Munoz Sandoval, Diana/0000-0001-8350-3989; corpe, christopher/0000-0003-1994-8312	National Natural Science Foundation of China [31270732]; Biotechnology and Biological Sciences Research Council, United Kingdom [BB/H004866/1]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Biotechnology and Biological Sciences Research Council, United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	National Natural Science Foundation of China, Grant/Award Number: 31270732; Biotechnology and Biological Sciences Research Council, United Kingdom, Grant/Award Number: BB/H004866/1	Ai ZY, 2017, J FOOD SCI TECH MYS, V54, P1212, DOI 10.1007/s13197-017-2558-z; Boyer S, 1996, FEBS LETT, V396, P218, DOI 10.1016/0014-5793(96)01102-7; Bryans JA, 2007, J AM COLL NUTR, V26, P471, DOI 10.1080/07315724.2007.10719638; BURANT CF, 1992, BIOCHEMISTRY-US, V31, P10414, DOI 10.1021/bi00157a032; BURANT CF, 1994, J CLIN INVEST, V93, P578, DOI 10.1172/JCI117010; Castro-Acosta ML, 2016, P NUTR SOC, V75, P342, DOI 10.1017/S0029665116000240; Chen HX, 2009, EUR FOOD RES TECHNOL, V229, P629, DOI 10.1007/s00217-009-1088-y; Corpe CP, 1996, PFLUG ARCH EUR J PHY, V432, P192, DOI 10.1007/s004240050124; Diamant Michaela, 2006, Curr Diab Rep, V6, P279, DOI 10.1007/s11892-006-0061-4; Drozdowski LA, 2006, WORLD J GASTROENTERO, V12, P1657, DOI 10.3748/wjg.v12.i11.1657; Feng WY, 2006, CURR DRUG METAB, V7, P755, DOI 10.2174/138920006778520552; Fu QY, 2017, MOLECULES, V22, DOI 10.3390/molecules22050849; GRAHAM HN, 1992, PREV MED, V21, P334, DOI 10.1016/0091-7435(92)90041-F; Grefner N. M., 2010, Cell and Tissue Biology, V4, P354, DOI 10.1134/S1990519X10040085; Harbowy ME, 1997, CRIT REV PLANT SCI, V16, P415, DOI 10.1080/713608154; Hashimoto T, 1999, BIOSCI BIOTECH BIOCH, V63, P2252, DOI 10.1271/bbb.63.2252; He Q, 2007, FOOD CHEM, V101, P1178, DOI 10.1016/j.foodchem.2006.03.020; Hirayama BA, 2001, BRIT J PHARMACOL, V134, P484, DOI 10.1038/sj.bjp.0704274; Hossain SJ, 2002, J AGR FOOD CHEM, V50, P5215, DOI 10.1021/jf020252e; Johnston K, 2005, FEBS LETT, V579, P1653, DOI 10.1016/j.febslet.2004.12.099; Joost HG, 2001, MOL MEMBR BIOL, V18, P247, DOI 10.1080/09687680110090456; Kao YH, 2006, MOL NUTR FOOD RES, V50, P188, DOI 10.1002/mnfr.200500109; Kellett GL, 2008, ANNU REV NUTR, V28, P35, DOI 10.1146/annurev.nutr.28.061807.155518; Kellett GL, 2005, DIABETES, V54, P3056, DOI 10.2337/diabetes.54.10.3056; Kobayashi Y, 2000, J AGR FOOD CHEM, V48, P5618, DOI 10.1021/jf0006832; Koh LW, 2010, J AGR FOOD CHEM, V58, P148, DOI 10.1021/jf903011g; Kwon O, 2007, FASEB J, V21, P366, DOI 10.1096/fj.06-6620com; Liu J, 2011, J AGR FOOD CHEM, V59, P4582, DOI 10.1021/jf200355q; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lochocka K, 2015, SCI REP-UK, V5, DOI 10.1038/srep12015; Lotfy M, 2017, CURR DIABETES REV, V13, P3, DOI 10.2174/1573399812666151016101622; Ros JL, 2015, PLANTA MED, V81, P975, DOI 10.1055/s-0035-1546131; Macintyre AN, 2014, CELL METAB, V20, P61, DOI 10.1016/j.cmet.2014.05.004; MAHRAOUI L, 1994, BIOCHEM J, V298, P629, DOI 10.1042/bj2980629; Manzano S, 2010, MOL NUTR FOOD RES, V54, P1773, DOI 10.1002/mnfr.201000019; Mi YS, 2017, FASEB J, V31, P4998, DOI 10.1096/fj.201700400RR; Moreira L, 2013, EXP CELL RES, V319, P1784, DOI 10.1016/j.yexcr.2013.05.001; Ochiai H, 2009, BIOCHEM PHARMACOL, V78, P1069, DOI 10.1016/j.bcp.2009.06.007; Qu FF, 2019, MOL NUTR FOOD RES, V63, DOI 10.1002/mnfr.201801039; ROBERTS EAH, 1949, BIOCHEM J, V45, P538, DOI 10.1042/bj0450538; Shi Z, 1997, TEA PROCESSING; Shimizu M, 2000, BIOFACTORS, V13, P61, DOI 10.1002/biof.5520130111; Snoussi C, 2014, J NUTR BIOCHEM, V25, P557, DOI 10.1016/j.jnutbio.2014.01.006; Solayman M, 2016, CURR PHARM DESIGN, V22, P549, DOI 10.2174/1381612822666151125001111; SOREQ H, 1992, METHOD ENZYMOL, V207, P225; Sterrett JJ, 2016, AM J MED SCI, V351, P342, DOI 10.1016/j.amjms.2016.01.019; Sun LJ, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201700324; Tang WP, 2013, J FUNCT FOODS, V5, P1784, DOI 10.1016/j.jff.2013.08.007; ter Horst KW, 2017, NUTRIENTS, V9, DOI 10.3390/nu9090981; Thounaojam MC, 2015, EVID-BASED COMPL ALT, V2015, P2; Wan XC., 2003, TEA BIOCH; Wang J, 2017, ONCOTARGET, V8, P16875, DOI 10.18632/oncotarget.15171; Waring W.S, 2016, MEDICINE, V44, P138, DOI [10.1016/J.MPMED.2015.12.011, DOI 10.1016/J.MPMED.2015.12.011]; WELSCH CA, 1989, J NUTR, V119, P1698, DOI 10.1093/jn/119.11.1698; Whiteley CG, 1999, BIOCHEM EDUC, V27, P15, DOI 10.1016/S0307-4412(98)00265-9; WITHYCOMBE WA, 1965, BIOCHEM J, V94, P384, DOI 10.1042/bj0940384; WRIGHT EM, 1993, ANNU REV PHYSIOL, V55, P575, DOI 10.1146/annurev.ph.55.030193.003043; Xing LJ, 2019, J AGR FOOD CHEM, V67, P1029, DOI 10.1021/acs.jafc.8b06146; Xu HB, 2020, INT J BIOL MACROMOL, V145, P527, DOI 10.1016/j.ijbiomac.2019.12.161; Zhou DR, 2009, FOOD CHEM, V113, P110, DOI 10.1016/j.foodchem.2008.07.033; Zimmet P, 2016, NAT REV ENDOCRINOL, V12, P616, DOI 10.1038/nrendo.2016.105; Zimmet PZ, 2014, LANCET DIABETES ENDO, V2, P56, DOI 10.1016/S2213-8587(13)70112-8	62	19	19	8	31	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					9995	10010		10.1096/fj.202000057RR	http://dx.doi.org/10.1096/fj.202000057RR		JUN 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32564472	Green Published, hybrid			2022-12-28	WOS:000541821100001
J	Ci, SS; Xia, W; Liang, WC; Qin, LH; Zhang, YL; Dianov, GL; Wang, MN; Zhao, XQ; Wu, CY; Alagamuthu, KK; Hu, ZG; He, LF; Pan, FY; Guo, ZG				Ci, Shusheng; Xia, Wen; Liang, Weichu; Qin, Lihong; Zhang, Yilan; Dianov, Grigory L.; Wang, Meina; Zhao, Xingqi; Wu, Congye; Alagamuthu, Karthick Kumar; Hu, Zhigang; He, Lingfeng; Pan, Feiyan; Guo, Zhigang			Src-mediated phosphorylation of GAPDH regulates its nuclear localization and cellular response to DNA damage	FASEB JOURNAL			English	Article						base excision repair; chemotherapy; DNA damage; GAPDH; Pol beta; Src	HUMAN GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; BASE EXCISION-REPAIR; BETA-GENE MUTATION; POLYMERASE-BETA; PROTEIN; CANCER; ACTIVATION; EXPRESSION; RESISTANCE; KINASE	Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is a key enzyme involved in energy metabolism. Recently, GAPDH has been suggested to have extraglycolytic functions in DNA repair, but the underlying mechanism for the GAPDH response to DNA damage remains unclear. Here, we demonstrate that the tyrosine kinase Src is activated under DNA damage stress and phosphorylates GAPDH at Tyr41. This phosphorylation of GAPDH is essential for its nuclear translocation and DNA repair function. Blocking the nuclear import of GAPDH by suppressing Src signaling or through a GAPDH Tyr41 mutation impairs its response to DNA damage. Nuclear GAPDH is recruited to DNA lesions and associates with DNA polymerase beta (Pol beta) to function in DNA repair. Nuclear GAPDH promotes Pol beta polymerase activity and increases base excision repair (BER) efficiency. Furthermore, GAPDH knockdown dramatically decreases BER efficiency and sensitizes cells to DNA damaging agents. Importantly, the knockdown of GAPDH in colon cancer SW480 cells and xenograft models effectively enhances their sensitivity to the chemotherapeutic drug 5-FU. In summary, our findings provide mechanistic insight into the new function of GAPDH in DNA repair and suggest a potential therapeutic target in chemotherapy.	[Ci, Shusheng; Xia, Wen; Liang, Weichu; Zhang, Yilan; Dianov, Grigory L.; Wang, Meina; Zhao, Xingqi; Alagamuthu, Karthick Kumar; Hu, Zhigang; He, Lingfeng; Pan, Feiyan; Guo, Zhigang] Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Mol & Med Biotechnol, 1 Wen Yuan Rd, Nanjing 210023, Peoples R China; [Qin, Lihong] 7 Peoples Hosp ChangZhou, Dept Oncol, Changzhou, Jiangsu, Peoples R China; [Dianov, Grigory L.] Novosibirsk State Univ, Dept Nat Sci, Novosibirsk, Russia; [Dianov, Grigory L.] Univ Oxford, Oxford Inst Radiat Oncol, Dept Oncol, Oxford, England; [Wu, Congye] Nanjing Med Univ, Nanjing First Hosp, Dept Oncol, Nanjing, Peoples R China	Nanjing Normal University; Novosibirsk State University; University of Oxford; Nanjing Medical University	Pan, FY; Guo, ZG (corresponding author), Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Mol & Med Biotechnol, 1 Wen Yuan Rd, Nanjing 210023, Peoples R China.	panfeiyan@njnu.edu.cn; guozgang@gmail.com		He, Lingfeng/0000-0002-9668-419X	National Natural Science Foundation of China [81872284]; Changzhou Sci Tech Program [CE20175035]; Jiangsu Key Research and Development Program [BE2018714]; Natural Science Foundation of the Jiangsu Higher Education Institutions of China [18KJA180006]; Priority Academic Program Development of Jiangsu Higher Education Institution; Russian Science Foundation [19-74-20069]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Changzhou Sci Tech Program; Jiangsu Key Research and Development Program; Natural Science Foundation of the Jiangsu Higher Education Institutions of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institution; Russian Science Foundation(Russian Science Foundation (RSF))	National Natural Science Foundation of China, Grant/Award Number: 81872284; Changzhou Sci & Tech Program, Grant/Award Number: CE20175035; Jiangsu Key Research and Development Program, Grant/Award Number: BE2018714; Natural Science Foundation of the Jiangsu Higher Education Institutions of China, Grant/Award Number: 18KJA180006; Priority Academic Program Development of Jiangsu Higher Education Institution; Russian Science Foundation, Grant/Award Number: 19-74-20069	Abdel-Fatah TMA, 2014, MOL ONCOL, V8, P520, DOI 10.1016/j.molonc.2014.01.001; Azam S, 2008, J BIOL CHEM, V283, P30632, DOI 10.1074/jbc.M801401200; Bennett RAO, 1997, P NATL ACAD SCI USA, V94, P7166, DOI 10.1073/pnas.94.14.7166; Bergoglio V, 2002, CANCER RES, V62, P3511; Bohr VA, 2002, J INHERIT METAB DIS, V25, P215, DOI 10.1023/A:1015681929316; Bradshaw JM, 2010, CELL SIGNAL, V22, P1175, DOI 10.1016/j.cellsig.2010.03.001; BRUNS GAP, 1976, SCIENCE, V192, P55, DOI 10.1126/science.176725; Chang CM, 2015, MOL CELL, V60, P930, DOI 10.1016/j.molcel.2015.10.037; Colell A, 2009, CELL DEATH DIFFER, V16, P1573, DOI 10.1038/cdd.2009.137; Dastoor Z, 2001, J CELL SCI, V114, P1643; DOBASHI Y, 1994, CANCER RES, V54, P2827; El-Andaloussi N, 2006, MOL CELL, V22, P51, DOI 10.1016/j.molcel.2006.02.013; Elsberger B, 2010, CURR CANCER DRUG TAR, V10, P683, DOI 10.2174/156800910793605802; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Hasan S, 2002, MOL CELL, V10, P1213, DOI 10.1016/S1097-2765(02)00745-1; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Hou XW, 2017, FASEB J, V31, P3179, DOI 10.1096/fj.201601082R; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Kedar PS, 2002, J BIOL CHEM, V277, P31115, DOI 10.1074/jbc.M201497200; Kosova AA, 2015, MUTAT RES-FUND MOL M, V779, P46, DOI 10.1016/j.mrfmmm.2015.06.005; KUMAR A, 1990, BIOCHEMISTRY-US, V29, P7156, DOI 10.1021/bi00483a002; Kuo LJ, 2008, IN VIVO, V22, P305; Lai YH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12465; Lord CJ, 2012, NATURE, V481, P287, DOI 10.1038/nature10760; MATSUMOTO Y, 1995, SCIENCE, V269, P699, DOI 10.1126/science.7624801; Matsuzaki J, 1996, MOL CARCINOGEN, V15, P38, DOI 10.1002/(SICI)1098-2744(199601)15:1<38::AID-MC6>3.0.CO;2-O; Miyamoto H, 1999, INT J CANCER, V83, P708, DOI 10.1002/(SICI)1097-0215(19991126)83:5<708::AID-IJC24>3.0.CO;2-C; MURPHY SM, 1993, MOL CELL BIOL, V13, P5290, DOI 10.1128/MCB.13.9.5290; NAGY E, 1995, J BIOL CHEM, V270, P2755, DOI 10.1074/jbc.270.6.2755; Nicholls C, 2012, CLIN EXP PHARMACOL P, V39, P674, DOI 10.1111/j.1440-1681.2011.05599.x; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; Pearl LH, 2015, NAT REV CANCER, V15, P166, DOI 10.1038/nrc3891; Ray S, 2018, NUCLEIC ACIDS RES, V46, P242, DOI 10.1093/nar/gkx1147; Revillion F, 2000, EUR J CANCER, V36, P1038, DOI 10.1016/S0959-8049(00)00051-4; Roskoski R, 2015, PHARMACOL RES, V94, P9, DOI 10.1016/j.phrs.2015.01.003; Sen N, 2008, NAT CELL BIOL, V10, P866, DOI 10.1038/ncb1747; Sirover MA, 2005, J CELL BIOCHEM, V95, P45, DOI 10.1002/jcb.20399; Sobol RW, 2001, PROG NUCLEIC ACID RE, V68, P57; Sobol RW, 1996, NATURE, V379, P183, DOI 10.1038/379183a0; Stabile LP, 2013, CLIN CANCER RES, V19, P380, DOI 10.1158/1078-0432.CCR-12-1555; Sukhanova M, 2010, MUTAT RES-FUND MOL M, V685, P80, DOI 10.1016/j.mrfmmm.2009.08.009; Tisdale EJ, 2004, J BIOL CHEM, V279, P54046, DOI 10.1074/jbc.M409472200; Tisdale EJ, 2007, TRAFFIC, V8, P733, DOI 10.1111/j.1600-0854.2007.00569.x; TOKUI T, 1991, J BIOL CHEM, V266, P10820; TOKUNAGA K, 1987, CANCER RES, V47, P5616; Wong HK, 2005, J CELL BIOCHEM, V95, P794, DOI 10.1002/jcb.20448; Zhang SY, 2011, NAT MED, V17, P461, DOI 10.1038/nm.2309; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X	48	8	8	3	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10443	10461		10.1096/fj.201902904RR	http://dx.doi.org/10.1096/fj.201902904RR		JUN 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32539222	Bronze			2022-12-28	WOS:000541637300001
J	DeDreu, J; Bowen, CJ; Logan, CM; Pal-Ghosh, S; Parlanti, P; Stepp, MA; Menko, AS				DeDreu, JodiRae; Bowen, Caitlin J.; Logan, Caitlin M.; Pal-Ghosh, Sonali; Parlanti, Paola; Stepp, Mary Ann; Menko, A. Sue			An immune response to the avascular lens following wounding of the cornea involves ciliary zonule fibrils	FASEB JOURNAL			English	Article						cornea wounding; ciliary zonules; immune response; lens	NEUTROPHIL EXTRACELLULAR TRAPS; DRAINING LYMPH-NODE; MHC CLASS-II; AQUEOUS-HUMOR; CLINICAL-FEATURES; GROWTH-FACTOR; T-CELLS; RAT EYE; MOUSE; ANTIGEN	The lens and central cornea are avascular. It was assumed that the adult lens had no source of immune cells and that the basement membrane capsule surrounding the lens was a barrier to immune cell migration. Yet, microfibril-associated protein-1 (MAGP1)-rich ciliary zonules that originate from the vasculature-rich ciliary body and extend along the surface of the lens capsule, form a potential conduit for immune cells to the lens. In response to cornea debridement wounding, we find increased expression of MAGP1 throughout the central corneal stroma. The immune cells that populate this typically avascular region after wounding closely associate with this MAGP1-rich matrix. These results suggest that MAGP1-rich microfibrils support immune cell migration post-injury. Using this cornea wound model, we investigated whether there is an immune response to the lens following cornea injury involving the lens-associated MAGP1-rich ciliary zonules. Our results provide the first evidence that following corneal wounding immune cells are activated to travel along zonule fibers that extend anteriorly along the equatorial surface of the lens, from where they migrate across the anterior lens capsule. These results demonstrate that lens-associated ciliary zonules are directly involved in the lens immune response and suggest the ciliary body as a source of immune cells to the avascular lens.	[DeDreu, JodiRae; Bowen, Caitlin J.; Logan, Caitlin M.; Menko, A. Sue] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; [Pal-Ghosh, Sonali; Stepp, Mary Ann] George Washington Univ, Sch Med & Hlth Sci, Dept Anat & Cell Biol, Washington, DC 20052 USA; [Parlanti, Paola] George Washington Univ, Sch Med & Hlth Sci, Nanofabricat & Imaging Ctr, Washington, DC 20052 USA; [Stepp, Mary Ann] George Washington Univ, Sch Med & Hlth Sci, Dept Ophthalmol, Washington, DC 20052 USA; [Menko, A. Sue] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Dept Ophthalmol, Philadelphia, PA 19107 USA	Jefferson University; George Washington University; George Washington University; George Washington University; Jefferson University	Menko, AS (corresponding author), Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, 564 Jefferson Alumni Hall,1020 Locust St, Philadelphia, PA 19107 USA.; Menko, AS (corresponding author), Thomas Jefferson Univ, Wills Vis Res Ctr, 564 Jefferson Alumni Hall,1020 Locust St, Philadelphia, PA 19107 USA.	sue.menko@jefferson.edu	Parlanti, Paola/AAN-1477-2020; Stepp, Mary Ann/ABF-2702-2020	Parlanti, Paola/0000-0002-2163-1296; Menko, A. Sue/0000-0002-7514-4696	HHS \ NIH \ National Eye Institute (NEI) [EY021784]	HHS \ NIH \ National Eye Institute (NEI)	HHS vertical bar NIH vertical bar National Eye Institute (NEI), Grant/Award Number: EY021784	Agarwal P, 2015, MOL VIS, V21, P612; Al-Mansour Yousef S., 2010, International Ophthalmology, V30, P501, DOI 10.1007/s10792-010-9379-7; Bassnett S, 2019, EXP EYE RES, V185, DOI 10.1016/j.exer.2019.05.025; Beene LC, 2013, INVEST OPHTH VIS SCI, V54, P8337, DOI 10.1167/iovs.13-13121; Bell K, 2018, CURR NEUROPHARMACOL, V16, P942, DOI 10.2174/1570159X15666170720094529; Blanco-Mezquita JT, 2013, INVEST OPHTH VIS SCI, V54, P6262, DOI 10.1167/iovs.13-11710; Blum-Hareuveni T, 2017, AM J OPHTHALMOL, V177, P139, DOI 10.1016/j.ajo.2017.02.023; Bonfioli Adriana A, 2005, Semin Ophthalmol, V20, P147, DOI 10.1080/08820530500232035; Bouchenaki Nadia, 2010, International Ophthalmology, V30, P511, DOI 10.1007/s10792-010-9366-z; Calzada MJ, 2004, J BIOL CHEM, V279, P41734, DOI 10.1074/jbc.M406267200; Camelo S, 2006, INVEST OPHTH VIS SCI, V47, P1039, DOI 10.1167/iovs.05-1041; Chan FL, 1997, HISTOCHEM CELL BIOL, V107, P289, DOI 10.1007/s004180050114; Chan NSW, 2018, ASIA-PAC J OPHTHALMO, V7, P192, DOI 10.22608/APO.2018116; Chee SP, 2008, AM J OPHTHALMOL, V145, P834, DOI 10.1016/j.ajo.2007.12.015; Chen L, 2005, INVEST OPHTH VIS SCI, V46, P4536, DOI 10.1167/iovs.05-0975; Craft CS, 2014, DIABETES, V63, P1920, DOI 10.2337/db13-1604; Cursiefen C, 2004, J CLIN INVEST, V113, P1040, DOI 10.1172/JCI200420465; Dang ZX, 2014, J LEUKOCYTE BIOL, V95, P431, DOI 10.1189/jlb.0612294; De Maria A, 2017, INVEST OPHTH VIS SCI, V58, P573, DOI 10.1167/iovs.16-20866; Denniston AK, 2012, INVEST OPHTH VIS SCI, V53, P888, DOI 10.1167/iovs.11-8802; Denniston AK, 2011, J IMMUNOL, V186, P305, DOI 10.4049/jimmunol.1001450; Dick AD, 2016, OPHTHALMOLOGY, V123, P655, DOI 10.1016/j.ophtha.2015.10.028; Dollt C, 2017, ONCOTARGET, V8, P103682, DOI 10.18632/oncotarget.21771; Feneck EM, 2018, EXP EYE RES, V177, P35, DOI 10.1016/j.exer.2018.07.024; Ferrara M, 2019, OCUL IMMUNOL INFLAMM, V27, P410, DOI 10.1080/09273948.2017.1420202; Forrester JV, 2008, MUCOSAL IMMUNOL, V1, P372, DOI 10.1038/mi.2008.27; Forrester JV, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00338; Forslow A, 2007, CELL MOL LIFE SCI, V64, P66, DOI 10.1007/s00018-006-6255-8; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Gonzalez G, 2018, WIRES DEV BIOL, V7, DOI 10.1002/wdev.303; Hakkim A, 2010, P NATL ACAD SCI USA, V107, P9813, DOI 10.1073/pnas.0909927107; Halper J, 2014, ADV EXP MED BIOL, V802, P31, DOI 10.1007/978-94-007-7893-1_3; Hamrah P, 2002, INVEST OPHTH VIS SCI, V43, P639; Hanssen E, 2001, MATRIX BIOL, V20, P77, DOI 10.1016/S0945-053X(01)00122-6; Hegde S, 2017, LIFE SCI, V171, P30, DOI 10.1016/j.lfs.2016.12.019; Hubmacher D, 2014, INVEST OPHTH VIS SCI, V55, P7934, DOI 10.1167/iovs.14-15453; Ito M, 1999, ANAT EMBRYOL, V200, P403, DOI 10.1007/s004290050289; Jackson DG, 2001, TRENDS IMMUNOL, V22, P317, DOI 10.1016/S1471-4906(01)01936-6; Jackson DG, 2003, TRENDS CARDIOVAS MED, V13, P1, DOI 10.1016/S1050-1738(02)00189-5; Jackson DG, 2004, APMIS, V112, P526, DOI 10.1111/j.1600-0463.2004.apm11207-0811.x; Jiang J, 2018, INVEST OPHTH VIS SCI, V59, P4986, DOI 10.1167/iovs.18-25067; Joachim SC, 2007, CURR EYE RES, V32, P501, DOI 10.1080/02713680701375183; Knop Erich, 2007, Chem Immunol Allergy, V92, P36, DOI 10.1159/000099252; Krautgartner WD, 2010, ULTRASTRUCT PATHOL, V34, P226, DOI 10.3109/01913121003725721; Kruger P, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004651; Kuffova L, 2008, J IMMUNOL, V180, P1353, DOI 10.4049/jimmunol.180.3.1353; Kuznetsova SA, 2006, J CELL SCI, V119, P4499, DOI 10.1242/jcs.03171; Lee YC, 2010, INVEST OPHTH VIS SCI, V51, P4746, DOI 10.1167/iovs.09-5132; Lemp MA, 2005, AM J OPHTHALMOL, V140, P898, DOI 10.1016/j.ajo.2005.06.031; Li RHL, 2018, FRONT VET SCI, V5, DOI 10.3389/fvets.2018.00291; Litwiniuk M, 2016, WOUNDS, V28, P78; Logan CM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16456-5; Logan CM, 2017, DEV BIOL, V428, P118, DOI 10.1016/j.ydbio.2017.05.022; Mahajan A, 2019, J LEUKOCYTE BIOL, V105, P1087, DOI 10.1002/JLB.HI0718-249RR; Mahajan A, 2016, FRONT IMMUNOL, V7, P1, DOI 10.3389/fimmu.2016.00035; Marzeda AM, 2018, J HISTOCHEM CYTOCHEM, V66, P289, DOI 10.1369/0022155418757443; Matsuba M, 2011, EXP EYE RES, V93, P534, DOI 10.1016/j.exer.2011.06.018; McLeod DS, 2012, INVEST OPHTH VIS SCI, V53, P7912, DOI 10.1167/iovs.12-10140; MCMENAMIN PG, 1992, IMMUNOLOGY, V77, P385; Mecham RP, 2015, MATRIX BIOL, V47, P13, DOI 10.1016/j.matbio.2015.05.003; Meek KM, 2015, PROG RETIN EYE RES, V49, P1, DOI 10.1016/j.preteyeres.2015.07.001; Meier Fabio M, 2002, Ophthalmol Clin North Am, V15, P365, DOI 10.1016/S0896-1549(02)00033-0; Mobaraki M, 2019, FRONT BIOENG BIOTECH, V7, DOI 10.3389/fbioe.2019.00135; Nishida T, 1999, INVEST OPHTH VIS SCI, V40, P2268; Nishida-Fukuda H, 2016, J BIOL CHEM, V291, P10490, DOI 10.1074/jbc.M115.683201; Nishitani K, 2006, EXP EYE RES, V83, P223, DOI 10.1016/j.exer.2005.12.008; Ohta K, 2000, J IMMUNOL, V164, P1185, DOI 10.4049/jimmunol.164.3.1185; Pajoohesh-Ganji A, 2016, DEV DYNAM, V245, P132, DOI [10.1002/DVDY.24365, 10.1002/dvdy.24365]; Pal-Ghosh S, 2014, INVEST OPHTH VIS SCI, V55, P2757, DOI 10.1167/iovs.13-13557; Papayannopoulos V, 2018, NAT REV IMMUNOL, V18, P134, DOI 10.1038/nri.2017.105; Plskova J, 2002, BRIT J OPHTHALMOL, V86, P108, DOI 10.1136/bjo.86.1.108; Plskova J, 2002, TRANSPLANTATION, V73, P210; Ransohoff RM, 2012, NAT REV IMMUNOL, V12, P623, DOI 10.1038/nri3265; Schauer C, 2014, NAT MED, V20, P511, DOI 10.1038/nm.3547; Shi YR, 2013, INVEST OPHTH VIS SCI, V54, P2504, DOI 10.1167/iovs.13-11619; Stepp MA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35090-3; Streilein JW, 2003, NAT REV IMMUNOL, V3, P879, DOI 10.1038/nri1224; Taylor AW, 1997, CURR EYE RES, V16, P900, DOI 10.1076/ceyr.16.9.900.5043; Thanabalasuriar A, 2019, J LEUKOCYTE BIOL, V105, P1083, DOI 10.1002/JLB.3CE0419-130R; Thanabalasuriar A, 2019, CELL HOST MICROBE, V25, P526, DOI 10.1016/j.chom.2019.02.007; Travis MA, 2014, ANNU REV IMMUNOL, V32, P51, DOI 10.1146/annurev-immunol-032713-120257; White TL, 2017, INVEST OPHTH VIS SCI, V58, P2106, DOI 10.1167/iovs.16-21358; Worbs T, 2017, NAT REV IMMUNOL, V17, P30, DOI 10.1038/nri.2016.116; Xu HX, 2007, INVEST OPHTH VIS SCI, V48, P1674, DOI 10.1167/iovs.06-1034; Xu HP, 2007, INVEST OPHTH VIS SCI, V48, P2162, DOI 10.1167/iovs.06-0783; Zhu MD, 2000, EXP EYE RES, V70, P767, DOI 10.1006/exer.2000.0844; Zindel J, 2020, ANNU REV PATHOL-MECH, V15, P493, DOI 10.1146/annurev-pathmechdis-012419-032847; Zuliani-Alvarez L, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01718-7	88	8	8	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9316	9336		10.1096/fj.202000289R	http://dx.doi.org/10.1096/fj.202000289R		MAY 2020	21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32452112	Green Published, hybrid			2022-12-28	WOS:000535407400001
J	Liu, ZL; Deng, YW; Li, T; Zhu, FS; Zhou, XJ; He, Y				Liu Zhonglong; Deng Yiwen; Li Tao; Zhu Fengshuo; Zhou Xiaojun; He Yue			The opposite functions of miR-24 in the osteogenesis and adipogenesis of adipose-derived mesenchymal stem cells are mediated by the HOXB7/beta-catenin complex	FASEB JOURNAL			English	Article						adipogenesis; adipose-derived mesenchymal stem cells (ADMSCs); miR-24; HOXB7; beta-catenin signal pathway; opposite functions; osteogenesis	MESOPOROUS SILICA NANOPARTICLES; MICRORNA EXPRESSION; STROMAL CELLS; DIFFERENTIATION; PROLIFERATION; DELIVERY; HOXB7; RUNX2	Adipose-derived mesenchymal stem cells (ADMSCs) used in combination with nanoparticles or scaffolds represent promising candidates for bone engineering. Compared to bone marrow-derived MSCs (BMMSCs), ADMSCs show a relatively low capacity for osteogenesis. In the current study, miR-24 was identified as an osteogenesis- and adipogenesis-related miRNA that performs opposing roles (inhibition in osteogenesis and promotion in adipogenesis) during these two differentiation processes. Through bioinformatics analysis and luciferase reporter assays, homeobox protein Hox-B7 (HOXB7) was identified as a potential novel downstream target of miR-24 that contains a miR-24 binding site in the 3 '-UTR of its mRNA. Overexpression of HOXB7 could partly halt the inhibitory effect of miR-24 on osteogenesis, and downregulation of HOXB7 could also partly suppress the positive effect of miR-24 on adipogenesis. Furthermore, immunoprecipitation experiments found that HOXB7 and beta-catenin formed a functional complex that acted as an essential modulator during osteogenesis and adipogenesis of ADMSCs. After transfecting ADMSCs with an MSNs-PEI-miR-24 agomir or antagomir and loading the cells onto gelatin-chitosan scaffolds, the compounds were assessed for their abilities to repair the critical-sized calvarial defects in rats. Comprehensive evaluation, including micro-CT, sequential fluorescent labeling, and immunohistochemistry analysis, revealed that silencing miR-24 distinctly promoted in vivo bone remolding, whereas overexpression of miR-24 significantly repressed bone formation. Taken together, our findings demonstrated opposite roles for the miR-24/HOXB7/beta-catenin signaling pathway in the osteogenesis and adipogenesis of ADMSCs, which may provide a novel mechanism for determining the balance between these two biological processes.	[Liu Zhonglong; Zhu Fengshuo; He Yue] Shanghai Jiao Tong Univ, Natl Clin Res Ctr Stomatol, Dept Oral Maxillofacial & Head & Neck Oncol, Shanghai Peoples Hosp 9,Sch Med, Shanghai 200011, Peoples R China; [Deng Yiwen] Shanghai Jiao Tong Univ, Natl Clin Res Ctr Stomatol, Dept Oral Mucosal Dis, Shanghai Peoples Hosp 9,Sch Med, Shanghai, Peoples R China; [Li Tao; Zhou Xiaojun] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Orthoped, Shanghai 200011, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	He, Y (corresponding author), Shanghai Jiao Tong Univ, Natl Clin Res Ctr Stomatol, Dept Oral Maxillofacial & Head & Neck Oncol, Shanghai Peoples Hosp 9,Sch Med, Shanghai 200011, Peoples R China.; Zhou, XJ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Orthoped, Shanghai 200011, Peoples R China.	xjz362@163.com; eddielew@alumni.sjtu.edu.cn	Zhou, Xiaojun/ABA-5017-2020	Zhou, Xiaojun/0000-0001-5040-8053	National Natural Science Foundation of China [NSFC: 81570949, 81900969]; Shanghai Sailing Program [19YF1426200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Sailing Program	This work was supported by the National Natural Science Foundation of China (NSFC: 81570949, 81900969), and Shanghai Sailing Program (19YF1426200).	Baglio SR, 2013, GENE, V527, P321, DOI 10.1016/j.gene.2013.06.021; Bellavia D, 2019, BONE, V122, P52, DOI 10.1016/j.bone.2019.02.013; Bertucci A, 2019, ACS APPL MATER INTER, V11, P23926, DOI 10.1021/acsami.9b07980; Bhattarai SR, 2010, PHARM RES-DORDR, V27, P2556, DOI 10.1007/s11095-010-0245-0; Candini O, 2015, STEM CELLS, V33, P939, DOI 10.1002/stem.1897; Castano IM, 2016, SCI REP-UK, V6, DOI 10.1038/srep27941; Chen X, 2015, BIOMATERIALS, V53, P239, DOI 10.1016/j.biomaterials.2015.02.071; Clark EA, 2014, STEM CELLS, V32, P1074, DOI 10.1002/stem.1623; Deng Y, 2013, BIOMATERIALS, V34, P6717, DOI 10.1016/j.biomaterials.2013.05.042; Di Ianni T, 2019, J CONTROL RELEASE, V309, P1, DOI 10.1016/j.jconrel.2019.07.024; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Fang SJ, 2015, INT J MOL SCI, V16, P8227, DOI 10.3390/ijms16048227; Gao D, 2018, AM J PHYSIOL-CELL PH, V315, pC675, DOI 10.1152/ajpcell.00291.2017; Gao J, 2011, J CELL BIOCHEM, V112, P1844, DOI 10.1002/jcb.23106; Gao RT, 2015, INT J CLIN EXP MED, V8, P10459; Geng HY, 2017, CHEM-EUR J, V23, P10878, DOI 10.1002/chem.201701806; Hassan MQ, 2010, P NATL ACAD SCI USA, V107, P19879, DOI 10.1073/pnas.1007698107; Hong PY, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1358-y; Hu CX, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1310-1; Huang C, 2017, CELL TISSUE RES, V368, P229, DOI 10.1007/s00441-016-2462-2; Huang J, 2010, STEM CELLS, V28, P357, DOI 10.1002/stem.288; Huang S, 2012, STEM CELLS DEV, V21, P2531, DOI 10.1089/scd.2012.0014; Jiao J, 2016, MAT SCI ENG C-MATER, V67, P26, DOI 10.1016/j.msec.2016.04.091; Jin M, 2016, BIOCHEM BIOPH RES CO, V474, P76, DOI 10.1016/j.bbrc.2016.04.073; Jin T, 2015, J CELL BIOCHEM, V116, P2804, DOI 10.1002/jcb.25225; Kim DY, 2017, HISTOL HISTOPATHOL, V32, P1, DOI 10.14670/HH-11-798; Kim YJ, 2009, J BONE MINER RES, V24, P816, DOI 10.1359/JBMR.081230; Li BB, 2018, CURR STEM CELL RES T, V13, P26, DOI 10.2174/1574888X12666170605112727; Liu JJ, 2016, BIOMATERIALS, V83, P51, DOI 10.1016/j.biomaterials.2016.01.008; Liu ZL, 2018, STEM CELLS INT, V2018, DOI 10.1155/2018/5845402; Maria ATJ, 2017, CLIN REV ALLERG IMMU, V52, P234, DOI 10.1007/s12016-016-8552-9; Niemeyer P, 2010, BIOMATERIALS, V31, P3572, DOI 10.1016/j.biomaterials.2010.01.085; Papaioannou G, 2014, CELL MOL LIFE SCI, V71, P4747, DOI 10.1007/s00018-014-1700-6; Park H, 2015, DIFFERENTIATION, V90, P91, DOI 10.1016/j.diff.2015.10.010; Qi YC, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1362-2; Qureshi AT, 2013, BIOMATERIALS, V34, P7799, DOI 10.1016/j.biomaterials.2013.07.004; Saleh B, 2019, SMALL, V15, DOI 10.1002/smll.201902232; Scioli MG, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20133296; Seifert A, 2015, WORLD J STEM CELLS, V7, P583, DOI 10.4252/wjsc.v7.i3.583; Sekar D, 2015, CURR PHARM BIOTECHNO, V16, P43, DOI 10.2174/138920101601150105100851; Seo Y, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20153827; Shao M, 2019, COLLOID SURFACE B, V183, DOI 10.1016/j.colsurfb.2019.110427; Su X, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.221; Wang ZS, 2016, INT J NANOMED, V11, DOI 10.2147/IJN.S104851; Wu GS, 2016, CARBOHYD POLYM, V138, P49, DOI 10.1016/j.carbpol.2015.11.044; Xie Q, 2017, SCI REP-UK, V7, DOI 10.1038/srep42840; Xie Q, 2016, BIOMATERIALS, V75, P279, DOI 10.1016/j.biomaterials.2015.10.042; Yi X, 2020, J CELL PHYSIOL, V235, P328, DOI 10.1002/jcp.28972; Zhang JF, 2011, MOL BIOL CELL, V22, P3955, DOI 10.1091/mbc.E11-04-0356; Zhao WG, 2015, INT J MOL SCI, V16, P11699, DOI 10.3390/ijms160511699	50	5	5	3	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9034	9050		10.1096/fj.202000006RR	http://dx.doi.org/10.1096/fj.202000006RR		MAY 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32413244				2022-12-28	WOS:000533180100001
J	Feu, S; Unzueta, F; Llopis, A; Semple, JI; Ercilla, A; Guaita-Esteruelas, S; Jaumot, M; Freire, R; Agell, N				Feu, Sonia; Unzueta, Fernando; Llopis, Alba; Semple, Jennifer, I; Ercilla, Amaia; Guaita-Esteruelas, Sandra; Jaumot, Montserrat; Freire, Raimundo; Agell, Neus			OZF is a Claspin-interacting protein essential to maintain the replication fork progression rate under replication stress	FASEB JOURNAL			English	Article						Claspin; IPOND; OZF; replication stress; replisome; zinc-finger protein; ZNF146	ZINC-FINGER PROTEIN; DNA-REPLICATION; CELL-CYCLE; S-PHASE; ACTIVATION; CHK1; DEGRADATION; CANCER; MRC1; IDENTIFICATION	DNA replication is essential for cell proliferation and is one of the cell cycle stages where DNA is more vulnerable. Replication stress is a prominent property of tumor cells and an emerging target for cancer therapy. Although it is not directly involved in nucleotide incorporation, Claspin is a protein with relevant functions in DNA replication. It harbors a DNA-binding domain that interacts preferentially with branched or forked DNA molecules. It also acts as a platform for the interaction of proteins related to DNA damage checkpoint activation, DNA repair, DNA replication origin firing, and fork progression. In order to find new proteins potentially involved in the regulation of DNA replication, we performed a two-hybrid screen to discover new Claspin-binding proteins. This system allowed us to identify the zinc-finger protein OZF (ZNF146) as a new Claspin-interacting protein. OZF is also present at replication forks and co-immunoprecipitates not only with Claspin but also with other replisome components. Interestingly, OZF depletion does not affect DNA replication in a normal cell cycle, but its depletion induces a reduction in the fork progression rate under replication stress conditions. Our results suggest that OZF is a Claspin-binding protein with a specific function in fork progression under replication stress.	[Feu, Sonia; Unzueta, Fernando; Llopis, Alba; Ercilla, Amaia; Guaita-Esteruelas, Sandra; Jaumot, Montserrat; Agell, Neus] Univ Barcelona, Fac Med & Ciencies Salut, Inst Invest Biomed August Pi i Sunyer IDIBAP, Dept Biomed, C Casanova 143, Barcelona 08036, Spain; [Semple, Jennifer, I] Univ Bern, Inst Cell Biol, Bern, Switzerland; [Freire, Raimundo] Hosp Univ Canarias, FIISC, Unidad Invest, San Cristobal la Laguna, Spain; [Freire, Raimundo] Univ La Laguna, Inst Tecnol Biomed, San Cristobal la Laguna, Spain; [Freire, Raimundo] Univ Fernando Pessoa Canarias, Fac Ciencias Salud, Las Palmas Gran Canaria, Spain; [Ercilla, Amaia] CIC BioGUNE, Bizkaia Technol Pk, Bizkaia, Spain; [Guaita-Esteruelas, Sandra] Univ Rovira & Virgili, Hosp Univ St Joan, Inst Invest Sanitaria Pere Virgili, Unitat Med Vasc & Metabolismo,Unitat Recerca Lipi, Reus, Spain; [Guaita-Esteruelas, Sandra] Inst Salud Carlos III, CIBER Diabet & Enfermedades Metabol Asociadas CIB, Reus, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Bern; Universidad de la Laguna; Universidad de la Laguna; CIC bioGUNE; Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Instituto de Salud Carlos III	Agell, N (corresponding author), Univ Barcelona, Fac Med & Ciencies Salut, Inst Invest Biomed August Pi i Sunyer IDIBAP, Dept Biomed, C Casanova 143, Barcelona 08036, Spain.	neusagell@ub.edu	Ercilla, Amaia/Y-1824-2019; Freire, Raimundo/Q-7660-2019; Unzueta, Fernando/AAH-1979-2021; Semple, Jennifer/K-4782-2014	Ercilla, Amaia/0000-0001-8999-7131; Freire, Raimundo/0000-0003-4473-8894; Unzueta, Fernando/0000-0002-8099-6199; Semple, Jennifer/0000-0001-7221-9560; Unzueta Payeras, Fernando/0000-0002-1464-7038; Llopis, Alba/0000-0001-6374-7177; Jaumot, Montserrat/0000-0003-2864-357X				Antoine K, 2005, J CELL BIOCHEM, V95, P763, DOI 10.1002/jcb.20487; Antoine K, 2005, MOL CELL BIOCHEM, V271, P215, DOI 10.1007/s11010-005-6417-2; Aranda S, 2014, NUCLEIC ACIDS RES, V42, P6972, DOI 10.1093/nar/gku374; Azenha D, 2017, DNA REPAIR, V59, P27, DOI 10.1016/j.dnarep.2017.09.002; Bassermann F, 2008, CELL, V134, P256, DOI 10.1016/j.cell.2008.05.043; Bennett LN, 2006, FEBS LETT, V580, P4176, DOI 10.1016/j.febslet.2006.06.071; Bester AC, 2011, CELL, V145, P435, DOI 10.1016/j.cell.2011.03.044; Bianco JN, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08886-8; Branzei D, 2010, NAT REV MOL CELL BIO, V11, P208, DOI 10.1038/nrm2852; Burrell RA, 2013, NATURE, V494, P492, DOI 10.1038/nature11935; Cabrera E, 2017, ONCOGENE, V36, P678, DOI 10.1038/onc.2016.239; Cazzalini O, 2010, MUTAT RES-REV MUTAT, V704, P12, DOI 10.1016/j.mrrev.2010.01.009; Christiano C, 2003, J BIOL CHEM, V278, P30057, DOI 10.1074/jbc.M301136200; Cortazar AR, 2018, CANCER RES, V78, P6320, DOI 10.1158/0008-5472.CAN-18-1669; Deegan TD, 2016, CURR OPIN STRUC BIOL, V37, P145, DOI 10.1016/j.sbi.2016.01.014; Duch A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02756-x; Ercilla A, 2019, CELL MOL LIFE SCI, V44, P4745; Ercilla A, 2016, NUCLEIC ACIDS RES, V44, P4745, DOI 10.1093/nar/gkw132; Errico A, 2012, CRIT REV BIOCHEM MOL, V47, P222, DOI 10.3109/10409238.2012.655374; Errico A, 2010, EMBO REP, V11, P270, DOI 10.1038/embor.2010.27; Ferbus D, 1996, EUR J BIOCHEM, V236, P991, DOI 10.1111/j.1432-1033.1996.00991.x; Ferbus D, 1999, HYBRIDOMA, V18, P431, DOI 10.1089/hyb.1999.18.431; Ferbus D, 2003, J PATHOL, V200, P177, DOI 10.1002/path.1337; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Fragkos M, 2015, NAT REV MOL CELL BIO, V16, P360, DOI 10.1038/nrm4002; Gaillard H, 2015, NAT REV CANCER, V15, P276, DOI 10.1038/nrc3916; Graham JE, 2017, CELL, V169, P1201, DOI 10.1016/j.cell.2017.05.041; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heller RC, 2011, CELL, V146, P80, DOI 10.1016/j.cell.2011.06.012; Hodgson B, 2007, MOL BIOL CELL, V18, P3894, DOI 10.1091/mbc.E07-05-0500; Ilves I, 2010, MOL CELL, V37, P247, DOI 10.1016/j.molcel.2009.12.030; Kumagai A, 2000, MOL CELL, V6, P839, DOI 10.1016/S1097-2765(00)00082-4; Kumagai A, 2004, J BIOL CHEM, V279, P49599, DOI 10.1074/jbc.M408353200; LECHALONY C, 1994, J MOL BIOL, V236, P399, DOI 10.1006/jmbi.1994.1151; Lehner B, 2004, GENOMICS, V83, P153, DOI 10.1016/S0888-7543(03)00235-0; Lin SY, 2004, P NATL ACAD SCI USA, V101, P6484, DOI 10.1073/pnas.0401847101; Liu YY, 2010, J BIOL CHEM, V285, P5974, DOI 10.1074/jbc.M109.076109; Llopis A, 2012, CELL CYCLE, V11, P3627, DOI 10.4161/cc.21917; Lou HQ, 2008, MOL CELL, V32, P106, DOI 10.1016/j.molcel.2008.08.020; Lujan SA, 2016, TRENDS CELL BIOL, V26, P640, DOI 10.1016/j.tcb.2016.04.012; Macheret M, 2015, ANNU REV PATHOL-MECH, V10, P425, DOI 10.1146/annurev-pathol-012414-040424; Mailand N, 2006, MOL CELL, V23, P307, DOI 10.1016/j.molcel.2006.06.016; Mamely I, 2006, CURR BIOL, V16, P1950, DOI 10.1016/j.cub.2006.08.026; Marians KJ, 2018, ANNU REV BIOCHEM, V87, P217, DOI 10.1146/annurev-biochem-062917-011921; Masai H, 2017, CURR GENET, V63, P813, DOI 10.1007/s00294-017-0690-y; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Pasero P, 2019, MOL CELL ONCOL, V6, DOI 10.1080/23723556.2019.1607455; Pellegrini L, 2016, TRENDS BIOCHEM SCI, V41, P859, DOI 10.1016/j.tibs.2016.07.011; Petermann E, 2008, MOL BIOL CELL, V19, P2373, DOI 10.1091/mbc.E07-10-1035; Petermann E, 2010, MOL CELL, V37, P492, DOI 10.1016/j.molcel.2010.01.021; Proetorius-Ibba M, 2007, DNA REPAIR, V6, P578, DOI 10.1016/j.dnarep.2006.11.009; R Core Team, 2019, R LANG ENV STAT COMP; RStudio Team,, 2019, RSTUDIO INT DEV R; Scorah J, 2009, CELL CYCLE, V8, P1036, DOI 10.4161/cc.8.7.8040; Semple JI, 2007, CELL DEATH DIFFER, V14, P1433, DOI 10.1038/sj.cdd.4402134; Semple JI, 2005, BIOTECHNIQUES, V38, P927, DOI 10.2144/05386RR03; Smits VAJ, 2019, FEBS J, V286, P441, DOI 10.1111/febs.14594; Szyjka SJ, 2005, MOL CELL, V19, P691, DOI 10.1016/j.molcel.2005.06.037; Yang CC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12135; Yeeles JTP, 2016, MOL CELL, V65, P1; Zheng L, 2000, MOL CELL, V6, P757, DOI 10.1016/S1097-2765(00)00075-7	61	2	2	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6907	6919		10.1096/fj.201901926R	http://dx.doi.org/10.1096/fj.201901926R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32267586				2022-12-28	WOS:000531325500062
J	Yeh, YT; Lu, TJ; Lian, GT; Lung, MC; Lee, YL; Chiang, AN; Hsieh, SC				Yeh, Yu-Te; Lu, Ting-Jang; Lian, Guan-Ting; Lung, Meng-Chuan; Lee, Yu-Lin; Chiang, An-Na; Hsieh, Shu-Chen			Chinese olive (Canarium album L.) fruit regulates glucose utilization by activating AMP-activated protein kinase	FASEB JOURNAL			English	Article						AMPK; Chinese olive (Canarium album L; ); high-fat diet; glucose uptake; mitochondrial	INSULIN-RESISTANCE; SKELETAL-MUSCLE; GLYCOGEN-SYNTHASE; MOLECULAR-MECHANISMS; GLUT4 TRANSLOCATION; IN-VIVO; INHIBITION; METFORMIN; POLYPHENOLS; EXERCISE	A growing body of evidence demonstrates obesity-induced insulin resistance is associated with the development of metabolic diseases. This study was designed to investigate ethyl acetate fraction of Chinese olive fruit extract (CO-EtOAc)-mediated attenuation of obesity and hyperglycemia in a mouse model. About 60% HFD-fed mice were treated intragastrically with CO-EtOAc for last 6 weeks, and body weight, blood biochemical parameters as well as hepatic inflammation response were investigated. Our results showed that CO-EtOAc treatment significantly reduced the formation of hepatic lipid droplets, body weight gain, blood glucose, and improved serum biochemical parameters in HFD-induced obese and insulin resistant mice. We further explored the molecular mechanism underlying the blood glucose modulating effect of CO-EtOAc using L6 myotubes model. We conclude that CO-EtOAc effectively increases the glycogen content and glucose uptake by stimulating the membrane translocation of glucose transporter 4. In addition, CO-EtOAc depolarizes the mitochondrial membrane and decreases the mitochondrial oxygen consumption, which may result in AMPK activation and the consequent mitochondrial fission. This study shows that CO-EtOAc prevents the development of obesity in mice fed with HFD and is also capable of stimulating glucose uptake. The possible mechanism might be due to the effects of CO-EtOAc on activation of AMPK and promotion of mitochondrial fission.	[Yeh, Yu-Te; Lu, Ting-Jang; Lian, Guan-Ting; Lung, Meng-Chuan; Hsieh, Shu-Chen] Natl Taiwan Univ, Inst Food Sci & Technol, Taipei 106, Taiwan; [Yeh, Yu-Te] Johns Hopkins Univ, Johns Hopkins All Childrens Hosp, Inst Fundamental Biomed Res, Dept Med,Div Endocrinol Diabet & Metab,Sch Med, St Petersburg, FL USA; [Lee, Yu-Lin; Chiang, An-Na] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei, Taiwan	National Taiwan University; Johns Hopkins University; Johns Hopkins Medicine; National Yang Ming Chiao Tung University	Hsieh, SC (corresponding author), Natl Taiwan Univ, Inst Food Sci & Technol, Taipei 106, Taiwan.	schsieh@ntu.edu.tw		LU, TING-JANG/0000-0002-3956-8272	Ministry of Science and Technology, Taiwan (MOST) [104&-3011&-B&-010-001-1-4-2, 104&-2320-B-002-039]	Ministry of Science and Technology, Taiwan (MOST)(Ministry of Science and Technology, Taiwan)	Ministry of Science and Technology, Taiwan (MOST), Grant/Award Number: 104&-3011&-B&-010&-001&-1&-4&-2 and 104&-2320&-B&-002&-039	Atanasov AG, 2015, BIOTECHNOL ADV, V33, P1582, DOI 10.1016/j.biotechadv.2015.08.001; Bahadoran Z, 2013, J DIABETES METAB DIS, V12, DOI 10.1186/2251-6581-12-43; Boden G, 1999, P ASSOC AM PHYSICIAN, V111, P241, DOI 10.1046/j.1525-1381.1999.99220.x; Calmettes G, 2015, J MOL CELL CARDIOL, V78, P107, DOI 10.1016/j.yjmcc.2014.09.020; Cao J, 2014, J BIOL CHEM, V289, P20435, DOI 10.1074/jbc.M114.567271; Chen XP, 2009, CELL BIOCHEM FUNCT, V27, P407, DOI 10.1002/cbf.1596; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dali-Youcef N, 2013, ANN MED, V45, P242, DOI 10.3109/07853890.2012.705015; DEFRONZO RA, 1995, NEW ENGL J MED, V333, P541, DOI 10.1056/NEJM199508313330902; Doan KV, 2015, ENDOCRINOLOGY, V156, P157, DOI 10.1210/en.2014-1354; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Gaemers IC, 2011, BBA-MOL BASIS DIS, V1812, P447, DOI 10.1016/j.bbadis.2011.01.003; Gledhill JR, 2007, P NATL ACAD SCI USA, V104, P13632, DOI 10.1073/pnas.0706290104; Graham TE, 2007, HORM METAB RES, V39, P717, DOI 10.1055/s-2007-985879; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Grover JK, 2002, J ETHNOPHARMACOL, V81, P81, DOI 10.1016/S0378-8741(02)00059-4; Gupta RN, 2009, INT J DIABETES DEV C, V29, P170, DOI 10.4103/0973-3930.57349; Hardie DG, 2014, CELL METAB, V20, P939, DOI 10.1016/j.cmet.2014.09.013; Hawley SA, 2010, CELL METAB, V11, P554, DOI 10.1016/j.cmet.2010.04.001; Hsieh SC, 2016, FOOD FUNCT, V7, P4797, DOI [10.1039/c6fo01202g, 10.1039/C6FO01202G]; Hu RK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00925-y; Hur KY, 2015, J DIABETES INVEST, V6, P600, DOI 10.1111/jdi.12328; Jeon M, 2016, BIOCHEM BIOPH RES CO, V479, P22, DOI 10.1016/j.bbrc.2016.08.178; Kanamaru Yusuke, 2012, J Signal Transduct, V2012, P931215, DOI 10.1155/2012/931215; Lazar MA, 2005, SCIENCE, V307, P373, DOI 10.1126/science.1104342; Lee EY, 2017, YONSEI MED J, V58, P312, DOI 10.3349/ymj.2017.58.2.312; Liew YF, 2005, J NUTR, V135, P2151, DOI 10.1093/jn/135.9.2151; LILLIOJA S, 1986, J CLIN ENDOCR METAB, V62, P922, DOI 10.1210/jcem-62-5-922; Liu HY, 2008, FOOD RES INT, V41, P363, DOI 10.1016/j.foodres.2007.12.012; Lizcano JM, 2002, CURR BIOL, V12, pR236, DOI 10.1016/S0960-9822(02)00777-7; Manchester J, 1996, P NATL ACAD SCI USA, V93, P10707, DOI 10.1073/pnas.93.20.10707; MUECKLER M, 1994, EUR J BIOCHEM, V219, P713, DOI 10.1111/j.1432-1033.1994.tb18550.x; Musi N, 2006, CURR MED CHEM, V13, P583, DOI 10.2174/092986706776055724; Nagano T, 2015, FOOD SCI TECHNOL RES, V21, P489, DOI 10.3136/fstr.21.489; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Polce SA, 2018, NUTRIENTS, V10, DOI 10.3390/nu10050531; Poulose N, 2011, J DIABETES METAB, V2, DOI 10.4172/2155-6156.1000149; Prasad CNV, 2010, FEBS LETT, V584, P531, DOI 10.1016/j.febslet.2009.11.092; Rizza RA, 2010, DIABETES, V59, P2697, DOI 10.2337/db10-1032; Sajan MP, 2010, AM J PHYSIOL-ENDOC M, V298, pE179, DOI 10.1152/ajpendo.00392.2009; Shepherd PR, 1999, NEW ENGL J MED, V341, P248, DOI 10.1056/NEJM199907223410406; Solini A, 2001, HYPERTENSION, V37, P1492, DOI 10.1161/01.HYP.37.6.1492; Sriwijitkamol A, 2007, DIABETES, V56, P836, DOI 10.2337/db06-1119; Stanford KI, 2014, ADV PHYSIOL EDUC, V38, P308, DOI 10.1152/advan.00080.2014; Tantama M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3550; Taylor R, 1996, J CLIN INVEST, V97, P126, DOI 10.1172/JCI118379; Thornton C, 2017, NEURONAL SIGNALING, V1, P1; Toyama EQ, 2016, SCIENCE, V351, P275, DOI 10.1126/science.aab4138; Unger RH, 2003, ENDOCRINOLOGY, V144, P5159, DOI 10.1210/en.2003-0870; Xiao JB, 2015, CURR MED CHEM, V22, P23; Yamada E, 2010, FUTURE MED CHEM, V2, P1785, DOI 10.4155/FMC.10.264; Yang JZ, 2014, PROG MOL BIOL TRANSL, V121, P133, DOI 10.1016/B978-0-12-800101-1.00005-3; Yeh YT, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19553-1; Yeh YT, 2017, NUTRIENTS, V9, DOI 10.3390/nu9101123; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012; Zhang CS, 2016, CELL METAB, V23, P399, DOI 10.1016/j.cmet.2016.02.017; Zhang JD, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/4353510	57	4	6	1	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					7866	7884		10.1096/fj.201902494RR	http://dx.doi.org/10.1096/fj.201902494RR		APR 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32333610				2022-12-28	WOS:000529447300001
J	Chen, XJ; Hu, QY; Zhang, K; Teng, HJ; Li, MZ; Li, D; Wang, JS; Du, QS; Zhao, M				Chen, Xiaojuan; Hu, Qianying; Zhang, Ke; Teng, Huajing; Li, Mingzhen; Li, Dan; Wang, Jiesi; Du, Quansheng; Zhao, Mei			The clock-controlled chemokine contributes to neuroinflammation-induced depression	FASEB JOURNAL			English	Article						clock gene; cytokine; depression-like behavior; inflammation; Per2	CIRCADIAN-CLOCK; GENE; ABNORMALITIES; IMMUNOLOGY; EXPRESSION; MICROGLIA; ANXIETY	The circadian rhythm plays a central role in immune function, and its disruption has been closely linked to the etiology of depression. However, the mechanisms underlying the association between depression and circadian rhythm remain unclear. We found that mice deficient of Per2, a central clock component of circadian output, were resilient to neuroinflammation-induced depressive behavior. After repeated central lipopolysaccharide (LPS) injections, MCP-1, MIP-1 beta, and RANTES increased in wild type (WT) but not in Per2-deficient mice. In addition, intracerebroventricular injection of RANTES resulted in depression-like behavior, and Met-RANTES, a CCR5 antagonist, could reverse depression-like behavior induced by LPS treatments. These results indicated that the Per2 gene contributes to depression via chemokines, especially RANTES. Furthermore, BMAL1 expression decreased in LPS-treated Per2-deficient mice and BMAL1 could bind to the promoter of Rantes, indicating clock gene can act as a regulator for neuroinflammation. In conclusion, Rantes, a clock-controlled gene (CCG), is involved in clock-immunological mechanisms underlying the effects of Per2 on neuroinflammation-induced depression-like behavior.	[Chen, Xiaojuan; Hu, Qianying; Zhang, Ke; Li, Mingzhen; Li, Dan; Wang, Jiesi; Zhao, Mei] Inst Psychol, CAS Key Lab Mental Hlth, 16 Lincui Rd, Beijing 100101, Peoples R China; [Chen, Xiaojuan; Hu, Qianying; Zhang, Ke; Li, Dan; Wang, Jiesi; Zhao, Mei] Univ Chinese Acad Sci, Beijing, Peoples R China; [Teng, Huajing] Chinese Acad Sci, Beijing Inst Life Sci, Beijing, Peoples R China; [Du, Quansheng] Natl Nat Sci Fdn China, Dept Life Sci, Beijing, Peoples R China	Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; National Natural Science Foundation of China (NSFC)	Zhao, M (corresponding author), Inst Psychol, CAS Key Lab Mental Hlth, 16 Lincui Rd, Beijing 100101, Peoples R China.	zhaomei@psych.ac.cn	Wang, Jiesi/AAB-3815-2020	Wang, Jiesi/0000-0002-2425-4262; Teng, Huajing/0000-0001-9952-3618	National Natural Science Foundation of China [91132728, 31741062]; Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the National Natural Science Foundation of China (No. 91132728, 31741062); and Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences.	Albrecht Urs, 2013, Handb Exp Pharmacol, P227, DOI 10.1007/978-3-642-25950-0_9; Arjona A, 2006, BRAIN BEHAV IMMUN, V20, P469, DOI 10.1016/j.bbi.2005.10.002; Fonken LK, 2016, NEUROBIOL AGING, V47, P102, DOI 10.1016/j.neurobiolaging.2016.07.019; Fonken LK, 2015, BRAIN BEHAV IMMUN, V45, P171, DOI 10.1016/j.bbi.2014.11.009; Franklin TC, 2018, BIOL PSYCHIAT, V83, P50, DOI 10.1016/j.biopsych.2017.06.034; Geiger SS, 2015, IMMUNOLOGY, V146, P349, DOI 10.1111/imm.12525; Griesauer I, 2014, ANN MED, V46, P148, DOI 10.3109/07853890.2013.866440; Hampp G, 2008, CURR BIOL, V18, P678, DOI 10.1016/j.cub.2008.04.012; Jiang WG, 2013, PSYCHOPHARMACOLOGY, V227, P79, DOI 10.1007/s00213-012-2941-4; Keller M, 2009, P NATL ACAD SCI USA, V106, P21407, DOI 10.1073/pnas.0906361106; Kim M, 2018, BIOMOL THER, V26, P358, DOI 10.4062/biomolther.2017.131; Kinoshita C, 2012, NEUROREPORT, V23, P98, DOI 10.1097/WNR.0b013e32834e7ec2; Landgraf D, 2014, BEHAV NEUROSCI, V128, P344, DOI 10.1037/a0036029; Lavebratt C, 2010, AM J MED GENET B, V153B, P570, DOI 10.1002/ajmg.b.31021; Leighton SP, 2018, MOL PSYCHIATR, V23, P48, DOI 10.1038/mp.2017.205; Leistedt SJ, 2013, EUR NEUROPSYCHOPHARM, V23, P55, DOI 10.1016/j.euroneuro.2012.10.011; Li NY, 2015, INT J MOL SCI, V16, P6831, DOI 10.3390/ijms16046831; Liu JG, 2006, INFECT IMMUN, V74, P4750, DOI 10.1128/IAI.00287-06; Muller N, 2014, NEUROIMMUNOMODULAT, V21, P123, DOI 10.1159/000356540; Munhoz CD, 2006, J NEUROSCI, V26, P3813, DOI 10.1523/JNEUROSCI.4398-05.2006; Oglodek EA, 2014, PHARMACOL REP, V66, P920, DOI 10.1016/j.pharep.2014.06.001; Satyanarayanan SK, 2020, BRAIN BEHAV IMMUN, V85, P142, DOI 10.1016/j.bbi.2019.03.003; Silver AC, 2012, IMMUNITY, V36, P251, DOI 10.1016/j.immuni.2011.12.017; Simon NM, 2008, EUR NEUROPSYCHOPHARM, V18, P230, DOI 10.1016/j.euroneuro.2007.06.004; Spencer S, 2013, EUR J NEUROSCI, V37, P242, DOI 10.1111/ejn.12010; Stuart MJ, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00357; Suarez EC, 2004, PSYCHONEUROENDOCRINO, V29, P1119, DOI 10.1016/j.psyneuen.2004.01.002; Tang MM, 2017, BRAIN BEHAV IMMUN, V66, P322, DOI 10.1016/j.bbi.2017.05.013; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504	29	4	4	4	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8357	8366		10.1096/fj.201900581RRR	http://dx.doi.org/10.1096/fj.201900581RRR		APR 2020	10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32329129	hybrid			2022-12-28	WOS:000529406900001
J	Halpert, MM; Konduri, V; Liang, D; Vazquez-Perez, J; Hofferek, CJ; Weldon, SA; Baig, YY; Vedula, I; Levitt, JM; Decker, WK				Halpert, Matthew M.; Konduri, Vanaja; Liang, Dan; Vazquez-Perez, Jonathan; Hofferek, Colby J.; Weldon, Scott A.; Baig, Yunyu; Vedula, Indira; Levitt, Jonathan M.; Decker, William K.			MHC class I and II peptide homology regulates the cellular immune response	FASEB JOURNAL			English	Article						AIMp1; CTLA-4; dendritic cell; PAMP; PRR; T(H)1 polarization	TRANSFER-RNA SYNTHETASE; GMP-AMP SYNTHASE; DENDRITIC CELLS; CROSS-PRESENTATION; TLR LIGANDS; DNA SENSOR; RECOGNITION; INFECTION; CYTOKINE; MICE	Mammalian immune responses are initiated by "danger" signals--immutable molecular structures known as PAMPs. When detected by fixed, germline encoded receptors, pathogen-associated molecular pattern (PAMPs) subsequently inform the polarization of downstream adaptive responses depending upon identity and localization of the PAMP. Here, we report the existence of a completely novel "PAMP" that is not a molecular structure but an antigenic pattern. This pattern--the incidence of peptide epitopes with stretches of 100% sequence identity bound to both dendritic cell (DC) major histocompatibility (MHC) class I and MHC class II--strongly induces T(H)1 immune polarization and activation of the cellular immune response. Inherent in the existence of this PAMP is the concomitant existence of a molecular sensor complex with the ability to scan and compare amino acid sequence identities of bound class I and II peptides. We provide substantial evidence implicating the multienzyme aminoacyl-tRNA synthetase (mARS) complex and its AIMp1 structural component as the key constituents of this complex. The results demonstrate a wholly novel mechanism by which T-helper (T-H) polarization is governed and provide critical information for the design of vaccination strategies intended to provoke cell-mediated immunity.	[Halpert, Matthew M.; Konduri, Vanaja; Liang, Dan; Vazquez-Perez, Jonathan; Hofferek, Colby J.; Baig, Yunyu; Vedula, Indira; Levitt, Jonathan M.; Decker, William K.] Baylor Coll Med, Dept Pathol & Immunol, One Baylor Plaza, Houston, TX 77030 USA; [Weldon, Scott A.] Baylor Coll Med, Michael E DeBakey Dept Surg, Houston, TX 77030 USA; [Levitt, Jonathan M.] Baylor Coll Med, Scott Dept Urol, Houston, TX 77030 USA; [Levitt, Jonathan M.; Decker, William K.] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Decker, William K.] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Decker, WK (corresponding author), Baylor Coll Med, Dept Pathol & Immunol, One Baylor Plaza, Houston, TX 77030 USA.	decker@bcm.edu			HHS \ NIH \ National Institute of Allergy and Infectious Diseases (NIAID) [AI127387]; Cancer Prevention and Research Institute of Texas (CPRIT) [RP110545]	HHS \ NIH \ National Institute of Allergy and Infectious Diseases (NIAID); Cancer Prevention and Research Institute of Texas (CPRIT)	HHS vertical bar NIH vertical bar National Institute of Allergy and Infectious Diseases (NIAID), Grant/Award Number: AI127387; Cancer Prevention and Research Institute of Texas (CPRIT), Grant/Award Number: RP110545	Ablasser A, 2009, J IMMUNOL, V182, P6824, DOI 10.4049/jimmunol.0803001; Ahn SS, 2018, CLIN EXP RHEUMATOL, V36, P533; Albert ML, 1998, J EXP MED, V188, P1359, DOI 10.1084/jem.188.7.1359; Azouz NP, 2014, J IMMUNOL, V192, P4043, DOI 10.4049/jimmunol.1302196; Bafica A, 2005, J EXP MED, V202, P1715, DOI 10.1084/jem.20051782; Belizaire R, 2009, P NATL ACAD SCI USA, V106, P17463, DOI 10.1073/pnas.0908583106; BHARDWAJ N, 1994, J CLIN INVEST, V94, P797, DOI 10.1172/JCI117399; Bowie AG, 2008, NAT REV IMMUNOL, V8, P911, DOI 10.1038/nri2436; Carroll EC, 2016, IMMUNITY, V44, P597, DOI 10.1016/j.immuni.2016.02.004; Dabbagh K, 2002, J IMMUNOL, V168, P4524, DOI 10.4049/jimmunol.168.9.4524; Datta SK, 2003, J IMMUNOL, V170, P4102, DOI 10.4049/jimmunol.170.8.4102; Decker WK, 2008, J IMMUNOTHER, V31, P157, DOI 10.1097/CJI.0b013e31815eb0df; Decker WK, 2009, BLOOD, V113, P4213, DOI 10.1182/blood-2008-10-185470; Decker WK, 2006, VACCINE, V24, P3203, DOI 10.1016/j.vaccine.2006.01.029; Dow C, 2008, J VIROL, V82, P11734, DOI 10.1128/JVI.00435-08; Embgenbroich M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01643; Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121; Gallimore A, 1998, J EXP MED, V187, P1383, DOI 10.1084/jem.187.9.1383; Gao DX, 2015, P NATL ACAD SCI USA, V112, pE5699, DOI 10.1073/pnas.1516465112; GHOSH P, 1995, NATURE, V378, P457, DOI 10.1038/378457a0; Gorchakov R, 2005, J VIROL, V79, P9397, DOI 10.1128/JVI.79.15.9397-9409.2005; Guermonprez P, 2003, NATURE, V425, P397, DOI 10.1038/nature01911; Guilliams M, 2016, IMMUNITY, V45, P669, DOI 10.1016/j.immuni.2016.08.015; Guo M, 2010, NAT REV MOL CELL BIO, V11, P668, DOI 10.1038/nrm2956; Halpert MM, 2016, STEM CELLS DEV, V25, P774, DOI 10.1089/scd.2016.0009; Hausmann CD, 2008, FEMS MICROBIOL REV, V32, P705, DOI 10.1111/j.1574-6976.2008.00119.x; Helft J, 2015, IMMUNITY, V42, P1197, DOI 10.1016/j.immuni.2015.05.018; Hong HJ, 2012, CLIN IMMUNOL, V143, P256, DOI 10.1016/j.clim.2012.02.004; Hong SH, 2015, BIOMATERIALS, V44, P45, DOI 10.1016/j.biomaterials.2014.12.017; JAKUBOWSKI H, 1992, MICROBIOL REV, V56, P412, DOI 10.1128/MMBR.56.3.412-429.1992; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Kim E, 2006, J IMMUNOL, V176, P256, DOI 10.4049/jimmunol.176.1.256; Kim E, 2008, J IMMUNOL, V180, P2894, DOI 10.4049/jimmunol.180.5.2894; Kim MS, 2015, J IMMUNOL, V194, P4729, DOI 10.4049/jimmunol.1401352; Kleijmeer MJ, 2001, TRAFFIC, V2, P124, DOI 10.1034/j.1600-0854.2001.020207.x; Klein O, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15047-8; KNIGHT SC, 1993, RES VIROLOGY, V144, P75, DOI 10.1016/S0923-2516(06)80015-4; Ko YG, 2001, J BIOL CHEM, V276, P23028, DOI 10.1074/jbc.M101544200; Konduri V, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1213933; Konduri V, 2013, J INFECT DIS, V207, P1764, DOI 10.1093/infdis/jit087; KRUMMEL MF, 1995, J EXP MED, V182, P459, DOI 10.1084/jem.182.2.459; Kurts C, 1998, J EXP MED, V188, P409, DOI 10.1084/jem.188.2.409; Lamhamedi-Cherradi SE, 2008, J IMMUNOL, V180, P6000, DOI 10.4049/jimmunol.180.9.6000; Lee EY, 2016, NAT IMMUNOL, V17, P1252, DOI 10.1038/ni.3542; Liang D, 2015, INT REV IMMUNOL, V34, P367, DOI 10.3109/08830185.2015.1077829; Liang D, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01801; Lim HX, 2018, J IMMUNOL, V201, P2832, DOI 10.4049/jimmunol.1800386; LJUNGGREN HG, 1991, INT J CANCER, P38; Longhi MP, 2009, J EXP MED, V206, P1589, DOI 10.1084/jem.20090247; Luecke S, 2017, CYTOKINE, V98, P4, DOI 10.1016/j.cyto.2016.10.003; Martin WD, 1996, CELL, V84, P543, DOI 10.1016/S0092-8674(00)81030-2; Millien VO, 2013, SCIENCE, V341, P792, DOI 10.1126/science.1240342; Miyazaki T, 1996, CELL, V84, P531, DOI 10.1016/S0092-8674(00)81029-6; Murakami D, 2007, CLIN EXP ALLERGY, V37, P339, DOI 10.1111/j.1365-2222.2006.02633.x; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Navabi H, 2009, VACCINE, V27, P107, DOI 10.1016/j.vaccine.2008.10.024; Nembrini C, 2006, J IMMUNOL, V176, P7180, DOI 10.4049/jimmunol.176.12.7180; Park SG, 2005, AM J PATHOL, V166, P387, DOI 10.1016/S0002-9440(10)62262-6; Pilon C, 2009, MOL IMMUNOL, V46, P437, DOI 10.1016/j.molimm.2008.10.014; Qian C, 2013, ANN NY ACAD SCI, V1283, P67, DOI 10.1111/j.1749-6632.2012.06786.x; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Rodriguez MJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40449; Rohn TA, 2004, NAT IMMUNOL, V5, P909, DOI 10.1038/ni1108; Safdar A, 2009, VACCINE, V27, P1479, DOI 10.1016/j.vaccine.2009.01.017; Shi GP, 2013, J IMMUNOL, V191, P415, DOI 10.4049/jimmunol.1201732; Spranger S, 2010, J IMMUNOL, V185, P738, DOI 10.4049/jimmunol.1000060; Sprokholt JK, 2017, J IMMUNOL, V198, P4764, DOI 10.4049/jimmunol.1602121; Stephens R, 2002, J IMMUNOL, V169, P5468, DOI 10.4049/jimmunol.169.10.5468; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Strong BSI, 2011, J IMMUNOL, V187, P2193, DOI 10.4049/jimmunol.1100152; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Toribio R, 2010, P NATL ACAD SCI USA, V107, P9837, DOI 10.1073/pnas.1004110107; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156; Wolkers MC, 2004, SCIENCE, V304, P1314, DOI 10.1126/science.1096268; Wu MN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020923; Xagorari Angeliki, 2008, Open Microbiol J, V2, P49, DOI 10.2174/1874285800802010049	79	6	6	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8082	8101		10.1096/fj.201903002R	http://dx.doi.org/10.1096/fj.201903002R		APR 2020	20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32298026	Green Accepted			2022-12-28	WOS:000526651700001
J	Pecorelli, A; Ferrara, F; Messano, N; Cordone, V; Schiavone, ML; Cervellati, F; Woodby, B; Cervellati, C; Hayek, J; Valacchi, G				Pecorelli, Alessandra; Ferrara, Francesca; Messano, Nicolo; Cordone, Valeria; Schiavone, Maria Lucia; Cervellati, Franco; Woodby, Brittany; Cervellati, Carlo; Hayek, Joussef; Valacchi, Giuseppe			Alterations of mitochondrial bioenergetics, dynamics, and morphology support the theory of oxidative damage involvement in autism spectrum disorder	FASEB JOURNAL			English	Article						4-hydroxynonenal; fission; fusion; mitophagy; nuclear factor erythroid 2-related factor 2	CHILDREN; CELLS; ABNORMALITIES; STRESS; NRF2	Autism spectrum disorder (ASD) has been hypothesized to be a result of the interplay between genetic predisposition and increased vulnerability to early environmental insults. Mitochondrial dysfunctions appear also involved in ASD pathophysiology, but the mechanisms by which such alterations develop are not completely understood. Here, we analyzed ASD primary fibroblasts by measuring mitochondrial bioenergetics, ultrastructural and dynamic parameters to investigate the hypothesis that defects in these pathways could be interconnected phenomena responsible or consequence for the redox imbalance observed in ASD. High levels of 4-hydroxynonenal protein adducts together with increased NADPH (nicotinamide adenine dinucleotide phosphateoxidase) activity and mitochondrial superoxide production coupled with a compromised antioxidant response guided by a defective Nuclear Factor Erythroid 2-Related Factor 2 pathway confirmed an unbalanced redox homeostasis in ASD. Moreover, ASD fibroblasts showed overactive mitochondrial bioenergetics associated with atypical morphology and altered expression of mitochondrial electron transport chain complexes and dynamics-regulating factors. We suggest that many of the changes observed in mitochondria could represent compensatory mechanisms by which ASD cells try to adapt to altered energy demand, possibly resulting from a chronic oxinflammatory status.	[Pecorelli, Alessandra; Ferrara, Francesca; Messano, Nicolo; Schiavone, Maria Lucia; Woodby, Brittany; Valacchi, Giuseppe] NC State Univ, Plants Human Hlth Inst, Dept Anim Sci, NC Res Campus, Kannapolis, NC 28081 USA; [Ferrara, Francesca; Cordone, Valeria; Cervellati, Franco; Valacchi, Giuseppe] Univ Ferrara, Dept Biomed & Specialist Surg Sci, Ferrara, Italy; [Schiavone, Maria Lucia] Univ Siena, Dept Biotechnol Chem & Pharm, Siena, Italy; [Cervellati, Carlo] Univ Ferrara, Dept Biomed & Specialist Surg Sci, Sect Med Biochem Mol Biol & Genet, Ferrara, Italy; [Hayek, Joussef] Azienda Osped Univ Senese, Univ Gen Hosp, Child Neuropsychiat Unit, Siena, Italy; [Valacchi, Giuseppe] Kyung Hee Univ, Dept Food & Nutr, Seoul, South Korea	University of North Carolina; North Carolina State University; University of Ferrara; University of Siena; University of Ferrara; University of Siena; University Hospital of Siena; Kyung Hee University	Valacchi, G (corresponding author), NC State Univ, Plants Human Hlth Inst, Dept Anim Sci, NC Res Campus, Kannapolis, NC 28081 USA.	gvalacc@ncsu.edu	Cervellati, Carlo/K-6453-2015; Cordone, Valeria/HGB-2367-2022; Schiavone, Maria Lucia/AAV-6914-2021	Cervellati, Carlo/0000-0003-4777-6300; Cordone, Valeria/0000-0003-2791-8121; Schiavone, Maria Lucia/0000-0001-6728-3701; Woodby, Brittany/0000-0002-9518-9410				Auburger G, 2012, MOL NEUROBIOL, V46, P20, DOI 10.1007/s12035-012-8245-1; Baker N, 2019, MITOCHONDRION, V49, P259, DOI 10.1016/j.mito.2019.06.003; Bolte S, 2019, CELL MOL LIFE SCI, V76, P1275, DOI 10.1007/s00018-018-2988-4; Bu XS, 2017, NEUROPSYCH DIS TREAT, V13, P1633, DOI 10.2147/NDT.S129081; Carpita B, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/3717215; Carrasco M, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8040367; Castora FJ, 2019, PROG NEURO-PSYCHOPH, V92, P83, DOI 10.1016/j.pnpbp.2018.12.015; Cervellati C, 2015, BBA-MOL BASIS DIS, V1852, P2066, DOI 10.1016/j.bbadis.2015.07.014; Chen YX, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01487; Cheng JL, 2017, ADV EXP MED BIOL, V982, P359, DOI 10.1007/978-3-319-55330-6_20; Christensen DL, 2016, MMWR SURVEILL SUMM, V65, P1; Dong DY, 2018, AUTISM RES, V11, P1076, DOI 10.1002/aur.1966; Frye RE, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2012.143; Frye RE, 2012, J PEDIATR NEUROL, V10, P35, DOI 10.3233/JPN-2012-0530; Frye RE, 2011, J PEDIATR NEUROL, V9, P427, DOI 10.3233/JPN-2011-0507; Hayek J, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/5694058; Holmstrom Kira M., 2016, Current Opinion in Toxicology, V1, P80, DOI 10.1016/j.cotox.2016.10.002; Jastroch M, 2010, ESSAYS BIOCHEM, V47, P53, DOI [10.1042/BSE0470053, 10.1042/bse0470053]; Jyonouchi H, 2019, FRONT PSYCHIATRY, V10, DOI 10.3389/fpsyt.2019.00071; Klomparens EA, 2019, BRAIN CIRC, V5, P74, DOI 10.4103/bc.bc_7_19; Lai MC, 2014, LANCET, V383, P896, DOI 10.1016/S0140-6736(13)61539-1; Mohan S, 2018, BIOMED PHARMACOTHER, V108, P1866, DOI 10.1016/j.biopha.2018.10.019; Nadeem A, 2017, BRAIN BEHAV IMMUN, V61, P146, DOI 10.1016/j.bbi.2016.12.024; Napoli E, 2014, PEDIATRICS, V133, pE1405, DOI 10.1542/peds.2013-1545; Palmieri L, 2010, MOL PSYCHIATR, V15, P38, DOI 10.1038/mp.2008.63; Pecorelli A, 2020, REDOX BIOL, V28, DOI 10.1016/j.redox.2019.101334; Pecorelli A, 2016, CYTOKINE, V77, P180, DOI 10.1016/j.cyto.2015.10.002; Pecorelli A, 2013, BRAIN DEV-JPN, V35, P146, DOI 10.1016/j.braindev.2012.03.011; Perez MJ, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00553; Prior J.C., 2020, DRUG DISCOV TODAY, V32, P31, DOI [10.1016/j.ddmod.2020.11.005, DOI 10.1016/J.DDMOD.2020.11.005, DOI 10.1016/J.DDMOD.2019.11.001]; Rose S, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.15; Rose S, 2018, MOL DIAGN THER, V22, P571, DOI 10.1007/s40291-018-0352-x; Rose S, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-017-0089-z; Rose S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186377; Rose S, 2017, FASEB J, V31, P904, DOI 10.1096/fj.201601004R; Rose S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085436; Rossignol DA, 2012, MOL PSYCHIATR, V17, P290, DOI 10.1038/mp.2010.136; Siniscalco D, 2018, PHARMACEUTICALS-BASE, V11, DOI 10.3390/ph11020056; Stamova BS, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-30; Tang GM, 2013, NEUROBIOL DIS, V54, P349, DOI 10.1016/j.nbd.2013.01.006; Valacchi G, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00858; Zoroglu SS, 2004, EUR ARCH PSY CLIN N, V254, P143, DOI 10.1007/s00406-004-0456-7	42	13	13	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6521	6538		10.1096/fj.201902677R	http://dx.doi.org/10.1096/fj.201902677R		APR 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32246805				2022-12-28	WOS:000523592700001
J	Li, XH; Yang, ST; Han, L; Mao, KY; Yang, SY				Li, Xinhua; Yang, Shuting; Han, Lin; Mao, Keya; Yang, Shuying			Ciliary IFT80 is essential for intervertebral disc development and maintenance	FASEB JOURNAL			English	Article						annulus fibrosus; IFT80; intervertebral disc degeneration; nucleus pulposus; primary cilia	ENDOSCOPIC LUMBAR DISKECTOMY; PRIMARY CILIUM; ANNULUS FIBROSUS; HEDGEHOG; DEGENERATION; CELLS; CHONDROCYTES; EXPRESSION; MODELS; LENGTH	The intervertebral disc degeneration (IVDD)-related diseases occur in more than 90% of the population older than 50 years. Owing to the lack of understanding of the cellular mechanisms involved in IVDD formation effective treatment options are still unavailable. Primary cilia are microtubule-based organelles that play important roles in the organ development. Intraflagellar transport (IFT) proteins are essential for the assembly and bidirectional transport within the cilium. Role of cilia and IFT80 protein in intervertebral disc (IVD) development, maintenance, and degeneration are largely unknown. Using cilia-GFP mice, we found presence of cilia on growth plate (GP), cartilage endplate (EP) annulus fibrosus (AF), and nucleus pulposus (NP) with varying ciliary length. Cilia length in NP and AF during IVDD were significantly decreased. However, cilia numbers increased by 63% in AF during repair. Deletion of IFT80 in type II collagen-positive cells resulted in cilia loss in GP and EP, and disrupted IVD structure with disorganized and decreased GP, EP, and internal AF (IAF), and less compact and markedly decreased gel-like matrix in the NP. Deletion of IFT80 in type I collagen-positive cells led to a disorganized outer AF (OAF) with thinner, loosened, and disconnected fiber alignment. Mechanistic analyses showed that loss of IFT80 caused a significant increase in cell apoptosis in the IVD, and a marked decrease in expression of chondrogenic markers - type II collagen, sox9, aggrecan, and hedgehog (Hh) signaling components, including Gli1 and Patch1 in the IVD of IFT80(fl/fl); Col2-creERT mice, and Gli1 and Patch1 expression in the OAF of IFT80(fl/fl); Col1-creERT mice. Interestingly, Smoothened agonist-SAG rescued OAF cell proliferation and osteogenic differentiation. Our findings demonstrate that ciliary IFT80 is important for the maintenance of IVD cell organization and function through regulating the cell survival and Hh signaling.	[Li, Xinhua; Yang, Shuting; Yang, Shuying] Univ Penn, Sch Dent Med, Dept Basic & Translat Sci, 240 South 40th St,Levy 437, Philadelphia, PA 19104 USA; [Li, Xinhua] Tongji Univ, East Hosp, Sch Med, Dept Spinal Surg, Shanghai, Peoples R China; [Han, Lin] Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA; [Mao, Keya] Chinese PLA Gen Hosp 301 Hosp, Dept Orthoped, Beijing, Peoples R China; [Yang, Shuying] Univ Penn, Sch Med, Penn Ctr Musculoskeletal Disorders, Philadelphia, PA 19104 USA; [Yang, Shuying] Univ Penn, Sch Engn & Appl Sci, Sch Dent Med, Ctr Innovat & Precis Dent, Philadelphia, PA 19104 USA	University of Pennsylvania; Tongji University; Drexel University; University of Pennsylvania; University of Pennsylvania	Yang, SY (corresponding author), Univ Penn, Sch Dent Med, Dept Basic & Translat Sci, 240 South 40th St,Levy 437, Philadelphia, PA 19104 USA.	shuyingy@upenn.edu	Li, Xinhua/ABE-7575-2020	Yang, Shuying/0000-0002-7126-6901; Li, Xinhua/0000-0002-4387-3229	HHS\ NIH\ National Institute of Dental and Craniofacial Research (NIDCR) [DE023105]; HHS \ NIH \ National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [AR066101]; HHS \ NIH\ National Institute on Aging (NIA) [AG048388]	HHS\ NIH\ National Institute of Dental and Craniofacial Research (NIDCR); HHS \ NIH \ National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); HHS \ NIH\ National Institute on Aging (NIA)	HHS vertical bar NIH vertical bar National Institute of Dental and Craniofacial Research (NIDCR), Grant/Award Number: DE023105; HHS vertical bar NIH vertical bar National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Grant/Award Number: AR066101; HHS vertical bar NIH vertical bar National Institute on Aging (NIA), Grant/Award Number: AG048388	Adams MA, 2006, SPINE, V31, P2151, DOI 10.1097/01.brs.0000231761.73859.2c; Alini M, 2008, EUR SPINE J, V17, P2, DOI 10.1007/s00586-007-0414-y; Alvarez-Satta M, 2019, AGEING RES REV, V52, P53, DOI 10.1016/j.arr.2019.04.004; Ballarin-Gonzalez B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056029; Beales PL, 2007, NAT GENET, V39, P727, DOI 10.1038/ng2038; Bedore J, 2016, J CELL COMMUN SIGNAL, V10, P137, DOI 10.1007/s12079-016-0329-7; Boos N, 2002, SPINE, V27, P2631, DOI 10.1097/00007632-200212010-00002; Challis RC, 2015, CURR BIOL, V25, P2503, DOI 10.1016/j.cub.2015.07.065; Chang CF, 2012, OSTEOARTHR CARTILAGE, V20, P152, DOI 10.1016/j.joca.2011.11.009; Chang CF, 2013, J ORTHOP RES, V31, P350, DOI 10.1002/jor.22237; Choi BKA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220056; Choksi SP, 2014, DEVELOPMENT, V141, P1427, DOI 10.1242/dev.074666; Cornils A, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006325; Daly C, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/5952165; Donnelly E, 2008, ANAT REC, V291, P1062, DOI 10.1002/ar.20665; Dummer Anneloes, 2016, Cilia, V5, P7, DOI 10.1186/s13630-016-0028-2; Gambassi S, 2017, J CELL PHYSIOL, V232, P3103, DOI 10.1002/jcp.25761; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Grimes DT, 2016, SCIENCE, V352, P1341, DOI 10.1126/science.aaf6419; Killion CH, 2017, MOL BIOL CELL, V28, P1862, DOI 10.1091/mbc.E17-02-0084; Li Q, 2017, ACTA BIOMATER, V54, P356, DOI 10.1016/j.actbio.2017.02.043; Li XH, 2016, J CLIN NEUROSCI, V33, P19, DOI 10.1016/j.jocn.2016.01.043; Li XH, 2016, INT J SURG, V27, P8, DOI 10.1016/j.ijsu.2016.01.034; Li YW, 2017, ELIFE, V6, DOI 10.7554/eLife.23279; Liu C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108239; Maeda Y, 2007, P NATL ACAD SCI USA, V104, P6382, DOI 10.1073/pnas.0608449104; McCann MR, 2016, J DEV BIOL, V4, DOI 10.3390/jdb4010003; MILLER JM, 1988, SYST BOT, V13, P173, DOI 10.1097/00007632-198802000-00008; Moriguchi Y, 2016, GLOB SPINE J, V6, P497, DOI 10.1055/s-0036-1571955; Nakamichi R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12503; Nakamura E, 2006, DEV DYNAM, V235, P2603, DOI 10.1002/dvdy.20892; Noda K, 2016, P NATL ACAD SCI USA, V113, pE2589, DOI 10.1073/pnas.1519458113; Ponticos M, 2004, MATRIX BIOL, V22, P619, DOI 10.1016/j.matbio.2003.12.002; Raj P Prithvi, 2008, Pain Pract, V8, P18, DOI 10.1111/j.1533-2500.2007.00171.x; Rajesh Diviya, 2018, Curr Mol Biol Rep, V4, P173, DOI 10.1007/s40610-018-0107-9; Resnick A, 2007, BIOPHYS J, V93, P1380, DOI 10.1529/biophysj.107.105007; Risbud MV, 2011, CRIT REV EUKAR GENE, V21, P29, DOI 10.1615/CritRevEukarGeneExpr.v21.i1.30; Ruhlen R, 2014, OSTEOARTHR CARTILAGE, V22, P1071, DOI 10.1016/j.joca.2014.05.011; Seeger-Nukpezah T, 2012, CURR OPIN CELL BIOL, V24, P652, DOI 10.1016/j.ceb.2012.06.002; Shen X, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01450; Thorpe SD, 2017, J CELL PHYSIOL, V232, P2407, DOI 10.1002/jcp.25839; Tian ZZ, 2018, AM J PHYS MED REHAB, V97, P170, DOI 10.1097/PHM.0000000000000818; Tong W, 2017, TRANSL RES, V181, P49, DOI 10.1016/j.trsl.2016.11.008; Torre OM, 2018, FASEB J, V32, P4753, DOI 10.1096/fj.201701492R; Vergroesen PPA, 2015, OSTEOARTHR CARTILAGE, V23, P1057, DOI 10.1016/j.joca.2015.03.028; Vo NV, 2016, J ORTHOP RES, V34, P1289, DOI 10.1002/jor.23195; Wang CD, 2013, EXP CELL RES, V319, P623, DOI 10.1016/j.yexcr.2012.12.028; Wang SX, 2013, BBA-MOL BASIS DIS, V1832, P1582, DOI 10.1016/j.bbadis.2013.05.023; WHITE T L, 1990, Journal of Orthopaedic and Sports Physical Therapy, V12, P139; Yuan XM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144773; Yuan X, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11024; Zhang YJ, 2019, AM J PHYS MED REHAB, V98, P35, DOI 10.1097/PHM.0000000000001012; Zheng LW, 2018, BONE RES, V6, DOI 10.1038/s41413-018-0022-y	53	16	16	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6741	6756		10.1096/fj.201902838R	http://dx.doi.org/10.1096/fj.201902838R		MAR 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32227389	Bronze, Green Accepted			2022-12-28	WOS:000522486700001
J	Carmon, O; Laguerre, F; Riachy, L; Delestre-Delacour, C; Wang, QL; Tanguy, E; Jeandel, L; Cartier, D; Thahouly, T; Haeberle, AM; Fouillen, L; Rezazgui, O; Schapman, D; Haefele, A; Goumon, Y; Galas, L; Renard, PY; Alexandre, S; Vitale, N; Anouar, Y; Montero-Hadjadje, M				Carmon, Ophelie; Laguerre, Fanny; Riachy, Lina; Delestre-Delacour, Charlene; Wang, Qili; Tanguy, Emeline; Jeandel, Lydie; Cartier, Dorthe; Thahouly, Tamou; Haeberle, Anne-Marie; Fouillen, Laetitia; Rezazgui, Olivier; Schapman, Damien; Haefele, Alexandre; Goumon, Yannick; Galas, Ludovic; Renard, Pierre-Yves; Alexandre, Stephane; Vitale, Nicolas; Anouar, Youssef; Montero-Hadjadje, Maite			Chromogranin A preferential interaction with Golgi phosphatidic acid induces membrane deformation and contributes to secretory granule biogenesis	FASEB JOURNAL			English	Article						Golgi apparatus; membrane dynamics; organelle biogenesis; phospholipase D	DENSE-CORE VESICLES; PHOSPHOLIPASE D1; SECRETOGRANIN-II; PEPTIDE; LOCALIZATION; MECHANISMS; CATESTATIN; NETWORK; IDENTIFICATION; HYPERTENSION	Chromogranin A (CgA) is a key luminal actor of secretory granule biogenesis at the trans-Golgi network (TGN) level but the molecular mechanisms involved remain obscure. Here, we investigated the possibility that CgA acts synergistically with specific membrane lipids to trigger secretory granule formation. We show that CgA preferentially interacts with the anionic glycerophospholipid phosphatidic acid (PA). In accordance, bioinformatic analysis predicted a PA-binding domain (PABD) in CgA sequence that effectively bound PA (36:1) or PA (40:6) in membrane models. We identified PA (36:1) and PA (40:6) as predominant species in Golgi and granule membranes of secretory cells, and we found that CgA interaction with these PA species promotes artificial membrane deformation and remodeling. Furthermore, we demonstrated that disruption of either CgA PABD or phospholipase D (PLD) activity significantly alters secretory granule formation in secretory cells. Our findings show for the first time the ability of CgA to interact with PLD-generated PA, which allows membrane remodeling and curvature, key processes necessary to initiate secretory granule budding.	[Carmon, Ophelie; Laguerre, Fanny; Riachy, Lina; Delestre-Delacour, Charlene; Jeandel, Lydie; Cartier, Dorthe; Anouar, Youssef; Montero-Hadjadje, Maite] Normandie Univ, Inst Rech & Innovat Biomed Normandie, Lab Differenciat & Commun Neuronale & Neuroendocr, UNIROUEN,INSERM,U1239, F-76000 Rouen, France; [Wang, Qili; Tanguy, Emeline; Thahouly, Tamou; Haeberle, Anne-Marie; Goumon, Yannick; Vitale, Nicolas] Univ Strasbourg, CNRS, Inst Neurosci Cellulaires & Integrat, Strasbourg, France; [Fouillen, Laetitia] Univ Bordeaux, Lab Biogenese Membranaire, Plateforme Metabolome, UMR 5200,CNRS, Villenave Domon, France; [Rezazgui, Olivier; Haefele, Alexandre; Renard, Pierre-Yves] Normandie Univ, COBRA, UNIROUEN, INSA,Rouen CNRS,UMR 6014, Rouen, France; [Rezazgui, Olivier; Haefele, Alexandre; Renard, Pierre-Yves] FR 3038, Rouen, France; [Schapman, Damien; Galas, Ludovic] Normandie Univ, PRIMACEN, INSERM, UNIROUEN, Rouen, France; [Alexandre, Stephane] Normandie Univ, UNIROUEN, UMR 6270, Polymeres,Biopolymeres,Surfaces Lab,CNRS, Rouen, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC)	Montero-Hadjadje, M (corresponding author), Normandie Univ, Inst Rech & Innovat Biomed Normandie, Lab Differenciat & Commun Neuronale & Neuroendocr, UNIROUEN,INSERM,U1239, F-76000 Rouen, France.	maite.montero@univ-rouen.fr	Vitale, Nicolas/G-5967-2014; renard, pierre-yves/ABG-9624-2021; Anouar, Youssef/F-9683-2017; FOUILLEN, Laetitia/AAV-9710-2020	Vitale, Nicolas/0000-0002-4752-4907; renard, pierre-yves/0000-0001-9094-9778; FOUILLEN, Laetitia/0000-0002-1204-9296; Goumon, Yannick/0000-0003-4336-3437; Riachy, Lina/0000-0003-2543-3585; THAHOULY, Tamou/0000-0001-5980-6859; MONTERO, Maite/0000-0001-8859-893X	Fondation pour la Recherche Medicale (FRM) [DEI20151234424]; European Regional Development Fund (ERDF) [ERDF DO-IT2015]; Ministere de la Recherche et de l'Enseignement Superieur; European Union; Region Normandie; Agence Nationale de la Recherche (ANR) [ANR-11-INBS-0010]	Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); European Regional Development Fund (ERDF)(European Commission); Ministere de la Recherche et de l'Enseignement Superieur; European Union(European Commission); Region Normandie(Region Normandie); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR))	Fondation pour la Recherche Medicale (FRM), Grant/Award Number: DEI20151234424; European Regional Development Fund (ERDF), Grant/Award Number: ERDF DO-IT2015 and ERDF PACT-CBS; Ministere de la Recherche et de l'Enseignement Superieur; European Union and Region Normandie; Agence Nationale de la Recherche (ANR), Grant/Award Number: ANR-11-INBS-0010	Abbineni PS, 2019, J GEN PHYSIOL, V151, P118, DOI 10.1085/jgp.201812182; Ammar MR, 2015, SCI REP-UK, V5, DOI 10.1038/srep14778; Ammar MR, 2013, J NEUROSCI, V33, P19470, DOI 10.1523/JNEUROSCI.2283-13.2013; Anouar Y, 1998, J CLIN ENDOCR METAB, V83, P2944, DOI 10.1210/jc.83.8.2944; Aunis D, 2001, M S-MED SCI, V17, P418, DOI 10.4267/10608/1941; Bandyopadhyay GK, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00020; Benard M, 2015, BIOL CELL, V107, P419, DOI 10.1111/boc.201500004; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Blois A, 2006, REGUL PEPTIDES, V134, P30, DOI 10.1016/j.regpep.2005.11.003; BRAKS JAM, 1994, CELL, V78, P263, DOI 10.1016/0092-8674(94)90296-8; CHANAT E, 1991, J CELL BIOL, V115, P1505, DOI 10.1083/jcb.115.6.1505; Chevalier A, 2013, CHEM-EUR J, V19, P1686, DOI 10.1002/chem.201203427; Cruz-Garcia D, 2013, EMBO J, V32, P1717, DOI 10.1038/emboj.2013.116; Cullis PR, 1997, BBA-REV BIOMEMBRANES, V1331, P187, DOI 10.1016/S0304-4157(97)00006-3; Delestre-Delacour C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05617-1; Dhanvantari S, 2002, BIOCHEMISTRY-US, V41, P52, DOI 10.1021/bi015698n; Dondossola E, 2010, CELL MOL LIFE SCI, V67, P2107, DOI 10.1007/s00018-010-0319-5; Duran JM, 2012, EMBO J, V31, P4535, DOI 10.1038/emboj.2012.317; Elias S, 2012, ENDOCRINOLOGY, V153, P4444, DOI 10.1210/en.2012-1436; Elias S, 2010, CELL MOL NEUROBIOL, V30, P1189, DOI 10.1007/s10571-010-9595-8; Freyberg Z, 2003, TRENDS CELL BIOL, V13, P540, DOI 10.1016/j.tcb.2003.08.004; Freyberg Z, 2001, MOL BIOL CELL, V12, P943, DOI 10.1091/mbc.12.4.943; Galas L, 2018, CHEMOSENSORS, V6, DOI 10.3390/chemosensors6030040; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Gehart H, 2012, DEV CELL, V23, P756, DOI 10.1016/j.devcel.2012.07.019; Gondre-Lewis MC, 2006, J CELL SCI, V119, P1876, DOI 10.1242/jcs.02906; Gondre-Lewis MC, 2012, INT REV CEL MOL BIO, V299, P27, DOI 10.1016/B978-0-12-394310-1.00002-3; Graham J M, 2001, Curr Protoc Cell Biol, VChapter 3, DOI [10.1002/0471143030.cb0306s07, 10.1002/0471143030.cb0309s10]; Holthuis JCM, 2014, NATURE, V510, P48, DOI 10.1038/nature13474; Hummer BH, 2017, MOL BIOL CELL, V28, P3870, DOI 10.1091/mbc.E17-08-0491; Huston E, 2006, J CELL SCI, V119, P3799, DOI 10.1242/jcs.03106; Kang YK, 1997, FEBS LETT, V404, P87, DOI 10.1016/S0014-5793(97)00099-9; Kassas N, 2017, J BIOL CHEM, V292, P4266, DOI 10.1074/jbc.M116.742346; Kim T, 2001, CELL, V106, P499, DOI 10.1016/S0092-8674(01)00459-7; Kiranmayi M, 2016, HYPERTENSION, V68, P334, DOI 10.1161/HYPERTENSIONAHA.116.06568; Kooijman EE, 2003, TRAFFIC, V4, P162, DOI 10.1034/j.1600-0854.2003.00086.x; Mahapatra NR, 2005, J CLIN INVEST, V115, P1942, DOI 10.1172/JCI24354; Makowski Stefanie L., 2020, Advances in Biological Regulation, V75, P100661, DOI 10.1016/j.jbior.2019.100661; Miao R, 2019, J BIOL CHEM, V294, P6214, DOI 10.1074/jbc.RA118.006876; Montero-Hadjadje M, 2008, ACTA PHYSIOL, V192, P309, DOI 10.1111/j.1748-1716.2007.01806.x; Montero-Hadjadje M, 2002, CELL TISSUE RES, V310, P223, DOI 10.1007/s00441-002-0625-9; Montero-Hadjadje M, 2009, J BIOL CHEM, V284, P12420, DOI 10.1074/jbc.M805607200; Park SY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11324-4; Pasqua T, 2016, CELL TISSUE RES, V363, P693, DOI 10.1007/s00441-015-2316-3; Pierce MM, 1999, METHODS, V19, P213, DOI 10.1006/meth.1999.0852; Pomorski TG, 2016, PROG LIPID RES, V64, P69, DOI 10.1016/j.plipres.2016.08.003; Potocky M, 2014, NEW PHYTOL, V203, P483, DOI 10.1111/nph.12814; Rahajeng J, 2019, DEV CELL, V50, P573, DOI 10.1016/j.devcel.2019.05.038; Riebeling C, 2009, BBA-MOL CELL BIOL L, V1791, P876, DOI 10.1016/j.bbalip.2009.04.003; Sahu BS, 2012, J BIOL CHEM, V287, P43840, DOI 10.1074/jbc.M112.407916; Shui GH, 2010, MOL BIOSYST, V6, P1008, DOI 10.1039/b913353d; Siddhanta A, 1998, J BIOL CHEM, V273, P17995, DOI 10.1074/jbc.273.29.17995; Sugawara M, 2010, FASEB J, V24, P1737, DOI 10.1096/fj.09-142554; Surma MA, 2012, BBA-MOL CELL BIOL L, V1821, P1059, DOI 10.1016/j.bbalip.2011.12.008; Tanguy E, 2018, BIOMOLECULES, V8, DOI 10.3390/biom8020020; Tanguy E, 2016, J NEUROCHEM, V137, P904, DOI 10.1111/jnc.13577; Taupenot L, 2003, NEW ENGL J MED, V348, P1134, DOI 10.1056/NEJMra021405; Vitale N, 2002, J CELL BIOL, V159, P79, DOI 10.1083/jcb.200203027; Vitale N, 2001, EMBO J, V20, P2424, DOI 10.1093/emboj/20.10.2424; Zhukovsky MA, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00291	60	6	8	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6769	6790		10.1096/fj.202000074R	http://dx.doi.org/10.1096/fj.202000074R		MAR 2020	22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32227388	Green Submitted, Bronze			2022-12-28	WOS:000522484500001
J	Babu, SPSP; White, D; Corson, TW				Pran Babu, Sardar Pasha Sheik; White, Darcy; Corson, Timothy W.			Ferrochelatase regulates retinal neovascularization	FASEB JOURNAL			English	Article						angiogenesis; griseofulvin; heme synthesis; retina; vasculature	ENDOTHELIAL GROWTH-FACTOR; OXYGEN-INDUCED RETINOPATHY; MOUSE MODEL; ANTI-VEGF; ERYTHROPOIETIC PROTOPORPHYRIA; DIABETIC-RETINOPATHY; THERAPEUTIC TARGET; IN-VIVO; ANGIOGENESIS; INHIBITION	Ferrochelatase (FECH) is the terminal enzyme in heme biosynthesis. We previously showed that FECH is required for endothelial cell growth in vitro and choroidal neovascularization in vivo. But FECH has not been explored in retinal neovascularization, which underlies diseases like proliferative diabetic retinopathy and retinopathy of prematurity. Here, we investigated the inhibition of FECH using genetic and chemical approaches in the oxygen-induced retinopathy (OIR) mouse model. In OIR mice, FECH expression is upregulated and co-localized with neovascular tufts. Partial loss-of-functionFech(m1Pas) mutant mice showed reduced retinal neovascularization and endothelial cell proliferation in OIR. An intravitreal injection of the FECH inhibitorN-methyl protoporphyrin had similar effects. Griseofulvin is an antifungal drug that inhibits FECH as an off-target effect. Strikingly, intravitreal griseofulvin decreased both pathological tuft formation and areas of vasoobliteration compared to vehicle, suggesting potential as a FECH-targeting therapy. Ocular toxicity studies revealed that intravitreal injection of griseofulvin in adult mice does not disrupt retinal vasculature, function, or morphology. In sum, mutation and chemical inhibition ofFechreduces retinal neovascularization and promotes physiological angiogenesis, suggesting a dual effect on vascular repair upon FECH inhibition, without ocular toxicity. These findings suggest that FECH inhibitors could be repurposed to treat retinal neovascularization.	[Pran Babu, Sardar Pasha Sheik; White, Darcy; Corson, Timothy W.] Indiana Univ Sch Med, Eugene & Marilyn Glick Eye Inst, Indianapolis, IN 46202 USA; [Pran Babu, Sardar Pasha Sheik; White, Darcy; Corson, Timothy W.] Indiana Univ Sch Med, Dept Ophthalmol, Indianapolis, IN 46202 USA; [Corson, Timothy W.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Corson, Timothy W.] Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Corson, TW (corresponding author), Indiana Univ Sch Med, Eugene & Marilyn Glick Eye Inst, Dept Ophthalmol, 1160 West Michigan St, Indianapolis, IN 46202 USA.	tcorson@iu.edu	Corson, Timothy W./B-6851-2009	Corson, Timothy W./0000-0002-1402-7875	HHS \ NIH \ National Eye Institute (NEI) [R01EY025641]; BrightFocus Foundation (BrightFocus) [M2019069]	HHS \ NIH \ National Eye Institute (NEI); BrightFocus Foundation (BrightFocus)(BrightFocus Foundation)	HHS vertical bar NIH vertical bar National Eye Institute (NEI), Grant/Award Number: R01EY025641; BrightFocus Foundation (BrightFocus), Grant/Award Number: M2019069	Abbott NJ, 2002, J ANAT, V200, P629, DOI 10.1046/j.1469-7580.2002.00064.x; Aghdam KA, 2016, J AAPOS, V20, P539, DOI 10.1016/j.jaapos.2016.09.013; Aiello LP, 2005, NEW ENGL J MED, V353, P839, DOI 10.1056/NEJMe058142; Araujo JA, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00119; Barber AJ, 2003, INVEST OPHTH VIS SCI, V44, P5410, DOI 10.1167/iovs.03-0244; Basavarajappa HD, 2017, EMBO MOL MED, V9, P786, DOI 10.15252/emmm.201606561; Basavarajappa HD, 2015, J MED CHEM, V58, P5015, DOI 10.1021/acs.jmedchem.5b00449; BOULECHFAR S, 1993, GENOMICS, V16, P645, DOI 10.1006/geno.1993.1242; Bussolati B, 2004, BLOOD, V103, P761, DOI 10.1182/blood-2003-06-1974; Bussolati B, 2006, ANTIOXID REDOX SIGN, V8, P1153, DOI 10.1089/ars.2006.8.1153; Campochiaro PA, 2000, J CELL PHYSIOL, V184, P301, DOI 10.1002/1097-4652(200009)184:3<301::AID-JCP3>3.0.CO;2-H; Campochiaro PA, 2015, PROG RETIN EYE RES, V49, P67, DOI 10.1016/j.preteyeres.2015.06.002; Cardiff Robert D, 2014, Cold Spring Harb Protoc, V2014, P655, DOI 10.1101/pdb.prot073411; Chang AA, 2003, CLIN EXP OPHTHALMOL, V31, P300, DOI 10.1046/j.1442-9071.2003.00664.x; Chiabrando D, 2014, HAEMATOLOGICA, V99, P973, DOI 10.3324/haematol.2013.091991; Chiabrando D, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00061; Chung AS, 2011, ANNU REV CELL DEV BI, V27, P563, DOI 10.1146/annurev-cellbio-092910-154002; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; DeNiro M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022244; Economopoulou M, 2009, NAT MED, V15, P553, DOI 10.1038/nm.1947; Feit-Leichman RA, 2005, INVEST OPHTH VIS SCI, V46, P4281, DOI 10.1167/iovs.04-1361; Ferrara N, 2016, TRANSL VIS SCI TECHN, V5, DOI 10.1167/tvst.5.2.10; Fukushima Y, 2011, J CLIN INVEST, V121, P1974, DOI 10.1172/JCI44900; Gariano RF, 2005, NATURE, V438, P960, DOI 10.1038/nature04482; Hamza I, 2012, BBA-MOL CELL RES, V1823, P1617, DOI 10.1016/j.bbamcr.2012.04.009; Hartnett ME, 2012, NEW ENGL J MED, V367, P2515, DOI 10.1056/NEJMra1208129; Hofer T, 2003, BLOOD, V101, P348, DOI 10.1182/blood-2002-03-0773; Joyal JS, 2011, BLOOD, V117, P6024, DOI 10.1182/blood-2010-10-311589; Jozkowicz A, 2003, ANTIOXID REDOX SIGN, V5, P155, DOI 10.1089/152308603764816514; Karl Mike O, 2012, Methods Mol Biol, V884, P213, DOI 10.1007/978-1-61779-848-1_15; Kim CB, 2016, EYE BRAIN, V8, P67, DOI 10.2147/EB.S94447; Lecha M, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-19; Lee B, 2014, ORG BIOMOL CHEM, V12, P7673, DOI 10.1039/c4ob01604a; Liu K, 2015, BIOCHEM PHARMACOL, V98, P493, DOI 10.1016/j.bcp.2015.09.002; Liu YYL, 2004, LIFE SCI, V75, P2035, DOI 10.1016/j.lfs.2004.03.027; Loffler K, 2015, GLIA, V63, P1809, DOI 10.1002/glia.22846; Madan A, 2003, FRONT BIOSCI-LANDMRK, V8, pD1030, DOI 10.2741/1056; Martinez MDC, 2009, CELL MOL BIOL, V55, P127, DOI 10.1170/T862; Moran EP, 2016, AM J PHYSIOL-HEART C, V311, pH738, DOI 10.1152/ajpheart.00005.2016; Ozaki H, 1999, INVEST OPHTH VIS SCI, V40, P182; Pasha SPBS, 2018, J PHARMACOL EXP THER, V367, P108, DOI 10.1124/jpet.118.248088; Pasha SPBS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09743-8; Penn JS, 2008, PROG RETIN EYE RES, V27, P331, DOI 10.1016/j.preteyeres.2008.05.001; Petersen AB, 2014, CHEM REV, V114, P12088, DOI 10.1021/cr400368e; Sankar MJ, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009734.pub2; Sapieha P, 2010, J CLIN INVEST, V120, P3022, DOI 10.1172/JCI42142; Schmucker C, 2004, VISION RES, V44, P2445, DOI 10.1016/j.visres.2004.05.018; Schmucker C, 2004, VISION RES, V44, P1857, DOI 10.1016/j.visres.2004.03.011; Severance S, 2009, CHEM REV, V109, P4596, DOI 10.1021/cr9001116; Shetty T, ISCIENCE, DOI [10.1101/836304, DOI 10.1101/836304]; Shetty T, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.01015; Shi Z, 2006, BIOCHEM J, V399, P21, DOI 10.1042/BJ20060753; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; Smith CM, 2017, SCI REP-UK, V7, DOI 10.1038/srep41975; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Stahl A, 2010, INVEST OPHTH VIS SCI, V51, P2813, DOI 10.1167/iovs.10-5176; Sulaiman RS, 2018, ACS CHEM BIOL, V13, P45, DOI 10.1021/acschembio.7b00854; Sulaiman RS, 2016, SCI REP-UK, V6, DOI 10.1038/srep25509; Tsuboi H, 2007, J DERMATOL, V34, P790, DOI 10.1111/j.1346-8138.2007.00386.x; TUTOIS S, 1991, J CLIN INVEST, V88, P1730, DOI 10.1172/JCI115491; van Eeden PE, 2006, ADV EXP MED BIOL, V572, P163; Vandekeere S, 2018, CELL METAB, V28, P573, DOI 10.1016/j.cmet.2018.06.009; VanderVeen DK, 2019, SEMIN PERINATOL, V43, P375, DOI 10.1053/j.semperi.2019.05.011; VanderVeen DK, 2017, OPHTHALMOLOGY, V124, P619, DOI 10.1016/j.ophtha.2016.12.025; Wenzel Andrea A, 2015, Mol Vis, V21, P515; Wu AL, 2018, ASIA-PAC J OPHTHALMO, V7, P145, DOI 10.22608/APO.201837; Wu JH, 2016, J CHEM INF MODEL, V56, P2421, DOI 10.1021/acs.jcim.6b00216; Zhang B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200307; Zhao L, 2009, EXP EYE RES, V88, P1004, DOI 10.1016/j.exer.2008.12.013; Zhao M, 2011, EXP EYE RES, V93, P921, DOI 10.1016/j.exer.2011.10.013	70	11	11	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12419	12435		10.1096/fj.202000964R	http://dx.doi.org/10.1096/fj.202000964R		JUL 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32716567	Green Submitted, Green Accepted			2022-12-28	WOS:000556423500001
J	Chen, AZ; Bai, L; Zhong, KK; Shu, XQ; Wang, AL; Xiao, YT; Zhang, KJ; Shen, CY				Chen, Aizhong; Bai, Lei; Zhong, Keke; Shu, Xiaoqiu; Wang, Ailian; Xiao, Yatao; Zhang, Kejing; Shen, Chengyong			APC2(CDH1)negatively regulates agrin signaling by promoting the ubiquitination and proteolytic degradation of DOK7	FASEB JOURNAL			English	Article						agrin; APC; C; DOK7; MuSK; neuromuscular junction	NEUROMUSCULAR-JUNCTION FORMATION; TYROSINE KINASE MUSK; DISTINCT ROLES; CELL-CYCLE; D BOX; MUSCLE; RECEPTOR; COMPLEX; PROTEIN; MAINTENANCE	Neuromuscular junctions (NMJs) are peripheral synapses between motoneurons and skeletal muscle fibers that are critical for the control of muscle contraction. Dysfunction of these synapses has been implicated in congenital myasthenic syndrome (CMS). In vertebrates, agrin-LRP4-MuSK signaling plays a critical role in acetylcholine receptor (AChR) clustering and NMJ formation. The adaptor protein DOK7 is the downstream substrate of MuSK and also a cytoplasmic activator of MuSK. The role of DOK7 in the promotion of AChR clustering and the mechanisms involved have been well studied; however, the negative regulation of DOK7 after MuSK activation remains unknown. Anaphase-promoting complex 2 (APC2), the core subunit of APC/C E3 ligase complex, was originally believed to regulate cell-cycle transitions. Here, we show that APC2 is enriched at post-synapse of NMJs in postmitotic myotubes. In response to agrin stimulation, APC2 negatively regulates AChR clustering by promoting the ubiquitination of DOK7 at lysine 243 for its proteolytic degradation, which relies on MuSK kinase activity and the phosphorylation of tyrosine 106 in DOK7. Thus, this study provides a mechanism whereby agrin signaling is negatively regulated as part of vertebrate NMJ homeostasis.	[Chen, Aizhong; Bai, Lei; Zhong, Keke; Shu, Xiaoqiu; Wang, Ailian; Xiao, Yatao; Zhang, Kejing; Shen, Chengyong] Zhejiang Univ, Affiliated Hosp 1, Inst Translat Med, Sch Med, 268 Kaixuan Rd, Hangzhou, Zhejiang, Peoples R China; [Shen, Chengyong] Zhejiang Univ, Sch Med, Dept Neurobiol, Key Lab Med Neurobiol Zhejiang Prov, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Shen, CY (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Inst Translat Med, Sch Med, 268 Kaixuan Rd, Hangzhou, Zhejiang, Peoples R China.	cshen@zju.edu.cn		Chen, Aizhong/0000-0003-1962-7375	Zhejiang Provincial Natural Science Foundation of China [LR17H090001]; National Key Research and Development Program of China [2017YFA0104903]; National Natural Science Foundation of China [31671040, 31871203, 31701036]	Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We are grateful to the histology core at Zhejiang University for image analysis and Shen laboratory members for their suggestions. We are grateful to Dr Lin Mei, Dr Yi Sun, Dr Yongchao Zhao, and Dr Qingqing Wang for materials and suggestions. This work was supported, in part, by grants from Zhejiang Provincial Natural Science Foundation of China (LR17H090001 to SC), the National Key Research and Development Program of China (2017YFA0104903 to SC), and National Natural Science Foundation of China (31671040, 31871203 to SC, 31701036 to KZ).	Alfieri C, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170204; Arimura S, 2014, SCIENCE, V345, P1505, DOI 10.1126/science.1250744; Beeson D, 2006, SCIENCE, V313, P1975, DOI 10.1126/science.1130837; Bergamin E, 2010, MOL CELL, V39, P100, DOI 10.1016/j.molcel.2010.06.007; Bezakova G, 2003, NAT REV MOL CELL BIO, V4, P295, DOI 10.1038/nrm1074; Bobo-Jimenez V, 2017, P NATL ACAD SCI USA, V114, P4513, DOI 10.1073/pnas.1616024114; Bromann PA, 2004, GENE EXPR PATTERNS, V4, P77, DOI 10.1016/S1567-133X(03)00146-7; Burden SJ, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009167; Buyan A, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005028; Cossins J, 2012, HUM MOL GENET, V21, P3765, DOI 10.1093/hmg/dds198; Darabid H, 2014, NAT REV NEUROSCI, P1; DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9; Durnberger G, 2014, MOL CELL PROTEOMICS, V13, P1993, DOI 10.1074/mcp.M113.036087; Eguchi T, 2020, BIOCHEM BIOPH RES CO, V523, P214, DOI 10.1016/j.bbrc.2019.12.011; Fu AKY, 2011, NAT NEUROSCI, V14, P181, DOI 10.1038/nn.2715; Ganner A, 2009, P NATL ACAD SCI USA, V106, P17799, DOI 10.1073/pnas.0909465106; Garcia-Higuera I, 2008, NAT CELL BIOL, V10, P802, DOI 10.1038/ncb1742; Gieffers C, 1999, P NATL ACAD SCI USA, V96, P11317, DOI 10.1073/pnas.96.20.11317; Glass DJ, 1996, CELL, V85, P513, DOI 10.1016/S0092-8674(00)81252-0; Guo ZG, 2012, MOL CELL, V47, P444, DOI 10.1016/j.molcel.2012.05.042; Hallock PT, 2010, GENE DEV, V24, P2451, DOI 10.1101/gad.1977710; Hamuro J, 2008, J BIOL CHEM, V283, P5518, DOI 10.1074/jbc.M708607200; He J, 2013, MOL CELL, V50, P649, DOI 10.1016/j.molcel.2013.04.024; Herbst R, 2000, EMBO J, V19, P67, DOI 10.1038/sj.emboj.7592228b; Hettwer S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088739; Huang J, 2016, GENE DEV, V30, P622, DOI 10.1101/gad.274324.115; Huang J, 2015, NEURON, V86, P726, DOI 10.1016/j.neuron.2015.03.049; Hubbard SR, 2013, BBA-PROTEINS PROTEOM, V1834, P2166, DOI 10.1016/j.bbapap.2013.02.034; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Inoue A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000113; Juo P, 2004, CURR BIOL, V14, P2057, DOI 10.1016/j.cub.2004.11.010; Khan MM, 2014, AUTOPHAGY, V10, P123, DOI 10.4161/auto.26841; Kim N, 2008, CELL, V135, P334, DOI 10.1016/j.cell.2008.10.002; Kim N, 2008, NAT NEUROSCI, V11, P19, DOI 10.1038/nn2026; Kimata Y, 2019, TRENDS CELL BIOL, V29, P591, DOI 10.1016/j.tcb.2019.03.001; King RW, 1996, MOL BIOL CELL, V7, P1343, DOI 10.1091/mbc.7.9.1343; Li L, 2018, ANNU REV PHYSIOL, V80, P159, DOI 10.1146/annurev-physiol-022516-034255; Li L, 2016, NEURON, V92, P1007, DOI 10.1016/j.neuron.2016.10.023; Li WH, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006062; Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025; Liu SZ, 2013, P NATL ACAD SCI USA, V110, P2175, DOI 10.1073/pnas.1217781110; Liu Y, 2009, DEV BIOL, V330, P153, DOI 10.1016/j.ydbio.2009.03.023; Lu Z, 2007, J CELL BIOL, V177, P1077, DOI 10.1083/jcb.200610060; Luo SW, 2008, NEURON, V60, P97, DOI 10.1016/j.neuron.2008.08.013; Miyoshi S, 2017, EMBO MOL MED, V9, P880, DOI 10.15252/emmm.201607298; Morgan DO, 2013, MOL CELL, V50, P609, DOI 10.1016/j.molcel.2013.05.023; Nam S, 2009, J BIOL CHEM, V284, P8192, DOI 10.1074/jbc.M808230200; NITKIN RM, 1987, J CELL BIOL, V105, P2471, DOI 10.1083/jcb.105.6.2471; Okada K, 2006, SCIENCE, V312, P1802, DOI 10.1126/science.1127142; Penas C, 2015, CELL REP, V11, P249, DOI 10.1016/j.celrep.2015.03.016; Perez-Garcia MJ, 2012, CELL REPORTS, V2, P497, DOI 10.1016/j.celrep.2012.08.004; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Pfleger CM, 2000, GENE DEV, V14, P655; Pines J, 2011, NAT REV MOL CELL BIO, V12, P427, DOI 10.1038/nrm3132; Pohl C, 2019, SCIENCE, V366, P818, DOI 10.1126/science.aax3769; Rape M, 2018, NAT REV MOL CELL BIO, V19, P59, DOI 10.1038/nrm.2017.83; Rudolf R, 2013, AGE, V35, P1663, DOI 10.1007/s11357-012-9468-9; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Shen CY, 2018, ELIFE, V7, DOI 10.7554/eLife.34625; Shepherd JD, 2018, NAT NEUROSCI, V21, P1294, DOI 10.1038/s41593-018-0244-8; Shi L, 2012, TRENDS NEUROSCI, V35, P441, DOI 10.1016/j.tins.2012.04.005; Tao YM, 2013, NAT NEUROSCI, V16, P290, DOI 10.1038/nn.3320; Tezuka T, 2014, P NATL ACAD SCI USA, V111, P16556, DOI 10.1073/pnas.1408409111; Till JH, 2002, STRUCTURE, V10, P1187, DOI 10.1016/S0969-2126(02)00814-6; Tintignac LA, 2015, PHYSIOL REV, V95, P809, DOI 10.1152/physrev.00033.2014; van Roessel P, 2004, CELL, V119, P707, DOI 10.1016/j.cell.2004.11.028; Walsh MK, 2003, NEURON, V37, P67, DOI 10.1016/S0896-6273(02)01142-X; Wang BB, 2020, FASEB J, V34, P5144, DOI 10.1096/fj.201901693RR; Wang L, 2020, NATURE, V577, P682, DOI 10.1038/s41586-019-1915-7; Wirth KG, 2004, GENE DEV, V18, P88, DOI 10.1101/gad.285404; Wu HT, 2012, NEURON, V75, P94, DOI 10.1016/j.neuron.2012.04.033; Wu HT, 2010, DEVELOPMENT, V137, P1017, DOI 10.1242/dev.038711; Xiao YT, 2020, HUM MOL GENET, V29, P1784, DOI 10.1093/hmg/ddz154; Xing GL, 2019, ELIFE, V8, DOI 10.7554/eLife.49180; Yau R, 2016, NAT CELL BIOL, V18, P579, DOI 10.1038/ncb3358; Zhang B, 2008, NEURON, V60, P285, DOI 10.1016/j.neuron.2008.10.006	76	3	3	1	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12009	12023		10.1096/fj.202000485R	http://dx.doi.org/10.1096/fj.202000485R		JUL 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32687671				2022-12-28	WOS:000553641600001
J	Stoye, NM; Guilherme, MD; Endres, K				Stoye, Nicolai M.; dos Santos Guilherme, Malena; Endres, Kristina			Alzheimer's disease in the gut-Major changes in the gut of 5xFAD model mice with ApoA1 as potential key player	FASEB JOURNAL			English	Article						A-beta; enteric nervous system; FoxA2; lipids	APOLIPOPROTEIN-A-I; ENTERIC NERVOUS-SYSTEM; CEREBRAL AMYLOID ANGIOPATHY; HIGH-DENSITY-LIPOPROTEIN; BETA PROTEIN-PRECURSOR; SPINAL-CORD-INJURY; MOUSE MODEL; CHOLINERGIC NEURONS; CHOLESTEROL EFFLUX; DIABETES-MELLITUS	Alzheimer's disease (AD) affects around 33 million people worldwide, which makes it the most prominent form of dementia. The main focus of AD research has been on the central nervous system (CNS) for long, but in recent years, the gut gained more attention. The intestinal tract is innervated by the enteric nervous system (ENS), built of numerous different types of neurons showing great similarity to neurons of the CNS. It already has been demonstrated that the amyloid precursor protein, which plays a major role in AD pathology, is also expressed in these cells. We analyzed gut tissue of AD model mice (5xFAD) and the respective wild-type littermates at different pathological stages: pre-pathological, early pathological and late pathological. Our results show significant difference in function of the intestine of 5xFAD mice as compared to wild-type mice. Using a pathway array detecting 84 AD-related gene products, we found ApoA1 expression significantly altered in colon tissue of 5xFAD mice. Furthermore, we unveil ApoA1's beneficial impact on cell viability and calcium homeostasis of cultured enteric neurons of 5xFAD animals. With this study, we demonstrate that the intestine is altered in AD-like pathology and that ApoA1 might be one key player within the gut.	[Stoye, Nicolai M.; dos Santos Guilherme, Malena; Endres, Kristina] Johannes Gutenberg Univ Mainz, Dept Psychiat & Psychotherapy, Univ Med Ctr, Untere Zahlbacher Str 8, D-55131 Mainz, Germany	Johannes Gutenberg University of Mainz	Endres, K (corresponding author), Johannes Gutenberg Univ Mainz, Dept Psychiat & Psychotherapy, Univ Med Ctr, Untere Zahlbacher Str 8, D-55131 Mainz, Germany.	Kristina.Endres@unimedizin-mainz.de	Endres, Kristina/K-4960-2015	Endres, Kristina/0000-0002-1099-8287	Stiftung Rheinland-Pfalz fur Innovation (Rheinland-Pfalz Foundation for Innovation) [961 - 386261/1129]; Alfons Geib-Stiftung	Stiftung Rheinland-Pfalz fur Innovation (Rheinland-Pfalz Foundation for Innovation); Alfons Geib-Stiftung	Stiftung Rheinland-Pfalz fur Innovation (Rheinland-Pfalz Foundation for Innovation), Grant/Award Number: 961 - 386261/1129; Alfons Geib-Stiftung	Alzheimer's Disease International, 2018, WORLD ALZH REP 2018; Anwar MA, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00098; Arciello A, 2016, FEBS LETT, V590, P4171, DOI 10.1002/1873-3468.12468; Arispe N, 2004, J MEMBRANE BIOL, V197, P33, DOI 10.1007/s00232-003-0638-7; Arispe N, 2007, BBA-BIOMEMBRANES, V1768, P1952, DOI 10.1016/j.bbamem.2007.03.014; Arvanitakis Z, 2004, ARCH NEUROL-CHICAGO, V61, P661, DOI 10.1001/archneur.61.5.661; BarrettConnor E, 1996, J AM GERIATR SOC, V44, P1147, DOI 10.1111/j.1532-5415.1996.tb01362.x; Bayliss W M, 1899, J Physiol, V24, P99; Brandscheid C, 2017, J ALZHEIMERS DIS, V56, P775, DOI 10.3233/JAD-160926; BREHMER A, 2006, ADV ANAT EMBRYOL CEL, V186, P1; BROOKES SJH, 1991, CELL TISSUE RES, V263, P471, DOI 10.1007/BF00327280; BROOKES SJH, 1991, NEUROSCIENCE, V42, P863, DOI 10.1016/0306-4522(91)90050-X; Button EB, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030462; Cimmino G, 2009, J CELL MOL MED, V13, P3226, DOI 10.1111/j.1582-4934.2008.00614.x; Collins JM, 2015, EXP NEUROL, V267, P219, DOI 10.1016/j.expneurol.2015.02.034; Cummings JL, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt269; DAVIES P, 1979, BRAIN RES, V171, P319, DOI 10.1016/0006-8993(79)90336-6; de Seny D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122904; Delvalle NM, 2018, AM J PHYSIOL-GASTR L, V315, pG473, DOI 10.1152/ajpgi.00155.2018; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012; Du XG, 2018, TRANSL NEURODEGENER, V7, DOI 10.1186/s40035-018-0107-y; Eimer WA, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-2; Elliott DA, 2010, CLIN LIPIDOL, V5, P555, DOI 10.2217/CLP.10.37; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Endres K, 2016, BMC NEUROSCI, V17, DOI 10.1186/s12868-016-0280-9; Fernandez-de Retana S, 2017, NEUROBIOL AGING, V60, P116, DOI 10.1016/j.neurobiolaging.2017.08.028; Ferri ALM, 2007, DEVELOPMENT, V134, P2761, DOI 10.1242/dev.000141; FINE KD, 1992, GASTROENTEROLOGY, V102, P1936, DOI 10.1016/0016-5085(92)90316-Q; Friedman JR, 2006, CELL MOL LIFE SCI, V63, P2317, DOI 10.1007/s00018-006-6095-6; Furness JB, 2006, ENTERIC NERVOUS SYSTEM, P1; Furness JB, 2012, NAT REV GASTRO HEPAT, V9, P286, DOI 10.1038/nrgastro.2012.32; GALLIGAN JJ, 1986, J PHARMACOL EXP THER, V238, P594; Garcia-Ayllon Maria-Salud, 2011, Front Mol Neurosci, V4, P22, DOI 10.3389/fnmol.2011.00022; Gershon MD, 1999, HOSP PRACT, V34, P31, DOI 10.3810/hp.1999.07.153; Giri M, 2016, CLIN INTERV AGING, V11, P665, DOI 10.2147/CIA.S105769; GLICKMAN RM, 1977, P NATL ACAD SCI USA, V74, P2569, DOI 10.1073/pnas.74.6.2569; Gorard DA, 1996, GUT, V39, P551, DOI 10.1136/gut.39.4.551; Guilherme MD, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.01008; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Halley P, 2014, CELL REP, V6, P222, DOI 10.1016/j.celrep.2013.12.015; Han XL, 2017, NEUROSCI LETT, V642, P59, DOI 10.1016/j.neulet.2017.01.061; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Harr SD, 1996, J NEUROCHEM, V66, P2429; Heuckeroth RO, 2018, NAT REV GASTRO HEPAT, V15, P152, DOI 10.1038/nrgastro.2017.149; Holzer P, 1997, PHARMACOL THERAPEUT, V73, P173, DOI 10.1016/S0163-7258(96)00195-7; Huang SW, 2017, J NEUROTRAUM, V34, P615, DOI 10.1089/neu.2016.4525; JOACHIM CL, 1989, NATURE, V341, P226, DOI 10.1038/341226a0; Johnson DK, 2006, ARCH NEUROL-CHICAGO, V63, P1312, DOI 10.1001/archneur.63.9.1312; Kajani S, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19071971; KAWANO M, 1995, CLIN CHIM ACTA, V239, P209, DOI 10.1016/0009-8981(95)06115-T; Kendziorski C, 2005, P NATL ACAD SCI USA, V102, P4252, DOI 10.1073/pnas.0500607102; Kim ER, 2012, J NEUROGASTROENTEROL, V18, P94, DOI 10.5056/jnm.2012.18.1.94; Kimura R, 2009, NEUROBIOL DIS, V33, P229, DOI 10.1016/j.nbd.2008.10.006; Kirkitadze MD, 2002, J NEUROSCI RES, V69, P567, DOI 10.1002/jnr.10328; Koch M, 2020, J LIPID RES, V61, P445, DOI 10.1194/jlr.P119000473; Kokiko-Cochran ON, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00672; Koldamova RP, 2001, BIOCHEMISTRY-US, V40, P3553, DOI 10.1021/bi002186k; Kraus Daniel, 2015, Bio Protoc, V5; Kulkarni S, 2017, P NATL ACAD SCI USA, V114, pE3709, DOI 10.1073/pnas.1619406114; LADIAS JAA, 1991, SCIENCE, V251, P561, DOI 10.1126/science.1899293; Landel V, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-33; Lane CA, 2018, EUR J NEUROL, V25, P59, DOI 10.1111/ene.13439; Larson ME, 2012, J NEUROCHEM, V120, P125, DOI 10.1111/j.1471-4159.2011.07478.x; Lebouvier T, 2010, NEUROGASTROENT MOTIL, V22, pE11, DOI 10.1111/j.1365-2982.2009.01368.x; Lefterov I, 2010, J BIOL CHEM, V285, P36945, DOI 10.1074/jbc.M110.127738; Leissring MA, 2002, P NATL ACAD SCI USA, V99, P4697, DOI 10.1073/pnas.072033799; Lemkul JA, 2012, BIOCHEMISTRY-US, V51, P5990, DOI 10.1021/bi300113x; Lewis TL, 2010, J BIOL CHEM, V285, P36958, DOI 10.1074/jbc.M110.127829; Li ZS, 2006, J NEUROSCI, V26, P2798, DOI 10.1523/JNEUROSCI.4720-05.2006; Liao KP, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001588; Lin HC, 2005, DIGEST DIS SCI, V50, P989, DOI 10.1007/s10620-005-2694-6; Liu HC, 2006, DEMENT GERIATR COGN, V21, P155, DOI 10.1159/000090676; MATTSON MP, 1992, J NEUROSCI, V12, P376, DOI 10.1523/jneurosci.12-02-00376.1992; Mayer EA, 2011, NAT REV NEUROSCI, V12, P453, DOI 10.1038/nrn3071; MCCONALOGUE K, 1994, BAILLIERE CLIN ENDOC, V8, P51, DOI 10.1016/S0950-351X(05)80226-5; Merched A, 2000, NEUROBIOL AGING, V21, P27, DOI 10.1016/S0197-4580(99)00103-7; Mohajeri MH, 2019, NUTRIENTS, V11, DOI 10.3390/nu11020424; MURPHY M, 1992, LANCET, V340, P1512, DOI 10.1016/0140-6736(92)92765-8; Niesor Eric J., 2015, Biology-Basel, V4, P17, DOI 10.3390/biology4010017; Nofer JR, 2015, HANDB EXP PHARMACOL, V224, P229, DOI 10.1007/978-3-319-09665-0_6; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Orr-Urtreger A, 2005, NEUROREPORT, V16, P1123, DOI 10.1097/00001756-200507130-00018; Ott A, 1999, NEUROLOGY, V53, P1937, DOI 10.1212/WNL.53.9.1937; Paillusson S, 2013, J NEUROCHEM, V125, P512, DOI 10.1111/jnc.12131; Pan XF, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00175; Pan-Montojo F, 2012, SCI REP-UK, V2, DOI 10.1038/srep00898; Paula-Lima AC, 2009, INT J BIOCHEM CELL B, V41, P1361, DOI 10.1016/j.biocel.2008.12.003; Peila R, 2002, DIABETES, V51, P1256, DOI 10.2337/diabetes.51.4.1256; PERRY EK, 1978, BRIT MED J, V2, P1457, DOI 10.1136/bmj.2.6150.1457; Phillips RJ, 2008, NEUROSCIENCE, V153, P733, DOI 10.1016/j.neuroscience.2008.02.074; Porter JL, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-82; Puig KL, 2015, J ALZHEIMERS DIS, V44, P1263, DOI 10.3233/JAD-142259; Rhee SK, 1998, J BIOL CHEM, V273, P13379, DOI 10.1074/jbc.273.22.13379; Saczynski JS, 2007, AM J EPIDEMIOL, V165, P985, DOI 10.1093/aje/kwm027; Sakono M, 2010, FEBS J, V277, P1348, DOI 10.1111/j.1742-4658.2010.07568.x; Semar S, 2013, J ALZHEIMERS DIS, V36, P7, DOI 10.3233/JAD-120511; Sengupta MB, 2017, MOL CELL BIOCHEM, V424, P45, DOI 10.1007/s11010-016-2841-8; Sengupta U, 2016, EBIOMEDICINE, V6, P42, DOI 10.1016/j.ebiom.2016.03.035; Sirnio P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05415-9; Smith TH, 2013, JOVE-J VIS EXP, DOI 10.3791/50688; Sochocka M, 2019, MOL NEUROBIOL, V56, P1841, DOI 10.1007/s12035-018-1188-4; Song F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034078; SONNENBERG A, 1994, AM J GASTROENTEROL, V89, P62; Stewart R, 2005, ARCH NEUROL-CHICAGO, V62, P55, DOI 10.1001/archneur.62.1.55; Stott SRW, 2013, J NEUROSCI, V33, P8022, DOI 10.1523/JNEUROSCI.4774-12.2013; Stoye NM, 2020, J ALZHEIMERS DIS REP, V4, P15, DOI 10.3233/ADR-190165; Stroud JC, 2012, P NATL ACAD SCI USA, V109, P7717, DOI 10.1073/pnas.1203193109; Stukas S, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001156; Tottey W, 2017, J NEUROGASTROENTEROL, V23, P124, DOI 10.5056/jnm16042; Umemoto T, 2013, CIRC RES, V112, P1345, DOI 10.1161/CIRCRESAHA.111.300581; Venkateswaran A, 2000, P NATL ACAD SCI USA, V97, P12097, DOI 10.1073/pnas.200367697; Vuilleumier N, 2013, SWISS MED WKLY, V143, DOI 10.4414/smw.2013.13781; Wang N, 2000, J BIOL CHEM, V275, P33053, DOI 10.1074/jbc.M005438200; Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049; Wessler I, 2008, BRIT J PHARMACOL, V154, P1558, DOI 10.1038/bjp.2008.185; Wolfrum C, 2004, NATURE, V432, P1027, DOI 10.1038/nature03047; Wruck W, 2016, J ALZHEIMERS DIS, V50, P1065, DOI 10.3233/JAD-150733; Xu WL, 2009, DIABETES, V58, P71, DOI 10.2337/db08-0586; Yeh FL, 2016, NEURON, V91, P328, DOI 10.1016/j.neuron.2016.06.015; Yeh TS, 2018, SPINAL CORD, V56, P151, DOI 10.1038/s41393-017-0009-3	122	11	11	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					11883	11899		10.1096/fj.201903128RR	http://dx.doi.org/10.1096/fj.201903128RR		JUL 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32681583	hybrid			2022-12-28	WOS:000552140700001
J	Azab, E; Chandler, KB; Uda, Y; Sun, NY; Hussein, A; Shuwaikan, R; Lu, V; Costello, CE; McComb, ME; Pajevic, PD				Azab, Ehab; Chandler, Kevin Brown; Uda, Yuhei; Sun, Ningyuan; Hussein, Amira; Shuwaikan, Raghad; Lu, Veronica; Costello, Catherine E.; McComb, Mark E.; Pajevic, Paola Divieti			Osteocytes control myeloid cell proliferation and differentiation through Gs alpha-dependent and -independent mechanisms	FASEB JOURNAL			English	Article						Gs alpha; macrophages; myeloid cells; neuropilin-1; osteoclast; osteocytes	GRANULIN-EPITHELIN PRECURSOR; DEMINERALIZED BONE-MATRIX; ENDOTHELIAL GROWTH-FACTOR; COLONY-STIMULATING FACTOR; INHIBITOR SCLEROSTIN; CERULOPLASMIN LEVELS; TARGETED ABLATION; GENE-EXPRESSION; PROGRANULIN; INTERLEUKIN-1	Osteocytes, the bone cells embedded in the mineralized matrix, control bone modeling, and remodeling through direct contact with adjacent cells and via paracrine and endocrine factors that affect cells in the bone marrow microenvironment or distant organs. Osteocytes express numerous G protein-coupled receptors (GPCRs) and thus mice lacking the stimulatory subunit of G-protein (Gs alpha) in osteocytes (Dmp1-Gs alpha(KO)mice) have abnormal myelopoiesis, osteopenia, and reduced adipose tissue. We previously reported that the severe osteopenia and the changes in adipose tissue present in these mice were mediated by increased sclerostin, which suppress osteoblast functions and promote browning of white adipocytes. Inversely, the myeloproliferation was driven by granulocyte colony-stimulating factor (G-CSF) and administration of neutralizing antibodies against G-CSF only partially restored the myeloproliferation, suggesting that additional osteocyte-derived factors might be involved. We hypothesized that osteocytes secrete Gs alpha-dependent factor(s) which regulate the myeloid cells proliferation. To identify osteocyte-secreted proteins, we used the osteocytic cell line Ocy454 expressing or lacking Gs alpha expression (Ocy454-Gs alpha(cont)and Ocy454-Gs alpha(KO)) to delineate the osteocyte "secretome" and its regulation by Gs alpha. Here we reported that factors secreted by osteocytes increased the number of myeloid colonies and promoted macrophage proliferation. The proliferation of myeloid cells was further promoted by osteocytes lacking Gs alpha expression. Myeloid cells can differentiate into bone-resorbing osteoclasts, therefore, we hypothesized that osteocyte-secreted factors might also regulate osteoclastogenesis in a Gs alpha-dependent manner. Conditioned medium (CM) from Ocy454 (both Gs alpha(cont)and Gs alpha(KO)) significanlty increased the proliferation of bone marrow mononuclear cells (BMNC) and, at the same time, inhibited their differentiation into mature osteoclasts via a Gs alpha-dependent mechanism. Proteomics analysis of CM from Ocy454 Gs alpha(cont)and Gs alpha(KO)cells identified neuropilin-1 (Nrp-1) and granulin (Grn) as osteocytic-secreted proteins upregulated in Ocy454-Gs alpha(KO)cells compared to Ocy454-Gs alpha(cont), whereas semaphorin3A was significantly suppressed. Treatment of Ocy454-Gs alpha(cont)cells with recombinant proteins or knockdown of Nrp-1 and Grn in Ocy454-Gs alpha(KO)cells partially rescued the inhibition of osteoclasts, demonstrating that osteocytes control osteoclasts differentiation through Nrp-1 and Grn which are regulated by Gs alpha signaling.	[Azab, Ehab; Uda, Yuhei; Sun, Ningyuan; Shuwaikan, Raghad; Lu, Veronica; Pajevic, Paola Divieti] Boston Univ, Dept Translat Dent Med, Henry M Goldman Sch Dent Med, Boston, MA 02118 USA; [Chandler, Kevin Brown; Costello, Catherine E.; McComb, Mark E.] Boston Univ, Ctr Biomed Mass Spectrometry, Sch Med, Boston, MA 02118 USA; [Hussein, Amira] Boston Univ, Dept Orthoped, Sch Med, Boston, MA 02118 USA; [Azab, Ehab] Umm Al Qura Univ, Sch Dent Med, Dept Basic & Clin Oral Sci, Periodontol Div, Mecca, Saudi Arabia	Boston University; Boston University; Boston University; Umm Al Qura University	Pajevic, PD (corresponding author), Boston Univ, Dept Translat Dent Med, Henry M Goldman Sch Dent Med, Boston, MA 02118 USA.	pdivieti@bu.edu	Azab, Ehab/F-5269-2019; Azab, Ehab/GQH-9122-2022; Uda, Yuhei/AAZ-4978-2021	Azab, Ehab/0000-0002-1122-3942; Uda, Yuhei/0000-0003-4705-6215; Chandler, Kevin/0000-0001-5514-9652	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [AR06221]; National Institute of General Medical Sciences (NIGMS) [GM104603]; National Center for Advancing Translational Science (NCATS) [TR001430]	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Center for Advancing Translational Science (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Grant/Award Number: AR06221; National Institute of General Medical Sciences (NIGMS), Grant/Award Number: GM104603; National Center for Advancing Translational Science (NCATS), Grant/Award Number: TR001430	AARDEN EM, 1994, J CELL BIOCHEM, V55, P287, DOI 10.1002/jcb.240550304; Bachelder RE, 2001, CANCER RES, V61, P5736; Behring JB, 2014, FASEB J, V28, P1975, DOI 10.1096/fj.13-233445; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; CANNISTRA SA, 1988, BLOOD, V71, P672; Cherian PP, 2003, J BIOL CHEM, V278, P43146, DOI 10.1074/jbc.M302993200; CONFORTI A, 1983, PHARMACOL RES COMMUN, V15, P859, DOI 10.1016/S0031-6989(83)80093-9; COZZOLINO F, 1989, P NATL ACAD SCI USA, V86, P2369, DOI 10.1073/pnas.86.7.2369; Dallas SL, 2013, ENDOCR REV, V34, P658, DOI 10.1210/er.2012-1026; Daniel R, 2000, J HISTOCHEM CYTOCHEM, V48, P999, DOI 10.1177/002215540004800713; DESHMUKH VK, 1985, PHARMACOL RES COMMUN, V17, P633, DOI 10.1016/0031-6989(85)90070-0; Feng JAQ, 2010, FASEB J, V24, P1879, DOI 10.1096/fj.09-144659; Fulzele K, 2018, BONE, V117, P138, DOI 10.1016/j.bone.2018.09.021; Fulzele K, 2017, J BONE MINER RES, V32, P373, DOI 10.1002/jbmr.3001; Fulzele K, 2013, BLOOD, V121, P930, DOI 10.1182/blood-2012-06-437160; Gagnon ML, 2000, P NATL ACAD SCI USA, V97, P2573, DOI 10.1073/pnas.040337597; Gu GL, 2005, BIOCHEM BIOPH RES CO, V335, P1095, DOI 10.1016/j.bbrc.2005.06.211; Guerra RR, 2007, GROWTH FACTORS, V25, P280, DOI 10.1080/08977190701781222; Harris SE, 2012, BONE, V50, P42, DOI 10.1016/j.bone.2011.09.038; Hayashi M, 2019, CELL METAB, V29, P627, DOI 10.1016/j.cmet.2018.12.021; Hayashi M, 2012, NATURE, V485, P69, DOI 10.1038/nature11000; He ZH, 1999, CANCER RES, V59, P3222; He ZH, 2003, J MOL MED-JMM, V81, P600, DOI 10.1007/s00109-003-0474-3; Heino Terhi J, 2009, Technol Health Care, V17, P49, DOI 10.3233/THC-2009-0534; Heino TJ, 2002, J CELL BIOCHEM, V85, P185, DOI 10.1002/jcb.10109; HEYWORTH CM, 1990, J CELL SCI, P57; Holt DJ, 2012, ADV DRUG DELIVER REV, V64, P1123, DOI 10.1016/j.addr.2012.04.002; Juppner H, 2006, J PEDIATR ENDOCR MET, V19, P641; Kalajzic I, 2005, J BIOL CHEM, V280, P24618, DOI 10.1074/jbc.M413834200; Kampen KR, 2013, CELL MOL LIFE SCI, V70, P1307, DOI 10.1007/s00018-012-1085-3; Kang SJ, 2013, SEMIN CELL DEV BIOL, V24, P163, DOI 10.1016/j.semcdb.2012.09.008; KAUSHANSKY K, 1988, J CLIN INVEST, V81, P92, DOI 10.1172/JCI113316; Kim AY, 2017, CELL TRANSPLANT, V26, P115, DOI 10.3727/096368916X693338; KOEFFLER HP, 1987, BLOOD, V70, P55; KOHLER P, 1986, ACTA ORTHOP SCAND, V57, P141; Kulkarni RN, 2010, CALCIFIED TISSUE INT, V87, P461, DOI 10.1007/s00223-010-9407-7; Marotti G, 1996, Ital J Anat Embryol, V101, P25; Matsubara T, 2012, CELL METAB, V15, P38, DOI 10.1016/j.cmet.2011.12.002; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Okura H, 2010, J ATHEROSCLER THROMB, V17, P568, DOI 10.5551/jat.3921; Parikh AA, 2004, AM J PATHOL, V164, P2139, DOI 10.1016/S0002-9440(10)63772-8; Piacibello W, 1997, LEUKEMIA, V11, P531, DOI 10.1038/sj.leu.2400603; Powell WF, 2011, J ENDOCRINOL, V209, P21, DOI 10.1530/JOE-10-0308; SOUZA LM, 1986, SCIENCE, V232, P61, DOI 10.1126/science.2420009; Spatz JM, 2015, J BIOL CHEM, V290, P16744, DOI 10.1074/jbc.M114.628313; TAICHMAN RS, 1994, J EXP MED, V179, P1677, DOI 10.1084/jem.179.5.1677; Tatsumi S, 2007, CELL METAB, V5, P464, DOI 10.1016/j.cmet.2007.05.001; Verlinden L, 2016, MOL CELL ENDOCRINOL, V432, P76, DOI 10.1016/j.mce.2015.09.009; Wein Marc N, 2015, J Bone Miner Res, V30, P400, DOI 10.1002/jbmr.2381; Weinstein LS, 2002, ANN NY ACAD SCI, V968, P173, DOI 10.1111/j.1749-6632.2002.tb04335.x; WIKTORJEDRZEJCZAK W, 1990, P NATL ACAD SCI USA, V87, P4828, DOI 10.1073/pnas.87.12.4828; Wildemann B., 2007, Cell and Tissue Banking, V8, P107, DOI 10.1007/s10561-006-9021-0; Wildemann B, 2007, J BIOMED MATER RES A, V81A, P437, DOI 10.1002/jbm.a.31085; YANG YC, 1986, CELL, V47, P3, DOI 10.1016/0092-8674(86)90360-0; Yao CX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144025; Yao CX, 2015, INT J MASS SPECTROM, V378, P347, DOI 10.1016/j.ijms.2014.10.006; Yao QQ, 2017, BIOCHEM BIOPH RES CO, V488, P634, DOI 10.1016/j.bbrc.2016.11.011; ZSEBO KM, 1988, BLOOD, V71, P99	58	5	5	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10191	10211		10.1096/fj.202000366R	http://dx.doi.org/10.1096/fj.202000366R		JUN 2020	21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32557809	Green Accepted, Bronze			2022-12-28	WOS:000541762000001
J	Lyozin, GT; Brunelli, L				Lyozin, George T.; Brunelli, Luca			DNA gap repair in Escherichia coli for multiplex site-directed mutagenesis	FASEB JOURNAL			English	Article						gap repair cloning; in vivo DNA engineering; protein engineering; reverse genetics	RECOMBINATION; LAMBDA; SYSTEM; TRANSFORMATION; CHROMOSOME	Site-directed mutagenesis allows the generation of novel DNA sequences that can be used for a variety of important applications such as the functional analysis of genetic variants. To overcome the limitations of existing site-directed mutagenesis approaches, we explored in vivo DNA gap repair. We found that site-specific mutations in plasmid DNA can be generated in Escherichia coli using mutant single-stranded oligonucleotides to target PCR-derived linear double-stranded plasmid DNA. We called this method DeGeRing, and we characterized its advantages, including non-biased multiplex mutagenesis, over existing site-directed mutagenesis methods such as recombineering (recombination-mediated genetic engineering), single DNA break repair (SDBR, introduced by W. Mandecki), and QuikChange (Agilent Technologies, La Jolla, CA). We determined the efficiency of DeGeRing to induce site-directed mutations with and without a phenotype in three K-12 E coli strains using multiple single-stranded oligonucleotides containing homological and heterological parts of various sizes. Virtual lack of background made the isolation of mutants with frequencies up to 10(-6) unnecessary. Our data show that endogenous DNA gap repair in E coli supports efficient multiplex site-directed mutagenesis. DeGeRing might facilitate the generation of mutant DNA sequences for protein engineering and the functional analysis of genetic variants in reverse genetics.	[Lyozin, George T.; Brunelli, Luca] Univ Nebraska Med Ctr, Dept Pediat, DRC 2,Rm 4034,601 S Saddle Creek Rd, Omaha, NE 68106 USA; [Lyozin, George T.; Brunelli, Luca] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE USA; [Brunelli, Luca] Univ Utah, Dept Pediat Neonatol, Salt Lake City, UT USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; Utah System of Higher Education; University of Utah	Brunelli, L (corresponding author), Univ Nebraska Med Ctr, Dept Pediat, DRC 2,Rm 4034,601 S Saddle Creek Rd, Omaha, NE 68106 USA.	Luca.Brunelli@hsc.utah.edu						Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; BOTSTEIN D, 1985, SCIENCE, V229, P1193, DOI 10.1126/science.2994214; CONLEY EC, 1984, MOL GEN GENET, V194, P211, DOI 10.1007/BF00383519; CONLEY EC, 1986, NUCLEIC ACIDS RES, V14, P8919; Costantino N, 2003, P NATL ACAD SCI USA, V100, P15748, DOI 10.1073/pnas.2434959100; Court DL, 2003, GENE, V315, P63, DOI 10.1016/S0378-1119(03)00728-5; Ellis HM, 2001, P NATL ACAD SCI USA, V98, P6742, DOI 10.1073/pnas.121164898; Erler A, 2009, J MOL BIOL, V391, P586, DOI 10.1016/j.jmb.2009.06.030; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; GIBBS RA, 1989, NUCLEIC ACIDS RES, V17, P2437, DOI 10.1093/nar/17.7.2437; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Lezin G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023457; Li XT, 2013, MOL MICROBIOL, V88, P906, DOI 10.1111/mmi.12231; Lyozin G, 2019, ISOLATION FULL SIZE, DOI [10.1101/549634, DOI 10.1101/549634]; Lyozin GT, 2020, FASEB J, V34, P3448, DOI 10.1096/fj.201902261R; Lyozin GT, 2014, NAT METHODS, V11, P966, DOI [10.1038/NMETH.3030, 10.1038/nmeth.3030]; Lyozin GT, 2017, CURR PROTOC MOL BIOL, V118, P861; Lyozin GT, 2019, DNA GAP REPAIR MEDIA, DOI [10.1101/313155, DOI 10.1101/313155]; MANDECKI W, 1986, P NATL ACAD SCI USA, V83, P7177, DOI 10.1073/pnas.83.19.7177; Murphy KC, 1998, J BACTERIOL, V180, P2063, DOI 10.1128/JB.180.8.2063-2071.1998; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; ORRWEAVER TL, 1983, P NATL ACAD SCI-BIOL, V80, P4417, DOI 10.1073/pnas.80.14.4417; Pattanayak V, 2014, METHOD ENZYMOL, V546, P47, DOI 10.1016/B978-0-12-801185-0.00003-9; Reddy TR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120681; Reddy TR, 2015, JOVE-J VIS EXP, DOI 10.3791/52155; Sawitzke JA, 2013, METHOD ENZYMOL, V533, P157, DOI 10.1016/B978-0-12-420067-8.00010-6; Sawitzke JA, 2011, J MOL BIOL, V407, P45, DOI 10.1016/j.jmb.2011.01.030; Swaminathan S, 2001, GENESIS, V29, P14, DOI 10.1002/1526-968X(200101)29:1<14::AID-GENE1001>3.0.CO;2-X; Thomason LC, 2007, PLASMID, V58, P148, DOI 10.1016/j.plasmid.2007.03.001; THOMPSON R, 1979, MOL GEN GENET, V169, P49, DOI 10.1007/BF00267544; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; Zhang Y, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-42; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417; Zhang YM, 2000, NAT BIOTECHNOL, V18, P1314, DOI 10.1038/82449	34	0	0	1	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6351	6368		10.1096/fj.201902260R	http://dx.doi.org/10.1096/fj.201902260R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32167210				2022-12-28	WOS:000531325500026
J	Wang, D; Pun, CCM; Huang, ST; Tang, TCM; Ho, KKW; Rothrauff, BB; Yung, PSH; Blocki, AM; Ker, EDF; Tuan, RS				Wang, Dan; Pun, Charmaine C. M.; Huang, Shuting; Tang, Thomas C. M.; Ho, Kevin K. W.; Rothrauff, Benjamin B.; Yung, Patrick S. H.; Blocki, Anna M.; Ker, Elmer D. F.; Tuan, Rocky S.			Tendon-derived extracellular matrix induces mesenchymal stem cell tenogenesis via an integrin/transforming growth factor-beta crosstalk-mediated mechanism	FASEB JOURNAL			English	Article						cell-matrix interaction; cell signaling; tendon regeneration; tissue engineering	TGF-BETA; STEM/PROGENITOR CELLS; STROMAL CELLS; COLLAGEN; DIFFERENTIATION; INTEGRIN; LIGAMENT; PROLIFERATION; TENOMODULIN; FIBRONECTIN	Treatment of tendon injuries is challenging. To develop means to augment tendon regeneration, we have previously prepared a soluble, low immunogenic (DNA-free), tendon extracellular matrix fraction (tECM) by urea extraction of juvenile bovine tendons, which is capable of enhancing transforming growth factor-beta (TGF-beta) mediated tenogenesis in human adipose-derived stem cells (hASCs). Here, we aimed to elucidate the mechanism of tECM-driven hASC tenogenic differentiation in vitro, focusing on the integrin and TGF-beta/SMAD pathways. Our results showed that tECM promoted hASC proliferation and tenogenic differentiation in vitro based on tenogenesis-associated markers. tECM also induced higher expression of several integrin subunits and TGF-beta receptors, and nuclear translocation of p-SMAD2 in hASCs. Pharmacological inhibition of integrin-ECM binding, focal adhesion kinase (FAK) signaling, or TGF-beta signaling independently led to compromised pro-tenogenic effects of tECM and actin fiber polymerization. Additionally, integrin blockade inhibited tECM-driven TGFBR2 expression, while inhibiting TGF-beta signaling decreased tECM-mediated expression of integrin alpha 1, alpha 2, and beta 1 in hASCs. Together, these findings suggest that the strong pro-tenogenic bioactivity of tECM is regulated via integrin/TGF-beta signaling crosstalk. Understanding how integrins interact with signaling by TGF-beta and/or other growth factors (GFs) within the tendon ECM microenvironment will provide a rational basis for an ECM-based approach for tendon repair.	[Wang, Dan; Pun, Charmaine C. M.; Huang, Shuting; Tang, Thomas C. M.; Yung, Patrick S. H.; Blocki, Anna M.; Ker, Elmer D. F.; Tuan, Rocky S.] Chinese Univ Hong Kong, Inst Tissue Engn & Regenerat Med, Hong Kong, Peoples R China; [Wang, Dan; Pun, Charmaine C. M.; Huang, Shuting; Tang, Thomas C. M.; Blocki, Anna M.; Ker, Elmer D. F.; Tuan, Rocky S.] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Peoples R China; [Ho, Kevin K. W.; Yung, Patrick S. H.] Chinese Univ Hong Kong, Fac Med, Dept Orthopaed & Traumatol, Hong Kong, Peoples R China; [Rothrauff, Benjamin B.; Tuan, Rocky S.] Univ Pittsburgh, Ctr Cellular & Mol Engn, Sch Med, Pittsburgh, PA USA; [Tuan, Rocky S.] Univ Pittsburgh, Sch Med, Dept Orthopaed Surg, Pittsburgh, PA 15261 USA; [Tuan, Rocky S.] Univ Pittsburgh, Swanson Sch Engn, Dept Bioengn, Pittsburgh, PA USA	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Tuan, RS (corresponding author), Chinese Univ Hong Kong, Inst Tissue Engn & Regenerat Med, Shatin, Hong Kong, Peoples R China.	tuanr@cuhk.edu.hk	Ker, Dai Fei Elmer/R-5959-2018; Blocki, Anna/R-7938-2018; Ho, Kevin Ki Wai/J-7703-2018; Yung, Patrick Shu-Hang/J-9054-2018	Ker, Dai Fei Elmer/0000-0003-3434-8390; Blocki, Anna/0000-0002-9878-3781; Ho, Kevin Ki Wai/0000-0001-8647-8475; Yung, Patrick Shu-Hang/0000-0002-7214-5503; Tang, Thomas/0000-0001-5328-245X	Chinese University of Hong Kong; Chinese University of Hong Kong [2018.092]; Innovation and Technology Commission Hong Kong (Innovation and Technology Commission of Hong Kong Special Administrative Government) [ITS/333/18]	Chinese University of Hong Kong(Chinese University of Hong Kong); Chinese University of Hong Kong(Chinese University of Hong Kong); Innovation and Technology Commission Hong Kong (Innovation and Technology Commission of Hong Kong Special Administrative Government)	The Chinese University of Hong Kong, Grant/Award Number: Starup grant; The Chinese University of Hong Kong, Grant/Award Number: Direct grant 2018.092; Innovation and Technology Commission Hong Kong (Innovation and Technology Commission of Hong Kong Special Administrative Government), Grant/Award Number: ITS/333/18	Banos Charles C., 2008, Birth Defects Research, V84, P228, DOI 10.1002/bdrc.20130; Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; Bean A. C., 2015, BIOMED MATER, V10, P1, DOI DOI 10.1088/1748-6041/10/1/015018; Bi YM, 2007, NAT MED, V13, P1219, DOI 10.1038/nm1630; Boraschi-Diaz I, 2017, FRONT PHYS-LAUSANNE, V5, DOI 10.3389/fphy.2017.00012; Brown JP, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0043-z; Chiquet-Ehrismann R, 2004, INT J BIOCHEM CELL B, V36, P1085, DOI 10.1016/j.biocel.2004.01.007; Daley WP, 2008, J CELL SCI, V121, P255, DOI 10.1242/jcs.006064; Docheva D, 2005, MOL CELL BIOL, V25, P699, DOI 10.1128/MCB.25.2.699-705.2005; Dunkman AA, 2014, ANN BIOMED ENG, V42, P619, DOI 10.1007/s10439-013-0915-2; Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820; Gabler C, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/6432742; Goncalves AI, 2018, J TISSUE ENG REGEN M, V12, P762, DOI 10.1002/term.2495; Halder SK, 2005, NEOPLASIA, V7, P509, DOI 10.1593/neo.04640; Handorf AM, 2015, ORGANOGENESIS, V11, P1, DOI 10.1080/15476278.2015.1019687; Harburger DS, 2009, J CELL SCI, V122, P159, DOI 10.1242/jcs.018093; Hayashida T, 2007, J CELL SCI, V120, P4230, DOI 10.1242/jcs.03492; Hochwald SN, 2009, CELL CYCLE, V8, P2435, DOI 10.4161/cc.8.15.9145; Hodivala-Dilke KM, 1998, J CELL BIOL, V142, P1357, DOI 10.1083/jcb.142.5.1357; Humphrey JD, 2014, NAT REV MOL CELL BIO, V15, P802, DOI 10.1038/nrm3896; Janson IA, 2015, J BIOMED MATER RES A, V103, P1246, DOI 10.1002/jbm.a.35254; Ker DFE, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-1027-6; Kim SH, 2011, J ENDOCRINOL, V209, P139, DOI 10.1530/JOE-10-0377; Kuo CK, 2008, TISSUE ENG PT A, V14, P1615, DOI 10.1089/ten.tea.2006.0415; Kuo CK, 2008, DEV DYNAM, V237, P1477, DOI 10.1002/dvdy.21547; Lin H, 2012, BIOMATERIALS, V33, P4480, DOI 10.1016/j.biomaterials.2012.03.012; Lin TW, 2004, J BIOMECH, V37, P865, DOI 10.1016/j.jbiomech.2003.11.005; LIU SH, 1995, CLIN ORTHOP RELAT R, P265; Longo UG, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/517165; Maeda T, 2011, CURR BIOL, V21, P933, DOI 10.1016/j.cub.2011.04.007; Margadant C, 2010, EMBO REP, V11, P97, DOI 10.1038/embor.2009.276; Martin-Bermudo MD, 2000, DEVELOPMENT, V127, P2607; Marturano JE, 2016, J BIOMECH, V49, P3281, DOI 10.1016/j.jbiomech.2016.08.011; Marturano JE, 2013, P NATL ACAD SCI USA, V110, P6370, DOI 10.1073/pnas.1300135110; Mather RC, 2013, J BONE JOINT SURG AM, V95A, P1993, DOI 10.2106/JBJS.L.01495; MCDONALD JA, 1982, J CELL BIOL, V92, P485, DOI 10.1083/jcb.92.2.485; Molloy T, 2003, SPORTS MED, V33, P381, DOI 10.2165/00007256-200333050-00004; Mueller MB, 2010, CELLS TISSUES ORGANS, V192, P158, DOI 10.1159/000313399; Munger JS, 2011, COLD SPRING HARB PER, V3, P1; Nguyen PK, BIOMATERIALS SCI INT; Omae H, 2009, J ORTHOP RES, V27, P937, DOI 10.1002/jor.20823; Pan XS, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0325; Popov C, 2015, BMC MOL BIOL, V16, DOI 10.1186/s12867-015-0036-6; Pryce BA, 2009, DEVELOPMENT, V136, P1351, DOI 10.1242/dev.027342; Ratcliffe A, 2015, ANN BIOMED ENG, V43, P819, DOI 10.1007/s10439-015-1263-1; Riley GP, 1996, AM J PATHOL, V149, P933; Robinson KA, 2017, MATRIX BIOL, V64, P81, DOI 10.1016/j.matbio.2017.08.004; Rothrauff BB, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0580-8; Schiele NR, 2013, CURR OPIN BIOTECH, V24, P834, DOI 10.1016/j.copbio.2013.07.003; SCHRECK PJ, 1995, J ORTHOP RES, V13, P174, DOI 10.1002/jor.1100130205; Schweitzer R, 2001, DEVELOPMENT, V128, P3855; Seif-Naraghi SB, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005503; Sharma RI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031504; Shen Francis H, 2006, Spine J, V6, P615, DOI 10.1016/j.spinee.2006.03.006; Shukunami C, 2006, DEV BIOL, V298, P234, DOI 10.1016/j.ydbio.2006.06.036; Sottile J, 2007, AM J PHYSIOL-CELL PH, V293, pC1934, DOI 10.1152/ajpcell.00130.2007; Thorpe CT, 2013, INT J EXP PATHOL, V94, P248, DOI 10.1111/iep.12027; Wang DH, 1999, J BIOL CHEM, V274, P12840, DOI 10.1074/jbc.274.18.12840; WILLIAMS IF, 1984, CONNECT TISSUE RES, V12, P211, DOI 10.3109/03008208409013684; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; Xue JX, 2012, BIOMATERIALS, V33, P5832, DOI 10.1016/j.biomaterials.2012.04.054; Yang G, 2017, TISSUE ENG PT A, V23, P166, DOI [10.1089/ten.tea.2015.0498, 10.1089/ten.TEA.2015.0498]; Yang G, 2013, BIOMATERIALS, V34, P9295, DOI 10.1016/j.biomaterials.2013.08.054; Yeo GC, 2019, P NATL ACAD SCI USA, V116, P2042, DOI 10.1073/pnas.1812951116; Yin Z, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600874; Zeng Q, 2007, BONE, V40, P374, DOI 10.1016/j.bone.2006.09.022; Zhang GY, 2006, J CELL BIOCHEM, V98, P1436, DOI 10.1002/jcb.20776; Zhang YY, 2009, BIOMATERIALS, V30, P4021, DOI 10.1016/j.biomaterials.2009.04.005	68	18	18	0	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8172	8186		10.1096/fj.201902377RR	http://dx.doi.org/10.1096/fj.201902377RR		APR 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32301551				2022-12-28	WOS:000526644300001
J	Liu, G; Baird, AW; Parsons, MJ; Fan, K; Skerrett-Byrne, DA; Nair, PM; Makanyengo, S; Chen, JB; Neal, R; Goggins, BJ; Tay, H; Mathe, A; Soh, WS; Minahan, K; Hansbro, PM; Nixon, B; McCaughan, GW; Holtmann, G; Colgan, SP; Keely, S				Liu, Gang; Baird, Alan W.; Parsons, Marie J.; Fan, Kening; Skerrett-Byrne, David A.; Nair, Prema M.; Makanyengo, Samwel; Chen, Jinbiao; Neal, Rachel; Goggins, Bridie J.; Tay, Hock; Mathe, Andrea; Soh, Wai S.; Minahan, Kyra; Hansbro, Phil M.; Nixon, Brett; McCaughan, Geoffrey W.; Holtmann, Gerald; Colgan, Sean P.; Keely, Simon			Platelet activating factor receptor acts to limit colitis-induced liver inflammation	FASEB JOURNAL			English	Article						extraintestinal manifestations in liver; inflammatory bowel disease; PAFR	SCLEROSING CHOLANGITIS; INNATE IMMUNITY; DOWN-REGULATION; BOWEL-DISEASE; MOUSE MODEL; MUCOSAL; INJURY; MICE; PAF; PATHOGENESIS	Liver inflammation is a common extraintestinal manifestation in inflammatory bowel disease (IBD), yet, the mechanisms driving gut-liver axis inflammation remain poorly understood. IBD leads to a breakdown in the integrity of the intestinal barrier causing an increase in portal and systemic gut-derived antigens, which challenge the liver. Here, we examined the role of platelet activating factor receptor (PAFR) in colitis-associated liver damage using dextran sulfate sodium (DSS) and anti-CD40-induced colitis models. Both DSS and anti-CD40 models exhibited liver inflammation associated with colitis. Colitis reduced global PAFR protein expression in mouse livers causing an exclusive re-localization of PAFR to the portal triad. The global decrease in liver PAFR was associated with increased sirtuin 1 while relocalized PAFR expression was limited to Kupffer cells (KCs) and co-localized with toll-like receptor 4. DSS activated the NLRP3-inflammasome and increased interleukin (IL)-1 beta in the liver. Antagonism of PAFR amplified the inflammasome response by increasing NLRP3, caspase-1, and IL-1 beta protein levels in the liver. LPS also increased NLRP3 response in human hepatocytes, however, overexpression of PAFR restored the levels of NLPR3 and caspase-1 proteins. Interestingly, KCs depletion also increased IL-1 beta protein in mouse liver after DSS challenge. These data suggest a protective role for PAFR-expressing KCs during colitis and that regulation of PAFR is important for gut-liver axis homeostasis.	[Liu, Gang; Parsons, Marie J.; Fan, Kening; Nair, Prema M.; Makanyengo, Samwel; Neal, Rachel; Goggins, Bridie J.; Mathe, Andrea; Soh, Wai S.; Minahan, Kyra; Keely, Simon] Univ Newcastle, Prior Res Ctr Digest Hlth & Neurogastroenterol, Newcastle, NSW, Australia; [Liu, Gang; Parsons, Marie J.; Fan, Kening; Skerrett-Byrne, David A.; Nair, Prema M.; Makanyengo, Samwel; Neal, Rachel; Goggins, Bridie J.; Tay, Hock; Mathe, Andrea; Soh, Wai S.; Minahan, Kyra; Nixon, Brett; Keely, Simon] Hunter Med Res Inst, Level 3,Lot 1, New Lambton Hts, NSW 2305, Australia; [Liu, Gang; Parsons, Marie J.; Fan, Kening; Nair, Prema M.; Makanyengo, Samwel; Neal, Rachel; Goggins, Bridie J.; Tay, Hock; Mathe, Andrea; Soh, Wai S.; Minahan, Kyra; Keely, Simon] Univ Newcastle, Fac Hlth & Med, Sch Biomed Sci & Pharm, Callaghan, NSW, Australia; [Liu, Gang; Hansbro, Phil M.] Univ Technol Sydney, Fac Sci, Sch Life Sci, Ultimo, NSW, Australia; [Liu, Gang; Hansbro, Phil M.] Centenary Inst, Ctr Inflammat, Camperdown, NSW, Australia; [Baird, Alan W.] Univ Coll Dublin, UCD Sch Vet Med, Dublin, Ireland; [Skerrett-Byrne, David A.; Nixon, Brett] Univ Newcastle, Prior Res Ctr Reprod Sci, Sch Environm & Life Sci, Callaghan, NSW, Australia; [Chen, Jinbiao; McCaughan, Geoffrey W.] Centenary Res Inst, Liver Injury & Canc Program, Camperdown, NSW, Australia; [Chen, Jinbiao; McCaughan, Geoffrey W.] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia; [Tay, Hock] Univ Newcastle, Prior Res Ctr Hlth Lungs, Newcastle, NSW, Australia; [Holtmann, Gerald] Princess Alexandra Hosp, Dept Gastroenterol & Hepatol, Woolloongabba, Qld, Australia; [Holtmann, Gerald] Univ Queensland, Fac Med, Woolloongabba, Qld, Australia; [Colgan, Sean P.] Univ Colorado, Anschutz Med Campus, Aurora, CO USA	University of Newcastle; Hunter Medical Research Institute; University of Newcastle; University of Newcastle; University of Technology Sydney; University of Sydney; Centenary Institute; University College Dublin; University of Newcastle; University of Sydney; Centenary Institute; University of Sydney; University of Newcastle; University of Queensland; University of Colorado System; University of Colorado Anschutz Medical Campus	Keely, S (corresponding author), Hunter Med Res Inst, Level 3,Lot 1, New Lambton Hts, NSW 2305, Australia.	Simon.Keely@newcastle.edu.au	Liu, Gang/AAU-3119-2020; Keely, Simon/AAV-9973-2020; Chen, Jinbiao/N-9905-2019; Hansbro, Phil/G-7486-2013; Skerrett-Byrne, David/ABB-8700-2021; Holtmann, Gerald/I-5341-2014	Liu, Gang/0000-0002-0489-2638; Keely, Simon/0000-0002-1248-9590; Chen, Jinbiao/0000-0003-0339-5880; Hansbro, Phil/0000-0002-4741-3035; Skerrett-Byrne, David/0000-0002-1804-1826; Soh, Wai Sinn/0000-0002-8361-0298; MCCAUGHAN, GEOFFREY/0000-0002-1483-1636; Holtmann, Gerald/0000-0002-0206-2358; Parsons, Marie/0000-0002-4046-2491	Cancer Institute NSW (Cancer Institute New South Wales); Department of Health \ National Health and Medical Research Council (NHMRC) [APP1128487]; Hunter Medical Research Institute (HMRI)	Cancer Institute NSW (Cancer Institute New South Wales); Department of Health \ National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Hunter Medical Research Institute (HMRI)	Cancer Institute NSW (Cancer Institute New South Wales); Department of Health vertical bar National Health and Medical Research Council (NHMRC), Grant/Award Number: APP1128487; Hunter Medical Research Institute (HMRI)	Ananthakrishnan AN, 2015, NAT REV GASTRO HEPAT, V12, P205, DOI 10.1038/nrgastro.2015.34; Avenaud P, 2003, INFECT IMMUN, V71, P3667, DOI 10.1128/IAI.71.6.3667-3672.2003; Beattie L, 2016, J HEPATOL, V65, P758, DOI 10.1016/j.jhep.2016.05.037; Birkl D, 2019, MUCOSAL IMMUNOL, V12, P909, DOI 10.1038/s41385-019-0150-8; Blokker BA, 2019, HEPATOLOGY, V69, P699, DOI 10.1002/hep.30275; DAHN MS, 1990, ARCH SURG-CHICAGO, V125, P441; de Oliveira MC, 2015, J NUTR BIOCHEM, V26, P978, DOI 10.1016/j.jnutbio.2015.04.004; De Robertis Mariangela, 2011, J Carcinog, V10, P9, DOI 10.4103/1477-3163.78279; Ebert EC, 2006, MAYO CLIN PROC, V81, P1232, DOI 10.4065/81.9.1232; El Kasmi KC, 2012, HEPATOLOGY, V55, P1518, DOI 10.1002/hep.25500; Fernandes ES, 2005, BRIT J PHARMACOL, V146, P209, DOI 10.1038/sj.bjp.0706327; Fickert P, 2004, GASTROENTEROLOGY, V127, P261, DOI 10.1053/j.gastro.2004.04.009; Fickert P, 2014, J HEPATOL, V60, P1290, DOI 10.1016/j.jhep.2014.02.006; Fillon S, 2006, J IMMUNOL, V177, P6182, DOI 10.4049/jimmunol.177.9.6182; Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893; Hernandez-Chirlaque C, 2016, J CROHNS COLITIS, V10, P1324, DOI 10.1093/ecco-jcc/jjw096; Karidis NP, 2006, WORLD J GASTROENTERO, V12, P3695, DOI 10.3748/wjg.v12.i23.3695; Keely S, 2014, MUCOSAL IMMUNOL, V7, P114, DOI 10.1038/mi.2013.29; Keely S, 2012, MUCOSAL IMMUNOL, V5, P7, DOI 10.1038/mi.2011.55; Keely S, 2010, MOL BIOL CELL, V21, P538, DOI 10.1091/mbc.E09-07-0573; Kim YH, 2015, VASC PHARMACOL, V72, P35, DOI 10.1016/j.vph.2015.04.015; Kim YH, 2016, PLATELETS, V27, P735, DOI 10.1080/09537104.2016.1190005; Kimura K, 2006, AM J PATHOL, V168, P786, DOI 10.2353/ajpath.2006.050314; Kitajima S, 1999, J VET MED SCI, V61, P67, DOI 10.1292/jvms.61.67; Knapp S, 2008, J IMMUNOL, V180, P3478, DOI 10.4049/jimmunol.180.5.3478; Kominsky DJ, 2011, J IMMUNOL, V186, P6505, DOI 10.4049/jimmunol.1002805; Levine Jonathan S, 2011, Gastroenterol Hepatol (N Y), V7, P235; Liu G, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.124529; Liu G, 2019, MUCOSAL IMMUNOL, V12, P862, DOI 10.1038/s41385-019-0163-3; Liu G, 2017, J PATHOL, V243, P510, DOI 10.1002/path.4979; Liu G, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86380; Loftus EV, 2005, GUT, V54, P91, DOI 10.1136/gut.2004.046615; Marks E, 2017, MUCOSAL IMMUNOL, V10, P1224, DOI 10.1038/mi.2016.135; Marks E, 2015, INFLAMM BOWEL DIS, V21, P267, DOI 10.1097/MIB.0000000000000277; Maroni L, 2017, AM J PATHOL, V187, P366, DOI 10.1016/j.ajpath.2016.10.010; Mateer SW, 2018, AM J PATHOL, V188, P1625, DOI 10.1016/j.ajpath.2018.03.016; MEAD JR, 1991, J INFECT DIS, V163, P1297, DOI 10.1093/infdis/163.6.1297; Nakamoto N, 2019, NAT MICROBIOL, V4, P492, DOI 10.1038/s41564-018-0333-1; Pollheimer MJ, 2011, BEST PRACT RES CL GA, V25, P727, DOI 10.1016/j.bpg.2011.10.009; Rojas-Feria M, 2013, WORLD J GASTROENTERO, V19, P7327, DOI 10.3748/wjg.v19.i42.7327; Sakaguchi T, 1999, HEPATOLOGY, V30, P959, DOI 10.1002/hep.510300414; Sewnath ME, 2004, AM J RESP CRIT CARE, V169, P413, DOI 10.1164/rccm.200303-311OC; Shah A, 2019, SEMIN LIVER DIS, V39, P432, DOI 10.1055/s-0039-1688501; Souza DG, 2009, P NATL ACAD SCI USA, V106, P14138, DOI 10.1073/pnas.0906467106; Sugatani J, 2014, FASEB J, V28, P440, DOI 10.1096/fj.13-233262; Tiegs G, 2010, J AUTOIMMUN, V34, P1, DOI 10.1016/j.jaut.2009.08.008; Traeger T, 2010, EUR J GASTROEN HEPAT, V22, P1039, DOI 10.1097/MEG.0b013e32833847db; Tripathi A, 2018, NAT REV GASTRO HEPAT, V15, P397, DOI 10.1038/s41575-018-0011-z; Uhlig HH, 2006, IMMUNITY, V25, P309, DOI 10.1016/j.immuni.2006.05.017; Viennois Emilie, 2013, BMC Res Notes, V6, P360, DOI 10.1186/1756-0500-6-360; Vinholt PJ, 2018, PLATELETS, V29, P520, DOI 10.1080/09537104.2017.1349308; Yang Y, 2004, GUT, V53, P877, DOI 10.1136/gut.2003.024893	52	7	7	3	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					7718	7732		10.1096/fj.201901779R	http://dx.doi.org/10.1096/fj.201901779R		APR 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32293760				2022-12-28	WOS:000526103000001
J	Eskilsson, A; Shionoya, K; Enerback, S; Engblom, D; Blomqvist, A				Eskilsson, Anna; Shionoya, Kiseko; Enerback, Sven; Engblom, David; Blomqvist, Anders			The generation of immune-induced fever and emotional stress-induced hyperthermia in mice does not involve brown adipose tissue thermogenesis	FASEB JOURNAL			English	Article						lipopolysaccharide; peroxisome proliferator-activated receptor-gamma coactivator-1 alpha; uncoupling protein-1; uncoupling protein-3; vasoconstriction	SKELETAL-MUSCLE; NONSHIVERING THERMOGENESIS; THERMOREGULATORY RESPONSES; UNCOUPLING PROTEINS; OXYGEN-CONSUMPTION; FEBRILE RESPONSES; BODY-TEMPERATURE; LIPOPOLYSACCHARIDE; RECEPTOR; ENDOTOXIN	We examined the role of brown adipose tissue (BAT) for fever and emotional stress-induced hyperthermia. Wild-type and uncoupling protein-1 (UCP-1) knockout mice were injected with lipopolysaccharide intraperitoneally or intravenously, or subjected to cage exchange, and body temperature monitored by telemetry. Both genotypes showed similar febrile responses to immune challenge and both displayed hyperthermia to emotional stress. Neither procedure resulted in the activation of BAT, such as the induction of UCP-1 or peroxisome proliferator-activated receptor-gamma coactivator-1 alpha (PGC-1 alpha) mRNA, or reduced BAT weight and triglyceride content. In contrast, in mice injected with a beta (3) agonist, UCP-1 and PGC-1 alpha were strongly induced, and BAT weight and triglyceride content reduced. Both lipopolysaccharide and the beta (3) agonist, and emotional stress, induced UCP-3 mRNA in skeletal muscle. A beta (3) antagonist did not attenuate lipopolysaccharide-induced fever, but augmented body temperature decrease and inhibited BAT activation when mice were exposed to cold. An alpha (1)/alpha (2b) antagonist or a 5HT(1A) agonist, which inhibit vasoconstriction, abolished lipopolysaccharide-induced fever, but had no effect on emotional stress-induced hyperthermia. These findings demonstrate that in mice, UCP-1-mediated BAT thermogenesis does not take part in inflammation-induced fever, which is dependent on peripheral vasoconstriction, nor in stress-induced hyperthermia. However, both phenomena may involve UCP-3-mediated muscle thermogenesis.	[Eskilsson, Anna; Shionoya, Kiseko; Engblom, David; Blomqvist, Anders] Linkoping Univ, Dept Biomed & Clin Sci, Linkoping, Sweden; [Enerback, Sven] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Med Biochem & Cell Biol, Gothenburg, Sweden	Linkoping University; University of Gothenburg	Blomqvist, A (corresponding author), Linkoping Univ, Div Neurobiol, Dept Biomed & Clin Sci, Linkoping, Sweden.	anders.blomqvist@liu.se						ARCHIE JP, 1977, ANN SURG, V186, P171, DOI 10.1097/00000658-197708000-00008; Bencsics A, 1995, BRAIN RES, V705, P302, DOI 10.1016/0006-8993(95)01154-4; Betz MJ, 2015, DIABETES, V64, P2352, DOI 10.2337/db15-0146; Bexis S, 2009, BRIT J PHARMACOL, V158, P259, DOI 10.1111/j.1476-5381.2009.00186.x; Blessing WW, 2004, NEUROSCIENCE, V123, P1, DOI 10.1016/j.neuroscience.2003.09.021; Blomqvist A, 2018, NEUROSCIENTIST, V24, P381, DOI 10.1177/1073858418760481; Boltana S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1381; Boss O, 1999, BIOCHEM BIOPH RES CO, V261, P870, DOI 10.1006/bbrc.1999.1145; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; CLEMMER TP, 1992, CRIT CARE MED, V20, P1395, DOI 10.1097/00003246-199210000-00006; Cypess AM, 2015, CELL METAB, V21, P33, DOI 10.1016/j.cmet.2014.12.009; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Dittner C, 2019, MOL METAB, V25, P20, DOI 10.1016/j.molmet.2019.05.005; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Enerback S, 2010, CELL METAB, V11, P248, DOI 10.1016/j.cmet.2010.03.008; Engstrom L, 2012, ENDOCRINOLOGY, V153, P4849, DOI 10.1210/en.2012-1375; Eskilsson A, 2014, J NEUROSCI, V34, P15957, DOI 10.1523/JNEUROSCI.3520-14.2014; Fischer AW, 2019, MOL METAB, V26, P1, DOI 10.1016/j.molmet.2019.05.006; FOSTER DO, 1982, CAN J PHYSIOL PHARM, V60, P747, DOI 10.1139/y82-104; Frisard MI, 2015, METABOLISM, V64, P416, DOI 10.1016/j.metabol.2014.11.007; Golozoubova V, 2001, FASEB J, V15, P2048, DOI 10.1096/fj.00-0536fje; Golozoubova V, 2006, AM J PHYSIOL-ENDOC M, V291, pE350, DOI 10.1152/ajpendo.00387.2005; Harada N, 2007, METABOLISM, V56, P517, DOI 10.1016/j.metabol.2006.11.011; HESSE DG, 1988, SURG GYNECOL OBSTET, V166, P147; JENNINGS G, 1987, BIOSCIENCE REP, V7, P517, DOI 10.1007/BF01116509; Joyner MJ, 2015, PHYSIOL REV, V95, P549, DOI 10.1152/physrev.00035.2013; Kataoka N, 2014, CELL METAB, V20, P346, DOI 10.1016/j.cmet.2014.05.018; KOZAK W, 1994, AM J PHYSIOL, V266, pR125, DOI 10.1152/ajpregu.1994.266.1.R125; LANGER SZ, 1984, J CARDIOVASC PHARM, V6, pS547, DOI 10.1097/00005344-198406004-00001; Liang HY, 2006, ADV PHYSIOL EDUC, V30, P145, DOI 10.1152/advan.00052.2006; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Liu E, 2012, AM J PHYSIOL-REG I, V302, pR1372, DOI 10.1152/ajpregu.00023.2012; Lkhagvasuren B, 2011, EUR J NEUROSCI, V34, P1442, DOI 10.1111/j.1460-9568.2011.07863.x; Lowell BB, 1997, ANNU REV MED, V48, P307; Machado NLS, 2018, CURR BIOL, V28, P2291, DOI 10.1016/j.cub.2018.05.064; Marks A, 2009, AM J PHYSIOL-REG I, V296, pR1239, DOI 10.1152/ajpregu.90723.2008; Meyer CW, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00520; Miyamoto T, 2017, BIOL PHARM BULL, V40, P11, DOI 10.1248/bpb.b16-00343; Morrison SF, 2019, ANNU REV PHYSIOL, V81, P285, DOI 10.1146/annurev-physiol-020518-114546; Morrison SF, 2018, HAND CLINIC, V156, P281, DOI 10.1016/B978-0-444-63912-7.00017-5; Morrison SF, 2016, AUTON NEUROSCI-BASIC, V196, P14, DOI 10.1016/j.autneu.2016.02.010; Nagase I, 1996, J CLIN INVEST, V97, P2898, DOI 10.1172/JCI118748; Nakamura K, 2011, AM J PHYSIOL-REG I, V301, pR1207, DOI 10.1152/ajpregu.00109.2011; Nakamura K, 2011, J PHYSIOL-LONDON, V589, P3641, DOI 10.1113/jphysiol.2011.210047; Nakamura Y, 2005, EUR J NEUROSCI, V22, P3137, DOI 10.1111/j.1460-9568.2005.04515.x; Nakamura Y, 2001, J VET MED SCI, V63, P309, DOI 10.1292/jvms.63.309; NAVARATNAM RLN, 1990, J TRAUMA, V30, P1104; Nedergaard J, 2018, HAND CLINIC, V156, P137, DOI 10.1016/B978-0-444-63912-7.00009-6; NICHOLLS DG, 1984, PHYSIOL REV, V64, P1, DOI 10.1152/physrev.1984.64.1.1; Nisoli E, 1996, MOL PHARMACOL, V49, P7; Oka T, 2003, J PHYSIOL-LONDON, V551, P945, DOI 10.1113/jphysiol.2003.048140; Okamatsu-Ogura Y, 2007, AM J PHYSIOL-ENDOC M, V292, pE1135, DOI 10.1152/ajpendo.00425.2006; Ootsuka Y, 2011, AM J PHYSIOL-REG I, V301, pR987, DOI 10.1152/ajpregu.00085.2011; Ouellet V, 2012, J CLIN INVEST, V122, P545, DOI 10.1172/JCI60433; Pohl EE, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00470; Rathner JA, 2008, AM J PHYSIOL-REG I, V295, pR343, DOI 10.1152/ajpregu.00115.2008; Riley CL, 2016, J PHYSIOL-LONDON, V594, P7455, DOI 10.1113/JP272971; Romanovsky AA, 1996, AM J PHYSIOL-REG I, V270, pR693, DOI 10.1152/ajpregu.1996.270.4.R693; Romanovsky AA, 1998, AM J PHYSIOL-REG I, V275, pR332, DOI 10.1152/ajpregu.1998.275.1.R332; Rudaya AY, 2005, AM J PHYSIOL-REG I, V289, pR1244, DOI 10.1152/ajpregu.00370.2005; Saha S, 2005, AM J PHYSIOL-REG I, V288, pR1100, DOI 10.1152/ajpregu.00872.2004; Sessler DI, 2016, LANCET, V387, P2655, DOI 10.1016/S0140-6736(15)00981-2; Steiner AA, 2005, AM J PHYSIOL-REG I, V289, pR348, DOI 10.1152/ajpregu.00223.2005; Steiner AA, 2004, FASEB J, V18, P1949, DOI 10.1096/fj.04-2295fje; Sun XY, 2003, AM J PHYSIOL-ENDOC M, V285, pE512, DOI 10.1152/ajpendo.00446.2002; SZEKELY M, 1973, ACTA PHYSIOL HUNG, V43, P85; SZEKELY M, 1979, ACTA PHYSIOL HUNG, V53, P265; Szentirmai E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197409; SZREDER Z, 1993, GEN PHARMACOL, V24, P455, DOI 10.1016/0306-3623(93)90332-R; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wanner SP, 2017, J NEUROSCI, V37, P6956, DOI 10.1523/JNEUROSCI.0100-17.2017; Yu XX, 2000, AM J PHYSIOL-ENDOC M, V279, pE433, DOI 10.1152/ajpendo.2000.279.2.E433	73	7	7	3	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5863	5876		10.1096/fj.201902945R	http://dx.doi.org/10.1096/fj.201902945R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32144818	hybrid, Green Published			2022-12-28	WOS:000530242100070
J	Korhonen, E; Piippo, N; Hytti, M; Hyttinen, JMT; Kaarniranta, K; Kauppinen, A				Korhonen, Eveliina; Piippo, Niina; Hytti, Maria; Hyttinen, Juha M. T.; Kaarniranta, Kai; Kauppinen, Anu			Only IL-1 beta release is inflammasome-dependent upon ultraviolet B irradiation although IL-18 is also secreted	FASEB JOURNAL			English	Article						DNA damage; NLRP3; IL-1 beta; IL-18; retinal pigment epithelium	PIGMENT EPITHELIAL-CELLS; UVB-INDUCED ACTIVATION; NUCLEAR-DNA DAMAGE; NLRP3 INFLAMMASOME; MACULAR DEGENERATION; OXIDATIVE STRESS; INTERLEUKIN-18; RADIATION; MITOCHONDRIAL; EXPRESSION	DNA damage accumulates in aged postmitotic retinal pigment epithelium (RPE) cells, a phenomenon associated with the development of age-related macular degeneration. In this study, we have experimentally induced DNA damage by ultraviolet B (UVB) irradiation in interleukin-1 alpha (IL-1 alpha)-primed ARPE-19 cells and examined inflammasome-mediated signaling. To reveal the mechanisms of inflammasome activation, cells were additionally exposed to high levels of extracellular potassium chloride, n-acetyl-cysteine, or mitochondria-targeted antioxidant MitoTEMPO, prior to UVB irradiation. Levels of interleukin-18 (IL-18) and IL-1 beta mRNAs were detected with qRT-PCR and secreted amounts of IL-1 beta, IL-18, and caspase-1 were measured with ELISA. The role of nucleotide-binding domain and leucine-rich repeat pyrin containing protein 3 (NLRP3) in UVB-induced inflammasome activation was verified by using the NLRP3-specific siRNA. Reactive oxygen species (ROS) levels were measured immediately after UVB exposure using the cell-permeant 2 ',7 '-dichlorodihydrofluorescein diacetate (H(2)DCFDA) indicator, the levels of cyclobutane pyrimidine dimers were assayed by cell-based ELISA, and the extracellular levels of adenosine triphosphate (ATP) determined using a commercial bioluminescence assay. We found that pro-IL-18 was constitutively expressed by ARPE-19 cells, whereas the expression of pro-IL-1 beta was inducible by IL-1 alpha priming. UVB induced the release of mature IL-18 and IL-1 beta but NLRP3 contributed only to the secretion of IL-1 beta. At the mechanistic level, the release of IL-1 beta was regulated by K+ efflux, whereas the secretion of IL-18 was dependent on ROS production. As well as K+ efflux, the cells released ATP following UVB exposure. Collectively, our data suggest that UVB clearly stimulates the secretion of mature IL-18 as a result of ROS induction, and this response is associated with DNA damage. Moreover, in human RPE cells, K+ efflux mediates the UVB-activated NLRP3 inflammasome signaling, leading to the processing of IL-1 beta.	[Korhonen, Eveliina; Piippo, Niina; Hytti, Maria; Kauppinen, Anu] Univ Eastern Finland, Sch Pharm, Fac Hlth Sci, Kuopio, Finland; [Korhonen, Eveliina] Univ Helsinki, HUSLAB, Helsinki, Finland; [Korhonen, Eveliina] Helsinki Univ Hosp, Helsinki, Finland; [Hyttinen, Juha M. T.; Kaarniranta, Kai] Univ Eastern Finland, Inst Clin Med, Dept Ophthalmol, Kuopio, Finland; [Kaarniranta, Kai] Kuopio Univ Hosp, Dept Ophthalmol, Kuopio, Finland	University of Eastern Finland; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland	Korhonen, E; Kauppinen, A (corresponding author), Univ Eastern Finland, Sch Pharm, Fac Hlth Sci, Kuopio, Finland.	eveliina.korhonen@uef.fi; anu.kauppinen@uef.fi	Hytti, Maria/AAE-4016-2019	Hytti, Maria/0000-0003-2150-6847; Hyttinen, Juha/0000-0002-3414-4032; Korhonen, Eveliina/0000-0002-5360-7258	Paivikki ja Sakari Sohlbergin Saatio (Paivikki and Sakari Sohlberg Foundation); Finnish Cultural Foundation \ Pohjois-Savon Rahasto (North Savo Regional Fund); Emil Aaltosen Saatio (Emil Aaltonen Foundation); Academy of Finland (Suomen Akatemia) [AK297267, AK307341, KK5503743]; Sigrid Juseliuksen Saatio (Sigrid Juselius Stiftelse); University of Eastern Finland; Mary and Georg C. Ehrnrooth Foundation; Sokeain ystavat ry; Silma-ja Kudospankkisaatio	Paivikki ja Sakari Sohlbergin Saatio (Paivikki and Sakari Sohlberg Foundation); Finnish Cultural Foundation \ Pohjois-Savon Rahasto (North Savo Regional Fund)(Finnish Cultural Foundation); Emil Aaltosen Saatio (Emil Aaltonen Foundation); Academy of Finland (Suomen Akatemia)(Academy of Finland); Sigrid Juseliuksen Saatio (Sigrid Juselius Stiftelse); University of Eastern Finland; Mary and Georg C. Ehrnrooth Foundation; Sokeain ystavat ry; Silma-ja Kudospankkisaatio	Paivikki ja Sakari Sohlbergin Saatio (Paivikki and Sakari Sohlberg Foundation); Finnish Cultural Foundation vertical bar Pohjois-Savon Rahasto (North Savo Regional Fund); Emil Aaltosen Saatio (Emil Aaltonen Foundation); Academy of Finland (Suomen Akatemia), Grant/Award Number: AK297267,AK307341 and KK5503743; Sigrid Juseliuksen Saatio (Sigrid Juselius Stiftelse); University of Eastern Finland strategical support; Mary and Georg C. Ehrnrooth Foundation; Sokeain ystavat ry; Silma-ja Kudospankkisaatio	Amores-Iniesta J, 2017, CELL REP, V21, P3414, DOI 10.1016/j.celrep.2017.11.079; Banerjee S, 2008, J BIOL CHEM, V283, P31371, DOI 10.1074/jbc.M802814200; Bauernfeind F, 2011, J IMMUNOL, V187, P613, DOI 10.4049/jimmunol.1100613; Blasiak J, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/5293258; Blasiak J, 2013, INT J MOL SCI, V14, P2996, DOI 10.3390/ijms14022996; Boersma PM, 2017, EXP EYE RES, V154, P1, DOI 10.1016/j.exer.2016.11.003; Bossaller L, 2012, J IMMUNOL, V189, P5508, DOI 10.4049/jimmunol.1202121; Boucher D, 2018, J EXP MED, V215, P827, DOI 10.1084/jem.20172222; Brandstetter C, 2015, J MOL MED, V93, P905, DOI 10.1007/s00109-015-1275-1; Burbach GJ, 2001, CURR EYE RES, V23, P64, DOI 10.1076/ceyr.23.1.64.5425; Chalam KV, 2011, EYE CONTACT LENS, V37, P225, DOI 10.1097/ICL.0b013e31821fbd3e; Cho DH, 2002, BIOCHEM BIOPH RES CO, V298, P289, DOI 10.1016/S0006-291X(02)02433-6; Feldmeyer L, 2007, CURR BIOL, V17, P1140, DOI 10.1016/j.cub.2007.05.074; Gicquel T, 2014, CLIN EXP PHARMACOL P, V41, P279, DOI 10.1111/1440-1681.12214; Gurung P, 2015, AM J PATHOL, V185, P17, DOI 10.1016/j.ajpath.2014.08.025; Han XJ, 2019, AUTOPHAGY, V15, P1860, DOI 10.1080/15548627.2019.1596481; Hanamsagar R, 2011, J NEUROCHEM, V119, P736, DOI 10.1111/j.1471-4159.2011.07481.x; Hasegawa T, 2016, BIOCHEM BIOPH RES CO, V477, P329, DOI 10.1016/j.bbrc.2016.06.106; He Y, 2016, TRENDS BIOCHEM SCI, V41, P1012, DOI 10.1016/j.tibs.2016.09.002; Hyttinen JMT, 2017, AGEING RES REV, V36, P64, DOI 10.1016/j.arr.2017.03.006; Ising C, 2019, NATURE, V575, P669, DOI 10.1038/s41586-019-1769-z; Ivanov IV, 2018, J BIOPHOTONICS, V11, DOI 10.1002/jbio.201700377; Iyer SS, 2013, IMMUNITY, V39, P311, DOI 10.1016/j.immuni.2013.08.001; Jo EK, 2016, CELL MOL IMMUNOL, V13, P148, DOI 10.1038/cmi.2015.95; Kagan DB, 2012, CLIN OPHTHALMOL, V6, P1471, DOI 10.2147/OPTH.S35139; Karmakar M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10555; Kauppinen A, 2016, CELL MOL LIFE SCI, V73, P1765, DOI 10.1007/s00018-016-2147-8; Kauppinen A, 2012, IMMUNOL LETT, V147, P29, DOI 10.1016/j.imlet.2012.05.005; Kerur N, 2013, INVEST OPHTH VIS SCI, V54, P7395, DOI 10.1167/iovs.13-12500; Keyel PA, 2014, CYTOKINE, V69, P136, DOI 10.1016/j.cyto.2014.03.007; Kim Y, 2014, P NATL ACAD SCI USA, V111, P16082, DOI 10.1073/pnas.1403814111; Korhonen E, 2019, CYTOKINE, V116, P70, DOI 10.1016/j.cyto.2018.12.015; Laliberte RE, 1999, J BIOL CHEM, V274, P36944, DOI 10.1074/jbc.274.52.36944; Lee HM, 2013, DIABETES, V62, P194, DOI 10.2337/db12-0420; Liu L, 2014, AGEING RES REV, V15, P6, DOI 10.1016/j.arr.2013.12.007; Loukovaara S, 2017, ACTA OPHTHALMOL, V95, P803, DOI 10.1111/aos.13427; Meunier E, 2017, TRENDS IMMUNOL, V38, P744, DOI 10.1016/j.it.2017.04.005; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Novick D, 2013, SEMIN IMMUNOL, V25, P439, DOI 10.1016/j.smim.2013.10.014; Perluigi M, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-13; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Piippo N, 2018, CELL PHYSIOL BIOCHEM, V49, P359, DOI 10.1159/000492886; Piippo N, 2014, BBA-MOL CELL RES, V1843, P3038, DOI 10.1016/j.bbamcr.2014.09.015; Puren AJ, 1999, P NATL ACAD SCI USA, V96, P2256, DOI 10.1073/pnas.96.5.2256; Rastogi RP, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/592980; Ravanat JL, 2001, J PHOTOCH PHOTOBIO B, V63, P88, DOI 10.1016/S1011-1344(01)00206-8; Richa, 2015, TOP CURR CHEM, V356, P203, DOI 10.1007/128_2014_531; Schuch AP, 2017, FREE RADICAL BIO MED, V107, P110, DOI 10.1016/j.freeradbiomed.2017.01.029; Schwarz A, 2006, J IMMUNOL, V176, P2896, DOI 10.4049/jimmunol.176.5.2896; Shi GP, 2015, INVEST OPHTH VIS SCI, V56, P1658, DOI 10.1167/iovs.14-14557; Sollberger G, 2015, J INVEST DERMATOL, V135, P1395, DOI 10.1038/jid.2014.551; Song CJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171940; Tarallo V, 2012, CELL, V149, P847, DOI 10.1016/j.cell.2012.03.036; Tseng WA, 2013, INVEST OPHTH VIS SCI, V54, P110, DOI 10.1167/iovs.12-10655; Ubels JL, 2011, EXP EYE RES, V92, P425, DOI 10.1016/j.exer.2011.02.019; van de Veerdonk FL, 2010, P NATL ACAD SCI USA, V107, P3030, DOI 10.1073/pnas.0914795107; Velez-Montoya R, 2014, RETINA-J RET VIT DIS, V34, P423, DOI 10.1097/IAE.0000000000000036; Voet S, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201810248; Wang YJ, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010073	59	11	12	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6437	6448		10.1096/fj.201902355RR	http://dx.doi.org/10.1096/fj.201902355RR		MAR 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	32190930	hybrid, Green Published			2022-12-28	WOS:000521549400001
J	Escate, R; Mata, P; Cepeda, JM; Padro, T; Badimon, L				Escate, Rafael; Mata, Pedro; Cepeda, Jose Maria; Padro, Teresa; Badimon, Lina			miR-505-3p controls chemokine receptor up-regulation in macrophages: role in familial hypercholesterolemia	FASEB JOURNAL			English	Article						LDL cholesterol; microRNAs; innate immunity; inflammatory markers; age	MICRORNAS; ATHEROSCLEROSIS; INFLAMMATION; LDL; LIPOPROTEINS; CELLS; CHOLESTEROL; PROTEIN; ACTIVATION; MECHANISMS	Familial hypercholesterolemia (FH) conveys a high risk of premature atherosclerosis as a result of lifelong exposure to high LDL cholesterol levels that are not fully reduced by standard-of-care lipid-lowering treatment. Inflammatory mediators have played a role in the progression of atherosclerotic lesions. Here, we investigated whether innate immunity cells in patients with FH have a specific proinflammatory phenotype that is distinct from that of cells in normal participants. To this end, miR-505-3p-a microRNA related to chronic inflammation-and its target genes were investigated in monocyte-derived macrophages (MACs) of patients with FH(FH-MACs) and non-FH controls (co-MACs). On the basis of the profiler PCR array analysis of agomiR-505-3p-transfected MACs, we identified the chemokine receptors, CCR3, CCR4, and CXCR1, as genes that are regulated by miR-505-3p via the transcription factor, RUNX1. miR-505-3p was significantly down-regulated, whereas CCR3, CCR4, CXCR, and RUNX1 were increased in FH-MAC compared with co-MAC, with the increase being more evident in the proinflammatory M1-like FH-MAC. Chemokine receptor levels were unrelated to LDL plasma levels at entry, but correlated with age in patients with FH, not in controls. In summary, we demonstrate for first time to our knowledge that MACs from FH-MACs have an inflammatory phenotype that is characterized by the up-regulation of CCR3, CCR4, and CXCR1 under the control of miR-505-3p. These results suggest a chronic inflammatory condition in FH innate immunity cells that is not reverted by standard lipid-lowering treatment.	[Escate, Rafael; Padro, Teresa; Badimon, Lina] Hosp Santa Creu & Sant Pau, Catalan Inst Cardiovasc Sci ICCC, St Pau Biomed Res Inst IIB St Pau, Ctr Invest Biomed Red Enfermedades Cardiovasc CIB, Barcelona, Spain; [Mata, Pedro] Fdn Hipercolesterolemia Familiar, Madrid, Spain; [Cepeda, Jose Maria] Hosp Vega Baja, Dept Internal Med, Orihuela, Spain; [Badimon, Lina] Univ Autonoma Barcelona, Barcelona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERCV; Hospital of Santa Creu i Sant Pau; Autonomous University of Barcelona	Padro, T (corresponding author), Cardiovasc Sci Inst ICCC, Cardiovasc Res Ctr, St Antoni Maria Claret 167, Barcelona 08025, Spain.	tpadro@csic-iccc.org	Escate, Rafael/D-3271-2016; BADIMON, LINA/S-2950-2019; Badimon, Lina/O-4711-2014	Escate, Rafael/0000-0002-8448-7244; Badimon, Lina/0000-0002-9162-2459	Fundacion Jesus Serra; Fundacion de Investigacion Cardiovascular, Barcelona; Institute of Health Carlos III (ISCIII) [FIS PI16/01915, TerCel-RD/12/0019/0026]; Institute of Health Carlos III (ISCIII) [Centro de Investigacion Biomedica en Red de Enfermedades Cardiovasculares (CIBERCV)] [CB16/11/00411]; Spanish Ministry of Economy and Competitiveness [SAF2016-76819-R]; European Regional Development Fund (FEDER) "Una Manera de Hacer Europa"; Department of Economy and Knowledge of the Government of Catalonia [2014SGR1303]; Centres de Recerca de Catalunya (CERCA) Programme/Generalitat de Catalunya	Fundacion Jesus Serra; Fundacion de Investigacion Cardiovascular, Barcelona; Institute of Health Carlos III (ISCIII); Institute of Health Carlos III (ISCIII) [Centro de Investigacion Biomedica en Red de Enfermedades Cardiovasculares (CIBERCV)]; Spanish Ministry of Economy and Competitiveness(Spanish Government); European Regional Development Fund (FEDER) "Una Manera de Hacer Europa"; Department of Economy and Knowledge of the Government of Catalonia; Centres de Recerca de Catalunya (CERCA) Programme/Generalitat de Catalunya	The authors acknowledge Dr. Esther Pena for help in confocal microscopy analysis, and Montse Gomez-Pardo (both from Catalan Institute of Cardiovascular Sciences) for technical assistance during the study. The authors are indebted to the patients for their valuable contribution and willingness to participate. The authors also thank Fundacion Jesus Serra and Fundacion de Investigacion Cardiovascular, Barcelona, for their continuous support. This work was supported by the Institute of Health Carlos III (ISCIII) [FIS PI16/01915 (to T.P.); TerCel-RD/12/0019/0026 and Centro de Investigacion Biomedica en Red de Enfermedades Cardiovasculares (CIBERCV) CB16/11/00411 (to L.B.)], the Spanish Ministry of Economy and Competitiveness [SAF2016-76819-R (to L.B.)], the European Regional Development Fund (FEDER) "Una Manera de Hacer Europa," the Secretary of University and Research, Department of Economy and Knowledge of the Government of Catalonia (2014SGR1303), and Centres de Recerca de Catalunya (CERCA) Programme/Generalitat de Catalunya. The authors declare no conflicts of interest.	Alonso R, 2008, ATHEROSCLEROSIS, V200, P315, DOI 10.1016/j.atherosclerosis.2007.12.024; Andreou L, 2015, TRENDS MOL MED, V21, P307, DOI 10.1016/j.molmed.2015.02.003; Antonopoulos AS, 2012, CURR PHARM DESIGN, V18, P1519; Authors/Task Force Members:, 2016, Atherosclerosis, V253, P281, DOI 10.1016/j.atherosclerosis.2016.08.018; Badimon L, 2006, CURR MOL MED, V6, P439, DOI 10.2174/156652406778018725; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bekkering S, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0645-3; BROWN MS, 1974, P NATL ACAD SCI USA, V71, P788, DOI 10.1073/pnas.71.3.788; Buttari B, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/257543; CLARKSON SB, 1988, J EXP MED, V167, P408, DOI 10.1084/jem.167.2.408; El Messal M, 2006, CLIN CHIM ACTA, V366, P185, DOI 10.1016/j.cca.2005.09.027; Escate R, 2016, ATHEROSCLEROSIS, V246, P177, DOI 10.1016/j.atherosclerosis.2016.01.002; Escate R, 2017, J CELL MOL MED, V21, P487, DOI 10.1111/jcmm.12993; FRIEDEWA WT, 1972, CLIN CHEM, V18, P499, DOI [10.1093/clinchem/18.6.499, DOI 10.1093/clinchem/18.6.499]; Greaves DR, 2001, ARTERIOSCL THROM VAS, V21, P923, DOI 10.1161/01.ATV.21.6.923; GUYTON JR, 1991, J LIPID RES, V32, P953; Haley KJ, 2000, CIRCULATION, V102, P2185; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hartmann P, 2015, CELL MOL LIFE SCI, V72, P3253, DOI 10.1007/s00018-015-1925-z; Hasan D, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-222; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Holven KB, 2003, EUR HEART J, V24, P1756, DOI 10.1016/S0195-668X(03)00467-6; Kratz M, 2014, CELL METAB, V20, P614, DOI 10.1016/j.cmet.2014.08.010; Leonard DA, 2011, CORONARY ARTERY DIS, V22, P491, DOI 10.1097/MCA.0b013e32834b67e2; Ley K, 2011, ARTERIOSCL THROM VAS, V31, P1506, DOI 10.1161/ATVBAHA.110.221127; Li XF, 2014, CIRCULATION, V129, P1244, DOI 10.1161/CIRCULATIONAHA.113.006840; Liu G, 2013, ARTERIOSCL THROM VAS, V33, P170, DOI 10.1161/ATVBAHA.112.300068; Liu Y, 1997, ARTERIOSCL THROM VAS, V17, P317, DOI 10.1161/01.ATV.17.2.317; Llorente-Cortes V, 2002, ARTERIOSCL THROM VAS, V22, P387, DOI 10.1161/hq0302.105367; Llorente-Cortes V, 2000, ARTERIOSCL THROM VAS, V20, P1572, DOI 10.1161/01.ATV.20.6.1572; Mata N, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-94; Mozas Pilar, 2004, Hum Mutat, V24, P187, DOI 10.1002/humu.9264; Netea MG, 2011, CELL HOST MICROBE, V9, P355, DOI 10.1016/j.chom.2011.04.006; Ninomiya M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066086; Packard RRS, 2008, CLIN CHEM, V54, P24, DOI 10.1373/clinchem.2007.097360; Raghuwanshi SK, 2012, J IMMUNOL, V189, P2824, DOI 10.4049/jimmunol.1201114; Raisch J, 2013, WORLD J GASTROENTERO, V19, P2985, DOI 10.3748/wjg.v19.i20.2985; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2014, LANCET, V384, P607, DOI 10.1016/S0140-6736(14)61009-6; Rogacev KS, 2012, J AM COLL CARDIOL, V60, P1512, DOI 10.1016/j.jacc.2012.07.019; Rousselle A, 2013, J CLIN INVEST, V123, P1343, DOI 10.1172/JCI66580; Suades R, 2014, THROMB HAEMOSTASIS, V111, P111, DOI 10.1160/TH13-07-0612; van Wijk DF, 2014, J AM COLL CARDIOL, V64, P1418, DOI 10.1016/j.jacc.2014.01.088; Viola A, 2008, ANNU REV PHARMACOL, V48, P171, DOI 10.1146/annurev.pharmtox.48.121806.154841; Vogt A, 2015, APPL CLIN GENET, V8, P27, DOI 10.2147/TACG.S44315; Weber C, 2011, J CLIN INVEST, V121, P2898, DOI 10.1172/JCI44925; Wierzbicki Anthony S, 2008, BMJ, V337, pa1095, DOI 10.1136/bmj.a1095; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Wu F, 2011, INFLAMM BOWEL DIS, V17, P241, DOI 10.1002/ibd.21450; Yang Y, 2015, CELL PHYSIOL BIOCHEM, V36, P1371, DOI 10.1159/000430303; Zernecke A, 2012, THROMB HAEMOSTASIS, V107, P626, DOI 10.1160/TH11-08-0603	51	24	25	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					601	612		10.1096/fj.201700476RR	http://dx.doi.org/10.1096/fj.201700476RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	32172543				2022-12-28	WOS:000425146900007
